GO:0000002	GO	BP	mitochondrial genome maintenance	AKT3,DNA2,LIG3,LONP1,MEF2A,MGME1,MPV17,OPA1,PARP1,PRIMPOL,SLC25A33,SLC25A36,SLC25A4,TYMP	The maintenance of the structure and integrity of the mitochondrial genome; includes replication and segregation of the mitochondrial chromosome.
GO:0000012	GO	BP	single strand break repair	APLF,APTX,LIG4,SIRT1,TDP1,TNP1	The repair of single strand breaks in DNA. Repair of such breaks is mediated by the same enzyme systems as are used in base excision repair.
GO:0000014	GO	MF	single-stranded DNA endodeoxyribonuclease activity	DCLRE1C,ERCC1,MRE11A,RAD50,RBBP8,SETMAR	Catalysis of the hydrolysis of ester linkages within a single-stranded deoxyribonucleic acid molecule by creating internal breaks.
GO:0000018	GO	BP	regulation of DNA recombination	ALYREF,BLM,CHEK1,CLCF1,FBXO18,FIGNL1,IL10,IL4,IL7R,KDM1A,KPNA1,KPNA2,MRE11A,MSH2,MSH3,MSH6,PARPBP,PAXIP1,POLQ,PPP4C,PPP4R2,PRDM9,RAD50,RAD51,RAD51AP1,RPA2,RTEL1,SIRT6,SPIDR,SUPT6H,TERF2,TERF2IP,TGFB1,THOC1,TNFSF13,TNFSF4,ZRANB3	Any process that modulates the frequency, rate or extent of DNA recombination, a DNA metabolic process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents.
GO:0000022	GO	BP	mitotic spindle elongation	AURKB,AURKC,KIF23,KIF4A,KIF4B,MAP10,PRC1,RACGAP1	The cell cycle process in which the distance is lengthened between poles of the spindle. Spindle elongation begins during prophase and ends during anaphase B.
GO:0000030	GO	MF	mannosyltransferase activity	ALG1,ALG12,ALG2,ALG3,ALG8,DPM1,DPM2,DPM3,PIGB,PIGV,PIGZ,POMT1,SDF2	Catalysis of the transfer of a mannosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
GO:0000038	GO	BP	very long-chain fatty acid metabolic process	ABCD1,ABCD2,ABCD3,ACAA1,ACOT1,ACOT2,ACOT4,ACOX1,ACSBG1,CYP4F12,CYP4F2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL7,HACD1,HACD2,HACD3,HACD4,PEX2,SLC27A5,SLC27A6,TECR	The chemical reactions and pathways involving a fatty acid which has a chain length greater than C22.
GO:0000041	GO	BP	transition metal ion transport	ATOX1,ATP2C1,ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,ATP7A,ATP7B,CCS,CLTC,CUTC,DNM2,HEPH,HFE,IREB2,LMTK2,MCOLN1,MFI2,MT3,PICALM,RAB11B,REP15,SCARA5,SLC11A1,SLC11A2,SLC30A1,SLC30A10,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC31A1,SLC31A2,SLC39A1,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6,SLC39A8,SLC40A1,STEAP3,TCIRG1,TF,TFR2,TFRC,TTYH1,ZP3	The directed movement of transition metal ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum and silver.
GO:0000045	GO	BP	autophagosome assembly	ATG101,ATG12,ATG13,ATG14,ATG16L1,ATG3,ATG4B,ATG4C,ATG5,ATG9A,ATG9B,BECN1,EMC6,MAP1LC3A,PACS2,RAB1A,RAB23,STX12,TP53INP2,WIPI2	The formation of a double membrane-bounded structure, the autophagosome, that occurs when a specialized membrane sac, called the isolation membrane, starts to enclose a portion of the cytoplasm.
GO:0000049	GO	MF	tRNA binding	AIMP1,ALKBH8,CARS,DARS2,EEF1A1,EIF2A,EIF2AK4,FARS2,IFIT5,IGHMBP2,KARS,PTCD1,SEPSECS,SLFN11,SSB,TERT,THG1L,TRMT10A,TRNT1,TYW5,XPOT,YARS2	Interacting selectively and non-covalently with transfer RNA.
GO:0000050	GO	BP	urea cycle	ARG1,ARG2,ASL,ASS1,CPS1,NAGS,OTC,SLC25A15,SLC25A2	The sequence of reactions by which arginine is synthesized from ornithine, then cleaved to yield urea and regenerate ornithine. The overall reaction equation is NH3 + CO2 + aspartate + 3 ATP + 2 H2O = urea + fumarate + 2 ADP + 2 phosphate + AMP + diphosphate.
GO:0000052	GO	BP	citrulline metabolic process	ALDH18A1,ASS1,CPS1,DDAH1,DDAH2,OTC,PADI2,PADI4	The chemical reactions and pathways involving citrulline, N5-carbamoyl-L-ornithine, an alpha amino acid not found in proteins.
GO:0000060	GO	BP	protein import into nucleus, translocation	AKR1C3,AKT1,BCL3,BCL6,CEP57,GCKR,IFNG,KPNB1,MT3,NUTF2,OPRD1,OR1D2,PHB2,RAN,RBM22,SEC61B,SIX3,TGFB1,TNF,TNPO1	A protein transport process that contributes to protein import into the nucleus, and that results in the vectorial transfer of a cargo-carrier protein complex through the nuclear pore complex from the cytoplasmic side to the nucleoplasmic side of the nuclear envelope.
GO:0000062	GO	MF	fatty-acyl-CoA binding	ACOT7,ALDH6A1,DBI,SCP2,SOAT1,SOAT2	Interacting selectively and non-covalently with acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with a fatty acyl group.
GO:0000070	GO	BP	mitotic sister chromatid segregation	BECN1,CCNB1,CDC23,CDCA5,CDCA8,CENPE,CHAMP1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,DIS3L2,DLGAP5,DSCC1,ESPL1,GSG2,INO80,KIF14,KIF18A,KIF22,KIF25,KIF2C,KIFC1,KLHL22,KNSTRN,KPNB1,MAU2,NAA50,NCAPD2,NCAPD3,NCAPG,NCAPH,NDC80,NIPBL,NUSAP1,PAPD7,PDS5B,PHF13,PIBF1,PINX1,PLK1,POGZ,PSRC1,RAB11A,RB1,RRS1,SEH1L,SMC1A,SMC2,SMC4,SPAG5,SPDL1,TEX14,VPS4A,VPS4B,ZNF207,ZW10,ZWINT	The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the mitotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner. One homolog of each morphologic type goes into each of the resulting chromosome sets.
GO:0000075	GO	BP	cell cycle checkpoint	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATF2,ATM,ATR,ATRIP,BABAM1,BCL2L1,BIRC5,BLM,BRCA1,BRCC3,BRE,BRIP1,BRSK1,BUB1,BUB1B,BUB3,CASC5,CASP2,CCNA2,CCND1,CCNE2,CCNG2,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDC45,CDC5L,CDC6,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CDKN2B,CDT1,CENPF,CEP63,CHEK1,CHEK2,CHFR,CLOCK,CLSPN,CRADD,CSNK2A1,CSNK2A2,DCLRE1B,DGKZ,DLG1,DNA2,DTL,E2F1,FAM175A,FANCG,FBXO31,FBXO6,FOXN3,FZR1,GML,GTSE1,H2AFX,HINFP,HMGA2,HORMAD1,HRAS,HUS1,INTS3,INTS7,KLHL22,KNTC1,MAD1L1,MAD2L1,MAD2L1BP,MAD2L2,MAPKAPK2,MDC1,MDM2,MUC1,NABP1,NABP2,NAE1,NBN,NEK11,NEK6,PIDD1,PLK1,PLK2,PLK3,PLK5,PML,PPP2R5C,PRCC,PRKDC,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAD1,RAD17,RAD9A,RB1,RBBP8,RBM38,RFWD2,RFWD3,RHNO1,RPA2,RPA4,RPS27A,RPS27L,SETMAR,SMC1A,SOX4,TAOK1,TAOK2,TAOK3,TERF1,TEX14,TGFB1,TICRR,TIPIN,TIPRL,TP53,TPR,TRIAP1,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UIMC1,USP17L2,USP28,WAC,WNT9A,ZNF207,ZNF830,ZW10,ZWILCH,ZWINT	A cell cycle process that controls cell cycle progression by monitoring the integrity of specific cell cycle events. A cell cycle checkpoint begins with detection of deficiencies or defects and ends with signal transduction.
GO:0000076	GO	BP	DNA replication checkpoint	CDC45,CDC6,CDT1,CLSPN,DNA2,NAE1,RAD17,RAD9A,TICRR,TIPIN,ZNF830	A cell cycle checkpoint that prevents the initiation of nuclear division until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.
GO:0000077	GO	BP	DNA damage checkpoint	ATF2,ATM,ATR,ATRIP,BABAM1,BLM,BRCA1,BRCC3,BRE,BRIP1,BRSK1,CASP2,CCNA2,CCND1,CDC14B,CDC5L,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CEP63,CHEK1,CHEK2,CLOCK,CLSPN,CRADD,DGKZ,DTL,E2F1,FAM175A,FBXO31,FBXO6,FOXN3,FZR1,GML,GTSE1,H2AFX,HINFP,HMGA2,HUS1,INTS7,MAPKAPK2,MDC1,MDM2,MUC1,NBN,NEK11,NEK6,PIDD1,PLK1,PLK5,PML,PPP2R5C,PRKDC,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAD1,RAD17,RAD9A,RBBP8,RBM38,RFWD2,RFWD3,RHNO1,RPA2,RPA4,RPS27A,RPS27L,SOX4,TAOK1,TAOK2,TAOK3,TIPIN,TIPRL,TP53,TRIAP1,UBA52,UBB,UBC,UIMC1,USP28,WAC	A cell cycle checkpoint that regulates progression through the cell cycle in response to DNA damage. A DNA damage checkpoint may blocks cell cycle progression (in G1, G2 or metaphase) or slow the rate at which S phase proceeds.
GO:0000079	GO	BP	regulation of cyclin-dependent protein serine/threonine kinase activity	ADAM17,AKT1,APC,ATRAID,BCCIP,BLM,CCND1,CCND2,CCND3,CCNE2,CCNG1,CCNK,CCNT1,CCNT2,CCNY,CDC25A,CDC25C,CDC37,CDC6,CDK5R1,CDK5R2,CDK5RAP1,CDK5RAP3,CDK7,CDKN1A,CDKN1B,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CDKN3,CEBPA,CKS1B,CKS2,CUL3,DAB2IP,DIRAS3,EGFR,FBXO31,FGF10,GADD45A,GTF2H1,GTPBP4,HERC5,HEXIM1,HEXIM2,HHEX,INCA1,LATS1,LATS2,MAPRE3,MEN1,MNAT1,MYOCD,NELL1,NR2F2,PDGFB,PIM1,PKD1,PKD2,PKMYT1,PLK1,PROX1,PSMD10,PSRC1,PTEN,RGCC,SERTAD1,TFAP4,UBE2C	Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.
GO:0000082	GO	BP	G1/S transition of mitotic cell cycle	ACVR1,ACVR1B,BACH1,BCAT1,BRD4,CACUL1,CAMK2A,CCNA1,CCNB1,CCND1,CCNE1,CCNE2,CCNH,CDC25A,CDC34,CDC45,CDC6,CDC7,CDCA5,CDK1,CDK2,CDK3,CDK4,CDK6,CDK7,CDKN1A,CDKN1B,CDKN2A,CDKN2C,CDKN2D,CDKN3,CDT1,CKS1B,CRLF3,CUL1,CUL2,CUL3,CUL4A,CUL5,DBF4,DHFR,E2F1,E2F7,EIF4E,EIF4EBP1,FBXO5,GFI1,GSPT1,HINFP,ID2,INHBA,KLF11,LATS2,MARK4,MCM10,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MCM8,MNAT1,NPAT,ORC1,ORC2,ORC3,ORC4,ORC5,ORC6,PCNA,PHF8,PIM2,PKMYT1,PLK2,PLK3,POLA1,POLA2,POLE,POLE2,PPP2R3B,PPP6C,PRIM1,PRIM2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSMF1,RB1,RCC1,RPA1,RPA2,RPA3,RPA4,RPS27A,RPS6KB1,RRM2,SKP1,SKP2,SPDYA,TFDP1,TFDP3,TRIM71,TYMS,UBA52,UBB,UBC,USP37,WEE1,ZPR1	The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
GO:0000083	GO	BP	regulation of transcription involved in G1/S transition of mitotic cell cycle	BACH1,BRD4,CCNA1,CCNE1,CDC45,CDC6,CDK1,CDT1,DHFR,E2F1,E2F7,FBXO5,GFI1,HINFP,ID2,KLF11,NPAT,ORC1,PCNA,POLA1,RB1,RRM2,TYMS,ZPR1	Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle.
GO:0000086	GO	BP	G2/M transition of mitotic cell cycle	ABCB1,ACTR1A,AJUBA,AKAP9,ALMS1,ARPP19,AURKA,BACH1,BIRC5,BORA,BRSK2,BTRC,CCNA1,CCNA2,CCNB1,CCNB2,CCNH,CCNY,CCP110,CDC25A,CDC25B,CDC25C,CDK1,CDK14,CDK2,CDK5RAP2,CDK7,CDKN1A,CDKN2B,CENPF,CENPJ,CEP131,CEP135,CEP152,CEP164,CEP192,CEP250,CEP290,CEP41,CEP57,CEP63,CEP70,CEP72,CEP76,CEP78,CETN2,CHEK2,CKAP5,CLASP1,CNTRL,CSNK1D,CSNK1E,CUL1,DCTN1,DCTN2,DCTN3,DNM2,DYNC1H1,DYNC1I2,DYNLL1,ENSA,EP300,FBXL15,FBXL7,FBXW11,FGFR1OP,FOXM1,HAUS2,HSP90AA1,KDM8,KHDRBS1,LATS1,LIN37,LIN52,LIN54,LIN9,MAPRE1,MARK4,MASTL,MELK,MNAT1,MYBL2,NDE1,NEDD1,NEK2,NES,NINL,NUMA1,ODF2,OFD1,OPTN,PAFAH1B1,PCM1,PCNT,PKMYT1,PLCB1,PLK1,PLK3,PLK4,PPP1CB,PPP1R12A,PPP1R12B,PPP2R1A,PPP2R2A,PRKACA,PRKAR2B,RAB8A,RBBP4,RPS27A,SDCCAG8,SFI1,SKP1,SSNA1,TAF2,TPD52L1,TUBA1A,TUBA4A,TUBB,TUBB4A,TUBB4B,TUBG1,TUBG2,TUBGCP2,TUBGCP3,TUBGCP4,TUBGCP5,TUBGCP6,UBA52,UBB,UBC,USH1C,WEE1,YWHAE,YWHAG	The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex.
GO:0000096	GO	BP	sulfur amino acid metabolic process	ADI1,AGXT,AHCY,APIP,BHMT,BHMT2,CBS,CDO1,CNDP2,CPS1,CSAD,CTH,DPEP1,ENOPH1,ETHE1,GCLC,GCLM,GGT1,GOT1,MAT1A,MRI1,MSRA,MTAP,MTHFD1,MTHFR,MTR,MTRR,MUT,NFS1,NOX4,PCYOX1,SLC25A10,SMS,SQRDL,SUOX,TST	The chemical reactions and pathways involving amino acids containing sulfur, comprising cysteine, homocysteine, methionine and selenocysteine.
GO:0000097	GO	BP	sulfur amino acid biosynthetic process	ADI1,APIP,BHMT,BHMT2,CBS,CDO1,CTH,ENOPH1,GGT1,GOT1,MRI1,MTAP,MTHFD1,MTR,MTRR	The chemical reactions and pathways resulting in the formation of amino acids containing sulfur, comprising cysteine, methionine and selenocysteine.
GO:0000098	GO	BP	sulfur amino acid catabolic process	AGXT,CBS,CDO1,CSAD,CTH,ETHE1,MTRR,SLC25A10,SQRDL,SUOX,TST	The chemical reactions and pathways resulting in the breakdown of amino acids containing sulfur, comprising cysteine, methionine and selenocysteine.
GO:0000099	GO	MF	sulfur amino acid transmembrane transporter activity	CTNS,SLC1A1,SLC1A4,SLC3A1,SLC7A11,SLC7A9	Enables the transfer of sulfur amino acids from one side of a membrane to the other. Sulphur amino acids contain sulfur in the form of cystine, methionine or their derivatives.
GO:0000101	GO	BP	sulfur amino acid transport	CTNS,SLC1A1,SLC1A4,SLC3A1,SLC7A9	The directed movement of amino acids containing sulfur (cystine, methionine and their derivatives) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0000109	GO	CC	nucleotide-excision repair complex	CETN2,CHRAC1,ERCC1,ERCC4,ERCC8,POLD1,POLE,POLE2,POLE3,POLE4,RAD23B,SLX4,XPC	Any complex formed of proteins that act in nucleotide-excision repair.
GO:0000118	GO	CC	histone deacetylase complex	APPL1,APPL2,CBX5,CHD3,CHD4,CHD5,CIR1,CSNK2A1,DNTTIP1,FAM60A,GATAD2A,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC8,HDAC9,HEY2,HINT1,ING2,MBD3,MECOM,MORF4L1,MTA2,NACC2,NCOR1,PHF12,PHF21A,RBBP4,RBBP7,SALL1,SAP18,SAP30,SIN3A,SUDS3,TAF6L,TAL1,TBL1X,TBL1XR1,ZNF217,ZNF541	A protein complex that possesses histone deacetylase activity.
GO:0000123	GO	CC	histone acetyltransferase complex	ACTB,ACTL6A,ATXN7L3,BRD1,BRD8,BRPF1,BRPF3,CSRP2BP,DMAP1,DR1,ELP2,ELP3,ELP4,ENY2,EP400,EPC1,HCFC1,IKBKAP,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,MAP3K7,MBIP,MCRS1,MEAF6,MORF4L1,MSL1,MSL2,MSL3,OGT,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SUPT20H,SUPT3H,SUPT7L,TADA1,TADA2A,TADA2B,TADA3,TAF10,TAF12,TAF2,TAF4,TAF5,TAF5L,TAF6,TAF6L,TAF7,TAF9,TAF9B,TRRAP,UBAP2L,USP22,WDR5,YEATS2,YEATS4	A protein complex that possesses histone acetyltransferase activity.
GO:0000125	GO	CC	PCAF complex	KAT2B,TADA2A,TAF10,TAF12,TAF9,TRRAP	A large multiprotein complex that possesses histone acetyltransferase activity and is involved in regulation of transcription. The composition is similar to that of the SAGA complex, but includes fewer Spt and Ada proteins, and more TAFs.
GO:0000127	GO	CC	transcription factor TFIIIC complex	GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6	A heterotrimeric transcription factor complex that is involved in regulating transcription from RNA polymerase III (Pol III) promoters. TFIIIC contains three conserved subunits that associate with the proximal Pol III promoter element, and additional subunits that associate with sequence elements downstream of the promoter and are more diverged among species. It also functions as a boundary element to partition genome content into distinct domains outside Pol III promoter regions.
GO:0000132	GO	BP	establishment of mitotic spindle orientation	CDK5RAP2,CENPA,DYNLT1,HTT,NDC80,NDE1,PAFAH1B1,SPDL1,ZW10	A cell cycle process that sets the alignment of mitotic spindle relative to other cellular structures.
GO:0000137	GO	CC	Golgi cis cisterna	ATL1,GOLGA2,LLGL1,NECAB3,TMEM59	The Golgi cisterna closest to the endoplasmic reticulum; the first processing compartment through which proteins pass after export from the ER.
GO:0000138	GO	CC	Golgi trans cisterna	AP4M1,B4GALT1,HID1,SGMS1,TMEM59	The Golgi cisterna farthest from the endoplasmic reticulum; the final processing compartment through which proteins pass before exiting the Golgi apparatus; the compartment in which N-linked protein glycosylation is completed.
GO:0000145	GO	CC	exocyst	EXOC1,EXOC2,EXOC3L1,EXOC8,RAB10,RALB,WASH1	A protein complex peripherally associated with the plasma membrane that determines where vesicles dock and fuse. At least eight complex components are conserved between yeast and mammals.
GO:0000146	GO	MF	microfilament motor activity	MYH10,MYH13,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYH9,MYO10,MYO1B,MYO1E,MYO3A,MYO5A,MYO5B,MYO6,MYO7A,MYO9B	Catalysis of movement along a microfilament, coupled to the hydrolysis of a nucleoside triphosphate (usually ATP).
GO:0000149	GO	MF	SNARE binding	BLOC1S6,CACNA1A,CAPN10,GABARAPL2,NBAS,NSF,RAB11A,SCFD1,SNAPIN,SNPH,STX17,STX7,STXBP1,STXBP5,SYT1,SYT6,UNC13A,VAMP2,VPS11,VPS18,VTI1B	Interacting selectively and non-covalently with a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein.
GO:0000151	GO	CC	ubiquitin ligase complex	ANAPC1,ANAPC10,ANAPC11,ANAPC13,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ARIH1,ASB4,BARD1,BMI1,BRAP,BRCA1,BRCC3,BRE,BTRC,BUB1B,CAND1,CBLL1,CBX2,CBX4,CBX7,CBX8,CCNF,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN1B,COMMD1,CRBN,CUL1,CUL2,CUL3,CUL4A,CUL4B,CUL5,CUL7,CUL9,DCAF10,DCAF11,DCAF12,DCAF13,DCAF16,DCAF17,DCAF4,DCAF5,DCAF6,DCAF7,DCAF8,DCUN1D1,DDB1,DDB2,DNAJA1,DTL,DYRK2,ENC1,ERCC8,FBXL15,FBXL19,FBXL2,FBXL3,FBXL4,FBXL5,FBXL7,FBXO10,FBXO11,FBXO17,FBXO18,FBXO2,FBXO21,FBXO24,FBXO25,FBXO27,FBXO31,FBXO4,FBXO44,FBXO6,FBXO7,FBXO8,FBXO9,FBXW11,FBXW4,FBXW5,FBXW7,FBXW8,FZR1,GAN,GPR37,HSPA1A,HSPA1B,HSPA8,KCTD10,KCTD13,KCTD17,KEAP1,KLHL12,KLHL13,KLHL2,KLHL20,KLHL21,KLHL22,KLHL25,KLHL3,KLHL41,KLHL42,KLHL7,KLHL8,KLHL9,LMO7,MAD2L2,MARCH6,NEDD4,OS9,PARK2,PCGF2,PCGF6,PHC1,PHC2,PHC3,PINK1,RBCK1,RBX1,RCHY1,RING1,RNF11,RNF144B,RNF168,RNF2,RNF20,RNF31,RNF40,RNF7,RNF8,SEL1L,SHARPIN,SKP1,SKP2,SMURF2,SPOP,SPOPL,STUB1,SUGT1,SYVN1,TCEB2,TNFAIP1,TOPORS,TRAF7,TRIM21,TRPC4AP,TSPAN17,UBE2A,UBE2B,UBE2C,UBE2D1,UBE2D2,UBE2E1,UBE2L3,UBE2N,UBE2S,UBE2V1,UBE4B,USP33,USP47,WWP1,WWP2,ZER1	A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex.
GO:0000152	GO	CC	nuclear ubiquitin ligase complex	ANAPC1,ANAPC10,ANAPC11,ANAPC13,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,BARD1,BMI1,BRCA1,BRCC3,BRE,BUB1B,CBX2,CBX4,CBX7,CBX8,CDC16,CDC20,CDC23,CDC26,CDC27,CUL7,FZR1,MAD2L2,PCGF2,PCGF6,PHC1,PHC2,PHC3,RING1,RNF2,UBE2C,UBE2S	A ubiquitin ligase complex found in the nucleus.
GO:0000153	GO	CC	cytoplasmic ubiquitin ligase complex	MARCH6,OS9,SEL1L,SYVN1,USP33	A ubiquitin ligase complex found in the cytoplasm.
GO:0000159	GO	CC	protein phosphatase type 2A complex	CYCS,NKD1,PPP2CA,PPP2CB,PPP2R1A,PPP2R2A,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R3B,PPP2R4,PPP2R5A,PPP2R5C,STRN,STRN3,STRN4	A protein complex that has protein serine/threonine phosphatase activity that is polycation-stimulated (PCS), being directly stimulated by protamine, polylysine, or histone H1; it constitutes a subclass of several enzymes activated by different histones and polylysine, and consists of catalytic, scaffolding, and regulatory subunits. The catalytic and scaffolding subunits form the core enzyme, and the holoenzyme also includes the regulatory subunit.
GO:0000164	GO	CC	protein phosphatase type 1 complex	NCK1,PPP1R15A,PPP1R15B,PPP1R9B,SHOC2	A protein complex that possesses magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity, and consists of a catalytic subunit and one or more regulatory subunits that dictates the phosphatase's substrate specificity, function, and activity.
GO:0000175	GO	MF	3'-5'-exoribonuclease activity	CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,DIS3,DIS3L,DIS3L2,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,ISG20,NOCT,PAN2,PAN3,PARN,PNPT1,TOE1,USB1	Catalysis of the sequential cleavage of mononucleotides from a free 3' terminus of an RNA molecule.
GO:0000176	GO	CC	nuclear exosome (RNase complex)	C1D,DIS3,EXOSC3,EXOSC9,MPHOSPH6	Complex of 3'-5' exoribonucleases found in the nucleus.
GO:0000177	GO	CC	cytoplasmic exosome (RNase complex)	CARHSP1,DIS3L,EXOSC3,GTPBP1,PNPT1,SUPV3L1	Complex of 3'-5' exoribonucleases found in the cytoplasm.
GO:0000178	GO	CC	exosome (RNase complex)	AICDA,C1D,CARHSP1,DIS3,DIS3L,EXOSC1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,GTPBP1,MPHOSPH6,PNPT1,SKIV2L2,SUPV3L1	Complex of 3'-5' exoribonucleases.
GO:0000182	GO	MF	rDNA binding	BEND3,DHX33,H2AFY,MAF1,MTOR,RPTOR,TSPYL2	Interacting selectively and non-covalently with DNA sequences encoding ribosomal RNA.
GO:0000183	GO	BP	chromatin silencing at rDNA	BAZ2A,BEND3,H3F3A,HIST1H3A,HIST1H4A,HIST2H3A,RRP8,SIRT1,SIRT2,SUV39H1,TAF1A,TAF1B,TAF1C,TAF1D,TBP	Repression of transcription of ribosomal DNA by altering the structure of chromatin.
GO:0000184	GO	BP	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	CASC3,CTIF,DCP2,EIF3E,EIF4A3,EIF4G1,ETF1,EXOSC10,FAU,GSPT1,GSPT2,MAGOH,MAGOHB,NCBP1,NCBP2,PABPC1,PARN,PNRC2,PPP2CA,PPP2R1A,PPP2R2A,RBM8A,RNPS1,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SMG1,SMG5,SMG6,SMG7,SMG8,SMG9,UBA52,UPF1,UPF2,UPF3A,UPF3B	The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.
GO:0000185	GO	BP	activation of MAPKKK activity	DAB2IP,GADD45A,GADD45B,GADD45G,MAP4K1,TNF,TRAF7	Any process that initiates the activity of the inactive enzyme MAP kinase kinase kinase (MAPKKK).
GO:0000187	GO	BP	activation of MAPK activity	ADAM8,ADORA2B,ADRA2A,ADRA2B,ADRA2C,ALK,BIRC7,BMP2,C5,C5AR1,CCL19,CD81,CDK1,CHRNA7,CXCR4,DAB2IP,DAXX,DBNL,DRD4,DUSP5,DUSP6,DUSP7,DUSP9,EPGN,ERN1,ERP29,FGF10,FGF2,FPR1,GHR,GHRL,GNG3,GRM4,HACD3,IKBKG,IL1B,INSR,IRAK1,IRAK2,KIT,LRRK2,MADD,MAP2K1,MAP2K2,MAP2K3,MAP2K5,MAP2K6,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPKAPK2,MAPKAPK3,MAPKAPK5,MDFIC,MOS,MUL1,NOD1,NOD2,NTF3,NTRK3,PAK3,PEA15,PIK3CB,PKN1,PLA2G1B,PLCE1,PRKAA1,PROK2,RIPK1,RIPK2,RPS27A,S1PR2,SAA1,SHC1,SOD1,TAB1,TAB2,TAB3,TDGF1,TGFA,THBS1,TLR4,TNF,TRAF6,UBA52,UBB,UBC,WNT5A	The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
GO:0000188	GO	BP	inactivation of MAPK activity	CAV1,DUSP1,DUSP10,DUSP16,DUSP2,DUSP22,DUSP3,DUSP6,DUSP7,DUSP8,GPS1,GPS2,LAX1,MBIP,PPP2CA,PPP2R1A,RGS3,RGS4,SPRED1,SPRED2	Any process that terminates the activity of the active enzyme MAP kinase.
GO:0000209	GO	BP	protein polyubiquitination	AMFR,ANAPC1,ANAPC10,ANAPC11,ANAPC13,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ARIH2,BARD1,BCL2,BFAR,BIRC2,BLMH,BRCA1,BTRC,CBFB,CDC16,CDC23,CDC26,CDC27,CDC34,CDKN2A,CHFR,CUL3,DDB2,DTL,DZIP3,ERCC8,FBXO4,FBXW11,FZR1,HACE1,HUWE1,ITCH,KLHL20,KLHL3,KLHL42,LNPEP,LRSAM1,MAGEL2,MARCH1,MARCH5,MARCH6,MARCH8,MKRN1,NEDD4,NEDD4L,NHLRC1,NPEPPS,PARK2,PPIL2,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBCK1,RC3H2,RFFL,RNF115,RNF126,RNF146,RNF152,RNF167,RNF168,RNF187,RNF20,RNF216,RNF31,RNF34,RNF4,RNF41,RNF5,RNF6,RNF8,RPS27A,RUSC1,SASH1,SHARPIN,SHPRH,SMURF1,STUB1,SYVN1,TMEM129,TNFAIP3,TNKS,TNKS2,TOPORS,TPP2,TRAF2,TRAF6,TRIM21,TRIM27,TRIM32,TRIM5,TRIM56,TTC3,UBA52,UBB,UBC,UBE2A,UBE2B,UBE2C,UBE2D1,UBE2D2,UBE2D3,UBE2D4,UBE2E1,UBE2E2,UBE2E3,UBE2G1,UBE2G2,UBE2H,UBE2K,UBE2L3,UBE2N,UBE2O,UBE2Q2,UBE2R2,UBE2S,UBE2T,UBE2V1,UBE2V2,UBE2W,UBE3A,UBE3C,UBOX5,UBR5,WWP2,ZFP91,ZNF738,ZNRF1	Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain.
GO:0000217	GO	MF	DNA secondary structure binding	BLM,ERCC5,HMGB1,HMGB2,HMGB3,MEN1,MSH2,MSH6,NEIL3,NR0B1,RAD18,RAD51B,RAD51C,RAD51D,RECQL4,WRN,XPC,XRCC2,XRCC3,YY1	Interacting selectively and non-covalently with DNA containing secondary structure elements such as four-way junctions, bubbles, loops, Y-form DNA, or double-strand/single-strand junctions.
GO:0000242	GO	CC	pericentriolar material	BBS4,BBS9,CDK5RAP2,CEP152,CEP85,HOOK3,LCK,NEK1,NIN,PCM1,TNKS,TNKS2,TUBE1	A network of small fibers that surrounds the centrioles in cells; contains the microtubule nucleating activity of the centrosome.
GO:0000244	GO	BP	spliceosomal tri-snRNP complex assembly	CD2BP2,DDX20,PRPF19,PRPF3,PRPF31,PRPF6,PRPF8,SART3,SRSF10,SRSF12,USP4	The formation of a tri-snRNP complex containing U4 and U6 (or U4atac and U6atac) snRNAs and U5 snRNAs and associated proteins. This includes reannealing of U4 and U6 (or U4atac and U6atac) snRNAs released from previous rounds of splicing to reform the U4/U6 snRNP (or U4atac/U6atac snRNP) as well as the subsequent association of the U5 snRNP with the U4/U6 snRNP (or U4atac/U6atac snRNP) to form a tri-snRNP that is ready to reassemble into another spliceosome complex.
GO:0000245	GO	BP	spliceosomal complex assembly	CELF1,CRNKL1,DDX1,DDX23,DDX39B,GCFC2,NOL3,PRPF19,PRPF6,PSIP1,RBM5,SCAF11,SETX,SF1,SF3A1,SF3A2,SF3A3,SLU7,SMN1,SNRNP200,SNRPD1,SNRPD2,SNRPE,SNRPG,SRPK2,SRSF1,SRSF10,SRSF12,SRSF5,SRSF6,SRSF9,TXNL4A,USP39,YTHDC1,ZRSR2	The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions.
GO:0000266	GO	BP	mitochondrial fission	ATG3,BAX,BNIP3,CCAR2,DNM1L,ERBB4,FIS1,GDAP1,MFF,MIEF1,MTFP1,MTFR1,MTFR2,MUL1,OPA1,PARK2,SLC25A46	The division of a mitochondrion within a cell to form two or more separate mitochondrial compartments.
GO:0000268	GO	MF	peroxisome targeting sequence binding	BRE,PEX19,PEX5,PEX5L,PEX7	Interacting selectively and non-covalently with a peroxisomal targeting sequence, any of several sequences of amino acids within a protein that can act as a signal for the localization of the protein into the peroxisome.
GO:0000281	GO	BP	mitotic cytokinesis	ANK3,ANLN,APC,BBS4,CEP55,CKAP2,CNTROB,CUL7,KIF20A,KIF23,KIF4A,KIF4B,MITD1,MYH10,NUSAP1,PLK1,RACGAP1,RASA1,SNX18,SNX33,SNX9,SPTBN1,STAMBP,USP8,ZNF365	A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.
GO:0000287	GO	MF	magnesium ion binding	AASDHPPT,ABL1,ABL2,ADCY2,ALPI,ALPP,ATP10D,BRSK1,BRSK2,CDC42BPA,CDC42BPB,CDC42BPG,CERK,CIB2,CIB3,CIB4,CLYBL,DCTPP1,DIS3L2,DXO,DYRK2,DYRK3,ENDOV,ENOSF1,EPHX2,ERN1,ERN2,EYA2,FAN1,FIGNL1,FOXK2,GCLC,GEM,GNAI1,GSS,HMGCL,HPGDS,HPRT1,ICK,IDH1,IDH2,IDI1,IMPA1,IRAK3,LATS1,LHPP,MAP2K7,MAP3K5,MAP3K6,MAPK12,MARK1,MARK2,MAST1,MAST2,MOV10L1,MSH2,MSH6,MTHFD2,MTPAP,NEK6,NIM1K,NLK,NLRC4,NME1,NT5C3A,NUAK2,NUDT16,NUDT18,NUDT3,NUDT5,OPA1,OXSR1,PAPOLA,PCK1,PDXK,PDXP,PGP,PI4K2A,PIF1,PINK1,PRKACB,PRTFDC1,PSPH,RRAGC,S100P,SIK1,SIK2,SIK3,SNCA,SNRK,SPHK1,SRPK1,SRPK2,SRR,STK11,STK26,STK3,STK36,STK38,STK38L,STK4,TDP2,TESC,THG1L,THTPA,TOP2A,TREX2,TSSK1B,TSSK2,TSSK3,TSSK4,TSSK6,WRN,YDJC	Interacting selectively and non-covalently with magnesium (Mg) ions.
GO:0000288	GO	BP	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	CNOT1,CNOT10,CNOT11,CNOT2,CNOT3,CNOT4,CNOT6,CNOT6L,CNOT7,CNOT8,DCP1A,DCP1B,DCP2,DCPS,DDX6,DIS3,EDC3,EDC4,EIF4A1,EIF4A2,EIF4A3,EIF4B,EIF4E,EIF4G1,EXOSC1,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,LSM1,LSM2,LSM3,LSM4,LSM5,LSM6,LSM7,NT5C3B,PABPC1,PAIP1,PAN2,PAN3,PARN,PATL1,RQCD1,TNKS1BP1,XRN1,ZFP36	A major pathway of degradation of nuclear-transcribed mRNAs that proceeds through a series of ordered steps that includes poly(A) tail shortening and that can regulate mRNA stability.
GO:0000289	GO	BP	nuclear-transcribed mRNA poly(A) tail shortening	CNOT1,CNOT10,CNOT11,CNOT2,CNOT3,CNOT4,CNOT6,CNOT6L,CNOT7,CNOT8,EIF4A1,EIF4A2,EIF4A3,EIF4B,EIF4E,EIF4G1,PABPC1,PAIP1,PAN2,PAN3,PARN,RQCD1,TNKS1BP1,ZFP36	Shortening of the poly(A) tail of a nuclear-transcribed mRNA from full length to an oligo(A) length.
GO:0000291	GO	BP	nuclear-transcribed mRNA catabolic process, exonucleolytic	CNOT6,CNOT7,CNOT8,DCP1A,DCP1B,DCP2,DCPS,DDX6,DIS3,DIS3L2,EDC3,EDC4,EXOSC1,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,LSM1,LSM2,LSM3,LSM4,LSM5,LSM6,LSM7,NT5C3B,PATL1,XRN1	The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA that occurs when the ends are not protected by the 5'-cap or the 3'-poly(A) tail.
GO:0000295	GO	MF	adenine nucleotide transmembrane transporter activity	SLC25A17,SLC25A24,SLC25A42,SLC25A6,SLC35B2	Catalysis of the transfer of adenine nucleotides (AMP, ADP, and ATP) from one side of the membrane to the other.
GO:0000302	GO	BP	response to reactive oxygen species	ADAM9,AKR1C3,APOA4,APOD,APOE,APTX,AQP1,AQP8,ATOX1,ATP7A,CAT,CCL19,CCR7,CCS,CDK2,CRYGD,CYCS,CYP1B1,DPEP1,ECT2,EGLN1,ERO1A,FABP1,FER,FOS,FOXO1,FXN,GLRX2,GPX1,GPX2,GPX3,GPX7,GPX8,GSR,GSTP1,GUCY1B3,HBA1,HBB,HDAC6,HMOX1,HP,HYAL1,HYAL2,IL6,IMPACT,KCNC2,MAP3K5,MAPK7,MMP3,MPV17,MT3,MTR,NET1,NFE2L2,NOS3,NUDT2,P4HB,PARK7,PAX2,PDCD10,PDGFRA,PDK2,PKD2,PLEKHA1,PLK3,PPIF,PRDX1,PRDX2,PRDX3,PRDX5,PRDX6,PTPRK,PTPRN,RELA,RHOB,ROMO1,RPS3,S100A7,SETX,SIRT1,SLC8A1,SOD1,SOD2,SOD3,STK24,STK25,STK26,TNFAIP3,TXN,TXN2,TXNRD1,TXNRD2,ZNF580	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
GO:0000305	GO	BP	response to oxygen radical	APOA4,ATP7A,MT3,NOS3,PRDX2,SOD1,SOD2,SOD3,TXNRD2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen radical stimulus. An oxygen radical is any oxygen species that carries a free electron; examples include hydroxyl radicals and the superoxide anion.
GO:0000307	GO	CC	cyclin-dependent protein kinase holoenzyme complex	BCCIP,CCND1,CCND2,CCND3,CCNH,CCNT1,CCNY,CDK12,CDK13,CDK14,CDK2,CDK4,CDK6,CDK9,CDKN1A,ERCC2,HOXC10,HSPD1,KDM5A,PUF60,SNW1,TAF7	Cyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner.
GO:0000338	GO	BP	protein deneddylation	COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,GPS1,TOR1A	The removal of a ubiquitin-like protein of the NEDD8 type from a protein.
GO:0000339	GO	MF	RNA cap binding	AGO2,DCPS,EIF4A1,EIF4E,EIF4E2,EIF4G3,LARP1,NCBP2,NCBP3,SNUPN	Interacting selectively and non-covalently with a 7-methylguanosine (m7G) group or derivative located at the 5' end of an RNA molecule.
GO:0000346	GO	CC	transcription export complex	ALYREF,CHTOP,DDX39B,NXF1,POLDIP3,SARNP,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,ZC3H11A	The transcription export (TREX) complex couples transcription elongation by RNA polymerase II to mRNA export. The complex associates with the polymerase and travels with it along the length of the transcribed gene. TREX is composed of the THO transcription elongation complex as well as other proteins that couple THO to mRNA export proteins. The TREX complex is known to be found in a wide range of eukaryotes, including S. cerevisiae and metazoans.
GO:0000380	GO	BP	alternative mRNA splicing, via spliceosome	CDK13,CELF4,HNRNPM,PQBP1,RBM17,SFPQ,SLU7,SRSF1,SRSF6	The process of generating multiple mRNA molecules from a given set of exons by differential use of exons from the primary transcript(s) to form multiple mature mRNAs that vary in their exon composition.
GO:0000381	GO	BP	regulation of alternative mRNA splicing, via spliceosome	CELF3,CELF4,CELF6,DDX5,MAGOH,NSRP1,PTBP1,RBFOX2,RBM11,RBM15B,RBM25,RBM4,RBM5,RBM8A,RBMX,RBMY1A1,RNPS1,SAP18,SRSF12,SRSF6,THRAP3,TRA2B,WTAP	Any process that modulates the frequency, rate or extent of alternative splicing of nuclear mRNAs.
GO:0000387	GO	BP	spliceosomal snRNP assembly	CD2BP2,CLNS1A,DDX20,GEMIN2,GEMIN4,GEMIN5,GEMIN6,GEMIN7,GEMIN8,NCBP1,NCBP2,PHAX,PRMT5,PRMT7,PRPF19,PRPF3,PRPF31,PRPF6,PRPF8,SART1,SART3,SMN1,SNRPB,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNUPN,SRSF10,SRSF12,STRAP,TGS1,USP4,WDR77	The aggregation, arrangement and bonding together of one or more snRNA and multiple protein components to form a ribonucleoprotein complex that is involved in formation of the spliceosome.
GO:0000389	GO	BP	mRNA 3'-splice site recognition	SF1,SF3A1,SF3A2,SF3A3,SLU7	Recognition of the intron 3'-splice site by components of the assembling U2- or U12-type spliceosome.
GO:0000394	GO	BP	RNA splicing, via endonucleolytic cleavage and ligation	C14orf166,CLP1,DDX1,ERN1,RTCB,TSEN2,TSEN54,ZBTB8OS	Splicing of RNA via recognition of the folded RNA structure that brings the 5' and 3' splice sites into proximity and cleavage of the RNA at both the 3' and 5' splice sites by an endonucleolytic mechanism, followed by ligation of the exons.
GO:0000400	GO	MF	four-way junction DNA binding	HMGB1,HMGB2,HMGB3,MEN1,MSH2,MSH6,RAD51B,RAD51C,RAD51D,XRCC2,XRCC3,YY1	Interacting selectively and non-covalently with DNA containing four-way junctions, also known as Holliday junctions, a structure where two DNA double strands are held together by reciprocal exchange of two of the four strands, one strand each from the two original helices.
GO:0000405	GO	MF	bubble DNA binding	BLM,ERCC5,HMGB1,NEIL3,RECQL4,WRN,XPC	Interacting selectively and non-covalently with DNA that contains a bubble. A bubble occurs when DNA contains a region of unpaired, single-stranded DNA flanked on both sides by regions of paired, double-stranded DNA.
GO:0000407	GO	CC	pre-autophagosomal structure	ATG101,ATG12,ATG13,ATG14,ATG5,ATG9A,RAB1B,RB1CC1,STX12,ULK1,ULK2,ULK3,WIPI1,WIPI2,ZFYVE1	A punctate structure localized in the vicinity of the vacuole that is required for the formation of autophagosomes.
GO:0000413	GO	BP	protein peptidyl-prolyl isomerization	FKBP1A,FKBP1B,PIN1,PPIA,PPIB	The modification of a protein by cis-trans isomerization of a proline residue.
GO:0000421	GO	CC	autophagosome membrane	GABARAP,GABARAPL1,GABARAPL2,MAP1LC3A,MAP1LC3B,MAP1LC3C,SH3GLB1,STX17,TECPR1,ULK1,VMP1,WIPI1	The lipid bilayer surrounding an autophagosome, a double-membrane-bounded vesicle in which endogenous cellular material is sequestered.
GO:0000422	GO	BP	mitophagy	ACIN1,ACTRT1,ADAMTS7,ADRB2,AKR1E2,ALPK1,AMBRA1,ANXA5,ASB2,ATG12,ATG13,ATG14,ATG5,ATP1B1,ATPIF1,BECN1,BLOC1S1,BNIP3,BOC,C5,C8orf59,CA7,CALCB,CAPS,CD163L1,CD93,CDKN2A,CHAF1B,CHST3,CLVS1,COX8A,CRNKL1,CSPG5,DKKL1,DNAAF2,DPF3,DZANK1,EIF2S1,EVA1B,FABP1,FAM131B,FAM13B,FANCC,FANCF,FBXO7,FCGR3B,FGFBP1,FIS1,FUNDC1,GABRA5,GDF5,GMIP,HAPLN1,HCAR1,HDAC6,HK2,HPR,HSF2BP,IPPK,IST1,ITPKC,KCNK3,KIAA1549L,KRCC1,KRT15,KRT6A,KRT73,LARP1B,LENG9,LMCD1,LSM4,MAP1A,MAP1LC3A,MAP1LC3B,MAP2K1,MAP3K12,MARK2,MBD5,MDH1,MEX3C,MFN1,MFN2,MRPS10,MRPS2,MSTN,MTERF3,MYH11,MYLK,MYOM1,NDUFB9,NEFM,NME2,NR2C2,NTHL1,NUP93,OBSCN,P2RX5,PARK2,PDK1,PEX13,PEX3,PFKP,PGK2,PHYHIP,PI4K2A,PIK3CA,PINK1,PLOD2,PNPO,PPY,PRKD2,PRKG1,REP15,RFWD3,RIMS3,RPS27A,SERPINB10,SFRP4,SLC1A3,SLC1A4,SLC22A3,SLC35B3,SLC35C1,SLC37A4,SLC6A1,SLCO1A2,SMURF1,SNRPB,SNRPD1,SNRPF,SNTG1,SPATA18,SQSTM1,STAT2,STK32A,STOM,SUPT3H,TBC1D5,TEX38,TMEM203,TMEM39A,TMEM39B,TOMM20,TOMM22,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TREM1,TXLNA,UBA52,UBB,UBC,USP30,VDAC1,YIPF1,ZCCHC17,ZNF189,ZNF593	The autophagic process in which mitochondria are delivered to the vacuole and degraded in response to changing cellular conditions.
GO:0000423	GO	BP	macromitophagy	ACIN1,ACTRT1,ADAMTS7,ADRB2,AKR1E2,ALPK1,AMBRA1,ANXA5,ASB2,ATG12,ATG13,ATG14,ATG5,ATP1B1,ATPIF1,BECN1,BLOC1S1,BOC,C5,C8orf59,CA7,CALCB,CAPS,CD163L1,CD93,CHAF1B,CHST3,CLVS1,COX8A,CRNKL1,CSPG5,DKKL1,DNAAF2,DPF3,DZANK1,EIF2S1,EVA1B,FABP1,FAM131B,FAM13B,FANCC,FANCF,FCGR3B,FGFBP1,GABRA5,GDF5,GMIP,HAPLN1,HCAR1,HDAC6,HK2,HPR,HSF2BP,IPPK,IST1,ITPKC,KCNK3,KIAA1549L,KRCC1,KRT15,KRT6A,KRT73,LARP1B,LENG9,LMCD1,LSM4,MAP1A,MAP1LC3A,MAP1LC3B,MAP2K1,MAP3K12,MBD5,MDH1,MEX3C,MFN1,MFN2,MRPS10,MRPS2,MSTN,MTERF3,MYH11,MYLK,MYOM1,NDUFB9,NEFM,NME2,NR2C2,NTHL1,NUP93,OBSCN,P2RX5,PARK2,PDK1,PEX13,PEX3,PFKP,PGK2,PHYHIP,PI4K2A,PIK3CA,PINK1,PLOD2,PNPO,PPY,PRKD2,PRKG1,REP15,RFWD3,RIMS3,RPS27A,SERPINB10,SFRP4,SLC1A3,SLC1A4,SLC22A3,SLC35B3,SLC35C1,SLC37A4,SLC6A1,SLCO1A2,SMURF1,SNRPB,SNRPD1,SNRPF,SNTG1,SQSTM1,STAT2,STK32A,STOM,SUPT3H,TBC1D5,TEX38,TMEM203,TMEM39A,TMEM39B,TOMM20,TOMM22,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TREM1,TXLNA,UBA52,UBB,UBC,VDAC1,YIPF1,ZCCHC17,ZNF189,ZNF593	Degradation of a mitochondrion by macroautophagy.
GO:0000445	GO	CC	THO complex part of transcription export complex	THOC1,THOC2,THOC3,THOC5,THOC6,THOC7	The THO complex when it is part of the TREX (TRanscription EXport) complex that is involved in coupling transcription to export of mRNAs to the cytoplasm. In S. cerevisiae, it is composed of four subunits: Hpr1, Tho2, Thp1, and Mft1, while the human complex is composed of 7 subunits.
GO:0000460	GO	BP	maturation of 5.8S rRNA	C1D,EXOSC10,EXOSC4,MPHOSPH6,NOL9,NOP14,PES1,SKIV2L2,UTP20,WDR12	Any process involved in the maturation of a precursor 5.8S ribosomal RNA (rRNA) molecule into a mature 5.8S rRNA molecule.
GO:0000502	GO	CC	proteasome complex	ADRM1,BAG6,DNAJB2,GET4,HSPB1,MARCH6,OS9,PAAF1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,SEL1L,SHFM1,SYVN1,UBL4A,UBQLN4,UBXN1,VCP	A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core.
GO:0000506	GO	CC	glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex	DPM2,PIGA,PIGC,PIGH,PIGP,PIGY,PYURF	An enzyme complex that catalyzes the transfer of GlcNAc from UDP-GlcNAc to an acceptor phosphatidylinositol, the first step in the production of GPI anchors for cell surface proteins. The complex contains PIG-A, PIG-C, PIG-H, PIG-Q, PIG-P, and DPM2 in human, and Eri1p, Gpi1p, Gpi2p, Gpi15p, Gpi19p, and Spt14p in budding yeast.
GO:0000578	GO	BP	embryonic axis specification	BASP1,COBL,CXXC4,FZD5,HOXD8,PLD6,PTCH1,RIPPLY1,RIPPLY2,SMAD2,SMAD6,STIL,T,TBX3,TDGF1,TDRD5,WNT1,WNT7A,WT1	The establishment, maintenance and elaboration of a pattern along a line or a point in an embryo.
GO:0000715	GO	BP	nucleotide-excision repair, DNA damage recognition	CETN2,COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,CUL4A,CUL4B,DDB1,DDB2,GPS1,PARP1,RAD23B,RBX1,RPS27A,UBA52,UBB,UBC,XPC	The identification of lesions in DNA, such as pyrimidine-dimers, intrastrand cross-links, and bulky adducts. The wide range of substrate specificity suggests the repair complex recognizes distortions in the DNA helix.
GO:0000722	GO	BP	telomere maintenance via recombination	APEX1,DNA2,FEN1,LIG1,NSMCE2,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,PRIM1,PRIM2,RAD51,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,SMC5,SMC6,TEP1,XRCC3	Any recombinational process that contributes to the maintenance of proper telomeric length.
GO:0000723	GO	BP	telomere maintenance	ACD,APEX1,ATM,CTC1,DCLRE1B,DKC1,DNA2,ERCC1,ERCC4,FBXO4,FEN1,GAR1,HIST1H4A,HIST3H3,LIG1,MRE11A,NBN,NHP2,NOP10,NSMCE2,OBFC1,PARP3,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POT1,PRIM1,PRIM2,PRKDC,PTGES3,RAD50,RAD51,RAD51D,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RTEL1,SLX1A,SLX4,SMC5,SMC6,SMG1,SMG6,SP100,TEP1,TERF1,TERF2,TERF2IP,TERT,TFIP11,TINF2,TNKS1BP1,UPF1,WRAP53,WRN,XRCC3,XRCC5,XRCC6,ZSCAN4	Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins and the length of telomeric DNA. These processes includes those that shorten and lengthen the telomeric DNA sequences.
GO:0000724	GO	BP	double-strand break repair via homologous recombination	ABL1,AP5S1,AP5Z1,ATM,ATR,ATRIP,BABAM1,BARD1,BLM,BRCA1,BRCA2,BRCC3,BRE,BRIP1,CDK2,CHEK1,CLSPN,DNA2,EME1,ERCC1,ERCC4,EXO1,FAM175A,FAN1,FBXO18,FEN1,GEN1,H2AFX,HELQ,HERC2,HIST1H4A,HIST3H3,HUS1,INO80,KAT5,KDM4D,LIG3,MCM9,MDC1,MEIOB,MMS22L,MORF4L1,MRE11A,MUS81,NABP1,NABP2,NBN,NSMCE2,PALB2,PARP1,PIAS4,POLN,POLQ,PPP4C,PPP4R2,PSMD14,RAD1,RAD17,RAD50,RAD51,RAD51AP1,RAD51B,RAD51C,RAD51D,RAD52,RAD54B,RAD9A,RAD9B,RBBP8,RFC2,RFC3,RFC4,RFC5,RHNO1,RMI1,RMI2,RNF138,RNF168,RNF4,RNF8,RPA1,RPA2,RPA3,RPS27A,RTEL1,SFPQ,SFR1,SIRT6,SLX1A,SLX4,SMC5,SPIDR,SUMO1,SUMO2,SWI5,SWSAP1,TIMELESS,TIPIN,TONSL,TOP3A,TOPBP1,TP53BP1,UBA52,UBB,UBC,UBE2I,UBE2N,UBE2V2,UIMC1,WHSC1,WRN,XRCC1,XRCC2,XRCC3,YY1,ZFYVE26,ZSWIM7	The error-free repair of a double-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences. A strand in the broken DNA searches for a homologous region in an intact chromosome to serve as the template for DNA synthesis. The restoration of two intact DNA molecules results in the exchange, reciprocal or nonreciprocal, of genetic material between the intact DNA molecule and the broken DNA molecule.
GO:0000726	GO	BP	non-recombinational repair	ATM,BABAM1,BARD1,BRCA1,BRCC3,BRE,C9orf142,DCLRE1C,FAM175A,H2AFX,HERC2,HIST1H4A,HIST3H3,KAT5,KDM2A,LIG3,LIG4,MDC1,MRE11A,NBN,NHEJ1,PAXIP1,PIAS4,POLA1,POLL,POLM,POLQ,PRKDC,PRPF19,PSMD14,RAD50,RAD52,RBBP8,RIF1,RNF138,RNF168,RNF8,SETMAR,SLX1A,SLX4,SUMO1,TP53BP1,UBE2N,UBE2V2,UIMC1,UVRAG,WHSC1,XRCC4,XRCC5,XRCC6,XRCC6BP1	A DNA repair process in which that does not require the exchange of genetic material between the broken DNA molecule and a homologous region of DNA.
GO:0000729	GO	BP	DNA double-strand break processing	BLM,DNA2,RAD52,RBBP8,RNF138,SETMAR,SLX1A,SLX4,SMARCAD1,UBE2N,UBE2V2	The 5' to 3' exonucleolytic resection of the DNA at the site of the break to form a 3' single-strand DNA overhang.
GO:0000731	GO	BP	DNA synthesis involved in DNA repair	CDKN2D,POLD1,POLD3,POLE,POLH,RFC3,SIRT1,WRN,WRNIP1	Synthesis of DNA that proceeds from the broken 3' single-strand DNA end and uses the homologous intact duplex as the template.
GO:0000733	GO	BP	DNA strand renaturation	BLM,RAD54L,RECQL,RECQL4,SMARCA1,SMARCAL1,TP53,ZRANB3	The identification and annealing of complementary base pairs in single-strand DNA.
GO:0000737	GO	BP	DNA catabolic process, endonucleolytic	CASP3,CECR2,DFFA,DFFB,FBXO18,FOXL2,H1F0,HMGB1,HMGB2,KPNA1,KPNB1,MUS81,SETMAR	The chemical reactions and pathways resulting in the breakdown of DNA, involving the hydrolysis of internal 3',5'-phosphodiester bonds in one or two strands of deoxyribonucleotides.
GO:0000768	GO	BP	syncytium formation by plasma membrane fusion	ADAM12,ADGRB3,CACNA1H,DCSTAMP,KCNH1,NOS1,SH3PXD2A,TMEM8C	The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.
GO:0000775	GO	CC	chromosome, centromeric region	AHCTF1,APC,ATRX,AURKB,BIRC5,BUB1,BUB1B,BUB3,CBX1,CBX3,CBX5,CCNB1,CDCA5,CDCA8,CENPA,CENPB,CENPC,CENPE,CENPF,CENPH,CENPI,CENPT,CENPV,CENPW,CHAMP1,CLASP1,CLASP2,CLIP1,CTCF,DAXX,DCTN1,DCTN2,DSCC1,DSN1,DYNC1I1,DYNC1LI1,DYNLL1,DYNLT3,H2AFY,HELLS,HJURP,INCENP,KIF22,KIF2C,KNSTRN,KNTC1,LRWD1,MAD1L1,MAD2L1,MEIKIN,MIS12,MTBP,NCAPD3,NDC80,NDE1,NDEL1,NEK2,NSL1,NUF2,NUP107,NUP133,NUP160,NUP37,NUP43,NUP85,NUP98,PAFAH1B1,PDS5A,PDS5B,PINX1,PLK1,PMF1,PPP1R12A,PPP2R1A,PPP2R5C,PSEN1,PSEN2,RAD21,RANGAP1,RCC2,SEC13,SEH1L,SGOL1,SGOL2,SKA1,SKA2,SKA3,SMC1A,SMC3,SPAG5,SPC24,SPC25,SPDL1,SS18L1,STAG1,STAG2,SUGT1,SUMO3,SUV420H2,TEX14,TPR,WAPL,XPO1,ZNF207,ZNF330,ZW10,ZWILCH,ZWINT	The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.
GO:0000776	GO	CC	kinetochore	AHCTF1,APC,AURKB,BIRC5,BUB1,BUB1B,BUB3,CCNB1,CENPA,CENPC,CENPE,CENPF,CENPH,CENPI,CENPT,CENPV,CENPW,CHAMP1,CLASP1,CLASP2,CLIP1,DCTN1,DCTN2,DSN1,DYNC1I1,DYNC1LI1,DYNLL1,DYNLT3,HJURP,INCENP,KIF22,KIF2C,KNSTRN,KNTC1,MAD1L1,MAD2L1,MEIKIN,MIS12,MTBP,NDC80,NDE1,NDEL1,NEK2,NSL1,NUF2,NUP107,NUP133,NUP160,NUP37,NUP43,NUP85,NUP98,PAFAH1B1,PINX1,PLK1,PMF1,PPP1R12A,PSEN1,PSEN2,RANGAP1,SEC13,SEH1L,SGOL1,SKA1,SKA2,SKA3,SMC1A,SPAG5,SPC24,SPC25,SPDL1,SS18L1,SUGT1,SUMO3,TEX14,TPR,XPO1,ZNF207,ZW10,ZWILCH,ZWINT	A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules.
GO:0000777	GO	CC	condensed chromosome kinetochore	AHCTF1,BIRC5,BUB1,BUB1B,CCNB1,CENPA,CENPE,CENPF,CHAMP1,DSN1,HJURP,MEIKIN,MIS12,NDC80,NSL1,NUP133,PLK1,PMF1,SKA1,SKA2,SKA3,SPC25,SPDL1	A multisubunit complex that is located at the centromeric region of a condensed chromosome and provides an attachment point for the spindle microtubules.
GO:0000778	GO	CC	condensed nuclear chromosome kinetochore	BUB1,CCNB1,CENPA,NDC80,PLK1	A multisubunit complex that is located at the centromeric region of a condensed nuclear chromosome and provides an attachment point for the spindle microtubules.
GO:0000779	GO	CC	condensed chromosome, centromeric region	AHCTF1,AURKB,BIRC5,BUB1,BUB1B,CBX3,CCNB1,CENPA,CENPC,CENPE,CENPF,CHAMP1,DSN1,HJURP,MEIKIN,MIS12,NDC80,NSL1,NUP133,PLK1,PMF1,SGOL1,SKA1,SKA2,SKA3,SPC25,SPDL1	The region of a condensed chromosome that includes the centromere and associated proteins, including the kinetochore. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.
GO:0000780	GO	CC	condensed nuclear chromosome, centromeric region	AURKB,BUB1,CCNB1,CENPA,CENPC,MEIKIN,NDC80,PLK1	The region of a condensed nuclear chromosome that includes the centromere and associated proteins, including the kinetochore. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.
GO:0000781	GO	CC	chromosome, telomeric region	ACD,ALYREF,APEX1,ATM,ATR,ATRX,BLM,BRCA2,C11orf85,C15orf43,CBX1,CBX3,CBX5,CCDC155,CCDC79,CDC73,CDK1,CHEK1,CHEK2,CTC1,DCLRE1B,DDB1,DNA2,ERCC1,ERCC4,FEN1,GAR1,H2AFX,H2AFY,H2AFY2,H3F3A,HAT1,HIST1H2AA,HIST1H2BA,HIST1H2BB,HIST1H3A,HIST1H4A,HMBOX1,KDM1A,LIG4,LRIF1,LRWD1,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MRE11A,MSH2,NABP1,NABP2,NAT10,NBN,NHP2,NLRP2,NSMCE2,OBFC1,ORC1,ORC2,ORC3,ORC4,ORC5,PARP1,PCNA,PIF1,PINX1,POLD1,POLR2B,POT1,PPP1CA,PPP1CB,PPP1CC,PPP1R10,PRKDC,PTGES3,PURA,RAD17,RAD50,RAD51,RAD51D,RNF8,RPA1,RPA2,SIRT2,SIRT6,SLX4,SMC5,SMC6,SMCHD1,SP100,SSB,TEN1,TERF1,TERF2,TERF2IP,TERT,TFIP11,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TINF2,TNKS,TNKS1BP1,TNKS2,TOX4,TP53BP1,UPF1,WDR82,WRNIP1,XRCC3,XRCC5,XRCC6,ZSCAN4	The terminal region of a linear chromosome that includes the telomeric DNA repeats and associated proteins.
GO:0000783	GO	CC	nuclear telomere cap complex	ACD,CCDC79,CTC1,OBFC1,POT1,TEN1,TERF1,TERF2,TERF2IP,TERT,TINF2,XRCC5,XRCC6	A complex of DNA and protein located at the end of a linear chromosome in the nucleus that protects and stabilizes a linear chromosome.
GO:0000784	GO	CC	nuclear chromosome, telomeric region	ACD,ALYREF,APEX1,ATM,ATR,ATRX,BRCA2,C11orf85,C15orf43,CBX1,CBX3,CBX5,CCDC79,CDC73,CDK1,CTC1,DCLRE1B,DDB1,DNA2,ERCC1,ERCC4,FEN1,GAR1,H2AFY,H2AFY2,H3F3A,HAT1,HIST1H2AA,HIST1H2BA,HIST1H2BB,HIST1H3A,HIST1H4A,HMBOX1,KDM1A,LIG4,LRIF1,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MRE11A,MSH2,NABP1,NABP2,NAT10,NBN,NHP2,NLRP2,OBFC1,ORC1,ORC2,ORC3,ORC4,ORC5,PARP1,PCNA,PIF1,PINX1,POLD1,POLR2B,POT1,PPP1CA,PPP1CB,PPP1CC,PPP1R10,PRKDC,PURA,RAD50,RAD51,RAD51D,RPA1,RPA2,SIRT6,SLX4,SMCHD1,SP100,SSB,TEN1,TERF1,TERF2,TERF2IP,TERT,TFIP11,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TINF2,TNKS,TNKS1BP1,TNKS2,TOX4,UPF1,WDR82,WRNIP1,XRCC3,XRCC5,XRCC6,ZSCAN4	The terminal region of a linear nuclear chromosome that includes the telomeric DNA repeats and associated proteins.
GO:0000786	GO	CC	nucleosome	H2AFB1,H2AFB2,H2AFY,H3F3A,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H2A,HIST3H3,KAT6B,MPHOSPH8,SLF1,TNP1	A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
GO:0000788	GO	CC	nuclear nucleosome	H2AFB1,H2AFB2,H3F3A,HIST1H3A,HIST3H2A,HIST3H3,MPHOSPH8	A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA in the nucleus into higher order structures.
GO:0000790	GO	CC	nuclear chromatin	ACTB,ACTL6A,ACTR5,ACTR8,ANP32E,APTX,AR,ARID1A,ASF1A,ASF1B,ASXL1,ATRX,BEND3,BRD8,BUD31,CBX1,CBX3,CBX5,CBX7,CBX8,CCAR2,CDCA5,CHAF1A,CHAF1B,CHD4,CITED2,CREB1,CREBBP,CSNK2A1,CTNNB1,DDX11,DFFA,DFFB,DLX5,DPF2,DVL3,E2F1,E2F4,EHMT2,EP400,ESR1,EZH2,FAM60A,FER,FOXC1,FOXD3,FOXH1,GABPA,GATA3,GATAD2B,H1F0,H1FNT,H2AFB1,H2AFB2,H2AFY,H2AFY2,H2AFZ,H3F3A,H3F3C,HAND2,HAT1,HDAC1,HDAC2,HEY2,HIRA,HIST1H1A,HIST1H1B,HIST1H1C,HIST1H1D,HIST1H1E,HIST1H3A,HIST3H2A,HIST3H3,HMGB2,HNRNPC,HNRNPK,ING2,ING3,INO80,INO80B,INO80C,INO80E,IPO4,IRF1,JUN,KAT5,KDM1A,KDM4C,KLF1,KLF4,KLHDC3,LDB1,MBD2,MBD3,MCRS1,MEF2A,MIXL1,MORF4L1,MPHOSPH8,MTA2,MUC1,MYOD1,NACC2,NASP,NCAPD3,NCOA1,NCOA3,NCOR1,NFATC1,NFRKB,NPM2,NR1D1,NR1H3,NR1H4,NRIP1,NSMF,NUFIP1,PAX6,PCGF2,PHF12,PHOX2A,PHOX2B,PLCB1,POGZ,POLR3D,POLR3G,POLR3GL,PPARD,PSIP1,RARA,RBBP4,RBMX,RCC1,RFX3,RUNX2,RUNX3,RUVBL1,RUVBL2,RXRA,SCRT2,SFR1,SIN3A,SIRT1,SIRT2,SIRT6,SIRT7,SLX4,SMAD2,SMAD3,SMAD4,SMARCA2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCD3,SMARCE1,SNAI2,SOX18,SP1,SPI1,STAT1,STAT3,SUDS3,SUV420H2,SWI5,T,TAL1,TBP,TCF12,TCF3,TCF4,TCF7L2,TFPT,TIMELESS,TIPIN,TNKS1BP1,TP53,TP63,TRNP1,TRRAP,UCHL5,UHRF1,UHRF2,USP3,WBP2,YY1,ZNF385A	The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
GO:0000791	GO	CC	euchromatin	ANKRD2,CBX3,CREB1,CTNNB1,DNMT3A,H1F0,H2AFZ,H3F3C,HIST1H1A,HIST1H1C,HIST1H1D,JUN,NR1H4,NSMF,RBMX,RUVBL2,SIRT1,TBP,TRNP1,UHRF1	A dispersed and relatively uncompacted form of chromatin.
GO:0000792	GO	CC	heterochromatin	ATRX,BAZ2A,BEND3,CBX1,CBX3,CBX5,CDKN2A,CENPC,CHD5,FOXC1,H2AFY,H2AFZ,HELLS,HIST1H1B,HIST1H1E,HMGA1,HMGA2,INCENP,LRWD1,MECP2,MPHOSPH8,NCAPD3,ORC2,PSIP1,RNF20,RNF40,RRP8,SALL1,SIRT1,SIRT2,SIRT6,SMARCAD1,SUV39H1,SUV420H2,TNKS1BP1,TOP2B,UBA1,UBE2A,UBE2B,UHRF1,UHRF2	A compact and highly condensed form of chromatin.
GO:0000793	GO	CC	condensed chromosome	AHCTF1,AURKB,AURKC,BIRC5,BLM,BRD4,BUB1,BUB1B,CBX3,CCNB1,CCNB1IP1,CDCA5,CENPA,CENPC,CENPE,CENPF,CHAMP1,CHEK1,CHMP1A,CTCF,DSN1,EID3,FKBP6,HJURP,HMGB1,HMGB2,KIFAP3,L3MBTL1,LIG4,LRPPRC,MEI4,MEIKIN,MIS12,NCAPD2,NCAPD3,NCAPG,NCAPH,NDC80,NDNL2,NIFK,NOL6,NSL1,NSMCE1,NSMCE2,NSMCE4A,NUP133,P3H4,PLK1,PMF1,RAD21,RAD21L1,RAD51,RCC1,RGS12,RNF212,RRS1,SETMAR,SGOL1,SGOL2,SKA1,SKA2,SKA3,SMARCA5,SMC1A,SMC1B,SMC2,SMC3,SMC4,SMC5,SMC6,SPC25,SPDL1,STAG3,SUV39H1,SYCE1,SYCE2,SYCE3,SYCP2,TEX11,TTN,TUBG1,UBE2I,WAPL	A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.
GO:0000794	GO	CC	condensed nuclear chromosome	AURKB,BLM,BRD4,BUB1,CCNB1,CCNB1IP1,CENPA,CENPC,CHEK1,CHMP1A,FKBP6,KIFAP3,LRPPRC,MEI4,MEIKIN,NCAPD3,NDC80,NIFK,NOL6,P3H4,PLK1,RAD51,RCC1,RGS12,RNF212,RRS1,SMC1A,STAG3,SUV39H1,SYCE1,SYCE2,SYCE3,SYCP2,TEX11,TTN,TUBG1,UBE2I	A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct nuclear chromosome.
GO:0000795	GO	CC	synaptonemal complex	BLM,CCNB1IP1,FKBP6,MEI4,RNF212,STAG3,SYCE1,SYCE2,SYCE3,SYCP2,TEX11,UBE2I	A proteinaceous scaffold found between homologous chromosomes during meiosis.
GO:0000796	GO	CC	condensin complex	NCAPD2,NCAPD3,NCAPG,NCAPH,SMC2,SMC4	A multisubunit protein complex that plays a central role in chromosome condensation.
GO:0000808	GO	CC	origin recognition complex	LRWD1,ORC1,ORC2,ORC3,ORC4,ORC5,ORC6,REPIN1	A multisubunit complex that is located at the replication origins of a chromosome.
GO:0000812	GO	CC	Swr1 complex	ANP32E,BRD8,EP400,ING3,KAT5,RUVBL1,RUVBL2,TRRAP	A multisubunit protein complex that is involved in chromatin remodeling. It is required for the incorporation of the histone variant H2AZ into chromatin. In S. cerevisiae, the complex contains Swr1p, a Swi2/Snf2-related ATPase, and 12 additional subunits.
GO:0000813	GO	CC	ESCRT I complex	MVB12A,MVB12B,TSG101,UBAP1,VPS28,VPS37A,VPS37B,VPS37C,VPS37D	An endosomal sorting complex required for transport. It consists of the class E vacuolar protein sorting (Vps) proteins and interacts with ubiquitinated cargoes.
GO:0000815	GO	CC	ESCRT III complex	CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP6,CHMP7,VPS4A	An endosomal sorting complex required for transport. Consists of two soluble subcomplexes of highly charged coiled-coil proteins and is required for sorting and/or concentration of multivesicular body (MVB) cargoes.
GO:0000819	GO	BP	sister chromatid segregation	BECN1,CCNB1,CDC23,CDCA5,CDCA8,CENPE,CHAMP1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,DDX11,DIS3L2,DLGAP5,DSCC1,ESPL1,FBXW7,GSG2,HDAC8,HORMAD1,HORMAD2,INO80,KIF14,KIF18A,KIF22,KIF25,KIF2C,KIFC1,KLHL22,KNSTRN,KPNB1,LATS1,MAU2,MCMBP,MEIKIN,MRE11A,NAA50,NCAPD2,NCAPD3,NCAPG,NCAPH,NDC80,NIPBL,NUSAP1,PAPD7,PDS5B,PHB2,PHF13,PIBF1,PINX1,PLK1,POGZ,PSRC1,RAB11A,RAD51C,RB1,REC8,RRS1,SEH1L,SMC1A,SMC2,SMC3,SMC4,SPAG5,SPDL1,STAG2,TEX14,VPS4A,VPS4B,ZNF207,ZW10,ZWINT	The cell cycle process in which sister chromatids are organized and then physically separated and apportioned to two or more sets.
GO:0000900	GO	MF	translation repressor activity, nucleic acid binding	CELF1,CELF4,CPEB1,CPEB2,CPEB3,PAIP2B,ZNF540	Antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct binding (through a selective and non-covalent interaction) to nucleic acid.
GO:0000910	GO	BP	cytokinesis	AHCTF1,ALKBH4,ANK3,ANLN,APC,ARHGEF11,ARL3,AURKB,BBS4,BCL2L1,BECN1,BIN3,BIRC5,BRCA2,CECR2,CEP55,CIT,CKAP2,CNTROB,CUL7,DAPK3,DCTN3,DIAPH2,ECT2,ESPL1,FMN2,INCENP,IST1,JTB,KIF13A,KIF20A,KIF23,KIF4A,KIF4B,KLHL13,KLHL9,MITD1,MYH10,MYH9,NEK6,NEK7,NOX5,NUSAP1,PIK3C3,PLK1,PRC1,RAB11A,RAB11FIP3,RAB11FIP4,RAB35,RACGAP1,RALA,RALB,RASA1,RHOA,RHOB,RHOC,ROCK2,ROPN1B,SEPT5,SEPT6,SEPT7,SNX18,SNX33,SNX9,SON,SPIRE1,SPIRE2,SPTBN1,STAMBP,TTC19,USP8,ZFYVE26,ZNF365	The division of the cytoplasm and the plasma membrane of a cell and its partitioning into two daughter cells.
GO:0000920	GO	BP	cell separation after cytokinesis	CEP55,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,KIF20A,MITD1,PDCD6IP,VPS4A,VPS4B	The process of physically separating progeny cells after cytokinesis; this may involve enzymatic digestion of septum or cell wall components.
GO:0000922	GO	CC	spindle pole	ASPM,AUNIP,AURKA,BIRC6,CALM1,CCNB1,CDC25B,CDC6,CDK5RAP2,CENPF,CEP128,CEP19,CEP44,CEP63,CEP85,CEP89,CEP95,CETN1,CKAP5,CSPP1,CTDP1,CUL3,DCTN1,DDX11,DLGAP5,DYNC1I1,DYNC1LI1,EML1,FAM175B,FAM83D,FBF1,GOLGA2,GPSM2,IKBKG,KATNA1,KATNB1,KIF11,KIF20B,KIF2A,KLHL21,KLHL22,KNTC1,LATS1,LATS2,MAP10,MTCL1,NDE1,NIN,NPM1,NUMA1,OR2A4,PKP4,PLK1,POC1A,POC1B,PSRC1,RAB11A,RGS14,SBDS,SGOL1,SMC3,SPDL1,TBCCD1,TOPORS,TPX2,TUBG1,TUBGCP3,UMOD,UNC119,VPS4A,VPS4B,WDR62,ZW10	Either of the ends of a spindle, where spindle microtubules are organized; usually contains a microtubule organizing center and accessory molecules, spindle microtubules and astral microtubules.
GO:0000930	GO	CC	gamma-tubulin complex	BLOC1S2,BRCA1,CENPJ,CEP290,CKAP5,MARK4,MZT1,MZT2A,MZT2B,TOPORS,TUBG1,TUBGCP4,TUBGCP5,TUBGCP6,UXT,ZNF365	A multiprotein complex composed of gamma-tubulin and other non-tubulin proteins. Gamma-tubulin complexes are localized to microtubule organizing centers, and play an important role in the nucleation of microtubules. The number and complexity of non-tubulin proteins associated with these complexes varies between species.
GO:0000932	GO	CC	cytoplasmic mRNA processing body	AGO2,AJUBA,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,BTBD1,BTBD2,CAPRIN1,CNOT1,CNOT3,CNOT7,DCP1A,DCP2,DDX6,DIS3L2,EDC4,EIF4E,LIMD1,LIN28A,LSM14A,MOV10,NANOS2,NANOS3,PATL1,PNRC2,PSMA2,PSMA4,PSMA6,PSMC2,PSMC3,PUM1,RC3H1,RQCD1,SQSTM1,TNRC6A,TOP1,TRIM5,TRIM71,WTIP,YTHDF2,ZC3H12A,ZC3H12D	A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. mRNA processing and binding proteins are localized to these foci.
GO:0000940	GO	CC	condensed chromosome outer kinetochore	BUB1,BUB1B,CCNB1,CENPE,CENPF,NDC80,NUP133,PLK1,SKA1,SKA2,SKA3,SPDL1	The region of a condensed chromosome kinetochore most external to centromeric DNA; this outer region mediates kinetochore-microtubule interactions.
GO:0000956	GO	BP	nuclear-transcribed mRNA catabolic process	AGO1,ATM,CASC3,CNOT1,CNOT10,CNOT11,CNOT2,CNOT3,CNOT4,CNOT6,CNOT6L,CNOT7,CNOT8,CSDE1,CTIF,DCP1A,DCP1B,DCP2,DCPS,DDX6,DHX34,DIS3,DIS3L2,DXO,EDC3,EDC4,EIF3E,EIF4A1,EIF4A2,EIF4A3,EIF4B,EIF4E,EIF4G1,ETF1,EXOSC1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,FAU,GSPT1,GSPT2,LSM1,LSM2,LSM3,LSM4,LSM5,LSM6,LSM7,MAGOH,MAGOHB,MTPAP,NBAS,NCBP1,NCBP2,NT5C3B,PABPC1,PAIP1,PAN2,PAN3,PAPD4,PAPD5,PARN,PATL1,PNRC2,PPP2CA,PPP2R1A,PPP2R2A,RBM8A,RC3H1,RNPS1,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RQCD1,SMG1,SMG5,SMG6,SMG7,SMG8,SMG9,THRAP3,TNKS1BP1,UBA52,UPF1,UPF2,UPF3A,UPF3B,XRN1,ZFP36	The chemical reactions and pathways resulting in the breakdown of nuclear-transcribed mRNAs in eukaryotic cells.
GO:0000959	GO	BP	mitochondrial RNA metabolic process	AARS2,DARS2,EARS2,ELAC2,FASTKD5,GTPBP3,HSD17B10,KIAA0391,MRPL12,MTERF1,MTO1,PNPT1,POLRMT,PUS1,SLC25A33,SUPV3L1,TARS2,TEFM,TFAM,TFB2M,TRIT1,TRMT10C,TRMT61B,TRMU,TRNT1,YARS2	The chemical reactions and pathways involving RNA transcribed from the mitochondrial genome and occurring in the mitochondrion.
GO:0000963	GO	BP	mitochondrial RNA processing	ELAC2,FASTKD5,GTPBP3,HSD17B10,KIAA0391,MTO1,PNPT1,PUS1,SUPV3L1,TRIT1,TRMT10C,TRMT61B,TRMU,TRNT1	The conversion of a primary RNA molecule transcribed from a mitochondrial genome into one or more mature RNA molecules; occurs in the mitochondrion.
GO:0000966	GO	BP	RNA 5'-end processing	NOP14,PIWIL2,PNPT1,TRMT10C,UTP20	Any process involved in forming the mature 5' end of an RNA molecule.
GO:0000974	GO	CC	Prp19 complex	CDC5L,CTNNBL1,HSPA8,POLR2A,PRPF19,U2AF2	A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
GO:0000978	GO	MF	RNA polymerase II core promoter proximal region sequence-specific DNA binding	ACTB,ACTL6A,AKNA,AR,ASCL1,ASCL2,ATF7,BATF3,BCL11A,BHLHE41,CDX4,CEBPE,CEBPZ,CHD4,CLOCK,CREB1,CREB3,CRX,CTCF,CTCFL,DDIT3,DLX4,DLX5,DPF2,E2F4,E2F8,EGR2,EHF,ELF1,ELF4,ELK1,ELK3,EN1,ESR1,ETS2,ETV1,ETV4,FOXA2,FOXI1,FOXJ2,FOXK2,FUBP3,GABPA,GATAD2B,GCFC2,GCM1,GLI3,GRHL1,GZF1,H2AFZ,HAND1,HDAC1,HDAC2,HHEX,HNRNPC,HNRNPK,HOXA10,HOXA5,HOXA7,HOXC11,HSF1,IFI16,INSM1,IRF1,IRF4,KLF5,MBD2,MBD3,MEF2A,MEF2B,MEIS2,MEOX2,MITF,MIXL1,MTA2,MTF1,MUC1,MXD1,MYB,MYBL1,MYBL2,MYC,MZF1,NACC2,NEUROG3,NFAT5,NFATC3,NFIA,NFIB,NFIC,NFKB2,NKX2-5,NKX2-8,NPAS4,NR1D1,NR1H2,NR3C1,NRF1,NRL,ONECUT2,OTX1,OTX2,PER1,PGR,PHOX2B,PLAG1,POU2F3,POU4F2,POU4F3,PPARA,PRDM1,PRDM5,RAX,RBBP4,RELA,RFX4,SIX1,SKIL,SMAD1,SMAD2,SMAD3,SMAD4,SMAD6,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SOX18,SP1,SREBF2,SRF,STAT1,STAT3,T,TBX2,TBX3,TCF12,TCF3,TCF4,TCF7L2,TFAM,TFAP2A,TGIF1,TP73,TXK,YBX1,ZGPAT,ZIC3,ZKSCAN3,ZNF148,ZNF217,ZNF219,ZNF281,ZNF395,ZNF536,ZNF639,ZNF746,ZSCAN21	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II.
GO:0000979	GO	MF	RNA polymerase II core promoter sequence-specific DNA binding	GATA1,H2AFY,H2AFZ,H3F3A,IRF7,MAZ,NLRC5,NSD1,PAX6,PAX8,RREB1,RUVBL2,SOX11,SOX3,SOX8,STAT1,TFAP2A,TFAP2B,WBP2	Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for transcription factors of the RNA polymerase II basal transcription machinery.
GO:0000980	GO	MF	RNA polymerase II distal enhancer sequence-specific DNA binding	ACTB,ACTL6A,ATF2,CDX1,CDX2,CHD4,CREB1,ESRRB,GATAD2B,GZF1,H2AFZ,H3F3A,HDAC1,HDAC2,HNRNPC,JUN,MBD2,MBD3,MEOX2,MIXL1,MTA2,NFATC1,NFKB1,NONO,NR1H4,NR5A1,NR5A2,POU4F1,RBBP4,REL,RELA,RUVBL2,SFPQ,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SPI1,T,ZBTB16	Interacting selectively and non-covalently with a RNA polymerase II (Pol II) distal enhancer. In mammalian cells, enhancers are distal sequences that increase the utilization of some promoters, and can function in either orientation and in any location (upstream or downstream) relative to the core promoter.
GO:0000982	GO	MF	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	AKNA,AR,ARNTL,ARNTL2,ASCL1,ASCL2,ATF7,BACH1,BATF3,BCL11A,BHLHE40,BHLHE41,CDX4,CEBPE,CEBPG,CEBPZ,CLOCK,CREB1,CREB3,CREB3L1,CREBBP,CRX,CTCF,CTCFL,DACH1,DBP,DDIT3,DLX4,DLX5,E2F4,E2F8,EGR2,EHF,ELF1,ELF4,ELK1,ELK3,EN1,ESR1,ETS2,ETV1,ETV4,FOXA1,FOXC2,FOXI1,FOXJ2,FOXK2,FUBP3,GABPA,GATA1,GATA3,GCFC2,GCM1,GFI1,GLI3,GLIS2,GRHL1,GZF1,HAND1,HAND2,HES1,HES5,HHEX,HMGA2,HNF1A,HNF4A,HNRNPK,HOXA10,HOXA5,HOXA7,HOXC11,HSF1,IFI16,INSM1,IRF1,IRF4,IRF7,KLF15,KLF4,KLF5,MEF2A,MEF2B,MEF2C,MEIS2,MEOX2,MITF,MIXL1,MTF1,MXD1,MYB,MYBL1,MYBL2,MYC,MYOCD,MZF1,NACC2,NEUROG3,NFAT5,NFATC3,NFIA,NFIB,NFIC,NFIL3,NFKB2,NFX1,NKX2-5,NKX2-8,NPAS4,NR1D1,NR1H2,NR1H4,NR3C1,NR4A1,NR4A2,NR4A3,NRF1,NRL,ONECUT1,ONECUT2,OTX1,OTX2,PGR,PHOX2B,PITX2,PLAG1,PLAGL2,PLSCR1,POU2F3,POU4F2,POU4F3,PPARA,PRDM1,PRDM5,RAX,RBPJ,RCOR1,RELA,REST,RFX4,SCRT2,SIX1,SKIL,SMAD1,SMAD2,SMAD4,SNAI1,SNAI2,SOX11,SOX12,SOX18,SOX4,SOX9,SP1,SREBF2,SRF,STAT3,TBX2,TBX3,TCF12,TCF21,TCF3,TCF4,TFAM,TFAP2A,TFAP2C,TGIF1,TP73,TXK,WT1,YBX1,YY1,ZFPM1,ZGPAT,ZIC3,ZKSCAN3,ZNF148,ZNF217,ZNF219,ZNF281,ZNF536,ZNF639,ZNF746,ZNF750,ZSCAN21	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to modulate transcription by RNAP II.
GO:0000983	GO	MF	transcription factor activity, RNA polymerase II core promoter sequence-specific	HEY1,HEY2,HEYL,MEF2C,SMAD3,SRF,STAT1,TFAP2B	Interacting selectively and non-covalently with a specific DNA sequence in an RNA polymerase II (Pol II) core promoter, the region composed of the transcription start site and binding sites for transcription factors of the Pol II basal transcription machinery, in order to modulate transcription by Pol II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
GO:0000987	GO	MF	core promoter proximal region sequence-specific DNA binding	ACTB,ACTL6A,AKNA,AR,ASCL1,ASCL2,ATF7,BATF3,BCL11A,BHLHE41,CDX4,CEBPE,CEBPZ,CHD4,CLOCK,CREB1,CREB3,CREBBP,CRX,CTCF,CTCFL,DDIT3,DLX4,DLX5,DMRT1,DPF2,E2F4,E2F8,EGR2,EHF,ELF1,ELF4,ELK1,ELK3,EN1,ESR1,ETS2,ETV1,ETV4,FOXA2,FOXI1,FOXJ2,FOXK2,FUBP3,GABPA,GATA3,GATAD2B,GCFC2,GCM1,GLI3,GRHL1,GZF1,H2AFZ,HAND1,HDAC1,HDAC2,HHEX,HNRNPC,HNRNPK,HOXA10,HOXA5,HOXA7,HOXC11,HSF1,IFI16,INSM1,IRF1,IRF4,KLF1,KLF4,KLF5,MBD2,MBD3,MEF2A,MEF2B,MEIS2,MEOX2,MITF,MIXL1,MTA2,MTF1,MUC1,MXD1,MYB,MYBL1,MYBL2,MYC,MZF1,NACC2,NEUROG3,NFAT5,NFATC3,NFIA,NFIB,NFIC,NFKB2,NKX2-5,NKX2-8,NPAS4,NR1D1,NR1H2,NR3C1,NRF1,NRL,ONECUT2,OTX1,OTX2,PAX2,PER1,PGR,PHOX2B,PLAG1,POU2F3,POU4F2,POU4F3,PPARA,PRDM1,PRDM5,RAX,RBBP4,RELA,RFX4,SIX1,SKIL,SMAD1,SMAD2,SMAD3,SMAD4,SMAD6,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SOX18,SP1,SREBF2,SRF,STAT1,STAT3,T,TBX2,TBX3,TCF12,TCF3,TCF4,TCF7L2,TFAM,TFAP2A,TGIF1,TP73,TXK,UBTF,UHRF1,YBX1,ZGPAT,ZIC3,ZKSCAN3,ZNF148,ZNF217,ZNF219,ZNF281,ZNF395,ZNF516,ZNF536,ZNF639,ZNF746,ZSCAN21	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to the core promoter. The transcribed region might be described as a gene, cistron, or operon.
GO:0000993	GO	MF	RNA polymerase II core binding	AGO1,AGO2,C14orf166,CCAR2,CDC73,ELP2,ELP3,ELP4,IKBKAP,PAF1,RECQL5,RPRD1B,SMYD2,UVSSA,WAC,ZNF326	Interacting selectively and non-covalently with RNA polymerase II core enzyme, a multisubunit eukaryotic nuclear RNA polymerase typically composed of twelve subunits.
GO:0001013	GO	MF	RNA polymerase I regulatory region DNA binding	BAZ2A,CEBPA,PIH1D1,RRN3,SMARCA4,SMARCB1,TAF1B,TAF1C,UBTF	Interacting selectively and non-covalently with a DNA region that controls the transcription of a region of DNA by RNA polymerase I. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
GO:0001046	GO	MF	core promoter sequence-specific DNA binding	ATF4,BAZ2A,CHD2,CIART,ESR1,ESR2,GATA1,GATA3,H2AFY,H2AFZ,H3F3A,IRF7,KLF10,KMT2A,MAZ,MEOX1,MTA1,MYOCD,NFYA,NLRC5,NR1D1,NR1D2,NR4A3,NRF1,NRIP1,NSD1,PAX6,PAX8,PIH1D1,PPARG,PRMT5,PROX1,REST,RORA,RREB1,RRN3,RUVBL2,SMARCA4,SMARCB1,SOX1,SOX11,SOX3,SOX4,SOX8,SOX9,SP1,STAT1,TAF1B,TAF1C,TFAP2A,TFAP2B,THRAP3,TOP1,TP53,UBTF,WBP2,ZFHX3,ZNF431,ZNF750	Interacting selectively and non-covalently with a sequence of DNA that is part of a core promoter region composed of the transcription start site and binding sites for the basal transcription machinery. The transcribed region might be described as a gene, cistron, or operon.
GO:0001047	GO	MF	core promoter binding	AGO1,AGO2,ARNTL,ATF4,BAZ2A,CALCOCO1,CCAR1,CHD2,CIART,CLOCK,CRY1,DHX36,E2F1,E2F2,E2F3,E2F7,E2F8,ELK4,EP300,ESR1,ESR2,EZH2,FOXO3,FOXP3,GATA1,GATA3,H2AFY,H2AFZ,H3F3A,HDAC1,HDAC4,HDAC5,HDAC6,HMGA2,HNRNPU,IFI16,INSM1,IRF7,IRF9,KLF10,KMT2A,MAZ,MED1,MEOX1,MTA1,MTF1,MYBBP1A,MYOCD,MYOD1,MYOG,NEUROG3,NFYA,NKX2-1,NKX3-1,NLRC5,NONO,NOTCH1,NPAS2,NR1D1,NR1D2,NR4A3,NRF1,NRIP1,NSD1,PAX6,PAX8,PIH1D1,PPARG,PRMT5,PROX1,PSPC1,RB1,RBMX,RELB,REST,RORA,RREB1,RRN3,RUNX1,RUVBL2,SFPQ,SMARCA4,SMARCB1,SOX1,SOX11,SOX3,SOX4,SOX8,SOX9,SP1,SPI1,STAT1,TAF1B,TAF1C,TFAP2A,TFAP2B,TFAP2C,THRAP3,TOP1,TP53,UBTF,WBP2,XBP1,ZFHX3,ZNF281,ZNF431,ZNF750	Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for the basal transcription machinery. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
GO:0001076	GO	MF	transcription factor activity, RNA polymerase II transcription factor binding	ANKRD1,ATF2,ATF4,BEND6,BHLHE40,BHLHE41,CITED2,CLOCK,CNOT2,CREB1,CREBBP,CTBP1,ELANE,EOMES,GATA4,HDAC1,HDGF,HIPK2,ISL1,JADE1,JUN,KLF4,LIF,LMO2,MED1,MED12,MED13,MED14,MED17,MED24,MED26,MED30,MED4,MEF2A,MIXL1,MYOCD,N4BP2L2,NACC2,NCOA1,NEUROD1,NFIB,NOTCH1,NOTCH2,NR1H4,NR3C1,PHF12,PITX2,POU1F1,PPARGC1A,PPARGC1B,PSIP1,RBBP8,RBM14,SMARCA2,SMARCA4,SOX11,SOX12,SOX3,SOX4,SPEN,T,TBX18,TBX20,TBX6,TCERG1,TCF4,TCP10L,TFAP2B,THRAP3,TLE1,TP53BP1,TRERF1,TRIM28,URI1,UXT,WBP2,WWOX,ZFPM2,ZMYND8	Interacting selectively and non-covalently with an RNA polymerase II transcription factor, which may be a single protein or a complex, in order to modulate transcription. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well.
GO:0001077	GO	MF	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	AKNA,AR,CDX4,CEBPE,CEBPG,CEBPZ,CREB1,CREB3,CREB3L1,CRX,CTCFL,DBP,DDIT3,DLX5,E2F4,EGR2,EHF,ELF1,ELF4,ELK1,ELK3,ESR1,ETV1,ETV4,FOXA1,FOXC2,FOXI1,FOXJ2,FOXK2,FUBP3,GABPA,GCM1,GLI3,GLIS2,GRHL1,HAND2,HMGA2,HNF1A,HNF4A,HNRNPK,HOXA10,HOXA5,HOXA7,HOXC11,IRF1,IRF4,KLF15,KLF4,KLF5,MEF2A,MEF2B,MEF2C,MEIS2,MEOX2,MITF,MIXL1,MTF1,MYB,MYBL1,MYBL2,MYC,MYOCD,MZF1,NFAT5,NFATC3,NFIA,NFIB,NFIC,NFKB2,NKX2-5,NKX2-8,NPAS4,NR1H2,NR1H4,NR3C1,NR4A1,NR4A2,NR4A3,NRF1,NRL,ONECUT1,ONECUT2,OTX1,OTX2,PGR,PHOX2B,PLAG1,PLAGL2,PLSCR1,POU2F3,POU4F2,POU4F3,PPARA,RAX,RBPJ,RELA,RFX4,SIX1,SMAD1,SMAD2,SMAD4,SOX11,SOX12,SOX18,SOX4,SOX9,SRF,STAT3,TCF12,TCF21,TCF4,TFAM,TFAP2A,TFAP2C,TP73,TXK,WT1,YBX1,ZIC3,ZNF639,ZNF750,ZSCAN21	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.
GO:0001078	GO	MF	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	ASCL1,ASCL2,ATF7,BACH1,BATF3,BCL11A,BHLHE40,BHLHE41,CREBBP,CTCF,DACH1,DLX4,E2F8,EN1,ETS2,GATA1,GATA3,GCFC2,GFI1,GZF1,HAND1,HES1,HES5,HHEX,HMGA2,HSF1,IFI16,INSM1,MXD1,MZF1,NACC2,NEUROG3,NFIL3,NFX1,NR1D1,PITX2,POU4F2,PPARA,PRDM1,PRDM5,RCOR1,RELA,REST,SCRT2,SKIL,SNAI1,SNAI2,SREBF2,TBX2,TBX3,TCF21,TCF3,TFAP2A,TFAP2C,TGIF1,YY1,ZFPM1,ZGPAT,ZKSCAN3,ZNF148,ZNF217,ZNF219,ZNF281,ZNF536,ZNF746	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to stop, prevent, or reduce the frequency, rate or extent of transcription from an RNA polymerase II promoter.
GO:0001085	GO	MF	RNA polymerase II transcription factor binding	ANKRD2,BHLHE40,BHLHE41,CREBBP,DMAP1,EGR2,EOMES,GSC,HIPK2,HNF4A,KLF4,MIXL1,NFATC1,SP1,SPI1,T,TBX20,TBX3,TBX6,TCF4,WWP2	Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.
GO:0001099	GO	MF	basal RNA polymerase II transcription machinery binding	AGO1,AGO2,C14orf166,CCAR2,CDC73,ELP2,ELP3,ELP4,IKBKAP,PAF1,RECQL5,RPRD1B,SMYD2,TCF4,UVSSA,WAC,ZNF326	Interacting selectively and non-covalently with the basal transcription machinery for RNA polymerase II which is composed of the RNA polymerase II core enzyme, a multisubunit eukaryotic nuclear RNA polymerase typically composed of twelve subunits, and the basal RNA polymerase II transcription factors, the minimal set of factors required for formation of the preinitiation complex (PIC) by the RNA polymerase.
GO:0001101	GO	BP	response to acid chemical	ABCB4,ABL2,ACER2,ADCY6,ADNP2,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AQP1,AQP3,ASXL1,ATP2B4,BRINP3,CAPN2,CCL19,CCL21,CCR7,CD36,CDKN2D,CPEB1,CPEB3,CPEB4,CTSH,DGAT2,DHFR,EGR1,EPHA3,FFAR1,FFAR2,FFAR3,FOLR1,FOLR2,FZD10,FZD4,FZD7,GLRA1,GNAS,GNB1,GNG2,GPRC6A,HLCS,HSD17B2,HTRA2,INS,IPO5,KCNK4,KMT2E,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LTK,LYN,MICB,MTOR,NDUFA13,NEURL1,NR1H4,NSMF,OGT,OR51E2,OVCA2,PAX2,PDGFB,PDK3,PDK4,PID1,PKD2,PPARG,PTGER2,PTGFR,PTK2B,PTK6,PTK7,RARA,RARG,RBP4,RET,RORB,RPTOR,RRAGA,RRAGB,RRAGC,RRAGD,RXRA,SETX,SH3BP4,SHMT1,SLC38A9,SNW1,SP100,TBX1,TESC,TGFBR3,TMBIM6,TMEM161A,TNFSF4,TWF2,UBR1,UBR2,WNT10B,WNT11,WNT2,WNT3,WNT3A,WNT5A,WNT5B,WNT6,WNT8A,WNT8B,WNT9A,WNT9B,XBP1,ZC3H12A,ZNF35	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by the chemical structure of the anion portion of a dissociated acid (rather than the acid acting as a proton donor). The acid chemical may be in gaseous, liquid or solid form.
GO:0001102	GO	MF	RNA polymerase II activating transcription factor binding	BHLHE40,BHLHE41,CREBBP,EGR2,EOMES,HIPK2,HNF4A,TBX20,TBX3,TBX6	Interacting selectively and non-covalently with an RNA polymerase II transcription activating factor, a protein involved in positive regulation of transcription.
GO:0001104	GO	MF	RNA polymerase II transcription cofactor activity	ANKRD1,BEND6,CITED2,CNOT2,CREBBP,CTBP1,ELANE,HDAC1,HDGF,HIPK2,ISL1,JADE1,MED1,MED12,MED13,MED14,MED17,MED24,MED26,MED30,MED4,MEF2A,N4BP2L2,NCOA1,NEUROD1,NFIB,PHF12,PITX2,POU1F1,PPARGC1A,PPARGC1B,PSIP1,RBBP8,RBM14,SMARCA2,SMARCA4,SOX11,SOX12,SOX3,SOX4,TBX18,TBX20,TCERG1,TCP10L,TFAP2B,THRAP3,TLE1,TP53BP1,TRERF1,TRIM28,URI1,UXT,WBP2,WWOX,ZFPM2,ZMYND8	Interacting selectively and non-covalently with an RNA polymerase II (RNAP II) regulatory transcription factor and also with the RNAP II basal transcription machinery in order to modulate transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between regulatory transcription factors and the basal RNAP II transcription machinery.
GO:0001105	GO	MF	RNA polymerase II transcription coactivator activity	ANKRD1,CREBBP,HIPK2,ISL1,JADE1,MEF2A,NCOA1,NEUROD1,PITX2,POU1F1,PSIP1,SMARCA2,SMARCA4,SOX11,SOX12,SOX4,TBX20,TFAP2B,TRIM28,WBP2,WWOX,ZFPM2	Interacting selectively and non-covalently with an RNA polymerase II (RNAP II) regulatory transcription factor and also with the RNAP II basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between activating transcription factors and the basal RNAP II transcription machinery.
GO:0001106	GO	MF	RNA polymerase II transcription corepressor activity	BEND6,CITED2,CTBP1,ELANE,HDAC1,HDGF,N4BP2L2,NFIB,PHF12,RBBP8,SOX3,TBX18,TCERG1,TCP10L,TFAP2B,TLE1,URI1,UXT,ZMYND8	Interacting selectively and non-covalently with an RNA polymerase II repressing transcription factor and also with the RNA polymerase II basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind DNA, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
GO:0001158	GO	MF	enhancer sequence-specific DNA binding	ACTB,ACTL6A,ATF2,CDX1,CDX2,CHD4,CREB1,ESRRB,FOXN4,GATA2,GATAD2B,GZF1,H2AFZ,H3F3A,HDAC1,HDAC2,HMGB2,HNRNPC,ISL1,JUN,MBD2,MBD3,MEOX2,MIXL1,MTA2,NFATC1,NFKB1,NONO,NR1H4,NR5A1,NR5A2,POU4F1,RBBP4,REL,RELA,RUVBL2,SFPQ,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SOX11,SOX9,SPI1,T,TFAP2B,XBP1,YY1,ZBTB16	Interacting selectively and non-covalently with a specific sequence of DNA that is part of an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
GO:0001159	GO	MF	core promoter proximal region DNA binding	ACTB,ACTL6A,AKNA,AR,ASCL1,ASCL2,ATF7,BATF3,BCL11A,BHLHE41,CDX4,CEBPE,CEBPZ,CHD4,CLOCK,CREB1,CREB3,CREBBP,CRX,CTCF,CTCFL,DDIT3,DLX4,DLX5,DMRT1,DPF2,E2F4,E2F8,EGR2,EHF,ELF1,ELF4,ELK1,ELK3,EN1,ESR1,ETS2,ETV1,ETV4,FOXA2,FOXI1,FOXJ2,FOXK2,FUBP3,GABPA,GATA3,GATAD2B,GCFC2,GCM1,GLI3,GRHL1,GZF1,H2AFZ,HAND1,HDAC1,HDAC2,HHEX,HNRNPC,HNRNPK,HOXA10,HOXA5,HOXA7,HOXC11,HSF1,IFI16,INSM1,IRF1,IRF4,KLF1,KLF4,KLF5,MBD2,MBD3,MEF2A,MEF2B,MEIS2,MEOX2,MITF,MIXL1,MTA2,MTF1,MUC1,MXD1,MYB,MYBL1,MYBL2,MYC,MZF1,NACC2,NEUROG3,NFAT5,NFATC3,NFIA,NFIB,NFIC,NFKB2,NKX2-2,NKX2-5,NKX2-8,NPAS4,NR1D1,NR1H2,NR3C1,NRF1,NRL,ONECUT2,OTX1,OTX2,PAX2,PER1,PGR,PHOX2B,PLAG1,POU2F3,POU4F2,POU4F3,PPARA,PRDM1,PRDM5,RAX,RBBP4,RELA,RFX4,SIX1,SKIL,SMAD1,SMAD2,SMAD3,SMAD4,SMAD6,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SOX18,SP1,SREBF2,SRF,STAT1,STAT3,T,TBX2,TBX3,TCF12,TCF3,TCF4,TCF7L2,TFAM,TFAP2A,TGIF1,TP73,TXK,UBTF,UHRF1,YBX1,ZGPAT,ZIC3,ZKSCAN3,ZNF148,ZNF217,ZNF219,ZNF281,ZNF395,ZNF516,ZNF536,ZNF639,ZNF746,ZSCAN21	Interacting selectively and non-covalently with a region of DNA that is in cis with and relatively close to the core promoter. The transcribed region might be described as a gene, cistron, or operon.
GO:0001161	GO	MF	intronic transcription regulatory region sequence-specific DNA binding	GRHL2,HSF1,HSF2,NKX2-1,ZNF350	Interacting selectively and non-covalently with an intronic DNA sequence that regulates the transcription of the transcript it is contained within.
GO:0001164	GO	MF	RNA polymerase I CORE element sequence-specific DNA binding	BAZ2A,PIH1D1,RRN3,SMARCA4,SMARCB1,TAF1B,TAF1C,UBTF	Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for transcription factors of the RNA polymerase I transcription machinery. This site is often referred to as the CORE element. In mammalian cells, the CORE element functions in conjunction with the Upstream Control Element (UCE), while in fungi, protozoa, and plants, the CORE element functions without a UCE.
GO:0001190	GO	MF	transcriptional activator activity, RNA polymerase II transcription factor binding	ANKRD1,CLOCK,CREB1,CREBBP,HIPK2,ISL1,JADE1,JUN,KLF4,LMO2,MEF2A,MIXL1,NCOA1,NEUROD1,NOTCH1,NR1H4,PITX2,POU1F1,PSIP1,SMARCA2,SMARCA4,SOX11,SOX12,SOX4,TBX20,TFAP2B,TRIM28,WBP2,WWOX,ZFPM2	Interacting selectively and non-covalently with an RNA polymerase II transcription factor, which may be a single protein or a complex, in order to increase the frequency, rate or extent of transcription from an RNA polymerase II promoter. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well.
GO:0001191	GO	MF	transcriptional repressor activity, RNA polymerase II transcription factor binding	ANKRD1,BEND6,BHLHE40,BHLHE41,CITED2,CLOCK,CREB1,CREBBP,CTBP1,ELANE,EOMES,HDAC1,HDGF,HIPK2,ISL1,JADE1,JUN,KLF4,LMO2,MEF2A,MIXL1,N4BP2L2,NCOA1,NEUROD1,NFIB,NOTCH1,NR1H4,PHF12,PITX2,POU1F1,PSIP1,RBBP8,SMARCA2,SMARCA4,SOX11,SOX12,SOX3,SOX4,SPEN,T,TBX18,TBX20,TBX6,TCERG1,TCP10L,TFAP2B,TLE1,TRIM28,URI1,UXT,WBP2,WWOX,ZFPM2,ZMYND8	Interacting selectively and non-covalently with an RNA polymerase II transcription factor, which may be a single protein or a complex, in order to stop, prevent, or reduce the frequency, rate or extent of transcription from an RNA polymerase II promoter. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well.
GO:0001205	GO	MF	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	CDX1,HMGA1,MEOX2,MIXL1,NFATC1,NFKB1,REL,RELA	Interacting selectively and non-covalently with a sequence of DNA that is in a distal enhancer region for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.
GO:0001227	GO	MF	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	AEBP1,ARHGAP35,ARID5B,ASCL1,ASCL2,ATF7,BACH1,BATF3,BCL11A,BHLHE40,BHLHE41,CDX2,CGGBP1,CHCHD3,CREBBP,CTCF,DACH1,DLX4,E2F8,E4F1,EN1,ESX1,ETS2,ETV6,ETV7,FOXD3,FOXO3,GATA1,GATA3,GCFC2,GFI1,GZF1,HAND1,HES1,HES5,HHEX,HMGA2,HOXD9,HSF1,IFI16,INSM1,MITF,MLX,MNT,MXD1,MZF1,NACC2,NEUROG3,NFIL3,NFKB1,NFX1,NR1D1,PITX2,POU4F2,POU5F1,PPARA,PPARD,PRDM1,PRDM5,RCOR1,RELA,REST,SATB1,SCRT2,SKIL,SNAI1,SNAI2,SREBF2,TBX2,TBX3,TCF21,TCF3,TFAP2A,TFAP2C,TGIF1,YY1,ZBTB16,ZBTB4,ZEB1,ZFPM1,ZGPAT,ZKSCAN3,ZNF148,ZNF217,ZNF219,ZNF281,ZNF350,ZNF536,ZNF746	Interacting selectively and non-covalently with a sequence of DNA that is in the regulatory region for RNA polymerase II (RNAP II) in order to stop, prevent, or reduce the frequency, rate or extent of transcription from an RNA polymerase II promoter.
GO:0001228	GO	MF	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	AIRE,AKNA,ALX1,AR,ATF1,ATF2,ATF3,ATF5,BARX2,CDX1,CDX4,CEBPA,CEBPE,CEBPG,CEBPZ,CREB1,CREB3,CREB3L1,CREB3L3,CRX,CTCFL,DBP,DDIT3,DLX5,E2F4,EAF2,EGR2,EHF,ELF1,ELF4,ELK1,ELK3,ESR1,ETV1,ETV4,ETV5,FOXA1,FOXC1,FOXC2,FOXF1,FOXF2,FOXI1,FOXJ2,FOXK2,FUBP3,GABPA,GCM1,GLI3,GLIS2,GRHL1,GRHL2,GRHL3,HAND2,HIF1A,HMGA1,HMGA2,HNF1A,HNF4A,HNRNPK,HOXA10,HOXA5,HOXA7,HOXC11,HOXD8,HSF2,IRF1,IRF2,IRF4,KLF15,KLF4,KLF5,LEF1,LMO2,MEF2A,MEF2B,MEF2C,MEIS2,MEOX2,MITF,MIXL1,MTF1,MYB,MYBL1,MYBL2,MYC,MYOCD,MYOD1,MYOG,MZF1,NFAT5,NFATC1,NFATC3,NFIA,NFIB,NFIC,NFKB1,NFKB2,NHLH1,NKX2-5,NKX2-8,NPAS4,NR1H2,NR1H4,NR1I2,NR1I3,NR3C1,NR4A1,NR4A2,NR4A3,NRF1,NRL,ONECUT1,ONECUT2,OTX1,OTX2,PGR,PHOX2B,PLAG1,PLAGL1,PLAGL2,PLSCR1,POU2F3,POU4F2,POU4F3,PPARA,RAX,RBPJ,REL,RELA,RFX4,RFX6,RUNX1,RXRB,SIX1,SMAD1,SMAD2,SMAD4,SOX11,SOX12,SOX18,SOX4,SOX9,SRF,STAT3,TCF12,TCF21,TCF4,TFAM,TFAP2A,TFAP2C,TP53,TP73,TXK,WT1,YBX1,ZIC3,ZNF639,ZNF750,ZSCAN21	Interacting selectively and non-covalently with a sequence of DNA that is in the transcription regulatory region for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.
GO:0001501	GO	BP	skeletal system development	ACAN,ADAMTS4,AEBP1,AHSG,ALPL,ALX1,ALX4,AMELX,ANKH,ANKRD11,ANXA2,ARSE,ATP7A,BGLAP,BMP1,BMP2,BMP3,BMP4,BMP5,BMP6,BMP7,BMP8B,BMPR1B,BMPR2,CDH11,CER1,CHD7,CHI3L1,CHRD,CLEC3A,CMKLR1,COL10A1,COL11A2,COL12A1,COL13A1,COL19A1,COL1A1,COL1A2,COL2A1,COL9A2,COMP,CREB3L2,CTNNB1,CYP26B1,DEAF1,DLL3,DLX5,DLX6,DSCAML1,DSPP,DYM,EBP,EIF2AK3,EIF4A3,EN1,ETS2,EVC,EXT1,EXTL1,FBN1,FBN2,FGF2,FGF4,FGF8,FGFR1,FGFR2,FGFR3,FOXP1,FREM1,FRZB,FUZ,GDF10,GDF11,GDF2,GDF3,GDF5,GH1,GHRL,GLI2,GNAS,GPLD1,HES5,HHIP,HMGA2,HOXA1,HOXA11,HOXA13,HOXD3,IFITM5,IFT140,IGF1,IGF2,IGFBP4,IHH,IL17F,INHA,INPPL1,IRX5,ITGB8,KIAA1217,KIT,KLF10,LECT1,LECT2,LHX1,LRP5,LRRC17,LTF,MATN3,MED1,MEF2C,MEGF8,MEPE,MGP,MMP13,MSX2,MTHFD1,MTHFD1L,MYOC,NFIB,NKX3-2,NOG,NOV,NPPC,NPR3,OSR1,OSR2,P3H1,PAPSS1,PAPSS2,PAX1,PCSK5,PDGFRA,PHEX,PITX1,PITX2,PLS3,PLXNB1,POSTN,PPIB,PRDX1,PRELP,PTGER4,PTH,PTH1R,PTHLH,PTPRC,RAB23,RAB33B,RBP4,RHOA,RPS6KA3,RYR1,SBDS,SCX,SEMA4D,SH3PXD2B,SHOX,SHOX2,SIX1,SKI,SNX19,SOX11,SOX4,SOX9,SPP2,STC1,SUFU,SULF1,SULF2,TBX1,TBX3,TBX4,TCOF1,TEAD4,TFAP2A,TGFB1,TGFBR1,TGFBR2,TLL1,TNFRSF11B,TRAPPC2,TRPS1,TWIST1,UFD1L,VKORC1,WNT1,WNT5A,WNT7A,WNT7B,WNT9A,WWOX,ZBTB16,ZNF385A	The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
GO:0001502	GO	BP	cartilage condensation	ALX1,BMP1,BMPR1B,MGP,SOX9,WNT7A	The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes.
GO:0001503	GO	BP	ossification	ALOX15,ALPL,ALYREF,AMELX,ASPN,ATP5B,ATP6V0A4,ATP6V1B1,BCAP29,BGLAP,BMP2,BMP4,CASR,CAT,CCDC47,CDH11,CER1,CLEC3B,CLEC5A,CLTC,COL13A1,COL6A1,CREB3L1,DDX21,DHX36,DHX9,DLX5,DNAJC13,DSPP,EGFR,EIF2AK3,EPHA2,EXT1,EXT2,FASN,FBL,FBXL15,FGFR2,FGFR3,FIGNL1,FZD1,GDF2,GLI1,GLI2,GPLD1,GTPBP4,HNRNPC,HNRNPU,HSD17B4,HSPE1,IARS,IBSP,IFITM5,IGF1,INPPL1,ITGA11,LGR4,LIMD1,MEF2C,MEN1,MINPP1,MRC2,MSX2,MYBBP1A,MYOC,NF1,NOG,OSTF1,PAM16,PHB,PLXNB1,PSMC2,RBMX,RDH14,RHOA,RPS15,RRAS2,RRBP1,RSL1D1,RUNX2,RYR1,SBDS,SCX,SEMA4D,SEMA7A,SND1,SNRNP200,SOX2,SOX8,SP7,STATH,SYNCRIP,TNC,TPM4,TUFT1,TWIST1,UFL1,VCAN,WNT3,ZBTB40	The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
GO:0001504	GO	BP	neurotransmitter uptake	GLUL,SLC1A3,SLC38A1,SLC6A4,SNAP25,SNCA	The directed movement of neurotransmitters into neurons or glial cells. This process leads to inactivation and recycling of neurotransmitters.
GO:0001505	GO	BP	regulation of neurotransmitter levels	ABAT,ACHE,ALDH2,ALDH5A1,ALDH9A1,APBA1,ATP1A2,BAIAP3,BLOC1S6,BRSK1,BZRAP1,CAMK2A,CASK,CDK5,CHAT,CHRNA3,CHRNB4,CLN3,COLQ,COMT,CPLX1,DAGLA,DNAJC5,DOC2B,DRD1,DRD2,DRD3,DRD4,DTNBP1,DVL1,GABRA2,GAD1,GAD2,GCHFR,GDNF,GLS,GLS2,GLUL,GPER1,GPM6B,GRM4,HRH3,HSPA8,KCNMB4,LIN7A,LIN7B,LIN7C,LRRK2,MAOA,MEF2C,NLGN1,NOS1,NRXN1,NRXN2,OTOF,PAH,PARK2,PCLO,PER2,PIP5K1C,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PTPRN2,RAB3A,RAB3B,RAB3GAP1,RAB5A,RIMS1,RIMS2,RIMS3,RIMS4,SEPT5,SLC17A7,SLC18A2,SLC18A3,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC22A2,SLC30A1,SLC32A1,SLC38A1,SLC38A2,SLC44A4,SLC5A7,SLC6A1,SLC6A11,SLC6A12,SLC6A13,SLC6A3,SLC6A4,SNAP25,SNAPIN,SNCA,SNCAIP,SNPH,STX1A,STX1B,STXBP1,SYN1,SYN2,SYNJ1,SYT1,SYT11,TOR1A,UNC13A,UNC13B,VAMP2	Any process that modulates levels of neurotransmitter.
GO:0001508	GO	BP	action potential	AKAP6,AKAP7,ANK2,ANK3,ATP1A1,ATP1A2,ATP1B1,CACNA1D,CAV3,CHRNA1,CHRNA4,CLN3,CNTNAP1,DMD,FGF12,GJA1,GJC1,GPD1L,GPER1,HCN4,KCNA1,KCNA2,KCNA5,KCNB1,KCND2,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNMB2,KCNMB3,KCNMB4,KCNQ1,MYH14,NEDD4L,PKP2,RYR2,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SNTA1,SRI,YWHAE,YWHAH	A process in which membrane potential cycles through a depolarizing spike, triggered in response to depolarization above some threshold, followed by repolarization. This cycle is driven by the flow of ions through various voltage gated channels with different thresholds and ion specificities.
GO:0001510	GO	BP	RNA methylation	ALKBH8,BCDIN3D,CMTR1,CMTR2,FTSJ2,HENMT1,KIAA1429,MEPCE,METTL1,METTL14,METTL2A,METTL2B,METTL3,NSUN2,NSUN4,RNMT,TGS1,TRDMT1,TRMT10A,TRMT61B,WTAP	Posttranscriptional addition of a methyl group to either a nucleotide or 2'-O ribose in a polyribonucleotide. Usually uses S-adenosylmethionine as a cofactor.
GO:0001516	GO	BP	prostaglandin biosynthetic process	AKR1C3,CBR1,CD74,EDN1,EDN2,FAM213B,HPGD,HPGDS,MIF,PNPLA8,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,TBXAS1	The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring.
GO:0001517	GO	MF	N-acetylglucosamine 6-O-sulfotransferase activity	CHST2,CHST4,CHST5,CHST6,CHST7	Catalysis of the reaction: 3'-phosphoadenosine 5'-phosphosulfate + N-acetyl-D-glucosamine = adenosine 3',5'-bisphosphate + N-acetyl-D-glucosamine 6-sulfate.
GO:0001518	GO	CC	voltage-gated sodium channel complex	SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SCN8A	A sodium channel in a cell membrane whose opening is governed by the membrane potential.
GO:0001523	GO	BP	retinoid metabolic process	ABCA4,ADH4,ADH7,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ALDH1A2,ALDH1A3,ALDH8A1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CLPS,CYP1B1,CYP26A1,CYP26B1,CYP26C1,CYP4V2,DHRS3,DHRS9,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,NAPEPLD,OPN1LW,OPN1MW,OPN1SW,PLB1,PNLIP,RARRES2,RBP1,RBP2,RBP3,RBP4,RDH10,RDH11,RDH12,RDH5,RDH8,RETSAT,RHO,RLBP1,RPE65,SCPEP1,SDC1,SDC2,SDC3,SDC4,SDR16C5,STRA6,TTR,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
GO:0001525	GO	BP	angiogenesis	AAMP,ACVRL1,ADAM8,ADIPOR2,ADM2,ANG,ANGPT1,APOD,ATP5B,ATPIF1,BMP4,BMPER,C1GALT1,CALCRL,CCBE1,CCL2,CDH13,CEACAM1,COL4A1,CTNNB1,CXCL8,DLL1,DLL4,E2F7,E2F8,EFNB2,EGF,EGR3,EIF2AK3,ENG,ENPEP,EPGN,EPHB1,EPHB2,EPHB3,EPHB4,ERAP1,ESM1,FGF2,FGFR2,FLT4,GDF2,GPLD1,GREM1,HAND1,HMOX1,ID1,IL18,ITGA5,ITGB1BP1,ITGB3,JAG1,JAM3,JMJD6,KDR,LAMA5,LOXL2,MCAM,MED1,MYH9,NCL,NDNF,NOTCH4,NOV,NOX1,NOX5,NR4A1,NRP1,NRP2,NRXN1,NRXN3,OTULIN,PARVA,PDGFA,PDGFRA,PDGFRB,PLXDC1,PLXND1,PRKX,PROK2,PTK2,PTK2B,RAMP1,RAMP2,RASIP1,RBPJ,ROBO1,ROBO4,RORA,S100A7,SCG2,SEMA3E,SEMA5A,SFRP2,SHH,SIRT1,SLC12A6,SLIT2,SOX17,SRF,SRPK2,STAB2,TBX1,TCF21,TDGF1,TEK,TGFB2,TGFBR2,THBS1,THY1,TMPRSS6,VASH1,VEGFA,XBP1	Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
GO:0001527	GO	CC	microfibril	ADAMTS10,ADAMTSL5,FBN1,FBN2,LTBP1,MFAP1,MFAP2,MFAP4	Extracellular matrix components occurring independently or along with elastin. Thought to have force-bearing functions in tendon. In addition to fibrillins, microfibrils may contain other associated proteins.
GO:0001530	GO	MF	lipopolysaccharide binding	BPI,BPIFA2,BPIFC,CD14,CD6,DEFB114,DROSHA,HMGB1,HSPD1,LBP,P2RX7,RNASE7,SCARB1,SELP,TLR2,TLR4,TRIL	Interacting selectively and non-covalently with lipopolysaccharide.
GO:0001533	GO	CC	cornified envelope	ANXA1,CDSN,CNFN,CSTA,DSP,EVPL,IVL,KAZN,LCE1D,LOR,SCEL,SPRR1A,SPRR1B,SPRR2A,SPRR2B,SPRR2F,SPRR2G,TGM1	A type of plasma membrane that has been modified through addition of distinct intracellular and extracellular components, including ceramide, found in cornifying epithelial cells (corneocytes).
GO:0001537	GO	MF	N-acetylgalactosamine 4-O-sulfotransferase activity	CHST11,CHST13,CHST14,CHST8,CHST9	Catalysis of the reaction: 3'-phosphoadenosine 5'-phosphosulfate + N-acetyl-D-galactosamine = adenosine 3',5'-bisphosphate + N-acetyl-D-galactosamine 4-sulfate.
GO:0001539	GO	BP	cilium or flagellum-dependent cell motility	CCDC39,CFAP54,DNAAF2,DNAH1,DNAH17,DNAH2,DNAH3,DNAH7,DNAH8,DRC1,RFX3	Cell motility due to movement of eukaryotic cilia or bacterial-type flagella or archaeal-type flagella.
GO:0001540	GO	MF	beta-amyloid binding	ACHE,APBB1,APBB2,APOA1,APOE,BCHE,CLSTN1,COL25A1,FZD5,GSAP,MAPK8IP2,SORL1,TGFB2	Interacting selectively and non-covalently with beta-amyloid peptide/protein and/or its precursor.
GO:0001541	GO	BP	ovarian follicle development	ANG,BMPR1B,CEBPB,EIF2B2,EIF2B4,EIF2B5,EREG,FOXL2,FSHR,INHA,INHBA,INHBB,KIT,SOD1,VEGFA,ZNF830	The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
GO:0001561	GO	BP	fatty acid alpha-oxidation	HACL1,HAO1,PEX13,PHYH,SLC25A17,SLC27A2	A metabolic pathway by which 3-methyl branched fatty acids are degraded. These compounds are not degraded by the normal peroxisomal beta-oxidation pathway, because the 3-methyl blocks the dehydrogenation of the hydroxyl group by hydroxyacyl-CoA dehydrogenase. The 3-methyl branched fatty acid is converted in several steps to pristenic acid, which can then feed into the beta-oxidative pathway.
GO:0001568	GO	BP	blood vessel development	AAMP,ACVR2B,ACVRL1,ADAM8,ADIPOR2,ADM,ADM2,AGGF1,AHR,ANG,ANGPT1,ANGPT2,ANGPTL3,APOD,ATP5B,ATP7A,ATPIF1,BMP4,BMPER,BMPR2,C1GALT1,CALCRL,CAV1,CCBE1,CCL2,CCM2,CDH13,CEACAM1,COL1A1,COL1A2,COL4A1,CTNNB1,CUL7,CXCL8,CYP1B1,DLL1,DLL4,E2F7,E2F8,EFNB2,EGF,EGFL7,EGR1,EGR3,EIF2AK3,ENG,ENPEP,EPGN,EPHB1,EPHB2,EPHB3,EPHB4,ERAP1,ESM1,FGF2,FGFR2,FLT1,FLT4,FOLR1,FOXF1,FOXS1,GATA6,GDF2,GJA5,GLMN,GPLD1,GREM1,HAND1,HAS2,HES1,HEY1,HEY2,HMOX1,HOXA1,HPGD,ID1,IL18,ITGA5,ITGB1BP1,ITGB3,ITGB8,JAG1,JAM3,JMJD6,KDR,LAMA5,LOXL2,LRP1,LRP5,LYL1,MCAM,MED1,MEF2C,MESP1,MYH9,MYLK,NCL,NDNF,NF1,NKX2-5,NOTCH1,NOTCH4,NOV,NOX1,NOX5,NR4A1,NRP1,NRP2,NRXN1,NRXN3,OSR1,OTULIN,PARVA,PAX6,PDGFA,PDGFB,PDGFRA,PDGFRB,PKD1,PKD2,PLXDC1,PLXND1,PRKX,PROK2,PROX1,PTK2,PTK2B,RAMP1,RAMP2,RAPGEF2,RASA1,RASIP1,RBPJ,ROBO1,ROBO4,RORA,S100A7,S1PR1,SCG2,SEMA3E,SEMA5A,SERPINF2,SFRP2,SHH,SIRT1,SLC12A6,SLIT2,SMAD7,SOX17,SOX18,SOX4,SRF,SRPK2,STAB2,STRA6,SYK,TBX1,TBX2,TBX20,TBX5,TCF21,TCF7L2,TDGF1,TEK,TFAP2B,TGFB2,TGFBR1,TGFBR2,THBS1,THY1,TMPRSS6,TNNI3,VASH1,VEGFA,WNT7B,WT1,XBP1	The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
GO:0001569	GO	BP	patterning of blood vessels	COL4A1,CTNNB1,DLL4,ENG,GDF2,NOTCH4,NRP1,SEMA3E,SFRP2,SHH,TGFBR2,VEGFA	The process that regulates the coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
GO:0001570	GO	BP	vasculogenesis	ADM,AGGF1,CAV1,CCM2,CUL7,EGFL7,ENG,GLMN,HAS2,HEY2,KDR,NKX2-5,NOTCH1,PDGFRB,RAMP2,RASA1,RASIP1,SHH,SOX17,SOX18,TBX5,TGFBR2,TNNI3,VEGFA,WNT7B,WT1	The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
GO:0001573	GO	BP	ganglioside metabolic process	CLN6,NEU2,NEU3,NEU4,ST3GAL5,ST6GALNAC6,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA6	The chemical reactions and pathways involving ceramide oligosaccharides carrying in addition to other sugar residues, one or more sialic acid residues.
GO:0001574	GO	BP	ganglioside biosynthetic process	ST3GAL5,ST6GALNAC6,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA6	The chemical reactions and pathways resulting in the formation of ceramide oligosaccharides carrying in addition to other sugar residues, one or more sialic acid residues.
GO:0001578	GO	BP	microtubule bundle formation	ARMC4,BBS2,CAPN6,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CDK5RAP2,CFAP46,CFAP74,CHP1,CLASP1,CLIP1,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,GAS2L1,GAS2L2,KIF20A,LRGUK,LRRC6,MAP1S,MTCL1,NCKAP5L,PIH1D3,PLK1,PSRC1,RP1,RSPH1,RSPH4A,RSPH9,SPAG1,SPAG16,SPAST,TPPP,TPPP3,TTLL3,ZMYND10,ZNF207	A process that results in a parallel arrangement of microtubules.
GO:0001580	GO	BP	detection of chemical stimulus involved in sensory perception of bitter taste	AZGP1,CA6,CST1,CST2,CST4,LPO,PIGR,PIP,RTP3,RTP4,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8	The series of events required for a bitter taste stimulus to be received and converted to a molecular signal.
GO:0001614	GO	MF	purinergic nucleotide receptor activity	P2RX1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,P2RY1,P2RY12	Combining with a purine nucleotide and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0001618	GO	MF	virus receptor activity	ACE2,CD55,CLEC4M,CLEC5A,DPP4,HAVCR1,HYAL2,SERPINB3,SIVA1	Combining with a virus component and mediating entry of the virus into the cell.
GO:0001649	GO	BP	osteoblast differentiation	ALPL,ALYREF,AMELX,ATP5B,BCAP29,BMP2,BMP4,CAT,CCDC47,CLEC5A,CLTC,COL6A1,CREB3L1,DDX21,DHX9,DLX5,DNAJC13,EPHA2,FASN,FBL,FIGNL1,FZD1,GLI1,GLI2,GTPBP4,HNRNPC,HNRNPU,HSD17B4,HSPE1,IARS,IBSP,ITGA11,LGR4,LIMD1,MEF2C,MEN1,MRC2,MSX2,MYBBP1A,MYOC,NF1,NOG,PHB,PSMC2,RBMX,RDH14,RPS15,RRAS2,RRBP1,RSL1D1,RUNX2,SEMA7A,SND1,SNRNP200,SOX2,SOX8,SP7,SYNCRIP,TNC,TPM4,UFL1,VCAN,WNT3	The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
GO:0001653	GO	MF	peptide receptor activity	ACKR2,ACKR3,ACKR4,AGTR1,AVPR2,BDKRB2,C5AR1,CALCR,CALCRL,CCKBR,CCR1,CCR2,CCR3,CCR4,CCR5,CCR6,CCR7,CCR8,CCR9,CMKLR1,CX3CR1,CXCR1,CXCR2,CXCR3,CXCR4,EDNRA,EDNRB,F2R,FPR1,GAL,GALR1,GALR2,GALR3,GCGR,GP1BA,GPR143,GPR17,GPR37,GPR37L1,GPR75,HCRTR2,INPP5K,KISS1R,MAS1,MC1R,MC2R,MC3R,MC4R,MCHR1,NLRP6,NMUR1,NMUR2,NPBWR1,NPBWR2,NPFFR1,NPR1,NPR2,NPR3,NPSR1,NPY1R,NPY2R,NPY5R,NTSR1,OGFR,OPRD1,OPRK1,OPRL1,OPRM1,PRLHR,RAMP1,SORCS1,SORCS2,SORCS3,SSTR1,TACR1,TACR2	Combining with an extracellular or intracellular peptide to initiate a change in cell activity.
GO:0001654	GO	BP	eye development	ABCB5,ACVR2B,ACVRL1,ADAMTS18,AGTPBP1,AHI1,ALDH1A3,ATF6,ATOH7,BBS4,BLOC1S3,BMPR1B,BMPR2,CEP290,CHD7,CHRDL1,COL4A1,COL5A1,COL5A2,CRYBA4,CRYGD,CYP1B1,DLL1,DSCAM,EPHA2,FOXC1,FOXE3,FOXL2,FOXN4,FZD4,GDF3,GPM6A,HDAC1,HDAC2,HES5,HIPK1,HIPK2,IFT122,IFT140,INHBA,KDM2B,LHX1,LRP5,MAB21L2,MED1,MEGF11,MYO7A,NES,NEUROD1,NEUROD4,NF1,NIPBL,NKD1,NPHP1,NRP1,OSR2,PAX2,PAX6,PDGFRA,PDGFRB,PHACTR4,PITX2,PITX3,POU4F2,PPP2R3A,PROM1,PROX1,PRSS56,PTF1A,PTPRM,RAB18,RAB3GAP1,RARG,RBP4,RORB,RP1,SALL2,SCO2,SDK1,SDK2,SH3PXD2B,SHROOM2,SIPA1L3,SIX3,SKI,SLC39A5,SMOC1,SOX11,SOX8,SOX9,STAT3,STRA6,TBX2,TDRD7,TENM3,TFAP2A,TGFB2,TH,THY1,TOPORS,TSPAN12,TULP1,TWIST1,UNC45B,VEGFA,WNT16,WNT2,WNT2B,WNT5A,WNT5B,WNT6,WNT7A,WNT7B,WNT9A,WNT9B,WT1,ZNF513	The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
GO:0001655	GO	BP	urogenital system development	ACE,ADIPOQ,AGT,AGTR1,AHI1,ALOX15B,ANGPT1,ANGPT2,AR,ARL3,BAG6,BASP1,BMP2,BMP4,BMP7,C1GALT1,CD24,CENPF,CEP290,CER1,CITED1,COL4A1,COL4A3,COL4A4,CTSH,DACT2,DLL1,EGR1,ENPEP,EPHB2,EPHB3,FGF1,FGF2,FGFR2,FOXD1,FOXF1,GATA3,GDNF,GLI2,GPC3,HAS2,HNF1B,HOXA11,HOXD11,HYAL2,IFT140,IQGAP1,ITGA3,ITGA6,ITGA8,ITGB4,JAG1,KLF15,KLHL3,LHX1,LRP4,LRRK2,MAGI2,MEF2C,MPV17,MTSS1,MYC,MYO1E,NF1,NIPBL,NKX3-1,NPHP3,NPNT,OSR1,OSR2,PAX2,PAX8,PCSK5,PCSK9,PDGFB,PDGFRA,PDGFRB,PKD1,PKD2,PKHD1,PLCE1,PODXL,POU3F3,PRKX,PROM1,PTPRO,RBP4,REN,RET,ROBO2,SALL1,SHH,SIX1,SIX2,SIX4,SLIT2,SMO,SOX17,SOX4,SOX8,SOX9,STAT1,STRA6,SULF1,SULF2,TBX18,TCF21,TFAP2A,TFAP2B,TGFBR1,TRAF3IP1,VANGL2,VEGFA,WFS1,WNK4,WNT4,WNT7B,WT1,ZBTB16	The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.
GO:0001656	GO	BP	metanephros development	ADIPOQ,BASP1,BMP4,CITED1,CTSH,EGR1,FOXD1,GATA3,GDNF,NF1,NIPBL,OSR1,OSR2,PAX2,PAX8,PDGFB,PDGFRA,PDGFRB,POU3F3,RET,ROBO2,SALL1,SHH,SIX1,SIX2,SIX4,SMO,SOX8,SOX9,STAT1,TCF21,WNT4,WNT7B,WT1	The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0001657	GO	BP	ureteric bud development	BMP2,BMP4,BMP7,CER1,CITED1,FGF1,FGF2,FGFR2,FOXD1,GATA3,GDNF,GPC3,HOXA11,HOXD11,LHX1,MYC,NPNT,OSR1,PAX2,ROBO2,SALL1,SHH,SIX1,SLIT2,TCF21,WT1	The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
GO:0001658	GO	BP	branching involved in ureteric bud morphogenesis	BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GDNF,HOXA11,HOXD11,MYC,NPNT,PAX2,SALL1,SHH,SIX1,TCF21,WT1	The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
GO:0001659	GO	BP	temperature homeostasis	ACADL,ACADVL,CIDEA,DRD2,FOXO1,NR1D1,PPARGC1A,STAT3,TNFRSF11A	A homeostatic process in which an organism modulates its internal body temperature.
GO:0001664	GO	MF	G-protein coupled receptor binding	ADRA2A,ADRBK1,APELA,ARHGEF11,ARHGEF12,ARRDC3,BICD1,C1QBP,C3,C5,CCKBR,CCL11,CCL13,CCL19,CCL2,CCL21,CCL23,CCL24,CCL25,CCL28,CCL3,CCL5,CCL7,CCR2,CECR1,CKLF,CREB3,CX3CL1,CXCL10,CXCL11,CXCL12,CXCL13,CXCL16,CXCL3,CXCL8,CXCL9,DLG4,EDN1,GAL,GHRL,GNAI1,GPRC5B,HSPA1A,HSPA1B,NEDD4,NPPA,PDE4D,PF4,PICK1,POMC,PROK2,QRFP,RALA,RAPGEF2,REEP1,RTP1,RTP2,RYK,S100A14,SAA1,SHANK1,SPX,WNT1,WNT8A,XCL1,YARS	Interacting selectively and non-covalently with a G-protein coupled receptor.
GO:0001666	GO	BP	response to hypoxia	ACAA2,ADA,ADAM17,ADAM8,AJUBA,ALAS2,ALKBH5,ANG,ANGPTL4,AQP1,ARNT,ARNT2,BACH1,BMP2,BMP7,BNIP3,BNIP3L,CA9,CAV1,CBFA2T3,CHRNA4,CHRNA7,CHRNB2,CITED2,CPEB1,CPEB2,CREBBP,CUL2,DDIT4,DPP4,EGLN1,EGLN2,EGLN3,ENG,EP300,EPAS1,EPO,FABP1,FAM162A,FMN2,FUNDC1,GATA6,HIF1A,HIF1AN,HIF3A,HIPK2,HMOX2,HP1BP3,HSP90B1,HYOU1,ITPR1,ITPR2,KCND2,KCNMA1,LIMD1,LOXL2,MGARP,MT3,MTOR,NARFL,NDNF,NF1,NKX3-1,NOTCH1,NPEPPS,OPRD1,P4HB,PDK1,PDK3,PINK1,PLK3,PML,PRKAA1,PTGIS,RBPJ,RBX1,RGCC,RORA,RPS27A,RYR1,RYR2,SIRT1,SIRT2,SLC8A3,SMAD3,SMAD4,STOX1,SUV39H1,SUV39H2,TBL2,TCEB1,TCEB2,TERT,TGFB2,TGFB3,TH,THBS1,TIGAR,TWIST1,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBQLN1,UCP2,USF1,VEGFA,VHL,WTIP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
GO:0001667	GO	BP	ameboidal-type cell migration	ANLN,APELA,ARSB,CALCA,CDH13,CENPV,CER1,CORO1B,CORO1C,CXCL13,CYP1B1,DPP4,EFNB2,EGR3,EMP2,EPHB4,ERBB4,FAP,FAT2,FERMT1,FGF2,FOLR1,GDNF,GIPC1,GPLD1,GREM1,HTR2B,ID1,ITGA4,ITGB7,KDR,KIT,KRT16,KRT2,LOXL2,MEGF8,MYH9,NANOS1,NOS3,NOV,NR4A1,NRP1,NRTN,PHACTR4,PHOX2B,PIK3CA,PITX2,PKN1,PKN2,PKN3,PLEKHG5,PLXND1,PRKX,PRSS3,PTP4A3,RAB13,RHOA,ROBO1,S100A2,S100P,SCG2,SEMA3A,SHH,SLIT2,SOX8,SRF,SRGAP2,STARD13,TBX1,TDGF1,TNFSF12,VEGFA,ZEB2	Cell migration that is accomplished by extension and retraction of a pseudopodium.
GO:0001669	GO	CC	acrosomal vesicle	ACR,CASC5,CXADR,CYLC1,EQTN,FAM170B,IQCF1,LRGUK,SERPINA5,SPACA7,TEKT3,ZP3	A structure in the head of a spermatozoon that contains acid hydrolases, and is concerned with the breakdown of the outer membrane of the ovum during fertilization. It lies just beneath the plasma membrane and is derived from the lysosome.
GO:0001671	GO	MF	ATPase activator activity	AHSA1,ATP1B1,ATP1B2,ATP1B3,DNAJB1,DNAJB6,DNAJC1,DNAJC10,DNAJC24,MYBPC3,TOR1AIP1,TOR1AIP2	Binds to and increases the ATP hydrolysis activity of an ATPase.
GO:0001672	GO	BP	regulation of chromatin assembly or disassembly	MAP1S,PADI2,PARP10,SPTY2D1,TAL1,TLK1,TLK2,TPR	Any process that modulates the frequency, rate or extent of chromatin assembly or disassembly.
GO:0001676	GO	BP	long-chain fatty acid metabolic process	ABCC1,ABCD1,ACAA1,ACOT1,ACOT2,ACOT4,ACOT7,ACOT8,ACOX1,ACSBG1,ACSBG2,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AKR1C3,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AWAT1,CBR1,CPT1A,CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2J2,CYP2U1,CYP4A11,CYP4F12,CYP4F2,CYP4F3,DAGLA,DAGLB,DPEP1,ELOVL1,ELOVL2,ELOVL3,ELOVL5,ELOVL6,EPHX2,FAAH,FAAH2,FADS1,FADS2,FAM213B,GGT1,GGT5,GPX1,GPX4,HPGD,HPGDS,HSD17B4,LTA4H,LTC4S,MAPKAPK2,MGLL,PLA2G10,PLA2G4A,PLA2G4B,PLA2G4C,PNPLA8,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,SCP2,SLC27A2,SLC27A4,SLC27A6,TBXAS1	The chemical reactions and pathways involving long-chain fatty acids, A long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
GO:0001678	GO	BP	cellular glucose homeostasis	CARTPT,CYP7A1,ERN1,FOXA3,FOXO1,GAS6,GNB2L1,GPER1,KCNB1,MLXIPL,OGT,PAX2,PDK3,PIK3R1,PIK3R2,PPARGC1A,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SIRT1,SOX4,XBP1	A cellular homeostatic process involved in the maintenance of an internal steady state of glucose within a cell or between a cell and its external environment.
GO:0001701	GO	BP	in utero embryonic development	ADAM10,ARNT2,BMP2,CASP8,CHD7,E2F7,E2F8,EOMES,FGFR2,FLCN,FOXD3,FOXF1,FUT8,HAND2,HEY1,HEY2,HINFP,HOPX,HORMAD1,LIG4,LMX1B,MBNL1,MYH6,NASP,PDGFB,PKD1,PKD2,PLK4,POU5F1,RBPJ,SOX8,SRF,STIL,TET1,TFEB,TGFB3,TGFBR1,VEGFA,WNT7B,ZP3,ZPR1	The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
GO:0001702	GO	BP	gastrulation with mouth forming second	FOXA2,LHX1,MEGF8,NAT8B,OTX2,T	A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
GO:0001704	GO	BP	formation of primary germ layer	ATOH8,BMP4,BMPR2,CDC73,CRB2,CTR9,EOMES,EYA2,FN1,HMGA2,HOXA11,INHBA,ITGA5,ITGAV,KDM6B,KIF16B,KLF4,LEO1,LHX1,MIXL1,NANOG,NODAL,PAF1,PAX2,POU5F1,RTF1,SCX,SIX2,SMAD2,SNAI1,SOX17,SOX2,SOX7,TBX20,TRIM15,VTN	The formation of the ectoderm, mesoderm and endoderm during gastrulation.
GO:0001706	GO	BP	endoderm formation	CDC73,CTR9,EOMES,FN1,HMGA2,INHBA,ITGA5,ITGAV,LEO1,LHX1,MIXL1,NANOG,NODAL,PAF1,POU5F1,RTF1,SOX17,SOX2,SOX7,TBX20,VTN	The formation of the endoderm during gastrulation.
GO:0001707	GO	BP	mesoderm formation	BMP4,BMPR2,CRB2,EOMES,EYA2,HMGA2,HOXA11,KDM6B,KLF4,PAX2,SCX,SIX2,SMAD2,SNAI1,TBX20,TRIM15	The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
GO:0001708	GO	BP	cell fate specification	DLL1,EYA2,FOXA2,GLI2,GSC,HOXA11,ISL1,NANOG,NRP1,PAX2,POU4F1,POU5F1,RBPJ,SHH,SIX2,SOX17,SOX2,SOX9,TBX1	The process involved in the specification of cell identity. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
GO:0001709	GO	BP	cell fate determination	CYP26B1,DLL1,DSCAML1,GATA3,IFRD1,ISL1,JAG1,KLF4,MCL1,MEF2C,MESP1,NOTCH2,NOTCH4,NTF4,PAX2,POU5F1,POU6F2,SOX17,TBX2,TRIM15	A process involved in cell fate commitment. Once determination has taken place, a cell becomes committed to differentiate down a particular pathway regardless of its environment.
GO:0001710	GO	BP	mesodermal cell fate commitment	EYA2,HOXA11,KLF4,PAX2,SIX2,TRIM15	The cell differentiation process that results in commitment of a cell to become part of the mesoderm.
GO:0001711	GO	BP	endodermal cell fate commitment	CDC73,CTR9,LEO1,NANOG,PAF1,POU5F1,RTF1,SOX17,SOX2	The cell differentiation process that results in commitment of a cell to become part of the endoderm.
GO:0001725	GO	CC	stress fiber	ABLIM1,ABLIM3,ACTA1,ACTN1,AMOT,CNN2,CORO1B,DAAM1,FBLIM1,FHOD1,FSCN1,GAS2L1,GAS2L2,LCP1,LIMA1,MICALL2,MYH10,MYH9,MYLK,NEBL,PGM5,PTK2,PXN,SEPT11,SEPT12,SEPT7,SEPT9,SHROOM4,SIPA1L3,SORBS1,TEK,TPM1,TPM3,TPM4,ZYX	A contractile actin filament bundle that consists of short actin filaments with alternating polarity, cross-linked by alpha-actinin and possibly other actin bundling proteins, and with myosin present in a periodic distribution along the fiber.
GO:0001726	GO	CC	ruffle	ABCA7,ACTN1,ADAM17,AIF1,AKT2,ALS2,AMOT,APC,ARAP3,ARF4,ARF6,ARFIP2,ARHGEF2,ASAP3,BCAR1,BMX,C2CD5,CD2AP,CDK6,CDKL5,CLASP2,COBL,CTTN,CYFIP1,DBNL,DDX58,DLC1,EEF1A1,EPS8,EPS8L1,EPS8L2,EZR,FAP,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FGR,FSCN1,IFIT5,INPP5J,INPP5K,IQGAP1,ITGA5,ITGAV,ITGB1,ITGB1BP1,ITGB3,KANK1,KIF18A,LAYN,LCP1,MACF1,MKLN1,MTM1,MTMR14,MTSS1,MYADM,MYH9,MYO5A,MYO6,NME1,NME2,PACSIN1,PAK1,PDPN,PDXP,PIP5K1A,PLCG1,PLEK,PLEKHA1,PODXL,PPP1R9B,PTK6,RINL,ROCK1,RPS3,S100A11,S100A6,S100B,SH3YL1,SNTG1,SPATA13,TESC,TIRAP,TLN1,TPM1,TRPV4,TWF1,VIL1,WWC1	Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork.
GO:0001738	GO	BP	morphogenesis of a polarized epithelium	AHI1,CELSR1,FUZ,MSN,RAB10,SLC9A3R1,SYNE4,TRAF3IP1,VANGL2	The morphogenetic process in which the anatomical structures of a polarized epithelium are generated and organized. A polarized epithelium is an epithelium where the epithelial sheet is oriented with respect to the planar axis.
GO:0001750	GO	CC	photoreceptor outer segment	ABCA4,CIB2,DHRS3,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNGT1,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,MAK,MYO7A,NAPEPLD,OCRL,OPN1LW,OPN1MW,OPN1SW,PCDH15,PDE6A,PDE6B,PDE6G,PROM1,RHO,RP1,RP1L1,RPGR,SHANK2,SPTBN5,TULP1	The outer segment of a vertebrate photoreceptor that contains discs of photoreceptive membranes.
GO:0001754	GO	BP	eye photoreceptor cell differentiation	AGTPBP1,BBS4,CEP290,DSCAM,MYO7A,NKD1,PPP2R3A,PROM1,RORB,RP1,SDK2,SOX8,SOX9,STAT3,TH,THY1,TOPORS,TULP1,VEGFA	The process in which a relatively unspecialized cell acquires the specialized features of a photoreceptor cell, as found in the eye, the primary visual organ of most organisms.
GO:0001755	GO	BP	neural crest cell migration	CORO1C,ERBB4,FOLR1,GDNF,HTR2B,NRP1,NRTN,PHACTR4,PHOX2B,PITX2,SEMA3A,SHH,SOX8,TBX1	The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
GO:0001756	GO	BP	somitogenesis	COBL,CRB2,DLL1,FOXB1,LFNG,PPP2R3A,RIPPLY1,RIPPLY2	The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
GO:0001758	GO	MF	retinal dehydrogenase activity	AKR1B10,AKR1C3,AKR1C4,ALDH1A2,ALDH8A1	Catalysis of the reaction: retinal + NAD+ + H2O = retinoate + NADH. Acts on both 11-trans and 13-cis forms of retinal.
GO:0001763	GO	BP	morphogenesis of a branching structure	BMP2,BMP4,CITED1,COL13A1,COL4A1,CTNNB1,CTSH,DLL4,DRD2,ENG,EPHA2,EPHA7,FGF1,FGF10,FGF2,FGFR2,FOXD1,FOXF1,GDF2,GDNF,GLI2,HOXA11,HOXD11,MET,MYC,NKX3-1,NOTCH4,NPNT,NRP1,PAK1,PAX2,PKD1,RASIP1,SALL1,SEMA3E,SFRP2,SHH,SIX1,SLIT2,SOX8,SOX9,TCF21,TDGF1,TGFBR2,VEGFA,WT1	The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
GO:0001764	GO	BP	neuron migration	ADGRL3,CCK,CDK5,CDK5R1,CDKL5,DCDC2,DCX,DDIT4,DISC1,DNER,DRD1,DRD2,DYX1C1,ELP3,FGF13,FGFR1,GPM6A,KIAA0319,LHX1,LHX6,MARK1,MARK2,MDGA1,MEF2C,NDNF,NR4A2,NRCAM,NRP1,NTRK2,PAFAH1B1,PEX13,PHOX2B,POMGNT2,RAPGEF2,RELN,SEMA3A,SPOCK1,TUBB2B,USP9X	The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
GO:0001765	GO	BP	membrane raft assembly	ANXA2,CAV1,CAV2,CAV3,EMP2,FLOT1,FLOT2,PACSIN2,RFTN1,S100A10	The aggregation, arrangement and bonding together of a set of components to form a membrane raft, a small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalizes cellular processes.
GO:0001771	GO	BP	immunological synapse formation	CCL19,CCL21,CCR7,CD6,PRF1	The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
GO:0001772	GO	CC	immunological synapse	ALCAM,CD37,CD53,CD6,CD81,CORO1A,DLG1,DUSP3,EZR,GZMA,GZMB,LAT,LCK,LGALS3,MYH9,PDCD6IP,PRKAR1A,PTPRJ,SCIMP,SNX27,SOCS6,STOML2,STX7	An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
GO:0001773	GO	BP	myeloid dendritic cell activation	BATF,BATF2,BATF3,CAMK4,CSF2,DCSTAMP,DOCK2,HMGB1,IL4,PYCARD,SLAMF1,TGFBR2,UBD	The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0001776	GO	BP	leukocyte homeostasis	AKT1,ANXA1,FADD,FLT3,FOXP3,HCAR2,HMGB1,IL6,JAK3,LYN,MEF2C,NCKAP1L,PDE4B,PMAIP1,RIPK3,SIVA1,TNFAIP3,TNFSF14,ZC3H8	The process of regulating the proliferation and elimination of cells of the immune system such that the total number of cells of a particular cell type within a whole or part of an organism is stable over time in the absence of an outside stimulus.
GO:0001780	GO	BP	neutrophil homeostasis	ANXA1,HCAR2,HMGB1,IL6,PDE4B	The process of regulating the proliferation and elimination of neutrophils such that the total number of neutrophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
GO:0001784	GO	MF	phosphotyrosine binding	CBLC,FGR,LDLRAP1,PTPN5,SAMSN1	Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
GO:0001786	GO	MF	phosphatidylserine binding	ANXA13,ANXA9,AXL,CD300A,CPNE1,CPNE6,FCHO2,GAS6,HMGB1,JPH2,MARK1,OSBPL10,OSBPL5,OSBPL8,RASGRP1,RPE65,SCARB1,SCIN,SDPR,SYTL2,THBS1,TRIM72	Interacting selectively and non-covalently with phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.
GO:0001816	GO	BP	cytokine production	ABCA1,ADAMTS3,AIM2,BATF,BCL10,BTN3A1,BTN3A2,CCL19,CCR7,CD28,CD36,CD46,CD55,CHGA,CHI3L1,CMA1,CXCR3,F2RL1,FOXP1,GBP5,HIF1A,HMGB1,HSPD1,IL12B,IL17F,IL18,IL4,IRF7,ITK,KIT,KLRF2,LEP,LILRB1,LTBP3,NLRC4,NOD1,NOD2,NOS2,NOX5,NR1H4,PCSK5,PIK3CD,PIK3CG,PLA2G1B,PLA2R1,PNP,PTGS2,RAB1A,RFTN1,RGCC,S100A12,S100A13,S100A8,S100A9,SLC11A1,STOML2,TBK1,TLR2,TLR4,TLR6,TLR9,TMEM173,TNFSF4,TRIM27,TRIM56,TXK	The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0001818	GO	BP	negative regulation of cytokine production	ADIPOQ,AGER,ANXA1,ANXA4,APOA1,APOA2,APOD,ARRB1,ASB1,ATG12,ATG5,AXL,BCL3,BPI,BST2,BTN2A2,C1QBP,C1QTNF3,C5AR2,CACTIN,CD24,CD274,CD34,CD84,CDH3,CHID1,CHRNA7,CIDEA,CMKLR1,CUEDC2,CYLD,DDX58,DHX58,DLL1,ELANE,EZR,F2RL1,FBLN1,FFAR4,FN1,FOXJ1,FOXP3,FURIN,GAS6,GATA6,GBA,GBP1,GHRL,GHSR,GSTP1,HAVCR2,HDAC7,HERC5,HFE,HLA-DRB1,HMGB1,IFIH1,IFNA2,IFNB1,IFNG,IFNL1,IKBKE,IL10,IL12A,IL12B,IL23A,IL23R,IL36RN,IL6,IL6R,INHA,INHBA,INHBB,IRAK3,IRF3,IRG1,ISG15,ITCH,JAK3,KAT5,KLF4,LBP,LEF1,LGALS9,LGR4,LILRB1,LTF,MAP2K5,MAVS,MC1R,MEFV,MUL1,NCKAP1L,NFKBIL1,NLRC3,NLRC5,NLRP12,NLRP3,NLRX1,NR1H4,ORM1,OTUD5,OTUD7B,PCBP2,PDCD1LG2,PIBF1,PIN1,POMC,PPM1B,PRNP,PTGER4,PTPN22,PYCARD,PYDC2,RAC1,RARA,REL,RELB,RGCC,RNF125,RNF135,RNF216,RPS27A,RPS6KA4,RPS6KA5,SFTPD,SIGIRR,SLAMF1,SLC11A1,SRGN,SSC5D,TAX1BP1,TBK1,TGFB1,TGFB2,TGFB3,THBS1,TICAM2,TIGIT,TLR4,TLR9,TNF,TNFAIP3,TNFRSF21,TNFSF4,TRAF3,TRAF3IP1,TRIB2,TRIM25,TRIM27,UBA52,UBA7,UBB,UBC,UBE2D3,UBE2L6,VIMP,XCL1,ZC3H12A,ZFPM1	Any process that stops, prevents, or reduces the rate of production of a cytokine.
GO:0001822	GO	BP	kidney development	ACE,ADIPOQ,AGT,AGTR1,AHI1,ANGPT1,ANGPT2,ARL3,BAG6,BASP1,BMP2,BMP4,BMP7,C1GALT1,CD24,CENPF,CEP290,CER1,CITED1,COL4A3,COL4A4,CTSH,DACT2,DLL1,EGR1,ENPEP,FGF1,FGF2,FGFR2,FOXD1,GATA3,GDNF,GLI2,GPC3,HAS2,HNF1B,HOXA11,HOXD11,HYAL2,IQGAP1,ITGA3,ITGA8,JAG1,KLF15,KLHL3,LHX1,LRP4,LRRK2,MAGI2,MEF2C,MPV17,MTSS1,MYC,MYO1E,NF1,NIPBL,NPHP3,NPNT,OSR1,OSR2,PAX2,PAX8,PCSK5,PCSK9,PDGFB,PDGFRA,PDGFRB,PKD1,PKHD1,PLCE1,PODXL,POU3F3,PRKX,PROM1,PTPRO,REN,RET,ROBO2,SALL1,SHH,SIX1,SIX2,SIX4,SLIT2,SMO,SOX4,SOX8,SOX9,STAT1,STRA6,SULF1,SULF2,TCF21,TFAP2A,TFAP2B,TGFBR1,TRAF3IP1,VANGL2,VEGFA,WFS1,WNK4,WNT4,WNT7B,WT1,ZBTB16	The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
GO:0001823	GO	BP	mesonephros development	BMP2,BMP4,BMP7,CER1,CITED1,FGF1,FGF2,FGFR2,FOXD1,GATA3,GDNF,GPC3,HOXA11,HOXD11,LHX1,MYC,NPNT,OSR1,OSR2,PAX2,PAX8,ROBO2,SALL1,SHH,SIX1,SLIT2,TCF21,WT1,ZBTB16	The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.
GO:0001824	GO	BP	blastocyst development	HOPX,HORMAD1,NASP,POU5F1,SRF,TET1,ZP3,ZPR1	The process whose specific outcome is the progression of the blastocyst over time, from its formation to the mature structure. The mammalian blastocyst is a hollow ball of cells containing two cell types, the inner cell mass and the trophectoderm.
GO:0001836	GO	BP	release of cytochrome c from mitochondria	BAK1,BAX,BBC3,BCL2,BCL2L1,BID,CLU,DNM1L,FIS1,GGCT,IFI6,MFF,SFN,SOD2,TIMM50	The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
GO:0001837	GO	BP	epithelial to mesenchymal transition	AMELX,BMP2,BMP7,CTNNB1,CUL7,EFNA1,EOMES,FAM83D,FGF8,FOXF2,GSC,GSK3B,HAS2,HEY1,HEY2,HEYL,HGF,HIF1A,HMGA2,HNRNPAB,LEF1,LOXL2,LOXL3,LRP6,NOG,NOTCH1,OLFM1,RBPJ,S100A4,SNAI1,SNAI2,SOX9,TGFB1,TGFB2,TGFBR1,TGFBR3,TRIM28,WNT8A	A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
GO:0001838	GO	BP	embryonic epithelial tube formation	BBS4,BCL10,CELSR1,COBL,DEAF1,DLC1,DVL2,FOLR1,FUZ,GATA3,GRHL2,GRHL3,IFT122,KDM2B,LMO4,MTHFD1,MTHFD1L,OSR1,PAX2,PAX8,PHACTR4,PLXNB2,PRICKLE1,SCRIB,SEMA4C,SIX1,SKI,SOX11,SOX4,SOX8,SOX9,STIL,TSC2,VANGL2	The morphogenesis of an embryonic epithelium into a tube-shaped structure.
GO:0001841	GO	BP	neural tube formation	BBS4,BCL10,CELSR1,COBL,DEAF1,DLC1,DVL2,FOLR1,FUZ,GRHL2,GRHL3,IFT122,KDM2B,LMO4,MTHFD1,MTHFD1L,PAX2,PHACTR4,PLXNB2,PRICKLE1,SCRIB,SEMA4C,SKI,SOX11,SOX4,STIL,TSC2,VANGL2	The formation of a tube from the flat layer of ectodermal cells known as the neural plate. This will give rise to the central nervous system.
GO:0001843	GO	BP	neural tube closure	BBS4,BCL10,CELSR1,COBL,DEAF1,DLC1,DVL2,FOLR1,FUZ,GRHL2,GRHL3,IFT122,KDM2B,LMO4,MTHFD1,MTHFD1L,PAX2,PHACTR4,PLXNB2,PRICKLE1,SCRIB,SEMA4C,SKI,STIL,TSC2,VANGL2	The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
GO:0001845	GO	BP	phagolysosome assembly	CORO1A,RAB20,RAB34,RAB39A,RAB7A	The process that results in the fusion of a phagosome, a vesicle formed by phagocytosis, with a lysosome.
GO:0001846	GO	MF	opsonin binding	APCS,C1QBP,C4A,CALR,CD93,CR1,CRP,ITGAV,MASP2,PHB,PTX3	Interacting selectively and non-covalently with an opsonin, such as a complement component or antibody, deposited on the surface of a bacteria, virus, immune complex, or other particulate material.
GO:0001848	GO	MF	complement binding	APCS,C1QBP,C4A,C4B,CALR,CD93,CFB,CR1,CR2,CRP,MASP2,PHB,PTX3	Interacting selectively and non-covalently with any component or product of the complement cascade.
GO:0001849	GO	MF	complement component C1q binding	APCS,C1QBP,C4A,CALR,CD93,CRP,PTX3	Interacting selectively and non-covalently with the C1q component of the classical complement cascade.
GO:0001867	GO	BP	complement activation, lectin pathway	FCN1,FCN2,FCN3,MASP1,MASP2,MBL2	Any process involved in the activation of any of the steps of the lectin pathway of the complement cascade which allows for the direct killing of microbes and the regulation of other immune processes.
GO:0001878	GO	BP	response to yeast	ANG,APP,CALCA,CAMP,NPY,TAC1,VIP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a yeast species.
GO:0001881	GO	BP	receptor recycling	ARFGEF2,FAM109A,FAM109B,LMTK2,RAB11B,REP15	The process that results in the return of receptor molecules to an active state and an active cellular location after they have been stimulated by a ligand. An active state is when the receptor is ready to receive a signal.
GO:0001885	GO	BP	endothelial cell development	ENG,EZR,F11R,F2RL1,GSTM3,ICAM1,MARVELD2,MET,MLLT4,MSN,MYADM,PDE2A,PDE4D,PPP1R16B,RAP1A,RAP1B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3,RDX,SOX18,STC1,TJP1,TJP2,WNT7B	The progression of an endothelial cell over time, from its formation to the mature structure.
GO:0001887	GO	BP	selenium compound metabolic process	AHCY,AIMP1,AIMP2,CBS,CTH,DARS,EEF1E1,EEFSEC,EPRS,FAU,GNMT,GSR,HNMT,IARS,INMT,KARS,LARS,MARS,MAT1A,NNMT,PAPSS1,PAPSS2,PSTK,QARS,RARS,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SARS,SCLY,SECISBP2,SEPHS2,SEPSECS,TXNRD1,UBA52	The chemical reactions and pathways involving compounds that contain selenium, such as selenocysteine.
GO:0001889	GO	BP	liver development	ARID5B,CCDC39,CCDC40,CEBPA,CEBPB,CEBPG,CITED2,COBL,DNAAF1,E2F7,E2F8,LSR,NF1,NKX2-8,NPHP3,PCSK9,PHF2,PKD2,RPS6KA1,TGFBR3,XBP1,ZIC3	The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
GO:0001890	GO	BP	placenta development	ANG,ASCL2,CASP8,CITED1,CUL7,E2F7,E2F8,EOMES,FGFR2,GHRL,GHSR,HEY1,HEY2,ITGB8,LEP,NODAL,PDGFB,PKD1,PKD2,PLK4,PPARD,PPARG,PTK2,RBPJ,SOD1,SPP1,TFEB,WNT7B	The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
GO:0001891	GO	CC	phagocytic cup	ABCA7,AIF1,BIN2,CORO1A,GNB2L1,MYO1G,TNF	An invagination of the cell membrane formed by an actin dependent process during phagocytosis. Following internalization it is converted into a phagosome.
GO:0001892	GO	BP	embryonic placenta development	CASP8,E2F7,E2F8,EOMES,FGFR2,HEY1,HEY2,PDGFB,PKD1,PKD2,PLK4,RBPJ,TFEB,WNT7B	The embryonically driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
GO:0001894	GO	BP	tissue homeostasis	ARMS2,BARD1,BBS1,BBS10,BBS2,BBS4,CD34,CDH23,CDH3,CHMP4B,CIB2,CLRN1,CNGB1,CTSH,CUBN,CXADR,DFNB31,DRAM2,F2R,FOXC1,GCNT2,GPR55,IL7,IQCB1,MAK,MKKS,MUC13,MUC4,MUC6,NAPSA,NOD2,NPHP3,P2RX4,PBLD,PCDH15,POC1B,PRDX5,PROM1,PTH,PTK2B,RBP4,RDH12,RP1,RP1L1,RPE65,SCX,SERPINA3,SFTPD,SOD1,SOX9,SPATA7,SRC,STRAP,TLR4,TLR9,TPP1,TULP1,USH1C,USH1G,USH2A,VEGFA,ZNF675	A homeostatic process involved in the maintenance of an internal steady state within a defined tissue of an organism, including control of cellular proliferation and death and control of metabolic function.
GO:0001895	GO	BP	retina homeostasis	ARMS2,BBS1,BBS10,BBS2,BBS4,CDH23,CDH3,CIB2,CLRN1,CNGB1,DFNB31,DRAM2,IQCB1,MAK,MKKS,NPHP3,PCDH15,POC1B,PROM1,RDH12,RP1,RP1L1,RPE65,SOD1,SPATA7,TULP1,USH1C,USH1G,USH2A	A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
GO:0001906	GO	BP	cell killing	ALB,APOL1,AZU1,C9,CAMP,CEBPG,CLEC2A,CORO1A,CTSH,EMP2,GZMB,KIR3DL1,KLRF2,LYST,MICA,RAB27A,RAET1E,RAET1G,SLAMF7,STXBP2,TUBB,TUBB4B,ULBP1,ULBP2,ULBP3,VAMP7	Any process in an organism that results in the killing of its own cells or those of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions.
GO:0001909	GO	BP	leukocyte mediated cytotoxicity	AZU1,CEBPG,CLEC2A,CORO1A,CTSH,EMP2,GZMB,KIR3DL1,KLRF2,LYST,MICA,RAET1E,RAET1G,SLAMF7,STXBP2,TUBB,TUBB4B,ULBP1,ULBP2,ULBP3,VAMP7	The directed killing of a target cell by a leukocyte.
GO:0001910	GO	BP	regulation of leukocyte mediated cytotoxicity	AGER,AP1G1,ARRB2,CADM1,CD226,CRTAM,F2RL1,FADD,HLA-A,HLA-B,HLA-E,ICAM1,IL12A,IL12B,IL12RB1,IL21,IL23A,IL23R,KLRK1,LAMP1,LEP,LGALS9,LILRB1,MICA,NCR1,NCR3,NOS2,PIK3R6,PTPRC,PVR,PVRL2,RASGRP1,RIPK3,SERPINB4,SERPINB9,SLAMF6,STAP1,STX7,XCL1	Any process that modulates the frequency, rate, or extent of leukocyte mediated cytotoxicity.
GO:0001911	GO	BP	negative regulation of leukocyte mediated cytotoxicity	ARRB2,HLA-A,HLA-B,HLA-E,LGALS9,LILRB1,MICA,PTPRC,SERPINB4,SERPINB9	Any process that stops, prevents, or reduces the rate of leukocyte mediated cytotoxicity.
GO:0001912	GO	BP	positive regulation of leukocyte mediated cytotoxicity	AP1G1,CADM1,CD226,CRTAM,F2RL1,FADD,HLA-A,HLA-B,HLA-E,IL12A,IL12B,IL12RB1,IL21,IL23A,IL23R,KLRK1,LAMP1,NCR3,NOS2,PVR,PVRL2,RASGRP1,SLAMF6,STAP1,STX7,XCL1	Any process that activates or increases the frequency, rate or extent of leukocyte mediated cytotoxicity.
GO:0001914	GO	BP	regulation of T cell mediated cytotoxicity	AGER,FADD,HLA-A,HLA-B,HLA-E,IL12A,IL12B,IL12RB1,IL23A,IL23R,LILRB1,PTPRC,PVR,PVRL2,RIPK3,STX7,XCL1	Any process that modulates the frequency, rate, or extent of T cell mediated cytotoxicity.
GO:0001916	GO	BP	positive regulation of T cell mediated cytotoxicity	FADD,HLA-A,HLA-B,HLA-E,IL12A,IL12B,IL12RB1,IL23A,IL23R,PVR,PVRL2,STX7,XCL1	Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
GO:0001917	GO	CC	photoreceptor inner segment	ARMS2,ARR3,CIB2,DRAM2,GNAT1,GNAT2,MAK,MYO7A,NOS1,RDH12,RHO,RP1,SHANK2,TULP1	The inner segment of a vertebrate photoreceptor containing mitochondria, ribosomes and membranes where opsin molecules are assembled and passed to be part of the outer segment discs.
GO:0001919	GO	BP	regulation of receptor recycling	AP1AR,BVES,ECE1,KIF16B,LAMTOR1,NSF,OPTN,PCSK9,RAMP3,SCRIB,SNCA,TBC1D16,TRAT1,VAMP3	Any process that modulates the frequency, rate, or extent of receptor recycling.
GO:0001921	GO	BP	positive regulation of receptor recycling	BVES,ECE1,NSF,RAMP3,SCRIB,SNCA,VAMP3	Any process that activates or increases the frequency, rate or extent of receptor recycling.
GO:0001931	GO	CC	uropod	FLOT1,FLOT2,MYH9,PIP5K1B,PIP5K1C,SCIMP,SELPLG	A membrane projection with related cytoskeletal components at the trailing edge of a cell in the process of migrating or being activated, found on the opposite side of the cell from the leading edge or immunological synapse, respectively.
GO:0001935	GO	BP	endothelial cell proliferation	ACVRL1,BMP4,BMPER,BMPR2,CALCA,CD34,DLG1,ERN1,HMOX1,ITGB1BP1,LOXL2,NOX5,PRKX,SEMA5A,TEK,THAP1,XBP1	The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
GO:0001936	GO	BP	regulation of endothelial cell proliferation	ACVRL1,AGGF1,AIMP1,AKT1,ANG,APOE,APOH,ARNT,ATOH8,ATP5A1,ATPIF1,BMP2,BMP4,BMPR2,CAV1,CAV2,CCL11,CCL24,CCL26,CDH13,CXCR3,DLL4,ECM1,EGFL7,EGR3,ENG,F3,FGF2,FLT4,GDF2,GHRL,HIF1A,HMGB2,HTR2B,ITGB3,KDR,KRIT1,LEP,MYDGF,NF1,NR2F2,NR4A1,NRP1,NRP2,PDCD10,PDCD6,PDCL3,PDGFB,PLXNB3,PPP1R16B,PRKCA,PRKD1,PRKD2,PROX1,PTPRM,RGCC,SCG2,SEMA5A,SIRT1,SPARC,STAT1,SULF1,SYNJ2BP,TEK,TGFBR1,THBS1,THBS4,TNFSF12,VASH1,VASH2,VEGFA,VEGFB,WNT5A,XDH,ZNF580	Any process that modulates the frequency, rate, or extent of endothelial cell proliferation.
GO:0001937	GO	BP	negative regulation of endothelial cell proliferation	AIMP1,APOE,APOH,ATOH8,ATP5A1,ATPIF1,CAV1,CAV2,CXCR3,DLL4,ENG,GDF2,GHRL,KRIT1,NF1,NR2F2,PDCD10,PTPRM,RGCC,SCG2,SPARC,STAT1,SULF1,SYNJ2BP,THBS1,VASH1,XDH	Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
GO:0001938	GO	BP	positive regulation of endothelial cell proliferation	AGGF1,AKT1,ANG,ARNT,BMP2,BMP4,BMPR2,CCL11,CCL24,CCL26,CDH13,ECM1,EGFL7,EGR3,F3,FGF2,FLT4,GDF2,HIF1A,HMGB2,HTR2B,ITGB3,KDR,MYDGF,NR4A1,NRP1,NRP2,PDCD6,PDCL3,PDGFB,PLXNB3,PPP1R16B,PRKCA,PRKD1,PRKD2,PROX1,SCG2,SEMA5A,SIRT1,TEK,TGFBR1,THBS4,TNFSF12,VASH2,VEGFA,VEGFB,WNT5A,ZNF580	Any process that activates or increases the rate or extent of endothelial cell proliferation.
GO:0001941	GO	BP	postsynaptic membrane organization	APOE,CHRNB1,DLG4,DNAJA3,LRP4,MUSK,NLGN1,NLGN2,NLGN3,NRXN1,NRXN2,SHANK3	A process which results in the assembly, arrangement of constituent parts, or disassembly of a postsynaptic membrane, the specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft).
GO:0001942	GO	BP	hair follicle development	ALX4,APCDD1,ATP7A,FGFR2,FOXE1,FUZ,GNAS,HDAC1,HDAC2,INHBA,KRT17,KRT71,KRT84,PDGFA,SOX9,SPINK5,TGFB2,TGM3,WNT10A	The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
GO:0001944	GO	BP	vasculature development	AAMP,ACVR2B,ACVRL1,ADAM8,ADIPOR2,ADM,ADM2,AGGF1,AHR,ANG,ANGPT1,ANGPT2,ANGPTL3,APOD,ATP5B,ATP7A,ATPIF1,BMP4,BMPER,BMPR2,C1GALT1,CALCA,CALCRL,CAV1,CCBE1,CCL2,CCM2,CDH13,CEACAM1,COL1A1,COL1A2,COL4A1,CTNNB1,CUL7,CXCL8,CYP1B1,DLL1,DLL4,E2F7,E2F8,EFNB2,EGF,EGFL7,EGR1,EGR3,EIF2AK3,ENG,ENPEP,EPGN,EPHB1,EPHB2,EPHB3,EPHB4,ERAP1,ERRFI1,ESM1,FBXW7,FGF2,FGFR2,FLT1,FLT4,FOLR1,FOXC2,FOXF1,FOXS1,FZD4,GATA6,GDF2,GJA5,GLMN,GPLD1,GREM1,HAND1,HAS2,HES1,HEY1,HEY2,HMOX1,HOXA1,HPGD,ID1,IL18,ITGA5,ITGB1BP1,ITGB3,ITGB8,JAG1,JAM3,JMJD6,KDR,LAMA5,LOXL2,LRP1,LRP5,LYL1,MCAM,MED1,MEF2C,MESP1,MYH9,MYLK,NCL,NDNF,NF1,NKX2-5,NOTCH1,NOTCH4,NOV,NOX1,NOX5,NR2F2,NR4A1,NRP1,NRP2,NRXN1,NRXN3,OSR1,OTULIN,PARVA,PAX6,PDGFA,PDGFB,PDGFRA,PDGFRB,PDPN,PIK3CA,PKD1,PKD2,PLXDC1,PLXND1,PRKX,PROK2,PROX1,PTK2,PTK2B,PTPN14,RAMP1,RAMP2,RAPGEF2,RASA1,RASIP1,RBPJ,ROBO1,ROBO4,RORA,S100A7,S1PR1,SCG2,SEMA3E,SEMA5A,SERPINF2,SFRP2,SHH,SIRT1,SLC12A6,SLIT2,SMAD7,SOX17,SOX18,SOX4,SRF,SRPK2,STAB2,STK11,STRA6,SYK,TBX1,TBX2,TBX20,TBX5,TCF21,TCF7L2,TDGF1,TEK,TFAP2B,TGFB2,TGFBR1,TGFBR2,THBS1,THY1,TMPRSS6,TNNI3,VASH1,VEGFA,WNT7B,WT1,XBP1	The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
GO:0001945	GO	BP	lymph vessel development	ACVR2B,ACVRL1,BMPR2,CCBE1,FLT4,FOXC2,NR2F2,PDPN,PROX1,PTPN14,SOX18,SYK,TBX1,VEGFA	The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure.
GO:0001946	GO	BP	lymphangiogenesis	ACVR2B,ACVRL1,BMPR2,CCBE1,FLT4,FOXC2,PDPN,PROX1,PTPN14,SOX18	Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels.
GO:0001947	GO	BP	heart looping	AHI1,BBS4,BBS5,BBS7,CCDC103,CCDC39,CCDC40,DLL1,DNAAF1,ENG,FOLR1,FOXN4,GATA4,HAND1,HAND2,IHH,MEF2C,MESP1,MICAL2,MKKS,NKX2-5,NOTCH1,NPHP3,PKD2,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX2,TBX20,VANGL2,ZIC3	The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
GO:0001948	GO	MF	glycoprotein binding	AGR2,AGR3,AGRN,AZU1,CECR1,CFH,COMP,ERLEC1,FBXO17,FBXO27,FBXO6,FCN2,FLNA,HPSE2,HRG,IGF2R,LACRT,OS9,PLAT,SEMA5A,THBS1,VWF	Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.
GO:0001952	GO	BP	regulation of cell-matrix adhesion	ACER2,ACVRL1,ADAM15,APOD,ARHGAP6,BCAS3,CASK,CCL21,CCL25,CCL28,CCR7,CD36,CDH13,CDK6,CDKN2A,CIB1,CLASP1,CLASP2,COL16A1,CORO1C,CSF1,DAPK3,DLC1,DMTN,EFNA5,EMP2,EPHA1,EPHA3,GPM6B,GSK3B,HOXA7,HRG,ITGB1BP1,KDR,LIMS1,MACF1,MINK1,MYOC,NF1,NF2,PHLDB2,PIK3CB,PLAU,PLEKHA2,PLET1,PPM1F,PTEN,PTK2,PTK2B,PTPRJ,RAC1,RASA1,RCC2,ROCK1,ROCK2,S100A10,SEMA3E,SERPINE1,SFRP1,SLC9A1,SRC,TEK,THBS1,TSC1,UTRN,VEGFA	Any process that modulates the frequency, rate or extent of attachment of a cell to the extracellular matrix.
GO:0001953	GO	BP	negative regulation of cell-matrix adhesion	ACER2,ACVRL1,ADAM15,APOD,ARHGAP6,BCAS3,CASK,CDKN2A,CLASP2,CORO1C,DLC1,DMTN,HOXA7,ITGB1BP1,MYOC,NF2,PHLDB2,PLET1,PTEN,RASA1,RCC2,SEMA3E,SERPINE1,SRC,THBS1	Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
GO:0001954	GO	BP	positive regulation of cell-matrix adhesion	CCL21,CCL25,CCL28,CCR7,CD36,CDH13,CDK6,CIB1,COL16A1,CSF1,EMP2,EPHA1,GSK3B,HRG,KDR,LIMS1,MYOC,PLEKHA2,PPM1F,PTK2B,PTPRJ,RAC1,ROCK1,S100A10,SFRP1,TEK,TSC1,UTRN,VEGFA	Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix.
GO:0001956	GO	BP	positive regulation of neurotransmitter secretion	DTNBP1,GPER1,NLGN1,RAB3GAP1,STX1B,UNC13B	Any process that activates or increases the frequency, rate or extent of the regulated release of a neurotransmitter.
GO:0001958	GO	BP	endochondral ossification	BMP4,COL13A1,DLX5,FGFR3,INPPL1,MEF2C,SCX	Replacement ossification wherein bone tissue replaces cartilage.
GO:0001959	GO	BP	regulation of cytokine-mediated signaling pathway	ADIPOQ,AGPAT1,AGPAT2,APOA1,AXL,BIRC2,BIRC3,CACTIN,CASP8,CCL5,CD24,CD74,CDC37,CHUK,CLIP3,CPNE1,CSF1,CYLD,DNAJA3,EDN1,F2RL1,FADD,GAS6,GFI1,GNB2L1,GSTP1,HIF1A,HIPK1,HSP90AB1,HSPA1A,HSPA1B,IFNA1,IFNA10,IFNA14,IFNA16,IFNA17,IFNA2,IFNA21,IFNA4,IFNA5,IFNA6,IFNA7,IFNA8,IFNAR1,IFNAR2,IFNB1,IFNG,IFNGR1,IFNGR2,IKBKB,IKBKG,IL1RN,IL36RN,IL6ST,IRAK1,IRAK2,IRAK3,JAK1,JAK2,MADD,MAVS,MUL1,NLRC5,NLRP2P,NR1H2,NR1H3,OTULIN,PADI2,PALM3,PARK2,PELI3,PIAS1,PPARG,PTPN1,PTPN11,PTPN2,PTPN6,PTPRC,PXDN,PYCARD,PYDC1,PYDC2,RBCK1,RFFL,RIPK1,RNF31,ROBO1,RPS27A,SHARPIN,SIGIRR,SLIT2,SLIT3,SOCS1,SOCS3,SPHK1,STAP1,STAT1,STAT2,SUMO1,SYK,TAX1BP1,TICAM2,TNF,TNFAIP3,TNFRSF1A,TRADD,TRAF1,TRAF2,TRAIP,TREM2,TRIM6,TXK,TYK2,UBA52,UBB,UBC,UBE2K,USP18,VRK2,WNT5A,ZNF675	Any process that modulates the frequency, rate or extent of the cytokine mediated signaling pathway.
GO:0001960	GO	BP	negative regulation of cytokine-mediated signaling pathway	ADIPOQ,APOA1,CACTIN,CCL5,DNAJA3,F2RL1,GAS6,GSTP1,IL1RN,IL36RN,IL6ST,IRAK3,MUL1,NLRC5,NLRP2P,NR1H2,NR1H3,PADI2,PALM3,PELI3,PPARG,PTPN2,PTPRC,PXDN,PYDC1,PYDC2,RFFL,ROBO1,SIGIRR,SLIT2,SLIT3,STAP1,TRAIP,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of the cytokine mediated signaling pathway.
GO:0001961	GO	BP	positive regulation of cytokine-mediated signaling pathway	AGPAT1,AGPAT2,AXL,CD74,CPNE1,CSF1,EDN1,FADD,GAS6,GFI1,HIF1A,HSPA1A,HSPA1B,MAVS,NLRC5,PARK2,TICAM2,TREM2,TRIM6,TXK,UBE2K,WNT5A	Any process that activates or increases the frequency, rate or extent of a cytokine mediated signaling pathway.
GO:0001963	GO	BP	synaptic transmission, dopaminergic	CRH,CRHBP,DRD5,SNCA,TH	The process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine.
GO:0001964	GO	BP	startle response	CTNNA2,DRD1,DRD2,DRD3,GLRA1,GLRB,GRID2,PTEN	An action or movement due to the application of a sudden unexpected stimulus.
GO:0001965	GO	MF	G-protein alpha-subunit binding	F2R,F2RL1,HTR2B,OPRM1,RIC8B	Interacting selectively and non-covalently with a G-protein alpha subunit. The alpha subunit binds a guanine nucleotide.
GO:0001968	GO	MF	fibronectin binding	ITGAV,ITGB3,LACRT,LRRC15,PLEKHA2,SFRP2,SSC5D,THBS1,VEGFA	Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
GO:0001972	GO	MF	retinoic acid binding	CYP26A1,CYP26B1,CYP26C1,LCN12,NR2F2,RARA,SERPINA5,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	Interacting selectively and non-covalently with retinoic acid, 3,7-dimethyl-9-(2,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid.
GO:0001974	GO	BP	blood vessel remodeling	ACE,ACVR2B,ACVRL1,AGT,AGTR2,ATP7A,BMPR2,CCR2,DLL4,MEF2C,NOS3	The reorganization or renovation of existing blood vessels.
GO:0001976	GO	BP	neurological system process involved in regulation of systemic arterial blood pressure	ACE2,CALCA,DRD2,SOD2,TNNI3	The regulation of blood pressure mediated by detection of stimuli and a neurological response.
GO:0001977	GO	BP	renal system process involved in regulation of blood volume	CYP11B2,CYP4F12,EMP2,F2R,F2RL1,GAS6,PDGFB,PTPRO	A slow mechanism of blood pressure regulation that responds to changes in pressure resulting from fluid and salt intake by modulating the quantity of blood in the circulatory system.
GO:0001990	GO	BP	regulation of systemic arterial blood pressure by hormone	ACE,ACE2,AGT,AGTR1,AGTR2,ANPEP,ATP6AP2,CMA1,CORIN,CPA3,CTSG,CTSZ,CYP11B2,ECE1,EDN1,EDN2,EDN3,ENPEP,MME,NOS3,RASL10B,REN,SERPINF2	The process in which hormones modulate the force with which blood passes through the circulatory system. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
GO:0001991	GO	BP	regulation of systemic arterial blood pressure by circulatory renin-angiotensin	ACE,ACE2,AGT,AGTR2,ANPEP,ATP6AP2,CMA1,CPA3,CTSG,CTSZ,ECE1,ENPEP,MME,REN	The process in which angiotensinogen metabolites in the bloodstream modulate the force with which blood passes through the circulatory system. The process begins when renin is released and cleaves angiotensinogen.
GO:0002002	GO	BP	regulation of angiotensin levels in blood	ACE,ACE2,AGT,ANPEP,ATP6AP2,CMA1,CPA3,CTSG,CTSZ,ECE1,ENPEP,MME,REN	The process that modulates the level of angiotensin in the blood by balancing the maturation of renin substrate to mature angiotensin and the catabolism of mature angiotensin.
GO:0002003	GO	BP	angiotensin maturation	ACE,ACE2,AGT,ANPEP,ATP6AP2,CMA1,CPA3,CTSG,CTSZ,ENPEP,MME,REN	The process leading to the attainment of the full functional capacity of angiotensin by conversion of renin substrate into mature angiotensin in the blood.
GO:0002009	GO	BP	morphogenesis of an epithelium	ACVR1,ACVRL1,AHI1,ARHGAP12,ATP7A,BBS4,BBS5,BBS7,BCL10,BMP2,BMP4,CCDC103,CCDC39,CCDC40,CCM2,CELSR1,CEP290,CITED1,COBL,COL4A1,COL5A1,CSF1R,CSNK2B,CTNNB1,CTSH,CYR61,DDR1,DEAF1,DLC1,DLL1,DLL4,DNAAF1,DVL2,ENG,EPHA2,FGF1,FGF10,FGF2,FGFR2,FLRT3,FOLR1,FOXD1,FOXE1,FOXF1,FOXN4,FUZ,GATA3,GATA4,GDF2,GDNF,GLI2,GRHL2,GRHL3,HAND1,HAND2,HES1,HOXA11,HOXD11,IFT122,IHH,KDF1,KDM2B,KLHL3,KLK14,KRT16,KRT17,KRT6A,KRT71,LHX1,LIN7C,LMO4,MEF2C,MEGF8,MESP1,MET,MICAL2,MKKS,MMP12,MPP5,MSN,MTHFD1,MTHFD1L,MTSS1,MYC,NKX2-5,NKX3-1,NOTCH1,NOTCH4,NPHP3,NPNT,NRP1,OSR1,PAK1,PAX2,PAX8,PDCD10,PHACTR4,PKD1,PKD2,PLET1,PLXNB2,PODXL,PRICKLE1,PRKD2,PRKX,PROX1,RAB10,RASIP1,RBPJ,RHOA,RHOB,RHOC,RIPK4,RYR2,SALL1,SCRIB,SEMA3E,SEMA4C,SETDB2,SFRP2,SHH,SIX1,SIX2,SIX4,SKI,SLC9A3R1,SLIT2,SMO,SOX11,SOX17,SOX18,SOX4,SOX8,SOX9,SRF,STARD13,STIL,SYNE4,TBX2,TBX20,TCF21,TFAP2A,TGFB2,TGFBR2,TGM3,TIMELESS,TOR1A,TRAF3IP1,TSC2,VANGL2,VCL,VEGFA,WNK4,WNT10A,WNT16,WNT5A,WNT7A,WNT7B,WT1,ZIC3	The process in which the anatomical structures of epithelia are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.
GO:0002011	GO	BP	morphogenesis of an epithelial sheet	ACVRL1,ARHGAP12,COL5A1,CYR61,DDR1,DLL4,FLRT3,LIN7C,MEGF8,MMP12,MPP5,NOTCH1,PDCD10,PHACTR4,PLET1,RHOA,RHOC,SOX11,TBX20,TOR1A,WNT7A	The process in which the anatomical structures of an epithelial sheet are generated and organized. An epithelial sheet is a flat surface consisting of closely packed epithelial cells.
GO:0002020	GO	MF	protease binding	BCL2,BFAR,ITGAV,ITGB3,MAGEA3,PINK1,VWF	Interacting selectively and non-covalently with any protease or peptidase.
GO:0002026	GO	BP	regulation of the force of heart contraction	ADRBK1,ATP2B4,CAMK2D,CSRP3,EDN2,GLRX3,MYH6,MYH7,MYL2,MYL3,MYL4,NOS1,PLN,RYR2,SLC8A1,SLC9A1	Any process that modulates the extent of heart contraction, changing the force with which blood is propelled.
GO:0002027	GO	BP	regulation of heart rate	AGTR2,AKAP9,ANK2,ATP2A2,CACNA1D,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CTNNA3,DMD,DRD2,DSC2,DSG2,DSP,EDN1,EDN2,EDN3,FKBP1B,GPD1L,HCN4,HRC,JUP,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,MYH6,MYH7,NOS1AP,NPPA,PDE4D,PKP2,PLN,PRKACA,RANGRF,RYR2,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SNTA1,SPTBN4,SPX,SRI,TNNI3K,TPM1,YWHAE	Any process that modulates the frequency or rate of heart contraction.
GO:0002028	GO	BP	regulation of sodium ion transport	ACTN4,AGT,AHCYL1,ANK3,ATP1A1,ATP1A2,ATP1B1,ATP1B2,ATP1B3,ATP2B4,BPIFA1,CAMK2D,CAV3,CHP1,CNKSR3,COMMD1,DLG1,DMD,DRD2,DRD4,FGF12,FXYD1,GLRX,GPD1L,NEDD4,NEDD4L,NKX2-5,NOS1,P2RX4,P2RX7,PCSK9,PER1,PKP2,PRKCE,PTPN3,RANGRF,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SIK1,SLC9A1,SLC9A3R1,SNTA1,SPTBN4,TESC,UTRN,WNK2,WNK3,YWHAH	Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0002029	GO	BP	desensitization of G-protein coupled receptor protein signaling pathway	ADM,ADRB2,ADRBK1,ARRB1,ARRB2,CALCA,DRD3,GTF2H2	The process that stops, prevents, or reduces the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity after prolonged stimulation with an agonist of the pathway.
GO:0002031	GO	BP	G-protein coupled receptor internalization	ADM,ARRB1,ARRB2,CALCA,DRD3,GTF2H2	The process that results in the uptake of a G-protein coupled receptor into an endocytic vesicle.
GO:0002039	GO	MF	p53 binding	BRD4,CDKN2AIP,CHD8,GSK3B,MAPKAPK5,PLK3,PSME3,RNF20,STK11,TP53RK,USP7	Interacting selectively and non-covalently with one of the p53 family of proteins.
GO:0002040	GO	BP	sprouting angiogenesis	ACVRL1,ANGPT1,BMP4,BMPER,CCBE1,CDH13,DLL1,E2F7,E2F8,EFNB2,EGR3,EPHB4,ESM1,FGF2,FLT4,GPLD1,GREM1,ITGB1BP1,JMJD6,KDR,LOXL2,NR4A1,NRP1,OTULIN,PARVA,PTK2B,RAMP2,ROBO1,SEMA3E,SEMA5A,SLIT2,SRF,TDGF1,TEK,THBS1,VEGFA	The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
GO:0002042	GO	BP	cell migration involved in sprouting angiogenesis	EFNB2,EGR3,EPHB4,FGF2,GPLD1,GREM1,KDR,NR4A1,NRP1,ROBO1,SLIT2,SRF,TDGF1,VEGFA	The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
GO:0002043	GO	BP	blood vessel endothelial cell proliferation involved in sprouting angiogenesis	ACVRL1,BMP4,BMPER,ITGB1BP1,SEMA5A	The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
GO:0002052	GO	BP	positive regulation of neuroblast proliferation	CTNNB1,DISC1,DRD2,FZD3,SMARCD3,VEGFA,ZNF335	Any process that activates or increases the rate of neuroblast proliferation.
GO:0002053	GO	BP	positive regulation of mesenchymal cell proliferation	CHRD,FGFR2,LRP5,MYC,PDGFA,SHH,SOX9,STAT1,TBX1,TGFBR2,VEGFA	The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
GO:0002062	GO	BP	chondrocyte differentiation	AMELX,BMP2,BMP4,BMPR1B,BMPR2,CREB3L2,EIF2AK3,FGFR3,GPLD1,HMGA2,MEF2C,NFIB,NOV,NPPC,OSR1,OSR2,SCX,SNX19,SOX9,SULF1,SULF2,TGFB1,WNT7A	The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
GO:0002063	GO	BP	chondrocyte development	BMPR1B,BMPR2,EIF2AK3,SOX9,SULF1,SULF2	The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
GO:0002064	GO	BP	epithelial cell development	BASP1,BMP4,BMP5,BMP6,CDK6,CITED1,CLDN3,DACT2,DLL1,ENG,EPHA2,EXPH5,EZR,F11R,F2RL1,FZD7,GATA3,GRHL2,GSTM3,ICAM1,IQGAP1,JAG1,LRTOMT,MAGI2,MARVELD2,MET,MLLT4,MSN,MYADM,MYO1E,NKX6-1,PAX2,PAX6,PDE2A,PDE4D,PDGFB,PODXL,PPP1R16B,RAB13,RAB25,RAP1A,RAP1B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3,RDX,RILPL1,RILPL2,ROS1,SIPA1L3,SIX2,SIX3,SMO,SOD1,SOX18,SOX8,STC1,STRC,TJP1,TJP2,TMEM79,WNT5B,WNT7A,WNT7B,WT1	The process whose specific outcome is the progression of an epithelial cell over time, from its formation to the mature structure. An epithelial cell is a cell usually found in a two-dimensional sheet with a free surface.
GO:0002065	GO	BP	columnar/cuboidal epithelial cell differentiation	BCCIP,BMP2,BMP4,BMP5,BMP6,C10orf11,CDK6,CDX2,CITED1,DLL1,FGF8,FGFR2,GATA4,GATA5,GATA6,HES5,INSM1,JAG2,KIT,LRTOMT,MEF2C,MITF,NEUROD1,NKX6-1,PAX6,PDX1,RFX6,ROS1,SOD1,SOX11,SOX4,STRC,USP13,WNT11	The process in which a relatively unspecialized cell acquires specialized features of a columnar/cuboidal epithelial cell. A columnar/cuboidal epithelial cell is a cell usually found in a two dimensional sheet with a free surface. Columnar/cuboidal epithelial cells take on the shape of a column or cube.
GO:0002066	GO	BP	columnar/cuboidal epithelial cell development	BMP4,BMP5,BMP6,CDK6,DLL1,NKX6-1,PAX6,ROS1	The process whose specific outcome is the progression of a columnar/cuboidal epithelial cell over time, from its formation to the mature structure. A columnar/cuboidal epithelial cell is a cell usually found in a two dimensional sheet with a free surface. Columnar/cuboidal epithelial cells take on the shape of a column or cube.
GO:0002067	GO	BP	glandular epithelial cell differentiation	BMP2,BMP4,BMP5,BMP6,CDK6,DLL1,FGFR2,INSM1,NEUROD1,NKX6-1,PAX6,PDX1,RFX6	The process in which a relatively unspecialized cell acquires specialized features of a glandular epithelial cell. A glandular epithelial cell is a columnar/cuboidal epithelial cell found in a two dimensional sheet with a free surface exposed to the lumen of a gland.
GO:0002068	GO	BP	glandular epithelial cell development	BMP4,BMP5,BMP6,CDK6,DLL1,NKX6-1,PAX6	The process whose specific outcome is the progression of a glandular epithelial cell over time, from its formation to the mature structure. A glandular epithelial cell is a columnar/cuboidal epithelial cell is a cell found in a two dimensional sheet with a free surface exposed to the lumen of a gland.
GO:0002072	GO	BP	optic cup morphogenesis involved in camera-type eye development	PAX2,PHACTR4,SOX11,TFAP2A,WNT16,WNT5A	The invagination of the optic vesicle to form two-walled indentations, the optic cups, that will go on to form the retina. This process begins with the optic vesicle becoming a two-walled structure and its subsequent shape changes. It does not include the fate commitment of cells to become the pigmented retina and the neural retina. An example of this process is found in Mus musculus.
GO:0002080	GO	CC	acrosomal membrane	EQTN,FAM170B,SERPINA5,TEKT3,ZP3	The membrane that surrounds the acrosomal lumen. The acrosome is a special type of lysosome in the head of a spermatozoon that contains acid hydrolases and is concerned with the breakdown of the outer membrane of the ovum during fertilization.
GO:0002082	GO	BP	regulation of oxidative phosphorylation	ACTN3,ATP7A,MLXIPL,PARK7,PINK1,PPIF,SLC25A33,SNCA,UQCC2,VCP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.
GO:0002088	GO	BP	lens development in camera-type eye	CRYGD,EPHA2,FOXE3,MED1,PITX3,SHROOM2,SIX3,SKI,SOX11,TDRD7,UNC45B,WNT2,WNT2B,WNT5A,WNT5B,WNT7A,WNT7B	The process whose specific outcome is the progression of the lens over time, from its formation to the mature structure. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
GO:0002089	GO	BP	lens morphogenesis in camera-type eye	EPHA2,PITX3,SHROOM2,SKI,SOX11,TDRD7	The process in which the anatomical structures of the lens are generated and organized. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
GO:0002090	GO	BP	regulation of receptor internalization	AHI1,ANGPT1,ANXA2,ARF1,ARRB1,ARRB2,ATAD1,ATXN2,CD63,DKK1,DLG4,FLOT1,GREM1,HAMP,MAGI2,MTMR2,NTF3,PCSK9,PICK1,RSPO1,SCYL2,SDCBP,SELE,SFRP4,TBC1D5,UBQLN2,VEGFA,WNT3A	Any process that modulates the frequency, rate or extent of receptor internalization.
GO:0002091	GO	BP	negative regulation of receptor internalization	ANXA2,ATXN2,DLG4,MTMR2,SDCBP,UBQLN2	Any process that stops, prevents, or reduces the frequency, rate or extent of receptor internalization.
GO:0002092	GO	BP	positive regulation of receptor internalization	AHI1,ANGPT1,ARRB1,ARRB2,ATAD1,CD63,GREM1,HAMP,MAGI2,NTF3,PCSK9,PICK1,SCYL2,SELE,SFRP4,TBC1D5,VEGFA,WNT3A	Any process that activates or increases the frequency, rate or extent of receptor internalization.
GO:0002098	GO	BP	tRNA wobble uridine modification	ALKBH8,CTU1,CTU2,MOCS3,URM1	The process in which a uridine in position 34 of a tRNA is post-transcriptionally modified.
GO:0002102	GO	CC	podosome	ADAM8,BIN2,DBNL,FERMT3,FSCN1,GSN,KIF9,LCP1,LPXN,SH3PXD2A,SH3PXD2B,VCAM1	An actin-rich adhesion structure characterized by formation upon cell substrate contact and localization at the substrate-attached part of the cell, contain an F-actin-rich core surrounded by a ring structure containing proteins such as vinculin and talin, and have a diameter of 0.5 mm.
GO:0002116	GO	CC	semaphorin receptor complex	NRP1,NRP2,PLXNA1,PLXNA2,PLXNA3,PLXNA4,PLXNB1	A stable binary complex of a neurophilin and a plexin, together forming a functional semaphorin receptor.
GO:0002178	GO	CC	palmitoyltransferase complex	GOLGA7,ORMDL3,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,ZDHHC9	A protein complex with palmitoyltransferase activity.
GO:0002181	GO	BP	cytoplasmic translation	DENR,EIF2D,EIF3A,MCTS1,RBM4,RPL36A	The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein.
GO:0002183	GO	BP	cytoplasmic translational initiation	DENR,EIF2D,EIF3A,MCTS1,RBM4	The process preceding formation of the peptide bond between the first two amino acids of a protein in the cytoplasm. This includes the formation of a complex of the ribosome, mRNA, and an initiation complex that contains the first aminoacyl-tRNA.
GO:0002200	GO	BP	somatic diversification of immune receptors	AICDA,BATF,CD40LG,CTNNBL1,EXOSC3,EXOSC6,HMGB1,HMGB2,HSPD1,LIG4,MSH2,MSH6,POLL,POLQ,RAG1,RAG2,RNF168,RNF8,TCF3,VPRBP	The somatic process allowing for the production of immune receptors whose specificity is not encoded in the germline genomic sequences.
GO:0002220	GO	BP	innate immune response activating cell surface receptor signaling pathway	BCL10,BTRC,CALM1,CARD11,CARD9,CASP8,CD209,CHUK,CLEC4A,CLEC4C,CLEC4D,CLEC4E,CLEC6A,CLEC7A,CREBBP,CUL1,EP300,FBXW11,FCER1G,FCN1,FFAR2,FYN,HRAS,ICAM2,ICAM3,IKBKB,IKBKG,IL1B,ITPR1,ITPR2,ITPR3,KRAS,LYN,MALT1,MAP3K14,MAP3K7,NFATC1,NFATC2,NFATC3,NFKB1,NFKB2,NFKBIA,NRAS,PAK1,PAK2,PAK3,PDPK1,PLCG2,PPP3CA,PPP3CB,PPP3R1,PRKACA,PRKACB,PRKACG,PRKCD,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PYCARD,RAF1,RELA,RELB,RPS27A,RPS6KA5,SKP1,SRC,SYK,TAB1,TAB2,TAB3,TRAF6,UBA3,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2M,UBE2N,UBE2V1	Any series of molecular signals leading to activation of the innate immune response generated as a consequence of binding to a cell surface receptor.
GO:0002221	GO	BP	pattern recognition receptor signaling pathway	ATF1,ATF2,BCL10,BIRC2,BIRC3,BTK,BTRC,CARD9,CASP8,CD14,CD36,CHUK,CLEC7A,CNPY3,COLEC12,CREB1,CTSB,CTSK,CTSL,CTSS,CUL1,CYLD,DDX58,DMBT1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FADD,FBXW11,FCN1,FFAR2,FOS,HSP90B1,HSPD1,IFIH1,IKBKB,IKBKE,IKBKG,IRAK1,IRAK2,IRAK3,IRAK4,IRF3,IRF7,ITCH,ITGAM,ITGB2,JUN,LBP,LGMN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MARCO,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,NR1H4,OTULIN,PELI1,PELI2,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,PIK3AP1,PIK3C3,PIK3R4,PPP2R5D,PRKCE,REG3G,RELA,RFTN1,RIPK1,RIPK2,RIPK3,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,S100A14,SARM1,SKP1,TAB1,TAB2,TAB3,TANK,TBK1,TICAM1,TICAM2,TIRAP,TLR1,TLR10,TLR2,TLR3,TLR4,TLR5,TLR6,TLR7,TLR8,TLR9,TNFAIP3,TNIP1,TNIP2,TNIP3,TRAF3,TRAF6,TRIL,TRIM5,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBE2N,UBE2V1,UNC93B1	Any series of molecular signals generated as a consequence of a pattern recognition receptor (PRR) binding to one of its physiological ligands. PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species, or damage-associated molecular pattern (DAMPs), endogenous molecules released from damaged cells.
GO:0002223	GO	BP	stimulatory C-type lectin receptor signaling pathway	BCL10,BTRC,CALM1,CARD11,CARD9,CASP8,CD209,CHUK,CLEC4A,CLEC4C,CLEC4D,CLEC4E,CLEC6A,CLEC7A,CREBBP,CUL1,EP300,FBXW11,FCER1G,FYN,HRAS,ICAM2,ICAM3,IKBKB,IKBKG,IL1B,ITPR1,ITPR2,ITPR3,KRAS,LYN,MALT1,MAP3K14,MAP3K7,NFATC1,NFATC2,NFATC3,NFKB1,NFKB2,NFKBIA,NRAS,PAK1,PAK2,PAK3,PDPK1,PLCG2,PPP3CA,PPP3CB,PPP3R1,PRKACA,PRKACB,PRKACG,PRKCD,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PYCARD,RAF1,RELA,RELB,RPS27A,RPS6KA5,SKP1,SRC,SYK,TAB1,TAB2,TAB3,TRAF6,UBA3,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2M,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.
GO:0002224	GO	BP	toll-like receptor signaling pathway	ATF1,ATF2,BCL10,BIRC2,BIRC3,BTK,BTRC,CASP8,CD14,CD36,CHUK,CNPY3,COLEC12,CREB1,CTSB,CTSK,CTSL,CTSS,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FADD,FBXW11,FOS,HSP90B1,HSPD1,IKBKB,IKBKE,IKBKG,IRAK1,IRAK2,IRAK3,IRAK4,IRF3,IRF7,ITGAM,ITGB2,JUN,LBP,LGMN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,NR1H4,PELI1,PELI2,PIK3AP1,PIK3C3,PIK3R4,PPP2R5D,PRKCE,REG3G,RELA,RFTN1,RIPK1,RIPK2,RIPK3,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,S100A14,SARM1,SKP1,TAB1,TAB2,TAB3,TANK,TBK1,TICAM1,TICAM2,TIRAP,TLR1,TLR10,TLR2,TLR3,TLR4,TLR5,TLR6,TLR7,TLR8,TLR9,TNIP1,TNIP2,TNIP3,TRAF3,TRAF6,TRIL,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBE2N,UBE2V1,UNC93B1	Any series of molecular signals generated as a consequence of binding to a toll-like receptor. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
GO:0002227	GO	BP	innate immune response in mucosa	APOA4,BPIFB1,CAMP,DEFA1,DEFA3,DEFB1,FAU,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,LTF,NOS2,PLA2G1B,RNASE3,RPL39	Any process of the innate immune response that takes place in the mucosal tissues.
GO:0002228	GO	BP	natural killer cell mediated immunity	CEBPG,CLEC2A,CORO1A,GZMB,KIR3DL1,KLRC2,KLRD1,KLRF2,LYST,MICA,RAET1E,RAET1G,SLAMF7,TUBB,TUBB4B,ULBP1,ULBP2,ULBP3,VAMP7	The promotion of an immune response by natural killer cells through direct recognition of target cells or through the release of cytokines.
GO:0002230	GO	BP	positive regulation of defense response to virus by host	ACIN1,ACKR3,ACTRT1,AIM2,ALKBH5,ALPK1,ANXA5,APOBEC3F,APOBEC3G,ASB2,ATP1B1,C1orf210,C8orf59,CA7,CCDC36,CD163L1,CD93,CHAF1B,CHST3,CLDN7,COX8A,CPA3,CREB3,CRNKL1,CSPG5,DDX58,DKKL1,DNAAF2,DPF3,EIF2AK4,EIF2S1,FABP1,FAM131B,FAM13B,FANCL,FCGR3B,FGF14,FGF7,FGFBP1,FXR2,GABRA5,GMIP,HCAR1,HILPDA,HIST1H3A,HPR,IL12B,IL12RB1,IL23A,IL23R,IST1,ITPKC,KCNQ1,KIAA1549L,KRT6A,LENG9,LILRB1,LMCD1,LSM4,MAP1A,MAVS,MB21D1,MBD5,MDH1,MRPS10,MRPS2,MSTN,MTSS1,MYLK,MYOM1,NTHL1,NUP93,PDK4,PEX13,PEX3,PHYHIP,PML,PNPO,PPY,RBM18,REEP2,REP15,RFWD3,SCN1A,SERPINB10,SIN3A,SLC1A3,SLC25A19,SLC35B3,SLC35C1,SLC37A4,SMURF1,SNRPB,SNRPB2,SNRPD1,SNTG1,STAT2,STOM,SUPT3H,TEAD4,TMEM173,TMEM203,TMEM39A,TMEM39B,TNIK,TRAF3IP2,TREM1,TRIM6,UBA52,YIPF1,ZC3H12A,ZCCHC17,ZNF189,ZNF681	Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication.
GO:0002237	GO	BP	response to molecule of bacterial origin	ADAM17,ADAM9,ANKRD1,AXL,B2M,C4B,CACTIN,CCL2,CCL3,CCL5,CD14,CD24,CD36,CD6,CDC73,CITED1,CPS1,CTR9,CXCL10,CXCL2,CXCL8,CYP27B1,DAB2IP,ERBB2IP,F2R,FER,FOXP1,FZD5,GCH1,GSTP1,HCK,HMGB2,HNRNPA0,IFNAR1,IL10,IL12A,IL18,IL1B,IL23R,IL6,IRAK1,IRAK3,IRF5,IRG1,JAK2,LBP,LGALS9,LIAS,LILRB2,LY96,LYN,MAPK14,MAPK8,MAPKAPK2,MAPKAPK3,MEF2C,MTA1,MTDH,NFKB1,NFKBIL1,NLRP3,NOCT,NOD2,NR1D1,NR1H3,OTUD5,PAF1,PALM3,PDE4B,PRDX3,PRKCE,PTPN22,PYCARD,RPS6KA3,SBNO2,SCARB1,SELE,SELP,SERPINE1,SHPK,SIRT2,SLC11A1,SLPI,SNCA,SSC5D,STAP1,TGFB1,TICAM2,TIRAP,TLR1,TLR2,TLR4,TLR6,TLR9,TNF,TNFAIP3,TNFRSF11A,TNFRSF1B,TNFSF4,TNIP2,TNIP3,TRAF6,TRIB1,TRIM6,VIMP,XBP1,ZC3H12A	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
GO:0002244	GO	BP	hematopoietic progenitor cell differentiation	ACE,BATF,BMP4,FLT3,FST,FSTL3,GATA1,HOXB4,IL11,INHBA,KIT,LIG4,MED1,MEOX1,MIXL1,MLF1,PTPRC,SFRP1,SHH,SOX4,SP7,TGFB1,ZFPM1,ZNF385A	The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
GO:0002250	GO	BP	adaptive immune response	ADAM17,BATF,BCL10,BTK,BTN3A2,BTN3A3,C1QA,C1QB,C1QC,C1R,C1S,CD27,CD40LG,CD46,CD55,CD74,CTSH,CXCL13,EBI3,EMP2,EXOSC3,EXOSC6,GNL1,HLA-DQB1,HLA-DRB1,HLA-E,HMGB1,HSPD1,IL12B,IL18,IL18BP,IL4,IL6,IRF4,ITK,JAG1,JCHAIN,LEF1,LIG4,LY9,MEF2C,MICA,MSH2,MSH6,MYO1G,PIK3CD,PIK3CG,RFTN1,RIPK2,RNF168,RNF8,RORA,RORC,SLA2,SLAMF6,SLC11A1,SYK,TLR4,TLR6,TLR8,TNFRSF11A,TNFRSF21,TXK,ZAP70,ZP3	An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process, and allowing for enhanced response to subsequent exposures to the same antigen (immunological memory).
GO:0002251	GO	BP	organ or tissue specific immune response	APOA4,BPIFB1,CAMP,DEFA1,DEFA3,DEFB1,FAU,FFAR2,FFAR3,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,IFNL2,IFNLR1,IL6,IL6R,LTF,NOS2,OTUD7B,PIGR,PLA2G1B,RAB17,RNASE3,RPL39	An immune response taking place in an organ or tissues such as the liver, brain, mucosa, or nervous system tissues.
GO:0002260	GO	BP	lymphocyte homeostasis	AKT1,FADD,FOXP3,JAK3,LYN,MEF2C,NCKAP1L,PMAIP1,RIPK3,SIVA1,TNFAIP3,TNFSF14,ZC3H8	The process of regulating the proliferation and elimination of lymphocytes such that the total number of lymphocytes within a whole or part of an organism is stable over time in the absence of an outside stimulus.
GO:0002262	GO	BP	myeloid cell homeostasis	ALAS2,ANXA1,ATPIF1,CASP3,CEBPG,DMTN,DYRK3,EPO,FLVCR1,G6PD,GATA1,HCAR2,HCLS1,HIPK2,HMGB1,HMOX1,IKZF1,IL6,INHA,INHBA,JAK2,KIT,KLF1,KMT2E,LYN,MED1,NCKAP1L,PDE4B,PTPN2,RPS14,RPS17,RPS19,RPS24,SLC25A38,SOD1,TAL1,TGFBR3,VEGFA,ZFPM1	The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
GO:0002263	GO	BP	cell activation involved in immune response	ANXA3,ATP7A,BATF,C8orf4,CCL3,CD1C,CD244,CD40LG,CHGA,CORO1A,DLL1,DOCK2,EIF2AK4,EOMES,EXOSC3,EXOSC6,F2RL1,FOXP1,GBF1,GPR183,HMGB1,HSPD1,ICAM1,IFNB1,IL12B,IL6,IRF4,ITGAL,KIT,KLRF2,LBP,LCP1,LEF1,LFNG,LIG4,LILRB1,LY9,MFNG,MILR1,MRGPRX2,MSH2,MSH6,NOTCH2,NR4A3,PIK3CD,PIK3CG,PTGER4,PTK2B,PYCARD,RNF168,RNF8,RORA,RORC,S100A13,SBNO2,SH2D1B,SLAMF1,SLAMF6,SLC11A1,SNAP23,SYK,TNFSF18,VAMP2,VAMP7,ZFPM1	A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
GO:0002274	GO	BP	myeloid leukocyte activation	ADAM10,ADAM9,AIF1,ANXA3,AZU1,BATF,BATF2,BATF3,CAMK4,CCL3,CCL5,CD93,CHGA,CLU,CRTC3,CSF1,CSF2,CXCL8,CXCR2,DCSTAMP,DOCK2,EDN2,F2RL1,FOXP1,HMGB1,HYAL2,IL4,KIT,KMT2E,LBP,MILR1,MRGPRX2,MT1G,NR4A3,PIK3CD,PIK3CG,PREX1,PRG3,PRKCD,PYCARD,S100A12,S100A13,SBNO2,SLAMF1,SLC11A1,SNAP23,SNCA,SPACA3,SYK,TGFBR2,TLR1,TLR4,UBD,VAMP2,VAMP7	A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.
GO:0002275	GO	BP	myeloid cell activation involved in immune response	ANXA3,CCL3,CHGA,DOCK2,KIT,LBP,MILR1,MRGPRX2,NR4A3,PIK3CD,PIK3CG,PYCARD,S100A13,SBNO2,SLAMF1,SNAP23,SYK,VAMP2,VAMP7	A change in the morphology or behavior of a myeloid cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
GO:0002285	GO	BP	lymphocyte activation involved in immune response	ATP7A,BATF,CD1C,CD244,CD40LG,CORO1A,DLL1,EIF2AK4,EOMES,EXOSC3,EXOSC6,F2RL1,FOXP1,GPR183,HMGB1,HSPD1,ICAM1,IFNB1,IL12B,IL6,IRF4,ITGAL,KLRF2,LCP1,LEF1,LFNG,LIG4,LILRB1,LY9,MFNG,MSH2,MSH6,NOTCH2,PTGER4,PTK2B,RNF168,RNF8,RORA,RORC,SLAMF6,SLC11A1,TNFSF18,VAMP7,ZFPM1	A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
GO:0002286	GO	BP	T cell activation involved in immune response	ATP7A,BATF,CD1C,EIF2AK4,EOMES,F2RL1,FOXP1,HMGB1,ICAM1,IL12B,IL6,IRF4,ITGAL,LCP1,LEF1,LILRB1,LY9,PTGER4,RORA,RORC,SLAMF6,SLC11A1,TNFSF18,ZFPM1	The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.
GO:0002293	GO	BP	alpha-beta T cell differentiation involved in immune response	ATP7A,BATF,EOMES,FOXP1,HMGB1,IL12B,IL6,IRF4,LEF1,LY9,PTGER4,RORA,RORC,SLAMF6,ZFPM1	The process in which an antigenically naive alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.
GO:0002295	GO	BP	T-helper cell lineage commitment	BATF,IL6,IRF4,LY9,SLAMF6,ZFPM1	The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper cell, a CD4-positive, alpha-beta T cell specialized to promote various immunological processes.
GO:0002312	GO	BP	B cell activation involved in immune response	BATF,CD40LG,DLL1,EXOSC3,EXOSC6,GPR183,HSPD1,IFNB1,LFNG,LIG4,MFNG,MSH2,MSH6,NOTCH2,PTK2B,RNF168,RNF8	The change in morphology and behavior of a mature or immature B cell during an immune response, resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
GO:0002313	GO	BP	mature B cell differentiation involved in immune response	DLL1,GPR183,LFNG,MFNG,NOTCH2,PTK2B	The process in which a naive B cell acquires the specialized features of a mature or memory B cell during an immune response.
GO:0002315	GO	BP	marginal zone B cell differentiation	DLL1,LFNG,MFNG,NOTCH2,PTK2B	The process in which a B cell in the spleen acquires the specialized features of a marginal zone B cell. Marginal zone B cells are localized in a distinct anatomical region of the spleen that represents the major antigen-filtering and scavenging area (by specialized macrophages resident there). It appears that they are preselected to express a BCR repertoire similar to B-1 B cells, biased toward bacterial cell wall constituents and senescent self-components (such as oxidized LDL).
GO:0002320	GO	BP	lymphoid progenitor cell differentiation	BATF,BMP4,FLT3,LIG4,SHH,SOX4	The process in which a precursor cell type acquires the specialized features of a lymphoid progenitor cell. Lymphoid progenitor cells include progenitor cells for any of the lymphoid lineages.
GO:0002327	GO	BP	immature B cell differentiation	ATM,FNIP1,KIT,LRRC8A,RAG1,RAG2	The process in which a precursor cell type acquires the specialized features of an immature B cell.
GO:0002347	GO	BP	response to tumor cell	CRTAM,MICA,PLK5,PRF1,TXNIP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a tumor cell.
GO:0002366	GO	BP	leukocyte activation involved in immune response	ANXA3,ATP7A,BATF,CCL3,CD1C,CD244,CD40LG,CHGA,CORO1A,DLL1,DOCK2,EIF2AK4,EOMES,EXOSC3,EXOSC6,F2RL1,FOXP1,GPR183,HMGB1,HSPD1,ICAM1,IFNB1,IL12B,IL6,IRF4,ITGAL,KIT,KLRF2,LBP,LCP1,LEF1,LFNG,LIG4,LILRB1,LY9,MFNG,MILR1,MRGPRX2,MSH2,MSH6,NOTCH2,NR4A3,PIK3CD,PIK3CG,PTGER4,PTK2B,PYCARD,RNF168,RNF8,RORA,RORC,S100A13,SBNO2,SH2D1B,SLAMF1,SLAMF6,SLC11A1,SNAP23,SYK,TNFSF18,VAMP2,VAMP7,ZFPM1	A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
GO:0002367	GO	BP	cytokine production involved in immune response	CD55,CHGA,HSPD1,IL4,KIT,NOD2,SLC11A1,TLR2	The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus contributing to an immune response, resulting in an increase in its intracellular or extracellular levels.
GO:0002377	GO	BP	immunoglobulin production	AICDA,BATF,CD40LG,CTNNBL1,EXOSC3,EXOSC6,GALNT2,HLA-DQB1,HLA-DRB1,HSPD1,LIG4,MSH2,MSH6,POLL,POLQ,PTPRC,RNF168,RNF8,TCF3	The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0002381	GO	BP	immunoglobulin production involved in immunoglobulin mediated immune response	BATF,CD40LG,EXOSC3,EXOSC6,HLA-DQB1,HLA-DRB1,HSPD1,LIG4,MSH2,MSH6,RNF168,RNF8	The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus during an immune response, resulting in an increase in its intracellular or extracellular levels.
GO:0002385	GO	BP	mucosal immune response	APOA4,BPIFB1,CAMP,DEFA1,DEFA3,DEFB1,FAU,FFAR2,FFAR3,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,IFNL2,IFNLR1,LTF,NOS2,OTUD7B,PIGR,PLA2G1B,RAB17,RNASE3,RPL39	An immune response taking place in mucosal tissues, including those of the intestinal tract, nasal and upper respiratory tract, and genital tract.
GO:0002407	GO	BP	dendritic cell chemotaxis	CCL19,CCL21,CCL5,CCR1,CCR2,CCR5,CCR6,CCR7,CXCR1,CXCR2,CXCR4,HMGB1,PIK3CG,TRPM4	The movement of a dendritic cell in response to an external stimulus.
GO:0002431	GO	BP	Fc receptor mediated stimulatory signaling pathway	ABI1,ABL1,ACTB,ACTG1,ACTR2,ACTR3,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BAIAP2,BRK1,CD247,CD3G,CDC42,CFL1,CRK,CYFIP1,CYFIP2,DOCK1,ELMO1,ELMO2,FCGR1A,FCGR2A,FCGR3A,FGR,FYN,GRB2,HCK,HSP90AA1,HSP90AB1,ITPR1,ITPR2,ITPR3,LIMK1,LYN,MAPK1,MAPK3,MYH2,MYO10,MYO1C,MYO1G,NCK1,NCKAP1,NCKAP1L,NCKIPSD,NR4A3,PAK1,PIK3CA,PIK3CB,PIK3R1,PIK3R2,PLA2G6,PLCG1,PLCG2,PLD2,PLPP4,PRKCD,PRKCE,PTK2,RAC1,SRC,SYK,VAV1,VAV2,VAV3,WAS,WASF2,WASL,WIPF1,WIPF2,WIPF3,YES1	A series of molecular signals generated as a consequence of a the binding of the Fc portion of an immunoglobulin by an Fc receptor capable of activating or perpetuating an immune response. The Fc portion of an immunoglobulin is its C-terminal constant region.
GO:0002437	GO	BP	inflammatory response to antigenic stimulus	CD6,HLA-DRB1,HMGB2,PNMA1,TNF	An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
GO:0002440	GO	BP	production of molecular mediator of immune response	AICDA,BATF,CD40LG,CD55,CHGA,CTNNBL1,EXOSC3,EXOSC6,GALNT2,HLA-DQB1,HLA-DRB1,HSPD1,IL4,KIT,KLK3,LIG4,MSH2,MSH6,NOD2,POLL,POLQ,PTPRC,RNF168,RNF8,SLC11A1,TCF3,TLR2	The synthesis or release of any molecular mediator of the immune response, resulting in an increase in its intracellular or extracellular levels.
GO:0002443	GO	BP	leukocyte mediated immunity	ACE,ADAM17,ANXA3,AZU1,BATF,BTN3A2,BTN3A3,C1QA,C1QB,C1QC,C1R,C1S,CCL3,CD27,CD40LG,CD46,CD55,CD74,CEBPG,CHGA,CLEC2A,CORO1A,CTSH,EMP2,EXOSC3,EXOSC6,GNL1,GZMB,HLA-DQB1,HLA-DRB1,HSPD1,IL4,IL6,IL6R,IRAK4,JAG1,KIR3DL1,KIT,KLRC2,KLRD1,KLRF2,KMT2E,LIG4,LYST,MICA,MILR1,MRGPRX2,MSH2,MSH6,MYO1G,NR4A3,PIK3CD,PIK3CG,PLA2G1B,RAET1E,RAET1G,RFTN1,RNF168,RNF8,S100A13,SLA2,SLAMF7,SLC11A1,SNAP23,STXBP2,TLR8,TUBB,TUBB4B,ULBP1,ULBP2,ULBP3,VAMP2,VAMP7,ZP3	Any process involved in the carrying out of an immune response by a leukocyte.
GO:0002444	GO	BP	myeloid leukocyte mediated immunity	ACE,ADAM17,ANXA3,AZU1,CCL3,CHGA,IL6,IL6R,IRAK4,KIT,KMT2E,MILR1,MRGPRX2,NR4A3,PIK3CD,PIK3CG,PLA2G1B,S100A13,SNAP23,VAMP2,VAMP7	Any process involved in the carrying out of an immune response by a myeloid leukocyte.
GO:0002446	GO	BP	neutrophil mediated immunity	ACE,ADAM17,ANXA3,AZU1,IL6,IL6R,IRAK4,KMT2E,PLA2G1B,VAMP7	Any process involved in the carrying out of an immune response by a neutrophil.
GO:0002449	GO	BP	lymphocyte mediated immunity	BATF,BTN3A2,BTN3A3,C1QA,C1QB,C1QC,C1R,C1S,CD27,CD40LG,CD46,CD55,CD74,CEBPG,CLEC2A,CORO1A,CTSH,EMP2,EXOSC3,EXOSC6,GNL1,GZMB,HLA-DQB1,HLA-DRB1,HSPD1,IL4,JAG1,KIR3DL1,KLRC2,KLRD1,KLRF2,LIG4,LYST,MICA,MSH2,MSH6,MYO1G,RAET1E,RAET1G,RFTN1,RNF168,RNF8,SLA2,SLAMF7,SLC11A1,TLR8,TUBB,TUBB4B,ULBP1,ULBP2,ULBP3,VAMP7,ZP3	Any process involved in the carrying out of an immune response by a lymphocyte.
GO:0002455	GO	BP	humoral immune response mediated by circulating immunoglobulin	C1QA,C1QB,C1QC,C1R,C1S,HLA-DQB1,HLA-DRB1,ZP3	An immune response dependent upon secreted immunoglobulin. An example of this process is found in Mus musculus.
GO:0002456	GO	BP	T cell mediated immunity	BTN3A2,BTN3A3,CD46,CD55,CTSH,EMP2,GNL1,IL4,JAG1,MICA,MYO1G,RFTN1,SLC11A1	Any process involved in the carrying out of an immune response by a T cell.
GO:0002460	GO	BP	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	ADAM17,BATF,BTN3A2,BTN3A3,C1QA,C1QB,C1QC,C1R,C1S,CD27,CD40LG,CD46,CD55,CD74,CTSH,CXCL13,EBI3,EMP2,EXOSC3,EXOSC6,GNL1,HLA-DQB1,HLA-DRB1,HMGB1,HSPD1,IL12B,IL18,IL18BP,IL4,IL6,IRF4,JAG1,LEF1,LIG4,LY9,MEF2C,MICA,MSH2,MSH6,MYO1G,RFTN1,RNF168,RNF8,RORA,RORC,SLA2,SLAMF6,SLC11A1,TLR4,TLR6,TLR8,ZP3	An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains, and allowing for enhanced responses upon subsequent exposures to the same antigen (immunological memory). Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies). An example of this is the adaptive immune response found in Mus musculus.
GO:0002474	GO	BP	antigen processing and presentation of peptide antigen via MHC class I	ACE,B2M,BCAP31,BLMH,CALR,CANX,CD207,CD36,CTSS,CYBA,CYBB,ERAP1,ERAP2,FCGR1A,FCGR1B,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,IFI30,ITGAV,ITGB5,LNPEP,NCF1,NCF2,NCF4,NPEPPS,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RPS27A,SAR1B,SEC13,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,TAP1,TAP2,TAPBP,TPP2,UBA52,UBB,UBC,UBE2A	The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
GO:0002478	GO	BP	antigen processing and presentation of exogenous peptide antigen	ACTR1A,ACTR1B,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARF1,B2M,CALR,CANX,CD207,CD36,CD74,CENPE,CLTA,CLTC,CTSD,CTSE,CTSF,CTSL,CTSS,CTSV,CYBA,CYBB,DCTN1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DNM2,DYNC1H1,DYNC1I1,DYNC1I2,DYNC1LI2,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,FCGR1A,FCGR1B,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,IFI30,ITGAV,ITGB5,KIF11,KIF15,KIF18A,KIF22,KIF23,KIF26A,KIF2A,KIF2B,KIF2C,KIF3A,KIF3B,KIF3C,KIF4A,KIF4B,KIF5A,KIFAP3,KLC1,KLC2,LGMN,LNPEP,NCF1,NCF2,NCF4,OSBPL1A,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAB7A,RACGAP1,RILP,RPS27A,SAR1B,SEC13,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SH3GL2,SPTBN2,TAP1,TAP2,TAPBP,UBA52,UBB,UBC	The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.
GO:0002479	GO	BP	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	B2M,CALR,CD207,CD36,CYBA,CYBB,FCGR1A,FCGR1B,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,ITGAV,ITGB5,NCF1,NCF2,NCF4,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RPS27A,SEC61A1,SEC61A2,SEC61B,SEC61G,TAP1,TAP2,TAPBP,UBA52,UBB,UBC	The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
GO:0002480	GO	BP	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	B2M,CTSS,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,LNPEP	The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
GO:0002483	GO	BP	antigen processing and presentation of endogenous peptide antigen	B2M,ERAP1,ERAP2,HLA-A,HLA-B,HLA-C,HLA-E,TAP1,TAP2	The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell.
GO:0002495	GO	BP	antigen processing and presentation of peptide antigen via MHC class II	ACTR1A,ACTR1B,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARF1,CANX,CD74,CENPE,CLTA,CLTC,CTSD,CTSE,CTSF,CTSL,CTSS,CTSV,DCTN1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DNM2,DYNC1H1,DYNC1I1,DYNC1I2,DYNC1LI2,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IFI30,KIF11,KIF15,KIF18A,KIF22,KIF23,KIF26A,KIF2A,KIF2B,KIF2C,KIF3A,KIF3B,KIF3C,KIF4A,KIF4B,KIF5A,KIFAP3,KLC1,KLC2,LGMN,MARCH1,OSBPL1A,RAB7A,RACGAP1,RILP,SAR1B,SEC13,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SH3GL2,SPTBN2	The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
GO:0002501	GO	BP	peptide antigen assembly with MHC protein complex	CALR,HLA-DMA,HLA-DMB,HLA-DRA,HLA-DRB1	The binding of a peptide to the antigen binding groove of an MHC protein complex.
GO:0002507	GO	BP	tolerance induction	FOXJ1,HAVCR2,IRG1,LGALS9,LYN,TNFAIP3	A process that directly activates any of the steps required for tolerance, a physiologic state in which the immune system does not react destructively against the components of an organism that harbors it or against antigens that are introduced to it.
GO:0002521	GO	BP	leukocyte differentiation	ADAM17,ADGRG3,AICDA,ANXA1,ANXA2,ATM,ATP7A,BATF,BATF2,BATF3,BLNK,BMP4,CAMK4,CASP8,CBFA2T3,CCL19,CCR7,CD1D,CD28,CD3D,CD4,CD74,CD79A,CDC42,CEBPA,CEBPG,CHD7,CLCF1,CR2,CSF1,CSF1R,CSF2,CSF3,DCSTAMP,DLL1,DLL4,EFNA2,EOMES,EPHA2,F2RL1,FADD,FARP2,FLT3,FNIP1,FOXP1,FOXP3,GAB2,GATA1,GATA2,GLI3,GLO1,GPR183,HDAC4,HDAC5,HDAC9,HHEX,HMGB1,IFI16,IKZF1,IL10,IL11,IL12B,IL2,IL31RA,IL4,IL6,IRF4,ITGA4,ITGB1,JAG2,JAGN1,JAK3,KIT,KLF6,LCK,LEF1,LEP,LEPR,LFNG,LIG4,LRRC8A,LY9,LYL1,LYN,MAPK14,MFNG,MMP9,MSH2,MT1G,NFAM1,NHEJ1,NOTCH2,OCSTAMP,PARP1,PIK3CD,PIR,PLCG2,PPARG,PRTN3,PTGER4,PTK2B,PTPN2,PTPN22,PTPRC,RAG1,RAG2,RHOH,RIPK3,RORA,RORC,RRAS,RSAD2,SH3PXD2A,SHH,SLAMF6,SNX10,SOX4,TCF3,TGFBR2,THEMIS,THOC5,TNFRSF11A,TNFSF11,TREM2,UBD,VCAM1,VEGFA,VPRBP,ZAP70,ZFPM1	The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a leukocyte. A leukocyte is an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
GO:0002523	GO	BP	leukocyte migration involved in inflammatory response	ADAM8,FFAR2,S100A8,S100A9,SELE	The movement of a leukocyte within or between different tissues and organs of the body contributing to an inflammatory response.
GO:0002526	GO	BP	acute inflammatory response	AHSG,ANO6,APCS,APOL2,CD6,CEBPB,CRP,CTNNBIP1,F12,F3,IL1RN,IL22,IL6,IL6R,INS,KLKB1,LBP,MBL2,MYLK3,PLSCR1,SAA1,SIGIRR,TNFSF4,VNN1	Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
GO:0002544	GO	BP	chronic inflammatory response	CAMP,CEBPB,CXCL13,TNF,VNN1	Inflammation of prolonged duration (weeks or months) in which active inflammation, tissue destruction, and attempts at repair are proceeding simultaneously. Although it may follow acute inflammation, chronic inflammation frequently begins insidiously, as a low-grade, smoldering, often asymptomatic response.
GO:0002548	GO	BP	monocyte chemotaxis	ANXA1,CALCA,CCL2,CCL23,CCL3,CCL5,CCL7,FLT1,IL6,IL6R,LGALS3,PDGFB,PTPRO,RPS19,S100A12,TNFRSF11A,TNFSF11	The movement of a monocyte in response to an external stimulus.
GO:0002562	GO	BP	somatic diversification of immune receptors via germline recombination within a single locus	BATF,CD40LG,EXOSC3,EXOSC6,HMGB1,HMGB2,HSPD1,LIG4,MSH2,MSH6,RAG1,RAG2,RNF168,RNF8,TCF3,VPRBP	The process in which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
GO:0002573	GO	BP	myeloid leukocyte differentiation	ANXA2,BATF,BATF2,BATF3,BMP4,CAMK4,CASP8,CBFA2T3,CCL19,CCR7,CDC42,CEBPA,CSF1,CSF1R,CSF2,CSF3,DCSTAMP,EFNA2,EPHA2,F2RL1,FARP2,FOXP1,GAB2,GATA1,GATA2,GLO1,IFI16,IL31RA,IL4,JAGN1,KIT,LEF1,MAPK14,MMP9,MT1G,OCSTAMP,PARP1,PIK3CD,PIR,PPARG,PRTN3,SH3PXD2A,SNX10,TGFBR2,THOC5,TNFRSF11A,TNFSF11,UBD,VEGFA	The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage.
GO:0002576	GO	BP	platelet degranulation	A2M,ABCC4,ACTN1,ACTN2,ACTN4,ALB,ALDOA,APOA1,APP,BRPF3,CALM1,CALU,CAP1,CD36,CD63,CD9,CFD,CFL1,CLU,DMTN,EGF,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FLNA,FN1,GAS6,HABP4,HGF,HRG,HSPA5,IGF1,IGF2,ITGA2B,ITGB3,KNG1,LAMP2,LEFTY2,LYN,MMRN1,PDGFA,PDGFB,PECAM1,PF4,PFN1,PLEK,PLG,PPBP,PPIA,PROS1,PSAP,SCG3,SELP,SERPINA1,SERPINE1,SERPINF2,SERPING1,SOD1,SPARC,SRGN,STXBP1,SYK,TF,TGFB1,TGFB2,TGFB3,THBS1,TIMP1,TLN1,TMSB4X,TTN,TUBA4A,VCL,VEGFA,VEGFB,VEGFC,VWF,WDR1	The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
GO:0002577	GO	BP	regulation of antigen processing and presentation	CCL19,CCL21,CCR7,HFE,HLA-DOA,HLA-DOB,LILRB2,NOD1,NOD2,PYCARD,SLC11A1,TAPBPL,THBS1,TREM2,WAS	Any process that modulates the frequency, rate, or extent of antigen processing and presentation.
GO:0002578	GO	BP	negative regulation of antigen processing and presentation	HFE,HLA-DOA,HLA-DOB,LILRB2,TAPBPL,THBS1	Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation.
GO:0002579	GO	BP	positive regulation of antigen processing and presentation	CCL19,CCL21,CCR7,NOD1,NOD2,PYCARD,SLC11A1,TREM2	Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation.
GO:0002580	GO	BP	regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	HLA-DOA,HLA-DOB,PYCARD,THBS1,TREM2	Any process that modulates the frequency, rate, or extent of antigen processing and presentation of antigen (peptide or polysaccharide) via MHC class II.
GO:0002583	GO	BP	regulation of antigen processing and presentation of peptide antigen	HFE,HLA-DOA,HLA-DOB,PYCARD,TAPBPL,TREM2	Any process that modulates the frequency, rate, or extent of antigen processing and presentation of peptide antigen.
GO:0002604	GO	BP	regulation of dendritic cell antigen processing and presentation	CCL19,CCL21,CCR7,NOD1,NOD2,SLC11A1,THBS1	Any process that modulates the frequency, rate, or extent of dendritic cell antigen processing and presentation.
GO:0002606	GO	BP	positive regulation of dendritic cell antigen processing and presentation	CCL19,CCL21,CCR7,NOD1,NOD2,SLC11A1	Any process that activates or increases the frequency, rate, or extent of dendritic cell antigen processing and presentation.
GO:0002634	GO	BP	regulation of germinal center formation	BCL6,FOXJ1,MEF2C,RC3H1,TNFAIP3	Any process that modulates the frequency, rate, or extent of germinal center formation.
GO:0002637	GO	BP	regulation of immunoglobulin production	CLCF1,HLA-E,IL10,IL4,IL6,MZB1,PAXIP1,RBP4,STX4,SUPT6H,TGFB1,THOC1,TNFRSF4,TNFSF13,TNFSF4,XBP1,XCL1	Any process that modulates the frequency, rate, or extent of immunoglobulin production.
GO:0002639	GO	BP	positive regulation of immunoglobulin production	CLCF1,HLA-E,IL4,IL6,MZB1,PAXIP1,RBP4,STX4,TGFB1,TNFRSF4,TNFSF13,TNFSF4,XBP1,XCL1	Any process that activates or increases the frequency, rate, or extent of immunoglobulin production.
GO:0002643	GO	BP	regulation of tolerance induction	CLC,FOXJ1,FOXP3,HLA-B,HLA-G,HMGB1,IL2RA,IRAK3,LILRB2,TGFBR2	Any process that modulates the frequency, rate, or extent of tolerance induction.
GO:0002645	GO	BP	positive regulation of tolerance induction	FOXJ1,HLA-G,IRAK3,LILRB2,TGFBR2	Any process that activates or increases the frequency, rate, or extent of tolerance induction.
GO:0002664	GO	BP	regulation of T cell tolerance induction	CLC,FOXP3,HLA-B,HLA-G,IL2RA,LILRB2,TGFBR2	Any process that modulates the frequency, rate, or extent of T cell tolerance induction.
GO:0002673	GO	BP	regulation of acute inflammatory response	A2M,ADAM8,APCS,C1QBP,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CCR7,CD46,CD55,CD59,CFB,CFH,CFI,CFP,CR1,CREB3L3,F12,FFAR2,FFAR3,GSTP1,IL1B,IL6,IL6ST,INS,KLKB1,MASP1,NLRP3,OSM,OSMR,PHB,PROS1,PTGER3,PTGS2,SERPING1,SUSD4,TNF,TNFRSF11A,TNFSF11,VIMP,VTN,ZP3	Any process that modulates the frequency, rate, or extent of an acute inflammatory response.
GO:0002674	GO	BP	negative regulation of acute inflammatory response	APCS,GSTP1,INS,NLRP3,VIMP	Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response.
GO:0002675	GO	BP	positive regulation of acute inflammatory response	ADAM8,CCR7,CREB3L3,F12,FFAR2,FFAR3,IL1B,IL6,IL6ST,KLKB1,OSM,OSMR,PTGER3,PTGS2,TNF,TNFRSF11A,TNFSF11,ZP3	Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response.
GO:0002685	GO	BP	regulation of leukocyte migration	ADAM10,ADAM17,ADAM8,AIF1,ANO6,ANXA1,APOD,BMP5,C1QBP,C5,C5AR2,CALR,CAMK1D,CCL19,CCL2,CCL20,CCL21,CCL25,CCL28,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD300A,CD74,CMKLR1,CREB3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,DAPK2,EDN2,EDN3,F2RL1,F7,FADD,FIGF,GAS6,GCSAM,GREM1,HMGB1,HMOX1,HOXA7,ICAM1,IL12A,IL6,IL6R,JAM3,KLRK1,LGALS3,LGALS9,LYN,MIA3,MPP1,MSN,NBL1,NCKAP1L,NOV,P2RY12,PADI2,PLA2G7,PLCB1,PLVAP,PTGER4,PTK2B,PYCARD,RAC1,RAC2,RARRES2,RIPK3,S100A14,S100A7,SERPINE1,SLIT2,STAP1,STK10,THBS1,THBS4,TIRAP,TMEM102,TNF,TNFRSF18,TNFSF18,VEGFA,VEGFB,VEGFC,WASL,WNT5A,XCL1,ZNF580,ZP3	Any process that modulates the frequency, rate, or extent of leukocyte migration.
GO:0002686	GO	BP	negative regulation of leukocyte migration	APOD,BMP5,C5,C5AR2,CCL2,CCL21,CCL25,CCL28,CD300A,CXCL12,GCSAM,GREM1,HMOX1,HOXA7,KLRK1,NBL1,NOV,PADI2,PLCB1,PTGER4,SLIT2,STAP1,WASL	Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte migration.
GO:0002687	GO	BP	positive regulation of leukocyte migration	ADAM10,ADAM17,ADAM8,AIF1,ANO6,C1QBP,CALR,CAMK1D,CCL19,CCL20,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CMKLR1,CREB3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,DAPK2,EDN2,EDN3,F2RL1,F7,FADD,FIGF,GAS6,HMGB1,ICAM1,IL12A,IL6,IL6R,LGALS3,LGALS9,MIA3,NCKAP1L,PLA2G7,PLVAP,PTK2B,PYCARD,RAC1,RAC2,RARRES2,S100A14,S100A7,SERPINE1,THBS1,THBS4,TIRAP,TMEM102,TNF,TNFRSF18,TNFSF18,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZNF580,ZP3	Any process that activates or increases the frequency, rate, or extent of leukocyte migration.
GO:0002688	GO	BP	regulation of leukocyte chemotaxis	ADAM10,ADAM17,AIF1,ANO6,C1QBP,C5,C5AR2,CALR,CAMK1D,CCL19,CCL2,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CMKLR1,CREB3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,DAPK2,EDN2,EDN3,F2RL1,F7,FIGF,GAS6,GREM1,HMGB1,IL12A,IL6,IL6R,JAM3,KLRK1,LGALS9,LYN,MPP1,NBL1,NCKAP1L,NOV,PADI2,PLA2G7,PTK2B,RAC1,RAC2,RARRES2,S100A14,S100A7,SERPINE1,SLIT2,STAP1,THBS1,THBS4,TIRAP,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZNF580	Any process that modulates the frequency, rate, or extent of leukocyte chemotaxis.
GO:0002689	GO	BP	negative regulation of leukocyte chemotaxis	C5,C5AR2,CCL2,GREM1,KLRK1,NBL1,NOV,PADI2,SLIT2,STAP1	Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte chemotaxis.
GO:0002690	GO	BP	positive regulation of leukocyte chemotaxis	ADAM10,ADAM17,AIF1,ANO6,C1QBP,CALR,CAMK1D,CCL19,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CMKLR1,CREB3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,DAPK2,EDN2,EDN3,F2RL1,F7,FIGF,GAS6,HMGB1,IL12A,IL6,IL6R,LGALS9,NCKAP1L,PLA2G7,PTK2B,RAC1,RAC2,RARRES2,S100A14,S100A7,SERPINE1,THBS1,THBS4,TIRAP,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZNF580	Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis.
GO:0002691	GO	BP	regulation of cellular extravasation	ADAM8,CCL21,CCL25,CCL28,CCR2,CXCL12,FADD,ICAM1,PLCB1,PLVAP,PTGER4,RIPK3	Any process that modulates the frequency, rate, or extent of cellular extravasation.
GO:0002692	GO	BP	negative regulation of cellular extravasation	CCL21,CCL25,CCL28,CXCL12,PLCB1,PTGER4	Any process that stops, prevents, or reduces the frequency, rate, or extent of cellular extravasation.
GO:0002693	GO	BP	positive regulation of cellular extravasation	ADAM8,CCR2,FADD,ICAM1,PLVAP	Any process that activates or increases the frequency, rate, or extent of cellular extravasation.
GO:0002695	GO	BP	negative regulation of leukocyte activation	ANXA1,ATM,BMP4,BPI,BTN2A2,CCR2,CD274,CD300A,CD84,CDKN2A,CEBPB,CTLA4,DUSP3,FER,FOXJ1,FOXP3,GLI3,GLMN,GPER1,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,IL31RA,INHA,INHBA,IRF1,JAK3,KIAA0922,LAX1,LGALS3,LGALS9,LILRB1,LILRB2,LST1,MICA,MILR1,MNDA,NR1H3,PDCD1LG2,PIBF1,PRKAR1A,PRNP,PTPN2,PTPN22,RC3H1,SAMSN1,SFRP1,SFTPD,SLA2,SOCS5,SOX11,THOC1,TIGIT,TNFAIP3,TNFRSF21,TNFSF4,XCL1,ZC3H12A,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte activation.
GO:0002696	GO	BP	positive regulation of leukocyte activation	ADAM8,AGER,AIF1,AKT1,ANXA1,AP1G1,AXL,BCL2,BTK,BTLA,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CCR7,CD1D,CD2,CD226,CD24,CD247,CD27,CD274,CD276,CD28,CD38,CD3D,CD3E,CD3G,CD4,CD46,CD47,CD55,CD6,CD74,CD80,CD81,CD86,CDC42,CHRNB2,CLCF1,CSK,CTLA4,DPP4,EBI3,F2RL1,FADD,FGF10,FGR,FLOT2,FOXP3,FYN,GAB2,GAS6,GATA3,GLI2,GLI3,GPR183,GRAP2,GRB2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL33,IL4,IL6,IL6ST,IL7,IRS2,KLRK1,LAMP1,LBP,LCK,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MEF2C,MIF,MLST8,MMP14,MTOR,MYB,NCK1,NCK2,NCKAP1L,NFATC2,NKAP,NLRP3,NOD2,NR4A3,PAK1,PAK2,PAK3,PAXIP1,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PVRL2,PYCARD,RAC1,RARA,RASAL3,RICTOR,SART1,SHH,SIRPG,SNX4,SOCS5,SPACA3,SRC,STAP1,STX4,SYK,TCF3,TESPA1,TGFB1,TGFBR2,THBS1,THY1,TIRAP,TMIGD2,TNFRSF14,TNFRSF4,TNFSF11,TNFSF13,TNFSF13B,TNFSF4,TNIP2,TRAF2,TRAF6,VAMP7,VAMP8,VAV1,VAV3,VCAM1,VNN1,WNT5A,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZNF335,ZP3,ZP4	Any process that activates or increases the frequency, rate, or extent of leukocyte activation.
GO:0002698	GO	BP	negative regulation of immune effector process	A2M,ANXA1,APOA1,APOA2,ARRB2,BST2,C1QBP,C4BPA,C4BPB,CCR2,CD300A,CD55,CD84,CR1,CUEDC2,DHX58,EIF2AK2,FER,FOXJ1,FOXP3,HAVCR2,HFE,HLA-A,HLA-B,HLA-E,IFIT1,IFNA2,IFNB1,IFNL1,IL10,INS,IRAK3,ITCH,JAK3,LGALS3,LGALS9,LILRB1,MASP1,MICA,MICB,MUL1,PCBP2,PPM1B,PTPRC,RC3H1,RPS19,SEC14L1,SERPINB4,SERPINB9,SERPING1,SOCS5,SUSD4,TARBP2,TGFB1,TGFB2,TGFB3,THOC1,TKFC,TNF,TNFSF4,TRAF3IP1,TSPAN6,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune effector process.
GO:0002699	GO	BP	positive regulation of immune effector process	ANKRD17,ANXA1,AP1G1,B2M,BCL10,C12orf4,CADM1,CCL19,CCR2,CD226,CD244,CD300A,CD46,CD74,CD80,CD84,CD86,CLCF1,CRTAM,DDX60,DEFB103A,DHX58,F2RL1,FADD,FER,FES,FFAR2,FFAR3,FGR,FZD5,GAB2,GPRC5B,HLA-A,HLA-B,HLA-DMB,HLA-E,HSPD1,IFNG,IL12A,IL12B,IL12RB1,IL1B,IL21,IL23A,IL23R,IL4,IL6,KLK5,KLK7,KLRK1,LAMP1,LBP,LGALS9,LILRB1,LYN,MALT1,MAP3K7,MYB,MZB1,NCR3,NLRP3,NOS2,NR4A3,PAXIP1,PGC,PHB,PRKCZ,PUM1,PUM2,PVR,PVRL2,RARA,RASGRP1,RBP4,RPS19,RSAD2,SEMA7A,SH2D1B,SLAMF6,SNX4,SOCS5,STAP1,STX4,STX7,STXBP2,TGFB1,TNFRSF4,TNFSF13,TNFSF4,TRAF2,TRAF6,TRIM15,TRIM6,UNC13D,USP17L2,VAMP7,VAMP8,WNT5A,XBP1,XCL1,ZBTB1,ZC3HAV1,ZP3	Any process that activates or increases the frequency, rate, or extent of an immune effector process.
GO:0002700	GO	BP	regulation of production of molecular mediator of immune response	APOA1,APOA2,B2M,BCL10,BST2,BTK,CD244,CD74,CLC,CLCF1,CUEDC2,DEFB103A,F2RL1,FFAR2,FFAR3,FOXP3,FZD5,GPRC5B,HFE,HLA-A,HLA-E,IFNA2,IFNB1,IL10,IL4,IL6,IRAK3,JAK3,KLK5,KLK7,LILRB1,MALT1,MAP3K7,MZB1,NLRP3,NR4A3,PAXIP1,PGC,PRKCZ,RBP4,RSAD2,SEMA7A,STX4,SUPT6H,TGFB1,TGFB2,TGFB3,THOC1,TNF,TNFRSF4,TNFSF13,TNFSF4,TRAF2,TRAF6,TRIL,TRIM6,TRPM4,WNT5A,XBP1,XCL1	Any process that modulates the frequency, rate, or extent of the production of molecular mediator of immune response.
GO:0002701	GO	BP	negative regulation of production of molecular mediator of immune response	APOA1,APOA2,BST2,CUEDC2,FOXP3,HFE,IFNA2,IFNB1,IL10,IRAK3,JAK3,LILRB1,TGFB1,TGFB2,TGFB3,THOC1,TNF,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of the production of molecular mediator of immune response.
GO:0002702	GO	BP	positive regulation of production of molecular mediator of immune response	B2M,BCL10,CD244,CD74,CLCF1,DEFB103A,F2RL1,FFAR2,FFAR3,FZD5,GPRC5B,HLA-A,HLA-E,IL4,IL6,KLK5,KLK7,MALT1,MAP3K7,MZB1,NLRP3,NR4A3,PAXIP1,PGC,PRKCZ,RBP4,RSAD2,SEMA7A,STX4,TGFB1,TNFRSF4,TNFSF13,TNFSF4,TRAF2,TRAF6,TRIM6,WNT5A,XBP1,XCL1	Any process that activates or increases the frequency, rate, or extent of the production of molecular mediator of immune response.
GO:0002703	GO	BP	regulation of leukocyte mediated immunity	AGER,AP1G1,ARRB2,B2M,BST2,BTK,C12orf4,C4BPA,C4BPB,CADM1,CCR2,CD226,CD300A,CD84,CLC,CLCF1,CR1,CRTAM,F2RL1,FADD,FES,FGR,FOXJ1,FOXP3,FZD5,GAB2,HFE,HLA-A,HLA-B,HLA-E,HMGB1,HSPD1,ICAM1,IFNA2,IFNB1,IL10,IL12A,IL12B,IL12RB1,IL1B,IL21,IL23A,IL23R,IL4,JAK3,KLRK1,LAMP1,LEP,LGALS9,LILRB1,LYN,MALT1,MAP3K7,MICA,NCR1,NCR3,NLRP3,NOS2,PAXIP1,PIK3R6,PRKCZ,PTPRC,PVR,PVRL2,RASGRP1,RIPK3,RSAD2,SERPINB4,SERPINB9,SH2D1B,SLAMF6,SNX4,STAP1,STX4,STX7,STXBP2,SUPT6H,SUSD4,SYK,TGFB1,THOC1,TNFSF13,TNFSF4,TRAF2,TRAF6,TRPM4,UNC13D,VAMP7,VAMP8,WAS,XCL1,ZBTB1,ZP3	Any process that modulates the frequency, rate, or extent of leukocyte mediated immunity.
GO:0002704	GO	BP	negative regulation of leukocyte mediated immunity	ARRB2,BST2,C4BPA,C4BPB,CCR2,CD300A,CD84,CR1,FOXJ1,FOXP3,HFE,HLA-A,HLA-B,HLA-E,IFNA2,IFNB1,JAK3,LGALS9,LILRB1,MICA,PTPRC,SERPINB4,SERPINB9,SUSD4,THOC1,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte mediated immunity.
GO:0002705	GO	BP	positive regulation of leukocyte mediated immunity	AP1G1,B2M,CADM1,CD226,CLCF1,CRTAM,F2RL1,FADD,FGR,FZD5,GAB2,HLA-A,HLA-B,HLA-E,HSPD1,IL12A,IL12B,IL12RB1,IL1B,IL21,IL23A,IL23R,IL4,KLRK1,LAMP1,MALT1,MAP3K7,NCR3,NLRP3,NOS2,PAXIP1,PRKCZ,PVR,PVRL2,RASGRP1,RSAD2,SH2D1B,SLAMF6,SNX4,STAP1,STX4,STX7,TGFB1,TNFSF13,TNFSF4,TRAF2,TRAF6,VAMP7,VAMP8,XCL1,ZBTB1,ZP3	Any process that activates or increases the frequency, rate, or extent of leukocyte mediated immunity.
GO:0002706	GO	BP	regulation of lymphocyte mediated immunity	AGER,AP1G1,ARRB2,B2M,BTK,C4BPA,C4BPB,CADM1,CD226,CLC,CLCF1,CR1,CRTAM,FADD,FOXJ1,FOXP3,FZD5,HFE,HLA-A,HLA-B,HLA-E,HMGB1,HSPD1,IFNA2,IFNB1,IL10,IL12A,IL12B,IL12RB1,IL1B,IL21,IL23A,IL23R,IL4,KLRK1,LAMP1,LEP,LGALS9,LILRB1,MALT1,MAP3K7,MICA,NCR1,NCR3,NLRP3,PAXIP1,PIK3R6,PRKCZ,PTPRC,PVR,PVRL2,RASGRP1,RIPK3,RSAD2,SERPINB4,SERPINB9,SH2D1B,SLAMF6,STX7,SUPT6H,SUSD4,TGFB1,THOC1,TNFSF13,TNFSF4,TRAF2,TRAF6,TRPM4,WAS,XCL1,ZBTB1,ZP3	Any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity.
GO:0002707	GO	BP	negative regulation of lymphocyte mediated immunity	ARRB2,C4BPA,C4BPB,CR1,FOXJ1,FOXP3,HFE,HLA-A,HLA-B,HLA-E,IFNA2,IFNB1,LGALS9,LILRB1,MICA,PTPRC,SERPINB4,SERPINB9,SUSD4,THOC1,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of lymphocyte mediated immunity.
GO:0002708	GO	BP	positive regulation of lymphocyte mediated immunity	AP1G1,B2M,CADM1,CD226,CLCF1,CRTAM,FADD,FZD5,HLA-A,HLA-B,HLA-E,HSPD1,IL12A,IL12B,IL12RB1,IL1B,IL21,IL23A,IL23R,IL4,KLRK1,LAMP1,MALT1,MAP3K7,NCR3,NLRP3,PAXIP1,PRKCZ,PVR,PVRL2,RASGRP1,RSAD2,SH2D1B,SLAMF6,STX7,TGFB1,TNFSF13,TNFSF4,TRAF2,TRAF6,XCL1,ZBTB1,ZP3	Any process that activates or increases the frequency, rate, or extent of lymphocyte mediated immunity.
GO:0002709	GO	BP	regulation of T cell mediated immunity	AGER,B2M,CLC,FADD,FOXP3,FZD5,HFE,HLA-A,HLA-B,HLA-E,HMGB1,HSPD1,IFNA2,IFNB1,IL12A,IL12B,IL12RB1,IL1B,IL23A,IL23R,LILRB1,MALT1,MAP3K7,NLRP3,PRKCZ,PTPRC,PVR,PVRL2,RIPK3,RSAD2,STX7,TNFSF4,TRAF2,TRAF6,TRPM4,WAS,XCL1,ZBTB1,ZP3	Any process that modulates the frequency, rate, or extent of T cell mediated immunity.
GO:0002710	GO	BP	negative regulation of T cell mediated immunity	FOXP3,HFE,IFNA2,IFNB1,LILRB1,PTPRC,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell mediated immunity.
GO:0002711	GO	BP	positive regulation of T cell mediated immunity	B2M,FADD,FZD5,HLA-A,HLA-B,HLA-E,HSPD1,IL12A,IL12B,IL12RB1,IL1B,IL23A,IL23R,MALT1,MAP3K7,NLRP3,PRKCZ,PVR,PVRL2,RSAD2,STX7,TNFSF4,TRAF2,TRAF6,XCL1,ZBTB1,ZP3	Any process that activates or increases the frequency, rate, or extent of T cell mediated immunity.
GO:0002712	GO	BP	regulation of B cell mediated immunity	BTK,C4BPA,C4BPB,CD226,CLCF1,CR1,FOXJ1,IL10,IL4,PAXIP1,PVRL2,SUPT6H,SUSD4,TGFB1,THOC1,TNFSF13,TNFSF4,XCL1	Any process that modulates the frequency, rate, or extent of B cell mediated immunity.
GO:0002715	GO	BP	regulation of natural killer cell mediated immunity	AP1G1,ARRB2,CADM1,CD226,CRTAM,HLA-A,HLA-B,HLA-E,IL12A,IL12B,IL21,KLRK1,LAMP1,LEP,LGALS9,LILRB1,MICA,NCR1,NCR3,PIK3R6,PVR,PVRL2,RASGRP1,SERPINB4,SERPINB9,SH2D1B,SLAMF6	Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.
GO:0002717	GO	BP	positive regulation of natural killer cell mediated immunity	AP1G1,CADM1,CD226,CRTAM,HLA-E,IL12A,IL12B,IL21,KLRK1,LAMP1,NCR3,PVR,PVRL2,RASGRP1,SH2D1B,SLAMF6	Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.
GO:0002718	GO	BP	regulation of cytokine production involved in immune response	APOA1,APOA2,B2M,BCL10,BST2,BTK,CD74,CLC,CUEDC2,F2RL1,FFAR2,FFAR3,FOXP3,FZD5,GPRC5B,HFE,HLA-A,IFNA2,IFNB1,IL10,IRAK3,JAK3,LILRB1,MALT1,MAP3K7,NLRP3,NR4A3,PRKCZ,RSAD2,SEMA7A,TGFB1,TGFB2,TGFB3,TNF,TNFSF4,TRAF2,TRAF6,TRIL,TRIM6,TRPM4,WNT5A,XCL1	Any process that modulates the frequency, rate, or extent of cytokine production that contributes to an immune response.
GO:0002719	GO	BP	negative regulation of cytokine production involved in immune response	APOA1,APOA2,BST2,CUEDC2,FOXP3,HFE,IFNA2,IFNB1,IL10,IRAK3,JAK3,LILRB1,TGFB1,TGFB2,TGFB3,TNF,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine production contributing to an immune response.
GO:0002720	GO	BP	positive regulation of cytokine production involved in immune response	B2M,BCL10,CD74,F2RL1,FFAR2,FFAR3,FZD5,GPRC5B,HLA-A,MALT1,MAP3K7,NLRP3,NR4A3,PRKCZ,RSAD2,SEMA7A,TNFSF4,TRAF2,TRAF6,TRIM6,WNT5A,XCL1	Any process that activates or increases the frequency, rate, or extent of cytokine production that contributes to an immune response.
GO:0002724	GO	BP	regulation of T cell cytokine production	B2M,CLC,FOXP3,FZD5,HFE,HLA-A,IFNA2,IFNB1,MALT1,MAP3K7,NLRP3,PRKCZ,RSAD2,TNFSF4,TRAF2,TRAF6,TRPM4,XCL1	Any process that modulates the frequency, rate, or extent of T cell cytokine production.
GO:0002725	GO	BP	negative regulation of T cell cytokine production	FOXP3,HFE,IFNA2,IFNB1,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell cytokine production.
GO:0002726	GO	BP	positive regulation of T cell cytokine production	B2M,FZD5,HLA-A,MALT1,MAP3K7,NLRP3,PRKCZ,RSAD2,TNFSF4,TRAF2,TRAF6,XCL1	Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
GO:0002739	GO	BP	regulation of cytokine secretion involved in immune response	APOA1,APOA2,F2RL1,IL10,LILRB1,TNF,TRIM6,WNT5A	Any process that modulates the frequency, rate, or extent of cytokine secretion contributing to an immune response.
GO:0002740	GO	BP	negative regulation of cytokine secretion involved in immune response	APOA1,APOA2,IL10,LILRB1,TNF	Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response.
GO:0002753	GO	BP	cytoplasmic pattern recognition receptor signaling pathway	CARD9,CASP8,CHUK,CYLD,DDX58,IFIH1,IKBKB,IKBKG,IRAK1,IRAK2,IRF3,IRF7,ITCH,MAP2K6,MAP3K7,NOD1,NOD2,OTULIN,RELA,RIPK2,RPS27A,TAB1,TAB2,TAB3,TNFAIP3,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of a cytoplasmic pattern recognition receptor (PRR) binding to one of its physiological ligands. PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species, or damage-associated molecular pattern (DAMPs), endogenous molecules released from damaged cells.
GO:0002755	GO	BP	MyD88-dependent toll-like receptor signaling pathway	ATF1,ATF2,BTK,BTRC,CD14,CD36,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,HSPD1,IKBKB,IKBKG,IRAK1,IRAK2,IRAK3,IRAK4,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PPP2R5D,REG3G,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TIRAP,TLR1,TLR10,TLR2,TLR4,TLR5,TLR6,TNIP1,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the MyD88 adaptor molecule mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
GO:0002756	GO	BP	MyD88-independent toll-like receptor signaling pathway	ATF1,ATF2,BIRC2,BIRC3,BTRC,CASP8,CD14,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FADD,FBXW11,FOS,IKBKB,IKBKE,IKBKG,IRAK1,IRAK2,IRF3,IRF7,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PPP2R5D,PRKCE,RELA,RIPK1,RIPK2,RIPK3,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SARM1,SKP1,TAB1,TAB2,TAB3,TANK,TBK1,TICAM1,TICAM2,TLR3,TLR4,TNIP2,TNIP3,TRAF3,TRAF6,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3	Any series of molecular signals generated as a consequence of binding to a toll-like receptor not relying on the MyD88 adaptor molecule. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
GO:0002760	GO	BP	positive regulation of antimicrobial humoral response	DEFB103A,IRG1,KLK5,KLK7,PGC	Any process that activates or increases the frequency, rate, or extent of an antimicrobial humoral response.
GO:0002761	GO	BP	regulation of myeloid leukocyte differentiation	ADIPOQ,APCS,ATP6AP1,BGLAP,C1QC,CALCA,CAMK4,CARTPT,CASP8,CCL3,CCR1,CEBPB,CSF1,CTNNBIP1,DCSTAMP,FADD,FAM213A,FOXP1,FSTL3,GPR55,HAX1,HCLS1,HOXA7,IFNG,IL12B,IL17A,IL23A,IL23R,IL34,IL4,INHA,INHBA,IRF7,KMT2E,LEF1,LIF,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,MTOR,MYC,OCSTAMP,OGT,PF4,PRDM16,PRKCA,PTPN2,RARA,RIPK1,RUNX1,TESC,TLR3,TLR4,TNF,TNFSF11,TRAF6,ZFPM1,ZNF675	Any process that modulates the frequency, rate, or extent of myeloid leukocyte differentiation.
GO:0002762	GO	BP	negative regulation of myeloid leukocyte differentiation	ADIPOQ,APCS,C1QC,CALCA,CARTPT,CCL3,FSTL3,GPR55,HOXA7,IL4,INHA,INHBA,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,MYC,PRDM16,PTPN2,RARA,RUNX1,TLR3,TLR4,ZFPM1,ZNF675	Any process that stops, prevents, or reduces the frequency, rate, or extent of myeloid leukocyte differentiation.
GO:0002763	GO	BP	positive regulation of myeloid leukocyte differentiation	ATP6AP1,CALCA,CASP8,CCR1,CSF1,CTNNBIP1,DCSTAMP,FADD,HAX1,HCLS1,IFNG,IL12B,IL17A,IL23A,IL23R,IL34,KMT2E,LEF1,LIF,OCSTAMP,OGT,PF4,PRKCA,RIPK1,RUNX1,TESC,TNF,TNFSF11,TRAF6	Any process that activates or increases the frequency, rate, or extent of myeloid leukocyte differentiation.
GO:0002767	GO	BP	immune response-inhibiting cell surface receptor signaling pathway	HLA-G,KIR2DL1,LILRB1,LILRB2,LYN	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response.
GO:0002791	GO	BP	regulation of peptide secretion	ABCC8,ADCY5,ADRA2A,ADRA2C,AKAP5,ANO1,ARL2,ARL2BP,ARNTL,BAD,BLK,BMP8A,BRSK2,CACNA1A,CACNA1C,CACNA1D,CACNA1E,CACNA2D2,CAPN10,CCL5,CD74,CDK16,CFTR,CHD7,CHRM3,CLOCK,CRHBP,DOC2B,DRD2,EFNA5,ENSA,EPHA5,FAM3D,FFAR1,FFAR2,FFAR3,FGA,FGB,FGG,FOXA2,G6PC2,GCG,GCK,GHRH,GHRHR,GHRL,GIP,GLP1R,GLUD1,GNAS,GPER1,GPLD1,HFE,HLA-DRB1,HNF4A,HTR2C,IFNG,IL1B,INHBB,INS,IQGAP1,IRS1,IRS2,ISL1,ITPR1,ITPR2,ITPR3,KCNA5,KCNB1,KCNC2,KCNG2,KCNJ11,KCNS3,MARCKS,MCU,MTNR1B,MYRIP,NEUROD1,NLGN2,NOS2,NOV,NR1D1,NR1H4,PARK2,PASK,PAX8,PCSK1,PER2,PIM3,PPP3CB,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PSMD9,RAP1A,RAPGEF3,RAPGEF4,RASL10B,RBP4,REST,RFX3,RFX6,SEC11A,SEC11C,SFRP1,SIRT4,SLC25A4,SLC25A5,SLC25A6,SLC2A1,SLC2A2,SLC30A8,SLC8B1,SNAP25,SOX4,SPCS1,SPCS2,SPCS3,STX1A,STX4,STXBP1,STXBP4,SYT5,TCF7L2,TFAP2B,TFR2,TMEM27,TNF,TNFSF11,UQCC2,VAMP2	Any process that modulates the frequency, rate, or extent of peptide secretion.
GO:0002792	GO	BP	negative regulation of peptide secretion	ADRA2A,BMP8A,CD74,CRHBP,FAM3D,INHBB,IRS1,KCNB1,KCNJ11,NOV,PARK2,PIM3,PSMD9,REST,SFRP1,SIRT4	Any process that stops, prevents, or reduces the frequency, rate, or extent of peptide secretion.
GO:0002819	GO	BP	regulation of adaptive immune response	AGER,ALOX15,ANXA1,B2M,BCL6,BTK,C4BPA,C4BPB,CCL19,CCR2,CD226,CD80,CLC,CLCF1,CR1,EIF2AK4,FADD,FOXJ1,FOXP3,FZD5,HFE,HLA-A,HLA-B,HLA-E,HMGB1,HSPD1,IFNA2,IFNB1,IL10,IL12A,IL12B,IL12RB1,IL1B,IL23A,IL23R,IL27,IL4,IL6ST,IRF1,IRF7,JAK3,LILRB1,MALT1,MAP3K7,MEF2C,NLRP10,NLRP3,PAXIP1,PRKCQ,PRKCZ,PTPRC,PVR,PVRL2,PYCARD,RC3H1,RIPK3,RSAD2,SAMSN1,SIRT1,SLC11A1,SOCS5,STX7,SUPT6H,SUSD4,TGFB1,THOC1,TNFAIP3,TNFSF13,TNFSF4,TRAF2,TRAF6,TRIM27,TRPM4,WAS,XCL1,ZBTB1,ZP3	Any process that modulates the frequency, rate, or extent of an adaptive immune response.
GO:0002820	GO	BP	negative regulation of adaptive immune response	ALOX15,C4BPA,C4BPB,CR1,FOXJ1,FOXP3,HFE,IFNA2,IFNB1,JAK3,LILRB1,PTPRC,RC3H1,SAMSN1,SUSD4,THOC1,TNFSF4,TRIM27,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of an adaptive immune response.
GO:0002821	GO	BP	positive regulation of adaptive immune response	ANXA1,B2M,CCL19,CCR2,CD226,CD80,CLCF1,EIF2AK4,FADD,FZD5,HLA-A,HLA-B,HLA-E,HSPD1,IL12A,IL12B,IL12RB1,IL1B,IL23A,IL23R,IL4,IL6ST,MALT1,MAP3K7,NLRP10,NLRP3,PAXIP1,PRKCQ,PRKCZ,PVR,PVRL2,PYCARD,RSAD2,SIRT1,SLC11A1,SOCS5,STX7,TGFB1,TNFSF13,TNFSF4,TRAF2,TRAF6,XCL1,ZBTB1,ZP3	Any process that activates or increases the frequency, rate, or extent of an adaptive immune response.
GO:0002822	GO	BP	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	AGER,ANXA1,B2M,BCL6,BTK,C4BPA,C4BPB,CCL19,CCR2,CD226,CD80,CLC,CLCF1,CR1,FADD,FOXJ1,FOXP3,FZD5,HFE,HLA-A,HLA-B,HLA-E,HMGB1,HSPD1,IFNA2,IFNB1,IL10,IL12A,IL12B,IL12RB1,IL1B,IL23A,IL23R,IL27,IL4,JAK3,LILRB1,MALT1,MAP3K7,MEF2C,NLRP10,NLRP3,PAXIP1,PRKCQ,PRKCZ,PTPRC,PVR,PVRL2,RC3H1,RIPK3,RSAD2,SLC11A1,SOCS5,STX7,SUPT6H,SUSD4,TGFB1,THOC1,TNFAIP3,TNFSF13,TNFSF4,TRAF2,TRAF6,TRPM4,WAS,XCL1,ZBTB1,ZP3	Any process that modulates the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata.
GO:0002823	GO	BP	negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	C4BPA,C4BPB,CR1,FOXJ1,FOXP3,HFE,IFNA2,IFNB1,JAK3,LILRB1,PTPRC,RC3H1,SUSD4,THOC1,TNFSF4,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata.
GO:0002824	GO	BP	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	ANXA1,B2M,CCL19,CCR2,CD226,CD80,CLCF1,FADD,FZD5,HLA-A,HLA-B,HLA-E,HSPD1,IL12A,IL12B,IL12RB1,IL1B,IL23A,IL23R,IL4,MALT1,MAP3K7,NLRP10,NLRP3,PAXIP1,PRKCQ,PRKCZ,PVR,PVRL2,RSAD2,SLC11A1,SOCS5,STX7,TGFB1,TNFSF13,TNFSF4,TRAF2,TRAF6,XCL1,ZBTB1,ZP3	Any process that activates or increases the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata.
GO:0002825	GO	BP	regulation of T-helper 1 type immune response	ANXA1,CCL19,CCR2,CD80,IL12B,IL12RB1,IL23A,IL23R,IL27,JAK3,NLRP10,SLC11A1,SOCS5,TNFSF4,XCL1	Any process that modulates the frequency, rate, or extent of a T-helper 1 type immune response.
GO:0002827	GO	BP	positive regulation of T-helper 1 type immune response	ANXA1,CCL19,CCR2,CD80,IL12B,IL12RB1,IL23A,IL23R,NLRP10,SLC11A1,SOCS5,XCL1	Any process that activates or increases the frequency, rate, or extent of a T-helper 1 type immune response.
GO:0002828	GO	BP	regulation of type 2 immune response	ANXA1,CCR2,CD86,IFNA2,IFNB1,IFNL1,NLRP3,NOD2,PRKCZ,RARA,RSAD2,SOCS5,TNFSF4,XCL1	Any process that modulates the frequency, rate, or extent of a type 2 immune response.
GO:0002829	GO	BP	negative regulation of type 2 immune response	ANXA1,CCR2,IFNA2,IFNB1,IFNL1,SOCS5	Any process that stops, prevents, or reduces the frequency, rate, or extent of a type 2 immune response.
GO:0002830	GO	BP	positive regulation of type 2 immune response	CD86,NLRP3,NOD2,PRKCZ,RARA,RSAD2,TNFSF4,XCL1	Any process that activates or increases the frequency, rate, or extent of a type 2 immune response.
GO:0002832	GO	BP	negative regulation of response to biotic stimulus	C1QBP,CACTIN,DEFB114,DHX58,EIF2AK2,IFIT1,IRG1,ITCH,LTF,MICB,MUL1,NFKBIL1,PCBP2,PPM1B,SEC14L1,SIGIRR,SIRT2,TARBP2,TKFC,TNFAIP3,TRAF3IP1,TRIB1,TSPAN6	Any process that stops, prevents, or reduces the frequency, rate, or extent of a response to biotic stimulus.
GO:0002833	GO	BP	positive regulation of response to biotic stimulus	ANKRD17,BMP6,CD180,CD226,CRTAM,CYBA,DDX60,DEFB103A,DHX58,F2RL1,HRG,HSPD1,IL12A,IL12B,IRG1,KLK5,KLK7,LRSAM1,LY86,PGC,PRKCA,PUM1,PUM2,PVR,PVRL2,SASH1,TRIM15,USP17L2,ZC3HAV1	Any process that activates or increases the frequency, rate, or extent of a response to biotic stimulus.
GO:0002837	GO	BP	regulation of immune response to tumor cell	CD226,CRTAM,HMGB1,HRG,HSPD1,IL12A,IL12B,PVR,PVRL2	Any process that modulates the frequency, rate, or extent of an immune response to tumor cell.
GO:0002839	GO	BP	positive regulation of immune response to tumor cell	CD226,CRTAM,HRG,HSPD1,IL12A,IL12B,PVR,PVRL2	Any process that activates or increases the frequency, rate, or extent of an immune response to tumor cell.
GO:0002860	GO	BP	positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	CD226,CRTAM,IL12A,IL12B,PVR,PVRL2	Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated cytotoxicity directed against tumor cell target.
GO:0002886	GO	BP	regulation of myeloid leukocyte mediated immunity	C12orf4,CCR2,CD300A,CD84,F2RL1,FES,FGR,GAB2,LGALS9,LYN,SNX4,STAP1,STX4,STXBP2,SYK,UNC13D,VAMP7,VAMP8	Any process that modulates the frequency, rate, or extent of myeloid leukocyte mediated immunity.
GO:0002888	GO	BP	positive regulation of myeloid leukocyte mediated immunity	F2RL1,FGR,GAB2,SNX4,STAP1,STX4,VAMP7,VAMP8	Any process that activates or increases the frequency, rate, or extent of myeloid leukocyte mediated immunity.
GO:0002889	GO	BP	regulation of immunoglobulin mediated immune response	C4BPA,C4BPB,CD226,CLCF1,CR1,FOXJ1,IL10,IL4,PAXIP1,PVRL2,SUPT6H,SUSD4,TGFB1,THOC1,TNFSF13,TNFSF4,XCL1	Any process that modulates the frequency, rate, or extent of an immunoglobulin mediated immune response.
GO:0002890	GO	BP	negative regulation of immunoglobulin mediated immune response	C4BPA,C4BPB,CR1,FOXJ1,SUSD4,THOC1	Any process that stops, prevents, or reduces the frequency, rate, or extent of an immunoglobulin mediated immune response.
GO:0002891	GO	BP	positive regulation of immunoglobulin mediated immune response	CD226,CLCF1,IL4,PAXIP1,PVRL2,TGFB1,TNFSF13,TNFSF4,XCL1	Any process that activates or increases the frequency, rate, or extent of an immunoglobulin mediated immune response.
GO:0002902	GO	BP	regulation of B cell apoptotic process	AURKB,BCL10,BCL6,BTK,FNIP1,FOXP1,IL10,IL2,IRS2,NOC2L	Any process that modulates the frequency, rate, or extent of B cell apoptotic process.
GO:0002903	GO	BP	negative regulation of B cell apoptotic process	AURKB,BCL10,BCL6,FOXP1,IL2,IRS2,NOC2L	Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell apoptotic process.
GO:0002920	GO	BP	regulation of humoral immune response	A2M,C1QBP,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CCR7,CD46,CD55,CD59,CFB,CFH,CFI,CFP,CR1,CXCL13,DEFB103A,FOXJ1,IRG1,KLK5,KLK7,MASP1,PGC,PHB,PROS1,SERPING1,SUSD4,VTN,ZP3,ZP4	Any process that modulates the frequency, rate, or extent of a humoral immune response.
GO:0002921	GO	BP	negative regulation of humoral immune response	A2M,C4BPA,C4BPB,CD55,CR1,FOXJ1,MASP1,SERPING1,SUSD4	Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response.
GO:0002922	GO	BP	positive regulation of humoral immune response	CCR7,DEFB103A,IRG1,KLK5,KLK7,PGC,PHB,ZP3,ZP4	Any process that activates or increases the frequency, rate, or extent of a humoral immune response.
GO:0002924	GO	BP	negative regulation of humoral immune response mediated by circulating immunoglobulin	C4BPA,C4BPB,CR1,FOXJ1,SUSD4	Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin.
GO:0002931	GO	BP	response to ischemia	CAMK2A,CIB1,CPEB4,FAM175B,HYOU1,MLYCD,PER2,PPIF,TIGAR	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply.
GO:0002934	GO	BP	desmosome organization	DSG2,DSP,JUP,PKP2,PKP3,PRKCA,SNAI2	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a desmosome. A desmosome is a patch-like intercellular junction found in vertebrate tissues, consisting of parallel zones of two cell membranes, separated by an space of 25-35 nm, and having dense fibrillar plaques in the subjacent cytoplasm.
GO:0003002	GO	BP	regionalization	ACVR2B,AHI1,AIDA,ARL13B,ASCL1,ATP6AP2,BASP1,BMI1,BMP2,BMP4,BMPR2,CELSR2,CER1,CHRD,CITED2,COBL,CRB2,CXXC4,CYP26B1,CYP26C1,DDIT3,DLL1,DLL4,DNAAF1,DSCAML1,DVL2,FBXL15,FGF10,FGFR2,FOXA2,FOXB1,FOXD1,FOXN4,FZD5,GATA4,GLI2,GREM1,HHEX,HOXA11,HOXD11,HOXD3,HOXD8,ISL1,KDM2B,LFNG,LHX1,LMX1B,LRP5,LRP6,MDFI,MEF2C,MEGF8,MESP1,MTF2,NBL1,NOG,NTF4,OSR1,OTX2,PAX2,PAX8,PBX3,PCSK5,PITX2,PKD1L1,PLD6,PPP2R3A,PTCH1,RELN,RIPPLY1,RIPPLY2,SETDB2,SFRP1,SHH,SIX2,SIX3,SKI,SMAD2,SMAD6,SMO,T,TBX1,TBX20,TBX3,TDGF1,TDRD5,TGFBR1,WNT8A,WNT8B,WT1	The pattern specification process that results in the subdivision of an axis or axes in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
GO:0003006	GO	BP	developmental process involved in reproduction	ALOX15B,AMH,AMHR2,ANG,ANKRD7,AR,ASCL2,BASP1,BBS2,BBS4,BMPR1B,CABYR,CASC5,CASP8,CATSPERD,CBX2,CCDC182,CDKL2,CEBPB,CELF1,CELF4,CENPI,CEP57,CFTR,CHD5,CHD7,CIB1,CITED1,CITED2,CSDE1,CSF1,CUL7,CYP17A1,DAZL,DDX25,DEAF1,DMRT1,DMRT3,DNAJC19,DPY19L2,DZIP1,E2F7,E2F8,EIF2B2,EIF2B4,EIF2B5,EOMES,EREG,FGF8,FGFR2,FIGLA,FMN2,FOXF2,FOXL2,FSHR,GALNTL5,GATA1,GATA3,GATA4,GHRL,GHSR,H1FNT,HEY1,HEY2,HIST1H2BA,HNF1B,HORMAD1,HSD17B3,ING2,INHA,INHBA,INHBB,IQCF1,IRF2BPL,IRX5,ITGB8,KIAA0430,KIT,KMT2D,LEP,LHB,LHCGR,LHX1,LRRC6,MAST2,MEA1,MEI4,MKKS,MSH2,NANOS3,NCOA4,NIPBL,NKX3-1,NME5,NODAL,NPHP1,NR0B1,NR5A1,PAFAH1B1,PDGFB,PDGFRA,PIWIL1,PIWIL2,PKD1,PKD2,PLD6,PLK4,PPARD,PPARG,PRKACA,PRKACG,PSME4,PTCHD3,PTK2,PTPN11,PTPRN,PVRL2,RAB13,RBMY1B,RBP4,RBPJ,RHBDD1,RNF8,RQCD1,SCX,SHH,SIX4,SLC26A3,SLC26A6,SOD1,SOX15,SOX3,SOX8,SOX9,SPAG6,SPANXB1,SPP1,SRD5A1,SRD5A2,SRPK1,SRY,STRA6,SYCP3,TBX3,TCF21,TDRD1,TDRD5,TFEB,TMEM119,TNP1,TRIP13,TSPY1,TSSK1B,TSSK2,TSSK6,VEGFA,WNT4,WNT5A,WNT7A,WNT7B,WT1,ZNF830,ZP3	A developmental process in which a progressive change in the state of some part of an organism specifically contributes to its ability to form offspring.
GO:0003007	GO	BP	heart morphogenesis	ACTC1,ACVR1,AHI1,ANKRD1,BAZ1B,BBS4,BBS5,BBS7,BMP10,BMP2,BMP4,BMPR1A,CCDC103,CCDC39,CCDC40,CHD7,CITED2,CLDN5,CPE,DCHS1,DLC1,DLL1,DLL4,DNAAF1,DSP,DVL2,EFNA1,ENG,EPHB4,FGF8,FGFR2,FKBP1A,FLRT2,FOLR1,FOXF1,FOXN4,GATA3,GATA4,GATA6,GJA5,GSK3A,HAND1,HAND2,HAS2,HES1,HEY1,HEY2,HEYL,HTR2B,IHH,INSR,ISL1,JAG1,LEFTY1,MEF2C,MEGF8,MESP1,MICAL2,MKKS,MYBPC3,MYH6,MYH7,MYL2,MYL3,MYLK2,NIPBL,NKX2-5,NOTCH1,NOTCH2,NPHP3,NPY1R,NPY2R,NPY5R,NRG1,OLFM1,PARVA,PITX2,PKD2,PKP2,PROX1,PTK2,RBP4,RBPJ,RYR1,RYR2,S1PR1,SETDB2,SFRP2,SHH,SMAD7,SMO,SNAI2,SOX11,SOX17,SOX18,SOX4,SOX9,SRF,STIL,T,TBX1,TBX2,TBX20,TBX5,TCAP,TEK,TGFB2,TGFBR1,TGFBR3,TH,TNNC1,TNNI3,TNNT2,TPM1,TTN,VANGL2,VEGFA,ZFPM1,ZFPM2,ZIC3	The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
GO:0003009	GO	BP	skeletal muscle contraction	CCDC78,CHRNA1,GAA,JSRP1,MYH14,MYH3,MYH7,MYH8,RCSD1,STAC3,TNNC2,TNNI2,TNNT1,TNNT3	A process in which force is generated within skeletal muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. In the skeletal muscle, the muscle contraction takes advantage of an ordered sarcomeric structure and in most cases it is under voluntary control.
GO:0003012	GO	BP	muscle system process	ACTA1,ACTA2,ACTC1,ACTG2,ACTN2,ACTN3,ADRA1A,ADRBK1,ALDOA,ANK2,ANKRD2,ANXA1,ANXA2,ANXA6,ARHGEF11,ASPH,ATP1A1,ATP1A2,ATP1B1,ATP2A1,ATP2A2,BDKRB2,CACNA1H,CACNA1S,CACNG1,CALD1,CALM1,CAMK2D,CAMTA2,CASQ2,CAV3,CCDC78,CFLAR,CHRNA1,CHRNB1,CHRNB2,CHRND,CHRNE,CHRNG,CKMT2,CLCN1,CRYAB,CSRP3,CYBA,DES,DMD,DRD2,DTNA,DYSF,EDN1,EDN2,EDN3,EDNRA,EDNRB,EMD,FGF12,FXYD1,GAA,GALR2,GAMT,GDNF,GJA1,GJC1,GLRA1,GNAO1,GPD1L,GSN,GSTM2,HCN4,HDAC4,HMOX1,HRC,HTR1D,HTR2B,IGF1,IL1B,ITGA1,ITGB5,JSRP1,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP2,KCNJ12,KCNJ2,KCNMA1,KCNQ1,KLHL41,KNG1,LMOD1,LTB4R,MYBPC1,MYBPC2,MYBPC3,MYH11,MYH13,MYH14,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL10,MYL12A,MYL12B,MYL2,MYL3,MYL4,MYL5,MYL6,MYL6B,MYL7,MYL9,MYLK,MYLK2,MYLPF,MYOC,MYOF,MYOG,MYOT,NEB,NEDD4L,NOS1,NOS3,OXTR,P2RX4,P2RX6,PABPN1,PDLIM5,PGAM2,PIK3C2A,PIK3CA,PKP2,PLN,PXN,RCSD1,RGS2,ROCK1,ROCK2,RYR1,RYR2,SCN1B,SCN2B,SCN3B,SCN4A,SCN4B,SCN5A,SGCA,SLC6A8,SLC8A1,SMPX,SMTN,SNTA1,SNTB1,SOD1,SORBS1,SORBS2,SORBS3,SSPN,STAC3,STBD1,SULF1,SULF2,TACR2,TAZ,TCAP,TLN1,TMOD1,TMOD4,TNNC1,TNNC2,TNNI1,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPCN2,TPM1,TPM2,TPM3,TPM4,TRDN,TRIM72,TTN,UTRN,UTS2,VCL,VIM,VIPR1	A organ system process carried out at the level of a muscle. Muscle tissue is composed of contractile cells or fibers.
GO:0003014	GO	BP	renal system process	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,AGT,AGTR1,AKR1C3,AQP1,AQP2,AQP3,AQP4,AVP,AVPR2,CHRNA3,CHRNB2,CHRNB4,CYP11B2,CYP4F12,EMP2,F2R,F2RL1,GAS6,GNAS,GSN,HAS2,HBB,HNF1A,HYAL2,INPP5K,ITGA3,JCHAIN,KCNMA1,KCNQ1,KLHL3,KNG1,LGMN,MYO1E,MYO5B,NPPB,NPR1,NPR3,PDGFB,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKRIP1,PTPRO,RAB11A,RAB11FIP2,SERPINF2,SGK1,SLC22A6,SLC9A3R1,SULF1,SULF2,TFAP2B,WFS1,WNK4,XPNPEP3	A organ system process carried out by any of the organs or tissues of the renal system. The renal system maintains fluid balance, and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels; in other species, the renal system may comprise related structures (e.g., nephrocytes and malpighian tubules in Drosophila).
GO:0003015	GO	BP	heart process	ACE,ACTC1,ADRBK1,ANK2,ATP1A1,ATP1A2,ATP1B1,CAMK2D,CASQ2,CAV1,CAV3,CSRP3,DMD,FGF12,GAA,GJA1,GJC1,GPD1L,GPX1,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,MYBPC3,MYH6,MYH7,MYL2,MYL3,MYL4,MYLK2,NEDD4L,PDE4D,PIK3CA,PKP2,RAMP3,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SNTA1,SOD1,SRC,TAZ,TCAP,TNNC1,TNNI3,TPM1,TRDN,TTN	A circulatory system process carried out by the heart. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
GO:0003018	GO	BP	vascular process in circulatory system	ACE,ACE2,ADCY6,ADM,ADRA1A,AGT,AGTR1,AGTR2,AMOT,ANGPT1,AZU1,BDKRB2,BMPR2,CALCA,CAV1,CPS1,CRP,CTNNBIP1,DOCK4,DOCK5,ECE1,EDN1,EDN2,EDN3,EDNRA,EDNRB,EPHX2,F2R,F2RL1,FGA,FGB,FGFBP3,FGG,GCLC,GCLM,GPER1,HMOX1,HTR2B,INS,ITGB1BP1,KCNMB2,KCNMB4,KEL,MYLK3,NOS1,NOS3,NPPB,NPR1,PDE2A,PDE3A,PER2,PIK3C2A,PTPRJ,RAMP2,SCPEP1,SERPINF2,SLC8A1,SLIT2,SMTNL1,SOD1,SOD2,SRC,TEK,TGFB1,TRPV4,VEGFA,YES1	A circulatory process that occurs at the level of the vasculature.
GO:0003044	GO	BP	regulation of systemic arterial blood pressure mediated by a chemical signal	ACE,ACE2,AGT,AGTR1,AGTR2,ANPEP,ATP6AP2,CMA1,CORIN,CPA3,CTSG,CTSZ,CYP11B2,ECE1,EDN1,EDN2,EDN3,ENPEP,MME,NOS3,PDE4D,RASL10B,REN,SERPINF2,SOD2,TPM1	The regulation of blood pressure mediated by biochemical signaling: hormonal, autocrine or paracrine.
GO:0003062	GO	BP	regulation of heart rate by chemical signal	KCNH2,NOS1AP,PDE4D,TPM1,YWHAE	The regulation of the rate of heart contraction mediated by chemical signaling, hormonal, autocrine or paracrine.
GO:0003071	GO	BP	renal system process involved in regulation of systemic arterial blood pressure	AGT,AGTR1,CYP11B2,CYP4F12,EMP2,F2R,F2RL1,GAS6,PDGFB,PTPRO,SERPINF2	Renal process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
GO:0003073	GO	BP	regulation of systemic arterial blood pressure	ACE,ACE2,AGT,AGTR1,AGTR2,ANPEP,ATP6AP2,BMPR2,CALCA,CMA1,CORIN,CPA3,CTSG,CTSZ,CYP11B2,CYP4F12,DDAH1,DRD2,ECE1,EDN1,EDN2,EDN3,EMP2,ENG,ENPEP,F2R,F2RL1,GAS6,GSK3A,MME,NOS3,OR51E2,PDE4D,PDGFB,PLCB3,PTPRO,RASL10B,REN,SERPINF2,SOD2,SPX,TNNI3,TPM1	The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
GO:0003081	GO	BP	regulation of systemic arterial blood pressure by renin-angiotensin	ACE,ACE2,AGT,AGTR1,AGTR2,ANPEP,ATP6AP2,CMA1,CPA3,CTSG,CTSZ,ECE1,ENPEP,MME,REN,SERPINF2	The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system.
GO:0003091	GO	BP	renal water homeostasis	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,AQP1,AQP2,AQP3,AQP4,AVP,AVPR2,CYP11B2,CYP4F12,GNAS,HAS2,HYAL2,MYO5B,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,RAB11A,RAB11FIP2,TFAP2B,WFS1	Renal process involved in the maintenance of an internal steady state of water in the body.
GO:0003093	GO	BP	regulation of glomerular filtration	EMP2,F2R,F2RL1,GAS6,PDGFB,PTPRO	Any process that modulates the frequency, rate or extent of glomerular filtration. Glomerular filtration is the process in which blood is filtered by the glomerulus into the renal tubule.
GO:0003094	GO	BP	glomerular filtration	JCHAIN,MYO1E,SULF1,SULF2,XPNPEP3	The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.
GO:0003100	GO	BP	regulation of systemic arterial blood pressure by endothelin	ECE1,EDN1,EDN2,EDN3,NOS3	The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.
GO:0003140	GO	BP	determination of left/right asymmetry in lateral mesoderm	CITED2,DAND5,FOXH1,SHH,SMO	The establishment of the lateral mesoderm with respect to the left and right halves.
GO:0003143	GO	BP	embryonic heart tube morphogenesis	ACVR1,AHI1,BBS4,BBS5,BBS7,CCDC103,CCDC39,CCDC40,DLL1,DNAAF1,ENG,FOLR1,FOXN4,GATA4,HAND1,HAND2,HES1,IHH,MEF2C,MEGF8,MESP1,MICAL2,MKKS,NKX2-5,NOTCH1,NPHP3,PKD2,RYR2,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX2,TBX20,VANGL2,ZIC3	The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
GO:0003148	GO	BP	outflow tract septum morphogenesis	FGF8,FGFR2,GATA6,ISL1,NKX2-5,PARVA,TBX1,TBX2,TBX20,ZFPM2	The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
GO:0003151	GO	BP	outflow tract morphogenesis	CITED2,CLDN5,DVL2,FGF8,FGFR2,FOLR1,GATA6,GJA5,HAND2,HES1,HEY2,HEYL,ISL1,JAG1,MEF2C,NIPBL,NKX2-5,NPY1R,NPY2R,NPY5R,PARVA,PITX2,RBPJ,RYR1,SFRP2,SOX11,SOX17,SOX18,TBX1,TBX2,TBX20,VEGFA,ZFPM1,ZFPM2	The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
GO:0003156	GO	BP	regulation of organ formation	BMP2,BMP4,CITED2,DKK1,HAND2,HES1,MESP1,POU5F1,SIX1,SULF1,WNT3A,WT1	Any process that modulates the rate, frequency or extent of organ formation. Organ formation is the process pertaining to the initial formation of an organ from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure, such as inductive events, and ends when the structural rudiment of the organ is recognizable, such as a condensation of mesenchymal cells into the organ rudiment.
GO:0003157	GO	BP	endocardium development	ACVR1,NOTCH1,NRG1,PROX1,RBPJ,SOX17,SOX18	The process whose specific outcome is the progression of the endocardium over time, from its formation to the mature structure. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
GO:0003158	GO	BP	endothelium development	ACVR1,ACVR2B,ACVRL1,BMP4,BMPR2,CCM2,CSNK2B,CTNNB1,DLL1,EDF1,ENG,EZR,F11R,F2RL1,GSTM3,HEY1,HEY2,ICAM1,JAG1,KDM6B,KDR,LAMA5,MARVELD2,MESP1,MET,MLLT4,MSN,MYADM,NOTCH1,NR2F2,NRG1,NRP1,PDE2A,PDE4D,PPP1R16B,PRKD2,PROX1,RAP1A,RAP1B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3,RBPJ,RDX,RHOA,RHOB,SCUBE1,SETSIP,SOX17,SOX18,STARD13,STC1,TJP1,TJP2,WNT7B	The process whose specific outcome is the progression of an endothelium over time, from its formation to the mature structure. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.
GO:0003159	GO	BP	morphogenesis of an endothelium	ACVRL1,BMP4,CCM2,CSNK2B,CTNNB1,NOTCH1,PRKD2,PROX1,RBPJ,RHOA,RHOB,SOX17,SOX18,STARD13	The process in which the anatomical structure of an endothelium is generated and organized. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.
GO:0003160	GO	BP	endocardium morphogenesis	NOTCH1,PROX1,RBPJ,SOX17,SOX18	The process in which the anatomical structure of the endocardium is generated and organized. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
GO:0003171	GO	BP	atrioventricular valve development	ACVR1,BMP2,DCHS1,EFNA1,GJA5,HEY1,HEY2,HEYL,NOTCH1,OLFM1,SOX4,TBX20,ZFPM1	The progression of the atrioventricular valve over time, from its formation to the mature structure.
GO:0003174	GO	BP	mitral valve development	ACVR1,DCHS1,EFNA1,GJA5,NOTCH1,SOX4,ZFPM1	The progression of the mitral valve over time, from its formation to the mature structure.
GO:0003179	GO	BP	heart valve morphogenesis	ACVR1,BMP2,DCHS1,EFNA1,GATA3,GJA5,HEY1,HEY2,HEYL,JAG1,MEF2C,NOTCH1,NOTCH2,OLFM1,SCX,SOX4,SOX9,STRA6,TBX20,TWIST1,ZFPM1	The process in which the structure of a heart valve is generated and organized.
GO:0003180	GO	BP	aortic valve morphogenesis	EFNA1,GATA3,NOTCH1,TBX20,TWIST1	The process in which the structure of the aortic valve is generated and organized.
GO:0003181	GO	BP	atrioventricular valve morphogenesis	ACVR1,BMP2,DCHS1,EFNA1,HEY1,HEY2,HEYL,NOTCH1,OLFM1,SOX4,ZFPM1	The process in which the structure of the atrioventricular valve is generated and organized.
GO:0003183	GO	BP	mitral valve morphogenesis	ACVR1,DCHS1,EFNA1,NOTCH1,SOX4,ZFPM1	The process in which the structure of the mitral valve is generated and organized.
GO:0003184	GO	BP	pulmonary valve morphogenesis	GJA5,HEY1,HEY2,HEYL,JAG1,NOTCH1,NOTCH2,STRA6,TBX20	The process in which the structure of the pulmonary valve is generated and organized.
GO:0003188	GO	BP	heart valve formation	DCHS1,EFNA1,GJA5,HEY1,NOTCH1,OLFM1,SCX,TBX20,ZFPM1	The developmental process pertaining to the initial formation of a heart valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
GO:0003190	GO	BP	atrioventricular valve formation	DCHS1,HEY1,NOTCH1,OLFM1,ZFPM1	The developmental process pertaining to the initial formation of the atrioventricular valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
GO:0003197	GO	BP	endocardial cushion development	ACVR1,BMP2,BMP4,BMPR1A,CRELD1,DCHS1,FGF8,FOXF1,GATA4,HEY1,HEYL,ISL1,JAG1,NOTCH1,RBPJ,SNAI2,SOX9,TBX2,TBX20	The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
GO:0003198	GO	BP	epithelial to mesenchymal transition involved in endocardial cushion formation	FGF8,HEY1,HEYL,NOTCH1,RBPJ,SNAI2	A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell that will contribute to the formation of the endocardial cushion.
GO:0003203	GO	BP	endocardial cushion morphogenesis	BMP2,BMPR1A,DCHS1,FGF8,HEY1,HEYL,ISL1,NOTCH1,RBPJ,SNAI2,SOX9,TBX2,TBX20	The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
GO:0003205	GO	BP	cardiac chamber development	ACVR1,ANK2,BMP10,BMP4,CITED2,CPE,CRELD1,DAND5,DLL4,DSP,FGF8,FGFR2,FKBP1A,FOXF1,GATA3,GATA4,GATA6,GJA5,GSK3A,HAND1,HES1,HEY1,HEY2,HEYL,ISL1,JAG1,MEF2C,MESP1,MYBPC3,MYH6,MYH7,MYL2,MYL3,NACA,NKX2-5,NOTCH1,NOTCH2,NPHP3,NPY2R,NPY5R,NRG1,PARVA,PKP2,PROX1,RBP4,RBPJ,RYR2,SALL1,SCN5A,SFRP2,SMAD7,SOX11,SOX4,STRA6,TBX1,TBX2,TBX20,TBX5,TEK,TGFBR3,TMEM65,TNNC1,TNNI3,TNNT2,TPM1,ZFPM1,ZFPM2	The progression of a cardiac chamber over time, from its formation to the mature structure. A cardiac chamber is an enclosed cavity within the heart.
GO:0003206	GO	BP	cardiac chamber morphogenesis	ACVR1,BMP10,CITED2,CPE,DLL4,DSP,FGF8,FGFR2,FKBP1A,FOXF1,GATA3,GATA4,GATA6,GSK3A,HAND1,HES1,HEY1,HEY2,HEYL,ISL1,JAG1,MEF2C,MESP1,MYBPC3,MYH6,MYH7,MYL2,MYL3,NKX2-5,NOTCH1,NOTCH2,NPY2R,NPY5R,NRG1,PARVA,PKP2,PROX1,RBP4,RBPJ,RYR2,SFRP2,SMAD7,SOX11,SOX4,TBX1,TBX2,TBX20,TBX5,TEK,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,ZFPM1,ZFPM2	The process in which a cardiac chamber is generated and organized. A cardiac chamber is an enclosed cavity within the heart.
GO:0003207	GO	BP	cardiac chamber formation	HAND1,MEF2C,MESP1,NOTCH1,SOX11,SOX4,TBX20,TBX5	The developmental process pertaining to the initial formation of a cardiac chamber from unspecified parts. A cardiac chamber is an enclosed cavity within the heart.
GO:0003208	GO	BP	cardiac ventricle morphogenesis	BMP10,CPE,DLL4,DSP,FGFR2,FKBP1A,FOXF1,GATA3,GATA4,GSK3A,HAND1,HEY1,HEY2,HEYL,ISL1,JAG1,MEF2C,MESP1,MYBPC3,MYH6,MYH7,MYL2,MYL3,NKX2-5,NOTCH1,NPY2R,NPY5R,NRG1,PKP2,PROX1,RBPJ,RYR2,SFRP2,SMAD7,SOX11,SOX4,TBX20,TBX5,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,ZFPM2	The process in which the cardiac ventricle is generated and organized. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart.
GO:0003209	GO	BP	cardiac atrium morphogenesis	ACVR1,BMP10,DLL4,GATA4,HEY2,ISL1,MESP1,MYH6,NKX2-5,NOTCH1,NOTCH2,PROX1,SOX4,TBX20,ZFPM1	The process in which the cardiac atrium is generated and organized. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle.
GO:0003211	GO	BP	cardiac ventricle formation	HAND1,MEF2C,MESP1,SOX11,SOX4,TBX5	The developmental process pertaining to the initial formation of a cardiac ventricle from unspecified parts. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart.
GO:0003214	GO	BP	cardiac left ventricle morphogenesis	CPE,FOXF1,GSK3A,HAND1,HEY2,NOTCH1,NPY2R,NPY5R,RBPJ,RYR2,SFRP2,TBX5	The process in which the left cardiac ventricle is generated and organized.
GO:0003215	GO	BP	cardiac right ventricle morphogenesis	GATA3,GATA4,HAND1,HEY2,ISL1,JAG1,NKX2-5,SOX4,TBX20,ZFPM2	The process in which the right cardiac ventricle is generated and organized.
GO:0003229	GO	BP	ventricular cardiac muscle tissue development	BMP10,DLL4,DSG2,DSP,FGFR2,FKBP1A,HAND1,ISL1,MYBPC3,MYH6,MYH7,MYL2,MYL3,NKX2-5,NOTCH1,NRG1,PKP2,PROX1,RBPJ,RYR2,SMAD7,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,ZFPM2	The process whose specific outcome is the progression of ventricular cardiac muscle over time, from its formation to the mature structure.
GO:0003230	GO	BP	cardiac atrium development	ACVR1,ANK2,BMP10,DAND5,DLL4,GATA4,GJA5,HEY2,ISL1,MESP1,MYH6,NKX2-5,NOTCH1,NOTCH2,NPHP3,PROX1,SOX4,TBX20,ZFPM1	The process whose specific outcome is the progression of a cardiac atrium over time, from its formation to the mature structure. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle.
GO:0003231	GO	BP	cardiac ventricle development	BMP10,CITED2,CPE,DAND5,DLL4,DSP,FGFR2,FKBP1A,FOXF1,GATA3,GATA4,GJA5,GSK3A,HAND1,HES1,HEY1,HEY2,HEYL,ISL1,JAG1,MEF2C,MESP1,MYBPC3,MYH6,MYH7,MYL2,MYL3,NACA,NKX2-5,NOTCH1,NPY2R,NPY5R,NRG1,PKP2,PROX1,RBPJ,RYR2,SALL1,SCN5A,SFRP2,SMAD7,SOX11,SOX4,STRA6,TBX20,TBX5,TGFBR3,TMEM65,TNNC1,TNNI3,TNNT2,TPM1,ZFPM1,ZFPM2	The process whose specific outcome is the progression of a cardiac ventricle over time, from its formation to the mature structure. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart.
GO:0003254	GO	BP	regulation of membrane depolarization	ANK3,B2M,BCL2,CAMK2D,CAV3,DCN,FHL1,GJA5,GNB2L1,GPD1L,HCN4,IFI6,KDR,LRRK2,MLLT11,MYOC,NEDD4L,PTPN3,RANGRF,SCN10A,SCN1B,SCN2B,SCN3B,SCN5A,SMAD7,SRC	Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive.
GO:0003256	GO	BP	regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	GREM1,MYOCD,NOTCH1,RBPJ,SRF,T,TBX2	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that contributes to the differentiation of a myocardial precursor cell.
GO:0003272	GO	BP	endocardial cushion formation	BMPR1A,DCHS1,FGF8,HEY1,HEYL,NOTCH1,RBPJ,SNAI2,TBX20	The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
GO:0003279	GO	BP	cardiac septum development	ACVR1,ANK2,BMP4,CITED2,CRELD1,DAND5,FGF8,FGFR2,GATA3,GATA4,GATA6,GJA5,HAND1,HES1,HEY1,HEY2,HEYL,ISL1,JAG1,NKX2-5,NOTCH1,NOTCH2,NPHP3,PARVA,PROX1,SALL1,SMAD7,SOX11,SOX4,STRA6,TBX1,TBX2,TBX20,TBX5,ZFPM1,ZFPM2	The progression of a cardiac septum over time, from its initial formation to the mature structure.
GO:0003281	GO	BP	ventricular septum development	CITED2,DAND5,FGFR2,GATA3,GATA4,GJA5,HES1,HEY1,HEY2,HEYL,NKX2-5,NOTCH1,PROX1,SALL1,SMAD7,SOX11,SOX4,STRA6,TBX5,ZFPM1,ZFPM2	The progression of the ventricular septum over time from its formation to the mature structure.
GO:0003283	GO	BP	atrial septum development	ACVR1,ANK2,DAND5,GATA4,GJA5,HEY2,ISL1,NKX2-5,NOTCH2,NPHP3,SOX4,TBX20,ZFPM1	The progression of the atrial septum over time, from its initial formation to the mature structure.
GO:0003300	GO	BP	cardiac muscle hypertrophy	CAMTA2,CSRP3,HDAC4,HTR2B,PDLIM5,RYR2,SORBS2,TCAP,TTN	The enlargement or overgrowth of all or part of the heart muscle due to an increase in size of cardiac muscle cells without cell division.
GO:0003309	GO	BP	type B pancreatic cell differentiation	BMP4,BMP5,BMP6,CDK6,DLL1,INSM1,NKX6-1,PDX1,RFX6	The process in which relatively unspecialized cells acquire specialized structural and/or functional features of a type B pancreatic cell. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
GO:0003323	GO	BP	type B pancreatic cell development	BMP4,BMP5,BMP6,CDK6,DLL1,NKX6-1	The process whose specific outcome is the progression of a type B pancreatic cell over time, from its formation to the mature structure. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin.
GO:0003333	GO	BP	amino acid transmembrane transport	PQLC2,SLC16A12,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC25A26,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A9,SLC3A1,SLC6A14,SLC6A20,SLC6A8,SLC7A11	The directed movement of amino acids, organic acids containing one or more amino substituents across a membrane by means of some agent such as a transporter or pore.
GO:0003338	GO	BP	metanephros morphogenesis	BMP4,PAX2,PAX8,SALL1,SIX2,SMO,SOX8,SOX9,WNT7B,WT1	The process in which the anatomical structures of the metanephros are generated and organized.
GO:0003341	GO	BP	cilium movement	ADCY10,ARMC4,CABYR,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CFAP54,DNAAF1,DNAAF5,DNAH5,DNAH7,DNAI1,DNAI2,DYX1C1,LRRC6,NPHP3,OFD1,RFX3,ROPN1L,RSPH4A,RSPH9,SPA17	The directed, self-propelled movement of a cilium.
GO:0003351	GO	BP	epithelial cilium movement	ADCY10,CABYR,CCDC103,CCDC39,CCDC40,DNAAF1,LRRC6,NPHP3,OFD1,RFX3,ROPN1L,SPA17	The directed, self-propelled movement of a cilium of an epithelial cell. This movement is usually coordinated between many epithelial cells, and serves to move fluid.
GO:0003352	GO	BP	regulation of cilium movement	ARMC4,BBS2,BBS4,CCDC39,CCDC40,CCSAP,CFAP20,DNAAF1,DNAH11,MKKS	Any process that modulates the rate, frequency, or extent of cilium movement, the directed, self-propelled movement of a cilium.
GO:0003356	GO	BP	regulation of cilium beat frequency	ARMC4,CCDC39,CCDC40,DNAAF1,DNAH11	Any process that modulates the frequency of cilium movement, the directed, self-propelled movement of a cilium.
GO:0003357	GO	BP	noradrenergic neuron differentiation	ASCL1,HAND2,INSM1,PHOX2A,PHOX2B,SOX11,SOX4	The process in which a relatively unspecialized cell acquires specialized features of an noradrenergic neuron, a neuron that secretes noradrenaline.
GO:0003376	GO	BP	sphingosine-1-phosphate signaling pathway	EZR,S1PR1,S1PR2,SPHK1,SPHK2	A series of molecular signals initiated by the sphingolipid sphingosine-1-phosphate (S1P) binding to a receptor on the surface of the cell, and which proceeds with the activated receptor transmitting the signal by promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
GO:0003382	GO	BP	epithelial cell morphogenesis	BASP1,BMP4,CITED1,CLDN3,DACT2,FZD7,GATA3,GRHL2,MET,PAX2,RAB25,RILPL1,RILPL2,SIPA1L3,SIX2,SMO,STC1,WT1	The change in form that occurs when an epithelial cell progresses from its initial formation to its mature state.
GO:0003401	GO	BP	axis elongation	BMP4,FGF1,FGF10,FGFR2,MAGI2,SOX9	The developmental growth that results in the elongation of a line that defines polarity or symmetry in an anatomical structure.
GO:0003407	GO	BP	neural retina development	AHI1,ATOH7,DSCAM,FOXN4,GPM6A,LHX1,MEGF11,NEUROD1,NEUROD4,PROM1,PTF1A,PTPRM,RORB,RP1,SDK1,SDK2,SOX8,SOX9,THY1,TOPORS,TSPAN12	The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells.
GO:0003416	GO	BP	endochondral bone growth	CER1,DDR2,EVC,FGFR3,NPPC,STC1	The increase in size or mass of an endochondral bone that contributes to the shaping of the bone.
GO:0003678	GO	MF	DNA helicase activity	ASCC3,ATRX,BLM,BRIP1,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD8,DDX3X,DHX9,DNA2,ERCC2,ERCC3,FBXO18,G3BP1,HELB,IGHMBP2,INO80,MCM4,MCM6,MCM7,MRE11A,NBN,PIF1,RAD50,RAD54B,RECQL,RECQL4,RECQL5,RTEL1,RUVBL1,RUVBL2,SETX,SUPV3L1,WRN	Catalysis of the reaction: NTP + H2O = NDP + phosphate, to drive the unwinding of a DNA helix.
GO:0003680	GO	MF	AT DNA binding	CRIP1,HAND2,HMGA1,HMGA2,KMT2A,MEF2C	Interacting selectively and non-covalently with oligo(A) and oligo(T) tracts of DNA (AT DNA).
GO:0003684	GO	MF	damaged DNA binding	APEX1,APTX,CREBBP,CRY2,CUL4B,DDB1,DDB2,EP300,ERCC1,ERCC3,ERCC4,FANCG,FEN1,GTF2H3,HMGB1,HMGB2,MPG,MSH2,MSH3,MSH6,NBN,OGG1,PCNA,PNKP,POLD1,POLQ,RAD1,RAD18,RBBP8,RPA1,RPA2,RPA3,RPS3,TDG,UNG,XPA,XPC	Interacting selectively and non-covalently with damaged DNA.
GO:0003691	GO	MF	double-stranded telomeric DNA binding	APEX1,HMBOX1,PURA,TERF1,TERF2,XRCC5,XRCC6	Interacting selectively and non-covalently with double-stranded telomere-associated DNA.
GO:0003696	GO	MF	satellite DNA binding	CENPB,HEY1,HEY2,HEYL,MBD2,MBD4,MLH3	Interacting selectively and non-covalently with satellite DNA, the many tandem repeats (identical or related) of a short basic repeating unit; many have a base composition or other property different from the genome average that allows them to be separated from the bulk (main band) genomic DNA.
GO:0003697	GO	MF	single-stranded DNA binding	BLM,BRCA2,CRY2,CTC1,DDX11,ERCC1,ERCC4,ERCC5,FBXO18,FUBP1,HMGB1,HMGB2,HNRNPA1,HNRNPA2B1,HNRNPDL,HNRNPK,HSPD1,IGHMBP2,JCHAIN,LUZP4,MEIOB,MLH1,MSH2,MSH3,NABP1,NABP2,NEIL3,OBFC1,PCBP1,PMS2,POT1,PURA,PURB,RAD23A,RAD23B,RAD51,RAD51AP1,RAD51B,RAD51D,RBMS1,RNF138,RPA1,RPA2,RPA3,RPA4,RTF1,SETMAR,SSBP2,SUB1,SWSAP1,TDP1,TDP2,TERF1,TERF2,TERF2IP,TREX1,WBP11,XPC	Interacting selectively and non-covalently with single-stranded DNA.
GO:0003705	GO	MF	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	ARNT,ATF2,BHLHE40,BHLHE41,CDX1,CEBPA,CEBPB,CIR1,CREB1,GTF2IRD1,GZF1,HIF1A,HMGA1,IRF8,JUN,MEOX2,MIXL1,MYF5,MYOD1,NFATC1,NFIX,NFKB1,NR1H4,NR5A1,NR5A2,POU4F1,PROX1,PTH,PURA,REL,RELA,RFX1,RFX3,SOX17,SOX9,SPI1,SRY,T,TFAP4,USF1,USF2,ZBTB16,ZFHX3	Interacting selectively and non-covalently with a sequence of DNA that is in a distal enhancer region for RNA polymerase II (RNAP II) in order to modulate transcription by RNAP II.
GO:0003707	GO	MF	steroid hormone receptor activity	AR,ESR1,ESR2,GPER1,LEF1,NKX3-1,NR1I3,NR3C1,NR3C2,OR51E2,PGRMC2,PPARA	Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function.
GO:0003714	GO	MF	transcription corepressor activity	AES,AJUBA,ALX1,ANKRD1,APEX1,ARHGAP35,ASXL1,ATF3,ATF5,ATN1,BASP1,BATF3,BCOR,BEND6,BHLHE40,BHLHE41,BRD7,C1QBP,CASP8AP2,CBFA2T2,CBFA2T3,CBX4,CCAR1,CCND1,CDYL,CIR1,CITED2,CREG1,CRYM,CTBP1,CTCF,DAXX,DDIT3,DDX54,DNMT3B,DR1,E2F6,E2F7,E2F8,E4F1,EID1,ELANE,ELK3,ENO1,ERF,FEV,GPS2,HAND1,HDAC1,HDAC3,HDAC9,HDGF,HEYL,HIF3A,HIPK2,HIRA,HOXC6,HSBP1,HSF4,ID3,ID4,JAZF1,JUNB,KCNIP3,KCTD1,KDM5B,KLF12,LDB1,LHX1,LHX9,LIMD1,LMCD1,LOXL2,MAP3K10,MECP2,MEIS2,MNT,MSC,MTA1,MXD1,MXD4,MXI1,MYBBP1A,N4BP2L2,NAB2,NANOG,NCOR1,NCOR2,NEUROD2,NFIB,NFIL3,NOC2L,NPAT,NR0B1,NR0B2,NR1D1,NR1H4,NR2F2,NRIP1,NSD1,PAWR,PBXIP1,PEX14,PFDN5,PHF12,PIAS1,PPP1R13L,PRMT5,PROX1,PSMC3,RARA,RBBP8,RBFOX2,RELB,RLIM,RUNX1T1,SAP18,SAP30,SCAI,SETD8,SF1,SFMBT1,SIAH2,SIRT1,SKI,SKIL,SKOR2,SMARCA4,SNW1,SOX3,SP100,SRSF2,SSX1,SUFU,TAF9B,TBL1X,TBL1XR1,TBX18,TCERG1,TCP10L,TDP2,TFAP2B,TFCP2L1,TFEC,TGIF1,THRB,TLE1,TLE2,TONSL,TRIB3,TRIM22,TRIM28,UBP1,URI1,UXT,WNT4,YAF2,YAP1,YBX3,YY1,ZEB1,ZFPM2,ZHX1,ZHX2,ZMYND11,ZMYND8,ZNF136,ZNF274,ZNF281,ZNF366,ZNF593,ZNF85	Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
GO:0003720	GO	MF	telomerase activity	DKC1,HMBOX1,PTGES3,TEP1,TERF1,TERF2,TERT	Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence.
GO:0003724	GO	MF	RNA helicase activity	DDX1,DDX10,DDX17,DDX18,DDX20,DDX21,DDX23,DDX24,DDX25,DDX39B,DDX3X,DDX43,DDX5,DDX54,DDX56,DDX6,DHX15,DHX16,DHX8,DHX9,EIF4A3,G3BP1,IGHMBP2,MOV10L1,RAD54B,SKIV2L,SNRNP200,SUPV3L1,UPF1	Catalysis of the reaction: NTP + H2O = NDP + phosphate, to drive the unwinding of a RNA helix.
GO:0003725	GO	MF	double-stranded RNA binding	ACTN1,ADARB1,ADARB2,AGO1,AGO2,AGO3,AGO4,APTX,CLTC,DDX58,DDX60,DGCR8,DHX15,DHX30,DHX36,DHX58,DICER1,DUS2,EIF2AK2,EIF4A1,ELAVL1,HSP90AB1,HSPD1,IFIH1,ILF2,ILF3,LRRFIP1,MBNL1,MSN,MTDH,MYH4,OAS1,OAS2,OAS3,OASL,PRKRA,PRKRIP1,RFTN1,SLC3A2,STAU2,SUPV3L1,TARBP2,TFRC,TLR3,TLR7,TLR8,TUBA1B,TUBB4B,VIM,ZNF346	Interacting selectively and non-covalently with double-stranded RNA.
GO:0003727	GO	MF	single-stranded RNA binding	A1CF,ADARB2,AGO1,AGO2,AGO3,AGO4,ATXN1,DDX1,DDX3X,DDX58,DDX60,DHX58,DIS3L2,EIF4A3,ENDOV,HNRNPA1,HNRNPC,HNRNPDL,HNRNPF,HNRNPH1,IFIH1,IFIT5,JMJD6,KHDRBS1,LONP1,LUZP4,NXF1,PABPC1,PABPC3,PABPC4,PATL1,PNPT1,PTBP1,RBM11,RBPMS,SNRPC,TIA1,TLR7,TLR8,ZFP36	Interacting selectively and non-covalently with single-stranded RNA.
GO:0003729	GO	MF	mRNA binding	ACO1,ADARB1,ANGEL2,AUH,C1QBP,CALR,CARHSP1,CELF1,CELF3,CIRBP,CLUH,CPEB1,CPEB2,CPEB3,CPSF1,CPSF6,CRYZ,DDX3X,DHFR,DHFRL1,DXO,EIF4A1,EIF4A3,ELAVL1,ELAVL2,ELAVL4,ESRP1,ESRP2,FMR1,FYTTD1,GRSF1,HNRNPA2B1,HNRNPAB,HNRNPC,HNRNPLL,IGF2BP1,IGF2BP2,IGF2BP3,IREB2,LARP1,LUC7L3,NCBP2,NCBP3,NOCT,NSRP1,NUDT16,NUDT21,PARK7,PARN,PCBP1,PIWIL1,PUM1,PUM2,PURB,RBM24,RBM25,RBM38,RBM4,RBM5,RBM8A,RBMX,RBMY1A1,RC3H1,RNF20,RNF40,RNPS1,RPL35,RPL7,RPS13,RPS14,RPS2,RPS26,RPS3,RPS5,SECISBP2,SERBP1,SLBP,SRRM4,SRSF1,SSB,TARDBP,TDRD7,TPR,TRA2B,TUT1,UNK,UPF3B,XPO5,YBX3,ZC3H12A,ZFP36,ZFP36L1,ZNF385A	Interacting selectively and non-covalently with messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
GO:0003730	GO	MF	mRNA 3'-UTR binding	ANGEL2,AUH,CARHSP1,CIRBP,CPEB1,CPEB2,CPEB3,CPSF1,CRYZ,ELAVL1,ELAVL2,ELAVL4,HNRNPA2B1,HNRNPC,IGF2BP1,IGF2BP2,IGF2BP3,LARP1,PARN,PUM1,PUM2,RBM24,RBM38,RBM4,RC3H1,RNF20,RNF40,RNPS1,SECISBP2,SERBP1,TARDBP,TUT1,YBX3,ZC3H12A,ZFP36,ZNF385A	Interacting selectively and non-covalently with the 3' untranslated region of an mRNA molecule.
GO:0003735	GO	MF	structural constituent of ribosome	FAU,MRPL10,MRPL11,MRPL13,MRPL18,MRPL27,MRPL28,MRPL32,MRPL34,MRPL35,MRPL37,MRPL41,MRPL42,MRPL43,MRPL51,MRPL52,MRPL55,MRPL57,MRPL9,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS24,MRPS33,MRPS36,MRPS6,MRPS7,NDUFA7,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS15A,RPS17,RPS19,RPS2,RPS20,RPS24,RPS27A,RPS29,RPS3,RPS4X,RPS4Y1,RPS5,UBA52	The action of a molecule that contributes to the structural integrity of the ribosome.
GO:0003743	GO	MF	translation initiation factor activity	AGO2,COPS5,EIF1,EIF2A,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EIF2D,EIF2S1,EIF2S2,EIF2S3,EIF3A,EIF3B,EIF3C,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M,EIF4E,EIF4G1,EIF4G2,EIF5,EIF5B	Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide.
GO:0003746	GO	MF	translation elongation factor activity	EEF1A1,EEF1B2,EIF5A,GFM1,TUFM	Functions in chain elongation during polypeptide synthesis at the ribosome.
GO:0003755	GO	MF	peptidyl-prolyl cis-trans isomerase activity	FKBP1A,FKBP1B,FKBP4,FKBP5,PIN1,PPIA,PPIB,PPID,PPIE,PPIH	Catalysis of the reaction: peptidyl-proline (omega=180) = peptidyl-proline (omega=0).
GO:0003756	GO	MF	protein disulfide isomerase activity	ERP44,GLRX2,ITGB3,P4HB,PDIA4,PDIA5,PIGK,QSOX1	Catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins.
GO:0003774	GO	MF	motor activity	APPBP2,BBS4,CENPE,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH6,DNAH7,DNAH8,DNAH9,DNAI2,DNALI1,DYNC1I1,DYNC1I2,DYNC2H1,DYNLRB1,DYNLRB2,KIF11,KIF13A,KIF13B,KIF14,KIF15,KIF16B,KIF18A,KIF18B,KIF19,KIF1A,KIF1B,KIF1C,KIF20B,KIF24,KIF2A,KIF3A,KIF3B,KIF3C,KIF5A,KIF5B,KIF5C,KIF7,KIFC1,KLC1,MYH10,MYH13,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYH9,MYL6,MYL6B,MYO10,MYO1B,MYO1E,MYO3A,MYO5A,MYO5B,MYO6,MYO7A,MYO9B,PIN1,SMC1A,SMC3,STARD9	Catalysis of the generation of force resulting either in movement along a microfilament or microtubule, or in torque resulting in membrane scission, coupled to the hydrolysis of a nucleoside triphosphate.
GO:0003777	GO	MF	microtubule motor activity	APPBP2,BBS4,CENPE,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH6,DNAH7,DNAH8,DNAI2,DNALI1,DYNC1I1,DYNC1I2,DYNLRB1,DYNLRB2,KIF11,KIF13A,KIF13B,KIF14,KIF16B,KIF18A,KIF19,KIF1B,KIF20B,KIF24,KIF3A,KIF3B,KIF5B,KIF5C,KIF7,KIFC1,SMC1A,SMC3,STARD9	Catalysis of movement along a microtubule, coupled to the hydrolysis of a nucleoside triphosphate (usually ATP).
GO:0003779	GO	MF	actin binding	ABL1,ABL2,ABRA,ACE,ACTN1,ACTN4,ACTR2,ACTR3,ADD1,ADD2,AIF1,AIF1L,ALDOA,ALKBH4,ANG,ANLN,ANTXR1,ANXA8,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,AVIL,BCL7B,BLOC1S6,CAPZB,CCDC88A,CCR5,CGN,CLASP2,COBL,CORO1A,CORO1B,CORO1C,CORO2B,CORO7,COTL1,CXCR4,CYFIP1,DAG1,DBN1,DBNL,DMD,DMTN,EGFR,EMD,EPS8,EPS8L1,EPS8L2,ESPN,EZR,FLII,FLNA,FLNB,FMN2,FMNL1,FSCN1,FSCN2,FXYD5,GAS2L2,GAS2L3,GBP1,GIPC1,GSN,HPCA,IQGAP2,ITGB1,KCNMA1,KLHL1,KLHL2,LCP1,LIMA1,LSP1,MACF1,MAEA,MAP1S,MARCKS,MEFV,MICAL1,MICAL2,MICAL3,MICALL2,MKL1,MSRB1,MSRB2,MTSS1,MYH10,MYH14,MYH3,MYH8,MYH9,MYL2,MYL3,MYL4,MYO10,MYO16,MYO18A,MYO1B,MYO1D,MYO1E,MYO1F,MYO6,MYO7A,MYO9B,NCALD,NEBL,NEXN,NOD2,NRAP,PACRG,PARVG,PAWR,PDLIM5,PFN1,PHACTR1,PHACTR4,PICK1,PIP,PLEKHH2,PPP1R42,PRKCE,PTK2,RDX,RUSC1,SCIN,SHROOM1,SHROOM2,SHROOM4,SHTN1,SLC6A4,SMTN,SORBS1,SPTA1,SPTB,SPTBN4,SPTBN5,SSFA2,SSH1,SSH2,SVIL,SYNE1,SYNE2,SYNE3,SYNPO,TLN2,TNNC1,TNNC2,TNNI2,TNNI3,TNNT2,TNNT3,TPM1,TPM2,TRIOBP,TRPV4,TTN,TULP1,TWF1,TWF2,UTRN,VCL,VIL1,WIPF1	Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments.
GO:0003785	GO	MF	actin monomer binding	ABL1,ABL2,COBL,CORO1A,LIMA1,MKL1,MTSS1,MYL2,MYL3,MYL4,PFN1,PRKCE,TWF1,TWF2	Interacting selectively and non-covalently with monomeric actin, also known as G-actin.
GO:0003810	GO	MF	protein-glutamine gamma-glutamyltransferase activity	F13A1,TGM1,TGM2,TGM3,TGM4,TGM6	Catalysis of the reaction: protein glutamine + alkylamine = protein N5-alkylglutamine + NH3. This reaction is the formation of the N6-(L-isoglutamyl)-L-lysine isopeptide, resulting in cross-linking polypeptide chains; the gamma-carboxamide groups of peptidyl-glutamine residues act as acyl donors, and the 6-amino-groups of peptidyl-lysine residues act as acceptors, to give intra- and intermolecular N6-(5-glutamyl)lysine cross-links.
GO:0003823	GO	MF	antigen binding	ANXA11,ATP1B1,CD1C,CD1D,CD209,CD74,CD81,CLEC4M,FCN2,FCN3,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HSP90AA1,HSP90AB1,HSPA8,IL7R,JCHAIN,KIR2DL3,KLRC2,KLRD1,LAG3,LILRA1,LILRA2,LILRB4,MS4A1,PKM,SLAMF1,SLC7A5,SLC7A8,SLC7A9,TAP1,TAPBP,TSPAN4,YWHAE	Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
GO:0003840	GO	MF	gamma-glutamyltransferase activity	GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3	Catalysis of the reaction: (5-L-glutamyl)-peptide + an amino acid = peptide + 5-L-glutamyl-amino acid.
GO:0003841	GO	MF	1-acylglycerol-3-phosphate O-acyltransferase activity	AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5	Catalysis of the reaction: acyl-CoA + 1-acyl-sn-glycerol-3-phosphate = CoA + 1,2-diacyl-sn-glycerol-3-phosphate.
GO:0003857	GO	MF	3-hydroxyacyl-CoA dehydrogenase activity	EHHADH,HADH,HADHA,HADHB,HSD17B4,HSD17B8	Catalysis of the reaction: (S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH + H(+).
GO:0003887	GO	MF	DNA-directed DNA polymerase activity	CHRAC1,POLA1,POLB,POLD1,POLD3,POLE,POLG,POLL,POLM,POLN,POLQ,PRIMPOL	Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a DNA template and a 3'hydroxyl group.
GO:0003899	GO	MF	DNA-directed RNA polymerase activity	CRCP,MED20,MED21,POLA1,POLR1C,POLR2A,POLR2D,POLR2E,POLR2J,POLR2L,POLR3A,POLR3C,POLR3F,POLR3G,POLR3H,POLR3K,POLRMT,PRIMPOL	Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template, i.e. the catalysis of DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'.
GO:0003906	GO	MF	DNA-(apurinic or apyrimidinic site) lyase activity	ALKBH1,APEX1,APLF,HMGA1,HMGA2,NEIL3,NTHL1,OGG1,RPS3	Catalysis of the cleavage of the C-O-P bond 3' to the apurinic or apyrimidinic site in DNA by a beta-elimination reaction, leaving a 3'-terminal unsaturated sugar and a product with a terminal 5'-phosphate.
GO:0003916	GO	MF	DNA topoisomerase activity	TOP1,TOP2A,TOP2B,TOP3A,TOP3B	Catalysis of the transient cleavage and passage of individual DNA strands or double helices through one another, resulting a topological transformation in double-stranded DNA.
GO:0003923	GO	MF	GPI-anchor transamidase activity	GPAA1,PIGK,PIGS,PIGT,PIGU	Catalysis of the formation of the linkage between a protein and a glycosylphosphatidylinositol anchor. The reaction probably occurs by subjecting a peptide bond to nucleophilic attack by the amino group of ethanolamine-GPI, transferring the protein from a signal peptide to the GPI anchor.
GO:0003924	GO	MF	GTPase activity	ARF1,ARF3,ARF4,ARF5,ARF6,ARFRP1,ARHGAP5,ARHGDIB,ARL1,ARL2,ARL4C,ARL4D,ARL8A,ARL8B,ATL1,ATL2,ATL3,CDC42,DDX3X,DIRAS1,DIRAS3,DNM1L,DNM2,DNM3,EFTUD1,EIF5,GEM,GFM1,GFM2,GIMAP7,GNAI1,GNAI3,GNAS,GNAT1,GNB1,GNB2,GNB3,GNB5,GNG10,GNG11,GNG3,GNG5,GNG8,GNGT1,GNGT2,GNL2,GSPT1,GTPBP1,GTPBP4,HRAS,LRRK2,LSG1,MRAS,MTG1,MTG2,NKIRAS1,NKIRAS2,NUDT1,OPA1,RAB11A,RAB11B,RAB14,RAB17,RAB18,RAB1A,RAB21,RAB22A,RAB23,RAB27A,RAB27B,RAB28,RAB2A,RAB30,RAB31,RAB32,RAB33A,RAB33B,RAB35,RAB38,RAB3A,RAB3B,RAB3C,RAB3D,RAB43,RAB4A,RAB5A,RAB5B,RAB5C,RAB6A,RAB6B,RAB6C,RAB7A,RAB8A,RAB8B,RAB9A,RABL2A,RABL2B,RAC1,RAC2,RAC3,RALB,RAN,RAP1A,RAP1B,RAP1GAP,RAP2A,RASD1,RASD2,RASL10A,RERG,RHEB,RHOA,RHOB,RHOD,RHOF,RHOG,RHOJ,RHOQ,RIT2,RND1,RND2,RND3,RRAD,RRAGA,RRAGB,RRAGC,RRAS,RRAS2,SAR1B,SEPT4,SEPT5,SEPT9,SRP54,TBCC,TRIM23	Catalysis of the reaction: GTP + H2O = GDP + phosphate.
GO:0003950	GO	MF	NAD+ ADP-ribosyltransferase activity	ART3,PARP1,PARP10,PARP11,PARP16,PARP3,PARP4,PARP9,SIRT4,SIRT6,TIPARP,TNKS,TNKS2	Catalysis of the reaction: NAD+ + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
GO:0003995	GO	MF	acyl-CoA dehydrogenase activity	ACAD11,ACADL,ACADM,ACADS,ACADVL,IVD	Catalysis of the reaction: acyl-CoA + acceptor = 2,3-dehydroacyl-CoA + reduced acceptor.
GO:0003997	GO	MF	acyl-CoA oxidase activity	ACAA1,ACADL,ACOX1,ACOX2,ACOX3	Catalysis of the reaction: acyl-CoA + O2 = trans-2,3-dehydroacyl-CoA + hydrogen peroxide.
GO:0004000	GO	MF	adenosine deaminase activity	ADA,ADAR,ADARB1,ADAT1,CECR1	Catalysis of the reaction: adenosine + H2O = inosine + NH3.
GO:0004003	GO	MF	ATP-dependent DNA helicase activity	ASCC3,BLM,BRIP1,CHD1,CHD1L,CHD2,CHD3,CHD4,DDX3X,DHX9,G3BP1,HELB,IGHMBP2,MCM4,MCM6,MCM7,MRE11A,NBN,PIF1,RAD50,RECQL,RECQL4,RTEL1,RUVBL2,WRN	Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of the DNA helix.
GO:0004004	GO	MF	ATP-dependent RNA helicase activity	DDX18,DDX20,DDX21,DDX23,DDX25,DDX39B,DDX3X,DDX43,DDX54,DDX56,DHX8,DHX9,EIF4A3,G3BP1,IGHMBP2,MOV10L1,SKIV2L,SNRNP200,SUPV3L1,UPF1	Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of an RNA helix.
GO:0004012	GO	MF	phospholipid-translocating ATPase activity	ABCB4,ATP10A,ATP10D,ATP11B,ATP8B1	Catalysis of the movement of phospholipids from one membrane bilayer leaflet to the other, driven by the hydrolysis of ATP.
GO:0004016	GO	MF	adenylate cyclase activity	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,GNAS	Catalysis of the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
GO:0004022	GO	MF	alcohol dehydrogenase (NAD) activity	ADH1A,ADH1B,ADH1C,ADH4,ADH6,ADH7,DHRS9	Catalysis of the reaction: an alcohol + NAD+ = an aldehyde or ketone + NADH + H+.
GO:0004029	GO	MF	aldehyde dehydrogenase (NAD) activity	ADH5,ALDH1A1,ALDH1B1,ALDH2,ALDH3A1,ALDH3A2,ALDH4A1,ALDH7A1,ALDH9A1	Catalysis of the reaction: an aldehyde + NAD+ + H2O = an acid + NADH + H+.
GO:0004032	GO	MF	alditol:NADP+ 1-oxidoreductase activity	AKR1A1,AKR1C1,AKR1C2,AKR1C3,AKR7A2	Catalysis of the reaction: an alditol + NADP+ = an aldose + NADPH + H+.
GO:0004033	GO	MF	aldo-keto reductase (NADP) activity	AKR1A1,AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,AKR7A3,ALDH3A1,CYB5A,KCNAB1,KCNAB2,MIOX,RDH11,SPR	Catalysis of the reaction: an alcohol + NADP+ = an aldehyde or a ketone + NADPH + H+.
GO:0004064	GO	MF	arylesterase activity	APMAP,CA1,CA2,PON1,PON3	Catalysis of the reaction: a phenyl acetate + H2O = a phenol + acetate.
GO:0004065	GO	MF	arylsulfatase activity	ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,SULF1,SULF2	Catalysis of the reaction: a phenol sulfate + H2O = a phenol + sulfate.
GO:0004114	GO	MF	3',5'-cyclic-nucleotide phosphodiesterase activity	PDE10A,PDE11A,PDE1A,PDE1B,PDE1C,PDE2A,PDE3B,PDE4A,PDE4B,PDE4D,PDE5A,PDE6A,PDE6B,PDE7A,PDE8A,PDE8B,PDE9A	Catalysis of the reaction: nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate.
GO:0004126	GO	MF	cytidine deaminase activity	AICDA,APOBEC1,APOBEC2,APOBEC3A,APOBEC3F,APOBEC3G,APOBEC3H,CDA	Catalysis of the reaction: cytidine + H2O = uridine + NH3.
GO:0004129	GO	MF	cytochrome-c oxidase activity	COX10,COX11,COX15,COX4I2,COX6B1,CYB5A,MT-CO1,MT-CO2,NDUFA4	Catalysis of the reaction: 4 ferrocytochrome c + O2 + 4 H+ = 4 ferricytochrome c + 2 H2O.
GO:0004143	GO	MF	diacylglycerol kinase activity	DGKD,DGKH,DGKK,DGKQ,DGKZ	Catalysis of the reaction: NTP + 1,2-diacylglycerol = NDP + 1,2-diacylglycerol-3-phosphate.
GO:0004175	GO	MF	endopeptidase activity	ACE,ACE2,ACR,ADAM10,ADAM17,ADAM33,ADAM9,ADAMDEC1,ADAMTS12,ADAMTS3,ADAMTS7,APEH,ASPRV1,ASTL,ATG4B,ATG4C,ATG4D,BACE1,BACE2,BMP1,C1S,CAPN1,CAPN10,CAPN2,CAPN3,CAPN7,CAPNS1,CASP1,CASP10,CASP14,CASP2,CASP3,CASP6,CASP7,CASP8,CASP9,CELA3B,CFB,CLC,CLPP,CMA1,CORIN,CPNE1,CTRB1,CTSB,CTSE,CTSF,CTSG,CTSH,CTSK,CTSL,CTSO,CTSS,ECE1,ECE2,ELANE,F10,F11,F12,F2,F9,FAP,FURIN,GZMA,GZMB,GZMH,GZMM,HM13,HPN,HTRA2,HTRA3,HTRA4,IDE,KEL,KLK1,KLK12,KLK13,KLK14,KLK15,KLK2,KLK3,KLK5,KLK6,KLK8,KLK9,LGMN,LPA,MALT1,MASP1,MASP2,MBTPS1,MME,MMP1,MMP12,MMP13,MMP14,MMP2,MMP20,MMP24,MMP28,MMP3,MMP8,MMP9,NAPSA,NRD1,OMA1,P4HB,PARL,PCSK1,PCSK2,PCSK5,PCSK6,PCSK9,PDIA3,PGC,PIP,PITRM1,PLAT,PLAU,PLG,PMPCA,PROC,PRSS1,PRSS2,PRSS3,PRSS36,PRSS50,PRSS56,PSEN1,PSMA6,PSMB6,RCE1,REN,RHBDD1,RHBDL2,SENP1,SFRP1,SPG7,SPPL2A,SPPL2B,SPPL3,TASP1,TINAG,TMPRSS13,TMPRSS3,TMPRSS4,TMPRSS6,TPP1,TPP2,TPSAB1,TPSB2,TRABD2A,TRABD2B,TYSND1,UCHL1,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP2,USP20,USP30,USP33,USP34,USP37,USP49,USP5,USP6,USP7,USP8,USP9X	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
GO:0004177	GO	MF	aminopeptidase activity	ANPEP,BLMH,CTSH,DPP3,DPP4,DPP8,ENPEP,ERAP1,ERAP2,FAP,LAP3,LNPEP,LTA4H,METAP1,METAP1D,METAP2,NAALAD2,NPEPPS,RNPEP,TRHDE,XPNPEP1,XPNPEP3	Catalysis of the hydrolysis of N-terminal amino acid residues from in a polypeptide chain.
GO:0004180	GO	MF	carboxypeptidase activity	ACE2,AEBP1,AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,BLMH,CNDP2,CPA2,CPA3,CPA4,CPA6,CPB1,CPE,CPM,CTSA,FOLH1,NAALAD2,PEPD,PRCP,SCPEP1	Catalysis of the hydrolysis of the terminal or penultimate peptide bond at the C-terminal end of a peptide or polypeptide.
GO:0004181	GO	MF	metallocarboxypeptidase activity	AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,CPA2,CPA3,CPA4,CPA6,FOLH1,PEPD	Catalysis of the hydrolysis of C-terminal amino acid residues from a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
GO:0004190	GO	MF	aspartic-type endopeptidase activity	ASPRV1,BACE1,BACE2,CTSE,HM13,NAPSA,PGC,PIP,REN,SPPL2A,SPPL2B,SPPL3	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile.
GO:0004197	GO	MF	cysteine-type endopeptidase activity	ATG4C,ATG4D,CAPN1,CAPN10,CAPN2,CAPN3,CAPNS1,CASP1,CASP10,CASP14,CASP2,CASP3,CASP6,CASP7,CASP8,CASP9,CLC,CTSB,CTSF,CTSH,CTSK,CTSL,CTSO,CTSS,LGMN,MALT1,PDIA3,SFRP1,TINAG,UCHL1,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP2,USP20,USP30,USP33,USP34,USP37,USP49,USP5,USP6,USP7,USP8,USP9X	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.
GO:0004198	GO	MF	calcium-dependent cysteine-type endopeptidase activity	CAPN1,CAPN10,CAPN2,CAPN3,CAPNS1	Catalysis of the hydrolysis of nonterminal peptide bonds in a polypeptide chain by a mechanism using a cysteine residue at the enzyme active center, and requiring the presence of calcium.
GO:0004222	GO	MF	metalloendopeptidase activity	ADAM10,ADAM17,ADAM33,ADAM9,ADAMDEC1,ADAMTS12,ADAMTS3,ADAMTS7,ASTL,BMP1,ECE1,ECE2,FAP,IDE,KEL,MME,MMP1,MMP12,MMP13,MMP14,MMP20,MMP24,MMP28,MMP9,NRD1,OMA1,PITRM1,PMPCA,SPG7,TRABD2A,TRABD2B	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
GO:0004252	GO	MF	serine-type endopeptidase activity	ACR,APEH,C1S,CELA3B,CFB,CLPP,CMA1,CORIN,CTRB1,CTSG,CTSH,F10,F11,F12,F2,FAP,FURIN,GZMA,GZMB,GZMH,GZMM,HPN,HTRA2,KLK1,KLK12,KLK13,KLK14,KLK15,KLK2,KLK3,KLK5,KLK6,KLK8,KLK9,LPA,MASP1,MASP2,MBTPS1,MMP2,MMP8,PCSK1,PCSK2,PCSK5,PCSK6,PCSK9,PLAT,PLAU,PLG,PROC,PRSS1,PRSS2,PRSS3,PRSS36,PRSS56,RHBDD1,RHBDL2,TMPRSS13,TMPRSS3,TMPRSS4,TMPRSS6,TPSAB1,TPSB2,TYSND1	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
GO:0004301	GO	MF	epoxide hydrolase activity	AKR7A2,EPHX1,EPHX2,LTA4H,RNPEP	Catalysis of the reaction: an epoxide + H2O = a glycol.
GO:0004303	GO	MF	estradiol 17-beta-dehydrogenase activity	AKR1B15,HSD17B1,HSD17B14,HSD17B2,HSD17B8	Catalysis of the reaction: estradiol-17-beta + NADP+ = estrone + NADPH + H+.
GO:0004312	GO	MF	fatty acid synthase activity	ELOVL1,ELOVL2,ELOVL5,FASN,MCAT,OXSM	Catalysis of the reaction: acetyl-CoA + n malonyl-CoA + 2n NADPH + 2n H+ = long-chain fatty acid + n+1 CoA + n CO2 + 2n NADP+.
GO:0004364	GO	MF	glutathione transferase activity	GSTA1,GSTA2,GSTA3,GSTA4,GSTA5,GSTK1,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTO1,GSTP1,GSTT2B,GSTZ1,MGST1,MGST2	Catalysis of the reaction: R-X + glutathione = H-X + R-S-glutathione. R may be an aliphatic, aromatic or heterocyclic group; X may be a sulfate, nitrile or halide group.
GO:0004385	GO	MF	guanylate kinase activity	CARD11,CASK,DLG1,DLG2,GUK1,MAGI3,MPP1,MPP2,MPP3,TJP2	Catalysis of the reaction: ATP + GMP = ADP + GDP.
GO:0004386	GO	MF	helicase activity	ASCC3,ATRX,BLM,BRIP1,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD8,DDX1,DDX10,DDX11,DDX17,DDX18,DDX19B,DDX20,DDX21,DDX23,DDX24,DDX25,DDX39B,DDX3X,DDX43,DDX5,DDX54,DDX56,DDX6,DHX15,DHX16,DHX8,DHX9,DNA2,EIF4A1,EIF4A2,EIF4A3,ERCC2,ERCC3,FBXO18,G3BP1,HELB,IGHMBP2,INO80,MCM4,MCM6,MCM7,MOV10L1,MRE11A,NBN,PIF1,RAD50,RAD54B,RECQL,RECQL4,RECQL5,RTEL1,RUVBL1,RUVBL2,SETX,SKIV2L,SNRNP200,SUPV3L1,UPF1,WRN	Catalysis of the reaction: NTP + H2O = NDP + phosphate, to drive the unwinding of a DNA or RNA helix.
GO:0004402	GO	MF	histone acetyltransferase activity	ATF2,BRCA2,CLOCK,CREBBP,CSRP2BP,ELP3,ELP4,EP300,EPC1,HAT1,HCFC1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,MCRS1,NAA50,NAA60,NCOA3,OGT,PHF20,SAP130,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,USP22,WDR5	Catalysis of the reaction: acetyl-CoA + histone = CoA + acetyl-histone.
GO:0004407	GO	MF	histone deacetylase activity	HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC8,HDAC9,NACC2,SALL1,SIRT1,SIRT2,SIRT6,SIRT7,SUDS3	Catalysis of the reaction: histone N6-acetyl-L-lysine + H2O = histone L-lysine + acetate. This reaction represents the removal of an acetyl group from a histone, a class of proteins complexed to DNA in chromatin and chromosomes.
GO:0004415	GO	MF	hyalurononglucosaminidase activity	CD44,CEMIP,HYAL1,HYAL2,HYAL3,MGEA5	Catalysis of the random hydrolysis of (1->4) linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate.
GO:0004435	GO	MF	phosphatidylinositol phospholipase C activity	BDKRB2,C3AR1,CASR,CCKBR,CCL5,CCR1,CCR5,CHRM1,CHRM3,CHRM5,EDNRA,F2RL2,PLCB1,PLCB2,PLCE1,PLCG1,PLCG2,PLD4	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H(2)O = 1,2-diacylglycerol + 1D-myo-inositol 1,4,5-trisphosphate + H(+).
GO:0004438	GO	MF	phosphatidylinositol-3-phosphatase activity	MTM1,MTMR1,MTMR14,MTMR2,MTMR3,PTEN	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 3-phosphate + H2O = 1-phosphatidyl-1D-myo-inositol + phosphate.
GO:0004467	GO	MF	long-chain fatty acid-CoA ligase activity	ACSBG1,ACSBG2,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,SLC27A2,SLC27A4	Catalysis of the reaction: ATP + a long-chain carboxylic acid + CoA = AMP + diphosphate + an acyl-CoA; a long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
GO:0004497	GO	MF	monooxygenase activity	AGMO,AKR1C1,AKR1C2,AKR1C3,CH25H,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A2,CYP1B1,CYP21A2,CYP26A1,CYP26B1,CYP26C1,CYP27A1,CYP27B1,CYP2A6,CYP2B6,CYP2C18,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP2D7,CYP2E1,CYP2F1,CYP2J2,CYP39A1,CYP3A4,CYP3A43,CYP3A5,CYP3A7,CYP46A1,CYP4A11,CYP4F11,CYP4F12,CYP4F2,CYP4F3,CYP4F8,CYP51A1,CYP7A1,CYP8B1,DBH,DOHH,FMO1,FMO2,FMO3,FMO4,KMO,MICAL1,MICAL2,MICAL3,NOS1,NOS2,NOS3,PAH,PAM,SQLE,TH,TYR	Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.
GO:0004518	GO	MF	nuclease activity	AEN,AGO2,ALKBH1,ANG,APEX1,APLF,APTX,AZGP1,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,CPSF3,DBR1,DCLRE1A,DCLRE1B,DCLRE1C,DCP2,DDX1,DFFB,DGCR8,DICER1,DIS3,DIS3L,DIS3L2,DNA2,DNASE1L1,DNASE1L2,DNASE1L3,DROSHA,DXO,EDC3,ENDOU,ENDOV,ENPP1,ERCC1,ERCC4,ERCC5,ERI1,ERN1,ERN2,EXO1,EXO5,EXOG,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FAN1,FEN1,GEN1,HMGA1,HMGA2,ISG20,MBD4,MEIOB,MGME1,MRE11A,MUS81,N4BP2,NEIL3,NME1,NOCT,NTHL1,OGG1,PAN2,PAN3,PARN,PGAP1,PMS2,PNKP,PNPT1,POP1,PPP1R8,RAD1,RAD50,RAD51C,RAD9A,RAG1,RBBP8,REXO2,RNASE2,RNASE3,RNASE4,RNASE6,RNASE7,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,RNASET2,RPS3,SETMAR,SLFN14,SLX1A,SLX4,SMG6,TOE1,TREX1,TREX2,USB1,WRN,XRCC3,XRN2,ZC3H12A,ZRANB3	Catalysis of the hydrolysis of ester linkages within nucleic acids.
GO:0004519	GO	MF	endonuclease activity	AGO2,ALKBH1,ANG,APEX1,APLF,CPSF3,DBR1,DCLRE1C,DGCR8,DICER1,DIS3,DNA2,DROSHA,EDC3,ENDOU,ENDOV,ERCC1,ERCC4,ERCC5,ERN1,ERN2,EXO1,EXOG,FAN1,FEN1,GEN1,HMGA1,HMGA2,MBD4,MRE11A,MUS81,N4BP2,NEIL3,NTHL1,OGG1,PMS2,PNKP,POP1,RAD50,RAD51C,RAG1,RBBP8,RNASE4,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,RPS3,SETMAR,SLFN14,SLX1A,SLX4,SMG6,XRCC3,ZC3H12A,ZRANB3	Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks.
GO:0004520	GO	MF	endodeoxyribonuclease activity	ALKBH1,APEX1,APLF,DCLRE1C,DNA2,ENDOV,ERCC1,ERCC4,ERCC5,EXO1,FAN1,FEN1,GEN1,HMGA1,HMGA2,MBD4,MRE11A,MUS81,NEIL3,NTHL1,OGG1,RAD50,RAD51C,RBBP8,RPS3,SETMAR,SLX1A,SLX4,XRCC3,ZRANB3	Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks.
GO:0004521	GO	MF	endoribonuclease activity	AGO2,APEX1,CPSF3,DBR1,DGCR8,DICER1,DROSHA,EDC3,ENDOU,ENDOV,ERN1,EXO1,FEN1,POP1,RNASE4,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,SLFN14,SMG6,ZC3H12A	Catalysis of the hydrolysis of ester linkages within ribonucleic acid by creating internal breaks.
GO:0004523	GO	MF	RNA-DNA hybrid ribonuclease activity	APEX1,EXO1,FEN1,RNASEH1,RNASEH2A	Catalysis of the endonucleolytic cleavage of RNA in RNA-DNA hybrids to 5'-phosphomonoesters.
GO:0004527	GO	MF	exonuclease activity	AEN,APEX1,APLF,APTX,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,CPSF3,DCLRE1A,DCLRE1B,DCLRE1C,DCP2,DIS3,DIS3L,DIS3L2,DXO,ENPP1,ERI1,EXO1,EXO5,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FAN1,FEN1,ISG20,MEIOB,MGME1,MRE11A,NOCT,PAN2,PAN3,PARN,PNPT1,RAD1,RAD50,RAD9A,REXO2,TOE1,TREX1,TREX2,USB1,WRN,XRN2,ZC3H12A	Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 3' or 5' end.
GO:0004532	GO	MF	exoribonuclease activity	CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,DCP2,DIS3,DIS3L,DIS3L2,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,ISG20,NOCT,PAN2,PAN3,PARN,PNPT1,TOE1,USB1,XRN2,ZC3H12A	Catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of an RNA molecule.
GO:0004535	GO	MF	poly(A)-specific ribonuclease activity	CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,NOCT,PAN2,PAN3,PARN,TOE1	Catalysis of the exonucleolytic cleavage of poly(A) to 5'-AMP.
GO:0004536	GO	MF	deoxyribonuclease activity	ALKBH1,APEX1,APLF,APTX,DCLRE1A,DCLRE1C,DFFB,DNA2,DNASE1L1,DNASE1L2,DNASE1L3,ENDOV,ERCC1,ERCC4,ERCC5,EXO1,EXO5,FAN1,FEN1,GEN1,HMGA1,HMGA2,ISG20,MBD4,MEIOB,MGME1,MRE11A,MUS81,NEIL3,NME1,NTHL1,OGG1,RAD50,RAD51C,RBBP8,RPS3,SETMAR,SLX1A,SLX4,TREX1,TREX2,XRCC3,ZRANB3	Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acid.
GO:0004540	GO	MF	ribonuclease activity	AGO2,ANG,APEX1,AZGP1,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,CPSF3,DBR1,DCP2,DGCR8,DICER1,DIS3,DIS3L,DIS3L2,DROSHA,EDC3,ENDOU,ENDOV,ERN1,EXO1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FEN1,ISG20,NOCT,PAN2,PAN3,PARN,PNPT1,POP1,PPP1R8,RNASE2,RNASE3,RNASE4,RNASE6,RNASE7,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,RNASET2,SLFN14,SMG6,TOE1,USB1,XRN2,ZC3H12A	Catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.
GO:0004550	GO	MF	nucleoside diphosphate kinase activity	AK1,AK4,AK5,AK7,AK8,AK9,CMPK1,CMPK2,NME1,NME2,NME6	Catalysis of the reaction: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate.
GO:0004551	GO	MF	nucleotide diphosphatase activity	ENPP1,ENPP3,ENPP4,FHIT,NUDT12,NUDT2	Catalysis of the reaction: a dinucleotide + H2O = 2 mononucleotides.
GO:0004553	GO	MF	hydrolase activity, hydrolyzing O-glycosyl compounds	ABHD10,ACER1,ACER2,ACER3,AMY2A,CD44,CEMIP,CHIA,CHIT1,EDEM1,EDEM2,EDEM3,FUCA1,FUCA2,GAA,GALC,GANC,GBA,GBA2,GBA3,GLA,GLB1,GUSB,HPSE,HPSE2,HYAL1,HYAL2,HYAL3,IDUA,KL,LCT,LYZ,MAN1A1,MAN1B1,MAN1C1,MGAM,MGEA5,MOGS,NAGA,NEU1,NEU2,NEU3,NEU4,PARG,SI,SPACA3,TREH	Catalysis of the hydrolysis of any O-glycosyl bond.
GO:0004571	GO	MF	mannosyl-oligosaccharide 1,2-alpha-mannosidase activity	EDEM1,EDEM2,EDEM3,MAN1B1,MAN1C1	Catalysis of the hydrolysis of the terminal (1->2)-linked alpha-D-mannose residues in an oligo-mannose oligosaccharide.
GO:0004576	GO	MF	oligosaccharyl transferase activity	ALG5,DAD1,DDOST,OSTC,RPN1,RPN2,STT3A,STT3B,TUSC3	Catalysis of the transfer of a oligosaccharyl group to an acceptor molecule, typically another carbohydrate or a lipid.
GO:0004579	GO	MF	dolichyl-diphosphooligosaccharide-protein glycotransferase activity	DAD1,DDOST,OSTC,RPN1,RPN2,STT3A,STT3B,TUSC3	Catalysis of the reaction: dolichyl diphosphooligosaccharide + protein L-asparagine = dolichyl diphosphate + a glycoprotein with the oligosaccharide chain attached by glycosylamine linkage to protein L-asparagine.
GO:0004596	GO	MF	peptide alpha-N-acetyltransferase activity	NAA10,NAA11,NAA16,NAA30,NAA50,NAA60	Catalysis of the reaction: acetyl-CoA + peptide = CoA + N-alpha-acetylpeptide. This reaction is the acetylation of the N-terminal amino acid residue of a peptide or protein.
GO:0004601	GO	MF	peroxidase activity	CAT,CLIC2,CYGB,GPX1,GPX2,GPX3,GPX4,GPX7,GSTK1,GSTZ1,HBA1,HBB,IPCEF1,LPO,MGST1,MGST3,MPO,PRDX1,PRDX2,PRDX3,PRDX4,PRDX5,PTGS1,PTGS2,PXDN,PXDNL,TPO,TXNDC17	Catalysis of the reaction: donor + hydrogen peroxide = oxidized donor + 2 H2O.
GO:0004602	GO	MF	glutathione peroxidase activity	CLIC2,GPX1,GPX2,GPX3,GPX4,GSTK1,GSTZ1,MGST1	Catalysis of the reaction: 2 glutathione + hydrogen peroxide = oxidized glutathione + 2 H2O.
GO:0004620	GO	MF	phospholipase activity	ABHD3,BDKRB2,C3AR1,CASR,CCKBR,CCL5,CCR1,CCR5,CHRM1,CHRM3,CHRM5,CLC,EDNRA,ENPP2,ENPP7,F2RL2,GPLD1,LIPC,LIPG,LIPH,LIPI,LPL,LYPLA1,LYPLAL1,MGLL,PDIA3,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G6,PLA2G7,PLCB1,PLCB2,PLCB3,PLCB4,PLCE1,PLCG1,PLCG2,PLCH1,PLCL1,PLD4,PLD6,PNLIPRP2,PNPLA3,PNPLA8,PRDX6,RARRES3,SMPD4	Catalysis of the hydrolysis of a glycerophospholipid.
GO:0004622	GO	MF	lysophospholipase activity	CLC,ENPP2,LYPLA1,LYPLAL1,MGLL,PLA2G15,PLA2G4B	Catalysis of the reaction: 2-lysophosphatidylcholine + H2O = glycerophosphocholine + a carboxylate.
GO:0004623	GO	MF	phospholipase A2 activity	ABHD3,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G6,PLA2G7,PNPLA3,PNPLA8,PRDX6,RARRES3	Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.
GO:0004629	GO	MF	phospholipase C activity	BDKRB2,C3AR1,CASR,CCKBR,CCL5,CCR1,CCR5,CHRM1,CHRM3,CHRM5,EDNRA,F2RL2,PDIA3,PLCB1,PLCB2,PLCB3,PLCB4,PLCE1,PLCG1,PLCG2,PLCH1,PLCL1,PLD4	Catalysis of the reaction: a phospholipid + H2O = 1,2-diacylglycerol + a phosphatidate.
GO:0004652	GO	MF	polynucleotide adenylyltransferase activity	MTPAP,PAPD4,PAPOLA,PAPOLG,TUT1	Catalysis of the template-independent extension of the 3'- end of an RNA or DNA strand by addition of one adenosine molecule at a time. Cannot initiate a chain 'de novo'. The primer, depending on the source of the enzyme, may be an RNA or DNA fragment, or oligo(A) bearing a 3'-OH terminal group.
GO:0004653	GO	MF	polypeptide N-acetylgalactosaminyltransferase activity	C1GALT1C1,GALNT1,GALNT10,GALNT11,GALNT2,GALNT3,GALNT5,GALNT9	Catalysis of the reaction: UDP-N-acetyl-D-galactosamine + polypeptide = UDP + N-acetyl-D-galactosaminyl-polypeptide. This reaction is the modification of serine or threonine residues in polypeptide chains by the transfer of a N-acetylgalactose from UDP-N-acetylgalactose to the hydroxyl group of the amino acid; it is the first step in O-glycan biosynthesis.
GO:0004659	GO	MF	prenyltransferase activity	CHM,COX10,DHDDS,FDFT1,FNTA,FNTB,GGPS1,NUS1,PGGT1B,RABGGTA,RABGGTB,UBIAD1	Catalysis of the transfer of a prenyl group from one compound (donor) to another (acceptor).
GO:0004661	GO	MF	protein geranylgeranyltransferase activity	CHM,FNTA,PGGT1B,RABGGTA,RABGGTB	Catalysis of the covalent addition of a geranylgeranyl (20-carbon isoprenoid) group via thioether linkages to a cysteine residue at or near the C terminus of a protein.
GO:0004675	GO	MF	transmembrane receptor protein serine/threonine kinase activity	ACVR1,ACVR1B,ACVR1C,ACVR2A,ACVR2B,ACVRL1,BMPR1A,BMPR1B,BMPR2,ENG,HFE2,LTBP1,LTBP4,TGFBR1,TGFBR2,TGFBR3	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
GO:0004683	GO	MF	calmodulin-dependent protein kinase activity	CAMK1,CAMK2D,CAMK4,DAPK1,EEF2K,MYLK2,MYLK3,PHKG2,PTK2B	Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; and ATP + a protein threonine = ADP + protein threonine phosphate. These reactions require the presence of calcium-bound calmodulin.
GO:0004690	GO	MF	cyclic nucleotide-dependent protein kinase activity	AKAP13,PRKAA1,PRKACA,PRKACB,PRKAG1,PRKG1,PRKX	Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires the presence of a cyclic nucleotide.
GO:0004691	GO	MF	cAMP-dependent protein kinase activity	AKAP13,PRKAA1,PRKACA,PRKACB,PRKAG1,PRKX	Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires the presence of cAMP.
GO:0004693	GO	MF	cyclin-dependent protein serine/threonine kinase activity	CCNK,CDK1,CDK14,CDK2,CDK4,CDK6,CDK9	Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. This reaction requires the binding of a regulatory cyclin subunit and full activity requires stimulatory phosphorylation by a CDK-activating kinase (CAK).
GO:0004697	GO	MF	protein kinase C activity	CCL3,PRKCA,PRKCD,PRKCE,PRKCG,PRKCH,PRKCI,PRKD1	Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires diacylglycerol.
GO:0004702	GO	MF	receptor signaling protein serine/threonine kinase activity	ALK,EGFR,IKBKE,IRAK1,MAP3K1,MAP3K10,MAP3K11,MAP3K13,MAP3K14,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAPK10,MAPK11,MAPK13,MAPK14,MAPK15,MAPK3,MAPK6,MAPK8,MAPK9,MOS,NLK,PPP4C,STK10,STK39,TGFB2	Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
GO:0004704	GO	MF	NF-kappaB-inducing kinase activity	ALK,IKBKE,IRAK1,MAP3K14,PPP4C	Catalysis of the phosphorylation of the alpha or beta subunit of the inhibitor of kappaB kinase complex (IKK).
GO:0004707	GO	MF	MAP kinase activity	MAPK10,MAPK11,MAPK13,MAPK14,MAPK15,MAPK3,MAPK6,MAPK8,MAPK9,NLK	Catalysis of the reaction: protein + ATP = protein phosphate + ADP. This reaction is the phosphorylation of proteins. Mitogen-activated protein kinase; a family of protein kinases that perform a crucial step in relaying signals from the plasma membrane to the nucleus. They are activated by a wide range of proliferation- or differentiation-inducing signals; activation is strong with agonists such as polypeptide growth factors and tumor-promoting phorbol esters, but weak (in most cell backgrounds) by stress stimuli.
GO:0004708	GO	MF	MAP kinase kinase activity	LRRK2,MAP2K1,MAP2K2,MAP2K7,MAP3K9,MAPK10,MAPK14,MAPKAPK3,MAPKAPK5,PAK3	Catalysis of the concomitant phosphorylation of threonine (T) and tyrosine (Y) residues in a Thr-Glu-Tyr (TEY) thiolester sequence in a MAP kinase (MAPK) substrate.
GO:0004709	GO	MF	MAP kinase kinase kinase activity	EGFR,MAP3K1,MAP3K10,MAP3K11,MAP3K13,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MOS	Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.
GO:0004712	GO	MF	protein serine/threonine/tyrosine kinase activity	AKT1,AURKA,AURKB,AURKC,LRRK2,MAP2K1,MAP2K2,MAP2K7,MAP3K9,MAPK10,MAPK14,MAPKAPK3,MAPKAPK5,PAK3,PRKAA2,PRKACA,PRKCG,RELN,RPS6KA1,RPS6KA2,RPS6KB1,SGK1,TNK2	Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
GO:0004713	GO	MF	protein tyrosine kinase activity	ABL1,ABL2,ALK,BAZ1B,BCR,BLK,BMX,BTK,CAMKK2,CLK1,CRIM1,CSF1R,CSK,DDR1,DDR2,DYRK1A,DYRK2,EFEMP1,EFNA3,EFNA4,EFNB3,EGFR,EPHA1,EPHA10,EPHA2,EPHA3,EPHA4,EPHA5,EPHA7,EPHA8,EPHB1,EPHB2,EPHB3,EPHB4,ERBB2,ERBB4,FER,FES,FGFR1,FGFR1OP,FGFR2,FGFR3,FGFR4,FGFRL1,FGR,FLT1,FLT3,FLT4,FYN,HCK,IGF1R,IGF2R,INSR,INSRR,ITK,JAK1,JAK2,JAK3,KDR,KIT,LCK,LTK,LYN,MATK,MELK,MET,MST1R,MUSK,NRP1,NRP2,NTRK1,NTRK2,PDGFRA,PDGFRB,PDGFRL,PEAK1,PKDCC,PTK2,PTK2B,PTK6,RET,ROR1,ROS1,RYK,SCYL1,SHC1,SRC,SRMS,SYK,TEC,TEK,TNK1,TNK2,TRIM27,TTN,TYK2,TYRO3,WEE1,YES1,ZAP70	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
GO:0004714	GO	MF	transmembrane receptor protein tyrosine kinase activity	ALK,CRIM1,CSF1R,DDR1,DDR2,EFEMP1,EFNA3,EFNA4,EFNB3,EGFR,EPHA1,EPHA10,EPHA2,EPHA3,EPHA4,EPHA5,EPHA7,EPHA8,EPHB1,EPHB2,EPHB3,EPHB4,ERBB2,ERBB4,FGFR1,FGFR2,FGFR3,FGFR4,FGFRL1,FLT1,FLT3,FLT4,IGF1R,IGF2R,INSR,INSRR,KDR,KIT,MST1R,NRP1,NRP2,NTRK1,NTRK2,PDGFRA,PDGFRB,PDGFRL,ROR1,RYK,TRIM27,TYRO3	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
GO:0004715	GO	MF	non-membrane spanning protein tyrosine kinase activity	ABL1,ABL2,BLK,BMX,BTK,CLK1,DYRK1A,FER,FES,FGR,FYN,ITK,LYN,MELK,PEAK1,PKDCC,PTK2,PTK2B,PTK6,SRC,SYK,TEC,TNK1,YES1,ZAP70	Catalysis of the reaction: ATP + a non-membrane spanning protein L-tyrosine = ADP + a non-membrane spanning protein L-tyrosine phosphate.
GO:0004721	GO	MF	phosphoprotein phosphatase activity	CAMK2G,CDC14A,CDC14B,CDC25B,CDC25C,CDKN3,CTDNEP1,CTDP1,CTDSP1,CTDSP2,CYCS,DLG1,DLGAP5,DUSP1,DUSP10,DUSP16,DUSP18,DUSP2,DUSP21,DUSP26,DUSP3,DUSP4,DUSP6,DUSP7,DUSP9,EPM2A,EYA1,EYA2,EYA3,LCK,MTM1,MTMR2,MTMR3,MTMR4,MTMR6,PDP1,PDXP,PGAM5,PGP,PLPP2,PLPP3,PPEF1,PPEF2,PPM1A,PPM1B,PPM1D,PPM1E,PPM1F,PPM1G,PPM1H,PPM1K,PPM1L,PPM1M,PPP1CA,PPP1CB,PPP1CC,PPP1R3C,PPP1R3D,PPP2CB,PPP2R2A,PPP2R3B,PPP2R5D,PPP3CA,PPP3CB,PPP3R1,PPP4C,PPP4R1,PPP5C,PPP6C,PTEN,PTP4A1,PTP4A2,PTP4A3,PTPN1,PTPN11,PTPN12,PTPN13,PTPN14,PTPN2,PTPN22,PTPN23,PTPN3,PTPN5,PTPN6,PTPN9,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRS,PTPRT,PTPRU,PTPRZ1,RPAP2,SBF1,SSH1,SSH2,SSU72,TIMM50,UBLCP1	Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
GO:0004722	GO	MF	protein serine/threonine phosphatase activity	CAMK2G,CDC14A,CDC14B,CDKN3,CTDNEP1,CTDP1,CTDSP1,CTDSP2,CYCS,EPM2A,LCK,MTMR3,MTMR4,MTMR6,PDP1,PGAM5,PPEF1,PPEF2,PPM1A,PPM1B,PPM1D,PPM1E,PPM1F,PPM1G,PPM1K,PPM1L,PPM1M,PPP1CA,PPP1CB,PPP1CC,PPP1R3C,PPP1R3D,PPP2CB,PPP2R2A,PPP2R3B,PPP2R5D,PPP3CA,PPP3CB,PPP3R1,PPP4C,PPP5C,PPP6C,PTEN,RPAP2,SSU72,TIMM50,UBLCP1	Catalysis of the reaction: protein serine phosphate + H2O = protein serine + phosphate, and protein threonine phosphate + H2O = protein threonine + phosphate.
GO:0004723	GO	MF	calcium-dependent protein serine/threonine phosphatase activity	CAMK2G,PPM1A,PPM1F,PPP3CA,PPP3CB,PPP3R1	Catalysis of the reactions: protein serine phosphate + H2O = protein serine + phosphate; and protein threonine phosphate + H2O = protein threonine + phosphate. These reactions require the presence of calcium ions.
GO:0004725	GO	MF	protein tyrosine phosphatase activity	CDC14B,CDC25B,CDC25C,CDKN3,DUSP1,DUSP18,DUSP21,DUSP26,DUSP3,EPM2A,EYA1,EYA2,EYA3,MTMR3,MTMR6,PGP,PTEN,PTP4A1,PTP4A2,PTP4A3,PTPN1,PTPN11,PTPN12,PTPN13,PTPN14,PTPN2,PTPN22,PTPN23,PTPN3,PTPN5,PTPN6,PTPN9,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRS,PTPRT,PTPRU,PTPRZ1,TIMM50	Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
GO:0004738	GO	MF	pyruvate dehydrogenase activity	DLAT,DLD,PDHA1,PDHA2,PDHB,PDHX	Catalysis of the oxidative decarboxylation of pyruvate.
GO:0004745	GO	MF	retinol dehydrogenase activity	ADH4,ADH7,AKR1C3,BMP2,DHRS9,RDH10,RDH11,RDH12,RDH16,RDH5,RDH8,SDR16C5,SDR9C7	Catalysis of the reaction: retinol + NAD+ = retinal + NADH + H+.
GO:0004758	GO	MF	serine C-palmitoyltransferase activity	SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB	Catalysis of the reaction: L-serine + H(+) + palmitoyl-CoA = 3-dehydrosphinganine + CO(2) + CoA.
GO:0004806	GO	MF	triglyceride lipase activity	AADAC,AOAH,CEL,LIPC,LIPF,LPL,PNLIP,PNLIPRP1,PNLIPRP2,PNPLA2,PNPLA3	Catalysis of the reaction: triacylglycerol + H2O = diacylglycerol + a carboxylate.
GO:0004812	GO	MF	aminoacyl-tRNA ligase activity	AARS2,CARS,DARS2,EARS2,EPRS,FARS2,GARS,HARS,HARS2,IARS,KARS,LARS,LARS2,MARS,MARS2,NARS2,QARS,RARS,SARS,SARS2,TARS,VARS,WARS,YARS,YARS2	Catalysis of the formation of aminoacyl-tRNA from ATP, amino acid, and tRNA with the release of diphosphate and AMP.
GO:0004843	GO	MF	ubiquitin-specific protease activity	ATXN3,ATXN3L,BAP1,BRCC3,COPS5,CYLD,EIF3F,JOSD2,MYSM1,OTUB1,OTUB2,OTUD1,OTUD3,OTUD4,OTUD5,OTUD6A,OTUD7A,OTUD7B,OTULIN,STAMBP,TNFAIP3,TNIP1,UCHL5,UFD1L,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP17L2,USP18,USP19,USP2,USP21,USP22,USP25,USP28,USP3,USP30,USP31,USP33,USP34,USP35,USP36,USP37,USP38,USP4,USP42,USP44,USP45,USP46,USP47,USP49,USP5,USP51,USP6,USP7,USP8,USP9X,USP9Y,VCPIP1,YOD1,ZRANB1	Catalysis of the thiol-dependent hydrolysis of a peptide bond formed by the C-terminal glycine of ubiquitin and another protein.
GO:0004859	GO	MF	phospholipase inhibitor activity	ANGPTL3,ANXA1,ANXA2,ANXA4,ANXA5,APOC1,PDC,SNCB	Stops, prevents or reduces the activity of a phospholipase, an enzyme that catalyzes of the hydrolysis of a phospholipid.
GO:0004860	GO	MF	protein kinase inhibitor activity	CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CIB1,DNAJC3,DUS2,DUSP19,FGFR1OP,GMFB,GMFG,GNB2L1,H2AFY,HEXIM1,HEXIM2,HSPB1,HYAL2,IBTK,INCA1,KAT2B,MAPK8IP1,MBIP,NCK1,NPM1,PKIA,PPP1R1B,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKRIP1,SFN,SH3BP5,SOCS1,SOCS3,SPRED1,SPRED2,SPRY2,TAOK3,TRIB1,YWHAG	Stops, prevents or reduces the activity of a protein kinase, an enzyme which phosphorylates a protein.
GO:0004861	GO	MF	cyclin-dependent protein serine/threonine kinase inhibitor activity	CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,HEXIM1,HEXIM2,INCA1,KAT2B	Stops, prevents or reduces the activity of a cyclin-dependent protein serine/threonine kinase.
GO:0004862	GO	MF	cAMP-dependent protein kinase inhibitor activity	PKIA,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B	Stops, prevents or reduces the activity of a cAMP-dependent protein kinase.
GO:0004864	GO	MF	protein phosphatase inhibitor activity	CABIN1,LMTK2,PPME1,PPP1R1A,PPP1R1B,PPP1R1C,PPP1R2,PPP1R8,PPP1R9B,PTN,SAG,SET	Stops, prevents or reduces the activity of a protein phosphatase, an enzyme that hydrolyzes phosphate groups from phosphorylated proteins.
GO:0004866	GO	MF	endopeptidase inhibitor activity	A2M,AGT,AMBP,APP,AVP,BIRC5,BIRC6,BIRC7,BST2,CAST,CD27,COL4A3,CRB2,CST3,CST4,CST5,CST7,CSTA,CSTB,DPEP1,FETUB,FURIN,GAS6,ITIH2,ITIH3,ITIH4,KNG1,LCN1,LEF1,LPA,MT3,NGF,NOL3,PCSK1N,PI3,PRDX3,PRDX5,PROL1,PROS1,PSMF1,PTTG1,PZP,RECK,RENBP,RPS6KA1,RPS6KA3,SERPINA1,SERPINA3,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB8,SERPINB9,SERPINC1,SERPIND1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SLPI,SNCA,SPINK1,SPINK2,SPINK5,SPINK9,SPINT2,SPOCK1,SPOCK3,SPP2,TFAP2B,TFPI,TIMP1,TIMP3,TIMP4,TNFAIP8,TNFSF14,UCHL5,USP14,VIL1,WFDC12,WFDC2,XIAP	Stops, prevents or reduces the activity of an endopeptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides.
GO:0004867	GO	MF	serine-type endopeptidase inhibitor activity	A2M,AGT,AMBP,APP,FURIN,SERPINA1,SERPINA3,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB8,SERPINB9,SERPINC1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SLPI,SPINK5,SPINK9,SPINT2,SPOCK1,WFDC12,WFDC2	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
GO:0004869	GO	MF	cysteine-type endopeptidase inhibitor activity	AVP,BIRC5,BIRC6,BIRC7,CD27,CST3,CST4,CST5,CSTA,CSTB,DPEP1,GAS6,KNG1,LCN1,LEF1,MT3,NOL3,PRDX3,PRDX5,PTTG1,RPS6KA1,RPS6KA3,SERPINB13,SERPINB3,SERPINB9,SNCA,SPOCK1,TFAP2B,TNFAIP8,TNFSF14,VIL1,XIAP	Stops, prevents or reduces the activity of a cysteine-type endopeptidase, any enzyme that hydrolyzes peptide bonds in polypeptides by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.
GO:0004879	GO	MF	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	AHR,AR,BRD8,ESR1,ESR2,ESRRA,ESRRB,GLMP,GPER1,NKX3-1,NR0B1,NR1D1,NR1D2,NR1H3,NR1H4,NR1I2,NR1I3,NR2E3,NR2F2,NR2F6,NR4A2,NR4A3,NR5A1,NR5A2,NR6A1,PPARA,PPARD,PPARG,PTGER3,RARA,RXRA,RXRB,STAT3,THRA,THRB,VDR	Combining with a signal and transmitting the signal to the transcriptional machinery by interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II.
GO:0004887	GO	MF	thyroid hormone receptor activity	BRD8,NR2F6,NR4A3,THRA,THRB	Combining with thyroid hormone and transmitting the signal to the transcriptional machinery by interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II.
GO:0004889	GO	MF	acetylcholine-activated cation-selective channel activity	CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CHRNB4	Enables the transmembrane transfer of a cation by a channel that opens upon binding acetylcholine.
GO:0004890	GO	MF	GABA-A receptor activity	GABRB1,GABRB2,GABRB3,GABRG2,GABRR3	Combining with the amino acid gamma-aminobutyric acid (GABA, 4-aminobutyrate) to initiate a change in cell activity. GABA-A receptors function as chloride channels.
GO:0004896	GO	MF	cytokine receptor activity	ACKR2,ACKR3,ACKR4,CCR1,CCR2,CCR3,CCR4,CCR5,CCR6,CCR7,CCR8,CCR9,CD44,CD74,CMKLR1,CNTFR,CSF2RB,CX3CR1,CXCR1,CXCR2,CXCR3,CXCR4,EPOR,FLT3,GFRA1,GPR17,GPR75,IFNAR1,IFNAR2,IFNGR1,IFNGR2,IFNLR1,IL10RB,IL12RB1,IL12RB2,IL13RA2,IL15RA,IL17RA,IL17RB,IL17RC,IL1R1,IL1R2,IL1RAPL2,IL1RL1,IL1RL2,IL21R,IL22RA1,IL22RA2,IL23R,IL2RB,IL2RG,IL31RA,IL3RA,IL4R,IL5RA,IL6R,IL6ST,IL7R,IL9R,LEPR,LIFR,MPL,OSMR,PRLR	Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0004904	GO	MF	interferon receptor activity	IFNAR1,IFNAR2,IFNGR1,IFNGR2,IL22RA1	Combining with an interferon and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0004931	GO	MF	extracellular ATP-gated cation channel activity	P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7	Enables the transmembrane transfer of a cation by a channel that opens when extracellular ATP has been bound by the channel complex or one of its constituent parts.
GO:0004935	GO	MF	adrenergic receptor activity	ADRA1A,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3	Combining with epinephrine or norepinephrine and transmitting the signal across the membrane by activating the alpha-subunit of an associated heterotrimeric G-protein complex.
GO:0004950	GO	MF	chemokine receptor activity	ACKR2,ACKR3,ACKR4,CCR1,CCR2,CCR3,CCR4,CCR5,CCR6,CCR7,CCR8,CCR9,CMKLR1,CX3CR1,CXCR1,CXCR2,CXCR3,CXCR4,GPR17,GPR75	Combining with a chemokine, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Chemokines are a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria.
GO:0004952	GO	MF	dopamine neurotransmitter receptor activity	DRD1,DRD2,DRD3,DRD4,DRD5	Combining with the neurotransmitter dopamine to initiate a change in cell activity.
GO:0004953	GO	MF	icosanoid receptor activity	CYSLTR1,CYSLTR2,HPGD,LTB4R,LTB4R2,PPARG,PTGDR,PTGDR2,PTGER3,PTGER4,PTGFR,TBXA2R	Combining with an icosanoid to initiate a change in cell activity.
GO:0004954	GO	MF	prostanoid receptor activity	HPGD,PPARG,PTGDR,PTGDR2,PTGER3,PTGER4,PTGFR,TBXA2R	Combining with a prostanoid, any compound based on or derived from the prostanoate structure, to initiate a change in cell activity.
GO:0004955	GO	MF	prostaglandin receptor activity	HPGD,PPARG,PTGDR,PTGDR2,PTGER3,PTGER4,PTGFR	Combining with a prostaglandin (PG) to initiate a change in cell activity.
GO:0004970	GO	MF	ionotropic glutamate receptor activity	GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN3A,PTK2B	Catalysis of the transmembrane transfer of an ion by a channel that opens when glutamate has been bound by the channel complex or one of its constituent parts.
GO:0004977	GO	MF	melanocortin receptor activity	MC1R,MC2R,MC3R,MC4R,OPRM1	Combining with melanocortin to initiate a change in cell activity.
GO:0004984	GO	MF	olfactory receptor activity	OR10A3,OR10A5,OR1C1,OR1D2,OR1E1,OR1Q1,OR2D2,OR2M4,OR2S2,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR7A5,OR8B8,OR8G1	Combining with an odorant and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity in response to detection of smell.
GO:0004985	GO	MF	opioid receptor activity	NPBWR1,NPBWR2,OGFR,OPRD1,OPRK1,OPRL1,OPRM1	Combining with an opioid (any narcotic derived from or resembling opium), and transmitting the signal across the membrane by activating an associated G-protein.
GO:0004993	GO	MF	G-protein coupled serotonin receptor activity	HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,HTR4,HTR5A	Combining with the biogenic amine serotonin and transmitting the signal across the membrane by activating an associated G-protein. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates.
GO:0005001	GO	MF	transmembrane receptor protein tyrosine phosphatase activity	PTPN6,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRS,PTPRU,PTPRZ1	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
GO:0005003	GO	MF	ephrin receptor activity	EFNA3,EFNA4,EFNB3,EPHA1,EPHA10,EPHA3,EPHA4,EPHA5,EPHA7,EPHA8,EPHB1,EPHB2,EPHB3,EPHB4	Combining with an ephrin to initiate a change in cell activity.
GO:0005004	GO	MF	GPI-linked ephrin receptor activity	EPHA3,EPHA4,EPHA5,EPHA7,EPHA8	Combining with a GPI-anchored ephrin to initiate a change in cell activity.
GO:0005005	GO	MF	transmembrane-ephrin receptor activity	EFNA3,EFNA4,EFNB3,EPHA1,EPHA10,EPHA4,EPHA5,EPHB1,EPHB2	Combining with a transmembrane ephrin to initiate a change in cell activity.
GO:0005007	GO	MF	fibroblast growth factor-activated receptor activity	FGFR1,FGFR2,FGFR3,FGFR4,FGFRL1	Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
GO:0005021	GO	MF	vascular endothelial growth factor-activated receptor activity	FLT1,FLT3,FLT4,KDR,NRP1,NRP2,PDGFRA	Combining with a vascular endothelial growth factor (VEGF) and transmitting the signal across the plasma membrane to initiate a change in cell activity.
GO:0005024	GO	MF	transforming growth factor beta-activated receptor activity	ACVRL1,ENG,LTBP1,LTBP4,TGFBR1,TGFBR2,TGFBR3	Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
GO:0005031	GO	MF	tumor necrosis factor-activated receptor activity	EDA2R,TNFRSF11A,TNFRSF14,TNFRSF18,TNFRSF19,TNFRSF1A,TNFRSF25	Combining with tumor necrosis factor, a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function.
GO:0005035	GO	MF	death receptor activity	EDA2R,TNFRSF10A,TNFRSF11A,TNFRSF14,TNFRSF18,TNFRSF19,TNFRSF1A,TNFRSF25	Combining with an extracellular messenger (called a death ligand), and transmitting the signal from one side of the plasma membrane to the other to initiate apoptotic or necrotic cell death.
GO:0005041	GO	MF	low-density lipoprotein receptor activity	CD36,CXCL16,LDLR,LRP12,LRP6,STAB1,STAB2,VLDLR	Combining with a low-density lipoprotein particle and delivering the low-density lipoprotein into the cell via endocytosis.
GO:0005044	GO	MF	scavenger receptor activity	ACKR2,ACKR3,CD163,COLEC12,CXCL16,DMBT1,SCARA3,SCARF1,SSC5D,STAB1,STAB2	Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
GO:0005048	GO	MF	signal sequence binding	AP2B1,AP2M1,BRAP,BRE,CABP1,CEMIP,KCNIP2,KDELR1,KDELR2,KPNA1,KPNA2,KPNA3,KPNB1,PEX19,PEX5,PEX5L,PEX7,SRP54,TNPO1,TNPO2	Interacting selectively and non-covalently with a signal sequence, a specific peptide sequence found on protein precursors or mature proteins that dictates where the mature protein is localized.
GO:0005057	GO	MF	receptor signaling protein activity	ADRB1,ALK,ARF1,BAG1,BAG4,CD19,CD3E,CDKN1B,DAXX,DCLK1,EGFR,ENG,FCGR1A,FKBP1B,FLRT1,FLRT2,FLRT3,GNAZ,IFITM1,IKBKE,IL1RL1,IL4R,INSR,IRAK1,ITPR1,ITPR3,KDR,LYN,MAP3K1,MAP3K10,MAP3K11,MAP3K13,MAP3K14,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAPK10,MAPK11,MAPK13,MAPK14,MAPK15,MAPK3,MAPK6,MAPK8,MAPK9,MOS,NCR1,NLK,NSMAF,PDCL,PGAM5,PIP4K2B,PKD2,PLCE1,PLCG1,PPP4C,RGS14,RYR1,RYR2,RYR3,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD6,SMAD7,SMAD9,STK10,STK39,TGFB2,TGFBR1,TPCN1,TPCN2,TRPA1,TYRO3,TYROBP	Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell.
GO:0005068	GO	MF	transmembrane receptor protein tyrosine kinase adaptor activity	BLNK,FRS2,GAB2,IRS1,PIK3R1,SHC1,STAP1,TRAT1	The binding activity of a molecule that brings together a transmembrane receptor protein tyrosine kinase and one or more other molecules, permitting them to function in a coordinated way.
GO:0005070	GO	MF	SH3/SH2 adaptor activity	ARHGAP1,ARHGAP4,ARHGAP6,BLNK,CD28,CHN1,CHN2,CLNK,CNTNAP1,CRKL,EPS8,GAB1,GRAP,GRAP2,GRB2,GRB7,IRS4,ITSN2,LASP1,LAT,NCK1,NCK2,PAG1,RUSC1,SH2B2,SH2D1A,SH2D2A,SH2D3A,SH2D3C,SH3BGR,SH3BGRL,SH3BP2,SHB,SKAP1,SKAP2,SLA,SLA2,SOCS2,SORBS1,SRC,STAM,TOB1,TP53BP2,VAV3	Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
GO:0005072	GO	MF	transforming growth factor beta receptor, cytoplasmic mediator activity	CDKN1B,ENG,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD6,SMAD7,SMAD9	Activity of any of the molecules that transmit the signal from a TGF-beta receptor through the cytoplasm to the nucleus.
GO:0005080	GO	MF	protein kinase C binding	ADAM9,AVPR1A,AVPR1B,DACT1,DACT2,DACT3,GNB2L1,GRK5,HINT1,HSPB1,IRS1,ITGAV,PDLIM5,PICK1,PLEK,TRPV4,UGT1A10,UGT1A7	Interacting selectively and non-covalently with protein kinase C.
GO:0005085	GO	MF	guanyl-nucleotide exchange factor activity	ADRB1,ALS2,ANKRD27,ARFGEF1,ARFGEF2,ARHGEF10,ARHGEF11,ARHGEF15,ARHGEF16,ARHGEF17,ARHGEF18,ARHGEF2,ARHGEF4,ARHGEF5,ARHGEF6,ARHGEF7,CYTH1,CYTH2,CYTH3,CYTH4,DENND1A,DENND1B,DENND1C,DENND2A,DENND2C,DENND2D,DENND3,DENND4A,DENND4B,DENND4C,DENND5A,DENND5B,DENND6A,DENND6B,DIS3,DOCK2,DOCK5,ECT2,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EPS8L1,EPS8L2,FARP1,FARP2,FFAR1,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FNIP1,GAPVD1,GBF1,GCGR,HERC1,HERC2,ITSN1,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MADD,NET1,P2RY12,PLCE1,PREX1,PREX2,PTGIR,RAB3GAP1,RAB3GAP2,RAB3IL1,RAB3IP,RABGEF1,RABIF,RALGPS1,RANGRF,RAP1A,RAPGEF1,RAPGEF2,RAPGEF3,RAPGEF4,RAPGEF5,RAPGEF6,RASGEF1A,RASGEF1B,RASGRF1,RASGRP1,RASGRP2,RASGRP3,RASGRP4,RCBTB2,RCC1,RGL1,RGL2,RGP1,RIC1,RIN2,RIN3,RINL,SBF1,SBF2,SERGEF,SOS1,SPATA13,ST5,TBXA2R,TIAM1,TIAM2,TRIO,VAV1,VAV2,VAV3	Stimulates the exchange of guanyl nucleotides associated with a GTPase. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0005086	GO	MF	ARF guanyl-nucleotide exchange factor activity	ARFGEF2,CYTH1,CYTH2,CYTH3,CYTH4,HERC1	Stimulates the exchange of guanyl nucleotides associated with the GTPase ARF. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0005087	GO	MF	Ran guanyl-nucleotide exchange factor activity	ALS2,RANGRF,RCBTB2,RCC1,SERGEF	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ran family. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0005088	GO	MF	Ras guanyl-nucleotide exchange factor activity	ADRB1,ALS2,ARHGEF10,ARHGEF11,ARHGEF15,ARHGEF16,ARHGEF2,ARHGEF4,ARHGEF6,DENND1A,DENND1B,DENND1C,DENND2A,DENND2C,DENND2D,DENND3,DENND4A,DENND4B,DENND4C,DENND5A,DENND5B,DENND6A,DENND6B,DOCK2,ECT2,EPS8L1,EPS8L2,FARP1,FARP2,MADD,PREX1,PREX2,RAB3GAP1,RAB3GAP2,RAB3IL1,RAB3IP,RABGEF1,RALGPS1,RANGRF,RAP1A,RAPGEF1,RAPGEF2,RAPGEF3,RAPGEF4,RAPGEF5,RASGEF1A,RASGEF1B,RASGRF1,RASGRP1,RASGRP4,RCBTB2,RCC1,RGL1,RGL2,RGP1,RIC1,RIN2,RIN3,SBF1,SBF2,SERGEF,SOS1,SPATA13,ST5,TIAM1	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0005089	GO	MF	Rho guanyl-nucleotide exchange factor activity	ALS2,ARHGEF10,ARHGEF11,ARHGEF15,ARHGEF16,ARHGEF2,ARHGEF4,ARHGEF6,DOCK2,ECT2,EPS8L1,EPS8L2,FARP1,FARP2,PREX1,PREX2,SPATA13,TIAM1	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Rho family. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0005092	GO	MF	GDP-dissociation inhibitor activity	GDI1,GPSM2,ITGB1BP1,RANBP1,RGS14,SH3BP4	Prevents the dissociation of GDP from a GTPase, thereby preventing GTP from binding.
GO:0005095	GO	MF	GTPase inhibitor activity	ARL2,CDC42SE1,CPEB2,GPS1,GPS2,IPO5,IQGAP1,IQGAP2,PDE6D,RHOH,RTKN,SLIT2,TNK2	Stops, prevents or reduces the activity of any enzyme that catalyzes the hydrolysis of GTP to GDP and orthophosphate.
GO:0005096	GO	MF	GTPase activator activity	ADAP1,ADGRB3,ALDH1A1,ARAP1,ARAP3,ARFGAP1,ARFGAP3,ARHGAP1,ARHGAP15,ARHGAP18,ARHGAP26,ARHGAP27,ARHGAP35,ARHGAP8,ARHGAP9,ARHGEF10L,ARHGEF6,ARRB1,ASAP3,BNIP2,CDC42EP2,DEPDC5,DLC1,DOCK4,ECT2,ELMOD1,ELMOD2,ERRFI1,EVI5,EVI5L,GMIP,GNAQ,GNB5,HACD3,HTR2B,JUN,LLGL1,LRRK2,MYO9B,NCKAP1L,NF1,NPRL2,NPRL3,OCRL,PGAM5,PLCB1,PREX1,PREX2,RAB3GAP1,RABGAP1,RABGAP1L,RACGAP1,RALBP1,RALGAPA1,RALGAPA2,RALGAPB,RAP1GAP,RAP1GDS1,RAPGEF2,RASA4,RASGRP3,RGS1,RGS10,RGS11,RGS14,RGS16,RGS2,RGS20,RGS3,RGS4,RGS5,RGS6,RGS7,RGS8,RP2,SGSM2,SGSM3,SH3BGRL3,SIPA1,SOS1,SRGAP2,SYDE1,SYDE2,TBC1D10B,TBC1D15,TBC1D16,TBC1D2,TBC1D20,TBC1D25,TBC1D30,TBC1D7,TBCD,THY1,TSC2,USP6NL,VAV3,WNT11	Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.
GO:0005104	GO	MF	fibroblast growth factor receptor binding	FGF10,FGF17,FGF18,FGF5,FGF8,NPTN	Interacting selectively and non-covalently with the fibroblast growth factor receptor (FGFR).
GO:0005112	GO	MF	Notch binding	AAK1,ADAM17,CHAC1,DLL3,DTX1,GALNT11,JAG1	Interacting selectively and non-covalently with the Notch (N) protein, a surface receptor.
GO:0005114	GO	MF	type II transforming growth factor beta receptor binding	BAMBI,ENG,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR3	Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
GO:0005123	GO	MF	death receptor binding	BID,CASP8AP2,FEM1B,MADD,MYD88,PIDD1,TMBIM1	Interacting selectively and non-covalently with any member of the death receptor (DR) family. The DR family falls within the tumor necrosis factor receptor superfamily and is characterized by a cytoplasmic region of ~80 residues termed the death domain (DD).
GO:0005125	GO	MF	cytokine activity	ADIPOQ,AIMP1,BMP4,C5,CCL11,CCL13,CCL19,CCL21,CCL23,CCL24,CCL25,CCL28,CCL3,CCL4,CCL5,CCL7,CKLF,CLCF1,CRLF1,CSF1,CSF3,CX3CL1,CXCL10,CXCL11,CXCL12,CXCL13,CXCL16,CXCL3,CXCL8,CXCL9,EDN1,FAM3B,FAM3C,FAM3D,FGF2,HMGB1,IFNB1,IFNL4,IL10,IL12A,IL12B,IL17F,IL18,IL19,IL1A,IL1B,IL2,IL26,IL33,IL6,INHA,INHBA,INHBB,LIF,MIF,NRG1,OSM,PF4,SCG2,SCGB3A1,SECTM1,SLURP1,TGFB1,TGFB2,TIMP1,TNF,TNFRSF11B,TNFSF11,TNFSF12,TXLNA,VEGFA,WNT1,WNT2,WNT7A,XCL1	Functions to control the survival, growth, differentiation and effector function of tissues and cells.
GO:0005126	GO	MF	cytokine receptor binding	BAMBI,BID,BRE,C5,CASP8AP2,CCL11,CCL13,CCL19,CCL2,CCL21,CCL23,CCL24,CCL25,CCL28,CCL3,CCL5,CCL7,CCR2,CKLF,CLCF1,CNTF,CREB3,CRLF1,CSF1,CSF3,CX3CL1,CXCL10,CXCL11,CXCL12,CXCL13,CXCL16,CXCL3,CXCL8,CXCL9,DNAJA3,EFNA5,ENG,ERAP1,FEM1B,FKBP1A,GH1,GREM1,IFNA14,IFNA16,IFNA17,IFNA2,IFNA21,IFNA4,IFNA5,IFNA7,IFNA8,IFNB1,IFNK,IFNW1,IL10,IL11,IL12A,IL12B,IL1B,IL1RN,IL2,IL20,IL21,IL22,IL23A,IL25,IL27,IL3,IL34,IL36A,IL36B,IL37,IL4,IL6,INHBC,ITGA5,ITGB3,JAK1,JAK2,LIF,MADD,MYD88,PF4,PIBF1,PIDD1,PRL,PXDN,S100A14,SDCBP,SMAD6,SOCS2,SPRED1,SPRED2,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1,TIMM50,TMBIM1,TNF,TNFSF11,TNFSF18,TNFSF4,TRAF2,TRAP1,TRIP6,XCL1,YARS	Interacting selectively and non-covalently with a cytokine receptor.
GO:0005132	GO	MF	type I interferon receptor binding	IFNA16,IFNA17,IFNA2,IFNA4,IFNA7,IFNB1,IFNK	Interacting selectively and non-covalently with an interferon-type I receptor, a heterodimeric complex composed of an alpha subunit (IFNAR1) and a beta subunit (IFNAR2).
GO:0005149	GO	MF	interleukin-1 receptor binding	ERAP1,IL1B,IL1RN,IL36A,IL36B,IL37,TRIP6	Interacting selectively and non-covalently with the interleukin-1 receptor.
GO:0005154	GO	MF	epidermal growth factor receptor binding	ARF4,CBLC,EFEMP1,EGF,EPGN,EREG,FER,SHC1,SNX1,SNX2,SNX4,TGFA,TNK2	Interacting selectively and non-covalently with the epidermal growth factor receptor.
GO:0005158	GO	MF	insulin receptor binding	ENPP1,GRB10,IGF1R,INS,INSL3,PHIP,SNX1,SNX2,SNX4,SORBS1	Interacting selectively and non-covalently with the insulin receptor.
GO:0005159	GO	MF	insulin-like growth factor receptor binding	IGF1,IGF2,INS,INSL4,INSR,YWHAH	Interacting selectively and non-covalently with the insulin-like growth factor receptor.
GO:0005160	GO	MF	transforming growth factor beta receptor binding	BAMBI,ENG,FKBP1A,INHBC,SMAD6,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1	Interacting selectively and non-covalently with the transforming growth factor beta receptor.
GO:0005161	GO	MF	platelet-derived growth factor receptor binding	FIGF,ITGA5,ITGB3,PDGFA,PDGFB,TYMP	Interacting selectively and non-covalently with the platelet-derived growth factor receptor.
GO:0005178	GO	MF	integrin binding	ACTN1,ACTN2,ACTN3,ACTN4,ADAM10,ADAM11,ADAM15,ADAM2,ADAM22,ADAM23,ADAM9,ADAMTS13,ADAMTS5,ADAMTS8,COL16A1,COL3A1,COL4A3,COL5A1,DMP1,ECM2,EGFL6,FBLN1,FBLN5,FCER2,FERMT3,FN1,ICAM1,ICAM4,IGF1,ITGB1BP1,LAMA5,LTBP4,MADCAM1,NPNT,SFRP2,SRC,TGFBI,THBS1,THBS4,TNXB,VCAM1,VTN	Interacting selectively and non-covalently with an integrin.
GO:0005179	GO	MF	hormone activity	ADCYAP1,ADIPOQ,AGRP,AGT,AMH,APELA,AVP,BMP10,C19orf80,CALCB,CCK,CCL25,CGA,CGB,CGB1,CGB2,CHGB,CORT,CRH,CSHL1,EDN1,EDN2,EDN3,FAM132A,FAM132B,FSHB,GAL,GHRH,GHRL,GNRH1,GRP,GUCA2A,HAMP,IGF1,INHA,INHBA,INHBB,INS,INSL6,METRNL,NMB,NPPA,NPPB,NPY,PENK,PNOC,POMC,PPY,PRLH,PYY,QRFP,SCT,SPX,SST,UCN,VIP	The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
GO:0005184	GO	MF	neuropeptide hormone activity	ADCYAP1,AGRP,AVP,CALCB,CCK,CORT,CRH,GAL,GRP,NPPA,NPY,PENK,PNOC,QRFP,SPX,UCN,VIP	The action characteristic of a neuropeptide hormone, any peptide hormone that acts in the central nervous system. A neuropeptide is any of several types of molecules found in brain tissue, composed of short chains of amino acids; they include endorphins, enkephalins, vasopressin, and others. They are often localized in axon terminals at synapses and are classified as putative neurotransmitters, although some are also hormones.
GO:0005200	GO	MF	structural constituent of cytoskeleton	ACTA1,ACTB,ACTG1,ACTL6B,ACTL7A,ACTL7B,ACTR2,ACTR3,ADD3,AGRN,ANK1,ANK3,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BFSP1,BFSP2,BICD1,CCDC6,CD2AP,CTNNA2,DES,DSP,EPB41,EPB41L3,EPB41L4B,EPB42,ERBB2IP,HIP1,INA,KRT14,KRT15,KRT16,KRT17,KRT19,KRT2,KRT20,KRT31,KRT5,KRT6A,KRT6B,KRT84,KRT9,LOR,MAPT,MSN,NEFH,NEFL,NEFM,PLS1,PPL,SORBS2,SORBS3,SPTA1,SPTAN1,SPTBN1,SPTBN2,SPTBN4,SYNM,TLN1,TPM1,TUBE1,TUBG1,TUBGCP3,TUBGCP4,VILL,VIM,YEATS4	The action of a molecule that contributes to the structural integrity of a cytoskeletal structure.
GO:0005201	GO	MF	extracellular matrix structural constituent	ACAN,AMELX,AMELY,ANOS1,BGN,CD4,CHI3L1,COL11A1,COL11A2,COL12A1,COL14A1,COL15A1,COL19A1,COL1A2,COL2A1,COL3A1,COL4A1,COL4A2,COL4A4,COL5A3,COL8A2,COL9A1,COL9A2,COL9A3,COMP,DSPP,EFEMP2,EMILIN2,FBLN1,FBLN2,FBN1,FBN2,IMPG1,IMPG2,LAMA1,LAMA4,LAMB1,LAMC1,LUM,MATN3,MEPE,MFAP5,MGP,MUC17,MUC3A,MUC4,MUC5AC,MUC6,OPTC,PXDN,STATH,TFPI2,TINAGL1,TUFT1	The action of a molecule that contributes to the structural integrity of the extracellular matrix.
GO:0005217	GO	MF	intracellular ligand-gated ion channel activity	AQP1,CFTR,CNGA3,CNGB1,CNGB3,FKBP1B,HCN1,HCN2,HCN4,ITPR1,ITPR3,KCNA10,PKD2,RYR1,RYR2,RYR3,TPCN1,TPCN2,TRPA1	Enables the transmembrane transfer of an ion by a channel that opens when a specific intracellular ligand has been bound by the channel complex or one of its constituent parts.
GO:0005218	GO	MF	intracellular ligand-gated calcium channel activity	FKBP1B,ITPR1,ITPR3,PKD2,RYR1,RYR2,RYR3,TPCN1,TPCN2,TRPA1	Enables the transmembrane transfer of a calcium ion by a channel that opens when a specific intracellular ligand has been bound by the channel complex or one of its constituent parts.
GO:0005221	GO	MF	intracellular cyclic nucleotide activated cation channel activity	AQP1,CNGA3,CNGB1,CNGB3,HCN1,HCN2,HCN4,KCNA10	Enables the transmembrane transfer of a cation by a channel that opens when intracellular cyclic nucleotide has been bound by the channel complex or one of its constituent parts.
GO:0005227	GO	MF	calcium activated cation channel activity	ANO1,ANO10,ANO6,CALHM1,CCT8L2,HPN,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,MTMR6,PKD2L1,TMEM63C,TRPM4	Enables the calcium concentration-regulatable energy-independent passage of cations across a lipid bilayer down a concentration gradient.
GO:0005229	GO	MF	intracellular calcium activated chloride channel activity	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,NMUR2,TTYH3	Enables the transmembrane transfer of chloride by a channel that opens in response to stimulus by a calcium ion or ions. Transport by a channel involves catalysis of facilitated diffusion of a solute (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel, without evidence for a carrier-mediated mechanism.
GO:0005230	GO	MF	extracellular ligand-gated ion channel activity	CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CHRNB4,GLRA1,GLRA2,GLRA3,GLRB,GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN3A,HTR3B,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,PTK2B,TRPV1	Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular ligand has been bound by the channel complex or one of its constituent parts.
GO:0005231	GO	MF	excitatory extracellular ligand-gated ion channel activity	CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CHRNB4,GLRA1,GLRA2,GLRA3,GLRB,HTR3B,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,TRPV1	Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular excitatory ligand has been bound by the channel complex or one of its constituent parts. Excitatory ligands, such as acetylcholine or glutamate, open cation-selective channels.
GO:0005242	GO	MF	inward rectifier potassium channel activity	KCNE2,KCNH2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK6,KCNQ5	Enables the transmembrane transfer of a potassium ion by an inwardly-rectifying voltage-gated channel. An inwardly rectifying current-voltage relation is one where at any given driving force the inward flow of K+ ions exceeds the outward flow for the opposite driving force. The inward-rectification is due to a voltage-dependent block of the channel pore by a specific ligand or ligands, and as a result the macroscopic conductance depends on the difference between membrane voltage and the K+ equilibrium potential rather than on membrane voltage itself.
GO:0005243	GO	MF	gap junction channel activity	GJA1,GJA10,GJA5,GJB3,GJD2,PANX1,PANX2,PANX3	A wide pore channel activity that enables a direct cytoplasmic connection from one cell to an adjacent cell. The gap junction can pass large solutes as well as electrical signals between cells. Gap junctions consist of two gap junction hemi-channels, or connexons, one contributed by each membrane through which the gap junction passes.
GO:0005244	GO	MF	voltage-gated ion channel activity	ANO1,ANO6,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,CALHM1,CLCN6,GAS6,GPR89A,HCN1,HCN2,HCN3,HCN4,HVCN1,IL1RAPL1,ITGAV,KCNA1,KCNA2,KCNA3,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK18,KCNK2,KCNK6,KCNMA1,KCNQ1,KCNQ2,KCNQ3,KCNQ5,KCNS1,KCNS3,NCS1,NOX1,OPRM1,PKD2,REST,RYR1,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,SLC17A3,TPCN2,VDAC1,VDAC2,VDAC3	Enables the transmembrane transfer of an ion by a voltage-gated channel. An ion is an atom or group of atoms carrying an electric charge by virtue of having gained or lost one or more electrons. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0005245	GO	MF	voltage-gated calcium channel activity	CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,GAS6,IL1RAPL1,ITGAV,NCS1,OPRM1,PKD2,RYR1,TPCN2	Enables the transmembrane transfer of a calcium ion by a voltage-gated channel. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0005246	GO	MF	calcium channel regulator activity	AMBP,CAV3,CCDC109B,FKBP1B,ITPR1,NPY,NPY2R,NRXN1,NRXN2,PACSIN3,PHPT1,PRKG1,SGK1,SGK3,SLC30A1,SRI,STIM1,STIM2,TMEM110	Modulates the activity of a calcium channel.
GO:0005248	GO	MF	voltage-gated sodium channel activity	HCN1,HCN2,HCN3,HCN4,PKD2,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A	Enables the transmembrane transfer of a sodium ion by a voltage-gated channel. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0005249	GO	MF	voltage-gated potassium channel activity	HCN1,HCN2,HCN3,HCN4,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK18,KCNK2,KCNK6,KCNMA1,KCNQ1,KCNQ2,KCNQ3,KCNQ5,KCNS1,KCNS3,REST	Enables the transmembrane transfer of a potassium ion by a voltage-gated channel. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0005251	GO	MF	delayed rectifier potassium channel activity	KCNA1,KCNA2,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNE1,KCNE2,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNQ1,KCNS1,KCNS3	Enables the transmembrane transfer of a potassium ion by a delayed rectifying voltage-gated channel. A delayed rectifying current-voltage relation is one where channel activation kinetics are time-dependent, and inactivation is slow.
GO:0005253	GO	MF	anion channel activity	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,BEST1,BEST2,BSND,CCT8L2,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,GPR89A,LRRC8A,NMUR2,SLC17A3,SLC1A4,SLC26A7,SLC26A8,SLC26A9,TTYH1,TTYH3,VDAC1,VDAC2,VDAC3	Enables the energy-independent passage of anions across a lipid bilayer down a concentration gradient.
GO:0005254	GO	MF	chloride channel activity	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,BEST1,BEST2,BSND,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR2,SLC1A4,SLC26A7,SLC26A8,SLC26A9,TTYH1,TTYH3	Enables the facilitated diffusion of a chloride (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
GO:0005261	GO	MF	cation channel activity	ABCC8,ANO1,ANO10,ANO6,AQP1,ASIC1,ASIC3,CACFD1,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,CALHM1,CCT8L2,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CHRNB4,CNGA3,CNGB1,CNGB3,CUL5,FKBP1B,GAR1,GAS6,GRIN1,GRIN3B,HCN1,HCN2,HCN3,HCN4,HPN,HTR3B,HVCN1,IL1RAPL1,ITGAV,ITPR1,ITPR3,JPH2,KCNA1,KCNA10,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNF1,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK10,KCNK13,KCNK16,KCNK17,KCNK18,KCNK2,KCNK3,KCNK4,KCNK5,KCNK6,KCNK7,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,KCNQ1,KCNQ2,KCNQ3,KCNQ4,KCNQ5,KCNS1,KCNS3,KCNU1,MCOLN1,MCU,MTMR6,NALCN,NCS1,NOX1,NOX5,OPRM1,ORAI1,P2RX1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,PANX1,PDE2A,PIEZO1,PKD1,PKD1L1,PKD1L3,PKD2,PKD2L1,PSEN1,RASA3,REST,RYR1,RYR2,RYR3,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHROOM2,SLC40A1,SLC4A11,STIM2,TMEM175,TMEM38A,TMEM38B,TMEM63C,TPCN1,TPCN2,TRPA1,TRPC1,TRPC3,TRPC4,TRPC5,TRPM1,TRPM3,TRPM4,TRPV1,TRPV2,TRPV4,TRPV5,TRPV6,ZP3	Enables the energy-independent passage of cations across a lipid bilayer down a concentration gradient.
GO:0005262	GO	MF	calcium channel activity	CACFD1,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,CUL5,FKBP1B,GAS6,GRIN1,GRIN3B,IL1RAPL1,ITGAV,ITPR1,ITPR3,JPH2,MCU,NCS1,OPRM1,ORAI1,P2RX1,PANX1,PDE2A,PKD1,PKD1L1,PKD2,PKD2L1,PSEN1,RASA3,RYR1,RYR2,RYR3,STIM2,TPCN1,TPCN2,TRPA1,TRPC1,TRPC3,TRPC4,TRPC5,TRPM1,TRPV1,TRPV4,TRPV5,TRPV6,ZP3	Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
GO:0005267	GO	MF	potassium channel activity	ABCC8,AQP1,CCT8L2,HCN1,HCN2,HCN3,HCN4,HPN,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNF1,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK10,KCNK13,KCNK16,KCNK17,KCNK18,KCNK2,KCNK3,KCNK4,KCNK5,KCNK6,KCNK7,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,KCNQ1,KCNQ2,KCNQ3,KCNQ4,KCNQ5,KCNS1,KCNS3,KCNU1,MTMR6,PKD2,PKD2L1,REST,TMEM175,TMEM38A,TMEM38B	Enables the facilitated diffusion of a potassium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
GO:0005272	GO	MF	sodium channel activity	ASIC1,ASIC3,HCN1,HCN2,HCN3,HCN4,KCNK1,NALCN,PKD2,PKD2L1,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHROOM2,SLC4A11	Enables the facilitated diffusion of a sodium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
GO:0005310	GO	MF	dicarboxylic acid transmembrane transporter activity	SLC13A2,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A22,SLC26A1,SLC26A6,SLC26A7,SLC26A8,SLC7A11	Enables the transfer of dicarboxylic acids from one side of the membrane to the other. A dicarboxylic acid is an organic acid with two COOH groups.
GO:0005313	GO	MF	L-glutamate transmembrane transporter activity	SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A7,SLC25A12,SLC25A13,SLC25A22,SLC7A11	Enables the transfer of L-glutamate from one side of a membrane to the other. L-glutamate is the anion of 2-aminopentanedioic acid.
GO:0005319	GO	MF	lipid transporter activity	ABCA1,ABCA12,ABCB11,ABCB4,ABCD1,ABCG1,ABCG4,ABCG5,ABCG8,AKR1C4,APOA1,APOA2,APOA4,APOB,APOC4,APOD,APOE,APOF,APOL3,APOM,ATP10A,ATP10D,ATP11B,ATP8B1,CETP,CFHR4,COL4A3BP,CPTP,GLTP,MFSD2A,MTTP,NPC1,OSBP,OSBPL5,OSBPL8,PCTP,PITPNA,PITPNC1,PITPNM1,PITPNM3,PLEKHA8,PLSCR1,PLSCR2,PLSCR4,PRELID1,PRELID3A,RBP4,SCP2,SFTPA1,SLC22A9,SLC27A4,SLCO2A1,TNFAIP8L3,TRIAP1	Enables the directed movement of lipids into, out of or within a cell, or between cells.
GO:0005326	GO	MF	neurotransmitter transporter activity	GABRQ,SLC18A3,SLC6A15,SLC6A16,SLC6A2,SLC6A4	Enables the directed movement of a neurotransmitter into, out of or within a cell, or between cells. Neurotransmitters are any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.
GO:0005337	GO	MF	nucleoside transmembrane transporter activity	SLC25A17,SLC25A24,SLC25A26,SLC25A42,SLC25A6,SLC28A1,SLC28A2,SLC35B2	Enables the transfer of a nucleoside, a nucleobase linked to either beta-D-ribofuranose (ribonucleoside) or 2-deoxy-beta-D-ribofuranose, (a deoxyribonucleotide) from one side of a membrane to the other.
GO:0005338	GO	MF	nucleotide-sugar transmembrane transporter activity	SLC35A1,SLC35A3,SLC35B1,SLC35B4,SLC35D1,SLC35D2	Enables the transfer of a nucleotide-sugar from one side of the membrane to the other. A nucleotide-sugar is any nucleotide in which the distal phosphoric residue of a nucleoside 5'-diphosphate is in glycosidic linkage with a monosaccharide or monosaccharide derivative.
GO:0005342	GO	MF	organic acid transmembrane transporter activity	ABCB11,AKR1C4,AQP9,CTNS,OCA2,PQLC2,SERINC1,SLC13A2,SLC16A1,SLC16A12,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC17A3,SLC17A5,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC22A12,SLC22A16,SLC22A4,SLC22A5,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC26A1,SLC26A6,SLC26A7,SLC26A8,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A7,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC6A14,SLC6A20,SLC6A5,SLC6A8,SLC6A9,SLC7A10,SLC7A11,SLC7A2,SLC7A4,SLC7A5,SLC7A6,SLC7A8,SLC7A9	Enables the transfer of organic acids, any acidic compound containing carbon in covalent linkage, from one side of the membrane to the other.
GO:0005343	GO	MF	organic acid:sodium symporter activity	SLC13A2,SLC23A1,SLC38A1,SLC6A5,SLC6A9	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: organic acid(out) + Na+(out) = organic acid(in) + Na+(in).
GO:0005346	GO	MF	purine ribonucleotide transmembrane transporter activity	SLC25A17,SLC25A24,SLC25A42,SLC25A6,SLC35B2	Enables the transfer of a purine ribonucleotide, any compound consisting of a purine ribonucleoside (a purine organic base attached to a ribose sugar) esterified with (ortho)phosphate, from one side of a membrane to the other.
GO:0005355	GO	MF	glucose transmembrane transporter activity	PPBP,SLC2A1,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC5A1,SLC5A2	Enables the transfer of the hexose monosaccharide glucose from one side of the membrane to the other.
GO:0005372	GO	MF	water transmembrane transporter activity	AQP1,AQP2,AQP3,AQP4,AQP5,AQP6,AQP7,AQP8,AQP9,MIP	Enables the directed movement of water (H2O) from one side of a membrane to the other.
GO:0005385	GO	MF	zinc ion transmembrane transporter activity	SLC11A2,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC39A11,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6	Enables the transfer of zinc (Zn) ions from one side of a membrane to the other.
GO:0005388	GO	MF	calcium-transporting ATPase activity	ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + Ca2+(cis) = ADP + phosphate + Ca2+(trans).
GO:0005391	GO	MF	sodium:potassium-exchanging ATPase activity	ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + Na+(in) + K+(out) = ADP + phosphate + Na+(out) + K+(in).
GO:0005432	GO	MF	calcium:sodium antiporter activity	SLC3A2,SLC8A1,SLC8A2,SLC8A3,SLC8B1	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Ca2+(in) + Na+(out) = Ca2+(out) + Na+(in).
GO:0005436	GO	MF	sodium:phosphate symporter activity	SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC34A2,SLC34A3	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Na+(out) + phosphate(out) = Na+(in) + phosphate(in).
GO:0005484	GO	MF	SNAP receptor activity	BET1L,BNIP1,GOSR1,SNAP29,STX16,STX17,STX5,VTI1A,YKT6	Acting as a marker to identify a membrane and interacting selectively with one or more SNAREs on another membrane to mediate membrane fusion.
GO:0005487	GO	MF	nucleocytoplasmic transporter activity	NUP107,NUP133,NUP153,NUP160,NUP62,RAN,RBM22,TPR,UPF3A,UPF3B,XPO1,XPO5	Enables the directed movement of substances between the nucleus and the cytoplasm of a cell.
GO:0005496	GO	MF	steroid binding	ABCA1,ABCG1,AKR1C1,AKR1C2,AKR1D1,ALDH1A1,ANXA6,APOA1,APOA2,APOC3,APOD,APOF,AR,ATP1A1,ATP1A2,ATP1A3,CAV1,CETP,CYP3A4,ERLIN1,ESR1,ESR2,GC,GPER1,GPR183,NPC1,NPC2,NR1H3,NR1H4,NR3C1,OSBP,OSBP2,OSBPL10,OSBPL1A,OSBPL2,OSBPL3,OSBPL5,OSBPL7,OSBPL8,PLA2G1B,PMP2,PROM2,PTCH1,PYGL,RORA,RORC,SCP2,SERPINA6,SHBG,SOAT1,SOAT2,STARD3,SYP,TSPO,TSPO2,UGT1A1,UGT1A8,VDR	Interacting selectively and non-covalently with a steroid, any of a large group of substances that have in common a ring system based on 1,2-cyclopentanoperhydrophenanthrene.
GO:0005501	GO	MF	retinoid binding	ADH4,ADH7,ALDH1A2,CRABP1,CRABP2,CYP26A1,CYP26B1,CYP26C1,LCN12,NR2F2,OPN4,PTGDS,RARA,RBP1,RBP2,RBP3,RBP4,RBP5,SERPINA5,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	Interacting selectively and non-covalently with retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
GO:0005504	GO	MF	fatty acid binding	ADH5,ALB,ALOX5AP,APOC1,FABP3,FABP4,FABP5,FFAR4,HNF4A,LPAR1,NDUFAB1,OXER1,PMP2,PPARD,PPARG,PTGDS,S100A8,S100A9,SCP2,STX3,UGT1A8,VIL1	Interacting selectively and non-covalently with fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
GO:0005506	GO	MF	iron ion binding	ACO2,ACP5,AGMO,ALKBH1,ALKBH2,ALKBH3,ALKBH8,ALOX15,ALOX15B,ALOX5,CYP3A4,DNAJC24,EGLN2,ETHE1,FBXL5,FDX1,FECH,FTH1,FTL,FTO,FXN,HAAO,HEPH,HIF1AN,ISCU,JMJD6,KDM3A,KDM7A,LCN2,LTF,MFI2,MIOX,NFU1,PHF2,PHF8,SCD,SNCA,TET1,TET2,TF,TYW5	Interacting selectively and non-covalently with iron (Fe) ions.
GO:0005507	GO	MF	copper ion binding	ACR,ALB,ANG,AOC1,AOC3,APOA4,ATOX1,ATP7A,ATP7B,CCS,COA6,COMMD1,COX17,CUTC,DCT,GPC1,HEPH,IL1A,LOXL3,MT3,P2RX4,PARK7,PRNP,RNF7,S100A12,S100A13,S100A5,SCO2,SNCA,SOD1,TP53,TYR	Interacting selectively and non-covalently with copper (Cu) ions.
GO:0005509	GO	MF	calcium ion binding	ADAM8,ADAMTS13,ADGRL3,AGRN,AIF1,ALOX15B,AMY2A,ANXA1,ANXA4,ANXA8,AOC1,AOC3,APCS,ARSA,ASPH,ASPN,ATP2A1,ATP2A2,ATP2B2,ATP2C1,BNIP2,BRAF,C2CD5,CABP4,CABP5,CABS1,CABYR,CALB1,CALM1,CALR,CALU,CAMKK2,CAPN3,CASQ1,CASQ2,CDH24,CDHR5,CDK5R1,CETN2,CHP1,CHP2,CIB1,CIB2,CIB3,CIB4,CLEC3B,COMP,CPNE1,CPNE6,CRACR2A,CRNN,CRP,CSN2,DHH,DMP1,DNASE1L2,DNASE1L3,DNER,DSG1,DSPP,DUOX2,DYSF,EML1,ENPP1,ENPP2,ESYT2,F9,FBLN1,FBN1,FKBP9,GALNT3,GCA,GRIN1,GRM7,GSN,HPCA,HPGDS,HRC,HSP90B1,HSPA5,IHH,IQGAP1,ITIH1,ITSN1,KCNIP1,KCNIP2,KCNIP4,LCP1,LRP1,LTBP4,MAN1B1,MAN1C1,MASP1,MCTP1,MCTP2,MELK,MEX3B,MICU1,MMP13,MYL2,NCS1,NDUFAB1,NOL3,NOTCH4,NRXN1,OCM,OCM2,OTOF,PADI4,PCLO,PDCD6,PGS1,PITPNM2,PITPNM3,PKD2,PKD2L1,PLA2G1B,PLA2G4A,PLA2G4B,PLSCR1,PLSCR2,PLSCR4,PNLIPRP1,PNLIPRP2,PON1,PPP3CA,PPP3CB,PPP3R1,PRF1,PRSS2,PRSS3,PSPH,RAPGEF2,RASGRP1,RASGRP2,RASGRP3,RET,RGN,RPH3A,RUNX1,S100A12,S100A13,S100A14,S100A16,S100A2,S100A5,S100A6,S100A7,S100A8,S100A9,S100B,SCGN,SCIN,SCUBE1,SDF4,SHH,SLC25A12,SLC25A13,SLC25A24,SLC8A1,SLIT1,SLIT2,SLIT3,SNCA,SNCB,SPARC,SPOCK1,SPOCK2,SRI,SRR,STIM1,STIM2,SYT11,TCHH,TESC,TGM3,THBS1,THBS3,THBS4,TNNC1,TPD52,TPM4,TPT1,TTN,VIL1	Interacting selectively and non-covalently with calcium ions (Ca2+).
GO:0005513	GO	BP	detection of calcium ion	ASPH,CALM1,CASQ2,CASR,KCNIP2,KCNMB2,KCNMB3,KCNMB4,RYR2,STIM1,SYT1	The series of events in which a calcium ion stimulus is received by a cell and converted into a molecular signal.
GO:0005516	GO	MF	calmodulin binding	ATP2B2,ATP2B4,ATPIF1,CAMK2G,CAMKK2,CAMSAP1,CFAP221,DAPK1,DAPK2,EEA1,EEF2K,GRIN1,IQCB1,KCNQ1,MIP,MYH3,MYLK2,MYO1D,MYO1E,MYO3A,MYO6,MYO7A,MYO9B,PPP3CA,PPP3CB,PPP3R1,RGS1,RGS16,RGS2,RGS4,RIT1,RYR1,RYR2,SPHK1,STRN,STRN3,STRN4,TRPV4,TRPV6,TTN,VAMP2	Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.
GO:0005518	GO	MF	collagen binding	ACHE,ADAM9,ANTXR1,C1QTNF1,CCBE1,CD44,CHADL,COCH,COL14A1,COL5A3,COMP,CTSB,CTSK,CTSL,CTSS,DDR1,DDR2,DSPP,FN1,GP6,ITGA1,ITGA10,ITGA11,ITGA2,ITGB1,LACRT,LRRC15,LUM,MMP13,MMP9,MRC2,NID1,NID2,P3H1,PCOLCE,PCOLCE2,PDGFA,PDGFB,PODN,PPIB,SERPINH1,SPARC,THBS1,USH2A,VWF	Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
GO:0005520	GO	MF	insulin-like growth factor binding	IGF1R,IGFALS,IGFBP1,IGFBP2,IGFBP3,ITGAV	Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
GO:0005521	GO	MF	lamin binding	BNIP3L,IFI27,LBR,PKP1,SUN2,TMPO	Interacting selectively and non-covalently with lamin; any of a group of intermediate-filament proteins that form the fibrous matrix on the inner surface of the nuclear envelope.
GO:0005523	GO	MF	tropomyosin binding	CALD1,S100A6,TNNT1,TNNT2,TNNT3	Interacting selectively and non-covalently with tropomyosin, a protein associated with actin filaments both in cytoplasm and, in association with troponin, in the thin filament of striated muscle.
GO:0005525	GO	MF	GTP binding	ADSS,ADSSL1,ANXA6,ARF4,ARF6,ARFIP2,ARHGEF5,ARL1,ARL2,ARL3,ARL4A,ARL8A,ARL8B,ATL1,CDC42,DIRAS1,DIRAS2,DNM2,EEF1A1,EIF2B2,GCH1,GEM,GIMAP7,GLUD1,GLUD2,GNAI1,GNAT1,GNAT2,GNL1,GNL2,GNL3,GTPBP4,HRAS,INSR,LANCL2,LRRK2,LSG1,MX2,NME1,NMUR2,NOA1,NUDT16,PCK1,RAB10,RAB11B,RAB13,RAB14,RAB1B,RAB21,RAB22A,RAB26,RAB27A,RAB27B,RAB28,RAB29,RAB2A,RAB31,RAB32,RAB35,RAB38,RAB39A,RAB4A,RAB5A,RAB6A,RAB7A,RAB8A,RAB9A,RAC1,RAC2,RALA,RALB,RAN,RANBP17,RAP1B,RAP2A,RAP2B,RAP2C,RHEB,RHEBL1,RHOA,RHOB,RHOH,RRAGA,RRAGB,RRAGC,SCG5,SEPHS1,SEPT12,SEPT6,SRP54,THG1L,TPX2,TRIM23	Interacting selectively and non-covalently with GTP, guanosine triphosphate.
GO:0005528	GO	MF	FK506 binding	FKBP1A,FKBP1B,FKBP2,FKBP3,FKBP4,NFATC1	Interacting selectively and non-covalently with the 23-membered macrolide lactone FK506.
GO:0005537	GO	MF	mannose binding	ACR,CD207,CD209,CLEC17A,CLN5,LMAN1,LMAN2,LMAN2L,MBL2	Interacting selectively and non-covalently with mannose, a monosaccharide hexose, stereoisomeric with glucose, that occurs naturally only in polymerized forms called mannans.
GO:0005539	GO	MF	glycosaminoglycan binding	AAMP,ADAMTSL5,ADGRE2,AGRN,ANG,AOC1,APOA5,APOB,APOE,AZU1,C1QBP,CD44,CEL,CEMIP,CFH,CLEC3B,COL13A1,COL25A1,COL5A1,COMP,CTSG,CXCL10,CXCL11,CXCL13,DPYSL3,ELANE,ENG,EPYC,FGF1,FGF10,FGF12,FGF14,FGFBP1,FGFBP3,FGFR1,FGFR4,FGFRL1,FN1,GREM2,HABP2,HBEGF,HRG,HYAL2,IMPG2,JCHAIN,KNG1,LAYN,LIPH,LIPI,LPA,LPL,LTBP4,LTF,MDK,MPO,NDNF,NLRP3,NOD1,NOD2,PAFAH1B1,PCOLCE,PCOLCE2,PCSK6,PDCD5,PF4,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,PODXL2,POSTN,REG4,RNASE7,SELL,SELP,SEMA5A,SERPINA5,SERPINE2,SFRP1,SLIT2,STAB2,TENM1,TGFBR2,TGFBR3,THBS1,THBS3,THBS4,TLR2,TNXB,VCAN,VEGFA,ZNF146	Interacting selectively and non-covalently with any glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
GO:0005540	GO	MF	hyaluronic acid binding	C1QBP,CD44,CEMIP,HYAL2,IMPG2,LAYN,STAB2	Interacting selectively and non-covalently with hyaluronic acid, a polymer composed of repeating dimeric units of glucuronic acid and N-acetyl glucosamine.
GO:0005542	GO	MF	folic acid binding	DHFR,FOLR1,FOLR2,MTHFS,TYMS	Interacting selectively and non-covalently with folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
GO:0005544	GO	MF	calcium-dependent phospholipid binding	ANXA1,ANXA2,ANXA3,ANXA4,ANXA5,ANXA6,ANXA8,C2CD5,CPNE1,CPNE3,DOC2B,DYSF,ESYT2,PCLO,PLA2G4A,PLA2G4B,RPH3A,SYT1,SYT11,SYT2,SYT3,SYT7	Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester, in the presence of calcium.
GO:0005545	GO	MF	1-phosphatidylinositol binding	EEA1,EPB41,FRMPD2,PICALM,PLEKHA4,PLEKHA5,SCARB1,SCIN,SNX10,SNX9,SYT1,WDFY1,WDFY3,ZFYVE1,ZFYVE16,ZFYVE9	Interacting selectively and non-covalently with phosphatidylinositol, any glycophospholipid with its sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
GO:0005546	GO	MF	phosphatidylinositol-4,5-bisphosphate binding	ACTN2,ADAP2,ALOX15,AMER1,AMER2,ANXA2,ANXA8,COMMD1,FAM21C,FCHO2,FRMPD4,JPH2,KCNJ1,KCNJ2,KCNQ1,KRIT1,LDLRAP1,MAPKAP1,MARK1,MYO1B,MYO1G,PARD3,PFN1,PFN2,PHLDA3,PLCB1,RAB35,RAG2,RPH3A,SCIN,SESTD1,SLC9A1,SNX18,SNX20,SNX21,SYTL2,TIRAP,TTPA,TULP1,TULP3,TWF1,TWF2,VIL1	Interacting selectively and non-covalently with phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions.
GO:0005547	GO	MF	phosphatidylinositol-3,4,5-trisphosphate binding	ADAP2,AKT1,ANXA8,ARAP1,ARAP2,ARAP3,ARHGAP9,BTK,COMMD1,CYTH3,DAPP1,FAM21C,FERMT2,GAB2,GBF1,IQGAP1,IQGAP2,JPH2,KIF16B,MAPKAP1,MYO10,MYO1B,MYO1G,OGT,PARD3,PHLDA3,RACGAP1,RAG2,ZFYVE1,ZFYVE16	Interacting selectively and non-covalently with phosphatidylinositol-3,4,5-trisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3', 4' and 5' positions.
GO:0005548	GO	MF	phospholipid transporter activity	ABCA1,ABCB4,ABCG1,ATP10A,ATP10D,ATP11B,ATP8B1,CETP,CPTP,MFSD2A,MTTP,OSBPL5,OSBPL8,PCTP,PITPNA,PITPNC1,PITPNM1,PITPNM3,PLSCR1,PLSCR2,PLSCR4,PRELID1,PRELID3A,SCP2,TNFAIP8L3,TRIAP1	Enables the directed movement of phospholipids into, out of or within a cell, or between cells. Phospholipids are a class of lipids containing phosphoric acid as a mono- or diester.
GO:0005577	GO	CC	fibrinogen complex	FBLN1,FGA,FGB,FGG,FGL1,FGL2,FN1,SERPINF2,THBS1	A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
GO:0005578	GO	CC	proteinaceous extracellular matrix	ACHE,ADAMTS10,ADAMTS13,ADAMTS3,ADAMTS9,ADAMTSL5,AGRN,AMELX,AMTN,ANG,ANOS1,APLP1,ASPN,BGN,CASK,CCBE1,CD151,CD248,CHI3L1,COL11A1,COL11A2,COL12A1,COL14A1,COL15A1,COL19A1,COL1A1,COL1A2,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A3,COL6A6,COL7A1,COL8A1,COL8A2,COLQ,CRISP3,DAG1,DGCR6,DST,ECM1,ECM2,EFEMP1,EFEMP2,ERBB2IP,FBLN1,FBN1,FBN2,FLRT1,FLRT2,FLRT3,FRAS1,FREM3,GPC1,GPLD1,HPSE2,IMPG1,IMPG2,KERA,LAMA1,LAMA2,LAMA3,LAMA4,LAMA5,LAMB1,LAMB2,LAMC1,LAMC3,LOXL2,LTBP1,LTBP2,LTBP4,LUM,MATN2,MFAP1,MFAP2,MFAP4,MGP,MMP11,MMP19,MMP25,MMP26,MMP28,MUC4,MUC5AC,NID1,NID2,NPNT,ODAM,P3H2,PI3,POSTN,SFRP1,SNCA,SPOCK2,TFPI2,TGFB1,THBS4,TINAG,TNXB,USH2A,VEGFA,WNT8A	A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.
GO:0005581	GO	CC	collagen trimer	COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL19A1,COL1A1,COL1A2,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A3,COL7A1,COL8A1,COL9A1,COL9A2,COL9A3,LUM,TNXB	A protein complex consisting of three collagen chains assembled into a left-handed triple helix. These trimers typically assemble into higher order structures.
GO:0005583	GO	CC	fibrillar collagen trimer	COL11A1,COL11A2,COL1A1,COL1A2,COL2A1,COL3A1,COL5A1,COL5A2,COL5A3,LUM,TNXB	Any triple helical collagen trimer that forms fibrils.
GO:0005587	GO	CC	collagen type IV trimer	COL4A1,COL4A2,COL4A3,COL4A4,COL4A6	A collagen heterotrimer containing type IV alpha chains; [alpha1(IV)]2alpha2(IV) trimers are commonly observed, although more type IV alpha chains exist and may be present in type IV trimers; type IV collagen triple helices associate to form 3 dimensional nets within basement membranes.
GO:0005593	GO	CC	FACIT collagen trimer	COL12A1,COL14A1,COL16A1,COL9A1,COL9A2,COL9A3	A collagen trimer that associates with collagen fibrils and consists of collagen monomers that contain two or more relatively short triple-helical domains connected by non-triple-helical sequences.
GO:0005604	GO	CC	basement membrane	ACHE,AGRN,AMTN,ANG,APLP1,CASK,CD151,COL15A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL8A1,COL8A2,COLQ,DAG1,DST,EFEMP2,ERBB2IP,FBN1,FRAS1,FREM3,LAMA1,LAMA2,LAMA3,LAMA4,LAMA5,LAMB1,LAMB2,LAMC1,LOXL2,NID1,NID2,P3H2,THBS4,TINAG,USH2A	A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
GO:0005605	GO	CC	basal lamina	ACHE,AGRN,AMTN,ANG,COL4A4,COLQ,LAMA1,LAMA4,LAMA5,LAMB1,LAMB2,LAMC1	A thin sheet of proteoglycans and glycoproteins, especially laminin, secreted by cells as an extracellular matrix.
GO:0005637	GO	CC	nuclear inner membrane	ATP11B,ATP1B4,C11orf85,C15orf43,CBX3,CCDC79,EMD,GHRHR,IFI27,LBR,LEMD2,LEMD3,MATR3,PSEN2,SIRT1,SMAD1,SMAD3,TMEM120B	The inner, i.e. lumen-facing, lipid bilayer of the nuclear envelope.
GO:0005640	GO	CC	nuclear outer membrane	DHCR7,EMD,GHRHR,GUCY2D,GUCY2F,ITPR3,PSEN1,RETSAT,SYNE4	The outer, i.e. cytoplasm-facing, lipid bilayer of the nuclear envelope; continuous with the endoplasmic reticulum of the cell and sometimes studded with ribosomes.
GO:0005643	GO	CC	nuclear pore	AAAS,AGFG1,AHCTF1,EIF5A,IPO4,IPO5,IPO7,KPNA1,KPNA3,KPNB1,MAD1L1,MAD2L1,MX2,NDC1,NUP107,NUP133,NUP153,NUP160,NUP205,NUP37,NUP43,NUP62,NUP85,NUP88,NUP93,NUP98,NUTF2,RAE1,RAN,RANBP17,RANBP2,RANGAP1,RGPD8,SEC13,SEH1L,SENP2,SNUPN,SUMO1,TNKS,TPR,XPO7,XPOT	Any of the numerous similar discrete openings in the nuclear envelope of a eukaryotic cell, where the inner and outer nuclear membranes are joined.
GO:0005655	GO	CC	nucleolar ribonuclease P complex	POP1,POP7,RPP30,RPP38,RPP40	A ribonuclease P complex located in the nucleolus of a eukaryotic cell, where it catalyzes the 5' endonucleolytic cleavage of precursor tRNAs to yield mature tRNAs. Eukaryotic nucleolar ribonuclease P complexes generally contain a single RNA molecule that is necessary but not sufficient for catalysis, and several protein molecules.
GO:0005657	GO	CC	replication fork	BAZ1B,BCAS2,BCL6,CDC5L,CHRAC1,ERCC5,HELB,MCM3,MMS22L,PCNA,PLRG1,POLA1,POLD3,POLE,POLE2,POLE3,POLE4,PRPF19,PURA,PURB,RAD18,RAD51B,RAD51C,RAD51D,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPA4,SMARCA5,SMARCAD1,SMARCAL1,TONSL,UBE2B,UHRF1,XPA,XRCC2,XRCC3,ZMIZ2,ZRANB3	The Y-shaped region of a replicating DNA molecule, resulting from the separation of the DNA strands and in which the synthesis of new strands takes place. Also includes associated protein complexes.
GO:0005662	GO	CC	DNA replication factor A complex	BCAS2,CDC5L,ERCC5,PLRG1,PRPF19,PURA,PURB,RPA1,RPA2,RPA3,RPA4,SMARCAL1,TONSL,XPA	A conserved heterotrimeric complex that binds nonspecifically to single-stranded DNA and is required for multiple processes in eukaryotic DNA metabolism, including DNA replication, DNA repair, and recombination. In all eukaryotic organisms examined the complex is composed of subunits of approximately 70, 30, and 14 kDa.
GO:0005663	GO	CC	DNA replication factor C complex	PCNA,RFC1,RFC2,RFC3,RFC4,RFC5	A complex that loads the DNA polymerase processivity factor proliferating cell nuclear antigen (PCNA) onto DNA, thereby permitting processive DNA synthesis catalyzed by DNA polymerase. In eukaryotes the complex consists of five polypeptides.
GO:0005664	GO	CC	nuclear origin of replication recognition complex	LRWD1,ORC1,ORC2,ORC3,ORC4,ORC5,REPIN1	A multisubunit complex that is located at the replication origins of a chromosome in the nucleus.
GO:0005665	GO	CC	DNA-directed RNA polymerase II, core complex	CHD6,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,PPARGC1A,URI1	RNA polymerase II, one of three nuclear DNA-directed RNA polymerases found in all eukaryotes, is a multisubunit complex; typically it produces mRNAs, snoRNAs, and some of the snRNAs. Two large subunits comprise the most conserved portion including the catalytic site and share similarity with other eukaryotic and bacterial multisubunit RNA polymerases. The largest subunit of RNA polymerase II contains an essential carboxyl-terminal domain (CTD) composed of a variable number of heptapeptide repeats (YSPTSPS). The remainder of the complex is composed of smaller subunits (generally ten or more), some of which are also found in RNA polymerases I and III. Although the core is competent to mediate ribonucleic acid synthesis, it requires additional factors to select the appropriate template.
GO:0005666	GO	CC	DNA-directed RNA polymerase III complex	POLR1C,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K	RNA polymerase III, one of three nuclear DNA-directed RNA polymerases found in all eukaryotes, is a multisubunit complex; typically it produces 5S rRNA, tRNAs and some of the small nuclear RNAs. Two large subunits comprise the most conserved portion including the catalytic site and share similarity with other eukaryotic and bacterial multisubunit RNA polymerases. The remainder of the complex is composed of smaller subunits (generally ten or more), some of which are also found in RNA polymerase I and others of which are also found in RNA polymerases I and II. Although the core is competent to mediate ribonucleic acid synthesis, it requires additional factors to select the appropriate template.
GO:0005667	GO	CC	transcription factor complex	AHR,ARNT,ASCC1,ATF1,ATF4,BEX1,BRF1,CCNH,CD3EAP,CDK7,CEBPA,CEBPB,CREB1,CTNNB1,DDIT3,E2F1,EDF1,EPAS1,ERCC2,ERCC3,ERCC5,FIGLA,FOXE3,FOXF1,FOXF2,FOXH1,GATA1,GATA4,GCM1,GFI1B,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6,HAND1,HAND2,HAX1,HCLS1,HDAC9,HES6,HIF1A,HIPK2,HMGA1,HNRNPAB,HOXA11,HYAL2,ING2,IVNS1ABP,KAT2A,KDM1A,LDB1,LEF1,LMO2,LMO4,MED17,MED23,MED27,MED7,MEF2A,MEF2B,MLXIPL,MMS19,MNAT1,MTA2,MYF5,MYF6,MYOD1,MYOG,NAA15,NAA16,NCOA6,NEUROD1,NFYA,NFYB,NFYC,NHLH2,NKX2-5,NONO,NR1H3,NR5A1,NR5A2,NR6A1,PARP1,PITX2,PMF1,POU5F1,PPARG,PRKDC,PRMT2,PTF1A,RARG,RB1,RELA,RFX3,RXRA,SCX,SFPQ,SIX1,SKI,SMAD2,SMAD3,SMAD4,SNAPC4,SNF8,SNW1,SOX17,SOX2,STAT3,SUB1,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF1B,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TAL1,TBP,TCF12,TCF3,TCF4,TCF7L2,TP53,TRIM28,TRRAP,USF1,VDR,WWOX,XRCC6,ZFHX3,ZFPM1	A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
GO:0005669	GO	CC	transcription factor TFIID complex	EDF1,TAF1,TAF10,TAF11,TAF12,TAF13,TAF2,TAF3,TAF4,TAF5,TAF6,TAF7,TAF8,TAF9,TAF9B,TBP,TP53	A complex composed of TATA binding protein (TBP) and TBP associated factors (TAFs); the total mass is typically about 800 kDa. Most of the TAFs are conserved across species. In TATA-containing promoters for RNA polymerase II (Pol II), TFIID is believed to recognize at least two distinct elements, the TATA element and a downstream promoter element. TFIID is also involved in recognition of TATA-less Pol II promoters. Binding of TFIID to DNA is necessary but not sufficient for transcription initiation from most RNA polymerase II promoters.
GO:0005671	GO	CC	Ada2/Gcn5/Ada3 transcription activator complex	CSRP2BP,DR1,HCFC1,KAT2A,KAT2B,MAP3K7,MBIP,POLE3,POLE4,SGF29,TADA3,UBAP2L,WDR5,YEATS2	A multiprotein complex that possesses histone acetyltransferase and is involved in regulation of transcription. Contains either GCN5 or PCAF in a mutually exclusive manner. The budding yeast complex includes Gcn5p, two proteins of the Ada family, and two TBP-associate proteins (TAFs); analogous complexes in other species have analogous compositions, and usually contain homologs of the yeast proteins. Both ATAC- or SAGA (see GO:0000124, SAGA complex) are involved in the acetylation of histone H3K9 and K14 residues.
GO:0005675	GO	CC	holo TFIIH complex	CCNH,CDK7,ERCC2,ERCC3,ERCC5,GTF2H1,GTF2H2,GTF2H3,GTF2H4,MMS19,MNAT1	A complex that is capable of kinase activity directed towards the C-terminal Domain (CTD) of the largest subunit of RNA polymerase II and is essential for initiation at RNA polymerase II promoters in vitro. It is composed of  the core TFIIH complex and the TFIIK complex.
GO:0005677	GO	CC	chromatin silencing complex	BAHD1,BAZ2A,RRP8,SIRT1,SIRT2,SUV39H1	Any protein complex that mediates changes in chromatin structure that result in transcriptional silencing.
GO:0005680	GO	CC	anaphase-promoting complex	ANAPC1,ANAPC10,ANAPC11,ANAPC13,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,BUB1B,CDC16,CDC20,CDC23,CDC26,CDC27,CUL7,FZR1,MAD2L2,UBE2C,UBE2S	A ubiquitin ligase complex that degrades mitotic cyclins and anaphase inhibitory protein, thereby triggering sister chromatid separation and exit from mitosis. Substrate recognition by APC occurs through degradation signals, the most common of which is termed the Dbox degradation motif, originally discovered in cyclin B.
GO:0005681	GO	CC	spliceosomal complex	ADAR,ALYREF,API5,AQR,BCAS2,CACTIN,CCAR2,CDC40,CDC5L,CRNKL1,CTNNBL1,CWC15,CWC22,CWC27,DDX23,DDX39B,DDX41,DDX5,DGCR14,DHX15,DHX35,DHX38,DHX8,EFTUD2,EIF4A3,FRG1,GCFC2,GPATCH1,HNRNPA1,HNRNPA2B1,HNRNPA3,HNRNPC,HNRNPDL,HNRNPF,HNRNPH1,HNRNPH3,HNRNPK,HNRNPM,HNRNPR,HNRNPU,ISY1,IVNS1ABP,LSM2,LSM3,MAGOH,PABPC1,PDCD7,PHF5A,PLRG1,PNN,PPIE,PPIH,PPIL1,PPIL3,PPWD1,PRPF18,PRPF19,PRPF3,PRPF31,PRPF4,PRPF4B,PRPF6,PRPF8,RALY,RBM22,RBM5,RBM8A,RBMX,RNPC3,SART1,SF1,SF3A1,SF3A2,SF3A3,SF3B1,SF3B2,SF3B3,SF3B4,SF3B5,SF3B6,SKIV2L2,SLU7,SNRNP200,SNRNP25,SNRNP35,SNRNP40,SNRNP48,SNRNP70,SNRPA,SNRPA1,SNRPB,SNRPB2,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNRPN,SNW1,SRRM1,SRRM2,SRSF1,SYF2,SYNCRIP,TFIP11,TXNL4A,U2AF1,U2AF2,UPF1,WDR83,XAB2,YBX1,ZCCHC8,ZCRB1,ZMAT5,ZNF326,ZRSR2	Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.
GO:0005682	GO	CC	U5 snRNP	CD2BP2,DDX23,PRPF6,PRPF8,SNRNP200,SNRNP40	A ribonucleoprotein complex that contains small nuclear RNA U5.
GO:0005683	GO	CC	U7 snRNP	LSM10,LSM11,SNRPB,SNRPD3,SNRPE,SNRPF,SNRPG	A ribonucleoprotein complex that contains the U7 snRNA and is required for the 3'-end processing of replication-dependent histone pre-mRNAs.
GO:0005684	GO	CC	U2-type spliceosomal complex	DHX15,GCFC2,PRPF31,SF3A1,TFIP11,U2AF2	Any spliceosomal complex that forms during the splicing of a messenger RNA primary transcript to excise an intron that has canonical consensus sequences near the 5' and 3' ends.
GO:0005685	GO	CC	U1 snRNP	SNRNP70,SNRPA,SNRPB,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG	A ribonucleoprotein complex that contains small nuclear RNA U1.
GO:0005687	GO	CC	U4 snRNP	DDX39B,PRPF31,SNRPB,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG	A ribonucleoprotein complex that contains small nuclear RNA U4.
GO:0005689	GO	CC	U12-type spliceosomal complex	DHX15,PDCD7,PHF5A,RNPC3,SF3B1,SF3B2,SF3B3,SF3B4,SF3B5,SF3B6,SNRNP25,SNRNP35,SNRNP48,SNRPB,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,YBX1,ZCRB1,ZMAT5,ZRSR2	Any spliceosomal complex that forms during the splicing of a messenger RNA primary transcript to excise an intron; the series of U12-type spliceosomal complexes is involved in the splicing of the majority of introns that contain atypical AT-AC terminal dinucleotides, as well as other non-canonical introns. The entire splice site signal, not just the terminal dinucleotides, is involved in determining which spliceosome utilizes the site.
GO:0005697	GO	CC	telomerase holoenzyme complex	DKC1,GAR1,GNL3L,HMBOX1,HNRNPC,HNRNPU,LSM11,NAT10,NHP2,NOP10,NVL,PTGES3,SMG6,SNRPB,SNRPD3,SNRPE,TEP1,TERT,WRAP53	Telomerase is a ribonucleoprotein enzyme complex, with a minimal catalytic core composed of a catalytic reverse transcriptase subunit and an RNA subunit that provides the template for telomeric DNA addition. In vivo, the holoenzyme complex often contains additional subunits.
GO:0005719	GO	CC	nuclear euchromatin	CBX3,CREB1,CTNNB1,H1F0,H2AFZ,H3F3C,HIST1H1A,HIST1H1C,HIST1H1D,JUN,NR1H4,NSMF,RBMX,RUVBL2,SIRT1,TBP,TRNP1	The dispersed less dense form of chromatin in the interphase nucleus. It exists in at least two forms, a some being in the form of transcriptionally active chromatin which is the least condensed, while the rest is inactive euchromatin which is more condensed than active chromatin but less condensed than heterochromatin.
GO:0005720	GO	CC	nuclear heterochromatin	ATRX,BEND3,CBX1,CBX3,CBX5,FOXC1,H2AFY,H2AFZ,HIST1H1B,HIST1H1E,MPHOSPH8,NCAPD3,PSIP1,SIRT1,SIRT2,SIRT6,SUV420H2,TNKS1BP1,UHRF2	A condensed form of chromatin, occurring in the nucleus during interphase, that stains strongly with basophilic dyes. The DNA of heterochromatin is typically replicated at a later stage in the cell-division cycle than euchromatin.
GO:0005721	GO	CC	pericentric heterochromatin	ATRX,CBX3,CBX5,CENPC,H2AFY,HELLS,INCENP,LRWD1,NCAPD3,SUV420H2	Heterochromatin that is located adjacent to the CENP-A rich centromere 'central core' and characterized by the modified histone H3K9me3.
GO:0005732	GO	CC	small nucleolar ribonucleoprotein complex	DKC1,FBL,GAR1,MPHOSPH10,NAF1,NHP2,NOP10,NOP56,NOP58,POP1,RRP9,SNRNP40,SNU13	A ribonucleoprotein complex that contains an RNA molecule of the small nucleolar RNA (snoRNA) family and associated proteins. Most are involved in a step of processing of rRNA: cleavage, 2'-O-methylation, or pseudouridylation. The majority, though not all, fall into one of two classes, box C/D type or box H/ACA type.
GO:0005741	GO	CC	mitochondrial outer membrane	ABCB6,ACACB,ACSL1,AGK,AGPAT5,AIFM2,AMBRA1,ATF2,ATP5G2,ATP5G3,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BMF,BNIP3,BNIP3L,BPHL,CASP8,CISD2,COASY,CPT1A,CPT1B,CYB5A,CYB5R3,CYP27B1,DAO,DMPK,DNM1L,FIS1,FUNDC1,GDAP1,GPAM,GPAT2,HADHB,HAX1,HK2,IFI27,KMO,LRRK2,MAOA,MAOB,MARCH5,MAVS,MCL1,MFF,MFN1,MFN2,MGARP,MIEF1,MIEF2,MOAP1,MSTO1,MTERF3,MUL1,MYOC,NLRX1,OPA1,PHB2,PINK1,PLD6,PMAIP1,PPP2R2B,PRNP,QTRT1,QTRTD1,RAB11FIP5,RAF1,RHOT1,RHOT2,RMDN3,RSAD2,SAMM50,SLC25A46,SLC8A3,SPATA18,SPG20,TIGAR,TMEM173,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,USP30,VDAC1	The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
GO:0005742	GO	CC	mitochondrial outer membrane translocase complex	PINK1,TOMM20,TOMM22,TOMM40,TOMM5,TOMM7,TOMM70A	A large complex of the mitochondrial outer membrane that mediates transport of proteins into all mitochondrial compartments.
GO:0005744	GO	CC	mitochondrial inner membrane presequence translocase complex	PAM16,SLC25A6,TIMM10,TIMM17A,TIMM17B,TIMM21,TIMM23	The protein transport machinery of the mitochondrial inner membrane that contains three essential Tim proteins: Tim17 and Tim23 are thought to build a preprotein translocation channel while Tim44 interacts transiently with the matrix heat-shock protein Hsp70 to form an ATP-driven import motor.
GO:0005746	GO	CC	mitochondrial respiratory chain	BCS1L,COX15,COX4I2,FOXRED1,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NNT,OXA1L,PARK7,SDHA,SDHB,SDHC,SDHD,SNCA,SURF1,UQCC3,UQCRB,UQCRC1,UQCRH	The protein complexes that form the mitochondrial electron transport system (the respiratory chain), associated with the inner mitochondrial membrane. The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient.
GO:0005747	GO	CC	mitochondrial respiratory chain complex I	FOXRED1,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,PARK7,SNCA	A protein complex located in the mitochondrial inner membrane that forms part of the mitochondrial respiratory chain. It contains about 25 different polypeptide subunits, including NADH dehydrogenase (ubiquinone), flavin mononucleotide and several different iron-sulfur clusters containing non-heme iron. The iron undergoes oxidation-reduction between Fe(II) and Fe(III), and catalyzes proton translocation linked to the oxidation of NADH by ubiquinone.
GO:0005753	GO	CC	mitochondrial proton-transporting ATP synthase complex	ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATPIF1,MT-ATP6,MT-ATP8,PPIF,USMG5	A proton-transporting ATP synthase complex found in the mitochondrial membrane.
GO:0005758	GO	CC	mitochondrial intermembrane space	AIFM1,AK2,ARL2,ARL2BP,BLOC1S1,CHCHD10,CHCHD4,COA6,CPOX,CYCS,DIABLO,FBXL4,GATM,HAX1,HSD3B1,HSD3B2,HTRA2,MICU1,MICU2,MYOC,NDUFA8,NDUFB7,NDUFS1,OPA1,PANK2,PINK1,PNPT1,PPOX,PRELID1,SDHAF3,SIRT5,SOD1,STAR,STOML2,TIMM10,TIMM10B,TIMM13,TIMM23,TIMM8A,TIMM8B,TIMM9,TRAP1,TRIAP1,UQCC2	The region between the inner and outer lipid bilayers of the mitochondrial envelope.
GO:0005761	GO	CC	mitochondrial ribosome	ICT1,MPV17L2,MRPL10,MRPL11,MRPL12,MRPL13,MRPL18,MRPL20,MRPL23,MRPL27,MRPL28,MRPL3,MRPL32,MRPL34,MRPL35,MRPL36,MRPL37,MRPL39,MRPL40,MRPL41,MRPL42,MRPL43,MRPL48,MRPL49,MRPL51,MRPL52,MRPL55,MRPL57,MRPL9,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS24,MRPS26,MRPS28,MRPS33,MRPS35,MRPS36,MRPS6,MRPS7,MRPS9,MTERF4,MTG1,MTG2,NDUFA7,NSUN4	A ribosome found in the mitochondrion of a eukaryotic cell; contains a characteristic set of proteins distinct from those of cytosolic ribosomes.
GO:0005762	GO	CC	mitochondrial large ribosomal subunit	ICT1,MPV17L2,MRPL10,MRPL12,MRPL13,MRPL23,MRPL27,MRPL3,MRPL36,MRPL41,MRPL51,MRPL52,MRPL55,MTERF4,NSUN4	The larger of the two subunits of a mitochondrial ribosome. Two sites on the ribosomal large subunit are involved in translation: the aminoacyl site (A site) and peptidyl site (P site).
GO:0005763	GO	CC	mitochondrial small ribosomal subunit	MRPL42,MRPS11,MRPS12,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS24,MRPS26,MRPS28,MRPS33,MRPS35,MRPS36,MRPS6,MRPS7,MRPS9	The smaller of the two subunits of a mitochondrial ribosome.
GO:0005767	GO	CC	secondary lysosome	ADAM8,CRHBP,LRRK2,NCF1,NCF2,NCF4,SQSTM1	Vacuole formed by the fusion of a lysosome with an organelle (autosome) or with a primary phagosome.
GO:0005769	GO	CC	early endosome	ADRB1,ALS2,ANKFY1,ANKRD27,ANXA1,AOC3,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,ATP9A,B2M,CAV1,CD207,CD4,CD8B,CFTR,CHMP1A,CLCN3,CLIP3,CLN3,CNTNAP2,COMMD1,CXCR4,DKK1,DNAJC13,DNER,DYSF,ECE1,EEA1,EGFR,EHD1,EPHA3,EPHA4,EPHB1,F2R,F2RL1,FAM109A,FAM109B,FAM21A,FAM21C,FCGR1A,FCGR1B,FIG4,FLOT1,FZD5,GPER1,HFE,HGS,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,HSPD1,IGF2R,KCNH1,KCNQ1,KDR,KIAA0196,KIAA0319,KIF16B,KREMEN2,LAMP5,LDLR,LDLRAD4,LDLRAP1,LIPG,LLGL1,LMTK2,LNPEP,LRP6,MAP2K1,MAP2K2,MAPK1,MAPK3,MARCH1,MGRN1,MLC1,MMGT1,MTMR4,MVB12B,MYO1B,MYO5A,NEURL1B,NF2,NOX1,NRP1,NTRK1,OCRL,PARM1,PCSK9,PHB,PIKFYVE,PMEPA1,PRDX3,PTPN1,PTPN23,RAB11FIP5,RAB14,RAB21,RAB22A,RAB31,RAB32,RAB38,RAB5A,RABGAP1L,RABGEF1,RAP1A,RAPGEF1,RIN3,RPS6KC1,RUBCN,RUSC1,SDCCAG3,SLC11A2,SLC9A6,SNX1,SNX12,SNX13,SNX16,SNX17,SNX20,SNX21,SNX27,SNX3,SNX4,SNX5,SNX6,SNX8,SORL1,SORT1,STEAP2,STX6,STX7,STX8,SYNDIG1,TBC1D16,TF,TGFBRAP1,TICAM2,TMEM127,TMEM163,TOM1,TRAK1,TSG101,USP10,USP8,UVRAG,VAC14,VAMP8,VCAM1,VIPAS39,VPS11,VPS16,VPS26A,VPS26B,VPS28,VPS33A,VPS33B,VPS35,VPS4A,VPS8,WASH1,WDFY1,WDFY2,WLS,WNT3A,ZFYVE16,ZFYVE28,ZFYVE9	A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
GO:0005770	GO	CC	late endosome	ABCA5,ANKRD27,ANXA2,ANXA6,ANXA8,AP5M1,AP5S1,ATG9A,ATP7A,ATP7B,BACE1,CD63,CHID1,CHMP2B,CLCN3,CLN3,CLTCL1,CTNS,CTSH,CXCR4,CYB561A3,DYSF,EXOC8,F2R,FIG4,FYCO1,HLA-DRA,HLA-DRB1,HLA-DRB5,HTT,IGF2R,KCNQ1,KIAA1324,KIDINS220,LAMP1,LAMP2,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LDLR,MAGI2,MAP2K1,MAP2K2,MAPK1,MAPK3,MARCH1,MICALL1,MTM1,MVB12B,MYO5A,NAPSA,NBR1,NTRK1,OSBPL1A,PARM1,PCSK9,PGA3,PGA4,PGA5,PIK3C3,PIK3R4,PIKFYVE,PMEL,RAB14,RAB27A,RAB27B,RAB7A,RAB7B,RAB9A,RAP1A,RAPGEF2,RILP,RNF13,RUBCN,SDF4,SFTPB,SFTPC,SLC11A1,SLC11A2,SLC30A2,SLC30A3,SLC30A4,SLC38A9,SLC9A9,SNF8,SNX14,SNX16,SPPL2A,SRC,STX7,STX8,TF,TICAM2,TMEM192,TMEM55A,TMEM55B,TMEM59,TMEM9,TSG101,UVRAG,VAC14,VAMP5,VAMP7,VAMP8,VIPAS39,VPS11,VPS16,VPS18,VPS26B,VPS33A,VPS33B,VPS36,VPS39,VPS41,VPS4A,VTI1B	A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
GO:0005771	GO	CC	multivesicular body	BACE1,BST2,CD63,CD79A,CRHBP,CTSH,EGFR,LRAT,LRRK2,NAPSA,PGA3,PGA4,PGA5,PMEL,RAB11A,RAB27A,RAB27B,SFTPB,SFTPC,STEAP3,TPT1,TSG101,ZP2,ZP3	A type of endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.
GO:0005775	GO	CC	vacuolar lumen	ACAN,AGRN,ARSA,ARSB,ASAH1,ATP13A2,BCAN,BGN,CD74,CSPG4,CSPG5,CTSA,CTSB,CTSD,CTSF,CTSK,CTSL,CTSS,CTSV,CUBN,DCN,DEFA1,DEFA3,FMOD,FUCA1,GAA,GALC,GALNS,GBA,GC,GIF,GLA,GLB1,GM2A,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,GYG1,GYG2,HEXA,HEXB,HPSE,HSP90AA1,HSPA8,HSPG2,HYAL1,IDS,IDUA,IFI30,KERA,LAMP2,LGMN,LUM,NAGLU,NCAN,NEU1,NEU4,OGN,OMD,PPT1,PPT2,PRELP,PSAP,SCARB2,SDC1,SDC2,SDC3,SDC4,SGSH,SMPD1,TCN2,TPP1,TXNDC5,VCAN	The volume enclosed within the vacuolar membrane.
GO:0005776	GO	CC	autophagosome	ATG14,ATG16L1,ATG5,C9orf72,CALCOCO2,CLN3,FYCO1,GABARAP,GABARAPL1,GABARAPL2,HTT,LRRK2,MAP1LC3A,MAP1LC3B,MAP1LC3C,NBR1,ORAI1,OSBPL7,PIP4K2A,PIP4K2B,PIP4K2C,RAB23,RALB,SH3GLB1,SQSTM1,STX17,TBC1D14,TBC1D25,TBC1D5,TECPR1,TP53INP1,TP53INP2,UBQLN1,UBQLN4,ULK1,USP33,VMP1,VTI1A,WDFY3,WIPI1,WIPI2,ZFYVE1	A double-membrane-bounded compartment that engulfs endogenous cellular material as well as invading microorganisms to target them to the vacuole/lysosome for degradation as part of macroautophagy.
GO:0005777	GO	CC	peroxisome	ABCD1,ABCD2,ABCD3,ABCD4,ACAA1,ACAD11,ACBD5,ACOT4,ACOT6,ACOT8,ACOX1,ACOX2,ACOX3,AGPS,AGXT,ALDH3A2,AMACR,AOC1,ATAD1,BAAT,CAT,CNOT1,CRAT,CROT,CRYM,DAO,DDO,DECR2,DHRS4,DNM1L,ECH1,ECI2,EHHADH,EPHX2,FABP1,FAR1,FAR2,FIS1,GNPAT,GRHPR,GSTK1,HACL1,HAO1,HAO2,HMGCL,HMGCR,HSD17B4,HSDL2,IDE,IDH1,IDI1,IDI2,IMPDH2,ISOC1,KIAA0430,LONP2,MAP2K2,MAVS,MFF,MGST1,MLYCD,MPV17,MPV17L,MUL1,MYO5A,NOS2,NUDT12,NUDT7,PAOX,PECR,PEX1,PEX10,PEX11A,PEX11B,PEX11G,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,PHYH,PIPOX,PMVK,PNPLA8,POMC,PRDX5,PXMP2,PXMP4,PXT1,RAB8B,SCP2,SLC25A17,SLC27A2,SOD1,SZT2,TKT,TMEM135,TRIM37,TTC1,TYSND1,VIM,ZADH2	A small organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism.
GO:0005778	GO	CC	peroxisomal membrane	ABCD1,ABCD2,ABCD3,AGPS,ATAD1,CAT,CNOT1,DAO,DECR2,DHRS4,FAR1,FIS1,GNPAT,HMGCR,HSD17B4,IMPDH2,MAP2K2,MAVS,MGST1,PECR,PEX1,PEX10,PEX11A,PEX11B,PEX11G,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX3,PEX5,PNPLA8,PXMP2,PXMP4,RAB8B,SLC25A17,SLC27A2,TTC1	The lipid bilayer surrounding a peroxisome.
GO:0005779	GO	CC	integral component of peroxisomal membrane	ABCD1,FIS1,PEX10,PEX11A,PEX11B,PEX12,PEX13,PEX16,PEX2,PEX3,SLC25A17,SLC27A2	The component of the peroxisomal membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0005782	GO	CC	peroxisomal matrix	ABCD3,ACAA1,ACOT4,ACOT6,ACOT8,ACOX1,ACOX2,ACOX3,AGPS,AGXT,AMACR,BAAT,CAT,CRAT,CROT,CRYM,DAO,ECI2,FABP1,FAR1,FAR2,GNPAT,GRHPR,HACL1,HAO1,HAO2,HSD17B4,IDH1,MLYCD,PAOX,PEX5,PEX7,PHYH,PIPOX,POMC,PRDX5,SCP2	The volume contained within the membranes of a peroxisome; in many cells the matrix contains a crystalloid core largely composed of urate oxidase.
GO:0005786	GO	CC	signal recognition particle, endoplasmic reticulum targeting	SRP14,SRP19,SRP54,SRP68,SRP72,SRP9	A ribonucleoprotein particle of 325 kDa composed of a 7S (300 nucleotide) RNA molecule and a complex of six different polypeptides. This binds both to the N-terminal signal peptide for proteins destined for the endoplasmic reticulum as they emerge from the large ribosomal subunit and also to the ribosome. This binding arrests further translation thereby preventing the proteins from being released into the cytosol. The SRP-ribosome complex then diffuses to the endoplasmic reticulum where it is bound to the signal recognition particle receptor, which allows resumption of protein synthesis and facilitates the passage of the growing polypeptide chain through the translocon. Through a process involving GTP hydrolysis, the SRP-SRP receptor complex dissociates and SRP returns to the cytosol. Of the six polypeptides of SRP the 54 kDa subunit (SRP54) is the central player. It contains an N-terminal GTPase domain and a C-terminal domain that binds directly to the signal peptide and the SRP RNA. Examples of this component are found in Mus musculus, Saccharomyces cerevisiae and Arabidopsis thaliana.
GO:0005788	GO	CC	endoplasmic reticulum lumen	ADAMTS13,ADAMTS5,ADAMTS7,ADAMTSL1,ADAMTSL4,APOA1,APOA2,APOA4,APOB,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,ASPH,B2M,BACE1,BGLAP,CALR,CANX,CASQ1,CASQ2,CES1,CES2,CFP,CLN6,CNPY3,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL20A1,COL21A1,COL22A1,COL23A1,COL24A1,COL25A1,COL26A1,COL27A1,COL28A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,COLGALT1,COLGALT2,CRTAP,CTSC,CTSZ,CYP2W1,DNAJB11,DNAJC10,DNAJC3,ERAP1,ERAP2,ERLEC1,ERO1A,ERP29,ERP44,ESD,F10,F2,F5,F7,F8,F9,FKBP14,FMO1,FOXRED2,GANAB,GAS6,GCG,GHRL,GIP,GPX7,GPX8,HRC,HSP90B1,HSPA5,HYOU1,INS,KDELC1,LIPC,MBTPS1,MINPP1,MTTP,MYDGF,MZB1,NTF4,OS9,P3H1,P3H2,P3H3,P4HB,PDGFA,PDGFB,PDGFC,PDGFD,PDIA3,PDIA5,PLAUR,POGLUT1,PPIB,PRKCSH,PROC,PROZ,PTGS2,RNASET2,SEP15,SERPINA1,SERPINH1,SHH,SLC27A2,SPON1,STS,SUMF1,SUMF2,THBS1,TOR1A,TOR1B,TOR2A,TOR3A,TRDN,TXNDC12,TXNDC16,UGGT1,UGGT2,WNT1,WNT3,WNT3A,WNT4,WNT5A,WNT5B,WNT6,WNT7A,WNT7B	The volume enclosed by the membranes of the endoplasmic reticulum.
GO:0005790	GO	CC	smooth endoplasmic reticulum	CASQ1,ERP29,FTCD,GBA2,HSD3B1,HSD3B2,HYOU1,PSEN1,SLMAP,STX17,SYVN1,TH	The smooth endoplasmic reticulum (smooth ER or SER) has no ribosomes attached to it. The smooth ER is the recipient of the proteins synthesized in the rough ER. Those proteins to be exported are passed to the Golgi complex, the resident proteins are returned to the rough ER and the lysosomal proteins after phosphorylation of their mannose residues are passed to the lysosomes. Glycosylation of the glycoproteins also continues. The smooth ER is the site of synthesis of lipids, including the phospholipids. The membranes of the smooth ER also contain enzymes that catalyze a series of reactions to detoxify both lipid-soluble drugs and harmful products of metabolism. Large quantities of certain compounds such as phenobarbital cause an increase in the amount of the smooth ER.
GO:0005791	GO	CC	rough endoplasmic reticulum	CA4,CFTR,EPHA5,FKRP,HM13,LRAT,PSEN1,PTGDS,RAB14,RANGRF,RPN1,SEC61B,SEC62,SPPL3,SRP9,SSR4,SUCO,TMEM97,UBA1,ZC3H12A	The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins), the proteins of the lysosomes, or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae.
GO:0005793	GO	CC	endoplasmic reticulum-Golgi intermediate compartment	ANPEP,AREG,ATP2A1,AZIN2,BET1,CA4,CD55,CD59,CLN8,CNIH1,CNIH2,CNIH3,CNIH4,COL7A1,CSNK1D,CTSC,CTSZ,ERGIC1,ERP44,F5,F8,FN1,FOLR1,FTCD,GBF1,GJB2,GOLGA2,GOLGB1,GORASP1,GOSR2,GRIA1,HSPA5,INS,IST1,KDELR1,LAMP5,LMAN1,LMAN2,MAN1A1,MCFD2,MPPE1,NAT8,NAT8B,NUCB1,NUCB2,P4HB,PDIA6,PROM1,PTPN2,RAB1B,RAB37,RGMB,SCYL1,SEC22B,SEC23IP,SERPINA1,SERPINH1,SLC35C2,SPPL3,STX17,STX5,SURF4,TGFA,TM6SF2,TMED1,TMED10,TMED2,TMED3,TMED5,TMED7,TMED9,UGGT1,WHAMM,YIF1A,YKT6	A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi  and Golgi-to-ER transport.
GO:0005795	GO	CC	Golgi stack	AKAP9,AP4M1,ATL1,B3GALT6,B4GALT1,CLN3,COG2,GALNT2,GCNT1,GOLGA2,GOLGA5,GOLGA7,GOLGB1,GOLPH3,GPR89A,HID1,HLA-A,LLGL1,LPCAT2,MARCH4,MARCH9,NECAB3,NSF,OCRL,PLK3,RAB14,RAB21,RAB27B,RAB30,RAB34,SGMS1,SORL1,STX16,TMBIM4,TMEM115,TMEM59,TRAPPC4,VRK1,ZFYVE1	The set of thin, flattened membrane-bounded compartments, called cisternae, that form the central portion of the Golgi complex. The stack usually comprises cis, medial, and trans cisternae; the cis- and trans-Golgi networks are not considered part of the stack.
GO:0005796	GO	CC	Golgi lumen	ACAN,AGRN,AGRP,BCAN,BGLAP,BGN,CGA,CSPG4,CSPG5,DCN,DEFA1,DEFA3,DEFA4,DEFA5,DEFA6,DEFB1,DEFB103A,DEFB4A,F10,F2,F7,F9,FMOD,FURIN,GAS6,GOLIM4,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HS3ST1,HSPG2,INS,KERA,LALBA,LHB,LUM,MMP11,MMP14,MMP16,MUC1,MUC12,MUC13,MUC15,MUC16,MUC17,MUC20,MUC21,MUC3A,MUC4,MUC5AC,MUC5B,MUC6,MUC7,MUCL1,NCAN,NGF,OGN,OMD,PCSK5,PCSK6,PPIL2,PRELP,PROC,PROS1,PROZ,RAB33B,SDC1,SDC2,SDC3,SDC4,SDF4,SOD3,TGFB1,VCAN,WNT1,WNT3,WNT3A,WNT4,WNT5A,WNT5B,WNT6,WNT7A,WNT7B,ZG16	The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
GO:0005798	GO	CC	Golgi-associated vesicle	ADAM10,AFTPH,AP1G2,AP1S1,AP2A1,AP3B2,ARCN1,ARFGAP1,ATP7A,BACE1,C3orf58,CFTR,CNGA2,CNGA4,CNGB1,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,CSPG5,FURIN,GJA1,GOPC,GPR89A,IGF2R,ITM2B,LDLRAP1,LRRK2,NCALD,OCRL,PI4KA,PKD1,RAB14,RAB27B,RASSF9,RHO,RHOQ,SCFD1,SCYL1,SPG21,SPPL2A,SPPL2B,SPPL3,STEAP2,STK26,SYNRG,TMED10,TMED2,TMED3,TMED7,TMED9,TYR,VPS41,ZDHHC13,ZDHHC17	Any vesicle associated with the Golgi complex and involved in mediating transport within the Golgi or between the Golgi and other parts of the cell.
GO:0005801	GO	CC	cis-Golgi network	AKAP9,ANGEL1,AZIN2,B3GAT3,BCL9,COPZ2,FAM134B,FKTN,GBF1,GOLGA2,GOLGA5,GOLIM4,HOOK3,IFT20,MPPE1,RAB30,SCFD1,SCYL1,SLC35C2,TMED10,TMED5	The network of interconnected tubular and cisternal structures located at the convex side of the Golgi apparatus, which abuts the endoplasmic reticulum.
GO:0005802	GO	CC	trans-Golgi network	AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP4B1,AP4E1,AP4M1,AP4S1,APP,ARFGEF1,ARFGEF2,ARFIP1,ARFIP2,ARFRP1,ARL1,ATG9A,ATP2C1,ATP7A,ATP7B,ATP9A,ATP9B,ATXN2,AZIN2,BACE1,BICD1,BIRC6,CA4,CABP7,CALN1,CBY1,CD74,CDH1,CHAC1,CHID1,CHST2,CHST4,CLASP2,CLIP3,CLN3,CLTA,CLTC,CLTCL1,CLVS1,CLVS2,CNST,CORO7,DENND5A,DPY30,FAM109A,FAM109B,FURIN,GBF1,GCC2,GCNT1,GGA2,GGA3,GNAS,GOLGA1,GOLGA4,GOLPH3,GOLPH3L,GPER1,GSAP,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IGF2R,INPP5K,KIAA1324,KIF13A,KLHL20,LGR5,LGR6,LLGL1,MARCH1,MARCH4,MARCH9,MLANA,MMP24,MYO18A,MYO1B,NBEA,OCRL,OPTN,PIFO,PLEKHA8,POSTN,PRKD1,RAB10,RAB11A,RAB13,RAB21,RAB29,RAB30,RAB31,RAB6A,RAB7B,RAC1,RBFOX1,RGS20,SCAMP1,SCAMP2,SCAMP5,SCOC,SLC11A2,SLC24A5,SLC9A7,SMPD4,SNX9,SORL1,STX10,STX16,STX6,STX8,TAS2R16,TGFBI,TGOLN2,TMEM165,TMEM79,VAMP2,VAMP7,VPS54,WIPI1,WLS	The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
GO:0005811	GO	CC	lipid particle	ABHD5,ACSL3,ACSL4,AIFM2,ALOX15,ANXA2,BCAP31,CAV1,CIDEA,CKAP4,CYB5R3,DGAT2,EHD1,FAAH2,FABP4,FAF2,G0S2,GAPDH,GIMAP2,GIMAP7,HILPDA,HSD17B11,HSD17B13,IRAK1,LDAH,LIPE,LPCAT1,LPCAT2,LSS,NSDHL,PLIN1,PLIN2,PLIN3,PLIN4,PLIN5,PNPLA2,RAB3GAP1,RAB5C,RAB7A,RAP1B,RSAD2,SCCPDH,TRAF6,TRAP1,VCP	An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins.
GO:0005814	GO	CC	centriole	AGBL2,AGBL4,AHI1,ALMS1,BBS4,BIRC5,C2CD3,CAPG,CCDC146,CCDC151,CCDC78,CCDC92,CCHCR1,CCNF,CCP110,CCSAP,CENPJ,CEP104,CEP128,CEP135,CEP152,CEP162,CEP164,CEP170,CEP19,CEP250,CEP295,CEP41,CEP63,CEP76,CEP83,CEP89,CETN1,CETN2,CETN3,CFAP20,CNTLN,CNTROB,CROCC,DZIP1,DZIP1L,FBF1,HSPA1A,HSPA1B,HSPA6,HTT,IFT88,KIF24,MDM1,MPHOSPH9,ODF2,OFD1,PCNT,PLA2G3,PLK2,PLK4,POC1A,POC1B,RAN,SASS6,SAXO1,SCLT1,SDCCAG8,SIRT2,SPICE1,STARD9,STIL,TOP2A,TOPORS,TSKS,TTBK2,TUBGCP3,WDR34	A cellular organelle, found close to the nucleus in many eukaryotic cells, consisting of a small cylinder with microtubular walls, 300-500 nm long and 150-250 nm in diameter. It contains nine short, parallel, peripheral microtubular fibrils, each fibril consisting of one complete microtubule fused to two incomplete microtubules. Cells usually have two centrioles, lying at right angles to each other. At division, each pair of centrioles generates another pair and the twin pairs form the pole of the mitotic spindle.
GO:0005819	GO	CC	spindle	AGBL5,ANXA11,ARL3,ARL8A,ARL8B,ASPM,ATAT1,AUNIP,AURKA,AURKB,AURKC,BIRC5,BIRC6,BUB1B,CALM1,CAPG,CAPN6,CBX1,CBX3,CCNB1,CCSAP,CDC16,CDC20,CDC25B,CDC27,CDC42,CDC6,CDK1,CDK5RAP2,CENPE,CENPF,CENPV,CEP128,CEP19,CEP44,CEP63,CEP85,CEP89,CEP95,CETN1,CHAMP1,CIAO1,CKAP5,CLASP1,CLASP2,CLTC,CLTCL1,CSNK1D,CSPP1,CTDP1,CUL3,CYLD,DCTN1,DDX11,DIAPH1,DLGAP5,DYNC1I1,DYNC1LI1,DYNLL1,ECT2,EFHC1,EML1,EML2,ERCC2,FAM175B,FAM83D,FAM96B,FBF1,FBXO5,GEM,GOLGA2,GPSM2,GSG2,HDAC3,HEPACAM2,HSPA2,IKBKG,INCENP,JTB,KATNA1,KATNB1,KIF11,KIF14,KIF18A,KIF18B,KIF20A,KIF20B,KIF22,KIF23,KIF2A,KIF3A,KIF3B,KIF4A,KIFAP3,KLHL21,KLHL22,KNSTRN,KNTC1,LATS1,LATS2,MAD1L1,MAD2L1,MAD2L2,MAEA,MAK,MAP10,MAP4,MAPK1,MAPRE1,MMS19,MTCL1,MZT1,MZT2A,MZT2B,NCOR1,NDE1,NEDD9,NIN,NPM1,NUMA1,OR2A4,PAFAH1B1,PARP4,PIN4,PINX1,PKD2,PKHD1,PKP4,PLK1,POC1A,POC1B,POLB,PRC1,PSRC1,RAB11A,RACGAP1,RCC2,RGS14,RPS3,SBDS,SEPT12,SGOL1,SHCBP1L,SIRT2,SKA1,SKA2,SKA3,SLC25A5,SMC3,SPAG5,SPDL1,SPICE1,TBCCD1,TBL1X,TBL1XR1,TERF1,TOPORS,TPR,TPX2,TTK,TUBG1,TUBGCP3,UMOD,UNC119,VPS4A,VPS4B,WDR62,ZW10	The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart.
GO:0005827	GO	CC	polar microtubule	CUL3,KLHL21,KLHL22,TUBG1,TUBGCP3	Any of the spindle microtubules that come from each pole and overlap at the spindle midzone. This interdigitating structure consisting of antiparallel microtubules is responsible for pushing the poles of the spindle apart.
GO:0005828	GO	CC	kinetochore microtubule	CLASP1,CLASP2,KIF18A,KNTC1,RAB11A,ZW10	Any of the spindle microtubules that attach to the kinetochores of chromosomes by their plus ends, and maneuver the chromosomes during mitotic or meiotic chromosome segregation.
GO:0005832	GO	CC	chaperonin-containing T-complex	CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,TCP1	A multisubunit ring-shaped complex that mediates protein folding in the cytosol without a cofactor.
GO:0005834	GO	CC	heterotrimeric G-protein complex	ARRB1,GNA14,GNA15,GNAI1,GNAS,GNAT2,GNB1,GNG2,GNG5,GNGT2,RGS19	Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G-protein coupled receptors to an effector protein.
GO:0005838	GO	CC	proteasome regulatory particle	PSMD1,PSMD10,PSMD12,PSMD13,PSMD14,PSMD2,PSMD5,PSMD8,PSMD9	A multisubunit complex, which caps one or both ends of the proteasome core complex. This complex recognizes and unfolds ubiquitinated proteins, and translocates them to the proteasome core complex.
GO:0005839	GO	CC	proteasome core complex	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMF1	A multisubunit barrel shaped endoprotease complex, which is the core of the proteasome complex.
GO:0005840	GO	CC	ribosome	ABCF1,APEX1,APOD,DDX3X,DNAJC21,EIF2AK2,EIF2AK4,EIF2D,FAU,FMR1,FXR2,GNB2L1,HBA1,HSPA14,ICT1,LARP4B,MCTS1,MPV17L2,MRPL10,MRPL11,MRPL12,MRPL13,MRPL18,MRPL20,MRPL23,MRPL27,MRPL28,MRPL3,MRPL32,MRPL34,MRPL35,MRPL36,MRPL37,MRPL39,MRPL40,MRPL41,MRPL42,MRPL43,MRPL48,MRPL49,MRPL51,MRPL52,MRPL55,MRPL57,MRPL9,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS24,MRPS26,MRPS28,MRPS33,MRPS35,MRPS36,MRPS6,MRPS7,MRPS9,MTERF4,MTG1,MTG2,NCK1,NDUFA7,NR0B1,NSUN4,NUFIP1,NUFIP2,RBM3,RPL10,RPL10A,RPL10L,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL39L,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RRBP1,SERP1,SF1,SRP68,UBA52	An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.
GO:0005844	GO	CC	polysome	ABCF1,AGO1,AGO2,ATXN2,CALR,DIS3L2,DRG1,EIF2AK4,EIF2S1,EPM2A,FMR1,IMPACT,LARP4B,NAA30,NAA35,NAA38,NR0B1,NUFIP2,PSMA1,PSMA6,RPL7A,RPS3,RPS4X,RPS4Y1,UNK	A multiribosomal structure representing a linear array of ribosomes held together by messenger RNA. They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro.
GO:0005845	GO	CC	mRNA cap binding complex	AGO2,CYFIP1,EIF4E,EIF4E1B,EIF4E2,EIF4E3,FAM103A1,FMR1,NCBP1,NCBP2,RNMT	Any protein complex that binds to an mRNA cap at any time in the lifetime of the mRNA.
GO:0005847	GO	CC	mRNA cleavage and polyadenylation specificity factor complex	CPSF1,CPSF2,CPSF3,CPSF4,CSNK1A1,CSTF2,PIP5K1A,TUT1	A multisubunit complex that binds to the canonical AAUAAA hexamer and to U-rich upstream sequence elements on the pre-mRNA, thereby stimulating the otherwise weakly active and nonspecific polymerase to elongate efficiently RNAs containing a poly(A) signal.
GO:0005849	GO	CC	mRNA cleavage factor complex	CPSF1,CPSF2,CPSF3,CPSF4,CPSF6,CPSF7,CSNK1A1,CSTF2,NUDT21,PCF11,PIP5K1A,TUT1	Any macromolecular complex involved in cleavage or polyadenylation of mRNA molecules.
GO:0005851	GO	CC	eukaryotic translation initiation factor 2B complex	EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EIF2S1	A multisubunit guanine nucleotide exchange factor which catalyzes the exchange of GDP bound to initiation factor eIF2 for GTP, generating active eIF2-GTP. In humans, it is composed of five subunits, alpha, beta, delta, gamma and epsilon.
GO:0005852	GO	CC	eukaryotic translation initiation factor 3 complex	COPS5,DDX3X,EIF3A,EIF3B,EIF3C,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M	A complex of several polypeptides that plays at least two important roles in protein synthesis: First, eIF3 binds to the 40S ribosome and facilitates loading of the Met-tRNA/eIF2.GTP ternary complex to form the 43S preinitiation complex. Subsequently, eIF3 apparently assists eIF4 in recruiting mRNAs to the 43S complex. The eIF3 complex contains five conserved core subunits, and may contain several additional proteins; the non-core subunits are thought to mediate association of the complex with specific sets of mRNAs.
GO:0005858	GO	CC	axonemal dynein complex	CCDC114,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAI1,DNAI2,DNALI1,DYNC2LI1,NME8	A dynein complex found in eukaryotic cilia and flagella; the motor domain heads interact with adjacent microtubules to generate a sliding force which is converted to a bending motion. May contain two or three dynein heavy chains as well as several light chains.
GO:0005859	GO	CC	muscle myosin complex	MYBPC3,MYH1,MYH11,MYH13,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL3,MYL5,MYL6B,MYL9,MYLPF,MYOM1,TRIM32	A filament of myosin found in a muscle cell of any type.
GO:0005861	GO	CC	troponin complex	TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3	A complex of accessory proteins (typically troponin T, troponin I and troponin C) found associated with actin in muscle thin filaments; involved in calcium regulation of muscle contraction.
GO:0005865	GO	CC	striated muscle thin filament	ACTA1,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TTN	Filaments formed of actin and associated proteins; attached to Z discs at either end of sarcomeres in myofibrils.
GO:0005868	GO	CC	cytoplasmic dynein complex	CCDC114,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAI1,DNAI2,DNALI1,DYNC1H1,DYNC1I1,DYNC1LI1,DYNC2LI1,DYNLL1,DYNLRB1,DYNLRB2,DYNLT1,DYNLT3,NME8,SNX4,TOPORS,TPR	Any dynein complex that catalyzes movement along a cytoplasmic microtubule; cytoplasmic dynein complexes participates in many transport activities in eukaryotes, such as mRNA localization, intermediate filament transport, nuclear envelope breakdown, apoptosis, transport of centrosomal proteins, mitotic spindle assembly, virus transport, kinetochore functions, and movement of signaling and spindle checkpoint proteins. Subunits associated with the dynein heavy chain mediate association between dynein heavy chain and cargoes, and may include light chains and light intermediate chains.
GO:0005871	GO	CC	kinesin complex	KIF15,KIF3A,KIF3B,KIFAP3,KLC1,KLC2	Any complex that includes a dimer of molecules from the kinesin superfamily, a group of related proteins that contain an extended region of predicted alpha-helical coiled coil in the main chain that likely produces dimerization. The native complexes of several kinesin family members have also been shown to contain additional peptides, often designated light chains as all of the noncatalytic subunits that are currently known are smaller than the chain that contains the motor unit. Kinesin complexes generally possess a force-generating enzymatic activity, or motor, which converts the free energy of the gamma phosphate bond of ATP into mechanical work.
GO:0005874	GO	CC	microtubule	ACTR1A,ACTR1B,APC2,ARFGEF2,ARHGEF2,ARL3,ARL6,ASPM,AURKA,BCAS3,BCL10,BCL2L11,BICD1,BIRC5,C9orf9,CALM1,CAMSAP1,CAPN6,CCSAP,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CDC16,CDC27,CDK1,CDK5RAP2,CDK5RAP3,CENPE,CEP162,CEP57,CKAP2,CKAP5,CLASP1,CLASP2,CLIP1,CLMP,CNP,CRHBP,CSNK1D,CUL3,CYLD,CYP2A6,DCTN1,DCXR,DLG1,DNM1L,DNM2,DPYSL2,DST,DYNC1H1,DYNC1I2,DYNC2H1,DYNC2LI1,ENKD1,FAM175B,FGF13,GAS2L1,GAS2L2,GAS8,GRAMD3,GTSE1,HDAC3,HDAC6,HID1,IQGAP1,IQGAP2,KCNAB2,KIF11,KIF14,KIF18A,KIF18B,KIF2A,KIF2C,KIF3A,KIF3B,KIF4A,KIF9,KIFAP3,KLHL21,KLHL22,KNSTRN,KNTC1,KRIT1,LRPPRC,MACF1,MAP10,MAP1S,MAP2K2,MAP3K11,MAP6,MAPRE1,MAPRE3,MARK4,MID1,MID2,MTA1,MTUS2,NCKAP5L,NCOR1,NDRG1,NUMA1,ODF3L2,PAFAH1B1,PARP4,PLK1,POLB,PRC1,PSRC1,RAB11A,RADIL,REEP2,SAA1,SARM1,SAXO1,SCTR,SEPT9,SERP1,SIRT2,SKA1,SKA2,SKA3,SLAIN2,SNPH,SPAG5,SRPRB,SVIL,SYBU,TBCC,TBCD,TBCE,TBL1X,TBL1XR1,TCP1,TCP11L1,TMEM214,TPPP,TRIM54,TRIM55,TRIM63,TRPV4,TUBA1A,TUBA1B,TUBA1C,TUBA4A,TUBB,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBB4B,TUBB6,TUBB8,TUBG1,TUBG2,TUBGCP2,TUBGCP3,VIMP,ZW10	Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.
GO:0005875	GO	CC	microtubule associated complex	ACTR1A,APPBP2,AURKB,AURKC,CCDC114,CLIP2,DCTN2,DCX,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAI1,DNAI2,DNALI1,DYNC1H1,DYNC1I1,DYNC1LI1,DYNC2LI1,DYNLL1,DYNLRB1,DYNLRB2,DYNLT1,DYNLT3,EML1,EML2,FNTA,FNTB,HAUS1,HAUS2,HAUS3,HAUS4,HAUS5,HAUS6,HAUS7,HAUS8,HDAC6,KATNB1,KIF15,KIF1B,KIF3A,KIF3B,KIFAP3,KLC1,KLC2,MAP1B,MAP2,MAP4,MAP7,MAPT,MEFV,MID1,NME8,PAFAH1B1,PEA15,PXN,RABGAP1,RANBP9,RP1,SHTN1,SNX4,STAU1,TOPORS,TPR	Any multimeric complex connected to a microtubule.
GO:0005876	GO	CC	spindle microtubule	ARL3,AURKA,BIRC5,CALM1,CAPN6,CCSAP,CDC16,CDC27,CDK1,CLASP1,CLASP2,CSNK1D,CUL3,HDAC3,KIF11,KIF18A,KIF18B,KIF2A,KIF3A,KIF3B,KIF4A,KIFAP3,KLHL21,KLHL22,KNTC1,NCOR1,NUMA1,PAFAH1B1,PARP4,PLK1,POLB,PRC1,PSRC1,RAB11A,SKA1,SKA2,SKA3,TBL1X,TBL1XR1,TUBG1,TUBGCP3,ZW10	Any microtubule that is part of a mitotic or meiotic spindle; anchored at one spindle pole.
GO:0005881	GO	CC	cytoplasmic microtubule	APC2,ARFGEF2,ARL3,ARL6,BCAS3,BCL10,BICD1,BIRC5,C9orf9,CCSAP,CEP162,CKAP2,CLASP1,CLASP2,CLMP,CYLD,CYP2A6,DCXR,DYNC2LI1,ENKD1,GRAMD3,GTSE1,HID1,KIF18B,KIF2C,MAP10,MAPRE3,MID1,MTUS2,NUMA1,ODF3L2,PAFAH1B1,REEP2,SAA1,SAXO1,SCTR,SERP1,SNPH,SRPRB,TMEM214,TRPV4,TUBGCP2,VIMP	Any microtubule in the cytoplasm of a cell.
GO:0005882	GO	CC	intermediate filament	CLIP1,CSNK1A1,DLGAP2,DSP,FAM83H,FBF1,FLG,GPER1,KRT10,KRT13,KRT14,KRT16,KRT18,KRT2,KRT20,KRT3,KRT4,KRT5,KRT6C,KRT7,KRT71,KRT75,KRT76,KRT8,KRT80,KRT82,KRT84,LDLRAP1,LMNA,MICAL1,NARF,NCKIPSD,NEFH,NEFL,NES,PKP1,PKP2,PNN,PRPH,SHANK2,SLC1A4,SYNM,TCHP,TLK2,UPP2,VIM	A cytoskeletal structure that forms a distinct elongated structure, characteristically 10 nm in diameter, that occurs in the cytoplasm of eukaryotic cells. Intermediate filaments form a fibrous system, composed of chemically heterogeneous subunits and involved in mechanically integrating the various components of the cytoplasmic space. Intermediate filaments may be divided into five chemically distinct classes: Type I, acidic keratins; Type II, basic keratins; Type III, including desmin, vimentin and others; Type IV, neurofilaments and related filaments; and Type V, lamins.
GO:0005883	GO	CC	neurofilament	DLGAP2,LDLRAP1,NEFH,NEFL,SHANK2	A type of intermediate filament found in the core of neuronal axons. Neurofilaments are heteropolymers composed of three type IV polypeptides: NF-L, NF-M, and NF-H (for low, middle, and high molecular weight). Neurofilaments are responsible for the radial growth of an axon and determine axonal diameter.
GO:0005884	GO	CC	actin filament	ACKR2,ACTA1,ACTC1,ACTN1,ACTN2,ACTN3,AIF1,AIF1L,AMOT,APC2,ARHGAP6,CD2AP,COBL,CORO1A,CORO1B,CTTN,DMTN,DNAJA3,DPYSL3,ESPN,EZR,GAS2,HCK,IQGAP1,IQGAP2,LCP1,LRRC16A,MARK2,MYO1A,MYO1B,MYO1C,MYO3A,MYO5A,MYO6,MYO9B,PAK1,PALLD,PAWR,PKD2,RAC1,RAC2,RAC3,RCSD1,RHOQ,SHROOM4,TEK,TSC1	A filamentous structure formed of a two-stranded helical polymer of the protein actin and associated proteins. Actin filaments are a major component of the contractile apparatus of skeletal muscle and the microfilaments of the cytoskeleton of eukaryotic cells. The filaments, comprising polymerized globular actin molecules, appear as flexible structures with a diameter of 5-9 nm. They are organized into a variety of linear bundles, two-dimensional networks, and three dimensional gels. In the cytoskeleton they are most highly concentrated in the cortex of the cell just beneath the plasma membrane.
GO:0005885	GO	CC	Arp2/3 protein complex	ACTR2,ACTR3,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5	A stable protein complex that contains two actin-related proteins, Arp2 and Arp3, and five novel proteins (ARPC1-5), and functions in the nucleation of branched actin filaments.
GO:0005890	GO	CC	sodium:potassium-exchanging ATPase complex	ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,FXYD1,FXYD2	Sodium:potassium-exchanging ATPases are tetrameric proteins, consisting of two large alpha subunits and two smaller beta subunits. The alpha subunits bear the active site and penetrate the membrane, while the beta subunits carry oligosaccharide groups and face the cell exterior.
GO:0005891	GO	CC	voltage-gated calcium channel complex	CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG3,CACNG6,CACNG7,CACNG8,CASQ2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,HSPA2,NOS1,NOS1AP,PDE4B,PDE4D,TRDN	A protein complex that forms a transmembrane channel through which calcium ions may pass in response to changes in membrane potential.
GO:0005892	GO	CC	acetylcholine-gated channel complex	CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB3,CHRNB4,STXBP5	A homo- or hetero-pentameric protein complex that forms a transmembrane channel through which ions may pass in response to acetylcholine binding.
GO:0005901	GO	CC	caveola	AKAP6,ATP2B4,BMPR1A,BMPR2,CAV1,CAV2,CBL,CDH1,CDH13,CLN3,CORO1C,DLC1,EHD2,EMP2,F2R,FLOT1,FLOT2,HCK,HDAC6,INSR,IRS1,JAK2,KCNA5,KCNMA1,KIF18A,LRP4,LRP6,LRP8,LRRK2,MAPK1,MAPK3,MLC1,MYOF,NOS1AP,NOS3,PACSIN2,PLVAP,PRKCDBP,PTCH1,PTGIS,PTRF,RANGRF,SCARB1,SCN5A,SELE,SLC6A3,SMO,SRC,TGFBR2	A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adiptocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis.  Caveolae may be pinched off to form free vesicles within the cytoplasm.
GO:0005902	GO	CC	microvillus	ANGPT1,AOC3,ATP6V1B1,CLIC4,CLRN1,ENPP7,EZR,FSCN1,GIF,GRXCR2,HYAL2,ITGAV,ITGB3,LRRK2,MSN,MYO1A,MYO1C,PDGFA,PODXL,PROM2,RAPGEF3,RDX,SLC9A3R1,TBC1D10A,TEK,TGFB1,VCAM1,VIL1,WWOX	Thin cylindrical membrane-covered projections on the surface of an animal cell containing a core bundle of actin filaments. Present in especially large numbers on the absorptive surface of intestinal cells.
GO:0005903	GO	CC	brush border	AQP1,ATP6V0A4,B4GALT1,CA4,CD36,CDHR2,CLIC1,CUBN,ENPEP,ESPN,EZR,ITLN1,ITPR3,MME,MYL6,MYO1A,MYO1B,MYO1D,PDZD3,PDZK1,PEX19,PLS1,RALGDS,SHANK2,SI,SLC17A3,SLC22A12,SLC22A5,SLC26A4,SLC26A6,SLC34A1,SLC34A2,SLC3A1,SLC7A9,SLC9A3,SOAT2,TMPRSS15,USH1C,VCL,VIL1	The dense covering of microvilli on the apical surface of a epithelial cells in tissues such as the intestine, kidney, and choroid plexus; the microvilli aid absorption by increasing the surface area of the cell.
GO:0005905	GO	CC	coated pit	ACKR3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,CLTCL1,CTTN,DAB2,DNM2,EGFR,EPS15,FCHO1,FCHO2,HSPD1,ITSN1,LDLR,LDLRAP1,NECAP2,PICALM,RAB35,RAMP2,REPS1,SELE,SGIP1,SORT1,TBC1D5,TF,TFRC,TNK2	A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
GO:0005913	GO	CC	cell-cell adherens junction	APC,CAMSAP3,CDH1,CDH2,CTNNA3,CTNNB1,FAT2,FLOT1,FLOT2,JUP,KIFC3,NDRG1,NRAP,PGM5,PLEKHA7,PTPRM,PVRL1,PVRL2,SCRIB,SHROOM2,SMAD7,SORBS1,VCL,ZYX	An adherens junction which connects a cell to another cell.
GO:0005915	GO	CC	zonula adherens	CAMSAP3,JUP,KIFC3,PLEKHA7,PVRL2,SORBS1,VCL	A cell-cell adherens junction which forms a continuous belt near the apex of epithelial cells.
GO:0005921	GO	CC	gap junction	DSC1,GJA1,GJA4,GJA5,GJB3,GJC1,GJD3,NOV	A cell-cell junction that is composed of an array of small channels that permit small molecules to pass from one cell to another. At gap junctions, the membranes of two adjacent cells are separated by a uniform narrow gap of about 2-4 nm that is spanned by channel-forming proteins called connexins, which form hexagonal tubes called connexons.
GO:0005923	GO	CC	bicellular tight junction	AMICA1,AMOT,AMOTL1,ANK3,AOC1,APC,BVES,CGN,CLDN1,CLDN10,CLDN11,CLDN12,CLDN14,CLDN15,CLDN16,CLDN17,CLDN18,CLDN19,CLDN2,CLDN20,CLDN22,CLDN23,CLDN3,CLDN4,CLDN5,CLDN6,CLDN7,CLDN8,CLDN9,CLMP,CXADR,DDX58,DLG1,ECT2,EPCAM,F11R,FRMPD2,INADL,MAGI2,MARVELD2,MARVELD3,MICALL2,MPP7,MTDH,OCLN,PARD3,PARD6A,PARD6B,RAB13,RAP2B,RAP2C,RAPGEF2,SHROOM2,STRN,TBCD,TGFBR1,TJP1,TJP2,TJP3,UBN1,VAPA,WNK3,WNK4,YBX3	An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
GO:0005930	GO	CC	axoneme	AMBRA1,ARFGEF2,ARL6,ARMC4,ATG14,ATG16L1,ATG5,ATG7,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CCSAP,CEP162,CFAP221,CFAP46,CFAP54,CFAP74,DCDC2,DNAAF1,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAH9,DNAI1,DNAI2,DNALI1,DRC1,DYNC2LI1,EFHC1,GABARAP,IFT140,INPP5E,MAP1LC3B,NME8,PIK3C3,PIK3R4,RP1L1,RPGRIP1L,RSPH4A,RSPH9,SAXO1,SEPT7,SPAG16,SPAG6,SPATA7,SPEF1,TTLL3,TTLL8,WDPCP,WDR34,WDR35	The bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements.
GO:0005938	GO	CC	cell cortex	AKT2,ANLN,ARF6,ARFIP2,ASPH,BSN,C2CD5,CAPN2,CD302,CDH1,CDH2,CLASP1,CLASP2,CLDN5,CNKSR1,COBL,CORO1A,CTNNB1,CTTN,CYTIP,DBNL,DLC1,DLG4,EEF1A1,EPB41,EPB41L2,EPS8,ERMN,EXOC1,EXOC2,EXOC3L1,EXOC8,EZR,FAM110C,FGFR2,FLOT1,FLOT2,FMN2,GIPC1,GPSM2,GRM7,GSN,GYPC,GYS2,LANCL2,LASP1,LLGL1,MAEA,MAPRE1,MELK,MKLN1,MYADM,MYH10,MYH9,MYO1A,MYO5B,MYO6,MYO9B,MYZAP,NCL,NEDD4,NSMF,NUMA1,OSBPL8,PAFAH1B1,PCLO,PFN1,PHLDB1,PHLDB2,PKD2,PLEKHH2,RAB10,RALB,RAPGEF3,RDX,RHOA,RYR1,SCIN,SELE,SEPT12,SEPT2,SHROOM2,SHROOM4,SLC2A1,SLC4A1,SNCA,SPINK5,SPIRE1,SPIRE2,SPTA1,SPTAN1,SPTBN2,SPTBN4,SPTBN5,STIM1,TCHP,TMEM110,TRPC4,TRPV4,TSC1,VCL,WASH1,WDPCP	The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
GO:0005942	GO	CC	phosphatidylinositol 3-kinase complex	ATG14,BECN1,MTOR,NRBF2,PIK3C3,PIK3CA,PIK3CD,PIK3CG,PIK3R1,PIK3R4,PIK3R5,PIK3R6	A protein complex capable of phosphatidylinositol 3-kinase activity and containing subunits of any phosphatidylinositol 3-kinase (PI3K) enzyme. These complexes are divided in three classes (called I, II and III) that differ for their presence across taxonomic groups and for the type of their constituents. Catalytic subunits of phosphatidylinositol 3-kinase enzymes are present in all 3 classes; regulatory subunits of phosphatidylinositol 3-kinase enzymes are present in classes I and III; adaptor proteins have been observed in class II complexes and may be present in other classes too.
GO:0005976	GO	BP	polysaccharide metabolic process	AGL,ALG1,B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GAT1,CALM1,CHIA,CHST1,CHST7,CPS1,CSGALNACT1,CSGALNACT2,EPM2A,EXT1,EXT2,G6PC,GAA,GAL3ST3,GBE1,GSK3B,GYG1,GYG2,GYS1,GYS2,HAS1,HAS2,HAS3,MGAM,NANS,NHLRC1,NR1D1,PER2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PPP1R3C,PRKAG2,PYGB,PYGL,PYGM,RPS27A,STBD1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways involving a polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
GO:0005977	GO	BP	glycogen metabolic process	AGL,CALM1,CPS1,EPM2A,G6PC,GAA,GBE1,GSK3B,GYG1,GYG2,GYS1,GYS2,NHLRC1,NR1D1,PER2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PPP1R3C,PRKAG2,PYGB,PYGL,PYGM,RPS27A,STBD1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages.
GO:0005978	GO	BP	glycogen biosynthetic process	EPM2A,GBE1,GYG1,GYG2,GYS1,GYS2,NHLRC1,NR1D1,PER2,PGM1,PGM2,PPP1R3C,RPS27A,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways resulting in the formation of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.
GO:0005979	GO	BP	regulation of glycogen biosynthetic process	AKT1,AKT2,DYRK2,ENPP1,GCK,GRB10,GSK3A,GSK3B,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,PASK,PPP1R3F,PTH,SORBS1,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
GO:0005980	GO	BP	glycogen catabolic process	AGL,CALM1,CPS1,GAA,GYG1,GYG2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PYGB,PYGL,PYGM,STBD1	The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.
GO:0005984	GO	BP	disaccharide metabolic process	B4GALT1,GAA,IDUA,LALBA,SLC2A1,TREH	The chemical reactions and pathways involving any disaccharide, sugars composed of two monosaccharide units.
GO:0005996	GO	BP	monosaccharide metabolic process	ABHD10,ADIPOQ,ADPGK,AGL,AKR1A1,AKR1B1,ALDH5A1,ALDOA,ALDOB,ALDOC,APOD,ATF4,BRAT1,BRS3,CALM1,CHST1,CHST15,CRTC2,CRY1,CRYL1,CYB5A,CYB5R3,DCXR,ENO1,ENO2,ENO3,EPM2A,FBP1,FBP2,FPGT,FUCA1,FUCA2,FUOM,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,G6PC,G6PD,GAA,GAL3ST3,GALE,GALK1,GALM,GALT,GAPDH,GAPDHS,GBE1,GCK,GDPGP1,GHRL,GOT1,GOT2,GPI,GSTO1,GSTO2,GYG1,GYG2,GYS1,GYS2,HECTD4,HK1,HK2,HK3,IRS2,KCNJ11,KHK,LRP5,MDH1,MDH2,NHLRC1,NUDT5,OAS1,OMA1,PC,PCK1,PCK2,PER2,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PKLR,PKM,PMM1,PPARD,PPARGC1A,PPP1R3C,PPP2R5D,PRKACA,PRKACB,PRKACG,PYGB,PYGL,PYGM,RBP4,RPS27A,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC2A1,SLC2A3,SLC35A2,SLC35D1,SLC37A4,SORD,TALDO1,TFAP2B,TKFC,TKT,TKTL1,TPI1,UBA52,UBB,UBC,UGDH,UGP2,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7,XYLB	The chemical reactions and pathways involving monosaccharides, the simplest carbohydrates. They are polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides.
GO:0006000	GO	BP	fructose metabolic process	AKR1B1,ALDOA,ALDOB,ALDOC,FBP1,FBP2,KHK,SORD,TKFC	The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in a open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey.
GO:0006004	GO	BP	fucose metabolic process	FPGT,FUCA1,FUCA2,FUOM,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9	The chemical reactions and pathways involving fucose, or 6-deoxygalactose, which has two enantiomers, D-fucose and L-fucose.
GO:0006006	GO	BP	glucose metabolic process	ADIPOQ,ADPGK,AGL,AKR1A1,ALDH5A1,ALDOA,ALDOB,ALDOC,APOD,ATF4,BRAT1,BRS3,CALM1,CRTC2,CRY1,DCXR,ENO1,ENO2,ENO3,EPM2A,FBP1,FBP2,G6PC,GAA,GALM,GAPDH,GAPDHS,GBE1,GCK,GDPGP1,GHRL,GOT1,GOT2,GPI,GYG1,GYG2,GYS1,GYS2,HECTD4,HK1,HK2,HK3,IRS2,KCNJ11,LRP5,MDH1,MDH2,NHLRC1,OAS1,OMA1,PC,PCK1,PCK2,PER2,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PKLR,PKM,PPARD,PPARGC1A,PPP1R3C,PPP2R5D,PRKACA,PRKACB,PRKACG,PYGB,PYGL,PYGM,RBP4,RPS27A,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC37A4,SORD,TFAP2B,TKTL1,TPI1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
GO:0006007	GO	BP	glucose catabolic process	ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LRP5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PKLR,PKM,PPP2R5D,TKTL1,TPI1	The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose.
GO:0006012	GO	BP	galactose metabolic process	CHST1,GALE,GALK1,GALM,GALT,PGM1,PGM2,SLC35A2	The chemical reactions and pathways involving galactose, the aldohexose galacto-hexose. D-galactose is widely distributed in combined form in plants, animals and microorganisms as a constituent of oligo- and polysaccharides; it also occurs in galactolipids and as its glucoside in lactose and melibiose.
GO:0006022	GO	BP	aminoglycan metabolic process	ABCC5,ACAN,AGRN,ANGPT1,ARSB,B3GALT6,B3GAT1,B3GAT2,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B3GNT8,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,BCAN,BGN,CD44,CEMIP,CHIA,CHIT1,CHP1,CHPF,CHPF2,CHST1,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST5,CHST6,CHST7,CHST9,CHSY1,CHSY3,CLN6,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,EXT1,EXT2,FGF2,FMOD,FUCA1,GAL3ST3,GALNS,GALNT5,GCNT2,GLB1,GLCE,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,GXYLT1,HAS1,HAS2,HAS3,HEXA,HEXB,HGSNAT,HMMR,HPSE,HPSE2,HS2ST1,HS3ST1,HS3ST2,HS3ST3A1,HS3ST3B1,HS3ST5,HS3ST6,HS6ST1,HS6ST2,HSPG2,HYAL1,HYAL2,HYAL3,HYAL4,IDS,IDUA,IL1B,KERA,LUM,LYVE1,NAGLU,NCAN,NDNF,NDST1,NDST2,OGN,OMD,PAPSS1,PAPSS2,PRELP,PXYLP1,SDC1,SDC2,SDC3,SDC4,SGSH,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SLC35D2,SLC9A1,SPACA3,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6,STAB2,TGFB1,UGDH,UST,VCAN,XYLT1,XYLT2	The chemical reactions and pathways involving aminoglycans, any polymer containing amino groups that consists of more than about 10 monosaccharide residues joined to each other by glycosidic linkages.
GO:0006023	GO	BP	aminoglycan biosynthetic process	ABCC5,ACAN,AGRN,ANGPT1,B3GALT6,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B3GNT8,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,BCAN,BGN,CEMIP,CHPF,CHPF2,CHST1,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST5,CHST6,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,EXT1,EXT2,FMOD,GALNT5,GCNT2,GLCE,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HAS1,HAS2,HAS3,HEXA,HS2ST1,HS3ST1,HS3ST2,HS3ST3A1,HS3ST3B1,HS3ST5,HS3ST6,HS6ST1,HS6ST2,HSPG2,HYAL1,IL1B,KERA,LUM,NCAN,NDST1,NDST2,OGN,OMD,PRELP,PXYLP1,SDC1,SDC2,SDC3,SDC4,SLC35D2,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6,UGDH,UST,VCAN,XYLT1,XYLT2	The chemical reactions and pathways resulting in the formation of aminoglycans, any polymer containing amino groups that consists of more than about 10 monosaccharide residues joined to each other by glycosidic linkages.
GO:0006024	GO	BP	glycosaminoglycan biosynthetic process	ABCC5,ACAN,AGRN,ANGPT1,B3GALT6,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,BCAN,BGN,CEMIP,CHPF,CHPF2,CHST1,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST5,CHST6,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,EXT1,EXT2,FMOD,GALNT5,GCNT2,GLCE,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HAS1,HAS2,HAS3,HEXA,HS2ST1,HS3ST1,HS3ST2,HS3ST3A1,HS3ST3B1,HS3ST5,HS3ST6,HS6ST1,HS6ST2,HSPG2,HYAL1,IL1B,KERA,LUM,NCAN,NDST1,NDST2,OGN,OMD,PRELP,PXYLP1,SDC1,SDC2,SDC3,SDC4,SLC35D2,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6,UGDH,UST,VCAN,XYLT1,XYLT2	The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
GO:0006026	GO	BP	aminoglycan catabolic process	ACAN,AGRN,ARSB,BCAN,BGN,CD44,CEMIP,CHIA,CHIT1,CHP1,CSPG4,CSPG5,DCN,FGF2,FMOD,FUCA1,GALNS,GLB1,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,HEXA,HEXB,HGSNAT,HMMR,HPSE,HPSE2,HSPG2,HYAL1,HYAL2,HYAL3,HYAL4,IDS,IDUA,KERA,LUM,LYVE1,NAGLU,NCAN,OGN,OMD,PRELP,SDC1,SDC2,SDC3,SDC4,SGSH,SLC9A1,SPACA3,STAB2,TGFB1,VCAN	The chemical reactions and pathways resulting in the breakdown of aminoglycans, any polymer containing amino groups that consists of more than about 10 monosaccharide residues joined to each other by glycosidic linkages.
GO:0006027	GO	BP	glycosaminoglycan catabolic process	ACAN,AGRN,ARSB,BCAN,BGN,CD44,CEMIP,CHP1,CSPG4,CSPG5,DCN,FGF2,FMOD,FUCA1,GALNS,GLB1,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,HEXA,HEXB,HGSNAT,HMMR,HPSE,HPSE2,HSPG2,HYAL1,HYAL2,HYAL3,HYAL4,IDS,IDUA,KERA,LUM,LYVE1,NAGLU,NCAN,OGN,OMD,PRELP,SDC1,SDC2,SDC3,SDC4,SGSH,SLC9A1,SPACA3,STAB2,TGFB1,VCAN	The chemical reactions and pathways resulting in the breakdown of glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars.
GO:0006029	GO	BP	proteoglycan metabolic process	ADAMTS12,AGRN,ARSB,B3GALT6,B3GAT1,B3GAT2,B3GAT3,B4GALT7,BCAN,BGN,BMPR1B,BMPR2,CANT1,CHPF,CHPF2,CHST11,CHST12,CHST13,CHST14,CHST15,CHST3,CHST7,CHST8,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,EXT1,EXT2,FOXL1,GAL3ST3,GAL3ST4,GLCE,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GXYLT1,HEXA,HEXB,HPSE,HS3ST3B1,HS3ST4,HS3ST5,HSPG2,HYAL1,IDS,IDUA,IGF1,LECT1,NCAN,NDNF,PXYLP1,SDC1,SDC2,SDC3,SDC4,SGSH,SULF1,SULF2,UST,VCAN,XYLT2	The chemical reactions and pathways involving proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
GO:0006040	GO	BP	amino sugar metabolic process	AMDHD2,B4GALNT2,CHIA,CHIT1,CHST2,CHST4,CHST5,CHST6,CHST7,CSGALNACT1,EXTL2,FN3K,GFPT1,GFPT2,GNE,GNPDA1,GNPNAT1,LARGE,MGEA5,NAGK,NANP,NPL,PGM3,RENBP,SLC35A3,ST3GAL1,ST3GAL2,ST6GAL1,UAP1	The chemical reactions and pathways involving any amino sugar, sugars containing an amino group in place of a hydroxyl group.
GO:0006044	GO	BP	N-acetylglucosamine metabolic process	CHST2,CHST4,CHST5,CHST6,CHST7,EXTL2,LARGE,MGEA5	The chemical reactions and pathways involving N-acetylglucosamine. The D isomer is a common structural unit of glycoproteins in plants, bacteria and animals; it is often the terminal sugar of an oligosaccharide group of a glycoprotein.
GO:0006047	GO	BP	UDP-N-acetylglucosamine metabolic process	GFPT1,GFPT2,GNPNAT1,PGM3,SLC35A3,UAP1	The chemical reactions and pathways involving UDP-N-acetylglucosamine, a substance composed of N-acetylglucosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.
GO:0006048	GO	BP	UDP-N-acetylglucosamine biosynthetic process	GFPT1,GFPT2,GNPNAT1,PGM3,UAP1	The chemical reactions and pathways resulting in the formation of UDP-N-acetylglucosamine, a substance composed of N-acetylglucosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.
GO:0006054	GO	BP	N-acetylneuraminate metabolic process	AMDHD2,GNE,NAGK,NANP,NPL,RENBP,ST3GAL1,ST6GAL1	The chemical reactions and pathways involving N-acetylneuraminate, the anion of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid.
GO:0006069	GO	BP	ethanol oxidation	ACSS1,ACSS2,ADH1A,ADH1B,ADH1C,ADH4,ADH5,ADH6,ADH7,ALDH1A1,ALDH1B1,ALDH2	An ethanol metabolic process in which ethanol is converted to acetyl-CoA via acetaldehyde and acetate.
GO:0006071	GO	BP	glycerol metabolic process	ANGPTL3,COQ2,COQ3,GK,GOT1,PCK1,PGP	The chemical reactions and pathways involving glycerol, 1,2,3-propanetriol, a sweet, hygroscopic, viscous liquid, widely distributed in nature as a constituent of many lipids.
GO:0006073	GO	BP	cellular glucan metabolic process	AGL,CALM1,CPS1,EPM2A,G6PC,GAA,GBE1,GSK3B,GYG1,GYG2,GYS1,GYS2,MGAM,NHLRC1,NR1D1,PER2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PPP1R3C,PRKAG2,PYGB,PYGL,PYGM,RPS27A,STBD1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways involving glucans, polysaccharides consisting only of glucose residues.
GO:0006081	GO	BP	cellular aldehyde metabolic process	ADH4,AGXT,AGXT2,AKR1A1,AKR1B10,AKR1C1,AKR1C3,AKR7A2,AKR7A3,ALDH1A1,ALDH1A3,ALDH3A1,ALDH3A2,ALDH3B1,ALDH7A1,ALDH8A1,ALDH9A1,ALDOB,AMT,BCKDHA,BCKDHB,BCO1,BCO2,CYP1B1,DAO,DBT,DERA,DHTKD1,DLAT,DLD,DLST,G6PD,GCSH,GLDC,GRHPR,HAO1,HOGA1,KDM3A,KHK,LIAS,LIPT1,LIPT2,NDUFAB1,OGDH,PARK7,PDHA1,PDHB,PDHX,PDXK,PDXP,PGD,PGLS,PGM2,RDH10,RDH11,RPE,RPIA,SDR16C5,SHPK,TALDO1,TKFC,TKT	The chemical reactions and pathways involving aldehydes, any organic compound with the formula R-CH=O, as carried out by individual cells.
GO:0006084	GO	BP	acetyl-CoA metabolic process	ACACA,ACACB,ACLY,ACSS1,DLD,MLYCD,NUDT7,PDHA1,PDHB,PDHX,PIPOX	The chemical reactions and pathways involving acetyl-CoA, a derivative of coenzyme A in which the sulfhydryl group is acetylated; it is a metabolite derived from several pathways (e.g. glycolysis, fatty acid oxidation, amino-acid catabolism) and is further metabolized by the tricarboxylic acid cycle. It is a key intermediate in lipid and terpenoid biosynthesis.
GO:0006085	GO	BP	acetyl-CoA biosynthetic process	ACLY,ACSS1,DLD,MLYCD,PDHA1,PDHB,PDHX	The chemical reactions and pathways resulting in the formation of acetyl-CoA, a derivative of coenzyme A in which the sulfhydryl group is acetylated.
GO:0006090	GO	BP	pyruvate metabolic process	ALDOA,ALDOB,ALDOC,BSG,DLAT,DLD,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GLO1,GPI,HAGH,HK1,HK2,HK3,HOGA1,LDHA,LDHAL6B,LDHB,LDHC,ME3,MPC1,MPC2,NR4A3,PCK1,PDHA1,PDHA2,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,SDS,SLC16A1,SLC16A3,SLC16A8,SRR,TPI1	The chemical reactions and pathways involving pyruvate, 2-oxopropanoate.
GO:0006094	GO	BP	gluconeogenesis	ALDOA,ALDOB,ALDOC,ATF4,CRTC2,CRY1,ENO1,ENO2,ENO3,FBP1,FBP2,G6PC,GAPDH,GAPDHS,GOT1,GOT2,GPI,MDH1,MDH2,PC,PCK1,PCK2,PER2,PFKFB1,PGAM1,PGAM2,PGK1,PGM1,PPARGC1A,PRKACA,PRKACB,PRKACG,RBP4,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,TPI1	The formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol.
GO:0006096	GO	BP	glycolytic process	ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TPI1	The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
GO:0006098	GO	BP	pentose-phosphate shunt	DERA,G6PD,PGD,PGLS,PGM2,RPE,RPIA,SHPK,TALDO1,TKT	The glucose-6-phosphate catabolic process in which, coupled to NADPH synthesis, glucose-6-P is oxidized with the formation of carbon dioxide (CO2) and ribulose 5-phosphate; ribulose 5-P then enters a series of reactions interconverting sugar phosphates. The pentose phosphate pathway is a major source of reducing equivalents for biosynthesis reactions and is also important for the conversion of hexoses to pentoses.
GO:0006099	GO	BP	tricarboxylic acid cycle	ACO2,CS,DLD,DLST,FH,IDH2,IDH3A,IDH3B,IDH3G,MDH2,NNT,OGDH,PDHA1,PDHB,SDHA,SDHB,SDHC,SDHD,SUCLA2,SUCLG1,SUCLG2	A nearly universal metabolic pathway in which the acetyl group of acetyl coenzyme A is effectively oxidized to two CO2 and four pairs of electrons are transferred to coenzymes. The acetyl group combines with oxaloacetate to form citrate, which undergoes successive transformations to isocitrate, 2-oxoglutarate, succinyl-CoA, succinate, fumarate, malate, and oxaloacetate again, thus completing the cycle. In eukaryotes the tricarboxylic acid is confined to the mitochondria. See also glyoxylate cycle.
GO:0006101	GO	BP	citrate metabolic process	ACLY,ACO1,ACO2,CS,DLD,DLST,FH,GHR,IDH2,IDH3A,IDH3B,IDH3G,MDH2,NNT,OGDH,PDHA1,PDHB,SDHA,SDHB,SDHC,SDHD,STAT5A,STAT5B,SUCLA2,SUCLG1,SUCLG2	The chemical reactions and pathways involving citrate, 2-hydroxy-1,2,3-propanetricarboyxlate. Citrate is widely distributed in nature and is an important intermediate in the TCA cycle and the glyoxylate cycle.
GO:0006103	GO	BP	2-oxoglutarate metabolic process	AADAT,ADHFE1,D2HGDH,GHR,GOT1,GOT2,GPT2,IDH1,IDH2,L2HGDH,STAT5A,STAT5B,TAT	The chemical reactions and pathways involving oxoglutarate, the dianion of 2-oxoglutaric acid. It is a key constituent of the TCA cycle and a key intermediate in amino-acid metabolism.
GO:0006105	GO	BP	succinate metabolic process	ALDH5A1,GAD1,GHR,SDHA,STAT5A,STAT5B	The chemical reactions and pathways involving succinate, also known as butanedioate or ethane dicarboxylate, the dianion of succinic acid. Succinate is an important intermediate in metabolism and a component of the TCA cycle.
GO:0006107	GO	BP	oxaloacetate metabolic process	ACLY,GHR,NIT2,STAT5A,STAT5B	The chemical reactions and pathways involving oxaloacetate, the anion of oxobutanedioic acid, an important intermediate in metabolism, especially as a component of the TCA cycle.
GO:0006109	GO	BP	regulation of carbohydrate metabolic process	ACER2,ACTN3,ADIPOQ,ADIPOR1,AKT1,AKT2,AP2A1,ARFGEF1,ARNT,ARPP19,BAD,C1QTNF3,CBFA2T3,CD244,CHP1,CLK2,CLTC,DYRK2,ECD,EGF,ENPP1,ENTPD5,FBP1,FKTN,FOXA2,GAPDHS,GCGR,GCK,GCKR,GOLGA2,GPER1,GPLD1,GRB10,GSK3A,GSK3B,HDAC4,HIF1A,HRH1,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,KAT2B,LHCGR,MLXIP,MLXIPL,MLYCD,MT3,NCOR1,NFKB1,NR1D1,OGT,P2RX7,PARK2,PASK,PDGFB,PDK1,PDK2,PDK3,PDK4,PGAM1,PHKG2,PLEK,PMAIP1,PPARA,PPARGC1A,PPP1R3B,PPP1R3F,PRKAA1,PRKAA2,PRKAG1,PRKAG2,PRKCE,PTH,PTH1R,PTK2B,PTPN2,PUM3,RAMP1,RORA,RORC,SDHAF3,SIK1,SIRT1,SLC51B,SNCA,SOGA1,SORBS1,TGFB1,TIGAR,TINF2,TMEM59,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving carbohydrates.
GO:0006110	GO	BP	regulation of glycolytic process	ACTN3,ARNT,CBFA2T3,ECD,ENTPD5,FBP1,GAPDHS,GCK,HDAC4,HIF1A,IGF1,INS,INSR,MLXIPL,NCOR1,OGT,P2RX7,PGAM1,PPARA,PRKAA1,PRKAA2,PRKAG1,PRKAG2	Any process that modulates the frequency, rate or extent of glycolysis.
GO:0006111	GO	BP	regulation of gluconeogenesis	ADIPOQ,ARPP19,C1QTNF3,CLK2,FBP1,GCK,INS,NR1D1,OGT,PDK2,PPARGC1A,PTPN2,SDHAF3,SIK1,SOGA1,VIMP	Any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol.
GO:0006112	GO	BP	energy reserve metabolic process	ABCC8,ACACA,ACACB,ACLY,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA2A,ADRA2C,ADRB3,AGL,AGPAT1,AKAP5,ARL2,ARL2BP,CACNA1A,CACNA1C,CACNA1D,CACNA1E,CACNA2D2,CALM1,CHRM3,CPS1,EPM2A,FASN,FFAR1,G6PC,GAA,GBE1,GCG,GCGR,GFPT1,GFPT2,GLP1R,GNAS,GNB1,GNB2,GNB3,GNB4,GNG10,GNG11,GNG12,GNG13,GNG2,GNG3,GNG4,GNG5,GNG7,GNG8,GSK3B,GYG1,GYG2,GYS1,GYS2,INS,IQGAP1,ITPR1,ITPR2,ITPR3,KCNB1,KCNC2,KCNG2,KCNJ11,KCNS3,LEPR,MARCKS,MLX,MLXIPL,MRAP2,MT3,MYC,NHLRC1,NR1D1,PER2,PFKFB1,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PID1,PKLR,PPP1R3C,PPP2R5D,PRKAA2,PRKAB2,PRKACA,PRKACB,PRKACG,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PYGB,PYGL,PYGM,RAP1A,RAPGEF3,RAPGEF4,RPS27A,SLC25A4,SLC25A5,SLC25A6,SLC2A1,SLC2A2,SNAP25,STBD1,STK11,STX1A,STXBP1,SYT5,TALDO1,TKT,UBA52,UBB,UBC,UGP2,VAMP2	The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen.
GO:0006119	GO	BP	oxidative phosphorylation	ATP5C1,ATP5D,CHCHD10,COA6,COX10,COX15,GBAS,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,SDHAF2,SURF1,TAZ,TEFM,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH	The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.
GO:0006120	GO	BP	mitochondrial electron transport, NADH to ubiquinone	MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3	The transfer of electrons from NADH to ubiquinone that occurs during oxidative phosphorylation, mediated by the multisubunit enzyme known as complex I.
GO:0006140	GO	BP	regulation of nucleotide metabolic process	ABCA1,ACR,ACTN3,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,APOE,ARNT,ATP7A,ATPIF1,AVPR2,CALCA,CALCR,CALCRL,CALM1,CAP1,CAP2,CBFA2T3,CCR2,CDA,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD2,DRD3,DRD4,DRD5,ECD,EDNRA,EDNRB,EGLN1,ENTPD5,FBP1,FLCN,FZD2,GABBR2,GAPDHS,GCK,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GNB2L1,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,GUCA1C,GUCA2A,GUCA2B,HDAC4,HIF1A,HTR1B,IGF1,INS,INSR,LHCGR,LTB4R2,MAPK7,MC1R,MC2R,MC3R,MC4R,MC5R,ME1,ME2,MLXIPL,MRAP,MRAP2,MTNR1A,NCOR1,NF1,NOS3,NPPC,NTRK1,NTRK2,OGT,OPRM1,OXER1,P2RX7,P2RY11,PALM,PARK7,PDE2A,PDZD3,PF4,PGAM1,PID1,PINK1,PKD2,PPARA,PPARGC1A,PPIF,PRKAA1,PRKAA2,PRKAG1,PRKAG2,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RCVRN,RLN2,SLC25A33,SNCA,THBS1,TIGAR,UQCC2,VCP,VEGFA,VIP,WNT5A	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nucleotides.
GO:0006144	GO	BP	purine nucleobase metabolic process	ADA,ADAL,ADK,ADSL,ADSS,ADSSL1,AMPD1,AMPD2,AMPD3,APRT,ATIC,CAT,DCK,DGUOK,DPYD,GART,GDA,GMPR,GMPR2,GMPS,GPX1,HPRT1,IMPDH1,IMPDH2,LHPP,NT5C,NT5C1A,NT5C1B,NT5C2,NT5E,PAICS,PFAS,PNP,PPAT,PRPS1,SHMT1,XDH	The chemical reactions and pathways involving purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.
GO:0006164	GO	BP	purine nucleotide biosynthetic process	ACOT7,ADA,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,AQP1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,COASY,GBAS,GNAS,GUCY1A3,GUCY1B3,HPRT1,HTR2B,HTR2C,MT-ATP6,MT-ATP8,MTHFD1,NPPA,NPPB,NPPC,NPR1,NPR2,OAS1,OAS2,PANK2,PAPSS1,PAPSS2,PFAS,PPAT,PPCDC,PPCS,PRKAG2,PRPS1,RAMP2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0006165	GO	BP	nucleoside diphosphate phosphorylation	AK1,AK4,AK5,AK7,AK8,AK9,ALDOA,ALDOB,ALDOC,CMPK1,CMPK2,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TPI1	The process of introducing a phosphate group into a nucleoside diphosphate to produce a nucleoside triphosphate.
GO:0006171	GO	BP	cAMP biosynthetic process	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,CALCRL,GNAS,RAMP2,TAAR1	The chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0006182	GO	BP	cGMP biosynthetic process	AQP1,GUCY1A3,GUCY1B3,HTR2B,HTR2C,NPPA,NPPB,NPPC,NPR1,NPR2	The chemical reactions and pathways resulting in the formation of cyclic GMP, guanosine 3',5'-phosphate.
GO:0006195	GO	BP	purine nucleotide catabolic process	AMPD3,CAT,GDA,GPX1,HINT1,HPRT1,MLYCD,MPG,MUTYH,NT5C,NT5C1A,NT5C1B,NT5C2,NT5E,NUDT1,NUDT15,NUDT16,NUDT18,NUDT7,OGG1,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A,PNP,SAMHD1,XDH	The chemical reactions and pathways resulting in the breakdown of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0006198	GO	BP	cAMP catabolic process	PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D	The chemical reactions and pathways resulting in the breakdown of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0006206	GO	BP	pyrimidine nucleobase metabolic process	AGXT2,ALDH6A1,CAD,CDA,DCK,DCTD,DHODH,DPYD,DPYS,DUT,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,PUDP,TK1,TK2,TYMP,TYMS,UCK1,UCK2,UMPS,UPB1,UPP1,UPP2	The chemical reactions and pathways involving pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases.
GO:0006213	GO	BP	pyrimidine nucleoside metabolic process	AGXT2,AK3,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CAD,CDA,CMPK1,CTPS1,DCK,DCTD,DHFRL1,DHODH,DPYD,DPYS,DUT,ENTPD4,ERH,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,PUDP,TK1,TK2,TYMP,TYMS,UCK1,UCK2,UMPS,UPB1,UPP1,UPP2	The chemical reactions and pathways involving any pyrimidine nucleoside, one of a family of organic molecules consisting of a pyrimidine base covalently bonded to ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
GO:0006220	GO	BP	pyrimidine nucleotide metabolic process	AK3,AK5,CMPK1,CTPS1,CTPS2,DCK,ENTPD4,MBD4,NEIL1,NEIL2,NT5C,NT5M,NTHL1,OGG1,PRPS1,SMUG1,TDG,TYMP,TYMS,UMPS,UNG	The chemical reactions and pathways involving a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0006221	GO	BP	pyrimidine nucleotide biosynthetic process	AK5,CMPK1,CTPS1,PRPS1,TYMS,UMPS	The chemical reactions and pathways resulting in the formation of a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0006244	GO	BP	pyrimidine nucleotide catabolic process	ENTPD4,MBD4,NEIL1,NEIL2,NT5C,NT5M,NTHL1,OGG1,SMUG1,TDG,UNG	The chemical reactions and pathways resulting in the breakdown of a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0006260	GO	BP	DNA replication	ACD,ACHE,ALYREF,APEX1,APITD1,ATM,ATR,ATRIP,ATRX,BAZ1A,BLM,BOD1L1,BRCA2,CDC25A,CDC25C,CDC34,CDC45,CDC6,CDC7,CDK1,CDK2,CDK2AP1,CDK9,CHEK1,CLSPN,DBF4,DKC1,DNA2,DUT,EGF,FAM111A,FANCM,FBXO18,FEN1,GAR1,GINS1,GINS2,GINS3,GINS4,HELB,HMBOX1,HMGA1,HUS1,IGF1,IGHMBP2,ING4,ING5,KAT7,KCTD13,KIAA0101,KIN,LIG1,LRWD1,MCM10,MCM2,MCM3,MCM3AP,MCM4,MCM5,MCM6,MCM7,MCM8,MCMBP,MGME1,MMS22L,MRE11A,NAP1L1,NASP,NCOA6,NHP2,NOL8,NOP10,NT5M,NUP98,ORC1,ORC2,ORC3,ORC4,ORC5,ORC6,PCNA,PNKP,POLA1,POLA2,POLB,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLE3,POLG,POLG2,POLL,POT1,PPIA,PRIM1,PRIM2,PRIMPOL,PTGES3,PTMS,PURA,RAD1,RAD17,RAD50,RAD51,RAD9A,RAD9B,RBM14,RBMS1,RECQL4,RECQL5,REV1,REV3L,RFC1,RFC2,RFC3,RFC4,RFC5,RNASEH2A,RPA1,RPA2,RPA3,RPA4,RTEL1,SET,SETMAR,SIRT1,SLBP,SLC25A33,SMARCAL1,SPHAR,STRA13,TBRG1,TEP1,TERF1,TERF2,TERF2IP,TERT,TFAM,THOC1,TICRR,TNFAIP1,TNKS1BP1,TONSL,TREX1,TYMP,UPF1,WRAP53,WRN,ZNF830,ZPR1,ZRANB3	The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.
GO:0006261	GO	BP	DNA-dependent DNA replication	ALYREF,APEX1,APITD1,ATRX,BAZ1A,BLM,BOD1L1,BRCA2,CDC34,CDC45,CDK2AP1,CDK9,DNA2,FANCM,FBXO18,FEN1,GINS1,GINS2,GINS3,GINS4,HELB,HMGA1,LIG1,LRWD1,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MCM8,MCMBP,MGME1,MMS22L,ORC1,ORC2,ORC4,ORC5,PCNA,PNKP,POLA1,POLA2,POLB,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLG,POLG2,PRIM1,PRIM2,PRIMPOL,PURA,RAD51,REV3L,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPA4,RTEL1,SETMAR,SLBP,SLC25A33,SMARCAL1,STRA13,TFAM,THOC1,TONSL,UPF1,WRN,ZNF830,ZPR1,ZRANB3	A DNA replication process that uses parental DNA as a template for the DNA-dependent DNA polymerases that synthesize the new strands.
GO:0006265	GO	BP	DNA topological change	ERCC3,HMGB1,HMGB2,TOP1,TOP2A,TOP2B,TOP3A	The process in which a transformation is induced in the topological structure of a double-stranded DNA helix, resulting in a change in linking number.
GO:0006266	GO	BP	DNA ligation	C9orf142,HMGB1,HMGB2,LIG1,LIG3,LIG4,MGMT,TOP2A,XRCC4,XRCC6	The re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase.
GO:0006270	GO	BP	DNA replication initiation	CDC34,LRWD1,MCM2,ORC1,ORC2,ORC4,ORC5,POLA1,POLA2,POLE,POLE2,PRIM1,PRIM2,PURA,RPA4	The process in which DNA-dependent DNA replication is started; this involves the separation of a stretch of the DNA double helix, the recruitment of DNA polymerases and the initiation of polymerase action.
GO:0006271	GO	BP	DNA strand elongation involved in DNA replication	APEX1,CDC45,DNA2,FEN1,GINS1,GINS2,GINS3,GINS4,LIG1,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MCM8,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,PRIM1,PRIM2,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3	The process in which a DNA strand is synthesized from template DNA during replication by the action of polymerases, which add nucleotides to the 3' end of the nascent DNA strand.
GO:0006275	GO	BP	regulation of DNA replication	ACD,ACVRL1,ANKRD17,AREG,ATM,ATR,ATRX,AURKB,BLM,BMP4,BMP5,BMP6,CALR,CCDC88A,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CDAN1,CDC6,CDC7,CDT1,CERS1,CHEK2,CSF2,CTC1,DBF4B,DKC1,DNA2,DSCC1,E2F7,E2F8,EGFR,EHMT2,ENPP7,EPO,EREG,ESCO1,ESCO2,FBXO18,FBXW7,FGF10,GDF2,GLI1,GLI2,GMNN,GNL3L,GREM1,GRHL2,GTPBP4,HMBOX1,HNRNPA1,HNRNPC,HNRNPU,HRAS,IGF1,IGF1R,IL3,INO80,INS,INSR,KITLG,KLF4,LIG3,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MCRS1,MEN1,MRE11A,NAT10,NBN,NEK2,NEK7,NF2,NVL,OBFC1,PARM1,PCNA,PDGFA,PDGFB,PDGFC,PDGFRA,PDS5A,PID1,PIF1,PINX1,PKIB,PLA2G1B,PML,PNKP,POT1,PPP2CA,PPP2R1A,PRKCQ,RAD17,RBBP6,S100A11,SHC1,SMC1A,SMC3,SMG5,SMG6,SRC,STAG2,STOML2,TCP1,TEN1,TERF1,TERF2,TGFB1,TGFB3,TICRR,TINF2,TIPIN,TNKS,TNKS2,TP53,TSPYL2,WAPL,WIZ,WRAP53,WRNIP1,ZBTB38,ZNF830,ZRANB3	Any process that modulates the frequency, rate or extent of DNA replication.
GO:0006278	GO	BP	RNA-dependent DNA replication	ACD,ATM,DKC1,GAR1,HMBOX1,MRE11A,NHP2,NOP10,POT1,PPIA,PTGES3,RAD50,RFC1,TEP1,TERF1,TERF2,TERF2IP,TERT,TNKS1BP1,WRAP53	A DNA replication process that uses RNA as a template for RNA-dependent DNA polymerases (e.g. reverse transcriptase) that synthesize the new strands.
GO:0006282	GO	BP	regulation of DNA repair	APEX1,AXIN2,BABAM1,BRCA1,BRCC3,BRE,CDK9,CHEK1,DEK,EGFR,ERCC8,EYA1,EYA3,FAM175A,FBXO18,FGF10,FIGNL1,FOXM1,H2AFX,HMGA2,HMGB1,KDM1A,KDM4D,NPAS2,NUDT16,OGG1,OTUB1,PARPBP,PCNA,PML,POLH,POLQ,PPP4C,PPP4R2,PRKCG,RAD51,RAD51AP1,RAD52,RNF168,RNF169,RNF8,RPA2,RPS3,RTEL1,SETMAR,SIRT1,SIRT6,SLF1,SLF2,SPIDR,TERF2,TERF2IP,TFIP11,TIGAR,TMEM161A,TRIM28,TRIP12,TWIST1,UBE2N,UBE2V1,UBE2V2,UBR5,UIMC1,USP1	Any process that modulates the frequency, rate or extent of DNA repair.
GO:0006283	GO	BP	transcription-coupled nucleotide-excision repair	AQR,CCNH,CDK7,COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,CUL4A,CUL4B,DDB1,EP300,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,ERCC6,ERCC8,GPS1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HMGN1,ISY1,LIG1,LIG3,MNAT1,PCNA,POLD1,POLD2,POLD3,POLD4,POLK,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,PPIE,PRPF19,RBX1,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,TCEA1,UBA52,UBB,UBC,USP7,UVSSA,XAB2,XPA,XRCC1,ZNF830	The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway.
GO:0006284	GO	BP	base-excision repair	APEX1,CCNO,DNA2,ERCC6,FEN1,HMGA1,HMGA2,HUWE1,LIG1,LIG3,MBD4,MPG,MUTYH,NEIL1,NEIL2,NEIL3,NTHL1,OGG1,PARG,PARP1,PCNA,PNKP,POLB,POLD1,POLD2,POLD3,POLD4,POLE,POLG,POLQ,PRMT6,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,SMUG1,TDG,TP53,UNG,USP47,WRN,XRCC1	In base excision repair, an altered base is removed by a DNA glycosylase enzyme, followed by excision of the resulting sugar phosphate. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase.
GO:0006285	GO	BP	base-excision repair, AP site formation	MBD4,MPG,MUTYH,NEIL1,NEIL2,NTHL1,OGG1,SMUG1,TDG,UNG	The formation of an AP site, a deoxyribose sugar with a missing base, by DNA glycosylase which recognizes an altered base in DNA and catalyzes its hydrolytic removal. This sugar phosphate is the substrate recognized by the AP endonuclease, which cuts the DNA phosphodiester backbone at the 5' side of the altered site to leave a gap which is subsequently repaired.
GO:0006289	GO	BP	nucleotide-excision repair	AQR,ATXN3,BRCA2,CCNH,CDK7,CETN2,CHD1L,COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,CUL4A,CUL4B,DDB1,DDB2,EP300,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,ERCC6,ERCC8,FAN1,GPS1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HMGN1,ISY1,LIG1,LIG3,LIG4,MMS19,MNAT1,NTHL1,OGG1,PARP1,PCNA,PNKP,POLD1,POLD2,POLD3,POLD4,POLE,POLK,POLL,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,PPIE,PRPF19,RAD23A,RAD23B,RBBP8,RBX1,RFC1,RFC2,RFC3,RFC4,RFC5,RNF111,RPA1,RPA2,RPA3,RPA4,RPS27A,SIRT1,SLC30A9,SLX4,SUMO1,SUMO2,SUMO3,TCEA1,TP53,UBA52,UBB,UBC,UBE2I,UBE2N,UBE2V2,USP45,USP7,UVSSA,XAB2,XPA,XPC,XRCC1,ZNF830	A DNA repair process in which a small region of the strand surrounding the damage is removed from the DNA helix as an oligonucleotide. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase. Nucleotide excision repair recognizes a wide range of substrates, including damage caused by UV irradiation (pyrimidine dimers and 6-4 photoproducts) and chemicals (intrastrand cross-links and bulky adducts).
GO:0006297	GO	BP	nucleotide-excision repair, DNA gap filling	LIG1,LIG3,LIG4,PCNA,POLD1,POLD2,POLD3,POLD4,POLE,POLK,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,UBA52,UBB,UBC,XRCC1	Repair of the gap in the DNA helix by DNA polymerase and DNA ligase after the portion of the strand containing the lesion has been removed by pyrimidine-dimer repair enzymes.
GO:0006298	GO	BP	mismatch repair	ABL1,EXO1,LIG1,MLH1,MLH3,MSH2,MSH3,MSH6,MUTYH,PCNA,PMS2,POLD1,POLD2,POLD3,POLD4,RNASEH2A,RPA1,RPA2,RPA3,SETD2,TDG,TP73,TREX1	A system for the correction of errors in which an incorrect base, which cannot form hydrogen bonds with the corresponding base in the parent strand, is incorporated into the daughter strand. The mismatch repair system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination.
GO:0006301	GO	BP	postreplication repair	BRCA1,CUL4A,CUL4B,DDB1,DTL,FAAP20,ISG15,KIAA0101,MAD2L2,MSH2,NPLOC4,PCNA,POLD1,POLD2,POLD3,POLD4,POLH,POLI,POLK,POLN,PRIMPOL,RAD18,RBX1,RCHY1,REV1,REV3L,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,SPRTN,TRIM25,UBA52,UBA7,UBB,UBC,UBE2A,UBE2B,UBE2L6,UBE2N,UFD1L,USP1,USP10,USP43,VCP,WDR33,ZBTB1,ZBTB32	The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication. Includes pathways that remove replication-blocking lesions in conjunction with DNA replication.
GO:0006302	GO	BP	double-strand break repair	ABL1,ACTR5,AP5S1,AP5Z1,APBB1,APLF,APTX,ATM,ATR,ATRIP,BABAM1,BARD1,BAZ1B,BLM,BRCA1,BRCA2,BRCC3,BRE,BRIP1,C9orf142,CDCA5,CDK2,CHEK1,CHEK2,CIB1,CLSPN,DCLRE1C,DDX1,DNA2,DTX3L,EME1,ERCC1,ERCC4,EXO1,EYA1,EYA2,EYA3,FAM175A,FAN1,FBXO18,FEN1,GEN1,H2AFX,HELQ,HERC2,HIST1H4A,HIST3H3,HUS1,INO80,KAT5,KDM2A,KDM4A,KDM4B,KDM4D,KPNA2,LIG3,LIG4,MAD2L2,MAPK8,MCM9,MDC1,MEIOB,MMS22L,MORF4L1,MRE11A,MTA1,MUS81,NABP1,NABP2,NBN,NHEJ1,NSMCE2,PALB2,PAPD7,PARP1,PARP3,PARP9,PAXIP1,PIAS4,POLA1,POLL,POLM,POLN,POLQ,PPP4C,PPP4R2,PPP5C,PRKDC,PRPF19,PSMD14,RAD1,RAD17,RAD21,RAD50,RAD51,RAD51AP1,RAD51B,RAD51C,RAD51D,RAD52,RAD54B,RAD9A,RAD9B,RBBP8,RFC2,RFC3,RFC4,RFC5,RHNO1,RIF1,RMI1,RMI2,RNF138,RNF168,RNF4,RNF8,RPA1,RPA2,RPA3,RPS27A,RTEL1,SETMAR,SETX,SFPQ,SFR1,SIRT6,SLX1A,SLX4,SMARCA5,SMARCAD1,SMC5,SPIDR,SUMO1,SUMO2,SWI5,SWSAP1,TDP1,TDP2,TIMELESS,TIPIN,TONSL,TOP3A,TOPBP1,TP53,TP53BP1,TRIP13,UBA52,UBB,UBC,UBE2I,UBE2N,UBE2V2,UIMC1,UVRAG,VCP,WHSC1,WRN,XRCC1,XRCC2,XRCC3,XRCC4,XRCC5,XRCC6,XRCC6BP1,YY1,ZFYVE26,ZSWIM7	The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix.
GO:0006303	GO	BP	double-strand break repair via nonhomologous end joining	ATM,BABAM1,BARD1,BRCA1,BRCC3,BRE,C9orf142,DCLRE1C,FAM175A,H2AFX,HERC2,HIST1H4A,HIST3H3,KAT5,KDM2A,LIG3,LIG4,MDC1,MRE11A,NBN,NHEJ1,PAXIP1,PIAS4,POLA1,POLL,POLM,POLQ,PRKDC,PRPF19,PSMD14,RAD50,RIF1,RNF168,RNF8,SETMAR,SUMO1,TP53BP1,UBE2N,UBE2V2,UIMC1,UVRAG,WHSC1,XRCC4,XRCC5,XRCC6,XRCC6BP1	The repair of a double-strand break in DNA in which the two broken ends are rejoined with little or no sequence complementarity. Information at the DNA ends may be lost due to the modification of broken DNA ends. This term covers instances of separate pathways, called classical (or canonical) and alternative nonhomologous end joining (C-NHEJ and A-NHEJ). These in turn may further branch into sub-pathways, but evidence is still unclear.
GO:0006304	GO	BP	DNA modification	AICDA,ALKBH1,ALKBH2,ALKBH3,APEX1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ASCC1,ASCC2,ASCC3,ASZ1,ATF7IP,ATRX,BAZ2A,BEND3,CTCFL,DMAP1,DNMT1,DNMT3A,DNMT3B,DNMT3L,DPPA3,EHMT1,EHMT2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,FKBP6,FOS,FTO,GATAD2A,H3F3A,HIST1H3A,HIST1H4A,HIST2H3A,KMT2E,MAEL,MBD4,MGMT,MPG,MTRR,MUTYH,NEIL1,NEIL2,NTHL1,OGG1,PICK1,PIWIL2,PIWIL4,PLD6,PRMT7,SMUG1,TDG,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH,TET1,TET2,TET3,TRDMT1,UHRF1,UNG,ZFP57	The covalent alteration of one or more nucleotide sites in DNA, resulting in a change in its properties.
GO:0006306	GO	BP	DNA methylation	ASZ1,ATF7IP,ATRX,BAZ2A,BEND3,CTCFL,DMAP1,DNMT1,DNMT3A,DNMT3B,DNMT3L,DPPA3,EHMT1,EHMT2,FKBP6,FOS,GATAD2A,H3F3A,HIST1H3A,HIST1H4A,HIST2H3A,KMT2E,MAEL,MGMT,MTRR,PICK1,PIWIL2,PIWIL4,PLD6,PRMT7,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH,TET3,TRDMT1,UHRF1,ZFP57	The covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
GO:0006307	GO	BP	DNA dealkylation involved in DNA repair	ALKBH1,ALKBH2,ALKBH3,ASCC1,ASCC2,ASCC3,FTO,MGMT,MPG	The repair of alkylation damage, e.g. the removal of the alkyl group at the O6-position of guanine by O6-alkylguanine-DNA alkyltransferase (AGT).
GO:0006308	GO	BP	DNA catabolic process	AIFM1,CASP3,CECR2,DFFA,DFFB,FBXO18,FOXL2,H1F0,HMGB1,HMGB2,ISG20,KPNA1,KPNB1,MUS81,SETMAR,XRN2	The cellular DNA metabolic process resulting in the breakdown of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one.
GO:0006309	GO	BP	apoptotic DNA fragmentation	CASP3,CECR2,DFFA,DFFB,FOXL2,H1F0,HMGB1,HMGB2,KPNA1,KPNB1	The cleavage of DNA during apoptosis, which usually occurs in two stages: cleavage into fragments of about 50 kbp followed by cleavage between nucleosomes to yield 200 bp fragments.
GO:0006310	GO	BP	DNA recombination	ABL1,AP5S1,AP5Z1,APEX1,APITD1,ATM,ATR,ATRIP,ATRX,BABAM1,BARD1,BATF,BLM,BRCA1,BRCA2,BRCC3,BRE,BRIP1,CCNB1IP1,CD40LG,CDK2,CHEK1,CLSPN,DNA2,EME1,ENDOG,ERCC1,ERCC4,EXO1,EXOSC3,EXOSC6,FAM175A,FAN1,FANCM,FBXO18,FEN1,GEN1,H2AFX,HELQ,HERC2,HIST1H4A,HIST3H3,HMGB1,HMGB2,HMGB3,HSPD1,HUS1,IGHMBP2,INO80,KAT5,KDM4D,KLHDC3,LIG1,LIG3,LIG4,MCM9,MDC1,MEIOB,MLH3,MMS22L,MORF4L1,MRE11A,MSH2,MSH4,MSH6,MUS81,NABP1,NABP2,NBN,NCOA6,NSMCE2,PALB2,PARP1,PCNA,PIAS4,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLN,POLQ,PPP4C,PPP4R2,PRDM9,PRIM1,PRIM2,PSMD14,RAD1,RAD17,RAD21,RAD50,RAD51,RAD51AP1,RAD51B,RAD51C,RAD51D,RAD52,RAD54B,RAD54L,RAD9A,RAD9B,RAG1,RAG2,RBBP8,RBM14,RBPJ,REC8,RFC1,RFC2,RFC3,RFC4,RFC5,RHNO1,RMI1,RMI2,RNF138,RNF168,RNF212,RNF4,RNF8,RPA1,RPA2,RPA3,RPS27A,RTEL1,SFPQ,SFR1,SIRT6,SLX1A,SLX4,SMC5,SMC6,SPIDR,STRA13,SUMO1,SUMO2,SUPV3L1,SWI5,SWSAP1,SYCE3,SYCP1,TCF3,TEP1,TEX11,THAP9,TIMELESS,TIPIN,TONSL,TOP3A,TOPBP1,TP53BP1,TREX1,TRIP13,TSN,UBA52,UBB,UBC,UBE2I,UBE2N,UBE2V2,UIMC1,VPRBP,WHSC1,WRN,XRCC1,XRCC2,XRCC3,YY1,ZFYVE26,ZSWIM7	Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Intrachromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.
GO:0006312	GO	BP	mitotic recombination	APEX1,DNA2,ERCC1,FEN1,GEN1,LIG1,NSMCE2,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,PRIM1,PRIM2,RAD51,RAD54B,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,SMC5,SMC6,TEP1,XRCC3	The exchange, reciprocal or nonreciprocal, of genetic material between one DNA molecule and a homologous region of DNA that occurs during mitotic cell cycles.
GO:0006323	GO	BP	DNA packaging	ACIN1,AIFM1,ANP32B,APITD1,ASF1A,ASF1B,ASH1L,ATRX,BAHD1,BRD2,CABIN1,CASC5,CDAN1,CDCA5,CDKN2A,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHAF1A,CHAF1B,CHD5,CHMP1A,CTCF,DAXX,DFFB,ERN2,GPER1,H1FNT,H1FOO,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HELLS,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H3,HJURP,HMGA1,HMGA2,HMGB2,IPO4,ITGB3BP,KAT6A,KAT6B,M1AP,MIS18A,MIS18BP1,NAA10,NAA60,NASP,NCAPD2,NCAPD3,NCAPG,NCAPH,NOC2L,NPM1,NUSAP1,OIP5,PADI4,PAF1,PAPD7,PHF13,PRM1,PRM2,PSME4,RBBP4,RBBP7,RSF1,RUVBL1,SART3,SMARCA5,SMC2,SMC4,SOX9,SPTY2D1,SRPK1,STRA13,SYCP3,TOP2A,TP53,TSSK6,UBN1	Any process in which DNA and associated proteins are formed into a compact, orderly structure.
GO:0006333	GO	BP	chromatin assembly or disassembly	ANP32B,APITD1,ARID1A,ARID2,ASF1A,ASF1B,ATRX,BAHD1,BRD2,CABIN1,CASC5,CDAN1,CDKN2A,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHAF1A,CHAF1B,CTCF,DAXX,H1FOO,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HDAC8,HELLS,HIRA,HIRIP3,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H2A,HIST3H3,HJURP,HMGA1,HMGA2,HMGB2,IPO4,ITGB3BP,KAT6B,M1AP,MIS18A,MIS18BP1,MTA2,NAA60,NASP,NFE2,NOC2L,NPM1,OIP5,PADI4,PAF1,RBBP4,RBBP7,RSF1,RUVBL1,SART3,SET,SMARCA4,SMARCA5,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,SOX9,SPTY2D1,STRA13,SUPT16H,SUV39H2,TNP1,TP53,UBN1	The formation or destruction of chromatin structures.
GO:0006334	GO	BP	nucleosome assembly	ANP32B,APITD1,ASF1A,ASF1B,ATRX,BRD2,CABIN1,CASC5,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPW,CHAF1A,CHAF1B,DAXX,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H3,HJURP,HMGB2,IPO4,ITGB3BP,KAT6B,MIS18A,MIS18BP1,NAA60,NASP,NPM1,OIP5,PADI4,RBBP4,RBBP7,RSF1,RUVBL1,SART3,SMARCA5,SOX9,SPTY2D1,STRA13,UBN1	The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA.
GO:0006335	GO	BP	DNA replication-dependent nucleosome assembly	ASF1A,ASF1B,CHAF1A,CHAF1B,HAT1,HIST1H3A,HIST1H4A,IPO4,NASP,RBBP4	The formation of nucleosomes on newly replicated DNA, coupled to strand elongation.
GO:0006336	GO	BP	DNA replication-independent nucleosome assembly	APITD1,ASF1A,ASF1B,ATRX,CABIN1,CASC5,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPW,H3F3A,HAT1,HIRA,HIST1H4A,HJURP,IPO4,ITGB3BP,MIS18A,MIS18BP1,NASP,NPM1,OIP5,RBBP4,RBBP7,RSF1,RUVBL1,SMARCA5,STRA13,UBN1	The formation of nucleosomes outside the context of DNA replication.
GO:0006337	GO	BP	nucleosome disassembly	ARID1A,ARID2,HIST1H2BA,HIST3H2A,HMGA1,NFE2,SET,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,SUPT16H,TNP1	The controlled breakdown of nucleosomes, the beadlike structural units of eukaryotic chromatin composed of histones and DNA.
GO:0006338	GO	BP	chromatin remodeling	ACTB,ACTL6A,ACTL6B,ANP32E,APITD1,ARID1A,ARID1B,ATRX,BAHD1,BAZ1A,BAZ1B,BAZ2A,BPTF,BRD4,BRDT,CASC5,CBX3,CDKN2A,CECR2,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHD1L,CHD4,CHD5,CHD8,CHEK1,CHRAC1,DAXX,ESR1,FOXA1,FOXP3,GATAD2B,HDAC1,HDAC2,HDAC4,HDAC5,HELLS,HIST1H2BA,HIST1H4A,HJURP,HMGA1,HMGA2,HNRNPC,INO80,ITGB3BP,KAT2A,KAT2B,KMT2B,MBD2,MBD3,MIS18A,MIS18BP1,MTA2,MYB,MYC,MYSM1,NASP,NPM1,NPM2,OIP5,PADI2,PADI4,PBRM1,PIH1D1,PSME4,RB1,RBBP4,RBBP7,RNF8,RSF1,RUVBL1,RUVBL2,SMARCA1,SMARCA2,SMARCA4,SMARCA5,SMARCAD1,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,SOX9,SPTY2D1,STRA13,SUPT4H1,SUPT5H,SUPT6H,SUV39H2,SYCP3,TAF6L,TNP1,TOP1,ZBTB1	Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation.
GO:0006342	GO	BP	chromatin silencing	BAZ2A,BEND3,H3F3A,HDAC2,HDAC5,HELLS,HIST1H3A,HIST1H4A,HIST2H3A,KMT2D,RRP8,SIRT1,SIRT2,SIRT4,SIRT5,SUV39H1,TAF1A,TAF1B,TAF1C,TAF1D,TBP,UBR2	Repression of transcription by altering the structure of chromatin, e.g. by conversion of large regions of DNA into an inaccessible state often called heterochromatin.
GO:0006349	GO	BP	regulation of gene expression by genetic imprinting	CTCFL,DIRAS3,DNMT3A,DNMT3L,IGF2,KDM1B,PRMT7,ZFP57	Heritable alterations in the activity of a gene that depend on whether it passed through the paternal or the maternal germline, but that are not encoded by DNA itself.
GO:0006353	GO	BP	DNA-templated transcription, termination	ALYREF,CCNH,CD3EAP,CDC40,CDK7,CLP1,CPSF1,CPSF2,CPSF3,CPSF7,CRCP,CSTF1,CSTF2,CSTF3,DHX38,ERCC2,ERCC3,FIP1L1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,LSM10,LSM11,MAGOH,MAZ,MNAT1,MTERF1,NCBP1,NCBP2,NUDT21,PABPN1,PAPOLA,PCF11,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2A,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,PRMT5,PTRF,RBM8A,RNPS1,SETX,SLBP,SMN1,SNRPB,SNRPD3,SNRPE,SNRPF,SNRPG,SRRM1,SRSF1,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TTF1,TTF2,TWISTNB,U2AF1,U2AF2,UBTF,UPF3B,ZNF473,ZNRD1	The cellular process that completes DNA-templated transcription; the formation of phosphodiester bonds ceases, the RNA-DNA hybrid dissociates, and RNA polymerase releases the DNA.
GO:0006354	GO	BP	DNA-templated transcription, elongation	ADRM1,CCNH,CCNK,CCNT1,CCNT2,CD3EAP,CDK7,CDK9,CRCP,CTDP1,ELL,ELL3,ELP2,ELP3,ELP4,ERCC2,ERCC3,GTF2A1,GTF2A2,GTF2B,GTF2E1,GTF2E2,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,IKBKAP,MNAT1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,SETD2,SSRP1,SUPT16H,SUPT4H1,SUPT5H,TAF1,TAF10,TAF11,TAF12,TAF13,TAF1A,TAF1B,TAF1C,TAF1D,TAF1L,TAF2,TAF3,TAF4,TAF4B,TAF5,TAF6,TAF9,TAF9B,TBP,TCEA1,TCEA2,TCEB1,TCEB2,TCEB3,TWISTNB,UBTF,ZNRD1	The extension of an RNA molecule after transcription initiation and promoter clearance at a DNA-dependent RNA polymerase promoter by the addition of ribonucleotides catalyzed by an RNA polymerase.
GO:0006356	GO	BP	regulation of transcription from RNA polymerase I promoter	ATF4,DHX33,EIF2AK3,ERBB2,FLNA,H2AFY,H2AFY2,MED1,MTOR,NCL,NOL11,PHF8,PIH1D1,POLR2K,POLR2L,PPP1R15A,RASL11A,SMARCA4,SMARCB1,TFAM,UBTF	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase I promoter.
GO:0006359	GO	BP	regulation of transcription from RNA polymerase III promoter	AR,BRCA1,CEBPA,CHD8,ELL,ERBB2,ICE1,ICE2,MAF1,MTOR,NAB2,POLR3C,POLR3F,PRDX5,RPTOR,TENM1,ZC3H8,ZNF143,ZNF345,ZNF76	Any process that modulates the frequency, rate or extent of transcription from an RNA ploymerase III promoter.
GO:0006360	GO	BP	transcription from RNA polymerase I promoter	CCNH,CD3EAP,CDK7,CEBPA,ERCC2,ERCC3,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,KAT2B,MAPK3,MNAT1,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,PTRF,RRN3,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TTF1,TWISTNB,UBTF,ZNRD1	The synthesis of RNA from a DNA template by RNA polymerase I (RNAP I), originating at an RNAP I promoter.
GO:0006361	GO	BP	transcription initiation from RNA polymerase I promoter	CCNH,CD3EAP,CDK7,ERCC2,ERCC3,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,KAT2B,MAPK3,MNAT1,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,PTRF,RRN3,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TWISTNB,UBTF,ZNRD1	Any process involved in the assembly of the RNA polymerase I preinitiation complex (PIC) at an RNA polymerase I promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.
GO:0006362	GO	BP	transcription elongation from RNA polymerase I promoter	CCNH,CD3EAP,CDK7,ERCC2,ERCC3,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,MNAT1,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TWISTNB,UBTF,ZNRD1	The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase I specific promoter by the addition of ribonucleotides catalyzed by RNA polymerase I.
GO:0006363	GO	BP	termination of RNA polymerase I transcription	CCNH,CD3EAP,CDK7,ERCC2,ERCC3,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,MNAT1,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,PTRF,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TTF1,TWISTNB,UBTF,ZNRD1	The process in which the synthesis of an RNA molecule by RNA polymerase I using a DNA template is completed. RNAP I termination requires binding of a terminator protein so specific sequences downstream of the transcription unit.
GO:0006364	GO	BP	rRNA processing	BOP1,C1D,CIRH1A,DDX27,DDX47,DIS3,DKC1,EMG1,ERI1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FBL,FTSJ2,GEMIN4,IMP4,MPHOSPH6,NHP2,NOC4L,NOL11,NOL6,NOL8,NOL9,NOLC1,NOP14,NOP56,NOP58,NSUN4,PES1,PIN4,RPL11,RPL14,RPL26,RPL35A,RPL5,RPL7,RPS14,RPS15,RPS16,RPS17,RPS19,RPS24,RPS28,RPS6,RPS7,RRP36,RRP9,SBDS,SKIV2L2,UTP20,WDR12,WDR55	Any process involved in the conversion of a primary ribosomal RNA (rRNA) transcript into one or more mature rRNA molecules.
GO:0006368	GO	BP	transcription elongation from RNA polymerase II promoter	ADRM1,CCNH,CCNK,CCNT1,CCNT2,CDK7,CDK9,CTDP1,ELL,ELL3,ELP2,ELP3,ELP4,ERCC2,ERCC3,GTF2A1,GTF2A2,GTF2B,GTF2E1,GTF2E2,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,IKBKAP,MNAT1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,SETD2,SSRP1,SUPT16H,SUPT4H1,SUPT5H,TAF1,TAF10,TAF11,TAF12,TAF13,TAF1L,TAF2,TAF3,TAF4,TAF4B,TAF5,TAF6,TAF9,TAF9B,TBP,TCEA1,TCEB1,TCEB2,TCEB3	The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II.
GO:0006369	GO	BP	termination of RNA polymerase II transcription	ALYREF,CDC40,CLP1,CPSF1,CPSF2,CPSF3,CPSF7,CSTF1,CSTF2,CSTF3,DHX38,FIP1L1,LSM10,LSM11,MAGOH,MAZ,NCBP1,NCBP2,NUDT21,PABPN1,PAPOLA,PCF11,RBM8A,RNPS1,SLBP,SNRPB,SNRPD3,SNRPE,SNRPF,SNRPG,SRRM1,SRSF1,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,TTF2,U2AF1,U2AF2,UPF3B,ZNF473	The process in which the synthesis of an RNA molecule by RNA polymerase II using a DNA template is completed.
GO:0006370	GO	BP	7-methylguanosine mRNA capping	CCNH,CDK7,CMTR1,CMTR2,ERCC2,ERCC3,FAM103A1,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,MNAT1,NCBP1,NCBP2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,RNGTT,RNMT,SUPT5H	Addition of the 7-methylguanosine cap to the 5' end of a nascent messenger RNA transcript.
GO:0006376	GO	BP	mRNA splice site selection	CELF1,NOL3,PSIP1,SETX,SF1,SF3A1,SF3A2,SF3A3,SLU7,SRSF1,SRSF10,SRSF12,SRSF5,SRSF6,SRSF9,YTHDC1	Selection of a splice site by components of the assembling spliceosome.
GO:0006378	GO	BP	mRNA polyadenylation	AHCYL1,APP,CDC73,CPSF1,CPSF3,CPSF6,CSTF1,CSTF2,CSTF3,GRSF1,LEO1,MTPAP,NUDT21,PABPC1,PAF1,PAPOLA,PNPT1,SSU72,SYMPK,TUT1,ZC3H3	The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript.
GO:0006379	GO	BP	mRNA cleavage	AGO2,CPSF1,CPSF3,CSTF1,CSTF2,CSTF3,ERN1,MOV10,NCBP1,NCBP2,PCF11,RNASE4,TUT1	Any process in which a pre-mRNA or mRNA molecule is cleaved at specific sites or in a regulated manner.
GO:0006383	GO	BP	transcription from RNA polymerase III promoter	BDP1,BRF1,BRF2,CRCP,ELL,GTF3A,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6,ICE1,ICE2,IVNS1ABP,POLR1C,POLR1D,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,POU2F1,SNAPC1,SNAPC2,SNAPC3,SNAPC4,SNAPC5,TBP,TROVE2,ZC3H8,ZNF143,ZNF345	The synthesis of RNA from a DNA template by RNA polymerase III, originating at an RNAP III promoter.
GO:0006385	GO	BP	transcription elongation from RNA polymerase III promoter	CRCP,POLR1C,POLR1D,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K	The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase III promoter by the addition of ribonucleotides catalyzed by RNA polymerase III.
GO:0006386	GO	BP	termination of RNA polymerase III transcription	CRCP,POLR1C,POLR1D,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K	The process in which transcription by RNA polymerase III is terminated; Pol III has an intrinsic ability to terminate transcription upon incorporation of 4 to 6 contiguous U residues.
GO:0006388	GO	BP	tRNA splicing, via endonucleolytic cleavage and ligation	C14orf166,CLP1,DDX1,RTCB,TSEN2,TSEN54,ZBTB8OS	Splicing of tRNA substrates via recognition of the folded RNA structure that brings the 5' and 3' splice sites into proximity and cleavage of the RNA at both the 3' and 5' splice sites by an endonucleolytic mechanism, followed by ligation of the exons.
GO:0006390	GO	BP	transcription from mitochondrial promoter	MRPL12,MTERF1,POLRMT,SLC25A33,TEFM,TFAM,TFB2M	The synthesis of RNA from a mitochondrial DNA template, usually by a specific mitochondrial RNA polymerase.
GO:0006398	GO	BP	mRNA 3'-end processing by stem-loop binding and cleavage	CPSF2,CPSF3,LSM11,SLBP,ZNF473	Any mRNA 3'-end processing that involves the binding to and cleavage of a stem-loop structure. For example, histone mRNAs contain a highly conserved stem-loop sequence at the 3' end of the mRNA with a 6 base pairs (bp) stem and a 4-nt loop. The mRNA is cleaved between these two elements, after the fourth or fifth nucleotide, which is typically an adenosine.
GO:0006399	GO	BP	tRNA metabolic process	AAAS,AARS,AARS2,ADAT1,ADAT2,ADAT3,AIMP1,AIMP2,ALKBH8,C14orf166,C2orf49,CARS,CARS2,CDKAL1,CLP1,CPSF1,CPSF4,CSTF2,CTU1,CTU2,DARS,DARS2,DDX1,DUS2,EARS2,EEF1E1,ELAC2,EPRS,FAM98B,FARS2,FARSA,FARSB,GARS,GATB,GATC,GTPBP3,HARS,HARS2,HSD17B10,IARS,IARS2,KARS,KIAA0391,KIAA1456,LAGE3,LARS,LARS2,LCMT2,MARS,MARS2,METTL1,METTL2A,METTL2B,MOCS3,MTO1,NARS,NARS2,NDC1,NSUN2,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,OSGEP,PARS2,POM121,POM121C,POP1,POP4,POP5,POP7,PPA1,PPA2,PTCD1,PUS1,PUS7,QARS,QRSL1,QTRT1,QTRTD1,RAE1,RAN,RANBP2,RARS,RARS2,RPP14,RPP21,RPP25,RPP30,RPP38,RPP40,RTCB,SARS,SARS2,SEH1L,SSB,TARS,TARS2,THG1L,TP53RK,TPR,TPRKB,TRDMT1,TRIT1,TRMT1,TRMT10A,TRMT10C,TRMT11,TRMT112,TRMT12,TRMT13,TRMT44,TRMT5,TRMT6,TRMT61A,TRMT61B,TRMU,TRNT1,TSEN15,TSEN2,TSEN34,TSEN54,TYW1,TYW3,TYW5,URM1,VARS,VARS2,WARS,WARS2,WDR4,XPOT,YARS,YARS2,ZBTB8OS	The chemical reactions and pathways involving tRNA, transfer RNA, a class of relatively small RNA molecules responsible for mediating the insertion of amino acids into the sequence of nascent polypeptide chains during protein synthesis. Transfer RNA is characterized by the presence of many unusual minor bases, the function of which has not been completely established.
GO:0006400	GO	BP	tRNA modification	ADAT1,ADAT2,ADAT3,ALKBH8,CDKAL1,CTU1,CTU2,DUS2,EPRS,GTPBP3,HSD17B10,KIAA1456,LAGE3,LCMT2,METTL1,METTL2A,METTL2B,MOCS3,MTO1,NSUN2,OSGEP,PUS1,PUS7,QTRT1,QTRTD1,SSB,THG1L,TP53RK,TPRKB,TRDMT1,TRIT1,TRMT1,TRMT10A,TRMT10C,TRMT11,TRMT112,TRMT12,TRMT13,TRMT44,TRMT5,TRMT6,TRMT61A,TRMT61B,TRMU,TYW1,TYW3,TYW5,URM1,WDR4	The covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically.
GO:0006402	GO	BP	mRNA catabolic process	AGO1,AGO3,AGO4,ATM,CASC3,CNOT1,CNOT10,CNOT11,CNOT2,CNOT3,CNOT4,CNOT6,CNOT6L,CNOT7,CNOT8,CSDE1,CTIF,DCP1A,DCP1B,DCP2,DCPS,DDX6,DHX34,DIS3,DIS3L2,DXO,EDC3,EDC4,EIF3E,EIF4A1,EIF4A2,EIF4A3,EIF4B,EIF4E,EIF4G1,ERN1,ETF1,EXOSC1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,FAU,GSPT1,GSPT2,LSM1,LSM2,LSM3,LSM4,LSM5,LSM6,LSM7,MAGOH,MAGOHB,MTPAP,NANOS2,NBAS,NCBP1,NCBP2,NT5C3B,NUDT16,PABPC1,PAIP1,PAN2,PAN3,PAPD4,PAPD5,PARN,PATL1,PNPT1,PNRC2,PPP2CA,PPP2R1A,PPP2R2A,RBM8A,RC3H1,RNH1,RNPS1,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RQCD1,SLFN14,SMG1,SMG5,SMG6,SMG7,SMG8,SMG9,SUPV3L1,THRAP3,TNKS1BP1,UBA52,UPF1,UPF2,UPF3A,UPF3B,XRN1,ZFP36,ZFP36L2	The chemical reactions and pathways resulting in the breakdown of mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes.
GO:0006403	GO	BP	RNA localization	AGFG1,ALKBH5,ALYREF,ATM,ATR,ATXN2,BICD1,BUD13,C14orf166,CCT2,CCT4,CDC40,CHTOP,CKAP5,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,EXOSC10,FBL,FIP1L1,FLOT1,FYTTD1,GLE1,HHEX,HNRNPA1,HNRNPA2B1,KIF5C,LUZP4,MAGOH,MEX3D,MRPL18,NCBP1,NCBP2,NOP58,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,PHAX,PIH1D1,PNPT1,POLDIP3,PRPF6,RAE1,RAN,RBFOX1,RBM8A,RFTN1,RNPS1,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,TCP1,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,TST,U2AF1,U2AF2,UPF1,UPF2,UPF3B,WRAP53,XPO5,XPOT,ZC3H11A,ZC3H3,ZNF385A,ZNHIT6	A process in which RNA is transported to, or maintained in, a specific location.
GO:0006405	GO	BP	RNA export from nucleus	AGFG1,ALKBH5,ALYREF,BUD13,CDC40,CHTOP,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FYTTD1,GLE1,HHEX,HNRNPA1,HNRNPA2B1,LUZP4,MAGOH,NCBP1,NCBP2,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,PHAX,POLDIP3,RAE1,RAN,RBM8A,RNPS1,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO5,XPOT,ZC3H11A,ZC3H3	The directed movement of RNA from the nucleus to the cytoplasm.
GO:0006406	GO	BP	mRNA export from nucleus	AGFG1,ALKBH5,ALYREF,BUD13,CDC40,CHTOP,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FYTTD1,GLE1,HHEX,HNRNPA2B1,LUZP4,MAGOH,NCBP1,NCBP2,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,POLDIP3,RAE1,RBM8A,RNPS1,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,U2AF1,U2AF2,UPF1,UPF2,UPF3B,ZC3H11A,ZC3H3	The directed movement of mRNA from the nucleus to the cytoplasm.
GO:0006414	GO	BP	translational elongation	AURKAIP1,CHCHD1,DAP3,DIO2,EEF1A1,EEF1B2,EEF1D,EEF1G,EEF2,EEF2K,FAU,GADD45GIP1,GFM1,ICT1,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,PTCD3,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SELT,SEPSECS,TRNAU1AP,TSFM,TUFM,UBA52	The successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis.
GO:0006415	GO	BP	translational termination	APEH,AURKAIP1,CHCHD1,DAP3,ETF1,FAU,GADD45GIP1,GFM2,GSPT2,ICT1,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,MRRF,MTRF1L,PTCD3,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,UBA52	The process resulting in the release of a polypeptide chain from the ribosome, usually in response to a termination codon (UAA, UAG, or UGA in the universal genetic code).
GO:0006418	GO	BP	tRNA aminoacylation for protein translation	AARS,AARS2,AIMP1,AIMP2,CARS,CARS2,DARS,DARS2,EARS2,EEF1E1,EPRS,FARS2,FARSA,FARSB,GARS,HARS,HARS2,IARS,IARS2,KARS,LARS,LARS2,MARS,MARS2,NARS,NARS2,PARS2,PPA1,PPA2,QARS,RARS,RARS2,SARS,SARS2,TARS,TARS2,VARS,VARS2,WARS,WARS2,YARS,YARS2	The synthesis of aminoacyl tRNA by the formation of an ester bond between the 3'-hydroxyl group of the most 3' adenosine of the tRNA, to be used in ribosome-mediated polypeptide synthesis.
GO:0006446	GO	BP	regulation of translational initiation	AGO2,ATF4,BOLL,CCL5,CTIF,DAZ1,DAZL,DDX1,DDX3X,DNAJC3,EIF1,EIF1B,EIF2AK1,EIF2AK2,EIF2AK3,EIF2AK4,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EIF2S1,EIF3B,EIF3E,EIF3H,EIF4B,EIF4EBP1,EIF4EBP2,EIF4EBP3,EIF4G1,EIF4G2,EIF4G3,EIF4H,EIF5,EIF5B,FMR1,HSPB1,IMPACT,KHDRBS1,KLHL25,METTL3,MTIF2,NCBP1,NCBP2,NCK1,NCK2,NPM1,PAIP2,PAIP2B,PPP1CA,PPP1R15A,PPP1R15B,RBM4,RPL13A,RPS6KB1,RPS6KB2,TPR,UHMK1,YTHDF1,YTHDF2	Any process that modulates the frequency, rate or extent of translational initiation.
GO:0006448	GO	BP	regulation of translational elongation	CPEB2,CPEB3,EIF5A,RPS5,USP16	Any process that modulates the frequency, rate, extent or accuracy of translational elongation.
GO:0006449	GO	BP	regulation of translational termination	ETF1,HRSP12,MTRF1,OGFOD1,UPF1	Any process that modulates the frequency, rate or extent of translational termination.
GO:0006457	GO	BP	protein folding	ACTB,AIP,ALG12,APCS,APOA2,ATF6,BAG1,BAG2,BAG3,BAG4,BAG5,CALR,CANX,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CHCHD4,CHORDC1,CLU,CRTAP,CSNK2A1,DERL2,DNAJA2,DNAJA3,DNAJA4,DNAJB1,DNAJB2,DNAJB6,DNAJB8,DNAJC10,DNAJC19,DNAJC2,DNAJC21,DNAJC24,DNAJC4,DNAJC7,EDEM1,EDEM2,EDEM3,ENTPD5,ERO1A,ERO1B,ERP29,ERP44,FKBP1A,FKBP1B,FKBP4,FKBP5,FKBP6,FKBP9,FUT10,GANAB,GLRX2,HSP90AA1,HSP90B1,HSPA14,HSPA1A,HSPA1B,HSPA1L,HSPA2,HSPA4L,HSPA5,HSPA6,HSPA8,HSPBP1,HSPD1,ITGB3,LMAN1,LMAN2L,LRPAP1,LTBP4,MAN1B1,MESDC2,MLEC,MOGS,MPDU1,NFYC,OS9,P3H1,P4HB,PDIA2,PDIA3,PDIA4,PDIA5,PDIA6,PEX19,PFDN1,PFDN2,PFDN4,PFDN5,PFDN6,PIGK,PPIA,PPIB,PPID,PRKCSH,PTGES3,QSOX1,RP2,RUVBL2,SACS,SEL1L,SEP15,SIL1,SPHK1,ST13,SYVN1,TBCA,TBCB,TBCC,TBCD,TBCE,TCP1,TOR1A,TRAP1,TTC1,TUBA1A,TUBA1B,TUBA1C,TUBA3C,TUBA3E,TUBA4A,TUBA4B,TUBA8,TUBAL3,TUBB1,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBB4B,TUBB6,UGGT1,UGGT2,VBP1,WFS1	The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure.
GO:0006458	GO	BP	'de novo' protein folding	ACTB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CHCHD4,DNAJC2,ENTPD5,ERO1A,FKBP1A,FKBP1B,HSPA14,HSPD1,PFDN1,PFDN2,PFDN4,PFDN5,PFDN6,SEP15,SPHK1,TBCA,TBCB,TBCC,TBCD,TBCE,TCP1,TUBA1A,TUBA1B,TUBA1C,TUBA3C,TUBA3E,TUBA4A,TUBA4B,TUBA8,TUBAL3,TUBB1,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBB4B,TUBB6,UGGT1,VBP1	The process of assisting in the folding of a nascent peptide chain into its correct tertiary structure.
GO:0006465	GO	BP	signal peptide processing	BGLAP,CLN5,F10,F2,F7,F9,FURIN,GAS6,PCSK5,PROC,PROS1,PROZ	The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
GO:0006469	GO	BP	negative regulation of protein kinase activity	ABL1,ADAR,ADARB1,ADIPOQ,AIDA,AKT1,AKT1S1,APC,APOE,BMP4,BMP7,CAV1,CAV3,CBLC,CD300A,CDK5RAP1,CDK5RAP3,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CEBPA,CEP85,CHP1,CIB1,CORO1C,CRIPAK,CUL3,DAB2IP,DBNDD2,DEPTOR,DNAJA1,DNAJA3,DNAJC3,DUS2,DUSP1,DUSP10,DUSP16,DUSP19,DUSP2,DUSP22,DUSP26,DUSP3,DUSP6,DUSP7,DUSP8,DVL1,EPHA1,ERRFI1,FBXO31,FGFR1OP,GBA,GMFB,GMFG,GNAQ,GNB2L1,GPRC5A,GPS1,GPS2,GSTP1,H2AFY,HEXIM1,HEXIM2,HHEX,HIPK3,HSPB1,HYAL2,IBTK,IGF1R,IL1B,INCA1,INPP5K,IRAK3,ITGB1BP1,LATS1,LATS2,LAX1,LRP5,LRP6,LYN,MAPK8IP1,MBIP,MEN1,MVP,MYOCD,NCK1,NF1,NPM1,NR2F2,PAK2,PAQR3,PARK7,PDCD4,PDPK1,PKIA,PLK1,PPM1E,PPM1F,PPP1R1B,PPP2CA,PPP2R1A,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCD,PRKRIP1,PTEN,PTK6,PTPN1,PTPN22,PTPRC,PTPRJ,PYCARD,PYDC1,RGS14,RGS2,RGS3,RGS4,SERPINB3,SFN,SH3BP5,SIRT1,SMPD1,SNX6,SOCS1,SOCS3,SOCS4,SOCS5,SORL1,SPRED1,SPRED2,SRCIN1,STK38,TAF7,TAOK3,TARBP2,TFAP4,THY1,TRIB1,TRIB2,TRIB3,TRIM27,TSC2,UBE2C,UCHL1,WWTR1,YWHAG,ZFYVE28,ZGPAT,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity.
GO:0006470	GO	BP	protein dephosphorylation	BTRC,CAMK2G,CDC14B,CDC25B,CDC25C,CDKN3,CTDNEP1,CTDP1,CTDSP1,CTDSP2,CTTNBP2NL,CYCS,DAPP1,DLG1,DLGAP5,DUSP1,DUSP10,DUSP11,DUSP12,DUSP13,DUSP18,DUSP2,DUSP21,DUSP22,DUSP26,DUSP3,DUSP4,DUSP5,DUSP6,DUSP7,DUSP8,DUSP9,EPM2A,EYA1,EYA2,EYA3,FBXW11,LCK,LHPP,MTM1,MTMR2,MTMR3,MTMR4,MTMR6,MTMR7,NCK1,PDP1,PDXP,PGP,PHPT1,PLPP2,PLPP3,PPEF1,PPEF2,PPM1A,PPM1B,PPM1D,PPM1E,PPM1F,PPM1G,PPM1M,PPP1CA,PPP1CB,PPP1CC,PPP1R12A,PPP1R15A,PPP1R15B,PPP1R3C,PPP2CA,PPP2CB,PPP2R1A,PPP2R2A,PPP2R3A,PPP2R3B,PPP2R5D,PPP3CA,PPP3CB,PPP3R1,PPP4C,PPP4R1,PPP5C,PPP6C,PTEN,PTP4A1,PTP4A2,PTP4A3,PTPN1,PTPN11,PTPN12,PTPN13,PTPN14,PTPN18,PTPN2,PTPN21,PTPN22,PTPN23,PTPN3,PTPN4,PTPN5,PTPN6,PTPN7,PTPN9,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRH,PTPRJ,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRT,PTPRU,PTPRZ1,RPAP2,RPRD1A,RPRD1B,SBF1,SDHAF2,SSH1,SSH2,SSU72,TIMM50,TPTE,UBLCP1	The process of removing one or more phosphoric residues from a protein.
GO:0006471	GO	BP	protein ADP-ribosylation	ARF4,ART4,PARP1,PARP10,PARP16,PARP3,PARP4,SIRT2,SIRT4,SIRT6,TNKS,TNKS2	The transfer, from NAD, of ADP-ribose to protein amino acids.
GO:0006473	GO	BP	protein acetylation	AANAT,ACTL6A,APBB1,ASL,ATAT1,ATF2,BAG6,BEND3,BLOC1S1,BRCA2,BRD1,BRD8,BRPF1,BRPF3,CHD5,CLOCK,CPA4,CREBBP,CSRP2BP,DMAP1,DR1,DSCC1,EHHADH,ELP3,ELP4,EP300,EP400,EPC1,ESCO1,ESCO2,FOXO1,GTF3C4,HAT1,HCFC1,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,KMT2A,LDB1,LEF1,MAP3K7,MBIP,MCRS1,MDH2,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60,NAT8,NAT8B,NCOA3,OGT,PCK1,PER1,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SIRT1,SPI1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TRIM16,TRRAP,USP22,WDR5,YEATS2,YEATS4	The addition of an acetyl group to a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.
GO:0006474	GO	BP	N-terminal protein amino acid acetylation	AANAT,CREBBP,EP300,KAT2B,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60	The acetylation of the N-terminal amino acid of proteins.
GO:0006475	GO	BP	internal protein amino acid acetylation	ACTL6A,APBB1,ASL,ATAT1,ATF2,BAG6,BEND3,BRCA2,BRD1,BRD8,BRPF1,BRPF3,CHD5,CLOCK,CPA4,CREBBP,CSRP2BP,DMAP1,DR1,EHHADH,ELP3,ELP4,EP300,EP400,EPC1,GTF3C4,HAT1,HCFC1,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,KMT2A,LDB1,LEF1,MAP3K7,MBIP,MCRS1,MDH2,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA10,NAA50,NAA60,NAT8,NAT8B,NCOA3,OGT,PCK1,PER1,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SPI1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TRIM16,TRRAP,USP22,WDR5,YEATS2,YEATS4	The addition of an acetyl group to a non-terminal amino acid in a protein.
GO:0006476	GO	BP	protein deacetylation	BAZ2A,ELK4,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC9,MORF4L1,NACC2,PER1,PER2,PHB,PRDM5,RCOR1,REST,SALL1,SFPQ,SIN3A,SIRT1,SIRT2,SIRT3,SIRT4,SIRT5,SIRT6,SIRT7,SMARCAD1,SUDS3	The removal of an acetyl group from a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.
GO:0006479	GO	BP	protein methylation	ARMT1,ASH1L,ASH2L,BEND3,BHMT,CARM1,CHD5,COPRS,CTCFL,CTR9,CXXC1,DPY30,EEF2KMT,EHMT1,EHMT2,ETF1,EZH2,FBL,FBXO11,GSPT1,KDM6A,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,MEN1,METTL20,METTL21A,METTL21C,N6AMT1,NR1H4,NSD1,NTMT1,OGT,PAXIP1,PCMT1,PRDM4,PRDM5,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RAB6A,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SNRPB,SNRPD3,SUV39H1,SUV39H2,TET2,TET3,TRMT112,VCPKMT,WDR5,WDR61,WDR82,WHSC1L1,ZNF335	The addition of a methyl group to a protein amino acid. A methyl group is derived from methane by the removal of a hydrogen atom.
GO:0006482	GO	BP	protein demethylation	ALKBH4,HIST1H4A,JMJD6,KDM1A,KDM1B,KDM2A,KDM3A,KDM4A,KDM4C,KDM4D,KDM5B,KDM5C,KDM5D,KDM7A,KDM8,PHF2,PHF8,PPME1	The removal of a methyl group, from a protein amino acid. A methyl group is derived from methane by the removal of a hydrogen atom.
GO:0006488	GO	BP	dolichol-linked oligosaccharide biosynthetic process	ALG1,ALG10,ALG10B,ALG11,ALG12,ALG13,ALG14,ALG2,ALG3,ALG5,ALG6,ALG8,ALG9,CMAS,CTSA,DHDDS,DOLK,DOLPP1,DPAGT1,DPM1,DPM2,DPM3,FPGT,FUK,FUOM,GFPT1,GFPT2,GLB1,GMDS,GMPPA,GMPPB,GNE,GNPNAT1,MPDU1,MPI,MVD,NANP,NANS,NEU1,NEU2,NEU3,NEU4,NPL,NUS1,PGM3,PMM1,PMM2,RFT1,SLC17A5,SLC35A1,SLC35C1,SRD5A3,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL5,ST3GAL6,ST6GAL1,ST6GAL2,ST6GALNAC1,ST6GALNAC2,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,TSTA3,UAP1	The chemical reactions and pathways resulting in the formation of dolichol-linked oligosaccharide, usually by a stepwise addition of glycosyl chains to endoplasmic reticulum membrane-bound dolichol-P.
GO:0006489	GO	BP	dolichyl diphosphate biosynthetic process	DHDDS,DOLK,DOLPP1,MVD,NUS1,SRD5A3	The chemical reactions and pathways resulting in the formation of dolichyl diphosphate, a diphosphorylated dolichol derivative.
GO:0006491	GO	BP	N-glycan processing	FUT8,GNPTAB,MAN1A2,MGAT4A,MGAT4B,ST8SIA2,ST8SIA3,ST8SIA4	The conversion of N-linked glycan (N = nitrogen) structures from the initially transferred oligosaccharide to a mature form, by the actions of glycosidases and glycosyltransferases. The early processing steps are conserved and play roles in glycoprotein folding and trafficking.
GO:0006493	GO	BP	protein O-linked glycosylation	A4GNT,ADAMTS13,ADAMTS5,ADAMTS7,ADAMTSL1,ADAMTSL4,B3GALNT2,B3GLCT,B3GNT2,B3GNT3,B3GNT4,B3GNT5,B3GNT6,B3GNT7,B3GNT8,B4GALT5,B4GAT1,C1GALT1,C1GALT1C1,CFP,CHST4,DPM1,DPM2,DPM3,EOGT,FKRP,FKTN,GALNT1,GALNT10,GALNT11,GALNT12,GALNT13,GALNT14,GALNT15,GALNT2,GALNT3,GALNT4,GALNT5,GALNT6,GALNT7,GALNT8,GALNT9,GCNT1,GCNT3,GCNT4,GXYLT1,GXYLT2,GYLTL1B,ISPD,KCNE1,LARGE,MUC1,MUC12,MUC13,MUC15,MUC16,MUC17,MUC20,MUC21,MUC3A,MUC4,MUC5AC,MUC5B,MUC6,MUC7,MUCL1,OGT,PGM3,POFUT1,POFUT2,POGLUT1,POMGNT1,POMGNT2,POMK,POMT1,SDF2,SPON1,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST6GAL1,ST6GALNAC2,ST6GALNAC4,ST8SIA6,TET1,TET2,TET3,THBS1,TMEM5,TRAK1	A protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the hydroxyl group of peptidyl-serine, peptidyl-threonine, peptidyl-hydroxylysine, or peptidyl-hydroxyproline, or via the phenol group of peptidyl-tyrosine, forming an O-glycan.
GO:0006497	GO	BP	protein lipidation	ALOX12B,ATG10,ATG7,CLIP3,DPM1,DPM2,DPM3,GOLGA7,GPAA1,MBOAT4,MPPE1,NMT1,NMT2,OAS2,PGAP1,PGAP2,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PORCN,PPM1A,PPM1B,PYURF,ZDHHC1,ZDHHC12,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	The covalent attachment of lipid groups to an amino acid in a protein.
GO:0006501	GO	BP	C-terminal protein lipidation	DPM1,DPM2,DPM3,GPAA1,PGAP1,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PLAUR	The covalent attachment of a lipid group to the carboxy terminus of a protein.
GO:0006505	GO	BP	GPI anchor metabolic process	DPM1,DPM2,DPM3,GPAA1,GPLD1,MPPE1,PGAP1,PGAP2,PGAP3,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PYURF	The chemical reactions and pathways involving glycosylphosphatidylinositol anchors, molecular mechanisms for attaching membrane proteins to the lipid bilayer of cell membranes. Structurally they consist of a molecule of phosphatidylinositol to which is linked, via the C-6 hydroxyl of the inositol, a carbohydrate chain. This chain is in turn linked to the protein through an ethanolamine phosphate group, the amino group of which is in amide linkage with the C-terminal carboxyl of the protein chain, the phosphate group being esterified to the C-6 hydroxyl of the terminal mannose of the core carbohydrate chain.
GO:0006506	GO	BP	GPI anchor biosynthetic process	DPM1,DPM2,DPM3,GPAA1,MPPE1,PGAP1,PGAP2,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PYURF	The chemical reactions and pathways resulting in the formation of a glycosylphosphatidylinositol (GPI) anchor that attaches some membrane proteins to the lipid bilayer of the cell membrane. The phosphatidylinositol group is linked via the C-6 hydroxyl residue of inositol to a carbohydrate chain which is itself linked to the protein via an ethanolamine phosphate group, its amino group forming an amide linkage with the C-terminal carboxyl of the protein. Some GPI anchors have variants on this canonical linkage.
GO:0006509	GO	BP	membrane protein ectodomain proteolysis	ADAM10,ADAM17,ADAM9,APH1A,BACE1,BACE2,DAG1,ERAP1,MYH9,NCSTN,PRKCQ,PSEN1,PSEN2,PSENEN,RBMX,SPPL2A,SPPL2B	The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain).
GO:0006513	GO	BP	protein monoubiquitination	BCOR,CDC73,CTR9,CUL3,CUL4B,DDB1,DDB2,DTL,DTX3L,FANCL,HUWE1,KDM2B,KLHL12,KLHL22,LEO1,MGRN1,NEURL1,PAF1,PARK2,PCGF1,RAG1,RBX1,RING1,RNF126,RNF168,RNF2,RNF20,RNF40,RYBP,SKP1,TOPORS,TRIM21,TRIM25,TRIM37,UBE2B,UBE2D3,UBE2E1,UBE2O,UBE2R2,UBE2T,UBE2W,UHRF1,WAC	Addition of a single ubiquitin group to a protein.
GO:0006515	GO	BP	misfolded or incompletely synthesized protein catabolic process	ATXN3,DERL1,HDAC6,OMA1,RNF126,RNF5,STUB1,TOR1A,UBE2W,UFD1L,VCP,YME1L1	The chemical reactions and pathways resulting in the breakdown of misfolded or attenuated proteins.
GO:0006516	GO	BP	glycoprotein catabolic process	ADAMTS12,ADAMTS9,EDEM1,EDEM2,EDEM3,FBXO2,GPC1,HPSE,MAN1B1,MGEA5,NEU4,NGLY1,STT3B	The chemical reactions and pathways resulting in the breakdown of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
GO:0006517	GO	BP	protein deglycosylation	AGA,EDEM1,EDEM2,EDEM3,MAN1A1,MAN1A2,MAN1B1,MAN1C1,MAN2B1,MGEA5,PARK7	The removal of sugar residues from a glycosylated protein.
GO:0006521	GO	BP	regulation of cellular amino acid metabolic process	ATCAY,ATP2B4,AZIN1,BHMT,GATA3,HPN,INS,NQO1,NR1H4,OAZ1,OAZ2,OAZ3,ODC1,PARK7,PAX8,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amino acids.
GO:0006525	GO	BP	arginine metabolic process	ARG1,ART4,ASL,DDAH1,DDAH2,NOS1,NOS2,NOS3	The chemical reactions and pathways involving arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
GO:0006527	GO	BP	arginine catabolic process	ARG1,ASL,DDAH1,DDAH2,NOS1,NOS2,NOS3	The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.
GO:0006531	GO	BP	aspartate metabolic process	ASPA,ASS1,DDO,GOT1,GOT2	The chemical reactions and pathways involving aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid.
GO:0006534	GO	BP	cysteine metabolic process	AGXT,CBS,CDO1,CTH,GCLC,GGT1	The chemical reactions and pathways involving cysteine, 2-amino-3-mercaptopropanoic acid.
GO:0006536	GO	BP	glutamate metabolic process	AADAT,ALDH18A1,ALDH5A1,FPGS,GAD1,GCLC,GCLM,GGT1,GLS,GLUD1,GLUD2,GLUL,GOT1,GOT2,MTHFS,NAGS,TAT	The chemical reactions and pathways involving glutamate, the anion of 2-aminopentanedioic acid.
GO:0006541	GO	BP	glutamine metabolic process	ALDH5A1,CAD,GLS,GLUD1,GLUL,NIT2,SIRT4	The chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid.
GO:0006544	GO	BP	glycine metabolic process	AGXT,AGXT2,BAAT,DMGDH,GCSH,GLDC,GLYAT,SHMT1,SHMT2,SLC25A32	The chemical reactions and pathways involving glycine, aminoethanoic acid.
GO:0006548	GO	BP	histidine catabolic process	AMDHD1,CARNS1,FTCD,HAL,HDC,HNMT,UROC1	The chemical reactions and pathways resulting in the breakdown of histidine, 2-amino-3-(1H-imidazol-4-yl)propanoic acid.
GO:0006554	GO	BP	lysine catabolic process	AADAT,AASS,ALDH7A1,CRYM,DLD,DLST,GCDH,HYKK,OGDH,PHYKPL,PIPOX,SLC25A21	The chemical reactions and pathways resulting in the breakdown of lysine, 2,6-diaminohexanoic acid.
GO:0006555	GO	BP	methionine metabolic process	ADI1,APIP,BHMT,BHMT2,ENOPH1,GOT1,MRI1,MSRA,MTAP,MTHFD1,MTHFR,MTR,MTRR,SMS	The chemical reactions and pathways involving methionine (2-amino-4-(methylthio)butanoic acid), a sulfur-containing, essential amino acid found in peptide linkage in proteins.
GO:0006559	GO	BP	L-phenylalanine catabolic process	ASRGL1,CCBL1,FAH,GSTZ1,HGD,HPD,IL4I1,PAH,PCBD1,QDPR,TAT	The chemical reactions and pathways resulting in the breakdown of phenylalanine, 2-amino-3-phenylpropanoic acid.
GO:0006560	GO	BP	proline metabolic process	ALDH18A1,ALDH4A1,DAO,PRODH,PYCR1,PYCR2,PYCRL	The chemical reactions and pathways involving proline (pyrrolidine-2-carboxylic acid), a chiral, cyclic, nonessential alpha-amino acid found in peptide linkage in proteins.
GO:0006563	GO	BP	L-serine metabolic process	CBS,PHGDH,PSAT1,PSPH,SDS,SHMT1,SHMT2,SRR	The chemical reactions and pathways involving L-serine, the L-enantiomer of serine, i.e. (2S)-2-amino-3-hydroxypropanoic acid.
GO:0006568	GO	BP	tryptophan metabolic process	AADAT,ACMSD,AFMID,ATP7A,CCBL1,CCBL2,HAAO,IDO1,IDO2,KMO,KYNU,TDO2	The chemical reactions and pathways involving tryptophan, the chiral amino acid 2-amino-3-(1H-indol-3-yl)propanoic acid.
GO:0006569	GO	BP	tryptophan catabolic process	AADAT,ACMSD,AFMID,CCBL1,CCBL2,HAAO,IDO1,IDO2,KMO,KYNU,TDO2	The chemical reactions and pathways resulting in the breakdown of tryptophan, the chiral amino acid 2-amino-3-(1H-indol-3-yl)propanoic acid.
GO:0006570	GO	BP	tyrosine metabolic process	DCT,HPD,TAT,TH,TYR	The chemical reactions and pathways involving tyrosine, an aromatic amino acid, 2-amino-3-(4-hydroxyphenyl)propanoic acid.
GO:0006573	GO	BP	valine metabolic process	ALDH6A1,GHR,HIBADH,STAT5A,STAT5B	The chemical reactions and pathways involving valine, 2-amino-3-methylbutanoic acid.
GO:0006576	GO	BP	cellular biogenic amine metabolic process	AADAT,AANAT,ABHD3,ACHE,ACMSD,ADI1,AFMID,AGMAT,AMD1,APIP,APOA1,APOA2,APOA4,ARG1,ARG2,ASL,ASMT,ASS1,ATP7A,AZIN1,AZIN2,CCBL1,CCBL2,CDS1,CEPT1,CETP,CHAT,CHKA,CHKB,CHPT1,CKB,CKM,CKMT1A,CKMT2,CLN3,CPS1,DBI,DDC,DMGDH,ENOPH1,ENPP2,ENPP6,ENPP7,GAMT,GATM,GOT1,GPAT4,GPLD1,HAAO,HDC,IDO1,IDO2,KMO,KYNU,LCAT,LIPC,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LPIN1,LPIN2,LPIN3,MAOA,MBOAT1,MBOAT2,MRI1,MTAP,NAGS,NQO1,OAZ1,OAZ2,OAZ3,ODC1,OTC,PAFAH1B1,PAOX,PCYT1A,PCYT1B,PEMT,PHOSPHO1,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLB1,PLBD1,PNPLA8,PON1,PRG3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,SAMD8,SAT1,SAT2,SGMS1,SGMS2,SLC25A15,SLC25A2,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SLC6A8,SMOX,SMPD1,SMPD2,SMPD3,SMPD4,SMS,SRM,SULT1B1,TDO2,TPH1,TPH2	The chemical reactions and pathways occurring at the level of individual cells involving any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters.
GO:0006577	GO	BP	amino-acid betaine metabolic process	ACADL,ACADM,ALDH9A1,BBOX1,BHMT,CPT1A,CRAT,CROT,SHMT1,TMLHE	The chemical reactions and pathways involving any betaine, the N-trimethyl derivative of an amino acid.
GO:0006584	GO	BP	catecholamine metabolic process	ATP7A,DAO,DBH,DDC,DRD1,DRD2,DRD3,DRD4,GATA3,GCH1,HAND2,INSM1,LRTOMT,MAOA,MAOB,PAH,PARK2,PNMT,SNCA,SNCAIP,TGFB2,TH	The chemical reactions and pathways involving any of a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.
GO:0006586	GO	BP	indolalkylamine metabolic process	AADAT,AANAT,ACMSD,AFMID,ASMT,ATP7A,CCBL1,CCBL2,DDC,HAAO,IDO1,IDO2,KMO,KYNU,TDO2,TPH1,TPH2	The chemical reactions and pathways involving indolalkylamines, indole or indole derivatives containing a primary, secondary, or tertiary amine group.
GO:0006590	GO	BP	thyroid hormone generation	CPQ,DIO1,DIO2,DIO3,DUOX1,DUOX2,FOXE1,IYD,SLC5A5,TPO	The formation of either of the compounds secreted by the thyroid gland, mainly thyroxine and triiodothyronine. This is achieved by the iodination and joining of tyrosine molecules to form the precursor thyroglobin, proteolysis of this precursor gives rise to the thyroid hormones.
GO:0006595	GO	BP	polyamine metabolic process	ADI1,AGMAT,AMD1,APIP,ARG1,ARG2,ASL,ASS1,AZIN1,AZIN2,CKB,CKM,CKMT1A,CKMT2,CPS1,ENOPH1,GAMT,GATM,GOT1,MRI1,MTAP,NAGS,NQO1,OAZ1,OAZ2,OAZ3,ODC1,OTC,PAOX,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,SAT1,SAT2,SLC25A15,SLC25A2,SLC6A8,SMOX,SMS,SRM	The chemical reactions and pathways involving polyamines, any organic compound containing two or more amino groups.
GO:0006596	GO	BP	polyamine biosynthetic process	ODC1,PAOX,SAT1,SMOX,SRM	The chemical reactions and pathways resulting in the formation of polyamines, any organic compound containing two or more amino groups.
GO:0006600	GO	BP	creatine metabolic process	CKB,CKM,CKMT1A,CKMT2,GAMT,GATM,GHR,SLC6A8,STAT5A,STAT5B	The chemical reactions and pathways involving creatine (N-(aminoiminomethyl)-N-methylglycine), a compound synthesized from the amino acids arginine, glycine, and methionine that occurs in muscle.
GO:0006606	GO	BP	protein import into nucleus	ADAR,AKR1C3,AKT1,BCL3,BCL6,C11orf73,CBLB,CEP57,DAG1,EGF,F2R,FYB,GCKR,GDF5,HES1,IFNG,IPO13,IPO5,IPO9,JAK2,JAK3,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,MCM3AP,MT3,NCKIPSD,NOP58,NUP205,NUP98,NUTF2,OPRD1,OR1D2,PDIA3,PHB2,PPP1R10,PRICKLE1,PTTG1IP,RAN,RANBP17,RANBP2,RBM22,RERE,RPAIN,RPL23,SEC61B,SIX3,STAT3,SYK,TGFB1,TGFB2,TNF,TNPO1,TNPO3,TPR,TRPS1,TSC2,ZFYVE9	The directed movement of a protein from the cytoplasm to the nucleus.
GO:0006607	GO	BP	NLS-bearing protein import into nucleus	CBLB,DAG1,FYB,IPO5,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,NCKIPSD,RANBP2,RERE,TRPS1	The directed movement of a protein bearing a nuclear localization signal (NLS) from the cytoplasm into the nucleus, across the nuclear membrane.
GO:0006611	GO	BP	protein export from nucleus	ADAR,CALR,CHP1,CSE1L,DUSP16,EGR2,EIF5A,NUP214,NUPL2,NUTF2,PKD1,RAN,SMURF1,STRADA,STRADB,STYX,TGFB1,XPO1,XPO5,XPO6,XPO7	The directed movement of a protein from the nucleus into the cytoplasm.
GO:0006612	GO	BP	protein targeting to membrane	ANK1,ANK3,ARL6,ATG3,ATG4C,BSG,CHM,CHMP4A,CHMP4B,DDOST,EHD3,FAU,GAS6,ICMT,INPP5K,KCNB1,KCNB2,MICALL1,MYADM,MYO1C,NCF1,NKD2,PACS1,PACS2,PARD3,PEX16,PEX19,PEX3,PEX5,PIP5K1A,PRKCI,PTCH1,RAB3IP,RAB8B,RABGEF1,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPN1,RPN2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RTP3,RTP4,SDCBP,SEC11A,SEC11C,SEC61A1,SEC61B,SEC61G,SEC62,SEC63,SMURF1,SPCS1,SPCS2,SPCS3,SPTBN1,SRP14,SRP19,SRP54,SRP68,SRP72,SRP9,SRPR,SRPRB,SSR1,SSR2,SSR3,SSR4,TAOK2,TESC,TMED2,TRAM1,UBA52,ZFAND2B	The process of directing proteins towards a membrane, usually using signals contained within the protein.
GO:0006613	GO	BP	cotranslational protein targeting to membrane	DDOST,FAU,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPN1,RPN2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEC11A,SEC11C,SEC61A1,SEC61B,SEC61G,SEC62,SEC63,SPCS1,SPCS2,SPCS3,SRP14,SRP19,SRP54,SRP68,SRP72,SRP9,SRPR,SRPRB,SSR1,SSR2,SSR3,SSR4,TRAM1,UBA52,ZFAND2B	The targeting of proteins to a membrane that occurs during translation. The transport of most secretory proteins, particularly those with more than 100 amino acids, into the endoplasmic reticulum lumen occurs in this manner, as does the import of some proteins into mitochondria.
GO:0006614	GO	BP	SRP-dependent cotranslational protein targeting to membrane	DDOST,FAU,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPN1,RPN2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEC11A,SEC11C,SEC61A1,SEC61B,SEC61G,SEC63,SPCS1,SPCS2,SPCS3,SRP14,SRP19,SRP54,SRP68,SRP72,SRP9,SRPR,SRPRB,SSR1,SSR2,SSR3,SSR4,TRAM1,UBA52,ZFAND2B	The targeting of proteins to a membrane that occurs during translation and is dependent upon two key components, the signal-recognition particle (SRP) and the SRP receptor. SRP is a cytosolic particle that transiently binds to the endoplasmic reticulum (ER) signal sequence in a nascent protein, to the large ribosomal unit, and to the SRP receptor in the ER membrane.
GO:0006620	GO	BP	posttranslational protein targeting to membrane	CHMP4A,CHMP4B,SEC61A1,SEC62,SEC63	The targeting of proteins to a membrane that occurs after their translation. Some secretory proteins exhibit posttranslational transport into the endoplasmic reticulum (ER) lumen: they are synthesized in their entirety on free cytosolic ribosomes and then released into the cytosol, where they are bound by chaperones which keep them in an unfolded state, and subsequently are translocated across the ER membrane.
GO:0006621	GO	BP	protein retention in ER lumen	ANKRD13C,GPAA1,OS9,PDIA2,PDIA3	The retention in the endoplasmic reticulum (ER) lumen of soluble resident proteins. Sorting receptors retrieve proteins with ER localization signals, such as KDEL and HDEL sequences or some transmembrane domains, that have escaped to the cis-Golgi network and return them to the ER. Abnormally folded proteins and unassembled subunits are also selectively retained in the ER.
GO:0006622	GO	BP	protein targeting to lysosome	AP3M1,GCC2,GNPTAB,HGS,HSPA8,NAGPA,NEDD4,RAB7A,SCARB2,SNX16,SORL1,ZFYVE16	The process of directing proteins towards the lysosome using signals contained within the protein.
GO:0006623	GO	BP	protein targeting to vacuole	AP3M1,GCC2,GNPTAB,HGS,HSPA8,NAGPA,NEDD4,RAB7A,SCARB2,SMURF1,SNX16,SORL1,ZFYVE16	The process of directing proteins towards the vacuole, usually using signals contained within the protein.
GO:0006625	GO	BP	protein targeting to peroxisome	LONP2,PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,RAB8B,ZFAND6	The process of directing proteins towards the peroxisome, usually using signals contained within the protein.
GO:0006626	GO	BP	protein targeting to mitochondrion	AIP,CHCHD2,CHCHD4,COX19,DNAJC19,FBXO7,FIS1,GDAP1,GFER,GRPEL1,GRPEL2,HSP90AA1,HSPA4,HSPA9,IMMP2L,MFF,MFN2,MGARP,MIPEP,MTX1,MTX2,NDUFA13,PAM16,PDE2A,PMPCA,PMPCB,SAMM50,SLC25A6,TIMM10,TIMM10B,TIMM13,TIMM17A,TIMM17B,TIMM21,TIMM22,TIMM23,TIMM44,TIMM50,TIMM8A,TIMM8B,TIMM9,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TRNT1,TSPO	The process of directing proteins towards and into the mitochondrion, usually mediated by mitochondrial proteins that recognize signals contained within the imported protein.
GO:0006631	GO	BP	fatty acid metabolic process	AASDH,ABCC1,ABCD1,ABCD2,ABCD3,ACAA1,ACACA,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADSB,ACADVL,ACOT1,ACOT11,ACOT2,ACOT4,ACOT7,ACOT8,ACOX1,ACOX2,ACOX3,ACSBG1,ACSBG2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSM1,ADH7,ADIPOQ,ADIPOR1,ADIPOR2,AKR1C2,AKR1C3,ALDH5A1,ALKBH7,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AMACR,ANGPTL3,AWAT1,BDH2,CBR1,CD74,CEL,CPT1A,CRAT,CROT,CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2J2,CYP2U1,CYP4A11,CYP4F12,CYP4F2,CYP4F3,CYP4F8,CYP4V2,DAGLA,DAGLB,DECR1,DECR2,DEGS1,DPEP1,ECHS1,ECI1,ECI2,EDN1,EDN2,EHHADH,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,EPHX2,ETFA,ETFB,ETFDH,FAAH,FAAH2,FADS1,FADS2,FADS3,FAM213B,FASN,GCDH,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GHR,GPX1,GPX4,HACD1,HACD2,HACD3,HACD4,HACL1,HADH,HADHA,HADHB,HAO1,HAO2,HPGD,HPGDS,HSD17B4,LIAS,LIPC,LPIN1,LPL,LTA4H,LTC4S,MAPKAPK2,MCAT,MCEE,MECR,MGLL,MGST2,MIF,MLYCD,MMAA,MSMO1,MUT,NDUFAB1,OXSM,PCCA,PCCB,PER2,PEX13,PEX2,PHYH,PLA2G10,PLA2G15,PLA2G1B,PLA2G4A,PLA2G4B,PLA2G4C,PNPLA8,PPARD,PPARGC1A,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGR2,PTGS1,PTGS2,SCD,SCD5,SCP2,SGPL1,SLC25A17,SLC27A2,SLC27A4,SLC27A5,SLC27A6,STAT5A,STAT5B,TBXAS1,TECR,THEM4,THNSL2,UGT1A7,UGT1A8,XBP1	The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
GO:0006633	GO	BP	fatty acid biosynthetic process	ABCD3,ACACA,ACOT7,ACSF3,AKR1C3,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,CBR1,CD74,DECR2,DEGS1,EDN1,EDN2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FADS1,FADS3,FAM213B,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,HACD1,HACD2,HACD3,HACD4,HPGD,HPGDS,LIAS,LIPC,LPL,LTA4H,MCAT,MGST2,MIF,MLYCD,NDUFAB1,OXSM,PLA2G1B,PNPLA8,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,SCD,SCD5,TBXAS1,TECR,THNSL2,XBP1	The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
GO:0006635	GO	BP	fatty acid beta-oxidation	ABCD1,ABCD2,ABCD3,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOT8,ACOX1,ACOX2,ACOX3,ADIPOQ,AMACR,BDH2,CRAT,CROT,DECR1,ECHS1,ECI1,EHHADH,ETFA,ETFB,ETFDH,GCDH,HADH,HADHA,HADHB,HSD17B4,MCEE,MMAA,MUT,PCCA,PCCB,PEX2,PPARD,SCP2,SLC25A17,SLC27A2	A fatty acid oxidation process that results in the complete oxidation of a long-chain fatty acid. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and occurs by successive cycles of reactions during each of which the fatty acid is shortened by a two-carbon fragment removed as acetyl coenzyme A; the cycle continues until only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
GO:0006636	GO	BP	unsaturated fatty acid biosynthetic process	AKR1C3,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,CBR1,CD74,DECR2,DEGS1,EDN1,EDN2,FADS1,FADS3,FAM213B,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,HPGD,HPGDS,LTA4H,MGST2,MIF,PLA2G1B,PNPLA8,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,SCD,SCD5,TBXAS1	The chemical reactions and pathways resulting in the formation of an unsaturated fatty acid, any fatty acid containing one or more double bonds between carbon atoms.
GO:0006637	GO	BP	acyl-CoA metabolic process	ACACA,ACACB,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSM2A,ACSS1,AGK,BAAT,DGAT1,DGAT2,DLD,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FAR1,FAR2,FASN,GLYAT,GPAT4,HACD1,HACD2,HSD17B12,HSD17B4,MCEE,MLYCD,NUDT7,OLAH,OXSM,PDHA1,PDHB,PDHX,PIPOX,PPT1,PPT2,SCD,SLC25A1,SUCLA2,SUCLG2,TECR,THEM4,THEM5	The chemical reactions and pathways involving acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with an acyl group.
GO:0006639	GO	BP	acylglycerol metabolic process	ABHD12,ABHD5,ABHD6,ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AGK,AGMO,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,ANG,APOA2,APOA5,APOC3,APOE,APOH,AWAT1,CAV1,CAV3,CEL,CETP,CPS1,DAGLA,DGAT1,DGAT2,DGKD,DGKK,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,FASN,GK,GPAM,GPAT2,GPAT3,GPAT4,GPD1,GPD1L,HACD1,HACD2,HSD17B12,LCLAT1,LIPC,LIPE,LIPF,LPCAT1,LPCAT4,LPIN1,LPIN2,LPL,MGLL,OLAH,PCK1,PGS1,PLCE1,PLIN1,PNLIPRP2,PNPLA2,PNPLA3,PPP1CA,PPP1CB,PPP1CC,PPT1,PPT2,PRKACA,PRKACB,PRKACG,SCD,SIRT1,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways involving acylglycerol, any mono-, di- or triester of glycerol with (one or more) fatty acids.
GO:0006641	GO	BP	triglyceride metabolic process	ABHD5,ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AGK,AGMO,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,APOA2,APOA5,APOC3,APOE,APOH,CAV1,CAV3,CEL,CETP,CPS1,DGAT1,DGAT2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,FASN,GK,GPAM,GPAT2,GPAT3,GPAT4,GPD1,GPD1L,HACD1,HACD2,HSD17B12,LCLAT1,LIPC,LIPE,LIPF,LPCAT1,LPCAT4,LPIN1,LPIN2,LPL,MGLL,OLAH,PCK1,PLIN1,PNLIPRP2,PNPLA3,PPP1CA,PPP1CB,PPP1CC,PPT1,PPT2,PRKACA,PRKACB,PRKACG,SCD,SIRT1,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
GO:0006643	GO	BP	membrane lipid metabolic process	A4GALT,ACER1,ACER2,ACER3,AGMO,ALDH3A2,ALDH3B1,ALDH5A1,ALOX12B,ALOXE3,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,ASAH1,ASAH2,B3GNT5,B4GALNT1,B4GALT4,CERK,CERS1,CERS2,CERS3,CERS4,CERS5,CERS6,CLN3,CLN6,CLN8,COL4A3BP,CPTP,CSNK1G2,CTSA,CYP1B1,DEGS1,DEGS2,DPM1,DPM2,DPM3,ELOVL1,ENPP7,FA2H,GALC,GBA,GBA2,GBA3,GBGT1,GLA,GLB1,GLTP,GM2A,GPAA1,GPLD1,HACD1,HACD2,HEXA,HEXB,KDSR,LARGE,MPPE1,NAGA,NEU1,NEU2,NEU3,NEU4,NSMAF,ORMDL1,ORMDL2,ORMDL3,PGAP1,PGAP2,PGAP3,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLA2G15,PLAUR,PLPP1,PLPP2,PLPP3,PNLIPRP2,PPM1L,PPP2CA,PPP2R1A,PPT1,PRKD1,PSAP,PYURF,SAMD8,SERINC1,SGMS1,SGMS2,SGPL1,SGPP1,SGPP2,SMPD1,SMPD2,SMPD3,SMPD4,SPHK1,SPHK2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,ST3GAL5,ST3GAL6,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,STS,SUMF1,TEX2,UGCG,UGT8,VAPA,VAPB	The chemical reactions and pathways involving membrane lipids, any lipid found in or associated with a biological membrane.
GO:0006646	GO	BP	phosphatidylethanolamine biosynthetic process	ALOX15,CEPT1,CHKA,CHKB,EPT1,ETNK1,ETNK2,ETNPPL,LPIN1,LPIN2,LPIN3,PCYT2,PHOSPHO1,PISD,SLC27A1	The chemical reactions and pathways resulting in the formation of phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
GO:0006654	GO	BP	phosphatidic acid biosynthetic process	ABHD5,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,DDHD1,DDHD2,GNPAT,GPAM,GPAT2,GPAT3,GPAT4,GPD1,GPD1L,LCLAT1,LPCAT1,LPCAT4,PLA2G10,PLA2G12A,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G4A,PLA2G4B,PLA2G4D,PLA2G5,PLD1,PLD2,SLC27A1	The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
GO:0006655	GO	BP	phosphatidylglycerol biosynthetic process	CDS2,CRLS1,PGS1,PLA2G6,PLD1,PLD2,PLD3,PLD4,PLD6,PTPMT1,SLC27A1,TAMM41,TAZ	The chemical reactions and pathways resulting in the formation of phosphatidylglycerols, any of a class of phospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol.
GO:0006656	GO	BP	phosphatidylcholine biosynthetic process	ABHD3,ACHE,APOA1,APOA2,CDS1,CEPT1,CHAT,CHKA,CHKB,CHPT1,GPAT4,LCAT,LPIN1,LPIN2,LPIN3,PCYT1A,PCYT1B,PEMT,PHOSPHO1,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5	The chemical reactions and pathways resulting in the formation of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
GO:0006657	GO	BP	CDP-choline pathway	CDS1,CEPT1,CHKA,CHKB,CHPT1,PCYT1A,PCYT1B	The phosphatidylcholine biosynthetic process that begins with the phosphorylation of choline and ends with the combination of CDP-choline with diacylglycerol to form phosphatidylcholine.
GO:0006658	GO	BP	phosphatidylserine metabolic process	LPCAT3,LPCAT4,MBOAT1,PLA1A,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G4A,PLA2G4B,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLSCR1,PTDSS1,PTDSS2,SERINC1,SERINC5,SLC27A1	The chemical reactions and pathways involving phosphatidylserines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of L-serine. They are important constituents of cell membranes.
GO:0006661	GO	BP	phosphatidylinositol biosynthetic process	ARF1,ARF3,ATM,CDIPT,CDS1,DPM1,DPM2,DPM3,FGF2,FIG4,GPAA1,IMPA1,INPP4A,INPP4B,INPP5D,INPP5E,INPP5J,INPP5K,INPPL1,MPPE1,MTM1,MTMR1,MTMR14,MTMR2,MTMR3,MTMR4,MTMR6,MTMR7,OCRL,PGAP1,PGAP2,PI4K2A,PI4K2B,PI4KA,PI4KB,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PIK3C2A,PIK3C2B,PIK3C2G,PIK3C3,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIK3R3,PIK3R4,PIK3R5,PIK3R6,PIKFYVE,PIP4K2A,PIP4K2B,PIP4K2C,PIP5K1A,PIP5K1B,PIP5K1C,PLAUR,PLCG2,PTEN,PYURF,SACM1L,SLC27A1,SYNJ1,SYNJ2,TPTE2,VAC14	The chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
GO:0006664	GO	BP	glycolipid metabolic process	A4GALT,ALDH5A1,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,ASAH1,B3GNT5,B4GALNT1,CERK,CLN3,CLN6,CPTP,CTSA,DPM1,DPM2,DPM3,ENPP7,GALC,GBA,GBA2,GBA3,GBGT1,GLA,GLB1,GLTP,GM2A,GPAA1,GPLD1,HEXA,HEXB,LARGE,MPPE1,NAGA,NEU1,NEU2,NEU3,NEU4,PGAP1,PGAP2,PGAP3,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PNLIPRP2,PSAP,PYURF,SMPD1,SMPD2,SMPD3,SMPD4,ST3GAL5,ST3GAL6,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,STS,SUMF1,UGCG,UGT8	The chemical reactions and pathways involving glycolipids, a class of 1,2-di-O-acylglycerols joined at oxygen 3 by a glycosidic linkage to a carbohydrate part (usually a mono-, di- or tri-saccharide). Some substances classified as bacterial glycolipids have the sugar group acylated by one or more fatty acids and the glycerol group may be absent.
GO:0006665	GO	BP	sphingolipid metabolic process	A4GALT,ACER1,ACER2,ACER3,ALDH3A2,ALDH3B1,ALDH5A1,ALOX12B,ALOXE3,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,ASAH1,ASAH2,B4GALNT1,CERK,CERS1,CERS2,CERS3,CERS4,CERS5,CERS6,CLN3,CLN6,CLN8,COL4A3BP,CPTP,CSNK1G2,CTSA,DEGS1,DEGS2,ELOVL1,ENPP7,FA2H,GALC,GBA,GBA2,GBA3,GLA,GLB1,GLTP,GM2A,HACD1,HACD2,HEXA,HEXB,KDSR,LARGE,NEU1,NEU2,NEU3,NEU4,NSMAF,ORMDL1,ORMDL2,ORMDL3,PLA2G15,PLPP1,PLPP2,PLPP3,PPM1L,PPP2CA,PPP2R1A,PPT1,PRKD1,PSAP,SAMD8,SERINC1,SGMS1,SGMS2,SGPL1,SGPP1,SGPP2,SMPD1,SMPD2,SMPD3,SMPD4,SPHK1,SPHK2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,ST3GAL5,ST6GALNAC3,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,STS,SUMF1,TEX2,UGCG,UGT8,VAPA,VAPB	The chemical reactions and pathways involving sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).
GO:0006670	GO	BP	sphingosine metabolic process	ACER1,ACER2,ACER3,GBA,SGPP2,SPHK1,SPHK2	The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
GO:0006672	GO	BP	ceramide metabolic process	ACER1,ALDH5A1,ALOX12B,ALOXE3,ASAH1,ASAH2,CERK,CERS1,CERS3,CERS5,CLN3,CLN6,CLN8,GALC,GBA,GBA3,GLA,NEU2,NEU3,NEU4,NSMAF,ORMDL1,ORMDL2,ORMDL3,PLA2G15,PPP2CA,PPP2R1A,SAMD8,SGPL1,SMPD1,SMPD4,ST3GAL5,ST6GALNAC3,ST6GALNAC6,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA6,UGCG	The chemical reactions and pathways involving ceramides, any N-acylated sphingoid.
GO:0006677	GO	BP	glycosylceramide metabolic process	ALDH5A1,CLN3,GALC,GBA,GBA3,GLA,ST6GALNAC3,ST6GALNAC6,UGCG	The chemical reactions and pathways involving glycosylceramides, any compound formed by the replacement of the glycosidic hydroxyl group of a cyclic form of a monosaccharide (or derivative) by a ceramide group.
GO:0006684	GO	BP	sphingomyelin metabolic process	CLN3,ENPP7,SAMD8,SGMS1,SGMS2,SMPD1,SMPD2,SMPD3,SMPD4	The chemical reactions and pathways involving sphingomyelin, N-acyl-4-sphingenyl-1-O-phosphorylcholine, any of a class of phospholipids in which the amino group of sphingosine is in amide linkage with one of several fatty acids, while the terminal hydroxyl group of sphingosine is esterified to phosphorylcholine.
GO:0006687	GO	BP	glycosphingolipid metabolic process	A4GALT,ALDH5A1,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,ASAH1,B4GALNT1,CERK,CLN3,CLN6,CPTP,CTSA,ENPP7,GALC,GBA,GBA2,GBA3,GLA,GLB1,GLTP,GM2A,HEXA,HEXB,LARGE,NEU1,NEU2,NEU3,NEU4,PSAP,SMPD1,SMPD2,SMPD3,SMPD4,ST3GAL5,ST6GALNAC3,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,STS,SUMF1,UGCG,UGT8	The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide.
GO:0006688	GO	BP	glycosphingolipid biosynthetic process	A4GALT,LARGE,ST3GAL5,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,UGCG	The chemical reactions and pathways resulting in the formation of glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.
GO:0006690	GO	BP	icosanoid metabolic process	ABCC1,ACOX1,AKR1C2,AKR1C3,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AWAT1,CBR1,CD74,CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2J2,CYP2U1,CYP4A11,CYP4F12,CYP4F2,CYP4F22,CYP4F3,CYP4F8,DAGLA,DAGLB,DPEP1,EDN1,EDN2,EPHX2,FAAH,FAAH2,FADS1,FAM213B,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GPX1,GPX4,HPGD,HPGDS,LTA4H,LTC4S,MAPKAPK2,MGLL,MGST2,MIF,PLA2G10,PLA2G1B,PLA2G4A,PLA2G4B,PLA2G4C,PNPLA8,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGR2,PTGS1,PTGS2,TBXAS1	The chemical reactions and pathways involving icosanoids, any of a group of C20 polyunsaturated fatty acids.
GO:0006691	GO	BP	leukotriene metabolic process	ABCC1,ALOX12,ALOX15,ALOX5,ALOX5AP,CYP4A11,CYP4F12,CYP4F2,CYP4F3,DPEP1,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,LTA4H,LTC4S,MAPKAPK2,MGST2,PLA2G1B,PRG3,PTGR1	The chemical reactions and pathways involving leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
GO:0006693	GO	BP	prostaglandin metabolic process	ACOX1,AKR1C2,AKR1C3,CBR1,CD74,CYP4F8,EDN1,EDN2,FAM213B,HPGD,HPGDS,MIF,PNPLA8,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGR2,PTGS1,PTGS2,TBXAS1	The chemical reactions and pathways involving prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring due to the formation of a bond between two carbons of a fatty acid. They have a wide range of biological activities.
GO:0006694	GO	BP	steroid biosynthetic process	ABCB11,ACAA2,ACLY,ACOT8,ACOX2,ADM,AKR1B1,AKR1B15,AKR1C3,AKR1C4,AKR1D1,AMACR,ARV1,BAAT,CACNA1H,CH25H,CNBP,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP21A2,CYP27A1,CYP27B1,CYP39A1,CYP3A4,CYP46A1,CYP51A1,CYP7A1,CYP7B1,CYP8B1,DHCR24,DHCR7,EBP,FDFT1,FDPS,FDX1,FDX1L,FDXR,FSHB,G6PD,GGPS1,HMGCR,HMGCS1,HSD11B1,HSD11B2,HSD17B1,HSD17B11,HSD17B3,HSD17B4,HSD17B6,HSD17B7,HSD17B8,HSD3B1,HSD3B2,HSD3B7,IDI1,IDI2,LBR,LHB,LSS,MED1,MSMO1,MVD,MVK,NPC1L1,NR0B1,NSDHL,PMVK,PRKAG2,PRLR,RDH8,SC5D,SCP2,SLC27A2,SLC27A5,SQLE,SRD5A1,SRD5A2,SRD5A3,STAR,STARD5,TFCP2L1,TM7SF2,TRERF1,WNT4	The chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus; includes de novo formation and steroid interconversion by modification.
GO:0006695	GO	BP	cholesterol biosynthetic process	ACAA2,ACLY,ARV1,CNBP,CYP51A1,DHCR24,DHCR7,EBP,FDFT1,FDPS,G6PD,GGPS1,HMGCR,HMGCS1,HSD17B7,IDI1,IDI2,LBR,LSS,MSMO1,MVD,MVK,NPC1L1,NSDHL,PMVK,SC5D,SQLE,TM7SF2	The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0006699	GO	BP	bile acid biosynthetic process	ABCB11,ACOT8,ACOX2,AKR1C4,AKR1D1,AMACR,BAAT,CH25H,CYP27A1,CYP39A1,CYP46A1,CYP7A1,CYP7B1,CYP8B1,HSD17B4,HSD3B7,SCP2,SLC27A2,SLC27A5	The chemical reactions and pathways resulting in the formation of bile acids, any of a group of steroid carboxylic acids occurring in bile.
GO:0006700	GO	BP	C21-steroid hormone biosynthetic process	ADM,AKR1B1,CACNA1H,CYP11A1,CYP11B1,CYP11B2,FDX1,FDX1L,FDXR,FSHB,LHB,SCP2,STAR,STARD5	The chemical reactions and pathways resulting in the formation of C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones.
GO:0006702	GO	BP	androgen biosynthetic process	AKR1C3,CYP17A1,HSD17B3,HSD17B6,HSD3B1,HSD3B2,MED1,SRD5A1,SRD5A2,SRD5A3,WNT4	The chemical reactions and pathways resulting in the formation of androgens, C19 steroid hormones that can stimulate the development of male sexual characteristics.
GO:0006703	GO	BP	estrogen biosynthetic process	AKR1B15,CYP19A1,HSD17B1,HSD17B11,HSD17B8,HSD3B1	The chemical reactions and pathways resulting in the formation of estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants.
GO:0006704	GO	BP	glucocorticoid biosynthetic process	CACNA1H,CYP11B1,CYP11B2,CYP17A1,CYP21A2,HSD11B1,HSD11B2,HSD3B1,HSD3B2	The chemical reactions and pathways resulting in the formation of glucocorticoids, hormonal C21 corticosteroids synthesized from cholesterol.
GO:0006705	GO	BP	mineralocorticoid biosynthetic process	CACNA1H,CYP11B1,CYP11B2,CYP21A2,HSD3B1,HSD3B2	The chemical reactions and pathways resulting in the formation of mineralocorticoids, hormonal C21 corticosteroids synthesized from cholesterol.
GO:0006706	GO	BP	steroid catabolic process	AKR1D1,CEL,CYP1A2,CYP24A1,CYP3A4,CYP46A1,CYP7A1,FGF23,HSD17B11,HSD17B14,HSD17B6,MT3,SCARF1,SNX17,STS,TRERF1,UGT2B4,YWHAH	The chemical reactions and pathways resulting in the breakdown of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
GO:0006707	GO	BP	cholesterol catabolic process	AKR1D1,CEL,CYP46A1,CYP7A1,MT3,SCARF1,SNX17,TRERF1	The chemical reactions and pathways resulting in the breakdown of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0006720	GO	BP	isoprenoid metabolic process	ABCA4,ADH4,ADH7,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ALDH1A2,ALDH1A3,ALDH3A2,ALDH8A1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CLPS,CYP1A2,CYP1B1,CYP26A1,CYP26B1,CYP26C1,CYP2C19,CYP2C9,CYP2D6,CYP2E1,CYP3A4,CYP4V2,DHRS3,DHRS9,DPAGT1,DPM1,GGPS1,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HSPG2,IDI1,IDI2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,MVD,MVK,NAPEPLD,NUS1,OPN1LW,OPN1MW,OPN1SW,PDSS1,PDSS2,PECR,PHYH,PLB1,PNLIP,RARRES2,RBP1,RBP2,RBP3,RBP4,RDH10,RDH11,RDH12,RDH5,RDH8,RETSAT,RHO,RLBP1,RPE65,SCPEP1,SDC1,SDC2,SDC3,SDC4,SDR16C5,SRD5A3,STRA6,TTR,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving isoprenoid compounds, isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues.
GO:0006721	GO	BP	terpenoid metabolic process	ABCA4,ADH4,ADH7,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ALDH1A2,ALDH1A3,ALDH3A2,ALDH8A1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CLPS,CYP1A2,CYP1B1,CYP26A1,CYP26B1,CYP26C1,CYP2C19,CYP2C9,CYP2D6,CYP2E1,CYP3A4,CYP4V2,DHRS3,DHRS9,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,NAPEPLD,OPN1LW,OPN1MW,OPN1SW,PECR,PLB1,PNLIP,RARRES2,RBP1,RBP2,RBP3,RBP4,RDH10,RDH11,RDH12,RDH5,RDH8,RETSAT,RHO,RLBP1,RPE65,SCPEP1,SDC1,SDC2,SDC3,SDC4,SDR16C5,STRA6,TTR,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving terpenoids, any member of a class of compounds characterized by an isoprenoid chemical structure and including derivatives with various functional groups.
GO:0006730	GO	BP	one-carbon metabolic process	MTHFD1,MTHFR,MTHFS,SHMT1,SHMT2,TYMS	The chemical reactions and pathways involving the transfer of one-carbon units in various oxidation states.
GO:0006732	GO	BP	coenzyme metabolic process	AASDHPPT,ACACA,ACACB,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSM2A,ACSS1,ADCK3,AGK,ALDOA,ALDOB,ALDOC,BAAT,BHMT2,COASY,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,CROT,CYP4F11,CYP4F2,DERA,DGAT1,DGAT2,DHFR,DHFRL1,DLD,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,ENO1,ENO2,ENO3,FAR1,FAR2,FASN,FMO1,FMO2,FPGS,FTCD,G6PD,GAPDH,GAPDHS,GCH1,GCK,GLYAT,GNMT,GPAT4,GPD1L,GPHN,GPI,HACD1,HACD2,HK1,HK2,HK3,HSD17B12,HSD17B4,IDH1,KCNAB2,LDHA,LIAS,MAT2A,MAT2B,MCEE,ME1,MLYCD,MOCOS,MOCS1,MOCS2,MOCS3,MTHFD1,MTHFD1L,MTHFD2,MTHFR,MTHFS,MTRR,NADK,NADK2,NADSYN1,NAMPT,NAPRT,NFS1,NMNAT1,NMNAT2,NMNAT3,NOX1,NUDT12,NUDT7,OLAH,OXSM,PANK1,PANK2,PDHA1,PDHB,PDHX,PDSS1,PDSS2,PDXK,PDZD11,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGD,PGK1,PGK2,PGLS,PGM1,PGM2,PIPOX,PKLR,PKM,PNP,PPCDC,PPCS,PPP2R5D,PPT1,PPT2,PRDX5,PTGIS,PTGS2,QPRT,RPE,RPIA,SCD,SHMT1,SHMT2,SHPK,SLC19A1,SLC25A1,SLC25A16,SLC25A32,SLC46A1,SLC5A6,SPR,SUCLA2,SUCLG2,TALDO1,TECR,THEM4,THEM5,THTPA,TKT,TP53I3,TPI1,TYMS,UBIAD1,VCP,VNN1,VNN2	The chemical reactions and pathways involving coenzymes, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.
GO:0006733	GO	BP	oxidoreduction coenzyme metabolic process	ADCK3,ALDOA,ALDOB,ALDOC,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,DERA,DLD,ENO1,ENO2,ENO3,FMO1,FMO2,G6PD,GAPDH,GAPDHS,GCK,GPD1L,GPI,HK1,HK2,HK3,IDH1,KCNAB2,LDHA,ME1,NADK,NADK2,NADSYN1,NAMPT,NAPRT,NMNAT1,NMNAT2,NMNAT3,NOX1,NUDT12,PDHB,PDHX,PDSS1,PDSS2,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGD,PGK1,PGK2,PGLS,PGM1,PGM2,PKLR,PKM,PNP,PPP2R5D,PRDX5,PTGIS,PTGS2,QPRT,RPE,RPIA,SHPK,TALDO1,TKT,TP53I3,TPI1,UBIAD1,VCP	The chemical reactions and pathways involving coenzymes that are required, in addition to an enzyme and a substrate, for an oxidoreductase reaction to proceed.
GO:0006734	GO	BP	NADH metabolic process	ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PKLR,PKM,PPP2R5D,TPI1,VCP	The chemical reactions and pathways involving reduced nicotinamide adenine dinucleotide (NADH), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
GO:0006739	GO	BP	NADP metabolic process	DERA,FMO1,FMO2,G6PD,IDH1,KCNAB2,ME1,NOX1,NUDT12,PGD,PGLS,PGM2,PRDX5,RPE,RPIA,SHPK,TALDO1,TKT,TP53I3	The chemical reactions and pathways involving nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; metabolism may be of either the oxidized form, NADP, or the reduced form, NADPH.
GO:0006744	GO	BP	ubiquinone biosynthetic process	ADCK3,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,PDSS1,PDSS2,UBIAD1	The chemical reactions and pathways resulting in the formation of ubiquinone, a lipid-soluble electron-transporting coenzyme.
GO:0006749	GO	BP	glutathione metabolic process	ALDH5A1,CHAC1,CHAC2,CNDP2,CTNS,DPEP1,ETHE1,G6PD,GCLC,GCLM,GGCT,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GLRX2,GPX1,GSS,GSTA1,GSTA2,GSTA3,GSTA4,GSTA5,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTP1,GSTZ1,HAGH,MGST2,NAT8,OPLAH,SOD1	The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle.
GO:0006750	GO	BP	glutathione biosynthetic process	CHAC1,CHAC2,CNDP2,GCLC,GCLM,GGCT,GGT1,GGT2,GSS,HAGH,MGST2,OPLAH	The chemical reactions and pathways resulting in the formation of glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins.
GO:0006754	GO	BP	ATP biosynthetic process	AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,GBAS,MT-ATP6,MT-ATP8,PRKAG2,SLC25A13,STOML2,SURF1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
GO:0006757	GO	BP	ATP generation from ADP	AK9,ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TPI1	The process of introducing a phosphate group into ADP, adenosine diphosphate, to produce ATP.
GO:0006760	GO	BP	folic acid-containing compound metabolic process	DHFR,DHFRL1,FPGS,FTCD,MTHFD1,MTHFD1L,MTHFD2,MTHFR,MTHFS,MTRR,SHMT1,SHMT2,SLC19A1,SLC25A32,SLC46A1,TYMS	The chemical reactions and pathways involving a folic acid-containing compound, i.e. any of a group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid or L-glutamate units.
GO:0006766	GO	BP	vitamin metabolic process	AASDHPPT,ABCC1,ABCD4,ACACA,ACACB,ACP5,ACPP,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ALDH1A2,AMN,AOX1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,BTD,CBR1,CD320,CLPS,COASY,CTRB1,CTRB2,CTRC,CUBN,CYB5A,CYB5R3,CYP11A1,CYP1A1,CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP27B1,CYP2R1,CYP3A4,CYP4F11,CYP4F12,CYP4F2,DHFR,ENPP1,FASN,FGF23,FLAD1,FPGS,GC,GIF,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GPHN,GSTO1,GSTO2,HLCS,HSPG2,LDLR,LGMN,LMBRD1,LPL,LRAT,LRP1,LRP2,LRP8,MCCC1,MCCC2,MMAA,MMAB,MMACHC,MMADHC,MOCOS,MOCS1,MOCS2,MOCS3,MTHFD1,MTHFD1L,MTHFR,MTHFS,MTR,MTRR,MUT,NADK,NADSYN1,NAMPT,NAPRT,NFS1,NMNAT1,NMNAT2,NMNAT3,PANK1,PANK2,PC,PCCA,PCCB,PDXK,PDZD11,PLB1,PNLIP,PNPO,PPCDC,PPCS,PRSS1,PRSS3,PSAT1,PTGIS,PTGS2,QPRT,RBP1,RBP2,RBP4,RDH11,RFK,RLBP1,RPE65,RXRA,SDC1,SDC2,SDC3,SDC4,SHMT1,SHMT2,SLC19A1,SLC19A2,SLC19A3,SLC23A1,SLC23A2,SLC25A16,SLC25A32,SLC2A1,SLC2A3,SLC46A1,SLC52A3,SLC5A6,TCN1,TCN2,THTPA,TKTL1,TPK1,TTR,UBIAD1,VKORC1,VKORC1L1,VNN1,VNN2	The chemical reactions and pathways involving vitamins. Vitamin is a general term for a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. Vitamins may be water-soluble or fat-soluble and usually serve as components of coenzyme systems.
GO:0006767	GO	BP	water-soluble vitamin metabolic process	AASDHPPT,ABCC1,ABCD4,ACACA,ACACB,ACP5,ACPP,AMN,AOX1,BTD,CD320,COASY,CTRB1,CTRB2,CTRC,CUBN,CYB5A,CYB5R3,DHFR,ENPP1,FASN,FLAD1,FPGS,GIF,GPHN,GSTO1,GSTO2,HLCS,LMBRD1,MCCC1,MCCC2,MMAA,MMAB,MMACHC,MMADHC,MOCOS,MOCS1,MOCS2,MOCS3,MTHFD1,MTHFD1L,MTHFR,MTHFS,MTR,MTRR,MUT,NADK,NADSYN1,NAMPT,NAPRT,NFS1,NMNAT1,NMNAT2,NMNAT3,PANK1,PANK2,PC,PCCA,PCCB,PDXK,PDZD11,PNPO,PPCDC,PPCS,PRSS1,PRSS3,PSAT1,PTGIS,PTGS2,QPRT,RFK,SHMT1,SHMT2,SLC19A1,SLC19A2,SLC19A3,SLC23A1,SLC23A2,SLC25A16,SLC25A32,SLC2A1,SLC2A3,SLC46A1,SLC52A3,SLC5A6,TCN1,TCN2,THTPA,TKTL1,TPK1,VNN1,VNN2	The chemical reactions and pathways involving any of a diverse group of vitamins that are soluble in water.
GO:0006768	GO	BP	biotin metabolic process	ACACA,ACACB,BTD,HLCS,MCCC1,MCCC2,PC,PCCA,PCCB,PDZD11,SLC5A6	The chemical reactions and pathways involving biotin, cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid; the (+) enantiomer is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions.
GO:0006771	GO	BP	riboflavin metabolic process	ACP5,ENPP1,FLAD1,RFK,SLC52A3	The chemical reactions and pathways involving riboflavin (vitamin B2), the precursor for the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD).
GO:0006775	GO	BP	fat-soluble vitamin metabolic process	AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ALDH1A2,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CBR1,CLPS,CUBN,CYP11A1,CYP1A1,CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP27B1,CYP2R1,CYP3A4,CYP4F11,CYP4F12,CYP4F2,FGF23,GC,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HSPG2,LDLR,LGMN,LPL,LRAT,LRP1,LRP2,LRP8,PLB1,PNLIP,RBP1,RBP2,RBP4,RDH11,RLBP1,RPE65,SDC1,SDC2,SDC3,SDC4,TTR,UBIAD1,VKORC1,VKORC1L1	The chemical reactions and pathways involving of any of a diverse group of vitamins that are soluble in organic solvents and relatively insoluble in water.
GO:0006778	GO	BP	porphyrin-containing compound metabolic process	ABCB6,ALAD,ALAS1,ALAS2,AMBP,ATPIF1,BDH2,BLVRA,BLVRB,COX10,COX15,CPOX,FECH,FXN,HMBS,HMOX1,HMOX2,NFE2L1,PPOX,SLC25A38,SUCLA2,TSPO,UGT1A1,UGT1A4,UROD,UROS	The chemical reactions and pathways involving any member of a large group of derivatives or analogs of porphyrin. Porphyrins consists of a ring of four pyrrole nuclei linked each to the next at their alpha positions through a methine group.
GO:0006779	GO	BP	porphyrin-containing compound biosynthetic process	ABCB6,ALAD,ALAS1,ALAS2,ATPIF1,COX10,COX15,CPOX,FECH,FXN,HMBS,NFE2L1,PPOX,SLC25A38,SUCLA2,TSPO,UROD,UROS	The chemical reactions and pathways resulting in the formation of any member of a large group of derivatives or analogs of porphyrin. Porphyrin consists of a ring of four pyrrole nuclei linked each to the next at their alpha positions through a methine group.
GO:0006783	GO	BP	heme biosynthetic process	ALAD,ALAS1,ALAS2,ATPIF1,COX10,COX15,CPOX,FECH,FXN,HMBS,NFE2L1,PPOX,SLC25A38,TSPO,UROD,UROS	The chemical reactions and pathways resulting in the formation of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring, from less complex precursors.
GO:0006801	GO	BP	superoxide metabolic process	ALOX12,APOA4,ATP7A,CYB5R4,CYBA,CYBB,DUOX1,MT3,NCF1,NCF2,NOS2,NOS3,NOX1,NOX4,NOX5,NOXA1,NRROS,PRDX2,PREX1,PRG3,SH3PXD2A,SH3PXD2B,SOD1,SOD2,SOD3	The chemical reactions and pathways involving superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species.
GO:0006805	GO	BP	xenobiotic metabolic process	AADAC,ABHD10,ABHD14B,ACSM1,ACSM2B,ACSS1,ACSS2,ACY1,ACY3,ADH1A,ADH1B,ADH1C,ADH4,ADH5,ADH6,ADH7,AHCY,AHR,AKR1A1,AKR1C1,AKR7A2,AKR7A3,AKR7L,ALDH1A1,ALDH1B1,ALDH2,ALDH3A1,AOC1,AOC2,AOC3,AS3MT,BPHL,BPNT1,CES1,CES2,CHAC1,CHAC2,CMBL,CNDP2,COMT,CRYZ,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A1,CYP1A2,CYP1B1,CYP21A2,CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP27A1,CYP27B1,CYP2A13,CYP2A6,CYP2B6,CYP2C18,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP2D7,CYP2E1,CYP2F1,CYP2J2,CYP2R1,CYP2S1,CYP2U1,CYP2W1,CYP39A1,CYP3A4,CYP3A43,CYP3A5,CYP3A7,CYP46A1,CYP4A11,CYP4B1,CYP4F11,CYP4F12,CYP4F2,CYP4F22,CYP4F3,CYP4F8,CYP4V2,CYP51A1,CYP7A1,CYP7B1,CYP8B1,DPEP1,EPHX1,EPHX2,ESD,FDX1,FDX1L,FDXR,FMO1,FMO2,FMO3,GCLC,GCLM,GGCT,GGT1,GGT2,GLYAT,GRIN1,GSS,GSTA1,GSTA2,GSTA3,GSTA4,GSTK1,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTO1,GSTO2,GSTP1,GSTT2B,GSTZ1,HNF4A,HPGDS,LPO,MAOA,MAOB,MAT1A,MAT2A,MAT2B,MGST1,MGST2,MGST3,MTR,MTRR,NAT1,NAT2,NNMT,NQO1,NR1I2,OPLAH,PAOX,PAPSS1,PAPSS2,PTGIS,PTGS1,RORA,RORC,S100A12,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SLC35D1,SMOX,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1,TBXAS1,TPMT,UGDH,UGP2,UGT1A1,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2B11,UGT2B15,UGT2B28,UGT2B4	The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.
GO:0006809	GO	BP	nitric oxide biosynthetic process	AKT1,ARG2,CYP1B1,DDAH2,GCH1,GCHFR,NOS1,NOS2,NOS3,NQO1,SPR	The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.
GO:0006813	GO	BP	potassium ion transport	ABCC8,ABCC9,AQP1,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,CCT8L2,CHP1,FXYD2,HCN1,HCN2,HCN3,HCN4,HPN,KCNA1,KCNA10,KCNA2,KCNA3,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB3,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNF1,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNH4,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ15,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK16,KCNK17,KCNK18,KCNK2,KCNK3,KCNK4,KCNK5,KCNK6,KCNK7,KCNK9,KCNMA1,KCNMB1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,KCNQ1,KCNQ2,KCNQ3,KCNQ4,KCNS1,KCNS2,KCNS3,KCNV1,MTMR6,PKD2L1,REST,SLC12A6,SLC9A7,TMEM175	The directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006814	GO	BP	sodium ion transport	ABCB11,ANO6,ASIC1,ASIC2,ASIC3,ASIC4,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,FXYD2,HCN1,HCN2,HCN3,HCN4,KCNK1,KLHL3,NALCN,NDUFA9,NEDD4L,PKD2,PKD2L1,SCN10A,SCN11A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4A,SCN4B,SCN5A,SCN7A,SCN8A,SCN9A,SCNN1A,SCNN1B,SCNN1D,SCNN1G,SGK1,SHROOM2,SLC12A3,SLC13A4,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC23A1,SLC24A1,SLC24A5,SLC34A2,SLC34A3,SLC38A7,SLC3A2,SLC4A11,SLC4A4,SLC4A5,SLC4A7,SLC8A1,SLC8A2,SLC8A3,SLC9A1,SLC9A2,SLC9A3,SLC9A5,SLC9A6,SLC9A7,TRAPPC10,WNK4	The directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006816	GO	BP	calcium ion transport	ADRA1A,ANK2,ANO6,ASPH,ATP2A1,ATP2A2,ATP2A3,ATP2B2,ATP2B4,ATP2C1,BBC3,CACFD1,CACNA1C,CACNA1D,CACNA1G,CACNA1H,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG3,CACNG6,CACNG7,CACNG8,CALCRL,CAMK2A,CASR,CAV1,CCDC109B,CCL19,CCL21,CCL3,CCL5,CCL8,CCR1,CCR5,CCR7,CDH23,CHERP,CHRNA4,CHRNA7,CHRNB2,CRACR2A,CRACR2B,CSN2,CUL5,CYP27B1,DRD2,ERO1A,F2R,FGF2,FKBP1A,FKBP1B,FYN,GAS6,GRIN1,GRIN3A,HTR2A,HTR2B,HTR2C,IBTK,IL1RAPL1,ITGAV,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KCNN4,LCK,MCOLN1,MCOLN2,MCOLN3,MCU,MCUR1,MICU1,MICU2,NMUR1,NMUR2,NOL3,NPY,P2RX1,PANX1,PDE2A,PKD1,PKD2,PLCG2,PSEN1,PTPRC,RAMP1,RAMP2,RAMP3,RASA3,RYR1,RYR2,RYR3,SLC24A1,SLC35G1,SLC3A2,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLN,SMDT1,STIM2,STOML2,TMEM165,TPT1,TRDN,TRPA1,TRPC1,TRPC3,TRPC4,TRPC4AP,TRPC5,TRPC6,TRPC7,TRPM1,TRPM2,TRPM3,TRPM4,TRPM5,TRPM6,TRPM7,TRPM8,TRPV1,TRPV2,TRPV3,TRPV4,TRPV5,TRPV6,XCL1,ZP3	The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006817	GO	BP	phosphate ion transport	ADAMTS8,SLC17A1,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC25A3,SLC34A1,SLC34A2,SLC34A3	The directed movement of phosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006818	GO	BP	hydrogen transport	ADHFE1,ATP1A4,ATP4B,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,ATP6AP1,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1E1,ATP6V1F,ATP6V1H,COX10,COX11,COX15,COX4I1,COX4I2,COX5A,COX5B,COX6B1,COX7A1,COX7A2L,COX7B,COX8A,CYB5A,HVCN1,MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CYB,NDUFA4,NNT,NOX1,NOX5,SLC15A1,SLC15A2,SLC17A5,SLC23A2,SLC25A14,SLC25A27,SLC2A10,SLC2A9,SLC46A1,SLC4A11,SLC9A1,STOML2,TCIRG1,UCP1,UCP2,UCP3,UQCR10,UQCRC1,UQCRH,VPS9D1	The directed movement of hydrogen (H2 or H+), into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006821	GO	BP	chloride transport	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,BEST1,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,CLIC4,CLIC5,FXYD1,FXYD3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR1,NMUR2,SLC12A1,SLC12A2,SLC12A3,SLC12A4,SLC12A9,SLC1A4,SLC26A1,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC4A1,SLC4A10,TTYH1,TTYH3	The directed movement of chloride into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006825	GO	BP	copper ion transport	ATOX1,ATP7A,ATP7B,CCS,CUTC,SLC11A2,SLC31A1,SLC31A2	The directed movement of copper (Cu) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006826	GO	BP	iron ion transport	ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,CLTC,DNM2,HEPH,HFE,IREB2,LMTK2,MCOLN1,MFI2,PICALM,RAB11B,REP15,SCARA5,SLC11A1,SLC11A2,SLC40A1,STEAP3,TCIRG1,TF,TFR2,TFRC,TTYH1	The directed movement of iron (Fe) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006828	GO	BP	manganese ion transport	ATP2C1,SLC11A1,SLC11A2,SLC30A10,ZP3	The directed movement of manganese (Mn) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006829	GO	BP	zinc II ion transport	MT3,SLC11A2,SLC30A1,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC39A1,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6,SLC39A8	The directed movement of zinc (Zn II) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006833	GO	BP	water transport	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,AQP1,AQP10,AQP11,AQP2,AQP3,AQP4,AQP5,AQP6,AQP7,AQP8,AQP9,AVP,AVPR2,GNAS,HAS2,HYAL2,MIP,MYO5B,PDZD3,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,RAB11A,RAB11FIP2	The directed movement of water (H2O) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006835	GO	BP	dicarboxylic acid transport	ARL6IP5,BZRAP1,CPLX1,FOLR1,FOLR2,FOLR3,GIPC1,GLS,GLS2,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PRAF2,RAB3A,RIMS1,SLC13A2,SLC17A7,SLC19A1,SLC19A2,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC22A6,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A22,SLC25A32,SLC26A1,SLC26A6,SLC26A7,SLC26A8,SLC38A2,SLC46A1,SLC7A11,SNAP25,STX1A,STXBP1,SYT1,UNC13B,VAMP2	The directed movement of dicarboxylic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006836	GO	BP	neurotransmitter transport	ABAT,ALDH5A1,APBA1,BAIAP3,BLOC1S6,BRSK1,BZRAP1,CASK,CDK5,CHAT,CPLX1,DNAJC5,DOC2B,DVL1,GABRA2,GABRQ,GAD1,GAD2,GLS,GLS2,GLUL,GRM4,HRH3,HSPA8,LIN7A,LIN7B,LIN7C,MAOA,NLGN1,NRXN1,NRXN2,OTOF,PCLO,PIP5K1C,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PTPRN2,RAB3A,RIMS1,RIMS2,SEPT5,SLC17A7,SLC18A2,SLC18A3,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC22A2,SLC32A1,SLC38A1,SLC38A2,SLC5A7,SLC6A1,SLC6A11,SLC6A12,SLC6A13,SLC6A15,SLC6A16,SLC6A4,SNAP25,SNAPIN,SNCA,SNPH,STX1A,STX1B,STXBP1,SYN2,SYNJ1,SYT1,UNC13A,UNC13B,VAMP2	The directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Neurotransmitters are any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.
GO:0006839	GO	BP	mitochondrial transport	ACAA2,ACACA,ACACB,AIP,AKT1,ALKBH7,ATF2,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BLOC1S2,BMF,BNIP3,CAMK2A,CASP8,CCDC109B,CHCHD2,CHCHD4,COX19,CPT1A,CPT1B,CPT2,DNAJC19,DYNLL1,DYNLL2,E2F1,FBXO7,FIS1,FLVCR1,GDAP1,GFER,GRPEL1,GRPEL2,GSK3A,GSK3B,GZMB,HEBP2,HSP90AA1,HSPA1A,HSPA4,HSPA9,IMMP2L,KIF1BP,MAPK8,MCU,MCUR1,MFF,MFN2,MGARP,MICU1,MICU2,MIPEP,MOAP1,MPV17L,MRPL18,MT-ATP6,MT-ATP8,MTX1,MTX2,MUL1,NAIF1,NDUFA13,NMT1,PAM16,PDE2A,PMAIP1,PMPCA,PMPCB,PNPT1,PPIF,PPP3CC,PPP3R1,PRKAA2,PRKAB2,PRKAG2,RHOT1,RHOT2,SAMM50,SFN,SIVA1,SLC25A12,SLC25A13,SLC25A15,SLC25A20,SLC25A24,SLC25A33,SLC25A5,SLC25A6,SLC35F6,SLC8A3,SLC8B1,SMDT1,STARD3,STOML2,TFDP1,THEM4,TIMM10,TIMM10B,TIMM13,TIMM17A,TIMM17B,TIMM21,TIMM22,TIMM23,TIMM44,TIMM50,TIMM8A,TIMM8B,TIMM9,TMEM102,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TP53,TRNT1,TSPO,TST,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	Transport of substances into, out of or within a mitochondrion.
GO:0006851	GO	BP	mitochondrial calcium ion transport	CCDC109B,MCU,MCUR1,MICU1,MICU2,SLC8A3,SLC8B1,SMDT1,STOML2	The directed movement of calcium ions (Ca2+) into, out of or within a mitochondrion.
GO:0006853	GO	BP	carnitine shuttle	ACACA,ACACB,CPT1A,CPT1B,CPT2,PRKAA2,PRKAB2,PRKAG2,SLC25A20	The transfer of acyl groups to and from acyl-CoA molecules to form O-acylcarnitine, which can exchange across the mitochondrial inner membrane with unacylated carnitine.
GO:0006855	GO	BP	drug transmembrane transport	ABCB1,ABCG2,ATP8B1,EBP,SLC17A3,SLC22A1,SLC22A18,SLC22A2,SLC22A3,SLC22A5,TMEM30A	The process in which a drug is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0006862	GO	BP	nucleotide transport	ABCC11,CALHM1,SLC25A17,SLC25A19,SLC25A24,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC35A1,SLC35A2,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2	The directed movement of a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate, into, out of or within a cell.
GO:0006865	GO	BP	amino acid transport	ARL6IP5,BZRAP1,CLN3,CPLX1,CTNS,FOLR1,FOLR2,FOLR3,GIPC1,GLS,GLS2,OCA2,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PQLC2,PRAF2,RAB3A,RIMS1,SERINC1,SLC11A1,SLC16A10,SLC16A12,SLC17A7,SLC19A1,SLC19A2,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC25A26,SLC25A32,SLC36A1,SLC36A2,SLC36A4,SLC38A1,SLC38A2,SLC38A3,SLC38A4,SLC38A5,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC43A2,SLC46A1,SLC6A12,SLC6A14,SLC6A15,SLC6A17,SLC6A18,SLC6A19,SLC6A20,SLC6A5,SLC6A6,SLC6A7,SLC6A8,SLC7A1,SLC7A10,SLC7A11,SLC7A2,SLC7A3,SLC7A4,SLC7A5,SLC7A6,SLC7A7,SLC7A8,SLC7A9,SNAP25,STX1A,STXBP1,SYT1,UNC13B,VAMP2	The directed movement of amino acids, organic acids containing one or more amino substituents, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0006869	GO	BP	lipid transport	ABCA1,ABCA12,ABCA5,ABCA7,ABCB11,ABCB4,ABCC3,ABCC4,ABCD1,ABCG1,ABCG4,ABCG5,ABCG8,ACACA,ACACB,ACE,ACSL1,ACSL3,AKR1C1,AKR1C4,ALB,APOA1,APOA2,APOA4,APOA5,APOB,APOC1,APOC2,APOC3,APOD,APOE,APOH,APOL2,APOM,ATP10A,ATP10B,ATP10D,ATP11A,ATP11B,ATP11C,ATP8A1,ATP8B1,ATP9A,ATP9B,BAAT,BDKRB2,CAV1,CD36,CEL,CETP,CFHR4,CHKA,CLN8,CLU,COL4A3BP,CPT1A,CPT1B,CPT2,CPTP,DRD2,DRD3,DRD4,FABP3,FABP6,GHRL,GLTP,INHBA,LBP,LCAT,LCN1,LCN12,LDLR,LDLRAP1,LEP,LIPC,LIPG,MFSD2A,MSR1,MTTP,NCOA1,NCOA2,NMUR2,NOS2,NPC1,NPC1L1,NPC2,NR1H4,OSBP,OSBPL5,OSBPL8,PCTP,PITPNA,PITPNB,PITPNC1,PITPNM1,PITPNM3,PLA2G10,PLA2G1B,PLEKHA8,PNPLA8,PPARA,PPARD,PPARG,PRELID1,PRELID3A,PRKAA2,PRKAB2,PRKAG2,PSAP,RBP4,RXRA,SCARB1,SCP2,SFTPA1,SLC10A1,SLC10A2,SLC22A9,SLC25A17,SLC25A20,SLC27A1,SLC27A2,SLC27A4,SLC27A5,SLC27A6,SLC51A,SLC51B,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3,SLCO2A1,SOAT1,SOAT2,SPX,STX12,TMEM30A,TNFAIP8L3,TRIAP1,VPS4A	The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
GO:0006874	GO	BP	cellular calcium ion homeostasis	ABL1,ABL2,ADCY5,ADRA1A,AGTR1,ANK2,ATP1B1,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP7B,AVPR1B,BAK1,BAX,BBC3,BCAP31,BCL2,BDKRB1,C1QTNF1,C3AR1,CACNA1A,CACNA1C,CALCA,CALCB,CALCR,CALR,CAMK2D,CASQ2,CASR,CAV1,CAV3,CCDC109B,CCKBR,CCL1,CCL11,CCL13,CCL14,CCL15,CCL19,CCL21,CCL23,CCL3,CCL5,CCL7,CCL8,CCR1,CCR2,CCR3,CCR4,CCR5,CCR7,CCR9,CD24,CD36,CD40,CD52,CD55,CDH23,CHERP,CHRNA10,CHRNA7,CHRNA9,CIB2,CLN3,CSRP3,CXCL12,CXCL13,CXCR4,CYSLTR1,DLG4,DMPK,DRD1,DRD2,DRD3,DRD4,DRD5,EDN1,EDN2,EDNRA,ELANE,EPHX2,ERO1A,ESR1,F2,F2R,F2RL1,FGF2,FIS1,FKBP1B,GCM2,GHRL,GLP1R,GNA15,GPER1,GRM1,HERPUD1,HMGB1,HRC,HSP90B1,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KCTD17,KNG1,LCK,LPAR1,LPAR2,LPAR3,MCHR1,MCU,MCUR1,MICU1,MICU2,NMUR2,NOL3,NPTN,OPRL1,OPRM1,P2RY1,P2RY4,PDE6A,PDE6B,PDGFRA,PKD2,PKHD1,PLCE1,PLCG2,PLN,PML,PRKACA,PROK2,PSEN1,PTPRC,RAP1GDS1,RGN,RMDN3,RYR1,RYR2,S1PR3,S1PR4,SAA1,SLC30A1,SLC35G1,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SMDT1,SPPL3,STC1,STIM2,STOML2,TAC1,TGM2,TMEM165,TMEM203,TNNI3,TPCN2,TPT1,TRDN,TRPC1,TRPM1,TRPV4,VAPB,WFS1,XCL1,XCR1	Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.
GO:0006878	GO	BP	cellular copper ion homeostasis	APP,ARF1,ATP7A,ATP7B,CCDC22,MT2A,PRNP	Any process involved in the maintenance of an internal steady state of copper ions at the level of a cell.
GO:0006879	GO	BP	cellular iron ion homeostasis	ABCB6,ABCG2,ALAS2,ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,BMP6,CP,CYBRD1,FAM132B,FLVCR1,FTH1,FTL,FTMT,FXN,GDF2,HAMP,HEPH,HFE2,HMOX1,HMOX2,LCN2,LTF,MCOLN1,MYC,NDFIP1,NUBP1,SCARA5,SLC11A1,SLC11A2,SLC22A17,SLC40A1,SLC46A1,SMAD4,SOD1,SRI,STEAP3,TCIRG1,TF,TFR2,TFRC,TMPRSS6	Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
GO:0006882	GO	BP	cellular zinc ion homeostasis	LCK,MT3,S100A8,S100A9,SLC30A1,SLC30A5,SLC30A8,SLC39A13,SLC39A14,SLC39A6	Any process involved in the maintenance of an internal steady state of zinc ions at the level of a cell.
GO:0006883	GO	BP	cellular sodium ion homeostasis	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,NEDD4L,SLC8A1,SLC9A1,TMPRSS3	Any process involved in the maintenance of an internal steady state of sodium ions at the level of a cell.
GO:0006884	GO	BP	cell volume homeostasis	ANO6,AQP1,CLCN3,CLCN6,KCNMA1,LRRC8A,P2RX7,SHANK3,SLC12A4,TRPV4	Any process involved in maintaining the steady state of a cell's volume. The cell's volume refers to the three-dimensional space occupied by a cell.
GO:0006885	GO	BP	regulation of pH	ATP1A4,ATP5B,ATP6AP1,ATP6V0A4,ATP6V0E1,ATP6V0E2,ATP6V1B1,ATP6V1H,BCL2,CA2,CFTR,CHP1,CLCN3,CLN3,CLN5,CLN6,GPR89A,LRRK2,NOX1,PDK2,PDK4,PPT1,RAB20,RAB38,RAB39A,RAB7A,SLC11A1,SLC26A3,SLC26A4,SLC26A6,SLC9A1,SLC9A7,TMEM165	Any process involved in the maintenance of an internal equilibrium of hydrogen ions, thereby modulating the internal pH, within an organism or cell.
GO:0006887	GO	BP	exocytosis	A2M,ABCA12,ABCC4,ACTN1,ACTN2,ACTN4,ALB,ALDOA,ANK1,ANXA3,APOA1,APP,ARFGEF1,BLOC1S6,BRPF3,CADPS,CALM1,CALU,CAP1,CCL3,CCL5,CCL8,CCR1,CD36,CD63,CD9,CDK16,CDK5,CFD,CFL1,CHGA,CLU,COPS5,CORO1A,CPLX1,CPLX2,CRHBP,DMTN,DNAJC5,DOC2B,EGF,EXOC1,EXOC3L1,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FLNA,FN1,GAS6,HABP4,HCK,HGF,HRG,HSPA5,IGF1,IGF2,ITGA2B,ITGB3,JAGN1,KCNB1,KIT,KLRF2,KNG1,LAMP2,LEFTY2,LYN,MIA3,MILR1,MMRN1,MRGPRX2,NLGN1,NR4A3,NSF,OTOF,PCLO,PDGFA,PDGFB,PECAM1,PF4,PFN1,PIK3C2A,PIK3CD,PIK3CG,PIP5K1C,PLEK,PLG,PPBP,PPIA,PPP3CB,PROS1,PRSS12,PSAP,PTPRN2,RAB11A,RAB11B,RAB11FIP2,RAB11FIP5,RAB26,RAB27A,RAB31,RAB3A,RAB8A,RABEPK,RIMS1,RIMS2,RIMS3,S100A13,SCG3,SCIN,SCRN1,SDF4,SELP,SEPT5,SERPINA1,SERPINE1,SERPINF2,SERPING1,SNAP23,SNAP25,SNAP29,SNAPIN,SNPH,SOD1,SPARC,SRGN,STEAP2,STX1B,STXBP1,SYK,SYNJ1,SYT1,SYT6,SYTL1,SYTL2,TF,TGFB1,TGFB2,TGFB3,THBS1,TIMP1,TLN1,TMED10,TMEM79,TMSB4X,TTN,TUBA4A,UNC13B,VAMP2,VAMP3,VAMP7,VCL,VEGFA,VEGFB,VEGFC,VTI1B,VWF,WASH1,WDR1,YKT6,ZP4	A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle by fusion of the vesicle with the plasma membrane of a cell. Steps that prepare vesicles for fusion with the membrane (e.g. docking and priming) are included in this process. This is the process in which most molecules are secreted from eukaryotic cells.
GO:0006888	GO	BP	ER to Golgi vesicle-mediated transport	ANK1,ANK2,ANK3,ANKRD28,ARCN1,AREG,ARF4,ARFGAP1,ARFGAP2,ARFGAP3,BET1,BET1L,BGLAP,CD55,CD59,CNIH1,CNIH2,CNIH3,CNIH4,COG1,COG2,COG3,COG4,COG5,COG6,COG7,COG8,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,CSNK1D,CTAGE5,CTSC,CTSZ,CUL3,DCTN1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DYNC1H1,DYNC1I1,DYNC1I2,DYNC1LI2,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,ERGIC1,F10,F2,F5,F7,F8,F9,FOLR1,GAS6,GBF1,GOLGA2,GOLGB1,GOPC,GORASP1,GOSR1,GOSR2,GRIA1,INS,KDELR1,KLHL12,LMAN1,LMAN2L,MCFD2,MIA3,MPPE1,NAPA,NRBP1,NSF,PPP6C,PPP6R1,PPP6R3,PREB,PROC,PROS1,PROZ,RAB1A,RAB1B,RANGRF,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC22C,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,SPAST,SPTA1,SPTAN1,SPTB,SPTBN1,SPTBN2,SPTBN4,SPTBN5,STX17,STX5,TBC1D20,TFG,TGFA,TMED10,TMED2,TMED3,TMED7,TMED9,TMEM115,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1,VAMP7,VAPA,VAPB,VTI1A,WHAMM,YKT6,ZW10	The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
GO:0006890	GO	BP	retrograde vesicle-mediated transport, Golgi to ER	ARCN1,ARF1,ARFGAP1,COG3,COG4,COG7,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,GBF1,HTT,LMAN2,NBAS,PICK1,RAB6A,RAB6B,RER1,SCFD1,SCYL1,TAPBP,TMED10,TMEM115,UVRAG	The directed movement of substances from the Golgi back to the endoplasmic reticulum, mediated by vesicles bearing specific protein coats such as COPI or COG.
GO:0006891	GO	BP	intra-Golgi vesicle-mediated transport	COG1,COG2,COG3,COG5,COPB1,COPB2,COPE,COPG2,COPZ1,GABARAPL2,GOLGA3,GOSR1,NAPA,NAPG,OPTN,RAB33B,RAB6A,SORL1	The directed movement of substances within the Golgi, mediated by small transport vesicles. These either fuse with the cis-Golgi or with each other to form the membrane stacks known as the cis-Golgi reticulum (network).
GO:0006892	GO	BP	post-Golgi vesicle-mediated transport	AMN,ANK3,ANKFY1,AP1AR,AP1B1,AP1G1,AP1G2,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP3B2,AP4B1,AP4E1,AP4M1,AP4S1,APP,ARF1,ARFGEF2,ARFRP1,ARL3,ARRB1,BBS1,BBS2,BLOC1S1,BLOC1S3,BLOC1S4,BLOC1S6,BLZF1,C16orf62,CCDC22,CCDC93,CHMP2A,CLINT1,CLTA,CLTC,CLVS1,CLVS2,COMMD1,CORO7,DNAJC6,DNM2,DOPEY1,DOPEY2,DTNBP1,EPS15,EXOC5,FTH1,FTL,GBF1,GOLGA4,GOLGA7,GOLPH3,GOPC,HGS,HSPA8,KIF13A,KIF16B,KLHL20,KRT18,LAMP1,LLGL1,MACF1,MON2,MYO1B,MYO5A,NAPA,OPTN,OSBPL5,PUM1,RAB10,RAB14,RAB26,RAB31,RAB34,RAB3IP,RP2,SCAMP1,SCAMP2,SCAMP3,SCFD1,SH3D19,SH3GL2,SNAP23,SORL1,SORT1,SPTBN1,STEAP2,STX4,TXNDC5,VAMP2,VAMP7,VAMP8,VPS13A,WIPI1	The directed movement of substances from the Golgi to other parts of the cell, including organelles and the plasma membrane, mediated by small transport vesicles.
GO:0006893	GO	BP	Golgi to plasma membrane transport	AMN,ANK3,ARFGEF2,ARFRP1,BBS1,BBS2,BLZF1,C16orf62,CCDC22,CCDC93,COMMD1,GOLGA4,GOLGA7,GOLPH3,GOPC,KIF13A,KRT18,LLGL1,MACF1,OPTN,OSBPL5,RAB10,RAB26,RAB31,RAB34,RAB3IP,SPTBN1,STEAP2,VAMP2	The directed movement of substances from the Golgi to the plasma membrane in transport vesicles that move from the trans-Golgi network to the plasma membrane, where they fuse and release their contents by exocytosis.
GO:0006895	GO	BP	Golgi to endosome transport	AP1AR,AP2A1,AP4M1,CORO7,DOPEY1,DOPEY2,EPS15,GBF1,KIF16B,KLHL20,MON2,RAB14,SORT1,VPS13A,WIPI1	The directed movement of substances from the Golgi to early sorting endosomes. Clathrin vesicles transport substances from the trans-Golgi to endosomes.
GO:0006898	GO	BP	receptor-mediated endocytosis	ACKR2,ACKR3,ADM,ADRB2,ADRBK1,ADRBK2,ALB,AMBP,AMN,AP1S1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOA1,APOB,APOE,APOL1,ARHGAP27,ARRB1,ARRB2,ASGR2,CALCA,CALCR,CALCRL,CALR,CANX,CAV1,CAV2,CAV3,CD163,CD36,CD81,CD9,CDK5,CETP,CLEC9A,CLN3,CLTC,CLTCL1,COL1A1,COL1A2,COL3A1,COL4A1,COL4A2,COLEC11,COLEC12,CTTN,CUBN,CXCL16,CXCL8,CXCR1,CXCR2,DAB2,DLL1,DMBT1,DNM1,DNM2,DRD3,EGFR,EPS15,FCER1G,FCHO1,FCHO2,FNBP1L,FOLR1,FOLR2,FTH1,FTL,GHR,GRB2,GRK4,GTF2H2,HBA1,HBB,HIP1R,HP,HPR,HPX,HSP90AA1,HSP90B1,HSPH1,HYOU1,IGF2R,ITGB1,ITGB2,ITSN1,LDLR,LDLRAP1,LGALS3BP,LILRB1,LPA,LRP1,LRP12,LRP3,LRP8,LRPAP1,M6PR,MAPK1,MAPK3,MARCO,MASP1,MICALL1,MLC1,MRC1,MSR1,NEDD4,NLGN3,PACSIN1,PACSIN2,PDLIM7,PI4KB,PICALM,PIP5K1C,PLA2R1,PPT1,RAB31,RAB5A,RABEPK,RAMP1,RAMP2,RAMP3,SAA1,SCARA3,SCARA5,SCARB1,SCARF1,SCGB3A2,SCYL2,SFTPD,SNCA,SNX1,SNX9,SORL1,SPARC,SSC5D,STAB1,STAB2,STON2,SYK,SYNJ1,TFR2,VLDLR	An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
GO:0006900	GO	BP	membrane budding	ANKRD28,ANXA2,AP2S1,ARCN1,AREG,ARF1,ARFGAP1,BET1,CALY,CD59,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,EPS15,F5,F8,FCHO1,FCHO2,FNBP1L,FOLR1,GBF1,GOLGA2,GOLPH3,GORASP1,GOSR2,GRIA1,HIP1,KLHL12,LMAN1,LRSAM1,MCFD2,MVB12A,MYO18A,NAPA,NSF,PDCD6IP,PICALM,PIK3C2A,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,RILP,S100A10,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,SNX3,STX5,TBC1D20,TFG,TGFA,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,TSG101,USO1,VAPA,VAPB,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1,WASL	The evagination of a membrane, resulting in formation of a vesicle.
GO:0006901	GO	BP	vesicle coating	ANKRD28,AP2S1,ARCN1,AREG,ARF1,ARFGAP1,BET1,CALY,CD59,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,EPS15,F5,F8,FCHO1,FCHO2,FOLR1,GBF1,GOLGA2,GORASP1,GOSR2,GRIA1,HIP1,KLHL12,LMAN1,MCFD2,NAPA,NSF,PICALM,PIK3C2A,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,STX5,TFG,TGFA,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1	A protein coat is added to the vesicle to form the proper shape of the vesicle and to target the vesicle for transport to its destination.
GO:0006903	GO	BP	vesicle targeting	ANKRD28,AP1AR,AP1M2,ARCN1,AREG,ARF1,ARFGAP1,BET1,CD59,CLASP1,CLASP2,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,F5,F8,FOLR1,GBF1,GOLGA2,GORASP1,GOSR2,GRIA1,KLHL12,LMAN1,LRMP,MCFD2,NAPA,NLGN1,NSF,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEPT5,SERPINA1,SNAP23,SNAP29,STX5,TFG,TGFA,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1,WIPI1,YKT6	The process in which vesicles are directed to specific destination membranes. Targeting involves coordinated interactions among cytoskeletal elements (microtubules or actin filaments), motor proteins, molecules at the vesicle membrane and target membrane surfaces, and vesicle cargo.
GO:0006904	GO	BP	vesicle docking involved in exocytosis	BLOC1S6,CPLX2,KCNB1,PLEK,RAB8A,RABEPK,SNAP25,SNPH,STX1B,SYTL2,VAMP3,VTI1B,YKT6	The initial attachment of a vesicle membrane to a target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane, that contributes to exocytosis.
GO:0006906	GO	BP	vesicle fusion	ANKFY1,CAV2,EEA1,LRMP,NKD2,RAB20,RAB34,RAB39A,RAB7A,RAB8A,TGFBRAP1,VAMP4,VAMP7,VPS11,VPS39,VPS41,VPS4A,VPS8,VTI1A	Fusion of the membrane of a transport vesicle with its target membrane.
GO:0006907	GO	BP	pinocytosis	AHSG,DOCK2,MAPKAPK2,MAPKAPK3,PPT1,PYCARD,SNX33,SNX5	An endocytosis process that results in the uptake of liquid material by cells from their external environment; literally 'cell drinking'. Liquid is enclosed in vesicles, called pinosomes, formed by invagination of the plasma membrane.
GO:0006909	GO	BP	phagocytosis	ABI1,ABL1,ACTB,ACTG1,ACTR2,ACTR3,ADORA1,ADORA2A,AIF1,ALOX15,ANXA1,ANXA3,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,AXL,BAIAP2,BIN2,BRK1,C4B,CD14,CD247,CD302,CD3G,CD93,CDC42,CEACAM4,CFL1,CLEC7A,COLEC12,CORO1A,CORO1C,CRK,CRP,CYFIP1,CYFIP2,DOCK1,ELMO1,ELMO2,FCGR1A,FCGR2A,FCGR3A,FCN1,FCN2,FCN3,FGR,FYN,GAS6,GRB2,GSN,GULP1,HCK,HMGB1,HSP90AA1,HSP90AB1,ITPR1,ITPR2,ITPR3,LBP,LIMK1,LRP1,LYN,MAPK1,MAPK3,MBL2,MERTK,MYH2,MYH9,MYO10,MYO1C,MYO1G,NCK1,NCKAP1,NCKAP1L,NCKIPSD,NR1H3,PAK1,PECAM1,PIK3CA,PIK3CB,PIK3R1,PIK3R2,PIP5K1A,PIP5K1C,PLA2G6,PLCG1,PLCG2,PLD2,PLPP4,PRKCD,PRKCE,PTK2,RAB20,RAB34,RAB39A,RAB7A,RAC1,RARA,SCARB1,SCFD1,SLC11A1,SRC,SYK,TGM2,THBS1,TYRO3,VAMP7,VAV1,VAV2,VAV3,WAS,WASF2,WASL,WIPF1,WIPF2,WIPF3,XKR8,YES1	An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
GO:0006910	GO	BP	phagocytosis, recognition	CLEC7A,COLEC12,FCN1,FCN2,FCN3,SCARB1	The initial step in phagocytosis involving adhesion to bacteria, immune complexes and other particulate matter, or an apoptotic cell and based on recognition of factors such as bacterial cell wall components, opsonins like complement and antibody or protein receptors and lipids like phosphatidyl serine, and leading to intracellular signaling in the phagocytosing cell.
GO:0006911	GO	BP	phagocytosis, engulfment	AIF1,BIN2,DOCK1,ELMO1,FCGR1A,GSN,GULP1,MYH9,THBS1,VAMP7,XKR8	The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.
GO:0006913	GO	BP	nucleocytoplasmic transport	AAAS,ADAR,AGFG1,AKR1C3,AKT1,ALKBH5,ALYREF,ANP32A,ATXN1,BCL3,BCL6,BUD13,C11orf73,CALR,CBLB,CDC40,CEP57,CHP1,CHTOP,CITED1,CPSF1,CPSF2,CPSF3,CSE1L,DAG1,DDX19B,DDX25,DDX39A,DDX39B,DHX38,DUSP16,EGF,EGR2,EIF4E,EIF5A,F2R,FIP1L1,FYB,FYTTD1,GCKR,GDF5,GLE1,HES1,HHEX,HNRNPA1,HNRNPA2B1,HTATIP2,IFNG,IPO13,IPO5,IPO9,JAK2,JAK3,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,LSG1,LUZP4,MAGOH,MALT1,MCM3AP,MT3,MYBBP1A,NCBP1,NCBP2,NCKIPSD,NEMF,NMD3,NOP58,NPM1,NSRP1,NUP107,NUP133,NUP160,NUP205,NUP214,NUP98,NUPL2,NUTF2,NXF1,NXF2,NXF3,NXF5,OPRD1,OR1D2,PABPN1,PDIA3,PHAX,PHB2,PKD1,POLDIP3,PPP1R10,PRICKLE1,PTTG1IP,RAE1,RAN,RANBP17,RANBP2,RBM22,RBM8A,RERE,RGS14,RITA1,RNPS1,RPAIN,RPL23,RPS15,RSRC1,SARNP,SEC61B,SET,SIX3,SLBP,SMG1,SMG5,SMG6,SMG7,SMURF1,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,STAT3,STRADA,STRADB,STYX,SYK,TGFB1,TGFB2,TGS1,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TNF,TNPO1,TNPO3,TPR,TRPS1,TSC1,TSC2,U2AF1,U2AF2,UPF1,UPF2,UPF3A,UPF3B,XPO1,XPO5,XPO6,XPO7,XPOT,ZC3H11A,ZC3H3,ZFYVE9	The directed movement of molecules between the nucleus and the cytoplasm.
GO:0006919	GO	BP	activation of cysteine-type endopeptidase activity involved in apoptotic process	ACER2,AIFM1,ANP32B,APAF1,BAD,BAX,BBC3,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,COL4A3,CTSH,CYCS,DAP,DIABLO,DLC1,DNAJA3,EIF2AK3,F2R,F3,FADD,FAM162A,FAS,FASLG,GNB2L1,HIP1,HSPD1,HSPE1,IFI27,IFT57,JAK2,LCK,LY96,MTCH1,MUL1,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NOD1,PDCD2,PPARG,PYCARD,RET,RIPK1,ROBO1,RPS27L,S100A8,S100A9,SENP1,SLC11A2,SMAD3,SNCA,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
GO:0006921	GO	BP	cellular component disassembly involved in execution phase of apoptosis	ACIN1,ACVR1C,ADD1,APC,BCAP31,BIRC2,BLCAP,BMX,CAPN10,CASP3,CASP6,CASP7,CASP8,CDH1,CDK5RAP3,CECR2,CLSPN,CTNNB1,DBNL,DEDD2,DFFA,DFFB,DNM1L,DSG1,DSG2,DSG3,DSP,ERN2,FNTA,FOXL2,GAS2,GPER1,GSN,H1F0,HMGB1,HMGB2,KPNA1,KPNB1,LMNA,LMNB1,MAPT,OCLN,PAK2,PKP1,PLEC,PRKCD,PRKCQ,PTK2,ROCK1,SATB1,SPTAN1,STK24,STK26,TARDBP,TJP1,TJP2,TOP2A,VIM	The breakdown of structures such as organelles, proteins, or other macromolecular structures during apoptosis.
GO:0006927	GO	BP	transformed cell apoptotic process	BAX,DAB2IP,FAM162A,PLK5,RHOB,TNF	Any apoptotic process in a transformed cell, a cell that has undergone changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm.
GO:0006929	GO	BP	substrate-dependent cell migration	ANKS1A,CD2AP,CUZD1,EPHA8,ITGA11,ITGA2,ITGB1BP1,NTN1,OPHN1,P2RY12,PTPRC,ROBO1,SDCBP,SHTN1,SLIT2,VEGFC	The orderly movement of a cell from one site to another along a substrate such as the extracellular matrix; the migrating cell forms a protrusion that attaches to the substrate.
GO:0006930	GO	BP	substrate-dependent cell migration, cell extension	CD2AP,NTN1,OPHN1,P2RY12,SDCBP,SHTN1	The formation of a cell surface protrusion, such as a lamellipodium or filopodium, at the leading edge of a migrating cell.
GO:0006936	GO	BP	muscle contraction	ACTA1,ACTA2,ACTC1,ACTG2,ACTN2,ACTN3,ADRA1A,ADRBK1,ALDOA,ANK2,ANKRD2,ANXA1,ANXA2,ANXA6,ARHGEF11,ASPH,ATP1A1,ATP1A2,ATP1B1,BDKRB2,CACNA1H,CACNA1S,CACNG1,CALD1,CALM1,CAMK2D,CASQ2,CAV3,CCDC78,CHRNA1,CHRNB1,CHRNB2,CHRND,CHRNE,CHRNG,CKMT2,CLCN1,CRYAB,CSRP3,DES,DMD,DRD2,DTNA,DYSF,EDN1,EDN2,EDN3,EDNRA,EDNRB,EMD,FGF12,FXYD1,GAA,GALR2,GAMT,GDNF,GJA1,GJC1,GLRA1,GNAO1,GPD1L,HCN4,HRC,HTR1D,HTR2B,ITGA1,ITGB5,JSRP1,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP2,KCNJ12,KCNJ2,KCNMA1,KCNQ1,KLHL41,KNG1,LMOD1,LTB4R,MYBPC1,MYBPC2,MYBPC3,MYH11,MYH13,MYH14,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL10,MYL12A,MYL12B,MYL2,MYL3,MYL4,MYL5,MYL6,MYL6B,MYL7,MYL9,MYLK,MYLK2,MYLPF,MYOF,MYOT,NEB,NEDD4L,NOS1,OXTR,P2RX6,PABPN1,PGAM2,PIK3C2A,PIK3CA,PKP2,PXN,RCSD1,ROCK1,ROCK2,RYR1,RYR2,SCN1B,SCN2B,SCN3B,SCN4A,SCN4B,SCN5A,SGCA,SLC6A8,SLC8A1,SMPX,SMTN,SNTA1,SNTB1,SORBS1,SORBS3,SSPN,STAC3,STBD1,SULF1,SULF2,TACR2,TAZ,TCAP,TLN1,TMOD1,TMOD4,TNNC1,TNNC2,TNNI1,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPCN2,TPM1,TPM2,TPM3,TPM4,TRDN,TRIM72,TTN,UTRN,UTS2,VCL,VIM,VIPR1	A process in which force is generated within muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis.
GO:0006937	GO	BP	regulation of muscle contraction	ACTN3,ADRA1A,ADRBK1,ANK2,ASPH,ATP1A2,ATP1B1,ATP2A1,ATP2A2,BMP10,CACNA1C,CALM1,CAMK2D,CASQ1,CASQ2,CAV1,CAV3,CHRNA3,CLIC2,CNN1,CTNNA3,CTTN,DAPK3,DMD,DOCK4,DOCK5,DSC2,DSG2,DSP,F2R,FKBP1B,GJA5,GPER1,GSTM2,GSTO1,HCN4,HRC,JUP,KCNA1,KCNB2,KCNJ2,KCNQ1,MYBPC3,MYBPH,MYH7,MYL2,MYL3,MYL5,MYL9,MYLK2,MYOCD,NKX2-5,NMU,NMUR2,NOS1,NOS1AP,NPPA,P2RX4,PDE4B,PDE4D,PIK3CG,PKP2,PLCE1,PLN,PPP1R12B,PRKACA,PROK2,RGS2,RNF207,RYR2,SCN10A,SCN5A,SLC8A1,SLC8A3,SLC9A1,SMAD7,SOD1,SPHK1,SRF,SRI,STC1,TNNC1,TNNC2,TNNI1,TNNI3K,TNNT1,TNNT3,TPM1,ZC3H12A	Any process that modulates the frequency, rate or extent of muscle contraction.
GO:0006939	GO	BP	smooth muscle contraction	ADRA1A,BDKRB2,CHRNB2,DRD2,EDN1,EDN2,EDN3,EDNRA,EDNRB,GDNF,HTR1D,HTR2B,KCNMA1,KNG1,MYH11,MYLK,PIK3C2A,ROCK1,ROCK2,SLC8A1,SMTN,SULF1,SULF2,TPCN2	A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length.
GO:0006940	GO	BP	regulation of smooth muscle contraction	CAV1,CHRNA3,CNN1,CTTN,DAPK3,DOCK4,DOCK5,F2R,GPER1,KCNB2,MYOCD,NMU,NMUR2,PLCE1,PROK2,SOD1,SPHK1,SRF	Any process that modulates the frequency, rate or extent of smooth muscle contraction.
GO:0006941	GO	BP	striated muscle contraction	ADRBK1,ALDOA,ANK2,ARHGEF11,ATP1A1,ATP1A2,ATP1B1,CAMK2D,CASQ2,CAV3,CCDC78,CHRNA1,CSRP3,DMD,DTNA,FGF12,GAA,GJA1,GJC1,GPD1L,JSRP1,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,KLHL41,MYBPC3,MYH14,MYH3,MYH6,MYH7,MYH8,MYL3,MYL4,MYLK2,NEDD4L,NOS1,PGAM2,PIK3CA,PKP2,RCSD1,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SMPX,SNTA1,STAC3,TAZ,TCAP,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT3,TPM1,TTN	A process in which force is generated within striated muscle tissue, resulting in the shortening of the muscle. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Striated muscle is a type of muscle in which the repeating units (sarcomeres) of the contractile myofibrils are arranged in registry throughout the cell, resulting in transverse or oblique striations observable at the level of the light microscope.
GO:0006942	GO	BP	regulation of striated muscle contraction	ACTN3,ADRA1A,ADRBK1,ANK2,ASPH,ATP1A2,ATP1B1,ATP2A1,ATP2A2,BMP10,CACNA1C,CALM1,CAMK2D,CASQ1,CASQ2,CAV1,CAV3,CLIC2,CTNNA3,DMD,DSC2,DSG2,DSP,FKBP1B,GJA5,GSTM2,GSTO1,HCN4,HRC,JUP,KCNJ2,KCNQ1,MYBPC3,MYBPH,MYH7,MYL2,MYL3,NKX2-5,NOS1,NOS1AP,NPPA,P2RX4,PDE4B,PDE4D,PIK3CG,PKP2,PLN,PRKACA,RGS2,RNF207,RYR2,SCN10A,SCN5A,SLC8A1,SLC8A3,SLC9A1,SMAD7,SRI,STC1,TNNI1,TNNI3K,TNNT3,ZC3H12A	Any process that modulates the frequency, rate or extent of striated muscle contraction.
GO:0006949	GO	BP	syncytium formation	ADAM12,ADGRB3,CACNA1H,DCSTAMP,ERVFRD-1,ERVW-1,KCNH1,NOS1,SH3PXD2A,TMEM8C	The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane. Syncytia are normally derived from single cells that fuse or fail to complete cell division.
GO:0006953	GO	BP	acute-phase response	AHSG,APCS,APOL2,CEBPB,CRP,IL1RN,IL22,IL6,IL6R,INS,LBP,MBL2,PLSCR1,SAA1,SIGIRR	An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
GO:0006954	GO	BP	inflammatory response	ABCF1,ADAM8,ADORA1,ADORA2A,AFAP1L2,AHSG,AIF1,ALOX15,ANO6,ANXA1,AOAH,AOC3,AOX1,APCS,APOL2,APOL3,AZU1,BDKRB2,BLNK,BMP2,C3AR1,CAMP,CARD18,CCL11,CCL19,CCL2,CCL21,CCL3,CCL5,CCR2,CCR7,CCRL2,CD40LG,CD6,CDO1,CEBPB,CHIA,CHUK,CRH,CRHBP,CRP,CSF1R,CTNNBIP1,CXCL13,CXCL6,CXCL8,CXCR1,CXCR2,CXCR4,CYBA,CYBB,CYP4F11,EPHX2,F11R,F12,F2R,F3,FFAR2,FOLR2,FOS,FPR2,GPR68,HDAC4,HDAC5,HDAC9,HIF1A,HLA-DRB1,HMGB1,HMGB2,HMOX1,HNRNPA0,HRH1,HYAL1,HYAL3,IFNA2,IKBKB,IKBKG,IL10,IL10RB,IL18,IL18RAP,IL1A,IL1B,IL1RN,IL22,IL6,IL6R,IL9,INS,IRAK2,ITCH,ITGAL,ITGB2,KIT,KLKB1,KLRG1,KNG1,KRT16,LBP,LGALS9,LIAS,LTA4H,LY75,LYZ,MAPKAPK2,MBL2,MEFV,MGLL,MMP25,MYLK3,NCR3,NFAM1,NFATC3,NFATC4,NFE2L1,NFKB1,NFRKB,NFX1,NLRC4,NLRP3,NMI,NOD1,NOX1,NOX4,NRROS,ODAM,ORM1,PARP4,PIK3CD,PIK3CG,PLA2G2D,PLA2G2E,PLA2G4B,PLA2G4C,PLSCR1,PNMA1,PRDX5,PROK2,PTX3,PXK,RAC1,RELA,RIPK2,S100A8,S100A9,SAA1,SCG2,SCUBE1,SELE,SERPINA3,SIGIRR,SIGLEC1,SLC11A1,SNAP23,SYK,TACR1,TBK1,TGFB1,THBS1,TNF,TNFAIP6,TNFRSF1A,TNFSF4,TOLLIP,TPST1,VNN1,XCR1	The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
GO:0006956	GO	BP	complement activation	C1QA,C1QB,C1QC,C1R,C1S,C2,C3,C4A,C4B,C5,C6,C7,C8A,C8B,CFB,CFD,CFH,CFHR1,CFHR5,CFP,CLU,FCN1,FCN2,FCN3,MASP1,MASP2,MBL2,RGCC	Any process involved in the activation of any of the steps of the complement cascade, which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes; the initial steps of complement activation involve one of three pathways, the classical pathway, the alternative pathway, and the lectin pathway, all of which lead to the terminal complement pathway.
GO:0006957	GO	BP	complement activation, alternative pathway	C3,CFB,CFD,CFHR5,CFP	Any process involved in the activation of any of the steps of the alternative pathway of the complement cascade which allows for the direct killing of microbes and the regulation of other immune processes.
GO:0006958	GO	BP	complement activation, classical pathway	C1QA,C1QB,C1QC,C1R,C1S	Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes.
GO:0006959	GO	BP	humoral immune response	ADM,ANG,APP,AZU1,B2M,BCL2,BLNK,BPIFA1,BST1,BST2,C1QA,C1QB,C1QC,C1R,C1S,C2,C3,C4A,C4B,C5,C6,C7,C8A,C8B,CALCA,CAMP,CCL2,CCR6,CD28,CD83,CFB,CFD,CFH,CFHR1,CFHR5,CFP,CLU,CST9,DEFA1,DEFA3,DEFA4,DEFA5,DEFA6,DEFB1,DMBT1,EBI3,FAU,FCN1,FCN2,FCN3,FGA,FGB,FOXJ1,GPI,GPR183,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,HLA-A,HLA-DQB1,HLA-DRB1,HLA-E,IL36RN,IL6,IL7,JCHAIN,KLK3,LTF,LY86,MASP1,MASP2,MBL2,MEF2C,MNX1,MS4A1,NPY,PAX5,PDCD1,PLA2G1B,PLA2G6,POU2AF1,POU2F2,PSMB10,RGCC,RNASE3,RNASE7,RPL39,SEMG1,SEMG2,SLPI,ST6GAL1,TAC1,TFE3,TFEB,TNFRSF21,TREM1,TREM2,VIP,YTHDF2,ZP3	An immune response mediated through a body fluid.
GO:0006968	GO	BP	cellular defense response	ADORA2A,ADORA2B,BECN1,C5AR1,CCR2,CCR3,CCR5,CCR6,CCR9,CD160,CD19,CD300C,CD5L,CLEC5A,CX3CR1,CXCL9,CXCR2,DCDC2,FCMR,FOSL1,GAGE1,GNLY,HLA-G,IL1RL2,IL4,ITGB1,ITK,KIR2DL4,KIR3DL2,KLRC2,KLRC3,KLRC4,KLRG1,LBP,LGALS3BP,LILRB2,LSP1,LY96,MNDA,NCF2,NCR1,NCR2,PAGE1,PRF1,PTK2B,RAB23,RELA,SH2D1A,SPN,TCIRG1,TRAT1,TYROBP,UMOD,VEZF1,ZNF148	A defense response that is mediated by cells.
GO:0006970	GO	BP	response to osmotic stress	AQP1,AQP9,ARHGEF2,ATF2,CAB39,CAPN3,DDX3X,EPO,ICOSLG,KCNMA1,KMO,LRRC8A,MAP2K7,MAP7,MAPK13,MARVELD3,MYLK,PKD2,PLK3,RCSD1,SERPINB6,SLC12A6,STK39,TLR3,TNF,TRPV4,YBX3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.
GO:0006972	GO	BP	hyperosmotic response	AQP1,ARHGEF2,EPO,ICOSLG,RCSD1,TLR3,YBX3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.
GO:0006975	GO	BP	DNA damage induced protein phosphorylation	ABL1,ATM,CHEK1,CHEK2,CRY1,MAP2K6,MAPK12,MAPK3	The widespread phosphorylation of various molecules, triggering many downstream processes, that occurs in response to the detection of DNA damage.
GO:0006977	GO	BP	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	ATM,CASP2,CDK2,CDKN1A,CDKN1B,CRADD,GML,GTSE1,MDM2,MUC1,PIDD1,PML,PPP2R5C,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RPS27A,SOX4,TP53,TRIAP1,UBA52,UBB,UBC	A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle.
GO:0006978	GO	BP	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BRCA1,FOXM1,HIPK2,ING4,KAT5,MUC1,RBM38,RPS6KA6,SP100,TFAP4,TP53	A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, resulting in the induction of the transcription of p21 (also known as WAF1, CIP1 and SDI1) or any equivalent protein, in response to the detection of DNA damage.
GO:0006979	GO	BP	response to oxidative stress	ABL1,ADAM9,ADIPOQ,ADNP2,AKR1C3,AKT1,ALDH3B1,ANGPTL7,ANKRD2,APOA4,APOD,APOE,APTX,AQP1,AQP8,ARL6IP5,ARNT,ARNTL,ATF4,ATOX1,ATP7A,CAT,CCL19,CCR7,CCS,CDK2,CHD6,CHRNA4,CPEB2,CRYGD,CYCS,CYGB,CYP1B1,DGKK,DHRS2,DPEP1,DUSP1,ECT2,EGLN1,ERCC1,ERCC2,ERCC3,ERCC6,ERCC8,ERO1A,ETFDH,ETV5,FABP1,FER,FOS,FOXO1,FOXO3,FXN,G6PD,GCLC,GCLM,GLRX2,GPX1,GPX2,GPX3,GPX7,GPX8,GSR,GSS,GSTP1,GUCY1B3,HBA1,HBB,HDAC6,HIF1A,HMOX1,HP,HSPA1A,HSPA1B,HTRA2,HYAL1,HYAL2,IL6,IMPACT,IPCEF1,KCNC2,KRT1,LIAS,LONP1,LPO,LRRK2,MAP3K5,MAPK7,MBL2,MGST1,MICB,MMP3,MPO,MPV17,MT3,MTR,NAPRT,NDUFA12,NDUFA6,NDUFB4,NDUFS2,NDUFS8,NEIL1,NET1,NFE2L2,NOS3,NUDT1,NUDT2,OGG1,OXR1,P4HB,PARK2,PARK7,PARP1,PAX2,PDCD10,PDGFRA,PDK1,PDK2,PDLIM1,PINK1,PKD2,PLA2R1,PLEKHA1,PLK3,PML,PNKP,PNPT1,PPARGC1A,PPIF,PRDX1,PRDX2,PRDX3,PRDX5,PRDX6,PRKCD,PRKD1,PRNP,PRODH,PSIP1,PTPRK,PTPRN,PYCR1,PYCR2,RAD52,RBM11,RELA,RGS14,RHOB,ROMO1,RPS3,S100A7,SCARA3,SELK,SEPP1,SETX,SGK2,SIRT1,SIRT2,SLC11A2,SLC25A24,SLC8A1,SNCA,SOD1,SOD2,SOD3,SRXN1,STK24,STK25,STK26,STX2,STX4,TMEM161A,TNFAIP3,TP53,TXN,TXN2,TXNRD1,TXNRD2,VIMP,VKORC1L1,VNN1,VRK2,WNT16,WRN,XBP1,ZNF580,ZNF622	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
GO:0006983	GO	BP	ER overload response	ATG10,EIF2AK3,GSK3B,TP53,VIMP,WFS1	The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB.
GO:0006984	GO	BP	ER-nucleus signaling pathway	ARHGEF10L,ASNS,ATF3,ATF4,ATF6,ATF6B,ATG10,CALR,CCL2,CXCL8,DDIT3,EIF2AK3,EIF2S1,ERLIN1,ERLIN2,GSK3B,HERPUD1,HSP90B1,HSPA5,IGFBP1,INSIG1,INSIG2,MBTPS1,MBTPS2,NFE2L2,SCAP,TP53,VIMP,WFS1,XBP1	Any series of molecular signals that conveys information from the endoplasmic reticulum to the nucleus, usually resulting in a change in transcriptional regulation.
GO:0006986	GO	BP	response to unfolded protein	ACADVL,ADD1,AMFR,ARFGAP1,ASNA1,ASNS,ATF3,ATF4,ATF6,ATF6B,ATP6V0D1,BAK1,BAX,BHLHA15,CALR,CCL2,CDK5RAP3,CREB3,CREB3L1,CTDSP2,CTH,CUL7,CXCL8,CXXC1,DAB2IP,DCTN1,DDIT3,DDX11,DERL1,DERL2,DERL3,DNAJA1,DNAJB1,DNAJB11,DNAJB2,DNAJB4,DNAJB9,DNAJC3,DNAJC4,EDEM1,EIF2AK3,EIF2S1,EP300,ERN1,ERP44,EXTL3,FKBP14,GFPT1,GOSR2,GSK3A,HDGF,HERPUD1,HSP90AA1,HSP90AB1,HSP90B1,HSPA1L,HSPA2,HSPA4,HSPA4L,HSPA5,HSPA6,HSPA8,HSPB1,HSPB2,HSPB3,HSPB7,HSPD1,HSPE1,HSPH1,HYOU1,IGFBP1,KDELR3,KLHDC3,LMNA,MBTPS1,MBTPS2,MYDGF,NFE2L2,PACRG,PARK2,PARP16,PDIA5,PDIA6,PLA2G4B,PPP2R5B,PREB,PTPN1,RHBDD1,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SERP1,SERPINH1,SHC1,SRPR,SRPRB,SSR1,STT3B,SULT1A3,SYVN1,TATDN2,TBL2,TLN1,TOR1B,TPP1,TSPYL2,VAPB,VCP,VIMP,WFS1,WIPI1,XBP1,YIF1A,YOD1,ZBTB17	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.
GO:0006987	GO	BP	activation of signaling protein activity involved in unfolded protein response	BAK1,BAX,DAB2IP,ERN1,PARP16,PTPN1,VAPB	The conversion of a specific protein, possessing protein kinase and endoribonuclease activities, to an active form as a result of signaling via the unfolded protein response.
GO:0006997	GO	BP	nucleus organization	AAAS,AHCTF1,ANKLE2,ASUN,ATXN7,BANF1,CCNB1,CCNB2,CDK1,CHD5,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CNEP1R1,CTDNEP1,DMPK,EMD,ETS1,GPER1,H1FNT,HIPK2,HIST1H2BA,LEMD2,LMNA,LPIN1,NDC1,NEK6,NEK9,NUMA1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PLK1,PML,POM121,POM121C,PPP2CA,PPP2R1A,PPP2R2A,PRKCA,PRKCB,PSME4,RAE1,RANBP2,REEP3,REEP4,RPS19,SEH1L,SRPK1,SRPK2,SUN1,SUN2,SYCP3,SYNE1,TARDBP,TMEM43,TNP1,TOR1A,TOR1AIP2,TPR,TSSK6,USPL1,VPS4A,VPS4B,VRK1,WBP2NL,WEE2,ZPR1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nucleus.
GO:0006998	GO	BP	nuclear envelope organization	AAAS,ANKLE2,ASUN,BANF1,CCNB1,CCNB2,CDK1,CNEP1R1,CTDNEP1,DMPK,EMD,GPER1,LEMD2,LMNA,LPIN1,NDC1,NEK6,NEK9,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PLK1,POM121,POM121C,PPP2CA,PPP2R1A,PPP2R2A,PRKCA,PRKCB,RAE1,RANBP2,REEP3,REEP4,SEH1L,SUN1,SUN2,TARDBP,TMEM43,TOR1A,TOR1AIP2,TPR,VRK1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear envelope.
GO:0006999	GO	BP	nuclear pore organization	AHCTF1,NDC1,NUP107,NUP133,NUP153,NUP205,NUP93,NUP98,SEH1L,TPR	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear pore.
GO:0007004	GO	BP	telomere maintenance via telomerase	ACD,ATM,DKC1,GAR1,MRE11A,NHP2,NOP10,POT1,RAD50,RFC1,TERF1,TERF2,TERF2IP,TERT,TNKS1BP1,WRAP53	The maintenance of proper telomeric length by the addition of telomeric repeats by telomerase.
GO:0007006	GO	BP	mitochondrial membrane organization	ACAA2,AKT1,ALKBH7,APOO,ATF2,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BLOC1S2,BMF,BNIP3,CAMK2A,CASP8,CHCHD3,CHCHD6,COX18,DYNLL1,DYNLL2,E2F1,GSK3A,GSK3B,GZMB,HEBP2,HSP90AA1,HSPA1A,HSPA4,IMMT,LETM1,MAPK8,MFN2,MOAP1,MPV17L,MUL1,NAIF1,NDUFA13,NMT1,OPA1,PMAIP1,PPIF,PPP3CC,PPP3R1,RHOT1,RHOT2,SAMM50,SFN,SIVA1,SLC25A46,SLC25A5,SLC35F6,TAZ,TFDP1,THEM4,TIMM10,TIMM22,TIMM50,TIMM9,TMEM102,TOMM22,TP53,UQCC3,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrial membrane, either of the lipid bilayer surrounding a mitochondrion.
GO:0007007	GO	BP	inner mitochondrial membrane organization	APOO,CHCHD3,CHCHD6,IMMT,LETM1,NDUFA13,OPA1,SAMM50,TAZ,TIMM10,TIMM22,TIMM9,UQCC3	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial inner membrane.
GO:0007009	GO	BP	plasma membrane organization	A4GALT,ABCA12,ABCA7,ACTN2,ADIPOQ,AMN,ANK1,ANK2,ANK3,ANO6,ARFRP1,ATP1B1,ATP1B3,BBS1,BBS2,BIN2,BLZF1,BSG,CALCR,CAV1,CAV2,CAV3,CDH1,CHMP4A,CLASP2,CLU,COL5A1,CRB3,CXCR4,DENND4C,DLG1,DPP10,DPP6,EFR3A,EFR3B,EHD2,EHD3,EMP2,EPB41L3,EZR,F11R,FAM126A,FCHO2,FGF13,FLOT1,FLOT2,FNBP1L,GAS6,GOLGA4,GOLGA7,GOLPH3,IKBKB,INPP5K,JUP,KCNB1,KCNB2,KCNIP3,KCNIP4,KIF13A,KRT18,MACF1,MAP7,MICALL1,MYADM,MYO5A,MYOF,MYRF,NKD2,OPTN,P2RX7,P2RY1,PACS1,PACS2,PACSIN1,PACSIN2,PACSIN3,PIGW,PIP5K1A,PKP2,PKP3,PLEKHF1,PLSCR1,PLSCR2,PLSCR4,PPIL2,PTCH1,PTEN,RAB10,RAB11A,RAB13,RAB26,RAB31,RAB34,RAB8A,RAMP1,RAMP2,RAMP3,RAP2A,RAPGEF2,RAPGEF6,RDX,RILPL1,RILPL2,ROCK1,ROCK2,S100A10,SCN3B,SCP2,SERP1,SLC9A3R1,SMURF1,SNX33,SNX9,SOD1,SPTBN1,SPTBN4,STX2,STXBP1,TESC,TMED2,TMEM150A,TMEM88,TNF,TNFRSF1A,TNIK,TRIM72,TSPAN14,TSPAN15,TSPAN33,TSPAN5,TTC7A,TTC7B,VAMP2,WHAMM,WNT4,XKR8,ZFYVE27	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the plasma membrane.
GO:0007015	GO	BP	actin filament organization	ABI1,ABI2,ACTA1,ACTC1,ACTN1,ACTR2,ACTR3,ADD1,ADD2,AIF1,ALDOA,ANG,ARAP1,ARHGAP6,ARHGEF2,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARRB1,BAIAP2,BCAR1,BIN3,CATIP,CDC42EP2,CLRN1,COBL,CORO1B,CORO7,CUL3,DBN1,DLG1,DMTN,DPYSL3,DSTN,EMP2,EPS8,ERMN,EVL,EZR,FAT1,FLNA,FMN2,FSCN1,FSCN2,GHRL,GHSR,GSN,HSP90B1,INPPL1,IQGAP2,ITGB5,JAK2,JMY,KCTD13,LCP1,LIMA1,LRRC16A,MAD2L2,MAGEL2,MICAL1,MICAL2,MICAL3,MICALL2,MSRB1,MSRB2,MYO1B,NEBL,NEDD9,PAWR,PDXP,PHACTR1,PLA2G1B,PREX1,PROX1,RAC1,RAC2,RHOD,RHOF,RND1,RUFY3,SCIN,SHROOM1,SHROOM4,SHTN1,SORBS1,SPIRE1,SPIRE2,SPTA1,SRC,TCAP,TNFAIP1,TRIM27,TRPV4,TTC17,TTN,VIL1,WAS,WASF1,WASF3,WASH1,WASL,WHAMM,ZYX	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
GO:0007016	GO	BP	cytoskeletal anchoring at plasma membrane	ANK3,DAG1,EPB41L3,EZR,FLNB,JUP,SHANK1,SPTBN4,TLN1	A cytoskeleton organization process that directly or indirectly links cytoskeletal filaments to the plasma membrane.
GO:0007018	GO	BP	microtubule-based movement	ADCY10,AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,APBA1,APP,ARHGAP21,ARMC4,BICD1,BICD2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CABYR,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CDC42,CENPE,CEP131,CFAP54,CLN3,COPG1,DLGAP5,DNAAF1,DNAAF5,DNAH5,DNAH7,DNAI1,DNAI2,DTNBP1,DYNC1I1,DYNC1I2,DYNLRB1,DYNLRB2,DYX1C1,FMN2,FYCO1,HAP1,HIF1A,HTT,ICK,IFT122,IFT27,IFT43,IFT46,IFT74,IFT81,KIF11,KIF13A,KIF13B,KIF15,KIF18A,KIF1A,KIF1B,KIF22,KIF23,KIF26A,KIF2A,KIF2B,KIF2C,KIF3A,KIF3B,KIF3C,KIF4A,KIF4B,KIF5A,KIF5B,KIF9,KIFAP3,KIFC1,KLC1,KLC2,KPNB1,LRPPRC,LRRC6,MAP1S,MAP4,MGARP,NEFL,NPHP3,OFD1,OPA1,PAFAH1B1,PCM1,PEX14,RAB1A,RAB6A,RACGAP1,RFX3,RHOT1,RHOT2,ROPN1L,RPGR,RSPH4A,RSPH9,SNAPIN,SOD1,SPA17,SSX2IP,TTC26,UBB,UXT,WDR19,WDR35	A microtubule-based process that is mediated by motor proteins and results in the movement of organelles, other microtubules, or other particles along microtubules.
GO:0007019	GO	BP	microtubule depolymerization	CCSAP,KIF18A,KIF18B,KIF19,KIF24,KIF2B,KIF2C,NCKAP5L,STMN1	The removal of tubulin heterodimers from one or both ends of a microtubule.
GO:0007020	GO	BP	microtubule nucleation	AKAP9,BLOC1S2,CENPJ,CLASP1,CLASP2,CSNK1D,GOLGA2,RANBP9,SLAIN2,TUBGCP2,TUBGCP3,TUBGCP4,TUBGCP5,TUBGCP6	The process in which tubulin alpha-beta heterodimers begin aggregation to form an oligomeric tubulin structure (a microtubule seed). Microtubule nucleation is the initiating step in the formation of a microtubule in the absence of any existing microtubules ('de novo' microtubule formation).
GO:0007026	GO	BP	negative regulation of microtubule depolymerization	APC,ARHGEF2,AURKA,AURKB,CCNB1,CIB1,CLASP1,CLASP2,FGF13,GAS2L1,GAS2L2,KATNB1,MID1IP1,SBDS,STMN2,TRIM54	Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.
GO:0007029	GO	BP	endoplasmic reticulum organization	ATL1,ATL2,ATL3,BAG6,BNIP1,CAV2,DOPEY1,DOPEY2,EIF2AK3,GET4,RAB10,RAB18,REEP1,REEP2,RTN3,RTN4,SEC16A,SEC16B,SEC61A1,SHTN1,STX18,TOR1AIP2,TOR1B,TRDN,UBL4A,VAPB	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endoplasmic reticulum.
GO:0007030	GO	BP	Golgi organization	ARFGEF1,ARHGAP21,ARHGEF7,ARL1,ATL2,ATL3,BAG5,BCAS3,BLZF1,CDC42,CDK1,CLASP1,CLASP2,COG1,COG2,COG3,COG4,CSNK1A1,CSNK1D,CUL7,DYM,DYNC2H1,FBXW8,GAK,GBF1,GCC2,GOLGA2,GOLGA5,GOLGB1,GOLPH3,GOLPH3L,GORASP1,HACE1,HTT,LMAN1,LRRK2,MYO18A,NPLOC4,OBSL1,OPTN,PDCD10,PLEKHM2,PLK3,PRKD1,PRMT5,RAB1A,RAB29,RAB2A,RAB30,RAB43,SEC23IP,SPTBN5,STK25,STX16,STX17,STX5,STX6,SURF4,SYNE1,TBC1D20,TMED2,TMED5,TMED9,USP6NL,VAMP4,VRK1,VTI1A,YWHAZ,ZW10	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the Golgi apparatus.
GO:0007031	GO	BP	peroxisome organization	ABCD1,ABCD3,ACBD5,ACOT8,ACOX1,DNM1L,FIS1,LONP2,MFF,PEX1,PEX10,PEX11A,PEX11B,PEX11G,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,RAB8B,SEC16B,TMEM135,ZFAND6	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a peroxisome. A peroxisome is a small, membrane-bounded organelle that uses dioxygen (O2) to oxidize organic molecules.
GO:0007032	GO	BP	endosome organization	AKTIP,ALS2,ALS2CL,ANXA8,ARFGEF2,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CLCN3,DNAJC13,DNM1,EXOC8,FAM109A,FAM109B,FAM160A2,HGS,HOOK1,HOOK2,HOOK3,IST1,KIAA1033,LAMTOR1,MVB12A,PDCD6IP,PLEKHF1,RAB11A,RAB27A,SNF8,SNX10,SNX33,STAM,STAM2,TSG101,USP8,VPS18,VPS25,VPS28,VPS33B,VPS36,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of endosomes.
GO:0007033	GO	BP	vacuole organization	ABCA1,AKTIP,ARSB,ATG101,ATG12,ATG13,ATG14,ATG16L1,ATG3,ATG4B,ATG4C,ATG5,ATG9A,ATG9B,BECN1,CHMP3,CLN3,CLN5,CLN6,CLVS1,CLVS2,CORO1A,EMC6,FAM160A2,GAA,GNPTAB,HOOK1,HOOK2,HOOK3,HPS1,HPS4,LAMTOR1,LRRK2,MAP1LC3A,MBTPS1,MT3,MYO7A,NAGPA,NDP,PACS2,PPT1,RAB1A,RAB20,RAB23,RAB34,RAB39A,RAB7A,RUBCN,SNAP29,SNX14,STX12,STX17,TECPR1,TFEB,TMEM165,TP53INP2,TPCN2,TPP1,TSG101,UVRAG,VAMP8,VPS16,VPS18,VPS33A,WIPI2,ZKSCAN3	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a vacuole.
GO:0007034	GO	BP	vacuolar transport	ADRB2,AKTIP,ANKFY1,AP1G1,AP3M1,ARSB,ATG14,BECN2,CHMP7,DENND3,FAM160A2,GCC2,GNPTAB,GPRASP1,HGS,HGSNAT,HMGXB4,HOOK1,HOOK2,HOOK3,HSPA8,KIF13A,LAMP1,M6PR,MGRN1,MTM1,NAGPA,NEDD4,NPC1,PCSK9,RAB12,RAB7A,RHOB,RILP,SCARB2,SCYL2,SMURF1,SNAPIN,SNX16,SORL1,SORT1,SPTBN5,TGFBRAP1,TRAK1,USE1,VAMP7,VIPAS39,VPS11,VPS16,VPS18,VPS33A,VPS39,VPS41,ZFYVE16	The directed movement of substances into, out of or within a vacuole.
GO:0007035	GO	BP	vacuolar acidification	ATP6V0E1,ATP6V0E2,ATP6V1H,CLN3,CLN5,CLN6,PPT1,SLC11A1	Any process that reduces the pH of the vacuole, measured by the concentration of the hydrogen ion.
GO:0007040	GO	BP	lysosome organization	ABCA1,AKTIP,ARSB,CLN3,CLN5,CLN6,CLVS1,CLVS2,CORO1A,FAM160A2,GAA,GNPTAB,HOOK1,HOOK2,HOOK3,HPS1,HPS4,LAMTOR1,LRRK2,MBTPS1,MT3,MYO7A,NAGPA,PPT1,RAB20,RAB34,RAB39A,RAB7A,TFEB,TMEM165,TPCN2,TPP1,VPS18,ZKSCAN3	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lysosome. A lysosome is a cytoplasmic, membrane-bounded organelle that is found in most animal cells and that contains a variety of hydrolases.
GO:0007041	GO	BP	lysosomal transport	ADRB2,AKTIP,ANKFY1,AP1G1,AP3M1,ARSB,ATG14,BECN2,DENND3,FAM160A2,GCC2,GNPTAB,GPRASP1,HGS,HGSNAT,HMGXB4,HOOK1,HOOK2,HOOK3,HSPA8,KIF13A,LAMP1,M6PR,MGRN1,MTM1,NAGPA,NEDD4,NPC1,PCSK9,RAB12,RAB7A,RHOB,RILP,SCARB2,SCYL2,SNAPIN,SNX16,SORL1,SORT1,SPTBN5,TGFBRAP1,TRAK1,USE1,VAMP7,VIPAS39,VPS11,VPS16,VPS18,VPS33A,VPS39,VPS41,ZFYVE16	The directed movement of substances into, out of or within a lysosome.
GO:0007043	GO	BP	cell-cell junction assembly	AMOT,APC,ARL2,CD9,CDH5,CLDN1,CLDN12,CLDN14,CLDN15,CLDN17,CLDN18,CLDN20,CLDN22,CLDN23,CLDN3,CLDN5,CLDN9,CNTNAP1,CRB3,CTNNA1,DLG1,DSG1,ECT2,EPB41L3,F11R,FBF1,FLCN,FRMPD2,FSCN1,GJA1,GJA4,GJA5,GJB1,GJB2,GJC1,GJD3,GRHL2,INADL,JUP,LIM2,MARVELD2,MARVELD3,MICALL2,MPP5,MPP7,OCLN,PARD3,PARD6A,PARD6B,PARD6G,PKN2,PKP2,PKP3,PKP4,PRKCA,PRKCI,PTPRO,RAB13,RAMP2,RHOA,RHOC,STRN,TBCD,TJP1,TLN1,TLN2,TRPV4,VCL	The aggregation, arrangement and bonding together of a set of components to form a junction between cells.
GO:0007044	GO	BP	cell-substrate junction assembly	ACTN1,ACTN2,ACTN3,ARHGEF7,CD151,COL17A1,CTTN,DLC1,DST,FERMT2,ITGA6,ITGB4,KRT14,KRT5,LAMA3,LAMA5,LAMB3,LAMC1,LAMC2,PIP5K1A,PLEC,PTPRK,RCC2,RHOD,SORBS1,TAOK2,TESK2,THY1,TRIP6,WHAMM	The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.
GO:0007050	GO	BP	cell cycle arrest	ABL1,APBB1,APBB2,APC,ATM,BARD1,BTG4,CAB39,CAB39L,CALR,CDC123,CDK6,CDK7,CDKN1A,CDKN1B,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CDKN3,CUL1,CUL2,CUL3,CUL4A,CUL5,CXCL8,DDIT3,DHCR24,DUSP1,E4F1,EIF4G2,ERN1,FAP,FOXO4,GADD45A,GADD45GIP1,GAS2L1,GAS6,GAS7,HBP1,HRAS,IFNG,IFNW1,IL12A,IL12B,ING4,INHA,INHBA,IRF1,IRF6,JMY,KAT2B,KHDRBS1,KIF20B,KLLN,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MAGI2,MAP2K1,MAP2K6,MAPK12,MCPH1,MLF1,MLST8,MTOR,MYC,NBN,NKX3-1,NOTCH2,PA2G4,PKD1,PKD2,PLAGL1,PML,PNPT1,PPM1A,PPP1R15A,PPP1R9B,PPP2R3B,PRKAA1,PRKAA2,PRKAB1,PRKAB2,PRKAG1,PRKAG2,PRKAG3,RASSF1,RB1,RBM38,RGCC,RHEB,RPTOR,RRAGA,RRAGB,RRAGC,RRAGD,SART1,SESN1,SKIL,SMAD3,SOX2,STK11,STRADA,STRADB,TBRG1,TBRG4,TCF7L2,TGFB1,TGFB2,TGFBR1,THBS1,TP53,TP53INP1,TSC1,TSC2,UHMK1,WDR6,ZBTB49	A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
GO:0007051	GO	BP	spindle organization	ARHGEF10,ASPM,ASUN,AUNIP,AURKB,AURKC,CEP126,CEP192,CEP63,CEP72,CHD3,CHEK2,CKAP5,CLASP1,CLASP2,CSNK1D,DLG1,DYNC1H1,EML1,EZR,FAM175B,FLNA,GOLGA2,GPSM2,HAUS1,HAUS2,HAUS3,HAUS4,HAUS5,HAUS6,HAUS7,HAUS8,HDAC3,INO80,KIF11,KIF23,KIF2A,KIF3B,KIF4A,KIF4B,KIFC1,KIZ,KNSTRN,KPNB1,MAP10,MAP4,MOS,NCOR1,NDC80,NEK2,NEK6,NEK7,NTMT1,PCNT,PIBF1,PLK2,PRC1,RAB11A,RACGAP1,RAN,RCC1,RGS14,RHOA,RPS3,SMC1A,SPAG5,SPC25,SPICE1,STARD9,STIL,STMN1,SUN2,TNKS,TPX2,TTK,TUBG1,WDR62,ZNF207	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the spindle, the array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during DNA segregation and serves to move the duplicated chromosomes apart.
GO:0007052	GO	BP	mitotic spindle organization	ARHGEF10,ASUN,AURKB,AURKC,CEP126,CHEK2,CLASP1,CLASP2,DYNC1H1,EML1,FAM175B,FLNA,GOLGA2,GPSM2,KIF11,KIF23,KIF2A,KIF3B,KIF4A,KIF4B,KIFC1,KPNB1,MAP10,MAP4,NDC80,PCNT,PIBF1,PLK2,PRC1,RAB11A,RACGAP1,RAN,RCC1,RHOA,SMC1A,SPC25,SPICE1,STIL,STMN1,SUN2,TNKS,TPX2,TTK,WDR62,ZNF207	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a mitotic cell cycle.
GO:0007059	GO	BP	chromosome segregation	APITD1,ARL8A,ARL8B,AURKB,AURKC,BAG6,BECN1,BRCA1,BUB3,C11orf85,C15orf43,CASC5,CCDC79,CCNB1,CCNB1IP1,CDC23,CDCA5,CDCA8,CDK5RAP2,CENPC,CENPE,CENPF,CENPT,CENPW,CHAMP1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,DDX11,DDX3X,DIS3L2,DLGAP5,DSCC1,ERCC2,ESPL1,FAM175B,FAM83D,FAM96B,FANCM,FBXW7,FMN2,GEM,GSG2,HDAC8,HJURP,HORMAD1,HORMAD2,INCENP,INO80,KIF14,KIF18A,KIF22,KIF25,KIF2C,KIFC1,KLHL22,KNSTRN,KPNB1,LATS1,M1AP,MAU2,MCMBP,MEI4,MEIKIN,MEIOB,MIS12,MMS19,MRE11A,NAA50,NAA60,NCAPD2,NCAPD3,NCAPG,NCAPH,NDC80,NDEL1,NEK2,NEK6,NIPBL,NTMT1,NUF2,NUSAP1,P3H4,PAPD7,PDS5B,PHB2,PHF13,PIBF1,PINX1,PLK1,PMF1,POGZ,PPP2R1A,PSRC1,RAB11A,RAD51C,RB1,RCC1,REC8,RECQL5,RGS14,RIOK3,RNF212,RPS3,RRS1,SEH1L,SETDB2,SGOL1,SKA1,SKA2,SKA3,SMARCAD1,SMC1A,SMC2,SMC3,SMC4,SPAG5,SPC25,SPDL1,SPICE1,SRPK1,STAG2,STAG3,STRA13,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TEX14,TLK2,TOP2A,TRIP13,VPS4A,VPS4B,ZNF207,ZW10,ZWINT	The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
GO:0007062	GO	BP	sister chromatid cohesion	CDCA5,DDX11,DSCC1,FBXW7,GSG2,HDAC8,HORMAD1,HORMAD2,KIF22,MAU2,MCMBP,MEIKIN,MRE11A,NAA50,NIPBL,PAPD7,PDS5B,PHB2,POGZ,RAD51C,RB1,REC8,SMC1A,SMC3,STAG2	The cell cycle process in which the sister chromatids of a replicated chromosome are associated with each other.
GO:0007063	GO	BP	regulation of sister chromatid cohesion	AXIN2,BUB1,CDCA5,CTCF,CTNNB1,ESPL1,H2AFY,HDAC8,NSMCE2,RB1,SLF1,SLF2,SMC5,WAPL	Any process that modulates the frequency, rate or extent of sister chromatid cohesion.
GO:0007064	GO	BP	mitotic sister chromatid cohesion	CDCA5,DSCC1,GSG2,MAU2,NAA50,NIPBL,PDS5B,POGZ,RB1,SMC1A	The cell cycle process in which the sister chromatids of a replicated chromosome are joined along the entire length of the chromosome, from their formation in S phase through metaphase during a mitotic cell cycle. This cohesion cycle is critical for high fidelity chromosome transmission.
GO:0007067	GO	BP	mitotic nuclear division	ABL1,AKAP8,ANAPC11,ARHGEF10,ARPP19,AURKA,AURKB,AURKC,BECN1,BIRC5,BUB1B,CCNB1,CDC23,CDC27,CDCA5,CDCA8,CDK11A,CDK11B,CENPE,CETN2,CHAMP1,CHEK2,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CIT,CLASP1,CLASP2,CLIP1,CLTC,CLTCL1,CTDP1,CUL3,DCTN1,DCTN2,DIS3L2,DLGAP5,DSCC1,EML4,ENSA,EPS8,ESPL1,FAM175B,FBXL7,FBXO5,FLNA,GEM,GOLGA2,GSG2,HGF,INO80,JTB,KIF11,KIF14,KIF15,KIF18A,KIF22,KIF23,KIF25,KIF2A,KIF2C,KIF3B,KIF4A,KIF4B,KIFC1,KLHL22,KNSTRN,KPNB1,MAP10,MASTL,MAU2,NAA50,NCAPD2,NCAPD3,NCAPG,NCAPH,NDC80,NEK2,NEK3,NIPBL,NOLC1,NUSAP1,PAPD7,PBK,PBRM1,PDS5B,PHF13,PIBF1,PINX1,PKMYT1,PLK1,POGZ,PPP1R12A,PPP2R2D,PPP5C,PSRC1,PTEN,RAB11A,RACGAP1,RAN,RB1,RECQL5,RHOA,RRS1,SEH1L,SETDB2,SIRT7,SKA1,SKA2,SKA3,SMARCA4,SMC1A,SMC2,SMC3,SMC4,SPAG5,SPDL1,SPICE1,SUGT1,TEX14,TPX2,UBE2C,UBE2S,USP16,VPS4A,VPS4B,YEATS4,ZNF207,ZNF268,ZW10,ZWINT	A cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.
GO:0007076	GO	BP	mitotic chromosome condensation	CDCA5,CHMP1A,NCAPD2,NCAPD3,NCAPG,NCAPH,NUSAP1,PAPD7,PHF13,SMC2,SMC4	The cell cycle process in which chromatin structure is compacted prior to and during mitosis in eukaryotic cells.
GO:0007077	GO	BP	mitotic nuclear envelope disassembly	AAAS,BANF1,CCNB1,CCNB2,CDK1,CNEP1R1,CTDNEP1,EMD,LMNA,LPIN1,NDC1,NEK6,NEK9,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PLK1,POM121,POM121C,PRKCA,PRKCB,RAE1,RANBP2,SEH1L,TPR,VRK1	The cell cycle process in which the controlled breakdown of the nuclear envelope during mitotic cell division occurs.
GO:0007080	GO	BP	mitotic metaphase plate congression	BECN1,CCNB1,CDC23,CDCA5,CDCA8,CENPE,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,KIF14,KIF18A,KIF22,KIF2C,KIFC1,KPNB1,PIBF1,PINX1,PSRC1,RAB11A,RRS1,SEH1L,SPDL1,VPS4A,VPS4B,ZW10	The cell cycle process in which chromosomes are aligned at the metaphase plate, a plane halfway between the poles of the mitotic spindle, during mitosis.
GO:0007084	GO	BP	mitotic nuclear envelope reassembly	ANKLE2,BANF1,EMD,LMNA,PPP2CA,PPP2R1A,PPP2R2A,REEP3,REEP4,VRK1	The cell cycle process that results in reformation of the nuclear envelope during mitotic cell division.
GO:0007088	GO	BP	regulation of mitotic nuclear division	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANLN,APC,ATM,AURKA,AURKAIP1,BECN1,BIRC5,BMP4,BMP7,BORA,BUB1,BUB1B,BUB3,CCDC8,CCNB1,CCSAP,CD28,CDC16,CDC20,CDC23,CDC25C,CDC26,CDC27,CDC6,CDCA5,CDK13,CENPE,CENPF,CEP85,CHEK1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4B,CHMP4C,CHMP5,CSNK2A1,CSNK2A2,CUL3,CUL7,CUL9,DAPK3,DLGAP5,DMRT1,DRD3,DUSP1,DYNC1LI1,EDN1,EDN3,EGF,EPGN,EREG,ESPL1,FBXO5,GEN1,H2AFY,IGF1,IGF2,IL1A,IL1B,INS,INSR,KIF11,KIF20B,KLHL22,KNTC1,L3MBTL1,LCMT1,LRP5,MAD1L1,MAD2L1,MAD2L1BP,MAD2L2,MOS,NEK2,NEK6,NME6,NPM2,NSMCE2,NUSAP1,OBSL1,PCID2,PDGFB,PDGFRB,PDXP,PHB2,PHIP,PIN1,PKMYT1,PLK1,PPP1R9B,PRMT5,PTEN,RB1,RCC1,RGCC,SIRT2,SLF1,SLF2,SMC5,TERF1,TEX14,TGFA,TOM1L1,TOM1L2,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,VPS4B,XRCC3,ZNF207,ZW10	Any process that modulates the frequency, rate or extent of mitosis.
GO:0007093	GO	BP	mitotic cell cycle checkpoint	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATF2,ATM,BCL2L1,BLM,BUB1,BUB1B,BUB3,CASP2,CCNA2,CCND1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CDKN2B,CENPF,CHEK2,CHFR,CLSPN,CRADD,CSNK2A1,CSNK2A2,DGKZ,DLG1,FBXO31,FOXN3,GML,GTSE1,HMGA2,HRAS,INTS3,KLHL22,KNTC1,MAD1L1,MAD2L1,MAD2L1BP,MAD2L2,MDC1,MDM2,MUC1,NABP1,NABP2,NAE1,NBN,NEK11,PIDD1,PLK1,PLK2,PLK3,PML,PPP2R5C,PRCC,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAD17,RB1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SETMAR,SMC1A,SOX4,TAOK3,TERF1,TEX14,TGFB1,TICRR,TIPIN,TP53,TPR,TRIAP1,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP17L2,WNT9A,ZNF207,ZNF830,ZW10,ZWILCH,ZWINT	A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
GO:0007094	GO	BP	mitotic spindle assembly checkpoint	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	A cell cycle checkpoint that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and chromosomes are attached to the spindle.
GO:0007095	GO	BP	mitotic G2 DNA damage checkpoint	ATM,BLM,CCNA2,CDK5RAP3,FOXN3,HMGA2,NBN,TAOK3	A mitotic cell cycle checkpoint that detects and negatively regulates progression through the G2/M transition of the cell cycle in response to DNA damage.
GO:0007096	GO	BP	regulation of exit from mitosis	ANLN,BIRC5,CDC23,CDCA5,KNTC1,MAD2L1BP,NPM2,PHB2,PPP1R9B,RGCC,SIRT2,UBE2C,ZW10	Any process involved in the progression from anaphase/telophase to G1 that is associated with a conversion from high to low mitotic CDK activity.
GO:0007098	GO	BP	centrosome cycle	ARHGEF10,BRCA2,BRSK1,C2CD3,CCP110,CDK1,CDK2,CDK5RAP2,CENPJ,CEP135,CEP152,CEP192,CEP250,CEP63,CEP72,CETN2,CETN3,CNTROB,CTNNB1,FBXW5,KIF3B,NDE1,NEK2,NPM1,PKD2,PLK4,ROCK2,SASS6,STIL,TUBE1,USP33,WDR62	The cell cycle process in which centrosome duplication and separation takes place. The centrosome cycle can operate with a considerable degree of independence from other processes of the cell cycle.
GO:0007099	GO	BP	centriole replication	C2CD3,CCP110,CDK2,CDK5RAP2,CENPJ,CEP135,CEP152,CEP63,CEP72,CETN2,CNTROB,PLK4,SASS6,WDR62	The cell cycle process in which a daughter centriole is formed perpendicular to an existing centriole. An immature centriole contains a ninefold radially symmetric array of single microtubules; mature centrioles consist of a radial array of nine microtubule triplets, doublets, or singlets depending upon the species and cell type.
GO:0007126	GO	BP	meiotic nuclear division	APITD1,ASZ1,ATM,BAG6,BOLL,BRDT,C11orf85,C15orf43,CCDC79,CCNA1,CCNB1IP1,CDK2,CYP26B1,DMC1,DPEP3,DUSP13,EREG,FANCM,FKBP6,FMN2,GOLGA2,HORMAD1,HORMAD2,HSPA2,ING2,KIAA0430,KLHDC3,M1AP,MEI4,MEIKIN,MEIOB,MLH3,MRE11A,MSH4,MSH6,P3H4,PIM2,PLD6,PRDM9,RAD21,RAD50,RAD51,RAD51B,RAD51D,RAD54B,RAD54L,REC8,RNF212,SGOL1,SMC1A,SMC3,SPDYA,SPIRE1,SPIRE2,STAG3,STRA13,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,SYCP3,TDRD12,TDRD9,TDRKH,TEX11,TEX14,TEX40,TOP3A,TRIP13,WEE2,XRCC2,ZFP42,ZW10	One of the two nuclear divisions that occur as part of the meiotic cell cycle.
GO:0007127	GO	BP	meiosis I	APITD1,ATM,BAG6,BRDT,C11orf85,C15orf43,CCDC79,CCNA1,CCNB1IP1,FANCM,FMN2,HORMAD1,ING2,KLHDC3,MEI4,MEIKIN,MEIOB,MLH3,MRE11A,MSH4,MSH6,P3H4,PRDM9,RAD21,RAD50,RAD51,RAD51B,RAD51D,RAD54B,REC8,RNF212,STAG3,STRA13,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,SYCP3,TEX11,TRIP13	The first meiotic nuclear division in which homologous chromosomes are paired and segregated from each other, producing two haploid daughter nuclei.
GO:0007129	GO	BP	synapsis	BAG6,C11orf85,C15orf43,CCDC79,CCNB1IP1,HORMAD1,MEI4,MEIOB,P3H4,RNF212,STAG3,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TRIP13	The meiotic cell cycle process where side by side pairing and physical juxtaposition of homologous chromosomes is created during meiotic prophase. Synapsis begins when the chromosome arms begin to pair from the clustered telomeres and ends when synaptonemal complex or linear element assembly is complete.
GO:0007130	GO	BP	synaptonemal complex assembly	BAG6,HORMAD1,P3H4,STAG3,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TRIP13	The cell cycle process in which the synaptonemal complex is formed. This is a structure that holds paired chromosomes together during prophase I of meiosis and that promotes genetic recombination.
GO:0007131	GO	BP	reciprocal meiotic recombination	APITD1,ATM,CCNB1IP1,FANCM,KLHDC3,MEIOB,MLH3,MRE11A,MSH4,RAD21,RAD50,RAD51,RAD51B,RAD51D,RAD54B,REC8,RNF212,STRA13,SYCE3,SYCP1,TEX11,TRIP13	The cell cycle process in which double strand breaks are formed and repaired through a double Holliday junction intermediate. This results in the equal exchange of genetic material between non-sister chromatids in a pair of homologous chromosomes. These reciprocal recombinant products ensure the proper segregation of homologous chromosomes during meiosis I and create genetic diversity.
GO:0007140	GO	BP	male meiosis	ASZ1,BRDT,CCNA1,CYP26B1,DPEP3,HSPA2,ING2,M1AP,MEIKIN,MEIOB,PIM2,SPDYA,SYCP3,TDRD12,TDRD9,TDRKH,TEX14,TEX40	A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the male germline.
GO:0007143	GO	BP	female meiotic division	EREG,FMN2,KIAA0430,MEIKIN,MEIOB,SPIRE1,SPIRE2,WEE2	A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline.
GO:0007156	GO	BP	homophilic cell adhesion via plasma membrane adhesion molecules	AMIGO1,AMIGO2,CADM1,CADM3,CD84,CDH1,CDH13,CDH17,CEACAM1,CELSR2,DSCAM,DSCAML1,DSG2,FAT2,ITGB1,MPZL2,NPTN,PKD1,PTPRM,PTPRT,PVRL1,PVRL2,PVRL3,ROBO1,ROBO2,SDK1,SDK2,TENM3,TRO	The attachment of a plasma membrane adhesion molecule in one cell to an identical molecule in an adjacent cell.
GO:0007157	GO	BP	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	ADGRL1,ALCAM,AMICA1,AMIGO1,AMIGO2,AMIGO3,CADM1,CADM3,CBLN1,CD164,CD209,CD6,CXADR,DCHS1,FAT4,GRID2,ICAM1,IL1RAPL1,ITGAL,NLGN1,NRXN1,PTPRD,PVRL1,REG3A,SELE,TENM2,UMOD,VCAM1	The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.
GO:0007158	GO	BP	neuron cell-cell adhesion	CDK5R1,CNTN4,NCAM2,NINJ2,NLGN1,NLGN2,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,RET	The attachment of a neuron to another cell via adhesion molecules.
GO:0007159	GO	BP	leukocyte cell-cell adhesion	ADA,ADAM17,AMICA1,ANXA1,APOA4,ATP7A,BATF,BMP7,BTN3A1,CALCA,CASP8,CCL19,CCL21,CCL5,CCR7,CD1C,CD1D,CD2,CD209,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD40LG,CD44,CD7,CD74,CD80,CD86,CD8A,CD8B,CEBPB,CERCAM,CHD7,CLEC4M,CLEC7A,CTPS1,CXADR,DDOST,DLL4,DOCK8,DPP4,EIF2AK4,ELF4,EOMES,F2RL1,FADD,FERMT3,FKBP1A,FOXP1,FOXP3,GCNT1,GLI3,GOLPH3,HLA-E,HMGB1,HSPD1,ICAM1,ICOSLG,IL12B,IL1B,IL2,IL6,INS,IRF4,ITGA4,ITGAL,ITGB1,ITGB2,ITGB7,ITK,JAG2,KIF13B,KIT,LAT,LCK,LCP1,LEF1,LEP,LEPR,LFNG,LIG4,LILRB1,LY9,MADCAM1,MICA,MICB,NCK1,NCK2,NHEJ1,NT5E,PIK3CD,PIK3CG,PODXL2,PPP3CA,PPP3CB,PRLR,PTGER4,PTPN2,PTPN22,PTPRC,RAC2,RAG1,RAG2,RHOH,RIPK3,ROCK1,RORA,RORC,RSAD2,S100A8,S100A9,SELE,SELP,SEMA4D,SHH,SLA2,SLAMF6,SLC11A1,SOX4,STOML2,SYK,THEMIS,TNF,TNFRSF4,TNFSF14,TNFSF18,TNFSF4,TNIP1,TREML2,TSTA3,UMOD,VCAM1,ZAP70,ZFPM1	The attachment of a leukocyte to another cell via adhesion molecules.
GO:0007160	GO	BP	cell-matrix adhesion	ACTN1,ACTN2,ACTN3,ADAM15,ADAM9,ADAMTS12,ADAMTS13,ARHGEF7,BCAM,CCL21,CD34,CD44,CD63,COL17A1,COL3A1,CTTN,DDR1,DEFB118,DLC1,ECM2,EMP2,FBLN5,FERMT2,FGA,FGB,FGG,HOXD3,HPSE,ILK,ITGA1,ITGA10,ITGA11,ITGA2,ITGA3,ITGA4,ITGA7,ITGA8,ITGAL,ITGAV,ITGB1,ITGB1BP1,ITGB2,ITGB3,ITGB4,ITGB5,ITGB7,LAMA5,LYVE1,MADCAM1,MKLN1,NPNT,PARVG,PIP5K1A,PKD1,PPFIA1,PPFIA2,PTPRK,RAC1,RCC2,RHOD,SGCE,SIGLEC1,SORBS1,TAOK2,TESK2,THBS3,THY1,TIAM1,TIMM10B,TMEM8B,TRIP6,TSC1,VCAM1,VCL,VTN,WHAMM,ZYX	The binding of a cell to the extracellular matrix via adhesion molecules.
GO:0007162	GO	BP	negative regulation of cell adhesion	ACER2,ACTN4,ACVRL1,ADAM10,ADAM15,ADAM22,ADAMDEC1,ADAMTS18,ADIPOQ,ALOX12,ANGPT1,ANXA1,AP1AR,APOA1,APOD,ARHGAP6,ARHGDIA,ARHGDIB,ARHGDIG,ASS1,B4GALNT2,BCAS3,BMP2,BMP4,BTN2A2,C1QTNF1,CASK,CBLL1,CCL21,CCL25,CCL28,CD164,CD274,CD300A,CDH1,CDH13,CDKN2A,CEBPB,CLASP2,CORO1C,CTLA4,CXCL12,CYP1B1,DACT2,DLC1,DMTN,DSCAM,DUSP3,EPCAM,ERBB3,FBLN1,FOXJ1,FOXP3,FXYD5,FZD4,FZD7,GBP1,GCNT2,GLI3,GLMN,GTPBP4,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,HOXA7,HRG,IFNA2,IFNB1,IFNL1,IHH,IL10,IL1RN,IRF1,ITGB1BP1,JAK3,KANK1,KIAA0922,KLF4,KNG1,LAX1,LEF1,LGALS3,LGALS9,LILRB1,LILRB2,LPXN,MAD2L2,MAP2K5,MAPK7,MFI2,MIA3,MUC1,MYADM,MYOC,NF2,NOTCH1,PDCD1LG2,PDE3B,PHLDB2,PLET1,PLG,PLXNB1,PLXNB3,PODXL,PPARA,PRKAR1A,PRKCD,PRKG1,PRNP,PTEN,PTK2,PTPN2,PTPN22,PTPRC,PTPRO,RASA1,RC3H1,RCC2,RDX,RGCC,RND1,SEMA3E,SEMA4D,SEMA5A,SERPINE1,SERPINE2,SFTPD,SIPA1,SNAI2,SOCS5,SPINT2,SPN,SPOCK1,SRC,TACSTD2,TBCD,TGFB1,TGFBI,THBS1,TIGIT,TNFRSF21,TNFSF4,TRPV4,WNT1,XCL1,ZC3H8,ZNF703	Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
GO:0007163	GO	BP	establishment or maintenance of cell polarity	ANK1,AQP1,ARHGEF11,BRSK1,BRSK2,CAP1,CAP2,CCL19,CCL21,CCL4,CCR7,CD3G,CDC42,CDC42BPB,CDK5RAP2,CENPA,CKAP5,CLASP1,CLASP2,CLIC4,CRB1,CRB2,DLG1,DOCK7,DST,DYNLT1,EPHB1,ERBB2IP,FAT1,FBF1,FERMT1,FGF13,FOXJ1,FSCN1,GBF1,GOLPH3,HTT,KIF2C,LMNA,MAP4,MAP7,MARK2,MOS,MPP7,MSN,MTCL1,MYO18A,NCKAP1L,NDC80,NDE1,PAFAH1B1,PARD3,PARD6B,PARVA,PARVB,PRKCI,PRKCZ,PTK2,RAB10,RAB11FIP2,SCRIB,SDCCAG8,SFRP5,SHTN1,SIPA1L3,SLC9A1,SLC9A3R1,SNX27,SPDL1,SPN,STK11,SYNE4,WNT7B,WWC1,ZW10	Any cellular process that results in the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.
GO:0007168	GO	BP	receptor guanylyl cyclase signaling pathway	GUCA1B,GUCY2C,GUCY2D,GUCY2F,NPPA,NPPB,NPPC,NPR1,NPR2,PDZD3	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses guanylyl cyclase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007171	GO	BP	activation of transmembrane receptor protein tyrosine kinase activity	ADRB2,ANGPT1,ANGPT4,CHRNA3,EFNA5,EGF,NRG1,NRG3,PILRB,PRLR	Any process that initiates the activity of the inactive transmembrane receptor protein tyrosine kinase activity.
GO:0007172	GO	BP	signal complex assembly	CD3E,MAPK8IP2,NCK1,NCK2,PXN,SRC	The aggregation, arrangement and bonding together of a set of components to form a complex capable of relaying a signal within a cell.
GO:0007175	GO	BP	negative regulation of epidermal growth factor-activated receptor activity	CBLC,ERRFI1,GPRC5A,SNX6,SOCS4,SOCS5,ZFYVE28,ZGPAT	Any process that stops, prevents, or reduces the frequency, rate or extent of EGF-activated receptor activity.
GO:0007176	GO	BP	regulation of epidermal growth factor-activated receptor activity	ADAM17,ADRA2A,ADRA2B,ADRA2C,APP,CBLC,EGF,EPGN,EREG,ERRFI1,FBXW7,GPRC5A,NCK2,SHC1,SNX6,SOCS4,SOCS5,TGFA,ZFYVE28,ZGPAT	Any process that modulates the frequency, rate or extent of EGF-activated receptor activity.
GO:0007178	GO	BP	transmembrane receptor protein serine/threonine kinase signaling pathway	ACVR1,ACVR1B,ACVR1C,ACVR2A,ACVR2B,ACVRL1,ADAM9,ARHGEF18,ARRB2,ATOH8,ATP1B4,BAMBI,BMP10,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CBL,CCNC,CCNK,CCNT1,CCNT2,CDH5,CDK8,CDK9,CDKN2B,CER1,CFC1,CGN,CHRD,CHRDL1,CITED1,CITED2,CLDN5,COL1A2,COL3A1,DLX5,E2F4,E2F5,EID2,ENG,F11R,FAM83G,FERMT2,FKBP1A,FMOD,FNTA,FOS,FOXH1,FSTL1,FURIN,GCNT2,GDF10,GDF15,GDF2,GDF5,GDF6,GDF7,GDF9,GREM2,HDAC1,HFE,HFE2,HIPK2,HPGD,ID1,INHBA,INHBB,IRAK1,ITGB5,JUN,JUNB,KLF10,LEFTY1,LEFTY2,LTBP1,LTBP2,LTBP4,MAGI2,MAPK3,MEGF8,MEN1,MTMR4,MYC,NCOR1,NCOR2,NEDD4L,NEDD8,NLK,NOG,PARD3,PARD6A,PARP1,PDGFB,PMEPA1,POU5F1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRKCZ,PTK2,PTPRK,PXN,RBL1,RGMB,RHOA,RNF111,RPS27A,RUNX2,SCX,SERPINE1,SKI,SKIL,SLC33A1,SLC39A5,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD6,SMAD7,SMAD9,SMURF1,SMURF2,SNW1,SP1,SRC,STRAP,STUB1,TFDP1,TFDP2,TGFB1,TGFB1I1,TGFB2,TGFB3,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1,TGIF1,TGIF2,TMEM100,TRIM33,UBA52,UBB,UBC,UBE2D1,UBE2D3,UBE2M,UCHL5,USP15,USP9X,USP9Y,WWTR1,XPO1,ZFYVE16,ZFYVE9,ZYX	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007179	GO	BP	transforming growth factor beta receptor signaling pathway	ACVR1,ACVRL1,ADAM9,ARHGEF18,ARRB2,ATP1B4,BAMBI,BMPR1A,CBL,CCNC,CCNK,CCNT1,CCNT2,CDH5,CDK8,CDK9,CDKN2B,CGN,CITED1,CLDN5,COL1A2,COL3A1,E2F4,E2F5,EID2,ENG,F11R,FERMT2,FKBP1A,FMOD,FNTA,FOS,FOXH1,FURIN,GCNT2,GDF10,GDF15,GDF5,GDF9,HDAC1,HPGD,ID1,ITGB5,JUN,JUNB,KLF10,LEFTY1,LEFTY2,LTBP2,MEN1,MTMR4,MYC,NCOR1,NCOR2,NEDD4L,NEDD8,NLK,PARD3,PARD6A,PARP1,PDGFB,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRKCZ,PTK2,PTPRK,PXN,RBL1,RHOA,RNF111,RPS27A,SERPINE1,SKI,SKIL,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD7,SMURF1,SMURF2,SNW1,SP1,SRC,STRAP,STUB1,TFDP1,TFDP2,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1,TGIF1,TGIF2,TRIM33,UBA52,UBB,UBC,UBE2D1,UBE2D3,UBE2M,UCHL5,USP15,USP9X,USP9Y,WWTR1,XPO1,ZFYVE9,ZYX	A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007183	GO	BP	SMAD protein complex assembly	EID2,FKBP1A,SMAD1,SMAD2,SMAD3,SMAD4,TGFB1,ZFYVE9	The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
GO:0007184	GO	BP	SMAD protein import into nucleus	GDF5,JUN,TGFB1,TGFB2,ZFYVE9	The directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
GO:0007185	GO	BP	transmembrane receptor protein tyrosine phosphatase signaling pathway	FRS2,PTN,PTPRD,PTPRF,PTPRU,TRIO	A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses protein tyrosine phosphatase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007187	GO	BP	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADCYAP1,ADGRD1,ADORA2A,ADRA1B,ADRA1D,ADRA2A,ADRB1,ADRB2,ADRB3,AGT,AGTR2,ANXA1,APLP1,AVPR2,CACNA1D,CALCR,CALCRL,CCL2,CCR1,CCR3,CHRM2,CHRM5,CNR1,CNR2,CORT,CRHR1,CRHR2,DRD1,DRD2,DRD3,DRD4,DRD5,FFAR3,FLNA,FPR1,GABBR1,GALR2,GCGR,GHRH,GHRHR,GNAI1,GNAI2,GNAI3,GNAL,GNAS,GNAT3,GNB1,GNG2,GPER1,GPR26,GPR3,GPR37,GPR37L1,GPR78,GRIK3,GRK5,GRM4,GRM7,GRM8,HRH2,HRH3,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR4,HTR6,HTR7,LHCGR,LPAR1,LPAR3,MC1R,MC2R,MC3R,MC4R,MC5R,MCHR1,MTNR1A,MTNR1B,NPY,NPY1R,OPRD1,OPRK1,OPRL1,OPRM1,P2RY12,PDE4D,PRKACB,PTGER2,PTGER4,PTGIR,PTH1R,PTHLH,RAPGEF2,RGS1,SSTR1,SSTR2,SSTR3,SSTR4,SSTR5,TSHR,VIP,VIPR1,WASF2,XCR1	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide.
GO:0007188	GO	BP	adenylate cyclase-modulating G-protein coupled receptor signaling pathway	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADCYAP1,ADGRD1,ADORA2A,ADRA1B,ADRA1D,ADRA2A,ADRB1,ADRB2,ADRB3,APLP1,AVPR2,CACNA1D,CALCR,CCR3,CHRM2,CHRM5,CNR1,CORT,CRHR1,CRHR2,DRD1,DRD2,DRD3,DRD4,DRD5,FFAR3,FLNA,FPR1,GABBR1,GALR2,GCGR,GHRH,GHRHR,GNAI1,GNAI2,GNAI3,GNAL,GNAS,GNAT3,GNB1,GNG2,GPER1,GPR26,GPR3,GPR37,GPR37L1,GPR78,GRIK3,GRK5,GRM4,GRM7,GRM8,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,LPAR1,MC4R,MCHR1,NPY1R,OPRK1,OPRL1,P2RY12,PDE4D,PRKACB,PTGER2,PTGER4,PTGIR,PTH1R,PTHLH,RAPGEF2,RGS1,VIP,WASF2	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through activation or inhibition of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP (cAMP).
GO:0007189	GO	BP	adenylate cyclase-activating G-protein coupled receptor signaling pathway	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADCYAP1,ADGRD1,ADORA2A,ADRB1,CALCR,CRHR1,DRD1,DRD3,DRD5,GHRH,GHRHR,GNAL,GNAS,GNB1,GNG2,GPER1,GPR26,GPR3,GPR78,PDE4D,PTGER2,PTGIR,PTH1R,PTHLH,RAPGEF2,VIP	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
GO:0007190	GO	BP	activation of adenylate cyclase activity	ACR,ADCYAP1,ADCYAP1R1,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,GIPR,GLP1R,GNAS,LHCGR,NTRK1,NTRK2,P2RY11,PRKCA,RAF1	Any process that initiates the activity of the inactive enzyme adenylate cyclase.
GO:0007191	GO	BP	adenylate cyclase-activating dopamine receptor signaling pathway	DRD1,DRD3,DRD5,GNAS,GNB1,GNG2	The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
GO:0007193	GO	BP	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA2A,APLP1,CHRM5,CORT,DRD2,DRD3,DRD4,FFAR3,FLNA,GABBR1,GNAI1,GNAI2,GNAI3,GNAL,GNAT3,GPR37,GPR37L1,GRIK3,GRM4,GRM7,GRM8,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,LPAR1,MCHR1,NPY1R,OPRK1,OPRL1,P2RY12,RGS1	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP).
GO:0007194	GO	BP	negative regulation of adenylate cyclase activity	ADRA2A,CCR2,DRD2,DRD3,DRD4,EDNRB,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,LTB4R2,OPRM1,PALM,PRKCA	Any process that stops, prevents, or reduces the frequency, rate or extent of adenylate cyclase activity.
GO:0007200	GO	BP	phospholipase C-activating G-protein coupled receptor signaling pathway	ACTN2,ADRA2A,AGT,AGTR1,ANO1,CALCA,CCKAR,CCKBR,CHRM1,CHRM2,CXCR2,DRD1,DRD2,DRD5,ESR1,F2R,F2RL3,FPR1,GNA15,GRM1,GRM5,HOMER1,HRH1,HTR2C,LHCGR,LPAR1,LTB4R,MC3R,NMBR,NMUR1,NMUR2,OPRD1,OPRK1,OPRM1,P2RY11,P2RY4,P2RY6,PLCE1,PTH1R,TACR1	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG).
GO:0007202	GO	BP	activation of phospholipase C activity	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,ANG,ARHGAP6,AVPR1A,AVPR1B,C5AR1,CALM1,CAMK4,CREB1,EDNRA,EGFR,GNA15,GNAQ,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,LPAR1,LPAR2,NGF,NMUR1,NTRK1,PDE1A,PDE1B,PDE1C,PLCB2,PLCG1,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,S1PR4,SELE,TXK	The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.
GO:0007204	GO	BP	positive regulation of cytosolic calcium ion concentration	ABL1,ABL2,ADCY5,ADRA1A,AGTR1,ATP2B4,AVPR1B,BBC3,BCAP31,BDKRB1,C1QTNF1,C3AR1,CACNA1A,CACNA1C,CALCA,CALCR,CAV3,CCKBR,CCL19,CCL21,CCL3,CCR1,CCR3,CCR4,CCR5,CCR7,CCR9,CD24,CD36,CD52,CD55,CHERP,CHRNA10,CHRNA9,CIB2,CXCL13,CXCR4,CYSLTR1,DLG4,DRD1,DRD2,EDN1,EDN2,EDNRA,ERO1A,ESR1,F2R,F2RL1,FGF2,FIS1,GHRL,GLP1R,GNA15,GPER1,GRM1,HMGB1,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KNG1,LCK,LPAR1,LPAR2,LPAR3,MCHR1,NMUR2,NOL3,NPTN,OPRL1,OPRM1,P2RY1,P2RY4,PDGFRA,PKD2,PLCE1,PLCG2,PROK2,PTPRC,RYR1,RYR2,S1PR3,S1PR4,SAA1,SLC8A1,SPPL3,TAC1,TRDN,TRPM1,TRPV4,XCL1,XCR1	Any process that increases the concentration of calcium ions in the cytosol.
GO:0007205	GO	BP	protein kinase C-activating G-protein coupled receptor signaling pathway	AZU1,CHRM1,DGKD,DGKH,F2R,GAP43,HTR2B,PARD3,PICK1,PLCE1,PLPP1,PRKD3	The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of protein kinase C (PKC). PKC is activated by second messengers including diacylglycerol (DAG).
GO:0007210	GO	BP	serotonin receptor signaling pathway	HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,HTR4,HTR5A,HTR7	The series of molecular signals generated as a consequence of a serotonin receptor binding to one of its physiological ligands.
GO:0007212	GO	BP	dopamine receptor signaling pathway	ADCY6,DRD1,DRD2,DRD3,DRD4,DRD5,FLNA,GNAI3,GNAS,GNB1,GNG2	The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands.
GO:0007213	GO	BP	G-protein coupled acetylcholine receptor signaling pathway	ADRBK1,AGRN,CDK5R1,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,GNA11,GNA15,GNAQ,GNB1,PLCB1,RGS10,RGS8	Any series of molecular signals initiated by an acetylcholine receptor on the surface of the target cell binding to one of its physiological ligands, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction and ends with regulation of a downstream cellular process, e.g. transcription.
GO:0007214	GO	BP	gamma-aminobutyric acid signaling pathway	GABBR1,GABBR2,GABRA2,GABRB2,GABRE,GABRR1,GABRR3	The series of molecular signals generated by the binding of gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid which acts as a neurotransmitter in some organisms, to a cell surface receptor.
GO:0007215	GO	BP	glutamate receptor signaling pathway	APP,CDK5R1,CLN3,CPEB4,GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN3A,GRIN3B,GRM1,GRM4,GRM5,GRM6,GRM7,GRM8,HOMER1,HOMER2,HOMER3,KCNB1,PLCB1,PTK2B,TRPM1	A series of molecular signals initiated by the binding of glutamate to a glutamate receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007216	GO	BP	G-protein coupled glutamate receptor signaling pathway	GRIK3,GRM1,GRM4,GRM5,GRM6,GRM7,GRM8,HOMER1,HOMER2,HOMER3,TRPM1	A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. Ends with regulation of a downstream cellular process, e.g. transcription.
GO:0007217	GO	BP	tachykinin receptor signaling pathway	ADRBK1,GRK5,TACR1,TACR2,TACR3	The series of molecular signals generated as a consequence of a tachykinin, i.e. a short peptide with the terminal sequence (Phe-X-Gly-Leu-Met-NH2), binding to a cell surface receptor.
GO:0007218	GO	BP	neuropeptide signaling pathway	ADCYAP1,AGRP,CPE,GALR1,GALR2,GALR3,GLRA1,GLRA2,GLRB,GPR143,GRP,KISS1R,MC2R,NMUR1,NPFFR1,NPPA,NPSR1,NPVF,NPY1R,NPY2R,NPY5R,NTSR1,NXPH2,NXPH3,NXPH4,OPRM1,PRLHR,QRFP,RAPGEF2,SORCS1,SORCS2,SORCS3,SORT1	The series of molecular signals generated as a consequence of a peptide neurotransmitter binding to a cell surface receptor.
GO:0007219	GO	BP	Notch signaling pathway	ADAM10,AGO1,AGO2,AGO3,AGO4,APH1A,APH1B,ARRB1,ARRB2,ASCL1,B4GALT1,BMP2,CCNC,CCND1,CDK8,CNTN1,CREB1,CREBBP,CUL1,DLK1,DLL1,DLL4,DNER,DTX1,E2F1,E2F3,EP300,FBXW7,FCER2,FURIN,GALNT11,GMDS,GZMB,HDAC1,HDAC10,HDAC3,HDAC5,HDAC7,HDAC9,HES1,HES5,HEY1,HEY2,HEYL,HIF1A,HOXD3,ITCH,JAG1,JAG2,KAT2B,LFNG,MAML1,MAML2,MAML3,MDK,MIB1,MOV10,MYC,NCOR1,NCOR2,NCSTN,NOTCH1,NOTCH2,NOTCH3,NOTCH4,NRARP,NUMB,POFUT1,POGLUT1,PSEN2,PSENEN,RBPJ,RBX1,RPS27A,SKP1,SNAI1,SNAI2,SNW1,TBL1X,TBL1XR1,TFDP1,TFDP2,TLE1,TLE2,TLE3,TLE4,TNRC6A,TNRC6B,TNRC6C,TP53,UBA52,UBB,UBC,ZNF423	A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007220	GO	BP	Notch receptor processing	ADAM10,ADAM17,APH1A,APH1B,DLL1,DLL4,GALNT11,JAG1,JAG2,NCSTN,NOTCH1,NOTCH2,NOTCH3,NOTCH4,PSEN1,PSEN2,PSENEN,RPS27A,UBA52,UBB,UBC	The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor.
GO:0007224	GO	BP	smoothened signaling pathway	ARL13B,B9D1,CC2D2A,DISP1,DISP2,DYRK2,EVC2,GLI1,GLI2,GLI3,HES5,IFT27,IHH,KIAA0586,MAP3K10,PKD2L1,PTCH1,PTCHD1,PTCHD2,SEPT2,SHH,SMO,STIL,STK36,TCTN2,TCTN3,TMEM17,TMEM231,TTBK2,TTC26	A series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened.
GO:0007229	GO	BP	integrin-mediated signaling pathway	ADAM10,ADAM11,ADAM15,ADAM9,ADAMTS1,ADAMTS13,ANGPTL3,APOA1,BCAR1,CCM2,CD47,CDH17,CEACAM1,COL16A1,COL3A1,CUL3,DOCK1,DST,ERBB2IP,FERMT2,FERMT3,FGR,HCK,ILK,ITGA10,ITGA11,ITGA2,ITGA2B,ITGAV,ITGB1,ITGB1BP1,ITGB2,ITGB3,ITGB5,ITGB7,LAMA5,LAT,MADCAM1,MYH9,NEDD9,NME2,PLEK,PRKD1,PTK2,PTK2B,RCC2,SEMA7A,SRC,SYK,TEC,ZNF304,ZYX	A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0007249	GO	BP	I-kappaB kinase/NF-kappaB signaling	BCL3,BIRC2,BIRC3,CD14,CD27,CHUK,DAB2IP,ERC1,IKBKB,IKBKG,IRAK1BP1,IRAK2,LY96,MAP3K14,MAP3K7,NKIRAS1,NKIRAS2,NLRC3,NLRP12,PRDX4,RBCK1,RIPK1,RIPK2,RNF31,ROCK1,ROCK2,RPS27A,SHARPIN,TAB1,TAB2,TAB3,TBK1,TIAF1,TICAM1,TICAM2,TLR2,TLR3,TLR4,TLR7,TLR8,TLR9,TNF,TNFRSF1A,TNFSF14,TRADD,TRAF2,TRAF6,TRIP6,UBA52,UBB,UBC,ZNF268,ZNF675	The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
GO:0007250	GO	BP	activation of NF-kappaB-inducing kinase activity	CARD10,CARD14,CHI3L1,COPS8,IRAK1,MALT1,MAP3K7,TLR3,TLR6,TNFRSF10A,TNFRSF10B,TNFSF15,TRAF2,TRAF6,ZFP91	The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues.
GO:0007252	GO	BP	I-kappaB phosphorylation	CHUK,DAB2IP,ERC1,IKBKB,MAP3K7,PRDX4,TLR2,TLR3,TLR4,TLR7,TLR9	The process of introducing a phosphate group into an inhibitor of kappa B (I-kappaB) protein. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing bound NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
GO:0007253	GO	BP	cytoplasmic sequestering of NF-kappaB	CCDC22,FAF1,G3BP2,IL10,NFKBIA,PSMD10	The selective interaction of the transcription factor NF-kappaB with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus.
GO:0007254	GO	BP	JNK cascade	ADORA2B,ARHGEF6,BIRC7,CCL19,CRKL,DAB2IP,DAXX,DBNL,DUSP10,DUSP9,ERN1,GPS1,GPS2,HACD3,IKBKG,IRAK1,IRAK2,MAP2K4,MAP2K7,MAP3K10,MAP3K11,MAP3K12,MAP3K13,MAP3K2,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K3,MAP4K5,MAPK10,MAPK8,MAPK9,MDFIC,MINK1,MUL1,NOD1,NOD2,PKN1,PTGER4,RIPK1,RIPK2,RPS27A,SH2D3A,SH2D3C,TAB1,TAB2,TAB3,TNFRSF19,TNIK,TRAF6,TRIB1,UBA52,UBB,UBC,WNT5A	An intracellular protein kinase cascade containing at least a JNK (a MAPK), a JNKK (a MAPKK) and a JUN3K (a MAP3K). The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
GO:0007257	GO	BP	activation of JUN kinase activity	BIRC7,CCL19,DAB2IP,DAXX,DBNL,ERN1,HACD3,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K5,MAP3K6,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MDFIC,MUL1,PKN1,RIPK1,WNT5A	The initiation of the activity of the inactive enzyme JUN kinase (JNK).
GO:0007259	GO	BP	JAK-STAT cascade	ADAM17,CCL2,CCR2,CISH,CLCF1,CSH1,CTR9,EGF,F2R,FER,FGFR3,GH1,GH2,GHR,HES1,IFNAR1,IFNAR2,IFNL4,IL15,IL21,IRS1,IRS2,JAK2,JAK3,LYN,MAPK1,MAPK3,NMI,PIAS1,PKD1,PKD2,PRL,PRLR,PTK6,PTPN1,PTPN6,SOCS1,SOCS2,SOCS3,SOCS6,STAMBP,STAT1,STAT2,STAT3,STAT4,STAT5A,STAT5B	Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The JAK-STAT cascade begins with activation of STAT proteins by members of the JAK family of tyrosine kinases, proceeds through dimerization and subsequent nuclear translocation of STAT proteins, and ends with regulation of target gene expression by STAT proteins.
GO:0007260	GO	BP	tyrosine phosphorylation of STAT protein	F2R,FER,IFNL4,IL15,IL21,JAK2,JAK3,PTK6	The process of introducing a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
GO:0007262	GO	BP	STAT protein import into nucleus	EGF,F2R,HES1,JAK2,JAK3	The directed movement of dimerized STAT (Signal Transducers and Activators of Transcription) proteins into the nucleus following activation by members of the janus activated kinase (JAK) family of tyrosine kinases.
GO:0007263	GO	BP	nitric oxide mediated signal transduction	AGT,AGTR2,APOE,CD36,DDAH1,DDAH2,FPR1,GUCY1B3,KCNC2,MAFA,NDNF,NEUROD1,PDX1	Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms.
GO:0007266	GO	BP	Rho protein signal transduction	ADRA2A,AGTR1,ARHGAP1,ARHGAP29,ARHGAP4,ARHGAP5,ARHGAP6,ARHGDIA,ARHGDIB,ARHGDIG,ARHGEF1,ARHGEF11,ARHGEF3,CDH13,CFL1,COL1A2,CTNNAL1,EPS8L1,EPS8L2,LIMK1,MYO9B,NTN1,PHACTR4,RHOA,RHOB,RHOD,RHOG,ROPN1B,RTKN,SHTN1,TAX1BP3	A series of molecular signals within the cell that are mediated by a member of the Rho family of proteins switching to a GTP-bound active state.
GO:0007269	GO	BP	neurotransmitter secretion	ABAT,ALDH5A1,APBA1,BAIAP3,BLOC1S6,BRSK1,BZRAP1,CASK,CDK5,CHAT,CPLX1,DNAJC5,DOC2B,DVL1,GAD1,GAD2,GLS,GLS2,GRM4,HRH3,HSPA8,LIN7A,LIN7B,LIN7C,MAOA,NLGN1,NRXN1,NRXN2,OTOF,PCLO,PIP5K1C,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PTPRN2,RAB3A,RIMS1,RIMS2,SEPT5,SLC17A7,SLC18A2,SLC18A3,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC22A2,SLC32A1,SLC38A2,SLC5A7,SLC6A1,SLC6A11,SLC6A12,SLC6A13,SNAP25,SNAPIN,SNPH,STX1A,STX1B,STXBP1,SYN2,SYNJ1,SYT1,UNC13A,UNC13B,VAMP2	The regulated release of neurotransmitter into the synaptic cleft. A neurotransmitter is any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, gamma-aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin.
GO:0007270	GO	BP	neuron-neuron synaptic transmission	CRH,CRHBP,DLGAP2,DRD2,DRD5,GABRA1,GABRB2,GABRG2,GLRA1,GRID2,KIF1B,PTEN,SLC1A4,SLC6A5,SNCA,TH	The process of communication from a neuron to another neuron across a synapse.
GO:0007271	GO	BP	synaptic transmission, cholinergic	ACHE,APOE,CHRNA10,CHRNA3,CHRNA4,CHRNB1,CHRNB2,CHRNB3,CHRNB4,CHRNE,COLQ,NQO1,RAPSN	The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse using the neurotransmitter acetylcholine.
GO:0007274	GO	BP	neuromuscular synaptic transmission	CHRNA1,CHRNA3,CHRNB1,CHRNB2,CHRNB4,DTNA,KIF1B,STAC3	The process of communication from a neuron to a muscle, across a synapse.
GO:0007276	GO	BP	gamete generation	ACE,ADAM28,ADAM29,ADGRG2,ALKBH5,ANG,ARNTL,ASZ1,AZIN2,BAG6,BBS2,BBS4,BCL2L10,BCL2L2,BMP15,BMPR1B,BPY2,BRD2,BRDT,CABYR,CASC5,CATSPERD,CCNA1,CCNI,CCT6B,CDK16,CDY1,CDY2A,CDYL,CELF1,CELF4,CEP57,CFAP54,CFTR,CGB,CHD5,CIB1,CLOCK,CTCFL,CXADR,CYLC1,CYP26B1,DAZL,DDX25,DEAF1,DEFB118,DIAPH2,DMC1,DMRT1,DNAH9,DNMT3L,DPY19L2,DUSP13,DYNLL1,DZIP1,EIF5A2,ELL3,EREG,FAM50A,FIGLA,FKBP6,FMN2,FOXJ1,FSHB,FSHR,GALNTL5,GDF9,GGN,GGT1,H1FNT,HERC4,HIST1H2BA,HORMAD1,HPGD,HSF2BP,HSPA2,IFT81,ING2,INSL3,IQCF1,KDM2B,KHDRBS3,KIAA0430,KIT,KMT2D,LGR4,LRGUK,M1AP,MAEL,MAK,MAST2,MCM8,MCM9,MEI4,MKKS,MTL5,NANOS2,NANOS3,NDRG3,NLRP14,NME5,NPAP1,NPHP1,NR6A1,OR7C1,PAFAH1B1,PARN,PICK1,PIWIL1,PIWIL2,PIWIL4,PLD6,PLPP1,PLPP3,PRKACA,PRKACG,PRKAG1,PRM1,PRM2,PRMT7,PROK2,PSME4,PTCHD3,PTTG1,PUM1,PVRL2,RBMY1B,RBMY1F,REC8,RHBDD1,RHOXF1,RNF8,ROPN1B,ROS1,RUVBL1,SERPINA5,SHCBP1L,SLC26A3,SLC26A6,SOD1,SOX8,SOX9,SPA17,SPAG11B,SPAG4,SPAG6,SPAG9,SPANXA1,SPANXB1,SPATA2,SPATA6,SPO11,SRPK1,SYCE3,SYCP1,SYCP3,TDRD1,TDRD12,TDRD5,TDRD6,TDRD7,TDRD9,TDRKH,TDRP,TESK2,TGFBR1,TMEM119,TMEM203,TNP1,TOB2,TRIM27,TRIP13,TSGA10,TSSK1B,TSSK2,TSSK3,TSSK6,TXNDC2,TYRO3,UBE2B,USP9X,USP9Y,VCX,WDR33,WFDC2,WT1,YBX2,ZNF296,ZNF35,ZNF830,ZP3	The generation and maintenance of gametes in a multicellular organism. A gamete is a haploid reproductive cell.
GO:0007281	GO	BP	germ cell development	ANG,BBS2,BBS4,BMPR1B,CABYR,CASC5,CATSPERD,CELF1,CELF4,CEP57,CFTR,CHD5,CIB1,DAZL,DDX25,DEAF1,DPY19L2,DZIP1,EREG,FIGLA,FMN2,GALNTL5,H1FNT,HIST1H2BA,HORMAD1,ING2,IQCF1,KIAA0430,KMT2D,MEI4,MKKS,NANOS3,NME5,PAFAH1B1,PIWIL1,PIWIL2,PLD6,PRKACA,PSME4,PTCHD3,PVRL2,RNF8,SLC26A3,SLC26A6,SPAG6,SPANXB1,SRPK1,SYCP3,TDRD1,TDRD5,TNP1,TRIP13,TSSK1B,TSSK2,TSSK6,WT1,ZNF830,ZP3	The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
GO:0007283	GO	BP	spermatogenesis	ACE,ADAM28,ADAM29,ADGRG2,ALKBH5,ARNTL,ASZ1,AZIN2,BAG6,BBS2,BBS4,BCL2L10,BCL2L2,BPY2,BRD2,BRDT,CABYR,CASC5,CATSPERD,CCNA1,CCNI,CCT6B,CDK16,CDY1,CDY2A,CDYL,CEP57,CFAP54,CFTR,CHD5,CIB1,CLOCK,CYLC1,CYP26B1,DDX25,DEFB118,DMC1,DNAH9,DNMT3L,DPY19L2,DUSP13,EIF5A2,ELL3,FAM50A,FKBP6,FOXJ1,FSHR,GALNTL5,GGT1,H1FNT,HERC4,HIST1H2BA,HORMAD1,HSF2BP,HSPA2,IFT81,ING2,INSL3,IQCF1,KDM2B,KHDRBS3,KIT,LGR4,LRGUK,M1AP,MAEL,MAK,MAST2,MEI4,MKKS,MTL5,NANOS2,NANOS3,NDRG3,NLRP14,NME5,NPAP1,NPHP1,NR6A1,OR7C1,PAFAH1B1,PIWIL1,PIWIL4,PLD6,PRKACA,PRKACG,PRKAG1,PRM1,PRM2,PROK2,PSME4,PTCHD3,PTTG1,PUM1,PVRL2,RBMY1B,RBMY1F,REC8,RHBDD1,RNF8,ROPN1B,ROS1,RUVBL1,SERPINA5,SHCBP1L,SLC26A3,SLC26A6,SOD1,SOX8,SOX9,SPA17,SPAG11B,SPAG4,SPAG6,SPAG9,SPANXA1,SPANXB1,SPATA2,SPATA6,SPO11,SRPK1,SYCE3,SYCP1,SYCP3,TDRD1,TDRD12,TDRD5,TDRD6,TDRD7,TDRD9,TDRKH,TDRP,TESK2,TMEM119,TMEM203,TNP1,TRIM27,TRIP13,TSGA10,TSSK1B,TSSK2,TSSK3,TSSK6,TXNDC2,TYRO3,UBE2B,USP9Y,VCX,WDR33,WFDC2,YBX2,ZNF296,ZNF35	The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
GO:0007286	GO	BP	spermatid development	BBS2,BBS4,CABYR,CASC5,CATSPERD,CEP57,CFTR,CHD5,CIB1,DDX25,DPY19L2,GALNTL5,H1FNT,HIST1H2BA,ING2,IQCF1,MKKS,NME5,PAFAH1B1,PIWIL1,PLD6,PRKACA,PSME4,PTCHD3,PVRL2,RNF8,SLC26A3,SLC26A6,SPAG6,SPANXB1,SRPK1,SYCP3,TDRD5,TNP1,TSSK1B,TSSK2,TSSK6	The process whose specific outcome is the progression of a spermatid over time, from its formation to the mature structure.
GO:0007289	GO	BP	spermatid nucleus differentiation	CHD5,H1FNT,HIST1H2BA,PSME4,SRPK1,SYCP3,TNP1,TSSK6	The specialization of the spermatid nucleus during the development of a spermatid into a mature male gamete competent for fertilization.
GO:0007292	GO	BP	female gamete generation	ANG,BCL2L10,BMP15,BMPR1B,CGB,DIAPH2,DMC1,DYNLL1,EREG,FIGLA,FMN2,FSHB,FSHR,GDF9,HORMAD1,HPGD,KIAA0430,KMT2D,M1AP,MCM8,MCM9,MEI4,PARN,PIWIL2,PLD6,SPO11,TDRD5,TOB2,TRIP13,USP9X,ZNF830,ZP3	Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.
GO:0007338	GO	BP	single fertilization	ACR,ADAM2,ADAM20,ADAM21,ADAM30,ADCY3,AKAP3,AKAP4,ASTL,B4GALT1,BPY2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CD9,CDK1,CLGN,CRISP1,DAZ2,DNALI1,FETUB,GNPDA1,HVCN1,IGSF8,IZUMO1,IZUMO1R,KCNU1,MST1R,NPM2,OR10J1,OVGP1,PKDREJ,PLCB1,ROPN1B,SERPINA5,SLC22A16,SMCP,SPA17,SPAM1,STX2,SYT6,TNP1,TUBGCP3,UBAP2L,UBXN8,WBP2NL,WEE2,ZAN,ZP1,ZP2,ZP3,ZP4	The union of male and female gametes to form a zygote.
GO:0007339	GO	BP	binding of sperm to zona pellucida	ADAM2,ADAM20,ADAM21,ADAM30,B4GALT1,FETUB,OVGP1,SPAM1,UBAP2L,ZAN,ZP1,ZP2,ZP3,ZP4	The process in which the sperm binds to the zona pellucida glycoprotein layer of the egg. The process begins with the attachment of the sperm plasma membrane to the zona pellucida and includes attachment of the acrosome inner membrane to the zona pellucida after the acrosomal reaction takes place.
GO:0007340	GO	BP	acrosome reaction	ACR,ADCY3,AKAP3,PKDREJ,ROPN1B,STX2,SYT6,ZP4	The discharge, by sperm, of a single, anterior secretory granule following the sperm's attachment to the zona pellucida surrounding the oocyte. The process begins with the fusion of the outer acrosomal membrane with the sperm plasma membrane and ends with the exocytosis of the acrosomal contents into the egg.
GO:0007342	GO	BP	fusion of sperm to egg plasma membrane	ADAM2,CD9,CRISP1,IZUMO1,IZUMO1R,ROPN1B,SERPINA5	The binding and fusion of a sperm, having penetrated the zona pellucida, with the plasma membrane of the oocyte. Binding occurs at the posterior (post-acrosomal) region of the sperm head.
GO:0007368	GO	BP	determination of left/right symmetry	AHI1,ARL6,ARMC4,BBS4,BBS5,BBS7,CCDC103,CCDC151,CCDC39,CCDC40,CFC1,CITED2,DAND5,DLL1,DNAAF1,DNAH11,DNAH5,DNAI1,DNAI2,DYX1C1,ENG,FOLR1,FOXH1,FOXN4,GALNT11,GATA4,HAND1,HAND2,IHH,KIF3B,LEFTY1,LRRC6,MEF2C,MEGF8,MESP1,MICAL2,MKKS,NKX2-5,NOTCH1,NPHP3,OFD1,PITX2,PKD1L1,PKD2,RFX3,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX1,TBX2,TBX20,VANGL2,ZIC3	The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
GO:0007369	GO	BP	gastrulation	APELA,ATOH8,BMP4,BMPR2,CDC73,CER1,CRB2,CTR9,EOMES,EYA2,FGF8,FN1,FOXA2,GSC,HMGA2,HOXA11,INHBA,ITGA5,ITGAV,KDM6B,KIF16B,KLF4,LEO1,LHX1,MEGF8,MESP1,MIXL1,MKKS,NANOG,NAT8B,NODAL,NPHP3,NR4A3,OTX2,PAF1,PAX2,POU5F1,RTF1,SCX,SIX2,SMAD2,SNAI1,SOX17,SOX2,SOX7,T,TBX20,TRIM15,VTN,WNT8B	A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
GO:0007379	GO	BP	segment specification	BMI1,COBL,DVL2,MTF2,OSR1,RIPPLY1	The process in which segments assume individual identities; exemplified in insects by the actions of the products of the homeotic genes.
GO:0007389	GO	BP	pattern specification process	ACVR2B,AHI1,AIDA,ARL13B,ARL6,ARMC4,ASCL1,ATP6AP2,BASP1,BBS4,BBS5,BBS7,BCOR,BMI1,BMP2,BMP4,BMPR2,CCDC103,CCDC151,CCDC39,CCDC40,CELSR2,CER1,CFC1,CHRD,CITED2,COBL,COL4A1,CRB2,CTNNB1,CXXC4,CYP26B1,CYP26C1,DAND5,DDIT3,DLL1,DLL4,DNAAF1,DNAH11,DNAH5,DNAI1,DNAI2,DSCAML1,DVL2,DYX1C1,ENG,ERBB4,FBXL15,FGF10,FGFR2,FOLR1,FOXA2,FOXB1,FOXD1,FOXH1,FOXJ1,FOXN4,FZD5,GALNT11,GATA4,GDF2,GLI2,GREM1,HAND1,HAND2,HHEX,HOXA11,HOXB1,HOXD11,HOXD3,HOXD8,IHH,ISL1,KDM2B,KIF3B,LEFTY1,LFNG,LHX1,LMX1B,LRP5,LRP6,LRRC6,MDFI,MEF2C,MEGF8,MESP1,MICAL2,MID1,MKKS,MTF2,NBL1,NKX2-5,NOG,NOTCH1,NOTCH4,NPHP3,NRP1,NTF4,OFD1,OSR1,OTX2,PAX2,PAX8,PBX3,PCSK5,PITX2,PKD1L1,PKD2,PLD6,PPP2R3A,PTCH1,RELN,RFX3,RIPPLY1,RIPPLY2,SEMA3E,SETDB2,SFRP1,SFRP2,SHH,SHROOM3,SIX1,SIX2,SIX3,SKI,SMAD1,SMAD2,SMAD5,SMAD6,SMO,SOX17,SOX18,SRF,STC1,STIL,T,TBX1,TBX2,TBX20,TBX3,TDGF1,TDRD5,TGFBR1,TGFBR2,TTC8,VANGL2,VEGFA,WNT1,WNT7A,WNT8A,WNT8B,WT1,ZIC1,ZIC3	Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
GO:0007398	GO	BP	ectoderm development	AMER2,EDA,EDA2R,KRT6B,LHX1,SMURF1,STX2,VAX2,ZBTB7B	The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.
GO:0007405	GO	BP	neuroblast proliferation	ARTN,DOCK7,EML1,FGF13,FGFR2,NUMB,NUMBL,PAFAH1B1,PLXNB2,RAB10,RACGAP1,SHH,SOX5,TEAD3	The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
GO:0007413	GO	BP	axonal fasciculation	AMIGO1,CDK5R1,CNTN4,EPHA3,EPHA4,EPHB2,EPHB3,MEGF8,NRCAM,RTN4,SEMA5A	The collection of axons into a bundle of rods, known as a fascicle.
GO:0007416	GO	BP	synapse assembly	ACHE,ADGRL3,BDNF,CDK5,DBNL,DNER,DNM3,DRD1,DRD2,DSCAM,DVL1,FARP1,FLRT3,FZD1,FZD5,GPM6A,IL1RAPL1,LRP4,NLGN1,NLGN2,NLGN3,NLGN4X,NRCAM,NRXN1,NRXN2,PCDHB10,PCDHB11,PCDHB13,PCDHB14,PCDHB16,PCDHB2,PCDHB3,PCDHB4,PCDHB5,PCDHB6,PCDHB9,PLXND1,POU4F1,PTEN,PTPRD,RYK,SDK1,SDK2,SHANK2,SHANK3,SLITRK6,SPOCK2,WNT3A,WNT5A,WNT7A	The aggregation, arrangement and bonding together of a set of components to form a synapse.
GO:0007420	GO	BP	brain development	ABCB6,AFF2,AGTPBP1,AGTR2,AHI1,APOD,ARHGAP11B,ARL13B,ARNT2,ATF5,ATP7A,BAG6,BBS2,BBS4,BMP2,BMP4,BPTF,BTBD3,CA10,CBLN1,CCDC85C,CDK5R1,CDK5RAP1,CDK5RAP2,CDK5RAP3,CDK6,CENPF,CEP290,CHD5,CHD8,CHRNB2,CLP1,CNTN4,CNTNAP2,COL3A1,COL4A1,CTNNA2,CTNS,DAB2IP,DDIT4,DLC1,DLL1,DLX2,DMBX1,DOCK7,DRAXIN,DRD1,DRD2,DSCAML1,ECE2,EFHC1,EGR2,EML1,EOMES,EPHA5,EPHA7,EPHB2,EPHB3,ERBB4,FAIM2,FAT4,FGF13,FGFR2,FOXB1,FOXJ1,FOXP2,GHRH,GLI2,GRID2,GSK3B,H2AFY2,HAP1,HES1,HES5,HESX1,HOOK3,HTR6,INHBA,KDM2B,KDM7A,KIF14,LAMB1,LHX1,LHX6,LRP8,LRRK2,MAP1S,MDGA1,MKKS,MYO16,NCOA6,NDE1,NDUFS4,NES,NEUROD1,NEUROD2,NF1,NFIB,NIPBL,NKX2-1,NKX2-2,NKX2-6,NLGN4X,NOG,NR0B1,NRXN1,NTRK2,NUMB,NUMBL,OTX2,PAFAH1B1,PAX2,PCDH18,PCM1,PEX13,PHF8,PHGDH,PHOX2B,PITPNM1,PITX2,PITX3,PLCB1,PLXNB2,POMK,POU6F1,PPT1,PROX1,PTCH1,PTEN,PTF1A,PTPN11,QARS,RAB18,RAB3GAP1,RAPGEF2,RELN,ROBO1,ROBO2,ROGDI,RORA,RTN4,RYK,SALL1,SCN5A,SDF4,SEMA3A,SEMA4C,SEMA5A,SHANK3,SHH,SHROOM2,SHROOM4,SIX3,SKI,SLC23A1,SLC6A17,SLC6A4,SLIT1,SLIT2,SMARCA1,SMO,SOX3,SRGAP2,SRGAP2C,STIL,SZT2,TBR1,TGFBR2,TRAPPC9,TRNP1,TYRO3,UBE3A,UTP3,VAX2,VCX3A,WDR62,WNT1,WNT2,WNT3A,WNT5A,WNT7A,ZIC1,ZIC2,ZNF335	The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
GO:0007422	GO	BP	peripheral nervous system development	ALDH3A2,ARHGEF10,ASIC2,DICER1,EGR2,ERBB3,ETV1,GDNF,GFRA3,GPC1,GSTM3,ISL1,ISL2,MYOC,NCMAP,NEUROG3,NF1,NFASC,PARD3,PMP22,POU4F1,RUNX1,RUNX3,SCN8A,SERPINI1,SIRT2,SKI,SOD1,SOX8,UGT8	The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands.
GO:0007423	GO	BP	sensory organ development	ABCB5,ACVR2B,ACVRL1,ADAMTS18,AGTPBP1,AHI1,ALDH1A3,ATF6,ATOH7,ATP6V1B1,BBS4,BLOC1S3,BMP2,BMPR1B,BMPR2,CEP290,CHD7,CHRDL1,COL4A1,COL5A1,COL5A2,CRYBA4,CRYGD,CYP1B1,DFNB31,DLL1,DSCAM,ECE1,EPHA2,EPHB2,FGFR2,FOXC1,FOXE3,FOXL2,FOXN4,FZD4,GATA3,GDF3,GLI3,GPM6A,GRXCR1,GSC,HDAC1,HDAC2,HES5,HIPK1,HIPK2,HOXA1,HPN,IFT122,IFT140,INHBA,JAG2,KCNQ1,KDM2B,LHX1,LRP5,LRTOMT,MAB21L2,MAFB,MED1,MEGF11,MPV17,MYO7A,NES,NEUROD1,NEUROD4,NF1,NIPBL,NKD1,NKX2-6,NOG,NPHP1,NRP1,NTF4,OSR1,OSR2,PAX2,PAX6,PAX8,PDGFRA,PDGFRB,PHACTR4,PHOX2B,PITX2,PITX3,POU3F4,POU4F2,PPP2R3A,PROM1,PROX1,PRSS56,PTF1A,PTPN11,PTPRM,RAB18,RAB3GAP1,RARG,RBP4,RORB,RP1,SALL1,SALL2,SCO2,SDK1,SDK2,SH3PXD2B,SHROOM2,SIPA1L3,SIX1,SIX3,SIX4,SKI,SLC39A5,SMOC1,SOD1,SOX11,SOX3,SOX8,SOX9,STAT3,STRA6,STRC,TBX1,TBX2,TDRD7,TENM3,TFAP2A,TGFB2,TH,THY1,TOPORS,TSPAN12,TULP1,TWIST1,UNC45B,USH2A,VEGFA,WNT10A,WNT16,WNT2,WNT2B,WNT5A,WNT5B,WNT6,WNT7A,WNT7B,WNT9A,WNT9B,WT1,ZIC1,ZNF513	The process whose specific outcome is the progression of sensory organs over time, from its formation to the mature structure.
GO:0007492	GO	BP	endoderm development	APELA,CDC73,CTR9,EOMES,FN1,GATA4,HMGA2,HOXC11,INHBA,ITGA5,ITGAV,KIF16B,LAMC1,LEO1,LHX1,MIXL1,NANOG,NODAL,PAF1,POU5F1,RTF1,SOX17,SOX2,SOX7,TBX20,VTN	The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
GO:0007498	GO	BP	mesoderm development	APELA,BMP4,BMPR2,BMX,BTK,CITED2,CRB2,DAND5,EOMES,EYA2,FOXC2,FOXH1,GDF11,HCK,HES7,HMGA2,HOXA11,IKZF1,IKZF3,JAK2,KDM6B,KLF4,MATK,MESDC2,MESP1,MEST,NODAL,PAX2,SCX,SECTM1,SHH,SIX2,SMAD2,SMO,SNAI1,T,TBX1,TBX20,TBX3,TBX6,TCF15,TIE1,TRIM15,VEGFA	The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
GO:0007512	GO	BP	adult heart development	BMP10,MYH6,MYH7,NKX2-5,SCUBE1,TCAP	The process whose specific outcome is the progression of the adult heart over time, from its formation to the mature structure.
GO:0007517	GO	BP	muscle organ development	ACHE,ACTA1,ACTC1,AEBP1,ANKRD1,ANKRD2,BASP1,BMP10,BMP2,BVES,CACNA1H,CAPN3,CAV1,CAV2,CAV3,CFLAR,CHD2,CHODL,CHRNA1,CHRND,COL6A3,COPRS,CSRP3,CTF1,CXCL10,DISP1,DLL1,DLL4,DMD,DSP,EGR3,EMD,EVC,FGFR2,FHL1,FHL3,FKBP1A,FKTN,FOXL2,HAND1,HBEGF,HEY2,IGF1,IGSF8,ISL1,ITGA11,ITGA7,ITGB1BP2,KLHL41,LAMA2,LARGE,LEMD2,LMNA,MAPK12,MEF2A,MEF2B,MEF2C,MEF2D,MEGF10,MKX,MRAS,MSTN,MYBPC3,MYF5,MYF6,MYH14,MYH3,MYH6,MYH7,MYL2,MYL3,MYL6,MYL6B,MYLK,MYLK2,MYLPF,MYOD1,MYOG,NEB,NKX2-5,NOTCH1,NRG1,PKP2,POU6F1,PROX1,RBPJ,RYR1,RYR2,S1PR1,SGCA,SGCD,SGCE,SGCG,SIX1,SIX4,SKI,SKIL,SMAD7,SMTN,SOX6,SPEG,SRI,STRA6,SVIL,TAGLN,TAZ,TBX1,TBX20,TCAP,TCF12,TCF21,TEAD4,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,TRIM72,TTN,UTRN,VAMP5,WT1,ZBTB18,ZBTB42,ZFPM1,ZFPM2	The process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work.
GO:0007519	GO	BP	skeletal muscle tissue development	ACTA1,CAV1,CAV2,CFLAR,CHRNA1,CHRND,CSRP3,DLL1,FOXL2,IGSF8,KLHL41,LEMD2,MEF2C,MEGF10,MYF5,MYF6,MYH14,MYL6,MYL6B,MYLK2,MYLPF,MYOD1,MYOG,RYR1,SIX1,SIX4,SKI,SKIL,SVIL,TAZ,TCF21,ZBTB18	The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
GO:0007520	GO	BP	myoblast fusion	ADAM12,ADGRB3,CACNA1H,KCNH1,NOS1,TMEM8C	A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
GO:0007528	GO	BP	neuromuscular junction development	CACNB2,CHRNA1,DNAJA3,DVL1,F2R,LRP4,LRRK2,MUSK,NRD1,ZC4H2	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction.
GO:0007530	GO	BP	sex determination	AMH,CITED2,DMRT1,NR5A1,SIX4,SOX3,SOX9,SRD5A1,SRY,TCF21,WNT4,WT1	Any process that establishes and transmits the specification of sexual status of an individual organism.
GO:0007548	GO	BP	sex differentiation	AMH,AMHR2,ANG,ANKRD7,AR,BASP1,BMPR1B,CBX2,CCDC182,CDKL2,CEBPB,CENPI,CHD7,CSDE1,CYP17A1,DMRT1,DMRT3,DNAJC19,EIF2B2,EIF2B4,EIF2B5,EREG,FGF8,FOXF2,FOXL2,FSHR,GATA1,GATA3,GATA4,HNF1B,HSD17B3,ING2,INHA,INHBA,INHBB,IRX5,KIT,LHB,LHCGR,LHX1,LRRC6,MEA1,MKKS,MSH2,NCOA4,NIPBL,NR0B1,PDGFRA,PRKACG,PTPN11,PTPRN,RAB13,RBMY1B,RBP4,RQCD1,SCX,SHH,SIX4,SOD1,SOX15,SOX8,SOX9,SRD5A2,STRA6,TBX3,TCF21,TSPY1,VEGFA,WNT4,WNT5A,WNT7A,WT1,ZNF830	The establishment of the sex of an organism by physical differentiation.
GO:0007565	GO	BP	female pregnancy	ADCYAP1,AMBP,APOL2,BCL2,BYSL,CALCA,CLIC5,COL16A1,CORIN,CRH,CRHBP,CRHR1,EMP2,EPYC,FSHB,GHRL,GHSR,GNAS,HAVCR2,HPGD,IDO1,IL1B,INSL4,IRG1,LGALS9,LNPEP,NPPA,OVGP1,PAPPA,PCSK5,PPARD,PRL,PRLHR,PRLR,PSG1,PSG11,PSG2,PSG3,PSG4,PSG5,PSG6,PSG7,PSG9,PTHLH,PZP,RLN1,RLN2,RPL29,SCGB1A1,SOD1,SPP1,TAC3,TEAD3,TFCP2L1,TRO	The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
GO:0007566	GO	BP	embryo implantation	CALCA,EMP2,IL1B,IRG1,PCSK5,PPARD,PRLR,RPL29,SCGB1A1,SOD1,SPP1,TRO	Attachment of the blastocyst to the uterine lining.
GO:0007567	GO	BP	parturition	CRH,CRHR1,HPGD,MAFF,PLA2G4B,PLA2G4C,PTGFR	The reproductive process in which the parent is separated from its offspring either by giving birth to live young or by laying eggs.
GO:0007568	GO	BP	aging	ADRA1A,APOD,ARNTL,ATM,ATR,BBC3,CALR,CDKN1A,CDKN2A,CHEK1,CHEK2,CISD2,HMGA1,HMGA2,HRAS,ID2,IDE,KAT6A,KL,KRT14,KRT16,KRT25,KRT33B,KRT83,KRTAP4-3,KRTAP4-5,KRTAP4-7,KRTAP4-8,KRTAP4-9,LIMS1,LOXL2,LRRK2,MAGEA2,MAP2K1,MAPK14,MAPKAPK5,MORC3,MSH6,NOX4,NPM1,NSMCE2,OPA1,PDCD4,PLA2R1,PML,PRKCD,ROMO1,SIRT1,SMC5,SMC6,SOD1,SOD2,SRF,TBX2,TBX3,TERF2,TERT,TP53,TPRA1,ULK3,WNT16,WRN	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death (GO:0016265) and may succeed developmental maturation (GO:0021700).
GO:0007569	GO	BP	cell aging	ARNTL,ATM,ATR,CALR,CDKN1A,CDKN2A,CHEK1,CHEK2,HMGA1,HMGA2,HRAS,ID2,KAT6A,LIMS1,MAGEA2,MAP2K1,MAPK14,MAPKAPK5,MORC3,NOX4,NPM1,NSMCE2,OPA1,PDCD4,PLA2R1,PML,PRKCD,ROMO1,SIRT1,SMC5,SMC6,SOD1,SRF,TBX2,TBX3,TERF2,TERT,TP53,ULK3,WNT16,WRN	An aging process that has as participant a cell after a cell has stopped dividing. Cell aging may occur when a cell has temporarily stopped dividing through cell cycle arrest (GO:0007050) or when a cell has permanently stopped dividing, in which case it is undergoing cellular senescence (GO:0090398). May precede cell death (GO:0008219) and succeed cell maturation (GO:0048469).
GO:0007584	GO	BP	response to nutrient	AQP3,CDKN2B,CDKN2D,CHMP1A,CYP24A1,CYP27B1,ENSA,FOLR1,FOLR2,FOXA2,GAS6,GCGR,GIPR,GNAI2,HLCS,KYNU,MTOR,NCOA1,NR1H4,OGT,PDK2,PIM1,PPARG,SPP1,SST,SSTR1,SSTR2,USF1,USF2,VDR,XBP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
GO:0007585	GO	BP	respiratory gaseous exchange	BPGM,CFTR,COX11,COX15,COX5B,CSF2RB,CYSLTR1,ECEL1,EDNRA,ELN,GAA,HNMT,NDUFA12,TMPRSS11D,UCP3	The process of gaseous exchange between an organism and its environment. In plants, microorganisms, and many small animals, air or water makes direct contact with the organism's cells or tissue fluids, and the processes of diffusion supply the organism with dioxygen (O2) and remove carbon dioxide (CO2). In larger animals the efficiency of gaseous exchange is improved by specialized respiratory organs, such as lungs and gills, which are ventilated by breathing mechanisms.
GO:0007586	GO	BP	digestion	ABCG5,ABCG8,ACE,ACE2,ADRA2A,AKR1B10,AKR1C1,AKR1C2,AKR1D1,AMY1A,AMY2A,AMY2B,APOA4,CCKAR,CCKBR,CD36,CEL,CELA3A,CHIA,CLPS,COPA,CTRL,CTSE,CYP39A1,ENPEP,F11R,FABP2,GALR1,GALR2,GKN1,HTR3A,KCNQ1,LCT,LDLR,LEP,LIPC,LIPG,LIPH,LIPI,LIPK,LIPM,LIPN,LMF1,MEP1A,MEP1B,MGAM,MLNR,MUC13,MUC4,MUC6,NMU,NOD2,NPC1L1,NPY4R,PBLD,PLA2G1B,PNLIP,PNLIPRP2,PPARGC1A,PPY,PRSS3,PYY,RBP4,SCT,SCTR,SERPINA3,SI,SLC15A1,SLC26A6,SLC46A1,SOAT2,SOX9,SST,SSTR1,SSTR2,STATH,STRAP,SULT2A1,TFF1,TFF2,TFF3,TJP2,TLR4,TLR9,TREH,UCN2,UGT1A1,VIPR1	The whole of the physical, chemical, and biochemical processes carried out by multicellular organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
GO:0007588	GO	BP	excretion	ABCG5,ABCG8,ADORA2B,AQP2,AQP3,AQP5,AQP6,AQP7,AQP9,ATP6V0A4,ATP6V1B1,AVPR2,CHRNA3,CHRNB2,CHRNB4,CLCN5,CLCNKA,CLCNKB,CLDN16,GRHPR,HMOX1,KCNJ1,KCNK5,KCNMA1,NEDD4L,NFAT5,NPHP1,NPHS1,SCNN1B,SCNN1G,SCTR,SLC22A18,SLC26A3,TACR2,UGT1A7,UNC13B	The elimination by an organism of the waste products that arise as a result of metabolic activity. These products include water, carbon dioxide (CO2), and nitrogenous compounds.
GO:0007589	GO	BP	body fluid secretion	AGR2,APLN,CEL,COPA,CSN2,CSN3,ERBB4,FGF10,FOXB1,GPAT4,GUCA1B,LACRT,NPPB,NPR1,OXTR,PRLR,SCT,SLC22A2,SLC22A4,STATH,VAMP8,VEGFA,VIP	The controlled release of a fluid by a cell or tissue in an animal.
GO:0007595	GO	BP	lactation	APLN,CSN2,CSN3,ERBB4,FOXB1,GPAT4,OXTR,PRLR,VEGFA	The secretion of milk by the mammary gland.
GO:0007597	GO	BP	blood coagulation, intrinsic pathway	A2M,APOH,C1QBP,F10,F11,F12,F2,F8,F9,GP1BA,GP1BB,GP5,GP9,KLKB1,KNG1,PRCP,SERPING1,VWF	A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.
GO:0007598	GO	BP	blood coagulation, extrinsic pathway	F10,F3,F7,F9,TFPI	A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
GO:0007601	GO	BP	visual perception	ABLIM1,AOC2,ATF6,ATXN7,BBS2,BEST1,CABP4,CACNA1F,CACNA2D4,CHRNB2,CNGB1,COL11A1,COL18A1,COL1A1,COL2A1,CRYAA,CRYBA1,CRYBA4,CRYBB1,CRYBB3,CRYGA,CRYGB,CRYGC,CRYGD,CRYZ,CYP1B1,DHRS3,DNAJC19,DRAM2,EFEMP1,EML2,EYA3,EYA4,EYS,FSCN2,GJA3,GJA8,GNAT1,GNAT2,GPR143,GPR179,GRM6,GRM8,GUCA1C,GUCY2F,IMPG1,IMPG2,KIFC3,KRT12,MYO7A,MYO9A,OAT,OCLM,OPA1,OPA3,PAX2,PAX6,PITPNA,POU4F3,POU6F2,PRR4,RABGGTA,RABGGTB,RAX,RBP3,RDH10,RDH12,RGS16,RP2,RPE65,RPGR,SDR16C5,SFRP5,SIX3,SIX6,SLC24A1,TH,TRPM1,TULP1,TULP2,TYR,VAX2,WFS1,ZIC2	The series of events required for an organism to receive a visual stimulus, convert it to a molecular signal, and recognize and characterize the signal. Visual stimuli are detected in the form of photons and are processed to form an image.
GO:0007602	GO	BP	phototransduction	ABCA4,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CALM1,CAMKMT,CDS1,CHRM1,CLPS,CNGA1,CNGB1,CYP4V2,DHRS3,FNTA,FNTB,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNB5,GNGT1,GNGT2,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,METAP1,METAP2,NAPEPLD,NMT1,NMT2,NR2E3,OPN1LW,OPN1MW,OPN1SW,OPN3,OPN4,PDC,PDE6A,PDE6B,PDE6G,PITPNM1,PLB1,PLEKHB1,PNLIP,PPEF1,PRKCA,PRKCQ,RBP1,RBP2,RBP3,RBP4,RCVRN,RDH10,RDH11,RDH12,RDH5,RDH8,RGS9,RGS9BP,RHO,RLBP1,RP1,RPE65,SAG,SDC1,SDC2,SDC3,SDC4,SLC24A1,STRA6,TRPC3,TTR,UNC119	The sequence of reactions within a cell required to convert absorbed photons into a molecular signal.
GO:0007603	GO	BP	phototransduction, visible light	ABCA4,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CALM1,CAMKMT,CHRM1,CLPS,CNGA1,CNGB1,CYP4V2,DHRS3,FNTA,FNTB,GNA11,GNAQ,GNAT1,GNB1,GNB5,GNGT1,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,METAP1,METAP2,NAPEPLD,NMT1,NMT2,OPN1LW,OPN1MW,OPN1SW,PDE6A,PDE6B,PDE6G,PLB1,PNLIP,PPEF1,PRKCA,PRKCQ,RBP1,RBP2,RBP3,RBP4,RCVRN,RDH10,RDH11,RDH12,RDH5,RDH8,RGS9,RGS9BP,RHO,RLBP1,RP1,RPE65,SAG,SDC1,SDC2,SDC3,SDC4,SLC24A1,STRA6,TTR	The sequence of reactions within a cell required to convert absorbed photons from visible light into a molecular signal. A visible light stimulus is electromagnetic radiation that can be perceived visually by an organism; for organisms lacking a visual system, this can be defined as light with a wavelength within the range 380 to 780 nm.
GO:0007605	GO	BP	sensory perception of sound	ALDH7A1,ATP2B2,ATP6V0A4,ATP6V1B1,CACNA1D,CDH23,CEACAM16,CEMIP,CHRNB2,CLIC5,CLRN1,COL11A1,COL11A2,COL1A1,COL2A1,COL4A3,CRYM,DCDC2,DFNA5,DFNB31,EML2,EYA1,FAM65B,GRM7,GRXCR1,GRXCR2,HOXA1,HPN,KCNE1,KCNQ1,KIT,KPTN,LOXHD1,LRTOMT,MARVELD2,MKKS,MYH14,MYO1A,MYO3A,MYO7A,NDP,NDUFB9,NIPBL,OTOR,P2RX2,PAX3,PCDH15,SERPINB6,SLC26A4,SLC26A5,SLC52A3,SNAI2,SOD1,SPTBN4,TBL1X,TBX1,TFAP2A,TIMM10,TIMM13,TIMM8B,TIMM9,TPRN,TSPEAR,USH1C,USH1G,USH2A,WDR1,WFS1,ZNF354A	The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.
GO:0007606	GO	BP	sensory perception of chemical stimulus	ADCY3,ASIC1,ASIC2,ASIC3,AZGP1,BBS4,BEST2,C5AR1,CA6,CALHM1,CD36,CST1,CST2,CST4,DRD2,GFY,GNAS,LPO,MKKS,OBP2A,OBP2B,OR10A3,OR10A5,OR10J1,OR1C1,OR1D2,OR1D5,OR1E1,OR1E2,OR1Q1,OR2C1,OR2D2,OR2H2,OR2M4,OR2S2,OR3A1,OR3A2,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR7A5,OR8B8,OR8G1,PIGR,PIP,PKD1L3,PKD2L1,RTP3,RTP4,SLC24A4,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R60,TAS2R7,TAS2R8,TAS2R9,UBR3	The series of events required for an organism to receive a sensory chemical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
GO:0007608	GO	BP	sensory perception of smell	ADCY3,BBS4,BEST2,DRD2,GFY,GNAS,MKKS,OBP2B,OR10A3,OR10A5,OR1C1,OR1D2,OR1D5,OR1E1,OR1Q1,OR2C1,OR2D2,OR2H2,OR2M4,OR2S2,OR3A1,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR7A5,OR8B8,OR8G1,SLC24A4,UBR3	The series of events required for an organism to receive an olfactory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Olfaction involves the detection of chemical composition of an organism's ambient medium by chemoreceptors. This is a neurological process.
GO:0007610	GO	BP	behavior	ABAT,ABCA7,ACE2,ADCY3,ADCY8,AGRP,ANKH,APP,ATAD1,ATP7A,BBS2,BBS4,BHLHB9,BRS3,C1QL1,CALB1,CAMK4,CARTPT,CASR,CCK,CCKAR,CCKBR,CCL3,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CIART,CLDN5,CLN3,CNTNAP2,CPEB3,CRH,CRHBP,CUX2,DLG4,DRD1,DRD2,DRD3,DRD4,DYNLRB1,EGFR,EIF2AK4,EIF4EBP2,FGF13,FOXA2,FOXB1,FYN,GALR2,GALR3,GCG,GDNF,GHRL,GHSR,GRID1,GRIN1,GRIN2A,GRIN2B,HOXA1,HPGDS,HTR1A,HTR2C,ID2,KLK8,LEP,LRRK2,MAPK8IP2,MBD5,MCHR1,MEF2C,MKKS,MRAP2,MTA1,MTNR1A,MUSK,MYH14,NETO1,NF1,NLGN3,NLGN4X,NLGN4Y,NMUR2,NOVA1,NPHP1,NPHP4,NPW,NPY,NPY2R,NPY4R,NRXN1,NRXN2,NRXN3,NTF4,NTRK2,OBP2B,OPRK1,OPRM1,PAFAH1B1,PARK2,PEX13,PJA2,PLCB1,PLK2,PMCH,PPP3CB,PTEN,PTPRZ1,PUM1,PYY,QRFP,RASD2,RASGRF1,RGS14,S100B,SGK1,SHANK1,SHANK2,SHANK3,SLC6A4,SLC8A2,SLC8A3,SOD1,SPTBN4,STAT3,STRA6,STRN,TAS2R1,TAS2R5,TBX1,TH,THBS1,THBS4,TP53,TRPV1,TSC1,UBR3,USP2,VLDLR	The internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.
GO:0007611	GO	BP	learning or memory	ABCA7,ADCY3,ADCY8,APP,ATAD1,BHLHB9,CALB1,CAMK4,CHRNA7,CHRNB2,CLDN5,CLN3,CNTNAP2,CPEB3,CRH,CRHBP,CUX2,DLG4,DRD1,DRD2,DRD3,EGFR,EIF2AK4,EIF4EBP2,FGF13,FOXB1,FYN,GALR2,GALR3,GRIN1,GRIN2A,GRIN2B,KLK8,MAPK8IP2,MEF2C,MUSK,NETO1,NF1,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,NTF4,NTRK2,PAFAH1B1,PJA2,PLCB1,PLK2,PPP3CB,PTEN,PTPRZ1,RASGRF1,RGS14,S100B,SGK1,SHANK1,SHANK2,SHANK3,SLC8A2,SLC8A3,STRA6,TH,VLDLR	The acquisition and processing of information and/or the storage and retrieval of this information over time.
GO:0007612	GO	BP	learning	ADCY3,APP,ATAD1,CHRNB2,CLDN5,CLN3,CNTNAP2,DLG4,DRD1,DRD2,DRD3,EIF2AK4,FGF13,FOXB1,FYN,GRIN1,MAPK8IP2,NETO1,NF1,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,NTRK2,PPP3CB,RGS14,SHANK1,SHANK2,SHANK3,SLC8A2,SLC8A3,STRA6,TH	Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience.
GO:0007613	GO	BP	memory	ABCA7,ATAD1,CALB1,CAMK4,CHRNA7,CHRNB2,CPEB3,CUX2,EIF2AK4,EIF4EBP2,FGF13,KLK8,MUSK,NETO1,NTF4,PJA2,PLCB1,PLK2,PPP3CB,RASGRF1,RGS14,SGK1,SHANK1,SHANK3,SLC8A2,SLC8A3,TH,VLDLR	The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).
GO:0007616	GO	BP	long-term memory	CALB1,CAMK4,CPEB3,EIF2AK4,NTF4,PJA2,RASGRF1,RGS14,SGK1,SHANK1	The memory process that deals with the storage, retrieval and modification of information a long time (typically weeks, months or years) after receiving that information. This type of memory is typically dependent on gene transcription regulated by second messenger activation.
GO:0007618	GO	BP	mating	APP,DRD1,EDDM3A,KLK14,MTNR1A,OR2H2,SEMG1,TAC1	The pairwise union of individuals for the purpose of sexual reproduction, ultimately resulting in the formation of zygotes.
GO:0007623	GO	BP	circadian rhythm	AANAT,AHR,ARNTL,ARNTL2,ATF4,AVP,BHLHE40,BHLHE41,BTRC,CARTPT,CIART,CLOCK,CPT1A,CREB1,CRY1,CRY2,CSNK1D,CSNK1E,CUL1,DBP,DRD2,DRD3,DYRK1A,EGR3,EP300,F7,FBXL3,GFPT1,GSK3B,HDAC1,HDAC2,HDAC3,HEBP1,HNRNPD,HNRNPU,ID2,KDM5A,KMT2A,LGR4,MAGED1,MC3R,METTL3,MTA1,MYBBP1A,NAMPT,NCOA2,NCOR1,NGFR,NOCT,NONO,NPAS2,NR1D1,NRIP1,OGT,PER1,PER2,PML,PPARA,PPARGC1A,PPP1CA,PPP1CB,PPP1CC,PRKCDBP,PRMT5,PTEN,RAI1,RBM4,RBM4B,RELB,RORA,RORC,RPS27A,SERPINE1,SIRT1,SKP1,SREBF1,TIMELESS,TNFRSF11A,TOP1,TP53,UBA52,UBB,UBC,USP2,ZFHX3	Any biological process in an organism that recurs with a regularity of approximately 24 hours.
GO:0007626	GO	BP	locomotory behavior	ANKH,APP,ATP7A,C1QL1,CHRNA3,CHRNB2,CIART,DRD1,DRD2,DRD3,DRD4,FOXA2,GDNF,HPGDS,ID2,MTA1,NOVA1,NPY2R,NTF4,OPRK1,PAFAH1B1,PARK2,PEX13,PTEN,PUM1,QRFP,RASD2,SOD1,SPTBN4,STRN,TH,TSC1,USP2	The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions.
GO:0007631	GO	BP	feeding behavior	ACE2,AGRP,BRS3,CARTPT,CCK,CCKAR,CCKBR,FYN,GALR2,GALR3,GCG,GHRL,GHSR,HTR2C,LEP,MCHR1,MRAP2,NMUR2,NPW,NPY,NPY4R,PEX13,PMCH,PYY,STAT3,STRA6,UBR3	Behavior associated with the intake of food.
GO:0007632	GO	BP	visual behavior	APP,CHRNB2,DRD1,DRD2,DRD3,DYNLRB1,FOXB1,GRIN1,HOXA1,NETO1,NF1,NPHP1,NPHP4,RGS14	The behavior of an organism in response to a visual stimulus.
GO:0007635	GO	BP	chemosensory behavior	ADCY3,CASR,OBP2B,TAS2R1,TAS2R5,TRPV1	Behavior that is dependent upon the sensation of chemicals.
GO:0008009	GO	MF	chemokine activity	C5,CCL11,CCL13,CCL19,CCL21,CCL23,CCL24,CCL25,CCL28,CCL3,CCL5,CCL7,CKLF,CX3CL1,CXCL10,CXCL11,CXCL12,CXCL13,CXCL16,CXCL3,CXCL8,CXCL9,PF4,XCL1	The function of a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria.
GO:0008013	GO	MF	beta-catenin binding	AMER1,APC2,AR,ASH2L,AXIN1,AXIN2,BCL9L,BTRC,CARM1,CBY1,CDH1,CDH2,CHD8,DACT1,DACT2,DLG5,DVL3,FOXO1,FOXO4,GRIP1,KANK1,LEF1,NR4A2,PARK2,PIN1,SALL1,SETD1A,SHROOM2,SKP1,TCF7,TCF7L2,VCL	Interacting selectively and non-covalently with the beta subunit of the catenin complex.
GO:0008016	GO	BP	regulation of heart contraction	ABCC9,ACE2,ADRA1A,ADRBK1,AGT,AGTR2,AHCYL1,AKAP9,ANK2,ASPH,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2A3,ATP2B1,ATP2B2,ATP2B3,ATP2B4,BMP10,CACNA1C,CACNA1D,CACNA1F,CACNA1H,CACNA1S,CACNA2D1,CACNA2D2,CACNA2D3,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG1,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,CALM1,CAMK2D,CASQ1,CASQ2,CAV1,CAV3,CELF2,CLIC2,CORIN,CSRP3,CTNNA3,CXADR,CYP2J2,DES,DMD,DMPK,DRD2,DSC2,DSG2,DSP,EDN1,EDN2,EDN3,FKBP1B,FOXN4,FXYD1,FXYD2,FXYD3,FXYD4,FXYD6,FXYD7,GJA1,GJA5,GJC1,GLRX3,GPD1L,GSK3A,GSTM2,GSTO1,HCN4,HRC,HSPB7,ITPR1,ITPR2,ITPR3,JUP,KCNA5,KCND1,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNG2,KCNH2,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ11,KCNJ12,KCNJ14,KCNJ2,KCNJ4,KCNK1,KCNK15,KCNK3,KCNK6,KCNQ1,MEF2A,MYH6,MYH7,MYL2,MYL3,MYL4,NKX2-5,NOS1,NOS1AP,NPPA,NPPC,NPR1,NPR2,ORAI1,P2RX4,PDE4B,PDE4D,PIK3CG,PKP2,PLN,PRKACA,RANGRF,RGS2,RNF207,RYR1,RYR2,RYR3,S100A1,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SLC8A2,SLC8A3,SLC9A1,SMAD7,SNTA1,SPTBN4,SPX,SRI,STC1,STIM1,TBX2,TGFB2,TH,TMEM65,TNNI3,TNNI3K,TNNT2,TPM1,TRDN,TRPC1,YWHAE,ZC3H12A	Any process that modulates the frequency, rate or extent of heart contraction. Heart contraction is the process in which the heart decreases in volume in a characteristic way to propel blood through the body.
GO:0008017	GO	MF	microtubule binding	APC,ARHGEF2,ARL3,BCL2L11,BIRC5,CAMSAP1,CAMSAP2,CAMSAP3,CAPN6,CCDC88A,CCSAP,CDK5RAP2,CHP1,CLASP1,CLASP2,CLIP1,CLIP3,CRIPT,DCX,DNM2,DST,DYNC1I1,EML1,EML2,EZR,FAM175B,FAM83D,FGF13,FNTA,FTCD,GABARAPL2,GAPDH,GAS2L1,GAS2L2,GAS2L3,GOLGA2,HDAC6,HOOK3,KATNA1,KATNB1,KIF14,KIF18A,KIF20B,KIF23,KIF26A,KIF2C,KIF5B,KRIT1,LRPPRC,LRRK2,MAP10,MAP1S,MAP7D3,MAPRE1,MAPRE3,MAPT,MARK4,MDM1,MID1,MID2,MTCL1,MTUS2,NDE1,NDRG1,NEFH,NEFM,NME8,PAFAH1B1,PEX14,PLK1,POLB,PRNP,PSRC1,RAB11A,RACGAP1,RAE1,RCC2,REEP1,REEP4,RGS14,RP1,RPS3,S100A8,S100A9,SAXO1,SBDS,SGIP1,SKA1,SKA2,SPAST,STARD9,STIM1,SUN2,TERF1,TPPP,TRPV4,TUBGCP5,TUBGCP6,UXT,VAPA,VAPB,WHAMM,ZNF207	Interacting selectively and non-covalently with microtubules, filaments composed of tubulin monomers.
GO:0008021	GO	CC	synaptic vesicle	AMPH,BRSK1,CDK16,CLCN3,CLN3,COPS4,COPS5,DLG4,DMXL2,DTNBP1,GABRA2,GIPC1,GRIN1,HCRT,ICA1,MME,MT3,MTMR2,OTOF,PPT1,PTPRN,PTPRN2,RAB11B,RAB3A,RAB5A,RPH3A,SEMA4C,SEPT5,SLC17A6,SLC17A7,SLC17A8,SLC18A2,SLC30A3,SLC32A1,SLC6A17,SNAPIN,SNCAIP,SV2A,SV2B,SV2C,SVOP,SYN1,SYN2,SYN3,SYNGR3,SYP,SYT1,SYT11,SYT2,TMEM163,TOR1A,TPRG1L,TRAPPC4,VAMP1,VAMP2,VTI1A,VTI1B	A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
GO:0008022	GO	MF	protein C-terminus binding	BAIAP2,BAIAP3,BCAM,CAV3,CSK,CTBP1,DGKZ,EFHC1,EP300,HSPB7,IFT46,IFT52,ITGB3BP,KSR1,MAGI1,MAP2K1,MAPRE1,MLLT4,PXK,SAE1,SASH1,SHANK1,SHANK3,TOPBP1,TRIM3	Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxy function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
GO:0008023	GO	CC	transcription elongation factor complex	AFF1,AFF4,CCNT1,CDC73,CDK9,CTR9,EAF1,EAF2,ELL,ELL2,ELL3,ELP2,ELP3,ELP4,ERCC6,ICE1,ICE2,IKBKAP,LEO1,MLLT1,MLLT3,MMS22L,NELFA,NELFB,NELFCD,NELFE,NUFIP1,PAF1,PEX2,RTF1,SNW1,SUPT4H1,SUPT5H,TAF7,TCEA2,TONSL,TTF2,WDR61,ZC3H8	Any protein complex that interacts with RNA polymerase II to increase (positive transcription elongation factor) or reduce (negative transcription elongation factor) the rate of transcription elongation.
GO:0008026	GO	MF	ATP-dependent helicase activity	ASCC3,BLM,BRIP1,CHD1,CHD1L,CHD2,CHD3,CHD4,DDX1,DDX18,DDX20,DDX21,DDX23,DDX25,DDX39B,DDX3X,DDX43,DDX54,DDX56,DHX8,DHX9,EIF4A3,G3BP1,HELB,IGHMBP2,MCM4,MCM6,MCM7,MOV10L1,MRE11A,NBN,PIF1,RAD50,RECQL,RECQL4,RTEL1,RUVBL2,SKIV2L,SNRNP200,SUPV3L1,UPF1,WRN	Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.
GO:0008028	GO	MF	monocarboxylic acid transmembrane transporter activity	ABCB11,AKR1C4,SLC16A1,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC1A4,SLC22A16,SLC22A4,SLC22A5,SLC26A6	Enables the transfer of monocarboxylic acids from one side of the membrane to the other. A monocarboxylic acid is an organic acid with one COOH group.
GO:0008033	GO	BP	tRNA processing	AAAS,AARS,ADAT1,ADAT2,ADAT3,ALKBH8,C14orf166,C2orf49,CDKAL1,CLP1,CPSF1,CPSF4,CSTF2,CTU1,CTU2,DDX1,DUS2,ELAC2,EPRS,FAM98B,FARS2,GTPBP3,HSD17B10,KARS,KIAA0391,KIAA1456,LAGE3,LCMT2,METTL1,METTL2A,METTL2B,MOCS3,MTO1,NDC1,NSUN2,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,OSGEP,POM121,POM121C,POP1,POP4,POP5,POP7,PTCD1,PUS1,PUS7,QTRT1,QTRTD1,RAE1,RAN,RANBP2,RPP14,RPP21,RPP25,RPP30,RPP38,RPP40,RTCB,SARS,SEH1L,SSB,THG1L,TP53RK,TPR,TPRKB,TRDMT1,TRIT1,TRMT1,TRMT10A,TRMT10C,TRMT11,TRMT112,TRMT12,TRMT13,TRMT44,TRMT5,TRMT6,TRMT61A,TRMT61B,TRMU,TRNT1,TSEN15,TSEN2,TSEN34,TSEN54,TYW1,TYW3,TYW5,URM1,WDR4,XPOT,ZBTB8OS	The process in which a pre-tRNA molecule is converted to a mature tRNA, ready for addition of an aminoacyl group.
GO:0008037	GO	BP	cell recognition	ADAM2,ADAM20,ADAM21,ADAM30,AMIGO1,APP,B4GALT1,CADM1,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCL19,CCL21,CCR7,CD209,CD226,CD5,CD6,CDK5R1,CLEC4M,CLEC7A,CNTN4,CNTNAP2,CNTNAP3,COLEC12,CRTAM,CSGALNACT1,DSCAM,EPHA3,EPHA4,EPHB2,EPHB3,FCN1,FCN2,FCN3,FETUB,FUT3,HVCN1,IZUMO1,IZUMO1R,KCNU1,LAMA5,MEGF8,NCR3,NRCAM,NTM,OPCML,OVGP1,PCDH12,PECAM1,PRF1,ROBO1,ROBO2,ROBO3,RTN4,SCARB1,SEMA5A,SPAM1,ST6GALNAC6,UBAP2L,VCAN,ZAN,ZP1,ZP2,ZP3,ZP4	The process in which a cell in an organism interprets its surroundings.
GO:0008038	GO	BP	neuron recognition	AMIGO1,APP,CDK5R1,CNTN4,CNTNAP2,DSCAM,EPHA3,EPHA4,EPHB2,EPHB3,MEGF8,NRCAM,NTM,OPCML,PCDH12,ROBO1,ROBO2,ROBO3,RTN4,SEMA5A	The process in which a neuronal cell in a multicellular organism interprets its surroundings.
GO:0008045	GO	BP	motor neuron axon guidance	CHN1,EPHA4,LHX1,LHX9,SLIT1,SLIT2	The process in which the migration of an axon growth cone of a motor neuron is directed to a specific target site in response to a combination of attractive and repulsive cues.
GO:0008053	GO	BP	mitochondrial fusion	BAX,CHCHD3,FAM73A,FAM73B,FIS1,GDAP1,MFF,MFN1,MFN2,OPA1,PLD6,STOML2,USP30	Merging of two or more mitochondria within a cell to form a single compartment.
GO:0008061	GO	MF	chitin binding	CHI3L1,CHI3L2,CHIA,CHIT1,FIBCD1	Interacting selectively and non-covalently with chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues.
GO:0008064	GO	BP	regulation of actin polymerization or depolymerization	ABI2,ACTN2,ACTR2,ACTR3,ADD1,ADD2,ALOX15,ARF1,ARF6,ARFGEF1,ARHGAP18,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPIN,BAIAP2L1,BRK1,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CFL2,CORO1A,CORO1B,CSF3,CTTN,CXCL12,CYFIP1,EPS8,F2RL1,FAM21C,FER,GSN,HAX1,HCK,HCLS1,IQGAP2,JMY,KANK1,LATS1,LIMA1,LRRC16A,MAGEL2,MTPN,MYADM,NCK1,NCK2,NCKAP1,NCKAP1L,PAK3,PDXP,PFN1,PFN2,PICK1,PLEK,PLEKHH2,PRKCD,PRKCE,PTK2B,PYCARD,RASA1,SCIN,SEMA5A,SH3BGRL3,SLIT2,TENM1,TMSB4Y,TRIM27,TRIOBP,TWF1,TWF2,VASP,VIL1,WASF1,WASH1,WHAMM	Any process that modulates the frequency, rate or extent of the assembly or disassembly of actin filaments by the addition or removal of actin monomers from a filament.
GO:0008066	GO	MF	glutamate receptor activity	GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN3A,GRM1,GRM2,GRM3,GRM4,GRM5,GRM6,GRM7,GRM8,PTK2B	Combining with glutamate and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0008076	GO	CC	voltage-gated potassium channel complex	ABCC8,ABCC9,AKAP9,AMIGO1,CNTNAP1,CNTNAP2,CTTN,DLG2,DLG4,DPP6,HCN2,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNH4,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ1,KCNJ11,KCNJ14,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN4,KCNQ1,KCNS1,KCNS2,LRRC26,NOS1AP,SNAP25,STX1A,SUMO1,VAMP2	A protein complex that forms a transmembrane channel through which potassium ions may cross a cell membrane in response to changes in membrane potential.
GO:0008080	GO	MF	N-acetyltransferase activity	AANAT,ATAT1,ATF2,BRCA2,CLOCK,CREBBP,CSRP2BP,ELP3,ELP4,EP300,EPC1,GNPNAT1,HAT1,HCFC1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,MCRS1,NAA10,NAA11,NAA16,NAA30,NAA50,NAA60,NAGS,NAT8,NAT8B,NAT8L,NCOA3,OGT,PHF20,SAP130,SAT2,SMARCE1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,USP22,WDR5	Catalysis of the transfer of an acetyl group to a nitrogen atom on the acceptor molecule.
GO:0008081	GO	MF	phosphoric diester hydrolase activity	APEX1,BDKRB2,C3AR1,CASR,CCKBR,CCL5,CCR1,CCR5,CHRM1,CHRM3,CHRM5,EDNRA,ENPP1,ENPP6,ENPP7,F2RL2,GDE1,GPLD1,MPPE1,PDE10A,PDE11A,PDE1A,PDE1B,PDE1C,PDE2A,PDE3B,PDE4A,PDE4B,PDE4D,PDE5A,PDE6A,PDE6B,PDE7A,PDE8A,PDE8B,PDE9A,PDIA3,PLCB1,PLCB2,PLCB3,PLCB4,PLCE1,PLCG1,PLCG2,PLCH1,PLCL1,PLD4,PLD6,SMPD4,TDP1,TDP2	Catalysis of the hydrolysis of a phosphodiester to give a phosphomonoester and a free hydroxyl group.
GO:0008083	GO	MF	growth factor activity	AGT,AMBN,AMELX,ANGPTL3,CECR1,CLCF1,CLEC11A,CNTF,CSF1,CSPG5,DKK1,EGF,ENDOU,EPGN,F2,FGF1,FGF10,FGF2,FGF8,GRN,HBEGF,HGF,IGF2,IL10,IL11,IL12A,IL12B,IL2,IL4,IL6,IL7,INHA,INHBA,JAG1,JAG2,LACRT,LIF,MDK,NDP,NRG1,NRG3,NTF3,NUDT6,OSGIN1,OSM,PDGFA,PDGFB,PGF,REG1A,TDGF1,TGFA,THPO,VEGFA	The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
GO:0008088	GO	BP	axo-dendritic transport	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,APBA1,APP,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,DTNBP1,HAP1,HIF1A,KIF1A,KIF1B,KIF3B,KIF4A,MGARP,NEFL,OPA1,PAFAH1B1,SNAPIN,SOD1	The directed movement of organelles or molecules along microtubules in neuron projections.
GO:0008089	GO	BP	anterograde axonal transport	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,DTNBP1,HAP1,KIF1A,KIF1B,KIF3B,KIF4A,MGARP,NEFL,SNAPIN,SOD1	The directed movement of organelles or molecules along microtubules from the cell body toward the cell periphery in nerve cell axons.
GO:0008090	GO	BP	retrograde axonal transport	HAP1,MGARP,NEFL,PAFAH1B1,SOD1	The directed movement of organelles or molecules along microtubules from the cell periphery toward the cell body in nerve cell axons.
GO:0008091	GO	CC	spectrin	EPB41,EPB41L2,SPTA1,SPTAN1,SPTBN2,SPTBN4,SPTBN5	Membrane associated dimeric protein (240 and 220 kDa) of erythrocytes. Forms a complex with ankyrin, actin and probably other components of the membrane cytoskeleton, so that there is a mesh of proteins underlying the plasma membrane, potentially restricting the lateral mobility of integral proteins.
GO:0008093	GO	MF	cytoskeletal adaptor activity	ABI2,ANK1,BICD1,BIN3,GAS2L1,GAS2L2,NCK1,NCK2,OBSL1,SDCBP,SORBS2	The binding activity of a molecule that brings together a cytoskeletal protein and one or more other molecules, permitting them to function in a coordinated way.
GO:0008094	GO	MF	DNA-dependent ATPase activity	ASCC3,ATRX,BLM,BPTF,BRIP1,CCNH,CDK7,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD6,CHD8,DDX11,DDX3X,DHX36,DHX9,DNA2,ERCC2,ERCC3,ERCC6,FBXO18,G3BP1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HELB,IGHMBP2,MCM4,MCM6,MCM7,MNAT1,MRE11A,NBN,PIF1,POLQ,RAD50,RAD51,RAD51B,RAD51D,RAD54B,RBBP4,RECQL,RECQL4,RFC3,RTEL1,RUVBL2,SMARCA1,SMARCA2,SMARCA4,SMARCAL1,TOP2A,TOP2B,TTF2,WRN	Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction requires the presence of single- or double-stranded DNA, and it drives another reaction.
GO:0008105	GO	BP	asymmetric protein localization	COLQ,ERBB2IP,GOPC,MAL,RAB10,SHROOM2,SHROOM3,VANGL2	Any process in which a protein is transported to, or maintained in, a specific location such that it is distributed asymmetrically.
GO:0008106	GO	MF	alcohol dehydrogenase (NADP+) activity	AKR1A1,AKR1C1,AKR1C2,AKR1C3,AKR7A2,ALDH3A1,RDH11	Catalysis of the reaction: an alcohol + NADP+ = an aldehyde + NADPH + H+.
GO:0008131	GO	MF	primary amine oxidase activity	AOC1,AOC3,MAOA,MAOB,VCAM1	Catalysis of the reaction: a primary amine + H2O + O2 = an aldehyde + NH3 + hydrogen peroxide.
GO:0008134	GO	MF	transcription factor binding	AIP,ANKRD2,APBB1,APBB2,ARHGEF2,ARNT2,ASXL1,ATF2,ATF7,BCL10,BHLHE40,BHLHE41,BPTF,BRD7,BRMS1,C1QBP,CAMTA2,CBX5,CDKN2A,CEBPG,CNOT1,CNOT2,COMMD7,CREB3,CREBBP,CREM,CRTC1,CTNNB1,CXXC5,DACT2,DAPK3,DAXX,DDX3X,DMAP1,DR1,DRG1,EGR2,EIF4E,ENPP2,EOMES,ERCC3,ESRRB,ETS1,FAM89B,FOSB,FOXP3,GAS2L1,GATA4,GPX3,GSC,HAND2,HDAC1,HDAC11,HDAC3,HDAC8,HDAC9,HES1,HES2,HES3,HES4,HES5,HES6,HES7,HEY1,HEY2,HEYL,HHEX,HIPK2,HMGA1,HMGB2,HMGN3,HNF4A,HYAL1,IFI16,IRF4,JMJD1C,KAT6A,KAT6B,KAT8,KDM1A,KLF4,LMO4,MAFB,MAGEA2,MAPK14,MAPK9,MDFIC,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,MEIS2,MIXL1,MTOR,MYBBP1A,NCOA3,NCOA6,NFATC1,NFKB1,NFKBIA,NLRP3,NOC2L,NPM1,NR1D1,NR4A2,NSD1,NUP62,OASL,PARD6A,PAX6,PIAS2,PPARG,PPARGC1A,PPID,PRAME,PRDM5,PSIP1,PSMD9,PURA,PURB,RARG,RBFOX2,RBPJ,RNF19A,RPTOR,RUNX1,SIK1,SNF8,SNW1,SOST,SP1,SPI1,STK36,SUFU,SUMO1,T,TAF12,TAF1B,TBX20,TBX3,TBX6,TCF4,TCP10L,THRA,THRAP3,TLE1,TMEM173,TRIB2,TRIM32,TRIP12,TRIP6,WWP2,ZMYND8,ZNHIT3	Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.
GO:0008135	GO	MF	translation factor activity, RNA binding	ABCF1,AGO2,COPS5,CPEB3,EEF1A1,EEF1A2,EEF1B2,EEF1D,EEF2K,EIF1,EIF1AX,EIF2A,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EIF2D,EIF2S1,EIF2S2,EIF2S3,EIF3A,EIF3B,EIF3C,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4E,EIF4E2,EIF4G1,EIF4G2,EIF4G3,EIF4H,EIF5,EIF5A,EIF5B,ETF1,GATB,GFM1,GSPT1,GTF2H2,GTF2H3,ICT1,MTIF2,MTIF3,MTRF1,SOX11,TUFM	Functions during translation by interacting selectively and non-covalently with RNA during polypeptide synthesis at the ribosome.
GO:0008137	GO	MF	NADH dehydrogenase (ubiquinone) activity	MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3	Catalysis of the reaction: NADH + H+ + ubiquinone = NAD+ + ubiquinol.
GO:0008138	GO	MF	protein tyrosine/serine/threonine phosphatase activity	CDKN3,DUSP1,DUSP3,DUSP6,DUSP7,MTMR2,SBF1	Catalysis of the reactions: protein serine + H2O = protein serine + phosphate; protein threonine phosphate + H2O = protein threonine + phosphate; and protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
GO:0008139	GO	MF	nuclear localization sequence binding	BRAP,CABP1,KPNA1,KPNA2,KPNA3,KPNB1,TNPO1,TNPO2	Interacting selectively and non-covalently with a nuclear localization sequence, a specific peptide sequence that acts as a signal to localize the protein within the nucleus.
GO:0008140	GO	MF	cAMP response element binding protein binding	ATF2,CREB3,CREM,CRTC1,DAPK3,SIK1	Interacting selectively and non-covalently with a cAMP response element binding protein (a CREB protein).
GO:0008142	GO	MF	oxysterol binding	GPR183,OSBP,OSBPL5,RORA,RORC	Interacting selectively and non-covalently with oxysterol, an oxidized form of cholesterol.
GO:0008143	GO	MF	poly(A) binding	DDX1,DDX3X,EIF4A3,HNRNPDL,KHDRBS1,PABPC1,PABPC3,PABPC4,RBPMS,TIA1	Interacting selectively and non-covalently with a sequence of adenylyl residues in an RNA molecule, such as the poly(A) tail, a sequence of adenylyl residues at the 3' end of eukaryotic mRNA.
GO:0008144	GO	MF	drug binding	ACE,ACR,ALB,AOC1,ATP5O,CHKA,CYP2C9,CYP2D6,DCK,DHFR,DRD2,DRD3,DRD4,FKBP1A,FKBP1B,FKBP2,FKBP3,FKBP4,FOLR1,FOLR2,FSCN1,GABRA1,HMGB2,HTR2A,HTR2B,HTR2C,MT2A,MT3,NFATC1,NKTR,NR1I2,PDE2A,PNP,PPARA,PPARD,PPARG,PPIC,PPID,PPIE,PPIG,PPIH,PPP3CA,PPP3CB,PYGL,SFRP1,SIGMAR1,SMO,SRP54,TOP2A,UGT1A7,UGT1A8	Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
GO:0008146	GO	MF	sulfotransferase activity	CHST1,CHST10,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST4,CHST5,CHST6,CHST7,CHST8,CHST9,GAL3ST1,GAL3ST2,GAL3ST3,GAL3ST4,HS3ST1,HS3ST2,HS3ST3A1,HS3ST3B1,HS3ST4,HS3ST5,HS3ST6,HS6ST1,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C3,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1	Catalysis of the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the hydroxyl group of an acceptor, producing the sulfated derivative and 3'-phosphoadenosine 5'-phosphate.
GO:0008154	GO	BP	actin polymerization or depolymerization	ABI1,ABI2,AIF1,ANG,ARHGAP6,CATIP,COBL,CORO7,DSTN,EVL,GHRL,GHSR,GSN,JAK2,MICAL1,MICAL2,MICAL3,MICALL2,MSRB1,MSRB2,PREX1,RAC1,TTC17,VIL1,WAS,WASF1,WASF3,WASL	Assembly or disassembly of actin filaments by the addition or removal of actin monomers from a filament.
GO:0008156	GO	BP	negative regulation of DNA replication	ACD,ATR,BLM,CDAN1,CDC6,CERS1,CHEK2,CTC1,ENPP7,FBXO18,FBXW7,GDF2,GMNN,GNL3L,GTPBP4,HNRNPA1,HNRNPC,HNRNPU,LIG3,MCRS1,MEN1,MRE11A,NAT10,NF2,OBFC1,PDS5A,PID1,PIF1,PINX1,PML,POT1,RAD17,S100A11,SMC1A,SMC3,SRC,STAG2,TEN1,TERF1,TERF2,TGFB1,TGFB3,TINF2,TP53,TSPYL2,WAPL,ZNF830,ZRANB3	Any process that stops, prevents, or reduces the frequency, rate or extent of DNA replication.
GO:0008157	GO	MF	protein phosphatase 1 binding	AKAP11,KCNQ1,PHACTR4,PPP1R15A,PPP1R9B,SH3RF2,SHOC2,TCTEX1D4	Interacting selectively and non-covalently with the enzyme protein phosphatase 1.
GO:0008168	GO	MF	methyltransferase activity	ALKBH8,ARMT1,AS3MT,ASH1L,ASH2L,ASMT,BCDIN3D,BHMT,BHMT2,CARM1,CARNMT1,CMTR1,CMTR2,COMT,COQ3,CXXC1,DNMT1,DNMT3A,DNMT3B,DOT1L,DPH5,EED,EEF2KMT,EHMT1,EHMT2,EMG1,EZH2,FBL,FBXO11,FTSJ2,GAMT,GCSH,GNMT,HENMT1,ICMT,INMT,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,LRTOMT,MEN1,MEPCE,METTL1,METTL14,METTL20,METTL21A,METTL21C,METTL2A,METTL2B,METTL3,MGMT,MTR,N6AMT1,NDUFAF7,NSD1,NSUN2,NSUN4,NTMT1,PCMT1,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,RNMT,RRP8,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,SUZ12,TGS1,TRDMT1,TRMT112,TRMT61B,TYMS,VCPKMT,WBSCR22,WDR4,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the transfer of a methyl group to an acceptor molecule.
GO:0008170	GO	MF	N-methyltransferase activity	ASH1L,ASH2L,CARM1,CXXC1,DOT1L,EEF2KMT,EHMT1,EHMT2,EZH2,FBL,FBXO11,GNMT,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,METTL20,METTL21A,METTL21C,NSD1,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,RNMT,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,VCPKMT,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the transfer of a methyl group to the nitrogen atom of an acceptor molecule.
GO:0008171	GO	MF	O-methyltransferase activity	ARMT1,ASMT,BCDIN3D,CMTR1,CMTR2,COMT,COQ3,FTSJ2,HENMT1,ICMT,LCMT1,LRTOMT,PCMT1	Catalysis of the transfer of a methyl group to the oxygen atom of an acceptor molecule.
GO:0008173	GO	MF	RNA methyltransferase activity	ALKBH8,BCDIN3D,CMTR1,CMTR2,EMG1,FTSJ2,HENMT1,MEPCE,METTL1,METTL14,METTL2A,METTL2B,METTL3,NSUN2,RNMT,TGS1,TRDMT1,TRMT61B,WDR4	Catalysis of the transfer of a methyl group from a donor to a nucleoside residue in an RNA molecule.
GO:0008174	GO	MF	mRNA methyltransferase activity	CMTR1,CMTR2,METTL14,METTL3,RNMT	Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to a nucleoside residue in an mRNA molecule.
GO:0008175	GO	MF	tRNA methyltransferase activity	ALKBH8,METTL1,METTL2A,METTL2B,NSUN2,TRDMT1,TRMT61B,WDR4	Catalysis of the transfer of a methyl group from a donor to a nucleoside residue in a tRNA molecule.
GO:0008180	GO	CC	COP9 signalosome	AMOT,AMOTL1,ATP5A1,BASP1,COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,DOCK7,DYNLL1,EPB41L2,FLOT1,GPS1,GRB2,HSP90AB1,HSPA1L,HSPA5,HSPA6,LAT,MYH9,NCKIPSD,NOD2,PLCG1,STOML2,TESPA1,THEMIS,TMOD1,VPRBP,WDR6	A protein complex that catalyzes the deneddylation of proteins, including the cullin component of SCF ubiquitin E3 ligase; deneddylation increases the activity of cullin family ubiquitin ligases. The signalosome is involved in many regulatory process, including some which control development, in many species; also regulates photomorphogenesis in plants; in many species its subunits are highly similar to those of the proteasome.
GO:0008186	GO	MF	RNA-dependent ATPase activity	DDX17,DDX18,DDX20,DDX21,DDX23,DDX25,DDX39B,DDX3X,DDX43,DDX54,DDX56,DHX8,DHX9,EIF4A3,G3BP1,IGHMBP2,MOV10L1,SKIV2L,SNRNP200,SUPV3L1,UPF1,YTHDC2	Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction requires the presence of RNA, and it drives another reaction.
GO:0008187	GO	MF	poly-pyrimidine tract binding	ATXN1,DIS3L2,HNRNPC,HNRNPH1,KHDRBS1,PABPC1,PABPC4,PATL1,PNPT1,PTBP1,RBM11	Interacting selectively and non-covalently with any stretch of pyrimidines (cytosine or uracil) in an RNA molecule.
GO:0008188	GO	MF	neuropeptide receptor activity	GAL,GALR1,GALR2,GALR3,GPR143,HCRTR2,KISS1R,MCHR1,NMUR1,NMUR2,NPFFR1,NPSR1,NPY1R,NPY2R,NPY5R,NTSR1,OPRM1,PRLHR,SORCS1,SORCS2,SORCS3,SSTR1,TACR1,TACR2	Combining with a neuropeptide to initiate a change in cell activity.
GO:0008190	GO	MF	eukaryotic initiation factor 4E binding	ANGEL1,DDX3X,EIF4EBP1,EIF4EBP2,EIF4G1,HHEX,OTX2	Interacting selectively and non-covalently with eukaryotic initiation factor 4E, a polypeptide factor involved in the initiation of ribosome-mediated translation.
GO:0008191	GO	MF	metalloendopeptidase inhibitor activity	BST2,COL4A3,FETUB,NGF,RECK,SPOCK1,SPOCK3,TIMP1,TIMP3,TIMP4	Stops, prevents or reduces the activity of metalloendopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain and contain a chelated metal ion at their active sites which is essential to their catalytic activity.
GO:0008194	GO	MF	UDP-glycosyltransferase activity	A4GNT,B3GALNT2,B3GALT1,B3GALT4,B3GALT5,B3GALT6,B3GAT2,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT5,B3GNT6,B3GNT8,B4GALNT2,B4GALNT3,B4GALNT4,B4GALT1,B4GALT7,B4GAT1,C1GALT1C1,CHSY1,CSGALNACT1,CSGALNACT2,EOGT,EXT1,EXT2,EXTL2,GALNT1,GALNT10,GALNT11,GALNT2,GALNT3,GALNT5,GALNT9,GCNT2,GCNT4,GXYLT1,GXYLT2,GYLTL1B,GYS1,GYS2,HAS1,HAS2,HAS3,HEXA,HEXB,HYAL1,LARGE,LFNG,MGAT1,MGAT5,OGT,PIGA,PIGP,PLOD3,POGLUT1,POMGNT1,POMGNT2,UGGT1,UGGT2,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7,UGT3A1,UGT3A2,XYLT1,XYLT2	Catalysis of the transfer of a glycosyl group from a UDP-sugar to a small hydrophobic molecule.
GO:0008198	GO	MF	ferrous iron binding	ACP5,ALKBH1,ALKBH2,ALKBH3,DNAJC24,EGLN2,FECH,FTO,FXN,HAAO,HEPH,SNCA,TET2,TF	Interacting selectively and non-covalently with ferrous iron, Fe(II).
GO:0008200	GO	MF	ion channel inhibitor activity	AMBP,ANKRD36C,CAMK2D,CAV1,CAV3,CCDC109B,CFTR,ENSA,FKBP1B,GNB2L1,HAMP,ITPR1,KCNK2,KCNMB2,KCNV1,NEDD4,NEDD4L,PACSIN3,PCSK9,PDZD3,PHPT1,RASA1,RSC1A1,SCN1B,SLC30A1,STX1A,STX7,STX8,VAMP8,VTI1B,WNK1,WNK3,WNK4	Stops, prevents, or reduces the activity of an ion channel.
GO:0008201	GO	MF	heparin binding	AAMP,ADAMTSL5,ANG,AOC1,APOA5,APOB,APOE,AZU1,CEL,CFH,CLEC3B,COL13A1,COL25A1,COL5A1,COMP,CTSG,CXCL10,CXCL11,CXCL13,ELANE,FGF1,FGF10,FGF12,FGF14,FGFBP1,FGFBP3,FGFR1,FGFR4,FGFRL1,FN1,GREM2,HBEGF,HRG,KNG1,LIPH,LIPI,LPA,LPL,LTF,MDK,MPO,NDNF,PAFAH1B1,PCOLCE,PCOLCE2,PCSK6,PDCD5,PF4,POSTN,REG4,SELL,SELP,SERPINA5,SERPINE2,SFRP1,SLIT2,TENM1,TGFBR3,THBS1,THBS3,THBS4,TNXB,VEGFA,ZNF146	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
GO:0008202	GO	BP	steroid metabolic process	ABCA1,ABCB11,ABCC3,ABCG1,ACAA1,ACAA2,ACLY,ACOT8,ACOX2,ADM,AKR1B1,AKR1B10,AKR1B15,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR1D1,ALB,AMACR,ANGPTL3,APOA1,APOA4,APOB,APOE,APOL2,ARV1,BAAT,CACNA1H,CEL,CELA3A,CELA3B,CETP,CH25H,CLN6,CLN8,CNBP,CUBN,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A1,CYP1A2,CYP1B1,CYP21A2,CYP24A1,CYP27A1,CYP27B1,CYP2A6,CYP2B6,CYP2C19,CYP2C9,CYP2D6,CYP2E1,CYP2R1,CYP39A1,CYP3A4,CYP3A5,CYP46A1,CYP4V2,CYP51A1,CYP7A1,CYP7B1,CYP8B1,DHCR24,DHCR7,DHRS2,DHRS4,DHRS9,EBP,FABP6,FDFT1,FDPS,FDX1,FDX1L,FDXR,FGF23,FSHB,G6PD,GBA2,GC,GGPS1,HMGCR,HMGCS1,HSD11B1,HSD11B2,HSD17B1,HSD17B11,HSD17B14,HSD17B3,HSD17B4,HSD17B6,HSD17B7,HSD17B8,HSD3B1,HSD3B2,HSD3B7,IDI1,IDI2,IL4,LBR,LCAT,LDLRAP1,LGMN,LHB,LRP2,LSS,MED1,MSMO1,MT3,MVD,MVK,NCOA1,NCOA2,NPC1,NPC1L1,NR0B1,NR0B2,NR1H4,NR1I2,NSDHL,OSBPL1A,OSBPL5,PMVK,PPARD,PRKAG2,PRLR,RDH8,RXRA,SC5D,SCARF1,SCP2,SHH,SLC10A1,SLC10A2,SLC27A2,SLC27A5,SLCO1A2,SLCO1B1,SLCO1B3,SNX17,SOAT1,SOAT2,SQLE,SRD5A1,SRD5A2,SRD5A3,STAR,STARD3,STARD5,STS,SULT1A1,SULT1E1,SULT2A1,SULT2B1,TFCP2L1,TM7SF2,TRERF1,TSPO,UGT1A1,UGT1A8,UGT2B11,UGT2B15,UGT2B17,UGT2B4,UGT2B7,WNT4,WWOX,YWHAH	The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
GO:0008203	GO	BP	cholesterol metabolic process	ABCA1,ABCG1,ACAA2,ACLY,AKR1D1,ANGPTL3,APOA1,APOA4,APOB,APOE,APOL2,ARV1,CEL,CELA3A,CELA3B,CETP,CLN6,CLN8,CNBP,CYP11A1,CYP46A1,CYP51A1,CYP7A1,DHCR24,DHCR7,EBP,FDFT1,FDPS,FDX1,G6PD,GGPS1,HMGCR,HMGCS1,HSD17B7,IDI1,IDI2,IL4,LBR,LCAT,LDLRAP1,LSS,MSMO1,MT3,MVD,MVK,NPC1L1,NR0B2,NSDHL,OSBPL1A,OSBPL5,PMVK,PPARD,RXRA,SC5D,SCARF1,SNX17,SOAT1,SOAT2,SQLE,STARD3,TM7SF2,TRERF1	The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues.
GO:0008206	GO	BP	bile acid metabolic process	ABCB11,ABCC3,ACAA1,ACOT8,ACOX2,AKR1C1,AKR1C4,AKR1D1,ALB,AMACR,BAAT,CH25H,CYP27A1,CYP39A1,CYP46A1,CYP7A1,CYP7B1,CYP8B1,FABP6,GBA2,HSD17B4,HSD3B7,NCOA1,NCOA2,NPC1,NR1H4,RXRA,SCP2,SLC10A1,SLC10A2,SLC27A2,SLC27A5,SLCO1A2,SLCO1B1,SLCO1B3	The chemical reactions and pathways involving bile acids, any of a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine.
GO:0008207	GO	BP	C21-steroid hormone metabolic process	ADM,AKR1B1,AKR1C1,AKR1C2,AKR1C3,AKR1D1,CACNA1H,CYP11A1,CYP11B1,CYP11B2,CYP17A1,DHRS2,DHRS9,FDX1,FDX1L,FDXR,FSHB,LHB,SCP2,STAR,STARD5	The chemical reactions and pathways involving C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones.
GO:0008209	GO	BP	androgen metabolic process	AKR1C3,AKR1C4,AKR1D1,CYP17A1,CYP3A4,DHRS9,HSD17B11,HSD17B3,HSD17B4,HSD17B6,HSD3B1,HSD3B2,MED1,SHH,SRD5A1,SRD5A2,SRD5A3,UGT2B7,WNT4	The chemical reactions and pathways involving androgens, C19 steroid hormones that can stimulate the development of male sexual characteristics.
GO:0008210	GO	BP	estrogen metabolic process	AKR1B15,CYP19A1,CYP1B1,HSD17B1,HSD17B11,HSD17B4,HSD17B8,HSD3B1,SULT1A1,SULT1E1,UGT1A1,UGT2B11,UGT2B4	The chemical reactions and pathways involving estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants.
GO:0008211	GO	BP	glucocorticoid metabolic process	CACNA1H,CYP11B1,CYP11B2,CYP17A1,CYP21A2,HSD11B1,HSD11B2,HSD3B1,HSD3B2,YWHAH	The chemical reactions and pathways involving glucocorticoids, hormonal C21 corticosteroids synthesized from cholesterol. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
GO:0008217	GO	BP	regulation of blood pressure	ACE,ACE2,ACSM3,ACVRL1,ADIPOQ,AGT,AGTR1,AGTR2,ANPEP,ATP6AP2,BMPR2,BRS3,CALCA,CARTPT,CD34,CHGA,CMA1,COL1A2,CORIN,CPA3,CTSG,CTSZ,CYP11B1,CYP11B2,CYP4F12,CYP4F2,DDAH1,DLL1,DRD2,DRD3,ECE1,EDN1,EDN2,EDN3,EMP2,ENG,ENPEP,EPHX2,ERAP1,ERAP2,F2R,F2RL1,FFAR3,GAS6,GCGR,GCH1,GNB3,GSK3A,ID2,LRP5,MME,MYH6,NOS3,NOX1,NPPA,NPPB,NPR1,NPR2,NPR3,OR51E2,P2RX4,PDE4D,PDGFB,PLCB3,POMC,PPARG,PTGS1,PTGS2,PTPRO,QRFP,RAMP2,RASL10B,REN,RENBP,SCPEP1,SERPINF2,SGK1,SOD1,SOD2,SPX,TNNI3,TPM1,UTS2	Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
GO:0008227	GO	MF	G-protein coupled amine receptor activity	ADRA1A,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,CHRM2,CHRM3,HRH1,HRH4,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,HTR4,HTR5A,HTR6,TAAR5	Combining with an extracellular amine and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
GO:0008228	GO	BP	opsonization	C4B,CRP,FCN2,LBP,MBL2	The process in which a microorganism (or other particulate material) is rendered more susceptible to phagocytosis by coating with an opsonin, a blood serum protein such as a complement component or antibody.
GO:0008234	GO	MF	cysteine-type peptidase activity	ATG4A,ATG4B,ATG4C,ATG4D,ATXN3,ATXN3L,BAP1,BLMH,BRCC3,CAPN1,CAPN10,CAPN15,CAPN2,CAPN3,CAPNS1,CASP1,CASP10,CASP14,CASP2,CASP3,CASP5,CASP6,CASP7,CASP8,CASP9,CLC,COPS5,CTSB,CTSC,CTSF,CTSH,CTSK,CTSL,CTSO,CTSS,CTSV,CTSW,CTSZ,CYLD,EIF3F,ESPL1,JOSD2,LGMN,MALT1,MYSM1,OTUB1,OTUB2,OTUD1,OTUD3,OTUD4,OTUD5,OTUD6A,OTUD7A,OTUD7B,OTULIN,PDIA3,SENP1,SENP2,SENP6,SFRP1,STAMBP,TINAG,TNFAIP3,TNIP1,UCHL1,UCHL5,UFD1L,UFSP2,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP17L2,USP18,USP19,USP2,USP20,USP21,USP22,USP25,USP28,USP3,USP30,USP31,USP33,USP34,USP35,USP36,USP37,USP38,USP4,USP42,USP44,USP45,USP46,USP47,USP49,USP5,USP51,USP6,USP7,USP8,USP9X,USP9Y,USPL1,VCPIP1,YOD1,ZRANB1	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.
GO:0008235	GO	MF	metalloexopeptidase activity	AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,CPA2,CPA3,CPA4,CPA6,CPQ,DPEP1,ENPEP,ERAP1,FOLH1,LAP3,METAP1,METAP1D,METAP2,NUDT16,PEPD,RNPEP,XPNPEP1,ZMPSTE24	Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
GO:0008236	GO	MF	serine-type peptidase activity	ACE,ACR,APEH,C1R,C1S,CELA3B,CFB,CFD,CLPP,CMA1,CORIN,CTRB1,CTSA,CTSG,CTSH,DPP4,DPP7,ENDOU,F10,F11,F12,F2,F7,FAP,FURIN,GZMA,GZMB,GZMH,GZMK,GZMM,HGFAC,HPN,HTRA1,HTRA2,HTRA3,KLK1,KLK10,KLK11,KLK12,KLK13,KLK14,KLK15,KLK2,KLK3,KLK4,KLK5,KLK6,KLK7,KLK8,KLK9,LPA,MASP1,MASP2,MBTPS1,MMP2,MMP8,NAALAD2,PCSK1,PCSK2,PCSK5,PCSK6,PCSK9,PLAT,PLAU,PLG,PRCP,PREP,PROC,PRSS1,PRSS12,PRSS16,PRSS2,PRSS21,PRSS3,PRSS36,PRSS56,PRSS8,PRTN3,RHBDD1,RHBDL2,SCPEP1,ST14,TMPRSS11B,TMPRSS11E,TMPRSS13,TMPRSS2,TMPRSS3,TMPRSS4,TMPRSS6,TMPRSS7,TPP1,TPSAB1,TPSB2,TPSD1,TPSG1,TYSND1,ZFYVE9	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
GO:0008237	GO	MF	metallopeptidase activity	ACE,ADAM10,ADAM11,ADAM12,ADAM15,ADAM17,ADAM18,ADAM2,ADAM20,ADAM21,ADAM23,ADAM28,ADAM29,ADAM30,ADAM33,ADAM8,ADAM9,ADAMDEC1,ADAMTS1,ADAMTS12,ADAMTS13,ADAMTS2,ADAMTS3,ADAMTS4,ADAMTS5,ADAMTS6,ADAMTS7,ADAMTS8,ADAMTS9,AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,ANPEP,ASTL,BMP1,BRCC3,CHMP1A,COPS5,CPA2,CPA3,CPA4,CPA6,CPQ,DPEP1,ECE1,ECE2,ECEL1,ENPEP,ERAP1,ERAP2,FAP,FOLH1,IDE,KEL,LAP3,LNPEP,METAP1,METAP1D,METAP2,MME,MMP1,MMP12,MMP13,MMP14,MMP2,MMP20,MMP24,MMP28,MMP9,MYSM1,NRD1,NUDT16,OMA1,PAPPA,PAPPA2,PEPD,PITRM1,PMPCA,PSMD14,RNPEP,SPG7,TRABD2A,TRABD2B,XPNPEP1,ZMPSTE24	Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
GO:0008238	GO	MF	exopeptidase activity	ACE,ACE2,AEBP1,AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,ANPEP,APEH,ASRGL1,BACE1,BLMH,CNDP2,CPA2,CPA3,CPA4,CPA6,CPB1,CPE,CPM,CPQ,CTSA,CTSH,DPEP1,DPP3,DPP4,DPP8,ENPEP,ERAP1,ERAP2,FAP,FOLH1,GGH,GGT1,LAP3,LNPEP,LTA4H,METAP1,METAP1D,METAP2,MME,NAALAD2,NPEPPS,NUDT16,PEPD,PRCP,RNPEP,SCPEP1,TPP1,TRHDE,UCHL1,XPNPEP1,XPNPEP3,ZMPSTE24	Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain, in a reaction that requires a free N-terminal amino group, C-terminal carboxyl group or both.
GO:0008239	GO	MF	dipeptidyl-peptidase activity	DPP3,DPP4,DPP8,FAP,NAALAD2	Catalysis of the hydrolysis of N-terminal dipeptides from a polypeptide chain.
GO:0008242	GO	MF	omega peptidase activity	APEH,ASRGL1,BACE1,GGH,GGT1,UCHL1	Catalysis of the removal of terminal peptide residues that are substituted, cyclized or linked by isopeptide bonds (peptide linkages other than those of alpha-carboxyl to alpha-amino groups).
GO:0008250	GO	CC	oligosaccharyltransferase complex	DAD1,DDOST,KRTCAP2,MAGT1,OSTC,RPN1,RPN2,STT3A,STT3B,TUSC3	A protein complex that is found in the endoplasmic reticulum membrane of eukaryotes and transfers lipid-linked oligosaccharide precursor to asparagine residues on nascent proteins. In yeast, the complex includes at least nine different subunits, whereas in mammalian cells at least three different forms of the complex have been detected.
GO:0008252	GO	MF	nucleotidase activity	ACPP,NT5C,NT5C1A,NT5C3A,NT5E,NT5M	Catalysis of the reaction: a nucleotide + H2O = a nucleoside + phosphate.
GO:0008266	GO	MF	poly(U) RNA binding	ATXN1,DIS3L2,HNRNPC,HNRNPH1,KHDRBS1,PABPC1,PABPC4,PATL1,PNPT1,RBM11	Interacting selectively and non-covalently with a sequence of uracil residues in an RNA molecule.
GO:0008272	GO	BP	sulfate transport	RACGAP1,SLC13A4,SLC26A1,SLC26A11,SLC26A2,SLC26A4,SLC26A6,SLC26A7,SLC26A8	The directed movement of sulfate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0008274	GO	CC	gamma-tubulin ring complex	BRCA1,MZT1,MZT2A,MZT2B,TUBGCP4,TUBGCP5,TUBGCP6	A multiprotein complex composed of gamma-tubulin and other non-tubulin proteins that forms a flexible open ring structure thought to be the unit of nucleation at the minus end of a microtubule.
GO:0008276	GO	MF	protein methyltransferase activity	ARMT1,ASH1L,ASH2L,CARM1,CXXC1,DOT1L,EED,EEF2KMT,EHMT1,EHMT2,EZH2,FBL,FBXO11,ICMT,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,MEN1,METTL20,METTL21A,METTL21C,N6AMT1,NSD1,NTMT1,PCMT1,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,SUZ12,TRMT112,VCPKMT,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the transfer of a methyl group (CH3-) to a protein.
GO:0008277	GO	BP	regulation of G-protein coupled receptor protein signaling pathway	ACPP,ADA,ADCYAP1,ADM,ADRA2A,ADRB2,ADRBK1,ARRB1,ARRB2,ATP2B4,BECN2,BICD1,C3,CALCA,CALM1,CAMKMT,CAV2,CCL5,CNGA1,CNGB1,CRY1,CXCL8,DRD2,DRD3,DTNBP1,DYNLT1,EDN1,F2,FNTA,FNTB,GIT1,GIT2,GNAT1,GNB1,GNB5,GNG4,GNG7,GNGT1,GPER1,GPRASP1,GRK1,GRK4,GRK5,GRK6,GRK7,GSK3A,GTF2H2,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,KLK14,KLK5,KLK6,LRRK2,METAP1,METAP2,MGLL,MGRN1,NMT1,NMT2,NOS1,PALM,PDCL,PDE6A,PDE6B,PDE6G,PHB,PLCB1,PLCE1,PLEK,PPEF1,PPP1R9B,PRKCA,PRKCQ,RAMP1,RASGRP4,RCVRN,RGS11,RGS12,RGS16,RGS2,RGS20,RGS3,RGS4,RGS5,RGS6,RGS8,RGS9,RGS9BP,RHO,RIC8B,RPGRIP1L,SAG,SNCA,SYP,TULP3,UBQLN2,USP20,USP33	Any process that modulates the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity.
GO:0008278	GO	CC	cohesin complex	CDCA5,RAD21,RAD21L1,SGOL1,SGOL2,SMC1A,SMC1B,SMC3,STAG3,WAPL	A protein complex that is required for sister chromatid cohesion in eukaryotes. The cohesin complex forms a molecular ring complex, and is composed of structural maintenance of chromosomes (SMC) and kleisin proteins. For example, in yeast, the complex is composed of the SMC proteins Smc1p and Smc3p, and the kleisin protein Scc1p. In vertebrates, the complex is composed of the SMC1 (SMC1A or SMC1B) and SMC3 heterodimer attached via their hinge domains to a kleisin (RAD21, REC8 or RAD21L) which links them, and one STAG protein (STAG1, STAG2 or STAG3).
GO:0008287	GO	CC	protein serine/threonine phosphatase complex	CNEP1R1,CTDNEP1,CYCS,NCK1,NKD1,PPP1CA,PPP1CB,PPP1CC,PPP1R10,PPP1R12A,PPP1R15A,PPP1R15B,PPP1R9B,PPP2CA,PPP2CB,PPP2R1A,PPP2R2A,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R3B,PPP2R4,PPP2R5A,PPP2R5C,PPP3CA,PPP3CB,PPP3R1,PPP4R1,PPP4R2,PPP4R4,SHOC2,STRN,STRN3,STRN4,TOX4,WDR82	A complex, normally consisting of a catalytic and a regulatory subunit, which catalyzes the removal of a phosphate group from a serine or threonine residue of a protein.
GO:0008296	GO	MF	3'-5'-exodeoxyribonuclease activity	EXO5,ISG20,MEIOB,TREX1,TREX2	Catalysis of the sequential cleavage of mononucleotides from a free 3' terminus of a DNA molecule.
GO:0008297	GO	MF	single-stranded DNA exodeoxyribonuclease activity	EXO1,EXO5,ISG20,MEIOB,MGME1	Catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of a single-stranded DNA molecule.
GO:0008299	GO	BP	isoprenoid biosynthetic process	BCO1,DHRS9,DPAGT1,IDI1,IDI2,MVD,MVK,NUS1,PDSS1,PDSS2	The chemical reactions and pathways resulting in the formation of any isoprenoid compound, isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues.
GO:0008300	GO	BP	isoprenoid catabolic process	AKR1B10,AKR1C3,BCO2,CYP26A1,CYP26B1,CYP26C1,SRD5A3	The chemical reactions and pathways resulting in the breakdown of any isoprenoid compound, isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues.
GO:0008301	GO	MF	DNA binding, bending	CRIP1,FOXC1,FOXD1,FOXD4,FOXI1,FOXL1,HHEX,HMGA2,HMGB1,HMGB2,HMGB3,LEF1,TERF1,TFAM,TOP2A,TRERF1	The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
GO:0008305	GO	CC	integrin complex	ITGA1,ITGA10,ITGA11,ITGA2,ITGA3,ITGA4,ITGA8,ITGA9,ITGAD,ITGAL,ITGAV,ITGB1,ITGB2,ITGB3,ITGB5,ITGB7,ITGB8,MYH9	A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands.
GO:0008306	GO	BP	associative learning	ADCY3,APP,CHRNB2,CLN3,DRD1,DRD2,DRD3,FOXB1,GRIN1,NETO1,NF1,RGS14,SHANK1	Learning by associating a stimulus (the cause) with a particular outcome (the effect).
GO:0008307	GO	MF	structural constituent of muscle	ACTN2,ACTN3,ANKRD2,ASPH,CAPN3,CSRP3,DAG1,DMD,KRT19,MYBPC1,MYBPC2,MYBPC3,MYBPH,MYH11,MYH8,MYL1,MYL2,MYL3,MYL5,MYL6,MYL6B,MYL9,MYLPF,MYOM1,MYOM2,MYOT,NEB,NEBL,NEXN,OBSCN,PLEC,SMTN,SORBS2,SYNM,TCAP,TPM1,TPM2,TPM4,TTN	The action of a molecule that contributes to the structural integrity of a muscle fiber.
GO:0008308	GO	MF	voltage-gated anion channel activity	ANO1,ANO6,CLCN6,GPR89A,SLC17A3,VDAC1,VDAC2,VDAC3	Enables the transmembrane transfer of an anion by a voltage-gated channel. An anion is a negatively charged ion. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0008318	GO	MF	protein prenyltransferase activity	CHM,FNTA,FNTB,PGGT1B,RABGGTA,RABGGTB	Catalysis of the covalent addition of an isoprenoid group such as a farnesyl or geranylgeranyl group via thioether linkages to a cysteine residue in a protein.
GO:0008320	GO	MF	protein transmembrane transporter activity	AZGP1,GPIHBP1,MCL1,SLC11A2,TIMM22,TOMM20,TOMM22,TOMM40,TOMM7,TOMM70A	Enables the transfer of a protein from one side of a membrane to the other.
GO:0008327	GO	MF	methyl-CpG binding	CHTOP,ERH,LRWD1,MBD1,MBD2,MBD3,PRMT1,PRMT5,UHRF1,WDR77,ZBTB21,ZBTB33,ZBTB38,ZBTB4	Interacting selectively and non-covalently with a methylated cytosine/guanine dinucleotide.
GO:0008328	GO	CC	ionotropic glutamate receptor complex	CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CNIH2,CNIH3,DLG4,GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIN1,GRIN2A,GRIN2B,GRIN3A,GRIN3B,OLFM2,PTK2B,SHANK1,SHANK2,SHISA9	A multimeric assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand-gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex.
GO:0008329	GO	MF	signaling pattern recognition receptor activity	CD14,CLEC7A,COLEC12,DMBT1,FCN1,LY96,MARCO,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,SCARB1,TLR2,TLR4,TRIM5	Combining with a pathogen-associated molecular pattern (PAMP), a structure conserved among microbial species, or damage-associated molecular pattern (DAMP), an endogenous molecule released from damaged cells), and transmitting a signal to initiate a change in cell activity.
GO:0008331	GO	MF	high voltage-gated calcium channel activity	CACNA1C,CACNA1D,CACNA1S,CACNB2,CACNB4	Enables the transmembrane transfer of a calcium ion by a high voltage-gated channel. A high voltage-gated channel is a channel whose open state is dependent on high voltage across the membrane in which it is embedded.
GO:0008333	GO	BP	endosome to lysosome transport	ADRB2,AKTIP,ATG14,BECN2,DENND3,FAM160A2,GPRASP1,HMGXB4,HOOK1,HOOK2,HOOK3,KIF13A,M6PR,MGRN1,MTM1,RAB12,RAB7A,RHOB,RILP,SCYL2,SNAPIN,SNX16,SORT1,TGFBRAP1,TRAK1,VAMP7,VIPAS39,VPS11,VPS16,VPS18,VPS33A,VPS39,VPS41	The directed movement of substances from endosomes to lysosomes.
GO:0008334	GO	BP	histone mRNA metabolic process	ATM,CPSF2,CPSF3,DCP2,EXOSC10,EXOSC4,LSM1,LSM10,LSM11,MTPAP,NCBP1,NCBP2,PAPD4,PAPD5,SLBP,SNRPB,SNRPD3,SNRPE,SNRPF,SNRPG,SSB,UPF1,XRN1,ZNF473	The chemical reactions and pathways involving an mRNA encoding a histone.
GO:0008340	GO	BP	determination of adult lifespan	BBC3,IDE,LRRK2,MSH6,TP53	The control of viability and duration in the adult phase of the life-cycle.
GO:0008343	GO	BP	adult feeding behavior	BRS3,CARTPT,GHRL,GHSR,LEP,NPY	Feeding behavior in a fully developed and mature organism.
GO:0008344	GO	BP	adult locomotory behavior	APP,DRD1,DRD2,DRD4,FOXA2,GDNF,NTF4,PAFAH1B1,PARK2,PUM1,SPTBN4,TSC1	Locomotory behavior in a fully developed and mature organism.
GO:0008347	GO	BP	glial cell migration	AZU1,CCL2,CCL3,DAB2IP,LAMB1,PAFAH1B1,RTN4,SRGAP2,SRGAP2C,TGFB2,VCAN	The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
GO:0008353	GO	MF	RNA polymerase II carboxy-terminal domain kinase activity	CCNH,CCNK,CDK1,CDK12,CDK13,CDK7,CDK9,ERCC2,ERCC3,GTF2H1,GTF2H2,GTF2H3,GTF2H4,MAPK1,MNAT1	Catalysis of the reaction: ATP + (DNA-directed RNA polymerase II) = ADP + phospho-(DNA-directed RNA polymerase II); phosphorylation occurs on residues in the carboxy-terminal domain (CTD) repeats.
GO:0008356	GO	BP	asymmetric cell division	DOCK7,FGF13,GOLGA2,ING2,PARD3,RAB10,RGS14,SOX5,TEAD3	The asymmetric division of cells to produce two daughter cells with different developmental potentials. It is of fundamental significance for the generation of cell diversity.
GO:0008360	GO	BP	regulation of cell shape	ALDOA,ANXA1,ARAP1,ARAP3,ARHGAP15,ARHGAP18,ARHGEF18,ATP10A,BAIAP2,BAMBI,BRWD1,BRWD3,BVES,C21orf2,CCL11,CCL13,CCL2,CCL24,CCL3,CCL7,CDC42EP1,CDC42EP2,CDC42EP4,CDC42EP5,COCH,CSF1R,DAG1,DIAPH1,DLC1,DLG1,DMTN,EPB41L3,EPS8,ERMN,EZR,FES,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FGR,FMNL1,FMNL3,HCK,HPN,ITGB2,KDR,KIT,LIMD1,LPAR1,MKLN1,MSN,MYH9,MYO10,PARVB,PLXNB1,PLXNB2,PRPF40A,PTK2,PTK2B,RASA1,RDX,RHOU,SEMA3E,SEMA4D,SEPT7,SH3KBP1,SLC9A3R1,STRIP2,SYNE3,TAOK2,TBCCD1,TPM1,VEGFA,VIL1,WASF3,WDPCP	Any process that modulates the surface configuration of a cell.
GO:0008361	GO	BP	regulation of cell size	ABL1,AKT1S1,AMOT,ANO6,APOE,AQP1,BCL11A,BDNF,CAV3,CDKL5,CLASP2,CLCN3,CLCN6,CTTN,DCC,DEPTOR,DNM2,DSCAM,EDN1,FGF13,GOLGA4,ISLR2,KCNMA1,L1CAM,LAMTOR4,LAMTOR5,LIMK1,LRRC8A,MACF1,MAPT,MEGF8,MSN,MT3,NRCAM,NRP1,NTN1,OLFM1,P2RX7,PLEK,PRR16,PTEN,RAC1,RAP1GAP2,RARG,RDX,RNF6,RPTOR,RTN4,RTN4R,RUFY3,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SHANK3,SHTN1,SLC12A4,SLC9A3R1,TMEM123,TRPV4,TWF2,VAV1,VAV2,VAV3,VEGFA	Any process that modulates the size of a cell.
GO:0008366	GO	BP	axon ensheathment	ACSBG1,AMIGO1,ARHGEF10,CD9,CLU,CNTNAP1,CXCR4,DICER1,EIF2B2,EIF2B4,EIF2B5,EPB41L3,FAM126A,GPC1,HES5,KLK6,MAL,MBP,MYOC,MYRF,NCMAP,NF1,NFASC,PARD3,PLP1,POU3F1,PPARD,PRX,PTEN,SBF2,SCN2A,SCN8A,SIRT2,SKI,SLC8A3,SOD1,TENM4,TNFRSF21,ZNF24	Any process in which the axon of a neuron is insulated, and that insulation maintained, thereby preventing dispersion of the electrical signal.
GO:0008373	GO	MF	sialyltransferase activity	ST3GAL1,ST3GAL5,ST3GAL6,ST6GAL1,ST6GAL2,ST6GALNAC1,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6	Catalysis of the transfer of sialic acid to an acceptor molecule, typically the terminal portions of the sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins.
GO:0008374	GO	MF	O-acyltransferase activity	AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,CPT1A,CPT2,CRAT,CROT,DGAT1,DGAT2,GNPAT,GPAM,GPAT2,GPAT3,GPAT4,IFNB1,LCAT,LPCAT1,LPCAT2,LPCAT3,MBOAT4,PLA2G15,PNPLA3,SOAT1,SOAT2,TAZ	Catalysis of the transfer of an acyl group to an oxygen atom on the acceptor molecule.
GO:0008375	GO	MF	acetylglucosaminyltransferase activity	A4GNT,B3GALNT2,B3GNT2,B3GNT3,B3GNT4,B3GNT5,B3GNT6,B3GNT8,B4GAT1,EOGT,EXT1,EXT2,EXTL2,GCNT2,GCNT4,HEXA,HEXB,LARGE,LFNG,MGAT1,MGAT5,OGT,PIGA,PIGP,POMGNT1,POMGNT2	Catalysis of the transfer of an N-acetylglucosaminyl residue from UDP-N-acetyl-glucosamine to a sugar.
GO:0008376	GO	MF	acetylgalactosaminyltransferase activity	B3GALNT2,B4GALNT2,B4GALNT3,B4GALNT4,C1GALT1C1,CHSY1,CSGALNACT1,CSGALNACT2,EXTL2,GALNT1,GALNT10,GALNT11,GALNT2,GALNT3,GALNT5,GALNT9	Catalysis of the transfer of an N-acetylgalactosaminyl residue from UDP-N-acetyl-galactosamine to an oligosaccharide.
GO:0008378	GO	MF	galactosyltransferase activity	A4GALT,B3GALT1,B3GALT4,B3GALT5,B3GALT6,B3GNT6,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,C1GALT1,PLOD3	Catalysis of the transfer of a galactosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
GO:0008385	GO	CC	IkappaB kinase complex	CHUK,DNAJA3,ERC1,IKBKB,IKBKG,MAP3K13,PYCARD,PYDC1,TRIM40	A trimeric protein complex that phosphorylates inhibitory-kappaB (I-kappaB) proteins. The complex is composed of two kinase subunits (alpha and beta) and a regulatory gamma subunit (also called NEMO). In a resting state, NF-kappaB dimers are bound to inhibitory IKB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
GO:0008395	GO	MF	steroid hydroxylase activity	CH25H,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP21A2,CYP27A1,CYP2C19,CYP2C9,CYP39A1,CYP3A4,CYP46A1,CYP7A1,CYP8B1	Catalysis of the formation of a hydroxyl group on a steroid by incorporation of oxygen from O2.
GO:0008406	GO	BP	gonad development	ANG,ANKRD7,BASP1,BMPR1B,CCDC182,CEBPB,CSDE1,DMRT1,EIF2B2,EIF2B4,EIF2B5,EREG,FGF8,FOXL2,FSHR,GATA1,GATA3,GATA4,ING2,INHA,INHBA,INHBB,IRX5,KIT,LHB,LHCGR,LRRC6,MEA1,MKKS,MSH2,NCOA4,NR0B1,PDGFRA,PRKACG,PTPRN,RAB13,RBMY1B,SCX,SIX4,SOD1,SOX15,SOX8,SOX9,SRD5A2,TCF21,VEGFA,WNT4,WT1,ZNF830	The process whose specific outcome is the progression of the gonad over time, from its formation to the mature structure. The gonad is an animal organ that produces gametes; in some species it also produces hormones.
GO:0008408	GO	MF	3'-5' exonuclease activity	APEX1,APLF,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,DIS3,DIS3L,DIS3L2,ERI1,EXO5,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,ISG20,MEIOB,MRE11A,NOCT,PAN2,PAN3,PARN,PNPT1,RAD1,RAD50,RAD9A,REXO2,TOE1,TREX1,TREX2,USB1,WRN	Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 3' end.
GO:0008409	GO	MF	5'-3' exonuclease activity	APTX,CPSF3,DCLRE1A,DCLRE1B,DCLRE1C,DXO,EXO1,EXO5,FAN1,FEN1,XRN2	Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 5' end.
GO:0008417	GO	MF	fucosyltransferase activity	FUT1,FUT10,FUT2,FUT3,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,POFUT1,POFUT2	Catalysis of the transfer of a fucosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
GO:0008420	GO	MF	CTD phosphatase activity	CTDP1,CTDSP1,CTDSP2,PPM1M,RPAP2,SSU72	Catalysis of the reaction: phospho-(DNA-directed RNA polymerase) + H2O = (DNA-directed RNA polymerase) + phosphate.
GO:0008429	GO	MF	phosphatidylethanolamine binding	CD300A,ESYT2,MAP1LC3A,NF1,PEBP1	Interacting selectively and non-covalently with phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
GO:0008430	GO	MF	selenium binding	DIO1,DIO2,GPX3,RPH3A,SELT,SEP15	Interacting selectively and non-covalently with selenium (Se).
GO:0008443	GO	MF	phosphofructokinase activity	PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP	Catalysis of the transfer of a phosphate group, usually from ATP, to a fructose substrate molecule.
GO:0008469	GO	MF	histone-arginine N-methyltransferase activity	CARM1,PRMT1,PRMT2,PRMT5,PRMT6,PRMT7,PRMT8	Catalysis of the reaction: S-adenosyl-L-methionine + (histone)-arginine = S-adenosyl-L-homocysteine + (histone)-N-methyl-arginine.
GO:0008483	GO	MF	transaminase activity	AADAT,ABAT,AGXT,AGXT2,CCBL1,CCBL2,GOT1,GOT2,GPT,GPT2,PSAT1,TAT	Catalysis of the transfer of an amino group to an acceptor, usually a 2-oxo acid.
GO:0008484	GO	MF	sulfuric ester hydrolase activity	ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,GALNS,GNS,IDS,STS,SULF1,SULF2	Catalysis of the reaction: RSO-R' + H2O = RSOOH + R'H. This reaction is the hydrolysis of any sulfuric ester bond, any ester formed from sulfuric acid, O=SO(OH)2.
GO:0008494	GO	MF	translation activator activity	ABCF1,BOLL,DAZ1,DAZL,LARP1,PABPC1,PAIP1,RPS27L	Any of a group of soluble proteins functioning in the activation of ribosome-mediated translation of mRNA into a polypeptide.
GO:0008503	GO	MF	benzodiazepine receptor activity	GABRA2,GABRA3,GABRA4,GABRA6,GABRG2	Combining with benzodiazepines, a class of drugs with hypnotic, anxiolytic, anticonvulsive, amnestic and myorelaxant properties, to initiate a change in cell activity.
GO:0008504	GO	MF	monoamine transmembrane transporter activity	SLC18A1,SLC18A2,SLC6A2,SLC6A3,SLC6A4	Enables the transfer of monoamines, organic compounds that contain one amino group that is connected to an aromatic ring by an ethylene group (-CH2-CH2-), from one side of the membrane to the other.
GO:0008509	GO	MF	anion transmembrane transporter activity	ABCA1,ABCB11,ABCC11,ABCC3,ADAMTS8,AKR1C4,ANKH,ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,AQP9,ASNA1,BEST1,BEST2,BSND,CCT8L2,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,CTNS,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,GPR89A,LRRC8A,MFSD10,NMUR2,OCA2,PQLC2,SERINC1,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A2,SLC13A4,SLC16A1,SLC16A12,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC17A1,SLC17A2,SLC17A3,SLC17A4,SLC17A5,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC20A1,SLC20A2,SLC22A11,SLC22A16,SLC22A4,SLC22A5,SLC22A6,SLC22A7,SLC22A8,SLC22A9,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A15,SLC25A17,SLC25A22,SLC25A24,SLC25A3,SLC25A42,SLC25A6,SLC26A1,SLC26A11,SLC26A2,SLC26A3,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC34A1,SLC34A2,SLC34A3,SLC35A1,SLC35A3,SLC35B2,SLC35B4,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A7,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC4A1,SLC4A11,SLC4A2,SLC4A4,SLC4A5,SLC4A7,SLC5A5,SLC6A14,SLC6A20,SLC6A5,SLC6A8,SLC6A9,SLC7A10,SLC7A11,SLC7A2,SLC7A4,SLC7A5,SLC7A6,SLC7A8,SLC7A9,SLCO1A2,SLCO1B1,SLCO1B3,SLCO2B1,TTYH1,TTYH3,VDAC1,VDAC2,VDAC3	Enables the transfer of a negatively charged ion from one side of a membrane to the other.
GO:0008514	GO	MF	organic anion transmembrane transporter activity	ABCB11,ABCC11,ABCC3,AKR1C4,AQP9,CFTR,CTNS,MFSD10,OCA2,PQLC2,SERINC1,SLC13A2,SLC16A1,SLC16A12,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC17A3,SLC17A5,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC22A11,SLC22A16,SLC22A4,SLC22A5,SLC22A6,SLC22A7,SLC22A9,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A15,SLC25A17,SLC25A22,SLC25A24,SLC25A42,SLC25A6,SLC26A1,SLC26A3,SLC26A6,SLC26A7,SLC26A8,SLC35A1,SLC35A3,SLC35B2,SLC35B4,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A7,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC4A1,SLC4A11,SLC4A4,SLC4A5,SLC4A7,SLC6A14,SLC6A20,SLC6A5,SLC6A8,SLC6A9,SLC7A10,SLC7A11,SLC7A2,SLC7A4,SLC7A5,SLC7A6,SLC7A8,SLC7A9,SLCO1A2,SLCO1B1,SLCO1B3,SLCO2B1	Enables the transfer of organic anions from one side of a membrane to the other. Organic anions are atoms or small molecules with a negative charge which contain carbon in covalent linkage.
GO:0008517	GO	MF	folic acid transporter activity	FOLR1,FOLR2,SLC19A1,SLC19A2,SLC25A32,SLC46A1	Enables the directed movement of folic acid (pteroylglutamic acid) into, out of or within a cell, or between cells. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
GO:0008519	GO	MF	ammonium transmembrane transporter activity	AQP1,AZIN2,OAZ3,RHAG,RHBG,RHCG,SLC12A2,SLC18A3,SLC22A16,SLC22A4,SLC22A5,SLC44A1,SLC44A2,SLC5A7,SLC6A3,SLC6A4	Enables the transfer of ammonium from one side of a membrane to the other. Ammonium is the cation NH4+ which is formed from N2 by root-nodule bacteria in leguminous plants and is an excretory product in ammonotelic animals.
GO:0008526	GO	MF	phosphatidylinositol transporter activity	PITPNA,PITPNC1,PITPNM1,PITPNM3,SCP2,TNFAIP8L3	Enables the directed movement of phosphatidylinositol into, out of or within a cell, or between cells. Phosphatidylinositol refers to any glycophospholipids with its sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
GO:0008527	GO	MF	taste receptor activity	PKD1L3,PKD2L1,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8,TAS2R9	Combining with soluble compounds to initiate a change in cell activity. These receptors are responsible for the sense of taste.
GO:0008528	GO	MF	G-protein coupled peptide receptor activity	ACKR2,ACKR3,ACKR4,AGTR1,AVPR2,BDKRB2,C5AR1,CALCR,CALCRL,CCKBR,CCR1,CCR2,CCR3,CCR4,CCR5,CCR6,CCR7,CCR8,CCR9,CMKLR1,CX3CR1,CXCR1,CXCR2,CXCR3,CXCR4,EDNRA,EDNRB,F2R,FPR1,GAL,GALR1,GALR2,GALR3,GCGR,GP1BA,GPR143,GPR17,GPR37,GPR37L1,GPR75,HCRTR2,INPP5K,KISS1R,MAS1,MC1R,MC2R,MC3R,MC4R,MCHR1,NLRP6,NMUR1,NMUR2,NPBWR1,NPBWR2,NPFFR1,NPR1,NPR3,NPSR1,NPY1R,NPY2R,NPY5R,NTSR1,OGFR,OPRD1,OPRK1,OPRL1,OPRM1,PRLHR,RAMP1,SORCS1,SORCS2,SORCS3,SSTR1,TACR1,TACR2	Combining with a peptide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
GO:0008535	GO	BP	respiratory chain complex IV assembly	BCS1L,COA1,COA3,COA6,COX10,COX11,COX14,COX15,COX18,MT-CO3,SURF1,TIMM21	The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex IV (also known as cytochrome c oxidase), the terminal member of the respiratory chain of the mitochondrion and some aerobic bacteria. Cytochrome c oxidases are multi-subunit enzymes containing from 13 subunits in the mammalian mitochondrial form to 3-4 subunits in the bacterial forms.
GO:0008536	GO	MF	Ran GTPase binding	RANBP1,RANBP9,RANGRF,RGPD8,XPO5	Interacting selectively and non-covalently with Ran, a conserved Ras-like GTP-binding protein, implicated in nucleocytoplasmic transport, cell cycle progression, spindle assembly, nuclear organization and nuclear envelope (NE) assembly.
GO:0008542	GO	BP	visual learning	APP,CHRNB2,DRD1,DRD2,DRD3,FOXB1,GRIN1,NETO1,NF1,RGS14	Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.
GO:0008544	GO	BP	epidermis development	ALDH3A2,ALX4,ANXA1,APCDD1,ATP2A2,ATP2C1,ATP7A,BNC1,CALML5,CASP14,CDH3,CDSN,CERS3,CLIC4,COL17A1,COL7A1,CRABP2,CSTA,CTGF,CTNNB1,DCT,DLL1,DSP,EDA2R,EDAR,ELF3,EMP1,EPHA2,ERCC2,ERCC3,EREG,EVPL,EXPH5,FABP5,FGF7,FGFR2,FLG,FLOT2,FOXE1,FOXN1,FUZ,GJB5,GLI1,GLI2,GNAS,GRHL1,GRHL2,GRHL3,GRXCR1,HDAC1,HDAC2,HES5,HOXB13,INHBA,IVL,JAG1,JAG2,KDF1,KLK14,KLK5,KLK7,KRT14,KRT15,KRT16,KRT17,KRT2,KRT31,KRT32,KRT34,KRT5,KRT71,KRT83,KRT84,KRT85,KRT9,KRTAP5-9,LAMA3,LAMB3,LAMC2,LCE2B,LOR,LRTOMT,MED1,NTF4,PDGFA,PIP5K1A,PITX2,PLOD1,POU2F3,PTHLH,RBP2,S100A7,SCEL,SOD1,SOX9,SPINK5,SPRR1A,SPRR1B,SPRR2A,SPRR2B,SPRR2D,SPRR2E,SPRR2F,SPRR2G,SPRR3,ST14,STRC,STS,TGFB2,TGM1,TGM3,TGM5,TXNIP,UGCG,USH2A,WAS,WNT10A,WNT16,ZNF750	The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
GO:0008556	GO	MF	potassium-transporting ATPase activity	ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP4B	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + K+(out) = ADP + phosphate + K+(in).
GO:0008565	GO	MF	protein transporter activity	ABCG1,AP2S1,ARFGAP3,AZGP1,C11orf73,CALCR,CALCRL,CCT6B,CHMP7,COG2,COG3,COX18,CSE1L,EIF4ENIF1,GPIHBP1,IPO5,IPO9,ITGB1BP1,LRP1,MCL1,MLC1,NUPL2,PGAP2,RAMP1,RAMP2,RAMP3,RANGRF,RAP1A,SEC61G,SLC11A2,TIMM22,TOMM20,TOMM22,TOMM40,TOMM5,TOMM7,TOMM70A,TSNAX,VLDLR,VPS26A,XPO6,XPO7,ZFYVE16	Enables the directed movement of proteins into, out of or within a cell, or between cells.
GO:0008574	GO	MF	ATP-dependent microtubule motor activity, plus-end-directed	KIF14,KIF16B,KIF18A,KIF19,KIF20B,KIF3A,KIF3B	Catalysis of movement along a microtubule toward the plus end, coupled to the hydrolysis of ATP.
GO:0008584	GO	BP	male gonad development	ANKRD7,CSDE1,DMRT1,GATA1,GATA3,GATA4,ING2,INHBA,LHB,LHCGR,LRRC6,MEA1,MSH2,NCOA4,NR0B1,PRKACG,RAB13,RBMY1B,SCX,SIX4,SOX15,SOX8,SOX9,SRD5A2,TCF21,WNT4	The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
GO:0008585	GO	BP	female gonad development	ANG,BMPR1B,CCDC182,CEBPB,EIF2B2,EIF2B4,EIF2B5,EREG,FOXL2,FSHR,INHA,INHBA,INHBB,KIT,PDGFRA,PTPRN,SOD1,VEGFA,WNT4,ZNF830	The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
GO:0008588	GO	BP	release of cytoplasmic sequestered NF-kappaB	CD27,NLRP12,TNFSF14,TRIP6,ZNF268	The release of NF-kappaB from specific molecules in the cytoplasm to which it was bound, thereby allowing its translocation into the nucleus.
GO:0008589	GO	BP	regulation of smoothened signaling pathway	BTRC,CHRD,CREBBP,DCDC2,EVC,FGFR2,FUZ,GAS1,GLI1,GLI3,GLIS2,GPR161,HHIP,IFT122,IHH,INTU,KIF7,OTX2,PTCH1,PTCH2,RORA,SFRP1,SHH,STK36,SUFU,TULP3,ULK3,ZIC1	Any process that modulates the frequency, rate or extent of smoothened signaling.
GO:0008593	GO	BP	regulation of Notch signaling pathway	AAK1,C8orf4,CD46,CHAC1,DLK1,DLK2,DLL1,DLL4,DTX1,EGFL7,FBXW7,GALNT11,GATA2,HEY1,HIF1AN,ITGB1BP1,JAG1,JAG2,LFNG,MAGEA1,MESP1,MMP14,NEURL1,NOD2,NOV,NRARP,OVOL2,PDCD10,RITA1,STAT3,SYNJ2BP,TP63,TSPAN14,TSPAN5,WNT1	Any process that modulates the frequency, rate or extent of the Notch signaling pathway.
GO:0008595	GO	BP	anterior/posterior axis specification, embryo	BASP1,FZD5,HOXD8,PLD6,T,TBX3,TDGF1,TDRD5,WT1	The specification of the anterior/posterior axis of the embryo by the products of genes expressed maternally and genes expressed in the zygote.
GO:0008599	GO	MF	protein phosphatase type 1 regulator activity	PHACTR4,PPP1R15A,PPP1R16B,PPP1R1B,PPP1R7	Modulation of the activity of the enzyme protein phosphatase type 1.
GO:0008601	GO	MF	protein phosphatase type 2A regulator activity	ANKLE2,ARPP19,EIF2AK2,ENSA,IGBP1,PPME1,PPP2R1A,PPP2R2A,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5C,SET	Modulation of the activity of the enzyme protein phosphatase type 2A.
GO:0008603	GO	MF	cAMP-dependent protein kinase regulator activity	CXCL10,PRKAG1,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B	Modulation of the activity of the enzyme cAMP-dependent protein kinase.
GO:0008608	GO	BP	attachment of spindle microtubules to kinetochore	AURKB,AURKC,BUB3,CASC5,CENPE,CHAMP1,FAM175B,NDC80,RB1,SEH1L,SGOL1,TEX14,ZNF207	The process in which spindle microtubules become physically associated with the proteins making up the kinetochore complex.
GO:0008611	GO	BP	ether lipid biosynthetic process	AGPS,FAR1,FAR2,GNPAT,PEX7	The chemical reactions and pathways resulting in the formation of ether lipids, lipids that contain (normally) one lipid alcohol in ether linkage to one of the carbon atoms (normally C-1) of glycerol.
GO:0008622	GO	CC	epsilon DNA polymerase complex	CHRAC1,POLE,POLE2,POLE3,POLE4	A heterotetrameric DNA polymerase complex that catalyzes processive DNA synthesis in the absence of PCNA, but is further stimulated in the presence of PCNA. The complex contains a large catalytic subunit and three small subunits, and is best characterized in Saccharomyces, in which the subunits are named Pol2p, Dpb2p, Dpb3p, and Dpb4p. Some evidence suggests that DNA polymerase epsilon is the leading strand polymerase; it is also involved in nucleotide-excision repair and mismatch repair.
GO:0008625	GO	BP	extrinsic apoptotic signaling pathway via death domain receptors	BAG3,BAX,BCL2,BID,BLOC1S2,CASP8,CASP8AP2,CRADD,DAB2IP,DAXX,DDX3X,DDX47,DEDD2,DIABLO,FADD,FASLG,GABARAP,KIAA0141,MOAP1,NGF,SORT1,TNF,TNFRSF10A,TNFRSF10B,TNFRSF1A,TRADD	A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
GO:0008630	GO	BP	intrinsic apoptotic signaling pathway in response to DNA damage	ABL1,AEN,BAG6,BCL2L11,BCL3,BRCA1,CASP2,CASP9,CDIP1,CHEK2,CIDEB,CRIP1,DDIT4,DYRK2,E2F1,EP300,EPHA2,FNIP2,HIC1,HIPK2,HTRA2,IFI16,IKBKE,MOAP1,MSH6,PHLDA3,PML,PPP2R5C,PYCARD,RPS27L,SFN,SIRT1,SNW1,TOPORS,TP53,TP73,USP28	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
GO:0008631	GO	BP	intrinsic apoptotic signaling pathway in response to oxidative stress	ARL6IP5,CYP1B1,MAP3K5,PDCD10,PDK1,PRKCD,PRODH,STK24,STK25,ZNF622	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, and ends when the execution phase of apoptosis is triggered.
GO:0008635	GO	BP	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	APAF1,BAX,CASP3,CASP7,CASP9,CYCS	Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c.
GO:0008637	GO	BP	apoptotic mitochondrial changes	ACAA2,AIFM2,ATF2,ATG3,ATP2A1,BAK1,BAX,BBC3,BCL2,BCL2L1,BID,BLOC1S2,BNIP3,CAMK2A,CCAR2,CDKN2A,CLU,DNM1L,ERBB4,FIS1,GGCT,HK2,IFI6,IFIT2,MFF,MOAP1,NAIF1,NDUFS1,RHOT1,RHOT2,SFN,SOD2,THEM4,TIMM50	The morphological and physiological alterations undergone by mitochondria during apoptosis.
GO:0008641	GO	MF	small protein activating enzyme activity	ATG7,MOCS3,NAE1,SAE1,UBA1,UBA2,UBA3,UBA5,UBA6,UBA7	Catalysis of the activation of small proteins, such as ubiquitin or ubiquitin-like proteins, through the formation of an ATP-dependent high-energy thiolester bond.
GO:0008643	GO	BP	carbohydrate transport	AAAS,AQP1,AQP2,AQP7,AQP9,BRAF,EDNRA,G6PC,G6PC2,G6PC3,GCK,GCKR,GH1,HK1,HK2,HK3,HNF1A,INS,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PLA2G1B,POM121,POM121C,PPARD,PPBP,RAB4B,RAE1,RANBP2,SEH1L,SLC23A1,SLC23A2,SLC26A6,SLC2A1,SLC2A10,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC2A8,SLC2A9,SLC35B1,SLC37A4,SLC5A1,SORBS1,SORT1,TPR	The directed movement of carbohydrate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Carbohydrates are any of a group of organic compounds based of the general formula Cx(H2O)y.
GO:0008652	GO	BP	cellular amino acid biosynthetic process	ADI1,AGXT,AGXT2,ALDH18A1,APIP,ASNS,ASPA,BHMT,BHMT2,CARNS1,CBS,CCBL1,CDO1,CPS1,CTH,DHFR,ENOPH1,FOLH1,FPGS,GADL1,GAMT,GATM,GGT1,GLS,GLS2,GLUD1,GLUD2,GLUL,GOT1,GOT2,GPT,GPT2,MRI1,MTAP,MTHFD1,MTR,MTRR,NAALAD2,OAT,OTC,PADI2,PADI4,PAH,PHGDH,PLOD1,PSAT1,PSPH,PYCR1,PYCR2,PYCRL,SEPHS2,SRR	The chemical reactions and pathways resulting in the formation of amino acids, organic acids containing one or more amino substituents.
GO:0008656	GO	MF	cysteine-type endopeptidase activator activity involved in apoptotic process	APAF1,BAD,BCL2L13,CARD8,CASP1,CASP8AP2,CDKN1B,CTSH,GNB2L1,NGFRAP1,NKX3-1,NLRP1,NLRP12,NOD1,PYCARD,RPS27L	Increases the rate of proteolysis catalyzed by a cysteine-type endopeptidase involved in the apoptotic process.
GO:0008757	GO	MF	S-adenosylmethionine-dependent methyltransferase activity	ARMT1,AS3MT,ASH1L,ASH2L,ASMT,BHMT2,CARM1,CARNMT1,CMTR1,CMTR2,CXXC1,DNMT1,DNMT3A,DNMT3B,DOT1L,DPH5,EEF2KMT,EHMT1,EHMT2,EMG1,EZH2,FBL,FBXO11,FTSJ2,GAMT,GNMT,ICMT,INMT,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,LRTOMT,MEN1,MEPCE,METTL1,METTL14,METTL20,METTL21A,METTL21C,METTL2A,METTL2B,METTL3,NSD1,NSUN2,PCMT1,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,RNMT,RRP8,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,TRDMT1,TRMT61B,VCPKMT,WDR4,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to a substrate.
GO:0008821	GO	MF	crossover junction endodeoxyribonuclease activity	GEN1,RAD51C,SLX1A,SLX4,XRCC3	Catalysis of the endonucleolytic cleavage at a junction such as a reciprocal single-stranded crossover between two homologous DNA duplexes (Holliday junction).
GO:0009008	GO	MF	DNA-methyltransferase activity	DNMT1,DNMT3A,DNMT3B,MGMT,TRDMT1	Catalysis of the transfer of a methyl group to a DNA molecule.
GO:0009055	GO	MF	electron carrier activity	ADH5,AIFM1,AKR1A1,AKR1B1,AKR1C4,AKR7A2,AKR7A3,ALDH2,ALDH4A1,AOC2,ASPH,COX10,COX11,COX15,COX4I2,COX5A,COX6B1,CYB5A,CYBA,CYBB,CYC1,CYCS,CYP19A1,CYP1A2,DEGS1,DHDH,DHRS3,DMGDH,ETFA,ETFB,ETFDH,FDX1,GLDC,GLRX2,GPX2,GSR,HAAO,HSD17B6,IDH3B,IDO1,LOXL2,MAOB,ME1,ME2,MT-CO1,MT-CO2,NCF1,NCF2,NDUFA4,NDUFS1,NDUFS2,NDUFS3,NDUFS6,NDUFV2,NOX4,NQO2,P4HA2,PHGDH,QDPR,RDH16,SDHD,SRD5A1,TSTA3,UGDH,UQCR11	Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
GO:0009060	GO	BP	aerobic respiration	ACO2,BLOC1S1,CS,DLD,DLST,FH,IDH2,IDH3A,IDH3B,IDH3G,MDH2,ME3,MTFR1,MTFR2,NNT,OGDH,OXA1L,PDHA1,PDHB,SDHA,SDHB,SDHC,SDHD,SIRT3,SLC25A14,SUCLA2,SUCLG1,SUCLG2,SURF1,UQCRB,UQCRC1,UQCRC2,UQCRH	The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which requires oxygen as the terminal electron acceptor.
GO:0009062	GO	BP	fatty acid catabolic process	ABCD1,ABCD2,ABCD3,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOT8,ACOX1,ACOX2,ACOX3,ADIPOQ,AMACR,BDH2,CEL,CRAT,CROT,CYP4A11,CYP4F12,CYP4F2,DECR1,ECHS1,ECI1,ECI2,EHHADH,ETFA,ETFB,ETFDH,FAAH,GCDH,HACL1,HADH,HADHA,HADHB,HAO1,HSD17B4,LPIN1,MCEE,MMAA,MUT,PCCA,PCCB,PEX13,PEX2,PHYH,PLA2G15,PPARD,SCP2,SLC25A17,SLC27A2	The chemical reactions and pathways resulting in the breakdown of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
GO:0009063	GO	BP	cellular amino acid catabolic process	AADAT,AASS,ABAT,ACAD8,ACADSB,ACAT1,ACMSD,AFMID,AGXT,AGXT2,ALDH4A1,ALDH5A1,ALDH6A1,ALDH7A1,ALDH9A1,AMDHD1,ARG1,ASL,ASPA,ASRGL1,AUH,BBOX1,BCAT1,BCAT2,BCKDHA,BCKDHB,BCKDK,CARNS1,CBS,CCBL1,CCBL2,CDO1,CRYM,CSAD,CTH,DAO,DBT,DDAH1,DDAH2,DDO,DLD,DLST,ETHE1,FAH,FTCD,GAD1,GCDH,GCSH,GLDC,GLS,GLUD1,GLUD2,GLUL,GOT1,GOT2,GSTZ1,HAAO,HAL,HDC,HGD,HIBADH,HIBCH,HMGCL,HNMT,HOGA1,HPD,HSD17B10,HYKK,IDO1,IDO2,IL4I1,IVD,KMO,KYNU,MCCC1,MCCC2,MTHFS,MTRR,NOS1,NOS2,NOS3,OGDH,OTC,PAH,PCBD1,PHYKPL,PIPOX,PPM1K,PRODH,QDPR,SDS,SHMT1,SLC25A10,SLC25A21,SQRDL,SUOX,TAT,TDO2,THNSL2,TMLHE,TST,UROC1	The chemical reactions and pathways resulting in the breakdown of amino acids, organic acids containing one or more amino substituents.
GO:0009064	GO	BP	glutamine family amino acid metabolic process	AADAT,ALDH18A1,ALDH4A1,ALDH5A1,ARG1,ART4,ASL,ASRGL1,CAD,DAO,DDAH1,DDAH2,FPGS,GAD1,GCLC,GCLM,GGT1,GLS,GLUD1,GLUD2,GLUL,GOT1,GOT2,MTHFS,NAGS,NIT2,NOS1,NOS2,NOS3,PRODH,PYCR1,PYCR2,PYCRL,SIRT4,TAT	The chemical reactions and pathways involving amino acids of the glutamine family, comprising arginine, glutamate, glutamine and proline.
GO:0009065	GO	BP	glutamine family amino acid catabolic process	ALDH4A1,ARG1,ASL,ASRGL1,DAO,DDAH1,DDAH2,GAD1,GLS,GLUD1,GLUD2,GLUL,NOS1,NOS2,NOS3,PRODH	The chemical reactions and pathways resulting in the breakdown of amino acids of the glutamine family, comprising arginine, glutamate, glutamine and proline.
GO:0009066	GO	BP	aspartate family amino acid metabolic process	AADAT,AASS,ADI1,ALDH7A1,APIP,ASNS,ASPA,ASRGL1,ASS1,BHMT,BHMT2,CRYM,DDO,DLD,DLST,ENOPH1,GCDH,GOT1,GOT2,HYKK,MRI1,MSRA,MTAP,MTHFD1,MTHFR,MTR,MTRR,NIT2,OGDH,PHYKPL,PIPOX,PLOD1,SLC25A21,SMS	The chemical reactions and pathways involving amino acids of the aspartate family, comprising asparagine, aspartate, lysine, methionine and threonine.
GO:0009067	GO	BP	aspartate family amino acid biosynthetic process	ADI1,APIP,ASNS,BHMT,BHMT2,ENOPH1,GOT1,MRI1,MTAP,MTHFD1,MTR,MTRR,PLOD1	The chemical reactions and pathways resulting in the formation of amino acids of the aspartate family, comprising asparagine, aspartate, lysine, methionine and threonine.
GO:0009068	GO	BP	aspartate family amino acid catabolic process	AADAT,AASS,ALDH7A1,ASPA,ASRGL1,CRYM,DDO,DLD,DLST,GCDH,GOT1,GOT2,HYKK,OGDH,PHYKPL,PIPOX,SLC25A21	The chemical reactions and pathways resulting in the breakdown of amino acids of the aspartate family, comprising asparagine, aspartate, lysine, methionine and threonine.
GO:0009069	GO	BP	serine family amino acid metabolic process	AGXT,AGXT2,BAAT,CBS,CDO1,CTH,DAO,DMGDH,EEFSEC,FAU,GCLC,GCSH,GGT1,GLDC,GLYAT,MTHFD1,MTRR,PHGDH,PSAT1,PSPH,PSTK,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SARS,SDS,SECISBP2,SEPHS2,SEPSECS,SHMT1,SHMT2,SLC25A32,SRR,THNSL2,UBA52	The chemical reactions and pathways involving amino acids of the serine family, comprising cysteine, glycine, homoserine, selenocysteine and serine.
GO:0009070	GO	BP	serine family amino acid biosynthetic process	AGXT,AGXT2,CBS,CTH,GGT1,MTHFD1,PHGDH,PSAT1,PSPH,SEPHS2,SRR	The chemical reactions and pathways resulting in the formation of amino acids of the serine family, comprising cysteine, glycine, homoserine, selenocysteine and serine.
GO:0009071	GO	BP	serine family amino acid catabolic process	AGXT,CBS,DAO,GCSH,GLDC,SDS,SHMT1,THNSL2	The chemical reactions and pathways resulting in the breakdown of amino acids of the serine family, comprising cysteine, glycine, homoserine, selenocysteine and serine.
GO:0009072	GO	BP	aromatic amino acid family metabolic process	AADAT,ACMSD,AFMID,ASRGL1,ATP7A,CCBL1,CCBL2,DCT,FAH,GSTZ1,HAAO,HGD,HPD,IDO1,IDO2,IL4I1,KMO,KYNU,PAH,PCBD1,QDPR,TAT,TDO2,TH,TYR	The chemical reactions and pathways involving aromatic amino acid family, amino acids with aromatic ring (phenylalanine, tyrosine, tryptophan).
GO:0009074	GO	BP	aromatic amino acid family catabolic process	AADAT,ACMSD,AFMID,ASRGL1,CCBL1,CCBL2,FAH,GSTZ1,HAAO,HGD,HPD,IDO1,IDO2,IL4I1,KMO,KYNU,PAH,PCBD1,QDPR,TAT,TDO2	The chemical reactions and pathways resulting in the breakdown of aromatic amino acid family, amino acids with aromatic ring (phenylalanine, tyrosine, tryptophan).
GO:0009081	GO	BP	branched-chain amino acid metabolic process	ACAD8,ACADSB,ACAT1,ALDH6A1,ALDH9A1,AUH,BBOX1,BCAT1,BCAT2,BCKDHA,BCKDHB,BCKDK,DBT,DLD,GHR,HIBADH,HIBCH,HMGCL,HSD17B10,IVD,MCCC1,MCCC2,PPM1K,SHMT1,STAT5A,STAT5B,TMLHE	The chemical reactions and pathways involving amino acids containing a branched carbon skeleton, comprising isoleucine, leucine and valine.
GO:0009083	GO	BP	branched-chain amino acid catabolic process	ACAD8,ACADSB,ACAT1,ALDH6A1,ALDH9A1,AUH,BBOX1,BCAT1,BCAT2,BCKDHA,BCKDHB,BCKDK,DBT,DLD,HIBADH,HIBCH,HMGCL,HSD17B10,IVD,MCCC1,MCCC2,PPM1K,SHMT1,TMLHE	The chemical reactions and pathways resulting in the breakdown of amino acids containing a branched carbon skeleton, comprising isoleucine, leucine and valine.
GO:0009084	GO	BP	glutamine family amino acid biosynthetic process	ALDH18A1,GLS,GLUD1,GLUD2,GLUL,PYCR1,PYCR2,PYCRL	The chemical reactions and pathways resulting in the formation of amino acids of the glutamine family, comprising arginine, glutamate, glutamine and proline.
GO:0009086	GO	BP	methionine biosynthetic process	ADI1,APIP,BHMT,BHMT2,ENOPH1,GOT1,MRI1,MTAP,MTHFD1,MTR,MTRR	The chemical reactions and pathways resulting in the formation of methionine (2-amino-4-(methylthio)butanoic acid), a sulfur-containing, essential amino acid found in peptide linkage in proteins.
GO:0009108	GO	BP	coenzyme biosynthetic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSS1,ADCK3,AGK,COASY,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,DHFR,DLD,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FASN,FPGS,GCH1,HACD1,HACD2,HSD17B12,LIAS,MAT2A,MAT2B,ME1,MLYCD,MOCS1,MOCS2,MOCS3,MTHFD1,NMNAT1,NMNAT2,NMNAT3,OLAH,PANK1,PANK2,PDHA1,PDHB,PDHX,PDSS1,PDSS2,PDXK,PNP,PPCDC,PPCS,PPT1,PPT2,SCD,SLC25A1,SLC25A16,SPR,TECR,THEM4,THEM5,UBIAD1	The chemical reactions and pathways resulting in the formation of coenzymes, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.
GO:0009109	GO	BP	coenzyme catabolic process	ACOT7,CYP4F11,CYP4F2,MLYCD,MTHFS,NUDT12,NUDT7,VCP	The chemical reactions and pathways resulting in the breakdown of coenzymes, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.
GO:0009110	GO	BP	vitamin biosynthetic process	BCO1,CYP27B1,CYP3A4,PSAT1,RFK,UBIAD1	The chemical reactions and pathways resulting in the formation of a vitamin, one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0009111	GO	BP	vitamin catabolic process	CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP4F11,CYP4F2,FGF23,MTHFS	The chemical reactions and pathways resulting in the breakdown of a vitamin, one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0009112	GO	BP	nucleobase metabolic process	ADA,ADAL,ADK,ADSL,ADSS,ADSSL1,AGXT2,ALDH6A1,AMPD1,AMPD2,AMPD3,APRT,ATIC,CAD,CAT,CDA,DCK,DCTD,DGUOK,DHODH,DPYD,DPYS,DUT,GART,GDA,GMPR,GMPR2,GMPS,GPX1,HPRT1,IMPDH1,IMPDH2,LHPP,NT5C,NT5C1A,NT5C1B,NT5C2,NT5C3A,NT5E,NT5M,PAICS,PFAS,PNP,PPAT,PRPS1,PUDP,SHMT1,TK1,TK2,TYMP,TYMS,UCK1,UCK2,UMPS,UPB1,UPP1,UPP2,XDH	The chemical reactions and pathways involving a nucleobase, a nitrogenous base that is a constituent of a nucleic acid, e.g. the purines: adenine, guanine, hypoxanthine, xanthine and the pyrimidines: cytosine, uracil, thymine.
GO:0009113	GO	BP	purine nucleobase biosynthetic process	GMPS,HPRT1,PAICS,PRPS1,SHMT1	The chemical reactions and pathways resulting in the formation of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.
GO:0009123	GO	BP	nucleoside monophosphate metabolic process	ADK,ADSL,ADSS,ADSSL1,AK3,AK4,AK5,AK9,ALDOA,ALDOB,ALDOC,AMPD2,AMPD3,ATIC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CARD11,CASK,CHCHD10,CMPK1,COA6,COX10,COX15,CTNS,DCK,DGUOK,DLG1,DLG2,DNPH1,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GART,GBAS,GCK,GMPR2,GMPS,GPI,HK1,HK2,HK3,HPRT1,HSPA1A,HSPA1B,HSPA8,IMPDH1,IMPDH2,LDHA,LHPP,MAGI3,MPP1,MPP2,MPP3,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,OLA1,PAICS,PDE6A,PDE6B,PFAS,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPAT,PPP2R5D,PRKAG2,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TJP2,TK1,TPI1,TYMS,UMPS,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.
GO:0009124	GO	BP	nucleoside monophosphate biosynthetic process	ADK,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,ATIC,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,CMPK1,DCK,DGUOK,GART,GBAS,GMPS,IMPDH1,IMPDH2,LHPP,MT-ATP6,MT-ATP8,PAICS,PFAS,PPAT,PRKAG2,SLC25A13,STOML2,SURF1,TGFB1,TK1,TYMS,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.
GO:0009132	GO	BP	nucleoside diphosphate metabolic process	AK1,AK4,AK5,AK7,AK8,AK9,ALDOA,ALDOB,ALDOC,BAD,CARD11,CASK,CMPK1,CMPK2,DLG1,DLG2,ENO1,ENO2,ENO3,ENTPD4,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,MAGI3,MPP1,MPP2,MPP3,NUDT16,NUDT18,NUDT5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TJP2,TPI1	The chemical reactions and pathways involving a nucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with diphosphate on the sugar.
GO:0009141	GO	BP	nucleoside triphosphate metabolic process	AK1,AK3,AK4,AK5,AK7,AK8,AK9,ALDOA,ALDOB,ALDOC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CHCHD10,CMPK1,CMPK2,COA6,COX10,COX15,CTNS,CTPS1,DCTPP1,ENO1,ENO2,ENO3,ENPP1,ENPP3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GNAI3,GPI,HK1,HK2,HK3,HSPA1A,HSPA1B,HSPA8,LDHA,LRRK2,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NME2,NUDT1,NUDT15,NUDT16,OLA1,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,PRKAG2,RHOQ,SAMHD1,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.
GO:0009142	GO	BP	nucleoside triphosphate biosynthetic process	AK1,AK4,AK5,AK7,AK8,AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,CMPK1,CMPK2,CTPS1,GBAS,MT-ATP6,MT-ATP8,NME2,PRKAG2,SLC25A13,STOML2,SURF1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.
GO:0009143	GO	BP	nucleoside triphosphate catabolic process	DCTPP1,ENPP1,ENPP3,NUDT1,NUDT15,NUDT16,SAMHD1	The chemical reactions and pathways resulting in the breakdown of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.
GO:0009144	GO	BP	purine nucleoside triphosphate metabolic process	AK3,AK4,AK9,ALDOA,ALDOB,ALDOC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CHCHD10,COA6,COX10,COX15,CTNS,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GNAI3,GPI,HK1,HK2,HK3,HSPA1A,HSPA1B,HSPA8,LDHA,LRRK2,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUDT1,NUDT15,NUDT16,OLA1,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,PRKAG2,RHOQ,SAMHD1,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.
GO:0009151	GO	BP	purine deoxyribonucleotide metabolic process	AK5,AK9,MPG,MUTYH,NUDT1,NUDT15,NUDT16,NUDT18,OGG1,SAMHD1	The chemical reactions and pathways involving purine deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a purine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009152	GO	BP	purine ribonucleotide biosynthetic process	ACOT7,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,AQP1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,COASY,GBAS,GNAS,GUCY1A3,GUCY1B3,HTR2B,HTR2C,MT-ATP6,MT-ATP8,NPPA,NPPB,NPPC,NPR1,NPR2,PANK2,PAPSS1,PAPSS2,PFAS,PPCDC,PPCS,PRKAG2,RAMP2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009154	GO	BP	purine ribonucleotide catabolic process	AMPD3,HINT1,HPRT1,MLYCD,NUDT16,NUDT18,NUDT7,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A	The chemical reactions and pathways resulting in the breakdown of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009155	GO	BP	purine deoxyribonucleotide catabolic process	MPG,MUTYH,NUDT1,NUDT15,NUDT16,NUDT18,OGG1,SAMHD1	The chemical reactions and pathways resulting in the breakdown of purine deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a purine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009156	GO	BP	ribonucleoside monophosphate biosynthetic process	ADK,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,ATIC,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,CMPK1,GART,GBAS,GMPS,IMPDH1,IMPDH2,LHPP,MT-ATP6,MT-ATP8,PAICS,PFAS,PPAT,PRKAG2,SLC25A13,STOML2,SURF1,TGFB1,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.
GO:0009161	GO	BP	ribonucleoside monophosphate metabolic process	ADK,ADSL,ADSS,ADSSL1,AK3,AK4,AK5,AK9,ALDOA,ALDOB,ALDOC,AMPD2,AMPD3,ATIC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CARD11,CASK,CHCHD10,CMPK1,COA6,COX10,COX15,CTNS,DLG1,DLG2,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GART,GBAS,GCK,GMPR2,GMPS,GPI,HK1,HK2,HK3,HPRT1,HSPA1A,HSPA1B,HSPA8,IMPDH1,IMPDH2,LDHA,LHPP,MAGI3,MPP1,MPP2,MPP3,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,OLA1,PAICS,PDE6A,PDE6B,PFAS,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPAT,PPP2R5D,PRKAG2,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TJP2,TPI1,UMPS,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.
GO:0009162	GO	BP	deoxyribonucleoside monophosphate metabolic process	DCK,DGUOK,DNPH1,TK1,TYMS	The chemical reactions and pathways involving a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.
GO:0009163	GO	BP	nucleoside biosynthetic process	ACOT7,ADA,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CAD,CDA,CHCHD10,CMPK1,COASY,CTPS1,DCK,DCTD,DHFRL1,DHODH,DUT,GBAS,HPRT1,MAT2A,MAT2B,MT-ATP6,MT-ATP8,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,PRKAG2,PUDP,QTRT1,QTRTD1,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TGFB1,TK1,TK2,TYMP,TYMS,UCK1,UCK2,UMPS,UPP1,UPP2,VPS9D1	The chemical reactions and pathways resulting in the formation of any one of a family of organic molecules consisting of a purine or pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
GO:0009164	GO	BP	nucleoside catabolic process	ADA,AGXT2,AMPD3,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,CECR1,DERA,DPYD,DPYS,ENPP4,ENTPD4,HPRT1,MLYCD,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,NUDT18,NUDT7,PNP,TYMP,UPB1,UPP1,UPP2	The chemical reactions and pathways resulting in the breakdown of any one of a family of organic molecules consisting of a purine or pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
GO:0009165	GO	BP	nucleotide biosynthetic process	ACOT7,ADA,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,AQP1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,CMPK1,COASY,CTPS1,GARS,GBAS,GNAS,GUCY1A3,GUCY1B3,HPRT1,HTR2B,HTR2C,MB21D1,ME1,MT-ATP6,MT-ATP8,MTHFD1,NMNAT1,NMNAT2,NMNAT3,NPPA,NPPB,NPPC,NPR1,NPR2,OAS1,OAS2,PANK2,PAPSS1,PAPSS2,PFAS,PNP,PPAT,PPCDC,PPCS,PRKAG2,PRPS1,RAMP2,RRM1,RRM2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,TYMS,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).
GO:0009166	GO	BP	nucleotide catabolic process	AMPD3,CAT,ENTPD4,GDA,GPX1,HINT1,HPRT1,MBD4,MLYCD,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5C1A,NT5C1B,NT5C2,NT5E,NT5M,NTHL1,NUDT1,NUDT12,NUDT15,NUDT16,NUDT18,NUDT3,NUDT7,OGG1,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A,PNP,SAMHD1,SMUG1,TDG,UNG,VCP,XDH	The chemical reactions and pathways resulting in the breakdown of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).
GO:0009167	GO	BP	purine ribonucleoside monophosphate metabolic process	ADSL,ADSS,ADSSL1,AK3,AK4,AK5,AK9,ALDOA,ALDOB,ALDOC,AMPD2,AMPD3,ATIC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CARD11,CASK,CHCHD10,COA6,COX10,COX15,CTNS,DLG1,DLG2,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GART,GBAS,GCK,GMPR2,GMPS,GPI,HK1,HK2,HK3,HPRT1,HSPA1A,HSPA1B,HSPA8,IMPDH1,IMPDH2,LDHA,LHPP,MAGI3,MPP1,MPP2,MPP3,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,OLA1,PAICS,PDE6A,PDE6B,PFAS,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPAT,PPP2R5D,PRKAG2,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TJP2,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.
GO:0009168	GO	BP	purine ribonucleoside monophosphate biosynthetic process	ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,ATIC,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,GART,GBAS,GMPS,IMPDH1,IMPDH2,LHPP,MT-ATP6,MT-ATP8,PAICS,PFAS,PPAT,PRKAG2,SLC25A13,STOML2,SURF1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.
GO:0009179	GO	BP	purine ribonucleoside diphosphate metabolic process	AK5,AK9,ALDOA,ALDOB,ALDOC,BAD,CARD11,CASK,DLG1,DLG2,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,MAGI3,MPP1,MPP2,MPP3,NUDT16,NUDT18,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TJP2,TPI1	The chemical reactions and pathways involving purine ribonucleoside diphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with diphosphate on the sugar.
GO:0009185	GO	BP	ribonucleoside diphosphate metabolic process	AK5,AK9,ALDOA,ALDOB,ALDOC,BAD,CARD11,CASK,DLG1,DLG2,ENO1,ENO2,ENO3,ENTPD4,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,MAGI3,MPP1,MPP2,MPP3,NUDT16,NUDT18,NUDT5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TJP2,TPI1	The chemical reactions and pathways involving a ribonucleoside diphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with diphosphate on the sugar.
GO:0009187	GO	BP	cyclic nucleotide metabolic process	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,AMPD2,AQP1,CALCRL,GNAS,GUCY1A3,GUCY1B3,HTR2B,HTR2C,MB21D1,NPPA,NPPB,NPPC,NPR1,NPR2,NUDT4,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE8A,PDE8B,PDE9A,PTH,PTHLH,RAMP2,TAAR1	The chemical reactions and pathways involving a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
GO:0009190	GO	BP	cyclic nucleotide biosynthetic process	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,AMPD2,AQP1,CALCRL,GNAS,GUCY1A3,GUCY1B3,HTR2B,HTR2C,MB21D1,NPPA,NPPB,NPPC,NPR1,NPR2,RAMP2,TAAR1	The chemical reactions and pathways resulting in the formation of a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
GO:0009199	GO	BP	ribonucleoside triphosphate metabolic process	AK3,AK4,AK9,ALDOA,ALDOB,ALDOC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CHCHD10,COA6,COX10,COX15,CTNS,CTPS1,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GNAI3,GPI,HK1,HK2,HK3,HSPA1A,HSPA1B,HSPA8,LDHA,LRRK2,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,OLA1,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,PRKAG2,RHOQ,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.
GO:0009201	GO	BP	ribonucleoside triphosphate biosynthetic process	AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,CTPS1,GBAS,MT-ATP6,MT-ATP8,PRKAG2,SLC25A13,STOML2,SURF1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.
GO:0009205	GO	BP	purine ribonucleoside triphosphate metabolic process	AK3,AK4,AK9,ALDOA,ALDOB,ALDOC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CHCHD10,COA6,COX10,COX15,CTNS,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GNAI3,GPI,HK1,HK2,HK3,HSPA1A,HSPA1B,HSPA8,LDHA,LRRK2,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,OLA1,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,PRKAG2,RHOQ,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.
GO:0009214	GO	BP	cyclic nucleotide catabolic process	PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A	The chemical reactions and pathways resulting in the breakdown of a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
GO:0009215	GO	BP	purine deoxyribonucleoside triphosphate metabolic process	AK9,NUDT1,NUDT15,NUDT16,SAMHD1	The chemical reactions and pathways involving purine deoxyribonucleoside triphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.
GO:0009218	GO	BP	pyrimidine ribonucleotide metabolic process	AK3,AK5,CMPK1,CTPS1,ENTPD4,UMPS	The chemical reactions and pathways involving a pyrimidine ribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009219	GO	BP	pyrimidine deoxyribonucleotide metabolic process	MBD4,NEIL1,NEIL2,NT5C,NT5M,NTHL1,OGG1,SMUG1,TDG,TYMS,UNG	The chemical reactions and pathways involving a pyrimidine deoxynucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009223	GO	BP	pyrimidine deoxyribonucleotide catabolic process	MBD4,NEIL1,NEIL2,NT5C,NT5M,NTHL1,OGG1,SMUG1,TDG,UNG	The chemical reactions and pathways resulting in the breakdown of a pyrimidine deoxyribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009225	GO	BP	nucleotide-sugar metabolic process	B4GALNT2,CSGALNACT1,EXTL2,FUT8,GFPT1,GFPT2,GMDS,GMPPA,GMPPB,GNPNAT1,MPI,PGM3,PMM1,PMM2,SLC35A3,SLC35D1,TSTA3,UAP1,UGDH,UGGT1,UGGT2,UGP2	The cellular chemical reactions and pathways involving nucleotide-sugars, any nucleotide-carbohydrate in which the distal phosphoric residue of a nucleoside 5'-diphosphate is in glycosidic linkage with a monosaccharide or monosaccharide derivative.
GO:0009226	GO	BP	nucleotide-sugar biosynthetic process	GFPT1,GFPT2,GMDS,GMPPA,GMPPB,GNPNAT1,MPI,PGM3,PMM1,PMM2,SLC35D1,TSTA3,UAP1,UGDH,UGP2	The chemical reactions and pathways resulting in the formation of nucleotide-sugars, any nucleotide-carbohydrate in which the distal phosphoric residue of a nucleoside 5'-diphosphate is in glycosidic linkage with a monosaccharide or monosaccharide derivative.
GO:0009235	GO	BP	cobalamin metabolic process	ABCC1,ABCD4,AMN,CD320,CTRB1,CTRB2,CTRC,CUBN,GIF,LMBRD1,MMAA,MMAB,MMACHC,MMADHC,MTR,MTRR,MUT,PRSS1,PRSS3,TCN1,TCN2	The chemical reactions and pathways involving cobalamin (vitamin B12), a water-soluble vitamin characterized by possession of a corrin nucleus containing a cobalt atom.
GO:0009247	GO	BP	glycolipid biosynthetic process	A4GALT,B3GNT5,DPM1,DPM2,DPM3,GBGT1,GPAA1,LARGE,MPPE1,PGAP1,PGAP2,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PYURF,ST3GAL5,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,UGCG	The chemical reactions and pathways resulting in the formation of glycolipid, a class of 1,2-di-O-acylglycerols joined at oxygen 3 by a glycosidic linkage to a carbohydrate part (usually a mono-, di- or tri-saccharide).
GO:0009251	GO	BP	glucan catabolic process	AGL,CALM1,CPS1,GAA,GYG1,GYG2,MGAM,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PYGB,PYGL,PYGM,STBD1	The chemical reactions and pathways resulting in the breakdown of glucans, polysaccharides consisting only of glucose residues.
GO:0009260	GO	BP	ribonucleotide biosynthetic process	ACOT7,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,AQP1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,CMPK1,COASY,CTPS1,GBAS,GNAS,GUCY1A3,GUCY1B3,HTR2B,HTR2C,MT-ATP6,MT-ATP8,NPPA,NPPB,NPPC,NPR1,NPR2,PANK2,PAPSS1,PAPSS2,PFAS,PPCDC,PPCS,PRKAG2,RAMP2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009261	GO	BP	ribonucleotide catabolic process	AMPD3,ENTPD4,HINT1,HPRT1,MLYCD,NUDT16,NUDT18,NUDT7,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A	The chemical reactions and pathways resulting in the breakdown of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009262	GO	BP	deoxyribonucleotide metabolic process	AK5,AK9,MBD4,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5M,NTHL1,NUDT1,NUDT15,NUDT16,NUDT18,OGG1,RRM1,RRM2,SAMHD1,SMUG1,TDG,TYMS,UNG	The chemical reactions and pathways involving a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009264	GO	BP	deoxyribonucleotide catabolic process	MBD4,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5M,NTHL1,NUDT1,NUDT15,NUDT16,NUDT18,OGG1,SAMHD1,SMUG1,TDG,UNG	The chemical reactions and pathways resulting in the breakdown of a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009266	GO	BP	response to temperature stimulus	AAAS,ACOT11,AKT1,AKT1S1,ANO1,ATM,ATR,ATXN3,BAG1,BAG2,BAG3,BAG4,BAG5,C11orf73,C8orf4,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CCAR2,CIRBP,CLPB,CREBBP,CRNN,CRYAB,DNAJB1,DNAJB4,DNAJB6,DNAJC2,DNAJC3,DNAJC7,EIF2AK3,EIF2AK4,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EP300,EPHB1,ERO1A,FGF1,FGF16,FKBP4,FOXO1,GCLC,GLRX2,GMPR,GSK3B,HDAC6,HMOX1,HSBP1,HSF1,HSP90AA1,HSP90AB1,HSPA1A,HSPA1B,HSPA1L,HSPA2,HSPA6,HSPA8,HSPB8,HSPD1,HSPH1,HTR2B,HTRA2,IGF1,IL1A,KCNK4,MAP2K7,MAPK1,MAPK3,MAPKAPK2,METRNL,MICA,MICB,MLST8,MMP24,MTOR,NDC1,NFKBIA,NOS1,NOS3,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PDCD6,POM121,POM121C,PSIP1,PTGES3,RAE1,RANBP2,RBBP7,RPA1,RPA2,RPA3,RPTOR,SAXO1,SEH1L,SIRT1,SLU7,SOD1,THBS1,TPR,TRPV2,TRPV4,VCP,YBX3,YWHAE	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
GO:0009267	GO	BP	cellular response to starvation	ALB,AOC1,ASNS,ATF4,ATG14,ATG7,BECN1,BHLHA15,CARTPT,CDKN1A,CPEB4,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,FADS1,FNIP1,FOXO1,GAS2L1,HSPA5,HSPA8,IFI16,IMPACT,INHBB,KIAA1324,KLF10,LRRK2,MIOS,MTMR3,MYBBP1A,NPRL2,NPRL3,NUAK2,NUPR1L,PCSK9,PDK4,PICK1,PIK3C3,PIK3R4,PMAIP1,PRKAA1,PRKAA2,RALB,RNF152,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SREBF1,SREBF2,TBL2,TP53,USP33,WDR24,WDR59,WRN,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
GO:0009268	GO	BP	response to pH	ACER1,ASIC1,CHP1,CTSS,GPLD1,GPR65,HVCN1,HYAL1,IMPACT,INSRR,KCNK18,KCNK4,NOX1,PKD1L3,PKD2L1,RAB11B,RAB11FIP5,SLC9A1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus. pH is a measure of the acidity or basicity of an aqueous solution.
GO:0009298	GO	BP	GDP-mannose biosynthetic process	GMPPA,GMPPB,MPI,PMM1,PMM2	The chemical reactions and pathways resulting in the formation of GDP-mannose, a substance composed of mannose in glycosidic linkage with guanosine diphosphate.
GO:0009299	GO	BP	mRNA transcription	ARNT,ATF4,C5AR1,DDIT3,DDX5,EEF1D,EREG,HIF1A,HIPK3,HSF1,LMO2,MED1,MYOG,POU5F1,SOX17,SOX18,SRF,ZBTB1	The cellular synthesis of messenger RNA (mRNA) from a DNA template.
GO:0009301	GO	BP	snRNA transcription	ELL,ELL2,ELL3,ICE1,ICE2,RPAP2,SNAPC2,SNAPC3,SNAPC4,ZC3H8	The synthesis of small nuclear RNA (snRNA) from a DNA template.
GO:0009303	GO	BP	rRNA transcription	ANG,BRF1,GTF3A,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6,NIFK,POLR1E,RNASEK,SIRT7,SPIN1,TAF1B	The synthesis of ribosomal RNA (rRNA), any RNA that forms part of the ribosomal structure, from a DNA template.
GO:0009304	GO	BP	tRNA transcription	BRF1,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6	The synthesis of transfer RNA (tRNA) from a DNA template.
GO:0009306	GO	BP	protein secretion	ABCA1,AIM2,ARL4D,BTN3A1,BTN3A2,CAMK2G,CANX,CCL19,CCR7,CD36,CHI3L1,CYB5R4,DMTN,EIF2AK3,F2RL1,FAM3B,FGG,FOXP1,GAL,GBP5,GNAS,GOLPH3,HMGB1,HNF1A,KLRF2,LEP,LILRB1,LTBP2,MAFA,NECAB3,NEUROD1,NLRC4,NOD2,NOS2,NOX5,NR1H4,OLFM2,PDIA4,PDX1,PLEK,PNP,PPY,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RIMS2,S100A12,S100A13,SCG2,SLC30A8,SNX19,STEAP3,SVBP,TLR2,TLR4,TLR6,TRIM27,VIP	The controlled release of proteins from a cell.
GO:0009308	GO	BP	amine metabolic process	AADAT,AANAT,ABHD3,ACHE,ACMSD,ADI1,AFMID,AGMAT,AMD1,AOC3,APIP,APOA1,APOA2,APOA4,ARG1,ARG2,ASL,ASMT,ASS1,ATP7A,AZIN1,AZIN2,CCBL1,CCBL2,CDS1,CEPT1,CETP,CHAT,CHKA,CHKB,CHPT1,CKB,CKM,CKMT1A,CKMT2,CLN3,CPS1,DBI,DDC,DMGDH,ENOPH1,ENPP2,ENPP6,ENPP7,GAMT,GATM,GOT1,GPAT4,GPLD1,HAAO,HDC,IDO1,IDO2,INMT,KMO,KYNU,LCAT,LIPC,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LPIN1,LPIN2,LPIN3,MAOA,MBOAT1,MBOAT2,MRI1,MTAP,NAGS,NQO1,OAZ1,OAZ2,OAZ3,ODC1,OTC,PAFAH1B1,PAOX,PCYT1A,PCYT1B,PEMT,PHOSPHO1,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLB1,PLBD1,PNPLA8,PON1,PRG3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,SAMD8,SAT1,SAT2,SGMS1,SGMS2,SLC25A15,SLC25A2,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SLC6A8,SMOX,SMPD1,SMPD2,SMPD3,SMPD4,SMS,SRM,SULT1A1,SULT1A2,SULT1B1,SULT1C2,TDO2,TPH1,TPH2,VCAM1	The chemical reactions and pathways involving any organic compound that is weakly basic in character and contains an amino or a substituted amino group, as carried out by individual cells. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom.
GO:0009309	GO	BP	amine biosynthetic process	AANAT,ASMT,DDC,HDC,ODC1,PAOX,PRG3,SAT1,SMOX,SRM,SULT1A2,TPH1,TPH2	The chemical reactions and pathways resulting in the formation of any organic compound that is weakly basic in character and contains an amino or a substituted amino group. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom.
GO:0009311	GO	BP	oligosaccharide metabolic process	B4GALT1,FUT3,FUT8,GAA,GAL3ST3,GAL3ST4,GLA,GNPTAB,IDUA,LALBA,MAN1A2,MAN1B1,MGAT2,MGAT4A,MGAT4B,MPDU1,NEU1,NEU2,NEU3,NEU4,SLC2A1,ST3GAL6,ST6GAL2,ST6GALNAC5,ST6GALNAC6,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA6,TREH	The chemical reactions and pathways involving oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
GO:0009312	GO	BP	oligosaccharide biosynthetic process	B4GALT1,FUT3,FUT8,LALBA,MPDU1,SLC2A1,ST6GALNAC5,ST6GALNAC6	The chemical reactions and pathways resulting in the formation of oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
GO:0009313	GO	BP	oligosaccharide catabolic process	NEU1,NEU2,NEU3,NEU4,TREH	The chemical reactions and pathways resulting in the breakdown of oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
GO:0009394	GO	BP	2'-deoxyribonucleotide metabolic process	AK5,AK9,MBD4,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5M,NTHL1,NUDT1,NUDT15,NUDT16,NUDT18,OGG1,SAMHD1,SMUG1,TDG,TYMS,UNG	The chemical reactions and pathways involving a 2'-deoxyribonucleotide, a compound consisting of 2'-deoxyribonucleoside (a base linked to a 2'-deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
GO:0009395	GO	BP	phospholipid catabolic process	ANGPTL3,APOA2,ENPP2,LIPC,LIPG,PLA2G15,PLA2G4B,PLA2G4C,PNLIPRP2,PNPLA8,PRDX6,SMPD3,SMPD4	The chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester.
GO:0009404	GO	BP	toxin metabolic process	ARL1,AS3MT,CYP1A2,CYP2W1,FMO1,FMO2	The chemical reactions and pathways involving a toxin, a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism.
GO:0009408	GO	BP	response to heat	AAAS,AKT1,AKT1S1,ANO1,ATM,ATR,ATXN3,BAG1,BAG2,BAG3,BAG4,BAG5,C11orf73,C8orf4,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CCAR2,CLPB,CREBBP,CRNN,CRYAB,DNAJB1,DNAJB4,DNAJB6,DNAJC2,DNAJC7,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,EP300,FGF1,FKBP4,GCLC,GSK3B,HDAC6,HMOX1,HSBP1,HSF1,HSP90AA1,HSP90AB1,HSPA1A,HSPA1B,HSPA1L,HSPA2,HSPA6,HSPA8,HSPB8,HSPH1,HTRA2,IGF1,IL1A,MAP2K7,MAPK1,MAPK3,MAPKAPK2,MICA,MICB,MLST8,MTOR,NDC1,NOS1,NOS3,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PDCD6,POM121,POM121C,PSIP1,PTGES3,RAE1,RANBP2,RBBP7,RPA1,RPA2,RPA3,RPTOR,SEH1L,SIRT1,SLU7,SOD1,THBS1,TPR,TRPV4,VCP,YWHAE	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
GO:0009409	GO	BP	response to cold	ACOT11,CIRBP,DNAJC3,EIF2AK3,EIF2AK4,FOXO1,GMPR,HSP90AA1,HSPA2,HSPD1,METRNL,NFKBIA,SAXO1,YBX3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.
GO:0009411	GO	BP	response to UV	ACTR5,AKT1,AQP1,ATF4,ATR,AURKB,BAK1,BCL3,BRSK1,CASP9,CAT,CCAR2,CCND1,CDC25A,CDKN1A,CDKN2D,CERS1,CHEK1,CIRBP,CREBBP,CRIP1,CUL4B,DCUN1D3,DDB1,DDB2,DTL,EGFR,EIF2AK4,EIF2S1,ELANE,EP300,ERCC2,ERCC3,ERCC4,ERCC5,ERCC6,ERCC8,FBXW7,FEN1,GPX1,GTF2H2,HIST3H2A,HYAL1,HYAL2,HYAL3,IL12A,IL12B,IMPACT,INO80,IVL,KDM1A,KIAA0101,MAP2K7,MAP3K4,MAP4K3,MAPK8,MC1R,MEN1,MFAP4,MME,MSH2,MSH6,N4BP1,NEDD4,NOC2L,PCNA,POLD1,POLH,PPID,PRIMPOL,PTPRK,RELA,REV1,RHBDD1,RHNO1,RPAIN,RUVBL2,SCARA3,SDF4,SERPINB13,SIRT1,SPRTN,STK11,TMEM161A,TRIAP1,TRIM32,UBE2A,UBE2B,UBE4B,USF1,USP1,USP28,USP47,UVSSA,WRN,XPC,YY1,ZBTB1,ZRANB3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
GO:0009437	GO	BP	carnitine metabolic process	ACADL,ACADM,ALDH9A1,BBOX1,CPT1A,CRAT,CROT,SHMT1,TMLHE	The chemical reactions and pathways involving carnitine (hydroxy-trimethyl aminobutyric acid), a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane.
GO:0009451	GO	BP	RNA modification	A1CF,ADAR,ADARB1,ADAT1,ADAT2,ADAT3,ALKBH5,ALKBH8,APOBEC1,APOBEC3F,APOBEC3G,BCDIN3D,CDKAL1,CMTR1,CMTR2,CTU1,CTU2,DUS2,EPRS,FTO,FTSJ2,GTPBP3,HENMT1,HSD17B10,KIAA1429,KIAA1456,LAGE3,LCMT2,MEPCE,METTL1,METTL14,METTL2A,METTL2B,METTL3,MOCS3,MTO1,NHP2,NOP10,NSUN2,NSUN4,NUDT16,OSGEP,PARN,PUS1,PUS7,QTRT1,QTRTD1,RNMT,SSB,TGS1,THG1L,TP53RK,TPRKB,TRDMT1,TRIT1,TRMT1,TRMT10A,TRMT10C,TRMT11,TRMT112,TRMT12,TRMT13,TRMT44,TRMT5,TRMT6,TRMT61A,TRMT61B,TRMU,TYW1,TYW3,TYW5,URM1,WDR4,WTAP	The covalent alteration of one or more nucleotides within an RNA molecule to produce an RNA molecule with a sequence that differs from that coded genetically.
GO:0009452	GO	BP	7-methylguanosine RNA capping	CCNH,CDK7,CMTR1,CMTR2,ERCC2,ERCC3,FAM103A1,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,METTL1,MNAT1,NCBP1,NCBP2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,RNGTT,RNMT,SUPT5H	The sequence of enzymatic reactions by which the 5' cap structure, an inverted 7-methylguanosine linked via a 5'-5' triphosphate bridge (m7G(5')ppp(5')X) to the first transcribed residue, is added to a nascent transcript.
GO:0009566	GO	BP	fertilization	ACR,ADAM2,ADAM20,ADAM21,ADAM30,ADCY3,AKAP3,AKAP4,ASTL,B4GALT1,BPY2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CD9,CDK1,CLGN,CRISP1,DAZ2,DNALI1,FETUB,FUT10,GNPDA1,HVCN1,IGSF8,IZUMO1,IZUMO1R,KCNU1,KLK14,MEIOB,MST1R,NPM2,OR10J1,OVGP1,PKDREJ,PLCB1,ROPN1B,SERPINA5,SLC22A16,SMCP,SPA17,SPAM1,STX2,SYT6,TDRD12,TDRD9,TDRKH,TNP1,TUBGCP3,UBAP2L,UBXN8,WBP2NL,WEE2,ZAN,ZP1,ZP2,ZP3,ZP4	The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
GO:0009581	GO	BP	detection of external stimulus	ABCA4,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ANO1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CACNA1F,CACNA2D4,CALM1,CAMKMT,CDS1,CHRM1,CLPS,CNGA1,CNGB1,COL11A1,CSRP3,CYP4V2,DHRS3,ELOVL4,EPHB1,EYS,FNTA,FNTB,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNB5,GNGT1,GNGT2,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GRK1,GRK4,GRK7,GRM6,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HPN,HSPG2,JUP,KCNA1,KCNK4,KIT,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,METAP1,METAP2,MKKS,MMP24,NAPEPLD,NMT1,NMT2,NR2E3,OPN1LW,OPN1MW,OPN1SW,OPN3,OPN4,PDC,PDE6A,PDE6B,PDE6G,PIEZO2,PITPNM1,PKD1,PKD2,PLB1,PLEKHB1,PNLIP,PPEF1,PRKCA,PRKCQ,RBP1,RBP2,RBP3,RBP4,RCVRN,RDH10,RDH11,RDH12,RDH5,RDH8,RGS9,RGS9BP,RHO,RLBP1,RP1,RPE65,SAG,SDC1,SDC2,SDC3,SDC4,SDR16C5,SLC24A1,STRA6,TCAP,TRPC3,TTN,TTR,TULP1,UNC119	The series of events in which an external stimulus is received by a cell and converted into a molecular signal.
GO:0009582	GO	BP	detection of abiotic stimulus	ABCA4,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ANO1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CACNA1F,CACNA2D4,CALM1,CAMKMT,CDS1,CHRM1,CLPS,CNGA1,CNGB1,COL11A1,CSRP3,CYP4V2,DHRS3,ELOVL4,EPHB1,EYS,FNTA,FNTB,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNB5,GNGT1,GNGT2,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GRK1,GRK4,GRK7,GRM6,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HPN,HSPG2,JUP,KCNA1,KCNK4,KIT,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,METAP1,METAP2,MKKS,MMP24,NAPEPLD,NMT1,NMT2,NPFFR2,NR2E3,OPN1LW,OPN1MW,OPN1SW,OPN3,OPN4,PDC,PDE6A,PDE6B,PDE6G,PIEZO2,PITPNM1,PKD1,PKD2,PLB1,PLEKHB1,PNLIP,PPEF1,PRKCA,PRKCQ,RBP1,RBP2,RBP3,RBP4,RCVRN,RDH10,RDH11,RDH12,RDH5,RDH8,RGS9,RGS9BP,RHO,RLBP1,RP1,RPE65,SAG,SDC1,SDC2,SDC3,SDC4,SDR16C5,SLC24A1,STRA6,TAC1,TACR1,TCAP,TIMELESS,TRPC3,TTN,TTR,TULP1,UNC119	The series of events in which an (non-living) abiotic stimulus is received by a cell and converted into a molecular signal.
GO:0009583	GO	BP	detection of light stimulus	ABCA4,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CACNA1F,CACNA2D4,CALM1,CAMKMT,CDS1,CHRM1,CLPS,CNGA1,CNGB1,CYP4V2,DHRS3,ELOVL4,EYS,FNTA,FNTB,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNB5,GNGT1,GNGT2,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GRK1,GRK4,GRK7,GRM6,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,METAP1,METAP2,NAPEPLD,NMT1,NMT2,NR2E3,OPN1LW,OPN1MW,OPN1SW,OPN3,OPN4,PDC,PDE6A,PDE6B,PDE6G,PITPNM1,PLB1,PLEKHB1,PNLIP,PPEF1,PRKCA,PRKCQ,RBP1,RBP2,RBP3,RBP4,RCVRN,RDH10,RDH11,RDH12,RDH5,RDH8,RGS9,RGS9BP,RHO,RLBP1,RP1,RPE65,SAG,SDC1,SDC2,SDC3,SDC4,SDR16C5,SLC24A1,STRA6,TRPC3,TTR,TULP1,UNC119	The series of events in which a light stimulus (in the form of photons) is received and converted into a molecular signal.
GO:0009584	GO	BP	detection of visible light	ABCA4,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CACNA1F,CACNA2D4,CALM1,CAMKMT,CHRM1,CLPS,CNGA1,CNGB1,CYP4V2,DHRS3,ELOVL4,EYS,FNTA,FNTB,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNB5,GNGT1,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GRK1,GRK4,GRK7,GRM6,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,METAP1,METAP2,NAPEPLD,NMT1,NMT2,OPN1LW,OPN1MW,OPN1SW,OPN3,PDE6A,PDE6B,PDE6G,PLB1,PNLIP,PPEF1,PRKCA,PRKCQ,RBP1,RBP2,RBP3,RBP4,RCVRN,RDH10,RDH11,RDH12,RDH5,RDH8,RGS9,RGS9BP,RHO,RLBP1,RP1,RPE65,SAG,SDC1,SDC2,SDC3,SDC4,SDR16C5,SLC24A1,STRA6,TTR,TULP1	The series of events in which a visible light stimulus is received by a cell and converted into a molecular signal. A visible light stimulus is electromagnetic radiation that can be perceived visually by an organism; for organisms lacking a visual system, this can be defined as light with a wavelength within the range 380 to 780 nm.
GO:0009593	GO	BP	detection of chemical stimulus	ABCG1,ASPH,AZGP1,C4B,CA6,CALM1,CASQ2,CASR,CST1,CST2,CST4,CYB5R4,ENG,GCK,KCNIP2,KCNMB2,KCNMB3,KCNMB4,LBP,LPO,LY96,NKX6-1,NOD2,OR10A3,OR10A5,OR1C1,OR1D2,OR1D5,OR1E1,OR1Q1,OR2C1,OR2D2,OR2H2,OR2M4,OR2S2,OR3A1,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR8B8,OR8G1,PDX1,PIGR,PIP,PKD1L3,PKD2L1,RTP3,RTP4,RYR2,SCARB1,SSC5D,STIM1,SYT1,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8,TAS2R9,TGFB3,TLR1,TLR2,TLR4,TLR6,UGT2A1	The series of events in which a chemical stimulus is received by a cell and converted into a molecular signal.
GO:0009595	GO	BP	detection of biotic stimulus	C4B,CD1D,CRTAM,HLA-A,HLA-B,HLA-DRB1,LBP,LY96,NLRC4,NLRP3,NOD1,NOD2,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,SCARB1,SMO,SSC5D,TLR1,TLR2,TLR4,TLR6	The series of events in which a biotic stimulus, one caused or produced by a living organism, is received and converted into a molecular signal.
GO:0009597	GO	BP	detection of virus	DDX58,IFIH1,SERINC3,SERINC5,TLR3	The series of events in which a stimulus from a virus is received and converted into a molecular signal.
GO:0009612	GO	BP	response to mechanical stimulus	ANKRD1,AQP1,CNN2,CNTNAP2,COL11A1,CSRP3,DMD,DNAH1,HABP4,HPN,INHBB,JUP,KCNA1,KCNK4,KIT,MKKS,NPPA,NRXN1,NRXN2,PDE2A,PIEZO2,PKD1,PKD2,PTGER4,RYR2,SHANK3,SLC8A1,SLC9A1,SOX9,STRA6,TCAP,TRPV4,TTN	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
GO:0009615	GO	BP	response to virus	ABCC9,ABCE1,ADAR,APOBEC3A,APOBEC3B,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ATG7,AZU1,BANF1,BATF3,BCL2,BCL3,BNIP3,BNIP3L,BST2,BTBD17,CCL11,CCL19,CCL22,CCL4,CCL5,CCL8,CD207,CHUK,CREBZF,CXADR,CXCL12,CXCR4,DDX3X,DDX58,DDX60,DHX58,DUOX2,EIF2AK2,EXOSC4,EXOSC5,F2RL1,FADD,FCN3,FGR,FOSL1,GLI2,HYAL1,HYAL2,HYAL3,IFI16,IFI44,IFIH1,IFIT1,IFIT2,IFIT3,IFIT5,IFITM1,IFITM2,IFITM3,IFNA17,IFNA2,IFNA4,IFNA7,IFNAR1,IFNAR2,IFNB1,IFNE,IFNG,IFNGR1,IFNGR2,IFNL1,IFNL2,IFNL3,IFNL4,IFNLR1,IFNW1,IKBKB,IKBKG,IL12A,IL6,IRAK3,IRF1,IRF3,IRF7,ISG15,ISG20,IVNS1ABP,LAMTOR5,LGALS9,LILRB1,LYST,MAPK11,MAPK14,MAVS,MICA,MST1R,MX1,MX2,NCBP3,OAS1,OAS2,OAS3,OASL,OPRK1,PLSCR1,PMAIP1,PRF1,PRKRA,PTPRC,PYCARD,RELA,RNASEL,RPS15A,RSAD2,SAMHD1,SERINC3,SERINC5,SLFN11,SPACA3,TBK1,TLR3,TLR7,TLR8,TMEM173,TNF,TNFSF4,TRIM22,TRIM5,TRIM56,URI1,XCL1,ZC3H12A,ZC3HAV1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
GO:0009620	GO	BP	response to fungus	ANG,APP,C10orf99,CALCA,CAMP,CHIA,CLEC6A,HRG,IL36RN,LTF,NLRP10,NPY,S100A12,S100A8,S100A9,SYK,TAC1,TLR4,VIP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a fungus.
GO:0009636	GO	BP	response to toxic substance	AHR,ALB,AOC1,AOC3,APOA4,APOE,APOM,AQP10,ATP7A,BAX,BCL2,BPHL,CAT,CCL3,CCL4,CCL5,CERS1,CES1,CIITA,CLIC2,CRIP1,CYB5R4,CYGB,DHRS2,EPHX2,EPX,ETS1,FABP1,FAM213A,GPX1,GPX2,GPX3,GPX4,GPX7,GSR,GSTK1,GSTM1,GSTM2,GSTM3,GSTO1,GSTO2,GSTZ1,HBA1,HBB,HDAC6,HID1,HSP90AA1,HYAL1,IPCEF1,JAK1,JAK2,MARC1,MARC2,MEF2C,MGST1,MGST3,MPST,MT3,NOS3,NQO1,OPRD1,PARK2,PARK7,PDZD3,PINK1,PRDX2,PRDX3,PRDX4,PRDX5,PRDX6,PTGS1,PTGS2,PXDN,PXDNL,SLC23A1,SLC30A4,SLC6A14,SLC6A4,SLC7A11,SLC7A8,SOD1,SOD2,SOD3,SRF,TP53INP1,TPO,TRPM6,TXNDC17,TXNDC2,TXNRD1,TXNRD2,TXNRD3,UBIAD1,VIMP,ZC3H8	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
GO:0009648	GO	BP	photoperiodism	BHLHE40,CLOCK,CRTC1,CRY1,CRY2,FBXL3,ID2,MTA1,PER1,PML,PPP1CA,PPP1CB,PPP1CC,RBM4,RBM4B,SIK1,TP53,USP2	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a period of light or dark of a given length, measured relative to a particular duration known as the 'critical day length'. The critical day length varies between species.
GO:0009649	GO	BP	entrainment of circadian clock	ARNTL2,BHLHE40,CHRM1,CRTC1,CRY1,CRY2,FBXL3,GNA11,GNAQ,ID2,MTA1,PER1,PML,PPP1CA,PPP1CB,PPP1CC,RBM4,RBM4B,SIK1,TP53,USP2	The synchronization of a circadian rhythm to environmental time cues such as light.
GO:0009650	GO	BP	UV protection	CAT,ERCC2,ERCC5,FEN1,GPX1,MC1R,MFAP4,SCARA3,SDF4	Any process in which an organism or cell protects itself from ultraviolet radiation (UV), which may also result in resistance to repeated exposure to UV.
GO:0009651	GO	BP	response to salt stress	AQP1,CAPN3,KMO,SLC12A6,TNF	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
GO:0009698	GO	BP	phenylpropanoid metabolic process	CYP2A6,CYP2D6,EPHX2,UGT1A7,UGT1A8	The chemical reactions and pathways involving aromatic derivatives of trans-cinnamic acid.
GO:0009743	GO	BP	response to carbohydrate	ADIPOQ,APOA2,CALCRL,CLEC7A,COLEC12,CYP7A1,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,ERN1,GAS6,GCK,GCKR,GNB2L1,GPER1,GPLD1,GYS2,HNF4A,IRS2,KCNB1,LPL,MAFA,ME1,MLXIPL,NEUROD1,NKX6-1,PAX2,PDK3,PDX1,PFKL,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SLC26A6,SLC2A5,SLC30A8,SOX4,TCF7L2,THBS1,VAMP2,XBP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus.
GO:0009746	GO	BP	response to hexose	ADIPOQ,APOA2,CYP7A1,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,ERN1,GAS6,GCK,GCKR,GNB2L1,GPER1,GPLD1,GYS2,HNF4A,IRS2,KCNB1,LPL,MAFA,MLXIPL,NEUROD1,NKX6-1,PAX2,PDK3,PDX1,PFKL,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SLC26A6,SLC2A5,SLC30A8,SOX4,TCF7L2,THBS1,VAMP2,XBP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hexose stimulus.
GO:0009749	GO	BP	response to glucose	ADIPOQ,APOA2,CYP7A1,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,ERN1,GAS6,GCK,GNB2L1,GPER1,GPLD1,GYS2,HNF4A,IRS2,KCNB1,LPL,MAFA,MLXIPL,NEUROD1,NKX6-1,PAX2,PDK3,PDX1,PFKL,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SLC30A8,SOX4,TCF7L2,THBS1,VAMP2,XBP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
GO:0009755	GO	BP	hormone-mediated signaling pathway	ADIPOR1,ADIPOR2,BMP4,BMP7,CRHBP,CSNK2B,GHRL,GHSR,GPER1,KDM3A,LATS1,LATS2,LEF1,MED1,NKX3-1,NUP62,OR51E2,PGRMC2,PTH,SST,SSTR1,SSTR2,SSTR3,SSTR4,SSTR5,STAT5A,STAT5B,THRA	A series of molecular signals mediated by the detection of a hormone.
GO:0009791	GO	BP	post-embryonic development	BMP4,FGFR2,KLF4,LHX1,SCUBE1,STK36,SZT2,VEGFA	The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
GO:0009798	GO	BP	axis specification	AHI1,BASP1,BCOR,CER1,CITED2,COBL,CXXC4,DDIT3,FOXA2,FZD5,HOXD8,LHX1,LRP5,LRP6,MDFI,OTX2,PITX2,PKD1L1,PLD6,PTCH1,RIPPLY1,RIPPLY2,SETDB2,SFRP1,SHH,SIX2,SIX3,SKI,SMAD2,SMAD6,STC1,STIL,T,TBX3,TDGF1,TDRD5,TTC8,WNT1,WNT7A,WNT8A,WT1	The establishment, maintenance and elaboration of a pattern along a line or around a point.
GO:0009799	GO	BP	specification of symmetry	AHI1,ARL6,ARMC4,BBS4,BBS5,BBS7,BMP4,CCDC103,CCDC151,CCDC39,CCDC40,CER1,CFC1,CITED2,DAND5,DLL1,DNAAF1,DNAH11,DNAH5,DNAI1,DNAI2,DYX1C1,ENG,FOLR1,FOXH1,FOXN4,GALNT11,GATA4,GREM1,HAND1,HAND2,IHH,KIF3B,LEFTY1,LRRC6,MEF2C,MEGF8,MESP1,MICAL2,MKKS,NBL1,NKX2-5,NOTCH1,NPHP3,OFD1,PITX2,PKD1L1,PKD2,RFX3,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX1,TBX2,TBX20,VANGL2,WNT8B,ZIC3	The establishment of an organism's body plan or part of an organism such that a similar arrangement in form and relationship of parts around a common axis, or around each side of a plane is created.
GO:0009812	GO	BP	flavonoid metabolic process	SULT1A1,SULT1A3,SULT1B1,UGT1A1,UGT1A10,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving flavonoids, a group of water-soluble phenolic derivatives containing a flavan skeleton including flavones, flavonols and flavanoids, and anthocyanins.
GO:0009820	GO	BP	alkaloid metabolic process	BCHE,CYP1A2,CYP2D6,CYP3A4,CYP3A5,NAMPT,NAPRT,PTGIS,PTGS2	The chemical reactions and pathways involving alkaloids, nitrogen containing natural products which are not otherwise classified as peptides, nonprotein amino acids, amines, cyanogenic glycosides, glucosinolates, cofactors, phytohormones or primary metabolites (such as purine or pyrimidine bases).
GO:0009838	GO	BP	abscission	AURKB,CHMP4C,IST1,SPG20,VPS4A,ZFYVE19	The controlled shedding of a body part.
GO:0009855	GO	BP	determination of bilateral symmetry	AHI1,ARL6,ARMC4,BBS4,BBS5,BBS7,CCDC103,CCDC151,CCDC39,CCDC40,CER1,CFC1,CITED2,DAND5,DLL1,DNAAF1,DNAH11,DNAH5,DNAI1,DNAI2,DYX1C1,ENG,FOLR1,FOXH1,FOXN4,GALNT11,GATA4,GREM1,HAND1,HAND2,IHH,KIF3B,LEFTY1,LRRC6,MEF2C,MEGF8,MESP1,MICAL2,MKKS,NBL1,NKX2-5,NOTCH1,NPHP3,OFD1,PITX2,PKD1L1,PKD2,RFX3,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX1,TBX2,TBX20,VANGL2,WNT8B,ZIC3	The establishment of an organism's body plan or part of an organism with respect to a single longitudinal plane. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
GO:0009880	GO	BP	embryonic pattern specification	BASP1,COBL,CXXC4,ERBB4,FGFR2,FZD5,HOXD8,LHX1,PLD6,PTCH1,RIPPLY1,RIPPLY2,SHH,SMAD1,SMAD2,SMAD5,SMAD6,STIL,T,TBX3,TDGF1,TDRD5,WNT1,WNT7A,WT1	The process that results in the patterns of cell differentiation that will arise in an embryo.
GO:0009881	GO	MF	photoreceptor activity	CRY1,CRY2,ELOVL4,GNAT2,OPN1LW,OPN1MW,OPN3,OPN4	The function of absorbing and responding to incidental electromagnetic radiation, particularly visible light. The response may involve a change in conformation.
GO:0009895	GO	BP	negative regulation of catabolic process	ACTN3,ADRA2A,AGAP2,AKT1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANXA2,APC,APOA2,APOC1,APOC3,ATG7,ATM,ATP2B4,ATRAID,AZIN1,AZIN2,BAG5,BAG6,BCL2,BCL2L1,BSCL2,BUB1,BUB1B,BUB3,CBFA2T3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CDK5RAP3,CDKN2A,CENPF,CHMP4A,CHMP4B,CIDEA,CLN3,CSNK2A1,CSNK2A2,CST3,DAB2IP,DAP,DERL2,DERL3,DFFA,DHX34,EGFR,EGLN1,ERLEC1,FBP1,FEZ1,FEZ2,FHIT,FLNA,FMN2,FURIN,GABARAPL2,GIPC1,GOLGA2,GPLD1,GSK3A,HCAR2,HDAC4,HFE,HGF,HP,HSP90AB1,HTR2B,IL10,IL1B,INS,IRAK3,KDM4A,KIF25,KLHL22,LEP,LEPR,LRRK2,LZTS1,MAD1L1,MAD2L1,MAD2L2,MAPK7,MDM4,MET,METTL20,MT3,MTMR2,MTOR,N4BP1,NBAS,NELL1,NRBP2,OS9,PABPC1,PANO1,PARK7,PDCL3,PDE3B,PHB,PHF23,PIN1,PINK1,PLIN5,PLK1,PML,PPARA,PRKAA1,PRKCG,PSMF1,PTPN22,PTPN3,QSOX1,RASIP1,RGP1,RIC1,RILP,RRAGA,RUBCN,SCFD1,SDCBP,SERPINB12,SF3B3,SIRT2,SMAD3,SMAD4,SNCA,SNRNP70,SNX12,SNX3,SVIP,TAF9,TBC1D14,TERF1,TEX14,TIMP1,TIMP3,TLK2,TNF,TOB1,TPR,TRIM39,TRIM40,TSC1,TTK,UBAC2,UBE2C,UBE2D1,UBE2E1,UBE2G2,UBE2J1,UBQLN1,UBQLN4,UBXN1,USP14,USP25,USP44,WAC,WDR6,YOD1,ZKSCAN3,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances.
GO:0009897	GO	CC	external side of plasma membrane	ABCG1,ACE,ADA,ADAM9,AMOT,ANXA1,AQP4,ATP6AP2,B4GALT1,BCAM,BMPR1A,CA4,CCR1,CCR5,CD14,CD19,CD2,CD244,CD276,CD28,CD33,CD34,CD3E,CD4,CD59,CD79A,CD8A,CEACAM5,CHRNA4,CHRNB2,CLCN3,CLPTM1,CTLA4,CUBN,ECE1,EFNA5,ENG,ENOX2,ENPEP,EPHA5,F10,F3,FCGR3A,FCN1,FCRL6,FGA,FGB,FGG,FOLR1,FOLR2,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GP1BA,GPC4,GPIHBP1,HFE,HLA-DRB1,HYAL2,IL2RB,IL2RG,LDLR,LILRB1,MCAM,MUC17,NCAM1,NRCAM,P4HB,PCSK9,PKHD1,PLG,PTPRC,SCUBE1,SELP,SEMA7A,SERPINA5,SERPINE2,SLC22A11,SLC2A4,STAB2,TAS2R16,TF,TFR2,TFRC,TGFBR2,TGFBR3,THBS1,THY1,TLR4,TMEM123,TNF,TNFRSF11A,VCAM1	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
GO:0009898	GO	CC	cytoplasmic side of plasma membrane	ACP1,ALOX15,ARRB1,BIRC2,CACNB4,CAV2,CDH1,CDK16,CHMP4A,CHMP4B,CHUK,CYLD,CYTH1,CYTH3,DIABLO,DLG1,DLG4,DSG1,ERRFI1,ESYT2,ESYT3,EXOC1,EZR,FARP1,FER,FERMT2,FES,G6PD,GEM,GNA14,GNA15,GNAI1,GNAS,GNAT2,GNB1,GNB1L,GNG2,GNG5,GNGT2,HCK,HTRA2,IKBKB,IQGAP1,JUP,KCNAB1,KCNAB2,KCNIP1,KRAS,LDLRAP1,MAP2K2,MIEN1,MYZAP,NPHS2,PGM5,PKP4,PTEN,PTP4A1,PTPN22,PTPN3,PTPN4,PTPN7,RAB21,RACGAP1,RASA3,RGS1,RGS19,RGS2,RGS8,RNF31,S100A6,SHROOM4,SNX18,SNX5,SNX9,SPTA1,SPTB,TGM3,TH,TIAM1,TRAF2,TRAF3,TRAF5,TRAF6	The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
GO:0009913	GO	BP	epidermal cell differentiation	ANXA1,CASP14,CDH3,CDSN,CERS3,CLIC4,CSTA,CTNNB1,DSP,EPHA2,ERCC2,ERCC3,EREG,EVPL,EXPH5,FLG,GLI1,GLI2,GRXCR1,HDAC1,HDAC2,HES5,IVL,JAG1,JAG2,KRT16,KRT2,LOR,LRTOMT,MED1,PIP5K1A,PITX2,S100A7,SCEL,SOD1,SPINK5,SPRR1A,SPRR1B,SPRR2A,SPRR2B,SPRR2F,SPRR2G,SPRR3,ST14,STRC,TGM1,TGM3,TXNIP,USH2A,WNT16	The process in which a relatively unspecialized cell acquires specialized features of an epidermal cell, any of the cells making up the epidermis.
GO:0009914	GO	BP	hormone transport	CAMK2G,CDK16,CRHR1,CRYM,CYB5R4,EDN1,EDN3,EIF2AK3,EXOC3L1,FAM3B,GAL,GHRH,GHRL,GHSR,HNF1A,IL6,INHBA,LTBP4,MAFA,NEUROD1,PDX1,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RIMS2,SERPINA7,SLC16A2,SLC22A9,SLC30A8,SNAP23,SNX19,TBX3,VIP	The directed movement of hormones into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0009925	GO	CC	basal plasma membrane	ANK3,AQP1,C5AR2,CD34,DST,ERBB2IP,LDLRAP1,MET,MUC20,MYO1C,PKD2,SHROOM4,TACSTD2,TEK,TF	The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
GO:0009948	GO	BP	anterior/posterior axis specification	BASP1,CER1,DDIT3,FOXA2,FZD5,HOXD8,LHX1,OTX2,PLD6,RIPPLY1,RIPPLY2,SHH,SIX2,SKI,T,TBX3,TDGF1,TDRD5,WNT8A,WT1	The establishment, maintenance and elaboration of the anterior/posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
GO:0009950	GO	BP	dorsal/ventral axis specification	CXXC4,FZD5,LRP5,LRP6,MDFI,SFRP1,SMAD2,SMAD6	The establishment, maintenance and elaboration of the dorsal/ventral axis. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
GO:0009952	GO	BP	anterior/posterior pattern specification	ACVR2B,ATP6AP2,BASP1,BMP2,BMP4,BMPR2,CELSR2,CER1,COBL,CRB2,CYP26C1,DDIT3,DLL1,FOXA2,FOXB1,FZD5,GATA4,HHEX,HOXD3,HOXD8,KDM2B,LFNG,LHX1,NOG,OSR1,OTX2,PBX3,PCSK5,PLD6,PPP2R3A,RIPPLY1,RIPPLY2,SHH,SIX2,SKI,SMAD2,T,TBX1,TBX3,TDGF1,TDRD5,TGFBR1,WNT8A,WT1	The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
GO:0009953	GO	BP	dorsal/ventral pattern formation	AIDA,ASCL1,CER1,CHRD,CXXC4,DLL4,DSCAML1,FBXL15,FOXN4,FZD5,GLI2,GREM1,HOXA11,HOXD11,LHX1,LMX1B,LRP5,LRP6,MDFI,NBL1,NOG,PTCH1,SFRP1,SHH,SIX3,SMAD2,SMAD6,TBX20,WNT8B	The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
GO:0009954	GO	BP	proximal/distal pattern formation	CYP26B1,DLL1,GLI2,OSR1,SIX3	The regionalization process in which specific areas of cell differentiation are determined along a proximal/distal axis. The proximal/distal axis is defined by a line that runs from main body (proximal end) of an organism outward (distal end).
GO:0009972	GO	BP	cytidine deamination	APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA	The removal of amino group in the presence of water.
GO:0009975	GO	MF	cyclase activity	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,GNAS,GUCY1A3,GUCY1B3,NPR1,NPR2,TKFC	Catalysis of a ring closure reaction.
GO:0009988	GO	BP	cell-cell recognition	ADAM2,ADAM20,ADAM21,ADAM30,B4GALT1,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCL19,CCL21,CCR7,CD209,CD6,CLEC4M,FETUB,FUT3,HVCN1,IZUMO1,IZUMO1R,KCNU1,OVGP1,PRF1,SPAM1,ST6GALNAC6,UBAP2L,ZAN,ZP1,ZP2,ZP3,ZP4	Cell recognition between cells. May involve the formation of specialized cell junctions.
GO:0009991	GO	BP	response to extracellular stimulus	ALB,AOC1,AQP3,ASNS,ATF4,ATG14,ATG7,BBS2,BBS4,BCL10,BECN1,BHLHA15,BMP8A,CARTPT,CBS,CDKN1A,CDKN2B,CDKN2D,CHMP1A,CPEB4,CYP24A1,CYP27B1,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,ENSA,FADS1,FNIP1,FOLR1,FOLR2,FOXA2,FOXO1,GAS2L1,GAS6,GCGR,GHRH,GHRL,GHSR,GIPR,GLRX2,GNAI2,HLCS,HSPA5,HSPA8,HTR2C,IFI16,IMPACT,INHBB,KCNB1,KIAA1324,KIF26A,KLF10,KYNU,LEP,LRRK2,MIOS,MKKS,MTMR3,MTOR,MYBBP1A,NCOA1,NENF,NOCT,NPRL2,NPRL3,NPY,NR1H4,NR4A2,NUAK2,NUDT1,NUPR1L,OGT,OMA1,PCSK9,PDK2,PDK4,PICK1,PIK3C3,PIK3R4,PIM1,PMAIP1,POMC,PPARA,PPARG,PPARGC1A,PPP1R9B,PRKAA1,PRKAA2,RALB,RASGRP4,RNF152,RPS19,RPTOR,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SPP1,SPX,SREBF1,SREBF2,SST,SSTR1,SSTR2,TBC1D5,TBL2,TP53,TSC1,ULK1,ULK2,USF1,USF2,USP33,VDR,WDR24,WDR59,WRN,XBP1,ZFP36	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus.
GO:0010001	GO	BP	glial cell differentiation	ARHGEF10,CDH2,CDK5,CDK6,CLU,DICER1,DLL1,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,ERBB3,FGF10,GPC1,HES1,HES5,MMP24,MT3,MXRA8,MYOC,MYRF,NCMAP,NF1,NFIB,PARD3,PAX2,PHOX2B,PICK1,PTEN,PTPRZ1,RELN,SIRT2,SKI,SLC8A3,SOD1,SOX11,SOX2,SOX4,SOX8,STAT3,TENM4	The process in which a relatively unspecialized cell acquires the specialized features of a glial cell.
GO:0010002	GO	BP	cardioblast differentiation	ECE2,GREM1,MYOCD,NOTCH1,NRG1,RBPJ,REST,SRF,T,TBX2,TGFB2	The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
GO:0010035	GO	BP	response to inorganic substance	ACER1,ACO1,ADAM9,ADCY1,ADCY10,AHCYL1,AKR1C3,ALG2,ALOX15,ALOX5AP,ANK3,ANXA11,AOC1,APOA4,APTX,AQP1,AQP2,AQP3,AQP9,ASPH,ATP13A2,ATP2B4,ATP5D,ATP7A,ATP7B,ATRX,B2M,BCL2,BLM,BMP6,BNIP3,BRAF,CALM1,CAMK2D,CAPN3,CARF,CASQ2,CASR,CAV1,CCL19,CCR7,CDH1,CDK2,CDKN1B,CHP2,CLIC4,CPNE1,CPNE3,CPNE7,CRHBP,CRIP1,CYP1B1,D2HGDH,DMTN,DPEP1,ECT2,EGLN1,FABP1,FBP1,FGA,FGB,FGG,FOXO1,FXN,GLRA1,GLRX2,GPLD1,GPX1,GUCY1B3,HAAO,HAMP,HBA1,HBB,HDAC6,HFE,HMOX1,HOMER1,HP,HVCN1,IL1A,IL6,IMPACT,IQGAP1,ITPR3,KCNA1,KCNC2,KCNIP2,KCNMA1,KCNMB2,KCNMB3,KCNMB4,LCE1D,LOXL2,LRRK2,MAP3K5,MAPK7,MEF2A,MEF2C,MMP3,MT1A,MT1B,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MT3,MT4,MTF1,MTL5,MTR,NDRG1,NEDD4,NEDD4L,NET1,NEUROD2,NFE2L2,NOS3,PARK2,PARK7,PAX2,PDCD10,PDCD6,PKD2,PLEKHA1,PPIF,PPP3CA,PRDX2,PRDX3,PRNP,RASA4,RASGRP2,RELA,RHOB,RPS3,RYR2,RYR3,SCN5A,SEC31A,SETX,SIRT1,SLC25A12,SLC25A13,SLC25A24,SLC30A5,SLC34A1,SLFN14,SNCA,SOD1,SOD2,SOD3,SPIDR,STIM1,STK24,STK25,STK26,SYT1,TF,TFAP2A,TFR2,THBS1,TIGAR,TNFAIP3,TNFSF4,TNNT2,TRPC1,TRPC3,TTN,TXNRD2,ZACN,ZNF580,ZNF658	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus.
GO:0010038	GO	BP	response to metal ion	ACER1,ACO1,ADAM9,ADCY1,AHCYL1,AKR1C3,ALG2,ALOX15,ALOX5AP,ANK3,ANXA11,AOC1,AQP1,AQP2,AQP3,AQP9,ASPH,ATP13A2,ATP5D,ATP7A,ATP7B,B2M,BCL2,BMP6,BNIP3,BRAF,CALM1,CAMK2D,CAPN3,CARF,CASQ2,CASR,CAV1,CDH1,CDKN1B,CHP2,CLIC4,CPNE1,CPNE3,CPNE7,CRHBP,CRIP1,D2HGDH,DMTN,DPEP1,ECT2,FBP1,FGA,FGB,FGG,FXN,GLRA1,GPLD1,HAAO,HAMP,HFE,HOMER1,HVCN1,IL1A,IQGAP1,ITPR3,KCNA1,KCNIP2,KCNMA1,KCNMB2,KCNMB3,KCNMB4,LCE1D,LOXL2,LRRK2,MEF2A,MEF2C,MT1A,MT1B,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MT3,MT4,MTF1,MTL5,NDRG1,NEDD4,NEDD4L,NEUROD2,PARK2,PARK7,PDCD6,PPIF,PPP3CA,PRNP,RASA4,RASGRP2,RYR2,RYR3,SCN5A,SEC31A,SLC25A12,SLC25A13,SLC25A24,SLC30A5,SLC34A1,SLFN14,SNCA,STIM1,SYT1,TF,TFAP2A,TFR2,THBS1,TIGAR,TNNT2,TRPC1,TRPC3,TTN,ZACN,ZNF658	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
GO:0010039	GO	BP	response to iron ion	ACO1,B2M,BCL2,BMP6,FXN,HAMP,HFE,SNCA,TF,TFAP2A,TFR2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
GO:0010042	GO	BP	response to manganese ion	ADAM9,ATP13A2,D2HGDH,LRRK2,PARK2,SLFN14	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a manganese ion stimulus.
GO:0010043	GO	BP	response to zinc ion	CRIP1,D2HGDH,GLRA1,HAAO,HVCN1,MT1F,MT1G,MT1M,SLC30A5,ZACN,ZNF658	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
GO:0010092	GO	BP	specification of organ identity	BMP4,FGF10,FGFR2,ISL1,MEF2C,MESP1,PAX2,PAX8	The regionalization process in which the identity of an organ primordium is specified. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
GO:0010107	GO	BP	potassium ion import	ABCC9,ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,FXYD2,KCNE2,KCNJ11,KCNJ2,SLC12A6	The directed movement of potassium ions into a cell or organelle.
GO:0010155	GO	BP	regulation of proton transport	ACTN4,CHP1,DRD4,NOX5,PPIF,SLC30A5,SLC9A3R1,TESC	Any process that modulates the frequency, rate or extent of proton transport into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0010165	GO	BP	response to X-ray	BLM,BRCC3,IKBIP,LIG4,MSH2,NIPBL,XRCC4,XRRA1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz).
GO:0010171	GO	BP	body morphogenesis	ANKRD11,ATP6AP2,CLDN5,CRISPLD1,CRISPLD2,FUZ,GREM2,IFT122,MSX1,MYH3,NIPBL,PTPN11,RAB3GAP1,RRAS,SKI,STRA6,TBX1,TGFB3,ZNF281	The process in which the anatomical structures of the soma are generated and organized.
GO:0010181	GO	MF	FMN binding	HAO1,MTRR,NDOR1,NOS1,NOS2,NOS3	Interacting selectively and non-covalently with FMN, flavin mononucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
GO:0010212	GO	BP	response to ionizing radiation	AEN,ATM,ATR,BABAM1,BLM,BRAT1,BRCA1,BRCC3,BRE,CDKN1A,CLK2,CLOCK,CRYAB,DCUN1D3,ECT2,EEF1D,EYA1,EYA3,FAM175A,FANCD2,FIGNL1,GADD45A,GRB2,H2AFX,HUS1,IFI16,IKBIP,INIP,INO80,INTS3,INTS7,KAT5,KDM1A,KDM4D,LIG4,MAPK14,MEN1,MSH2,MTA1,MYC,NABP1,NABP2,NET1,NHEJ1,NIPBL,PAXIP1,PRKAA1,RAD1,RAD51,RAD51AP1,RAD9A,RFWD2,RFWD3,RHNO1,RHOB,RNF168,RNF8,SIRT1,SPIDR,STK11,SWI5,TICRR,TLK2,TMEM109,TOPBP1,TP53,TSPYL5,UIMC1,USP28,WRN,XRCC4,XRRA1,YAP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
GO:0010224	GO	BP	response to UV-B	CDKN1A,CRIP1,HYAL1,HYAL2,HYAL3,IL12A,IL12B,IVL,MFAP4,MME,MSH2,RELA,STK11	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-B radiation stimulus. UV-B radiation (UV-B light) spans the wavelengths 280 to 315 nm.
GO:0010225	GO	BP	response to UV-C	BCL3,DCUN1D3,ERCC5,IMPACT,MAP3K4,POLH,WRN,YY1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-C radiation stimulus. UV-C radiation (UV-C light) spans the wavelengths 100 to 280 nm.
GO:0010248	GO	BP	establishment or maintenance of transmembrane electrochemical gradient	ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,BAK1,BAX,FXYD2	The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore.
GO:0010259	GO	BP	multicellular organismal aging	BBC3,CISD2,IDE,LRRK2,MSH6,TP53,WRN	An aging process that has as participant a whole multicellular organism. Multicellular organism aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Multicellular organisms aging includes processes like cellular senescence and organ senescence, but is more inclusive. May precede death (GO:0016265) of an organism and may succeed developmental maturation (GO:0021700).
GO:0010310	GO	BP	regulation of hydrogen peroxide metabolic process	HDAC6,HP,MMP3,MPV17L,NOXA1,NOXO1,RAC1,RAC2,SNCA,ZNF205	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.
GO:0010314	GO	MF	phosphatidylinositol-5-phosphate binding	FAM21C,JPH2,LANCL2,PHLDA3,PLEKHF1,SESTD1,SH3PXD2B,SNX3,WIPI2	Interacting selectively and non-covalently with phosphatidylinositol-5-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 5' position.
GO:0010324	GO	BP	membrane invagination	AIF1,BIN2,CHMP2A,CHMP4A,DOCK1,ELMO1,FCGR1A,FCHO2,FNBP1L,GSN,GULP1,HGS,MYH9,SMURF1,SNX3,THBS1,VAMP7,XKR8	The infolding of a membrane, resulting in formation of a vesicle.
GO:0010332	GO	BP	response to gamma radiation	ATM,ATR,CRYAB,DCUN1D3,FANCD2,KDM1A,LIG4,MEN1,MYC,PRKAA1,TLK2,TMEM109,TP53,TSPYL5,WRN,YAP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
GO:0010388	GO	BP	cullin deneddylation	COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,GPS1	The modification of cullins by removal of ubiquitin-like protein NEDD8 (RUB1).
GO:0010389	GO	BP	regulation of G2/M transition of mitotic cell cycle	ATM,BLM,BRD4,CCNA2,CCND1,CDC7,CDK4,CDK5RAP3,CDKN2A,CENPF,CLSPN,DBF4B,FHL1,FOXN3,HMGA2,KCNH5,KIF14,NAE1,NBN,PHOX2B,RAB11A,RAD51B,RAD51C,RCC2,RINT1,STOX1,TAOK3,TICRR,USP47,VPS4B,ZNF830	Any process that modulates the rate or extent of progression from G2 phase to M phase of the mitotic cell cycle.
GO:0010390	GO	BP	histone monoubiquitination	BCOR,CDC73,CTR9,CUL4B,DDB1,DDB2,DTX3L,KDM2B,LEO1,PAF1,PCGF1,RAG1,RING1,RNF168,RNF2,RNF20,RNF40,RYBP,SKP1,TRIM37,UBE2E1,UHRF1,WAC	The modification of histones by addition of a single ubiquitin group.
GO:0010447	GO	BP	response to acidic pH	CHP1,CTSS,GPR65,IMPACT,NOX1,PKD1L3,PKD2L1,RAB11B,RAB11FIP5,SLC9A1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus with pH < 7. pH is a measure of the acidity or basicity of an aqueous solution.
GO:0010452	GO	BP	histone H3-K36 methylation	ASH1L,NSD1,SETD2,SETD3,SETMAR	The modification of histone H3 by addition of one or more methyl groups to lysine at position 36 of the histone.
GO:0010453	GO	BP	regulation of cell fate commitment	BMP4,DKK1,FGF2,FGFR2,FZD7,GDF3,IL12B,IL12RB1,IL23A,IL23R,MESP1,POU5F1,WNT3A	Any process that modulates the frequency, rate or extent of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
GO:0010455	GO	BP	positive regulation of cell fate commitment	DKK1,FGF2,IL12B,IL12RB1,IL23A,IL23R,MESP1,WNT3A	Any process that activates, maintains or increases the frequency or rate of cell fate commitment. Cell fate commitment is the commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
GO:0010457	GO	BP	centriole-centriole cohesion	CEP135,CEP250,CEP68,CNTLN,CROCC,SGOL1	The process in which the two centrioles within a centrosome remain tightly paired.
GO:0010458	GO	BP	exit from mitosis	CLASP1,CLASP2,CTDP1,EPS8,PPP2R2D,SIRT7,UBE2C,UBE2S	The cell cycle transition where a cell leaves M phase and enters a new G1 phase. M phase is the part of the mitotic cell cycle during which mitosis and cytokinesis take place.
GO:0010459	GO	BP	negative regulation of heart rate	AGTR2,FKBP1B,PLN,SPTBN4,SPX,SRI	Any process that stops, prevents or reduces the frequency or rate of heart contraction.
GO:0010460	GO	BP	positive regulation of heart rate	ATP2A2,EDN1,EDN2,EDN3,HRC,KCNQ1,NPPA,PDE4D,RYR2,SCN3B,TPM1	Any process that activates or increases the frequency or rate of heart contraction.
GO:0010463	GO	BP	mesenchymal cell proliferation	BMP2,FGF4,FGF7,FGFR2,GPC3,OSR1,SHH,STAT1	The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
GO:0010464	GO	BP	regulation of mesenchymal cell proliferation	BMP4,CHRD,CTNNBIP1,FGFR2,LRP5,MYC,NFIB,PDGFA,SHH,SOX9,STAT1,TBX1,TGFBR2,VEGFA,WNT5A	Any process that modulates the frequency, rate or extent of mesenchymal cell proliferation. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.
GO:0010466	GO	BP	negative regulation of peptidase activity	A2M,AGT,AKT1,AMBP,ANXA8,APP,AQP1,AVP,BCL2L12,BIRC5,BIRC6,BST2,CASP8,CD27,CD44,CDKN2D,CFLAR,COL4A3,CR1,CRB2,CSNK2A1,CST1,CST2,CST3,CST4,CST5,CST6,CST7,CST8,CSTA,CSTB,DDX3X,DHCR24,DNAJA3,DNAJB6,DPEP1,ECM1,EPPIN,FABP1,FADD,FAS,FASLG,FETUB,FNIP1,FURIN,GAS6,GPX1,HGF,IFI16,IFI6,IGBP1,ITIH2,ITIH3,ITIH4,KLF4,KNG1,LAMTOR5,LCN1,LEF1,LPA,MAGEA3,MAP2K5,MMP9,MT3,NAIP,NGF,NOL3,PAK2,PARK7,PAX2,PCID2,PI3,PICALM,PIH1D1,PLAUR,PRDX3,PRDX5,PROL1,PROS1,PSMF1,PTTG1,PZP,RAF1,RECK,RFFL,RIPK1,RNF34,RPS6KA1,RPS6KA3,SERPINA1,SERPINA10,SERPINA2,SERPINA3,SERPINA4,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB10,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB7,SERPINB8,SERPINB9,SERPINC1,SERPIND1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SERPINI1,SERPINI2,SFN,SH3RF1,SIAH2,SNCA,SORL1,SPINT1,SPINT2,SPOCK1,SPOCK3,SPP2,SRC,TFAP2B,TFPI,THBS1,TIMP1,TIMP3,TIMP4,TNFAIP8,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF14,TRADD,TRAF2,TRIAP1,UBXN1,UCHL5,USP14,USP47,VEGFA,VTN,WFDC12,WFDC2,XIAP	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
GO:0010469	GO	BP	regulation of receptor activity	ADAM17,ADRA2A,ADRA2B,ADRA2C,AKAP6,ANXA2,APP,ASPH,BICD1,BUD31,CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CBLC,CFTR,CHRFAM7A,CLIC2,CNIH2,CNIH3,CRH,CRHBP,DAPK1,DLG4,DMD,EGF,EPGN,EREG,ERRFI1,FBXW7,FKBP1A,FKBP1B,FOXH1,GPRC5A,GREM1,GSTM2,GSTO1,HAP1,HDAC6,HEYL,HFE,HRC,HTT,IGF2,JPH1,JPH2,JPH3,JPH4,KCNE2,MAPK8IP2,MED1,MED16,MEF2C,MINK1,NCK2,NCOA3,NLGN1,NLGN2,NLGN3,NOS1,NRXN1,OPRM1,PARK7,PCSK9,PDE4D,PKD2,PLAU,PPARGC1B,PRKACA,PRKCD,PTK2B,RELN,SERPINE1,SHANK1,SHANK3,SHC1,SNX6,SOCS4,SOCS5,SRI,TGFA,TRDN,ZFYVE28,ZGPAT	Any process that modulates the frequency, rate or extent of receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.
GO:0010470	GO	BP	regulation of gastrulation	ADIPOQ,APOA1,CLASP1,CLASP2,COL5A1,COL5A2,DAG1,DKK1,FOXA2,FZD7,GNB2L1,IL1RN,KLF4,LHX1,MAP2K5,MAPK7,MESP1,MYADM,OSR1,OTX2,PHLDB1,PHLDB2,SCX,TENM4,WNT3A	Any process that modulates the rate or extent of gastrulation. Gastrulation is the complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals.
GO:0010485	GO	MF	H4 histone acetyltransferase activity	BRCA2,ELP3,HAT1,HCFC1,KANSL1,KANSL2,KANSL3,KAT8,MCRS1,NAA50,NAA60,OGT,PHF20,USP22,WDR5	Catalysis of the reaction: acetyl-CoA + histone H4 = CoA + acetyl-histone H4.
GO:0010494	GO	CC	cytoplasmic stress granule	ATXN2,ATXN2L,CAPRIN1,CIRBP,DDX1,DDX3X,DDX6,EIF2S1,EIF4E,GRB7,IGF2BP1,LARP4B,LIN28A,LSM14A,MBNL1,NANOS3,OGFOD1,PABPC1,PABPC4,PUM1,PUM2,RBM4,RC3H1,STAU1,TIA1,TIAL1,YBX1,ZFP36	A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress.
GO:0010501	GO	BP	RNA secondary structure unwinding	AGO1,AGO2,AGO3,AGO4,DDX39B,DDX3X,DHX36	The process in which a secondary structure of RNA are broken or 'melted'.
GO:0010506	GO	BP	regulation of autophagy	ABL1,ABL2,ACTL6A,ADRB2,AKT1,AMBRA1,ATG4B,ATG7,ATM,BAD,BCL2,BCL2L1,BECN1,BNIP3,BNIP3L,CALCOCO2,CHMP4A,CHMP4B,CISD2,CLN3,CSNK2A2,CTSA,CTSK,DAP,DAPK1,DAPK2,DAPK3,DCN,DNM1L,DRAM1,DRAM2,EEF1A1,EEF1A2,EIF2AK4,EPM2A,ERN1,FBXL2,FBXW7,FEZ1,FEZ2,FLCN,FOXO1,FZD5,GFAP,GOLGA2,GSK3A,HAX1,HGF,HMGB1,HTR2B,HTRA2,IFNG,IFT20,IFT88,KAT2A,KAT8,KDM4A,KDR,KIAA1324,KIF25,LARP1,LEP,LEPR,LRRK2,LRSAM1,LZTS1,MAP1LC3B,MAPT,MEFV,MET,MID2,MT3,MTDH,MTMR3,MTOR,NRBF2,NRBP2,PAFAH1B2,PARK2,PARK7,PHF23,PIK3CB,PIK3R2,PIKFYVE,PIM2,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,PLEKHF1,PLK2,POLR3A,PRKAA1,PRKAA2,PTPN22,QSOX1,RAB1B,RAB33B,RAB3GAP1,RAB3GAP2,RAB7A,RALB,RASIP1,RB1CC1,RNF152,RPL28,RRAGA,RUBCN,RUVBL1,SCFD1,SCOC,SH3BP4,SH3GLB1,SIRT1,SIRT2,SLC17A9,SNCA,SNRNP70,SOGA1,SPTLC1,SPTLC2,SQSTM1,SREBF1,SREBF2,STK11,SUPT5H,SVIP,TBC1D14,TBC1D25,TBC1D5,TFEB,TLK2,TMEM59,TP53INP1,TP53INP2,TPCN1,TPCN2,TRIM13,TRIM21,TRIM22,TRIM65,TRIM8,TSC1,U2AF1,U2AF2,UBQLN1,UBQLN2,UBQLN4,ULK1,ULK2,USP10,USP13,USP33,USP36,VDAC1,VMP1,WAC,WBP11,WDFY3,WDR6,WDR75,XBP1,ZBTB17,ZC3H12A,ZDHHC8,ZKSCAN3	Any process that modulates the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
GO:0010507	GO	BP	negative regulation of autophagy	AKT1,ATG7,BCL2,BCL2L1,CHMP4A,CHMP4B,CLN3,DAP,FEZ1,FEZ2,GOLGA2,HGF,HTR2B,KDM4A,KIF25,LEP,LEPR,LRRK2,LZTS1,MET,MT3,MTOR,NRBP2,PHF23,PINK1,PTPN22,QSOX1,RASIP1,RRAGA,RUBCN,SCFD1,SIRT2,SNCA,SNRNP70,TBC1D14,TLK2,TSC1,UBQLN1,UBQLN4,WDR6,ZKSCAN3	Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
GO:0010508	GO	BP	positive regulation of autophagy	ADRB2,AMBRA1,ATG4B,ATG7,BAD,BECN1,BNIP3,BNIP3L,CALCOCO2,DCN,EIF2AK4,EPM2A,FLCN,FOXO1,IFNG,KDR,KIAA1324,LARP1,LRRK2,LRSAM1,MEFV,MID2,MTDH,PAFAH1B2,PARK7,PIK3CB,PIM2,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,PLEKHF1,PLK2,PRKAA1,PRKAA2,RAB3GAP1,RAB3GAP2,RALB,RNF152,SCOC,SH3BP4,SH3GLB1,SIRT1,SPTLC1,SPTLC2,SQSTM1,STK11,SUPT5H,SVIP,TBC1D5,TFEB,TMEM59,TP53INP1,TP53INP2,TPCN1,TRIM13,TRIM21,TRIM22,TRIM65,TRIM8,ULK1,WAC,WDFY3,XBP1,ZC3H12A	Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
GO:0010510	GO	BP	regulation of acetyl-CoA biosynthetic process from pyruvate	DLAT,DLD,PDHA1,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of acetyl-CoA from pyruvate.
GO:0010511	GO	BP	regulation of phosphatidylinositol biosynthetic process	HTR2A,HTR2B,HTR2C,PDGFA,PDGFB,ZP3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol.
GO:0010517	GO	BP	regulation of phospholipase activity	ABL1,ABL2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,AGTR1,ANG,ANGPTL3,ANXA8,APOC2,ARF4,ARHGAP6,ARL1,AVPR1A,AVPR1B,BICD1,C5AR1,CALM1,CAMK4,CCL5,CREB1,EDNRA,EGFR,ESR1,FGF2,FGFR1,FGFR2,FGFR3,FLT1,GNA15,GNAQ,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,KIT,LPAR1,LPAR2,LRP1,NGF,NMUR1,NMUR2,NTRK1,PDE1A,PDE1B,PDE1C,PDGFRA,PDGFRB,PDPK1,PLA2G1B,PLA2G5,PLA2R1,PLCB2,PLCG1,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,RGS2,S1PR4,SELE,SNCA,TXK	Any process that modulates the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
GO:0010518	GO	BP	positive regulation of phospholipase activity	ABL2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,AGTR1,ANG,APOC2,ARF4,ARHGAP6,ARL1,AVPR1A,AVPR1B,C5AR1,CALM1,CAMK4,CCL5,CREB1,EDNRA,EGFR,ESR1,FGF2,FGFR1,FGFR2,FGFR3,FLT1,GNA15,GNAQ,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,KIT,LPAR1,LPAR2,NGF,NMUR1,NMUR2,NTRK1,PDE1A,PDE1B,PDE1C,PDGFRA,PDGFRB,PDPK1,PLA2G1B,PLA2G5,PLCB2,PLCG1,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,S1PR4,SELE,TXK	Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
GO:0010519	GO	BP	negative regulation of phospholipase activity	ABL1,ANGPTL3,ANXA8,BICD1,PLA2R1,RGS2	Any process that decreases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
GO:0010521	GO	MF	telomerase inhibitor activity	CTC1,MCRS1,OBFC1,PINX1,POT1,TEN1,TINF2	Stops, prevents or reduces the activity of a telomerase. Telomerase catalyzes the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence.
GO:0010522	GO	BP	regulation of calcium ion transport into cytosol	AKAP6,ANK2,ASPH,ATP1A2,CACNA1C,CALCA,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CAV1,CEMIP,CLIC2,CXCL10,CXCL11,CXCL9,CXCR3,DIAPH1,DMD,DRD1,EPO,F2,F2R,F2RL3,FKBP1A,FKBP1B,GPER1,GSTM2,GSTO1,HAP1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,LACRT,NOS1,NPSR1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PDE4D,PDPK1,PKD2,PLA2G1B,PLCG1,PML,PRKACA,PTK2B,RYR2,SLC8A1,SNCA,SRI,THY1,TRDN,TRPC1,TRPC3,XCL1	Any process that modulates the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
GO:0010523	GO	BP	negative regulation of calcium ion transport into cytosol	CALCA,CALM1,CASQ2,CLIC2,EPO,FKBP1B,GSTM2,GSTO1,NOS1,PKD2,SRI,TRDN	Any process that decreases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
GO:0010524	GO	BP	positive regulation of calcium ion transport into cytosol	AKAP6,ASPH,CALM1,CAPN3,CAV1,CEMIP,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,F2,F2R,F2RL3,GPER1,GSTM2,GSTO1,HAP1,HTT,JPH2,LACRT,NPSR1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PDPK1,PKD2,PLA2G1B,PLCG1,SNCA,THY1,TRDN,TRPC1,TRPC3,XCL1	Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
GO:0010529	GO	BP	negative regulation of transposition	APOBEC3A,APOBEC3B,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ZNF91,ZNF93	Any process that decreases the frequency, rate or extent of transposition. Transposition results in the movement of discrete segments of DNA between nonhomologous sites.
GO:0010533	GO	BP	regulation of activation of Janus kinase activity	AGT,CCL5,CD300A,GH1,IL12B,IL23A,IL23R,IL6R	Any process that modulates the frequency or rate of activation of JAK protein. The activation of JAK protein is the process of introducing a phosphate group to a tyrosine residue of a JAK (Janus Activated Kinase) protein, thereby activating it.
GO:0010534	GO	BP	regulation of activation of JAK2 kinase activity	AGT,CCL5,CD300A,GH1,IL12B,IL23A,IL23R	Any process that modulates the frequency or rate of activation of JAK2 protein. The activation of JAK2 protein is the process of introducing a phosphate group to a tyrosine residue of a JAK2 (Janus Activated Kinase 2) protein, thereby activating it.
GO:0010535	GO	BP	positive regulation of activation of JAK2 kinase activity	AGT,CCL5,GH1,IL12B,IL23A,IL23R	Any process that increase the frequency or rate of activation of JAK2 protein. The activation of JAK2 protein is the process of introducing a phosphate group to a tyrosine residue of a JAK2 (Janus Activated Kinase 2) protein, thereby activating it.
GO:0010536	GO	BP	positive regulation of activation of Janus kinase activity	AGT,CCL5,GH1,IL12B,IL23A,IL23R,IL6R	Any process that increases the frequency or rate of activation of JAK protein. The activation of JAK protein is the process of introducing a phosphate group to a tyrosine residue of a JAK (Janus Activated Kinase) protein, thereby activating it.
GO:0010543	GO	BP	regulation of platelet activation	ADAMTS18,ALOX12,APOE,C1QTNF1,DMTN,F2,HRG,LYN,NOS3,PDGFA,PDGFB,PDGFRA,PLEK,PRKCA,PRKCD,PRKCQ,PRKG1,SELP,SERPINE2,SYK,TEC,THBD,TLR4	Any process that modulates the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.
GO:0010544	GO	BP	negative regulation of platelet activation	ADAMTS18,ALOX12,APOE,C1QTNF1,F2,NOS3,PDGFA,PDGFB,PDGFRA,PRKCD,PRKG1,SERPINE2,THBD	Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.
GO:0010559	GO	BP	regulation of glycoprotein biosynthetic process	ABCA7,ACER2,ACOT8,ARFGEF1,BACE2,CCL19,CCL21,CCR7,CHP1,CTNNB1,FKTN,GATA1,GOLGA2,IGF1,ITM2B,JAK3,KAT2B,MT3,NECAB3,PLCB1,PUM3,PXYLP1,RAMP1,SLC51B,SOAT1,TCF7L2,TINF2,TMEM59	Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
GO:0010560	GO	BP	positive regulation of glycoprotein biosynthetic process	ARFGEF1,CCL19,CCL21,CCR7,CHP1,CTNNB1,GOLGA2,IGF1,PLCB1,PXYLP1,RAMP1,SLC51B,SOAT1,TCF7L2	Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
GO:0010561	GO	BP	negative regulation of glycoprotein biosynthetic process	ABCA7,ACER2,ACOT8,BACE2,ITM2B,JAK3,TINF2,TMEM59	Any process that decreases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
GO:0010565	GO	BP	regulation of cellular ketone metabolic process	ABCD2,ACADL,ACADVL,ADIPOQ,AKR1C3,AKT1,AKT2,APOA4,APOA5,APOC1,APOC2,APOC3,ARPP19,ATCAY,ATP2B4,AZIN1,BHMT,BMP2,BMP5,BMP6,BRCA1,C1QTNF3,CAV1,CLK2,CYP7A1,DKK3,DLAT,DLD,ERLIN1,ERLIN2,FABP3,FBP1,FGF19,FGFR4,GATA3,GCK,HPN,INS,IRS1,IRS2,LONP2,METTL20,MID1IP1,MLXIPL,MLYCD,NCOR2,NQO1,NR1D1,NR1H2,NR1H3,NR1H4,NR4A3,OAZ1,OAZ2,OAZ3,ODC1,OGT,PANK2,PARK7,PAX8,PDHA1,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR,PIBF1,PLIN5,PPARA,PPARGC1A,PRKAA2,PRKAB2,PRKAG2,PRKCE,PROX1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTGS2,PTPN2,REST,SDHAF3,SIK1,SIRT1,SIRT4,SIRT5,SOGA1,STK11,TRIB3,TWIST1,TYSND1,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VIMP,WNT4	Any process that modulates the chemical reactions and pathways involving any of a class of organic compounds that contain the carbonyl group, CO, and in which the carbonyl group is bonded only to carbon atoms. The general formula for a ketone is RCOR, where R and R are alkyl or aryl groups.
GO:0010566	GO	BP	regulation of ketone biosynthetic process	AKR1C3,BMP2,BMP5,BMP6,DKK3,REST,SIRT5,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a ketone, carried out by individual cells.
GO:0010569	GO	BP	regulation of double-strand break repair via homologous recombination	CHEK1,FBXO18,FIGNL1,KDM1A,PARPBP,POLQ,PPP4C,PPP4R2,RAD51,RAD51AP1,RPA2,RTEL1,SIRT6,SPIDR,TERF2IP	Any process that modulates the frequency, rate or extent of the error-free repair of a double-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences.
GO:0010571	GO	BP	positive regulation of nuclear cell cycle DNA replication	ATRX,CDC7,DBF4B,INO80,WIZ	Any process that activates or increases the frequency, rate or extent of The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.
GO:0010574	GO	BP	regulation of vascular endothelial growth factor production	ARNT,ATF4,BRCA1,C3,C5,CCBE1,CCR2,CYP1B1,EIF2AK3,FLT4,GATA4,HIF1A,HPSE,IL1A,IL1B,IL6,IL6ST,ISL1,NODAL,PTGS2,RORA,SULF1,SULF2,TGFB1	Any process that modulates the frequency, rate, or extent of production of vascular endothelial growth factor.
GO:0010575	GO	BP	positive regulation of vascular endothelial growth factor production	ARNT,ATF4,BRCA1,C3,C5,CCBE1,CYP1B1,EIF2AK3,FLT4,GATA4,HIF1A,HPSE,IL1A,IL1B,IL6ST,ISL1,NODAL,PTGS2,RORA,SULF1,SULF2,TGFB1	Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
GO:0010579	GO	BP	positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	ADCYAP1,ADGRD1,ADORA2A,CRHR1,GPER1,VIP	Any process that increases the frequency, rate or extent of adenylate cyclase (AC) activity that is an integral part of a G-protein coupled receptor signaling pathway.
GO:0010586	GO	BP	miRNA metabolic process	BCDIN3D,DIS3L2,LIN28A,LIN28B,TRIM71,ZCCHC11	The chemical reactions and pathways involving miRNA, microRNA, a class of single-stranded RNA molecules of about 21-23 nucleotides in length, which regulates gene expression.
GO:0010591	GO	BP	regulation of lamellipodium assembly	ARPC2,BRK1,CLRN1,DMTN,EPHA2,FER,FSCN1,HRG,NCKAP1,PLXNB3,RAC1,RAC2,SLIT2,TWF2,WASF2,WNT1	Any process that modulates the rate, frequency or extent of the formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
GO:0010592	GO	BP	positive regulation of lamellipodium assembly	ARPC2,BRK1,CLRN1,FSCN1,NCKAP1,RAC1,RAC2,TWF2,WASF2,WNT1	Any process that increases the rate, frequency or extent of the formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
GO:0010594	GO	BP	regulation of endothelial cell migration	AAMP,ACVRL1,AGT,AGTR2,AKT1,AMOT,ANGPT1,ANGPT2,ANGPT4,ANXA3,APOE,APOH,ATOH8,BCAR1,BCAS3,BMP10,BMP4,BMPER,BMPR2,CIB1,CSNK2B,CXCL13,DAB2IP,DCN,DLL4,EDN1,EMP2,EPHA2,ETS1,FGF1,FGF16,FGF18,FGF2,FGF4,FGFR1,FLT4,FOXC2,FOXP1,GATA3,GDF2,GPLD1,HDAC5,HDAC7,HDAC9,HMGB1,HRG,HSPB1,ITGB1BP1,ITGB3,KDR,KLF4,KRIT1,MAP2K5,MET,MMRN2,NF1,NOTCH1,NR2F2,NRP1,NRP2,PDCD10,PDCD6,PDGFB,PLCG1,PLPP3,PRKCA,PRKD1,PRKD2,PROX1,PTGS2,PTK2,PTK2B,PTPRM,RGCC,RHOA,RHOB,ROCK2,SASH1,SCARB1,SEMA5A,SH3BGRL3,SLIT2,SP100,SPARC,SRPX2,STARD13,STC1,SVBP,SYNJ2BP,TDGF1,TEK,TGFB1,THBS1,VASH1,VEGFA,WNT5A,ZC3H12A,ZNF580	Any process that modulates the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
GO:0010595	GO	BP	positive regulation of endothelial cell migration	AAMP,AGT,AKT1,AMOT,ANGPT1,ANGPT4,ANXA3,ATOH8,BCAR1,BCAS3,BMP4,BMPR2,CIB1,EDN1,ETS1,FGF16,FGF18,FGF2,FGFR1,FLT4,FOXC2,FOXP1,GATA3,GPLD1,HDAC7,HDAC9,HSPB1,ITGB1BP1,ITGB3,KDR,MET,NRP1,NRP2,PDCD6,PDGFB,PLCG1,PLPP3,PRKCA,PRKD1,PRKD2,PROX1,PTGS2,PTK2B,RHOB,ROCK2,SASH1,SCARB1,SEMA5A,SPARC,SRPX2,TDGF1,TEK,TGFB1,THBS1,VEGFA,WNT5A,ZC3H12A,ZNF580	Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
GO:0010596	GO	BP	negative regulation of endothelial cell migration	ACVRL1,AGTR2,ANGPT2,ANGPT4,APOE,APOH,BMP10,CSNK2B,CXCL13,DAB2IP,DCN,DLL4,FGF2,GDF2,HDAC5,HMGB1,HRG,ITGB1BP1,KLF4,KRIT1,MAP2K5,MMRN2,NOTCH1,NR2F2,PDCD10,PTPRM,RGCC,RHOA,SLIT2,SP100,STARD13,STC1,SVBP,SYNJ2BP,TGFB1,THBS1,VASH1	Any process that decreases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
GO:0010603	GO	BP	regulation of cytoplasmic mRNA processing body assembly	ATXN2L,CNOT1,CNOT2,CNOT6,CNOT6L	Any process that modulates the rate, frequency, or extent of the aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body.
GO:0010611	GO	BP	regulation of cardiac muscle hypertrophy	AGT,AKAP6,ATP2B4,BMP10,CAMK2D,CAV3,EDN1,GLRX3,GSK3A,IGF1,IL6ST,LMCD1,MTPN,NR4A3,P2RX4,PARP1,PDE9A,PRKCA,RGS2,SLC9A1,TRPC3	Any process that modulates the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
GO:0010613	GO	BP	positive regulation of cardiac muscle hypertrophy	AGT,AKAP6,BMP10,CAMK2D,EDN1,IGF1,IL6ST,MTPN,NR4A3,PARP1,PDE9A,PRKCA,SLC9A1,TRPC3	Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
GO:0010614	GO	BP	negative regulation of cardiac muscle hypertrophy	ATP2B4,BMP10,CAV3,GLRX3,GSK3A,P2RX4,RGS2	Any process that decreases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
GO:0010631	GO	BP	epithelial cell migration	ANLN,ARSB,CALCA,CDH13,CORO1B,CXCL13,CYP1B1,DPP4,EFNB2,EGR3,EMP2,EPHB4,FAP,FAT2,FERMT1,FGF2,GIPC1,GPLD1,GREM1,ID1,KDR,KIT,KRT16,KRT2,LOXL2,MYH9,NANOS1,NOS3,NOV,NR4A1,NRP1,PIK3CA,PKN1,PKN2,PKN3,PLEKHG5,PLXND1,PRKX,PRSS3,PTP4A3,RAB13,RHOA,ROBO1,S100A2,S100P,SCG2,SLIT2,SRF,STARD13,TDGF1,TNFSF12,VEGFA,ZEB2	The orderly movement of an epithelial cell from one site to another, often during the development of a multicellular organism.
GO:0010632	GO	BP	regulation of epithelial cell migration	AAMP,ACVRL1,ADAM9,AGT,AGTR2,AKT1,AMOT,ANGPT1,ANGPT2,ANGPT4,ANXA3,APOE,APOH,ARSB,ATOH8,BCAR1,BCAS3,BMP10,BMP4,BMPER,BMPR2,CAPN7,CIB1,CLASP1,CLASP2,CORO1C,CSNK2B,CTSH,CXCL13,DAB2IP,DCN,DLL4,EDN1,EMP2,ENPP2,EPB41L4B,EPHA2,ETS1,EVL,FGF1,FGF10,FGF16,FGF18,FGF2,FGF4,FGF7,FGFR1,FLT4,FOXC2,FOXP1,GATA3,GDF2,GLIPR2,GPLD1,HDAC5,HDAC6,HDAC7,HDAC9,HIF1A,HMGB1,HRG,HSPB1,HYAL1,IFNG,IL4,INSL3,ITGB1BP1,ITGB3,KDR,KLF4,KRIT1,MACF1,MAP2K5,MARVELD3,MCC,MET,MMP9,MMRN2,NF1,NOTCH1,NR2F2,NRP1,NRP2,PBLD,PDCD10,PDCD6,PDGFB,PFN1,PFN2,PLCG1,PLPP3,PPM1F,PRKCA,PRKCE,PRKD1,PRKD2,PROX1,PTGS2,PTK2,PTK2B,PTPN23,PTPRG,PTPRM,PTPRR,RAB11A,RAB25,RGCC,RHOA,RHOB,ROCK2,RREB1,SASH1,SCARB1,SEMA5A,SH3BGRL3,SLIT2,SOX9,SP100,SPARC,SRC,SRPX2,STARD13,STC1,STRAP,SVBP,SYNJ2BP,TACSTD2,TDGF1,TEK,TGFB1,TGFB2,THBS1,VASH1,VEGFA,VIL1,WNT5A,ZC3H12A,ZNF580	Any process that modulates the frequency, rate or extent of epithelial cell migration.
GO:0010633	GO	BP	negative regulation of epithelial cell migration	ACVRL1,AGTR2,ANGPT2,ANGPT4,APOE,APOH,BMP10,CORO1C,CSNK2B,CXCL13,DAB2IP,DCN,DLL4,EVL,FGF2,GDF2,HDAC5,HMGB1,HRG,IL4,ITGB1BP1,KLF4,KRIT1,MAP2K5,MARVELD3,MCC,MMRN2,NOTCH1,NR2F2,PBLD,PDCD10,PFN2,PTPN23,PTPRG,PTPRM,PTPRR,RGCC,RHOA,SLIT2,SP100,STARD13,STC1,STRAP,SVBP,SYNJ2BP,TACSTD2,TGFB1,THBS1,VASH1	Any process that stops, prevents, or reduces the frequency, rate or extent of epithelial cell migration.
GO:0010634	GO	BP	positive regulation of epithelial cell migration	AAMP,ADAM9,AGT,AKT1,AMOT,ANGPT1,ANGPT4,ANXA3,ATOH8,BCAR1,BCAS3,BMP4,BMPR2,CAPN7,CIB1,CLASP1,CLASP2,CTSH,EDN1,ENPP2,EPB41L4B,ETS1,FGF10,FGF16,FGF18,FGF2,FGF7,FGFR1,FLT4,FOXC2,FOXP1,GATA3,GLIPR2,GPLD1,HDAC6,HDAC7,HDAC9,HIF1A,HSPB1,HYAL1,IFNG,INSL3,ITGB1BP1,ITGB3,KDR,MET,MMP9,NRP1,NRP2,PDCD6,PDGFB,PFN1,PLCG1,PLPP3,PPM1F,PRKCA,PRKCE,PRKD1,PRKD2,PROX1,PTGS2,PTK2B,RAB11A,RAB25,RHOB,ROCK2,RREB1,SASH1,SCARB1,SEMA5A,SOX9,SPARC,SRC,SRPX2,TDGF1,TEK,TGFB1,TGFB2,THBS1,VEGFA,VIL1,WNT5A,ZC3H12A,ZNF580	Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
GO:0010635	GO	BP	regulation of mitochondrial fusion	BNIP3,MUL1,OMA1,PARK2,PID1,PLD6,VAT1	Any process that modulates the frequency, rate or extent of merging of two or more mitochondria within a cell to form a single compartment.
GO:0010637	GO	BP	negative regulation of mitochondrial fusion	BNIP3,MUL1,OMA1,PARK2,VAT1	Any process that decreases the frequency, rate or extent of merging of two or more mitochondria within a cell to form a single compartment.
GO:0010640	GO	BP	regulation of platelet-derived growth factor receptor signaling pathway	ADIPOQ,APOD,F3,F7,LRP1,NDRG4,PTGIR,PTPN2,PTPRJ,SLC9A3R1,SNCA	Any process that modulates the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
GO:0010642	GO	BP	negative regulation of platelet-derived growth factor receptor signaling pathway	ADIPOQ,APOD,LRP1,NDRG4,PTGIR,PTPN2,PTPRJ,SLC9A3R1,SNCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
GO:0010644	GO	BP	cell communication by electrical coupling	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,CACNA1C,FKBP1B,GJA1,GJA5,KCNA1,PKP2,PRKACA,RYR2,SLC8A1	The process that mediates signaling interactions between one cell and another cell by transfer of current between their adjacent cytoplasms via intercellular protein channels.
GO:0010649	GO	BP	regulation of cell communication by electrical coupling	ASPH,CALM1,CAMK2D,CASQ2,CAV1,HRC,PDE4D,SLC8A1,SRI,TRDN	Any process that modulates the frequency, rate or extent of cell communication via electrical coupling. Cell communication via electrical coupling is the process that mediates signaling interactions between one cell and another cell by transfer of current between their adjacent cytoplasms via intercellular protein channels.
GO:0010656	GO	BP	negative regulation of muscle cell apoptotic process	ALOX12,APOH,BMP7,HAND2,IGF1,LRP6,NACA,NKX2-5,NRG1,ZC3H12A	Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
GO:0010660	GO	BP	regulation of muscle cell apoptotic process	ALOX12,APOH,BMP7,CAMK2A,CAMK2D,CDKN2A,HAND2,IFNG,IGF1,IL12A,IL12B,LRP6,LTK,NACA,NKX2-5,NRG1,SIRT1,ZC3H12A	Any process that modulates the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
GO:0010661	GO	BP	positive regulation of muscle cell apoptotic process	CAMK2A,CAMK2D,CDKN2A,IFNG,IL12A,IL12B,LTK	Any process that increases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
GO:0010662	GO	BP	regulation of striated muscle cell apoptotic process	BMP7,CAMK2A,CAMK2D,HAND2,LTK,NACA,NKX2-5,NRG1	Any process that modulates the rate or extent of striated muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a striated muscle cell and result in its death.
GO:0010664	GO	BP	negative regulation of striated muscle cell apoptotic process	BMP7,HAND2,NACA,NKX2-5,NRG1	Any process that increases the rate or extent of striated muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a striated muscle cell and result in its death.
GO:0010665	GO	BP	regulation of cardiac muscle cell apoptotic process	CAMK2A,CAMK2D,HAND2,LTK,NKX2-5,NRG1	Any process that modulates the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
GO:0010669	GO	BP	epithelial structure maintenance	CXADR,MUC13,MUC4,MUC6,NOD2,PBLD,RBP4,SERPINA3,SOX9,STRAP,TLR4,TLR9	A tissue homeostatic process required for the maintenance of epithelial structure.
GO:0010675	GO	BP	regulation of cellular carbohydrate metabolic process	ACER2,ACTN3,ADIPOQ,ADIPOR1,AKT1,AKT2,ARFGEF1,ARNT,ARPP19,BAD,C1QTNF3,CBFA2T3,CD244,CHP1,CLK2,DYRK2,ECD,ENPP1,ENTPD5,FBP1,FKTN,FOXA2,GAPDHS,GCGR,GCK,GCKR,GOLGA2,GPER1,GPLD1,GRB10,GSK3A,GSK3B,HDAC4,HIF1A,HRH1,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,KAT2B,LHCGR,MLXIPL,MLYCD,MT3,NCOR1,NR1D1,OGT,P2RX7,PARK2,PASK,PDK1,PDK2,PDK3,PDK4,PGAM1,PHKG2,PLEK,PMAIP1,PPARA,PPARGC1A,PPP1R3B,PPP1R3F,PRKAA1,PRKAA2,PRKAG1,PRKAG2,PRKCE,PTH,PTH1R,PTK2B,PTPN2,PUM3,RAMP1,RORA,RORC,SDHAF3,SIK1,SIRT1,SLC51B,SNCA,SOGA1,SORBS1,TIGAR,TINF2,TMEM59,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VIMP	Any process that modulates the rate, extent or frequency of the chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
GO:0010676	GO	BP	positive regulation of cellular carbohydrate metabolic process	ACTN3,AKT1,AKT2,ARNT,ARPP19,BAD,CD244,DYRK2,ENTPD5,GAPDHS,GCK,GPER1,GPLD1,HIF1A,HRH1,IGF1,IGF2,INS,INSR,IRS1,IRS2,LHCGR,MLXIPL,P2RX7,PHKG2,PMAIP1,PPARGC1A,PRKAA1,PRKAA2,PRKCE,PTH,PTH1R,PTPN2,SNCA,SORBS1,TIGAR	Any process that increases the rate, extent or frequency of the chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
GO:0010677	GO	BP	negative regulation of cellular carbohydrate metabolic process	ACTN3,ADIPOQ,C1QTNF3,CBFA2T3,CLK2,ENPP1,FBP1,FOXA2,GCK,GCKR,GRB10,GSK3A,GSK3B,HDAC4,INPP5K,INS,PARK2,PASK,PLEK,PPARA,SIK1,SOGA1,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VIMP	Any process that decreases the rate, extent or frequency of the chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
GO:0010712	GO	BP	regulation of collagen metabolic process	AMELX,BMP4,CIITA,F2,F2R,FAP,HDAC2,IL6,IL6R,ITGB1,MFAP4,PRDX5,RGCC,SCX,SERPINF2,SUCO,TGFB1,TGFB3,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the metabolism of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
GO:0010715	GO	BP	regulation of extracellular matrix disassembly	CLASP1,CLASP2,CST3,DDR1,DDR2,DPP4,FAP,FGFR4,FSCN1,MFI2,TGFB1	Any process that modulates the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.
GO:0010717	GO	BP	regulation of epithelial to mesenchymal transition	ALX1,AXIN2,BAMBI,BCL9L,BMP2,BMP5,CLASP1,CLASP2,COL1A1,CRB2,CTNNB1,DAB2,DAB2IP,DAG1,EFNA1,ELL3,EPHA3,EZH2,FAM195B,FOXA1,FOXA2,FUZ,GCNT2,GLIPR2,GREM1,HPN,LDLRAD4,LEF1,MAD2L2,NKX2-1,NOTCH1,OLFM1,OVOL2,PBLD,PHLDB1,PHLDB2,PPP2CA,RGCC,SDCBP,SDHAF2,SERPINB3,SFRP1,SFRP2,SMAD2,SMAD3,SMAD4,SMAD7,SNAI1,STRAP,TBX5,TCF7L2,TGFB1,TGFB1I1,TGFB2,TGFB3,TGFBR1,TWIST1,VASN,WWTR1,ZNF703	Any process that modulates the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
GO:0010718	GO	BP	positive regulation of epithelial to mesenchymal transition	ALX1,AXIN2,BAMBI,BCL9L,BMP2,COL1A1,CRB2,CTNNB1,DAB2,EZH2,GCNT2,GLIPR2,LEF1,NOTCH1,OLFM1,RGCC,SDCBP,SERPINB3,SMAD2,SMAD3,SMAD4,SNAI1,TCF7L2,TGFB1,TGFB1I1,TGFB2,TGFB3,TWIST1,WWTR1,ZNF703	Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
GO:0010719	GO	BP	negative regulation of epithelial to mesenchymal transition	BMP5,DAB2IP,EFNA1,FOXA1,FOXA2,FUZ,HPN,LDLRAD4,MAD2L2,NKX2-1,OVOL2,PBLD,PPP2CA,SDHAF2,SFRP1,SFRP2,SMAD7,STRAP,TBX5,VASN	Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
GO:0010721	GO	BP	negative regulation of cell development	ACTN4,ADCY6,AP1AR,APOE,ARHGDIA,ARHGEF1,ASCL1,BAG5,BCL11A,BMP5,BMP7,CALR,CAV3,CBFA2T2,CIB1,CNTN4,COL3A1,CORO1C,DAB2IP,DCC,DICER1,DLL1,DMTN,DPYSL3,DRD3,DTX1,DYNLT1,EDNRB,EFNA1,EIF2AK4,EPHA4,F2,FBLN1,FGF13,FKBP4,FOXA1,FOXA2,FUZ,GAK,GAL,GBP1,GDI1,GFI1,GORASP1,GSK3A,GSK3B,HDAC2,HES1,HES5,HOOK3,HPN,ID2,IGF1,ITGB1BP1,ITM2C,KANK1,KIAA0319,KLK8,LDLRAD4,LILRB1,LINGO1,LPAR1,LRP4,LTF,MAD2L2,MAG,MED1,MFI2,MT3,NF1,NGEF,NGFR,NKX2-1,NLGN1,NOG,NOTCH1,NPPC,OMG,OVOL2,PAQR3,PAX2,PAX6,PAX8,PBLD,PCM1,PPP2CA,PTEN,PTPRO,RAB29,RAPGEF2,RCC2,REST,RHOA,RNF10,RNF6,RTN4,RTN4R,RUFY3,S1PR3,SDHAF2,SEMA5A,SFRP1,SFRP2,SIRT2,SIX3,SKI,SLIT2,SMAD7,SORL1,SOX11,SOX2,SOX3,SOX9,SPOCK1,SRGAP2,SRGAP2C,STAT1,STMN2,STRAP,TACSTD2,TBX5,THY1,TRPV4,VASN,WEE2,WNT3A,WNT7A,YWHAH,ZNF706	Any process that decreases the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
GO:0010737	GO	BP	protein kinase A signaling	EZR,GAL,LCP1,RAB13,RDX,ZP4	A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.
GO:0010738	GO	BP	regulation of protein kinase A signaling	ADIPOQ,AKAP12,AKAP5,AKAP6,FSHR,LRRK2,MC1R,MIF,PJA2	Any process that modulates the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.
GO:0010739	GO	BP	positive regulation of protein kinase A signaling	ADIPOQ,AKAP12,AKAP5,MC1R,MIF	Any process that increases the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.
GO:0010743	GO	BP	regulation of macrophage derived foam cell differentiation	ABCA1,ABCA5,ABCG1,ADIPOQ,AGT,AGTR1,ALOX15B,APOB,CD36,CETP,CRP,CSF1,CSF2,ITGAV,ITGB3,LPL,MAPK9,MSR1,NFKB1,NFKBIA,NR1H2,NR1H3,PF4,PLA2G10,PLA2G2A,PPARA,PPARG,PRKCH	Any process that modulates the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
GO:0010744	GO	BP	positive regulation of macrophage derived foam cell differentiation	AGT,AGTR1,ALOX15B,APOB,CD36,CSF1,CSF2,LPL,MAPK9,MSR1,NFKB1,PF4,PLA2G10,PLA2G2A,PRKCH	Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
GO:0010745	GO	BP	negative regulation of macrophage derived foam cell differentiation	ABCA1,ABCA5,ABCG1,ADIPOQ,CETP,CRP,ITGAV,ITGB3,NFKBIA,NR1H2,NR1H3,PPARA,PPARG	Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
GO:0010755	GO	BP	regulation of plasminogen activation	CLEC3B,F12,HPN,MFI2,SERPINE1,SERPINE2,SERPINF2,THBS1	Any process that modulates the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin.
GO:0010758	GO	BP	regulation of macrophage chemotaxis	C5,CCL5,CMKLR1,CSF1,PTK2B,RARRES2,STAP1,THBS1	Any process that modulates the rate, frequency or extent of macrophage chemotaxis. Macrophage chemotaxis is the movement of a macrophage in response to an external stimulus.
GO:0010759	GO	BP	positive regulation of macrophage chemotaxis	CCL5,CMKLR1,CSF1,RARRES2,THBS1	Any process that increases the rate, frequency or extent of macrophage chemotaxis. Macrophage chemotaxis is the movement of a macrophage in response to an external stimulus.
GO:0010762	GO	BP	regulation of fibroblast migration	ARHGEF7,CORO1C,DDR2,DMTN,FGF2,GNA12,HAS1,HYAL2,ITGB1BP1,PRKCE,PRR5L,RFFL,TGFB1,THBS1	Any process that modulates the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
GO:0010763	GO	BP	positive regulation of fibroblast migration	ARHGEF7,DDR2,DMTN,PRKCE,TGFB1,THBS1	Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
GO:0010765	GO	BP	positive regulation of sodium ion transport	ACTN4,AHCYL1,ANK3,ATP1B1,ATP1B2,ATP1B3,CHP1,CNKSR3,DMD,DRD4,FXYD1,GLRX,GPD1L,NKX2-5,NOS1,PKP2,SCN1B,SCN3B,SCN4B,SCN5A,SLC9A1,TESC,WNK2,WNK3	Any process that increases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0010769	GO	BP	regulation of cell morphogenesis involved in differentiation	ABL1,ACTN4,ADGRB3,ALX1,AMIGO1,AP1AR,APOA1,APOE,ARHGDIA,ARHGEF1,ARHGEF7,AXIN2,BAMBI,BCL11A,BCL9L,BDNF,BHLHB9,BMP2,BMP5,C1QBP,CALR,CAMK2B,CAPRIN1,CAPRIN2,CDC42,CDK5,CDK5R1,CDKL5,CFL1,CHN1,CHRNA3,CHRNB2,CIB1,CLASP1,CLASP2,COL1A1,CORO1C,CRB2,CTNNB1,CTTN,CUL7,CUX1,CUX2,DAB2,DAB2IP,DAG1,DCC,DMTN,DNM2,DSCAM,EFNA1,ELL3,EPHA3,EPHA4,EPHB3,EZH2,FAM195B,FAM21C,FBLN1,FBXW8,FGA,FGB,FGF13,FGG,FLNA,FOXA1,FOXA2,FUZ,GBP1,GCNT2,GDI1,GLIPR2,GOLGA4,GORASP1,GREM1,HPN,IL1RAPL1,ISLR2,ITGB1BP1,KANK1,KIF13B,L1CAM,LDLRAD4,LEF1,LIF,LIMK1,LIMS1,LINGO1,LRP4,LRP8,LRRC16A,LRRC4C,LRRK2,MACF1,MAD2L2,MAG,MAPT,MARK2,MEGF8,MFI2,MT3,MYADM,MYOC,NEDD4,NGEF,NGF,NGFR,NKX2-1,NLGN1,NOTCH1,NRCAM,NRP1,NSMF,NTN1,NTRK2,OBSL1,OLFM1,OLFM4,OMG,OVOL2,PAX2,PAX8,PBLD,PDLIM5,PHLDB1,PHLDB2,PPP2CA,PTEN,PTK2,PTPRD,PTPRO,RAC1,RAC3,RAP2A,RAPGEF2,RCC2,RELN,RGCC,RHOA,RNF6,ROBO1,ROBO2,RREB1,RTN4,RTN4R,RUFY3,S100A10,SARM1,SDC2,SDCBP,SDHAF2,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SERPINB3,SFRP1,SFRP2,SHANK3,SHTN1,SIPA1L1,SKIL,SLIT2,SMAD2,SMAD3,SMAD4,SMAD7,SNAI1,SRCIN1,STAT1,STRAP,TACSTD2,TBX5,TCF7L2,TGFB1,TGFB1I1,TGFB2,TGFB3,TGFBR1,THY1,TNIK,TRIOBP,TWF2,TWIST1,VASN,VEGFA,WWTR1,YWHAH,ZNF703	Any process that modulates the frequency, rate or extent of cell morphogenesis contributing to cell differentiation. Cell morphogenesis involved in differentiation is the change in form (cell shape and size) that occurs when relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history.
GO:0010770	GO	BP	positive regulation of cell morphogenesis involved in differentiation	ALX1,AMIGO1,APOA1,ARHGDIA,ARHGEF7,AXIN2,BAMBI,BCL11A,BCL9L,BDNF,BHLHB9,BMP2,C1QBP,CALR,CAMK2B,CAPRIN1,CAPRIN2,CDC42,CDKL5,CIB1,COL1A1,CRB2,CTNNB1,CUL7,CUX1,CUX2,DAB2,DMTN,DSCAM,EZH2,FBXW8,FGA,FGB,FGG,FLNA,GCNT2,GLIPR2,GOLGA4,IL1RAPL1,ISLR2,L1CAM,LEF1,LIF,LIMK1,LIMS1,LRP8,LRRC16A,MACF1,MAPT,MEGF8,MYADM,MYOC,NGF,NGFR,NOTCH1,NRP1,NTN1,NTRK2,OBSL1,OLFM1,OLFM4,PAX2,PAX8,PTPRD,RAC1,RAC3,RELN,RGCC,RHOA,ROBO1,ROBO2,RREB1,RUFY3,S100A10,SDCBP,SEMA4D,SEMA5A,SEMA7A,SERPINB3,SHTN1,SKIL,SLIT2,SMAD2,SMAD3,SMAD4,SNAI1,TCF7L2,TGFB1,TGFB1I1,TGFB2,TGFB3,TRIOBP,TWF2,TWIST1,VEGFA,WWTR1,ZNF703	Any process that increases the frequency, rate or extent of cell morphogenesis contributing to cell differentiation. Cell morphogenesis involved in differentiation is the change in form (cell shape and size) that occurs when relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history.
GO:0010771	GO	BP	negative regulation of cell morphogenesis involved in differentiation	ACTN4,AP1AR,ARHGDIA,ARHGEF1,BCL11A,BMP5,CORO1C,DAB2IP,DCC,DMTN,EFNA1,FBLN1,FGF13,FOXA1,FOXA2,FUZ,GBP1,GDI1,GORASP1,HPN,ITGB1BP1,KANK1,LDLRAD4,LINGO1,LRP4,MAD2L2,MAG,MFI2,MT3,NGEF,NGFR,NKX2-1,NLGN1,OMG,OVOL2,PBLD,PPP2CA,PTEN,PTPRO,RAPGEF2,RCC2,RHOA,RNF6,RTN4,RTN4R,RUFY3,SDHAF2,SEMA5A,SFRP1,SFRP2,SLIT2,SMAD7,STAT1,STRAP,TACSTD2,TBX5,THY1,VASN,YWHAH	Any process that decreases the frequency, rate or extent of cell morphogenesis contributing to cell differentiation. Cell morphogenesis involved in differentiation is the change in form (cell shape and size) that occurs when relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history.
GO:0010792	GO	BP	DNA double-strand break processing involved in repair via single-strand annealing	RAD52,RBBP8,RNF138,SLX1A,SLX4	The 5' to 3' exonucleolytic resection of the DNA at the site of the break to form a 3' single-strand DNA overhang that results in the repair of a double strand break via single-strand annealing.
GO:0010799	GO	BP	regulation of peptidyl-threonine phosphorylation	AXIN1,AZU1,BMP7,CAB39,CALM1,CEMIP,CHI3L1,DDIT4,DMTN,EGF,INPP5K,MAPK1,PARD3,PLK1,PPEF2,PRKAG2,RIPK2,S1PR2,SIRT2,SMAD7,SPHK1,SPRED1,SPRED2,SPRY2,STOX1,TGFB1,TRIM6,UBE2K,WNK3	Any process that modulates the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
GO:0010800	GO	BP	positive regulation of peptidyl-threonine phosphorylation	AXIN1,AZU1,BMP7,CAB39,CALM1,CEMIP,CHI3L1,EGF,MAPK1,PLK1,PRKAG2,RIPK2,S1PR2,SPHK1,STOX1,TGFB1,TRIM6,UBE2K,WNK3	Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
GO:0010801	GO	BP	negative regulation of peptidyl-threonine phosphorylation	CALM1,DDIT4,DMTN,INPP5K,PARD3,PPEF2,SIRT2,SMAD7,SPRED1,SPRED2,SPRY2	Any process that decreases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
GO:0010803	GO	BP	regulation of tumor necrosis factor-mediated signaling pathway	ADIPOQ,APOA1,BIRC2,BIRC3,CASP8,CHUK,CLIP3,CPNE1,CYLD,F2RL1,GAS6,GNB2L1,GSTP1,HIPK1,HSPA1A,HSPA1B,IKBKB,IKBKG,MADD,NLRP2P,OTULIN,PARK2,PELI3,PTPN2,PYCARD,PYDC1,PYDC2,RBCK1,RFFL,RIPK1,RNF31,RPS27A,SHARPIN,SPHK1,SYK,TAX1BP1,TNF,TNFAIP3,TNFRSF1A,TRADD,TRAF1,TRAF2,TRAIP,UBA52,UBB,UBC,ZNF675	Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
GO:0010804	GO	BP	negative regulation of tumor necrosis factor-mediated signaling pathway	ADIPOQ,APOA1,F2RL1,GAS6,GSTP1,NLRP2P,PELI3,PTPN2,PYDC1,PYDC2,RFFL,TRAIP,ZNF675	Any process that decreases the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
GO:0010810	GO	BP	regulation of cell-substrate adhesion	ACER2,ACTN4,ACVRL1,ADAM15,AGR2,ALOX15,AP1AR,APOA1,APOD,ARHGAP6,ARHGEF7,ARL2,ATXN3,BCAS3,C1QBP,CALR,CASK,CCL21,CCL25,CCL28,CCR7,CD36,CDC42,CDH13,CDK6,CDKN2A,CIB1,CLASP1,CLASP2,COL16A1,CORO1C,CSF1,DAPK3,DLC1,DMTN,EFNA5,EMP2,EPHA1,EPHA3,FAM21C,FBLN1,FGA,FGB,FGG,FLNA,FN1,FZD4,FZD7,GBP1,GCNT2,GPM6B,GSK3B,HACD1,HOXA7,HRG,ITGB1BP1,JAK2,KANK1,KDR,LIMS1,LRRC16A,MACF1,MFI2,MINK1,MYADM,MYOC,NDNF,NF1,NF2,NOTCH1,NPNT,OLFM4,PHLDB2,PIK3CB,PLAU,PLEKHA2,PLET1,PLG,PPM1F,PTEN,PTK2,PTK2B,PTPRJ,PTPRO,RAC1,RAC2,RAC3,RASA1,RCC2,ROCK1,ROCK2,RREB1,RSU1,S100A10,SEMA3E,SERPINE1,SFRP1,SLC9A1,SPOCK1,SRC,TACSTD2,TBCD,TEK,THBS1,TRIOBP,TSC1,UTRN,VEGFA,WNT1	Any process that modulates the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
GO:0010811	GO	BP	positive regulation of cell-substrate adhesion	AGR2,ALOX15,APOA1,ARHGEF7,ARL2,C1QBP,CALR,CCL21,CCL25,CCL28,CCR7,CD36,CDC42,CDH13,CDK6,CIB1,COL16A1,CSF1,DMTN,EMP2,EPHA1,FBLN1,FGA,FGB,FGG,FLNA,FN1,GSK3B,HACD1,HRG,JAK2,KDR,LIMS1,LRRC16A,MYADM,MYOC,NDNF,NPNT,OLFM4,PLEKHA2,PPM1F,PTK2B,PTPRJ,RAC1,RAC3,ROCK1,RREB1,RSU1,S100A10,SFRP1,TEK,TRIOBP,TSC1,UTRN,VEGFA	Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
GO:0010812	GO	BP	negative regulation of cell-substrate adhesion	ACER2,ACTN4,ACVRL1,ADAM15,AP1AR,APOD,ARHGAP6,BCAS3,CASK,CDKN2A,CLASP2,CORO1C,DLC1,DMTN,FBLN1,FZD4,FZD7,GBP1,GCNT2,HOXA7,ITGB1BP1,KANK1,MFI2,MYOC,NF2,NOTCH1,PHLDB2,PLET1,PLG,PTEN,PTPRO,RASA1,RCC2,SEMA3E,SERPINE1,SPOCK1,SRC,TACSTD2,TBCD,THBS1,WNT1	Any process that decreases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
GO:0010818	GO	BP	T cell chemotaxis	CCL3,CCR2,CXCL10,CXCL11,PIK3CD,PIK3CG	The directed movement of a T cell in response to an external stimulus. A T cell is a type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
GO:0010819	GO	BP	regulation of T cell chemotaxis	ADAM10,ADAM17,CCL5,CCR2,CXCL10,CXCL13,S100A7,WNT5A,XCL1	Any process that modulates the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus.
GO:0010820	GO	BP	positive regulation of T cell chemotaxis	ADAM10,ADAM17,CCL5,CCR2,CXCL13,S100A7,WNT5A,XCL1	Any process that increases the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus.
GO:0010821	GO	BP	regulation of mitochondrion organization	ABLIM3,ACAA2,ACSM6,ACTL6A,AKT1,AMBRA1,ARIH2,ATG13,ATG7,ATPIF1,AVP,BAD,BAG4,BAK1,BAP1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BECN1,BID,BIK,BMF,BNIP3,C1QBP,CASP8,CDKL2,CDKN2A,CIDEB,COA3,CSNK2A2,CTSK,CYB5R1,DCN,DDHD1,DNM1L,DPCR1,DPH6,DTWD2,DYNLL1,DYNLL2,E2F1,ELMOD1,EPT1,FAM162A,FAM20B,FBXW7,FIS1,FLCN,FXN,FZD5,GLS2,GOLPH3,GPER1,GPHA2,GPR26,GPX1,GSK3A,GSK3B,GZMB,HAX1,HES1,HGF,HHAT,HNMT,HPS4,HRK,HSPA1A,HSPA1L,HTRA2,HUWE1,IFNL3,IGF1,IL9R,INF2,ITGAX,KAT2A,KCNN3,KDR,LEPROT,LIG3,LRRC46,LRRK2,MALSU1,MAP1LC3B,MAPK8,MARCH5,MFF,MGARP,MICALL2,MIEF1,MIEF2,MIS18A,MLLT11,MMP9,MOAP1,MPV17L,MPV17L2,MRGPRE,MTG1,MTG2,MTOR,MUL1,MYBPC1,NBPF3,NKAP,NMT1,NMUR1,NOL3,NPEPPS,NRG1,OMA1,OPA1,OR13C4,OSCP1,PARK2,PARK7,PARL,PDCD5,PEMT,PID1,PINK1,PLAGL2,PLAUR,PLD6,PMAIP1,POLR3A,PPARGC1A,PPIF,PPP3CC,PPP3R1,PRELID1,PRELID3A,PSMB7,PSMD10,PSMD8,PYCARD,RAC2,RHOU,RMND1,RNASE2,RNF31,RPL28,RUVBL1,SAE1,SFN,SH3GLB1,SIAH3,SIVA1,SLC17A9,SLC25A5,SLC35F6,SNIP1,SQSTM1,SREBF1,SREBF2,STARD7,STOML2,STOX1,TDRD12,TFDP1,TMEM102,TNFSF10,TOMM7,TP53,TRIAP1,TSGA13,U2AF1,U2AF2,UBE2D3,UBE2J2,UBE2L3,UBL4B,UBL5,UGCG,UQCC1,UQCC2,USP36,VAT1,VDAC1,VPS11,WBP11,WDR46,WDR75,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZBED3,ZBTB17,ZDHHC8,ZNF205	Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
GO:0010822	GO	BP	positive regulation of mitochondrion organization	ABLIM3,ACSM6,ACTL6A,AKT1,AMBRA1,ARIH2,ATG13,BAD,BAK1,BAP1,BAX,BBC3,BCL2,BCL2L11,BECN1,BID,BIK,BMF,BNIP3,C1QBP,CASP8,CDKL2,CIDEB,COA3,CSNK2A2,CTSK,CYB5R1,DCN,DDHD1,DNM1L,DPCR1,DPH6,DTWD2,DYNLL1,DYNLL2,E2F1,ELMOD1,EPT1,FAM162A,FAM20B,FBXW7,FIS1,FZD5,GLS2,GPER1,GPHA2,GPR26,GSK3A,GSK3B,GZMB,HES1,HHAT,HNMT,HPS4,HRK,HSPA1L,HTRA2,HUWE1,IFNL3,IL9R,ITGAX,KAT2A,KCNN3,KDR,LEPROT,LRRC46,MAPK8,MARCH5,MFF,MGARP,MICALL2,MIEF1,MIEF2,MIS18A,MLLT11,MMP9,MOAP1,MPV17L2,MRGPRE,MUL1,MYBPC1,NBPF3,NKAP,NMT1,NMUR1,NPEPPS,NRG1,OR13C4,OSCP1,PARK2,PARK7,PDCD5,PEMT,PINK1,PLAGL2,PLAUR,PLD6,PMAIP1,POLR3A,PPARGC1A,PPIF,PPP3CC,PPP3R1,PRELID3A,PSMB7,PSMD8,PYCARD,RAC2,RHOU,RMND1,RNASE2,RNF31,RPL28,RUVBL1,SAE1,SFN,SH3GLB1,SIVA1,SLC17A9,SNIP1,SREBF2,STARD7,STOML2,TDRD12,TFDP1,TNFSF10,TOMM7,TP53,TSGA13,U2AF1,U2AF2,UBE2D3,UBE2J2,UBE2L3,UBL4B,UBL5,UGCG,UQCC1,UQCC2,USP36,VPS11,WBP11,WDR46,WDR75,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZBED3,ZBTB17,ZDHHC8,ZNF205	Any process that increases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
GO:0010823	GO	BP	negative regulation of mitochondrion organization	ACAA2,AKT1,AVP,BAG4,BCL2L1,BNIP3,FLCN,FXN,GPX1,HGF,HSPA1A,IGF1,LIG3,LRRK2,MALSU1,MPV17L,MTOR,MUL1,NOL3,OMA1,OPA1,PARK2,PID1,PINK1,PPIF,PRELID1,PSMD10,SIAH3,SLC25A5,SLC35F6,TRIAP1,VAT1	Any process that decreases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a mitochondrion.
GO:0010824	GO	BP	regulation of centrosome duplication	BRCA1,CCNF,CDK5RAP2,CENPJ,CEP131,CEP76,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CHMP5,GEN1,MDM1,NPM1,PDCD6IP,PKHD1,PLK2,PLK4,RAB6C,RBM14,SPICE1,TMEM67,TRIM37,VPS4B,XRCC3	Any process that modulates the frequency, rate or extent of centrosome duplication. Centrosome duplication is the replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized.
GO:0010826	GO	BP	negative regulation of centrosome duplication	BRCA1,CCNF,CDK5RAP2,CHMP2A,MDM1,NPM1,RBM14,TMEM67,TRIM37	Any process that decreases the frequency, rate or extent of centrosome duplication. Centrosome duplication is the replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized.
GO:0010827	GO	BP	regulation of glucose transport	AAAS,ADIPOQ,AKT1,AKT2,APPL1,ARPP19,C2CD5,C3,CAPN10,CLIP3,CLTCL1,CREBL2,ENPP1,FAM132A,FFAR3,FFAR4,FGF19,FGF21,GCK,GCKR,GRB10,GSK3A,IGF1,IL1B,INPP5K,INS,INSR,IRS1,IRS2,ITLN1,LEP,MZB1,NDC1,NGFR,NR4A3,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,OSBPL8,PEA15,PID1,PIK3R1,PIK3R2,PIK3R3,POM121,POM121C,PRKAG2,PRKCB,PRKCI,PTH,PTPN11,RAE1,RANBP2,RARRES2,RHOQ,SEH1L,SORBS1,TPR,TRIB3,VIMP	Any process that modulates the frequency, rate or extent of glucose transport. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0010828	GO	BP	positive regulation of glucose transport	ADIPOQ,AKT1,AKT2,ARPP19,C2CD5,C3,CAPN10,CLIP3,CLTCL1,CREBL2,FFAR3,FGF19,FGF21,IGF1,INS,INSR,IRS1,IRS2,ITLN1,NR4A3,OSBPL8,PIK3R1,PIK3R2,PIK3R3,PRKCI,PTH,PTPN11,RARRES2,RHOQ,SORBS1	Any process that increases the frequency, rate or extent of glucose transport. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0010829	GO	BP	negative regulation of glucose transport	ENPP1,GRB10,GSK3A,IL1B,INPP5K,LEP,MZB1,PEA15,PID1,PRKCB,VIMP	Any process that decreases the frequency, rate or extent of glucose transport. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0010830	GO	BP	regulation of myotube differentiation	BHLHA15,BHLHE41,CD53,CEACAM5,CFLAR,DMPK,EHD1,EHD2,FLOT1,HDAC4,HDAC5,HDAC9,MAML1,MAPK14,MMP14,MYOD1,MYOG,NACA,NKX2-5,NOTCH1,NOV,RBM24,SIK1,SMYD1,TBX1,XBP1	Any process that modulates the frequency, rate or extent of myotube differentiation. Myotube differentiation is the process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
GO:0010831	GO	BP	positive regulation of myotube differentiation	CD53,EHD1,EHD2,FLOT1,MAML1,MAPK14,MMP14,MYOD1,MYOG,SMYD1,TBX1	Any process that increases the frequency, rate or extent of myotube differentiation. Myotube differentiation is the process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
GO:0010832	GO	BP	negative regulation of myotube differentiation	BHLHA15,BHLHE41,CEACAM5,CFLAR,HDAC4,HDAC5,NKX2-5,NOTCH1,NOV,XBP1	Any process that decreases the frequency, rate or extent of myotube differentiation. Myotube differentiation is the process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
GO:0010833	GO	BP	telomere maintenance via telomere lengthening	ACD,APEX1,ATM,DKC1,DNA2,FEN1,GAR1,LIG1,MRE11A,NHP2,NOP10,OBFC1,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POT1,PRIM1,PRIM2,RAD50,RAD51,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RTEL1,TERF1,TERF2,TERF2IP,TERT,TINF2,TNKS1BP1,UPF1,WRAP53,ZSCAN4	Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins and lengthening the telomeric DNA.
GO:0010837	GO	BP	regulation of keratinocyte proliferation	CASK,CDH3,FGF10,FGF7,KLF9,MED1,OVOL2,PRKD1,PTPRK,REG3A,REG3G,SNAI2,SRSF6,STXBP4,TGM1,VDR	Any process that modulates the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population.
GO:0010838	GO	BP	positive regulation of keratinocyte proliferation	CDH3,FGF10,FGF7,REG3A,REG3G,STXBP4,TGM1	Any process that increases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population.
GO:0010839	GO	BP	negative regulation of keratinocyte proliferation	CASK,KLF9,MED1,PTPRK,SNAI2,VDR	Any process that decreases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population.
GO:0010842	GO	BP	retina layer formation	AHI1,DSCAM,FOXN4,LHX1,MEGF11,PROM1,PTF1A,PTPRM,SDK1,SDK2,TOPORS,TSPAN12	The process in which the vertebrate retina is organized into three laminae: the outer nuclear layer (ONL), which contains photoreceptor nuclei; the inner nuclear layer (INL), which contains amacrine, bipolar and horizontal cells; and the retinal ganglion cell (RGC) layer. Between the inner and outer nuclear layers, the outer plexiform layer (OPL) contains connections between the photoreceptors and bipolar and horizontal cells. The inner plexiform layer (IPL) is positioned between the INL and the ganglion cell layer and contains the dendrites of RGCs and processes of bipolar and amacrine cells. Spanning all layers of the retina are the radially oriented Mueller glia.
GO:0010851	GO	MF	cyclase regulator activity	GRM7,GUCA1C,GUCA2A,GUCA2B,PDZD3,RCVRN	Modulates the activity of an enzyme that catalyzes a ring closure reaction.
GO:0010862	GO	BP	positive regulation of pathway-restricted SMAD protein phosphorylation	ACVR1,ACVR2A,ACVRL1,BMP10,BMP2,BMP4,BMP5,BMP6,BMP7,BMPR1A,BMPR2,CSNK2B,DAB2,ENG,GDF10,GDF2,GDF6,GDF7,HFE,INHBA,NODAL,RBPMS,SDCBP,SMAD4,TGFB1,TGFB3,TGFBR1,TTK	Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
GO:0010863	GO	BP	positive regulation of phospholipase C activity	ABL2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,ANG,ARHGAP6,AVPR1A,AVPR1B,C5AR1,CALM1,CAMK4,CREB1,EDNRA,EGFR,ESR1,FGF2,FGFR1,FLT1,GNA15,GNAQ,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,KIT,LPAR1,LPAR2,NGF,NMUR1,NTRK1,PDE1A,PDE1B,PDE1C,PDGFRA,PDGFRB,PLCB2,PLCG1,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,S1PR4,SELE,TXK	Any process that increases the rate of phospholipase C activity.
GO:0010866	GO	BP	regulation of triglyceride biosynthetic process	C3,CNEP1R1,CTDNEP1,FBXW7,FITM2,GPLD1,LDLR,NR1H2,NR1H3,PLIN5,SCARB1,SIK1,SREBF1	Any process that modulates the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
GO:0010867	GO	BP	positive regulation of triglyceride biosynthetic process	CNEP1R1,CTDNEP1,GPLD1,LDLR,NR1H2,NR1H3,PLIN5,SCARB1,SREBF1	Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
GO:0010869	GO	BP	regulation of receptor biosynthetic process	ADIPOQ,ANKRD13C,CNPY2,EDN1,FGF21,HDAC1,HDAC2,HDAC6,HIF1A,HNRNPK,HOXA5,ITGAV,ITGB3,NR1D1,NR1H3,NR2F1,PPARA,PPARG,SCAP	Any process that modulates the frequency or rate of receptor biosynthesis. Receptor biosynthesis is the collection of chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
GO:0010870	GO	BP	positive regulation of receptor biosynthetic process	CNPY2,EDN1,FGF21,HDAC1,HDAC2,HDAC6,HIF1A,HNRNPK,HOXA5,NR1H3,NR2F1,SCAP	Any process that increases the frequency or rate of receptor biosynthesis. Receptor biosynthesis is the collection of chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
GO:0010871	GO	BP	negative regulation of receptor biosynthetic process	ADIPOQ,ITGAV,ITGB3,NR1D1,PPARA,PPARG	Any process that decreases the frequency or rate of receptor biosynthesis. Receptor biosynthesis is the collection of chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
GO:0010872	GO	BP	regulation of cholesterol esterification	ABCG1,AGT,AGTR1,APOA1,APOA2,APOA4,APOC1,APOE,LAMTOR1	Any process that modulates the frequency, rate or extent of cholesterol esterification. Cholesterol esterification is the lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.
GO:0010873	GO	BP	positive regulation of cholesterol esterification	AGT,AGTR1,APOA1,APOA2,APOA4,APOC1,APOE	Any process that increases the frequency, rate or extent of cholesterol esterification. Cholesterol esterification is the lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.
GO:0010874	GO	BP	regulation of cholesterol efflux	ABCA12,ABCA7,ADIPOQ,APOE,CETP,LAMTOR1,LRP1,NFKBIA,NR1H2,NR1H3,PLA2G10,PLTP,PON1,PTCH1,SHH,SIRT1,SREBF2	Any process that modulates the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
GO:0010875	GO	BP	positive regulation of cholesterol efflux	ABCA12,ABCA7,ADIPOQ,APOE,LRP1,NFKBIA,NR1H2,NR1H3,PLTP,PON1,PTCH1,SIRT1	Any process that increases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
GO:0010876	GO	BP	lipid localization	ABCA1,ABCA12,ABCA5,ABCA7,ABCB11,ABCB4,ABCC3,ABCC4,ABCD1,ABCG1,ABCG4,ABCG5,ABCG8,ACACA,ACACB,ACE,ACSL1,ACSL3,AKR1C1,AKR1C4,ALB,ANGPTL3,APOA1,APOA2,APOA4,APOA5,APOB,APOC1,APOC2,APOC3,APOD,APOE,APOH,APOL2,APOM,ATP10A,ATP10B,ATP10D,ATP11A,ATP11B,ATP11C,ATP8A1,ATP8B1,ATP9A,ATP9B,BAAT,BDKRB2,BSCL2,CAV1,CD36,CEL,CETP,CFHR4,CHKA,CIDEA,CLN8,CLU,COL4A3BP,CPT1A,CPT1B,CPT2,CPTP,DGAT1,DGAT2,DRD2,DRD3,DRD4,ENPP1,FABP3,FABP6,FFAR2,GHRL,GLTP,IL1B,INHBA,LBP,LCAT,LCN1,LCN12,LDLR,LDLRAP1,LEP,LIPC,LIPG,MFSD2A,MSR1,MTTP,NCOA1,NCOA2,NMUR2,NOS2,NPC1,NPC1L1,NPC2,NR1H4,OSBP,OSBPL5,OSBPL8,PCTP,PITPNA,PITPNB,PITPNC1,PITPNM1,PITPNM3,PLA2G10,PLA2G1B,PLEKHA8,PNPLA8,PPARA,PPARD,PPARG,PRELID1,PRELID3A,PRKAA2,PRKAB2,PRKAG2,PSAP,RBP4,RXRA,SCARB1,SCP2,SFTPA1,SLC10A1,SLC10A2,SLC22A9,SLC25A17,SLC25A20,SLC27A1,SLC27A2,SLC27A4,SLC27A5,SLC27A6,SLC51A,SLC51B,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3,SLCO2A1,SOAT1,SOAT2,SPX,STOML2,STX12,TMEM30A,TNF,TNFAIP8L3,TRIAP1,VPS4A	Any process in which a lipid is transported to, or maintained in, a specific location.
GO:0010880	GO	BP	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	AKAP6,ANK2,ASPH,ATP1A2,CACNA1C,CALM1,CAMK2D,CASQ1,CASQ2,CLIC2,DMD,FKBP1B,GSTM2,GSTO1,HRC,PDE4D,PRKACA,RYR2,SLC8A1,SRI,TRDN	Any process that modulates the rate, frequency or extent of release of sequestered calcium ion into cytosol by the sarcoplasmic reticulum, the process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels.
GO:0010881	GO	BP	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	ANK2,ASPH,ATP1A2,CACNA1C,CALM1,CAMK2D,CASQ2,CLIC2,DMD,FKBP1B,GSTM2,GSTO1,HRC,PRKACA,RYR2,SLC8A1	Any process that modulates the frequency, rate or extent of cardiac muscle contraction via the regulation of the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol. The sarcoplasmic reticulum is the endoplasmic reticulum of striated muscle, specialised for the sequestration of calcium ions that are released upon receipt of a signal relayed by the T tubules from the neuromuscular junction.
GO:0010882	GO	BP	regulation of cardiac muscle contraction by calcium ion signaling	ANK2,ASPH,ATP1A2,ATP1B1,ATP2A2,CACNA1C,CALM1,CAMK2D,CASQ2,CLIC2,DMD,FKBP1B,GSTM2,GSTO1,HRC,PRKACA,RYR2,SLC8A1,SLC9A1	Any process that modulates the frequency, rate or extent of cardiac muscle contraction by changing the calcium ion signals that trigger contraction.
GO:0010883	GO	BP	regulation of lipid storage	ABCA1,ABCG1,ABHD5,ALKBH7,APOB,APOC4,C3,CIDEA,CRP,EHD1,FBXW7,FITM1,FITM2,FTO,HILPDA,IL6,ITGAV,ITGB3,LPL,MSR1,NFKB1,NFKBIA,NR1H2,NR1H3,OSBPL11,OSBPL8,PLA2G10,PLIN5,PNPLA2,PPARA,PPARG,PTPN2,SCARB1,SREBF2,TNF,ZC3H12A	Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
GO:0010884	GO	BP	positive regulation of lipid storage	APOB,APOC4,C3,CIDEA,EHD1,FITM1,FITM2,HILPDA,LPL,MSR1,NFKB1,OSBPL11,PLA2G10,PLIN5,SCARB1,SREBF2,ZC3H12A	Any process that increases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
GO:0010885	GO	BP	regulation of cholesterol storage	ABCA1,ABCG1,APOB,EHD1,LPL,MSR1,NR1H2,NR1H3,PPARA,PPARG,SCARB1,SREBF2	Any process that modulates the rate or extent of cholesterol storage. Cholesterol storage is the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0010886	GO	BP	positive regulation of cholesterol storage	APOB,EHD1,LPL,MSR1,SCARB1,SREBF2	Any process that increases the rate or extent of cholesterol storage. Cholesterol storage is the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0010887	GO	BP	negative regulation of cholesterol storage	ABCA1,ABCG1,NR1H2,NR1H3,PPARA,PPARG	Any process that decreases the rate or extent of cholesterol storage. Cholesterol storage is the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0010888	GO	BP	negative regulation of lipid storage	ABCA1,ABCG1,ABHD5,CRP,IL6,ITGAV,ITGB3,NFKBIA,NR1H2,NR1H3,OSBPL8,PNPLA2,PPARA,PPARG,PTPN2,TNF	Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
GO:0010889	GO	BP	regulation of sequestering of triglyceride	ABHD5,APOC4,CIDEA,FITM1,FITM2,LPL,OSBPL11,OSBPL8,PLIN5,PNPLA2,PPARA,PPARG	Any process that modulates the rate, frequency or extent of sequestering of triglyceride. Triglyceride sequestration is the process of binding or confining any triester of glycerol such that it is separated from other components of a biological system.
GO:0010890	GO	BP	positive regulation of sequestering of triglyceride	APOC4,CIDEA,FITM1,FITM2,LPL,OSBPL11,PLIN5	Any process that increases the rate, frequency or extent of sequestering of triglyceride. Triglyceride sequestration is the process of binding or confining any triester of glycerol such that it is separated from other components of a biological system.
GO:0010891	GO	BP	negative regulation of sequestering of triglyceride	ABHD5,OSBPL8,PNPLA2,PPARA,PPARG	Any process that modulates the rate, frequency or extent of sequestering of triglyceride. Triglyceride sequestration is the process of binding or confining any triester of glycerol such that it is separated from other components of a biological system.
GO:0010893	GO	BP	positive regulation of steroid biosynthetic process	ABCG1,BMP6,FGF1,IFNG,IL1B,NR1D1,PRKAA1,TNF,WNT4	Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
GO:0010894	GO	BP	negative regulation of steroid biosynthetic process	APOE,BMP2,BMP5,CYP27B1,DKK3,ERLIN1,ERLIN2,FGF19,GFI1,NFKB1,NR1H4,PROX1,REST,SCAP,SNAI1,SNAI2,SOD1,WNT4	Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
GO:0010896	GO	BP	regulation of triglyceride catabolic process	AADAC,ABHD5,APOA4,APOA5,APOC2,APOC3,GPLD1,PLIN5,PNPLA2	Any process that modulates the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of triglyceride.
GO:0010898	GO	BP	positive regulation of triglyceride catabolic process	AADAC,ABHD5,APOA4,APOA5,APOC2,PNPLA2	Any process that increases the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of triglyceride.
GO:0010901	GO	BP	regulation of very-low-density lipoprotein particle remodeling	APOA1,APOA2,APOA5,APOC2,APOC3	Any process that modulates the rate, frequency or extent of very-low-density lipoprotein particle remodeling. Very-low-density lipoprotein particle remodeling is the acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid.
GO:0010906	GO	BP	regulation of glucose metabolic process	ACTN3,ADIPOQ,ADIPOR1,AKT1,AKT2,ARPP19,BAD,C1QTNF3,CLK2,DYRK2,ENPP1,FBP1,FOXA2,GCGR,GCK,GCKR,GPLD1,GRB10,GSK3A,GSK3B,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,MLYCD,NR1D1,OGT,PARK2,PASK,PDK1,PDK2,PDK3,PDK4,PGAM1,PHKG2,PMAIP1,PPARGC1A,PPP1R3B,PPP1R3F,PTH,PTPN2,RORA,RORC,SDHAF3,SIK1,SIRT1,SOGA1,SORBS1,TIGAR,VIMP	Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.
GO:0010907	GO	BP	positive regulation of glucose metabolic process	ACTN3,AKT1,AKT2,ARPP19,DYRK2,GCK,GPLD1,IGF1,IGF2,INS,INSR,IRS1,IRS2,PHKG2,PMAIP1,PPARGC1A,PTH,PTPN2,SORBS1	Any process that increases the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.
GO:0010919	GO	BP	regulation of inositol phosphate biosynthetic process	CD244,GPER1,HRH1,LHCGR,PLEK,PTH1R,PTK2B,SNCA	Any process that modulates the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.
GO:0010921	GO	BP	regulation of phosphatase activity	AGTR2,AKAP6,ANKLE2,ARFGEF3,ARPP19,BMP2,CALM1,CAMSAP3,CASC5,CCDC8,CD2BP2,CD300A,CDK5RAP3,CEP192,CHP1,CHP2,CNST,CRY2,CSRNP2,CSRNP3,DLG2,DLG3,EIF2AK2,ELFN1,ELFN2,ELL,ENSA,FARP1,FKBP15,FKBP1A,FKBP1B,GPATCH2,GPLD1,GRXCR1,HSP90B1,HTT,IFNG,IGBP1,IKBKB,ITGA1,KIAA0430,LMTK3,MAGI2,MASTL,MEF2C,MPHOSPH10,MYO1D,NCKAP1L,NIFK,NUAK1,PCDH11X,PCIF1,PDGFRB,PKMYT1,PLEK,PPME1,PPP1R12A,PPP1R15A,PPP1R17,PPP1R26,PPP1R27,PPP1R35,PPP1R36,PPP1R37,PPP2R1A,PPP2R2A,PPP2R2B,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5A,PPP2R5B,PPP2R5C,PPP2R5D,PPP2R5E,PPP4R4,PPP6R1,PPP6R3,RBM26,RIMBP2,RIPK3,ROCK1,ROCK2,RRP1B,SEMA4D,SET,SFI1,SH2D4A,SH3RF2,SLC7A14,SPOCD1,SPRED1,SYTL2,TGFB2,TIPRL,TMEM132D,TMEM225,TNF,TSC1,TSKS,UBN1,URI1,WDR81,WNK1,ZCCHC9,ZFYVE1	Any process that modulates the rate or frequency of phosphatase activity. Phosphatases catalyze the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
GO:0010922	GO	BP	positive regulation of phosphatase activity	AGTR2,AKAP6,BMP2,CALM1,CD300A,CHP2,GPLD1,IFNG,ITGA1,MAGI2,MEF2C,PDGFRB,PLEK,PPP1R12A,PPP1R15A,PPP2R4,RIPK3	Any process that increases the rate or frequency of phosphatase activity. Phosphatases catalyze the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
GO:0010923	GO	BP	negative regulation of phosphatase activity	ARFGEF3,CAMSAP3,CASC5,CCDC8,CD2BP2,CEP192,CHP1,CNST,CRY2,CSRNP2,CSRNP3,DLG2,DLG3,ELFN1,ELFN2,ELL,FARP1,FKBP15,FKBP1A,FKBP1B,GPATCH2,GRXCR1,IKBKB,KIAA0430,LMTK3,MASTL,MPHOSPH10,MYO1D,NCKAP1L,NIFK,PCDH11X,PCIF1,PKMYT1,PPP1R15A,PPP1R26,PPP1R27,PPP1R35,PPP1R36,PPP1R37,PPP2R4,PPP4R4,RBM26,RIMBP2,ROCK1,ROCK2,RRP1B,SEMA4D,SFI1,SH2D4A,SH3RF2,SLC7A14,SPOCD1,SPRED1,SYTL2,TGFB2,TIPRL,TMEM132D,TMEM225,TNF,TSKS,UBN1,URI1,WDR81,WNK1,ZCCHC9,ZFYVE1	Any process that decreases the rate or frequency of phosphatase activity. Phosphatases catalyze the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
GO:0010927	GO	BP	cellular component assembly involved in morphogenesis	ABCC4,ABLIM1,ABLIM3,ACTA1,ACTC1,ACTN2,ACTR2,AHI1,ANKRD1,ARL13B,ARL6,ARMC4,ATP6V0D1,ATP6V1D,B9D1,B9D2,BBIP1,BBOF1,BBS1,BBS10,BBS2,BBS4,BBS5,BMP10,C2CD3,C5orf42,CAPN3,CASC5,CASQ1,CC2D2A,CCDC103,CCDC113,CCDC114,CCDC13,CCDC151,CCDC28B,CCDC39,CCDC40,CCNO,CD9,CEP126,CEP162,CEP164,CEP250,CEP290,CEP41,CEP83,CEP89,CFAP46,CFAP54,CFAP74,CFLAR,CNTNAP1,CSNK1D,CSRP3,DICER1,DISC1,DMD,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,DZIP1,DZIP1L,E2F4,EHD1,EHD3,EPB41L3,FAM161A,FBF1,FLNA,FNBP1L,FOPNL,FOXJ1,FUZ,GPC1,ICK,IFT172,IFT20,IFT46,IFT74,IFT81,INTU,IQCB1,KIAA0586,KIF24,KIF27,KIF3A,KLHL41,KRT19,LRGUK,LRRC6,MCIDAS,MEF2A,MKKS,MKS1,MYH11,MYH3,MYH6,MYL2,MYLK3,MYOZ1,MYPN,NCMAP,NEBL,NEK1,NME8,OBSCN,OBSL1,OCRL,PAFAH1B1,PCM1,PCNT,PDGFRA,PDGFRB,PIBF1,PIH1D3,PKHD1,POC1B,PROX1,RAB17,RAB23,RAB3IP,RAB8A,RFX3,RP1,RPGR,RSG1,RSPH1,RSPH4A,RSPH9,SCLT1,SEPT2,SIX4,SNAP29,SNX10,SPAG1,SPAG16,SPATA6,SSX2IP,STK36,TCAP,TCTN2,TENM4,TMEM107,TMEM138,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TPM1,TTBK2,TTC26,TTC8,TTLL3,TTN,VANGL2,WDR35,ZMYND10	The cellular component assembly that is part of the initial shaping of the component during its developmental progression.
GO:0010935	GO	BP	regulation of macrophage cytokine production	CD74,CUEDC2,GPRC5B,IRAK3,SEMA7A,TGFB1,TGFB2,TGFB3,WNT5A	Any process that modulates the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0010936	GO	BP	negative regulation of macrophage cytokine production	CUEDC2,IRAK3,TGFB1,TGFB2,TGFB3	Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0010939	GO	BP	regulation of necrotic cell death	ARHGEF2,BIRC2,BIRC3,CASP8,CFLAR,FADD,FAS,FASLG,HEBP2,MT3,RIPK1,RIPK3,RPS27A,SLC25A4,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2,UBA52,UBB,UBC,YBX3	Any process that modulates the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.
GO:0010944	GO	BP	negative regulation of transcription by competitive promoter binding	BHLHE41,CREB1,DACH1,HHEX,MAD2L2,MUC1,OVOL2,PHB,SMAD7,TFAP2A	Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-dependent transcription using a mechanism that involves direct competition for interaction with a promoter binding site.
GO:0010950	GO	BP	positive regulation of endopeptidase activity	ACER2,ACVR1C,ADRM1,AIFM1,AIM2,ANP32B,APAF1,ARL6IP5,ASPH,BAD,BAK1,BAX,BBC3,BCAP31,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CIDEB,COL4A3,CR1,CTSH,CYCS,CYFIP2,DAP,DAPK1,DDX3X,DIABLO,DLC1,DNAJA3,EIF2AK3,F2R,F3,FADD,FAM162A,FAS,FASLG,FIS1,FOXL2,GNB2L1,GPER1,GSN,HIP1,HMGB1,HSPD1,HSPE1,HTRA2,IFI16,IFI27,IFT57,JAK2,LCK,LGALS9,LY96,MAP3K5,MEFV,MTCH1,MUL1,MYC,NDUFA13,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NLRP2,NLRP3,NOD1,NODAL,PDCD2,PDCD5,PDCD6,PERP,PICALM,PMAIP1,PPARG,PPM1F,PRELID1,PSMD14,PSME3,PYCARD,REST,RET,RIPK1,ROBO1,RPS27L,RPS3,S100A8,S100A9,SEMG1,SEMG2,SENP1,SERPINB3,SIRT1,SLC11A2,SMAD3,SNCA,SOX7,TBC1D10A,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	Any process that increases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
GO:0010951	GO	BP	negative regulation of endopeptidase activity	A2M,AGT,AKT1,AMBP,ANXA8,APP,AQP1,AVP,BCL2L12,BIRC5,BIRC6,BST2,CASP8,CD27,CD44,CDKN2D,CFLAR,COL4A3,CR1,CRB2,CSNK2A1,CST1,CST2,CST3,CST4,CST5,CST6,CST7,CST8,CSTA,CSTB,DDX3X,DHCR24,DNAJA3,DNAJB6,DPEP1,FABP1,FADD,FAS,FASLG,FETUB,FNIP1,FURIN,GAS6,GPX1,HGF,IFI16,IFI6,IGBP1,ITIH2,ITIH3,ITIH4,KLF4,KNG1,LAMTOR5,LCN1,LEF1,LPA,MAGEA3,MAP2K5,MMP9,MT3,NAIP,NGF,NOL3,PAK2,PARK7,PAX2,PCID2,PI3,PICALM,PIH1D1,PLAUR,PRDX3,PRDX5,PROL1,PROS1,PSMF1,PTTG1,PZP,RAF1,RECK,RFFL,RIPK1,RNF34,RPS6KA1,RPS6KA3,SERPINA1,SERPINA10,SERPINA2,SERPINA3,SERPINA4,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB10,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB7,SERPINB8,SERPINB9,SERPINC1,SERPIND1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SERPINI1,SERPINI2,SFN,SH3RF1,SIAH2,SNCA,SORL1,SPINT1,SPINT2,SPOCK1,SPOCK3,SPP2,SRC,TFAP2B,TFPI,THBS1,TIMP1,TIMP3,TIMP4,TNFAIP8,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF14,TRADD,TRAF2,TRIAP1,UCHL5,USP14,USP47,VEGFA,VTN,WFDC12,WFDC2,XIAP	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
GO:0010952	GO	BP	positive regulation of peptidase activity	ACER2,ACVR1C,ADRM1,AIFM1,AIM2,ANP32B,APAF1,ARL6IP5,ASPH,BAD,BAK1,BAX,BBC3,BCAP31,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CIDEB,CLPX,COL4A3,CR1,CTSH,CYCS,CYFIP2,DAP,DAPK1,DDX3X,DIABLO,DLC1,DNAJA3,EIF2AK3,F2R,F3,FADD,FAM162A,FAS,FASLG,FIS1,FOXL2,GNB2L1,GPER1,GSN,HIP1,HMGB1,HSPD1,HSPE1,HTRA2,IFI16,IFI27,IFT57,JAK2,LCK,LGALS9,LY96,MAP3K5,MAPK12,MEFV,MTCH1,MUL1,MYC,NDUFA13,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NLRP2,NLRP3,NOD1,NODAL,PCOLCE,PCOLCE2,PDCD2,PDCD5,PDCD6,PERP,PICALM,PINK1,PMAIP1,PPARG,PPM1F,PRELID1,PSMD14,PSME3,PYCARD,REST,RET,RIPK1,ROBO1,RPS27L,RPS3,S100A8,S100A9,SEMG1,SEMG2,SENP1,SERPINB3,SIRT1,SLC11A2,SMAD3,SNCA,SOX7,TBC1D10A,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	Any process that increases the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins.
GO:0010954	GO	BP	positive regulation of protein processing	ADAM8,ASTL,C19orf80,CCBE1,CLEC3B,F12,GSN,HPN,KLKB1,MFI2,MYH9,NKD2,PHB,RHBDD1	Any process that increases the rate, frequency or extent of protein maturation by peptide bond cleavage.
GO:0010955	GO	BP	negative regulation of protein processing	A2M,BCL2L12,C4BPA,C4BPB,CD55,CHAC1,CR1,GAS1,LRRK2,MAGEA3,MASP1,NOL3,SERPINE1,SERPINE2,SERPINF2,SERPING1,SNX12,SUSD4,THBS1,TMEM59,USP17L2	Any process that decreases the rate, frequency or extent of protein maturation by peptide bond cleavage.
GO:0010957	GO	BP	negative regulation of vitamin D biosynthetic process	CYP27B1,GFI1,NFKB1,SNAI1,SNAI2	Any process that decreases the rate, frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
GO:0010965	GO	BP	regulation of mitotic sister chromatid separation	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CENPE,CENPF,CSNK2A1,CSNK2A2,CUL3,DLGAP5,DUSP1,DYNC1LI1,ESPL1,FBXO5,GEN1,KLHL22,LCMT1,MAD1L1,MAD2L1,MAD2L2,MOS,NEK6,NSMCE2,PCID2,PLK1,PTEN,RB1,SMC5,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of mitotic sister chromatid separation. Mitotic sister chromatid separation is the process in which sister chromatids are physically detached from each other during mitosis.
GO:0010970	GO	BP	microtubule-based transport	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,APBA1,APP,ARHGAP21,BICD1,BICD2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CDC42,CEP131,CLN3,COPG1,DTNBP1,DYNC1I1,FYCO1,HAP1,HIF1A,HTT,ICK,IFT122,IFT27,IFT43,IFT46,IFT74,IFT81,KIF13A,KIF1A,KIF1B,KIF3A,KIF3B,KIF4A,KIF5B,KIFAP3,LRPPRC,MAP1S,MGARP,NEFL,OPA1,PAFAH1B1,PCM1,PEX14,RAB1A,RAB6A,RHOT1,RHOT2,RPGR,SNAPIN,SOD1,SSX2IP,TTC26,UBB,UXT,WDR19,WDR35	The transport of organelles or other particles from one location in the cell to another along microtubules.
GO:0010971	GO	BP	positive regulation of G2/M transition of mitotic cell cycle	BRD4,CCND1,CDC7,CDK4,DBF4B,PHOX2B,RAB11A,RAD51B,RAD51C,RCC2,STOX1,VPS4B	Any process that increases the rate or extent of progression from G2 phase to M phase of the mitotic cell cycle.
GO:0010972	GO	BP	negative regulation of G2/M transition of mitotic cell cycle	ATM,BLM,CCNA2,CDK5RAP3,CLSPN,FHL1,FOXN3,HMGA2,NAE1,NBN,TAOK3,TICRR,USP47,ZNF830	Any cell cycle regulatory process that decreases the rate or extent of progression of a cell from G2 to M phase of the mitotic cell cycle.
GO:0010975	GO	BP	regulation of neuron projection development	ABL1,ABL2,ADCY6,ADGRB3,AKT1,AMIGO1,APOE,ARF6,ARHGDIA,ARHGEF1,ARSB,AVIL,BAG5,BCL11A,BDNF,BHLHB9,BMP5,BMP7,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CBFA2T2,CCDC88A,CDK5,CDK5R1,CDKL5,CFL1,CHN1,CHRNA3,CHRNB2,CIB1,CLASP2,COBL,CPEB3,CPNE5,CPNE6,CPNE9,CTTN,CUL7,CUX1,CUX2,DAB2IP,DBN1,DCC,DMD,DNM2,DPYSL3,DSCAM,EFNA1,EPHA3,EPHA4,EPHB3,FAM134C,FBXW8,FES,FGF13,FKBP4,FOXO6,FRMD7,GAK,GDI1,GFI1,GOLGA4,GORASP1,HDAC2,IL1RAPL1,ISLR2,ITM2C,ITSN2,KANK1,KIAA0319,KIDINS220,KIF13B,KLK8,L1CAM,LIMK1,LINGO1,LPAR1,LRP4,LRP8,LRRC4C,LRRK2,LTK,LYN,MACF1,MAG,MAGI2,MAPT,MARK2,MEF2C,MEGF8,MT3,NCS1,NDNF,NDRG4,NEDD4,NEDD4L,NEURL1,NGEF,NGF,NGFR,NLGN1,NPTN,NRCAM,NRP1,NSMF,NTN1,NTRK1,NTRK2,OBSL1,OLFM1,OMG,PACSIN1,PAQR3,PDLIM5,PLK5,PRKCI,PRKD1,PSEN1,PTEN,PTK2B,PTK6,PTK7,PTPRD,PTPRO,RAB17,RAB29,RAP1A,RAP2A,RAPGEF1,RAPGEF2,RASAL1,RELN,RET,RHOA,RIMS1,RIMS2,RNF6,ROBO1,ROBO2,RTN4,RTN4R,RUFY3,SARM1,SCARF1,SCN1B,SDC2,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SETX,SHANK1,SHANK3,SHTN1,SIPA1L1,SKIL,SLIT2,SMURF1,SNX3,SPOCK1,SRCIN1,SRGAP2C,STK24,STMN2,SYT1,SYT17,SYT2,SYT3,SYT4,TENM3,THY1,TNIK,TRPV4,TWF2,ULK4,UNC13A,VEGFA,VLDLR,WNT3A,WNT5A,YWHAH	Any process that modulates the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
GO:0010976	GO	BP	positive regulation of neuron projection development	ABL2,AMIGO1,APOE,ARHGDIA,ARSB,AVIL,BCL11A,BDNF,BHLHB9,BMP5,BMP7,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CBFA2T2,CDKL5,COBL,CPEB3,CPNE5,CPNE6,CPNE9,CUL7,CUX1,CUX2,DAB2IP,DMD,DPYSL3,DSCAM,EPHA3,FAM134C,FBXW8,FES,FOXO6,GOLGA4,IL1RAPL1,ISLR2,ITSN2,KIDINS220,L1CAM,LIMK1,LRP8,LTK,LYN,MACF1,MAGI2,MAPT,MARK2,MEGF8,NDNF,NDRG4,NEDD4L,NEURL1,NGF,NGFR,NLGN1,NPTN,NRP1,NTN1,NTRK1,NTRK2,OBSL1,PACSIN1,PLK5,PRKCI,PRKD1,PSEN1,PTK2B,PTK6,PTK7,PTPRD,RAP1A,RAPGEF1,RAPGEF2,RASAL1,RELN,RET,RHOA,RIMS1,RIMS2,ROBO1,ROBO2,RUFY3,SCARF1,SCN1B,SEMA4D,SEMA5A,SEMA7A,SETX,SHANK1,SHANK3,SHTN1,SKIL,SLIT2,SMURF1,SNX3,STMN2,SYT1,SYT17,SYT2,SYT3,SYT4,TENM3,TWF2,UNC13A,VEGFA,VLDLR,WNT5A	Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
GO:0010977	GO	BP	negative regulation of neuron projection development	ADCY6,APOE,ARHGDIA,ARHGEF1,BAG5,BCL11A,CBFA2T2,CIB1,DCC,DPYSL3,EFNA1,EPHA4,FGF13,FKBP4,GAK,GDI1,GFI1,GORASP1,HDAC2,ITM2C,KANK1,KIAA0319,KLK8,LINGO1,LPAR1,LRP4,MAG,MT3,NGEF,NGFR,NLGN1,OMG,PAQR3,PTEN,PTPRO,RAB29,RAPGEF2,RHOA,RNF6,RTN4,RTN4R,RUFY3,SEMA5A,SLIT2,SPOCK1,SRGAP2C,STMN2,THY1,TRPV4,WNT3A,YWHAH	Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
GO:0010984	GO	BP	regulation of lipoprotein particle clearance	APOC1,APOC2,APOC3,CNPY2,FGF21,GPIHBP1,GPLD1,HNRNPK,LIPG,LRPAP1,NR1H4,PCSK9	Any process that modulates the rate, frequency, or extent of lipoprotein particle clearance. Lipoprotein particle clearance is the process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
GO:0010985	GO	BP	negative regulation of lipoprotein particle clearance	APOC1,APOC2,APOC3,LRPAP1,PCSK9	Any process that decreases the rate, frequency, or extent of lipoprotein particle clearance. Lipoprotein particle clearance is the process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
GO:0010988	GO	BP	regulation of low-density lipoprotein particle clearance	APOC3,CNPY2,FGF21,HNRNPK,NR1H4,PCSK9	Any process that modulates the rate, frequency or extent of low-density lipoprotein particle clearance. Low-density lipoprotein particle clearance is the process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
GO:0010993	GO	BP	regulation of ubiquitin homeostasis	PARK2,PINK1,TRIM6,UBE2C,UBE2K,UBE2S	Any process that modulates the rate, frequency, or extent of ubiquitin homeostasis. Ubiquitin homeostasis is any process involved in the maintenance of an internal steady state of ubiquitin monomers and free ubiquitin chains at the level of the cell.
GO:0010994	GO	BP	free ubiquitin chain polymerization	PARK2,TRIM6,UBE2C,UBE2K,UBE2S	The process of creating free ubiquitin chains, compounds composed of a large number of ubiquitin monomers. These chains are not conjugated to a protein.
GO:0012507	GO	CC	ER to Golgi transport vesicle membrane	AREG,B2M,CD59,CD74,CNIH1,CNIH2,CNIH3,FOLR1,GOSR2,GRIA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,LMAN1,MCFD2,SAR1B,SEC13,SEC22B,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,STX5,TGFA,TMED10,TMED2,TMED7,USO1,VMA21	The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.
GO:0012510	GO	CC	trans-Golgi network transport vesicle membrane	AFTPH,AP1G2,AP1S1,AP2A1,LDLRAP1,NCALD,RASSF9,SYNRG	The lipid bilayer surrounding a vesicle transporting substances between the trans-Golgi network and other parts of the cell.
GO:0014002	GO	BP	astrocyte development	CDK6,DLL1,EIF2B5,MT3,NF1	The process aimed at the progression of an astrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
GO:0014003	GO	BP	oligodendrocyte development	CLU,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,HES5,MYRF,PTEN,TENM4	The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system.
GO:0014013	GO	BP	regulation of gliogenesis	BIN1,BMP2,CDK1,CLCF1,CSF1,CXCR4,DICER1,DRD3,EPHA4,F2,HES1,HES5,NF1,NOG,NOTCH1,P2RY12,PRKCH,PRKCI,PTPRZ1,RNF10,SERPINE2,SIRT2,SKI,SOX11,SOX8,TENM4,TNFRSF21	Any process that modulates the frequency, rate or extent of gliogenesis, the formation of mature glia.
GO:0014014	GO	BP	negative regulation of gliogenesis	DICER1,DRD3,F2,HES1,HES5,NF1,NOG,NOTCH1,RNF10,SIRT2,SKI,SOX11	Any process that stops, prevents, or reduces the frequency, rate or extent of gliogenesis, the formation of mature glia.
GO:0014015	GO	BP	positive regulation of gliogenesis	BIN1,BMP2,CLCF1,CSF1,CXCR4,DICER1,HES1,NOTCH1,PRKCH,PRKCI,SERPINE2,SOX8,TENM4	Any process that activates or increases the frequency, rate or extent of gliogenesis, the formation of mature glia.
GO:0014031	GO	BP	mesenchymal cell development	AMELX,BMP2,BMP7,CORO1C,CTNNB1,CUL7,CYP26C1,EFNA1,EOMES,ERBB4,FAM83D,FGF8,FOLR1,FOXC1,FOXF2,GDNF,GSC,GSK3B,HAND2,HAS2,HES1,HEY1,HEY2,HEYL,HGF,HIF1A,HMGA2,HNRNPAB,HTR2B,JAG1,LEF1,LOXL2,LOXL3,LRP6,NOG,NOTCH1,NRG1,NRP1,NRTN,OLFM1,PHACTR4,PHOX2B,PITX2,RBPJ,S100A4,SEMA3A,SHH,SNAI1,SNAI2,SOX11,SOX8,SOX9,TBX1,TGFB1,TGFB2,TGFBR1,TGFBR3,TRIM28,WNT8A	The process aimed at the progression of a mesenchymal cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
GO:0014032	GO	BP	neural crest cell development	CORO1C,CYP26C1,ERBB4,FOLR1,GDNF,HAND2,HES1,HTR2B,JAG1,NRG1,NRP1,NRTN,PHACTR4,PHOX2B,PITX2,SEMA3A,SHH,SNAI2,SOX11,SOX8,TBX1	The process aimed at the progression of a neural crest cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
GO:0014033	GO	BP	neural crest cell differentiation	CORO1C,CYP26C1,ERBB4,FOLR1,GDNF,GSC,HAND2,HES1,HTR2B,JAG1,LRP6,MEF2C,NRG1,NRP1,NRTN,PHACTR4,PHOX2B,PITX2,SEMA3A,SHH,SNAI2,SOX11,SOX8,TBX1,WNT8A	The process in which a relatively unspecialized cell acquires specialized features of a neural crest cell.
GO:0014037	GO	BP	Schwann cell differentiation	ARHGEF10,DICER1,ERBB3,GPC1,MYOC,NCMAP,NF1,PARD3,SIRT2,SKI,SOD1	The process in which a relatively unspecialized cell acquires the specialized features of a Schwann cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function.
GO:0014047	GO	BP	glutamate secretion	BZRAP1,CPLX1,GIPC1,GLS,GLS2,PPFIA1,PPFIA2,PPFIA3,PPFIA4,RAB3A,RIMS1,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC38A2,SNAP25,STX1A,STXBP1,SYT1,UNC13B,VAMP2	The controlled release of glutamate by a cell. The glutamate is the most abundant excitatory neurotransmitter in the nervous system.
GO:0014059	GO	BP	regulation of dopamine secretion	CHRNA4,CHRNB2,DRD3,DTNBP1,GDNF,KCNA2,PARK2,SNCA	Any process that modulates the frequency, rate or extent of the regulated release of dopamine.
GO:0014061	GO	BP	regulation of norepinephrine secretion	ADRA2A,ADRA2B,ADRA2C,FFAR3,KCNB1,STX1A	Any process that modulates the frequency, rate or extent of the regulated release of norepinephrine.
GO:0014065	GO	BP	phosphatidylinositol 3-kinase signaling	C1QBP,EDN1,ERBB2,ERBB3,GATA3,HTR2A,HTR2B,IGF1,IGF1R,IRS1,LTK,NF1,NYAP1,NYAP2,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIK3R5,PLEKHA1,SIRT2,TYRO3,XBP1	A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
GO:0014066	GO	BP	regulation of phosphatidylinositol 3-kinase signaling	AGT,BECN1,C3orf58,CBL,CCL5,CSF3,DAB2IP,DCN,ENTPD5,ERBB3,F2R,F2RL1,FBXL2,FGFR1,FGR,FLT1,FLT3,FSHR,GH1,GPER1,HAX1,HCLS1,HCST,HGF,IGF1,INS,JAK2,KDR,KIT,LEP,MYDGF,MYOC,NEDD4,NKX3-1,NTRK2,PDGFA,PDGFB,PDGFRA,PDGFRB,PIK3AP1,PIK3IP1,PLXNB1,PPP1R16B,PTEN,PTK2,PTPN13,PTPN6,SELP,SEMA4D,SIRT1,SLC9A3R1,SOX9,STAMBP,TEK,TGFB2,TSC2,TWIST1,UNC5B,WNT16	Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
GO:0014067	GO	BP	negative regulation of phosphatidylinositol 3-kinase signaling	DAB2IP,PIK3IP1,PTEN,SLC9A3R1,STAMBP,TSC2,TWIST1	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
GO:0014068	GO	BP	positive regulation of phosphatidylinositol 3-kinase signaling	AGT,BECN1,CBL,CCL5,CSF3,DCN,ERBB3,F2R,F2RL1,FGFR1,FGR,FLT1,FLT3,FSHR,GH1,GPER1,HAX1,HCLS1,HCST,HGF,IGF1,INS,JAK2,KDR,KIT,LEP,MYDGF,MYOC,NEDD4,NKX3-1,NTRK2,PDGFA,PDGFB,PDGFRA,PDGFRB,PIK3AP1,PLXNB1,PTK2,PTPN6,SELP,SEMA4D,SIRT1,SOX9,TEK,TGFB2,UNC5B,WNT16	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
GO:0014069	GO	CC	postsynaptic density	BCR,CABP1,CACNA1C,CACNG5,CACNG8,CDK5,CDK5R1,CHRNA3,CNIH2,CPEB4,CRIPT,DLG4,DNM3,DTNBP1,GPER1,GRIA1,GRIN1,LRP4,MAGI2,MAPK8IP2,MTMR2,NETO1,NEURL1,NLGN1,NSF,NSMF,P2RY1,PDLIM5,PTK2B,RGS14,SEMA4C,SH2D5,SHANK1,SHANK2,SHANK3,SIGMAR1,SIPA1L1,SPOCK1,SRCIN1,SRGAP2,STRN,SYNDIG1	The postsynaptic density is a region that lies adjacent to the cytoplasmic face of the postsynaptic membrane at excitatory synapse. It forms a disc that consists of a range of proteins with different functions, some of which contact the cytoplasmic domains of ion channels in the postsynaptic membrane. The proteins making up the disc include receptors, and structural proteins linked to the actin cytoskeleton. They also include signalling machinery, such as protein kinases and phosphatases. The postsynaptic density may be part of a neuron or a muscle cell or a glial cell.
GO:0014074	GO	BP	response to purine-containing compound	AANAT,AKAP6,AKAP7,AKAP9,AQP1,ASPH,CASQ2,CFTR,CIB2,CITED1,CRHBP,DGKQ,DMTN,DUOX1,DUOX2,EZR,GSTM2,HCN1,HCN2,HCN4,HSP90B1,IGFBP5,INPP5K,KCNE1,KCNJ11,KCNQ1,NDUFS4,P2RX4,P2RX7,P2RY11,P2RY12,PDE2A,PDE3A,PDE4D,PDXP,RAP1A,RAP1B,RAPGEF1,RAPGEF2,RAPGEF3,RYR1,RYR2,RYR3,SLC26A3,SLC26A6,SLC8A1,SSH1,STAT1,TRPC3,TRPV1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purine-containing compound stimulus.
GO:0014701	GO	CC	junctional sarcoplasmic reticulum membrane	AKAP6,ASPH,CASQ2,JPH1,JPH2,JPH3,JPH4,RYR1,RYR2,TRDN	The part of the sarcoplasmic reticulum membrane that contains calcium release channels, is devoted to calcium release and is juxtaposed to transverse tubule membrane. The junctional sarcoplasmic reticulum membrane consists of the junctional region of the terminal cisterna membrane.
GO:0014704	GO	CC	intercalated disc	AKAP6,ANK2,ANK3,ATP1B1,ATP2A2,CDH2,CTNNA3,CXADR,DES,DLG1,DSC2,DSG2,DSP,FGF13,GJA1,GJA5,GJC1,JUP,KCNA5,NRAP,OBSL1,PAK1,PGM5,PKP2,RANGRF,SCN1B,SCN4B,SCN5A,SLC8A1,TMEM65,VAMP5,YWHAH	A complex cell-cell junction at which myofibrils terminate in cardiomyocytes; mediates mechanical and electrochemical integration between individual cardiomyocytes. The intercalated disc contains regions of tight mechanical attachment (fasciae adherentes and desmosomes) and electrical coupling (gap junctions) between adjacent cells.
GO:0014706	GO	BP	striated muscle tissue development	ACTA1,ACTC1,ACVR1,ANKRD1,BMP10,BMP2,C3orf58,CAV1,CAV2,CBY1,CFLAR,CHRNA1,CHRND,CSRP3,CXADR,DLL1,DLL4,DSG2,DSP,FGFR2,FKBP1A,FOXL2,HAND1,HEY2,IGSF8,ISL1,KDM6B,KLHL41,LEMD2,MAML1,MEF2A,MEF2C,MEGF10,MESP1,MYBPC3,MYF5,MYF6,MYH11,MYH14,MYH6,MYH7,MYL2,MYL3,MYL6,MYL6B,MYLK2,MYLK3,MYLPF,MYOCD,MYOD1,MYOG,NDUFV2,NEBL,NKX2-5,NKX2-6,NOTCH1,NRG1,OBSL1,PDGFRA,PDGFRB,PDLIM5,PKP2,PROX1,RBP4,RBPJ,RYR1,RYR2,S1PR1,SIK1,SIX1,SIX4,SKI,SKIL,SLC8A1,SMAD7,SORBS2,SVIL,TAZ,TBX2,TBX20,TCAP,TCF21,TGFB2,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,TTN,VEGFA,WNT3A,WT1,ZBTB18,ZFPM1,ZFPM2	The process whose specific outcome is the progression of a striated muscle over time, from its formation to the mature structure. Striated muscle contain fibers that are divided by transverse bands into striations, and cardiac and skeletal muscle are types of striated muscle. Skeletal muscle myoblasts fuse to form myotubes and eventually multinucleated muscle fibers. The fusion of cardiac cells is very rare and can only form binucleate cells.
GO:0014731	GO	CC	spectrin-associated cytoskeleton	ANK1,ANK3,DMTN,EPB41,RHBG,SPTA1,SPTB,SPTBN1	The part of the cytoskeleton composed of spectrin, protein 4.1 and ankyrin. Spectrin-associated cytoskeleton is associated with the plasma membrane.
GO:0014807	GO	BP	regulation of somitogenesis	CDX1,CDX2,DLL1,LFNG,NKD1,PPP2R3A	Any process that modulates the frequency, rate or extent of somitogenesis.
GO:0014808	GO	BP	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	CCL3,CCR5,NOL3,RYR1,RYR2,TRDN	The process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels.
GO:0014812	GO	BP	muscle cell migration	DDR1,ITGB1BP1,ITGB3,NOV,PARVA,PDGFRB,ROCK1,SIX1,THBS4	The orderly movement of a muscle cell from one site to another, often during the development of a multicellular organism.
GO:0014819	GO	BP	regulation of skeletal muscle contraction	ACTN3,ATP2A1,CASQ1,CAV3,DMD,GSTM2,GSTO1,KCNJ2,MYH7,SLC8A3	Any process that modulates the frequency, rate or extent of skeletal muscle contraction.
GO:0014821	GO	BP	phasic smooth muscle contraction	DRD2,EDN1,EDN2,EDN3,EDNRB,GDNF,HTR1D,HTR2B	A process in which force is generated within phasic smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. In the phasic smooth muscle, the muscle contraction occurs without an ordered sarcomeric structure. Phasic smooth muscle contraction occurs in a series of discrete contractions and relaxations.
GO:0014829	GO	BP	vascular smooth muscle contraction	EDN1,EDN2,EDN3,EDNRA,EDNRB,PIK3C2A,SLC8A1	A process, occurring in the vascular tissue, whereby actin/myosin complex activity generates force through ATP hydrolysis resulting in a change in smooth muscle geometry. This process is always coupled to chemo-mechanical energy conversion.
GO:0014842	GO	BP	regulation of skeletal muscle satellite cell proliferation	ANGPT1,CFLAR,FGF2,MSTN,MYOG	Any process that modulates the frequency, rate or extent of skeletal muscle satellite cell proliferation.
GO:0014850	GO	BP	response to muscle activity	AGT,CAPN3,FNDC5,METRNL,MYOG,PERM1,PPARGC1A,RYR2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muscle activity stimulus.
GO:0014855	GO	BP	striated muscle cell proliferation	BMP10,C3orf58,MEGF10,TGFB2,TGFBR3	The multiplication or reproduction of striated muscle cells, resulting in the expansion of a cell population. Striated muscles contain fibers that are divided by transverse bands into striations, and cardiac and skeletal muscle are types of striated muscle.
GO:0014866	GO	BP	skeletal myofibril assembly	ACTA1,ACTC1,CFLAR,MYH11,PROX1,TCAP,TTN	The process whose specific outcome is the progression of the skeletal myofibril over time, from its formation to the mature structure. A skeletal myofibril is a myofibril specific to skeletal muscle cells.
GO:0014874	GO	BP	response to stimulus involved in regulation of muscle adaptation	ACTN3,AGT,FBXO32,HDAC4,MYOG,SCN5A,TRIM63	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. This occurs as part of the regulation of muscle adaptation.
GO:0014888	GO	BP	striated muscle adaptation	ACTN3,CAMTA2,CFLAR,GSN,HDAC4,MYOC,MYOG,TCAP	Any process in which striated muscle adapts, with consequent modifications to structural and/or functional phenotypes, in response to a stimulus. Stimuli include contractile activity, loading conditions, substrate supply, and environmental factors. These adaptive events occur in both muscle fibers and associated structures (motoneurons and capillaries), and they involve alterations in regulatory mechanisms, contractile properties and metabolic capacities.
GO:0014894	GO	BP	response to denervation involved in regulation of muscle adaptation	ACTN3,FBXO32,HDAC4,MYOG,SCN5A	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a denervation stimulus. This process occurs as part of the regulation of muscle adaptation.
GO:0014896	GO	BP	muscle hypertrophy	CAMTA2,CSRP3,CYBA,HDAC4,HTR2B,IGF1,MYOC,PDLIM5,RYR2,SORBS2,TCAP,TTN	The muscle system process that results in enlargement or overgrowth of all or part of a muscle organ due to an increase in the size of its muscle cells. Physiological hypertrophy is a normal process during development (it stops in cardiac muscle after adolescence) and can also be brought on in response to demand. In athletes cardiac and skeletal muscles undergo hypertrophy stimulated by increasing muscle activity on exercise. Smooth muscle cells in the uterus undergo hypertrophy during pregnancy.
GO:0014897	GO	BP	striated muscle hypertrophy	CAMTA2,CSRP3,HDAC4,HTR2B,MYOC,PDLIM5,RYR2,SORBS2,TCAP,TTN	The enlargement or overgrowth of all or part of an organ due to an increase in size of muscle cells without cell division. In the case of striated muscle, this happens due to the additional synthesis of sarcomeric proteins and assembly of myofibrils.
GO:0014902	GO	BP	myotube differentiation	ACTA1,ADAM12,ADGRB3,CACNA1H,CAV2,IGF1,KCNH1,MYOD1,NOS1,RYR1,SIX4,SKI,SORT1,TMEM8C	The process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotube differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual myotubes can fuse to form bigger myotubes and start to contract. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
GO:0014904	GO	BP	myotube cell development	ACTA1,CAV2,IGF1,MYOD1,RYR1,SKI	The process aimed at the progression of a myotube cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
GO:0014909	GO	BP	smooth muscle cell migration	DDR1,ITGB3,NOV,PARVA,PDGFRB	The orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism.
GO:0014910	GO	BP	regulation of smooth muscle cell migration	ACE,ADIPOQ,AIF1,CCL5,CORO1B,DOCK4,DOCK5,DOCK7,IGF1,IGFBP3,IGFBP5,LRP1,NDRG4,NRP1,PDGFA,PDGFB,PDGFRB,PLAU,SERPINE1,SLIT2,SORL1,TPM1,TRIB1,VTN	Any process that modulates the frequency, rate or extent of smooth muscle cell migration.
GO:0014911	GO	BP	positive regulation of smooth muscle cell migration	AIF1,CCL5,DOCK4,DOCK5,DOCK7,IGF1,NRP1,PDGFB,PDGFRB,VTN	Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.
GO:0014912	GO	BP	negative regulation of smooth muscle cell migration	ADIPOQ,AIF1,CORO1B,IGFBP3,IGFBP5,LRP1,NDRG4,SERPINE1,SLIT2,TPM1,TRIB1	Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
GO:0015012	GO	BP	heparan sulfate proteoglycan biosynthetic process	B3GAT3,CSGALNACT1,EXT1,EXT2,GLCE,HS3ST3B1,HS3ST5,XYLT2	The chemical reactions and pathways resulting in the formation of the heparan sulfate proteoglycan, a glycosaminoglycan with repeat unit consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues; the former are a mixture of sulfated and nonsulfated D-glucuronic acid and L-iduronic acid; the L-iduronic acid is either sulfated or acetylated on its amino group as well as being sulfated on one of its hydroxyl groups; heparan sulfate chains are covalently linked to peptidyl-serine by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylosyl to serine residues.
GO:0015020	GO	MF	glucuronosyltransferase activity	B3GAT2,B3GAT3,B4GAT1,CSGALNACT1,EXT1,EXT2,GYLTL1B,LARGE,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7,UGT3A1	Catalysis of the reaction: UDP-glucuronate + acceptor = UDP + acceptor beta-D-glucuronoside.
GO:0015026	GO	MF	coreceptor activity	ACVR2A,CCR5,CCR8,CD28,CD4,CD80,CD86,CD8A,CD8B,CXCR4,HFE2,LRP6,LY96,NRP1,PVRL1,PVRL2,RAMP2,TGFBR3,TMIGD2,ZP2	Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
GO:0015030	GO	CC	Cajal body	AK6,ANGEL2,CDK2,COIL,DKC1,EFTUD2,ELL,FBL,GAR1,HINFP,ICE1,ICE2,ISG20,LSG1,LSM10,NHP2,NOP10,NOP58,NPAT,OIP5,PRPF3,PRPF31,PRPF4,SART1,SART3,SMN1,SNRPC,SRRM2,TOE1,U2AF1,USPL1,WRAP53,ZC3H8,ZNF473,ZPR1	A class of nuclear body, first seen after silver staining by Ramon y Cajal in 1903, enriched in small nuclear ribonucleoproteins, and certain general RNA polymerase II transcription factors; ultrastructurally, they appear as a tangle of coiled, electron-dense threads roughly 0.5 micrometers in diameter; involved in aspects of snRNP biogenesis; the protein coilin serves as a marker for Cajal bodies. Some argue that Cajal bodies are the sites for preassembly of transcriptosomes, unitary particles involved in transcription and processing of RNA.
GO:0015035	GO	MF	protein disulfide oxidoreductase activity	CCS,CHCHD4,DNAJC10,ENOX2,GFER,GLRX,STAB1,STAB2	Catalysis of the reaction: a protein with reduced sulfide groups = a protein with oxidized disulfide bonds.
GO:0015036	GO	MF	disulfide oxidoreductase activity	CCS,CHCHD4,DNAJC10,ENOX2,GFER,GLRX,GLRX2,GSR,GSTO1,GSTO2,PDIA2,PDIA3,STAB1,STAB2,TMX1,TXNDC12,TXNL1	Catalysis of the reaction: substrate with reduced sulfide groups = substrate with oxidized disulfide bonds.
GO:0015037	GO	MF	peptide disulfide oxidoreductase activity	GLRX,GLRX2,GSR,GSTO1,GSTO2,TXNDC12	Catalysis of the reaction: a peptide with reduced sulfide groups = a peptide with oxidized disulfide bonds.
GO:0015038	GO	MF	glutathione disulfide oxidoreductase activity	GLRX,GLRX2,GSR,GSTO1,GSTO2	Catalysis of the reaction: 2 glutathione + electron acceptor = glutathione disulfide + electron donor.
GO:0015077	GO	MF	monovalent inorganic cation transmembrane transporter activity	ABCB11,ABCC8,AQP1,ASIC1,ASIC3,ASIC4,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP1B4,ATP4B,ATP5A1,ATP5B,ATP5S,ATP6V0C,ATP6V0E1,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1F,AZIN2,CCT8L2,COX10,COX11,COX15,COX4I2,COX6B1,CYB5A,HCN1,HCN2,HCN3,HCN4,HPN,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNF1,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK10,KCNK13,KCNK16,KCNK17,KCNK18,KCNK2,KCNK3,KCNK4,KCNK5,KCNK6,KCNK7,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,KCNQ1,KCNQ2,KCNQ3,KCNQ4,KCNQ5,KCNS1,KCNS3,KCNU1,MT-CO1,MT-CO2,MT-CYB,MTMR6,NALCN,NDUFA4,NNT,OAZ3,PKD2,PKD2L1,REST,RHAG,RHBG,RHCG,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHROOM2,SLC11A1,SLC12A2,SLC12A6,SLC13A2,SLC13A4,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC18A3,SLC20A1,SLC20A2,SLC22A16,SLC22A4,SLC22A5,SLC23A1,SLC23A2,SLC24A1,SLC24A2,SLC24A5,SLC34A2,SLC34A3,SLC38A1,SLC3A2,SLC44A1,SLC44A2,SLC46A1,SLC4A11,SLC4A4,SLC4A5,SLC4A7,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A3,SLC6A4,SLC6A5,SLC6A9,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7,TMEM175,TMEM38A,TMEM38B,TRAPPC10,UQCR10,UQCRC1	Enables the transfer of a inorganic cations with a valency of one from one side of a membrane to the other. Inorganic cations are atoms or small molecules with a positive charge that do not contain carbon in covalent linkage.
GO:0015078	GO	MF	hydrogen ion transmembrane transporter activity	ATP4B,ATP5A1,ATP5B,ATP5S,ATP6V0C,ATP6V0E1,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1F,COX10,COX11,COX15,COX4I2,COX6B1,CYB5A,MT-CO1,MT-CO2,MT-CYB,NDUFA4,NNT,SLC11A1,SLC46A1,SLC9A1,SLC9A3,SLC9A7,UQCR10,UQCRC1	Enables the transfer of hydrogen ions from one side of a membrane to the other.
GO:0015079	GO	MF	potassium ion transmembrane transporter activity	ABCC8,AQP1,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP4B,CCT8L2,HCN1,HCN2,HCN3,HCN4,HPN,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNF1,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK10,KCNK13,KCNK16,KCNK17,KCNK18,KCNK2,KCNK3,KCNK4,KCNK5,KCNK6,KCNK7,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,KCNQ1,KCNQ2,KCNQ3,KCNQ4,KCNQ5,KCNS1,KCNS3,KCNU1,MTMR6,PKD2,PKD2L1,REST,SLC12A6,SLC24A1,SLC24A2,SLC24A5,SLC9A7,TMEM175,TMEM38A,TMEM38B	Enables the transfer of potassium ions (K+) from one side of a membrane to the other.
GO:0015081	GO	MF	sodium ion transmembrane transporter activity	ABCB11,ASIC1,ASIC3,ASIC4,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,HCN1,HCN2,HCN3,HCN4,KCNK1,NALCN,PKD2,PKD2L1,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHROOM2,SLC13A2,SLC13A4,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC23A1,SLC23A2,SLC24A1,SLC24A2,SLC24A5,SLC34A2,SLC34A3,SLC38A1,SLC3A2,SLC4A11,SLC4A4,SLC4A5,SLC4A7,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A4,SLC6A5,SLC6A9,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7,TRAPPC10	Enables the transfer of sodium ions (Na+) from one side of a membrane to the other.
GO:0015085	GO	MF	calcium ion transmembrane transporter activity	ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,CACFD1,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,CUL5,FKBP1B,GAS6,GRIN1,GRIN3B,IL1RAPL1,ITGAV,ITPR1,ITPR2,ITPR3,JPH2,MCU,NCS1,OPRM1,ORAI1,P2RX1,PANX1,PDE2A,PKD1,PKD1L1,PKD2,PKD2L1,PSEN1,RASA3,RYR1,RYR2,RYR3,SLC24A1,SLC24A2,SLC24A5,SLC3A2,SLC8A1,SLC8A2,SLC8A3,SLC8B1,STIM2,TPCN1,TPCN2,TRPA1,TRPC1,TRPC3,TRPC4,TRPC5,TRPM1,TRPV1,TRPV4,TRPV5,TRPV6,ZP3	Enables the transfer of calcium (Ca) ions from one side of a membrane to the other.
GO:0015095	GO	MF	magnesium ion transmembrane transporter activity	CLDN16,MAGT1,MMGT1,TUSC3,ZDHHC13,ZDHHC17	Enables the transfer of magnesium (Mg) ions from one side of a membrane to the other.
GO:0015101	GO	MF	organic cation transmembrane transporter activity	AZIN2,OAZ3,SLC22A1,SLC22A13,SLC22A14,SLC22A16,SLC22A2,SLC22A3,SLC22A4,SLC22A5,SLC25A17,SLC25A42,SLC7A8	Enables the transfer of organic cations from one side of a membrane to the other. Organic cations are atoms or small molecules with a positive charge that contain carbon in covalent linkage.
GO:0015103	GO	MF	inorganic anion transmembrane transporter activity	ADAMTS8,ANKH,ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,ASNA1,BEST1,BEST2,BSND,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR2,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A4,SLC17A1,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC1A4,SLC20A1,SLC20A2,SLC25A3,SLC26A1,SLC26A2,SLC26A3,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC34A1,SLC34A2,SLC34A3,SLC4A1,SLC4A11,SLC4A4,SLC4A5,SLC4A7,SLC5A5,TTYH1,TTYH3	Enables the transfer of inorganic anions from one side of a membrane to the other. Inorganic anions are atoms or small molecules with a negative charge which do not contain carbon in covalent linkage.
GO:0015106	GO	MF	bicarbonate transmembrane transporter activity	CFTR,SLC26A3,SLC26A6,SLC26A7,SLC4A1,SLC4A11,SLC4A4,SLC4A5,SLC4A7	Enables the transfer of bicarbonate from one side of a membrane to the other. Bicarbonate is the hydrogencarbonate ion, HCO3-.
GO:0015108	GO	MF	chloride transmembrane transporter activity	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,BEST1,BEST2,BSND,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR2,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC1A4,SLC26A1,SLC26A3,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC4A1,TTYH1,TTYH3	Enables the transfer of chloride ions from one side of a membrane to the other.
GO:0015114	GO	MF	phosphate ion transmembrane transporter activity	ADAMTS8,SLC17A1,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC25A3,SLC34A1,SLC34A2,SLC34A3	Enables the transfer of phosphate (PO4 3-) ions from one side of a membrane to the other.
GO:0015116	GO	MF	sulfate transmembrane transporter activity	SLC13A4,SLC26A1,SLC26A2,SLC26A4,SLC26A6,SLC26A7,SLC26A8	Enables the transfer of sulfate ions, SO4(2-), from one side of a membrane to the other.
GO:0015144	GO	MF	carbohydrate transmembrane transporter activity	AQP1,AQP2,AQP3,PPBP,SLC17A5,SLC23A1,SLC23A2,SLC2A1,SLC2A10,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC2A9,SLC5A1,SLC5A2	Enables the transfer of carbohydrate from one side of the membrane to the other.
GO:0015145	GO	MF	monosaccharide transmembrane transporter activity	PPBP,SLC23A1,SLC23A2,SLC2A1,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC5A1,SLC5A2	Enables the transfer of a monosaccharide from one side of a membrane to the other.
GO:0015149	GO	MF	hexose transmembrane transporter activity	PPBP,SLC2A1,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC5A1,SLC5A2	Enables the transfer of a hexose sugar, a monosaccharide with 6 carbon atoms, from one side of a membrane to the other.
GO:0015165	GO	MF	pyrimidine nucleotide-sugar transmembrane transporter activity	SLC35A1,SLC35A3,SLC35B1,SLC35B4,SLC35D1	Enables the transfer of a pyrimidine nucleotide-sugar from one side of the membrane to the other. Pyrimidine nucleotide-sugars are pyrimidine nucleotides in glycosidic linkage with a monosaccharide or monosaccharide derivative.
GO:0015166	GO	MF	polyol transmembrane transporter activity	AQP1,AQP2,AQP3,AQP9,SLC5A3	Enables the transfer of a polyol from one side of the membrane to the other. A polyol is any polyhydric alcohol.
GO:0015171	GO	MF	amino acid transmembrane transporter activity	CTNS,OCA2,PQLC2,SERINC1,SLC16A12,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A7,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC6A14,SLC6A20,SLC6A5,SLC6A8,SLC6A9,SLC7A10,SLC7A11,SLC7A2,SLC7A4,SLC7A5,SLC7A6,SLC7A8,SLC7A9	Enables the transfer of amino acids from one side of a membrane to the other. Amino acids are organic molecules that contain an amino group and a carboxyl group.
GO:0015172	GO	MF	acidic amino acid transmembrane transporter activity	SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A22,SLC7A11	Enables the transfer of acidic amino acids from one side of a membrane to the other. Acidic amino acids have a pH below 7.
GO:0015174	GO	MF	basic amino acid transmembrane transporter activity	PQLC2,SLC38A3,SLC3A1,SLC7A2,SLC7A4	Catalysis of the transfer of basic amino acids from one side of a membrane to the other. Basic amino acids have a pH above 7.
GO:0015175	GO	MF	neutral amino acid transmembrane transporter activity	SERINC1,SLC1A1,SLC1A4,SLC1A5,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A7,SLC3A2,SLC43A1,SLC6A5,SLC6A9,SLC7A10,SLC7A11,SLC7A5,SLC7A8,SLC7A9	Catalysis of the transfer of neutral amino acids from one side of a membrane to the other. Neutral amino acids have a pH of 7.
GO:0015179	GO	MF	L-amino acid transmembrane transporter activity	CTNS,OCA2,PQLC2,SERINC1,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC36A2,SLC36A4,SLC38A3,SLC38A7,SLC3A1,SLC6A5,SLC6A9,SLC7A10,SLC7A11,SLC7A9	Enables the transfer of an L-amino acid from one side of a membrane to the other. L-amino acids are the L-enantiomers of amino acids.
GO:0015197	GO	MF	peptide transporter activity	ABCB9,CDH17,DISP1,SLC15A1,SLC15A2,TAP1,TAP2,TAPBP	Enables the directed movement of peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another, into, out of or within a cell, or between cells.
GO:0015205	GO	MF	nucleobase transmembrane transporter activity	AQP9,SLC23A1,SLC23A2,SLC25A4,SLC25A5	Enables the transfer of a nucleobase, any nitrogenous base that is a constituent of a nucleoside, nucleotide, or nucleic acidfrom one side of a membrane to the other.
GO:0015211	GO	MF	purine nucleoside transmembrane transporter activity	SLC25A17,SLC25A24,SLC25A26,SLC25A42,SLC25A6,SLC28A2,SLC35B2	Enables the transfer of a purine nucleoside, a purine base covalently bonded to a ribose or deoxyribose sugar, from one side of a membrane to the other.
GO:0015215	GO	MF	nucleotide transmembrane transporter activity	ABCC11,SLC25A17,SLC25A19,SLC25A24,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC35A1,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2	Enables the transfer of a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate, from one side of a membrane to the other.
GO:0015216	GO	MF	purine nucleotide transmembrane transporter activity	ABCC11,SLC25A17,SLC25A24,SLC25A42,SLC25A6,SLC35B2	Enables the transfer of a purine nucleotide, any compound consisting of a purine nucleoside esterified with (ortho)phosphate, from one side of a membrane to the other.
GO:0015232	GO	MF	heme transporter activity	ABCB6,ABCB7,ABCG2,FLVCR1,FLVCR2	Enables the directed movement of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring, into, out of or within a cell, or between cells.
GO:0015238	GO	MF	drug transmembrane transporter activity	ABCG2,EBP,SLC17A3,SLC19A2,SLC19A3,SLC22A18,SLC22A5,SLC38A3	Enables the directed movement of a drug from one side of a membrane to the other. A drug is any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
GO:0015248	GO	MF	sterol transporter activity	ABCA1,ABCG1,ABCG4,ABCG5,ABCG8,APOA1,APOA2,APOA4,APOB,CETP,NPC1,OSBP	Enables the directed movement of sterols into, out of or within a cell, or between cells. Sterol are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.
GO:0015250	GO	MF	water channel activity	AQP1,AQP3,AQP5,AQP6,AQP7,AQP8,AQP9,MIP	Transport systems of this type enable facilitated diffusion of water (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.
GO:0015269	GO	MF	calcium-activated potassium channel activity	CCT8L2,HPN,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,MTMR6,PKD2L1	Enables the calcium concentration-regulatable energy-independent passage of potassium ions across a lipid bilayer down a concentration gradient.
GO:0015271	GO	MF	outward rectifier potassium channel activity	KCNA5,KCND2,KCND3,KCNIP2,KCNK18,KCNK2,KCNQ1,REST	Enables the transmembrane transfer of a potassium ion by an outwardly-rectifying voltage-gated channel. An outwardly rectifying current-voltage relation is one where at any given driving force the outward flow of K+ ions exceeds the inward flow for the opposite driving force.
GO:0015276	GO	MF	ligand-gated ion channel activity	ANXA6,AQP1,ASIC1,CFTR,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB4,CNGA3,CNGB1,CNGB3,FKBP1B,GABRB1,GABRB3,GLRA1,GLRA2,GLRA3,GLRB,GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN3A,HCN1,HCN2,HCN4,HTR3B,ITPR1,ITPR3,KCNA10,KCNE2,KCNH2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK6,KCNQ5,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,PKD2,PTK2B,RYR1,RYR2,RYR3,SCNN1A,SCNN1B,SCNN1G,SHROOM2,TPCN1,TPCN2,TRPA1,TRPV1,ZACN	Enables the transmembrane transfer of an ion by a channel that opens when a specific ligand has been bound by the channel complex or one of its constituent parts.
GO:0015277	GO	MF	kainate selective glutamate receptor activity	GRIK1,GRIK2,GRIK3,GRIK4,GRIK5	An ionotropic glutamate receptor activity that exhibits fast gating by glutamate, acts by opening a cation channel permeable to sodium and potassium, and for which kainate is an agonist.
GO:0015278	GO	MF	calcium-release channel activity	FKBP1B,ITPR1,ITPR3,JPH2,PKD2,RASA3,RYR1,RYR2,RYR3,TPCN1,TPCN2,TRPA1,TRPV1	Enables the transmembrane transfer of a calcium ion by a channel that opens when a specific ligand has been bound by the channel complex or one of its constituent parts.
GO:0015279	GO	MF	store-operated calcium channel activity	ORAI1,STIM2,TRPC3,TRPC4,TRPC5,ZP3	A ligand-gated ion channel activity which transports calcium in response to emptying of intracellular calcium stores.
GO:0015280	GO	MF	ligand-gated sodium channel activity	ASIC1,SCNN1A,SCNN1B,SCNN1G,SHROOM2	Enables the transmembrane transfer of a sodium ion by a channel that opens when a specific ligand has been bound by the channel complex or one of its constituent parts.
GO:0015291	GO	MF	secondary active transmembrane transporter activity	ANKH,CDH17,MCU,MFSD2A,SLC11A1,SLC11A2,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A2,SLC13A4,SLC15A1,SLC15A2,SLC16A2,SLC16A7,SLC17A2,SLC17A3,SLC17A4,SLC17A5,SLC17A7,SLC19A1,SLC20A1,SLC20A2,SLC22A11,SLC22A4,SLC22A6,SLC22A7,SLC22A8,SLC22A9,SLC23A1,SLC23A2,SLC24A1,SLC24A2,SLC24A5,SLC25A11,SLC25A16,SLC25A6,SLC26A1,SLC26A6,SLC26A9,SLC2A10,SLC2A9,SLC34A2,SLC34A3,SLC38A1,SLC3A2,SLC46A2,SLC4A1,SLC4A4,SLC4A5,SLC4A7,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A4,SLC6A5,SLC6A9,SLC7A11,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7,SLCO1B1,SLCO2B1	Catalysis of the transfer of a solute from one side of a membrane to the other, up its concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction and is driven by a chemiosmotic source of energy, not direct ATP coupling. Chemiosmotic sources of energy include uniport, symport or antiport.
GO:0015293	GO	MF	symporter activity	MFSD2A,SLC11A2,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A2,SLC13A4,SLC15A1,SLC15A2,SLC17A2,SLC17A3,SLC17A4,SLC17A5,SLC17A7,SLC20A1,SLC20A2,SLC23A1,SLC23A2,SLC2A10,SLC2A9,SLC34A2,SLC34A3,SLC38A1,SLC46A2,SLC4A4,SLC4A5,SLC4A7,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A4,SLC6A5,SLC6A9	Enables the active transport of a solute across a membrane by a mechanism whereby two or more species are transported together in the same direction in a tightly coupled process not directly linked to a form of energy other than chemiosmotic energy.
GO:0015294	GO	MF	solute:cation symporter activity	SLC11A2,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A2,SLC13A4,SLC15A1,SLC15A2,SLC17A2,SLC17A3,SLC17A4,SLC17A5,SLC17A7,SLC20A1,SLC20A2,SLC23A1,SLC23A2,SLC2A10,SLC2A9,SLC34A2,SLC34A3,SLC38A1,SLC4A4,SLC4A5,SLC4A7,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A4,SLC6A5,SLC6A9	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: solute(out) + cation(out) = solute(in) + cation(in).
GO:0015295	GO	MF	solute:proton symporter activity	SLC11A2,SLC15A1,SLC15A2,SLC17A5,SLC2A10,SLC2A9	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: solute(out) + H+(out) = solute(in) + H+(in).
GO:0015296	GO	MF	anion:cation symporter activity	SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A2,SLC13A4,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC23A1,SLC34A2,SLC34A3,SLC4A4,SLC4A5,SLC4A7,SLC6A5,SLC6A9	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: anion(out) + cation(out) = anion(in) + cation(in).
GO:0015297	GO	MF	antiporter activity	SLC11A1,SLC22A11,SLC22A4,SLC22A6,SLC22A8,SLC22A9,SLC24A1,SLC24A2,SLC24A5,SLC25A11,SLC25A16,SLC25A6,SLC26A1,SLC26A6,SLC26A9,SLC3A2,SLC4A1,SLC7A11,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7	Enables the active transport of a solute across a membrane by a mechanism whereby two or more species are transported in opposite directions in a tightly coupled process not directly linked to a form of energy other than chemiosmotic energy. The reaction is: solute A(out) + solute B(in) = solute A(in) + solute B(out).
GO:0015301	GO	MF	anion:anion antiporter activity	SLC22A11,SLC22A6,SLC22A8,SLC22A9,SLC25A11,SLC25A6,SLC26A1,SLC26A6,SLC26A9,SLC4A1,SLC7A11	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: anion A(out) + anion B(in) = anion A(in) + anion B(out).
GO:0015347	GO	MF	sodium-independent organic anion transmembrane transporter activity	SLC22A11,SLC22A6,SLC22A7,SLC22A9,SLCO1B1,SLCO2B1	Catalysis of the transfer of organic anions from one side of a membrane to the other, in a sodium independent manner.
GO:0015368	GO	MF	calcium:cation antiporter activity	SLC24A1,SLC24A2,SLC24A5,SLC3A2,SLC8A1,SLC8A2,SLC8A3,SLC8B1	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Ca2+(in) + cation(out) = Ca2+(out) + cation(in).
GO:0015370	GO	MF	solute:sodium symporter activity	SLC13A2,SLC23A1,SLC23A2,SLC38A1,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A4,SLC6A5,SLC6A9	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: solute(out) + Na+(out) = solute(in) + Na+(in).
GO:0015405	GO	MF	P-P-bond-hydrolysis-driven transmembrane transporter activity	ABCA12,ABCA2,ABCA3,ABCA8,ABCB1,ABCB11,ABCB4,ABCB6,ABCB9,ABCD1,ABCD4,ABCG1,ABCG2,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V0E2,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1,CFTR,SLC11A2,TAP2,TAPBP,TOMM20	Primary active transport of a solute across a membrane, driven by the hydrolysis of the diphosphate bond of inorganic pyrophosphate, ATP, or another nucleoside triphosphate. The transport protein may or may not be transiently phosphorylated, but the substrate is not phosphorylated. Primary active transport is catalysis of the transport of a solute across a membrane, up the solute's concentration gradient, by binding the solute and undergoing a series of conformational changes. Transport works equally well in either direction and is driven by a primary energy source.
GO:0015459	GO	MF	potassium channel regulator activity	ABCC9,ADRB2,AKAP9,AMIGO1,ARPP19,CAV1,CAV3,CHP1,DLG1,DPP10,DPP6,DRD2,DRD4,ENSA,KCNAB1,KCNAB2,KCNAB3,KCNE1,KCNE2,KCNE3,KCNE5,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNK2,KCNMB2,KCNMB3,KCNS1,KCNS3,KCNV1,LRRC26,NEDD4L,RASA1,SGK1,SGK2,SGK3,SUMO1,YWHAE	Modulates the activity of a potassium channel.
GO:0015464	GO	MF	acetylcholine receptor activity	ANXA9,CHRM2,CHRM3,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB4,CHRNE,CHRNG	Combining with acetylcholine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0015485	GO	MF	cholesterol binding	ABCA1,ABCG1,ANXA6,APOA1,APOA2,APOC3,APOD,APOF,CAV1,CETP,ERLIN1,NPC1,NPC2,NR1H3,OSBP2,OSBPL10,OSBPL1A,OSBPL2,OSBPL3,OSBPL5,OSBPL7,OSBPL8,PMP2,PROM2,PTCH1,SCP2,SOAT1,SOAT2,STARD3,SYP,TSPO,TSPO2	Interacting selectively and non-covalently with cholesterol (cholest-5-en-3-beta-ol); the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0015491	GO	MF	cation:cation antiporter activity	SLC11A1,SLC22A4,SLC24A1,SLC24A2,SLC24A5,SLC3A2,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: cation A(out) + cation B(in) = cation A(in) + cation B(out).
GO:0015605	GO	MF	organophosphate ester transmembrane transporter activity	ABCC11,SLC25A17,SLC25A19,SLC25A24,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC35A1,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2,SLC37A4	Enables the transfer of organophosphate esters from one side of a membrane to the other. Organophosphate esters are small organic molecules containing phosphate ester bonds.
GO:0015631	GO	MF	tubulin binding	AGBL1,AGBL4,AGBL5,AGTPBP1,ALDOA,APC,ARHGEF2,ARL3,ARL4C,ARL8A,ARL8B,ATF5,B4GALT1,B9D2,BBS4,BCAS3,BCL2L11,BIRC5,BLOC1S2,BRCA1,BRSK1,CAMSAP1,CAMSAP2,CAMSAP3,CAPN6,CCDC88A,CCSAP,CDK5RAP2,CENPJ,CHP1,CLASP1,CLASP2,CLIP1,CLIP3,CRIPT,DAG1,DCX,DIXDC1,DNM2,DST,DYNC1I1,EMD,EML1,EML2,EZR,FAM110C,FAM175B,FAM83D,FGF13,FNTA,FTCD,GABARAP,GABARAPL1,GABARAPL2,GAPDH,GAS2L1,GAS2L2,GAS2L3,GOLGA2,GPAA1,HDAC6,HOOK3,HTT,IFT74,IFT81,INO80,KATNA1,KATNB1,KIF14,KIF18A,KIF20B,KIF23,KIF26A,KIF2C,KIF5B,KRIT1,LRPPRC,LRRK2,MAP10,MAP1S,MAP7D3,MAPRE1,MAPRE3,MAPT,MARK4,MDM1,MID1,MID2,MTCL1,MTUS2,NCALD,NDE1,NDRG1,NEFH,NEFM,NME8,OFD1,PACRG,PAFAH1B1,PEX14,PIFO,PLK1,POLB,PPP1R42,PRNP,PSRC1,RAB11A,RAB11FIP5,RABGAP1,RACGAP1,RAD51D,RAE1,RCC2,REEP1,REEP4,RGS14,RITA1,RP1,RPS3,S100A8,S100A9,SAXO1,SBDS,SGIP1,SKA1,SKA2,SPAST,STARD9,STIM1,STMN1,SUN2,TBCD,TERF1,TPPP,TPPP3,TPR,TRPV4,TTLL4,TTLL6,TTLL7,TUBGCP3,TUBGCP5,TUBGCP6,UXT,VAPA,VAPB,WASH1,WHAMM,ZNF207	Interacting selectively and non-covalently with monomeric or multimeric forms of tubulin, including microtubules.
GO:0015643	GO	MF	toxic substance binding	ALB,AZU1,CHRNA7,DSG1,EPHX2,TMEM181	Interacting selectively and non-covalently with a toxic substance, a poisonous substance that causes damage to biological systems.
GO:0015645	GO	MF	fatty acid ligase activity	ACSBG1,ACSBG2,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,SLC27A2,SLC27A4,SLC27A5	Catalysis of the ligation of a fatty acid to an acceptor, coupled to the hydrolysis of ATP.
GO:0015662	GO	MF	ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism	ABCB11,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP7A,ATP7B	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O = ADP + phosphate, to directly drive the transport of ions across a membrane. The reaction is characterized by the transient formation of a high-energy aspartyl-phosphoryl-enzyme intermediate.
GO:0015665	GO	MF	alcohol transmembrane transporter activity	ABCG1,AQP1,AQP2,AQP3,AQP9,SLC44A1,SLC44A2,SLC5A3,SLC5A7	Enables the transfer of an alcohol from one side of the membrane to the other. An alcohol is any carbon compound that contains a hydroxyl group.
GO:0015669	GO	BP	gas transport	AQP1,AQP5,CYGB,HBA1,HBB,IPCEF1,MYC,NGB,RHAG	The directed movement of substances that are gaseous in normal living conditions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015671	GO	BP	oxygen transport	CYGB,HBA1,HBB,IPCEF1,MYC,NGB	The directed movement of oxygen (O2) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015695	GO	BP	organic cation transport	AZIN2,OAZ3,SLC22A1,SLC22A13,SLC22A14,SLC22A16,SLC22A18,SLC22A2,SLC22A3,SLC22A4,SLC22A5,SLC25A17,SLC25A42,SLC7A8	The directed movement of organic cations into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Organic cations are atoms or small molecules with a positive charge which contain carbon in covalent linkage.
GO:0015696	GO	BP	ammonium transport	ACACA,ACACB,AQP1,AZIN2,CPT1A,CPT1B,CPT2,OAZ3,PDZK1,PRKAA2,PRKAB2,PRKAG2,RHAG,RHBG,RHCG,SEC14L1,SLC12A2,SLC18A2,SLC18A3,SLC22A16,SLC22A4,SLC22A5,SLC25A20,SLC44A1,SLC44A2,SLC44A4,SLC6A3,SLC6A4,SNAP23,SNCA,SYK,TAF7	The directed movement of ammonium into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Ammonium is the cation NH4+ which is formed from N2 by root-nodule bacteria in leguminous plants and is an excretory product in ammonotelic animals.
GO:0015697	GO	BP	quaternary ammonium group transport	ACACA,ACACB,CPT1A,CPT1B,CPT2,PDZK1,PRKAA2,PRKAB2,PRKAG2,SLC22A16,SLC22A3,SLC22A4,SLC22A5,SLC25A20	The directed movement into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore of quaternary ammonium compounds, any compound that can be regarded as derived from ammonium hydroxide or an ammonium salt by replacement of all four hydrogen atoms of the NH4+ ion by organic groups.
GO:0015698	GO	BP	inorganic anion transport	ADAMTS8,ANKH,ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,APOL1,ASNA1,BEST1,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN6,CLCN7,CLIC1,CLIC3,CLIC4,CLIC5,ENPP1,FXYD1,FXYD3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR1,NMUR2,RACGAP1,SLC11A1,SLC12A1,SLC12A2,SLC12A3,SLC12A4,SLC12A9,SLC13A4,SLC17A1,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC1A4,SLC20A1,SLC20A2,SLC25A3,SLC26A1,SLC26A11,SLC26A2,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC34A1,SLC34A2,SLC34A3,SLC4A1,SLC4A10,SLC4A11,SLC5A5,TTYH1,TTYH3	The directed movement of inorganic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Inorganic anions are atoms or small molecules with a negative charge which do not contain carbon in covalent linkage.
GO:0015701	GO	BP	bicarbonate transport	AQP1,CA1,CA12,CA13,CA14,CA2,CA3,CA4,CA5A,CA5B,CA6,CA7,CA9,HBA1,HBB,RHAG,SLC26A6,SLC26A7,SLC26A9,SLC4A1,SLC4A10,SLC4A11,SLC4A2,SLC4A3,SLC4A4,SLC4A5,SLC4A7,SLC4A8,SLC4A9	The directed movement of bicarbonate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015718	GO	BP	monocarboxylic acid transport	ABCB11,ABCB4,ABCC3,ABCC4,ABCD1,ACACA,ACACB,ACE,ACSL1,ACSL3,AKR1C1,AKR1C4,ALB,APOE,ATP8B1,BAAT,BDKRB2,CD36,CPT1A,CPT1B,CPT2,DRD2,DRD3,DRD4,EMB,FABP3,FABP6,LCN1,LCN12,LEP,MFSD2A,NCOA1,NCOA2,NMUR2,NOS2,NR1H4,PDZK1,PLA2G1B,PNPLA8,PPARA,PPARD,PPARG,PRKAA2,PRKAB2,PRKAG2,RXRA,SLC10A1,SLC10A2,SLC16A1,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC16A8,SLC1A4,SLC22A13,SLC22A16,SLC22A4,SLC22A5,SLC22A9,SLC25A17,SLC25A20,SLC26A6,SLC27A1,SLC27A2,SLC27A4,SLC27A5,SLC27A6,SLC51A,SLC51B,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3,SPX	The directed movement of monocarboxylic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015721	GO	BP	bile acid and bile salt transport	ABCB11,ABCB4,ABCC3,AKR1C1,AKR1C4,ALB,ATP8B1,BAAT,FABP6,NCOA1,NCOA2,NR1H4,RXRA,SLC10A1,SLC10A2,SLC27A5,SLC51A,SLC51B,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3	The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015748	GO	BP	organophosphate ester transport	ABCA1,ABCA12,ABCA7,ABCB4,ABCC11,ABCG1,APOA1,APOA2,APOA4,APOC1,APOC2,APOC3,APOE,ATP10A,ATP10B,ATP10D,ATP11A,ATP11B,ATP11C,ATP8A1,ATP8B1,ATP9A,ATP9B,CALHM1,CETP,CPTP,LDLR,MTTP,NPC2,OSBPL5,OSBPL8,PCTP,PITPNA,PITPNB,PITPNC1,PITPNM1,PITPNM3,PLA2G10,PRELID1,PRELID3A,SCARB1,SCP2,SLC17A3,SLC25A17,SLC25A19,SLC25A24,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC35A1,SLC35A2,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2,SLC37A4,TMEM30A,TNFAIP8L3,TRIAP1	The directed movement of organophosphate esters into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Organophosphate esters are small organic molecules containing phosphate ester bonds.
GO:0015749	GO	BP	monosaccharide transport	AAAS,BRAF,EDNRA,G6PC,G6PC2,G6PC3,GCK,GCKR,GH1,HK1,HK2,HK3,HNF1A,INS,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PLA2G1B,POM121,POM121C,PPARD,PPBP,RAB4B,RAE1,RANBP2,SEH1L,SLC23A1,SLC23A2,SLC2A1,SLC2A10,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC2A8,SLC2A9,SLC37A4,SLC5A1,SORBS1,SORT1,TPR	The directed movement of monosaccharides into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Monosaccharides are the simplest carbohydrates; they are polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides.
GO:0015758	GO	BP	glucose transport	AAAS,BRAF,EDNRA,G6PC,G6PC2,G6PC3,GCK,GCKR,GH1,HK1,HK2,HK3,HNF1A,INS,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PLA2G1B,POM121,POM121C,PPARD,PPBP,RAB4B,RAE1,RANBP2,SEH1L,SLC2A1,SLC2A10,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC2A8,SLC2A9,SLC37A4,SLC5A1,SORBS1,SORT1,TPR	The directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015781	GO	BP	pyrimidine nucleotide-sugar transport	SLC35A1,SLC35A2,SLC35A3,SLC35B1,SLC35B4,SLC35D1	The directed movement of pyrimidine nucleotide-sugars into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Pyrimidine nucleotide-sugars are pyrimidine nucleotides in glycosidic linkage with a monosaccharide or monosaccharide derivative.
GO:0015791	GO	BP	polyol transport	AQP1,AQP2,AQP7,AQP9,PGAP1,SLC26A6	The directed movement of polyols, any polyhydric alcohol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015802	GO	BP	basic amino acid transport	CLN3,PQLC2,SLC11A1,SLC38A3,SLC3A1,SLC7A2,SLC7A4	The directed movement of basic amino acids, amino acids with a pH above 7, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015804	GO	BP	neutral amino acid transport	SERINC1,SLC1A1,SLC1A4,SLC1A5,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC3A2,SLC43A1,SLC6A15,SLC6A17,SLC6A20,SLC6A5,SLC6A7,SLC7A10,SLC7A5,SLC7A8,SLC7A9	The directed movement of neutral amino acids, amino acids with no net charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015807	GO	BP	L-amino acid transport	ARL6IP5,CTNS,PQLC2,PRAF2,SERINC1,SLC11A1,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC36A4,SLC38A3,SLC3A1,SLC6A17,SLC6A20,SLC6A5,SLC7A10,SLC7A11,SLC7A9	The directed movement of L-enantiomer amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015810	GO	BP	aspartate transport	SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC25A12,SLC25A13	The directed movement of aspartate, the anion of aspartic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015813	GO	BP	L-glutamate transport	ARL6IP5,PRAF2,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A22,SLC7A11	The directed movement of L-glutamate, the L enantiomer anion of 2-aminopentanedioic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015824	GO	BP	proline transport	SLC1A4,SLC36A2,SLC36A4,SLC6A15,SLC6A17,SLC6A20,SLC6A7	The directed movement of proline, pyrrolidine-2-carboxylic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015833	GO	BP	peptide transport	ABCB9,CAMK2G,CD209,CDH17,CDK16,CLEC4M,CRHR1,CYB5R4,DISP1,EDN1,EDN3,EIF2AK3,EXOC3L1,FAM3B,GAL,GHRH,GHRL,GHSR,HNF1A,IL6,LTBP4,MAFA,NEUROD1,PDX1,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RIMS2,SLC30A8,SLC9A3R1,SNX19,TAP1,TAP2,TAPBP,VIP	The directed movement of peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015844	GO	BP	monoamine transport	PICK1,SLC18A1,SLC18A2,SLC6A2,SLC6A3,SLC6A4,SNCA,SYK	The directed movement of monoamines, organic compounds that contain one amino group that is connected to an aromatic ring by an ethylene group (-CH2-CH2-), into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015849	GO	BP	organic acid transport	ABCB11,ABCB4,ABCC3,ABCC4,ABCD1,ACACA,ACACB,ACE,ACSL1,ACSL3,AKR1C1,AKR1C4,ALB,APOE,AQP9,ARL6IP5,ATP8B1,BAAT,BDKRB2,BZRAP1,CD36,CLN3,CPLX1,CPT1A,CPT1B,CPT2,CTNS,DRD2,DRD3,DRD4,EMB,FABP3,FABP6,FOLR1,FOLR2,FOLR3,GIPC1,GLS,GLS2,LCN1,LCN12,LEP,MFSD2A,NCOA1,NCOA2,NMUR2,NOS2,NR1H4,OCA2,PDZK1,PLA2G1B,PNPLA8,PPARA,PPARD,PPARG,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PQLC2,PRAF2,PRKAA2,PRKAB2,PRKAG2,RAB3A,RIMS1,RXRA,SERINC1,SLC10A1,SLC10A2,SLC11A1,SLC13A2,SLC16A1,SLC16A10,SLC16A12,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC16A8,SLC17A3,SLC17A5,SLC17A7,SLC19A1,SLC19A2,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC22A12,SLC22A13,SLC22A16,SLC22A4,SLC22A5,SLC22A6,SLC22A9,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A15,SLC25A17,SLC25A20,SLC25A22,SLC25A26,SLC25A32,SLC26A1,SLC26A6,SLC26A7,SLC26A8,SLC27A1,SLC27A2,SLC27A4,SLC27A5,SLC27A6,SLC35D1,SLC36A1,SLC36A2,SLC36A4,SLC38A1,SLC38A2,SLC38A3,SLC38A4,SLC38A5,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC43A2,SLC46A1,SLC51A,SLC51B,SLC6A12,SLC6A14,SLC6A15,SLC6A17,SLC6A18,SLC6A19,SLC6A20,SLC6A5,SLC6A6,SLC6A7,SLC6A8,SLC7A1,SLC7A10,SLC7A11,SLC7A2,SLC7A3,SLC7A4,SLC7A5,SLC7A6,SLC7A7,SLC7A8,SLC7A9,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3,SNAP25,SPX,STX1A,STXBP1,SYT1,UNC13B,VAMP2	The directed movement of organic acids, any acidic compound containing carbon in covalent linkage, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015850	GO	BP	organic hydroxy compound transport	ABCA1,ABCA5,ABCA7,ABCB11,ABCB4,ABCC3,ABCG1,ABCG4,ABCG5,ABCG8,ACACA,ACACB,AKR1C1,AKR1C4,ALB,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,AQP1,AQP2,AQP7,AQP9,ATP8B1,BAAT,CAV1,CD36,CEL,CETP,CLU,CPT1A,CPT1B,CPT2,EMB,FABP6,GHRL,LCAT,LDLR,LDLRAP1,LIPC,LIPG,MFSD10,MSR1,NCOA1,NCOA2,NPC1,NPC1L1,NPC2,NR1H4,OSBP,OSBPL5,PDZK1,PGAP1,PRKAA2,PRKAB2,PRKAG2,RBP4,RXRA,SCARB1,SEC14L1,SLC10A1,SLC10A2,SLC16A1,SLC16A7,SLC16A8,SLC18A2,SLC22A16,SLC22A4,SLC22A5,SLC25A20,SLC26A6,SLC27A5,SLC44A1,SLC44A2,SLC51A,SLC51B,SLC6A3,SLC6A4,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3,SNCA,SOAT1,SOAT2,STX12,SYK,VPS4A	The directed movement of an organic hydroxy compound (organic alcohol) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. An organic hydroxy compound is an organic compound having at least one hydroxy group attached to a carbon atom.
GO:0015851	GO	BP	nucleobase transport	AQP9,SLC23A1,SLC23A2,SLC25A4,SLC25A5,VDAC3	The directed movement of a nucleobase, any nitrogenous base that is a constituent of a nucleoside, nucleotide, or nucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015858	GO	BP	nucleoside transport	CALHM1,SLC25A17,SLC25A24,SLC25A26,SLC25A42,SLC25A6,SLC28A1,SLC28A2,SLC29A1,SLC29A2,SLC35B2	The directed movement of a nucleoside, a nucleobase linked to either beta-D-ribofuranose (ribonucleoside) or 2-deoxy-beta-D-ribofuranose, (a deoxyribonucleotide), into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015860	GO	BP	purine nucleoside transmembrane transport	SLC25A17,SLC25A26,SLC25A42,SLC28A2,SLC35B2	The directed movement of a purine nucleoside across a membrane. A purine nucleoside is a purine base covalently bonded to a ribose or deoxyribose sugar.
GO:0015865	GO	BP	purine nucleotide transport	ABCC11,CALHM1,SLC25A17,SLC25A24,SLC25A42,SLC25A6,SLC35B2	The directed movement of a purine nucleotide, any compound consisting of a purine nucleoside esterified with (ortho)phosphate, into, out of or within a cell.
GO:0015867	GO	BP	ATP transport	CALHM1,SLC25A17,SLC25A24,SLC25A42,SLC25A6	The directed movement of ATP, adenosine triphosphate, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015868	GO	BP	purine ribonucleotide transport	CALHM1,SLC25A17,SLC25A24,SLC25A42,SLC25A6,SLC35B2	The directed movement of a purine ribonucleotide, any compound consisting of a purine ribonucleoside (a purine organic base attached to a ribose sugar) esterified with (ortho)phosphate, into, out of or within a cell.
GO:0015879	GO	BP	carnitine transport	ACACA,ACACB,CPT1A,CPT1B,CPT2,PDZK1,PRKAA2,PRKAB2,PRKAG2,SLC22A16,SLC22A4,SLC22A5,SLC25A20	The directed movement of carnitine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Carnitine is a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane.
GO:0015884	GO	BP	folic acid transport	FOLR1,FOLR2,FOLR3,SLC19A1,SLC19A2,SLC25A32,SLC46A1	The directed movement of folic acid (pteroylglutamic acid) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
GO:0015886	GO	BP	heme transport	ABCB6,ABCB7,ABCG2,FLVCR1,FLVCR2,SLC48A1	The directed movement of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015893	GO	BP	drug transport	ABCB1,ABCG2,ATP8B1,EBP,MFSD10,NR1I2,PDZK1,SLC15A2,SLC17A3,SLC22A1,SLC22A18,SLC22A2,SLC22A3,SLC22A5,SLC46A1,TMEM30A	The directed movement of a drug, a substance used in the diagnosis, treatment or prevention of a disease, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015908	GO	BP	fatty acid transport	ABCC4,ABCD1,ACACA,ACACB,ACE,ACSL1,ACSL3,APOE,BDKRB2,CD36,CPT1A,CPT1B,CPT2,DRD2,DRD3,DRD4,FABP3,LCN1,LCN12,LEP,MFSD2A,NMUR2,NOS2,PLA2G1B,PNPLA8,PPARA,PPARD,PPARG,PRKAA2,PRKAB2,PRKAG2,SLC22A9,SLC25A17,SLC25A20,SLC27A1,SLC27A2,SLC27A4,SLC27A6,SPX	The directed movement of fatty acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Fatty acids are aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
GO:0015909	GO	BP	long-chain fatty acid transport	ABCD1,ACACA,ACACB,ACE,ACSL1,ACSL3,APOE,BDKRB2,CD36,CPT1A,CPT1B,CPT2,DRD2,DRD3,DRD4,FABP3,LCN1,LCN12,NMUR2,PLA2G1B,PNPLA8,PPARG,PRKAA2,PRKAB2,PRKAG2,SLC25A20,SLC27A1,SLC27A2,SLC27A4,SLC27A6,SPX	The directed movement of long-chain fatty acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
GO:0015914	GO	BP	phospholipid transport	ABCA1,ABCA12,ABCA7,ABCB4,ABCG1,APOA1,APOA2,APOA4,APOC1,APOC2,APOC3,APOE,ATP10A,ATP10B,ATP10D,ATP11A,ATP11B,ATP11C,ATP8A1,ATP8B1,ATP9A,ATP9B,CETP,CPTP,LDLR,MTTP,NPC2,OSBPL5,OSBPL8,PCTP,PITPNA,PITPNB,PITPNC1,PITPNM1,PITPNM3,PLA2G10,PRELID1,PRELID3A,SCARB1,SCP2,TMEM30A,TNFAIP8L3,TRIAP1	The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester.
GO:0015918	GO	BP	sterol transport	ABCA1,ABCA5,ABCA7,ABCG1,ABCG4,ABCG5,ABCG8,AKR1C1,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,CAV1,CD36,CEL,CETP,CLU,LCAT,LDLR,LDLRAP1,LIPC,LIPG,MSR1,NPC1,NPC1L1,NPC2,OSBP,OSBPL5,SCARB1,SOAT1,SOAT2,STX12,VPS4A	The directed movement of sterols into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Sterols are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.
GO:0015919	GO	BP	peroxisomal membrane transport	ABCD1,PEX16,PEX19,PEX3,PEX5,RAB8B	The directed movement of substances to, from or across the peroxisomal membrane.
GO:0015923	GO	MF	mannosidase activity	EDEM1,EDEM2,EDEM3,MAN1A1,MAN1B1,MAN1C1	Catalysis of the hydrolysis of mannosyl compounds, substances containing a group derived from a cyclic form of mannose or a mannose derivative.
GO:0015926	GO	MF	glucosidase activity	GAA,GANC,GBA2,GBA3,KL,MGAM,MOGS,SI	Catalysis of the hydrolysis of glucosyl compounds, substances containing a group derived from a cyclic form of glucose or a glucose derivative.
GO:0015929	GO	MF	hexosaminidase activity	CD44,CEMIP,HYAL1,HYAL2,HYAL3,MGEA5,NAGA	Catalysis of the cleavage of hexosamine or N-acetylhexosamine residues (e.g. N-acetylglucosamine) residues from gangliosides or other glycoside oligosaccharides.
GO:0015931	GO	BP	nucleobase-containing compound transport	ABCC11,AGFG1,ALKBH5,ALYREF,ATXN2,BUD13,C14orf166,CALHM1,CDC40,CHTOP,CKAP5,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FLOT1,FYTTD1,GLE1,HHEX,HNRNPA1,HNRNPA2B1,KIF5C,LUZP4,MAGOH,MRPL18,NCBP1,NCBP2,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,PHAX,PNPT1,POLDIP3,RAE1,RAN,RBFOX1,RBM8A,RFTN1,RNPS1,SARNP,SLBP,SLC25A17,SLC25A19,SLC25A24,SLC25A26,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC28A1,SLC28A2,SLC29A1,SLC29A2,SLC35A1,SLC35A2,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,TST,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO5,XPOT,ZC3H11A,ZC3H3	The directed movement of nucleobases, nucleosides, nucleotides and nucleic acids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0015932	GO	MF	nucleobase-containing compound transmembrane transporter activity	ABCC11,SLC25A17,SLC25A19,SLC25A24,SLC25A26,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC28A1,SLC28A2,SLC35A1,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2	Enables the transfer of nucleobases, nucleosides, nucleotides and nucleic acids from one side of a membrane to the other.
GO:0015934	GO	CC	large ribosomal subunit	FXR2,ICT1,MPV17L2,MRPL10,MRPL12,MRPL13,MRPL23,MRPL27,MRPL3,MRPL36,MRPL41,MRPL51,MRPL52,MRPL55,MTERF4,NSUN4,RBM3,RPL10,RPL10A,RPL10L,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL39L,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,UBA52	The larger of the two subunits of a ribosome. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site).
GO:0015935	GO	CC	small ribosomal subunit	DDX3X,EIF2D,FAU,GNB2L1,HBA1,MCTS1,MRPL42,MRPS11,MRPS12,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS24,MRPS26,MRPS28,MRPS33,MRPS35,MRPS36,MRPS6,MRPS7,MRPS9,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	The smaller of the two subunits of a ribosome.
GO:0015936	GO	BP	coenzyme A metabolic process	ACOT7,COASY,CROT,MCEE,MLYCD,NUDT7,PANK2,PPCDC,PPCS	The chemical reactions and pathways involving coenzyme A, 3'-phosphoadenosine-(5')diphospho(4')pantatheine, an acyl carrier in many acylation and acyl-transfer reactions in which the intermediate is a thiol ester.
GO:0015937	GO	BP	coenzyme A biosynthetic process	ACOT7,COASY,PANK2,PPCDC,PPCS	The chemical reactions and pathways resulting in the formation of coenzyme A, 3'-phosphoadenosine-(5')diphospho(4')pantatheine, an acyl carrier in many acylation and acyl-transfer reactions in which the intermediate is a thiol ester.
GO:0015939	GO	BP	pantothenate metabolic process	AASDHPPT,COASY,FASN,PANK1,PANK2,PDZD11,PPCDC,PPCS,SLC25A16,SLC5A6,VNN1,VNN2	The chemical reactions and pathways involving pantothenate, the anion of pantothenic acid, the amide of beta-alanine and pantoic acid. It is a B complex vitamin that is a constituent of coenzyme A and is distributed ubiquitously in foods.
GO:0015949	GO	BP	nucleobase-containing small molecule interconversion	AK1,AK2,AK4,AK5,AK6,AK7,AK8,AK9,CMPK1,CTPS1,CTPS2,DCTPP1,DTYMK,GLRX,GSR,GUK1,NME1,NME2,NME4,RRM1,RRM2,RRM2B,TXN,TXNRD1	The chemical reactions and pathways by which a nucleobase, nucleoside or nucleotide small molecule is synthesized from another nucleobase, nucleoside or nucleotide small molecule.
GO:0015986	GO	BP	ATP synthesis coupled proton transport	ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,MT-ATP6,MT-ATP8,STOML2,VPS9D1	The transport of protons across a membrane to generate an electrochemical gradient (proton-motive force) that powers ATP synthesis.
GO:0015992	GO	BP	proton transport	ATP1A4,ATP4B,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,ATP6AP1,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0E1,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1E1,ATP6V1F,ATP6V1H,COX10,COX11,COX15,COX4I1,COX4I2,COX5A,COX5B,COX6B1,COX7A1,COX7A2L,COX7B,COX8A,CYB5A,HVCN1,MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CYB,NDUFA4,NNT,NOX1,NOX5,SLC15A1,SLC15A2,SLC17A5,SLC25A14,SLC25A27,SLC2A10,SLC2A9,SLC46A1,SLC4A11,SLC9A1,STOML2,TCIRG1,UCP1,UCP2,UCP3,UQCR10,UQCRC1,UQCRH,VPS9D1	The directed movement of protons (hydrogen ions) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0016004	GO	MF	phospholipase activator activity	APOC2,ARHGAP6,CCL3,CCL5,CCL8,PDPK1,STX4	Increases the activity of a phospholipase, an enzyme that catalyzes of the hydrolysis of a glycerophospholipid.
GO:0016010	GO	CC	dystrophin-associated glycoprotein complex	CAV3,DAG1,DMD,MAGEE1,PGM5,SGCA,SGCB,SGCD,SGCE,SGCZ,SNTA1,SNTB1,SNTB2,SNTG1,SNTG2	A multiprotein complex that forms a strong mechanical link between the cytoskeleton and extracellular matrix; typical of, but not confined to, muscle cells. The complex is composed of transmembrane, cytoplasmic, and extracellular proteins, including dystrophin, sarcoglycans, dystroglycan, dystrobrevins, syntrophins, sarcospan, caveolin-3, and NO synthase.
GO:0016015	GO	MF	morphogen activity	CER1,DAND5,GREM1,NBL1,NODAL,SHH	Acts as a trigger for a pattern specification process when present at a specific concentration within a gradient.
GO:0016018	GO	MF	cyclosporin A binding	NKTR,PPIC,PPID,PPIE,PPIG,PPIH	Interacting selectively and non-covalently with cyclosporin A, a cyclic undecapeptide that contains several N-methylated and unusual amino acids.
GO:0016019	GO	MF	peptidoglycan receptor activity	CD14,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4	Combining with a peptidoglycan and transmitting the signal to initiate a change in cell activity.
GO:0016042	GO	BP	lipid catabolic process	ABCD1,ABCD2,ABCD3,ABHD12,ABHD5,ABHD6,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACER1,ACOT8,ACOX1,ACOX2,ACOX3,ADIPOQ,AKR1B10,AKR1C3,AKR1D1,AMACR,ANGPTL3,APOA2,APOA4,APOA5,APOC3,BCO2,BDH2,CEL,CPS1,CRAT,CROT,CYP1A2,CYP1B1,CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP3A4,CYP46A1,CYP4A11,CYP4F12,CYP4F2,CYP7A1,DAGLA,DECR1,ECHS1,ECI1,ECI2,EHHADH,ENPP2,ETFA,ETFB,ETFDH,FAAH,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,FGF23,GALC,GBA,GBA3,GCDH,GLA,HACL1,HADH,HADHA,HADHB,HAO1,HSD17B11,HSD17B14,HSD17B4,HSD17B6,LIPC,LIPE,LIPG,LIPH,LIPI,LPIN1,LPL,MCEE,MGLL,MMAA,MT3,MUT,NAGA,NEU2,NEU3,NEU4,PCCA,PCCB,PEX13,PEX2,PHYH,PLA2G15,PLA2G1B,PLA2G4B,PLA2G4C,PLIN1,PNLIPRP2,PNPLA3,PNPLA8,PPARD,PPP1CA,PPP1CB,PPP1CC,PPT1,PRDX6,PRKACA,PRKACB,PRKACG,RAB7A,SCARF1,SCP2,SGPL1,SIRT2,SLC25A17,SLC27A2,SMPD3,SMPD4,SNX17,SPHK1,SRD5A3,STS,TRERF1,UGT2B4,YWHAH	The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
GO:0016045	GO	BP	detection of bacterium	CD1D,HLA-A,HLA-B,HLA-DRB1,NLRC4,NOD1,NOD2,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,SSC5D,TLR1,TLR2,TLR6	The series of events in which a stimulus from a bacterium is received and converted into a molecular signal.
GO:0016049	GO	BP	cell growth	ALCAM,APP,AR,ARIH2,ATAD3A,ATP6V0E1,ATP6V0E2,BDNF,BIN3,BRAT1,CAV3,CDK5,COBL,CPNE1,CYFIP1,DDX5,DGKD,EIF2AK4,ENOX2,ENTPD5,ERBB2IP,FLRT1,FLRT3,IMPACT,IQGAP1,ITGAV,ITGB3,KMT2D,LAMTOR1,LAMTOR2,LUZP4,MTOR,MTPN,NDNF,NDRG4,NLGN3,NOP58,NOTCH2,NRP1,NRP2,NUBP1,NUPR1,PAK4,PAK7,PDLIM5,PPP3CB,PRMT2,RASGRP4,ROS1,RPTOR,RRAGC,SEC61A1,SEMA3A,SEMA3F,SGMS1,SLC3A2,SLC9A6,SLIT1,SLIT2,SLIT3,SOCS5,SORBS2,SOX9,TGFBR3,TNN,TYMS,USP9X,XBP1,XRN2	The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.
GO:0016050	GO	BP	vesicle organization	ABCA1,ANKFY1,ANKRD28,ANXA2,AP1G1,AP1M1,AP2S1,AP3B1,AP3D1,ARCN1,AREG,ARF1,ARFGAP1,BET1,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CALY,CASC5,CAV1,CAV2,CD34,CD59,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CORO1A,CSNK1D,CTSC,CTSZ,CUL3,DLG4,DTNBP1,EEA1,EPS15,F2R,F2RL3,F5,F8,FCHO1,FCHO2,FNBP1L,FOLR1,GBF1,GOLGA2,GOLPH3,GORASP1,GOSR2,GPR143,GRIA1,HIP1,KIF13A,KLHL12,LMAN1,LRMP,LRSAM1,LYST,MCFD2,MVB12A,MYO18A,NAPA,NKD2,NSF,PAFAH1B1,PDCD6IP,PICALM,PIK3C2A,PLEKHF1,PMEL,PPP6C,PPP6R1,PPP6R3,PREB,PTPRN,RAB1A,RAB1B,RAB20,RAB32,RAB34,RAB38,RAB39A,RAB7A,RAB8A,RILP,S100A10,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,SHROOM2,SNAPIN,SNX11,SNX19,SNX3,SORT1,SRGN,STX5,STXBP1,SYP,TBC1D20,TFG,TGFA,TGFBRAP1,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,TSG101,USO1,VAMP4,VAMP7,VAPA,VAPB,VPS11,VPS28,VPS33B,VPS37A,VPS37B,VPS37C,VPS37D,VPS39,VPS41,VPS4A,VPS4B,VPS8,VTA1,VTI1A,WASL,ZFYVE16	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a vesicle.
GO:0016051	GO	BP	carbohydrate biosynthetic process	AKR1B1,ALDOA,ALDOB,ALDOC,ALG1,ATF4,B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GALT1,B4GAT1,CHST15,CRTC2,CRY1,CSGALNACT1,CSGALNACT2,ENO1,ENO2,ENO3,EPM2A,EXT1,EXT2,FBP1,FBP2,FUT3,FUT8,G6PC,G6PD,GAPDH,GAPDHS,GBE1,GOT1,GOT2,GPI,GYG1,GYG2,GYS1,GYS2,HAS1,HAS2,HAS3,LALBA,MDH1,MDH2,MPDU1,NANS,NHLRC1,NR1D1,PC,PCK1,PCK2,PER2,PFKFB1,PGAM1,PGAM2,PGK1,PGM1,PGM2,PGP,PPARGC1A,PPP1R3C,PRKACA,PRKACB,PRKACG,RBP4,RPS27A,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC2A1,SORD,ST6GALNAC5,ST6GALNAC6,ST8SIA6,TALDO1,TKT,TPI1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
GO:0016052	GO	BP	carbohydrate catabolic process	ABHD10,AGL,AKR1A1,ALDOA,ALDOB,ALDOC,AMY2A,CALM1,CPS1,CRYL1,DCXR,ENO1,ENO2,ENO3,ENOSF1,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,GAA,GALE,GALK1,GALT,GAPDH,GAPDHS,GCK,GPI,GYG1,GYG2,HK1,HK2,HK3,KHK,LDHA,LRP5,MGAM,MIOX,NAGA,NEU1,NEU2,NEU3,NEU4,NUDT5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PKLR,PKM,PPP2R5D,PYGB,PYGL,PYGM,SORD,STBD1,TKFC,TKTL1,TPI1,TREH,XYLB	The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
GO:0016055	GO	BP	Wnt signaling pathway	APC,ARL6,AXIN1,CAV1,CD24,CDH3,CELSR2,CHD8,CPE,CTNNB1,DDX3X,DVL1,DVL2,DVL3,FERMT2,FZD1,FZD10,FZD2,FZD3,FZD4,FZD5,FZD6,FZD7,FZD8,GATA3,GSK3B,HOXB9,KLHL12,LEF1,LRP5,LRP6,LRRK2,MAGI2,MARK4,MYC,MYOC,NDP,NR4A2,OTULIN,PLCG2,PLPP3,PORCN,PPM1A,PPP2R3A,PTEN,PTK7,PTPRU,RAB5A,RARG,RYK,SCYL2,SFRP1,SNAI2,SOX4,STRN,TBL1X,TBL1XR1,TCF7L2,UBE2B,VPS35,WNT1,WNT10B,WNT2,WNT2B,WNT3,WNT3A,WNT4,WNT5A,WNT5B,WNT7A,WNT7B,WNT8A	The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
GO:0016056	GO	BP	rhodopsin mediated signaling pathway	CALM1,CAMKMT,CNGA1,CNGB1,FNTA,FNTB,GNAT1,GNB1,GNB5,GNGT1,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,METAP1,METAP2,NMT1,NMT2,PDE6A,PDE6B,PDE6G,PPEF1,PRKCA,PRKCQ,RCVRN,RGS9,RGS9BP,RHO,SAG,SLC24A1	The series of molecular signals generated as a consequence of excitation of rhodopsin by a photon and the events that convert the absorbed photons into a cellular response.
GO:0016064	GO	BP	immunoglobulin mediated immune response	BATF,C1QA,C1QB,C1QC,C1R,C1S,CD27,CD40LG,CD74,EXOSC3,EXOSC6,HLA-DQB1,HLA-DRB1,HSPD1,LIG4,MSH2,MSH6,RNF168,RNF8,TLR8,ZP3	An immune response mediated by immunoglobulins, whether cell-bound or in solution.
GO:0016072	GO	BP	rRNA metabolic process	BOP1,C1D,CIRH1A,DDX27,DDX47,DEDD2,DIS3,DIS3L,DKC1,EMG1,ERI1,ERN2,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FBL,FTSJ2,GEMIN4,IMP4,MPHOSPH6,NHP2,NIFK,NOC4L,NOL11,NOL6,NOL8,NOL9,NOLC1,NOP14,NOP56,NOP58,NSUN4,PES1,PIN4,RPL11,RPL14,RPL26,RPL35A,RPL5,RPL7,RPS14,RPS15,RPS16,RPS17,RPS19,RPS24,RPS28,RPS6,RPS7,RRP36,RRP9,SBDS,SKIV2L2,SLFN14,UTP20,WDR12,WDR55,XRN1	The chemical reactions and pathways involving rRNA, ribosomal RNA, a structural constituent of ribosomes.
GO:0016073	GO	BP	snRNA metabolic process	CPSF3L,ELL,ELL2,ELL3,ICE1,ICE2,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,MEPCE,RPAP2,SNAPC2,SNAPC3,SNAPC4,TUT1,USB1,ZC3H8	The chemical reactions and pathways involving snRNA, small nuclear RNA, any of various low-molecular-mass RNA molecules found in the eukaryotic nucleus as components of the small nuclear ribonucleoprotein.
GO:0016075	GO	BP	rRNA catabolic process	DEDD2,DIS3,DIS3L,ERN2,EXOSC10,EXOSC9,SLFN14,XRN1	The chemical reactions and pathways resulting in the breakdown of rRNA, ribosomal RNA, a structural constituent of ribosomes.
GO:0016079	GO	BP	synaptic vesicle exocytosis	BLOC1S6,CDK5,DNAJC5,DOC2B,NLGN1,OTOF,PCLO,PIP5K1C,RAB3A,RIMS1,RIMS2,SEPT5,SNAP25,SNAPIN,SNPH,STX1B,SYNJ1,SYT1,UNC13B,VAMP2	Fusion of intracellular membrane-bounded vesicles with the pre-synaptic membrane of the neuronal cell resulting in release of neurotransmitter into the synaptic cleft.
GO:0016093	GO	BP	polyprenol metabolic process	AKR1B10,AKR1C3,DPAGT1,DPM1,NUS1,SRD5A3	The chemical reactions and pathways involving polyprenols, prenols with more than 4 isoprenoid residues, which may be all-trans, or a mixture of cis and trans.
GO:0016098	GO	BP	monoterpenoid metabolic process	CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP2E1,CYP3A4	The chemical reactions and pathways involving monoterpenoid compounds, terpenoids having a C10 skeleton.
GO:0016101	GO	BP	diterpenoid metabolic process	ABCA4,ADH4,ADH7,AGRN,AKR1B10,AKR1C1,AKR1C3,AKR1C4,ALDH1A2,ALDH1A3,ALDH3A2,ALDH8A1,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,APOM,BCO1,BCO2,CLPS,CYP1B1,CYP26A1,CYP26B1,CYP26C1,CYP4V2,DHRS3,DHRS9,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,HSPG2,LDLR,LPL,LRAT,LRP1,LRP2,LRP8,NAPEPLD,OPN1LW,OPN1MW,OPN1SW,PECR,PLB1,PNLIP,RARRES2,RBP1,RBP2,RBP3,RBP4,RDH10,RDH11,RDH12,RDH5,RDH8,RETSAT,RHO,RLBP1,RPE65,SCPEP1,SDC1,SDC2,SDC3,SDC4,SDR16C5,STRA6,TTR,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving diterpenoid compounds, terpenoids with four isoprene units.
GO:0016115	GO	BP	terpenoid catabolic process	AKR1B10,AKR1C3,CYP26A1,CYP26B1,CYP26C1	The chemical reactions and pathways resulting in the breakdown of terpenoids, any member of a class of compounds characterized by an isoprenoid chemical structure.
GO:0016125	GO	BP	sterol metabolic process	ABCA1,ABCG1,ACAA2,ACLY,AKR1D1,ANGPTL3,APOA1,APOA4,APOB,APOE,APOL2,ARV1,CEL,CELA3A,CELA3B,CETP,CLN6,CLN8,CNBP,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1B1,CYP21A2,CYP27A1,CYP39A1,CYP46A1,CYP4V2,CYP51A1,CYP7A1,CYP7B1,CYP8B1,DHCR24,DHCR7,EBP,FDFT1,FDPS,FDX1,FDX1L,FDXR,G6PD,GGPS1,HMGCR,HMGCS1,HSD17B7,IDI1,IDI2,IL4,LBR,LCAT,LDLRAP1,LSS,MSMO1,MT3,MVD,MVK,NPC1L1,NR0B2,NSDHL,OSBPL1A,OSBPL5,PMVK,PPARD,PRKAG2,RXRA,SC5D,SCARF1,SNX17,SOAT1,SOAT2,SQLE,STARD3,TM7SF2,TRERF1	The chemical reactions and pathways involving sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.
GO:0016126	GO	BP	sterol biosynthetic process	ACAA2,ACLY,ARV1,CNBP,CYP51A1,DHCR24,DHCR7,EBP,FDFT1,FDPS,G6PD,GGPS1,HMGCR,HMGCS1,HSD17B7,IDI1,IDI2,LBR,LSS,MSMO1,MVD,MVK,NPC1L1,NSDHL,PMVK,PRKAG2,SC5D,SQLE,TM7SF2	The chemical reactions and pathways resulting in the formation of sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.
GO:0016137	GO	BP	glycoside metabolic process	ABHD10,AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,CBR4,FUCA1,FUCA2,GBA2,GBA3	The chemical reactions and pathways involving glycosides, compounds in which a glycosyl group is substituted into a hydroxyl, thiol or selenol group in another compound.
GO:0016139	GO	BP	glycoside catabolic process	ABHD10,FUCA1,FUCA2,GBA2,GBA3	The chemical reactions and pathways resulting in the breakdown of glycosides, compounds in which a glycosyl group is substituted into a hydroxyl, thiol or selenol group in another compound.
GO:0016174	GO	MF	NAD(P)H oxidase activity	AIFM1,CYB5R4,DUOX1,DUOX2,KMO,NOX4	Catalysis of the reaction: NAD(P)H + H+ + O2 = NAD(P)+ + hydrogen peroxide.
GO:0016175	GO	MF	superoxide-generating NADPH oxidase activity	CYBA,CYBB,NCF1,NOX1,NOX5,PAX2	Catalysis of the reaction: NAD(P)H + O2 = NAD(P)H + O2-.
GO:0016176	GO	MF	superoxide-generating NADPH oxidase activator activity	AGT,NCF4,NOXA1,NOXO1,PDGFB	Increases the activity of the enzyme superoxide-generating NADPH oxidase.
GO:0016180	GO	BP	snRNA processing	CPSF3L,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,TUT1,USB1	Any process involved in the conversion of a primary small nuclear RNA (snRNA) transcript into a mature snRNA molecule.
GO:0016197	GO	BP	endosomal transport	ABCA1,ADRB2,AKTIP,ALMS1,ANKFY1,ANKRD27,ANKRD50,ANXA8,AP1AR,AP1G1,AP1M1,AP2A1,AP3D1,AP4M1,AP5B1,AP5M1,AP5S1,AP5Z1,ARFRP1,ARL1,ARL4C,ATG14,BECN2,BET1L,BLOC1S3,BLOC1S5,BLOC1S6,CD63,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CLTC,CLTCL1,COMMD1,CORO7,DCLK1,DCTN1,DENND2A,DENND3,DENND5A,DOPEY1,DOPEY2,DPY30,EEA1,EHD1,EHD2,EHD3,EHD4,EMP2,EPS15,ERC1,EVI5,FAM109A,FAM109B,FAM160A2,FAM21A,FAM21C,GBF1,GCC2,GOSR1,GPRASP1,HGS,HMGXB4,HOOK1,HOOK2,HOOK3,KIAA1033,KIF13A,KIF16B,KLHL20,LMTK2,LYST,M6PR,MAGEL2,MGRN1,MICALL1,MICALL2,MON2,MTM1,MYO1D,PICALM,PIK3C3,PIKFYVE,RAB10,RAB11A,RAB11B,RAB11FIP3,RAB12,RAB13,RAB14,RAB17,RAB32,RAB35,RAB38,RAB5A,RAB5B,RAB5C,RAB6A,RAB7A,RAB7B,RASSF9,RBSN,RGP1,RHOB,RHOBTB3,RIC1,RILP,RNF126,RPS27A,SCYL2,SDCCAG3,SGSM2,SGSM3,SNAPIN,SNF8,SNX1,SNX16,SNX17,SNX18,SNX2,SNX27,SNX33,SNX4,SNX5,SNX6,SNX8,SNX9,SORT1,SPAG9,SQSTM1,STAM,STAM2,STX10,STX16,STX5,STX6,STX8,TBC1D10A,TBC1D10B,TBC1D10C,TBC1D14,TBC1D17,TBC1D5,TGFBRAP1,TINAGL1,TOM1,TRAK1,TRIM27,TSG101,UBA52,UBB,UBC,UBE2O,USP6NL,VAMP3,VAMP7,VIPAS39,VPS11,VPS13A,VPS16,VPS18,VPS25,VPS26A,VPS26B,VPS28,VPS29,VPS33A,VPS35,VPS36,VPS37A,VPS37B,VPS37C,VPS37D,VPS39,VPS41,VPS4A,VPS4B,VPS50,VPS51,VPS52,VPS53,VTA1,VTI1A,WASH1,WIPI1,YKT6,ZFYVE16	The directed movement of substances into, out of, or mediated by an endosome, a membrane-bounded organelle that carries materials newly ingested by endocytosis. It passes many of the materials to lysosomes for degradation.
GO:0016202	GO	BP	regulation of striated muscle tissue development	ACTN3,AKAP6,ARNTL,BMP10,BMP2,BMP4,CENPF,DDX17,DDX5,DKK1,DLL1,EFNB2,ERBB4,FGF2,FGF3,FGF8,FGFR2,FLOT1,GPC1,GREM1,GSK3A,HDAC9,MEF2C,MEGF10,MKL2,MSTN,MTPN,MYOCD,MYOG,NACA,NOG,NOTCH1,NR1D2,NRG1,PRICKLE1,RBP4,RBPJ,SIRT2,SIX4,SOX15,TBX1,TBX2,TBX20,TBX5,TGFB1,TP73,UQCC2,USP19,WNT3A	Any process that modulates the frequency, rate or extent of striated muscle development.
GO:0016208	GO	MF	AMP binding	ACSS2,APRT,FBP1,PRKAG1,PYGL	Interacting selectively and non-covalently with AMP, adenosine monophosphate.
GO:0016209	GO	MF	antioxidant activity	ALB,APOA4,APOE,APOM,CAT,CLIC2,CYGB,FABP1,FAM213A,GPX1,GPX2,GPX3,GPX4,GPX7,GSR,GSTK1,GSTO1,GSTO2,GSTZ1,HBA1,HBB,IPCEF1,LPO,MGST1,MGST3,MPO,MT3,PRDX1,PRDX2,PRDX3,PRDX4,PRDX5,PRDX6,PTGS1,PTGS2,PXDN,PXDNL,SOD1,SOD2,SOD3,TP53INP1,TPO,TXNDC17,TXNDC2,TXNRD2,TXNRD3,UBIAD1,VIMP	Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage.
GO:0016226	GO	BP	iron-sulfur cluster assembly	CIAO1,FXN,HSCB,ISCU,MMS19,NARFL,NFS1,NFU1,NUBP1,SDHAF1	The incorporation of iron and exogenous sulfur into a metallo-sulfur cluster.
GO:0016229	GO	MF	steroid dehydrogenase activity	AKR1B15,AKR1C1,AKR1C3,AKR1C4,DHRS9,HSD17B1,HSD17B10,HSD17B11,HSD17B14,HSD17B2,HSD17B4,HSD17B8,HSD3B1,HSD3B2,HSD3B7,SRD5A1,SRD5A3	Catalysis of an oxidation-reduction (redox) reaction in which one substrate is a sterol derivative.
GO:0016233	GO	BP	telomere capping	ACD,DCLRE1B,MRE11A,NBN,POT1,PRKDC,RAD50,TERF2,TERF2IP,TFIP11	A process in which telomeres are protected from degradation and fusion, thereby ensuring chromosome stability by protecting the ends from both degradation and from being recognized as damaged DNA. May be mediated by specific single- or double-stranded telomeric DNA binding proteins.
GO:0016234	GO	CC	inclusion body	ATF4,ATXN1,ATXN3,BAG5,CABIN1,CCZ1,CCZ1B,CDH1,CLU,DBF4B,DNAJB2,EEF2,EID1,EPS15,EVX1,GIT1,GPX1,HAP1,HDAC6,HERPUD1,HOXD3,HSPA1A,HSPA1B,HSPB7,LRRK2,MAPT,MECOM,MIOX,MT3,MVB12A,NBN,NEFH,NEFM,NUP153,NUP98,ORC6,PARK2,PICALM,PINK1,POLD1,PSEN1,RAB11B,RAD18,RANBP2,RNF32,SEC62,SFMBT2,SLF1,SLFN11,SNCA,SNCB,SQSTM1,STUB1,SYNE2,TPR,TRIM37,TRIM66,UBD,UBQLN1,URB2,WDFY3,XRN2	A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers.
GO:0016235	GO	CC	aggresome	CABIN1,CCZ1,CCZ1B,CDH1,DBF4B,EEF2,EID1,EPS15,EVX1,GIT1,HDAC6,HOXD3,HSPB7,MECOM,MVB12A,ORC6,PARK2,POLD1,PSEN1,RAB11B,RNF32,SEC62,SFMBT2,SLFN11,SYNE2,TRIM37,TRIM66,UBD,UBQLN1,URB2,XRN2	An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules.
GO:0016239	GO	BP	positive regulation of macroautophagy	ADRB2,AMBRA1,ATG7,BECN1,BNIP3,BNIP3L,CALCOCO2,DCN,EPM2A,KDR,KIAA1324,LARP1,LRSAM1,PAFAH1B2,PARK7,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,PRKAA2,RAB3GAP1,RAB3GAP2,RALB,SCOC,SH3GLB1,SIRT1,SPTLC1,SPTLC2,SQSTM1,SUPT5H,TRIM13,ULK1,WAC,WDFY3	Any process, such as recognition of nutrient depletion, that activates or increases the rate of macroautophagy to bring cytosolic macromolecules to the vacuole/lysosome for degradation.
GO:0016241	GO	BP	regulation of macroautophagy	ACTL6A,ADRB2,AMBRA1,ATG7,BECN1,BNIP3,BNIP3L,CALCOCO2,CHMP4A,CHMP4B,CLN3,CSNK2A2,CTSK,DCN,DNM1L,EPM2A,ERN1,FBXW7,FEZ1,FEZ2,FZD5,GSK3A,HAX1,HTRA2,IFT20,IFT88,KAT2A,KDR,KIAA1324,LARP1,LRRK2,LRSAM1,LZTS1,MAP1LC3B,MTMR3,MTOR,NRBP2,PAFAH1B2,PARK2,PARK7,PHF23,PIKFYVE,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,POLR3A,PRKAA2,QSOX1,RAB1B,RAB33B,RAB3GAP1,RAB3GAP2,RAB7A,RALB,RPL28,RUBCN,RUVBL1,SCFD1,SCOC,SH3GLB1,SIRT1,SLC17A9,SPTLC1,SPTLC2,SQSTM1,SREBF1,SREBF2,SUPT5H,TBC1D14,TBC1D25,TRIM13,TSC1,U2AF1,U2AF2,UBQLN1,UBQLN2,UBQLN4,ULK1,USP36,VDAC1,WAC,WBP11,WDFY3,WDR75,ZBTB17,ZDHHC8	Any process that modulates the frequency, rate or extent of macroautophagy.
GO:0016242	GO	BP	negative regulation of macroautophagy	CHMP4A,CHMP4B,CLN3,FEZ1,FEZ2,LRRK2,LZTS1,MTOR,NRBP2,PHF23,PINK1,QSOX1,RUBCN,SCFD1,TSC1,UBQLN1,UBQLN4	Any process that stops, prevents, or reduces the frequency, rate or extent of macroautophagy.
GO:0016246	GO	BP	RNA interference	AGO2,CELF1,CLP1,DICER1,PRKRA,TARBP2,TERT	The process in which double-stranded RNAs silence cognate genes. Involves posttranscriptional gene inactivation ('silencing') both of transgenes or dsRNA introduced into a germline, and of the host gene(s) homologous to the transgenes or dsRNA. This silencing is triggered by the introduction of transgenes or double-stranded RNA (dsRNA), and can occur through a specific decrease in the level of mRNA, or by negative regulation of translation, of both host genes and transgenes.
GO:0016247	GO	MF	channel regulator activity	ABCC9,ADRB2,AGT,AKAP9,AMBP,AMIGO1,ANKRD36C,ARPP19,ATP2B4,BCL2,CAMK2D,CAV1,CAV3,CCDC109B,CFTR,CHP1,CHRNA7,DLG1,DPP10,DPP6,DRD2,DRD4,ENSA,FGF12,FGF13,FKBP1B,FXYD1,GNB2L1,GPD1L,GPLD1,HAMP,ITPR1,KCNAB1,KCNAB2,KCNAB3,KCNE1,KCNE2,KCNE3,KCNE5,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNK2,KCNMB2,KCNMB3,KCNS1,KCNS3,KCNV1,LRRC26,NEDD4,NEDD4L,NOS1,NPY,NPY2R,NRXN1,NRXN2,PACSIN3,PCSK9,PDZD3,PHPT1,PKP2,PRKG1,PTPN3,RANGRF,RASA1,RSC1A1,SCN1B,SCN2B,SCN3B,SCN4B,SGK1,SGK2,SGK3,SLC30A1,SLC9A3R1,SNF8,SNTA1,SRI,STIM1,STIM2,STX1A,STX7,STX8,SUMO1,TMEM110,TMPRSS3,VAMP8,VTI1B,WNK1,WNK3,WNK4,YWHAE,YWHAH	Modulates the activity of a channel. A channel catalyzes energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel.
GO:0016248	GO	MF	channel inhibitor activity	AMBP,ANKRD36C,BCL2,CAMK2D,CAV1,CAV3,CCDC109B,CFTR,ENSA,FKBP1B,GNB2L1,HAMP,ITPR1,KCNK2,KCNMB2,KCNV1,NEDD4,NEDD4L,PACSIN3,PCSK9,PDZD3,PHPT1,RASA1,RSC1A1,SCN1B,SLC30A1,STX1A,STX7,STX8,VAMP8,VTI1B,WNK1,WNK3,WNK4	Stops, prevents, or reduces the activity of a channel. A channel catalyzes energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel.
GO:0016254	GO	BP	preassembly of GPI anchor in ER membrane	DPM2,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGV,PIGW,PIGX	The stepwise addition of the components of the GPI anchor on to phosphatidylinositol lipids in the endoplasmic reticulum membrane.
GO:0016255	GO	BP	attachment of GPI anchor to protein	GPAA1,PGAP1,PIGK,PIGS,PIGT,PIGU,PLAUR	A transamidation reaction that results in the cleavage of the polypeptide chain and the concomitant transfer of the GPI anchor to the newly formed carboxy-terminal amino acid of the anchored protein. The cleaved C-terminal contains the C-terminal GPI signal sequence of the newly synthesized polypeptide chain.
GO:0016259	GO	BP	selenocysteine metabolic process	EEFSEC,FAU,PSTK,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SARS,SECISBP2,SEPHS2,SEPSECS,UBA52	The chemical reactions and pathways involving selenocysteine, an essential component of glutathione peroxidase and some other proteins.
GO:0016264	GO	BP	gap junction assembly	GJA1,GJA5,GJB1,GJB2,GJC1,GJD3,PKP2	Assembly of gap junctions, which are found in most animal tissues, and serve as direct connections between the cytoplasms of adjacent cells. They provide open channels through the plasma membrane, allowing ions and small molecules (less than approximately a thousand daltons) to diffuse freely between neighboring cells, but preventing the passage of proteins and nucleic acids.
GO:0016266	GO	BP	O-glycan processing	A4GNT,B3GNT2,B3GNT3,B3GNT4,B3GNT5,B3GNT6,B3GNT7,B3GNT8,B4GALT5,C1GALT1,C1GALT1C1,CHST4,GALNT1,GALNT10,GALNT11,GALNT12,GALNT13,GALNT14,GALNT15,GALNT2,GALNT3,GALNT4,GALNT5,GALNT6,GALNT7,GALNT8,GALNT9,GCNT1,GCNT3,GCNT4,GXYLT1,GXYLT2,MUC1,MUC12,MUC13,MUC15,MUC16,MUC17,MUC20,MUC21,MUC3A,MUC4,MUC5AC,MUC5B,MUC6,MUC7,MUCL1,POFUT1,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST6GAL1,ST6GALNAC2,ST6GALNAC4	The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure.
GO:0016274	GO	MF	protein-arginine N-methyltransferase activity	CARM1,FBXO11,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8	Catalysis of the reaction: S-adenosyl-L-methionine + (protein)-arginine = S-adenosyl-L-homocysteine + (protein)-N-methyl-arginine.
GO:0016279	GO	MF	protein-lysine N-methyltransferase activity	ASH1L,ASH2L,CXXC1,DOT1L,EEF2KMT,EHMT1,EHMT2,EZH2,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,METTL20,METTL21A,METTL21C,NSD1,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,VCPKMT,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to the epsilon-amino group of a lysine residue in a protein substrate.
GO:0016281	GO	CC	eukaryotic translation initiation factor 4F complex	EIF4A1,EIF4A2,EIF4B,EIF4E,EIF4EBP3,EIF4G1,EIF4G2,EIF4G3,EIF4H	The eukaryotic translation initiation factor 4F complex is composed of eIF4E, eIF4A and eIF4G; it is involved in the recognition of the mRNA cap, ATP-dependent unwinding of the 5'-terminal secondary structure and recruitment of the mRNA to the ribosome.
GO:0016289	GO	MF	CoA hydrolase activity	ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT7,ACOT8,ACOT9,ACSBG2,BAAT,GNPAT,HIBCH,NUDT7,PPT1,THEM4,THEM5	Catalysis of the reaction: X-CoA + H2O = X + CoA; X may be any group.
GO:0016290	GO	MF	palmitoyl-CoA hydrolase activity	ACOT7,ACOT8,GNPAT,PPT1,THEM4,THEM5	Catalysis of the reaction: palmitoyl-CoA + H2O = CoA + palmitate.
GO:0016298	GO	MF	lipase activity	AADAC,ABHD12,ABHD3,ABHD6,AOAH,BDKRB2,C3AR1,CASR,CCKBR,CCL5,CCR1,CCR5,CEL,CHRM1,CHRM3,CHRM5,CLC,EDNRA,ENPP2,ENPP7,F2RL2,GPLD1,LDAH,LIPA,LIPC,LIPF,LIPG,LIPH,LIPI,LPL,LYPLA1,LYPLAL1,MGLL,PDIA3,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G6,PLA2G7,PLCB1,PLCB2,PLCB3,PLCB4,PLCE1,PLCG1,PLCG2,PLCH1,PLCL1,PLD4,PLD6,PNLIP,PNLIPRP1,PNLIPRP2,PNPLA2,PNPLA3,PNPLA8,PRDX6,RARRES3,SMPD4	Catalysis of the hydrolysis of a lipid or phospholipid.
GO:0016303	GO	MF	1-phosphatidylinositol-3-kinase activity	ATM,PIK3C2G,PIK3C3,PIK3CA,PIK3CD,PIK3R2,PIK3R3	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
GO:0016307	GO	MF	phosphatidylinositol phosphate kinase activity	PIK3C2A,PIK3C2B,PIK3C2G,PIKFYVE,PIP4K2A,PIP4K2B,PIP5K1A,PIP5K1B	Catalysis of the reaction: ATP + a phosphatidylinositol phosphate = ADP + a phosphatidylinositol bisphosphate.
GO:0016308	GO	MF	1-phosphatidylinositol-4-phosphate 5-kinase activity	PIKFYVE,PIP4K2A,PIP4K2B,PIP5K1A,PIP5K1B	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4-phosphate + ATP = 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ADP + 2 H(+).
GO:0016311	GO	BP	dephosphorylation	ACP6,ACPP,ALPI,ALPP,ALPPL2,APTX,BTRC,CAMK2G,CDC14B,CDC25B,CDC25C,CDKN3,CTDNEP1,CTDP1,CTDSP1,CTDSP2,CTTNBP2NL,CYCS,DAPP1,DLG1,DLGAP5,DUSP1,DUSP10,DUSP11,DUSP12,DUSP13,DUSP16,DUSP18,DUSP2,DUSP21,DUSP22,DUSP26,DUSP3,DUSP4,DUSP5,DUSP6,DUSP7,DUSP8,DUSP9,ENOPH1,EPHX2,EPM2A,EYA1,EYA2,EYA3,FBP1,FBXW11,G6PC3,IMPA1,IMPA2,INPP5B,INPP5K,ITPK1,LCK,LHPP,LPIN2,MINPP1,MTM1,MTMR1,MTMR2,MTMR3,MTMR4,MTMR6,MTMR7,NANP,NCK1,NT5C,NT5C1A,NT5C3A,NT5M,NUDT16,PDP1,PDXP,PFKFB1,PGAM5,PGP,PHPT1,PLPP1,PLPP2,PLPP3,PLPP4,PLPP5,PNKP,PON1,PPEF1,PPEF2,PPM1A,PPM1B,PPM1D,PPM1E,PPM1F,PPM1G,PPM1M,PPP1CA,PPP1CB,PPP1CC,PPP1R12A,PPP1R15A,PPP1R15B,PPP1R3C,PPP2CA,PPP2CB,PPP2R1A,PPP2R2A,PPP2R3A,PPP2R3B,PPP2R5D,PPP3CA,PPP3CB,PPP3R1,PPP4C,PPP4R1,PPP5C,PPP6C,PSPH,PTEN,PTP4A1,PTP4A2,PTP4A3,PTPN1,PTPN11,PTPN12,PTPN13,PTPN14,PTPN18,PTPN2,PTPN21,PTPN22,PTPN23,PTPN3,PTPN4,PTPN5,PTPN6,PTPN7,PTPN9,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRH,PTPRJ,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRT,PTPRU,PTPRZ1,PXYLP1,RNGTT,RPAP2,RPRD1A,RPRD1B,SACM1L,SBF1,SDHAF2,SGPP2,SSH1,SSH2,SSU72,SYNJ1,THNSL2,THTPA,TIGAR,TIMM50,TMEM55A,TMEM55B,TPTE,UBLCP1	The process of removing one or more phosphoric (ester or anhydride) residues from a molecule.
GO:0016322	GO	BP	neuron remodeling	ANKS1A,APP,EPHA8,FARP2,RND1,SCARF1	The developmentally regulated remodeling of neuronal projections such as pruning to eliminate the extra dendrites and axons projections set up in early stages of nervous system development.
GO:0016323	GO	CC	basolateral plasma membrane	ABCC1,ABCC4,ADRA2A,ANK1,ANK2,ANK3,ANXA13,ANXA2,AQP1,ATP6V1B1,ATP7A,ATP7B,B4GALT1,BEST1,BSND,C5AR1,C5AR2,CADM1,CAV1,CD34,CDH17,CEACAM5,CFTR,CLDN19,CNNM2,CTNNB1,CXADR,DLG1,DST,DSTYK,EGFR,ENPP1,EPCAM,ERBB2,ERBB2IP,ERBB3,ERBB4,EZR,FLOT1,FLOT2,FOLR1,FRMPD2,GPIHBP1,HEPH,KCNC2,KCNJ4,KCNQ1,LDLR,LDLRAP1,LPO,MARVELD2,MET,MLC1,MUC20,MYO1A,MYO1C,MYO1D,NAIP,NDRG4,NKD2,NOD1,NOD2,PDGFB,PDZD11,PIANP,PKD1,PKD2,PTH1R,RAB17,RHBG,RHCG,SHROOM4,SLC12A6,SLC16A10,SLC19A1,SLC22A6,SLC22A8,SLC22A9,SLC23A2,SLC26A6,SLC26A7,SLC29A1,SLC29A2,SLC40A1,SLC4A1,SLC4A11,SLC4A4,STX2,STX4,TACSTD2,TEK,TF,TFRC,TGFA,TJP1,TLR9,TRPC4,UMOD	The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
GO:0016324	GO	CC	apical plasma membrane	ABCB4,ABCC2,ABCG5,ABCG8,ADAM17,ADGRG2,AHCYL1,AKAP7,AMN,ANO1,ANXA1,ANXA13,AQP1,AQP2,AQP5,ATP6V0A4,ATP6V0D2,ATP6V1B1,ATP6V1E1,ATP8B1,BST2,CA4,CAV1,CD34,CFAP126,CFTR,CNTFR,CUBN,CYP4A11,CYP4F12,CYP4F2,DLL1,DPP4,DRAM2,DSTYK,DUOX1,ENPEP,EPCAM,EXOC1,EZR,FOLR1,GIF,GPIHBP1,GPR143,HYAL2,IL6R,JAG1,KCNC2,KCNE1,KCNMA1,LRP2,MAL,MARVELD2,MSN,MTDH,MUC13,MUC17,NOTCH1,NRG1,OSMR,P2RX2,PDGFRB,PFKM,PKHD1,PLD1,PLET1,PODXL,PTEN,PTH1R,PTPRO,RAB17,RAPGEF2,RAPGEF6,RDX,RHCG,SCNN1A,SEPT7,SHANK2,SHROOM2,SHROOM3,SHROOM4,SLC11A2,SLC12A3,SLC17A3,SLC19A1,SLC1A1,SLC22A11,SLC22A12,SLC22A13,SLC22A18,SLC22A4,SLC22A5,SLC23A1,SLC23A2,SLC26A4,SLC26A6,SLC26A9,SLC29A1,SLC2A5,SLC30A5,SLC34A2,SLC34A3,SLC46A1,SLC6A20,SLC7A9,SLC9A3,SLC9A3R1,STK26,STX3,TCIRG1,TDGF1,TEK,TF,THY1,TLR9,TNIK,UMOD,USH2A,VANGL2,WDPCP	The region of the plasma membrane located at the apical end of the cell.
GO:0016327	GO	CC	apicolateral plasma membrane	CLDN5,CXADR,MPDZ,MTCL1,NEDD4	The apical end of the lateral plasma membrane of epithelial cells.
GO:0016328	GO	CC	lateral plasma membrane	AKAP7,ANK3,ANXA1,APC,ARL2,ATP6V1B1,AXIN1,BVES,CDH1,CORO1C,CTNNB1,DMD,DVL1,EPCAM,MARK2,MTCL1,MYO1A,MYO1C,NKD2,PTPRO,RAB13,SCN5A,SNTA1,TACSTD2,TBCD,VANGL2	The portion of the plasma membrane at the lateral side of the cell. In epithelial cells, lateral plasma membranes are on the sides of cells which lie at the interface of adjacent cells.
GO:0016331	GO	BP	morphogenesis of embryonic epithelium	BBS4,BCL10,CELSR1,COBL,DEAF1,DLC1,DVL2,FGFR2,FOLR1,FUZ,GATA3,GRHL2,GRHL3,IFT122,KDF1,KDM2B,LMO4,MTHFD1,MTHFD1L,OSR1,PAX2,PAX8,PHACTR4,PLXNB2,PRICKLE1,SCRIB,SEMA4C,SIX1,SKI,SOX11,SOX4,SOX8,SOX9,STIL,TFAP2A,TSC2,VANGL2,WNT16,WNT5A,WNT7B	The process in which the anatomical structures of embryonic epithelia are generated and organized.
GO:0016338	GO	BP	calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	CLDN1,CLDN10,CLDN11,CLDN12,CLDN14,CLDN15,CLDN16,CLDN17,CLDN18,CLDN19,CLDN2,CLDN20,CLDN22,CLDN23,CLDN4,CLDN5,CLDN6,CLDN7,CLDN8,CLDN9	The attachment of one cell to another cell via adhesion molecules that do not require the presence of calcium for the interaction.
GO:0016339	GO	BP	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	ATP2C1,CDH13,CDH17,CDH23,DCHS1,DSG1,NLGN1,NRXN1,PCDHB10,PCDHB11,PCDHB13,PCDHB14,PCDHB16,PCDHB2,PCDHB3,PCDHB4,PCDHB5,PCDHB6,PCDHB9,PCDHGB4,PCDHGC3	The attachment of one cell to another cell via adhesion molecules that require the presence of calcium for the interaction.
GO:0016342	GO	CC	catenin complex	APC,APC2,CDH1,CDH2,CTNNA1,CTNNB1,JUP,SMAD7	Complex of peripheral cytoplasmic proteins (alpha-, beta- and gamma-catenin) that interact with the cytoplasmic region of uvomorulin/E-cadherin to connect it to the actin cytoskeleton.
GO:0016358	GO	BP	dendrite development	APP,ARF4,BBS4,BMP7,BTBD3,CELSR2,CTNNA2,CTNND2,DLG4,DVL1,EPHB1,EPHB2,EPHB3,FARP1,FLRT1,GHRL,HDAC2,LRP4,LST1,MAP6,MAPK8IP2,MEF2A,MINK1,PAK3,PTEN,SHANK1,SHANK3,SLC12A5,SRGAP2,STRN,TMEM106B,TRAPPC4,TULP1,WNT7A	The process whose specific outcome is the progression of the dendrite over time, from its formation to the mature structure. A dendrite is a freely branching protoplasmic process of a nerve cell.
GO:0016363	GO	CC	nuclear matrix	AKAP8,AKAP8L,ALOX5,ATN1,ATXN1,BLM,CAD,CASK,CENPF,CHMP1A,CLIC4,DCAF7,DNMT3A,ERCC8,FIGN,GFI1,GFI1B,GHRHR,HLCS,HNRNPM,KIN,MAEA,MBD1,MEN1,MYB,NCOR2,NONO,NSMF,NUFIP1,OGG1,PHB2,PML,POLA1,PRPF40A,PSMA6,RUNX1T1,SCAF8,SFPQ,SMARCAD1,SMC3,SNW1,SPARC,SPTBN4,TENM1,TEP1,TP53,UHRF1,YEATS4,ZNF703	The dense fibrillar network lying on the inner side of the nuclear membrane.
GO:0016405	GO	MF	CoA-ligase activity	ACSM1,ACSS1,ACSS2,SUCLA2,SUCLG2	Catalysis of the reaction: substrate + ATP + CoASH = AMP + diphosphate + substrate-CoA.
GO:0016407	GO	MF	acetyltransferase activity	AANAT,ACAT2,ATAT1,ATF2,BRCA2,CLOCK,CRAT,CREBBP,CSRP2BP,DLAT,ELP3,ELP4,EP300,EPC1,GCAT,GNPAT,GNPNAT1,HADHA,HAT1,HCFC1,IFNB1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,LPCAT2,MCRS1,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60,NAGS,NAT8,NAT8B,NAT8L,NCOA3,OGT,PHF20,SAP130,SAT2,SMARCE1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,USP22,WDR5	Catalysis of the transfer of an acetyl group to an acceptor molecule.
GO:0016408	GO	MF	C-acyltransferase activity	ACAA2,ACAT2,GCAT,HADHA,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB	Catalysis of the transfer of an acyl group to a carbon atom on the acceptor molecule.
GO:0016409	GO	MF	palmitoyltransferase activity	CPT1A,CPT2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,YKT6,ZDHHC1,ZDHHC12,ZDHHC13,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	Catalysis of the transfer of a palmitoyl (CH3-[CH2]14-CO-) group to an acceptor molecule.
GO:0016410	GO	MF	N-acyltransferase activity	AANAT,ALAS2,ATAT1,ATF2,BAAT,BRCA2,CERS1,CERS5,CLOCK,CREBBP,CSRP2BP,ELP3,ELP4,EP300,EPC1,GNPNAT1,HAT1,HCFC1,HRASLS5,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,MCRS1,NAA10,NAA11,NAA16,NAA30,NAA50,NAA60,NAGS,NAT8,NAT8B,NAT8L,NCOA3,NMT1,NMT2,OGT,PHF20,SAP130,SAT2,SMARCE1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,USP22,WDR5	Catalysis of the transfer of an acyl group to a nitrogen atom on the acceptor molecule.
GO:0016411	GO	MF	acylglycerol O-acyltransferase activity	AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,DGAT1,DGAT2,PNPLA3	Catalysis of the transfer of an acyl group to an oxygen atom on the acylglycerol molecule.
GO:0016441	GO	BP	posttranscriptional gene silencing	ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,CELF1,CLP1,CNOT1,CNOT6,CNOT7,CNOT8,DGCR8,DICER1,DROSHA,HNRNPA2B1,LIMD1,LIN28A,LIN28B,METTL3,MOV10,PRKRA,PUM1,RAN,RBM4,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TERT,TNRC6A,TNRC6B,TNRC6C,TRIM71,WTIP,XPO5,ZCCHC11,ZFP36	The inactivation of gene expression by a posttranscriptional mechanism.
GO:0016442	GO	CC	RISC complex	AGO1,AGO2,AGO3,AGO4,DCP2,DDX6,EIF4E,LIMD1	A ribonucleoprotein complex that contains members of the Argonaute family of proteins, small interfering RNAs (siRNAs) or microRNAs (miRNAs), and miRNA or siRNA-complementary mRNAs, in addition to a number of accessory factors. The RISC complex is involved in posttranscriptional repression of gene expression through downregulation of translation or induction of mRNA degradation.
GO:0016445	GO	BP	somatic diversification of immunoglobulins	AICDA,BATF,CD40LG,CTNNBL1,EXOSC3,EXOSC6,HSPD1,LIG4,MSH2,MSH6,POLL,POLQ,RNF168,RNF8,TCF3	The somatic process that results in the generation of sequence diversity of immunoglobulins.
GO:0016447	GO	BP	somatic recombination of immunoglobulin gene segments	BATF,CD40LG,EXOSC3,EXOSC6,HSPD1,LIG4,MSH2,MSH6,RNF168,RNF8,TCF3	The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, as known as immunoglobulin gene segments, within a single locus.
GO:0016458	GO	BP	gene silencing	AAAS,ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,ASZ1,BAZ2A,BEND3,CELF1,CHMP1A,CLP1,CNOT1,CNOT6,CNOT7,CNOT8,DDX4,DGCR8,DICER1,DROSHA,FKBP6,H3F3A,HDAC2,HDAC5,HELLS,HENMT1,HIST1H3A,HIST1H4A,HIST2H3A,HNRNPA2B1,IPO8,KMT2D,LIMD1,LIN28A,LIN28B,MAEL,METTL3,MOV10,MOV10L1,MYBL1,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPC1,PIWIL1,PIWIL2,PIWIL4,PLD6,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POM121,POM121C,PRKRA,PUM1,RAE1,RAN,RANBP2,RBM4,RRP8,SCMH1,SEH1L,SIRT1,SIRT2,SIRT4,SIRT5,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,SUV39H1,TAF1A,TAF1B,TAF1C,TAF1D,TARBP2,TBP,TDRD1,TDRD12,TDRD6,TDRD9,TDRKH,TERT,TNRC6A,TNRC6B,TNRC6C,TPR,TRIM71,TSN,TSNAX,UBR2,WTIP,XPO5,ZCCHC11,ZFP36	Any process carried out at the cellular level that results in either long-term transcriptional repression via action on chromatin structure or RNA mediated, post-transcriptional repression of gene expression.
GO:0016459	GO	CC	myosin complex	ACTG2,BMF,DYNLL2,MYBPC3,MYH1,MYH10,MYH11,MYH13,MYH14,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYH9,MYL1,MYL2,MYL3,MYL5,MYL6,MYL6B,MYL7,MYL9,MYLPF,MYO18B,MYO1C,MYO1E,MYO1F,MYO6,MYO9A,MYOM1,SHROOM1,SHROOM4,TRIM32	A protein complex, formed of one or more myosin heavy chains plus associated light chains and other proteins, that functions as a molecular motor; uses the energy of ATP hydrolysis to move actin filaments or to move vesicles or other cargo on fixed actin filaments; has magnesium-ATPase activity and binds actin. Myosin classes are distinguished based on sequence features of the motor, or head, domain, but also have distinct tail regions that are believed to bind specific cargoes.
GO:0016460	GO	CC	myosin II complex	MYBPC3,MYH1,MYH10,MYH11,MYH13,MYH14,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYH9,MYL1,MYL3,MYL5,MYL6B,MYL9,MYLPF,MYOM1,SHROOM1,SHROOM4,TRIM32	A myosin complex containing two class II myosin heavy chains, two myosin essential light chains and two myosin regulatory light chains. Also known as classical myosin or conventional myosin, the myosin II class includes the major muscle myosin of vertebrate and invertebrate muscle, and is characterized by alpha-helical coiled coil tails that self assemble to form a variety of filament structures.
GO:0016461	GO	CC	unconventional myosin complex	MYL6,MYL6B,MYO18B,MYO1C,MYO1F,MYO6,MYO9A	A portmanteau term for myosins other than myosin II.
GO:0016469	GO	CC	proton-transporting two-sector ATPase complex	ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP6AP1,ATP6V0A4,ATP6V0D1,ATP6V0D2,ATP6V1A,ATP6V1B1,ATP6V1C1,ATP6V1D,ATP6V1E1,ATP6V1F,ATP6V1H,ATPIF1,MT-ATP6,MT-ATP8,PPIF,USMG5	A large protein complex that catalyzes the synthesis or hydrolysis of ATP by a rotational mechanism, coupled to the transport of protons across a membrane. The complex comprises a membrane sector (F0, V0, or A0) that carries out proton transport and a cytoplasmic compartment sector (F1, V1, or A1) that catalyzes ATP synthesis or hydrolysis. Two major types have been characterized: V-type ATPases couple ATP hydrolysis to the transport of protons across a concentration gradient, whereas F-type ATPases, also known as ATP synthases, normally run in the reverse direction to utilize energy from a proton concentration or electrochemical gradient to synthesize ATP. A third type, A-type ATPases have been found in archaea, and are closely related to eukaryotic V-type ATPases but are reversible.
GO:0016471	GO	CC	vacuolar proton-transporting V-type ATPase complex	ATP6V0A4,ATP6V0D1,ATP6V0D2,ATP6V1B1,ATP6V1F,ATP6V1H	A proton-transporting two-sector ATPase complex found in the vacuolar membrane, where it acts as a proton pump to mediate acidification of the vacuolar lumen.
GO:0016485	GO	BP	protein processing	ACE,ACE2,ACER2,ADAMTS13,ADAMTS3,AGT,AIFM1,ANP32B,ANPEP,APAF1,APH1A,APH1B,APOH,ASPH,ASPRV1,ATP6AP2,BACE2,BAD,BAK1,BAX,BBC3,BCL2L10,BCL2L11,BCL2L13,BGLAP,BOK,CARD8,CASP1,CASP2,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CGA,CGB,CIDEB,CLN3,CLN5,CMA1,COL4A3,CORIN,CPA3,CTSG,CTSH,CTSS,CTSZ,CUZD1,CYCS,CYFIP2,DAP,DIABLO,DLC1,DNAJA3,ECE1,ECE2,EIF2AK3,ENPEP,F10,F11,F12,F2,F2R,F3,F7,F9,FADD,FAM162A,FAS,FASLG,FGA,FGB,FGG,FSHB,FURIN,FXN,GAS6,GGT1,GNB2L1,HFE2,HIP1,HSPD1,HSPE1,HTRA2,IFI16,IFI27,IFT57,IMMP2L,JAK2,KLK6,KLKB1,LCK,LHB,LONP2,LY96,METAP2,MIPEP,MME,MTCH1,MUL1,NCSTN,NGF,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NMT2,NOD1,OMA1,PCSK1,PCSK2,PCSK5,PCSK6,PCSK7,PCSK9,PDCD2,PERP,PLAT,POMC,PPARG,PPP2R5C,PROC,PROS1,PROZ,PRSS3,PSEN1,PSEN2,PSENEN,PTCH1,PYCARD,RCE1,REN,RET,RIPK1,ROBO1,RPS27A,RPS27L,S100A8,S100A9,SCG5,SENP1,SLC11A2,SMAD3,SNCA,SRGN,STOML2,TBC1D10A,TICAM1,TICAM2,TLR3,TLR4,TMPRSS2,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,TSG101,TSHB,TYSND1,UBA52,UBB,UBC,USP17L2,VCP,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,XDH,XPNPEP3	Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein.
GO:0016486	GO	BP	peptide hormone processing	ACE,ACE2,AGT,ANPEP,ATP6AP2,BACE2,CGA,CGB,CMA1,CORIN,CPA3,CTSG,CTSZ,ECE1,ECE2,ENPEP,FSHB,FURIN,LHB,MME,NGF,PCSK1,PCSK2,PCSK5,PCSK6,PCSK7,POMC,REN,SCG5,TSHB	The generation of a mature peptide hormone by posttranslational processing of a prohormone.
GO:0016502	GO	MF	nucleotide receptor activity	P2RX1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,P2RY1,P2RY12,P2RY14,P2RY4	Combining with a nucleotide and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. A nucleotide is a compound that consists of a nucleoside esterified with a phosphate molecule.
GO:0016504	GO	MF	peptidase activator activity	ADRM1,APAF1,BAD,BCL2L13,CARD8,CASP1,CASP8AP2,CAV1,CDKN1B,CLPX,CTSH,EBAG9,GNB2L1,MAL,NGFRAP1,NKX3-1,NLRP1,NLRP12,NOD1,PCOLCE,PCOLCE2,PINK1,PSMD14,PSME3,PSME4,PYCARD,RPS27L,VCP	Binds to and increases the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
GO:0016505	GO	MF	peptidase activator activity involved in apoptotic process	APAF1,BAD,BCL2L13,CARD8,CASP1,CASP8AP2,CDKN1B,CTSH,EBAG9,GNB2L1,MAL,NGFRAP1,NKX3-1,NLRP1,NLRP12,NOD1,PYCARD,RPS27L	Increases the activity of a peptidase that is involved in the apoptotic process.
GO:0016514	GO	CC	SWI/SNF complex	ACTL6A,ACTL6B,ARID1A,ARID1B,NCR1,RB1,SMARCA2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1	A SWI/SNF-type complex that contains nine or more proteins, including both conserved (core) and nonconserved components; the Swi2/Snf2 ATPase is one of the core components.
GO:0016525	GO	BP	negative regulation of angiogenesis	AMOT,ANGPT4,APOH,CCR2,COL4A2,COL4A3,CXCR3,DAB2IP,DCN,DLL4,ECSCR,FASLG,FOXC1,FOXO4,GDF2,GHRL,GTF2I,HDAC5,HHEX,HOXA5,HRG,IL17F,ITGB1BP1,KLF4,KLK3,KRIT1,LECT1,MAP2K5,MMRN2,NOTCH1,NPPB,NPR1,PDCD10,PDE3B,PF4,PML,PTPRM,RGCC,RHOA,ROCK1,ROCK2,SEMA3E,SERPINE1,SERPINF1,SPARC,SPINK5,STAB1,STARD13,STAT1,SULF1,SYNJ2BP,TEK,THBS1,THBS2,VASH1	Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
GO:0016528	GO	CC	sarcoplasm	AKAP6,ASPH,ATP2A1,ATP2A2,ATP2A3,CASQ1,CASQ2,CCDC78,CHERP,CLEC18B,DMPK,FKBP1A,FKBP1B,GSN,GSTM2,HRC,ITPR2,JPH1,JPH2,JPH3,JPH4,KLHL41,MRLN,NOS1,NOS1AP,PLEC,PLN,RYR1,RYR2,RYR3,S100A1,SLN,SPOCK1,SRI,SYNE2,THBS1,THBS4,TMEM38A,TMEM38B,TRDN	The cytoplasm of a muscle cell; includes the sarcoplasmic reticulum.
GO:0016529	GO	CC	sarcoplasmic reticulum	AKAP6,ASPH,ATP2A1,ATP2A2,ATP2A3,CASQ1,CASQ2,CCDC78,CHERP,CLEC18B,DMPK,FKBP1A,FKBP1B,GSTM2,HRC,ITPR2,JPH1,JPH2,JPH3,JPH4,KLHL41,MRLN,NOS1,NOS1AP,PLN,RYR1,RYR2,RYR3,S100A1,SLN,SRI,SYNE2,THBS1,THBS4,TMEM38A,TMEM38B,TRDN	A fine reticular network of membrane-limited elements that pervades the sarcoplasm of a muscle cell; continuous over large portions of the cell and with the nuclear envelope; that part of the endoplasmic reticulum specialized for calcium release, uptake and storage.
GO:0016538	GO	MF	cyclin-dependent protein serine/threonine kinase regulator activity	CCNY,CDK4,CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,HEXIM1,HEXIM2,INCA1,KAT2B	Modulates the activity of a cyclin-dependent protein serine/threonine kinase, enzymes of the protein kinase family that are regulated through association with cyclins and other proteins.
GO:0016540	GO	BP	protein autoprocessing	F12,FXN,HFE2,HTRA2,KLK6,PCSK9,TMPRSS2	Processing which a protein carries out itself. This involves actions such as the autolytic removal of residues to generate the mature form of the protein.
GO:0016553	GO	BP	base conversion or substitution editing	A1CF,ADAR,ADARB1,APOBEC1,APOBEC3F,APOBEC3G,METTL3,NUDT16	Any base modification or substitution events that result in alterations in the coding potential or structural properties of RNAs as a result of changes in the base-pairing properties of the modified ribonucleoside(s).
GO:0016556	GO	BP	mRNA modification	A1CF,ADAR,ADARB1,APOBEC1,CMTR1,CMTR2,KIAA1429,METTL14,METTL3,WTAP	The covalent alteration of one or more nucleotides within an mRNA molecule to produce an mRNA molecule with a sequence that differs from that coded genetically.
GO:0016558	GO	BP	protein import into peroxisome matrix	PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX2,PEX26,PEX5,PEX6,PEX7	The import of proteins into the peroxisomal matrix. A peroxisome targeting signal (PTS) binds to a soluble receptor protein in the cytosol, and the resulting complex then binds to a receptor protein in the peroxisome membrane and is imported. The cargo protein is then released into the peroxisome matrix.
GO:0016559	GO	BP	peroxisome fission	ACOT8,ACOX1,DNM1L,FIS1,MFF,PEX11A,PEX11B,PEX11G,PEX19,SEC16B	The division of a mature peroxisome within a cell to form two or more separate peroxisome compartments.
GO:0016571	GO	BP	histone methylation	ASH1L,ASH2L,BEND3,CARM1,CHD5,COPRS,CTCFL,CTR9,CXXC1,DPY30,EHMT1,EHMT2,EZH2,FBL,KDM6A,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,NR1H4,NSD1,OGT,PAXIP1,PRDM4,PRDM5,PRMT1,PRMT2,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD8,SETDB2,SETMAR,SUV39H1,SUV39H2,TET2,TET3,WDR5,WDR61,WDR82,WHSC1L1,ZNF335	The modification of histones by addition of methyl groups.
GO:0016572	GO	BP	histone phosphorylation	AURKB,BAZ1B,CDK2,CHEK1,GSG2,HMGA2,JAK2,MAP3K12,NEK11,PKN1,PRKCA,PRKCB,PRKCD,RPS6KA4,RPS6KA5,VPRBP,VRK1	The modification of histones by addition of phosphate groups.
GO:0016573	GO	BP	histone acetylation	ACTL6A,APBB1,ATF2,BEND3,BRCA2,BRD1,BRD8,BRPF1,BRPF3,CHD5,CLOCK,CPA4,CREBBP,CSRP2BP,DMAP1,DR1,ELP3,ELP4,EP300,EP400,EPC1,GTF3C4,HAT1,HCFC1,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,KMT2A,LDB1,LEF1,MAP3K7,MBIP,MCRS1,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA50,NAA60,NCOA3,OGT,PER1,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SPI1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TRIM16,TRRAP,USP22,WDR5,YEATS2,YEATS4	The modification of a histone by the addition of an acetyl group.
GO:0016574	GO	BP	histone ubiquitination	BCOR,CDC73,CTR9,CUL4B,DDB1,DDB2,DTX3L,HUWE1,KDM2B,LEO1,PAF1,PCGF1,PHC1,RAG1,RING1,RNF168,RNF2,RNF20,RNF40,RNF8,RYBP,SKP1,TRIM37,UBE2A,UBE2B,UBE2E1,UBE2N,UBR2,UHRF1,USP22,WAC	The modification of histones by addition of ubiquitin groups.
GO:0016575	GO	BP	histone deacetylation	BAZ2A,ELK4,HDAC1,HDAC10,HDAC11,HDAC2,HDAC4,HDAC5,HDAC6,HDAC9,MORF4L1,NACC2,PER1,PER2,PHB,PRDM5,RCOR1,REST,SALL1,SFPQ,SIRT1,SIRT2,SIRT6,SIRT7,SMARCAD1,SUDS3	The modification of histones by removal of acetyl groups.
GO:0016577	GO	BP	histone demethylation	HIST1H4A,JMJD6,KDM1A,KDM1B,KDM2A,KDM3A,KDM4A,KDM4C,KDM4D,KDM5B,KDM5C,KDM5D,KDM7A,KDM8,PHF8	The modification of histones by removal of methyl groups.
GO:0016578	GO	BP	histone deubiquitination	ASXL1,ATXN7,ATXN7L3,BAP1,BRCC3,ENY2,KAT2A,MYSM1,SUPT3H,TAF10,TRRAP,UIMC1,USP15,USP16,USP21,USP22,USP3,USP49	The modification of histones by removal of ubiquitin groups.
GO:0016579	GO	BP	protein deubiquitination	ASXL1,ATXN3,ATXN3L,ATXN7,ATXN7L3,BABAM1,BAP1,BRCC3,BRE,COPS5,CYLD,EIF3F,ENY2,FAM175B,JOSD2,KAT2A,MYSM1,OTUB1,OTUB2,OTUD1,OTUD3,OTUD4,OTUD5,OTUD6A,OTUD7A,OTUD7B,OTULIN,PSMD14,SHMT2,STAMBP,SUPT3H,TAF10,TNFAIP3,TRRAP,UCHL1,UCHL5,UIMC1,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP17L2,USP19,USP2,USP20,USP21,USP22,USP25,USP26,USP28,USP3,USP30,USP31,USP32,USP33,USP34,USP35,USP36,USP37,USP38,USP4,USP42,USP44,USP45,USP46,USP47,USP49,USP5,USP51,USP6,USP7,USP8,USP9X,USP9Y,VCPIP1,WDR48,YOD1,ZRANB1	The removal of one or more ubiquitin groups from a protein.
GO:0016580	GO	CC	Sin3 complex	CSNK2A1,FAM60A,HDAC1,HDAC2,HEY2,ING2,MORF4L1,NCOR1,PHF12,RBBP4,SIN3A,SUDS3	A multiprotein complex that functions broadly in eukaryotic organisms as a transcriptional repressor of protein-coding genes, through the gene-specific deacetylation of histones. Amongst its subunits, the Sin3 complex contains Sin3-like proteins, and a number of core proteins that are shared with the NuRD complex (including histone deacetylases and histone binding proteins). The Sin3 complex does not directly bind DNA itself, but is targeted to specific genes through protein-protein interactions with DNA-binding proteins.
GO:0016581	GO	CC	NuRD complex	APPL1,APPL2,CHD3,CHD4,CHD5,CSNK2A1,GATAD2A,HDAC1,HDAC2,MBD3,MTA2,NACC2,RBBP4,RBBP7,SALL1	An approximately 2 MDa multi-subunit complex that exhibits ATP-dependent chromatin remodeling activity in addition to histone deacetylase (HDAC) activity, and has been shown to establish transcriptional repression of a number of target genes in vertebrates, invertebrates and fungi. Amongst its subunits, the NuRD complex contains histone deacetylases, histone binding proteins and Mi-2-like proteins.
GO:0016584	GO	BP	nucleosome positioning	CTCF,H1FOO,PAF1,RSF1,SMARCA5	Ordering of successions of nucleosomes into regular arrays so that nucleosomes are positioned at defined distances from one another.
GO:0016589	GO	CC	NURF complex	BPTF,HMGXB4,RBBP4,SMARCA1,SMARCA5	An ISWI complex that contains an ATPase subunit of the ISWI family (SNF2L in mammals), a NURF301 homolog (BPTF in humans), and additional subunits, though the composition of these additional subunits varies slightly with species. NURF is involved in regulation of transcription from TRNA polymerase II promoters.
GO:0016591	GO	CC	DNA-directed RNA polymerase II, holoenzyme	CCNH,CDC73,CDK7,CHD6,CPSF3L,CTR9,EDF1,ERCC2,ERCC3,ERCC5,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,KAT2A,LEO1,MMS19,MNAT1,MYO6,PAF1,PEX2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POLR2M,PPARGC1A,RECQL5,RPAP2,RPRD1A,RPRD1B,RPRD2,RTF1,SHFM1,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TBP,TP53,TRRAP,URI1,WDR61	Large protein complex composed of the RNA polymerase core complex and a variety of other proteins including transcription factor complexes TFIIA, D, E, F, and H which are required for promoter recognition, and the Mediator subcomplex. Catalyzes the synthesis of eukaryotic pre-mRNA.
GO:0016592	GO	CC	mediator complex	CDK8,GLI3,MED1,MED11,MED12,MED13,MED14,MED16,MED17,MED18,MED20,MED21,MED22,MED24,MED26,MED29,MED30,MED4,MED6,MED8,PPARGC1B,RBM14,THRAP3	A protein complex that interacts with the carboxy-terminal domain of the largest subunit of RNA polymerase II and plays an active role in transducing the signal from a transcription factor to the transcriptional machinery. The mediator complex is required for activation of transcription of most protein-coding genes, but can also act as a transcriptional corepressor. The Saccharomyces complex contains several identifiable subcomplexes: a head domain comprising Srb2, -4, and -5, Med6, -8, and -11, and Rox3 proteins; a middle domain comprising Med1, -4, and -7, Nut1 and -2, Cse2, Rgr1, Soh1, and Srb7 proteins; a tail consisting of Gal11p, Med2p, Pgd1p, and Sin4p; and a regulatory subcomplex comprising Ssn2, -3, and -8, and Srb8 proteins. Metazoan mediator complexes have similar modular structures and include homologs of yeast Srb and Med proteins.
GO:0016593	GO	CC	Cdc73/Paf1 complex	CDC73,CTR9,LEO1,PAF1,PEX2,RTF1,WDR61	A multiprotein complex that associates with RNA polymerase II and general RNA polymerase II transcription factor complexes and may be involved in both transcriptional initiation and elongation. In Saccharomyces the complex contains Paf1p, Cdc73p, Ctr9p, Rtf1p, and Leo1p.
GO:0016594	GO	MF	glycine binding	ALAS2,GLRA1,GLRA2,GLRB,GNMT,GRIN1,GRIN2B,GRIN3A,GRIN3B,SRR	Interacting selectively and non-covalently with glycine, aminoethanoic acid.
GO:0016597	GO	MF	amino acid binding	AGXT,ALAS2,ANXA13,ANXA9,ASS1,AXL,CAD,CD300A,CPNE1,CPNE6,DHFR,FCHO2,FOLR1,FOLR2,GAS6,GCLC,GLRA1,GLRA2,GLRB,GLUD1,GLUD2,GNMT,GPR143,GRIN1,GRIN2B,GRIN3A,GRIN3B,GRM7,HMGB1,JPH2,MARK1,MTHFS,NEDD4,NOS1,NOS2,NOS3,OSBPL10,OSBPL5,OSBPL8,PIN1,RASGRP1,RPE65,SCARB1,SCIN,SDPR,SHMT1,SRR,SYTL2,THBS1,THNSL2,TRIM72,TYMS,UBR1,UBR2,YARS2	Interacting selectively and non-covalently with an amino acid, organic acids containing one or more amino substituents.
GO:0016600	GO	CC	flotillin complex	CBL,CDH1,CORO1C,FLOT1,FLOT2,LRP4,SLC6A3	A protein complex that contains flotillin-1 and flotillin-2, and may contain associated proteins. Flotillins associate into membrane microdomains resembling caveolae.
GO:0016601	GO	BP	Rac protein signal transduction	ABI2,AIF1,BRK1,CDH13,CYFIP1,DBNL,ELMO1,EPS8,FARP2,HACD3,HACE1,NCKAP1,RHOG,TIAM1,WASF1	A series of molecular signals within the cell that are mediated by a member of the Rac family of proteins switching to a GTP-bound active state.
GO:0016604	GO	CC	nuclear body	ACIN1,AFF2,AK6,AKAP17A,ALKBH5,ANGEL2,APEX1,ATPAF2,ATR,ATRX,ATXN2L,BASP1,BCLAF1,BLM,C8orf4,CASP8AP2,CBX5,CD2BP2,CDC5L,CDK12,CDK13,CDK2,CDK9,CDKN2A,CHEK2,CHFR,CHTOP,CIITA,COIL,CPSF6,CREB3,CREBBP,CREBRF,CSNK1A1,CSTF2,CWC22,CXXC1,DAXX,DDX1,DGKQ,DKC1,DYRK1A,EFTUD2,EIF3E,ELF4,ELL,EP400,FBL,FTO,FYTTD1,GAR1,GEMIN5,GEMIN6,GEMIN7,GFI1,GLIS2,HIF1A,HINFP,HIPK2,HNRNPM,ICE1,ICE2,IFI16,IKBKE,ISG20,KAT6A,KIAA1429,KLHL20,LRCH4,LSG1,LSM10,MAGEA2,MAPK7,MBD1,MDM2,MECOM,MEF2C,METTL3,MLIP,MORC3,MRE11A,MTDH,MTOR,N4BP1,NACC1,NACC2,NBN,NCOR2,NHP2,NONO,NOP10,NOP58,NPAT,NSMCE2,NSRP1,NUDT21,NXF1,OGG1,OIP5,PARK7,PHF5A,PIAS1,PIAS2,PIP5K1A,PLCB1,PML,POLDIP3,PPIH,PPP1R8,PQBP1,PRPF19,PRPF3,PRPF31,PRPF4,RAD51,RB1,RBM11,RBM15,RBM25,RBM4,RGS14,RNF4,RPA1,RPA2,RPAIN,RREB1,RSRC1,SAP18,SARNP,SART1,SART3,SATB1,SENP2,SFPQ,SIRT1,SKI,SKIL,SLU7,SMC5,SMC6,SMN1,SNRPC,SON,SP100,SPRTN,SPTBN4,SQSTM1,SRRM2,SRSF1,SRSF2,SRSF5,SRSF6,SUMO1,SUMO2,TDP2,TENM1,TENM2,TERT,TFIP11,THAP7,THRAP3,TIMM50,TOE1,TOP3A,TOPBP1,TOPORS,TP53,TRIM16,TRIM69,TRIM8,TUT1,U2AF1,U2AF2,UBE2I,UBOX5,USP7,USPL1,WBP4,WDFY3,WRAP53,WT1,WTAP,ZBTB1,ZBTB16,ZC3H13,ZC3H8,ZFHX3,ZMYM2,ZNF473,ZPR1	Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
GO:0016605	GO	CC	PML body	ATR,ATRX,BLM,CASP8AP2,CBX5,CDK9,CHEK2,CHFR,CIITA,DAXX,EIF3E,ELF4,HIPK2,IKBKE,ISG20,KAT6A,KLHL20,LRCH4,MAGEA2,MAPK7,MLIP,MORC3,MRE11A,MTOR,N4BP1,NBN,NSMCE2,PARK7,PIAS1,PIAS2,PML,RAD51,RB1,RNF4,RPA1,RPA2,RPAIN,SATB1,SENP2,SIRT1,SKI,SKIL,SMC5,SMC6,SP100,SPTBN4,SQSTM1,SUMO1,SUMO2,TDP2,TENM2,TERT,TOP3A,TOPBP1,TOPORS,TP53,TRIM16,TRIM8,UBE2I,WDFY3,ZBTB16,ZMYM2	A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection.
GO:0016607	GO	CC	nuclear speck	ACIN1,AFF2,AKAP17A,ALKBH5,APEX1,ATPAF2,ATXN2L,BASP1,BCLAF1,C8orf4,CD2BP2,CDC5L,CDK12,CDK13,CHTOP,CSNK1A1,CWC22,CXXC1,DGKQ,DYRK1A,EFTUD2,ELL,EP400,FTO,FYTTD1,GLIS2,HIF1A,IFI16,KIAA1429,MBD1,MECOM,MEF2C,METTL3,NSRP1,NXF1,OGG1,PHF5A,PIP5K1A,PLCB1,POLDIP3,PPIH,PPP1R8,PQBP1,PRPF19,PRPF31,PRPF4,RBM11,RBM15,RBM25,RBM4,RSRC1,SAP18,SARNP,SLU7,SON,SPRTN,SRRM2,SRSF1,SRSF2,SRSF5,SRSF6,TENM1,TFIP11,THAP7,THRAP3,TIMM50,TOPORS,TRIM69,TUT1,U2AF1,U2AF2,WBP4,WT1,WTAP,ZBTB16,ZC3H13	A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
GO:0016614	GO	MF	oxidoreductase activity, acting on CH-OH group of donors	ABCC4,ADH1A,ADH1B,ADH1C,ADH4,ADH5,ADH6,ADH7,ADHFE1,AKR1A1,AKR1B1,AKR1B10,AKR1B15,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,AKR7A3,ALDH3A1,ALDH3A2,BDH1,BDH2,BMP2,CBR1,CBR3,CRYL1,CYB5A,D2HGDH,DCXR,DHRS2,DHRS4,DHRS9,EHHADH,FAM213B,G6PD,GPD2,GRHPR,HADH,HADHA,HADHB,HAO1,HAO2,HIBADH,HMGCR,HPGD,HSD17B1,HSD17B10,HSD17B14,HSD17B2,HSD17B4,HSD17B8,HSD3B1,HSD3B2,HSD3B7,IDH1,IDH2,IDH3G,KCNAB1,KCNAB2,KDSR,L2HGDH,LDHA,MDH1,MDH2,ME1,ME2,ME3,MIOX,PGD,PHGDH,RDH10,RDH11,RDH12,RDH16,RDH5,RDH8,SDR16C5,SDR9C7,SORD,SPR,TSTA3,UGDH,VKORC1,VKORC1L1	Catalysis of an oxidation-reduction (redox) reaction in which a CH-OH group act as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016615	GO	MF	malate dehydrogenase activity	MDH1,MDH2,ME1,ME2,ME3	Catalysis of the reversible conversion of pyruvate or oxaloacetate to malate.
GO:0016616	GO	MF	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	ABCC4,ADH1A,ADH1B,ADH1C,ADH4,ADH5,ADH6,ADH7,AKR1A1,AKR1B1,AKR1B10,AKR1B15,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,AKR7A3,ALDH3A1,BDH1,BDH2,BMP2,CBR1,CBR3,CRYL1,CYB5A,DCXR,DHRS2,DHRS4,DHRS9,EHHADH,FAM213B,G6PD,GRHPR,HADH,HADHA,HADHB,HIBADH,HMGCR,HPGD,HSD17B1,HSD17B10,HSD17B14,HSD17B2,HSD17B4,HSD17B8,HSD3B1,HSD3B2,HSD3B7,IDH1,IDH2,IDH3G,KCNAB1,KCNAB2,KDSR,LDHA,MDH1,MDH2,ME1,ME3,MIOX,PGD,PHGDH,RDH10,RDH11,RDH12,RDH16,RDH5,RDH8,SDR16C5,SDR9C7,SORD,SPR,TSTA3,UGDH	Catalysis of an oxidation-reduction (redox) reaction in which a CH-OH group acts as a hydrogen or electron donor and reduces NAD+ or NADP.
GO:0016620	GO	MF	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	ADH4,ADH5,AKR1B10,AKR1C3,AKR1C4,ALDH18A1,ALDH1A1,ALDH1A2,ALDH1A3,ALDH1B1,ALDH2,ALDH3A1,ALDH3A2,ALDH3B1,ALDH3B2,ALDH4A1,ALDH5A1,ALDH6A1,ALDH7A1,ALDH8A1,ALDH9A1,DLAT,DLD,FAR1,FAR2,GAPDH,GAPDHS,PDHB,PDHX	Catalysis of an oxidation-reduction (redox) reaction in which an aldehyde or ketone (oxo) group acts as a hydrogen or electron donor and reduces NAD or NADP.
GO:0016627	GO	MF	oxidoreductase activity, acting on the CH-CH group of donors	ACAA1,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOX1,ACOX2,ACOX3,AKR1C1,AKR1C2,AKR1C3,BDH2,BLVRA,BLVRB,CPOX,DECR1,DECR2,DHCR24,DHCR7,DHODH,DPYD,IVD,MECR,PECR,PPOX,PTGR2,RETSAT,SDHA,SDHD,SRD5A1,SRD5A2,SRD5A3	Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016628	GO	MF	oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor	AKR1C1,AKR1C2,AKR1C3,BDH2,BLVRA,BLVRB,DECR1,DECR2,DHCR24,DHCR7,DPYD,MECR,PECR,PTGR2,SRD5A3	Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces NAD or NADP.
GO:0016634	GO	MF	oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor	ACAA1,ACADL,ACOX1,ACOX2,ACOX3,CPOX,PPOX	Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces oxygen.
GO:0016638	GO	MF	oxidoreductase activity, acting on the CH-NH2 group of donors	AOC1,AOC3,DAO,DDO,GLDC,GLUD1,GLUD2,LOXL2,LOXL3,MAOA,MAOB,PNPO,VCAM1	Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH2 group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016641	GO	MF	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	AOC1,AOC3,DAO,DDO,LOXL2,LOXL3,MAOA,MAOB,PNPO,VCAM1	Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH2 group acts as a hydrogen or electron donor and reduces an oxygen molecule.
GO:0016645	GO	MF	oxidoreductase activity, acting on the CH-NH group of donors	AASS,AIFM2,BLVRB,DHFR,DHFRL1,DMGDH,ETFDH,MTHFD1,MTHFD2,MTHFR,PAOX,PIPOX,PRODH,PYCR1,PYCRL,SARDH,SMOX	Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016646	GO	MF	oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor	AASS,BLVRB,DHFR,DHFRL1,MTHFD1,MTHFD2,MTHFR,PYCR1,PYCRL	Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH group acts as a hydrogen or electron donor and reduces NAD or NADP.
GO:0016651	GO	MF	oxidoreductase activity, acting on NAD(P)H	ADH4,AIFM1,AKR1C1,AKR1C2,AKR1C3,AKR1C4,CBR1,CBR4,CRYZ,CRYZL1,CYB5R2,CYB5R3,CYB5R4,CYBA,CYBB,DCXR,DECR1,DHDH,DHRS4,DLD,DUOX1,DUOX2,ECSIT,GMPR2,GSR,KMO,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MTRR,NCF1,NDUFA1,NDUFA10,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NNT,NOX1,NOX4,NOX5,NQO1,NQO2,PAX2,POR,PRDX3,TP53I3,TXNDC17,TXNDC2,TXNRD1,TXNRD2,TXNRD3	Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016653	GO	MF	oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor	CYB5R2,CYB5R3,CYB5R4,MTRR,NQO1,POR	Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a heme protein.
GO:0016655	GO	MF	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	ADH4,AKR1C1,AKR1C2,AKR1C3,AKR1C4,CBR1,CBR4,CRYZ,CRYZL1,DCXR,DHRS4,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NQO2,TP53I3	Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a quinone or a similar acceptor molecule.
GO:0016667	GO	MF	oxidoreductase activity, acting on a sulfur group of donors	CCS,CHCHD4,DLD,DNAJC10,ENOX2,GFER,GLRX,GLRX2,GSR,GSTO1,GSTO2,IFI30,MSRB1,MSRB2,MSRB3,PCYOX1,PDIA2,PDIA3,PRDX3,QSOX1,SQRDL,SRXN1,STAB1,STAB2,SUOX,TMX1,TMX3,TXNDC12,TXNDC17,TXNDC2,TXNL1,TXNRD2,TXNRD3	Catalysis of an oxidation-reduction (redox) reaction in which a sulfur-containing group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016668	GO	MF	oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor	DLD,GSR,PRDX3,TXNDC17,TXNDC2,TXNRD2,TXNRD3	Catalysis of an oxidation-reduction (redox) reaction in which a sulfur-containing group acts as a hydrogen or electron donor and reduces NAD or NADP.
GO:0016684	GO	MF	oxidoreductase activity, acting on peroxide as acceptor	CAT,CLIC2,CYGB,GPX1,GPX2,GPX3,GPX4,GPX7,GSTK1,GSTZ1,HBA1,HBB,IPCEF1,LPO,MGST1,MGST3,MPO,PARK7,PRDX1,PRDX2,PRDX3,PRDX4,PRDX5,PTGS1,PTGS2,PXDN,PXDNL,TPO,TXNDC17	Catalysis of an oxidation-reduction (redox) reaction in which the peroxide group acts as a hydrogen or electron acceptor.
GO:0016701	GO	MF	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen	ADI1,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOXE3,BCO1,BCO2,CDO1,ETHE1,HAAO,HPD,IDO1,IDO2,MIOX,PIR,PTGS2,TDO2	Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from one donor, and molecular oxygen is incorporated into a donor.
GO:0016702	GO	MF	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	ADI1,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOXE3,BCO1,BCO2,CDO1,ETHE1,HAAO,HPD,IDO1,IDO2,PIR,PTGS2,TDO2	Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from one donor, and two oxygen atoms is incorporated into a donor.
GO:0016705	GO	MF	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	AGMO,AKR1C1,AKR1C2,AKR1C3,ALKBH1,ALKBH2,ALKBH3,ALKBH4,ALKBH5,ALKBH8,BBOX1,CYGB,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A2,CYP1B1,CYP26A1,CYP26B1,CYP26C1,CYP27B1,CYP2A6,CYP2D7,CYP2E1,CYP2F1,CYP2J2,CYP39A1,CYP46A1,CYP4A11,CYP4F11,CYP4F12,CYP4F2,CYP4F8,CYP51A1,CYP7A1,CYP8B1,DBH,DOHH,EGLN1,EGLN2,EGLN3,FADS1,FMO1,FMO2,FMO3,FMO4,FTO,HIF1AN,HMOX1,HMOX2,JMJD6,KDM1B,KDM4A,KDM7A,KDM8,KMO,MICAL1,MICAL2,MICAL3,NOS1,NOS2,NOS3,OGFOD1,P3H1,P3H2,P4HB,P4HTM,PAH,PAM,PHF8,PHYH,PTGS1,PTGS2,SCD,SCD5,SQLE,TET1,TET2,TET3,TH,TMLHE,TYR,TYW5	Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from each of two donors, and molecular oxygen is reduced or incorporated into a donor.
GO:0016706	GO	MF	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	ALKBH1,ALKBH2,ALKBH3,ALKBH4,ALKBH5,ALKBH8,BBOX1,EGLN1,EGLN2,EGLN3,FTO,HIF1AN,JMJD6,KDM4A,KDM7A,KDM8,OGFOD1,P3H1,P3H2,P4HB,P4HTM,PHF8,PHYH,TET1,TET2,TET3,TMLHE,TYW5	Catalysis of the reaction: A + 2-oxoglutarate + O2 = B + succinate + CO2. This is an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from 2-oxoglutarate and one other donor, and one atom of oxygen is incorporated into each donor.
GO:0016709	GO	MF	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	AKR1C1,AKR1C2,AKR1C3,CYP27B1,CYP2E1,CYP46A1,CYP4A11,CYP4F11,CYP4F12,CYP4F2,CYP51A1,CYP7A1,FMO1,FMO2,FMO3,FMO4,KMO,MICAL1,MICAL2,MICAL3,NOS1,NOS2,NOS3,SQLE	Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from NADH or NADPH and one other donor, and one atom of oxygen is incorporated into one donor.
GO:0016712	GO	MF	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	CYP19A1,CYP1A2,CYP1B1,CYP2D7,CYP2F1	Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from reduced flavin or flavoprotein and one other donor, and one atom of oxygen is incorporated into one donor.
GO:0016713	GO	MF	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen	CYP11A1,CYP11B1,CYP11B2,CYP4A11,CYP4F12,CYP4F2,CYP4F8	Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from reduced iron-sulfur protein and one other donor, and one atom of oxygen is incorporated into one donor.
GO:0016722	GO	MF	oxidoreductase activity, oxidizing metal ions	CP,CYB561,CYBRD1,ETFDH,FRRS1,FXN,HEPH,HEPHL1,MTRR	Catalysis of an oxidation-reduction in which the oxidation state of metal ion is altered.
GO:0016725	GO	MF	oxidoreductase activity, acting on CH or CH2 groups	AOX1,CYP1A2,CYP2C8,CYP2C9,CYP3A4,RRM1,RRM2,XDH	Catalysis of an oxidation-reduction (redox) reaction in which a CH2 group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016741	GO	MF	transferase activity, transferring one-carbon groups	ALKBH8,ARMT1,AS3MT,ASH1L,ASH2L,ASMT,ATIC,BCDIN3D,BHMT,BHMT2,CAD,CARM1,CARNMT1,CMTR1,CMTR2,COMT,COQ3,CXXC1,DNMT1,DNMT3A,DNMT3B,DOT1L,DPH5,EED,EEF2KMT,EHMT1,EHMT2,EMG1,EZH2,FBL,FBXO11,FTCD,FTSJ2,GAMT,GATM,GCSH,GNMT,HENMT1,ICMT,INMT,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,LRTOMT,MEN1,MEPCE,METTL1,METTL14,METTL20,METTL21A,METTL21C,METTL2A,METTL2B,METTL3,MGMT,MTR,N6AMT1,NDUFAF7,NSD1,NSUN2,NSUN4,NTMT1,OTC,PCMT1,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,RNMT,RRP8,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SHMT1,SHMT2,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,SUZ12,TGS1,TRDMT1,TRMT112,TRMT61B,TYMS,VCPKMT,WBSCR22,WDR4,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the transfer of a one-carbon group from one compound (donor) to another (acceptor).
GO:0016746	GO	MF	transferase activity, transferring acyl groups	AANAT,ABHD5,ACAA2,ACAT2,ACLY,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,ALAS2,ATAT1,ATE1,ATF2,BAAT,BRCA2,CERS1,CERS5,CLOCK,CLYBL,CPT1A,CPT2,CRAT,CREBBP,CROT,CS,CSRP2BP,DGAT1,DGAT2,DLAT,ELOVL1,ELOVL2,ELOVL5,ELP3,ELP4,EP300,EPC1,F13A1,FASN,GCAT,GGACT,GGCT,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GLYAT,GNPAT,GNPNAT1,GPAM,GPAT2,GPAT3,GPAT4,HADHA,HAT1,HCFC1,HGSNAT,HMGCS2,HRASLS5,IFNB1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,LCAT,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LRAT,MBOAT4,MCAT,MCRS1,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60,NAGS,NAT8,NAT8B,NAT8L,NCOA3,NMT1,NMT2,OGT,OXSM,PHF20,PLA2G15,PNPLA3,PORCN,QPCT,QPCTL,SAP130,SAT2,SMARCE1,SOAT1,SOAT2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TAZ,TGM1,TGM2,TGM3,TGM4,TGM6,USP22,WDR5,YKT6,ZDHHC1,ZDHHC12,ZDHHC13,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	Catalysis of the transfer of an acyl group from one compound (donor) to another (acceptor).
GO:0016747	GO	MF	transferase activity, transferring acyl groups other than amino-acyl groups	AANAT,ABHD5,ACAA2,ACAT2,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,ALAS2,ATAT1,ATF2,BAAT,BRCA2,CERS1,CERS5,CLOCK,CPT1A,CPT2,CRAT,CREBBP,CROT,CSRP2BP,DGAT1,DGAT2,DLAT,ELOVL1,ELOVL2,ELOVL5,ELP3,ELP4,EP300,EPC1,FASN,GCAT,GLYAT,GNPAT,GNPNAT1,GPAM,GPAT2,GPAT3,GPAT4,HADHA,HAT1,HCFC1,HRASLS5,IFNB1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,LCAT,LPCAT1,LPCAT2,LPCAT3,LPCAT4,MBOAT4,MCAT,MCRS1,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60,NAGS,NAT8,NAT8B,NAT8L,NCOA3,NMT1,NMT2,OGT,OXSM,PHF20,PLA2G15,PNPLA3,PORCN,SAP130,SAT2,SMARCE1,SOAT1,SOAT2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TAZ,USP22,WDR5,YKT6,ZDHHC1,ZDHHC12,ZDHHC13,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	Catalysis of the transfer of an acyl group, other than amino-acyl, from one compound (donor) to another (acceptor).
GO:0016755	GO	MF	transferase activity, transferring amino-acyl groups	ATE1,F13A1,GGACT,GGCT,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,QPCT,QPCTL,TGM1,TGM2,TGM3,TGM4,TGM6	Catalysis of the transfer of an amino-acyl group from one compound (donor) to another (acceptor).
GO:0016757	GO	MF	transferase activity, transferring glycosyl groups	A4GALT,A4GNT,ALG1,ALG12,ALG2,ALG3,ALG5,ALG6,ALG8,APRT,ART3,ART4,B3GALNT2,B3GALT1,B3GALT4,B3GALT5,B3GALT6,B3GAT2,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT5,B3GNT6,B3GNT8,B4GALNT2,B4GALNT3,B4GALNT4,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,C1GALT1,C1GALT1C1,CHSY1,CSGALNACT1,CSGALNACT2,DAD1,DDOST,DPM1,DPM2,DPM3,EOGT,EXT1,EXT2,EXTL2,FUT1,FUT10,FUT2,FUT3,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,GALNT1,GALNT10,GALNT11,GALNT2,GALNT3,GALNT5,GALNT9,GCNT2,GCNT4,GDPGP1,GXYLT1,GXYLT2,GYLTL1B,GYS1,GYS2,HAS1,HAS2,HAS3,HEXA,HEXB,HPRT1,HYAL1,LARGE,LFNG,MGAT1,MGAT5,MTAP,NAPRT,OGT,OSTC,PARP1,PARP10,PARP11,PARP16,PARP3,PARP4,PARP9,PIGA,PIGB,PIGP,PIGV,PIGZ,PLOD3,PNP,POFUT1,POFUT2,POGLUT1,POMGNT1,POMGNT2,POMT1,PYGB,PYGL,QPRT,QTRT1,QTRTD1,RPN1,RPN2,SDF2,SIRT4,SIRT6,ST3GAL1,ST3GAL5,ST3GAL6,ST6GAL1,ST6GAL2,ST6GALNAC1,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,STT3A,STT3B,TIPARP,TNKS,TNKS2,TUSC3,UGGT1,UGGT2,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7,UGT3A1,UGT3A2,UMPS,UPP2,XYLT1,XYLT2	Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor).
GO:0016758	GO	MF	transferase activity, transferring hexosyl groups	A4GALT,A4GNT,ALG1,ALG12,ALG2,ALG3,ALG5,ALG6,ALG8,B3GALNT2,B3GALT1,B3GALT4,B3GALT5,B3GALT6,B3GAT2,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT5,B3GNT6,B3GNT8,B4GALNT2,B4GALNT3,B4GALNT4,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,C1GALT1,C1GALT1C1,CHSY1,CSGALNACT1,CSGALNACT2,DAD1,DDOST,DPM1,DPM2,DPM3,EOGT,EXT1,EXT2,EXTL2,FUT1,FUT10,FUT2,FUT3,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,GALNT1,GALNT10,GALNT11,GALNT2,GALNT3,GALNT5,GALNT9,GCNT2,GCNT4,GDPGP1,GYLTL1B,GYS1,GYS2,HAS1,HAS2,HAS3,HEXA,HEXB,HYAL1,LARGE,LFNG,MGAT1,MGAT5,MTAP,OGT,OSTC,PIGA,PIGB,PIGP,PIGV,PIGZ,PLOD3,POFUT1,POFUT2,POGLUT1,POMGNT1,POMGNT2,POMT1,PYGB,PYGL,RPN1,RPN2,SDF2,STT3A,STT3B,TUSC3,UGGT1,UGGT2,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7,UGT3A1	Catalysis of the transfer of a hexosyl group from one compound (donor) to another (acceptor).
GO:0016763	GO	MF	transferase activity, transferring pentosyl groups	APRT,ART3,ART4,GXYLT1,GXYLT2,GYLTL1B,HPRT1,LARGE,MTAP,NAPRT,PARP1,PARP10,PARP11,PARP16,PARP3,PARP4,PARP9,PNP,QPRT,QTRT1,QTRTD1,SIRT4,SIRT6,TIPARP,TNKS,TNKS2,UMPS,UPP2,XYLT1,XYLT2	Catalysis of the transfer of a pentosyl group from one compound (donor) to another (acceptor).
GO:0016765	GO	MF	transferase activity, transferring alkyl or aryl (other than methyl) groups	AGPS,CHM,COX10,DHDDS,DHPS,FDFT1,FNTA,FNTB,GGPS1,GSTA1,GSTA2,GSTA3,GSTA4,GSTA5,GSTK1,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTO1,GSTP1,GSTT2B,GSTZ1,HMBS,MAT2A,MGST1,MGST2,MMAB,NUS1,PDSS1,PDSS2,PGGT1B,RABGGTA,RABGGTB,SRM,TRIT1,UBIAD1	Catalysis of the transfer of an alkyl or aryl (but not methyl) group from one compound (donor) to another (acceptor).
GO:0016769	GO	MF	transferase activity, transferring nitrogenous groups	AADAT,ABAT,AGXT,AGXT2,CCBL1,CCBL2,GAPDH,GATM,GOT1,GOT2,GPT,GPT2,PSAT1,TAT	Catalysis of the transfer of a nitrogenous group from one compound (donor) to another (acceptor).
GO:0016776	GO	MF	phosphotransferase activity, phosphate group as acceptor	AK1,AK3,AK4,AK5,AK6,AK7,AK8,AK9,CARD11,CASK,CMPK1,CMPK2,DLG1,DLG2,DTYMK,GUK1,IP6K3,MAGI3,MPP1,MPP2,MPP3,NME1,NME2,NME6,PMVK,PPIP5K1,PPIP5K2,TJP2	Catalysis of the transfer of a phosphorus-containing group from one compound (donor) to a phosphate group (acceptor).
GO:0016779	GO	MF	nucleotidyltransferase activity	ABL1,CDS1,CDS2,CHRAC1,CMAS,COASY,CRCP,DKC1,DNTT,FICD,HMBOX1,MB21D1,MED20,MED21,MOCS3,MTPAP,NANS,NMNAT1,NMNAT2,NMNAT3,OAS1,OAS2,OAS3,PAPD4,PAPOLA,PAPOLG,PAPSS1,PAPSS2,PCYT1A,PCYT2,PNPT1,POLA1,POLB,POLD1,POLD3,POLE,POLG,POLL,POLM,POLN,POLQ,POLR1C,POLR2A,POLR2D,POLR2E,POLR2J,POLR2L,POLR3A,POLR3C,POLR3F,POLR3G,POLR3H,POLR3K,POLRMT,PRIMPOL,PTGES3,RNGTT,TAMM41,TEP1,TERF1,TERF2,TERT,THG1L,TRNT1,TUT1,UAP1,UGP2,USP14,ZCCHC11,ZCCHC6	Catalysis of the transfer of a nucleotidyl group to a reactant.
GO:0016780	GO	MF	phosphotransferase activity, for other substituted phosphate groups	AASDHPPT,CDIPT,CDS1,CEPT1,CHPT1,DPAGT1,EPT1,GNPTAB,PGS1,PIGF,PIGG,SGMS1,SGMS2	Catalysis of the transfer of a substituted phosphate group, other than diphosphate or nucleotidyl residues, from one compound (donor) to a another (acceptor).
GO:0016782	GO	MF	transferase activity, transferring sulfur-containing groups	CHST1,CHST10,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST4,CHST5,CHST6,CHST7,CHST8,CHST9,GAL3ST1,GAL3ST2,GAL3ST3,GAL3ST4,HS3ST1,HS3ST2,HS3ST3A1,HS3ST3B1,HS3ST4,HS3ST5,HS3ST6,HS6ST1,LIAS,MOCS2,MOCS3,NFS1,OXCT1,SUGCT,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C3,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1,URM1	Catalysis of the transfer of a sulfur-containing group from one compound (donor) to another (acceptor).
GO:0016783	GO	MF	sulfurtransferase activity	LIAS,MOCS2,MOCS3,NFS1,URM1	Catalysis of the transfer of sulfur atoms from one compound (donor) to another (acceptor).
GO:0016790	GO	MF	thiolester hydrolase activity	ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT7,ACOT8,ACOT9,ACSBG2,BAAT,ESD,GNPAT,HAGH,HIBCH,LYPLA1,NUDT7,PPT1,PPT2,THEM4,THEM5,UFSP2	Catalysis of the reaction: RCO-SR' + H2O = RCOOH + HSR'. This reaction is the hydrolysis of a thiolester bond, an ester formed from a carboxylic acid and a thiol (i.e., RCO-SR'), such as that found in acetyl-coenzyme A.
GO:0016791	GO	MF	phosphatase activity	ACP5,ACP6,ACPP,ALPI,ALPP,ALPPL2,APTX,CAMK2G,CDC14A,CDC14B,CDC25B,CDC25C,CDKN3,CTDNEP1,CTDP1,CTDSP1,CTDSP2,CYCS,DLG1,DLGAP5,DUSP1,DUSP10,DUSP11,DUSP16,DUSP18,DUSP2,DUSP21,DUSP26,DUSP3,DUSP4,DUSP6,DUSP7,DUSP9,ENOPH1,EPHX2,EPM2A,EYA1,EYA2,EYA3,FBP1,FIG4,G6PC,G6PC3,IMPA1,IMPA2,INPP1,INPP5A,INPP5B,INPP5E,INPP5K,ITPK1,LCK,LHPP,LPIN2,MINPP1,MTM1,MTMR1,MTMR14,MTMR2,MTMR3,MTMR4,MTMR6,NANP,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,NUDT16,OCRL,PDP1,PDXP,PFKFB1,PGAM5,PGP,PHPT1,PIKFYVE,PLPP1,PLPP2,PLPP3,PLPP4,PLPP5,PNKP,PON1,PPEF1,PPEF2,PPM1A,PPM1B,PPM1D,PPM1E,PPM1F,PPM1G,PPM1H,PPM1K,PPM1L,PPM1M,PPP1CA,PPP1CB,PPP1CC,PPP1R3C,PPP1R3D,PPP2CB,PPP2R2A,PPP2R3B,PPP2R5D,PPP3CA,PPP3CB,PPP3R1,PPP4C,PPP4R1,PPP5C,PPP6C,PSPH,PTEN,PTP4A1,PTP4A2,PTP4A3,PTPMT1,PTPN1,PTPN11,PTPN12,PTPN13,PTPN14,PTPN2,PTPN22,PTPN23,PTPN3,PTPN5,PTPN6,PTPN9,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRS,PTPRT,PTPRU,PTPRZ1,PXYLP1,RNGTT,RPAP2,SACM1L,SBF1,SGPP2,SSH1,SSH2,SSU72,SYNJ1,TIGAR,TIMM50,TMEM55A,TMEM55B,UBLCP1	Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
GO:0016796	GO	MF	exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	APEX1,APTX,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,DCLRE1A,DCP2,DIS3,DIS3L,DIS3L2,EXO1,EXO5,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FEN1,ISG20,MEIOB,MGME1,NOCT,PAN2,PAN3,PARN,PNPT1,TOE1,TREX1,TREX2,USB1,XRN2	Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 3' or 5' end to yield 5' phosphomonoesters.
GO:0016798	GO	MF	hydrolase activity, acting on glycosyl bonds	ABHD10,ACER1,ACER2,ACER3,ADPRH,AMY2A,APEX1,CCNO,CD44,CEMIP,CHIA,CHIT1,DNPH1,EDEM1,EDEM2,EDEM3,FUCA1,FUCA2,GAA,GALC,GANC,GBA,GBA2,GBA3,GLA,GLB1,GUSB,HPSE,HPSE2,HYAL1,HYAL2,HYAL3,IDUA,KL,LCT,LYZ,MACROD1,MACROD2,MAN1A1,MAN1B1,MAN1C1,MBD4,MGAM,MGEA5,MOGS,NAGA,NEIL1,NEIL3,NEU1,NEU2,NEU3,NEU4,NTHL1,OGG1,PARG,PCNA,SI,SMUG1,SPACA3,TDG,TREH,UNG	Catalysis of the hydrolysis of any glycosyl bond.
GO:0016799	GO	MF	hydrolase activity, hydrolyzing N-glycosyl compounds	ADPRH,APEX1,CCNO,DNPH1,MBD4,NEIL3,NTHL1,OGG1,PCNA,SMUG1,TDG,UNG	Catalysis of the hydrolysis of any N-glycosyl bond.
GO:0016801	GO	MF	hydrolase activity, acting on ether bonds	AHCY,AKR7A2,ALOX12,EPHX1,EPHX2,LTA4H,RNPEP,TMEM86B	Catalysis of the hydrolysis of any ether or thioether bond, -O- or -S- respectively.
GO:0016803	GO	MF	ether hydrolase activity	AKR7A2,ALOX12,EPHX1,EPHX2,LTA4H,RNPEP,TMEM86B	Catalysis of the hydrolysis of an ether bond, -O-.
GO:0016810	GO	MF	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	ACER1,ACER2,ACER3,ACR,ACY3,ADA,ADAR,ADARB1,ADAT1,AGA,AICDA,AMDHD2,AMPD2,APOBEC1,APOBEC2,APOBEC3A,APOBEC3B,APOBEC3F,APOBEC3G,APOBEC3H,ARG2,ASAH1,ASPA,ASRGL1,ATIC,CAD,CDA,CECR1,DARS,DDAH1,DDAH2,DPYS,DPYSL2,FAAH,GCH1,GLS,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC8,HDAC9,KLK3,MTHFD1,MTHFD2,NAAA,NACC2,NIT1,NIT2,OPLAH,PADI2,PADI4,PDF,PGLYRP2,PIGL,SALL1,SIRT1,SIRT2,SIRT4,SIRT5,SIRT6,SIRT7,SUDS3,VNN1,VNN2,VNN3,WDYHV1	Catalysis of the hydrolysis of any carbon-nitrogen bond, C-N, with the exception of peptide bonds.
GO:0016811	GO	MF	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	ACER1,ACER2,ACER3,ACR,ACY3,AGA,AMDHD2,ASAH1,ASPA,ASRGL1,DARS,FAAH,GLS,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC8,HDAC9,KLK3,NACC2,NIT2,PDF,PGLYRP2,PIGL,SALL1,SIRT1,SIRT2,SIRT4,SIRT5,SIRT6,SIRT7,SUDS3,VNN1,VNN2,VNN3,WDYHV1	Catalysis of the hydrolysis of any non-peptide carbon-nitrogen bond in a linear amide.
GO:0016813	GO	MF	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines	ARG2,DDAH1,DDAH2,PADI2,PADI4	Catalysis of the hydrolysis of any non-peptide carbon-nitrogen bond in a linear amidine, a compound of the form R-C(=NH)-NH2.
GO:0016814	GO	MF	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines	ADA,ADAR,ADARB1,ADAT1,AICDA,AMPD2,APOBEC1,APOBEC2,APOBEC3A,APOBEC3B,APOBEC3F,APOBEC3G,APOBEC3H,ATIC,CDA,CECR1,GCH1,MTHFD1,MTHFD2	Catalysis of the hydrolysis of any non-peptide carbon-nitrogen bond in a cyclic amidine, a compound of the form R-C(=NH)-NH2.
GO:0016829	GO	MF	lyase activity	ACMSD,ACO1,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADSL,ALAD,ALDOA,ALDOB,ALDOC,ALKBH1,AMD1,APEX1,APLF,AUH,BCKDHA,BCKDHB,CA1,CA2,CA4,CA6,CBS,CTH,CYP17A1,DDC,DERA,ECHDC1,ECHS1,EHHADH,ENOSF1,ETNPPL,FAHD1,FECH,FTCD,GAD1,GADL1,GLO1,GMDS,GNAS,GUCY1A3,GUCY1B3,HACD1,HACD2,HACD3,HACD4,HACL1,HADHB,HDC,HMGA1,HMGA2,HMGB1,HMGCL,HMGCLL1,HOGA1,HSD17B4,IRG1,L3HYPDH,LTC4S,MGST2,MLYCD,MOCS1,MVD,NEIL3,NPL,NPR1,NPR2,NTHL1,ODC1,OGG1,PAICS,PAM,PARK7,PCK1,PCK2,PHYKPL,POLB,POLQ,PPCDC,PTGES2,PTS,PUS1,RPS3,SCLY,SDS,SGPL1,SRR,TKFC,UMPS,URAD,UROC1,UROD,UROS,UXS1,XRCC5,XRCC6	Catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. They differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring.
GO:0016830	GO	MF	carbon-carbon lyase activity	ACMSD,ALDOA,ALDOB,ALDOC,AMD1,BCKDHA,BCKDHB,CYP17A1,DDC,DERA,ECHDC1,FAHD1,GAD1,GADL1,HACL1,HDC,HMGCL,HMGCLL1,HOGA1,IRG1,MLYCD,MOCS1,MVD,NPL,ODC1,PAICS,PCK1,PCK2,PPCDC,SGPL1,UMPS,URAD,UROD,UXS1	Catalysis of the cleavage of C-C bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond.
GO:0016831	GO	MF	carboxy-lyase activity	ACMSD,AMD1,BCKDHA,BCKDHB,DDC,ECHDC1,FAHD1,GAD1,GADL1,HDC,IRG1,MLYCD,MVD,ODC1,PAICS,PCK1,PCK2,PPCDC,UMPS,URAD,UROD,UXS1	Catalysis of the nonhydrolytic addition or removal of a carboxyl group to or from a compound.
GO:0016832	GO	MF	aldehyde-lyase activity	ALDOA,ALDOB,ALDOC,CYP17A1,DERA,HOGA1,SGPL1	Catalysis of the cleavage of a C-C bond in a molecule containing a hydroxyl group and a carbonyl group to form two smaller molecules, each being an aldehyde or a ketone.
GO:0016835	GO	MF	carbon-oxygen lyase activity	ACO1,ALAD,ALKBH1,APEX1,APLF,AUH,CA1,CA2,CA4,CA6,CBS,ECHS1,EHHADH,ENOSF1,ETNPPL,GMDS,HACD1,HACD2,HACD3,HACD4,HADHB,HMGA1,HMGA2,HSD17B4,L3HYPDH,NEIL3,NTHL1,OGG1,PARK7,POLQ,PTS,PUS1,RPS3,UROC1,UROS,XRCC5,XRCC6	Catalysis of the breakage of a carbon-oxygen bond.
GO:0016836	GO	MF	hydro-lyase activity	ACO1,ALAD,AUH,CA1,CA2,CA4,CA6,CBS,ECHS1,EHHADH,ENOSF1,GMDS,HACD1,HACD2,HACD3,HACD4,HADHB,HSD17B4,L3HYPDH,PARK7,PUS1,UROC1,UROS	Catalysis of the cleavage of a carbon-oxygen bond by elimination of water.
GO:0016840	GO	MF	carbon-nitrogen lyase activity	ADSL,FTCD,PAM,SDS,SRR	Catalysis of the release of ammonia or one of its derivatives, with the formation of a double bond or ring. Enzymes with this activity may catalyze the actual elimination of the ammonia, amine or amide, e.g. CH-CH(-NH-R) = C=CH- + NH2-R. Others, however, catalyze elimination of another component, e.g. water, which is followed by spontaneous reactions that lead to breakage of the C-N bond, e.g. L-serine ammonia-lyase (EC:4.3.1.17), so that the overall reaction is C(-OH)-CH(-NH2) = CH2-CO- + NH3, i.e. an elimination with rearrangement. The sub-subclasses of EC:4.3 are the ammonia-lyases (EC:4.3.1), lyases acting on amides, amidines, etc. (EC:4.3.2), the amine-lyases (EC:4.3.3), and other carbon-nitrogen lyases (EC:4.3.99).
GO:0016846	GO	MF	carbon-sulfur lyase activity	CTH,GLO1,LTC4S,MGST2,SCLY	Catalysis of the elimination of hydrogen sulfide or substituted H2S.
GO:0016849	GO	MF	phosphorus-oxygen lyase activity	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,GNAS,GUCY1A3,GUCY1B3,NPR1,NPR2,TKFC	Catalysis of the cleavage of a phosphorus-oxygen bond by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond.
GO:0016853	GO	MF	isomerase activity	ALOX12,ALOX15,ALOXE3,AMACR,DCT,DDT,DHRS9,DSE,EBP,ECI1,ECI2,ERP44,FKBP1A,FKBP1B,FKBP4,FKBP5,FUOM,GALE,GALM,GLCE,GLRX2,GNE,GNPDA1,GPI,GSTZ1,HPGDS,HSD3B1,HSD3B2,IDI1,IDI2,ISYNA1,ITGB3,MCEE,MIF,P4HB,PDIA4,PDIA5,PGAM1,PGAM2,PGAM4,PGM1,PGM2,PGM3,PIGK,PIN1,PMM1,PPIA,PPIB,PPID,PPIE,PPIH,PTGDS,PTGES,PTGES3,PTGIS,QSOX1,RENBP,RPE,RPIA,SRR,TOP1,TOP2A,TOP2B,TOP3A,TOP3B,TPI1,TSTA3	Catalysis of the geometric or structural changes within one molecule. Isomerase is the systematic name for any enzyme of EC class 5.
GO:0016854	GO	MF	racemase and epimerase activity	AMACR,DHRS9,DSE,FUOM,GALE,GALM,GLCE,GNE,MCEE,RENBP,RPE,SRR	Catalysis of a reaction that alters the configuration of one or more chiral centers in a molecule.
GO:0016857	GO	MF	racemase and epimerase activity, acting on carbohydrates and derivatives	DSE,FUOM,GALE,GALM,GLCE,GNE,RENBP,RPE	Catalysis of a reaction that alters the configuration of one or more chiral centers in a carbohydrate molecule.
GO:0016859	GO	MF	cis-trans isomerase activity	FKBP1A,FKBP1B,FKBP4,FKBP5,GSTZ1,PIN1,PPIA,PPIB,PPID,PPIE,PPIH	Catalysis of a reaction that interconverts cis and trans isomers. Atoms or groups are termed cis or trans to one another when they lie respectively on the same or on opposite sides of a reference plane identifiable as common among stereoisomers.
GO:0016860	GO	MF	intramolecular oxidoreductase activity	DCT,DDT,EBP,ECI1,ECI2,ERP44,GLRX2,GNPDA1,GPI,HPGDS,HSD3B1,HSD3B2,IDI1,IDI2,ITGB3,MIF,P4HB,PDIA4,PDIA5,PIGK,PTGDS,PTGES,PTGES3,PTGIS,QSOX1,RPIA,TPI1	Catalysis of an oxidation-reduction (redox) reaction in which the hydrogen donor and acceptor are the same molecule, and no oxidized product appears.
GO:0016863	GO	MF	intramolecular oxidoreductase activity, transposing C=C bonds	DCT,DDT,EBP,ECI1,ECI2,HSD3B1,HSD3B2,IDI1,IDI2,MIF	Catalysis of an oxidation-reduction (redox) reaction in which the hydrogen donor and acceptor are the same molecule, one or more carbon-carbon double bonds in the molecule are rearranged, and no oxidized product appears.
GO:0016868	GO	MF	intramolecular transferase activity, phosphotransferases	PGAM1,PGAM2,PGAM4,PGM1,PGM2,PGM3,PMM1	Catalysis of the transfer of a phosphate group from one position to another within a single molecule.
GO:0016874	GO	MF	ligase activity	AARS2,AASDH,ACACA,ACACB,ACSBG1,ACSBG2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSM1,ACSM2A,ACSS1,ACSS2,ADSS,ADSSL1,ASNS,ASS1,ATG7,CAD,CARNS1,CARS,CPS1,CTPS1,DARS2,DPH6,EARS2,EPRS,FARS2,FPGS,GARS,GATB,GATC,GCLC,GCLM,GMPS,GSS,HARS,HARS2,HLCS,IARS,KARS,LARS,LARS2,LIAS,LIG1,LIG3,LIG4,MARS,MARS2,MCCC1,MCCC2,MDM2,MOCS3,MTHFD1,MTHFD1L,MTHFS,NADSYN1,NAE1,NARS2,NEURL1B,PAICS,PC,PFAS,PPCS,QARS,QRSL1,RARS,RIMKLA,RIMKLB,RNF139,RTCB,SAE1,SARS,SARS2,SLC27A2,SLC27A4,SLC27A5,SUCLA2,SUCLG2,TARS,TTLL1,TTLL3,TTLL7,TTLL8,UBA1,UBA2,UBA3,UBA5,UBA6,UBA7,UBE2M,VARS,WARS,YARS,YARS2	Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
GO:0016877	GO	MF	ligase activity, forming carbon-sulfur bonds	AASDH,ACSBG1,ACSBG2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSM1,ACSM2A,ACSS1,ACSS2,ATG7,MOCS3,NAE1,SAE1,SLC27A2,SLC27A4,SLC27A5,SUCLA2,SUCLG2,UBA1,UBA2,UBA3,UBA5,UBA6,UBA7	Catalysis of the joining of two molecules via a carbon-sulfur bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
GO:0016878	GO	MF	acid-thiol ligase activity	AASDH,ACSF3,ACSL4,ACSM1,ACSM2A,ACSS1,ACSS2,SLC27A2,SUCLA2,SUCLG2	Catalysis of the joining of an acid and a thiol via a carbon-sulfur bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
GO:0016879	GO	MF	ligase activity, forming carbon-nitrogen bonds	ADSS,ADSSL1,ASNS,ASS1,CAD,CARNS1,CPS1,CTPS1,DPH6,FPGS,GATB,GATC,GCLC,GCLM,GMPS,GSS,HLCS,LIAS,MTHFD1,MTHFD1L,MTHFS,NADSYN1,PAICS,PFAS,PPCS,QRSL1,RIMKLA,RIMKLB,TTLL1,TTLL3,TTLL7,TTLL8,UBE2M	Catalysis of the joining of two molecules, or two groups within a single molecule, via a carbon-nitrogen bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
GO:0016881	GO	MF	acid-amino acid ligase activity	CARNS1,DPH6,FPGS,GCLC,GCLM,GSS,PAICS,PPCS,TTLL1,TTLL3,TTLL7,TTLL8,UBE2M	Catalysis of the ligation of an acid to an amino acid via a carbon-nitrogen bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
GO:0016884	GO	MF	carbon-nitrogen ligase activity, with glutamine as amido-N-donor	ASNS,CAD,GATB,GATC,NADSYN1,PFAS,QRSL1	Catalysis of the transfer of the amide nitrogen of glutamine to a variety of substrates. GATases catalyze two separate reactions at two active sites, which are located either on a single polypeptide chain or on different subunits. In the glutaminase reaction, glutamine is hydrolyzed to glutamate and ammonia, which is added to an acceptor substrate in the synthase reaction.
GO:0016885	GO	MF	ligase activity, forming carbon-carbon bonds	ACACA,ACACB,MCCC1,MCCC2,PC	Catalysis of the joining of two molecules via a carbon-carbon bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
GO:0016888	GO	MF	endodeoxyribonuclease activity, producing 5'-phosphomonoesters	DNA2,ENDOV,FAN1,FEN1,SLX1A,SLX4	Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acids by creating internal breaks to yield 5'-phosphomonoesters.
GO:0016889	GO	MF	endodeoxyribonuclease activity, producing 3'-phosphomonoesters	GEN1,MUS81,RAD51C,SLX1A,SLX4,XRCC3	Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acids by creating internal breaks to yield 3'-phosphomonoesters.
GO:0016891	GO	MF	endoribonuclease activity, producing 5'-phosphomonoesters	AGO2,APEX1,DBR1,DGCR8,DICER1,DROSHA,EDC3,ENDOV,EXO1,FEN1,POP1,RNASEH1,RNASEH2A	Catalysis of the hydrolysis of ester linkages within ribonucleic acids by creating internal breaks to yield 5'-phosphomonoesters.
GO:0016893	GO	MF	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	AGO2,APEX1,DBR1,DGCR8,DICER1,DNA2,DROSHA,EDC3,ENDOV,EXO1,FAN1,FEN1,POP1,RNASEH1,RNASEH2A,SLX1A,SLX4	Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks to yield 5'-phosphomonoesters.
GO:0016894	GO	MF	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters	GEN1,MUS81,RAD51C,RNASE4,RNASE8,SLX1A,SLX4,XRCC3	Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks to yield 3'-phosphomonoesters.
GO:0016895	GO	MF	exodeoxyribonuclease activity, producing 5'-phosphomonoesters	APEX1,APTX,DCLRE1A,EXO1,EXO5,FEN1,ISG20,MEIOB,MGME1,TREX1,TREX2	Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acids by removing nucleotide residues from the 3' or 5' end to yield 5' phosphomonoesters.
GO:0016896	GO	MF	exoribonuclease activity, producing 5'-phosphomonoesters	CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,DCP2,DIS3,DIS3L,DIS3L2,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,ISG20,NOCT,PAN2,PAN3,PARN,PNPT1,TOE1,USB1,XRN2	Catalysis of the hydrolysis of ester linkages within ribonucleic acids by removing nucleotide residues from the 3' or 5' end to yield 5' phosphomonoesters.
GO:0016903	GO	MF	oxidoreductase activity, acting on the aldehyde or oxo group of donors	ADH4,ADH5,ADH7,AKR1B1,AKR1B10,AKR1C3,AKR1C4,ALDH18A1,ALDH1A1,ALDH1A2,ALDH1A3,ALDH1B1,ALDH2,ALDH3A1,ALDH3A2,ALDH3B1,ALDH3B2,ALDH4A1,ALDH5A1,ALDH6A1,ALDH7A1,ALDH8A1,ALDH9A1,AOX1,DLAT,DLD,FAR1,FAR2,GAPDH,GAPDHS,HAO1,OGDH,PDHA1,PDHA2,PDHB,PDHX	Catalysis of an oxidation-reduction (redox) reaction in which an aldehyde or ketone (oxo) group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
GO:0016917	GO	MF	GABA receptor activity	GABBR1,GABBR2,GABRA1,GABRB1,GABRB2,GABRB3,GABRG2,GABRR3	Combining with gamma-aminobutyric acid (GABA), and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. (GABA, 4-aminobutyrate) is an amino acid which acts as a neurotransmitter in some organisms.
GO:0016922	GO	MF	ligand-dependent nuclear receptor binding	BAZ2A,ISL1,MED1,NR1H4,TRIP4	Interacting selectively and non-covalently, in a ligand dependent manner, with a nuclear receptor protein.
GO:0016925	GO	BP	protein sumoylation	AAAS,AURKA,AURKB,BCL11A,BIRC5,BLM,BMI1,BRCA1,CBX2,CBX4,CBX8,CDCA8,CDKN2A,CETN2,EID3,EYA1,HDAC7,HERC2,HNRNPC,HNRNPK,IFIH1,INCENP,L3MBTL2,MDC1,MITF,MTA1,NDC1,NDNL2,NOP58,NSMCE1,NSMCE2,NSMCE4A,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PARP1,PCGF2,PCNA,PHC1,PHC2,PHC3,PIAS1,PIAS2,PIAS3,PIAS4,PML,POM121,POM121C,RAD21,RAD52,RAE1,RANBP2,RANGAP1,RING1,RNF168,RNF2,RPA1,SAE1,SCMH1,SEH1L,SENP1,SENP2,SENP5,SMC1A,SMC3,SMC5,SMC6,SP100,SP3,STAG1,STAG2,SUMO1,SUMO2,SUMO3,TDG,TOP1,TOP2A,TOP2B,TOPORS,TP53BP1,TPR,TRIM28,TRPM4,UBA2,UBE2I,WRN,XPC,XRCC4	The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxyl terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.
GO:0016973	GO	BP	poly(A)+ mRNA export from nucleus	HHEX,PABPN1,POLDIP3,THOC2,ZC3H11A,ZC3H3	The directed movement of poly(A)+ mRNA out of the nucleus into the cytoplasm.
GO:0017002	GO	MF	activin-activated receptor activity	ACVR1,ACVR1B,ACVR1C,ACVR2A,ACVR2B,ACVRL1,BMPR2	Combining with activin and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Activin is one of two gonadal glycoproteins related to transforming growth factor beta.
GO:0017004	GO	BP	cytochrome complex assembly	BCS1L,COA1,COA3,COA6,COX10,COX11,COX14,COX15,COX18,CYBA,MT-CO3,SLC25A33,SURF1,TIMM21,TTC19,UQCC1,UQCC2,UQCC3	The aggregation, arrangement and bonding together of a cytochrome complex. A cytochrome complex is a protein complex in which at least one of the proteins is a cytochrome, i.e. a heme-containing protein involved in catalysis of redox reactions.
GO:0017015	GO	BP	regulation of transforming growth factor beta receptor signaling pathway	ADAM17,ADAMTSL2,ASPN,BAMBI,BCL9L,CAV1,CD109,CDKN1C,CDKN2B,CIDEA,CITED1,CITED2,DAB2,DAND5,EID2,ENG,FAM89B,FBN1,FBN2,FLCN,FOLR1,GIPC1,HIPK2,HTRA3,HTRA4,IL17F,ING2,ITGA3,LDLRAD4,LEMD3,LTBP1,LTBP4,MEN1,MTMR4,NEDD4L,NKX2-1,PBLD,PDPK1,PEG10,PIN1,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRDM16,RPS27A,SDCBP,SIRT1,SKI,SKIL,SKOR2,SMAD2,SMAD3,SMAD4,SMAD6,SMAD7,SMURF1,SMURF2,SNW1,SNX25,SNX6,STK11,STRAP,STUB1,TGFB1,TGFB1I1,TGFBR1,TGFBR2,THBS1,TRIM33,UBA52,UBB,UBC,UCHL5,USP15,VASN,XPO1,ZFYVE9,ZNF703	Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
GO:0017016	GO	MF	Ras GTPase binding	ABI2,ALS2,ANKFY1,ANKRD27,ARFIP2,ARHGEF2,ATP6AP1,BICD2,BRK1,C9orf72,CCDC64,CDC42EP4,CDKL5,CHM,CHML,CYFIP1,DAPK3,DMXL2,DOCK4,DOCK7,EPS8,ERC1,FLNA,FMNL1,GOLGA5,HACE1,IQGAP2,KCTD13,MAPKAP1,MLLT4,NCKAP1,NDRG1,NGFR,NSF,PARD6A,PKN1,PLCE1,RAB11FIP3,RAB8A,RABGAP1L,RABGGTA,RABGGTB,RANBP1,RANBP9,RANGRF,RAPGEF4,RAPGEF6,RGP1,RGPD8,RHOH,RIC1,RILP,RIMS1,RIN3,RTKN,SGSM3,SOD1,SPHK2,SRGAP2,TMEM127,TNFAIP1,TRIOBP,UNC13D,WASF1,WHAMM,XPO5,YBX3	Interacting selectively and non-covalently with any member of the Ras superfamily of monomeric GTPases.
GO:0017022	GO	MF	myosin binding	ACTA1,ACTC1,CXCR4,DMD,GIPC1,MYBPC3,MYH8,MYL2,MYL3,MYL4,SPTBN5,TRIM32,TRIOBP,USH2A	Interacting selectively and non-covalently with any part of a myosin complex; myosins are any of a superfamily of molecular motor proteins that bind to actin and use the energy of ATP hydrolysis to generate force and movement along actin filaments.
GO:0017034	GO	MF	Rap guanyl-nucleotide exchange factor activity	RAP1A,RAPGEF1,RAPGEF2,RAPGEF3,RAPGEF5	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Rap family. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0017038	GO	BP	protein import	ADAR,AKR1C3,AKT1,APOE,BCL3,BCL6,C11orf73,CBLB,CEP57,CHCHD4,CLU,DAG1,EGF,F2R,FYB,GCKR,GDF5,GPIHBP1,HES1,HSP90AA1,HSPA4,IFNG,IPO13,IPO5,IPO9,JAK2,JAK3,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,LAMP2,MCM3AP,MT3,NCKIPSD,NDUFA13,NOP58,NUP205,NUP98,NUTF2,OPRD1,OR1D2,PAM16,PDIA3,PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,PHB2,PPP1R10,PRICKLE1,PTTG1IP,RAB8B,RAN,RANBP17,RANBP2,RBM22,RERE,RPAIN,RPL23,SAMM50,SEC61B,SIX3,SNX33,STAT3,SYK,TGFB1,TGFB2,TIMM10,TIMM21,TIMM22,TIMM9,TNF,TNPO1,TNPO3,TOMM22,TPR,TRPS1,TSC2,ZFYVE9	The targeting and directed movement of proteins into a cell or organelle.  Not all import involves an initial targeting event.
GO:0017046	GO	MF	peptide hormone binding	ACVR1,CALCR,CRHBP,ECE1,GALR1,GALR2,GALR3,IDE,INSR,NPR3,PIK3R1,PTH1R	Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
GO:0017048	GO	MF	Rho GTPase binding	ABI2,ARFIP2,ARHGEF2,BRK1,CDC42EP4,CDKL5,CYFIP1,DAPK3,DOCK4,DOCK7,EPS8,FLNA,FMNL1,IQGAP2,KCTD13,NCKAP1,PARD6A,PKN1,RHOH,RTKN,SOD1,SRGAP2,TNFAIP1,TRIOBP,WASF1,WHAMM,YBX3	Interacting selectively and non-covalently with Rho protein, any member of the Rho subfamily of the Ras superfamily of monomeric GTPases. Proteins in the Rho subfamily are involved in relaying signals from cell-surface receptors to the actin cytoskeleton.
GO:0017049	GO	MF	GTP-Rho binding	CDC42EP4,KCTD13,PKN1,RTKN,TNFAIP1,TRIOBP,WHAMM	Interacting selectively and non-covalently with the GTP-bound form of the Rho protein.
GO:0017053	GO	CC	transcriptional repressor complex	AKIRIN2,APPL1,APPL2,ARID4A,CBX5,CCND1,CHD3,CHD4,CHD5,CORO2A,CSNK2A1,CTBP1,CTBP2,DEPDC1,ELANE,GATA1,GATAD2A,GFI1,GPS2,HDAC1,HDAC2,HDAC3,HDAC4,HDGF,HEY2,HMGB1,INSM1,JAZF1,MBD3,MIER1,MTA2,N4BP2L2,NACC2,NCOR1,NCOR2,PASD1,PHF12,PRDM16,RBBP4,RBBP7,RBBP8,RCOR1,REST,RLIM,SALL1,SKI,SPEN,TBL1X,TBL1XR1,TFAP4,ZBTB16,ZFPM1,ZNF224,ZNF350	A protein complex that possesses activity that prevents or downregulates transcription.
GO:0017056	GO	MF	structural constituent of nuclear pore	NDC1,NUP107,NUP153,NUP205,NUP93,NUP98	The action of a molecule that contributes to the structural integrity of the nuclear pore complex.
GO:0017059	GO	CC	serine C-palmitoyltransferase complex	ORMDL3,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB	An enzyme complex that catalyzes the transfer of a palmitoyl on to serine, forming 3-dehydro-D-sphinganine.
GO:0017069	GO	MF	snRNA binding	DDX21,DDX39B,EIF5A,GEMIN5,HEXIM1,HEXIM2,ISG20,LSM11,LSM2,LSM7,LSM8,NCBP2,PRPF31,RBM22,SART3,SNU13	Interacting selectively and non-covalently with a small nuclear RNA (snRNA).
GO:0017070	GO	MF	U6 snRNA binding	DDX39B,EIF5A,LSM2,LSM7,LSM8,RBM22,SART3	Interacting selectively and non-covalently with the U6 small nuclear RNA (U6 snRNA).
GO:0017075	GO	MF	syntaxin-1 binding	NSF,SNPH,STXBP1,STXBP5,SYT1,UNC13A,VAMP2	Interacting selectively and non-covalently with the SNAP receptor syntaxin-1.
GO:0017080	GO	MF	sodium channel regulator activity	AGT,ATP2B4,CAMK2D,CAV3,FGF12,FGF13,FXYD1,GPD1L,GPLD1,NEDD4,NEDD4L,NOS1,PCSK9,PKP2,PTPN3,RANGRF,SCN1B,SCN2B,SCN3B,SCN4B,SGK1,SGK2,SGK3,SNTA1,TMPRSS3,YWHAH	Modulates the activity of a sodium channel.
GO:0017081	GO	MF	chloride channel regulator activity	CFTR,CHRNA7,SGK1,SGK3,SLC9A3R1,STX1A,STX7,STX8,VAMP8,VTI1B,WNK1,WNK3,WNK4	Modulates the activity of a chloride channel.
GO:0017091	GO	MF	AU-rich element binding	CPEB1,CPEB2,CPEB3,CPSF1,DND1,ELAVL1,ELAVL3,ELAVL4,EXOSC4,EXOSC8,EXOSC9,HNRNPA0,MEX3D,NUDT21,ZC3H12A,ZFP36,ZFP36L2	Interacting selectively and non-covalently with a region of RNA containing frequent adenine and uridine bases.
GO:0017108	GO	MF	5'-flap endonuclease activity	DNA2,FAN1,FEN1,SLX1A,SLX4	Catalysis of the cleavage of a 5' flap structure in DNA, but not other DNA structures; processes the 5' ends of Okazaki fragments in lagging strand DNA synthesis.
GO:0017112	GO	MF	Rab guanyl-nucleotide exchange factor activity	ALS2,DENND1A,DENND1B,DENND1C,DENND2A,DENND2C,DENND2D,DENND3,DENND4A,DENND4B,DENND4C,DENND5A,DENND5B,DENND6A,DENND6B,MADD,RAB3GAP1,RAB3GAP2,RAB3IL1,RAB3IP,RABGEF1,RGP1,RIC1,RIN2,RIN3,SBF1,SBF2,ST5	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Rab family. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0017119	GO	CC	Golgi transport complex	COG1,COG2,COG3,COG4,COG5,COG6,COG7,COG8,GOLGA3,SCFD1,TMEM115	A complex of proteins that, in vitro, stimulates intra-Golgi transport; a 13S complex, about 800 kDa in size and consists of at least five polypeptides. In yeast, this complex is called the Sec34/35 complex and is composed of eight subunits (Sec34p, Sec35p, Dor1p, Cod1p, Cod2p, Cod3p, Cod4p, and Cod5p).
GO:0017121	GO	BP	phospholipid scrambling	ABCA7,ANO6,P2RX7,PLSCR1,PLSCR2,PLSCR4,XKR8	The movement of a population of phospholipid molecules from one leaflet of the plasma membrane bilayer to the opposite leaflet, resulting in loss of lipid asymmetry and surface exposure of phosphatidylserine (PS) and phosphatidylethanolamine (PE).
GO:0017124	GO	MF	SH3 domain binding	ABI2,ADAM9,ARHGAP27,CABYR,CASP9,CBLC,CNTNAP1,DAB2IP,DNM2,DPYSL3,DRD4,ESPN,EVL,GRB2,MAPK15,PARK2,PLSCR1,PTPN22,SHANK1,SHANK3,SKAP1,SOCS7	Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.
GO:0017127	GO	MF	cholesterol transporter activity	ABCA1,ABCG1,ABCG4,ABCG5,ABCG8,APOA1,APOA2,APOA4,APOB,CETP	Enables the directed movement of cholesterol into, out of or within a cell, or between cells. Cholesterol is the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0017134	GO	MF	fibroblast growth factor binding	CXCL13,FGFR1,FGFR2,FGFR3,FGFR4,GPC1,THBS1	Interacting selectively and non-covalently with a fibroblast growth factor.
GO:0017137	GO	MF	Rab GTPase binding	ALS2,ANKFY1,ANKRD27,ATP6AP1,BICD2,C9orf72,CCDC64,CHM,CHML,DMXL2,ERC1,GOLGA5,HACE1,NDRG1,NGFR,NSF,RAB11FIP3,RAB8A,RABGAP1L,RABGGTA,RABGGTB,RGP1,RIC1,RILP,RIMS1,RIN3,SGSM3,TMEM127,UNC13D	Interacting selectively and non-covalently with Rab protein, any member of the Rab subfamily of the Ras superfamily of monomeric GTPases.
GO:0017144	GO	BP	drug metabolic process	ADAL,ADH1A,BCHE,CAD,CBR1,CYP1A1,CYP1A2,CYP2A6,CYP2B6,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP2D7,CYP2E1,CYP3A4,CYP3A5,CYP4F12,CYP4F2,DPEP1,EPHX2,FMO2,GUK1,NOS1,NR1I2,NT5C2,PCK1,UGT1A1,UGT1A7,UGT1A8,VKORC1	The chemical reactions and pathways involving a drug, a substance used in the diagnosis, treatment or prevention of a disease; as used here antibiotic substances (see antibiotic metabolism) are considered to be drugs, even if not used in medical or veterinary practice.
GO:0017145	GO	BP	stem cell division	CDKN2A,CUL3,DOCK7,FGF13,FGFR2,ING2,NUMB,NUMBL,RAB10,SOX5,TEAD3,TGFB2,WWTR1,ZFP36L2	The self-renewing division of a stem cell. A stem cell is an undifferentiated cell, in the embryo or adult, that can undergo unlimited division and give rise to one or several different cell types.
GO:0017146	GO	CC	NMDA selective glutamate receptor complex	GRIN1,GRIN2A,GRIN2B,GRIN3A,GRIN3B,PTK2B,SHANK1	An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. NMDA receptors are composed of assemblies of NR1 subunits (Figure 3) and NR2 subunits, which can be one of four separate gene products (NR2A-D). Expression of both subunits are required to form functional channels. The glutamate binding domain is formed at the junction of NR1 and NR2 subunits. NMDA receptors are permeable to calcium ions as well as being permeable to other ions. Thus NMDA receptor activation leads to a calcium influx into the post-synaptic cells, a signal thought to be crucial for the induction of NMDA-receptor dependent LTP and LTD.
GO:0017147	GO	MF	Wnt-protein binding	APCDD1,FRZB,FZD6,LRP5,LRP6,PTPRO,RYK,SFRP1,SFRP4,TRABD2A,TRABD2B,WLS	Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
GO:0017148	GO	BP	negative regulation of translation	ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,ATF4,BTG2,CALR,CAPRIN1,CELF1,CELF4,CIRBP,CNOT1,CNOT6,CNOT7,CNOT8,CPEB1,CPEB2,CPEB3,DAPK1,DAPK3,DDX3X,DGCR8,DICER1,DROSHA,EIF2AK1,EIF2AK2,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1,EIF3E,EIF4A3,EIF4E2,EIF4EBP1,EIF4EBP2,EIF4EBP3,ENC1,EPRS,FMR1,GAPDH,GIGYF2,GNB2L1,GRB7,HNRNPA2B1,IGF2BP1,IGF2BP2,IGF2BP3,IGFBP5,ILF3,LIMD1,LIN28A,LIN28B,MALSU1,METTL14,METTL3,MEX3D,MOV10,NANOS1,NANOS2,NANOS3,PAIP2,PAIP2B,PATL2,PML,PRG3,PRKRA,PUM1,RAN,RBM4,RNF139,RPL13A,RPS3,SAMD4A,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,SYNCRIP,TARBP2,TNRC6A,TNRC6C,TOB1,TPR,TRIM71,TSC1,UNK,WT1,WTIP,XPO5,ZC3H12A,ZC3H12D,ZCCHC11,ZFP36,ZNF540	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA.
GO:0017154	GO	MF	semaphorin receptor activity	NRP1,NRP2,PLXNA1,PLXNA2,PLXNB1,PLXNB2,PLXNB3,PLXND1	Combining with a semaphorin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0017156	GO	BP	calcium ion regulated exocytosis	BLOC1S6,CDK5,DNAJC5,DOC2B,NLGN1,OTOF,PCLO,PIP5K1C,PPP3CB,RAB3A,RIMS1,RIMS2,RIMS3,SCIN,SDF4,SEPT5,SNAP25,SNAPIN,SNPH,STX1B,SYNJ1,SYT1,SYT6,UNC13B,VAMP2,VAMP7,ZP4	The release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle by fusion of the vesicle with the plasma membrane of a cell, induced by a rise in cytosolic calcium-ion levels.
GO:0017157	GO	BP	regulation of exocytosis	ADRA2A,ANXA1,AP1G1,ATP6AP1,C12orf4,CACNA1H,CCR2,CD300A,CD84,CFTR,CHMP2A,CLASP1,CLASP2,CPLX1,CPLX2,DOC2A,DOC2B,EXPH5,F2RL1,FAM170B,FES,FGA,FGB,FGG,FGR,GAB2,GLRA1,HAP1,HGS,IFNG,IL1RAPL1,IQCF1,KCNB1,LAMP1,LGALS9,LRRK2,LYN,NLGN1,NSF,PDCD6IP,PLCB1,RAB15,RAB21,RAB26,RAB27A,RAB27B,RAB2B,RAB33B,RAB3A,RAB3D,RAB3GAP1,RAB5A,RAB7A,RAB9A,RALA,RALB,REST,RIMS2,RIMS3,RIMS4,RSG1,SCAMP5,SDC1,SDC4,SDCBP,SEPT5,SMPD3,SNCA,SNF8,SNX4,SPINK13,STAM,STX1A,STX1B,STX4,STXBP1,STXBP2,STXBP3,STXBP5,STXBP6,SYK,SYN1,SYT1,SYTL4,TMEM27,TRPV6,TSG101,UNC13B,UNC13D,VAMP2,VAMP7,VAMP8,VPS4A,VPS4B,ZP3,ZP4	Any process that modulates the frequency, rate or extent of exocytosis.
GO:0017158	GO	BP	regulation of calcium ion-dependent exocytosis	ADRA2A,CACNA1H,DOC2A,DOC2B,FAM170B,GLRA1,IQCF1,KCNB1,LRRK2,NLGN1,PLCB1,RAB3A,RAB3GAP1,RAB5A,REST,RIMS3,RIMS4,SCAMP5,SEPT5,SPINK13,STX1A,STX1B,STXBP1,STXBP3,SYN1,TMEM27,TRPV6,UNC13B,ZP3,ZP4	Any process that modulates the frequency, rate or extent of calcium ion-dependent exocytosis.
GO:0017169	GO	MF	CDP-alcohol phosphatidyltransferase activity	CDIPT,CDS1,CEPT1,CHPT1,EPT1,PGS1,PIGF	Catalysis of the reaction: CDP + alcohol = CMP + phosphatidyl alcohol.
GO:0017171	GO	MF	serine hydrolase activity	AADAC,ACE,ACHE,ACR,APEH,C1R,C1S,CELA2A,CELA3B,CFB,CFD,CLPP,CMA1,CORIN,CTRB1,CTSA,CTSG,CTSH,DPP4,DPP7,ENDOU,F10,F11,F12,F2,F7,FAP,FURIN,GZMA,GZMB,GZMH,GZMK,GZMM,HGFAC,HPN,HTRA1,HTRA2,HTRA3,KLK1,KLK10,KLK11,KLK12,KLK13,KLK14,KLK15,KLK2,KLK3,KLK4,KLK5,KLK6,KLK7,KLK8,KLK9,LPA,MASP1,MASP2,MBTPS1,MMP2,MMP8,NAALAD2,PCSK1,PCSK2,PCSK5,PCSK6,PCSK9,PLAT,PLAU,PLG,PRCP,PREP,PROC,PRSS1,PRSS12,PRSS16,PRSS2,PRSS21,PRSS3,PRSS36,PRSS56,PRSS8,PRTN3,RHBDD1,RHBDL2,SCPEP1,ST14,TMPRSS11B,TMPRSS11E,TMPRSS13,TMPRSS2,TMPRSS3,TMPRSS4,TMPRSS6,TMPRSS7,TPP1,TPSAB1,TPSB2,TPSD1,TPSG1,TYSND1,ZFYVE9	Catalysis of the hydrolysis of a substrate by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
GO:0017183	GO	BP	peptidyl-diphthamide biosynthetic process from peptidyl-histidine	DPH1,DPH2,DPH3,DPH5,DPH6,DPH7,EEF2	The modification of peptidyl-histidine to 2'-(3-carboxamido-3-(trimethylammonio)propyl)-L-histidine, known as diphthamide, found in translation elongation factor EF-2. The process occurs in eukaryotes and archaea but not eubacteria.
GO:0017187	GO	BP	peptidyl-glutamic acid carboxylation	BGLAP,F10,F2,F7,F9,FURIN,GAS6,GGCX,PROC,PROS1,PROZ,VKORC1,VKORC1L1	The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
GO:0018022	GO	BP	peptidyl-lysine methylation	ASH1L,ASH2L,BEND3,CHD5,CTR9,CXXC1,DPY30,EEF2KMT,EHMT1,EHMT2,EZH2,KDM6A,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,METTL20,METTL21A,METTL21C,NSD1,OGT,PAXIP1,PRDM5,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SUV39H1,SUV39H2,TET2,TET3,VCPKMT,WDR5,WDR61,WDR82,ZNF335	The methylation of peptidyl-lysine to form either the mono-, di- or trimethylated derivative.
GO:0018023	GO	BP	peptidyl-lysine trimethylation	BEND3,CTR9,EEF2KMT,KMT2A,METTL20,OGT,SETD2,SETD3,SUV39H1,SUV39H2,TET2,TET3,VCPKMT,WDR61,ZNF335	The methylation of peptidyl-lysine to form peptidyl-N6,N6,N6-trimethyl-L-lysine.
GO:0018024	GO	MF	histone-lysine N-methyltransferase activity	ASH1L,ASH2L,CXXC1,DOT1L,EHMT1,EHMT2,EZH2,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,NSD1,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the reaction: S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine + histone N6-methyl-L-lysine. The methylation of peptidyl-lysine in histones forms N6-methyl-L-lysine, N6,N6-dimethyl-L-lysine and N6,N6,N6-trimethyl-L-lysine derivatives.
GO:0018026	GO	BP	peptidyl-lysine monomethylation	EHMT1,SETD3,SETD6,SETD7,SETD8,SMYD2	The methylation of peptidyl-lysine to form peptidyl-N6-methyl-L-lysine.
GO:0018027	GO	BP	peptidyl-lysine dimethylation	ASH1L,EHMT1,EHMT2,SETD2,SETD3,SETD7,SETMAR,SMYD2,SUV39H1,SUV39H2	The methylation of peptidyl-lysine to form peptidyl-N6,N6-dimethyl-L-lysine.
GO:0018065	GO	BP	protein-cofactor linkage	CTH,GAD1,NDUFAB1,NNAT,SDHAF2	The covalent attachment of a cofactor to a protein.
GO:0018095	GO	BP	protein polyglutamylation	CEP41,CFAP20,TTLL1,TTLL4,TTLL6,TTLL7	The addition of one or more alpha-linked glutamyl units to the gamma carboxyl group of peptidyl-glutamic acid.
GO:0018105	GO	BP	peptidyl-serine phosphorylation	ADRBK1,AKT1,ATM,ATR,AURKB,CAB39,CAMK2A,CAMK2D,CDK1,CDK2,CDK5,CDK5R1,CLSPN,CSNK1A1,CSNK1D,CSNK1E,CSNK1G1,CSNK1G2,CSNK1G3,EIF2AK3,ERN1,GAS6,GSK3B,HIPK2,HIPK3,HMGA2,IKBKB,LMTK2,LRRK2,MAP2K2,MAP3K10,MAP3K12,MAP4K1,MAPK1,MAPK12,MAPK13,MAPK14,MAPK8,MAPKAPK2,MAPKAPK3,MKNK1,MORC3,MTOR,NEK6,NLK,PAK2,PDGFB,PDK3,PINK1,PKD1,PLK1,PLK2,PRKACA,PRKCE,PRKCZ,PRKD1,PRKD2,PRKDC,PRKX,RICTOR,RIPK1,RPS6KA4,RPS6KA5,SMG1,STK39,STK4,TAF1,TBK1,TDGF1,TGFBR1,TGFBR2,TLK2,TNKS,TTBK2,UHMK1,ULK1,VRK1	The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
GO:0018107	GO	BP	peptidyl-threonine phosphorylation	ACVR1,ACVR1B,AKT1,CAD,CAMK2D,CDK1,CDK5R1,CHEK1,DYRK1A,GSG2,GSK3B,HIPK2,HIPK3,LMTK2,LRRK2,MAP3K10,MAP3K12,MAPK1,MAPK8,MARK2,MYLK2,NLK,OXSR1,PDPK1,PKN1,PRKCA,PRKCB,PRKCD,STK39,TAF1,TGFBR1,TGFBR2,TNKS,VPRBP,VRK1,WNK1	The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
GO:0018108	GO	BP	peptidyl-tyrosine phosphorylation	ABI1,ABI2,ABL1,ABL2,ALK,AXL,BAZ1B,BCR,BTK,CAMKK2,CSF1R,DDR1,DDR2,DYRK1A,DYRK2,EFEMP1,EGFR,EPHA1,EPHA2,EPHA4,EPHA7,EPHB2,EPHB4,ERBB2,ERBB4,F2R,FER,FES,FGFR1,FGFR1OP,FGFR2,FGFR3,FGFR4,FGR,FLT1,FLT3,FLT4,FYN,GHR,HCK,IFNL4,IGF1R,IL15,IL21,INSR,INSRR,JAK2,JAK3,KDR,KIT,LTK,LYN,MAPK3,MELK,MERTK,MET,MUSK,NTRK1,PDGFB,PDGFRA,PDGFRB,PEAK1,PIBF1,PKDCC,PRLR,PTK2,PTK2B,PTK6,PTPN6,RELN,RET,ROR1,ROR2,RYK,SCYL1,SHC1,SRC,SRMS,TEC,TEK,TIE1,TRIM27,TTK,TTN,TYRO3,ZAP70	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
GO:0018119	GO	BP	peptidyl-cysteine S-nitrosylation	GAPDH,NOS1,NOS2,S100A8,S100A9	The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine.
GO:0018126	GO	BP	protein hydroxylation	EGLN1,EGLN2,EGLN3,HIF1AN,JMJD6,OGFOD1,P3H1,P3H2,P4HB	The addition of a hydroxy group to a protein amino acid.
GO:0018146	GO	BP	keratan sulfate biosynthetic process	ACAN,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GAT1,CHST1,CHST2,CHST5,CHST6,FMOD,KERA,LUM,OGN,OMD,PRELP,SLC35D2,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6	The chemical reactions and pathways resulting in the formation of keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues.
GO:0018149	GO	BP	peptide cross-linking	ABCA7,ANXA1,COL3A1,CSTA,DSP,EVPL,FN1,IVL,LOR,NDNF,SPRR1A,SPRR1B,TGM3,THBS1	The formation of a covalent cross-link between or within protein chains.
GO:0018195	GO	BP	peptidyl-arginine modification	CARM1,COPRS,FBXO11,NR1H4,PADI2,PADI4,PRDM4,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8	The modification of peptidyl-arginine.
GO:0018198	GO	BP	peptidyl-cysteine modification	CLIP3,GAPDH,GOLGA7,MOCS3,NOS1,NOS2,PRDX3,RAB6A,S100A8,S100A9,TMX3,ZDHHC21,ZDHHC7,ZDHHC9	The modification of peptidyl-cysteine.
GO:0018200	GO	BP	peptidyl-glutamic acid modification	AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,BGLAP,CEP41,CFAP20,F10,F2,F7,F9,FOLH1,FURIN,GAS6,GGCX,PROC,PROS1,PROZ,TTLL1,TTLL4,TTLL6,TTLL7,VKORC1,VKORC1L1	The modification of peptidyl-glutamic acid.
GO:0018202	GO	BP	peptidyl-histidine modification	DPH1,DPH2,DPH3,DPH5,DPH6,DPH7,EEF2,HIF1AN	The modification of peptidyl-histidine.
GO:0018206	GO	BP	peptidyl-methionine modification	APOA1,APOA2,METAP1,METAP1D,METAP2,NAA30,NAA60,PDF	The modification of peptidyl-methionine.
GO:0018208	GO	BP	peptidyl-proline modification	EGLN1,EGLN2,EGLN3,FKBP1A,FKBP1B,NTMT1,OGFOD1,P3H1,P3H2,P4HB,PIN1,PPIA,PPIB	The modification of peptidyl-proline.
GO:0018209	GO	BP	peptidyl-serine modification	ADRBK1,AKT1,ATM,ATR,AURKB,CAB39,CAMK2A,CAMK2D,CDK1,CDK2,CDK5,CDK5R1,CLSPN,CSNK1A1,CSNK1D,CSNK1E,CSNK1G1,CSNK1G2,CSNK1G3,EIF2AK3,ERN1,GALNT1,GALNT2,GALNT3,GAS6,GSK3B,HIPK2,HIPK3,HMGA2,IKBKB,LMTK2,LRRK2,MAP2K2,MAP3K10,MAP3K12,MAP4K1,MAPK1,MAPK12,MAPK13,MAPK14,MAPK8,MAPKAPK2,MAPKAPK3,MBOAT4,MKNK1,MORC3,MTOR,NDNF,NEK6,NLK,NTMT1,PAK2,PDGFB,PDK3,PINK1,PKD1,PLK1,PLK2,PRKACA,PRKCE,PRKCZ,PRKD1,PRKD2,PRKDC,PRKX,RICTOR,RIPK1,RPS6KA4,RPS6KA5,SMG1,STK39,STK4,TAF1,TBK1,TDGF1,TGFBR1,TGFBR2,TLK2,TNKS,TTBK2,UHMK1,ULK1,VRK1	The modification of peptidyl-serine.
GO:0018210	GO	BP	peptidyl-threonine modification	ACVR1,ACVR1B,AKT1,CAD,CAMK2D,CDK1,CDK5R1,CHEK1,DYRK1A,GALNT1,GALNT11,GALNT2,GALNT3,GSG2,GSK3B,HIPK2,HIPK3,LMTK2,LRRK2,MAP3K10,MAP3K12,MAPK1,MAPK8,MARK2,MYLK2,NLK,OXSR1,PDPK1,PKN1,PRKCA,PRKCB,PRKCD,STK39,TAF1,TGFBR1,TGFBR2,TNKS,VPRBP,VRK1,WNK1	The modification of peptidyl-threonine.
GO:0018216	GO	BP	peptidyl-arginine methylation	CARM1,COPRS,FBXO11,NR1H4,PRDM4,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8	The addition of a methyl group to an arginine residue in a protein.
GO:0018230	GO	BP	peptidyl-L-cysteine S-palmitoylation	CLIP3,GOLGA7,ZDHHC21,ZDHHC7,ZDHHC9	The covalent attachment of a palmitoyl group to a sulfur (S) atom within a cysteine residue to form peptidyl-S-palmitoyl-L-cysteine.
GO:0018342	GO	BP	protein prenylation	AIPL1,CHM,CHML,FNTA,FNTB,PGGT1B,RABGGTA,RABGGTB	The covalent attachment of a prenyl group to a protein; geranyl, farnesyl, or geranylgeranyl groups may be added.
GO:0018344	GO	BP	protein geranylgeranylation	CHM,CHML,FNTA,PGGT1B,RABGGTA,RABGGTB	The covalent attachment of a geranylgeranyl group to a protein.
GO:0018345	GO	BP	protein palmitoylation	CLIP3,GOLGA7,ZDHHC1,ZDHHC12,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	The covalent attachment of a palmitoyl group to a protein.
GO:0018377	GO	BP	protein myristoylation	NMT1,NMT2,OAS2,PPM1A,PPM1B	The covalent attachment of a myristoyl group to a protein.
GO:0018393	GO	BP	internal peptidyl-lysine acetylation	ACTL6A,APBB1,ATAT1,ATF2,BAG6,BEND3,BRCA2,BRD1,BRD8,BRPF1,BRPF3,CHD5,CLOCK,CPA4,CREBBP,CSRP2BP,DMAP1,DR1,ELP3,ELP4,EP300,EP400,EPC1,GTF3C4,HAT1,HCFC1,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,KMT2A,LDB1,LEF1,MAP3K7,MBIP,MCRS1,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA50,NAA60,NAT8,NAT8B,NCOA3,OGT,PER1,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SPI1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TRIM16,TRRAP,USP22,WDR5,YEATS2,YEATS4	The addition of an acetyl group to a non-terminal lysine residue in a protein.
GO:0018394	GO	BP	peptidyl-lysine acetylation	ACTL6A,APBB1,ATAT1,ATF2,BAG6,BEND3,BLOC1S1,BRCA2,BRD1,BRD8,BRPF1,BRPF3,CHD5,CLOCK,CPA4,CREBBP,CSRP2BP,DMAP1,DR1,ELP3,ELP4,EP300,EP400,EPC1,GTF3C4,HAT1,HCFC1,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,KMT2A,LDB1,LEF1,MAP3K7,MBIP,MCRS1,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA50,NAA60,NAT8,NAT8B,NCOA3,OGT,PER1,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SIRT1,SPI1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TRIM16,TRRAP,USP22,WDR5,YEATS2,YEATS4	The acetylation of peptidyl-lysine.
GO:0018410	GO	BP	C-terminal protein amino acid modification	AGBL1,AGBL4,AGTPBP1,DPM1,DPM2,DPM3,FOLH1,GPAA1,LCMT1,PGAP1,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PLAUR	The alteration of the C-terminal amino acid residue in a protein.
GO:0018904	GO	BP	ether metabolic process	AGMO,AGPS,CYP2W1,FAR1,FAR2,GNPAT,PEX7,TMEM86B	The chemical reactions and pathways involving organic ethers, any anhydride of the general formula R1-O-R2, formed between two identical or nonidentical organic hydroxy compounds.
GO:0018958	GO	BP	phenol-containing compound metabolic process	ATP7A,CITED1,CPQ,DAO,DBH,DCT,DDC,DIO1,DIO2,DIO3,DRD1,DRD2,DRD3,DRD4,DUOX1,DUOX2,FOXE1,GATA3,GCH1,HAND2,HTR1A,INSM1,IYD,LRTOMT,MAOA,MAOB,PAH,PARK2,PNMT,SLC5A5,SNCA,SNCAIP,SULT1A2,SULT1B1,TGFB2,TH,TPO,TRPC1,TYR	The chemical reactions and pathways involving a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring.
GO:0019001	GO	MF	guanyl nucleotide binding	ADSS,ADSSL1,ANXA6,ARF4,ARF6,ARFIP2,ARHGEF5,ARL1,ARL2,ARL3,ARL4A,ARL8A,ARL8B,ATL1,CDC42,CNGA3,CNGB1,CNGB3,DIRAS1,DIRAS2,DNM2,EEF1A1,EIF2B2,GCH1,GEM,GIMAP7,GLUD1,GLUD2,GNAI1,GNAI3,GNAT1,GNAT2,GNL1,GNL2,GNL3,GTPBP4,HRAS,INSR,LANCL2,LRRK2,LSG1,MIEF1,MX2,NME1,NMUR2,NOA1,NUDT16,PCK1,PDE10A,PDE11A,PDE2A,PDE5A,RAB10,RAB11B,RAB12,RAB13,RAB14,RAB17,RAB18,RAB1B,RAB21,RAB22A,RAB26,RAB27A,RAB27B,RAB28,RAB29,RAB2A,RAB31,RAB32,RAB35,RAB38,RAB39A,RAB3B,RAB4A,RAB5A,RAB5B,RAB5C,RAB6A,RAB7A,RAB8A,RAB8B,RAB9A,RAB9B,RAC1,RAC2,RALA,RALB,RAN,RANBP17,RAP1B,RAP2A,RAP2B,RAP2C,RERG,RHEB,RHEBL1,RHOA,RHOB,RHOH,RRAGA,RRAGB,RRAGC,RRAS,SAMHD1,SCG5,SEPHS1,SEPT12,SEPT6,SRP54,THG1L,TMEM173,TPX2,TRIM23	Interacting selectively and non-covalently with guanyl nucleotides, any compound consisting of guanosine esterified with (ortho)phosphate.
GO:0019003	GO	MF	GDP binding	ARL3,ARL8B,GEM,GNAI1,GNAI3,GNAT1,MIEF1,RAB10,RAB11B,RAB12,RAB14,RAB17,RAB18,RAB21,RAB22A,RAB27A,RAB27B,RAB28,RAB29,RAB2A,RAB31,RAB35,RAB3B,RAB4A,RAB5A,RAB5B,RAB5C,RAB7A,RAB8A,RAB8B,RAB9A,RAB9B,RALA,RALB,RAN,RAP1B,RAP2B,RAP2C,RERG,RRAGC,RRAS,SEPT12,SRP54,TRIM23	Interacting selectively and non-covalently with GDP, guanosine 5'-diphosphate.
GO:0019005	GO	CC	SCF ubiquitin ligase complex	BTRC,CCNF,CUL1,FBXL15,FBXL19,FBXL2,FBXL3,FBXL5,FBXL7,FBXO17,FBXO18,FBXO2,FBXO25,FBXO27,FBXO31,FBXO4,FBXO44,FBXO6,FBXO9,FBXW11,FBXW5,FBXW7,RBX1,SKP1,SKP2,TRIM21,USP47	A ubiquitin ligase complex in which a cullin from the Cul1 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by a Skp1 adaptor and an F-box protein. SCF complexes are involved in targeting proteins for degradation by the proteasome. The best characterized complexes are those from yeast and mammals (with core subunits named Cdc53/Cul1, Rbx1/Hrt1/Roc1).
GO:0019042	GO	BP	viral latency	BANF1,CREB3,HCFC1,HMGA1,IRF7,LIG4,PPIA,PSIP1,XRCC4,XRCC5,XRCC6	The process by which, after initial infection, a virus lies dormant within a cell and viral production ceases. The process ends when the virus switches from latency and starts to replicate.
GO:0019043	GO	BP	establishment of viral latency	BANF1,CREB3,HMGA1,IRF7,LIG4,PPIA,PSIP1,XRCC4,XRCC5,XRCC6	A process by which a virus establishes a latent state within its host, either as an integrated provirus within the host genome or as an episome, where viral genome remains in the cytoplasm or nucleus as distinct objects.
GO:0019048	GO	BP	modulation by virus of host morphology or physiology	AAAS,ATG7,BCL2L1,CCNK,CD209,CD4,CLEC4M,CPSF4,DAG1,EIF2AK2,EIF2AK4,HIPK2,HYAL2,INSR,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,POM121,POM121C,RAE1,RANBP2,RRAGA,RXRA,SEH1L,SLC25A6,SMAD3,TGFB1,TPR,VAPA,VAPB,ZC3H12A	The process in which a virus effects a change in the structure or processes of its host organism.
GO:0019054	GO	BP	modulation by virus of host process	AAAS,ATG7,BCL2L1,CCNK,CD4,CPSF4,EIF2AK2,EIF2AK4,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,POM121,POM121C,RAE1,RANBP2,SEH1L,SLC25A6,TGFB1,TPR,VAPA,VAPB,ZC3H12A	The process in which a virus effects a change in the processes and activities of its host organism.
GO:0019060	GO	BP	intracellular transport of viral protein in host cell	DERL1,DYNLT1,IFIT1,TAP1,TAP2	The directed movement of a viral protein within the host cell.
GO:0019062	GO	BP	virion attachment to host cell	ACE2,CD209,CD81,CLEC4M,GAS6,HSP90AB1,ICAM1,LRRC15,PVRL2	The process by which a virion protein binds to molecules on the host cellular surface or host cell surface projection.
GO:0019068	GO	BP	virion assembly	APOE,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,DDX6,FURIN,LRSAM1,MVB12A,NMT2,PC,PDCD6IP,PPIA,RAB1A,RAB1B,RAB43,RPS27A,TBC1D20,TSG101,UBA52,UBB,UBC,USP6NL,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1	A late phase of the viral life cycle during which all the components necessary for the formation of a mature virion collect at a particular site in the cell and the basic structure of the virus particle is formed.
GO:0019076	GO	BP	viral release from host cell	IST1,PPIA,PPID,RAB7A,VPS4A,VPS4B	The dissemination of mature viral particles from the host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane.
GO:0019079	GO	BP	viral genome replication	ADRBK1,CCL2,CD209,CLEC4M,CTBP1,CTBP2,CXCR6,DEK,GAS6,HTATSF1,NFIA,SMARCB1,SUPT5H,UBP1,VCP	Any process involved directly in viral genome replication, including viral nucleotide metabolism.
GO:0019080	GO	BP	viral gene expression	AAAS,EIF2AK4,FAU,FURIN,NDC1,NMT2,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,POM121,POM121C,RAE1,RANBP2,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEH1L,TPR,TSG101,UBA52,UBB,UBC,USF1,USF2,VPS28,VPS37A,VPS37B,VPS37C,VPS37D	A process by which a viral gene is converted into a mature gene product or products (proteins or RNA). This includes viral transcription, processing to produce a mature RNA product, and viral translation.
GO:0019082	GO	BP	viral protein processing	FURIN,NMT2,RPS27A,TSG101,UBA52,UBB,UBC,VPS28,VPS37A,VPS37B,VPS37C,VPS37D	Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.
GO:0019083	GO	BP	viral transcription	AAAS,FAU,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,POM121,POM121C,RAE1,RANBP2,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEH1L,TPR,UBA52,USF1,USF2	The process by which a viral genome, or part of a viral genome, is transcribed within the host cell.
GO:0019104	GO	MF	DNA N-glycosylase activity	APEX1,CCNO,MBD4,NEIL3,NTHL1,OGG1,PCNA,SMUG1,TDG,UNG	Catalysis of the removal of damaged bases by cleaving the N-C1' glycosidic bond between the target damaged DNA base and the deoxyribose sugar. The reaction releases a free base and leaves an apurinic/apyrimidinic (AP) site.
GO:0019184	GO	BP	nonribosomal peptide biosynthetic process	BDH2,CHAC1,CHAC2,CNDP2,GCLC,GCLM,GGCT,GGT1,GGT2,GSS,HAGH,MGST2,OPLAH	The biosynthetic process in which peptide bond formation occurs in the absence of the translational machinery. Examples include the synthesis of antibiotic peptides, and glutathione.
GO:0019199	GO	MF	transmembrane receptor protein kinase activity	ACVR1,ACVR1B,ACVR1C,ACVR2A,ACVR2B,ACVRL1,ALK,BMPR1A,BMPR1B,BMPR2,CRIM1,CSF1R,DDR1,DDR2,EFEMP1,EFNA3,EFNA4,EFNB3,EGFR,ENG,EPHA1,EPHA10,EPHA2,EPHA3,EPHA4,EPHA5,EPHA7,EPHA8,EPHB1,EPHB2,EPHB3,EPHB4,ERBB2,ERBB4,FGFR1,FGFR2,FGFR3,FGFR4,FGFRL1,FLT1,FLT3,FLT4,HFE2,IGF1R,IGF2R,INSR,INSRR,KDR,KIT,LTBP1,LTBP4,MST1R,NRP1,NRP2,NTRK1,NTRK2,PDGFRA,PDGFRB,PDGFRL,ROR1,RYK,TGFBR1,TGFBR2,TGFBR3,TRIM27,TYRO3	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: a protein + ATP = a phosphoprotein + ADP.
GO:0019200	GO	MF	carbohydrate kinase activity	GALK1,GALK2,GCK,GNE,HK1,HK2,HK3,KHK,NAGK,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,XYLB	Catalysis of the transfer of a phosphate group, usually from ATP, to a carbohydrate substrate molecule.
GO:0019201	GO	MF	nucleotide kinase activity	AK4,AK6,AK7,AK8,CARD11,CASK,CMPK2,DLG1,DLG2,DTYMK,GUK1,MAGI3,MPP1,MPP2,MPP3,PNKP,TJP2	Catalysis of the reaction: ATP + nucleoside monophosphate = ADP + nucleoside diphosphate.
GO:0019203	GO	MF	carbohydrate phosphatase activity	EPM2A,FBP1,G6PC,G6PC3,PFKFB1,TIGAR	Catalysis of the reaction: carbohydrate phosphate + H2O = carbohydrate + phosphate.
GO:0019205	GO	MF	nucleobase-containing compound kinase activity	AK1,AK3,AK4,AK5,AK6,AK7,AK8,AK9,CARD11,CASK,CLP1,CMPK1,CMPK2,DCK,DGUOK,DLG1,DLG2,DTYMK,GUK1,MAGI3,MPP1,MPP2,MPP3,N4BP2,NME1,NME2,NME6,NOL9,NT5C2,PNKP,TJP2	Catalysis of the transfer of a phosphate group, usually from ATP or GTP, to a nucleobase, nucleoside, nucleotide or polynucleotide substrate.
GO:0019207	GO	MF	kinase regulator activity	AFAP1L2,AHSG,ALS2,ANGPT4,APC,BCCIP,BCL10,CAB39,CALM1,CCKBR,CCL5,CCNY,CD24,CDK4,CDK5R1,CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CIB1,CSNK2B,CXCL10,DAXX,DBF4B,DNAJC3,DUS2,DUSP19,EFNA5,EGF,ELP3,ELP4,ERBB3,ERCC6,FAF1,FAM20A,FGF13,FGFR1OP,GAS6,GHRL,GMFB,GMFG,GNB2L1,GPRC5B,GREM1,GSTP1,H2AFY,HEXIM1,HEXIM2,HSPB1,HYAL2,IBTK,IGF2,IKBKAP,IL2,INCA1,IQGAP1,KAT2B,LRP6,LTF,MADD,MALT1,MAP2K1,MAP2K2,MAPK8IP1,MAPK8IP2,MARK2,MBIP,MOB1B,MT3,NCK1,NCKAP1L,NKX3-1,NPM1,NRG1,NRG3,PAK2,PARP16,PIK3R1,PIK3R6,PKIA,PPP1R1B,PRKAG1,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKRIP1,RGCC,RHOH,SFN,SH3BP5,SOCS1,SOCS3,SPRED1,SPRED2,SPRY2,STK11,STK3,STK4,STRADA,TAOK3,TRIB1,WNT11,YWHAG	Modulates the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
GO:0019208	GO	MF	phosphatase regulator activity	ANKLE2,ANP32E,ARPP19,B3GAT3,BMP2,CABIN1,CALM1,DMPK,EIF2AK2,ENSA,FRS2,GTF2F1,IGBP1,IGFBP3,LMTK2,PHACTR4,PPME1,PPP1R12A,PPP1R15A,PPP1R16B,PPP1R1A,PPP1R1B,PPP1R1C,PPP1R2,PPP1R7,PPP1R8,PPP1R9B,PPP2R1A,PPP2R2A,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5C,PPP4R1,PPP4R2,PPP4R4,PTN,SAG,SET,SHOC2,TESC,ZEB2	Modulates the activity of a phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a substrate molecule.
GO:0019209	GO	MF	kinase activator activity	AFAP1L2,ALS2,ANGPT4,BCL10,CAB39,CALM1,CCL5,CD24,CDK5R1,CDKN1A,DAXX,DBF4B,DUSP19,EFNA5,EGF,ERBB3,ERCC6,FAM20A,FGF13,GAS6,GHRL,GPRC5B,GREM1,IGF2,IL2,IQGAP1,LTF,MADD,MALT1,MAP2K1,MAP2K2,MAPK8IP2,MARK2,MOB1B,MT3,NCKAP1L,NKX3-1,NRG1,NRG3,PAK2,PARP16,PRKAG2,RGCC,SPRY2,STK11,STK3,STK4,STRADA,WNT11	Binds to and increases the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
GO:0019210	GO	MF	kinase inhibitor activity	AHSG,CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CIB1,DNAJC3,DUS2,DUSP19,FGFR1OP,GMFB,GMFG,GNB2L1,H2AFY,HEXIM1,HEXIM2,HSPB1,HYAL2,IBTK,INCA1,KAT2B,LRP6,MAPK8IP1,MBIP,NCK1,NPM1,PKIA,PPP1R1B,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKRIP1,RHOH,SFN,SH3BP5,SOCS1,SOCS3,SPRED1,SPRED2,SPRY2,TAOK3,TRIB1,YWHAG	Stops, prevents or reduces the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
GO:0019211	GO	MF	phosphatase activator activity	B3GAT3,BMP2,CALM1,FRS2,GTF2F1,IGFBP3,PHACTR4,PPP1R15A,PPP2R4	Increases the activity of a phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a substrate molecule.
GO:0019212	GO	MF	phosphatase inhibitor activity	ANP32E,ARPP19,CABIN1,ENSA,LMTK2,PPME1,PPP1R1A,PPP1R1B,PPP1R1C,PPP1R2,PPP1R8,PPP1R9B,PTN,SAG,SET,TESC	Stops, prevents or reduces the activity of a phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a substrate molecule.
GO:0019213	GO	MF	deacetylase activity	AADAC,AMDHD2,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC8,HDAC9,MACROD1,MACROD2,NACC2,OARD1,PIGL,SALL1,SIN3A,SIRT1,SIRT2,SIRT6,SIRT7,SUDS3	Catalysis of the hydrolysis of an acetyl group or groups from a substrate molecule.
GO:0019215	GO	MF	intermediate filament binding	FAM83H,MTM1,NES,PKP1,PKP2,SYNM	Interacting selectively and non-covalently with an intermediate filament, a distinct elongated structure, characteristically 10 nm in diameter, that occurs in the cytoplasm of higher eukaryotic cells. Intermediate filaments form a fibrous system, composed of chemically heterogeneous subunits and involved in mechanically integrating the various components of the cytoplasmic space.
GO:0019216	GO	BP	regulation of lipid metabolic process	AADAC,ABCD2,ABCG1,ABHD5,ACADL,ACADVL,ACSL3,ADIPOQ,ADIPOR1,ADRA2A,ADRB2,AGT,AGTR1,AKR1C3,AKT1,AKT2,AMBRA1,ANGPTL3,APOA1,APOA2,APOA4,APOA5,APOC1,APOC2,APOC3,APOD,APOE,ATG14,BBS4,BMP2,BMP5,BMP6,BRCA1,BSCL2,C19orf80,C3,CAV1,CCKBR,CCL19,CCL21,CCR7,CD81,CIDEA,CNEP1R1,CREB1,CREBL2,CTDNEP1,CYP27B1,CYP7A1,DAB2IP,DKK3,DLAT,DLD,EDF1,EEF1A2,EPHA8,EPHX2,ERBB4,ERLIN1,ERLIN2,FABP3,FBXW7,FGF1,FGF19,FGF2,FGFR3,FGFR4,FGR,FITM2,FLT1,FLT3,GFI1,GNB2L1,GPER1,GPLD1,H2AFY,HCAR2,HNF4A,HSD17B13,HTR2A,HTR2B,HTR2C,ID2,IFNG,IL1B,INS,IRS1,IRS2,KIT,LAMTOR1,LDLR,LDLRAP1,LONP2,METTL20,MID1IP1,MLXIPL,MLYCD,MTOR,NFKB1,NOD2,NPC2,NR1D1,NR1D2,NR1H2,NR1H3,NR1H4,NR4A3,NR5A1,NSMAF,PANK2,PDE3B,PDGFA,PDGFB,PDGFRA,PDGFRB,PDHA1,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR,PIBF1,PIK3IP1,PIK3R1,PIK3R4,PIK3R6,PLIN5,PLPP1,PNPLA2,PPARA,PPARGC1A,PPP2R5A,PRKAA1,PRKAA2,PRKAB2,PRKAG2,PRKCD,PROX1,PTGS2,PTK2,PTK2B,RARRES2,RB1,RBL1,RBL2,REST,RORA,RORC,RUBCN,SAMD8,SCAP,SCARB1,SCP2,SEC14L2,SERPINA3,SIK1,SIRT1,SIRT4,SLC27A1,SMPD2,SMPD3,SNAI1,SNAI2,SOD1,SORBS1,SPTLC1,SPTLC2,SREBF1,STK11,STOML2,STUB1,TEK,TGFB1,THRSP,TM6SF2,TNF,TNFAIP8L3,TNFRSF1A,TRIB3,TWIST1,TYSND1,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VDR,WNT4,XBP1,ZP3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving lipids.
GO:0019217	GO	BP	regulation of fatty acid metabolic process	ABCD2,ACADL,ACADVL,ADIPOQ,AKT1,AKT2,APOA4,APOA5,APOC1,APOC2,APOC3,BRCA1,CAV1,DLAT,DLD,ERLIN1,ERLIN2,FABP3,INS,IRS1,IRS2,LONP2,METTL20,MID1IP1,MLXIPL,MLYCD,NR1H2,NR1H3,NR4A3,PANK2,PDHA1,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR,PIBF1,PLIN5,PPARA,PPARGC1A,PRKAA2,PRKAB2,PRKAG2,PTGS2,SIRT1,SIRT4,STK11,TRIB3,TWIST1,TYSND1,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
GO:0019218	GO	BP	regulation of steroid metabolic process	ABCG1,ACADL,ACADVL,AGT,AGTR1,AKR1C3,APOA1,APOA2,APOA4,APOC1,APOE,BMP2,BMP5,BMP6,CYP27B1,CYP7A1,DKK3,EPHX2,ERLIN1,ERLIN2,FGF1,FGF19,FGFR4,GFI1,IFNG,IL1B,LAMTOR1,LDLRAP1,NFKB1,NR1D1,NR1H4,NR5A1,PANK2,PRKAA1,PROX1,REST,RORA,RORC,SCAP,SCP2,SEC14L2,SIRT1,SNAI1,SNAI2,SOD1,STUB1,TNF,UGT1A1,UGT1A8,VDR,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving steroids.
GO:0019226	GO	BP	transmission of nerve impulse	ANK3,CHRNA1,CNTNAP1,CNTNAP2,DRD1,GPER1,KCNA1,KCNA2,KCNMB2,KCNMB3,KCNMB4,MYH14,PAFAH1B1,SCN1B,SOD1,SPTBN4	The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission.
GO:0019228	GO	BP	neuronal action potential	ANK3,CHRNA1,GPER1,KCNA1,KCNA2,KCNMB2,KCNMB3,KCNMB4,MYH14	An action potential that occurs in a neuron.
GO:0019229	GO	BP	regulation of vasoconstriction	ACE,ACE2,ADM,ADRA1A,AGT,AGTR1,BDKRB2,BMPR2,CAV1,DOCK4,DOCK5,ECE1,F2R,FGA,FGB,FGG,KCNMB2,KCNMB4,PER2,SMTNL1	Any process that modulates the frequency, rate or extent of reductions in the diameter of blood vessels.
GO:0019233	GO	BP	sensory perception of pain	ALOXE3,ANO1,CHRNA4,CHRNB2,EPHB1,FAM134B,KCNA1,KCNA2,KCNK4,MME,MMP24,MRGPRX2,OPRK1,OPRL1,OPRM1,P2RX4,P2RX7,PROK2,TRPA1	The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process.
GO:0019239	GO	MF	deaminase activity	ADA,ADAR,ADARB1,ADAT1,AICDA,AMPD2,APOBEC1,APOBEC2,APOBEC3A,APOBEC3B,APOBEC3F,APOBEC3G,APOBEC3H,CDA,CECR1,FTCD,GNPDA1	Catalysis of the removal of an amino group from a substrate, producing ammonia (NH3).
GO:0019240	GO	BP	citrulline biosynthetic process	ALDH18A1,CPS1,OTC,PADI2,PADI4	The chemical reactions and pathways resulting in the formation of citrulline, N5-carbamoyl-L-ornithine, an alpha amino acid not found in proteins.
GO:0019318	GO	BP	hexose metabolic process	ADIPOQ,ADPGK,AGL,AKR1A1,AKR1B1,ALDH5A1,ALDOA,ALDOB,ALDOC,APOD,ATF4,BRAT1,BRS3,CALM1,CHST1,CHST15,CRTC2,CRY1,DCXR,ENO1,ENO2,ENO3,EPM2A,FBP1,FBP2,FPGT,FUCA1,FUCA2,FUOM,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,G6PC,GAA,GALE,GALK1,GALM,GALT,GAPDH,GAPDHS,GBE1,GCK,GDPGP1,GHRL,GOT1,GOT2,GPI,GYG1,GYG2,GYS1,GYS2,HECTD4,HK1,HK2,HK3,IRS2,KCNJ11,KHK,LRP5,MDH1,MDH2,NHLRC1,OAS1,OMA1,PC,PCK1,PCK2,PER2,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PKLR,PKM,PMM1,PPARD,PPARGC1A,PPP1R3C,PPP2R5D,PRKACA,PRKACB,PRKACG,PYGB,PYGL,PYGM,RBP4,RPS27A,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC35A2,SLC37A4,SORD,TFAP2B,TKFC,TKTL1,TPI1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways involving a hexose, any monosaccharide with a chain of six carbon atoms in the molecule.
GO:0019319	GO	BP	hexose biosynthetic process	AKR1B1,ALDOA,ALDOB,ALDOC,ATF4,CHST15,CRTC2,CRY1,ENO1,ENO2,ENO3,FBP1,FBP2,G6PC,GAPDH,GAPDHS,GOT1,GOT2,GPI,MDH1,MDH2,PC,PCK1,PCK2,PER2,PFKFB1,PGAM1,PGAM2,PGK1,PGM1,PPARGC1A,PRKACA,PRKACB,PRKACG,RBP4,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SORD,TPI1	The chemical reactions and pathways resulting in the formation of hexose, any monosaccharide with a chain of six carbon atoms in the molecule.
GO:0019320	GO	BP	hexose catabolic process	ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,GALE,GALK1,GALT,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,KHK,LRP5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PGM1,PGM2,PKLR,PKM,PPP2R5D,TKFC,TKTL1,TPI1	The chemical reactions and pathways resulting in the breakdown of hexose, any monosaccharide with a chain of six carbon atoms in the molecule.
GO:0019321	GO	BP	pentose metabolic process	DCXR,G6PD,NUDT5,TALDO1,TKT,XYLB	The chemical reactions and pathways involving a pentose, any monosaccharide with a chain of five carbon atoms in the molecule.
GO:0019359	GO	BP	nicotinamide nucleotide biosynthetic process	ME1,NMNAT1,NMNAT2,NMNAT3,PNP	The chemical reactions and pathways resulting in the formation of nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.
GO:0019367	GO	BP	fatty acid elongation, saturated fatty acid	ELOVL1,ELOVL3,ELOVL4,ELOVL6,ELOVL7	Elongation of a saturated fatty acid chain.
GO:0019368	GO	BP	fatty acid elongation, unsaturated fatty acid	ELOVL1,ELOVL2,ELOVL3,ELOVL5,ELOVL7	Elongation of a fatty acid chain into which one or more C-C double bonds have been introduced.
GO:0019369	GO	BP	arachidonic acid metabolic process	ABCC1,AKR1C3,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AWAT1,CBR1,CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2J2,CYP2U1,CYP4A11,CYP4F12,CYP4F2,CYP4F3,DAGLA,DAGLB,DPEP1,EPHX2,FAAH,FAAH2,FAM213B,GGT1,GGT5,GPX1,GPX4,HPGD,HPGDS,LTA4H,LTC4S,MAPKAPK2,MGLL,PLA2G10,PLA2G4A,PLA2G4B,PLA2G4C,PNPLA8,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,TBXAS1	The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
GO:0019370	GO	BP	leukotriene biosynthetic process	ALOX5,ALOX5AP,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,LTA4H,MGST2,PLA2G1B,PRG3	The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
GO:0019371	GO	BP	cyclooxygenase pathway	AKR1C3,CBR1,FAM213B,HPGD,HPGDS,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,TBXAS1	The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2.
GO:0019372	GO	BP	lipoxygenase pathway	ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,GPX1,GPX4,HPGD,LTC4S,PTGS2	The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase.
GO:0019373	GO	BP	epoxygenase P450 pathway	CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2J2,CYP4A11,CYP4F12,CYP4F2,EPHX2	The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids.
GO:0019377	GO	BP	glycolipid catabolic process	GALC,GBA,GBA3,GLA,NAGA,NEU2,NEU3,NEU4,PNLIPRP2	The chemical reactions and pathways resulting in the breakdown of glycolipid, a class of 1,2-di-O-acylglycerols joined at oxygen 3 by a glycosidic linkage to a carbohydrate part (usually a mono-, di- or tri-saccharide).
GO:0019388	GO	BP	galactose catabolic process	GALE,GALK1,GALT,PGM1,PGM2	The chemical reactions and pathways resulting in the breakdown of galactose, the aldohexose galacto-hexose.
GO:0019395	GO	BP	fatty acid oxidation	ABCD1,ABCD2,ABCD3,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOT8,ACOX1,ACOX2,ACOX3,ACSM1,ADH7,ADIPOQ,ADIPOR1,ADIPOR2,ALOX12,AMACR,BDH2,CRAT,CROT,CYP4V2,DECR1,ECHS1,ECI1,EHHADH,ETFA,ETFB,ETFDH,GCDH,HACL1,HADH,HADHA,HADHB,HAO1,HAO2,HSD17B4,MCEE,MMAA,MUT,PCCA,PCCB,PEX13,PEX2,PHYH,PPARD,PPARGC1A,SCP2,SLC25A17,SLC27A2	The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.
GO:0019400	GO	BP	alditol metabolic process	ANGPTL3,COQ2,COQ3,GK,GOT1,PCK1,PGP,SORD	The chemical reactions and pathways involving alditols, any polyhydric alcohol derived from the acyclic form of a monosaccharide by reduction of its aldehyde or keto group to an alcoholic group.
GO:0019430	GO	BP	removal of superoxide radicals	APOA4,ATP7A,MT3,NOS3,PRDX2,SOD1,SOD2,SOD3	Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2).
GO:0019432	GO	BP	triglyceride biosynthetic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AGK,AGMO,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,DGAT1,DGAT2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FASN,GK,GPAM,GPAT2,GPAT3,GPAT4,GPD1,GPD1L,HACD1,HACD2,HSD17B12,LCLAT1,LPCAT1,LPCAT4,LPIN1,LPIN2,OLAH,PCK1,PNPLA3,PPT1,PPT2,SCD,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways resulting in the formation of a triglyceride, any triester of glycerol.
GO:0019433	GO	BP	triglyceride catabolic process	ABHD5,APOA5,APOC3,CPS1,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,LIPC,LIPE,LPL,MGLL,PLIN1,PNPLA3,PPP1CA,PPP1CB,PPP1CC,PRKACA,PRKACB,PRKACG	The chemical reactions and pathways resulting in the breakdown of a triglyceride, any triester of glycerol.
GO:0019471	GO	BP	4-hydroxyproline metabolic process	ALDH4A1,EGLN1,EGLN2,EGLN3,GOT2,HOGA1,P4HB,PRODH	The chemical reactions and pathways involving 4-hydroxyproline, C5H9NO3, a derivative of the amino acid proline. The presence of hydroxyproline is essential to produce stable triple helical tropocollagen, hence the problems caused by ascorbate deficiency in scurvy. This unusual amino acid is also present in considerable amounts in the major glycoprotein of primary plant cell walls.
GO:0019509	GO	BP	L-methionine biosynthetic process from methylthioadenosine	ADI1,APIP,ENOPH1,GOT1,MRI1,MTAP	The generation of L-methionine (2-amino-4-(methylthio)butanoic acid) from methylthioadenosine.
GO:0019511	GO	BP	peptidyl-proline hydroxylation	EGLN1,EGLN2,EGLN3,OGFOD1,P3H1,P3H2,P4HB	The hydroxylation of peptidyl-proline to form peptidyl-hydroxyproline.
GO:0019530	GO	BP	taurine metabolic process	BAAT,CDO1,GHR,STAT5A,STAT5B	The chemical reactions and pathways involving taurine (2-aminoethanesulfonic acid), a sulphur-containing amino acid derivative important in the metabolism of fats.
GO:0019534	GO	MF	toxin transporter activity	ABCG1,LRP6,MFSD10,SLC17A3,SLC7A8	Enables the directed movement of a toxin into, out of or within a cell, or between cells. A toxin is a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism.
GO:0019585	GO	BP	glucuronate metabolic process	ABHD10,AKR1A1,CRYL1,DCXR,SLC35D1,SORD,UGDH,UGP2,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7,XYLB	The chemical reactions and pathways involving glucuronate, any salt or ester of glucuronic acid, the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group.
GO:0019626	GO	BP	short-chain fatty acid catabolic process	MCEE,MMAA,MUT,PCCA,PCCB	The chemical reactions and pathways resulting in the breakdown of fatty acids with a chain length of less than C6.
GO:0019627	GO	BP	urea metabolic process	ARG1,ARG2,ASL,ASS1,CPS1,CYP2C9,NAGS,OTC,SLC25A15,SLC25A2	The chemical reactions and pathways involving urea, the water soluble compound O=C-(NH2)2.
GO:0019640	GO	BP	glucuronate catabolic process to xylulose 5-phosphate	AKR1A1,CRYL1,DCXR,SORD,XYLB	The chemical reactions and pathways resulting in the breakdown of glucuronate into other compounds, including xylulose 5-phosphate.
GO:0019673	GO	BP	GDP-mannose metabolic process	GMDS,GMPPA,GMPPB,MPI,PMM1,PMM2,TSTA3	The chemical reactions and pathways involving GDP-mannose, a substance composed of mannose in glycosidic linkage with guanosine diphosphate.
GO:0019674	GO	BP	NAD metabolic process	ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPD1L,GPI,HK1,HK2,HK3,NADK,NADK2,NADSYN1,NAMPT,NAPRT,NMNAT1,NMNAT2,NMNAT3,NUDT12,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PKLR,PKM,PNP,PPP2R5D,PTGIS,PTGS2,QPRT,TPI1,VCP	The chemical reactions and pathways involving nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
GO:0019682	GO	BP	glyceraldehyde-3-phosphate metabolic process	ALDOB,DERA,G6PD,KHK,PGD,PGLS,PGM2,RPE,RPIA,SHPK,TALDO1,TKFC,TKT	The chemical reactions and pathways involving glyceraldehyde-3-phosphate, an important intermediate in glycolysis.
GO:0019722	GO	BP	calcium-mediated signaling	ADGRL1,AGTR1,ANK2,ASPH,ATP1A2,ATP1B1,ATP2A2,AZU1,BCAP31,BTK,CACNA1C,CALM1,CAMK2D,CAMKK2,CASQ1,CASQ2,CCL3,CCR5,CLIC2,CXCL8,CXCR4,DMD,DMTN,EDN1,EDN2,EGFR,EIF2AK3,FIS1,FKBP1B,GPR143,GSTM2,GSTO1,HRC,HTR2B,KDR,LACRT,LAT,LAT2,LRRK2,MCTP1,MCTP2,MCU,NFATC1,NMUR1,NMUR2,NUDT4,P2RY11,PDPK1,PLA2G4B,PLCE1,PLCG1,PLCG2,PPP3CA,PPP3CB,PPP3R1,PRKACA,PTGDR2,PTGFR,RYR2,SELE,SELP,SLC8A1,SLC9A1,SPHK1,TENM2,TPCN2,TREML1,VCAM1	Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
GO:0019724	GO	BP	B cell mediated immunity	BATF,C1QA,C1QB,C1QC,C1R,C1S,CD27,CD40LG,CD74,EXOSC3,EXOSC6,HLA-DQB1,HLA-DRB1,HSPD1,LIG4,MSH2,MSH6,RNF168,RNF8,SLA2,TLR8,ZP3	Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells.
GO:0019730	GO	BP	antimicrobial humoral response	ADM,ANG,APP,AZU1,B2M,BPIFA1,CALCA,CAMP,CST9,DEFA1,DEFA3,DEFA4,DEFA5,DEFA6,DEFB1,DMBT1,FAU,FGA,FGB,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,HLA-A,HLA-E,IL36RN,JCHAIN,KLK3,LTF,NPY,PLA2G1B,PLA2G6,RNASE3,RNASE7,RPL39,SEMG1,SEMG2,SLPI,TAC1,VIP	An immune response against microbes mediated through a body fluid. Examples of this process are seen in the antimicrobial humoral response of Drosophila melanogaster and Mus musculus.
GO:0019731	GO	BP	antibacterial humoral response	ADM,ANG,APP,B2M,BPIFA1,CALCA,CAMP,DEFA1,DEFA3,DEFA4,DEFA5,DEFA6,DEFB1,DMBT1,FAU,FGA,FGB,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,HLA-A,HLA-E,JCHAIN,KLK3,LTF,NPY,PLA2G1B,PLA2G6,RNASE3,RNASE7,RPL39,SEMG1,SEMG2,SLPI,TAC1,VIP	An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
GO:0019732	GO	BP	antifungal humoral response	ANG,APP,CALCA,CAMP,IL36RN,LTF,NPY,TAC1,VIP	An immune response against a fungus mediated through a body fluid. An example of this process is the antifungal humoral response in Drosophila melanogaster.
GO:0019748	GO	BP	secondary metabolic process	AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,ARL1,AS3MT,BDH2,CBR4,CITED1,CYP1A2,CYP2A6,CYP2D6,CYP2W1,DCT,EPHX2,FMO1,FMO2,TRPC1,TYR,UGT1A7,UGT1A8	The chemical reactions and pathways resulting in many of the chemical changes of compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon. In multicellular organisms secondary metabolism is generally carried out in specific cell types, and may be useful for the organism as a whole. In unicellular organisms, secondary metabolism is often used for the production of antibiotics or for the utilization and acquisition of unusual nutrients.
GO:0019751	GO	BP	polyol metabolic process	ACER1,ACER2,ACER3,ANGPTL3,CALM1,COQ2,COQ3,CYP27B1,CYP3A4,FGF2,GBA,GK,GOT1,IMPA1,IMPA2,INPP1,INPP4A,INPP4B,INPP5A,INPP5B,INPP5D,INPP5J,INPP5K,INPPL1,IP6K1,IP6K2,IP6K3,IPMK,IPPK,ISYNA1,ITPK1,ITPKA,ITPKB,ITPKC,MINPP1,MIOX,NUDT10,NUDT11,NUDT3,NUDT4,OCRL,PCK1,PGP,PLCB1,PLCB2,PLCB3,PLCB4,PLCD1,PLCD3,PLCE1,PLCG1,PLCG2,PLCH1,PLCH2,PLCZ1,PLD4,PPIP5K1,PPIP5K2,PTEN,SCP2,SGPP2,SORD,SPHK1,SPHK2,SYNJ1	The chemical reactions and pathways involving a polyol, any alcohol containing three or more hydroxyl groups attached to saturated carbon atoms.
GO:0019755	GO	BP	one-carbon compound transport	AQP1,AQP5,RHAG,SLC14A1,SLC14A2	The directed movement of one-carbon compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0019783	GO	MF	ubiquitin-like protein-specific protease activity	ATXN3,ATXN3L,BAP1,BRCC3,COPS5,CYLD,EIF3F,JOSD2,MYSM1,OTUB1,OTUB2,OTUD1,OTUD3,OTUD4,OTUD5,OTUD6A,OTUD7A,OTUD7B,OTULIN,SENP1,SENP2,SENP6,STAMBP,TNFAIP3,TNIP1,UCHL5,UFD1L,UFSP2,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP17L2,USP18,USP19,USP2,USP21,USP22,USP25,USP28,USP3,USP30,USP31,USP33,USP34,USP35,USP36,USP37,USP38,USP4,USP42,USP44,USP45,USP46,USP47,USP49,USP5,USP51,USP6,USP7,USP8,USP9X,USP9Y,USPL1,VCPIP1,YOD1,ZRANB1	Catalysis of the hydrolysis of peptide or isopeptide bonds within small proteins such as ubiquitin or ubiquitin-like proteins (e.g. APG8, ISG15, NEDD8, SUMO), or between the small protein and a larger protein to which it has been conjugated.
GO:0019789	GO	MF	SUMO transferase activity	MUL1,NSMCE2,PIAS1,PIAS2,PIAS4,TOPORS,UBE2I	Catalysis of the transfer of SUMO from one protein to another via the reaction X-SUMO + Y --> Y-SUMO + X, where both X-SUMO and Y-SUMO are covalent linkages.
GO:0019825	GO	MF	oxygen binding	ALB,CBS,CYP17A1,CYP19A1,CYP1A1,CYP1B1,CYP26A1,CYP2A7,CYP2C18,CYP2C19,CYP2E1,CYP3A4,CYP3A5,CYP3A7,CYP4B1,CYP8B1,EGLN2,HBB,HIF1AN,NOX4	Interacting selectively and non-covalently with oxygen (O2).
GO:0019827	GO	BP	stem cell population maintenance	CDC73,CDH2,CTNNB1,CTR9,DIS3L2,DLL1,DPPA4,EPAS1,EPHA1,FGF2,FOXD3,FZD7,KIT,KLF4,LEO1,LIG4,LIN28A,METTL14,METTL3,MMP24,MTF2,NANOG,NANOS2,NOG,NOTCH2,PADI4,PBX1,PIWIL2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU5F1,PRDM14,PROX1,RTF1,SALL1,SALL4,SETD6,SIX2,SKI,SMAD2,SMAD4,SOX2,SOX9,SRRT,STAT3,TDGF1,TET1,ZCCHC11,ZFP36L2,ZIC3,ZNF358,ZSCAN10	The process by which an organism or tissue maintains a population of stem cells of a single type.  This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.
GO:0019829	GO	MF	cation-transporting ATPase activity	ABCB11,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + cation(out) = ADP + phosphate + cation(in).
GO:0019835	GO	BP	cytolysis	ALB,APOL1,BAK1,C9,PRF1	The rupture of cell membranes and the loss of cytoplasm.
GO:0019838	GO	MF	growth factor binding	A2M,ACVR1,CD36,COL1A1,COL1A2,COL2A1,COL3A1,COL4A1,COL5A1,COL6A1,CXCL13,ERBB2,ERBB3,FGFR1,FGFR2,FGFR3,FGFR4,FURIN,GPC1,HAP1,HAX1,HYAL2,IGF1R,IGFALS,IGFBP1,IGFBP2,IGFBP3,IL1RN,IL2RB,IL2RG,ITGAV,LTBP4,NRD1,NRP1,NRP2,NTRK1,NTRK2,NTRK3,PCSK6,PDGFRA,PDGFRB,PXDN,SRPX2,TGFB3,TGFBR1,TGFBR2,TGFBR3,THBS1	Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
GO:0019842	GO	MF	vitamin binding	ADH4,ADH7,AFM,ALDH1A2,CD320,DHFR,FOLR1,FOLR2,GC,GIF,HACL1,HLCS,MCCC1,MTHFS,OPN4,PCCA,PYGL,RBP4,SEC14L2,TCN2,TTPA,TYMS,VDR	Interacting selectively and non-covalently with a vitamin, one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0019843	GO	MF	rRNA binding	ANG,CIRBP,DDX21,DDX28,ERAL1,ERI1,FASTKD2,FASTKD5,MRPL18,MTERF4,PTCD3,PTRF,RPS3,SBDS,TST	Interacting selectively and non-covalently with ribosomal RNA.
GO:0019852	GO	BP	L-ascorbic acid metabolic process	CYB5A,CYB5R3,GSTO1,GSTO2,SLC23A1,SLC23A2,SLC2A1,SLC2A3	The chemical reactions and pathways involving L-ascorbic acid, (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate; L-ascorbic acid is vitamin C and has co-factor and anti-oxidant activities in many species.
GO:0019855	GO	MF	calcium channel inhibitor activity	AMBP,CCDC109B,FKBP1B,ITPR1,PACSIN3,PHPT1,SLC30A1	Stops, prevents, or reduces the activity of a calcium channel.
GO:0019865	GO	MF	immunoglobulin binding	AMBP,FCGRT,HRG,JCHAIN,LGALS3,PIP,UMOD,VWF	Interacting selectively and non-covalently with an immunoglobulin.
GO:0019867	GO	CC	outer membrane	ABCB6,ACACB,ACSL1,AGK,AGPAT5,AIFM2,AMBRA1,ANKH,ATF2,ATP5G2,ATP5G3,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BMF,BNIP3,BNIP3L,BPHL,CASP8,CISD2,COASY,CPT1A,CPT1B,CYB5A,CYB5R3,CYP27B1,DAO,DHCR7,DMPK,DNM1L,EMD,FAM73A,FAM73B,FIS1,FUNDC1,GDAP1,GHRHR,GPAM,GPAT2,GUCY2D,GUCY2F,HADHB,HAX1,HK2,IFI27,ITPR3,KMO,LRRK2,MAOA,MAOB,MARCH5,MAVS,MCL1,MFF,MFN1,MFN2,MGARP,MIEF1,MIEF2,MOAP1,MSTO1,MTERF3,MUL1,MYOC,NLRX1,OPA1,PHB2,PINK1,PLD6,PMAIP1,PPP2R2B,PRNP,PSEN1,QTRT1,QTRTD1,RAB11FIP5,RAF1,RETSAT,RHOT1,RHOT2,RMDN3,RSAD2,SAMM50,SLC24A1,SLC25A46,SLC8A3,SPATA18,SPG20,SYNE4,TIGAR,TMEM173,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,USP30,VDAC1	The external membrane of Gram-negative bacteria or certain organelles such as mitochondria and chloroplasts; freely permeable to most ions and metabolites.
GO:0019869	GO	MF	chloride channel inhibitor activity	CFTR,STX1A,STX7,STX8,VAMP8,VTI1B,WNK1,WNK3,WNK4	Stops, prevents, or reduces the activity of a chloride channel.
GO:0019870	GO	MF	potassium channel inhibitor activity	CAV1,CAV3,ENSA,KCNK2,NEDD4L,RASA1	Stops, prevents, or reduces the activity of a potassium channel.
GO:0019871	GO	MF	sodium channel inhibitor activity	CAMK2D,NEDD4,NEDD4L,PCSK9,SCN1B	Stops, prevents, or reduces the activity of a sodium channel.
GO:0019882	GO	BP	antigen processing and presentation	ACE,ACTR1A,ACTR1B,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARF1,B2M,BCAP31,BLMH,CALR,CANX,CD1D,CD207,CD209,CD36,CD74,CD8A,CENPE,CLEC4M,CLTA,CLTC,CTSD,CTSE,CTSF,CTSH,CTSL,CTSS,CTSV,CYBA,CYBB,DCTN1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DNM2,DYNC1H1,DYNC1I1,DYNC1I2,DYNC1LI2,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,ERAP1,ERAP2,FCGR1A,FCGR1B,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,IFI30,ITGAV,ITGB5,KIF11,KIF15,KIF18A,KIF22,KIF23,KIF26A,KIF2A,KIF2B,KIF2C,KIF3A,KIF3B,KIF3C,KIF4A,KIF4B,KIF5A,KIFAP3,KLC1,KLC2,LGMN,LNPEP,MARCH1,NCF1,NCF2,NCF4,NPEPPS,OSBPL1A,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAB10,RAB27A,RAB32,RAB33A,RAB34,RAB35,RAB3B,RAB3C,RAB4A,RAB5B,RAB6A,RAB7A,RAB8B,RACGAP1,RFTN1,RILP,RPS27A,SAR1B,SEC13,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SH3GL2,SLC11A1,SPTBN2,TAP1,TAP2,TAPBP,TPP2,UBA52,UBB,UBC,UBE2A	The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
GO:0019883	GO	BP	antigen processing and presentation of endogenous antigen	B2M,CD1D,CD74,ERAP1,ERAP2,HLA-A,HLA-B,HLA-C,HLA-E,TAP1,TAP2	The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of endogenous origin on its cell surface in association with an MHC protein complex.
GO:0019885	GO	BP	antigen processing and presentation of endogenous peptide antigen via MHC class I	B2M,ERAP1,ERAP2,HLA-A,HLA-B,HLA-C,TAP1,TAP2	The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
GO:0019886	GO	BP	antigen processing and presentation of exogenous peptide antigen via MHC class II	ACTR1A,ACTR1B,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARF1,CANX,CD74,CENPE,CLTA,CLTC,CTSD,CTSE,CTSF,CTSL,CTSS,CTSV,DCTN1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DNM2,DYNC1H1,DYNC1I1,DYNC1I2,DYNC1LI2,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IFI30,KIF11,KIF15,KIF18A,KIF22,KIF23,KIF26A,KIF2A,KIF2B,KIF2C,KIF3A,KIF3B,KIF3C,KIF4A,KIF4B,KIF5A,KIFAP3,KLC1,KLC2,LGMN,OSBPL1A,RAB7A,RACGAP1,RILP,SAR1B,SEC13,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SH3GL2,SPTBN2	The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
GO:0019887	GO	MF	protein kinase regulator activity	AFAP1L2,ALS2,ANGPT4,APC,CAB39,CALM1,CCL5,CCNY,CD24,CDK4,CDK5R1,CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CIB1,CSNK2B,CXCL10,DAXX,DBF4B,DNAJC3,DUS2,DUSP19,EFNA5,EGF,ELP3,ELP4,ERBB3,ERCC6,FAF1,FAM20A,FGF13,FGFR1OP,GAS6,GHRL,GMFB,GMFG,GNB2L1,GPRC5B,GREM1,H2AFY,HEXIM1,HEXIM2,HSPB1,HYAL2,IBTK,IGF2,IKBKAP,INCA1,IQGAP1,KAT2B,LTF,MADD,MAP2K1,MAP2K2,MAPK8IP1,MAPK8IP2,MARK2,MBIP,MT3,NCK1,NCKAP1L,NKX3-1,NPM1,NRG1,NRG3,PAK2,PARP16,PKIA,PPP1R1B,PRKAG1,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKRIP1,RGCC,SFN,SH3BP5,SOCS1,SOCS3,SPRED1,SPRED2,SPRY2,STK11,STK3,STK4,STRADA,TAOK3,TRIB1,WNT11,YWHAG	Modulates the activity of a protein kinase, an enzyme which phosphorylates a protein.
GO:0019888	GO	MF	protein phosphatase regulator activity	ANKLE2,ARPP19,B3GAT3,CABIN1,CALM1,DMPK,EIF2AK2,ENSA,IGBP1,IGFBP3,LMTK2,PHACTR4,PPME1,PPP1R15A,PPP1R16B,PPP1R1A,PPP1R1B,PPP1R1C,PPP1R2,PPP1R7,PPP1R8,PPP1R9B,PPP2R1A,PPP2R2A,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5C,PPP4R1,PPP4R2,PPP4R4,PTN,SAG,SET,SHOC2	Modulates the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule.
GO:0019894	GO	MF	kinesin binding	AP1AR,CROCC,KIF1B,KLC2,MAPK8IP2,MAPK8IP3,NEFH,PLEKHM2,SPTBN5	Interacting selectively and non-covalently and stoichiometrically with kinesin, a member of a superfamily of microtubule-based motor proteins that perform force-generating tasks such as organelle transport and chromosome segregation.
GO:0019897	GO	CC	extrinsic component of plasma membrane	AAK1,ALOX15,ANXA1,APC,APC2,ARRB1,CAV2,CDH1,CDH2,CDK16,CTNNA1,CTNNB1,CUBN,CYLD,CYTH1,CYTH3,DLG4,DNAJA3,EEA1,EPN3,ERRFI1,ESYT2,ESYT3,FARP1,FCN1,FER,FERMT2,FES,GNA14,GNA15,GNAI1,GNAS,GNAT2,GNB1,GNG2,GNG5,GNGT2,HCK,IQGAP1,JUP,KCNAB1,KCNAB2,KCNIP1,KRAS,MYZAP,NLRP10,PCSK9,PLG,RACGAP1,RGS1,RGS19,RGS8,S100A6,SCUBE1,SERPINE2,SMAD7,SNX18,SNX5,SNX9,STOML2,SYTL1,SYTL2,TDGF1,TF,TGM3,TIAM1,USP8	The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region.
GO:0019898	GO	CC	extrinsic component of membrane	AAK1,ALOX15,ALOX15B,ANXA1,APC,APC2,ARRB1,ATG14,AZU1,BECN1,BLOC1S6,BST1,CAV2,CDH1,CDH2,CDK16,CNTFR,CTNNA1,CTNNB1,CUBN,CYLD,CYTH1,CYTH3,DLG4,DMBT1,DNAJA3,EEA1,EHD2,EPN3,ERRFI1,ESYT2,ESYT3,EZR,FARP1,FCN1,FER,FERMT2,FES,FOLR3,GFRA1,GFRA2,GFRA3,GML,GNA14,GNA15,GNAI1,GNAS,GNAT2,GNB1,GNG2,GNG5,GNGT2,GOLGA3,HCK,HID1,IQGAP1,JAKMIP1,JUP,KCNAB1,KCNAB2,KCNIP1,KRAS,MGLL,MICALL1,MITD1,MMP27,MTMR3,MTOR,MUC16,MYZAP,NCF1,NDUFAF5,NLRP10,NMT1,NMT2,NOA1,NRBF2,PACSIN2,PAM16,PCSK9,PIK3C3,PIK3CA,PIK3CD,PIK3CG,PIK3R1,PIK3R4,PIK3R5,PIK3R6,PLAUR,PLG,PML,PRNP,RAB7A,RACGAP1,RGS1,RGS19,RGS6,RGS8,RPH3A,S100A6,SCUBE1,SERPINE2,SMAD7,SNX10,SNX16,SNX18,SNX33,SNX5,SNX9,STOML2,SYT6,SYTL1,SYTL2,SYTL4,TAMM41,TDGF1,TF,TGM3,TIAM1,TOR1A,TPR,ULK1,UMOD,USP8,WDFY3,ZC3H12A,ZFYVE1	The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region.
GO:0019900	GO	MF	kinase binding	ABI2,ACTA2,ADAM10,ADAM9,ADCY6,ANGPT4,AP1B1,AP2A1,AP2A2,ATF7,AVPR1A,AVPR1B,AXIN1,BARD1,BCL10,BLNK,BTG1,CADPS,CASP9,CD3E,CDC42,CDK5RAP1,CDK5RAP3,CHP1,CLTC,DAB2IP,DACT1,DACT2,DACT3,DLG2,DLG3,DLG4,DNAJC3,DNM1,DOK7,DUSP19,DUSP3,FAF1,FAM83A,FAM83B,FGR,FIZ1,FRS2,GAB2,GHR,GNAT1,GNB2L1,GPRC5B,GRB7,GRK5,GSTP1,HINT1,HSPB1,IBTK,IL31RA,IRS1,ITGAV,JAK2,JTB,KAT2B,KCNQ1,LAX1,LLGL1,LRP4,MAD2L2,MAP3K13,MAPK4,MAPK8IP2,MAPK8IP3,MARVELD3,MICALCL,NBR1,NFATC1,NRG1,NRG3,NSF,PAX6,PDE3B,PDLIM5,PICK1,PIK3R1,PINK1,PIP5K1A,PITPNM3,PJA2,PLEK,PRKAG1,PRKAG2,PRKAG3,PRKRIP1,PTK2,PTPN22,PTPRR,RB1,RGCC,RPS6KA4,RYR2,SASH1,SGOL1,SHC1,SNAP91,SQSTM1,SRCIN1,STAP1,STAT3,STX1B,SV2A,SYN1,TAX1BP1,TMEM173,TNIP1,TNIP2,TOB1,TPR,TRAT1,TRIB1,TRIB3,TRPV4,UGT1A10,UGT1A7,VRK1,VRK2	Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
GO:0019901	GO	MF	protein kinase binding	ACTA2,ADAM10,ADAM9,ADCY6,ANGPT4,AP1B1,AP2A1,AP2A2,ATF7,AVPR1A,AVPR1B,AXIN1,BCL10,BLNK,CADPS,CASP9,CD3E,CDC42,CDK5RAP1,CDK5RAP3,CLTC,DAB2IP,DACT1,DACT2,DACT3,DNAJC3,DNM1,DOK7,DUSP19,DUSP3,FAF1,FAM83A,FAM83B,FGR,FIZ1,FRS2,GAB2,GHR,GNAT1,GNB2L1,GPRC5B,GRB7,GRK5,GSTP1,HINT1,HSPB1,IBTK,IL31RA,IRS1,ITGAV,JAK2,JTB,KAT2B,KCNQ1,LAX1,LLGL1,LRP4,MAD2L2,MAP3K13,MAPK4,MARVELD3,MICALCL,NBR1,NFATC1,NRG1,NRG3,NSF,PAX6,PDE3B,PDLIM5,PICK1,PIK3R1,PINK1,PITPNM3,PJA2,PLEK,PRKAG1,PRKAG2,PRKAG3,PRKRIP1,PTK2,PTPRR,RGCC,RPS6KA4,RYR2,SASH1,SHC1,SNAP91,SQSTM1,SRCIN1,STAP1,STAT3,STX1B,SV2A,SYN1,TMEM173,TNIP1,TNIP2,TOB1,TPR,TRAT1,TRIB1,TRIB3,TRPV4,UGT1A10,UGT1A7,VRK1,VRK2	Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
GO:0019902	GO	MF	phosphatase binding	AKAP11,ANKLE2,ARPP19,ATP2B4,CARHSP1,CEP192,CHCHD3,CNST,CSRNP2,CTSC,CTTNBP2NL,DAB2IP,DLG3,DLG4,DZIP3,ELFN1,ELFN2,ELL,ENSA,FOXO1,GRIN3A,HSP90B1,KCNQ1,MAP2K7,MASTL,MVP,MYOZ2,PHACTR4,PPME1,PPP1R15A,PPP1R21,PPP1R26,PPP1R27,PPP1R32,PPP1R35,PPP1R36,PPP1R37,PPP1R9B,PPP2R4,PPP3CB,SFI1,SH2D4A,SH3RF2,SH3YL1,SHOC2,SLC9A1,SMG5,SMG7,SOD1,SPRED1,STRN,STRN3,STRN4,SYTL2,TCTEX1D4,TRPC4AP,TSC2,VRK3,WNK1	Interacting selectively and non-covalently with any phosphatase.
GO:0019903	GO	MF	protein phosphatase binding	AKAP11,ANKLE2,ARPP19,ATP2B4,CTTNBP2NL,DAB2IP,DLG4,ENSA,FOXO1,GRIN3A,HSP90B1,KCNQ1,MAP2K7,MASTL,MVP,MYOZ2,PHACTR4,PPME1,PPP1R15A,PPP1R9B,PPP2R4,PPP3CB,SH3RF2,SHOC2,SLC9A1,SMG5,SMG7,SOD1,STRN,STRN3,STRN4,TCTEX1D4,VRK3	Interacting selectively and non-covalently with any protein phosphatase.
GO:0019904	GO	MF	protein domain specific binding	ABI2,ACOX1,ACTN2,ADAM9,AIP,ANGEL1,ARHGAP27,ARHGAP29,ATF4,ATP2B2,AXIN1,BAX,CABYR,CADM1,CARD19,CASP9,CBLC,CCDC88C,CDC5L,CFTR,CIT,CITED1,CLCN3,CNTNAP1,CRIM1,CRIPT,CSRP2BP,CTBP1,CUL3,DAB2IP,DAG1,DDIT3,DLG4,DNM2,DPYSL3,DRD4,EPHA4,ERC1,ESPN,ESRRG,EVL,FZD4,GNB2L1,GNG12,GNG5,GRB2,GRIA1,GRID2,GRM7,HMGA2,HSP90AA1,HSP90AB1,IRS1,KIDINS220,KIF14,LAT2,LAX1,LCK,LDB1,LDB2,LILRB1,LIN7C,MAP2K2,MAPK15,MLF1,NFE2,NLGN1,NLK,NOD1,NUP62,PAG1,PARK2,PICK1,PLSCR1,PTPN22,RAPGEF2,RIPK2,SH3PXD2B,SHANK1,SHANK3,SIT1,SKAP1,SLC26A6,SLC9A3,SOCS7,SQSTM1,SRRM2,SRSF10,SRSF12,STMN3,STUB1,TGFBR3,THAP7,TMEM88,TNK2,TRIM28,TRPV4,VAPA,VAPB,VRK2,WBP1,WBP2NL,YWHAH	Interacting selectively and non-covalently with a specific domain of a protein.
GO:0019905	GO	MF	syntaxin binding	BLOC1S6,CACNA1A,NSF,RAB11A,SCFD1,SNPH,STXBP1,STXBP5,SYT1,SYT6,UNC13A,VAMP2,VPS11,VPS18	Interacting selectively and non-covalently with a syntaxin, a SNAP receptor involved in the docking of synaptic vesicles at the presynaptic zone of a synapse.
GO:0019907	GO	CC	cyclin-dependent protein kinase activating kinase holoenzyme complex	CCNH,ERCC2,HOXC10,HSPD1,KDM5A,PUF60	A cyclin-dependent kinase activating kinase complex capable of activating cyclin-dependent kinases by threonine phosphorylation, thus regulating cell cycle progression. consists of a kinase, cyclin and optional assembly factors, in human CDK7, CCNH and MNAT1. CAK activity is itself regulated throughout the cell cycle by T-loop phosphorylation of its kinase component (CDK7 in human). Phosphorylation of serine residues during mitosis inactivates the enzyme. Also capable of CAK phosphorylating the carboxyl-terminal domain (CTD) of RNA polymerase II and other transcription activating proteins, as part of the general transcription factor TFIIH.
GO:0019908	GO	CC	nuclear cyclin-dependent protein kinase holoenzyme complex	BCCIP,CCNH,CCNT1,CDK12,CDK13,CDK9,ERCC2,HOXC10,HSPD1,KDM5A,PUF60,SNW1,TAF7	Cyclin-dependent protein kinase (CDK) complex found in the nucleus.
GO:0019915	GO	BP	lipid storage	ANGPTL3,BSCL2,CAV1,CD36,CIDEA,DGAT1,DGAT2,ENPP1,FFAR2,IL1B,SOAT1,TNF	The accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
GO:0019932	GO	BP	second-messenger-mediated signaling	ADCY1,ADCY2,ADCYAP1,ADGRL1,AGT,AGTR1,AGTR2,AKAP6,ANK2,APOE,ASPH,ATP1A2,ATP1B1,ATP2A2,AZU1,BCAP31,BTK,CACNA1C,CALM1,CAMK2D,CAMKK2,CASQ1,CASQ2,CCL3,CCR5,CD36,CLIC2,CXCL8,CXCR4,DDAH1,DDAH2,DGKD,DGKQ,DMD,DMTN,EDN1,EDN2,EDN3,EGFR,EIF2AK3,EPHA5,FIS1,FKBP1B,FPR1,GAL,GHRH,GHRHR,GLP1R,GPR143,GSTM2,GSTO1,GUCY1B3,HRC,HRH1,HTR2B,ITPR1,ITPR2,ITPR3,KCNC2,KDR,LACRT,LAT,LAT2,LRRK2,MAFA,MAPK7,MCTP1,MCTP2,MCU,NDNF,NDUFS4,NEUROD1,NFATC1,NMUR1,NMUR2,NUDT4,P2RY11,PDE2A,PDE3A,PDE4D,PDPK1,PDX1,PDZD3,PLA2G4B,PLCE1,PLCG1,PLCG2,PPP2CA,PPP2R1A,PPP3CA,PPP3CB,PPP3R1,PRKACA,PTGDR2,PTGFR,RAPGEF2,RAPGEF3,RIMS2,RYR2,SELE,SELP,SLC8A1,SLC9A1,SOX9,SPHK1,TENM2,TPCN2,TREML1,VCAM1	Any intracellular signal transduction in which the signal is passed on within the cell via a second messenger; a small molecule or ion that can be quickly generated or released from intracellular stores, and can diffuse within the cell. Second-messenger signaling includes production or release of the second messenger, and effectors downstream of the second messenger that further transmit the signal within the cell.
GO:0019933	GO	BP	cAMP-mediated signaling	ADCY1,ADCY2,ADCYAP1,AKAP6,DGKQ,EPHA5,GAL,GHRH,GHRHR,GLP1R,MAPK7,NDUFS4,PDE2A,PDE3A,PDE4D,RAPGEF2,RAPGEF3,RIMS2,SOX9	Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell.
GO:0019934	GO	BP	cGMP-mediated signaling	APOE,CD36,GUCY1B3,KCNC2,PDE2A,PDE3A,PDZD3	Any intracellular signal transduction in which the signal is passed on within the cell via cyclic GMP (cGMP). Includes production of cGMP, and downstream effectors that further transmit the signal within the cell.
GO:0019935	GO	BP	cyclic-nucleotide-mediated signaling	ADCY1,ADCY2,ADCYAP1,AKAP6,APOE,CD36,DGKQ,EPHA5,GAL,GHRH,GHRHR,GLP1R,GUCY1B3,KCNC2,MAPK7,NDUFS4,NUDT4,PDE2A,PDE3A,PDE4D,PDZD3,RAPGEF2,RAPGEF3,RIMS2,SOX9	Any intracellular signal transduction in which the signal is passed on within the cell via a cyclic nucleotide. Includes production or release of the cyclic nucleotide, and downstream effectors that further transmit the signal within the cell.
GO:0019955	GO	MF	cytokine binding	A2M,ACKR3,ACVR1,CD36,CER1,CHRD,CSF1R,CXCR3,GREM1,HAX1,HMGB1,HYAL2,IFNAR1,IL17F,IL18BP,IL1RN,IL22RA2,IL2RB,IL2RG,IL31RA,ITGAV,KIT,KLHL20,LTBP4,NBL1,NRP1,NRP2,PXDN,TGFB3,TGFBR1,TGFBR2,TGFBR3,THBS1	Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
GO:0019985	GO	BP	translesion synthesis	CUL4A,CUL4B,DDB1,DTL,FAAP20,ISG15,KIAA0101,MAD2L2,NPLOC4,PCNA,POLD1,POLD2,POLD3,POLD4,POLH,POLI,POLK,POLN,PRIMPOL,RAD18,RBX1,RCHY1,REV1,REV3L,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,SPRTN,TRIM25,UBA52,UBA7,UBB,UBC,UBE2B,UBE2L6,UFD1L,USP1,USP10,USP43,VCP,ZBTB1,ZBTB32	The replication of damaged DNA by synthesis across a lesion in the template strand; a specialized DNA polymerase or replication complex inserts a defined nucleotide across from the lesion which allows DNA synthesis to continue beyond the lesion. This process can be mutagenic depending on the damaged nucleotide and the inserted nucleotide.
GO:0019992	GO	MF	diacylglycerol binding	CHPT1,DGKD,RAPGEF2,RASGRP1,RASGRP2,RASGRP3,RASGRP4	Interacting selectively and non-covalently with diacylglycerol, a diester of glycerol and two fatty acids.
GO:0020037	GO	MF	heme binding	ABCB6,AMBP,BACH1,CAT,CBS,CYB5B,CYBB,CYCS,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A2,CYP1B1,CYP24A1,CYP26A1,CYP26B1,CYP2A13,CYP2A6,CYP2B6,CYP2C19,CYP2D6,CYP2E1,CYP46A1,CYP4F11,CYP51A1,DGCR8,EIF2AK1,FLVCR2,GUCY1B3,HEBP1,HMOX1,HRG,JAK2,NOS1,NOS2,NOS3,NOX4,NOX5,NR1D1,PTGES2,PTGIS,PTGS2,PXDN,PXDNL,SDHC,SDHD,SRC,STC2	Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.
GO:0021510	GO	BP	spinal cord development	ASCL1,CHRD,DLL1,DLL4,DRAXIN,FOXN4,GLI2,ISL1,LHX1,MDGA1,MDGA2,NF1,PROX1,RELN,SOX11,SOX12,SOX4,TBX20,ZC4H2,ZPR1	The process whose specific outcome is the progression of the spinal cord over time, from its formation to the mature structure. The spinal cord primarily conducts sensory and motor nerve impulses between the brain and the peripheral nervous tissues.
GO:0021511	GO	BP	spinal cord patterning	ASCL1,CHRD,DLL4,FOXN4,GLI2,RELN	The regionalization process that regulates the coordinated growth and establishes the non-random spatial arrangement of the spinal cord.
GO:0021513	GO	BP	spinal cord dorsal/ventral patterning	ASCL1,CHRD,DLL4,FOXN4,GLI2	The process that regulates the coordinated growth and differentiation that establishes the non-random dorsal-ventral spatial arrangement of the spinal cord.
GO:0021515	GO	BP	cell differentiation in spinal cord	ASCL1,DLL4,DRAXIN,FOXN4,GLI2,ISL1,LHX1,MDGA1,MDGA2,SOX4,TBX20,ZC4H2	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells of the spinal cord. Differentiation includes the processes involved in commitment of a cell to a specific fate.
GO:0021517	GO	BP	ventral spinal cord development	ASCL1,DLL4,FOXN4,GLI2,ISL1,MDGA2,SOX4,TBX20,ZC4H2	The process whose specific outcome is the progression of the ventral region of the spinal cord over time, from its formation to the mature structure. The neurons of the ventral region of the mature spinal cord participate in motor output.
GO:0021522	GO	BP	spinal cord motor neuron differentiation	ISL1,MDGA2,SOX4,TBX20,ZC4H2	The process in which neuroepithelial cells in the ventral neural tube acquire specialized structural and/or functional features of motor neurons. Motor neurons innervate an effector (muscle or glandular) tissue and are responsible for transmission of motor impulses from the brain to the periphery. Differentiation includes the processes involved in commitment of a cell to a specific fate.
GO:0021533	GO	BP	cell differentiation in hindbrain	AGTPBP1,ATP7A,CBLN1,FAIM2,GRID2,LHX1,NOG,NRXN1,PHOX2B,PROX1	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mature cells of the hindbrain. Differentiation includes the processes involved in commitment of a cell to a specific fate.
GO:0021536	GO	BP	diencephalon development	BMP2,CHRNB2,DRD2,FOXB1,GHRH,GLI2,NKX2-1,NKX2-6,NR0B1,PITX2,RAB3GAP1,SEMA5A,SIX3,SLC6A4,SOX3	The process whose specific outcome is the progression of the diencephalon over time, from its formation to the mature structure. The diencephalon is the paired caudal parts of the prosencephalon from which the thalamus, hypothalamus, epithalamus and subthalamus are derived; these regions regulate autonomic, visceral and endocrine function, and process information directed to the cerebral cortex.
GO:0021537	GO	BP	telencephalon development	AGTPBP1,ARHGAP11B,ARL13B,BBS2,BBS4,BMP2,BMP4,BTBD3,CCDC85C,CDK6,COL3A1,DAB2IP,DRD1,DRD2,EFHC1,EPHA5,EPHB2,EPHB3,ERBB4,FAT4,FGF13,FOXB1,FOXP2,GSK3B,HES5,HTR6,INHBA,KDM2B,KIF14,LAMB1,LHX6,LRP8,LRRK2,MKKS,NDE1,NEUROD1,NF1,NFIB,NTRK2,NUMB,NUMBL,PAFAH1B1,PEX13,PLCB1,PROX1,PTEN,RELN,ROBO1,ROBO2,RTN4,RYK,SALL1,SCN5A,SEMA3A,SHANK3,SIX3,SKI,SLIT2,SRGAP2,SRGAP2C,SZT2,TRAPPC9,WDR62,WNT5A	The process whose specific outcome is the progression of the telencephalon over time, from its formation to the mature structure. The telencephalon is the paired anteriolateral division of the prosencephalon plus the lamina terminalis from which the olfactory lobes, cerebral cortex, and subcortical nuclei are derived.
GO:0021543	GO	BP	pallium development	ARHGAP11B,BBS2,BBS4,BTBD3,CCDC85C,CDK6,COL3A1,DAB2IP,EFHC1,EPHA5,FAT4,FGF13,GSK3B,HTR6,KIF14,LAMB1,LHX6,LRP8,MKKS,NDE1,NEUROD1,NF1,NTRK2,PAFAH1B1,PEX13,PLCB1,PROX1,PTEN,RELN,ROBO1,RTN4,SLIT2,SRGAP2,SRGAP2C,TRAPPC9,WDR62	The process whose specific outcome is the progression of the pallium over time, from its formation to the mature structure. The pallium is the roof region of the telencephalon.
GO:0021545	GO	BP	cranial nerve development	ATOH7,CHD7,CHRNB2,ERBB3,HOXA1,ISL1,PAX2,PHOX2B,POU4F1,SALL1,SIX4,TBX1,TFAP2A,TMEM126A	The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.
GO:0021549	GO	BP	cerebellum development	AGTPBP1,ATP7A,CBLN1,CLP1,DLL1,FAIM2,GLI2,GRID2,KIF14,LHX1,MYO16,NEUROD1,NEUROD2,NLGN4X,NRXN1,PROX1,PTF1A,SCN5A,SDF4,TRNP1,WNT1	The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.
GO:0021575	GO	BP	hindbrain morphogenesis	AGTPBP1,ATP7A,CBLN1,DLC1,DLL1,FAIM2,GLI2,GRID2,KIF14,LHX1,NRXN1,PROX1,TRNP1,WNT1	The process in which the anatomical structure of the hindbrain is generated and organized. The hindbrain is the region consisting of the medulla, pons and cerebellum. Areas of the hindbrain control motor and autonomic functions.
GO:0021587	GO	BP	cerebellum morphogenesis	AGTPBP1,ATP7A,CBLN1,DLL1,FAIM2,GLI2,GRID2,KIF14,LHX1,NRXN1,PROX1,TRNP1,WNT1	The process in which the anatomical structure of the cerebellum is generated and organized. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. The cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.
GO:0021591	GO	BP	ventricular system development	CDK6,CENPF,KDM2B,NUMB,NUMBL,RAPGEF2	The process whose specific outcome is the progression of the brain ventricular system over time, from its formation to the mature structure. The brain ventricular system consists of four communicating cavities within the brain that are continuous with the central canal of the spinal cord. These cavities include two lateral ventricles, the third ventricle and the fourth ventricle. Cerebrospinal fluid fills the ventricles and is produced by the choroid plexus.
GO:0021602	GO	BP	cranial nerve morphogenesis	CHRNB2,HOXA1,PAX2,TBX1,TFAP2A	The process in which the anatomical structure of the cranial nerves are generated and organized. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.
GO:0021675	GO	BP	nerve development	ATOH7,CHD7,CHRNB2,DICER1,ERBB3,HOXA1,ISL1,NRP1,NRP2,NTRK1,PAX2,PHOX2B,POU4F1,SALL1,SEMA3A,SEMA3F,SIX4,SULF1,SULF2,TBX1,TFAP2A,TMEM126A	The process whose specific outcome is the progression of a nerve over time, from its formation to the mature structure.
GO:0021681	GO	BP	cerebellar granular layer development	CBLN1,FAIM2,GRID2,KIF14,NRXN1,PROX1	The process whose specific outcome is the progression of the cerebellar granule layer over time, from its formation to the mature structure. The granular layer is the innermost layer of the cerebellar cortex. This layer contains densely packed small neurons, mostly granule cells. Some Golgi cells are found at the outer border. Granule neurons send parallel fibers to the upper molecular layer, where they synapse with Purkinje cell dendrites. Mossy fibers from the pontine nuclei in the white matter synapse with granule cell axons, Golgi cell axons and unipolar brush interneuron axons at cerebellar glomeruli in the granule cell layer.
GO:0021683	GO	BP	cerebellar granular layer morphogenesis	CBLN1,GRID2,KIF14,NRXN1,PROX1	The process in which the anatomical structure of the cerebellar granular layer is generated and organized. The granular layer is the innermost layer of the cerebellar cortex. This layer contains densely packed small neurons, mostly granule cells. Some Golgi cells are found at the outer border. Granule neurons send parallel fibers to the upper molecular layer, where they synapse with Purkinje cell dendrites. Mossy fibers from the pontine nuclei in the white matter synapse with granule cell axons, Golgi cell axons and unipolar brush interneuron axons at cerebellar glomeruli in the granule cell layer.
GO:0021692	GO	BP	cerebellar Purkinje cell layer morphogenesis	AGTPBP1,ATP7A,DLL1,FAIM2,KIF14,LHX1	The process in which the anatomical structure of the cerebellar Purkinje cell layer is generated and organized. The Purkinje cell layer lies just underneath the molecular layer of the cerebellar cortex. It contains the neuronal cell bodies of the Purkinje cells that are arranged side by side in a single layer. Candelabrum interneurons are vertically oriented between the Purkinje cells. Purkinje neurons are inhibitory and provide the output of the cerebellar cortex through axons that project into the white matter. Extensive dendritic trees from the Purkinje cells extend upward in a single plane into the molecular layer where they synapse with parallel fibers of granule cells.
GO:0021695	GO	BP	cerebellar cortex development	AGTPBP1,ATP7A,CBLN1,CLP1,DLL1,FAIM2,GLI2,GRID2,KIF14,LHX1,NEUROD2,NRXN1,PROX1,TRNP1	The process whose specific outcome is the progression of the cerebellar cortex over time, from its formation to the mature structure. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function.
GO:0021696	GO	BP	cerebellar cortex morphogenesis	AGTPBP1,ATP7A,CBLN1,DLL1,FAIM2,GLI2,GRID2,KIF14,LHX1,NRXN1,PROX1,TRNP1	The process in which the anatomical structure of the cranial nerves are generated and organized. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function.
GO:0021697	GO	BP	cerebellar cortex formation	AGTPBP1,ATP7A,CBLN1,DLL1,FAIM2,GRID2,LHX1,NRXN1,PROX1	The process that gives rise to the cerebellar cortex. This process pertains to the initial formation of a structure from unspecified parts. The cerebellar cortex is a thin mantle of gray matter that covers the surface of each cerebral hemisphere. It has a characteristic morphology with convolutions (gyri) and crevices (sulci) that have specific functions. Six layers of nerve cells and the nerve pathways that connect them comprise the cerebellar cortex. Together, these regions are responsible for the processes of conscious thought, perception, emotion and memory as well as advanced motor function.
GO:0021700	GO	BP	developmental maturation	ACVRL1,AGRN,ANG,ANKS1A,AP1G1,AP1M1,AP3D1,APP,BLOC1S3,BLOC1S5,BLOC1S6,BMP2,CABYR,CATSPERD,CCL19,CCL21,CD63,CFTR,CLN5,CNTN2,CNTNAP2,DLG4,EPHA8,EREG,FARP2,FGFR3,G6PD,GH1,HES5,IGF1,IL21,IQCF1,KCNIP2,LHX6,LYL1,MTCH1,MYOC,NKX6-1,NRCAM,NRXN1,PAX2,PICALM,PICK1,PLD6,PLXNB1,PPARG,PRKACA,PTEN,RAB32,RAB38,RFX3,RHOA,RND1,RYR1,S1PR1,SCARF1,SEMA4D,SHANK1,SIX3,SLC26A3,SLC26A6,SPINK5,SPTBN4,STXBP1,SYP,TDRD5,TGFB2,TMEM79,VEGFA	A developmental process, independent of morphogenetic (shape) change, that is required for an anatomical structure, cell or cellular component to attain its fully functional state.
GO:0021756	GO	BP	striatum development	BBS2,BBS4,FOXP2,INHBA,MKKS,SHANK3	The progression of the striatum over time from its initial formation until its mature state. The striatum is a region of the forebrain consisting of the caudate nucleus, putamen and fundus striati.
GO:0021761	GO	BP	limbic system development	BBS2,BBS4,CDK6,EPHA5,FGF13,FGFR2,FOXB1,GSK3B,KIF14,LRP8,MKKS,NEUROD1,NKX2-6,NR0B1,PAFAH1B1,PROX1,PTEN,RAB3GAP1,RELN,SOX3	The progression of the limbic system over time from its initial formation until its mature state. The limbic system is a collection of structures in the brain involved in emotion, motivation and emotional aspects of memory.
GO:0021766	GO	BP	hippocampus development	BBS2,BBS4,CDK6,EPHA5,FGF13,GSK3B,KIF14,LRP8,MKKS,NEUROD1,PAFAH1B1,PROX1,PTEN,RELN	The progression of the hippocampus over time from its initial formation until its mature state.
GO:0021772	GO	BP	olfactory bulb development	AGTPBP1,ERBB4,KIF14,LRRK2,ROBO1,ROBO2,SALL1,SEMA3A,SKI,SLIT2,WNT5A	The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex.
GO:0021782	GO	BP	glial cell development	ARHGEF10,CDK6,CLU,DICER1,DLL1,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,HES5,MT3,MXRA8,MYOC,MYRF,NCMAP,NF1,PARD3,PICK1,PTEN,SIRT2,SKI,SOD1,SOX11,SOX4,TENM4	The process aimed at the progression of a glial cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
GO:0021795	GO	BP	cerebral cortex cell migration	DAB2IP,EFHC1,FGF13,HTR6,LAMB1,LHX6,PAFAH1B1,PEX13,RELN,ROBO1,RTN4,SLIT2,SRGAP2,SRGAP2C	The orderly movement of cells from one site to another in the cerebral cortex.
GO:0021799	GO	BP	cerebral cortex radially oriented cell migration	DAB2IP,LAMB1,LHX6,PAFAH1B1,RTN4,SRGAP2,SRGAP2C	The migration of cells in the developing cerebral cortex in which cells move from the ventricular and/or subventricular zone toward the surface of the brain.
GO:0021801	GO	BP	cerebral cortex radial glia guided migration	DAB2IP,LAMB1,PAFAH1B1,RTN4,SRGAP2,SRGAP2C	The radial migration of neuronal or glial precursor cells along radial glial cells during the development of the cerebral cortex.
GO:0021846	GO	BP	cell proliferation in forebrain	DOCK7,FGFR2,HOOK3,KIF14,NUMB,NUMBL,PCM1,SIX3,WNT3A,WNT7A	The creation of greater cell numbers in the forebrain due to cell division of progenitor cells.
GO:0021854	GO	BP	hypothalamus development	FOXB1,NKX2-6,NR0B1,RAB3GAP1,SOX3	The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state.
GO:0021872	GO	BP	forebrain generation of neurons	ATP7A,DRD1,DRD2,ERBB4,FGFR2,HES1,INHBA,LHX6,NUMB,NUMBL,RAPGEF2,ROBO1,ROBO2,SALL1,SHANK3,SLIT2,WNT5A	The process in which nerve cells are generated in the forebrain. This includes the production of neuroblasts from and their differentiation into neurons.
GO:0021879	GO	BP	forebrain neuron differentiation	ATP7A,DRD1,DRD2,ERBB4,FGFR2,INHBA,LHX6,RAPGEF2,ROBO1,ROBO2,SALL1,SHANK3,SLIT2,WNT5A	The process in which a relatively unspecialized cell acquires specialized features of a neuron that will reside in the forebrain.
GO:0021884	GO	BP	forebrain neuron development	ATP7A,DRD1,DRD2,FGFR2,LHX6,RAPGEF2,ROBO1,ROBO2,SLIT2,WNT5A	The process whose specific outcome is the progression of a neuron that resides in the forebrain, from its initial commitment to its fate, to the fully functional differentiated cell.
GO:0021885	GO	BP	forebrain cell migration	ARL13B,DAB2IP,DRD1,DRD2,EFHC1,FGF13,FOXB1,HTR6,LAMB1,LHX6,LRRK2,PAFAH1B1,PEX13,RELN,ROBO1,RTN4,SLIT2,SRGAP2,SRGAP2C,TYRO3	The orderly movement of a cell from one site to another at least one of which is located in the forebrain.
GO:0021889	GO	BP	olfactory bulb interneuron differentiation	ERBB4,ROBO1,ROBO2,SALL1,SLIT2,WNT5A	The process in which a neuroblast acquires specialized features of an interneuron residing in the olfactory bulb.
GO:0021915	GO	BP	neural tube development	ALDH1A2,ARL13B,ATP6AP2,BBS4,BCL10,CELSR1,CHRD,COBL,DACT1,DEAF1,DLC1,DVL2,FOLR1,FOXB1,FUZ,GLI2,GRHL2,GRHL3,HES5,IFT122,KDM2B,LMO4,MTHFD1,MTHFD1L,PAX2,PHACTR4,PLXNB2,PRICKLE1,PROX1,PTCH1,SCRIB,SEMA4C,SKI,SOX11,SOX4,STIL,TRIM71,TSC2,VANGL2,ZNF358	The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
GO:0021952	GO	BP	central nervous system projection neuron axonogenesis	CHRNB2,EPHA4,EPHB1,GLI2,NFIB,PAFAH1B1,SCN1B,SLIT2,SPTBN4,SZT2	Generation of a long process of a CNS neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells in a different central nervous system region.
GO:0021953	GO	BP	central nervous system neuron differentiation	AGTPBP1,ASCL1,ATP7A,CBLN1,CHD5,CHRNB2,DLL4,DRAXIN,DRD1,DRD2,EPHA4,EPHB1,ERBB4,FAIM2,FGFR2,FOXN4,GBA2,GLI2,GRID2,INHBA,ISL1,LHX1,LHX6,MDGA1,MDGA2,NFIB,NRXN1,NTRK2,PAFAH1B1,PHOX2B,PROX1,PTEN,RAPGEF2,ROBO1,ROBO2,SALL1,SCN1B,SHANK3,SLIT2,SOX4,SPOCK1,SPTBN4,SZT2,TBX20,WNT5A,ZC4H2	The process in which a relatively unspecialized cell acquires specialized features of a neuron whose cell body resides in the central nervous system.
GO:0021954	GO	BP	central nervous system neuron development	ATP7A,CHRNB2,DRD1,DRD2,EPHA4,EPHB1,FGFR2,GBA2,GLI2,LHX6,NFIB,NTRK2,PAFAH1B1,PHOX2B,PTEN,RAPGEF2,ROBO1,ROBO2,SCN1B,SLIT2,SPTBN4,SZT2,WNT5A	The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
GO:0021955	GO	BP	central nervous system neuron axonogenesis	CHRNB2,EPHA4,EPHB1,GLI2,NFIB,PAFAH1B1,PHOX2B,PTEN,SCN1B,SLIT2,SPTBN4,SZT2	Generation of a long process from a neuron whose cell body resides in the central nervous system. The process carries efferent (outgoing) action potentials from the cell body towards target cells.
GO:0021983	GO	BP	pituitary gland development	BMP2,DRD2,GHRH,GLI2,NR0B1,PITX2,SIX3,SOX3	The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands.
GO:0021987	GO	BP	cerebral cortex development	ARHGAP11B,BBS2,BBS4,BTBD3,CCDC85C,COL3A1,DAB2IP,EFHC1,FAT4,FGF13,GSK3B,HTR6,KIF14,LAMB1,LHX6,MKKS,NDE1,NF1,NTRK2,PAFAH1B1,PEX13,PLCB1,RELN,ROBO1,RTN4,SLIT2,SRGAP2,SRGAP2C,TRAPPC9,WDR62	The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
GO:0022010	GO	BP	central nervous system myelination	CLU,HES5,MYRF,PTEN,TENM4	The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of oligodendrocytes in the central nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
GO:0022011	GO	BP	myelination in peripheral nervous system	ARHGEF10,DICER1,MYOC,NCMAP,NF1,PARD3,SIRT2,SKI,SOD1	The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of Schwann cells in the peripheral nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
GO:0022029	GO	BP	telencephalon cell migration	ARL13B,DAB2IP,DRD1,DRD2,EFHC1,FGF13,FOXB1,HTR6,LAMB1,LHX6,LRRK2,PAFAH1B1,PEX13,RELN,ROBO1,RTN4,SLIT2,SRGAP2,SRGAP2C	The orderly movement of a cell from one site to another at least one of which is located in the telencephalon.
GO:0022038	GO	BP	corpus callosum development	EPHB2,EPHB3,PAFAH1B1,RYK,SZT2	The process whose specific outcome is the progression of the corpus callosum over time, from its formation to the mature structure. The corpus callosum is a thick bundle of nerve fibers comprising a commissural plate connecting the two cerebral hemispheres. It consists of contralateral axon projections that provide communication between the right and left cerebral hemispheres.
GO:0022400	GO	BP	regulation of rhodopsin mediated signaling pathway	CALM1,CAMKMT,CNGA1,CNGB1,FNTA,FNTB,GNAT1,GNB1,GNB5,GNGT1,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,METAP1,METAP2,NMT1,NMT2,PDE6A,PDE6B,PDE6G,PPEF1,PRKCA,PRKCQ,RCVRN,RGS9,RGS9BP,RHO,SAG	Any process that modulates the frequency, rate or extent of rhodopsin-mediated signaling.
GO:0022405	GO	BP	hair cycle process	ALX4,APCDD1,ATP7A,CDH3,FGFR2,FOXE1,FUZ,GNAS,HDAC1,HDAC2,INHBA,KRT17,KRT71,KRT84,PDGFA,SOX18,SOX9,SPINK5,TGFB2,TGM3,WNT10A	A multicellular organismal process involved in the cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair; one of the collection or mass of filaments growing from the skin of an animal, and forming a covering for a part of the head or for any part or the whole of the body.
GO:0022406	GO	BP	membrane docking	BLOC1S6,CAV2,CEP83,CHP1,CPLX2,KCNB1,PEX13,PEX16,PEX5,PLEK,RAB7A,RAB8A,RABEPK,ROCK1,SNAP25,SNPH,SNX3,STX1B,SYTL2,VAMP3,VTI1B,YKT6	The initial attachment of a membrane or protein to a target membrane. Docking requires only that the proteins come close enough to interact and adhere.
GO:0022408	GO	BP	negative regulation of cell-cell adhesion	ADAMTS18,ADIPOQ,ALOX12,ANXA1,APOA1,ASS1,B4GALNT2,BMP2,BMP4,BTN2A2,C1QTNF1,CCL21,CCL25,CCL28,CD274,CD300A,CDH1,CDKN2A,CEBPB,CTLA4,CXCL12,DUSP3,EPCAM,FOXJ1,FOXP3,FXYD5,GLI3,GLMN,GTPBP4,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,IL1RN,IRF1,JAK3,KIAA0922,KLF4,LAX1,LEF1,LGALS3,LGALS9,LILRB1,LILRB2,MAD2L2,MAP2K5,MAPK7,MYADM,NF2,PDCD1LG2,PLG,PODXL,PPARA,PRKAR1A,PRKCD,PRKG1,PRNP,PTK2,PTPN2,PTPN22,RC3H1,RDX,RGCC,SERPINE2,SFTPD,SNAI2,SOCS5,SPINT2,TGFB1,TIGIT,TNFRSF21,TNFSF4,TRPV4,WNT1,XCL1,ZC3H8,ZNF703	Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
GO:0022409	GO	BP	positive regulation of cell-cell adhesion	ADAM8,AGER,AIF1,AKT1,ANXA1,BMP7,BTLA,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CD1D,CD24,CD247,CD274,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD44,CD46,CD47,CD55,CD6,CD80,CD86,CDC42,CITED2,CSK,CTLA4,CX3CL1,CXCL13,DENND6A,DMTN,DPP4,EBI3,FADD,FGA,FGB,FGG,FLOT1,FLOT2,FOXA1,FOXA2,FOXP3,FSTL3,FYN,GATA3,GCNT2,GLI2,GLI3,GRAP2,GRB2,HAS2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,KLRK1,LCK,LEF1,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MLST8,MTOR,MYB,NCK1,NCK2,NCKAP1L,NKAP,NLRP3,NOD2,NODAL,NR4A3,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIEZO1,PIK3CA,PIK3R1,PLPP3,PNP,PODXL,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RICTOR,RNASE10,SART1,SERPINF2,SHH,SIRPG,SMAD7,SNAI2,SOCS5,SRC,TESPA1,TGFBR2,THY1,TMIGD2,TNF,TNFRSF14,TNFSF11,TNFSF4,TRAF2,TRAF6,VAV1,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZP3,ZP4	Any process that activates or increases the rate or extent of cell adhesion to another cell.
GO:0022412	GO	BP	cellular process involved in reproduction in multicellular organism	ADAM2,ANG,BBS2,BBS4,BMPR1B,CABYR,CASC5,CATSPERD,CD9,CELF1,CELF4,CEP57,CFTR,CHD5,CIB1,CRISP1,CXADR,DAZL,DDX25,DEAF1,DMRT1,DPY19L2,DZIP1,EREG,FIGLA,FMN2,FSHR,GALNTL5,H1FNT,HIST1H2BA,HORMAD1,ING2,INHBA,IQCF1,IZUMO1,IZUMO1R,KIAA0430,KMT2D,MAST2,MEI4,MKKS,NANOS3,NME5,NPHP1,PAFAH1B1,PIWIL1,PIWIL2,PLD6,PLPP1,PLPP3,PRKACA,PSME4,PTCHD3,PVRL2,RHBDD1,RNF8,ROPN1B,SERPINA5,SLC26A3,SLC26A6,SPAG6,SPANXB1,SRPK1,SYCP3,TDRD1,TDRD5,TGFBR1,TMEM119,TNP1,TRIP13,TSSK1B,TSSK2,TSSK6,WT1,ZNF830,ZP3	A process, occurring at the cellular level, that is involved in the reproductive function of a multicellular organism.
GO:0022417	GO	BP	protein maturation by protein folding	AIP,CALR,CHCHD4,FKBP1A,FKBP1B,WFS1	The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that results in the attainment of the full functional capacity of a protein.
GO:0022600	GO	BP	digestive system process	ABCG5,ABCG8,ADRA2A,AKR1C1,CD36,CEL,COPA,F11R,KCNQ1,LDLR,LEP,MUC13,MUC4,MUC6,NOD2,NPC1L1,PBLD,RBP4,SCT,SERPINA3,SLC26A6,SLC46A1,SOAT2,SOX9,STATH,STRAP,TJP2,TLR4,TLR9	A physical, chemical, or biochemical process carried out by living organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
GO:0022602	GO	BP	ovulation cycle process	ANG,BMPR1B,CEBPB,EIF2B2,EIF2B4,EIF2B5,EREG,FOXL2,FSHR,INHA,INHBA,INHBB,KIT,PDGFRA,PTPRN,SOD1,TGFB2,TGFB3,VEGFA,ZNF830	A process involved in the sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
GO:0022612	GO	BP	gland morphogenesis	CAV1,CEBPB,CSF1R,ELF3,EPHA2,FGF10,FGFR2,MSN,NKX3-1,RPS6KA1,SCRIB,SLC9A3R1,SOX9	The process in which the anatomical structures of a gland are generated and organized.
GO:0022613	GO	BP	ribonucleoprotein complex biogenesis	ADAR,AGO1,AGO2,AGO3,AGO4,ATXN2,ATXN2L,BICD1,BMS1,BOP1,C1D,C1QBP,CD2BP2,CELF1,CIRBP,CIRH1A,CLNS1A,CLP1,CRNKL1,DDX1,DDX20,DDX23,DDX27,DDX28,DDX31,DDX39B,DDX3X,DDX47,DDX6,DENR,DHX30,DICER1,DIS3,DKC1,DYNC1H1,EFTUD1,EIF2A,EIF2D,EIF3A,EIF6,EMG1,ERAL1,ERI1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FAM103A1,FASTKD2,FBL,FTSJ2,GCFC2,GEMIN2,GEMIN4,GEMIN5,GEMIN6,GEMIN7,GEMIN8,GRB7,IMP4,LIMD1,LSM14A,MALSU1,MCTS1,MPHOSPH6,MPV17L2,NAF1,NCBP1,NCBP2,NHP2,NMD3,NOC4L,NOL11,NOL3,NOL6,NOL8,NOL9,NOLC1,NOP14,NOP56,NOP58,NPM1,NSUN4,NUFIP1,NVL,OGFOD1,PATL1,PES1,PHAX,PIH1D1,PIN4,PQBP1,PRMT5,PRMT7,PRPF19,PRPF3,PRPF31,PRPF6,PRPF8,PSIP1,RAN,RBM5,RC3H1,RPL11,RPL14,RPL26,RPL35A,RPL5,RPL7,RPS14,RPS15,RPS16,RPS17,RPS19,RPS24,RPS28,RPS6,RPS7,RRP36,RRP9,SART1,SART3,SBDS,SCAF11,SDAD1,SETX,SF1,SF3A1,SF3A2,SF3A3,SHQ1,SKIV2L2,SLU7,SMN1,SNRNP200,SNRPB,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNUPN,SRPK2,SRSF1,SRSF10,SRSF12,SRSF5,SRSF6,SRSF9,STRAP,TAF9,TARBP2,TGS1,TICRR,TSC1,TSR1,TXNL4A,USP39,USP4,UTP20,VCX,WDR12,WDR55,WDR77,XPO1,YTHDC1,ZNF658,ZNHIT6,ZRSR2	A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a complex containing RNA and proteins. Includes the biosynthesis of the constituent RNA and protein molecules, and those macromolecular modifications that are involved in synthesis or assembly of the ribonucleoprotein complex.
GO:0022615	GO	BP	protein to membrane docking	PEX13,PEX16,PEX5,RAB7A,SNX3	The initial attachment of a protein to a target membrane, mediated by a proteins protruding from the target membrane. Docking requires only that the proteins come close enough to interact and adhere.
GO:0022616	GO	BP	DNA strand elongation	APEX1,CDC45,DCLRE1B,DNA2,FEN1,GINS1,GINS2,GINS3,GINS4,LIG1,MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MCM8,MRE11A,NBN,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,PRIM1,PRIM2,RAD50,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,TERT	The DNA metabolic process in which a DNA strand is synthesized by adding nucleotides to the 3' end of an existing DNA stand.
GO:0022617	GO	BP	extracellular matrix disassembly	A2M,ACAN,ADAM10,ADAM15,ADAM17,ADAM8,ADAM9,ADAMTS4,ADAMTS5,BCAN,BMP1,BSG,CAPN1,CAPNS1,CASP3,CD44,CDH1,CMA1,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL23A1,COL25A1,COL26A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL6A5,COL6A6,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,CTRB1,CTRB2,CTSB,CTSD,CTSG,CTSK,CTSL,CTSS,CTSV,DCN,ELANE,ELN,ENG,EXOC8,FBN1,FBN2,FLOT1,FN1,FURIN,HPN,HSPG2,KIF9,KLK2,KLK7,KLKB1,LAMA3,LAMA5,LAMB1,LAMB3,LAMC1,LAMC2,LCP1,MMP1,MMP10,MMP11,MMP12,MMP13,MMP14,MMP15,MMP16,MMP19,MMP2,MMP20,MMP3,MMP7,MMP8,MMP9,NCSTN,NID1,NOXO1,PHYKPL,PLG,PRSS1,PRSS2,PSEN1,SH3PXD2B,SPP1,TIMP1,TIMP2,TLL1,TLL2,TPSAB1,WASH1	A process that results in the breakdown of the extracellular matrix.
GO:0022618	GO	BP	ribonucleoprotein complex assembly	ADAR,AGO1,AGO2,AGO3,AGO4,ATXN2,ATXN2L,BICD1,BMS1,C1QBP,CD2BP2,CELF1,CIRBP,CLNS1A,CLP1,CRNKL1,DDX1,DDX20,DDX23,DDX28,DDX39B,DDX3X,DDX6,DENR,DHX30,DICER1,DYNC1H1,EFTUD1,EIF2A,EIF2D,EIF3A,EIF6,ERAL1,FAM103A1,FASTKD2,GCFC2,GEMIN2,GEMIN4,GEMIN5,GEMIN6,GEMIN7,GEMIN8,GRB7,LIMD1,LSM14A,MCTS1,MPV17L2,NCBP1,NCBP2,NOL3,NPM1,NUFIP1,OGFOD1,PATL1,PHAX,PIH1D1,PQBP1,PRMT5,PRMT7,PRPF19,PRPF3,PRPF31,PRPF6,PRPF8,PSIP1,RBM5,RC3H1,RPS14,RPS19,SART1,SART3,SBDS,SCAF11,SETX,SF1,SF3A1,SF3A2,SF3A3,SHQ1,SLU7,SMN1,SNRNP200,SNRPB,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNUPN,SRPK2,SRSF1,SRSF10,SRSF12,SRSF5,SRSF6,SRSF9,STRAP,TAF9,TARBP2,TGS1,TICRR,TSR1,TXNL4A,USP39,USP4,VCX,WDR77,YTHDC1,ZNHIT6,ZRSR2	The aggregation, arrangement and bonding together of proteins and RNA molecules to form a ribonucleoprotein complex.
GO:0022624	GO	CC	proteasome accessory complex	PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9	A protein complex, that caps one or both ends of the proteasome core complex and regulates entry into, or exit from, the proteasome core complex.
GO:0022625	GO	CC	cytosolic large ribosomal subunit	FXR2,RPL10,RPL10A,RPL10L,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL39L,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,UBA52	The large subunit of a ribosome located in the cytosol.
GO:0022626	GO	CC	cytosolic ribosome	APOD,DDX3X,EIF2AK4,EIF2D,FAU,FXR2,HBA1,MCTS1,NUFIP1,RPL10,RPL10A,RPL10L,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL39L,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,UBA52	A ribosome located in the cytosol.
GO:0022627	GO	CC	cytosolic small ribosomal subunit	DDX3X,EIF2D,FAU,HBA1,MCTS1,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA	The small subunit of a ribosome located in the cytosol.
GO:0022804	GO	MF	active transmembrane transporter activity	ABCA12,ABCA2,ABCA3,ABCA8,ABCB1,ABCB11,ABCB4,ABCB6,ABCB9,ABCD1,ABCD4,ABCG1,ABCG2,ANKH,AQP9,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V0E2,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1,CDH17,CFTR,MCU,MFSD2A,SLC11A1,SLC11A2,SLC12A2,SLC12A5,SLC12A6,SLC12A9,SLC13A2,SLC13A4,SLC15A1,SLC15A2,SLC16A2,SLC16A7,SLC17A2,SLC17A3,SLC17A4,SLC17A5,SLC17A7,SLC18A1,SLC18A2,SLC19A1,SLC20A1,SLC20A2,SLC22A11,SLC22A16,SLC22A4,SLC22A6,SLC22A7,SLC22A8,SLC22A9,SLC23A1,SLC23A2,SLC24A1,SLC24A2,SLC24A5,SLC25A11,SLC25A16,SLC25A6,SLC26A1,SLC26A6,SLC26A9,SLC2A10,SLC2A9,SLC34A2,SLC34A3,SLC38A1,SLC3A2,SLC46A2,SLC4A1,SLC4A4,SLC4A5,SLC4A7,SLC5A1,SLC5A2,SLC5A3,SLC5A7,SLC6A2,SLC6A3,SLC6A4,SLC6A5,SLC6A9,SLC7A11,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7,SLCO1B1,SLCO2B1,TAP2,TAPBP,TOMM20	Catalysis of the transfer of a specific substance or related group of substances from one side of a membrane to the other, up the solute's concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction.
GO:0022829	GO	MF	wide pore channel activity	AQP9,GJA1,GJA10,GJA5,GJB3,GJD2,PANX1,PANX2,PANX3,PRF1	Enables the transport of a solute across a membrane via a large pore, un-gated channel. Examples include gap junctions, which transport substances from one cell to another; and porins which transport substances in and out of bacteria, mitochondria and chloroplasts.
GO:0022836	GO	MF	gated channel activity	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,ANXA6,AQP1,ASIC1,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,CALHM1,CCT8L2,CFTR,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB4,CLCN6,CNGA3,CNGB1,CNGB3,FKBP1B,GABRB1,GABRB3,GAS6,GLRA1,GLRA2,GLRA3,GLRB,GPR89A,GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN3A,HCN1,HCN2,HCN3,HCN4,HPN,HTR3B,HVCN1,IL1RAPL1,ITGAV,ITPR1,ITPR3,KCNA1,KCNA10,KCNA2,KCNA3,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK18,KCNK2,KCNK4,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,KCNQ1,KCNQ2,KCNQ3,KCNQ5,KCNS1,KCNS3,MTMR6,NCS1,NMUR2,NOX1,OPRM1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,PKD2,PKD2L1,PTK2B,REST,RYR1,RYR2,RYR3,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHROOM2,SLC17A3,TMEM63C,TPCN1,TPCN2,TRPA1,TRPM4,TRPV1,TRPV4,TTYH3,VDAC1,VDAC2,VDAC3,ZACN	Enables the transmembrane transfer of a solute by a channel that opens in response to a specific stimulus.
GO:0022839	GO	MF	ion gated channel activity	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO7,ANO8,ANO9,CALHM1,CCT8L2,HPN,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN4,MTMR6,NMUR2,PKD2L1,TMEM63C,TRPM4,TTYH3	Enables the transmembrane transfer of a solute by a channel that opens in response to a specific ion stimulus.
GO:0022840	GO	MF	leak channel activity	KCNK1,KCNK2,KCNK3,PANX1,TMEM175	Enables the transport of a solute across a membrane via a narrow pore channel that is open even in an unstimulated or 'resting' state.
GO:0022843	GO	MF	voltage-gated cation channel activity	CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,GAS6,HCN1,HCN2,HCN3,HCN4,HVCN1,IL1RAPL1,ITGAV,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNIP2,KCNJ1,KCNJ10,KCNJ11,KCNJ12,KCNJ13,KCNJ16,KCNJ18,KCNJ2,KCNJ3,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK18,KCNK2,KCNK6,KCNMA1,KCNQ1,KCNQ2,KCNQ3,KCNQ5,KCNS1,KCNS3,NCS1,NOX1,OPRM1,PKD2,REST,RYR1,SCN10A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN5A,SCN8A,TPCN2	Enables the transmembrane transfer of a cation by a voltage-gated channel. A cation is a positively charged ion. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0022898	GO	BP	regulation of transmembrane transporter activity	ACTN2,ACTN4,ADRA2A,AGT,AHCYL1,AHNAK,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ANO9,ASPH,ATP1A2,ATP1B1,ATP1B2,ATP1B3,BCL2,CAB39,CACNA1D,CACNB4,CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CFTR,CHP1,CHRFAM7A,CLIC2,CNIH2,CNIH3,CRACR2A,CRH,CRHBP,CRHR1,CTSS,DAPK1,DLG4,DMD,DRD2,DRD4,EPO,FGF12,FHL1,FKBP1A,FKBP1B,FXYD1,GAL,GALR2,GLRX,GNB5,GPD1L,GSTM2,GSTO1,HAMP,HAP1,HOMER1,HRC,HTT,INS,JPH1,JPH2,JPH3,JPH4,KCNAB1,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNIP2,KCNQ1,KCNRG,KCNS1,KCNS2,MAPK8IP2,MEF2C,MINK1,MMP9,NEDD4,NEDD4L,NLGN1,NLGN2,NLGN3,NOS1,NOS1AP,NPPA,NRXN1,OPRM1,PCSK9,PDE4B,PDE4D,PKD2,PLN,PPIF,PRKACA,PRKCE,PTK2B,PTPN3,RANGRF,RELN,RIPK1,RNF207,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SHANK1,SHANK3,SLC9A1,SLC9A3R1,SLN,SRI,STIM1,STIM2,STK39,SUMO1,TCAF1,TCAF2,TESC,TLR9,TMEM110,TRDN,TRPC6,UBQLN1,UTRN,VAMP2,WNK2,WNK3,WWP2,YWHAE,YWHAH	Any process that modulates the frequency, rate or extent of transmembrane transporter activity.
GO:0022900	GO	BP	electron transport chain	ACAD9,ALDH5A1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,COA6,COX10,COX15,COX4I1,COX5A,COX5B,COX6A1,COX6B1,COX6C,COX7A2L,COX7B,COX7C,COX8A,CYB561,CYC1,CYCS,ECSIT,ETFA,ETFB,ETFDH,MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFAF2,NDUFAF3,NDUFAF4,NDUFAF5,NDUFAF6,NDUFAF7,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUBPL,PPARGC1A,SDHA,SDHAF2,SDHB,SDHC,SDHD,SLC25A12,SLC25A13,SLC25A14,SLC25A27,TAZ,TIMMDC1,TMEM126B,UCP1,UCP2,UCP3,UQCC3,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRC2,UQCRFS1,UQCRH,UQCRQ	A process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
GO:0022904	GO	BP	respiratory electron transport chain	ACAD9,ALDH5A1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,COA6,COX10,COX15,COX4I1,COX5A,COX5B,COX6A1,COX6B1,COX6C,COX7A2L,COX7B,COX7C,COX8A,CYC1,CYCS,ECSIT,ETFA,ETFB,ETFDH,MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFAF2,NDUFAF3,NDUFAF4,NDUFAF5,NDUFAF6,NDUFAF7,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUBPL,PPARGC1A,SDHA,SDHAF2,SDHB,SDHC,SDHD,SLC25A12,SLC25A13,SLC25A14,SLC25A27,TAZ,TIMMDC1,TMEM126B,UCP1,UCP2,UCP3,UQCC3,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRC2,UQCRFS1,UQCRH,UQCRQ	A process in which a series of electron carriers operate together to transfer electrons from donors such as NADH and FADH2 to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
GO:0023026	GO	MF	MHC class II protein complex binding	ANXA11,ATP1B1,CD74,CD81,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DRA,HLA-DRB1,HSP90AA1,HSP90AB1,HSPA8,MS4A1,PKM,YWHAE	Interacting selectively and non-covalently with the class II major histocompatibility complex.
GO:0023041	GO	BP	neuronal signal transduction	KCNA1,NLGN1,NRXN1,OLFM1,P2RY11,RTN4R	The process in which an activated neuronal cell receptor conveys information down a signaling pathway, resulting in a change in the function or state of a cell. This process may be intracellular or intercellular.
GO:0023061	GO	BP	signal release	ABAT,ALDH5A1,APBA1,BAIAP3,BLOC1S6,BRSK1,BZRAP1,CAMK2G,CASK,CDK16,CDK5,CHAT,CPLX1,CRHR1,CYB5R4,DNAJC5,DOC2B,DVL1,EDN1,EDN3,EIF2AK3,EXOC3L1,FAM3B,GAD1,GAD2,GAL,GHRH,GHRL,GHSR,GLS,GLS2,GRM4,HNF1A,HRH3,HSPA8,IL6,INHBA,LIN7A,LIN7B,LIN7C,LTBP4,MAFA,MAOA,NEUROD1,NLGN1,NRXN1,NRXN2,OTOF,PCLO,PDX1,PIP5K1C,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RAB3A,RIMS1,RIMS2,SEPT5,SLC17A7,SLC18A2,SLC18A3,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC22A2,SLC30A8,SLC32A1,SLC38A2,SLC5A7,SLC6A1,SLC6A11,SLC6A12,SLC6A13,SNAP23,SNAP25,SNAPIN,SNPH,SNX19,STX1A,STX1B,STXBP1,SYN2,SYNJ1,SYT1,TBX3,UNC13A,UNC13B,VAMP2,VIP	The process in which a signal is secreted or discharged into the extracellular medium from a cellular source.
GO:0030004	GO	BP	cellular monovalent inorganic cation homeostasis	ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP5B,ATP6V0E1,ATP6V0E2,ATP6V1H,BCL2,CA2,CFTR,CHP1,CLCN3,CLN3,CLN5,CLN6,GPR89A,KCNJ2,KCNMA1,LRRK2,NEDD4L,NOX1,PPT1,RAB20,RAB38,RAB39A,RAB7A,SLC11A1,SLC26A3,SLC26A6,SLC8A1,SLC9A1,TFAP2B,TMEM165,TMPRSS3	Any process involved in the maintenance of an internal steady state of monovalent inorganic cations at the level of a cell.
GO:0030007	GO	BP	cellular potassium ion homeostasis	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,KCNJ2,KCNMA1	Any process involved in the maintenance of an internal steady state of potassium ions at the level of a cell.
GO:0030010	GO	BP	establishment of cell polarity	ARHGEF11,BRSK1,BRSK2,CCL19,CCL21,CCR7,CDK5RAP2,CENPA,CLASP1,DOCK7,DYNLT1,EPHB1,FBF1,FERMT1,FGF13,FOXJ1,FSCN1,GBF1,GOLPH3,HTT,MAP4,MARK2,MOS,MPP7,MSN,MYO18A,NDC80,NDE1,PAFAH1B1,PARD3,PRKCZ,PTK2,RAB10,RAB11FIP2,SCRIB,SDCCAG8,SIPA1L3,SLC9A3R1,SNX27,SPDL1,STK11,SYNE4,WWC1,ZW10	The specification and formation of anisotropic intracellular organization or cell growth patterns.
GO:0030011	GO	BP	maintenance of cell polarity	ANK1,CRB2,DST,NCKAP1L,SLC9A1	The maintenance of established anisotropic intracellular organization or cell growth patterns.
GO:0030014	GO	CC	CCR4-NOT complex	CNOT1,CNOT10,CNOT11,CNOT2,CNOT3,CNOT4,CNOT6,CNOT6L,CNOT7,CNOT8,CPEB3,PATL1,RQCD1,TNKS1BP1,TOB1	The evolutionarily conserved CCR4-NOT complex is involved in several aspects of mRNA metabolism, including repression and activation of mRNA initiation, control of mRNA elongation, and the deadenylation and subsequent degradation of mRNA. In Saccharomyces the CCR4-NOT complex comprises a core complex of 9 proteins (Ccr4p, Caf1p, Caf40p, Caf130p, Not1p, Not2p, Not3p, Not4p, and Not5p), Caf4p, Caf16p, and several less well characterized proteins.
GO:0030016	GO	CC	myofibril	ABRA,ACTA1,ACTC1,ACTN2,AHNAK,AHNAK2,ALDOA,ANK2,ANK3,ANKRD1,ANKRD2,ARHGEF25,ATP2A1,ATP2B4,BIN1,BMP10,CACNA1C,CACNA1D,CACNA1S,CALM1,CAPN3,CASQ2,CAV3,CFL2,CSRP3,DES,DMD,DNAJB6,DST,FKBP1A,FKBP1B,FLNC,HABP4,HRC,IGFN1,KCNE1,KLHL41,KRT19,KY,LDB3,MYBPC1,MYBPC3,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL2,MYL3,MYL4,MYL7,MYLK2,MYOM1,MYOM3,MYOT,MYOZ2,MYPN,MYZAP,NEB,NEBL,NEXN,NOS1AP,OBSCN,OBSL1,PAK1,PDE4B,PDE4DIP,PGM5,PLEC,PPP1R12A,PPP1R12B,PPP2R5A,PSMA6,RYR1,RYR2,SCN1A,SCN3B,SCN5A,SCN8A,SCO1,SCO2,SLC4A1,SLC8A1,SORBS2,SRI,SVIL,SYNE1,SYNE2,SYNM,SYNPO2,TCAP,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TRIM32,TTN,TWF1,TWF2,VCL	The contractile element of skeletal and cardiac muscle; a long, highly organized bundle of actin, myosin, and other proteins that contracts by a sliding filament mechanism.
GO:0030017	GO	CC	sarcomere	ABRA,ACTA1,ACTC1,ACTN2,AHNAK2,ALDOA,ANK2,ANKRD1,ANKRD2,ATP2A1,ATP2B4,BIN1,BMP10,CACNA1C,CACNA1D,CACNA1S,CALM1,CAPN3,CASQ2,CAV3,CFL2,CSRP3,DES,DMD,DNAJB6,DST,FKBP1A,FKBP1B,HABP4,HRC,IGFN1,KCNE1,KLHL41,KY,LDB3,MYBPC3,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL2,MYL3,MYL4,MYL7,MYLK2,MYOM1,MYOM3,MYOT,MYOZ2,MYPN,MYZAP,NEB,NEBL,NEXN,NOS1AP,OBSCN,OBSL1,PAK1,PDE4B,PPP1R12A,PPP1R12B,PPP2R5A,PSMA6,RYR1,RYR2,SCN1A,SCN3B,SCN5A,SCN8A,SLC4A1,SLC8A1,SORBS2,SRI,SYNE1,SYNE2,SYNPO2,TCAP,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TRIM32,TTN	The repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
GO:0030018	GO	CC	Z disc	ACTN2,AHNAK2,ANK2,ATP2B4,BIN1,BMP10,CACNA1C,CACNA1D,CAPN3,CASQ2,CAV3,CSRP3,DES,DMD,DNAJB6,DST,FKBP1A,FKBP1B,HRC,IGFN1,KCNE1,KY,LDB3,MYOT,MYOZ2,MYPN,NEB,NEBL,NEXN,NOS1AP,OBSCN,OBSL1,PAK1,PDE4B,PPP1R12A,PPP1R12B,RYR2,SCN1A,SCN3B,SCN5A,SCN8A,SLC4A1,SLC8A1,SORBS2,SRI,SYNE2,SYNPO2,TCAP,TTN	Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached.
GO:0030020	GO	MF	extracellular matrix structural constituent conferring tensile strength	COL11A2,COL12A1,COL2A1,COL9A1,COL9A2,COL9A3	A constituent of the extracellular matrix that enables the matrix to resist longitudinal stress.
GO:0030027	GO	CC	lamellipodium	ABI1,ABI2,ABI3,ABLIM1,ABLIM3,ACTA1,ACTA2,ACTC1,ACTG2,AIF1,ALS2,AMOT,ANTXR1,APBB1,APBB2,APC,APC2,ARAP3,ARHGEF6,ARHGEF7,ARPIN,BRK1,CCDC88A,CDH1,CDH2,CIB1,CLRN1,CORO1A,CORO1B,CORO1C,CTTN,CYFIP1,DAG1,DBNL,DGKZ,DPP4,DPYSL3,EVL,FAP,FER,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FLOT1,FLOT2,FSCN1,HAX1,IQGAP2,ITGAV,ITGB1BP1,ITGB3,KCNA2,LRRC16A,MYLK,NME2,PARVB,PDPN,PDXP,PHACTR4,PIP5K1A,PKD2,PKN2,PLCG1,PLEKHG5,PLEKHH2,PLXND1,PODXL,PPP1R9B,PTK2B,PTPN13,PTPRM,PTPRO,PXN,RAB13,RAC1,RAC2,RAPGEF3,RDX,RHOA,ROCK1,RUFY3,SCYL3,SH3BGRL3,SHTN1,SLC39A6,SLC9A1,SPATA13,SRGAP2,STMN2,STX2,STX3,STX4,SYNE2,TESC,TRPV4,TSC1,TWF2,VAMP7,VIL1,WASF2	A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments.
GO:0030031	GO	BP	cell projection assembly	ABCC4,ABLIM1,ABLIM3,ACTN2,ACTR2,AHI1,AIF1,ANO6,ARFIP2,ARHGEF4,ARHGEF6,ARHGEF7,ARL13B,ARL6,ARMC4,ATP6V0D1,ATP6V1D,B9D1,B9D2,BBIP1,BBOF1,BBS1,BBS10,BBS2,BBS4,BBS5,C2CD3,C5orf42,CC2D2A,CCDC103,CCDC113,CCDC114,CCDC13,CCDC151,CCDC28B,CCDC39,CCDC40,CCDC88A,CCL21,CCNO,CD2AP,CDH13,CEP126,CEP162,CEP164,CEP250,CEP290,CEP41,CEP83,CEP89,CFAP46,CFAP54,CFAP74,CSNK1D,CYFIP1,DISC1,DMD,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DNM3,DRC1,DYX1C1,DZIP1,DZIP1L,E2F4,EHD1,EHD3,EMP1,EMP2,EMP3,EZR,FAM161A,FBF1,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FLNA,FNBP1L,FOPNL,FOXJ1,FSCN1,FUZ,FXYD5,GOLPH3,ICK,IFT172,IFT20,IFT46,IFT74,IFT81,INPP5K,INTU,IQCB1,KIAA0586,KIF24,KIF27,KIF3A,KIT,LRGUK,LRRC16A,LRRC6,MCIDAS,MKKS,MKS1,MTSS1,MYLK,NEFH,NEK1,NME8,NTN1,OCRL,OPHN1,P2RX7,P2RY12,PARVB,PCM1,PCNT,PDGFA,PIBF1,PIH1D3,PIP5K1A,PKHD1,PMP22,POC1B,PPP1R9B,PTPRO,RAB17,RAB23,RAB3IP,RAB8A,RAC1,RAC3,RAP2A,RAPGEF2,RAPGEF6,RFX3,RHOD,RP1,RPGR,RSG1,RSPH1,RSPH4A,RSPH9,S1PR1,S1PR2,SCLT1,SDCBP,SEPT2,SHTN1,SLC9A3R1,SNAP29,SNX10,SPAG1,SPAG16,SPATA13,SPATA6,SRGAP2,SRGAP2C,SSX2IP,STK26,STK36,TCTN2,TMEM107,TMEM138,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TNIK,TTBK2,TTC26,TTC8,TTLL3,VANGL2,VCL,WDR35,WHAMM,ZMYND10	Formation of a prolongation or process extending from a cell, e.g. a flagellum or axon.
GO:0030032	GO	BP	lamellipodium assembly	ABLIM1,ABLIM3,ARFIP2,ARHGEF4,ARHGEF6,ARHGEF7,CCDC88A,CDH13,CYFIP1,GOLPH3,KIT,LRRC16A,PARVB,PTPRO,RAC1,RHOD,S1PR1,SPATA13,SRGAP2,VCL,WHAMM	Formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
GO:0030033	GO	BP	microvillus assembly	EZR,FXYD5,RAP2A,RAPGEF2,RAPGEF6,SLC9A3R1,STK26,TNIK	Formation of a microvillus, a thin cylindrical membrane-covered projection on the surface of a cell.
GO:0030041	GO	BP	actin filament polymerization	AIF1,ANG,ARHGAP6,CATIP,COBL,CORO7,GSN,JAK2,MICALL2,MSRB1,MSRB2,PREX1,RAC1,TTC17,VIL1,WASF1,WASF3	Assembly of actin filaments by the addition of actin monomers to a filament.
GO:0030048	GO	BP	actin filament-based movement	ACTA1,ACTC1,ACTN2,ACTN3,ACTN4,ANK2,CAMK2D,CAV3,DES,DMD,EMP2,FGF12,FNBP1L,GJA1,GJC1,GPD1L,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,MYBPC1,MYBPC2,MYBPC3,MYH10,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYH9,MYL1,MYL2,MYL3,MYL4,MYL6,MYL6B,MYO1B,MYO1E,MYO5A,MYO6,MYO7A,MYO9B,NEB,NEDD4L,PARVA,PKP2,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SHTN1,SNTA1,SUN2,SYNE2,TCAP,TMOD1,TNNC1,TNNC2,TNNI1,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TTN,VIL1,VIM,WASL	Movement of organelles or other particles along actin filaments, or sliding of actin filaments past each other, mediated by motor proteins.
GO:0030049	GO	BP	muscle filament sliding	ACTA1,ACTC1,ACTN2,ACTN3,DES,DMD,MYBPC1,MYBPC2,MYBPC3,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL2,MYL3,MYL4,MYL6,MYL6B,NEB,TCAP,TMOD1,TNNC1,TNNC2,TNNI1,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TTN,VIM	The sliding of actin thin filaments and myosin thick filaments past each other in muscle contraction. This involves a process of interaction of myosin located on a thick filament with actin located on a thin filament. During this process ATP is split and forces are generated.
GO:0030056	GO	CC	hemidesmosome	COL17A1,DST,ERBB2IP,ITGB4,PLEC	A cell-substrate junction (attachment structure) found in epithelial cells that links intermediate filaments to extracellular matrices via transmembrane complexes. In vertebrates, hemidesmosomes mediate contact between the basal side of epithelial cells and the basal lamina. In C. elegans, hemidesmosomes connect epithelial cells to distinct extracellular matrices on both the apical and basal cell surfaces.
GO:0030057	GO	CC	desmosome	B4GALT1,CDSN,DSC2,DSG1,DSG2,JAM3,JUP,KAZN,PKP1,PKP2,PKP4,UBA1,VCL	A cell-cell junction in which: on the cytoplasmic surface of each interacting plasma membrane is a dense plaque composed of a mixture of intracellular anchor proteins; a bundle of keratin intermediate filaments is attached to the surface of each plaque; transmembrane adhesion proteins of the cadherin family bind to the plaques and interact through their extracellular domains to hold the adjacent membranes together by a Ca2+-dependent mechanism.
GO:0030071	GO	BP	regulation of mitotic metaphase/anaphase transition	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CENPE,CENPF,CSNK2A1,CSNK2A2,CUL3,DLGAP5,DUSP1,DYNC1LI1,ESPL1,GEN1,KLHL22,LCMT1,MAD1L1,MAD2L1,MAD2L2,NEK6,NSMCE2,PCID2,PLK1,PTEN,RB1,SMC5,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of the onset of anaphase (chromosome movement) in the mitotic cell cycle.
GO:0030072	GO	BP	peptide hormone secretion	CAMK2G,CDK16,CRHR1,CYB5R4,EDN1,EDN3,EIF2AK3,EXOC3L1,FAM3B,GAL,GHRH,GHRL,GHSR,HNF1A,IL6,LTBP4,MAFA,NEUROD1,PDX1,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RIMS2,SLC30A8,SNX19,VIP	The regulated release of a peptide hormone from a cell.
GO:0030073	GO	BP	insulin secretion	CAMK2G,CYB5R4,EIF2AK3,FAM3B,GAL,HNF1A,MAFA,NEUROD1,PDX1,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RIMS2,SLC30A8,SNX19	The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin.
GO:0030091	GO	BP	protein repair	MSRA,MSRB1,MSRB2,MSRB3,PCMT1,TXN	The process of restoring a protein to its original state after damage by such things as oxidation or spontaneous decomposition of residues.
GO:0030098	GO	BP	lymphocyte differentiation	ADAM17,ADGRG3,AICDA,ANXA1,ATM,ATP7A,BATF,BLNK,CD1D,CD28,CD3D,CD4,CD74,CD79A,CEBPG,CHD7,CLCF1,CR2,DLL1,DLL4,EOMES,FADD,FLT3,FNIP1,FOXP1,FOXP3,GLI3,GPR183,HDAC4,HDAC5,HDAC9,HHEX,HMGB1,IKZF1,IL10,IL11,IL12B,IL2,IL4,IL6,IRF4,ITGA4,ITGB1,JAG2,JAK3,KIT,KLF6,LCK,LEF1,LEP,LEPR,LFNG,LIG4,LRRC8A,LY9,LYL1,MFNG,MSH2,NFAM1,NHEJ1,NOTCH2,PIK3CD,PLCG2,PTGER4,PTK2B,PTPN2,PTPN22,PTPRC,RAG1,RAG2,RHOH,RIPK3,RORA,RORC,RSAD2,SHH,SLAMF6,SOX4,TCF3,THEMIS,VCAM1,VPRBP,ZAP70,ZFPM1	The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
GO:0030099	GO	BP	myeloid cell differentiation	ACTN1,ALAS2,ANXA2,ATPIF1,BATF,BATF2,BATF3,BMP4,CAMK4,CASP3,CASP8,CASP9,CBFA2T3,CCL19,CCR7,CDC42,CEBPA,CEBPG,CIB1,CSF1,CSF1R,CSF2,CSF3,DCSTAMP,DMTN,DYRK3,EFNA2,EPHA2,EPO,F2RL1,FARP2,FLVCR1,FOXP1,G6PD,GAB2,GATA1,GATA2,GLO1,HCLS1,HIPK2,IFI16,IKZF1,IL11,IL31RA,IL4,INHA,INHBA,JAGN1,JAK2,KAT6A,KAT8,KIT,KLF1,KMT2E,LEF1,LYN,MAPK14,MED1,MEF2C,MMP9,MT1G,MYH9,NBEAL2,NCOA6,OCSTAMP,PARP1,PIK3CD,PIR,PPARG,PRDX3,PRKX,PRTN3,PTPN2,RASGRP4,RPS14,RPS19,RUNX1,SH3PXD2A,SLC25A38,SNRK,SNX10,TAL1,TET2,TGFBR2,TGFBR3,THOC5,TIRAP,TNFRSF11A,TNFSF11,UBD,VEGFA,VPS33A,ZBTB16,ZFPM1,ZNF385A	The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.
GO:0030100	GO	BP	regulation of endocytosis	AAK1,ABCA7,ABL1,ABL2,ADIPOQ,AHI1,AHSG,ALOX15,ANGPT1,ANKFY1,ANO6,ANXA2,AP2S1,APOA5,APOC1,APOC2,APOC3,ARF1,ARF6,ARRB1,ARRB2,ATAD1,ATXN2,AXL,AZU1,B2M,BICD1,C2,C3,C4A,C4B,C4BPA,C4BPB,CALR,CALY,CAMK1D,CAV1,CBL,CBLL1,CCL19,CCL2,CCL21,CD300A,CD63,CDH13,CLIP3,CYBA,DAB2,DKK1,DLG4,DLL1,DOCK2,F2RL1,FGR,FLOT1,GAS6,GATA2,GNB2L1,GREM1,HAMP,HCK,HFE,HIP1,HNRNPK,IL1B,ITGAV,LDLRAP1,LGALS3,LILRB1,LMAN2,LRSAM1,MAGI2,MERTK,MTMR2,NCKAP1L,NEDD4L,NLGN1,NR1H2,NR1H3,NTF3,PACSIN3,PCSK9,PICALM,PICK1,PIK3CB,PPT1,PRKD1,PROM2,PRTN3,PTPN1,PYCARD,RAB21,RAB27A,RAC1,RSPO1,RUBCN,SCAMP5,SCARB1,SCYL2,SDCBP,SELE,SERPINE1,SFRP4,SFTPD,SGIP1,SLC11A1,SNAP91,SNCA,SNX12,SNX17,SNX3,SNX33,SPACA3,SRC,STAP1,STON1,STON2,SYK,SYNJ1,TBC1D5,TF,TFR2,TNF,TNK2,TOR1A,TSC2,TSPAN1,TUB,TULP1,UBQLN2,UNC119,VEGFA,VPS28,VTN,WASL,WNT3A,ZFYVE16	Any process that modulates the frequency, rate or extent of endocytosis.
GO:0030101	GO	BP	natural killer cell activation	CASP8,CD2,CD244,CORO1A,ELF4,IFNB1,IFNK,IL12B,IL2,IL21R,KLRF2,KLRK1,NCR1,PIK3CD,SLAMF7,SNX27,ULBP1,ULBP2,ULBP3,VAMP7	The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0030104	GO	BP	water homeostasis	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ALOX12,ALOX12B,ALOXE3,AQP1,AQP2,AQP3,AQP4,AQP9,AVP,AVPR2,BPIFA1,CLDN1,CLDN4,CYP11B2,CYP4F12,GNAS,HAS2,HYAL2,KDF1,KRT16,MYO5B,NEDD4L,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,RAB11A,RAB11FIP2,SCNN1A,SCNN1B,SCNN1G,SFN,TFAP2B,TMEM79,TP63,TRPV4,WFS1	Any process involved in the maintenance of an internal steady state of water within an organism or cell.
GO:0030117	GO	CC	membrane coat	AFTPH,AP1G1,AP1G2,AP1S1,AP1S2,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,AP3M2,AP3S1,AP3S2,AP4M1,AP5B1,AP5M1,AP5S1,AP5Z1,ARCN1,ARL6,BAIAP2L2,C3orf58,CHMP1B,CHMP2A,CHMP4A,CHMP4B,CLTA,CLTB,CLTC,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,EGFR,KCNQ5,LDLRAP1,NCALD,NECAP2,PICALM,SCYL1,SEC24C,SEC24D,SEC31A,SEC31B,SGIP1,SYNJ1,SYNRG,TBC1D5,TMED3,TMED7,VMA21,VPS33A,VPS33B,VPS41	Any of several different proteinaceous coats that can associate with membranes. Membrane coats include those formed by clathrin plus an adaptor complex, the COPI and COPII complexes, and possibly others. They are found associated with membranes on many vesicles as well as other membrane features such as pits and perhaps tubules.
GO:0030118	GO	CC	clathrin coat	AFTPH,AP1G2,AP1S1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,BAIAP2L2,CLTA,CLTB,CLTC,EGFR,KCNQ5,LDLRAP1,NCALD,NECAP2,PICALM,SGIP1,SYNRG,TBC1D5,VPS33A,VPS33B,VPS41	A membrane coat found on coated pits and some coated vesicles; consists of polymerized clathrin triskelions, each comprising three clathrin heavy chains and three clathrin light chains, linked to the membrane via one of the AP adaptor complexes.
GO:0030119	GO	CC	AP-type membrane coat adaptor complex	AFTPH,AP1G1,AP1G2,AP1S1,AP1S2,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,AP3M2,AP3S1,AP3S2,AP4M1,AP5B1,AP5M1,AP5S1,AP5Z1,EGFR,LDLRAP1,PICALM,SGIP1,SYNRG,TBC1D5,VPS33A,VPS33B,VPS41	Any of several heterotetrameric complexes that link clathrin (or another coat-forming molecule, as hypothesized for AP-3 and AP-4) to a membrane surface; they are found on coated pits and coated vesicles, and mediate sorting of cargo proteins into vesicles. Each AP complex contains two large (a beta and one of either an alpha, gamma, delta, or epsilon) subunits (110-130 kDa), a medium (mu) subunit (approximately 50 kDa), and a small (sigma) subunit (15-20 kDa).
GO:0030120	GO	CC	vesicle coat	AFTPH,AP1G2,AP1S1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARCN1,C3orf58,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,EGFR,LDLRAP1,NCALD,NECAP2,PICALM,SCYL1,SEC24C,SEC24D,SEC31A,SEC31B,SGIP1,SYNRG,TBC1D5,TMED3,TMED7,VMA21	A membrane coat found on a coated vesicle.
GO:0030121	GO	CC	AP-1 adaptor complex	AFTPH,AP1G2,AP1S1,LDLRAP1,SYNRG	A heterotetrameric AP-type membrane coat adaptor complex that consists of beta1, gamma, mu1 and sigma1 subunits and links clathrin to the membrane surface of a vesicle; vesicles with AP-1-containing coats are normally found primarily in the trans-Golgi network. In at least humans, the AP-1 complex can be heterogeneric due to the existence of multiple subunit isoforms encoded by different genes (gamma1 and gamma2, mu1A and mu1B, and sigma1A, sigma1B and sigma1C).
GO:0030122	GO	CC	AP-2 adaptor complex	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,EGFR,LDLRAP1,PICALM,SGIP1,TBC1D5	A heterotetrameric AP-type membrane coat adaptor complex that consists of alpha, beta2, mu2 and sigma2 subunits, and links clathrin to the membrane surface of a vesicle; vesicles with AP-2-containing coats are normally found primarily near the plasma membrane, on endocytic vesicles. In at least humans, the AP-2 complex can be heterogeneric due to the existence of multiple subunit isoforms encoded by different alpha genes (alphaA and alphaC).
GO:0030123	GO	CC	AP-3 adaptor complex	AP3S1,AP3S2,VPS33A,VPS33B,VPS41	A heterotetrameric AP-type membrane coat adaptor complex that consists of beta3, delta, mu3 and sigma3 subunits and is found associated with endosomal membranes. AP-3 does not appear to associate with clathrin in all organisms. In at least humans, the AP-3 complex can be heterogeneric due to the existence of multiple subunit isoforms encoded by different genes (beta3A and beta3B, mu3A and mu3B, and sigma3A and sigma3B).
GO:0030125	GO	CC	clathrin vesicle coat	AFTPH,AP1G2,AP1S1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,EGFR,LDLRAP1,NCALD,NECAP2,PICALM,SGIP1,SYNRG,TBC1D5	A clathrin coat found on a vesicle.
GO:0030126	GO	CC	COPI vesicle coat	ARCN1,C3orf58,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,SCYL1,TMED3,TMED7	One of two multimeric complexes that forms a membrane vesicle coat. The mammalian COPI subunits are called alpha-, beta-, beta'-, gamma-, delta-, epsilon- and zeta-COP. Vesicles with COPI coats are found associated with Golgi membranes at steady state.
GO:0030127	GO	CC	COPII vesicle coat	SEC24C,SEC24D,SEC31A,TMED7,VMA21	One of two multimeric complexes that forms a membrane vesicle coat. COPII is best characterized in S. cerevisiae, where the subunits are called Sar1p, Sec13p, Sec31p, Sec23p, and Sec24p. Vesicles with COPII coats are found associated with endoplasmic reticulum (ER) membranes at steady state.
GO:0030130	GO	CC	clathrin coat of trans-Golgi network vesicle	AFTPH,AP1G2,AP1S1,AP2A1,LDLRAP1,NCALD,SYNRG	A clathrin coat found on a vesicle of the trans-Golgi network.
GO:0030131	GO	CC	clathrin adaptor complex	AFTPH,AP1G2,AP1S1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,EGFR,LDLRAP1,PICALM,SGIP1,SYNRG,TBC1D5	A membrane coat adaptor complex that links clathrin to a membrane.
GO:0030133	GO	CC	transport vesicle	AFTPH,AMPH,ANXA13,AP1AR,AP1G2,AP1S1,AP2A1,AP3S1,APH1B,AQP2,AQP6,ARCN1,AREG,ATP7A,AZIN2,B2M,BET1,BGN,BLOC1S3,BLOC1S5,BLOC1S6,BRSK1,C14orf1,CA4,CAV2,CD55,CD59,CD74,CDK16,CHP1,CLCN3,CLN3,CNIH1,CNIH2,CNIH3,CNST,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPS4,COPS5,COPZ1,COPZ2,CRISPLD2,CTSC,CTSZ,DLG4,DMXL2,DPYSL3,DTNBP1,ERP29,F5,F8,FGFR3,FGFR4,FGFRL1,FOLR1,FURIN,GABRA2,GALNT15,GIPC1,GOLGA2,GOPC,GOSR2,GRIA1,GRIN1,HCRT,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,ICA1,IGF2R,INS,KDELR1,KLHL12,LDLRAP1,LMAN1,LMAN2L,MCFD2,MME,MT3,MTMR2,NCALD,NRSN1,NRSN2,OTOF,PLEKHF2,PPT1,PTPRN,PTPRN2,RAB11B,RAB14,RAB1B,RAB27A,RAB27B,RAB3A,RAB5A,RAB6A,RASSF9,RPH3A,SAR1B,SEC13,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEMA4C,SEPT5,SERPINA1,SLC17A6,SLC17A7,SLC17A8,SLC18A1,SLC18A2,SLC18A3,SLC30A3,SLC32A1,SLC6A17,SNAPIN,SNCAIP,SPG21,SSPN,STEAP2,STX17,STX5,SV2A,SV2B,SV2C,SVOP,SYN1,SYN2,SYN3,SYNGR3,SYNRG,SYP,SYT1,SYT11,SYT13,SYT2,SYTL2,TGFA,TGOLN2,TMED10,TMED2,TMED3,TMED7,TMED9,TMEM163,TMEM168,TMEM187,TOR1A,TPRG1L,TRAPPC4,UNC13D,USO1,VAMP1,VAMP2,VMA21,VTI1A,VTI1B,YIPF1,YIPF2,YIPF3,YKT6	Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell.
GO:0030134	GO	CC	ER to Golgi transport vesicle	AREG,B2M,CD59,CD74,CNIH1,CNIH2,CNIH3,COL7A1,CTSC,CTSZ,F5,F8,FOLR1,GOLGA2,GOSR2,GRIA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,KLHL12,LMAN1,LMAN2L,MCFD2,SAR1B,SEC13,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,STX17,STX5,TGFA,TMED10,TMED2,TMED7,USO1,VMA21	A vesicle that mediates transport from the endoplasmic reticulum to the Golgi complex; bears a coat formed of the COPII coat complex proteins; such vesicles found associated with endoplasmic reticulum (ER) membranes at steady state, and are involved in ER to Golgi (anterograde) vesicle transport.
GO:0030135	GO	CC	coated vesicle	AAK1,AFTPH,AP1B1,AP1G1,AP1G2,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,AP3B2,APOB,ARCN1,AREG,ATP7A,B2M,C3orf58,CD207,CD59,CD74,CD9,CEMIP,CLTC,CLTCL1,CLVS1,CLVS2,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,CTLA4,CTSC,CTSZ,DAB2,DENND1A,DNAJC5,DVL2,ECE1,EGFR,EPN3,F5,F8,FAM109A,FAM109B,FCGR1A,FCGR1B,FCHO1,FCHO2,FOLR1,FURIN,FZD2,FZD4,FZD5,GAD1,GAD2,GGA2,GOLGA2,GOPC,GOSR2,GRIA1,HBEGF,HIP1,HIP1R,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HSPA8,HSPD1,IGF2R,KLHL12,LDLR,LDLRAP1,LMAN1,LMAN2L,MALL,MCFD2,MYO1E,MYO6,NCALD,NECAP2,NUMB,OCRL,PICALM,RAB14,RAB27B,RAB35,RAB3A,RASSF9,ROR2,SAR1B,SCAMP1,SCYL1,SEC13,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEC31B,SERPINA1,SFTA3,SFTPA1,SFTPA2,SFTPB,SFTPC,SFTPD,SGIP1,SH3GL2,SLC17A7,SLC18A1,SLC18A2,SLC18A3,SLC2A4,SLC32A1,SNX18,SNX3,SNX9,SORT1,SPG21,STEAP2,STX17,STX5,STX6,SYNRG,SYT1,TBC1D5,TGFA,TMED10,TMED2,TMED3,TMED7,TMED9,TNK2,TYRP1,UNC13D,USO1,VAMP2,VAMP3,VMA21,VPS33B,VPS41,VTI1A,VWF,WNT5A	Small membrane-bounded organelle formed by pinching off of a coated region of membrane. Some coats are made of clathrin, whereas others are made from other proteins.
GO:0030136	GO	CC	clathrin-coated vesicle	AAK1,AFTPH,AP1B1,AP1G1,AP1G2,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOB,ATP7A,CD207,CD74,CD9,CEMIP,CLTC,CLTCL1,CLVS1,CLVS2,CTLA4,DAB2,DENND1A,DNAJC5,DVL2,ECE1,EGFR,EPN3,FAM109A,FAM109B,FCGR1A,FCGR1B,FCHO1,FCHO2,FURIN,FZD2,FZD4,FZD5,GAD1,GAD2,GGA2,GOPC,HBEGF,HIP1,HIP1R,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HSPA8,IGF2R,LDLR,LDLRAP1,MALL,MYO1E,MYO6,NCALD,NECAP2,NUMB,OCRL,PICALM,RAB14,RAB27B,RAB35,RAB3A,RASSF9,ROR2,SCAMP1,SFTA3,SFTPA1,SFTPA2,SFTPB,SFTPC,SFTPD,SGIP1,SH3GL2,SLC17A7,SLC18A1,SLC18A2,SLC18A3,SLC2A4,SLC32A1,SNX18,SNX3,SNX9,SORT1,SPG21,STEAP2,STX6,SYNRG,SYT1,TBC1D5,TMED10,TMED9,TNK2,TYRP1,UNC13D,VAMP2,VAMP3,VPS33B,VPS41,VTI1A,VWF,WNT5A	A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.
GO:0030137	GO	CC	COPI-coated vesicle	AP3B2,ARCN1,C3orf58,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,SCYL1,TMED10,TMED2,TMED3,TMED7	A vesicle with a coat formed of the COPI coat complex proteins. COPI-coated vesicles are found associated with Golgi membranes at steady state, are involved in Golgi to endoplasmic reticulum (retrograde) vesicle transport, and possibly also in intra-Golgi transport.
GO:0030140	GO	CC	trans-Golgi network transport vesicle	AFTPH,AP1G2,AP1S1,AP2A1,ATP7A,FURIN,GOPC,IGF2R,LDLRAP1,NCALD,RAB14,RAB27B,RASSF9,SPG21,STEAP2,SYNRG,TMED10,TMED9	A vesicle that mediates transport between the trans-Golgi network and other parts of the cell.
GO:0030141	GO	CC	secretory granule	A2M,ABCA12,ABCA3,ABCC4,ACR,ACTN1,ACTN2,ACTN4,ADAM8,ALB,ALDOA,ANXA11,ANXA3,ANXA7,APOA1,APP,ASTL,AZU1,BRCA2,CA4,CAMP,CARTPT,CASC5,CD36,CD63,CD9,CFD,CKAP4,CLCN3,CLU,CPA3,CPE,CRHBP,CRISP3,CTSG,CTSH,CUZD1,CXADR,CYBA,CYLC1,DBH,DEFA1,DEFA3,DEFA4,DEFA5,DENND4C,DMBT1,ECE1,EGF,ELANE,EQTN,EXOC3,EXOC3L1,F13A1,F5,F8,FAM170B,FGA,FGB,FGG,FIGF,FN1,GAS6,GCG,GHRHR,GHRL,GIP,HEXA,HEXB,HGF,HILPDA,HPS4,HRG,HSPD1,ICA1,IGF1,IGF2,INS,IQCF1,ITGA2B,ITGB3,ITPR1,KLK5,KLK7,KNG1,LACRT,LAMP2,LEFTY2,LRGUK,LTF,MMRN1,MPO,MYO5A,MYRIP,NAPSA,OLFM4,PCSK1,PCSK2,PCSK5,PDGFA,PDGFB,PECAM1,PF4,PLG,POMC,PPBP,PROS1,PTPRN,PTPRN2,RAB10,RAB11FIP5,RAB13,RAB26,RAB4B,RPH3A,SCG3,SCG5,SELP,SERPINA1,SERPINA5,SERPINE1,SERPINE2,SERPINF2,SERPING1,SFTA3,SFTPA1,SFTPA2,SFTPB,SFTPC,SFTPD,SLC11A1,SLC2A4,SLC30A5,SLC30A8,SNAP23,SNAPIN,SNCA,SPACA3,SPACA7,SPARC,SPINK5,SRGN,SRI,STX3,STX4,STX7,STXBP1,STXBP2,STXBP3,TEKT3,TF,TGFB1,TGFB2,TGFB3,THBS1,THBS2,TIMP1,TMED10,TMED2,TMSB4X,TOR1A,TREML1,UNC13D,VAMP1,VAMP2,VAMP7,VAMP8,VEGFA,VEGFB,VEGFC,VPS33B,VWF,ZP2,ZP3	A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
GO:0030145	GO	MF	manganese ion binding	ABL1,ABL2,ADCY2,ATP2C1,B4GALT1,B4GALT7,DYRK2,ENDOU,FAM20C,GALNT1,GALNT2,GALNT3,GYLTL1B,HMGCL,IDI1,IMPA1,LARGE,ME1,MPPE1,MTPAP,NEK4,NUDT16,PAPOLA,PCK1,PIM1,PPM1M,PRIMPOL,SOD2,TDP2,WRN,XPNPEP1	Interacting selectively and non-covalently with manganese (Mn) ions.
GO:0030148	GO	BP	sphingolipid biosynthetic process	A4GALT,ACER1,ACER2,ACER3,ALDH3A2,ALDH3B1,ALOX12B,ALOXE3,CERS1,CERS2,CERS3,CERS4,CERS5,CERS6,CLN8,COL4A3BP,CSNK1G2,DEGS1,DEGS2,ELOVL1,FA2H,GBA,HACD1,HACD2,KDSR,LARGE,PLPP1,PLPP2,PLPP3,PPM1L,PRKD1,SAMD8,SGMS1,SGMS2,SGPL1,SGPP1,SGPP2,SMPD1,SMPD4,SPHK1,SPHK2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,ST3GAL5,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,UGCG,VAPA,VAPB	The chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).
GO:0030149	GO	BP	sphingolipid catabolic process	ACER1,GALC,GBA,GBA3,GLA,NEU2,NEU3,NEU4,PPT1,SGPL1,SMPD3,SMPD4,SPHK1	The chemical reactions and pathways resulting in the breakdown of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).
GO:0030159	GO	MF	receptor signaling complex scaffold activity	CARD10,CD3E,CD3G,DEDD2,DLG5,G3BP2,GRIP1,LDLRAP1,LRRK2,MAGI2,MMS19,NCK1,NCK2,NUP62,RGS14,ROPN1B,SHANK1,SHANK2,SHANK3	Functions to provide a physical support for the assembly of a multiprotein receptor signaling complex.
GO:0030165	GO	MF	PDZ domain binding	ACOX1,ARHGAP29,ATP2B2,CADM1,CCDC88C,CFTR,CIT,CLCN3,CRIM1,CRIPT,DLG4,ERC1,FZD4,GNG12,GNG5,GRIA1,GRID2,GRM7,KIDINS220,KIF14,MAP2K2,NLGN1,RAPGEF2,SLC26A6,SLC9A3,TGFBR3,TMEM88	Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.
GO:0030166	GO	BP	proteoglycan biosynthetic process	B3GAT3,BCAN,BGN,BMPR1B,BMPR2,CANT1,CHPF,CHPF2,CHST11,CHST12,CHST13,CHST14,CHST15,CHST3,CHST7,CHST8,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,EXT1,EXT2,FOXL1,GAL3ST3,GAL3ST4,GLCE,HS3ST3B1,HS3ST5,IGF1,NCAN,PXYLP1,UST,VCAN,XYLT2	The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
GO:0030169	GO	MF	low-density lipoprotein particle binding	ANKRA2,CD36,CDH13,COLEC12,CRP,LIPC,MSR1,PCSK9,SCARB1,SCARF1,STAB1,STAB2,THBS1	Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.
GO:0030170	GO	MF	pyridoxal phosphate binding	ABAT,ACCS,AGXT,ALB,CBS,CTH,PDXK,SDS,SHMT1,SHMT2,SRR,THNSL2	Interacting selectively and non-covalently with pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.
GO:0030173	GO	CC	integral component of Golgi membrane	A4GALT,ACER2,ACER3,B4GAT1,CHST12,CSGALNACT1,CSGALNACT2,ENTPD4,GALNT2,GFY,LARGE,MAN1C1,PCSK7,QSOX1,RER1,SGMS1,SGMS2,SLC39A13,STEAP2,TBC1D20,UBIAD1	The component of the Golgi membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0030175	GO	CC	filopodium	ABI1,ABI2,ACTA1,ACTA2,ACTC1,ACTG2,ACTN2,ANTXR1,ARF6,CD302,CDC42,CIB1,CXADR,DAG1,DMD,EZR,FGF13,FSCN1,GAP43,GPM6A,IQGAP2,ITGA3,ITGAV,ITGB1,ITGB3,LCP1,MSN,MTM1,MYO10,MYO1B,MYO3A,MYO5A,NLGN1,PALM,PDPN,PODXL,PPP1R9B,RAPGEF3,RDX,RUFY3,SHTN1,SPATA13,SYNE2,TBC1D10C,TENM2,TRPV4,TWF1,TWF2,UTRN,VCAM1,VIL1	Thin, stiff, actin-based protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal or dendritic growth cone, or a dendritic shaft.
GO:0030176	GO	CC	integral component of endoplasmic reticulum membrane	ABCB9,ACER3,AMFR,ANKLE2,ASPH,ATF6,ATF6B,BCAP31,BFAR,BNIP1,BSCL2,CALR,CANX,CD74,CLN3,CREB3,DCSTAMP,DERL1,DERL2,DERL3,DGAT2,DHRS9,DOLK,DOLPP1,DPAGT1,DPM3,EDEM1,EIF2AK3,ELOVL1,ELOVL4,EMC1,EMC10,EMC2,EMC3,EMC4,EMC6,EMC7,EMC8,EMC9,ERN1,ESYT1,EXT1,FAM134B,FITM2,G6PC,GPAA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HM13,HSPA5,INSIG1,INSIG2,LRIT1,MARCH6,MBOAT4,MMGT1,PIGK,PIGS,PIGT,PIGU,PKD2,RHBDD1,RTN1,RTN2,RTN4,SAMD8,SARAF,SEC61A1,SGPL1,SLC27A2,SLC27A5,SLC37A4,SPCS1,SPPL2A,SPPL2B,SPPL2C,SPPL3,SREBF2,STIM1,SYVN1,TAP1,TAP2,TAPBP,TBL2,TECR,UBXN8,VIMP,WFS1,XBP1	The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0030177	GO	BP	positive regulation of Wnt signaling pathway	AMER1,APC,ARNTL,ATP6AP2,ATP6V0C,ATP6V1C2,AXIN1,AXIN2,BAMBI,BMP2,CAPRIN2,CAV1,CCAR2,CDC73,COL1A1,CSNK1A1,CSNK1D,CSNK1E,CSNK1G2,CSNK2A1,CTNNB1,DAB2,DACT1,DAPK3,DEPDC1B,DISC1,DIXDC1,DKK2,DVL1,DVL2,DVL3,FGFR2,FRAT1,FRAT2,FZD1,FZD2,FZD5,GPRC5B,GSK3B,HHEX,ILK,JUP,KANK1,LGR4,LGR5,LGR6,LRP5,LRP6,LRRK1,LRRK2,MACF1,MLLT3,NFKB1,NKD1,NRARP,PIN1,PPM1A,PPP1CA,PPP2R3A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RNF146,RNF220,RPS27A,RSPO1,SALL1,SFRP1,SFRP2,SFRP4,SKI,SMAD3,SMARCA4,SMURF2,SOX4,SPIN1,SULF1,SULF2,TERT,TLR2,TMEM198,TNKS,TNKS2,TRPM4,UBA52,UBB,UBC,UBR5,USP34,WLS,WNT1,WNT2,WNT2B,WNT3A,WNT4,WNT8A,WNT8B,XIAP,ZBED3,ZRANB1	Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
GO:0030178	GO	BP	negative regulation of Wnt signaling pathway	AES,AMER1,AMER2,APC,APC2,APCDD1,APOE,AXIN1,AXIN2,BICC1,BMP2,CAV1,CBY1,CHD8,CITED1,CSNK1A1,CTNND1,CUL3,CXXC4,CYLD,DAB2,DAB2IP,DACT1,DACT3,DDIT3,DKK1,DKK2,DKK3,DKK4,DRAXIN,DVL1,DVL2,DVL3,FRZB,FUZ,FZD6,GLI1,GLI3,GNB2L1,GRB10,GREM1,GSK3A,GSK3B,HDAC1,HECW1,HIC1,HMGXB4,INVS,KIAA0922,KLHL12,KREMEN2,LATS1,LATS2,LEF1,LIMD1,LRP1,LRP4,LRP6,MAD2L2,MCC,MDFI,MED12,MESP1,MLLT3,NFATC1,NKD1,NKD2,NKX2-5,NLK,NOG,NOTUM,NPHP3,NXN,PARK2,PFDN5,PPP2R3A,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTPRO,RBX1,RNF43,RPS27A,SCYL2,SDHAF2,SFRP1,SFRP2,SFRP4,SFRP5,SIAH2,SNAI2,SOST,SOX17,SOX2,SOX9,STK3,STK4,TAX1BP3,TBX18,TCF7L2,TLE1,TLE2,TMEM88,TRABD2A,TRABD2B,UBA52,UBB,UBC,WIF1,WNT11,WNT3A,WNT4,WNT5A,WNT9A,WWOX,WWTR1,ZNRF3	Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
GO:0030183	GO	BP	B cell differentiation	ADAM17,ADGRG3,AICDA,ATM,BLNK,CD79A,CEBPG,CLCF1,CR2,DLL1,FLT3,FNIP1,GPR183,HDAC4,HDAC5,HDAC9,HHEX,IL10,IL11,IL4,ITGA4,ITGB1,JAK3,KIT,KLF6,LFNG,LRRC8A,LYL1,MFNG,MSH2,NFAM1,NHEJ1,NOTCH2,PLCG2,PTK2B,PTPN2,RAG1,RAG2,TCF3,VCAM1,VPRBP	The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
GO:0030193	GO	BP	regulation of blood coagulation	ADAMTS18,ALOX12,ANO6,APOE,APOH,ASIC2,C1QTNF1,CAV1,CD34,CLEC4M,DMTN,EDN1,ENPP4,F11,F12,F2,F2R,F2RL1,F3,FAM46A,FAP,FGA,FGB,FGG,FOXA2,GP1BA,HPSE,HRG,KLKB1,KNG1,KRT1,LBH,LYN,NOS3,PDGFA,PDGFB,PDGFRA,PLAT,PLAU,PLAUR,PLEK,PLG,PRKCA,PRKCD,PRKCQ,PRKG1,PROC,SCARA5,SELP,SERPINB2,SERPINE1,SERPINE2,SERPINF2,STAB2,STX2,STXBP5,SYK,TC2N,TEC,THBD,THBS1,TLR4,TMPRSS6,USF1,VAV2,VTN	Any process that modulates the frequency, rate or extent of blood coagulation.
GO:0030194	GO	BP	positive regulation of blood coagulation	ANO6,APOH,DMTN,ENPP4,F12,F2,F2R,F3,HPSE,PLEK,PLG,SELP,SERPINE1,SERPINF2,THBD,THBS1,TLR4,USF1	Any process that activates or increases the frequency, rate or extent of blood coagulation.
GO:0030195	GO	BP	negative regulation of blood coagulation	ADAMTS18,ALOX12,APOE,APOH,C1QTNF1,CD34,EDN1,F11,F12,F2,FGA,FGB,FGG,GP1BA,HRG,KLKB1,KNG1,KRT1,NOS3,PDGFA,PDGFB,PDGFRA,PLAT,PLAU,PLAUR,PLG,PRKCD,PRKG1,PROC,SERPINB2,SERPINE1,SERPINE2,SERPINF2,THBD,TMPRSS6,VTN	Any process that stops, prevents, or reduces the frequency, rate or extent of blood coagulation.
GO:0030199	GO	BP	collagen fibril organization	ADAMTS3,ATP7A,COL11A1,COL11A2,COL12A1,COL14A1,COL1A1,COL1A2,COL2A1,COL3A1,COL5A1,COL5A2,COL5A3,CYP1B1,DDR2,GREM1,LOXL2,LUM,NF1,SCX,SERPINF2,TGFB2,TGFBR1	Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
GO:0030201	GO	BP	heparan sulfate proteoglycan metabolic process	B3GAT3,CSGALNACT1,EXT1,EXT2,GLCE,GPC1,HPSE,HS3ST3B1,HS3ST4,HS3ST5,SULF1,SULF2,XYLT2	The chemical reactions and pathways involving any proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.
GO:0030203	GO	BP	glycosaminoglycan metabolic process	ABCC5,ACAN,AGRN,ANGPT1,ARSB,B3GALT6,B3GAT1,B3GAT2,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,BCAN,BGN,CD44,CEMIP,CHP1,CHPF,CHPF2,CHST1,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST5,CHST6,CHST7,CHST9,CHSY1,CHSY3,CLN6,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,EXT1,EXT2,FGF2,FMOD,FUCA1,GALNS,GALNT5,GCNT2,GLB1,GLCE,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,GXYLT1,HAS1,HAS2,HAS3,HEXA,HEXB,HGSNAT,HMMR,HPSE,HPSE2,HS2ST1,HS3ST1,HS3ST2,HS3ST3A1,HS3ST3B1,HS3ST5,HS3ST6,HS6ST1,HS6ST2,HSPG2,HYAL1,HYAL2,HYAL3,HYAL4,IDS,IDUA,IL1B,KERA,LUM,LYVE1,NAGLU,NCAN,NDNF,NDST1,NDST2,OGN,OMD,PAPSS1,PAPSS2,PRELP,PXYLP1,SDC1,SDC2,SDC3,SDC4,SGSH,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SLC35D2,SLC9A1,SPACA3,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6,STAB2,TGFB1,UGDH,UST,VCAN,XYLT1,XYLT2	The chemical reactions and pathways involving glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars. Formerly known as mucopolysaccharides, they include hyaluronic acid and chondroitin, which provide lubrication in joints and form part of the matrix of cartilage. The three-dimensional structure of these molecules enables them to trap water, which forms a gel and gives glycosaminoglycans their elastic properties.
GO:0030204	GO	BP	chondroitin sulfate metabolic process	AGRN,ARSB,B3GALT6,B3GAT1,B3GAT2,B3GAT3,B4GALT7,BCAN,BGN,CHPF,CHPF2,CHST11,CHST12,CHST13,CHST14,CHST15,CHST3,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GXYLT1,HEXA,HEXB,HSPG2,HYAL1,IDS,IDUA,NCAN,NDNF,SDC1,SDC2,SDC3,SDC4,UST,VCAN	The chemical reactions and pathways involving chondroitin sulfate, any member of a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues, the repeat units of which consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate. They usually occur linked to a protein to form proteoglycans. Two subgroups exist, one in which the sulfate is on the 4-position (chondroitin sulfate A) and the second in which it is in the 6-position (chondroitin sulfate C). They often are polydisperse and often differ in the degree of sulfation from tissue to tissue. The chains of repeating disaccharide are covalently linked to the side chains of serine residues in the polypeptide backbone of a protein by a glycosidic attachment through the trisaccharide unit galactosyl-galactosyl-xylosyl. Chondroitin sulfate B is more usually known as dermatan sulfate.
GO:0030205	GO	BP	dermatan sulfate metabolic process	BCAN,BGN,CHST12,CHST14,CSPG4,CSPG5,DCN,DSE,DSEL,IDUA,NCAN,UST,VCAN	The chemical reactions and pathways involving dermatan sulfate, any of a group of glycosaminoglycans with repeats consisting of beta-(1,4)-linked L-iduronyl-beta-(1,3)-N-acetyl-D-galactosamine 4-sulfate units. They are important components of ground substance or intercellular cement of skin and some connective tissues.
GO:0030206	GO	BP	chondroitin sulfate biosynthetic process	BCAN,BGN,CHPF,CHPF2,CHST11,CHST12,CHST13,CHST15,CHST3,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,NCAN,VCAN	The chemical reactions and pathways resulting in the formation of chondroitin sulfate, any member of a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues, the repeat units of which consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate.
GO:0030207	GO	BP	chondroitin sulfate catabolic process	ARSB,BCAN,BGN,CSPG4,CSPG5,DCN,HEXA,HEXB,HYAL1,IDS,IDUA,NCAN,VCAN	The chemical reactions and pathways resulting in the breakdown of chondroitin sulfate, any member of a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues, the repeat units of which consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate.
GO:0030208	GO	BP	dermatan sulfate biosynthetic process	BCAN,BGN,CHST12,CHST14,CSPG4,CSPG5,DCN,DSE,DSEL,NCAN,UST,VCAN	The chemical reactions and pathways resulting in the formation of dermatan sulfate, any glycosaminoglycan with repeats consisting of beta-(1,4)-linked L-iduronyl-beta-(1,3)-N-acetyl-D-galactosamine 4-sulfate units.
GO:0030212	GO	BP	hyaluronan metabolic process	ABCC5,CD44,CEMIP,CHP1,FGF2,GUSB,HAS1,HAS2,HAS3,HEXA,HEXB,HMMR,HYAL1,HYAL2,HYAL3,IL1B,LYVE1,SLC9A1,STAB2,TGFB1	The chemical reactions and pathways involving hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
GO:0030213	GO	BP	hyaluronan biosynthetic process	ABCC5,CEMIP,HAS1,HAS2,HAS3,HYAL1,IL1B	The chemical reactions and pathways resulting in the formation of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
GO:0030214	GO	BP	hyaluronan catabolic process	CD44,CEMIP,CHP1,FGF2,GUSB,HEXA,HEXB,HMMR,HYAL1,HYAL2,HYAL3,LYVE1,SLC9A1,STAB2,TGFB1	The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
GO:0030216	GO	BP	keratinocyte differentiation	ANXA1,CASP14,CDH3,CDSN,CERS3,CLIC4,CSTA,DSP,EPHA2,EREG,EVPL,EXPH5,FLG,IVL,JAG1,KRT16,KRT2,LOR,MED1,PIP5K1A,S100A7,SCEL,SPRR1A,SPRR1B,SPRR2A,SPRR2B,SPRR2F,SPRR2G,SPRR3,ST14,TGM1,TGM3,TXNIP,WNT16	The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte.
GO:0030217	GO	BP	T cell differentiation	ADAM17,ANXA1,ATP7A,BATF,CD1D,CD28,CD3D,CD4,CD74,CHD7,DLL4,EOMES,FADD,FOXP1,FOXP3,GLI3,HMGB1,IL12B,IL2,IL6,IRF4,JAG2,KIT,LCK,LEF1,LEP,LEPR,LFNG,LIG4,LY9,NHEJ1,PIK3CD,PTGER4,PTPN2,PTPN22,PTPRC,RAG1,RAG2,RHOH,RIPK3,RORA,RORC,RSAD2,SHH,SLAMF6,SOX4,THEMIS,ZAP70,ZFPM1	The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
GO:0030218	GO	BP	erythrocyte differentiation	ALAS2,ATPIF1,CASP3,CEBPG,DMTN,DYRK3,EPO,FLVCR1,G6PD,GATA1,HCLS1,HIPK2,IKZF1,INHA,INHBA,JAK2,KIT,KLF1,KMT2E,LYN,MED1,PTPN2,RPS14,RPS19,SLC25A38,TAL1,TGFBR3,VEGFA,ZFPM1	The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
GO:0030219	GO	BP	megakaryocyte differentiation	GATA1,IL11,KIT,MED1,ZFPM1,ZNF385A	The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
GO:0030220	GO	BP	platelet formation	ACTN1,CASP3,CASP9,CIB1,GATA1,MEF2C,MYH9,NBEAL2,VPS33A,ZFPM1	The process in which platelets bud from long processes extended by megakaryocytes.
GO:0030224	GO	BP	monocyte differentiation	BMP4,CSF1R,IFI16,MT1G,PIR,PPARG,THOC5,VEGFA	The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
GO:0030225	GO	BP	macrophage differentiation	BMP4,CASP8,CDC42,CSF1,CSF1R,IL31RA,MMP9,PARP1,VEGFA	The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
GO:0030228	GO	MF	lipoprotein particle receptor activity	CD36,CXCL16,LDLR,LRP12,LRP6,LRP8,SCARB1,STAB1,STAB2,VLDLR	Combining with a lipoprotein particle and delivering the lipoprotein particle into the cell via endocytosis. A lipoprotein particle, also known as a lipoprotein, is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.
GO:0030235	GO	MF	nitric-oxide synthase regulator activity	AKT1,ATP2B4,EGFR,ESR1,HSP90AA1,HSP90AB1	Modulates the activity of nitric oxide synthase.
GO:0030239	GO	BP	myofibril assembly	ACTA1,ACTC1,ACTN2,ANKRD1,BMP10,CAPN3,CASQ1,CFLAR,CSRP3,KLHL41,KRT19,MEF2A,MYH11,MYH3,MYH6,MYL2,MYLK3,MYOZ1,MYPN,NEBL,OBSCN,OBSL1,PDGFRA,PDGFRB,PROX1,SIX4,TCAP,TPM1,TTN	Formation of myofibrils, the repeating units of striated muscle.
GO:0030240	GO	BP	skeletal muscle thin filament assembly	ACTA1,ACTC1,PROX1,TCAP,TTN	The aggregation, arrangement and bonding together of proteins to form the actin-based thin filaments of myofibrils in skeletal muscle.
GO:0030246	GO	MF	carbohydrate binding	ACR,ALDOA,ALDOB,C4B,CALR,CD207,CD209,CD34,CHIA,CLEC11A,CLEC17A,CLEC18A,CLEC18C,CLEC4M,CLEC6A,CLEC7A,CLN5,COLEC12,ENG,FBP1,FCN2,FUOM,G6PD,GAL3ST3,GALK1,GCK,LGALS12,LGALS16,LGALS8,LGALS9,LMAN1,LMAN2,LMAN2L,LOXL2,MBL2,MLEC,PFKL,PFKM,PPP1R3F,PYGL,REG4,SELE,SELP,SFTPD,SIGLEC1,SIGLEC9,SLC2A3,SORD,STBD1,UPK1A,ZP3	Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
GO:0030247	GO	MF	polysaccharide binding	CLEC18A,CLEC18C,FCN2,PPP1R3F,REG4,STBD1	Interacting selectively and non-covalently with any polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
GO:0030249	GO	MF	guanylate cyclase regulator activity	GUCA1C,GUCA2A,GUCA2B,PDZD3,RCVRN	Modulates the activity of guanylate cyclase.
GO:0030252	GO	BP	growth hormone secretion	CDK16,GHRH,GHRL,GHSR,LTBP4,RAB1A	The regulated release of growth hormone from secretory granules into the blood.
GO:0030258	GO	BP	lipid modification	ABCD1,ABCD2,ABCD3,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOT8,ACOX1,ACOX2,ACOX3,ACSM1,ADH7,ADIPOQ,ADIPOR1,ADIPOR2,ALOX12,AMACR,BDH2,CERK,CRAT,CROT,CYP4V2,DECR1,DGKZ,ECHS1,ECI1,EFR3A,EFR3B,EHHADH,EPHX2,ETFA,ETFB,ETFDH,FAM126A,GCDH,HACL1,HADH,HADHA,HADHB,HAO1,HAO2,HSD17B4,INPP5B,INPP5K,IP6K1,IP6K2,LCAT,MCEE,MMAA,MTM1,MTMR1,MTMR2,MTMR3,MUT,PCCA,PCCB,PEX13,PEX2,PHYH,PI4K2A,PI4KA,PIK3CA,PIK3R1,PIKFYVE,PIP4K2A,PIP4K2B,PIP5K1A,PIP5K1B,PLA2G7,PLPP1,PLPP4,PLPP5,PPARD,PPARGC1A,PTEN,SACM1L,SCP2,SLC25A17,SLC27A2,SMG1,SOAT1,SOAT2,SPHK1,SPHK2,SYNJ1,TMEM150A,TMEM55A,TMEM55B,TTC7B	The covalent alteration of one or more fatty acids in a lipid, resulting in a change in the properties of the lipid.
GO:0030260	GO	BP	entry into host cell	ACE2,ADRBK1,AXL,CAV1,CAV2,CCR5,CD4,CD55,CD81,CLEC4M,CLEC5A,CXCR4,DPP4,EPS15,GAS6,HAVCR1,HYAL2,ITCH,ITGAV,ITGB3,NPC1,PPIA,PVRL1,PVRL2,SERPINB3,SIVA1,VAMP8,WWP1,WWP2,ZNF639	The invasion by an organism of a cell of its host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
GO:0030261	GO	BP	chromosome condensation	ACIN1,AIFM1,CDCA5,CHMP1A,DFFB,ERN2,GPER1,NCAPD2,NCAPD3,NCAPG,NCAPH,NUSAP1,PAPD7,PHF13,SMC2,SMC4,TOP2A	The progressive compaction of dispersed interphase chromatin into threadlike chromosomes prior to mitotic or meiotic nuclear division, or during apoptosis, in eukaryotic cells.
GO:0030262	GO	BP	apoptotic nuclear changes	ACIN1,ACVR1C,BLCAP,CASP3,CDK5RAP3,CECR2,DEDD2,DFFA,DFFB,ERN2,FOXL2,GPER1,H1F0,HMGB1,HMGB2,KPNA1,KPNB1,TARDBP,TOP2A	Alterations undergone by nuclei at the molecular and morphological level as part of the execution phase of apoptosis.
GO:0030263	GO	BP	apoptotic chromosome condensation	ACIN1,DFFB,ERN2,GPER1,TOP2A	The compaction of chromatin during apoptosis.
GO:0030276	GO	MF	clathrin binding	AFTPH,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,CALY,CEMIP,DAB2,DNER,HIP1,LDLR,LDLRAP1,NCALD,PICALM,SYT6,TOM1,TOM1L1,TOM1L2	Interacting selectively and non-covalently with a clathrin heavy or light chain, the main components of the coat of coated vesicles and coated pits, and which also occurs in synaptic vesicles.
GO:0030277	GO	BP	maintenance of gastrointestinal epithelium	MUC13,MUC4,MUC6,NOD2,PBLD,RBP4,SERPINA3,SOX9,STRAP,TLR4,TLR9	Protection of epithelial surfaces of the gastrointestinal tract from proteolytic and caustic digestive agents.
GO:0030278	GO	BP	regulation of ossification	ACVR1,ACVR2A,ACVR2B,AHSG,ANKH,ANO6,ATP6AP1,ATRAID,BCOR,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CCL3,CCR1,CDK6,CHRD,CHSY1,CITED1,CTNNBIP1,CYP27B1,CYR61,DDR2,DDX5,ECM1,ENPP1,FBN2,FGF23,FGFR2,GDF10,GPM6B,GREM1,HDAC7,HGF,IFITM1,IGF1,IL6,IL6R,IL6ST,KL,LIMD1,LRP4,LRP5,LTF,MEF2C,MEN1,NBR1,NELL1,NOCT,NOG,NOTCH1,NPNT,OSR1,OSR2,P2RX7,PKDCC,PRKACA,PRKD1,PTCH1,PTH,PTK2,PTK2B,RBPJ,RORB,S1PR1,SEMA4D,SFRP1,SKI,SLC8A1,SMOC1,SNAI2,SOST,SOX11,SOX9,SRGN,STATH,SUCO,SUFU,TFAP2A,TMEM119,TP63,TWIST1,TWIST2,TXLNG,WNT4,WNT5A,WNT7B,ZBTB16,ZHX3	Any process that modulates the frequency, rate or extent of bone formation.
GO:0030279	GO	BP	negative regulation of ossification	AHSG,BCOR,CCL3,CCR1,CDK6,CHRD,CHSY1,CITED1,ECM1,FGF23,GDF10,GREM1,HDAC7,LIMD1,LRP4,LRP5,MEF2C,MEN1,NBR1,NOCT,NOG,NOTCH1,PTCH1,PTK2B,RBPJ,RORB,SEMA4D,SFRP1,SKI,SOST,SOX9,SRGN,STATH,SUFU,TWIST1,TWIST2	Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation.
GO:0030280	GO	MF	structural constituent of epidermis	KRT10,KRT36,KRT82,KRTAP1-3,KRTAP5-8,PKP1	The action of a molecule that contributes to the structural integrity of an epidermal cutaneous structure.
GO:0030282	GO	BP	bone mineralization	ALOX15,ASPN,BGLAP,BMP2,CER1,CLEC3B,EIF2AK3,FBXL15,FGFR2,FGFR3,IFITM5,IGF1,LGR4,MINPP1,SBDS,TUFT1,ZBTB40	The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
GO:0030284	GO	MF	estrogen receptor activity	ESR1,ESR2,GPER1,LEF1,NKX3-1	Combining with estrogen and transmitting the signal within the cell to trigger a change in cell activity or function.
GO:0030286	GO	CC	dynein complex	CCDC114,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAI1,DNAI2,DNALI1,DYNC1H1,DYNC1I1,DYNC1LI1,DYNC2LI1,DYNLL1,DYNLRB1,DYNLRB2,DYNLT1,DYNLT3,HDAC6,NME8,SNX4,TOPORS,TPR	Any of several large complexes that contain two or three dynein heavy chains and several light chains, and have microtubule motor activity.
GO:0030291	GO	MF	protein serine/threonine kinase inhibitor activity	CDKN1A,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CIB1,H2AFY,HEXIM1,HEXIM2,HSPB1,INCA1,KAT2B,PKIA,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,SFN,SPRED1,SPRED2,SPRY2,YWHAG	Stops, prevents or reduces the activity of a protein serine/threonine kinase.
GO:0030295	GO	MF	protein kinase activator activity	AFAP1L2,ALS2,ANGPT4,CAB39,CALM1,CCL5,CD24,CDK5R1,CDKN1A,DAXX,DBF4B,DUSP19,EFNA5,EGF,ERBB3,ERCC6,FAM20A,FGF13,GAS6,GHRL,GPRC5B,GREM1,IGF2,IQGAP1,LTF,MADD,MAP2K1,MAP2K2,MAPK8IP2,MARK2,MT3,NCKAP1L,NKX3-1,NRG1,NRG3,PAK2,PARP16,PRKAG2,RGCC,SPRY2,STK11,STK3,STK4,STRADA,WNT11	Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein.
GO:0030296	GO	MF	protein tyrosine kinase activator activity	AFAP1L2,ANGPT4,CCL5,CD24,EFNA5,EGF,ERBB3,ERCC6,GAS6,GHRL,GREM1,NRG1,NRG3,PAK2	Increases the activity of a protein tyrosine kinase, an enzyme which phosphorylates a tyrosyl phenolic group on a protein.
GO:0030297	GO	MF	transmembrane receptor protein tyrosine kinase activator activity	ANGPT4,EFNA5,EGF,GREM1,NRG1,NRG3	Binds to and increases the activity of a transmembrane receptor protein tyrosine kinase.
GO:0030299	GO	BP	intestinal cholesterol absorption	ABCG5,ABCG8,AKR1C1,CD36,CEL,LDLR,NPC1L1,SOAT2	Uptake of cholesterol into the blood by absorption from the small intestine.
GO:0030301	GO	BP	cholesterol transport	ABCA1,ABCA5,ABCA7,ABCG1,ABCG4,ABCG5,ABCG8,AKR1C1,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,CAV1,CD36,CEL,CETP,CLU,LCAT,LDLR,LDLRAP1,LIPC,LIPG,MSR1,NPC1,NPC1L1,NPC2,OSBPL5,SCARB1,SOAT1,SOAT2,STX12,VPS4A	The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0030307	GO	BP	positive regulation of cell growth	ACSL4,ADAM10,ADAM17,ADNP2,AKAP6,AKT1,ALOX12,BCL11A,BCL2,BDNF,CDC42,CDKL5,CDKN2AIP,CIB1,CPNE5,CPNE6,CPNE9,CSNK2A1,CSNK2A3,CXCL16,DDX3X,DERL2,DNPH1,DSCAM,ERBB2,EXOSC2,EXOSC4,EXOSC9,FGFR1OP,FXN,GOLGA4,H3F3A,H3F3C,HIST1H1B,HPN,HYAL1,IL2,INO80,INS,ISLR2,ITSN2,L1CAM,LEF1,LGI1,LIMK1,MACF1,MAPT,MEGF8,MMP14,MTPN,N6AMT1,NCBP1,NEDD4L,NOL8,NRG1,NRP1,NTN1,PPP1R1C,PRSS2,PSMD10,RASAL1,RIMS1,RIMS2,RPS6KA1,RPS6KA3,RUFY3,S100A8,S100A9,SDCBP,SEMA4D,SEMA5A,SEMA7A,SFRP1,SFRP2,SHTN1,SLC25A33,SLC44A4,SMURF1,SPHK1,SUPV3L1,SYT1,SYT17,SYT2,SYT3,SYT4,TAF9,TAF9B,TGFB2,TGFBR1,TRIM32,TWF2,UNC13A,USP47,VEGFA,ZNF639	Any process that activates or increases the frequency, rate, extent or direction of cell growth.
GO:0030308	GO	BP	negative regulation of cell growth	ACVR1B,ACVRL1,ADAM15,AGTR2,APBB1,APBB2,BCL11A,BCL6,BMP10,BMPR2,BST2,BTG1,CAPRIN2,CCAR2,CCDC85B,CDA,CDHR2,CDKN1A,CDKN1B,CDKN2A,CDKN2AIP,CDKN2C,CDKN2D,CRLF3,CYP27B1,DACT3,DCBLD2,DCC,DCSTAMP,DCUN1D3,DDX3X,EI24,ENO1,ENPP1,ESR2,FBP1,FGF13,FHL1,FLCN,FRZB,GAL,GAS2L1,GDF2,GJA1,GNB2L1,GNG4,GSK3A,HNF4A,HRG,HYAL1,HYAL2,ING1,INHBA,IP6K2,JADE1,MSX1,MT3,MUL1,MYL2,NAIF1,NDRG3,NDUFA13,NDUFS3,NME6,NOV,NPPB,NPR1,OSGIN1,PHB,PML,PPP1R9B,PPP2CA,PPP2R1A,PPT1,PSRC1,PTPRJ,RBBP7,RERG,RNF6,RTN4,RTN4R,SCGB3A1,SEMA5A,SERTAD2,SERTAD3,SFRP1,SFRP2,SH3BP4,SIPA1,SIRT1,SLIT2,SLIT3,SMAD3,SMAD4,SMARCA2,SMARCA4,SOX17,ST7L,STK11,TCHP,TGFB1,TGFB2,TP53,TP53TG5,TSPYL2,WFDC1,WNT11,WT1,ZC3H12D	Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
GO:0030309	GO	BP	poly-N-acetyllactosamine metabolic process	B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GAT1,GAL3ST3	The chemical reactions and pathways involving poly-N-acetyllactosamine, a carbohydrate composed of N-acetyllactosamine repeats (Gal-beta-1,4-GlcNAc-beta-1,3)n.
GO:0030311	GO	BP	poly-N-acetyllactosamine biosynthetic process	B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GAT1	The chemical reactions and pathways resulting in the formation of poly-N-acetyllactosamine, a carbohydrate composed of N-acetyllactosamine repeats (Gal-beta-1,4-GlcNAc-beta-1,3)n.
GO:0030315	GO	CC	T-tubule	AHNAK,AHNAK2,AKAP6,ANK2,ANK3,ATP2B4,BIN1,CACNA1D,CACNA1S,CACNA2D1,CACNB2,CAPN3,CAV3,DYSF,KCNJ11,NOS1AP,SCN1B,SCN5A,SLC30A1,SLC8A1,SRI	Invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril. The ends of T-tubules make contact with the sarcoplasmic reticulum membrane.
GO:0030316	GO	BP	osteoclast differentiation	ANXA2,CSF1,CSF1R,DCSTAMP,EFNA2,EPHA2,FARP2,FOXP1,GAB2,GLO1,MAPK14,OCSTAMP,SH3PXD2A,SNX10,TNFRSF11A,TNFSF11	The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
GO:0030317	GO	BP	sperm motility	ADCY3,AKAP4,ASUN,ATP1A4,ATP2B4,CATSPERD,CCDC39,CCDC40,DDX4,DNAH1,DNAH11,DNAH5,DNAI1,GAPDHS,GAS8,ING2,LRRC6,PIH1D3,ROPN1B,SLC22A16,SMCP,SORD,TEKT3,TNP1	Any process involved in the controlled movement of a sperm cell.
GO:0030318	GO	BP	melanocyte differentiation	C10orf11,CITED1,KIT,MEF2C,MITF,USP13	The process in which a relatively unspecialized cell acquires specialized features of a melanocyte.
GO:0030320	GO	BP	cellular monovalent inorganic anion homeostasis	ENPP1,GCM2,SLC12A5,SLC34A2,SLC34A3,TFAP2B,XPR1	Any process involved in the maintenance of an internal steady state of monovalent inorganic anions at the level of a cell.
GO:0030323	GO	BP	respiratory tube development	ASCL1,ATP7A,BAG6,BMP4,BMPR2,CCDC39,CCDC40,CEBPA,CHI3L1,CTSH,DNAAF1,ERRFI1,FGF10,FGF7,FGFR2,FOXF1,FOXJ1,GLI2,GRHL2,HECA,ITGA3,NFIB,NPHP3,PCSK5,PDGFA,PDPN,PKDCC,RBP4,SFTPD,SHH,SOX11,STRA6,TCF21,TGFB3,VEGFA,WNT7B,ZIC3	The process whose specific outcome is the progression of the respiratory tube over time, from its formation to the mature structure. The respiratory tube is assumed to mean any tube in the respiratory tract.
GO:0030324	GO	BP	lung development	ASCL1,ATP7A,BAG6,BMP4,BMPR2,CCDC39,CCDC40,CEBPA,CHI3L1,CTSH,DNAAF1,ERRFI1,FGF10,FGF7,FGFR2,FOXF1,FOXJ1,GLI2,GRHL2,ITGA3,NFIB,NPHP3,PDGFA,PDPN,PKDCC,RBP4,SFTPD,SHH,SOX11,STRA6,TCF21,TGFB3,VEGFA,WNT7B,ZIC3	The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
GO:0030325	GO	BP	adrenal gland development	CITED2,INSM1,MDK,NF1,NR0B1,STRA6,WT1	The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
GO:0030326	GO	BP	embryonic limb morphogenesis	AFF3,CREBBP,CTNNB1,CYP26B1,ECE1,FBXW4,GLI3,HDAC1,HDAC2,HOXA11,IHH,MBNL1,MEGF8,MSX1,MYH3,NIPBL,NOG,OSR1,OSR2,PTCH1,RARG,SALL1,SHH,SKI,TBX2,TBX3,TBX5,TFAP2A,TWIST1,WNT7A,ZNF358	The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
GO:0030330	GO	BP	DNA damage response, signal transduction by p53 class mediator	ATM,ATRX,BATF,BCL3,BRCA1,CASP2,CDK2,CDKN1A,CDKN1B,CRADD,E2F7,FOXM1,GML,GTSE1,HIPK2,ING4,KAT5,MDM2,MUC1,MYO6,NBN,PAXIP1,PIDD1,PML,PPP2R5C,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RPS27A,RPS6KA6,SOX4,SP100,TFAP4,TP53,TRIAP1,UBA52,UBB,UBC,USP10	A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
GO:0030331	GO	MF	estrogen receptor binding	CNOT1,DDX17,DDX5,DDX54,DYX1C1,ISL1,LEF1,NCOA6,NKX3-1,NSD1,PHB2,PPARGC1B,PPID,PRMT2,RERG,TAF10,WIPI1,XBP1,ZNF366	Interacting selectively and non-covalently with an estrogen receptor.
GO:0030336	GO	BP	negative regulation of cell migration	ACVR1C,ACVRL1,ADAM15,ADARB1,ADIPOQ,AGTR2,AIF1,ALOX15B,ANGPT2,ANGPT4,APOD,APOE,APOH,ARAP3,ARHGDIB,ARPIN,BMP10,BMP5,BST2,C5,C5AR2,CCL2,CCL21,CCL25,CCL28,CD300A,CHRD,CITED2,CLASP1,CLASP2,CLIC4,COL3A1,CORO1B,CORO1C,CSNK2B,CXCL12,CXCL13,CYP1B1,DAB2IP,DACH1,DAG1,DCN,DLC1,DLL4,DPEP1,DPYSL3,DRD2,ENG,EPHA1,EVL,FAM60A,FGF2,FLCN,FUZ,GCSAM,GDF2,GREM1,GTPBP4,HAS1,HDAC5,HMGB1,HMOX1,HOXA7,HRG,HYAL2,IFITM1,IGFBP3,IGFBP5,IL4,ITGB1BP1,KANK1,KLF4,KLRK1,KRIT1,KRT16,LDLRAD4,LRP1,MAGI2,MAP2K5,MARVELD3,MCC,MIA3,MMRN2,NBL1,NDRG4,NF1,NF2,NKX2-1,NODAL,NOG,NOTCH1,NOV,NR2F2,PADI2,PBLD,PDCD10,PFN2,PHLDB2,PKP2,PLCB1,PLXNB3,PODN,PTEN,PTGER4,PTPN23,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRR,PTPRU,RAP2C,RECK,RGCC,RHOA,RHOB,RNF20,RNF41,SCAI,SERPINE1,SFRP1,SFRP2,SHH,SLIT2,SMAD7,SP100,SRGAP2,STAP1,STARD13,STC1,STK24,STRAP,SULF1,SVBP,SYNJ2BP,TACSTD2,TBX5,TCAF1,TGFB1,THBS1,THY1,TIMP1,TP53INP1,TPM1,TRIB1,VASH1,VCL,WASL,WNT11	Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
GO:0030346	GO	MF	protein phosphatase 2B binding	ATP2B4,MYOZ2,PPP3CB,SLC9A1,SOD1	Interacting selectively and non-covalently with the enzyme protein phosphatase 2B.
GO:0030371	GO	MF	translation repressor activity	CELF1,CELF4,CIRBP,CPEB1,CPEB2,CPEB3,EIF4EBP1,EIF4EBP2,EIF4EBP3,NANOS1,PAIP2,PAIP2B,SAMD4A,TRIM71,ZNF540	Antagonizes ribosome-mediated translation of mRNA into a polypeptide.
GO:0030374	GO	MF	ligand-dependent nuclear receptor transcription coactivator activity	ACTN1,ACTN4,ATXN7L3,BUD31,CALCOCO1,CARM1,CCAR1,DCAF6,ENY2,FGF2,GLMP,HELZ2,HMGA1,KDM1A,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,NCOA1,NCOA2,NCOA7,PKN1,PPARG,PPARGC1A,PPARGC1B,PRKCB,PSMC3IP,SFR1,SMARCD3,SS18,THRAP3,TRERF1,USP22,WDR77,ZMIZ2	The function of a transcription cofactor that activates transcription in conjuction with a ligand-dependent nuclear receptor from a RNA polymerase II promoter; does not bind DNA itself.
GO:0030388	GO	BP	fructose 1,6-bisphosphate metabolic process	ALDOA,ALDOB,ALDOC,PFKL,TIGAR	The chemical reactions and pathways involving fructose 1,6-bisphosphate, also known as FBP. The D enantiomer is a metabolic intermediate in glycolysis and gluconeogenesis.
GO:0030414	GO	MF	peptidase inhibitor activity	A2M,A2ML1,AGT,AMBP,APP,AVP,BIRC5,BIRC6,BIRC7,BST2,CAST,CD27,COL4A3,CRB2,CST3,CST4,CST5,CST7,CSTA,CSTB,DPEP1,FETUB,FURIN,GAS6,GPC3,ITIH2,ITIH3,ITIH4,KNG1,LCN1,LEF1,LPA,MT3,NGF,NOL3,PCSK1N,PI3,PRDX3,PRDX5,PROL1,PROS1,PSMF1,PTTG1,PZP,RECK,RENBP,RPS6KA1,RPS6KA3,SERPINA1,SERPINA3,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB8,SERPINB9,SERPINC1,SERPIND1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SLPI,SNCA,SPINK1,SPINK2,SPINK5,SPINK9,SPINT2,SPOCK1,SPOCK3,SPP2,TFAP2B,TFPI,TIMP1,TIMP3,TIMP4,TNFAIP8,TNFSF14,UCHL5,USP14,VIL1,WFDC12,WFDC2,XIAP	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
GO:0030424	GO	CC	axon	AAK1,ACADM,ADAM22,ADGRL1,ADGRL3,ALCAM,ANK3,APP,ATCAY,AZIN2,BIN1,CABP4,CAD,CALB1,CCK,CCSAP,CDK5,CDK5R1,CLASP2,CNTN2,CNTN4,CNTNAP1,CNTNAP2,COBL,CPNE6,CPT1C,CRHBP,CTNNA2,DAB2IP,DLG2,DLG4,DOCK7,DRD2,DSCAM,DST,DTNBP1,EPB41L3,EPHA4,EPHB2,ERMN,FGF13,FKBP4,FLRT3,GARS,GHRH,GHRL,GPER1,GPM6A,GRIK3,GRIN1,GRM7,HDAC6,HEPACAM,HTT,IGHMBP2,IQGAP1,KCNA1,KCNA2,KCNA4,KCNAB2,KCNB1,KCNC2,KCNQ2,KCNQ3,KIF13B,L1CAM,LDLRAP1,LLGL1,LRRK2,LRRTM1,MAPT,MME,MTMR2,MUL1,MYO1D,MYOC,NCMAP,NEFH,NEFL,NEFM,NF1,NFASC,NFIB,NRCAM,NRP1,NRXN1,OLFM1,PACSIN1,PAK1,PARD3,PARK7,PINK1,PPT1,PRSS12,PTPRN,PTPRO,RAB3A,RAB5A,RNF6,ROBO2,RTN4R,RUFY3,SACS,SCN1B,SCN2A,SCN8A,SEMA6A,SETX,SHTN1,SIRT2,SLC38A7,SLC6A3,SNCA,SPOCK1,SPTBN1,SPTBN4,SRCIN1,STAT1,TBC1D24,TGFB2,UHMK1,UNC13B,ZFYVE27,ZPR1	The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
GO:0030425	GO	CC	dendrite	ACAD9,ACTN2,ADCY2,ALS2,AMIGO1,APOD,APOE,APP,ARF4,ARFGEF2,ARHGEF15,ATCAY,ATXN10,AZIN2,BNIP3,BSN,CALB1,CAPN2,CCR2,CDK5,CDK5R1,CDKL5,CHRNA3,CHRNA4,CLU,CNIH2,CNIH3,COBL,CPEB3,CPEB4,CPNE6,CPT1C,CRHBP,CRIPT,DBN1,DGKI,DLG4,DNER,DNM3,DRD2,DTNBP1,ELFN1,EPHA4,EPHA5,EPHB2,FARP1,FGF13,FRMPD4,GCHFR,GIPC1,GNB2L1,GPER1,GRIA1,GRID2,GRIK3,GRIN1,GRM7,HDAC6,HTT,IL1RAPL1,KCNA1,KCNA2,KCNB1,KCNB2,KCNC2,KCND2,KCNE3,KPNA1,LRP4,LRRK2,MAGEE1,MAGI2,MAP1S,MAPT,MLPH,MME,MTMR2,MYO1D,NCDN,NEURL1,NF1,NLGN1,NLGN4X,NR1D1,NSF,NSMF,OPA1,P2RY1,PAK1,PI4K2A,PLK2,PRKAR2B,PRKCG,PTK2B,PTPRO,RAB17,RAB27A,RAB5A,RBM3,RELN,RGS12,RGS14,RGS8,RPL28,RPS6,RUFY3,SACS,SARM1,SHANK1,SHANK2,SIPA1L1,SKOR1,SLC32A1,SOD1,SRCIN1,SRGAP2,STAT1,STAU1,STRN,STRN3,STX4,SYNDIG1,SYNPO,TENM2,TMEM185A,TRAPPC4,TRIM9,TUBB3,UHMK1,WFS1,ZFYVE27,ZNF385A	A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
GO:0030426	GO	CC	growth cone	ADGRL1,ALS2,ANG,APBB1,APBB2,CDK5,CDK5R1,CDKL5,CIB1,CLASP2,COBL,CTTN,CXADR,DBN1,DNM2,DOCK7,DPYSL3,DSCAM,DTNBP1,DVL1,ERC2,FGF13,FKBP4,FLRT3,FRMD7,FSCN1,GPM6A,IGHMBP2,IQGAP1,KLC1,L1CAM,LAMP5,LRRK2,LRRTM1,MAPT,MYO5A,NRSN1,NRXN1,OLFM1,OTX2,PTK2B,PTPRO,RAC3,RASGRF1,RTN4R,RUFY3,SETX,SHANK2,SHTN1,SNAP25,SNCA,STMN2,STX3,TENM2,THY1,TOR1A,TRPV4,TWF2,USP9X,ZFYVE27,ZPR1	The migrating motile tip of a growing nerve cell axon or dendrite.
GO:0030427	GO	CC	site of polarized growth	ADGRL1,ALS2,ANG,APBB1,APBB2,CDK5,CDK5R1,CDKL5,CIB1,CLASP2,COBL,CTTN,CXADR,DBN1,DNM2,DOCK7,DPYSL3,DSCAM,DTNBP1,DVL1,ERC2,FGF13,FKBP4,FLRT3,FRMD7,FSCN1,GPM6A,IGHMBP2,IQGAP1,KLC1,L1CAM,LAMP5,LRRK2,LRRTM1,MAPT,MYO5A,NRSN1,NRXN1,OLFM1,OTX2,PI4K2A,PTK2B,PTPRO,RAC3,RASGRF1,RTN4R,RUFY3,SETX,SHANK2,SHTN1,SNAP25,SNCA,STMN2,STX3,TENM2,THY1,TOR1A,TRPV4,TWF2,USP9X,ZFYVE27,ZPR1	Any part of a cell where non-isotropic growth takes place.
GO:0030433	GO	BP	ER-associated ubiquitin-dependent protein catabolic process	AMFR,DERL1,DERL2,DERL3,DNAJB2,DNAJB9,DNAJC10,EDEM1,ERLEC1,ERLIN1,ERLIN2,FAF2,FBXO6,FOXRED2,HSP90B1,HSPA5,JKAMP,MAN1B1,NPLOC4,OS9,RNF103,RNF185,RNF5,SEC61B,SEL1L,STT3B,SYVN1,TMEM129,TMEM67,TMUB1,TOR1A,TRIM13,UBE2G2,UBE2J1,UBE2J2,UBQLN1,UBQLN2,UBXN4,UBXN8,UFD1L,USP19,VCP,VIMP,WFS1,YOD1	The chemical reactions and pathways resulting in the breakdown of proteins transported from the endoplasmic reticulum and targeted to cytoplasmic proteasomes for degradation. This process acts on misfolded proteins as well as in the regulated degradation of correctly folded proteins.
GO:0030449	GO	BP	regulation of complement activation	A2M,C1QBP,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CD46,CD55,CD59,CFB,CFH,CFI,CFP,CR1,MASP1,PHB,PROS1,SERPING1,SUSD4,VTN	Any process that modulates the frequency, rate or extent of complement activation.
GO:0030488	GO	BP	tRNA methylation	ALKBH8,METTL2A,METTL2B,NSUN2,TRDMT1,TRMT10A,TRMT61B	The posttranscriptional addition of methyl groups to specific residues in a tRNA molecule.
GO:0030490	GO	BP	maturation of SSU-rRNA	CIRH1A,NOL11,NOP14,RPS14,RPS19,UTP20	Any process involved in the maturation of a precursor Small SubUnit (SSU) ribosomal RNA (rRNA) molecule into a mature SSU-rRNA molecule.
GO:0030496	GO	CC	midbody	AGBL5,ALKBH4,ANKRD54,ANXA11,ANXA2,ARL2BP,ARL3,ARL8A,ARL8B,AURKA,AURKB,AURKC,BIRC5,BIRC6,C6orf89,CAPG,CDC42,CDCA8,CDK1,CENPE,CENPF,CEP44,CEP55,CHMP4A,CHMP4B,CHMP4C,CLIC4,CTDP1,CTNND1,CYLD,DDX11,ECT2,ERH,FAM175B,FLCN,GDI1,GEM,GNAI1,GNAI2,GNAI3,GNB2L1,HEPACAM2,HSP90B1,HSPA5,IQGAP1,IST1,JTB,KATNA1,KEAP1,KIF13A,KIF14,KIF20A,KIF20B,KIF23,KIF4A,KLHL9,MAK,MAP10,MAPRE3,MITD1,MPLKIP,MTCL1,MYH10,NUP62,OR2A4,PDXP,PIK3C3,PIN1,PKN1,PKN2,PKP4,PLK1,PRC1,PSRC1,RAB11FIP3,RAB11FIP4,RACGAP1,RALB,RAN,RCC2,SCCPDH,SDCCAG3,SEPT12,SH3GLB1,SIRT2,SLC2A1,SPAST,SPG20,SVIL,TEX14,TOPORS,TTC19,USP8,UVRAG,VPS37B,VPS4A,VPS4B,ZFYVE19,ZFYVE26,ZNF330	A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis.
GO:0030497	GO	BP	fatty acid elongation	ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,HACD1,HACD2,HACD3,HACD4,TECR	The elongation of a fatty acid chain by the sequential addition of two-carbon units.
GO:0030500	GO	BP	regulation of bone mineralization	ACVR1,ACVR2A,ACVR2B,AHSG,ANKH,ANO6,ATRAID,BCOR,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CCL3,CCR1,CYP27B1,DDR2,ECM1,ENPP1,FBN2,FGF23,GPM6B,GREM1,KL,LTF,MEF2C,NBR1,NELL1,OSR1,OSR2,P2RX7,PKDCC,PTH,PTK2B,S1PR1,SLC8A1,SRGN,STATH,TFAP2A,TMEM119,TWIST1,TXLNG,WNT4	Any process that modulates the frequency, rate or extent of bone mineralization.
GO:0030501	GO	BP	positive regulation of bone mineralization	ACVR1,ACVR2A,ACVR2B,ANO6,ATRAID,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,FBN2,GPM6B,KL,LTF,MEF2C,NELL1,OSR1,OSR2,P2RX7,PKDCC,PTH,SLC8A1,TFAP2A,TMEM119,WNT4	Any process that activates or increases the frequency, rate or extent of bone mineralization.
GO:0030502	GO	BP	negative regulation of bone mineralization	AHSG,BCOR,CCL3,CCR1,ECM1,FGF23,GREM1,PTK2B,SRGN,STATH	Any process that stops, prevents, or reduces the frequency, rate or extent of bone mineralization.
GO:0030506	GO	MF	ankyrin binding	CACNA1D,KCTD6,NRCAM,RHCG,SCN5A,SLC8A1,SPTBN1,SPTBN4,TNKS1BP1	Interacting selectively and non-covalently with ankyrin, a 200 kDa cytoskeletal protein that attaches other cytoskeletal proteins to integral membrane proteins.
GO:0030507	GO	MF	spectrin binding	ADD1,ADD2,ANK1,ANK3,CAMSAP1,DCTN2,DMTN,DYNC1I1,EPB41,KIF3A,MYO10,MYO7A,SPTBN4,SPTBN5,USH1C,USH1G	Interacting selectively and non-covalently with spectrin, a protein that is the major constituent of the erythrocyte cytoskeletal network. It associates with band 4.1 (see band protein) and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane. It is composed of nonhomologous chains, alpha and beta, which aggregate side-to-side in an antiparallel fashion to form dimers, tetramers, and higher polymers.
GO:0030509	GO	BP	BMP signaling pathway	ACVR1,ACVR2A,ACVR2B,ACVRL1,BMP10,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CER1,CHRD,CHRDL1,DLX5,ENG,FAM83G,FSTL1,GDF2,GDF6,GDF7,GREM2,HFE,HFE2,MAPK3,MEGF8,NOG,POU5F1,RGMB,RUNX2,SCX,SKI,SLC33A1,SLC39A5,SMAD1,SMAD4,SMAD5,SMAD6,SMAD7,SMAD9,SMURF1,SMURF2,TGFBR3,TMEM100,UBE2D1,UBE2D3,USP15,USP9X,USP9Y,ZFYVE16	A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0030510	GO	BP	regulation of BMP signaling pathway	ACVRL1,BMP4,BMPER,BMPR2,CAV1,CER1,CHRD,CRB2,CYR61,DAND5,ENG,FBN1,FBXL15,FOXD1,FSTL3,GDF3,GDF5,GREM1,HES5,HIPK2,HTRA3,ITGA3,LEMD3,NBL1,NOG,NOTCH1,PCSK6,RBPJ,SKI,SKOR1,SMAD2,SMAD4,SMAD6,SMAD7,SMURF1,SOST,SOX11,SULF1,TFAP2B,TRIM33,UBE2O,VWC2,WNT1,XIAP,ZNF423	Any process that modulates the frequency, rate or extent of the activity of any BMP receptor signaling pathway.
GO:0030511	GO	BP	positive regulation of transforming growth factor beta receptor signaling pathway	ADAM17,CDKN1C,CDKN2B,CITED1,CITED2,DAB2,FLCN,GIPC1,HIPK2,ING2,MEN1,SDCBP,SMAD4,SNW1,STK11,TGFB1I1,THBS1	Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity.
GO:0030512	GO	BP	negative regulation of transforming growth factor beta receptor signaling pathway	ADAM17,ADAMTSL2,ASPN,BAMBI,BCL9L,CAV1,CD109,CIDEA,DAND5,EID2,ENG,FAM89B,FBN1,FBN2,HTRA3,HTRA4,LDLRAD4,LEMD3,LTBP1,MTMR4,NEDD4L,NKX2-1,PBLD,PDPK1,PEG10,PIN1,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRDM16,RPS27A,SIRT1,SKI,SKIL,SKOR2,SMAD2,SMAD3,SMAD6,SMAD7,SMURF1,SMURF2,SNX25,SNX6,STRAP,STUB1,TGFB1,TGFB1I1,TGFBR1,TGFBR2,UBA52,UBB,UBC,UCHL5,USP15,VASN,XPO1,ZFYVE9	Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
GO:0030513	GO	BP	positive regulation of BMP signaling pathway	ACVRL1,BMP4,BMPR2,CRB2,CYR61,ENG,FBXL15,FOXD1,GDF5,HES5,NOTCH1,RBPJ,SMAD2,SMAD4,SOX11,SULF1,UBE2O,ZNF423	Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
GO:0030514	GO	BP	negative regulation of BMP signaling pathway	BMPER,CAV1,CER1,CHRD,DAND5,FBN1,FSTL3,GDF3,GREM1,HIPK2,HTRA3,LEMD3,NBL1,NOG,NOTCH1,SKI,SKOR1,SMAD6,SMAD7,SMURF1,SOST,TRIM33,VWC2,WNT1	Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
GO:0030515	GO	MF	snoRNA binding	DDX21,ISG20,NHP2,NOP14,NOP56,NOP58,NUDT1,NUDT16,NUDT16L1,NUDT4,NUDT5,NUDT7,NUFIP1,RRP9,SNU13	Interacting selectively and non-covalently with small nucleolar RNA.
GO:0030516	GO	BP	regulation of axon extension	ABL1,APOE,BCL11A,CDKL5,CLASP2,CTTN,DNM2,DSCAM,GOLGA4,ISLR2,L1CAM,LIMK1,MACF1,MAPT,MEGF8,MT3,NRCAM,NRP1,NTN1,OLFM1,RNF6,RTN4,RTN4R,RUFY3,SEMA3A,SEMA5A,SEMA7A,SHTN1,TWF2,VEGFA	Any process that modulates the rate, direction or extent of axon extension.
GO:0030517	GO	BP	negative regulation of axon extension	BCL11A,MT3,RNF6,RTN4,RTN4R,SEMA5A	Any process that stops, prevents, or reduces the frequency, rate or extent of axon outgrowth.
GO:0030518	GO	BP	intracellular steroid hormone receptor signaling pathway	AR,ARID1A,BRCA1,CALCOCO1,CALR,CCNE1,CDK7,CTNNB1,DAXX,DDX54,DEFA1,DEFA3,EGLN2,ESR1,ESR2,FHL2,GPER1,GRIP1,KAT5,KDM3A,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,NCOA1,NCOA3,NCOA4,NCOA6,NEDD4,NKX3-1,NR1I3,NRIP1,PADI2,PHB,PIAS1,PIAS2,PLPP1,PMEPA1,POU4F2,PPARGC1A,PPARGC1B,RAN,RB1,RBFOX2,RBM14,RHOXF1,RNF14,RNF4,SCGB2A1,SRC,TADA3,TGFB1I1,THRAP3,TRIP4,UBR5,YWHAH	A series of molecular signals generated as a consequence of a intracellular steroid hormone receptor binding to one of its physiological ligands.
GO:0030520	GO	BP	intracellular estrogen receptor signaling pathway	ARID1A,DDX54,DEFA1,DEFA3,EGLN2,ESR1,ESR2,NCOA6,PADI2,POU4F2,PPARGC1B,RBFOX2,RBM14,TADA3,TRIP4	Any series of molecular signals generated as a consequence of an intracellular estrogen receptor binding to one of its physiological ligands. The pathway begins with receptor-ligand binding, and ends with regulation of a downstream cellular process (e.g. transcription).
GO:0030521	GO	BP	androgen receptor signaling pathway	AR,ARID1A,BRCA1,CCNE1,CDK7,CTNNB1,DAXX,FHL2,GRIP1,KAT5,KDM3A,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,NCOA1,NCOA3,NCOA4,NKX3-1,NR1I3,NRIP1,PIAS1,PIAS2,PLPP1,PMEPA1,PPARGC1A,RAN,RB1,RNF14,RNF4,SCGB2A1,TGFB1I1,THRAP3	Any series of molecular signals generated as a consequence of an androgen binding to its receptor.
GO:0030522	GO	BP	intracellular receptor signaling pathway	ACTN4,AHR,AIM2,ALOXE3,APP,AR,ARID1A,BCL2,BCL2L1,BRCA1,BRD8,CALCOCO1,CALR,CARD9,CASP1,CASP8,CCNE1,CDK7,CHUK,CRY1,CRY2,CTNNB1,CYLD,CYP24A1,DAXX,DCBLD2,DDX54,DDX58,DEFA1,DEFA3,EGLN2,ESR1,ESR2,ESRRA,ESRRB,FHL2,GLMP,GPER1,GRIP1,HSP90AB1,IFIH1,IKBKB,IKBKG,IRAK1,IRAK2,IRF3,IRF7,ITCH,KAT5,KDM3A,KMT2E,MAP2K6,MAP3K7,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,MEFV,NCOA1,NCOA3,NCOA4,NCOA6,NEDD4,NKX3-1,NLRC4,NLRP1,NLRP3,NOD1,NOD2,NOTCH2,NR0B1,NR1D1,NR1D2,NR1H3,NR1H4,NR1I2,NR1I3,NR2E3,NR2F1,NR2F2,NR2F6,NR4A1,NR4A2,NR4A3,NR5A1,NR6A1,NRIP1,OTULIN,P2RX7,PADI2,PANX1,PDK3,PHB,PIAS1,PIAS2,PIM1,PLPP1,PMEPA1,POU4F2,PPARA,PPARD,PPARG,PPARGC1A,PPARGC1B,PSTPIP1,PTGER3,PYCARD,RAN,RARA,RARG,RB1,RBFOX2,RBM14,RELA,RHOXF1,RIPK2,RNF14,RNF34,RNF4,RORA,RORB,RORC,RPS27A,RXRA,SCGB2A1,SLA2,SNW1,SP100,SRC,STAT3,SUGT1,TAB1,TAB2,TAB3,TADA3,TBX1,TGFB1I1,THRA,THRAP3,THRB,TNFAIP3,TRAF6,TRIP4,TXN,TXNIP,UBA52,UBB,UBC,UBE2N,UBE2V1,UBR5,VDR,YWHAH	Any series of molecular signals initiated by a ligand binding to an receptor located within a cell.
GO:0030532	GO	CC	small nuclear ribonucleoprotein complex	ARFGEF1,CD2BP2,DDX23,DDX39B,GEMIN4,LSM10,LSM11,LSM4,LSM6,PHF5A,PPIH,PRPF31,PRPF4,PRPF6,PRPF8,SART3,SF3A2,SF3B1,SF3B3,SLU7,SNRNP200,SNRNP40,SNRNP70,SNRPA,SNRPA1,SNRPB,SNRPB2,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNRPN,TGS1	A complex composed of RNA of the small nuclear RNA (snRNA) class and protein, found in the nucleus of a eukaryotic cell. These are typically named after the snRNA(s) they contain, e.g. U1 snRNP or U4/U6 snRNP. Many, but not all, of these complexes are involved in splicing of nuclear mRNAs.
GO:0030534	GO	BP	adult behavior	ABAT,APP,BBS2,BBS4,BRS3,CARTPT,CHRNA3,CHRNA4,CHRNA5,CHRNB1,CHRNB2,CNTNAP2,CRHBP,DRD1,DRD2,DRD3,DRD4,FOXA2,GDNF,GHRL,GHSR,LEP,NLGN3,NLGN4X,NPY,NRXN1,NRXN2,NRXN3,NTF4,OPRM1,PAFAH1B1,PARK2,PUM1,SHANK1,SHANK2,SHANK3,SPTBN4,TSC1	Behavior in a fully developed and mature organism.
GO:0030539	GO	BP	male genitalia development	HSD17B3,LHCGR,SHH,TBX3,WT1	The process whose specific outcome is the progression of the male genitalia over time, from its formation to the mature structure.
GO:0030544	GO	MF	Hsp70 protein binding	C11orf73,DNAJA1,PACRG,PPEF2,PPID,RPS3,STUB1	Interacting selectively and non-covalently with Hsp70 proteins, any of a group of heat shock proteins around 70kDa in size.
GO:0030545	GO	MF	receptor regulator activity	ADH7,AGTR2,ANGPT4,ANXA2,CCL5,CDK5,CXCL13,DKK1,EFNA5,EGF,ESR2,GAS6,GREM1,IGF2,IL18BP,IL1RN,LRPAP1,MED1,MED16,NRG1,NRG3,PCSK9,PPARGC1B,PXDN,SFRP2,WNT1,WNT10B,WNT2,WNT3,WNT3A,WNT4,WNT5A,WNT7A,WNT8A	The function of interacting (directly or indirectly) with receptors such that the proportion of receptors in the active form is changed.
GO:0030546	GO	MF	receptor activator activity	ANGPT4,ANXA2,CDK5,CXCL13,EFNA5,EGF,GAS6,GREM1,IGF2,MED1,MED16,NRG1,NRG3,PPARGC1B,SFRP2,WNT1,WNT10B,WNT2,WNT3,WNT3A,WNT4,WNT5A,WNT7A,WNT8A	The function of interacting (directly or indirectly) with receptors such that the proportion of receptors in the active form is increased.
GO:0030547	GO	MF	receptor inhibitor activity	ADH7,AGTR2,CCL5,DKK1,ESR2,IL18BP,IL1RN,LRPAP1,PCSK9,PXDN	The function of interacting (directly or indirectly) with receptors such that the proportion of receptors in the active form is decreased.
GO:0030551	GO	MF	cyclic nucleotide binding	CNGA3,CNGB1,CNGB3,HCN1,PDE10A,PDE11A,PDE2A,PDE4A,PDE4B,PDE4D,PDE5A,RAPGEF2,RAPGEF4,TMEM173	Interacting selectively and non-covalently with a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
GO:0030552	GO	MF	cAMP binding	HCN1,PDE10A,PDE2A,PDE4A,PDE4B,PDE4D,RAPGEF2,RAPGEF4	Interacting selectively and non-covalently with cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate).
GO:0030553	GO	MF	cGMP binding	CNGA3,CNGB1,CNGB3,PDE10A,PDE11A,PDE2A,PDE5A	Interacting selectively and non-covalently with cGMP, the nucleotide cyclic GMP (guanosine 3',5'-cyclophosphate).
GO:0030574	GO	BP	collagen catabolic process	ADAM10,ADAM17,ADAM9,ADAMTS3,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL23A1,COL25A1,COL26A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL6A5,COL6A6,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,CTSB,CTSD,CTSK,CTSL,CTSS,ELANE,FURIN,KLK6,MMP1,MMP10,MMP11,MMP12,MMP13,MMP14,MMP15,MMP19,MMP2,MMP20,MMP3,MMP7,MMP8,MMP9,MRC2,PHYKPL,PRSS2	The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells.
GO:0030575	GO	BP	nuclear body organization	ETS1,HIPK2,PML,SRPK2,USPL1,ZPR1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of any of the extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
GO:0030593	GO	BP	neutrophil chemotaxis	AMICA1,CCL3,CKLF,CXADR,CXCL3,CXCL8,CXCR2,EDN2,EDN3,GBF1,ITGB2,LGALS3,NCKAP1L,PDE4B,PIK3CD,PIK3CG,PIP5K1C,PLA2G1B,S100A12,S100A8,S100A9,SAA1,SYK,TGFB2,XCL1	The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
GO:0030594	GO	MF	neurotransmitter receptor activity	ANXA9,CHRM2,CHRM3,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB4,CHRNE,CHRNG,DRD1,DRD2,DRD3,DRD4,DRD5,GABRA2,GABRA3,GABRA4,GABRA6,GABRB3,GABRG2,GLRA3,GRIN3B,P2RY11	Combining with a neurotransmitter and transmitting the signal to initiate a change in cell activity.
GO:0030595	GO	BP	leukocyte chemotaxis	ADAM8,ADGRE2,AMICA1,ANXA1,AZU1,CALCA,CCL11,CCL13,CCL19,CCL2,CCL21,CCL23,CCL24,CCL3,CCL5,CCL7,CCR1,CCR2,CCR5,CCR6,CCR7,CHGA,CKLF,CX3CL1,CXADR,CXCL10,CXCL11,CXCL13,CXCL3,CXCL8,CXCR1,CXCR2,CXCR4,EDN2,EDN3,EDNRB,FFAR2,FLT1,GAS6,GBF1,HMGB1,IL10,IL6,IL6R,ITGB2,KIT,LGALS3,LYST,NCKAP1L,PDE4B,PDGFB,PF4,PIK3CD,PIK3CG,PIP5K1C,PLA2G1B,PTPRO,RPS19,S100A12,S100A8,S100A9,SAA1,SBDS,SCG2,SFTPD,SYK,TGFB2,TNFRSF11A,TNFSF11,TRPM4,VEGFA,XCL1	The movement of a leukocyte in response to an external stimulus.
GO:0030618	GO	MF	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	SMAD1,SMAD2,SMAD3,SMAD5,SMAD9	A TGF-beta cytoplasmic mediator that is phosphorylated by a TGFbeta receptor and complexes with a common-partner mediator. The- heterocomplex translocates to the nucleus to regulate transcription.
GO:0030641	GO	BP	regulation of cellular pH	ATP1A4,ATP5B,ATP6V0E1,ATP6V0E2,ATP6V1H,BCL2,CA2,CFTR,CHP1,CLCN3,CLN3,CLN5,CLN6,GPR89A,LRRK2,NOX1,PPT1,RAB20,RAB38,RAB39A,RAB7A,SLC11A1,SLC26A3,SLC26A6,SLC9A1,TMEM165	Any process involved in the maintenance of an internal equilibrium of hydrogen ions (protons) within a cell or between a cell and its external environment.
GO:0030643	GO	BP	cellular phosphate ion homeostasis	ENPP1,GCM2,SLC34A2,SLC34A3,XPR1	Any process involved in the maintenance of an internal steady state of phosphate ions at the level of a cell.
GO:0030656	GO	BP	regulation of vitamin metabolic process	AKR1C3,CYP27B1,GFI1,IFNG,IL1B,NFKB1,SNAI1,SNAI2,TNF,VDR	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a vitamin, one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0030658	GO	CC	transport vesicle membrane	AFTPH,AP1G2,AP1S1,AP2A1,AQP2,AQP6,AREG,B2M,CA4,CD59,CD74,CNIH1,CNIH2,CNIH3,DTNBP1,FOLR1,GOSR2,GRIA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,ICA1,LDLRAP1,LMAN1,MCFD2,NCALD,OTOF,PTPRN2,RAB3A,RASSF9,RPH3A,SAR1B,SEC13,SEC22B,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEMA4C,SLC17A6,SLC17A7,SLC17A8,SLC18A1,SLC18A2,SLC18A3,SLC32A1,STX5,SV2A,SV2B,SV2C,SYN2,SYNRG,SYT1,SYT2,TGFA,TMED10,TMED2,TMED7,USO1,VAMP1,VAMP2,VMA21	The lipid bilayer surrounding a transport vesicle.
GO:0030660	GO	CC	Golgi-associated vesicle membrane	AFTPH,AP1G2,AP1S1,AP2A1,ARCN1,ARFGAP1,C3orf58,CFTR,CNGA2,CNGA4,CNGB1,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,CSPG5,GJA1,GOPC,GPR89A,ITM2B,LDLRAP1,NCALD,PI4KA,PKD1,RASSF9,RHO,RHOQ,SCYL1,SPPL2A,SPPL2B,SPPL3,SYNRG,TMED3,TMED7,ZDHHC13,ZDHHC17	The lipid bilayer surrounding a vesicle associated with the Golgi apparatus.
GO:0030662	GO	CC	coated vesicle membrane	AFTPH,AP1B1,AP1G1,AP1G2,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOB,ARCN1,AREG,B2M,C3orf58,CD207,CD59,CD74,CD9,CEMIP,CLTC,CLVS1,CLVS2,CNIH1,CNIH2,CNIH3,COPA,COPB1,COPB2,COPE,COPG1,COPG2,COPZ1,COPZ2,DNAJC5,EGFR,FCGR1A,FCGR1B,FOLR1,FZD2,FZD4,FZD5,GAD1,GAD2,GOSR2,GRIA1,HBEGF,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HSPA8,LDLR,LDLRAP1,LMAN1,MCFD2,NCALD,NECAP2,PICALM,RAB3A,RASSF9,ROR2,SAR1B,SCYL1,SEC13,SEC22B,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEC31B,SGIP1,SH3GL2,SLC17A7,SLC18A1,SLC18A2,SLC18A3,SLC32A1,STX5,SYNRG,SYT1,TBC1D5,TGFA,TMED10,TMED2,TMED3,TMED7,TYRP1,USO1,VAMP2,VMA21,WNT5A	The lipid bilayer surrounding a coated vesicle.
GO:0030665	GO	CC	clathrin-coated vesicle membrane	AFTPH,AP1B1,AP1G1,AP1G2,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOB,CD207,CD74,CD9,CEMIP,CLTC,CLVS1,CLVS2,DNAJC5,EGFR,FCGR1A,FCGR1B,FZD2,FZD4,FZD5,GAD1,GAD2,HBEGF,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HSPA8,LDLR,LDLRAP1,NCALD,NECAP2,PICALM,RAB3A,RASSF9,ROR2,SGIP1,SH3GL2,SLC17A7,SLC18A1,SLC18A2,SLC18A3,SLC32A1,SYNRG,SYT1,TBC1D5,TYRP1,VAMP2,WNT5A	The lipid bilayer surrounding a clathrin-coated vesicle.
GO:0030666	GO	CC	endocytic vesicle membrane	ANXA3,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOB,ATG12,ATG5,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,B2M,CACNG2,CACNG3,CACNG4,CACNG8,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CAV1,CD163,CD207,CD36,CD74,CD9,CLTC,CLVS1,CLVS2,COLEC12,CYBA,CYBB,DLG4,DMBT1,DNM2,EGFR,FCGR1A,FCGR1B,FZD2,FZD4,FZD5,GPR161,GRIA1,GRIA2,GRIA3,GRIA4,HBEGF,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,LDLR,LDLRAP1,LRP1,MARCO,MDM2,MSR1,NOS3,NOSTRIN,PICALM,PICK1,PIK3C3,PIK3R4,PTCH1,RAC2,ROR2,RPS27A,SCARB1,SCARF1,SGIP1,SH3GL2,SLC11A1,SMO,STAB1,STAB2,TBC1D5,TCIRG1,TYRP1,UBA52,UBB,UBC,WASL,WLS,WNT1,WNT3,WNT3A,WNT4,WNT5A,WNT5B,WNT6,WNT7A,WNT7B	The lipid bilayer surrounding an endocytic vesicle.
GO:0030667	GO	CC	secretory granule membrane	ABCA3,ABCC4,ADAM8,ANXA7,AZU1,CA4,CD36,CD63,CD9,CPE,CUZD1,DMBT1,EQTN,EXOC3,FAM170B,ICA1,ITGA2B,ITGB3,ITPR1,LAMP2,PECAM1,PTPRN2,RAB26,SELP,SERPINA5,SLC11A1,SLC30A5,SLC30A8,SNCA,SPARC,SRI,TEKT3,TMED10,TMED2,VAMP1,VAMP2,VAMP7,VAMP8,ZP3	The lipid bilayer surrounding a secretory granule.
GO:0030669	GO	CC	clathrin-coated endocytic vesicle membrane	AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOB,CD207,CD74,CD9,CLTC,CLVS1,CLVS2,EGFR,FCGR1A,FCGR1B,FZD2,FZD4,FZD5,HBEGF,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,LDLR,LDLRAP1,PICALM,ROR2,SGIP1,SH3GL2,TBC1D5,TYRP1,WNT5A	The lipid bilayer surrounding a clathrin-coated endocytic vesicle.
GO:0030670	GO	CC	phagocytic vesicle membrane	ANXA3,ATG12,ATG5,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,B2M,CYBA,CYBB,DMBT1,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,PIK3C3,PIK3R4,RAC2,SLC11A1,TCIRG1	The lipid bilayer surrounding a phagocytic vesicle.
GO:0030672	GO	CC	synaptic vesicle membrane	DTNBP1,ICA1,OTOF,PTPRN2,RPH3A,SEMA4C,SLC17A6,SLC17A7,SLC17A8,SLC32A1,SV2A,SV2B,SV2C,SYN2,SYT1,SYT2,VAMP1,VAMP2	The lipid bilayer surrounding a synaptic vesicle.
GO:0030674	GO	MF	protein binding, bridging	ABI2,ADAP2,AMFR,ANK1,ANK2,ANK3,ANXA1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARHGAP1,ARHGAP4,ARHGAP6,BCL3,BFAR,BICD1,BIN3,BLNK,CBX5,CD28,CHN1,CHN2,CLNK,CNKSR1,CNTLN,CNTNAP1,COL11A1,COL11A2,COL14A1,COL19A1,COL1A2,COL8A2,CRKL,CSTA,DAB2,DSP,EPS8,EVPL,FBXW7,FKBP4,FLRT1,FLRT2,FLRT3,FRS2,GAB1,GAB2,GAS2L1,GAS2L2,GATAD2A,GRAP,GRAP2,GRB2,GRB7,IRS1,IRS4,ITSN2,IVL,LASP1,LAT,LDLRAP1,LOR,MEN1,MMS19,NCK1,NCK2,NEFH,NEFL,NMD3,OBSL1,PAG1,PICALM,PIK3R1,PPP2R3A,PPP4R2,PSMC6,RAD50,RBM14,RUSC1,SDCBP,SH2B2,SH2D1A,SH2D1B,SH2D2A,SH2D3A,SH2D3C,SH3BGR,SH3BGRL,SH3BP2,SHB,SHC1,SKAP1,SKAP2,SLA,SLA2,SLC9A1,SOCS2,SORBS1,SORBS2,SPRR1A,SPRR1B,SRC,ST13,STAM,STAP1,STUB1,TCAP,TIRAP,TJP2,TOB1,TP53BP2,TRAT1,TRDN,VAV3	The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
GO:0030676	GO	MF	Rac guanyl-nucleotide exchange factor activity	ALS2,ARHGEF2,ARHGEF4,DOCK2,EPS8L1,EPS8L2,FARP1,FARP2,PREX2,SPATA13,TIAM1	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Rac family. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
GO:0030684	GO	CC	preribosome	BOP1,NOP14,PES1,PIN4,UTP20,WDR12	Any complex of pre-rRNAs, ribosomal proteins, and associated proteins formed during ribosome biogenesis.
GO:0030686	GO	CC	90S preribosome	BOP1,NOP14,PES1,UTP20,WDR12	A large ribonucleoprotein complex considered to be the earliest preribosomal complex. In S. cerevisiae, it has a size of 90S and consists of the 35S pre-rRNA, early-associating ribosomal proteins most of which are part of the small ribosomal subunit, the U3 snoRNA and associated proteins.
GO:0030695	GO	MF	GTPase regulator activity	ADAP1,ADGRB3,ALDH1A1,ARAP1,ARAP3,ARFGAP1,ARFGAP3,ARHGAP1,ARHGAP15,ARHGAP18,ARHGAP26,ARHGAP27,ARHGAP35,ARHGAP8,ARHGAP9,ARHGEF10L,ARHGEF6,ARL2,ARL2BP,ARRB1,ASAP3,BNIP2,CDC42EP2,CDC42SE1,CPEB2,DEPDC5,DLC1,DOCK4,ECT2,ELMOD1,ELMOD2,ERRFI1,EVI5,EVI5L,GDI1,GMIP,GNAQ,GNB5,GPS1,GPS2,GPSM2,HACD3,HTR2B,IPO5,IPO7,IQGAP1,IQGAP2,ITGB1BP1,JUN,KRIT1,LLGL1,LRRK2,MYO9B,NCKAP1L,NF1,NPRL2,NPRL3,OCRL,PDE6D,PGAM5,PLCB1,PREX1,PREX2,RAB3GAP1,RABGAP1,RABGAP1L,RACGAP1,RALBP1,RALGAPA1,RALGAPA2,RALGAPB,RALGDS,RANBP1,RAP1GAP,RAP1GDS1,RAPGEF2,RASA4,RASGRP3,RGS1,RGS10,RGS11,RGS12,RGS14,RGS16,RGS2,RGS20,RGS3,RGS4,RGS5,RGS6,RGS7,RGS8,RHOH,RIMS1,RIN2,RP2,RTKN,RUNDC3A,SGSM2,SGSM3,SH3BGRL3,SH3BP4,SIPA1,SLIT2,SOS1,SRGAP2,SYDE1,SYDE2,TBC1D10B,TBC1D15,TBC1D16,TBC1D2,TBC1D20,TBC1D25,TBC1D30,TBC1D7,TBCD,THY1,TNK2,TSC2,USP6NL,VAV3,WAS,WASL,WNT11	Modulates the rate of GTP hydrolysis by a GTPase.
GO:0030705	GO	BP	cytoskeleton-dependent intracellular transport	ACTN4,AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,APBA1,APP,ARHGAP21,BICD1,BICD2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CDC42,CEP131,CLN3,COPG1,DTNBP1,DYNC1I1,FNBP1L,FYCO1,HAP1,HIF1A,HTT,ICK,IFT122,IFT27,IFT43,IFT46,IFT74,IFT81,KIF13A,KIF1A,KIF1B,KIF3A,KIF3B,KIF4A,KIF5B,KIFAP3,LRPPRC,MAP1S,MGARP,MYO10,MYO5A,NEFL,OPA1,PAFAH1B1,PCM1,PEX14,RAB1A,RAB6A,RHOT1,RHOT2,RPGR,SNAPIN,SOD1,SSX2IP,SUN2,SYNE2,TTC26,TUBA1A,TUBA1B,TUBA1C,TUBB,UBB,UXT,WASL,WDR19,WDR35	The directed movement of substances along cytoskeletal fibers such as microfilaments or microtubules within a cell.
GO:0030742	GO	MF	GTP-dependent protein binding	ARFIP2,EEA1,PARD6A,RAB5B,RAPGEF6,RASGRP4	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules) using energy from the hydrolysis of GTP.
GO:0030799	GO	BP	regulation of cyclic nucleotide metabolic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,APOE,AVPR2,CALCA,CALCR,CALCRL,CALM1,CAP1,CAP2,CCR2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,EGLN1,FZD2,GABBR2,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GNB2L1,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,GUCA1C,GUCA2A,GUCA2B,HTR1B,LHCGR,LTB4R2,MAPK7,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,MTNR1A,NF1,NOS3,NPPC,NTRK1,NTRK2,OPRM1,OXER1,P2RY11,PALM,PDE2A,PDZD3,PF4,PKD2,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RCVRN,RLN2,THBS1,VEGFA,VIP,WNT5A	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving cyclic nucleotides.
GO:0030800	GO	BP	negative regulation of cyclic nucleotide metabolic process	ADRA2A,AKAP6,APLP1,CCR2,DRD2,DRD3,DRD4,EDNRB,EGLN1,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,HTR1B,LTB4R2,MAPK7,OPRM1,PALM,PDE2A,PDZD3,PRKCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving cyclic nucleotides.
GO:0030801	GO	BP	positive regulation of cyclic nucleotide metabolic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,APOE,AVPR2,CALCA,CALCR,CALCRL,CALM1,CAP1,CAP2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD5,EDNRA,FZD2,GHRH,GHRHR,GIPR,GLP1R,GNAS,GNB2L1,GPER1,GPR161,GPR65,GSK3A,GUCA1C,GUCA2A,GUCA2B,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,P2RY11,PF4,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RCVRN,RLN2,VIP,WNT5A	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving cyclic nucleotides.
GO:0030802	GO	BP	regulation of cyclic nucleotide biosynthetic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,APOE,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CCR2,CRHR1,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,GABBR2,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,GUCA1C,GUCA2A,GUCA2B,HTR1B,LHCGR,LTB4R2,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,OPRM1,OXER1,P2RY11,PALM,PDE2A,PDZD3,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RCVRN,RLN2,VIP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cyclic nucleotides.
GO:0030803	GO	BP	negative regulation of cyclic nucleotide biosynthetic process	ADRA2A,AKAP6,APLP1,CCR2,DRD2,DRD3,DRD4,EDNRB,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,HTR1B,LTB4R2,OPRM1,PALM,PDE2A,PDZD3,PRKCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cyclic nucleotides.
GO:0030804	GO	BP	positive regulation of cyclic nucleotide biosynthetic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,APOE,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,GHRH,GHRHR,GIPR,GLP1R,GNAS,GPER1,GPR161,GPR65,GSK3A,GUCA1C,GUCA2A,GUCA2B,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,P2RY11,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RCVRN,RLN2,VIP	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cyclic nucleotides.
GO:0030811	GO	BP	regulation of nucleotide catabolic process	ACTN3,ARNT,CBFA2T3,ECD,EGLN1,ENTPD5,FBP1,GAPDHS,GCK,GNB2L1,GSK3A,HDAC4,HIF1A,IGF1,INS,INSR,MAPK7,MLXIPL,NCOR1,OGT,P2RX7,PGAM1,PPARA,PRKAA1,PRKAA2,PRKAG1,PRKAG2,RAPGEF3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.
GO:0030812	GO	BP	negative regulation of nucleotide catabolic process	ACTN3,CBFA2T3,EGLN1,FBP1,GSK3A,HDAC4,MAPK7,PPARA	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.
GO:0030813	GO	BP	positive regulation of nucleotide catabolic process	ACTN3,ARNT,ENTPD5,GAPDHS,GNB2L1,HIF1A,IGF1,INS,INSR,MLXIPL,P2RX7,PRKAA1,PRKAA2,RAPGEF3	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.
GO:0030814	GO	BP	regulation of cAMP metabolic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CCR2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,EGLN1,GABBR2,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GNB2L1,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,HTR1B,LHCGR,LTB4R2,MAPK7,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,NF1,NPPC,NTRK1,NTRK2,OPRM1,OXER1,P2RY11,PALM,PDE2A,PF4,PKD2,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RLN2,VIP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0030815	GO	BP	negative regulation of cAMP metabolic process	ADRA2A,AKAP6,APLP1,CCR2,DRD2,DRD3,DRD4,EDNRB,EGLN1,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,HTR1B,LTB4R2,MAPK7,OPRM1,PALM,PDE2A,PRKCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0030816	GO	BP	positive regulation of cAMP metabolic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD5,EDNRA,GHRH,GHRHR,GIPR,GLP1R,GNAS,GNB2L1,GPER1,GPR161,GPR65,GSK3A,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,NF1,NTRK1,NTRK2,P2RY11,PF4,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RLN2,VIP	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0030817	GO	BP	regulation of cAMP biosynthetic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CCR2,CRHR1,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,GABBR2,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,HTR1B,LHCGR,LTB4R2,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,NF1,NTRK1,NTRK2,OPRM1,OXER1,P2RY11,PALM,PDE2A,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RLN2,VIP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0030818	GO	BP	negative regulation of cAMP biosynthetic process	ADRA2A,AKAP6,APLP1,CCR2,DRD2,DRD3,DRD4,EDNRB,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,HTR1B,LTB4R2,OPRM1,PALM,PDE2A,PRKCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0030819	GO	BP	positive regulation of cAMP biosynthetic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,GHRH,GHRHR,GIPR,GLP1R,GNAS,GPER1,GPR161,GPR65,GSK3A,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,NF1,NTRK1,NTRK2,P2RY11,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RLN2,VIP	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0030823	GO	BP	regulation of cGMP metabolic process	APOE,FZD2,GUCA1C,GUCA2A,GUCA2B,MTNR1A,NOS3,NPPC,PDZD3,RCVRN,THBS1,VEGFA,WNT5A	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving cGMP.
GO:0030825	GO	BP	positive regulation of cGMP metabolic process	APOE,FZD2,GUCA1C,GUCA2A,GUCA2B,MTNR1A,NOS3,RCVRN,WNT5A	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving cGMP.
GO:0030826	GO	BP	regulation of cGMP biosynthetic process	APOE,GUCA1C,GUCA2A,GUCA2B,MTNR1A,NOS3,PDZD3,RCVRN	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cGMP.
GO:0030828	GO	BP	positive regulation of cGMP biosynthetic process	APOE,GUCA1C,GUCA2A,GUCA2B,MTNR1A,NOS3,RCVRN	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cGMP.
GO:0030832	GO	BP	regulation of actin filament length	ABI2,ACTN2,ACTR2,ACTR3,ADD1,ADD2,ALOX15,ARF1,ARF6,ARFGEF1,ARHGAP18,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPIN,BAIAP2L1,BRK1,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CFL2,CORO1A,CORO1B,CSF3,CTTN,CXCL12,CYFIP1,EPS8,F2RL1,FAM21C,FER,GSN,HAX1,HCK,HCLS1,IQGAP2,JMY,KANK1,LATS1,LIMA1,LRRC16A,MAGEL2,MTPN,MYADM,NCK1,NCK2,NCKAP1,NCKAP1L,NEB,PAK3,PDXP,PFN1,PFN2,PICK1,PLEK,PLEKHH2,PRKCD,PRKCE,PTK2B,PYCARD,RASA1,SCIN,SEMA5A,SH3BGRL3,SLIT2,TENM1,TMSB4Y,TRIM27,TRIOBP,TWF1,TWF2,VASP,VIL1,WASF1,WASH1,WHAMM	Any process that controls the length of actin filaments in a cell.
GO:0030833	GO	BP	regulation of actin filament polymerization	ABI2,ACTR2,ACTR3,ADD1,ADD2,ALOX15,ARF1,ARF6,ARFGEF1,ARHGAP18,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPIN,BAIAP2L1,BRK1,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CORO1A,CORO1B,CSF3,CTTN,CYFIP1,EPS8,FAM21C,FER,GSN,HAX1,HCK,HCLS1,IQGAP2,JMY,KANK1,LATS1,LRRC16A,MAGEL2,MTPN,MYADM,NCK1,NCK2,NCKAP1,NCKAP1L,PAK3,PFN1,PFN2,PICK1,PRKCD,PRKCE,PTK2B,PYCARD,RASA1,SCIN,SLIT2,TENM1,TMSB4Y,TRIM27,TRIOBP,TWF1,TWF2,VASP,VIL1,WASF1,WASH1,WHAMM	Any process that modulates the frequency, rate or extent of the assembly of actin filaments by the addition of actin monomers to a filament.
GO:0030834	GO	BP	regulation of actin filament depolymerization	ACTN2,ADD1,ADD2,CFL2,EPS8,F2RL1,FAM21C,GSN,LIMA1,LRRC16A,MTPN,PDXP,PLEK,PLEKHH2,SCIN,SEMA5A,SH3BGRL3,TRIOBP,TWF2,VIL1	Any process that modulates the frequency, rate or extent of the disassembly of actin filaments by the removal of actin monomers from a filament.
GO:0030835	GO	BP	negative regulation of actin filament depolymerization	ADD1,ADD2,EPS8,GSN,LIMA1,PLEKHH2,SCIN,TRIOBP,TWF2,VIL1	Any process that stops, prevents, or reduces the frequency, rate or extent of actin depolymerization.
GO:0030836	GO	BP	positive regulation of actin filament depolymerization	ACTN2,CFL2,F2RL1,FAM21C,LRRC16A,PDXP,PLEK,SEMA5A,VIL1	Any process that activates or increases the frequency, rate or extent of actin depolymerization.
GO:0030837	GO	BP	negative regulation of actin filament polymerization	ADD1,ADD2,ARFGEF1,EPS8,GSN,KANK1,MYADM,PFN1,PFN2,PRKCD,SCIN,SLIT2,TMSB4Y,TRIOBP,TWF1,TWF2,VIL1	Any process that stops, prevents, or reduces the frequency, rate or extent of actin polymerization.
GO:0030838	GO	BP	positive regulation of actin filament polymerization	ACTR2,ACTR3,ALOX15,ARF6,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BAIAP2L1,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CSF3,CTTN,FAM21C,FER,HCK,IQGAP2,JMY,LRRC16A,MAGEL2,NCK1,NCK2,NCKAP1L,PFN1,PFN2,PRKCE,PTK2B,PYCARD,SCIN,TENM1,TRIM27,VASP,WASH1	Any process that activates or increases the frequency, rate or extent of actin polymerization.
GO:0030850	GO	BP	prostate gland development	ALOX15B,AR,FGFR2,NKX3-1,SHH,SOX9	The process whose specific outcome is the progression of the prostate gland over time, from its formation to the mature structure. The prostate gland is a partly muscular, partly glandular body that is situated near the base of the mammalian male urethra and secretes an alkaline viscid fluid which is a major constituent of the ejaculatory fluid.
GO:0030851	GO	BP	granulocyte differentiation	CBFA2T3,CEBPA,CSF3,GATA1,GATA2,JAGN1,LEF1	The process in which a myeloid precursor cell acquires the specialized features of a granulocyte. Granulocytes are a class of leukocytes characterized by the presence of granules in their cytoplasm. These cells are active in allergic immune reactions such as arthritic inflammation and rashes. This class includes basophils, eosinophils and neutrophils.
GO:0030852	GO	BP	regulation of granulocyte differentiation	ADIPOQ,C1QC,HAX1,HCLS1,KMT2E,LEF1,OGT,PRDM16,RARA,RUNX1,TESC	Any process that modulates the frequency, rate or extent of granulocyte differentiation.
GO:0030853	GO	BP	negative regulation of granulocyte differentiation	ADIPOQ,C1QC,PRDM16,RARA,RUNX1	Any process that stops, prevents, or reduces the frequency, rate or extent of granulocyte differentiation.
GO:0030854	GO	BP	positive regulation of granulocyte differentiation	HAX1,HCLS1,KMT2E,LEF1,OGT,RUNX1,TESC	Any process that activates or increases the frequency, rate or extent of granulocyte differentiation.
GO:0030855	GO	BP	epithelial cell differentiation	ACVR1,ACVR2B,ACVRL1,AKR1C1,AKT1,AKT2,ANXA1,ASCL1,BASP1,BCCIP,BDH2,BMP2,BMP4,BMP5,BMP6,BMPR2,C10orf11,CASP14,CCDC67,CCNO,CD24,CDH3,CDK6,CDSN,CDX2,CERS3,CES1,CITED1,CLDN3,CLIC4,CRYGD,CSTA,CTNNB1,DAB2,DACT2,DHRS9,DLL1,DMBT1,DMRT1,DSP,E2F4,E2F7,E2F8,EDF1,ENG,EPHA2,ERBB4,ERCC2,ERCC3,EREG,EVPL,EXPH5,EZR,F11R,F2RL1,FGF8,FGFR2,FLG,FOXB1,FZD7,GATA3,GATA4,GATA5,GATA6,GLI1,GLI2,GRHL2,GRXCR1,GSTM3,HDAC1,HDAC2,HES5,HEY1,HEY2,ICAM1,ID2,INSM1,IQGAP1,IRF6,IVL,JAG1,JAG2,KDM6B,KIT,KLF15,KRT16,KRT2,KRT3,KRT4,LAMA5,LOR,LRTOMT,MAGI2,MARVELD2,MCIDAS,MED1,MEF2C,MESP1,MET,MITF,MLLT4,MSN,MTSS1,MYADM,MYO1E,NEUROD1,NFIB,NKX6-1,NOTCH1,NR2F2,NRG1,NRP1,PAX2,PAX6,PDE2A,PDE4D,PDGFB,PDX1,PIP5K1A,PITX2,PODXL,PPARG,PPP1R16B,PROM1,PROX1,PTPRO,RAB10,RAB13,RAB25,RAP1A,RAP1B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3,RBPJ,RDX,RFX6,RHCG,RILPL1,RILPL2,ROS1,S100A7,SCEL,SCUBE1,SCX,SETSIP,SIPA1L3,SIX1,SIX2,SIX3,SLC9A3R1,SMO,SOD1,SOX11,SOX17,SOX18,SOX4,SOX8,SOX9,SPINK5,SPRR1A,SPRR1B,SPRR2A,SPRR2B,SPRR2F,SPRR2G,SPRR3,ST14,STC1,STRC,SYNE4,TAGLN,TAGLN2,TBX1,TCF21,TDRD7,TGM1,TGM3,TJP1,TJP2,TMEM79,TST,TXNIP,UPK1A,UPK1B,UPK2,UPK3A,USH2A,USP13,VEGFA,WNT11,WNT16,WNT5B,WNT7A,WNT7B,WT1,ZNF703	The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
GO:0030856	GO	BP	regulation of epithelial cell differentiation	ADIPOQ,AHI1,ALOX15B,AQP3,ARNTL,ATOH8,BAD,BMP4,BTG1,CAV1,CD24,CDH5,CLDN5,CLOCK,CTNNB1,CYP27B1,DLL1,ERRFI1,FOXE3,FOXJ1,GATA3,GDF3,GRHL2,GSK3A,GSK3B,H2AFY,H2AFY2,HOXA7,IFNG,IKBKB,IL13,IL1B,IL20,KDF1,KIAA1109,LHX1,LIF,MED1,MESP1,NCOA3,NKX6-1,NME2,NOTCH4,OSR1,OVOL2,PAX2,PAX8,PRKCH,PRKX,PROC,PROM1,REG3A,REG3G,RFX3,RHEB,ROCK1,ROCK2,S1PR2,S1PR3,SFN,SFRP4,SOX9,SRSF6,STAT1,TMEM100,TNF,TNFRSF1A,TRIM16,VDR,XDH,ZEB2	Any process that modulates the frequency, rate or extent of epithelial cell differentiation.
GO:0030857	GO	BP	negative regulation of epithelial cell differentiation	CAV1,DLL1,FOXE3,GDF3,GRHL2,GSK3A,GSK3B,HOXA7,IFNG,IL13,NOTCH4,OSR1,OVOL2,REG3A,REG3G,S1PR3,SRSF6,STAT1,XDH	Any process that stops, prevents, or reduces the frequency, rate or extent of epithelial cell differentiation.
GO:0030858	GO	BP	positive regulation of epithelial cell differentiation	ADIPOQ,AHI1,ATOH8,BAD,BMP4,BTG1,CD24,CDH5,CLDN5,CYP27B1,FOXJ1,H2AFY,H2AFY2,IL13,IL20,KDF1,LHX1,LIF,MED1,MESP1,NCOA3,NKX6-1,NME2,PAX2,PAX8,PRKCH,PROC,PROM1,RFX3,S1PR2,SFN,SFRP4,SOX9,TMEM100,TRIM16,VDR,ZEB2	Any process that activates or increases the frequency, rate or extent of epithelial cell differentiation.
GO:0030863	GO	CC	cortical cytoskeleton	ANLN,BSN,CAPN2,CDH1,CDH2,CLASP1,CLASP2,CLDN5,CORO1A,CTTN,DLC1,DLG4,EEF1A1,EPB41,EPB41L2,EZR,FLOT1,FLOT2,GSN,GYPC,GYS2,LANCL2,LASP1,LLGL1,MAEA,MAPRE1,MYADM,MYH9,MYO1A,MYZAP,NSMF,PCLO,PLEKHH2,RAPGEF3,RDX,SELE,SHROOM2,SHROOM4,SLC2A1,SLC4A1,SPTA1,SPTAN1,SPTBN2,SPTBN4,SPTBN5,TRPC4,TRPV4,VCL	The portion of the cytoskeleton that lies just beneath the plasma membrane.
GO:0030864	GO	CC	cortical actin cytoskeleton	ANLN,CAPN2,CDH1,CDH2,CLDN5,CORO1A,DLC1,EEF1A1,EPB41,EPB41L2,FLOT1,FLOT2,GSN,GYS2,LANCL2,LASP1,LLGL1,MAEA,MYADM,MYH9,MYO1A,MYZAP,PLEKHH2,RAPGEF3,RDX,SHROOM2,SHROOM4,SLC2A1,SPTA1,SPTAN1,SPTBN2,SPTBN4,SPTBN5,TRPV4,VCL	The portion of the actin cytoskeleton, comprising filamentous actin and associated proteins, that lies just beneath the plasma membrane.
GO:0030865	GO	BP	cortical cytoskeleton organization	ARF6,DLG1,EPB41L3,EZR,FMNL1,FMNL2,IKBKB,LLGL1,NCKAP1L,NLGN1,PLEK,RAB13,RACGAP1,RHOQ,ROCK1,ROCK2,STRIP1,TNF,TRPV4	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures in the cell cortex, i.e. just beneath the plasma membrane.
GO:0030866	GO	BP	cortical actin cytoskeleton organization	ARF6,DLG1,FMNL1,FMNL2,IKBKB,LLGL1,NCKAP1L,PLEK,RAB13,RACGAP1,RHOQ,ROCK1,ROCK2,STRIP1,TNF	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of actin-based cytoskeletal structures in the cell cortex, i.e. just beneath the plasma membrane.
GO:0030867	GO	CC	rough endoplasmic reticulum membrane	CFTR,SEC61B,SRP9,SSR4,UBA1	The lipid bilayer surrounding the rough endoplasmic reticulum.
GO:0030870	GO	CC	Mre11 complex	MRE11A,NBN,RAD50,SP100,TERF2,TERF2IP	Trimeric protein complex that possesses endonuclease activity; involved in meiotic recombination, DNA repair and checkpoint signaling. In Saccharomyces cerevisiae, the complex comprises Mre11p, Rad50p, and Xrs2p; complexes identified in other species generally contain proteins orthologous to the Saccharomyces cerevisiae proteins.
GO:0030877	GO	CC	beta-catenin destruction complex	APC,AXIN1,AXIN2,CACYBP,CSNK1A1,CTNNB1,CTNNBIP1,DACT1,GSK3A,GSK3B,SIAH1	A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome.
GO:0030878	GO	BP	thyroid gland development	FOXE1,HOXD3,NKX2-1,NKX2-5,PAX8,SIX1,TBX1	The process whose specific outcome is the progression of the thyroid gland over time, from its formation to the mature structure. The thyroid gland is an endoderm-derived gland that produces thyroid hormone.
GO:0030879	GO	BP	mammary gland development	AKT1,AKT2,APLN,CAV1,CSF1R,CSN2,CSN3,ELF3,EPHA2,ERBB4,FGF10,FGFR2,FOXB1,GLI2,GPAT4,ID2,IRF6,JAK2,NOTCH4,NRG1,OXTR,PRLR,SCRIB,TBX3,TDGF1,TGFB3,VEGFA,ZNF703	The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
GO:0030880	GO	CC	RNA polymerase complex	CCNH,CDC73,CDK7,CHD6,CPSF3L,CTR9,EDF1,ERCC2,ERCC3,ERCC5,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HELB,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,KAT2A,LEO1,MCM3,MMS19,MNAT1,MYO6,PAF1,PAPD4,PEX2,POLA1,POLR1C,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POLR2M,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,PPARGC1A,RECQL5,RPAP2,RPRD1A,RPRD1B,RPRD2,RTF1,SHFM1,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TBP,TERT,TP53,TRRAP,URI1,WDR61	Any complex that possesses RNA polymerase activity; generally comprises a catalytic subunit and one or more additional subunits.
GO:0030888	GO	BP	regulation of B cell proliferation	AHR,ATM,BCL2,CD300A,CD38,CD74,CD81,CDKN2A,CHRNB2,CLCF1,CTLA4,GPR183,IKZF3,IL10,IL2,IL21,IL4,IL7,IRS2,MEF2C,MIF,MNDA,MZB1,NCKAP1L,NFATC2,PTPRC,RC3H1,TCF3,TIRAP,TNFRSF21,TNFRSF4,TNFSF13B,VAV3	Any process that modulates the frequency, rate or extent of B cell proliferation.
GO:0030889	GO	BP	negative regulation of B cell proliferation	ATM,CD300A,CDKN2A,CTLA4,IL10,MNDA,RC3H1,TNFRSF21	Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
GO:0030890	GO	BP	positive regulation of B cell proliferation	BCL2,CD38,CD74,CD81,CHRNB2,CLCF1,GPR183,IL2,IL21,IL4,IL7,IRS2,MEF2C,MIF,NCKAP1L,NFATC2,PTPRC,TCF3,TIRAP,TNFRSF4,TNFSF13B,VAV3	Any process that activates or increases the rate or extent of B cell proliferation.
GO:0030893	GO	CC	meiotic cohesin complex	RAD21L1,SMC1A,SMC1B,SMC3,STAG3	A cohesin complex that mediates sister chromatid cohesion during meiosis; has a subunit composition distinct from that of the mitotic cohesin complex.
GO:0030894	GO	CC	replisome	BCAS2,CDC5L,CHRAC1,ERCC5,HELB,MCM3,PCNA,PLRG1,POLA1,POLD3,POLE,POLE2,POLE3,POLE4,PRPF19,PURA,PURB,RPA1,RPA2,RPA3,RPA4,SMARCAL1,TONSL,XPA	A multi-component enzymatic machine at the replication fork which mediates DNA replication. Includes DNA primase, one or more DNA polymerases, DNA helicases, and other proteins.
GO:0030897	GO	CC	HOPS complex	AKTIP,HOOK1,HOOK2,HOOK3,STX17,UVRAG,VIPAS39,VPS11,VPS16,VPS18,VPS33A,VPS33B,VPS39,VPS41	A multimeric protein complex that associates with the vacuolar membrane, late endosomal (multivesicular body) and lysosomal membranes. HOPS is a tethering complex involved in vesicle fusion.
GO:0030898	GO	MF	actin-dependent ATPase activity	MYH10,MYH14,MYH6,MYH7,MYH9,MYL6,MYO10,MYO1D,MYO3A	Catalysis of the reaction: ATP + H2O = ADP + phosphate. This reaction requires the presence of an actin filament to accelerate release of ADP and phosphate.
GO:0030900	GO	BP	forebrain development	AGTPBP1,ARHGAP11B,ARL13B,ATP7A,BBS2,BBS4,BMP2,BMP4,BTBD3,CCDC85C,CDK6,CHD5,CHRNB2,COL3A1,DAB2IP,DLC1,DOCK7,DRAXIN,DRD1,DRD2,EFHC1,EPHA5,EPHB2,EPHB3,ERBB4,FAT4,FGF13,FGFR2,FOXB1,FOXP2,GHRH,GLI2,GSK3B,HES1,HES5,HOOK3,HTR6,INHBA,KDM2B,KIF14,LAMB1,LHX1,LHX6,LRP8,LRRK2,MKKS,NDE1,NEUROD1,NF1,NFIB,NKX2-1,NKX2-6,NR0B1,NTRK2,NUMB,NUMBL,OTX2,PAFAH1B1,PCM1,PEX13,PITX2,PLCB1,PROX1,PTEN,RAB3GAP1,RAPGEF2,RELN,ROBO1,ROBO2,RTN4,RYK,SALL1,SCN5A,SEMA3A,SEMA5A,SHANK3,SHH,SIX3,SKI,SLC6A4,SLIT1,SLIT2,SMO,SOX3,SRGAP2,SRGAP2C,STIL,SZT2,TRAPPC9,TYRO3,VAX2,WDR62,WNT3A,WNT5A,WNT7A	The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
GO:0030901	GO	BP	midbrain development	FGFR2,FOXB1,KDM2B,KDM7A,OTX2,PITX3,RYK,SHH,WNT1,WNT2	The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
GO:0030902	GO	BP	hindbrain development	AGTPBP1,AHI1,ARL13B,ATF5,ATP7A,CBLN1,CEP290,CLP1,CTNNA2,DLC1,DLL1,FAIM2,GLI2,GRID2,KDM2B,KIF14,LHX1,MYO16,NEUROD1,NEUROD2,NLGN4X,NOG,NRXN1,PHOX2B,PROX1,PTF1A,RORA,SCN5A,SDF4,SEMA4C,SHH,TRNP1,WNT1	The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
GO:0030904	GO	CC	retromer complex	ANKFY1,DCTN1,DENND5A,FAM21C,MAGEL2,RAB7A,SDCCAG3,SLC11A2,SNX1,SNX2,SNX27,SNX3,SNX5,SNX6,SNX8,TBC1D5,TRIM27,VPS26A,VPS26B,VPS29,VPS35	A conserved hetero-pentameric membrane-associated complex involved in retrograde transport from endosomes to the Golgi apparatus. The budding yeast retromer comprises Vps35p, Vps29p, Vps26p, Vps5p, and Vps17p. The mammalian complex shows slight variation in composition compared to yeast, and comprises SNX1 or SNX2, SNX5 or SNX6, VPS26A or VPS26B, VPS29, and VPS35.
GO:0030914	GO	CC	STAGA complex	KAT2A,SAP130,SUPT3H,SUPT7L,TADA1,TADA3,TAF10,TAF12,TAF5L,TAF6L,TAF9,TRRAP	A large multiprotein complex that possesses histone acetyltransferase and is involved in regulation of transcription. The composition is similar to that of the SAGA complex; for example, the human complex contains the transcription-transformation cofactor TRRAP, hGCN5L acetylase, novel human ADA-like and SPT-like cofactors, and a subset of TAFs.
GO:0030915	GO	CC	Smc5-Smc6 complex	EID3,NDNL2,NSMCE1,NSMCE2,NSMCE4A,SMC5,SMC6	A conserved complex that contains a heterodimer of SMC proteins (Smc5p and Smc6p, or homologs thereof) and several other proteins, and is involved in DNA repair and maintaining cell cycle arrest following DNA damage. In S. cerevisiae, this is an octameric complex called Mms21-Smc5-Smc6 complex, with at least five of its subunits conserved in fission yeast and humans.
GO:0030947	GO	BP	regulation of vascular endothelial growth factor receptor signaling pathway	ARNT,DAB2IP,FLT1,GRB10,HHEX,HIF1A,IL1B,ITGA5,ITGB3,MMRN2,MT3,NEDD4,PDCD6,PRKCB,PRKD2,PTPN1,VEGFA,VEGFB,VTN	Any process that modulates the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
GO:0030948	GO	BP	negative regulation of vascular endothelial growth factor receptor signaling pathway	DAB2IP,HHEX,MMRN2,NEDD4,PDCD6,PTPN1	Any process that stops, prevents, or reduces the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
GO:0030949	GO	BP	positive regulation of vascular endothelial growth factor receptor signaling pathway	ARNT,FLT1,GRB10,HIF1A,IL1B,ITGA5,ITGB3,MT3,PRKCB,PRKD2,VEGFA,VEGFB,VTN	Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
GO:0030953	GO	BP	astral microtubule organization	CLASP1,DLG1,EZR,KPNB1,RAB11A	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of astral microtubules, any of the spindle microtubules that radiate in all directions from the spindle poles.
GO:0030955	GO	MF	potassium ion binding	ATP1A1,ATP1A2,ATP1B1,HDAC4,KCNJ11,PDXK	Interacting selectively and non-covalently with potassium (K+) ions.
GO:0030968	GO	BP	endoplasmic reticulum unfolded protein response	ACADVL,ADD1,AMFR,ARFGAP1,ASNA1,ASNS,ATF3,ATF4,ATF6,ATF6B,ATP6V0D1,BAK1,BAX,BHLHA15,CALR,CCL2,CDK5RAP3,CREB3,CREB3L1,CTDSP2,CTH,CUL7,CXCL8,CXXC1,DAB2IP,DCTN1,DDIT3,DDX11,DERL1,DERL2,DERL3,DNAJB11,DNAJB9,DNAJC3,EDEM1,EIF2AK3,EIF2S1,EP300,ERN1,EXTL3,FKBP14,GFPT1,GOSR2,GSK3A,HDGF,HERPUD1,HSP90B1,HSPA5,HYOU1,IGFBP1,KDELR3,KLHDC3,LMNA,MBTPS1,MBTPS2,MYDGF,NFE2L2,PARP16,PDIA5,PDIA6,PLA2G4B,PPP2R5B,PREB,PTPN1,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SERP1,SHC1,SRPR,SRPRB,SSR1,SULT1A3,SYVN1,TATDN2,TBL2,TLN1,TPP1,TSPYL2,VAPB,VCP,VIMP,WFS1,WIPI1,XBP1,YIF1A,YOD1,ZBTB17	The series of molecular signals generated as a consequence of the presence of unfolded proteins in the endoplasmic reticulum (ER) or other ER-related stress; results in changes in the regulation of transcription and translation.
GO:0030970	GO	BP	retrograde protein transport, ER to cytosol	AUP1,DERL1,DERL2,FAF2,HERPUD1,HM13,HSP90B1,NPLOC4,RHBDD1,SEC61B,SEL1L,SYVN1,TMEM129,UFD1L,VCP,VIMP	The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon.
GO:0030971	GO	MF	receptor tyrosine kinase binding	ANGPT4,BLNK,FIZ1,FRS2,GAB2,GNB2L1,IRS1,LRP4,NRG1,NRG3,PIK3R1,PITPNM3,SHC1,SQSTM1,STAP1,TOB1,TRAT1	Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
GO:0030983	GO	MF	mismatched DNA binding	MSH2,MSH3,MSH6,PCNA,PMS2,TDG,XPC	Interacting selectively and non-covalently with double-stranded DNA containing one or more mismatches.
GO:0030990	GO	CC	intraciliary transport particle	DYNC2LI1,HSPB11,IFT122,IFT140,IFT172,IFT20,IFT22,IFT27,IFT43,IFT46,IFT52,IFT57,IFT74,IFT80,IFT81,IFT88,TRAF3IP1,TTC21B,TTC26,TULP3,WDR19,WDR35	A nonmembrane-bound oligomeric protein complex that participates in bidirectional transport of molecules (cargo) along axonemal microtubules.
GO:0030991	GO	CC	intraciliary transport particle A	IFT122,IFT140,IFT43,TTC21B,TULP3,WDR19,WDR35	The smaller subcomplex of the intraciliary transport particle; characterized complexes have molecular weights of 710-760 kDa.
GO:0030992	GO	CC	intraciliary transport particle B	HSPB11,IFT172,IFT20,IFT22,IFT27,IFT46,IFT52,IFT57,IFT74,IFT80,IFT81,IFT88,TRAF3IP1,TTC26	The larger subcomplex of the intraciliary transport particle; characterized complexes have molecular weights around 550 kDa.
GO:0031010	GO	CC	ISWI-type complex	BAZ1A,BPTF,CECR2,CHRAC1,HMGXB4,RBBP4,SMARCA1,SMARCA5	Any nuclear protein complex that contains an ATPase subunit of the imitation switch (ISWI) family. ISWI ATPases are involved in assembling chromatin and in sliding and spacing nucleosomes to regulate transcription of nuclear RNA polymerases I, II, and III and also DNA replication, recombination and repair.
GO:0031011	GO	CC	Ino80 complex	ACTL6A,ACTR5,ACTR8,INO80,INO80B,INO80C,INO80E,MCRS1,NFRKB,RUVBL1,RUVBL2,TFPT,UCHL5,YY1	A multisubunit protein complex that contains the Ino80p ATPase; exhibits chromatin remodeling activity and 3' to 5' DNA helicase activity.
GO:0031016	GO	BP	pancreas development	AKT1,BMP4,BMP5,BMP6,CCDC39,CCDC40,CDK6,DLL1,DNAAF1,EIF2AK3,FOXA2,FOXA3,FOXF1,FOXO1,GCK,HES1,HNF1B,HNF4A,HNF4G,IAPP,IL6,IL6R,INS,INSM1,ISL1,NEUROD1,NEUROG3,NKX2-2,NKX6-1,NPHP3,NR5A2,ONECUT1,ONECUT3,PAX4,PAX6,PDX1,PKLR,PTF1A,RFX3,RFX6,SLC2A2,TCF7L2,ZIC3	The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
GO:0031018	GO	BP	endocrine pancreas development	AKT1,BMP4,BMP5,BMP6,CDK6,DLL1,EIF2AK3,FOXA2,FOXA3,FOXO1,GCK,HES1,HNF1B,HNF4A,HNF4G,IAPP,IL6,IL6R,INS,INSM1,NEUROD1,NEUROG3,NKX2-2,NKX6-1,NR5A2,ONECUT1,ONECUT3,PAX4,PAX6,PDX1,PKLR,PTF1A,RFX3,RFX6,SLC2A2	The process whose specific outcome is the progression of the endocrine pancreas over time, from its formation to the mature structure. The endocrine pancreas is made up of islet cells that produce insulin, glucagon and somatostatin.
GO:0031023	GO	BP	microtubule organizing center organization	ARHGEF10,ARL2,BBS4,BCAS3,BRCA2,BRSK1,C2CD3,CCP110,CDK1,CDK2,CDK5RAP2,CENPJ,CEP135,CEP152,CEP192,CEP250,CEP63,CEP68,CEP72,CETN2,CETN3,CHD3,CKAP5,CLASP1,CLASP2,CNTLN,CNTROB,CROCC,CTNNB1,FBXW5,GCC2,GOLGA2,HAUS1,HAUS2,HAUS3,HAUS4,HAUS5,HAUS6,HAUS7,HAUS8,HEPACAM2,KIAA0101,KIF3B,NDE1,NEK2,NPM1,PAFAH1B1,PCM1,PKD2,PLK1,PLK4,PPP1R12A,ROCK2,SASS6,SGOL1,SLC16A1,SSX2IP,STIL,TUBE1,USP33,UVRAG,UXT,WDR62,XRCC2	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a microtubule organizing center, a structure from which microtubules grow.
GO:0031032	GO	BP	actomyosin structure organization	ACTA1,ACTC1,ACTN2,ALKBH4,ANKRD1,ARRB1,BMP10,CAPN3,CASQ1,CDC42BPA,CDC42BPB,CFLAR,CSRP3,CUL3,EPB41L4B,F11R,ITGB5,KCTD13,KLHL41,KRT19,MEF2A,MYH10,MYH11,MYH14,MYH3,MYH6,MYH9,MYL2,MYLK3,MYO18A,MYOZ1,MYPN,NEBL,OBSCN,OBSL1,PDGFRA,PDGFRB,PHACTR1,PROX1,RACGAP1,SIX4,SORBS1,SRC,TCAP,TNFAIP1,TPM1,TTN,ZYX	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures containing both actin and myosin or paramyosin. The myosin may be organized into filaments.
GO:0031047	GO	BP	gene silencing by RNA	AAAS,ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,ASZ1,CELF1,CLP1,CNOT1,CNOT6,CNOT7,CNOT8,DDX4,DGCR8,DICER1,DROSHA,FKBP6,H3F3A,HENMT1,HIST1H3A,HIST1H4A,HIST2H3A,HNRNPA2B1,IPO8,LIMD1,LIN28A,LIN28B,MAEL,METTL3,MOV10,MOV10L1,MYBL1,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPC1,PIWIL1,PIWIL2,PIWIL4,PLD6,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POM121,POM121C,PRKRA,RAE1,RAN,RANBP2,RBM4,SEH1L,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TDRD1,TDRD12,TDRD6,TDRD9,TDRKH,TERT,TNRC6A,TNRC6B,TNRC6C,TPR,TRIM71,TSN,TSNAX,WTIP,XPO5,ZCCHC11,ZFP36	Any process in which RNA molecules inactivate expression of target genes.
GO:0031053	GO	BP	primary miRNA processing	DGCR8,DROSHA,HNRNPA2B1,METTL3,SMAD1,SMAD2,SMAD3,SRRT	Any process involved in the conversion of a primary microRNA transcript into a pre-microRNA molecule.
GO:0031054	GO	BP	pre-miRNA processing	ADAR,AGO1,AGO2,AGO3,AGO4,DICER1,LIN28A,LIN28B,PRKRA,TARBP2,ZCCHC11	Any process involved in the conversion of a pre-microRNA transcript into a mature microRNA molecule.
GO:0031055	GO	BP	chromatin remodeling at centromere	APITD1,CASC5,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,HELLS,HIST1H4A,HJURP,ITGB3BP,MIS18A,MIS18BP1,NPM1,OIP5,RBBP4,RBBP7,RSF1,RUVBL1,SMARCA5,STRA13	Dynamic structural changes in centromeric DNA.
GO:0031056	GO	BP	regulation of histone modification	ARRB1,AUTS2,BCOR,BRCA1,BRD7,C6orf89,CAMK2D,CDK9,CHEK1,CHTOP,CTBP1,CTCFL,CTNNB1,CTR9,DNMT1,DNMT3B,EID1,FLCN,FOXP3,H2AFY,HIST1H1B,IL1B,IWS1,JARID2,KDM1A,KDM5A,KMT2A,LIF,MAPK3,MAPK8,MTF2,MTHFR,MUC1,MYB,MYOCD,NIPBL,NOC2L,NOS1,NSD1,OGT,OTUB1,PAF1,PAXIP1,PHF1,PHF19,PIH1D1,PML,PPARGC1A,PRDM12,PRKD1,PRKD2,RNF20,RNF40,RPS6KA4,RPS6KA5,RUVBL2,SART3,SET,SIN3A,SIRT1,SMAD4,SMARCB1,SNCA,SNW1,SPI1,SUPT6H,TAF7,TET1,TRIP12,TWIST1,UBE2N,UBR5,USP17L2,VEGFA,WBP2,WDR61,XBP1	Any process that modulates the frequency, rate or extent of the covalent alteration of a histone.
GO:0031057	GO	BP	negative regulation of histone modification	BCOR,BRCA1,CTBP1,DNMT1,DNMT3B,FOXP3,H2AFY,JARID2,KDM5A,MTF2,NOC2L,OTUB1,PHF1,PIH1D1,SET,SIN3A,SIRT1,SMARCB1,SNCA,SPI1,SUPT6H,TAF7,TRIP12,TWIST1,UBR5,USP17L2	Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent alteration of a histone.
GO:0031058	GO	BP	positive regulation of histone modification	ARRB1,AUTS2,BRCA1,BRD7,C6orf89,CDK9,CHTOP,CTBP1,CTNNB1,CTR9,DNMT1,DNMT3B,FOXP3,HIST1H1B,IL1B,JARID2,KDM1A,KMT2A,LIF,MAPK3,MTF2,MUC1,MYB,NIPBL,NOS1,OGT,PAF1,PAXIP1,PHF1,PHF19,PIH1D1,PML,PPARGC1A,PRDM12,PRKD1,PRKD2,RNF20,RNF40,RPS6KA4,RPS6KA5,RUVBL2,SART3,SIRT1,SMAD4,SMARCB1,SNW1,TET1,UBE2N,VEGFA,WBP2,WDR61,XBP1	Any process that activates or increases the frequency, rate or extent of the covalent alteration of a histone.
GO:0031060	GO	BP	regulation of histone methylation	AUTS2,BCOR,BRCA1,CHTOP,CTCFL,CTNNB1,CTR9,DNMT1,DNMT3B,H2AFY,HIST1H1B,IWS1,JARID2,KMT2A,MTF2,MTHFR,MYB,NSD1,OGT,PAF1,PAXIP1,PHF1,PHF19,PIH1D1,PRDM12,SIRT1,SMAD4,SMARCB1,SNW1,SUPT6H,TET1,WDR61,XBP1	Any process that modulates the frequency, rate or extent of the covalent addition of methyl groups to histones.
GO:0031061	GO	BP	negative regulation of histone methylation	BCOR,BRCA1,DNMT1,DNMT3B,H2AFY,JARID2,MTF2,PHF1,PIH1D1,SMARCB1,SUPT6H	Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of methyl groups to histones.
GO:0031062	GO	BP	positive regulation of histone methylation	AUTS2,BRCA1,CHTOP,CTNNB1,CTR9,DNMT1,DNMT3B,HIST1H1B,JARID2,KMT2A,MTF2,MYB,OGT,PAF1,PAXIP1,PHF1,PHF19,PRDM12,SIRT1,SMAD4,SNW1,TET1,WDR61,XBP1	Any process that activates or increases the frequency, rate or extent of the covalent addition of methyl groups to histones.
GO:0031063	GO	BP	regulation of histone deacetylation	C6orf89,CAMK2D,CTBP1,FOXP3,KDM5A,MAPK8,NIPBL,PML,PRKD1,PRKD2,USP17L2,VEGFA	Any process that modulates the frequency, rate or extent of the removal of acetyl groups from histones.
GO:0031065	GO	BP	positive regulation of histone deacetylation	C6orf89,CTBP1,NIPBL,PML,PRKD1,PRKD2,VEGFA	Any process that activates or increases the frequency, rate or extent of the removal of acetyl groups from histones.
GO:0031069	GO	BP	hair follicle morphogenesis	ATP7A,FGFR2,FOXE1,KRT17,KRT71,TGFB2,TGM3,WNT10A	The process in which the anatomical structures of the hair follicle are generated and organized.
GO:0031072	GO	MF	heat shock protein binding	AHR,ARNTL,BCOR,C11orf73,CSNK2A1,DAXX,DNAJA1,DNAJB6,ERN1,FAF1,FKBP6,HDAC6,HIF1A,KDR,LIMK1,NASP,NOD2,NPAS2,PACRG,PDXP,PPEF2,PPID,RPS3,STUB1,TPR,USP19	Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock.
GO:0031076	GO	BP	embryonic camera-type eye development	KDM2B,NES,PAX2,PHACTR4,PROX1,SIX3,SOX11,STRA6,TBX2,TFAP2A,TH,TWIST1,WNT16,WNT5A	The process occurring during the embryonic phase whose specific outcome is the progression of the eye over time, from its formation to the mature structure.
GO:0031080	GO	CC	nuclear pore outer ring	AHCTF1,NUP107,NUP133,NUP160,NUP37,NUP43,NUP85,NUP98,SEC13,SEH1L	A subcomplex of the nuclear pore complex (NPC) that forms the outer rings of the core scaffold, a lattice-like structure that gives the NPC its shape and strength. In S. cerevisiae, the two outer rings each contain multiple copies of the following proteins: Nup133p, Nup120p, Nup145Cp, Nup85p, Nup84p, Seh1p, and Sec13p. In vertebrates, the two outer rings each contain multiple copies of the following proteins: Nup133, Nup160, Nup96, Nup75, Nup107, Seh1, Sec13, Nup43, Nup37, and ALADIN. Components are arranged in 8-fold symmetrical 'spokes' around the central transport channel. A single 'spoke', can be isolated and is sometimes referred to as the Nup84 complex (S. cerevisiae) or the Nup107-160 complex (vertebrates).
GO:0031083	GO	CC	BLOC-1 complex	BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,DTNBP1,KIAA1033,KXD1,PI4K2A,SNAP25,SNAP47,SNAPIN,STX12	A protein complex required for the biogenesis of specialized organelles of the endosomal-lysosomal system, such as melanosomes and platelet dense granules. Many of the protein subunits are conserved between mouse and human; the mouse complex contains the Pallidin, Muted, Cappuccino, Dysbindin, Snapin, BLOS1, BLOS2, AND BLOS3 proteins.
GO:0031088	GO	CC	platelet dense granule membrane	ABCC4,CD63,ITPR1,LAMP2,SELP	The lipid bilayer surrounding the platelet dense granule.
GO:0031091	GO	CC	platelet alpha granule	A2M,ACTN1,ACTN2,ACTN4,ALB,ALDOA,APP,CD36,CD9,CFD,CLU,EGF,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FN1,GAS6,HGF,HRG,IGF1,IGF2,ITGA2B,ITGB3,KNG1,LEFTY2,MMRN1,PDGFA,PDGFB,PECAM1,PF4,PLG,PPBP,PROS1,SELP,SERPINA1,SERPINA5,SERPINE1,SERPINE2,SERPINF2,SERPING1,SNCA,SPARC,SRGN,STXBP1,STXBP3,TGFB1,TGFB2,TGFB3,THBS1,THBS2,TIMP1,TMSB4X,TREML1,VAMP7,VEGFA,VEGFB,VEGFC,VPS33B,VWF	A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
GO:0031092	GO	CC	platelet alpha granule membrane	CD36,CD9,ITGA2B,ITGB3,PECAM1,SELP,SNCA,SPARC	The lipid bilayer surrounding the platelet alpha granule.
GO:0031093	GO	CC	platelet alpha granule lumen	A2M,ACTN1,ACTN2,ACTN4,ALB,ALDOA,APP,CFD,CLU,EGF,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FN1,GAS6,HGF,HRG,IGF1,IGF2,KNG1,LEFTY2,MMRN1,PDGFA,PDGFB,PF4,PLG,PPBP,PROS1,SERPINA1,SERPINE1,SERPINF2,SERPING1,SPARC,SRGN,TGFB1,TGFB2,TGFB3,THBS1,TIMP1,TMSB4X,VEGFA,VEGFB,VEGFC,VWF	The volume enclosed by the membrane of the platelet alpha granule.
GO:0031094	GO	CC	platelet dense tubular network	ATP2A1,ATP2A2,ATP2A3,DMTN,EHD1,F2R,ITPR1,ITPR2,ITPR3,MRVI1,SERPINA5	A network of membrane-bounded compartments found in blood platelets, where they regulate platelet activation by sequestering or releasing calcium. The dense tubular network exists as thin elongated membranes in resting platelets, and undergoes a major ultrastructural change, to a rounded vesicular form, upon addition of thrombin.
GO:0031095	GO	CC	platelet dense tubular network membrane	ATP2A1,ATP2A2,ATP2A3,DMTN,EHD1,ITPR1,ITPR2,ITPR3,MRVI1	The lipid bilayer surrounding the platelet dense tubular network.
GO:0031098	GO	BP	stress-activated protein kinase signaling cascade	ADORA2B,ARHGEF6,ATF1,ATF2,BIRC7,BTRC,CCDC88C,CCL19,CCM2,CHUK,CREB1,CRKL,CUL1,DAB2IP,DAXX,DBNL,DUSP10,DUSP3,DUSP4,DUSP6,DUSP7,DUSP9,ELK1,ERN1,FBXW11,FOS,GPS1,GPS2,HACD3,IKBKB,IKBKG,IRAK1,IRAK2,JUN,LGALS9,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K10,MAP3K11,MAP3K12,MAP3K13,MAP3K2,MAP3K5,MAP3K6,MAP3K7,MAP3K8,MAP3K9,MAP4K1,MAP4K2,MAP4K3,MAP4K5,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MDFIC,MEF2A,MEF2C,MINK1,MUL1,NFKB1,NOD1,NOD2,PKN1,PPP2R5D,PTGER4,RBM4,RIPK1,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SH2D3A,SH2D3C,SKP1,TAB1,TAB2,TAB3,TAOK2,TNFRSF19,TNIK,TNIP2,TRAF6,TRIB1,UBA52,UBB,UBC,WNT5A	A series of molecular signals in which a stress-activated protein kinase (SAPK) cascade relays one or more of the signals.
GO:0031099	GO	BP	regeneration	APOD,CEBPB,CFLAR,CPQ,DHFR,ERBB4,EYS,FOLR1,IGF1,KLK6,LARGE,MTR,NACA,NOV,RTN4RL1,RTN4RL2	The regrowth of a lost or destroyed body part, such as an organ or tissue.
GO:0031103	GO	BP	axon regeneration	APOD,DHFR,FOLR1,MTR,RTN4RL1,RTN4RL2	The regrowth of axons following their loss or damage.
GO:0031109	GO	BP	microtubule polymerization or depolymerization	AKAP9,BLOC1S2,CCSAP,CENPJ,CLASP1,CLASP2,CSNK1D,FGF13,GOLGA2,KIF18A,KIF18B,KIF19,KIF24,KIF2B,KIF2C,MAP7D3,NCKAP5L,RANBP9,SLAIN2,STMN1,TPPP,TRPV4,TUBGCP2,TUBGCP3,TUBGCP4,TUBGCP5,TUBGCP6,ZNF207	Assembly or disassembly of microtubules by the addition or removal of tubulin heterodimers from a microtubule.
GO:0031110	GO	BP	regulation of microtubule polymerization or depolymerization	ABL1,APC,ARHGEF2,ARL2,AURKA,AURKB,CAV3,CCNB1,CIB1,CLASP1,CLASP2,CLIP1,CLIP3,EML2,FES,FGF13,FKBP4,GAS2L1,GAS2L2,KATNB1,MAPRE1,MAPT,MID1IP1,PSRC1,RPS3,SBDS,SKA1,SKA2,SKA3,SLAIN2,SNCA,STMN2,TBCD,TERF1,TRIM54,TRPV4	Any process that modulates the frequency, rate or extent of microtubule polymerization or depolymerization by the addition or removal of tubulin heterodimers from a microtubule.
GO:0031111	GO	BP	negative regulation of microtubule polymerization or depolymerization	APC,ARHGEF2,AURKA,AURKB,CCNB1,CIB1,CLASP1,CLASP2,CLIP3,EML2,FGF13,FKBP4,GAS2L1,GAS2L2,KATNB1,MAPRE1,MID1IP1,SBDS,SNCA,STMN2,TBCD,TRIM54	Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization or depolymerization.
GO:0031112	GO	BP	positive regulation of microtubule polymerization or depolymerization	ARL2,CAV3,CLASP1,CLIP1,FES,KATNB1,MAPT,PSRC1,RPS3,SLAIN2,STMN2,TERF1,TRPV4	Any process that activates or increases the frequency, rate or extent of microtubule polymerization or depolymerization.
GO:0031113	GO	BP	regulation of microtubule polymerization	ABL1,ARL2,CAV3,CLASP1,CLASP2,CLIP1,CLIP3,EML2,FES,MAPRE1,MAPT,PSRC1,RPS3,SLAIN2,SNCA,STMN2,TBCD,TERF1	Any process that modulates the frequency, rate or extent of microtubule polymerization.
GO:0031114	GO	BP	regulation of microtubule depolymerization	APC,ARHGEF2,AURKA,AURKB,CCNB1,CIB1,CLASP1,CLASP2,FGF13,GAS2L1,GAS2L2,KATNB1,MID1IP1,SBDS,STMN2,TRIM54,TRPV4	Any process that modulates the frequency, rate or extent of microtubule depolymerization.
GO:0031115	GO	BP	negative regulation of microtubule polymerization	CLIP3,EML2,MAPRE1,SNCA,STMN2,TBCD	Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization.
GO:0031116	GO	BP	positive regulation of microtubule polymerization	ARL2,CAV3,CLASP1,CLIP1,FES,MAPT,PSRC1,RPS3,SLAIN2,TERF1	Any process that activates or increases the frequency, rate or extent of microtubule polymerization.
GO:0031122	GO	BP	cytoplasmic microtubule organization	CCDC13,CEP126,CHP1,CIB1,CLASP1,CRIPT,DLG1,EZR,HOOK3,KIF19,KPNB1,MAP10,PCM1,PLK3,RAB11A,SLAIN2,STMN3,TRDN,TRPV4	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures formed of microtubules and associated proteins in the cytoplasm of a cell.
GO:0031123	GO	BP	RNA 3'-end processing	AHCYL1,ALYREF,APP,CDC40,CDC73,CLP1,CPSF1,CPSF2,CPSF3,CPSF6,CPSF7,CSTF1,CSTF2,CSTF3,DHX38,ELAC2,ERI1,FIP1L1,GRSF1,LEO1,LIN28A,LIN28B,LSM10,LSM11,MAGOH,MTPAP,NCBP1,NCBP2,NUDT21,PABPC1,PABPN1,PAF1,PAPOLA,PCF11,PNPT1,PTCD1,RBM8A,RNPS1,SLBP,SNRPB,SNRPD3,SNRPE,SNRPF,SNRPG,SRRM1,SRSF1,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,SSU72,SUPV3L1,SYMPK,TRNT1,TUT1,U2AF1,U2AF2,UPF3B,USB1,ZC3H3,ZCCHC11,ZCCHC6,ZNF473	Any process involved in forming the mature 3' end of an RNA molecule.
GO:0031124	GO	BP	mRNA 3'-end processing	AHCYL1,ALYREF,APP,CDC40,CDC73,CLP1,CPSF1,CPSF2,CPSF3,CPSF6,CPSF7,CSTF1,CSTF2,CSTF3,DHX38,FIP1L1,GRSF1,LEO1,LSM10,LSM11,MAGOH,MTPAP,NCBP1,NCBP2,NUDT21,PABPC1,PABPN1,PAF1,PAPOLA,PCF11,PNPT1,RBM8A,RNPS1,SLBP,SNRPB,SNRPD3,SNRPE,SNRPF,SNRPG,SRRM1,SRSF1,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,SSU72,SYMPK,TUT1,U2AF1,U2AF2,UPF3B,ZC3H3,ZNF473	Any process involved in forming the mature 3' end of an mRNA molecule.
GO:0031128	GO	BP	developmental induction	BMP2,BMP4,FZD5,POU5F1,SALL1,SIX1,SOX8,SOX9,WNT1	A developmental process involving two tissues in which one tissue (the inducer) produces a signal that directs cell fate commitment of cells in the second tissue (the responder).
GO:0031143	GO	CC	pseudopodium	ACTN1,ACTN2,ACTN3,ACTN4,CAPN2,F2RL1,MSN,RAB25,VAMP7	A temporary protrusion or retractile process of a cell, associated with flowing movements of the protoplasm, and serving for locomotion and feeding.
GO:0031145	GO	BP	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,AURKA,AURKB,BTRC,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDK2,CUL1,FBXO5,FZR1,MAD2L1,NEK2,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTTG1,RPS27A,SKP1,SKP2,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2S	The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by the anaphase-promoting complex, and mediated by the proteasome.
GO:0031146	GO	BP	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	CCNF,CUL1,FBXL15,FBXL2,FBXL3,FBXL5,FBXL7,FBXO2,FBXO31,FBXO4,FBXO6,FBXO9,FBXW11,FBXW5,FBXW7,KIF14,RBX1,SKP1	The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by an SCF (Skp1/Cul1/F-box protein) complex, and mediated by the proteasome.
GO:0031201	GO	CC	SNARE complex	BET1L,BLOC1S6,BNIP1,CPLX1,CPLX2,DOC2B,GOSR1,SCAMP5,SCFD1,SNAP23,SNAP25,SNAP29,SNX4,STX12,STX16,STX17,STX1A,STX3,STX4,STX5,STX6,STXBP2,VAMP2,VAMP3,VAMP7,VAMP8,VTI1A,YKT6	A protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. One well-characterized example is the neuronal SNARE complex formed of synaptobrevin 2, syntaxin 1a, and SNAP-25.
GO:0031209	GO	CC	SCAR complex	ABI1,ABI2,BRK1,CYFIP1,NCKAP1,NCKAP1L,WASF1,WASF2	A heterotetrameric complex that includes orthologues of human PIR121, Nap125 and HSPC300 and regulates actin polymerization and/or depolymerization through small GTPase mediated signal transduction.
GO:0031210	GO	MF	phosphatidylcholine binding	APOA2,APOA4,APOA5,APOC1,CETP,CHMP2A,CHMP3,ESYT2,JCHAIN,NF1,PCTP,RASGRP1,RPE65,SERPINA5	Interacting selectively and non-covalently with phosphatidylcholine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of choline.
GO:0031214	GO	BP	biomineral tissue development	ALOX15,AMELX,ASPN,BGLAP,BMP2,CER1,CLEC3B,COL1A1,DDR2,EIF2AK3,FAM20A,FAM20C,FBXL15,FGFR2,FGFR3,HACD1,IFITM5,IGF1,LGR4,MINPP1,SBDS,STIM1,TBX1,TUFT1,ZBTB40	Formation of hard tissues that consist mainly of inorganic compounds, and also contain a small amounts of organic matrices that are believed to play important roles in their formation.
GO:0031225	GO	CC	anchored component of membrane	CA4,CD14,CD160,CD59,EFNA5,FOLR1,FOLR2,GAS1,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GP1BA,GPIHBP1,HYAL2,LYPD3,MDGA1,MFI2,NTNG1,NTNG2,PKHD1,RGMB,RHBG,RTN4RL1,RTN4RL2,SVIP,TREH,ULBP1,ULBP2,ULBP3,UMOD	The component of a membrane consisting of the gene products that are tethered to the membrane only by a covalently attached anchor, such as a lipid group that is embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping.
GO:0031227	GO	CC	intrinsic component of endoplasmic reticulum membrane	ABCB9,ACER3,AMFR,ANKLE2,ASPH,ATF6,ATF6B,BCAP31,BFAR,BNIP1,BSCL2,CALR,CANX,CD74,CLN3,CREB3,DCSTAMP,DERL1,DERL2,DERL3,DGAT2,DHRS9,DOLK,DOLPP1,DPAGT1,DPM3,EDEM1,EIF2AK3,ELOVL1,ELOVL4,EMC1,EMC10,EMC2,EMC3,EMC4,EMC6,EMC7,EMC8,EMC9,ERN1,ESYT1,ESYT2,ESYT3,EXT1,FAM134B,FITM2,G6PC,GPAA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HM13,HSPA5,INSIG1,INSIG2,LRIT1,MARCH6,MBOAT4,MMGT1,PGAP3,PIGK,PIGS,PIGT,PIGU,PKD2,RHBDD1,RTN1,RTN2,RTN4,SAMD8,SARAF,SEC61A1,SGPL1,SLC27A2,SLC27A5,SLC37A4,SPCS1,SPPL2A,SPPL2B,SPPL2C,SPPL3,SREBF2,STIM1,SYVN1,TAP1,TAP2,TAPBP,TBL2,TECR,UBXN8,VIMP,WFS1,XBP1	The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0031228	GO	CC	intrinsic component of Golgi membrane	A4GALT,ACER2,ACER3,B4GAT1,CHST12,CHST2,CHST4,CHST5,CSGALNACT1,CSGALNACT2,ENTPD4,GALNT2,GFY,GOLGA7,LARGE,MAN1C1,PCSK7,QSOX1,RER1,SGMS1,SGMS2,SLC39A13,STEAP2,TBC1D20,UBIAD1,ZDHHC9	The component of the Golgi membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0031231	GO	CC	intrinsic component of peroxisomal membrane	ABCD1,FIS1,PEX10,PEX11A,PEX11B,PEX11G,PEX12,PEX13,PEX16,PEX2,PEX3,SLC25A17,SLC27A2	The component of the peroxisomal membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0031232	GO	CC	extrinsic component of external side of plasma membrane	ANXA1,CUBN,FCN1,PCSK9,PLG,SERPINE2,TF	The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its external surface, but not integrated into the hydrophobic region.
GO:0031233	GO	CC	intrinsic component of external side of plasma membrane	ADAM9,CA4,CD14,CD59,CEACAM5,EFNA5,F10,F3,FOLR1,FOLR2,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GP1BA,GPIHBP1,HYAL2,PKHD1	The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
GO:0031234	GO	CC	extrinsic component of cytoplasmic side of plasma membrane	ALOX15,ARRB1,CAV2,CDK16,CYLD,CYTH1,CYTH3,DLG4,ERRFI1,ESYT2,ESYT3,FARP1,FER,FERMT2,FES,GNA14,GNA15,GNAI1,GNAS,GNAT2,GNB1,GNG2,GNG5,GNGT2,HCK,IQGAP1,KCNAB1,KCNAB2,KCNIP1,KRAS,MYZAP,RACGAP1,RGS1,RGS19,RGS8,S100A6,SNX18,SNX5,SNX9,TGM3,TIAM1	The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its cytoplasmic surface, but not integrated into the hydrophobic region.
GO:0031235	GO	CC	intrinsic component of the cytoplasmic side of the plasma membrane	MIEN1,NPHS2,RASA3,SPTA1,SPTB	The component of a plasma membrane consisting of gene products and protein complexes that have some covalently attached part (e.g. peptide sequence or GPI anchor) which is embedded in the cytoplasmic side of the plasma membrane only.
GO:0031248	GO	CC	protein acetyltransferase complex	ACTB,ACTL6A,ATXN7L3,BRD1,BRD8,BRPF1,BRPF3,CSRP2BP,DMAP1,DR1,ELP2,ELP3,ELP4,ENY2,EP400,EPC1,HCFC1,IKBKAP,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,MAP3K7,MBIP,MCRS1,MEAF6,MORF4L1,MSL1,MSL2,MSL3,NAA10,NAA11,NAA15,NAA16,NAA30,NAA35,NAA38,NAA50,OGT,PHF20,POLE3,POLE4,RUVBL1,RUVBL2,SAP130,SGF29,SUPT20H,SUPT3H,SUPT7L,TADA1,TADA2A,TADA2B,TADA3,TAF10,TAF12,TAF2,TAF4,TAF5,TAF5L,TAF6,TAF6L,TAF7,TAF9,TAF9B,TRRAP,UBAP2L,USP22,WDR5,YEATS2,YEATS4	A complex that catalyzes the transfer of an acetyl group to a protein acceptor molecule.
GO:0031252	GO	CC	cell leading edge	AAK1,ABCA7,ABI1,ABI2,ABI3,ABLIM1,ABLIM3,ACTA1,ACTA2,ACTC1,ACTG2,ACTN1,ADAM17,ADGRE2,AIF1,AKT2,ALS2,AMOT,AMPH,ANTXR1,APBB1,APBB2,APC,APC2,ARAP3,ARF1,ARF4,ARF6,ARFIP2,ARHGAP44,ARHGEF2,ARHGEF6,ARHGEF7,ARPIN,ASAP3,BCAR1,BCAS3,BMX,BRK1,C2CD5,CCDC88A,CD2AP,CDC42BPA,CDC42BPB,CDC42BPG,CDH1,CDH2,CDK6,CDKL5,CIB1,CLASP2,CLRN1,CNTNAP2,COBL,CORO1A,CORO1B,CORO1C,CTTN,CXCR4,CYFIP1,DAG1,DBNL,DDX58,DGKZ,DLC1,DPP4,DPYSL3,DST,EEF1A1,EPB41L3,EPHA2,EPS8,EPS8L1,EPS8L2,EVL,EZR,FAP,FER,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FGR,FLOT1,FLOT2,FSCN1,GABRG2,GBF1,GPER1,GRIA1,HAX1,HDAC6,IFIT5,INPP5J,INPP5K,IQGAP1,IQGAP2,ITGA5,ITGAV,ITGB1,ITGB1BP1,ITGB3,ITGB4,JMY,KANK1,KCNA2,KIF18A,LAMP5,LAYN,LCP1,LRRC16A,MACF1,MKLN1,MTM1,MTMR14,MTSS1,MYADM,MYH9,MYLK,MYO5A,MYO6,NME1,NME2,PACSIN1,PAFAH1B1,PAK1,PARVB,PDPN,PDXP,PHACTR4,PHLDB2,PIP5K1A,PKD2,PKN2,PLCG1,PLEK,PLEKHA1,PLEKHG5,PLEKHH2,PLXND1,PODXL,PPP1R9B,PTK2B,PTK6,PTPN13,PTPRK,PTPRM,PTPRO,PXN,RAB13,RAC1,RAC2,RAPGEF3,RDX,RHOA,RINL,ROBO2,ROCK1,RPS3,RUFY3,S100A11,S100A6,S100B,SCIMP,SCRIB,SCYL3,SGCE,SH3BGRL3,SH3YL1,SHISA9,SHTN1,SLC39A6,SLC9A1,SNTG1,SPATA13,SPTBN1,SRGAP2,STMN2,STX2,STX3,STX4,SYNE2,TESC,TIRAP,TLN1,TPM1,TRPV4,TSC1,TWF1,TWF2,UNC5A,VAMP7,VIL1,WASF2,WWC1	The area of a motile cell closest to the direction of movement.
GO:0031253	GO	CC	cell projection membrane	ABCA4,ABCA7,ADAM17,AIF1,AKT2,ANTXR1,APC,APC2,AQP1,ARF4,ARF6,ARHGEF2,ARL13B,ATP6V0A4,B4GALT1,BBS4,BMX,C2CD5,CA4,CASK,CD36,CDKL5,CLASP2,CNGA2,CNGA4,CNGB1,CNTNAP2,CUBN,DDX58,DHRS3,DLC1,DMD,DMTN,DPP4,DRD1,DRD2,DRD5,EEF1A1,EHD1,EHD3,EPB41L3,EPS8,EPS8L1,EPS8L2,EVC,EVC2,FAM65B,FAP,FGR,FSCN1,GABRG2,GAP43,GNAT1,GNAT2,GNB1,GNGT1,GPER1,GPR161,GRIA1,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HHIP,IFIT5,INPP5K,ITGA3,ITGA5,ITGAV,ITGB1,ITGB3,ITLN1,KANK1,LAMP5,MACF1,NAPEPLD,NME1,NOX1,OPN1LW,OPN1MW,OPN1SW,PACSIN1,PALM,PDE6A,PDE6B,PDE6G,PDXP,PDZK1,PEX19,PIP5K1A,PKD1,PLEK,PLEKHA1,PODXL,PPP1R9B,PROM1,PTCH1,RAB35,RHO,ROBO2,RPS3,SCIMP,SCNN1A,SEPT2,SGCE,SH3YL1,SHANK2,SHANK3,SHISA9,SLC17A3,SLC22A12,SLC22A5,SLC26A4,SLC26A6,SLC34A1,SLC34A2,SLC39A6,SLC3A1,SLC7A9,SLC9A3,SLC9A3R1,SMO,SNAP29,SNTG1,SPATA13,SPTBN1,SPTBN5,SSTR3,SYNE2,TBC1D10C,TCTN2,TCTN3,TIRAP,TMEM17,TMEM231,TMEM67,TPM1,TRPV4,TWF1,UNC5A,USH2A,UTRN,WWC1	The portion of the plasma membrane surrounding a cell surface projection.
GO:0031256	GO	CC	leading edge membrane	ABCA7,ADAM17,ADGRE2,AIF1,AKT2,AMPH,ANTXR1,APC,APC2,ARF4,ARHGAP44,ARHGEF2,BMX,C2CD5,CDKL5,CLASP2,CNTNAP2,DDX58,DLC1,EEF1A1,EPB41L3,EPHA2,EPS8,EPS8L1,EPS8L2,FAP,FGR,GABRG2,GPER1,GRIA1,IFIT5,INPP5K,ITGA5,ITGAV,ITGB1,ITGB3,KANK1,LAMP5,MACF1,NME1,PACSIN1,PDXP,PIP5K1A,PLEK,PLEKHA1,PPP1R9B,PTPRK,ROBO2,RPS3,SCIMP,SGCE,SH3YL1,SHISA9,SLC39A6,SNTG1,SPATA13,SPTBN1,SYNE2,TIRAP,TPM1,TRPV4,TWF1,UNC5A,WWC1	The portion of the plasma membrane surrounding the leading edge of a motile cell.
GO:0031258	GO	CC	lamellipodium membrane	ANTXR1,APC2,ITGAV,ITGB3,SLC39A6,SYNE2	The portion of the plasma membrane surrounding a lamellipodium.
GO:0031264	GO	CC	death-inducing signaling complex	CASP10,CASP8,CFLAR,FADD,FAF1,FAS,RIPK1,TRADD	A protein complex formed by the association of signaling proteins with a death receptor upon ligand binding. The complex includes procaspases and death domain-containing proteins in addition to the ligand-bound receptor, and may control the activation of caspases 8 and 10.
GO:0031265	GO	CC	CD95 death-inducing signaling complex	CASP10,CASP8,FADD,FAF1,FAS	A protein complex formed upon binding of Fas/CD95/APO-1 to its ligand. The complex includes FADD/Mort1, procaspase-8/10 and c-FLIP in addition to the ligand-bound receptor.
GO:0031267	GO	MF	small GTPase binding	ABI2,ALS2,ANKFY1,ANKRD27,ARFIP2,ARHGEF2,ATP6AP1,BICD2,BRK1,C9orf72,CCDC64,CDC42EP4,CDKL5,CHM,CHML,CYFIP1,DAPK3,DMXL2,DOCK4,DOCK7,EPS8,ERC1,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,FLNA,FMNL1,GGA2,GGA3,GOLGA5,HACE1,IQGAP2,KCTD13,MAPKAP1,MLLT4,NCKAP1,NDRG1,NGFR,NSF,PARD6A,PKN1,PLCE1,RAB11FIP3,RAB8A,RABGAP1L,RABGGTA,RABGGTB,RANBP1,RANBP9,RANGRF,RAPGEF4,RAPGEF6,RGP1,RGPD8,RHOH,RIC1,RILP,RIMS1,RIN3,RTKN,SGSM3,SOD1,SPHK2,SRGAP2,TMEM127,TNFAIP1,TRIOBP,UNC13D,WASF1,WHAMM,XPO5,YBX3	Interacting selectively and non-covalently with a small monomeric GTPase.
GO:0031274	GO	BP	positive regulation of pseudopodium assembly	APC,CCL21,CCR7,CDC42,CDC42EP1,CDC42EP2,CDC42EP4,CDC42EP5,F2RL1,WASH1	Any process that activates or increases the frequency, rate or extent of the assembly of pseudopodia.
GO:0031279	GO	BP	regulation of cyclase activity	ACR,ADCYAP1,ADCYAP1R1,ADGRD1,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CALCR,CAP1,CAP2,CCR2,CRHR1,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,GABBR2,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GPER1,GRM2,GRM3,GRM7,GUCA1C,GUCA2A,GUCA2B,LHCGR,LTB4R2,MAPK14,MAPK3,MAPK8,NF1,NOS3,NTRK1,NTRK2,OPRM1,P2RY11,PALM,PDZD3,PRKCA,RAF1,RCVRN,VIP	Any process that modulates the frequency, rate or extent of cyclase activity.
GO:0031280	GO	BP	negative regulation of cyclase activity	ADRA2A,CCR2,DRD2,DRD3,DRD4,EDNRB,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,LTB4R2,OPRM1,PALM,PDZD3,PRKCA	Any process that stops or reduces the activity of a cyclase.
GO:0031281	GO	BP	positive regulation of cyclase activity	ACR,ADCYAP1,ADCYAP1R1,ADGRD1,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CALCR,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,GIPR,GLP1R,GNAS,GPER1,GUCA1C,GUCA2A,GUCA2B,LHCGR,MAPK14,MAPK3,MAPK8,NF1,NOS3,NTRK1,NTRK2,P2RY11,PRKCA,RAF1,RCVRN,VIP	Any process that activates or increases the activity of a cyclase.
GO:0031282	GO	BP	regulation of guanylate cyclase activity	GUCA1C,GUCA2A,GUCA2B,NOS3,PDZD3,RCVRN	Any process that modulates the frequency, rate or extent of guanylate cyclase activity.
GO:0031284	GO	BP	positive regulation of guanylate cyclase activity	GUCA1C,GUCA2A,GUCA2B,NOS3,RCVRN	Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity.
GO:0031290	GO	BP	retinal ganglion cell axon guidance	ALCAM,EPHB1,NRP1,PTPRM,ROBO2,SLIT2	The process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
GO:0031293	GO	BP	membrane protein intracellular domain proteolysis	ADAM17,APH1A,APH1B,MBTPS1,MBTPS2,NCSTN,NFKB1,NGFR,PSEN2,PSENEN,RELA,RHBDD1,SPPL2A,SPPL2B,TRAF6	The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
GO:0031295	GO	BP	T cell costimulation	AKT1,BTLA,CARD11,CAV1,CCL19,CCL21,CD24,CD247,CD274,CD28,CD3D,CD3E,CD3G,CD4,CD80,CD86,CDC42,CSK,CTLA4,DPP4,FYN,GRAP2,GRB2,HHLA2,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,ICOS,ICOSLG,KLRK1,LCK,LYN,MAP3K14,MAP3K8,MAPKAP1,MLST8,MTOR,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PRR5,PTPN11,PTPN6,RAC1,RICTOR,SRC,TMIGD2,TNFRSF14,VAV1,YES1	The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation.
GO:0031297	GO	BP	replication fork processing	ALYREF,APITD1,ATRX,BLM,BOD1L1,BRCA2,CDK9,FANCM,FBXO18,MMS22L,PCNA,PRIMPOL,RAD51,RTEL1,SETMAR,SMARCAL1,STRA13,THOC1,TONSL,WRN,ZRANB3	The process in which a DNA replication fork that has stalled (due to DNA damage, DNA secondary structure, bound proteins, dNTP shortage, or other causes) is repaired and replication is restarted.
GO:0031300	GO	CC	intrinsic component of organelle membrane	A4GALT,ABCB10,ABCB6,ABCB9,ABCD1,ACER2,ACER3,AMFR,ANKLE2,APOO,APOOL,ASPH,ATF6,ATF6B,B4GAT1,BAK1,BCAP31,BFAR,BNIP1,BNIP3,BSCL2,C11orf85,CALR,CANX,CCDC109B,CD74,CHCHD3,CHCHD6,CHST12,CHST2,CHST4,CHST5,CLN3,COA1,COA3,COX18,CPT1A,CREB3,CSGALNACT1,CSGALNACT2,DCSTAMP,DERL1,DERL2,DERL3,DGAT2,DHRS9,DMPK,DOLK,DOLPP1,DPAGT1,DPM3,ECE1,EDEM1,EIF2AK3,ELOVL1,ELOVL4,EMC1,EMC10,EMC2,EMC3,EMC4,EMC6,EMC7,EMC8,EMC9,ENTPD4,ERN1,ESYT1,ESYT2,ESYT3,ETFDH,EXT1,FAM134B,FIS1,FITM2,FUNDC1,G6PC,GABRA2,GALNT2,GDAP1,GFY,GOLGA7,GPAA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HM13,HSPA5,IMMT,INSIG1,INSIG2,ITM2B,L2HGDH,LARGE,LBR,LEMD2,LRIT1,MAN1C1,MARCH6,MBOAT4,MCU,MCUR1,MFF,MFN2,MGARP,MICU1,MMGT1,MUL1,OXA1L,PCSK7,PEX10,PEX11A,PEX11B,PEX11G,PEX12,PEX13,PEX16,PEX2,PEX3,PGAP3,PIGK,PIGS,PIGT,PIGU,PINK1,PKD2,PPOX,PQLC2,QSOX1,RER1,RHBDD1,RHOT1,RHOT2,RNF152,RTN1,RTN2,RTN4,SAMD8,SARAF,SEC61A1,SGMS1,SGMS2,SGPL1,SLC22A17,SLC25A17,SLC27A2,SLC27A5,SLC37A4,SLC39A13,SLC8B1,SMDT1,SPCS1,SPPL2A,SPPL2B,SPPL2C,SPPL3,SREBF2,STEAP2,STIM1,SYNE4,SYP,SYVN1,TAP1,TAP2,TAPBP,TBC1D20,TBL2,TECR,TIMM17A,TIMM17B,TIMM23,TMEM11,TMEM163,TMEM70,TOMM40,TRABD2A,TRABD2B,UBIAD1,UBXN8,UQCC3,VAMP5,VIMP,VOPP1,WFS1,XBP1,ZDHHC9	The component of the organelle membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0031301	GO	CC	integral component of organelle membrane	A4GALT,ABCB10,ABCB6,ABCB9,ABCD1,ACER2,ACER3,AMFR,ANKLE2,APOO,APOOL,ASPH,ATF6,ATF6B,B4GAT1,BAK1,BCAP31,BFAR,BNIP1,BNIP3,BSCL2,C11orf85,CALR,CANX,CCDC109B,CD74,CHCHD3,CHCHD6,CHST12,CLN3,COA1,COA3,COX18,CPT1A,CREB3,CSGALNACT1,CSGALNACT2,DCSTAMP,DERL1,DERL2,DERL3,DGAT2,DHRS9,DMPK,DOLK,DOLPP1,DPAGT1,DPM3,EDEM1,EIF2AK3,ELOVL1,ELOVL4,EMC1,EMC10,EMC2,EMC3,EMC4,EMC6,EMC7,EMC8,EMC9,ENTPD4,ERN1,ESYT1,ETFDH,EXT1,FAM134B,FIS1,FITM2,FUNDC1,G6PC,GABRA2,GALNT2,GDAP1,GFY,GPAA1,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HM13,HSPA5,IMMT,INSIG1,INSIG2,ITM2B,L2HGDH,LARGE,LBR,LEMD2,LRIT1,MAN1C1,MARCH6,MBOAT4,MCU,MCUR1,MFF,MGARP,MICU1,MMGT1,MUL1,OXA1L,PCSK7,PEX10,PEX11A,PEX11B,PEX12,PEX13,PEX16,PEX2,PEX3,PIGK,PIGS,PIGT,PIGU,PINK1,PKD2,PQLC2,QSOX1,RER1,RHBDD1,RHOT1,RHOT2,RNF152,RTN1,RTN2,RTN4,SAMD8,SARAF,SEC61A1,SGMS1,SGMS2,SGPL1,SLC22A17,SLC25A17,SLC27A2,SLC27A5,SLC37A4,SLC39A13,SLC8B1,SMDT1,SPCS1,SPPL2A,SPPL2B,SPPL2C,SPPL3,SREBF2,STEAP2,STIM1,SYNE4,SYP,SYVN1,TAP1,TAP2,TAPBP,TBC1D20,TBL2,TECR,TIMM17A,TIMM17B,TIMM23,TMEM11,TMEM163,TMEM70,TOMM40,TRABD2A,TRABD2B,UBIAD1,UBXN8,UQCC3,VAMP5,VIMP,VOPP1,WFS1,XBP1	The component of the organelle membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0031304	GO	CC	intrinsic component of mitochondrial inner membrane	APOO,APOOL,CCDC109B,CHCHD3,CHCHD6,COA1,COA3,COX18,ETFDH,IMMT,L2HGDH,MCU,MCUR1,PPOX,SMDT1,TIMM17A,TIMM17B,TIMM23,TMEM11,UQCC3	The component of the mitochondrial inner membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0031305	GO	CC	integral component of mitochondrial inner membrane	APOO,APOOL,CCDC109B,CHCHD3,CHCHD6,COA1,COA3,COX18,ETFDH,IMMT,L2HGDH,MCU,MCUR1,SMDT1,TIMM17A,TIMM17B,TIMM23,TMEM11,UQCC3	The component of the mitochondrial inner membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0031306	GO	CC	intrinsic component of mitochondrial outer membrane	ABCB6,BAK1,BNIP3,CPT1A,DMPK,FIS1,FUNDC1,GDAP1,MFN2,MGARP,MUL1,PINK1,RHOT1,RHOT2,TOMM40	The component of the mitochondrial outer membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0031307	GO	CC	integral component of mitochondrial outer membrane	ABCB6,BAK1,BNIP3,CPT1A,DMPK,FIS1,FUNDC1,GDAP1,MGARP,MUL1,PINK1,RHOT1,RHOT2,TOMM40	The component of the mitochondrial outer membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0031312	GO	CC	extrinsic component of organelle membrane	ANXA1,ATG14,GOLGA3,HID1,MMP27,NDUFAF5,NOA1,PAM16,PML,RAB7A,SNX10,SNX16,SNX5,TAMM41,TOR1A,ULK1,ZC3H12A,ZFYVE1	The component of an organelle membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region.
GO:0031330	GO	BP	negative regulation of cellular catabolic process	ACTN3,AKT1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANXA2,APC,APOC1,APOC3,ATG7,ATM,ATP2B4,ATRAID,BAG5,BAG6,BCL2,BCL2L1,BUB1,BUB1B,BUB3,CBFA2T3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CDK5RAP3,CDKN2A,CENPF,CHMP4A,CHMP4B,CLN3,CSNK2A1,CSNK2A2,CST3,DAB2IP,DAP,DFFA,DHX34,EGLN1,FBP1,FEZ1,FEZ2,FHIT,FURIN,GABARAPL2,GIPC1,GOLGA2,GPLD1,GSK3A,HDAC4,HFE,HGF,HP,HSP90AB1,HTR2B,IL10,INS,KDM4A,KIF25,KLHL22,LEP,LEPR,LRRK2,LZTS1,MAD1L1,MAD2L1,MAD2L2,MAPK7,MET,METTL20,MT3,MTMR2,MTOR,N4BP1,NBAS,NELL1,NRBP2,PABPC1,PANO1,PARK7,PDCL3,PHF23,PINK1,PLIN5,PLK1,PML,PPARA,PRKCG,PSMF1,PTPN22,PTPN3,QSOX1,RASIP1,RGP1,RIC1,RRAGA,RUBCN,SCFD1,SDCBP,SIRT2,SNCA,SNRNP70,SVIP,TAF9,TBC1D14,TERF1,TEX14,TIMP1,TIMP3,TLK2,TOB1,TPR,TRIM39,TSC1,TTK,UBE2C,UBE2D1,UBE2E1,UBQLN1,UBQLN4,UBXN1,USP14,USP44,WAC,WDR6,ZKSCAN3,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.
GO:0031332	GO	CC	RNAi effector complex	AGO1,AGO2,AGO3,AGO4,DCP2,DDX6,DICER1,EIF4E,LIMD1	Any protein complex that mediates the effects of small interfering RNAs on gene expression. Most known examples contain one or more members of the Argonaute family of proteins.
GO:0031333	GO	BP	negative regulation of protein complex assembly	ADD1,ADD2,ANKRD27,ARFGEF1,BCL11A,CLIP3,CLU,DACT1,DDX3X,DKK1,EML2,EPS8,GSK3B,GSN,HEY2,HIST3H3,HMGB1,IMPACT,INS,INSIG1,KANK1,KIF14,LCMT1,LDLRAD4,MAPRE1,MEFV,MYADM,OPRD1,PARK7,PEX14,PEX5,PFN1,PFN2,PMEPA1,PPM1A,PRKCD,PRKCZ,PTGER4,PYDC2,RAF1,SCIN,SLIT2,SMAD6,SNCA,SORL1,SOST,SRC,STMN2,SVIP,TBCD,TFIP11,THRA,TMC8,TMSB4Y,TRAF3IP1,TRIOBP,TWF1,TWF2,ULK1,VIL1	Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly.
GO:0031334	GO	BP	positive regulation of protein complex assembly	ACTR2,ACTR3,AIM2,AJUBA,ALOX15,ARF6,ARL2,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BAIAP2L1,BAX,BBC3,BCL2L11,BCLAF1,BID,BIK,BMF,CAV3,CCL11,CCL21,CCL24,CCL26,CCR7,CD36,CDC42EP2,CDC42EP5,CDH17,CLASP1,CLIP1,CSF2,CSF3,CTNNB1,CTTN,CXCL13,FAF1,FAM21C,FER,FES,FNIP1,FNIP2,FOSL1,FSCN1,GBP5,GNB2L1,GSK3B,HCK,HDAC6,HNF1A,HNF1B,HRK,ICE1,IDE,IL5,IQGAP2,JCHAIN,JMY,JUN,LCP1,LRRC16A,MAGEL2,MAPT,MED25,MIEF2,MITF,MMP1,MMP3,MPP7,NCK1,NCK2,NCKAP1L,NKX2-5,PAXIP1,PFN1,PFN2,PIEZO1,PIH1D1,PINK1,PLEK,PMAIP1,PRKCE,PSRC1,PTK2B,PYCARD,RPS3,SCIN,SETX,SH3GLB1,SLAIN2,SLF1,SLF2,SNX9,SPIDR,SRC,SRF,STUB1,SUMO1,TAF1,TAL1,TENM1,TERF1,TGFB1,TLR4,TLR6,TMEM27,TNF,TP53,TPPP,TRABD2A,TRABD2B,TRIM27,TWIST1,UNC13B,VASP,VCP,VEGFA,WASH1	Any process that activates or increases the frequency, rate or extent of protein complex assembly.
GO:0031338	GO	BP	regulation of vesicle fusion	AKT2,ANKRD27,ANXA1,ANXA2,C2CD5,DOC2B,RAB3A,RSG1,STXBP1,STXBP6,TMEM27	Any process that modulates the frequency, rate or extent of vesicle fusion.
GO:0031340	GO	BP	positive regulation of vesicle fusion	AKT2,ANXA1,ANXA2,C2CD5,DOC2B,TMEM27	Any process that activates or increases the frequency, rate or extent of vesicle fusion.
GO:0031341	GO	BP	regulation of cell killing	AGER,AP1G1,ARRB2,CADM1,CD226,CRTAM,F2RL1,FADD,FCER2,HLA-A,HLA-B,HLA-E,ICAM1,IFNG,IL12A,IL12B,IL12RB1,IL13,IL21,IL23A,IL23R,IL4,KLRK1,LAMP1,LEP,LGALS9,LILRB1,MICA,NCR1,NCR3,NOS2,P2RX7,PIK3R6,PTPRC,PVR,PVRL2,RASGRP1,RIPK3,SERPINB4,SERPINB9,SLAMF6,STAP1,STX7,XCL1	Any process that modulates the frequency, rate or extent of cell killing, the process in which a cell brings about the death of another cell, either in the same or a different organism.
GO:0031342	GO	BP	negative regulation of cell killing	ARRB2,HLA-A,HLA-B,HLA-E,IL13,IL4,LGALS9,LILRB1,MICA,PTPRC,SERPINB4,SERPINB9	Any process that stops, prevents, or reduces the frequency, rate or extent of cell killing.
GO:0031343	GO	BP	positive regulation of cell killing	AP1G1,CADM1,CD226,CRTAM,F2RL1,FADD,FCER2,HLA-A,HLA-B,HLA-E,IFNG,IL12A,IL12B,IL12RB1,IL21,IL23A,IL23R,KLRK1,LAMP1,NCR3,NOS2,PVR,PVRL2,RASGRP1,SLAMF6,STAP1,STX7,XCL1	Any process that activates or increases the frequency, rate or extent of cell killing.
GO:0031345	GO	BP	negative regulation of cell projection organization	ADCY6,APOE,ARHGDIA,ARHGEF1,ARPIN,BAG5,BCL11A,CBFA2T2,CCL21,CIB1,DCC,DPYSL3,EFNA1,EPHA4,EVI5L,EVL,FGF13,FKBP4,GAK,GDI1,GFI1,GORASP1,HDAC2,HRG,ITM2C,KANK1,KIAA0319,KLK8,LINGO1,LPAR1,LRP4,MAG,MT3,NGEF,NGFR,NLGN1,NRXN1,OMG,PAQR3,PFN2,PLXNB3,PRKCD,PTEN,PTPRO,RAB29,RAP1GAP,RAPGEF2,RHOA,RNF6,RTN4,RTN4R,RUFY3,SEMA5A,SLIT2,SPOCK1,SPRY2,SRGAP2C,STAP1,STMN2,TACSTD2,TBC1D30,TBC1D7,TCHP,THY1,TRPV4,WNT3A,YWHAH	Any process that stops, prevents, or reduces the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of cell projections.
GO:0031346	GO	BP	positive regulation of cell projection organization	ABL2,AGRN,AMIGO1,APC,APOE,ARAP1,ARHGDIA,ARHGEF7,ARPC2,ARSB,AVIL,BBS4,BCAS3,BCL11A,BDNF,BHLHB9,BMP5,BMP7,BRK1,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CBFA2T2,CCL19,CCL21,CCR7,CDC42,CDC42EP1,CDC42EP2,CDC42EP4,CDC42EP5,CDKL5,CLRN1,COBL,CORO1B,CORO1C,CPEB3,CPNE5,CPNE6,CPNE9,CUL7,CUX1,CUX2,DAB2IP,DMD,DPYSL3,DSCAM,ENPP2,EPHA3,EPS8L1,EPS8L2,F2RL1,FAM134C,FBXW8,FES,FNBP1L,FOXO6,FSCN1,FUZ,GOLGA4,GPM6A,HAP1,HRAS,HTT,IL1RAPL1,ISLR2,ITSN2,KCTD17,KIDINS220,L1CAM,LIMK1,LRP8,LRRC16A,LTK,LYN,MACF1,MAGI2,MAPT,MARK2,MEGF8,MIEN1,NCKAP1,NDNF,NDRG4,NEDD4L,NEURL1,NGF,NGFR,NLGN1,NPTN,NRP1,NTN1,NTRK1,NTRK2,OBSL1,P2RX7,PACSIN1,PALM,PFN1,PLK5,PRKCI,PRKD1,PROM2,PSEN1,PTK2B,PTK6,PTK7,PTPRD,RAC1,RAC2,RALA,RAP1A,RAPGEF1,RAPGEF2,RASAL1,RELN,RET,RHOA,RHOQ,RIMS1,RIMS2,ROBO1,ROBO2,RREB1,RUFY3,SAXO1,SCARF1,SCN1B,SEMA4D,SEMA5A,SEMA7A,SETX,SHANK1,SHANK3,SHTN1,SKIL,SLIT2,SMURF1,SNX3,SRC,STMN2,SYT1,SYT17,SYT2,SYT3,SYT4,TENM1,TENM2,TENM3,TGFB3,TWF2,UNC13A,VEGFA,VIL1,VLDLR,WASF2,WASH1,WASL,WNT1,WNT5A	Any process that activates or increases the frequency, rate or extent of the process involved in the formation, arrangement of constituent parts, or disassembly of cell projections.
GO:0031348	GO	BP	negative regulation of defense response	A2M,ADIPOQ,APCS,APOA1,APOD,APOE,ARRB2,C1QBP,C1QTNF3,CACTIN,CHID1,CR1,CUEDC2,DHX58,DNAJA3,EIF2AK2,ELANE,FEM1A,FFAR4,GATA3,GBA,GHRL,GHSR,GPER1,GSTP1,HLA-A,HLA-B,HLA-DRB1,HLA-E,IFI16,IFIT1,INS,IRAK3,IRG1,ISL1,ITCH,KLF4,LGALS9,LILRB1,MAPK7,MEFV,METRNL,MICA,MICB,MMP26,MUL1,MVK,NLRC5,NLRP12,NLRP3,NOV,NR1H2,NR1H3,OTULIN,PCBP2,PPARA,PPARG,PPM1B,PRKCD,PROC,PTGER4,PTGIS,PTPN2,PYDC2,RORA,RPS19,SAA1,SEC14L1,SERPINB4,SERPINB9,SERPING1,SHARPIN,SIRT2,SUSD4,TARBP2,TEK,TKFC,TNFAIP3,TNFAIP6,TNFRSF1A,TRAF3IP1,TRAFD1,TSPAN6,TYRO3,VIMP,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of a defense response.
GO:0031362	GO	CC	anchored component of external side of plasma membrane	CA4,CD14,CD59,EFNA5,FOLR1,FOLR2,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GP1BA,GPIHBP1,HYAL2,PKHD1	The component of the plasma membrane consisting of the gene products that are tethered to the external side of the membrane only by a covalently attached anchor, such as a lipid group embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping.
GO:0031365	GO	BP	N-terminal protein amino acid modification	AANAT,CREBBP,EP300,KAT2B,METAP1,METAP1D,METAP2,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60,NMT1,NMT2,NTMT1,PDF,PPM1A,PPM1B	The alteration of the N-terminal amino acid residue in a protein.
GO:0031369	GO	MF	translation initiation factor binding	ANGEL1,DDX3X,EIF2B4,EIF2B5,EIF4E,EIF4EBP1,EIF4EBP2,EIF4G1,HHEX,LARP1,OTX2,RPS24,TRIM32	Interacting selectively and non-covalently with a translation initiation factor, any polypeptide factor involved in the initiation of ribosome-mediated translation.
GO:0031371	GO	CC	ubiquitin conjugating enzyme complex	RNF20,RNF40,STUB1,UBE2A,UBE2B,UBE2N,UBE2V1,UBE2V2	Any complex that possesses ubiquitin conjugating enzyme activity.
GO:0031397	GO	BP	negative regulation of protein ubiquitination	ABL1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ARRB1,ARRB2,ATM,BAG5,BUB1,BUB1B,BUB3,CAV1,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN2A,CENPF,CHP1,CRY1,DNAJA1,FBXO5,FZR1,GLMN,GNL3L,GTPBP4,HDAC8,HFE,HSPA1A,HSPA1B,ISG15,KLHL22,LIMK1,MAD1L1,MAD2L1,MAD2L2,N4BP1,NXN,OGT,OTUB1,PARK7,PARP10,PDCL3,PER2,PINX1,PLK1,PML,PRKCG,PRMT3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSMF1,RPS27A,RPS3,SENP2,SMAD7,SOX4,SPOPL,SVBP,TERF1,TEX14,TNFAIP3,TPR,TRIM39,TRIP12,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBR5,UBXN1,UFL1,USP4,USP44,VPS28,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein.
GO:0031398	GO	BP	positive regulation of protein ubiquitination	ADRB2,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANGPT1,APITD1,ARRB2,AVPR2,AXIN1,BCL10,BIRC2,BIRC3,BMI1,BRCA1,BTRC,CAV1,CAV3,CCDC22,CCNB1,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDK5RAP3,CDK9,CLU,COMMD1,CTR9,CUL1,DERL1,DNAJA3,DNAJB2,FANCI,FBXO4,FBXO5,FBXW7,FKBP1A,FZR1,HAMP,HSPBP1,KDM1A,LRRK2,MAGEA2,MAGEC2,MALT1,MTA1,NDFIP1,NDFIP2,NDNL2,PARK2,PAXIP1,PHF23,PIN1,PINK1,PLK1,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTK2,PTPN22,PTTG1IP,RASSF1,RCHY1,RIPK2,RNF139,RNF20,RNF40,RPS27A,SENP2,SEPT4,SKP1,SMAD7,SMURF1,SPHK1,SPRTN,STRA13,STUB1,TBC1D7,TOPORS,TRAF6,TRIB3,TSPYL5,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2L3,UBE2N,UBE2S,UBE3A,UBQLN1,WFS1,XIAP	Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
GO:0031402	GO	MF	sodium ion binding	ATP1A1,ATP1A2,ATP1B1,CAPN3,PDXK,SLC34A2	Interacting selectively and non-covalently with sodium ions (Na+).
GO:0031406	GO	MF	carboxylic acid binding	ADH5,ADIPOQ,AGRN,AGXT,AKR1C1,AKR1C2,ALAS2,ALB,ALOX5AP,ANXA13,ANXA9,APOC1,ASS1,AXL,CAD,CD300A,CPNE1,CPNE6,CYP26A1,CYP26B1,CYP26C1,DHFR,FABP3,FABP4,FABP5,FCHO2,FCN1,FFAR4,FOLR1,FOLR2,GAS6,GCLC,GLRA1,GLRA2,GLRB,GLUD1,GLUD2,GNMT,GPR143,GRIN1,GRIN2B,GRIN3A,GRIN3B,GRM7,HIF1AN,HLCS,HMGB1,HNF4A,JPH2,LCN12,LPAR1,MARK1,MCCC1,MTHFS,NDUFAB1,NEDD4,NOS1,NOS2,NOS3,NR1H4,NR2F2,OSBPL10,OSBPL5,OSBPL8,OXER1,PCCA,PCK1,PIN1,PLA2G1B,PMP2,PPARD,PPARG,PTGDS,PYGL,RARA,RASGRP1,RPE65,S100A8,S100A9,SCARB1,SCIN,SCP2,SDPR,SELE,SELP,SERPINA5,SHMT1,SRR,ST8SIA2,ST8SIA3,ST8SIA4,STX3,SYTL2,THBS1,THNSL2,TRIM72,TYMS,UBR1,UBR2,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9,VDR,VIL1,YARS2	Interacting selectively and non-covalently with a carboxylic acid, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-).
GO:0031414	GO	CC	N-terminal protein acetyltransferase complex	NAA10,NAA11,NAA15,NAA16,NAA30,NAA35,NAA38,NAA50	A complex that catalyzes the transfer of an acetyl group to the N-terminal residue of a protein acceptor molecule.
GO:0031415	GO	CC	NatA complex	NAA10,NAA11,NAA15,NAA16,NAA50	A conserved complex that catalyzes the transfer of an acetyl group to an N-terminal Ser, Ala, Gly, or Thr residue of a protein acceptor molecule. In Saccharomyces the complex includes Nat1p and Ard1p, and may contain additional proteins.
GO:0031420	GO	MF	alkali metal ion binding	ATP1A1,ATP1A2,ATP1B1,CAPN3,HDAC4,IMPA1,KCNJ11,PDXK,SLC34A2	Interacting selectively and non-covalently with any alkali metal ion; alkali metals are those elements in group Ia of the periodic table, with the exception of hydrogen.
GO:0031428	GO	CC	box C/D snoRNP complex	FBL,NOP56,NOP58,RRP9,SNU13	A ribonucleoprotein complex containing small nucleolar RNA of the box C/D type that can carry out ribose-2'-O-methylation of target RNAs.
GO:0031430	GO	CC	M band	ANK2,KLHL41,MYOM1,MYOM3,OBSCN,OBSL1,PPP2R5A,TTN	The midline of aligned thick filaments in a sarcomere; location of specific proteins that link thick filaments. Depending on muscle type the M band consists of different numbers of M lines.
GO:0031440	GO	BP	regulation of mRNA 3'-end processing	AGO2,AHCYL1,BARD1,BTG2,CCNT1,CDC73,CDK9,CNOT1,CNOT7,CPEB3,CTR9,LEO1,NCBP1,NCBP2,NELFE,PABPC1,PAF1,PAPOLA,RNF20,RNF40,SUPT5H,TNRC6B,TNRC6C,TOB1,ZFP36	Any process that modulates the frequency, rate or extent of mRNA 3'-end processing, any process involved in forming the mature 3' end of an mRNA molecule.
GO:0031441	GO	BP	negative regulation of mRNA 3'-end processing	BARD1,CCNT1,CDK9,CTR9,NELFE,RNF20,RNF40,SUPT5H,TOB1	Any process that stops, prevents, or reduces the frequency, rate or extent of mRNA 3'-end processing.
GO:0031442	GO	BP	positive regulation of mRNA 3'-end processing	AGO2,BTG2,CDC73,CNOT1,CNOT7,CPEB3,LEO1,NCBP1,NCBP2,PABPC1,PAF1,TNRC6B,TNRC6C,TOB1,ZFP36	Any process that activates or increases the frequency, rate or extent of mRNA 3'-end processing.
GO:0031461	GO	CC	cullin-RING ubiquitin ligase complex	ANAPC1,ANAPC10,ANAPC11,ANAPC13,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ASB4,BTRC,BUB1B,CAND1,CCNF,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN1B,COMMD1,CRBN,CUL1,CUL2,CUL3,CUL4A,CUL4B,CUL5,CUL7,CUL9,DCAF10,DCAF11,DCAF12,DCAF13,DCAF16,DCAF17,DCAF4,DCAF5,DCAF6,DCAF7,DCAF8,DDB1,DDB2,DTL,ENC1,ERCC8,FBXL15,FBXL19,FBXL2,FBXL3,FBXL5,FBXL7,FBXO17,FBXO18,FBXO2,FBXO25,FBXO27,FBXO31,FBXO4,FBXO44,FBXO6,FBXO9,FBXW11,FBXW5,FBXW7,FBXW8,FZR1,GAN,KCTD10,KCTD13,KCTD17,KEAP1,KLHL12,KLHL13,KLHL2,KLHL20,KLHL21,KLHL22,KLHL25,KLHL3,KLHL41,KLHL42,KLHL7,KLHL8,KLHL9,MAD2L2,RBX1,RNF7,SKP1,SKP2,SPOP,SPOPL,TCEB2,TNFAIP1,TRIM21,TRPC4AP,UBE2C,UBE2S,USP47,ZER1	Any ubiquitin ligase complex in which the catalytic core consists of a member of the cullin family and a RING domain protein; the core is associated with one or more additional proteins that confer substrate specificity.
GO:0031462	GO	CC	Cul2-RING ubiquitin ligase complex	ASB4,COMMD1,CUL2,RBX1,TCEB2,ZER1	A ubiquitin ligase complex in which a cullin from the Cul2 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by an elongin-BC adaptor and a SOCS/BC box protein.
GO:0031463	GO	CC	Cul3-RING ubiquitin ligase complex	CUL3,ENC1,GAN,KCTD10,KCTD13,KCTD17,KEAP1,KLHL12,KLHL13,KLHL2,KLHL20,KLHL21,KLHL22,KLHL25,KLHL3,KLHL41,KLHL42,KLHL7,KLHL8,KLHL9,RBX1,SPOP,SPOPL,TNFAIP1	A ubiquitin ligase complex in which a cullin from the Cul3 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by a BTB-domain-containing protein.
GO:0031464	GO	CC	Cul4A-RING E3 ubiquitin ligase complex	CDKN1B,CRBN,CUL4A,DDB1,DTL,ERCC8,RBX1,TRPC4AP	A ubiquitin ligase complex in which a cullin from the Cul4A subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by an adaptor protein.
GO:0031465	GO	CC	Cul4B-RING E3 ubiquitin ligase complex	CUL4B,DDB1,DDB2,DTL,RBX1	A ubiquitin ligase complex in which a cullin from the Cul4B subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by unknown subunits.
GO:0031466	GO	CC	Cul5-RING ubiquitin ligase complex	ASB4,CUL5,RBX1,RNF7,TCEB2	A ubiquitin ligase complex in which a cullin from the Cul5 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by an elongin-BC adaptor and a SOCS/BC box protein.
GO:0031490	GO	MF	chromatin DNA binding	ACTB,ACTL6A,ACTN4,APEX1,CHD4,CLOCK,CTCF,EZH2,FOXC2,FOXO3,GATA1,GATAD2B,GRHL1,GRHL2,GRHL3,H1F0,H1FOO,H2AFY,H2AFY2,H2AFZ,H3F3A,H3F3C,HDAC1,HDAC2,HIST1H1A,HIST1H1B,HIST1H1C,HIST1H1D,HIST1H1E,HMGA2,HNRNPC,INSM1,MBD2,MBD3,MTA2,MYOD1,MYOG,NEUROG3,PER1,PPARGC1A,RARA,RBBP4,RCC1,RELA,RUVBL2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,STAT3,WBP2,XBP1,ZIC2	Interacting selectively and non-covalently with DNA that is assembled into chromatin.
GO:0031491	GO	MF	nucleosome binding	ACTB,ACTL6A,CHD4,DNTTIP1,GATAD2B,H1FOO,H2AFY,H2AFZ,H3F3A,H3F3C,HDAC1,HDAC2,HMGA2,HNRNPC,HP1BP3,L3MBTL1,MBD2,MBD3,MTA2,MUM1,NOC2L,RBBP4,RCC1,RNF168,RNF169,RNF4,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,UHRF1	Interacting selectively and non-covalently with a nucleosome, a complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
GO:0031492	GO	MF	nucleosomal DNA binding	ACTB,ACTL6A,CHD4,GATAD2B,H1FOO,H2AFY,H2AFZ,H3F3A,H3F3C,HDAC1,HDAC2,HMGA2,HNRNPC,MBD2,MBD3,MTA2,RBBP4,RCC1,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1	Interacting selectively and non-covalently with the DNA portion of a nucleosome.
GO:0031497	GO	BP	chromatin assembly	ANP32B,APITD1,ASF1A,ASF1B,ATRX,BAHD1,BRD2,CABIN1,CASC5,CDAN1,CDKN2A,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHAF1A,CHAF1B,CTCF,DAXX,H1FOO,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HELLS,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H3,HJURP,HMGA1,HMGA2,HMGB2,IPO4,ITGB3BP,KAT6B,M1AP,MIS18A,MIS18BP1,NAA60,NASP,NOC2L,NPM1,OIP5,PADI4,PAF1,RBBP4,RBBP7,RSF1,RUVBL1,SART3,SMARCA5,SOX9,SPTY2D1,STRA13,TP53,UBN1	The assembly of DNA, histone proteins, other associated proteins, and sometimes RNA, into chromatin structure, beginning with the formation of the basic unit, the nucleosome, followed by organization of the nucleosomes into higher order structures, ultimately giving rise to a complex organization of specific domains within the nucleus.
GO:0031503	GO	BP	protein complex localization	BIRC5,CEP131,CEP72,DLG1,EZR,GSG2,ICK,IFT122,IFT27,IFT43,IFT46,IFT74,IFT81,KLHL21,MIOS,MZT1,NACC2,NDC1,PCM1,RCC2,RPGR,SEH1L,SMAD7,SSX2IP,TTC26,WDR19,WDR35,ZNF365	A localization process that acts on a protein complex; the complex is transported to, or maintained in, a specific location.
GO:0031507	GO	BP	heterochromatin assembly	BAHD1,CDKN2A,CENPV,HELLS,HMGA1,HMGA2	The assembly of chromatin into heterochromatin, a compact and highly condensed form that is often, but not always, transcriptionally silent.
GO:0031512	GO	CC	motile primary cilium	DYNC2LI1,PAFAH1B1,PKD1,PKD2,SAXO1	A primary cilium which may contain a variable array of axonemal microtubules and also contains molecular motors. Motile primary cilia display a distinct twirling motion that directs fluid flow asymmetrically across the cellular surface to affect asymmetric body plan organization.
GO:0031513	GO	CC	nonmotile primary cilium	ABCA4,AHI1,ARL3,B9D1,B9D2,BBS4,BBS9,C5orf30,CC2D2A,CCSAP,CEP290,CEP89,CIB2,DCDC2,DHRS3,DRD1,DRD2,DRD5,FAM161A,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNGT1,GRK1,GRK4,GRK7,GRXCR1,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,IFT122,IQCB1,MAK,MCHR1,MKS1,MYO7A,NAPEPLD,NPHP1,OCRL,OPN1LW,OPN1MW,OPN1SW,PCDH15,PDE6A,PDE6B,PDE6G,PKD1L1,PKD2,PKD2L1,PROM1,RAB8A,RHO,RP1,RP1L1,RPGR,RPGRIP1,SHANK2,SPATA7,SPTBN5,SSTR3,STRC,TBCC,TCTN1,TCTN2,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TOPORS,TRAF3IP1,TTBK2,TULP1,UNC119B,WDR19	A primary cilium which contains a variable array of axonemal microtubules but does not contain molecular motors. Nonmotile primary cilia are found on many different cell types and function as sensory organelles that concentrate and organize sensory signaling molecules.
GO:0031514	GO	CC	motile cilium	ADCY10,AKAP3,AKAP4,ANXA1,ATP2B4,BBS2,BBS4,CABS1,CABYR,CATSPERD,DNAH1,DNAI2,FOPNL,GAS8,HAVCR1,IFT27,IFT46,IFT52,IFT74,IFT81,IFT88,MKKS,NPHP1,OXCT2,PGAM4,PRKACA,ROPN1B,ROPN1L,RPGR,RSPH1,RSPH4A,RSPH9,SAXO1,SCNN1A,SEPT12,SLC26A3,SLC26A6,SLC9A3R1,SORD,SPA17,SPATA6,TAS2R43,TCTEX1D4,TEKT3,TSSK1B,WDR19	A cilium which has a variable arrangement of axonemal microtubules, contains molecular motors, and beats with a characteristic whip-like pattern that promotes cell motility or transport of fluids and other cells across a cell surface. Motile cilia are typically found in multiple copies on epithelial cells that line the lumenal ducts of various tissues. Motile cilia may also function as sensory organelles.
GO:0031519	GO	CC	PcG protein complex	AEBP2,ASXL1,BAP1,BCOR,BMI1,CBX2,CBX4,CBX6,CBX7,CBX8,CSNK2A1,CSNK2A2,CSNK2B,EED,EZH1,EZH2,H2AFY,H2AFY2,HDAC2,JARID2,KDM2B,MTF2,PCGF1,PCGF2,PCGF3,PCGF5,PCGF6,PHC1,PHC2,PHC3,PHF1,PHF19,RBBP4,RBBP7,RING1,RNF2,RYBP,SCML2,SIRT1,SKP1,SUZ12,TRIM37,UBAP2L	A chromatin-associated multiprotein complex containing Polycomb Group proteins. In Drosophila, Polycomb group proteins are involved in the long-term maintenance of gene repression, and PcG protein complexes associate with Polycomb group response elements (PREs) in target genes to regulate higher-order chromatin structure.
GO:0031526	GO	CC	brush border membrane	AQP1,ATP6V0A4,B4GALT1,CA4,CD36,CUBN,ITLN1,PDZK1,PEX19,SHANK2,SLC17A3,SLC22A12,SLC22A5,SLC26A4,SLC26A6,SLC34A1,SLC34A2,SLC3A1,SLC7A9,SLC9A3	The portion of the plasma membrane surrounding the brush border.
GO:0031527	GO	CC	filopodium membrane	ANTXR1,ARF6,DMD,GAP43,ITGA3,ITGAV,ITGB3,PALM,SYNE2,TBC1D10C,UTRN	The portion of the plasma membrane surrounding a filopodium.
GO:0031529	GO	BP	ruffle organization	AIF1,ARF6,ARFIP2,CCL21,CCR7,CORO1B,CSF1R,CYFIP1,INPP5K,LIMA1,LRRC16A,PIP5K1A,PLEK,PLEKHA1,RAC1,TPM1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a ruffle, a projection at the leading edge of a crawling cell.
GO:0031532	GO	BP	actin cytoskeleton reorganization	ANTXR1,ANXA1,ARAP1,ATP2C1,BRSK2,CAPN10,CDC42BPA,CDC42BPB,CDC42BPG,CTTN,CXADR,DMTN,DTNBP1,EZR,FARP2,FER,FGF10,FGF7,FLNA,GPR65,GSN,INSRR,KIT,MICALL2,MINK1,MKLN1,MYH9,NPHS2,PAK1,PARVB,PHACTR1,PIP5K1A,PLEK,PTK7,PTPN1,RALA,RAP2A,RICTOR,S1PR1,S1PR2,SIPA1L1,TNIK,TRPV4,WHAMM	A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.
GO:0031543	GO	MF	peptidyl-proline dioxygenase activity	EGLN1,EGLN2,EGLN3,OGFOD1,P3H1,P3H2,P4HB	Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl hydroxy-L-proline + succinate + CO2.
GO:0031570	GO	BP	DNA integrity checkpoint	ATF2,ATM,ATR,ATRIP,BABAM1,BLM,BRCA1,BRCC3,BRE,BRIP1,BRSK1,CASP2,CCNA2,CCND1,CDC14B,CDC45,CDC5L,CDC6,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CDT1,CEP63,CHEK1,CHEK2,CLOCK,CLSPN,CRADD,DGKZ,DNA2,DTL,E2F1,FAM175A,FBXO31,FBXO6,FOXN3,FZR1,GML,GTSE1,H2AFX,HINFP,HMGA2,HUS1,INTS7,MAPKAPK2,MDC1,MDM2,MUC1,NAE1,NBN,NEK11,NEK6,PIDD1,PLK1,PLK5,PML,PPP2R5C,PRKDC,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAD1,RAD17,RAD9A,RBBP8,RBM38,RFWD2,RFWD3,RHNO1,RPA2,RPA4,RPS27A,RPS27L,SETMAR,SOX4,TAOK1,TAOK2,TAOK3,TICRR,TIPIN,TIPRL,TP53,TRIAP1,UBA52,UBB,UBC,UIMC1,USP28,WAC,ZNF830	A cell cycle process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and progresses through signal transduction and ends with cell cycle effector processes.
GO:0031571	GO	BP	mitotic G1 DNA damage checkpoint	ATM,CASP2,CCND1,CDK2,CDKN1A,CDKN1B,CRADD,DGKZ,FBXO31,GML,GTSE1,MDM2,MUC1,PIDD1,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SOX4,TP53,TRIAP1,UBA52,UBB,UBC	A mitotic cell cycle checkpoint that detects and negatively regulates progression through the G1/S transition of the cell cycle in response to DNA damage.
GO:0031572	GO	BP	G2 DNA damage checkpoint	ATM,BABAM1,BLM,BRCA1,BRCC3,BRE,BRSK1,CCNA2,CDC14B,CDK5RAP3,CHEK1,CLSPN,DTL,FAM175A,FOXN3,FZR1,HMGA2,MAPKAPK2,NBN,NEK11,NEK6,PLK1,PLK5,RBBP8,TAOK1,TAOK2,TAOK3,UIMC1	A cell cycle checkpoint that detects and negatively regulates progression from G2 to M phase in the cell cycle in response to DNA damage.
GO:0031573	GO	BP	intra-S DNA damage checkpoint	ATF2,CHEK2,MDC1,NEK11,TIPIN	A mitotic cell cycle checkpoint that slows DNA synthesis in response to DNA damage by the prevention of new origin firing and the stabilization of slow replication fork progression.
GO:0031577	GO	BP	spindle checkpoint	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BIRC5,BUB1,BUB1B,BUB3,CASC5,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	A cell cycle checkpoint that originates from the mitotic or meiotic spindle.
GO:0031579	GO	BP	membrane raft organization	ANXA2,CAV1,CAV2,CAV3,CD2,EMP2,FLOT1,FLOT2,MAL,MYADM,NPC1,PACSIN2,PPT1,RFTN1,S100A10	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of membrane rafts, small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes.
GO:0031581	GO	BP	hemidesmosome assembly	CD151,COL17A1,DST,ITGA6,ITGB4,KRT14,KRT5,LAMA3,LAMB3,LAMC1,LAMC2,PLEC	Assembly of hemidesmosomes, integrin-containing protein complexes that bind to laminin in the basal lamina. Hemidesmosomes form the contact between the basal surface of epithelial cells and the underlying basal lamina.
GO:0031588	GO	CC	nucleotide-activated protein kinase complex	PRKAA1,PRKAB2,PRKACA,PRKAG1,PRKAG2,PRKAR1A,PRKAR2A	A protein complex that possesses nucleotide-dependent protein kinase activity. The nucleotide can be AMP (in S. pombe and human) or ADP (in S. cerevisiae).
GO:0031589	GO	BP	cell-substrate adhesion	ACTN1,ACTN2,ACTN3,ADAM15,ADAM9,ADAMTS12,ADAMTS13,ANTXR1,ARHGEF7,BCAM,BVES,CCL21,CD34,CD44,CD63,COL17A1,COL3A1,CORO1A,CTTN,CUZD1,DDR1,DEFB118,DLC1,ECM2,EFNA1,EMP2,EPHA1,EPHB1,EPHB3,FBLN5,FER,FERMT2,FERMT3,FGA,FGB,FGG,FN1,HOXD3,HPSE,ILK,ITGA1,ITGA10,ITGA11,ITGA2,ITGA3,ITGA4,ITGA5,ITGA6,ITGA7,ITGA8,ITGAL,ITGAV,ITGB1,ITGB1BP1,ITGB2,ITGB3,ITGB4,ITGB5,ITGB7,KIF14,LAMA5,LAMB1,LAMC1,LYVE1,MADCAM1,MICALL2,MKLN1,NPNT,PARVA,PARVG,PEAK1,PIP5K1A,PKD1,PPFIA1,PPFIA2,PRKX,PTPRK,RAC1,RADIL,RCC2,RHOD,SGCE,SIGLEC1,SMAD6,SORBS1,SRCIN1,SRGAP2,TAOK2,TEK,TESK2,THBS3,THY1,TIAM1,TIMM10B,TMEM8B,TRIP6,TSC1,TYRO3,VAMP3,VCAM1,VCL,VTN,VWF,WHAMM,ZYX	The attachment of a cell to the underlying substrate via adhesion molecules.
GO:0031593	GO	MF	polyubiquitin binding	ATRIP,BAG6,BRCC3,BRE,DNAJB2,DZIP3,EPS15,FAAP20,FAM175A,FAM175B,HDAC6,IKBKE,IKBKG,OPTN,PARP10,PRPF8,RAD18,RAD23A,RAD23B,RNF168,RNF169,SHARPIN,SPRTN,TAB2,TNIP2,TNIP3,UBQLN1,UBQLN4,UBXN1,UIMC1,VCP,ZBTB1,ZFAND6,ZRANB1,ZRANB3	Interacting selectively and non-covalently with a polymer of ubiqutin.
GO:0031594	GO	CC	neuromuscular junction	CAV3,CDK5,CDK5R1,CHRNA1,CXADR,DNAJA3,F2R,ITGB1,LRP4,MUSK,SERPINE2,SLC8A3,SPOCK1,TBC1D24	The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential.
GO:0031616	GO	CC	spindle pole centrosome	AURKA,DLGAP5,FAM175B,NDE1,NPM1,TBCCD1	A centrosome from which one pole of a mitotic or meiotic spindle is organized.
GO:0031622	GO	BP	positive regulation of fever generation	IL1B,PTGER3,PTGS2,TNF,TNFRSF11A,TNFSF11	Any process that activates or increases the frequency, rate, or extent of fever generation.
GO:0031623	GO	BP	receptor internalization	ACKR3,ADM,ADRBK1,ADRBK2,ARRB1,ARRB2,CALCA,CALCR,CALCRL,CAV1,CAV3,CD36,CD81,CD9,CLTC,CXCL8,CXCR1,CXCR2,DNM2,DRD3,FCER1G,GHR,GRB2,GRK4,GTF2H2,ITGB1,ITGB2,LDLRAP1,LILRB1,NEDD4,PICALM,RAB31,RAB5A,RAMP1,RAMP2,RAMP3,SCYL2,SNCA,SNX1,SYK	A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane.
GO:0031625	GO	MF	ubiquitin protein ligase binding	ACVR1B,ATXN3,BAG5,CLU,CUL2,CUL5,FAF1,FAF2,GLMN,MAGEA2,MAGEC2,PRKACA,PRKACB,PRKAR1A,PRKAR2A,PRKAR2B,RBX1,TCEB2,TRIB1,TRIB2,TRIB3,TRIM28,UBXN1,UBXN7,WFS1	Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
GO:0031638	GO	BP	zymogen activation	ACER2,AIFM1,ANP32B,APAF1,APOH,ASPH,BAD,BAK1,BAX,BBC3,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CIDEB,COL4A3,CTSH,CUZD1,CYCS,CYFIP2,DAP,DIABLO,DLC1,DNAJA3,EIF2AK3,F11,F12,F2R,F3,F9,FADD,FAM162A,FAS,FASLG,FGA,FGB,FGG,GGT1,GNB2L1,HIP1,HSPD1,HSPE1,IFI16,IFI27,IFT57,JAK2,KLKB1,LCK,LY96,MTCH1,MUL1,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NOD1,PDCD2,PERP,PLAT,PPARG,PRSS3,PYCARD,RET,RIPK1,ROBO1,RPS27L,S100A8,S100A9,SENP1,SLC11A2,SMAD3,SNCA,TBC1D10A,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	The proteolytic processing of an inactive enzyme to an active form.
GO:0031639	GO	BP	plasminogen activation	APOH,F11,FGA,FGB,FGG,KLKB1,PLAT	The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
GO:0031640	GO	BP	killing of cells of other organism	ALB,APOL1,AZU1,C9,CAMP	Any process in an organism that results in the killing of cells of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions.
GO:0031641	GO	BP	regulation of myelination	DICER1,EIF2AK3,HES5,KIF14,KLK8,MYRF,NCMAP,PARD3,RNF10,SIRT2,TENM4,TNFRSF21,ZPR1	Any process that modulates the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
GO:0031643	GO	BP	positive regulation of myelination	DICER1,MYRF,NCMAP,PARD3,RNF10,TENM4	Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
GO:0031644	GO	BP	regulation of neurological system process	ACPP,CARTPT,CCL3,DICER1,EIF2AK3,F2R,GLRA1,HTR2C,KLK8,MGLL,MYRF,NCMAP,NOV,PARD3,PROL1,RNF10,SCN11A,SPX,TENM4,TMEM100,TNFRSF21	Any process that modulates the frequency, rate or extent of a neurophysiological process, an organ system process carried out by any of the organs or tissues of neurological system.
GO:0031645	GO	BP	negative regulation of neurological system process	EIF2AK3,GLRA1,KLK8,NOV,TNFRSF21	Any process that stops, prevents, or reduces the frequency, rate or extent of a neurophysiological process.
GO:0031646	GO	BP	positive regulation of neurological system process	CARTPT,DICER1,MYRF,NCMAP,PARD3,RNF10,TENM4	Any process that activates or increases the frequency, rate or extent of a neurophysiological process.
GO:0031647	GO	BP	regulation of protein stability	A1CF,AAK1,ACSM6,ANK2,APOA1,APOA2,APTX,ATP1B1,ATP1B2,ATP1B3,AURKA,BAG6,BTRC,CALR,CCAR2,CCDC88C,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CD81,CDC73,CDKN2A,CDKN2AIP,CHEK2,CHP1,CLU,COG3,COG7,CPN2,CREB1,CREBL2,CRTAP,CSN3,CTSA,CTSH,DACT1,DERL1,DNAJA3,DPH6,DSC3,DSG1,DVL1,DVL3,ELMOD1,EP300,FBXL3,FBXO7,FBXW11,FBXW7,FLNA,FLOT2,GAPDH,GET4,GIPC1,GNAQ,GNL3L,GOLGA7,GPIHBP1,GPR26,GSN,GTPBP4,HCFC1,HDAC3,HDAC6,HDAC8,HIST1H1B,HSPA1A,HSPA1B,HSPA8,HSPD1,IFT46,IGF1,ISOC2,KAT2A,LAMP1,LAMP2,LRRC46,MAPK1,MDM2,MORC3,MSX1,MT3,MUL1,NAA15,NAA16,NAPG,NCLN,NLK,NOMO2,P3H1,PANO1,PARK2,PARK7,PDCD10,PEX19,PEX2,PEX6,PFN1,PFN2,PHB,PHB2,PIK3R1,PIM2,PIN1,PINK1,PINX1,PLK1,PLPP3,PML,PPARGC1A,PPIB,PRKCD,PSMD8,PTEN,PYCARD,RASSF1,RASSF2,RNF128,RNF139,SEL1L,SENP2,SH3GLB1,SIAH3,SIRT1,SLC51B,SMAD3,SMAD7,SNCA,SOX17,SOX4,SREBF1,STK3,STK4,STUB1,STX12,STXBP4,SUGT1,SUMO1,SWSAP1,SYVN1,TAF9,TAF9B,TBRG1,TCP1,TELO2,TERT,TESC,TF,TMEM147,TMEM88,TNIP2,TOMM7,TRIM21,TRIM24,TSC1,TSPAN1,UBE2B,USP13,USP19,USP2,USP3,USP33,USP4,USP7,VHL,VPS11,VPS35,WFS1,WIZ,WNT10B,XBP1,ZBED3,ZNF207,ZSWIM7	Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation.
GO:0031648	GO	BP	protein destabilization	BTRC,CCDC88C,CDC73,CDKN2A,CTSH,DERL1,FBXL3,FBXW11,GSN,ISOC2,MDM2,MUL1,NCLN,NOMO2,PARK2,PEX2,PLK1,RNF139,SENP2,SIRT1,SNCA,SOX17,TMEM147,TRIM21,XBP1	Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation.
GO:0031657	GO	BP	regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	ADAM17,AKT1,EGFR,FGF10,PIM1,PKD1,PKD2,PTEN,RGCC	Any process that controls the frequency, rate or extent of G1 cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.
GO:0031659	GO	BP	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	ADAM17,AKT1,EGFR,FGF10,PIM1,PKD1,PKD2,RGCC	Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.
GO:0031663	GO	BP	lipopolysaccharide-mediated signaling pathway	CCL2,CCL3,CCL5,CD6,HCK,IL18,IL1B,IRAK1,LBP,LY96,LYN,MTDH,PRKCE,PTPN22,SCARB1,TGFB1,TLR2,TLR4,TNF	A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
GO:0031664	GO	BP	regulation of lipopolysaccharide-mediated signaling pathway	BMP6,CACTIN,CD180,CD55,DEFB114,IRG1,LTF,LY86,NFKBIL1,PRKCA,SASH1,SIGIRR,TNFAIP3,TRIB1,TRIM5	Any process that modulates the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.
GO:0031665	GO	BP	negative regulation of lipopolysaccharide-mediated signaling pathway	CACTIN,DEFB114,IRG1,LTF,NFKBIL1,SIGIRR,TNFAIP3,TRIB1	Any process that stops, prevents, or reduces the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.
GO:0031666	GO	BP	positive regulation of lipopolysaccharide-mediated signaling pathway	BMP6,CD180,LY86,PRKCA,SASH1	Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.
GO:0031667	GO	BP	response to nutrient levels	ALB,AOC1,AQP3,ASNS,ATF4,ATG14,ATG7,BBS2,BBS4,BCL10,BECN1,BHLHA15,BMP8A,CARTPT,CDKN1A,CDKN2B,CDKN2D,CHMP1A,CPEB4,CYP24A1,CYP27B1,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,ENSA,FADS1,FNIP1,FOLR1,FOLR2,FOXA2,FOXO1,GAS2L1,GAS6,GCGR,GHRH,GHRL,GHSR,GIPR,GNAI2,HLCS,HSPA5,HSPA8,HTR2C,IFI16,IMPACT,INHBB,KCNB1,KIAA1324,KLF10,KYNU,LEP,LRRK2,MIOS,MKKS,MTMR3,MTOR,MYBBP1A,NCOA1,NENF,NPRL2,NPRL3,NPY,NR1H4,NUAK2,NUPR1L,OGT,OMA1,PCSK9,PDK2,PDK4,PICK1,PIK3C3,PIK3R4,PIM1,PMAIP1,POMC,PPARA,PPARG,PPARGC1A,PRKAA1,PRKAA2,RALB,RNF152,RPTOR,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SPP1,SPX,SREBF1,SREBF2,SST,SSTR1,SSTR2,TBC1D5,TBL2,TP53,TSC1,ULK1,ULK2,USF1,USF2,USP33,VDR,WDR24,WDR59,WRN,XBP1,ZFP36	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
GO:0031668	GO	BP	cellular response to extracellular stimulus	ALB,AOC1,ASNS,ATF4,ATG14,ATG7,BECN1,BHLHA15,CARTPT,CBS,CDKN1A,CDKN2B,CHMP1A,CPEB4,CYP24A1,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,FADS1,FNIP1,FOLR1,FOLR2,FOXA2,FOXO1,GAS2L1,GAS6,GLRX2,HSPA5,HSPA8,IFI16,IMPACT,INHBB,KCNB1,KIAA1324,KIF26A,KLF10,LRRK2,MIOS,MTMR3,MTOR,MYBBP1A,NCOA1,NPRL2,NPRL3,NR1H4,NR4A2,NUAK2,NUDT1,NUPR1L,PCSK9,PDK2,PDK4,PICK1,PIK3C3,PIK3R4,PIM1,PMAIP1,PPP1R9B,PRKAA1,PRKAA2,RALB,RNF152,RPTOR,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SREBF1,SREBF2,TBL2,TP53,TSC1,ULK1,USF1,USF2,USP33,VDR,WDR24,WDR59,WRN,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus.
GO:0031669	GO	BP	cellular response to nutrient levels	ALB,AOC1,ASNS,ATF4,ATG14,ATG7,BECN1,BHLHA15,CARTPT,CDKN1A,CDKN2B,CHMP1A,CPEB4,CYP24A1,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,FADS1,FNIP1,FOLR1,FOLR2,FOXA2,FOXO1,GAS2L1,GAS6,HSPA5,HSPA8,IFI16,IMPACT,INHBB,KCNB1,KIAA1324,KLF10,LRRK2,MIOS,MTMR3,MTOR,MYBBP1A,NCOA1,NPRL2,NPRL3,NR1H4,NUAK2,NUPR1L,PCSK9,PDK2,PDK4,PICK1,PIK3C3,PIK3R4,PIM1,PMAIP1,PRKAA1,PRKAA2,RALB,RNF152,RPTOR,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SREBF1,SREBF2,TBL2,TP53,TSC1,ULK1,USF1,USF2,USP33,VDR,WDR24,WDR59,WRN,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
GO:0031670	GO	BP	cellular response to nutrient	CDKN2B,CHMP1A,CYP24A1,FOLR1,FOLR2,FOXA2,GAS6,NCOA1,NR1H4,PDK2,PIM1,USF1,USF2,VDR,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
GO:0031672	GO	CC	A band	ANK2,ATP2A1,KLHL41,MYBPC3,MYL3,MYL4,MYL7,MYOM1,MYOM3,OBSCN,OBSL1,PPP1R12A,PPP1R12B,PPP2R5A,TTN	The dark-staining region of a sarcomere, in which myosin thick filaments are present; the center is traversed by the paler H zone, which in turn contains the M line.
GO:0031674	GO	CC	I band	ACTC1,ACTN2,AHNAK2,ALDOA,ANK2,ANKRD1,ANKRD2,ATP2A1,ATP2B4,BIN1,BMP10,CACNA1C,CACNA1D,CACNA1S,CAPN3,CASQ2,CAV3,CFL2,CSRP3,DES,DMD,DNAJB6,DST,FKBP1A,FKBP1B,HRC,IGFN1,KCNE1,KY,LDB3,MYL3,MYOT,MYOZ2,MYPN,MYZAP,NEB,NEBL,NEXN,NOS1AP,OBSCN,OBSL1,PAK1,PDE4B,PPP1R12A,PPP1R12B,RYR1,RYR2,SCN1A,SCN3B,SCN5A,SCN8A,SLC4A1,SLC8A1,SORBS2,SRI,SYNE2,SYNPO2,TCAP,TTN	A region of a sarcomere that appears as a light band on each side of the Z disc, comprising a region of the sarcomere where thin (actin) filaments are not overlapped by thick (myosin) filaments; contains actin, troponin, and tropomyosin; each sarcomere includes half of an I band at each end.
GO:0031690	GO	MF	adrenergic receptor binding	ADRA2A,ADRBK1,ARRDC3,C1QBP,DLG4,NEDD4,PDE4D,RAPGEF2	Interacting selectively and non-covalently with an adrenergic receptor.
GO:0031848	GO	BP	protection from non-homologous end joining at telomere	ACD,DCLRE1B,TERF2,TERF2IP,TFIP11	A process that prevents non-homologous end joining at telomere, thereby ensuring that telomeres do not fuse.
GO:0031901	GO	CC	early endosome membrane	ANXA1,B2M,CAV1,CD207,CD8B,CLIP3,DKK1,DNAJC13,EGFR,EHD1,EPHA4,EPHB1,FCGR1A,FCGR1B,FIG4,FZD5,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,KCNH1,KREMEN2,LAMP5,LDLRAD4,LLGL1,LRP6,MARCH1,MTMR4,PIKFYVE,PMEPA1,RAB21,RAB5A,SLC9A6,SNX1,SNX20,SNX21,SNX3,SNX4,SNX5,SNX6,SNX8,SYNDIG1,TMEM163,VAC14,VPS33B,WLS,WNT3A,ZFYVE16,ZFYVE28,ZFYVE9	The lipid bilayer surrounding an early endosome.
GO:0031902	GO	CC	late endosome membrane	ANXA2,ANXA6,ANXA8,CD63,CYB561A3,FIG4,HLA-DRA,HLA-DRB1,HLA-DRB5,LAMP2,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MARCH1,PIKFYVE,PMEL,RAB27A,RAB27B,RAB7A,RNF13,SLC11A1,SLC11A2,SLC38A9,SLC9A9,SNF8,TMEM55A,TMEM55B,VAC14,VAMP7,VAMP8,VPS36,VPS39,VPS41,VTI1B	The lipid bilayer surrounding a late endosome.
GO:0031904	GO	CC	endosome lumen	AP4B1,AP4E1,AP4M1,AP4S1,APOB,APP,B2M,CD63,CTSB,CTSH,CTSK,CTSL,CTSS,INS,JAK2,LNPEP,NAPSA,PGA3,PGA4,PGA5,PRLR,SFTPB,SFTPC	The volume enclosed by the membrane of an endosome.
GO:0031929	GO	BP	TOR signaling	CCDC88A,EIF4EBP1,EIF4EBP2,FLCN,FNIP1,GATA3,LARP1,MTOR,PINK1,PRR5L,RHEBL1,RPS6,RPS6KB1,RPTOR	A series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors.
GO:0031931	GO	CC	TORC1 complex	AKT1S1,LARP1,MLST8,MTOR,RPTOR,TELO2,TTI1	A protein complex that contains at least TOR (target of rapamycin) and Raptor (regulatory-associated protein of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of S6K. In Saccharomyces, the complex contains Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p.
GO:0031932	GO	CC	TORC2 complex	MLST8,MTOR,PRR5,PRR5L,RICTOR,RPL23A,TELO2,TTI1	A protein complex that contains at least TOR (target of rapamycin) and Rictor (rapamycin-insensitive companion of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of PKB (also called AKT). In Saccharomyces, the complex contains Avo1p, Avo2p, Tsc11p, Lst8p, Bit61p, Slm1p, Slm2p, and Tor2p.
GO:0031935	GO	BP	regulation of chromatin silencing	AICDA,APOBEC1,ASF1A,HMGA1,MIER1,PHF2,PHF8,POU5F1,SIN3A,SIRT1,TET1	Any process that affects the rate, extent or location of chromatin silencing.
GO:0031936	GO	BP	negative regulation of chromatin silencing	AICDA,APOBEC1,ASF1A,HMGA1,PHF2,PHF8,TET1	Any process that stops, prevents, or reduces the frequency, rate or extent of chromatin silencing.
GO:0031941	GO	CC	filamentous actin	CD2AP,DPYSL3,ESPN,IQGAP2,LRRC16A,MYO1A,MYO1C,MYO3A,MYO6,MYO9B,PAK1,PKD2,RAC3,SHROOM4	A two-stranded helical polymer of the protein actin.
GO:0031943	GO	BP	regulation of glucocorticoid metabolic process	BMP2,BMP5,DKK3,REST,STUB1,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving glucocorticoids.
GO:0031952	GO	BP	regulation of protein autophosphorylation	ACE,ADIPOQ,CALM1,CAV1,CHP1,ENG,ENPP1,EPHA7,ERRFI1,GREM1,IMPACT,INS,MOB1B,MRE11A,MVP,NBN,NEK10,NLRP12,PDGFA,PDGFB,RAD50,RAP2A,RAP2C,RASSF2,TOM1L1,VEGFA	Any process that modulates the frequency, rate or extent of addition of the phosphorylation by a protein of one or more of its own residues.
GO:0031953	GO	BP	negative regulation of protein autophosphorylation	ADIPOQ,CAV1,CHP1,ENG,ENPP1,ERRFI1,IMPACT,MVP,NLRP12	Any process that stops, prevents or decreases the rate of the phosphorylation by a protein of one or more of its own residues.
GO:0031954	GO	BP	positive regulation of protein autophosphorylation	ACE,CALM1,GREM1,INS,MRE11A,NBN,NEK10,PDGFA,PDGFB,RAD50,RAP2A,RAP2C,RASSF2,TOM1L1,VEGFA	Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
GO:0031958	GO	BP	corticosteroid receptor signaling pathway	ARID1A,CALR,GPER1,NCOA6,NEDD4,RBM14,YWHAH	Any series of molecular signals generated as a consequence of a corticosteroid binding to its receptor.
GO:0031960	GO	BP	response to corticosteroid	ADAM9,AKR1C3,ANXA1,AQP1,CALCR,GHRHR,GPER1,IL10,IL1RN,IL6,ISL1,KLF9,PDCD7,REST,TNF,UBE2L3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.
GO:0031965	GO	CC	nuclear membrane	AAAS,ADRA1A,ADRA1B,AEN,AHCTF1,AK9,AKIRIN1,ALOX5,ALOX5AP,ANXA4,APEH,AQP1,ATP11B,ATP1B4,BCL2,BRAP,BRIP1,C11orf85,C15orf43,C2orf42,CBX3,CCDC79,CCND2,CDC14B,CDK4,CEP131,CEP170,CEP70,CERS2,CNEP1R1,CTDNEP1,CUEDC2,DCTN5,DGKH,DHCR7,DHRS4,DMPK,DNAJC2,DTX2,DUX4,ELF4,EMD,EPC1,EVX1,FAM188A,FAM76B,FZR1,GAPDH,GCH1,GCHFR,GHRHR,GRK5,GTF3C3,GTPBP4,GUCY2D,GUCY2F,HACD3,HN1,HPN,HSD17B1,IFI27,INA,IPO5,ITPR3,KLHDC2,KLK6,KPNB1,LBR,LEMD2,LEMD3,LMNA,LMNB1,LPIN1,MATR3,MCM3AP,MRGPRF,MRPL19,MRPS14,MRPS15,MRPS23,MRTO4,MX1,MYO6,NDC1,NDUFB4,NOS1AP,NR4A1,NRXN1,NSMF,NUP107,NUP133,NUP153,NUP205,NUP35,NUP50,NUP62,NUP93,NUP98,OSBPL3,OSBPL6,PAK1,PCM1,PHF20,PHF8,PLCD4,PLRG1,PML,PRICKLE1,PRPF38A,PSEN1,PSEN2,PTCHD2,PUM2,RANBP2,RANGAP1,RAP1GAP2,RB1CC1,RCC1,RETSAT,RNF6,RPS6KA2,SCAI,SCRN1,SENP1,SEPHS1,SIRT1,SIX2,SLC16A3,SLC30A1,SMAD1,SMAD3,SUMO1,SUN1,SUN2,SYNE1,SYNE2,SYNE4,TBC1D20,TFPT,TMC6,TMC8,TMEM120B,TMEM18,TMEM38A,TMEM38B,TMEM57,TMEM97,TMPO,TNKS,TNRC18,TPR,TRIB3,TRIM27,TSPO,TXLNG,WDR3,WTAP,XPO1,YBX1,ZC3HC1,ZNF224,ZNF354C,ZNF383	Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
GO:0031968	GO	CC	organelle outer membrane	ABCB6,ACACB,ACSL1,AGK,AGPAT5,AIFM2,AMBRA1,ATF2,ATP5G2,ATP5G3,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BMF,BNIP3,BNIP3L,BPHL,CASP8,CISD2,COASY,CPT1A,CPT1B,CYB5A,CYB5R3,CYP27B1,DAO,DHCR7,DMPK,DNM1L,EMD,FIS1,FUNDC1,GDAP1,GHRHR,GPAM,GPAT2,GUCY2D,GUCY2F,HADHB,HAX1,HK2,IFI27,ITPR3,KMO,LRRK2,MAOA,MAOB,MARCH5,MAVS,MCL1,MFF,MFN1,MFN2,MGARP,MIEF1,MIEF2,MOAP1,MSTO1,MTERF3,MUL1,MYOC,NLRX1,OPA1,PHB2,PINK1,PLD6,PMAIP1,PPP2R2B,PRNP,PSEN1,QTRT1,QTRTD1,RAB11FIP5,RAF1,RETSAT,RHOT1,RHOT2,RMDN3,RSAD2,SAMM50,SLC25A46,SLC8A3,SPATA18,SPG20,SYNE4,TIGAR,TMEM173,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,USP30,VDAC1	The outer, i.e. cytoplasm-facing in a cellular organelle, lipid bilayer of an organelle envelope.
GO:0031970	GO	CC	organelle envelope lumen	AIFM1,AK2,ALOX5,APP,ARL2,ARL2BP,BLOC1S1,CHCHD10,CHCHD4,COA6,CPOX,CYCS,DIABLO,FBXL4,GATM,HAX1,HSD3B1,HSD3B2,HTRA2,MICU1,MICU2,MYOC,NDUFA8,NDUFB7,NDUFS1,OPA1,PANK2,PINK1,PNPT1,PPOX,PRELID1,SDHAF3,SIRT5,SOD1,SORL1,STAR,STOML2,TIMM10,TIMM10B,TIMM13,TIMM23,TIMM8A,TIMM8B,TIMM9,TRAP1,TRIAP1,TUBB,UQCC2	The region between the inner and outer lipid bilayers of an organelle envelope.
GO:0031983	GO	CC	vesicle lumen	A2M,ACTN1,ACTN2,ACTN4,ALB,ALDOA,APOA1,APOB,APOE,APP,BACE1,CALR,CFD,CLU,DBH,DEFA1,DEFA3,DEFA5,EGF,EGFR,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FN1,GAS6,GCG,GHRL,GIP,HBA1,HBB,HGF,HP,HPX,HRG,HSP90AA1,HSP90B1,HSPH1,HYOU1,IGF1,IGF2,INS,KNG1,LEFTY2,LTF,MMRN1,PCSK1,PCSK2,PDGFA,PDGFB,PF4,PLG,POMC,PPBP,PROS1,SAA1,SCG3,SCGB3A2,SERPINA1,SERPINE1,SERPINF2,SERPING1,SPARC,SRGN,TF,TGFB1,TGFB2,TGFB3,THBS1,TIMP1,TMSB4X,VEGFA,VEGFB,VEGFC,VWF	The volume enclosed by the membrane or protein that forms a vesicle.
GO:0031984	GO	CC	organelle subcompartment	AKAP9,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP4B1,AP4E1,AP4M1,AP4S1,APP,ARFGEF1,ARFGEF2,ARFIP1,ARFIP2,ARFRP1,ARL1,ASPH,ATG9A,ATL1,ATP2C1,ATP7A,ATP7B,ATP9A,ATP9B,ATXN2,AZIN2,B3GALT6,B4GALT1,BACE1,BICD1,BIRC6,CA4,CABP7,CALN1,CBY1,CD74,CDH1,CHAC1,CHID1,CHST2,CHST4,CLASP2,CLIP3,CLN3,CLTA,CLTC,CLTCL1,CLVS1,CLVS2,CNST,COG2,CORO7,DENND5A,DPY30,FAM109A,FAM109B,FKBP1A,FURIN,GALNT2,GBF1,GCC2,GCNT1,GGA2,GGA3,GNAS,GOLGA1,GOLGA2,GOLGA4,GOLGA5,GOLGA7,GOLGB1,GOLPH3,GOLPH3L,GPER1,GPR89A,GSAP,HID1,HLA-A,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IGF2R,INPP5K,KIAA1324,KIF13A,KLHL20,KPNB1,LGR5,LGR6,LLGL1,LPCAT2,MARCH1,MARCH4,MARCH9,MLANA,MMP24,MYO18A,MYO1B,NBEA,NECAB3,NSF,OCRL,OPTN,OSBPL8,PARP16,PIFO,PLEKHA8,PLK3,POSTN,PRKD1,RAB10,RAB11A,RAB13,RAB14,RAB18,RAB21,RAB27B,RAB29,RAB30,RAB31,RAB34,RAB3GAP1,RAB6A,RAB7B,RAC1,RBFOX1,RGS20,RYR1,SCAMP1,SCAMP2,SCAMP5,SCOC,SGMS1,SLC11A2,SLC24A5,SLC9A7,SMPD4,SNX9,SORL1,STIM1,STX10,STX16,STX6,STX8,TAS2R16,TGFBI,TGOLN2,TMBIM4,TMEM110,TMEM115,TMEM165,TMEM59,TMEM79,TRAPPC4,VAMP2,VAMP7,VPS54,VRK1,WIPI1,WLS,ZFYVE1,ZFYVE27	A compartment that consists of a lumen and an enclosing membrane, and is part of an organelle.
GO:0031985	GO	CC	Golgi cisterna	AP4M1,ATL1,B3GALT6,B4GALT1,GCNT1,GOLGA2,GOLGA5,GOLPH3,GPR89A,HID1,HLA-A,LLGL1,NECAB3,RAB21,RAB30,RAB34,SGMS1,SORL1,STX16,TMEM115,TMEM59	Any of the thin, flattened membrane-bounded compartments that form the central portion of the Golgi complex.
GO:0031998	GO	BP	regulation of fatty acid beta-oxidation	ABCD2,AKT1,AKT2,IRS1,IRS2,LONP2,METTL20,PLIN5,PPARA,TWIST1,TYSND1	Any process that modulates the frequency, rate or extent of fatty acid bbeta-oxidation.
GO:0032000	GO	BP	positive regulation of fatty acid beta-oxidation	ABCD2,AKT2,IRS1,IRS2,PLIN5,PPARA,TWIST1	Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation.
GO:0032006	GO	BP	regulation of TOR signaling	AKT1S1,ARAF,ARNTL,ATM,DDIT4,DEPDC5,DEPTOR,EPM2A,FAM83D,FBXO9,FLCN,FNIP1,GAS6,GNA12,GOLPH3,GPAT3,GSK3A,HDAC3,HTR6,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LEP,MAPKAPK5,MIOS,MLST8,NPRL2,NPRL3,PDCD6,PIH1D1,PKHD1,PRKAA1,PRKAA2,RFFL,RHEB,RICTOR,RNF152,ROS1,RPTOR,RRAGA,RRAGB,RRAGC,RRAGD,SEC13,SEH1L,SH3BP4,SIRT1,SLC38A9,STK11,TBC1D7,TELO2,TMEM127,TNFAIP8L1,TSC1,TTI1,UBR1,UBR2,WDR24,WDR59,XBP1	Any process that modulates the frequency, rate or extent of TOR signaling.
GO:0032007	GO	BP	negative regulation of TOR signaling	AKT1S1,ARNTL,ATM,DDIT4,DEPDC5,DEPTOR,EPM2A,FLCN,FNIP1,GSK3A,MAPKAPK5,NPRL2,NPRL3,PDCD6,PRKAA1,PRKAA2,RNF152,SH3BP4,SIRT1,STK11,TBC1D7,TMEM127,TNFAIP8L1,TSC1,UBR1,UBR2	Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling.
GO:0032008	GO	BP	positive regulation of TOR signaling	FLCN,GAS6,GOLPH3,HDAC3,HTR6,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LEP,MIOS,MLST8,PIH1D1,RHEB,RICTOR,RPTOR,RRAGA,RRAGB,RRAGD,SEC13,SEH1L,SLC38A9,TELO2,WDR24,WDR59,XBP1	Any process that activates or increases the frequency, rate or extent of TOR signaling.
GO:0032009	GO	CC	early phagosome	SNX3,SYK,TLR7,TLR9,UNC93B1	A membrane-bounded intracellular vesicle as initially formed upon the ingestion of particulate material by phagocytosis.
GO:0032020	GO	BP	ISG15-protein conjugation	HERC5,ISG15,UBA7,UBE2E1,UBE2E2	The covalent addition to a protein of ISG15, a ubiquitin-like protein.
GO:0032024	GO	BP	positive regulation of insulin secretion	ANO1,BAD,BLK,CAPN10,CFTR,DOC2B,GCK,GHRL,GLUD1,GPER1,GPLD1,HLA-DRB1,IRS2,ISL1,MCU,MYRIP,NLGN2,PPP3CB,PSMD9,RBP4,RFX6,SLC30A8,SOX4,STX4,TCF7L2,TMEM27	Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.
GO:0032026	GO	BP	response to magnesium ion	ANK3,FBP1,KCNA1,RYR3,SLFN14,SNCA,THBS1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus.
GO:0032039	GO	CC	integrator complex	CPSF3L,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,SHFM1	A protein complex that stably associates with the C-terminus of RNA polymerase II and mediates 3'-end processing of small nuclear RNAs generated by RNA polymerase II.
GO:0032042	GO	BP	mitochondrial DNA metabolic process	DNA2,LIG3,LONP1,MGME1,PARP1,PRIMPOL,SLC25A33	The chemical reactions and pathways involving mitochondrial DNA.
GO:0032048	GO	BP	cardiolipin metabolic process	CRLS1,HADHA,HADHB,LCLAT1,PGS1,PLA2G4A,PLA2G6,PTPMT1,SLC27A1,TAMM41,TAZ,THEM5	The chemical reactions and pathways involving cardiolipin, 1,3-bis(3-phosphatidyl)glycerol.
GO:0032049	GO	BP	cardiolipin biosynthetic process	CRLS1,PGS1,PLA2G6,PTPMT1,SLC27A1,TAMM41,TAZ	The chemical reactions and pathways resulting in the formation of cardiolipin, 1,3-bis(3-phosphatidyl)glycerol.
GO:0032052	GO	MF	bile acid binding	AKR1C1,AKR1C2,NR1H4,PLA2G1B,PYGL,VDR	Interacting selectively and non-covalently with bile acids, any of a group of steroid carboxylic acids occurring in bile.
GO:0032055	GO	BP	negative regulation of translation in response to stress	ATF4,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1,PML,RBM4	Any process that stops, prevents or reduces the rate of translation as a result of a stimulus indicating the organism is under stress.
GO:0032056	GO	BP	positive regulation of translation in response to stress	DNAJC3,EIF2AK4,IMPACT,NCK1,PPP1R15A	Any process that activates or increases the frequency, rate or extent of translation as a result of a stimulus indicating the organism is under stress.
GO:0032057	GO	BP	negative regulation of translational initiation in response to stress	ATF4,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1	Any process that stops, prevents or reduces the rate of translation initiation as a result of a stimulus indicating the organism is under stress.
GO:0032060	GO	BP	bleb assembly	ANO6,EMP1,EMP2,EMP3,MYLK,P2RX7,PMP22	The assembly of a bleb, a cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Plasma membrane blebbing occurs during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses.
GO:0032069	GO	BP	regulation of nuclease activity	AKT1,BAK1,BAX,DAB2IP,ERN1,GZMA,HMGB1,HMGB2,HSPA1A,NEIL1,NPM1,OAS1,OAS3,PARP16,PCNA,PRKCD,PTPN1,RPS3,SIRT1,TMBIM6,VAPB	Any process that modulates the frequency, rate or extent of nuclease activity, the hydrolysis of ester linkages within nucleic acids.
GO:0032070	GO	BP	regulation of deoxyribonuclease activity	AKT1,GZMA,HMGB1,NPM1,PCNA,PRKCD,RPS3,SIRT1	Any process that modulates the frequency, rate or extent of deoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid.
GO:0032071	GO	BP	regulation of endodeoxyribonuclease activity	AKT1,GZMA,HMGB1,NPM1,PRKCD,RPS3,SIRT1	Any process that modulates the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks.
GO:0032075	GO	BP	positive regulation of nuclease activity	AKT1,BAK1,BAX,DAB2IP,ERN1,HMGB2,HSPA1A,PARP16,PCNA,PRKCD,PTPN1,RPS3,VAPB	Any process that activates or increases the frequency, rate or extent of nuclease activity, the hydrolysis of ester linkages within nucleic acids.
GO:0032088	GO	BP	negative regulation of NF-kappaB transcription factor activity	AIM2,ANXA4,ARRB1,ARRB2,BMP7,BRMS1,CACTIN,CDK5RAP3,CDKN2A,CHP1,CMKLR1,COMMD1,COMMD6,COMMD7,CYLD,CYP1B1,DAB2IP,DAP,DNAJA3,ERBB2IP,FOXJ1,FOXP3,GFI1,HAVCR2,IRAK1,IRAK2,IRAK3,IRG1,ITCH,KLF4,MAP2K5,NFKBIA,NFKBIL1,NLRC3,NLRC5,NLRP12,NLRP2P,NLRP3,OTULIN,PARP10,PKHD1,PRMT2,PSMD10,PTGIS,PYCARD,PYDC1,PYDC2,RBCK1,RWDD3,SETD6,SIRT1,SIVA1,TAX1BP1,TCEAL7,TLR9,TNFAIP3,TRAF3,TRIM21,TRIM37,TRIM40,UFL1,USP7,ZC3H12A,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB.
GO:0032091	GO	BP	negative regulation of protein binding	ADAM15,ADIPOQ,ADRB2,AES,ANXA2,ARRB2,AURKA,AURKB,B2M,BAX,CAMK1,CAV1,CCL23,CSNK1E,CTNNBIP1,DAB2,DACT1,DKK1,DVL1,GNL3L,GOLGA2,GSK3B,GTPBP4,HFE,HSPA5,IFIT1,IFIT2,IL10,ISL1,ITGA4,ITGB1BP1,KDM1A,LEF1,LRPAP1,LRRK2,MAPK8,MITD1,NES,NKX3-1,NOG,PARK7,PDGFB,PEX14,PIN1,PRKCD,PTPRF,RALB,ROCK1,RUVBL2,SLPI,SORL1,TFIP11,TMBIM6,TMC8,USP33,ZFPM1	Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
GO:0032092	GO	BP	positive regulation of protein binding	ABL1,ADD1,ADD2,AKTIP,AMFR,B2M,BAMBI,BMP2,BMP4,CAPRIN2,CAV1,CSF3,DACT1,DERL1,EPB41,FKBP1A,FLOT1,GNL3L,GSK3B,HFE,HIPK2,LRRK2,MEF2C,MEN1,MMP9,NRP1,PARK7,PKD1,RALB,RAN,RAPGEF2,SPPL3,STK3,STK4,TCF7L2,TERT,TIAM1,TIRAP,TMEM173,TRAF2,TRAF4,TRIB3,USP33,VTN,WNT3A,ZNF268	Any process that activates or increases the frequency, rate or extent of protein binding.
GO:0032095	GO	BP	regulation of response to food	BBS2,BBS4,CARTPT,GHRL,GHSR,LEP,MKKS,MT3,NENF,NPY,PPARA,PRKCG,SPX	Any process that modulates the frequency, rate or extent of a response to a food stimulus.
GO:0032098	GO	BP	regulation of appetite	BBS2,BBS4,CARTPT,GHRL,GHSR,HTR2C,LEP,MKKS,NENF,NPY,POMC,PPARA,SPX	Any process which modulates appetite, the desire or physical craving for food.
GO:0032099	GO	BP	negative regulation of appetite	BBS2,BBS4,CARTPT,LEP,MKKS,NENF,PPARA,SPX	Any process that reduces appetite.
GO:0032102	GO	BP	negative regulation of response to external stimulus	ADAMTS18,ADIPOQ,AIF1,ALOX12,ANGPT2,APCS,APOA1,APOD,APOE,APOH,BBS2,BBS4,C1QBP,C1QTNF1,C1QTNF3,C5,C5AR2,CACTIN,CARTPT,CASK,CCL2,CD109,CD34,CHID1,CHMP4A,CHMP4B,CLASP1,CLASP2,CLN3,CORO1B,CTNNA2,CUEDC2,CXCL13,DEFB114,DHX58,DRD1,DRD2,DRD3,EDN1,EIF2AK2,ELANE,EPHA4,F11,F12,F2,FEM1A,FEZ1,FEZ2,FFAR4,FGA,FGB,FGF2,FGG,GATA3,GBA,GHRL,GHSR,GP1BA,GPER1,GREM1,GRID2,GSTP1,HLA-DRB1,HRG,IFIT1,INS,IRG1,ISL1,ITCH,KANK2,KLF4,KLK8,KLKB1,KLRK1,KNG1,KRT1,LEP,LRRK2,LTF,LZTS1,MAPK7,MEFV,METRNL,MICB,MKKS,MMP26,MTOR,MUL1,MVK,NBL1,NENF,NFKBIL1,NLRP12,NLRP3,NOS3,NOTCH1,NOV,NR1H3,NRBP2,OTULIN,PADI2,PCBP2,PDGFA,PDGFB,PDGFRA,PHF23,PHLDB2,PINK1,PLAT,PLAU,PLAUR,PLG,PPARA,PPM1B,PRKCD,PRKG1,PROC,PTEN,PTGER4,PTGIS,PTPN2,PTPRO,PYDC2,QSOX1,ROBO1,ROBO2,RORA,RPS19,RUBCN,SAA1,SCFD1,SEC14L1,SEMA5A,SERPINB2,SERPINE1,SERPINE2,SERPINF2,SHARPIN,SIGIRR,SIRT2,SLIT2,SNAI2,SPX,STAP1,TARBP2,TEK,THBD,THBS1,TKFC,TMPRSS6,TNFAIP3,TNFAIP6,TNFRSF1A,TRAF3IP1,TRIB1,TSC1,TSPAN6,TYRO3,UBQLN1,UBQLN4,VIMP,VTN,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of a response to an external stimulus.
GO:0032103	GO	BP	positive regulation of response to external stimulus	ADAM10,ADAM17,ADAM8,ADRB2,AGT,AGTR1,AIF1,AMBRA1,ANKRD17,ANO6,APOH,ATG7,AZU1,BECN1,BMP6,BNIP3,BNIP3L,C1QBP,CALCOCO2,CALR,CAMK1D,CCL19,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD180,CD6,CD74,CDH13,CMKLR1,CREB3,CREB3L3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,CXCR3,CYBA,CYP27B1,DAPK2,DCN,DDX60,DEFB103A,DHX58,DSCAM,EDN2,EDN3,EPM2A,F12,F2,F2RL1,F3,F7,FFAR2,FFAR3,FGF16,FGF18,FGF2,FGFR1,FIGF,GAS6,GBP5,GHRL,GHSR,GPRC5B,HMGB1,HSPB1,HYAL2,IL12A,IL12B,IL15,IL18,IL1B,IL2,IL21,IL23A,IL33,IL6,IL6R,IL6ST,IRG1,KDR,KIAA1324,KLK5,KLK7,KLKB1,LARP1,LBP,LGALS9,LRSAM1,LY86,MAPK13,MEGF8,MET,NCKAP1L,NLRP12,NOD2,NPY,NRP1,NTF3,NTRK3,OSM,OSMR,PAFAH1B2,PARK7,PDE2A,PDGFB,PDGFRB,PGC,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,PLA2G2A,PLA2G7,PLG,PPM1F,PRKAA2,PRKCA,PRKD1,PRKD2,PTGER3,PTGER4,PTGS2,PTK2B,PUM1,PUM2,RAB3GAP1,RAB3GAP2,RAC1,RAC2,RALB,RARRES2,RPS19,S100A12,S100A14,S100A7,S100A8,S100A9,SASH1,SCARF1,SCG2,SCOC,SEMA5A,SERPINE1,SERPINF2,SH3GLB1,SIRT1,SLIT2,SNW1,SNX4,SPTLC1,SPTLC2,SQSTM1,STX3,STX4,SUPT5H,TGFB1,THBD,THBS1,THBS4,TIRAP,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TNFRSF11A,TNFRSF1A,TNFSF11,TNFSF4,TNIP1,TRIM13,TRIM15,ULK1,USF1,USP17L2,VAMP7,VAMP8,VEGFA,VEGFB,VEGFC,WAC,WDFY3,WNT5A,XCL1,ZC3HAV1,ZNF580,ZP3	Any process that activates, maintains or increases the rate of a response to an external stimulus.
GO:0032107	GO	BP	regulation of response to nutrient levels	ACTL6A,ADRB2,AMBRA1,ATG7,BBS2,BBS4,BECN1,BNIP3,BNIP3L,CALCOCO2,CARTPT,CHMP4A,CHMP4B,CLN3,CSNK2A2,CTSK,CYP27B1,DCN,DNM1L,EPM2A,ERN1,FBXW7,FEZ1,FEZ2,FZD5,GHRL,GHSR,GSK3A,HAX1,HTRA2,IFT20,IFT88,KANK2,KAT2A,KDR,KIAA1324,LARP1,LEP,LRRK2,LRSAM1,LZTS1,MAP1LC3B,MKKS,MT3,MTMR3,MTOR,NENF,NPY,NRBP2,PAFAH1B2,PARK2,PARK7,PHF23,PIKFYVE,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,POLR3A,PPARA,PRKAA2,PRKCG,QSOX1,RAB1B,RAB33B,RAB3GAP1,RAB3GAP2,RAB7A,RALB,RPL28,RUBCN,RUVBL1,SCFD1,SCOC,SH3GLB1,SIRT1,SLC17A9,SNAI2,SNW1,SPTLC1,SPTLC2,SPX,SQSTM1,SREBF1,SREBF2,SUPT5H,TBC1D14,TBC1D25,TRIM13,TSC1,U2AF1,U2AF2,UBQLN1,UBQLN2,UBQLN4,ULK1,USP36,VDAC1,WAC,WBP11,WDFY3,WDR75,ZBTB17,ZDHHC8	Any process that modulates the frequency, rate or extent of a response to nutrient levels.
GO:0032108	GO	BP	negative regulation of response to nutrient levels	BBS2,BBS4,CARTPT,CHMP4A,CHMP4B,CLN3,FEZ1,FEZ2,KANK2,LEP,LRRK2,LZTS1,MKKS,MTOR,NENF,NRBP2,PHF23,PINK1,PPARA,QSOX1,RUBCN,SCFD1,SNAI2,SPX,TSC1,UBQLN1,UBQLN4	Any process that stops, prevents, or reduces the frequency, rate or extent of a response to nutrient levels.
GO:0032109	GO	BP	positive regulation of response to nutrient levels	ADRB2,AMBRA1,ATG7,BECN1,BNIP3,BNIP3L,CALCOCO2,CYP27B1,DCN,EPM2A,GHRL,GHSR,KDR,KIAA1324,LARP1,LRSAM1,NPY,PAFAH1B2,PARK7,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,PRKAA2,RAB3GAP1,RAB3GAP2,RALB,SCOC,SH3GLB1,SIRT1,SNW1,SPTLC1,SPTLC2,SQSTM1,SUPT5H,TRIM13,ULK1,WAC,WDFY3	Any process that activates or increases the frequency, rate or extent of a response to nutrient levels.
GO:0032135	GO	MF	DNA insertion or deletion binding	MSH2,MSH3,MSH6,PCNA,PMS2,XPC	Interacting selectively and non-covalently with double-stranded DNA containing insertions or deletions.
GO:0032148	GO	BP	activation of protein kinase B activity	ADRA2A,ADRA2B,ADRA2C,ANG,CCDC88A,DYNAP,GAS6,INS,INSR,ITGB1BP1,MT3,NTF3,NTRK3,OSBPL8,PARK7,PDGFB,PDPK1,PINK1,TXN,WNT5A	Any process that initiates the activity of the inactive enzyme protein kinase B.
GO:0032154	GO	CC	cleavage furrow	ECT2,LIMA1,MASTL,MEN1,MYH10,MYH9,MYLK,OR2A4,PDXP,PKN1,PKN2,RAB11A,RAB11FIP3,RAB11FIP4,RACGAP1,RALA,RHOB,RHOC,SEPT12,SPIRE1,SPIRE2,STAMBP,SVIL,ZFYVE19	In animal cells, the first sign of cleavage, or cytokinesis, is the appearance of a shallow groove in the cell surface near the old metaphase plate. A contractile ring containing actin and myosin is located just inside the plasma membrane at the location of the furrow. Ring contraction is associated with centripetal growth of the membrane that deepens the cleavage furrow and divides the cytoplasm of the two daughter cells. While the term 'cleavage furrow' was initially associated with animal cells, such a structure occurs in many other types of cells, including unicellular protists.
GO:0032155	GO	CC	cell division site part	ANLN,ECT2,LIMA1,MAEA,MASTL,MEN1,MYH10,MYH9,MYLK,OR2A4,PDXP,PKN1,PKN2,RAB11A,RAB11FIP3,RAB11FIP4,RACGAP1,RALA,RHOB,RHOC,SEPT12,SPIRE1,SPIRE2,STAMBP,SVIL,ZFYVE19	Any constituent part of the cell division plane, the eventual plane of cell division in a dividing cell.
GO:0032182	GO	MF	ubiquitin-like protein binding	ATRIP,BAG6,BCL10,BRCC3,BRE,CASP8AP2,CBX4,CRY1,CRY2,CXCR4,DNAJB2,DNAJC2,DYRK2,DZIP3,EPS15,FAAP20,FAF1,FAF2,FAM175A,FAM175B,FAN1,HDAC6,HERC2,HSPB1,IKBKE,IKBKG,KIF18A,MARK4,MVB12A,NBR1,NEDD4,NUP62,OPTN,OTUB1,PARK2,PARP10,PER2,PRPF8,RAD18,RAD23A,RAD23B,RBCK1,RNF111,RNF168,RNF169,RNF31,RNF4,SHARPIN,SIMC1,SIRT2,SMAD3,SPRTN,SQSTM1,TAB2,TERF1,TNIP2,TNIP3,TOM1L1,TOP2A,TRIM32,TSG101,UBAP1,UBE2N,UBQLN1,UBQLN4,UBXN1,UBXN7,UCHL1,UCHL3,UIMC1,USP13,USP16,USP25,USP5,USPL1,VCP,VPS28,VPS36,ZBTB1,ZFAND6,ZRANB1,ZRANB3	Interacting selectively and non-covalently with a small conjugating protein such as ubiquitin or a ubiquitin-like protein.
GO:0032183	GO	MF	SUMO binding	CASP8AP2,CBX4,HERC2,RNF111,RNF4,SIMC1,USP25,USPL1	Interacting selectively and non-covalently with the small ubiquitin-like protein SUMO.
GO:0032200	GO	BP	telomere organization	ACD,APEX1,ATM,CTC1,DCLRE1B,DKC1,DNA2,DOT1L,ERCC1,ERCC4,FBXO4,FEN1,GAR1,H3F3A,HIST1H3A,HIST1H4A,HIST3H3,LIG1,MRE11A,NBN,NHP2,NOP10,NSMCE2,OBFC1,PARP3,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POT1,PRIM1,PRIM2,PRKDC,PTGES3,RAD50,RAD51,RAD51D,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RTEL1,SLX1A,SLX4,SMC5,SMC6,SMG1,SMG6,SP100,TEP1,TERF1,TERF2,TERF2IP,TERT,TFIP11,TINF2,TNKS1BP1,UPF1,WRAP53,WRN,XRCC3,XRCC5,XRCC6,ZSCAN4	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of telomeres, terminal regions of a linear chromosome that include the telomeric DNA repeats and associated proteins.
GO:0032201	GO	BP	telomere maintenance via semi-conservative replication	APEX1,DNA2,FEN1,LIG1,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,PRIM1,PRIM2,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RTEL1,UPF1	The process in which telomeric DNA is synthesized semi-conservatively by the conventional replication machinery and telomeric accessory factors as part of cell cycle DNA replication.
GO:0032204	GO	BP	regulation of telomere maintenance	ACD,ATM,ATR,ATRX,AURKB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CTC1,DHX36,ERCC1,ERCC4,GNL3L,HDAC8,HMBOX1,HNRNPA1,HNRNPC,HNRNPU,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MCRS1,MRE11A,MYC,NABP2,NAT10,NBN,NEK2,NEK7,OBFC1,PARP1,PIF1,PINX1,PKIB,PML,PNKP,POT1,PRKCQ,RAD50,RTEL1,SLX1A,SLX4,SMG5,SMG6,SRC,TCP1,TEN1,TERF1,TERF2,TERF2IP,TINF2,TNKS,TNKS2,USP7,WRAP53,XRCC5	Any process that modulates the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.
GO:0032205	GO	BP	negative regulation of telomere maintenance	ACD,ATM,ERCC1,ERCC4,GNL3L,HNRNPA1,HNRNPC,HNRNPU,MCRS1,NAT10,NBN,PARP1,PINX1,PML,RAD50,RTEL1,SMG6,SRC,TERF1,TERF2,TERF2IP,TINF2,TNKS,TNKS2,XRCC5	Any process that stops, prevents, or reduces the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.
GO:0032206	GO	BP	positive regulation of telomere maintenance	ACD,ATM,ATR,ATRX,AURKB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,DHX36,ERCC1,HMBOX1,HNRNPA1,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MRE11A,NABP2,NBN,NEK2,NEK7,OBFC1,PKIB,PNKP,POT1,PRKCQ,RAD50,RTEL1,SLX1A,SLX4,TCP1,TERF2,TINF2,TNKS,TNKS2,WRAP53	Any process that activates or increases the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.
GO:0032210	GO	BP	regulation of telomere maintenance via telomerase	ACD,ATM,ATR,AURKB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,GNL3L,HMBOX1,HNRNPA1,HNRNPC,HNRNPU,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NAT10,NEK2,NEK7,OBFC1,PINX1,PKIB,PML,PNKP,POT1,PRKCQ,SMG5,SMG6,SRC,TCP1,TERF1,TERF2,TINF2,TNKS,TNKS2,WRAP53	Any process that modulates the frequency, rate or extent of the addition of telomeric repeats by telomerase.
GO:0032211	GO	BP	negative regulation of telomere maintenance via telomerase	ACD,GNL3L,HNRNPA1,HNRNPC,HNRNPU,NAT10,PINX1,PML,SRC,TERF1,TINF2	Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of telomeric repeats by telomerase.
GO:0032212	GO	BP	positive regulation of telomere maintenance via telomerase	ACD,ATM,ATR,AURKB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,HMBOX1,HNRNPA1,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NEK2,NEK7,OBFC1,PKIB,PNKP,POT1,PRKCQ,TCP1,TNKS,TNKS2,WRAP53	Any process that activates or increases the frequency, rate or extent of the addition of telomeric repeats by telomerase.
GO:0032225	GO	BP	regulation of synaptic transmission, dopaminergic	CHRNB2,CNTNAP4,DRD1,DRD2,DRD3,DRD4,FLOT1,GDNF,RAB3B,SNCA,TOR1A	Any process that modulates the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine.
GO:0032228	GO	BP	regulation of synaptic transmission, GABAergic	ADRA1A,CNTNAP4,DRD2,HAP1,NLGN1,NLGN2,STXBP1,SYN3,USP46	Any process that modulates the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA).
GO:0032231	GO	BP	regulation of actin filament bundle assembly	ALMS1,AMOT,APOA1,ARAP1,ARHGAP6,ARHGEF10,ARHGEF10L,ARHGEF15,ARHGEF5,ASAP3,CLASP1,CLASP2,CTGF,DLC1,EPHA1,EVL,FHOD1,GPR65,INPP5K,ITGB1BP1,LIMK1,LPAR1,LRRC16A,MYOC,NF2,PAK1,PARK2,PFN1,PFN2,PHLDB2,PLEK,PPFIA1,PPM1E,PPM1F,PTGER4,RAC1,RAPGEF3,RDX,RGCC,RHOA,ROCK1,ROCK2,S100A10,SERPINF2,SFRP1,SHANK1,SHANK3,SLC9A1,SORBS3,SYNPO,TACSTD2,TPM1,TSC1,VIL1,WASF2,WNT11	Any process that modulates the frequency, rate or extent of the assembly of actin filament bundles.
GO:0032232	GO	BP	negative regulation of actin filament bundle assembly	ARAP1,ARHGAP6,CLASP1,CLASP2,DLC1,INPP5K,MYOC,PARK2,PFN1,PHLDB2,PPFIA1,SHANK1,SHANK3,TACSTD2,WASF2	Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly of actin filament bundles.
GO:0032233	GO	BP	positive regulation of actin filament bundle assembly	AMOT,APOA1,ARHGEF10,ARHGEF10L,ARHGEF15,ARHGEF5,CTGF,EPHA1,EVL,FHOD1,GPR65,ITGB1BP1,LIMK1,LPAR1,LRRC16A,MYOC,NF2,PAK1,PFN2,PLEK,PPM1E,PPM1F,RAC1,RAPGEF3,RGCC,RHOA,S100A10,SERPINF2,SFRP1,SORBS3,SYNPO,TPM1,VIL1,WNT11	Any process that activates or increases the frequency, rate or extent of the assembly of actin filament bundles.
GO:0032237	GO	BP	activation of store-operated calcium channel activity	ASPH,CRACR2A,STIM1,STIM2,TMEM110	A process that initiates the activity of an inactive store-operated calcium channel.
GO:0032239	GO	BP	regulation of nucleobase-containing compound transport	IWS1,KHDRBS1,NCBP2,NUDT4,NUP153,RIPK1,SETD2,SUPT6H,TPR,ZC3H3	Any process that modulates the frequency, rate or extent of the directed movement of nucleobases, nucleosides, nucleotides and nucleic acids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032259	GO	BP	methylation	AHCY,ALKBH8,ARMT1,AS3MT,ASH1L,ASH2L,ASZ1,ATF7IP,ATRX,BAZ2A,BCDIN3D,BEND3,BHMT,CARM1,CHD5,CMTR1,CMTR2,COMT,COPRS,CTCFL,CTR9,CXXC1,CYP1A2,DMAP1,DNMT1,DNMT3A,DNMT3B,DNMT3L,DPPA3,DPY30,EEF2KMT,EHMT1,EHMT2,ETF1,EZH2,FAM103A1,FBL,FBXO11,FKBP6,FOS,FTSJ2,GATAD2A,GCSH,GSPT1,GSTO1,H3F3A,HENMT1,HIST1H3A,HIST1H4A,HIST2H3A,INMT,KDM6A,KIAA1429,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,MAEL,MAT1A,MAT2A,MAT2B,MEN1,MEPCE,METTL1,METTL14,METTL20,METTL21A,METTL21C,METTL2A,METTL2B,METTL3,MGMT,MTR,MTRR,N6AMT1,NDUFAF7,NNMT,NR1H4,NSD1,NSUN2,NSUN4,NTMT1,OGT,PAXIP1,PCMT1,PICK1,PIWIL2,PIWIL4,PLD6,PRDM4,PRDM5,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RAB6A,RBBP5,RNMT,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SNRPB,SNRPD3,SUV39H1,SUV39H2,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH,TET2,TET3,TGS1,TPMT,TRDMT1,TRMT10A,TRMT112,TRMT61B,UHRF1,VCPKMT,WDR5,WDR61,WDR82,WHSC1L1,WTAP,ZFP57,ZNF335	The process in which a methyl group is covalently attached to a molecule.
GO:0032266	GO	MF	phosphatidylinositol-3-phosphate binding	BBS5,DAB2IP,FAM21C,JPH2,KIF16B,LANCL2,NCF4,PARD3,PHLDA3,PLEKHF1,SESTD1,SH3PXD2B,SNX13,SNX20,SNX21,SNX27,SNX3,TECPR1,WIPI1,WIPI2,ZFYVE19,ZFYVE26,ZFYVE28	Interacting selectively and non-covalently with phosphatidylinositol-3-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' position.
GO:0032271	GO	BP	regulation of protein polymerization	ABI2,ABL1,ACTR2,ACTR3,ADD1,ADD2,ALOX15,ARF1,ARF6,ARFGEF1,ARHGAP18,ARL2,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPIN,BAIAP2L1,BRK1,CAV3,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CLASP1,CLASP2,CLIP1,CLIP3,CORO1A,CORO1B,CSF3,CTTN,CYFIP1,EML2,EPS8,FAM21C,FER,FES,GSN,HAX1,HCK,HCLS1,IQGAP2,JMY,KANK1,LATS1,LRRC16A,MAGEL2,MAPRE1,MAPT,MTPN,MYADM,NCK1,NCK2,NCKAP1,NCKAP1L,PAK3,PFN1,PFN2,PICK1,PINK1,PRKCD,PRKCE,PSRC1,PTK2B,PYCARD,RASA1,RPS3,SCIN,SLAIN2,SLIT2,SNCA,STMN2,TBCD,TENM1,TERF1,TMSB4Y,TPPP,TRIM27,TRIOBP,TWF1,TWF2,VASP,VIL1,WASF1,WASH1,WHAMM	Any process that modulates the frequency, rate or extent of the process of creating protein polymers.
GO:0032272	GO	BP	negative regulation of protein polymerization	ADD1,ADD2,ARFGEF1,CLIP3,EML2,EPS8,GSN,KANK1,MAPRE1,MYADM,PFN1,PFN2,PRKCD,SCIN,SLIT2,SNCA,STMN2,TBCD,TMSB4Y,TRIOBP,TWF1,TWF2,VIL1	Any process that stops, prevents, or reduces the frequency, rate or extent of the process of creating protein polymers.
GO:0032273	GO	BP	positive regulation of protein polymerization	ACTR2,ACTR3,ALOX15,ARF6,ARL2,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BAIAP2L1,CAV3,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CLASP1,CLIP1,CSF3,CTTN,FAM21C,FER,FES,HCK,IQGAP2,JMY,LRRC16A,MAGEL2,MAPT,NCK1,NCK2,NCKAP1L,PFN1,PFN2,PINK1,PRKCE,PSRC1,PTK2B,PYCARD,RPS3,SCIN,SLAIN2,TENM1,TERF1,TPPP,TRIM27,VASP,WASH1	Any process that activates or increases the frequency, rate or extent of the process of creating protein polymers.
GO:0032281	GO	CC	AMPA glutamate receptor complex	CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CNIH2,CNIH3,DLG4,GRIA1,GRIA2,GRIA3,GRIA4,OLFM2	An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. The AMPA receptors mediate fast synaptic transmission in the CNS and are composed of subunits GluR1-4, products from separate genes. These subunits have an extracellular N-terminus and an intracellular C-terminus.
GO:0032288	GO	BP	myelin assembly	CD9,CNTNAP1,DICER1,EPB41L3,GPC1,NCMAP,TENM4	The process in which the wraps of cell membrane that constitute myelin are laid down around an axon in the central or peripheral nervous system.
GO:0032303	GO	BP	regulation of icosanoid secretion	ACSL4,CYP4A11,CYP4F2,IL1B,P2RX4,PLA2G10,PLA2R1,SYK,TNFRSF11A,TNFSF11	Any process that modulates the frequency, rate or extent of the controlled release of an icosanoid from a cell.
GO:0032305	GO	BP	positive regulation of icosanoid secretion	CYP4A11,CYP4F2,IL1B,P2RX4,PLA2G10,PLA2R1,TNFRSF11A,TNFSF11	Any process that activates or increases the frequency, rate or extent of the controlled release of an icosanoid from a cell.
GO:0032306	GO	BP	regulation of prostaglandin secretion	ACSL4,IL1B,P2RX4,PLA2G10,TNFRSF11A,TNFSF11	Any process that modulates the frequency, rate or extent of the regulated release of a prostaglandin from a cell.
GO:0032308	GO	BP	positive regulation of prostaglandin secretion	IL1B,P2RX4,PLA2G10,TNFRSF11A,TNFSF11	Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell.
GO:0032309	GO	BP	icosanoid secretion	ABCC4,ACE,BDKRB2,DRD2,DRD3,DRD4,LEP,NMUR2,NOS2,PLA2G1B,PNPLA8	The controlled release of icosanoids, any of a group of C20 polyunsaturated fatty acids from a cell or a tissue.
GO:0032324	GO	BP	molybdopterin cofactor biosynthetic process	GPHN,MOCOS,MOCS1,MOCS2,MOCS3,NFS1	The chemical reactions and pathways resulting in the formation of the molybdopterin cofactor (Moco), essential for the catalytic activity of some enzymes, e.g. sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The cofactor consists of a mononuclear molybdenum (Mo-molybdopterin) or tungsten ion (W-molybdopterin) coordinated by one or two molybdopterin ligands.
GO:0032330	GO	BP	regulation of chondrocyte differentiation	ACVRL1,ADAMTS12,ADAMTS7,CHADL,EFEMP1,GDF5,GREM1,HOXA11,LOXL2,NKX3-2,PKDCC,PTHLH,SCIN,SNAI2,SOX5,SOX6,SOX9,TGFBR1,TRPS1,WNT9A,ZBTB16	Any process that modulates the frequency, rate or extent of chondrocyte differentiation.
GO:0032331	GO	BP	negative regulation of chondrocyte differentiation	ADAMTS12,ADAMTS7,CHADL,EFEMP1,GDF5,GREM1,NKX3-2,PTHLH,SNAI2,SOX9,TGFBR1,WNT9A	Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.
GO:0032332	GO	BP	positive regulation of chondrocyte differentiation	ACVRL1,GDF5,HOXA11,LOXL2,PKDCC,SOX5,SOX6,SOX9,ZBTB16	Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation.
GO:0032347	GO	BP	regulation of aldosterone biosynthetic process	BMP2,BMP5,BMP6,DKK3,REST,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone.
GO:0032350	GO	BP	regulation of hormone metabolic process	AKR1C3,ARNT,BMP2,BMP5,BMP6,DKK3,FFAR3,GATA3,HIF1A,HPN,PAX8,REST,STC2,STUB1,TCF7L2,TRERF1,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
GO:0032351	GO	BP	negative regulation of hormone metabolic process	AKR1C3,BMP2,BMP5,DKK3,REST,WNT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
GO:0032352	GO	BP	positive regulation of hormone metabolic process	ARNT,BMP6,GATA3,HIF1A,HPN,PAX8,WNT4	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
GO:0032353	GO	BP	negative regulation of hormone biosynthetic process	BMP2,BMP5,DKK3,REST,WNT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.
GO:0032355	GO	BP	response to estradiol	CCDC62,CRHBP,CTNNB1,EGFR,ESR1,FOXA1,GH1,GHR,GPER1,H2AFZ,KAT5,MYOD1,MYOG,NCOA3,NRIP1,RAMP3,RUVBL2,SOCS2,STAT3,STAT5B,STRN3,TGFB1,WNT8B,ZNF703	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
GO:0032357	GO	MF	oxidized purine DNA binding	MSH2,MSH3,MSH6,OGG1,RPS3	Interacting selectively and non-covalently with oxidized purine residues in DNA.
GO:0032364	GO	BP	oxygen homeostasis	ALAS2,EGLN1,HIF1A,NARFL,SOD2,WNT7B	A homeostatic process involved in the maintenance of an internal steady state of oxygen within an organism or cell.
GO:0032365	GO	BP	intracellular lipid transport	ABCA1,ABCG1,ACACA,ACACB,COL4A3BP,CPT1A,CPT1B,CPT2,LDLRAP1,NPC2,PLEKHA8,PRKAA2,PRKAB2,PRKAG2,SLC25A20,VPS4A	The directed movement of lipids within cells.
GO:0032367	GO	BP	intracellular cholesterol transport	ABCA1,ABCG1,LDLRAP1,NPC2,VPS4A	The directed movement of cholesterol, cholest-5-en-3-beta-ol, within cells.
GO:0032368	GO	BP	regulation of lipid transport	ABCA12,ABCA2,ABCA7,ABCB4,ABCG5,ABCG8,ACSL4,ADIPOQ,AKT1,AKT2,APOA2,APOA4,APOC1,APOC2,APOC3,APOE,C1QTNF1,CETP,CRH,CRHR1,CYP4A11,CYP4F2,GAL,GALR1,GDF9,GHRL,HNRNPK,IL1B,IRS2,ITGAV,ITGB3,LAMTOR1,LIPG,LRP1,NCOR1,NFKB1,NFKBIA,NKX3-1,NR1H2,NR1H3,NUS1,P2RX4,PARK2,PLA2G10,PLA2R1,PLTP,PON1,PPARA,PPARG,PRELID1,PRKCD,PTCH1,PTCHD2,SCP2,SHH,SIRT1,SREBF2,SYK,THBS1,TNFRSF11A,TNFSF11,TRIAP1,TSPO	Any process that modulates the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032369	GO	BP	negative regulation of lipid transport	ABCG5,ABCG8,ACSL4,AKT1,AKT2,APOA2,APOC1,APOC2,APOC3,APOE,CYP4F2,IRS2,ITGAV,ITGB3,NFKB1,NR1H2,NR1H3,PLA2G10,PLA2R1,SHH,SREBF2,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032370	GO	BP	positive regulation of lipid transport	ABCA12,ABCA7,ABCB4,ADIPOQ,APOE,C1QTNF1,CRH,CYP4A11,CYP4F2,GAL,GALR1,GHRL,IL1B,LIPG,LRP1,NFKBIA,NKX3-1,NR1H2,NR1H3,P2RX4,PLA2G10,PLA2R1,PLTP,PON1,PRELID1,PRKCD,PTCH1,SCP2,SIRT1,TNFRSF11A,TNFSF11,TRIAP1	Any process that activates or increases the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032374	GO	BP	regulation of cholesterol transport	ABCA12,ABCA2,ABCA7,ABCB4,ABCG5,ABCG8,ADIPOQ,APOA2,APOA4,APOC1,APOC2,APOC3,APOE,CETP,LAMTOR1,LIPG,LRP1,NFKB1,NFKBIA,NR1H2,NR1H3,NUS1,PLA2G10,PLTP,PON1,PPARG,PTCH1,SCP2,SHH,SIRT1,SREBF2,TSPO	Any process that modulates the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032375	GO	BP	negative regulation of cholesterol transport	ABCG5,ABCG8,APOA2,APOC1,APOC2,APOC3,APOE,NFKB1,PLA2G10,SHH,SREBF2	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032376	GO	BP	positive regulation of cholesterol transport	ABCA12,ABCA7,ABCB4,ADIPOQ,APOE,LIPG,LRP1,NFKBIA,NR1H2,NR1H3,PLTP,PON1,PTCH1,SCP2,SIRT1	Any process that activates or increases the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032387	GO	BP	negative regulation of intracellular transport	ACAA2,ADIPOQ,ANXA13,APC2,APOD,AXIN2,BAG4,BARD1,BMP7,BST2,C1QTNF3,CABP1,CALCA,CALM1,CASQ2,CCDC22,CD300A,CD84,CHP1,CLIC2,CREB3,CRYAA,CRYAB,CSK,CYLD,DAB2IP,DACT3,DERL2,DERL3,DMTN,DYRK2,EMD,EPO,ERLEC1,FAF1,FAM89B,FKBP1B,G3BP2,GAS6,GDI1,GOPC,GSK3B,GSTM2,GSTO1,HSPA1A,IL10,INPP5K,INSIG1,ITGB1BP1,KCNE1,LGALS9,LRRK2,MDFI,MDFIC,MPV17L,MRLN,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOS1,NOV,NUP153,OS9,PARK7,PARP10,PBLD,PDE2A,PKD1,PKD2,PKDCC,PLN,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,RANGAP1,SFRP5,SIAH3,SLC25A5,SLC35F6,SLC9A3R1,SNAI2,SNX12,SNX3,SOX4,SP100,SRI,SUFU,SVIP,TONSL,TPR,TRDN,TRIM15,UBAC2,UBE2G2,UBE2J1,USP17L2,VPS35,WWTR1,YOD1,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of substances within cells.
GO:0032391	GO	CC	photoreceptor connecting cilium	ARL3,CEP290,FAM161A,IFT122,IQCB1,NPHP1,RP1,RP1L1,RPGRIP1,SPATA7,SPTBN5,TBCC,TOPORS,WDR19	A nonmotile primary cilium that has a 9+0 microtubule array and forms the portion of the axoneme traversing the boundary between the photoreceptor inner and outer segments.
GO:0032392	GO	BP	DNA geometric change	ASCC3,ATRX,BLM,BRIP1,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD8,DDX1,DDX3X,DHX9,DNA2,ERCC2,ERCC3,FBXO18,G3BP1,HELB,HMGA1,HMGB1,HMGB2,HMGB3,IGHMBP2,INO80,MRE11A,MTERF1,NBN,PIF1,POT1,PURA,RAD50,RAD51,RAD54B,RECQL,RECQL4,RECQL5,RTEL1,RUVBL1,RUVBL2,SETX,SUPV3L1,WRN,XRCC5,XRCC6,ZRANB3	The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases.
GO:0032393	GO	MF	MHC class I receptor activity	CD160,CTSH,KIR3DL1,KLRF1,LILRB1,LILRB2,MR1	Combining with an MHC class I protein complex to initiate a change in cellular activity. Class I here refers to classical class I molecules.
GO:0032395	GO	MF	MHC class II receptor activity	HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,KRT17	Combining with an MHC class II protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
GO:0032400	GO	BP	melanosome localization	ARL6,BBS2,BBS4,BBS5,BBS7,BLOC1S3,BLOC1S5,BLOC1S6,GPR143,MKKS,RAB11A,RAB11B,RAB17,RAB27A,SHROOM2,VPS33A,VPS33B	Any process in which a melanosome is transported to, and/or maintained in, a specific location within the cell.
GO:0032401	GO	BP	establishment of melanosome localization	ARL6,BBS2,BBS4,BBS5,BBS7,BLOC1S3,BLOC1S5,BLOC1S6,GPR143,MKKS,RAB11A,RAB11B,RAB17,SHROOM2	The directed movement of a melanosome to a specific location.
GO:0032402	GO	BP	melanosome transport	ARL6,BBS2,BBS4,BBS5,BBS7,BLOC1S3,BLOC1S5,BLOC1S6,GPR143,MKKS,RAB11A,RAB11B,RAB17	The directed movement of melanosomes into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032404	GO	MF	mismatch repair complex binding	ATR,MLH1,MSH2,MSH6,MUTYH,PCNA,PMS2,TREX1	Interacting selectively and non-covalently with a mismatch repair complex.
GO:0032405	GO	MF	MutLalpha complex binding	ATR,MSH2,MSH6,PCNA,TREX1	Interacting selectively and non-covalently with the mismatch repair complex MutLalpha.
GO:0032407	GO	MF	MutSalpha complex binding	ATR,MLH1,MUTYH,PMS2,TREX1	Interacting selectively and non-covalently with the mismatch repair complex MutSalpha.
GO:0032409	GO	BP	regulation of transporter activity	ACTN2,ACTN4,ADRA2A,AGT,AHCYL1,AHNAK,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ANO9,APOA2,ASPH,ATP1A2,ATP1B1,ATP1B2,ATP1B3,BCL2,CAB39,CACNA1D,CACNB4,CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CFTR,CHP1,CHRFAM7A,CLIC2,CNIH2,CNIH3,CRACR2A,CRH,CRHBP,CRHR1,CTSS,CTTNBP2NL,DAPK1,DLG4,DMD,DRD2,DRD4,EPO,FGF12,FHL1,FKBP1A,FKBP1B,FXYD1,GAL,GALR2,GLRX,GNB5,GPD1L,GSTM2,GSTO1,HAMP,HAP1,HOMER1,HRC,HTT,INS,JPH1,JPH2,JPH3,JPH4,KCNAB1,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNIP2,KCNQ1,KCNRG,KCNS1,KCNS2,KMT2A,MAPK8IP2,MEF2C,MINK1,MMP9,NDFIP1,NDFIP2,NEDD4,NEDD4L,NLGN1,NLGN2,NLGN3,NOS1,NOS1AP,NPPA,NRXN1,OPRM1,PCSK9,PDE4B,PDE4D,PKD2,PLN,PON1,PPARG,PPIF,PRKACA,PRKCD,PRKCE,PTK2B,PTPN3,RANGRF,RELN,RIPK1,RNF207,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SGK1,SGK2,SHANK1,SHANK3,SLC9A1,SLC9A3R1,SLN,SNCA,SRI,STIM1,STIM2,STK39,SUMO1,SYNGR3,TCAF1,TCAF2,TESC,TLR9,TMEM110,TRDN,TRPC6,UBQLN1,UTRN,VAMP2,WNK2,WNK3,WWP2,YWHAE,YWHAH	Any process that modulates the activity of a transporter.
GO:0032410	GO	BP	negative regulation of transporter activity	ACTN2,ADRA2A,AGT,ANK3,ANO9,APOA2,ATP1A2,CAB39,CALM1,CAMK2D,CASQ2,CAV3,CHRFAM7A,CLIC2,CRHR1,CTTNBP2NL,DRD2,DRD4,EPO,FKBP1B,GNB5,GSTM2,GSTO1,HAMP,KCNE1,KCNE2,KCNE3,KCNQ1,KCNRG,MMP9,NDFIP1,NDFIP2,NEDD4,NEDD4L,PCSK9,PKD2,PLN,PPIF,PRKCE,RNF207,SLN,SNCA,SRI,STK39,SUMO1,TCAF2,TLR9,TRDN,UBQLN1,WWP2	Any process that stops or reduces the activity of a transporter.
GO:0032411	GO	BP	positive regulation of transporter activity	ACTN2,ACTN4,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ASPH,ATP1B1,ATP1B2,ATP1B3,CALM1,CFTR,CHP1,CRACR2A,CTSS,DMD,DRD4,GAL,GALR2,GLRX,GSTM2,GSTO1,HAP1,HTT,JPH2,KMT2A,NLGN3,NOS1AP,NPPA,PKD2,PON1,PRKCD,RELN,RNF207,RYR2,SGK1,SGK2,SHANK3,SLC9A1,STIM1,STIM2,SYNGR3,TCAF1,TESC,TMEM110,TRDN,TRPC6,WNK2,WNK3	Any process that activates or increases the activity of a transporter.
GO:0032412	GO	BP	regulation of ion transmembrane transporter activity	ACTN2,ACTN4,ADRA2A,AGT,AHCYL1,AHNAK,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ANO9,ASPH,ATP1A2,ATP1B1,ATP1B2,ATP1B3,CAB39,CACNA1D,CACNB4,CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CFTR,CHP1,CHRFAM7A,CLIC2,CNIH2,CNIH3,CRACR2A,CRH,CRHBP,CRHR1,CTSS,DAPK1,DLG4,DMD,DRD2,DRD4,EPO,FGF12,FHL1,FKBP1A,FKBP1B,FXYD1,GAL,GALR2,GLRX,GNB5,GPD1L,GSTM2,GSTO1,HAMP,HAP1,HOMER1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,KCNAB1,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNIP2,KCNQ1,KCNRG,KCNS1,KCNS2,MAPK8IP2,MEF2C,MINK1,MMP9,NEDD4,NEDD4L,NLGN1,NLGN2,NLGN3,NOS1,NOS1AP,NPPA,NRXN1,OPRM1,PCSK9,PDE4B,PDE4D,PKD2,PLN,PPIF,PRKACA,PRKCE,PTK2B,PTPN3,RANGRF,RELN,RIPK1,RNF207,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SHANK1,SHANK3,SLC9A1,SLC9A3R1,SLN,SRI,STIM1,STIM2,STK39,SUMO1,TCAF1,TCAF2,TESC,TLR9,TMEM110,TRDN,TRPC6,UBQLN1,UTRN,VAMP2,WNK2,WNK3,WWP2,YWHAE,YWHAH	Any process that modulates the activity of an ion transporter.
GO:0032413	GO	BP	negative regulation of ion transmembrane transporter activity	ACTN2,ADRA2A,AGT,ANK3,ANO9,ATP1A2,CAB39,CALM1,CAMK2D,CASQ2,CAV3,CHRFAM7A,CLIC2,CRHR1,DRD2,DRD4,EPO,FKBP1B,GNB5,GSTM2,GSTO1,HAMP,KCNE1,KCNE2,KCNE3,KCNQ1,KCNRG,MMP9,NEDD4,NEDD4L,PCSK9,PKD2,PLN,PRKCE,RNF207,SLN,SRI,STK39,SUMO1,TCAF2,TLR9,TRDN,UBQLN1	Any process that stops or reduces the activity of an ion transporter.
GO:0032414	GO	BP	positive regulation of ion transmembrane transporter activity	ACTN2,ACTN4,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ASPH,ATP1B1,ATP1B2,ATP1B3,CALM1,CFTR,CHP1,CRACR2A,CTSS,DMD,DRD4,GAL,GALR2,GLRX,GSTM2,GSTO1,HAP1,HTT,JPH2,NLGN3,NOS1AP,NPPA,PKD2,RELN,RNF207,RYR2,SHANK3,SLC9A1,STIM1,STIM2,TCAF1,TESC,TMEM110,TRDN,TRPC6,WNK2,WNK3	Any process that activates or increases the activity of an ion transporter.
GO:0032415	GO	BP	regulation of sodium:proton antiporter activity	ACTN4,CHP1,DRD4,SLC9A3R1,TESC	Any process that modulates the activity of a sodium:hydrogen antiporter, which catalyzes the reaction: Na+(out) + H+(in) = Na+(in) + H+(out).
GO:0032418	GO	BP	lysosome localization	CHGA,HDAC6,KIT,LAMTOR1,MAP6,MILR1,MRGPRX2,NR4A3,PIK3CD,PIK3CG,RAB34,S100A13,SNAP23,TMEM106B,VPS33A,VPS33B	Any process in which a lysosome is transported to, and/or maintained in, a specific location.
GO:0032420	GO	CC	stereocilium	CDH23,CEACAM16,CIB2,DFNB31,DOCK4,EPS8,FAM65B,GRXCR1,LOXHD1,PCDH15,STRC,TPRN,TSPEAR,TWF2,USH1C,USH2A	An actin-based protrusion from the apical surface of auditory and vestibular hair cells and of neuromast cells. These protrusions are supported by a bundle of cross-linked actin filaments (an actin cable), oriented such that the plus (barbed) ends are at the tip of the protrusion, capped by a tip complex which bridges to the plasma. Bundles of stereocilia act as mechanosensory organelles.
GO:0032421	GO	CC	stereocilium bundle	CDH23,CEACAM16,CIB2,DCDC2,DFNB31,DOCK4,EPS8,FAM65B,GRXCR1,LOXHD1,PCDH15,STRC,TPRN,TSPEAR,TWF2,USH1C,USH2A	A bundle of cross-linked stereocilia, arranged around a kinocilium on the apical surface of a sensory hair cell (e.g. a neuromast, auditory or vestibular hair cell). Stereocilium bundles act as mechanosensory organelles by responding to fluid motion or fluid pressure changes.
GO:0032429	GO	BP	regulation of phospholipase A2 activity	AGTR1,ANG,ANXA8,EGFR,LRP1,NMUR2,PLA2G1B,PLA2R1	Any process that modulates the activity of the enzyme phospholipase A2.
GO:0032430	GO	BP	positive regulation of phospholipase A2 activity	AGTR1,ANG,EGFR,NMUR2,PLA2G1B	Any process that activates or increases the activity of the enzyme phospholipase A2.
GO:0032432	GO	CC	actin filament bundle	ABLIM1,ABLIM3,ACTA1,ACTN1,AMOT,CNN2,CORO1B,DAAM1,FBLIM1,FHOD1,FSCN1,GAS2L1,GAS2L2,LCP1,LIMA1,MICALL2,MYH10,MYH9,MYLK,NEBL,PGM5,PTK2,PXN,SEPT11,SEPT12,SEPT7,SEPT9,SHROOM4,SIPA1L3,SORBS1,TEK,TPM1,TPM3,TPM4,VIL1,ZYX	An assembly of actin filaments that are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness.
GO:0032433	GO	CC	filopodium tip	CIB1,MYO10,MYO5A,NLGN1,VIL1	The end of a filopodium distal to the body of the cell.
GO:0032434	GO	BP	regulation of proteasomal ubiquitin-dependent protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ARAF,ATM,ATRAID,BAG5,BAG6,BCAP31,BUB1,BUB1B,BUB3,CAV1,CBFA2T3,CCAR2,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CEBPA,CENPE,CENPF,CLU,COMMD1,CSNK1A1,CSNK1D,CSNK1E,CSNK2A1,CSNK2A2,CUL3,DAB2,DAB2IP,DLGAP5,DNAJB2,DUSP1,DVL1,DYNC1LI1,ESPL1,FHIT,GEN1,GIPC1,GLMN,GNA12,GNB2L1,GSK3B,HERPUD1,HFE,HSP90AB1,HSPBP1,KEAP1,KLHL22,LCMT1,LRRK2,MAD1L1,MAD2L1,MAD2L2,MDM2,N4BP1,NEK6,NELL1,NFE2L2,NKD2,NSMCE2,NUB1,PANO1,PARK2,PARK7,PCID2,PIAS1,PLK1,PLK3,PRICKLE1,PSMD10,PTEN,RAD23A,RAD23B,RB1,RCHY1,RFWD2,SDCBP,SGTA,SIRT2,SMAD7,SMC5,SOCS5,STUB1,SUMO1,SUMO2,SVIP,TAF1,TAF9,TERF1,TEX14,TLK2,TPR,TRIB1,TRIB2,TTK,UBE2C,UBE2D1,UBE2E1,UBQLN1,UBQLN2,UBQLN4,UBXN1,UFL1,USP14,USP44,USP5,VCP,WAC,XBP1,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
GO:0032435	GO	BP	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,ATRAID,BAG5,BAG6,BUB1,BUB1B,BUB3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,DAB2IP,FHIT,GIPC1,HFE,HSP90AB1,KLHL22,MAD1L1,MAD2L1,MAD2L2,N4BP1,NELL1,PANO1,PARK7,PLK1,SDCBP,SVIP,TAF9,TERF1,TEX14,TLK2,TPR,TTK,UBE2C,UBE2D1,UBE2E1,UBXN1,USP14,USP44,WAC,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
GO:0032436	GO	BP	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BCAP31,CAV1,CBFA2T3,CEBPA,CLU,CSNK1A1,CSNK1D,CSNK1E,CUL3,DAB2,DLGAP5,DNAJB2,DVL1,ESPL1,GNB2L1,GSK3B,HERPUD1,HSPBP1,KEAP1,LRRK2,MDM2,NFE2L2,NKD2,NSMCE2,NUB1,PARK2,PIAS1,PLK1,PLK3,PRICKLE1,PSMD10,PTEN,RB1,RCHY1,RFWD2,SGTA,SIRT2,SMAD7,SMC5,SOCS5,STUB1,SUMO1,SUMO2,TAF1,TRIB1,TRIB2,UBQLN1,UBQLN2,USP5,VCP,XBP1	Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
GO:0032438	GO	BP	melanosome organization	AP1G1,AP1M1,AP3B1,AP3D1,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,DTNBP1,GPR143,KIF13A,LYST,PMEL,RAB32,RAB38,SHROOM2,SNAPIN	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a melanosome. A melanosome is a tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored.
GO:0032451	GO	MF	demethylase activity	ALKBH2,ALKBH4,ALKBH5,CYP1A2,CYP51A1,FTO,HIST1H4A,JMJD6,KDM1A,KDM1B,KDM2B,KDM4A,KDM4C,KDM4D,KDM5B,KDM5C,KDM5D,KDM7A,KDM8,PHF2,PHF8	Catalysis of the removal of a methyl group from a substrate.
GO:0032452	GO	MF	histone demethylase activity	HIST1H4A,JMJD6,KDM1A,KDM1B,KDM2B,KDM4A,KDM4C,KDM4D,KDM5B,KDM5C,KDM5D,KDM7A,KDM8,PHF2,PHF8	Catalysis of the removal of a methyl group from a histone.
GO:0032453	GO	MF	histone demethylase activity (H3-K4 specific)	KDM1A,KDM1B,KDM5B,KDM5C,KDM5D	Catalysis of the removal of a methyl group from lysine at position 4 of the histone H3 protein.
GO:0032454	GO	MF	histone demethylase activity (H3-K9 specific)	KDM1A,KDM4C,KDM4D,KDM7A,PHF2,PHF8	Catalysis of the reaction: histone H3 N6-methyl-L-lysine (position 9) + alpha-ketoglutarate + O2 = succinate + CO2 + formaldehyde + lysine. This reaction is the removal of a methyl group from lysine at position 9 of the histone H3 protein.
GO:0032456	GO	BP	endocytic recycling	ARL4C,EHD1,EHD2,EHD3,EHD4,EPS15,LMTK2,MICALL1,MICALL2,RAB11FIP3,RAB13,RAB14,RAB17,SNF8,SNX4,VPS50,VPS51,VPS52,VPS53	The directed movement of membrane-bounded vesicles from recycling endosomes back to the plasma membrane where they are recycled for further rounds of transport.
GO:0032459	GO	BP	regulation of protein oligomerization	AIM2,BAX,BBC3,BCL11A,BCL2L11,BID,BIK,BMF,CLU,DNM1L,GNB2L1,HIST3H3,HRK,IDE,INS,JCHAIN,MIEF2,MMP1,MMP3,OPRD1,PEX14,PEX5,PMAIP1,SH3GLB1,SNX9,SORL1,SRC,TMC8,TP53,TRABD2A,TRABD2B	Any process that modulates the frequency, rate or extent of protein oligomerization.
GO:0032460	GO	BP	negative regulation of protein oligomerization	BCL11A,CLU,HIST3H3,INS,OPRD1,PEX14,PEX5,SORL1,SRC,TMC8	Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization.
GO:0032461	GO	BP	positive regulation of protein oligomerization	AIM2,BAX,BBC3,BCL2L11,BID,BIK,BMF,GNB2L1,HRK,IDE,JCHAIN,MIEF2,MMP1,MMP3,PMAIP1,SH3GLB1,SNX9,TP53,TRABD2A,TRABD2B	Any process that activates or increases the frequency, rate or extent of protein oligomerization.
GO:0032462	GO	BP	regulation of protein homooligomerization	BBC3,BCL11A,BCL2L11,BID,BIK,BMF,CLU,GNB2L1,HRK,MIEF2,PEX14,PEX5,SRC	Any process that modulates the frequency, rate or extent of protein homooligomerization.
GO:0032463	GO	BP	negative regulation of protein homooligomerization	BCL11A,CLU,PEX14,PEX5,SRC	Any process that stops, prevents, or reduces the frequency, rate or extent of protein homooligomerization.
GO:0032464	GO	BP	positive regulation of protein homooligomerization	BBC3,BCL2L11,BID,BIK,BMF,GNB2L1,HRK,MIEF2	Any process that activates or increases the frequency, rate or extent of protein homooligomerization.
GO:0032465	GO	BP	regulation of cytokinesis	ADAM17,AKT1,ATRAID,AURKB,AURKC,BBS4,BECN1,BIRC6,CALM1,CCND1,CCND2,CCND3,CCNY,CCP110,CDC25B,CDC42,CDC6,CDKN1A,CENPV,CETN2,CHMP4C,CIT,CSPP1,CUL3,CXCR5,DAB2IP,DRD2,DRD3,E2F7,E2F8,ECT2,EGFR,FGF10,FLCN,GIPC1,GIT1,KIF14,KIF20B,KIF23,KLHL21,MAP10,MAPRE3,MRGPRX2,NELL1,OPN1LW,OPN1MW,OR1A2,OR2A4,PDGFB,PDXP,PIK3C3,PIK3R4,PIM1,PIN1,PKD1,PKD2,PKN2,PKP4,PLK3,PRKCE,PROX1,PRPF40A,PSMD10,PSRC1,RACGAP1,RGCC,RHOA,RXFP3,SDCCAG3,SH3GLB1,SPAST,SSTR5,STOX1,SVIL,TAS1R2,TAS2R13,UVRAG,VPS4A,ZFYVE19	Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.
GO:0032466	GO	BP	negative regulation of cytokinesis	AURKB,CHMP4C,E2F7,E2F8,VPS4A,ZFYVE19	Any process that stops, prevents, or reduces the frequency, rate or extent of the division of the cytoplasm of a cell, and its separation into two daughter cells.
GO:0032467	GO	BP	positive regulation of cytokinesis	AURKB,AURKC,CDC25B,CDC42,CDC6,CENPV,CIT,CSPP1,CUL3,CXCR5,DRD2,DRD3,ECT2,GIPC1,KIF14,KIF20B,KIF23,MAP10,MRGPRX2,OPN1LW,OPN1MW,OR1A2,OR2A4,PKN2,PKP4,PRKCE,RACGAP1,RHOA,RXFP3,SPAST,SSTR5,SVIL,TAS1R2,TAS2R13	Any process that activates or increases the frequency, rate or extent of the division of the cytoplasm of a cell, and its separation into two daughter cells.
GO:0032469	GO	BP	endoplasmic reticulum calcium ion homeostasis	ATP2A1,ATP2A2,BAK1,BAX,BBC3,BCAP31,BCL2,CAMK2D,FIS1,HERPUD1,KCTD17,PML,PSEN1,RAP1GDS1,TGM2,WFS1	Any process involved in the maintenance of an internal steady state of calcium ions within the endoplasmic reticulum of a cell or between the endoplasmic reticulum and its surroundings.
GO:0032471	GO	BP	negative regulation of endoplasmic reticulum calcium ion concentration	ATP2A1,BBC3,BCAP31,FIS1,RAP1GDS1,TGM2	Any process that decreases the concentration of calcium ions in the endoplasmic reticulum.
GO:0032479	GO	BP	regulation of type I interferon production	ATG12,ATG5,CACTIN,CHUK,CRCP,CREBBP,CTNNB1,CYLD,DDX3X,DDX41,DDX58,DHX36,DHX58,DHX9,DTX4,EP300,FLOT1,HAVCR2,HERC5,HSPD1,IFI16,IFIH1,IKBKB,IKBKE,IKBKG,IL10,IRAK1,IRF1,IRF3,IRF5,IRF7,IRG1,ISG15,ITCH,LILRB1,LRRFIP1,MAVS,MB21D1,MRE11A,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NLRC5,NLRP4,NLRX1,OTUD5,PCBP2,PIN1,POLR1C,POLR1D,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,PPM1B,PRKDC,PTPN22,PYCARD,REL,RELA,RELB,RIPK1,RIPK2,RIPK3,RNF125,RNF135,RNF216,RPS27A,STAT6,TAX1BP1,TBK1,TIRAP,TLR2,TLR3,TLR4,TLR7,TLR8,TLR9,TMEM173,TNFAIP3,TRAF3,TRAF3IP1,TREX1,TRIM15,TRIM21,TRIM25,TRIM32,TRIM56,UBA52,UBA7,UBB,UBC,UBE2D3,UBE2L6,XRCC5,XRCC6,ZBP1,ZC3HAV1	Any process that modulates the frequency, rate, or extent of interferon type I production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
GO:0032480	GO	BP	negative regulation of type I interferon production	ATG12,ATG5,CACTIN,CYLD,DDX58,DHX58,HAVCR2,HERC5,IFIH1,IKBKE,IL10,IRF3,IRG1,ISG15,ITCH,LILRB1,MAVS,NLRC5,NLRX1,OTUD5,PCBP2,PIN1,PPM1B,PYCARD,REL,RELB,RNF125,RNF135,RNF216,RPS27A,TAX1BP1,TBK1,TNFAIP3,TRAF3,TRAF3IP1,TRIM25,UBA52,UBA7,UBB,UBC,UBE2D3,UBE2L6	Any process that stops, prevents, or reduces the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
GO:0032481	GO	BP	positive regulation of type I interferon production	CHUK,CRCP,CREBBP,CTNNB1,DDX3X,DDX41,DDX58,DHX36,DHX58,DHX9,DTX4,EP300,FLOT1,HSPD1,IFI16,IFIH1,IKBKB,IKBKG,IRAK1,IRF1,IRF3,IRF5,IRF7,LRRFIP1,MAVS,MB21D1,MRE11A,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NLRP4,POLR1C,POLR1D,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,PRKDC,PTPN22,RELA,RIPK1,RIPK2,RIPK3,RNF135,RPS27A,STAT6,TBK1,TLR2,TLR3,TLR4,TLR7,TLR8,TLR9,TMEM173,TREX1,TRIM15,TRIM21,TRIM32,TRIM56,UBA52,UBB,UBC,XRCC5,XRCC6,ZBP1,ZC3HAV1	Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
GO:0032486	GO	BP	Rap protein signal transduction	PLK2,RAP1A,RAP1B,RAP2A,RAP2B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3	A series of molecular signals within the cell that are mediated by a member of the Rap family of proteins switching to a GTP-bound active state.
GO:0032490	GO	BP	detection of molecule of bacterial origin	C4B,LBP,LY96,NOD2,SCARB1,SSC5D,TLR1,TLR2,TLR4,TLR6	The series of events in which a stimulus from a molecule of bacterial origin is received and converted into a molecular signal.
GO:0032493	GO	BP	response to bacterial lipoprotein	CD14,CD36,SSC5D,TIRAP,TLR1,TLR2,TLR6	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bacterial lipoprotein stimulus.
GO:0032495	GO	BP	response to muramyl dipeptide	ARHGEF2,ERBB2IP,IRF5,NLRP1,NOD1,NOD2,PTPN22,RIPK2	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan.
GO:0032496	GO	BP	response to lipopolysaccharide	ADAM17,ADAM9,ANKRD1,AXL,B2M,CACTIN,CCL2,CCL3,CCL5,CD14,CD6,CDC73,CITED1,CPS1,CTR9,CXCL10,CXCL8,CYP27B1,DAB2IP,ERBB2IP,F2R,FER,FOXP1,GCH1,GSTP1,HCK,HMGB2,HNRNPA0,IFNAR1,IL10,IL12A,IL18,IL1B,IL23R,IL6,IRAK1,IRAK3,IRG1,JAK2,LBP,LGALS9,LIAS,LILRB2,LY96,LYN,MAPK14,MAPK8,MAPKAPK2,MAPKAPK3,MEF2C,MTA1,MTDH,NFKB1,NFKBIL1,NLRP3,NOCT,NR1D1,NR1H3,OTUD5,PAF1,PALM3,PDE4B,PRDX3,PRKCE,PTPN22,PYCARD,RPS6KA3,SBNO2,SCARB1,SELE,SELP,SERPINE1,SHPK,SLC11A1,SLPI,SNCA,STAP1,TGFB1,TICAM2,TIRAP,TLR2,TLR4,TNF,TNFAIP3,TNFRSF11A,TNFRSF1B,TNFSF4,TNIP2,TNIP3,TRAF6,TRIB1,TRIM6,VIMP,XBP1,ZC3H12A	Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
GO:0032506	GO	BP	cytokinetic process	ALKBH4,AURKB,CNTROB,RACGAP1,RHOA,SNX18,SNX33,SNX9,SPIRE1,SPIRE2	A cellular process that is involved in cytokinesis (the division of the cytoplasm of a cell and its separation into two daughter cells).
GO:0032507	GO	BP	maintenance of protein location in cell	AKT1,ANK3,ANKRD13C,ARL2,ARL2BP,BBS4,BCL3,CAV1,CCDC22,CD4,CREB3,DAG1,EPB41L3,EZR,FAF1,FLNA,FLNB,G3BP2,GET4,GOLPH3,GOPC,GPAA1,GSN,HK1,HK2,HSPA5,IL10,JUP,LATS1,MDFI,MORC3,MXI1,NFKBIA,NFKBIE,NFKBIL1,OS9,PDIA2,PDIA3,PINK1,PKD1,PKD2,PML,PSMD10,SCIN,SHANK1,SORL1,SPTBN4,SUN1,SUN2,SUPT7L,SYNE1,SYNE2,SYNE3,TAF3,TAF8,TLN1,TMSB4Y,TONSL,TOPORS,TWF1,TWF2,YWHAB	Any process in which a protein is maintained in a specific location within, or in the membrane of, a cell, and is prevented from moving elsewhere.
GO:0032508	GO	BP	DNA duplex unwinding	ASCC3,ATRX,BLM,BRIP1,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD8,DDX1,DDX3X,DHX9,DNA2,ERCC2,ERCC3,FBXO18,G3BP1,HELB,HMGA1,IGHMBP2,INO80,MRE11A,NBN,PIF1,POT1,PURA,RAD50,RAD51,RAD54B,RECQL,RECQL4,RECQL5,RTEL1,RUVBL1,RUVBL2,SETX,SUPV3L1,WRN,XRCC5,XRCC6	The process in which interchain hydrogen bonds between two strands of DNA are broken or 'melted', generating a region of unpaired single strands.
GO:0032509	GO	BP	endosome transport via multivesicular body sorting pathway	LYST,RILP,SNF8,SORT1,VPS4B	The directed movement of substances from endosomes to lysosomes or vacuoles by a pathway in which molecules are sorted into multivesicular bodies, which then fuse with the target compartment.
GO:0032515	GO	BP	negative regulation of phosphoprotein phosphatase activity	CRY2,FKBP1A,FKBP1B,IKBKB,MASTL,NCKAP1L,PPP1R15A,PPP2R4,PPP4R4,ROCK1,ROCK2,TIPRL,TNF	Any process that stops or reduces the activity of a phosphoprotein phosphatase.
GO:0032516	GO	BP	positive regulation of phosphoprotein phosphatase activity	AGTR2,AKAP6,CALM1,CD300A,ITGA1,MAGI2,PDGFRB,PPP1R12A,PPP1R15A,PPP2R4	Any process that activates or increases the activity of a phosphoprotein phosphatase.
GO:0032526	GO	BP	response to retinoic acid	ABL2,ACER2,ADNP2,AQP1,AQP3,ASXL1,BRINP3,CDKN2D,CTSH,EPHA3,FZD10,FZD4,FZD7,HSD17B2,HTRA2,KMT2E,LTK,LYN,MICB,NDUFA13,OGT,OVCA2,PAX2,PPARG,PTK2B,PTK6,PTK7,RARA,RARG,RBP4,RET,RORB,RXRA,SETX,SNW1,SP100,TBX1,TESC,TMEM161A,TWF2,WNT10B,WNT11,WNT2,WNT3,WNT3A,WNT5A,WNT5B,WNT6,WNT8A,WNT8B,WNT9A,WNT9B,ZNF35	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
GO:0032527	GO	BP	protein exit from endoplasmic reticulum	AUP1,DERL1,DERL2,FAF2,HERPUD1,HM13,HSP90B1,NPLOC4,RANGRF,RHBDD1,SEC61B,SEL1L,SYVN1,TMEM129,UFD1L,VCP,VIMP	The directed movement of proteins from the endoplasmic reticulum.
GO:0032530	GO	BP	regulation of microvillus organization	ATP8B1,FSCN1,PLD1,PODXL,RAP1GAP,TWF2	Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a microvillus.
GO:0032534	GO	BP	regulation of microvillus assembly	ATP8B1,FSCN1,PLD1,PODXL,RAP1GAP	A process that modulates the formation of a microvillus.
GO:0032535	GO	BP	regulation of cellular component size	ABI2,ABL1,ACTN2,ACTR2,ACTR3,ADD1,ADD2,AKT1S1,ALOX15,AMOT,ANO6,APOE,AQP1,ARF1,ARF6,ARFGEF1,ARHGAP18,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPIN,BAIAP2L1,BCL11A,BDNF,BRK1,CAV3,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CDKL5,CFL2,CLASP2,CLCN3,CLCN6,CORO1A,CORO1B,CSF3,CTTN,CXCL12,CYFIP1,DCC,DEPTOR,DNM2,DSCAM,EDN1,EPS8,F2RL1,FAM21C,FER,FGF13,GOLGA4,GSN,HAX1,HCK,HCLS1,HP1BP3,IQGAP2,ISLR2,JMY,KANK1,KCNMA1,L1CAM,LAMTOR4,LAMTOR5,LATS1,LIMA1,LIMK1,LRRC16A,LRRC8A,MACF1,MAGEL2,MAPT,MEGF8,MSN,MT3,MTPN,MYADM,NCK1,NCK2,NCKAP1,NCKAP1L,NEB,NRCAM,NRP1,NTN1,OLFM1,P2RX7,PAK3,PDXP,PEX11A,PEX11B,PEX11G,PFN1,PFN2,PICK1,PLEK,PLEKHH2,PRKCD,PRKCE,PRR16,PTEN,PTK2B,PYCARD,RAB11A,RAB22A,RAB3B,RAB5A,RAC1,RAP1GAP2,RARG,RASA1,RDX,RILP,RNF6,RPTOR,RTN4,RTN4R,RUFY3,SCIN,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SH3BGRL3,SHANK3,SHTN1,SLC12A4,SLC9A3R1,SLIT2,SNF8,TENM1,TMEM123,TMSB4Y,TRIM27,TRIOBP,TRPV4,TWF1,TWF2,VASP,VAV1,VAV2,VAV3,VEGFA,VIL1,WASF1,WASH1,WHAMM	A process that modulates the size of a cellular component.
GO:0032543	GO	BP	mitochondrial translation	AARS2,AURKAIP1,CHCHD1,DAP3,DARS2,EARS2,GADD45GIP1,GATB,GATC,GFM1,GFM2,ICT1,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL57,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,MRRF,MTFMT,MTIF2,MTIF3,MTRF1L,NDUFA7,NOA1,PTCD3,QRSL1,TARS2,TSFM,TUFM,YARS2	The chemical reactions and pathways resulting in the formation of a protein in a mitochondrion. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein; the mitochondrion has its own ribosomes and transfer RNAs, and uses a genetic code that differs from the nuclear code.
GO:0032561	GO	MF	guanyl ribonucleotide binding	ADSS,ADSSL1,ANXA6,ARF4,ARF6,ARFIP2,ARHGEF5,ARL1,ARL2,ARL3,ARL4A,ARL8A,ARL8B,ATL1,CDC42,CNGA3,CNGB1,CNGB3,DIRAS1,DIRAS2,DNM2,EEF1A1,EIF2B2,GCH1,GEM,GIMAP7,GLUD1,GLUD2,GNAI1,GNAI3,GNAT1,GNAT2,GNL1,GNL2,GNL3,GTPBP4,HRAS,INSR,LANCL2,LRRK2,LSG1,MIEF1,MX2,NME1,NMUR2,NOA1,NUDT16,PCK1,PDE10A,PDE11A,PDE2A,PDE5A,RAB10,RAB11B,RAB12,RAB13,RAB14,RAB17,RAB18,RAB1B,RAB21,RAB22A,RAB26,RAB27A,RAB27B,RAB28,RAB29,RAB2A,RAB31,RAB32,RAB35,RAB38,RAB39A,RAB3B,RAB4A,RAB5A,RAB5B,RAB5C,RAB6A,RAB7A,RAB8A,RAB8B,RAB9A,RAB9B,RAC1,RAC2,RALA,RALB,RAN,RANBP17,RAP1B,RAP2A,RAP2B,RAP2C,RERG,RHEB,RHEBL1,RHOA,RHOB,RHOH,RRAGA,RRAGB,RRAGC,RRAS,SCG5,SEPHS1,SEPT12,SEPT6,SRP54,THG1L,TMEM173,TPX2,TRIM23	Interacting selectively and non-covalently with a guanyl ribonucleotide, any compound consisting of guanosine esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.
GO:0032570	GO	BP	response to progesterone	CAV1,IRG1,NR1H3,SRC,TGFB1,TGFB2,TGFB3,THBS1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
GO:0032587	GO	CC	ruffle membrane	ABCA7,ADAM17,AIF1,AKT2,APC,ARF4,ARHGEF2,BMX,C2CD5,CDKL5,CLASP2,DDX58,DLC1,EEF1A1,EPS8,EPS8L1,EPS8L2,FAP,FGR,IFIT5,INPP5K,ITGA5,ITGAV,ITGB1,ITGB3,KANK1,MACF1,NME1,PACSIN1,PDXP,PIP5K1A,PLEK,PLEKHA1,PPP1R9B,RPS3,SH3YL1,SNTG1,SPATA13,TIRAP,TPM1,TRPV4,TWF1,WWC1	The portion of the plasma membrane surrounding a ruffle.
GO:0032588	GO	CC	trans-Golgi network membrane	AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP4B1,AP4E1,AP4M1,AP4S1,APP,ARFIP1,ARFIP2,CABP7,CALN1,CD74,CLIP3,CLTA,CLTC,CLVS1,CLVS2,GNAS,GOLPH3L,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,KIF13A,LGR5,LGR6,LLGL1,MARCH1,MMP24,MYO1B,RAB31,SCAMP2,SCAMP5,SLC24A5,STX6,TMEM165,TMEM79	The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network.
GO:0032589	GO	CC	neuron projection membrane	CNTNAP2,EPB41L3,GABRG2,GPER1,GRIA1,LAMP5,ROBO2,SGCE,SHISA9,SPTBN1,UNC5A	The portion of the plasma membrane surrounding a neuron projection.
GO:0032590	GO	CC	dendrite membrane	GABRG2,GPER1,GRIA1,LAMP5,SGCE,SHISA9	The portion of the plasma membrane surrounding a dendrite.
GO:0032592	GO	CC	integral component of mitochondrial membrane	ABCB10,ABCB6,APOO,APOOL,BAK1,BNIP3,CCDC109B,CHCHD3,CHCHD6,COA1,COA3,COX18,CPT1A,DMPK,ETFDH,FIS1,FUNDC1,GDAP1,IMMT,L2HGDH,MCU,MCUR1,MFF,MGARP,MICU1,MUL1,OXA1L,PINK1,RHOT1,RHOT2,SLC8B1,SMDT1,TIMM17A,TIMM17B,TIMM23,TMEM11,TMEM70,TOMM40,UQCC3	The component of the mitochondrial membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
GO:0032593	GO	CC	insulin-responsive compartment	DENND4C,MYO5A,RAB10,RAB13,RAB4B,SLC2A4	A small membrane-bounded vesicle that releases its contents by exocytosis in response to insulin stimulation; the contents are enriched in GLUT4, IRAP and VAMP2.
GO:0032602	GO	BP	chemokine production	CXCR3,F2RL1,FOXP1,IL18,S100A8,S100A9,TNFSF4	The appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0032609	GO	BP	interferon-gamma production	BTN3A1,BTN3A2,F2RL1,IL12B,IL18,LILRB1,TRIM27	The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon.
GO:0032611	GO	BP	interleukin-1 beta production	ABCA1,AIM2,CD36,CMA1,F2RL1,GBP5,NLRC4,TLR4,TLR6	The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0032612	GO	BP	interleukin-1 production	ABCA1,AIM2,CD36,CMA1,F2RL1,GBP5,NLRC4,S100A13,TLR4,TLR6	The appearance of interleukin-1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0032637	GO	BP	interleukin-8 production	CHI3L1,LEP,NOD1,NOS2,PLA2G1B,RAB1A	The appearance of interleukin-8 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
GO:0032642	GO	BP	regulation of chemokine production	ADAM17,ADCYAP1,ADIPOQ,ALOX15B,APOD,AZU1,C1QTNF3,C5,CD74,CHIA,CSF1R,DDX3X,EIF2AK2,ELANE,F2RL1,FFAR2,FFAR3,GSTP1,HIF1A,HMOX1,IL10,IL1B,IL33,IL6,IL6R,KLF4,LGALS9,MAP2K5,MAVS,MEFV,MUL1,PYCARD,SIGIRR,SNAI2,TICAM2,TIRAP,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TWIST1,WNT5A	Any process that modulates the frequency, rate, or extent of chemokine production.
GO:0032645	GO	BP	regulation of granulocyte macrophage colony-stimulating factor production	CD80,CD84,DDX58,IL12B,IL17F,IL18,IL1B,IL23A,IL23R,ISL1,PAEP,RASGRP1,TLR9	Any process that modulates the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.
GO:0032647	GO	BP	regulation of interferon-alpha production	DDX58,HAVCR2,HSPD1,IFIH1,IL10,IRF3,IRF5,IRF7,MAVS,RIPK2,TBK1,TLR3,TLR4,TLR7,TLR8,TLR9,ZC3HAV1	Any process that modulates the frequency, rate, or extent of interferon-alpha production.
GO:0032648	GO	BP	regulation of interferon-beta production	CACTIN,DDX3X,DDX58,FLOT1,IFIH1,IRF1,IRF3,IRF5,IRF7,LILRB1,MAVS,POLR3A,POLR3B,POLR3C,POLR3D,POLR3F,POLR3G,PPM1B,PYCARD,REL,RELB,RIPK2,RNF135,RNF216,TBK1,TIRAP,TLR2,TLR3,TLR4,TLR7,TLR8,TLR9,TRAF3,ZC3HAV1	Any process that modulates the frequency, rate, or extent of interferon-beta production.
GO:0032649	GO	BP	regulation of interferon-gamma production	AXL,C1QBP,CCR2,CCR7,CD14,CD2,CD244,CD274,CD276,CEBPG,EBI3,FADD,FOXP3,FZD5,GAS6,HAVCR2,HLA-A,HLA-DPA1,HLA-DPB1,HLA-DRB1,HMGB1,HSPD1,IFNL1,IL12A,IL12B,IL12RB1,IL12RB2,IL18,IL1B,IL21,IL23A,IL23R,IL27,IL36RN,INHA,INHBA,ISG15,ISL1,LGALS9,LILRB1,NR1H4,PDCD1LG2,PDE4B,PDE4D,PRNP,PTPN22,PYCARD,RARA,RASGRP1,RIPK3,SLAMF6,SLC11A1,TLR3,TLR4,TLR7,TLR8,TLR9,TNFSF4,TXK,XCL1,ZC3H12A,ZFPM1,ZP3	Any process that modulates the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
GO:0032651	GO	BP	regulation of interleukin-1 beta production	AIM2,APOA1,AZU1,CARD8,CCL19,CCL3,CCR7,F2R,FOXP1,GHRL,GHSR,GSTP1,HSPB1,IFI16,ISL1,LGALS9,MEFV,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,PYDC2,TRIM16,WNT5A,ZC3H12A	Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.
GO:0032652	GO	BP	regulation of interleukin-1 production	AIM2,ANXA1,APOA1,AZU1,CALCA,CARD8,CCL19,CCL3,CCR7,F2R,FOXP1,GAS6,GHRL,GHSR,GSTP1,HMGB1,HSPB1,IFI16,IL10,ISL1,LGALS9,MEFV,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,PYDC2,SAA1,TLR4,TRIM16,WNT5A,ZC3H12A	Any process that modulates the frequency, rate, or extent of interleukin-1 production.
GO:0032653	GO	BP	regulation of interleukin-10 production	AGER,CD274,CD34,CD46,DLL1,FOXP3,HLA-DRB1,HMGB1,HSPD1,IL12B,IL23A,IL23R,IRF4,JAK3,LGALS9,LILRB1,NOD2,PDCD1LG2,PIBF1,PRKCZ,PYCARD,TIGIT,TLR4,TLR9,TNFRSF21,TNFSF4,TRIB2,XCL1	Any process that modulates the frequency, rate, or extent of interleukin-10 production.
GO:0032655	GO	BP	regulation of interleukin-12 production	AGER,C1QBP,CCL19,CCR7,CD40LG,CMKLR1,FOXP1,HLA-B,HLA-G,HMGB1,HSPD1,IFNG,IL10,IL12B,IL23A,IL23R,IRAK3,IRF5,ISL1,JAK3,LGALS9,LILRB1,LTB,MAPK11,MAPK14,MAST2,MEFV,PIBF1,PLCB1,RIPK2,SLAMF1,THBS1,TIGIT,TIRAP,TLR2,TLR3,TLR4,TLR9,TNFSF4	Any process that modulates the frequency, rate, or extent of interleukin-12 production.
GO:0032656	GO	BP	regulation of interleukin-13 production	GATA3,HLA-E,IFNA2,IFNL1,IL4,IRF4,LEF1,LGALS9,PAEP,PRKCZ,RARA,TNFRSF21,TNFSF4	Any process that modulates the frequency, rate, or extent of interleukin-13 production.
GO:0032660	GO	BP	regulation of interleukin-17 production	FOXP3,IFNG,IL12A,IL12B,IL15,IL18,IL2,IL21,IL23A,IL23R,IL36RN,LY9,MYD88,NCKAP1L,NOD2,PRKCQ,PRNP,SLAMF6,TGFB1,TLR4,TNFSF4	Any process that modulates the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
GO:0032661	GO	BP	regulation of interleukin-18 production	CD84,IL10,NLRP12,TLR2,TLR9	Any process that modulates the frequency, rate, or extent of interleukin-18 production.
GO:0032663	GO	BP	regulation of interleukin-2 production	ANXA1,CCR2,CD28,CD34,CD4,CD80,CD86,EZR,FOXP3,GBP1,GLMN,HAVCR2,HDAC7,IL17F,IL1A,IL1B,IRF4,KAT5,MALT1,MAP3K7,PDE4B,PDE4D,PRKD2,PRNP,RUNX1,SFTPD,SPTBN1,TNFAIP3,TRAF2,TRAF6,TRIM27,XCL1	Any process that modulates the frequency, rate, or extent of interleukin-2 production.
GO:0032667	GO	BP	regulation of interleukin-23 production	CSF2,IFNG,IL17A,IL17RA,MYD88,RAC1,TLR4	Any process that modulates the frequency, rate, or extent of interleukin-23 production.
GO:0032673	GO	BP	regulation of interleukin-4 production	CD86,CEBPB,FOXP3,GATA3,HAVCR2,HLA-DRB1,HLA-E,IRF4,LEF1,LGALS9,NLRP3,PRKCQ,PRKCZ,RARA,TNFSF4,ZFPM1,ZP3	Any process that modulates the frequency, rate, or extent of interleukin-4 production.
GO:0032674	GO	BP	regulation of interleukin-5 production	GATA3,IFNA2,IFNL1,IL9,LEF1,PDE4D,PRKCZ,RARA,TNFRSF21	Any process that modulates the frequency, rate, or extent of interleukin-5 production.
GO:0032675	GO	BP	regulation of interleukin-6 production	AFAP1L2,ARHGEF2,ARRB1,BPI,C1QTNF3,C5AR2,CYBA,DDX58,EREG,F2R,F2RL1,FOXJ1,GAS6,GBA,GHRL,GHSR,HLA-B,HMGB1,HSPD1,HYAL2,IL10,IL17F,IL1B,IL6,IL6R,IRAK3,ISL1,LBP,LGALS9,LILRB2,MAPK13,MAPKAPK2,MYD88,NCKAP1L,NLRC3,NLRP10,NLRP12,NOD2,ORM1,PAEP,PTPN22,PYCARD,RAB7B,SLAMF1,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR6,TLR9,TNF,TNFAIP3,TNFSF4,TWIST1,VIMP,WNT5A,XBP1,ZC3H12A	Any process that modulates the frequency, rate, or extent of interleukin-6 production.
GO:0032677	GO	BP	regulation of interleukin-8 production	ADIPOQ,AFAP1L2,ANXA1,ANXA4,APOA2,ARRB1,BCL10,BCL3,BPI,C5AR2,CACTIN,CALCA,CAMP,CD2,CD244,CD58,CRP,DDIT3,DDX58,ELANE,F2R,F2RL1,FADD,FCN1,FFAR2,GDF2,HSPA1A,HSPA1B,HYAL2,IL10,IL17F,IL1B,IL6R,KLF4,LBP,LGALS9,MAP2K5,MAVS,NLRP10,NOD2,OTUD7B,PARK7,PRG3,PRKD2,PTPN22,PYCARD,RIPK1,SERPINE1,SSC5D,TIRAP,TLR2,TLR3,TLR4,TLR5,TLR7,TLR8,TLR9,TNF,ZNF580	Any process that modulates the frequency, rate, or extent of interleukin-8 production.
GO:0032680	GO	BP	regulation of tumor necrosis factor production	ADIPOQ,ARFGEF2,ARHGEF2,AZU1,BPI,C5AR2,CACTIN,CCL19,CCL3,CCR2,CD14,CD2,CD34,CHRNA7,CIDEA,CLU,CYBA,FADD,FOXP1,GAS6,GHRL,GHSR,GSTP1,HAVCR2,HLA-E,HSPB1,IL10,IL12B,IL23A,IRAK3,ISL1,JAK2,LBP,LGALS9,LILRB1,LTF,LY96,MAPKAPK2,MAVS,MC1R,NFKBIL1,NLRC3,NOD2,NR1H4,ORM1,PF4,POMC,PTPN22,PYCARD,RARA,RASGRP1,RIPK1,SLAMF1,SPN,THBS1,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR9,TNFAIP3,TNFRSF8,TRIM27,TWIST1,VIMP,ZC3H12A,ZFP36	Any process that modulates the frequency, rate, or extent of tumor necrosis factor production.
GO:0032682	GO	BP	negative regulation of chemokine production	APOD,C1QTNF3,ELANE,F2RL1,GSTP1,IL10,IL6,KLF4,LGALS9,MAP2K5,MEFV,MUL1,SIGIRR,TICAM2	Any process that stops, prevents, or reduces the frequency, rate, or extent of chemokine production.
GO:0032688	GO	BP	negative regulation of interferon-beta production	CACTIN,LILRB1,PPM1B,PYCARD,REL,RELB	Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-beta production.
GO:0032689	GO	BP	negative regulation of interferon-gamma production	AXL,C1QBP,CD274,FOXP3,GAS6,HAVCR2,HLA-DRB1,HMGB1,IL36RN,INHA,INHBA,LGALS9,LILRB1,NR1H4,PDCD1LG2,PRNP,RARA,TLR4,TNFSF4,XCL1,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
GO:0032691	GO	BP	negative regulation of interleukin-1 beta production	APOA1,GHRL,GHSR,GSTP1,MEFV,NLRP3,PYDC2,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.
GO:0032692	GO	BP	negative regulation of interleukin-1 production	APOA1,GAS6,GHRL,GHSR,GSTP1,IL10,MEFV,NLRP12,NLRP3,PYDC2,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 production.
GO:0032693	GO	BP	negative regulation of interleukin-10 production	AGER,CD274,DLL1,FOXP3,IL12B,IL23A,IL23R,JAK3,LILRB1,PDCD1LG2,TNFRSF21,TRIB2	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production.
GO:0032695	GO	BP	negative regulation of interleukin-12 production	C1QBP,CMKLR1,IL10,IRAK3,JAK3,LILRB1,MEFV,PIBF1,SLAMF1,THBS1,TIGIT	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.
GO:0032700	GO	BP	negative regulation of interleukin-17 production	FOXP3,IFNG,IL12A,IL12B,IL36RN,NCKAP1L,PRNP,TLR4,TNFSF4	Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
GO:0032703	GO	BP	negative regulation of interleukin-2 production	CD34,EZR,FOXP3,GBP1,HAVCR2,HDAC7,KAT5,PRNP,SFTPD,TNFAIP3,TRIM27,XCL1	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-2 production.
GO:0032715	GO	BP	negative regulation of interleukin-6 production	ARRB1,BPI,C1QTNF3,C5AR2,FOXJ1,GAS6,GBA,GHRL,GHSR,IL10,IRAK3,NCKAP1L,NLRC3,NLRP12,ORM1,PTPN22,SLAMF1,TLR4,TLR9,TNF,TNFAIP3,VIMP,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
GO:0032717	GO	BP	negative regulation of interleukin-8 production	ANXA1,ANXA4,ARRB1,BCL3,BPI,CACTIN,ELANE,IL10,IL6R,KLF4,MAP2K5,OTUD7B,PTPN22,SSC5D,TLR9	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production.
GO:0032720	GO	BP	negative regulation of tumor necrosis factor production	ADIPOQ,BPI,C5AR2,CACTIN,CD34,CHRNA7,CIDEA,GAS6,GHRL,GHSR,GSTP1,HAVCR2,IL10,IRAK3,LBP,LGALS9,LILRB1,MC1R,NFKBIL1,NLRC3,NR1H4,ORM1,POMC,PTPN22,RARA,SLAMF1,TLR4,TNFAIP3,TRIM27,VIMP,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
GO:0032722	GO	BP	positive regulation of chemokine production	ADAM17,ADCYAP1,ADIPOQ,ALOX15B,AZU1,C5,CD74,CHIA,CSF1R,DDX3X,EIF2AK2,FFAR2,FFAR3,HIF1A,HMOX1,IL1B,IL33,IL6,IL6R,LGALS9,MAVS,PYCARD,TICAM2,TIRAP,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TWIST1,WNT5A	Any process that activates or increases the frequency, rate, or extent of chemokine production.
GO:0032725	GO	BP	positive regulation of granulocyte macrophage colony-stimulating factor production	CD80,DDX58,IL12B,IL18,IL1B,IL23A,IL23R,ISL1,PAEP,RASGRP1,TLR9	Any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.
GO:0032727	GO	BP	positive regulation of interferon-alpha production	DDX58,HSPD1,IFIH1,IRF3,IRF5,IRF7,MAVS,RIPK2,TBK1,TLR3,TLR4,TLR7,TLR8,TLR9,ZC3HAV1	Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.
GO:0032728	GO	BP	positive regulation of interferon-beta production	DDX3X,DDX58,FLOT1,IFIH1,IRF1,IRF3,IRF5,IRF7,MAVS,POLR3A,POLR3B,POLR3C,POLR3D,POLR3F,POLR3G,RIPK2,RNF135,TBK1,TLR2,TLR3,TLR4,TLR7,TLR8,TLR9,ZC3HAV1	Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
GO:0032729	GO	BP	positive regulation of interferon-gamma production	CCR2,CD14,CD2,CD244,CD276,CEBPG,EBI3,FADD,FZD5,HLA-A,HLA-DPA1,HLA-DPB1,HSPD1,IFNL1,IL12A,IL12B,IL12RB1,IL12RB2,IL18,IL1B,IL21,IL23A,IL23R,IL27,ISL1,LGALS9,PDE4B,PDE4D,PTPN22,PYCARD,RASGRP1,SLAMF6,SLC11A1,TLR3,TLR4,TLR7,TLR8,TLR9,TNFSF4,TXK,ZFPM1,ZP3	Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
GO:0032731	GO	BP	positive regulation of interleukin-1 beta production	AIM2,AZU1,CARD8,CCL19,CCL3,HSPB1,IFI16,ISL1,LGALS9,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,TRIM16,WNT5A	Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production.
GO:0032732	GO	BP	positive regulation of interleukin-1 production	AIM2,AZU1,CALCA,CARD8,CCL19,CCL3,HMGB1,HSPB1,IFI16,ISL1,LGALS9,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,SAA1,TLR4,TRIM16,WNT5A	Any process that activates or increases the frequency, rate, or extent of interleukin-1 production.
GO:0032733	GO	BP	positive regulation of interleukin-10 production	CD274,CD34,CD46,HMGB1,HSPD1,IL12B,IL23A,IRF4,LGALS9,NOD2,PIBF1,PRKCZ,PYCARD,TIGIT,TLR4,TLR9,TNFSF4,XCL1	Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.
GO:0032735	GO	BP	positive regulation of interleukin-12 production	AGER,CCL19,CCR7,CD40LG,HLA-G,HMGB1,HSPD1,IFNG,IL12B,IL23A,IL23R,IRF5,ISL1,LGALS9,LTB,MAPK11,MAPK14,PLCB1,RIPK2,TIRAP,TLR2,TLR3,TLR4,TLR9,TNFSF4	Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
GO:0032736	GO	BP	positive regulation of interleukin-13 production	GATA3,HLA-E,IL4,IRF4,LGALS9,PAEP,PRKCZ,RARA,TNFSF4	Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
GO:0032740	GO	BP	positive regulation of interleukin-17 production	IL12B,IL15,IL18,IL2,IL21,IL23A,IL23R,LY9,MYD88,NOD2,PRKCQ,SLAMF6,TGFB1	Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
GO:0032743	GO	BP	positive regulation of interleukin-2 production	ANXA1,CCR2,CD28,CD4,CD80,CD86,GLMN,IL1A,IL1B,IRF4,MALT1,MAP3K7,PDE4B,PDE4D,PRKD2,RUNX1,SPTBN1,TRAF2,TRAF6	Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.
GO:0032747	GO	BP	positive regulation of interleukin-23 production	CSF2,IFNG,IL17A,IL17RA,MYD88	Any process that activates or increases the frequency, rate, or extent of interleukin-23 production.
GO:0032753	GO	BP	positive regulation of interleukin-4 production	CD86,CEBPB,GATA3,HAVCR2,HLA-E,IRF4,LGALS9,NLRP3,PRKCQ,PRKCZ,RARA,TNFSF4,ZP3	Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
GO:0032754	GO	BP	positive regulation of interleukin-5 production	GATA3,IL9,PDE4D,PRKCZ,RARA	Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.
GO:0032755	GO	BP	positive regulation of interleukin-6 production	ARHGEF2,CYBA,DDX58,EREG,F2R,F2RL1,HMGB1,HSPD1,HYAL2,IL1B,IL6,IL6R,ISL1,LBP,LGALS9,LILRB2,MAPK13,MYD88,NLRP10,NOD2,PAEP,PYCARD,RAB7B,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR6,TLR9,TNFSF4,TWIST1,WNT5A,XBP1	Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
GO:0032757	GO	BP	positive regulation of interleukin-8 production	ADIPOQ,AFAP1L2,APOA2,BCL10,CALCA,CAMP,CD2,CD244,CD58,DDIT3,DDX58,ELANE,F2R,F2RL1,FADD,FCN1,FFAR2,GDF2,HSPA1A,HSPA1B,HYAL2,IL1B,LBP,LGALS9,MAVS,NLRP10,NOD2,PARK7,PRG3,PRKD2,PYCARD,RIPK1,SERPINE1,TIRAP,TLR2,TLR3,TLR4,TLR5,TLR7,TLR8,TLR9,TNF,ZNF580	Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
GO:0032760	GO	BP	positive regulation of tumor necrosis factor production	ARFGEF2,ARHGEF2,AZU1,CCL19,CCL3,CCR2,CD14,CD2,CLU,CYBA,FADD,HAVCR2,HLA-E,HSPB1,IL12B,IL23A,ISL1,JAK2,LBP,LGALS9,LY96,MAVS,NOD2,PF4,PYCARD,RASGRP1,RIPK1,SPN,THBS1,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR9,TNFRSF8,TWIST1	Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
GO:0032768	GO	BP	regulation of monooxygenase activity	AGTR2,AKT1,APOE,ATP2B4,CALM1,CAV1,CAV3,CDH3,CYGB,CYP27B1,DDAH1,DDAH2,DHFR,DNM2,EGFR,ENG,ESR1,FCER2,GCH1,GCHFR,GDNF,GFI1,GLA,HIF1A,HSP90AA1,HTR2B,IFNG,IL1B,INS,LEP,LYPLA1,NFKB1,NOS1AP,NOS3,NOSIP,NOSTRIN,NPR3,PARK7,POR,PRKG2,PTS,SCARB1,SNCA,SPR,TERF2,TERT,TNF,VDR,WASL,ZDHHC21	Any process that modulates the activity of a monooxygenase.
GO:0032769	GO	BP	negative regulation of monooxygenase activity	ATP2B4,CAV3,CYP27B1,ENG,GFI1,GLA,NFKB1,NOSIP,SNCA	Any process that stops or reduces the activity of a monooxygenase.
GO:0032770	GO	BP	positive regulation of monooxygenase activity	AGTR2,AKT1,APOE,CDH3,DHFR,ESR1,FCER2,GCH1,GDNF,HIF1A,HTR2B,IFNG,IL1B,INS,NOS1AP,NPR3,PARK7,POR,SCARB1,TERF2,TERT,TNF	Any process that activates or increases the activity of a monooxygenase.
GO:0032776	GO	BP	DNA methylation on cytosine	DNMT1,DNMT3A,DNMT3B,DNMT3L,H3F3A,HIST1H3A,HIST1H4A,HIST2H3A,TRDMT1,UHRF1	The covalent transfer of a methyl group to C-5 or N-4 of cytosine in a DNA molecule.
GO:0032780	GO	BP	negative regulation of ATPase activity	ABCA7,ATPIF1,LTF,OXA1L,PAM16,PLN,PPIF,PXK,TLR9,TNNI3,TNNT2	Any process that stops or reduces the rate of ATP hydrolysis by an ATPase.
GO:0032781	GO	BP	positive regulation of ATPase activity	ABCA7,AHSA1,ALDOB,ATP1B1,ATP1B2,ATP1B3,CHTOP,DNAJB1,DNAJB11,DNAJB6,DNAJC1,DNAJC10,DNAJC24,DNAJC9,FGF10,GABARAPL2,MYBPC3,MYL3,MYL4,PFN1,PFN2,PLSCR1,RGN,RYR2,SETMAR,TNNT2,TOR1AIP1,TOR1AIP2,TPM1,UHRF1	Any process that activates or increases the rate of ATP hydrolysis by an ATPase.
GO:0032784	GO	BP	regulation of DNA-templated transcription, elongation	ALYREF,BRD4,CCAR2,CDC73,CTR9,DDX39B,EAPP,ELL,ELL3,ERCC6,HMGN1,HTATSF1,LDB1,LEO1,PAF1,RECQL5,RNF168,RNF8,RTF1,SUPT16H,SUPT4H1,SUPT5H,SUPT6H,TCEA2,TCEB3B,THOC1,THOC5,TSFM,WDR61,ZMYND11,ZNF326	Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
GO:0032785	GO	BP	negative regulation of DNA-templated transcription, elongation	EAPP,RECQL5,RNF168,RNF8,SUPT4H1,SUPT5H	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
GO:0032786	GO	BP	positive regulation of DNA-templated transcription, elongation	ALYREF,BRD4,CDC73,CTR9,DDX39B,EAPP,ELL,ELL3,ERCC6,HMGN1,LEO1,PAF1,RTF1,SUPT16H,SUPT4H1,SUPT5H,SUPT6H,THOC1,THOC5,WDR61	Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
GO:0032790	GO	BP	ribosome disassembly	DENR,EIF2D,GFM2,MCTS1,MRRF,MTIF2,MTIF3	The disaggregation of a ribosome into its constituent components; includes the dissociation of ribosomal subunits.
GO:0032792	GO	BP	negative regulation of CREB transcription factor activity	ADGRG3,DDIT3,EIF2AK4,FOXP3,SIK1	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor CREB.
GO:0032793	GO	BP	positive regulation of CREB transcription factor activity	CAMK1D,CRTC1,CRTC2,EPHA5,LRP8,OPRD1,PRKD1,PRKD2,RELN,RPS6KA4,RPS6KA5,TSSK4,VEGFA	Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
GO:0032797	GO	CC	SMN complex	DDX20,GEMIN2,GEMIN4,GEMIN5,GEMIN6,GEMIN7,GEMIN8,IGHMBP2,SMN1,STRAP,ZPR1	A protein complex that contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and Unrip proteins; the complex is found in the cytoplasm and in nuclear Gems, and is involved in spliceosomal snRNP assembly in the cytoplasm and in pre-mRNA splicing in the nucleus.
GO:0032801	GO	BP	receptor catabolic process	BECN1,BECN2,GPRASP1,KIF16B,LGMN,NEDD4,PCSK9,PIK3R4,RNF43,SH3GLB1,SMURF1,SNX25,TGFB1,UVRAG,ZNRF3	The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
GO:0032806	GO	CC	carboxy-terminal domain protein kinase complex	CCNH,CCNT1,CDK7,CDK9,ERCC2,ERCC3,ERCC5,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HOXC10,HSPD1,KDM5A,MMS19,MNAT1,PUF60,SNW1,TAF7	A protein complex that phosphorylates amino acid residues of RNA polymerase II C-terminal domain repeats; phosphorylation occurs mainly on Ser2 and Ser5.
GO:0032809	GO	CC	neuronal cell body membrane	AMIGO1,DAB2IP,FLRT1,KCNA2,KCNB1,KCNB2,KCNC1,KCNC2,KCND2,KCNE3,RGS8,UNC5A	The plasma membrane of a neuron cell body - excludes the plasma membrane of cell projections such as axons and dendrites.
GO:0032813	GO	MF	tumor necrosis factor receptor superfamily binding	BID,BRE,CASP8AP2,FEM1B,MADD,MYD88,PIDD1,TMBIM1,TNF,TNFSF11,TNFSF18,TNFSF4,TRAF2,TRAP1	Interacting selectively and non-covalently with any member of the tumor necrosis factor receptor superfamily.
GO:0032814	GO	BP	regulation of natural killer cell activation	AP1G1,AXL,GAS6,IL12A,IL12B,IL18,IL23A,IL23R,LAMP1,LEP,MICA,PIBF1,PTPN22,ZBTB1	Any process that modulates the frequency, rate or extent of natural killer cell activation.
GO:0032816	GO	BP	positive regulation of natural killer cell activation	AP1G1,AXL,GAS6,IL12A,IL12B,IL18,IL23A,IL23R,LAMP1,ZBTB1	Any process that activates or increases the frequency, rate or extent of natural killer cell activation.
GO:0032817	GO	BP	regulation of natural killer cell proliferation	IL12B,IL18,IL23A,IL23R,LEP,PTPN22	Any process that modulates the frequency, rate or extent of natural killer cell proliferation.
GO:0032835	GO	BP	glomerulus development	ANGPT1,ANGPT2,BASP1,BMP4,CD24,COL4A3,COL4A4,EGR1,ENPEP,IQGAP1,JAG1,KLF15,MAGI2,MEF2C,MPV17,MTSS1,MYO1E,OSR1,PDGFB,PDGFRA,PDGFRB,PLCE1,PODXL,PROM1,PTPRO,SULF1,SULF2,TCF21,WT1	The progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft which forms a close network with the visceral epithelium (podocytes) and the mesangium to form the filtration barrier and is surrounded by Bowman's capsule in nephrons of the vertebrate kidney. The glomerulus is part of the nephron and is restricted to one body segment.
GO:0032836	GO	BP	glomerular basement membrane development	COL4A3,COL4A4,MPV17,MYO1E,SULF1,SULF2,WT1	The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.
GO:0032838	GO	CC	cell projection cytoplasm	AMBRA1,ARFGEF2,ARL6,ARMC4,ATG14,ATG16L1,ATG5,ATG7,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CCSAP,CDKL5,CEP162,CFAP221,CFAP46,CFAP54,CFAP74,DCDC2,DLG4,DNAAF1,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAH9,DNAI1,DNAI2,DNALI1,DRC1,DYNC2LI1,EFHC1,GABARAP,GRIK3,IFT140,INPP5E,LRRK2,MAP1LC3B,NME8,PIK3C3,PIK3R4,RP1L1,RPGRIP1L,RSPH4A,RSPH9,SAXO1,SEPT7,SOD1,SPAG16,SPAG6,SPATA7,SPEF1,TTLL3,TTLL8,UHMK1,WDPCP,WDR34,WDR35	All of the contents of a cell projection, excluding the plasma membrane surrounding the projection.
GO:0032839	GO	CC	dendrite cytoplasm	CDKL5,DLG4,GRIK3,LRRK2,SOD1,UHMK1	All of the contents of a dendrite, excluding the surrounding plasma membrane.
GO:0032845	GO	BP	negative regulation of homeostatic process	ACD,ADRA2A,ATM,BBC3,BCL10,BCL2,CALCA,CALM1,CARTPT,CASQ2,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,CLIC2,DRD2,EPO,ERCC1,ERCC4,ERO1A,F2R,FADD,FGF2,FKBP1B,FLCN,GAS2L1,GNL3L,GSTM2,GSTO1,HNRNPA1,HNRNPC,HNRNPU,HOXA5,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,LCK,LDB1,MAFB,MCRS1,NAT10,NBN,NOL3,NOS1,P2RX7,PARP1,PIM3,PINX1,PKD2,PLCG2,PML,PTPRC,RAD50,RTEL1,RYR1,RYR2,SMG6,SPX,SRC,SRI,TERF1,TERF2,TERF2IP,TINF2,TNFAIP3,TNKS,TNKS2,TRDN,XCL1,XRCC5	Any process that stops, prevents, or reduces the frequency, rate, or extent of a homeostatic process.
GO:0032846	GO	BP	positive regulation of homeostatic process	ACD,ACOX1,ACVR1B,ACVR2A,ADAM8,AKAP6,ANKRD54,ANO1,ARNT,ASPH,ATM,ATP6AP1,ATR,ATRX,AURKB,CALM1,CAPN3,CASQ2,CAV1,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CEMIP,CFTR,CLIC2,CXCL10,CXCL11,CXCL9,CXCR3,DCSTAMP,DHX36,DRD1,ERCC1,ETS1,F2,F2R,F2RL3,FKBP1B,FOXO3,GATA1,GPER1,GPLD1,GSTM2,GSTO1,HAP1,HCAR2,HIF1A,HLA-DRB1,HMBOX1,HMGB2,HNF4A,HNRNPA1,HTT,IL1B,INHBA,INPP5K,JPH2,KNG1,LACRT,LGALS9,MAP2K7,MAP3K4,MAPK1,MAPK14,MAPK15,MAPK3,MAPKAPK5,MC4R,MED1,METRNL,MRE11A,NABP2,NBN,NCKAP1L,NEK2,NEK7,NPC1,NPPB,NPR1,NPSR1,NR1H3,OBFC1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PDPK1,PIH1D1,PKD2,PKIB,PLA2G1B,PLCG1,PNKP,POT1,PPARGC1A,PPP3CB,PRKCQ,PRMT1,PTGER3,PTGS2,RAD50,RFX6,RTEL1,RYR2,SLC22A5,SLC30A2,SLX1A,SLX4,SMARCA4,SMARCB1,SNCA,SRI,STX4,SYK,TAL1,TCP1,TERF2,THY1,TINF2,TMEM27,TNF,TNFRSF11A,TNFSF11,TNKS,TNKS2,TRDN,TRPC1,TRPC3,WRAP53,XCL1,ZNF16	Any process that activates or increases the frequency, rate, or extent of a homeostatic process.
GO:0032872	GO	BP	regulation of stress-activated MAPK cascade	AIDA,AMBP,ARHGEF5,ARL6IP5,AXIN1,BIRC7,BMP2,CARD9,CCL19,CCL21,CCR7,CD27,COPS5,CTGF,DAB2IP,DACT1,DAXX,DBNL,DLG1,DNAJA1,DUSP19,DUSP3,DVL2,DVL3,EDA2R,EDN1,EIF2AK2,EPHB1,ERN1,EZR,F2RL1,FGF19,FKTN,FLT4,FOXM1,FOXO1,FZD10,FZD7,GADD45A,GADD45B,GADD45G,GPS2,GSTP1,HACD3,HDAC3,HIPK2,HIPK3,HMGB1,HRAS,IGBP1,IGF1R,IL26,ITCH,LEP,LTBR,MAP2K1,MAP2K2,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K4,MAP4K5,MAPK1,MAPK3,MAPK8IP1,MAPK8IP2,MAPK8IP3,MARVELD3,MDFIC,MECOM,MEN1,MID1,MINK1,MUL1,MYC,NBR1,NCOR1,NOD2,PAK1,PARK2,PDCD10,PDCD4,PER1,PHLPP1,PINK1,PKN1,PLCB1,PPEF2,PRMT1,PTK2B,PTPN22,PYCARD,RAP2A,RASGRP1,RASSF2,RIPK1,RPS3,SASH1,SDCBP,SEMA4C,SERPINB3,SERPINF2,SLAMF1,STK25,TAOK1,TAOK2,TAOK3,TGFB2,TIRAP,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TPD52L1,TRAF2,TRAF4,TRAF6,ULK4,UNC5CL,VEGFA,WNT16,WNT5A,XDH,ZMYND11,ZNF622,ZNF675	Any process that modulates the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
GO:0032873	GO	BP	negative regulation of stress-activated MAPK cascade	AIDA,AMBP,DACT1,DLG1,DNAJA1,DUSP19,DUSP3,EZR,F2RL1,FKTN,FOXM1,FOXO1,GPS2,GSTP1,HDAC3,HIPK3,IGBP1,ITCH,MARVELD3,MECOM,MEN1,MYC,NCOR1,PARK2,PDCD4,PER1,PINK1,PTPN22,SERPINB3,TAOK3,ZMYND11,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
GO:0032874	GO	BP	positive regulation of stress-activated MAPK cascade	ARHGEF5,ARL6IP5,AXIN1,BIRC7,BMP2,CARD9,CCL19,CCL21,CCR7,CD27,CTGF,DAB2IP,DAXX,DBNL,DUSP19,DVL2,DVL3,EDA2R,EDN1,EIF2AK2,ERN1,F2RL1,FGF19,FLT4,FZD10,FZD7,GADD45A,GADD45B,GADD45G,HACD3,HIPK2,HMGB1,HRAS,IL26,LEP,LTBR,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MDFIC,MID1,MINK1,MUL1,NOD2,PAK1,PDCD10,PKN1,PLCB1,PRMT1,PTK2B,PYCARD,RASGRP1,RASSF2,RIPK1,RPS3,SASH1,SDCBP,SEMA4C,SERPINF2,SLAMF1,STK25,TAOK1,TAOK2,TAOK3,TGFB2,TIRAP,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TPD52L1,TRAF2,TRAF4,TRAF6,UNC5CL,VEGFA,WNT16,WNT5A,XDH,ZNF622	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
GO:0032875	GO	BP	regulation of DNA endoreduplication	E2F7,E2F8,FBXW7,MRE11A,SMC1A,SMC3,STAG2	Any process that modulates the frequency, rate or extent of DNA endoreduplication.
GO:0032876	GO	BP	negative regulation of DNA endoreduplication	FBXW7,MRE11A,SMC1A,SMC3,STAG2	Any process that stops, prevents, or reduces the frequency, rate or extent of DNA endoreduplication.
GO:0032878	GO	BP	regulation of establishment or maintenance of cell polarity	ARFGEF1,BCAS3,CDH5,FLOT2,GNB2L1,GSN,KANK1,KIF20B,KRIT1,LLGL2,PTK2B,RAP1B,ROCK1,ROCK2,RUFY3,SHTN1,TEK	Any process that modulates the frequency, rate or extent of the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.
GO:0032881	GO	BP	regulation of polysaccharide metabolic process	AKT1,AKT2,AP2A1,CLTC,DYRK2,EGF,ENPP1,GCGR,GCK,GRB10,GSK3A,GSK3B,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,NFKB1,PASK,PDGFB,PHKG2,PPP1R3B,PPP1R3F,PTH,SORBS1,TGFB1,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving polysaccharides.
GO:0032885	GO	BP	regulation of polysaccharide biosynthetic process	AKT1,AKT2,AP2A1,CLTC,DYRK2,EGF,ENPP1,GCK,GRB10,GSK3A,GSK3B,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,NFKB1,PASK,PDGFB,PPP1R3F,PTH,SORBS1,TGFB1,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides.
GO:0032886	GO	BP	regulation of microtubule-based process	ABL1,APC,ARHGEF2,ARL2,ARMC4,ATF5,AURKA,AURKB,BBS2,BBS4,BECN1,BORA,BRCA1,CAMSAP3,CAV3,CCDC39,CCDC40,CCNB1,CCNF,CCSAP,CDC42,CDK5RAP2,CENPJ,CEP131,CEP250,CEP76,CEP85,CFAP20,CHEK1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CHMP5,CIB1,CLASP1,CLASP2,CLIP1,CLIP3,CTNNB1,CYLD,DIAPH1,DNAAF1,DNAH11,ECT2,EFNA5,EML2,EPHA3,ERBB2,FES,FGF13,FKBP4,GAS2L1,GAS2L2,GEN1,GSK3B,HAP1,HDAC6,IGBP1,KATNB1,KIF11,KLHL42,KNSTRN,LAMP1,MACF1,MAP10,MAPRE1,MAPT,MDM1,MEMO1,MID1IP1,MKKS,NEFH,NEK2,NPM1,PARP3,PDCD6IP,PHLDB1,PHLDB2,PKHD1,PLK1,PLK2,PLK4,PSRC1,RAB6C,RACGAP1,RBM14,RCC2,RNF4,RPS3,SBDS,SENP6,SIRT2,SKA1,SKA2,SKA3,SLAIN2,SNCA,SPAG5,SPICE1,STMN2,TBCD,TERF1,TMEM67,TPR,TPX2,TRAF3IP1,TRIM37,TRIM54,TRPV4,VPS4B,XRCC3	Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.
GO:0032890	GO	BP	regulation of organic acid transport	ACSL4,AKT1,AKT2,ATP1A2,CYP4A11,CYP4F2,GRM7,IL1B,IRS2,NCOR1,P2RX4,PER2,PLA2G10,PLA2R1,RAB3GAP1,SYK,THBS1,TNFRSF11A,TNFSF11	Any process that modulates the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032891	GO	BP	negative regulation of organic acid transport	ACSL4,AKT1,AKT2,CYP4F2,GRM7,IRS2,PLA2R1,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032892	GO	BP	positive regulation of organic acid transport	CYP4A11,CYP4F2,IL1B,P2RX4,PLA2G10,PLA2R1,RAB3GAP1,TNFRSF11A,TNFSF11	Any process that activates or increases the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0032897	GO	BP	negative regulation of viral transcription	CCL3,CCL4,CCL5,HDAC1,HMGA2,IFITM3,INPP5K,JUN,MID2,POU2F3,REST,SP100,TARDBP,TFAP4,TRIM11,TRIM13,TRIM14,TRIM21,TRIM27,TRIM31,TRIM32,TRIM62,ZNF639	Any process that stops, prevents, or reduces the frequency, rate or extent of viral transcription.
GO:0032909	GO	BP	regulation of transforming growth factor beta2 production	CDH3,GATA6,HIF1A,SMAD3,SMAD4,TGFB2	Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
GO:0032922	GO	BP	circadian regulation of gene expression	AHR,ARNTL,ATF4,BHLHE40,CARTPT,CIART,CLOCK,CRY1,CRY2,CSNK1D,CSNK1E,DRD2,DRD3,GFPT1,HDAC1,HDAC2,HNRNPU,ID2,KDM5A,KMT2A,LGR4,MAGED1,MC3R,MTA1,MYBBP1A,NAMPT,NCOA2,NGFR,NOCT,NPAS2,NR1D1,NRIP1,OGT,PER1,PER2,PML,PPARA,PPARGC1A,PPP1CA,PPP1CB,PPP1CC,PRKCDBP,PRMT5,RAI1,RBM4B,RELB,RORA,RORC,SIRT1,TOP1,USP2,ZFHX3	Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours.
GO:0032924	GO	BP	activin receptor signaling pathway	ACVR1,ACVR1B,ACVR1C,ACVR2A,ACVR2B,ACVRL1,BMP10,BMPR2,CFC1,CITED2,FOXH1,GDF2,GDF6,GDF7,HFE2,INHBA,INHBB,SMAD2,SMAD3,TGFBR1	A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0032925	GO	BP	regulation of activin receptor signaling pathway	ACVR1,ACVR1B,ACVR2A,ACVR2B,CER1,CSNK2B,DACT2,DAND5,FKBP1A,FST,FSTL3,LEMD3,MAGI2,NODAL,SHH,SKI,SMAD2,SMAD7	Any process that modulates the frequency, rate or extent of the activity of any activin receptor signaling pathway.
GO:0032926	GO	BP	negative regulation of activin receptor signaling pathway	ACVR1,CER1,DACT2,DAND5,FST,FSTL3,LEMD3,MAGI2,SKI	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
GO:0032927	GO	BP	positive regulation of activin receptor signaling pathway	ACVR1B,ACVR2A,ACVR2B,CSNK2B,NODAL,SMAD2	Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.
GO:0032928	GO	BP	regulation of superoxide anion generation	AATF,CRP,F2RL1,GSTP1,PRKCD,SOD1,SYK,TGFB1	Any process that modulates the frequency, rate or extent of enzymatic generation of superoxide by a cell.
GO:0032930	GO	BP	positive regulation of superoxide anion generation	CRP,F2RL1,GSTP1,PRKCD,SOD1,TGFB1	Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
GO:0032933	GO	BP	SREBP signaling pathway	ARHGEF10L,ERLIN1,ERLIN2,INSIG1,INSIG2,SCAP	A series of molecular signals from the endoplasmic reticulum to the nucleus generated as a consequence of decreased levels of one or more sterols (and in some yeast, changes in oxygen levels) and which proceeds through activation of a sterol response element binding transcription factor (SREBP) to result in up-regulation of target gene transcription.
GO:0032934	GO	MF	sterol binding	ABCA1,ABCG1,ANXA6,APOA1,APOA2,APOC3,APOD,APOF,CAV1,CETP,ERLIN1,GPR183,NPC1,NPC2,NR1H3,OSBP,OSBP2,OSBPL10,OSBPL1A,OSBPL2,OSBPL3,OSBPL5,OSBPL7,OSBPL8,PMP2,PROM2,PTCH1,RORA,RORC,SCP2,SOAT1,SOAT2,STARD3,SYP,TSPO,TSPO2	Interacting selectively and non-covalently with a sterol, any steroid containing a hydroxy group in the 3 position, closely related to cholestan-3-ol.
GO:0032941	GO	BP	secretion by tissue	AGR2,APLN,CEL,COPA,CSN2,CSN3,ERBB4,FGF10,FOXB1,GPAT4,LACRT,OXTR,PRLR,SCT,STATH,VAMP8,VEGFA	The controlled release of a substance by a tissue.
GO:0032943	GO	BP	mononuclear cell proliferation	ACE,BCL2,BTN3A1,CD40,CD40LG,CD79A,CR2,CTPS1,DOCK8,ELF4,FLT3,HELLS,HSPD1,IFNB1,IL10,LILRB1,MEF2C,MS4A1,PIK3CG,PPP3CB,PTPRC,SLC11A1,TNFRSF4,TNFSF14,TNFSF18	The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.
GO:0032944	GO	BP	regulation of mononuclear cell proliferation	AGER,AHR,AIF1,ANXA1,ATM,BCL2,BMP4,BTN2A2,CCL19,CCL5,CCR2,CD1D,CD209,CD24,CD274,CD276,CD28,CD300A,CD38,CD3E,CD46,CD55,CD6,CD74,CD81,CDKN2A,CEBPB,CHRNB2,CLC,CLCF1,CSF1,CTLA4,EBI3,FADD,FGF10,FOXP3,GLMN,GPR183,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DRB1,HLA-E,HLA-G,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IHH,IKZF3,IL10,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL27,IL4,IL6,IL6ST,IL7,IRF1,IRS2,KIAA0922,LEP,LGALS3,LGALS9,LILRB1,LILRB2,LST1,MEF2C,MIF,MNDA,MZB1,NCK1,NCK2,NCKAP1L,NFATC2,PDCD1LG2,PNP,PRKAR1A,PRNP,PTPN22,PTPRC,PYCARD,RASAL3,RC3H1,RIPK3,SFTPD,SHH,SOX11,TCF3,TIRAP,TMIGD2,TNFRSF21,TNFRSF4,TNFSF13B,TNFSF18,TNFSF4,VAV3,VCAM1,XCL1,ZNF335,ZP3,ZP4	Any process that modulates the frequency, rate or extent of mononuclear cell proliferation.
GO:0032946	GO	BP	positive regulation of mononuclear cell proliferation	AGER,AIF1,ANXA1,BCL2,CCL19,CCL5,CCR2,CD1D,CD24,CD274,CD276,CD28,CD38,CD3E,CD46,CD55,CD6,CD74,CD81,CHRNB2,CLCF1,CSF1,EBI3,FADD,FGF10,GPR183,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-E,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,IRS2,LEP,LGALS9,LILRB2,MEF2C,MIF,NCK1,NCK2,NCKAP1L,NFATC2,PNP,PTPRC,PYCARD,RASAL3,SHH,TCF3,TIRAP,TMIGD2,TNFRSF4,TNFSF13B,TNFSF4,VAV3,VCAM1,XCL1,ZNF335,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation.
GO:0032947	GO	MF	protein complex scaffold	AKAP6,AKAP9,ARRB2,AXIN1,C9orf142,CAPN3,CARD10,CAV1,CAV3,CD3E,CD3G,CHCHD3,CNOT1,DEDD2,DLG5,DUSP19,EIF3B,G3BP2,GNB2L1,GRIP1,ISCU,ITSN1,KLHL17,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LDLRAP1,LRRK2,MAGI2,MAPK8IP2,MAPK8IP3,MMS19,MPP7,NCK1,NCK2,NUP62,PKP2,RGS14,ROPN1B,SASH1,SHANK1,SHANK2,SHANK3,SLC9A1,SMARCD1,WWC1,WWC2,WWC3	Functions to provide a physical support for the assembly of a multiprotein complex.
GO:0032956	GO	BP	regulation of actin cytoskeleton organization	ABI2,ABL1,ABL2,ACTN2,ACTR2,ACTR3,ADD1,ADD2,ALMS1,ALOX15,AMOT,APOA1,ARAP1,ARF1,ARF6,ARFGEF1,ARHGAP18,ARHGAP6,ARHGEF10,ARHGEF10L,ARHGEF15,ARHGEF19,ARHGEF5,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,ARPIN,ASAP3,BAIAP2,BAIAP2L1,BCAS3,BMP10,BRK1,BST2,CAV3,CCDC88A,CCL11,CCL21,CCL24,CCL26,CCR7,CDC42EP2,CDC42EP5,CDK5,CFL2,CLASP1,CLASP2,CORO1A,CORO1B,CRK,CSF1R,CSF3,CTGF,CTTN,CXCL12,CYFIP1,DAPK3,DLC1,DMTN,EDN1,EFNA5,EPHA1,EPHA3,EPHA5,EPS8,EVL,F11R,F2RL1,FAM21C,FER,FES,FHOD1,FSCN1,FZD10,GPM6B,GPR65,GRHL3,GSN,HAX1,HCK,HCLS1,HRAS,HRG,INPP5K,IQGAP2,ITGB1BP1,JMY,KANK1,LATS1,LIMA1,LIMK1,LPAR1,LRP1,LRRC16A,MAGEL2,MLST8,MTOR,MTPN,MYADM,MYLK3,MYOC,NCK1,NCK2,NCKAP1,NCKAP1L,NEB,NF2,NTF3,NTRK3,ODAM,OR2A4,PAK1,PAK3,PARK2,PDGFA,PDGFRA,PDGFRB,PDXP,PFN1,PFN2,PHLDB2,PHPT1,PICK1,PLEK,PLEKHH2,PPFIA1,PPM1E,PPM1F,PRKCD,PRKCE,PROX1,PTGER4,PTK2B,PYCARD,RAC1,RAPGEF3,RASA1,RDX,RGCC,RHOA,RHOQ,RICTOR,ROCK1,ROCK2,S100A10,SCIN,SEMA3E,SEMA5A,SERPINF2,SFRP1,SH3BGRL3,SHANK1,SHANK3,SLC9A1,SLIT2,SORBS3,STAP1,SYNPO,TACSTD2,TEK,TENM1,TMSB4Y,TPM1,TRIM27,TRIOBP,TSC1,TWF1,TWF2,VASP,VIL1,WASF1,WASF2,WASH1,WHAMM,WNT11	Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
GO:0032963	GO	BP	collagen metabolic process	ADAM10,ADAM17,ADAM9,ADAMTS3,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL23A1,COL25A1,COL26A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL6A5,COL6A6,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,CTSB,CTSD,CTSK,CTSL,CTSS,ELANE,FURIN,HIF1A,KLK6,MMP1,MMP10,MMP11,MMP12,MMP13,MMP14,MMP15,MMP19,MMP2,MMP20,MMP3,MMP7,MMP8,MMP9,MRC2,P3H1,P3H2,PHYKPL,PRSS2,TNXB,TRAM2	The chemical reactions and pathways involving collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
GO:0032965	GO	BP	regulation of collagen biosynthetic process	AMELX,BMP4,CIITA,F2,F2R,HDAC2,IL6,IL6R,PRDX5,RGCC,SCX,SERPINF2,SUCO,TGFB1,TGFB3,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
GO:0032967	GO	BP	positive regulation of collagen biosynthetic process	AMELX,BMP4,F2,F2R,HDAC2,PRDX5,RGCC,SCX,SERPINF2,SUCO,TGFB1,TGFB3,WNT4	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
GO:0032968	GO	BP	positive regulation of transcription elongation from RNA polymerase II promoter	BRD4,CDC73,CTR9,EAPP,ELL,LEO1,PAF1,RTF1,SUPT6H,WDR61	Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
GO:0032981	GO	BP	mitochondrial respiratory chain complex I assembly	ACAD9,AIFM1,BCS1L,COA1,ECSIT,FOXRED1,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND5,MT-ND6,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFAF2,NDUFAF3,NDUFAF4,NDUFAF5,NDUFAF6,NDUFAF7,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUBPL,OXA1L,TAZ,TIMM21,TIMMDC1,TMEM126B	The aggregation, arrangement and bonding together of a set of components to form mitochondrial respiratory chain complex I.
GO:0032982	GO	CC	myosin filament	ACTG2,MYBPC3,MYH10,MYH14,MYH7,MYH8,MYH9,MYOM1,TRIM32	A protein complex containing myosin heavy chains, plus associated light chains and other proteins, in which the myosin heavy chains are arranged into a filament.
GO:0032988	GO	BP	ribonucleoprotein complex disassembly	DENR,EIF2D,GFM2,KIF5B,KLC1,MCTS1,MRRF,MTIF2,MTIF3,TFIP11	The disaggregation of a protein-RNA complex into its constituent components.
GO:0032993	GO	CC	protein-DNA complex	ACD,ATF6B,BCAS2,CCDC79,CDC5L,CHRAC1,CTC1,CTNNB1,DDIT3,ERCC5,H2AFB1,H2AFB2,H2AFY,H3F3A,HELB,HHEX,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H2A,HIST3H3,HMGA2,HOXA11,JUP,KAT6B,LEF1,MCM3,MPHOSPH8,MYOG,NFE2L2,NFYA,NFYB,NFYC,OBFC1,PAX2,PCNA,PLRG1,POLA1,POLD3,POLE,POLE2,POLE3,POLE4,POT1,PRPF19,PURA,PURB,RPA1,RPA2,RPA3,RPA4,SLF1,SMARCAL1,TCF7L2,TEN1,TERF1,TERF2,TERF2IP,TERT,TINF2,TNP1,TONSL,XPA,XRCC5,XRCC6	A macromolecular complex containing both protein and DNA molecules.
GO:0032994	GO	CC	protein-lipid complex	APOA1,APOA2,APOA4,APOA5,APOB,APOC1,APOC2,APOC3,APOC4,APOE,APOH,APOL1,APOM,BIN1,CETP,CLU,HPR,LCAT,LPA,PCYOX1,PEX3,PLA2G7,PON1,VIMP	A macromolecular complex containing separate protein and lipid molecules.  Separate in this context means not covalently bound to each other.
GO:0033002	GO	BP	muscle cell proliferation	BMP10,C3orf58,MEGF10,NAA35,NOV,TGFB2,TGFBR3	The expansion of a muscle cell population by cell division.
GO:0033003	GO	BP	regulation of mast cell activation	C12orf4,CD226,CD300A,CD84,FER,FES,FGR,GAB2,LGALS9,LYN,MILR1,NR4A3,PLSCR1,PVRL2,SNX4,STXBP2,UNC13D,VAMP7,VAMP8	Any process that modulates the frequency, rate, or extent of mast cell activation.
GO:0033004	GO	BP	negative regulation of mast cell activation	CD300A,CD84,FER,LGALS9,MILR1	Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
GO:0033005	GO	BP	positive regulation of mast cell activation	CD226,FGR,GAB2,NR4A3,PVRL2,SNX4,VAMP7,VAMP8	Any process that activates or increases the frequency, rate, or extent of mast cell activation.
GO:0033006	GO	BP	regulation of mast cell activation involved in immune response	C12orf4,CD300A,CD84,FER,FES,FGR,GAB2,LGALS9,LYN,SNX4,STXBP2,UNC13D,VAMP7,VAMP8	Any process that modulates the frequency, rate, or extent of mast cell activation as part of an immune response.
GO:0033013	GO	BP	tetrapyrrole metabolic process	ABCB6,ABCC1,ABCD4,ALAD,ALAS1,ALAS2,AMBP,AMN,ATPIF1,BDH2,BLVRA,BLVRB,CD320,COX10,COX15,CPOX,CTRB1,CTRB2,CTRC,CUBN,FECH,FXN,GIF,HMBS,HMOX1,HMOX2,LMBRD1,MMAA,MMAB,MMACHC,MMADHC,MTR,MTRR,MUT,NFE2L1,PPOX,PRSS1,PRSS3,SLC25A38,SUCLA2,TCN1,TCN2,TSPO,UGT1A1,UGT1A4,UROD,UROS	The chemical reactions and pathways involving tetrapyrroles, natural pigments containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.
GO:0033017	GO	CC	sarcoplasmic reticulum membrane	AKAP6,ASPH,ATP2A1,ATP2A2,CASQ1,CASQ2,CHERP,DMPK,FKBP1B,ITPR2,JPH1,JPH2,JPH3,JPH4,KLHL41,MRLN,NOS1,NOS1AP,PLN,RYR1,RYR2,RYR3,TMEM38A,TMEM38B,TRDN	The lipid bilayer surrounding the sarcoplasmic reticulum.
GO:0033018	GO	CC	sarcoplasmic reticulum lumen	ASPH,CASQ1,CASQ2,HRC,TRDN	The volume enclosed by the membranes of the sarcoplasmic reticulum.
GO:0033032	GO	BP	regulation of myeloid cell apoptotic process	ADAM17,ADIPOQ,APOH,CDKN2A,EPO,HCAR2,IRF7,MAEA,MEF2C,NOD2,SIRT1,VIMP	Any process that modulates the frequency, rate, or extent of myeloid cell apoptotic process.
GO:0033033	GO	BP	negative regulation of myeloid cell apoptotic process	APOH,EPO,IRF7,MAEA,NOD2,VIMP	Any process that stops, prevents, or reduces the frequency, rate, or extent of a myeloid cell apoptotic process.
GO:0033034	GO	BP	positive regulation of myeloid cell apoptotic process	ADIPOQ,CDKN2A,HCAR2,MEF2C,SIRT1	Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process.
GO:0033038	GO	MF	bitter taste receptor activity	TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8	Combining with soluble bitter compounds to initiate a change in cell activity. These receptors are responsible for the sense of bitter taste.
GO:0033045	GO	BP	regulation of sister chromatid segregation	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AXIN2,BECN1,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CDCA5,CENPE,CENPF,CSNK2A1,CSNK2A2,CTCF,CTNNB1,CUL3,DLGAP5,DUSP1,DYNC1LI1,ESPL1,FBXO5,GEN1,H2AFY,HDAC8,KLHL22,LCMT1,MAD1L1,MAD2L1,MAD2L2,MOS,NEK6,NSMCE2,PCID2,PLK1,PTEN,RB1,SLF1,SLF2,SMC5,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,WAPL,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of sister chromatid segregation.
GO:0033046	GO	BP	negative regulation of sister chromatid segregation	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,ESPL1,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,WAPL,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation.
GO:0033047	GO	BP	regulation of mitotic sister chromatid segregation	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BECN1,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CENPE,CENPF,CSNK2A1,CSNK2A2,CUL3,DLGAP5,DUSP1,DYNC1LI1,ESPL1,FBXO5,GEN1,H2AFY,KLHL22,LCMT1,MAD1L1,MAD2L1,MAD2L2,MOS,NEK6,NSMCE2,PCID2,PLK1,PTEN,RB1,SLF1,SLF2,SMC5,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of sister chromatid segregation during mitosis.
GO:0033059	GO	BP	cellular pigmentation	AP1G1,AP1M1,AP3B1,AP3D1,ARL6,BBS2,BBS4,BBS5,BBS7,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CD63,DTNBP1,GPR143,KIF13A,LYST,MKKS,PMEL,POMC,RAB11A,RAB11B,RAB17,RAB27A,RAB32,RAB38,SHROOM2,SHROOM3,SNAPIN,VPS33A,VPS33B	The deposition or aggregation of coloring matter in a cell.
GO:0033061	GO	CC	DNA recombinase mediator complex	RAD51B,RAD51C,RAD51D,SFR1,SWI5,XRCC2,XRCC3	A protein complex containing accessory proteins which bind a recombinase (e.g. Rad51) and bind single-stranded DNA (ssDNA), and promote nucleation of the recombinase onto ssDNA.
GO:0033077	GO	BP	T cell differentiation in thymus	ADAM17,CD3D,FADD,GLI3,JAG2,LIG4,RAG1,RAG2,RIPK3,SHH,ZAP70	The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
GO:0033081	GO	BP	regulation of T cell differentiation in thymus	ADAM8,BMP4,CAMK4,CDKN2A,CLPTM1,FOXJ1,GLI2,IHH,KIAA0922,PTPN2,SHH,SOD1,TESPA1,VNN1,ZC3H8	Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus.
GO:0033084	GO	BP	regulation of immature T cell proliferation in thymus	BMP4,CDKN2A,IHH,KIAA0922,SHH	Any process that modulates the frequency, rate or extent of immature T cell proliferation in the thymus.
GO:0033085	GO	BP	negative regulation of T cell differentiation in thymus	BMP4,CDKN2A,FOXJ1,IHH,KIAA0922,PTPN2,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation in the thymus.
GO:0033089	GO	BP	positive regulation of T cell differentiation in thymus	ADAM8,GLI2,IHH,SHH,TESPA1,VNN1	Any process that activates or increases the frequency, rate or extent of T cell differentiation in the thymus.
GO:0033108	GO	BP	mitochondrial respiratory chain complex assembly	AARS2,ACAD9,AIFM1,BCS1L,COA1,COA3,COX14,ECSIT,FOXRED1,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND5,MT-ND6,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFAF2,NDUFAF3,NDUFAF4,NDUFAF5,NDUFAF6,NDUFAF7,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUBPL,OXA1L,SAMM50,SDHAF1,SLC25A33,TAZ,TIMM21,TIMMDC1,TMEM126B,TTC19,UQCC1,UQCC2,UQCC3	The aggregation, arrangement and bonding together of a set of components to form a mitochondrial respiratory chain complex.
GO:0033116	GO	CC	endoplasmic reticulum-Golgi intermediate compartment membrane	AREG,AZIN2,BET1,CD55,CD59,CNIH1,CNIH2,CNIH3,COL7A1,CSNK1D,CTSC,CTSZ,F5,F8,FOLR1,GOLGA2,GORASP1,GOSR2,GRIA1,INS,KDELR1,LAMP5,LMAN1,MCFD2,NAT8,NAT8B,RAB1B,SEC22B,SERPINA1,SPPL3,STX5,TGFA,TM6SF2,TMED10,TMED2,TMED3,TMED7,TMED9,WHAMM,YKT6	The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.
GO:0033119	GO	BP	negative regulation of RNA splicing	ACIN1,C1QBP,PTBP1,PTBP2,PTBP3,RBMX,RNPS1,RPS13,RPS26,SAP18,SFSWAP,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,TMBIM6,U2AF2	Any process that stops, prevents, or reduces the frequency, rate or extent of RNA splicing.
GO:0033120	GO	BP	positive regulation of RNA splicing	CELF3,CELF4,ERN1,HNRNPLL,HSPA1A,PIK3R1,POLR2A,RBM20,RBM22,RBMX,SETX,SNW1,THRAP3,TRA2B,U2AF2,ZPR1	Any process that activates or increases the frequency, rate or extent of RNA splicing.
GO:0033121	GO	BP	regulation of purine nucleotide catabolic process	ACTN3,EGLN1,GNB2L1,MAPK7,RAPGEF3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.
GO:0033127	GO	BP	regulation of histone phosphorylation	CDK9,H2AFY,IL1B,MAPK3,RPS6KA4,RPS6KA5,TWIST1	Any process that modulates the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.
GO:0033129	GO	BP	positive regulation of histone phosphorylation	CDK9,IL1B,MAPK3,RPS6KA4,RPS6KA5	Any process that activates or increases the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.
GO:0033135	GO	BP	regulation of peptidyl-serine phosphorylation	AKAP9,AKT1,ARAF,ATP2B4,AVP,AXIN1,BRAF,CAMK1,CAPRIN2,CAV1,CD44,CNKSR3,CREBL2,CSF3,DDIT4,DKK1,DMD,DMTN,DOCK7,FNIP1,FNIP2,GAS6,GNB2L1,GPD1L,HAX1,HCLS1,HRC,IFNB1,IFNG,IL11,IL6,INPP5K,LATS1,LIF,MAD2L2,MIF,MLXIPL,NCK1,NCK2,NLRP2P,NSD1,NTF3,NTRK3,OPRD1,OSM,PAK1,PAQR3,PARK7,PDCD10,PDE4D,PFN2,PINK1,PPM1F,PPP1R15A,PRKD1,PRKD2,RAF1,RAPGEF3,RASSF2,RIPK2,SFRP2,SMAD7,SNCA,SPRY2,SPTBN4,STK4,STOX1,TBK1,TENM1,TERF2IP,TGFB1,TNF,TRIM6,TXN,VEGFA,WNT3A	Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-serine.
GO:0033137	GO	BP	negative regulation of peptidyl-serine phosphorylation	CAV1,CNKSR3,DDIT4,DKK1,DMD,DMTN,GNB2L1,GPD1L,INPP5K,MLXIPL,NCK1,NCK2,NLRP2P,PAQR3,PDE4D,PPM1F,RASSF2,SMAD7	Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.
GO:0033138	GO	BP	positive regulation of peptidyl-serine phosphorylation	AKAP9,AKT1,ARAF,ATP2B4,AVP,AXIN1,BRAF,CAMK1,CAPRIN2,CAV1,CD44,CREBL2,CSF3,DOCK7,FNIP1,FNIP2,GAS6,HAX1,HCLS1,IFNB1,IFNG,IL11,IL6,LATS1,LIF,MAD2L2,MIF,NTF3,NTRK3,OPRD1,OSM,PAK1,PARK7,PDCD10,PFN2,PINK1,PPP1R15A,PRKD1,PRKD2,RAF1,RAPGEF3,RIPK2,SFRP2,SNCA,SPRY2,STK4,STOX1,TBK1,TENM1,TERF2IP,TGFB1,TNF,TRIM6,TXN,VEGFA,WNT3A	Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
GO:0033143	GO	BP	regulation of intracellular steroid hormone receptor signaling pathway	ARNTL,ARRB2,BRCA1,BUD31,CALR,CARM1,CLOCK,CNOT1,CNOT2,CRIPAK,CRY1,CRY2,DAB2,DDRGK1,DDX17,DDX5,DYX1C1,EP300,FOXA1,FOXH1,FOXP1,HDAC1,HDAC6,HEYL,ISL1,KANK2,KMT2D,LMO3,NODAL,NR0B1,PAK1,PARK7,PER1,PHB,PIAS2,PRMT2,RNF14,RNF6,RQCD1,SFRP1,SIRT1,SMARCA4,STRN3,TCF21,TRIM68,UBA5,UFL1,UFM1,UFSP2,ZNF366	Any process that modulates the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.
GO:0033144	GO	BP	negative regulation of intracellular steroid hormone receptor signaling pathway	ARNTL,BRCA1,CALR,CLOCK,CNOT1,CNOT2,CRIPAK,CRY1,CRY2,DAB2,FOXH1,FOXP1,HDAC1,HEYL,ISL1,KANK2,NODAL,NR0B1,PER1,PHB,PIAS2,RQCD1,SFRP1,SIRT1,SMARCA4,STRN3,TCF21,ZNF366	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.
GO:0033145	GO	BP	positive regulation of intracellular steroid hormone receptor signaling pathway	BUD31,DDX17,DDX5,FOXA1,KMT2D,LMO3,PAK1,PARK7	Any process that activates or increases the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.
GO:0033146	GO	BP	regulation of intracellular estrogen receptor signaling pathway	BRCA1,CARM1,CNOT1,CNOT2,CRIPAK,DDRGK1,DDX17,DDX5,DYX1C1,FOXA1,FOXH1,ISL1,KANK2,KMT2D,PAK1,RQCD1,STRN3,UBA5,UFL1,UFM1,UFSP2,ZNF366	Any process that modulates the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.
GO:0033147	GO	BP	negative regulation of intracellular estrogen receptor signaling pathway	BRCA1,CNOT1,CNOT2,CRIPAK,FOXH1,ISL1,KANK2,RQCD1,STRN3,ZNF366	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.
GO:0033148	GO	BP	positive regulation of intracellular estrogen receptor signaling pathway	DDX17,DDX5,FOXA1,KMT2D,PAK1	Any process that activates or increases the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.
GO:0033151	GO	BP	V(D)J recombination	HMGB1,HMGB2,LIG4,RAG1,RAG2,TCF3,VPRBP	The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
GO:0033158	GO	BP	regulation of protein import into nucleus, translocation	GAS6,IGF1,MAVS,OGG1,PARP10,PDE2A,SIRT1,TMEM173,TXN,UBR5	Any process that modulates the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.
GO:0033162	GO	CC	melanosome membrane	DCT,GPR143,OCA2,TH,TYR,TYRP1	The lipid bilayer surrounding a melanosome.
GO:0033169	GO	BP	histone H3-K9 demethylation	KDM1A,KDM3A,KDM4C,KDM4D,KDM7A,PHF8	The modification of histone H3 by the removal of a methyl group from lysine at position 9 of the histone.
GO:0033173	GO	BP	calcineurin-NFAT signaling cascade	LACRT,NFATC1,PPP3CA,PPP3CB,PPP3R1	Any intracellular signal transduction in which the signal is passed on within the by activation of a member of the NFAT protein family as a consequence of NFAT dephosphorylation by Ca(2+)-activated calcineurin. The cascade begins with calcium-dependent activation of the phosphatase calcineurin. Calcineurin dephosphorylates multiple phosphoserine residues on NFAT, resulting in the translocation of NFAT to the nucleus. The cascade ends with regulation of transcription by NFAT. The calcineurin-NFAT cascade lies downstream of many cell surface receptors, including G-protein coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) that signal to mobilize calcium ions (Ca2+).
GO:0033176	GO	CC	proton-transporting V-type ATPase complex	ATP6V0A4,ATP6V0D1,ATP6V0D2,ATP6V1B1,ATP6V1D,ATP6V1F,ATP6V1H	A proton-transporting two-sector ATPase complex that couples ATP hydrolysis to the transport of protons across a concentration gradient. The resulting transmembrane electrochemical potential of H+ is used to drive a variety of (i) secondary active transport systems via H+-dependent symporters and antiporters and (ii) channel-mediated transport systems. The complex comprises a membrane sector (V0) that carries out proton transport and a cytoplasmic compartment sector (V1) that catalyzes ATP hydrolysis. V-type ATPases are found in the membranes of organelles such as vacuoles, endosomes, and lysosomes, and in the plasma membrane.
GO:0033178	GO	CC	proton-transporting two-sector ATPase complex, catalytic domain	ATP5B,ATP5C1,ATP5D,ATP5E,ATP6V1H	A protein complex that forms part of a proton-transporting two-sector ATPase complex and catalyzes ATP hydrolysis or synthesis. The catalytic domain (F1, V1, or A1) comprises a hexameric catalytic core and a central stalk, and is peripherally associated with the membrane when the two-sector ATPase is assembled.
GO:0033182	GO	BP	regulation of histone ubiquitination	CDK9,CTR9,KDM1A,OTUB1,RNF20,RNF40,TRIP12,UBE2N,UBR5	Any process that modulates the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.
GO:0033184	GO	BP	positive regulation of histone ubiquitination	CDK9,CTR9,KDM1A,RNF20,RNF40	Any process that activates or increases the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.
GO:0033194	GO	BP	response to hydroperoxide	APOA4,GPX3,MGST1,PRKCD,STX2,STX4	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroperoxide stimulus. Hydroperoxides are monosubstitution products of hydrogen peroxide, HOOH.
GO:0033198	GO	BP	response to ATP	ASPH,CIB2,DGKQ,HSP90B1,KCNJ11,P2RX4,P2RX7,P2RY11,P2RY12,PDXP,RYR3,SSH1,TRPC3,TRPV1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.
GO:0033209	GO	BP	tumor necrosis factor-mediated signaling pathway	ADAM17,AIM2,BAG4,BIRC2,BIRC3,BTRC,CARD14,CASP8,CD27,CD40,CD40LG,CD70,CDIP1,CHUK,CLIP3,COMMD7,CUL1,CYLD,EDA,EDA2R,EDAR,EDARADD,FADD,FBXW11,FOXO3,GNB2L1,IKBKB,IKBKG,JAK2,LTA,LTB,LTBR,MADD,MAP3K14,MAP3K7,NFKB2,NSMAF,OTULIN,PLVAP,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTK2B,PYCARD,PYDC1,RBCK1,RELB,RIPK1,RNF31,RPS27A,SHARPIN,SKP1,SMPD2,SMPD3,STAT1,TAB1,TAB2,TAB3,TAX1BP1,TNF,TNFAIP3,TNFRSF11A,TNFRSF11B,TNFRSF12A,TNFRSF13B,TNFRSF13C,TNFRSF14,TNFRSF17,TNFRSF18,TNFRSF19,TNFRSF1A,TNFRSF1B,TNFRSF25,TNFRSF4,TNFRSF6B,TNFSF11,TNFSF12,TNFSF13,TNFSF13B,TNFSF14,TNFSF15,TNFSF18,TNFSF4,TRADD,TRAF1,TRAF2,TRAF3,TXNDC17,UBA3,UBA52,UBB,UBC,UBE2M	A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0033210	GO	BP	leptin-mediated signaling pathway	BBS2,BBS4,LEP,LEPR,MKKS,MT3,SIRT1,STAT3	A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body.
GO:0033218	GO	MF	amide binding	ACHE,ACVR1,ANG,AP2B1,AP2M1,APBB1,APBB2,APOA1,APOE,BCHE,BRAP,BRE,CABP1,CALCR,CD1C,CD209,CEMIP,CLEC4M,CLIP3,CLSTN1,COL25A1,COL4A3BP,CPTP,CRHBP,CRIP1,DHFR,ECE1,FOLH1,FOLR1,FOLR2,FURIN,FZD5,GALR1,GALR2,GALR3,GSAP,GSS,GSTM1,GSTM2,GSTM3,GSTM4,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLCS,IDE,INSR,KCNIP2,KDELR1,KDELR2,KPNA1,KPNA2,KPNA3,KPNB1,LANCL1,MAPK8IP2,MAS1,MCCC1,MME,MTHFS,NKTR,NMUR2,NOD2,NPR3,PCCA,PCSK5,PEX19,PEX5,PEX5L,PEX7,PIK3R1,PLEKHA8,PPIC,PPID,PPIE,PPIG,PPIH,PTGES,PTGES2,PTH1R,SLC7A5,SLC7A8,SLC7A9,SORL1,SRP54,TAP1,TAPBP,TGFB2,TLR2,TLR6,TNPO1,TNPO2,TPP1,TYMS	Interacting selectively and non-covalently with an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group.
GO:0033233	GO	BP	regulation of protein sumoylation	CAPN3,CDKN2A,CTNNB1,EGR1,HDAC4,MAGEA2,MUL1,PARK7,PIAS1,PIAS3,PIAS4,RASD2,RWDD3	Any process that modulates the frequency, rate or extent of the addition of SUMO groups to a protein.
GO:0033234	GO	BP	negative regulation of protein sumoylation	CAPN3,CTNNB1,MAGEA2,PARK7,PIAS3	Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of SUMO groups to a protein.
GO:0033235	GO	BP	positive regulation of protein sumoylation	CDKN2A,HDAC4,MUL1,PIAS1,PIAS3,PIAS4,RASD2,RWDD3	Any process that activates or increases the frequency, rate or extent of the addition of SUMO groups to a protein.
GO:0033238	GO	BP	regulation of cellular amine metabolic process	ACSL3,APOC1,ATCAY,ATP2B4,AZIN1,BHMT,CHRNB2,DRD4,GATA3,HPN,HPRT1,HTR1A,INS,LDLR,NQO1,NR1H4,OAZ1,OAZ2,OAZ3,ODC1,PAOX,PARK2,PARK7,PAX8,PRKCD,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,SCARB1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform amines.
GO:0033240	GO	BP	positive regulation of cellular amine metabolic process	ACSL3,GATA3,HPN,HPRT1,NR1H4,PAOX,PARK7,PAX8,PRKCD	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amines.
GO:0033256	GO	CC	I-kappaB/NF-kappaB complex	BCL3,DNAJA3,NFKB1,NFKB2,NFKBIA	A protein complex containing an inhibitory-kappaB (I-kappaB/IKB) protein and one or more copies of an NF-kappaB protein. In the resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm.
GO:0033260	GO	BP	nuclear DNA replication	APEX1,DNA2,FEN1,LIG1,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,PRIM1,PRIM2,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RTEL1,SLBP,UPF1	The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.
GO:0033262	GO	BP	regulation of nuclear cell cycle DNA replication	ATRX,CDC7,CHEK2,DBF4B,INO80,TERF1,TERF2,TIPIN,WIZ	Any process that modulates the frequency, rate or extent of The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.
GO:0033267	GO	CC	axon part	AAK1,ANK3,BIN1,CABP4,CAD,CLASP2,CNTN2,CNTNAP1,CNTNAP2,COBL,CRHBP,DAB2IP,DLG2,DLG4,EPB41L3,ERMN,FKBP4,FLRT3,GHRH,GPER1,GPM6A,GRIK3,GRIN1,KCNA1,KCNA2,KCNAB2,KCNQ2,KCNQ3,L1CAM,LRRK2,MYOC,NCMAP,NFASC,NRCAM,NRXN1,OLFM1,PACSIN1,PARD3,PTPRN,RAB3A,RAB5A,ROBO2,RTN4R,SCN1B,SCN2A,SCN8A,SHTN1,SIRT2,SPOCK1,SPTBN1,SPTBN4,TBC1D24,UNC13B	A part of an axon, a cell projection of a neuron.
GO:0033268	GO	CC	node of Ranvier	ANK3,BIN1,CNTN2,KCNQ2,KCNQ3,MYOC,NFASC,SCN1B,SCN2A,SCN8A,SPOCK1,SPTBN4	An axon part that is a gap in the myelin where voltage-gated sodium channels cluster and saltatory conduction is executed.
GO:0033270	GO	CC	paranode region of axon	CNTNAP1,EPB41L3,ERMN,KCNA1,NCMAP,SIRT2	An axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath.
GO:0033273	GO	BP	response to vitamin	AQP3,CDKN2D,CYP24A1,CYP27B1,FOLR1,FOLR2,GAS6,HLCS,KYNU,PIM1,SPP1,VDR	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin stimulus.
GO:0033276	GO	CC	transcription factor TFTC complex	KAT2A,SUPT3H,TADA3,TAF10,TAF12,TAF2,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF9,TAF9B,TRRAP	A protein complex that does not contain either a TATA-binding protein (TBP) or a TBP-like factor, but is composed of several TAFIIs and other proteins, including a histone acetyltransferase. This complex is able to nucleate transcription initiation by RNA polymerase II, can mediate transcriptional activation, and has histone acetyltransferase activity.
GO:0033280	GO	BP	response to vitamin D	AQP3,CDKN2D,CYP24A1,CYP27B1,PIM1,SPP1,VDR	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
GO:0033293	GO	MF	monocarboxylic acid binding	ADH5,AKR1C1,AKR1C2,ALB,ALOX5AP,APOC1,CYP26A1,CYP26B1,CYP26C1,FABP3,FABP4,FABP5,FFAR4,HLCS,HNF4A,LCN12,LPAR1,MCCC1,NDUFAB1,NR1H4,NR2F2,OXER1,PCCA,PLA2G1B,PMP2,PPARD,PPARG,PTGDS,PYGL,RARA,S100A8,S100A9,SCP2,SERPINA5,STX3,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9,VDR,VIL1	Interacting selectively and non-covalently with a monocarboxylic acid, any organic acid containing one carboxyl (COOH) group or anion (COO-).
GO:0033344	GO	BP	cholesterol efflux	ABCA1,ABCA5,ABCA7,ABCG1,ABCG4,ABCG5,ABCG8,APOA1,APOA2,APOA4,APOC1,APOC2,APOC3,APOE,APOM,NPC1,NPC2,SCARB1,SOAT1,SOAT2,STX12	The directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
GO:0033363	GO	BP	secretory granule organization	ABCA1,BLOC1S1,BLOC1S2,BLOC1S3,CASC5,F2R,F2RL3,LYST,PAFAH1B1,SRGN,VPS33B	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.
GO:0033391	GO	CC	chromatoid body	ARNTL,CLOCK,DDX25,PIWIL1,PIWIL2,TDRD5,TDRD6,TDRD7	A ribonucleoprotein complex found in the cytoplasm of male germ cells, composed of exceedingly thin filaments that are consolidated into a compact mass or into dense strands of varying thickness that branch to form an irregular network. Contains mRNAs, miRNAs, and protein components involved in miRNA processing (such as Argonaute proteins and the endonuclease Dicer) and in RNA decay (such as the decapping enzyme DCP1a and GW182).
GO:0033483	GO	BP	gas homeostasis	ALAS2,CAV1,EGLN1,GSTP1,HIF1A,NARFL,SOD2,WNT7B	A homeostatic process involved in the maintenance of an internal steady state of a gas within an organism or cell.
GO:0033504	GO	BP	floor plate development	CHRD,COBL,FOXB1,GLI2,STIL	The progression of the floor plate over time from its initial formation until its mature state.
GO:0033522	GO	BP	histone H2A ubiquitination	BCOR,CUL4B,DDB1,DDB2,KDM2B,PCGF1,RING1,RNF168,RNF2,RNF8,RYBP,SKP1,TRIM37,UBE2A,UBE2B,UBR2	The modification of histone H2A by addition of one or more ubiquitin groups.
GO:0033523	GO	BP	histone H2B ubiquitination	CDC73,CTR9,LEO1,PAF1,RNF20,RNF40,RNF8,UBE2E1,WAC	The modification of histone H2B by addition of ubiquitin groups.
GO:0033539	GO	BP	fatty acid beta-oxidation using acyl-CoA dehydrogenase	ACAD11,ACADL,ACADM,ACADVL,ETFA,ETFB,ETFDH,GCDH	A fatty acid beta-oxidation pathway in which the initial step of each oxidation cycle, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA dehydrogenase; the electrons removed by oxidation pass through the respiratory chain to oxygen and leave H2O as the product. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
GO:0033540	GO	BP	fatty acid beta-oxidation using acyl-CoA oxidase	ABCD1,ACAA1,ACOT8,ACOX1,ACOX2,ACOX3,AMACR,CRAT,CROT,HSD17B4,SCP2	A fatty acid beta-oxidation pathway in which the initial step, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA oxidase; the electrons removed by oxidation pass directly to oxygen and produce hydrogen peroxide, which is cleaved by peroxisomal catalases. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
GO:0033549	GO	MF	MAP kinase phosphatase activity	DUSP1,DUSP10,DUSP3,DUSP6,DUSP7	Catalysis of the reaction: a phosphorylated MAP kinase + H2O = a MAP kinase + phosphate.
GO:0033555	GO	BP	multicellular organismal response to stress	DRD4,GCH1,HTR1A,HTR2C,MAPK8IP2,NOS1,PRKCG,PTEN,RELN,RET,THBS1,THBS4	Any process that results in a change in state or activity of a multicellular organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
GO:0033558	GO	MF	protein deacetylase activity	HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC8,HDAC9,NACC2,SALL1,SIN3A,SIRT1,SIRT2,SIRT6,SIRT7,SUDS3	Catalysis of the hydrolysis of an acetyl group or groups from a protein substrate.
GO:0033559	GO	BP	unsaturated fatty acid metabolic process	ABCC1,ABCD1,ACAA1,ACOT8,ACOX1,ACSL1,AKR1C2,AKR1C3,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AWAT1,CBR1,CD74,CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2J2,CYP2U1,CYP4A11,CYP4F12,CYP4F2,CYP4F3,CYP4F8,DAGLA,DAGLB,DECR2,DEGS1,DPEP1,EDN1,EDN2,ELOVL1,ELOVL2,ELOVL3,ELOVL5,EPHX2,FAAH,FAAH2,FADS1,FADS2,FADS3,FAM213B,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GPX1,GPX4,HPGD,HPGDS,HSD17B4,LTA4H,LTC4S,MAPKAPK2,MGLL,MGST2,MIF,PLA2G10,PLA2G1B,PLA2G4A,PLA2G4B,PLA2G4C,PNPLA8,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGR2,PTGS1,PTGS2,SCD,SCD5,SCP2,TBXAS1	The chemical reactions and pathways involving an unsaturated fatty acid, any fatty acid containing one or more double bonds between carbon atoms.
GO:0033572	GO	BP	transferrin transport	ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,CLTC,DNM2,LMTK2,MCOLN1,RAB11B,REP15,SLC11A2,STEAP3,TCIRG1,TF,TFR2,TFRC	The directed movement of transferrin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0033588	GO	CC	Elongator holoenzyme complex	ELP2,ELP3,ELP4,ELP5,ELP6,IKBKAP	A heterohexameric protein complex that is involved in modification of wobble nucleosides in tRNA. The complex can associate physically with hyperphosphorylated RNA polymerase II; it contains two discrete heterotrimeric subcomplexes.
GO:0033599	GO	BP	regulation of mammary gland epithelial cell proliferation	BRCA2,DEAF1,GATA3,GPX1,ROBO1,RREB1,ZNF703	Any process that modulates the frequency, rate or extent of mammary gland epithelial cell proliferation.
GO:0033605	GO	BP	positive regulation of catecholamine secretion	ADRBK1,CARTPT,CHRNB2,GDNF,KCNB1,STX1A	Any process that activates or increases the frequency, rate or extent of the regulated release of a catecholamine.
GO:0033612	GO	MF	receptor serine/threonine kinase binding	BMP10,BMP2,BMP3,BMP4,BMP5,BMP6,MAGI2,NODAL,SMAD6	Interacting selectively and non-covalently with a receptor that possesses protein serine/threonine kinase activity.
GO:0033613	GO	MF	activating transcription factor binding	BHLHE40,BHLHE41,CREBBP,EGR2,EOMES,GATA4,HAND2,HIPK2,HNF4A,PPARG,PSIP1,TBX20,TBX3,TBX6	Interacting selectively and non-covalently with an activating transcription factor, any protein whose activity is required to initiate or upregulate transcription.
GO:0033617	GO	BP	mitochondrial respiratory chain complex IV assembly	BCS1L,COA1,COA3,COX14,TIMM21	The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex IV (also known as cytochrome c oxidase) in the mitochondrial inner membrane.
GO:0033619	GO	BP	membrane protein proteolysis	ADAM10,ADAM17,ADAM9,APH1A,APH1B,BACE1,BACE2,CTSH,DAG1,ERAP1,HM13,MBTPS1,MBTPS2,MYH9,NAPSA,NCSTN,NFKB1,NGFR,PARL,PRKCQ,PSEN1,PSEN2,PSENEN,RBMX,RELA,RET,RHBDD1,SPPL2A,SPPL2B,SPPL3,TMPRSS6,TRAF6	The proteolytic cleavage of a transmembrane protein leading to the release of its intracellular or ecto-domains.
GO:0033622	GO	BP	integrin activation	COL16A1,FERMT2,FERMT3,FN1,ITGB1BP1,MZB1	The aggregation, arrangement and bonding together of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, that lead to the increased affinity of the integrin for its extracellular ligands.
GO:0033623	GO	BP	regulation of integrin activation	CDH17,CXCL13,FARP2,FBLIM1,KIF14,PIEZO1,PLEK,PTGER4,SELP,SRC	Any process that modulates the frequency, rate, or extent of integrin activation.
GO:0033625	GO	BP	positive regulation of integrin activation	CDH17,CXCL13,PIEZO1,PLEK,SRC	Any process that activates or increases the frequency, rate, or extent of integrin activation.
GO:0033627	GO	BP	cell adhesion mediated by integrin	ADAM17,ADAM9,COL16A1,ITGA11,ITGA2,NOV,NPNT,VTN	The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.
GO:0033628	GO	BP	regulation of cell adhesion mediated by integrin	ACER2,ADA,ADAM9,CCL21,CCL5,CIB1,CXCL13,CYP1B1,DPP4,EFNA1,EPHA2,EPHA8,FERMT3,FOXC2,HRG,ITGB1BP1,LYN,MUC1,NCKAP1L,PDE3B,PIEZO1,PIK3CG,PLAU,PODXL,PTK2,PTPN11,RAC3,RET,SERPINE1,SFRP2,SNAI2,SYK,TESC,TGFB2	Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
GO:0033629	GO	BP	negative regulation of cell adhesion mediated by integrin	ACER2,CYP1B1,HRG,MUC1,PDE3B,SERPINE1,SNAI2	Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
GO:0033630	GO	BP	positive regulation of cell adhesion mediated by integrin	ADAM9,CCL21,CCL5,CIB1,CXCL13,FOXC2,NCKAP1L,PIEZO1,PODXL,RAC3,RET,SFRP2,SYK,TGFB2	Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
GO:0033632	GO	BP	regulation of cell-cell adhesion mediated by integrin	ADA,CCL5,CXCL13,DPP4,FERMT3,PIEZO1,PODXL	Any process that modulates the frequency, rate, or extent of cell-cell adhesion mediated by integrin.
GO:0033643	GO	CC	host cell part	AQP1,AXL,BICD1,LMAN1,PI4K2A,SCO1	Any constituent part of a host cell. The host is defined as the larger of the organisms involved in a symbiotic interaction.
GO:0033673	GO	BP	negative regulation of kinase activity	ABL1,ADAR,ADARB1,ADIPOQ,AIDA,AKT1,AKT1S1,APC,APOE,BMP4,BMP7,CAV1,CAV3,CBLC,CD300A,CDK5RAP1,CDK5RAP3,CDKN1B,CDKN1C,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CEBPA,CEP85,CHP1,CIB1,CORO1C,CRIPAK,CUL3,DAB2IP,DBNDD2,DEPTOR,DNAJA1,DNAJA3,DNAJC3,DUS2,DUSP1,DUSP10,DUSP16,DUSP19,DUSP2,DUSP22,DUSP26,DUSP3,DUSP6,DUSP7,DUSP8,DVL1,EPHA1,ERRFI1,FBXO31,FGFR1OP,FOXA2,GBA,GCKR,GMFB,GMFG,GNAQ,GNB2L1,GPRC5A,GPS1,GPS2,GSTP1,H2AFY,HEXIM1,HEXIM2,HHEX,HIPK3,HSPB1,HYAL2,IBTK,IGF1R,IL1B,INCA1,INPP5K,IRAK3,IRS2,ITGB1BP1,LATS1,LATS2,LAX1,LRP5,LRP6,LYN,MAPK8IP1,MBIP,MEN1,MVP,MYOCD,NCK1,NF1,NPM1,NPRL2,NR2F2,PAK2,PAQR3,PARK2,PARK7,PDCD4,PDPK1,PIK3IP1,PKIA,PLK1,PPM1E,PPM1F,PPP1R1B,PPP2CA,PPP2R1A,PPP2R5A,PRDX3,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCD,PRKRIP1,PTEN,PTK6,PTPN1,PTPN22,PTPRC,PTPRJ,PYCARD,PYDC1,RGS14,RGS2,RGS3,RGS4,RUBCN,SERPINB3,SFN,SH3BP5,SIRT1,SMPD1,SNX6,SOCS1,SOCS3,SOCS4,SOCS5,SORL1,SPRED1,SPRED2,SRCIN1,STK38,TAF7,TAOK3,TARBP2,TFAP4,THY1,TRIB1,TRIB2,TRIB3,TRIM27,TSC2,UBE2C,UCHL1,WWTR1,YWHAG,ZFYVE28,ZGPAT,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
GO:0033683	GO	BP	nucleotide-excision repair, DNA incision	CHD1L,CUL4A,CUL4B,DDB1,DDB2,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,FAN1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,NTHL1,OGG1,PARP1,PCNA,POLD1,POLD2,POLD3,POLD4,POLK,RBX1,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,UBA52,UBB,UBC,XPA	A process that results in the endonucleolytic cleavage of the damaged strand of DNA. The incision occurs at the junction of single-stranded DNA and double-stranded DNA that is formed when the DNA duplex is unwound.
GO:0033688	GO	BP	regulation of osteoblast proliferation	ATRAID,BMP2,CYR61,EIF2AK2,FGFR2,GREM1,HPSE,LTF,NELL1,NPR3,PLXNB1,RHOA,SFRP1,SOX8,TMEM119	Any process that modulates the frequency, rate or extent of osteoblast proliferation.
GO:0033689	GO	BP	negative regulation of osteoblast proliferation	ATRAID,EIF2AK2,GREM1,NELL1,PLXNB1,SFRP1	Any process that stops, prevents or reduces the rate or extent of osteoblast proliferation.
GO:0033690	GO	BP	positive regulation of osteoblast proliferation	BMP2,CYR61,HPSE,LTF,SOX8,TMEM119	Any process that activates or increases the rate or extent of osteoblast proliferation.
GO:0033691	GO	MF	sialic acid binding	ADIPOQ,AGRN,FCN1,SELE,SELP,ST8SIA2,ST8SIA3,ST8SIA4	Interacting selectively and non-covalently with sialic acid, any of a variety of N- or O- substituted derivatives of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria.
GO:0033692	GO	BP	cellular polysaccharide biosynthetic process	ALG1,B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GAT1,CSGALNACT1,CSGALNACT2,EPM2A,EXT1,EXT2,GBE1,GYG1,GYG2,GYS1,GYS2,HAS1,HAS2,HAS3,NANS,NHLRC1,NR1D1,PER2,PGM1,PGM2,PPP1R3C,RPS27A,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways resulting in the formation of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, occurring at the level of an individual cell.
GO:0033700	GO	BP	phospholipid efflux	ABCA1,ABCA12,ABCA7,ABCG1,APOA1,APOA2,APOA4,APOC1,APOC2,APOC3,APOE	The directed movement of a phospholipid out of a cell or organelle.
GO:0033762	GO	BP	response to glucagon	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,CREB1,CRY1,GCG,GCGR,GNAS,GNB1,GNB2,GNB3,GNB4,GNG10,GNG11,GNG12,GNG13,GNG2,GNG3,GNG4,GNG5,GNG7,GNG8,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
GO:0033764	GO	MF	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	AKR1B15,AKR1C1,AKR1C3,AKR1C4,DHRS9,HSD17B1,HSD17B10,HSD17B14,HSD17B2,HSD17B4,HSD17B8,HSD3B1,HSD3B2,HSD3B7	Catalysis of an oxidation-reduction (redox) reaction in which a CH-OH group acts as a hydrogen or electron donor and reduces NAD+ or NADP, and in which one substrate is a sterol derivative.
GO:0033860	GO	BP	regulation of NAD(P)H oxidase activity	AGT,AGTR1,DRD5,INS,RFK	Any process that modulates the activity of the enzyme NAD(P)H oxidase.
GO:0033875	GO	BP	ribonucleoside bisphosphate metabolic process	ABHD14B,ACOT7,BPNT1,COASY,CROT,ENPP1,MCEE,MLYCD,NUDT7,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1	The chemical reactions and pathways involving a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.
GO:0033962	GO	BP	cytoplasmic mRNA processing body assembly	ATXN2,DDX6,DYNC1H1,LIMD1,LSM14A,PATL1,RC3H1	The aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body.
GO:0034030	GO	BP	ribonucleoside bisphosphate biosynthetic process	ACOT7,COASY,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,SLC26A1,SLC26A2,SLC35B2,SLC35B3	The chemical reactions and pathways resulting in the formation of a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.
GO:0034032	GO	BP	purine nucleoside bisphosphate metabolic process	ABHD14B,ACOT7,BPNT1,COASY,CROT,ENPP1,MCEE,MLYCD,NUDT7,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1	The chemical reactions and pathways involving a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.
GO:0034033	GO	BP	purine nucleoside bisphosphate biosynthetic process	ACOT7,COASY,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,SLC26A1,SLC26A2,SLC35B2,SLC35B3	The chemical reactions and pathways resulting in the formation of a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.
GO:0034045	GO	CC	pre-autophagosomal structure membrane	ATG12,ATG14,ATG5,RAB1B,RB1CC1,ULK1,ULK2,WIPI1,WIPI2	A cellular membrane associated with the pre-autophagosomal structure.
GO:0034047	GO	BP	regulation of protein phosphatase type 2A activity	ANKLE2,ARPP19,EIF2AK2,ENSA,HTT,IGBP1,MASTL,PPME1,PPP2R1A,PPP2R2A,PPP2R2B,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5A,PPP2R5B,PPP2R5C,PPP2R5D,PPP2R5E,SET,TIPRL	Any process that modulates the activity of the enzyme protein phosphatase type 2A.
GO:0034058	GO	BP	endosomal vesicle fusion	ANKFY1,TGFBRAP1,VPS11,VPS39,VPS41,VPS4A,VPS8	The homotypic fusion of endocytic vesicles to form or add to an early endosome.
GO:0034061	GO	MF	DNA polymerase activity	CHRAC1,DKC1,HMBOX1,POLA1,POLB,POLD1,POLD3,POLE,POLG,POLL,POLM,POLN,POLQ,PRIMPOL,PTGES3,TEP1,TERF1,TERF2,TERT	Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a nucleic acid template and a 3'hydroxyl group.
GO:0034062	GO	MF	RNA polymerase activity	CRCP,MED20,MED21,POLA1,POLR1C,POLR2A,POLR2D,POLR2E,POLR2J,POLR2L,POLR3A,POLR3C,POLR3F,POLR3G,POLR3H,POLR3K,POLRMT,PRIMPOL,TERT	Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); the synthesis of RNA from ribonucleotide triphosphates in the presence of a nucleic acid template.
GO:0034063	GO	BP	stress granule assembly	ATXN2,ATXN2L,BICD1,CIRBP,DDX3X,DYNC1H1,GRB7,OGFOD1,PQBP1	The aggregation, arrangement and bonding together of proteins and RNA molecules to form a stress granule.
GO:0034067	GO	BP	protein localization to Golgi apparatus	ARFRP1,ARL1,ATP9B,COG7,CSNK1D,GBF1,GCC2,GOLPH3,IFT20,LACRT,NRAS,OBSL1,OPTN,RAB33B,RAB6A,SORL1	A process in which a protein is transported to, or maintained in, a location within the Golgi apparatus.
GO:0034080	GO	BP	CENP-A containing nucleosome assembly	APITD1,CASC5,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPW,HIST1H4A,HJURP,ITGB3BP,MIS18A,MIS18BP1,NPM1,OIP5,RBBP4,RBBP7,RSF1,RUVBL1,SMARCA5,STRA13	The formation of nucleosomes containing the histone H3 variant CENP-A to form centromeric chromatin. This specialised chromatin occurs at centromeric region in point centromeres,  and the central core in modular centromeres.
GO:0034098	GO	CC	VCP-NPL4-UFD1 AAA ATPase complex	DERL1,FAF1,FAF2,NPLOC4,UBXN1,UBXN7,UFD1L,VCP	A multiprotein ATPase complex required for the efficient dislocation of ER-lumenal degradation substrates, and their subsequent proteolysis by the proteasome. In budding yeast, this complex includes Cdc48p, Npl4p and Ufd1p proteins. In mammals, this complex includes a hexamer of VCP/p97 (a cytosolic ATPase) and trimers of each of its cofactors UFD1L and NPL4 (NPLOC4) (e.g. a 6:3:3 stoichiometry).
GO:0034101	GO	BP	erythrocyte homeostasis	ALAS2,ATPIF1,CASP3,CEBPG,DMTN,DYRK3,EPO,FLVCR1,G6PD,GATA1,HCLS1,HIPK2,HMOX1,IKZF1,INHA,INHBA,JAK2,KIT,KLF1,KMT2E,LYN,MED1,PTPN2,RPS14,RPS17,RPS19,RPS24,SLC25A38,TAL1,TGFBR3,VEGFA,ZFPM1	Any process of regulating the production and elimination of erythrocytes within an organism.
GO:0034103	GO	BP	regulation of tissue remodeling	ADAM8,ATP6AP1,BGLAP,CALCA,CARTPT,CSF1R,DCSTAMP,FLT4,GREM1,HRG,IL12B,IL15,IL18,IL2,IL21,IL23A,ITGB3,LEP,LEPR,MC4R,NF1,P2RX7,PML,S1PR1,SFRP1,SRC,SUCO,SYK,TGFB1,THBS4,TMBIM1,TNFAIP3,TNFSF11	Any process that modulates the frequency, rate, or extent of tissue remodeling.
GO:0034105	GO	BP	positive regulation of tissue remodeling	ADAM8,ATP6AP1,DCSTAMP,HRG,IL12B,IL15,IL18,IL2,IL21,IL23A,MC4R,PML,SYK,TMBIM1,TNFSF11	Any process that activates or increases the frequency, rate, or extent of tissue remodeling.
GO:0034109	GO	BP	homotypic cell-cell adhesion	ACTB,ACTG1,ADA,ADAM17,AMICA1,ANXA1,ATP7A,BATF,BMP7,BTN3A1,CASP8,CCL19,CCL21,CCR7,CD1C,CD1D,CD2,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD44,CD7,CD74,CD80,CD86,CD8A,CD8B,CEACAM5,CEBPB,CHD7,CLEC7A,CLIC1,CSRP1,CTNNA3,CTPS1,CXADR,DDOST,DLL4,DOCK8,DPP4,DSC2,DSG2,DSP,EIF2AK4,ELF4,EOMES,F2RL1,FADD,FERMT3,FGA,FGB,FGG,FIBP,FKBP1A,FLNA,FOXP1,FOXP3,GAS6,GATA1,GLI3,GNAS,HBB,HLA-E,HMGB1,HSPB1,HSPD1,ICAM1,ICOSLG,IL12B,IL1B,IL2,IL6,ILK,INS,IRF4,ITGAL,ITGB3,ITK,JAG2,JUP,KIF13B,KIT,LAT,LCK,LCP1,LEF1,LEP,LEPR,LFNG,LIG4,LILRB1,LY9,MEGF10,MEGF11,METAP1,MICA,MICB,MYH9,MYL12A,MYL9,NCK1,NCK2,NHEJ1,P2RY12,PDGFRA,PIK3CB,PIK3CD,PIK3CG,PKP2,PLEK,PLPP3,PPP3CA,PPP3CB,PRLR,PTGER4,PTPN2,PTPN22,PTPRC,RAC2,RAG1,RAG2,RAP2B,RHOH,RIPK3,RORA,RORC,RSAD2,S100A8,S100A9,SEMA4D,SHH,SLA2,SLAMF6,SLC11A1,SOX4,STOML2,STXBP1,STXBP3,THEMIS,TLN1,TNFRSF4,TNFSF14,TNFSF18,TNFSF4,TREML2,TYRO3,VCL,ZAP70,ZFPM1	The attachment of a cell to a second cell of the identical type via adhesion molecules.
GO:0034111	GO	BP	negative regulation of homotypic cell-cell adhesion	ADAMTS18,ALOX12,ANXA1,BMP4,BTN2A2,C1QTNF1,CD274,CD300A,CDKN2A,CEBPB,CTLA4,DUSP3,FOXJ1,FOXP3,GLI3,GLMN,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,IRF1,JAK3,KIAA0922,LAX1,LGALS3,LGALS9,LILRB1,LILRB2,PDCD1LG2,PRKAR1A,PRKCD,PRKG1,PRNP,PTPN2,PTPN22,RC3H1,RDX,SERPINE2,SFTPD,SOCS5,TIGIT,TNFRSF21,TNFSF4,XCL1,ZC3H8,ZNF703	Any process that stops, prevents, or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.
GO:0034112	GO	BP	positive regulation of homotypic cell-cell adhesion	ADAM8,AGER,AIF1,AKT1,ANXA1,BTLA,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CD1D,CD24,CD247,CD274,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD44,CD46,CD47,CD55,CD6,CD80,CD86,CDC42,CSK,CTLA4,DMTN,DPP4,EBI3,FADD,FLOT2,FOXP3,FYN,GATA3,GLI2,GLI3,GRAP2,GRB2,HAS2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,KLRK1,LCK,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MLST8,MTOR,MYB,NCK1,NCK2,NCKAP1L,NKAP,NLRP3,NOD2,NR4A3,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RICTOR,SART1,SHH,SIRPG,SOCS5,SRC,TESPA1,TGFBR2,THY1,TMIGD2,TNFRSF14,TNFSF11,TNFSF4,TRAF2,TRAF6,VAV1,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZP3,ZP4	Any process that activates or increases the frequency, rate, or extent of homotypic cell-cell adhesion.
GO:0034113	GO	BP	heterotypic cell-cell adhesion	CD1D,CD2,CD58,CTNNA3,DSC2,DSG2,DSP,ITGA4,ITGA5,ITGA7,ITGAD,ITGAV,ITGAX,ITGB1,ITGB2,ITGB3,ITGB7,JUP,LILRB2,MADCAM1,PARVA,PKP2,RNASE10	The attachment of a cell to a cell of a different type via adhesion molecules.
GO:0034114	GO	BP	regulation of heterotypic cell-cell adhesion	ADIPOQ,APOA1,BMP7,CD44,FGA,FGB,FGG,FLOT1,GCNT2,IL1B,IL1RN,KLF4,MAP2K5,MAPK7,MYADM,TNF	Any process that modulates the frequency, rate, or extent of heterotypic cell-cell adhesion.
GO:0034115	GO	BP	negative regulation of heterotypic cell-cell adhesion	ADIPOQ,APOA1,IL1RN,KLF4,MAP2K5,MAPK7,MYADM	Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
GO:0034116	GO	BP	positive regulation of heterotypic cell-cell adhesion	BMP7,CD44,FGA,FGB,FGG,FLOT1,GCNT2,IL1B,TNF	Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
GO:0034121	GO	BP	regulation of toll-like receptor signaling pathway	BIRC2,BIRC3,BPIFB1,CACTIN,CAV1,CYBA,DAB2IP,F2RL1,FLOT1,GFI1,HMGB1,IRAK3,IRF1,IRF7,IRG1,LBP,LGR4,LTF,LYN,NFKBIL1,NLRP2P,NR1D1,NR1H3,PTPN22,RAB7B,RSAD2,TICAM2,TIRAP,TLR2,TLR3,TLR5,TLR9,TNFAIP3,TYRO3,WDFY1	Any process that modulates the frequency, rate, or extent of toll-like receptor signaling pathway.
GO:0034122	GO	BP	negative regulation of toll-like receptor signaling pathway	BPIFB1,CACTIN,DAB2IP,F2RL1,IRAK3,IRG1,LGR4,LYN,NFKBIL1,NLRP2P,NR1D1,RAB7B,TICAM2,TLR9,TNFAIP3,TYRO3	Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor signaling pathway.
GO:0034123	GO	BP	positive regulation of toll-like receptor signaling pathway	CAV1,CYBA,F2RL1,FLOT1,HMGB1,LBP,LTF,NR1H3,PTPN22,RSAD2,TICAM2,TIRAP,TLR2,TLR3,TLR5,TLR9,WDFY1	Any process that activates or increases the frequency, rate, or extent of toll-like receptor signaling pathway.
GO:0034134	GO	BP	toll-like receptor 2 signaling pathway	ATF1,ATF2,BTK,BTRC,CD14,CD36,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,IKBKB,IKBKG,IRAK1,IRAK2,IRAK4,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PIK3AP1,PPP2R5D,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TIRAP,TLR1,TLR2,TLR4,TLR6,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to toll-like receptor 2.
GO:0034135	GO	BP	regulation of toll-like receptor 2 signaling pathway	CYBA,F2RL1,IRG1,LYN,TIRAP,TNFAIP3	Any process that modulates the frequency, rate, or extent of toll-like receptor 2 signaling pathway.
GO:0034138	GO	BP	toll-like receptor 3 signaling pathway	ATF1,ATF2,BIRC2,BIRC3,BTRC,CASP8,CD14,CHUK,COLEC12,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FADD,FBXW11,FOS,IKBKB,IKBKE,IKBKG,IRAK1,IRAK2,IRF3,IRF7,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PPP2R5D,RELA,RFTN1,RIPK1,RIPK2,RIPK3,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SARM1,SKP1,TAB1,TAB2,TAB3,TANK,TBK1,TICAM1,TICAM2,TLR3,TLR4,TNIP2,TRAF3,TRAF6,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UNC93B1	Any series of molecular signals generated as a consequence of binding to toll-like receptor 3.
GO:0034139	GO	BP	regulation of toll-like receptor 3 signaling pathway	CAV1,F2RL1,FLOT1,PTPN22,TIRAP,TNFAIP3,WDFY1	Any process that modulates the frequency, rate, or extent of toll-like receptor 3 signaling pathway.
GO:0034141	GO	BP	positive regulation of toll-like receptor 3 signaling pathway	CAV1,F2RL1,FLOT1,PTPN22,TIRAP,WDFY1	Any process that activates or increases the frequency, rate, or extent of toll-like receptor 3 signaling pathway.
GO:0034142	GO	BP	toll-like receptor 4 signaling pathway	ATF1,ATF2,BIRC2,BIRC3,BTK,BTRC,CASP8,CD14,CD36,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FADD,FBXW11,FOS,IKBKB,IKBKE,IKBKG,IRAK1,IRAK2,IRAK4,IRF3,IRF7,ITGAM,ITGB2,JUN,LBP,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,NR1H4,PELI1,PELI2,PIK3AP1,PPP2R5D,PRKCE,RELA,RIPK1,RIPK2,RIPK3,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,S100A14,SARM1,SKP1,TAB1,TAB2,TAB3,TANK,TBK1,TICAM1,TICAM2,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR6,TNIP2,TNIP3,TRAF3,TRAF6,TRIL,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to toll-like receptor 4.
GO:0034143	GO	BP	regulation of toll-like receptor 4 signaling pathway	BPIFB1,DAB2IP,F2RL1,IRG1,LBP,LTF,LYN,NR1D1,NR1H3,PTPN22,RAB7B,TICAM2,TIRAP,TNFAIP3,WDFY1	Any process that modulates the frequency, rate, or extent of toll-like receptor 4 signaling pathway.
GO:0034144	GO	BP	negative regulation of toll-like receptor 4 signaling pathway	BPIFB1,DAB2IP,IRG1,LYN,NR1D1,RAB7B,TICAM2,TNFAIP3	Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 4 signaling pathway.
GO:0034145	GO	BP	positive regulation of toll-like receptor 4 signaling pathway	F2RL1,LBP,LTF,NR1H3,PTPN22,TICAM2,TIRAP,WDFY1	Any process that activates or increases the frequency, rate, or extent of toll-like receptor 4 signaling pathway.
GO:0034146	GO	BP	toll-like receptor 5 signaling pathway	ATF1,ATF2,BTRC,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,IKBKB,IKBKG,IRAK1,IRAK2,IRAK4,JUN,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PPP2R5D,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TLR10,TLR5,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to toll-like receptor 5.
GO:0034162	GO	BP	toll-like receptor 9 signaling pathway	ATF1,ATF2,BTRC,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,IKBKB,IKBKG,IRAK1,IRAK2,IRAK4,IRF7,JUN,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PIK3AP1,PIK3C3,PIK3R4,PPP2R5D,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TLR7,TLR8,TLR9,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1,UNC93B1	Any series of molecular signals generated as a consequence of binding to toll-like receptor 9.
GO:0034166	GO	BP	toll-like receptor 10 signaling pathway	ATF1,ATF2,BTRC,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,IKBKB,IKBKG,IRAK1,IRAK2,IRAK4,JUN,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PPP2R5D,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TLR10,TLR5,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to toll-like receptor 10.
GO:0034184	GO	BP	positive regulation of maintenance of mitotic sister chromatid cohesion	H2AFY,NSMCE2,SLF1,SLF2,SMC5	Any process that increases the extent to which the association between sister chromatids of a replicated chromosome is maintained during a mitotic cell cycle.
GO:0034185	GO	MF	apolipoprotein binding	LIPC,LRP1,LRP8,PCSK9,VLDLR	Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.
GO:0034198	GO	BP	cellular response to amino acid starvation	ATF4,CDKN1A,DAP,DEPDC5,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,IMPACT,MIOS,NPRL2,NPRL3,RNF152,RRAGA,RRAGB,RRAGC,SEH1L,SH3GLB1,WDR24,WDR59	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids.
GO:0034199	GO	BP	activation of protein kinase A activity	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B	Any process that initiates the activity of the inactive enzyme protein kinase A.
GO:0034212	GO	MF	peptide N-acetyltransferase activity	ATAT1,ATF2,BRCA2,CLOCK,CREBBP,CSRP2BP,ELP3,ELP4,EP300,EPC1,HAT1,HCFC1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,MCRS1,NAA10,NAA11,NAA16,NAA30,NAA50,NAA60,NCOA3,OGT,PHF20,SAP130,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,USP22,WDR5	Catalysis of the acetylation of an amino acid residue of a peptide or protein, according to the reaction: acetyl-CoA + peptide = CoA + N-acetylpeptide.
GO:0034214	GO	BP	protein hexamerization	OAT,PANX1,PANX2,PANX3,SPAST	The formation of a protein hexamer, a macromolecular structure consisting of six noncovalently associated identical or nonidentical subunits.
GO:0034219	GO	BP	carbohydrate transmembrane transport	PPBP,SLC2A1,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC35B1,SLC5A1	The process in which a carbohydrate is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0034235	GO	MF	GPI anchor binding	CEACAM5,DPEP1,GPAA1,MPPE1,PIGK,PIGU,THY1,VNN1	Interacting selectively and non-covalently with any glycosylphosphatidylinositol anchor. GPI anchors serve to attach membrane proteins to the lipid bilayer of cell membranes.
GO:0034237	GO	MF	protein kinase A regulatory subunit binding	AKAP6,ARFGEF1,ARFGEF2,KCNQ1,PJA2,RYR2	Interacting selectively and non-covalently with one or both of the regulatory subunits of protein kinase A.
GO:0034243	GO	BP	regulation of transcription elongation from RNA polymerase II promoter	BRD4,CDC73,CTR9,EAPP,ELL,LEO1,PAF1,RECQL5,RNF168,RNF8,RTF1,SUPT6H,WDR61,ZMYND11	Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
GO:0034249	GO	BP	negative regulation of cellular amide metabolic process	ABCA7,ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,APOE,ATF4,BTG2,CALR,CAPRIN1,CELF1,CELF4,CIRBP,CLU,CNOT1,CNOT6,CNOT7,CNOT8,CPEB1,CPEB2,CPEB3,DAPK1,DAPK3,DDX3X,DGCR8,DICER1,DROSHA,EIF2AK1,EIF2AK2,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1,EIF3E,EIF4A3,EIF4E2,EIF4EBP1,EIF4EBP2,EIF4EBP3,ENC1,EPRS,FMR1,GAPDH,GIGYF2,GNB2L1,GRB7,HAP1,HNRNPA2B1,IGF2BP1,IGF2BP2,IGF2BP3,IGFBP5,ILF3,LIMD1,LIN28A,LIN28B,MALSU1,METTL14,METTL3,MEX3D,MOV10,NANOS1,NANOS2,NANOS3,PAIP2,PAIP2B,PATL2,PML,PRG3,PRKAA1,PRKRA,PUM1,RAN,RBM4,RNF139,RPL13A,RPS3,SAMD4A,SMAD1,SMAD2,SMAD3,SNIP1,SORL1,SRRT,SYNCRIP,TARBP2,TNRC6A,TNRC6C,TOB1,TPR,TRIM71,TSC1,UNK,WT1,WTIP,XPO5,ZC3H12A,ZC3H12D,ZCCHC11,ZFP36,ZNF540	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving amides.
GO:0034250	GO	BP	positive regulation of cellular amide metabolic process	ABCF1,APOE,BCDIN3D,BCL3,BOLL,C1QBP,CCL5,CD28,CIRBP,CLU,COA3,CPEB3,DAZ1,DAZL,DDX3X,DEFB103A,DNAJC3,DND1,EEF2,EIF2AK4,EIF2B5,EIF4A3,EIF5A,ELAVL1,ERBB2,FAM129A,GNB2L1,GSAP,HNRNPD,IL6,IMPACT,KHDRBS1,LARP1,LARP4B,LRRTM3,METTL3,MPV17L2,MTOR,NCK1,NPM1,NSMAF,PABPC1,PAIP1,PASK,PICALM,PIWIL2,POLDIP3,POU5F1,PPP1R15A,PRKCD,PRR16,RBM3,RMND1,RPS27L,RPS4X,RPS6KB1,RPS6KB2,SAMD4A,SMPD2,SMPD3,SOX4,TGFB1,THBS1,TNF,TNFRSF1A,UHMK1,UPF3A,UPF3B,UQCC1,UQCC2,USP16,YBX3,YTHDF1,YTHDF2,ZC3H12A	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amides.
GO:0034260	GO	BP	negative regulation of GTPase activity	ARFGEF1,ARL2,BCAS3,CDC42SE1,CPEB2,DAB2IP,F11R,FICD,FZD10,GMIP,GPS1,GPS2,HRAS,IPO5,IQGAP1,IQGAP2,KLRK1,LRRK2,PLXNB3,RASA4,RCC2,RDX,RHOH,RTKN,SH3BP4,SLIT2,TMED2,TNK2,USP17L2	Any process that stops or reduces the rate of GTP hydrolysis by a GTPase.
GO:0034308	GO	BP	primary alcohol metabolic process	ACSS1,ACSS2,ADH1A,ADH1B,ADH1C,ADH4,ADH5,ADH6,ADH7,AKR1B10,AKR1C3,ALDH1A1,ALDH1B1,ALDH2,ALDH3A2,CYP1B1,DHRS3,DHRS9,HAO1,IGF1,PARK7,PECR,RBP4,RDH10,RDH11,RDH12,RETSAT,SDR16C5	The chemical reactions and pathways involving primary alcohols. A primary alcohol is any alcohol in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
GO:0034314	GO	BP	Arp2/3 complex-mediated actin nucleation	ACTR2,ACTR3,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,IQGAP2,JMY,MAGEL2,TRIM27,WASH1	The actin nucleation process in which actin monomers combine to form a new branch on the side of an existing actin filament; mediated by the Arp2/3 protein complex and its interaction with other proteins.
GO:0034315	GO	BP	regulation of Arp2/3 complex-mediated actin nucleation	ABI2,ARF1,BRK1,CORO1B,CYFIP1,NCKAP1,PICK1,WASF1	Any process that modulates the frequency, rate or extent of actin nucleation mediated by the Arp2/3 complex and interacting proteins.
GO:0034329	GO	BP	cell junction assembly	ACTB,ACTG1,ACTN1,ACTN2,ACTN3,AMOT,ANG,APC,ARHGEF6,ARHGEF7,ARL2,CADM1,CADM2,CADM3,CD151,CD9,CDH1,CDH10,CDH11,CDH12,CDH13,CDH15,CDH17,CDH18,CDH2,CDH24,CDH3,CDH4,CDH5,CDH6,CDH7,CDH8,CDH9,CLDN1,CLDN12,CLDN14,CLDN15,CLDN17,CLDN18,CLDN20,CLDN22,CLDN23,CLDN3,CLDN5,CLDN9,CNTNAP1,COL17A1,CRB3,CTNNA1,CTNNB1,CTNND1,CTTN,DLC1,DLG1,DSG1,DST,ECT2,EPB41L3,F11R,FBF1,FBLIM1,FERMT2,FLCN,FLNA,FLNC,FRMPD2,FSCN1,GJA1,GJA4,GJA5,GJB1,GJB2,GJC1,GJD3,GRHL2,ILK,INADL,ITGA6,ITGB1,ITGB4,JUP,KRT14,KRT5,LAMA3,LAMA5,LAMB3,LAMC1,LAMC2,LIM2,LIMS1,LIMS2,MARVELD2,MARVELD3,MICALL2,MLLT4,MPP5,MPP7,OCLN,PARD3,PARD6A,PARD6B,PARD6G,PARVA,PARVB,PIP5K1A,PIP5K1C,PKN2,PKP2,PKP3,PKP4,PLEC,PRKCA,PRKCI,PTPRK,PTPRO,PVR,PVRL1,PVRL2,PVRL3,PVRL4,PXN,RAB13,RAMP2,RCC2,RHOA,RHOC,RHOD,RSU1,SMAD7,SORBS1,STRN,TAOK2,TBCD,TESK1,TESK2,THY1,TJP1,TLN1,TLN2,TRIP6,TRPV4,VASP,VCL,VMP1,WHAMM,ZNF703	A cellular process that results in the aggregation, arrangement and bonding together of a set of components to form a cell junction.
GO:0034330	GO	BP	cell junction organization	ACTB,ACTG1,ACTN1,ACTN2,ACTN3,AMOT,ANG,APC,ARHGEF6,ARHGEF7,ARL2,CADM1,CADM2,CADM3,CAMSAP3,CD151,CD9,CDH1,CDH10,CDH11,CDH12,CDH13,CDH15,CDH17,CDH18,CDH2,CDH24,CDH3,CDH4,CDH5,CDH6,CDH7,CDH8,CDH9,CLDN1,CLDN12,CLDN14,CLDN15,CLDN17,CLDN18,CLDN20,CLDN22,CLDN23,CLDN3,CLDN5,CLDN9,CNTNAP1,COL17A1,CRB3,CSF1R,CTNNA1,CTNNB1,CTNND1,CTTN,CXADR,DLC1,DLG1,DSG1,DSG2,DSP,DST,ECT2,EPB41L3,F11R,FBF1,FBLIM1,FERMT2,FLCN,FLNA,FLNC,FRMPD2,FSCN1,GJA1,GJA4,GJA5,GJB1,GJB2,GJC1,GJD3,GRHL2,ILK,INADL,ITGA6,ITGB1,ITGB4,JUP,KIFC3,KRT14,KRT5,LAMA3,LAMA5,LAMB3,LAMC1,LAMC2,LIM2,LIMS1,LIMS2,MARVELD2,MARVELD3,MICALL2,MLLT4,MPP5,MPP7,NLGN2,NLGN4X,OCLN,PARD3,PARD6A,PARD6B,PARD6G,PARVA,PARVB,PIP5K1A,PIP5K1C,PKN2,PKP2,PKP3,PKP4,PLEC,PLEKHA7,PRKCA,PRKCI,PTPRK,PTPRO,PVR,PVRL1,PVRL2,PVRL3,PVRL4,PXN,RAB13,RAB8B,RAMP2,RCC2,RHOA,RHOC,RHOD,RSU1,SMAD3,SMAD7,SNAI2,SORBS1,STRN,TAOK2,TBCD,TESK1,TESK2,TGFB1,TGFB2,TGFB3,THY1,TJP1,TLN1,TLN2,TRIP6,TRPV4,VASP,VCL,VMP1,WHAMM,ZNF703	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell junction. A cell junction is a specialized region of connection between two cells or between a cell and the extracellular matrix.
GO:0034331	GO	BP	cell junction maintenance	CAMSAP3,CSF1R,KIFC3,NLGN2,PARD6A,PKP2,PLEKHA7	The organization process that preserves a cell junction in a stable functional or structural state. A cell junction is a specialized region of connection between two cells or between a cell and the extracellular matrix.
GO:0034332	GO	BP	adherens junction organization	ACTB,ACTG1,ACTN1,ACTN2,ACTN3,ANG,ARHGEF7,CADM1,CADM2,CADM3,CDH1,CDH10,CDH11,CDH12,CDH13,CDH15,CDH17,CDH18,CDH2,CDH24,CDH3,CDH4,CDH5,CDH6,CDH7,CDH8,CDH9,CTNNA1,CTNNB1,CTNND1,CTTN,DLC1,FERMT2,JUP,LAMA5,MLLT4,PIP5K1A,PIP5K1C,PKP2,PTPRK,PVR,PVRL1,PVRL2,PVRL3,PVRL4,RAB8B,RAMP2,RCC2,RHOD,SMAD7,SORBS1,TAOK2,TBCD,TESK2,THY1,TRIP6,VCL,WHAMM,ZNF703	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.
GO:0034333	GO	BP	adherens junction assembly	ACTN1,ACTN2,ACTN3,ARHGEF7,CTNNB1,CTTN,DLC1,FERMT2,LAMA5,PIP5K1A,PIP5K1C,PTPRK,RAMP2,RCC2,RHOD,SMAD7,SORBS1,TAOK2,TBCD,TESK2,THY1,TRIP6,VCL,WHAMM,ZNF703	The aggregation, arrangement and bonding together of a set of components to form an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.
GO:0034340	GO	BP	response to type I interferon	ADAR,BST2,EGR1,GBP2,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,IFI27,IFI35,IFI6,IFIT1,IFIT2,IFIT3,IFITM1,IFITM2,IFITM3,IFNA1,IFNA10,IFNA14,IFNA16,IFNA17,IFNA2,IFNA21,IFNA4,IFNA5,IFNA6,IFNA7,IFNA8,IFNAR1,IFNAR2,IFNB1,IP6K2,IRF1,IRF2,IRF3,IRF4,IRF5,IRF6,IRF7,IRF8,IRF9,ISG15,ISG20,JAK1,MX1,MX2,OAS1,OAS2,OAS3,OASL,PSMB8,PTPN1,PTPN11,PTPN6,RNASEL,RSAD2,SAMHD1,SHMT2,SOCS1,SOCS3,SP100,STAT1,STAT2,TRIM56,TYK2,USP18,XAF1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a type I interferon stimulus. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
GO:0034341	GO	BP	response to interferon-gamma	AIF1,AQP4,B2M,BST2,CALCOCO2,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CCL2,CD44,CD58,CIITA,CITED1,CXCL16,CYP27B1,DAPK1,DAPK3,DNAJA3,EPRS,FCGR1A,FCGR1B,GAPDH,GBP1,GBP2,GBP6,GCH1,HCK,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,ICAM1,IFI30,IFITM1,IFITM2,IFITM3,IFNG,IFNGR1,IFNGR2,IL12RB1,IL23R,IRF1,IRF2,IRF3,IRF4,IRF5,IRF6,IRF7,IRF8,IRF9,IRG1,JAK1,JAK2,KYNU,LGALS9,MEFV,MID1,MT2A,NCAM1,OAS1,OAS2,OAS3,OASL,PIAS1,PML,PRKCD,PTAFR,PTPN1,PTPN11,PTPN2,PTPN6,RPL13A,SLC11A1,SLC26A6,SNCA,SOCS1,SOCS3,SP100,STAT1,SUMO1,SYNCRIP,TDGF1,TRIM21,TRIM22,TRIM25,TRIM26,TRIM31,TRIM34,TRIM38,TRIM5,TRIM62,TRIM68,TRIM8,VCAM1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon.
GO:0034351	GO	BP	negative regulation of glial cell apoptotic process	CCL2,DLL1,GAS6,PRKCA,PRKCD,PRKCH,PRKCI	Any process that stops, prevents, or reduces the frequency, rate, or extent of glial cell apoptotic process.
GO:0034358	GO	CC	plasma lipoprotein particle	APOA1,APOA2,APOA4,APOA5,APOB,APOC1,APOC2,APOC3,APOC4,APOE,APOH,APOL1,APOM,CETP,CLU,HPR,LCAT,LPA,PCYOX1,PLA2G7,PON1,VIMP	A spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Plasma lipoprotein particles transport lipids, which are non-covalently associated with the particles, in the blood or lymph.
GO:0034361	GO	CC	very-low-density lipoprotein particle	APOA1,APOA2,APOA4,APOA5,APOB,APOC1,APOC2,APOC3,APOC4,APOE,APOH,APOL1,APOM,PCYOX1,VIMP	A triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm. It is found in blood and transports endogenous products (newly synthesized cholesterol and triglycerides) from the liver.
GO:0034362	GO	CC	low-density lipoprotein particle	APOB,APOC2,APOE,APOM,PLA2G7,VIMP	A lipoprotein particle, rich in cholesterol esters and low in triglycerides that is typically composed of APOB100 and APOE and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. LDL particles are formed from VLDL particles (via IDL) by the loss of triglyceride and gain of cholesterol ester. They transport endogenous cholesterol (and to some extent triglycerides) from peripheral tissues back to the liver.
GO:0034364	GO	CC	high-density lipoprotein particle	APOA1,APOA2,APOA4,APOA5,APOC1,APOC2,APOC3,APOC4,APOE,APOH,APOL1,APOM,CETP,CLU,HPR,LCAT,PON1	A lipoprotein particle with a high density (typically 1.063-1.21 g/ml) and a diameter of 5-10 nm that contains APOAs and may contain APOCs and APOE; found in blood and carries lipids from body tissues to the liver as part of the reverse cholesterol transport process.
GO:0034366	GO	CC	spherical high-density lipoprotein particle	APOA1,APOA2,APOC2,APOC3,APOM,CLU,HPR,PON1	A mature high-density lipoprotein (HDL) particle, converted from discoidal HDL particles following the esterification of cholesterol in the particle by phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT).
GO:0034369	GO	BP	plasma lipoprotein particle remodeling	ABCA5,ABCG1,AGT,AGTR1,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,CETP,LCAT,LIPC,LIPG,LPL,MPO,PLA2G2A,PLA2G7,PLTP,SCARB1	The acquisition, loss or modification of a protein or lipid within a plasma lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the esterification of cholesterol by phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT).
GO:0034370	GO	BP	triglyceride-rich lipoprotein particle remodeling	APOA2,APOA4,APOC2,APOE,CETP,LCAT,LIPC,LPL	The acquisition, loss or modification of a protein or lipid within a triglyceride-rich lipoprotein particle, including the hydrolysis of triglyceride by lipoprotein lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride from a triglyceride-rich lipoprotein particle.
GO:0034372	GO	BP	very-low-density lipoprotein particle remodeling	APOA4,APOC2,APOE,CETP,LCAT,LIPC,LPL	The acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid.
GO:0034374	GO	BP	low-density lipoprotein particle remodeling	ABCG1,AGT,AGTR1,APOA2,APOB,CETP,LIPC,MPO,PLA2G2A,PLA2G7	The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
GO:0034375	GO	BP	high-density lipoprotein particle remodeling	ABCA5,ABCG1,APOA1,APOA2,APOA4,APOC1,APOC3,APOE,APOM,CETP,LCAT,LIPC,LIPG,PLTP,SCARB1	The acquisition, loss or modification of a protein or lipid within a high-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
GO:0034377	GO	BP	plasma lipoprotein particle assembly	ABCA1,ABCA7,ACSL3,APOA1,APOA2,APOA4,APOB,APOC1,APOC3,APOE,APOM,DGAT1,MTTP,SOAT1,SOAT2	The aggregation and arrangement of proteins and lipids to form a plasma lipoprotein particle.
GO:0034379	GO	BP	very-low-density lipoprotein particle assembly	ACSL3,APOB,APOC1,APOC3,DGAT1,SOAT1,SOAT2	The aggregation and arrangement of proteins and lipids in the liver to form a very-low-density lipoprotein particle.
GO:0034380	GO	BP	high-density lipoprotein particle assembly	ABCA1,ABCA7,APOA1,APOA2,APOE,APOM	The aggregation and arrangement of proteins and lipids to form a high-density lipoprotein particle.
GO:0034381	GO	BP	plasma lipoprotein particle clearance	ADIPOQ,APOA1,APOA2,APOB,APOC1,APOC2,APOC3,APOE,APOM,CD36,DGAT2,EHD1,HMOX1,LDLR,LDLRAP1,LIPC,MSR1,SCARB1,VLDLR	The process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
GO:0034382	GO	BP	chylomicron remnant clearance	APOC1,APOC2,APOC3,APOE,LIPC	The process in which a chylomicron remnant is removed from the blood via receptor-mediated endocytosis into liver cells and its constituent parts degraded.
GO:0034383	GO	BP	low-density lipoprotein particle clearance	ADIPOQ,APOB,CD36,DGAT2,EHD1,HMOX1,LDLR,LDLRAP1,SCARB1	The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
GO:0034384	GO	BP	high-density lipoprotein particle clearance	APOA1,APOA2,APOC2,APOE,APOM,SCARB1	The process in which a high-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
GO:0034389	GO	BP	lipid particle organization	BSCL2,CIDEC,FAF2,FITM1,FITM2,PLIN5,PPIA,PPID,RAB18,RAB3GAP1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lipid particle.
GO:0034391	GO	BP	regulation of smooth muscle cell apoptotic process	APOH,CDKN2A,IFNG,IGF1,IL12A,IL12B,LRP6,SIRT1	Any process that modulates the frequency, rate, or extent of smooth muscle cell apoptotic process.
GO:0034394	GO	BP	protein localization to cell surface	ANGPT1,ANK2,ARF6,CTNNB1,EMP2,FBLN5,FCN1,FGF10,FGF7,FLNA,GPIHBP1,MRAP,MRAP2,PTPRK,PTPRU,SMURF1,USP4,VCL,WNT11	A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane.
GO:0034399	GO	CC	nuclear periphery	AKAP8,AKAP8L,ALOX5,ATF4,ATF7,ATN1,ATXN1,BLM,CAD,CASK,CENPF,CHMP1A,CLIC4,DCAF7,DNMT3A,ERCC8,FIGN,GFI1,GFI1B,GHRHR,HLCS,HNRNPM,KIN,LMNA,MAEA,MAPT,MBD1,MEN1,MYB,NARF,NCOR2,NONO,NSMF,NUFIP1,NUP107,NUP153,NUP205,NUP93,NUP98,OGG1,PHB2,PML,POLA1,PRPF40A,PSIP1,PSMA6,RUNX1T1,SCAF8,SFPQ,SMARCAD1,SMC3,SNW1,SP100,SPARC,SPTBN4,TELO2,TENM1,TEP1,TP53,TPR,UHRF1,YEATS4,ZNF703	The portion of the nuclear lumen proximal to the inner nuclear membrane.
GO:0034405	GO	BP	response to fluid shear stress	AKT1,ASS1,CITED2,HDAC3,KLF2,KLF4,MAP2K5,MAPK7,MEF2C,MTSS1,NFE2L2,P2RX4,PKD2,SREBF2,XBP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
GO:0034440	GO	BP	lipid oxidation	ABCD1,ABCD2,ABCD3,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOT8,ACOX1,ACOX2,ACOX3,ACSM1,ADH7,ADIPOQ,ADIPOR1,ADIPOR2,ALOX12,AMACR,BDH2,CRAT,CROT,CYP4V2,DECR1,ECHS1,ECI1,EHHADH,ETFA,ETFB,ETFDH,GCDH,HACL1,HADH,HADHA,HADHB,HAO1,HAO2,HSD17B4,MCEE,MMAA,MUT,PCCA,PCCB,PEX13,PEX2,PHYH,PLA2G7,PPARD,PPARGC1A,SCP2,SLC25A17,SLC27A2	The removal of one or more electrons from a lipid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.
GO:0034446	GO	BP	substrate adhesion-dependent cell spreading	ANTXR1,BVES,EFNA1,EPHA1,EPHB3,FER,FERMT2,FERMT3,FN1,ILK,ITGA4,ITGA8,ITGAV,ITGB3,ITGB7,KIF14,LAMA5,LAMB1,LAMC1,MICALL2,PARVA,PEAK1,RAC1,RADIL,SRCIN1,SRGAP2,TEK,TYRO3,VAMP3	The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.
GO:0034450	GO	MF	ubiquitin-ubiquitin ligase activity	AMFR,ANAPC11,PPIL2,PRPF19,RBX1,STUB1,UBE2K,UBOX5,UBR5	Isoenergetic transfer of ubiquitin from one protein to an existing ubiquitin chain via the reaction X-ubiquitin + Y-ubiquitin -> Y-ubiquitin-ubiquitin + X, where both the X-ubiquitin and Y-ubiquitin-ubiquitin linkages are thioester bonds between the C-terminal glycine of ubiquitin and a sulfhydryl side group of a cysteine residue.
GO:0034451	GO	CC	centriolar satellite	ALDOB,BBS4,BBS9,C2CD3,CCDC113,CCDC13,CCDC14,CEP131,CEP290,CEP72,EXOC7,FLOT1,FOPNL,KIAA0753,KRT18,OFD1,PAX2,PCM1,PCNT,PIBF1,SPAG5,SSX2IP,ZMYND10	A small (70-100 nm) cytoplasmic granule that contains a number of centrosomal proteins; centriolar satellites traffic toward microtubule minus ends and are enriched near the centrosome.
GO:0034452	GO	MF	dynactin binding	BBS4,BICD1,CCDC64,PAFAH1B1,SNX5,SNX6,SPTBN5	Interacting selectively and non-covalently with any part of a dynactin complex; dynactin is a large protein complex that activates dynein-based motor activity.
GO:0034453	GO	BP	microtubule anchoring	AURKB,AURKC,BBS4,BICD1,BICD2,BUB3,CAMSAP3,CASC5,CENPE,CHAMP1,CLASP1,CLASP2,DAG1,FAM175B,GCC2,HOOK3,NDC80,PCM1,PEX14,RB1,SEH1L,SGOL1,TEX14,ZNF207	Any process in which a microtubule is maintained in a specific location in a cell.
GO:0034464	GO	CC	BBSome	ARL6,BBIP1,BBS1,BBS2,BBS4,BBS5,BBS7,BBS9,TTC8	A protein complex that associates with the primary cilium and is involved in cilium biogenesis; consists of seven conserved proteins: BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9.
GO:0034481	GO	MF	chondroitin sulfotransferase activity	CHST11,CHST12,CHST13,CHST3,CHST7	Catalysis of the reaction: 3'-phosphoadenosine 5'-phosphosulfate + chondroitin = adenosine 3',5'-bisphosphate + chondroitin sulfate.
GO:0034501	GO	BP	protein localization to kinetochore	AURKB,CASC5,CDK1,CHAMP1,GSG2,MTBP,RCC2,SPDL1,ZW10	Any process in which a protein is transported to, or maintained at, the kinetochore.
GO:0034502	GO	BP	protein localization to chromosome	ACD,ATR,ATRX,AURKB,BRCA2,CASC5,CDK1,CENPA,CHAMP1,GSG2,H2AFY,H2AFY2,HIST1H1B,LRWD1,MTBP,NABP2,PARP3,PIH1D1,PINX1,PLK1,POT1,RAD21,RB1,RCC2,RUVBL2,SGF29,SLF1,SLF2,SPDL1,TERF2,TERF2IP,TERT,TINF2,TNKS,TNKS2,WAPL,WRAP53,ZW10	Any process in which a protein is transported to, or maintained at, a specific location on a chromosome.
GO:0034504	GO	BP	protein localization to nucleus	ABCA7,ADAR,AKR1C3,AKT1,ARL2,ARL2BP,ASUN,BBS4,BCL3,BCL6,BMP4,BMP7,C11orf73,CALR,CBLB,CEP57,CNEP1R1,COL1A1,CTDNEP1,DAG1,DVL1,EGF,F2R,FYB,GCKR,GDF5,HES1,HHEX,IFNG,IPO13,IPO5,IPO9,JAK2,JAK3,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,LMNA,MCM3AP,MDM2,MORC3,MSX1,MT3,NCKIPSD,NOP58,NUP205,NUP98,NUTF2,OPRD1,OR1D2,PAF1,PDIA3,PHB2,PIKFYVE,PINX1,PML,PPP1R10,PRICKLE1,PTTG1IP,RAN,RANBP17,RANBP2,RBM22,RERE,RPAIN,RPL11,RPL23,SEC61B,SIX1,SIX3,SIX4,STAT3,SUN1,SUN2,SUPT7L,SYK,SYNE1,TAF3,TAF8,TGFB1,TGFB2,TNF,TNPO1,TNPO3,TOPORS,TOR1A,TOR1AIP1,TOR1AIP2,TPR,TRPS1,TSC2,WRAP53,ZFYVE9	A process in which a protein is transported to, or maintained in, a location within the nucleus.
GO:0034505	GO	BP	tooth mineralization	AMELX,COL1A1,FAM20A,HACD1,STIM1,TBX1	The process in which calcium salts are deposited into calcareous tooth structures such as dental enamel, dentin and cementum.
GO:0034508	GO	BP	centromere complex assembly	APITD1,CASC5,CENPA,CENPC,CENPE,CENPF,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,HELLS,HIST1H4A,HJURP,ITGB3BP,MIS12,MIS18A,MIS18BP1,NPM1,OIP5,POGZ,RBBP4,RBBP7,RSF1,RUVBL1,SMARCA5,STRA13	The aggregation, arrangement and bonding together of proteins and centromeric DNA molecules to form a centromeric protein-DNA complex. Includes the formation of the chromatin structures which form a platform for the kinetochore, and assembly of the kinetochore onto this specialized chromatin. In fission yeast and higher eukaryotes this process also includes the formation of heterochromatin at the outer repeat (pericentric) regions of the centromere.
GO:0034518	GO	CC	RNA cap binding complex	AGO2,CYFIP1,EIF4E,EIF4E1B,EIF4E2,EIF4E3,FAM103A1,FMR1,NCBP1,NCBP2,NCBP3,RNMT	Any protein complex that binds to a specialized RNA cap structure at any time in the lifetime of the RNA.
GO:0034551	GO	BP	mitochondrial respiratory chain complex III assembly	BCS1L,SLC25A33,TTC19,UQCC1,UQCC2,UQCC3	The aggregation, arrangement and bonding together of a set of components to form the cytochrome bc(1) complex (also known as ubiquinol-cytochrome c reductase), in the mitochondrial inner membrane.
GO:0034587	GO	BP	piRNA metabolic process	ASZ1,DDX4,FKBP6,HENMT1,MAEL,MOV10L1,MYBL1,PIWIL1,PIWIL2,PIWIL4,PLD6,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,TDRD1,TDRD12,TDRD6,TDRD9,TDRKH	The chemical reactions and pathways involving piRNAs, Piwi-associated RNAs, a class of 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.
GO:0034593	GO	MF	phosphatidylinositol bisphosphate phosphatase activity	FIG4,INPP5B,MTM1,MTMR2,MTMR3,PIKFYVE,PTEN,SYNJ1,TMEM55A,TMEM55B	Catalysis of the reaction: phosphatidylinositol bisphosphate + H2O = phosphatidylinositol phosphate + phosphate.
GO:0034595	GO	MF	phosphatidylinositol phosphate 5-phosphatase activity	FIG4,INPP5B,INPP5K,PIKFYVE,SYNJ1	Catalysis of the removal of the 5-phosphate group of a phosphatidylinositol phosphate.
GO:0034599	GO	BP	cellular response to oxidative stress	ABL1,ADNP2,AKR1C3,ALDH3B1,ANKRD2,APOA4,AQP1,ARL6IP5,ARNT,ARNTL,ATF4,ATP7A,CDK2,CHD6,CPEB2,CRYGD,CYP1B1,DHRS2,DPEP1,ECT2,ETV5,FABP1,FER,FOS,FOXO1,FOXO3,FXN,G6PD,GPX1,GUCY1B3,HDAC6,HIF1A,HMOX1,HSPA1A,HSPA1B,HTRA2,IL6,IMPACT,KCNC2,LONP1,LRRK2,MAP3K5,MAPK7,MGST1,MMP3,MPV17,MT3,MTR,NET1,NFE2L2,NOS3,PARK7,PARP1,PAX2,PDCD10,PDGFRA,PDK1,PDK2,PINK1,PKD2,PLA2R1,PLEKHA1,PML,PNPT1,PPARGC1A,PPIF,PRDX2,PRDX3,PRDX5,PRKCD,PRKD1,PRODH,PTPRK,PYCR1,PYCR2,RAD52,RBM11,RELA,RHOB,ROMO1,RPS3,SETX,SIRT1,SIRT2,SLC11A2,SLC25A24,SLC8A1,SNCA,SOD1,SOD2,SOD3,STK24,STK25,TMEM161A,TNFAIP3,TP53,VIMP,VKORC1L1,VRK2,WNT16,XBP1,ZNF580,ZNF622	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
GO:0034605	GO	BP	cellular response to heat	AAAS,AKT1S1,ANO1,ATM,ATR,ATXN3,BAG1,BAG2,BAG3,BAG4,BAG5,C11orf73,C8orf4,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CCAR2,CLPB,CREBBP,CRYAB,DNAJB1,DNAJB6,DNAJC2,DNAJC7,EP300,FGF1,FKBP4,GSK3B,HDAC6,HMOX1,HSBP1,HSF1,HSP90AA1,HSP90AB1,HSPA1A,HSPA1B,HSPA1L,HSPA6,HSPA8,HSPB8,HSPH1,HTRA2,IL1A,MAPK1,MAPK3,MAPKAPK2,MLST8,MTOR,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PDCD6,POM121,POM121C,PTGES3,RAE1,RANBP2,RBBP7,RPA1,RPA2,RPA3,RPTOR,SEH1L,SIRT1,SLU7,THBS1,TPR,TRPV4,VCP,YWHAE	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
GO:0034612	GO	BP	response to tumor necrosis factor	ADAM10,ADAM17,ADAM9,ADAMTS12,ADAMTS7,ADIPOQ,AFF3,AIM2,ANKRD1,ARHGEF2,BAG4,BIRC2,BIRC3,BRCA1,BTRC,CACTIN,CARD14,CASP3,CASP8,CCL2,CD27,CD40,CD40LG,CD58,CD70,CDIP1,CHI3L1,CHUK,CIB1,CLIP3,COMMD7,CRHBP,CUL1,CXCL16,CYLD,DAB2IP,DCSTAMP,EDA,EDA2R,EDAR,EDARADD,ERBB2IP,FADD,FBXW11,FOXO3,GBA,GCH1,GNB2L1,GPER1,IGBP1,IKBKB,IKBKG,INPP5K,IRG1,JAK2,LTA,LTB,LTBR,MADD,MAP2K7,MAP3K14,MAP3K7,MAP4K3,NFE2L2,NFKB2,NPNT,NSMAF,OCSTAMP,OTULIN,PID1,PLVAP,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTK2B,PYCARD,PYDC1,RBCK1,RELA,RELB,RIPK1,RNF31,RPS27A,SELE,SFRP1,SHARPIN,SIRT1,SKP1,SMPD2,SMPD3,SMPD4,STAT1,TAB1,TAB2,TAB3,TAX1BP1,TDGF1,TNF,TNFAIP3,TNFRSF11A,TNFRSF11B,TNFRSF12A,TNFRSF13B,TNFRSF13C,TNFRSF14,TNFRSF17,TNFRSF18,TNFRSF19,TNFRSF1A,TNFRSF1B,TNFRSF21,TNFRSF25,TNFRSF4,TNFRSF6B,TNFSF11,TNFSF12,TNFSF13,TNFSF13B,TNFSF14,TNFSF15,TNFSF18,TNFSF4,TRADD,TRAF1,TRAF2,TRAF3,TRIM32,TXNDC17,UBA3,UBA52,UBB,UBC,UBE2M,YBX3,YTHDC2,ZC3H12A,ZFAND6,ZNF268	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
GO:0034614	GO	BP	cellular response to reactive oxygen species	AKR1C3,APOA4,AQP1,ATP7A,CDK2,CRYGD,CYP1B1,DPEP1,ECT2,FABP1,FER,FOS,FOXO1,FXN,GUCY1B3,HDAC6,IL6,IMPACT,KCNC2,MAP3K5,MAPK7,MMP3,MPV17,MT3,MTR,NET1,NFE2L2,NOS3,PARK7,PAX2,PDCD10,PDGFRA,PDK2,PKD2,PLEKHA1,PPIF,PRDX2,PRDX3,PRDX5,PTPRK,RELA,RHOB,ROMO1,RPS3,SETX,SIRT1,SLC8A1,SOD1,SOD2,SOD3,STK25,TNFAIP3,ZNF580	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
GO:0034620	GO	BP	cellular response to unfolded protein	ACADVL,ADD1,AMFR,ARFGAP1,ASNA1,ASNS,ATF3,ATF4,ATF6,ATF6B,ATP6V0D1,BAK1,BAX,BHLHA15,CALR,CCL2,CDK5RAP3,CREB3,CREB3L1,CTDSP2,CTH,CUL7,CXCL8,CXXC1,DAB2IP,DCTN1,DDIT3,DDX11,DERL1,DERL2,DERL3,DNAJB11,DNAJB9,DNAJC3,EDEM1,EIF2AK3,EIF2S1,EP300,ERN1,EXTL3,FKBP14,GFPT1,GOSR2,GSK3A,HDGF,HERPUD1,HSP90B1,HSPA5,HYOU1,IGFBP1,KDELR3,KLHDC3,LMNA,MBTPS1,MBTPS2,MYDGF,NFE2L2,PACRG,PARK2,PARP16,PDIA5,PDIA6,PLA2G4B,PPP2R5B,PREB,PTPN1,RHBDD1,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SERP1,SHC1,SRPR,SRPRB,SSR1,SULT1A3,SYVN1,TATDN2,TBL2,TLN1,TPP1,TSPYL2,VAPB,VCP,VIMP,WFS1,WIPI1,XBP1,YIF1A,YOD1,ZBTB17	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.
GO:0034629	GO	BP	cellular protein complex localization	CEP72,DLG1,EZR,GSG2,KLHL21,MIOS,MZT1,NACC2,NDC1,RCC2,SEH1L,SMAD7,ZNF365	A protein complex localization process that takes place at the cellular level; as a result, a protein complex is transported to, or maintained in, a specific location within a cell.
GO:0034637	GO	BP	cellular carbohydrate biosynthetic process	ALG1,B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GALT1,B4GAT1,CSGALNACT1,CSGALNACT2,EPM2A,EXT1,EXT2,GBE1,GOT1,GYG1,GYG2,GYS1,GYS2,HAS1,HAS2,HAS3,LALBA,NANS,NHLRC1,NR1D1,PCK1,PER2,PGM1,PGM2,PGP,PPP1R3C,RPS27A,SLC2A1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, carried out by individual cells.
GO:0034644	GO	BP	cellular response to UV	ACTR5,AQP1,ATF4,ATR,AURKB,BAK1,CASP9,CDC25A,CDKN1A,CERS1,CHEK1,CREBBP,CRIP1,CUL4B,DDB1,DDB2,EIF2AK4,EIF2S1,EP300,ERCC4,FBXW7,HIST3H2A,HYAL1,HYAL2,HYAL3,IMPACT,INO80,KDM1A,MC1R,MFAP4,MME,N4BP1,NEDD4,NOC2L,PCNA,POLD1,PPID,PTPRK,RHBDD1,RHNO1,RUVBL2,SIRT1,STK11,TMEM161A,TRIAP1,USP28,USP47,XPC,YY1,ZBTB1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
GO:0034656	GO	BP	nucleobase-containing small molecule catabolic process	ADPRM,NUDT1,NUDT15,NUDT16,NUDT18,NUDT5,NUDT9	The chemical reactions and pathways resulting in the breakdown of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide.
GO:0034661	GO	BP	ncRNA catabolic process	DEDD2,DIS3,DIS3L,DIS3L2,ERN2,EXOSC10,EXOSC3,EXOSC9,LIN28A,LIN28B,NUDT16,POP1,SLFN14,XRN1,ZCCHC11	The chemical reactions and pathways resulting in the breakdown of non-coding RNA transcripts (ncRNAs). Includes the breakdown of cryptic unstable transcripts (CUTs).
GO:0034694	GO	BP	response to prostaglandin	ADCY6,AKR1C2,AKR1C3,CCL19,CCL21,CCR7,GNAS,GNB1,GNG2,PTGER2,PTGFR,TGFBR3,TNFSF4	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin stimulus.
GO:0034695	GO	BP	response to prostaglandin E	ADCY6,CCL19,CCL21,CCR7,GNAS,GNB1,GNG2,PTGER2,TGFBR3,TNFSF4	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
GO:0034698	GO	BP	response to gonadotropin	LHCGR,NOTCH1,NSMF,PAX8,TGFBR3,WT1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
GO:0034702	GO	CC	ion channel complex	ABCC8,ABCC9,AKAP6,AKAP9,AMIGO1,ANO6,ASPH,ATP2A1,BEST1,BEST2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCDC109B,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB3,CHRNB4,CNIH2,CNIH3,CNTNAP1,CNTNAP2,CTTN,DLG2,DLG4,DPP6,FKBP1B,GLRA3,GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIN1,GRIN2A,GRIN2B,GRIN3A,GRIN3B,HCN2,HSPA2,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNH4,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ1,KCNJ11,KCNJ14,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK4,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN4,KCNQ1,KCNS1,KCNS2,LRRC26,LRRC8A,MCU,MICU1,MICU2,NOS1,NOS1AP,OLFM2,PDE4B,PDE4D,PKD1L1,PKD1L3,PKD2L1,PPP2R4,PRKACA,PTK2B,RYR2,SCN10A,SCN1B,SCN2A,SCN2B,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHANK1,SHANK2,SHISA9,SMDT1,SNAP25,STX1A,STXBP5,SUMO1,TRDN,TRPC4,TRPC5,VAMP2	A protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.
GO:0034703	GO	CC	cation channel complex	ABCC8,ABCC9,AKAP6,AKAP9,AMIGO1,ASPH,ATP2A1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG3,CACNG6,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCDC109B,CNTNAP1,CNTNAP2,CTTN,DLG2,DLG4,DPP6,FKBP1B,HCN2,HSPA2,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNH4,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ1,KCNJ11,KCNJ14,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK4,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN4,KCNQ1,KCNS1,KCNS2,LRRC26,MCU,MICU1,MICU2,NOS1,NOS1AP,PDE4B,PDE4D,PKD1L1,PKD1L3,PKD2L1,PPP2R4,PRKACA,RYR2,SCN10A,SCN1B,SCN2A,SCN2B,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SMDT1,SNAP25,STX1A,SUMO1,TRDN,TRPC4,TRPC5,VAMP2	An ion channel complex through which cations pass.
GO:0034704	GO	CC	calcium channel complex	AKAP6,ASPH,ATP2A1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG3,CACNG6,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCDC109B,FKBP1B,HSPA2,MCU,MICU1,MICU2,NOS1,NOS1AP,PDE4B,PDE4D,PKD1L1,PKD2L1,PPP2R4,PRKACA,RYR2,SMDT1,TRDN,TRPC4,TRPC5	An ion channel complex through which calcium ions pass.
GO:0034705	GO	CC	potassium channel complex	ABCC8,ABCC9,AKAP9,AMIGO1,CNTNAP1,CNTNAP2,CTTN,DLG2,DLG4,DPP6,HCN2,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNH4,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ1,KCNJ11,KCNJ14,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK4,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN4,KCNQ1,KCNS1,KCNS2,LRRC26,NOS1AP,SNAP25,STX1A,SUMO1,VAMP2	An ion channel complex through which potassium ions pass.
GO:0034706	GO	CC	sodium channel complex	SCN10A,SCN1B,SCN2A,SCN2B,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G	An ion channel complex through which sodium ions pass.
GO:0034708	GO	CC	methyltransferase complex	ACTB,AEBP2,ASH2L,CBX5,CHD8,CLNS1A,CXXC1,DPY30,E2F6,EED,ERH,EZH1,EZH2,H2AFY,H2AFY2,HCFC1,HDAC2,HDAC9,INO80C,JARID2,KANSL1,KAT8,KDM6A,KIAA1429,KMT2A,KMT2B,KMT2C,KMT2E,LAS1L,MAX,MCRS1,MEN1,METTL14,METTL3,MGA,MTF2,NCOA6,OGT,PAGR1,PAXIP1,PELP1,PHF1,PHF19,PHF20,PPP1CA,PPP1CB,PPP1CC,PRDM4,PRMT1,PRMT5,PRPF31,RBBP4,RBBP5,RBBP7,RNF2,RUVBL1,RUVBL2,SENP3,SETD1A,SETD1B,SIRT1,SNRPB,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,STK38,SUZ12,TAF1,TAF4,TAF6,TAF7,TAF9,TEX10,TRIM37,WDR5,WDR77,WDR82,WTAP,ZNF335	A protein complex that possesses methyltransferase activity.
GO:0034709	GO	CC	methylosome	CLNS1A,ERH,PRMT1,PRMT5,SNRPB,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,WDR77	A large (20 S) protein complex that possesses protein arginine methyltransferase activity and modifies specific arginines to dimethylarginines in the arginine- and glycine-rich domains of several spliceosomal Sm proteins, thereby targeting these proteins to the survival of motor neurons (SMN) complex for assembly into small nuclear ribonucleoprotein (snRNP) core particles. Proteins found in the methylosome include the methyltransferase JBP1 (PRMT5), pICln (CLNS1A), MEP50 (WDR77), and unmethylated forms of SM proteins that have RG domains.
GO:0034713	GO	MF	type I transforming growth factor beta receptor binding	ENG,FKBP1A,SMAD6,TGFB1,TGFB3,TGFBR2	Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
GO:0034715	GO	CC	pICln-Sm protein complex	CLNS1A,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF	A protein complex that contains pICln (CLNS1A) and several Sm proteins, including SmD1, SmD2, SmE, SmF, and SmG.
GO:0034719	GO	CC	SMN-Sm protein complex	DDX20,GEMIN2,GEMIN4,GEMIN5,GEMIN6,GEMIN7,GEMIN8,SMN1,SNRPB,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,STRAP	A protein complex formed by the association of several methylated Sm proteins with the SMN complex; the latter contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and unrip proteins; additional proteins, including galectin-1 and galectin-3, are also found in the SMN-SM complex. The SMN-Sm complex is involved in spliceosomal snRNP assembly in the cytoplasm.
GO:0034720	GO	BP	histone H3-K4 demethylation	KDM1A,KDM1B,KDM5B,KDM5C,KDM5D	The modification of histone H3 by the removal of a methyl group from lysine at position 4 of the histone.
GO:0034728	GO	BP	nucleosome organization	ANP32B,ANP32E,APITD1,ARID1A,ARID2,ASF1A,ASF1B,ATRX,BRD2,BRDT,CABIN1,CASC5,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPW,CHAF1A,CHAF1B,CHD5,CTCF,DAXX,H1FOO,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H2A,HIST3H3,HJURP,HMGA1,HMGB2,IPO4,ITGB3BP,KAT6B,MIS18A,MIS18BP1,NAA60,NASP,NFE2,NPM1,OIP5,PADI4,PAF1,PSME4,RBBP4,RBBP7,RNF8,RSF1,RUVBL1,SART3,SET,SETD2,SMARCA4,SMARCA5,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,SOX9,SPTY2D1,STRA13,SUPT16H,SYCP3,TNP1,UBN1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of one or more nucleosomes.
GO:0034754	GO	BP	cellular hormone metabolic process	AANAT,ADH4,ADM,AKR1B1,AKR1B15,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR1D1,ALDH1A2,ALDH1A3,ALDH8A1,ASMT,BCO2,CACNA1H,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1B1,CYP21A2,CYP26A1,CYP26B1,CYP26C1,CYP3A4,DHRS2,DHRS3,DHRS9,ECE1,FDX1,FDX1L,FDXR,FSHB,HSD17B1,HSD17B11,HSD17B3,HSD17B4,HSD17B6,HSD17B8,HSD3B1,HSD3B2,LHB,MED1,RBP4,RDH10,RDH11,RDH12,RETSAT,SCP2,SCPEP1,SDR16C5,SHH,SRD5A1,SRD5A2,SRD5A3,STAR,STARD5,SULT1A1,SULT1E1,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9,UGT2B11,UGT2B4,UGT2B7,WNT4	The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone, as carried out by individual cells.
GO:0034763	GO	BP	negative regulation of transmembrane transport	ACTN2,ADRA2A,AGT,AKT1,AKT2,ANK3,ANO9,APOA2,APOC3,ATP1A2,CAB39,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CHRFAM7A,CLIC2,COMMD1,CRHR1,CTTNBP2NL,DRD2,DRD4,EPO,EPPIN,FKBP1B,GNB5,GSTM2,GSTO1,HAMP,IRS2,KCNE1,KCNE2,KCNE3,KCNE5,KCNH2,KCNQ1,KCNRG,MMP9,MRLN,NEDD4,NEDD4L,OAZ3,PCSK9,PKD2,PLN,PPIF,PRKCE,RNF207,SEMG1,SLC30A1,SLN,SRI,STK39,SUMO1,TCAF2,THBS1,TLR9,TRDN,TRIM27,UBQLN1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.
GO:0034764	GO	BP	positive regulation of transmembrane transport	ACTN2,ACTN4,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ANO6,ASPH,ATP1B1,ATP1B2,ATP1B3,AZIN1,AZIN2,CA2,CALM1,CAPN3,CCL2,CCL3,CEMIP,CFTR,CHP1,CRACR2A,CTSS,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,DMD,DRD1,DRD4,F2,F2R,F2RL3,FXYD1,GAL,GALR2,GLRX,GPER1,GRM6,GSTM2,GSTO1,HAP1,HTT,JPH2,KCNE1,KCNE5,KCNH2,KCNQ1,LACRT,LGALS3,NLGN3,NOS1,NOS1AP,NPPA,NPSR1,P2RX7,PDCD5,PDGFB,PDGFRB,PDPK1,PDZK1,PKD2,PLCG1,RELN,RNF207,RYR2,SHANK3,SLC26A6,SLC9A1,SNCA,STC1,STIM1,STIM2,TCAF1,TESC,THY1,TMEM110,TRDN,TRPC1,TRPC6,WNK2,WNK3,XCL1,ZP3	Any process that activates or increases the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.
GO:0034766	GO	BP	negative regulation of ion transmembrane transport	ACTN2,ADRA2A,AGT,AKT1,AKT2,ANK3,ANO9,ATP1A2,CAB39,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CHRFAM7A,CLIC2,COMMD1,CRHR1,DRD2,DRD4,EPO,EPPIN,FKBP1B,GNB5,GSTM2,GSTO1,HAMP,IRS2,KCNE1,KCNE2,KCNE3,KCNE5,KCNH2,KCNQ1,KCNRG,MMP9,MRLN,NEDD4,NEDD4L,PCSK9,PKD2,PLN,PRKCE,RNF207,SEMG1,SLC30A1,SLN,SRI,STK39,SUMO1,TCAF2,THBS1,TLR9,TRDN,TRIM27,UBQLN1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.
GO:0034767	GO	BP	positive regulation of ion transmembrane transport	ACTN2,ACTN4,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ANO6,ASPH,ATP1B1,ATP1B2,ATP1B3,CALM1,CAPN3,CCL2,CCL3,CEMIP,CFTR,CHP1,CRACR2A,CTSS,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,DMD,DRD1,DRD4,F2,F2R,F2RL3,FXYD1,GAL,GALR2,GLRX,GPER1,GRM6,GSTM2,GSTO1,HAP1,HTT,JPH2,KCNE1,KCNE5,KCNH2,KCNQ1,LACRT,LGALS3,NLGN3,NOS1,NOS1AP,NPPA,NPSR1,P2RX7,PDGFB,PDGFRB,PDPK1,PDZK1,PKD2,PLCG1,RELN,RNF207,RYR2,SHANK3,SLC9A1,SNCA,STC1,STIM1,STIM2,TCAF1,TESC,THY1,TMEM110,TRDN,TRPC1,TRPC6,WNK2,WNK3,XCL1,ZP3	Any process that activates or increases the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.
GO:0034774	GO	CC	secretory granule lumen	A2M,ACTN1,ACTN2,ACTN4,ALB,ALDOA,APOA1,APP,CFD,CLU,DBH,DEFA1,DEFA3,DEFA5,EGF,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FN1,GAS6,GCG,GHRL,GIP,HGF,HRG,IGF1,IGF2,INS,KNG1,LEFTY2,MMRN1,PCSK1,PCSK2,PDGFA,PDGFB,PF4,PLG,POMC,PPBP,PROS1,SCG3,SERPINA1,SERPINE1,SERPINF2,SERPING1,SPARC,SRGN,TF,TGFB1,TGFB2,TGFB3,THBS1,TIMP1,TMSB4X,VEGFA,VEGFB,VEGFC,VWF	The volume enclosed by the membrane of a secretory granule.
GO:0034776	GO	BP	response to histamine	AOC1,DIAPH1,DRD2,DRD3,DRD4,GABRB1,GABRB2,GABRB3,GABRG2,HRH1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.
GO:0034968	GO	BP	histone lysine methylation	ASH1L,ASH2L,BEND3,CHD5,CTR9,CXXC1,DPY30,EHMT2,EZH2,KDM6A,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,NSD1,OGT,PAXIP1,PRDM5,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD8,SETDB2,SETMAR,SUV39H1,SUV39H2,TET2,TET3,WDR5,WDR61,WDR82,ZNF335	The modification of a histone by addition of one or more methyl groups to a lysine residue.
GO:0034969	GO	BP	histone arginine methylation	CARM1,COPRS,NR1H4,PRDM4,PRMT1,PRMT2,PRMT5,PRMT6,PRMT7,PRMT8	The modification of a histone by addition of a methyl group to an arginine residue.
GO:0034975	GO	BP	protein folding in endoplasmic reticulum	CALR,CANX,DNAJC10,HSP90B1,HSPA5,PDIA2,PDIA3	A protein folding process that takes place in the endoplasmic reticulum (ER). Secreted, plasma membrane and organelle proteins are folded in the ER, assisted by chaperones and foldases (protein disulphide isomerases), and additional factors required for optimal folding (ATP, Ca2+ and an oxidizing environment to allow disulfide bond formation).
GO:0034976	GO	BP	response to endoplasmic reticulum stress	ACADVL,ADD1,AIFM1,ALOX15,AMFR,ARFGAP1,ASNA1,ASNS,ATF3,ATF4,ATF6,ATF6B,ATG10,ATP2A1,ATP2A2,ATP6V0D1,ATXN3,AUP1,BAG6,BAK1,BAX,BBC3,BCL2,BCL2L11,BHLHA15,BRSK2,CALR,CASP4,CCL2,CDK5RAP3,CEBPB,CHAC1,CREB3,CREB3L1,CREB3L3,CREBRF,CTDSP2,CTH,CUL7,CXCL8,CXXC1,DAB2IP,DCTN1,DDIT3,DDRGK1,DDX11,DERL1,DERL2,DERL3,DNAJB11,DNAJB2,DNAJB9,DNAJC10,DNAJC3,EDEM1,EDEM2,EDEM3,EIF2AK3,EIF2AK4,EIF2B5,EIF2S1,EP300,ERLEC1,ERLIN1,ERLIN2,ERN1,ERN2,ERO1A,ERP44,EXTL3,FAF2,FAM129A,FBXO6,FKBP14,FLOT1,FOXRED2,GET4,GFPT1,GOSR2,GSK3A,GSK3B,HDGF,HERPUD1,HM13,HSP90B1,HSPA5,HYOU1,IGFBP1,ITPR1,JKAMP,JUN,KDELR3,KLHDC3,LMNA,MAN1B1,MAP3K5,MARCH6,MBTPS1,MBTPS2,MYDGF,NCK1,NFE2L2,NPLOC4,OS9,P4HB,PARK2,PARP16,PDIA5,PDIA6,PIK3R1,PIK3R2,PLA2G4B,PPP1R15A,PPP2R5B,PREB,PTPN1,RHBDD1,RNF103,RNF139,RNF185,RNF5,SCAMP5,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SEL1L,SELK,SERP1,SHC1,SRPR,SRPRB,SSR1,STT3B,STUB1,SULT1A3,SYVN1,TATDN2,TBL2,THBS1,THBS4,TLN1,TMEM129,TMEM67,TMUB1,TMX1,TNFRSF10B,TOR1A,TP53,TPP1,TRAF2,TRIB3,TRIM13,TRIM25,TSPYL2,TTC23L,UBA5,UBE2G2,UBE2J1,UBE2J2,UBQLN1,UBQLN2,UBXN4,UBXN8,UFC1,UFD1L,UFL1,UFM1,USP13,USP19,VAPB,VCP,VIMP,WFS1,WIPI1,XBP1,YIF1A,YOD1,ZBTB17	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
GO:0034983	GO	BP	peptidyl-lysine deacetylation	HDAC4,HDAC6,HDAC9,SIRT1,SIRT2,SIRT3,SIRT4	The removal of an acetyl group from an acetylated lysine residue in a peptide or protein.
GO:0034993	GO	CC	LINC complex	SUN1,SUN2,SYNE1,SYNE2,SYNE3	A protein complex that spans the nuclear outer and inner membranes, thereby linking the major cytoplasmic cytoskeleton elements to the nuclear lumen; the complex is conserved in eukaryotes and contains proteins with SUN and KASH domains.
GO:0035004	GO	MF	phosphatidylinositol 3-kinase activity	ATM,PIK3C2A,PIK3C2B,PIK3C2G,PIK3C3,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R2,PIK3R3,PIK3R6	Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol 3-phosphate. This reaction is the addition of a phosphate group to phosphatidylinositol or one of its phosphorylated derivatives at the 3' position of the inositol ring.
GO:0035019	GO	BP	somatic stem cell population maintenance	DPPA4,EPAS1,EPHA1,FGF2,FOXD3,KLF4,LIG4,LIN28A,NANOG,NOG,PBX1,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU5F1,PRDM14,SALL1,SALL4,SIX2,SKI,SMAD2,SMAD4,SOX2,SOX9,STAT3,TDGF1,ZFP36L2,ZIC3,ZSCAN10	Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
GO:0035020	GO	BP	regulation of Rac protein signal transduction	ALS2,ARF6,OGT,RASGRF1,STMN3	Any process that modulates the frequency, rate or extent of Rac protein signal transduction.
GO:0035023	GO	BP	regulation of Rho protein signal transduction	ABCA1,ABRA,ADRA1A,APOA1,APOC3,APOE,ARAP3,ARHGEF2,ARRB1,COL3A1,CUL3,DLC1,EPS8L1,EPS8L2,F2R,F2RL1,FLCN,GPR55,KANK1,KCTD13,LPAR1,MYOC,RAC1,RAF1,SCAI,TNFAIP1	Any process that modulates the frequency, rate or extent of Rho protein signal transduction.
GO:0035024	GO	BP	negative regulation of Rho protein signal transduction	ADRA1A,ARAP3,CUL3,DLC1,FLCN,KANK1,KCTD13,MYOC,SCAI,TNFAIP1	Any process that stops, prevents, or reduces the frequency, rate or extent of Rho protein signal transduction.
GO:0035025	GO	BP	positive regulation of Rho protein signal transduction	ABRA,APOA1,ARRB1,COL3A1,F2R,F2RL1,GPR55,LPAR1,RAC1	Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.
GO:0035032	GO	CC	phosphatidylinositol 3-kinase complex, class III	ATG14,BECN1,NRBF2,PIK3C3,PIK3R4	A phosphatidylinositol 3-kinase complex that contains a catalytic class III phosphoinositide 3-kinase (PI3K) subunit bound to a regulatory (adaptor) subunit. Additional adaptor proteins may be present. Class III PI3Ks have a substrate specificity restricted to phosphatidylinositol (PI).
GO:0035036	GO	BP	sperm-egg recognition	ADAM2,ADAM20,ADAM21,ADAM30,B4GALT1,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,FETUB,HVCN1,IZUMO1,IZUMO1R,KCNU1,OVGP1,SPAM1,UBAP2L,ZAN,ZP1,ZP2,ZP3,ZP4	The initial contact step made between the sperm plasma membrane and outer layer of the egg during fertilization.
GO:0035050	GO	BP	embryonic heart tube development	ACVR1,AHI1,BBS4,BBS5,BBS7,BMP2,CCDC103,CCDC39,CCDC40,CITED2,DLL1,DNAAF1,ENG,FOLR1,FOXN4,GATA4,HAND1,HAND2,HES1,IFT122,IHH,MEF2C,MEGF8,MESP1,MICAL2,MKKS,NKX2-5,NKX2-6,NOTCH1,NPHP3,PKD2,RYR2,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX2,TBX20,VANGL2,ZIC3	The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
GO:0035051	GO	BP	cardiocyte differentiation	ACTC1,ACVR1,BMP10,BMP2,CBY1,CSRP3,CXADR,ECE2,FOLR1,GATA6,GREM1,HAND2,HES1,HEY2,ISL1,JAG1,KDM6B,MAML1,MEF2A,MEF2C,MESP1,MYH11,MYH6,MYL2,MYLK3,MYOCD,NEBL,NKX2-5,NKX2-6,NOTCH1,NRG1,OBSL1,PDGFRA,PDGFRB,PDLIM5,PITX2,POU5F1,PROX1,RBPJ,REST,SIK1,SLC8A1,SORBS2,SOX17,SOX18,SRF,T,TBX2,TCAP,TGFB2,TTN,VEGFA,WNT3A,WT1	The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a cell that will form part of the cardiac organ of an individual.
GO:0035058	GO	BP	nonmotile primary cilium assembly	ARL13B,BBS1,BBS10,BBS4,C2CD3,CCDC13,CEP250,CEP89,CSNK1D,DISC1,FUZ,PCM1,PIBF1,VANGL2	The assembly of a primary cilium which contains a variable array of axonemal microtubules but does not contain molecular motors. Nonmotile primary cilia are found on many different cell types and function as sensory organelles that concentrate and organize sensory signaling molecules.
GO:0035064	GO	MF	methylated histone binding	ATRX,CBX5,CBX8,CDY1,CDYL,CHD1,CHD5,CHD8,DPPA3,GLYR1,ING1,ING2,ING3,ING4,ING5,KAT8,KDM4A,KDM7A,L3MBTL1,L3MBTL2,LOXL2,LRWD1,MPHOSPH8,MSH6,MSL3,MTF2,NCAPD3,NCAPG2,PHF1,PHF13,PHF19,PHF2,PHF8,RAG2,RBBP5,RRP8,SGF29,SPIN1,SUZ12,TDRD3,TP53BP1,UHRF1,WDR5,ZMYND11	Interacting selectively and non-covalently with a histone protein in which a residue has been modified by methylation. Histones are any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes.
GO:0035065	GO	BP	regulation of histone acetylation	ARRB1,AUTS2,BRCA1,BRD7,CHEK1,CTBP1,EID1,FLCN,FOXP3,IL1B,IWS1,KMT2A,LIF,MAPK3,MUC1,MYOCD,NOC2L,NOS1,PAXIP1,PIH1D1,PPARGC1A,RPS6KA4,RPS6KA5,RUVBL2,SET,SIN3A,SIRT1,SMAD4,SMARCB1,SNCA,SPI1,TAF7,WBP2	Any process that modulates the frequency, rate or extent of the addition of an acetyl group to a histone protein.
GO:0035066	GO	BP	positive regulation of histone acetylation	ARRB1,AUTS2,BRCA1,BRD7,FOXP3,IL1B,LIF,MAPK3,MUC1,NOS1,PAXIP1,PIH1D1,PPARGC1A,RPS6KA4,RPS6KA5,RUVBL2,SMAD4,SMARCB1,WBP2	Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.
GO:0035067	GO	BP	negative regulation of histone acetylation	CTBP1,NOC2L,PIH1D1,SET,SIN3A,SIRT1,SNCA,SPI1,TAF7	Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of an acetyl group to a histone protein.
GO:0035082	GO	BP	axoneme assembly	ARMC4,BBS2,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CFAP46,CFAP74,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,LRGUK,LRRC6,PIH1D3,RP1,RSPH1,RSPH4A,RSPH9,SPAG1,SPAG16,TTLL3,ZMYND10	The assembly and organization of an axoneme, the bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements.
GO:0035088	GO	BP	establishment or maintenance of apical/basal cell polarity	ANK1,CLIC4,CRB2,ERBB2IP,FOXJ1,FSCN1,MARK2,MSN,MTCL1,PRKCI,SCRIB,SLC9A3R1,SYNE4	Any cellular process that results in the specification, formation or maintenance polarization of a cell's architecture along its apical/basal axis so that the apical and basal regions of the cell have different membrane, extracellular matrix and sub-membrane cellular components.
GO:0035089	GO	BP	establishment of apical/basal cell polarity	FOXJ1,FSCN1,MSN,SCRIB,SLC9A3R1,SYNE4	The specification and formation of the polarity of a cell along its apical/basal axis.
GO:0035091	GO	MF	phosphatidylinositol binding	ACTN2,ADAP2,AKT1,ALOX15,AMER1,AMER2,ANKFY1,ANXA2,ANXA8,ARAP1,ARAP2,ARAP3,ARFIP1,ARFIP2,ARHGAP9,BBS5,BTK,CCDC88A,CEACAM5,CLVS1,CLVS2,COL4A3BP,COMMD1,CYTH3,DAB2IP,DAPP1,DPEP1,EEA1,EPB41,ESYT2,FAM21C,FCHO2,FERMT2,FES,FRMPD2,FRMPD4,GAB2,GBF1,GOLPH3,GOLPH3L,GPAA1,GRB7,HIP1,HIP1R,ING2,IQGAP1,IQGAP2,ITPR1,JPH2,KCNJ1,KCNJ2,KCNQ1,KIF16B,KRIT1,LANCL2,LDLRAP1,MAPKAP1,MARK1,MITD1,MPPE1,MTM1,MYO10,MYO1B,MYO1E,MYO1G,NCF1,NCF4,OGT,OSBP,OSBPL5,OSBPL8,PARD3,PASK,PFN1,PFN2,PHF12,PHLDA3,PICALM,PIGK,PIGU,PLCB1,PLEK,PLEKHA1,PLEKHA4,PLEKHA5,PLEKHA8,PLEKHF1,PXK,RAB35,RACGAP1,RAG2,RNF34,RPH3A,SCARB1,SCIN,SEPT12,SESTD1,SH3PXD2B,SH3YL1,SLC9A1,SNX1,SNX10,SNX11,SNX12,SNX13,SNX14,SNX16,SNX17,SNX18,SNX20,SNX21,SNX27,SNX3,SNX4,SNX5,SNX8,SNX9,SYT1,SYTL2,TECPR1,THY1,TIRAP,TNFAIP8L3,TTPA,TULP1,TULP3,TWF1,TWF2,VIL1,VNN1,WDFY1,WDFY3,WIPI1,WIPI2,ZFYVE1,ZFYVE16,ZFYVE19,ZFYVE26,ZFYVE28,ZFYVE9	Interacting selectively and non-covalently with any inositol-containing glycerophospholipid, i.e. phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
GO:0035092	GO	BP	sperm chromatin condensation	CHD5,H1FNT,HIST1H2BA,PSME4,SRPK1,SYCP3,TSSK6	The progressive compaction of the spermatid chromatin so that it reaches a level of condensation that is not compatible with nuclear activities such as transcription or DNA replication.
GO:0035094	GO	BP	response to nicotine	BAD,BCL2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,HMOX1,NFKB1,RELA,TNF	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
GO:0035095	GO	BP	behavioral response to nicotine	CHRNA3,CHRNA4,CHRNA5,CHRNB1,CHRNB2	Any process that results in a change in the behavior of an organism as a result of a nicotine stimulus.
GO:0035097	GO	CC	histone methyltransferase complex	ACTB,AEBP2,ASH2L,CBX5,CHD8,CXXC1,DPY30,E2F6,EED,EZH1,EZH2,H2AFY,H2AFY2,HCFC1,HDAC2,HDAC9,INO80C,JARID2,KANSL1,KAT8,KDM6A,KMT2A,KMT2B,KMT2C,KMT2E,LAS1L,MAX,MCRS1,MEN1,MGA,MTF2,NCOA6,OGT,PAGR1,PAXIP1,PELP1,PHF1,PHF19,PHF20,PPP1CA,PPP1CB,PPP1CC,PRDM4,PRMT5,PRPF31,RBBP4,RBBP5,RBBP7,RNF2,RUVBL1,RUVBL2,SENP3,SETD1A,SETD1B,SIRT1,STK38,SUZ12,TAF1,TAF4,TAF6,TAF7,TAF9,TEX10,TRIM37,WDR5,WDR82,ZNF335	A multimeric complex that is able to catalyze the addition of methyl groups to histone proteins.
GO:0035098	GO	CC	ESC/E(Z) complex	AEBP2,EED,EZH1,EZH2,H2AFY,H2AFY2,HDAC2,JARID2,MTF2,PHF1,PHF19,RBBP4,RBBP7,SIRT1,SUZ12,TRIM37	A multimeric protein complex that can methylate lysine-27 and lysine-9 residues of histone H3. In Drosophila the core subunits of the complex include ESC, E(Z), CAF1 (NURF-55) and SU(Z)12. In mammals the core subunits of the complex include EED, EZH2, SUZ12 and RBBP4.
GO:0035102	GO	CC	PRC1 complex	BMI1,CBX2,CBX4,CBX7,CBX8,PCGF2,PCGF6,PHC1,PHC2,PHC3,RING1,RNF2	A multiprotein complex that mediates monoubiquitination of lysine residues of histone H2A (lysine-118 in Drosophila or lysine-119 in mammals). The complex is required for stable long-term maintenance of transcriptionally repressed states and is involved in chromatin remodeling.
GO:0035108	GO	BP	limb morphogenesis	AFF3,BMPR1B,CREBBP,CTNNB1,CYP26B1,ECE1,FBXW4,FGFR2,GLI3,HDAC1,HDAC2,HOXA11,IHH,MBNL1,MEGF8,MSX1,MYH3,NIPBL,NOG,OSR1,OSR2,PCSK5,PTCH1,RARG,SALL1,SHH,SKI,SOX11,SOX4,TBX2,TBX3,TBX4,TBX5,TFAP2A,TFAP2B,TWIST1,WNT3,WNT7A,ZNF141,ZNF358	The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
GO:0035115	GO	BP	embryonic forelimb morphogenesis	NIPBL,OSR1,OSR2,TBX3,TBX5,TFAP2A,WNT7A,ZNF358	The process, occurring in the embryo, by which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
GO:0035116	GO	BP	embryonic hindlimb morphogenesis	AFF3,OSR1,OSR2,RARG,WNT7A	The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
GO:0035136	GO	BP	forelimb morphogenesis	NIPBL,OSR1,OSR2,TBX3,TBX5,TFAP2A,TFAP2B,WNT7A,ZNF358	The process in which the anatomical structures of the forelimb are generated and organized. The forelimbs are the front limbs of an animal, e.g. the arms of a human.
GO:0035137	GO	BP	hindlimb morphogenesis	AFF3,OSR1,OSR2,RARG,TFAP2B,WNT7A	The process in which the anatomical structures of the hindlimb are generated and organized.
GO:0035145	GO	CC	exon-exon junction complex	ACIN1,ALYREF,CASC3,EIF4A3,MAGOH,MAGOHB,PNN,POLDIP3,R3HCC1L,RBM8A,RNPS1,SAP18,SMG6,SRSF1,TDRD3,THRAP3,UPF1,UPF2,UPF3A,UPF3B	A multi-subunit complex deposited by the spliceosome upstream of messenger RNA exon-exon junctions. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay.
GO:0035148	GO	BP	tube formation	ATOH8,BBS4,BCAS3,BCL10,BMP4,CELSR1,COBL,DAB2IP,DEAF1,DLC1,DVL2,FOLR1,FUZ,GATA3,GRHL2,GRHL3,HOXA1,IFT122,ITGB1BP1,KDM2B,LMO4,MTHFD1,MTHFD1L,NOTCH1,OSR1,PAX2,PAX8,PHACTR4,PLXNB2,PODXL,PRICKLE1,SCRIB,SDCCAG8,SEMA4C,SIX1,SKI,SOX11,SOX4,SOX8,SOX9,STIL,TSC2,VANGL2,VEGFA	Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
GO:0035162	GO	BP	embryonic hemopoiesis	FLT3LG,IL3,KDR,KIT,KITLG,KMT2A,TAL1,TGFBR2,THOC5,TPO,VEGFA,ZFPM1	The stages of blood cell formation that take place within the embryo.
GO:0035173	GO	MF	histone kinase activity	AURKB,BAZ1B,CDK1,CDK2,CHEK1,GSG2,JAK2,PKN1,PRKAA1,PRKAA2,PRKCA,PRKCB,VPRBP,VRK1	Catalysis of the transfer of a phosphate group to a histone. Histones are any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes.
GO:0035176	GO	BP	social behavior	CHRNB2,CNTNAP2,DRD3,DRD4,EIF4EBP2,GRID1,MAPK8IP2,MKKS,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,PTEN,SHANK1,SHANK2,SHANK3,SLC6A4,TBX1	Behavior directed towards society, or taking place between members of the same species. Occurs predominantly, or only, in individuals that are part of a group.
GO:0035184	GO	MF	histone threonine kinase activity	CHEK1,GSG2,PKN1,PRKCA,PRKCB,VPRBP,VRK1	Catalysis of the transfer of a phosphate group to a threonine residue of a histone. Histones are any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes.
GO:0035194	GO	BP	posttranscriptional gene silencing by RNA	ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,CELF1,CLP1,CNOT1,CNOT6,CNOT7,CNOT8,DGCR8,DICER1,DROSHA,HNRNPA2B1,LIMD1,LIN28A,LIN28B,METTL3,MOV10,PRKRA,RAN,RBM4,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TERT,TNRC6A,TNRC6B,TNRC6C,TRIM71,WTIP,XPO5,ZCCHC11,ZFP36	Any process of posttranscriptional gene inactivation (silencing) mediated by small RNA molecules that may trigger mRNA degradation or negatively regulate translation.
GO:0035195	GO	BP	gene silencing by miRNA	ADAR,AGO1,AGO2,AGO3,AGO4,AJUBA,CNOT1,CNOT6,CNOT7,CNOT8,DGCR8,DICER1,DROSHA,HNRNPA2B1,LIMD1,LIN28A,LIN28B,METTL3,MOV10,PRKRA,RAN,RBM4,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TNRC6A,TNRC6C,TRIM71,WTIP,XPO5,ZCCHC11,ZFP36	Downregulation of gene expression through the action of microRNAs (miRNAs), endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), miRNAs can downregulate gene expression by either of two posttranscriptional mechanisms: endolytic cleavage of mRNA cleavage or translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA.
GO:0035196	GO	BP	production of miRNAs involved in gene silencing by miRNA	ADAR,AGO1,AGO2,AGO3,AGO4,DGCR8,DICER1,DROSHA,HNRNPA2B1,LIN28A,LIN28B,METTL3,PRKRA,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,ZCCHC11	Cleavage of stem-loop RNA precursors into microRNAs (miRNAs), a class of small RNAs that primarily silence genes by blocking the translation of mRNA transcripts into protein.
GO:0035197	GO	MF	siRNA binding	AGO2,DICER1,TARBP2,TLR7,TLR9	Interacting selectively and non-covalently with a small interfering RNA, a 21-23 nucleotide RNA that is processed from double stranded RNA (dsRNA) by an RNAse enzyme.
GO:0035198	GO	MF	miRNA binding	AGO1,AGO2,AGO3,AGO4,HNRNPA2B1,MEF2C,PNPT1,POU5F1,RBM4,SOX2,TRIM71,ZC3H12A	Interacting selectively and non-covalently with a microRNA, a 21-23 nucleotide RNA that is processed from a stem-loop RNA precursor (pre-miRNA) that is encoded within plant and animal genomes.
GO:0035235	GO	BP	ionotropic glutamate receptor signaling pathway	APP,CDK5R1,CLN3,CPEB4,GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN3A,GRIN3B,PTK2B	A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell, followed by the movement of ions through a channel in the receptor complex. Ends with regulation of a downstream cellular process, e.g. transcription.
GO:0035239	GO	BP	tube morphogenesis	ACVR1,ACVRL1,AGR2,AHI1,ATOH8,BBS4,BBS5,BBS7,BCAS3,BCL10,BMP2,BMP4,CCDC103,CCDC39,CCDC40,CCM2,CELSR1,CITED1,COBL,COL4A1,CSF1R,CSNK2B,CTNNB1,CTSH,DAB2IP,DACT1,DEAF1,DLC1,DLL1,DLL4,DNAAF1,DVL2,ENG,EPHA2,EPHB3,FGF1,FGF10,FGF2,FGFR2,FOLR1,FOXD1,FOXF1,FOXN4,FUZ,GATA3,GATA4,GDF2,GDNF,GLI1,GLI2,GRHL2,GRHL3,HAND1,HAND2,HES1,HOXA1,HOXA11,HOXD11,ID2,IFT122,IHH,ITGB1BP1,KDM2B,KLHL3,LHX1,LMO4,MEF2C,MEGF8,MESP1,MET,MICAL2,MKKS,MTHFD1,MTHFD1L,MTSS1,MYC,NIPBL,NKX2-5,NKX3-1,NOTCH1,NOTCH4,NPHP3,NPNT,NRP1,OSR1,PAK1,PAX2,PAX8,PDGFRA,PHACTR4,PKD1,PKD2,PLXNB2,PODXL,PRICKLE1,PRKD2,PRKX,RASIP1,RBPJ,RHOA,RHOB,RYR2,SALL1,SCRIB,SDCCAG8,SEMA3E,SEMA4C,SETDB2,SFRP2,SHH,SIX1,SIX2,SKI,SLIT2,SMO,SOX11,SOX17,SOX18,SOX4,SOX8,SOX9,SRF,STARD13,STIL,STRA6,TBX1,TBX2,TBX20,TCF21,TGFBR2,TSC2,VANGL2,VEGFA,WNK4,WT1,ZIC3	The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
GO:0035246	GO	BP	peptidyl-arginine N-methylation	FBXO11,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8	The addition of a methyl group onto a nitrogen atom of an arginine residue in a protein.
GO:0035247	GO	BP	peptidyl-arginine omega-N-methylation	PRMT1,PRMT5,PRMT6,PRMT7,PRMT8	The addition of a methyl group onto a terminal nitrogen (omega nitrogen) atom of an arginine residue in a protein.
GO:0035250	GO	MF	UDP-galactosyltransferase activity	B3GALT1,B3GALT4,B3GALT5,B3GALT6,B4GALT1,B4GALT7,PLOD3	Catalysis of the transfer of a galactose group from UDP-galactose to an acceptor molecule.
GO:0035251	GO	MF	UDP-glucosyltransferase activity	GYS1,GYS2,POGLUT1,UGGT1,UGGT2	Catalysis of the transfer of a glucosyl group from UDP-glucose to an acceptor molecule.
GO:0035254	GO	MF	glutamate receptor binding	CAMK2A,DLG4,SHANK1,SHANK2,SHANK3,SYNDIG1	Interacting selectively and non-covalently with a glutamate receptor.
GO:0035257	GO	MF	nuclear hormone receptor binding	ASXL1,BRCA1,BUD31,CALR,CCNE1,CDK7,CNOT1,CRX,CTNNB1,DDX17,DDX5,DDX54,DYX1C1,FHL2,FOXP1,GAS2L1,GRIP1,HMGA1,HMGN3,ISL1,JMJD1C,KAT5,KDM1A,KDM3A,LEF1,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,NCOA1,NCOA3,NCOA4,NCOA6,NCOA7,NKX3-1,NR4A2,NRIP1,NSD1,NUP62,OASL,PHB2,PIAS1,PIAS2,PKN1,PPARG,PPARGC1A,PPARGC1B,PPID,PRAME,PRKCB,PRMT2,RAN,RARG,RB1,RERG,RNF4,SNW1,TACC2,TAF10,TCF21,TGFB1I1,THRAP3,TRIP12,TRIP6,WIPI1,XBP1,ZNF366,ZNHIT3	Interacting selectively and non-covalently with a nuclear hormone receptor, a ligand-dependent receptor found in the nucleus of the cell.
GO:0035258	GO	MF	steroid hormone receptor binding	BRCA1,CALR,CCNE1,CDK7,CNOT1,CTNNB1,DDX17,DDX5,DDX54,DYX1C1,FHL2,FOXP1,GRIP1,ISL1,KAT5,KDM1A,KDM3A,LEF1,NCOA1,NCOA3,NCOA4,NCOA6,NKX3-1,NRIP1,NSD1,PHB2,PIAS1,PIAS2,PKN1,PPARGC1A,PPARGC1B,PPID,PRKCB,PRMT2,RAN,RB1,RERG,RNF4,TAF10,TCF21,TGFB1I1,WIPI1,XBP1,ZNF366	Interacting selectively and non-covalently with a steroid hormone receptor.
GO:0035265	GO	BP	organ growth	BMP10,C3orf58,CER1,DDR2,DLL1,EVC,FGF10,FGF7,FGFR2,FGFR3,LEP,LEPR,MESP1,NLGN4X,NOTCH1,NPPC,PDLIM5,S1PR1,SORBS2,SOX9,STC1,TGFB2,TGFBR3	The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
GO:0035267	GO	CC	NuA4 histone acetyltransferase complex	ACTB,ACTL6A,BRD8,DMAP1,EP400,EPC1,ING3,KAT5,MEAF6,MORF4L1,RUVBL1,RUVBL2,TRRAP,YEATS4	A complex having histone acetylase activity on chromatin, as well as ATPase, DNA helicase and structural DNA binding activities. The complex is thought to be involved in double-strand DNA break repair. Subunits of the human complex include HTATIP/TIP60, TRRAP, RUVBL1, BUVBL2, beta-actin and BAF53/ACTL6A. In yeast, the complex has 13 subunits, including the catalytic subunit Esa1 (homologous to human Tip60).
GO:0035269	GO	BP	protein O-linked mannosylation	B4GAT1,DPM1,DPM2,DPM3,FKRP,FKTN,GYLTL1B,ISPD,LARGE,POMGNT2,SDF2,TMEM5	The transfer of mannose from dolichyl activated mannose to the hydroxyl group of a seryl or threonyl residue of a protein acceptor molecule, to form an O-linked protein-sugar linkage.
GO:0035270	GO	BP	endocrine system development	AKT1,BMP2,BMP4,BMP5,BMP6,CDK6,CITED2,DLL1,DRD2,EIF2AK3,FOXA2,FOXA3,FOXE1,FOXO1,GCK,GCM2,GHRH,GLI2,HES1,HNF1B,HNF4A,HNF4G,HOXD3,IAPP,IL6,IL6R,INS,INSM1,MDK,NEUROD1,NEUROG3,NF1,NKX2-1,NKX2-2,NKX2-5,NKX6-1,NR0B1,NR5A2,ONECUT1,ONECUT3,PAX4,PAX6,PAX8,PDX1,PITX2,PKLR,PTF1A,RFX3,RFX6,SIX1,SIX3,SLC2A2,SOX3,STRA6,TBX1,TGFBR1,WT1	Progression of the endocrine system over time, from its formation to a mature structure. The endocrine system is a system of hormones and ductless glands, where the glands release hormones directly into the blood, lymph or other intercellular fluid, and the hormones circulate within the body to affect distant organs. The major glands that make up the human endocrine system are the hypothalamus, pituitary, thyroid, parathryoids, adrenals, pineal body, and the reproductive glands which include the ovaries and testes.
GO:0035272	GO	BP	exocrine system development	FGF10,FGFR2,IGSF3,NKX3-1,PTF1A,RAB26	Progression of the exocrine system over time, from its formation to a mature structure. The exocrine system is a system of hormones and glands, where the glands secrete straight to a target site via ducts or tubes. The human exocrine system includes the salivary glands, sweat glands and many glands of the digestive system.
GO:0035278	GO	BP	miRNA mediated inhibition of translation	AGO1,AGO2,AGO3,AGO4,RBM4,TNRC6A,TNRC6C,TRIM71,ZFP36	The process in which microRNAs (miRNAs) block the translation of target mRNAs into proteins. Once incorporated into a RNA-induced silencing complex (RISC), a miRNA will typically mediate repression of translation if the miRNA imperfectly base-pairs with the 3' untranslated regions of target mRNAs
GO:0035280	GO	BP	miRNA loading onto RISC involved in gene silencing by miRNA	ADAR,AGO1,AGO2,AGO3,AGO4,DICER1,TARBP2	The transfer of a microRNA (miRNA) strand from a miRNA:miRNA duplex onto the RNA-initiated silencing complex (RISC).
GO:0035282	GO	BP	segmentation	BASP1,BMI1,BMP4,COBL,CRB2,DLL1,DVL2,FOXB1,FZD5,HOXD8,LFNG,MTF2,OSR1,PLD6,PPP2R3A,RIPPLY1,RIPPLY2,T,TBX3,TDGF1,TDRD5,WT1	The regionalization process that divides an organism or part of an organism into a series of semi-repetitive parts, or segments, often arranged along a longitudinal axis.
GO:0035295	GO	BP	tube development	ACVR1,ACVRL1,AGR2,AHI1,ALDH1A2,ARL13B,ASCL1,ATOH8,ATP6AP2,ATP7A,BAG6,BBS4,BBS5,BBS7,BCAS3,BCL10,BMP2,BMP4,BMP7,BMPR2,CCDC103,CCDC39,CCDC40,CCM2,CDX2,CEBPA,CELSR1,CER1,CHD8,CHI3L1,CHRD,CITED1,CITED2,CLMP,COBL,COL4A1,CSF1R,CSNK2B,CTNNB1,CTSH,DAB2IP,DACT1,DACT2,DEAF1,DLC1,DLL1,DLL4,DNAAF1,DVL2,EDNRB,ENG,EPHA2,EPHB3,ERRFI1,FGF1,FGF10,FGF2,FGF7,FGFR2,FOLR1,FOXB1,FOXD1,FOXF1,FOXJ1,FOXL1,FOXN4,FUZ,GATA3,GATA4,GATA5,GATA6,GDF2,GDNF,GLI1,GLI2,GLI3,GPC3,GRHL2,GRHL3,HAND1,HAND2,HECA,HES1,HES5,HNF1B,HOXA1,HOXA11,HOXD11,ID2,IFT122,IHH,ING2,ITGA3,ITGA6,ITGB1BP1,ITGB3,ITGB4,KDM2B,KIT,KLHL3,LHX1,LMO4,MEF2C,MEGF8,MESP1,MET,MICAL2,MIXL1,MKKS,MTHFD1,MTHFD1L,MTSS1,MYC,NFIB,NIPBL,NKX2-5,NKX2-6,NKX3-1,NOTCH1,NOTCH4,NPHP3,NPNT,NRP1,OSR1,PAK1,PAX2,PAX8,PCSK5,PDGFA,PDGFRA,PDPN,PHACTR4,PKD1,PKD2,PKDCC,PLXNB2,PODXL,POU3F3,PRICKLE1,PRKD2,PRKX,PROX1,PTCH1,RARB,RARRES2,RASIP1,RBP4,RBPJ,RET,RHOA,RHOB,ROBO2,RYR2,SALL1,SCRIB,SDCCAG8,SEMA3E,SEMA4C,SETDB2,SFRP2,SFTPD,SHH,SIX1,SIX2,SKI,SLIT2,SMO,SOX11,SOX17,SOX18,SOX4,SOX8,SOX9,SRF,STARD13,STAT1,STIL,STRA6,TBX1,TBX2,TBX20,TCF21,TFAP2B,TGFB3,TGFBR2,TRIM71,TSC2,VANGL2,VEGFA,WNK4,WNT4,WNT7B,WT1,ZIC3,ZNF358	The process whose specific outcome is the progression of a tube over time, from its initial formation to a mature structure. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues including lung and trachea, kidney, the mammary gland, the vascular system and the gastrointestinal and urinary-genital tracts.
GO:0035303	GO	BP	regulation of dephosphorylation	AGTR2,AKAP6,ANKLE2,ARFGEF3,ARPP19,BMP2,CALM1,CAMSAP3,CASC5,CCDC8,CD2BP2,CD300A,CDCA2,CDK5RAP3,CEP192,CHP1,CHP2,CNEP1R1,CNST,CRY2,CSRNP2,CSRNP3,DLC1,DLG2,DLG3,DUSP26,EIF2AK2,ELFN1,ELFN2,ELL,ENSA,FARP1,FKBP15,FKBP1A,FKBP1B,GBA,GPATCH2,GPLD1,GRXCR1,HSP90B1,HTT,IFNG,IGBP1,IKBKB,INPP5K,ITGA1,KIAA0430,LMTK3,MAGI2,MASTL,MEF2C,MPHOSPH10,MYO1D,NCKAP1L,NIFK,NSMF,NUAK1,PCDH11X,PCIF1,PDGFRB,PKMYT1,PLEK,PPME1,PPP1R12A,PPP1R15A,PPP1R16B,PPP1R17,PPP1R26,PPP1R27,PPP1R35,PPP1R36,PPP1R37,PPP1R7,PPP2R1A,PPP2R2A,PPP2R2B,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5A,PPP2R5B,PPP2R5C,PPP2R5D,PPP2R5E,PPP4R4,PPP6R1,PPP6R3,PRKCD,RBM26,RIMBP2,RIPK3,ROCK1,ROCK2,RRP1B,SEMA4D,SET,SFI1,SH2D4A,SH3RF2,SLC7A14,SMG5,SMG6,SMG7,SMPD1,SPOCD1,SPPL3,SPRED1,SYMPK,SYTL2,TGFB1,TGFB2,TIPRL,TMEM132D,TMEM225,TNF,TSC1,TSKS,UBN1,URI1,WDR81,WNK1,YWHAB,YWHAE,ZCCHC9,ZFYVE1	Any process that modulates the frequency, rate or extent of removal of phosphate groups from a molecule.
GO:0035304	GO	BP	regulation of protein dephosphorylation	AGTR2,AKAP6,ANKLE2,ARFGEF3,ARPP19,BMP2,CALM1,CAMSAP3,CASC5,CCDC8,CD2BP2,CD300A,CDCA2,CDK5RAP3,CEP192,CHP1,CHP2,CNEP1R1,CNST,CRY2,CSRNP2,CSRNP3,DLC1,DLG2,DLG3,DUSP26,EIF2AK2,ELFN1,ELFN2,ELL,ENSA,FARP1,FKBP15,FKBP1A,FKBP1B,GBA,GPATCH2,GPLD1,GRXCR1,HSP90B1,HTT,IFNG,IGBP1,IKBKB,ITGA1,KIAA0430,LMTK3,MAGI2,MASTL,MEF2C,MPHOSPH10,MYO1D,NCKAP1L,NIFK,NSMF,NUAK1,PCDH11X,PCIF1,PDGFRB,PKMYT1,PLEK,PPME1,PPP1R12A,PPP1R15A,PPP1R16B,PPP1R17,PPP1R26,PPP1R27,PPP1R35,PPP1R36,PPP1R37,PPP1R7,PPP2R1A,PPP2R2A,PPP2R2B,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5A,PPP2R5B,PPP2R5C,PPP2R5D,PPP2R5E,PPP4R4,PPP6R1,PPP6R3,PRKCD,RBM26,RIMBP2,RIPK3,ROCK1,ROCK2,RRP1B,SEMA4D,SET,SFI1,SH2D4A,SH3RF2,SLC7A14,SMPD1,SPOCD1,SPPL3,SPRED1,SYMPK,SYTL2,TGFB1,TGFB2,TIPRL,TMEM132D,TMEM225,TNF,TSC1,TSKS,UBN1,URI1,WDR81,WNK1,YWHAB,YWHAE,ZCCHC9,ZFYVE1	Any process that modulates the frequency, rate or extent of removal of phosphate groups from a protein.
GO:0035305	GO	BP	negative regulation of dephosphorylation	ARFGEF3,CAMSAP3,CASC5,CCDC8,CD2BP2,CEP192,CHP1,CNST,CRY2,CSRNP2,CSRNP3,DLG2,DLG3,ELFN1,ELFN2,ELL,FARP1,FKBP15,FKBP1A,FKBP1B,GPATCH2,GRXCR1,IKBKB,INPP5K,KIAA0430,LMTK3,MASTL,MPHOSPH10,MYO1D,NCKAP1L,NIFK,PCDH11X,PCIF1,PKMYT1,PPP1R15A,PPP1R16B,PPP1R26,PPP1R27,PPP1R35,PPP1R36,PPP1R37,PPP2R4,PPP4R4,RBM26,RIMBP2,ROCK1,ROCK2,RRP1B,SEMA4D,SFI1,SH2D4A,SH3RF2,SLC7A14,SPOCD1,SPRED1,SYTL2,TGFB2,TIPRL,TMEM132D,TMEM225,TNF,TSKS,UBN1,URI1,WDR81,WNK1,YWHAB,YWHAE,ZCCHC9,ZFYVE1	Any process the stops, prevents, or reduces the frequency, rate or extent of removal of phosphate groups from a molecule.
GO:0035307	GO	BP	positive regulation of protein dephosphorylation	AGTR2,AKAP6,ANKLE2,BMP2,CALM1,CD300A,CDCA2,CHP2,CNEP1R1,DLC1,DUSP26,GBA,GPLD1,IFNG,ITGA1,MAGI2,MEF2C,NSMF,PDGFRB,PLEK,PPP1R12A,PPP1R15A,PPP1R16B,PPP1R7,PPP2R4,PPP2R5A,PRKCD,RIPK3,SMPD1,SPPL3,SYMPK,TGFB1	Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
GO:0035308	GO	BP	negative regulation of protein dephosphorylation	ARFGEF3,CAMSAP3,CASC5,CCDC8,CD2BP2,CEP192,CHP1,CNST,CRY2,CSRNP2,CSRNP3,DLG2,DLG3,ELFN1,ELFN2,ELL,FARP1,FKBP15,FKBP1A,FKBP1B,GPATCH2,GRXCR1,IKBKB,KIAA0430,LMTK3,MASTL,MPHOSPH10,MYO1D,NCKAP1L,NIFK,PCDH11X,PCIF1,PKMYT1,PPP1R15A,PPP1R16B,PPP1R26,PPP1R27,PPP1R35,PPP1R36,PPP1R37,PPP2R4,PPP4R4,RBM26,RIMBP2,ROCK1,ROCK2,RRP1B,SEMA4D,SFI1,SH2D4A,SH3RF2,SLC7A14,SPOCD1,SPRED1,SYTL2,TGFB2,TIPRL,TMEM132D,TMEM225,TNF,TSKS,UBN1,URI1,WDR81,WNK1,YWHAB,YWHAE,ZCCHC9,ZFYVE1	Any process the stops, prevents, or reduces the frequency, rate or extent of removal of phosphate groups from a protein.
GO:0035313	GO	BP	wound healing, spreading of epidermal cells	ACVRL1,COL5A1,MMP12,PLET1,WNT7A	The migration of an epidermal cell along or through a wound gap that contributes to the reestablishment of a continuous epidermis.
GO:0035315	GO	BP	hair cell differentiation	CTNNB1,ERCC2,ERCC3,GRXCR1,HES5,JAG2,LRTOMT,PITX2,SOD1,SPINK5,STRC,USH2A	The process in which a relatively unspecialized cell acquires specialized features of a hair cell.
GO:0035326	GO	MF	enhancer binding	ACTB,ACTL6A,AHR,ARNT,ATF2,CDX1,CDX2,CHD4,CREB1,ELL3,ESRRB,FOXH1,FOXN4,GATA2,GATAD2B,GZF1,H2AFZ,H3F3A,HDAC1,HDAC2,HMGB2,HNRNPC,ISL1,JUN,LEF1,MBD2,MBD3,MEOX2,MIXL1,MTA2,NFATC1,NFKB1,NONO,NR1H4,NR5A1,NR5A2,POU4F1,RAI1,RBBP4,REL,RELA,RUVBL2,SFPQ,SMAD2,SMAD3,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SOX11,SOX9,SPI1,T,TCF12,TCF3,TFAP2B,TIPARP,XBP1,YY1,ZBTB16	Interacting selectively and non-covalently with an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
GO:0035327	GO	CC	transcriptionally active chromatin	AFF4,BCAS3,CTR9,ELL,ESR1,EXOSC10,EXOSC3,EXOSC4,EXOSC5,H2AFB1,H2AFB2,ICE1,ICE2,PADI2,PELP1,PSIP1,TTC37,WDR61,ZC3H8	The ordered and organized complex of DNA and protein that forms regions of the chromosome that are being actively transcribed.
GO:0035329	GO	BP	hippo signaling	AMOT,AMOTL1,AMOTL2,CASP3,DCHS1,DVL2,FAT4,LATS1,LATS2,MOB1A,MOB1B,NPHP4,SAV1,STK3,STK4,TEAD1,TEAD2,TEAD3,TEAD4,TJP1,TJP2,WWC1,WWTR1,YAP1,YWHAB,YWHAE	The series of molecular signals mediated by the serine/threonine kinase Hippo or one of its orthologs. In Drosophila, Hippo in complex with the scaffold protein Salvador (Sav), phosphorylates and activates Warts (Wts), which in turn phosphorylates and inactivates the Yorkie (Yki) transcriptional activator. The core fly components hippo, sav, wts and mats are conserved in mammals as STK4/3 (MST1/2), SAV1/WW45, LATS1/2 and MOB1.
GO:0035330	GO	BP	regulation of hippo signaling	AJUBA,LIMD1,NEK8,NF2,SOX11,WTIP,WWC1,WWC2,WWC3	Any process that modulates the frequency, rate or extent of hippo signaling.
GO:0035331	GO	BP	negative regulation of hippo signaling	AJUBA,LIMD1,WTIP,WWC1,WWC2,WWC3	Any process that stops, prevents, or reduces the frequency, rate or extent of hippo signaling.
GO:0035335	GO	BP	peptidyl-tyrosine dephosphorylation	CDC14B,CDC25B,CDC25C,CDKN3,DUSP1,DUSP11,DUSP12,DUSP18,DUSP2,DUSP21,DUSP26,DUSP3,DUSP5,DUSP6,DUSP7,DUSP8,EPM2A,EYA2,EYA3,MTMR3,MTMR4,MTMR6,MTMR7,PGP,PTEN,PTP4A1,PTP4A2,PTP4A3,PTPN1,PTPN11,PTPN12,PTPN13,PTPN14,PTPN18,PTPN2,PTPN21,PTPN22,PTPN23,PTPN3,PTPN4,PTPN6,PTPN7,PTPN9,PTPRA,PTPRB,PTPRC,PTPRD,PTPRE,PTPRF,PTPRG,PTPRH,PTPRJ,PTPRK,PTPRM,PTPRN2,PTPRO,PTPRR,PTPRT,PTPRU,PTPRZ1,TIMM50,TPTE	The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
GO:0035336	GO	BP	long-chain fatty-acyl-CoA metabolic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AGK,DGAT1,DGAT2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FAR1,FAR2,FASN,HACD1,HACD2,HSD17B12,OLAH,PPT1,PPT2,SCD,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways involving long-chain fatty-acyl-CoAs, any derivative of coenzyme A in which the sulfhydryl group is in a thioester linkage with a long-chain fatty-acyl group. Long-chain fatty-acyl-CoAs have chain lengths of C13 or more.
GO:0035337	GO	BP	fatty-acyl-CoA metabolic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSM2A,AGK,DGAT1,DGAT2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FAR1,FAR2,FASN,HACD1,HACD2,HSD17B12,HSD17B4,MCEE,MLYCD,OLAH,PPT1,PPT2,SCD,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways involving a fatty-acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with a fatty-acyl group.
GO:0035338	GO	BP	long-chain fatty-acyl-CoA biosynthetic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AGK,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FASN,HACD1,HACD2,HSD17B12,OLAH,PPT1,PPT2,SCD,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways resulting in the formation of a long-chain fatty-acyl-CoA any derivative of coenzyme A in which the sulfhydryl group is in a thioester linkage with a long-chain fatty-acyl group. Long-chain fatty-acyl-CoAs have chain lengths of C13 or more.
GO:0035356	GO	BP	cellular triglyceride homeostasis	C1QTNF3,DGAT2,FITM2,NR1H4,SIRT1,XBP1	Any process involved in the maintenance of an internal steady state of triglyceride within a cell or between a cell and its external environment.
GO:0035357	GO	BP	peroxisome proliferator activated receptor signaling pathway	ACTN4,ALOXE3,PDK3,PPARG,RXRA	The series of molecular signals initiated by binding of a ligand to any of the peroxisome proliferator activated receptors (alpha, beta or gamma) in the nuclear membrane, and ending with the initiation or termination of the transcription of target genes.
GO:0035358	GO	BP	regulation of peroxisome proliferator activated receptor signaling pathway	ALOX15,ASXL1,ASXL2,CITED2,LMO3,PLIN5,PTGIS,SIRT1	Any process that modulates the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway.
GO:0035371	GO	CC	microtubule plus-end	CDK5RAP2,CKAP5,CLASP1,CLASP2,CLIP1,DST,KIF18B,KIF2C,KNSTRN,NCKAP5L,SLAIN2,SPAG5	The growing (plus) end of a microtubule. In vitro, microtubules polymerize more quickly at the plus end than at the minus end. In vivo, microtubule growth occurs only at the plus end, and the plus end switches between periods of growth and shortening, a behavior known as dynamic instability.
GO:0035372	GO	BP	protein localization to microtubule	CHAMP1,CRIPT,DIAPH1,KIF20B,MAPRE1,MID1,MID2	A process in which a protein is transported to, or maintained at, a microtubule.
GO:0035404	GO	BP	histone-serine phosphorylation	AURKB,HMGA2,RPS6KA4,RPS6KA5,VRK1	The modification of histones by addition of a phosphate group to a serine residue.
GO:0035405	GO	BP	histone-threonine phosphorylation	CHEK1,GSG2,PKN1,PRKCA,PRKCB,VPRBP,VRK1	The modification of histones by addition of a phosphate group to a threonine residue.
GO:0035412	GO	BP	regulation of catenin import into nucleus	APC2,AXIN2,BAMBI,DAB2IP,DACT1,DACT3,EGF,EGFR,EMD,FZD7,GNAQ,KANK1,POU5F1,SEMA5A,SFRP5,SLC9A3R1,SMAD3,SNAI2,UBR5,WNT3A,WWTR1	Any process that modulates the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus.
GO:0035413	GO	BP	positive regulation of catenin import into nucleus	BAMBI,DACT1,EGF,EGFR,KANK1,POU5F1,SEMA5A,SMAD3,UBR5,WNT3A	Any process that increases the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus.
GO:0035414	GO	BP	negative regulation of catenin import into nucleus	APC2,AXIN2,DAB2IP,DACT3,EMD,SFRP5,SLC9A3R1,SNAI2,WWTR1	Any process that decreases the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus.
GO:0035418	GO	BP	protein localization to synapse	DLG4,NLGN1,NLGN2,NPHS1,NRXN1,NRXN2,SHANK1	Any process in which a protein is transported to, and/or maintained at the synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
GO:0035435	GO	BP	phosphate ion transmembrane transport	ADAMTS8,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC25A3,SLC34A2	The directed movement of phosphate across a membrane by means of some agent such as a transporter or pore.
GO:0035437	GO	BP	maintenance of protein localization in endoplasmic reticulum	ANKRD13C,GPAA1,HSPA5,OS9,PDIA2,PDIA3	Any process in which a protein is maintained in the endoplasmic reticulum and prevented from moving elsewhere. These include sequestration within the endoplasmic reticulum, protein stabilization to prevent transport elsewhere and the active retrieval of proteins that escape the endoplasmic reticulum.
GO:0035455	GO	BP	response to interferon-alpha	ADAR,AXL,BST2,EIF2AK2,GAS6,IFITM1,IFITM2,IFITM3,IFNAR1,IFNAR2,KLHL20,MX2,OAS1,TPR	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-alpha stimulus. Interferon-alpha is a type I interferon.
GO:0035456	GO	BP	response to interferon-beta	BST2,CDC34,HTRA2,IFITM1,IFITM2,IFITM3,IFNB1,IKBKE,IRF1,IRG1,NDUFA13,PLSCR1,PNPT1,STAT1,TRIM6,UBE2G2,UBE2K,XAF1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.
GO:0035457	GO	BP	cellular response to interferon-alpha	AXL,GAS6,IFNAR1,OAS1,TPR	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-alpha stimulus. Interferon-alpha is a type I interferon.
GO:0035458	GO	BP	cellular response to interferon-beta	CDC34,HTRA2,IFNB1,IRF1,IRG1,NDUFA13,PNPT1,STAT1,TRIM6,UBE2G2,UBE2K	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.
GO:0035459	GO	BP	cargo loading into vesicle	KIF13A,PICALM,RAB1A,TBC1D20,TMED10,TMED2	The formation of a protein complex between the coat proteins and proteins that are going to be transported by a vesicle.
GO:0035469	GO	BP	determination of pancreatic left/right asymmetry	CCDC39,CCDC40,DNAAF1,NPHP3,ZIC3	Determination of the asymmetric location of the pancreas with respect to the left and right halves of the organism.
GO:0035497	GO	MF	cAMP response element binding	ATF2,CREB1,CREB3L1,CREB3L2,E4F1,HMGA2,JUN	Interacting selectively and non-covalently with the cyclic AMP response element (CRE), a short palindrome-containing sequence found in the promoters of genes whose expression is regulated in response to cyclic AMP.
GO:0035507	GO	BP	regulation of myosin-light-chain-phosphatase activity	IKBKB,NCKAP1L,NUAK1,PPP1R12A,ROCK1,ROCK2,TNF	Any process that modulates the frequency, rate or extent of myosin-light-chain-phosphatase activity.
GO:0035509	GO	BP	negative regulation of myosin-light-chain-phosphatase activity	IKBKB,NCKAP1L,ROCK1,ROCK2,TNF	Any process that stops, prevents, or reduces the frequency, rate or extent of myosin-light-chain-phosphatase activity.
GO:0035510	GO	BP	DNA dealkylation	AICDA,ALKBH1,ALKBH2,ALKBH3,APEX1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,ASCC1,ASCC2,ASCC3,FTO,MGMT,MPG,TDG,TET1,TET2,TET3	The removal of an alkyl group from one or more nucleotides within an DNA molecule.
GO:0035511	GO	BP	oxidative DNA demethylation	ALKBH2,ALKBH3,FTO,TDG,TET1,TET2,TET3	Removal of the methyl group from one or more nucleotides within a DNA molecule involving the oxidation (i.e. electron loss) of one or more atoms.
GO:0035518	GO	BP	histone H2A monoubiquitination	BCOR,CUL4B,DDB1,DDB2,KDM2B,PCGF1,RING1,RNF168,RNF2,RYBP,SKP1,TRIM37	The modification of histone H2A by addition of a single ubiquitin group.
GO:0035519	GO	BP	protein K29-linked ubiquitination	ITCH,PARK2,UBE2D4,UBE2S,UBE2T	A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 29 of the ubiquitin monomers, is added to a protein. K29-linked ubiquitination targets the substrate protein for degradation.
GO:0035520	GO	BP	monoubiquitinated protein deubiquitination	ASXL1,ATXN3,BAP1,MYSM1,USP1,USP15,USP16,USP47	The removal of the ubiquitin group from a monoubiquitinated protein.
GO:0035561	GO	BP	regulation of chromatin binding	BTAF1,HMBOX1,KDM4D,MED25,WAPL	Any process that modulates the frequency, rate or extent of chromatin binding. Chromatin binding is the selective interaction with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
GO:0035567	GO	BP	non-canonical Wnt signaling pathway	DVL1,DVL2,DVL3,FZD10,FZD4,FZD6,FZD7,MAGI2,MYOC,RYK,WNT4,WNT5A	The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via effectors other than beta-catenin.
GO:0035581	GO	BP	sequestering of extracellular ligand from receptor	CD46,CER1,DAND5,FBN1,FBN2,LTBP1,NBL1	The process of binding or confining an extracellular signaling ligand, such that the ligand is unable to bind to its cell surface receptor.
GO:0035584	GO	BP	calcium-mediated signaling using intracellular calcium source	ADGRL1,AZU1,BCAP31,DMTN,FIS1,FKBP1B,GPR143,KDR,PRKACA,PTGFR,RYR2,SELP,TENM2,VCAM1	A series of molecular signals in which a cell uses calcium ions released from an intracellular store to convert a signal into a response.
GO:0035586	GO	MF	purinergic receptor activity	ADORA2A,P2RX1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,P2RY1,P2RY11,P2RY12	Combining with a purine or purine derivative (purine nucleoside or purine nucleotide) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. A nucleotide is a compound that consists of a nucleoside esterified with a phosphate molecule.
GO:0035587	GO	BP	purinergic receptor signaling pathway	ANO6,P2RX1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,P2RY11,P2RY12	The series of molecular signals generated as a consequence of a receptor binding to an extracellular purine or purine derivative to initiate a change in cell activity.
GO:0035590	GO	BP	purinergic nucleotide receptor signaling pathway	ANO6,P2RX1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX6,P2RX7,P2RY12	The series of molecular signals generated as a consequence of a receptor binding to an extracellular purine nucleotide to initiate a change in cell activity.
GO:0035591	GO	MF	signaling adaptor activity	ARHGAP1,ARHGAP4,ARHGAP6,BLNK,CD28,CHN1,CHN2,CLNK,CNTNAP1,CRKL,DAB2IP,DUSP19,EPS8,FRS2,GAB1,GAB2,GNB2L1,GRAP,GRAP2,GRB2,GRB7,HOMER1,IRS1,IRS4,ITSN2,LASP1,LAT,LDLRAP1,MAPK8IP2,MAPK8IP3,MPP7,NCK1,NCK2,PAG1,PIK3R1,RUSC1,SH2B2,SH2D1A,SH2D2A,SH2D3A,SH2D3C,SH3BGR,SH3BGRL,SH3BP2,SHB,SHC1,SKAP1,SKAP2,SLA,SLA2,SOCS2,SORBS1,SRC,STAM,STAP1,TOB1,TP53BP2,TRAT1,VAV3	The binding activity of a molecule that brings together two or more molecules in a signaling pathway, permitting those molecules to function in a coordinated way. Adaptor molecules themselves do not have catalytic activity.
GO:0035601	GO	BP	protein deacylation	BAZ2A,ELK4,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC9,MORF4L1,NACC2,NOTUM,PER1,PER2,PHB,PPT1,PRDM5,RCOR1,REST,SALL1,SFPQ,SIN3A,SIRT1,SIRT2,SIRT3,SIRT4,SIRT5,SIRT6,SIRT7,SMARCAD1,SUDS3	The removal of an acyl group, any group or radical of the form RCO- where R is an organic group, from a protein amino acid.
GO:0035608	GO	BP	protein deglutamylation	AGBL1,AGBL2,AGBL3,AGBL4,AGBL5,AGTPBP1,FOLH1	The removal of a glutamate residue from a protein. Glutamate residues in proteins can be gene-encoded, or added as side chains during the protein modification process of polyglutamylation.
GO:0035610	GO	BP	protein side chain deglutamylation	AGBL1,AGBL2,AGBL3,AGBL4,AGTPBP1	The removal of a glutamate residue from the side chain of a protein. Glutamate side chains are added to glutamic acid residues within the primary protein sequence during polyglutamylation.
GO:0035615	GO	MF	clathrin adaptor activity	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,DAB2,LDLRAP1,PICALM	The binding activity of a molecule that brings together clathrin and one or more other molecules, permitting them to function in a coordinated way.
GO:0035624	GO	BP	receptor transactivation	ADAM17,ADRA2A,ADRA2B,ADRA2C,NCOA3	The process in which a receptor is activated by another receptor. Receptor transactivation can occur through different mechanisms and includes cross-talk between signaling pathways where one receptor activates a receptor for a different ligand, and also activation of subunits within a receptor oligomer.
GO:0035631	GO	CC	CD40 receptor complex	BIRC2,CD40,CHUK,DIABLO,HTRA2,IKBKB,RNF31,TRAF2,TRAF3,TRAF5,TRAF6	A protein complex that contains at least CD40 (a cell surface receptor of the tumour necrosis factor receptor (TNFR) superfamily), and other signaling molecules.
GO:0035637	GO	BP	multicellular organismal signaling	ABCC9,AHCYL1,AKAP9,ANK2,ANK3,ASPH,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2A3,ATP2B1,ATP2B2,ATP2B3,ATP2B4,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D2,CACNA2D3,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG1,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,CAMK2D,CASQ1,CASQ2,CAV1,CHRNA1,CNTNAP1,CNTNAP2,CORIN,CTNNA3,CXADR,DMPK,DRD1,DSC2,DSG2,DSP,FKBP1B,FXYD1,FXYD2,FXYD3,FXYD4,FXYD6,FXYD7,GJA1,GJA5,GJC1,GPER1,HCN4,ITPR1,ITPR2,ITPR3,JUP,KCNA1,KCNA2,KCNA5,KCND1,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ11,KCNJ12,KCNJ14,KCNJ2,KCNJ4,KCNK1,KCNK15,KCNK3,KCNK6,KCNMB2,KCNMB3,KCNMB4,KCNQ1,MEF2A,MYH14,NOS1,NPPA,NPPC,NPR1,NPR2,ORAI1,PAFAH1B1,PKP2,PLN,PRKACA,RNF207,RYR1,RYR2,RYR3,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SLC8A2,SLC8A3,SLC9A1,SOD1,SPTBN4,STIM1,TNNI3,TNNI3K,TRDN,TRPC1,YWHAE	The transfer of information occurring at the level of a multicellular organism.
GO:0035646	GO	BP	endosome to melanosome transport	AP1G1,AP1M1,AP3D1,BLOC1S3,BLOC1S5,BLOC1S6,CD63,RAB32,RAB38	The directed movement of substances from endosomes to the melanosome, a specialised lysosome-related organelle.
GO:0035666	GO	BP	TRIF-dependent toll-like receptor signaling pathway	ATF1,ATF2,BIRC2,BIRC3,BTRC,CASP8,CD14,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FADD,FBXW11,FOS,IKBKB,IKBKE,IKBKG,IRAK1,IRAK2,IRF3,IRF7,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PPP2R5D,RELA,RIPK1,RIPK2,RIPK3,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TANK,TBK1,TICAM1,TICAM2,TLR3,TLR4,TNIP2,TRAF3,TRAF6,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3	Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
GO:0035690	GO	BP	cellular response to drug	ADIPOQ,AIM2,CERS1,CRHBP,DPEP1,EIF2B5,FBP1,GAS6,GPLD1,HTR1B,IL1B,KCNE2,KCNH2,KCNQ1,MEF2C,MT2A,MT3,MYC,PDE2A,PDE4B,PPM1E,PPM1F,PPP3CA,PPP3CB,RAP2A,RBM22,REST,TFRC	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
GO:0035710	GO	BP	CD4-positive, alpha-beta T cell activation	ATP7A,BATF,CEBPB,FOXP1,FOXP3,HMGB1,IL12B,IL6,IRF4,LEF1,LY9,PTGER4,RORA,RORC,RSAD2,SLAMF6,STOML2,TNFSF4,ZFPM1	The change in morphology and behavior of a CD4-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
GO:0035725	GO	BP	sodium ion transmembrane transport	ABCB11,ANO6,ASIC1,ASIC2,ASIC3,ASIC4,ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,FXYD2,HCN1,HCN2,HCN3,HCN4,KCNK1,NALCN,PKD2,PKD2L1,SCN10A,SCN11A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4A,SCN4B,SCN5A,SCN7A,SCN8A,SCN9A,SCNN1A,SCNN1B,SCNN1D,SCNN1G,SHROOM2,SLC12A3,SLC13A4,SLC17A2,SLC17A4,SLC17A7,SLC20A1,SLC20A2,SLC23A1,SLC24A1,SLC24A5,SLC34A2,SLC3A2,SLC4A11,SLC4A4,SLC4A5,SLC4A7,SLC8A1,SLC8A2,SLC8A3,SLC9A1,SLC9A2,SLC9A3,SLC9A5,SLC9A6,SLC9A7,TRAPPC10	A process in which a sodium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0035729	GO	BP	cellular response to hepatocyte growth factor stimulus	BCAR1,HGF,NRP1,SIRT2,TDGF1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus.
GO:0035735	GO	BP	intraciliary transport involved in cilium morphogenesis	CEP131,IFT74,IFT81,PCM1,SSX2IP	The bidirectional movement of large protein complexes along microtubules within a cilium that contributes to cilium morphogenesis.
GO:0035751	GO	BP	regulation of lysosomal lumen pH	CLN3,CLN5,CLN6,LRRK2,PPT1,TMEM165	Any process that modulates the pH of the lysosomal lumen, measured by the concentration of the hydrogen ion.
GO:0035767	GO	BP	endothelial cell chemotaxis	CORO1B,CXCL13,EGR3,NOV,NR4A1,NRP1,PLEKHG5,RAB13,VEGFA	The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
GO:0035770	GO	CC	ribonucleoprotein granule	ACTB,AGO2,AJUBA,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ARNTL,ASZ1,ATXN2,ATXN2L,BTBD1,BTBD2,CAPRIN1,CARHSP1,CDC42,CIRBP,CLOCK,CNOT1,CNOT3,CNOT7,DCP1A,DCP2,DDX1,DDX25,DDX28,DDX3X,DDX4,DDX6,DHX30,DHX9,DIS3L2,DYNC1I1,EDC4,EIF2S1,EIF4E,FASTKD2,FASTKD5,FMR1,GRB7,GRSF1,HENMT1,HNRNPU,IGF2BP1,INA,IQGAP1,LARP4B,LIMD1,LIN28A,LSM14A,MAEL,MAPT,MBNL1,MOV10,MYH1,NANOS2,NANOS3,NCL,OGFOD1,PABPC1,PABPC4,PATL1,PIWIL1,PIWIL2,PIWIL4,PNRC2,PSMA2,PSMA4,PSMA6,PSMC2,PSMC3,PUM1,PUM2,RAC1,RBM4,RC3H1,ROCK2,RPL28,RPL6,RPLP0,RPS4X,RPS6,RQCD1,SQSTM1,STAU1,TDRD1,TDRD5,TDRD6,TDRD7,TDRD9,TDRKH,TIA1,TIAL1,TNRC6A,TOP1,TRIM5,TRIM71,TUBA1A,TUBB,UHMK1,WTIP,YBX1,YTHDF2,ZC3H12A,ZC3H12D,ZFP36	A non-membranous macromolecular complex containing proteins and translationally silenced mRNAs. RNA granules contain proteins that control the localization, stability, and translation of their RNA cargo. Different types of RNA granules (RGs) exist, depending on the cell type and cellular conditions.
GO:0035773	GO	BP	insulin secretion involved in cellular response to glucose stimulus	PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5	The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin, in response to a glucose stimulus.
GO:0035774	GO	BP	positive regulation of insulin secretion involved in cellular response to glucose stimulus	ANO1,CFTR,GPLD1,HLA-DRB1,PPP3CB,RFX6,STX4,TMEM27	Any process that increases the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
GO:0035791	GO	BP	platelet-derived growth factor receptor-beta signaling pathway	ABL1,CLASP2,PDGFA,PDGFB,PDGFRB,PDGFRL,PTPN1	A series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0035794	GO	BP	positive regulation of mitochondrial membrane permeability	ATF2,BLOC1S2,BNIP3,HEBP2,MOAP1,RHOT1,RHOT2	Any process that increases the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.
GO:0035809	GO	BP	regulation of urine volume	ADCY6,HAS2,HYAL2,INPP5K,KNG1,NPPB,NPR1,NPR3,TFAP2B	Any process that modulates the amount of urine excreted from the body over a unit of time.
GO:0035810	GO	BP	positive regulation of urine volume	HAS2,HYAL2,INPP5K,KNG1,NPPB,NPR1,NPR3,TFAP2B	Any process that increases the amount of urine excreted from the body over a unit of time.
GO:0035813	GO	BP	regulation of renal sodium excretion	AGT,AGTR1,CORIN,KNG1,NPPB,NPR1,SPX	Any process that modulates the amount of sodium excreted in urine over a unit of time.
GO:0035821	GO	BP	modification of morphology or physiology of other organism	AAAS,ALB,APCS,APOE,APOL1,AQP1,ATG7,AZU1,BCL2L1,C9,CAMP,CAV2,CCL3,CCL4,CCL5,CCNK,CD209,CD4,CFL1,CHD1,CLEC4M,CPSF4,DAG1,EIF2AK2,EIF2AK4,EP300,HDAC1,HIPK2,HMGA2,HPN,HYAL2,INPP5K,INSR,ITGAV,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,LEF1,LTF,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,PC,POM121,POM121C,POU2F3,PPIB,PTX3,RAB9A,RAE1,RANBP2,REST,RNASE7,RRAGA,RXRA,SEH1L,SERPINB9,SLC25A6,SMAD3,SMARCA4,SMARCB1,SNW1,SP1,SUGT1,TAF11,TARDBP,TBC1D20,TFAP4,TGFB1,TNIP1,TPR,VAPA,VAPB,YTHDC2,ZC3H12A,ZNF502,ZNF639	The process in which an organism effects a change in the structure or processes of a second organism.
GO:0035850	GO	BP	epithelial cell differentiation involved in kidney development	BASP1,CD24,IQGAP1,JAG1,KLF15,MAGI2,MEF2C,MTSS1,MYO1E,PDGFB,PODXL,PROM1,PTPRO,WT1	The process in which relatively unspecialized cells acquire specialized structural and/or functional features of an epithelial cell that characterize the cells of the kidney as it progresses from its formation to the mature state.
GO:0035859	GO	CC	Seh1-associated complex	DEPDC5,MIOS,NPRL2,NPRL3,RRAGA,SEC13,SEH1L,WDR24,WDR59	A protein complex that associates dynamically with the vacuolar membrane, and is proposed to have a role in membrane-associated trafficking or regulatory processes. In S. cerevisiae the complex contains Seh1p, Sec13p, Npr2p, Npr3p, Iml1p, Mtc5p, Rtc1p, and Sea4p.
GO:0035861	GO	CC	site of double-strand break	APLF,ATF2,C9orf142,H2AFX,KDM4D,MRE11A,NBN,PARP3,PHF1,PRPF19,RAD18,RAD50,RAD51,RFWD3,RNF138,RNF168,RNF169,RNF8,RPA2,SETMAR,SLF1,SLF2,SMARCAD1,SMARCAL1,SMC5,SMC6,VCP	A region of a chromosome at which a DNA double-strand break has occurred. DNA damage signaling and repair proteins accumulate at the lesion to respond to the damage and repair the DNA to form a continuous DNA helix.
GO:0035869	GO	CC	ciliary transition zone	AHI1,B9D1,B9D2,BBS4,BBS9,C5orf30,CC2D2A,CCSAP,CEP290,MKS1,TCTN1,TCTN2,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TRAF3IP1,TTBK2,UNC119B	A region of the cilium between the basal body and proximal segment that is characterized by Y-shaped assemblages that connect axonemal microtubules to the ciliary membrane. The ciliary transition zone appears to function as a gate that controls ciliary membrane composition.
GO:0035871	GO	BP	protein K11-linked deubiquitination	OTUB2,OTUD3,OTUD6A,OTUD7A,OTUD7B,TNFAIP3,USP30,USP37,VCPIP1,YOD1	A protein deubiquitination process in which a K11-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 11 of the ubiquitin monomers, is removed from a protein.
GO:0035872	GO	BP	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	AIM2,APP,BCL2,BCL2L1,CARD9,CASP1,CASP8,CHUK,CYLD,HSP90AB1,IKBKB,IKBKG,IRAK1,IRAK2,ITCH,MAP2K6,MAP3K7,MEFV,NLRC4,NLRP1,NLRP3,NOD1,NOD2,OTULIN,P2RX7,PANX1,PSTPIP1,PYCARD,RELA,RIPK2,RNF34,RPS27A,SUGT1,TAB1,TAB2,TAB3,TNFAIP3,TRAF6,TXN,TXNIP,UBA52,UBB,UBC,UBE2N,UBE2V1	A series of molecular signals generated as a consequence of a nucleotide-binding domain, leucine rich repeat containing receptor (NLR) binding to one of its physiological ligands. NLRs are cytoplasmic receptors defined by their tripartite domain architecture that contains: a variable C-terminus, a middle nucleotide-binding domain, and a LRR domain that is variable in the repeats composition and number. The NLR signaling pathway begins with binding of a ligand to a NLR receptor and ends with regulation of a downstream cellular process.
GO:0035881	GO	BP	amacrine cell differentiation	FOXN4,NEUROD1,NEUROD4,PTF1A,RORB	The process in which a relatively unspecialized cell acquires specialized features of an amacrine cell, an interneuron generated in the inner nuclear layer (INL) of the vertebrate retina. Amacrine cells integrate, modulate, and interpose a temporal domain in the visual message presented to the retinal ganglion cells, with which they synapse in the inner plexiform layer. Amacrine cells lack large axons.
GO:0035883	GO	BP	enteroendocrine cell differentiation	BMP4,BMP5,BMP6,CDK6,DLL1,INSM1,NEUROD1,NKX6-1,PAX6,PDX1,RFX6	The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of an enteroendocrine cell. Enteroendocrine cells are hormonally active epithelial cells in the gut that constitute the diffuse neuroendocrine system.
GO:0035886	GO	BP	vascular smooth muscle cell differentiation	GATA6,HES1,MESP1,NOTCH1,RAMP2,VEGFA	The process in which a relatively unspecialized cell acquires specialized features of a vascular smooth muscle cell.
GO:0035909	GO	BP	aorta morphogenesis	DLL4,HES1,HEY1,HEY2,JAG1,LRP1,MYLK,PDGFRB,PROX1,RBPJ,SOX4,TBX1,TBX2,TFAP2B	The process in which the anatomical structures of an aorta are generated and organized. An aorta is an artery that carries blood from the heart to other parts of the body.
GO:0035914	GO	BP	skeletal muscle cell differentiation	KLHL41,LEMD2,MEGF10,MYLK2,SIX4	The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.
GO:0035924	GO	BP	cellular response to vascular endothelial growth factor stimulus	DAB2IP,DLL4,EGR3,ERN1,FLT1,FLT3,FLT4,FOXC1,HSPB1,ITGB1BP1,KDR,MAPK14,MAPKAPK2,MYO1C,NOTCH1,NR4A1,NRP1,PDGFRA,PDGFRB,PRKD1,PRKD2,RAMP2,VEGFA,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
GO:0035925	GO	MF	mRNA 3'-UTR AU-rich region binding	CPEB1,CPEB2,CPEB3,CPSF1,ELAVL1,ZC3H12A,ZFP36	Interacting selectively and non-covalently with a region containing frequent adenine and uridine bases within the 3' untranslated region of a mRNA molecule.
GO:0035965	GO	BP	cardiolipin acyl-chain remodeling	HADHA,HADHB,LCLAT1,PLA2G4A,PLA2G6,TAZ,THEM5	Remodeling the acyl chains of premature (de novo synthesized) cardiolipin (1,3-bis(3-phosphatidyl)glycerol), through sequential deacylation and re-acylation reactions, to generate mature cardiolipin containing high-levels of unsaturated fatty acids.
GO:0035966	GO	BP	response to topologically incorrect protein	ACADVL,ADD1,AMFR,ARFGAP1,ASNA1,ASNS,ATF3,ATF4,ATF6,ATF6B,ATP6V0D1,ATXN3,BAK1,BAX,BHLHA15,CALR,CCL2,CDK5RAP3,CLU,CREB3,CREB3L1,CTDSP2,CTH,CUL7,CXCL8,CXXC1,DAB2IP,DCTN1,DDIT3,DDX11,DERL1,DERL2,DERL3,DNAJA1,DNAJB1,DNAJB11,DNAJB2,DNAJB4,DNAJB9,DNAJC3,DNAJC4,EDEM1,EIF2AK3,EIF2S1,EP300,ERN1,ERP44,EXTL3,F12,FKBP14,GFPT1,GOSR2,GSK3A,HDAC6,HDGF,HERPUD1,HSP90AA1,HSP90AB1,HSP90B1,HSPA1L,HSPA2,HSPA4,HSPA4L,HSPA5,HSPA6,HSPA8,HSPB1,HSPB2,HSPB3,HSPB7,HSPD1,HSPE1,HSPH1,HYOU1,IGFBP1,KDELR3,KLHDC3,LMNA,MBTPS1,MBTPS2,MYDGF,NFE2L2,PACRG,PARK2,PARP16,PDIA5,PDIA6,PLA2G4B,PPP2R5B,PREB,PTPN1,RHBDD1,RNF126,RNF5,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SERP1,SERPINH1,SHC1,SRPR,SRPRB,SSR1,STT3B,STUB1,SULT1A3,SYVN1,TATDN2,TBL2,TLN1,TOR1A,TOR1B,TPP1,TSPYL2,UBE2W,UFD1L,VAPB,VCP,VIMP,WFS1,WIPI1,XBP1,YIF1A,YOD1,ZBTB17	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.
GO:0035967	GO	BP	cellular response to topologically incorrect protein	ACADVL,ADD1,AMFR,ARFGAP1,ASNA1,ASNS,ATF3,ATF4,ATF6,ATF6B,ATP6V0D1,ATXN3,BAK1,BAX,BHLHA15,CALR,CCL2,CDK5RAP3,CREB3,CREB3L1,CTDSP2,CTH,CUL7,CXCL8,CXXC1,DAB2IP,DCTN1,DDIT3,DDX11,DERL1,DERL2,DERL3,DNAJB11,DNAJB9,DNAJC3,EDEM1,EIF2AK3,EIF2S1,EP300,ERN1,EXTL3,FKBP14,GFPT1,GOSR2,GSK3A,HDAC6,HDGF,HERPUD1,HSP90B1,HSPA5,HYOU1,IGFBP1,KDELR3,KLHDC3,LMNA,MBTPS1,MBTPS2,MYDGF,NFE2L2,PACRG,PARK2,PARP16,PDIA5,PDIA6,PLA2G4B,PPP2R5B,PREB,PTPN1,RHBDD1,RNF126,RNF5,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SERP1,SHC1,SRPR,SRPRB,SSR1,STUB1,SULT1A3,SYVN1,TATDN2,TBL2,TLN1,TOR1A,TPP1,TSPYL2,UBE2W,UFD1L,VAPB,VCP,VIMP,WFS1,WIPI1,XBP1,YIF1A,YOD1,ZBTB17	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.
GO:0035970	GO	BP	peptidyl-threonine dephosphorylation	DUSP1,PDP1,PPM1A,PPM1B,PPM1D,PPM1E,PPM1F,PPM1G	The removal of phosphoric residues from peptidyl-O-phospho-L-threonine to form peptidyl-threonine.
GO:0035987	GO	BP	endodermal cell differentiation	CDC73,CTR9,FN1,HMGA2,INHBA,ITGA5,ITGAV,LEO1,MIXL1,NANOG,NODAL,PAF1,POU5F1,RTF1,SOX17,SOX2,VTN	The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo.
GO:0035994	GO	BP	response to muscle stretch	ANKRD1,CSRP3,DMD,NPPA,RYR2,SLC8A1,SLC9A1,TCAP,TTN	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a myofibril being extended beyond its slack length.
GO:0035999	GO	BP	tetrahydrofolate interconversion	MTHFD1,MTHFR,MTHFS,SHMT1,TYMS	The chemical reactions and pathways by which one-carbon (C1) units are transferred between tetrahydrofolate molecules, to synthesise other tetrahydrofolate molecules.
GO:0036002	GO	MF	pre-mRNA binding	DDX5,ERI1,PTBP1,RBM22,RBM4,SLBP,SLU7,SRSF6,TARBP2,U2AF2,ZRSR2	Interacting selectively and non-covalently with pre-messenger RNA (pre-mRNA), an intermediate molecule between DNA and protein that may contain introns and, at least in part, encodes one or more proteins. Introns are removed from pre-mRNA to form a mRNA molecule.
GO:0036003	GO	BP	positive regulation of transcription from RNA polymerase II promoter in response to stress	ATF3,ATF4,ATF6,ATF6B,CEBPB,CHD6,CREB3L1,CREB3L3,DDIT3,HIF1A,HSPA5,KLF2,MAPK7,MBTPS2,MT3,MUC1,NFE2L2,NOTCH1,RBPJ,TP53,VEGFA,XBP1	Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
GO:0036006	GO	BP	cellular response to macrophage colony-stimulating factor stimulus	CSF1R,DCSTAMP,FER,MST1R,PDE1B,PDE2A	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a macrophage colony-stimulating factor stimulus.
GO:0036010	GO	BP	protein localization to endosome	ACAP2,ARF6,MICALL1,NRP1,PACSIN2,RAB35,TMEM30A,TOLLIP	A process in which a protein is transported to, or maintained in, a location within an endosome.
GO:0036019	GO	CC	endolysosome	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,CLTA,CLTC,CTSB,CTSK,CTSL,CTSS,TLR3,TLR7,TLR8,TLR9	An transient hybrid organelle formed by fusion of a late endosome with a lysosome, and in which active degradation takes place.
GO:0036020	GO	CC	endolysosome membrane	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,CLTA,CLTC,TLR3,TLR7,TLR8,TLR9	The lipid bilayer surrounding an endolysosome. An endolysosome is a transient hybrid organelle formed by fusion of a late endosome with a lysosome.
GO:0036038	GO	CC	TCTN-B9D complex	AHI1,B9D1,B9D2,CC2D2A,CEP290,MKS1,TCTN1,TCTN2,TMEM17,TMEM216,TMEM231,TMEM67	A protein complex that is located at the ciliary transition zone and consists of tectonic proteins, B9 domain-containing proteins and other proteins. Acts as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. In mouse, members of the complex include TCTN1, TCTN2, B9D1, MKS1, CC2D2A and other proteins.
GO:0036041	GO	MF	long-chain fatty acid binding	ALOX5AP,FABP3,LPAR1,OXER1,PPARD,PPARG,S100A8,S100A9,SCP2,STX3,VIL1	Interacting selectively and non-covalently with a long-chain fatty acid. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
GO:0036057	GO	CC	slit diaphragm	IQGAP1,MAGI2,NPHS1,NPHS2,PODXL	A specialized cell-cell junction found between the interdigitating foot processes of the glomerular epithelium (the podocytes) in the vertebrate kidney, which is adapted for facilitating glomerular filtration.
GO:0036064	GO	CC	ciliary basal body	AGBL2,AGBL4,AHI1,B9D1,B9D2,BBOF1,BBS2,BBS4,BBS5,CCDC151,CCSAP,CEP19,CEP41,CFAP126,CFAP20,CYLD,DYNC2LI1,DZIP1,DZIP1L,EVC,FAM161A,FOPNL,ICK,IFT140,IFT46,IFT57,IFT81,IFT88,KIAA0586,MARK4,MKS1,ODF2,OFD1,PIFO,PKD2,PKHD1,POC1A,POC1B,PTPN23,RAB28,RAB3IP,RP2,RPGR,RPGRIP1L,RSG1,RTTN,SAXO1,SPATA7,SSX2IP,TBC1D30,TBC1D7,TOPORS,TTBK2,TTC8,TTLL6,WDR34,WDR35	A membrane-tethered, short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum) that is similar in structure to a centriole and derives from it. The cilium basal body is the site of assembly and remodelling of the cilium and serves as a nucleation site for axoneme growth. As well as anchoring the cilium, it is thought to provide a selective gateway regulating the entry of ciliary proteins and vesicles by intraflagellar transport.
GO:0036065	GO	BP	fucosylation	ADAMTS13,ADAMTS5,ADAMTS7,ADAMTSL1,ADAMTSL4,B3GLCT,CFP,FUT10,FUT2,FUT3,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,POFUT1,POFUT2,SPON1,THBS1	The covalent attachment of a fucosyl group to an acceptor molecule.
GO:0036066	GO	BP	protein O-linked fucosylation	ADAMTS13,ADAMTS5,ADAMTS7,ADAMTSL1,ADAMTSL4,B3GLCT,CFP,POFUT1,POFUT2,SPON1,THBS1	The process of transferring a fucosyl group to a serine or threonine residues in a protein acceptor molecule, to form an O-linked protein-sugar linkage.
GO:0036089	GO	BP	cleavage furrow formation	AURKB,RHOA,SNX18,SNX33,SNX9,SPIRE1,SPIRE2	Generation of the cleavage furrow, a shallow groove in the cell surface near the old metaphase plate that marks the site of cytokinesis. This process includes the recruitment and localized activation of signals such as RhoA at the site of the future furrow to ensure that furrowing initiates at the correct site in the cell.
GO:0036092	GO	BP	phosphatidylinositol-3-phosphate biosynthetic process	ATM,FIG4,INPP4B,PIK3C2G,PIK3C3,PIK3CA,PIK3CD,PIK3R2,PIK3R3,PIKFYVE	The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
GO:0036109	GO	BP	alpha-linolenic acid metabolic process	ABCD1,ACAA1,ACOT8,ACOX1,ACSL1,ELOVL1,ELOVL2,ELOVL3,ELOVL5,FADS1,FADS2,HSD17B4,SCP2	The chemical reactions and pathways involving alpha-linolenic acid, an unsaturated omega-6 fatty acid that has the molecular formula C18H32O2.
GO:0036119	GO	BP	response to platelet-derived growth factor	CORO1B,FER,HAS1,HAS2,HYAL1,PDGFRB	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus.
GO:0036120	GO	BP	cellular response to platelet-derived growth factor stimulus	CORO1B,HAS1,HAS2,HYAL1,PDGFRB	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus.
GO:0036126	GO	CC	sperm flagellum	AKAP3,ATP2B4,CATSPERD,DNAH1,DNAI2,PGAM4,PRKACA,RPGR,SAXO1,SEPT12,SLC26A3,SLC26A6,SLC9A3R1,SPA17,SPATA6,TCTEX1D4,TEKT3	A microtubule-based flagellum (or cilium) that is part of a sperm, a mature male germ cell that develops from a spermatid.
GO:0036128	GO	CC	CatSper complex	CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,HSPA2	A sperm-specific voltage-gated calcium channel that controls the intracellular calcium ion concentration and, thereby, the swimming behavior of sperm. Consists of a heteromeric tetramer surrounding a calcium ion- selective pore. May also contain additional auxiliary subunits.
GO:0036148	GO	BP	phosphatidylglycerol acyl-chain remodeling	CRLS1,LPCAT1,LPCAT4,LPGAT1,PLA2G10,PLA2G12A,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4D,PLA2G4F,PLA2G5	Remodeling the acyl chains of phosphatidylglycerol, through sequential deacylation and re-acylation reactions, to generate phosphatidylglycerol containing different types of fatty acid acyl chains.
GO:0036149	GO	BP	phosphatidylinositol acyl-chain remodeling	MBOAT7,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G4A,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLBD1	Remodeling the acyl chains of phosphatidylinositol, through sequential deacylation and re-acylation reactions, to generate phosphatidylinositol containing different types of fatty acid acyl chains.
GO:0036150	GO	BP	phosphatidylserine acyl-chain remodeling	LPCAT3,LPCAT4,MBOAT1,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G4A,PLA2G4B,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5	Remodeling the acyl chains of phosphatidylserine, through sequential deacylation and re-acylation reactions, to generate phosphatidylserine containing different types of fatty acid acyl chains.
GO:0036151	GO	BP	phosphatidylcholine acyl-chain remodeling	DBI,LPCAT1,LPCAT2,LPCAT3,LPCAT4,MBOAT2,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLB1,PLBD1,PNPLA8	Remodeling the acyl chains of phosphatidylcholine, through sequential deacylation and re-acylation reactions, to generate phosphatidylcholine containing different types of fatty acid acyl chains.
GO:0036152	GO	BP	phosphatidylethanolamine acyl-chain remodeling	LPCAT3,LPCAT4,MBOAT1,MBOAT2,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLBD1,PNPLA8	Remodeling the acyl chains of phosphatidylethanolamine, through sequential deacylation and re-acylation reactions, to generate phosphatidylethanolamine containing different types of fatty acid acyl chains.
GO:0036155	GO	BP	acylglycerol acyl-chain remodeling	AWAT1,DGAT1,DGAT2,MGLL,PNPLA2,PNPLA3	Remodeling the acyl chains of an acylglycerol, through sequential deacylation and re-acylation reactions, to generate an acylglycerol containing different types of fatty acid acyl chains.
GO:0036157	GO	CC	outer dynein arm	CCDC114,DNAH5,DNAI1,DNAI2,NME8	Outer arm structure present on the outer doublet microtubules of ciliary and flagellar axonemes. Outer dynein arms contain 2-3 heavy chains, two or more intermediate chains and a cluster of 4-8 light chains. Inner and outer dynein arms have different functions in the generation of microtubule-based motility.
GO:0036158	GO	BP	outer dynein arm assembly	ARMC4,CCDC103,CCDC114,CCDC151,DNAAF1,DNAAF5,DNAH5,DNAI1,DNAI2,DYX1C1,LRRC6,ZMYND10	The aggregation, arrangement and bonding together of a set of components to form an axonemal dynein outer arm, an outer arm structure present on the outer doublet microtubules of ciliary and flagellar axonemes.
GO:0036159	GO	BP	inner dynein arm assembly	CCDC103,CCDC39,CCDC40,DNAAF1,DNAAF5,DNAH1,DNAH7,DYX1C1,LRRC6,ZMYND10	The aggregation, arrangement and bonding together of a set of components to form an axonemal dynein inner arm, an inner arm structure present on the outer doublet microtubules of ciliary and flagellar axonemes.
GO:0036230	GO	BP	granulocyte activation	ANXA3,CCL3,CCL5,CXCL8,CXCR2,F2RL1,KMT2E,PREX1,PRG3,PRKCD,SYK,VAMP2,VAMP7	The change in morphology and behavior of a granulocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0036257	GO	BP	multivesicular body organization	CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,HGS,IST1,MVB12A,PDCD6IP,RAB11A,RAB27A,SNF8,STAM,STAM2,TSG101,VPS25,VPS28,VPS36,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a multivesicular body. A multivesicular body is a type of late endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.
GO:0036258	GO	BP	multivesicular body assembly	CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,HGS,IST1,MVB12A,PDCD6IP,RAB11A,SNF8,STAM,STAM2,TSG101,VPS25,VPS28,VPS36,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1	The aggregation, arrangement and bonding together of a set of components to form a multivesicular body, a type of late endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.
GO:0036260	GO	BP	RNA capping	CCNH,CDK7,CMTR1,CMTR2,ERCC2,ERCC3,FAM103A1,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,METTL1,MNAT1,NCBP1,NCBP2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,RNGTT,RNMT,SUPT5H,TGS1	The sequence of enzymatic reactions by which a cap structure is added to the 5' end of a nascent RNA polymerase II transcript. All RNA polymerase II transcripts receive a 7-methyl-G cap. Then for (at least) small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs), the7-methyl-G cap is hypermethylated to become a 2,2,7-trimethylguanosine (TMG) cap.
GO:0036289	GO	BP	peptidyl-serine autophosphorylation	ATM,ERN1,MAP2K2,PINK1,RIPK1	The phosphorylation by a protein of one or more of its own serine amino acid residues, or a serine residue on an identical protein.
GO:0036293	GO	BP	response to decreased oxygen levels	ACAA2,ADA,ADAM17,ADAM8,AJUBA,ALAS2,ALKBH5,ANG,ANGPTL4,AQP1,ARNT,ARNT2,BACH1,BMP2,BMP7,BNIP3,BNIP3L,CA9,CAV1,CBFA2T3,CHRNA4,CHRNA7,CHRNB2,CITED2,CPEB1,CPEB2,CPEB4,CREBBP,CUL2,DDIT4,DPP4,EGLN1,EGLN2,EGLN3,ENG,EP300,EPAS1,EPO,FABP1,FAM162A,FMN2,FUNDC1,GATA6,HIF1A,HIF1AN,HIF3A,HIPK2,HMOX2,HP1BP3,HSP90B1,HYOU1,ITPR1,ITPR2,KCND2,KCNMA1,LIMD1,LOXL2,MGARP,MT3,MTOR,NARFL,NDNF,NF1,NKX3-1,NOTCH1,NPEPPS,OPRD1,P4HB,PDK1,PDK3,PICK1,PINK1,PLK3,PML,PRKAA1,PTGIS,RBPJ,RBX1,RGCC,RORA,RPS27A,RYR1,RYR2,SIRT1,SIRT2,SLC8A3,SMAD3,SMAD4,STOX1,SUV39H1,SUV39H2,TBL2,TCEB1,TCEB2,TERT,TGFB2,TGFB3,TH,THBS1,TIGAR,TSC1,TWIST1,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBQLN1,UCP2,USF1,VEGFA,VHL,WTIP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting a decline in the level of oxygen.
GO:0036294	GO	BP	cellular response to decreased oxygen levels	ACAA2,ADAM8,AQP1,ARNT,BACH1,BMP7,BNIP3,BNIP3L,CA9,CITED2,CPEB1,CPEB2,CPEB4,CREBBP,CUL2,EGLN1,EGLN2,EGLN3,EP300,EPAS1,EPO,FABP1,FAM162A,FMN2,GATA6,HIF1A,HIF1AN,HIF3A,HIPK2,HP1BP3,HYOU1,KCND2,MGARP,MTOR,NDNF,NKX3-1,NOTCH1,NPEPPS,OPRD1,P4HB,PDK1,PDK3,PICK1,PINK1,PLK3,PTGIS,RBPJ,RBX1,RGCC,RORA,RPS27A,SIRT1,SIRT2,SLC8A3,STOX1,SUV39H1,SUV39H2,TBL2,TCEB1,TCEB2,TERT,TIGAR,TSC1,TWIST1,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBQLN1,VEGFA,VHL	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting a decline in the level of oxygen.
GO:0036297	GO	BP	interstrand cross-link repair	APITD1,ATR,ATRIP,DCLRE1A,EME1,ERCC1,ERCC4,EXO5,FAAP100,FAAP20,FAAP24,FAN1,FANCA,FANCB,FANCC,FANCD2,FANCE,FANCF,FANCG,FANCI,FANCL,FANCM,MUS81,POLN,RNF168,RNF8,RPA1,RPA2,RPA3,RPS27A,SLX1A,SLX4,STRA13,UBA52,UBB,UBC,UBE2T,USP1,ZBTB32	Removal of a DNA interstrand crosslink (a covalent attachment of DNA bases on opposite strands of the DNA) and restoration of the DNA. DNA interstrand crosslinks occur when both strands of duplex DNA are covalently tethered together (e.g. by an exogenous or endogenous agent), thus preventing the strand unwinding necessary for essential DNA functions such as transcription and replication.
GO:0036302	GO	BP	atrioventricular canal development	FOXN4,HAS2,PTPN11,RBPJ,TBX2	The progression of the atrioventricular canal over time, from its formation to the mature structure. The atrioventricular canal is the part of the heart connecting the atrium to the cardiac ventricle.
GO:0036303	GO	BP	lymph vessel morphogenesis	ACVR2B,ACVRL1,BMPR2,CCBE1,FLT4,FOXC2,PDPN,PROX1,PTPN14,SOX18,VEGFA	The process in which the anatomical structures of lymph vessels are generated and organized. The lymph vessel is the vasculature carrying lymph.
GO:0036310	GO	MF	annealing helicase activity	BLM,RAD54L,RECQL,RECQL4,SMARCA1,SMARCAL1,ZRANB3	Catalysis of the ATP-dependent rewinding of single-stranded DNA (ssDNA) to reform base pairs between strands. Often acts on ssDNA bubbles bound by replication protein A (RPA).
GO:0036314	GO	BP	response to sterol	CCL3,CCR5,CYP7A1,DYNAP,GPLD1,LRP6,MLC1,OSBPL7,PTCH1,RORA,RORC,SMAD2,SMO,TGFB1,TGFBR1,TGFBR2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sterol stimulus.
GO:0036315	GO	BP	cellular response to sterol	CYP7A1,DYNAP,GPLD1,LRP6,MLC1,OSBPL7,PTCH1,RORA,RORC,SMO	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sterol stimulus.
GO:0036336	GO	BP	dendritic cell migration	CCL19,CCL21,CCL5,CCR1,CCR2,CCR5,CCR6,CCR7,CXCR1,CXCR2,CXCR4,EPS8,HMGB1,NLRP10,PIK3CG,TRPM4	The movement of a dendritic cell within or between different tissues and organs of the body.
GO:0036376	GO	BP	sodium ion export from cell	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,FXYD2	The directed movement of sodium ions out of a cell.
GO:0036379	GO	CC	myofilament	ACTA1,MYBPC3,MYOM1,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TRIM32,TTN	Any of the smallest contractile units of a myofibril (striated muscle fiber).
GO:0036452	GO	CC	ESCRT complex	CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP6,CHMP7,HGS,MVB12A,MVB12B,SNF8,STAM,STAM2,TSG101,UBAP1,VPS25,VPS28,VPS36,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A	An endosomal sorting complex required for transport.
GO:0036464	GO	CC	cytoplasmic ribonucleoprotein granule	ACTB,AGO2,AJUBA,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ARNTL,ASZ1,ATXN2,ATXN2L,BTBD1,BTBD2,CAPRIN1,CARHSP1,CDC42,CIRBP,CLOCK,CNOT1,CNOT3,CNOT7,DCP1A,DCP2,DDX1,DDX25,DDX3X,DDX4,DDX6,DHX9,DIS3L2,DYNC1I1,EDC4,EIF2S1,EIF4E,FMR1,GRB7,HENMT1,HNRNPU,IGF2BP1,INA,IQGAP1,LARP4B,LIMD1,LIN28A,LSM14A,MAEL,MAPT,MBNL1,MOV10,MYH1,NANOS2,NANOS3,NCL,OGFOD1,PABPC1,PABPC4,PATL1,PIWIL1,PIWIL2,PIWIL4,PNRC2,PSMA2,PSMA4,PSMA6,PSMC2,PSMC3,PUM1,PUM2,RAC1,RBM4,RC3H1,ROCK2,RPL28,RPL6,RPLP0,RPS4X,RPS6,RQCD1,SQSTM1,STAU1,TDRD1,TDRD5,TDRD6,TDRD7,TDRD9,TDRKH,TIA1,TIAL1,TNRC6A,TOP1,TRIM5,TRIM71,TUBA1A,TUBB,UHMK1,WTIP,YBX1,YTHDF2,ZC3H12A,ZC3H12D,ZFP36	A ribonucleoprotein granule located in the cytoplasm.
GO:0036465	GO	BP	synaptic vesicle recycling	CANX,CDK5,ITSN1,PACSIN1,PIP5K1C,PLD2,RAB3A,RAB5A,SNCA,STON2,SYNJ1,WNT3A,WNT7A	The trafficking of synaptic vesicles from the pre-synaptic membrane so the vesicle can dock and prime for another round of exocytosis and neurotransmitter release. Recycling occurs after synaptic vesicle exocytosis, and is necessary to replenish presynaptic vesicle pools, sustain transmitter release and preserve the structural integrity of the presynaptic membrane.
GO:0036477	GO	CC	somatodendritic compartment	ACAD9,ACTN2,ADCY2,ALS2,AMIGO1,ANG,APOB,APOD,APOE,APP,ARF4,ARFGEF2,ARHGEF15,ARHGEF7,ATCAY,ATP7A,ATXN10,AZIN2,BNIP3,BSN,CAD,CALB1,CAPN2,CCR2,CDC42,CDK5,CDK5R1,CDKL5,CHRNA3,CHRNA4,CIB1,CLU,CNIH2,CNIH3,COBL,CPEB3,CPEB4,CPNE6,CPT1C,CREB3,CRHBP,CRIPT,CTNND2,DAB2IP,DBN1,DGKI,DLG4,DNER,DNM3,DRD2,DTNBP1,EFHC1,ELFN1,ELOVL5,EPHA4,EPHA5,EPHB2,FARP1,FBXO31,FGF13,FLRT1,FRMD7,FRMPD4,GAL,GCHFR,GIPC1,GLRA1,GNB2L1,GPER1,GPM6A,GRIA1,GRID2,GRIK3,GRIN1,GRIN3A,GRIN3B,GRM7,HCFC1,HDAC6,HPN,HTT,IL1RAPL1,ITPR3,KCNA1,KCNA2,KCNB1,KCNB2,KCNC1,KCNC2,KCND2,KCNE3,KPNA1,LRP4,LRRK2,MAGEE1,MAGI2,MAP1S,MAPT,MLPH,MME,MTMR2,MUL1,MYO1D,NCDN,NEURL1,NF1,NLGN1,NLGN4X,NR1D1,NRSN1,NRXN1,NSF,NSMF,OLFM1,OPA1,P2RY1,PAK1,PI4K2A,PICALM,PLK2,PRKAR2B,PRKCG,PTK2B,PTPRN,PTPRO,RAB17,RAB27A,RAB5A,RAC3,RAPGEF2,RBM3,RELN,RGS12,RGS14,RGS8,RPL28,RPS6,RTN4R,RUFY3,SACS,SARM1,SHANK1,SHANK2,SHTN1,SIPA1L1,SIRT2,SKOR1,SLC32A1,SLC38A7,SLC6A3,SNCAIP,SOD1,SPTBN4,SRCIN1,SRGAP2,SRR,STAT1,STAU1,STMN2,STRN,STRN3,STX4,SYNDIG1,SYNPO,TENM2,TGFB2,TH,TMEM100,TMEM185A,TRAPPC4,TRIM9,TUBB3,UBB,UHMK1,UNC5A,VTI1A,VTI1B,WFS1,ZFYVE27,ZNF385A,ZPR1	The region of a neuron that includes the cell body (cell soma) and the dendrite, but excludes the axon.
GO:0036498	GO	BP	IRE1-mediated unfolded protein response	ACADVL,ADD1,ARFGAP1,ASNA1,ATP6V0D1,CTDSP2,CUL7,CXXC1,DCTN1,DDX11,DNAJB11,DNAJB9,DNAJC3,EDEM1,ERN1,EXTL3,FKBP14,GFPT1,GOSR2,GSK3A,HDGF,HSPA5,HYOU1,KDELR3,KLHDC3,LMNA,MYDGF,PDIA5,PDIA6,PLA2G4B,PPP2R5B,PREB,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SEC62,SEC63,SERP1,SHC1,SRPR,SRPRB,SSR1,SULT1A3,SYVN1,TATDN2,TLN1,TPP1,TSPYL2,WFS1,WIPI1,XBP1,YIF1A,ZBTB17	A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.
GO:0036499	GO	BP	PERK-mediated unfolded protein response	ASNS,ATF3,ATF4,CCL2,CXCL8,DDIT3,EIF2AK3,EIF2S1,HERPUD1,HSPA5,IGFBP1,NFE2L2	A series of molecular signals mediated by the endoplasmic reticulum membrane stress sensor PERK (PKR-like ER kinase). Begins with activation of PERK in response to endoplasmic reticulum (ER) stress and ends with regulation of a downstream cellular process, e.g. transcription. The main substrate of PERK is the translation initiation factor eIF2alpha. Serine-phosphorylation of eIF2alpha by PERK inactivates eIF2alpha and inhibits general protein translation. In addition, eIF2alpha phosphorylation preferentially increases the translation of selective mRNAs such as ATF4 (activating transcription factor 4), which up regulates a subset of UPR genes required to restore folding capacity.
GO:0036500	GO	BP	ATF6-mediated unfolded protein response	ATF6,ATF6B,CALR,DDIT3,HSP90B1,HSPA5,MBTPS1,MBTPS2,XBP1	A series of molecular signals mediated by the endoplasmic reticulum membrane stress sensor ATF6 (activating transcription factor 6). Begins with activation of ATF6 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. Under conditions of endoplasmic reticulum stress, ATF6 translocates to the Golgi where it is processed by proteases to release a cytoplasmic domain (ATF6f), which operates as a transcriptional activator of many genes required to restore folding capacity.
GO:0036503	GO	BP	ERAD pathway	AMFR,ATXN3,AUP1,BAG6,BRSK2,DERL1,DERL2,DERL3,DNAJB2,DNAJB9,DNAJC10,EDEM1,EDEM2,EDEM3,ERLEC1,ERLIN1,ERLIN2,FAF2,FBXO6,FOXRED2,GET4,HERPUD1,HM13,HSP90B1,HSPA5,JKAMP,MAN1B1,MARCH6,NPLOC4,OS9,PARK2,RHBDD1,RNF103,RNF139,RNF185,RNF5,SEC61B,SEL1L,STT3B,STUB1,SYVN1,TMEM129,TMEM67,TMUB1,TOR1A,TRIM13,TRIM25,UBE2G2,UBE2J1,UBE2J2,UBQLN1,UBQLN2,UBXN4,UBXN8,UFD1L,USP13,USP19,VCP,VIMP,WFS1,YOD1	The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.
GO:0036508	GO	BP	protein alpha-1,2-demannosylation	EDEM1,EDEM2,EDEM3,MAN1A1,MAN1A2,MAN1B1,MAN1C1	The removal of one or more alpha 1,2-linked mannose residues from a mannosylated protein.
GO:0036513	GO	CC	Derlin-1 retrotranslocation complex	AMFR,DERL1,HM13,RNF139,RNF185,RNF5,SEL1L,SVIP,SYVN1,VCP,VIMP	A protein complex that functions in the retrotranslocation step of ERAD (ER-associated protein degradation), and includes at its core Derlin-1 oligomers forming a retrotranslocation channel.
GO:0038003	GO	BP	opioid receptor signaling pathway	NPBWR1,NPBWR2,OGFR,OPRD1,OPRK1,OPRL1	The series of molecular signals generated as a consequence of an opioid receptor binding to one of its physiological ligands.
GO:0038024	GO	MF	cargo receptor activity	ACKR2,ACKR3,ASGR2,CD163,CD36,COLEC12,CXCL16,DAB2,DMBT1,FOLR2,LDLR,LRP12,LRP6,LRP8,LRPAP1,SCARA3,SCARA5,SCARB1,SCARF1,SSC5D,STAB1,STAB2,TFR2,TFRC,VLDLR	Combining selectively with an extracellular substance and delivering the substance into the cell via endocytosis.
GO:0038027	GO	BP	apolipoprotein A-I-mediated signaling pathway	ABCA1,ABCA7,ITGAV,ITGB3,RHOA	A series of molecular signals initiated by the binding of apolipoprotein A-I to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0038030	GO	BP	non-canonical Wnt signaling pathway via MAPK cascade	DVL3,FZD10,FZD7,MYOC,WNT4	The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, where the signal is passed on via the MAPKKK cascade.
GO:0038033	GO	BP	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	HSPB1,KDR,PRKD1,PRKD2,VEGFA	A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a VEGFR on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
GO:0038061	GO	BP	NIK/NF-kappaB signaling	ALK,BIRC2,BIRC3,BTRC,CARD10,CARD14,CHI3L1,CHUK,COPS8,CUL1,FBXW11,IKBKE,IRAK1,MALT1,MAP3K14,MAP3K7,NFKB2,PPP4C,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RELB,RPS27A,SKP1,TLR3,TLR6,TNFRSF10A,TNFRSF10B,TNFSF15,TRAF2,TRAF6,UBA3,UBA52,UBB,UBC,UBE2M,ZFP91	The process in which a signal is passed on to downstream components within the cell through the NIK-dependent processing and activation of NF-KappaB. Begins with activation of the NF-KappaB-inducing kinase (NIK), which in turn phosphorylates and activates IkappaB kinase alpha (IKKalpha). IKKalpha phosphorylates the NF-Kappa B2 protein (p100) leading to p100 processing and release of an active NF-KappaB (p52).
GO:0038083	GO	BP	peptidyl-tyrosine autophosphorylation	ABL1,DDR1,IGF1R,KDR,MAPK3,PTK2B,SRMS,TEC	The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein.
GO:0038084	GO	BP	vascular endothelial growth factor signaling pathway	FLT1,FLT3,FLT4,FOXC1,HSPB1,KDR,MYO1C,NRP1,PDGFRA,PDGFRB,PRKD1,PRKD2,VEGFA	A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0038089	GO	BP	positive regulation of cell migration by vascular endothelial growth factor signaling pathway	HSPB1,KDR,MYO1C,PRKD1,PRKD2,VEGFA	A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a receptor on the surface of a cell, which activates or increases the frequency, rate or extent of the orderly movement of a cell from one site to another.
GO:0038092	GO	BP	nodal signaling pathway	ACVR1B,ACVR1C,CFC1,CITED2,FOXH1,SMAD2,SMAD3	A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0038096	GO	BP	Fc-gamma receptor signaling pathway involved in phagocytosis	ABI1,ABL1,ACTB,ACTG1,ACTR2,ACTR3,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BAIAP2,BRK1,CD247,CD3G,CDC42,CFL1,CRK,CYFIP1,CYFIP2,DOCK1,ELMO1,ELMO2,FCGR1A,FCGR2A,FCGR3A,FGR,FYN,GRB2,HCK,HSP90AA1,HSP90AB1,ITPR1,ITPR2,ITPR3,LIMK1,LYN,MAPK1,MAPK3,MYH2,MYO10,MYO1C,MYO1G,NCK1,NCKAP1,NCKAP1L,NCKIPSD,PAK1,PIK3CA,PIK3CB,PIK3R1,PIK3R2,PLA2G6,PLCG1,PLCG2,PLD2,PLPP4,PRKCD,PRKCE,PTK2,RAC1,SRC,SYK,VAV1,VAV2,VAV3,WAS,WASF2,WASL,WIPF1,WIPF2,WIPF3,YES1	An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.
GO:0038123	GO	BP	toll-like receptor TLR1:TLR2 signaling pathway	ATF1,ATF2,BTK,BTRC,CD14,CD36,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,IKBKB,IKBKG,IRAK1,IRAK2,IRAK4,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PPP2R5D,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TIRAP,TLR1,TLR2,TLR4,TLR6,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	A series of molecular signals initiated by the binding of a heterodimeric TLR1:TLR2 complex to one of it's physiological ligands, followed by transmission of the signal by the activated receptor, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0038124	GO	BP	toll-like receptor TLR6:TLR2 signaling pathway	ATF1,ATF2,BTK,BTRC,CD14,CD36,CHUK,CREB1,CUL1,DUSP3,DUSP4,DUSP6,DUSP7,ELK1,FBXW11,FOS,IKBKB,IKBKG,IRAK1,IRAK2,IRAK4,JUN,LY96,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K1,MAP3K7,MAP3K8,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MEF2A,MEF2C,MYD88,NFKB1,NFKB2,NFKBIA,NFKBIB,NOD1,NOD2,PELI1,PELI2,PPP2R5D,RELA,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SKP1,TAB1,TAB2,TAB3,TIRAP,TLR1,TLR2,TLR4,TLR6,TNIP2,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	A series of molecular signals initiated by the binding of a heterodimeric TLR6:TLR2 complex to one of it's physiological ligands, followed by transmission of the signal by the activated receptor, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0038166	GO	BP	angiotensin-activated signaling pathway	ACTN2,AGTR1,AGTR2,AHCYL1,CA2,CAMK2A,CAV1,SLC26A6,SRC	The series of molecular signals generated as a consequence of angiotensin II binding to an angiotensin receptor on the surface of the cell, and proceeding with the activated receptor transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity. Ends with regulation of a downstream cellular process, e.g. transcription.
GO:0038170	GO	BP	somatostatin signaling pathway	SSTR1,SSTR2,SSTR3,SSTR4,SSTR5	The series of molecular signals generated as a consequence of the peptide somatostatin (SST) binding to a somatostatin receptor (SSTR). The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.
GO:0038180	GO	BP	nerve growth factor signaling pathway	KIDINS220,MAGI2,RAP1A,RAPGEF1,RAPGEF2,SORT1	A series of molecular signals initiated by the binding of nerve growth factor (NGF) to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0038201	GO	CC	TOR complex	AKT1S1,LARP1,MLST8,MTOR,PRR5,PRR5L,RICTOR,RPL23A,RPTOR,TELO2,TTI1	A protein complex that contains at least TOR (target of rapamycin) in complex with other signaling components. Mediates the phosphorylation and activation of downstream signaling components including PKB (AKT) or S6K.
GO:0039531	GO	BP	regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway	ANKRD17,BIRC2,BIRC3,C1QBP,DDX60,DHX58,PUM1,PUM2,SEC14L1,TKFC,TRIM15,TSPAN6,USP17L2,ZC3HAV1	Any process that modulates the frequency, rate or extent of the series of molecular signals generated as a consequence of a virus or viral RNA binding to a pattern recognition receptor (PRR) located in the cytoplasm.
GO:0039532	GO	BP	negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway	C1QBP,DHX58,SEC14L1,TKFC,TSPAN6	Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of a virus or viral RNA binding to a pattern recognition receptor (PRR) located in the cytoplasm.
GO:0039533	GO	BP	regulation of MDA-5 signaling pathway	ANKRD17,C1QBP,DDX60,DHX58,TKFC,USP17L2	Any process that modulates the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA.
GO:0039535	GO	BP	regulation of RIG-I signaling pathway	ANKRD17,BIRC2,BIRC3,C1QBP,DDX60,DHX58,PUM1,PUM2,SEC14L1,TRIM15,USP17L2,ZC3HAV1	Any process that modulates the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) RIG-1 (also known as DDX58) binding to viral RNA.
GO:0039702	GO	BP	viral budding via host ESCRT complex	CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP6,CHMP7,MVB12A,PDCD6IP,TSG101,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B	Viral budding which uses a host ESCRT protein complex, or complexes, to mediate the budding process.
GO:0040001	GO	BP	establishment of mitotic spindle localization	CDK5RAP2,CENPA,CLASP1,DYNLT1,ESPL1,HTT,KPNB1,NDC80,NDE1,NUSAP1,PAFAH1B1,SPDL1,ZW10	The cell cycle process in which the directed movement of the mitotic spindle to a specific location in the cell occurs.
GO:0040007	GO	BP	growth	ALCAM,APOD,APP,AR,ARIH2,ATAD3A,ATP6V0E1,ATP6V0E2,BDNF,BIN3,BMP10,BMP4,BMPR1B,BRAT1,C3orf58,CAV3,CDK5,CER1,CFLAR,CHRNA1,CHRND,COBL,CPNE1,CPQ,CYFIP1,DDR2,DDX5,DGKD,DLL1,DMBX1,EIF2AK4,ENOX2,ENTPD5,ERBB2IP,ERBB4,EREG,EVC,EYS,FGF1,FGF10,FGF7,FGFR2,FGFR3,FLRT1,FLRT3,GAS1,GLI2,GNAS,HOXA11,IGF1,IMPACT,IQGAP1,ITGAV,ITGB3,KDF1,KLK6,KMT2D,LAMTOR1,LAMTOR2,LARGE,LEP,LEPR,LRP4,LUZP4,MAGI2,MESP1,MTOR,MTPN,NACA,NDNF,NDRG4,NIPBL,NLGN3,NLGN4X,NOP58,NOTCH1,NOTCH2,NOV,NPPC,NRP1,NRP2,NUBP1,NUPR1,PAK4,PAK7,PDLIM5,PPP3CB,PRMT2,RASGRP4,RFTN1,ROS1,RPTOR,RRAGC,S1PR1,SALL1,SEC61A1,SEMA3A,SEMA3F,SGMS1,SLC3A2,SLC9A6,SLIT1,SLIT2,SLIT3,SOCS5,SORBS2,SOX9,ST6GAL2,STC1,STIL,STRA6,TGFB2,TGFBR3,TNN,TYMS,USP9X,VEGFA,WNT7B,XBP1,XRN2,ZNF830,ZPR1	The increase in size or mass of an entire organism, a part of an organism or a cell.
GO:0040013	GO	BP	negative regulation of locomotion	ACVR1C,ACVRL1,ADAM15,ADARB1,ADIPOQ,AGTR2,AIF1,ALOX15B,ANGPT2,ANGPT4,APCS,APOD,APOE,APOH,ARAP3,ARHGDIB,ARPIN,BMP10,BMP5,BST2,C5,C5AR2,CCL2,CCL21,CCL25,CCL28,CD300A,CHRD,CITED2,CLASP1,CLASP2,CLIC4,COL3A1,CORO1B,CORO1C,CSNK2B,CXCL12,CXCL13,CYP1B1,DAB2IP,DACH1,DAG1,DCN,DLC1,DLL4,DPEP1,DPYSL3,DRD2,ELANE,ENG,EPHA1,EPPIN,EVL,FAM60A,FBLN1,FCN1,FCN3,FGF2,FLCN,FUZ,GATA3,GCSAM,GDF2,GREM1,GSN,GTPBP4,HAS1,HDAC5,HMGB1,HMOX1,HOXA7,HRG,HYAL2,IFITM1,IFITM2,IFITM3,IFNA2,IGFBP3,IGFBP5,IL4,ITGAV,ITGB1BP1,KANK1,KLF4,KLRK1,KRIT1,KRT16,LDLRAD4,LRP1,MAGI2,MAP2K5,MARVELD3,MCC,MIA3,MID2,MMRN2,NBL1,NDRG4,NF1,NF2,NKX2-1,NODAL,NOG,NOTCH1,NOV,NR2F2,PADI2,PBLD,PDCD10,PFN2,PHLDB2,PIN1,PKP2,PLCB1,PLXNB3,PODN,PTEN,PTGER4,PTPN2,PTPN23,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRO,PTPRR,PTPRU,PTX3,RAP2C,RECK,RGCC,RHOA,RHOB,RNF20,RNF41,ROBO1,ROBO2,SCAI,SEMA5A,SEMG1,SERPINE1,SFRP1,SFRP2,SHH,SLIT2,SMAD7,SNX3,SP100,SPINT2,SRGAP2,STAP1,STARD13,STC1,STK24,STRAP,SULF1,SVBP,SYNJ2BP,TACSTD2,TBX5,TCAF1,TGFB1,THBS1,THY1,TIMP1,TP53INP1,TPM1,TRIB1,TRIM11,TRIM26,TRIM31,TRIM5,VASH1,VCL,WAS,WASL,WNT11	Any process that stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism.
GO:0040014	GO	BP	regulation of multicellular organism growth	APP,BBS2,FGFR2,GH1,GHR,GHRH,GHRHR,GHRL,GHSR,GNAS,MBD5,PPIB,PTCH1,SOD1,STAT5A,STAT5B	Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
GO:0040018	GO	BP	positive regulation of multicellular organism growth	GH1,GHR,GHRH,GHRHR,GHRL,GHSR,PPIB	Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
GO:0040019	GO	BP	positive regulation of embryonic development	CLASP1,CLASP2,DAG1,FOXA2,GATA3,GDNF,GNB2L1,HES1,IGF1,LHX1,OSR1,OTX2,PHLDB1,PHLDB2,PLCB1,RBM19,SCX,SHH,SIX1,SIX4,TENM4,WNT1,WNT3A,WNT4	Any process that activates or increases the frequency, rate or extent of embryonic development.
GO:0040020	GO	BP	regulation of meiotic nuclear division	DMRT1,HORMAD1,NANOS2,NPM2,PLCB1,PRDM9,RAD1,SIRT2,WEE2	Any process that modulates the frequency, rate or extent of meiosis, the process in which the nucleus of a diploid cell divides twice forming four haploid cells, one or more of which usually function as gametes.
GO:0040029	GO	BP	regulation of gene expression, epigenetic	ACTB,ADAR,AEBP2,AGO1,AGO2,AGO3,AGO4,AICDA,AJUBA,ALKBH1,ALKBH2,ALKBH3,APEX1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,ARID1A,ARID1B,ARID4B,ASF1A,ASZ1,ATF7IP,ATRX,BAZ1B,BAZ2A,BEND3,CCNH,CD3EAP,CDK7,CELF1,CHEK1,CLP1,CNOT1,CNOT6,CNOT7,CNOT8,CTCF,CTCFL,DDX21,DEK,DGCR8,DICER1,DIRAS3,DMAP1,DNMT1,DNMT3A,DNMT3B,DNMT3L,DPPA3,DROSHA,EED,EHMT1,EHMT2,EP300,EPC1,ERCC2,ERCC3,ERCC6,EZH2,FKBP6,FOS,FTO,GATAD2A,GLMN,GPX1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,H2AFY,H2AFY2,H3F3A,HDAC1,HDAC2,HDAC4,HDAC5,HDAC6,HELLS,HIST1H3A,HIST1H4A,HIST2H3A,HMGA1,HNRNPA2B1,IFI16,IGF2,JARID2,KAT2A,KAT2B,KDM1B,KMT2B,KMT2D,KMT2E,LIMD1,LIN28A,LIN28B,MAEL,MBD2,METTL3,MGMT,MNAT1,MOV10,MTA1,MTF2,MTRR,MYBBP1A,MYO1C,PADI2,PHF1,PHF19,PHF2,PHF8,PICK1,PIWIL2,PIWIL4,PLD6,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,PRKRA,PRMT7,PUM1,RAN,RBBP4,RBBP7,RBM4,RLIM,RRP8,SAP130,SAP18,SAP30,SAP30BP,SAP30L,SF3B1,SIN3A,SIRT1,SIRT2,SIRT4,SIRT5,SLC50A1,SMAD1,SMAD2,SMAD3,SMARCA5,SMARCD1,SNIP1,SPI1,SRRT,SUDS3,SUV39H1,SUZ12,TAF1A,TAF1B,TAF1C,TAF1D,TARBP2,TBP,TDG,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH,TERT,TET1,TET2,TET3,TFAP2C,TNRC6A,TNRC6B,TNRC6C,TRDMT1,TRIM27,TRIM71,TTF1,TWISTNB,UBR2,UBTF,UHRF1,WBP2,WTIP,XPO5,ZCCHC11,ZFP36,ZFP57,ZNF335,ZNRD1	Any process that modulates the frequency, rate or extent of gene expression; the process is mitotically or meiotically heritable, or is stably self-propagated in the cytoplasm of a resting cell, and does not entail a change in DNA sequence.
GO:0040036	GO	BP	regulation of fibroblast growth factor receptor signaling pathway	DSTYK,FGFBP3,FGFR2,FUZ,GATA3,GPC1,LRIT3,NOG,NPTN,OTX2,PRKD2,SULF1,SULF2,THBS1	Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
GO:0040037	GO	BP	negative regulation of fibroblast growth factor receptor signaling pathway	FUZ,GATA3,GPC1,SULF1,SULF2,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
GO:0042026	GO	BP	protein refolding	BAG1,DNAJA2,DNAJA4,DNAJB1,DNAJB2,DNAJC7,FKBP1A,FKBP1B,HSP90AA1,HSPA1A,HSPA1B,HSPA1L,HSPA2,HSPA6,HSPA8,HSPD1,PTGES3	The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones.
GO:0042035	GO	BP	regulation of cytokine biosynthetic process	APOA2,ASB1,AZU1,BCL10,BCL3,CCR2,CD276,CD28,CD4,CD80,CD86,CEBPG,EBI3,ELANE,EREG,FOXJ1,FOXP3,GATA3,GHRL,GHSR,GLMN,HMOX1,HSPB1,IGF2BP1,IGF2BP2,IGF2BP3,IL10,IL12B,IL17F,IL1A,IL1B,IL21,IL27,IL6,IL9,INHA,INHBA,INHBB,IRF4,KLF4,LILRB1,LTB,MAP2K5,MAST2,NLRP12,PRG3,SFTPD,SIGIRR,SPN,THBS1,TIRAP,TLR1,TLR3,TLR4,TLR6,TLR7,TLR8,TLR9,TNF,TNFRSF8,TRIB2,WNT5A,ZFPM1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cytokines.
GO:0042036	GO	BP	negative regulation of cytokine biosynthetic process	ASB1,BCL3,ELANE,FOXJ1,FOXP3,GHRL,GHSR,IL10,IL6,INHA,INHBA,INHBB,KLF4,LILRB1,MAP2K5,NLRP12,SFTPD,SIGIRR,TRIB2,ZFPM1	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cytokines.
GO:0042043	GO	MF	neurexin family protein binding	NLGN1,NLGN2,NLGN3,NLGN4X,SYTL1,SYTL2,SYTL4	Interacting selectively and non-covalently with neurexins, synaptic cell surface proteins related to latrotoxin receptor, laminin and agrin. Neurexins act as cell recognition molecules at nerve terminals.
GO:0042044	GO	BP	fluid transport	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,AQP1,AQP10,AQP11,AQP2,AQP3,AQP4,AQP5,AQP6,AQP7,AQP8,AQP9,AVP,AVPR2,GNAS,HAS2,HYAL2,MIP,MYO5B,PDZD3,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,RAB11A,RAB11FIP2,SLC26A6,SLC4A11	The directed movement of substances that are in liquid form in normal living conditions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0042053	GO	BP	regulation of dopamine metabolic process	CHRNB2,DRD4,HPRT1,HTR1A,PARK2,PARK7	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving dopamine.
GO:0042054	GO	MF	histone methyltransferase activity	ASH1L,ASH2L,CARM1,CXXC1,DOT1L,EED,EHMT1,EHMT2,EZH2,FBL,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,MEN1,NSD1,PRMT1,PRMT2,PRMT5,PRMT6,PRMT7,PRMT8,RBBP5,SETD1A,SETD1B,SETD2,SETD3,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SMYD3,SUV39H1,SUV39H2,SUV420H1,SUZ12,WDR5,WDR82,WHSC1,WHSC1L1	Catalysis of the reaction: S-adenosyl-L-methionine + histone = S-adenosyl-L-homocysteine + methyl-histone. Histone methylation generally occurs on either an arginine or lysine residue.
GO:0042056	GO	MF	chemoattractant activity	BMP4,CCL15,CCL16,CCL3,CCL5,FGF10,FGF2,FGF7,FIGF,HGF,HMGB1,HMGB2,LGALS3,MIF,NTF3,PDGFB,SCG2,VEGFA,VEGFB,VEGFC	Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
GO:0042058	GO	BP	regulation of epidermal growth factor receptor signaling pathway	ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGR2,AGT,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APP,ARHGEF7,CBL,CBLC,CDC42,CDH13,CLTA,DAB2IP,EGF,EGFR,EPGN,EPN1,EPS15,EPS15L1,EREG,ERRFI1,FBXW7,FER,GPER1,GPRC5A,GRB2,HAP1,HGS,ITGA1,MMP9,MVB12A,MVB12B,NCK2,NUP62,PLAUR,PTPN2,PTPRJ,RAB7A,RHBDF1,RNF115,RNF126,RPS27A,SH3GL2,SH3KBP1,SHC1,SHKBP1,SNX6,SOCS4,SOCS5,SPRY1,SPRY2,STAM,STAM2,TGFA,UBA52,UBB,UBC,ZFYVE28,ZGPAT	Any process that modulates the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
GO:0042059	GO	BP	negative regulation of epidermal growth factor receptor signaling pathway	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARHGEF7,CBL,CBLC,CDC42,CLTA,DAB2IP,EGF,EGFR,EPN1,EPS15,EPS15L1,ERRFI1,GPRC5A,GRB2,HGS,ITGA1,PTPN2,PTPRJ,RAB7A,RNF115,RNF126,RPS27A,SH3GL2,SH3KBP1,SNX6,SOCS4,SOCS5,SPRY1,SPRY2,STAM,STAM2,UBA52,UBB,UBC,ZFYVE28,ZGPAT	Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
GO:0042063	GO	BP	gliogenesis	ARHGEF10,AZU1,CCL2,CCL3,CDH2,CDK5,CDK6,CLU,DAB2IP,DICER1,DLL1,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,ERBB3,FGF10,GPC1,HES1,HES5,LAMB1,MMP24,MT3,MXRA8,MYOC,MYRF,NCMAP,NF1,NF2,NFIB,PAFAH1B1,PARD3,PAX2,PHOX2B,PICK1,PTEN,PTPRZ1,RELN,RTN4,SIRT2,SKI,SLC8A3,SOD1,SOX11,SOX2,SOX4,SOX8,SRGAP2,SRGAP2C,STAT3,TENM4,TGFB2,VCAN	The process that results in the generation of glial cells. This includes the production of glial progenitors and their differentiation into mature glia.
GO:0042073	GO	BP	intraciliary transport	CEP131,ICK,IFT122,IFT27,IFT43,IFT46,IFT74,IFT81,PCM1,RPGR,SSX2IP,TTC26,WDR19,WDR35	The bidirectional movement of large protein complexes along microtubules within a cilium, mediated by motor proteins.
GO:0042088	GO	BP	T-helper 1 type immune response	EBI3,HLA-DRB1,HMGB1,IL12B,IL18,IL18BP,LEF1,TLR4,TLR6	An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin.
GO:0042089	GO	BP	cytokine biosynthetic process	BCL10,CD28,CMA1,IL12B,IL17F,IL18,IL4,NOD1,PCSK5	The chemical reactions and pathways resulting in the formation of cytokines, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
GO:0042093	GO	BP	T-helper cell differentiation	ATP7A,BATF,FOXP1,HMGB1,IL12B,IL6,IRF4,LEF1,LY9,PTGER4,RORA,RORC,SLAMF6,ZFPM1	The process in which a relatively unspecialized thymocyte acquires specialized features of a T-helper cell.
GO:0042098	GO	BP	T cell proliferation	BTN3A1,CTPS1,DOCK8,ELF4,LILRB1,PIK3CG,PPP3CB,SLC11A1,TNFRSF4,TNFSF14,TNFSF18	The expansion of a T cell population by cell division. Follows T cell activation.
GO:0042100	GO	BP	B cell proliferation	BCL2,CD40,CD40LG,CD79A,CR2,CTPS1,HSPD1,IFNB1,IL10,MEF2C,MS4A1,PTPRC	The expansion of a B cell population by cell division. Follows B cell activation.
GO:0042101	GO	CC	T cell receptor complex	ALCAM,BCL10,CARD11,CD247,CD3D,CD3E,CD3G,CD4,CD6,CD8A,CD8B,STOML2,SYK,TRAT1,ZAP70	A protein complex that contains a disulfide-linked heterodimer of T cell receptor (TCR) chains, which are members of the immunoglobulin superfamily, and mediates antigen recognition, ultimately resulting in T cell activation. The TCR heterodimer is associated with the CD3 complex, which consists of the nonpolymorphic polypeptides gamma, delta, epsilon, zeta, and, in some cases, eta (an RNA splice variant of zeta) or Fc epsilon chains.
GO:0042102	GO	BP	positive regulation of T cell proliferation	AGER,AIF1,ANXA1,CCL19,CCL5,CCR2,CD1D,CD24,CD274,CD276,CD28,CD3E,CD46,CD55,CD6,EBI3,FADD,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-E,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,LEP,LGALS9,LILRB2,NCK1,NCK2,NCKAP1L,PNP,PTPRC,PYCARD,RASAL3,SHH,TMIGD2,TNFSF4,VCAM1,XCL1,ZP3,ZP4	Any process that activates or increases the rate or extent of T cell proliferation.
GO:0042104	GO	BP	positive regulation of activated T cell proliferation	AGER,CD24,FADD,HHLA2,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IL12B,IL12RB1,IL18,IL2,IL23A,IL23R,PYCARD,TMIGD2	Any process that activates or increases the rate or extent of activated T cell proliferation.
GO:0042107	GO	BP	cytokine metabolic process	BCL10,CD28,CMA1,IL12B,IL17F,IL18,IL4,NOD1,PCSK5,TNFSF15	The chemical reactions and pathways involving cytokines, any of a group of proteins or glycoproteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
GO:0042108	GO	BP	positive regulation of cytokine biosynthetic process	APOA2,AZU1,BCL10,CCR2,CD276,CD28,CD4,CD80,CD86,CEBPG,EBI3,ELANE,EREG,GLMN,HMOX1,HSPB1,IL12B,IL1A,IL1B,IL21,IL27,IL9,IRF4,LTB,PRG3,SPN,THBS1,TIRAP,TLR1,TLR3,TLR4,TLR6,TLR7,TLR8,TLR9,TNF,TNFRSF8,WNT5A,ZFPM1	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cytokines.
GO:0042110	GO	BP	T cell activation	ADA,ADAM17,AMICA1,ANXA1,ATP7A,BATF,BTN3A1,CASP8,CCL19,CCL21,CCR7,CD1C,CD1D,CD2,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD7,CD74,CD80,CD86,CD8A,CD8B,CEBPB,CHD7,CLEC7A,CTPS1,CXADR,DDOST,DLL4,DOCK8,DPP4,EIF2AK4,ELF4,EOMES,F2RL1,FADD,FKBP1A,FOXP1,FOXP3,GLI3,HLA-E,HMGB1,HSPD1,ICAM1,ICOSLG,IL12B,IL2,IL6,INS,IRF4,ITGAL,ITK,JAG2,KIF13B,KIT,LAT,LCK,LCP1,LEF1,LEP,LEPR,LFNG,LIG4,LILRB1,LY9,MICA,MICB,NCK1,NCK2,NHEJ1,PIK3CD,PIK3CG,PPP3CA,PPP3CB,PRLR,PTGER4,PTPN2,PTPN22,PTPRC,RAG1,RAG2,RHOH,RIPK3,RORA,RORC,RSAD2,SHH,SLA2,SLAMF6,SLC11A1,SOX4,STOML2,THEMIS,TNFRSF4,TNFSF14,TNFSF18,TNFSF4,TREML2,ZAP70,ZFPM1	The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
GO:0042113	GO	BP	B cell activation	ADAM17,ADGRG3,AICDA,AKAP17A,ATM,BATF,BCL2,BLNK,BTK,CASP8,CD40,CD40LG,CD79A,CEBPG,CHRNA4,CHRNB2,CLCF1,CR2,CTPS1,DLL1,EXOSC3,EXOSC6,FLT3,FNIP1,GPR183,HDAC4,HDAC5,HDAC9,HHEX,HSPD1,IFNB1,IL10,IL11,IL4,ITGA4,ITGB1,JAK3,KIT,KLF6,LAT2,LAX1,LFNG,LIG4,LRRC8A,LYL1,MEF2C,MFNG,MS4A1,MSH2,MSH6,NFAM1,NHEJ1,NOTCH2,PIK3CD,PLCG2,PRKCB,PTK2B,PTPN2,PTPRC,RAG1,RAG2,RNF168,RNF8,TCF3,VCAM1,VPRBP,ZAP70	The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
GO:0042116	GO	BP	macrophage activation	AIF1,CD93,CLU,CRTC3,EDN2,FOXP1,LBP,SBNO2,SLC11A1,SNCA,SYK,TLR1,TLR4	A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0042117	GO	BP	monocyte activation	ADAM10,ADAM9,AZU1,CSF1,FOXP1,HYAL2,MT1G,SPACA3	The change in morphology and behavior of a monocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0042118	GO	BP	endothelial cell activation	BMPER,C8orf4,CXCL10,FOXP1,HOXA9,P2RX4,PRMT5,TGFBR1	The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0042119	GO	BP	neutrophil activation	ANXA3,CCL5,CXCL8,CXCR2,F2RL1,KMT2E,PREX1,PRG3,PRKCD,SYK,VAMP7	The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
GO:0042129	GO	BP	regulation of T cell proliferation	AGER,AIF1,ANXA1,BMP4,BTN2A2,CCL19,CCL5,CCR2,CD1D,CD209,CD24,CD274,CD276,CD28,CD3E,CD46,CD55,CD6,CDKN2A,CEBPB,CLC,EBI3,FADD,FOXP3,GLMN,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DRB1,HLA-E,HLA-G,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IHH,IL10,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL27,IL4,IL6,IL6ST,IRF1,KIAA0922,LEP,LGALS3,LGALS9,LILRB1,LILRB2,NCK1,NCK2,NCKAP1L,PDCD1LG2,PNP,PRKAR1A,PRNP,PTPRC,PYCARD,RASAL3,RC3H1,RIPK3,SFTPD,SHH,TMIGD2,TNFRSF21,TNFSF18,TNFSF4,VCAM1,XCL1,ZP3,ZP4	Any process that modulates the frequency, rate or extent of T cell proliferation.
GO:0042130	GO	BP	negative regulation of T cell proliferation	BMP4,BTN2A2,CD274,CDKN2A,CEBPB,FOXP3,GLMN,HLA-DRB1,HLA-G,IHH,IL10,KIAA0922,LGALS9,LILRB1,LILRB2,PDCD1LG2,PRKAR1A,PRNP,RC3H1,SFTPD,TNFRSF21,XCL1	Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
GO:0042133	GO	BP	neurotransmitter metabolic process	ABAT,ACHE,ALDH2,ALDH5A1,ALDH9A1,CLN3,COLQ,COMT,DAGLA,GCHFR,MAOA,NOS1,PAH,SLC22A2,SLC44A4,SLC5A7,SLC6A3	The chemical reactions and pathways involving neurotransmitters, any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell.
GO:0042136	GO	BP	neurotransmitter biosynthetic process	ACHE,ALDH2,ALDH9A1,COMT,DAGLA,MAOA,NOS1,PAH,SLC22A2,SLC44A4,SLC5A7,SLC6A3	The chemical reactions and pathways resulting in the formation of any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell.
GO:0042147	GO	BP	retrograde transport, endosome to Golgi	ANKFY1,ARFRP1,ARL1,BET1L,CLTC,CLTCL1,DCTN1,DENND2A,DENND5A,ERC1,EVI5,FAM109A,FAM109B,FAM21A,FAM21C,GBF1,GCC2,GOSR1,MAGEL2,PIKFYVE,RAB6A,RAB7A,RAB7B,RGP1,RHOBTB3,RIC1,RNF126,SGSM2,SNX1,SNX2,SNX5,SNX6,SNX8,SPAG9,STX10,STX16,STX5,STX6,TBC1D10A,TBC1D10B,TBC1D10C,TBC1D14,TBC1D17,TBC1D5,TRIM27,UBE2O,VAMP3,VPS26A,VPS26B,VPS29,VPS35,VPS51,VTI1A,WASH1,YKT6	The directed movement of membrane-bounded vesicles from endosomes back to the trans-Golgi network where they are recycled for further rounds of transport.
GO:0042149	GO	BP	cellular response to glucose starvation	ASNS,ATF4,ATG14,BECN1,BHLHA15,CPEB4,EIF2AK3,HSPA5,IFI16,IMPACT,MTMR3,MYBBP1A,NUAK2,PICK1,PIK3C3,PIK3R4,PMAIP1,PRKAA1,PRKAA2,RRP8,SH3GLB1,TBL2,TP53,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of glucose.
GO:0042157	GO	BP	lipoprotein metabolic process	ABCA1,ABCG1,ALB,ALOX12B,AMN,APOA1,APOA2,APOA4,APOB,APOC2,APOC3,APOE,ATG10,ATG7,BMP1,CETP,CLIP3,CUBN,DPM1,DPM2,DPM3,GOLGA7,GPAA1,HSPG2,LCAT,LDLR,LPA,LPL,MBOAT4,MPPE1,MTTP,NMT1,NMT2,NOTUM,NPC1L1,OAS2,P4HB,PGAP1,PGAP2,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLA2G7,PLAUR,PORCN,PPM1A,PPM1B,PPT1,PYURF,SCARB1,SDC1,ZDHHC1,ZDHHC12,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	The chemical reactions and pathways involving any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids.
GO:0042162	GO	MF	telomeric DNA binding	ACD,APEX1,CTC1,HMBOX1,HNRNPA1,HNRNPA2B1,HNRNPD,KDM1A,NABP2,NCL,OBFC1,PIF1,POT1,PURA,SMG1,SMG5,SMG6,SMG7,TEN1,TERF1,TERF2,TERF2IP,TERT,TINF2,UPF1,UPF2,UPF3A,XRCC5,XRCC6	Interacting selectively and non-covalently with a telomere, a specific structure at the end of a linear chromosome required for the integrity and maintenance of the end.
GO:0042165	GO	MF	neurotransmitter binding	ACHE,CHRM3,CHRNA1,CHRNA3,CHRNA4,CHRNA7,CHRNB1,CHRNB2,GRIN1,GRIN3B	Interacting selectively and non-covalently with a neurotransmitter, any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.
GO:0042166	GO	MF	acetylcholine binding	ACHE,CHRM3,CHRNA1,CHRNA3,CHRNA4,CHRNA7,CHRNB1,CHRNB2	Interacting selectively and non-covalently with acetylcholine, an acetic acid ester of the organic base choline that functions as a neurotransmitter, released at the synapses of parasympathetic nerves and at neuromuscular junctions.
GO:0042167	GO	BP	heme catabolic process	AMBP,BLVRA,BLVRB,HMOX1,HMOX2,UGT1A1,UGT1A4	The chemical reactions and pathways resulting in the breakdown of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.
GO:0042168	GO	BP	heme metabolic process	ALAD,ALAS1,ALAS2,AMBP,ATPIF1,BDH2,BLVRA,BLVRB,COX10,COX15,CPOX,FECH,FXN,HMBS,HMOX1,HMOX2,NFE2L1,PPOX,SLC25A38,TSPO,UGT1A1,UGT1A4,UROD,UROS	The chemical reactions and pathways involving heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.
GO:0042169	GO	MF	SH2 domain binding	DAG1,GNB2L1,IRS1,LAT2,LAX1,LCK,LILRB1,NLK,NUP62,PAG1,SH3PXD2B,SIT1,SKAP1,SQSTM1,TRPV4	Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class.
GO:0042171	GO	MF	lysophosphatidic acid acyltransferase activity	ABHD5,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5	Catalysis of the transfer of acyl groups from an acyl-CoA to lysophosphatidic acid to form phosphatidic acid.
GO:0042177	GO	BP	negative regulation of protein catabolic process	AGAP2,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANXA2,APC,ATM,ATRAID,AZIN1,AZIN2,BAG5,BAG6,BUB1,BUB1B,BUB3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CDK5RAP3,CDKN2A,CENPF,CSNK2A1,CSNK2A2,CST3,DAB2IP,DERL2,DERL3,EGFR,ERLEC1,FHIT,FLNA,FMN2,FURIN,GABARAPL2,GIPC1,HFE,HSP90AB1,IL10,INS,IRAK3,KLHL22,MAD1L1,MAD2L1,MAD2L2,MDM4,N4BP1,NELL1,OS9,PANO1,PARK7,PDCL3,PHB,PIN1,PLK1,PML,PRKCG,PSMF1,PTPN3,RGP1,RIC1,RILP,SDCBP,SERPINB12,SF3B3,SIRT2,SMAD3,SMAD4,SNX12,SNX3,SVIP,TAF9,TERF1,TEX14,TIMP1,TIMP3,TLK2,TPR,TRIM39,TRIM40,TTK,UBAC2,UBE2C,UBE2D1,UBE2E1,UBE2G2,UBE2J1,UBXN1,USP14,USP25,USP44,WAC,YOD1,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
GO:0042178	GO	BP	xenobiotic catabolic process	CRYZ,GSTM1,GSTM2,GSTM3,GSTM4,GSTO1	The chemical reactions and pathways resulting in the breakdown of a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.
GO:0042180	GO	BP	cellular ketone metabolic process	AADAT,ADCK3,ADH4,ADM,AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,CACNA1H,CBR1,CBR4,CCBL1,CCBL2,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,CRYZL1,CYP11B1,CYP11B2,CYP17A1,CYP2B6,CYP2W1,CYP4F11,CYP4F2,DHRS4,DHRS9,FSHB,IDO2,KDSR,KMO,LHB,PARK7,PDSS1,PDSS2,SCP2,UBIAD1,VKORC1,VKORC1L1	The chemical reactions and pathways involving any of a class of organic compounds that contain the carbonyl group, CO, and in which the carbonyl group is bonded only to carbon atoms, as carried out by individual cells. The general formula for a ketone is RCOR, where R and R are alkyl or aryl groups.
GO:0042181	GO	BP	ketone biosynthetic process	ADCK3,ADM,AKR1C3,CACNA1H,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,CYP11B1,CYP11B2,FSHB,LHB,PDSS1,PDSS2,SCP2,UBIAD1	The chemical reactions and pathways resulting in the formation of ketones, a class of organic compounds that contain the carbonyl group, CO, and in which the carbonyl group is bonded only to carbon atoms. The general formula for a ketone is RCOR, where R and R are alkyl or aryl groups.
GO:0042219	GO	BP	cellular modified amino acid catabolic process	ALDH4A1,CBS,GGACT,GGT1,GOT2,HOGA1,MTHFS,MTRR,PRODH	The chemical reactions and pathways resulting in the breakdown of compounds derived from amino acids, organic acids containing one or more amino substituents.
GO:0042220	GO	BP	response to cocaine	ABAT,CHRNB2,CRHBP,DRD2,DRD3,DRD4	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.
GO:0042246	GO	BP	tissue regeneration	APOD,CFLAR,CPQ,ERBB4,EYS,IGF1,KLK6,LARGE,NACA,NOV	The regrowth of lost or destroyed tissues.
GO:0042254	GO	BP	ribosome biogenesis	BMS1,BOP1,C1D,C1QBP,CIRH1A,DDX27,DDX28,DDX31,DDX3X,DDX47,DHX30,DIS3,DKC1,EFTUD1,EIF2A,EIF6,EMG1,ERAL1,ERI1,EXOSC10,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC7,EXOSC9,FASTKD2,FBL,FTSJ2,GEMIN4,IMP4,MALSU1,MPHOSPH6,MPV17L2,NAF1,NHP2,NMD3,NOC4L,NOL11,NOL6,NOL8,NOL9,NOLC1,NOP14,NOP56,NOP58,NPM1,NSUN4,NVL,PES1,PIN4,RAN,RPL11,RPL14,RPL26,RPL35A,RPL5,RPL7,RPS14,RPS15,RPS16,RPS17,RPS19,RPS24,RPS28,RPS6,RPS7,RRP36,RRP9,SBDS,SDAD1,SKIV2L2,TSC1,TSR1,UTP20,VCX,WDR12,WDR55,XPO1,ZNF658	A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits; includes transport to the sites of protein synthesis.
GO:0042255	GO	BP	ribosome assembly	BMS1,C1QBP,DDX28,DDX3X,DHX30,EFTUD1,EIF2A,EIF6,ERAL1,FASTKD2,MPV17L2,NPM1,RPS14,RPS19,SBDS,TSR1,VCX	The aggregation, arrangement and bonding together of the mature ribosome and of its subunits.
GO:0042256	GO	BP	mature ribosome assembly	C1QBP,DDX3X,EFTUD1,EIF6,SBDS	The aggregation, arrangement and bonding together of the large and small ribosomal subunits into a functional ribosome.
GO:0042267	GO	BP	natural killer cell mediated cytotoxicity	CEBPG,CLEC2A,CORO1A,GZMB,KIR3DL1,KLRF2,LYST,MICA,RAET1E,RAET1G,SLAMF7,TUBB,TUBB4B,ULBP1,ULBP2,ULBP3,VAMP7	The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
GO:0042268	GO	BP	regulation of cytolysis	BAD,CSF2,GPLD1,LILRB1,P2RX7,PAX2,PF4,RRAGA	Any process that modulates the frequency, rate or extent of the rupture of cell membranes and the loss of cytoplasm.
GO:0042269	GO	BP	regulation of natural killer cell mediated cytotoxicity	AP1G1,ARRB2,CADM1,CD226,CRTAM,HLA-A,HLA-B,HLA-E,IL12A,IL12B,IL21,KLRK1,LAMP1,LEP,LGALS9,LILRB1,MICA,NCR1,NCR3,PIK3R6,PVR,PVRL2,RASGRP1,SERPINB4,SERPINB9,SLAMF6	Any process that modulates the frequency, rate, or extent of natural killer cell mediated cytotoxicity.
GO:0042270	GO	BP	protection from natural killer cell mediated cytotoxicity	HLA-A,HLA-B,HLA-E,SERPINB4,SERPINB9	The process of protecting a cell from natural killer cell mediated cytotoxicity.
GO:0042273	GO	BP	ribosomal large subunit biogenesis	BOP1,DDX28,DHX30,FASTKD2,MALSU1,PES1,RPL11,RPL14,RPL26,RPL35A,RPL5,RPL7,SDAD1,WDR12	A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis.
GO:0042274	GO	BP	ribosomal small subunit biogenesis	CIRH1A,EMG1,ERAL1,NOL11,NOP14,RPS14,RPS15,RPS16,RPS17,RPS19,RPS24,RPS28,RPS6,RPS7,RRP36,UTP20	A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a small ribosomal subunit; includes transport to the sites of protein synthesis.
GO:0042276	GO	BP	error-prone translesion synthesis	MAD2L2,PCNA,POLI,POLK,REV1,REV3L,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,UBA52,UBB,UBC	The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions and causes an increase in the endogenous mutation level. For example, in E. coli, a low fidelity DNA polymerase, pol V, copies lesions that block replication fork progress. This produces mutations specifically targeted to DNA template damage sites, but it can also produce mutations at undamaged sites.
GO:0042277	GO	MF	peptide binding	ACHE,ACVR1,ANG,AP2B1,AP2M1,APBB1,APBB2,APOA1,APOE,BCHE,BRAP,BRE,CABP1,CALCR,CD1C,CD209,CEMIP,CLEC4M,CLSTN1,COL25A1,CRHBP,CRIP1,ECE1,FOLH1,FURIN,FZD5,GALR1,GALR2,GALR3,GSAP,GSS,GSTM1,GSTM2,GSTM3,GSTM4,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,IDE,INSR,KCNIP2,KDELR1,KDELR2,KPNA1,KPNA2,KPNA3,KPNB1,LANCL1,MAPK8IP2,MAS1,MME,NKTR,NMUR2,NOD2,NPR3,PCSK5,PEX19,PEX5,PEX5L,PEX7,PIK3R1,PPIC,PPID,PPIE,PPIG,PPIH,PTGES,PTGES2,PTH1R,SLC7A5,SLC7A8,SLC7A9,SORL1,SRP54,TAP1,TAPBP,TGFB2,TLR2,TLR6,TNPO1,TNPO2,TPP1	Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
GO:0042278	GO	BP	purine nucleoside metabolic process	ABHD14B,ACOT7,ACPP,ADA,ADSL,ADSS,ADSSL1,AK3,AK4,AK5,AK9,ALDOA,ALDOB,ALDOC,AMPD3,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,BHMT2,BPNT1,CARD11,CASK,CECR1,CHCHD10,COA6,COASY,COX10,COX15,CROT,CTNS,DGUOK,DLG1,DLG2,ENO1,ENO2,ENO3,ENPP1,ENPP4,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GMPR2,GNAI3,GNMT,GPI,HK1,HK2,HK3,HPRT1,HSPA1A,HSPA1B,HSPA8,LDHA,LRRK2,MACROD1,MACROD2,MAGI3,MAT2A,MAT2B,MCEE,MLYCD,MPP1,MPP2,MPP3,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MTRR,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUDT18,NUDT7,OARD1,OLA1,PANK2,PAPSS1,PAPSS2,PDE6A,PDE6B,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PNP,PPCDC,PPCS,PPP2R5D,PRKAG2,RHOQ,SDHAF2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1,SURF1,TAZ,TEFM,TGFB1,TJP2,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving one of a family of organic molecules consisting of a purine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
GO:0042285	GO	MF	xylosyltransferase activity	GXYLT1,GXYLT2,GYLTL1B,LARGE,XYLT1,XYLT2	Catalysis of the transfer of a xylosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
GO:0042287	GO	MF	MHC protein binding	ATP5A1,ATP5B,CD244,CD4,CD74,CD8A,CD8B,CLEC7A,DERL1,HLA-E,LAG3,LILRB1,LILRB2,MARCH1,TAPBP,TUBB,TUBB4B	Interacting selectively and non-covalently with major histocompatibility complex molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
GO:0042288	GO	MF	MHC class I protein binding	ATP5A1,ATP5B,CD244,CD8A,CD8B,DERL1,HLA-E,LILRB1,LILRB2,TAPBP,TUBB,TUBB4B	Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
GO:0042297	GO	BP	vocal learning	CNTNAP2,NRXN1,NRXN2,SHANK3,STRA6	A behavioral process whose outcome is a relatively long-lasting behavioral change whereby an organism modifies innate vocalizations to imitate sounds produced by others.
GO:0042301	GO	MF	phosphate ion binding	ADSS,ADSSL1,CHST14,G6PC,MTHFD2,PNP,RELA,RPH3A,SLC34A2	Interacting selectively and non-covalently with phosphate.
GO:0042304	GO	BP	regulation of fatty acid biosynthetic process	ACADL,ACADVL,APOA4,APOA5,APOC1,APOC2,APOC3,BRCA1,ERLIN1,ERLIN2,MID1IP1,MLXIPL,NR1H2,NR1H3,PDK4,PIBF1,PRKAA2,PRKAB2,PRKAG2,PTGS2,SIRT1,STK11,TRIB3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils.
GO:0042306	GO	BP	regulation of protein import into nucleus	AKAP6,APC2,APOD,AXIN2,BAMBI,BMP4,BMP6,BMP7,BMPR1A,C1QTNF3,C8orf4,CABP1,CCDC22,CCL19,CD27,CDH1,CHERP,CHP1,CHP2,CREB3,CSF3,CYLD,DAB2,DAB2IP,DACT1,DACT3,DDX58,DMAP1,DYRK2,ECT2,EGF,EGFR,EMD,ERBB4,FAF1,FAM89B,FLNA,FZD7,G3BP2,GAS6,GNAQ,GSK3B,HCLS1,HDAC3,HYAL2,IGF1,IL10,IL12B,IL1B,IL23A,IL6,IPO5,JUP,KANK1,KPNA1,LACRT,LGALS9,MAVS,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NODAL,NOV,OGG1,PARP10,PBLD,PDE2A,PIK3R1,PIK3R2,PKD1,PKD2,POU5F1,PPM1A,PPM1B,PPP3CA,PPP3CB,PPP3R1,PRKCD,PSMD10,PYDC2,RAB23,RBPMS,RHOA,SEMA5A,SFRP5,SIRT1,SLC9A1,SLC9A3R1,SMAD3,SMAD4,SNAI2,SPHK1,SPPL3,SUFU,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TONSL,TPR,TRIM28,TRIP6,TXN,UBR5,WNT3A,WWTR1,XBP1,ZC3H12A,ZIC1,ZNF268,ZPR1	Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
GO:0042307	GO	BP	positive regulation of protein import into nucleus	AKAP6,BAMBI,BMP4,BMP6,BMPR1A,C8orf4,CCL19,CD27,CDH1,CHERP,CHP2,CSF3,DAB2,DACT1,DDX58,DMAP1,ECT2,EGF,EGFR,ERBB4,FLNA,HCLS1,HDAC3,HYAL2,IGF1,IL12B,IL1B,IL23A,IL6,IPO5,JUP,KANK1,KPNA1,LACRT,LGALS9,MAVS,NLRP12,NODAL,PIK3R1,PIK3R2,POU5F1,PPP3CA,PPP3CB,PPP3R1,PRKCD,RBPMS,RHOA,SEMA5A,SLC9A1,SMAD3,SMAD4,SPHK1,SPPL3,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TPR,TRIM28,TRIP6,UBR5,WNT3A,XBP1,ZIC1,ZNF268,ZPR1	Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
GO:0042308	GO	BP	negative regulation of protein import into nucleus	APC2,APOD,AXIN2,BMP7,C1QTNF3,CABP1,CCDC22,CHP1,CREB3,CYLD,DAB2IP,DACT3,DYRK2,EMD,FAF1,FAM89B,G3BP2,GAS6,GSK3B,IL10,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOV,PARP10,PBLD,PDE2A,PKD1,PKD2,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,SFRP5,SLC9A3R1,SNAI2,SUFU,TONSL,WWTR1,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of proteins from the cytoplasm into the nucleus.
GO:0042310	GO	BP	vasoconstriction	EDN1,EDN2,EDN3,EDNRA,EDNRB,HTR2B,KEL,PIK3C2A,SLC8A1	A decrease in the diameter of blood vessels, especially arteries, usually causing an increase in blood pressure.
GO:0042312	GO	BP	regulation of vasodilation	ACE,ACE2,ADCY6,AGTR1,AGTR2,CALCA,CPS1,CRP,EPHX2,F2RL1,GPER1,HMOX1,INS,NOS1,NOS3,NPPB,NPR1,SCPEP1,SMTNL1	Any process that modulates the frequency, rate or extent of increases in the diameter of blood vessels.
GO:0042339	GO	BP	keratan sulfate metabolic process	ACAN,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GAT1,CHST1,CHST2,CHST5,CHST6,FMOD,GALNS,GLB1,GNS,HEXA,HEXB,KERA,LUM,OGN,OMD,PRELP,SLC35D2,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6	The chemical reactions and pathways involving keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues.
GO:0042340	GO	BP	keratan sulfate catabolic process	ACAN,FMOD,GALNS,GLB1,GNS,HEXA,HEXB,KERA,LUM,OGN,OMD,PRELP	The chemical reactions and pathways resulting in the breakdown of keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues.
GO:0042345	GO	BP	regulation of NF-kappaB import into nucleus	BMP7,C1QTNF3,C8orf4,CCDC22,CCL19,CD27,CYLD,FAF1,G3BP2,IL10,IL12B,IL1B,IL23A,LGALS9,NFKBIA,NLRP12,NLRP3,NOV,PPM1A,PPM1B,PSMD10,PYDC2,RHOA,SPHK1,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TNFSF14,TRIP6,ZC3H12A,ZNF268	Any process that modulates the frequency, rate or extent of the transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane.
GO:0042346	GO	BP	positive regulation of NF-kappaB import into nucleus	C8orf4,CCL19,CD27,IL12B,IL1B,IL23A,LGALS9,NLRP12,RHOA,SPHK1,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TNFSF14,TRIP6,ZNF268	Any process that activates or increases the frequency, rate or extent of transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane.
GO:0042347	GO	BP	negative regulation of NF-kappaB import into nucleus	BMP7,C1QTNF3,CCDC22,CYLD,FAF1,G3BP2,IL10,NFKBIA,NLRP3,NOV,PPM1A,PPM1B,PSMD10,PYDC2,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane.
GO:0042355	GO	BP	L-fucose catabolic process	FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9	The chemical reactions and pathways resulting in the breakdown of L-fucose (6-deoxy-Lgalactose).
GO:0042359	GO	BP	vitamin D metabolic process	CUBN,CYP11A1,CYP1A1,CYP24A1,CYP27B1,CYP2R1,CYP3A4,FGF23,GC,LGMN,LRP2	The chemical reactions and pathways involving vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
GO:0042363	GO	BP	fat-soluble vitamin catabolic process	CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP4F11,CYP4F2,FGF23	The chemical reactions and pathways resulting in the breakdown of any of a diverse group of vitamins that are soluble in organic solvents and relatively insoluble in water.
GO:0042373	GO	BP	vitamin K metabolic process	CBR1,CYP4F11,CYP4F2,UBIAD1,VKORC1,VKORC1L1	The chemical reactions and pathways involving any of the forms of vitamin K, quinone-derived vitamins which are involved in the synthesis of blood-clotting factors in mammals. Vitamin K substances share a methylated naphthoquinone ring structure and vary in the aliphatic side chains attached to the molecule.
GO:0042379	GO	MF	chemokine receptor binding	C5,CCL11,CCL13,CCL19,CCL2,CCL21,CCL23,CCL24,CCL25,CCL28,CCL3,CCL5,CCL7,CCR2,CKLF,CREB3,CX3CL1,CXCL10,CXCL11,CXCL12,CXCL13,CXCL16,CXCL3,CXCL8,CXCL9,PF4,S100A14,XCL1,YARS	Interacting selectively and non-covalently with any chemokine receptor.
GO:0042382	GO	CC	paraspeckles	CPSF6,HNRNPM,NONO,NUDT21,SFPQ	Discrete subnuclear bodies in the interchromatin nucleoplasmic space, often located adjacent to nuclear specks. 10-20 paraspeckles are typically found in human cell nuclei.
GO:0042383	GO	CC	sarcolemma	AHNAK,AHNAK2,AKAP6,ALOX12,ANK2,ANK3,AQP1,ATP1A1,ATP1B1,ATP2B4,BIN1,CACNA1D,CACNA1S,CACNA2D1,CACNB2,CAPN3,CAV3,CCDC78,CIB1,DES,DMD,DTNBP1,DYSF,FLNC,FXYD1,ITGB1,KCNJ11,NOS1,NOS1AP,PDE9A,PGM5,PLEC,SCN1B,SCN5A,SLC30A1,SLC8A1,SLC8A3,SRI,TRIM72	The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers.
GO:0042384	GO	BP	cilium assembly	ABCC4,ABLIM1,ABLIM3,ACTR2,AHI1,ARL13B,ARL6,ARMC4,ATP6V0D1,ATP6V1D,B9D1,B9D2,BBIP1,BBOF1,BBS1,BBS10,BBS2,BBS4,BBS5,C2CD3,C5orf42,CC2D2A,CCDC103,CCDC113,CCDC114,CCDC13,CCDC151,CCDC28B,CCDC39,CCDC40,CCNO,CEP126,CEP162,CEP164,CEP250,CEP290,CEP41,CEP83,CEP89,CFAP46,CFAP54,CFAP74,CSNK1D,DISC1,DMD,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,DZIP1,DZIP1L,E2F4,EHD1,EHD3,FAM161A,FBF1,FLNA,FNBP1L,FOPNL,FOXJ1,FUZ,ICK,IFT172,IFT20,IFT46,IFT74,IFT81,INTU,IQCB1,KIAA0586,KIF24,KIF27,KIF3A,LRGUK,LRRC6,MCIDAS,MKKS,MKS1,NEK1,NME8,OCRL,PCM1,PCNT,PIBF1,PIH1D3,PKHD1,POC1B,RAB17,RAB23,RAB3IP,RAB8A,RFX3,RP1,RPGR,RSG1,RSPH1,RSPH4A,RSPH9,SCLT1,SEPT2,SNAP29,SNX10,SPAG1,SPAG16,SPATA6,SSX2IP,STK36,TCTN2,TMEM107,TMEM138,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TTBK2,TTC26,TTC8,TTLL3,VANGL2,WDR35,ZMYND10	The assembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
GO:0042391	GO	BP	regulation of membrane potential	ABCB5,ABL1,ACTN2,ADRA1A,AGT,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ARL6IP5,ATP1A1,ATP1A2,ATP1B1,ATP1B2,ATP1B3,ATP2A2,ATPIF1,B2M,BAD,BAK1,BAX,BCL2,BCL2L1,BCO2,BEST2,BNIP3,CACFD1,CACNA1A,CACNA1B,CACNA1D,CACNA1E,CACNA1G,CACNA1H,CACNB3,CACNB4,CACNG2,CACNG4,CAMK2D,CASQ2,CAV1,CAV3,CDKN2A,CFTR,CHRNA1,CHRNA3,CHRNA4,CHRNB1,CHRNB2,CLN3,CNTNAP1,CTNNA3,CUX2,DCN,DLG1,DLG4,DMD,DRD4,DSC2,DSG2,DSP,EHD3,FGF12,FHL1,FXYD1,GJA1,GJA5,GJC1,GLRA1,GLRX,GNB2L1,GPD1L,GPER1,GRID2,GRIK3,GRIN1,HCN1,HCN2,HCN3,HCN4,HEBP2,IFI6,JUP,KCNA1,KCNA2,KCNA5,KCNB1,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP2,KCNJ11,KCNJ2,KCNK1,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN4,KCNQ1,KDR,KIF5B,LRRK2,MAPK8IP2,MEF2C,MLLT11,MTMR2,MYH14,MYOC,NDUFS1,NEDD4,NEDD4L,NLGN1,NLGN2,NLGN3,NLGN4X,NOS1AP,NPPA,NRXN1,OPRD1,P2RX4,P2RX7,PARK7,PID1,PINK1,PKP2,PLN,PMAIP1,PRDX3,PRELID1,PRKCZ,PTEN,PTK2B,PTPN3,PYCR1,RAB3GAP1,RANGRF,RELN,RIMS1,RIMS2,RIMS3,RIMS4,RNF207,RYR2,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SHANK1,SHANK3,SLC25A33,SLC25A36,SLC26A3,SLC8A1,SLC8B1,SLC9A1,SMAD7,SNTA1,SOD1,SPG20,SRC,SRI,STOML2,STOX1,STX1B,SUMO1,TRDN,UBB,UNC13B,VCP,WNT7A,WWP2,YWHAE,YWHAH	Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
GO:0042393	GO	MF	histone binding	AIRE,ANP32B,ANP32E,ASF1A,ATAD2B,ATRX,BAZ1B,BAZ2A,BCAS3,BRD1,BRD2,BRD3,BRD4,BRD7,BRD9,BRDT,CARM1,CBX5,CBX8,CDY1,CDYL,CHAF1B,CHD1,CHD2,CHD5,CHD8,COPRS,CTCFL,CTSL,DAXX,DEK,DNAJC2,DPPA3,DTX3L,GLYR1,HJURP,ING1,ING2,ING3,ING4,ING5,IPO9,JAK2,KAT8,KDM4A,KDM7A,KMT2A,L3MBTL1,L3MBTL2,LOXL2,LRWD1,MPHOSPH8,MSH6,MSL3,MTF2,MYSM1,NCAPD2,NCAPD3,NCAPG2,NOC2L,NPM1,NPM2,PHF1,PHF13,PHF19,PHF2,PHF8,PHIP,PKN1,PRKCB,PRMT6,PRMT7,PSME4,RAG1,RAG2,RBBP4,RBBP5,RCC1,RNF168,RNF20,RNF8,RRP8,RSF1,SART3,SET,SFMBT1,SFMBT2,SGF29,SMARCA4,SMARCA5,SNCA,SPIN1,SPTY2D1,SUPT6H,SUZ12,TAF1,TAF1L,TBL1X,TBL1XR1,TDRD3,TONSL,TP53BP1,TRIM24,UHRF1,UHRF2,UIMC1,USP15,USP16,USP49,WDR5,ZMYND11	Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity.
GO:0042398	GO	BP	cellular modified amino acid biosynthetic process	ALDH18A1,CHAC1,CHAC2,CNDP2,CPS1,DHFR,FPGS,GAMT,GATM,GCLC,GCLM,GGCT,GGT1,GGT2,GSS,HAGH,MAT2A,MAT2B,MGST2,MTHFD1,OPLAH,OTC,PADI2,PADI4,PLOD1,PLSCR1,PTDSS1,PTDSS2,SEPHS2,SLC27A1	The chemical reactions and pathways resulting in the formation of compounds derived from amino acids, organic acids containing one or more amino substituents.
GO:0042401	GO	BP	cellular biogenic amine biosynthetic process	AANAT,ASMT,DDC,HDC,ODC1,PAOX,PRG3,SAT1,SMOX,SRM,TPH1,TPH2	The chemical reactions and pathways occurring at the level of individual cells resulting in the formation of any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters.
GO:0042402	GO	BP	cellular biogenic amine catabolic process	AADAT,ACMSD,AFMID,CCBL1,CCBL2,HAAO,IDO1,IDO2,KMO,KYNU,PAOX,SMOX,TDO2	The chemical reactions and pathways occurring at the level of individual cells resulting in the breakdown of biogenic amines, any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters.
GO:0042403	GO	BP	thyroid hormone metabolic process	CPQ,DIO1,DIO2,DIO3,DUOX1,DUOX2,FOXE1,IYD,SLC5A5,SULT1B1,TPO	The chemical reactions and pathways involving any of the compounds secreted by the thyroid gland, largely thyroxine and triiodothyronine.
GO:0042405	GO	CC	nuclear inclusion body	ATXN1,ATXN3,NBN,NUP153,NUP98,RAD18,RANBP2,SLF1,STUB1,TPR	An intranuclear focus at which aggregated proteins have been sequestered.
GO:0042407	GO	BP	cristae formation	APOO,CHCHD3,CHCHD6,IMMT,LETM1,SAMM50,TAZ,UQCC3	The assembly of cristae, the inwards folds of the inner mitochondrial membrane.
GO:0042415	GO	BP	norepinephrine metabolic process	ATP7A,GATA3,HAND2,INSM1,TH	The chemical reactions and pathways involving norepinephrine, a hormone secreted by the adrenal medulla, and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts in the central nervous system. It is also the demethylated biosynthetic precursor of epinephrine.
GO:0042416	GO	BP	dopamine biosynthetic process	DAO,GCH1,SNCA,TGFB2,TH	The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
GO:0042417	GO	BP	dopamine metabolic process	ATP7A,DAO,DRD1,DRD2,DRD3,DRD4,GCH1,MAOA,MAOB,PARK2,SNCA,SNCAIP,TGFB2,TH	The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
GO:0042423	GO	BP	catecholamine biosynthetic process	DAO,DBH,DDC,GATA3,GCH1,HAND2,INSM1,PAH,PNMT,SNCA,TGFB2,TH	The chemical reactions and pathways resulting in the formation of any of a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.
GO:0042430	GO	BP	indole-containing compound metabolic process	AADAT,AANAT,ACMSD,AFMID,ASMT,ATP7A,CCBL1,CCBL2,DDC,HAAO,HTR1A,IDO1,IDO2,KMO,KYNU,TDO2,TPH1,TPH2	The chemical reactions and pathways involving compounds that contain an indole (2,3-benzopyrrole) skeleton.
GO:0042439	GO	BP	ethanolamine-containing compound metabolic process	ABHD3,ACHE,APOA1,APOA2,APOA4,CDS1,CEPT1,CETP,CHAT,CHKA,CHKB,CHPT1,CLN3,DBI,DMGDH,ENPP2,ENPP6,ENPP7,GPAT4,GPLD1,LCAT,LIPC,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LPIN1,LPIN2,LPIN3,MBOAT1,MBOAT2,PAFAH1B1,PCYT1A,PCYT1B,PEMT,PHOSPHO1,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLB1,PLBD1,PNPLA8,PON1,SAMD8,SGMS1,SGMS2,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SMPD1,SMPD2,SMPD3,SMPD4	The chemical reactions and pathways involving ethanolamine (2-aminoethanol) and compounds derived from it.
GO:0042440	GO	BP	pigment metabolic process	ALAD,ALAS1,ALAS2,AMBP,AP3D1,ATPIF1,BDH2,BLVRA,BLVRB,CITED1,COX10,COX15,CPOX,DCT,FECH,FXN,GMPS,GPR143,HMBS,HMOX1,HMOX2,HPRT1,NFE2L1,OCA2,PAICS,PPOX,PRPS1,SHMT1,SLC25A38,TRPC1,TSPO,TYR,UGT1A1,UGT1A10,UGT1A4,UGT1A7,UGT1A8,UGT1A9,UROD,UROS	The chemical reactions and pathways involving pigment, any general or particular coloring matter in living organisms, e.g. melanin.
GO:0042445	GO	BP	hormone metabolic process	AANAT,ACE,ACE2,ADH4,ADM,AGT,AKR1B1,AKR1B15,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR1D1,ALDH1A2,ALDH1A3,ALDH8A1,ALDH9A1,ANPEP,ASMT,ATP6AP2,BACE2,BCO2,CACNA1H,CGA,CGB,CHST9,CMA1,CORIN,CPA3,CPQ,CTSG,CTSZ,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1B1,CYP21A2,CYP26A1,CYP26B1,CYP26C1,CYP3A4,DHRS2,DHRS3,DHRS9,DIO1,DIO2,DIO3,DUOX1,DUOX2,ECE1,ECE2,ENPEP,FDX1,FDX1L,FDXR,FOXE1,FSHB,FURIN,HSD17B1,HSD17B11,HSD17B3,HSD17B4,HSD17B6,HSD17B8,HSD3B1,HSD3B2,IYD,KLK6,LHB,MED1,MME,NGF,PCSK1,PCSK2,PCSK5,PCSK6,PCSK7,POMC,RBP4,RDH10,RDH11,RDH12,REN,RETSAT,SCG5,SCP2,SCPEP1,SDR16C5,SHH,SLC5A5,SRD5A1,SRD5A2,SRD5A3,STAR,STARD5,SULT1A1,SULT1B1,SULT1E1,TPO,TSHB,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9,UGT2B11,UGT2B4,UGT2B7,WNT4	The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
GO:0042446	GO	BP	hormone biosynthetic process	AANAT,ADM,AKR1B1,AKR1B15,AKR1C3,ASMT,CACNA1H,CHST9,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP21A2,FDX1,FDX1L,FDXR,FSHB,HSD17B1,HSD17B11,HSD17B3,HSD17B6,HSD17B8,HSD3B1,HSD3B2,LHB,MED1,SCP2,SRD5A1,SRD5A2,SRD5A3,STAR,STARD5,WNT4	The chemical reactions and pathways resulting in the formation of any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
GO:0042447	GO	BP	hormone catabolic process	ACE,ECE1,HSD17B11,HSD17B6,UGT2B4	The chemical reactions and pathways resulting in the breakdown of any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
GO:0042448	GO	BP	progesterone metabolic process	ADM,AKR1C1,AKR1C2,AKR1C3,CYP17A1,DHRS9,FSHB,LHB,SCP2	The chemical reactions and pathways involving progesterone, a steroid hormone produced in the ovary which prepares and maintains the uterus for pregnancy. Also found in plants.
GO:0042454	GO	BP	ribonucleoside catabolic process	ADA,AMPD3,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,CECR1,ENPP4,ENTPD4,HPRT1,MLYCD,NUDT18,NUDT7,PNP	The chemical reactions and pathways resulting in the breakdown of any ribonucleoside, a nucleoside in which purine or pyrimidine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0042455	GO	BP	ribonucleoside biosynthetic process	ACOT7,ADA,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,CMPK1,COASY,CTPS1,GBAS,HPRT1,MAT2A,MAT2B,MT-ATP6,MT-ATP8,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,PRKAG2,QTRT1,QTRTD1,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TGFB1,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of any ribonucleoside, a nucleoside in which purine or pyrimidine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0042461	GO	BP	photoreceptor cell development	AHI1,ARL3,BBS4,CEP290,MYO7A,NRL,RORB,RP1,RP1L1,TH,THY1,TOPORS,TULP1,VEGFA	Development of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light.
GO:0042462	GO	BP	eye photoreceptor cell development	BBS4,CEP290,MYO7A,RORB,RP1,TH,THY1,TOPORS,TULP1,VEGFA	Development of a photoreceptor, a sensory cell in the eye that reacts to the presence of light. They usually contain a pigment that undergoes a chemical change when light is absorbed, thus stimulating a nerve.
GO:0042470	GO	CC	melanosome	DCT,GCHFR,GPR143,HPS4,ITGB3,MLANA,OCA2,PMEL,RAB17,RAB27A,RAB27B,RAB32,RAB38,SYTL1,SYTL2,TH,TMEM33,TYR,TYRP1	A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.
GO:0042471	GO	BP	ear morphogenesis	ATP6V1B1,CEP290,CHD7,EPHB2,FGFR2,GSC,HOXA1,HPN,NIPBL,NOG,OSR1,OSR2,PAX2,PAX8,POU3F4,PROX1,SALL1,SIX1,SOD1,SOX9,STRC,TBX1,TFAP2A,TWIST1,ZIC1	The process in which the anatomical structures of the ear are generated and organized. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.
GO:0042472	GO	BP	inner ear morphogenesis	ATP6V1B1,CEP290,CHD7,EPHB2,FGFR2,HOXA1,HPN,PAX2,PAX8,POU3F4,PROX1,SIX1,SOD1,SOX9,STRC,TBX1,TFAP2A,ZIC1	The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
GO:0042474	GO	BP	middle ear morphogenesis	GSC,NOG,OSR1,OSR2,TBX1	The process in which the anatomical structures of the middle ear are generated and organized. The middle ear is the air-filled cavity within the skull of vertebrates that lies between the outer ear and the inner ear. It is linked to the pharynx (and therefore to outside air) via the Eustachian tube and in mammals contains the three ear ossicles, which transmit auditory vibrations from the outer ear (via the tympanum) to the inner ear (via the oval window).
GO:0042475	GO	BP	odontogenesis of dentin-containing tooth	AMELX,AMTN,ANKRD11,BMP2,FAM20A,FOXC1,GLI2,HDAC1,HDAC2,ITGA6,ITGB4,KLK4,MSX1,ROGDI,SCN5A,SLC24A4,STIM1,TBX1,WNT6	The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
GO:0042476	GO	BP	odontogenesis	AMELX,AMTN,ANKRD11,AXIN2,BCOR,BMP2,BMP4,COL1A1,COL1A2,FAM20A,FGFR2,FOXC1,GLI2,HACD1,HDAC1,HDAC2,INHBA,ITGA6,ITGB4,KLK4,LAMB1,MSX1,OSR1,OSR2,PITX2,ROGDI,SCN5A,SLC24A4,STIM1,TBX1,TGFB2,TGFB3,TUFT1,WNT10A,WNT6,ZNF22	The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
GO:0042481	GO	BP	regulation of odontogenesis	AMELX,ASPN,BCOR,BMP2,CD34,MMP20,SHH,TFAP2A,WNT6	Any process that modulates the frequency, rate or extent of the formation and development of a tooth or teeth.
GO:0042482	GO	BP	positive regulation of odontogenesis	AMELX,BMP2,CD34,TFAP2A,WNT6	Any process that activates or increases the frequency, rate or extent of the formation and development of a tooth or teeth.
GO:0042491	GO	BP	auditory receptor cell differentiation	HES5,JAG2,LRTOMT,SOD1,STRC	The process in which a relatively unspecialized cell acquires specialized features of an auditory hair cell.
GO:0042493	GO	BP	response to drug	ABCA2,ABCA3,ABCB1,ABCB4,ABCC1,ABCC6,ABCG2,ADAM17,ADIPOQ,ADRA1A,AIM2,AOC1,APOD,AQP1,ATP8B1,BCAR3,BCL2,CD38,CDK4,CENPF,CERS1,CRHBP,CTPS1,CYP1A2,CYP2A6,CYP2B6,CYP2C19,CYP2C8,CYP2C9,CYP2D7,CYP3A4,DPEP1,DRD1,DRD2,DRD3,EBP,EIF2B5,FBP1,FZD1,GAS6,GATA4,GATA6,GCLM,GPLD1,HMGB2,HTR1B,HTR2A,HTR2B,HTR2C,IL1B,INHBA,KCNE2,KCNH2,KCNJ11,KCNQ1,LCK,MEF2C,MFSD10,MT2A,MT3,MYC,NAT8,NCKAP1L,NFATC2,NOS1,NR1I2,PAPD7,PARP4,PDE2A,PDE4B,PDZK1,PNP,PPM1E,PPM1F,PPP3CA,PPP3CB,PTPRM,RAB6C,RAP2A,RBM22,REST,SCN11A,SEMA3C,SFRP1,SLC15A2,SLC17A3,SLC22A1,SLC22A12,SLC22A18,SLC22A2,SLC22A3,SLC22A5,SLC46A1,SOD1,SRP14,SRP19,SRP54,SRP68,SRP72,TFRC,TGFB2,TGFBR2,TMEM30A,UBE2B,USP47,VAV3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
GO:0042509	GO	BP	regulation of tyrosine phosphorylation of STAT protein	ARL2BP,CCL5,CD40,CLCF1,CNTF,CRLF1,CSF1R,CSF2,CTF1,EPO,ERBB4,FGFR3,FLT3,GH1,GHR,HCLS1,HES1,HES5,IFNA2,IFNG,IFNL1,IGF1,IL12A,IL12B,IL18,IL2,IL20,IL21,IL22RA2,IL23A,IL23R,IL3,IL6,IL6R,IL6ST,JAK2,KIT,LIF,LYN,NF2,OSM,PIBF1,PPP2CA,PPP2R1A,PTPN2,SOCS1,TNFRSF18,TNFRSF1A,TNFSF18	Any process that modulates the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
GO:0042510	GO	BP	regulation of tyrosine phosphorylation of Stat1 protein	CD40,FGFR3,IFNG,IL12B,IL21,IL23A,IL23R,IL6ST,KIT,LIF,PTPN2,TNFRSF18,TNFRSF1A,TNFSF18	Any process that modulates the frequency, rate or extent of introducing a phosphate group to a tyrosine residue of a Stat1 protein.
GO:0042511	GO	BP	positive regulation of tyrosine phosphorylation of Stat1 protein	CD40,FGFR3,IFNG,IL21,IL6ST,KIT,LIF,TNFRSF18,TNFRSF1A,TNFSF18	Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat1 protein.
GO:0042516	GO	BP	regulation of tyrosine phosphorylation of Stat3 protein	ARL2BP,CLCF1,CNTF,CRLF1,CSF1R,CTF1,FGFR3,GH1,GHR,HES1,HES5,IFNA2,IL12B,IL18,IL20,IL21,IL22RA2,IL23A,IL23R,IL6,IL6R,IL6ST,JAK2,KIT,LIF,NF2,OSM,PPP2CA,PPP2R1A,PTPN2,SOCS1	Any process that modulates the frequency, rate or extent of introducing a phosphate group to a tyrosine residue of a Stat3 protein.
GO:0042517	GO	BP	positive regulation of tyrosine phosphorylation of Stat3 protein	ARL2BP,CLCF1,CNTF,CRLF1,CSF1R,CTF1,FGFR3,GH1,GHR,HES1,HES5,IFNA2,IL12B,IL18,IL20,IL21,IL23A,IL23R,IL6,IL6R,IL6ST,JAK2,KIT,LIF,OSM	Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat3 protein.
GO:0042518	GO	BP	negative regulation of tyrosine phosphorylation of Stat3 protein	NF2,PPP2CA,PPP2R1A,PTPN2,SOCS1	Any process that stops, prevents, or reduces the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat3 protein.
GO:0042519	GO	BP	regulation of tyrosine phosphorylation of Stat4 protein	IL12A,IL12B,IL23A,IL23R,PIBF1	Any process that modulates the frequency, rate or extent of introducing a phosphate group to a tyrosine residue of a Stat4 protein.
GO:0042522	GO	BP	regulation of tyrosine phosphorylation of Stat5 protein	CSF2,EPO,ERBB4,GH1,GHR,IGF1,IL12B,IL2,IL23A,IL23R,IL3,JAK2,KIT,NF2,PTPN2	Any process that modulates the frequency, rate or extent of introducing a phosphate group to a tyrosine residue of a Stat5 protein.
GO:0042523	GO	BP	positive regulation of tyrosine phosphorylation of Stat5 protein	CSF2,EPO,ERBB4,GH1,GHR,IGF1,IL12B,IL2,IL23A,IL23R,IL3,JAK2,KIT	Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat5 protein.
GO:0042531	GO	BP	positive regulation of tyrosine phosphorylation of STAT protein	ARL2BP,CCL5,CD40,CLCF1,CNTF,CRLF1,CSF1R,CSF2,CTF1,EPO,ERBB4,FGFR3,FLT3,GH1,GHR,HCLS1,HES1,HES5,IFNA2,IFNG,IFNL1,IGF1,IL12A,IL12B,IL18,IL2,IL20,IL21,IL23A,IL23R,IL3,IL6,IL6R,IL6ST,JAK2,KIT,LIF,LYN,OSM,PIBF1,TNFRSF18,TNFRSF1A,TNFSF18	Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
GO:0042532	GO	BP	negative regulation of tyrosine phosphorylation of STAT protein	NF2,PIBF1,PPP2CA,PPP2R1A,PTPN2,SOCS1	Any process that stops, prevents, or reduces the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
GO:0042534	GO	BP	regulation of tumor necrosis factor biosynthetic process	AZU1,CCR2,GHRL,GHSR,HSPB1,LILRB1,SPN,THBS1,TLR1,TLR4,TNFRSF8	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
GO:0042535	GO	BP	positive regulation of tumor necrosis factor biosynthetic process	AZU1,CCR2,HSPB1,SPN,THBS1,TLR1,TLR4,TNFRSF8	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
GO:0042537	GO	BP	benzene-containing compound metabolic process	AADAT,ACSM1,CCBL1,CCBL2,GSTM1,GSTM2,GSTM3,IDO2,KMO,KYNU	The chemical reactions and pathways involving benzene, C6H6, a volatile, very inflammable liquid, contained in the naphtha produced by the destructive distillation of coal, from which it is separated by fractional distillation, or any of its derivatives.
GO:0042542	GO	BP	response to hydrogen peroxide	ADAM9,APTX,AQP1,CYP1B1,ECT2,FABP1,FXN,GLRX2,GPX1,HBA1,HBB,HDAC6,HMOX1,HP,IL6,IMPACT,MAP3K5,MAPK7,NET1,NFE2L2,PARK7,PAX2,PDCD10,PLEKHA1,PPIF,PRDX3,RELA,RHOB,RPS3,SETX,SIRT1,SOD1,STK24,STK25,STK26,TNFAIP3,ZNF580	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
GO:0042551	GO	BP	neuron maturation	AGRN,ANKS1A,APP,CLN5,CNTN2,CNTNAP2,EPHA8,FARP2,KCNIP2,MTCH1,MYOC,NRCAM,PICK1,RND1,SCARF1,SPTBN4	A developmental process, independent of morphogenetic (shape) change, that is required for a neuron to attain its fully functional state.
GO:0042552	GO	BP	myelination	ACSBG1,AMIGO1,ARHGEF10,CD9,CLU,CNTNAP1,CXCR4,DICER1,EIF2B2,EIF2B4,EIF2B5,EPB41L3,FAM126A,GPC1,HES5,KLK6,MAL,MYOC,MYRF,NCMAP,NF1,NFASC,PARD3,PTEN,SBF2,SCN2A,SCN8A,SIRT2,SKI,SLC8A3,SOD1,TENM4,TNFRSF21,ZNF24	The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
GO:0042554	GO	BP	superoxide anion generation	ALOX12,CYBA,CYBB,DUOX1,NCF1,NCF2,NOX1,NOX4,NOX5,PRG3	The enzymatic generation of superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species, by a cell in response to environmental stress, thereby mediating the activation of various stress-inducible signaling pathways.
GO:0042555	GO	CC	MCM complex	MCM2,MCM3,MCM4,MCM5,MCM6,MCM7,MCM8,MCM9,MCMBP,MMS22L,TONSL	A hexameric protein complex required for the initiation and regulation of DNA replication.
GO:0042558	GO	BP	pteridine-containing compound metabolic process	DHFR,DHFRL1,FPGS,FTCD,GCH1,MTHFD1,MTHFD1L,MTHFD2,MTHFR,MTHFS,MTRR,QDPR,SHMT1,SHMT2,SLC19A1,SLC25A32,SLC46A1,SPR,TYMS	The chemical reactions and pathways involving any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid.
GO:0042559	GO	BP	pteridine-containing compound biosynthetic process	DHFR,FPGS,GCH1,MTHFD1,SPR	The chemical reactions and pathways resulting in the formation of any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid.
GO:0042562	GO	MF	hormone binding	ACVR1,ADIPOR1,ADIPOR2,ALDH1A1,AR,ATP1A1,ATP1A2,ATP1A3,CALCR,CDH13,CRHBP,CRYM,CTSH,ECE1,GALR1,GALR2,GALR3,GPER1,IDE,INSR,LHCGR,NPR3,NR3C1,NRD1,PIK3R1,PTH1R,SHBG,THRA,THRB	Interacting selectively and non-covalently with any hormone, naturally occurring substances secreted by specialized cells that affect the metabolism or behavior of other cells possessing functional receptors for the hormone.
GO:0042572	GO	BP	retinol metabolic process	ADH4,CYP1B1,DHRS3,DHRS9,RBP4,RDH10,RDH11,RDH12,RETSAT,SDR16C5	The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A.
GO:0042573	GO	BP	retinoic acid metabolic process	ALDH1A2,ALDH1A3,ALDH8A1,BCO2,CYP26A1,CYP26B1,CYP26C1,DHRS9,SCPEP1,UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving retinoic acid, one of the three components that makes up vitamin A.
GO:0042574	GO	BP	retinal metabolic process	AKR1C1,AKR1C3,ALDH1A3,ALDH8A1,BCO1,BCO2,CYP1B1,RDH10,RDH11,SDR16C5	The chemical reactions and pathways involving retinal, a compound that plays an important role in the visual process in most vertebrates. In the retina, retinal combines with opsins to form visual pigments. Retinal is one of the forms of vitamin A.
GO:0042575	GO	CC	DNA polymerase complex	CHRAC1,CRCP,DNA2,MAD2L2,POLD3,POLE,POLE2,POLE3,POLE4,REV3L	A protein complex that possesses DNA polymerase activity and is involved in template directed synthesis of DNA.
GO:0042581	GO	CC	specific granule	ADAM8,ANXA11,ANXA3,CAMP,CLCN3,CRISP3,LTF,OLFM4,SNAP23,STX3,STX4,STXBP2,STXBP3,VAMP1	Granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.
GO:0042582	GO	CC	azurophil granule	ANXA11,AZU1,DEFA1,DEFA3,DEFA4,HEXA,HEXB,MPO,SNAP23,STX3,STX7,STXBP2,VAMP7,VAMP8	Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
GO:0042589	GO	CC	zymogen granule membrane	CUZD1,DMBT1,TMED10,TMED2,VAMP2	The lipid bilayer surrounding a zymogen granule.
GO:0042590	GO	BP	antigen processing and presentation of exogenous peptide antigen via MHC class I	B2M,CALR,CD207,CD36,CTSS,CYBA,CYBB,FCGR1A,FCGR1B,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,IFI30,ITGAV,ITGB5,LNPEP,NCF1,NCF2,NCF4,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RPS27A,SEC61A1,SEC61A2,SEC61B,SEC61G,TAP1,TAP2,TAPBP,UBA52,UBB,UBC	The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
GO:0042593	GO	BP	glucose homeostasis	ACSM2A,ADIPOQ,ADIPOR1,ADIPOR2,ADRA2A,APPL1,BAD,CARTPT,CAV3,CEBPA,CRTC2,CRY1,CRY2,CYB5R4,CYP11B1,CYP7A1,ERN1,FFAR2,FGFR4,FOXA3,FOXO1,G6PC,G6PC2,GAS6,GCGR,GCK,GNB2L1,GPER1,HECTD4,HNF1A,HNF4A,INPP5K,INS,INSR,IRS1,KCNB1,LEPR,MBD5,MCU,MLXIPL,MTNR1B,NEUROD1,NGFR,OAS1,OGT,PAX2,PAX6,PCK1,PDK2,PDK3,PDK4,PIK3R1,PIK3R2,PPARG,PPARGC1A,PRKAA1,PRKAA2,PRKACA,PTPN2,PTPRN,PTPRN2,PYGL,RAB11B,RAB11FIP2,RAB11FIP5,RBP4,RFX6,RPS6,SIRT1,SLC2A4,SLC37A4,SLC8B1,SOX4,STAT3,STK11,TCF7L2,TFAP2B,USF1,WFS1,XBP1	Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
GO:0042594	GO	BP	response to starvation	ALB,AOC1,ASNS,ATF4,ATG14,ATG7,BECN1,BHLHA15,CARTPT,CDKN1A,CPEB4,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,FADS1,FNIP1,FOXO1,GAS2L1,GCGR,HSPA5,HSPA8,IFI16,IMPACT,INHBB,KIAA1324,KLF10,LRRK2,MIOS,MTMR3,MYBBP1A,NPRL2,NPRL3,NUAK2,NUPR1L,PCSK9,PDK4,PICK1,PIK3C3,PIK3R4,PMAIP1,PPARGC1A,PRKAA1,PRKAA2,RALB,RNF152,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SREBF1,SREBF2,TBC1D5,TBL2,TP53,ULK1,ULK2,USP33,WDR24,WDR59,WRN,XBP1,ZFP36	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment.
GO:0042599	GO	CC	lamellar body	ABCA12,ABCA3,CKAP4,CTSH,KLK5,KLK7,NAPSA,SFTA3,SFTPA1,SFTPA2,SFTPB,SFTPC,SFTPD,SPINK5	A membrane-bounded organelle, specialized for the storage and secretion of various substances (surfactant phospholipids, glycoproteins and acid phosphates) which are arranged in the form of tightly packed, concentric, membrane sheets or lamellae. Has some similar properties to, but is distinct from, a lysosome.
GO:0042605	GO	MF	peptide antigen binding	CD209,CLEC4M,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,SLC7A5,SLC7A8,SLC7A9,TAP1,TAPBP	Interacting selectively and non-covalently with an antigen peptide.
GO:0042611	GO	CC	MHC protein complex	CD74,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E	A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen.
GO:0042613	GO	CC	MHC class II protein complex	CD74,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5	A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen.
GO:0042622	GO	CC	photoreceptor outer segment membrane	DHRS3,GNAT1,GNAT2,NAPEPLD,OPN1LW,OPN1MW,OPN1SW,PROM1,RHO	The membrane surrounding the outer segment of a vertebrate photoreceptor.
GO:0042623	GO	MF	ATPase activity, coupled	ABCA12,ABCA2,ABCA3,ABCA8,ABCB1,ABCB11,ABCB4,ABCB6,ABCB9,ABCD1,ABCD4,ABCG1,ABCG2,ASCC3,ATP10A,ATP10D,ATP11B,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V0E2,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1,ATP8B1,ATRX,BLM,BPTF,BRIP1,CCNH,CCT8,CDK7,CFTR,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD6,CHD8,CLPX,DDX1,DDX11,DDX17,DDX18,DDX20,DDX21,DDX23,DDX25,DDX39B,DDX3X,DDX43,DDX54,DDX56,DHX36,DHX8,DHX9,DNA2,EIF4A3,ERCC2,ERCC3,ERCC6,FBXO18,G3BP1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HELB,HSPA1A,HSPA1B,HSPA6,HSPA8,IGHMBP2,KATNA1,KATNB1,KIF18A,LONP1,MCM4,MCM6,MCM7,MNAT1,MOV10L1,MRE11A,MYH10,MYH14,MYH3,MYH6,MYH7,MYH9,MYL6,MYO10,MYO1D,MYO1E,MYO3A,NBN,PEX1,PEX6,PIF1,POLQ,RAD50,RAD51,RAD51B,RAD51D,RAD54B,RALBP1,RBBP4,RECQL,RECQL4,RFC3,RTEL1,RUVBL2,SKIV2L,SMARCA1,SMARCA2,SMARCA4,SMARCAL1,SNRNP200,SPAST,SUPV3L1,TAP2,TAPBP,TNNT3,TOP2A,TOP2B,TTF2,UPF1,VPS4A,VPS4B,WRN,YTHDC2	Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction directly drives some other reaction, for example ion transport across a membrane.
GO:0042625	GO	MF	ATPase coupled ion transmembrane transporter activity	ABCB11,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V0E2,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1	Catalysis of the transfer of an ion from one side of a membrane to the other, driven by the reaction: ATP + H2O = ADP + phosphate.
GO:0042626	GO	MF	ATPase activity, coupled to transmembrane movement of substances	ABCA12,ABCA2,ABCA3,ABCA8,ABCB1,ABCB11,ABCB4,ABCB6,ABCB9,ABCD1,ABCD4,ABCG1,ABCG2,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V0E2,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1,CFTR,TAP2,TAPBP	Catalysis of the reaction: ATP + H2O = ADP + phosphate, to directly drive the active transport of a substance across a membrane.
GO:0042627	GO	CC	chylomicron	APOA2,APOA4,APOA5,APOB,APOC1,APOC2,APOC3,APOE,APOH	A large lipoprotein particle (diameter 75-1200 nm) composed of a central core of triglycerides and cholesterol surrounded by a protein-phospholipid coating. The proteins include one molecule of apolipoprotein B-48 and may include a variety of apolipoproteins, including APOAs, APOCs and APOE. Chylomicrons are found in blood or lymph and carry lipids from the intestines into other body tissues.
GO:0042629	GO	CC	mast cell granule	CHGA,CXCR2,KIT,MRGPRX2,PIK3CD,PIK3CG,S100A13,SNAP23,SRGN	Coarse, bluish-black staining cytoplasmic granules, bounded by a plasma membrane and found in mast cells and basophils. Contents include histamine, heparin, chondroitin sulfates, chymase and tryptase.
GO:0042632	GO	BP	cholesterol homeostasis	ABCA1,ABCG1,ABCG5,ABCG8,ACSM1,ACSM3,AKR1C1,ANGPTL3,APOA1,APOA2,APOA4,APOA5,APOB,APOC2,APOC3,APOE,APOM,CAV1,CAV3,CD24,CETP,CYP7A1,DGAT2,EHD1,EPHX2,FABP3,GPIHBP1,LAMTOR1,LCAT,LDLR,LDLRAP1,LIPC,LIPG,LRP5,MALL,NPC1,NPC2,NR1H3,PCSK9,PLA2G10,PTCHD2,SCARB1,SIRT1,SOAT1,SOAT2,TMEM97,XBP1	Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
GO:0042633	GO	BP	hair cycle	ALX4,APCDD1,ATP7A,CDH3,FGFR2,FOXE1,FUZ,GNAS,HDAC1,HDAC2,INHBA,KRT14,KRT16,KRT17,KRT25,KRT33B,KRT71,KRT83,KRT84,KRTAP4-3,KRTAP4-5,KRTAP4-7,KRTAP4-8,KRTAP4-9,PDGFA,SNRPE,SOX18,SOX9,SPINK5,TGFB2,TGM3,WNT10A	The cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair; one of the collection or mass of filaments growing from the skin of an animal, and forming a covering for a part of the head or for any part or the whole of the body.
GO:0042634	GO	BP	regulation of hair cycle	ARNTL,CDH3,CLOCK,FST,GAL,HPSE,NIPBL,PER1,TGFB2,TRPV3	Any process that modulates the frequency, rate or extent of the cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair.
GO:0042641	GO	CC	actomyosin	ABLIM1,ABLIM3,ACTA1,ACTC1,ACTN1,AMOT,CDC42BPA,CDC42BPB,CNN2,CORO1B,DAAM1,DBN1,FBLIM1,FHOD1,FSCN1,GAS2L1,GAS2L2,LCP1,LIMA1,MICALL2,MYH10,MYH14,MYH9,MYLK,MYO18A,NEBL,PGM5,PTK2,PXN,SEPT11,SEPT12,SEPT7,SEPT9,SHROOM4,SIPA1L3,SORBS1,TEK,TPM1,TPM3,TPM4,ZYX	Any complex of actin, myosin, and accessory proteins.
GO:0042645	GO	CC	mitochondrial nucleoid	ACADVL,ATP5B,CLPX,CPS1,DBT,DDX28,DHX30,DNA2,DNAJA3,FASTKD2,FASTKD5,GRSF1,HADHA,HADHB,HSPA9,LONP1,LRPPRC,LRRC59,MTERF1,POLDIP2,POLG,POLG2,POLRMT,SHMT2,SLC25A5,SSBP1,SUPV3L1,TEFM,TERT,TFAM,TFB1M,TFB2M,TOP1MT,TUFM,UQCC2,VDAC1,VDAC2	The region of a mitochondrion to which the DNA is confined.
GO:0042659	GO	BP	regulation of cell fate specification	DKK1,FGF2,FZD7,MESP1,POU5F1,WNT3A	Any process that mediates the adoption of a specific fate by a cell.
GO:0042692	GO	BP	muscle cell differentiation	ABL1,ACTA1,ACTC1,ACTN2,ACVR1,ADAM12,ADGRB3,ANK2,ANKRD1,BMP10,BMP2,BMP4,BNIP2,BOC,CACNA1H,CAPN3,CASQ1,CAV2,CAV3,CBY1,CDC42,CDH15,CDH2,CDK9,CDON,CFLAR,CHRNB1,CSRP3,CTNNA1,CTNNA2,CTNNB1,CXADR,DMD,EDNRB,EPAS1,FBXO40,GATA6,GLMN,GREM1,HES1,HEY1,HEY2,HINFP,IFRD1,IGF1,JAG1,KCNH1,KDM1A,KDM6B,KLHL41,KRT19,MAML1,MAP2K6,MAPK11,MAPK12,MAPK14,MBNL1,MEF2A,MEF2C,MEGF10,MESP1,MKL1,MYF5,MYF6,MYH11,MYH3,MYH6,MYL2,MYLK3,MYOCD,MYOD1,MYOG,MYOZ1,MYPN,NEBL,NEO1,NKX2-5,NKX2-6,NOS1,NOTCH1,NRG1,NTN3,OBSCN,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,RAMP2,RB1,RBPJ,REST,RORA,RYR1,SDC1,SEMA4C,SGCZ,SIK1,SIX4,SKI,SLC8A1,SORBS2,SORT1,SOX15,SPAG9,SRF,SYNE1,T,TBX1,TBX2,TCAP,TCF3,TCF7L2,TMEM8C,TPM1,TTN,VEGFA,WNT3A,WT1	The process in which a relatively unspecialized cell acquires specialized features of a muscle cell.
GO:0042693	GO	BP	muscle cell fate commitment	ACVR1,MEF2C,MYF5,MYF6,MYOD1,MYOG,TBX1,TBX2,WNT3A,WT1	The process in which the cellular identity of muscle cells is acquired and determined.
GO:0042698	GO	BP	ovulation cycle	ANG,BMPR1B,CEBPB,EIF2B2,EIF2B4,EIF2B5,EREG,FOXL2,FSHR,INHA,INHBA,INHBB,KIT,PDGFRA,PTPRN,SOD1,TGFB2,TGFB3,TYRO3,VEGFA,ZNF830	The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
GO:0042719	GO	CC	mitochondrial intermembrane space protein transporter complex	TIMM10,TIMM10B,TIMM13,TIMM8B,TIMM9	Soluble complex of the mitochondrial intermembrane space composed of various combinations of small Tim proteins; acts as a protein transporter to guide proteins to the Tim22 complex for insertion into the mitochondrial inner membrane.
GO:0042723	GO	BP	thiamine-containing compound metabolic process	ACPP,SLC19A2,SLC19A3,THTPA,TKTL1,TPK1	The chemical reactions and pathways involving thiamine (vitamin B1), and compounds derived from it.
GO:0042726	GO	BP	flavin-containing compound metabolic process	ACP5,ENPP1,FLAD1,RFK,SLC52A3,VCP	The chemical reactions and pathways involving a flavin, any derivative of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton, with a substituent on the 10 position.
GO:0042730	GO	BP	fibrinolysis	F2,FGA,FGB,FGG,GP1BA,HRG,KRT1,PLAT,PLAU,PLAUR,PLG,SERPINB2,SERPINE1,SERPINF2,TMPRSS6	A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
GO:0042733	GO	BP	embryonic digit morphogenesis	CREBBP,ECE1,GLI3,HDAC1,HDAC2,IHH,MSX1,NOG,OSR1,OSR2,SALL1,SHH,TBX2,TBX3,TWIST1,WNT7A	The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
GO:0042734	GO	CC	presynaptic membrane	ADGRL1,CASK,CNTNAP4,ERC1,ERC2,GPER1,KCNA1,KCNC2,NPTN,NRXN1,PDE2A,PI4K2A,PICALM,PICK1,RIMS1,SCRIB,SNAP25,SNCAIP,UNC13A	A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.
GO:0042737	GO	BP	drug catabolic process	CYP1A2,CYP2A6,CYP2B6,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP2D7,CYP3A4,CYP3A5,NOS1,NR1I2	The chemical reactions and pathways resulting in the breakdown of a drug, a substance used in the diagnosis, treatment or prevention of a disease.
GO:0042738	GO	BP	exogenous drug catabolic process	CYP1A2,CYP2A6,CYP2B6,CYP2C19,CYP2C8,CYP2C9,CYP2D7,CYP3A4,NOS1,NR1I2	The chemical reactions and pathways resulting in the breakdown of a drug that has originated externally to the cell or organism.
GO:0042742	GO	BP	defense response to bacterium	ADAM17,ADM,ANG,ANKRD17,ANXA3,APP,AZU1,B2M,BPIFA1,C10orf99,CALCA,CAMP,CEBPB,CFP,CHGA,CRP,CXCL13,DEFA1,DEFA3,DEFA4,DEFA5,DEFA6,DEFB1,DEFB118,DEFB127,DMBT1,DROSHA,ELANE,EPPIN,FAU,FCN2,FGA,FGB,FGR,GBP6,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,HLA-A,HLA-E,HMGB2,HTN1,HTN3,IFNE,IL12B,IL23A,IL23R,IL6,IL6R,ISG15,JCHAIN,KLK3,LALBA,LBP,LPO,LTF,LYST,MAVS,MBL2,MICA,MYD88,NLRC4,NLRP1,NLRP10,NOD1,NOD2,NOS2,NPY,OPTN,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,PLA2G1B,PLA2G2A,PLA2G6,PRB3,PRKCD,PYCARD,RAB1A,REG3G,RNASE3,RNASE7,RPL39,S100A12,S100A7,S100A8,S100A9,SELP,SEMG1,SEMG2,SERPINE1,SFTPD,SLC11A1,SLPI,SPACA3,SPN,STAB1,STAB2,SYK,TAC1,TIRAP,TLR2,TLR3,TLR4,TLR6,TLR9,VIP,WFDC12	Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
GO:0042743	GO	BP	hydrogen peroxide metabolic process	APOA4,CAT,CYBA,DUOX1,GPX1,GPX3,HBA1,HBB,MAOB,MPO,NOX1,PARK7,PRDX1,PRDX2,PRDX3,PRDX5,PXDN,PXDNL,SOD1	The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
GO:0042744	GO	BP	hydrogen peroxide catabolic process	APOA4,CAT,GPX1,GPX3,HBA1,HBB,MPO,PRDX1,PRDX2,PRDX3,PRDX5,PXDN,PXDNL	The chemical reactions and pathways resulting in the breakdown of hydrogen peroxide (H2O2).
GO:0042749	GO	BP	regulation of circadian sleep/wake cycle	CHRNB2,CRH,GHRH,GHRL,NLGN1,PER3,PTGDS	Any process that modulates the frequency, rate or extent of the circadian sleep/wake cycle.
GO:0042752	GO	BP	regulation of circadian rhythm	ADCY1,ARNTL,ARNTL2,BHLHE40,BTRC,CCAR2,CHRM1,CHRNB2,CIPC,CRH,CRTC1,CRY1,CRY2,CSNK1D,CSNK1E,DRD4,EZH2,FBXL3,FBXW11,GHRH,GHRL,GNA11,GNAQ,HNRNPD,ID2,KLF10,MAGEL2,MAPK10,MAPK8,MAPK9,MTA1,NKX2-1,NLGN1,NOCT,NONO,NR1D1,NR1D2,NR1H3,OPN3,OPN4,PASD1,PER1,PER2,PER3,PML,PPARA,PPARG,PPARGC1A,PPP1CA,PPP1CB,PPP1CC,PRKAA1,PRKAA2,PRKCG,PRKDC,PROX1,PSPC1,PTGDS,RBM4,RBM4B,ROCK2,RORA,RORB,RORC,SFPQ,SIK1,SIN3A,SUV39H1,SUV39H2,THRAP3,TIMELESS,TOP2A,TP53,UBE3A,USP2,ZFHX3	Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours.
GO:0042753	GO	BP	positive regulation of circadian rhythm	ARNTL,ARNTL2,BTRC,CRH,FBXW11,GHRH,GHRL,NKX2-1,NLGN1,RORA,RORC,THRAP3	Any process that activates or increases the frequency, rate or extent of a circadian rhythm behavior.
GO:0042754	GO	BP	negative regulation of circadian rhythm	CIPC,CRH,CRY1,CRY2,GHRL,PASD1,PER2,SFPQ,SIN3A,SUV39H1,SUV39H2	Any process that stops, prevents, or reduces the frequency, rate or extent of a circadian rhythm behavior.
GO:0042759	GO	BP	long-chain fatty acid biosynthetic process	ACOT7,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOXE3,ELOVL6	The chemical reactions and pathways resulting in the formation of long-chain fatty acids, any fatty acid with a chain length between C13 and C22.
GO:0042761	GO	BP	very long-chain fatty acid biosynthetic process	ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL7,HACD1,HACD2,HACD3,HACD4,TECR	The chemical reactions and pathways resulting in the formation of a fatty acid which has a chain length greater than C22.
GO:0042762	GO	BP	regulation of sulfur metabolic process	BHMT,CTNNB1,DLAT,DLD,PDHA1,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR,PXYLP1,SP1,TCF7L2	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving sulfur, the nonmetallic element sulfur or compounds that contain sulfur.
GO:0042765	GO	CC	GPI-anchor transamidase complex	GPAA1,PIGK,PIGS,PIGT,PIGU	An enzyme complex which in humans and yeast consists of at least five proteins; for example, the complex contains GAA1, GPI8, PIG-S, PIG-U, and PIG-T in human, and Gaa1p, Gab1p, Gpi8p, Gpi16p, and Gpi17p in yeast. Catalyzes the posttranslational attachment of the carboxyl-terminus of a precursor protein to a GPI-anchor.
GO:0042769	GO	BP	DNA damage response, detection of DNA damage	CUL4A,CUL4B,DDB1,DTL,HMGA2,MRPS11,MRPS26,MRPS35,MRPS9,PCNA,PNKP,POLD1,POLD2,POLD3,POLD4,RAD18,RBX1,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,RPS3,SOX4,UBA52,UBB,UBC,UBE2B,USP1,ZBTB32	The series of events required to receive a stimulus indicating DNA damage has occurred and convert it to a molecular signal.
GO:0042770	GO	BP	signal transduction in response to DNA damage	ABL1,ATM,ATRX,BATF,BCL3,BID,BRCA1,CASP2,CASP9,CDC5L,CDK2,CDKN1A,CDKN1B,CEP63,CHEK2,CRADD,E2F7,FOXM1,GADD45A,GML,GRB2,GTSE1,HIPK2,ING4,KAT5,MAD2L2,MAPK14,MDM2,MUC1,MYO6,NBN,PAXIP1,PIDD1,PML,PPP2R5C,PRKDC,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RPS27A,RPS6KA6,SMC1A,SOX4,SP100,TFAP4,TP53,TRIAP1,UBA52,UBB,UBC,USP10,WNT1	A cascade of processes induced by the detection of DNA damage within a cell.
GO:0042771	GO	BP	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	AEN,BAG6,BCL3,CDIP1,DDIT4,DYRK2,EP300,HIPK2,IFI16,PHLDA3,PML,PPP2R5C,PYCARD,RPS27L,SIRT1,SNW1,TP53,TP73,USP28	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
GO:0042772	GO	BP	DNA damage response, signal transduction resulting in transcription	BRCA1,FOXM1,HIPK2,ING4,KAT5,MAD2L2,MUC1,RBM38,RPS6KA6,SP100,TFAP4,TP53	A cascade of processes initiated in response to the detection of DNA damage, and resulting in the induction of transcription.
GO:0042773	GO	BP	ATP synthesis coupled electron transport	COA6,COX10,COX15,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,SDHAF2,TAZ,UQCC3,UQCR10	The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP.
GO:0042775	GO	BP	mitochondrial ATP synthesis coupled electron transport	COX10,COX15,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,SDHAF2,TAZ,UQCC3,UQCR10	The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP, as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane.
GO:0042776	GO	BP	mitochondrial ATP synthesis coupled proton transport	ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,MT-ATP6,MT-ATP8,STOML2	The transport of protons across a mitochondrial membrane to generate an electrochemical gradient (proton-motive force) that powers ATP synthesis.
GO:0042787	GO	BP	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	AREL1,ARIH2,BFAR,CBL,CBLC,DDB1,FBXL14,FBXO10,FBXO45,HACE1,KLHL25,KLHL3,KLHL8,MDM2,NEDD4,NEDD4L,OS9,PARK2,RBBP6,RCHY1,RFFL,RNF11,RNF126,RNF128,RNF144B,RNF146,RNF217,RNF34,RNF43,SIAH1,SMURF1,STUB1,SYVN1,TRIM25,TRIM32,TRIP12,UBE4B,UBR4,UHRF1,ZNRF4	The process in which a ubiquitin group, or multiple groups, are covalently attached to the target protein, thereby initiating the degradation of that protein.
GO:0042788	GO	CC	polysomal ribosome	ABCF1,FMR1,LARP4B,NR0B1,NUFIP2,RPL7A	A ribosome bound to mRNA that forms part of a polysome.
GO:0042789	GO	BP	mRNA transcription from RNA polymerase II promoter	ARNT,ATF4,C5AR1,DDIT3,HIF1A,LMO2,MED1,MYOG,POU5F1,SOX17,SOX18,SRF,ZBTB1	The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter.
GO:0042791	GO	BP	5S class rRNA transcription from RNA polymerase III type 1 promoter	GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6	The synthesis of 5S ribosomal RNA (rRNA), or an equivalent rRNA, from a DNA template by RNA polymerase III (Pol III), originating at a type 1 RNA polymerase III promoter.
GO:0042795	GO	BP	snRNA transcription from RNA polymerase II promoter	ELL,ELL2,ELL3,ICE1,ICE2,SNAPC4,ZC3H8	The synthesis of small nuclear RNA (snRNA) from a DNA template by RNA Polymerase II (Pol II), originating at a Pol II promoter.
GO:0042796	GO	BP	snRNA transcription from RNA polymerase III promoter	ELL,ICE1,ICE2,SNAPC4,ZC3H8	The synthesis of small nuclear RNA (snRNA) from a DNA template by RNA Polymerase III (Pol III), originating at a Pol III promoter.
GO:0042797	GO	BP	tRNA transcription from RNA polymerase III promoter	GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6	The synthesis of transfer RNA (tRNA) from a DNA template by RNA Polymerase III (Pol III), originating at a Pol III promoter.
GO:0042800	GO	MF	histone methyltransferase activity (H3-K4 specific)	ASH2L,CXXC1,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,RBBP5,SETD1A,SETD1B,SETMAR,WDR5,WDR82	Catalysis of the reaction: S-adenosyl-L-methionine + histone H3 L-lysine (position 4) = S-adenosyl-L-homocysteine + histone H3 N6-methyl-L-lysine (position 4). This reaction is the addition of a methyl group onto lysine at position 4 of the histone H3 protein.
GO:0042805	GO	MF	actinin binding	CSRP3,DAG1,MYOT,NRAP,PALLD,PDLIM5,PKD2,PROM1,SYNPO2,TTN	Interacting selectively and non-covalently with actinin, any member of a family of proteins that crosslink F-actin.
GO:0042809	GO	MF	vitamin D receptor binding	MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,SNW1,THRAP3	Interacting selectively and non-covalently with the vitamin D receptor, a nuclear receptor that mediates the action of vitamin D by binding DNA and controlling the transcription of hormone-sensitive genes.
GO:0042813	GO	MF	Wnt-activated receptor activity	FZD1,FZD3,FZD4,FZD5,FZD6,FZD8,LRP5,RYK	Combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity.
GO:0042826	GO	MF	histone deacetylase binding	BHLHE41,CAMTA2,DHX36,GLI3,HDAC10,HDAC9,HIC1,MAGEA1,MAGEA2,PKN1,PKN2,SUDS3	Interacting selectively and non-covalently with the enzyme histone deacetylase.
GO:0042827	GO	CC	platelet dense granule	ABCC4,CD63,HPS4,ITPR1,LAMP2,SELP	Electron-dense granule occurring in blood platelets that stores and secretes adenosine nucleotides and serotonin. They contain a highly condensed core consisting of serotonin, histamine, calcium, magnesium, ATP, ADP, pyrophosphate and membrane lysosomal proteins.
GO:0042832	GO	BP	defense response to protozoan	BATF,BATF2,CLEC7A,IRF4,LYST,SLC11A1	Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism.
GO:0042834	GO	MF	peptidoglycan binding	JCHAIN,NLRP3,NOD1,NOD2,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,RNASE7,TLR2	Interacting selectively and non-covalently, in a non-covalent manner, with peptidoglycan, any of a class of glycoconjugates found in bacterial cell walls.
GO:0042886	GO	BP	amide transport	ABCB9,CAMK2G,CD209,CDH17,CDK16,CLEC4M,COL4A3BP,CPTP,CRHR1,CYB5R4,DISP1,EDN1,EDN3,EIF2AK3,EXOC3L1,FAM3B,FOLR1,FOLR2,FOLR3,GAL,GHRH,GHRL,GHSR,HNF1A,IL6,LTBP4,MAFA,NEUROD1,PDX1,PLEKHA8,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RIMS2,SLC14A1,SLC14A2,SLC19A1,SLC19A2,SLC25A32,SLC30A8,SLC38A3,SLC46A1,SLC9A3R1,SNX19,TAP1,TAP2,TAPBP,VIP	The directed movement of an amide, any compound containing one, two, or three acyl groups attached to a nitrogen atom, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0042887	GO	MF	amide transmembrane transporter activity	ABCB9,CDH17,SLC14A1,SLC14A2,SLC15A1,SLC15A2,SLC38A3,TAP2,TAPBP	Enables directed movement of an amide, any compound containing one, two, or three acyl groups attached to a nitrogen atom, from one side of the membrane to the other.
GO:0042921	GO	BP	glucocorticoid receptor signaling pathway	ARID1A,CALR,NCOA6,NEDD4,RBM14,YWHAH	Any series of molecular signals generated as a consequence of a glucocorticoid binding to its receptor.
GO:0042953	GO	BP	lipoprotein transport	CD36,LRP1,PPARG,PRKCB,UNC119,UNC119B,ZDHHC17	The directed movement of any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0042974	GO	MF	retinoic acid receptor binding	ASXL1,CNOT1,HMGA1,NCOA6,NR4A2,NSD1,PPARG,PRAME,RARG,SNW1	Interacting selectively and non-covalently with the retinoic acid receptor, a ligand-regulated transcription factor belonging to the nuclear receptor superfamily.
GO:0042976	GO	BP	activation of Janus kinase activity	GHR,JAK2,PIBF1,PRLR,PTK2B	The process of introducing a phosphate group to a tyrosine residue of a JAK (Janus Activated Kinase) protein, thereby activating it.
GO:0042979	GO	MF	ornithine decarboxylase regulator activity	AZIN1,AZIN2,OAZ1,OAZ2,OAZ3,PRLR	Modulation of the activity of the enzyme ornithine decarboxylase.
GO:0042982	GO	BP	amyloid precursor protein metabolic process	ABCG1,ACHE,APH1A,CLN3,KLK6,LDLRAP1,NCSTN,PSEN1,PSEN2,PSENEN	The chemical reactions and pathways involving amyloid precursor protein (APP), the precursor of beta-amyloid, a glycoprotein associated with Alzheimer's disease.
GO:0042984	GO	BP	regulation of amyloid precursor protein biosynthetic process	ABCA7,BACE2,ITM2B,NECAB3,SOAT1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of amyloid precursor protein (APP), the precursor of beta-amyloid.
GO:0042987	GO	BP	amyloid precursor protein catabolic process	ABCG1,APH1A,CLN3,NCSTN,PSEN1,PSEN2,PSENEN	The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP), the precursor of beta-amyloid, a glycoprotein associated with Alzheimer's disease.
GO:0042989	GO	BP	sequestering of actin monomers	GSN,SCIN,TMSB4Y,TWF1,TWF2	The selective interaction of actin monomers with specific molecules that inhibit their polymerization by preventing their access to other monomers.
GO:0042990	GO	BP	regulation of transcription factor import into nucleus	AKAP6,BMP7,C1QTNF3,C8orf4,CCDC22,CCL19,CD27,CDH1,CHERP,CREB3,CSF3,CYLD,DDX58,DMAP1,DYRK2,FAF1,FLNA,G3BP2,GSK3B,HCLS1,HDAC3,IL10,IL12B,IL1B,IL23A,LACRT,LGALS9,MAVS,MDFI,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NOV,PIK3R1,PIK3R2,PKD1,PKD2,PPM1A,PPM1B,PPP3CA,PPP3CB,PPP3R1,PSMD10,PYDC2,RAB23,RHOA,SLC9A1,SMAD3,SPHK1,SPPL3,SUFU,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TONSL,TRIM28,TRIP6,XBP1,ZC3H12A,ZNF268	Any process that modulates the frequency, rate or extent of the movement of a transcription factor from the cytoplasm to the nucleus.
GO:0042992	GO	BP	negative regulation of transcription factor import into nucleus	BMP7,C1QTNF3,CCDC22,CREB3,CYLD,DYRK2,FAF1,G3BP2,GSK3B,IL10,MDFI,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOV,PKD1,PKD2,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,SUFU,TONSL,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of a transcription factor from the cytoplasm to the nucleus.
GO:0042993	GO	BP	positive regulation of transcription factor import into nucleus	AKAP6,C8orf4,CCL19,CD27,CDH1,CHERP,CSF3,DDX58,DMAP1,FLNA,HCLS1,HDAC3,IL12B,IL1B,IL23A,LACRT,LGALS9,MAVS,NLRP12,PIK3R1,PIK3R2,PPP3CA,PPP3CB,PPP3R1,RHOA,SLC9A1,SMAD3,SPHK1,SPPL3,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TRIM28,TRIP6,XBP1,ZNF268	Any process that activates or increases the frequency, rate or extent of the movement of a transcription factor from the cytoplasm to the nucleus.
GO:0042994	GO	BP	cytoplasmic sequestering of transcription factor	CCDC22,CREB3,FAF1,G3BP2,IL10,MDFI,MXI1,NFKBIA,NFKBIE,NFKBIL1,PKD1,PKD2,PSMD10,TONSL	The selective interaction of a transcription factor with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus.
GO:0042996	GO	BP	regulation of Golgi to plasma membrane protein transport	ACSL3,ANXA13,CNST,CSK,GNB2L1,GOPC,PKDCC	Any process that modulates the frequency, rate or extent of the transport of proteins from the Golgi to the plasma membrane.
GO:0043001	GO	BP	Golgi to plasma membrane protein transport	AMN,ANK3,ARFRP1,BBS1,BBS2,BLZF1,GOLGA4,GOLGA7,GOLPH3,KIF13A,KRT18,MACF1,OPTN,RAB10,RAB26,RAB31,RAB34,SPTBN1,VAMP2	The directed movement of proteins from the Golgi to the plasma membrane in transport vesicles that move from the trans-Golgi network to the plasma membrane.
GO:0043009	GO	BP	chordate embryonic development	ADAM10,ALDH1A2,ARL13B,ARNT2,ATP6AP2,BBS4,BCL10,BMP2,CASP8,CELSR1,CHD7,CHRD,COBL,COL1A1,COL2A1,CRB2,CTNNB1,DACT1,DEAF1,DLC1,DLL1,DSCAML1,DVL2,E2F7,E2F8,EIF4A3,EOMES,FGFR1,FGFR2,FLCN,FOLR1,FOXB1,FOXD3,FOXF1,FUT8,FUZ,GATA3,GLI2,GRHL2,GRHL3,GSC,HAND2,HES1,HES5,HEY1,HEY2,HINFP,HOPX,HORMAD1,HOXA1,HOXD3,IFT122,IRX5,ISL1,KDM2B,KIAA1217,LFNG,LHX1,LIG4,LMO4,LMX1B,LRP6,MBNL1,MEGF8,MTHFD1,MTHFD1L,MYH6,NASP,NKX2-5,NKX2-6,NOG,OSR1,OSR2,PAX2,PCSK5,PDGFB,PDGFRA,PHACTR4,PKD1,PKD2,PLK4,PLXNB2,POU5F1,PPP2R3A,PRICKLE1,PROX1,PTCH1,RBP4,RBPJ,RIPPLY1,RIPPLY2,SCRIB,SEMA4C,SIX1,SIX4,SKI,SOX11,SOX4,SOX8,SRF,STIL,SULF1,SULF2,TBX1,TET1,TFAP2A,TFEB,TGFB3,TGFBR1,TGFBR2,TRIM71,TSC2,TWIST1,VANGL2,VEGFA,WNT5A,WNT7B,WNT8A,WNT9A,ZNF358,ZP3,ZPR1	The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
GO:0043010	GO	BP	camera-type eye development	ACVR2B,ACVRL1,AHI1,ATOH7,BMPR2,CHD7,COL4A1,CRYBA4,CRYGD,CYP1B1,DLL1,DSCAM,EPHA2,FOXE3,FOXL2,FOXN4,FZD4,GPM6A,HDAC1,HDAC2,HES5,IFT122,IFT140,INHBA,KDM2B,LHX1,LRP5,MED1,MEGF11,NES,NEUROD1,NEUROD4,NF1,NPHP1,NRP1,OSR2,PAX2,PAX6,PDGFRA,PDGFRB,PHACTR4,PITX2,PITX3,POU4F2,PROM1,PROX1,PRSS56,PTF1A,PTPRM,RAB3GAP1,RBP4,RORB,RP1,SDK1,SDK2,SHROOM2,SIX3,SKI,SOX11,SOX8,SOX9,STRA6,TBX2,TDRD7,TENM3,TFAP2A,TH,THY1,TOPORS,TSPAN12,TWIST1,UNC45B,VEGFA,WNT16,WNT2,WNT2B,WNT5A,WNT5B,WNT6,WNT7A,WNT7B,WNT9A,WNT9B,WT1,ZNF513	The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
GO:0043011	GO	BP	myeloid dendritic cell differentiation	BATF,BATF2,BATF3,CAMK4,CSF2,DCSTAMP,IL4,TGFBR2,UBD	The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
GO:0043014	GO	MF	alpha-tubulin binding	ARL4C,ARL8A,ARL8B,B4GALT1,BBS4,FAM110C,FNTA,HDAC6,INO80,OFD1,PACRG,RACGAP1,TRPV4,TTLL7,WASH1	Interacting selectively and non-covalently with the microtubule constituent protein alpha-tubulin.
GO:0043015	GO	MF	gamma-tubulin binding	B9D2,BLOC1S2,BRSK1,DIXDC1,MARK4,NDRG1,OFD1,PIFO,RAB11FIP5,RACGAP1,RAD51D,TUBGCP3	Interacting selectively and non-covalently with the microtubule constituent protein gamma-tubulin.
GO:0043020	GO	CC	NADPH oxidase complex	CYBA,CYBB,NCF1,NCF2,NCF4,NOX1,NOXA1,NOXO1	A enzyme complex of which the core is a heterodimer composed of a light (alpha) and heavy (beta) chain, and requires several other water-soluble proteins of cytosolic origin for activity. Functions in superoxide generation by the NADPH-dependent reduction of O2.
GO:0043021	GO	MF	ribonucleoprotein complex binding	ABCF1,BAG6,C1QBP,CD2BP2,CPEB2,DDX3X,DHX29,EFTUD1,EIF2A,EIF2S1,EIF6,ERAL1,ERI1,ETF1,IGHMBP2,MTIF2,MTIF3,NAA10,NAA15,NAA16,NMD3,NPM1,NVL,OXA1L,PITX2,PPIH,PQBP1,PRPF31,PRPF6,PTCD3,SBDS,SEC61A1,SLFN14,SRP54,SRP9,TIMM50,UHMK1,YTHDF1	Interacting selectively and non-covalently with any complex of RNA and protein.
GO:0043022	GO	MF	ribosome binding	ABCF1,BAG6,C1QBP,CPEB2,EFTUD1,EIF2A,EIF2S1,EIF6,ERI1,ETF1,IGHMBP2,NAA10,NAA15,NAA16,OXA1L,SBDS,SEC61A1,SLFN14,YTHDF1	Interacting selectively and non-covalently with any part of a ribosome.
GO:0043024	GO	MF	ribosomal small subunit binding	CPEB2,DDX3X,DHX29,ERAL1,MTIF2,MTIF3,NPM1,PTCD3	Interacting selectively and non-covalently with any part of the small ribosomal subunit.
GO:0043025	GO	CC	neuronal cell body	AMIGO1,ANG,APOB,APOD,APOE,ARHGEF7,ATP7A,ATXN10,AZIN2,CAD,CALB1,CCR2,CDC42,CDK5,CDK5R1,CHRNA3,CHRNA4,CIB1,COBL,CREB3,CRHBP,CRIPT,CTNND2,DAB2IP,EFHC1,ELOVL5,EPHA5,FBXO31,FLRT1,FRMD7,GAL,GLRA1,GNB2L1,GPM6A,GRIA1,GRIK3,GRIN3A,GRIN3B,HCFC1,HDAC6,HPN,ITPR3,KCNA1,KCNA2,KCNB1,KCNB2,KCNC1,KCNC2,KCND2,KCNE3,LRP4,LRRK2,MAP1S,MUL1,MYO1D,NCDN,NEURL1,NRSN1,NRXN1,NSMF,OLFM1,PI4K2A,PICALM,PTK2B,PTPRN,RAB17,RAB5A,RAC3,RAPGEF2,RGS8,RTN4R,RUFY3,SHANK2,SHTN1,SIRT2,SKOR1,SLC38A7,SLC6A3,SNCAIP,SOD1,SPTBN4,SRR,STMN2,STRN,STRN3,TGFB2,TH,TMEM100,UBB,UNC5A,VTI1A,VTI1B,ZNF385A,ZPR1	The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
GO:0043027	GO	MF	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	AVP,BIRC5,CD27,DPEP1,GAS6,LEF1,MT3,NOL3,PRDX3,PRDX5,RPS6KA1,RPS6KA3,SERPINB9,SNCA,TFAP2B,TNFAIP8,TNFSF14,VIL1,XIAP	Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
GO:0043028	GO	MF	cysteine-type endopeptidase regulator activity involved in apoptotic process	APAF1,AVP,BAD,BCL2L13,BIRC5,CARD8,CASP1,CASP8AP2,CD27,CDKN1B,CTSH,DPEP1,FOXL2,GAS6,GNB2L1,LEF1,MT3,NGFRAP1,NKX3-1,NLRP1,NLRP12,NOD1,NOL3,PRDX3,PRDX5,PYCARD,RPS27L,RPS6KA1,RPS6KA3,SERPINB9,SNCA,TFAP2B,TNFAIP8,TNFSF14,VIL1,XIAP	Modulates the activity of a cysteine-type endopeptidase involved in the apoptotic process.
GO:0043029	GO	BP	T cell homeostasis	AKT1,FADD,FOXP3,JAK3,NCKAP1L,PMAIP1,RIPK3,SIVA1,TNFSF14,ZC3H8	The process of regulating the proliferation and elimination of T cells such that the total number of T cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
GO:0043030	GO	BP	regulation of macrophage activation	BPI,CD74,HSPD1,IL31RA,IL33,LBP,MIF,NR1H3,PLA2G10,SHPK,SPACA3,STAP1,THBS1,TNIP2,WNT5A,ZC3H12A	Any process that modulates the frequency or rate of macrophage activation.
GO:0043032	GO	BP	positive regulation of macrophage activation	HSPD1,IL33,LBP,SPACA3,STAP1,THBS1,TNIP2,WNT5A	Any process that stimulates, induces or increases the rate of macrophage activation.
GO:0043034	GO	CC	costamere	AHNAK,AHNAK2,ANK2,ANK3,DMD,FLNC,KRT19,PGM5,PLEC,SVIL,SYNM,VCL	Regular periodic sub membranous arrays of vinculin in skeletal and cardiac muscle cells, these arrays link Z-discs to the sarcolemma and are associated with links to extracellular matrix.
GO:0043039	GO	BP	tRNA aminoacylation	AARS,AARS2,AIMP1,AIMP2,CARS,CARS2,DARS,DARS2,EARS2,EEF1E1,EPRS,FARS2,FARSA,FARSB,GARS,GATB,GATC,HARS,HARS2,IARS,IARS2,KARS,LARS,LARS2,MARS,MARS2,NARS,NARS2,PARS2,PPA1,PPA2,QARS,QRSL1,RARS,RARS2,SARS,SARS2,TARS,TARS2,VARS,VARS2,WARS,WARS2,YARS,YARS2	The chemical reactions and pathways by which the various amino acids become bonded to their corresponding tRNAs. The most common route for synthesis of aminoacyl tRNA is by the formation of an ester bond between the 3'-hydroxyl group of the most 3' adenosine of the tRNA, usually catalyzed by the cognate aminoacyl-tRNA ligase. A given aminoacyl-tRNA ligase aminoacylates all species of an isoaccepting group of tRNA molecules.
GO:0043044	GO	BP	ATP-dependent chromatin remodeling	ACTB,ACTL6A,ANP32E,APITD1,CASC5,CECR2,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPW,CHD4,CHD5,CHD8,GATAD2B,HDAC1,HDAC2,HIST1H2BA,HIST1H4A,HJURP,HNRNPC,ITGB3BP,MBD2,MBD3,MIS18A,MIS18BP1,MTA2,NASP,NPM1,OIP5,PSME4,RBBP4,RBBP7,RNF8,RSF1,RUVBL1,SMARCA1,SMARCA4,SMARCA5,SMARCAD1,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,SPTY2D1,STRA13,SYCP3,TNP1	Dynamic structural changes to eukaryotic chromatin that require energy from the hydrolysis of ATP, ranging from local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation, mediated by ATP-dependent chromatin-remodelling factors.
GO:0043046	GO	BP	DNA methylation involved in gamete generation	ASZ1,CTCFL,FKBP6,MAEL,PICK1,PIWIL2,PIWIL4,PLD6,PRMT7,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH	The covalent transfer of a methyl group to C-5 of cytosine that contributes to the establishment of DNA methylation patterns in the gamete.
GO:0043047	GO	MF	single-stranded telomeric DNA binding	CTC1,HNRNPA1,HNRNPA2B1,NABP2,OBFC1,POT1,TERF1,TERF2,TERF2IP	Interacting selectively and non-covalently with single-stranded telomere-associated DNA.
GO:0043090	GO	BP	amino acid import	SLC11A1,SLC1A1,SLC1A2,SLC1A3,SLC3A2,SLC6A5	The directed movement of amino acids into a cell or organelle.
GO:0043092	GO	BP	L-amino acid import	SLC11A1,SLC1A1,SLC1A2,SLC1A3,SLC6A5	The directed movement of L-enantiomer amino acids into a cell or organelle.
GO:0043094	GO	BP	cellular metabolic compound salvage	ADA,ADAL,ADI1,ADK,AMPD1,AMPD2,AMPD3,APIP,APRT,BHMT,BHMT2,CDA,DCK,DGUOK,ENOPH1,GMPR,GMPR2,GOT1,HPRT1,MRI1,MTAP,PNP,PUDP,TK1,TK2,TYMP,UCK1,UCK2,UPP1,UPP2	Any process which produces a useful metabolic compound from derivatives of it without de novo synthesis, as carried out by individual cells.
GO:0043097	GO	BP	pyrimidine nucleoside salvage	CDA,DCK,PUDP,TK1,TK2,TYMP,UCK1,UCK2,UPP1,UPP2	Any process that generates a pyrimidine nucleoside, one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose, from derivatives of it, without de novo synthesis.
GO:0043101	GO	BP	purine-containing compound salvage	ADA,ADAL,ADK,AMPD1,AMPD2,AMPD3,APRT,DCK,DGUOK,GMPR,GMPR2,HPRT1,PNP	Any process that generates a purine-containing compound, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a purine base, from derivatives of them without de novo synthesis.
GO:0043112	GO	BP	receptor metabolic process	ACE2,ACKR3,ADM,ADRBK1,ADRBK2,ARFGEF2,ARRB1,ARRB2,BECN1,BECN2,CALCA,CALCR,CALCRL,CAV1,CAV3,CD36,CD81,CD9,CLTC,CXCL8,CXCR1,CXCR2,DNM2,DRD3,FAM109A,FAM109B,FCER1G,GHR,GPRASP1,GRB2,GRK4,GTF2H2,IL10,ITGB1,ITGB2,KIF16B,LDLRAP1,LGMN,LILRB1,LMTK2,NEDD4,PCSK9,PICALM,PIK3R4,PPARG,RAB11B,RAB31,RAB5A,RAMP1,RAMP2,RAMP3,REP15,RNF43,SCYL2,SH3GLB1,SMURF1,SNCA,SNX1,SNX25,SYK,TGFB1,TNF,UVRAG,ZNRF3	The chemical reactions and pathways involving a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
GO:0043113	GO	BP	receptor clustering	AGRN,APOE,DLG4,DNAJA3,DVL1,FLNA,ITGA4,ITGAL,ITGB1BP1,ITGB2,ITGB7,LRP4,MADCAM1,MAGI2,MUSK,NLGN1,NRXN1,NRXN2,PICK1,PIGR,SHANK3	The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
GO:0043114	GO	BP	regulation of vascular permeability	AMOT,ANGPT1,AZU1,BDKRB2,CTNNBIP1,FGFBP3,MYLK3,NPPB,NPR1,PDE2A,PDE3A,PTPRJ,RAMP2,SLIT2,SRC,TEK,TGFB1,TRPV4,VEGFA,YES1	Any process that modulates the extent to which blood vessels can be pervaded by fluid.
GO:0043116	GO	BP	negative regulation of vascular permeability	AMOT,ANGPT1,PDE2A,PDE3A,PTPRJ,RAMP2,SLIT2	Any process that reduces the extent to which blood vessels can be pervaded by fluid.
GO:0043117	GO	BP	positive regulation of vascular permeability	FGFBP3,PDE2A,PDE3A,TGFB1,TRPV4,VEGFA	Any process that increases the extent to which blood vessels can be pervaded by fluid.
GO:0043121	GO	MF	neurotrophin binding	FURIN,HAP1,NTRK1,NTRK2,NTRK3,PCSK6	Interacting selectively and non-covalently with a neurotrophin, any of a family of growth factors that prevent apoptosis in neurons and promote nerve growth.
GO:0043122	GO	BP	regulation of I-kappaB kinase/NF-kappaB signaling	ADIPOQ,ANKRD17,APOL3,ATP2C1,BIRC3,BMP7,BRD4,BST2,C18orf32,C1QTNF3,C8orf4,CANT1,CAPN3,CARD19,CARD8,CASP10,CASP8,CC2D1A,CCDC22,CCL19,CCL21,CCR7,CD27,CHUK,CLEC6A,CPNE1,CXXC5,CYLD,DAB2IP,DDRGK1,DNAJA3,ECM1,ECT2,EEF1D,ESR1,F2RL1,FAF1,FKBP1A,FLNA,G3BP2,GJA1,GOLT1B,GPR89A,GPRC5B,GSTP1,HMOX1,HSPB1,IKBKB,IKBKG,IL10,IL12B,IL1B,IL23A,IRAK1,IRAK4,LGALS1,LGALS9,LITAF,LTF,LURAP1,MALT1,MAP3K14,MAP3K7,MAVS,MIB2,MID2,MIER1,MTDH,MUL1,NDFIP1,NDFIP2,NEK6,NFKBIA,NLRC3,NLRP12,NLRP3,NOD1,NOD2,NOV,NR1H4,NUP62,OTUD7B,PARK2,PDPK1,PELI1,PELI2,PER1,PIM2,PINK1,PLEKHG5,PLK2,PPM1A,PPM1B,PPP5C,PRKCB,PRKD1,PSMD10,PYCARD,PYDC2,RBCK1,RHOA,RHOC,RHOH,RIPK1,RIPK2,RNF31,RORA,RPS27A,S100A12,S100A13,S100A4,S100B,SECTM1,SHARPIN,SHISA5,SIRT1,SLC20A1,SLC35B2,SLC44A2,SPHK1,SQSTM1,STAT1,TERF2IP,TFG,TICAM1,TICAM2,TIRAP,TLE1,TLR2,TLR3,TLR4,TLR6,TLR7,TLR9,TMED4,TMEM101,TMEM9B,TNF,TNFAIP3,TNFSF14,TNIP1,TNIP2,TNIP3,TRAF6,TRIM13,TRIM22,TRIM25,TRIM32,TRIM38,TRIM5,TRIM59,TRIM62,TRIM8,TRIP6,TSPAN6,UBA52,UBB,UBC,UBD,UBE2N,UBE2V1,UNC5CL,VAPA,WLS,ZC3H12A,ZC3HAV1,ZDHHC13,ZDHHC17,ZFAND6,ZMYND11,ZNF268	Any process that modulates I-kappaB kinase/NF-kappaB signaling.
GO:0043123	GO	BP	positive regulation of I-kappaB kinase/NF-kappaB signaling	ADIPOQ,ANKRD17,APOL3,ATP2C1,BIRC3,BRD4,BST2,C18orf32,C8orf4,CANT1,CASP10,CASP8,CC2D1A,CCDC22,CCL19,CCL21,CCR7,CD27,CHUK,CLEC6A,CXXC5,DDRGK1,ECM1,ECT2,EEF1D,F2RL1,FKBP1A,FLNA,GJA1,GOLT1B,GPR89A,GPRC5B,HMOX1,IKBKB,IKBKG,IL12B,IL1B,IL23A,IRAK1,IRAK4,LGALS1,LGALS9,LITAF,LTF,LURAP1,MALT1,MAP3K14,MAP3K7,MAVS,MIB2,MID2,MIER1,MTDH,MUL1,NDFIP1,NDFIP2,NEK6,NLRP12,NOD1,NOD2,NUP62,PARK2,PELI1,PELI2,PIM2,PINK1,PLEKHG5,PLK2,PPM1A,PPP5C,PRKCB,PRKD1,RBCK1,RHOA,RHOC,RIPK1,RIPK2,RNF31,RPS27A,S100A12,S100A13,S100A4,S100B,SECTM1,SHARPIN,SHISA5,SLC20A1,SLC35B2,SLC44A2,SPHK1,TERF2IP,TFG,TICAM1,TICAM2,TIRAP,TLR2,TLR3,TLR4,TLR6,TLR7,TLR9,TMED4,TMEM101,TMEM9B,TNF,TNFSF14,TNIP2,TRAF6,TRIM13,TRIM22,TRIM25,TRIM32,TRIM38,TRIM5,TRIM62,TRIM8,TRIP6,TSPAN6,UBA52,UBB,UBC,UBD,UBE2N,UBE2V1,UNC5CL,VAPA,WLS,ZC3HAV1,ZDHHC13,ZDHHC17,ZNF268	Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
GO:0043124	GO	BP	negative regulation of I-kappaB kinase/NF-kappaB signaling	ADIPOQ,BMP7,C1QTNF3,CARD19,CARD8,CASP8,CCDC22,CYLD,DAB2IP,DNAJA3,ESR1,FAF1,G3BP2,GSTP1,IL10,NFKBIA,NLRC3,NLRP12,NLRP3,NOV,NR1H4,OTUD7B,PER1,PPM1A,PPM1B,PSMD10,PYCARD,PYDC2,RHOH,RIPK1,RORA,SIRT1,STAT1,TLE1,TNFAIP3,TNIP1,TNIP3,TRIM59,ZC3H12A,ZMYND11	Any process that stops, prevents, or reduces the frequency, rate or extent of -kappaB kinase/NF-kappaB signaling.
GO:0043130	GO	MF	ubiquitin binding	ATRIP,BAG6,BCL10,BRCC3,BRE,CRY1,CRY2,CXCR4,DNAJB2,DNAJC2,DYRK2,DZIP3,EPS15,FAAP20,FAF1,FAF2,FAM175A,FAM175B,FAN1,HDAC6,HSPB1,IKBKE,IKBKG,KIF18A,MARK4,MVB12A,NBR1,NEDD4,NUP62,OPTN,OTUB1,PARK2,PARP10,PER2,PRPF8,RAD18,RAD23A,RAD23B,RBCK1,RNF168,RNF169,RNF31,SHARPIN,SIRT2,SMAD3,SPRTN,SQSTM1,TAB2,TERF1,TNIP2,TNIP3,TOM1L1,TOP2A,TRIM32,TSG101,UBAP1,UBE2N,UBQLN1,UBQLN4,UBXN1,UBXN7,UCHL1,UCHL3,UIMC1,USP13,USP16,USP25,USP5,VCP,VPS28,VPS36,ZBTB1,ZFAND6,ZRANB1,ZRANB3	Interacting selectively and non-covalently with ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation.
GO:0043138	GO	MF	3'-5' DNA helicase activity	ASCC3,ERCC3,FBXO18,RECQL4,WRN	Catalysis of the unwinding of the DNA helix in the direction 3' to 5'.
GO:0043139	GO	MF	5'-3' DNA helicase activity	DNA2,ERCC2,HELB,IGHMBP2,PIF1	Catalysis of the unwinding of the DNA helix in the direction 5' to 3'.
GO:0043142	GO	MF	single-stranded DNA-dependent ATPase activity	DNA2,HELB,PIF1,POLQ,RAD51	Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction requires the presence of single-stranded DNA, and it drives another reaction.
GO:0043149	GO	BP	stress fiber assembly	ARRB1,CUL3,ITGB5,KCTD13,PHACTR1,SORBS1,SRC,TNFAIP1,ZYX	The aggregation, arrangement and bonding together of a set of components to form a stress fiber. A stress fiber is a contractile actin filament bundle that consists of short actin filaments with alternating polarity.
GO:0043153	GO	BP	entrainment of circadian clock by photoperiod	BHLHE40,CRTC1,CRY1,CRY2,FBXL3,ID2,MTA1,PER1,PML,PPP1CA,PPP1CB,PPP1CC,RBM4,RBM4B,SIK1,TP53,USP2	The synchronization of a circadian rhythm to photoperiod, the intermittent cycle of light (day) and dark (night).
GO:0043154	GO	BP	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	AKT1,AQP1,AVP,BCL2L12,BIRC5,CASP8,CD27,CD44,CDKN2D,CFLAR,CSNK2A1,DDX3X,DHCR24,DNAJA3,DNAJB6,DPEP1,FABP1,FADD,FAS,FASLG,FNIP1,GAS6,GPX1,HGF,IFI6,IGBP1,KLF4,LAMTOR5,LEF1,MAGEA3,MAP2K5,MMP9,MT3,NAIP,NOL3,PAK2,PARK7,PAX2,PIH1D1,PLAUR,PRDX3,PRDX5,RAF1,RFFL,RIPK1,RNF34,RPS6KA1,RPS6KA3,SERPINB9,SFN,SH3RF1,SIAH2,SNCA,SRC,TFAP2B,THBS1,TNFAIP8,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF14,TRADD,TRAF2,TRIAP1,USP47,VEGFA,XIAP	Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
GO:0043162	GO	BP	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	MVB12A,MVB12B,NEDD4,PTPN23,RNF115,RNF126,TOM1L1,TSG101,UBAP1,VPS28,VPS37A,VPS4A,VPS4B	The chemical reactions and pathways resulting in the breakdown of a protein or peptide covalently tagged with ubiquitin, via the multivesicular body (MVB) sorting pathway; ubiquitin-tagged proteins are sorted into MVBs, and delivered to a lysosome/vacuole for degradation.
GO:0043171	GO	BP	peptide catabolic process	ACE,ACE2,ADAMTS13,CPQ,CTSH,ECE1,ENPEP,GGT1,IDE,LTA4H,TPP1,XPNPEP1	The chemical reactions and pathways resulting in the breakdown of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
GO:0043174	GO	BP	nucleoside salvage	CDA,DCK,HPRT1,PUDP,TK1,TK2,TYMP,UCK1,UCK2,UPP1,UPP2	Any process which produces a nucleotide, a nucleobase linked to either beta-D-ribofuranose (ribonucleoside) or 2-deoxy-beta-D-ribofuranose (a deoxyribonucleotide), from derivatives of it without de novo synthesis.
GO:0043175	GO	MF	RNA polymerase core enzyme binding	AGO1,AGO2,C14orf166,CCAR2,CDC73,ELP2,ELP3,ELP4,ERBB2,IKBKAP,PAF1,RECQL5,RPRD1B,SMYD2,SPTY2D1,UVSSA,WAC,ZNF326	Interacting selectively and non-covalently with an RNA polymerase core enzyme, containing a specific subunit composition defined as the core enzyme.
GO:0043178	GO	MF	alcohol binding	ABCA1,ABCG1,ADAP1,ADAP2,ADH4,ADH7,ANXA6,APOA1,APOA2,APOA4,APOA5,APOC1,APOC3,APOD,APOF,CAV1,CETP,CHMP2A,CHMP3,CRP,CYTH2,ERLIN1,ESYT2,GC,GPR183,ITPR3,JCHAIN,NF1,NPC1,NPC2,NR1H3,OSBP,OSBP2,OSBPL10,OSBPL1A,OSBPL2,OSBPL3,OSBPL5,OSBPL7,OSBPL8,PCTP,PMP2,PROM2,PTCH1,RASGRP1,RBP4,RORA,RORC,RPE65,RPH3A,SCP2,SERPINA5,SOAT1,SOAT2,STARD3,SYP,SYT2,TRPC1,TRPC3,TRPC6,TSPO,TSPO2,VDR	Interacting selectively and non-covalently with an alcohol, any of a class of alkyl compounds containing a hydroxyl group.
GO:0043186	GO	CC	P granule	ASZ1,CARHSP1,DDX4,HENMT1,MAEL,PIWIL1,PIWIL2,PIWIL4,TDRD1,TDRD5,TDRD9,TDRKH	A small cytoplasmic, non-membranous RNA/protein complex aggregates in the primordial germ cells of many higher eukaryotes.
GO:0043190	GO	CC	ATP-binding cassette (ABC) transporter complex	ABCA2,ABCA7,ABCB6,ABCB8,ABCD4,ABCF2,ABCG5,ABCG8	A complex for the transport of metabolites into and out of the cell, typically comprised of four domains; two membrane-associated domains and two ATP-binding domains at the intracellular face of the membrane, that form a central pore through the plasma membrane. Each of the four core domains may be encoded as a separate polypeptide or the domains can be fused in any one of a number of ways into multidomain polypeptides. In Bacteria and Archaebacteria, ABC transporters also include substrate binding proteins to bind substrate external to the cytoplasm and deliver it to the transporter.
GO:0043194	GO	CC	axon initial segment	ANK3,BIN1,KCNQ2,KCNQ3,NFASC,NRCAM,SCN8A,SPTBN4	Portion of the axon proximal to the neuronal cell body, at the level of the axon hillock. The action potentials that propagate along the axon are generated at the level of this initial segment.
GO:0043195	GO	CC	terminal bouton	AAK1,CABP4,CAD,GHRH,GRIK3,GRIN1,LRRK2,RAB3A,RAB5A,TBC1D24,UNC13B	Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it.
GO:0043197	GO	CC	dendritic spine	ACTN2,APP,ARF4,ARFGEF2,CDK5R1,CNIH2,CRIPT,DGKI,DLG4,DNM3,DTNBP1,FRMPD4,GIPC1,GPER1,GRIA1,GRID2,GRIN1,KCND2,MTMR2,NEURL1,NLGN1,NR1D1,PRKAR2B,PTPRO,RGS14,SHANK1,SHANK2,SIPA1L1,SRGAP2,STRN,STX4,SYNDIG1,SYNPO,TENM2	A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically recieving input from a single presynapse.  They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including \
GO:0043198	GO	CC	dendritic shaft	APP,CNIH2,CNIH3,CRIPT,GIPC1,GPER1,GRM7,NSF,PRKAR2B,SYNDIG1	Cylindric portion of the dendrite, directly stemming from the perikaryon, and carrying the dendritic spines.
GO:0043200	GO	BP	response to amino acid	CAPN2,CPEB1,CPEB3,CPEB4,FOLR1,FOLR2,GLRA1,GPRC6A,INS,IPO5,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MTOR,NEURL1,NSMF,RPTOR,RRAGA,RRAGB,RRAGC,RRAGD,SH3BP4,SLC38A9,TMBIM6,UBR1,UBR2,XBP1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
GO:0043202	GO	CC	lysosomal lumen	ACAN,AGRN,ARSA,ARSB,ASAH1,ATP13A2,BCAN,BGN,CD74,CSPG4,CSPG5,CTSA,CTSB,CTSD,CTSF,CTSK,CTSL,CTSS,CTSV,CUBN,DCN,FMOD,FUCA1,GAA,GALC,GALNS,GBA,GC,GIF,GLA,GLB1,GM2A,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,GYG1,GYG2,HEXA,HEXB,HPSE,HSP90AA1,HSPA8,HSPG2,HYAL1,IDS,IDUA,IFI30,KERA,LAMP2,LGMN,LUM,NAGLU,NCAN,NEU1,NEU4,OGN,OMD,PPT1,PPT2,PRELP,PSAP,SCARB2,SDC1,SDC2,SDC3,SDC4,SGSH,SMPD1,TCN2,TPP1,TXNDC5,VCAN	The volume enclosed within the lysosomal membrane.
GO:0043204	GO	CC	perikaryon	AZIN2,CCR2,CRHBP,CTNND2,GRIK3,HDAC6,KCNA2,KCNB1,KCNC2,KCNE3,LRRK2,NEURL1,NSMF,RUFY3,SHTN1,SIRT2,TH,TMEM100,ZPR1	The portion of the cell soma (cell body) that excludes the nucleus.
GO:0043205	GO	CC	fibril	ADAMTS10,ADAMTSL5,FBN1,FBN2,LTBP1,MFAP1,MFAP2,MFAP4,MUC5AC,ODAM,SNCA	Extracellular matrix material consisting of polysaccharides and protein.
GO:0043206	GO	BP	extracellular fibril organization	ADAMTS3,B4GALT7,COL3A1,COL5A1,CST3,FKBP1A,LTBP2,MFAP4,MUC5AC,SNCA	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of extracellular fibrils, extracellular matrix material consisting of polysaccharides and/or proteins.
GO:0043209	GO	CC	myelin sheath	CNTN2,FAM213B,ITPR3,MYO1D,NCMAP,PTEN,SIRT2	An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system.
GO:0043217	GO	BP	myelin maintenance	CLU,CXCR4,EPB41L3,MYRF,PTEN,SOD1	The process of preserving the structure and function of mature myelin. This includes maintaining the compact structure of myelin necessary for its electrical insulating characteristics as well as the structure of non-compact regions such as Schmidt-Lantermann clefts and paranodal loops. This does not include processes responsible for maintaining the nodes of Ranvier, which are not part of the myelin sheath.
GO:0043236	GO	MF	laminin binding	ACHE,ADAM9,AGRN,BCAM,CTSS,DAG1,GPC1,LACRT,LGALS3,LRRC15,NID1,PLEKHA2,SHH,SLIT2,SSC5D,THBS1	Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
GO:0043240	GO	CC	Fanconi anaemia nuclear complex	APITD1,FAAP20,FAAP24,FANCA,FANCB,FANCC,FANCE,FANCF,FANCG,FANCL,FANCM,STRA13	A protein complex composed of the Fanconi anaemia (FA) proteins including A, C, E, G and F (FANCA-F). Functions in the activation of the downstream protein FANCD2 by monoubiquitylation, and is essential for protection against chromosome breakage.
GO:0043242	GO	BP	negative regulation of protein complex disassembly	ADD1,ADD2,APC,ARHGEF2,AURKA,AURKB,CCNB1,CIB1,CLASP1,CLASP2,EPS8,FGF13,GAS2L1,GAS2L2,GSN,HDAC6,IRAK3,KATNB1,LIMA1,MID1IP1,PLEKHH2,SBDS,SCIN,SLN,STMN2,TNF,TRIM54,TRIOBP,TWF2,VIL1	Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
GO:0043243	GO	BP	positive regulation of protein complex disassembly	ACTN2,BNIP3,CFL2,F2RL1,FAM21C,KATNB1,LRRC16A,NES,PDXP,PLEK,SEMA5A,SETX,SLN,STMN2,SYNJ1,TNF,TRPV4,VIL1	Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
GO:0043244	GO	BP	regulation of protein complex disassembly	ACTN2,ADD1,ADD2,APC,ARHGEF2,AURKA,AURKB,BNIP3,CCNB1,CFL2,CIB1,CLASP1,CLASP2,EPS8,ETF1,F2RL1,FAM21C,FGF13,GAS2L1,GAS2L2,GSN,HDAC6,HRSP12,IRAK3,KATNB1,LIMA1,LRRC16A,MID1IP1,MTPN,MTRF1,NES,OGFOD1,PDXP,PLEK,PLEKHH2,SBDS,SCIN,SEMA5A,SETX,SH3BGRL3,SLN,STMN2,SYNJ1,TNF,TRIM54,TRIOBP,TRPV4,TWF2,UPF1,VIL1	Any process that modulates the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
GO:0043247	GO	BP	telomere maintenance in response to DNA damage	ACD,DCLRE1B,RTEL1,TERF2,TERF2IP,TFIP11	Any process that occur in response to the presence of critically short or damaged telomeres.
GO:0043248	GO	BP	proteasome assembly	ADRM1,POMP,PSMD10,PSMD11,PSMD5,PSMD9,PSMG1,PSMG2	The aggregation, arrangement and bonding together of a mature, active proteasome complex.
GO:0043252	GO	BP	sodium-independent organic anion transport	ALB,AVP,MFSD10,SLC22A6,SLC22A9,SLCO1A2,SLCO1B1,SLCO1B3,SLCO1C1,SLCO2A1,SLCO2B1,SLCO3A1,SLCO4A1,SLCO4C1	The directed, sodium-independent, movement of organic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0043255	GO	BP	regulation of carbohydrate biosynthetic process	ADIPOQ,AKT1,AKT2,AP2A1,ARPP19,C1QTNF3,CD244,CLK2,CLTC,DYRK2,EGF,ENPP1,FBP1,GCK,GPER1,GRB10,GSK3A,GSK3B,HRH1,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,LHCGR,NFKB1,NR1D1,OGT,PASK,PDGFB,PDK2,PLEK,PPARGC1A,PPP1R3F,PTH,PTH1R,PTK2B,PTPN2,SDHAF3,SIK1,SNCA,SOGA1,SORBS1,TGFB1,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of carbohydrates.
GO:0043256	GO	CC	laminin complex	LAMA1,LAMA5,LAMB1,LAMB2,LAMC1	A large, extracellular glycoprotein complex composed of three different polypeptide chains, alpha, beta and gamma. Provides an integral part of the structural scaffolding of basement membranes.
GO:0043266	GO	BP	regulation of potassium ion transport	ACTN2,ADRA2A,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ATP1B1,ATP1B2,ATP1B3,CAB39,CACNA1D,CASQ2,CAV1,CAV3,DLG1,DPP10,DPP6,DRD1,DRD2,FHL1,GAL,GALR2,KCNA5,KCNAB1,KCNAB2,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNH2,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNN2,KCNQ1,KCNRG,KCNS1,KCNS2,KIF5B,NEDD4,NEDD4L,NOS1,NOS1AP,NPPA,PTK2B,RNF207,STK39,SUMO1,VAMP2,WWP2,YWHAE	Any process that modulates the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0043267	GO	BP	negative regulation of potassium ion transport	ACTN2,ANK3,CAB39,CASQ2,CAV1,CAV3,KCNE1,KCNE2,KCNE3,KCNE5,KCNH2,KCNQ1,KCNRG,NEDD4L,NOS1,PTK2B,RNF207,STK39,SUMO1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0043268	GO	BP	positive regulation of potassium ion transport	ACTN2,ADRA2A,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ATP1B1,ATP1B2,ATP1B3,DLG1,DRD1,FHL1,GAL,GALR2,KCNE1,KCNE5,KCNH2,KCNQ1,KIF5B,NOS1AP,NPPA,RNF207	Any process that activates or increases the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0043270	GO	BP	positive regulation of ion transport	ABCA7,ABCB4,ACTN2,ACTN4,ADRA2A,AHCYL1,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ANO6,APOE,ASPH,ATP1B1,ATP1B2,ATP1B3,B2M,CACNA1D,CACNB2,CALM1,CAMK2A,CAPN3,CAV1,CCL2,CCL3,CCL4,CCL5,CCR1,CEMIP,CFTR,CHP1,CHRM1,CHRNB2,CNKSR3,CRACR2A,CREB3,CTSS,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,CYP4A11,CYP4F2,DLG1,DMD,DRD1,DRD2,DRD4,F2,F2R,F2RL3,FFAR1,FHL1,FXYD1,GAL,GALR2,GDNF,GLRX,GPD1L,GPER1,GRM6,GSTM2,GSTO1,HAP1,HFE,HTT,IL1B,JPH2,KCNE1,KCNE5,KCNH2,KCNQ1,KIF5B,LACRT,LGALS3,MYLK,NKX2-5,NLGN3,NOS1,NOS1AP,NPPA,NPSR1,ORAI1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PDGFB,PDGFRB,PDPK1,PDZK1,PKD2,PKP2,PLA2G10,PLA2G1B,PLA2R1,PLCG1,PRELID1,PRKCD,RAB3B,RAB3GAP1,RELN,RNF207,RYR2,SCN1B,SCN3B,SCN4B,SCN5A,SHANK3,SLC9A1,SNCA,SNX4,STC1,STIM1,STIM2,TCAF1,TESC,THY1,TMEM110,TNFRSF11A,TNFSF11,TRDN,TRIAP1,TRPC1,TRPC3,TRPC6,VAMP7,VAMP8,WFS1,WNK2,WNK3,XCL1,ZP3	Any process that activates or increases the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0043271	GO	BP	negative regulation of ion transport	ACSL4,ACTN2,ADRA2A,AGT,AKT1,AKT2,ANK3,ANO9,APOE,ATP1A2,CAB39,CALCA,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CHRFAM7A,CLIC2,COMMD1,CRHR1,CYP4F2,DRD2,DRD4,EPO,EPPIN,FKBP1B,GNB5,GPM6B,GRM7,GSTM2,GSTO1,HAMP,HTR1B,INPP5K,IRS2,KCNE1,KCNE2,KCNE3,KCNE5,KCNH2,KCNQ1,KCNRG,LILRB1,LILRB2,MMP9,MRLN,NEDD4,NEDD4L,NOS1,PACSIN3,PCSK9,PKD2,PLA2R1,PLN,PPIF,PRKCE,PTK2B,PXK,RNF207,SEMG1,SFRP4,SLC30A1,SLN,SNCA,SRI,STC1,STK39,SUMO1,TCAF2,THBS1,TLR9,TRDN,TRIM27,UBQLN1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0043277	GO	BP	apoptotic cell clearance	ALOX15,FCN1,FCN2,FCN3,GAS6,HMGB1,LRP1,NR1H3,RARA,SCARB1,TGM2,THBS1,TYRO3,XKR8	The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
GO:0043279	GO	BP	response to alkaloid	ABAT,BAD,BCL2,BLM,CASQ2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CRHBP,DRD2,DRD3,DRD4,GSTM2,HMOX1,HTR1B,NFKB1,PPP1R9B,PRKCG,RAD51,RELA,RYR1,RYR2,RYR3,SLC8A1,SPIDR,TNF,TRPV1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
GO:0043280	GO	BP	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	ACER2,ACVR1C,AIFM1,ANP32B,APAF1,ARL6IP5,BAD,BAX,BBC3,BCAP31,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,COL4A3,CTSH,CYCS,DAP,DAPK1,DDX3X,DIABLO,DLC1,DNAJA3,EIF2AK3,F2R,F3,FADD,FAM162A,FAS,FASLG,FIS1,FOXL2,GNB2L1,GPER1,GSN,HIP1,HMGB1,HSPD1,HSPE1,HTRA2,IFI27,IFT57,JAK2,LCK,LGALS9,LY96,MAP3K5,MTCH1,MUL1,MYC,NDUFA13,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NLRP2,NLRP3,NOD1,NODAL,PDCD2,PDCD5,PDCD6,PMAIP1,PPARG,PPM1F,PYCARD,REST,RET,RIPK1,ROBO1,RPS27L,RPS3,S100A8,S100A9,SENP1,SIRT1,SLC11A2,SMAD3,SNCA,SOX7,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
GO:0043281	GO	BP	regulation of cysteine-type endopeptidase activity involved in apoptotic process	ACER2,ACVR1C,AIFM1,AKT1,ANP32B,APAF1,AQP1,ARL6IP5,AVP,BAD,BAX,BBC3,BCAP31,BCL2L10,BCL2L11,BCL2L12,BCL2L13,BIRC5,BOK,CARD8,CASP1,CASP2,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CD27,CD44,CDKN1B,CDKN2A,CDKN2D,CFLAR,COL4A3,CSNK2A1,CTSH,CYCS,DAP,DAPK1,DDX3X,DHCR24,DIABLO,DLC1,DNAJA3,DNAJB6,DPEP1,EIF2AK3,EPHA7,F2R,F3,FABP1,FADD,FAM162A,FAS,FASLG,FIS1,FNIP1,FOXL2,GAS6,GNB2L1,GPER1,GPX1,GSN,HGF,HIP1,HMGB1,HSPD1,HSPE1,HTRA2,IFI27,IFI6,IFT57,IGBP1,JAK2,KIAA0141,KLF4,LAMTOR5,LCK,LEF1,LGALS9,LY96,MAGEA3,MAP2K5,MAP3K5,MMP9,MT3,MTCH1,MUL1,MYC,NAIP,NDUFA13,NGF,NGFR,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NLRP2,NLRP3,NOD1,NODAL,NOL3,PAK2,PARK7,PAX2,PDCD2,PDCD5,PDCD6,PIH1D1,PLAUR,PMAIP1,PPARG,PPM1F,PRDX3,PRDX5,PYCARD,RAF1,REST,RET,RFFL,RIPK1,RNF34,ROBO1,RPS27L,RPS3,RPS6KA1,RPS6KA3,S100A8,S100A9,SENP1,SERPINB9,SFN,SH3RF1,SIAH2,SIRT1,SLC11A2,SMAD3,SNCA,SOX2,SOX7,SRC,TFAP2B,THBS1,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFAIP8,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF14,TNFSF15,TRADD,TRAF2,TRIAP1,USP47,VCP,VEGFA,XDH,XIAP,YWHAE	Any process that modulates the activity of a cysteine-type endopeptidase involved in apoptosis.
GO:0043292	GO	CC	contractile fiber	ABRA,ACTA1,ACTC1,ACTN2,AHNAK,AHNAK2,ALDOA,ANK2,ANK3,ANKRD1,ANKRD2,ARHGEF25,ATP2A1,ATP2B4,BIN1,BMP10,CACNA1C,CACNA1D,CACNA1S,CALM1,CAPN3,CASQ2,CAV3,CDK5R1,CFL2,CSRP3,DES,DMD,DNAJB6,DST,FKBP1A,FKBP1B,FLNC,HABP4,HRC,IGFN1,KCNE1,KLHL41,KRT19,KY,LDB3,MYBPC1,MYBPC3,MYH1,MYH11,MYH13,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL2,MYL3,MYL4,MYL5,MYL6B,MYL7,MYL9,MYLK2,MYLPF,MYOM1,MYOM3,MYOT,MYOZ2,MYPN,MYZAP,NEB,NEBL,NEXN,NOS1AP,OBSCN,OBSL1,PAK1,PDE4B,PDE4DIP,PGM5,PLEC,PPP1R12A,PPP1R12B,PPP2R5A,PSMA6,RYR1,RYR2,SCN1A,SCN3B,SCN5A,SCN8A,SCO1,SCO2,SLC4A1,SLC8A1,SMTNL1,SORBS2,SRI,SVIL,SYNE1,SYNE2,SYNM,SYNPO2,TCAP,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TRIM32,TTN,TWF1,TWF2,VCL	Fibers, composed of actin, myosin, and associated proteins, found in cells of smooth or striated muscle.
GO:0043295	GO	MF	glutathione binding	GSS,GSTM1,GSTM2,GSTM3,GSTM4,LANCL1,PTGES,PTGES2	Interacting selectively and non-covalently with glutathione; a tripeptide composed of the three amino acids cysteine, glutamic acid and glycine.
GO:0043296	GO	CC	apical junction complex	AMICA1,AMOT,AMOTL1,ANK3,AOC1,APC,BVES,CAMSAP3,CCDC85C,CDH1,CGN,CLDN1,CLDN10,CLDN11,CLDN12,CLDN14,CLDN15,CLDN16,CLDN17,CLDN18,CLDN19,CLDN2,CLDN20,CLDN22,CLDN23,CLDN3,CLDN4,CLDN5,CLDN6,CLDN7,CLDN8,CLDN9,CLMP,CXADR,DDX58,DLG1,ECT2,EPCAM,F11R,FBF1,FRMPD2,INADL,JUP,KIFC3,MAGI2,MARVELD2,MARVELD3,MICALL2,MPP7,MTDH,OCLN,PARD3,PARD6A,PARD6B,PDZD3,PKN2,PLEKHA7,PVRL2,RAB13,RAP2B,RAP2C,RAPGEF2,RHOA,SHROOM2,SHROOM3,SORBS1,STRN,TBCD,TGFBR1,TJP1,TJP2,TJP3,UBN1,VAPA,VCL,WNK3,WNK4,YBX3	A functional unit located near the cell apex at the points of contact between epithelial cells, which in vertebrates is composed of the tight junction, the zonula adherens, and desmosomes and in some invertebrates, such as Drosophila, is composed of the subapical complex (SAC), the zonula adherens and the septate junction. Functions in the regulation of cell polarity, tissue integrity and intercellular adhesion and permeability.
GO:0043297	GO	BP	apical junction assembly	APC,ARL2,CLDN1,CLDN12,CLDN14,CLDN15,CLDN17,CLDN18,CLDN20,CLDN22,CLDN23,CLDN3,CLDN9,CRB3,CTNNA1,DLG1,ECT2,F11R,FBF1,FRMPD2,GRHL2,INADL,MARVELD2,MARVELD3,MICALL2,MPP5,MPP7,OCLN,PARD3,PARD6A,PARD6B,PARD6G,PKN2,PRKCI,RAB13,RAMP2,RHOA,RHOC,STRN,TBCD,VCL	The formation of an apical junction, a functional unit located near the cell apex at the points of contact between epithelial cells composed of the tight junction, the zonula adherens junction and the desmosomes, by the aggregation, arrangement and bonding together of its constituents.
GO:0043299	GO	BP	leukocyte degranulation	ANXA3,CCL3,CHGA,CORO1A,HCK,KIT,KLRF2,MILR1,MRGPRX2,NR4A3,PIK3CD,PIK3CG,S100A13,SNAP23,VAMP2,VAMP7	The regulated exocytosis of secretory granules by a leukocyte.
GO:0043300	GO	BP	regulation of leukocyte degranulation	AP1G1,C12orf4,CCR2,CD300A,CD84,F2RL1,FES,FGR,GAB2,LAMP1,LGALS9,LYN,SNX4,STX4,STXBP2,SYK,UNC13D,VAMP7,VAMP8	Any process that modulates the frequency, rate, or extent of leukocyte degranulation.
GO:0043302	GO	BP	positive regulation of leukocyte degranulation	AP1G1,F2RL1,FGR,GAB2,LAMP1,SNX4,STX4,VAMP7,VAMP8	Any process that activates or increases the frequency, rate or extent of leukocyte degranulation.
GO:0043303	GO	BP	mast cell degranulation	CHGA,KIT,MILR1,MRGPRX2,NR4A3,PIK3CD,PIK3CG,S100A13,SNAP23	The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a mast cell.
GO:0043304	GO	BP	regulation of mast cell degranulation	C12orf4,CD300A,CD84,FES,FGR,GAB2,LGALS9,LYN,SNX4,STXBP2,UNC13D,VAMP7,VAMP8	Any process that modulates the frequency, rate, or extent of mast cell degranulation.
GO:0043306	GO	BP	positive regulation of mast cell degranulation	FGR,GAB2,SNX4,VAMP7,VAMP8	Any process that activates or increases the frequency, rate or extent of mast cell degranulation.
GO:0043325	GO	MF	phosphatidylinositol-3,4-bisphosphate binding	ADAP2,AKT1,ANXA8,ARAP3,COMMD1,DAPP1,FAM21C,GAB2,KIF16B,MAPKAP1,MYO1G,NCF1,PHLDA3,PLEK,PLEKHA1,RAG2,SESTD1,TTPA,ZFYVE1	Interacting selectively and non-covalently with phosphatidylinositol-3,4-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' and 4' positions.
GO:0043330	GO	BP	response to exogenous dsRNA	CAV1,COLEC12,FLOT1,IFIT1,IFNB1,IRAK3,MAVS,MB21D1,MUL1,RALB,RFTN1,SLC3A2,TICAM1,TLR3,TMEM173	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.
GO:0043331	GO	BP	response to dsRNA	ADAR,AGO1,AGO2,AGO3,AGO4,CAV1,COLEC12,DGCR8,DICER1,DROSHA,FLOT1,HNRNPA2B1,IFIT1,IFNB1,IRAK3,LIN28A,LIN28B,MAVS,MB21D1,METTL3,MUL1,NPM1,PMAIP1,PRKRA,RALB,RFTN1,SLC3A2,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TERT,TICAM1,TLR3,TMEM173,ZCCHC11	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a double-stranded RNA stimulus.
GO:0043367	GO	BP	CD4-positive, alpha-beta T cell differentiation	ATP7A,BATF,FOXP1,FOXP3,HMGB1,IL12B,IL6,IRF4,LEF1,LY9,PTGER4,RORA,RORC,RSAD2,SLAMF6,ZFPM1	The process in which a relatively unspecialized T cell acquires specialized features of a mature CD4-positive, alpha-beta T cell.
GO:0043368	GO	BP	positive T cell selection	BATF,CD3D,FOXP3,IL6,IRF4,LY9,SHH,SLAMF6,THEMIS,ZAP70,ZFPM1	The process of sparing immature T cells which react with self-MHC protein complexes with low affinity levels from apoptotic death.
GO:0043369	GO	BP	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment	BATF,FOXP3,IL6,IRF4,LY9,SHH,SLAMF6,ZFPM1	The process in which an immature T cell commits to CD4-positive T cell lineage or the CD8-positive lineage of alpha-beta T cells.
GO:0043370	GO	BP	regulation of CD4-positive, alpha-beta T cell differentiation	ANXA1,CCL19,CD80,CD86,FOXP3,HMGB1,IFNG,IL12B,IL12RB1,IL23A,IL23R,IL27,IRF4,JAK3,LGALS9,MYB,NCKAP1L,NLRP3,PRKCZ,RARA,RC3H1,SOCS5,TNFSF4	Any process that modulates the frequency, rate, or extent of CD4-positive, alpha-beta T cell differentiation.
GO:0043371	GO	BP	negative regulation of CD4-positive, alpha-beta T cell differentiation	ANXA1,FOXP3,HMGB1,JAK3,RC3H1,SOCS5,TNFSF4	Any process that stops, prevents, or reduces the frequency, rate, or extent of CD4-positive, alpha-beta T cell differentiation.
GO:0043372	GO	BP	positive regulation of CD4-positive, alpha-beta T cell differentiation	ANXA1,CCL19,CD80,CD86,FOXP3,IFNG,IL12B,IL12RB1,IL23A,IL23R,LGALS9,MYB,NCKAP1L,NLRP3,PRKCZ,RARA,SOCS5,TNFSF4	Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell differentiation.
GO:0043373	GO	BP	CD4-positive, alpha-beta T cell lineage commitment	BATF,FOXP3,IL6,IRF4,LY9,SLAMF6,ZFPM1	The process in which an immature T cell becomes committed to becoming a CD4-positive, alpha-beta T cell.
GO:0043380	GO	BP	regulation of memory T cell differentiation	CD46,IFNL1,IL12B,IL12RB1,IL23A,IL23R,TNFSF4	Any process that modulates the frequency, rate, or extent of memory T cell differentiation.
GO:0043382	GO	BP	positive regulation of memory T cell differentiation	CD46,IL12B,IL12RB1,IL23A,IL23R,TNFSF4	Any process that activates or increases the frequency, rate or extent of memory T cell differentiation.
GO:0043388	GO	BP	positive regulation of DNA binding	ACD,CEBPG,EDF1,EGF,GATA3,HAND2,HES1,HMGA2,HMGB1,HMGB2,IGF1,MMP9,NEUROD1,NME1,PARK2,PARK7,PINX1,PLAUR,SIRT2,SKI,TGFB1,TRAF6,TRIM6,TWIST1,TXN	Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
GO:0043392	GO	BP	negative regulation of DNA binding	CPNE1,DDIT3,E2F1,GATA1,GZMA,HABP4,HAND1,HEY1,HEY2,HMGA2,IFI16,JAK2,JUN,KDM1A,LEF1,MAD2L2,MDFI,MSX2,NFIB,NFKBIA,PER2,RSF1,SIN3A,SMO,SOX11,SP100,SUMO1,TFAP4,TNKS,ZNF675	Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
GO:0043393	GO	BP	regulation of protein binding	ABL1,ADAM15,ADD1,ADD2,ADIPOQ,ADRB2,AES,AIDA,AKTIP,AMFR,ANXA2,ARRB2,AURKA,AURKB,B2M,BAK1,BAMBI,BAX,BCL2,BMP2,BMP4,BTBD1,CAMK1,CAPRIN2,CAV1,CCL23,CSF3,CSNK1E,CTNNBIP1,DAB2,DAB2IP,DACT1,DERL1,DKK1,DVL1,EPB41,FKBP1A,FLOT1,GNL3L,GOLGA2,GREM2,GSK3B,GTPBP4,HDAC4,HDAC5,HFE,HIPK2,HSPA5,IFIT1,IFIT2,IL10,ISL1,ITGA4,ITGB1BP1,KDM1A,LDLRAP1,LEF1,LRPAP1,LRRK2,MAPK8,MEF2C,MEN1,MITD1,MMP9,NES,NKX3-1,NOG,NRG1,NRP1,PARK7,PDGFB,PEX14,PIN1,PKD1,PLK1,PRKACA,PRKCD,PRMT7,PRMT8,PTPRF,RALB,RAN,RAPGEF2,ROCK1,RUVBL2,SLPI,SNAPIN,SORL1,SPPL3,STK3,STK4,TCF7L2,TERT,TFIP11,TIAM1,TIRAP,TMBIM6,TMC8,TMEM173,TRAF2,TRAF4,TRIB3,USP33,VTN,WNT3A,ZFPM1,ZNF268	Any process that modulates the frequency, rate or extent of protein binding.
GO:0043394	GO	MF	proteoglycan binding	AGRN,AZU1,CECR1,CFH,COMP,FCN2,HPSE2,HRG,SEMA5A,THBS1	Interacting selectively and non-covalently with a proteoglycan, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
GO:0043395	GO	MF	heparan sulfate proteoglycan binding	AGRN,AZU1,CFH,COMP,HPSE2,HRG,SEMA5A	Interacting selectively and non-covalently with a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit.
GO:0043401	GO	BP	steroid hormone mediated signaling pathway	BMP4,BMP7,GPER1,LEF1,NKX3-1,OR51E2,PGRMC2	A series of molecular signals mediated by a steroid hormone binding to a receptor.
GO:0043403	GO	BP	skeletal muscle tissue regeneration	CFLAR,EYS,IGF1,LARGE,NACA	The regrowth of skeletal muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.
GO:0043406	GO	BP	positive regulation of MAP kinase activity	ADAM8,ADORA2B,ADRA2A,ADRA2B,ADRA2C,ALK,ARHGEF5,BIRC7,BMP2,C5,C5AR1,CCL19,CD24,CD40,CD81,CDK1,CHRNA7,CXCR4,DAB2IP,DAXX,DBNL,DRD4,DUSP19,DUSP5,DUSP6,DUSP7,DUSP9,DVL2,DVL3,EDN1,EDN3,EGF,EGFR,ELANE,EPGN,ERBB2,ERN1,ERP29,EZH2,FGF1,FGF10,FGF18,FGF2,FGFR1,FLT1,FLT3,FPR1,FZD10,GH1,GHR,GHRL,GNG3,GRM4,HACD3,HRAS,HTR2B,IKBKG,IL1B,INSR,IRAK1,IRAK2,KIT,LRRK2,MADD,MAP2K1,MAP2K2,MAP2K3,MAP2K5,MAP2K6,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPKAPK2,MAPKAPK3,MAPKAPK5,MDFIC,MOS,MST1R,MUL1,NEK10,NOD1,NOD2,NTF3,NTRK3,PAK1,PAK3,PDCD10,PDGFA,PDGFB,PDGFRB,PEA15,PIK3CB,PIK3CG,PIK3R5,PIK3R6,PKN1,PLA2G1B,PLCE1,PRKAA1,PROK2,RASGRP1,RIPK1,RIPK2,RPS27A,RPS3,S100A12,S1PR2,SAA1,SASH1,SHC1,SOD1,TAB1,TAB2,TAB3,TAOK3,TDGF1,TENM1,TGFA,TGFB1,THBS1,TLR4,TLR6,TLR9,TNF,TNFRSF11A,TNFSF11,TPD52L1,TRAF2,TRAF6,UBA52,UBB,UBC,VEGFA,WNT5A	Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
GO:0043407	GO	BP	negative regulation of MAP kinase activity	ADIPOQ,AIDA,APOE,BMP4,BMP7,CAV1,CAV3,CBLC,CD300A,CDK5RAP3,DAB2IP,DNAJA1,DUSP1,DUSP10,DUSP16,DUSP19,DUSP2,DUSP22,DUSP3,DUSP6,DUSP7,DUSP8,GBA,GPS1,GPS2,GSTP1,HIPK3,HYAL2,IL1B,INPP5K,IRAK3,LAX1,LYN,MBIP,NF1,PAQR3,PDCD4,PPP2CA,PPP2R1A,PRKCD,PTPN1,PTPN22,PTPRJ,RGS14,RGS2,RGS3,RGS4,SERPINB3,SMPD1,SORL1,SPRED1,SPRED2,STK38,UCHL1,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
GO:0043409	GO	BP	negative regulation of MAPK cascade	ADIPOQ,AIDA,AMBP,APOE,BMP4,BMP7,C3orf33,CAV1,CAV3,CBLC,CD300A,CDK5RAP3,CNKSR3,DAB2IP,DACT1,DAG1,DLG1,DNAJA1,DUSP1,DUSP10,DUSP16,DUSP19,DUSP2,DUSP22,DUSP26,DUSP3,DUSP6,DUSP7,DUSP8,EZR,F2RL1,FBLN1,FKTN,FLCN,FOXM1,FOXO1,GBA,GBP1,GPER1,GPS1,GPS2,GSTP1,HDAC3,HIPK3,HYAL2,IGBP1,IGF1R,IL1B,INPP5K,IRAK3,ITCH,ITGB1BP1,LAX1,LMO3,LYN,MARVELD3,MBIP,MECOM,MEN1,MYC,NCOR1,NF1,P2RX7,PAQR3,PARK2,PDCD4,PER1,PHB,PIN1,PINK1,PPEF2,PPP2CA,PPP2R1A,PRKCD,PSMD10,PTPN1,PTPN2,PTPN22,PTPRJ,PTPRR,RANBP9,RGS14,RGS2,RGS3,RGS4,RPS6KA6,SERPINB3,SLC9A3R1,SMPD1,SORL1,SPRED1,SPRED2,SPRY1,SPRY2,STK38,SYNJ2BP,TAOK3,TLR4,TNIP1,UCHL1,WNK2,ZMYND11,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the MAPKKK cascade.
GO:0043414	GO	BP	macromolecule methylation	ALKBH8,ARMT1,ASH1L,ASH2L,ASZ1,ATF7IP,ATRX,BAZ2A,BCDIN3D,BEND3,BHMT,CARM1,CHD5,CMTR1,CMTR2,COPRS,CTCFL,CTR9,CXXC1,DMAP1,DNMT1,DNMT3A,DNMT3B,DNMT3L,DPPA3,DPY30,EEF2KMT,EHMT1,EHMT2,ETF1,EZH2,FBL,FBXO11,FKBP6,FOS,FTSJ2,GATAD2A,GSPT1,H3F3A,HENMT1,HIST1H3A,HIST1H4A,HIST2H3A,KDM6A,KIAA1429,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,LCMT1,MAEL,MEN1,MEPCE,METTL1,METTL14,METTL20,METTL21A,METTL21C,METTL2A,METTL2B,METTL3,MGMT,MTRR,N6AMT1,NR1H4,NSD1,NSUN2,NSUN4,NTMT1,OGT,PAXIP1,PCMT1,PICK1,PIWIL2,PIWIL4,PLD6,PRDM4,PRDM5,PRMT1,PRMT2,PRMT3,PRMT5,PRMT6,PRMT7,PRMT8,RAB6A,RBBP5,RNMT,SETD1A,SETD1B,SETD2,SETD3,SETD6,SETD7,SETD8,SETDB2,SETMAR,SMYD2,SNRPB,SNRPD3,SUV39H1,SUV39H2,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH,TET2,TET3,TGS1,TRDMT1,TRMT10A,TRMT112,TRMT61B,UHRF1,VCPKMT,WDR5,WDR61,WDR82,WHSC1L1,WTAP,ZFP57,ZNF335	The covalent attachment of a methyl residue to one or more monomeric units in a polypeptide, polynucleotide, polysaccharide, or other biological macromolecule.
GO:0043425	GO	MF	bHLH transcription factor binding	BHLHE40,BHLHE41,CREBBP,KDM1A,PSMD9,SP1	Interacting selectively and non-covalently with any of the basic Helix-Loop-Helix (bHLH) superfamily of transcription factors, important regulatory components in transcriptional networks of many developmental pathways.
GO:0043433	GO	BP	negative regulation of sequence-specific DNA binding transcription factor activity	ADGRG3,AIM2,ANXA4,ARRB1,ARRB2,BHLHE40,BMP7,BRMS1,BTRC,CACTIN,CDK5RAP3,CDKN2A,CEBPG,CHP1,CMKLR1,COMMD1,COMMD6,COMMD7,CTNNBIP1,CYLD,CYP1B1,DAB2IP,DAP,DDIT3,DNAJA3,EGLN1,EIF2AK4,ERBB2IP,ESR1,FLNA,FOXA2,FOXH1,FOXJ1,FOXP3,FOXS1,FZD6,GAS6,GFI1,GLIS2,HAND1,HAVCR2,HDAC2,HDAC4,HEYL,ID1,ID2,ID3,IRAK1,IRAK2,IRAK3,IRG1,ITCH,KDM1A,KEAP1,KLF4,MAD2L2,MAP2K5,MAP3K10,MEN1,NFKBIA,NFKBIL1,NLRC3,NLRC5,NLRP12,NLRP2P,NLRP3,NR0B1,NR0B2,OTULIN,PARP10,PBX1,PEX14,PHB2,PIAS2,PIM1,PKHD1,PLA2G10,PRMT2,PRNP,PROX1,PSMD10,PTCH1,PTGIS,PYCARD,PYDC1,PYDC2,RB1,RBCK1,RNF2,RWDD3,SETD6,SFRP4,SFRP5,SIGIRR,SIK1,SIRT1,SIVA1,SMAD7,SP100,SUFU,SUMO1,TAF3,TAX1BP1,TCEAL7,TCF7L2,TLR9,TNFAIP3,TNFRSF4,TNFSF4,TRAF3,TRIB1,TRIM21,TRIM37,TRIM40,UFL1,USP7,WFS1,WWP2,XCL1,ZC3H12A,ZNF431,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
GO:0043455	GO	BP	regulation of secondary metabolic process	CDH3,PGAM1,RAPGEF2,TIGAR,TYRP1,ZEB2	Any process that modulates the frequency, rate or extent of secondary metabolism, the chemical reactions and pathways involving compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon.
GO:0043457	GO	BP	regulation of cellular respiration	ACTN3,CBFA2T3,NOA1,NOS2,PARK7,PINK1,PNPT1,PRDM16,PRELID1,SNCA,TRAP1,VCP	Any process that modulates the frequency, rate or extent of cellular respiration, the enzymatic release of energy from organic compounds.
GO:0043462	GO	BP	regulation of ATPase activity	ABCA7,AHSA1,ALDOB,ATP1B1,ATP1B2,ATP1B3,ATPIF1,BRSK2,CHTOP,DNAJB1,DNAJB11,DNAJB6,DNAJC1,DNAJC10,DNAJC24,DNAJC9,FGF10,GABARAPL2,LTF,MYBPC3,MYH6,MYL3,MYL4,OXA1L,PAM16,PFN1,PFN2,PLN,PLSCR1,PPIF,PXK,RGN,RYR2,SETMAR,SLN,SNRNP70,TLR9,TNNC1,TNNI3,TNNT2,TNNT3,TOR1AIP1,TOR1AIP2,TPM1,TPM2,UHRF1	Any process that modulates the rate of ATP hydrolysis by an ATPase.
GO:0043467	GO	BP	regulation of generation of precursor metabolites and energy	ACTN3,AKT1,AKT2,ARNT,ATP7A,CBFA2T3,DYRK2,ECD,ENPP1,ENTPD5,FBP1,GAPDHS,GCGR,GCK,GRB10,GSK3A,GSK3B,HDAC4,HIF1A,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,MLXIPL,NCOR1,NOA1,NOS2,OGT,P2RX7,PARK7,PASK,PGAM1,PHKG2,PINK1,PNPT1,PPARA,PPIF,PPP1R3B,PPP1R3F,PRDM16,PRELID1,PRKAA1,PRKAA2,PRKAG1,PRKAG2,PTH,SLC25A33,SNCA,SORBS1,TRAP1,UQCC2,VCP,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and the processes involved in the liberation of energy from these substances.
GO:0043471	GO	BP	regulation of cellular carbohydrate catabolic process	ACTN3,ARNT,CBFA2T3,ECD,ENTPD5,FBP1,GAPDHS,GCK,GSK3A,HDAC4,HIF1A,IGF1,INS,INSR,MLXIPL,NCOR1,OGT,P2RX7,PGAM1,PHKG2,PPARA,PPP1R3B,PRKAA1,PRKAA2,PRKAG1,PRKAG2,TIGAR	Any process that modulates the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of carbohydrates, carried out by individual cells.
GO:0043473	GO	BP	pigmentation	AP1G1,AP1M1,AP3B1,AP3D1,ARL6,ATP6AP2,ATP7A,BBS2,BBS4,BBS5,BBS7,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,C10orf11,C12orf10,CD63,CITED1,DTNBP1,GPR143,KIF13A,KIT,LYST,MC1R,MEF2C,MITF,MKKS,NF1,OCA2,PMEL,POMC,RAB11A,RAB11B,RAB17,RAB27A,RAB32,RAB38,SHROOM2,SHROOM3,SNAI2,SNAPIN,TH,TYR,USP13,VPS33A,VPS33B,ZEB2	The accumulation of pigment in an organism, tissue or cell, either by increased deposition or by increased number of cells.
GO:0043482	GO	BP	cellular pigment accumulation	AP1G1,AP1M1,AP3D1,BLOC1S3,BLOC1S5,BLOC1S6,CD63,RAB32,RAB38,SHROOM2,SHROOM3	The aggregation of coloring matter in a particular location in a cell, occurring in response to some external stimulus.
GO:0043484	GO	BP	regulation of RNA splicing	ACIN1,AFF2,AHNAK,AKAP17A,BRDT,C1QBP,CELF1,CELF3,CELF4,CELF6,CLK1,CLK2,CLK3,CLK4,CWC22,DDX5,ERN1,ESRP1,ESRP2,FASTK,HNRNPF,HNRNPH1,HNRNPLL,HSPA1A,JMJD6,MAGOH,MBNL1,MBNL2,MBNL3,MYOD1,NSRP1,PIK3R1,POLR2A,PQBP1,PTBP1,PTBP2,PTBP3,RBFOX2,RBM11,RBM15B,RBM20,RBM22,RBM25,RBM38,RBM4,RBM5,RBM8A,RBMX,RBMY1A1,RNPS1,RPS13,RPS26,SAP18,SETX,SFSWAP,SNRNP70,SNW1,SON,SRPK1,SRPK2,SRRM4,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,THRAP3,TIA1,TMBIM6,TRA2B,U2AF2,WTAP,ZPR1	Any process that modulates the frequency, rate or extent of RNA splicing, the process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.
GO:0043486	GO	BP	histone exchange	ANP32E,APITD1,CASC5,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPW,CHD5,HIST1H2BA,HIST1H4A,HJURP,ITGB3BP,MIS18A,MIS18BP1,NASP,NPM1,OIP5,PSME4,RBBP4,RBBP7,RNF8,RSF1,RUVBL1,SMARCA5,SPTY2D1,STRA13,SYCP3,TNP1	The replacement, within chromatin, of resident histones or histone subunits with alternative, sometimes variant, histones or subunits.
GO:0043487	GO	BP	regulation of RNA stability	AKT1,ANGEL2,ANP32A,APEX1,AXIN2,CARHSP1,CIRBP,CPEB3,DCP1A,DCP2,DHX9,DIS3,DKC1,DXO,E2F1,EIF4G1,ELAVL1,EXOSC1,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,GDNF,HNRNPA0,HNRNPC,HNRNPD,HNRNPU,HSPA1A,HSPA8,HSPB1,IGF2BP1,KHSRP,MAPK11,MAPK14,MAPKAPK2,METTL14,METTL3,MEX3D,MYD88,NOCT,NUP214,PABPC1,PAIP1,PARN,PCID2,PRKCA,PRKCD,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PUM1,RBM24,RBM38,RC3H1,RPS27A,SERBP1,SET,SLC11A1,SYNCRIP,TARDBP,THRAP3,TIRAP,TNFSF13,TNPO1,TRIM71,UBA52,UBB,UBC,VIP,XPO1,XRN1,YBX1,YBX3,YTHDF2,YWHAB,YWHAZ,ZC3H12A,ZC3H12D,ZFP36,ZFP36L1	Any process that modulates the propensity of RNA molecules to degradation. Includes processes that both stabilize and destabilize RNAs.
GO:0043488	GO	BP	regulation of mRNA stability	AKT1,ANGEL2,ANP32A,APEX1,AXIN2,CARHSP1,CIRBP,CPEB3,DCP1A,DCP2,DHX9,DIS3,E2F1,EIF4G1,ELAVL1,EXOSC1,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,GDNF,HNRNPA0,HNRNPC,HNRNPD,HNRNPU,HSPA1A,HSPA8,HSPB1,IGF2BP1,KHSRP,MAPK11,MAPK14,MAPKAPK2,METTL14,METTL3,MEX3D,MYD88,NOCT,NUP214,PABPC1,PAIP1,PARN,PCID2,PRKCA,PRKCD,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PUM1,RBM24,RBM38,RC3H1,RPS27A,SERBP1,SET,SLC11A1,SYNCRIP,TARDBP,THRAP3,TIRAP,TNFSF13,TNPO1,TRIM71,UBA52,UBB,UBC,VIP,XPO1,XRN1,YBX1,YBX3,YTHDF2,YWHAB,YWHAZ,ZC3H12A,ZC3H12D,ZFP36,ZFP36L1	Any process that modulates the propensity of mRNA molecules to degradation. Includes processes that both stabilize and destabilize mRNAs.
GO:0043489	GO	BP	RNA stabilization	ANGEL2,AXIN2,CIRBP,DHX9,DKC1,E2F1,ELAVL1,GDNF,HNRNPA0,HNRNPC,HNRNPU,IGF2BP1,MAPK14,MAPKAPK2,MYD88,NOCT,PABPC1,PAIP1,RBM38,SLC11A1,SYNCRIP,TARDBP,THRAP3,TIRAP,VIP,YBX1,YBX3,ZFP36	Prevention of degradation of RNA molecules.
GO:0043491	GO	BP	protein kinase B signaling	CCL2,CCL3,CCL5,EPHA2,GAS6,IGF1,IL1B,MT3,NKX3-1,PAX2,PLK3,PTEN,SETX,SIRT2,TGFB1,THEM4,TNF,TSC2,TYRO3	A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
GO:0043492	GO	MF	ATPase activity, coupled to movement of substances	ABCA12,ABCA2,ABCA3,ABCA8,ABCB1,ABCB11,ABCB4,ABCB6,ABCB9,ABCD1,ABCD4,ABCG1,ABCG2,ATP10A,ATP10D,ATP11B,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP4B,ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V0E2,ATP6V1B2,ATP6V1C1,ATP7A,ATP7B,ATP8A1,ATP8B1,CFTR,RALBP1,TAP2,TAPBP	Catalysis of the reaction: ATP + H2O = ADP + phosphate, to directly drive the transport of a substance.
GO:0043495	GO	MF	protein anchor	AKAP6,CIB1,MYH9,NUP153,PDCD6,SLC4A1	Interacting selectively and non-covalently with both a protein or protein complex and a membrane, in order to maintain the localization of the protein at a specific location on the membrane.
GO:0043496	GO	BP	regulation of protein homodimerization activity	AIDA,BAK1,BAX,BCL2,GNL3L,HSPA5,ISL1,ITGA4,MEF2C,NRG1,PARK7,TIRAP,TRAF2,TRAF4,ZNF268	Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
GO:0043497	GO	BP	regulation of protein heterodimerization activity	BAK1,BCL2,DAB2IP,NRG1,ZNF268	Any process that modulates the frequency, rate or extent of protein heterodimerization, interacting selectively with a nonidentical protein to form a heterodimer.
GO:0043500	GO	BP	muscle adaptation	ACTN3,CAMTA2,CFLAR,CYBA,GSN,HDAC4,HMOX1,IL1B,MYOC,MYOG,NOS3,TCAP	A process in which muscle adapts, with consequent modifications to structural and/or functional phenotypes, in response to a stimulus. Stimuli include contractile activity, loading conditions, substrate supply, and environmental factors. These adaptive events occur in both muscle fibers and associated structures (motoneurons and capillaries), and they involve alterations in regulatory mechanisms, contractile properties and metabolic capacities.
GO:0043502	GO	BP	regulation of muscle adaptation	ACTN3,AGT,AKAP6,ATP2B4,BMP10,CAMK2B,CAMK2D,CAMK2G,CAV3,EDN1,FBXO32,GLRX3,GSK3A,HDAC4,IGF1,IL6ST,LMCD1,MTPN,MYOG,NOS3,NR4A3,P2RX4,PARP1,PDE9A,PRKCA,RGS2,SCN5A,SLC9A1,TRIM63,TRPC3	Any process that modulates the frequency, rate or extent of muscle adaptation.
GO:0043506	GO	BP	regulation of JUN kinase activity	AIDA,ARHGEF5,BIRC7,CCL19,DAB2IP,DAXX,DBNL,DNAJA1,DUSP19,DVL2,DVL3,EDN1,ERN1,FZD10,GSTP1,HACD3,HIPK3,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MDFIC,MUL1,PAK1,PDCD4,PKN1,PPEF2,PTPN22,RIPK1,RPS3,SASH1,SERPINB3,TAOK3,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TRAF2,TRAF6,WNT5A,ZNF675	Any process that modulates the frequency, rate or extent of JUN kinase activity.
GO:0043507	GO	BP	positive regulation of JUN kinase activity	ARHGEF5,BIRC7,CCL19,DAB2IP,DAXX,DBNL,DUSP19,DVL2,DVL3,EDN1,ERN1,FZD10,HACD3,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MDFIC,MUL1,PAK1,PKN1,RIPK1,RPS3,SASH1,TAOK3,TLR6,TLR9,TNF,TNFRSF11A,TRAF2,TRAF6,WNT5A	Any process that activates or increases the frequency, rate or extent of JUN kinase activity.
GO:0043508	GO	BP	negative regulation of JUN kinase activity	AIDA,DNAJA1,DUSP19,GSTP1,HIPK3,PDCD4,PTPN22,SERPINB3,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of JUN kinase activity.
GO:0043516	GO	BP	regulation of DNA damage response, signal transduction by p53 class mediator	ANKRD1,ATM,ATR,CD44,CD74,CDKN2A,DDX5,DYRK1A,EEF1E1,HIC1,KDM1A,MDM2,MIF,MSX1,PLA2R1,PMAIP1,PSMD10,PTTG1IP,SETD8,SIRT1,SMYD2,SNAI1,SNAI2,SPRED1,SPRED2,TWIST1,ZNF385A	Any process that modulates the frequency, rate or extent of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
GO:0043517	GO	BP	positive regulation of DNA damage response, signal transduction by p53 class mediator	ANKRD1,ATM,ATR,CDKN2A,DDX5,EEF1E1,HIC1,MSX1,PLA2R1,PMAIP1,SPRED1,SPRED2,ZNF385A	Any process that activates, maintains or increases the rate of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
GO:0043518	GO	BP	negative regulation of DNA damage response, signal transduction by p53 class mediator	CD44,CD74,DYRK1A,KDM1A,MDM2,MIF,PSMD10,PTTG1IP,SIRT1,SNAI1,SNAI2,TWIST1	Any process that stops, prevents, or reduces the frequency, rate or extent of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
GO:0043523	GO	BP	regulation of neuron apoptotic process	ADAM8,AGAP2,AKT1S1,ATF4,BAX,BBC3,BCL2,BHLHB9,CCL2,CCL3,CDK5,CDK5R1,CITED1,CLCF1,CLN3,CNTF,CPEB4,CRLF1,CTNNB1,DDIT3,EGLN2,EGLN3,EPHA7,ERBB3,F2R,FAIM2,FAM134B,FBXW7,FOXB1,FOXO3,GDNF,GRID2,GRM4,HIF1A,ISL1,KCNB1,KDM2B,KIF14,LGMN,LIG4,MCL1,MEF2C,MSH2,MT3,NAE1,NAIP,NDNF,NF1,NONO,NRBP2,NSMF,NTRK1,NTRK2,PARK2,PARK7,PCSK9,PINK1,POU4F1,PPARGC1A,PPT1,PRKCG,PRKCI,PTK2B,RASA1,SET,SIGMAR1,SIX1,SIX4,SOD1,SOD2,SRPK2,TFAP2A,TFAP2B,TGFB2,TGFB3,TOX3,TRIM2,TYRO3,UNC5B,VEGFB,VSTM2L,WFS1,ZPR1	Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
GO:0043524	GO	BP	negative regulation of neuron apoptotic process	ADAM8,AGAP2,BCL2,BHLHB9,CCL2,CITED1,CLCF1,CLN3,CNTF,CPEB4,CRLF1,ERBB3,F2R,FAM134B,FOXB1,GDNF,HIF1A,ISL1,KDM2B,KIF14,LGMN,LIG4,MEF2C,MSH2,MT3,NAIP,NDNF,NONO,NRBP2,NTRK1,NTRK2,PARK2,PARK7,PINK1,POU4F1,PPARGC1A,PPT1,PRKCG,PRKCI,PTK2B,RASA1,SET,SIX1,SIX4,SOD1,SOD2,TGFB3,TOX3,TYRO3,UNC5B,VEGFB,VSTM2L,WFS1,ZPR1	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
GO:0043525	GO	BP	positive regulation of neuron apoptotic process	ATF4,BAX,BBC3,CCL3,CDK5,CDK5R1,CTNNB1,DDIT3,EPHA7,FBXW7,FOXO3,MCL1,NF1,PCSK9,SRPK2,TFAP2A,TFAP2B,TGFB2	Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
GO:0043531	GO	MF	ADP binding	ABCG1,ACTA1,ADCK3,ATP5D,ERN1,GCLC,GLUD1,GLUD2,LONP1,ME1,MIEF1,MSH2,MSH6,MYH10,MYH9,MYO18A,MYO3A,MYO6,MYO9B,PPP5C,PRKAG1,PRKAG2,TAP1	Interacting selectively and non-covalently with ADP, adenosine 5'-diphosphate.
GO:0043534	GO	BP	blood vessel endothelial cell migration	EFNB2,EGR3,EMP2,EPHB4,FGF2,GPLD1,GREM1,ID1,KDR,MYH9,NR4A1,NRP1,ROBO1,SLIT2,SRF,TDGF1,VEGFA	The orderly movement of an endothelial cell into the extracellular matrix in order to form new blood vessels during angiogenesis.
GO:0043535	GO	BP	regulation of blood vessel endothelial cell migration	ACVRL1,AGTR2,AKT1,AMOT,ANGPT1,ANGPT2,ANGPT4,APOE,CIB1,CSNK2B,DLL4,EPHA2,FGF2,FOXC2,GDF2,HDAC5,HDAC7,HDAC9,HMGB1,HRG,HSPB1,ITGB1BP1,KLF4,MAP2K5,MMRN2,NF1,NOTCH1,PDCD10,PDGFB,PLCG1,PRKCA,PRKD1,PRKD2,PTGS2,RGCC,RHOA,SH3BGRL3,SRPX2,STARD13,TGFB1,THBS1,VASH1,VEGFA	Any process that modulates the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
GO:0043536	GO	BP	positive regulation of blood vessel endothelial cell migration	AKT1,AMOT,ANGPT1,ANGPT4,CIB1,FGF2,FOXC2,HDAC7,HDAC9,HSPB1,PDGFB,PLCG1,PRKCA,PRKD1,PRKD2,PTGS2,SRPX2,TGFB1,THBS1,VEGFA	Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
GO:0043537	GO	BP	negative regulation of blood vessel endothelial cell migration	ACVRL1,AGTR2,ANGPT2,ANGPT4,APOE,CSNK2B,DLL4,FGF2,GDF2,HDAC5,HMGB1,HRG,ITGB1BP1,KLF4,MAP2K5,MMRN2,NOTCH1,PDCD10,RGCC,RHOA,STARD13,TGFB1,THBS1,VASH1	Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
GO:0043539	GO	MF	protein serine/threonine kinase activator activity	ALS2,CAB39,CALM1,CDK5R1,FAM20A,IGF2,IQGAP1,LTF,MAP2K1,MAP2K2,PARP16,SPRY2,STK3,STK4,STRADA	Binds to and increases the activity of a protein serine/threonine kinase.
GO:0043542	GO	BP	endothelial cell migration	CALCA,CDH13,CORO1B,CXCL13,CYP1B1,DPP4,EFNB2,EGR3,EMP2,EPHB4,FAP,FGF2,GIPC1,GPLD1,GREM1,ID1,KDR,LOXL2,MYH9,NOS3,NOV,NR4A1,NRP1,PIK3CA,PLEKHG5,PLXND1,PRKX,PRSS3,PTP4A3,RAB13,RHOA,ROBO1,S100A2,S100P,SCG2,SLIT2,SRF,STARD13,TDGF1,TNFSF12,VEGFA	The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
GO:0043543	GO	BP	protein acylation	AANAT,ACTL6A,APBB1,ASL,ATAT1,ATF2,BAG6,BEND3,BLOC1S1,BRCA2,BRD1,BRD8,BRPF1,BRPF3,CHD5,CLIP3,CLOCK,CPA4,CREBBP,CSRP2BP,DMAP1,DR1,DSCC1,EHHADH,ELP3,ELP4,EP300,EP400,EPC1,ESCO1,ESCO2,FOXO1,GOLGA7,GTF3C4,HAT1,HCFC1,ING3,ING4,ING5,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT7,KAT8,KMT2A,LDB1,LEF1,MAP3K7,MBIP,MBOAT4,MCRS1,MDH2,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA10,NAA11,NAA15,NAA16,NAA30,NAA50,NAA60,NAT8,NAT8B,NCOA3,NMT1,NMT2,OAS2,OGT,PCK1,PER1,PHF20,POLE3,POLE4,PORCN,PPM1A,PPM1B,RUVBL1,RUVBL2,SAP130,SGF29,SIRT1,SPI1,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,TRIM16,TRRAP,USP22,WDR5,YEATS2,YEATS4,ZDHHC1,ZDHHC12,ZDHHC14,ZDHHC15,ZDHHC16,ZDHHC17,ZDHHC18,ZDHHC2,ZDHHC20,ZDHHC21,ZDHHC3,ZDHHC5,ZDHHC6,ZDHHC7,ZDHHC8,ZDHHC9	The addition of an acyl group, any group or radical of the form RCO- where R is an organic group, to a protein amino acid.
GO:0043548	GO	MF	phosphatidylinositol 3-kinase binding	CORO1A,DAB2IP,FAM83A,HCST,IRS1,PIK3AP1,PIK3R1	Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.
GO:0043550	GO	BP	regulation of lipid kinase activity	AMBRA1,ATG14,CCKBR,CCL19,CCL21,CCR7,CD81,DAB2IP,EEF1A2,EPHA8,ERBB4,FGF2,FGFR3,FGR,FLT1,FLT3,IRS1,KIT,NOD2,PDGFB,PDGFRA,PDGFRB,PIK3IP1,PIK3R1,PIK3R4,PIK3R6,PPP2R5A,PTK2,PTK2B,RB1,RBL1,RBL2,RUBCN,TEK,TGFB1,TNFAIP8L3	Any process that modulates the frequency, rate or extent of lipid kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a simple or complex lipid.
GO:0043551	GO	BP	regulation of phosphatidylinositol 3-kinase activity	AMBRA1,ATG14,CCKBR,CCL19,CCL21,CCR7,DAB2IP,EPHA8,ERBB4,FGF2,FGFR3,FGR,FLT1,FLT3,IRS1,KIT,NOD2,PDGFB,PDGFRA,PDGFRB,PIK3IP1,PIK3R1,PIK3R4,PIK3R6,PTK2,PTK2B,RUBCN,TEK,TGFB1,TNFAIP8L3	Any process that modulates the frequency, rate or extent of phosphatidylinositol 3-kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an inositol lipid at the 3' position of the inositol ring.
GO:0043552	GO	BP	positive regulation of phosphatidylinositol 3-kinase activity	AMBRA1,ATG14,CCL19,CCL21,CCR7,EPHA8,ERBB4,FGF2,FGFR3,FGR,FLT1,FLT3,IRS1,KIT,NOD2,PDGFB,PDGFRA,PDGFRB,PIK3R4,PTK2,PTK2B,TEK,TGFB1,TNFAIP8L3	Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
GO:0043555	GO	BP	regulation of translation in response to stress	ATF4,DNAJC3,EIF2AK1,EIF2AK2,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1,IMPACT,NCK1,PML,PPP1CA,PPP1R15A,RBM4,RPS6KA1,RPS6KA3	Modulation of the frequency, rate or extent of translation as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
GO:0043558	GO	BP	regulation of translational initiation in response to stress	ATF4,DNAJC3,EIF2AK1,EIF2AK2,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1,IMPACT,PPP1CA,PPP1R15A	Any process that modulates the frequency, rate or extent of translation initiation, as a result of a stimulus indicating the organism is under stress.
GO:0043566	GO	MF	structure-specific DNA binding	ACTB,ACTL6A,ACTN4,APEX1,BLM,CHD4,CLOCK,CTCF,DHX36,ENDOV,ERCC1,ERCC4,ERCC5,EZH2,FAN1,FOXC2,FOXO3,GATA1,GATAD2B,GRHL1,GRHL2,GRHL3,H1F0,H1FOO,H2AFY,H2AFY2,H2AFZ,H3F3A,H3F3C,HDAC1,HDAC2,HIST1H1A,HIST1H1B,HIST1H1C,HIST1H1D,HIST1H1E,HMGA2,HMGB1,HMGB2,HMGB3,HNRNPC,INSM1,LONP1,MBD2,MBD3,MEN1,MSH2,MSH6,MTA2,MYOD1,MYOG,NEIL3,NEUROG3,NR0B1,PER1,PIN4,PPARGC1A,PSIP1,RAD18,RAD51B,RAD51C,RAD51D,RARA,RBBP4,RCC1,RECQL4,RELA,RPS3,RUVBL2,SETMAR,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD2,SMARCE1,STAT3,TDG,TET1,WBP2,WRN,XBP1,XPC,XRCC2,XRCC3,YY1,ZBP1,ZIC2	Interacting selectively and non-covalently with DNA of a specific structure or configuration e.g. triplex DNA binding or bent DNA binding.
GO:0043567	GO	BP	regulation of insulin-like growth factor receptor signaling pathway	BMP2,BMP5,CDH3,CILP,GH1,GHRH,GHRHR,IGF1,IGFBP2,IGFBP5,NKX3-1,PHIP,WNT1	Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
GO:0043568	GO	BP	positive regulation of insulin-like growth factor receptor signaling pathway	CDH3,GH1,GHRH,GHRHR,IGF1,PHIP,WNT1	Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling.
GO:0043569	GO	BP	negative regulation of insulin-like growth factor receptor signaling pathway	BMP2,BMP5,CILP,IGFBP5,NKX3-1	Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling.
GO:0043574	GO	BP	peroxisomal transport	ABCD1,LONP2,PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,RAB8B,ZFAND6	Transport of substances into, out of or within a peroxisome, a small, membrane-bounded organelle that uses dioxygen (O2) to oxidize organic molecules.
GO:0043576	GO	BP	regulation of respiratory gaseous exchange	MTG1,MTG2,NLGN2,NLGN3,PASK,PHOX2B,TSHZ3	Any process that modulates the frequency, rate or extent of the process of gaseous exchange between an organism and its environment.
GO:0043583	GO	BP	ear development	AHI1,ATP6V1B1,BMP2,CEP290,CHD7,DFNB31,ECE1,EPHB2,FGFR2,GATA3,GRXCR1,GSC,HES5,HOXA1,HPN,JAG2,KCNQ1,LRTOMT,MPV17,NEUROD1,NIPBL,NOG,OSR1,OSR2,PAX2,PAX8,PHOX2B,POU3F4,PROX1,PTPN11,SALL1,SHROOM2,SIX1,SOD1,SOX9,STRA6,STRC,TBX1,TFAP2A,TWIST1,USH2A,ZIC1	The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.
GO:0043584	GO	BP	nose development	CHD7,GLI3,PROX1,SIX4,SKI,STRA6	The process whose specific outcome is the progression of the nose over time, from its formation to the mature structure. The nose is the specialized structure of the face that serves as the organ of the sense of smell and as part of the respiratory system. Includes the nasi externus (external nose) and cavitas nasi (nasal cavity).
GO:0043586	GO	BP	tongue development	HDAC1,HDAC2,NKX2-6,SIX4,TBX1,WNT10A	The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech.
GO:0043588	GO	BP	skin development	ABCB6,ALOX12,ALOX12B,ALOXE3,ALX4,ANXA1,APCDD1,ASCL4,ASPRV1,ATP7A,CASP14,CDH3,CDSN,CERS3,CLDN1,CLDN4,CLIC4,COL1A1,COL1A2,COL3A1,COL5A1,COL5A2,COL5A3,CSTA,DACT2,DHCR24,DLL1,DSP,EPHA2,EREG,ERRFI1,EVPL,EXPH5,FGFR2,FLG,FOXE1,FUZ,GNAS,HDAC1,HDAC2,INHBA,ITGA3,ITGA6,ITGB4,IVL,JAG1,KDF1,KRT16,KRT17,KRT2,KRT71,KRT84,KRT9,LOR,MED1,PDGFA,PIP5K1A,RYR1,S100A7,SCEL,SFN,SOX9,SPINK5,SPRR1A,SPRR1B,SPRR2A,SPRR2B,SPRR2F,SPRR2G,SPRR3,ST14,TGFB2,TGM1,TGM3,TMEM79,TP63,TXNIP,WNT10A,WNT16	The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
GO:0043596	GO	CC	nuclear replication fork	BAZ1B,BCAS2,CDC5L,CHRAC1,ERCC5,HELB,MCM3,MMS22L,PCNA,PLRG1,POLA1,POLD3,POLE,POLE2,POLE3,POLE4,PRPF19,PURA,PURB,RPA1,RPA2,RPA3,RPA4,SMARCA5,SMARCAD1,SMARCAL1,TONSL,XPA,ZMIZ2,ZRANB3	The Y-shaped region of a nuclear replicating DNA molecule, resulting from the separation of the DNA strands and in which the synthesis of new strands takes place. Also includes associated protein complexes.
GO:0043601	GO	CC	nuclear replisome	BCAS2,CDC5L,CHRAC1,ERCC5,HELB,MCM3,PLRG1,POLA1,POLD3,POLE,POLE2,POLE3,POLE4,PRPF19,PURA,PURB,RPA1,RPA2,RPA3,RPA4,SMARCAL1,TONSL,XPA	A multi-component enzymatic machine at the nuclear replication fork, which mediates DNA replication. Includes DNA primase, one or more DNA polymerases, DNA helicases, and other proteins.
GO:0043616	GO	BP	keratinocyte proliferation	CDH13,EREG,FERMT1,KLK8,KRT2,SDR16C5,WNT16	The multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population. Keratinocytes are epidermal cells which synthesize keratin and undergo a characteristic change as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin.
GO:0043618	GO	BP	regulation of transcription from RNA polymerase II promoter in response to stress	ANKRD2,ARNT,ATF3,ATF4,ATF6,ATF6B,BACH1,CA9,CEBPB,CHD6,CHEK1,CITED2,CREB3L1,CREB3L3,CREBBP,CUL2,DDIT3,EGLN1,EGLN2,EGLN3,EP300,EPAS1,EPO,HIF1A,HIF1AN,HIF3A,HMOX1,HSPA5,IMPACT,JUN,KLF2,MAPK7,MBTPS2,MT3,MUC1,NCK1,NEDD4,NFE2L2,NOTCH1,RBPJ,RBX1,RPS27A,SIRT2,STOX1,TCEB1,TCEB2,TP53,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,VEGFA,VHL,XBP1	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
GO:0043619	GO	BP	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	ANKRD2,ARNT,ATF4,CHD6,HIF1A,HMOX1,MT3	Modulation of the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
GO:0043620	GO	BP	regulation of DNA-templated transcription in response to stress	ANKRD2,ARNT,ATF3,ATF4,ATF6,ATF6B,BACH1,BCLAF1,C8orf4,CA9,CEBPB,CHD6,CHEK1,CITED2,CREB3L1,CREB3L3,CREBBP,CUL2,DDIT3,EGLN1,EGLN2,EGLN3,EP300,EPAS1,EPO,HIF1A,HIF1AN,HIF3A,HMOX1,HSPA5,IMPACT,JUN,KLF2,MAPK7,MBTPS2,MT3,MUC1,NCK1,NEDD4,NFE2L2,NOTCH1,RBPJ,RBX1,RGS14,RPS27A,RPS6KA1,RPS6KA3,SIRT2,STOX1,TCEB1,TCEB2,TP53,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,VEGFA,VHL,XBP1	Modulation of the frequency, rate or extent of transcription from a DNA template as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
GO:0043621	GO	MF	protein self-association	ADAM8,AGXT,ATXN1,CCDC88C,CCL5,DMTN,DYRK1A,FOXP1,NKX3-1,PCSK9,PTH1R,RSAD2,S100A7A,SLC2A1,SLC9A3R1,SPTBN5,SVIP,SYP,TCP10L,TNFAIP3,TRIM32,TTN,VAMP2	Interacting selectively and non-covalently with a domain within the same polypeptide.
GO:0043624	GO	BP	cellular protein complex disassembly	APEH,AURKAIP1,CCSAP,CHCHD1,DAP3,ETF1,FAU,GADD45GIP1,GFM2,GSPT2,ICT1,KIF18A,KIF18B,KIF19,KIF24,KIF2B,KIF2C,MICAL1,MICAL2,MICAL3,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,MRRF,MTRF1L,NCKAP5L,NRG1,PEX14,PTCD3,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,STMN1,SYNJ1,UBA52,VIL1,VPS4A,VPS4B	The disaggregation of a protein complex into its constituent components, occurring at the level of an individual cell. Protein complexes may have other associated non-protein prosthetic groups, such as nucleic acids, metal ions or carbohydrate groups.
GO:0043627	GO	BP	response to estrogen	ASH2L,BCAS3,BRCA1,CAV1,CCDC62,CITED1,CITED2,CITED4,CRHBP,CRIPAK,CTNNB1,EGFR,EP300,ESR1,FOXA1,GH1,GHR,GHRHR,GHRL,GPER1,H2AFZ,KAT5,KMT2D,MYOD1,MYOG,NCOA3,NRIP1,OCSTAMP,PELP1,RAMP3,RARA,RBBP5,RUVBL2,SFR1,SFRP1,SOCS2,STAT3,STAT5B,STRN3,TGFB1,TRIM24,TRIM25,UGT3A2,WBP2,WNT8B,ZNF366,ZNF703	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
GO:0043628	GO	BP	ncRNA 3'-end processing	ELAC2,ERI1,PTCD1,TRNT1,USB1	Any process involved in forming the mature 3' end of a non-coding RNA molecule.
GO:0043631	GO	BP	RNA polyadenylation	AHCYL1,APP,CDC73,CPSF1,CPSF3,CPSF6,CSTF1,CSTF2,CSTF3,GRSF1,LEO1,MTPAP,NUDT21,PABPC1,PAF1,PAPD4,PAPOLA,PAPOLG,PNPT1,SSU72,SYMPK,TUT1,ZC3H3	The enzymatic addition of a sequence of adenylyl residues at the 3' end of an RNA molecule.
GO:0043647	GO	BP	inositol phosphate metabolic process	CALM1,FGF2,IMPA1,IMPA2,INPP1,INPP4A,INPP4B,INPP5A,INPP5B,INPP5D,INPP5J,INPP5K,INPPL1,IP6K1,IP6K2,IP6K3,IPMK,IPPK,ISYNA1,ITPK1,ITPKA,ITPKB,ITPKC,MINPP1,NUDT10,NUDT11,NUDT3,NUDT4,OCRL,PLCB1,PLCB2,PLCB3,PLCB4,PLCD1,PLCD3,PLCE1,PLCG1,PLCG2,PLCH1,PLCH2,PLCZ1,PLD4,PPIP5K1,PPIP5K2,PTEN,SCP2,SYNJ1	The chemical reactions and pathways involving inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.
GO:0043648	GO	BP	dicarboxylic acid metabolic process	AADAT,ACLY,ACMSD,ACOT4,ACOT8,ACSF3,ADHFE1,ALDH18A1,ALDH5A1,ASPA,ASS1,D2HGDH,DDO,DHFR,FPGS,GAD1,GCLC,GCLM,GGT1,GHR,GLS,GLUD1,GLUD2,GLUL,GOT1,GOT2,GPT2,HAAO,HOGA1,IDH1,IDH2,KYNU,L2HGDH,MDH2,ME1,ME3,MTHFD1,MTHFD1L,MTHFR,MTHFS,MTRR,NAGS,NIT2,QPRT,SDHA,SHMT1,SHMT2,SLC19A1,SLC25A32,SLC46A1,STAT5A,STAT5B,TAT	The chemical reactions and pathways involving dicarboxylic acids, any organic acid containing two carboxyl (COOH) groups or anions (COO-).
GO:0043649	GO	BP	dicarboxylic acid catabolic process	ACOT4,ACOT8,ACSF3,ASPA,DDO,GAD1,GLUD1,GLUD2,GLUL,GOT1,GOT2,MTHFS,QPRT	The chemical reactions and pathways resulting in the breakdown of dicarboxylic acids, any organic acid containing two carboxyl (-COOH) groups.
GO:0043650	GO	BP	dicarboxylic acid biosynthetic process	GLS,GLUD1,GLUD2,HAAO,KYNU,MTHFD1	The chemical reactions and pathways resulting in the formation of dicarboxylic acids, any organic acid containing two carboxyl (-COOH) groups.
GO:0043651	GO	BP	linoleic acid metabolic process	ABCD1,ACSL1,ALOX12,ALOX12B,ALOXE3,CYP2J2,ELOVL1,ELOVL2,ELOVL3,ELOVL5,FADS1,FADS2,PNPLA8	The chemical reactions and pathways involving linoleic acid, an unsaturated omega-6 fatty acid that has the molecular formula C18H32O2.
GO:0043653	GO	BP	mitochondrial fragmentation involved in apoptotic process	ATG3,BAX,BNIP3,CCAR2,DNM1L,ERBB4,FIS1,MFF	The change in the morphology of the mitochondria in an apoptotic cell from a highly branched network to a fragmented vesicular form.
GO:0043657	GO	CC	host cell	AQP1,AXL,BICD1,DERL1,DYNLT1,IFIT1,LMAN1,PI4K2A,SCO1,TAP1,TAP2	A cell within a host organism. Includes the host plasma membrane and any external encapsulating structures such as the host cell wall and cell envelope.
GO:0043666	GO	BP	regulation of phosphoprotein phosphatase activity	AGTR2,AKAP6,ANKLE2,ARPP19,CALM1,CD300A,CRY2,EIF2AK2,ENSA,FKBP1A,FKBP1B,HSP90B1,HTT,IGBP1,IKBKB,ITGA1,MAGI2,MASTL,NCKAP1L,NUAK1,PDGFRB,PPME1,PPP1R12A,PPP1R15A,PPP2R1A,PPP2R2A,PPP2R2B,PPP2R2C,PPP2R2D,PPP2R3A,PPP2R4,PPP2R5A,PPP2R5B,PPP2R5C,PPP2R5D,PPP2R5E,PPP4R4,PPP6R1,PPP6R3,ROCK1,ROCK2,SET,TIPRL,TNF,TSC1	Any process that modulates the frequency, rate or extent of phosphoprotein phosphatase activity, the catalysis of the hydrolysis of phosphate from a phosphoprotein.
GO:0043679	GO	CC	axon terminus	AAK1,CABP4,CAD,CRHBP,FLRT3,GHRH,GPER1,GRIK3,GRIN1,KCNA1,KCNA2,LRRK2,PACSIN1,PTPRN,RAB3A,RAB5A,TBC1D24,UNC13B	Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal button is a specialized region of it.
GO:0043691	GO	BP	reverse cholesterol transport	ABCA1,ABCA5,ABCG1,APOA1,APOA2,APOA4,APOC2,APOC3,APOE,APOM,CETP,CLU,LCAT,LIPC,LIPG	The directed movement of peripheral cell cholesterol, cholest-5-en-3-beta-ol, towards the liver for catabolism.
GO:0043901	GO	BP	negative regulation of multi-organism process	ACVR1C,APCS,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ARHGDIB,ASTL,BPIFA1,BST2,BTBD17,C1QBP,CACTIN,CAMP,CCL3,CCL4,CCL5,CCNK,CHMP3,DEFB114,DHX58,EIF2AK2,EIF2AK4,FAM111A,FBLN1,FCN1,FCN3,GSN,HDAC1,HMGA2,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNA2,IFNB1,IFNL3,IGF1,ILF3,INPP5K,IRG1,ISG15,ISG20,ITCH,ITGAV,JUN,LTF,MAVS,MBL2,MICB,MID2,MUL1,MX1,NFKBIL1,NODAL,NPPC,OAS1,OAS3,OASL,PARK2,PARP10,PCBP2,PLSCR1,PML,POU2F3,PPM1B,PROX1,PTX3,REST,RNASEL,RSAD2,SEC14L1,SIGIRR,SIRT2,SLPI,SNX3,SP100,SPINK13,SRPK1,SRPK2,STAT1,TARBP2,TARDBP,TFAP4,TIMP1,TIRAP,TKFC,TNF,TNFAIP3,TNIP1,TRAF3IP1,TRIB1,TRIM11,TRIM13,TRIM14,TRIM15,TRIM21,TRIM26,TRIM27,TRIM28,TRIM31,TRIM32,TRIM35,TRIM5,TRIM6,TRIM62,TRIM8,TSPAN6,VAPA,VAPB,WEE2,ZC3H12A,ZC3HAV1,ZNF639,ZP2,ZP3,ZP4	Any process that stops, prevents, or reduces the frequency, rate or extent of a multi-organism process, a process in which an organism has an effect on another organism of the same or different species.
GO:0043902	GO	BP	positive regulation of multi-organism process	ACVR1B,ADAR,ADARB1,ANKRD17,APOE,BMP6,C1QBP,C9orf69,CACNA1H,CAV2,CCL5,CCNH,CCNT1,CD180,CD28,CDK7,CDK9,CFL1,CHD1,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CIB1,CTDP1,CYBA,DDB1,DDX3X,DDX60,DEFB103A,DHX58,ELL,EP300,ERCC2,ERCC3,F2RL1,FAM170B,FCER2,GLRA1,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HACD3,HPN,IFIT1,IFNG,INHBA,INHBB,IQCF1,IRG1,JUN,KLK5,KLK7,LEF1,LGALS1,LGALS9,LRSAM1,LY86,MDFIC,MNAT1,MVB12A,MVB12B,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,NOS2,NR5A2,OSBP,P4HB,PC,PGC,PKN2,PLCB1,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,PPIA,PPIB,PPID,PPIE,PPIH,PRKCA,PUM1,PUM2,RAB7A,RAD23A,RSF1,SASH1,SIRT2,SMARCA4,SMARCB1,SMURF2,SNW1,SP1,SRPK1,SRPK2,SSRP1,STAU1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TARBP2,TBC1D20,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TMPRSS2,TOP2A,TRIM11,TRIM15,TRIM38,TSG101,USP17L2,VAPA,VAPB,VPS37B,VPS4A,VPS4B,YTHDC2,ZC3HAV1,ZNF502,ZNF639,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of a multi-organism process, a process in which an organism has an effect on another organism of the same or different species.
GO:0043903	GO	BP	regulation of symbiosis, encompassing mutualism through parasitism	ADAR,ADARB1,APCS,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,APOE,BPIFA1,BST2,BTBD17,C9orf69,CAMP,CAV1,CAV2,CCL3,CCL4,CCL5,CCNH,CCNK,CCNT1,CD28,CDK7,CDK9,CFL1,CHD1,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CTDP1,CXCL8,DDB1,DDX3X,DERL1,DYNLT1,EIF2AK2,EIF2AK4,ELL,EP300,ERCC2,ERCC3,EXOC2,EXOC7,F2RL1,FAM111A,FBLN1,FCN1,FCN3,FUCA2,GSN,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HACD3,HDAC1,HMGA2,HPN,HS3ST5,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNA2,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,ITGAV,JUN,LEF1,LGALS1,LGALS9,LTF,MAVS,MBL2,MDFIC,MID2,MNAT1,MVB12A,MVB12B,MX1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,NR5A2,OAS1,OAS3,OASL,OSBP,P4HB,PARK2,PARP10,PC,PKN2,PLSCR1,PM20D1,PML,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU2F3,PPIA,PPIB,PPID,PPIE,PPIH,PROX1,PTX3,PVRL2,RAB7A,RAD23A,REST,RNASEL,RSAD2,RSF1,SLPI,SMARCA4,SMARCB1,SNF8,SNW1,SNX3,SP1,SP100,SRPK1,SRPK2,SSRP1,STAT1,STAU1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TAP1,TAP2,TARBP2,TARDBP,TBC1D20,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TIRAP,TMPRSS2,TNF,TNIP1,TOP2A,TRIM11,TRIM13,TRIM14,TRIM15,TRIM21,TRIM25,TRIM26,TRIM27,TRIM28,TRIM31,TRIM32,TRIM35,TRIM38,TRIM5,TRIM6,TRIM62,TRIM8,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,YTHDC2,ZC3H12A,ZC3HAV1,ZNF502,ZNF639	Any process that modulates the frequency, rate or extent of symbiosis, an interaction between two organisms living together in more or less intimate association.
GO:0043921	GO	BP	modulation by host of viral transcription	CCL3,CCL4,CCL5,CHD1,EP300,HDAC1,HMGA2,HPN,INPP5K,JUN,LEF1,POU2F3,REST,SMARCA4,SMARCB1,SNW1,SP1,TAF11,TARDBP,TFAP4,ZNF639	Any process in which a host organism modulates the frequency, rate or extent of viral transcription.
GO:0043922	GO	BP	negative regulation by host of viral transcription	CCL3,CCL4,CCL5,HDAC1,HMGA2,INPP5K,JUN,POU2F3,REST,TARDBP,TFAP4,ZNF639	Any process in which a host organism stops, prevents, or reduces the frequency, rate or extent of viral transcription.
GO:0043923	GO	BP	positive regulation by host of viral transcription	CHD1,EP300,HPN,JUN,LEF1,SMARCA4,SMARCB1,SNW1,SP1,TAF11,TFAP4,ZNF639	Any process in which a host organism activates or increases the frequency, rate or extent of viral transcription, the synthesis of either RNA on a template of DNA or DNA on a template of RNA.
GO:0043928	GO	BP	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	CNOT6,CNOT7,CNOT8,DCP1A,DCP1B,DCP2,DCPS,DDX6,DIS3,EDC3,EDC4,EXOSC1,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,LSM1,LSM2,LSM3,LSM4,LSM5,LSM6,LSM7,NT5C3B,PATL1,XRN1	The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA that occurs when the ends are not protected by the 3'-poly(A) tail.
GO:0043931	GO	BP	ossification involved in bone maturation	BMP2,IGF1,PLXNB1,RHOA,RYR1,SEMA4D	The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in the progression of the skeleton from its formation to its mature state.
GO:0043949	GO	BP	regulation of cAMP-mediated signaling	ADRB1,CDC34,CXCL10,CXCL11,CXCL9,CXCR3,GNAI1,GNAS,LHCGR,MGRN1,OPRM1,PDE3B,PEX5L,PF4,PTGIR,RAPGEF2,RASD2,UBE2B	Any process which modulates the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
GO:0043950	GO	BP	positive regulation of cAMP-mediated signaling	ADRB1,CXCL10,CXCL11,CXCL9,CXCR3,GNAS,LHCGR,OPRM1,PF4,PTGIR,RAPGEF2	Any process which activates, maintains or increases the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
GO:0043951	GO	BP	negative regulation of cAMP-mediated signaling	CDC34,MGRN1,OPRM1,PDE3B,UBE2B	Any process which stops, prevents, or reduces the frequency, rate or extent of cAMP-mediated signaling, a series of molecular signals in which a cell uses cyclic AMP to convert an extracellular signal into a response.
GO:0043954	GO	BP	cellular component maintenance	CAMSAP3,CSF1R,KIFC3,MTHFR,MTMR2,NLGN2,PARD6A,PICK1,PKP2,PLEKHA7,SUPV3L1	The organization process that preserves a cellular component in a stable functional or structural state.
GO:0043966	GO	BP	histone H3 acetylation	BRCA2,BRD1,BRPF1,BRPF3,CSRP2BP,DR1,ELP3,ELP4,ING4,ING5,JADE1,JADE2,JADE3,KAT2A,KAT2B,KAT6A,KAT6B,KAT7,LDB1,LEF1,MAP3K7,MBIP,MEAF6,MYOD1,PER1,POLE3,POLE4,SAP130,SGF29,SPI1,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF10,TAF12,TAF5L,TAF6L,TAF9,TRIM16,WDR5,YEATS2	The modification of histone H3 by the addition of an acetyl group.
GO:0043967	GO	BP	histone H4 acetylation	ACTL6A,APBB1,BEND3,BRCA2,BRD8,CHD5,DMAP1,ELP3,ELP4,EP300,EP400,EPC1,HAT1,HCFC1,ING3,ING4,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT7,KAT8,KMT2A,LEF1,MCRS1,MEAF6,MORF4L1,MSL1,MSL2,MSL3,MYOD1,NAA50,NAA60,OGT,PER1,PHF20,RUVBL1,RUVBL2,TRIM16,TRRAP,USP22,WDR5,YEATS4	The modification of histone H4 by the addition of an acetyl group.
GO:0043968	GO	BP	histone H2A acetylation	ACTL6A,BRD8,DMAP1,EP400,EPC1,ING3,MEAF6,MORF4L1,RUVBL1,RUVBL2,TRRAP,YEATS4	The modification of histone H2A by the addition of an acetyl group.
GO:0043981	GO	BP	histone H4-K5 acetylation	HCFC1,ING4,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT7,KAT8,MCRS1,MEAF6,OGT,PHF20,WDR5	The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 5 of the histone.
GO:0043982	GO	BP	histone H4-K8 acetylation	HCFC1,ING4,JADE1,JADE2,JADE3,KANSL1,KANSL2,KANSL3,KAT7,KAT8,MCRS1,MEAF6,OGT,PHF20,WDR5	The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 8 of the histone.
GO:0043983	GO	BP	histone H4-K12 acetylation	ING4,JADE1,JADE2,JADE3,KAT7,MEAF6	The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 12 of the histone.
GO:0043984	GO	BP	histone H4-K16 acetylation	HCFC1,KANSL1,KANSL2,KANSL3,KAT8,KMT2A,MCRS1,MSL1,MSL2,MSL3,OGT,PHF20,WDR5	The modification of histone H4 by the addition of an acetyl group to a lysine residue at position 16 of the histone.
GO:0043985	GO	BP	histone H4-R3 methylation	COPRS,PRDM4,PRMT1,PRMT5,PRMT6	The modification of histone H4 by addition of a methyl group to arginine at position 3 of the histone.
GO:0043995	GO	MF	histone acetyltransferase activity (H4-K5 specific)	HCFC1,KANSL1,KANSL2,KANSL3,KAT8,MCRS1,OGT,PHF20,WDR5	Catalysis of the reaction: acetyl-CoA + histone H4 L-lysine (position 5) = CoA + histone H4 N6-acetyl-L-lysine (position 5).
GO:0043996	GO	MF	histone acetyltransferase activity (H4-K8 specific)	HCFC1,KANSL1,KANSL2,KANSL3,KAT8,MCRS1,OGT,PHF20,WDR5	Catalysis of the reaction: acetyl-CoA + histone H4 L-lysine (position 8) = CoA + histone H4 N6-acetyl-L-lysine (position 8).
GO:0044003	GO	BP	modification by symbiont of host morphology or physiology	AAAS,ALB,APCS,ATG7,BCL2L1,C9,CCNK,CD209,CD4,CLEC4M,CPSF4,DAG1,EIF2AK2,EIF2AK4,HIPK2,HYAL2,INSR,ITGAV,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,POM121,POM121C,PTX3,RAE1,RANBP2,RRAGA,RXRA,SEH1L,SERPINB9,SLC25A6,SMAD3,SUGT1,TGFB1,TNIP1,TPR,VAPA,VAPB,ZC3H12A	The process in which a symbiont organism effects a change in the structure or processes of its host organism.
GO:0044030	GO	BP	regulation of DNA methylation	DPPA3,GRHL2,H1FOO,KDM1B,MPHOSPH8,SPI1	Any process that modulates the frequency, rate or extent of the covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
GO:0044033	GO	BP	multi-organism metabolic process	AAAS,EIF2AK4,FAU,FURIN,NDC1,NMT2,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,POM121,POM121C,RAE1,RANBP2,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEH1L,SMARCB1,SUPT5H,TPR,TSG101,UBA52,UBB,UBC,USF1,USF2,VPS28,VPS37A,VPS37B,VPS37C,VPS37D	A metabolic process - chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances - which involves more than one organism.
GO:0044058	GO	BP	regulation of digestive system process	ABCG5,ABCG8,AQP1,FGF10,HAMP,KCNQ1,NEUROD1,NR1H3,OPRK1,SGK1,SLC22A5	Any process that modulates the frequency, rate or extent of a digestive system process, a physical, chemical, or biochemical process carried out by living organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
GO:0044060	GO	BP	regulation of endocrine process	C1QTNF1,C1QTNF3,CRH,CRHBP,CRHR1,F2R,F2RL1,GAL,GALR1,GDF9,GHRL,HCAR2,IL1B,INHA,INHBA,NKX3-1,NPVF,OR51E2,RAB11FIP1,RAB11FIP3,RAB11FIP5	Any process that modulates the frequency, rate or extent of an endocrine process, a process involving the secretion of or response to endocrine hormones. An endocrine hormone is a hormone released into the circulatory system.
GO:0044062	GO	BP	regulation of excretion	AGT,AGTR1,CORIN,KNG1,NPPB,NPR1,SPX,STC1	Any process that modulates the frequency, rate, or extent of excretion, the elimination by an organism of the waste products that arise as a result of metabolic activity.
GO:0044065	GO	BP	regulation of respiratory system process	MTG1,MTG2,NLGN2,NLGN3,PHOX2B,TSHZ3	Any process that modulates the frequency, rate or extent of a respiratory system process, an organ system process carried out by any of the organs or tissues of the respiratory system.
GO:0044068	GO	BP	modulation by symbiont of host cellular process	AAAS,ATG7,BCL2L1,CCNK,CD4,CPSF4,EIF2AK2,EIF2AK4,ITGAV,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,POM121,POM121C,RAE1,RANBP2,SEH1L,SERPINB9,SLC25A6,TGFB1,TNIP1,TPR,VAPA,VAPB,ZC3H12A	Any process in which a symbiont organism modulates the frequency, rate or extent of a cellular process, any process that is carried out at the cellular level, but not necessarily restricted to a single cell, in its host organism.
GO:0044070	GO	BP	regulation of anion transport	ABCA7,ABCB4,ACSL4,AKT1,AKT2,ANO1,ANO6,ANO9,APOE,ATP1A2,CA2,CFTR,CHRNA3,CHRNA4,CHRNB2,CLCN1,CLCN2,CLCN3,CLCN4,CLCN6,CLCNKA,CLCNKB,CRY2,CYP4A11,CYP4F2,DRD1,DRD2,DRD3,DRD4,DTNBP1,FGF23,GDNF,GPM6B,GPR89A,GRM7,HTR1A,HTR1B,IL1B,IRS2,KCNA2,LILRB1,NCOR1,NOS1,P2RX4,PARK2,PDZK1,PER2,PLA2G10,PLA2R1,PRELID1,PRKCD,RAB11B,RAB3B,RAB3GAP1,RIPK1,SFRP4,SLC17A3,SNCA,SNX4,STC1,SYK,TCAF1,TCAF2,THBS1,TNFRSF11A,TNFSF11,TOR1A,TRIAP1,TTYH1,VAMP7,VAMP8,VDAC1,VDAC2,VDAC3	Any process that modulates the frequency, rate or extent of the directed movement of anions, atoms or small molecules with a net negative charge into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0044088	GO	BP	regulation of vacuole organization	ADRB2,AMBRA1,CALCOCO2,CHMP4A,CHMP4B,FEZ1,FEZ2,IFT20,IFT88,KIAA1324,LRRK2,LRSAM1,MTM1,MTMR3,PHF23,PIKFYVE,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,RAB1B,RAB33B,RAB3GAP1,RAB3GAP2,RAB7A,RALB,RUBCN,SCFD1,SH3GLB1,TBC1D14,TBC1D25,UBQLN1,UBQLN2,UBQLN4	Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a vacuole.
GO:0044090	GO	BP	positive regulation of vacuole organization	ADRB2,CALCOCO2,KIAA1324,LRSAM1,PIP4K2A,PIP4K2B,PIP4K2C,RAB3GAP1,RAB3GAP2,RALB,SH3GLB1	Any process that activates or increases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a vacuole.
GO:0044091	GO	BP	membrane biogenesis	ANK3,ANXA2,CAV1,CAV2,CAV3,CLIP3,EMP2,FLOT1,FLOT2,IL1RAPL1,LRP4,NLGN1,NLGN2,NLGN3,NLGN4X,NRXN1,NRXN2,PACSIN2,PEX16,PEX19,PTEN,PTPRD,RFTN1,S100A10,SPTBN1,STX2	A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a membrane.
GO:0044183	GO	MF	protein binding involved in protein folding	CALR,CD74,DNAJB8,HSPA1A,HSPA1B	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules) that contributes to the process of protein folding.
GO:0044216	GO	CC	other organism cell	AQP1,AXL,BICD1,C4B,C4BPA,C4BPB,DERL1,DYNLT1,IFIT1,LMAN1,PI4K2A,SCO1,TAP1,TAP2	A cell of a secondary organism with which the first organism is interacting.
GO:0044224	GO	CC	juxtaparanode region of axon	CNTN2,CNTNAP2,DLG2,DLG4,EPB41L3,KCNA1,KCNA2,KCNAB2,SIRT2	A region of an axon near a node of Ranvier that is between the paranode and internode regions.
GO:0044232	GO	CC	organelle membrane contact site	ACSL4,CANX,ESYT2,ESYT3,STX17,TOMM20,ZFYVE1	A zone of apposition between the membranes of two organelles, structured by bridging complexes. Membrane contact sites (MCSs) are specialized for communication, including the efficient traffic of small molecules such as Ca2+ ions and lipids, as well as enzyme-substrate interactions.
GO:0044233	GO	CC	ER-mitochondrion membrane contact site	ACSL4,CANX,STX17,TOMM20,ZFYVE1	A zone of apposition between endoplasmic-reticulum and mitochondrial membranes, structured by bridging complexes. These contact sites are thought to facilitate inter-organelle calcium and phospholipid exchange.
GO:0044236	GO	BP	multicellular organismal metabolic process	ACE,ACE2,ADAM10,ADAM17,ADAM9,ADAMTS3,APOA4,BMP8A,CEL,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL23A1,COL25A1,COL26A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL6A5,COL6A6,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,CTSB,CTSD,CTSK,CTSL,CTSS,ELANE,ENPEP,FURIN,GHR,HIF1A,KLK6,MMP1,MMP10,MMP11,MMP12,MMP13,MMP14,MMP15,MMP19,MMP2,MMP20,MMP3,MMP7,MMP8,MMP9,MRC2,OMA1,P3H1,P3H2,PHYKPL,PLA2G1B,PRSS2,TNXB,TRAM2	The chemical reactions and pathways in a single multicellular organism that occur at the tissue, organ, or organismal level. These processes, unlike cellular metabolism, can include transport of substances between cells when that transport is required.
GO:0044241	GO	BP	lipid digestion	ABCG5,ABCG8,AKR1C1,APOA4,CD36,CEL,CLPS,LDLR,LIPC,LIPG,LIPH,LIPI,LIPK,LIPM,LIPN,LMF1,NPC1L1,PLA2G1B,PNLIP,PNLIPRP2,SOAT2	The whole of the physical, chemical, and biochemical processes carried out by living organisms to break down ingested lipids into components that may be easily absorbed and directed into metabolism.
GO:0044242	GO	BP	cellular lipid catabolic process	ABCD1,ABCD2,ABCD3,ABHD12,ABHD5,ABHD6,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACER1,ACOT8,ACOX1,ACOX2,ACOX3,ADIPOQ,AKR1B10,AKR1C3,AMACR,ANGPTL3,APOA2,APOA5,APOC3,BCO2,BDH2,CEL,CPS1,CRAT,CROT,CYP1B1,CYP26A1,CYP26B1,CYP26C1,CYP4A11,CYP4F12,CYP4F2,DAGLA,DECR1,ECHS1,ECI1,ECI2,EHHADH,ENPP2,ETFA,ETFB,ETFDH,FAAH,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,GALC,GBA,GBA3,GCDH,GLA,HACL1,HADH,HADHA,HADHB,HAO1,HSD17B4,LIPC,LIPE,LIPG,LPIN1,LPL,MCEE,MGLL,MMAA,MT3,MUT,NAGA,NEU2,NEU3,NEU4,PCCA,PCCB,PEX13,PEX2,PHYH,PLA2G15,PLA2G4B,PLA2G4C,PLIN1,PNLIPRP2,PNPLA3,PNPLA8,PPARD,PPP1CA,PPP1CB,PPP1CC,PPT1,PRDX6,PRKACA,PRKACB,PRKACG,RAB7A,SCP2,SGPL1,SIRT2,SLC25A17,SLC27A2,SMPD3,SMPD4,SPHK1,SRD5A3	The chemical reactions and pathways resulting in the breakdown of lipids, as carried out by individual cells.
GO:0044243	GO	BP	multicellular organismal catabolic process	ACE,ACE2,ADAM10,ADAM17,ADAM9,ADAMTS3,APOA4,CEL,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL23A1,COL25A1,COL26A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL6A5,COL6A6,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,CTSB,CTSD,CTSK,CTSL,CTSS,ELANE,ENPEP,FURIN,KLK6,MMP1,MMP10,MMP11,MMP12,MMP13,MMP14,MMP15,MMP19,MMP2,MMP20,MMP3,MMP7,MMP8,MMP9,MRC2,PHYKPL,PLA2G1B,PRSS2	The chemical reactions and pathways resulting in the breakdown of substances in multicellular organisms that occur at the tissue, organ, or organismal level. These processes, unlike cellular metabolism, can include transport of substances between cells when that transport is required.
GO:0044245	GO	BP	polysaccharide digestion	AMY2A,LCT,MGAM,SI,TREH	The whole of the physical, chemical, and biochemical processes carried out by living organisms to break down ingested polysaccharides into components that may be easily absorbed and directed into metabolism.
GO:0044247	GO	BP	cellular polysaccharide catabolic process	AGL,CALM1,CPS1,GAA,GYG1,GYG2,MGAM,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PYGB,PYGL,PYGM,STBD1	The chemical reactions and pathways resulting in the breakdown of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, as carried out by individual cells.
GO:0044259	GO	BP	multicellular organismal macromolecule metabolic process	ACE,ACE2,ADAM10,ADAM17,ADAM9,ADAMTS3,COL10A1,COL11A1,COL11A2,COL12A1,COL13A1,COL14A1,COL15A1,COL16A1,COL17A1,COL18A1,COL19A1,COL1A1,COL1A2,COL23A1,COL25A1,COL26A1,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A5,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A2,COL6A3,COL6A5,COL6A6,COL7A1,COL8A1,COL8A2,COL9A1,COL9A2,COL9A3,CTSB,CTSD,CTSK,CTSL,CTSS,ELANE,ENPEP,FURIN,HIF1A,KLK6,MMP1,MMP10,MMP11,MMP12,MMP13,MMP14,MMP15,MMP19,MMP2,MMP20,MMP3,MMP7,MMP8,MMP9,MRC2,P3H1,P3H2,PHYKPL,PRSS2,TNXB,TRAM2	The chemical reactions and pathways involving macromolecules, large molecules including proteins, nucleic acids and carbohydrates, in multicellular organisms occurring at the tissue, organ, or organismal level.
GO:0044262	GO	BP	cellular carbohydrate metabolic process	ABHD10,AGL,ALG1,ANGPTL3,B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GALT1,B4GAT1,CALM1,COQ2,COQ3,CPS1,CSGALNACT1,CSGALNACT2,ENOSF1,EPM2A,EXT1,EXT2,G6PC,GAA,GAL3ST3,GBE1,GK,GLB1,GNPTAB,GNPTG,GOT1,GSK3B,GYG1,GYG2,GYS1,GYS2,HAS1,HAS2,HAS3,IDUA,IMPA1,IMPA2,INPP5K,IPPK,KHK,LALBA,MGAM,MIOX,NAGK,NANS,NHLRC1,NR1D1,PCK1,PER2,PFKFB2,PFKFB3,PFKFB4,PGM1,PGM2,PGP,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,POMK,PPIP5K1,PPIP5K2,PPP1R3C,PRKAG2,PTEN,PYGB,PYGL,PYGM,RPS27A,SLC2A1,SORD,STBD1,SYNJ1,TKFC,TREH,UBA52,UBB,UBC,UGP2,XYLB	The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
GO:0044264	GO	BP	cellular polysaccharide metabolic process	AGL,ALG1,B3GNT2,B3GNT3,B3GNT4,B3GNT8,B4GAT1,CALM1,CPS1,CSGALNACT1,CSGALNACT2,EPM2A,EXT1,EXT2,G6PC,GAA,GAL3ST3,GBE1,GSK3B,GYG1,GYG2,GYS1,GYS2,HAS1,HAS2,HAS3,MGAM,NANS,NHLRC1,NR1D1,PER2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PPP1R3C,PRKAG2,PYGB,PYGL,PYGM,RPS27A,STBD1,UBA52,UBB,UBC,UGP2	The chemical reactions and pathways involving polysaccharides, polymers of more than 10 monosaccharide residues joined by glycosidic linkages, as carried out by individual cells.
GO:0044272	GO	BP	sulfur compound biosynthetic process	ACACA,ACAN,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSS1,ADI1,AGK,AKR1A1,ANGPT1,APIP,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GAT1,BCAN,BGN,BHMT,BHMT2,CBS,CDO1,CHAC1,CHAC2,CHPF,CHPF2,CHST1,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST5,CHST6,CHST7,CHST9,CHSY1,CHSY3,CNDP2,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,CTH,DCN,DLD,DSE,DSEL,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,ENOPH1,ESD,EXT1,EXT2,FASN,FMOD,GCLC,GCLM,GGCT,GGT1,GGT2,GLCE,GOT1,GSS,GSTA1,GSTA2,GSTA3,GSTA4,GSTK1,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTO1,GSTO2,GSTP1,GSTT2B,GSTZ1,HACD1,HACD2,HAGH,HPGDS,HS3ST3B1,HS3ST5,HSD17B12,KERA,LIAS,LUM,MAT2A,MAT2B,MGST1,MGST2,MGST3,MLYCD,MPST,MRI1,MTAP,MTHFD1,MTR,MTRR,NCAN,OGN,OLAH,OMD,OPLAH,PAPSS1,PAPSS2,PDHA1,PDHB,PDHX,PPT1,PPT2,PRELP,PXYLP1,SCD,SLC25A1,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SLC35D2,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6,TECR,THEM4,THEM5,UST,VCAN,XYLT2	The chemical reactions and pathways resulting in the formation of compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.
GO:0044273	GO	BP	sulfur compound catabolic process	ACAN,ACOT7,AGXT,ARSB,BCAN,BGN,CBS,CDO1,CSAD,CSPG4,CSPG5,CTH,DCN,ETHE1,FMOD,GALNS,GGT1,GLB1,GNS,GPC1,HEXA,HEXB,HPSE,HYAL1,IDS,IDUA,KERA,LUM,MLYCD,MTRR,NCAN,NUDT7,OGN,OMD,PRELP,SLC25A10,SQRDL,SUOX,TST,VCAN	The chemical reactions and pathways resulting in the breakdown of compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.
GO:0044275	GO	BP	cellular carbohydrate catabolic process	ABHD10,AGL,CALM1,CPS1,ENOSF1,GAA,GYG1,GYG2,MGAM,MIOX,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PYGB,PYGL,PYGM,SORD,STBD1,TREH	The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
GO:0044291	GO	CC	cell-cell contact zone	AHNAK,AKAP6,ANK2,ANK3,ATP1B1,ATP2A2,BAIAP2L2,CDH2,CTNNA3,CXADR,DES,DLG1,DSC2,DSG2,DSP,FGF13,FGFRL1,FLCN,FLOT1,FLOT2,GJA1,GJA5,GJC1,JAM3,JUP,KCNA5,NRAP,OBSL1,PAK1,PGM5,PKP2,PKP4,RANGRF,RAP2B,RAP2C,SCN1B,SCN4B,SCN5A,SLC8A1,TIAM1,TMEM65,VAMP5,YWHAH	Extended zone of intimate apposition between two cells containing one or more types of intercellular junctions, e.g., the intercalated disk of muscle.
GO:0044295	GO	CC	axonal growth cone	CLASP2,COBL,FKBP4,FLRT3,GPM6A,L1CAM,NRXN1,OLFM1,RTN4R,SHTN1	The migrating motile tip of a growing nerve cell axon.
GO:0044297	GO	CC	cell body	ACTA1,ACTA2,ACTC1,ACTG2,AMIGO1,ANG,APOB,APOD,APOE,ARHGEF7,ATP7A,ATXN10,AZIN2,CAD,CALB1,CCR2,CDC42,CDK5,CDK5R1,CHRNA3,CHRNA4,CIB1,COBL,CREB3,CRHBP,CRIPT,CTNND2,CXADR,DAB2IP,DPYSL3,EFHC1,ELOVL5,EPHA5,FBXO31,FLRT1,FRMD7,GAL,GLRA1,GNB2L1,GPM6A,GRIA1,GRIK3,GRIN3A,GRIN3B,HCFC1,HDAC6,HPN,ITPR3,KCNA1,KCNA2,KCNB1,KCNB2,KCNC1,KCNC2,KCND2,KCNE3,LRP4,LRRK2,MAP1S,MAPT,MUL1,MYO1D,NCDN,NEURL1,NRSN1,NRXN1,NSMF,OLFM1,P2RY1,PI4K2A,PICALM,PINK1,PTK2B,PTPRN,RAB17,RAB5A,RAC3,RAPGEF2,RGS8,RPL28,RPS6,RTN4R,RUFY3,SHANK2,SHTN1,SIRT2,SKOR1,SLC38A7,SLC6A3,SNCAIP,SOD1,SPTBN4,SRR,STAU1,STMN2,STRN,STRN3,SYNDIG1,TGFB2,TH,TMEM100,TUBB,UBB,UNC5A,VTI1A,VTI1B,ZNF385A,ZPR1	The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
GO:0044304	GO	CC	main axon	ANK3,BIN1,CNTN2,CNTNAP1,CNTNAP2,CRHBP,DLG2,DLG4,EPB41L3,ERMN,KCNA1,KCNA2,KCNAB2,KCNQ2,KCNQ3,MYOC,NCMAP,NFASC,NRCAM,PARD3,ROBO2,SCN1B,SCN2A,SCN8A,SIRT2,SPOCK1,SPTBN1,SPTBN4	The main axonal trunk, as opposed to the collaterals; i.e., excluding collaterals, terminal, spines, or dendrites.
GO:0044306	GO	CC	neuron projection terminus	AAK1,CABP4,CAD,CRHBP,DLG4,DMD,FLRT1,FLRT3,GHRH,GPER1,GRIK3,GRIN1,KCNA1,KCNA2,LRRK2,MME,PACSIN1,PTPRN,RAB3A,RAB5A,SLC32A1,TBC1D24,TMEM57,UNC13B,VAMP2,VTI1A	The specialized, terminal region of a neuron projection such as an axon or a dendrite.
GO:0044309	GO	CC	neuron spine	ACTN2,APP,ARF4,ARFGEF2,CDK5R1,CNIH2,CRIPT,DGKI,DLG4,DNM3,DTNBP1,FRMPD4,GIPC1,GPER1,GRIA1,GRID2,GRIN1,KCND2,MTMR2,NEURL1,NLGN1,NR1D1,PRKAR2B,PTPRO,RGS14,SHANK1,SHANK2,SHANK3,SIPA1L1,SRGAP2,STRN,STX4,SYNDIG1,SYNPO,TENM2	A small membranous protrusion, often ending in a bulbous head and attached to the neuron by a narrow stalk or neck.
GO:0044314	GO	BP	protein K27-linked ubiquitination	PARK2,RNF6,UBE2D4,UBE2S,UBE2T	A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 27 of the ubiquitin monomers, is added to a protein.
GO:0044319	GO	BP	wound healing, spreading of cells	ACVRL1,COL5A1,CYR61,DDR1,MMP12,PDCD10,PLET1,RHOA,RHOC,TOR1A,WNT7A	The migration of a cell along or through a wound gap that contributes to the reestablishment of a continuous surface.
GO:0044320	GO	BP	cellular response to leptin stimulus	BBS2,BBS4,GCK,LEP,LEPR,MKKS,MT3,NR4A3,SIRT1,STAT3	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.
GO:0044321	GO	BP	response to leptin	BBS2,BBS4,CCND1,GCK,LEP,LEPR,MKKS,MT3,NR1D1,NR4A3,SIRT1,STAT3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism].
GO:0044322	GO	CC	endoplasmic reticulum quality control compartment	EDEM1,EDEM2,EDEM3,ERLEC1,MAN1B1,RHBDD1,SYVN1	A subcompartment of the endoplasmic reticulum in which proteins with improper or incorrect folding accumulate. Enzymes in this compartment direct proteins with major folding problems to translocation to the cytosol and degradation, and proteins with minor folding problems to the ER, to interact with chaperon proteins.
GO:0044325	GO	MF	ion channel binding	ANK2,ANK3,ASPH,CAMK2D,FGF12,FGF13,FKBP1A,FKBP1B,FXYD1,HAP1,HTT,KCNE2,NOS1,PDE4B,PDE4D,PKP2,RIMS2,RIMS3,RIMS4,RYR2,SLC8A1,SRI,TRDN,USP10	Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.
GO:0044342	GO	BP	type B pancreatic cell proliferation	BAD,BTBD10,C19orf80,NKX6-1,NOV	The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin.
GO:0044351	GO	BP	macropinocytosis	DOCK2,MAPKAPK2,MAPKAPK3,PYCARD,SNX33	An endocytosis process that results in the uptake of liquid material by cells from their external environment by the 'ruffling' of the cell membrane to form heterogeneously sized intracellular vesicles called macropinosomes, which can be up to 5 micrometers in size.
GO:0044380	GO	BP	protein localization to cytoskeleton	BBS4,C2CD3,CCDC14,CEP131,CEP83,CHAMP1,CRIPT,CSNK1D,DCTN2,DIAPH1,FAM83D,FAM83H,HOOK3,KIAA0753,KIF20B,KLHL21,MAPRE1,MID1,MID2,PCM1,PIBF1,SNX10,SPAG5,STIL	A process in which a protein is transported to, or maintained in, a location within the cytoskeleton.
GO:0044387	GO	BP	negative regulation of protein kinase activity by regulation of protein phosphorylation	ADAR,ADARB1,CDK5RAP3,CORO1C,DUSP26,NPM1,PPM1F	The stopping, prevention, or reduction in frequency, rate or extent of protein kinase activity as a result of regulating the phosphorylation status of that protein kinase.
GO:0044389	GO	MF	ubiquitin-like protein ligase binding	ACVR1B,ATXN3,BAG5,CDK5RAP3,CLU,CUL2,CUL5,FAF1,FAF2,GLMN,MAGEA2,MAGEC2,PRKACA,PRKACB,PRKAR1A,PRKAR2A,PRKAR2B,RBX1,TCEB2,TRIB1,TRIB2,TRIB3,TRIM28,UBXN1,UBXN7,WFS1	Interacting selectively and non-covalently with a ubiquitin-like protein ligase, such as ubiquitin-ligase.
GO:0044391	GO	CC	ribosomal subunit	DDX3X,EIF2D,FAU,FXR2,GNB2L1,HBA1,ICT1,MCTS1,MPV17L2,MRPL10,MRPL12,MRPL13,MRPL23,MRPL27,MRPL3,MRPL36,MRPL41,MRPL42,MRPL51,MRPL52,MRPL55,MRPS11,MRPS12,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS2,MRPS21,MRPS22,MRPS24,MRPS26,MRPS28,MRPS33,MRPS35,MRPS36,MRPS6,MRPS7,MRPS9,MTERF4,NSUN4,RBM3,RPL10,RPL10A,RPL10L,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL39L,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,UBA52	Either of the two subunits of a ribosome: the ribosomal large subunit or the ribosomal small subunit.
GO:0044406	GO	BP	adhesion of symbiont to host	ACE2,CD209,CD81,CLEC4M,GAS6,HSP90AB1,ICAM1,LRRC15,PVRL2,SCARB1	The attachment of a symbiont to its host via adhesion molecules, general stickiness etc., either directly or indirectly. The host is defined as the larger of the organisms involved in a symbiotic interaction.
GO:0044420	GO	CC	extracellular matrix component	ACHE,ADAMTS10,ADAMTSL5,AGRN,AMTN,ANG,APLP1,CASK,CD151,COL11A1,COL11A2,COL12A1,COL14A1,COL15A1,COL1A1,COL1A2,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A3,COL7A1,COL8A1,COL8A2,COLQ,DAG1,DST,EFEMP2,ELN,ERBB2IP,FBLN1,FBLN5,FBN1,FBN2,FRAS1,FREM3,LAMA1,LAMA2,LAMA3,LAMA4,LAMA5,LAMB1,LAMB2,LAMC1,LOXL2,LTBP1,LUM,MFAP1,MFAP2,MFAP4,MUC5AC,NID1,NID2,ODAM,P3H2,SNCA,THBS4,TINAG,TNXB,USH2A	Any constituent part of the extracellular matrix, the structure lying external to one or more cells, which provides structural support for cells or tissues; may be completely external to the cell (as in animals) or be part of the cell (as often seen in plants).
GO:0044439	GO	CC	peroxisomal part	ABCD1,ABCD2,ABCD3,ACAA1,ACOT4,ACOT6,ACOT8,ACOX1,ACOX2,ACOX3,AGPS,AGXT,AMACR,ATAD1,BAAT,CAT,CNOT1,CRAT,CROT,CRYM,DAO,DECR2,DHRS4,ECI2,FABP1,FAR1,FAR2,FIS1,GNPAT,GRHPR,HACL1,HAO1,HAO2,HMGCR,HSD17B4,IDH1,IMPDH2,MAP2K2,MAVS,MGST1,MLYCD,PAOX,PECR,PEX1,PEX10,PEX11A,PEX11B,PEX11G,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX3,PEX5,PEX7,PHYH,PIPOX,PNPLA8,POMC,PRDX5,PXMP2,PXMP4,RAB8B,SCP2,SLC25A17,SLC27A2,TTC1	Any constituent part of a peroxisome, a small, membrane-bounded organelle that uses dioxygen (O2) to oxidize organic molecules; contains some enzymes that produce and others that degrade hydrogen peroxide (H2O2).
GO:0044445	GO	CC	cytosolic part	AHR,AHSP,AIM2,APAF1,APOD,BAG6,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CARD8,CASP1,CASP10,CASP5,CASP8,CASP9,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CFLAR,CHUK,CIAO1,CYB5R3,DDX3X,DNAJA3,DTNBP1,EIF2AK4,EIF2D,ERC1,FADD,FAM96B,FAU,FXR2,GET4,GUCY1A3,GUCY1B3,HBA1,HBB,IKBKB,IKBKG,KIAA1033,KXD1,MAP3K13,MCTS1,MMS19,NARFL,NEFL,NLRC4,NLRP1,NLRP3,NUFIP1,PFKFB1,PFKL,PFKM,PI4K2A,PYCARD,PYDC1,RIPK1,RPL10,RPL10A,RPL10L,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL39L,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SNAP25,SNAP47,SNAPIN,STX12,TCP1,TICAM1,TRIM40,TSC1,TSC2,UBA52,UBL4A,UBQLN4	Any constituent part of cytosol, that part of the cytoplasm that does not contain membranous or particulate subcellular components.
GO:0044447	GO	CC	axoneme part	ARFGEF2,ARL6,CCDC114,CEP162,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAI1,DNAI2,DNALI1,DYNC2LI1,NME8,RSPH4A,SAXO1	Any constituent part of an axoneme, the bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements.
GO:0044448	GO	CC	cell cortex part	ANLN,ASPH,BSN,CAPN2,CDH1,CDH2,CLASP1,CLASP2,CLDN5,CORO1A,CTTN,DLC1,DLG4,EEF1A1,EPB41,EPB41L2,EXOC1,EXOC2,EXOC3L1,EXOC8,EZR,FLOT1,FLOT2,GSN,GYPC,GYS2,LANCL2,LASP1,LLGL1,MAEA,MAPRE1,MYADM,MYH9,MYO1A,MYO5B,MYZAP,NSMF,OSBPL8,PCLO,PHLDB1,PHLDB2,PKD2,PLEKHH2,RAB10,RALB,RAPGEF3,RDX,SELE,SEPT12,SHROOM2,SHROOM4,SLC2A1,SLC4A1,SPTA1,SPTAN1,SPTBN2,SPTBN4,SPTBN5,STIM1,TCHP,TMEM110,TRPC4,TRPV4,VCL,WASH1	Any constituent part of the cell cortex, the region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
GO:0044449	GO	CC	contractile fiber part	ABRA,ACTA1,ACTC1,ACTN2,AHNAK,AHNAK2,ALDOA,ANK2,ANK3,ANKRD1,ANKRD2,ATP2A1,ATP2B4,BIN1,BMP10,CACNA1C,CACNA1D,CACNA1S,CALM1,CAPN3,CASQ2,CAV3,CFL2,CSRP3,DES,DMD,DNAJB6,DST,FKBP1A,FKBP1B,FLNC,HABP4,HRC,IGFN1,KCNE1,KLHL41,KRT19,KY,LDB3,MYBPC3,MYH1,MYH11,MYH13,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL2,MYL3,MYL4,MYL5,MYL6B,MYL7,MYL9,MYLK2,MYLPF,MYOM1,MYOM3,MYOT,MYOZ2,MYPN,MYZAP,NEB,NEBL,NEXN,NOS1AP,OBSCN,OBSL1,PAK1,PDE4B,PGM5,PLEC,PPP1R12A,PPP1R12B,PPP2R5A,PSMA6,RYR1,RYR2,SCN1A,SCN3B,SCN5A,SCN8A,SLC4A1,SLC8A1,SORBS2,SRI,SVIL,SYNE1,SYNE2,SYNM,SYNPO2,TCAP,TNNC1,TNNC2,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TRIM32,TTN,VCL	Any constituent part of a contractile fiber, a fiber composed of actin, myosin, and associated proteins, found in cells of smooth or striated muscle.
GO:0044450	GO	CC	microtubule organizing center part	AGBL2,AGBL4,AHI1,ALDOB,ALMS1,BBS4,BBS9,BIRC5,BLOC1S2,BRCA1,C2CD3,CAPG,CCDC113,CCDC13,CCDC14,CCDC146,CCDC151,CCDC78,CCDC92,CCHCR1,CCNF,CCP110,CCSAP,CDK5RAP2,CENPJ,CEP104,CEP128,CEP131,CEP135,CEP152,CEP162,CEP164,CEP170,CEP19,CEP250,CEP290,CEP295,CEP41,CEP63,CEP72,CEP76,CEP83,CEP85,CEP89,CETN1,CETN2,CETN3,CFAP20,CKAP5,CLASP1,CNTLN,CNTROB,CROCC,DZIP1,DZIP1L,EXOC7,FBF1,FLOT1,FOPNL,HOOK3,HSPA1A,HSPA1B,HSPA6,HTT,IFT88,KATNB1,KIAA0753,KIF24,KRT18,LCK,MARK4,MDM1,MPHOSPH9,MZT1,MZT2A,MZT2B,NEK1,NIN,ODF2,OFD1,PAX2,PCM1,PCNT,PIBF1,PLA2G3,PLK2,PLK4,POC1A,POC1B,RAN,SASS6,SAXO1,SCLT1,SDCCAG8,SIRT2,SPAG5,SPICE1,SSX2IP,STARD9,STIL,TNKS,TNKS2,TOP2A,TOPORS,TSKS,TTBK2,TUBE1,TUBG1,TUBGCP3,TUBGCP4,TUBGCP5,TUBGCP6,UXT,WDR34,ZMYND10,ZNF365	Any constituent part of a microtubule organizing center, a region in a eukaryotic cell, such as a centrosome or basal body, from which microtubules grow.
GO:0044452	GO	CC	nucleolar part	BOP1,CD3EAP,CDKN2AIP,CIRH1A,CLEC3B,DKC1,FBL,GAR1,NHP2,NOL11,NOP10,NOP56,NOP58,PES1,POP1,POP7,RPP30,RPP38,RPP40,RRP9,SIRT7,SNU13,SURF6,TAF1B,WDR12	Any constituent part of a nucleolus, a small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis.
GO:0044455	GO	CC	mitochondrial membrane part	ABCB10,ABCB6,APOO,APOOL,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATPIF1,BAK1,BCS1L,BNIP3,CCDC109B,CHCHD3,CHCHD6,COA1,COA3,COX15,COX18,COX4I2,COX6B2,CPT1A,DMPK,ETFDH,FIS1,FOXRED1,FUNDC1,GDAP1,IMMP2L,IMMT,L2HGDH,LRRK2,MCU,MCUR1,MFF,MFN2,MGARP,MICU1,MICU2,MT-ATP6,MT-ATP8,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MUL1,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFAF5,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NNT,NOA1,OPA1,OXA1L,PAM16,PARK7,PINK1,PPIF,PPOX,RHOT1,RHOT2,SAMM50,SDHA,SDHB,SDHC,SDHD,SLC25A6,SLC8B1,SMDT1,SNCA,SURF1,TAMM41,TIMM10,TIMM17A,TIMM17B,TIMM21,TIMM23,TMEM11,TMEM70,TOMM20,TOMM22,TOMM40,TOMM5,TOMM7,TOMM70A,UQCC3,UQCRB,UQCRC1,UQCRH,USMG5	Any constituent part of a mitochondrial membrane, either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope.
GO:0044456	GO	CC	synapse part	AAK1,ACHE,ACTN2,ADGRL1,AMPH,APP,ARF4,ARFGEF2,ATAD1,BCR,BRSK1,BSN,CABP1,CABP4,CACNA1C,CACNG5,CACNG8,CAD,CASK,CDK16,CDK5,CDK5R1,CHRNA1,CHRNA3,CHRND,CLCN3,CLN3,CNIH2,CNIH3,CNTNAP4,COLQ,COPS4,COPS5,CPEB4,CRIPT,DGKI,DLG4,DMXL2,DNAJA3,DNM2,DNM3,DTNBP1,ERC1,ERC2,F2R,FLRT3,FRMPD4,GABRA2,GHRH,GIPC1,GPER1,GRIA1,GRID2,GRIK3,GRIN1,GRM7,HCRT,ICA1,IL1RAPL1,KCNA1,KCNC2,KCND2,LRP4,LRRK2,MAGEE1,MAGI2,MAPK8IP2,MME,MT3,MTMR2,MUSK,NETO1,NEURL1,NLGN1,NLGN2,NPTN,NR1D1,NRXN1,NSF,NSMF,NUFIP1,OTOF,P2RY1,PCLO,PDE2A,PDLIM5,PI4K2A,PICALM,PICK1,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PPT1,PRKAR2B,PTK2B,PTPRN,PTPRN2,PTPRO,RAB11B,RAB3A,RAB5A,RGS14,RIMS1,RIMS2,RIMS3,RIMS4,RPH3A,SCRIB,SEMA4C,SEPT5,SH2D5,SHANK1,SHANK2,SHANK3,SHISA9,SIGMAR1,SIPA1L1,SLC17A6,SLC17A7,SLC17A8,SLC18A2,SLC30A3,SLC32A1,SLC6A17,SNAP25,SNAPIN,SNCAIP,SPOCK1,SRCIN1,SRGAP2,SRPX2,STRN,STX4,SV2A,SV2B,SV2C,SVOP,SYN1,SYN2,SYN3,SYNDIG1,SYNE1,SYNGR3,SYNPO,SYP,SYT1,SYT11,SYT2,TBC1D24,TENM2,TMEM163,TMEM240,TOR1A,TPRG1L,TRAPPC4,TRPV1,UNC13A,UNC13B,UNC13C,VAMP1,VAMP2,VTI1A,VTI1B,ZC4H2	Any constituent part of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
GO:0044458	GO	BP	motile cilium assembly	BBOF1,BBS5,CCDC39,CCDC40,DMD,DNAAF1,DNAAF3,E2F4,LRRC6,MCIDAS,SPATA6,ZMYND10	The assembly of a motile cilium, a cilium that contains a regular longitudinal array of axonemal microtubules. In vertebrates, motile cilia are usually formed around a 9 + 2 microtubule core structure. Motile cilia are often found in tissues where propagation of fluid is necessary for proper organ development or function.
GO:0044539	GO	BP	long-chain fatty acid import	ACSL1,ACSL3,CD36,FABP3,SLC27A2,SLC27A4,SPX	The directed movement of long-chain fatty acids into a cell or organelle. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
GO:0044550	GO	BP	secondary metabolite biosynthetic process	BDH2,CITED1,CYP1A2,DCT,TRPC1,TYR	The chemical reactions and pathways resulting in the formation of secondary metabolites, the compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon.
GO:0044597	GO	BP	daunorubicin metabolic process	AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,CBR4	The chemical reactions and pathways involving daunorubicin, a chemotherapeutic of the anthracycline family that is given as a treatment for some types of cancer.
GO:0044598	GO	BP	doxorubicin metabolic process	AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,CBR4	The chemical reactions and pathways involving doxorubicin, an anthracycline antibiotic, used in cancer chemotherapy.
GO:0044706	GO	BP	multi-multicellular organism process	ADCYAP1,AMBP,APOL2,BCL2,BYSL,CALCA,CLIC5,COL16A1,CORIN,CRH,CRHBP,CRHR1,EDDM3A,EMP2,EPYC,FSHB,GHRL,GHSR,GNAS,HAVCR2,HPGD,IDO1,IL1B,INSL4,IRG1,KLK14,LGALS9,LNPEP,MAFF,NPPA,OVGP1,PAPPA,PCSK5,PLA2G4B,PLA2G4C,PPARD,PRL,PRLHR,PRLR,PSG1,PSG11,PSG2,PSG3,PSG4,PSG5,PSG6,PSG7,PSG9,PTGFR,PTHLH,PZP,RLN1,RLN2,RPL29,SCGB1A1,SEMG1,SMCP,SOD1,SPP1,TAC1,TAC3,TEAD3,TFCP2L1,TRO	A multicellular organism process which involves another multicellular organism of the same or different species.
GO:0044708	GO	BP	single-organism behavior	ABAT,ABCA7,ADCY3,ADCY8,APP,ATAD1,BBS2,BBS4,BHLHB9,BRS3,CALB1,CAMK4,CARTPT,CASR,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNB1,CHRNB2,CIART,CLDN5,CLN3,CNTNAP2,CPEB3,CRH,CRHBP,CUX2,DLG4,DRD1,DRD2,DRD3,DRD4,DYNLRB1,EGFR,EIF2AK4,EIF4EBP2,FGF13,FOXA2,FOXB1,FYN,GALR2,GALR3,GDNF,GHRL,GHSR,GRIN1,GRIN2A,GRIN2B,HOXA1,HTR1A,HTR2C,ID2,KLK8,LEP,LRRK2,MAPK8IP2,MBD5,MEF2C,MTA1,MUSK,MYH14,NETO1,NF1,NLGN3,NLGN4X,NLGN4Y,NPHP1,NPHP4,NPY,NRXN1,NRXN2,NRXN3,NTF4,NTRK2,OBP2B,OPRM1,PAFAH1B1,PARK2,PJA2,PLCB1,PLK2,PPP3CB,PTEN,PTPRZ1,PUM1,RASGRF1,RGS14,S100B,SGK1,SHANK1,SHANK2,SHANK3,SLC8A2,SLC8A3,SPTBN4,STRA6,TAS2R1,TAS2R5,TH,THBS1,THBS4,TRPV1,TSC1,USP2,VLDLR	The specific behavior of a single organism in response to external or internal stimuli.
GO:0044724	GO	BP	single-organism carbohydrate catabolic process	ABHD10,AGL,AKR1A1,ALDOA,ALDOB,ALDOC,CALM1,CPS1,CRYL1,DCXR,ENO1,ENO2,ENO3,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,GAA,GALE,GALK1,GALT,GAPDH,GAPDHS,GCK,GPI,GYG1,GYG2,HK1,HK2,HK3,KHK,LDHA,LRP5,MIOX,NEU1,NEU2,NEU3,NEU4,NUDT5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PGM2,PHKA1,PHKA2,PHKB,PHKG1,PHKG2,PKLR,PKM,PPP2R5D,PYGB,PYGL,PYGM,SORD,STBD1,TKFC,TKTL1,TPI1,TREH,XYLB	The chemical reactions and pathways resulting in the breakdown of carbohydrates, occurring within a single organism.
GO:0044728	GO	BP	DNA methylation or demethylation	AICDA,ALKBH1,ALKBH2,ALKBH3,APEX1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,ASZ1,ATF7IP,ATRX,BAZ2A,BEND3,CTCFL,DMAP1,DNMT1,DNMT3A,DNMT3B,DNMT3L,DPPA3,EHMT1,EHMT2,FKBP6,FOS,FTO,GATAD2A,H3F3A,HIST1H3A,HIST1H4A,HIST2H3A,KMT2E,MAEL,MGMT,MTRR,PICK1,PIWIL2,PIWIL4,PLD6,PRMT7,TDG,TDRD1,TDRD12,TDRD5,TDRD9,TDRKH,TET1,TET2,TET3,TRDMT1,UHRF1,ZFP57	The process of adding or removing a methyl group from one or more nucleotides within an DNA molecule.
GO:0044743	GO	BP	intracellular protein transmembrane import	CHCHD4,HSP90AA1,HSPA4,NDUFA13,PAM16,PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,RAB8B,SAMM50,TIMM10,TIMM21,TIMM22,TIMM9,TOMM22	The directed movement of proteins into an intracellular organelle, across a membrane.
GO:0044769	GO	MF	ATPase activity, coupled to transmembrane movement of ions, rotational mechanism	ATP5A1,ATP5B,ATP6V0C,ATP6V0E1,ATP6V1B2,ATP6V1C1	Catalysis of the transfer of ions from one side of a membrane to the other according to the reaction: ATP + H2O + ion(in) = ADP + phosphate + ion(out), by a rotational mechanism.
GO:0044773	GO	BP	mitotic DNA damage checkpoint	ATF2,ATM,BLM,CASP2,CCNA2,CCND1,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CHEK2,CRADD,DGKZ,FBXO31,FOXN3,GML,GTSE1,HMGA2,MDC1,MDM2,MUC1,NBN,NEK11,PIDD1,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SOX4,TAOK3,TIPIN,TP53,TRIAP1,UBA52,UBB,UBC	A mitotic cell cycle checkpoint that detects and negatively regulates progression through the cell cycle in response to DNA damage.
GO:0044774	GO	BP	mitotic DNA integrity checkpoint	ATF2,ATM,BLM,CASP2,CCNA2,CCND1,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CHEK2,CLSPN,CRADD,DGKZ,FBXO31,FOXN3,GML,GTSE1,HMGA2,MDC1,MDM2,MUC1,NAE1,NBN,NEK11,PIDD1,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SETMAR,SOX4,TAOK3,TICRR,TIPIN,TP53,TRIAP1,UBA52,UBB,UBC,ZNF830	A mitotic cell cycle process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and ends with signal transduction.
GO:0044782	GO	BP	cilium organization	ABCC4,ABLIM1,ABLIM3,ACTR2,AHI1,ARL13B,ARL6,ARMC4,ATP6V0D1,ATP6V1D,B9D1,B9D2,BBIP1,BBOF1,BBS1,BBS10,BBS2,BBS4,BBS5,C2CD3,C5orf42,CATIP,CC2D2A,CCDC103,CCDC113,CCDC114,CCDC13,CCDC151,CCDC28B,CCDC39,CCDC40,CCNO,CEP126,CEP131,CEP162,CEP164,CEP250,CEP290,CEP41,CEP83,CEP89,CFAP126,CFAP46,CFAP54,CFAP74,CSNK1D,DISC1,DMD,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,DZIP1,DZIP1L,E2F4,EHD1,EHD3,FAM161A,FBF1,FLNA,FNBP1L,FOPNL,FOXJ1,FUZ,ICK,IFT122,IFT172,IFT20,IFT27,IFT43,IFT46,IFT74,IFT81,INTU,IQCB1,KIAA0586,KIF24,KIF27,KIF3A,LRGUK,LRRC6,MCIDAS,MKKS,MKS1,NEK1,NME8,OCRL,PCM1,PCNT,PIBF1,PIH1D3,PKHD1,POC1B,RAB17,RAB23,RAB3IP,RAB8A,RFX3,RP1,RPGR,RSG1,RSPH1,RSPH4A,RSPH9,SCLT1,SEPT2,SNAP29,SNX10,SPAG1,SPAG16,SPATA6,SSX2IP,STK36,TCTN2,TMEM107,TMEM138,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TOPORS,TTBK2,TTC17,TTC26,TTC8,TTLL3,VANGL2,WDR19,WDR35,ZMYND10	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
GO:0044783	GO	BP	G1 DNA damage checkpoint	ATM,CASP2,CCND1,CDK2,CDKN1A,CDKN1B,CRADD,DGKZ,FBXO31,GML,GTSE1,MDM2,MUC1,PIDD1,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SOX4,TP53,TRIAP1,UBA52,UBB,UBC,WAC	A cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase in the cell cycle in response to DNA damage.
GO:0044786	GO	BP	cell cycle DNA replication	APEX1,DNA2,FEN1,LIG1,PCNA,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,PRIM1,PRIM2,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RTEL1,SLBP,UPF1,ZPR1	The DNA-dependent DNA replication that takes place as part of the cell cycle.
GO:0044788	GO	BP	modulation by host of viral process	APCS,APOE,CAV2,CCNK,CFL1,EIF2AK4,LTF,PARK2,PC,PPIB,PTX3,TBC1D20,VAPA,VAPB,YTHDC2,ZC3H12A,ZNF502	A process in which a host organism modulates the frequency, rate or extent of any of a process being mediated by a virus with which it is infected.
GO:0044791	GO	BP	positive regulation by host of viral release from host cell	CAV2,PC,VAPA,VAPB,ZNF502	A process in which a host organism activates or increases the frequency, rate or extent of the release of a virus with which it is infected, from its cells.
GO:0044793	GO	BP	negative regulation by host of viral process	APCS,CCNK,EIF2AK4,LTF,PARK2,PTX3,VAPA,VAPB,ZC3H12A	A process in which a host organism stops, prevents or reduces the frequency, rate or extent of a process being mediated by a virus with which it is infected.
GO:0044794	GO	BP	positive regulation by host of viral process	APOE,CAV2,CFL1,PC,PPIB,TBC1D20,VAPA,VAPB,YTHDC2,ZNF502	A process in which a host organism activates or increases the frequency, rate or extent of the release of a process being mediated by a virus with which it is infected.
GO:0044798	GO	CC	nuclear transcription factor complex	ARNT,ATF1,ATF4,BRF1,CCNH,CD3EAP,CDK7,CEBPA,CEBPB,CREB1,CTNNB1,DDIT3,E2F1,EDF1,ERCC2,ERCC3,ERCC5,FOXH1,GATA4,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6,HAND1,HIF1A,HIPK2,HMGA1,HNRNPAB,HYAL2,ING2,KAT2A,MMS19,MNAT1,MYF5,MYF6,NEUROD1,NFYA,NFYB,NFYC,NKX2-5,NONO,NR1H3,NR5A1,NR5A2,PPARG,PRMT2,RB1,RXRA,SFPQ,SMAD2,SMAD4,SNAPC4,STAT3,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF1B,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TBP,TCF12,TCF3,TCF7L2,TP53,TRIM28,TRRAP,VDR,WWOX	A protein complex, located in the nucleus, that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
GO:0044801	GO	BP	single-organism membrane fusion	ADAM2,ANKFY1,BAX,BNIP1,CAV2,CD9,CHCHD3,CHMP3,CLN3,CRISP1,EEA1,FAM73A,FAM73B,FIS1,GDAP1,IZUMO1,IZUMO1R,LRMP,MFF,MFN1,MFN2,NKD2,NSF,OPA1,PLD6,RAB20,RAB34,RAB39A,RAB7A,RAB8A,ROPN1B,RUBCN,SERPINA5,SLC25A46,SNAP29,SNX14,STOML2,STX17,TECPR1,TGFBRAP1,TMEM8C,TSG101,USP30,UVRAG,VAMP4,VAMP7,VAMP8,VPS11,VPS16,VPS33A,VPS39,VPS41,VPS4A,VPS8,VTI1A	The membrane organization process that joins two lipid bilayers to form a single membrane, involving only one organism.
GO:0044803	GO	BP	multi-organism membrane organization	CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,GAS6,HYAL2,LRSAM1,MVB12A,PDCD6IP,PVRL2,TSG101,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1	A process which results in the assembly, arrangement of constituent parts, or disassembly of a membrane, involving more than one organism.
GO:0044815	GO	CC	DNA packaging complex	H2AFB1,H2AFB2,H2AFY,H3F3A,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H2A,HIST3H3,KAT6B,MPHOSPH8,NCAPD2,NCAPD3,NCAPG,NCAPH,SLF1,SMC2,SMC4,TNP1	A protein complex that plays a role in the process of DNA packaging.
GO:0044818	GO	BP	mitotic G2/M transition checkpoint	ATM,BLM,CCNA2,CDK5RAP3,CLSPN,FOXN3,HMGA2,NAE1,NBN,TAOK3,TICRR,ZNF830	A cell cycle checkpoint that detects and negatively regulates progression from G2 to M phase as part of a mitotic cell cycle.
GO:0044819	GO	BP	mitotic G1/S transition checkpoint	ATM,CASP2,CCND1,CDK2,CDKN1A,CDKN1B,CRADD,DGKZ,FBXO31,GML,GTSE1,MDM2,MUC1,PIDD1,PLK3,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SOX4,TP53,TRIAP1,UBA52,UBB,UBC	A cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase as part of a mitotic cell cycle.
GO:0044827	GO	BP	modulation by host of viral genome replication	CCNK,EIF2AK4,PARK2,PPIB,TBC1D20,VAPA,VAPB,YTHDC2,ZC3H12A	A process in which a host organism modulates the frequency, rate or extent of viral genome replication.
GO:0044828	GO	BP	negative regulation by host of viral genome replication	CCNK,EIF2AK4,PARK2,VAPA,VAPB,ZC3H12A	A process in which a host organism stops, prevents or reduces the frequency, rate or extent of viral genome replication.
GO:0044829	GO	BP	positive regulation by host of viral genome replication	PPIB,TBC1D20,VAPA,VAPB,YTHDC2	A process in which a host organism activates or increases the frequency, rate or extent of  viral genome replication.
GO:0044853	GO	CC	plasma membrane raft	AKAP6,ATP2B4,BMPR1A,BMPR2,CAV1,CAV2,CBL,CDH1,CDH13,CLN3,CORO1C,DLC1,EHD2,EMP2,EZR,F2R,FLOT1,FLOT2,HCK,HDAC6,INSR,IRS1,JAK2,KCNA5,KCND2,KCNMA1,KIF18A,LCP2,LRP4,LRP6,LRP8,LRRK2,MAPK1,MAPK3,MLC1,MYOF,NOS1AP,NOS3,PACSIN2,PLVAP,PRKACA,PRKAR1A,PRKAR2A,PRKCDBP,PTCH1,PTGIS,PTRF,RANGRF,SCARB1,SCN5A,SELE,SLC6A3,SMO,SRC,TGFBR2	A membrane raft that is part of the plasma membrane.
GO:0044854	GO	BP	plasma membrane raft assembly	CAV1,CAV2,CAV3,FLOT1,PACSIN2	The aggregation, arrangement and bonding together of a set of components to form a plasma membrane raft.
GO:0045003	GO	BP	double-strand break repair via synthesis-dependent strand annealing	ATM,BARD1,BLM,BRCA1,BRCA2,BRIP1,DNA2,EXO1,KAT5,MRE11A,NBN,PALB2,RAD50,RAD51,RAD51AP1,RAD51B,RAD51C,RAD51D,RBBP8,RMI1,RMI2,RTEL1,TOP3A,WRN,XRCC2,XRCC3	SDSA is a major mechanism of double-strand break repair in mitosis which allows for the error-free repair of a double-strand break without the exchange of adjacent sequences. The broken DNA searches for and base pairs with a homologous region in an intact chromosome. DNA synthesis initiates from the 3' end of the invading DNA strand, using the intact chromosome as the template. Newly synthesized DNA is then displaced from the template and anneal with its complement on the other side of the double-strand break.
GO:0045005	GO	BP	DNA-dependent DNA replication maintenance of fidelity	ALYREF,APITD1,ATRX,BLM,BOD1L1,BRCA2,CDK9,FANCM,FBXO18,MMS22L,PCNA,PRIMPOL,RAD51,RTEL1,SETMAR,SMARCAL1,STRA13,THOC1,TONSL,WRN,ZNF830,ZRANB3	A DNA metabolic process that prevents or corrects errors to ensure that DNA is replicated accurately. Errors can be corrected either by intrinsic DNA polymerase proofreading activity or via mismatch repair.
GO:0045006	GO	BP	DNA deamination	APOBEC3A,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,EXOSC3,EXOSC4,EXOSC5,EXOSC6	The removal of an amino group from a nucleotide base in DNA. An example is the deamination of cytosine to produce uracil.
GO:0045008	GO	BP	depyrimidination	MBD4,NEIL1,NEIL2,NTHL1,OGG1,SMUG1,TDG,UNG	The disruption of the bond between the sugar in the backbone and the C or T base, causing the base to be removed and leaving a depyrimidinated sugar.
GO:0045010	GO	BP	actin nucleation	ACTR2,ACTR3,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,IQGAP2,JMY,MAGEL2,SCIN,TRIM27,WASH1	The initial step in the formation of an actin filament, in which actin monomers combine to form a new filament. Nucleation is slow relative to the subsequent addition of more monomers to extend the filament.
GO:0045019	GO	BP	negative regulation of nitric oxide biosynthetic process	ATP2B4,CAV1,CD34,GLA,OPRM1,PTGIS,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
GO:0045022	GO	BP	early endosome to late endosome transport	AKTIP,ANKRD27,EEA1,EMP2,FAM160A2,HOOK1,HOOK2,HOOK3,KIF16B,LMTK2,LYST,PIK3C3,RAB5A,RAB7A,RILP,SNF8,SNX16,STX8,VPS4B	The directed movement of substances, in membrane-bounded vesicles, from the early sorting endosomes to the late sorting endosomes; transport occurs along microtubules and can be experimentally blocked with microtubule-depolymerizing drugs.
GO:0045026	GO	BP	plasma membrane fusion	ADAM2,CD9,CRISP1,IZUMO1,IZUMO1R,NSF,ROPN1B,SERPINA5,TMEM8C	The joining of two or more lipid bilayer membranes that surround a cell.
GO:0045046	GO	BP	protein import into peroxisome membrane	PEX16,PEX19,PEX3,PEX5,RAB8B	The targeting of proteins into the peroxisomal membrane. The process is not well understood, but both signals and mechanism differ from those involved in peroxisomal matrix protein import.
GO:0045047	GO	BP	protein targeting to ER	CHMP4A,CHMP4B,DDOST,FAU,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPN1,RPN2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,SEC11A,SEC11C,SEC61A1,SEC61B,SEC61G,SEC62,SEC63,SPCS1,SPCS2,SPCS3,SRP14,SRP19,SRP54,SRP68,SRP72,SRP9,SRPR,SRPRB,SSR1,SSR2,SSR3,SSR4,TRAM1,UBA52,ZFAND2B	The process of directing proteins towards the endoplasmic reticulum (ER) using signals contained within the protein. One common mechanism uses a 16- to 30-residue signal sequence, typically located at the N-terminus of the protein and containing positively charged amino acids followed by a continuous stretch of hydrophobic residues, which directs the ribosome to the ER membrane and initiates transport of the growing polypeptide across the ER membrane.
GO:0045055	GO	BP	regulated exocytosis	ABCA12,ANXA3,BLOC1S6,CCL3,CDK5,CHGA,CORO1A,CRHBP,DNAJC5,DOC2B,HCK,KIT,KLRF2,MILR1,MRGPRX2,NLGN1,NR4A3,OTOF,PCLO,PIK3CD,PIK3CG,PIP5K1C,PPP3CB,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB26,RAB31,RAB3A,RIMS1,RIMS2,RIMS3,S100A13,SCIN,SDF4,SEPT5,SNAP23,SNAP25,SNAPIN,SNPH,STEAP2,STX1B,SYNJ1,SYT1,SYT6,TMED10,TMEM79,UNC13B,VAMP2,VAMP7,ZP4	A process of exocytosis in which soluble proteins and other substances are initially stored in secretory vesicles for later release. It is found mainly in cells that are specialized for secreting products such as hormones, neurotransmitters, or digestive enzymes rapidly on demand.
GO:0045056	GO	BP	transcytosis	FCGRT,GPIHBP1,MFSD2A,PIGR,RAB17,VPS35	The directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side.
GO:0045058	GO	BP	T cell selection	BATF,CD1D,CD3D,CD4,CD74,FOXP3,GLI3,IL6,IRF4,JAG2,LY9,SHH,SLAMF6,THEMIS,ZAP70,ZFPM1	The process in which T cells that express T cell receptors that are restricted by self MHC protein complexes and tolerant to self antigens are selected for further maturation.
GO:0045061	GO	BP	thymic T cell selection	CD3D,GLI3,JAG2,SHH,ZAP70	The process of T cell selection that occurs in the thymus.
GO:0045069	GO	BP	regulation of viral genome replication	ADAR,ADARB1,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,BST2,BTBD17,CCL5,CCNK,CD28,CXCL8,DDB1,DDX3X,EIF2AK2,EIF2AK4,FAM111A,HACD3,HMGA2,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,LTF,MAVS,MX1,NR5A2,OAS1,OAS3,OASL,PARK2,PARP10,PKN2,PLSCR1,PPIA,PPIB,PPID,PPIE,PPIH,PROX1,RAD23A,RNASEL,RSAD2,SLPI,SRPK1,SRPK2,STAU1,TARBP2,TBC1D20,TNF,TNIP1,TOP2A,TRIM6,VAPA,VAPB,YTHDC2,ZC3H12A,ZC3HAV1	Any process that modulates the frequency, rate or extent of viral genome replication.
GO:0045070	GO	BP	positive regulation of viral genome replication	ADAR,ADARB1,CCL5,CD28,DDB1,DDX3X,HACD3,IFIT1,NR5A2,PKN2,PPIA,PPIB,PPID,PPIE,PPIH,RAD23A,SRPK1,SRPK2,STAU1,TARBP2,TBC1D20,TOP2A,VAPA,VAPB,YTHDC2	Any process that activates or increases the frequency, rate or extent of viral genome replication.
GO:0045071	GO	BP	negative regulation of viral genome replication	APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,BST2,BTBD17,CCL5,CCNK,EIF2AK2,EIF2AK4,FAM111A,HMGA2,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,LTF,MAVS,MX1,OAS1,OAS3,OASL,PARK2,PARP10,PLSCR1,PROX1,RNASEL,RSAD2,SLPI,SRPK1,SRPK2,TNF,TNIP1,TRIM6,VAPA,VAPB,ZC3H12A,ZC3HAV1	Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.
GO:0045072	GO	BP	regulation of interferon-gamma biosynthetic process	CD276,CEBPG,EBI3,IL12B,IL21,IL27,INHA,INHBA,LILRB1,TLR3,TLR7,TLR8,TLR9,ZFPM1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-gamma.
GO:0045073	GO	BP	regulation of chemokine biosynthetic process	AZU1,ELANE,HMOX1,IL6,SIGIRR,TNF,WNT5A	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.
GO:0045076	GO	BP	regulation of interleukin-2 biosynthetic process	CD28,CD4,CD80,CD86,FOXP3,GLMN,IL17F,IL1A,IL1B,IRF4,SFTPD	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-2.
GO:0045078	GO	BP	positive regulation of interferon-gamma biosynthetic process	CD276,CEBPG,EBI3,IL12B,IL21,IL27,TLR3,TLR7,TLR8,TLR9,ZFPM1	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-gamma.
GO:0045086	GO	BP	positive regulation of interleukin-2 biosynthetic process	CD28,CD4,CD80,CD86,GLMN,IL1A,IL1B,IRF4	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-2.
GO:0045091	GO	BP	regulation of single stranded viral RNA replication via double stranded DNA intermediate	APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,CXCL8,HMGA2,INPP5K,TOP2A	Any process that modulates the frequency, rate or extent of single stranded viral RNA replication via double stranded DNA intermediate.
GO:0045095	GO	CC	keratin filament	CSNK1A1,FAM83H,FBF1,GPER1,KRT13,KRT14,KRT18,KRT3,KRT4,KRT5,KRT71,KRT82,KRT84,TCHP	A filament composed of acidic and basic keratins (types I and II), typically expressed in epithelial cells. The keratins are the most diverse classes of IF proteins, with a large number of keratin isoforms being expressed. Each type of epithelium always expresses a characteristic combination of type I and type II keratins.
GO:0045104	GO	BP	intermediate filament cytoskeleton organization	ATXN3,CSNK1A1,DES,DNAJB6,DSP,DST,ERBB2IP,FAM83H,KRT14,KRT18,KRT20,KRT3,KRT6C,KRT71,KRT74,KRT9,MTM1,NEFH,NEFL,NEFM,PKP1,PKP2,SOD1,SYNM,TOR1A	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising intermediate filaments and their associated proteins.
GO:0045109	GO	BP	intermediate filament organization	DES,DNAJB6,DSP,KRT14,KRT20,KRT71,KRT9,MTM1,NEFH,NEFL,NEFM,PKP1,PKP2	Control of the spatial distribution of intermediate filaments; includes organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
GO:0045110	GO	BP	intermediate filament bundle assembly	KRT14,NEFH,NEFL,NEFM,PKP1,PKP2	The formation of the bundles of intermediate filaments. Intermediate filament-associated proteins (IFAPs) cross-link intermediate filaments with one another, forming a bundle or a network, and with other cell structures, including the plasma membrane. The organization of intermediate filaments and their supportive function in various cells types depends in large part on their linkage to other cell structures via IFAPs.
GO:0045111	GO	CC	intermediate filament cytoskeleton	BCAS3,CCT8,CHD3,CLIP1,CLK3,CSNK1A1,CTNS,DDX60,DES,DLGAP2,DSP,DST,EIF1AD,ERAL1,EVPL,FAAP100,FAM83H,FBF1,FLG,GFAP,GPER1,HOXA13,INA,IP6K2,KRT10,KRT13,KRT14,KRT16,KRT18,KRT2,KRT20,KRT24,KRT3,KRT4,KRT5,KRT6C,KRT7,KRT71,KRT75,KRT76,KRT8,KRT80,KRT82,KRT84,LDLRAP1,LMNA,MDN1,MICAL1,MRPS23,MTRR,NARF,NCKIPSD,NDOR1,NEFH,NEFL,NES,NFATC4,NFKBIL1,NSFL1C,NUP35,OBFC1,PCDHB4,PHLDB2,PJA2,PKN2,PKP1,PKP2,PLEC,PNN,PRPH,PSMD10,SAP30BP,SEC62,SHANK2,SLC1A4,SMARCA2,SMG7,STAG2,STUB1,STXBP4,SYNE2,SYNM,TACC1,TCHP,TLK2,TRIM29,UPP2,VIM,XRN1,ZCCHC17,ZNF175	Cytoskeletal structure made from intermediate filaments, typically organized in the cytosol as an extended system that stretches from the nuclear envelope to the plasma membrane. Some intermediate filaments run parallel to the cell surface, while others traverse the cytosol; together they form an internal framework that helps support the shape and resilience of the cell.
GO:0045116	GO	BP	protein neddylation	NAE1,NEDD8,RBX1,RNF7,TRIM40,UBE2F,UBE2M	Covalent attachment of the ubiquitin-like protein NEDD8 (RUB1) to another protein.
GO:0045121	GO	CC	membrane raft	ABCA1,ACE2,ADAM17,ADCY2,AHNAK,AKAP6,ANGPT1,ANXA13,ANXA2,APP,ARID3A,ARID3C,ATP2B4,BMPR1A,BMPR2,BTK,CAPN2,CARD11,CAV1,CAV2,CAV3,CBL,CD14,CD226,CD24,CD36,CD4,CD48,CD55,CD79A,CDH1,CDH13,CLIP3,CLN3,CORO1C,CRB2,CTSD,CXADR,DLC1,DLL1,DMD,EGFR,EHD2,EMP2,ERLIN2,EZR,F2R,FAIM2,FAS,FLOT1,FLOT2,FURIN,FYN,GHSR,GJA1,GPC1,GPM6B,HCK,HDAC6,HYAL2,INSR,IRS1,ITGB1,ITLN1,JAK2,KCNA5,KCND2,KCNE3,KCNMA1,KCNQ1,KDR,KIF18A,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LAT,LAT2,LCK,LCP2,LDHB,LRP4,LRP6,LRP8,LRRK2,LYN,MAL,MAL2,MALL,MAPK1,MAPK3,MLC1,MYADM,MYO1C,MYOF,NOS1,NOS1AP,NOS3,NPHS2,NTSR1,PACSIN2,PAG1,PGK1,PI4K2A,PIKFYVE,PLSCR1,PLVAP,PPP2R1B,PPT1,PRKACA,PRKAR1A,PRKAR2A,PRKCDBP,PRNP,PROM2,PSEN1,PTCH1,PTGIS,PTRF,RANGRF,RAP2B,RFTN1,S100A10,SCARB1,SCN5A,SDCBP,SDPR,SELE,SERPINH1,SHH,SLC38A9,SLC6A3,SLC6A4,SLC9A1,SMO,SORBS1,SRC,STOM,STOML2,STX12,SULF1,TDGF1,TEK,TGFBR1,TGFBR2,THY1,TLR1,TLR2,TLR6,TNF,TNFRSF1A,TNFRSF1B,VCL,VDAC2,ZAP70	Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
GO:0045123	GO	BP	cellular extravasation	AMICA1,AZU1,CCL2,CX3CL1,FER,GCNT1,GOLPH3,ITGA4,ITGB1,ITGB7,MADCAM1,PECAM1,PIK3CD,PIK3CG,PODXL2,ROCK1,SELE,SELPLG,TNF,VCAM1	The migration of a leukocyte from the blood vessels into the surrounding tissue.
GO:0045124	GO	BP	regulation of bone resorption	ADAM8,ATP6AP1,BGLAP,CALCA,CARTPT,CSF1R,DCSTAMP,ITGB3,MC4R,NF1,P2RX7,S1PR1,SRC,SYK,TNFAIP3,TNFSF11	Any process that modulates the frequency, rate or extent of bone tissue loss (resorption).
GO:0045125	GO	MF	bioactive lipid receptor activity	FFAR1,LPAR1,S1PR1,S1PR2,SPHK1,SPHK2	Combining with a bioactive lipid and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. A bioactive lipid is a lipid for which changes in lipid levels result in functional consequences in a variety of cellular processes.
GO:0045132	GO	BP	meiotic chromosome segregation	APITD1,BAG6,C11orf85,C15orf43,CCDC79,CCNB1IP1,FANCM,FMN2,HORMAD1,HORMAD2,M1AP,MEI4,MEIKIN,MEIOB,P3H4,RNF212,SGOL1,STAG3,STRA13,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TRIP13	The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets during M phase of the meiotic cell cycle.
GO:0045137	GO	BP	development of primary sexual characteristics	ANG,ANKRD7,BASP1,BMPR1B,CBX2,CCDC182,CEBPB,CSDE1,DMRT1,EIF2B2,EIF2B4,EIF2B5,EREG,FGF8,FOXL2,FSHR,GATA1,GATA3,GATA4,ING2,INHA,INHBA,INHBB,IRX5,KIT,LHB,LHCGR,LRRC6,MEA1,MKKS,MSH2,NCOA4,NR0B1,PDGFRA,PRKACG,PTPRN,RAB13,RBMY1B,SCX,SIX4,SOD1,SOX15,SOX8,SOX9,SRD5A2,TCF21,VEGFA,WNT4,WT1,ZNF830	The process whose specific outcome is the progression of the primary sexual characteristics over time, from their formation to the mature structures. The primary sexual characteristics are the testes in males and the ovaries in females and they develop in response to sex hormone secretion.
GO:0045143	GO	BP	homologous chromosome segregation	BAG6,C11orf85,C15orf43,CCDC79,CCNB1IP1,FMN2,HORMAD1,MEI4,MEIKIN,MEIOB,P3H4,RNF212,STAG3,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TRIP13	The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the first division of the meiotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner; this pairing off, referred to as synapsis, permits genetic recombination. One homolog (both sister chromatids) of each morphologic type goes into each of the resulting chromosome sets.
GO:0045161	GO	BP	neuronal ion channel clustering	AGRN,CNTN2,CNTNAP2,KCNIP2,MTCH1,MYOC,NRCAM,PICK1,SPTBN4	The process in which voltage-gated ion channels become localized to distinct subcellular domains in the neuron. Specific targeting, clustering, and maintenance of these channels in their respective domains are essential to achieve high conduction velocities of action potential propagation.
GO:0045165	GO	BP	cell fate commitment	ACVR1,ASCL1,BATF,BMP2,BMP4,CDC73,CEBPB,CHD5,CTR9,CYP26B1,DLL1,DLL4,DOCK7,DSCAML1,EPAS1,EYA2,FGF13,FGFR2,FOXA2,FOXN4,FOXP3,GAS1,GATA1,GATA2,GATA3,GLI2,GSC,HES5,HOXA11,ID2,IFRD1,IL6,IRF4,ISL1,JAG1,JAG2,KLF4,LEO1,LY9,MCL1,MEF2C,MESP1,MYF5,MYF6,MYOD1,MYOG,NANOG,NOTCH2,NOTCH4,NR2F2,NRP1,NTF4,PAF1,PAX2,PAX6,POU4F1,POU5F1,POU6F2,PPARG,PROX1,RAB10,RBPJ,RORA,RORC,RTF1,SHH,SIX2,SLAMF6,SMAD2,SOX17,SOX2,SOX5,SOX8,SOX9,TAL1,TBX1,TBX2,TCF3,TCF7L2,TEAD3,TGFBR1,TRIM15,WNT3A,WNT8A,WT1,ZFPM1	The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
GO:0045171	GO	CC	intercellular bridge	AAMP,AURKB,BCL3,C12orf66,C9orf72,CD34,CDC7,CDCA8,CEP131,DNAJC8,EAF1,ESRRA,FAN1,IQCB1,KLK6,KMT2E,KRR1,LYRM1,PCIF1,PIK3CB,PPP1R13L,PRKCI,QSOX1,RAB11FIP3,RAB35,RBM44,RFXANK,SIN3A,SNRNP25,SP4,SRA1,TDP2,TEX14,THAP11,THOC1,TIRAP,TRIM45,TUT1,UNC119,USB1,XPA,ZBTB18	A direct connection between the cytoplasm of two cells that is formed following the completion of cleavage furrow ingression during cell division. They are usually present only briefly prior to completion of cytokinesis. However, in some cases, such as the bridges between germ cells during their development, they become stabilised.
GO:0045176	GO	BP	apical protein localization	GOPC,MAL,SHROOM2,SHROOM3,VANGL2	Any process in which a protein is transported to, or maintained in, apical regions of the cell.
GO:0045177	GO	CC	apical part of cell	ABCB4,ABCC2,ABCG5,ABCG8,ADAM17,ADGRG2,AHCYL1,AKAP7,AMN,ANO1,ANXA1,ANXA13,AQP1,AQP2,AQP5,AQP8,ARHGEF18,ATP6V0A4,ATP6V0D2,ATP6V1B1,ATP6V1E1,ATP8B1,BST2,C5AR1,C5AR2,CA2,CA4,CAV1,CD34,CFAP126,CFTR,CLCN5,CLIC4,CNTFR,CUBN,CYP4A11,CYP4F12,CYP4F2,DLL1,DPEP1,DPP4,DRAM2,DSTYK,DUOX1,DYNC2LI1,EMP2,ENPEP,EPB41L4B,EPCAM,EXOC1,EZR,FOLR1,GIF,GPIHBP1,GPR143,HFE,HYAL2,IFIT5,IL6R,ITPR3,JAG1,KCNC2,KCNE1,KCNMA1,LDLR,LRP2,MAL,MARVELD2,MSN,MTDH,MUC13,MUC17,MYO5B,NOTCH1,NRG1,OSMR,P2RX2,PDGFRB,PDZD3,PFKM,PKHD1,PLD1,PLET1,PODXL,PTEN,PTH1R,PTPRO,RAB17,RAPGEF2,RAPGEF6,RDX,RHCG,SCNN1A,SEPT7,SHANK2,SHROOM2,SHROOM3,SHROOM4,SIPA1L3,SLC11A2,SLC12A3,SLC17A3,SLC19A1,SLC1A1,SLC22A11,SLC22A12,SLC22A13,SLC22A18,SLC22A4,SLC22A5,SLC23A1,SLC23A2,SLC26A4,SLC26A6,SLC26A9,SLC29A1,SLC2A5,SLC30A5,SLC34A2,SLC34A3,SLC46A1,SLC6A20,SLC7A9,SLC9A3,SLC9A3R1,STK26,STX3,SVBP,TCHP,TCIRG1,TDGF1,TEK,TF,THY1,TJP1,TLR9,TNIK,UMOD,USH1C,USH2A,VANGL2,VASH1,VCAM1,WDPCP	The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
GO:0045178	GO	CC	basal part of cell	ANK3,AQP1,C5AR2,CD34,CLASP1,CLASP2,DOCK7,DST,ERBB2IP,HFE,LDLRAP1,MET,MUC20,MYO1C,PHLDB1,PHLDB2,PKD2,SHROOM4,SLC11A2,TACSTD2,TEK,TF	The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
GO:0045180	GO	CC	basal cortex	CLASP1,CLASP2,PHLDB1,PHLDB2,PKD2	The region that lies just beneath the plasma membrane on the basal edge of a cell.
GO:0045182	GO	MF	translation regulator activity	ABCF1,BOLL,CELF1,CELF4,CIRBP,CPEB1,CPEB2,CPEB3,DAZ1,DAZL,EIF4EBP1,EIF4EBP2,EIF4EBP3,IGF2BP1,IGF2BP2,IGF2BP3,LARP1,NANOS1,NEURL1,PABPC1,PAIP1,PAIP2,PAIP2B,RPS14,RPS27L,RPS9,SAMD4A,TRIM71,ZNF540	Any molecular function involved in the initiation, activation, perpetuation, repression or termination of polypeptide synthesis at the ribosome.
GO:0045185	GO	BP	maintenance of protein location	AKT1,ANK3,ANKRD13C,ARL2,ARL2BP,BBS4,BCL3,CAV1,CCDC22,CD4,CER1,CREB3,DAG1,EPB41L3,EZR,FAF1,FBN1,FBN2,FLNA,FLNB,G3BP2,GET4,GOLPH3,GOPC,GPAA1,GSN,HK1,HK2,HSPA5,IL10,JUP,LATS1,LTBP1,MDFI,MORC3,MXI1,NBL1,NFKBIA,NFKBIE,NFKBIL1,OS9,PDIA2,PDIA3,PINK1,PKD1,PKD2,PML,PSMD10,SCIN,SHANK1,SORL1,SPTBN4,SRGN,SUN1,SUN2,SUPT7L,SYNE1,SYNE2,SYNE3,TAF3,TAF8,TLN1,TMSB4Y,TONSL,TOPORS,TWF1,TWF2,YWHAB	Any process in which a protein is maintained in a location and prevented from moving elsewhere. These include sequestration, stabilization to prevent transport elsewhere and the active retrieval of proteins that do move away.
GO:0045187	GO	BP	regulation of circadian sleep/wake cycle, sleep	CHRNB2,CRH,GHRH,GHRL,PER3,PTGDS	Any process that modulates the frequency, rate or extent of sleep; a readily reversible state of reduced awareness and metabolic activity that occurs periodically in many animals.
GO:0045190	GO	BP	isotype switching	BATF,CD40LG,EXOSC3,EXOSC6,HSPD1,LIG4,MSH2,MSH6,RNF168,RNF8	The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus.
GO:0045191	GO	BP	regulation of isotype switching	CLCF1,IL10,IL4,PAXIP1,SUPT6H,TGFB1,THOC1,TNFSF13,TNFSF4	Any process that modulates the frequency, rate or extent of isotype switching.
GO:0045197	GO	BP	establishment or maintenance of epithelial cell apical/basal polarity	ANK1,CRB2,ERBB2IP,MARK2,MSN,MTCL1,PRKCI,SLC9A3R1,SYNE4	Any cellular process that results in the specification, formation or maintenance of the apicobasal polarity of an epithelial cell.
GO:0045211	GO	CC	postsynaptic membrane	ATAD1,CHRNA1,CHRND,CNIH2,CNIH3,DLG4,DNAJA3,DNM2,F2R,GRIN1,GRM7,IL1RAPL1,KCNC2,KCND2,MAGEE1,MUSK,NLGN2,P2RY1,PICALM,SCRIB,SHANK1,SHANK2,SRGAP2,STRN,SYNE1,TENM2,TRPV1,ZC4H2	A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane.
GO:0045214	GO	BP	sarcomere organization	ACTN2,ANKRD1,BMP10,CAPN3,CASQ1,KRT19,MYH3,MYH6,MYLK3,MYPN,OBSCN,SIX4,TCAP,TPM1,TTN	The myofibril assembly process that results in the organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
GO:0045216	GO	BP	cell-cell junction organization	ACTB,ACTG1,ACTN1,ACTN2,ACTN3,AMOT,ANG,APC,ARHGEF7,ARL2,CADM1,CADM2,CADM3,CAMSAP3,CD9,CDH1,CDH10,CDH11,CDH12,CDH13,CDH15,CDH17,CDH18,CDH2,CDH24,CDH3,CDH4,CDH5,CDH6,CDH7,CDH8,CDH9,CLDN1,CLDN12,CLDN14,CLDN15,CLDN17,CLDN18,CLDN20,CLDN22,CLDN23,CLDN3,CLDN5,CLDN9,CNTNAP1,CRB3,CSF1R,CTNNA1,CTNNB1,CTNND1,CTTN,CXADR,DLC1,DLG1,DSG1,DSG2,DSP,ECT2,EPB41L3,F11R,FBF1,FERMT2,FLCN,FRMPD2,FSCN1,GJA1,GJA4,GJA5,GJB1,GJB2,GJC1,GJD3,GRHL2,INADL,JUP,KIFC3,LAMA5,LIM2,MARVELD2,MARVELD3,MICALL2,MLLT4,MPP5,MPP7,NLGN2,NLGN4X,OCLN,PARD3,PARD6A,PARD6B,PARD6G,PIP5K1A,PIP5K1C,PKN2,PKP2,PKP3,PKP4,PLEKHA7,PRKCA,PRKCI,PTPRK,PTPRO,PVR,PVRL1,PVRL2,PVRL3,PVRL4,RAB13,RAB8B,RAMP2,RCC2,RHOA,RHOC,RHOD,SMAD3,SMAD7,SNAI2,SORBS1,STRN,TAOK2,TBCD,TESK2,TGFB1,TGFB2,TGFB3,THY1,TJP1,TLN1,TLN2,TRIP6,TRPV4,VCL,WHAMM,ZNF703	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
GO:0045217	GO	BP	cell-cell junction maintenance	CAMSAP3,CSF1R,KIFC3,NLGN2,PARD6A,PLEKHA7	The maintenance of junctions between cells.
GO:0045236	GO	MF	CXCR chemokine receptor binding	CXCL10,CXCL11,CXCL12,CXCL13,CXCL9,PF4,YARS	Interacting selectively and non-covalently with a chemokine receptor in the CXCR family.
GO:0045254	GO	CC	pyruvate dehydrogenase complex	DLAT,DLD,PDHA1,PDHB,PDHX,PDK2	Complex that carries out the oxidative decarboxylation of pyruvate to form acetyl-CoA; comprises subunits possessing three catalytic activities: pyruvate dehydrogenase (E1), dihydrolipoamide S-acetyltransferase (E2), and dihydrolipoamide dehydrogenase (E3).
GO:0045277	GO	CC	respiratory chain complex IV	COX4I2,MT-CO1,MT-CO2,MT-CO3,NDUFA4	A part of the respiratory chain, containing the 13 polypeptide subunits of cytochrome c oxidase, including cytochrome a and cytochrome a3. Catalyzes the oxidation of reduced cytochrome c by dioxygen (O2).
GO:0045292	GO	BP	mRNA cis splicing, via spliceosome	DCPS,DDX23,NCBP2,PSIP1,RBM22,SNRNP200,SRSF1,SRSF12,WBP4	The joining together, after removal of an intervening sequence composed of one or more introns, of two segments of the same RNA molecule via spliceosomal catalysis to produce an mRNA composed only of exon sequences that all came from the same primary transcript.
GO:0045296	GO	MF	cadherin binding	ANK3,CDH13,CDK5R1,CTNNA3,FXYD5,NDRG1,OLFM4,PTPRM,VCL	Interacting selectively and non-covalently with cadherin, a type I membrane protein involved in cell adhesion.
GO:0045309	GO	MF	protein phosphorylated amino acid binding	CBLC,FBXW7,FGR,LDLRAP1,NEDD4,PIN1,PTPN5,SAMSN1	Interacting selectively and non-covalently with a phosphorylated amino acid residue within a protein.
GO:0045329	GO	BP	carnitine biosynthetic process	ACADM,ALDH9A1,BBOX1,SHMT1,TMLHE	The chemical reactions and pathways resulting in the formation of carnitine (hydroxy-trimethyl aminobutyric acid), a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane.
GO:0045332	GO	BP	phospholipid translocation	ABCB4,ATP10A,ATP10B,ATP10D,ATP11A,ATP11B,ATP11C,ATP8A1,ATP8B1,ATP9A,ATP9B,TMEM30A	The movement of a phospholipid molecule from one leaflet of a membrane bilayer to the opposite leaflet.
GO:0045333	GO	BP	cellular respiration	ACAD9,ACO2,ALDH5A1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BLOC1S1,COA6,COX10,COX15,COX4I1,COX4I2,COX5A,COX5B,COX6A1,COX6B1,COX6C,COX7A2L,COX7B,COX7C,COX8A,CS,CYC1,CYCS,DLD,DLST,ECSIT,ETFA,ETFB,ETFDH,FASTKD1,FASTKD2,FASTKD3,FASTKD5,FH,IDH2,IDH3A,IDH3B,IDH3G,MDH2,ME3,MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MT-ND6,MTFR1,MTFR2,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFAF2,NDUFAF3,NDUFAF4,NDUFAF5,NDUFAF6,NDUFAF7,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NNT,NR4A3,NUBPL,OGDH,OXA1L,PDHA1,PDHB,PPARGC1A,SDHA,SDHAF2,SDHB,SDHC,SDHD,SIRT3,SLC25A12,SLC25A13,SLC25A14,SLC25A27,SUCLA2,SUCLG1,SUCLG2,SURF1,TAZ,TBRG4,TIMMDC1,TMEM126B,UCP1,UCP2,UCP3,UQCC3,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRC2,UQCRFS1,UQCRH,UQCRQ	The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration).
GO:0045334	GO	CC	clathrin-coated endocytic vesicle	AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOB,CD207,CD74,CD9,CLTC,CLVS1,CLVS2,CTLA4,DVL2,EGFR,FCGR1A,FCGR1B,FZD2,FZD4,FZD5,HBEGF,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,LDLR,LDLRAP1,MYO1E,MYO6,PICALM,RAB35,ROR2,SFTA3,SFTPA1,SFTPA2,SFTPB,SFTPC,SFTPD,SGIP1,SH3GL2,TBC1D5,TYRP1,WNT5A	A clathrin-coated, membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance.
GO:0045335	GO	CC	phagocytic vesicle	ABCA1,ADAM8,ANXA11,ANXA3,ATG12,ATG5,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,B2M,CD36,CLCN3,CORO1A,CYBA,CYBB,DMBT1,FMNL1,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,ITGAV,ITGB5,LTF,NCF1,NCF2,NCF4,PIK3C3,PIK3R4,RAB11A,RAB11B,RAB14,RAB20,RAB22A,RAB23,RAB31,RAB32,RAB34,RAB38,RAB39A,RAB43,RAB7A,RAB7B,RAB8A,RAB8B,RAB9A,RAB9B,RAC2,SLC11A1,SNX3,SRGAP2,STX12,SYK,TCIRG1,TLR7,TLR9,UNC93B1,VAMP7	A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis.
GO:0045343	GO	BP	regulation of MHC class I biosynthetic process	CIITA,HSPH1,IFNB1,IFNL1,NLRC5,NLRP12	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class I.
GO:0045345	GO	BP	positive regulation of MHC class I biosynthetic process	CIITA,HSPH1,IFNL1,NLRC5,NLRP12	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class I.
GO:0045346	GO	BP	regulation of MHC class II biosynthetic process	CIITA,HDAC2,IL10,IL4,PF4,SIRT1,XBP1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.
GO:0045354	GO	BP	regulation of interferon-alpha biosynthetic process	IL10,TLR3,TLR7,TLR8,TLR9	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-alpha.
GO:0045408	GO	BP	regulation of interleukin-6 biosynthetic process	EREG,FOXJ1,GHRL,GHSR,IL17F,NLRP12,TIRAP,TLR1,TLR6	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.
GO:0045414	GO	BP	regulation of interleukin-8 biosynthetic process	APOA2,BCL10,BCL3,ELANE,IL17F,KLF4,MAP2K5,PRG3,TLR4,TLR7,TLR8,TNF	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
GO:0045416	GO	BP	positive regulation of interleukin-8 biosynthetic process	APOA2,BCL10,ELANE,PRG3,TLR4,TLR7,TLR8,TNF	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
GO:0045428	GO	BP	regulation of nitric oxide biosynthetic process	AGTR2,AGXT2,AKT1,ASS1,ATP2B4,CAV1,CD34,CLU,DDAH1,DDAH2,EDN1,EGFR,ESR1,GLA,HBB,HSP90AA1,HSP90AB1,IFNG,IL1B,INS,INSR,KLF4,NOS1AP,OPRM1,P2RX4,PKD2,PTGIS,PTGS2,TNF,ZC3H12A	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
GO:0045429	GO	BP	positive regulation of nitric oxide biosynthetic process	AGTR2,AGXT2,AKT1,ASS1,CLU,DDAH1,DDAH2,EDN1,EGFR,ESR1,HBB,HSP90AA1,HSP90AB1,IFNG,IL1B,INS,INSR,KLF4,NOS1AP,OPRM1,P2RX4,PKD2,PTGS2,TNF	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
GO:0045444	GO	BP	fat cell differentiation	ADIG,ADIPOQ,AKT2,ALOXE3,ATF5,BBS2,BBS4,BBS7,BBS9,BSCL2,CBY1,CEBPA,CLIP3,CTBP1,CTBP2,EGR2,EP300,ERAP1,FFAR2,FOXO1,HMGA2,IL11,INHBB,KLF4,MED1,METRNL,MKKS,NR4A1,NR4A2,NR4A3,OSBPL11,OSBPL8,PER2,PPARG,PPARGC1A,PRDM16,PSMB8,SDF4,SENP2,SIRT1,SMAD6,SOX8,STEAP4,TCF7L2,TMEM120A,TMEM120B,TRIM32,UCP1,WNT5B,ZNF516	The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
GO:0045445	GO	BP	myoblast differentiation	EPAS1,GREM1,HINFP,IFRD1,IGF1,JAG1,MAPK12,MBNL1,MYOCD,NOTCH1,NRG1,RB1,RBPJ,REST,SDC1,SOX15,SRF,T,TBX2,TCF7L2	The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers.
GO:0045446	GO	BP	endothelial cell differentiation	ACVR1,ACVR2B,ACVRL1,BMPR2,DLL1,EDF1,ENG,EZR,F11R,F2RL1,GSTM3,HEY1,HEY2,ICAM1,JAG1,KDM6B,LAMA5,MARVELD2,MESP1,MET,MLLT4,MSN,MYADM,NOTCH1,NR2F2,NRG1,NRP1,PDE2A,PDE4D,PPP1R16B,PROX1,RAP1A,RAP1B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3,RBPJ,RDX,SCUBE1,SETSIP,SOX17,SOX18,STC1,TJP1,TJP2,WNT7B	The process in which a mesodermal, bone marrow or neural crest cell acquires specialized features of an endothelial cell, a thin flattened cell. A layer of such cells lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
GO:0045453	GO	BP	bone resorption	GPR55,IL7,PTH,PTK2B,SRC,TPP1,ZNF675	The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products.
GO:0045454	GO	BP	cell redox homeostasis	ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,CAMP,CYBA,CYBB,DDIT3,EGLN2,ERP44,GCLC,GLRX2,GPX1,KRIT1,LTF,NCF1,NCF2,NCF4,NOS1,NOS2,NOS3,SLC11A1,TCIRG1,TXNDC2,TXNRD3,VIMP	Any process that maintains the redox environment of a cell or compartment within a cell.
GO:0045471	GO	BP	response to ethanol	ADCY7,ADH6,ADH7,CHRNB2,CRHBP,DRD2,DRD4,GOT2,GRIN1,GRIN2A,GRIN2B,GRIN3A,OPRM1,SDF4,SOD1,TH	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
GO:0045475	GO	BP	locomotor rhythm	CIART,ID2,MTA1,PTEN,USP2	The rhythm of the locomotor activity of an organism during its 24 hour activity cycle.
GO:0045494	GO	BP	photoreceptor cell maintenance	BBS1,BBS10,BBS2,BBS4,CDH23,CIB2,CLRN1,DRAM2,IQCB1,MAK,MKKS,NPHP3,PCDH15,PROM1,RDH12,RP1,RP1L1,SPATA7,TULP1,USH1C,USH1G,USH2A	Any process preventing the degeneration of the photoreceptor, a specialized cell type that is sensitive to light.
GO:0045502	GO	MF	dynein binding	BICD1,CENPF,DNAAF1,HTT,NEFH,PAFAH1B1,PPP1R42,SMC3,SPTBN5	Interacting selectively and non-covalently with dynein, the multisubunit protein complex that is associated with microtubules.
GO:0045540	GO	BP	regulation of cholesterol biosynthetic process	ABCG1,APOE,ERLIN1,ERLIN2,FGF1,PRKAA1,SCAP,SEC14L2,SOD1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.
GO:0045541	GO	BP	negative regulation of cholesterol biosynthetic process	APOE,ERLIN1,ERLIN2,SCAP,SOD1	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.
GO:0045576	GO	BP	mast cell activation	CHGA,KIT,MILR1,MRGPRX2,NR4A3,PIK3CD,PIK3CG,S100A12,S100A13,SNAP23	The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
GO:0045577	GO	BP	regulation of B cell differentiation	BTK,CD27,IKZF3,INHA,INHBA,MMP14,NCKAP1L,SFRP1,SYK,XBP1	Any process that modulates the frequency, rate or extent of B cell differentiation.
GO:0045579	GO	BP	positive regulation of B cell differentiation	BTK,CD27,MMP14,NCKAP1L,SYK,XBP1	Any process that activates or increases the frequency, rate or extent of B cell differentiation.
GO:0045580	GO	BP	regulation of T cell differentiation	ADAM8,ANXA1,BMP4,CAMK4,CCL19,CD2,CD46,CD80,CD86,CDKN2A,CLPTM1,CTLA4,FOXJ1,FOXP3,GATA3,GLI2,GLI3,HLA-G,HMGB1,IFNA2,IFNB1,IFNG,IFNL1,IHH,IL12B,IL12RB1,IL23A,IL23R,IL27,IL4,IL7,IRF1,IRF4,JAK3,KIAA0922,LGALS9,LILRB2,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRELID1,PRKCZ,PTPN2,RARA,RC3H1,SART1,SHH,SOCS5,SOD1,SPINK5,TESPA1,TGFBR2,TNFSF4,VNN1,XBP1,ZAP70,ZBTB1,ZC3H8	Any process that modulates the frequency, rate or extent of T cell differentiation.
GO:0045581	GO	BP	negative regulation of T cell differentiation	ANXA1,BMP4,CDKN2A,CTLA4,FOXJ1,FOXP3,GLI3,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IRF1,JAK3,KIAA0922,PTPN2,RC3H1,SOCS5,TNFSF4,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation.
GO:0045582	GO	BP	positive regulation of T cell differentiation	ADAM8,ANXA1,CCL19,CD46,CD80,CD86,FOXP3,GATA3,GLI2,GLI3,HLA-G,IFNG,IHH,IL12B,IL12RB1,IL23A,IL23R,IL4,IL7,LGALS9,LILRB2,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRKCZ,RARA,SART1,SHH,SOCS5,TESPA1,TGFBR2,TNFSF4,VNN1,XBP1,ZAP70,ZBTB1	Any process that activates or increases the frequency, rate or extent of T cell differentiation.
GO:0045589	GO	BP	regulation of regulatory T cell differentiation	CD46,CTLA4,FOXP3,HLA-G,IFNG,IRF1,LGALS9,LILRB2,TNFSF4	Any process that modulates the frequency, rate or extent of differentiation of regulatory T cells.
GO:0045591	GO	BP	positive regulation of regulatory T cell differentiation	CD46,FOXP3,HLA-G,IFNG,LGALS9,LILRB2	Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
GO:0045598	GO	BP	regulation of fat cell differentiation	ADIG,ADIPOQ,ADIRF,AKT1,ARNTL,ASXL1,ASXL2,BBS12,BMP2,CARM1,CCDC85B,CEBPB,CMKLR1,CREB1,CREBL2,E2F1,ENPP1,FNDC5,FOXO1,FRZB,FTO,GATA2,GATA3,GPER1,IL6,INS,LEP,LMO3,LRP5,MEDAG,METRNL,NOCT,NR1D1,PPARD,PPARG,PTGS2,PTPRQ,RARRES2,RORA,RORC,SFRP1,SFRP2,SIRT1,SIRT2,SMAD3,SULT1E1,TAF8,TGFB1,TNF,TRIB2,TRIB3,WDFY2,WNT1,WNT10B,WNT5A,XBP1,ZBTB16,ZC3H12A,ZFPM1,ZFPM2,ZNF385A	Any process that modulates the frequency, rate or extent of adipocyte differentiation.
GO:0045599	GO	BP	negative regulation of fat cell differentiation	ADIPOQ,ARNTL,ASXL1,BBS12,CCDC85B,E2F1,ENPP1,FOXO1,GATA2,GATA3,GPER1,IL6,RORA,SIRT1,SIRT2,SMAD3,TGFB1,TNF,TRIB2,TRIB3,WNT1,WNT10B,WNT5A,ZFPM1,ZFPM2	Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
GO:0045600	GO	BP	positive regulation of fat cell differentiation	ADIG,ADIRF,AKT1,ASXL2,BMP2,CARM1,CEBPB,CMKLR1,CREB1,CREBL2,FNDC5,FRZB,INS,LMO3,LRP5,MEDAG,METRNL,NOCT,PPARD,PPARG,PTGS2,RARRES2,SFRP1,SFRP2,SULT1E1,WDFY2,XBP1,ZBTB16,ZC3H12A,ZNF385A	Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
GO:0045601	GO	BP	regulation of endothelial cell differentiation	ATOH8,BTG1,CDH5,CLDN5,IKBKB,IL1B,NOTCH4,PROC,ROCK1,ROCK2,S1PR2,S1PR3,TMEM100,TNF,TNFRSF1A,XDH	Any process that modulates the frequency, rate or extent of endothelial cell differentiation.
GO:0045603	GO	BP	positive regulation of endothelial cell differentiation	ATOH8,BTG1,CDH5,CLDN5,PROC,S1PR2,TMEM100	Any process that activates or increases the frequency, rate or extent of endothelial cell differentiation.
GO:0045604	GO	BP	regulation of epidermal cell differentiation	AQP3,BMP4,CYP27B1,DLL1,ERRFI1,GDF3,GRHL2,H2AFY,H2AFY2,HOXA7,IL20,KDF1,MED1,NCOA3,NME2,OVOL2,PRKCH,REG3A,REG3G,ROCK1,ROCK2,SFN,SFRP4,SRSF6,TRIM16,VDR	Any process that modulates the frequency, rate or extent of epidermal cell differentiation.
GO:0045605	GO	BP	negative regulation of epidermal cell differentiation	DLL1,GDF3,GRHL2,HOXA7,OVOL2,REG3A,REG3G,SRSF6	Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal cell differentiation.
GO:0045606	GO	BP	positive regulation of epidermal cell differentiation	BMP4,CYP27B1,H2AFY,H2AFY2,IL20,KDF1,MED1,NCOA3,NME2,PRKCH,SFN,SFRP4,TRIM16,VDR	Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.
GO:0045616	GO	BP	regulation of keratinocyte differentiation	AQP3,CYP27B1,ERRFI1,GRHL2,H2AFY,H2AFY2,HOXA7,IL20,MED1,NCOA3,NME2,OVOL2,PRKCH,REG3A,REG3G,ROCK1,ROCK2,SRSF6,TRIM16,VDR	Any process that modulates the frequency, rate or extent of keratinocyte differentiation.
GO:0045617	GO	BP	negative regulation of keratinocyte differentiation	GRHL2,HOXA7,OVOL2,REG3A,REG3G,SRSF6	Any process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte differentiation.
GO:0045618	GO	BP	positive regulation of keratinocyte differentiation	CYP27B1,H2AFY,H2AFY2,IL20,MED1,NCOA3,NME2,PRKCH,TRIM16,VDR	Any process that activates or increases the frequency, rate or extent of keratinocyte differentiation.
GO:0045619	GO	BP	regulation of lymphocyte differentiation	ADAM8,ANXA1,AXL,BMP4,BTK,CAMK4,CCL19,CD2,CD27,CD46,CD80,CD86,CDKN2A,CLPTM1,CTLA4,FOXJ1,FOXP3,GAS6,GATA3,GLI2,GLI3,HLA-G,HMGB1,IFNA2,IFNB1,IFNG,IFNL1,IHH,IKZF3,IL12B,IL12RB1,IL23A,IL23R,IL27,IL4,IL7,INHA,INHBA,IRF1,IRF4,JAK3,KIAA0922,LGALS9,LILRB2,MMP14,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRELID1,PRKCZ,PTPN2,RARA,RC3H1,SART1,SFRP1,SHH,SOCS5,SOD1,SPINK5,SYK,TESPA1,TGFBR2,TNFSF4,VNN1,XBP1,ZAP70,ZBTB1,ZC3H8	Any process that modulates the frequency, rate or extent of lymphocyte differentiation.
GO:0045620	GO	BP	negative regulation of lymphocyte differentiation	ANXA1,BMP4,CDKN2A,CTLA4,FOXJ1,FOXP3,GLI3,HMGB1,IFNA2,IFNB1,IFNL1,IHH,INHA,INHBA,IRF1,JAK3,KIAA0922,PTPN2,RC3H1,SFRP1,SOCS5,TNFSF4,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate or extent of lymphocyte differentiation.
GO:0045621	GO	BP	positive regulation of lymphocyte differentiation	ADAM8,ANXA1,AXL,BTK,CCL19,CD27,CD46,CD80,CD86,FOXP3,GAS6,GATA3,GLI2,GLI3,HLA-G,IFNG,IHH,IL12B,IL12RB1,IL23A,IL23R,IL4,IL7,LGALS9,LILRB2,MMP14,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRKCZ,RARA,SART1,SHH,SOCS5,SYK,TESPA1,TGFBR2,TNFSF4,VNN1,XBP1,ZAP70,ZBTB1	Any process that activates or increases the frequency, rate or extent of lymphocyte differentiation.
GO:0045622	GO	BP	regulation of T-helper cell differentiation	ANXA1,CCL19,CD80,CD86,FOXP3,IL12B,IL12RB1,IL23A,IL23R,IL27,IRF4,JAK3,MYB,NLRP3,PRKCZ,RARA,RC3H1,SOCS5,TNFSF4	Any process that modulates the frequency, rate or extent of T-helper cell differentiation.
GO:0045623	GO	BP	negative regulation of T-helper cell differentiation	ANXA1,FOXP3,JAK3,RC3H1,SOCS5,TNFSF4	Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper cell differentiation.
GO:0045624	GO	BP	positive regulation of T-helper cell differentiation	ANXA1,CCL19,CD80,CD86,IL12B,IL12RB1,IL23A,IL23R,MYB,NLRP3,PRKCZ,RARA,SOCS5,TNFSF4	Any process that activates or increases the frequency, rate or extent of T-helper cell differentiation.
GO:0045625	GO	BP	regulation of T-helper 1 cell differentiation	ANXA1,CCL19,CD80,IL27,JAK3,SOCS5,TNFSF4	Any process that modulates the frequency, rate or extent of T-helper 1 cell differentiation.
GO:0045628	GO	BP	regulation of T-helper 2 cell differentiation	ANXA1,CD86,NLRP3,PRKCZ,RARA,SOCS5,TNFSF4	Any process that modulates the frequency, rate or extent of T-helper 2 cell differentiation.
GO:0045630	GO	BP	positive regulation of T-helper 2 cell differentiation	CD86,NLRP3,PRKCZ,RARA,TNFSF4	Any process that activates or increases the frequency, rate or extent of T-helper 2 cell differentiation.
GO:0045637	GO	BP	regulation of myeloid cell differentiation	ACVR1B,ACVR2A,ADIPOQ,ANKRD54,APCS,ARNT,ATP6AP1,BGLAP,C1QC,CALCA,CAMK4,CARTPT,CASP8,CCL3,CCR1,CDC73,CDK6,CEBPB,CIB1,CSF1,CTNNBIP1,CTR9,DCSTAMP,ETS1,FADD,FAM213A,FES,FOXO3,FOXP1,FSTL3,GAS2L1,GATA1,GPR55,HAX1,HCLS1,HIF1A,HIST1H4A,HMGB2,HOXA5,HOXA7,HOXA9,HOXB8,IFNG,IL12B,IL17A,IL23A,IL23R,IL34,IL4,INHA,INHBA,IRF7,KMT2E,L3MBTL1,LDB1,LEF1,LEO1,LIF,LILRB1,LILRB3,LILRB4,LRRC17,LTF,LYN,MAFB,MAPK14,MED1,MEF2C,MEIS1,MEIS2,MTOR,MYC,NCKAP1L,OCSTAMP,OGT,PAF1,PF4,PRDM16,PRKCA,PRMT1,PTK2B,PTPN2,PURB,RAB7B,RARA,RIPK1,RUNX1,SCIN,SPI1,TAL1,TESC,THPO,TLR3,TLR4,TNF,TNFSF11,TRAF6,WDR61,ZBTB16,ZFPM1,ZNF16,ZNF675	Any process that modulates the frequency, rate or extent of myeloid cell differentiation.
GO:0045638	GO	BP	negative regulation of myeloid cell differentiation	ADIPOQ,APCS,C1QC,CALCA,CARTPT,CCL3,CDC73,CDK6,CIB1,CTR9,FSTL3,GAS2L1,GPR55,HIST1H4A,HOXA5,HOXA7,HOXA9,HOXB8,IL4,INHA,INHBA,LDB1,LEO1,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,MEIS1,MEIS2,MYC,PAF1,PF4,PRDM16,PRMT1,PTK2B,PTPN2,RARA,RUNX1,TLR3,TLR4,WDR61,ZBTB16,ZFPM1,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of myeloid cell differentiation.
GO:0045639	GO	BP	positive regulation of myeloid cell differentiation	ACVR1B,ACVR2A,ANKRD54,ARNT,ATP6AP1,CALCA,CASP8,CCR1,CSF1,CTNNBIP1,DCSTAMP,ETS1,FADD,FES,FOXO3,GATA1,HAX1,HCLS1,HIF1A,HMGB2,HOXA5,IFNG,IL12B,IL17A,IL23A,IL23R,IL34,INHBA,KMT2E,LEF1,LIF,MAPK14,MED1,NCKAP1L,OCSTAMP,OGT,PF4,PRKCA,PRMT1,RAB7B,RIPK1,RUNX1,SCIN,TAL1,TESC,THPO,TNF,TNFSF11,TRAF6,ZNF16	Any process that activates or increases the frequency, rate or extent of myeloid cell differentiation.
GO:0045646	GO	BP	regulation of erythrocyte differentiation	ACVR1B,ACVR2A,ANKRD54,ARNT,CDK6,ETS1,FOXO3,GAS2L1,GATA1,HIF1A,HMGB2,HOXA5,INHBA,LDB1,LYN,MAFB,MAPK14,MED1,NCKAP1L,PRMT1,SPI1,TAL1,ZFPM1,ZNF16	Any process that modulates the frequency, rate or extent of erythrocyte differentiation.
GO:0045648	GO	BP	positive regulation of erythrocyte differentiation	ACVR1B,ACVR2A,ANKRD54,ARNT,ETS1,FOXO3,GATA1,HIF1A,HMGB2,INHBA,MAPK14,MED1,NCKAP1L,PRMT1,TAL1,ZNF16	Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
GO:0045649	GO	BP	regulation of macrophage differentiation	ADIPOQ,C1QC,CALCA,CASP8,CSF1,FADD,IL34,INHA,INHBA,LIF,PF4,PRKCA,PTPN2,RIPK1	Any process that modulates the frequency, rate or extent of macrophage differentiation.
GO:0045650	GO	BP	negative regulation of macrophage differentiation	ADIPOQ,C1QC,INHA,INHBA,PTPN2	Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage differentiation.
GO:0045651	GO	BP	positive regulation of macrophage differentiation	CALCA,CASP8,CSF1,FADD,IL34,LIF,PF4,PRKCA,RIPK1	Any process that activates or increases the frequency, rate or extent of macrophage differentiation.
GO:0045652	GO	BP	regulation of megakaryocyte differentiation	CIB1,HIST1H4A,HMGB2,L3MBTL1,MEF2C,PF4,PRMT1,RAB7B,SCIN,TESC,THPO,ZNF16	Any process that modulates the frequency, rate or extent of megakaryocyte differentiation.
GO:0045654	GO	BP	positive regulation of megakaryocyte differentiation	HMGB2,RAB7B,SCIN,TESC,THPO,ZNF16	Any process that activates or increases the frequency, rate or extent of megakaryocyte differentiation.
GO:0045655	GO	BP	regulation of monocyte differentiation	APCS,CSF1,CTNNBIP1,DCSTAMP,FOXP1,HOXA7,IL34,IRF7,MYC	Any process that modulates the frequency, rate or extent of monocyte differentiation.
GO:0045661	GO	BP	regulation of myoblast differentiation	ANKRD2,BMP4,BOC,BTG1,CSRP3,DLL1,HIF1AN,IGFBP3,KLHL41,MAPK14,MEF2C,MSTN,MYOG,NOTCH1,PLCB1,PRICKLE1,SMYD1,SOX8,SOX9,TBX3,TGFB1,ZFHX3	Any process that modulates the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
GO:0045662	GO	BP	negative regulation of myoblast differentiation	ANKRD2,BMP4,CSRP3,DLL1,MSTN,NOTCH1,PRICKLE1,SOX8,SOX9,TBX3,TGFB1,ZFHX3	Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
GO:0045663	GO	BP	positive regulation of myoblast differentiation	BOC,BTG1,CSRP3,HIF1AN,IGFBP3,MAPK14,MEF2C,MYOG,PLCB1,SMYD1,ZFHX3	Any process that activates or increases the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
GO:0045665	GO	BP	negative regulation of neuron differentiation	ADCY6,APOE,ARHGDIA,ARHGEF1,ASCL1,BAG5,BCL11A,BMP7,CALR,CBFA2T2,CIB1,CNTN4,DCC,DLL1,DPYSL3,DTX1,EDNRB,EFNA1,EIF2AK4,EPHA4,FGF13,FKBP4,GAK,GDI1,GFI1,GORASP1,HDAC2,HES1,HES5,ID2,ITM2C,KANK1,KIAA0319,KLK8,LINGO1,LPAR1,LRP4,MAG,MED1,MT3,NGEF,NGFR,NLGN1,OMG,PAQR3,PTEN,PTPRO,RAB29,RAPGEF2,REST,RHOA,RNF6,RTN4,RTN4R,RUFY3,SEMA5A,SIX3,SLIT2,SOX2,SOX3,SOX9,SPOCK1,SRGAP2C,STMN2,THY1,TRPV4,WNT3A,YWHAH	Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation.
GO:0045666	GO	BP	positive regulation of neuron differentiation	ABL2,ADRA2B,ADRA2C,AMIGO1,APOE,ARHGDIA,ARSB,ASCL1,ATOH1,AVIL,BCL11A,BDNF,BHLHB9,BMP2,BMP5,BMP7,BRINP3,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CBFA2T2,CDKL5,COBL,CPEB3,CPNE1,CPNE5,CPNE6,CPNE9,CUL7,CUX1,CUX2,DAB2IP,DMD,DPYSL3,DSCAM,ECT2,EPHA3,FAM134C,FBXW8,FES,FGFR1,FOXO6,GOLGA4,GPRC5B,HEYL,HOXD3,IL1RAPL1,IMPACT,ISLR2,ITSN2,KIDINS220,L1CAM,LIMK1,LRP8,LTK,LYN,MACF1,MAGI2,MAPT,MARK2,MEF2C,MEGF8,MMD,MMD2,NBL1,NDNF,NDRG4,NEDD4L,NEURL1,NEUROD1,NEUROD2,NEUROG1,NGF,NGFR,NKX2-5,NLGN1,NPTN,NRCAM,NRP1,NTN1,NTRK1,NTRK2,OBSL1,PACSIN1,PLK5,PRKCI,PRKD1,PROX1,PSEN1,PTK2B,PTK6,PTK7,PTPRD,RAP1A,RAPGEF1,RAPGEF2,RASAL1,RELN,RET,RHOA,RIMS1,RIMS2,ROBO1,ROBO2,RUFY3,SCARF1,SCN1B,SEMA4D,SEMA5A,SEMA7A,SETX,SHANK1,SHANK3,SHTN1,SKIL,SLIT2,SMURF1,SNX3,SOX11,STMN2,SYT1,SYT17,SYT2,SYT3,SYT4,TCF3,TCF4,TENM3,TRIM32,TWF2,UNC13A,VEGFA,VLDLR,VWC2,WNT2,WNT5A,ZEB1	Any process that activates or increases the frequency, rate or extent of neuron differentiation.
GO:0045667	GO	BP	regulation of osteoblast differentiation	ACVR1,ACVR2A,ACVR2B,ATP6AP1,ATRAID,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CDK6,CHRD,CITED1,CTNNBIP1,CYR61,DDR2,DDX5,FBN2,FGF23,FGFR2,GDF10,HDAC7,HGF,IFITM1,IGF1,IL6,IL6R,IL6ST,LIMD1,LRP5,LTF,MEF2C,MEN1,NBR1,NELL1,NOCT,NOG,NOTCH1,NPNT,PRKACA,PRKD1,PTCH1,PTK2,RORB,SEMA4D,SKI,SMOC1,SNAI2,SOX11,SUCO,SUFU,TMEM119,TP63,TWIST1,TWIST2,WNT4,WNT7B,ZHX3	Any process that modulates the frequency, rate or extent of osteoblast differentiation.
GO:0045668	GO	BP	negative regulation of osteoblast differentiation	CDK6,CHRD,CITED1,FGF23,GDF10,HDAC7,LIMD1,LRP5,MEN1,NBR1,NOCT,NOG,NOTCH1,PTCH1,RORB,SEMA4D,SKI,SUFU,TWIST1,TWIST2	Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
GO:0045669	GO	BP	positive regulation of osteoblast differentiation	ACVR1,ACVR2A,ACVR2B,ATP6AP1,ATRAID,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CTNNBIP1,CYR61,DDR2,FBN2,HGF,IFITM1,IGF1,IL6,IL6R,IL6ST,LTF,MEF2C,NELL1,NPNT,PRKD1,SOX11,SUCO,TMEM119,TP63,WNT4,WNT7B,ZHX3	Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
GO:0045670	GO	BP	regulation of osteoclast differentiation	ATP6AP1,BGLAP,CALCA,CAMK4,CARTPT,CCL3,CCR1,CEBPB,CSF1,FAM213A,FSTL3,GPR55,IFNG,IL12B,IL17A,IL23A,IL23R,IL4,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,MTOR,OCSTAMP,TLR3,TLR4,TNF,TNFSF11,TRAF6,ZNF675	Any process that modulates the frequency, rate or extent of osteoclast differentiation.
GO:0045671	GO	BP	negative regulation of osteoclast differentiation	CALCA,CARTPT,CCL3,FSTL3,GPR55,IL4,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,TLR3,TLR4,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation.
GO:0045672	GO	BP	positive regulation of osteoclast differentiation	ATP6AP1,CCR1,CSF1,IFNG,IL12B,IL17A,IL23A,IL23R,OCSTAMP,TNF,TNFSF11,TRAF6	Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
GO:0045682	GO	BP	regulation of epidermis development	AQP3,BMP4,CDH3,CYP27B1,DLL1,ERRFI1,FST,GAL,GDF3,GRHL2,H2AFY,H2AFY2,HOXA7,HPSE,IL20,KDF1,MED1,NCOA3,NME2,OVOL2,PRKCH,REG3A,REG3G,ROCK1,ROCK2,SFN,SFRP4,SRSF6,TGFB2,TMEM79,TRIM16,VDR	Any process that modulates the frequency, rate or extent of epidermis development.
GO:0045683	GO	BP	negative regulation of epidermis development	CDH3,DLL1,GDF3,GRHL2,HOXA7,OVOL2,REG3A,REG3G,SRSF6	Any process that stops, prevents, or reduces the frequency, rate or extent of epidermis development.
GO:0045684	GO	BP	positive regulation of epidermis development	BMP4,CYP27B1,FST,GAL,H2AFY,H2AFY2,IL20,KDF1,MED1,NCOA3,NME2,PRKCH,SFN,SFRP4,TGFB2,TMEM79,TRIM16,VDR	Any process that activates or increases the frequency, rate or extent of epidermis development.
GO:0045685	GO	BP	regulation of glial cell differentiation	BIN1,BMP2,CDK1,CLCF1,CXCR4,DICER1,DRD3,EPHA4,F2,HES1,HES5,NF1,NOG,NOTCH1,SERPINE2,TENM4,TNFRSF21	Any process that modulates the frequency, rate or extent of glia cell differentiation.
GO:0045686	GO	BP	negative regulation of glial cell differentiation	DRD3,F2,HES1,HES5,NF1,NOG,NOTCH1	Any process that stops, prevents, or reduces the frequency, rate or extent of glia cell differentiation.
GO:0045687	GO	BP	positive regulation of glial cell differentiation	BIN1,BMP2,CLCF1,CXCR4,DICER1,HES1,NOTCH1,SERPINE2,TENM4	Any process that activates or increases the frequency, rate or extent of glia cell differentiation.
GO:0045714	GO	BP	regulation of low-density lipoprotein particle receptor biosynthetic process	ADIPOQ,CNPY2,FGF21,HNRNPK,ITGAV,ITGB3,SCAP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of low-density lipoprotein particle receptors.
GO:0045717	GO	BP	negative regulation of fatty acid biosynthetic process	ACADL,ACADVL,APOC1,APOC3,BRCA1,ERLIN1,ERLIN2,PIBF1,SIRT1,TRIB3	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids.
GO:0045719	GO	BP	negative regulation of glycogen biosynthetic process	ENPP1,GRB10,GSK3A,GSK3B,INPP5K,PASK,VIMP	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
GO:0045721	GO	BP	negative regulation of gluconeogenesis	ADIPOQ,C1QTNF3,CLK2,GCK,INS,SIK1,SOGA1	Any process that stops, prevents, or reduces the frequency, rate or extent of gluconeogenesis.
GO:0045723	GO	BP	positive regulation of fatty acid biosynthetic process	APOA4,APOA5,APOC2,MID1IP1,MLXIPL,NR1H2,NR1H3,PTGS2	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids.
GO:0045724	GO	BP	positive regulation of cilium assembly	BBS4,FUZ,HAP1,HTT,KCTD17,SAXO1	Any process that activates or increases the frequency, rate or extent of the formation of a cilium.
GO:0045725	GO	BP	positive regulation of glycogen biosynthetic process	AKT1,AKT2,DYRK2,GCK,IGF1,IGF2,INS,INSR,IRS1,IRS2,PTH,SORBS1	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
GO:0045727	GO	BP	positive regulation of translation	ABCF1,BCDIN3D,BCL3,BOLL,C1QBP,CCL5,CD28,CIRBP,COA3,CPEB3,DAZ1,DAZL,DDX3X,DNAJC3,DND1,EEF2,EIF2AK4,EIF2B5,EIF4A3,EIF5A,ELAVL1,ERBB2,FAM129A,HNRNPD,IL6,IMPACT,KHDRBS1,LARP1,LARP4B,METTL3,MPV17L2,MTOR,NCK1,NPM1,PABPC1,PAIP1,PASK,PIWIL2,POLDIP3,POU5F1,PPP1R15A,PRR16,RBM3,RMND1,RPS27L,RPS4X,RPS6KB1,RPS6KB2,SAMD4A,SOX4,TGFB1,THBS1,UHMK1,UPF3A,UPF3B,UQCC1,UQCC2,USP16,YBX3,YTHDF1,YTHDF2,ZC3H12A	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA.
GO:0045730	GO	BP	respiratory burst	CD24,CD52,CD55,CYBA,CYBB,HCK,NCF1,NCF2,NOX1,PGAM1,PIK3CD,PIK3CG,SLC11A1	A phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
GO:0045736	GO	BP	negative regulation of cyclin-dependent protein serine/threonine kinase activity	APC,CDK5RAP1,CDKN2A,CEBPA,CUL3,FBXO31,HEXIM1,HEXIM2,HHEX,INCA1,LATS1,LATS2,MEN1,MYOCD,NR2F2,PLK1,PTEN,TFAP4,UBE2C	Any process that stops, prevents, or reduces the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.
GO:0045737	GO	BP	positive regulation of cyclin-dependent protein serine/threonine kinase activity	ADAM17,AKT1,ATRAID,CCND1,CCND2,CCND3,CCNY,DAB2IP,EGFR,FGF10,MAPRE3,NELL1,PDGFB,PIM1,PKD1,PKD2,PROX1,PSMD10,PSRC1,RGCC	Any process that activates or increases the frequency, rate or extent of CDK activity.
GO:0045738	GO	BP	negative regulation of DNA repair	FBXO18,HMGA2,OGG1,OTUB1,PARPBP,POLQ,RNF169,RPS3,TERF2,TFIP11,TRIP12,TWIST1,UBR5	Any process that stops, prevents, or reduces the frequency, rate or extent of DNA repair.
GO:0045739	GO	BP	positive regulation of DNA repair	APEX1,BABAM1,BRCA1,BRCC3,BRE,EGFR,ERCC8,EYA1,EYA3,FAM175A,FGF10,FOXM1,H2AFX,HMGB1,KDM4D,NPAS2,NUDT16,PCNA,PRKCG,RNF168,RNF8,RPS3,SETMAR,SIRT1,SLF1,SLF2,SPIDR,TIGAR,TMEM161A,TRIM28,UBE2N,UIMC1	Any process that activates or increases the frequency, rate or extent of DNA repair.
GO:0045740	GO	BP	positive regulation of DNA replication	ACD,AREG,ATM,ATR,ATRX,AURKB,BMP4,BMP5,BMP6,CALR,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CDC7,CSF2,CTC1,DBF4B,DKC1,DNA2,E2F7,E2F8,EGFR,EPO,EREG,FGF10,GLI1,GLI2,GREM1,GRHL2,HMBOX1,HNRNPA1,HRAS,IGF1,IGF1R,IL3,INO80,INS,INSR,KITLG,KLF4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NEK2,NEK7,NVL,OBFC1,PARM1,PCNA,PDGFA,PDGFB,PDGFC,PDGFRA,PKIB,PLA2G1B,PNKP,POT1,PRKCQ,SHC1,STOML2,TCP1,TGFB3,TNKS,TNKS2,WIZ,WRAP53	Any process that activates or increases the frequency, rate or extent of DNA replication.
GO:0045741	GO	BP	positive regulation of epidermal growth factor-activated receptor activity	ADAM17,ADRA2A,ADRA2B,ADRA2C,EGF,EPGN,EREG,FBXW7,TGFA	Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.
GO:0045742	GO	BP	positive regulation of epidermal growth factor receptor signaling pathway	ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGR2,AGT,EGF,EPGN,EREG,FBXW7,GPER1,HAP1,MMP9,NUP62,PLAUR,SHKBP1,TGFA	Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
GO:0045744	GO	BP	negative regulation of G-protein coupled receptor protein signaling pathway	ADA,ADM,ADRA2A,ADRB2,ADRBK1,ARRB1,ARRB2,ATP2B4,BECN2,BICD1,CALCA,CCL5,CRY1,CXCL8,DRD2,DRD3,GPRASP1,GTF2H2,KLK14,MGRN1,NOS1,PALM,PLEK,RGS2,RPGRIP1L,SNCA	Any process that stops, prevents, or reduces the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity.
GO:0045745	GO	BP	positive regulation of G-protein coupled receptor protein signaling pathway	ACPP,C3,CAV2,DRD3,F2,GPER1,GSK3A,KLK14,KLK5,KLK6,LRRK2,PHB,UBQLN2	Any process that activates or increases the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity.
GO:0045746	GO	BP	negative regulation of Notch signaling pathway	C8orf4,CHAC1,DLK1,DLK2,DLL4,EGFL7,FBXW7,GATA2,HEY1,HIF1AN,LFNG,MAGEA1,MMP14,NEURL1,NRARP,OVOL2,RITA1	Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway.
GO:0045747	GO	BP	positive regulation of Notch signaling pathway	AAK1,DLL1,DLL4,ITGB1BP1,JAG1,JAG2,MESP1,NOD2,NOV,PDCD10,STAT3,TP63,TSPAN14,TSPAN5,WNT1	Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.
GO:0045760	GO	BP	positive regulation of action potential	ADRA1A,ANK3,NOS1AP,RNF207,SCN5A	Any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels.
GO:0045761	GO	BP	regulation of adenylate cyclase activity	ACR,ADCYAP1,ADCYAP1R1,ADGRD1,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CALCR,CAP1,CAP2,CCR2,CRHR1,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,GABBR2,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GPER1,GRM2,GRM3,GRM7,LHCGR,LTB4R2,NF1,NTRK1,NTRK2,OPRM1,P2RY11,PALM,PRKCA,RAF1,VIP	Any process that modulates the frequency, rate or extent of adenylate cyclase activity.
GO:0045762	GO	BP	positive regulation of adenylate cyclase activity	ACR,ADCYAP1,ADCYAP1R1,ADGRD1,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CALCR,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,GIPR,GLP1R,GNAS,GPER1,LHCGR,NF1,NTRK1,NTRK2,P2RY11,PRKCA,RAF1,VIP	Any process that activates or increases the frequency, rate or extent of adenylate cyclase activity.
GO:0045764	GO	BP	positive regulation of cellular amino acid metabolic process	GATA3,HPN,NR1H4,PARK7,PAX8	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amino acid.
GO:0045765	GO	BP	regulation of angiogenesis	ADM2,AGGF1,ALOX12,AMOT,ANGPT4,ANGPTL3,ANGPTL4,ANXA3,APOH,AQP1,BRCA1,BTG1,CCR2,CCR3,CD34,CHI3L1,CHRNA7,CIB1,COL4A2,COL4A3,CTNNB1,CTSH,CXCL13,CXCL8,CXCR3,CYP1B1,DAB2IP,DCN,DLL1,DLL4,ECM1,ECSCR,EGLN1,EMP2,EPHA1,EPHA2,ERBB2,ETS1,F3,FASLG,FGF1,FGF2,FLT1,FOXC1,FOXC2,FOXO4,GATA2,GATA4,GATA6,GDF2,GHRL,GTF2I,HDAC5,HDAC7,HDAC9,HHEX,HIF1A,HIPK1,HIPK2,HMOX1,HOXA5,HRG,HSPB1,HTATIP2,HYAL1,IL17F,IL1A,IL1B,IL6,ISL1,ITGA5,ITGB1BP1,JAK1,KDR,KLF4,KLK3,KRIT1,KRT1,LECT1,LEP,MAP2K5,MMRN2,MTDH,MYDGF,NF1,NODAL,NOS3,NOTCH1,NPPB,NPR1,NTRK1,PDCD10,PDCD6,PDCL3,PDE3B,PF4,PIK3R6,PLCG1,PLXND1,PML,PPP1R16B,PRKCA,PRKCB,PRKD1,PRKD2,PTGIS,PTGS2,PTPRM,RAMP2,RAPGEF3,RGCC,RHOA,RHOB,RLN2,RNH1,ROCK1,ROCK2,RRAS,RUNX1,SASH1,SEMA3E,SEMA5A,SERPINE1,SERPINF1,SFRP1,SFRP2,SP100,SPARC,SPHK1,SPINK5,SRPX2,STAB1,STARD13,STAT1,SULF1,SYNJ2BP,TEK,THBS1,THBS2,TMIGD2,TNFAIP3,TNFSF12,TSPAN12,TWIST1,VASH1,VASH2,VEGFA,VEGFB,WARS,WNT5A,ZC3H12A,ZNF304	Any process that modulates the frequency, rate or extent of angiogenesis.
GO:0045766	GO	BP	positive regulation of angiogenesis	ADM2,AGGF1,ALOX12,ANGPT4,ANGPTL3,ANGPTL4,ANXA3,AQP1,BRCA1,BTG1,CCR3,CD34,CHI3L1,CHRNA7,CIB1,CTSH,CXCL8,CXCR3,CYP1B1,DLL1,ECM1,EPHA1,F3,FGF1,FGF2,FLT1,FOXC2,GATA2,GATA4,GATA6,GDF2,HDAC7,HDAC9,HIF1A,HIPK1,HIPK2,HSPB1,HYAL1,IL1A,IL1B,ISL1,ITGA5,JAK1,KDR,MTDH,MYDGF,NODAL,NOS3,NTRK1,PDCD6,PDCL3,PIK3R6,PLCG1,PPP1R16B,PRKCA,PRKCB,PRKD1,PRKD2,PTGIS,PTGS2,RAMP2,RAPGEF3,RHOB,RLN2,RRAS,RUNX1,SASH1,SEMA5A,SERPINE1,SFRP2,SPHK1,SRPX2,TEK,THBS1,TMIGD2,TNFSF12,TWIST1,VASH2,VEGFA,VEGFB,WNT5A,ZC3H12A,ZNF304	Any process that activates or increases angiogenesis.
GO:0045773	GO	BP	positive regulation of axon extension	CDKL5,DSCAM,GOLGA4,ISLR2,L1CAM,LIMK1,MACF1,MAPT,MEGF8,NRP1,NTN1,RUFY3,SEMA5A,SEMA7A,SHTN1,TWF2,VEGFA	Any process that activates or increases the frequency, rate or extent of axon extension.
GO:0045776	GO	BP	negative regulation of blood pressure	ADIPOQ,BMPR2,CALCA,DRD2,DRD3,FFAR3,SCPEP1,SOD2	Any process in which the force of blood traveling through the circulatory system is decreased.
GO:0045777	GO	BP	positive regulation of blood pressure	CARTPT,CYP11B2,ENG,ID2,OR51E2,PDE4D,QRFP,SPX,TPM1	Any process in which the force of blood traveling through the circulatory system is increased.
GO:0045778	GO	BP	positive regulation of ossification	ACVR1,ACVR2A,ACVR2B,ANO6,ATP6AP1,ATRAID,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CTNNBIP1,CYR61,DDR2,FBN2,GPM6B,HGF,IFITM1,IGF1,IL6,IL6R,IL6ST,KL,LTF,MEF2C,NELL1,NPNT,OSR1,OSR2,P2RX7,PKDCC,PRKD1,PTH,SLC8A1,SOX11,SUCO,TFAP2A,TMEM119,TP63,WNT4,WNT5A,WNT7B,ZBTB16,ZHX3	Any process that activates or increases the frequency, rate or extent of bone formation.
GO:0045780	GO	BP	positive regulation of bone resorption	ADAM8,ATP6AP1,DCSTAMP,MC4R,SYK,TNFSF11	Any process that activates or increases the frequency, rate or extent of bone resorption.
GO:0045792	GO	BP	negative regulation of cell size	AKT1S1,CAV3,DEPTOR,PTEN,RDX	Any process that reduces cell size.
GO:0045794	GO	BP	negative regulation of cell volume	ANO6,CLCN3,KCNMA1,P2RX7,SHANK3	Any process that decreases cell volume.
GO:0045806	GO	BP	negative regulation of endocytosis	ADIPOQ,ANXA2,APOC1,APOC2,APOC3,ARF6,ATXN2,CAV1,CD300A,DLG4,GNB2L1,LGALS3,LILRB1,LRSAM1,MTMR2,NR1H2,NR1H3,PACSIN3,PICALM,PRKD1,PROM2,PRTN3,RAC1,RUBCN,SCAMP5,SDCBP,SNX3,SNX33,UBQLN2,UNC119	Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis.
GO:0045807	GO	BP	positive regulation of endocytosis	ABCA7,AHI1,AHSG,ANGPT1,ANKFY1,ANO6,APOA5,ARRB1,ARRB2,ATAD1,AXL,AZU1,B2M,BICD1,C2,C3,C4A,C4B,CALR,CALY,CAMK1D,CBL,CBLL1,CCL19,CCL2,CCL21,CD63,CLIP3,CYBA,DAB2,DLL1,DOCK2,F2RL1,FLOT1,GAS6,GATA2,GREM1,HAMP,HFE,HIP1,HNRNPK,IL1B,ITGAV,LDLRAP1,LMAN2,MAGI2,MERTK,NCKAP1L,NEDD4L,NLGN1,NTF3,PCSK9,PICK1,PPT1,PYCARD,RAB21,RAB27A,SCYL2,SELE,SERPINE1,SFRP4,SFTPD,SGIP1,SLC11A1,SNCA,SPACA3,STAP1,SYNJ1,TBC1D5,TF,TFR2,TNF,TOR1A,TSPAN1,TUB,TULP1,VEGFA,VPS28,VTN,WASL,WNT3A	Any process that activates or increases the frequency, rate or extent of endocytosis.
GO:0045814	GO	BP	negative regulation of gene expression, epigenetic	AEBP2,ARID4B,BAZ2A,BEND3,CCNH,CD3EAP,CDK7,DNMT1,DNMT3A,DNMT3B,EED,EPC1,ERCC2,ERCC3,EZH2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,H2AFY,H2AFY2,H3F3A,HDAC1,HDAC2,HDAC5,HELLS,HIST1H3A,HIST1H4A,HIST2H3A,JARID2,KMT2D,MBD2,MNAT1,MTF2,PHF1,PHF19,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,RBBP4,RBBP7,RRP8,SAP130,SAP18,SAP30,SAP30BP,SAP30L,SIN3A,SIRT1,SIRT2,SIRT4,SIRT5,SMARCA5,SPI1,SUDS3,SUV39H1,SUZ12,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TRIM27,TTF1,TWISTNB,UBR2,UBTF,ZNRD1	Any epigenetic process that stops, prevents or reduces the rate of gene expression.
GO:0045815	GO	BP	positive regulation of gene expression, epigenetic	ACTB,AICDA,APOBEC1,ARID1A,ARID1B,ASF1A,BAZ1B,CD3EAP,CHEK1,DDX21,DEK,EP300,ERCC6,H2AFY,H3F3A,HIST1H3A,HIST1H4A,HIST2H3A,HMGA1,KAT2A,KAT2B,KMT2B,MYBBP1A,MYO1C,PADI2,PHF2,PHF8,POLR1A,POLR1B,POLR1C,POLR1D,POLR1E,POLR2E,POLR2F,POLR2H,POLR2K,POLR2L,SF3B1,SLC50A1,SMARCA5,SMARCD1,TAF1A,TAF1B,TAF1C,TAF1D,TBP,TET1,TWISTNB,WBP2,ZNRD1	Any epigenetic process that activates or increases the rate of gene expression.
GO:0045820	GO	BP	negative regulation of glycolytic process	ACTN3,CBFA2T3,FBP1,HDAC4,PPARA	Any process that stops, prevents, or reduces the frequency, rate or extent of glycolysis.
GO:0045821	GO	BP	positive regulation of glycolytic process	ARNT,ENTPD5,GAPDHS,HIF1A,IGF1,INS,INSR,MLXIPL,P2RX7,PRKAA1,PRKAA2	Any process that activates or increases the frequency, rate or extent of glycolysis.
GO:0045822	GO	BP	negative regulation of heart contraction	ADRBK1,AGTR2,FKBP1B,PDE4D,PIK3CG,PLN,RNF207,SPTBN4,SPX,SRI,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction.
GO:0045823	GO	BP	positive regulation of heart contraction	ADRA1A,ATP2A2,EDN1,EDN2,EDN3,GSK3A,HRC,KCNQ1,NKX2-5,NOS1AP,NPPA,PDE4D,RGS2,RNF207,RYR2,SCN3B,TGFB2,TPM1	Any process that activates or increases the frequency, rate or extent of heart contraction.
GO:0045824	GO	BP	negative regulation of innate immune response	A2M,ARRB2,CACTIN,CR1,DHX58,DNAJA3,HLA-A,HLA-B,HLA-E,IFI16,INS,IRAK3,IRG1,LGALS9,LILRB1,MICA,MUL1,NLRC5,NR1H2,NR1H3,PPARG,PTPN2,RPS19,SERPINB4,SERPINB9,SERPING1,SUSD4,TNFAIP3,TRAFD1,TYRO3	Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.
GO:0045830	GO	BP	positive regulation of isotype switching	CLCF1,IL4,PAXIP1,TGFB1,TNFSF13,TNFSF4	Any process that activates or increases the frequency, rate or extent of isotype switching.
GO:0045833	GO	BP	negative regulation of lipid metabolic process	ACADL,ACADVL,ADRA2A,AKR1C3,AKT1,APOA2,APOC1,APOC2,APOC3,APOD,APOE,BMP2,BMP5,BRCA1,BSCL2,CIDEA,CYP27B1,DAB2IP,DKK3,ERLIN1,ERLIN2,FBXW7,FGF19,GFI1,GPER1,GPLD1,HCAR2,IL1B,INS,METTL20,NFKB1,NR1H4,PDE3B,PDGFA,PDGFB,PIBF1,PIK3IP1,PLIN5,PPP2R5A,PRKAA1,PROX1,REST,RUBCN,SCAP,SIK1,SIRT1,SIRT4,SLC27A1,SNAI1,SNAI2,SOD1,TNF,TRIB3,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,WNT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving lipids.
GO:0045834	GO	BP	positive regulation of lipid metabolic process	AADAC,ABCD2,ABCG1,ABHD5,ACSL3,ADIPOQ,ADRB2,AGT,AGTR1,AKT1,AKT2,AMBRA1,ANGPTL3,APOA1,APOA2,APOA4,APOA5,APOC1,APOC2,APOE,ATG14,BMP6,CCL19,CCL21,CCR7,CD81,CNEP1R1,CREB1,CREBL2,CTDNEP1,EEF1A2,EPHA8,ERBB4,FABP3,FGF1,FGF2,FGFR3,FGR,FLT1,FLT3,GNB2L1,GPLD1,HSD17B13,HTR2A,HTR2B,HTR2C,IFNG,IL1B,INS,IRS1,IRS2,KIT,LDLR,LDLRAP1,MID1IP1,MLXIPL,MLYCD,MTOR,NOD2,NR1D1,NR1H2,NR1H3,NR4A3,NSMAF,PDGFB,PDGFRA,PDGFRB,PIK3R4,PLIN5,PNPLA2,PPARA,PPARGC1A,PRKAA1,PRKCD,PTGS2,PTK2,PTK2B,SCARB1,SCP2,SIRT4,SMPD2,SMPD3,SORBS1,SPTLC1,SPTLC2,SREBF1,STOML2,TEK,TGFB1,TNF,TNFAIP8L3,TNFRSF1A,TWIST1,WNT4,XBP1,ZP3	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving lipids.
GO:0045837	GO	BP	negative regulation of membrane potential	ARL6IP5,BNIP3,HEBP2,PMAIP1,PRELID1	Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
GO:0045838	GO	BP	positive regulation of membrane potential	ANK3,BAD,GLRX,STOML2,VCP	Any process that activates or increases the frequency, rate or extent of establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
GO:0045839	GO	BP	negative regulation of mitotic nuclear division	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AURKAIP1,BMP4,BMP7,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CHEK1,CSNK2A1,CSNK2A2,KLHL22,MAD1L1,MAD2L1,MAD2L2,NME6,PLK1,RGCC,TERF1,TEX14,TOM1L1,TOM1L2,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
GO:0045840	GO	BP	positive regulation of mitotic nuclear division	AURKA,BECN1,BIRC5,CD28,CDCA5,CUL3,DLGAP5,DMRT1,DRD3,EDN1,EDN3,EGF,EPGN,EREG,ESPL1,H2AFY,IGF1,IGF2,IL1A,IL1B,INS,INSR,LRP5,NSMCE2,NUSAP1,PDGFB,PDGFRB,PHB2,PHIP,PLK1,PTEN,RB1,RGCC,SLF1,SLF2,SMC5,TERF1,TGFA,UBE2C	Any process that activates or increases the frequency, rate or extent of mitosis.
GO:0045842	GO	BP	positive regulation of mitotic metaphase/anaphase transition	CUL3,DLGAP5,ESPL1,NSMCE2,PLK1,PTEN,RB1,SMC5	Any process that activates or increases the frequency, rate or extent of the mitotic metaphase to anaphase transition.
GO:0045843	GO	BP	negative regulation of striated muscle tissue development	BMP2,BMP4,DKK1,FGF3,FGF8,GSK3A,MSTN,MYOCD,NOG,PRICKLE1,RBP4,SIRT2,SIX4,SOX15,TBX5,TGFB1,TP73,USP19	Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development.
GO:0045844	GO	BP	positive regulation of striated muscle tissue development	ACTN3,AKAP6,ARNTL,BMP10,BMP4,DLL1,EFNB2,ERBB4,FGF2,FGFR2,FLOT1,GPC1,GREM1,MEF2C,MKL2,MYOCD,MYOG,NACA,NOTCH1,NRG1,RBPJ,TBX1,TBX2,TBX20,TGFB1,WNT3A	Any process that activates or increases the frequency, rate or extent of striated muscle development.
GO:0045851	GO	BP	pH reduction	ATP6AP1,ATP6V0E1,ATP6V0E2,ATP6V1B1,ATP6V1H,CLCN3,CLN3,CLN5,CLN6,GPR89A,PPT1,RAB20,RAB38,RAB39A,RAB7A,SLC11A1	Any process that reduces the internal pH of an organism, part of an organism or a cell, measured by the concentration of the hydrogen ion.
GO:0045869	GO	BP	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,HMGA2,INPP5K	Any process that stops, prevents, or reduces the frequency, rate or extent of single stranded viral RNA replication via double stranded DNA intermediate.
GO:0045879	GO	BP	negative regulation of smoothened signaling pathway	BTRC,CHRD,GLI3,GLIS2,GPR161,HHIP,IFT122,KIF7,PTCH1,PTCH2,SUFU,TULP3,ULK3	Any process that stops, prevents, or reduces the frequency, rate or extent of smoothened signaling.
GO:0045880	GO	BP	positive regulation of smoothened signaling pathway	DCDC2,EVC,GLI1,IHH,KIF7,SFRP1,SHH,STK36,ULK3	Any process that activates or increases the frequency, rate or extent of smoothened signaling.
GO:0045907	GO	BP	positive regulation of vasoconstriction	ADRA1A,CAV1,F2R,FGA,FGB,FGG,SMTNL1	Any process that activates or increases the frequency, rate or extent of vasoconstriction.
GO:0045909	GO	BP	positive regulation of vasodilation	AGTR2,CALCA,CPS1,EPHX2,F2RL1,GPER1,HMOX1,INS,NOS1,NOS3,SCPEP1	Any process that activates or increases the frequency, rate or extent of vasodilation.
GO:0045910	GO	BP	negative regulation of DNA recombination	BLM,FBXO18,MSH2,MSH3,MSH6,PARPBP,POLQ,TERF2,TERF2IP,THOC1,ZRANB3	Any process that stops, prevents, or reduces the frequency, rate or extent of DNA recombination.
GO:0045911	GO	BP	positive regulation of DNA recombination	CLCF1,IL4,PAXIP1,PRDM9,TGFB1,TNFSF13,TNFSF4	Any process that activates or increases the frequency, rate or extent of DNA recombination.
GO:0045912	GO	BP	negative regulation of carbohydrate metabolic process	ACER2,ACTN3,ADIPOQ,AP2A1,C1QTNF3,CBFA2T3,CLK2,CLTC,ENPP1,FBP1,FOXA2,GCK,GCKR,GRB10,GSK3A,GSK3B,HDAC4,INPP5K,INS,PARK2,PASK,PLEK,PPARA,SIK1,SOGA1,TGFB1,TINF2,TMEM59,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VIMP	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving carbohydrate.
GO:0045913	GO	BP	positive regulation of carbohydrate metabolic process	ACTN3,AKT1,AKT2,ARFGEF1,ARNT,ARPP19,BAD,CD244,CHP1,DYRK2,EGF,ENTPD5,GAPDHS,GCK,GOLGA2,GPER1,GPLD1,HIF1A,HRH1,IGF1,IGF2,INS,INSR,IRS1,IRS2,LHCGR,MLXIPL,NFKB1,P2RX7,PDGFB,PHKG2,PMAIP1,PPARGC1A,PRKAA1,PRKAA2,PRKCE,PTH,PTH1R,PTPN2,RAMP1,SLC51B,SNCA,SORBS1,TIGAR	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving carbohydrate.
GO:0045916	GO	BP	negative regulation of complement activation	A2M,C4BPA,C4BPB,CD55,CR1,MASP1,SERPING1,SUSD4	Any process that stops, prevents, or reduces the frequency, rate or extent of complement activation.
GO:0045920	GO	BP	negative regulation of exocytosis	ADRA2A,ANXA1,CCR2,CD300A,CD84,IL1RAPL1,LGALS9,RAB33B,REST,SNCA,SPINK13,STXBP3,STXBP6,VPS4B	Any process that stops, prevents, or reduces the frequency, rate or extent of exocytosis.
GO:0045921	GO	BP	positive regulation of exocytosis	AP1G1,ATP6AP1,CACNA1H,CFTR,CHMP2A,CLASP1,CLASP2,DOC2B,EXPH5,F2RL1,FAM170B,FGA,FGB,FGG,FGR,GAB2,GLRA1,HGS,IFNG,IQCF1,KCNB1,LAMP1,NLGN1,PDCD6IP,PLCB1,RAB15,RAB27A,RAB27B,RAB2B,RAB3A,RAB3D,RAB5A,RAB7A,RAB9A,SCAMP5,SDC1,SDC4,SDCBP,SMPD3,SNF8,SNX4,STAM,STX1A,STX4,STXBP5,SYTL4,TMEM27,TSG101,UNC13B,UNC13D,VAMP7,VAMP8,VPS4A,VPS4B,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of exocytosis.
GO:0045922	GO	BP	negative regulation of fatty acid metabolic process	ACADL,ACADVL,AKT1,APOC1,APOC3,BRCA1,ERLIN1,ERLIN2,INS,METTL20,PIBF1,PLIN5,SIRT1,SIRT4,TRIB3,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
GO:0045923	GO	BP	positive regulation of fatty acid metabolic process	ABCD2,ADIPOQ,AKT2,APOA4,APOA5,APOC2,IRS1,IRS2,MID1IP1,MLXIPL,MLYCD,NR1H2,NR1H3,NR4A3,PLIN5,PPARA,PPARGC1A,PTGS2,TWIST1	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.
GO:0045926	GO	BP	negative regulation of growth	ACVR1B,ACVRL1,ADAM15,AGTR2,ALOX15B,APBB1,APBB2,BBC3,BBS2,BCL11A,BCL6,BMP10,BMP4,BMPR2,BST2,BTG1,CAMP,CAPRIN2,CCAR2,CCDC85B,CDA,CDHR2,CDKN1A,CDKN1B,CDKN2A,CDKN2AIP,CDKN2C,CDKN2D,CRLF3,CYP27B1,DACT3,DCBLD2,DCC,DCSTAMP,DCUN1D3,DDX3X,EI24,ENO1,ENPP1,ESR2,FBP1,FGF13,FGFR3,FHL1,FLCN,FRZB,GAL,GAS2L1,GDF2,GJA1,GNAS,GNB2L1,GNG4,GSK3A,HNF4A,HRG,HYAL1,HYAL2,ING1,ING4,ING5,INHBA,IP6K2,JADE1,MBL2,MSTN,MSX1,MT1A,MT1B,MT1E,MT1F,MT1G,MT1H,MT1M,MT1X,MT2A,MT3,MUL1,MYL2,NAIF1,NDRG3,NDUFA13,NDUFS3,NKD1,NME6,NOG,NOV,NPPB,NPR1,OSGIN1,PHB,PML,PNPT1,PPP1R9B,PPP2CA,PPP2R1A,PPT1,PSRC1,PTCH1,PTEN,PTPRJ,RBBP7,RBP4,RERG,RNF6,RTN4,RTN4R,SCGB3A1,SEMA5A,SERTAD2,SERTAD3,SFRP1,SFRP2,SH3BP4,SIPA1,SIRT1,SLC6A4,SLIT2,SLIT3,SMAD3,SMAD4,SMARCA2,SMARCA4,SOX17,ST7L,STK11,TBX5,TCHP,TGFB1,TGFB2,TIRAP,TP53,TP53TG5,TP73,TSPYL2,WFDC1,WNT11,WT1,WWC1,WWC2,WWC3,ZC3H12D	Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.
GO:0045927	GO	BP	positive regulation of growth	ACSL4,ACTN3,ADAM10,ADAM17,ADNP2,AGR2,AGRN,AKAP6,AKT1,ALOX12,BASP1,BCL11A,BCL2,BDNF,BMP10,CAPN3,CDC42,CDKL5,CDKN2AIP,CIB1,CPNE5,CPNE6,CPNE9,CSNK2A1,CSNK2A3,CXCL16,DDX3X,DERL2,DLL1,DNPH1,DSCAM,ERBB2,ERBB4,EXOSC2,EXOSC4,EXOSC9,FGF2,FGFR1OP,FGFR2,FXN,GH1,GHR,GHRH,GHRHR,GHRL,GHSR,GOLGA4,H3F3A,H3F3C,HIST1H1B,HPN,HYAL1,IGF1,IL2,INO80,INS,INSR,ISLR2,ITSN2,L1CAM,LEF1,LEP,LGI1,LIMK1,MACF1,MAPT,MEF2C,MEGF8,MMP14,MTPN,N6AMT1,NACA,NCBP1,NEDD4L,NOL8,NOTCH1,NRG1,NRP1,NTN1,OSBP,PLCB1,PPIB,PPM1F,PPP1R1C,PROX1,PRSS2,PSMD10,RASAL1,RBPJ,RIMS1,RIMS2,RPS6KA1,RPS6KA3,RUFY3,S100A8,S100A9,SDCBP,SEMA4D,SEMA5A,SEMA7A,SFRP1,SFRP2,SHTN1,SLC25A33,SLC44A4,SMURF1,SOX15,SPHK1,SUPV3L1,SYT1,SYT17,SYT2,SYT3,SYT4,TAF9,TAF9B,TBX2,TBX20,TGFB2,TGFBR1,TRIM32,TWF2,UNC13A,USP47,VEGFA,WFS1,WT1,ZNF639,ZP3,ZPR1	Any process that activates or increases the rate or extent of growth, the increase in size or mass of all or part of an organism.
GO:0045930	GO	BP	negative regulation of mitotic cell cycle	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANGEL2,APC,ATF2,ATM,AURKAIP1,BCL2L1,BLM,BMP4,BMP7,BRD7,BRINP3,BTG3,BUB1,BUB1B,BUB3,CASP2,CCNA2,CCND1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC73,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CDKN2B,CENPF,CHEK1,CHEK2,CHFR,CLSPN,CRADD,CSNK2A1,CSNK2A2,CTNNB1,DACT1,DGKZ,DLG1,E2F7,FBXO31,FHL1,FOXC1,FOXN3,FZD3,GAS1,GML,GTSE1,HECA,HMGA2,HRAS,INTS3,JADE1,KANK2,KLHL22,KNTC1,MAD1L1,MAD2L1,MAD2L1BP,MAD2L2,MDC1,MDM2,MUC1,MYO16,NABP1,NABP2,NACC2,NAE1,NBN,NEK11,NKX3-1,NME6,PIDD1,PKD2,PLK1,PLK2,PLK3,PML,PPP2R5C,PRCC,PRKDC,PRMT2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTPN3,RAD17,RB1,RBM38,RFWD2,RFWD3,RGCC,RPA2,RPS27A,RPS27L,SCRIB,SETMAR,SLC9A3R1,SLFN11,SMAD3,SMARCA4,SMC1A,SOX4,TAOK3,TERF1,TEX14,TGFB1,TICRR,TIPIN,TOM1L1,TOM1L2,TP53,TPR,TRIAP1,TRIM35,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP17L2,USP47,WNT9A,ZC3H12D,ZNF207,ZNF655,ZNF830,ZW10,ZWILCH,ZWINT	Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
GO:0045931	GO	BP	positive regulation of mitotic cell cycle	AIF1,ANKRD17,APP,ASNS,AURKA,BECN1,BIRC5,BRD4,CCNB1,CCND1,CD28,CDC25B,CDC6,CDC7,CDCA5,CDK10,CDK4,CUL3,DBF4B,DDX3X,DLGAP5,DMRT1,DRD3,DUSP3,DYNC1LI1,EDN1,EDN3,EGF,EIF4E,EIF4EBP1,EPGN,EREG,ESPL1,FOXA1,GEN1,H2AFY,HES1,IGF1,IGF2,IL1A,IL1B,INS,INSR,KIF20B,LRP5,LSM10,LSM11,MAD2L1,MDM2,NACC2,NKX3-1,NSMCE2,NUSAP1,PCID2,PDGFB,PDGFRB,PHB2,PHIP,PHOX2B,PKN2,PLCB1,PLK1,PPP1R1C,PRKCA,PTEN,RAB11A,RAD51B,RAD51C,RB1,RCC2,RDX,RGCC,RPS6KB1,SLF1,SLF2,SMC5,SPHK1,STOX1,TAL1,TERF1,TGFA,TPR,UBE2C,UBE2E2,USP2,USP22,VPS4B,XRCC3	Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
GO:0045932	GO	BP	negative regulation of muscle contraction	ADRBK1,ATP2A1,DOCK4,DOCK5,PIK3CG,RNF207,SOD1,TNNT1,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of muscle contraction.
GO:0045933	GO	BP	positive regulation of muscle contraction	ADRA1A,ATP2A1,CTTN,F2R,GPER1,GSTO1,KCNQ1,MYOCD,NOS1AP,NPPA,PROK2,RGS2,RNF207,SPHK1,SRF	Any process that activates or increases the frequency, rate or extent of muscle contraction.
GO:0045939	GO	BP	negative regulation of steroid metabolic process	APOE,BMP2,BMP5,CYP27B1,DKK3,ERLIN1,ERLIN2,FGF19,GFI1,NFKB1,NR1H4,PROX1,REST,SCAP,SNAI1,SNAI2,SOD1,UGT1A1,UGT1A8,WNT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving steroids.
GO:0045940	GO	BP	positive regulation of steroid metabolic process	ABCG1,AGT,AGTR1,APOA1,APOA2,APOA4,APOC1,APOE,BMP6,FGF1,IFNG,IL1B,LDLRAP1,NR1D1,PRKAA1,SCP2,TNF,WNT4	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving steroids.
GO:0045943	GO	BP	positive regulation of transcription from RNA polymerase I promoter	ATF4,DHX33,EIF2AK3,ERBB2,MTOR,NCL,NOL11,PHF8,PIH1D1,PPP1R15A,RASL11A,SMARCA4,SMARCB1,UBTF	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase I promoter.
GO:0045945	GO	BP	positive regulation of transcription from RNA polymerase III promoter	AR,CEBPA,CHD8,ELL,ERBB2,ICE1,ICE2,MTOR,RPTOR,ZC3H8	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase III promoter.
GO:0045947	GO	BP	negative regulation of translational initiation	AGO2,ATF4,EIF2AK1,EIF2AK3,EIF2AK4,EIF2B3,EIF2B4,EIF2B5,EIF2S1,EIF3E,EIF4EBP1,EIF4EBP2,EIF4EBP3,FMR1,PAIP2,PAIP2B,RBM4,RPL13A,TPR	Any process that stops, prevents, or reduces the frequency, rate or extent of translational initiation.
GO:0045948	GO	BP	positive regulation of translational initiation	BOLL,CCL5,DAZ1,DAZL,DDX3X,DNAJC3,EIF2AK4,EIF2B5,IMPACT,KHDRBS1,METTL3,NCK1,PPP1R15A,RPS6KB1,RPS6KB2,UHMK1,YTHDF1,YTHDF2	Any process that activates or increases the frequency, rate or extent of translational initiation.
GO:0045953	GO	BP	negative regulation of natural killer cell mediated cytotoxicity	ARRB2,HLA-A,HLA-B,HLA-E,LGALS9,LILRB1,MICA,SERPINB4,SERPINB9	Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
GO:0045954	GO	BP	positive regulation of natural killer cell mediated cytotoxicity	AP1G1,CADM1,CD226,CRTAM,IL12A,IL12B,IL21,KLRK1,LAMP1,NCR3,PVR,PVRL2,RASGRP1,SLAMF6	Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
GO:0045956	GO	BP	positive regulation of calcium ion-dependent exocytosis	CACNA1H,DOC2B,FAM170B,GLRA1,IQCF1,KCNB1,NLGN1,PLCB1,SCAMP5,STX1A,TMEM27,UNC13B,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of calcium ion-dependent exocytosis.
GO:0045980	GO	BP	negative regulation of nucleotide metabolic process	ACTN3,ADRA2A,AKAP6,APLP1,CBFA2T3,CCR2,CDA,DRD2,DRD3,DRD4,EDNRB,EGLN1,FBP1,FLCN,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,GSK3A,HDAC4,HTR1B,LTB4R2,MAPK7,MLXIPL,OPRM1,PALM,PDE2A,PDZD3,PID1,PPARA,PPIF,PRKCA,SNCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving nucleotides.
GO:0045981	GO	BP	positive regulation of nucleotide metabolic process	ABCA1,ACR,ACTN3,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,APOE,ARNT,AVPR2,CALCA,CALCR,CALCRL,CALM1,CAP1,CAP2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD5,EDNRA,ENTPD5,FZD2,GAPDHS,GHRH,GHRHR,GIPR,GLP1R,GNAS,GNB2L1,GPER1,GPR161,GPR65,GSK3A,GUCA1C,GUCA2A,GUCA2B,HIF1A,IGF1,INS,INSR,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MLXIPL,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,P2RX7,P2RY11,PARK7,PF4,PID1,PINK1,PPARGC1A,PRKAA1,PRKAA2,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RCVRN,RLN2,VCP,VIP,WNT5A	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving nucleotides.
GO:0045987	GO	BP	positive regulation of smooth muscle contraction	CTTN,F2R,GPER1,MYOCD,PROK2,SPHK1,SRF	Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.
GO:0045988	GO	BP	negative regulation of striated muscle contraction	ADRBK1,ATP2A1,PIK3CG,RNF207,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle contraction.
GO:0045989	GO	BP	positive regulation of striated muscle contraction	ADRA1A,ATP2A1,GSTO1,KCNQ1,NOS1AP,NPPA,RGS2,RNF207	Any process that activates or increases the frequency, rate or extent of striated muscle contraction.
GO:0045990	GO	BP	carbon catabolite regulation of transcription	CHMP1A,FOXA2,NCOA1,USF1,USF2	A transcription regulation process in which the presence of one carbon source leads to the modulation of the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other carbon sources.
GO:0045992	GO	BP	negative regulation of embryonic development	COL5A1,COL5A2,CTNNB1,DKK1,FUZ,FZD3,FZD7,GATA3,GPR161,LFNG,MESP1,RPS6KA6,SFRP2,SULF1,TBX2	Any process that stops, prevents, or reduces the frequency, rate or extent of embryonic development.
GO:0045995	GO	BP	regulation of embryonic development	ADIPOQ,APOA1,CCSAP,CDK1,CDX1,CDX2,CLASP1,CLASP2,COL5A1,COL5A2,CTNNB1,DAG1,DKK1,DLL1,FOXA2,FUZ,FZD3,FZD7,GATA3,GDNF,GNB2L1,GPR161,HES1,IGF1,IL1RN,INSR,KLF4,LFNG,LHX1,MAP2K5,MAPK7,MESP1,MYADM,NIPBL,NKD1,NPHP3,OSR1,OTX2,PHLDB1,PHLDB2,PLCB1,PPP2R3A,RBM19,RNF207,RPS6KA6,SCX,SEPT7,SFRP2,SHH,SIX1,SIX4,SOX17,SULF1,TBX18,TBX2,TENM4,WDPCP,WNT1,WNT3A,WNT4	Any process that modulates the frequency, rate or extent of embryonic development.
GO:0046006	GO	BP	regulation of activated T cell proliferation	AGER,BTN2A2,CD24,CD274,CLC,FADD,FOXP3,HHLA2,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IL12B,IL12RB1,IL18,IL2,IL23A,IL23R,LGALS9,PDCD1LG2,PRKAR1A,PRNP,PYCARD,RC3H1,RIPK3,TMIGD2	Any process that modulates the frequency, rate or extent of activated T cell proliferation.
GO:0046007	GO	BP	negative regulation of activated T cell proliferation	BTN2A2,CD274,FOXP3,LGALS9,PDCD1LG2,PRKAR1A,PRNP,RC3H1	Any process that stops, prevents or reduces the rate or extent of activated T cell proliferation.
GO:0046015	GO	BP	regulation of transcription by glucose	CHMP1A,FOXA2,RRP8,USF1,USF2	Any process involving glucose that modulates the frequency, rate or extent or transcription.
GO:0046030	GO	MF	inositol trisphosphate phosphatase activity	INPP1,INPP5A,INPP5B,INPP5E,INPP5K,SYNJ1	Catalysis of the reaction: myo-inositol trisphosphate + H2O = myo-inositol bisphosphate + phosphate.
GO:0046031	GO	BP	ADP metabolic process	AK5,AK9,ALDOA,ALDOB,ALDOC,BAD,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,TPI1	The chemical reactions and pathways involving ADP, adenosine 5'-diphosphate.
GO:0046033	GO	BP	AMP metabolic process	ADSL,ADSS,ADSSL1,AK3,AK4,AK9,AMPD3	The chemical reactions and pathways involving AMP, adenosine monophosphate.
GO:0046034	GO	BP	ATP metabolic process	AK4,AK9,ALDOA,ALDOB,ALDOC,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,CHCHD10,COA6,COX10,COX15,CTNS,ENO1,ENO2,ENO3,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GPI,HK1,HK2,HK3,HSPA1A,HSPA1B,HSPA8,LDHA,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,OLA1,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PPP2R5D,PRKAG2,SDHAF2,SLC25A13,STOML2,SURF1,TAZ,TEFM,TGFB1,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator.
GO:0046037	GO	BP	GMP metabolic process	CARD11,CASK,DLG1,DLG2,GMPR2,HPRT1,MAGI3,MPP1,MPP2,MPP3,PDE6A,PDE6B,TJP2	The chemical reactions and pathways involving GMP, guanosine monophosphate.
GO:0046039	GO	BP	GTP metabolic process	AK3,AK4,GNAI3,LRRK2,RHOQ	The chemical reactions and pathways involving GTP, guanosine triphosphate.
GO:0046058	GO	BP	cAMP metabolic process	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,CALCRL,GNAS,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PTH,PTHLH,RAMP2,TAAR1	The chemical reactions and pathways involving the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).
GO:0046068	GO	BP	cGMP metabolic process	AQP1,GUCY1A3,GUCY1B3,HTR2B,HTR2C,NPPA,NPPB,NPPC,NPR1,NPR2,PDE1B,PDE2A,PDE5A,PDE9A	The chemical reactions and pathways involving cyclic GMP, guanosine 3',5'-phosphate.
GO:0046112	GO	BP	nucleobase biosynthetic process	CAD,GMPS,HPRT1,PAICS,PRPS1,SHMT1	The chemical reactions and pathways resulting in the formation of a nucleobase, a nitrogenous base that is a constituent of a nucleic acid.
GO:0046128	GO	BP	purine ribonucleoside metabolic process	ABHD14B,ACOT7,ACPP,ADA,ADSL,ADSS,ADSSL1,AK3,AK4,AK5,AK9,ALDOA,ALDOB,ALDOC,AMPD3,ATP1A2,ATP1B1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,BAD,BHMT2,BPNT1,CARD11,CASK,CECR1,CHCHD10,COA6,COASY,COX10,COX15,CROT,CTNS,DGUOK,DLG1,DLG2,ENO1,ENO2,ENO3,ENPP1,ENPP4,ENTPD5,FIGNL1,GAPDH,GAPDHS,GBAS,GCK,GMPR2,GNAI3,GNMT,GPI,HK1,HK2,HK3,HPRT1,HSPA1A,HSPA1B,HSPA8,LDHA,LRRK2,MAGI3,MAT2A,MAT2B,MCEE,MLYCD,MPP1,MPP2,MPP3,MT-ATP6,MT-ATP8,MT-CO2,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,MTRR,MYH3,MYH4,MYH6,MYH7,MYH8,NADK,NDUFA1,NDUFA10,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NUDT18,NUDT7,OLA1,PANK2,PAPSS1,PAPSS2,PDE6A,PDE6B,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PNP,PPCDC,PPCS,PPP2R5D,PRKAG2,RHOQ,SDHAF2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1,SURF1,TAZ,TEFM,TGFB1,TJP2,TPI1,UQCC3,UQCR10,UQCRB,UQCRC1,UQCRC2,UQCRH,VPS9D1	The chemical reactions and pathways involving any ribonucleoside, a nucleoside in which purine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0046129	GO	BP	purine ribonucleoside biosynthetic process	ACOT7,ADA,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD10,COASY,GBAS,HPRT1,MAT2A,MAT2B,MT-ATP6,MT-ATP8,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,PRKAG2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of any purine ribonucleoside, a nucleoside in which purine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0046130	GO	BP	purine ribonucleoside catabolic process	ADA,AMPD3,CECR1,ENPP4,HPRT1,MLYCD,NUDT18,NUDT7,PNP	The chemical reactions and pathways resulting in the breakdown of any purine ribonucleoside, a nucleoside in which purine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0046131	GO	BP	pyrimidine ribonucleoside metabolic process	AK3,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,CMPK1,CTPS1,ENTPD4,UMPS,UPP2	The chemical reactions and pathways involving any ribonucleoside, a nucleoside in which pyrimidine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0046133	GO	BP	pyrimidine ribonucleoside catabolic process	APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,ENTPD4	The chemical reactions and pathways resulting in the breakdown of any ribonucleoside, a nucleoside in which a pyrimidine base is linked to a ribose (beta-D-ribofuranose) molecule.
GO:0046134	GO	BP	pyrimidine nucleoside biosynthetic process	CAD,CDA,CMPK1,CTPS1,DCK,DCTD,DHFRL1,DHODH,DUT,PUDP,TK1,TK2,TYMP,TYMS,UCK1,UCK2,UMPS,UPP1,UPP2	The chemical reactions and pathways resulting in the formation of one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
GO:0046135	GO	BP	pyrimidine nucleoside catabolic process	AGXT2,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,DPYD,DPYS,ENTPD4,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,TYMP,UPB1,UPP1,UPP2	The chemical reactions and pathways resulting in the breakdown of one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).
GO:0046137	GO	BP	negative regulation of vitamin metabolic process	AKR1C3,CYP27B1,GFI1,NFKB1,SNAI1,SNAI2	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving a vitamin, one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0046148	GO	BP	pigment biosynthetic process	ALAD,ALAS1,ALAS2,AP3D1,ATPIF1,CITED1,COX10,COX15,CPOX,DCT,FECH,FXN,GMPS,GPR143,HMBS,HPRT1,NFE2L1,OCA2,PAICS,PPOX,PRPS1,SHMT1,SLC25A38,TRPC1,TSPO,TYR,UROD,UROS	The chemical reactions and pathways resulting in the formation of a pigment, any general or particular coloring matter in living organisms, e.g. melanin.
GO:0046164	GO	BP	alcohol catabolic process	ADH4,AKR1B10,AKR1C3,AKR1D1,CEL,CYP24A1,CYP46A1,CYP7A1,ENPP2,FGF23,HAO1,IMPA1,IMPA2,INPP5K,LIPC,MIOX,MT3,NUDT3,PLA2G15,PNPLA8,PTEN,SCARF1,SMPD3,SMPD4,SNX17,SORD,SRD5A3,SYNJ1,TRERF1	The chemical reactions and pathways resulting in the breakdown of alcohols, any of a class of compounds containing one or more hydroxyl groups attached to a saturated carbon atom.
GO:0046165	GO	BP	alcohol biosynthetic process	ABHD3,ACAA2,ACER1,ACER2,ACER3,ACHE,ACLY,AKR1C3,APOA1,APOA2,ARV1,CACNA1H,CDS1,CEPT1,CHAT,CHKA,CHKB,CHPT1,CNBP,CYP11B1,CYP11B2,CYP27B1,CYP3A4,CYP51A1,DHCR24,DHCR7,DPAGT1,EBP,FDFT1,FDPS,FGF2,G6PD,GBA,GGPS1,GOT1,GPAT4,HMGCR,HMGCS1,HSD17B7,IDI1,IDI2,IP6K3,LBR,LCAT,LPCAT2,LPIN1,LPIN2,LPIN3,LSS,MSMO1,MVD,MVK,NPC1L1,NSDHL,NUS1,PARK7,PCK1,PCYT1A,PCYT1B,PEMT,PGP,PHOSPHO1,PLA2G4A,PMVK,PRKAG2,SAMD8,SC5D,SCP2,SGMS1,SGMS2,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SPHK1,SPHK2,SQLE,TM7SF2	The chemical reactions and pathways resulting in the formation of alcohols, any of a class of compounds containing one or more hydroxyl groups attached to a saturated carbon atom.
GO:0046173	GO	BP	polyol biosynthetic process	ACER1,ACER2,ACER3,CYP27B1,CYP3A4,FGF2,GBA,GOT1,IP6K3,PCK1,PGP,SCP2,SPHK1,SPHK2	The chemical reactions and pathways resulting in the formation of a polyol, any alcohol containing three or more hydroxyl groups attached to saturated carbon atoms.
GO:0046174	GO	BP	polyol catabolic process	IMPA1,IMPA2,INPP5K,MIOX,NUDT3,PTEN,SORD,SYNJ1	The chemical reactions and pathways resulting in the breakdown of a polyol, any alcohol containing three or more hydroxyl groups attached to saturated carbon atoms.
GO:0046185	GO	BP	aldehyde catabolic process	AGXT,AGXT2,ALDH3B1,HOGA1,PARK7,PDXP	The chemical reactions and pathways resulting in the breakdown of aldehydes, any organic compound with the formula R-CH=O.
GO:0046189	GO	BP	phenol-containing compound biosynthetic process	CITED1,DAO,DBH,DCT,DDC,GATA3,GCH1,HAND2,INSM1,PAH,PNMT,SNCA,TGFB2,TH,TRPC1,TYR	The chemical reactions and pathways resulting in the formation of a phenol, any compound containing one or more hydroxyl groups directly attached to an aromatic carbon ring.
GO:0046209	GO	BP	nitric oxide metabolic process	AKT1,ARG2,CALM1,CAV1,CPS1,CYGB,CYP1B1,DDAH1,DDAH2,DHFR,DNM2,GCH1,GCHFR,HSP90AA1,LYPLA1,NOS1,NOS2,NOS3,NOSIP,NOSTRIN,NQO1,PRKG2,PTS,SPR,WASL,ZDHHC21	The chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.
GO:0046219	GO	BP	indolalkylamine biosynthetic process	AANAT,ASMT,DDC,TPH1,TPH2	The chemical reactions and pathways resulting in the formation of indolalkylamines, indole or indole derivatives containing a primary, secondary, or tertiary amine group.
GO:0046320	GO	BP	regulation of fatty acid oxidation	ABCD2,ACADL,ACADVL,AKT1,AKT2,FABP3,IRS1,IRS2,LONP2,METTL20,MLYCD,NR4A3,PDK4,PLIN5,PPARA,PPARGC1A,PRKAG2,SIRT4,TWIST1,TYSND1	Any process that modulates the frequency, rate or extent of fatty acid oxidation.
GO:0046321	GO	BP	positive regulation of fatty acid oxidation	ABCD2,AKT2,IRS1,IRS2,MLYCD,NR4A3,PLIN5,PPARA,PPARGC1A,TWIST1	Any process that activates or increases the frequency, rate or extent of fatty acid oxidation.
GO:0046322	GO	BP	negative regulation of fatty acid oxidation	ACADL,ACADVL,AKT1,METTL20,PLIN5,SIRT4	Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid oxidation.
GO:0046324	GO	BP	regulation of glucose import	ADIPOQ,AKT1,AKT2,APPL1,ARPP19,CAPN10,CLTCL1,CREBL2,ENPP1,FAM132A,FFAR3,FGF19,FGF21,GRB10,GSK3A,IGF1,INS,INSR,IRS1,IRS2,ITLN1,LEP,MZB1,NGFR,OSBPL8,PEA15,PID1,PIK3R1,PIK3R2,PIK3R3,PRKAG2,PRKCI,PTH,PTPN11,RARRES2,RHOQ,SORBS1,VIMP	Any process that modulates the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
GO:0046325	GO	BP	negative regulation of glucose import	ENPP1,GRB10,GSK3A,LEP,MZB1,PEA15,PID1,VIMP	Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
GO:0046326	GO	BP	positive regulation of glucose import	ADIPOQ,AKT1,AKT2,ARPP19,CAPN10,CLTCL1,CREBL2,FFAR3,FGF19,FGF21,IGF1,INS,INSR,IRS1,IRS2,ITLN1,OSBPL8,PIK3R1,PIK3R2,PIK3R3,PRKCI,PTH,PTPN11,RARRES2,RHOQ,SORBS1	Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
GO:0046328	GO	BP	regulation of JNK cascade	AIDA,AMBP,ARHGEF5,AXIN1,BIRC7,CARD9,CCL19,CCL21,CCR7,CD27,COPS5,CTGF,DAB2IP,DACT1,DAXX,DBNL,DNAJA1,DUSP19,DUSP3,DVL2,DVL3,EDA2R,EDN1,EPHB1,ERN1,F2RL1,FGF19,FKTN,FLT4,FZD10,FZD7,GADD45A,GADD45B,GADD45G,GPS2,GSTP1,HACD3,HDAC3,HIPK2,HIPK3,HMGB1,HRAS,IGF1R,ITCH,LTBR,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K4,MAP4K5,MAPK8IP1,MAPK8IP2,MAPK8IP3,MARVELD3,MDFIC,MECOM,MEN1,MINK1,MUL1,NCOR1,NOD2,PAK1,PARK2,PDCD4,PER1,PHLPP1,PINK1,PKN1,PLCB1,PPEF2,PTK2B,PTPN22,PYCARD,RAP2A,RASGRP1,RASSF2,RIPK1,RPS3,SASH1,SDCBP,SERPINB3,SERPINF2,SLAMF1,TAOK1,TAOK2,TAOK3,TIRAP,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TPD52L1,TRAF2,TRAF4,TRAF6,ULK4,UNC5CL,WNT16,WNT5A,ZMYND11,ZNF622,ZNF675	Any process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade.
GO:0046329	GO	BP	negative regulation of JNK cascade	AIDA,AMBP,DACT1,DNAJA1,DUSP19,DUSP3,F2RL1,FKTN,GPS2,GSTP1,HDAC3,HIPK3,ITCH,MARVELD3,MECOM,MEN1,NCOR1,PARK2,PDCD4,PER1,PINK1,PTPN22,SERPINB3,TAOK3,ZMYND11,ZNF675	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the JNK cascade.
GO:0046330	GO	BP	positive regulation of JNK cascade	ARHGEF5,AXIN1,BIRC7,CARD9,CCL19,CCL21,CCR7,CD27,CTGF,DAB2IP,DAXX,DBNL,DUSP19,DVL2,DVL3,EDA2R,EDN1,ERN1,F2RL1,FGF19,FLT4,FZD10,FZD7,GADD45A,GADD45B,GADD45G,HACD3,HIPK2,HMGB1,HRAS,LTBR,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MDFIC,MINK1,MUL1,NOD2,PAK1,PKN1,PLCB1,PTK2B,PYCARD,RASGRP1,RASSF2,RIPK1,RPS3,SASH1,SDCBP,SERPINF2,SLAMF1,TAOK1,TAOK2,TAOK3,TIRAP,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TPD52L1,TRAF2,TRAF4,TRAF6,UNC5CL,WNT16,WNT5A,ZNF622	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
GO:0046332	GO	MF	SMAD binding	ACVR1,ACVR1B,ACVRL1,BMP2,BMPR1A,BMPR1B,DAB2,EID2,FOXH1,MAGI2,SNW1,STUB1,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1,USP9Y,YY1	Interacting selectively and non-covalently with a SMAD signaling protein.
GO:0046337	GO	BP	phosphatidylethanolamine metabolic process	ALOX15,CEPT1,CHKA,CHKB,EPT1,ETNK1,ETNK2,ETNPPL,HRASLS5,LPIN1,LPIN2,LPIN3,PCYT2,PHOSPHO1,PISD,PLA2G15,PNPLA8,SLC27A1	The chemical reactions and pathways involving phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine. It is a major structural phospholipid in mammalian systems. It tends to be more abundant than phosphatidylcholine in the internal membranes of the cell and is an abundant component of prokaryotic membranes.
GO:0046339	GO	BP	diacylglycerol metabolic process	ANG,APOA2,DAGLA,DGAT1,DGAT2,DGKD,DGKK,PGS1,PLCE1	The chemical reactions and pathways involving diacylglycerol, a glyceride in which any two of the R groups (positions not specified) are acyl groups while the remaining R group can be either H or an alkyl group.
GO:0046348	GO	BP	amino sugar catabolic process	AMDHD2,CHIA,CHIT1,GNPDA1,NAGK,NPL,RENBP	The chemical reactions and pathways resulting in the breakdown of any amino sugar, sugars containing an amino group in place of a hydroxyl group.
GO:0046349	GO	BP	amino sugar biosynthetic process	GFPT1,GFPT2,GNPNAT1,NANP,PGM3,UAP1	The chemical reactions and pathways resulting in the formation of any amino sugar, sugars containing an amino group in place of a hydroxyl group.
GO:0046364	GO	BP	monosaccharide biosynthetic process	AKR1B1,ALDOA,ALDOB,ALDOC,ATF4,CHST15,CRTC2,CRY1,ENO1,ENO2,ENO3,FBP1,FBP2,G6PC,G6PD,GAPDH,GAPDHS,GOT1,GOT2,GPI,MDH1,MDH2,PC,PCK1,PCK2,PER2,PFKFB1,PGAM1,PGAM2,PGK1,PGM1,PPARGC1A,PRKACA,PRKACB,PRKACG,RBP4,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SORD,TALDO1,TKT,TPI1	The chemical reactions and pathways resulting in the formation of monosaccharides, polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms.
GO:0046365	GO	BP	monosaccharide catabolic process	AKR1A1,ALDOA,ALDOB,ALDOC,CRYL1,DCXR,ENO1,ENO2,ENO3,FUT1,FUT10,FUT2,FUT4,FUT5,FUT6,FUT7,FUT8,FUT9,GALE,GALK1,GALT,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,KHK,LRP5,NUDT5,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PGM1,PGM2,PKLR,PKM,PPP2R5D,SORD,TKFC,TKTL1,TPI1,XYLB	The chemical reactions and pathways resulting in the breakdown of monosaccharides, polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms.
GO:0046386	GO	BP	deoxyribose phosphate catabolic process	MBD4,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5M,NTHL1,NUDT1,NUDT15,NUDT16,NUDT18,OGG1,SAMHD1,SMUG1,TDG,UNG	The chemical reactions and pathways resulting in the breakdown of deoxyribose phosphate, the phosphorylated sugar 2-deoxy-erythro-pentose.
GO:0046390	GO	BP	ribose phosphate biosynthetic process	ACOT7,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD2,AQP1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,CMPK1,COASY,CTPS1,G6PD,GBAS,GNAS,GUCY1A3,GUCY1B3,HTR2B,HTR2C,MT-ATP6,MT-ATP8,NPPA,NPPB,NPPC,NPR1,NPR2,PANK2,PAPSS1,PAPSS2,PFAS,PPCDC,PPCS,PRKAG2,PRPS1,RAMP2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of ribose phosphate, any phosphorylated ribose sugar.
GO:0046394	GO	BP	carboxylic acid biosynthetic process	ABCB11,ABCD3,ACACA,ACADM,ACOT7,ACOT8,ACOX2,ACSF3,ADI1,AGXT,AGXT2,AKR1C3,AKR1C4,AKR1D1,ALDH18A1,ALDH9A1,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AMACR,APIP,ASNS,ASPA,BAAT,BBOX1,BCAN,BGN,BHMT,BHMT2,CARNS1,CBR1,CBS,CCBL1,CD74,CDO1,CH25H,CHST12,CHST14,CPS1,CSPG4,CSPG5,CTH,CYP27A1,CYP39A1,CYP46A1,CYP7A1,CYP7B1,CYP8B1,DCN,DECR2,DEGS1,DHFR,DHRS9,DSE,DSEL,EDN1,EDN2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,ENOPH1,FADS1,FADS3,FAM213B,FOLH1,FPGS,GADL1,GAMT,GATM,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GLS,GLS2,GLUD1,GLUD2,GLUL,GOT1,GOT2,GPT,GPT2,HAAO,HACD1,HACD2,HACD3,HACD4,HOGA1,HPGD,HPGDS,HSD17B4,HSD3B7,KYNU,LIAS,LIPC,LPL,LTA4H,MCAT,MGST2,MIF,MLYCD,MRI1,MTAP,MTHFD1,MTR,MTRR,NAALAD2,NANP,NCAN,NDUFAB1,OAT,OTC,OXSM,PADI2,PADI4,PAH,PARK7,PER2,PHGDH,PLA2G1B,PLOD1,PNPLA8,PRG3,PSAT1,PSPH,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,PYCR1,PYCR2,PYCRL,SCD,SCD5,SCP2,SDS,SEPHS2,SHMT1,SLC27A2,SLC27A5,SLC35D1,SRR,SUCLA2,TBXAS1,TECR,THNSL2,TMLHE,UGDH,UGP2,UROS,UST,VCAN,XBP1	The chemical reactions and pathways resulting in the formation of carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups.
GO:0046395	GO	BP	carboxylic acid catabolic process	AADAT,AASS,ABAT,ABCD1,ABCD2,ABCD3,ABHD10,ACAA1,ACAD10,ACAD11,ACAD8,ACADL,ACADM,ACADS,ACADSB,ACADVL,ACAT1,ACMSD,ACOT4,ACOT8,ACOX1,ACOX2,ACOX3,ACSF3,ADIPOQ,AFMID,AGXT,AGXT2,AKR1A1,ALDH4A1,ALDH5A1,ALDH6A1,ALDH7A1,ALDH9A1,AMACR,AMDHD1,AMDHD2,ARG1,ASL,ASPA,ASRGL1,AUH,BBOX1,BCAT1,BCAT2,BCKDHA,BCKDHB,BCKDK,BDH2,CARNS1,CBS,CCBL1,CCBL2,CDO1,CEL,CRAT,CROT,CRYL1,CRYM,CSAD,CTH,CYP26A1,CYP26B1,CYP26C1,CYP4A11,CYP4F12,CYP4F2,DAO,DBT,DCXR,DDAH1,DDAH2,DDO,DECR1,DLD,DLST,ECHS1,ECI1,ECI2,EHHADH,ETFA,ETFB,ETFDH,ETHE1,FAAH,FAH,FTCD,GAD1,GCDH,GCSH,GLDC,GLS,GLUD1,GLUD2,GLUL,GOT1,GOT2,GSTZ1,HAAO,HACL1,HADH,HADHA,HADHB,HAL,HAO1,HDC,HGD,HIBADH,HIBCH,HMGCL,HNMT,HOGA1,HPD,HSD17B10,HSD17B4,HYKK,IDO1,IDO2,IDUA,IL4I1,IVD,KMO,KYNU,LPIN1,MCCC1,MCCC2,MCEE,MMAA,MTHFS,MTRR,MUT,NAGK,NOS1,NOS2,NOS3,NPL,OGDH,OTC,PAH,PCBD1,PCCA,PCCB,PEX13,PEX2,PHYH,PHYKPL,PIPOX,PLA2G15,PON1,PON3,PPARD,PPM1K,PRODH,QDPR,QPRT,RENBP,SCP2,SDS,SHMT1,SLC25A10,SLC25A17,SLC25A21,SLC27A2,SORD,SQRDL,SUOX,TAT,TDO2,THNSL2,TMLHE,TST,UROC1,XYLB	The chemical reactions and pathways resulting in the breakdown of carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups.
GO:0046415	GO	BP	urate metabolic process	ABCG2,GCKR,LRRC16A,PNP,PRPS1,SLC16A9,SLC17A1,SLC17A3,SLC22A11,SLC22A12,SLC2A9	The chemical reactions and pathways involving urate, the anion of uric acid, 2,6,8-trioxypurine, the end product of purine metabolism in certain mammals and the main excretory product in uricotelic animals.
GO:0046425	GO	BP	regulation of JAK-STAT cascade	AGT,ARL2BP,CAV1,CCL5,CD300A,CD40,CLCF1,CNTF,CRLF1,CRLF3,CSF1R,CSF2,CTF1,CYP1B1,DOT1L,EPO,ERBB4,F2R,FGFR3,FLT3,GH1,GHR,HCLS1,HES1,HES5,HGS,IFNA2,IFNB1,IFNG,IFNL1,IGF1,IKBKB,IL12A,IL12B,IL18,IL2,IL20,IL21,IL22RA2,IL23A,IL23R,IL26,IL3,IL6,IL6R,IL6ST,JAK2,KIT,LEP,LEPROT,LIF,LYN,NF2,NLK,NOTCH1,OSM,PIBF1,PIGU,PPP2CA,PPP2R1A,PRL,PRLR,PTK2B,PTPN2,SH2B2,SOCS1,TNFRSF18,TNFRSF1A,TNFSF18	Any process that modulates the frequency, rate or extent of the JAK-STAT signaling pathway.
GO:0046426	GO	BP	negative regulation of JAK-STAT cascade	CAV1,HGS,LEPROT,NF2,PIBF1,PPP2CA,PPP2R1A,PTPN2,SOCS1	Any process that stops, prevents, or reduces the frequency, rate or extent of the JAK-STAT signaling pathway activity.
GO:0046427	GO	BP	positive regulation of JAK-STAT cascade	ARL2BP,CCL5,CD40,CLCF1,CNTF,CRLF1,CRLF3,CSF1R,CSF2,CTF1,CYP1B1,EPO,ERBB4,F2R,FGFR3,FLT3,GH1,GHR,HCLS1,HES1,HES5,IFNA2,IFNG,IFNL1,IGF1,IL12A,IL12B,IL18,IL2,IL20,IL21,IL23A,IL23R,IL26,IL3,IL6,IL6R,IL6ST,JAK2,KIT,LEP,LIF,LYN,NOTCH1,OSM,PIBF1,PRL,PRLR,PTK2B,TNFRSF18,TNFRSF1A,TNFSF18	Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
GO:0046434	GO	BP	organophosphate catabolic process	AMPD3,ANGPTL3,APOA2,CAT,DCTPP1,DNPH1,ENPP1,ENPP2,ENPP3,ENTPD4,GDA,GPX1,HINT1,HPRT1,IMPA1,IMPA2,INPP5K,LIPC,LIPG,MBD4,MLYCD,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5C1A,NT5C1B,NT5C2,NT5E,NT5M,NTHL1,NUDT1,NUDT12,NUDT15,NUDT16,NUDT18,NUDT3,NUDT5,NUDT7,OGG1,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A,PDXP,PLA2G15,PLA2G4B,PLA2G4C,PNLIPRP2,PNP,PNPLA8,PON1,PRDX6,PTEN,SAMHD1,SMPD3,SMPD4,SMUG1,SYNJ1,TDG,UNG,VCP,XDH	The chemical reactions and pathways resulting in the breakdown of organophosphates, any phosphate-containing organic compound.
GO:0046456	GO	BP	icosanoid biosynthetic process	AKR1C3,ALOX12,ALOX15,ALOX5,ALOX5AP,CBR1,CD74,EDN1,EDN2,FADS1,FAM213B,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,HPGD,HPGDS,LTA4H,MGST2,MIF,PLA2G1B,PNPLA8,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,TBXAS1	The chemical reactions and pathways resulting in the formation of icosanoids, any of a group of C20 polyunsaturated fatty acids.
GO:0046459	GO	BP	short-chain fatty acid metabolic process	ACOT4,ACSM1,ALDH5A1,MCEE,MMAA,MUT,OXSM,PCCA,PCCB,THNSL2	The chemical reactions and pathways involving fatty acids with a chain length of less than C6.
GO:0046463	GO	BP	acylglycerol biosynthetic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,AGK,AGMO,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,ANG,DGAT1,DGAT2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FASN,GK,GPAM,GPAT2,GPAT3,GPAT4,GPD1,GPD1L,HACD1,HACD2,HSD17B12,LCLAT1,LPCAT1,LPCAT4,LPIN1,LPIN2,OLAH,PCK1,PLCE1,PNPLA3,PPT1,PPT2,SCD,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways resulting in the formation of acylglycerol, any mono-, di- or triester of glycerol with (one or more) fatty acids.
GO:0046464	GO	BP	acylglycerol catabolic process	ABHD12,ABHD5,ABHD6,APOA2,APOA5,APOC3,CPS1,DAGLA,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,LIPC,LIPE,LPL,MGLL,PLIN1,PNPLA3,PPP1CA,PPP1CB,PPP1CC,PRKACA,PRKACB,PRKACG	The chemical reactions and pathways resulting in the breakdown of acylglycerol, any mono-, di- or triester of glycerol with (one or more) fatty acids.
GO:0046466	GO	BP	membrane lipid catabolic process	ACER1,CYP1B1,GALC,GBA,GBA3,GLA,NAGA,NEU2,NEU3,NEU4,PNLIPRP2,PPT1,SGPL1,SMPD3,SMPD4,SPHK1	The chemical reactions and pathways resulting in the breakdown of membrane lipids, any lipid found in or associated with a biological membrane.
GO:0046467	GO	BP	membrane lipid biosynthetic process	A4GALT,ACER1,ACER2,ACER3,ALDH3A2,ALDH3B1,ALOX12B,ALOXE3,B3GNT5,CERS1,CERS2,CERS3,CERS4,CERS5,CERS6,CLN8,COL4A3BP,CSNK1G2,DEGS1,DEGS2,DPM1,DPM2,DPM3,ELOVL1,FA2H,GBA,GBGT1,GPAA1,HACD1,HACD2,KDSR,LARGE,MPPE1,PGAP1,PGAP2,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PLPP1,PLPP2,PLPP3,PPM1L,PRKD1,PYURF,SAMD8,SGMS1,SGMS2,SGPL1,SGPP1,SGPP2,SMPD1,SMPD4,SPHK1,SPHK2,SPTLC1,SPTLC2,SPTLC3,SPTSSA,SPTSSB,ST3GAL5,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,UGCG,VAPA,VAPB	The chemical reactions and pathways resulting in the formation of membrane lipids, any lipid found in or associated with a biological membrane.
GO:0046470	GO	BP	phosphatidylcholine metabolic process	ABHD3,ACHE,APOA1,APOA2,APOA4,CDS1,CEPT1,CETP,CHAT,CHKA,CHKB,CHPT1,DBI,ENPP2,GPAT4,GPLD1,LCAT,LIPC,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LPIN1,LPIN2,LPIN3,MBOAT1,MBOAT2,PCYT1A,PCYT1B,PEMT,PHOSPHO1,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLB1,PLBD1,PNPLA8,PON1,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5	The chemical reactions and pathways involving phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. They are important constituents of cell membranes.
GO:0046471	GO	BP	phosphatidylglycerol metabolic process	CDS2,CRLS1,HADHA,HADHB,LCLAT1,LPCAT1,LPCAT4,LPGAT1,PGS1,PLA2G10,PLA2G12A,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4D,PLA2G4F,PLA2G5,PLA2G6,PLD1,PLD2,PLD3,PLD4,PLD6,PTPMT1,SLC27A1,TAMM41,TAZ,THEM5	The chemical reactions and pathways involving phosphatidylglycerols, any of a class of phospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol. They are important constituents of cell membranes.
GO:0046474	GO	BP	glycerophospholipid biosynthetic process	ABHD3,ABHD4,ABHD5,ACHE,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,ALOX15,APOA1,APOA2,ARF1,ARF3,ATM,AWAT1,CDIPT,CDS1,CDS2,CEPT1,CHAT,CHKA,CHKB,CHPT1,CPNE1,CPNE3,CPNE6,CPNE7,CRLS1,DDHD1,DDHD2,DGAT1,DGAT2,DPM1,DPM2,DPM3,EPT1,ETNK1,ETNK2,ETNPPL,FAR1,FGF2,FIG4,GNPAT,GPAA1,GPAM,GPAT2,GPAT3,GPAT4,GPCPD1,GPD1,GPD1L,HADHA,HADHB,IMPA1,INPP4A,INPP4B,INPP5D,INPP5E,INPP5J,INPP5K,INPPL1,LCAT,LCLAT1,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LPGAT1,LPIN1,LPIN2,LPIN3,MBOAT1,MBOAT2,MBOAT7,MGLL,MPPE1,MTM1,MTMR1,MTMR14,MTMR2,MTMR3,MTMR4,MTMR6,MTMR7,OCRL,PCYT1A,PCYT1B,PCYT2,PEMT,PGAP1,PGAP2,PGS1,PHOSPHO1,PI4K2A,PI4K2B,PI4KA,PI4KB,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PIK3C2A,PIK3C2B,PIK3C2G,PIK3C3,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIK3R3,PIK3R4,PIK3R5,PIK3R6,PIKFYVE,PIP4K2A,PIP4K2B,PIP4K2C,PIP5K1A,PIP5K1B,PIP5K1C,PISD,PITPNB,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLAUR,PLB1,PLBD1,PLCG2,PLD1,PLD2,PLD3,PLD4,PLD6,PLSCR1,PNPLA2,PNPLA3,PNPLA8,PTDSS1,PTDSS2,PTEN,PTPMT1,PYURF,SACM1L,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SYNJ1,SYNJ2,TAMM41,TAZ,TPTE2,VAC14	The chemical reactions and pathways resulting in the formation of glycerophospholipids, any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl, or O-alkenyl group attached to the glycerol residue.
GO:0046475	GO	BP	glycerophospholipid catabolic process	ENPP2,LIPC,PLA2G15,PLA2G4B,PLA2G4C,PNPLA8,SMPD4	The chemical reactions and pathways resulting in the breakdown of glycerophospholipids, any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl, or O-alkenyl group attached to the glycerol residue.
GO:0046479	GO	BP	glycosphingolipid catabolic process	GALC,GBA,GBA3,GLA,NEU2,NEU3,NEU4	The chemical reactions and pathways resulting in the breakdown of glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.
GO:0046485	GO	BP	ether lipid metabolic process	AGMO,AGPS,FAR1,FAR2,GNPAT,PEX7,TMEM86B	The chemical reactions and pathways involving ether lipids, lipids that contain (normally) one lipid alcohol in ether linkage to one of the carbon atoms (normally C-1) of glycerol.
GO:0046487	GO	BP	glyoxylate metabolic process	AGXT,AGXT2,AMT,BCKDHA,BCKDHB,DAO,DBT,DHTKD1,DLAT,DLD,DLST,GCSH,GLDC,GRHPR,HAO1,HOGA1,LIAS,LIPT1,LIPT2,NDUFAB1,OGDH,PDHA1,PDHB,PDHX	The chemical reactions and pathways involving glyoxylate, the anion of glyoxylic acid, HOC-COOH.
GO:0046488	GO	BP	phosphatidylinositol metabolic process	ARF1,ARF3,ATM,CDIPT,CDS1,CSF1R,DPM1,DPM2,DPM3,DRD2,EFR3A,EFR3B,FAM126A,FGF2,FIG4,GPAA1,GPLD1,IMPA1,INPP4A,INPP4B,INPP5B,INPP5D,INPP5E,INPP5J,INPP5K,INPPL1,IP6K1,IP6K2,IP6K3,MBOAT7,MPPE1,MTM1,MTMR1,MTMR14,MTMR2,MTMR3,MTMR4,MTMR6,MTMR7,OCRL,PDGFRB,PGAP1,PGAP2,PGAP3,PI4K2A,PI4K2B,PI4KA,PI4KB,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PIK3C2A,PIK3C2B,PIK3C2G,PIK3C3,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIK3R3,PIK3R4,PIK3R5,PIK3R6,PIKFYVE,PIP4K2A,PIP4K2B,PIP4K2C,PIP5K1A,PIP5K1B,PIP5K1C,PITPNM3,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G4A,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLAUR,PLBD1,PLCB1,PLCG2,PLEK,PTEN,PYURF,SACM1L,SLC27A1,SMG1,SYNJ1,SYNJ2,TMEM150A,TMEM55A,TMEM55B,TPTE2,TTC7B,VAC14	The chemical reactions and pathways involving phosphatidylinositol, any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
GO:0046496	GO	BP	nicotinamide nucleotide metabolic process	ALDOA,ALDOB,ALDOC,DERA,DLD,ENO1,ENO2,ENO3,FMO1,FMO2,G6PD,GAPDH,GAPDHS,GCK,GPD1L,GPI,HK1,HK2,HK3,IDH1,KCNAB2,LDHA,ME1,NADK,NADK2,NADSYN1,NAMPT,NAPRT,NMNAT1,NMNAT2,NMNAT3,NOX1,NUDT12,PDHB,PDHX,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGD,PGK1,PGK2,PGLS,PGM1,PGM2,PKLR,PKM,PNP,PPP2R5D,PRDX5,PTGIS,PTGS2,QPRT,RPE,RPIA,SHPK,TALDO1,TKT,TP53I3,TPI1,VCP	The chemical reactions and pathways involving nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.
GO:0046500	GO	BP	S-adenosylmethionine metabolic process	BHMT2,GNMT,MAT2A,MAT2B,MTRR	The chemical reactions and pathways involving S-adenosylmethionine, S-(5'-adenosyl)-L-methionine, an important intermediate in one-carbon metabolism.
GO:0046503	GO	BP	glycerolipid catabolic process	ABHD12,ABHD5,ABHD6,APOA2,APOA5,APOC3,CPS1,DAGLA,ENPP2,FABP1,FABP12,FABP2,FABP3,FABP4,FABP5,FABP6,FABP7,FABP9,LIPC,LIPE,LPL,MGLL,PLA2G15,PLA2G4B,PLA2G4C,PLIN1,PNPLA3,PNPLA8,PPP1CA,PPP1CB,PPP1CC,PRKACA,PRKACB,PRKACG,SMPD4	The chemical reactions and pathways resulting in the breakdown of glycerolipids, any lipid with a glycerol backbone.
GO:0046512	GO	BP	sphingosine biosynthetic process	ACER1,ACER2,ACER3,GBA,SPHK1,SPHK2	The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
GO:0046513	GO	BP	ceramide biosynthetic process	ALOX12B,ALOXE3,CERS1,CERS3,CERS5,CLN8,GBA,SAMD8,SMPD1,SMPD4,ST3GAL5,ST6GALNAC6,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA6,UGCG	The chemical reactions and pathways resulting in the formation of ceramides, any N-acylated sphingoid.
GO:0046514	GO	BP	ceramide catabolic process	ACER1,GALC,GBA,GBA3,GLA,NEU2,NEU3,NEU4	The chemical reactions and pathways resulting in the breakdown of ceramides, any N-acetylated sphingoid.
GO:0046519	GO	BP	sphingoid metabolic process	ACER1,ACER2,ACER3,GBA,KDSR,SGPP2,SPHK1,SPHK2,SPTLC3	The chemical reactions and pathways involving sphingoids, any of a class of compounds comprising sphinganine and its homologues and stereoisomers, and derivatives of these compounds.
GO:0046520	GO	BP	sphingoid biosynthetic process	ACER1,ACER2,ACER3,GBA,SPHK1,SPHK2,SPTLC3	The chemical reactions and pathways resulting in the formation of sphingoids, any of a class of compounds comprising sphinganine and its homologues and stereoisomers, and derivatives of these compounds.
GO:0046527	GO	MF	glucosyltransferase activity	ALG6,GYS1,GYS2,PLOD3,POGLUT1,UGGT1,UGGT2	Catalysis of the transfer of a glucosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
GO:0046530	GO	BP	photoreceptor cell differentiation	AGTPBP1,AHI1,ARL3,BBS4,CEP290,DSCAM,MYO7A,NKD1,NRL,PPP2R3A,PROM1,RORB,RP1,RP1L1,SDK2,SOX8,SOX9,STAT3,TH,THY1,TOPORS,TULP1,VEGFA	The specialization of organization of a photoreceptor, a cell that responds to incident electromagnetic radiation, particularly visible light. An example of this process is found in Drosophila melanogaster.
GO:0046578	GO	BP	regulation of Ras protein signal transduction	ABCA1,ABRA,ADRA1A,ALS2,APOA1,APOC3,APOE,ARAP3,ARF6,ARHGEF2,ARRB1,COL3A1,CUL3,DAB2IP,DENND1A,DENND4B,DLC1,EPO,EPS8L1,EPS8L2,F2R,F2RL1,FBP1,FGF10,FLCN,FOXM1,GPR55,IGF1,KANK1,KCTD13,KIF14,LPAR1,MADD,MAPKAP1,MFN2,MMD2,MYOC,NOTCH2,NTRK1,NUP62,OGT,PLCE1,RAC1,RAF1,RALGPS1,RASAL3,RASGEF1A,RASGRF1,RASGRP1,RASGRP4,RDX,SCAI,SHOC2,SQSTM1,STAMBP,STMN3,SYNGAP1,TNFAIP1	Any process that modulates the frequency, rate or extent of Ras protein signal transduction.
GO:0046579	GO	BP	positive regulation of Ras protein signal transduction	ABRA,ALS2,APOA1,ARRB1,COL3A1,EPO,F2R,F2RL1,FGF10,GPR55,IGF1,LPAR1,MMD2,NOTCH2,NTRK1,RAC1,RASGEF1A,RASGRF1,RASGRP1,RASGRP4,SHOC2	Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction.
GO:0046580	GO	BP	negative regulation of Ras protein signal transduction	ADRA1A,ARAP3,CUL3,DAB2IP,DLC1,FBP1,FLCN,KANK1,KCTD13,MAPKAP1,MFN2,MYOC,RASAL3,SCAI,STAMBP,STMN3,SYNGAP1,TNFAIP1	Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction.
GO:0046596	GO	BP	regulation of viral entry into host cell	APCS,FCN1,FCN3,GSN,HS3ST5,IFITM1,IFITM2,IFITM3,IFNA2,LGALS1,LGALS9,MID2,P4HB,PTX3,PVRL2,SNX3,TMPRSS2,TRIM11,TRIM25,TRIM26,TRIM31,TRIM38,TRIM5,TRIM62	Any process that modulates the frequency, rate or extent of the viral entry into the host cell.
GO:0046597	GO	BP	negative regulation of viral entry into host cell	APCS,FCN1,FCN3,GSN,IFITM1,IFITM2,IFITM3,IFNA2,MID2,PTX3,SNX3,TRIM11,TRIM26,TRIM31,TRIM5	Any process that stops, prevents, or reduces the frequency, rate or extent of the entry of viral entry into a host cell.
GO:0046598	GO	BP	positive regulation of viral entry into host cell	LGALS1,LGALS9,P4HB,TMPRSS2,TRIM11,TRIM38	Any process that activates or increases the frequency, rate or extent of the introduction of viral entry into the host cell.
GO:0046599	GO	BP	regulation of centriole replication	BRCA1,CDK5RAP2,CENPJ,CEP76,CHMP2A,MDM1,NPM1,PLK2,PLK4,RBM14,SPICE1,TRIM37,VPS4B	Any process that modulates the frequency, rate or extent of the formation of a daughter centriole of an existing centriole.
GO:0046600	GO	BP	negative regulation of centriole replication	BRCA1,CDK5RAP2,CHMP2A,MDM1,RBM14,TRIM37	Any process that stops, prevents, or reduces the frequency, rate or extent of centriole replication.
GO:0046605	GO	BP	regulation of centrosome cycle	ATF5,AURKA,BRCA1,CCNF,CDK5RAP2,CENPJ,CEP131,CEP76,CEP85,CHEK1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CHMP5,GEN1,KIF11,MDM1,NEK2,NPM1,PDCD6IP,PKHD1,PLK2,PLK4,RAB6C,RBM14,SPICE1,TMEM67,TRIM37,VPS4B,XRCC3	Any process that modulates the frequency, rate or extent of the centrosome cycle, the processes of centrosome duplication and separation.
GO:0046620	GO	BP	regulation of organ growth	AKAP6,BASP1,BMP10,ERBB4,FGF2,FGFR2,GSK3A,MEF2C,NOG,NOTCH1,NRG1,PROX1,PTEN,RBP4,RBPJ,SLC6A4,SOD1,TBX2,TBX20,TBX5,TP73,WT1,WWC1,WWC2,WWC3	Any process that modulates the frequency, rate or extent of growth of an organ of an organism.
GO:0046621	GO	BP	negative regulation of organ growth	GSK3A,NOG,PTEN,RBP4,SLC6A4,TBX5,TP73,WWC1,WWC2,WWC3	Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organ of an organism.
GO:0046625	GO	MF	sphingolipid binding	CLIP3,COL4A3BP,CPTP,PLEKHA8,SELL,SELP,TRAF2	Interacting selectively and non-covalently with sphingolipids, a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).
GO:0046626	GO	BP	regulation of insulin receptor signaling pathway	AHSG,ENPP1,GRB10,GSK3A,IGF2,IL1B,INPP5K,INS,IRS1,KANK1,OGT,PID1,PRKCB,PRKCD,PRKCQ,PRKCZ,PTPN1,PTPN2,PTPRE,RPS6KB1,SIK2,SIRT1,SOCS1,TSC2,VWA2	Any process that modulates the frequency, rate or extent of insulin receptor signaling.
GO:0046627	GO	BP	negative regulation of insulin receptor signaling pathway	AHSG,ENPP1,GRB10,GSK3A,IL1B,INPP5K,IRS1,KANK1,PID1,PRKCB,PRKCD,PRKCQ,PRKCZ,PTPN1,PTPN2,PTPRE,RPS6KB1,SOCS1	Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
GO:0046628	GO	BP	positive regulation of insulin receptor signaling pathway	IGF2,INS,IRS1,PRKCZ,SIRT1	Any process that increases the frequency, rate or extent of insulin receptor signaling.
GO:0046631	GO	BP	alpha-beta T cell activation	ANXA1,ATP7A,BATF,CEBPB,ELF4,EOMES,FOXP1,FOXP3,HLA-E,HMGB1,IL12B,IL6,INS,IRF4,LEF1,LY9,PTGER4,RORA,RORC,RSAD2,SLAMF6,STOML2,TNFSF4,ZFPM1	The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
GO:0046632	GO	BP	alpha-beta T cell differentiation	ANXA1,ATP7A,BATF,EOMES,FOXP1,FOXP3,HMGB1,IL12B,IL6,IRF4,LEF1,LY9,PTGER4,RORA,RORC,RSAD2,SLAMF6,ZFPM1	The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex.
GO:0046634	GO	BP	regulation of alpha-beta T cell activation	AGER,ANXA1,CCL19,CCR2,CD300A,CD55,CD80,CD86,EBI3,FOXP3,GLI3,HFE,HLA-A,HLA-E,HMGB1,HSPH1,IFNG,IHH,IL12A,IL12B,IL12RB1,IL18,IL23A,IL23R,IL27,IRF1,IRF4,JAK3,LGALS9,LILRB1,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRKCQ,PRKCZ,RARA,RASAL3,RC3H1,SHH,SOCS5,TGFBR2,TNFSF4,XCL1	Any process that modulates the frequency, rate or extent of alpha-beta T cell activation.
GO:0046635	GO	BP	positive regulation of alpha-beta T cell activation	ANXA1,CCL19,CCR2,CD55,CD80,CD86,EBI3,FOXP3,GLI3,HLA-A,HLA-E,HSPH1,IFNG,IHH,IL12A,IL12B,IL12RB1,IL18,IL23A,IL23R,LGALS9,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRKCQ,PRKCZ,RARA,RASAL3,SHH,SOCS5,TGFBR2,TNFSF4,XCL1	Any process that activates or increases the frequency, rate or extent of alpha-beta T cell activation.
GO:0046636	GO	BP	negative regulation of alpha-beta T cell activation	ANXA1,CD300A,FOXP3,GLI3,HFE,HMGB1,IHH,JAK3,LGALS9,LILRB1,RC3H1,SOCS5,TNFSF4,XCL1	Any process that stops, prevents, or reduces the frequency, rate or extent of alpha-beta T cell activation.
GO:0046637	GO	BP	regulation of alpha-beta T cell differentiation	ANXA1,CCL19,CD80,CD86,FOXP3,GLI3,HMGB1,IFNG,IHH,IL12B,IL12RB1,IL23A,IL23R,IL27,IRF4,JAK3,LGALS9,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRKCZ,RARA,RC3H1,SHH,SOCS5,TGFBR2,TNFSF4	Any process that modulates the frequency, rate or extent of alpha-beta T cell differentiation.
GO:0046638	GO	BP	positive regulation of alpha-beta T cell differentiation	ANXA1,CCL19,CD80,CD86,FOXP3,GLI3,IFNG,IHH,IL12B,IL12RB1,IL23A,IL23R,LGALS9,MYB,NCKAP1L,NKAP,NLRP3,PNP,PRKCZ,RARA,SHH,SOCS5,TGFBR2,TNFSF4	Any process that activates or increases the frequency, rate or extent of alpha-beta T cell differentiation.
GO:0046639	GO	BP	negative regulation of alpha-beta T cell differentiation	ANXA1,FOXP3,GLI3,HMGB1,IHH,JAK3,RC3H1,SOCS5,TNFSF4	Any process that stops, prevents, or reduces the frequency, rate or extent of alpha-beta T cell differentiation.
GO:0046640	GO	BP	regulation of alpha-beta T cell proliferation	CCR2,CD55,EBI3,HLA-A,HLA-E,IL12B,IL18,IL23A,IRF1,LGALS9,RASAL3,TNFSF4,XCL1	Any process that modulates the frequency, rate or extent of alpha-beta T cell proliferation.
GO:0046641	GO	BP	positive regulation of alpha-beta T cell proliferation	CCR2,CD55,EBI3,HLA-A,HLA-E,IL12B,IL18,IL23A,LGALS9,RASAL3,TNFSF4,XCL1	Any process that activates or increases the frequency, rate or extent of alpha-beta T cell proliferation.
GO:0046649	GO	BP	lymphocyte activation	ADA,ADAM17,ADGRG3,AICDA,AKAP17A,AMICA1,ANXA1,ATM,ATP7A,BATF,BCL2,BLNK,BTK,BTN3A1,CASP8,CCL19,CCL21,CCR7,CD1C,CD1D,CD2,CD244,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD40,CD40LG,CD6,CD7,CD74,CD79A,CD80,CD86,CD8A,CD8B,CEBPB,CEBPG,CHD7,CHRNA4,CHRNB2,CLCF1,CLEC7A,CORO1A,CR2,CTPS1,CXADR,DDOST,DLL1,DLL4,DOCK8,DPP4,EIF2AK4,ELF4,EOMES,EXOSC3,EXOSC6,F2RL1,FADD,FKBP1A,FLT3,FNIP1,FOXP1,FOXP3,GLI3,GPR183,HDAC4,HDAC5,HDAC9,HELLS,HHEX,HLA-E,HMGB1,HSPD1,ICAM1,ICOSLG,IFNB1,IFNK,IKZF1,IL10,IL11,IL12B,IL2,IL21R,IL4,IL6,INS,IRF4,ITGA4,ITGAL,ITGB1,ITK,JAG2,JAK3,KIF13B,KIT,KLF6,KLRF2,KLRK1,LAT,LAT2,LAX1,LCK,LCP1,LEF1,LEP,LEPR,LFNG,LIG4,LILRB1,LRRC8A,LY9,LYL1,MEF2C,MFNG,MICA,MICB,MS4A1,MSH2,MSH6,NCK1,NCK2,NCR1,NFAM1,NHEJ1,NOTCH2,PIK3CD,PIK3CG,PLCG2,PPP3CA,PPP3CB,PRF1,PRKCB,PRLR,PTGER4,PTK2B,PTPN2,PTPN22,PTPRC,RAG1,RAG2,RHOH,RIPK3,RNF168,RNF8,RORA,RORC,RSAD2,SHH,SLA2,SLAMF6,SLAMF7,SLC11A1,SNX27,SOX4,STOML2,TCF3,THEMIS,TNFRSF4,TNFSF14,TNFSF18,TNFSF4,TREML2,ULBP1,ULBP2,ULBP3,VAMP7,VCAM1,VPRBP,ZAP70,ZFPM1	A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor.
GO:0046651	GO	BP	lymphocyte proliferation	BCL2,BTN3A1,CD40,CD40LG,CD79A,CR2,CTPS1,DOCK8,ELF4,FLT3,HELLS,HSPD1,IFNB1,IL10,LILRB1,MEF2C,MS4A1,PIK3CG,PPP3CB,PTPRC,SLC11A1,TNFRSF4,TNFSF14,TNFSF18	The expansion of a lymphocyte population by cell division.
GO:0046653	GO	BP	tetrahydrofolate metabolic process	DHFR,DHFRL1,MTHFD1,MTHFD1L,MTHFD2,MTHFR,MTHFS,SHMT1,SHMT2,TYMS	The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.
GO:0046655	GO	BP	folic acid metabolic process	DHFR,FPGS,MTHFD1,MTHFD1L,MTHFR,MTHFS,MTRR,SHMT1,SHMT2,SLC19A1,SLC25A32,SLC46A1	The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
GO:0046658	GO	CC	anchored component of plasma membrane	CA4,CD14,CD160,CD59,EFNA5,FOLR1,FOLR2,GAS1,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,GP1BA,GPIHBP1,HYAL2,LYPD3,MDGA1,MFI2,NTNG1,NTNG2,PKHD1,RGMB,RHBG,RTN4RL1,RTN4RL2,TREH,ULBP1,ULBP2,ULBP3	The component of the plasma membrane consisting of the gene products that are tethered to the membrane only by a covalently attached anchor, such as a lipid group, that is embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping.
GO:0046660	GO	BP	female sex differentiation	ANG,BMPR1B,CCDC182,CEBPB,EIF2B2,EIF2B4,EIF2B5,EREG,FOXL2,FSHR,INHA,INHBA,INHBB,KIT,LHX1,PDGFRA,PTPRN,RBP4,SOD1,STRA6,TBX3,VEGFA,WNT4,ZNF830	The establishment of the sex of a female organism by physical differentiation.
GO:0046661	GO	BP	male sex differentiation	AMH,AMHR2,ANKRD7,CSDE1,DMRT1,GATA1,GATA3,GATA4,HSD17B3,ING2,INHBA,LHB,LHCGR,LRRC6,MEA1,MSH2,NCOA4,NR0B1,PRKACG,RAB13,RBMY1B,SCX,SHH,SIX4,SOX15,SOX8,SOX9,SRD5A2,TBX3,TCF21,WNT4,WT1	The establishment of the sex of a male organism by physical differentiation.
GO:0046676	GO	BP	negative regulation of insulin secretion	ADRA2A,BMP8A,FAM3D,INHBB,IRS1,KCNB1,KCNJ11,NOV,PARK2,PIM3,PSMD9,REST,SFRP1,SIRT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.
GO:0046677	GO	BP	response to antibiotic	AOC1,AOC3,CIITA,CRIP1,CYB5R4,ETS1,HID1,HSP90AA1,HYAL1,JAK1,JAK2,MEF2C,ZC3H8	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.
GO:0046683	GO	BP	response to organophosphorus	AANAT,AKAP6,AKAP7,AKAP9,AQP1,ASPH,CFTR,CIB2,CITED1,CRHBP,DGKQ,DMTN,DUOX1,DUOX2,EZR,HCN1,HCN2,HCN4,HSP90B1,IGFBP5,INPP5K,KCNE1,KCNJ11,KCNQ1,NDUFS4,P2RX4,P2RX7,P2RY11,P2RY12,PDE2A,PDE3A,PDE4D,PDXP,RAP1A,RAP1B,RAPGEF1,RAPGEF2,RAPGEF3,RYR3,SLC26A3,SLC26A6,SSH1,STAT1,TRPC3,TRPV1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organophosphorus stimulus. Organophosphorus is a compound containing phosphorus bound to an organic molecule; several organophosphorus compounds are used as insecticides, and they are highly toxic cholinesterase inhibitors.
GO:0046685	GO	BP	response to arsenic-containing substance	ATF3,ATF4,CPEB2,DDX3X,GSTO1,GSTO2,MKNK2,PPIF,RBM4,RNF4,SRRT	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides.
GO:0046688	GO	BP	response to copper ion	AOC1,AQP1,AQP2,ATP5D,ATP7A,ATP7B,IL1A,LOXL2,PARK7,PRNP,SNCA	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
GO:0046689	GO	BP	response to mercury ion	AQP1,AQP2,AQP9,PARK7,SLC34A1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
GO:0046696	GO	CC	lipopolysaccharide receptor complex	BCL10,CD14,HSPD1,LY96,TLR4,TRIL	A multiprotein complex that consists of at least three proteins, CD14, TLR4, and MD-2, each of which is glycosylated and which functions as a lipopolysaccharide (LPS) receptor that primes the innate immune response against bacterial pathogens.
GO:0046703	GO	MF	natural killer cell lectin-like receptor binding	MICA,MICB,ULBP1,ULBP2,ULBP3	Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
GO:0046710	GO	BP	GDP metabolic process	CARD11,CASK,DLG1,DLG2,MAGI3,MPP1,MPP2,MPP3,NUDT18,TJP2	The chemical reactions and pathways involving GDP, guanosine 5'-diphosphate.
GO:0046716	GO	BP	muscle cell cellular homeostasis	ALDOA,CAPN3,CAV3,CHRNA1,DMD,GYLTL1B,LARGE,MSTN,PFKM,SGCZ,SOD1,SRF	The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.
GO:0046717	GO	BP	acid secretion	ABCB4,ABCC4,ACE,BDKRB2,BZRAP1,CPLX1,DRD2,DRD3,DRD4,GIPC1,GLS,GLS2,LEP,NMUR2,NOS2,PLA2G1B,PNPLA8,PPFIA1,PPFIA2,PPFIA3,PPFIA4,RAB3A,RIMS1,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC22A16,SLC26A6,SLC38A2,SLC9A3R1,SNAP25,STX1A,STXBP1,SYT1,UNC13B,VAMP2	The controlled release of acid by a cell or a tissue.
GO:0046718	GO	BP	viral entry into host cell	ACE2,ADRBK1,AXL,CAV1,CAV2,CD55,CD81,CLEC4M,CLEC5A,DPP4,EPS15,GAS6,HAVCR1,HYAL2,ITCH,ITGAV,ITGB3,NPC1,PVRL1,PVRL2,SERPINB3,SIVA1,VAMP8,WWP1,WWP2,ZNF639	The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
GO:0046719	GO	BP	regulation by virus of viral protein levels in host cell	DDB1,DERL1,DYNLT1,HACD3,IFIT1,STAT1,STAU1,TAP1,TAP2,TBC1D20,VAPB	Any virus-mediated process that modulates the levels of viral proteins in a cell.
GO:0046755	GO	BP	viral budding	CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,LRSAM1,MVB12A,PDCD6IP,TSG101,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,VPS4A,VPS4B,VTA1	A viral process by which enveloped viruses acquire a host-derived membrane enriched in viral proteins to form their external envelope. The process starts when nucleocapsids, assembled or in the process of being built, induce formation of a membrane curvature in the host plasma or organelle membrane and wrap up in the forming bud. The process ends when the bud is eventually pinched off by membrane scission to release the enveloped particle into the lumenal or extracellular space.
GO:0046777	GO	BP	protein autophosphorylation	AAK1,ABL1,ACVR1B,AKT1,ALK,ATM,ATR,AURKA,AURKB,BMX,CAD,CAMK2A,CAMK2B,CAMK2D,CAMKK2,CDK12,CDKL5,CHEK2,CLK2,CSF1R,DAPK1,DAPK2,DAPK3,DDR1,DDR2,DYRK1A,EEF2K,EGFR,EIF2AK1,EIF2AK2,EIF2AK3,EIF2AK4,EPHA1,EPHA4,EPHA8,EPHB1,EPHB3,EPHB4,ERBB2,ERBB4,ERN1,FER,FES,FGFR1,FGFR2,FGFR3,FGFR4,FGR,FLT1,FLT3,FLT4,GRK1,GRK5,GRK7,GSK3B,HCK,IGF1R,INSR,INSRR,IRAK1,JAK2,KDR,KIT,LMTK2,LRRK2,LYN,MAK,MAP2K2,MAP3K10,MAP3K11,MAP3K12,MAP3K13,MAP3K3,MAP3K9,MAP4K1,MAPK15,MAPK3,MAPKAPK5,MARK2,MELK,MEX3B,MINK1,MOS,MTOR,MUSK,MYLK2,MYO3A,NEK2,NEK6,NTRK1,NTRK2,PAK1,PAK2,PASK,PDGFRA,PDGFRB,PDPK1,PEAK1,PIM1,PINK1,PRKD1,PRKD2,PRKX,PTK2,PTK2B,PTK6,RIPK1,RIPK3,SIK1,SIK2,SLK,SMG1,SRC,SRMS,STK10,STK11,STK16,STK17B,STK24,STK25,STK26,STK33,STK4,TAF1,TAOK3,TEC,TEK,TNIK,TNK1,TSSK2,TXK,TYRO3,UHMK1,ULK1,ULK2,ULK3,VRK1,VRK2,WNK2,WNK3	The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
GO:0046782	GO	BP	regulation of viral transcription	CCL3,CCL4,CCL5,CCNH,CCNT1,CDK7,CDK9,CHD1,CTDP1,ELL,EP300,ERCC2,ERCC3,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HDAC1,HMGA2,HPN,IFITM3,INPP5K,JUN,LEF1,MDFIC,MID2,MNAT1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU2F3,REST,RSF1,SMARCA4,SMARCB1,SNW1,SP1,SP100,SSRP1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TARBP2,TARDBP,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TRIM11,TRIM13,TRIM14,TRIM21,TRIM27,TRIM31,TRIM32,TRIM62,ZNF639	Any process that modulates the frequency, rate or extent of the transcription of the viral genome.
GO:0046784	GO	BP	viral mRNA export from host cell nucleus	ALYREF,DDX39B,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7	The directed movement of intronless viral mRNA from the host nucleus to the cytoplasm for translation.
GO:0046785	GO	BP	microtubule polymerization	AKAP9,BLOC1S2,CENPJ,CLASP1,CLASP2,CSNK1D,FGF13,GOLGA2,MAP7D3,RANBP9,SLAIN2,TPPP,TRPV4,TUBGCP2,TUBGCP3,TUBGCP4,TUBGCP5,TUBGCP6,ZNF207	The addition of tubulin heterodimers to one or both ends of a microtubule.
GO:0046790	GO	MF	virion binding	APCS,CD209,CLEC4M,PPIA,PTX3,TSG101	Interacting selectively and non-covalently with a virion, either by binding to components of the capsid or the viral envelope.
GO:0046794	GO	BP	transport of virus	ALYREF,CAV1,CAV2,CD209,CLEC4M,DDX39B,DERL1,DYNLT1,EPS15,IFIT1,KPNA1,KPNB1,NMT2,RAN,RPS27A,TAP1,TAP2,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TSG101,UBA52,UBB,UBC,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,XPO1	The directed movement of a virus, or part of a virus, into, out of, or within a host cell.
GO:0046813	GO	BP	receptor-mediated virion attachment to host cell	ACE2,CD81,GAS6,ICAM1,LRRC15	The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface.
GO:0046822	GO	BP	regulation of nucleocytoplasmic transport	AAAS,AKAP6,ANP32B,APC2,APOD,AXIN2,BAMBI,BARD1,BMP4,BMP6,BMP7,BMPR1A,C1QTNF3,C8orf4,CABP1,CAMK1,CCDC22,CCL19,CD27,CDH1,CDKN2A,CHERP,CHP1,CHP2,CREB3,CSF3,CYLD,DAB2,DAB2IP,DACT1,DACT3,DDX58,DMAP1,DYRK2,ECT2,EGF,EGFR,EMD,ERBB4,FAF1,FAM89B,FLNA,FZD7,G3BP2,GAS6,GNAQ,GSK3B,HCLS1,HDAC3,HYAL2,IFI27,IGF1,IL10,IL12B,IL1B,IL23A,IL6,IPO5,IWS1,JUP,KANK1,KHDRBS1,KPNA1,LACRT,LGALS9,MAVS,MDFI,MDFIC,MX2,MXI1,NCBP2,NEDD4,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NODAL,NOV,NUDT4,NUP153,OGG1,PARK7,PARP10,PBLD,PDE2A,PIK3R1,PIK3R2,PKD1,PKD2,POU5F1,PPM1A,PPM1B,PPP3CA,PPP3CB,PPP3R1,PRKCD,PSMD10,PTPN14,PYDC2,RAB23,RANGAP1,RAPGEF3,RBM4,RBPMS,RHOA,SEMA5A,SETD2,SFRP5,SIRT1,SLC9A1,SLC9A3R1,SMAD3,SMAD4,SNAI2,SOX4,SP100,SPHK1,SPPL3,SUFU,SUPT6H,TCF7L2,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TONSL,TPR,TRIM28,TRIP6,TXN,UBR5,UHMK1,WNT3A,WWTR1,XBP1,XPO4,ZC3H12A,ZC3H3,ZIC1,ZNF268,ZPR1	Any process that modulates the frequency, rate or extent of the directed movement of substances between the nucleus and the cytoplasm.
GO:0046823	GO	BP	negative regulation of nucleocytoplasmic transport	APC2,APOD,AXIN2,BARD1,BMP7,C1QTNF3,CABP1,CCDC22,CHP1,CREB3,CYLD,DAB2IP,DACT3,DYRK2,EMD,FAF1,FAM89B,G3BP2,GAS6,GSK3B,IL10,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOV,NUP153,PARK7,PARP10,PBLD,PDE2A,PKD1,PKD2,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,RANGAP1,SFRP5,SLC9A3R1,SNAI2,SOX4,SP100,SUFU,TONSL,TPR,WWTR1,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of substances between the cytoplasm and the nucleus.
GO:0046824	GO	BP	positive regulation of nucleocytoplasmic transport	AKAP6,ANP32B,BAMBI,BMP4,BMP6,BMPR1A,C8orf4,CAMK1,CCL19,CD27,CDH1,CHERP,CHP2,CSF3,DAB2,DACT1,DDX58,DMAP1,ECT2,EGF,EGFR,EMD,ERBB4,FLNA,GAS6,GSK3B,HCLS1,HDAC3,HYAL2,IGF1,IL12B,IL1B,IL23A,IL6,IPO5,JUP,KANK1,KHDRBS1,KPNA1,LACRT,LGALS9,MAVS,NCBP2,NEDD4,NLRP12,NODAL,PIK3R1,PIK3R2,POU5F1,PPP3CA,PPP3CB,PPP3R1,PRKCD,RAPGEF3,RBPMS,RHOA,SEMA5A,SLC9A1,SMAD3,SMAD4,SPHK1,SPPL3,TCF7L2,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TPR,TRIM28,TRIP6,UBR5,WNT3A,XBP1,XPO4,ZIC1,ZNF268,ZPR1	Any process that activates or increases the frequency, rate or extent of the directed movement of substances between the nucleus and the cytoplasm.
GO:0046825	GO	BP	regulation of protein export from nucleus	ANP32B,BARD1,CAMK1,CDKN2A,EMD,GAS6,GSK3B,IFI27,IL1B,PARK7,PTPN14,RANGAP1,RAPGEF3,SOX4,SP100,TCF7L2,TPR,UHMK1,XPO4	Any process that modulates the frequency, rate or extent of the directed movement of proteins from the nucleus to the cytoplasm.
GO:0046826	GO	BP	negative regulation of protein export from nucleus	BARD1,PARK7,RANGAP1,SOX4,SP100	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of proteins from the nucleus into the cytoplasm.
GO:0046827	GO	BP	positive regulation of protein export from nucleus	ANP32B,CAMK1,EMD,GAS6,GSK3B,IL1B,RAPGEF3,TCF7L2,TPR,XPO4	Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.
GO:0046831	GO	BP	regulation of RNA export from nucleus	IWS1,KHDRBS1,NCBP2,NUDT4,NUP153,SETD2,SUPT6H,TPR,ZC3H3	Any process that modulates the frequency, rate or extent of the directed movement of RNA from the nucleus to the cytoplasm.
GO:0046834	GO	BP	lipid phosphorylation	CERK,DGKZ,EFR3A,EFR3B,FAM126A,IP6K1,IP6K2,PI4K2A,PI4KA,PIK3CA,PIK3R1,PIKFYVE,PIP4K2A,PIP4K2B,PIP5K1A,PIP5K1B,SMG1,SPHK1,SPHK2,TMEM150A,TTC7B	The process of introducing one or more phosphate groups into a lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents.
GO:0046835	GO	BP	carbohydrate phosphorylation	GNPTAB,GNPTG,IPPK,KHK,NAGK,PFKFB2,PFKFB3,PFKFB4,POMK,TKFC,XYLB	The process of introducing a phosphate group into a carbohydrate, any organic compound based on the general formula Cx(H2O)y.
GO:0046839	GO	BP	phospholipid dephosphorylation	EPHX2,INPP5B,INPP5K,MTM1,MTMR1,MTMR2,MTMR3,PLPP1,PLPP4,PLPP5,PTEN,SACM1L,SYNJ1,TMEM55A,TMEM55B	The process of removing one or more phosphate groups from a phosphorylated lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents.
GO:0046847	GO	BP	filopodium assembly	ARHGEF4,DNM3,EZR,FGD1,FGD2,FGD3,FGD4,FGD5,FGD6,PPP1R9B,RAB17,S1PR2,SPATA13,SRGAP2	The assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
GO:0046849	GO	BP	bone remodeling	EFNA2,EPHA2,GPR55,IL7,LGR4,NOTCH2,PTH,PTK2B,SRC,TPP1,ZNF675	The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
GO:0046850	GO	BP	regulation of bone remodeling	ADAM8,ATP6AP1,BGLAP,CALCA,CARTPT,CSF1R,DCSTAMP,GREM1,ITGB3,LEP,LEPR,MC4R,NF1,P2RX7,S1PR1,SFRP1,SRC,SUCO,SYK,TNFAIP3,TNFSF11	Any process that modulates the frequency, rate or extent of bone remodeling, the processes of bone formation and resorption that combine to maintain skeletal integrity.
GO:0046851	GO	BP	negative regulation of bone remodeling	CALCA,CARTPT,GREM1,P2RX7,SFRP1,TNFAIP3	Any process that stops, prevents, or reduces the frequency, rate or extent of bone remodeling.
GO:0046854	GO	BP	phosphatidylinositol phosphorylation	EFR3A,EFR3B,FAM126A,IP6K1,IP6K2,PI4K2A,PI4KA,PIK3CA,PIK3R1,PIKFYVE,PIP4K2A,PIP4K2B,PIP5K1A,PIP5K1B,SMG1,TMEM150A,TTC7B	The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
GO:0046855	GO	BP	inositol phosphate dephosphorylation	IMPA1,IMPA2,INPP5K,PTEN,SYNJ1	The process of removing a phosphate group from any mono- or polyphosphorylated inositol.
GO:0046856	GO	BP	phosphatidylinositol dephosphorylation	INPP5B,INPP5K,MTM1,MTMR1,MTMR2,MTMR3,PTEN,SACM1L,SYNJ1,TMEM55A,TMEM55B	The process of removing one or more phosphate groups from a phosphatidylinositol.
GO:0046879	GO	BP	hormone secretion	CAMK2G,CDK16,CRHR1,CYB5R4,EDN1,EDN3,EIF2AK3,EXOC3L1,FAM3B,GAL,GHRH,GHRL,GHSR,HNF1A,IL6,INHBA,LTBP4,MAFA,NEUROD1,PDX1,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,RAB1A,RIMS2,SLC30A8,SNAP23,SNX19,TBX3,VIP	The regulated release of hormones, substances with a specific regulatory effect on a particular organ or group of cells.
GO:0046883	GO	BP	regulation of hormone secretion	ABCC8,ADCY5,ADRA2A,ADRA2B,ADRA2C,AKAP5,ANO1,ANXA1,ARL2,ARL2BP,ARNTL,BAD,BLK,BMP8A,BRSK2,C1QTNF1,C1QTNF3,CACNA1A,CACNA1C,CACNA1D,CACNA1E,CACNA2D2,CAPN10,CARTPT,CCL5,CDK16,CFTR,CHD7,CHRM3,CLOCK,CRH,CRHBP,CRHR1,DOC2B,DRD2,EDN1,EDN3,EFNA5,ENSA,EPHA5,FAM3D,FFAR1,FFAR2,FFAR3,FGA,FGB,FGF23,FGG,FOXA2,G6PC2,GAL,GALR1,GCG,GCK,GDF9,GHRH,GHRHR,GHRL,GIP,GLP1R,GLUD1,GNAS,GPER1,GPLD1,HCAR2,HFE,HLA-DRB1,HNF4A,HTR2C,IFNG,IL11,IL1B,INHA,INHBA,INHBB,INS,IQGAP1,IRS1,IRS2,ISL1,ITPR1,ITPR2,ITPR3,KCNA5,KCNB1,KCNC2,KCNG2,KCNJ11,KCNS3,LIF,MARCKS,MCU,MTNR1B,MYRIP,NEUROD1,NKX3-1,NLGN2,NOS2,NOV,NPVF,NR1D1,NR1H4,OSM,PARK2,PASK,PAX8,PCSK1,PER2,PIM3,PPP3CB,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PSMD9,RAB11FIP1,RAB11FIP3,RAB11FIP5,RAP1A,RAPGEF3,RAPGEF4,RASL10B,RBP4,REST,RFX3,RFX6,SCG5,SEC11A,SEC11C,SFRP1,SIRT4,SLC25A4,SLC25A5,SLC25A6,SLC2A1,SLC2A2,SLC30A8,SLC8B1,SNAP25,SNX4,SOX11,SOX4,SPCS1,SPCS2,SPCS3,STX1A,STX4,STXBP1,STXBP4,SYT5,TCF7L2,TFAP2B,TFR2,TMEM27,TNF,TNFSF11,UQCC2,VAMP2,VAMP7,VAMP8	Any process that modulates the frequency, rate or extent of the regulated release of a hormone from a cell.
GO:0046885	GO	BP	regulation of hormone biosynthetic process	AKR1C3,ARNT,BMP2,BMP5,BMP6,DKK3,FFAR3,HIF1A,REST,STC2,TRERF1,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.
GO:0046887	GO	BP	positive regulation of hormone secretion	ANO1,BAD,BLK,C1QTNF1,C1QTNF3,CAPN10,CARTPT,CFTR,CRH,DOC2B,DRD2,EDN1,EDN3,FGA,FGB,FGG,GAL,GALR1,GCK,GHRH,GHRHR,GHRL,GLUD1,GPER1,GPLD1,HCAR2,HFE,HLA-DRB1,INHA,INHBA,INS,IRS2,ISL1,MCU,MYRIP,NKX3-1,NLGN2,PPP3CB,PSMD9,RASL10B,RBP4,RFX6,SLC30A8,SNX4,SOX11,SOX4,STX4,TCF7L2,TFR2,TMEM27,TNFSF11,VAMP7,VAMP8	Any process that activates or increases the frequency, rate or extent of the regulated release of a hormone from a cell.
GO:0046888	GO	BP	negative regulation of hormone secretion	ADRA2A,ADRA2B,ADRA2C,BMP8A,CRHBP,FAM3D,FGF23,IL11,IL1B,INHA,INHBA,INHBB,IRS1,KCNB1,KCNJ11,LIF,NOV,NPVF,OSM,PARK2,PIM3,PSMD9,RAB11FIP1,RAB11FIP3,RAB11FIP5,REST,SFRP1,SIRT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell.
GO:0046889	GO	BP	positive regulation of lipid biosynthetic process	ABCG1,ACSL3,AKT1,APOA4,APOA5,APOC2,APOE,BMP6,CNEP1R1,CREB1,CREBL2,CTDNEP1,FABP3,FGF1,GNB2L1,GPLD1,HSD17B13,HTR2A,HTR2B,HTR2C,IFNG,IL1B,INS,LDLR,MID1IP1,MLXIPL,MTOR,NR1D1,NR1H2,NR1H3,NSMAF,PLIN5,PRKAA1,PRKCD,PTGS2,SCARB1,SIRT4,SMPD2,SMPD3,SORBS1,SREBF1,TNF,TNFRSF1A,WNT4,XBP1,ZP3	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids.
GO:0046890	GO	BP	regulation of lipid biosynthetic process	ABCG1,ACADL,ACADVL,ACSL3,AKR1C3,AKT1,APOA4,APOA5,APOC1,APOC2,APOC3,APOE,BMP2,BMP5,BMP6,BRCA1,C3,CNEP1R1,CREB1,CREBL2,CTDNEP1,CYP27B1,CYP7A1,DKK3,ERLIN1,ERLIN2,FABP3,FBXW7,FGF1,FGF19,FGFR4,FITM2,GFI1,GNB2L1,GPER1,GPLD1,HSD17B13,HTR2A,HTR2B,HTR2C,IFNG,IL1B,INS,LDLR,MID1IP1,MLXIPL,MTOR,NFKB1,NR1D1,NR1H2,NR1H3,NR1H4,NR5A1,NSMAF,PDGFA,PDGFB,PDK4,PIBF1,PLIN5,PRKAA1,PRKAA2,PRKAB2,PRKAG2,PRKCD,PROX1,PTGS2,REST,SAMD8,SCAP,SCARB1,SEC14L2,SIK1,SIRT1,SIRT4,SLC27A1,SMPD2,SMPD3,SNAI1,SNAI2,SOD1,SORBS1,SREBF1,STK11,THRSP,TNF,TNFRSF1A,TRIB3,VDR,WNT4,XBP1,ZP3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids.
GO:0046902	GO	BP	regulation of mitochondrial membrane permeability	ACAA2,AKT1,ALKBH7,ATF2,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BLOC1S2,BMF,BNIP3,CAMK2A,CASP8,DYNLL1,DYNLL2,E2F1,GSK3A,GSK3B,GZMB,HEBP2,HSPA1A,MAPK8,MOAP1,MPV17L,MUL1,NAIF1,NMT1,PMAIP1,PPIF,PPP3CC,PPP3R1,RHOT1,RHOT2,SFN,SIVA1,SLC25A5,SLC35F6,TFDP1,THEM4,TMEM102,TP53,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.
GO:0046906	GO	MF	tetrapyrrole binding	ABCB6,AMBP,BACH1,CAT,CBS,CD320,CYB5B,CYBB,CYCS,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A2,CYP1B1,CYP24A1,CYP26A1,CYP26B1,CYP2A13,CYP2A6,CYP2B6,CYP2C19,CYP2D6,CYP2E1,CYP46A1,CYP4F11,CYP51A1,DGCR8,EIF2AK1,FLVCR2,GIF,GUCY1B3,HEBP1,HMOX1,HRG,JAK2,NOS1,NOS2,NOS3,NOX4,NOX5,NR1D1,PTGES2,PTGIS,PTGS2,PXDN,PXDNL,SDHC,SDHD,SRC,STC2,TCN2	Interacting selectively and non-covalently with a tetrapyrrole, a compound containing four pyrrole nuclei variously substituted and linked to each other through carbons at the alpha position.
GO:0046915	GO	MF	transition metal ion transmembrane transporter activity	ATP2C1,ATP7A,ATP7B,SLC11A1,SLC11A2,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC31A1,SLC39A11,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6,SLC40A1,TTYH1,ZP3	Enables the transfer of transition metal ions from one side of a membrane to the other. A transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum and silver.
GO:0046916	GO	BP	cellular transition metal ion homeostasis	ABCB6,ABCG2,ALAS2,APP,ARF1,ATP2C1,ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,ATP7A,ATP7B,BMP6,CCDC22,CP,CYBRD1,FAM132B,FLVCR1,FTH1,FTL,FTMT,FXN,GDF2,HAMP,HEPH,HFE2,HMOX1,HMOX2,LCK,LCN2,LTF,MCOLN1,MT2A,MT3,MYC,NDFIP1,NUBP1,PRNP,S100A8,S100A9,SCARA5,SLC11A1,SLC11A2,SLC22A17,SLC30A1,SLC30A5,SLC30A8,SLC39A13,SLC39A14,SLC39A6,SLC40A1,SLC46A1,SMAD4,SOD1,SRI,STEAP3,TCIRG1,TF,TFR2,TFRC,TMPRSS6	Any process involved in the maintenance of an internal steady state of transition metal ions at the level of a cell. A transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum and silver.
GO:0046920	GO	MF	alpha-(1->3)-fucosyltransferase activity	FUT10,FUT3,FUT4,FUT5,FUT6,FUT7,FUT9	Catalysis of the transfer of an L-fucosyl group from GDP-beta-L-fucose to an acceptor molecule to form an alpha-(1->6) linkage.
GO:0046928	GO	BP	regulation of neurotransmitter secretion	CAMK2A,CHRNA3,CHRNB4,DTNBP1,GPER1,KCNMB4,LRRK2,MEF2C,NLGN1,PARK2,RAB3A,RAB3GAP1,RAB5A,RIMS1,RIMS3,RIMS4,SEPT5,SLC30A1,SNCAIP,STX1B,STXBP1,SYN1,SYT11,UNC13B	Any process that modulates the frequency, rate or extent of the regulated release of a neurotransmitter from a cell.
GO:0046930	GO	CC	pore complex	BAK1,BAX,BCL2,C8A,CD34,NUP62,VDAC1	Any small opening in a membrane that allows the passage of gases and/or liquids.
GO:0046931	GO	BP	pore complex assembly	AHCTF1,ANO6,BAD,NDC1,NUP107,NUP153,NUP205,NUP93,NUP98,P2RX7	The aggregation, arrangement and bonding together of a set of components to form a pore complex. A pore complex is a small opening in a membrane that allows the passage of liquids and/or gases.
GO:0046939	GO	BP	nucleotide phosphorylation	AK1,AK2,AK4,AK5,AK6,AK7,AK8,AK9,ALDOA,ALDOB,ALDOC,CMPK1,CMPK2,DTYMK,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,LDHA,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGK1,PGK2,PGM1,PKLR,PKM,PNKP,PPP2R5D,TPI1	The process of introducing one or more phosphate groups into a nucleotide to produce a phosphorylated nucleoside.
GO:0046942	GO	BP	carboxylic acid transport	ABCB11,ABCB4,ABCC3,ABCC4,ABCD1,ACACA,ACACB,ACE,ACSL1,ACSL3,AKR1C1,AKR1C4,ALB,APOE,AQP9,ARL6IP5,ATP8B1,BAAT,BDKRB2,BZRAP1,CD36,CLN3,CPLX1,CPT1A,CPT1B,CPT2,CTNS,DRD2,DRD3,DRD4,EMB,FABP3,FABP6,FOLR1,FOLR2,FOLR3,GIPC1,GLS,GLS2,LCN1,LCN12,LEP,MFSD2A,NCOA1,NCOA2,NMUR2,NOS2,NR1H4,OCA2,PDZK1,PLA2G1B,PNPLA8,PPARA,PPARD,PPARG,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PQLC2,PRAF2,PRKAA2,PRKAB2,PRKAG2,RAB3A,RIMS1,RXRA,SERINC1,SLC10A1,SLC10A2,SLC11A1,SLC13A2,SLC16A1,SLC16A10,SLC16A12,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC16A8,SLC17A5,SLC17A7,SLC19A1,SLC19A2,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC22A13,SLC22A16,SLC22A4,SLC22A5,SLC22A6,SLC22A9,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A15,SLC25A17,SLC25A20,SLC25A22,SLC25A26,SLC25A32,SLC26A1,SLC26A6,SLC26A7,SLC26A8,SLC27A1,SLC27A2,SLC27A4,SLC27A5,SLC27A6,SLC35D1,SLC36A1,SLC36A2,SLC36A4,SLC38A1,SLC38A2,SLC38A3,SLC38A4,SLC38A5,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC43A2,SLC46A1,SLC51A,SLC51B,SLC6A12,SLC6A14,SLC6A15,SLC6A17,SLC6A18,SLC6A19,SLC6A20,SLC6A5,SLC6A6,SLC6A7,SLC6A8,SLC7A1,SLC7A10,SLC7A11,SLC7A2,SLC7A3,SLC7A4,SLC7A5,SLC7A6,SLC7A7,SLC7A8,SLC7A9,SLC9A3R1,SLCO1A2,SLCO1B1,SLCO1B3,SNAP25,SPX,STX1A,STXBP1,SYT1,UNC13B,VAMP2	The directed movement of carboxylic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Carboxylic acids are organic acids containing one or more carboxyl (COOH) groups or anions (COO-).
GO:0046943	GO	MF	carboxylic acid transmembrane transporter activity	ABCB11,AKR1C4,AQP9,CTNS,OCA2,PQLC2,SERINC1,SLC13A2,SLC16A1,SLC16A12,SLC16A2,SLC16A3,SLC16A4,SLC16A5,SLC16A6,SLC16A7,SLC17A5,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A5,SLC1A6,SLC1A7,SLC22A16,SLC22A4,SLC22A5,SLC23A1,SLC23A2,SLC25A1,SLC25A10,SLC25A11,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC26A1,SLC26A6,SLC26A7,SLC26A8,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A7,SLC38A9,SLC3A1,SLC3A2,SLC43A1,SLC6A14,SLC6A20,SLC6A5,SLC6A8,SLC6A9,SLC7A10,SLC7A11,SLC7A2,SLC7A4,SLC7A5,SLC7A6,SLC7A8,SLC7A9	Enables the transfer of carboxylic acids from one side of the membrane to the other. Carboxylic acids are organic acids containing one or more carboxyl (COOH) groups or anions (COO-).
GO:0046950	GO	BP	cellular ketone body metabolic process	AACS,ACAT1,BDH1,BDH2,HMGCL,HMGCLL1,HMGCS2,OXCT1	The chemical reactions and pathways involving ketone bodies, any one of the three substances: acetoacetate, D-3-hydroxybutyrate (beta-hydroxybutyrate) or acetone, as carried out by individual cells. Although 3-hydroxybutyrate is not a ketone, it is classed as a ketone body because it exists in an equilibrium with acetoacetate. Ketone bodies may accumulate in excessive amounts in the body in starvation, diabetes mellitus or in other defects of carbohydrate metabolism.
GO:0046951	GO	BP	ketone body biosynthetic process	AACS,ACAT1,BDH1,BDH2,HMGCL,HMGCLL1,HMGCS2	The chemical reactions and pathways resulting in the formation of ketone bodies, any one of the three substances: acetoacetate, D-3-hydroxybutyrate (beta-hydroxybutyrate) or acetone. Biosynthesis involves the formation of hydroxymethylglutaryl-CoA, which is cleaved to acetate and acetyl-CoA.
GO:0046961	GO	MF	proton-transporting ATPase activity, rotational mechanism	ATP5B,ATP6V0C,ATP6V0E1,ATP6V1B2,ATP6V1C1	Catalysis of the transfer of protons from one side of a membrane to the other according to the reaction: ATP + H2O + H+(in) = ADP + phosphate + H+(out), by a rotational mechanism.
GO:0046965	GO	MF	retinoid X receptor binding	HMGA1,NCOA6,NR4A2,NSD1,PPARG,RARG	Interacting selectively and non-covalently with a retinoid X receptor.
GO:0046966	GO	MF	thyroid hormone receptor binding	GAS2L1,HMGN3,JMJD1C,MED1,MED12,MED13,MED16,MED17,MED24,MED30,MED4,NCOA3,NCOA6,NSD1,NUP62,OASL,THRAP3,TRIP12,TRIP6,ZNHIT3	Interacting selectively and non-covalently with a thyroid hormone receptor.
GO:0046972	GO	MF	histone acetyltransferase activity (H4-K16 specific)	HCFC1,KANSL1,KANSL2,KANSL3,KAT8,MCRS1,OGT,PHF20,WDR5	Catalysis of the reaction: acetyl-CoA + histone H4 L-lysine (position 16) = CoA + histone H4 N6-acetyl-L-lysine (position 16). This reaction represents the addition of an acetyl group to the lysine at position 16 of histone H4.
GO:0046974	GO	MF	histone methyltransferase activity (H3-K9 specific)	EHMT1,EHMT2,SETDB2,SUV39H1,SUV39H2	Catalysis of the reaction: S-adenosyl-L-methionine + histone H3 L-lysine (position 9) = S-adenosyl-L-homocysteine + histone H3 N6-methyl-L-lysine (position 9). This reaction is the addition of a methyl group onto lysine at position 9 of the histone H3 protein.
GO:0046975	GO	MF	histone methyltransferase activity (H3-K36 specific)	ASH1L,NSD1,SETD2,SETD3,SETMAR,SMYD2	Catalysis of the reaction: S-adenosyl-L-methionine + histone H3 L-lysine (position 36) = S-adenosyl-L-homocysteine + histone H3 N6-methyl-L-lysine (position 36). This reaction is the addition of a methyl group onto lysine at position 36 of the histone H3 protein.
GO:0046977	GO	MF	TAP binding	HLA-A,HLA-B,HLA-C,TAP1,TAPBP	Interacting selectively and non-covalently with TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2.
GO:0046982	GO	MF	protein heterodimerization activity	ADCY2,ADCY5,ADRA1A,ADRA1B,ADRA2A,AHR,ARNT2,ATF4,BHLHA9,BHLHE41,BIRC5,BMP2,BMP6,BNIP3,BNIP3L,CABYR,CEBPB,CEBPG,CHUK,CLCF1,CLCN3,CLNS1A,CRLF1,CXCL13,DDIT3,DGKD,DVL3,EGFR,ERBB2,ERBB3,FAM73A,FAM73B,FLOT1,FLOT2,GABPA,GABPB1,GABPB2,HEXA,HEXB,HEYL,HIF1A,HNF1A,IKBKB,IKBKG,IKZF3,ITGA3,ITGB1,KCNB1,KCNB2,MAFA,MID1,MID2,MPP7,MTTP,MYF5,MYF6,MYOD1,MYOG,NEUROD1,NEUROD2,NFKB1,NKX2-5,NOTCH4,NPM1,NR2C2,NR4A1,NR4A2,P4HB,PDSS1,PDSS2,PIK3R2,PML,PPP2R4,PRMT5,PRMT8,RAB3GAP2,RALGAPA2,RALGAPB,RARA,RELA,RUNX1,RXRA,SAE1,SCGB1D1,SCGB2A1,SCUBE1,SCX,SEPHS1,SLC51A,SLC51B,SNX1,SNX2,SNX5,SNX6,TAS1R1,TAS1R2,TAS1R3,TBX18,TCF3,TCF4,TENM1,TENM2,TENM3,TERF1,TFDP3,TGFB2,TIRAP,TLR1,TLR2,TPD52,TPD52L1,TPD52L2,TXLNG,TYR,TYRP1,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,VEGFA,XBP1,ZBTB1,ZHX1,ZHX2,ZHX3	Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
GO:0047372	GO	MF	acylglycerol lipase activity	ABHD12,ABHD6,CEL,MGLL,PNLIPRP2	Catalysis of the reaction: H2O + acylglycerol = a fatty acid + glycerol.
GO:0047429	GO	MF	nucleoside-triphosphate diphosphatase activity	DCTPP1,ENPP1,ENPP3,NUDT1,NUDT15,NUDT16	Catalysis of the reaction: H2O + a nucleoside triphosphate = diphosphate + a nucleotide.
GO:0047484	GO	BP	regulation of response to osmotic stress	ARHGEF2,EPO,MBIP,MLC1,YBX3	Any process that modulates the rate or extent of the response to osmotic stress.
GO:0047485	GO	MF	protein N-terminus binding	ATM,HAX1,HDAC1,MAP2K1,PPP1CC,UNC13A	Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
GO:0047496	GO	BP	vesicle transport along microtubule	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CLN3,DTNBP1,DYNC1I1,FYCO1,HTT,KIF13A,KIF3A,KIF3B,KIF5B,KIFAP3,PAFAH1B1,RAB1A,SNAPIN	The directed movement of a vesicle along a microtubule, mediated by motor proteins. This process begins with the attachment of a vesicle to a microtubule, and ends when the vesicle reaches its final destination.
GO:0047497	GO	BP	mitochondrion transport along microtubule	HIF1A,LRPPRC,MAP1S,MGARP,NEFL,OPA1,RHOT1,RHOT2,UBB,UXT	The directed movement of a mitochondrion along a microtubule, mediated by motor proteins.
GO:0047498	GO	MF	calcium-dependent phospholipase A2 activity	PLA2G12A,PLA2G1B,PLA2G2A,PLA2G3,PLA2G4B	Catalysis of the reaction: phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. This reaction requires Ca2+.
GO:0047617	GO	MF	acyl-CoA hydrolase activity	ACOT1,ACOT11,ACOT13,ACOT2,ACOT4,ACOT7,ACOT8,ACSBG2,BAAT,GNPAT,PPT1,THEM4,THEM5	Catalysis of the reaction: acyl-CoA + H2O = CoA + a carboxylate.
GO:0048002	GO	BP	antigen processing and presentation of peptide antigen	ACE,ACTR1A,ACTR1B,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARF1,B2M,BCAP31,BLMH,CALR,CANX,CD207,CD209,CD36,CD74,CENPE,CLEC4M,CLTA,CLTC,CTSD,CTSE,CTSF,CTSL,CTSS,CTSV,CYBA,CYBB,DCTN1,DCTN2,DCTN3,DCTN4,DCTN5,DCTN6,DNM2,DYNC1H1,DYNC1I1,DYNC1I2,DYNC1LI2,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,ERAP1,ERAP2,FCGR1A,FCGR1B,HLA-A,HLA-B,HLA-C,HLA-DMA,HLA-DMB,HLA-DOA,HLA-DOB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,IFI30,ITGAV,ITGB5,KIF11,KIF15,KIF18A,KIF22,KIF23,KIF26A,KIF2A,KIF2B,KIF2C,KIF3A,KIF3B,KIF3C,KIF4A,KIF4B,KIF5A,KIFAP3,KLC1,KLC2,LGMN,LNPEP,MARCH1,NCF1,NCF2,NCF4,NPEPPS,OSBPL1A,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RAB7A,RACGAP1,RILP,RPS27A,SAR1B,SEC13,SEC23A,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEC61A1,SEC61A2,SEC61B,SEC61G,SH3GL2,SLC11A1,SPTBN2,TAP1,TAP2,TAPBP,TPP2,UBA52,UBB,UBC,UBE2A	The process in which an antigen-presenting cell expresses peptide antigen in association with an MHC protein complex on its cell surface, including proteolysis and transport steps for the peptide antigen both prior to and following assembly with the MHC protein complex. The peptide antigen is typically, but not always, processed from an endogenous or exogenous protein.
GO:0048008	GO	BP	platelet-derived growth factor receptor signaling pathway	ABL1,BCAR1,CLASP2,FER,NRP1,PDGFA,PDGFB,PDGFC,PDGFRA,PDGFRB,PDGFRL,PIK3C2A,PTPN1,PTPRJ,RGS14,VEGFA	The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.
GO:0048009	GO	BP	insulin-like growth factor receptor signaling pathway	AKT1,CRIM1,EIF2AK3,GHR,IGF1R,IGF2R,PIK3R1,PLCB1,TSC2	The series of molecular signals generated as a consequence of the insulin-like growth factor receptor binding to one of its physiological ligands.
GO:0048013	GO	BP	ephrin receptor signaling pathway	ACTB,ACTG1,ACTR2,ACTR3,ADAM10,ANKS1A,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APH1A,APH1B,ARHGEF28,ARHGEF7,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,CDC42,CDK5R1,CFL1,CHN1,CRK,DNM1,EFNA1,EFNA2,EFNA3,EFNA4,EFNA5,EFNB1,EFNB2,EFNB3,EPHA1,EPHA10,EPHA2,EPHA3,EPHA4,EPHA5,EPHA6,EPHA7,EPHA8,EPHB1,EPHB2,EPHB3,EPHB4,EPHB6,FYN,GIT1,GRIN1,GRIN2B,HRAS,ITSN1,KALRN,LIMK1,LYN,MMP2,MMP9,MYH10,MYH11,MYH14,MYH9,MYL12A,MYL12B,MYL6,MYL9,NCK2,NCSTN,NGEF,PAK1,PAK3,PSEN2,PSENEN,PTK2,PTPN11,RAC1,RASA1,RHOA,ROCK1,ROCK2,SDC2,SDCBP,SIPA1L1,SRC,TIAM1,VAV2,VAV3,WASL,YES1	The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
GO:0048015	GO	BP	phosphatidylinositol-mediated signaling	AGO1,AGO2,AGO3,AGO4,AKT1,AKT1S1,BAD,BTC,C1QBP,CASP9,CD19,CD28,CD80,CD86,CDKN1A,CDKN1B,CHUK,CREB1,CSF1R,EDN1,EGF,EGFR,ERBB2,ERBB3,ERBB4,EREG,EXOC1,EZR,FGF1,FGF10,FGF16,FGF17,FGF18,FGF19,FGF2,FGF20,FGF22,FGF23,FGF3,FGF4,FGF5,FGF6,FGF7,FGF8,FGF9,FGFR1,FGFR2,FGFR3,FGFR4,FOXO1,FOXO3,FOXO4,FRS2,FYN,GAB1,GAB2,GATA3,GPR143,GRB2,GSK3A,GSK3B,HBEGF,HTR2A,HTR2B,IGF1,IGF1R,IRS1,IRS2,KIT,KITLG,KL,KLB,LCK,LTK,MAPKAP1,MDM2,MLST8,MOV10,MTOR,MUC5AC,NF1,NGF,NR4A1,NRG1,NRG2,NRG4,NTRK1,NYAP1,NYAP2,OGT,PDGFA,PDGFB,PDGFRA,PDGFRB,PDPK1,PHLPP1,PHLPP2,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIK3R5,PLCH1,PLEKHA1,PRR5,PTAFR,PTEN,PTPN11,RHOA,RICTOR,RPS6KB1,RPS6KB2,SIRT2,THEM4,TNRC6A,TNRC6B,TNRC6C,TRAT1,TRIB3,TSC2,TYRO3,VAV1,XBP1,ZP3	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
GO:0048016	GO	BP	inositol phosphate-mediated signaling	EDN1,EDN2,EDN3,HRH1,ITPR1,ITPR2,ITPR3,LACRT,NFATC1,NMUR1,NMUR2,PLCE1,PPP3CA,PPP3CB,PPP3R1	Any intracellular signal transduction in which the signal is passed on within the cell via an inositol phosphate. Includes production of the inositol phosphate, and downstream effectors that further transmit the signal within the cell. Inositol phosphates are a group of mono- to poly-phosphorylated inositols, and include inositol monophosphate (IP), inositol trisphosphate (IP3), inositol pentakisphosphate (IP5) and inositol hexaphosphate (IP6).
GO:0048017	GO	BP	inositol lipid-mediated signaling	AGO1,AGO2,AGO3,AGO4,AKT1,AKT1S1,BAD,BTC,C1QBP,CASP9,CD19,CD28,CD80,CD86,CDKN1A,CDKN1B,CHUK,CREB1,CSF1R,EDN1,EGF,EGFR,ERBB2,ERBB3,ERBB4,EREG,EXOC1,EZR,FGF1,FGF10,FGF16,FGF17,FGF18,FGF19,FGF2,FGF20,FGF22,FGF23,FGF3,FGF4,FGF5,FGF6,FGF7,FGF8,FGF9,FGFR1,FGFR2,FGFR3,FGFR4,FOXO1,FOXO3,FOXO4,FRS2,FYN,GAB1,GAB2,GATA3,GPR143,GRB2,GSK3A,GSK3B,HBEGF,HTR2A,HTR2B,IGF1,IGF1R,IRS1,IRS2,KIT,KITLG,KL,KLB,LCK,LTK,MAPKAP1,MDM2,MLST8,MOV10,MTOR,MUC5AC,NF1,NGF,NR4A1,NRG1,NRG2,NRG4,NTRK1,NYAP1,NYAP2,OGT,PDGFA,PDGFB,PDGFRA,PDGFRB,PDPK1,PHLPP1,PHLPP2,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIK3R5,PLCH1,PLEKHA1,PRR5,PTAFR,PTEN,PTPN11,RHOA,RICTOR,RPS6KB1,RPS6KB2,SIRT2,THEM4,TNFAIP8L3,TNRC6A,TNRC6B,TNRC6C,TRAT1,TRIB3,TSC2,TYRO3,VAV1,XBP1,ZP3	A series of molecular signals in which a cell uses an inositol-containing lipid to convert a signal into a response. Inositol lipids include the phosphoinositides (phosphatidylinositol and its phosphorylated derivatives), ceramides containing inositol, and inositol glycolipids.
GO:0048018	GO	MF	receptor agonist activity	CXCL13,GAS6,GREM1,SFRP2,WNT1,WNT10B,WNT2,WNT3,WNT3A,WNT4,WNT5A,WNT7A,WNT8A	Interacts with receptors such that the proportion of receptors in the active form is increased.
GO:0048019	GO	MF	receptor antagonist activity	ADH7,AGTR2,CCL5,DKK1,ESR2,IL18BP,IL1RN,LRPAP1,PXDN	Interacts with receptors to reduce the action of another ligand, the agonist.
GO:0048020	GO	MF	CCR chemokine receptor binding	CCL19,CCL2,CCL21,CCL25,CCL5,CCR2,CREB3,CXCL13	Interacting selectively and non-covalently with a CCR chemokine receptor.
GO:0048024	GO	BP	regulation of mRNA splicing, via spliceosome	ACIN1,C1QBP,CELF3,CELF4,CELF6,CWC22,DDX5,JMJD6,MAGOH,NSRP1,PTBP1,RBFOX2,RBM11,RBM15B,RBM25,RBM4,RBM5,RBM8A,RBMX,RBMY1A1,RNPS1,SAP18,SFSWAP,SNW1,SRPK1,SRPK2,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,THRAP3,TIA1,TRA2B,U2AF2,WTAP	Any process that modulates the frequency, rate or extent of mRNA splicing via a spliceosomal mechanism.
GO:0048025	GO	BP	negative regulation of mRNA splicing, via spliceosome	ACIN1,C1QBP,PTBP1,RBMX,RNPS1,SAP18,SFSWAP,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,U2AF2	Any process that stops, prevents or reduces the rate or extent of mRNA splicing via a spliceosomal mechanism.
GO:0048026	GO	BP	positive regulation of mRNA splicing, via spliceosome	CELF3,CELF4,RBMX,SNW1,THRAP3,TRA2B	Any process that activates or increases the rate or extent of mRNA splicing via a spliceosomal mechanism.
GO:0048027	GO	MF	mRNA 5'-UTR binding	DDX3X,IGF2BP1,IGF2BP2,IGF2BP3,LARP1,RPS14	Interacting selectively and non-covalently with the 5' untranslated region of an mRNA molecule.
GO:0048029	GO	MF	monosaccharide binding	ACR,ALDOA,ALDOB,CD207,CD209,CLEC17A,CLN5,COLEC12,ENG,FBP1,FUOM,G6PD,GALK1,GCK,LGALS9,LMAN1,LMAN2,LMAN2L,MBL2,PFKL,PFKM,PYGL,SELP,SLC2A3,UPK1A	Interacting selectively and non-covalently with any monosaccharide. Monosaccharides are the simplest carbohydrates; they are polyhydroxy aldehydes H[CH(OH)]nC(=O)H or polyhydroxy ketones H[CHOH]nC(=O)[CHOH]mH with three or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides.
GO:0048037	GO	MF	cofactor binding	ABAT,ACCS,ACOT7,ACOX1,ADH4,AGPS,AGXT,AIFM2,ALAS2,ALB,ALDH6A1,AOC1,AOC3,ATAT1,BDH2,BIRC5,CAT,CBR3,CBR4,CBS,CRY2,CRYL1,CRYM,CRYZ,CRYZL1,CTBP1,CTH,CYB5R3,CYBB,DAO,DBI,DDO,DECR1,DHFR,DPYD,DUOX1,ETFA,ETFDH,FOXRED2,G6PD,GFER,GLUD1,GMDS,GRHPR,HACL1,HAO1,HIF1AN,HMGCR,HPGD,KCNAB1,KDM1A,KMO,MARC1,MARC2,ME1,ME3,MICAL1,MICAL2,MICAL3,MTHFR,MTRR,NDOR1,NDUFAB1,NNT,NOS1,NOS2,NOS3,NOX1,NOX4,NOX5,PDXK,PHYH,PPOX,PRODH,SCP2,SDHB,SDHD,SDS,SHMT1,SHMT2,SIRT2,SIRT5,SIRT6,SOAT1,SOAT2,SORD,SPR,SRR,THNSL2,TKT,TP53I3,UXS1,WWOX,XDH	Interacting selectively and non-covalently with a cofactor, a substance that is required for the activity of an enzyme or other protein. Cofactors may be inorganic, such as the metal atoms zinc, iron, and copper in certain forms, or organic, in which case they are referred to as coenzymes. Cofactors may either be bound tightly to active sites or bind loosely with the substrate.
GO:0048038	GO	MF	quinone binding	AOC1,AOC3,CBR4,ETFDH,SDHB,SDHD,TP53I3	Interacting selectively and non-covalently with a quinone, any member of a class of diketones derivable from aromatic compounds by conversion of two CH groups into CO groups with any necessary rearrangement of double bonds.
GO:0048041	GO	BP	focal adhesion assembly	ACTN1,ACTN2,ACTN3,ARHGEF7,CTTN,DLC1,FERMT2,LAMA5,PIP5K1A,PTPRK,RCC2,RHOD,SORBS1,TAOK2,TESK2,THY1,TRIP6,WHAMM	The aggregation and bonding together of a set of components to form a focal adhesion, a complex of intracellular signaling and structural proteins that provides a structural link between the internal actin cytoskeleton and the ECM, and also function as a locus of signal transduction activity.
GO:0048048	GO	BP	embryonic eye morphogenesis	ALDH1A3,KDM2B,PAX2,PHACTR4,PROX1,RARG,SIX3,SOX11,STRA6,TBX2,TFAP2A,TH,TWIST1,WNT16,WNT5A	The process occurring in the embryo by which the anatomical structures of the post-embryonic eye are generated and organized.
GO:0048066	GO	BP	developmental pigmentation	AP1G1,AP1M1,AP3D1,ATP6AP2,BLOC1S3,BLOC1S5,BLOC1S6,C10orf11,CD63,CITED1,GPR143,KIT,MEF2C,MITF,OCA2,RAB32,RAB38,TYR,USP13,ZEB2	The developmental process that results in the deposition of coloring matter in an organism, tissue or cell.
GO:0048069	GO	BP	eye pigmentation	AP3D1,ATP6AP2,GPR143,OCA2,TYR	Establishment of a pattern of pigment in the eye of an organism.
GO:0048070	GO	BP	regulation of developmental pigmentation	BLOC1S5,BLOC1S6,HPS4,VPS33A,ZEB2	Any process that modulates the frequency, rate or extent of the developmental process that results in the deposition of coloring matter in an organism.
GO:0048096	GO	BP	chromatin-mediated maintenance of transcription	ARID1A,ARID1B,BAZ1B,CHEK1,KMT2B,PADI2,SMARCD1	Maintenance of transcription by remodelling of chromatin into an 'open configuration'. Once established, this regulation is mitotically stable and is maintained over many cell divisions. It is also heritable.
GO:0048103	GO	BP	somatic stem cell division	CDKN2A,DOCK7,FGF13,FGFR2,NUMB,NUMBL,RAB10,SOX5,TEAD3,TGFB2,ZFP36L2	The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.
GO:0048145	GO	BP	regulation of fibroblast proliferation	AGT,AQP1,B4GALT7,BMI1,CD300A,CD74,CDC73,CDK4,CDK6,CDKN1A,CTNNB1,DAB2IP,DDR2,E2F1,EMD,EREG,FBLN1,FN1,FTH1,GAS6,GSTP1,IGF1,LIG4,MED25,MIF,MORC3,MYC,NDUFS4,NF1,PARP10,PDGFA,PDGFB,PDGFC,PDGFRA,PEX2,PLA2G1B,S100A6,SFRP1,SKI,SPHK1,TP53,TRIM32,WNT1,WNT2,WNT5A	Any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
GO:0048146	GO	BP	positive regulation of fibroblast proliferation	AGT,AQP1,BMI1,CD74,CDK4,CDK6,CDKN1A,DDR2,E2F1,EREG,FBLN1,FN1,GAS6,IGF1,LIG4,MIF,MYC,NDUFS4,PDGFA,PDGFB,PDGFC,PDGFRA,PLA2G1B,S100A6,SPHK1,WNT1,WNT2,WNT5A	Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
GO:0048147	GO	BP	negative regulation of fibroblast proliferation	B4GALT7,CD300A,CDC73,DAB2IP,EMD,FTH1,GSTP1,MED25,MORC3,MYC,NF1,PARP10,PEX2,SFRP1,SKI,TP53,TRIM32	Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
GO:0048167	GO	BP	regulation of synaptic plasticity	ANAPC2,APOE,ARF1,CAMK2A,CAMK2B,CDC20,CDK5,CNTN4,CPEB3,CPLX2,DBN1,DLG4,DRD2,EIF2AK4,EIF4EBP2,GIPC1,GRIK2,KCNB1,MEF2C,NETO1,NEURL1,NEUROD2,NPTN,NSMF,PICK1,PLK2,PPFIA3,PPP3CB,PRKCZ,PTK2B,RAB3A,RAB3GAP1,RAPGEF2,RASGRF1,RELN,RGS14,SHANK2,SHANK3,SHISA9,SIPA1L1,SLC8A2,SLC8A3,STX4,SYNGAP1,SYNGR1,SYP,VAMP2,YWHAG,YWHAH	A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
GO:0048168	GO	BP	regulation of neuronal synaptic plasticity	APOE,CAMK2A,CAMK2B,DBN1,DLG4,DRD2,GRIK2,NETO1,NEURL1,NPTN,NSMF,PPFIA3,RAB3A,RAB3GAP1,SHANK3,SHISA9,SLC8A2,SYNGR1,SYP	A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
GO:0048169	GO	BP	regulation of long-term neuronal synaptic plasticity	CAMK2B,DLG4,DRD2,NETO1,NEURL1,NPTN,SHANK3,SYNGR1,SYP	A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
GO:0048172	GO	BP	regulation of short-term neuronal synaptic plasticity	GRIK2,PPFIA3,RAB3A,RAB3GAP1,SHISA9,SLC8A2,SYNGR1,SYP	A process that modulates short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
GO:0048185	GO	MF	activin binding	ACVR1,ACVR1B,ACVRL1,ENG,SMURF1	Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
GO:0048188	GO	CC	Set1C/COMPASS complex	ASH2L,CXXC1,DPY30,HCFC1,RBBP5,SETD1A,SETD1B,WDR5,WDR82	A conserved protein complex that catalyzes methylation of histone H3. In Saccharomyces the complex contains Shg1p, Sdc1p, Swd1p, Swd2p, Swd3p, Spp1p, Bre2p, and the trithorax-related Set1p; in mammals it contains the catalytic subunit (SETD1A or SETD1B), WDR5, WDR82, RBBP5, ASH2L/ASH2, CXXC1/CFP1, HCFC1 and DPY30.
GO:0048194	GO	BP	Golgi vesicle budding	ARCN1,ARF1,ARFGAP1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,GBF1,GOLPH3,MYO18A,TMED10,TMED2,TMED9	The evagination of the Golgi membrane, resulting in formation of a vesicle.
GO:0048199	GO	BP	vesicle targeting, to, from or within Golgi	ANKRD28,AP1AR,ARCN1,AREG,ARF1,ARFGAP1,BET1,CD59,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,F5,F8,FOLR1,GBF1,GOLGA2,GORASP1,GOSR2,GRIA1,KLHL12,LMAN1,MCFD2,NAPA,NSF,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,STX5,TFG,TGFA,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1,WIPI1	The process in which vesicles are directed to specific destination membranes during transport to, from or within the Golgi apparatus; mediated by the addition of specific coat proteins, including COPI and COPII proteins and clathrin, to the membrane during vesicle formation.
GO:0048205	GO	BP	COPI coating of Golgi vesicle	ARCN1,ARF1,ARFGAP1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,GBF1,TMED10,TMED2,TMED9	The addition of COPI proteins and adaptor proteins to Golgi membranes during the formation of transport vesicles, forming a vesicle coat.
GO:0048208	GO	BP	COPII vesicle coating	ANKRD28,AREG,BET1,CD59,CNIH1,CNIH2,CNIH3,COL7A1,CSNK1D,CTSC,CTSZ,CUL3,F5,F8,FOLR1,GOLGA2,GORASP1,GOSR2,GRIA1,KLHL12,LMAN1,MCFD2,NAPA,NSF,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,STX5,TFG,TGFA,TMED10,TMED2,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1	The addition of COPII proteins and adaptor proteins to ER membranes during the formation of transport vesicles, forming a vesicle coat.
GO:0048227	GO	BP	plasma membrane to endosome transport	COMMD1,RAB11A,RAB35,RAB5B,RAB5C,SGSM3,SORT1,USP6NL	Transport of a vesicle from the plasma membrane to the endosome.
GO:0048232	GO	BP	male gamete generation	ACE,ADAM28,ADAM29,ADGRG2,ALKBH5,ARNTL,ASZ1,AZIN2,BAG6,BBS2,BBS4,BCL2L10,BCL2L2,BPY2,BRD2,BRDT,CABYR,CASC5,CATSPERD,CCNA1,CCNI,CCT6B,CDK16,CDY1,CDY2A,CDYL,CEP57,CFAP54,CFTR,CHD5,CIB1,CLOCK,CYLC1,CYP26B1,DDX25,DEFB118,DMC1,DNAH9,DNMT3L,DPY19L2,DUSP13,EIF5A2,ELL3,FAM50A,FKBP6,FOXJ1,FSHR,GALNTL5,GGT1,H1FNT,HERC4,HIST1H2BA,HORMAD1,HSF2BP,HSPA2,IFT81,ING2,INSL3,IQCF1,KDM2B,KHDRBS3,KIT,LGR4,LRGUK,M1AP,MAEL,MAK,MAST2,MCM8,MEI4,MKKS,MTL5,NANOS2,NANOS3,NDRG3,NLRP14,NME5,NPAP1,NPHP1,NR6A1,OR7C1,PAFAH1B1,PIWIL1,PIWIL4,PLD6,PRKACA,PRKACG,PRKAG1,PRM1,PRM2,PROK2,PSME4,PTCHD3,PTTG1,PUM1,PVRL2,RBMY1B,RBMY1F,REC8,RHBDD1,RNF8,ROPN1B,ROS1,RUVBL1,SERPINA5,SHCBP1L,SLC26A3,SLC26A6,SOD1,SOX8,SOX9,SPA17,SPAG11B,SPAG4,SPAG6,SPAG9,SPANXA1,SPANXB1,SPATA2,SPATA6,SPO11,SRPK1,SYCE3,SYCP1,SYCP3,TDRD1,TDRD12,TDRD5,TDRD6,TDRD7,TDRD9,TDRKH,TDRP,TESK2,TMEM119,TMEM203,TNP1,TRIM27,TRIP13,TSGA10,TSSK1B,TSSK2,TSSK3,TSSK6,TXNDC2,TYRO3,UBE2B,USP9Y,VCX,WDR33,WFDC2,YBX2,ZNF296,ZNF35	Generation of the male gamete; specialised haploid cells produced by meiosis and along with a female gamete takes part in sexual reproduction.
GO:0048240	GO	BP	sperm capacitation	CABYR,CATSPERD,CFTR,IQCF1,PRKACA,SLC26A3,SLC26A6	A process required for sperm to reach fertilization competence. Sperm undergo an incompletely understood series of morphological and molecular maturational processes, termed capacitation, involving, among other processes, protein tyrosine phosphorylation and increased intracellular calcium.
GO:0048245	GO	BP	eosinophil chemotaxis	CCL11,CCL13,CCL24,CCL3,CCL5,CCL7,LGALS3,SCG2	The movement of an eosinophil in response to an external stimulus.
GO:0048246	GO	BP	macrophage chemotaxis	AZU1,CCL2,CCL3,CCL5,CKLF,EDN2,EDNRB,LGALS3,SAA1,SFTPD	The movement of a macrophage in response to an external stimulus.
GO:0048247	GO	BP	lymphocyte chemotaxis	ADAM8,CCL3,CCR2,CKLF,CXCL10,CXCL11,CXCL13,GAS6,PIK3CD,PIK3CG,SAA1,XCL1	The directed movement of a lymphocyte in response to an external stimulus.
GO:0048251	GO	BP	elastic fiber assembly	ATP7A,FBLN5,MFAP4,MYH11,TNXB	Assembly of the extracellular matrix fibers that enables the matrix to recoil after transient stretching.
GO:0048255	GO	BP	mRNA stabilization	ANGEL2,AXIN2,CIRBP,DHX9,E2F1,ELAVL1,GDNF,HNRNPA0,HNRNPC,HNRNPU,IGF2BP1,MAPK14,MAPKAPK2,MYD88,NOCT,PABPC1,PAIP1,RBM38,SLC11A1,SYNCRIP,TARDBP,THRAP3,TIRAP,VIP,YBX1,YBX3,ZFP36	Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.
GO:0048256	GO	MF	flap endonuclease activity	DNA2,EXO1,FAN1,FEN1,MUS81,SLX1A,SLX4	Catalysis of the cleavage of a flap structure in DNA, but not other DNA structures; processes the ends of Okazaki fragments in lagging strand DNA synthesis.
GO:0048259	GO	BP	regulation of receptor-mediated endocytosis	AAK1,AHI1,ANGPT1,ANXA2,APOA5,APOC1,APOC2,APOC3,ARF1,ARF6,ARRB1,ARRB2,ATAD1,ATXN2,B2M,BICD1,CBL,CCL19,CCL21,CD63,DAB2,DKK1,DLG4,FLOT1,GREM1,HAMP,HFE,HIP1,HNRNPK,LDLRAP1,MAGI2,MTMR2,NEDD4L,NLGN1,NTF3,PCSK9,PICALM,PICK1,PIK3CB,PPT1,PROM2,RAB21,RAC1,RSPO1,SCYL2,SDCBP,SELE,SERPINE1,SFRP4,SGIP1,SNAP91,SRC,SYNJ1,TBC1D5,TF,TNK2,TOR1A,UBQLN2,UNC119,VEGFA,VTN,WASL,WNT3A	Any process that modulates the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
GO:0048260	GO	BP	positive regulation of receptor-mediated endocytosis	AHI1,ANGPT1,APOA5,ARRB1,ARRB2,ATAD1,B2M,BICD1,CBL,CCL19,CCL21,CD63,DAB2,GREM1,HAMP,HFE,HIP1,HNRNPK,LDLRAP1,MAGI2,NEDD4L,NLGN1,NTF3,PCSK9,PICK1,PPT1,RAB21,SCYL2,SELE,SERPINE1,SFRP4,SGIP1,SYNJ1,TBC1D5,TF,TOR1A,VEGFA,VTN,WASL,WNT3A	Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
GO:0048261	GO	BP	negative regulation of receptor-mediated endocytosis	ANXA2,APOC1,APOC2,APOC3,ARF6,ATXN2,DLG4,MTMR2,PICALM,PROM2,RAC1,SDCBP,UBQLN2,UNC119	Any process that stops, prevents, or reduces the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.
GO:0048265	GO	BP	response to pain	GCH1,PRKCG,RELN,RET,THBS1,THBS4	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli.
GO:0048268	GO	BP	clathrin coat assembly	AP2S1,CALY,EPS15,FCHO1,FCHO2,HIP1,PICALM,PIK3C2A	The process that results in the assembly of clathrin triskelia into the ordered structure known as a clathrin cage.
GO:0048278	GO	BP	vesicle docking	BLOC1S6,CAV2,CEP83,CPLX2,KCNB1,PLEK,RAB8A,RABEPK,SNAP25,SNPH,STX1B,SYTL2,VAMP3,VTI1B,YKT6	The initial attachment of a transport vesicle membrane to the target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane. Docking requires only that the two membranes come close enough for these proteins to interact and adhere.
GO:0048284	GO	BP	organelle fusion	ANKFY1,BAX,BNIP1,CAV2,CDK1,CHCHD3,CHMP3,CLN3,CYP26C1,EEA1,FAM73A,FAM73B,FIS1,GDAP1,LRMP,MFF,MFN1,MFN2,NKD2,OPA1,PLD6,RAB20,RAB34,RAB39A,RAB7A,RAB8A,RUBCN,SLC25A46,SNAP29,SNX14,STOML2,STX17,STX4,TECPR1,TGFBRAP1,TSG101,USP30,UVRAG,VAMP4,VAMP7,VAMP8,VPS11,VPS16,VPS33A,VPS39,VPS41,VPS4A,VPS8,VTI1A	The creation of a single organelle from two or more organelles.
GO:0048286	GO	BP	lung alveolus development	ATP7A,BMP4,BMPR2,ERRFI1,FGF10,FGFR2,PDGFA,PKDCC,SFTPD,STRA6,TCF21,TGFB3	The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
GO:0048306	GO	MF	calcium-dependent protein binding	ALG2,CASQ2,CHP1,CPNE3,DMBT1,NRXN1,NSMF,S100A11,S100A6,S100B,SLC9A1,SNAP25,STX2,TNNT3,VAMP2	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules), in the presence of calcium.
GO:0048311	GO	BP	mitochondrion distribution	ATCAY,CLUH,LRRK2,MEF2A,MSTO1,MTM1	Any process that establishes the spatial arrangement of mitochondria between and within cells.
GO:0048313	GO	BP	Golgi inheritance	CDK1,GBF1,GOLGA2,PDCD10,PLK3,STK25,STX5,VRK1,YWHAZ	The partitioning of Golgi apparatus between daughter cells at cell division.
GO:0048332	GO	BP	mesoderm morphogenesis	BMP4,BMPR2,CRB2,EOMES,EYA2,HMGA2,HOXA11,KDM6B,KLF4,PAX2,SCX,SIX2,SMAD2,SNAI1,TBX20,TBX3,TRIM15	The process in which the anatomical structures of the mesoderm are generated and organized.
GO:0048333	GO	BP	mesodermal cell differentiation	BMP4,EYA2,HMGA2,HOXA11,KDM6B,KLF4,PAX2,SIX2,TRIM15	The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
GO:0048365	GO	MF	Rac GTPase binding	ABI2,ARFIP2,ARHGEF2,BRK1,CDKL5,CYFIP1,DOCK4,DOCK7,EPS8,FLNA,FMNL1,IQGAP2,NCKAP1,PKN1,SOD1,SRGAP2,WASF1	Interacting selectively and non-covalently with Rac protein, any member of the Rac subfamily of the Ras superfamily of monomeric GTPases.
GO:0048368	GO	BP	lateral mesoderm development	CITED2,DAND5,FOXH1,MESP1,SHH,SMO,TBX20	The process whose specific outcome is the progression of the lateral mesoderm over time, from its formation to the mature structure.
GO:0048384	GO	BP	retinoic acid receptor signaling pathway	ACTN4,KMT2E,RARA,RARG,RXRA,SNW1,SP100,TBX1	The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands.
GO:0048385	GO	BP	regulation of retinoic acid receptor signaling pathway	AKR1C3,ASXL1,CALR,CNOT1,CTBP2,CYP26A1,CYP26B1,CYP26C1,EZH2,PRAME,SNW1,TRIM16	Any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity.
GO:0048387	GO	BP	negative regulation of retinoic acid receptor signaling pathway	ASXL1,CALR,CNOT1,CYP26A1,CYP26B1,CYP26C1,EZH2,PRAME	Any process that stops, prevents, or reduces the frequency, rate or extent of retinoic acid receptor signaling pathway activity.
GO:0048407	GO	MF	platelet-derived growth factor binding	COL1A1,COL1A2,COL2A1,COL3A1,COL4A1,COL5A1,COL6A1,PDGFRA,PDGFRB	Interacting selectively and non-covalently with platelet-derived growth factor.
GO:0048469	GO	BP	cell maturation	AGRN,ANG,ANKS1A,APP,CABYR,CATSPERD,CCL19,CCL21,CFTR,CLN5,CNTN2,CNTNAP2,EPHA8,EREG,FARP2,G6PD,HES5,IL21,IQCF1,KCNIP2,LHX6,MTCH1,MYOC,NKX6-1,NRCAM,PICK1,PLD6,PPARG,PRKACA,RFX3,RND1,SCARF1,SIX3,SLC26A3,SLC26A6,SPTBN4,TDRD5,TMEM79,VEGFA	A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
GO:0048477	GO	BP	oogenesis	ANG,BMPR1B,EREG,FIGLA,FMN2,HORMAD1,KIAA0430,KMT2D,MEI4,PIWIL2,PLD6,TDRD5,TRIP13,ZNF830,ZP3	The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
GO:0048483	GO	BP	autonomic nervous system development	ASCL1,CTNNB1,EDNRB,FZD3,GATA3,GDNF,INSM1,KIF26A,NF1,NRP1,NRP2,NTRK1,PHACTR4,PHOX2B,SEMA3A,SEMA3F,SOX11,SOX4,SOX8,TBX1,TFAP2A,TFAP2B	The process whose specific outcome is the progression of the autonomic nervous system over time, from its formation to the mature structure. The autonomic nervous system is composed of neurons that are not under conscious control, and is comprised of two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g. of the gut), and glands.
GO:0048484	GO	BP	enteric nervous system development	EDNRB,GDNF,KIF26A,PHACTR4,SOX8	The process whose specific outcome is the progression of the enteric nervous system over time, from its formation to the mature structure. The enteric nervous system is composed of two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gall bladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation.
GO:0048485	GO	BP	sympathetic nervous system development	ASCL1,CTNNB1,FZD3,GATA3,GDNF,INSM1,NF1,NRP1,NRP2,NTRK1,PHOX2B,SEMA3A,SEMA3F,SOX11,SOX4,TFAP2B	The process whose specific outcome is the progression of the sympathetic nervous system over time, from its formation to the mature structure. The sympathetic nervous system is one of the two divisions of the vertebrate autonomic nervous system (the other being the parasympathetic nervous system). The sympathetic preganglionic neurons have their cell bodies in the thoracic and lumbar regions of the spinal cord and connect to the paravertebral chain of sympathetic ganglia. Innervate heart and blood vessels, sweat glands, viscera and the adrenal medulla. Most sympathetic neurons, but not all, use noradrenaline as a post-ganglionic neurotransmitter.
GO:0048487	GO	MF	beta-tubulin binding	ARL8A,ARL8B,BBS4,BCAS3,EMD,FGF13,GABARAP,GABARAPL1,GABARAPL2,HTT,IFT74,LRPPRC,MAP1S,PACRG,PIFO,RACGAP1,TBCD,TRPV4,TTLL7,UXT,VAPB	Interacting selectively and non-covalently with the microtubule constituent protein beta-tubulin.
GO:0048488	GO	BP	synaptic vesicle endocytosis	CANX,CDK5,ITSN1,PACSIN1,PIP5K1C,SNCA,STON2,SYNJ1	Clathrin-mediated endocytosis of presynaptic membrane that recycles synaptic vesicle membrane and its components following synaptic vesicle exocytosis. This process starts with coating of the membrane with adaptor proteins and clathrin prior to invagination and ends when uncoating has finished.
GO:0048489	GO	BP	synaptic vesicle transport	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CANX,CDK5,DNAJC5,DNM2,DOC2B,DTNBP1,ITSN1,NLGN1,OTOF,PACSIN1,PCLO,PIP5K1C,PLD2,RAB27A,RAB3A,RAB5A,RIMS1,RIMS2,SEPT5,SNAP25,SNAPIN,SNCA,SNPH,STON2,STX1B,SYNJ1,SYT1,TOR1A,UNC13B,VAMP2,WNT3A,WNT7A	The directed movement of synaptic vesicles.
GO:0048490	GO	BP	anterograde synaptic vesicle transport	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,DTNBP1,SNAPIN	The directed movement of synaptic vesicle along axonal microtubules from the cell body to the presynapse.
GO:0048511	GO	BP	rhythmic process	AANAT,AHR,ANG,ARNTL,ARNTL2,ATF4,AVP,BHLHE40,BHLHE41,BMPR1B,BTRC,CARTPT,CEBPB,CIART,CLOCK,CPT1A,CREB1,CRY1,CRY2,CSNK1D,CSNK1E,CUL1,DBP,DRD2,DRD3,DYRK1A,EGR3,EIF2B2,EIF2B4,EIF2B5,ENOX2,EP300,EREG,F7,FBXL3,FOXL2,FSHR,GFPT1,GSK3B,HDAC1,HDAC2,HDAC3,HEBP1,HNRNPD,HNRNPU,ID2,INHA,INHBA,INHBB,KDM5A,KIT,KMT2A,LGR4,MAGED1,MC3R,METTL3,MTA1,MYBBP1A,NAMPT,NCOA2,NCOR1,NGFR,NOCT,NONO,NPAS2,NR1D1,NRIP1,OGT,PDGFRA,PER1,PER2,PML,PPARA,PPARGC1A,PPP1CA,PPP1CB,PPP1CC,PRKCDBP,PRMT5,PTEN,PTPRN,RAI1,RBM4,RBM4B,RELB,RORA,RORC,RPS27A,SERPINE1,SIRT1,SKP1,SOD1,SREBF1,TGFB2,TGFB3,TIMELESS,TNFRSF11A,TOP1,TP53,TYRO3,UBA52,UBB,UBC,USP2,VEGFA,ZFHX3,ZNF830	Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism.
GO:0048512	GO	BP	circadian behavior	CIART,ID2,MTA1,PTEN,TP53,USP2	The specific behavior of an organism that recurs with a regularity of approximately 24 hours.
GO:0048514	GO	BP	blood vessel morphogenesis	AAMP,ACVRL1,ADAM8,ADIPOR2,ADM,ADM2,AGGF1,ANG,ANGPT1,ANGPTL3,APOD,ATP5B,ATPIF1,BMP4,BMPER,C1GALT1,CALCRL,CAV1,CCBE1,CCL2,CCM2,CDH13,CEACAM1,COL4A1,CTNNB1,CUL7,CXCL8,CYP1B1,DLL1,DLL4,E2F7,E2F8,EFNB2,EGF,EGFL7,EGR3,EIF2AK3,ENG,ENPEP,EPGN,EPHB1,EPHB2,EPHB3,EPHB4,ERAP1,ESM1,FGF2,FGFR2,FLT1,FLT4,FOLR1,FOXF1,GDF2,GJA5,GLMN,GPLD1,GREM1,HAND1,HAS2,HES1,HEY1,HEY2,HMOX1,HOXA1,HPGD,ID1,IL18,ITGA5,ITGB1BP1,ITGB3,JAG1,JAM3,JMJD6,KDR,LAMA5,LOXL2,LRP1,LRP5,MCAM,MED1,MYH9,MYLK,NCL,NDNF,NF1,NKX2-5,NOTCH1,NOTCH4,NOV,NOX1,NOX5,NR4A1,NRP1,NRP2,NRXN1,NRXN3,OTULIN,PARVA,PDGFA,PDGFRA,PDGFRB,PLXDC1,PLXND1,PRKX,PROK2,PROX1,PTK2,PTK2B,RAMP1,RAMP2,RASA1,RASIP1,RBPJ,ROBO1,ROBO4,RORA,S100A7,SCG2,SEMA3E,SEMA5A,SERPINF2,SFRP2,SHH,SIRT1,SLC12A6,SLIT2,SMAD7,SOX17,SOX18,SOX4,SRF,SRPK2,STAB2,STRA6,SYK,TBX1,TBX2,TBX20,TBX5,TCF21,TDGF1,TEK,TFAP2B,TGFB2,TGFBR1,TGFBR2,THBS1,THY1,TMPRSS6,TNNI3,VASH1,VEGFA,WNT7B,WT1,XBP1	The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
GO:0048515	GO	BP	spermatid differentiation	BBS2,BBS4,CABYR,CASC5,CATSPERD,CEP57,CFTR,CHD5,CIB1,DDX25,DPY19L2,GALNTL5,H1FNT,HIST1H2BA,ING2,IQCF1,MAST2,MKKS,NME5,NPHP1,PAFAH1B1,PIWIL1,PLD6,PRKACA,PSME4,PTCHD3,PVRL2,RHBDD1,RNF8,SLC26A3,SLC26A6,SPAG6,SPANXB1,SRPK1,SYCP3,TDRD5,TMEM119,TNP1,TSSK1B,TSSK2,TSSK6	The process whose specific outcome is the progression of a spermatid over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
GO:0048520	GO	BP	positive regulation of behavior	ADAM10,ADAM17,AIF1,ANO6,AZU1,C1QBP,CALR,CAMK1D,CCL19,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CDH13,CFAP20,CMKLR1,CREB3,CRH,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,CXCR3,DAPK2,DSCAM,EDN2,EDN3,F2RL1,F3,F7,FGF16,FGF18,FGF2,FGFR1,FIGF,GAS6,GHRH,GHRL,HMGB1,HSPB1,IL12A,IL6,IL6R,KDR,LGALS9,MEF2C,MEGF8,MET,NCKAP1L,NLGN1,NR4A3,NRP1,NTF3,NTRK3,PDGFB,PDGFRB,PLA2G7,PPM1F,PRKD1,PRKD2,PTK2B,RAC1,RAC2,RARRES2,S100A14,S100A7,SCG2,SEMA5A,SERPINE1,SLIT2,STRA6,STX3,STX4,TGFB1,THBS1,THBS4,TIRAP,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZNF580	Any process that activates or increases the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.
GO:0048521	GO	BP	negative regulation of behavior	AIF1,ANGPT2,C5,C5AR2,CCL2,CORO1B,CRH,CXCL13,ELANE,GHRL,GREM1,HRG,INS,KLRK1,NBL1,NOTCH1,NOV,PADI2,PTPN2,PTPRO,ROBO1,ROBO2,SEMA5A,SLIT2,STAP1,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.
GO:0048524	GO	BP	positive regulation of viral process	ADAR,ADARB1,APOE,C9orf69,CAV2,CCL5,CCNH,CCNT1,CD28,CDK7,CDK9,CFL1,CHD1,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CTDP1,DDB1,DDX3X,ELL,EP300,ERCC2,ERCC3,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HACD3,HPN,IFIT1,JUN,LEF1,LGALS1,LGALS9,MDFIC,MNAT1,MVB12A,MVB12B,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,NR5A2,P4HB,PC,PKN2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,PPIA,PPIB,PPID,PPIE,PPIH,RAB7A,RAD23A,RSF1,SMARCA4,SMARCB1,SNW1,SP1,SRPK1,SRPK2,SSRP1,STAU1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TARBP2,TBC1D20,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TMPRSS2,TOP2A,TRIM11,TRIM38,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,YTHDC2,ZNF502,ZNF639	Any process that activates or increases the frequency, rate or extent of a multi-organism process in which a virus is a participant.
GO:0048525	GO	BP	negative regulation of viral process	APCS,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,BST2,BTBD17,CCL3,CCL4,CCL5,CCNK,CHMP3,EIF2AK2,EIF2AK4,FAM111A,FBLN1,FCN1,FCN3,GSN,HDAC1,HMGA2,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNA2,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,JUN,LTF,MAVS,MBL2,MID2,MX1,OAS1,OAS3,OASL,PARK2,PARP10,PLSCR1,PML,POU2F3,PROX1,PTX3,REST,RNASEL,RSAD2,SLPI,SNX3,SP100,SRPK1,SRPK2,STAT1,TARDBP,TFAP4,TNF,TNIP1,TRIM11,TRIM13,TRIM14,TRIM15,TRIM21,TRIM26,TRIM27,TRIM28,TRIM31,TRIM32,TRIM35,TRIM5,TRIM6,TRIM62,TRIM8,VAPA,VAPB,ZC3H12A,ZC3HAV1,ZNF639	Any process that stops, prevents, or reduces the frequency, rate or extent of a multi-organism process in which a virus is a participant.
GO:0048536	GO	BP	spleen development	ADAM17,CITED2,FADD,NKX2-5,PCID2,PITX2,RIPK3,TCF21	The process whose specific outcome is the progression of the spleen over time, from its formation to the mature structure. The spleen is a large vascular lymphatic organ composed of white and red pulp, involved both in hemopoietic and immune system functions.
GO:0048538	GO	BP	thymus development	EPHB3,FADD,FGF10,HAND2,HES1,RIPK3,SHH,SIX1,SOD1,TBX1,TGFBR1,ZBTB1	The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
GO:0048545	GO	BP	response to steroid hormone	ADAM9,AKR1C3,ANXA1,AQP1,ASH2L,ATP1A1,ATP1A2,ATP1A3,BCAS3,BMP4,BMP7,BRCA1,CALCR,CAV1,CCDC62,CITED1,CITED2,CITED4,CRHBP,CRIPAK,CTNNB1,EGFR,EP300,ESR1,FOXA1,GH1,GHR,GHRHR,GHRL,GPER1,H2AFZ,IL10,IL1RN,IL6,IRG1,ISL1,KAT5,KLF9,KMT2D,LEF1,MED1,MGARP,MSN,MYOD1,MYOG,NCOA3,NKX3-1,NR1H3,NR3C1,NRIP1,OCSTAMP,OR51E2,PDCD7,PELP1,PGRMC2,RAMP3,RARA,RBBP5,REST,ROCK2,RUVBL2,SFR1,SFRP1,SOCS2,SRC,STAT3,STAT5B,STRN3,TGFB1,TGFB2,TGFB3,THBS1,TNF,TRIM24,TRIM25,UBE2L3,UGT3A2,URI1,WBP2,WNT8B,ZNF366,ZNF703	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
GO:0048546	GO	BP	digestive tract morphogenesis	AGR2,AHI1,BBS7,DACT1,EPHB3,FGFR2,FOXF1,GATA4,GLI1,GLI2,ID2,NIPBL,PDGFRA,SIX2,SOX11,SOX17,STRA6,TCF21	The process in which the anatomical structures of the digestive tract are generated and organized. The digestive tract is the anatomical structure through which food passes and is processed.
GO:0048548	GO	BP	regulation of pinocytosis	ANKFY1,AXL,CAV1,NR1H2,NR1H3,PPT1,PROM2	Any process that modulates the frequency, rate or extent of pinocytosis. Pinocytosis is the process in which cells take in liquid material from their external environment; literally 'cell drinking'. Liquid is enclosed in vesicles, formed by invagination of the plasma membrane. These vesicles then move into the cell and pass their contents to endosomes.
GO:0048552	GO	BP	regulation of metalloenzyme activity	ATP7A,CAV1,CIB1,FGFR4,FXN,RLN2,TIMP1,TMBIM1	Any process that modulates the frequency, rate or extent of activity of a metalloenzyme. A metalloenzyme is any enzyme that contains metal.
GO:0048554	GO	BP	positive regulation of metalloenzyme activity	ATP7A,CAV1,CIB1,FGFR4,FXN	Any process that activates, maintains or increases the rate activity of a metalloenzyme. A metalloenzyme is any enzyme that contains metal.
GO:0048557	GO	BP	embryonic digestive tract morphogenesis	FGFR2,FOXF1,ID2,NIPBL,PDGFRA,SIX2,SOX11,TCF21	The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed.
GO:0048562	GO	BP	embryonic organ morphogenesis	ACVR1,AHI1,ALDH1A3,ATP6V1B1,BBS4,BBS5,BBS7,CCDC103,CCDC39,CCDC40,CEP290,CHD7,COL2A1,CRB2,CTNNB1,DLL1,DNAAF1,DSCAML1,EIF4A3,ENG,EPHB2,FGFR2,FOLR1,FOXE1,FOXF1,FOXN4,FUZ,GATA4,GSC,HAND1,HAND2,HES1,HOXA1,HOXD3,HPN,ID2,IHH,IRX5,KDM2B,LHX1,MEF2C,MEGF8,MESP1,MICAL2,MKKS,MTHFD1,MTHFD1L,NEUROD1,NIPBL,NKX2-5,NOG,NOTCH1,NPHP3,OSR1,OSR2,PAX2,PAX8,PDGFRA,PHACTR4,PKD2,POU3F4,PROX1,RARG,RBP4,RYR2,SALL1,SETDB2,SHH,SIX1,SIX2,SIX3,SMO,SOD1,SOX11,SOX17,SOX18,SOX9,SRF,STIL,STRA6,STRC,TBX1,TBX2,TBX20,TCF21,TFAP2A,TGFBR1,TGFBR2,TH,TWIST1,VANGL2,WNT16,WNT5A,ZIC1,ZIC3	Morphogenesis, during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
GO:0048565	GO	BP	digestive tract development	AGR2,AHI1,BBS7,CCDC103,CCDC39,CCDC40,CDX2,CHD8,CLMP,COBL,DACT1,DNAAF1,EDNRB,EPHB3,FGFR2,FOXF1,FOXL1,GATA4,GATA5,GATA6,GLI1,GLI2,GLI3,ID2,ITGA6,ITGB4,KIT,MEGF8,MIXL1,NIPBL,NKX2-6,NPHP3,PCSK5,PDGFRA,PKDCC,RARB,RARRES2,RET,SALL1,SIX2,SMO,SOX11,SOX17,STRA6,TBX2,TCF21,ZIC3	The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
GO:0048566	GO	BP	embryonic digestive tract development	FGFR2,FOXF1,GLI2,GLI3,ID2,NIPBL,PCSK5,PDGFRA,PKDCC,RARB,RARRES2,SALL1,SIX2,SOX11,STRA6,TCF21	The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
GO:0048568	GO	BP	embryonic organ development	ACVR1,AHI1,ALDH1A3,ATP6V1B1,BBS4,BBS5,BBS7,BMP2,CASP8,CCDC103,CCDC39,CCDC40,CEP290,CHD7,CITED2,COBL,COL2A1,CRB2,CTNNB1,DLL1,DNAAF1,DSCAML1,E2F7,E2F8,EIF4A3,ENG,EOMES,EPHB2,FGFR2,FLT3LG,FOLR1,FOXE1,FOXF1,FOXN4,FUZ,GATA4,GLI2,GLI3,GSC,HAND1,HAND2,HES1,HEY1,HEY2,HOXA1,HOXD3,HPN,ID2,IFT122,IHH,IL3,IRX5,KDM2B,KDR,KIT,KITLG,KMT2A,LHX1,MEF2C,MEGF8,MESP1,MICAL2,MKKS,MTHFD1,MTHFD1L,NES,NEUROD1,NIPBL,NKX2-5,NKX2-6,NOG,NOTCH1,NPHP3,OSR1,OSR2,PAX2,PAX8,PCSK5,PDGFA,PDGFB,PDGFRA,PHACTR4,PKD1,PKD2,PKDCC,PLK4,POU3F4,PROX1,RARB,RARG,RARRES2,RBP4,RBPJ,RYR2,SALL1,SETDB2,SHH,SIX1,SIX2,SIX3,SMO,SOD1,SOX11,SOX17,SOX18,SOX9,SRF,STIL,STRA6,STRC,TAL1,TBX1,TBX2,TBX20,TCF21,TFAP2A,TFEB,TGFBR1,TGFBR2,TH,THOC5,TPO,TWIST1,VANGL2,VEGFA,WNT16,WNT5A,WNT7B,ZFPM1,ZIC1,ZIC3	Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
GO:0048588	GO	BP	developmental cell growth	ALCAM,APP,ARIH2,BDNF,CDK5,COBL,CPNE1,CYFIP1,EIF2AK4,FLRT1,FLRT3,IMPACT,IQGAP1,KMT2D,NLGN3,NRP1,NRP2,PDLIM5,PPP3CB,PRMT2,SEMA3A,SEMA3F,SLC9A6,SLIT1,SLIT2,SLIT3,SORBS2,SOX9,USP9X	The growth of a cell, where growth contributes to the progression of the cell over time from one condition to another.
GO:0048589	GO	BP	developmental growth	ALCAM,APOD,APP,ARIH2,BDNF,BIN3,BMP10,BMP4,BMPR1B,C3orf58,CDK5,CER1,CFLAR,CHRNA1,CHRND,COBL,CPNE1,CPQ,CYFIP1,DDR2,DLL1,DMBX1,EIF2AK4,ERBB4,EREG,EVC,EYS,FGF1,FGF10,FGF7,FGFR2,FGFR3,FLRT1,FLRT3,GAS1,GLI2,GNAS,HOXA11,IGF1,IMPACT,IQGAP1,KDF1,KLK6,KMT2D,LARGE,LEP,LEPR,LRP4,MAGI2,MESP1,NACA,NIPBL,NLGN3,NLGN4X,NOTCH1,NOV,NPPC,NRP1,NRP2,PDLIM5,PPP3CB,PRMT2,S1PR1,SALL1,SEMA3A,SEMA3F,SLC9A6,SLIT1,SLIT2,SLIT3,SORBS2,SOX9,STC1,STIL,STRA6,TGFB2,TGFBR3,USP9X,WNT7B,ZPR1	The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
GO:0048592	GO	BP	eye morphogenesis	AGTPBP1,AHI1,ALDH1A3,BBS4,CEP290,COL5A1,COL5A2,DLL1,DSCAM,EPHA2,FOXE3,FOXN4,IFT122,KDM2B,LHX1,LRP5,MEGF11,MYO7A,NF1,NIPBL,NKD1,PAX2,PAX6,PHACTR4,PITX2,PITX3,PPP2R3A,PROM1,PROX1,PTF1A,PTPRM,RARG,RBP4,RORB,RP1,SDK1,SDK2,SHROOM2,SIX3,SKI,SOX11,SOX8,SOX9,STAT3,STRA6,TBX2,TDRD7,TENM3,TFAP2A,TH,THY1,TOPORS,TSPAN12,TULP1,TWIST1,VEGFA,WNT16,WNT2,WNT2B,WNT5A,WNT9A	The process in which the anatomical structures of the eye are generated and organized.
GO:0048593	GO	BP	camera-type eye morphogenesis	AHI1,DLL1,DSCAM,EPHA2,FOXE3,FOXN4,IFT122,KDM2B,LHX1,LRP5,MEGF11,NF1,PAX2,PAX6,PHACTR4,PITX2,PITX3,PROM1,PROX1,PTF1A,PTPRM,RBP4,RORB,RP1,SDK1,SDK2,SHROOM2,SIX3,SKI,SOX11,SOX8,SOX9,STRA6,TBX2,TDRD7,TENM3,TFAP2A,TH,THY1,TOPORS,TSPAN12,TWIST1,VEGFA,WNT16,WNT2,WNT2B,WNT5A,WNT9A	The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
GO:0048596	GO	BP	embryonic camera-type eye morphogenesis	KDM2B,PAX2,PHACTR4,PROX1,SIX3,SOX11,STRA6,TBX2,TFAP2A,TH,TWIST1,WNT16,WNT5A	The process in which the anatomical structures of the eye are generated and organized during embryonic development.
GO:0048598	GO	BP	embryonic morphogenesis	ACVR1,AFF3,AHI1,ALDH1A3,APELA,ATOH8,ATP6V1B1,BBS4,BBS5,BBS7,BCL10,BMP4,BMPR2,CCDC103,CCDC39,CCDC40,CDC73,CELSR1,CEP290,CER1,CHD7,COBL,COL2A1,CRB2,CREBBP,CTNNB1,CTR9,CYP26B1,DACT1,DEAF1,DLC1,DLL1,DLL4,DNAAF1,DSCAML1,DVL2,ECE1,EIF4A3,ENG,EOMES,EPHB2,EYA2,FBXW4,FGF2,FGF8,FGFR2,FLRT3,FLT1,FN1,FOLR1,FOXA2,FOXE1,FOXF1,FOXN4,FUZ,GATA3,GATA4,GLI2,GLI3,GREM2,GRHL2,GRHL3,GSC,HAND1,HAND2,HDAC1,HDAC2,HES1,HMGA2,HOXA1,HOXA11,HOXD3,HPN,HTR2B,ID2,IFT122,IHH,INHBA,IRX5,ITGA5,ITGAV,KDF1,KDM2B,KDM6B,KIF16B,KLF4,LEO1,LHX1,LMO4,MBNL1,MEF2C,MEGF8,MESP1,MICAL2,MIXL1,MKKS,MSX1,MTHFD1,MTHFD1L,MYH3,NANOG,NAT8B,NEUROD1,NIPBL,NKX2-5,NODAL,NOG,NOTCH1,NPHP3,NR4A3,OSR1,OSR2,OTX2,PAF1,PAX2,PAX8,PDGFRA,PHACTR4,PKD2,PLXNB2,POU3F4,POU5F1,PRICKLE1,PROX1,PTCH1,RARG,RBP4,RTF1,RYR2,SALL1,SCRIB,SCX,SEMA4C,SETDB2,SHH,SIX1,SIX2,SIX3,SIX4,SKI,SMAD2,SMO,SNAI1,SOD1,SOX11,SOX17,SOX18,SOX2,SOX4,SOX7,SOX8,SOX9,SRF,STIL,STRA6,STRC,T,TBX1,TBX2,TBX20,TBX3,TBX5,TCF21,TFAP2A,TGFBR1,TGFBR2,TH,TRIM15,TSC2,TWIST1,VANGL2,VTN,WNT16,WNT5A,WNT7A,WNT7B,WNT8B,ZIC1,ZIC3,ZNF281,ZNF358	The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
GO:0048599	GO	BP	oocyte development	ANG,EREG,FIGLA,KMT2D,PLD6,TDRD5,ZP3	The process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
GO:0048608	GO	BP	reproductive structure development	ALOX15B,ANG,ANKRD7,AR,ASCL2,BASP1,BMPR1B,CASP8,CCDC182,CEBPB,CHD7,CITED1,CSDE1,CUL7,DMRT1,DNAJC19,E2F7,E2F8,EIF2B2,EIF2B4,EIF2B5,EOMES,EREG,FGF8,FGFR2,FOXF2,FOXL2,FSHR,GATA1,GATA3,GATA4,GHRL,GHSR,HEY1,HEY2,HNF1B,HSD17B3,ING2,INHA,INHBA,INHBB,IRX5,ITGB8,KIT,LEP,LHB,LHCGR,LHX1,LRRC6,MEA1,MKKS,MSH2,NCOA4,NIPBL,NKX3-1,NODAL,NR0B1,PDGFB,PDGFRA,PKD1,PKD2,PLK4,PPARD,PPARG,PRKACG,PTK2,PTPN11,PTPRN,RAB13,RBMY1B,RBP4,RBPJ,SCX,SHH,SIX4,SOD1,SOX15,SOX8,SOX9,SPP1,SRD5A2,STRA6,TBX3,TCF21,TFEB,VEGFA,WNT4,WNT5A,WNT7B,WT1,ZNF830	The reproductive developmental process whose specific outcome is the progression of structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures.
GO:0048634	GO	BP	regulation of muscle organ development	ACTN3,AKAP6,ARNTL,BMP10,BMP2,BMP4,CENPF,DDX17,DDX5,DKK1,DLL1,EFNB2,ERBB4,FGF2,FGF3,FGF8,FGFR2,FLOT1,GPC1,GREM1,GSK3A,HDAC9,MEF2C,MEGF10,MKL2,MSTN,MTPN,MYOCD,MYOG,NACA,NOG,NOTCH1,NR1D2,NRG1,PRICKLE1,RBP4,RBPJ,SFMBT1,SHH,SIRT2,SIX4,SOX15,TBX1,TBX2,TBX20,TBX5,TGFB1,TP73,UQCC2,USP19,WNT3A	Any process that modulates the frequency, rate or extent of muscle development.
GO:0048635	GO	BP	negative regulation of muscle organ development	BMP2,BMP4,DKK1,FGF3,FGF8,GSK3A,MSTN,MYOCD,NOG,PRICKLE1,RBP4,SFMBT1,SIRT2,SIX4,SOX15,TBX5,TGFB1,TP73,USP19	Any process that stops, prevents, or reduces the frequency, rate or extent of muscle development.
GO:0048638	GO	BP	regulation of developmental growth	ABL1,ACTN3,AGR2,AGRN,AKAP6,APOE,APP,BASP1,BBS2,BCL11A,BDNF,BMP10,BMP4,CAPN3,CDKL5,CLASP2,CPNE5,CPNE6,CPNE9,CTTN,DCC,DLL1,DNM2,DSCAM,ERBB4,FGF13,FGF2,FGFR2,FGFR3,GAL,GH1,GHR,GHRH,GHRHR,GHRL,GHSR,GNAS,GOLGA4,GSK3A,IGF1,INSR,ISLR2,ITSN2,L1CAM,LEP,LIMK1,MACF1,MAPT,MBD5,MEF2C,MEGF8,MSTN,MT3,MUSK,NACA,NEDD4L,NIPBL,NKD1,NOG,NOTCH1,NRCAM,NRG1,NRP1,NTN1,OLFM1,PLCB1,PPIB,PPP2R3A,PROX1,PTCH1,PTEN,RASAL1,RBP4,RBPJ,RIMS1,RIMS2,RNF6,RTN4,RTN4R,RUFY3,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SHTN1,SIX1,SIX4,SLC6A4,SMURF1,SOD1,SOX15,STAT5A,STAT5B,SYT1,SYT17,SYT2,SYT3,SYT4,TBX2,TBX20,TBX5,TP73,TWF2,UNC13A,VEGFA,WT1,WWC1,WWC2,WWC3,ZP3	Any process that modulates the frequency, rate or extent of developmental growth.
GO:0048639	GO	BP	positive regulation of developmental growth	ACTN3,AGR2,AGRN,AKAP6,BASP1,BCL11A,BDNF,BMP10,CAPN3,CDKL5,CPNE5,CPNE6,CPNE9,DLL1,DSCAM,ERBB4,FGF2,FGFR2,GH1,GHR,GHRH,GHRHR,GHRL,GHSR,GOLGA4,IGF1,INSR,ISLR2,ITSN2,L1CAM,LEP,LIMK1,MACF1,MAPT,MEF2C,MEGF8,NACA,NEDD4L,NOTCH1,NRG1,NRP1,NTN1,PLCB1,PPIB,PROX1,RASAL1,RBPJ,RIMS1,RIMS2,RUFY3,SEMA4D,SEMA5A,SEMA7A,SHTN1,SMURF1,SOX15,SYT1,SYT17,SYT2,SYT3,SYT4,TBX2,TBX20,TWF2,UNC13A,VEGFA,WT1,ZP3	Any process that activates, maintains or increases the rate of developmental growth.
GO:0048640	GO	BP	negative regulation of developmental growth	BBS2,BCL11A,BMP4,DCC,FGF13,FGFR3,GAL,GNAS,GSK3A,MSTN,MT3,NKD1,NOG,PTCH1,PTEN,RBP4,RNF6,RTN4,RTN4R,SEMA5A,SLC6A4,TBX5,TP73,WWC1,WWC2,WWC3	Any process that stops, prevents, or reduces the frequency, rate or extent of developmental growth.
GO:0048641	GO	BP	regulation of skeletal muscle tissue development	ACTN3,ARNTL,DDX17,DDX5,DLL1,FLOT1,GPC1,HDAC9,MEF2C,MEGF10,MSTN,MYOCD,MYOG,NACA,NR1D2,SIX4,TBX1,TGFB1,UQCC2,USP19	Any process that modulates the frequency, rate or extent of skeletal muscle tissue development.
GO:0048642	GO	BP	negative regulation of skeletal muscle tissue development	MSTN,MYOCD,SIX4,TGFB1,USP19	Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
GO:0048643	GO	BP	positive regulation of skeletal muscle tissue development	ACTN3,ARNTL,DLL1,FLOT1,GPC1,MEF2C,MYOG,NACA,TBX1	Any process that activates, maintains or increases the rate of skeletal muscle tissue development.
GO:0048645	GO	BP	organ formation	BMP4,FGF10,FGFR2,FOLR1,ISL1,MEF2C,MESP1,NTF4,PAX2,PAX8,SOX17	The process pertaining to the initial formation of an organ from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure, such as inductive events, and ends when the structural rudiment of the organ is recognizable, such as a condensation of mesenchymal cells into the organ rudiment. Organs are a natural part or structure in an animal or a plant, capable of performing some special action (termed its function), which is essential to the life or well-being of the whole. The heart and lungs are organs of animals, and the petal and leaf are organs of plants. In animals the organs are generally made up of several tissues, one of which usually predominates, and determines the principal function of the organ.
GO:0048660	GO	BP	regulation of smooth muscle cell proliferation	ADIPOQ,AIF1,ANG,APOD,BMP4,CCL5,CDH13,CTNNB1,EDN1,ELANE,EREG,FOXP1,GPER1,HES5,HMOX1,ID2,IFNG,IGF1,IGFBP3,IGFBP5,IL12A,IL12B,IL6,IL6R,MFN2,NDRG4,NOX1,NR4A3,OGN,PDGFB,PDGFRB,PPARG,PRKDC,PTGIR,SERPINF2,STAT1,TCF7L2,TNF,TNFAIP3,TPM1,TRIB1,XRCC5,XRCC6	Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
GO:0048661	GO	BP	positive regulation of smooth muscle cell proliferation	AIF1,BMP4,CCL5,CDH13,EDN1,ELANE,EREG,FOXP1,HES5,HMOX1,ID2,IGF1,IL6,IL6R,NOX1,NR4A3,PDGFB,PDGFRB,SERPINF2,STAT1,TNF	Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
GO:0048662	GO	BP	negative regulation of smooth muscle cell proliferation	ADIPOQ,AIF1,ANG,APOD,GPER1,HMOX1,IFNG,IGFBP3,IGFBP5,IL12A,IL12B,MFN2,NDRG4,OGN,PPARG,PTGIR,TNFAIP3,TPM1,TRIB1	Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation.
GO:0048663	GO	BP	neuron fate commitment	ASCL1,DLL1,DLL4,FOXN4,GLI2,ID2,ISL1,JAG2,PAX6,POU4F1,SHH,TGFBR1	The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
GO:0048670	GO	BP	regulation of collateral sprouting	BCL11A,BDNF,DCC,FGF13,SEMA4D	Any process that modulates the frequency, rate or extent of collateral sprouting.
GO:0048675	GO	BP	axon extension	ALCAM,CDK5,CYFIP1,NLGN3,NRP1,NRP2,PPP3CB,SEMA3A,SEMA3F,SLC9A6,SLIT1,SLIT2,SLIT3,USP9X	Long distance growth of a single axon process involved in cellular development.
GO:0048678	GO	BP	response to axon injury	APOD,DHFR,DPYSL3,FLRT3,FOLR1,MTR,RTN4RL1,RTN4RL2,SOD1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus.
GO:0048701	GO	BP	embryonic cranial skeleton morphogenesis	EIF4A3,FGFR2,HOXA1,IRX5,LHX1,MTHFD1,MTHFD1L,PDGFRA,SIX1,TBX1,TFAP2A,TGFBR1,TGFBR2,TWIST1	The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
GO:0048704	GO	BP	embryonic skeletal system morphogenesis	COL2A1,CTNNB1,DSCAML1,EIF4A3,FGFR2,FUZ,HOXA1,HOXD3,IRX5,LHX1,MEGF8,MTHFD1,MTHFD1L,NOG,OSR1,OSR2,PDGFRA,SIX1,SOX11,TBX1,TFAP2A,TGFBR1,TGFBR2,TWIST1	The process in which the anatomical structures of the skeleton are generated and organized during the embryonic phase.
GO:0048705	GO	BP	skeletal system morphogenesis	ALX1,ANKRD11,BMP1,BMP4,BMPR1B,BMPR2,CER1,COL13A1,COL2A1,CTNNB1,CYP26B1,DLX5,DSCAML1,EIF4A3,FBN2,FGFR1,FGFR2,FGFR3,FREM1,FUZ,HHIP,HOXA1,HOXA11,HOXD3,IFITM5,IFT140,INPPL1,IRX5,LHX1,LRP5,LTF,MEF2C,MEGF8,MGP,MMP13,MSX2,MTHFD1,MTHFD1L,NOG,NPPC,OSR1,OSR2,PDGFRA,RAB23,RAB33B,SCX,SIX1,SKI,SOX11,SOX9,STC1,TBX1,TBX4,TFAP2A,TGFBR1,TGFBR2,TWIST1,WNT7A,WWOX	The process in which the anatomical structures of the skeleton are generated and organized.
GO:0048706	GO	BP	embryonic skeletal system development	COL1A1,COL2A1,CTNNB1,DEAF1,DSCAML1,EIF4A3,FGFR2,FUZ,HOXA1,HOXD3,IRX5,KIAA1217,LHX1,MEGF8,MTHFD1,MTHFD1L,NOG,OSR1,OSR2,PCSK5,PDGFRA,RBP4,SIX1,SOX11,SULF1,SULF2,TBX1,TFAP2A,TGFBR1,TGFBR2,TWIST1,WNT5A,WNT9A	The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
GO:0048708	GO	BP	astrocyte differentiation	CDK6,DLL1,EIF2B5,HES5,MT3,NF1,STAT3	The process in which a relatively unspecialized cell acquires the specialized features of an astrocyte. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
GO:0048709	GO	BP	oligodendrocyte differentiation	CDK5,CLU,EIF2B1,EIF2B2,EIF2B3,EIF2B4,EIF2B5,HES5,MYRF,PTEN,PTPRZ1,SLC8A3,SOX8,TENM4	The process in which a relatively unspecialized cell acquires the specialized features of an oligodendrocyte. An oligodendrocyte is a type of glial cell involved in myelinating the axons of neurons in the central nervous system.
GO:0048710	GO	BP	regulation of astrocyte differentiation	BIN1,BMP2,CLCF1,EPHA4,F2,HES1,HES5,NOG,NOTCH1,SERPINE2	Any process that modulates the frequency, rate or extent of astrocyte differentiation.
GO:0048711	GO	BP	positive regulation of astrocyte differentiation	BIN1,BMP2,CLCF1,HES1,NOTCH1,SERPINE2	Any process that activates or increases the frequency, rate or extent of astrocyte differentiation.
GO:0048713	GO	BP	regulation of oligodendrocyte differentiation	CXCR4,DRD3,HES1,HES5,NF1,NOTCH1,TENM4,TNFRSF21	Any process that modulates the frequency, rate or extent of oligodendrocyte differentiation.
GO:0048715	GO	BP	negative regulation of oligodendrocyte differentiation	DRD3,HES1,HES5,NF1,NOTCH1	Any process that stops, prevents, or reduces the frequency, rate or extent of oligodendrocyte differentiation.
GO:0048730	GO	BP	epidermis morphogenesis	ATP7A,FGFR2,FOXE1,KLK14,KRT17,KRT71,TGFB2,TGM3,WNT10A	The process in which the anatomical structures of the epidermis are generated and organized. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
GO:0048732	GO	BP	gland development	AKT1,AKT2,ALOX15B,APLN,AR,ARID5B,BMP2,CAV1,CCDC39,CCDC40,CEBPA,CEBPB,CEBPG,CITED2,COBL,CSF1R,CSN2,CSN3,DNAAF1,DRD2,E2F7,E2F8,ELF3,EPHA2,EPHB3,ERBB4,FADD,FGF10,FGFR2,FOXB1,FOXE1,GCM2,GHRH,GLI2,GPAT4,HAND2,HES1,HOXD3,ID2,IGSF3,INSM1,IRF6,JAK2,LSR,MDK,MSN,NF1,NKX2-1,NKX2-5,NKX2-8,NKX3-1,NOTCH4,NPHP3,NR0B1,NRG1,OXTR,PAX8,PCSK9,PHF2,PITX2,PKD2,PRLR,PTF1A,RIPK3,RPS6KA1,SCRIB,SHH,SIX1,SIX3,SLC9A3R1,SOD1,SOX3,SOX9,STRA6,TBX1,TBX3,TCF21,TDGF1,TGFB3,TGFBR1,TGFBR3,VEGFA,WNT10A,WT1,XBP1,ZBTB1,ZIC3,ZNF703	The process whose specific outcome is the progression of a gland over time, from its formation to the mature structure. A gland is an organ specialised for secretion.
GO:0048738	GO	BP	cardiac muscle tissue development	ACTC1,ACVR1,ANKRD1,BMP10,BMP2,C3orf58,CBY1,CSRP3,CXADR,DLL4,DSG2,DSP,FGFR2,FKBP1A,HAND1,HEY2,ISL1,KDM6B,MAML1,MEF2A,MEF2C,MESP1,MYBPC3,MYH11,MYH6,MYH7,MYL2,MYL3,MYLK2,MYLK3,MYOCD,NDUFV2,NEBL,NKX2-5,NKX2-6,NOTCH1,NRG1,OBSL1,PDGFRA,PDGFRB,PDLIM5,PKP2,PROX1,RBP4,RBPJ,RYR2,S1PR1,SIK1,SLC8A1,SMAD7,SORBS2,TAZ,TBX2,TBX20,TCAP,TGFB2,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,TTN,VEGFA,WNT3A,WT1,ZFPM1,ZFPM2	The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure.
GO:0048739	GO	BP	cardiac muscle fiber development	CXADR,MYH11,MYH6,TCAP,TTN,VEGFA	The process whose specific outcome is the progression of cardiac muscle fiber over time, from its formation to the mature structure.
GO:0048745	GO	BP	smooth muscle tissue development	BMP4,ENG,MYLK,NF1,OSR1,PROX1,STRA6	The process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure.
GO:0048747	GO	BP	muscle fiber development	ACTA1,CAV2,CHRNB1,CXADR,DMD,MYH11,MYH6,RYR1,SKI,TCAP,TTN,VEGFA	The process whose specific outcome is the progression of the muscle fiber over time, from its formation to the mature structure. In skeletal muscle, fibers are formed by the maturation of myotubes. They can be classed as slow, intermediate/fast or fast.
GO:0048754	GO	BP	branching morphogenesis of an epithelial tube	BMP2,BMP4,CITED1,COL4A1,CTNNB1,CTSH,DLL4,ENG,EPHA2,FGF1,FGF10,FGF2,FGFR2,FOXD1,FOXF1,GDF2,GDNF,GLI2,HOXA11,HOXD11,MET,MYC,NKX3-1,NOTCH4,NPNT,NRP1,PAK1,PAX2,PKD1,RASIP1,SALL1,SEMA3E,SFRP2,SHH,SIX1,SLIT2,TCF21,TGFBR2,VEGFA,WT1	The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
GO:0048762	GO	BP	mesenchymal cell differentiation	AMELX,BMP2,BMP7,CORO1C,CTNNB1,CUL7,CYP26C1,EFNA1,EOMES,ERBB4,FAM83D,FGF8,FGFR2,FOLR1,FOXC1,FOXF2,GDNF,GSC,GSK3B,HAND2,HAS2,HES1,HEY1,HEY2,HEYL,HGF,HIF1A,HMGA2,HNRNPAB,HTR2B,ISL1,JAG1,LEF1,LOXL2,LOXL3,LRP6,MEF2C,NOG,NOTCH1,NRG1,NRP1,NRTN,OLFM1,OSR1,PAX2,PHACTR4,PHOX2B,PITX2,RBPJ,S100A4,SEMA3A,SHH,SIX2,SNAI1,SNAI2,SOX11,SOX8,SOX9,STAT1,TBX1,TCF21,TGFB1,TGFB2,TGFBR1,TGFBR3,TRIM28,WNT4,WNT8A	The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
GO:0048771	GO	BP	tissue remodeling	ACE,ACVR2B,ACVRL1,AGT,AGTR2,ANXA1,ATP7A,BMPR2,CAV1,CCR2,DLL4,EFNA2,ELF3,EPHA2,F2R,GPR55,HIF1A,HMGB1,IL7,LGR4,MEF2C,NOS3,NOTCH2,PTH,PTK2B,SRC,TGFB1,TPP1,ZNF675	The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling.
GO:0048786	GO	CC	presynaptic active zone	BSN,ERC2,GPER1,GRM7,NUFIP1,PCLO,PPFIA1,PPFIA2,PPFIA3,PPFIA4,RIMS1,RIMS2,RIMS3,RIMS4,UNC13A,UNC13B,UNC13C	A specialized region of the plasma membrane and cell cortex of a presynaptic neuron; encompasses a region of the plasma membrane where synaptic vesicles dock and fuse, and a specialized cortical cytoskeletal matrix.
GO:0048793	GO	BP	pronephros development	AHI1,CEP290,HNF1B,OSR1,PAX2,PAX8	The process whose specific outcome is the progression of the pronephros over time, from its formation to the mature structure. In mammals, the pronephros is the first of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the pronephros is the fully functional embryonic kidney and is indispensable for larval life.
GO:0048799	GO	BP	organ maturation	BMP2,FGFR3,GH1,IGF1,PAX2,PLXNB1,RHOA,RYR1,SEMA4D	A developmental process, independent of morphogenetic (shape) change, that is required for an organ to attain its fully functional state. An organ is a tissue or set of tissues that work together to perform a specific function or functions.
GO:0048806	GO	BP	genitalia development	CHD7,DNAJC19,FOXF2,HNF1B,HSD17B3,LHCGR,LHX1,NIPBL,PTPN11,RBP4,SHH,STRA6,TBX3,WNT5A,WT1	The process whose specific outcome is the progression of the genitalia over time, from its formation to the mature structure.
GO:0048813	GO	BP	dendrite morphogenesis	BTBD3,CELSR2,CTNNA2,CTNND2,DLG4,DVL1,EPHB1,EPHB2,EPHB3,FARP1,LRP4,MAP6,MAPK8IP2,MEF2A,MINK1,PAK3,PTEN,SHANK1,SHANK3,TMEM106B,WNT7A	The process in which the anatomical structures of a dendrite are generated and organized. A dendrite is a freely branching protoplasmic process of a nerve cell.
GO:0048814	GO	BP	regulation of dendrite morphogenesis	ADGRB3,BHLHB9,CAMK2B,CAPRIN1,CAPRIN2,CDK5,CDK5R1,CDKL5,CFL1,CHRNA3,CHRNB2,CUL7,CUX1,CUX2,EFNA1,EPHA4,FBXW8,GORASP1,IL1RAPL1,LRP8,LRRK2,NEDD4,NGEF,NLGN1,NSMF,OBSL1,PDLIM5,PTEN,PTPRD,RAP2A,RAPGEF2,RELN,SARM1,SDC2,SEMA4D,SHANK3,SIPA1L1,SRCIN1,TNIK,YWHAH	Any process that modulates the frequency, rate or extent of dendrite morphogenesis.
GO:0048839	GO	BP	inner ear development	AHI1,ATP6V1B1,BMP2,CEP290,CHD7,DFNB31,EPHB2,FGFR2,GRXCR1,HES5,HOXA1,HPN,JAG2,KCNQ1,LRTOMT,MPV17,NEUROD1,PAX2,PAX8,PHOX2B,POU3F4,PROX1,PTPN11,SIX1,SOD1,SOX9,STRC,TBX1,TFAP2A,USH2A,ZIC1	The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
GO:0048841	GO	BP	regulation of axon extension involved in axon guidance	DSCAM,MEGF8,NRP1,SEMA3A,SEMA5A,VEGFA	Any process that modulates the frequency, rate or extent of axon extension involved in axon guidance.
GO:0048842	GO	BP	positive regulation of axon extension involved in axon guidance	DSCAM,MEGF8,NRP1,SEMA5A,VEGFA	Any process that activates, maintains or increases the frequency, rate or extent of axon extension involved in axon guidance.
GO:0048844	GO	BP	artery morphogenesis	ANGPTL3,BMP4,DLL4,ENG,FOLR1,FOXF1,GJA5,HES1,HEY1,HEY2,HOXA1,HPGD,JAG1,LRP1,MYLK,NF1,NOTCH1,NRP1,PDGFRB,PROX1,RBPJ,SMAD7,SOX4,STRA6,TBX1,TBX2,TFAP2B,TGFBR1,VEGFA	The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
GO:0048845	GO	BP	venous blood vessel morphogenesis	CCBE1,ENG,NOTCH1,PROX1,TBX20,VEGFA	The process in which the anatomical structures of venous blood vessels are generated and organized. Veins are blood vessels that transport blood from the body and its organs to the heart.
GO:0048846	GO	BP	axon extension involved in axon guidance	ALCAM,NRP1,NRP2,SEMA3A,SEMA3F,SLIT1,SLIT2,SLIT3	The long distance growth of a single cell process, that is involved in the migration of an axon growth cone, where the migration is directed to a specific target site by a combination of attractive and repulsive cues.
GO:0048854	GO	BP	brain morphogenesis	BBS2,BBS4,CTNNA2,MKKS,NF1,PAFAH1B1,PAX2,PTEN,SHANK3,SLC6A4,SLIT1,SMO	The process in which the anatomical structures of the brain are generated and organized. The brain is one of the two components of the central nervous system and is the center of thought and emotion. It is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
GO:0048857	GO	BP	neural nucleus development	CHRNB2,FOXP2,NFIB,NKX2-1,PHOX2B	The biological process whose specific outcome is the progression of a neural nucleus from its initial condition to its mature state. A neural nucleus is an anatomical structure consisting of a discrete aggregate of neuronal soma.
GO:0048863	GO	BP	stem cell differentiation	ACE,AMELX,BATF,BMP2,BMP7,CORO1C,CTNNB1,CUL7,CYP26C1,ECE2,EFNA1,ELL3,EOMES,EPCAM,ERBB4,FAM83D,FGF8,FGFR2,FOLR1,FOXC1,FOXF2,FOXO4,FZD1,GDNF,GPM6A,GREM1,GSC,GSK3B,HAND2,HAS2,HES1,HEY1,HEY2,HEYL,HGF,HIF1A,HMGA2,HNRNPAB,HOXB4,HTR2B,ISL1,JAG1,JARID2,KIT,LEF1,LOXL2,LOXL3,LRP6,MEF2C,MEOX1,MTF2,MYOCD,NOG,NOTCH1,NRG1,NRP1,NRTN,NTF4,OLFM1,OSR1,PAX2,PHACTR4,PHOX2B,PITX2,POU6F2,PSMD11,PTPRC,PUM1,RBPJ,REST,S100A4,SEMA3A,SETD6,SFRP1,SHH,SIX2,SIX3,SNAI1,SNAI2,SOX11,SOX21,SOX8,SOX9,SP7,SRF,STAT1,T,TBX1,TBX2,TCF21,TGFB1,TGFB2,TGFBR1,TGFBR3,TRIM28,WNT3,WNT4,WNT7A,WNT8A,ZNF281	The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
GO:0048864	GO	BP	stem cell development	AMELX,BMP2,BMP7,CORO1C,CTNNB1,CUL7,CYP26C1,EFNA1,EOMES,ERBB4,FAM83D,FGF8,FOLR1,FOXC1,FOXF2,GDNF,GSC,GSK3B,HAND2,HAS2,HES1,HEY1,HEY2,HEYL,HGF,HIF1A,HMGA2,HNRNPAB,HTR2B,JAG1,LEF1,LOXL2,LOXL3,LRP6,NOG,NOTCH1,NRG1,NRP1,NRTN,OLFM1,PHACTR4,PHOX2B,PITX2,PTPRC,RBPJ,S100A4,SEMA3A,SHH,SNAI1,SNAI2,SOX11,SOX8,SOX9,TBX1,TGFB1,TGFB2,TGFBR1,TGFBR3,TRIM28,WNT7A,WNT8A	The process whose specific outcome is the progression of the stem cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to its specific fate.
GO:0048871	GO	BP	multicellular organismal homeostasis	ACADL,ACADVL,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ALOX12,ALOX12B,ALOXE3,AMPD2,AQP1,AQP2,AQP3,AQP4,ARMS2,AVP,AVPR2,BARD1,BBS1,BBS10,BBS2,BBS4,BMP6,BPIFA1,CD34,CDH23,CDH3,CHMP4B,CIB2,CIDEA,CLDN1,CLDN4,CLRN1,CNGB1,CTSH,CUBN,CXADR,CYP11B2,CYP4F12,DFNB31,DRAM2,DRD2,F2R,FOXC1,FOXO1,GCNT2,GNAS,GPR55,HAMP,HAS2,HYAL2,IL7,IQCB1,KDF1,KRT16,LEPR,MAK,MKKS,MRAP2,MUC13,MUC4,MUC6,MYO5B,NAPSA,NOD2,NPHP3,NR1D1,NR4A3,OMA1,P2RX4,PBLD,PCDH15,POC1B,PPARGC1A,PRDX5,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PROM1,PTH,PTK2B,RAB11A,RAB11FIP2,RBP4,RDH12,RP1,RP1L1,RPE65,SCNN1A,SCNN1B,SCNN1G,SCX,SERPINA3,SFN,SFTPD,SLC11A1,SLC11A2,SLC40A1,SOD1,SOX9,SPATA7,SRC,STAT3,STRAP,TFAP2B,TLR4,TLR9,TMEM79,TNFRSF11A,TP63,TPP1,TRPV4,TULP1,USH1C,USH1G,USH2A,VEGFA,WFS1,ZNF675	Any process involved in the maintenance of an internal steady state at the level of the multicellular organism.
GO:0048872	GO	BP	homeostasis of number of cells	AKT1,ALAS2,ANXA1,ATPIF1,CASP3,CEBPG,DMTN,DYRK3,EPO,F2R,FADD,FLT3,FLVCR1,FOXP3,G6PD,GATA1,HCAR2,HCLS1,HIPK2,HMGB1,HMOX1,IKZF1,IL6,INHA,INHBA,JAK2,JAK3,KIT,KLF1,KMT2E,LYN,MED1,MEF2C,NCKAP1L,NOV,PDE4B,PMAIP1,PRDX5,PTPN2,RIPK3,RPS14,RPS17,RPS19,RPS24,SIVA1,SLC22A5,SLC25A38,SOD1,SOX9,TAL1,TGFBR3,TNFAIP3,TNFSF14,UBAP2L,VEGFA,ZC3H8,ZFPM1	Any biological process involved in the maintenance of the steady-state number of cells within a population of cells.
GO:0048935	GO	BP	peripheral nervous system neuron development	ETV1,ISL1,ISL2,POU4F1,RUNX1,RUNX3	The process whose specific outcome is the progression of a neuron whose cell body is located in the peripheral nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
GO:0050308	GO	MF	sugar-phosphatase activity	FBP1,G6PC,G6PC3,PFKFB1,TIGAR	Catalysis of the reaction: sugar phosphate + H2O = sugar + phosphate.
GO:0050321	GO	MF	tau-protein kinase activity	BRSK1,BRSK2,CDK5,GSK3A,GSK3B,MARK1,MARK2,MARK4,PHKG2	Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein.
GO:0050427	GO	BP	3'-phosphoadenosine 5'-phosphosulfate metabolic process	ABHD14B,BPNT1,ENPP1,PAPSS1,PAPSS2,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1	The chemical reactions and pathways involving 3'-phosphoadenosine 5'-phosphosulfate, a naturally occurring mixed anhydride. It is an intermediate in the formation of a variety of sulfo compounds in biological systems.
GO:0050428	GO	BP	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process	PAPSS1,PAPSS2,SLC26A1,SLC26A2,SLC35B2,SLC35B3	The chemical reactions and pathways resulting in the formation of 3'-phosphoadenosine 5'-phosphosulfate, a naturally occurring mixed anhydride. It is an intermediate in the formation of a variety of sulfo compounds in biological systems.
GO:0050431	GO	MF	transforming growth factor beta binding	ACVR1,CD36,HYAL2,ITGAV,LTBP4,TGFB3,TGFBR1,TGFBR2,TGFBR3,THBS1	Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
GO:0050433	GO	BP	regulation of catecholamine secretion	ADRA2A,ADRA2B,ADRA2C,ADRBK1,CARTPT,CHGA,CHRNA4,CHRNB2,DRD3,DTNBP1,FFAR3,GDNF,KCNA2,KCNB1,PARK2,SNCA,STX1A	Any process that modulates the frequency, rate or extent of the regulated release of catecholamines.
GO:0050434	GO	BP	positive regulation of viral transcription	CCNH,CCNT1,CDK7,CDK9,CHD1,CTDP1,ELL,EP300,ERCC2,ERCC3,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HPN,JUN,LEF1,MDFIC,MNAT1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,RSF1,SMARCA4,SMARCB1,SNW1,SP1,SSRP1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,ZNF639	Any process that activates or increases the frequency, rate or extent of viral transcription.
GO:0050435	GO	BP	beta-amyloid metabolic process	ACE,APEH,BACE1,IDE,MME,NAT8,NAT8B	The chemical reactions and pathways involving beta-amyloid, a glycoprotein associated with Alzheimer's disease, and its precursor, amyloid precursor protein (APP).
GO:0050482	GO	BP	arachidonic acid secretion	ACE,BDKRB2,DRD2,DRD3,DRD4,NMUR2,PLA2G1B,PNPLA8	The controlled release of arachidonic acid from a cell or a tissue.
GO:0050542	GO	MF	icosanoid binding	ALOX5AP,OXER1,PPARG,S100A8,S100A9,STX3	Interacting selectively and non-covalently with icosanoids, any C20 polyunsaturated fatty acids or their derivatives, including the leukotrienes and the prostanoids.
GO:0050544	GO	MF	arachidonic acid binding	ALOX5AP,PPARG,S100A8,S100A9,STX3	Interacting selectively and non-covalently with arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
GO:0050650	GO	BP	chondroitin sulfate proteoglycan biosynthetic process	B3GAT3,BCAN,BGN,CHPF,CHPF2,CHST11,CHST12,CHST13,CHST15,CHST3,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,NCAN,PXYLP1,VCAN,XYLT2	The chemical reactions and pathways resulting in the formation of chondroitin sulfate proteoglycan, any glycoprotein whose glycosaminoglycan units are chondroitin sulfate. Chondroitin sulfates are a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues; the repeat units consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate.
GO:0050651	GO	BP	dermatan sulfate proteoglycan biosynthetic process	B3GAT3,BCAN,BGN,CHST12,CHST14,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,NCAN,UST,VCAN	The chemical reactions and pathways resulting in the formation of dermatan sulfate proteoglycan, any glycoprotein whose glycosaminoglycan units are dermatan sulfate (chondroitin sulfate B). Dermatan sulfate is a glycosaminoglycan with repeats consisting of beta-(1,4)-linked L-iduronyl-beta-(1,3)-N-acetyl-D-galactosamine 4-sulfate units.
GO:0050654	GO	BP	chondroitin sulfate proteoglycan metabolic process	AGRN,ARSB,B3GALT6,B3GAT1,B3GAT2,B3GAT3,B4GALT7,BCAN,BGN,CHPF,CHPF2,CHST11,CHST12,CHST13,CHST14,CHST15,CHST3,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GXYLT1,HEXA,HEXB,HSPG2,HYAL1,IDS,IDUA,NCAN,NDNF,PXYLP1,SDC1,SDC2,SDC3,SDC4,UST,VCAN,XYLT2	The chemical reactions and pathways involving chondroitin sulfate proteoglycan, any glycoprotein whose glycosaminoglycan units are chondroitin sulfate. Chondroitin sulfates are a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues; the repeat units consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate.
GO:0050655	GO	BP	dermatan sulfate proteoglycan metabolic process	B3GAT3,BCAN,BGN,CHST12,CHST14,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,IDUA,NCAN,UST,VCAN	The chemical reactions and pathways involving dermatan sulfate proteoglycan, any glycoprotein whose glycosaminoglycan units are dermatan sulfate (chondroitin sulfate B). Dermatan sulfate is a glycosaminoglycan with repeats consisting of beta-(1,4)-linked L-iduronyl-beta-(1,3)-N-acetyl-D-galactosamine 4-sulfate units.
GO:0050656	GO	MF	3'-phosphoadenosine 5'-phosphosulfate binding	CHST12,CHST15,ENPP1,GAL3ST3,GAL3ST4,HS3ST5	Interacting selectively and non-covalently with 3'-phosphoadenosine 5'-phosphosulfate (PAPS), a naturally occurring mixed anhydride. It is an intermediate in the formation of a variety of sulfo compounds in biological systems.
GO:0050658	GO	BP	RNA transport	AGFG1,ALKBH5,ALYREF,ATXN2,BUD13,C14orf166,CDC40,CHTOP,CKAP5,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FLOT1,FYTTD1,GLE1,HHEX,HNRNPA1,HNRNPA2B1,KIF5C,LUZP4,MAGOH,MRPL18,NCBP1,NCBP2,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,PHAX,PNPT1,POLDIP3,RAE1,RAN,RBFOX1,RBM8A,RFTN1,RNPS1,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,TST,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO5,XPOT,ZC3H11A,ZC3H3	The directed movement of RNA, ribonucleic acids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0050660	GO	MF	flavin adenine dinucleotide binding	ACOX1,AGPS,AIFM2,CRY2,CYB5R3,CYBB,DAO,DPYD,ETFA,ETFDH,FOXRED2,GFER,KDM1A,KMO,MICAL1,MICAL2,MICAL3,MTHFR,MTRR,NDOR1,NOS1,NOS2,NOS3,NOX4,NOX5,PPOX,PRODH,XDH	Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
GO:0050661	GO	MF	NADP binding	CAT,CBR3,CBR4,CRYM,CRYZ,CRYZL1,DECR1,DHFR,DPYD,DUOX1,G6PD,GMDS,GRHPR,HMGCR,KCNAB1,ME1,MTRR,NDOR1,NNT,NOS1,NOS2,NOS3,NOX1,NOX5,SPR,TP53I3	Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.
GO:0050662	GO	MF	coenzyme binding	ACOT7,ACOX1,ADH4,AGPS,AIFM2,ALAS2,ALDH6A1,ATAT1,BDH2,CAT,CBR3,CBR4,CRY2,CRYL1,CRYM,CRYZ,CRYZL1,CTBP1,CYB5R3,CYBB,DAO,DBI,DECR1,DHFR,DPYD,DUOX1,ETFA,ETFDH,FOXRED2,G6PD,GFER,GLUD1,GMDS,GRHPR,HACL1,HAO1,HMGCR,HPGD,KCNAB1,KDM1A,KMO,MARC1,MARC2,ME1,MICAL1,MICAL2,MICAL3,MTHFR,MTRR,NDOR1,NNT,NOS1,NOS2,NOS3,NOX1,NOX4,NOX5,PPOX,PRODH,SCP2,SIRT2,SIRT5,SIRT6,SOAT1,SOAT2,SORD,SPR,TP53I3,UXS1,WWOX,XDH	Interacting selectively and non-covalently with a coenzyme, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.
GO:0050663	GO	BP	cytokine secretion	ABCA1,AIM2,BTN3A1,BTN3A2,CCL19,CCR7,CD36,CHI3L1,F2RL1,FOXP1,GBP5,HMGB1,KLRF2,LEP,LILRB1,NLRC4,NOD2,NOS2,NOX5,NR1H4,PNP,RAB1A,S100A12,S100A13,TLR2,TLR4,TLR6,TRIM27	The regulated release of cytokines from a cell. Cytokines are any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
GO:0050664	GO	MF	oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor	AIFM1,CYB5R4,CYBA,CYBB,DUOX1,DUOX2,KMO,NCF1,NOX1,NOX4,NOX5,PAX2	Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces an oxygen molecule.
GO:0050667	GO	BP	homocysteine metabolic process	CBS,CPS1,CTH,DPEP1,MTHFR,MTRR,MUT,NOX4	The chemical reactions and pathways involving homocysteine, the amino acid alpha-amino-gamma-mercaptobutanoic acid. Homocysteine is an important intermediate in the metabolic reactions of its S-methyl derivative, methionine.
GO:0050670	GO	BP	regulation of lymphocyte proliferation	AGER,AHR,AIF1,ANXA1,ATM,BCL2,BMP4,BTN2A2,CCL19,CCL5,CCR2,CD1D,CD209,CD24,CD274,CD276,CD28,CD300A,CD38,CD3E,CD46,CD55,CD6,CD74,CD81,CDKN2A,CEBPB,CHRNB2,CLC,CLCF1,CTLA4,EBI3,FADD,FGF10,FOXP3,GLMN,GPR183,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DRB1,HLA-E,HLA-G,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IHH,IKZF3,IL10,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL27,IL4,IL6,IL6ST,IL7,IRF1,IRS2,KIAA0922,LEP,LGALS3,LGALS9,LILRB1,LILRB2,LST1,MEF2C,MIF,MNDA,MZB1,NCK1,NCK2,NCKAP1L,NFATC2,PDCD1LG2,PNP,PRKAR1A,PRNP,PTPN22,PTPRC,PYCARD,RASAL3,RC3H1,RIPK3,SFTPD,SHH,SOX11,TCF3,TIRAP,TMIGD2,TNFRSF21,TNFRSF4,TNFSF13B,TNFSF18,TNFSF4,VAV3,VCAM1,XCL1,ZNF335,ZP3,ZP4	Any process that modulates the frequency, rate or extent of lymphocyte proliferation.
GO:0050671	GO	BP	positive regulation of lymphocyte proliferation	AGER,AIF1,ANXA1,BCL2,CCL19,CCL5,CCR2,CD1D,CD24,CD274,CD276,CD28,CD38,CD3E,CD46,CD55,CD6,CD74,CD81,CHRNB2,CLCF1,EBI3,FADD,FGF10,GPR183,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-E,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,IRS2,LEP,LGALS9,LILRB2,MEF2C,MIF,NCK1,NCK2,NCKAP1L,NFATC2,PNP,PTPRC,PYCARD,RASAL3,SHH,TCF3,TIRAP,TMIGD2,TNFRSF4,TNFSF13B,TNFSF4,VAV3,VCAM1,XCL1,ZNF335,ZP3,ZP4	Any process that activates or increases the rate or extent of lymphocyte proliferation.
GO:0050672	GO	BP	negative regulation of lymphocyte proliferation	ATM,BMP4,BTN2A2,CD274,CD300A,CDKN2A,CEBPB,CTLA4,FOXP3,GLMN,HLA-DRB1,HLA-G,IHH,IL10,KIAA0922,LGALS9,LILRB1,LILRB2,LST1,MNDA,PDCD1LG2,PRKAR1A,PRNP,RC3H1,SFTPD,SOX11,TNFRSF21,XCL1	Any process that stops, prevents or reduces the rate or extent of lymphocyte proliferation.
GO:0050673	GO	BP	epithelial cell proliferation	ACVRL1,BAD,BMP4,BMPER,BMPR2,BTBD10,C19orf80,C6orf89,CALCA,CD34,CDH13,CEBPB,DLG1,EPHA2,EREG,ERN1,FAP,FERMT1,FGF10,FGFR2,HMOX1,ID2,ITGB1BP1,KLK8,KRT2,LOXL2,MEF2C,MTSS1,NKX3-1,NKX6-1,NOV,NOX5,PRKX,RPS6KA1,SDR16C5,SEMA5A,SOX9,TEK,THAP1,WNT16,XBP1	The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances.
GO:0050678	GO	BP	regulation of epithelial cell proliferation	ACVRL1,AGGF1,AIMP1,AKT1,AMICA1,ANG,APOE,APOH,ARNT,ATOH8,ATP5A1,ATPIF1,BAD,BMP2,BMP4,BMP5,BMP6,BMPR2,BRCA2,C5AR1,CASK,CAV1,CAV2,CCL11,CCL24,CCL26,CDC73,CDH13,CDH3,CDK6,CDKN1C,CDKN2B,CXCR3,DAB2IP,DEAF1,DLL4,ECM1,EGFL7,EGFR,EGR3,ENG,EPGN,ERBB2,EREG,F3,FBXW7,FGF10,FGF2,FGF7,FGFR2,FLT4,FOXE3,FZD7,GATA3,GDF2,GDF5,GHRL,GPX1,HIF1A,HMGB2,HPN,HRAS,HTR2B,HYAL1,IGF1,IL26,ITGB3,KDR,KLF9,KRIT1,KRT4,LACRT,LAMB1,LAMC1,LEP,MAGED1,MARVELD3,MCC,MED1,MMP12,MTSS1,MYC,MYDGF,NF1,NFIB,NKX3-1,NME1,NME2,NOD2,NODAL,NR1D1,NR2F2,NR4A1,NR4A3,NRP1,NRP2,OSR1,OSR2,OVOL2,PAX2,PBLD,PDCD10,PDCD6,PDCL3,PDGFB,PEX2,PLXNB3,PPP1R16B,PRKCA,PRKD1,PRKD2,PROX1,PTPRK,PTPRM,REG3A,REG3G,RGCC,ROBO1,RREB1,RUNX3,SCG2,SCN5A,SEMA5A,SFRP1,SFRP2,SIRT1,SIX4,SNAI2,SOX11,SOX2,SOX9,SPARC,SRSF6,STAT1,STRAP,STXBP4,SULF1,SYNJ2BP,TBX1,TEK,TGFA,TGFB1,TGFB2,TGFBR1,TGFBR3,TGM1,THBS1,THBS4,TINF2,TNFSF12,VASH1,VASH2,VDR,VEGFA,VEGFB,WNT5A,WNT7A,XBP1,XDH,ZNF304,ZNF580,ZNF703	Any process that modulates the frequency, rate or extent of epithelial cell proliferation.
GO:0050679	GO	BP	positive regulation of epithelial cell proliferation	AGGF1,AKT1,AMICA1,ANG,ARNT,BAD,BMP2,BMP4,BMP5,BMP6,BMPR2,C5AR1,CCL11,CCL24,CCL26,CDH13,CDH3,ECM1,EGFL7,EGFR,EGR3,EPGN,ERBB2,F3,FGF10,FGF2,FGF7,FGFR2,FLT4,FOXE3,FZD7,GDF2,HIF1A,HMGB2,HPN,HRAS,HTR2B,HYAL1,IGF1,ITGB3,KDR,LACRT,LAMB1,LAMC1,MMP12,MYC,MYDGF,NME1,NME2,NOD2,NODAL,NR4A1,NR4A3,NRP1,NRP2,OSR1,OSR2,PAX2,PDCD6,PDCL3,PDGFB,PLXNB3,PPP1R16B,PRKCA,PRKD1,PRKD2,PROX1,REG3A,REG3G,RREB1,SCG2,SCN5A,SEMA5A,SFRP1,SIRT1,SOX11,SOX9,SRSF6,STXBP4,TBX1,TEK,TGFA,TGFBR1,TGM1,THBS4,TNFSF12,VASH2,VEGFA,VEGFB,WNT5A,WNT7A,XBP1,ZNF304,ZNF580,ZNF703	Any process that activates or increases the rate or extent of epithelial cell proliferation.
GO:0050680	GO	BP	negative regulation of epithelial cell proliferation	AIMP1,APOE,APOH,ATOH8,ATP5A1,ATPIF1,BRCA2,CASK,CAV1,CAV2,CDC73,CDK6,CDKN1C,CDKN2B,CXCR3,DAB2IP,DLL4,ENG,EREG,FBXW7,GATA3,GDF2,GDF5,GHRL,HPN,IL26,KLF9,KRIT1,KRT4,MAGED1,MARVELD3,MCC,MED1,MTSS1,NF1,NFIB,NKX3-1,NR2F2,PBLD,PDCD10,PEX2,PTPRK,PTPRM,RGCC,ROBO1,RUNX3,SCG2,SFRP1,SFRP2,SNAI2,SOX2,SOX9,SPARC,STAT1,STRAP,SULF1,SYNJ2BP,TGFB1,TGFB2,TGFBR3,THBS1,TINF2,VASH1,VDR,XDH	Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
GO:0050681	GO	MF	androgen receptor binding	BRCA1,CALR,CCNE1,CDK7,CTNNB1,DDX5,FHL2,FOXP1,GRIP1,KAT5,KDM1A,KDM3A,NCOA1,NCOA3,NCOA4,NRIP1,NSD1,PIAS1,PIAS2,PKN1,PPARGC1A,PRKCB,RAN,RB1,RNF4,TCF21,TGFB1I1,WIPI1	Interacting selectively and non-covalently with an androgen receptor.
GO:0050684	GO	BP	regulation of mRNA processing	ACIN1,AGO2,AHCYL1,BARD1,BTG2,C1QBP,CCNT1,CDC73,CDK11A,CDK11B,CDK9,CELF3,CELF4,CELF6,CNOT1,CNOT7,CPEB3,CPSF4,CTR9,CWC22,DDX5,HSPA1A,IWS1,JMJD6,LEO1,MAGOH,NCBP1,NCBP2,NELFE,NSRP1,PABPC1,PABPN1,PAF1,PAPOLA,PTBP1,PTCD2,RBFOX2,RBM11,RBM15B,RBM25,RBM4,RBM5,RBM8A,RBMX,RBMY1A1,RNF20,RNF40,RNPS1,SAP18,SFSWAP,SNW1,SRPK1,SRPK2,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,SUPT5H,SUPT6H,THRAP3,TIA1,TMBIM6,TNRC6B,TNRC6C,TOB1,TRA2B,U2AF2,WTAP,ZFP36	Any process that modulates the frequency, rate or extent of mRNA processing, those processes involved in the conversion of a primary mRNA transcript into a mature mRNA prior to its translation into polypeptide.
GO:0050685	GO	BP	positive regulation of mRNA processing	AGO2,BTG2,CDC73,CELF3,CELF4,CNOT1,CNOT7,CPEB3,HSPA1A,LEO1,NCBP1,NCBP2,PABPC1,PAF1,RBMX,SNW1,THRAP3,TNRC6B,TNRC6C,TOB1,TRA2B,ZFP36	Any process that activates or increases the frequency, rate or extent of mRNA processing.
GO:0050686	GO	BP	negative regulation of mRNA processing	ACIN1,BARD1,C1QBP,CCNT1,CDK9,CTR9,NELFE,PTBP1,RBMX,RNF20,RNF40,RNPS1,SAP18,SFSWAP,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,SUPT5H,TMBIM6,TOB1,U2AF2	Any process that stops, prevents, or reduces the frequency, rate or extent of mRNA processing.
GO:0050687	GO	BP	negative regulation of defense response to virus	C1QBP,DHX58,EIF2AK2,IFIT1,ITCH,MICB,MUL1,PCBP2,PPM1B,SEC14L1,TARBP2,TKFC,TRAF3IP1,TSPAN6	Any process that stops, prevents or reduces the rate or extent of antiviral mechanisms, thereby facilitating viral replication.
GO:0050688	GO	BP	regulation of defense response to virus	ACIN1,ACKR3,ACTRT1,AIM2,ALKBH5,ALPK1,ANKRD17,ANXA5,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APOBEC3F,APOBEC3G,ARF1,ASB2,ATP1B1,ATP6V1H,B2M,BIRC2,BIRC3,C1QBP,C1orf210,C8orf59,CA7,CCDC36,CD163L1,CD247,CD28,CD4,CD8B,CD93,CHAF1B,CHST3,CLDN7,COX8A,CPA3,CREB3,CRNKL1,CSPG5,DDX58,DDX60,DHX58,DKKL1,DNAAF2,DOCK2,DPF3,EIF2AK2,EIF2AK4,EIF2S1,ELMO1,ELMOD2,FABP1,FAM131B,FAM13B,FANCL,FCGR3B,FGF14,FGF7,FGFBP1,FXR2,FYN,GABRA5,GMIP,HCAR1,HCK,HERC5,HILPDA,HIST1H3A,HLA-A,HPR,IFIT1,IFNLR1,IL12B,IL12RB1,IL23A,IL23R,IST1,ITCH,ITPKC,KCNQ1,KIAA1549L,KRT6A,LCK,LENG9,LILRB1,LMCD1,LSM4,MAP1A,MAVS,MB21D1,MBD5,MDH1,MICB,MRPS10,MRPS2,MSTN,MTSS1,MUL1,MYLK,MYOM1,NTHL1,NUP93,PACS1,PAK2,PCBP2,PDK4,PEX13,PEX3,PHYHIP,PM20D1,PML,PNPO,PPM1B,PPY,PUM1,PUM2,RAC1,RBM18,REEP2,REP15,RFWD3,RNF216,SCN1A,SEC14L1,SERPINB10,SIN3A,SLC1A3,SLC25A19,SLC35B3,SLC35C1,SLC37A4,SMURF1,SNRPB,SNRPB2,SNRPD1,SNTG1,STAT2,STOM,SUPT3H,TARBP2,TEAD4,TKFC,TMEM173,TMEM203,TMEM39A,TMEM39B,TNFAIP3,TNIK,TRAF3,TRAF3IP1,TRAF3IP2,TREM1,TRIM15,TRIM6,TSPAN6,UBA52,USP17L2,YIPF1,ZC3H12A,ZC3HAV1,ZCCHC17,ZNF189,ZNF681	Any process that modulates the frequency, rate or extent of the antiviral response of a cell or organism.
GO:0050690	GO	BP	regulation of defense response to virus by virus	AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARF1,ATP6V1H,B2M,CD247,CD28,CD4,CD8B,DOCK2,EIF2AK2,ELMO1,FYN,HCK,HLA-A,LCK,PACS1,PAK2,RAC1	Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism.
GO:0050691	GO	BP	regulation of defense response to virus by host	ACIN1,ACKR3,ACTRT1,AIM2,ALKBH5,ALPK1,ANXA5,APOBEC3F,APOBEC3G,ASB2,ATP1B1,C1orf210,C8orf59,CA7,CCDC36,CD163L1,CD93,CHAF1B,CHST3,CLDN7,COX8A,CPA3,CREB3,CRNKL1,CSPG5,DDX58,DKKL1,DNAAF2,DPF3,EIF2AK4,EIF2S1,FABP1,FAM131B,FAM13B,FANCL,FCGR3B,FGF14,FGF7,FGFBP1,FXR2,GABRA5,GMIP,HCAR1,HILPDA,HIST1H3A,HPR,IFIT1,IFNLR1,IL12B,IL12RB1,IL23A,IL23R,IST1,ITPKC,KCNQ1,KIAA1549L,KRT6A,LENG9,LILRB1,LMCD1,LSM4,MAP1A,MAVS,MB21D1,MBD5,MDH1,MICB,MRPS10,MRPS2,MSTN,MTSS1,MUL1,MYLK,MYOM1,NTHL1,NUP93,PDK4,PEX13,PEX3,PHYHIP,PM20D1,PML,PNPO,PPY,RBM18,REEP2,REP15,RFWD3,RNF216,SCN1A,SERPINB10,SIN3A,SLC1A3,SLC25A19,SLC35B3,SLC35C1,SLC37A4,SMURF1,SNRPB,SNRPB2,SNRPD1,SNTG1,STAT2,STOM,SUPT3H,TARBP2,TEAD4,TMEM173,TMEM203,TMEM39A,TMEM39B,TNFAIP3,TNIK,TRAF3IP2,TREM1,TRIM6,UBA52,USP17L2,YIPF1,ZC3H12A,ZCCHC17,ZNF189,ZNF681	Any host process that modulates the frequency, rate, or extent of the antiviral response of a host cell or organism.
GO:0050699	GO	MF	WW domain binding	NFE2,RAPGEF2,TNK2,WBP1,WBP2NL	Interacting selectively and non-covalently with a WW domain of a protein, a small module composed of 40 amino acids and plays a role in mediating protein-protein interactions via proline-rich regions.
GO:0050701	GO	BP	interleukin-1 secretion	ABCA1,AIM2,CD36,F2RL1,GBP5,NLRC4,S100A13,TLR4,TLR6	The regulated release of interleukin-1 from a cell. Interleukin 1 is produced mainly by activated macrophages; it stimulates thymocyte proliferation by inducing interleukin 2 release and it is involved in the inflammatory response.
GO:0050702	GO	BP	interleukin-1 beta secretion	ABCA1,AIM2,CD36,F2RL1,GBP5,NLRC4,TLR4,TLR6	The regulated release of interleukin 1 beta from a cell.
GO:0050704	GO	BP	regulation of interleukin-1 secretion	AIM2,APOA1,CARD8,CCL19,CCL3,CCR7,FOXP1,GAS6,HMGB1,LGALS9,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,PYDC2,SAA1,TRIM16,WNT5A,ZC3H12A	Any process that modulates the frequency, rate or extent of the regulated release of interleukin-1 from a cell.
GO:0050706	GO	BP	regulation of interleukin-1 beta secretion	AIM2,APOA1,CARD8,CCL19,CCL3,CCR7,FOXP1,LGALS9,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,PYDC2,TRIM16,WNT5A,ZC3H12A	Any process that modulates the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell.
GO:0050707	GO	BP	regulation of cytokine secretion	AIM2,ALOX15B,ANXA1,ANXA4,APOA1,APOA2,BTN2A2,C1QTNF3,C5,C5AR2,CADM1,CAMP,CARD8,CCL19,CCL3,CCR7,CD2,CD244,CD274,CD34,CD58,CHIA,CIDEA,CLEC6A,CLEC9A,CRP,CRTAM,CSF1R,DRD2,EZR,F2R,F2RL1,FBLN1,FCN1,FFAR2,FFAR4,FGR,FN1,FOXP1,FOXP3,GAS6,GATA3,GBP1,GLMN,HAVCR2,HLA-DRB1,HMGB1,HTR2B,HYAL2,IFNA2,IL10,IL1A,IL26,IL33,IL36RN,INS,LGALS9,LGR4,LILRB1,MAPK11,MAPK14,MIF,NLRP1,NLRP10,NLRP12,NLRP2,NLRP3,NOD2,NR1H4,P2RX7,PAEP,PANX1,PRKCZ,PTGER4,PTPN22,PYCARD,PYDC1,PYDC2,RASGRP1,RGCC,SAA1,SCAMP5,SPTBN1,SRGN,SSC5D,TNF,TNFRSF21,TRIM16,TRIM27,TRIM6,TWIST1,WNT5A,XBP1,ZC3H12A	Any process that modulates the frequency, rate or extent of the regulated release of cytokines from a cell.
GO:0050709	GO	BP	negative regulation of protein secretion	ADRA2A,ANXA1,ANXA4,APOA1,APOA2,BMP8A,BTN2A2,C1QTNF3,C5AR2,CD34,CIDEA,DPH3,DRD2,DRD3,DRD4,ERP29,EZR,F2R,F2RL1,FAM3D,FBLN1,FFAR4,FN1,FOXP3,GAS6,GBP1,IFNA2,IL10,IL1B,IL36RN,INHBB,INS,IRS1,KCNB1,KCNJ11,LGR4,LILRB1,NLRP12,NLRP3,NOV,NR1H3,NR1H4,OPRM1,PARK2,PIM3,PSMD9,PTGER4,PTPN22,PYDC2,RAB11FIP1,RAB11FIP3,RAB11FIP5,REST,RGCC,RHBDF1,RHBDF2,RSAD2,SERGEF,SFRP1,SIRT4,SRGN,SSC5D,TNF,TNFRSF21,TRIM27,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a protein from a cell.
GO:0050710	GO	BP	negative regulation of cytokine secretion	ANXA1,ANXA4,APOA1,APOA2,BTN2A2,C1QTNF3,C5AR2,CD34,CIDEA,EZR,F2RL1,FBLN1,FFAR4,FN1,FOXP3,GAS6,GBP1,IFNA2,IL10,IL36RN,LGR4,LILRB1,NLRP12,NLRP3,NR1H4,PTGER4,PTPN22,PYDC2,RGCC,SRGN,SSC5D,TNF,TNFRSF21,TRIM27,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cytokines from a cell.
GO:0050711	GO	BP	negative regulation of interleukin-1 secretion	APOA1,GAS6,NLRP12,NLRP3,PYDC2,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of interleukin-1 from a cell.
GO:0050714	GO	BP	positive regulation of protein secretion	ACHE,ADAM8,ADAM9,AIM2,ALOX15B,ANG,ANKRD1,ANO1,BAD,BLK,BMP6,C1QTNF3,C5,CADM1,CAMP,CAPN10,CARD8,CCL19,CCL3,CD2,CD244,CD274,CD34,CD58,CFTR,CHIA,CLEC6A,CLEC9A,CRTAM,CSF1R,DNM1L,DOC2B,DRD2,EXOC1,EXPH5,EZR,F2R,F2RL1,FCN1,FFAR2,FGA,FGB,FGG,FGR,GATA3,GCK,GHRL,GLMN,GLUD1,GOLPH3,GOLPH3L,GPER1,GPLD1,HAVCR2,HCAR2,HLA-DRB1,HLA-E,HMGB1,HTR2B,HYAL2,IGF1,IL10,IL1A,IL26,IL33,IL6,INS,IRS2,ISL1,LGALS9,MAPK11,MAPK14,MCU,MIF,MYO18A,MYRIP,NLGN2,NLRP1,NLRP10,NLRP12,NLRP2,NLRP3,NOD2,OR51E2,P2RX7,PAEP,PANX1,PLA2G1B,PPIA,PPID,PPP3CB,PRKCZ,PSMD9,PTGER4,PTPN22,PYCARD,PYDC1,RASGRP1,RBP4,RFX6,RGCC,SAA1,SCAMP5,SLC30A8,SOX4,SPTBN1,STX4,SYTL4,TCF7L2,TGFB1,TGFB2,TGFB3,TMEM27,TNF,TNFRSF4,TNFSF4,TRIM16,TRIM6,TWIST1,WLS,WNT5A,XBP1	Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
GO:0050715	GO	BP	positive regulation of cytokine secretion	AIM2,ALOX15B,C1QTNF3,C5,CADM1,CAMP,CARD8,CCL19,CCL3,CD2,CD244,CD274,CD34,CD58,CHIA,CLEC6A,CLEC9A,CRTAM,CSF1R,DRD2,F2R,F2RL1,FCN1,FFAR2,FGR,GATA3,GLMN,HAVCR2,HMGB1,HTR2B,HYAL2,IL10,IL1A,IL26,IL33,INS,LGALS9,MAPK11,MAPK14,MIF,NLRP1,NLRP10,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PAEP,PANX1,PRKCZ,PTGER4,PTPN22,PYCARD,PYDC1,RASGRP1,RGCC,SAA1,SCAMP5,SPTBN1,TNF,TRIM16,TRIM6,TWIST1,WNT5A,XBP1	Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
GO:0050716	GO	BP	positive regulation of interleukin-1 secretion	AIM2,CARD8,CCL19,CCL3,HMGB1,LGALS9,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,SAA1,TRIM16,WNT5A	Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 from a cell.
GO:0050718	GO	BP	positive regulation of interleukin-1 beta secretion	AIM2,CARD8,CCL19,CCL3,LGALS9,NLRP1,NLRP12,NLRP2,NLRP3,NOD2,P2RX7,PANX1,PYCARD,PYDC1,TRIM16,WNT5A	Any process that activates or increases the frequency, rate or extent of the regulated release of interleukin-1 beta from a cell.
GO:0050727	GO	BP	regulation of inflammatory response	A2M,ACE2,ADAM8,ADAMTS12,ADIPOQ,AGT,AGTR1,AHSG,ANXA1,APCS,APOA1,APOD,APOE,BIRC2,BIRC3,BRD4,C1QBP,C1QTNF3,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CCL3,CCL5,CCR2,CCR7,CD46,CD55,CD59,CD6,CFB,CFH,CFI,CFP,CHID1,CMA1,CR1,CREB3L3,CUEDC2,ELANE,F12,FEM1A,FFAR2,FFAR3,FFAR4,FOXP1,GATA3,GBA,GBP5,GGT1,GHRL,GHSR,GPER1,GPRC5B,GSTP1,HCK,HLA-DRB1,HYAL2,IL12B,IL15,IL18,IL1B,IL2,IL20,IL21,IL23A,IL33,IL6,IL6ST,INS,IRG1,ISL1,JAK2,KLF4,KLKB1,LBP,LEP,MAPK13,MAPK14,MAPK7,MASP1,MEFV,METRNL,MGLL,MMP26,MTA1,MVK,MYD88,NLRP1,NLRP12,NLRP3,NLRP6,NOD2,NOS2,NOV,NR1D2,NR1H3,OSM,OSMR,OTULIN,PARK7,PDE2A,PER1,PHB,PIK3AP1,PLA2G2A,PLA2G7,PPARA,PRKCD,PROC,PROS1,PSMA6,PTGER3,PTGER4,PTGIS,PTGS2,PTPN2,PYDC2,RELA,RORA,RPS19,S100A12,S100A8,S100A9,SAA1,SBNO2,SELE,SEMA7A,SERPINE1,SERPING1,SETD6,SHARPIN,SHPK,SNX4,SUSD4,TEK,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TNFAIP3,TNFAIP6,TNFRSF11A,TNFRSF1A,TNFSF11,TNFSF4,TNIP1,TYRO3,VAMP7,VAMP8,VIMP,VTN,WNT5A,XCL1,XIAP,ZC3H12A,ZP3	Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
GO:0050728	GO	BP	negative regulation of inflammatory response	ADIPOQ,APCS,APOA1,APOD,APOE,C1QTNF3,CHID1,CUEDC2,ELANE,FEM1A,FFAR4,GATA3,GBA,GHRL,GHSR,GPER1,GSTP1,HLA-DRB1,INS,IRG1,ISL1,KLF4,MAPK7,MEFV,METRNL,MMP26,MVK,NLRP12,NLRP3,NOV,NR1H3,OTULIN,PPARA,PRKCD,PROC,PTGER4,PTGIS,PTPN2,PYDC2,RORA,RPS19,SAA1,SHARPIN,TEK,TNFAIP3,TNFAIP6,TNFRSF1A,TYRO3,VIMP,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
GO:0050729	GO	BP	positive regulation of inflammatory response	ADAM8,AGT,AGTR1,CCL3,CCR2,CCR7,CD6,CREB3L3,F12,FFAR2,FFAR3,GBP5,GPRC5B,HYAL2,IL12B,IL15,IL18,IL1B,IL2,IL21,IL23A,IL33,IL6,IL6ST,KLKB1,LBP,MAPK13,NLRP12,NOD2,OSM,OSMR,PDE2A,PLA2G2A,PLA2G7,PTGER3,PTGER4,PTGS2,RPS19,S100A12,S100A8,S100A9,SERPINE1,SNX4,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TNFRSF11A,TNFRSF1A,TNFSF11,TNFSF4,TNIP1,VAMP7,VAMP8,WNT5A,ZP3	Any process that activates or increases the frequency, rate or extent of the inflammatory response.
GO:0050730	GO	BP	regulation of peptidyl-tyrosine phosphorylation	ABL1,ACE,ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGT,ANGPT1,ANGPT4,APP,ARHGEF2,ARL2BP,CAV1,CBLC,CCL5,CD24,CD300A,CD40,CD44,CD74,CD80,CD81,CLCF1,CNTF,CRLF1,CSF1R,CSF2,CSF3,CSPG4,CTF1,DMTN,DOK7,EFNA1,EFNA5,EGF,EGFR,ENPP2,EPGN,EPHA7,EPO,ERBB3,ERBB4,ERCC6,EREG,ERRFI1,FBXW7,FGF10,FGF7,FGFR1OP,FGFR3,FLT3,GAS6,GATA1,GH1,GHR,GHRL,GNB2L1,GPRC5A,GPRC5B,GREM1,HAX1,HCLS1,HES1,HES5,HGF,HRG,HYAL2,IBTK,IFNA2,IFNG,IFNL1,IGF1,IGF2,IL11,IL12A,IL12B,IL18,IL2,IL20,IL21,IL22RA2,IL23A,IL23R,IL3,IL5,IL6,IL6R,IL6ST,INS,ITGA5,ITGB2,ITGB3,JAK2,KIT,LACRT,LIF,LRP8,LYN,MIF,MVP,NCK2,NF2,NRG1,NRP1,NTF3,OSM,PAK2,PDCL3,PDGFA,PDGFB,PIBF1,PPP2CA,PPP2R1A,PRKCD,PRKCZ,PTK2B,PTK6,PTPN1,PTPN2,PTPN6,RAP2B,RAP2C,RELN,RIPK2,SAMSN1,SEMA4D,SFRP1,SFRP2,SHC1,SNX6,SOCS1,SOCS4,SOCS5,SRC,SRCIN1,STAP1,TDGF1,TEC,TGFA,TGFB1,THBS4,TNFRSF18,TNFRSF1A,TNFSF18,TNK2,TP53,TREM2,UNC119,VEGFA,VEGFB,VTN,ZFYVE28,ZGPAT	Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
GO:0050731	GO	BP	positive regulation of peptidyl-tyrosine phosphorylation	ABL1,ACE,ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGT,ANGPT1,ANGPT4,ARHGEF2,ARL2BP,CCL5,CD24,CD40,CD44,CD74,CD80,CD81,CLCF1,CNTF,CRLF1,CSF1R,CSF2,CSF3,CSPG4,CTF1,DOK7,EFNA1,EFNA5,EGF,ENPP2,EPGN,EPO,ERBB3,ERBB4,ERCC6,EREG,FBXW7,FGF10,FGF7,FGFR3,FLT3,GAS6,GATA1,GH1,GHR,GHRL,GPRC5B,GREM1,HAX1,HCLS1,HES1,HES5,HGF,IFNA2,IFNG,IFNL1,IGF1,IGF2,IL11,IL12A,IL12B,IL18,IL2,IL20,IL21,IL23A,IL23R,IL3,IL5,IL6,IL6R,IL6ST,INS,ITGA5,ITGB3,JAK2,KIT,LACRT,LIF,LRP8,LYN,MIF,NRG1,NRP1,NTF3,OSM,PAK2,PDGFB,PIBF1,PTK2B,PTPN1,RELN,RIPK2,SEMA4D,SRC,SRCIN1,STAP1,TDGF1,TEC,TGFA,TGFB1,THBS4,TNFRSF18,TNFRSF1A,TNFSF18,TNK2,TP53,TREM2,UNC119,VEGFA,VEGFB,VTN	Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
GO:0050732	GO	BP	negative regulation of peptidyl-tyrosine phosphorylation	CAV1,CBLC,CD300A,DMTN,ERRFI1,FGFR1OP,GNB2L1,GPRC5A,HYAL2,IBTK,MVP,NF2,NTF3,PIBF1,PPP2CA,PPP2R1A,PRKCD,PRKCZ,PTK6,PTPN2,PTPN6,SAMSN1,SEMA4D,SFRP1,SFRP2,SNX6,SOCS1,SOCS4,SOCS5,SRCIN1,ZFYVE28,ZGPAT	Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
GO:0050746	GO	BP	regulation of lipoprotein metabolic process	APOA4,APOD,APOM,C19orf80,HHATL,ITGAV,ITGB3,RAB3GAP1,RAB3GAP2,SVIP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids.
GO:0050748	GO	BP	negative regulation of lipoprotein metabolic process	APOA4,APOD,APOM,HHATL,ITGAV,ITGB3	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids.
GO:0050750	GO	MF	low-density lipoprotein particle receptor binding	AP2M1,APOB,APOE,ARRB2,DKK1,DNAJA1,HSP90B1,LANCL1,LRPAP1,PCSK9,SNX17,SYT1	Interacting selectively and non-covalently with a low-density lipoprotein receptor.
GO:0050764	GO	BP	regulation of phagocytosis	ABCA7,ADIPOQ,AHSG,ALOX15,ANO6,AZU1,C2,C3,C4A,C4B,C4BPA,C4BPB,CALR,CAMK1D,CCL2,CD300A,CYBA,DOCK2,F2RL1,FGR,GAS6,GATA2,GNB2L1,HCK,IL1B,ITGAV,LMAN2,MERTK,NCKAP1L,PRTN3,PYCARD,RAB27A,SCARB1,SFTPD,SLC11A1,SNX3,SPACA3,STAP1,SYK,TNF,TUB,TULP1	Any process that modulates the frequency, rate or extent of phagocytosis, the process in which phagocytes engulf external particulate material.
GO:0050765	GO	BP	negative regulation of phagocytosis	ADIPOQ,CD300A,GNB2L1,PRTN3,SNX3	Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
GO:0050766	GO	BP	positive regulation of phagocytosis	ABCA7,AHSG,ANO6,AZU1,C2,C3,C4A,C4B,CALR,CAMK1D,CCL2,CYBA,DOCK2,F2RL1,GAS6,GATA2,IL1B,ITGAV,LMAN2,MERTK,NCKAP1L,PYCARD,RAB27A,SFTPD,SLC11A1,SPACA3,STAP1,TNF,TUB,TULP1	Any process that activates or increases the frequency, rate or extent of phagocytosis.
GO:0050768	GO	BP	negative regulation of neurogenesis	ADCY6,APOE,ARHGDIA,ARHGEF1,ASCL1,BAG5,BCL11A,BMP7,CALR,CBFA2T2,CIB1,CNTN4,COL3A1,DCC,DICER1,DLL1,DPYSL3,DRD3,DTX1,DYNLT1,EDNRB,EFNA1,EIF2AK4,EPHA4,F2,FGF13,FKBP4,GAK,GDI1,GFI1,GORASP1,HDAC2,HES1,HES5,HOOK3,ID2,ITM2C,KANK1,KIAA0319,KLK8,LINGO1,LPAR1,LRP4,MAG,MED1,MT3,NF1,NGEF,NGFR,NLGN1,NOG,NOTCH1,OMG,PAQR3,PAX6,PCM1,PTEN,PTPRO,RAB29,RAPGEF2,REST,RHOA,RNF10,RNF6,RTN4,RTN4R,RUFY3,SEMA5A,SIRT2,SIX3,SKI,SLIT2,SORL1,SOX11,SOX2,SOX3,SOX9,SPOCK1,SRGAP2,SRGAP2C,STMN2,THY1,TRPV4,WNT3A,WNT7A,YWHAH	Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
GO:0050769	GO	BP	positive regulation of neurogenesis	ABL2,ADRA2B,ADRA2C,AMIGO1,APOE,ARHGDIA,ARSB,ASCL1,ATOH1,AVIL,BCL11A,BDNF,BHLHB9,BIN1,BMP2,BMP5,BMP7,BRINP3,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CBFA2T2,CDKL5,CLCF1,COBL,CPEB3,CPNE1,CPNE5,CPNE6,CPNE9,CSF1,CTNNB1,CUL7,CUX1,CUX2,CXCR4,DAB2IP,DICER1,DISC1,DMD,DPYSL3,DRD2,DSCAM,ECT2,EPHA3,FAM134C,FBXW8,FES,FGFR1,FOXO6,FZD3,GOLGA4,GPER1,GPRC5B,HES1,HEYL,HOXD3,IL1RAPL1,IMPACT,ISLR2,ITSN2,KIDINS220,KIF20B,L1CAM,LIG4,LIMK1,LRP8,LTK,LYN,MACF1,MAGI2,MAPT,MARK2,MEF2C,MEGF8,MMD,MMD2,NBL1,NDNF,NDRG4,NEDD4L,NEURL1,NEUROD1,NEUROD2,NEUROG1,NGF,NGFR,NKX2-5,NLGN1,NOTCH1,NPTN,NRCAM,NRP1,NSMF,NTN1,NTRK1,NTRK2,NUMB,NUMBL,OBSL1,OPRM1,PACSIN1,PLK5,PRKCH,PRKCI,PRKD1,PROX1,PSEN1,PTK2B,PTK6,PTK7,PTPRD,RAP1A,RAPGEF1,RAPGEF2,RASAL1,RELN,RET,RGS14,RHOA,RIMS1,RIMS2,ROBO1,ROBO2,RUFY3,SCARF1,SCN1B,SEMA4D,SEMA5A,SEMA7A,SERPINE2,SERPINF1,SETX,SHANK1,SHANK3,SHTN1,SKIL,SLIT2,SMARCD3,SMURF1,SNW1,SNX3,SOX11,SOX8,SPEN,SRGAP2C,STMN2,SYT1,SYT17,SYT2,SYT3,SYT4,TCF3,TCF4,TENM3,TENM4,TRIM32,TWF2,UNC13A,VEGFA,VLDLR,VWC2,WNT2,WNT5A,ZEB1,ZNF335	Any process that activates or increases the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
GO:0050770	GO	BP	regulation of axonogenesis	ABL1,AMIGO1,APOE,ARHGDIA,ARHGEF1,BCL11A,BDNF,CDKL5,CHN1,CLASP2,CTTN,DCC,DNM2,DSCAM,EPHA4,EPHB3,FGF13,GDI1,GOLGA4,ISLR2,KIF13B,L1CAM,LIMK1,LINGO1,LRP4,LRRC4C,MACF1,MAG,MAPT,MARK2,MEGF8,MT3,NGF,NGFR,NRCAM,NRP1,NTN1,NTRK2,OLFM1,OMG,PTEN,PTPRO,RHOA,RNF6,ROBO1,ROBO2,RTN4,RTN4R,RUFY3,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SHTN1,SIPA1L1,SKIL,SLIT2,THY1,TWF2,VEGFA	Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
GO:0050771	GO	BP	negative regulation of axonogenesis	ARHGDIA,ARHGEF1,BCL11A,DCC,FGF13,GDI1,LINGO1,LRP4,MAG,MT3,NGFR,OMG,PTEN,PTPRO,RHOA,RNF6,RTN4,RTN4R,RUFY3,SEMA5A,SLIT2,THY1	Any process that stops, prevents, or reduces the frequency, rate or extent of axonogenesis.
GO:0050772	GO	BP	positive regulation of axonogenesis	AMIGO1,ARHGDIA,BCL11A,BDNF,CDKL5,DSCAM,GOLGA4,ISLR2,L1CAM,LIMK1,MACF1,MAPT,MEGF8,NGF,NGFR,NRP1,NTN1,NTRK2,RHOA,ROBO1,ROBO2,RUFY3,SEMA4D,SEMA5A,SEMA7A,SHTN1,SKIL,SLIT2,TWF2,VEGFA	Any process that activates or increases the frequency, rate or extent of axonogenesis.
GO:0050773	GO	BP	regulation of dendrite development	ADGRB3,APOE,ARF6,BCL11A,BHLHB9,BMP5,BMP7,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CDK5,CDK5R1,CDKL5,CFL1,CHRNA3,CHRNB2,COBL,CPEB3,CUL7,CUX1,CUX2,DAB2IP,DBN1,DCC,EFNA1,EPHA4,FBXW8,FOXO6,GORASP1,IL1RAPL1,KIAA0319,LRP8,LRRK2,MEF2C,NEDD4,NEURL1,NGEF,NLGN1,NSMF,OBSL1,PACSIN1,PDLIM5,PSEN1,PTEN,PTPRD,RAB17,RAP2A,RAPGEF2,RELN,SARM1,SDC2,SEMA4D,SHANK1,SHANK3,SIPA1L1,SRCIN1,SRGAP2C,TNIK,VLDLR,YWHAH	Any process that modulates the frequency, rate or extent of dendrite development.
GO:0050774	GO	BP	negative regulation of dendrite morphogenesis	EFNA1,GORASP1,NGEF,NLGN1,PTEN,RAPGEF2,YWHAH	Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis.
GO:0050775	GO	BP	positive regulation of dendrite morphogenesis	BHLHB9,CAMK2B,CAPRIN1,CAPRIN2,CDKL5,CUL7,CUX1,CUX2,FBXW8,IL1RAPL1,LRP8,OBSL1,PTPRD,RELN	Any process that activates or increases the frequency, rate or extent of dendrite morphogenesis.
GO:0050777	GO	BP	negative regulation of immune response	A2M,ALOX15,AMBP,ANXA1,APOA1,APOA2,ARRB2,BST2,C4BPA,C4BPB,CACTIN,CCR2,CD300A,CD55,CD84,COL3A1,CR1,CUEDC2,DHX58,DNAJA3,FER,FOXJ1,FOXP3,HAVCR2,HFE,HLA-A,HLA-B,HLA-DRB1,HLA-E,HLA-G,IFI16,IFNA2,IFNB1,IFNL1,IL10,INS,IRAK3,IRG1,JAK3,LGALS3,LGALS9,LILRB1,LILRB2,LYN,MASP1,MICA,MUL1,NLRC5,NR1H2,NR1H3,PPARG,PTPN2,PTPRC,RC3H1,RPS19,SAMSN1,SERPINB4,SERPINB9,SERPING1,SOCS5,SPINK5,SUSD4,TGFB1,TGFB2,TGFB3,THOC1,TNF,TNFAIP3,TNFSF4,TRAFD1,TRIM27,TYRO3,VIMP,XCL1	Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
GO:0050779	GO	BP	RNA destabilization	CPEB3,DXO,METTL14,METTL3,MEX3D,PUM1,TRIM71,ZC3H12A,ZC3H12D	Any process that decreases the stability of an RNA molecule, making it more vulnerable to degradative processes.
GO:0050786	GO	MF	RAGE receptor binding	HMGB1,HMGB2,S100A12,S100A8,S100A9	Interacting selectively and non-covalently with the RAGE receptor, the receptor for advanced glycation end-products.
GO:0050792	GO	BP	regulation of viral process	ADAR,ADARB1,APCS,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,APOE,BST2,BTBD17,C9orf69,CAV2,CCL3,CCL4,CCL5,CCNH,CCNK,CCNT1,CD28,CDK7,CDK9,CFL1,CHD1,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CTDP1,CXCL8,DDB1,DDX3X,DERL1,DYNLT1,EIF2AK2,EIF2AK4,ELL,EP300,ERCC2,ERCC3,FAM111A,FBLN1,FCN1,FCN3,GSN,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HACD3,HDAC1,HMGA2,HPN,HS3ST5,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNA2,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,JUN,LEF1,LGALS1,LGALS9,LTF,MAVS,MBL2,MDFIC,MID2,MNAT1,MVB12A,MVB12B,MX1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,NR5A2,OAS1,OAS3,OASL,P4HB,PARK2,PARP10,PC,PKN2,PLSCR1,PM20D1,PML,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU2F3,PPIA,PPIB,PPID,PPIE,PPIH,PROX1,PTX3,PVRL2,RAB7A,RAD23A,REST,RNASEL,RSAD2,RSF1,SLPI,SMARCA4,SMARCB1,SNF8,SNW1,SNX3,SP1,SP100,SRPK1,SRPK2,SSRP1,STAT1,STAU1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TAP1,TAP2,TARBP2,TARDBP,TBC1D20,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TMPRSS2,TNF,TNIP1,TOP2A,TRIM11,TRIM13,TRIM14,TRIM15,TRIM21,TRIM25,TRIM26,TRIM27,TRIM28,TRIM31,TRIM32,TRIM35,TRIM38,TRIM5,TRIM6,TRIM62,TRIM8,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,YTHDC2,ZC3H12A,ZC3HAV1,ZNF502,ZNF639	Any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts.
GO:0050795	GO	BP	regulation of behavior	ADAM10,ADAM17,AGRP,AHI1,AIF1,ANGPT2,ANO6,AZU1,C1QBP,C5,C5AR2,CALR,CAMK1D,CCL19,CCL2,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CDH13,CFAP20,CHRNB2,CMKLR1,CNTNAP4,CORO1B,CREB3,CRH,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,CXCR3,CXCR4,DAPK2,DSCAM,EDN2,EDN3,EFNB2,EIF2AK4,ELANE,F2RL1,F3,F7,FGF1,FGF16,FGF18,FGF2,FGF4,FGFR1,FIGF,GAS6,GHRH,GHRL,GREM1,HMGB1,HOXA1,HRG,HSPB1,HTR2B,IL12A,IL6,IL6R,INS,JAM3,KDR,KLRK1,LEPR,LGALS9,LYN,MEF2C,MEGF8,MET,MPP1,NBL1,NCKAP1L,NLGN1,NOTCH1,NOV,NR4A3,NRP1,NTF3,NTRK3,PADI2,PDGFB,PDGFRA,PDGFRB,PER3,PLA2G7,PPM1F,PRKD1,PRKD2,PTGDS,PTK2B,PTPN2,PTPRO,QRFP,RAC1,RAC2,RARRES2,RELN,ROBO1,ROBO2,S100A14,S100A7,SCG2,SEMA3A,SEMA5A,SERPINE1,SLIT2,STAP1,STAT3,STRA6,STX3,STX4,TGFB1,THBS1,THBS4,TIRAP,USP14,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZFHX3,ZNF580	Any process that modulates the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli.
GO:0050796	GO	BP	regulation of insulin secretion	ABCC8,ADCY5,ADRA2A,ADRA2C,AKAP5,ANO1,ARL2,ARL2BP,ARNTL,BAD,BLK,BMP8A,BRSK2,CACNA1A,CACNA1C,CACNA1D,CACNA1E,CACNA2D2,CAPN10,CCL5,CDK16,CFTR,CHRM3,CLOCK,DOC2B,EFNA5,ENSA,EPHA5,FAM3D,FFAR1,FOXA2,G6PC2,GCG,GCK,GHRL,GIP,GLP1R,GLUD1,GNAS,GPER1,GPLD1,HLA-DRB1,HNF4A,IFNG,IL1B,INHBB,INS,IQGAP1,IRS1,IRS2,ISL1,ITPR1,ITPR2,ITPR3,KCNA5,KCNB1,KCNC2,KCNG2,KCNJ11,KCNS3,MARCKS,MCU,MTNR1B,MYRIP,NEUROD1,NLGN2,NOS2,NOV,NR1D1,NR1H4,PARK2,PCSK1,PER2,PIM3,PPP3CB,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PSMD9,RAP1A,RAPGEF3,RAPGEF4,RBP4,REST,RFX3,RFX6,SEC11A,SEC11C,SFRP1,SIRT4,SLC25A4,SLC25A5,SLC25A6,SLC2A1,SLC2A2,SLC30A8,SLC8B1,SNAP25,SOX4,SPCS1,SPCS2,SPCS3,STX1A,STX4,STXBP1,STXBP4,SYT5,TCF7L2,TFAP2B,TMEM27,TNF,UQCC2,VAMP2	Any process that modulates the frequency, rate or extent of the regulated release of insulin.
GO:0050803	GO	BP	regulation of synapse structure or activity	ADGRL1,AGRN,ANAPC2,APOE,APP,ARF1,ARHGEF15,BDNF,BHLHB9,CAMK1,CAMK2A,CAMK2B,CDC20,CDK5,CHRNB2,CNTN4,CPEB3,CPLX2,CRIPT,CTNNA2,CUX2,DAB2IP,DBN1,DKK1,DLG4,DRD2,EIF2AK4,EIF4EBP2,EPHB1,EPHB2,EPHB3,FRMPD4,GHRL,GIPC1,GRIK2,KCNB1,KLK8,LRP4,LRRC4B,MEF2C,MUSK,NETO1,NEURL1,NEUROD2,NLGN1,NLGN2,NLGN3,NPTN,NRXN1,NSMF,PDLIM5,PICK1,PLK2,PPFIA3,PPP3CB,PPT1,PRKCZ,PTEN,PTK2B,RAB17,RAB3A,RAB3GAP1,RAPGEF2,RASGRF1,RELN,RGS14,ROBO2,SHANK2,SHANK3,SHISA9,SIPA1L1,SLC8A2,SLC8A3,SLIT1,SRPX2,STX4,SYNDIG1,SYNGAP1,SYNGR1,SYP,VAMP2,WNT7A,YWHAG,YWHAH	Any process that modulates the physical form or the activity of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
GO:0050804	GO	BP	modulation of synaptic transmission	ACHE,ADIPOQ,ADRA1A,ANAPC2,APOE,ARF1,ATAD1,ATP1A2,CAMK2A,CAMK2B,CDC20,CDK5,CHRFAM7A,CHRNA3,CHRNB2,CHRNB4,CNTN4,CNTNAP4,CPEB3,CPLX2,CUX2,DBN1,DLG4,DRD1,DRD2,DRD3,DRD4,DTNBP1,EIF2AK4,EIF4EBP2,FLOT1,GDNF,GIPC1,GPER1,GPM6B,GRIK1,GRIK2,GRIK3,GRIN1,HAP1,KCNB1,KCNMB4,LGI1,LRP8,LRRK2,MAPK8IP2,MEF2C,MTMR2,NETO1,NEURL1,NEUROD2,NLGN1,NLGN2,NLGN3,NLGN4X,NOS1,NPTN,NRXN1,NSMF,PARK2,PER2,PICK1,PLK2,PPFIA3,PPP3CB,PRKCZ,PTEN,PTK2B,PXK,RAB3A,RAB3B,RAB3GAP1,RAB5A,RAPGEF2,RASGRF1,RELN,RGS14,RIMS1,RIMS2,RIMS3,RIMS4,SEPT5,SHANK1,SHANK2,SHANK3,SHISA9,SIPA1L1,SLC30A1,SLC8A2,SLC8A3,SNCA,SNCAIP,STX1B,STX4,STXBP1,SYN1,SYN3,SYNGAP1,SYNGR1,SYNJ1,SYP,SYT1,SYT11,TOR1A,UNC13A,UNC13B,USP46,VAMP2,WNT7A,YWHAG,YWHAH	Any process that modulates the frequency or rate of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
GO:0050805	GO	BP	negative regulation of synaptic transmission	ACHE,ADIPOQ,ARF1,ATAD1,CHRFAM7A,DRD2,GPM6B,GRIK3,LRRK2,MTMR2,NLGN4X,NOS1,PARK2,PICK1,PLK2,PTEN,SHANK2,SLC30A1,SNCA,STXBP1,SYT11	Any process that stops, prevents, or reduces the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
GO:0050806	GO	BP	positive regulation of synaptic transmission	ADRA1A,CUX2,DLG4,DRD1,DRD2,DRD4,DTNBP1,FLOT1,GPER1,GRIK2,GRIN1,HAP1,LGI1,NLGN1,NLGN2,NLGN3,NPTN,NRXN1,PARK2,PLK2,PRKCZ,PTEN,PTK2B,RAB3B,RAB3GAP1,RELN,RGS14,RIMS1,RIMS2,SHANK1,SHANK2,SHANK3,SLC8A2,SLC8A3,STX1B,STX4,SYNJ1,SYT1,TOR1A,UNC13B,VAMP2,WNT7A	Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
GO:0050807	GO	BP	regulation of synapse organization	ADGRL1,AGRN,ANAPC2,APOE,ARHGEF15,BDNF,BHLHB9,CAMK1,CAMK2B,CDC20,CHRNB2,CRIPT,CTNNA2,CUX2,DAB2IP,DKK1,EPHB1,EPHB2,EPHB3,FRMPD4,GHRL,KLK8,LRP4,LRRC4B,MEF2C,MUSK,NEURL1,NEUROD2,NLGN1,NLGN2,NLGN3,NRXN1,PDLIM5,PTEN,RAB17,RELN,ROBO2,SHANK3,SLIT1,SRPX2,SYNDIG1,WNT7A	Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
GO:0050808	GO	BP	synapse organization	ACHE,ADGRL3,AGRN,APOE,BDNF,CACNB2,CDK5,CHRNA1,CHRNB1,CNTN2,CTNND2,DBNL,DLG4,DNAJA3,DNER,DNM3,DRD1,DRD2,DSCAM,DVL1,ELFN1,F2R,FARP1,FLRT3,FZD1,FZD5,GPM6A,IL1RAPL1,LRP4,LRRK2,MUSK,NLGN1,NLGN2,NLGN3,NLGN4X,NRCAM,NRD1,NRXN1,NRXN2,PAK3,PCDHB10,PCDHB11,PCDHB13,PCDHB14,PCDHB16,PCDHB2,PCDHB3,PCDHB4,PCDHB5,PCDHB6,PCDHB9,PIN1,PLXND1,POU4F1,PTEN,PTPRD,RAB39B,RYK,SDK1,SDK2,SEMA3E,SHANK1,SHANK2,SHANK3,SLITRK6,SPOCK2,SYNDIG1,WNT3A,WNT5A,WNT7A,WNT7B,ZC4H2	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
GO:0050810	GO	BP	regulation of steroid biosynthetic process	ABCG1,AKR1C3,APOE,BMP2,BMP5,BMP6,CYP27B1,CYP7A1,DKK3,ERLIN1,ERLIN2,FGF1,FGF19,FGFR4,GFI1,IFNG,IL1B,NFKB1,NR1D1,NR1H4,NR5A1,PRKAA1,PROX1,REST,SCAP,SEC14L2,SIRT1,SNAI1,SNAI2,SOD1,TNF,VDR,WNT4	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
GO:0050811	GO	MF	GABA receptor binding	ARFGEF2,GABARAPL1,GABARAPL2,JAKMIP1,PLCL2,TRAK2	Interacting selectively and non-covalently with the gamma-aminobutyric acid (GABA, 4-aminobutyrate) receptor.
GO:0050818	GO	BP	regulation of coagulation	ADAMTS18,ALOX12,ANO6,APOE,APOH,ASIC2,C1QTNF1,CAV1,CD34,CLEC4M,DMTN,EDN1,ENPP4,F11,F12,F2,F2R,F2RL1,F3,FAM46A,FAP,FGA,FGB,FGG,FOXA2,GP1BA,HPSE,HRG,HS3ST5,KLKB1,KNG1,KRT1,LBH,LYN,NOS3,PDGFA,PDGFB,PDGFRA,PLAT,PLAU,PLAUR,PLEK,PLG,PRKCA,PRKCD,PRKCQ,PRKG1,PROC,PROCR,SCARA5,SELP,SERPINB2,SERPINE1,SERPINE2,SERPINF2,STAB2,STX2,STXBP5,SYK,TC2N,TEC,THBD,THBS1,TLR4,TMPRSS6,USF1,VAV2,VTN	Any process that modulates the frequency, rate or extent of coagulation, the process in which a fluid solution, or part of it, changes into a solid or semisolid mass.
GO:0050819	GO	BP	negative regulation of coagulation	ADAMTS18,ALOX12,APOE,APOH,C1QTNF1,CD34,EDN1,F11,F12,F2,FGA,FGB,FGG,GP1BA,HRG,HS3ST5,KLKB1,KNG1,KRT1,NOS3,PDGFA,PDGFB,PDGFRA,PLAT,PLAU,PLAUR,PLG,PRKCD,PRKG1,PROC,PROCR,SERPINB2,SERPINE1,SERPINE2,SERPINF2,THBD,TMPRSS6,VTN	Any process that stops, prevents, or reduces the frequency, rate or extent of coagulation.
GO:0050821	GO	BP	protein stabilization	A1CF,AAK1,ANK2,APOA1,ATP1B1,ATP1B2,ATP1B3,BAG6,CALR,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CDKN2A,CHEK2,CHP1,CLU,COG3,COG7,CPN2,CREB1,CREBL2,CRTAP,CSN3,DNAJA3,DSC3,DSG1,DVL1,DVL3,EP300,FBXW7,FLNA,FLOT2,GAPDH,GNAQ,GOLGA7,GPIHBP1,GTPBP4,HCFC1,HIST1H1B,HSPA1A,HSPA1B,HSPD1,IFT46,IGF1,LAMP1,LAMP2,MORC3,MSX1,MT3,MUL1,NAA15,NAA16,NAPG,NLK,P3H1,PARK2,PARK7,PDCD10,PEX19,PEX6,PFN1,PFN2,PHB,PHB2,PIK3R1,PIM2,PIN1,PINK1,PLPP3,PML,PPARGC1A,PPIB,PRKCD,PTEN,RASSF1,RASSF2,SEL1L,SMAD3,SMAD7,SOX17,SOX4,STK3,STK4,STX12,STXBP4,SUMO1,SWSAP1,SYVN1,TAF9,TAF9B,TBRG1,TCP1,TELO2,TESC,TMEM88,TNIP2,TSC1,TSPAN1,UBE2B,USP13,USP19,USP2,USP33,USP7,VHL,WFS1,WIZ,WNT10B,ZBED3,ZNF207,ZSWIM7	Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
GO:0050829	GO	BP	defense response to Gram-negative bacterium	ADM,APP,AZU1,B2M,CALCA,CAMP,CHGA,DEFA4,DROSHA,FCN2,HMGB2,IL12B,IL23A,IL23R,IL6,IL6R,LBP,NLRP10,NOS2,NPY,OPTN,PRB3,PYCARD,RNASE7,S100A7,SELP,SERPINE1,SLC11A1,TAC1,TLR4,TLR9,VIP	Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
GO:0050830	GO	BP	defense response to Gram-positive bacterium	ADAM17,ADM,ANG,APP,B2M,C10orf99,CALCA,CAMP,CHGA,CRP,DEFA1,DEFA3,DEFA4,DEFB1,DROSHA,FAU,FCN2,FGR,H2BFS,HIST1H2BC,HIST1H2BE,HIST1H2BJ,HIST1H2BK,HIST2H2BE,HLA-A,HLA-E,HMGB2,IL6,IL6R,LBP,MBL2,MYD88,NPY,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,PLA2G1B,PLA2G2A,REG3G,RNASE3,RNASE7,RPL39,SPACA3,TAC1,TIRAP,TLR2,VIP	Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
GO:0050832	GO	BP	defense response to fungus	ANG,APP,C10orf99,CALCA,CAMP,CLEC6A,HRG,IL36RN,LTF,NLRP10,NPY,S100A12,S100A8,S100A9,TAC1,VIP	Reactions triggered in response to the presence of a fungus that act to protect the cell or organism.
GO:0050839	GO	MF	cell adhesion molecule binding	ACTN1,ACTN2,ACTN3,ACTN4,ADAM10,ADAM11,ADAM15,ADAM2,ADAM22,ADAM23,ADAM9,ADAMTS13,ADAMTS5,ADAMTS8,ADGRL1,ANK3,CDH1,CDH13,CDK5R1,COL16A1,COL3A1,COL4A3,COL5A1,CTNNA3,DMP1,ECM2,EGFL6,FBLN1,FBLN5,FCER2,FERMT3,FGA,FGB,FN1,FXYD5,ICAM1,ICAM4,IGF1,ITGA4,ITGAL,ITGB1BP1,ITGB2,ITGB7,LAMA5,LTBP4,MADCAM1,NDRG1,NLGN1,NLGN2,NLGN3,NLGN4X,NLGN4Y,NPNT,NPTN,NRXN1,NRXN2,NRXN3,OLFM4,PTPRD,PTPRM,SFRP2,SLC14A2,SRC,TENM2,TGFBI,THBS1,THBS4,TNXB,VCAM1,VCL,VTN	Interacting selectively and non-covalently with a cell adhesion molecule.
GO:0050840	GO	MF	extracellular matrix binding	ACHE,ADAM9,AGRN,BCAM,COL11A1,CTSS,DAG1,GPC1,ITGAV,ITGB3,LACRT,LGALS3,LRRC15,NID1,PLEKHA2,SHH,SLIT2,SSC5D,THBS1,VEGFA	Interacting selectively and non-covalently with a component of the extracellular matrix.
GO:0050848	GO	BP	regulation of calcium-mediated signaling	ACTN3,AKAP6,ATP2B4,CCL3,CCL4,CDH13,CHP1,CHP2,CIB1,CMKLR1,GBP1,GPR143,IGF1,ITPR1,LMCD1,NEUROD2,P2RX2,P2RX3,P2RX4,P2RX5,PLEK,PRNP,RGN,SLA2,SLC9A1,SPPL3,TMBIM4,TRAT1,TREM2	Any process that modulates the frequency, rate or extent of calcium-mediated signaling, the process in which a cell uses calcium ions to convert an extracellular signal into a response.
GO:0050849	GO	BP	negative regulation of calcium-mediated signaling	ACTN3,ATP2B4,CHP1,ITPR1,PLEK,PRNP,SLA2	Any process that stops, prevents, or reduces the frequency, rate or extent of calcium-mediated signaling.
GO:0050850	GO	BP	positive regulation of calcium-mediated signaling	AKAP6,CCL3,CCL4,CDH13,CHP2,CIB1,IGF1,LMCD1,NEUROD2,P2RX2,P2RX3,P2RX4,P2RX5,SLC9A1,SPPL3,TRAT1,TREM2	Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling.
GO:0050851	GO	BP	antigen receptor-mediated signaling pathway	BAX,BCAR1,BCL10,BCL2,BLK,BTK,BTN3A1,BTRC,CARD11,CD247,CD38,CD3D,CD3E,CD3G,CD4,CD79A,CHUK,CSK,CTLA4,CUL1,ENAH,FBXW11,FYB,FYN,GATA3,GRAP2,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IKBKB,IKBKG,INPP5D,ITK,LAT,LAT2,LCK,LCP2,MALT1,MAP3K7,MEF2C,MNDA,NCK1,NCKAP1L,NFATC2,NFKB1,NFKBIA,PAG1,PAK1,PAK2,PAK3,PDE4B,PDE4D,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PLCG1,PLCG2,PLEKHA1,PRKCB,PRKCQ,PRKD2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTPRC,PTPRJ,RBCK1,RELA,RFTN1,RIPK2,RNF31,RPS27A,SKAP1,SKP1,SLA2,SPG21,SPPL3,STOML2,SYK,TAB2,TEC,THEMIS,THY1,TNFRSF21,TRAF6,TRAT1,TXK,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2N,UBE2V1,VASP,VAV3,WAS,ZAP70	A series of molecular signals initiated by the cross-linking of an antigen receptor on a B or T cell.
GO:0050852	GO	BP	T cell receptor signaling pathway	BCAR1,BCL10,BTN3A1,BTRC,CARD11,CD247,CD3D,CD3E,CD3G,CD4,CHUK,CSK,CUL1,ENAH,FBXW11,FYB,FYN,GATA3,GRAP2,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IKBKB,IKBKG,INPP5D,ITK,LAT,LCK,LCP2,MALT1,MAP3K7,NCK1,NFKB1,NFKBIA,PAG1,PAK1,PAK2,PAK3,PDE4B,PDE4D,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3R1,PIK3R2,PLCG1,PLCG2,PRKCQ,PRKD2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTPRC,PTPRJ,RBCK1,RELA,RFTN1,RIPK2,RNF31,RPS27A,SKAP1,SKP1,SPPL3,STOML2,TAB2,THEMIS,THY1,TNFRSF21,TRAF6,TRAT1,TXK,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2N,UBE2V1,VASP,WAS,ZAP70	A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
GO:0050853	GO	BP	B cell receptor signaling pathway	BAX,BCAR1,BCL2,BLK,BTK,CD38,CD79A,CTLA4,LAT2,MEF2C,MNDA,NCKAP1L,NFATC2,PIK3CD,PLCG2,PLEKHA1,PRKCB,PTPRC,RFTN1,SYK,TEC,VAV3	A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
GO:0050854	GO	BP	regulation of antigen receptor-mediated signaling pathway	CD300A,DUSP3,EZR,GBP1,GCSAM,KCNN4,LCK,LGALS3,LPXN,LYN,NFAM1,PHPT1,PRKCB,PRKCH,PRKD2,PRNP,PTPN2,PTPN22,PTPRC,PTPRJ,RC3H1,STAP1,TESPA1,THY1,TRAT1	Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B- or T cell.
GO:0050855	GO	BP	regulation of B cell receptor signaling pathway	CD300A,GCSAM,LPXN,LYN,NFAM1,PRKCB,PRKCH,PTPN22,STAP1	Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell.
GO:0050856	GO	BP	regulation of T cell receptor signaling pathway	CD300A,DUSP3,EZR,GBP1,KCNN4,LCK,LGALS3,PHPT1,PRKD2,PRNP,PTPN2,PTPN22,PTPRJ,RC3H1,TESPA1,THY1,TRAT1	Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
GO:0050857	GO	BP	positive regulation of antigen receptor-mediated signaling pathway	KCNN4,LCK,NFAM1,PRKCB,PRKCH,PRKD2,PTPRC,STAP1,TESPA1,TRAT1	Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B- or T cell.
GO:0050858	GO	BP	negative regulation of antigen receptor-mediated signaling pathway	CD300A,DUSP3,EZR,GBP1,LGALS3,LPXN,PHPT1,PRNP,PTPN2,PTPN22,PTPRJ,THY1	Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B- or T cell.
GO:0050860	GO	BP	negative regulation of T cell receptor signaling pathway	DUSP3,EZR,GBP1,LGALS3,PHPT1,PRNP,PTPN2,PTPN22,PTPRJ,THY1	Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
GO:0050862	GO	BP	positive regulation of T cell receptor signaling pathway	KCNN4,LCK,PRKD2,TESPA1,TRAT1	Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
GO:0050863	GO	BP	regulation of T cell activation	ADAM8,AGER,AIF1,AKT1,ANXA1,BMP4,BTLA,BTN2A2,CAMK4,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CCR7,CD1D,CD2,CD209,CD24,CD247,CD274,CD276,CD28,CD300A,CD3D,CD3E,CD3G,CD4,CD46,CD47,CD55,CD6,CD80,CD86,CDC42,CDKN2A,CEBPB,CLC,CLPTM1,CSK,CTLA4,DPP4,DUSP3,EBI3,FADD,FLOT2,FOXJ1,FOXP3,FYN,GATA3,GLI2,GLI3,GLMN,GRAP2,GRB2,GSN,HAVCR2,HFE,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNA2,IFNB1,IFNG,IFNL1,IGF1,IGF2,IGFBP2,IHH,IL10,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL27,IL4,IL6,IL6ST,IL7,IRF1,IRF4,JAK3,KIAA0922,KLRK1,LAT,LAX1,LCK,LEP,LGALS3,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MLST8,MTOR,MYB,NCK1,NCK2,NCKAP1L,NKAP,NLRP3,NOD2,PAG1,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PRELID1,PRKAR1A,PRKCQ,PRKCZ,PRNP,PRR5,PTPN11,PTPN2,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RC3H1,RICTOR,RIPK3,SART1,SFTPD,SHH,SIRPG,SIT1,SOCS5,SOD1,SPINK5,SRC,TESPA1,TGFBR2,THY1,TIGIT,TMIGD2,TNFRSF14,TNFRSF21,TNFSF11,TNFSF18,TNFSF4,TRAF2,TRAF6,VAV1,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZC3H8,ZP3,ZP4	Any process that modulates the frequency, rate or extent of T cell activation.
GO:0050864	GO	BP	regulation of B cell activation	AHR,ATM,BCL2,BTK,CD27,CD300A,CD38,CD74,CD81,CDKN2A,CHRNB2,CLCF1,CTLA4,FOXJ1,GPR183,IKZF3,IL10,IL2,IL21,IL4,IL6,IL7,INHA,INHBA,IRS2,MEF2C,MIF,MMP14,MNDA,MZB1,NCKAP1L,NFATC2,NOD2,PAXIP1,PTPRC,RC3H1,SAMSN1,SFRP1,SLA2,SUPT6H,SYK,TCF3,TGFB1,THOC1,TIRAP,TNFAIP3,TNFRSF21,TNFRSF4,TNFSF13,TNFSF13B,TNFSF4,TNIP2,VAV3,XBP1	Any process that modulates the frequency, rate or extent of B cell activation.
GO:0050866	GO	BP	negative regulation of cell activation	ADAMTS18,ALOX12,ANXA1,APOE,ATM,BMP4,BPI,BTN2A2,C1QTNF1,CCR2,CD274,CD300A,CD84,CDKN2A,CEBPB,CTLA4,DUSP3,F2,FER,FOXJ1,FOXP3,GLI3,GLMN,GPER1,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,IL31RA,INHA,INHBA,IRF1,JAK3,KIAA0922,LAX1,LGALS3,LGALS9,LILRB1,LILRB2,LST1,MICA,MILR1,MNDA,NOS3,NR1H3,PDCD1LG2,PDGFA,PDGFB,PDGFRA,PIBF1,PRKAR1A,PRKCD,PRKG1,PRNP,PTPN2,PTPN22,RC3H1,SAMSN1,SERPINE2,SFRP1,SFTPD,SLA2,SOCS5,SOX11,THBD,THOC1,TIGIT,TNFAIP3,TNFRSF21,TNFSF4,XCL1,ZC3H12A,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate or extent of cell activation.
GO:0050867	GO	BP	positive regulation of cell activation	ADAM8,AGER,AIF1,AKT1,ANXA1,AP1G1,AXL,BCL2,BTK,BTLA,CAPN3,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CCR7,CD1D,CD2,CD226,CD24,CD247,CD27,CD274,CD276,CD28,CD38,CD3D,CD3E,CD3G,CD4,CD46,CD47,CD55,CD6,CD74,CD80,CD81,CD86,CDC42,CHRNB2,CLCF1,CSK,CTLA4,DMTN,DPP4,EBI3,F2RL1,FADD,FGF10,FGR,FLOT2,FOXP3,FYN,GAB2,GAS6,GATA3,GLI2,GLI3,GPR183,GRAP2,GRB2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL33,IL4,IL6,IL6ST,IL7,IRS2,KLRK1,LAMP1,LBP,LCK,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MEF2C,MIF,MLST8,MMP14,MTOR,MYB,NCK1,NCK2,NCKAP1L,NFATC2,NKAP,NLRP3,NOD2,NR4A3,PAK1,PAK2,PAK3,PAXIP1,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PLEK,PNP,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PVRL2,PYCARD,RAC1,RARA,RASAL3,RICTOR,RPS6KA1,SART1,SELP,SHH,SIRPG,SNX4,SOCS5,SOX15,SPACA3,SRC,STAP1,STX4,SYK,TCF3,TESPA1,TGFB1,TGFBR2,THBS1,THY1,TIRAP,TLR4,TMIGD2,TNFRSF14,TNFRSF4,TNFSF11,TNFSF13,TNFSF13B,TNFSF4,TNIP2,TRAF2,TRAF6,VAMP7,VAMP8,VAV1,VAV3,VCAM1,VNN1,WNT5A,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZNF335,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of activation.
GO:0050868	GO	BP	negative regulation of T cell activation	ANXA1,BMP4,BTN2A2,CD274,CD300A,CDKN2A,CEBPB,CTLA4,DUSP3,FOXJ1,FOXP3,GLI3,GLMN,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,IRF1,JAK3,KIAA0922,LAX1,LGALS3,LGALS9,LILRB1,LILRB2,PDCD1LG2,PRKAR1A,PRNP,PTPN2,PTPN22,RC3H1,SFTPD,SOCS5,TIGIT,TNFRSF21,TNFSF4,XCL1,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation.
GO:0050869	GO	BP	negative regulation of B cell activation	ATM,CD300A,CDKN2A,CTLA4,FOXJ1,IL10,INHA,INHBA,MNDA,RC3H1,SAMSN1,SFRP1,SLA2,THOC1,TNFAIP3,TNFRSF21	Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation.
GO:0050870	GO	BP	positive regulation of T cell activation	ADAM8,AGER,AIF1,AKT1,ANXA1,BTLA,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CD1D,CD24,CD247,CD274,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD46,CD47,CD55,CD6,CD80,CD86,CDC42,CSK,CTLA4,DPP4,EBI3,FADD,FLOT2,FOXP3,FYN,GATA3,GLI2,GLI3,GRAP2,GRB2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,KLRK1,LCK,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MLST8,MTOR,MYB,NCK1,NCK2,NCKAP1L,NKAP,NLRP3,NOD2,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RICTOR,SART1,SHH,SIRPG,SOCS5,SRC,TESPA1,TGFBR2,THY1,TMIGD2,TNFRSF14,TNFSF11,TNFSF4,TRAF2,TRAF6,VAV1,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of T cell activation.
GO:0050871	GO	BP	positive regulation of B cell activation	BCL2,BTK,CD27,CD38,CD74,CD81,CHRNB2,CLCF1,GPR183,IL2,IL21,IL4,IL6,IL7,IRS2,MEF2C,MIF,MMP14,NCKAP1L,NFATC2,NOD2,PAXIP1,PTPRC,SYK,TCF3,TGFB1,TIRAP,TNFRSF4,TNFSF13,TNFSF13B,TNFSF4,TNIP2,VAV3,XBP1	Any process that activates or increases the frequency, rate or extent of B cell activation.
GO:0050872	GO	BP	white fat cell differentiation	ADIG,CTBP1,CTBP2,PER2,PPARG,SIRT1	The process in which a relatively unspecialized cell acquires specialized features of a white adipocyte, an animal connective tissue cell involved in energy storage. White adipocytes have cytoplasmic lipids arranged in a unique vacuole.
GO:0050873	GO	BP	brown fat cell differentiation	ADIG,ADIPOQ,METRNL,PPARGC1A,PRDM16,UCP1,ZNF516	The process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.
GO:0050880	GO	BP	regulation of blood vessel size	ACE,ACE2,ADCY6,ADM,ADRA1A,AGT,AGTR1,AGTR2,BDKRB2,BMPR2,CALCA,CAV1,CPS1,CRP,DOCK4,DOCK5,ECE1,EDN1,EDN2,EDN3,EDNRA,EDNRB,EPHX2,F2R,F2RL1,FGA,FGB,FGG,GCLC,GCLM,GPER1,HMOX1,HTR2B,INS,ITGB1BP1,KCNMB2,KCNMB4,KEL,NOS1,NOS3,NPPB,NPR1,PER2,PIK3C2A,SCPEP1,SERPINF2,SLC8A1,SMTNL1,SOD1,SOD2	Any process that modulates the size of blood vessels.
GO:0050881	GO	BP	musculoskeletal movement	CCDC78,CHRNA1,CHRND,DRD3,GAA,JSRP1,MYH14,MYH3,MYH7,MYH8,RCSD1,STAC3,TNNC2,TNNI2,TNNT1,TNNT3,VTI1A	The movement of an organism or part of an organism using mechanoreceptors, the nervous system, striated muscle and/or the skeletal system.
GO:0050885	GO	BP	neuromuscular process controlling balance	CDH23,CLN3,CLRN1,MYO7A,NRXN1,PAFAH1B1,PCDH15,SHANK1,TPP1,USH1C,USH1G	Any process that an organism uses to control its balance, the orientation of the organism (or the head of the organism) in relation to the source of gravity. In humans and animals, balance is perceived through visual cues, the labyrinth system of the inner ears and information from skin pressure receptors and muscle and joint receptors.
GO:0050886	GO	BP	endocrine process	ACE,ACE2,AGT,AGTR1,AGTR2,ANPEP,ATP6AP2,CMA1,CORIN,CPA3,CRHR1,CTSG,CTSZ,CYP11B2,ECE1,EDN1,EDN2,EDN3,ENPEP,GHRL,INHBA,MME,NOS3,RASL10B,REN,SERPINF2,TBX3	The process that involves the secretion of or response to endocrine hormones. An endocrine hormone is a hormone released into the circulatory system.
GO:0050890	GO	BP	cognition	ABCA7,ADCY3,ADCY8,APP,ATAD1,BBS4,BHLHB9,CALB1,CAMK4,CBR3,CHD7,CHMP2B,CHRNA4,CHRNA7,CHRNB2,CLDN5,CLN3,CNTNAP2,CPEB3,CRH,CRHBP,CTNS,CUX2,CYFIP1,DGCR2,DLG4,DOPEY2,DRD1,DRD2,DRD3,EGFR,EIF2AK4,EIF4EBP2,FGF13,FOXB1,FYN,GALR2,GALR3,GNAS,GPR155,GRIN1,GRIN2A,GRIN2B,GRM5,GTF2A1L,HLA-DRA,HOXA1,JAKMIP1,KLK8,LCE1D,LHCGR,LINS1,MAGT1,MAPK8IP2,MEF2C,MUSK,NETO1,NF1,NIPBL,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,NTF4,NTRK2,OR52B4,PAFAH1B1,PJA2,PLCB1,PLK2,PPP3CB,PTCHD1,PTEN,PTPRZ1,RASGRF1,RGS14,RP9,S100B,SGK1,SHANK1,SHANK2,SHANK3,SHROOM4,SLC1A4,SLC8A2,SLC8A3,SOBP,ST3GAL4,STRA6,TH,TMPRSS11E,TTC8,TUSC3,VLDLR	The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
GO:0050891	GO	BP	multicellular organismal water homeostasis	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ALOX12,ALOX12B,ALOXE3,AQP1,AQP2,AQP3,AQP4,AVP,AVPR2,BPIFA1,CLDN1,CLDN4,CYP11B2,CYP4F12,GNAS,HAS2,HYAL2,KDF1,KRT16,MYO5B,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,RAB11A,RAB11FIP2,SCNN1A,SCNN1B,SCNN1G,SFN,TFAP2B,TMEM79,TP63,TRPV4,WFS1	Any process involved in the maintenance of an internal steady state of water within a tissue, organ, or a multicellular organism.
GO:0050892	GO	BP	intestinal absorption	ABCG5,ABCG8,ADRA2A,AKR1C1,CD36,CEL,F11R,KCNQ1,LDLR,LEP,NPC1L1,SLC26A6,SLC46A1,SOAT2,TJP2	Any process in which nutrients are taken up from the contents of the intestine.
GO:0050900	GO	BP	leukocyte migration	ADAM8,ADGRE2,AIMP1,AMICA1,ANGPT1,ANGPT2,ANGPT4,ANXA1,APOB,ATP1B1,ATP1B2,ATP1B3,AZU1,BSG,CALCA,CAV1,CCL11,CCL13,CCL19,CCL2,CCL21,CCL23,CCL24,CCL3,CCL5,CCL7,CCR1,CCR2,CCR5,CCR6,CCR7,CD177,CD2,CD244,CD34,CD44,CD47,CD48,CD58,CD74,CD84,CEACAM1,CEACAM6,CEACAM8,CHGA,CKLF,COL1A1,COL1A2,CX3CL1,CXADR,CXCL10,CXCL11,CXCL13,CXCL3,CXCL8,CXCR1,CXCR2,CXCR4,DOK2,EDN2,EDN3,EDNRB,EPS8,ESAM,F11R,F2,F2RL1,FCER1G,FER,FFAR2,FLT1,FN1,FOXJ1,FYN,GAS6,GATA3,GBF1,GCNT1,GLG1,GOLPH3,GP6,GRB14,GRB2,GRB7,HCK,HMGB1,HRAS,IL10,IL6,IL6R,INPP5D,IRAK4,ITGA3,ITGA4,ITGA5,ITGA6,ITGAL,ITGAM,ITGAV,ITGAX,ITGB1,ITGB2,ITGB3,ITGB7,JAM2,JAM3,KIT,KRAS,L1CAM,LCK,LGALS3,LYN,LYST,MADCAM1,MAG,MERTK,MIF,MMP1,MYH9,MYO1G,NCKAP1L,NLRP10,NRAS,OLR1,PDE4B,PDGFB,PECAM1,PF4,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIK3R1,PIK3R2,PIP5K1C,PLA2G1B,PLCG1,PODXL2,PPIA,PPIL2,PROC,PROCR,PROS1,PTPN11,PTPN6,PTPRO,RET,ROCK1,RPS19,S100A12,S100A8,S100A9,S1PR1,SAA1,SBDS,SCG2,SELE,SELL,SELP,SELPLG,SFTPD,SHC1,SIRPA,SIRPG,SLC16A1,SLC16A3,SLC16A8,SLC3A2,SLC7A10,SLC7A11,SLC7A5,SLC7A6,SLC7A7,SLC7A8,SLC7A9,SOS1,SPN,SRC,SYK,TBX21,TEK,TGFB2,THBD,TNF,TNFRSF11A,TNFSF11,TREM1,TRPM4,UMOD,VCAM1,VEGFA,XCL1,YES1,ZAP70	The movement of a leukocyte within or between different tissues and organs of the body.
GO:0050901	GO	BP	leukocyte tethering or rolling	GCNT1,GOLPH3,ITGA4,ITGB1,ITGB7,MADCAM1,PODXL2,ROCK1,SELE,TNF,VCAM1	Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection).
GO:0050905	GO	BP	neuromuscular process	AGTPBP1,CDH23,CHRNA1,CHRND,CLN3,CLRN1,CTNNA2,DRD1,DRD2,DRD3,GCH1,GLRA1,GLRB,GRID2,HOXA1,KCNA1,MYO7A,NRXN1,PAFAH1B1,PCDH15,PRRT2,PTEN,SHANK1,STRA6,TPP1,USH1C,USH1G	Any process pertaining to the functions of the nervous and muscular systems of an organism.
GO:0050906	GO	BP	detection of stimulus involved in sensory perception	ANO1,AZGP1,CA6,CACNA1F,CACNA2D4,CNGB1,COL11A1,CST1,CST2,CST4,EPHB1,EYS,GNAT1,GNAT2,GRM6,HPN,KCNA1,KCNK4,KIT,LPO,MKKS,MMP24,OR10A3,OR10A5,OR1C1,OR1D2,OR1D5,OR1E1,OR1Q1,OR2C1,OR2D2,OR2H2,OR2M4,OR2S2,OR3A1,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR8B8,OR8G1,PIEZO2,PIGR,PIP,PKD1L3,PKD2L1,RPE65,RTP3,RTP4,SDR16C5,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8,TAS2R9,TULP1	The series of events involved in sensory perception in which a sensory stimulus is received and converted into a molecular signal.
GO:0050907	GO	BP	detection of chemical stimulus involved in sensory perception	AZGP1,CA6,CST1,CST2,CST4,LPO,OR10A3,OR10A5,OR1C1,OR1D2,OR1D5,OR1E1,OR1Q1,OR2C1,OR2D2,OR2H2,OR2M4,OR2S2,OR3A1,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR8B8,OR8G1,PIGR,PIP,PKD1L3,PKD2L1,RTP3,RTP4,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8,TAS2R9	The series of events in which a chemical stimulus is received and converted into a molecular signal as part of sensory perception.
GO:0050908	GO	BP	detection of light stimulus involved in visual perception	CACNA1F,CACNA2D4,CNGB1,EYS,GNAT1,GNAT2,GRM6,RPE65,SDR16C5,TULP1	The series of events involved in visual perception in which a light stimulus is received and converted into a molecular signal.
GO:0050909	GO	BP	sensory perception of taste	ASIC1,ASIC2,ASIC3,AZGP1,CA6,CALHM1,CD36,CST1,CST2,CST4,LPO,PIGR,PIP,PKD1L3,PKD2L1,RTP3,RTP4,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R60,TAS2R7,TAS2R8,TAS2R9	The series of events required for an organism to receive a gustatory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Gustation involves the direct detection of chemical composition, usually through contact with chemoreceptor cells. This is a neurological process.
GO:0050911	GO	BP	detection of chemical stimulus involved in sensory perception of smell	OR10A3,OR10A5,OR1C1,OR1D2,OR1D5,OR1E1,OR1Q1,OR2C1,OR2D2,OR2H2,OR2M4,OR2S2,OR3A1,OR4D1,OR51B4,OR51B5,OR51B6,OR51E2,OR51I1,OR51I2,OR51J1,OR51M1,OR51V1,OR52A5,OR52D1,OR5AC2,OR5F1,OR6A2,OR6C2,OR6C3,OR8B8,OR8G1	The series of events involved in the perception of smell in which an olfactory chemical stimulus is received and converted into a molecular signal.
GO:0050912	GO	BP	detection of chemical stimulus involved in sensory perception of taste	AZGP1,CA6,CST1,CST2,CST4,LPO,PIGR,PIP,PKD1L3,PKD2L1,RTP3,RTP4,TAS1R1,TAS1R2,TAS1R3,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R7,TAS2R8,TAS2R9	The series of events involved in the perception of taste in which a gustatory chemical stimulus is received and converted into a molecular signal.
GO:0050913	GO	BP	sensory perception of bitter taste	AZGP1,CA6,CALHM1,CST1,CST2,CST4,LPO,PIGR,PIP,RTP3,RTP4,TAS2R1,TAS2R10,TAS2R13,TAS2R14,TAS2R16,TAS2R3,TAS2R30,TAS2R31,TAS2R38,TAS2R39,TAS2R4,TAS2R40,TAS2R43,TAS2R46,TAS2R5,TAS2R50,TAS2R60,TAS2R7,TAS2R8	The series of events required to receive a bitter taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
GO:0050915	GO	BP	sensory perception of sour taste	ASIC1,ASIC2,ASIC3,PKD1L3,PKD2L1	The series of events required to receive a sour taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
GO:0050918	GO	BP	positive chemotaxis	ANGPT1,BMP4,CCL15,CCL16,CCL3,CCL5,CORO1A,FGF10,FGF2,FGF7,FIGF,HGF,HMGB1,HMGB2,LGALS3,MET,MIF,NRP1,NTF3,PDGFB,PLXNB3,PTPRJ,SCG2,SCRIB,SEMA5A,TSC2,VEGFA,VEGFB,VEGFC	The directed movement of a motile cell or organism towards a higher concentration of a chemical.
GO:0050919	GO	BP	negative chemotaxis	APOA1,EPHA7,ITGAV,ITGB3,PDGFA,RHOA,ROBO1,RYK,SLIT1,SLIT2,SLIT3	The directed movement of a motile cell or organism towards a lower concentration of a chemical.
GO:0050920	GO	BP	regulation of chemotaxis	ADAM10,ADAM17,AIF1,ANGPT2,ANO6,AZU1,C1QBP,C5,C5AR2,CALR,CAMK1D,CCL19,CCL2,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CDH13,CMKLR1,CORO1B,CREB3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,CXCR3,CXCR4,DAPK2,DSCAM,EDN2,EDN3,EFNB2,ELANE,F2RL1,F3,F7,FGF1,FGF16,FGF18,FGF2,FGF4,FGFR1,FIGF,GAS6,GREM1,HMGB1,HRG,HSPB1,IL12A,IL6,IL6R,JAM3,KDR,KLRK1,LGALS9,LYN,MEGF8,MET,MPP1,NBL1,NCKAP1L,NOTCH1,NOV,NRP1,NTF3,NTRK3,PADI2,PDGFB,PDGFRA,PDGFRB,PLA2G7,PPM1F,PRKD1,PRKD2,PTK2B,PTPN2,PTPRO,RAC1,RAC2,RARRES2,ROBO1,ROBO2,S100A14,S100A7,SCG2,SEMA3A,SEMA5A,SERPINE1,SLIT2,STAP1,STX3,STX4,TGFB1,THBS1,THBS4,TIRAP,USP14,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZNF580	Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
GO:0050921	GO	BP	positive regulation of chemotaxis	ADAM10,ADAM17,AIF1,ANO6,AZU1,C1QBP,CALR,CAMK1D,CCL19,CCL21,CCL3,CCL4,CCL5,CCL7,CCR1,CCR2,CCR7,CD74,CDH13,CMKLR1,CREB3,CSF1,CXCL10,CXCL12,CXCL13,CXCL8,CXCR3,DAPK2,DSCAM,EDN2,EDN3,F2RL1,F3,F7,FGF16,FGF18,FGF2,FGFR1,FIGF,GAS6,HMGB1,HSPB1,IL12A,IL6,IL6R,KDR,LGALS9,MEGF8,MET,NCKAP1L,NRP1,NTF3,NTRK3,PDGFB,PDGFRB,PLA2G7,PPM1F,PRKD1,PRKD2,PTK2B,RAC1,RAC2,RARRES2,S100A14,S100A7,SCG2,SEMA5A,SERPINE1,SLIT2,STX3,STX4,TGFB1,THBS1,THBS4,TIRAP,VEGFA,VEGFB,VEGFC,WNT5A,XCL1,ZNF580	Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
GO:0050922	GO	BP	negative regulation of chemotaxis	AIF1,ANGPT2,C5,C5AR2,CCL2,CORO1B,CXCL13,ELANE,GREM1,HRG,KLRK1,NBL1,NOTCH1,NOV,PADI2,PTPN2,PTPRO,ROBO1,ROBO2,SEMA5A,SLIT2,STAP1,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
GO:0050926	GO	BP	regulation of positive chemotaxis	ANGPT2,AZU1,CDH13,CREB3,CXCL8,F2RL1,F3,F7,FIGF,KDR,NTF3,NTRK3,SCG2,VEGFA,VEGFB,VEGFC	Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
GO:0050927	GO	BP	positive regulation of positive chemotaxis	AZU1,CDH13,CREB3,CXCL8,F2RL1,F3,F7,FIGF,KDR,NTF3,NTRK3,SCG2,VEGFA,VEGFB,VEGFC	Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
GO:0050930	GO	BP	induction of positive chemotaxis	AZU1,CREB3,CXCL8,FIGF,NTF3,SCG2,VEGFA,VEGFB,VEGFC	Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
GO:0050931	GO	BP	pigment cell differentiation	AP1G1,AP1M1,AP3D1,BLOC1S3,BLOC1S5,BLOC1S6,C10orf11,CD63,CITED1,KIT,MEF2C,MITF,RAB32,RAB38,USP13	The process in which a relatively unspecialized cell acquires the specialized features of a pigmented cell, such as a melanocyte.
GO:0050951	GO	BP	sensory perception of temperature stimulus	ANO1,EPHB1,KCNK4,MMP24,TRPV1	The series of events required for an organism to receive a sensory temperature stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
GO:0050953	GO	BP	sensory perception of light stimulus	ABLIM1,AOC2,ATF6,ATXN7,BBS2,BEST1,CABP4,CACNA1F,CACNA2D4,CDH23,CHRNB2,CLRN1,CNGB1,COL11A1,COL18A1,COL1A1,COL2A1,CRYAA,CRYBA1,CRYBA4,CRYBB1,CRYBB3,CRYGA,CRYGB,CRYGC,CRYGD,CRYZ,CYP1B1,DFNB31,DHRS3,DNAJC19,DRAM2,EFEMP1,EML2,EYA3,EYA4,EYS,FSCN2,GJA3,GJA8,GNAT1,GNAT2,GPR143,GPR179,GRM6,GRM8,GUCA1C,GUCY2F,IMPG1,IMPG2,KIFC3,KRT12,MYO7A,MYO9A,OAT,OCLM,OPA1,OPA3,PAX2,PAX6,PCDH15,PITPNA,POU4F3,POU6F2,PRR4,RABGGTA,RABGGTB,RAX,RBP3,RDH10,RDH12,RGS16,RP2,RPE65,RPGR,SDR16C5,SFRP5,SIX3,SIX6,SLC24A1,TH,TRPM1,TULP1,TULP2,TYR,USH1C,USH1G,USH2A,VAX2,WFS1,ZIC2	The series of events required for an organism to receive a sensory light stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
GO:0050954	GO	BP	sensory perception of mechanical stimulus	ALDH7A1,ATP2B2,ATP6V0A4,ATP6V1B1,CACNA1D,CDH23,CEACAM16,CEMIP,CHRNB2,CLIC5,CLRN1,COL11A1,COL11A2,COL1A1,COL2A1,COL4A3,CRYM,DCDC2,DFNA5,DFNB31,EML2,EYA1,FAM65B,GRM7,GRXCR1,GRXCR2,HOXA1,HPN,KCNA1,KCNE1,KCNK4,KCNQ1,KIT,KPTN,LOXHD1,LRTOMT,MARVELD2,MKKS,MYH14,MYO1A,MYO3A,MYO7A,NDP,NDUFB9,NIPBL,OTOR,P2RX2,PAX3,PCDH15,PIEZO2,SERPINB6,SLC26A4,SLC26A5,SLC52A3,SNAI2,SOD1,SPTBN4,TBL1X,TBX1,TFAP2A,TIMM10,TIMM13,TIMM8B,TIMM9,TPRN,TSPEAR,USH1C,USH1G,USH2A,WDR1,WFS1,ZNF354A	The series of events required for an organism to receive a sensory mechanical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
GO:0050957	GO	BP	equilibrioception	CDH23,CLRN1,MYO7A,PCDH15,USH1C,USH1G	The series of events required for an organism to receive an orientational stimulus, convert it to a molecular signal, and recognize and characterize the signal. Equilibrioception refers to a combination of processes by which an organism can perceive its orientation with respect to gravity. In animals, stimuli come from labyrinth system of the inner ears, monitoring the direction of motion; visual stimuli, with information on orientation and motion; pressure receptors, which tell the organism which body surfaces are in contact with the ground; and proprioceptive cues, which report which parts of the body are in motion.
GO:0050974	GO	BP	detection of mechanical stimulus involved in sensory perception	COL11A1,HPN,KCNA1,KCNK4,KIT,MKKS,PIEZO2	The series of events in which a mechanical stimulus is received and converted into a molecular signal as part of sensory perception.
GO:0050982	GO	BP	detection of mechanical stimulus	COL11A1,CSRP3,HPN,JUP,KCNA1,KCNK4,KIT,MKKS,PIEZO2,PKD1,PKD2,TCAP,TTN	The series of events by which a mechanical stimulus is received and converted into a molecular signal.
GO:0050994	GO	BP	regulation of lipid catabolic process	AADAC,ABCD2,ABHD5,ADRA2A,ADRB2,AKT1,AKT2,ANGPTL3,APOA2,APOA4,APOA5,APOC1,APOC2,APOC3,BSCL2,CIDEA,GPLD1,HCAR2,IL1B,INS,IRS1,IRS2,LDLR,LONP2,METTL20,PDE3B,PLIN5,PNPLA2,PPARA,PRKAA1,PRKCD,RARRES2,SCARB1,SPTLC1,SPTLC2,TNF,TWIST1,TYSND1	Any process that modulates the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
GO:0050995	GO	BP	negative regulation of lipid catabolic process	ADRA2A,AKT1,APOA2,APOC1,APOC3,BSCL2,CIDEA,GPLD1,HCAR2,IL1B,INS,METTL20,PDE3B,PLIN5,PRKAA1,TNF	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
GO:0050996	GO	BP	positive regulation of lipid catabolic process	AADAC,ABCD2,ABHD5,ADRB2,AKT2,ANGPTL3,APOA2,APOA4,APOA5,APOC2,IL1B,IRS1,IRS2,PLIN5,PNPLA2,PPARA,PRKCD,SPTLC1,SPTLC2,TWIST1	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
GO:0050997	GO	MF	quaternary ammonium group binding	ACHE,APOA2,APOA4,APOA5,APOC1,CETP,CHMP2A,CHMP3,CHRM3,CHRNA1,CHRNA3,CHRNA4,CHRNA7,CHRNB1,CHRNB2,CRP,ESYT2,JCHAIN,NF1,PCTP,RASGRP1,RPE65,SERPINA5	Interacting selectively and non-covalently with a quaternary ammonium group, including glycine betaine, choline, carnitine and proline. A quaternary ammonium group is any compound that can be regarded as derived from ammonium hydroxide or an ammonium salt by replacement of all four hydrogen atoms of the NH4+ ion by organic groups.
GO:0050999	GO	BP	regulation of nitric-oxide synthase activity	AGTR2,AKT1,APOE,ATP2B4,CALM1,CAV1,CAV3,CYGB,DDAH1,DDAH2,DHFR,DNM2,EGFR,ENG,ESR1,FCER2,GCH1,GCHFR,GLA,HIF1A,HSP90AA1,HTR2B,IL1B,INS,LEP,LYPLA1,NOS1AP,NOS3,NOSIP,NOSTRIN,NPR3,PRKG2,PTS,SCARB1,SPR,TERF2,TERT,WASL,ZDHHC21	Any process that modulates the activity of the enzyme nitric-oxide synthase.
GO:0051000	GO	BP	positive regulation of nitric-oxide synthase activity	AGTR2,AKT1,APOE,DHFR,ESR1,FCER2,GCH1,HIF1A,HTR2B,INS,NOS1AP,NPR3,SCARB1,TERF2,TERT	Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
GO:0051001	GO	BP	negative regulation of nitric-oxide synthase activity	ATP2B4,CAV3,ENG,GLA,NOSIP	Any process that stops or reduces the activity of the enzyme nitric-oxide synthase.
GO:0051004	GO	BP	regulation of lipoprotein lipase activity	ANGPTL3,ANGPTL4,APOA4,APOA5,APOC1,APOC2,APOC3,APOH,GPIHBP1,NR1H2,NR1H3,SORT1	Any process that modulates the activity of the enzyme lipoprotein lipase.
GO:0051005	GO	BP	negative regulation of lipoprotein lipase activity	ANGPTL3,ANGPTL4,APOC1,APOC3,SORT1	Any process that stops or reduces the activity of the enzyme lipoprotein lipase.
GO:0051006	GO	BP	positive regulation of lipoprotein lipase activity	APOA4,APOA5,APOC2,APOH,GPIHBP1,NR1H2,NR1H3	Any process that activates or increases the activity of the enzyme lipoprotein lipase.
GO:0051010	GO	MF	microtubule plus-end binding	APC,CLASP1,CLASP2,CLIP1,DST,KIF18A,KIF2C,MAPRE1,STIM1	Interacting selectively and non-covalently with the plus end of a microtubule.
GO:0051014	GO	BP	actin filament severing	FMNL1,GSN,SCIN,SRGAP2,VIL1	The process in which an actin filament is broken down into smaller filaments.
GO:0051015	GO	MF	actin filament binding	ABL2,ACTN1,ACTN4,ACTR2,ACTR3,ADD1,ADD2,AIF1,AIF1L,ANTXR1,ANXA8,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BLOC1S6,CLASP2,CORO1A,CORO1B,CORO1C,CYFIP1,DBNL,EGFR,ESPN,EZR,FLNA,FMNL1,FSCN1,FSCN2,GAS2L2,IQGAP2,LCP1,LIMA1,MACF1,MAP1S,MARCKS,MICALL2,MYH10,MYH14,MYH3,MYH8,MYH9,MYL4,MYO10,MYO16,MYO18A,MYO1B,MYO1D,MYO1E,MYO6,MYO7A,NEBL,NEXN,PICK1,SCIN,SHROOM1,SHROOM2,SHROOM4,SHTN1,SLC6A4,SPTA1,SPTB,SSFA2,SVIL,SYNE1,SYNE3,TNNC1,TRIOBP,TRPV4,TTN,TULP1,VIL1	Interacting selectively and non-covalently with an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits.
GO:0051016	GO	BP	barbed-end actin filament capping	ADD1,ADD2,EPS8,TRIOBP,TWF2,VIL1	The binding of a protein or protein complex to the barbed (or plus) end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits.
GO:0051017	GO	BP	actin filament bundle assembly	ADD1,ADD2,AIF1,ARRB1,BAIAP2,CORO1B,CUL3,DMTN,DPYSL3,EPS8,EZR,FMN2,FSCN1,FSCN2,HSP90B1,ITGB5,KCTD13,LCP1,LIMA1,MYO1B,NEDD9,PAWR,PDXP,PHACTR1,RHOD,SHROOM1,SORBS1,SPIRE1,SPIRE2,SRC,TNFAIP1,ZYX	The assembly of actin filament bundles; actin filaments are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness.
GO:0051018	GO	MF	protein kinase A binding	AKAP11,AKAP17A,AKAP4,AKAP5,AKAP6,AKAP7,ARFGEF1,ARFGEF2,C18orf42,DACT1,DACT2,DACT3,KCNQ1,PJA2,RARA,RDX,RYR2,SPHKAP	Interacting selectively and non-covalently with any subunit of protein kinase A.
GO:0051019	GO	MF	mitogen-activated protein kinase binding	ATF7,MICALCL,NBR1,NFATC1,RPS6KA4,TNIP1,TPR	Interacting selectively and non-covalently with a mitogen-activated protein kinase.
GO:0051024	GO	BP	positive regulation of immunoglobulin secretion	HLA-E,IL6,RBP4,STX4,TNFRSF4,TNFSF4,XBP1	Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
GO:0051028	GO	BP	mRNA transport	AGFG1,ALKBH5,ALYREF,BUD13,CDC40,CHTOP,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FYTTD1,GLE1,HHEX,HNRNPA2B1,KIF5C,LUZP4,MAGOH,NCBP1,NCBP2,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,POLDIP3,RAE1,RBM8A,RNPS1,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,U2AF1,U2AF2,UPF1,UPF2,UPF3B,ZC3H11A,ZC3H3	The directed movement of mRNA, messenger ribonucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051043	GO	BP	regulation of membrane protein ectodomain proteolysis	ADAM8,ADAM9,ADRA2A,APOE,FURIN,GPLD1,IFNG,IL10,IL1B,NRD1,PACSIN3,PTPN3,SH3D19,SNX33,SNX9,TIMP1,TIMP3,TNF,TNFRSF1B	Any process that modulates the frequency, rate or extent of the proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain).
GO:0051044	GO	BP	positive regulation of membrane protein ectodomain proteolysis	ADAM8,ADAM9,ADRA2A,APOE,FURIN,GPLD1,IFNG,IL1B,NRD1,PACSIN3,SH3D19,SNX33,SNX9,TNF,TNFRSF1B	Any process that activates or increases the frequency, rate or extent of membrane protein ectodomain peptidolysis.
GO:0051048	GO	BP	negative regulation of secretion	ACSL4,ADRA2A,ADRA2B,ADRA2C,ANXA1,ANXA4,APOA1,APOA2,BMP8A,BTN2A2,C1QTNF3,C5AR2,CCR2,CD300A,CD34,CD74,CD84,CHGA,CIDEA,CRHBP,CYP4F2,DPH3,DRD2,DRD3,DRD4,EGF,ERBB3,ERP29,EZR,F2R,F2RL1,FAM3D,FBLN1,FFAR4,FGF23,FN1,FOXP3,GAS6,GBP1,GRM7,HTR1B,IFNA2,IL10,IL11,IL1B,IL1RAPL1,IL36RN,INHA,INHBA,INHBB,INS,IRS1,KCNB1,KCNJ11,LGALS9,LGR4,LIF,LILRB1,NLRP12,NLRP3,NOV,NPVF,NR1H3,NR1H4,NRG1,OPRM1,OSM,PARK2,PIM3,PLA2R1,PSMD9,PTGER4,PTPN22,PYDC2,RAB11FIP1,RAB11FIP3,RAB11FIP5,RAB33B,REST,RGCC,RHBDF1,RHBDF2,RSAD2,SERGEF,SFRP1,SIRT4,SLC30A1,SNCA,SPINK13,SPX,SRGN,SSC5D,STXBP3,STXBP6,SYT11,TNF,TNFRSF21,TRIM27,VAMP3,VAMP8,VPS4B,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a substance from a cell or a tissue.
GO:0051053	GO	BP	negative regulation of DNA metabolic process	ACD,ACVRL1,ADIPOQ,ANKRD1,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ATM,ATR,BLM,BMPR2,CDAN1,CDC6,CERS1,CHEK2,CTC1,DACH1,DFFA,DPPA3,ENPP7,ERCC1,ERCC4,FBXO18,FBXW7,GDF2,GMNN,GNL3L,GPER1,GTPBP4,GZMA,HMGA2,HNRNPA1,HNRNPC,HNRNPU,INPP5K,LIG3,MCRS1,MEN1,MRE11A,MSH2,MSH3,MSH6,NAT10,NBN,NF2,OBFC1,OGG1,OTUB1,PARP1,PARPBP,PDS5A,PID1,PIF1,PINX1,PML,POLQ,POT1,RAD17,RAD50,RNF169,RPS3,RTEL1,S100A11,SMC1A,SMC3,SMG6,SRC,STAG2,TEN1,TERF1,TERF2,TERF2IP,TFIP11,TGFB1,TGFB3,THOC1,TINF2,TNKS,TNKS2,TP53,TRIP12,TSPYL2,TWIST1,UBR5,WAPL,XRCC5,ZNF830,ZNF91,ZNF93,ZRANB3	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving DNA.
GO:0051054	GO	BP	positive regulation of DNA metabolic process	ACD,AKT1,APEX1,APLF,AREG,ATM,ATR,ATRX,AURKB,BABAM1,BAX,BMP4,BMP5,BMP6,BRCA1,BRCC3,BRE,CALR,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CDC7,CLCF1,CSF2,CTC1,DBF4B,DHX36,DKC1,DNA2,E2F7,E2F8,EGFR,EPO,ERCC1,ERCC8,EREG,EYA1,EYA3,FAM175A,FGF10,FGFR4,FOXM1,GLI1,GLI2,GREM1,GRHL2,H2AFX,HGF,HMBOX1,HMGB1,HNRNPA1,HRAS,IGF1,IGF1R,IL3,IL4,INO80,INS,INSR,KDM4D,KITLG,KLF4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MRE11A,MYC,NABP2,NBN,NEK2,NEK7,NPAS2,NUDT16,NVL,OBFC1,PARM1,PARP3,PAXIP1,PCNA,PDGFA,PDGFB,PDGFC,PDGFRA,PDGFRB,PKIB,PLA2G1B,PNKP,POT1,PRDM9,PRKCD,PRKCG,PRKCQ,PRKD2,RAD50,RAD51,RGCC,RNF168,RNF8,RPS3,RTEL1,SETMAR,SHC1,SIRT1,SLF1,SLF2,SLX1A,SLX4,SPIDR,STOML2,TCP1,TERF2,TGFB1,TGFB3,TIGAR,TINF2,TMEM161A,TNFSF13,TNFSF4,TNKS,TNKS2,TOP2A,TRIM28,UBE2N,UIMC1,WIZ,WRAP53	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving DNA.
GO:0051055	GO	BP	negative regulation of lipid biosynthetic process	ACADL,ACADVL,AKR1C3,APOC1,APOC3,APOE,BMP2,BMP5,BRCA1,CYP27B1,DKK3,ERLIN1,ERLIN2,FBXW7,FGF19,GFI1,GPER1,NFKB1,NR1H4,PDGFA,PDGFB,PIBF1,PRKAA1,PROX1,REST,SCAP,SIK1,SIRT1,SLC27A1,SNAI1,SNAI2,SOD1,TRIB3,WNT4	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids.
GO:0051056	GO	BP	regulation of small GTPase mediated signal transduction	A2M,ABCA1,ABR,ABRA,ADRA1A,AKAP13,ALS2,APOA1,APOC3,APOE,ARAP1,ARAP2,ARAP3,ARF6,ARHGAP1,ARHGAP10,ARHGAP11A,ARHGAP11B,ARHGAP12,ARHGAP15,ARHGAP17,ARHGAP18,ARHGAP19,ARHGAP20,ARHGAP22,ARHGAP23,ARHGAP24,ARHGAP25,ARHGAP26,ARHGAP28,ARHGAP29,ARHGAP30,ARHGAP31,ARHGAP32,ARHGAP33,ARHGAP35,ARHGAP36,ARHGAP39,ARHGAP4,ARHGAP40,ARHGAP44,ARHGAP5,ARHGAP6,ARHGAP8,ARHGAP9,ARHGDIA,ARHGDIB,ARHGDIG,ARHGEF11,ARHGEF12,ARHGEF16,ARHGEF17,ARHGEF18,ARHGEF2,ARHGEF3,ARHGEF4,ARHGEF6,ARHGEF7,ARHGEF9,ARRB1,BCR,CDC42,CHN1,CHN2,COL3A1,CUL3,DAB2IP,DENND1A,DENND4B,DEPDC1B,DEPDC7,DLC1,ECT2,EPO,EPS8L1,EPS8L2,F2R,F2RL1,FAM13A,FAM13B,FBP1,FGD1,FGD2,FGD3,FGD4,FGF10,FLCN,FOXM1,GDI1,GDI2,GMIP,GPR55,HMHA1,IGF1,INPP5B,ITSN1,KALRN,KANK1,KCTD13,KIF14,LPAR1,MADD,MAPKAP1,MCF2,MCF2L,MFN2,MMD2,MYO9A,MYO9B,MYOC,NET1,NGEF,NOTCH2,NTRK1,NUP62,OBSCN,OCRL,OGT,OPHN1,PIK3R2,PLCE1,PLEKHG2,PLEKHG5,RAC1,RAC2,RAC3,RACGAP1,RAF1,RALBP1,RALGPS1,RASAL3,RASGEF1A,RASGRF1,RASGRF2,RASGRP1,RASGRP4,RDX,RELN,RHOA,RHOB,RHOBTB1,RHOBTB2,RHOC,RHOD,RHOF,RHOG,RHOH,RHOJ,RHOQ,RHOT1,RHOT2,RHOU,RHOV,SCAI,SHOC2,SLIT2,SOS1,SOS2,SQSTM1,SRGAP1,SRGAP2,SRGAP3,STAMBP,STARD13,STARD8,STMN3,SYDE1,SYDE2,SYNGAP1,TAGAP,TIAM1,TIAM2,TNFAIP1,TRIO,TRIP10,VAV1,VAV2,VAV3	Any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction.
GO:0051057	GO	BP	positive regulation of small GTPase mediated signal transduction	ABRA,ALS2,APOA1,ARRB1,COL3A1,EPO,F2R,F2RL1,FGF10,GPR55,IGF1,LPAR1,MMD2,NOTCH2,NTRK1,RAC1,RASGEF1A,RASGRF1,RASGRP1,RASGRP4,RELN,SHOC2	Any process that activates or increases the frequency, rate or extent of small GTPase mediated signal transduction.
GO:0051058	GO	BP	negative regulation of small GTPase mediated signal transduction	ADRA1A,ARAP3,CUL3,DAB2IP,DLC1,FBP1,FLCN,KANK1,KCTD13,MAPKAP1,MFN2,MYOC,RASAL3,SCAI,SLIT2,STAMBP,STMN3,SYNGAP1,TNFAIP1	Any process that stops, prevents, or reduces the frequency, rate or extent of small GTPase mediated signal transduction.
GO:0051059	GO	MF	NF-kappaB binding	BCL10,BRMS1,CDKN2A,COMMD7,FOXP3,NFKBIA,NPM1	Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
GO:0051082	GO	MF	unfolded protein binding	AFG3L2,AHSP,AIP,AIPL1,APCS,CALR,CCT2,CDC37,CHAF1A,CHAF1B,CLN3,CRYAA,DNAJA2,DNAJA4,DNAJB1,DNAJB2,DNAJB6,DNAJB8,DNAJC4,ERLEC1,ERO1B,GRPEL1,HSPA1A,HSPA1B,HSPA1L,HSPA2,HSPA5,HSPA6,HSPA8,HSPA9,HSPD1,HSPE1,HTRA2,LMAN1,LRPAP1,MDN1,NAP1L4,NDUFAF1,NPM1,PFDN2,PFDN6,PPIA,PPIB,PTGES3,RP2,RUVBL2,SCAP,SCG5,SIL1,SPG7,SRSF10,SRSF12,TAPBP,TOMM20,TTC1,TUBB4B,UGGT1	Interacting selectively and non-covalently with an unfolded protein.
GO:0051084	GO	BP	'de novo' posttranslational protein folding	ACTB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CHCHD4,ENTPD5,ERO1A,PFDN1,PFDN2,PFDN4,PFDN5,PFDN6,SEP15,SPHK1,TBCA,TBCB,TBCC,TBCD,TBCE,TCP1,TUBA1A,TUBA1B,TUBA1C,TUBA3C,TUBA3E,TUBA4A,TUBA4B,TUBA8,TUBAL3,TUBB1,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBB4B,TUBB6,UGGT1,VBP1	The process of assisting in the correct noncovalent folding of newly formed polypeptides or folding intermediates of polypeptides that have exited the ribosome and/or have been stabilized and transferred by other chaperone proteins. This process could involve several cycles of ATP hydrolysis.
GO:0051087	GO	MF	chaperone binding	AHSA1,CALR,CLU,CTSC,DNAJA1,DNAJB6,DNAJC10,ERP29,HSPA5,HSPE1,HYOU1,PFDN4,PFDN6,PIH1D3,SACS,TBCA,TBCC,TBCD,TBCE,VWF	Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
GO:0051091	GO	BP	positive regulation of sequence-specific DNA binding transcription factor activity	ABRA,ADAM8,AGER,AGT,AIM2,AKT1,ALK,ANXA3,AR,ARHGEF2,ARHGEF5,ARID5B,ATF2,BCL10,BEX1,BTK,BUD31,CAMK1D,CAMK2A,CAPN3,CARD11,CARD14,CD40,CEBPG,CFLAR,CHUK,CIB1,CLOCK,CLU,CRTC1,CRTC2,CTNNB1,DDR2,DDRGK1,DDX58,DVL2,EDA,EDA2R,EIF2AK2,EP300,EPHA5,ERC1,ESR1,ESR2,FER,FOXA1,FZD1,FZD2,FZD4,GTF2A2,HDAC4,HDAC5,HIPK2,HSPA1A,HSPA1B,IKBKB,IKBKG,IL10,IL1B,IL6,INS,IRAK1,IRAK2,IRAK3,JMY,JUP,KDM1A,KIT,LGALS9,LRP6,LRP8,LTF,MALT1,MAP3K13,MAP3K7,MAVS,MBTPS2,MID2,MTDH,MTPN,MYOCD,NEUROD1,NEUROD2,NEUROG1,NEUROG2,NEUROG3,NFAM1,NFKB1,NFKB2,NFKBIA,NFKBIB,NHLH2,NKX2-2,NKX6-1,NLRC4,NLRP3,NOD1,NOD2,NODAL,NPM1,NTRK1,OPRD1,PARK7,PHB2,PIDD1,PLA2G1B,PLPP3,PPARG,PPARGC1A,PRDX3,PRKCB,PRKCH,PRKCI,PRKCQ,PRKCZ,PRKD1,PRKD2,PSMA6,PTEN,PYCARD,RAB7B,RBCK1,RELA,RELN,RGCC,RHEBL1,RIPK1,RIPK2,RIPK3,RIPK4,RNF25,RNF31,RPS27A,RPS3,RPS6KA4,RPS6KA5,S100A12,S100A8,S100A9,SHH,SMARCA4,SMARCB1,SMO,SP100,SPHK1,SRF,STK3,STK36,TAB1,TAB2,TAB3,TAF12,TCF3,TERF2IP,TIRAP,TLR2,TLR4,TLR9,TNF,TNFRSF11A,TNFSF11,TNFSF18,TP53BP1,TRADD,TRAF1,TRAF2,TRAF5,TRAF6,TRIM13,TRIM14,TRIM15,TRIM21,TRIM22,TRIM25,TRIM26,TRIM27,TRIM31,TRIM32,TRIM34,TRIM37,TRIM38,TRIM5,TRIM52,TRIM62,TRIM8,TSSK4,UBA52,UBB,UBC,UBE2N,UBE2V1,VEGFA,WNT1,WNT2,WNT5A,ZIC2	Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
GO:0051092	GO	BP	positive regulation of NF-kappaB transcription factor activity	ADAM8,AGER,AGT,AIM2,ALK,AR,ARHGEF2,BCL10,BTK,CAMK2A,CAPN3,CARD11,CARD14,CD40,CFLAR,CHUK,CIB1,CLOCK,CLU,DDRGK1,EDA,EDA2R,EIF2AK2,ERC1,FER,HSPA1A,HSPA1B,IKBKB,IKBKG,IL1B,INS,IRAK1,IRAK2,IRAK3,LGALS9,LTF,MALT1,MAP3K13,MAP3K7,MID2,MTDH,MTPN,NFKB1,NFKB2,NFKBIA,NFKBIB,NLRC4,NLRP3,NOD1,NOD2,NPM1,NTRK1,PIDD1,PLA2G1B,PRDX3,PRKCB,PRKCH,PRKCI,PRKCQ,PRKCZ,PRKD1,PRKD2,PSMA6,PYCARD,RAB7B,RBCK1,RELA,RHEBL1,RIPK1,RIPK2,RIPK3,RIPK4,RNF25,RNF31,RPS27A,RPS3,RPS6KA4,RPS6KA5,S100A12,S100A8,S100A9,SPHK1,TAB1,TAB2,TAB3,TERF2IP,TIRAP,TLR2,TLR4,TLR9,TNF,TNFRSF11A,TNFSF11,TNFSF18,TRADD,TRAF1,TRAF2,TRAF5,TRAF6,TRIM13,TRIM14,TRIM15,TRIM22,TRIM25,TRIM32,TRIM37,TRIM38,TRIM5,TRIM52,TRIM62,TRIM8,UBA52,UBB,UBC,UBE2N,UBE2V1,WNT5A	Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
GO:0051095	GO	BP	regulation of helicase activity	CHTOP,IFIT1,MSH2,MSH3,MSH6,POT1,SIRT1,SSBP1,TP53	Any process that modulates the frequency, rate or extent of helicase activity.
GO:0051096	GO	BP	positive regulation of helicase activity	CHTOP,MSH2,MSH3,MSH6,POT1,SSBP1	Any process that activates or increases the activity of a helicase.
GO:0051098	GO	BP	regulation of binding	ABL1,ACD,ADAM15,ADD1,ADD2,ADIPOQ,ADRB2,AES,AIDA,AKTIP,AMFR,ANXA2,ARHGEF7,ARRB2,AURKA,AURKB,B2M,BAK1,BAMBI,BAX,BCL2,BMP2,BMP4,BTAF1,BTBD1,CAMK1,CAPRIN2,CAV1,CCL23,CDK9,CEBPG,CLIC2,CPNE1,CSF3,CSNK1A1,CSNK1E,CSNK2B,CTNNBIP1,CYP2D6,DAB2,DAB2IP,DACT1,DDIT3,DERL1,DKK1,DOT1L,DPH3,DVL1,E2F1,EDF1,EGF,EPB41,EPHA4,FKBP1A,FLOT1,GATA1,GATA3,GNL3L,GOLGA2,GREM2,GSK3B,GTPBP4,GZMA,HABP4,HAND1,HAND2,HDAC4,HDAC5,HES1,HEY1,HEY2,HFE,HIPK2,HJURP,HMBOX1,HMGA2,HMGB1,HMGB2,HSPA5,IFI16,IFIT1,IFIT2,IGF1,IL10,ISL1,ITGA4,ITGB1BP1,JAK2,JUN,KDM1A,KDM4D,LDLRAP1,LEF1,LRPAP1,LRRK2,MAD2L2,MAPK8,MDFI,MED25,MEF2C,MEN1,MITD1,MMP9,MSX2,NES,NEUROD1,NFIB,NFKBIA,NKX3-1,NME1,NOG,NRG1,NRP1,NSD1,PARK2,PARK7,PDGFB,PER2,PEX14,PEX19,PIN1,PINX1,PKD1,PLAUR,PLK1,PLN,PON1,PRKACA,PRKCD,PRMT7,PRMT8,PTPRF,RALB,RAN,RAPGEF2,RARA,ROCK1,RSF1,RUVBL2,SIN3A,SIRT2,SKI,SLN,SLPI,SMAD2,SMO,SNAPIN,SORL1,SOX11,SP100,SPPL3,STK3,STK4,SUMO1,TCF7L2,TERT,TFAP4,TFIP11,TGFB1,TIAM1,TIRAP,TMBIM6,TMC8,TMEM173,TNKS,TRAF2,TRAF4,TRAF6,TRIB3,TRIM6,TWIST1,TXN,USP33,VTN,WAPL,WNT3A,ZFPM1,ZNF268,ZNF675	Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
GO:0051099	GO	BP	positive regulation of binding	ABL1,ACD,ADD1,ADD2,AKTIP,AMFR,B2M,BAMBI,BMP2,BMP4,CAPRIN2,CAV1,CDK9,CEBPG,CLIC2,CSF3,DACT1,DERL1,DPH3,EDF1,EGF,EPB41,FKBP1A,FLOT1,GATA3,GNL3L,GSK3B,HAND2,HES1,HFE,HIPK2,HMBOX1,HMGA2,HMGB1,HMGB2,IGF1,KDM4D,LRRK2,MED25,MEF2C,MEN1,MMP9,NEUROD1,NME1,NRP1,PARK2,PARK7,PINX1,PKD1,PLAUR,PON1,RALB,RAN,RAPGEF2,RARA,SIRT2,SKI,SPPL3,STK3,STK4,TCF7L2,TERT,TGFB1,TIAM1,TIRAP,TMEM173,TRAF2,TRAF4,TRAF6,TRIB3,TRIM6,TWIST1,TXN,USP33,VTN,WNT3A,ZNF268	Any process that activates or increases the rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
GO:0051100	GO	BP	negative regulation of binding	ADAM15,ADIPOQ,ADRB2,AES,ANXA2,ARRB2,AURKA,AURKB,B2M,BAX,BTAF1,CAMK1,CAV1,CCL23,CPNE1,CSNK1E,CTNNBIP1,CYP2D6,DAB2,DACT1,DDIT3,DKK1,DVL1,E2F1,GATA1,GNL3L,GOLGA2,GSK3B,GTPBP4,GZMA,HABP4,HAND1,HEY1,HEY2,HFE,HMGA2,HSPA5,IFI16,IFIT1,IFIT2,IL10,ISL1,ITGA4,ITGB1BP1,JAK2,JUN,KDM1A,LEF1,LRPAP1,LRRK2,MAD2L2,MAPK8,MDFI,MITD1,MSX2,NES,NFIB,NFKBIA,NKX3-1,NOG,PARK7,PDGFB,PER2,PEX14,PEX19,PIN1,PLN,PRKCD,PTPRF,RALB,ROCK1,RSF1,RUVBL2,SIN3A,SLN,SLPI,SMO,SORL1,SOX11,SP100,SUMO1,TFAP4,TFIP11,TMBIM6,TMC8,TNKS,USP33,WAPL,ZFPM1,ZNF675	Any process that stops or reduces the rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
GO:0051101	GO	BP	regulation of DNA binding	ACD,CEBPG,CPNE1,CSNK2B,DDIT3,DOT1L,E2F1,EDF1,EGF,GATA1,GATA3,GZMA,HABP4,HAND1,HAND2,HES1,HEY1,HEY2,HJURP,HMGA2,HMGB1,HMGB2,IFI16,IGF1,JAK2,JUN,KDM1A,LEF1,MAD2L2,MDFI,MMP9,MSX2,NEUROD1,NFIB,NFKBIA,NME1,NSD1,PARK2,PARK7,PER2,PINX1,PLAUR,RSF1,SIN3A,SIRT2,SKI,SMO,SOX11,SP100,SUMO1,TFAP4,TGFB1,TNKS,TRAF6,TRIM6,TWIST1,TXN,ZNF675	Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
GO:0051103	GO	BP	DNA ligation involved in DNA repair	C9orf142,HMGB1,HMGB2,LIG3,LIG4,XRCC4	The re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase, that contributes to DNA repair.
GO:0051105	GO	BP	regulation of DNA ligation	APLF,HMGB1,PARP3,RAD51,TFIP11	Any process that modulates the frequency, rate or extent of DNA ligation, the re-formation of a broken phosphodiester bond in the DNA backbone, carried out by DNA ligase.
GO:0051117	GO	MF	ATPase binding	ALDOB,ANK2,AR,ATPIF1,BRSK2,ESR1,GABARAPL2,PGR,PKD2,PLN,SLN	Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
GO:0051119	GO	MF	sugar transmembrane transporter activity	PPBP,SLC17A5,SLC23A1,SLC23A2,SLC2A1,SLC2A10,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC2A9,SLC5A1,SLC5A2	Catalysis of the transfer of a sugar from one side of the membrane to the other. A sugar is any member of a class of sweet, water-soluble, crystallizable carbohydrates, which are the monosaccharides and smaller oligosaccharides.
GO:0051122	GO	BP	hepoxilin biosynthetic process	ALOX12,ALOX12B,ALOX15,ALOX15B,ALOXE3	The chemical reactions and pathways resulting in the formation of hepoxilins, a class of bioactive icosanoids with roles in the regulation of cell physiology.
GO:0051125	GO	BP	regulation of actin nucleation	ABI2,ARF1,ARPIN,BRK1,CORO1A,CORO1B,CYFIP1,GSN,NCKAP1,PICK1,SCIN,VIL1,WASF1,WHAMM	Any process that modulates the frequency, rate or extent of actin nucleation, the initial step in the formation of an actin filament in which actin monomers combine to form a new filament.
GO:0051127	GO	BP	positive regulation of actin nucleation	ABI2,BRK1,CYFIP1,GSN,NCKAP1,SCIN,WASF1,WHAMM	Any process that activates or increases the frequency, rate or extent of actin nucleation, the initial step in the formation of an actin filament in which actin monomers combine to form a new filament.
GO:0051131	GO	BP	chaperone-mediated protein complex assembly	APCS,BBS10,BBS12,CCT2,CCT6B,CLU,HSP90AA1,HSPA4,HSPD1,PFDN6,THEG	The aggregation, arrangement and bonding together of a set of components to form a protein complex, mediated by chaperone molecules that do not form part of the finished complex.
GO:0051133	GO	BP	regulation of NK T cell activation	CD300A,HSPH1,IL12A,IL12B,IL23A,IL23R	Any process that modulates the frequency, rate or extent of natural killer T cell activation.
GO:0051135	GO	BP	positive regulation of NK T cell activation	HSPH1,IL12A,IL12B,IL23A,IL23R	Any process that activates or increases the frequency, rate or extent of natural killer T cell activation.
GO:0051145	GO	BP	smooth muscle cell differentiation	BMP4,EDNRB,GATA6,HES1,HEY1,HEY2,MEF2C,MESP1,MKL1,MYOCD,NOTCH1,RAMP2,VEGFA	The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary.
GO:0051146	GO	BP	striated muscle cell differentiation	ACTA1,ACTC1,ACTN2,ACVR1,ADAM12,ADGRB3,ANKRD1,BMP10,BMP2,CACNA1H,CAPN3,CASQ1,CAV2,CBY1,CFLAR,CHRNB1,CSRP3,CXADR,DMD,HEY2,IGF1,KCNH1,KDM6B,KLHL41,KRT19,MAML1,MEF2A,MEF2C,MESP1,MYH11,MYH3,MYH6,MYL2,MYLK3,MYOCD,MYOD1,MYOZ1,MYPN,NEBL,NKX2-5,NKX2-6,NOS1,NRG1,OBSCN,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,RYR1,SIK1,SIX4,SKI,SLC8A1,SORBS2,SORT1,TCAP,TMEM8C,TPM1,TTN,VEGFA,WNT3A,WT1	The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle.
GO:0051147	GO	BP	regulation of muscle cell differentiation	ABL1,AKAP6,ANKRD2,BHLHA15,BHLHE41,BMP10,BMP2,BMP4,BNIP2,BOC,BTG1,CAMK1,CAV3,CD53,CDC42,CDH15,CDH2,CDK9,CDON,CEACAM5,CFLAR,CSRP3,CTH,CTNNA1,CTNNA2,CTNNB1,DKK1,DLL1,DMPK,EDN1,EFNB2,EHD1,EHD2,EREG,FGFR2,FLOT1,FOXO4,GPER1,GREM1,GSK3A,HDAC4,HDAC5,HDAC9,HEY2,HIF1AN,IGFBP3,KLHL41,MAML1,MAP2K6,MAPK11,MAPK12,MAPK14,MEF2A,MEF2C,MEGF10,MESP1,MMP14,MSTN,MYF5,MYF6,MYLK3,MYOCD,MYOD1,MYOG,NACA,NEO1,NKX2-5,NOTCH1,NOV,NRG1,NTN3,OLFM2,PLCB1,PRICKLE1,PROX1,PTBP1,RBM24,RBM4,SHH,SIK1,SMYD1,SOX8,SOX9,SPAG9,SRF,SUPT6H,TBX1,TBX3,TCF3,TGFB1,WNT3A,XBP1,ZFHX3	Any process that modulates the frequency, rate or extent of muscle cell differentiation.
GO:0051148	GO	BP	negative regulation of muscle cell differentiation	ANKRD2,BHLHA15,BHLHE41,BMP2,BMP4,CAV3,CEACAM5,CFLAR,CSRP3,DKK1,DLL1,EREG,FOXO4,GSK3A,HDAC4,HDAC5,HEY2,MSTN,NKX2-5,NOTCH1,NOV,PRICKLE1,PTBP1,SHH,SOX8,SOX9,TBX3,TGFB1,XBP1,ZFHX3	Any process that stops, prevents, or reduces the frequency, rate or extent of muscle cell differentiation.
GO:0051149	GO	BP	positive regulation of muscle cell differentiation	ABL1,AKAP6,BMP10,BMP4,BNIP2,BOC,BTG1,CAMK1,CD53,CDC42,CDH15,CDH2,CDON,CSRP3,CTH,CTNNA1,CTNNA2,CTNNB1,EDN1,EFNB2,EHD1,EHD2,FLOT1,GPER1,GREM1,HIF1AN,IGFBP3,MAML1,MAP2K6,MAPK11,MAPK12,MAPK14,MEF2A,MEF2C,MESP1,MMP14,MYF5,MYF6,MYLK3,MYOCD,MYOD1,MYOG,NEO1,NRG1,NTN3,OLFM2,PLCB1,PROX1,RBM4,SHH,SMYD1,SPAG9,TBX1,TCF3,TGFB1,WNT3A,ZFHX3	Any process that activates or increases the frequency, rate or extent of muscle cell differentiation.
GO:0051150	GO	BP	regulation of smooth muscle cell differentiation	CTH,EREG,FGFR2,FOXO4,GPER1,HEY2,MYOCD,OLFM2,SHH,SRF	Any process that modulates the frequency, rate or extent of smooth muscle cell differentiation.
GO:0051152	GO	BP	positive regulation of smooth muscle cell differentiation	CTH,GPER1,MYOCD,OLFM2,SHH	Any process that activates or increases the frequency, rate or extent of smooth muscle cell differentiation.
GO:0051153	GO	BP	regulation of striated muscle cell differentiation	AKAP6,BHLHA15,BHLHE41,BMP10,BMP2,BMP4,CAV3,CD53,CEACAM5,CFLAR,DKK1,DMPK,EDN1,EFNB2,EHD1,EHD2,FLOT1,GREM1,GSK3A,HDAC4,HDAC5,HDAC9,MAML1,MAPK14,MEF2C,MESP1,MMP14,MYLK3,MYOCD,MYOD1,MYOG,NACA,NKX2-5,NOTCH1,NOV,NRG1,PRICKLE1,PROX1,RBM24,SIK1,SMYD1,TBX1,TGFB1,WNT3A,XBP1	Any process that modulates the frequency, rate or extent of striated muscle cell differentiation.
GO:0051154	GO	BP	negative regulation of striated muscle cell differentiation	BHLHA15,BHLHE41,BMP2,CAV3,CEACAM5,CFLAR,DKK1,GSK3A,HDAC4,HDAC5,NKX2-5,NOTCH1,NOV,PRICKLE1,XBP1	Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle cell differentiation.
GO:0051155	GO	BP	positive regulation of striated muscle cell differentiation	AKAP6,BMP10,BMP4,CD53,EDN1,EFNB2,EHD1,EHD2,FLOT1,GREM1,MAML1,MAPK14,MEF2C,MESP1,MMP14,MYLK3,MYOCD,MYOD1,MYOG,NRG1,PROX1,SMYD1,TBX1,TGFB1,WNT3A	Any process that activates or increases the frequency, rate or extent of striated muscle cell differentiation.
GO:0051168	GO	BP	nuclear export	ADAR,AGFG1,ALKBH5,ALYREF,ATXN1,BUD13,CALR,CDC40,CHP1,CHTOP,CPSF1,CPSF2,CPSF3,CSE1L,DDX19B,DDX25,DDX39A,DDX39B,DHX38,DUSP16,EGR2,EIF4E,EIF5A,FIP1L1,FYTTD1,GLE1,HHEX,HNRNPA1,HNRNPA2B1,LSG1,LUZP4,MAGOH,MALT1,NCBP1,NCBP2,NEMF,NMD3,NUP107,NUP133,NUP160,NUP214,NUPL2,NUTF2,NXF1,NXF2,NXF3,NXF5,PABPN1,PHAX,PKD1,POLDIP3,RAE1,RAN,RBM8A,RITA1,RNPS1,RPS15,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SMURF1,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,STRADA,STRADB,STYX,TGFB1,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO1,XPO5,XPO6,XPO7,XPOT,ZC3H11A,ZC3H3	The directed movement of substances out of the nucleus.
GO:0051169	GO	BP	nuclear transport	AAAS,ADAR,AGFG1,AKR1C3,AKT1,ALKBH5,ALYREF,ANP32A,ATXN1,BCL3,BCL6,BUD13,C11orf73,CALR,CBLB,CDC40,CEP57,CHP1,CHTOP,CITED1,CPSF1,CPSF2,CPSF3,CSE1L,DAG1,DDX19B,DDX25,DDX39A,DDX39B,DHX38,DUSP16,EGF,EGR2,EIF4E,EIF5A,F2R,FIP1L1,FYB,FYTTD1,GCKR,GDF5,GLE1,HES1,HHEX,HNRNPA1,HNRNPA2B1,HTATIP2,IFNG,IPO13,IPO5,IPO9,JAK2,JAK3,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,LSG1,LUZP4,MAGOH,MALT1,MCM3AP,MT3,MYBBP1A,NCBP1,NCBP2,NCKIPSD,NEMF,NMD3,NOC2L,NOP58,NPM1,NSRP1,NUP107,NUP133,NUP160,NUP205,NUP214,NUP98,NUPL2,NUTF2,NXF1,NXF2,NXF3,NXF5,OPRD1,OR1D2,PABPN1,PDIA3,PHAX,PHB2,PKD1,POLDIP3,PPP1R10,PRICKLE1,PTTG1IP,RAE1,RAN,RANBP17,RANBP2,RBM22,RBM8A,RERE,RGS14,RITA1,RNPS1,RPAIN,RPL23,RPS15,RSRC1,SARNP,SEC61B,SET,SIX3,SLBP,SMG1,SMG5,SMG6,SMG7,SMURF1,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,STAT3,STRADA,STRADB,STYX,SYK,TBRG1,TGFB1,TGFB2,TGS1,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TNF,TNPO1,TNPO3,TPR,TRPS1,TSC1,TSC2,U2AF1,U2AF2,UPF1,UPF2,UPF3A,UPF3B,WRN,XPO1,XPO5,XPO6,XPO7,XPOT,ZC3H11A,ZC3H3,ZFYVE9	The directed movement of substances into, out of, or within the nucleus.
GO:0051170	GO	BP	nuclear import	ADAR,AKR1C3,AKT1,BCL3,BCL6,C11orf73,CBLB,CEP57,DAG1,EGF,F2R,FYB,GCKR,GDF5,HES1,HNRNPA1,HTATIP2,IFNG,IPO13,IPO5,IPO9,JAK2,JAK3,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA6,KPNB1,MCM3AP,MT3,NCKIPSD,NOP58,NUP205,NUP98,NUTF2,OPRD1,OR1D2,PDIA3,PHB2,PPP1R10,PRICKLE1,PTTG1IP,RAN,RANBP17,RANBP2,RBM22,RERE,RPAIN,RPL23,SEC61B,SIX3,STAT3,SYK,TGFB1,TGFB2,TGS1,TNF,TNPO1,TNPO3,TPR,TRPS1,TSC2,ZFYVE9	The directed movement of substances into the nucleus.
GO:0051180	GO	BP	vitamin transport	AFM,AMN,APOA1,CUBN,FOLR1,FOLR2,FOLR3,GIF,SCARB1,SLC19A1,SLC19A2,SLC23A1,SLC23A2,SLC25A32,SLC35F3,SLC46A1,SLC52A1,SLC52A2,SLC52A3,TTPA	The directed movement of vitamins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A vitamin is one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0051181	GO	BP	cofactor transport	ABCB6,ABCB7,ABCG2,FLVCR1,FLVCR2,FOLR1,FOLR2,FOLR3,PPT1,SLC19A1,SLC19A2,SLC25A17,SLC25A26,SLC25A32,SLC25A42,SLC33A1,SLC46A1,SLC48A1	The directed movement of a cofactor into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A cofactor is a substance that is required for the activity of an enzyme or other protein.
GO:0051183	GO	MF	vitamin transporter activity	FOLR1,FOLR2,RBP4,SLC19A1,SLC19A2,SLC19A3,SLC23A1,SLC23A2,SLC25A32,SLC46A1,SLC52A1,SLC52A2,SLC52A3	Enables the directed movement of vitamins into, out of or within a cell, or between cells. A vitamin is one of a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body.
GO:0051184	GO	MF	cofactor transporter activity	ABCB6,ABCB7,ABCG2,FLVCR1,FLVCR2,FOLR1,FOLR2,SLC16A12,SLC19A1,SLC19A2,SLC25A17,SLC25A26,SLC25A32,SLC25A42,SLC46A1,SLC6A8	Enables the directed movement of a cofactor into, out of or within a cell, or between cells. A cofactor is a substance that is required for the activity of an enzyme or other protein.
GO:0051187	GO	BP	cofactor catabolic process	ACOT7,AMBP,BLVRA,BLVRB,CYP4F11,CYP4F2,HMOX1,HMOX2,MLYCD,MTHFS,NUDT12,NUDT7,PDXP,UGT1A1,UGT1A4,VCP	The chemical reactions and pathways resulting in the breakdown of a cofactor, a substance that is required for the activity of an enzyme or other protein.
GO:0051188	GO	BP	cofactor biosynthetic process	ABCB6,ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSS1,ADCK3,AGK,ALAD,ALAS1,ALAS2,ATPIF1,BDH2,COASY,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,COX10,COX15,CPOX,DHFR,DLD,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FASN,FECH,FPGS,FXN,GCH1,GPHN,HACD1,HACD2,HMBS,HSD17B12,LIAS,MAT2A,MAT2B,ME1,MLYCD,MOCOS,MOCS1,MOCS2,MOCS3,MTHFD1,NFE2L1,NFS1,NMNAT1,NMNAT2,NMNAT3,OLAH,PANK1,PANK2,PDHA1,PDHB,PDHX,PDSS1,PDSS2,PDXK,PNP,PPCDC,PPCS,PPOX,PPT1,PPT2,SCD,SLC25A1,SLC25A16,SLC25A38,SPR,SUCLA2,TECR,THEM4,THEM5,TSPO,UBIAD1,UROD,UROS	The chemical reactions and pathways resulting in the formation of a cofactor, a substance that is required for the activity of an enzyme or other protein.
GO:0051196	GO	BP	regulation of coenzyme metabolic process	ACTN3,ARNT,CBFA2T3,DLAT,DLD,ECD,ENTPD5,FBP1,GAPDHS,GCK,HDAC4,HIF1A,IGF1,INS,INSR,ME1,ME2,MLXIPL,NCOR1,OGT,P2RX7,PDHA1,PDHB,PDHX,PDK1,PDK2,PDK3,PDK4,PDP1,PDP2,PDPR,PGAM1,PPARA,PRKAA1,PRKAA2,PRKAG1,PRKAG2,TIGAR	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a coenzyme.
GO:0051197	GO	BP	positive regulation of coenzyme metabolic process	ACTN3,ARNT,ENTPD5,GAPDHS,HIF1A,IGF1,INS,INSR,MLXIPL,P2RX7,PRKAA1,PRKAA2	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a coenzyme.
GO:0051205	GO	BP	protein insertion into membrane	BAG6,COX18,EGFR,GET4,GRIN3B,MOAP1,REEP1,RTP1,RTP2,UBL4A	The process that results in the incorporation of a protein into a biological membrane.  Incorporation in this context means having some part or covalently attached group that is inserted into the the hydrophobic region of one or both bilayers.
GO:0051209	GO	BP	release of sequestered calcium ion into cytosol	BBC3,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,DRD2,ERO1A,F2R,FGF2,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,LCK,NOL3,PKD2,PLCG2,PTPRC,RYR1,RYR2,TRDN,XCL1	The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment.
GO:0051213	GO	MF	dioxygenase activity	ADI1,ALKBH1,ALKBH2,ALKBH3,ALKBH4,ALKBH5,ALKBH8,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOXE3,BBOX1,BCO1,BCO2,CDO1,CYGB,EGLN1,EGLN2,EGLN3,ETHE1,FTO,HAAO,HIF1AN,HPD,IDO1,IDO2,JMJD6,KDM4A,KDM7A,KDM8,OGFOD1,P3H1,P3H2,P4HB,P4HTM,PHF8,PHYH,PIR,PTGS2,TDO2,TET1,TET2,TET3,TMLHE,TYW5	Catalysis of an oxidation-reduction (redox) reaction in which both atoms of oxygen from one molecule of O2 are incorporated into the (reduced) product(s) of the reaction. The two atoms of oxygen may be distributed between two different products.
GO:0051216	GO	BP	cartilage development	ALX1,AMELX,ATP7A,BMP1,BMP2,BMP4,BMPR1B,BMPR2,CER1,CHI3L1,COL11A2,COL2A1,CREB3L2,EIF2AK3,FGF2,FGF4,FGFR3,GDF2,GDF5,GHRL,GPLD1,HES5,HMGA2,HOXA11,HOXD3,IHH,IL17F,ITGB8,MEF2C,MGP,NFIB,NOV,NPPC,OSR1,OSR2,SCX,SNX19,SOX9,STC1,SULF1,SULF2,TGFB1,WNT7A,WNT7B,ZBTB16	The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
GO:0051219	GO	MF	phosphoprotein binding	CBLC,FBXW7,FGR,IGF2R,LDLRAP1,LRP11,NEDD4,PAFAH1B1,PIN1,PTPN5,RRAGA,SAMSN1,SNCA,TBL2,THRAP3	Interacting selectively and non-covalently with a phosphorylated protein.
GO:0051220	GO	BP	cytoplasmic sequestering of protein	AKT1,ANKRD13C,CCDC22,CREB3,FAF1,FLNA,G3BP2,GET4,GOPC,GPAA1,HK1,HK2,HSPA5,IL10,LATS1,MDFI,MXI1,NFKBIA,NFKBIE,NFKBIL1,OS9,PDIA2,PDIA3,PINK1,PKD1,PKD2,PSMD10,TONSL,YWHAB	The selective interaction of a protein with specific molecules in the cytoplasm, thereby inhibiting its transport into other areas of the cell.
GO:0051224	GO	BP	negative regulation of protein transport	ADIPOQ,ADRA2A,ANXA1,ANXA13,ANXA4,APC2,APOA1,APOA2,APOD,AXIN2,BAG4,BARD1,BMP7,BMP8A,BTN2A2,C1QTNF3,C5AR2,CABP1,CCDC22,CD34,CHP1,CIDEA,CREB3,CSK,CYLD,DAB2IP,DACT3,DERL2,DERL3,DMTN,DPH3,DRD2,DRD3,DRD4,DYRK2,EMD,ERLEC1,ERP29,EZR,F2R,F2RL1,FAF1,FAM3D,FAM89B,FBLN1,FFAR4,FN1,FOXP3,G3BP2,GAS6,GBP1,GDI1,GOPC,GSK3B,IFNA2,IL10,IL1B,IL36RN,INHBB,INPP5K,INS,IRS1,ITGB1BP1,KCNB1,KCNE1,KCNJ11,LGR4,LILRB1,LRRK2,MDFI,MDFIC,MXI1,NDFIP1,NDFIP2,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NOV,NR1H3,NR1H4,OPRM1,OS9,PARK2,PARK7,PARP10,PBLD,PDE2A,PIM3,PKD1,PKD2,PKDCC,PPM1A,PPM1B,PSMD10,PSMD9,PTGER4,PTPN22,PYDC2,RAB11FIP1,RAB11FIP3,RAB11FIP5,RAB23,RANGAP1,REST,RGCC,RHBDF1,RHBDF2,RSAD2,SERGEF,SFRP1,SFRP5,SIAH3,SIRT4,SLC9A3R1,SNAI2,SNX12,SNX3,SOX4,SP100,SRGN,SSC5D,SUFU,SVIP,TNF,TNFRSF21,TONSL,TRIM27,UBAC2,UBE2G2,UBE2J1,USP17L2,WWP2,WWTR1,YOD1,ZC3H12A	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051225	GO	BP	spindle assembly	ARHGEF10,AURKB,AURKC,CEP192,CEP63,CHEK2,CLASP1,CSNK1D,FAM175B,FLNA,GOLGA2,HAUS1,HAUS2,HAUS3,HAUS4,HAUS5,HAUS6,HAUS7,HAUS8,HDAC3,INO80,KIF11,KIF23,KIF2A,KIF3B,KIF4A,KIF4B,KIFC1,KPNB1,MAP10,NCOR1,NEK2,NEK6,NEK7,PIBF1,RAB11A,RACGAP1,RCC1,RHOA,RPS3,SPICE1,STARD9,TNKS,TPX2,ZNF207	The aggregation, arrangement and bonding together of a set of components to form the spindle, the array of microtubules and associated molecules that serves to move duplicated chromosomes apart.
GO:0051233	GO	CC	spindle midzone	ARL8A,ARL8B,AURKC,BUB1B,CDC42,CDC6,CENPE,CENPV,CTDP1,EML1,GEM,KIF14,KIF20B,MAP10,OR2A4,PKP4,PLK1,RACGAP1,RCC2,UNC119	The area in the center of the spindle where the spindle microtubules from opposite poles overlap.
GO:0051235	GO	BP	maintenance of location	AKT1,ALB,ANGPTL3,ANK3,ANKRD13C,ARHGAP21,ARL2,ARL2BP,ATP2A1,ATP7B,BBS4,BCL3,BSCL2,CALR,CASQ2,CAV1,CCDC22,CD36,CD4,CER1,CIDEA,CREB3,DAG1,DGAT1,DGAT2,ENPP1,EPB41L3,EZR,FAF1,FBN1,FBN2,FFAR2,FLNA,FLNB,FTH1,G3BP2,GAA,GET4,GOLPH3,GOPC,GPAA1,GPSM2,GSN,HK1,HK2,HSP90B1,HSPA5,IL10,IL1B,JUP,LATS1,LTBP1,MDFI,MORC3,MXI1,NBL1,NFKBIA,NFKBIE,NFKBIL1,OS9,PDIA2,PDIA3,PINK1,PKD1,PKD2,PML,PSMD10,S100A7,S100A8,S100A9,SCIN,SHANK1,SLC18A2,SLC30A8,SOAT1,SORL1,SPTBN4,SRGN,SRI,SUN1,SUN2,SUPT7L,SYNE1,SYNE2,SYNE3,TAF3,TAF8,TBCCD1,TLN1,TMSB4Y,TNF,TONSL,TOPORS,TWF1,TWF2,UVRAG,YWHAB	Any process in which a cell, substance or cellular entity, such as a protein complex or organelle, is maintained in a location and prevented from moving elsewhere.
GO:0051236	GO	BP	establishment of RNA localization	AGFG1,ALKBH5,ALYREF,ATM,ATR,ATXN2,BUD13,C14orf166,CDC40,CHTOP,CKAP5,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FLOT1,FYTTD1,GLE1,HHEX,HNRNPA1,HNRNPA2B1,KIF5C,LUZP4,MAGOH,MRPL18,NCBP1,NCBP2,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,PHAX,PNPT1,POLDIP3,RAE1,RAN,RBFOX1,RBM8A,RFTN1,RNPS1,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,TST,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO5,XPOT,ZC3H11A,ZC3H3	The directed movement of RNA to a specific location.
GO:0051238	GO	BP	sequestering of metal ion	ATP7B,CALR,CASQ2,FTH1,HSP90B1,S100A7,S100A8,S100A9,SLC30A8,SRI	The process of binding or confining metal ions such that they are separated from other components of a biological system.
GO:0051250	GO	BP	negative regulation of lymphocyte activation	ANXA1,ATM,BMP4,BTN2A2,CD274,CD300A,CDKN2A,CEBPB,CTLA4,DUSP3,FOXJ1,FOXP3,GLI3,GLMN,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,INHA,INHBA,IRF1,JAK3,KIAA0922,LAX1,LGALS3,LGALS9,LILRB1,LILRB2,LST1,MICA,MNDA,PDCD1LG2,PIBF1,PRKAR1A,PRNP,PTPN2,PTPN22,RC3H1,SAMSN1,SFRP1,SFTPD,SLA2,SOCS5,SOX11,THOC1,TIGIT,TNFAIP3,TNFRSF21,TNFSF4,XCL1,ZC3H8	Any process that stops, prevents, or reduces the frequency, rate or extent of lymphocyte activation.
GO:0051251	GO	BP	positive regulation of lymphocyte activation	ADAM8,AGER,AIF1,AKT1,ANXA1,AP1G1,AXL,BCL2,BTK,BTLA,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CCR7,CD1D,CD24,CD247,CD27,CD274,CD276,CD28,CD38,CD3D,CD3E,CD3G,CD4,CD46,CD47,CD55,CD6,CD74,CD80,CD81,CD86,CDC42,CHRNB2,CLCF1,CSK,CTLA4,DPP4,EBI3,FADD,FGF10,FLOT2,FOXP3,FYN,GAS6,GATA3,GLI2,GLI3,GPR183,GRAP2,GRB2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,IRS2,KLRK1,LAMP1,LCK,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MEF2C,MIF,MLST8,MMP14,MTOR,MYB,NCK1,NCK2,NCKAP1L,NFATC2,NKAP,NLRP3,NOD2,PAK1,PAK2,PAK3,PAXIP1,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RICTOR,SART1,SHH,SIRPG,SOCS5,SRC,SYK,TCF3,TESPA1,TGFB1,TGFBR2,THY1,TIRAP,TMIGD2,TNFRSF14,TNFRSF4,TNFSF11,TNFSF13,TNFSF13B,TNFSF4,TNIP2,TRAF2,TRAF6,VAV1,VAV3,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZNF335,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of lymphocyte activation.
GO:0051256	GO	BP	mitotic spindle midzone assembly	AURKB,AURKC,KIF23,KIF4A,KIF4B,MAP10,RACGAP1	The cell cycle process, occurring during anaphase, in which the aggregation, arrangement and bonding together of a set of components forms the spindle midzone.
GO:0051258	GO	BP	protein polymerization	AIF1,AKAP9,ANG,ARHGAP6,ARL6,BLOC1S2,CASQ1,CASQ2,CATIP,CENPJ,CHMP2A,CHMP3,CHMP4A,CLASP1,CLASP2,COBL,CORO7,CSNK1D,DNM1L,FGA,FGB,FGF13,FGG,GOLGA2,GSN,JAK2,MAP7D3,MICALL2,MID1IP1,MSRB1,MSRB2,PARK2,PREX1,RAC1,RANBP9,SLAIN2,TPPP,TRIM6,TRPV4,TTC17,TUBGCP2,TUBGCP3,TUBGCP4,TUBGCP5,TUBGCP6,UBE2C,UBE2K,UBE2S,VIL1,WASF1,WASF3,ZNF207	The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
GO:0051259	GO	BP	protein oligomerization	AASS,ACACA,ACACB,ACTN2,ADIPOQ,ADSL,AHNAK,AKR1C1,ALDH5A1,ALDOA,AMFR,ANXA2,ANXA6,AR,ASIC1,ATG16L1,ATL1,ATL2,ATL3,ATPIF1,BAX,BCL10,BLM,BRK1,C1QTNF3,C2orf44,CALHM1,CAMK2D,CAMK2G,CAT,CAV1,CCDC88C,CCL5,CDA,CHMP2A,CHMP3,CHMP4A,CHMP4B,CLDN1,CLDN3,COLEC12,CPSF6,CPSF7,CRYAA,CRYAB,DCXR,DECR1,DERL1,DGKD,DGKH,DHRS4,DNM1L,DPAGT1,DPYS,DPYSL3,ECT2,EIF2AK3,EPPIN,FBP1,FGFRL1,FIS1,FLOT1,GBP5,GCH1,GLRA3,GLS,GOLGA2,GPX3,GRHPR,HACL1,HBA1,HBB,HGSNAT,HIST1H3A,HIST1H4A,HIST3H3,HLA-DRB1,HM13,HMGCL,HMGCR,HMOX1,HPRT1,IDE,IGF1R,IGHMBP2,IKBKE,INSR,IRAK1,ITPR3,KCNC1,KCNC2,KCNC3,KCNJ12,KCNJ2,LONP1,LRP4,MAGI2,MALT1,MFF,MGST1,MICU1,MLC1,MLKL,MUC20,NACC1,NACC2,NBR1,NLGN1,NLRC4,NLRP3,NOD1,NOD2,NOL3,NPM1,NUDT21,NUFIP1,OAS1,OAT,OLFM4,OXA1L,PANX1,PANX2,PANX3,PEX11B,PEX14,PEX5,PFKL,PFKM,PKD2L1,PNPT1,POLQ,PRF1,QPRT,RASGRP1,RBMX,RIPK1,RIPK3,RPS19,RXRA,RYR3,S100A10,SAMHD1,SCARA5,SCUBE3,SEMG1,SEMG2,SEPT11,SEPT7,SEPT9,SH3GLB1,SHMT1,SHMT2,SKI,SKIL,SLC6A4,SLC9A1,SMARCAD1,SNX2,SPAST,SPTBN5,SRR,STOM,STOML2,STX2,SYT1,TAF10,TEK,TERF1,TGM3,THG1L,TMEM120A,TMEM120B,TNFAIP3,TOR1A,TOR1B,TOR2A,TP53,TRIM21,TRIM22,TRIM27,TRIM28,TRIM34,TRIM4,TRIM5,TRIM6,TRIM72,TRMT61B,TRPA1,TRPV5,TYSND1,UPK1A,UXS1,VWA2,VWF,WIZ,XRCC6,ZBTB1,ZC3H12A,ZNHIT6	The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
GO:0051260	GO	BP	protein homooligomerization	ACACA,ACACB,ACTN2,ADIPOQ,AKR1C1,ALDH5A1,ALDOA,ANXA6,ASIC1,ATG16L1,ATL1,ATL2,ATL3,ATPIF1,BAX,BCL10,BRK1,CALHM1,CAT,CAV1,CCDC88C,CDA,CHMP2A,CHMP4A,CHMP4B,CLDN1,CLDN3,COLEC12,CRYAA,CRYAB,DCXR,DECR1,DERL1,DGKD,DNM1L,DPYS,DPYSL3,ECT2,EIF2AK3,FBP1,FGFRL1,FIS1,FLOT1,GBP5,GCH1,GLRA3,GLS,GOLGA2,GPX3,HM13,HMOX1,HPRT1,IDE,IGHMBP2,IKBKE,ITPR3,KCNC2,KCNJ12,KCNJ2,LONP1,MFF,MGST1,MICU1,MLKL,MUC20,NACC1,NACC2,NLGN1,NLRC4,OLFM4,PEX11B,PEX14,PKD2L1,PNPT1,POLQ,PRF1,RBMX,RIPK1,RIPK3,RXRA,RYR3,SAMHD1,SCARA5,SCUBE3,SHMT1,SKI,SKIL,SMARCAD1,SPAST,SPTBN5,SRR,STOM,SYT1,TAF10,TERF1,THG1L,TMEM120A,TOR1A,TOR1B,TOR2A,TRIM72,TRMT61B,TRPA1,TYSND1,VWA2,VWF,ZBTB1	The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
GO:0051261	GO	BP	protein depolymerization	CCSAP,KIF18A,KIF18B,KIF19,KIF24,KIF2B,KIF2C,MICAL1,MICAL2,MICAL3,NCKAP5L,STMN1,SYNJ1,VIL1,VPS4A,VPS4B	The process in which protein polymers, compounds composed of a large number of component monomers, are broken down. Depolymerization occurs by the successive removal of monomers from an existing poly- or oligomeric protein.
GO:0051262	GO	BP	protein tetramerization	AASS,ACACA,ACACB,ACTN2,ADSL,ALDH5A1,ALDOA,ANXA2,ATPIF1,CAT,CCL5,CDA,CPSF6,CPSF7,DCXR,DECR1,DHRS4,DNM1L,DPYS,FBP1,GBP5,GLS,GOLGA2,GPX3,HIST1H3A,HIST1H4A,HIST3H3,HLA-DRB1,HM13,HMGCL,HMGCR,HPRT1,IGF1R,INSR,KCNC1,KCNC3,KCNJ12,KCNJ2,LRP4,NUDT21,OXA1L,PEX5,RPS19,RXRA,RYR3,S100A10,SAMHD1,SHMT1,SHMT2,SRR,TGM3,THG1L,TP53,TRPA1,TRPV5,UXS1,XRCC6	The formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits.
GO:0051271	GO	BP	negative regulation of cellular component movement	ACTN1,ACVR1C,ACVRL1,ADAM15,ADARB1,ADIPOQ,AGTR2,AIF1,ALOX15B,ANGPT2,ANGPT4,APOD,APOE,APOH,ARAP3,ARHGDIB,ARPIN,BMP10,BMP5,BST2,C5,C5AR2,CCL2,CCL21,CCL25,CCL28,CD300A,CHRD,CITED2,CLASP1,CLASP2,CLIC4,COL3A1,CORO1B,CORO1C,CSNK2B,CXCL12,CXCL13,CYP1B1,DAB2IP,DACH1,DAG1,DCN,DLC1,DLL4,DPEP1,DPYSL3,DRD2,ENG,EPHA1,EPPIN,EVL,FAM60A,FBLN1,FGF2,FLCN,FUZ,GATA3,GCSAM,GDF2,GREM1,GTPBP4,HAS1,HDAC5,HMGB1,HMOX1,HOXA7,HRG,HYAL2,IFITM1,IGFBP3,IGFBP5,IL4,ITGB1BP1,KANK1,KLF4,KLRK1,KRIT1,KRT16,LDLRAD4,LRP1,MAGI2,MAP2K5,MARVELD3,MCC,MIA3,MMRN2,NBL1,NDRG4,NF1,NF2,NKX2-1,NODAL,NOG,NOTCH1,NOV,NR2F2,PADI2,PBLD,PDCD10,PFN2,PHLDB2,PIN1,PKHD1,PKP2,PLCB1,PLXNB3,PODN,PTEN,PTGER4,PTPN23,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRO,PTPRR,PTPRU,RAP2C,RECK,RGCC,RHOA,RHOB,RNF20,RNF207,RNF41,SCAI,SEMA5A,SEMG1,SERPINE1,SFRP1,SFRP2,SHH,SLIT2,SMAD7,SP100,SPINT2,SRGAP2,STAP1,STARD13,STC1,STK24,STRAP,SULF1,SVBP,SYNJ2BP,TACSTD2,TBX5,TCAF1,TGFB1,TGFBR3,THBS1,THY1,TIMP1,TP53INP1,TPM1,TRIB1,VASH1,VCL,WAS,WASL,WNT11	Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of a cellular component.
GO:0051279	GO	BP	regulation of release of sequestered calcium ion into cytosol	AKAP6,ANK2,ASPH,ATP1A2,CACNA1C,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CEMIP,CLIC2,CXCL10,CXCL11,CXCL9,CXCR3,DIAPH1,DMD,DRD1,F2,F2R,F2RL3,FKBP1A,FKBP1B,GPER1,GSTM2,GSTO1,HAP1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,LACRT,NOS1,NPSR1,PDE4D,PDPK1,PKD2,PLCG1,PRKACA,PTK2B,RYR2,SLC8A1,SNCA,SRI,THY1,TRDN,TRPC1,XCL1	Any process that modulates the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
GO:0051281	GO	BP	positive regulation of release of sequestered calcium ion into cytosol	AKAP6,ASPH,CALM1,CAPN3,CEMIP,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,F2,F2R,F2RL3,GPER1,GSTM2,GSTO1,HAP1,HTT,JPH2,LACRT,NPSR1,PDPK1,PKD2,PLCG1,SNCA,THY1,TRDN,TRPC1,XCL1	Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
GO:0051282	GO	BP	regulation of sequestering of calcium ion	AKAP6,ANK2,ASPH,ATP1A2,BBC3,CACNA1C,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CCL19,CCL21,CCL3,CCR5,CCR7,CEMIP,CHERP,CLIC2,CXCL10,CXCL11,CXCL9,CXCR3,DIAPH1,DMD,DRD1,DRD2,ERO1A,F2,F2R,F2RL3,FGF2,FKBP1A,FKBP1B,GPER1,GSTM2,GSTO1,HAP1,HRC,HTR2A,HTR2B,HTR2C,HTT,IBTK,ITPR1,JPH1,JPH2,JPH3,JPH4,LACRT,LCK,NOL3,NOS1,NPSR1,PDE4D,PDPK1,PKD2,PLCG1,PLCG2,PRKACA,PTK2B,PTPRC,RYR1,RYR2,SLC8A1,SNCA,SRI,THY1,TRDN,TRPC1,XCL1	Any process that modulates the frequency, rate or extent of the binding or confining calcium ions such that they are separated from other components of a biological system.
GO:0051284	GO	BP	positive regulation of sequestering of calcium ion	CALM1,CASQ2,CLIC2,FKBP1B,GSTM2,GSTO1,PKD2,RYR2,SRI,TRDN	Any process that activates or increases the frequency, rate or extent of the binding or confining calcium ions such that they are separated from other components of a biological system.
GO:0051287	GO	MF	NAD binding	ADH4,BDH2,CRYL1,CTBP1,GLUD1,GRHPR,HPGD,ME1,NNT,SIRT2,SIRT5,SIRT6,SORD,UXS1	Interacting selectively and non-covalently with nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NAD+, or the reduced form, NADH.
GO:0051289	GO	BP	protein homotetramerization	ACACA,ACACB,ACTN2,ALDH5A1,ALDOA,ATPIF1,CAT,CDA,DCXR,DECR1,DNM1L,DPYS,FBP1,GBP5,GLS,GOLGA2,GPX3,HM13,HPRT1,KCNJ12,KCNJ2,RXRA,RYR3,SAMHD1,SHMT1,SRR,THG1L,TRPA1	The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits.
GO:0051290	GO	BP	protein heterotetramerization	ANXA2,HIST1H3A,HIST1H4A,HIST3H3,INSR,LRP4,S100A10,XRCC6	The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
GO:0051291	GO	BP	protein heterooligomerization	ANXA2,CHMP2A,CHMP3,CLDN1,CLDN3,HBA1,HBB,HIST1H3A,HIST1H4A,HIST3H3,INSR,ITPR3,KCNC2,LRP4,MAGI2,RIPK1,RIPK3,S100A10,SEMG1,SEMG2,SEPT11,SEPT7,SEPT9,SKIL,TMEM120A,TMEM120B,WIZ,XRCC6	The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
GO:0051292	GO	BP	nuclear pore complex assembly	AHCTF1,NDC1,NUP107,NUP153,NUP205,NUP93,NUP98	The aggregation, arrangement and bonding together of a set of components to form a nuclear pore complex.
GO:0051293	GO	BP	establishment of spindle localization	CDK5RAP2,CENPA,CLASP1,DYNC1H1,DYNLT1,ESPL1,FMN2,HTT,KPNB1,MAP4,MOS,NDC80,NDE1,NUSAP1,PAFAH1B1,SPDL1,SPIRE1,SPIRE2,ZW10	The directed movement of the spindle to a specific location in the cell.
GO:0051294	GO	BP	establishment of spindle orientation	CDK5RAP2,CENPA,CLASP1,DYNLT1,HTT,MAP4,MOS,NDC80,NDE1,PAFAH1B1,SPDL1,ZW10	Any process that set the alignment of spindle relative to other cellular structures.
GO:0051297	GO	BP	centrosome organization	ARHGEF10,ARL2,BBS4,BRCA2,BRSK1,C2CD3,CCP110,CDK1,CDK2,CDK5RAP2,CENPJ,CEP135,CEP152,CEP192,CEP250,CEP63,CEP68,CEP72,CETN2,CETN3,CHD3,CKAP5,CNTLN,CNTROB,CROCC,CTNNB1,FBXW5,GOLGA2,HAUS1,HAUS2,HAUS3,HAUS4,HAUS5,HAUS6,HAUS7,HAUS8,HEPACAM2,KIAA0101,KIF3B,NDE1,NEK2,NPM1,PCM1,PKD2,PLK1,PLK4,PPP1R12A,ROCK2,SASS6,SGOL1,SLC16A1,SSX2IP,STIL,TUBE1,USP33,UVRAG,UXT,WDR62,XRCC2	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized.
GO:0051298	GO	BP	centrosome duplication	ARHGEF10,BRCA2,BRSK1,C2CD3,CCP110,CDK2,CDK5RAP2,CENPJ,CEP135,CEP152,CEP192,CEP63,CEP72,CETN2,CNTROB,FBXW5,NDE1,PKD2,PLK4,ROCK2,SASS6,STIL,USP33,WDR62	The replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized.
GO:0051301	GO	BP	cell division	AHCTF1,ALKBH4,ANK3,ANLN,APC,ARHGEF11,ARL3,AURKB,BBS4,BCAR1,BCL2L1,BECN1,BIN3,BIRC5,BRCA2,CCNO,CDKN2A,CECR2,CENPJ,CEP55,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CIT,CKAP2,CLASP1,CNTROB,CUL3,CUL7,DAPK3,DCTN3,DIAPH2,DOCK7,ECT2,ESPL1,FGF13,FGFR2,FMN2,GNAI1,GNAI2,GNAI3,GOLGA2,INCENP,ING2,IST1,JTB,KIF13A,KIF20A,KIF23,KIF4A,KIF4B,KLHL13,KLHL22,KLHL9,MAP4,MITD1,MYH10,MYH9,NEK6,NEK7,NOX5,NUMB,NUMBL,NUSAP1,PARD3,PDCD6IP,PIK3C3,PLK1,PRC1,RAB10,RAB11A,RAB11FIP3,RAB11FIP4,RAB35,RACGAP1,RALA,RALB,RASA1,RGS14,RHOA,RHOB,RHOC,ROCK2,ROPN1B,SEPT5,SEPT6,SEPT7,SKA1,SKA2,SNX18,SNX33,SNX9,SON,SOX5,SPG20,SPIRE1,SPIRE2,SPTBN1,STAMBP,TEAD3,TGFB2,TTC19,TUBA1A,TUBA1B,TUBA1C,TUBB,USP8,VPS4A,VPS4B,WWTR1,ZFP36L2,ZFYVE26,ZNF365	The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
GO:0051303	GO	BP	establishment of chromosome localization	BECN1,BIRC5,C11orf85,C15orf43,CCDC79,CCNB1,CDC23,CDCA5,CDCA8,CENPE,CENPF,CHAMP1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,DLGAP5,FAM83D,FMN2,GEM,KIF14,KIF18A,KIF22,KIF2C,KIFC1,KPNB1,NDE1,PIBF1,PINX1,PSRC1,RAB11A,RB1,RRS1,SEH1L,SPDL1,SPICE1,VPS4A,VPS4B,ZW10	The directed movement of a chromosome to a specific location.
GO:0051304	GO	BP	chromosome separation	APITD1,DIS3L2,FANCM,M1AP,MEIOB,RECQL5,SMARCAD1,STRA13,TEX14	The cell cycle process in which paired chromosomes are detached from each other. Chromosome separation begins with the release of cohesin complexes from chromosomes; in budding yeast, this includes the cleavage of cohesin complexes along the chromosome arms, followed by the separation of the centromeric regions. Chromosome separation also includes formation of chromatid axes mediated by condensins, and ends with the disentangling of inter-sister catenation catalyzed by topoisomerase II (topo II).
GO:0051307	GO	BP	meiotic chromosome separation	APITD1,FANCM,M1AP,MEIOB,STRA13	The process in which chromosomes are physically detached from each other during meiosis.
GO:0051310	GO	BP	metaphase plate congression	BECN1,CCNB1,CDC23,CDCA5,CDCA8,CENPE,CENPF,CHAMP1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,FAM83D,GEM,KIF14,KIF18A,KIF22,KIF2C,KIFC1,KPNB1,PIBF1,PINX1,PSRC1,RAB11A,RB1,RRS1,SEH1L,SPDL1,SPICE1,VPS4A,VPS4B,ZW10	The alignment of chromosomes at the metaphase plate, a plane halfway between the poles of the spindle.
GO:0051339	GO	BP	regulation of lyase activity	ACR,ADCYAP1,ADCYAP1R1,ADGRD1,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CALCR,CAP1,CAP2,CCR2,CRHR1,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,FTMT,FXN,GABBR2,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GPER1,GRM2,GRM3,GRM7,GUCA1C,GUCA2A,GUCA2B,LHCGR,LTB4R2,MTRR,NF1,NOS3,NTRK1,NTRK2,OPRM1,P2RY11,PALM,PARK7,PDZD3,PHPT1,PRKCA,RAF1,RCVRN,VIP	Any process that modulates the frequency, rate or extent of lyase activity, the catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. They differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring.
GO:0051340	GO	BP	regulation of ligase activity	ABL1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AXIN1,BAG5,BMI1,BTRC,BUB1,BUB1B,BUB3,CCNB1,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDKN2A,CENPF,CUL1,DUSP1,DYNC1LI1,FBXO5,FBXW7,FZR1,GEN1,KLHL22,LCMT1,LIMK1,MAD1L1,MAD2L1,MAD2L2,MAGEA2,MAGEC2,MID1IP1,NHEJ1,PARK7,PCID2,PIN1,PINK1,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RPS27A,SKP1,SMAD7,TERF1,TEX14,TFIP11,TOPORS,TPR,TRIB3,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2L3,UBE2N,UBE2S,USP44,XRCC3,XRCC4,ZNF207	Any process that modulates the frequency, rate or extent of ligase activity, the catalysis of the ligation of two substances with concomitant breaking of a diphosphate linkage, usually in a nucleoside triphosphate. Ligase is the systematic name for any enzyme of EC class 6.
GO:0051341	GO	BP	regulation of oxidoreductase activity	ABL1,ABL2,AGT,AGTR1,AGTR2,AKT1,APOE,ATP2B4,ATP7A,CALM1,CAV1,CAV3,CDH3,CYGB,CYP27B1,DAOA,DDAH1,DDAH2,DHFR,DNM2,DRD5,ECSIT,EDN1,EDN2,EGFR,ENG,ESR1,FCER2,FGF23,FTMT,FXN,GCH1,GCHFR,GDNF,GFI1,GLA,GZMA,HDAC6,HIF1A,HP,HSP90AA1,HTR2B,IFNG,IL1B,INS,LEP,LRRK2,LYPLA1,MT3,NFKB1,NOD2,NOS1AP,NOS3,NOSIP,NOSTRIN,NPR3,OXA1L,PARK2,PARK7,POR,PRDX5,PRKG2,PTS,RFK,SCARB1,SIRT4,SNCA,SPR,SZT2,TERF2,TERT,TMLHE,TNF,VDR,WASL,ZDHHC21	Any process that modulates the frequency, rate or extent of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
GO:0051342	GO	BP	regulation of cyclic-nucleotide phosphodiesterase activity	CALM1,EGLN1,GNAT1,GNB2L1,MAPK7	Any process that modulates the frequency, rate or extent of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.
GO:0051349	GO	BP	positive regulation of lyase activity	ACR,ADCYAP1,ADCYAP1R1,ADGRD1,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AVPR2,CALCA,CALCR,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,FTMT,FXN,GIPR,GLP1R,GNAS,GPER1,GUCA1C,GUCA2A,GUCA2B,LHCGR,NF1,NOS3,NTRK1,NTRK2,P2RY11,PARK7,PRKCA,RAF1,RCVRN,VIP	Any process that activates or increases the frequency, rate or extent of lyase activity, the catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond.
GO:0051350	GO	BP	negative regulation of lyase activity	ADRA2A,CCR2,DRD2,DRD3,DRD4,EDNRB,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,LTB4R2,MTRR,OPRM1,PALM,PDZD3,PHPT1,PRKCA	Any process that stops or reduces the rate of lyase activity, the catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond.
GO:0051351	GO	BP	positive regulation of ligase activity	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,AXIN1,BMI1,BTRC,CCNB1,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CUL1,FBXO5,FBXW7,FZR1,MAGEA2,MAGEC2,MID1IP1,NHEJ1,PIN1,PINK1,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RPS27A,SKP1,TOPORS,TRIB3,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2L3,UBE2N,UBE2S,XRCC4	Any process that activates or increases the frequency, rate or extent of ligase activity, the catalysis of the ligation of two substances with concomitant breaking of a diphosphate linkage, usually in a nucleoside triphosphate.
GO:0051352	GO	BP	negative regulation of ligase activity	ABL1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BAG5,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN2A,CENPF,FBXO5,FZR1,KLHL22,LIMK1,MAD1L1,MAD2L1,MAD2L2,PARK7,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSMF1,RPS27A,SMAD7,TERF1,TEX14,TFIP11,TPR,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP44,ZNF207	Any process that stops or reduces the rate of ligase activity, the catalysis of the ligation of two substances with concomitant breaking of a diphosphate linkage, usually in a nucleoside triphosphate.
GO:0051353	GO	BP	positive regulation of oxidoreductase activity	ABL1,ABL2,AGT,AGTR1,AGTR2,AKT1,APOE,ATP7A,CDH3,CYP27B1,DHFR,EDN1,EDN2,ESR1,FCER2,FGF23,FTMT,FXN,GCH1,GDNF,HIF1A,HTR2B,IFNG,IL1B,INS,NOD2,NOS1AP,NPR3,PARK7,POR,RFK,SCARB1,SNCA,TERF2,TERT,TNF,VDR	Any process that activates or increases the frequency, rate or extent of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered.
GO:0051354	GO	BP	negative regulation of oxidoreductase activity	ATP2B4,CAV3,CYP27B1,DAOA,DRD5,ENG,GFI1,GLA,GZMA,HDAC6,HP,INS,LRRK2,MT3,NFKB1,NOSIP,OXA1L,PARK2,PRDX5,SNCA,TMLHE	Any process that stops or reduces the rate of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered.
GO:0051378	GO	MF	serotonin binding	HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A	Interacting selectively and non-covalently with serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties.
GO:0051382	GO	BP	kinetochore assembly	CENPA,CENPC,CENPE,CENPF,CENPT,CENPW,MIS12,POGZ	The aggregation, arrangement and bonding together of a set of components to form the kinetochore, a multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules.
GO:0051383	GO	BP	kinetochore organization	CENPA,CENPC,CENPE,CENPF,CENPH,CENPT,CENPW,MIS12,POGZ	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the kinetochore, a multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules.
GO:0051384	GO	BP	response to glucocorticoid	ADAM9,ANXA1,AQP1,CALCR,GHRHR,IL10,IL1RN,IL6,ISL1,KLF9,PDCD7,REST,TNF,UBE2L3	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
GO:0051393	GO	MF	alpha-actinin binding	DAG1,MYOT,NRAP,PALLD,SYNPO2	Interacting selectively and non-covalently with alpha-actinin, one of a family of proteins that cross-link F-actin as antiparallel homodimers. Alpha-actinin has a molecular mass of 93-103 KDa; at the N-terminus there are two calponin homology domains, at the C-terminus there are two EF-hands. These two domains are connected by the rod domain. This domain is formed by triple-helical spectrin repeats.
GO:0051402	GO	BP	neuron apoptotic process	APP,ATN1,BCL2,BID,BNIP3,CDK5,ERBB3,GAPDH,LIG4,NAE1,NLRP1,SIAH1,TNFRSF21	Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
GO:0051403	GO	BP	stress-activated MAPK cascade	ADORA2B,ARHGEF6,ATF1,ATF2,BIRC7,BTRC,CCL19,CCM2,CHUK,CREB1,CRKL,CUL1,DAB2IP,DAXX,DBNL,DUSP10,DUSP3,DUSP4,DUSP6,DUSP7,DUSP9,ELK1,ERN1,FBXW11,FOS,GPS1,GPS2,HACD3,IKBKB,IKBKG,IRAK1,IRAK2,JUN,LGALS9,MAP2K1,MAP2K3,MAP2K4,MAP2K6,MAP2K7,MAP3K10,MAP3K11,MAP3K12,MAP3K13,MAP3K2,MAP3K5,MAP3K6,MAP3K7,MAP3K8,MAP3K9,MAP4K1,MAP4K2,MAP4K3,MAP4K5,MAPK1,MAPK10,MAPK11,MAPK14,MAPK3,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,MDFIC,MEF2A,MEF2C,MINK1,MUL1,NFKB1,NOD1,NOD2,PKN1,PPP2R5D,PTGER4,RBM4,RIPK1,RIPK2,RPS27A,RPS6KA1,RPS6KA2,RPS6KA3,RPS6KA5,SH2D3A,SH2D3C,SKP1,TAB1,TAB2,TAB3,TAOK2,TNFRSF19,TNIK,TNIP2,TRAF6,TRIB1,UBA52,UBB,UBC,WNT5A	A series of molecular signals in which a stress-activated MAP kinase cascade relays one or more of the signals; MAP kinase cascades involve at least three protein kinase activities and culminate in the phosphorylation and activation of a MAP kinase.
GO:0051410	GO	BP	detoxification of nitrogen compound	GSTM1,GSTM2,GSTM3,MARC1,MARC2	Any process that reduces or removes the toxicity of nitrogenous compounds which are dangerous or toxic. This includes the aerobic conversion of toxic compounds to harmless substances.
GO:0051427	GO	MF	hormone receptor binding	ADCYAP1,ASXL1,BRCA1,BUD31,CALR,CCNE1,CDK7,CNOT1,CRX,CTNNB1,DDX17,DDX5,DDX54,DYX1C1,FHL2,FOXP1,GAS2L1,GH1,GRIP1,HMGA1,HMGN3,ISL1,JAK1,JAK2,JMJD1C,KAT5,KDM1A,KDM3A,LEF1,MED1,MED12,MED13,MED14,MED16,MED17,MED24,MED30,MED4,NCOA1,NCOA3,NCOA4,NCOA6,NCOA7,NKX3-1,NR4A2,NRIP1,NSD1,NUP62,OASL,PHB2,PIAS1,PIAS2,PKN1,PPARG,PPARGC1A,PPARGC1B,PPID,PRAME,PRKCB,PRMT2,PTH,PTHLH,RAN,RARG,RB1,RERG,RNF4,SNW1,SOCS2,TACC2,TAF10,TCF21,TGFB1I1,THRAP3,TRIP12,TRIP6,WIPI1,XBP1,ZNF366,ZNHIT3	Interacting selectively and non-covalently with a receptor for hormones.
GO:0051436	GO	BP	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,FBXO5,FZR1,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSMF1,RPS27A,TERF1,TEX14,TPR,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP44,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin ligase activity that contributes to the mitotic cell cycle.
GO:0051437	GO	BP	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,BTRC,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CUL1,FBXO5,FZR1,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RPS27A,SKP1,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1	Any process that activates, maintains or increases the rate of ubiquitin ligase activity that contributes to the regulation of the mitotic cell cycle phase transition.
GO:0051438	GO	BP	regulation of ubiquitin-protein transferase activity	ABL1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AXIN1,BAG5,BMI1,BTRC,BUB1,BUB1B,BUB3,CCNB1,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDK2,CDKN2A,CENPF,CUL1,DUSP1,DYNC1LI1,FBXO5,FBXW7,FEM1A,FEM1B,FZR1,GEN1,KLHL22,LCMT1,LIMK1,MAD1L1,MAD2L1,MAD2L2,MAGEA2,MAGEC2,PARK7,PCID2,PIN1,PINK1,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RPS27A,SKP1,SMAD7,TERF1,TEX14,TOPORS,TPR,TRIB3,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2L3,UBE2N,UBE2S,USP44,XRCC3,ZER1,ZNF207	Any process that modulates the frequency, rate or extent of ubiquitin transferase activity.
GO:0051439	GO	BP	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BTRC,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDK2,CENPF,CUL1,FBXO5,FZR1,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RPS27A,SKP1,TERF1,TEX14,TPR,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP44,ZNF207	A cell cycle process that modulates the frequency, rate or extent of ubiquitin ligase activity that contributes to the mitotic cell cycle.
GO:0051443	GO	BP	positive regulation of ubiquitin-protein transferase activity	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,AXIN1,BMI1,BTRC,CCNB1,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CUL1,FBXO5,FBXW7,FZR1,MAGEA2,MAGEC2,PIN1,PINK1,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RPS27A,SKP1,TOPORS,TRIB3,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2L3,UBE2N,UBE2S	Any process that activates, maintains or increases the rate of ubiquitin transferase activity.
GO:0051444	GO	BP	negative regulation of ubiquitin-protein transferase activity	ABL1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BAG5,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN2A,CENPF,FBXO5,FZR1,KLHL22,LIMK1,MAD1L1,MAD2L1,MAD2L2,PARK7,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSMF1,RPS27A,SMAD7,TERF1,TEX14,TPR,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP44,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin transferase activity.
GO:0051445	GO	BP	regulation of meiotic cell cycle	DMRT1,DUSP1,HORMAD1,MOS,NANOS2,NPM2,NPPC,PLCB1,PRDM9,RAD1,SIRT2,WEE2	Any process that modulates the rate or extent of progression through the meiotic cell cycle.
GO:0051447	GO	BP	negative regulation of meiotic cell cycle	DMRT1,DUSP1,HORMAD1,MOS,NANOS2,NPPC,RAD1	Any process that stops, prevents or reduces the rate or extent of progression through the meiotic cell cycle.
GO:0051452	GO	BP	intracellular pH reduction	ATP6V0E1,ATP6V0E2,ATP6V1H,CLCN3,CLN3,CLN5,CLN6,GPR89A,PPT1,RAB20,RAB38,RAB39A,RAB7A,SLC11A1	Any process that reduces the internal pH of a cell, measured by the concentration of the hydrogen ion.
GO:0051453	GO	BP	regulation of intracellular pH	ATP5B,ATP6V0E1,ATP6V0E2,ATP6V1H,BCL2,CA2,CFTR,CHP1,CLCN3,CLN3,CLN5,CLN6,GPR89A,LRRK2,NOX1,PPT1,RAB20,RAB38,RAB39A,RAB7A,SLC11A1,SLC26A3,SLC26A6,SLC9A1,TMEM165	Any process that modulates the internal pH of a cell, measured by the concentration of the hydrogen ion.
GO:0051454	GO	BP	intracellular pH elevation	BCL2,CFTR,CLN3,NOX1,SLC26A3,SLC26A6	Any process that increases the internal pH of a cell, measured by the concentration of the hydrogen ion.
GO:0051457	GO	BP	maintenance of protein location in nucleus	ARL2,ARL2BP,BBS4,BCL3,MORC3,PML,SUN1,SUN2,SUPT7L,SYNE1,TAF3,TAF8,TOPORS	Any process in which a protein is maintained in the nucleus and prevented from moving elsewhere. These include sequestration within the nucleus, protein stabilization to prevent transport elsewhere and the active retrieval of proteins that escape the nucleus.
GO:0051480	GO	BP	regulation of cytosolic calcium ion concentration	ABL1,ABL2,ADCY5,ADRA1A,AGTR1,ATP2B2,ATP2B4,AVPR1B,BBC3,BCAP31,BDKRB1,C1QTNF1,C3AR1,CACNA1A,CACNA1C,CALCA,CALCR,CAV1,CAV3,CCKBR,CCL19,CCL21,CCL3,CCR1,CCR3,CCR4,CCR5,CCR7,CCR9,CD24,CD36,CD52,CD55,CDH23,CHERP,CHRNA10,CHRNA9,CIB2,CLN3,CXCL13,CXCR4,CYSLTR1,DLG4,DRD1,DRD2,EDN1,EDN2,EDNRA,ERO1A,ESR1,F2,F2R,F2RL1,FGF2,FIS1,FKBP1B,GHRL,GLP1R,GNA15,GPER1,GRM1,HMGB1,HRC,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KNG1,LCK,LPAR1,LPAR2,LPAR3,MCHR1,NMUR2,NOL3,NPTN,OPRL1,OPRM1,P2RY1,P2RY4,PDE6A,PDE6B,PDGFRA,PKD2,PLCE1,PLCG2,PLN,PRKACA,PROK2,PTPRC,RYR1,RYR2,S1PR3,S1PR4,SAA1,SLC35G1,SLC8A1,SLC8B1,SPPL3,TAC1,TRDN,TRPC1,TRPM1,TRPV4,XCL1,XCR1	Any process involved in the maintenance of an internal steady state of calcium ions within the cytosol of a cell or between the cytosol and its surroundings.
GO:0051482	GO	BP	positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway	AGTR1,CALCA,DRD1,DRD2,F2R,GRM1,HTR2C,LPAR1	Any process that increases the concentration of calcium ions in the cytosol that occurs as part of a PLC-activating G-protein coupled receptor signaling pathway. G-protein-activated PLC hydrolyses phosphatidylinositol-bisphosphate (PIP2) to release diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 then binds to calcium release channels in the endoplasmic reticulum (ER) to trigger calcium ion release into the cytosol.
GO:0051488	GO	BP	activation of anaphase-promoting complex activity	CDC14B,CDC20,FZR1,PLK1,PTEN,UBE2C,UBE2S	Any process that initiates the ubiquitin ligase activity of the anaphase-promoting complex.
GO:0051489	GO	BP	regulation of filopodium assembly	AGRN,ARAP1,ARF6,BCAS3,CCL21,CCR7,CDC42,DMTN,DPYSL3,FNBP1L,FSCN1,GAP43,GPM6A,MIEN1,MYO10,NEURL1,NLGN1,NRXN1,PALM,PPP1R16B,PRKCD,RAB17,RAB5A,RALA,RHOQ,SRGAP2C,TENM1,TENM2,TGFB3,WASL	Any process that modulates the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
GO:0051491	GO	BP	positive regulation of filopodium assembly	AGRN,ARAP1,BCAS3,CCL21,CCR7,DPYSL3,FNBP1L,FSCN1,GPM6A,MIEN1,NEURL1,NLGN1,PALM,RALA,RHOQ,TENM1,TENM2,TGFB3,WASL	Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
GO:0051492	GO	BP	regulation of stress fiber assembly	ALMS1,AMOT,APOA1,ARAP1,ARHGAP6,ARHGEF10,ARHGEF10L,ARHGEF15,ARHGEF5,ASAP3,CLASP1,CLASP2,CTGF,DLC1,EPHA1,EVL,FHOD1,GPR65,INPP5K,ITGB1BP1,LPAR1,LRRC16A,MYOC,NF2,PAK1,PFN1,PFN2,PHLDB2,PPFIA1,PPM1E,PPM1F,PTGER4,RAC1,RAPGEF3,RGCC,RHOA,ROCK1,ROCK2,S100A10,SERPINF2,SFRP1,SLC9A1,SORBS3,SYNPO,TACSTD2,TPM1,TSC1,WASF2,WNT11	Any process that modulates the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
GO:0051494	GO	BP	negative regulation of cytoskeleton organization	ADD1,ADD2,APC,ARAP1,ARFGEF1,ARHGAP6,ARHGEF2,ARPIN,AURKA,AURKB,BRCA1,CAV3,CCNB1,CCNF,CDK5RAP2,CHMP2A,CIB1,CLASP1,CLASP2,CLIP3,CORO1A,CORO1B,DLC1,EML2,EPS8,FGF13,FKBP4,GAS2L1,GAS2L2,GSN,INPP5K,KANK1,KATNB1,LIMA1,MAPRE1,MDM1,MID1IP1,MYADM,MYOC,NEK2,NPM1,PARK2,PFN1,PFN2,PHLDB2,PICK1,PLEKHH2,PPFIA1,PRKCD,RBM14,SBDS,SCIN,SHANK1,SHANK3,SLIT2,SNCA,STMN2,TACSTD2,TBCD,TMEM67,TMSB4Y,TRIM37,TRIM54,TRIOBP,TWF1,TWF2,VIL1,WASF2	Any process that stops, prevents, or reduces the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures.
GO:0051495	GO	BP	positive regulation of cytoskeleton organization	ABI2,ACTN2,ACTR2,ACTR3,ALOX15,AMOT,APOA1,ARF6,ARHGEF10,ARHGEF10L,ARHGEF15,ARHGEF5,ARL2,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5,BAIAP2L1,BCAS3,BECN1,BMP10,BRK1,CAV3,CCL11,CCL21,CCL24,CCL26,CCNB1,CCR7,CDC42EP2,CDC42EP5,CDK5,CFL2,CLASP1,CLIP1,CSF3,CTGF,CTTN,CYFIP1,EDN1,EPHA1,EVL,F2RL1,FAM21C,FER,FES,FHOD1,GPR65,GSN,HAX1,HCK,HCLS1,HRAS,IQGAP2,ITGB1BP1,JMY,KATNB1,LIMK1,LPAR1,LRRC16A,MAGEL2,MAPT,MYLK3,MYOC,NCK1,NCK2,NCKAP1,NCKAP1L,NES,NF2,NTF3,NTRK3,P2RX7,PAK1,PDXP,PFDN2,PFN1,PFN2,PLEK,PLK4,PPM1E,PPM1F,PRKCE,PROX1,PSRC1,PTK2B,PYCARD,RAC1,RAPGEF3,RCC2,RGCC,RHOA,RPS3,S100A10,SCIN,SEMA5A,SERPINF2,SFRP1,SIRT2,SLAIN2,SORBS3,STAP1,STMN2,SYNPO,TEK,TENM1,TERF1,TPM1,TRIM27,TRPV4,VASP,VIL1,VPS4B,WASF1,WASH1,WHAMM,WNT11	Any process that activates or increases the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures.
GO:0051496	GO	BP	positive regulation of stress fiber assembly	AMOT,APOA1,ARHGEF10,ARHGEF10L,ARHGEF15,ARHGEF5,CTGF,EPHA1,EVL,FHOD1,GPR65,ITGB1BP1,LPAR1,LRRC16A,MYOC,NF2,PAK1,PFN2,PPM1E,PPM1F,RAC1,RAPGEF3,RGCC,RHOA,S100A10,SERPINF2,SFRP1,SORBS3,TPM1,WNT11	Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
GO:0051497	GO	BP	negative regulation of stress fiber assembly	ARAP1,ARHGAP6,CLASP1,CLASP2,DLC1,INPP5K,MYOC,PFN1,PHLDB2,PPFIA1,TACSTD2,WASF2	Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
GO:0051503	GO	BP	adenine nucleotide transport	CALHM1,SLC25A17,SLC25A24,SLC25A42,SLC25A6,SLC35B2	The directed movement of adenine nucleotides, ATP, ADP, and/or AMP, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051532	GO	BP	regulation of NFAT protein import into nucleus	AKAP6,CHERP,DYRK2,GSK3B,LACRT,PPP3CA,PPP3CB,PPP3R1,SLC9A1,SPPL3,TNF	Any process that modulates the frequency, rate or extent of the movement of an NFAT protein from the cytoplasm to the nucleus.
GO:0051533	GO	BP	positive regulation of NFAT protein import into nucleus	AKAP6,CHERP,LACRT,PPP3CA,PPP3CB,PPP3R1,SLC9A1,SPPL3,TNF	Any process that activates or increases the frequency, rate or extent of the movement of an NFAT protein from the cytoplasm to the nucleus.
GO:0051536	GO	MF	iron-sulfur cluster binding	ACO1,CISD2,ETFDH,EXO5,FDX1,FXN,MOCS1,NFU1,NUBP1,NUBPL,RPS3,RSAD2,SDHB,XDH	Interacting selectively and non-covalently with an iron-sulfur cluster, a combination of iron and sulfur atoms.
GO:0051537	GO	MF	2 iron, 2 sulfur cluster binding	CISD2,FDX1,FXN,SDHB,XDH	Interacting selectively and non-covalently with a 2 iron, 2 sulfur (2Fe-2S) cluster; this cluster consists of two iron atoms, with two inorganic sulfur atoms found between the irons and acting as bridging ligands.
GO:0051539	GO	MF	4 iron, 4 sulfur cluster binding	ACO1,ETFDH,EXO5,MOCS1,NFU1,NUBPL,RSAD2,SDHB	Interacting selectively and non-covalently with a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.
GO:0051549	GO	BP	positive regulation of keratinocyte migration	ADAM9,EPB41L4B,FGF10,FGF7,MMP9	Any process that activates or increases the frequency, rate or extent of keratinocyte migration.
GO:0051552	GO	BP	flavone metabolic process	UGT1A1,UGT1A10,UGT1A7,UGT1A8,UGT1A9	The chemical reactions and pathways involving flavones, a class of pigmented plant compounds based on 2-phenyl-4H-1-benzopyran-4-one (2-phenylchromone).
GO:0051560	GO	BP	mitochondrial calcium ion homeostasis	ATP2A1,BCAP31,CCDC109B,FIS1,MCU,MCUR1,MICU1,MICU2,RAP1GDS1,SLC8A3,SLC8B1,SMDT1,TGM2	Any process involved in the maintenance of an internal steady state of calcium ions within the cytoplasm of a cell or between mitochondria and their surroundings.
GO:0051561	GO	BP	positive regulation of mitochondrial calcium ion concentration	ATP2A1,BCAP31,FIS1,MCU,MCUR1,MICU1,RAP1GDS1,TGM2	Any process that increases the concentration of calcium ions in mitochondria.
GO:0051567	GO	BP	histone H3-K9 methylation	BEND3,EHMT2,PRDM5,SETDB2,SUV39H1,SUV39H2	The modification of histone H3 by addition of one or more methyl groups to lysine at position 9 of the histone.
GO:0051568	GO	BP	histone H3-K4 methylation	ASH2L,BEND3,CTR9,CXXC1,DPY30,KDM6A,KMT2A,KMT2B,KMT2C,KMT2D,KMT2E,OGT,PAXIP1,RBBP5,SETD1A,SETD1B,SETMAR,TET2,TET3,WDR5,WDR61,WDR82,ZNF335	The modification of histone H3 by addition of one or more methyl groups to lysine at position 4 of the histone.
GO:0051569	GO	BP	regulation of histone H3-K4 methylation	AUTS2,BCOR,BRCA1,CTCFL,CTNNB1,CTR9,DNMT1,DNMT3B,H2AFY,KMT2A,MYB,OGT,PAXIP1,PIH1D1,SMAD4,SNW1,WDR61	Any process that modulates the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.
GO:0051570	GO	BP	regulation of histone H3-K9 methylation	BRCA1,DNMT1,DNMT3B,HIST1H1B,JARID2,MYB,PIH1D1,PRDM12,SIRT1,SMARCB1	Any process that modulates the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3.
GO:0051571	GO	BP	positive regulation of histone H3-K4 methylation	AUTS2,BRCA1,CTNNB1,CTR9,DNMT1,DNMT3B,KMT2A,MYB,OGT,PAXIP1,SMAD4,SNW1,WDR61	Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.
GO:0051573	GO	BP	negative regulation of histone H3-K9 methylation	BRCA1,DNMT1,DNMT3B,PIH1D1,SMARCB1	Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3.
GO:0051574	GO	BP	positive regulation of histone H3-K9 methylation	HIST1H1B,JARID2,MYB,PRDM12,SIRT1	Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3.
GO:0051575	GO	MF	5'-deoxyribose-5-phosphate lyase activity	HMGA1,HMGA2,POLQ,XRCC5,XRCC6	Catalysis of the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site in DNA where a DNA-(apurinic or apyrimidinic site) lyase has already cleaved the C-O-P bond 3' to the apurinic or apyrimidinic site.
GO:0051580	GO	BP	regulation of neurotransmitter uptake	ATP1A2,DRD1,DRD2,DRD3,DRD4,GDNF,GPM6B,NOS1,PARK2,PER2,RAB3B,SNCA,TOR1A	Any process that modulates the frequency, rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell.
GO:0051584	GO	BP	regulation of dopamine uptake involved in synaptic transmission	DRD1,DRD2,DRD3,DRD4,GDNF,RAB3B,SNCA,TOR1A	Any process that modulates the frequency, rate or extent of the directed movement of the catecholamine neurotransmitter dopamine into a cell.
GO:0051588	GO	BP	regulation of neurotransmitter transport	ATP1A2,CAMK2A,CHRNA3,CHRNB4,DRD1,DRD2,DRD3,DRD4,DTNBP1,GDNF,GPER1,GPM6B,KCNMB4,LRRK2,MEF2C,NLGN1,NOS1,PARK2,PER2,RAB3A,RAB3B,RAB3GAP1,RAB5A,RIMS1,RIMS3,RIMS4,SEPT5,SLC30A1,SNCA,SNCAIP,STX1B,STXBP1,SYN1,SYT11,TOR1A,UNC13B	Any process that modulates the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051589	GO	BP	negative regulation of neurotransmitter transport	GPM6B,NOS1,PARK2,SLC30A1,SNCA,SYT11	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051590	GO	BP	positive regulation of neurotransmitter transport	DRD2,DRD4,DTNBP1,GPER1,NLGN1,PARK2,RAB3B,RAB3GAP1,STX1B,UNC13B	Any process that activates or increases the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051591	GO	BP	response to cAMP	AANAT,AKAP6,AKAP7,AKAP9,AQP1,CFTR,CITED1,CRHBP,DMTN,DUOX1,DUOX2,EZR,HCN1,HCN2,HCN4,IGFBP5,INPP5K,KCNE1,KCNQ1,NDUFS4,PDE4D,RAP1A,RAP1B,RAPGEF1,RAPGEF2,RAPGEF3,SLC26A3,SLC26A6,STAT1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
GO:0051592	GO	BP	response to calcium ion	ACER1,ADAM9,ADCY1,AHCYL1,AKR1C3,ALG2,ALOX15,ALOX5AP,ANXA11,AQP3,ASPH,BRAF,CALM1,CAMK2D,CAPN3,CARF,CASQ2,CASR,CAV1,CHP2,CLIC4,CPNE1,CPNE3,CPNE7,CRHBP,DMTN,DPEP1,ECT2,FGA,FGB,FGG,GPLD1,HOMER1,IQGAP1,ITPR3,KCNIP2,KCNMA1,KCNMB2,KCNMB3,KCNMB4,LCE1D,MEF2A,MEF2C,NEDD4,NEUROD2,PDCD6,PPIF,PPP3CA,RASA4,RASGRP2,RYR2,RYR3,SCN5A,SEC31A,SLC25A12,SLC25A13,SLC25A24,STIM1,SYT1,THBS1,TNNT2,TRPC1,TRPC3,TTN	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
GO:0051602	GO	BP	response to electrical stimulus	MYOG,NEUROD2,NSMF,REST,TRIM63	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
GO:0051604	GO	BP	protein maturation	ACE,ACE2,ACER2,ADAMTS13,ADAMTS3,AGT,AIFM1,AIP,ANP32B,ANPEP,APAF1,APH1A,APH1B,APOH,ASPH,ASPRV1,ATP6AP2,BACE2,BAD,BAK1,BAX,BBC3,BCL2L10,BCL2L11,BCL2L13,BGLAP,BOK,CALR,CARD8,CASP1,CASP2,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CGA,CGB,CHCHD4,CIDEB,CLN3,CLN5,CMA1,COL4A3,CORIN,CPA3,CTSG,CTSH,CTSS,CTSZ,CUZD1,CYCS,CYFIP2,DAP,DIABLO,DLC1,DNAJA3,ECE1,ECE2,EIF2AK3,ENPEP,F10,F11,F12,F2,F2R,F3,F7,F9,FADD,FAM162A,FAS,FASLG,FGA,FGB,FGG,FKBP1A,FKBP1B,FSHB,FURIN,FXN,GAS6,GGT1,GNB2L1,HFE2,HIP1,HSPD1,HSPE1,HTRA2,IFI16,IFI27,IFT57,IMMP2L,JAK2,KLK6,KLKB1,LCK,LHB,LONP2,LY96,METAP2,MIPEP,MME,MTCH1,MUL1,NCSTN,NGF,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NMT2,NOD1,OMA1,PCSK1,PCSK2,PCSK5,PCSK6,PCSK7,PCSK9,PDCD2,PERP,PLAT,POMC,PPARG,PPP2R5C,PROC,PROS1,PROZ,PRSS3,PSEN1,PSEN2,PSENEN,PTCH1,PYCARD,RCE1,REN,RET,RIPK1,ROBO1,RPS27A,RPS27L,S100A8,S100A9,SCG5,SENP1,SLC11A2,SMAD3,SNCA,SORL1,SRGN,STOML2,STUB1,TBC1D10A,TESC,TICAM1,TICAM2,TLR3,TLR4,TMPRSS2,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,TSG101,TSHB,TSPAN14,TSPAN15,TSPAN33,TSPAN5,TYSND1,UBA52,UBB,UBC,USP17L2,VCP,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,WFS1,XDH,XPNPEP3	Any process leading to the attainment of the full functional capacity of a protein.
GO:0051607	GO	BP	defense response to virus	ABCC9,APOBEC3A,APOBEC3B,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,ATG7,AZU1,BCL2,BNIP3,BNIP3L,BST2,CD207,CXADR,DDX58,EXOSC4,EXOSC5,F2RL1,FADD,FCN3,IFI16,IFIH1,IFIT5,IFNA2,IFNB1,IFNE,IFNL1,IFNL2,IFNL3,IFNL4,IFNLR1,IL6,IRF1,IRF3,IRF7,ISG15,ISG20,LILRB1,LYST,MAVS,MICA,MX2,NCBP3,OAS1,OAS3,OPRK1,PLSCR1,PMAIP1,PRF1,PTPRC,PYCARD,RELA,RNASEL,RSAD2,SAMHD1,SERINC3,SERINC5,SLFN11,TLR3,TLR7,TLR8,TMEM173,TRIM5,TRIM56	Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
GO:0051642	GO	BP	centrosome localization	ASUN,DLG1,EZR,GPSM2,NIN,SUN2,SYNE2,TBCCD1	Any process in which a centrosome is transported to, and/or maintained in, a specific location within the cell.
GO:0051645	GO	BP	Golgi localization	ARHGAP21,CDC42,COPG1,HOOK3,PDCD10,SLC9A3R1,STK25,TBCCD1,UVRAG,YWHAZ	Any process in which the Golgi is transported to, and/or maintained in, a specific location within the cell.
GO:0051646	GO	BP	mitochondrion localization	ALB,ATCAY,ATP2A1,BRAT1,CLUH,HIF1A,LRPPRC,LRRK2,MAP1S,MARK2,MEF2A,MFN2,MGARP,MSTO1,MTM1,MUL1,NEFL,OPA1,RHOT1,RHOT2,UBB,UXT	Any process in which a mitochondrion or mitochondria are transported to, and/or maintained in, a specific location within the cell.
GO:0051647	GO	BP	nucleus localization	DOCK7,HOOK3,PCM1,SLC9A3R1,SUN2,SYNE2	Any process in which the nucleus is transported to, and/or maintained in, a specific location within the cell.
GO:0051648	GO	BP	vesicle localization	ACTN4,ANKRD28,AP1AR,AP1M2,AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,ARCN1,AREG,ARF1,ARFGAP1,ARL6,BBS2,BBS4,BBS5,BBS7,BET1,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CANX,CD59,CDK5,CLASP1,CLASP2,CLN3,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,DNAJC5,DNM2,DOC2B,DTNBP1,DYNC1I1,F5,F8,FNBP1L,FOLR1,FYCO1,GBF1,GOLGA2,GORASP1,GOSR2,GPR143,GRIA1,HTT,IKBKG,ITSN1,KIF13A,KIF3A,KIF3B,KIF5B,KIFAP3,KLHL12,LMAN1,LRMP,MCFD2,MKKS,MYO1A,MYO5A,NAPA,NLGN1,NRXN1,NSF,OTOF,PACSIN1,PAFAH1B1,PCLO,PIP5K1C,PLD2,PPP6C,PPP6R1,PPP6R3,PREB,RAB11A,RAB11B,RAB17,RAB1A,RAB1B,RAB27A,RAB3A,RAB5A,RIMS1,RIMS2,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEPT5,SERPINA1,SHROOM2,SNAP23,SNAP25,SNAP29,SNAPIN,SNCA,SNPH,STON2,STX1B,STX5,SYNDIG1,SYNJ1,SYT1,TFG,TGFA,TMED10,TMED2,TMED9,TOR1A,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,UNC13B,USO1,VAMP2,VPS33A,VPS33B,WASL,WIPI1,WNT3A,WNT7A,YKT6	Any process in which a vesicle or vesicles are transported to, and/or maintained in, a specific location.
GO:0051650	GO	BP	establishment of vesicle localization	ACTN4,ANKRD28,AP1AR,AP1M2,AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,ARCN1,AREG,ARF1,ARFGAP1,ARL6,BBS2,BBS4,BBS5,BBS7,BET1,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CANX,CD59,CDK5,CLASP1,CLASP2,CLN3,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,DNAJC5,DNM2,DOC2B,DTNBP1,DYNC1I1,F5,F8,FNBP1L,FOLR1,FYCO1,GBF1,GOLGA2,GORASP1,GOSR2,GPR143,GRIA1,HTT,IKBKG,ITSN1,KIF13A,KIF3A,KIF3B,KIF5B,KIFAP3,KLHL12,LMAN1,LRMP,MCFD2,MKKS,MYO5A,NAPA,NLGN1,NSF,OTOF,PACSIN1,PAFAH1B1,PCLO,PIP5K1C,PLD2,PPP6C,PPP6R1,PPP6R3,PREB,RAB11A,RAB11B,RAB17,RAB1A,RAB1B,RAB27A,RAB3A,RAB5A,RIMS1,RIMS2,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SEPT5,SERPINA1,SHROOM2,SNAP23,SNAP25,SNAP29,SNAPIN,SNCA,SNPH,STON2,STX1B,STX5,SYNJ1,SYT1,TFG,TGFA,TMED10,TMED2,TMED9,TOR1A,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,UNC13B,USO1,VAMP2,WASL,WIPI1,WNT3A,WNT7A,YKT6	The directed movement of a vesicle to a specific location.
GO:0051651	GO	BP	maintenance of location in cell	AKT1,ALB,ANK3,ANKRD13C,ARHGAP21,ARL2,ARL2BP,ATP2A1,BBS4,BCL3,CAV1,CCDC22,CD4,CREB3,DAG1,EPB41L3,EZR,FAF1,FLNA,FLNB,FTH1,G3BP2,GAA,GET4,GOLPH3,GOPC,GPAA1,GPSM2,GSN,HK1,HK2,HSPA5,IL10,JUP,LATS1,MDFI,MORC3,MXI1,NFKBIA,NFKBIE,NFKBIL1,OS9,PDIA2,PDIA3,PINK1,PKD1,PKD2,PML,PSMD10,SCIN,SHANK1,SORL1,SPTBN4,SRGN,SRI,SUN1,SUN2,SUPT7L,SYNE1,SYNE2,SYNE3,TAF3,TAF8,TBCCD1,TLN1,TMSB4Y,TONSL,TOPORS,TWF1,TWF2,UVRAG,YWHAB	Any process in which a substance or cellular entity, such as a protein complex or organelle, is maintained in a specific location within, or in the membrane of, a cell, and is prevented from moving elsewhere.
GO:0051653	GO	BP	spindle localization	ASPM,CDK5RAP2,CENPA,CLASP1,DYNC1H1,DYNLT1,ESPL1,FMN2,HTT,KPNB1,MAP4,MOS,NDC80,NDE1,NUSAP1,PAFAH1B1,SPDL1,SPIRE1,SPIRE2,ZW10	Any process in which is the spindle is transported to, and/or maintained in, a specific location.
GO:0051657	GO	BP	maintenance of organelle location	ALB,ARHGAP21,ATP2A1,GPSM2,TBCCD1,UVRAG	Any process in which an organelle is maintained in a specific location within a cell and prevented from moving elsewhere.
GO:0051668	GO	BP	localization within membrane	ANKRD28,ARCN1,AREG,ARF1,ARFGAP1,BET1,CD2,CD59,CDH13,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,F5,F8,FOLR1,GBF1,GOLGA2,GOLPH3,GORASP1,GOSR2,GRIA1,KLHL12,LMAN1,MAL,MCFD2,MYO18A,NAPA,NDC1,NSF,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,RAC1,RALA,RILP,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,SNX3,STX5,TBC1D20,TFG,TGFA,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1,VAPA,VAPB	Any process in which a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within a membrane.
GO:0051683	GO	BP	establishment of Golgi localization	ARHGAP21,CDC42,COPG1,PDCD10,SLC9A3R1,STK25,YWHAZ	The directed movement of the Golgi to a specific location.
GO:0051693	GO	BP	actin filament capping	ADD1,ADD2,EPS8,GSN,SCIN,TRIOBP,TWF2,VIL1	The binding of a protein or protein complex to the end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits.
GO:0051701	GO	BP	interaction with host	AAAS,ACE2,ADRBK1,ALB,APCS,ATG7,AXL,BCL2L1,C9,CAV1,CAV2,CCNK,CCR5,CD209,CD4,CD55,CD81,CLEC4M,CLEC5A,CPSF4,CXCR4,DAG1,DERL1,DPP4,DYNLT1,EIF2AK2,EIF2AK4,EPS15,GAS6,HAVCR1,HIPK2,HYAL2,IFIT1,INSR,ITCH,ITGAV,ITGB3,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,LTF,NDC1,NEDD4,NPC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,POM121,POM121C,PPIA,PTX3,PVRL1,PVRL2,RAE1,RANBP2,RRAGA,RXRA,SEH1L,SERPINB3,SERPINB9,SIVA1,SLC22A5,SLC25A6,SMAD3,SUGT1,TAP1,TAP2,TGFB1,TNIP1,TPR,VAMP8,VAPA,VAPB,WWP1,WWP2,ZC3H12A,ZNF639	An interaction between two organisms living together in more or less intimate association. The term host is used for the larger (macro) of the two members of a symbiosis; the various forms of symbiosis include parasitism, commensalism and mutualism.
GO:0051702	GO	BP	interaction with symbiont	APCS,APOE,AQP1,AZU1,CAMP,CAV2,CCL3,CCL4,CCL5,CCNK,CFL1,CHD1,DDB1,EIF2AK4,EP300,HDAC1,HMGA2,HPN,INPP5K,JUN,LEF1,LTF,PARK2,PC,POU2F3,PPIB,PTX3,RAB9A,REST,SMARCA4,SMARCB1,SNW1,SP1,SUGT1,TAF11,TARDBP,TBC1D20,TFAP4,VAPA,VAPB,YTHDC2,ZC3H12A,ZNF502,ZNF639	An interaction between two organisms living together in more or less intimate association. The term symbiont is used for the smaller (macro) of the two members of a symbiosis; the various forms of symbiosis include parasitism, commensalism and mutualism.
GO:0051705	GO	BP	multi-organism behavior	APP,CHRNB2,CNTNAP2,DRD1,DRD3,DRD4,EIF4EBP2,GRID1,MAPK8IP2,MKKS,MTNR1A,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,PEX13,PTEN,SHANK1,SHANK2,SHANK3,SLC6A4,TBX1,UBR3	Any process in which an organism has a behavioral effect on another organism of the same or different species.
GO:0051709	GO	BP	regulation of killing of cells of other organism	F2RL1,FCER2,IFNG,NOS2,P2RX7	Any process that modulates the frequency, rate or extent of the killing by an organism of cells in another organism.
GO:0051721	GO	MF	protein phosphatase 2A binding	ANKLE2,ARPP19,CTTNBP2NL,DAB2IP,ENSA,FOXO1,GRIN3A,MASTL,PPME1,PPP2R4,SMG5,SMG7,STRN,STRN3,STRN4	Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.
GO:0051769	GO	BP	regulation of nitric-oxide synthase biosynthetic process	CCL2,EDN1,FCER2,GSTP1,JAK2,KDR,NAMPT,NOD2,TLR2,TLR4,TLR9,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric-oxide synthase enzyme.
GO:0051770	GO	BP	positive regulation of nitric-oxide synthase biosynthetic process	CCL2,FCER2,JAK2,KDR,NAMPT,NOD2,TLR2,TLR4,TLR9	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric oxide synthase enzyme.
GO:0051775	GO	BP	response to redox state	ADH5,ARNTL,CLOCK,FKBP1B,GLRX2,NPAS2,RNF7,RYR2,SIRT2,VIMP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating redox state. Redox state refers to the balance of oxidized versus reduced forms of electron donors and acceptors in an organelle, cell or organ; plastoquinone, glutathione (GSH/GSSG), and nicotinamide nucleotides (NAD+/NADH and NADP+/NADPH) are among the most important.
GO:0051781	GO	BP	positive regulation of cell division	AURKA,AURKB,AURKC,BECN1,BIRC5,CD28,CDC25B,CDC42,CDC6,CDCA5,CENPV,CIT,CSPP1,CUL3,CXCR5,DLGAP5,DMRT1,DRD2,DRD3,ECT2,EDN1,EDN3,EGF,EPGN,EREG,ESPL1,FGF1,FGFR2,GIPC1,H2AFY,HTR2B,IGF1,IGF2,IL1A,IL1B,INS,INSR,KIF14,KIF20B,KIF23,LRP5,MAP10,MRGPRX2,NKX3-1,NPM2,NSMCE2,NUSAP1,OPN1LW,OPN1MW,OR1A2,OR2A4,PDGFB,PDGFRB,PHB2,PHIP,PKN2,PKP4,PLCB1,PLK1,PRDM9,PRKCE,PTEN,RACGAP1,RB1,RGCC,RHOA,RXFP3,SHH,SIRT2,SLF1,SLF2,SMC5,SPAST,SSTR5,SVIL,TAL1,TAS1R2,TAS2R13,TERF1,TGFA,UBE2C	Any process that activates or increases the frequency, rate or extent of cell division.
GO:0051782	GO	BP	negative regulation of cell division	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AURKAIP1,AURKB,BLM,BMP4,BMP7,BUB1,BUB1B,BUB3,C10orf99,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CHEK1,CHMP4C,CSNK2A1,CSNK2A2,DMRT1,E2F7,E2F8,HORMAD1,KLHL22,MAD1L1,MAD2L1,MAD2L2,MYC,NANOS2,NME6,PLK1,RAD1,RGCC,SUSD2,TERF1,TEX14,TOM1L1,TOM1L2,TPR,TTK,TXNIP,UBE2C,UBE2D1,UBE2E1,VPS4A,ZFYVE19,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of cell division.
GO:0051783	GO	BP	regulation of nuclear division	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANLN,APC,ATM,AURKA,AURKAIP1,BECN1,BIRC5,BMP4,BMP7,BORA,BUB1,BUB1B,BUB3,CCDC8,CCNB1,CCSAP,CD28,CDC16,CDC20,CDC23,CDC25C,CDC26,CDC27,CDC6,CDCA5,CDK13,CENPE,CENPF,CEP85,CHEK1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4B,CHMP4C,CHMP5,CSNK2A1,CSNK2A2,CUL3,CUL7,CUL9,DAPK3,DLGAP5,DMRT1,DRD3,DUSP1,DYNC1LI1,EDN1,EDN3,EGF,EPGN,EREG,ESPL1,FBXO5,GEN1,H2AFY,HORMAD1,IGF1,IGF2,IL1A,IL1B,INS,INSR,KIF11,KIF20B,KLHL22,KNTC1,L3MBTL1,LCMT1,LRP5,MAD1L1,MAD2L1,MAD2L1BP,MAD2L2,MOS,NANOS2,NEK2,NEK6,NME6,NPM2,NSMCE2,NUSAP1,OBSL1,PCID2,PDGFB,PDGFRB,PDXP,PHB2,PHIP,PIN1,PKMYT1,PLCB1,PLK1,PPP1R9B,PRDM9,PRMT5,PTEN,RAD1,RB1,RCC1,RGCC,SIRT2,SLF1,SLF2,SMC5,TERF1,TEX14,TGFA,TOM1L1,TOM1L2,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,VPS4B,WEE2,XRCC3,ZNF207,ZW10	Any process that modulates the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.
GO:0051784	GO	BP	negative regulation of nuclear division	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AURKAIP1,BMP4,BMP7,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CHEK1,CSNK2A1,CSNK2A2,DMRT1,HORMAD1,KLHL22,MAD1L1,MAD2L1,MAD2L2,NANOS2,NME6,PLK1,RAD1,RGCC,TERF1,TEX14,TOM1L1,TOM1L2,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	Any process that stops, prevents, or reduces the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.
GO:0051785	GO	BP	positive regulation of nuclear division	AURKA,BECN1,BIRC5,CD28,CDCA5,CUL3,DLGAP5,DMRT1,DRD3,EDN1,EDN3,EGF,EPGN,EREG,ESPL1,H2AFY,IGF1,IGF2,IL1A,IL1B,INS,INSR,LRP5,NPM2,NSMCE2,NUSAP1,PDGFB,PDGFRB,PHB2,PHIP,PLCB1,PLK1,PRDM9,PTEN,RB1,RGCC,SIRT2,SLF1,SLF2,SMC5,TERF1,TGFA,UBE2C	Any process that activates or increases the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.
GO:0051787	GO	MF	misfolded protein binding	BAG6,CLU,DNAJB9,DNAJC10,EDEM1,F12,HSPA5,STUB1	Interacting selectively and non-covalently with a misfolded protein.
GO:0051788	GO	BP	response to misfolded protein	ATXN3,CLU,DERL1,F12,HDAC6,RNF126,RNF5,STUB1,TOR1A,UBE2W,UFD1L,VCP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus.
GO:0051797	GO	BP	regulation of hair follicle development	CDH3,FST,GAL,HPSE,TGFB2	Any process that modulates the frequency, rate or extent of hair follicle development.
GO:0051817	GO	BP	modification of morphology or physiology of other organism involved in symbiotic interaction	AAAS,ALB,APCS,APOE,AQP1,ATG7,AZU1,BCL2L1,C9,CAMP,CAV2,CCL3,CCL4,CCL5,CCNK,CD209,CD4,CFL1,CHD1,CLEC4M,CPSF4,DAG1,EIF2AK2,EIF2AK4,EP300,HDAC1,HIPK2,HMGA2,HPN,HYAL2,INPP5K,INSR,ITGAV,JUN,KPNA1,KPNA2,KPNA3,KPNA4,KPNA5,KPNA7,KPNB1,LEF1,LTF,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,PABPN1,PARK2,PC,POM121,POM121C,POU2F3,PPIB,PTX3,RAB9A,RAE1,RANBP2,REST,RRAGA,RXRA,SEH1L,SERPINB9,SLC25A6,SMAD3,SMARCA4,SMARCB1,SNW1,SP1,SUGT1,TAF11,TARDBP,TBC1D20,TFAP4,TGFB1,TNIP1,TPR,VAPA,VAPB,YTHDC2,ZC3H12A,ZNF502,ZNF639	The process in which an organism effects a change in the structure or processes of a second organism, where the two organisms are in a symbiotic interaction.
GO:0051823	GO	BP	regulation of synapse structural plasticity	CAMK1,CAMK2B,CTNNA2,FRMPD4,SHANK3	Any process that modulates the frequency, rate or extent of synapse structural plasticity. Synapse structural plasticity is a type of cytoskeletal remodeling; this remodeling is induced by stimuli that can lead to long term potentiation and it can be activity-dependent or -independent. Examples of cytoskeletal changes include the formation of new spines and increase in spine size; this can be accompanied by the insertion of greater numbers of glutamate (or other neurotransmitter) receptors into the post-synaptic membrane.
GO:0051851	GO	BP	modification by host of symbiont morphology or physiology	APCS,APOE,AQP1,AZU1,CAMP,CAV2,CCL3,CCL4,CCL5,CCNK,CFL1,CHD1,EIF2AK4,EP300,HDAC1,HMGA2,HPN,INPP5K,JUN,LEF1,LTF,PARK2,PC,POU2F3,PPIB,PTX3,RAB9A,REST,SMARCA4,SMARCB1,SNW1,SP1,SUGT1,TAF11,TARDBP,TBC1D20,TFAP4,VAPA,VAPB,YTHDC2,ZC3H12A,ZNF502,ZNF639	The process in which an organism effects a change in the structure or processes of a symbiont organism. The symbiont is defined as the smaller of the organisms involved in a symbiotic interaction.
GO:0051861	GO	MF	glycolipid binding	CD1C,CEACAM5,CLIP3,DPEP1,GLTP,GPAA1,MPPE1,PIGK,PIGU,PLEKHA8,SELL,SELP,THY1,VNN1	Interacting selectively and non-covalently with a glycolipid, any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic group such as an acylglycerol, a sphingoid, a ceramide (N-acylsphingoid) or a prenyl phosphate.
GO:0051865	GO	BP	protein autoubiquitination	AMFR,BFAR,BRCA1,CNOT4,DDB2,ERCC8,LRSAM1,MARCH5,PARK2,RAG1,RCHY1,RNF10,RNF11,RNF115,RNF13,RNF141,RNF146,RNF181,RNF185,RNF187,RNF208,RNF213,RNF220,RNF4,RNF41,RNF8,STUB1,TRAF2,TRAF6,TRIM13,TRIM17,TRIM21,TRIM37,TRIM68,TRIM71,UBE2A,UBE2B,UBE2D2,UBE2D3,UBE2T,UBE3A,UHRF1,UHRF2,WWP2	The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink.
GO:0051879	GO	MF	Hsp90 protein binding	AHR,ARNTL,CSNK2A1,ERN1,FKBP6,HDAC6,HIF1A,KDR,NASP,NOD2,NPAS2,PACRG,PPEF2,PPID,RPS3,STUB1,USP19	Interacting selectively and non-covalently with Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size.
GO:0051881	GO	BP	regulation of mitochondrial membrane potential	ABL1,ARL6IP5,ATPIF1,BAD,BAK1,BAX,BCL2,BCL2L1,BCO2,CDKN2A,DCN,GNB2L1,HEBP2,IFI6,KDR,LRRK2,MLLT11,MYOC,NDUFS1,OPRD1,PARK7,PID1,PINK1,PMAIP1,PRDX3,PRELID1,PYCR1,SLC25A33,SLC25A36,SOD1,SPG20,SRC,STOML2,STOX1,UBB,VCP	Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
GO:0051890	GO	BP	regulation of cardioblast differentiation	GATA4,NKX2-5,PRICKLE1,TBX5,TGFB2,WNT3A	Any process that modulates the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
GO:0051893	GO	BP	regulation of focal adhesion assembly	ACVRL1,APOD,ARHGAP6,BCAS3,CLASP1,CLASP2,COL16A1,CORO1C,DAPK3,DLC1,DMTN,EFNA5,EPHA3,GPM6B,HRG,ITGB1BP1,KDR,LIMS1,MACF1,MYOC,PHLDB2,PPM1F,PTEN,PTK2,PTPRJ,RAC1,RCC2,ROCK1,ROCK2,S100A10,SFRP1,SLC9A1,SRC,TEK,THBS1,TSC1,VEGFA	Any process that modulates the frequency, rate or extent of focal adhesion formation, the establishment and maturation of focal adhesions.
GO:0051894	GO	BP	positive regulation of focal adhesion assembly	COL16A1,HRG,KDR,LIMS1,MYOC,PPM1F,PTPRJ,RAC1,ROCK1,S100A10,SFRP1,TEK,TSC1,VEGFA	Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
GO:0051895	GO	BP	negative regulation of focal adhesion assembly	ACVRL1,APOD,ARHGAP6,BCAS3,CLASP2,CORO1C,DLC1,DMTN,ITGB1BP1,PHLDB2,PTEN,RCC2,SRC,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
GO:0051896	GO	BP	regulation of protein kinase B signaling	ADAM8,AKR1C2,AKR1C3,ANGPT1,C1QBP,CCL19,CCL21,CCR7,CHI3L1,CIB1,CPNE1,CSF3,DAG1,DDIT3,DRD2,DRD3,EGFR,EPHA2,F10,F3,F7,FAM110C,FLCN,GAS6,GATA3,GCNT2,GNB2L1,GPER1,HAX1,HBEGF,HCLS1,HPSE,HYAL2,IGF2,IL26,INPP5K,INS,INSR,ITGB1BP1,LEP,MAGI2,MC1R,MST1R,MSTN,MTDH,MUL1,MYDGF,MYOC,OSBPL8,PARK7,PDCD6,PDGFA,PHLDA3,PHLPP1,PIK3CG,PIK3R5,PINK1,PKHD1,PLEKHA1,PTEN,PTK2,PTPRJ,RASD2,RICTOR,RNF41,RRAS,SEMA5A,SFRP5,SIRT1,SLC9A3R1,SPRY2,SRC,TCF7L2,TEK,TGFB1,TGFBR1,THBS1,THPO,TNFAIP8L3,TSC2,TSPYL5,TXN,VEGFB,XDH,ZP3	Any process that modulates the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
GO:0051897	GO	BP	positive regulation of protein kinase B signaling	ADAM8,AKR1C2,AKR1C3,ANGPT1,C1QBP,CCL19,CCL21,CCR7,CHI3L1,CPNE1,CSF3,EGFR,F10,F3,F7,FAM110C,GAS6,GATA3,GCNT2,HAX1,HBEGF,HCLS1,HPSE,IGF2,IL26,INS,INSR,ITGB1BP1,LEP,MC1R,MST1R,MTDH,MYDGF,MYOC,OSBPL8,PARK7,PDGFA,PIK3CG,PIK3R5,PINK1,PTK2,PTPRJ,RASD2,SEMA5A,SPRY2,SRC,TCF7L2,TEK,TGFB1,TGFBR1,THBS1,THPO,TNFAIP8L3,TSPYL5,TXN,VEGFB,ZP3	Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
GO:0051898	GO	BP	negative regulation of protein kinase B signaling	CIB1,DAG1,DDIT3,DRD2,DRD3,EPHA2,FLCN,GNB2L1,GPER1,HYAL2,INPP5K,MAGI2,MSTN,MUL1,PDCD6,PHLDA3,PHLPP1,PKHD1,PLEKHA1,PTEN,PTPRJ,SFRP5,SIRT1,SLC9A3R1,TSC2,XDH	Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
GO:0051899	GO	BP	membrane depolarization	ABL1,ANK2,ATP1A2,ATPIF1,BEST2,CACFD1,CACNA1A,CACNA1B,CACNA1D,CACNA1E,CACNB3,CACNB4,CACNG2,CACNG4,CAV1,CDKN2A,CHRNA4,CHRNB2,KCNH2,KCNJ2,P2RX4,P2RX7,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,YWHAH	The process in which membrane potential decreases with respect to its steady-state potential, usually from negative potential to a more positive potential. For example, the initial depolarization during the rising phase of an action potential is in the direction from the negative steady-state resting potential towards the positive membrane potential that will be the peak of the action potential.
GO:0051900	GO	BP	regulation of mitochondrial depolarization	BCL2,DCN,GNB2L1,IFI6,KDR,LRRK2,MLLT11,MYOC,SRC	Any process that modulates the frequency, rate or extent of the change in the membrane potential of the mitochondria from negative to positive.
GO:0051901	GO	BP	positive regulation of mitochondrial depolarization	DCN,GNB2L1,KDR,MLLT11,MYOC	Any process that activates, maintains or increases the frequency, rate or extent of the change in the membrane potential of the mitochondria from negative to positive.
GO:0051917	GO	BP	regulation of fibrinolysis	APOH,F11,F12,F2,FAP,KLKB1,PLG,SERPINE1,SERPINF2,THBD,THBS1,USF1	Any process that modulates the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.
GO:0051918	GO	BP	negative regulation of fibrinolysis	APOH,F2,PLG,SERPINE1,SERPINF2,THBD,THBS1,USF1	Any process that stops, prevents, or reduces the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.
GO:0051920	GO	MF	peroxiredoxin activity	PRDX1,PRDX2,PRDX3,PRDX4,PRDX5	Catalysis of the reaction: 2 R'-SH + ROOH = R'-S-S-R' + H2O + ROH.
GO:0051923	GO	BP	sulfation	CHST4,CHST5,HS3ST5,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,UST	The addition of a sulfate group to a molecule.
GO:0051924	GO	BP	regulation of calcium ion transport	ADRA2A,AHNAK,AKAP6,ANK2,ASPH,ATP1A2,ATP1B1,BCL2,CACNA1C,CACNA1D,CACNA2D1,CACNB2,CACNB4,CALCA,CALM1,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CAPN3,CASQ1,CASQ2,CAV1,CAV3,CCL2,CCL3,CCL4,CCL5,CCR1,CD84,CEMIP,CLIC2,CRACR2A,CREB3,CRHR1,CTNNB1,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,DIAPH1,DMD,DRD1,DRD2,DRD4,EGF,EPO,EPPIN,F2,F2R,F2RL3,FFAR1,FKBP1A,FKBP1B,GNB5,GPER1,GRIN3B,GRM6,GSTM2,GSTO1,HAP1,HOMER1,HRC,HTT,INPP5K,JPH1,JPH2,JPH3,JPH4,LACRT,LGALS3,LILRB1,LILRB2,LRRK2,MRLN,MYLK,NOS1,NOS1AP,NPPA,NPSR1,ORAI1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PACSIN3,PDE4B,PDE4D,PDGFB,PDGFRB,PDPK1,PKD2,PLA2G1B,PLCG1,PLN,PML,PRKACA,PTK2B,RYR2,SARAF,SEMG1,SLC30A1,SLC8A1,SLC9A1,SLN,SNCA,SRI,STC1,STIM1,STIM2,THY1,TLR9,TMEM110,TRDN,TRIM27,TRPC1,TRPC3,TRPC6,UBQLN1,WFS1,WNK3,XCL1,ZP3	Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051926	GO	BP	negative regulation of calcium ion transport	ADRA2A,ATP1A2,CALCA,CALM1,CASQ2,CAV3,CLIC2,CRHR1,DRD2,DRD4,EPO,EPPIN,FKBP1B,GNB5,GSTM2,GSTO1,INPP5K,LILRB1,LILRB2,MRLN,NOS1,PACSIN3,PKD2,PLN,SEMG1,SLC30A1,SLN,SRI,STC1,TLR9,TRDN,TRIM27,UBQLN1	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051928	GO	BP	positive regulation of calcium ion transport	AKAP6,ANK2,ASPH,ATP1B1,CACNA1D,CACNB2,CALM1,CAMK2A,CAPN3,CAV1,CCL2,CCL3,CCL4,CCL5,CCR1,CEMIP,CRACR2A,CREB3,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,DRD1,F2,F2R,F2RL3,FFAR1,GPER1,GRM6,GSTM2,GSTO1,HAP1,HTT,JPH2,LACRT,LGALS3,MYLK,NPSR1,ORAI1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PDGFB,PDGFRB,PDPK1,PKD2,PLA2G1B,PLCG1,RYR2,SLC9A1,SNCA,STC1,STIM1,STIM2,THY1,TMEM110,TRDN,TRPC1,TRPC3,TRPC6,WFS1,WNK3,XCL1,ZP3	Any process that activates or increases the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051930	GO	BP	regulation of sensory perception of pain	ACPP,CCL3,F2R,MGLL,NOV,PROL1,SCN11A,SPX,TMEM100	Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
GO:0051952	GO	BP	regulation of amine transport	ADRA2A,ADRA2B,ADRA2C,ADRBK1,ATP1A2,CARTPT,CHGA,CHRNA3,CHRNA4,CHRNB2,DRD1,DRD2,DRD3,DRD4,DTNBP1,FFAR3,GDNF,GRM7,KCNA2,KCNB1,PARK2,PER2,RAB3B,RAB3GAP1,SNCA,STX1A,TOR1A	Any process that modulates the frequency, rate or extent of the directed movement of amines into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051953	GO	BP	negative regulation of amine transport	ADRA2A,ADRA2B,ADRA2C,CHGA,GRM7,SNCA	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of amines into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051954	GO	BP	positive regulation of amine transport	ADRBK1,CARTPT,CHRNB2,DRD2,DRD4,GDNF,KCNB1,RAB3B,RAB3GAP1,STX1A	Any process that activates, maintains or increases the frequency, rate or extent of the directed movement of amines into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0051961	GO	BP	negative regulation of nervous system development	ADCY6,APOE,ARHGDIA,ARHGEF1,ARHGEF15,ASCL1,BAG5,BCL11A,BMP7,CALR,CBFA2T2,CHRD,CIB1,CNTN4,COL3A1,DCC,DICER1,DKK1,DLL1,DPYSL3,DRD3,DTX1,DYNLT1,EDNRB,EFNA1,EIF2AK3,EIF2AK4,EPHA4,F2,FGF13,FKBP4,GAK,GDI1,GFI1,GORASP1,GPR161,HDAC2,HES1,HES5,HOOK3,ID2,ITM2C,KANK1,KIAA0319,KLK8,LINGO1,LPAR1,LRP4,MAG,MED1,MT3,NEUROD2,NF1,NGEF,NGFR,NLGN1,NOG,NOTCH1,OMG,PAQR3,PAX6,PCM1,PTEN,PTPRO,RAB29,RAPGEF2,REST,RHOA,RNF10,RNF6,ROBO2,RTN4,RTN4R,RUFY3,SEMA5A,SIRT2,SIX3,SKI,SLIT1,SLIT2,SORL1,SOX11,SOX2,SOX3,SOX9,SPOCK1,SRGAP2,SRGAP2C,STMN2,THY1,TNFRSF21,TRPV4,WNT3A,WNT7A,YWHAH	Any process that stops, prevents, or reduces the frequency, rate or extent of nervous system development, the origin and formation of nervous tissue.
GO:0051962	GO	BP	positive regulation of nervous system development	ABL2,ADGRL1,ADRA2B,ADRA2C,AGRN,AMIGO1,ANAPC2,APOE,ARHGDIA,ARSB,ASCL1,ATOH1,AVIL,BCL11A,BDNF,BHLHB9,BIN1,BMP2,BMP5,BMP7,BRINP3,CAMK1,CAMK1D,CAMK2B,CAPRIN1,CAPRIN2,CBFA2T2,CDC20,CDKL5,CLCF1,COBL,CPEB3,CPNE1,CPNE5,CPNE6,CPNE9,CSF1,CTNNB1,CUL7,CUX1,CUX2,CXCR4,DAB2IP,DICER1,DISC1,DMD,DPYSL3,DRD2,DSCAM,ECT2,EPHA3,EPHB1,EPHB2,EPHB3,FAM134C,FBXW8,FES,FGFR1,FOXO6,FZD3,GHRL,GOLGA4,GPER1,GPRC5B,HES1,HEYL,HOXD3,IL1RAPL1,IMPACT,ISLR2,ITSN2,KIDINS220,KIF20B,L1CAM,LHX1,LIG4,LIMK1,LRP8,LRRC4B,LTK,LYN,MACF1,MAGI2,MAPT,MARK2,MEF2C,MEGF8,MMD,MMD2,MYRF,NBL1,NCMAP,NDNF,NDRG4,NEDD4L,NEURL1,NEUROD1,NEUROD2,NEUROG1,NGF,NGFR,NKX2-5,NLGN1,NLGN2,NLGN3,NOTCH1,NPTN,NRCAM,NRP1,NRXN1,NSMF,NTN1,NTRK1,NTRK2,NUMB,NUMBL,OBSL1,OPRM1,PACSIN1,PARD3,PAX2,PLK5,PRKCH,PRKCI,PRKD1,PROX1,PSEN1,PTK2B,PTK6,PTK7,PTPRD,RAP1A,RAPGEF1,RAPGEF2,RASAL1,RELN,RET,RGS14,RHOA,RIMS1,RIMS2,RNF10,ROBO1,ROBO2,RUFY3,SCARF1,SCN1B,SEMA4D,SEMA5A,SEMA7A,SERPINE2,SERPINF1,SETX,SHANK1,SHANK3,SHTN1,SKIL,SLIT2,SMARCD3,SMURF1,SNW1,SNX3,SOX11,SOX8,SPEN,SRGAP2C,SRPX2,STMN2,SYNDIG1,SYT1,SYT17,SYT2,SYT3,SYT4,TCF3,TCF4,TENM3,TENM4,TRIM32,TWF2,UNC13A,VEGFA,VLDLR,VWC2,WNT2,WNT5A,WNT7A,ZEB1,ZNF335	Any process that activates, maintains or increases the frequency, rate or extent of nervous system development, the origin and formation of nervous tissue.
GO:0051963	GO	BP	regulation of synapse assembly	AGRN,BDNF,BHLHB9,CHRNB2,CUX2,DKK1,EPHB1,EPHB2,EPHB3,GHRL,LRRC4B,MEF2C,MUSK,NLGN1,NLGN2,NLGN3,NRXN1,PDLIM5,RAB17,ROBO2,SLIT1,SRPX2,SYNDIG1,WNT7A	Any process that modulates the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
GO:0051965	GO	BP	positive regulation of synapse assembly	AGRN,BDNF,BHLHB9,CUX2,EPHB1,EPHB2,EPHB3,GHRL,LRRC4B,NLGN1,NLGN2,NLGN3,NRXN1,SRPX2,SYNDIG1,WNT7A	Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
GO:0051966	GO	BP	regulation of synaptic transmission, glutamatergic	ATAD1,ATP1A2,DRD1,DRD2,GRIK1,GRIK3,LRRK2,MAPK8IP2,MEF2C,NLGN1,NLGN2,NLGN3,NRXN1,PTK2B,RAB3GAP1,RELN,SHANK3,SYT1,UNC13A	Any process that modulates the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate.
GO:0051968	GO	BP	positive regulation of synaptic transmission, glutamatergic	DRD1,NLGN1,NLGN2,NLGN3,NRXN1,PTK2B,RAB3GAP1,RELN,SHANK3	Any process that activates, maintains or increases the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate.
GO:0051972	GO	BP	regulation of telomerase activity	ACD,AURKB,CCT2,CCT4,CERS1,CTC1,DKC1,GREM1,GRHL2,HMBOX1,KLF4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MCRS1,MEN1,NEK2,NEK7,NVL,OBFC1,PARM1,PIF1,PINX1,PKIB,PML,PNKP,POT1,PRKCQ,SRC,TCP1,TEN1,TERF1,TINF2,TNKS,TP53,WRAP53	Any process that modulates the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Telomerases catalyze extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence.
GO:0051973	GO	BP	positive regulation of telomerase activity	ACD,AURKB,CCT2,CCT4,DKC1,GREM1,GRHL2,HMBOX1,KLF4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NEK2,NEK7,NVL,OBFC1,PARM1,PKIB,PNKP,POT1,PRKCQ,TCP1,TNKS,WRAP53	Any process that activates or increases the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).
GO:0051974	GO	BP	negative regulation of telomerase activity	CERS1,CTC1,MCRS1,MEN1,OBFC1,PIF1,PINX1,PML,POT1,SRC,TEN1,TERF1,TINF2,TP53	Any process that stops or reduces the activity of the enzyme telomerase, which catalyzes of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).
GO:0051983	GO	BP	regulation of chromosome segregation	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,AURKB,AXIN2,BECN1,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC42,CDC6,CDCA5,CENPE,CENPF,CSNK2A1,CSNK2A2,CTCF,CTNNB1,CUL3,DLGAP5,DUSP1,DYNC1LI1,ECT2,ESPL1,FBXO5,GEN1,H2AFY,HDAC8,HORMAD1,KIF2B,KIF2C,KLHL22,KNSTRN,LCMT1,MAD1L1,MAD2L1,MAD2L2,MOS,NEK2,NEK6,NSMCE2,PCID2,PLK1,PTEN,RACGAP1,RAD18,RB1,RCC2,RNF4,SENP6,SIRT2,SLF1,SLF2,SMC5,SMC6,SPAG5,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,WAPL,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.
GO:0051984	GO	BP	positive regulation of chromosome segregation	BECN1,CCNB1,CDC6,CUL3,DLGAP5,ESPL1,H2AFY,NSMCE2,PLK1,PTEN,RAD18,RB1,RCC2,SIRT2,SLF1,SLF2,SMC5,SMC6	Any process that activates or increases the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.
GO:0051988	GO	BP	regulation of attachment of spindle microtubules to kinetochore	APC,BECN1,CCNB1,CDC42,ECT2,KNSTRN,NEK2,RACGAP1,RCC2,SIRT2,SPAG5	Any process that modulates the frequency, rate or extent of the attachment of spindle microtubules to the kinetochore.
GO:0052200	GO	BP	response to host defenses	EIF2AK2,LTF,SLC25A6,SMAD3,TGFB1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detecting the defenses of the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
GO:0052646	GO	BP	alditol phosphate metabolic process	ACP6,GK,GPAT2,LPCAT3,LPCAT4,MBOAT1,PLA1A,PLA2G10,PLA2G12A,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G4A,PLA2G4B,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLSCR1,PTDSS1,PTDSS2,SERINC1,SERINC5,SLC27A1	The chemical reactions and pathways involving alditol phosphates, any phosphorylated polyhydric alcohol derived from the acyclic form of a monosaccharide by reduction of its aldehyde or keto group to an alcoholic group.
GO:0052652	GO	BP	cyclic purine nucleotide metabolic process	ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADM,ADORA2A,AMPD2,AQP1,CALCRL,GNAS,GUCY1A3,GUCY1B3,HTR2B,HTR2C,NPPA,NPPB,NPPC,NPR1,NPR2,RAMP2,TAAR1	The chemical reactions and pathways involving a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue and the base is a purine.
GO:0052689	GO	MF	carboxylic ester hydrolase activity	AADAC,ABHD12,ABHD3,ABHD6,ACHE,AOAH,APMAP,BCHE,CA1,CA2,CEL,CES1,CES2,CLC,ENPP2,ESD,ICT1,LIPA,LIPC,LIPF,LIPG,LPL,LYPLA1,LYPLAL1,MGLL,NOTUM,PGLS,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G6,PLA2G7,PNLIP,PNLIPRP1,PNLIPRP2,PNPLA2,PNPLA3,PNPLA8,PON1,PON3,PPME1,PRDX6,RARRES3,RGN,RPE65,SIAE	Catalysis of the hydrolysis of a carboxylic ester bond.
GO:0052695	GO	BP	cellular glucuronidation	ABHD10,SLC35D1,UGDH,UGP2,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2A1,UGT2A3,UGT2B15,UGT2B17,UGT2B4,UGT2B7	The modification of an organic chemical by the conjugation of glucuronic acid. The substances resulting from glucuronidation are known as glucuronosides (or glucuronides) and are often much more water-soluble than the non-glucuronic acid-containing precursor.
GO:0052696	GO	BP	flavonoid glucuronidation	UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The modification of a flavonoid by the conjugation of glucuronic acid. The resultant flavonoid glucuronosides are often much more water-soluble than the precursor.
GO:0052697	GO	BP	xenobiotic glucuronidation	UGT1A1,UGT1A3,UGT1A7,UGT1A8,UGT1A9	The modification of a xenobiotic substance by the conjugation of glucuronic acid. The resultant glucuronosides are often much more water-soluble than the xenobiotic precursor, enabling efficient excretion.
GO:0052742	GO	MF	phosphatidylinositol kinase activity	ATM,PI4K2A,PI4KA,PI4KB,PIK3C2G,PIK3C3,PIK3CA,PIK3CD,PIK3R2,PIK3R3	Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate.
GO:0052744	GO	MF	phosphatidylinositol monophosphate phosphatase activity	MTM1,MTMR1,MTMR14,MTMR2,MTMR3,PTEN,SACM1L	Catalysis of the reaction: phosphatidylinositol monophosphate + H2O = phosphatidylinositol + phosphate.
GO:0052745	GO	MF	inositol phosphate phosphatase activity	IMPA1,IMPA2,INPP1,INPP5A,INPP5B,INPP5E,INPP5K,ITPK1,OCRL,PTEN,SYNJ1	Catalysis of the reaction: inositol phosphate(n) + H2O = inositol phosphate(n-1) + phosphate. This reaction is the removal of a phosphate group from an inositol phosphate.
GO:0052803	GO	BP	imidazole-containing compound metabolic process	AMDHD1,CARNS1,FTCD,HAL,HDC,HNMT,PRG3,UROC1	The chemical reactions and pathways involving imidazoles, five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.
GO:0052866	GO	MF	phosphatidylinositol phosphate phosphatase activity	FIG4,INPP5B,INPP5K,MTM1,MTMR1,MTMR14,MTMR2,MTMR3,PIKFYVE,PTEN,SACM1L,SYNJ1,TMEM55A,TMEM55B	Catalysis of the reaction: phosphatidylinositol phosphate(n) + H2O = phosphatidylinositol phosphate(n-1) + phosphate. This reaction is the removal of a phosphate group from a phosphatidylinositol phosphate.
GO:0055001	GO	BP	muscle cell development	ACTA1,ACTC1,ACTN2,ANK2,ANKRD1,BMP10,CAPN3,CASQ1,CAV2,CAV3,CFLAR,CHRNB1,CSRP3,CXADR,DMD,HES1,HEY2,IGF1,KDM1A,KLHL41,KRT19,MAML1,MEF2A,MEGF10,MYH11,MYH3,MYH6,MYL2,MYLK3,MYOD1,MYOZ1,MYPN,NEBL,NKX2-5,NKX2-6,NOTCH1,OBSCN,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,RAMP2,RYR1,SGCZ,SIX4,SKI,SLC8A1,SORBS2,TCAP,TPM1,TTN,VEGFA	The process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure. Muscle cell development does not include the steps involved in committing an unspecified cell to the muscle cell fate.
GO:0055002	GO	BP	striated muscle cell development	ACTA1,ACTC1,ACTN2,ANKRD1,BMP10,CAPN3,CASQ1,CAV2,CFLAR,CHRNB1,CSRP3,CXADR,DMD,HEY2,IGF1,KLHL41,KRT19,MAML1,MEF2A,MYH11,MYH3,MYH6,MYL2,MYLK3,MYOD1,MYOZ1,MYPN,NEBL,NKX2-5,NKX2-6,OBSCN,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,RYR1,SIX4,SKI,SLC8A1,SORBS2,TCAP,TPM1,TTN,VEGFA	The process whose specific outcome is the progression of a striated muscle cell over time, from its formation to the mature structure. Striated muscle cells contain fibers that are divided by transverse bands into striations, and cardiac and skeletal muscle are types of striated muscle.
GO:0055003	GO	BP	cardiac myofibril assembly	ACTC1,CSRP3,MEF2A,MYL2,MYLK3,NEBL,OBSL1,PDGFRA,PDGFRB,PROX1,TCAP,TTN	The process whose specific outcome is the progression of the cardiac myofibril over time, from its formation to the mature structure. A cardiac myofibril is a myofibril specific to cardiac muscle cells.
GO:0055006	GO	BP	cardiac cell development	ACTC1,BMP10,CSRP3,CXADR,HEY2,JAG1,MAML1,MEF2A,MYH11,MYH6,MYL2,MYLK3,NEBL,NKX2-5,NKX2-6,NOTCH1,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,SLC8A1,SORBS2,TCAP,TTN,VEGFA	The process whose specific outcome is the progression of a cardiac cell over time, from its formation to the mature state. A cardiac cell is a cell that will form part of the cardiac organ of an individual.
GO:0055007	GO	BP	cardiac muscle cell differentiation	ACTC1,ACVR1,BMP10,BMP2,CBY1,CSRP3,CXADR,HEY2,KDM6B,MAML1,MEF2A,MEF2C,MESP1,MYH11,MYH6,MYL2,MYLK3,MYOCD,NEBL,NKX2-5,NKX2-6,NRG1,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,SIK1,SLC8A1,SORBS2,TCAP,TTN,VEGFA,WNT3A,WT1	The process in which a cardiac muscle precursor cell acquires specialized features of a cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
GO:0055008	GO	BP	cardiac muscle tissue morphogenesis	ACTC1,ANKRD1,BMP10,BMP2,DLL4,DSP,FGFR2,FKBP1A,HAND1,ISL1,MYBPC3,MYH6,MYH7,MYL2,MYL3,MYLK2,NKX2-5,NOTCH1,NRG1,PKP2,PROX1,RBPJ,RYR2,S1PR1,SMAD7,TBX20,TCAP,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,TTN,ZFPM1,ZFPM2	The process in which the anatomical structures of cardiac muscle tissue are generated and organized.
GO:0055010	GO	BP	ventricular cardiac muscle tissue morphogenesis	BMP10,DLL4,DSP,FGFR2,FKBP1A,HAND1,ISL1,MYBPC3,MYH6,MYH7,MYL2,MYL3,NKX2-5,NOTCH1,NRG1,PKP2,PROX1,RBPJ,RYR2,SMAD7,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,ZFPM2	The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
GO:0055012	GO	BP	ventricular cardiac muscle cell differentiation	BMP10,HEY2,MEF2A,MEF2C,NKX2-5,NKX2-6,NRG1,PROX1	The process in which a relatively unspecialized cell acquires specialized features of a ventricular cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. The ventricle is the part of the heart that pumps blood out of the organ.
GO:0055013	GO	BP	cardiac muscle cell development	ACTC1,BMP10,CSRP3,CXADR,HEY2,MAML1,MEF2A,MYH11,MYH6,MYL2,MYLK3,NEBL,NKX2-5,NKX2-6,OBSL1,PDGFRA,PDGFRB,PDLIM5,PROX1,SLC8A1,SORBS2,TCAP,TTN,VEGFA	The process whose specific outcome is the progression of a cardiac muscle cell over time, from its formation to the mature state.
GO:0055015	GO	BP	ventricular cardiac muscle cell development	BMP10,HEY2,MEF2A,NKX2-5,NKX2-6,PROX1	The process whose specific outcome is the progression of a ventricular cardiac muscle cell over time, from its formation to the mature state. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. The ventricle is the part of the heart that pumps blood out of the organ.
GO:0055017	GO	BP	cardiac muscle tissue growth	BMP10,C3orf58,PDLIM5,S1PR1,SORBS2,TGFB2,TGFBR3	The increase in size or mass of a cardiac muscle, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
GO:0055021	GO	BP	regulation of cardiac muscle tissue growth	AKAP6,BMP10,ERBB4,FGF2,FGFR2,GSK3A,MEF2C,NOG,NOTCH1,NRG1,RBP4,RBPJ,TBX2,TBX20,TBX5,TP73	Any process that modulates the frequency, rate or extent of cardiac muscle growth.
GO:0055022	GO	BP	negative regulation of cardiac muscle tissue growth	GSK3A,NOG,RBP4,TBX5,TP73	Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle growth.
GO:0055023	GO	BP	positive regulation of cardiac muscle tissue growth	AKAP6,BMP10,ERBB4,FGF2,FGFR2,MEF2C,NOTCH1,NRG1,RBPJ,TBX2,TBX20	Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle growth.
GO:0055024	GO	BP	regulation of cardiac muscle tissue development	AKAP6,BMP10,BMP2,BMP4,DKK1,EFNB2,ERBB4,FGF2,FGF3,FGF8,FGFR2,GREM1,GSK3A,MEF2C,MYOCD,NOG,NOTCH1,NRG1,PRICKLE1,RBP4,RBPJ,TBX2,TBX20,TBX5,TGFB1,TP73,WNT3A	Any process that modulates the frequency, rate or extent of cardiac muscle tissue development.
GO:0055025	GO	BP	positive regulation of cardiac muscle tissue development	AKAP6,BMP10,BMP4,EFNB2,ERBB4,FGF2,FGFR2,GREM1,MEF2C,MYOCD,NOTCH1,NRG1,RBPJ,TBX2,TBX20,TGFB1,WNT3A	Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle tissue development.
GO:0055026	GO	BP	negative regulation of cardiac muscle tissue development	BMP2,DKK1,FGF3,FGF8,GSK3A,NOG,PRICKLE1,RBP4,TBX5,TP73	Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle tissue development.
GO:0055029	GO	CC	nuclear DNA-directed RNA polymerase complex	CCNH,CDC73,CDK7,CHD6,CPSF3L,CTR9,EDF1,ERCC2,ERCC3,ERCC5,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HELB,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,KAT2A,LEO1,MCM3,MMS19,MNAT1,MYO6,PAF1,PEX2,POLA1,POLR1C,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POLR2M,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,PPARGC1A,RECQL5,RPAP2,RPRD1A,RPRD1B,RPRD2,RTF1,SHFM1,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TBP,TP53,TRRAP,URI1,WDR61	A protein complex, located in the nucleus, that possesses DNA-directed RNA polymerase activity.
GO:0055037	GO	CC	recycling endosome	ABCG1,AP1G1,ARF6,ARFGEF2,ATG9A,ATP11A,ATP11B,ATP9A,AVL9,CFTR,CLIP3,COMMD1,DENND6A,DYNC1I1,EHD1,EHD2,EHD3,EHD4,FAM109A,FAM109B,GPER1,GPR161,GRIA1,HFE,LAMP5,LDLRAP1,LMTK2,MICALL1,MICALL2,MLC1,MYO5A,MYO5B,NDRG1,OR2A4,PACSIN2,RAB10,RAB11A,RAB11B,RAB11FIP3,RAB11FIP4,RAB11FIP5,RAB12,RAB13,RAB14,RAB17,RAB4B,RAB8A,RAN,RAP2A,RAP2B,RAP2C,REP15,SCAMP1,SCAMP2,SCAMP5,SDCCAG3,SLC11A2,SLC9A6,SLC9A7,SLC9A9,SNF8,SORL1,STX7,STX8,TBC1D14,TF,TFRC,TNF,TUBA1A,TUBG1,TUBGCP4,USP6,VAMP3,VAMP8,VIPAS39,VPS16,VPS50,VPS51,VPS52,VPS53,VTI1B,WASH1,ZFYVE27	An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
GO:0055038	GO	CC	recycling endosome membrane	ARF6,CLIP3,EHD1,EHD2,EHD3,EHD4,LAMP5,MICALL1,NDRG1,PACSIN2,RAB11FIP4,RAB12,RAB17,RAB8A,RAP2A,RAP2B,RAP2C,SCAMP1,SCAMP2,SCAMP5,SLC9A6,SLC9A7,ZFYVE27	The lipid bilayer surrounding a recycling endosome.
GO:0055057	GO	BP	neuroblast division	DOCK7,FGF13,FGFR2,NUMB,NUMBL,RAB10,SOX5,TEAD3	The process resulting in the physical partitioning and separation of a neuroblast into daughter cells. A neuroblast is any cell that will divide and give rise to a neuron.
GO:0055059	GO	BP	asymmetric neuroblast division	DOCK7,FGF13,RAB10,SOX5,TEAD3	The process resulting in the physical partitioning and separation of a neuroblast into two daughter cells with different developmental potentials.
GO:0055062	GO	BP	phosphate ion homeostasis	ENPP1,FGF23,FGFR4,GCM2,SFRP4,SLC34A1,SLC34A2,SLC34A3,TFAP2B,XPR1	Any process involved in the maintenance of an internal steady state of phosphate ions within an organism or cell.
GO:0055067	GO	BP	monovalent inorganic cation homeostasis	ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP5B,ATP6AP1,ATP6V0A4,ATP6V0E1,ATP6V0E2,ATP6V1B1,ATP6V1H,BCL2,CA2,CFTR,CHP1,CLCN3,CLN3,CLN5,CLN6,CYP11B2,CYP4F12,GPR89A,KCNH2,KCNJ2,KCNMA1,LRRK2,NEDD4L,NOX1,OTC,PDK2,PDK4,PPT1,RAB20,RAB38,RAB39A,RAB7A,SCNN1A,SCNN1B,SCNN1G,SLC11A1,SLC26A3,SLC26A4,SLC26A6,SLC8A1,SLC9A1,SLC9A7,TFAP2B,TMEM165,TMPRSS3	Any process involved in the maintenance of an internal steady state of monovalent inorganic cations within an organism or cell.
GO:0055069	GO	BP	zinc ion homeostasis	LCK,MT3,PARK2,S100A8,S100A9,SLC30A1,SLC30A5,SLC30A8,SLC39A13,SLC39A14,SLC39A6,TMC8	Any process involved in the maintenance of an internal steady state of zinc ions within an organism or cell.
GO:0055070	GO	BP	copper ion homeostasis	APP,ARF1,ATP7A,ATP7B,CCDC22,COMMD1,CUTC,MT2A,PRNP,XIAP	Any process involved in the maintenance of an internal steady state of copper ions within an organism or cell.
GO:0055072	GO	BP	iron ion homeostasis	ABCB6,ABCG2,ALAS2,ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,B2M,BDH2,BMP6,CP,CYBRD1,FAM132B,FBXL5,FLVCR1,FTH1,FTL,FTMT,FXN,GDF2,HAMP,HEPH,HFE,HFE2,HMOX1,HMOX2,LCN2,LTF,MCOLN1,MYC,NDFIP1,NEO1,NUBP1,PICALM,SCARA5,SLC11A1,SLC11A2,SLC22A17,SLC40A1,SLC46A1,SMAD4,SOD1,SRI,STEAP3,TCIRG1,TF,TFR2,TFRC,TMPRSS6	Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell.
GO:0055074	GO	BP	calcium ion homeostasis	ABL1,ABL2,ADCY5,ADRA1A,AGTR1,ANK2,ATP1B1,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP6V1B1,ATP7B,AVPR1B,BAK1,BAX,BBC3,BCAP31,BCL2,BDKRB1,C1QTNF1,C3AR1,CACNA1A,CACNA1C,CALCA,CALCB,CALCR,CALR,CAMK2D,CASQ2,CASR,CAV1,CAV3,CCDC109B,CCKBR,CCL1,CCL11,CCL13,CCL14,CCL15,CCL19,CCL21,CCL23,CCL3,CCL5,CCL7,CCL8,CCR1,CCR2,CCR3,CCR4,CCR5,CCR7,CCR9,CD24,CD36,CD40,CD52,CD55,CDH23,CHERP,CHRNA10,CHRNA7,CHRNA9,CIB2,CLN3,CSRP3,CXCL12,CXCL13,CXCR4,CYP27B1,CYSLTR1,DLG4,DMPK,DRD1,DRD2,DRD3,DRD4,DRD5,EDN1,EDN2,EDNRA,ELANE,EPHX2,ERO1A,ESR1,F2,F2R,F2RL1,FAM20A,FGF2,FIS1,FKBP1B,GCM2,GHRL,GLP1R,GNA15,GPER1,GRIN1,GRM1,HERPUD1,HMGB1,HRC,HSP90B1,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KCTD17,KNG1,LCK,LPAR1,LPAR2,LPAR3,MCHR1,MCU,MCUR1,MICU1,MICU2,NMUR2,NOL3,NPTN,OPRL1,OPRM1,P2RY1,P2RY4,PDE6A,PDE6B,PDGFRA,PKD2,PKHD1,PLCE1,PLCG2,PLN,PML,PRKACA,PROK2,PSEN1,PTPRC,RAP1GDS1,RGN,RMDN3,RYR1,RYR2,S100A14,S1PR3,S1PR4,SAA1,SLC30A1,SLC35G1,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SMDT1,SPPL3,STC1,STIM2,STOML2,TAC1,TFAP2B,TGM2,TMEM165,TMEM203,TMTC2,TNNI3,TPCN2,TPT1,TRDN,TRPC1,TRPM1,TRPV4,VAPB,WFS1,XCL1,XCR1	Any process involved in the maintenance of an internal steady state of calcium ions within an organism or cell.
GO:0055075	GO	BP	potassium ion homeostasis	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,CYP11B2,KCNH2,KCNJ2,KCNMA1,TFAP2B	Any process involved in the maintenance of an internal steady state of potassium ions within an organism or cell.
GO:0055076	GO	BP	transition metal ion homeostasis	ABCB6,ABCG2,ALAS2,APP,ARF1,ATP2C1,ATP6AP1,ATP6V0A1,ATP6V0A2,ATP6V0A4,ATP6V0B,ATP6V0C,ATP6V0D1,ATP6V0D2,ATP6V0E1,ATP6V0E2,ATP6V1A,ATP6V1B1,ATP6V1B2,ATP6V1C1,ATP6V1C2,ATP6V1D,ATP6V1E1,ATP6V1E2,ATP6V1F,ATP6V1G1,ATP6V1G2,ATP6V1G3,ATP6V1H,ATP7A,ATP7B,B2M,BDH2,BMP6,CCDC22,COMMD1,CP,CUTC,CYBRD1,FAM132B,FBXL5,FLVCR1,FTH1,FTL,FTMT,FXN,GDF2,HAMP,HEPH,HFE,HFE2,HMOX1,HMOX2,LCK,LCN2,LTF,MCOLN1,MT2A,MT3,MYC,NDFIP1,NEO1,NUBP1,PARK2,PICALM,PRNP,S100A8,S100A9,SCARA5,SLC11A1,SLC11A2,SLC22A17,SLC30A1,SLC30A5,SLC30A8,SLC39A13,SLC39A14,SLC39A6,SLC40A1,SLC46A1,SMAD4,SOD1,SRI,STEAP3,TCIRG1,TF,TFR2,TFRC,TMC8,TMPRSS6,XIAP	Any process involved in the maintenance of an internal steady state of transition metal ions within an organism or cell. A transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum and silver.
GO:0055078	GO	BP	sodium ion homeostasis	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,CYP11B2,CYP4F12,NEDD4L,SCNN1A,SCNN1B,SCNN1G,SLC8A1,SLC9A1,TFAP2B,TMPRSS3	Any process involved in the maintenance of an internal steady state of sodium ions within an organism or cell.
GO:0055081	GO	BP	anion homeostasis	ABCA1,ABCG1,ANGPTL3,APOA1,APOE,CA12,CETP,DGAT2,ENPP1,FABP3,FGF23,FGFR4,GCM2,HNF4A,INS,LIPG,MLXIPL,OTC,POLD1,PQLC2,PRKAA1,PRKAA2,SFRP4,SIRT1,SLC12A5,SLC34A1,SLC34A2,SLC34A3,TFAP2B,XBP1,XPR1	Any process involved in the maintenance of an internal steady state of anions within an organism or cell.
GO:0055083	GO	BP	monovalent inorganic anion homeostasis	CA12,ENPP1,FGF23,FGFR4,GCM2,OTC,SFRP4,SLC12A5,SLC34A1,SLC34A2,SLC34A3,TFAP2B,XPR1	Any process involved in the maintenance of an internal steady state of monovalent inorganic anions within an organism or cell.
GO:0055088	GO	BP	lipid homeostasis	ABCA1,ABCB4,ABCG1,ABCG5,ABCG8,ACOX1,ACSM1,ACSM2A,ACSM3,AKR1C1,ANGPTL3,ANGPTL4,APOA1,APOA2,APOA4,APOA5,APOB,APOC2,APOC3,APOC4,APOE,APOM,C19orf80,C1QTNF3,CAV1,CAV3,CD24,CEBPA,CETP,CYP7A1,DGAT2,EHD1,EPHX2,FABP3,FBXW7,FITM2,GCKR,GPIHBP1,HNF4A,INS,IRS2,LAMTOR1,LCAT,LDLR,LDLRAP1,LIPC,LIPG,LPL,LRP5,MALL,MLXIPL,NPC1,NPC2,NR1D2,NR1H3,NR1H4,PCSK9,PKP2,PLA2G10,POLD1,PPARG,PRKAA1,PRKAA2,PTCHD2,RORA,SCARB1,SIRT1,SOAT1,SOAT2,TMEM97,USF1,USF2,XBP1	Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.
GO:0055089	GO	BP	fatty acid homeostasis	APOE,DGAT2,INS,MLXIPL,POLD1,PRKAA1,PRKAA2,SIRT1,XBP1	Any process involved in the maintenance of an internal steady state of fatty acid within an organism or cell.
GO:0055091	GO	BP	phospholipid homeostasis	ABCA1,ABCG1,ANGPTL3,APOA1,CETP,FABP3,HNF4A,LIPG	Any process involved in the maintenance of an internal steady state of phospholipid within an organism or cell.
GO:0055094	GO	BP	response to lipoprotein particle	ADAM17,CD36,CD81,CD9,CDH13,FCER1G,ITGB1,ITGB2,PPARG,SYK	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipoprotein particle stimulus.
GO:0055098	GO	BP	response to low-density lipoprotein particle	CD36,CD81,CD9,CDH13,FCER1G,ITGB1,ITGB2,PPARG,SYK	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
GO:0055102	GO	MF	lipase inhibitor activity	ANGPTL3,ANXA1,ANXA2,ANXA4,ANXA5,APOA2,APOC1,APOC2,APOC3,FAF2,PDC,SNCB	Stops, prevents or reduces the activity of a lipase, an enzyme that catalyzes of the hydrolysis of a lipid.
GO:0055103	GO	MF	ligase regulator activity	CAPN3,CDKN2A,FBXW7,GLMN,TRIB1,TRIB2,TRIB3,UBE2L3	Modulates the activity of a ligase.
GO:0055106	GO	MF	ubiquitin-protein transferase regulator activity	CDKN2A,FBXW7,GLMN,TRIB1,TRIB2,TRIB3,UBE2L3	Modulates the activity of a ubiquitin-protein transferase, an enzyme that catalyzes the covalent attachment of ubiquitin to lysine in a substrate protein.
GO:0055117	GO	BP	regulation of cardiac muscle contraction	ADRA1A,ANK2,ASPH,ATP1A2,ATP1B1,ATP2A2,BMP10,CACNA1C,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CLIC2,CTNNA3,DMD,DSC2,DSG2,DSP,FKBP1B,GJA5,GSTM2,GSTO1,HCN4,HRC,JUP,KCNQ1,NKX2-5,NOS1,NOS1AP,NPPA,P2RX4,PDE4B,PDE4D,PIK3CG,PKP2,PLN,PRKACA,RGS2,RNF207,RYR2,SCN10A,SCN5A,SLC8A1,SLC9A1,SMAD7,SRI,STC1,TNNI3K,ZC3H12A	Any process that modulates the frequency, rate or extent of cardiac muscle contraction.
GO:0055119	GO	BP	relaxation of cardiac muscle	ATP1A1,ATP1A2,ATP1B1,ATP2A2,CAMK2D,GSTM2,KCNJ2,P2RX4,PLN,RGS2,SLC8A1	The process in which the extent of cardiac muscle contraction is reduced.
GO:0055123	GO	BP	digestive system development	AGR2,AHI1,BBS7,CCDC103,CCDC39,CCDC40,CDX2,CHD8,CLMP,COBL,DACT1,DNAAF1,EDNRB,EPHB3,FGFR2,FOXF1,FOXL1,GATA4,GATA5,GATA6,GLI1,GLI2,GLI3,ID2,ITGA6,ITGB4,KIT,MEGF8,MIXL1,NIPBL,NKX2-6,NPHP3,PCSK5,PDGFRA,PKDCC,PTF1A,RARB,RARRES2,RET,SALL1,SIX2,SMO,SOX11,SOX17,STRA6,TBX2,TCF21,ZIC3	The process whose specific outcome is the progression of the digestive system over time, from its formation to the mature structure. The digestive system is the entire structure in which digestion takes place. Digestion is all of the physical, chemical, and biochemical processes carried out by multicellular organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
GO:0060008	GO	BP	Sertoli cell differentiation	DMRT1,RAB13,SCX,SOX8,SOX9,TCF21	The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a Sertoli cell. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
GO:0060021	GO	BP	palate development	BCOR,CHD7,CLDN5,COL11A2,EPHB2,EPHB3,FOXE1,FOXF2,GABRB3,INHBA,LEF1,OSR1,OSR2,PKDCC,SKI,SMAD2,SMAD4,SOX11,SUMO1,TBX1,TCF21,TFAP2A,TGFB3,TGFBR1,TGFBR2,TGFBR3,WNT11,WNT3A,WNT5A,WNT7A,WNT8A	The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
GO:0060037	GO	BP	pharyngeal system development	FOLR1,GATA3,HES1,ISL1,NKX2-5,NKX2-6,PTCH1,SIX4,TBX1,TGFBR1	The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
GO:0060039	GO	BP	pericardium development	BMP2,DLL4,FLRT3,NKX2-6,NOTCH1,TBX20,TBX5,WT1	The process whose specific outcome is the progression of the pericardium over time, from its formation to the mature structure. The pericardium is a double-walled sac that contains the heart and the roots of the aorta, vena cava and the pulmonary artery.
GO:0060041	GO	BP	retina development in camera-type eye	ACVR2B,ACVRL1,AHI1,ATOH7,BMPR2,CHD7,COL4A1,CYP1B1,DLL1,DSCAM,FOXN4,FZD4,GPM6A,IFT140,LHX1,LRP5,MEGF11,NEUROD1,NEUROD4,NPHP1,NRP1,PAX2,PDGFRA,PDGFRB,POU4F2,PROM1,PROX1,PTF1A,PTPRM,RBP4,RORB,RP1,SDK1,SDK2,SKI,SOX8,SOX9,THY1,TOPORS,TSPAN12,ZNF513	The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
GO:0060042	GO	BP	retina morphogenesis in camera-type eye	AHI1,DLL1,DSCAM,FOXN4,LHX1,LRP5,MEGF11,PROM1,PROX1,PTF1A,PTPRM,RBP4,RORB,RP1,SDK1,SDK2,SOX8,SOX9,THY1,TOPORS,TSPAN12	The process in which the anatomical structure of the retina is generated and organized.
GO:0060043	GO	BP	regulation of cardiac muscle cell proliferation	BMP10,ERBB4,FGF2,FGFR2,MEF2C,NOG,NOTCH1,NRG1,RBP4,RBPJ,TBX2,TBX20,TBX5,TP73	Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation.
GO:0060045	GO	BP	positive regulation of cardiac muscle cell proliferation	BMP10,ERBB4,FGF2,FGFR2,MEF2C,NOTCH1,NRG1,RBPJ,TBX2,TBX20	Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
GO:0060046	GO	BP	regulation of acrosome reaction	CACNA1H,FAM170B,GLRA1,IQCF1,PLCB1,SPINK13,ZP3,ZP4	Any process that modulates the frequency, rate or extent of the acrosome reaction.
GO:0060047	GO	BP	heart contraction	ACE,ACTC1,ADRBK1,ANK2,ATP1A1,ATP1A2,ATP1B1,CAMK2D,CASQ2,CAV3,CSRP3,DMD,FGF12,GAA,GJA1,GJC1,GPD1L,GPX1,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,MYBPC3,MYH6,MYH7,MYL2,MYL3,MYL4,MYLK2,NEDD4L,PIK3CA,PKP2,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SNTA1,SOD1,TAZ,TCAP,TNNC1,TNNI3,TPM1,TRDN,TTN	The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
GO:0060048	GO	BP	cardiac muscle contraction	ADRBK1,ANK2,ATP1A1,ATP1A2,ATP1B1,CAMK2D,CASQ2,CAV3,CSRP3,DMD,FGF12,GAA,GJA1,GJC1,GPD1L,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,MYBPC3,MYH6,MYH7,MYL3,MYL4,MYLK2,NEDD4L,PIK3CA,PKP2,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SNTA1,TAZ,TCAP,TNNC1,TNNI3,TPM1,TTN	Muscle contraction of cardiac muscle tissue.
GO:0060049	GO	BP	regulation of protein glycosylation	ACER2,ARFGEF1,CHP1,FKTN,GOLGA2,KAT2B,MT3,PUM3,RAMP1,SLC51B,TINF2,TMEM59	Any process that modulates the frequency, rate or extent of protein glycosylation. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
GO:0060050	GO	BP	positive regulation of protein glycosylation	ARFGEF1,CHP1,GOLGA2,RAMP1,SLC51B	Any process that activates or increases the frequency, rate or extent of the glycosylation of one or more amino acid residues within a protein. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
GO:0060054	GO	BP	positive regulation of epithelial cell proliferation involved in wound healing	AMICA1,FGF10,FZD7,MMP12,WNT7A	Any process that activates or increases the rate or extent of epithelial cell proliferation, contributing to the restoration of integrity to a damaged tissue following an injury.
GO:0060065	GO	BP	uterus development	GATA3,LHX1,NIPBL,RBP4,STRA6	The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
GO:0060070	GO	BP	canonical Wnt signaling pathway	APC,AXIN1,CAV1,CDH3,CHD8,CTNNB1,DVL1,DVL2,DVL3,FZD1,FZD2,FZD3,FZD4,FZD5,FZD7,FZD8,GATA3,GSK3B,HOXB9,LEF1,LRP5,LRP6,LRRK2,MYC,NDP,NR4A2,OTULIN,PLPP3,PTEN,PTK7,PTPRU,RAB5A,RARG,RYK,SCYL2,SFRP1,SNAI2,SOX4,TBL1X,TBL1XR1,TCF7L2,UBE2B,WNT1,WNT10B,WNT2,WNT3,WNT3A,WNT4,WNT7A,WNT7B,WNT8A	The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
GO:0060071	GO	BP	Wnt signaling pathway, planar cell polarity pathway	DVL1,DVL2,DVL3,MAGI2,WNT5A	The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal via downstream effectors including C-Jun N-terminal kinase (JNK) to modulate cytoskeletal elements and control cell polarity.
GO:0060076	GO	CC	excitatory synapse	BCR,BSN,CABP1,CACNA1C,CACNG5,CACNG8,CDK5,CDK5R1,CHRNA3,CNIH2,CPEB4,CRIPT,DLG4,DNM3,DTNBP1,ELFN1,FGFR2,GPER1,GRIA1,GRIN1,LRP4,MAGI2,MAPK8IP2,MTMR2,NETO1,NEURL1,NLGN1,NLGN3,NLGN4X,NSF,NSMF,P2RY1,PDLIM5,PTK2B,RGS14,SEMA4C,SH2D5,SHANK1,SHANK2,SHANK3,SIGMAR1,SIPA1L1,SPOCK1,SRCIN1,SRGAP2,SRPX2,STRN,SYNDIG1	A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell.
GO:0060078	GO	BP	regulation of postsynaptic membrane potential	CHRNA3,CHRNA4,DRD4,GLRA1,GRID2,GRIN1,LRRK2,MAPK8IP2,MEF2C,NLGN3,RAB3GAP1	Any process that modulates the potential difference across a post-synaptic membrane.
GO:0060079	GO	BP	excitatory postsynaptic potential	CHRNA3,GRID2,GRIN1,LRRK2,MAPK8IP2,MEF2C,RAB3GAP1	A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
GO:0060090	GO	MF	binding, bridging	ABI2,ADAP2,AMFR,ANK1,ANK2,ANK3,ANXA1,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARHGAP1,ARHGAP4,ARHGAP6,BCL3,BFAR,BICD1,BIN3,BLNK,CBX5,CD28,CHN1,CHN2,CLNK,CNKSR1,CNTLN,CNTNAP1,COL11A1,COL11A2,COL14A1,COL19A1,COL1A2,COL8A2,CRKL,CSTA,DAB2,DAB2IP,DSP,DUSP19,EPS8,EVPL,FBXW7,FKBP4,FLRT1,FLRT2,FLRT3,FRS2,GAB1,GAB2,GAS2L1,GAS2L2,GAS6,GATAD2A,GNB2L1,GRAP,GRAP2,GRB2,GRB7,HOMER1,IRS1,IRS4,ITSN2,IVL,LASP1,LAT,LDLRAP1,LOR,MAPK8IP2,MAPK8IP3,MEN1,MMS19,MPP7,NCK1,NCK2,NEFH,NEFL,NMD3,OBSL1,PAG1,PDCD6,PICALM,PIK3R1,PPP2R3A,PPP4R2,PSMC6,RAD50,RBM14,RUSC1,SDCBP,SH2B2,SH2D1A,SH2D1B,SH2D2A,SH2D3A,SH2D3C,SH3BGR,SH3BGRL,SH3BP2,SHB,SHC1,SKAP1,SKAP2,SLA,SLA2,SLC9A1,SOCS2,SORBS1,SORBS2,SPRR1A,SPRR1B,SRC,ST13,STAM,STAP1,STUB1,TCAP,TIRAP,TJP2,TOB1,TP53BP2,TRAT1,TRDN,VAV3	The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
GO:0060099	GO	BP	regulation of phagocytosis, engulfment	ABCA7,ALOX15,ANO6,CD300A,F2RL1,NCKAP1L,STAP1	Any process that modulates the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
GO:0060100	GO	BP	positive regulation of phagocytosis, engulfment	ABCA7,ANO6,F2RL1,NCKAP1L,STAP1	Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis.
GO:0060113	GO	BP	inner ear receptor cell differentiation	DFNB31,GRXCR1,HES5,JAG2,LRTOMT,SOD1,STRC,USH2A	The process in which relatively unspecialized cells, acquire specialized structural and/or functional features of inner ear receptor cells. Inner ear receptor cells are mechanorecptors found in the inner ear responsible for transducing signals involved in balance and sensory perception of sound.
GO:0060119	GO	BP	inner ear receptor cell development	DFNB31,GRXCR1,LRTOMT,SOD1,STRC	The process whose specific outcome is the progression of an inner ear receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
GO:0060123	GO	BP	regulation of growth hormone secretion	CHD7,DRD2,GHRH,GHRHR,GHRL	Any process that modulates the frequency, rate or extent of the regulated release of growth hormone from a cell.
GO:0060134	GO	BP	prepulse inhibition	CTNNA2,DRD1,DRD2,DRD3,GRID2,PTEN	The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse.
GO:0060135	GO	BP	maternal process involved in female pregnancy	APOL2,GHRL,GHSR,HAVCR2,LGALS9,PPARD,SPP1	A reproductive process occurring in the mother that allows an embryo or fetus to develop within it.
GO:0060142	GO	BP	regulation of syncytium formation by plasma membrane fusion	ADAM9,CAMK1,CD53,CFLAR,DCSTAMP,EHD1,EHD2,FLOT1,MAPK14,MYOD1,MYOG,RAPGEF3	Any process that modulates the frequency, rate or extent of the formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.
GO:0060143	GO	BP	positive regulation of syncytium formation by plasma membrane fusion	ADAM9,CAMK1,CD53,DCSTAMP,EHD1,EHD2,FLOT1,MAPK14,MYOD1,RAPGEF3	Any process that increases the frequency, rate or extent of the formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.
GO:0060147	GO	BP	regulation of posttranscriptional gene silencing	AJUBA,BCDIN3D,DND1,LIMD1,POU5F1,PUM1,PUM2,TERT,TGFB1,TRIM71,WTIP,XPO5,ZC3H12A	Any process that modulates the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.
GO:0060148	GO	BP	positive regulation of posttranscriptional gene silencing	AJUBA,LIMD1,PUM1,PUM2,WTIP,XPO5	Any process that increases the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.
GO:0060149	GO	BP	negative regulation of posttranscriptional gene silencing	BCDIN3D,DND1,POU5F1,TERT,TGFB1,ZC3H12A	Any process that decreases the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.
GO:0060155	GO	BP	platelet dense granule organization	ABCA1,BLOC1S1,BLOC1S2,BLOC1S3,F2R,F2RL3	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a platelet dense granule. A platelet dense granule is an electron-dense granule occurring in blood platelets that stores and secretes adenosine nucleotides and serotonin. They contain a highly condensed core consisting of serotonin, histamine, calcium, magnesium, ATP, ADP, pyrophosphate and membrane lysosomal proteins.
GO:0060159	GO	BP	regulation of dopamine receptor signaling pathway	CAV2,DRD2,DRD3,DTNBP1,LRRK2,PALM,RGS8	Any process that modulates the frequency, rate or extent of a dopamine receptor signaling pathway activity. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands.
GO:0060170	GO	CC	ciliary membrane	ABCA4,ARL13B,BBS4,CASK,CNGA2,CNGA4,CNGB1,DHRS3,DRD1,DRD2,DRD5,EHD1,EHD3,EVC,EVC2,GNAT1,GNAT2,GNB1,GNGT1,GPR161,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HHIP,NAPEPLD,OPN1LW,OPN1MW,OPN1SW,PDE6A,PDE6B,PDE6G,PKD1,PROM1,PTCH1,RHO,SCNN1A,SEPT2,SHANK2,SHANK3,SMO,SNAP29,SPTBN5,SSTR3,TCTN2,TCTN3,TMEM17,TMEM231,TMEM67	The portion of the plasma membrane surrounding a cilium.
GO:0060173	GO	BP	limb development	AFF3,BMP4,BMPR1B,CHD7,COMP,CREBBP,CTNNB1,CYP26B1,ECE1,FBXW4,FGFR2,GLI3,GREM1,HDAC1,HDAC2,HOXA11,IFT122,IHH,INTU,ITGA6,ITGB4,KDF1,KRT84,LRP4,MBNL1,MEGF8,MSX1,MYH3,NIPBL,NOG,OSR1,OSR2,PCSK5,PITX2,PTCH1,RARG,SALL1,SCX,SHH,SKI,SMOC1,SOX11,SOX4,TBX2,TBX3,TBX4,TBX5,TFAP2A,TFAP2B,TWIST1,WNT3,WNT7A,ZNF141,ZNF358	The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin.
GO:0060191	GO	BP	regulation of lipase activity	ABL1,ABL2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,AGTR1,ANG,ANGPTL3,ANGPTL4,ANXA8,APOA2,APOA4,APOA5,APOC1,APOC2,APOC3,APOH,ARF4,ARHGAP6,ARL1,AVPR1A,AVPR1B,BICD1,C5AR1,CALM1,CAMK4,CCL5,CREB1,EDNRA,EGFR,ESR1,FGF2,FGFR1,FGFR2,FGFR3,FLT1,GNA15,GNAQ,GPIHBP1,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,KIT,LPAR1,LPAR2,LRP1,NGF,NMUR1,NMUR2,NR1H2,NR1H3,NTRK1,PDE1A,PDE1B,PDE1C,PDGFRA,PDGFRB,PDPK1,PLA2G1B,PLA2G5,PLA2R1,PLCB2,PLCG1,PLIN5,PNLIP,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,RGS2,RHOA,RHOC,S1PR4,SELE,SNCA,SORT1,TXK	Any process that modulates the frequency, rate or extent of lipase activity, the hydrolysis of a lipid or phospholipid.
GO:0060192	GO	BP	negative regulation of lipase activity	ABL1,ANGPTL3,ANGPTL4,ANXA8,APOA2,APOC1,APOC3,BICD1,PLA2R1,PLIN5,RGS2,SORT1	Any process that decreases the frequency, rate or extent of lipase activity, the hydrolysis of a lipid or phospholipid.
GO:0060193	GO	BP	positive regulation of lipase activity	ABL2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,AGTR1,ANG,APOA4,APOA5,APOC2,APOH,ARF4,ARHGAP6,ARL1,AVPR1A,AVPR1B,C5AR1,CALM1,CAMK4,CCL5,CREB1,EDNRA,EGFR,ESR1,FGF2,FGFR1,FGFR2,FGFR3,FLT1,GNA15,GNAQ,GPIHBP1,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,KIT,LPAR1,LPAR2,NGF,NMUR1,NMUR2,NR1H2,NR1H3,NTRK1,PDE1A,PDE1B,PDE1C,PDGFRA,PDGFRB,PDPK1,PLA2G1B,PLA2G5,PLCB2,PLCG1,PLIN5,PNLIP,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,RHOA,RHOC,S1PR4,SELE,TXK	Any process that increases the frequency, rate or extent of lipase activity, the hydrolysis of a lipid or phospholipid.
GO:0060198	GO	CC	clathrin-sculpted vesicle	DNAJC5,GAD1,GAD2,HSPA8,RAB3A,SLC17A7,SLC18A1,SLC18A2,SLC18A3,SLC32A1,SYT1,VAMP2	A clathrin-sculpted lipid bilayer membrane-enclosed vesicle after clathrin release.
GO:0060205	GO	CC	cytoplasmic membrane-bounded vesicle lumen	A2M,ACTN1,ACTN2,ACTN4,ALB,ALDOA,APOA1,APOB,APOE,APP,BACE1,CALR,CFD,CLU,DBH,DEFA1,DEFA3,DEFA5,EGF,F13A1,F5,F8,FGA,FGB,FGG,FIGF,FN1,GAS6,GCG,GHRL,GIP,HBA1,HBB,HGF,HP,HPX,HRG,HSP90AA1,HSP90B1,HSPH1,HYOU1,IGF1,IGF2,INS,KNG1,LEFTY2,LTF,MMRN1,PCSK1,PCSK2,PDGFA,PDGFB,PF4,PLG,POMC,PPBP,PROS1,SAA1,SCG3,SCGB3A2,SERPINA1,SERPINE1,SERPINF2,SERPING1,SPARC,SRGN,TF,TGFB1,TGFB2,TGFB3,THBS1,TIMP1,TMSB4X,VEGFA,VEGFB,VEGFC,VWF	The volume enclosed by the membrane of a cytoplasmic membrane-bounded vesicle.
GO:0060213	GO	BP	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	AGO2,BTG2,CNOT1,CNOT7,CPEB3,PABPC1,TNRC6B,TNRC6C,TOB1,ZFP36	Any process that increases the frequency, rate or extent of poly(A) tail shortening of a nuclear-transcribed mRNA. Poly(A) tail shortening is the decrease in length of the poly(A) tail of an mRNA from full length to an oligo(A) length.
GO:0060216	GO	BP	definitive hemopoiesis	HIPK1,LYL1,MFAP5,TEK,TGFBR3,ZFP36L2	A second wave of blood cell production that, in vertebrates, generates long-term hemopoietic stem cells that continously provide erythroid, myeloid and lymphoid lineages throughout adulthood.
GO:0060218	GO	BP	hematopoietic stem cell differentiation	ACE,BATF,HOXB4,MEOX1,SFRP1,SP7	The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
GO:0060219	GO	BP	camera-type eye photoreceptor cell differentiation	DSCAM,PROM1,RORB,RP1,SDK2,SOX8,SOX9,THY1,TOPORS	The process in which a relatively unspecialized cell acquires the specialized features of a photoreceptor cell in a camera-type eye.
GO:0060228	GO	MF	phosphatidylcholine-sterol O-acyltransferase activator activity	APOA1,APOA2,APOA4,APOC1,APOE	Increases the activity of phosphatidylcholine-sterol O-acyltransferase, an enzyme that converts cholesterol and phosphatidylcholine (lecithins) to cholesteryl esters and lyso-phosphatidylcholines.
GO:0060229	GO	MF	lipase activator activity	APOA5,APOC2,APOH,ARHGAP6,CCL3,CCL5,CCL8,PDPK1,STX4	Binds to and increases the activity of a lipase, an enzyme that catalyzes of the hydrolysis of a lipid.
GO:0060231	GO	BP	mesenchymal to epithelial transition	BASP1,BMP4,CITED1,FZD7,GATA3,PAX2,SIX2,SMO,WT1	A transition where a mesenchymal cell establishes apical/basolateral polarity, forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell.
GO:0060236	GO	BP	regulation of mitotic spindle organization	BORA,CCNB1,CCSAP,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4B,CHMP4C,CHMP5,PARP3,PLK1,PSRC1,SBDS,TPR,TPX2,VPS4B	Any process that modulates the rate, frequency or extent of the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a mitotic cell cycle.
GO:0060242	GO	BP	contact inhibition	FAP,PAK1,PTPRJ,SMO,YAP1	The cellular process in which cells stop growing or dividing in response to increased cell density.
GO:0060249	GO	BP	anatomical structure homeostasis	ACD,ALDOA,APEX1,ARMS2,ATM,BARD1,BBS1,BBS10,BBS2,BBS4,CAPN3,CAV3,CD34,CDH23,CDH3,CHMP2B,CHMP4B,CHRNA1,CIB2,CLRN1,CNGB1,CTC1,CTSH,CUBN,CXADR,DCLRE1B,DFNB31,DKC1,DMD,DNA2,DRAM2,ERCC1,ERCC4,F2R,FBXO4,FEN1,FGGY,FOXC1,GAR1,GCNT2,GPR55,GYLTL1B,HAAO,HIST1H4A,HIST3H3,IL7,IQCB1,LARGE,LIG1,MAK,MKKS,MRE11A,MSTN,MUC13,MUC4,MUC6,NAPSA,NBN,NELL2,NHP2,NOD2,NOP10,NPHP3,NSMCE2,OBFC1,P2RX4,PARK2,PARP3,PBLD,PCDH15,PCNA,PFKM,POC1B,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POT1,PRDX5,PRIM1,PRIM2,PRKDC,PROM1,PTGES3,PTH,PTK2B,RAD50,RAD51,RAD51D,RBP4,RDH12,RFC1,RFC2,RFC3,RFC4,RFC5,RP1,RP1L1,RPA1,RPA2,RPA3,RPE65,RTEL1,SCX,SERPINA3,SFTPD,SGCZ,SLX1A,SLX4,SMC5,SMC6,SMG1,SMG6,SOD1,SOX9,SP100,SPATA7,SRC,SRF,STRAP,TEP1,TERF1,TERF2,TERF2IP,TERT,TFIP11,TINF2,TLR4,TLR9,TNKS1BP1,TPP1,TULP1,TYRO3,UPF1,USH1C,USH1G,USH2A,VEGFA,WRAP53,WRN,XRCC3,XRCC5,XRCC6,ZNF675,ZSCAN4	A homeostatic process involved in the maintenance of an internal steady state within a defined anatomical structure of an organism, including control of cellular proliferation and death and control of metabolic function. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
GO:0060251	GO	BP	regulation of glial cell proliferation	DICER1,HES1,NOTCH1,PRKCH,PRKCI,RNF10,SKI,SOX11	Any process that modulates the frequency, rate or extent of glial cell proliferation.
GO:0060253	GO	BP	negative regulation of glial cell proliferation	DICER1,HES1,NOTCH1,RNF10,SKI,SOX11	Any process that stops or decreases the rate or extent of glial cell proliferation.
GO:0060259	GO	BP	regulation of feeding behavior	AGRP,CFAP20,EIF2AK4,INS,LEPR,NR4A3,QRFP,STAT3	Any process that modulates the rate, frequency or extent of the behavior associated with the intake of food.
GO:0060260	GO	BP	regulation of transcription initiation from RNA polymerase II promoter	ATF7IP,HEY2,HMGB1,HNF1A,HNF1B,NKX2-5,PAXIP1,SRF,TAF1,THRA	Any process that modulates the rate, frequency or extent of a process involved in starting transcription from an RNA polymerase II promoter.
GO:0060261	GO	BP	positive regulation of transcription initiation from RNA polymerase II promoter	HNF1A,HNF1B,NKX2-5,PAXIP1,SRF,TAF1	Any process that increases the rate, frequency or extent of a process involved in starting transcription from an RNA polymerase II promoter.
GO:0060263	GO	BP	regulation of respiratory burst	CAMK1D,INS,INSR,JCHAIN,LBP,NOXA1,NOXO1,RAC1,RAC2,RPS19	Any process that modulates the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
GO:0060267	GO	BP	positive regulation of respiratory burst	CAMK1D,INS,INSR,JCHAIN,LBP,RPS19	Any process that increases the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
GO:0060271	GO	BP	cilium morphogenesis	ABCC4,ABLIM1,ABLIM3,ACTR2,ACTR3,AHI1,ARL13B,ARL3,ARL6,ARMC4,ASAP1,ATP6V0D1,ATP6V1D,AVIL,B9D1,B9D2,BBIP1,BBOF1,BBS1,BBS10,BBS2,BBS4,BBS5,BBS7,C2CD3,C5orf30,C5orf42,CC2D2A,CCDC103,CCDC113,CCDC114,CCDC13,CCDC151,CCDC28B,CCDC39,CCDC40,CCNO,CEP126,CEP131,CEP162,CEP164,CEP250,CEP290,CEP41,CEP83,CEP89,CFAP20,CFAP221,CFAP46,CFAP54,CFAP74,CSNK1D,DISC1,DMD,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,DZIP1,DZIP1L,E2F4,EHD1,EHD3,FAM161A,FBF1,FLNA,FNBP1L,FOPNL,FOXJ1,FUZ,GALNT11,GSN,ICK,IFT122,IFT172,IFT20,IFT43,IFT46,IFT74,IFT81,IFT88,INTU,IQCB1,KIAA0586,KIF24,KIF27,KIF3A,LRGUK,LRRC6,MCIDAS,MKKS,MKS1,NEK1,NME8,NOTCH1,NPHP3,OCRL,OFD1,PARVA,PCM1,PCNT,PIBF1,PIH1D3,PKHD1,PLA2G3,POC1B,PTPN23,RAB17,RAB23,RAB3IP,RAB8A,RFX3,RP1,RPGR,RSG1,RSPH1,RSPH4A,RSPH9,SCLT1,SEPT2,SEPT7,SNAP29,SNX10,SPAG1,SPAG16,SPATA6,SSX2IP,STK36,TCTN1,TCTN2,TCTN3,TEKT3,TMEM107,TMEM138,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TTBK2,TTC26,TTC8,TTLL3,UNC119B,VANGL2,WDPCP,WDR35,ZMYND10	A process that is carried out at the cellular level and in which the structure of a cilium is organized.
GO:0060272	GO	BP	embryonic skeletal joint morphogenesis	COL2A1,CTNNB1,NOG,OSR1,OSR2	The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton.
GO:0060285	GO	BP	cilium-dependent cell motility	CCDC39,CFAP54,DNAAF2,DRC1,RFX3	Cell motility due to the motion of one or more eukaryotic cilia. A eukaryotic cilium is a specialized organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic (plasma) membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
GO:0060287	GO	BP	epithelial cilium movement involved in determination of left/right asymmetry	CCDC103,CCDC39,CCDC40,DNAAF1,LRRC6,NPHP3,OFD1,RFX3	The movement of cilia of epithelial cells resulting in the transport of signals which determine asymmetry in an organism's body plan with respect to the left and right halves.
GO:0060291	GO	BP	long-term synaptic potentiation	NPTN,PLK2,PRKCZ,PTK2B,RGS14,SHANK2,SLC8A2,SLC8A3,STX4,VAMP2	A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse.
GO:0060296	GO	BP	regulation of cilium beat frequency involved in ciliary motility	BBS2,BBS4,CCSAP,CFAP20,MKKS	Any process that modulates the frequency of cilium beating involved in ciliary motility.
GO:0060297	GO	BP	regulation of sarcomere organization	BMP10,CAV3,EDN1,MYLK3,PROX1	Any process that modulates the rate, frequency or extent myofibril assembly by organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
GO:0060306	GO	BP	regulation of membrane repolarization	AKAP6,AKAP7,AKAP9,ANK2,CACNA1D,CASQ2,CAV1,CAV3,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,NEDD4L,NOS1AP,NPPA,RNF207,SCN1B,SCN4B,SCN5A,SNTA1,YWHAE	Any process that modulates the establishment or extent of a membrane potential in the polarizing direction towards the resting potential, usually from positive to negative.
GO:0060307	GO	BP	regulation of ventricular cardiac muscle cell membrane repolarization	AKAP9,ANK2,CAV3,KCNE1,KCNE2,KCNE5,KCNH2,KCNQ1,NOS1AP,SCN1B,SCN4B,SCN5A,SNTA1	Any process that modulates the establishment or extent of a membrane potential in the polarizing direction towards the resting potential in a ventricular cardiomyocyte.
GO:0060314	GO	BP	regulation of ryanodine-sensitive calcium-release channel activity	AKAP6,ASPH,CALM1,CAMK2D,CASQ2,CLIC2,DMD,FKBP1A,FKBP1B,GSTM2,GSTO1,HRC,JPH1,JPH2,JPH3,JPH4,NOS1,PDE4D,PKD2,PRKACA,SRI,TRDN	Any process that modulates the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.
GO:0060315	GO	BP	negative regulation of ryanodine-sensitive calcium-release channel activity	CALM1,CASQ2,CLIC2,FKBP1B,GSTM2,GSTO1,PKD2,SRI,TRDN	Any process that decreases the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.
GO:0060316	GO	BP	positive regulation of ryanodine-sensitive calcium-release channel activity	AKAP6,ASPH,CALM1,GSTM2,GSTO1,JPH2,TRDN	Any process that increases the activity of a ryanodine-sensitive calcium-release channel. The ryanodine-sensitive calcium-release channel catalyzes the transmembrane transfer of a calcium ion by a channel that opens when a ryanodine class ligand has been bound by the channel complex or one of its constituent parts.
GO:0060317	GO	BP	cardiac epithelial to mesenchymal transition	BMP2,EFNA1,FGF8,HAS2,HEY1,HEY2,HEYL,NOTCH1,OLFM1,RBPJ,SNAI2,TGFB2,TGFBR1,TGFBR3	A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
GO:0060322	GO	BP	head development	ABCB6,AFF2,AGTPBP1,AGTR2,AHI1,ANKRD11,APOD,ARHGAP11B,ARL13B,ARNT2,ATF5,ATP6AP2,ATP7A,BAG6,BBS2,BBS4,BMP2,BMP4,BPTF,BTBD3,CA10,CBLN1,CCDC85C,CDK5R1,CDK5RAP1,CDK5RAP2,CDK5RAP3,CDK6,CENPF,CEP290,CHD5,CHD7,CHD8,CHRNB2,CLDN5,CLP1,CNTN4,CNTNAP2,COL3A1,COL4A1,CRISPLD1,CRISPLD2,CTNNA2,CTNS,DAB2IP,DDIT4,DLC1,DLL1,DLX2,DMBX1,DOCK7,DRAXIN,DRD1,DRD2,DSCAML1,ECE2,EFHC1,EGR2,EML1,EOMES,EPHA5,EPHA7,EPHB2,EPHB3,ERBB4,FAIM2,FAT4,FGF13,FGFR2,FLRT3,FOXB1,FOXJ1,FOXP2,GHRH,GLI2,GRID2,GSK3B,H2AFY2,HAP1,HES1,HES5,HESX1,HOOK3,HTR6,IL11RA,INHBA,KDM2B,KDM7A,KIF14,LAMB1,LHX1,LHX6,LRP8,LRRK2,MAP1S,MDGA1,MKKS,MSX1,MYH3,MYO16,NCOA6,NDE1,NDUFS4,NES,NEUROD1,NEUROD2,NF1,NFIB,NIPBL,NKX2-1,NKX2-2,NKX2-6,NLGN4X,NOG,NR0B1,NRXN1,NTRK2,NUMB,NUMBL,OSR2,OTX2,PAFAH1B1,PAX2,PCDH18,PCM1,PEX13,PHF8,PHGDH,PHOX2B,PITPNM1,PITX2,PITX3,PLCB1,PLXNB2,POMK,POU6F1,PPT1,PROX1,PTCH1,PTEN,PTF1A,PTPN11,QARS,RAB18,RAB3GAP1,RAPGEF2,RELN,ROBO1,ROBO2,ROGDI,RORA,RRAS,RTN4,RYK,SALL1,SCN5A,SDF4,SEMA3A,SEMA4C,SEMA5A,SHANK3,SHH,SHROOM2,SHROOM4,SIX3,SKI,SLC23A1,SLC6A17,SLC6A4,SLIT1,SLIT2,SMARCA1,SMO,SOX3,SRGAP2,SRGAP2C,STIL,STRA6,SZT2,TBR1,TBX1,TGFB3,TGFBR2,TRABD2A,TRAPPC9,TRNP1,TYRO3,UBE3A,UTP3,VAX2,VCX3A,WDR62,WNT1,WNT2,WNT3A,WNT5A,WNT7A,ZIC1,ZIC2,ZNF335	The biological process whose specific outcome is the progression of a head from an initial condition to its mature state. The head is the anterior-most division of the body.
GO:0060323	GO	BP	head morphogenesis	ANKRD11,ATP6AP2,CLDN5,CRISPLD1,CRISPLD2,MSX1,MYH3,NIPBL,PTPN11,RAB3GAP1,RRAS,SKI,STRA6,TBX1,TGFB3	The process in which the anatomical structures of the head are generated and organized. The head is the anterior-most division of the body.
GO:0060324	GO	BP	face development	ANKRD11,CHD7,CLDN5,CRISPLD1,CRISPLD2,MSX1,MYH3,NIPBL,PTPN11,RAB3GAP1,RRAS,SKI,SOX3,STRA6,TBX1,TGFB3,WNT5A	The biological process whose specific outcome is the progression of a face from an initial condition to its mature state. The face is the ventral division of the head.
GO:0060325	GO	BP	face morphogenesis	ANKRD11,CLDN5,CRISPLD1,CRISPLD2,MSX1,MYH3,NIPBL,PTPN11,RAB3GAP1,RRAS,SKI,STRA6,TBX1,TGFB3	The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
GO:0060326	GO	BP	cell chemotaxis	ADAM8,ADGRE2,AGTR1,AMICA1,ANXA1,ARHGEF16,ARRB2,AZU1,BCAR1,BIN2,C5,CALCA,CCL11,CCL13,CCL19,CCL2,CCL21,CCL23,CCL24,CCL25,CCL27,CCL28,CCL3,CCL5,CCL7,CCR1,CCR2,CCR5,CCR6,CCR7,CHGA,CKLF,CORO1B,CX3CL1,CXADR,CXCL1,CXCL10,CXCL11,CXCL12,CXCL13,CXCL14,CXCL2,CXCL3,CXCL5,CXCL6,CXCL8,CXCL9,CXCR1,CXCR2,CXCR4,DOCK4,EDN2,EDN3,EDNRB,EGR3,ELMO2,ENG,EPHA2,EPHB1,FFAR2,FLT1,GAS6,GBF1,HBEGF,HGF,HMGB1,HMGB2,HOXB9,IL10,IL6,IL6R,ITGB2,KIT,LEF1,LGALS3,LPAR1,LYST,NCKAP1L,NOV,NR4A1,NRP1,PARVA,PDE4B,PDGFB,PDGFRA,PDGFRB,PF4,PIK3CD,PIK3CG,PIP5K1A,PIP5K1C,PLA2G1B,PLEKHG5,PLXNB3,PRKCD,PRKCQ,PTPRO,RAB13,RHOG,RPS19,S100A12,S100A8,S100A9,SAA1,SBDS,SCG2,SEMA5A,SFTPD,SYK,TGFB2,TNFRSF11A,TNFSF11,TRPM4,VEGFA,XCL1	The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
GO:0060330	GO	BP	regulation of response to interferon-gamma	CDC37,DNAJA3,HSP90AB1,IFNG,IFNGR1,IFNGR2,JAK1,JAK2,NLRC5,NR1H2,NR1H3,PARP9,PIAS1,PPARG,PTPN1,PTPN11,PTPN2,PTPN6,SOCS1,SOCS3,STAT1,SUMO1,TXK	Any process that modulates the rate, frequency or extent of a response to interferon-gamma. Response to interferon gamma is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus.
GO:0060333	GO	BP	interferon-gamma-mediated signaling pathway	B2M,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CD44,CIITA,FCGR1A,FCGR1B,GBP1,GBP2,HCK,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,ICAM1,IFI30,IFNG,IFNGR1,IFNGR2,IRF1,IRF2,IRF3,IRF4,IRF5,IRF6,IRF7,IRF8,IRF9,JAK1,JAK2,MID1,MT2A,NCAM1,OAS1,OAS2,OAS3,OASL,PIAS1,PML,PRKCD,PTAFR,PTPN1,PTPN11,PTPN2,PTPN6,SOCS1,SOCS3,SP100,STAT1,SUMO1,TRIM21,TRIM22,TRIM25,TRIM26,TRIM31,TRIM34,TRIM38,TRIM5,TRIM62,TRIM68,TRIM8,VCAM1	A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
GO:0060334	GO	BP	regulation of interferon-gamma-mediated signaling pathway	CDC37,DNAJA3,HSP90AB1,IFNG,IFNGR1,IFNGR2,JAK1,JAK2,NLRC5,NR1H2,NR1H3,PIAS1,PPARG,PTPN1,PTPN11,PTPN2,PTPN6,SOCS1,SOCS3,STAT1,SUMO1,TXK	Any process that modulates the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor.
GO:0060336	GO	BP	negative regulation of interferon-gamma-mediated signaling pathway	DNAJA3,NR1H2,NR1H3,PPARG,PTPN2	Any process that decreases the rate, frequency or extent of the series of molecular events generated as a consequence of interferon-gamma binding to a cell surface receptor.
GO:0060337	GO	BP	type I interferon signaling pathway	ADAR,BST2,EGR1,GBP2,HLA-A,HLA-B,HLA-C,HLA-E,HLA-F,HLA-G,IFI27,IFI35,IFI6,IFIT1,IFIT2,IFIT3,IFITM1,IFITM2,IFITM3,IFNA1,IFNA10,IFNA14,IFNA16,IFNA17,IFNA2,IFNA21,IFNA4,IFNA5,IFNA6,IFNA7,IFNA8,IFNAR1,IFNAR2,IFNB1,IP6K2,IRF1,IRF2,IRF3,IRF4,IRF5,IRF6,IRF7,IRF8,IRF9,ISG15,ISG20,JAK1,MX1,MX2,OAS1,OAS2,OAS3,OASL,PSMB8,PTPN1,PTPN11,PTPN6,RNASEL,RSAD2,SAMHD1,SOCS1,SOCS3,SP100,STAT1,STAT2,TYK2,USP18,XAF1	A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
GO:0060338	GO	BP	regulation of type I interferon-mediated signaling pathway	CACTIN,CDC37,FADD,HSP90AB1,IFNA1,IFNA10,IFNA14,IFNA16,IFNA17,IFNA2,IFNA21,IFNA4,IFNA5,IFNA6,IFNA7,IFNA8,IFNAR1,IFNAR2,IFNB1,JAK1,MAVS,MUL1,NLRC5,PTPN1,PTPN11,PTPN2,PTPN6,SOCS1,SOCS3,STAT1,STAT2,TRIM6,TYK2,UBE2K,USP18,WNT5A	Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
GO:0060340	GO	BP	positive regulation of type I interferon-mediated signaling pathway	FADD,MAVS,NLRC5,TRIM6,UBE2K,WNT5A	Any process that increases the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
GO:0060343	GO	BP	trabecula formation	BMP10,FBN2,FKBP1A,HEY1,RBP4,TEK,TGFBR3	The process of creating a trabecula in an organ. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.
GO:0060347	GO	BP	heart trabecula formation	BMP10,FKBP1A,HEY1,RBP4,TEK,TGFBR3	The process of creating a trabecula in the heart. A trabecula is a tissue element in the form of a small beam, strut or rod.
GO:0060348	GO	BP	bone development	ANXA2,BMP2,BMP4,BMPR1B,BMPR2,CER1,COL13A1,CYP26B1,DLX5,DYM,FGF8,FGFR2,FGFR3,FOXP1,FREM1,GH1,GNAS,HOXA11,IFITM5,IGF1,INPPL1,KIT,LRP5,LRRC17,LTF,MED1,MEF2C,MEGF8,MMP13,MSX2,MYOC,NPPC,OSR2,P3H1,PITX2,PLS3,PLXNB1,PPIB,PTGER4,PTPRC,RAB23,RHOA,RYR1,SBDS,SCX,SEMA4D,SH3PXD2B,SKI,SOX9,STC1,SULF1,SULF2,TFAP2A,TWIST1,VKORC1,WNT1,ZNF385A	The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
GO:0060349	GO	BP	bone morphogenesis	BMP4,BMPR1B,BMPR2,CER1,COL13A1,CYP26B1,DLX5,FGFR2,FGFR3,FREM1,HOXA11,IFITM5,INPPL1,LRP5,LTF,MEF2C,MEGF8,MMP13,MSX2,NPPC,OSR2,RAB23,SCX,SKI,SOX9,STC1,TFAP2A,TWIST1	The process in which bones are generated and organized.
GO:0060350	GO	BP	endochondral bone morphogenesis	BMP4,BMPR1B,BMPR2,CER1,COL13A1,DLX5,FGFR3,HOXA11,INPPL1,MEF2C,NPPC,SCX,SOX9,STC1	The process in which bones are generated and organized as a result of the conversion of initial cartilaginous anlage into bone.
GO:0060351	GO	BP	cartilage development involved in endochondral bone morphogenesis	CER1,HOXA11,NPPC,SOX9,STC1	The process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones.
GO:0060353	GO	BP	regulation of cell adhesion molecule production	APOA1,CAV1,COLEC12,FLOT1,IL1B	Any process that modulates the rate, frequency or extent of cell adhesion molecule production. Cell adhesion molecule production is the appearance of a cell adhesion molecule as a result of its biosynthesis or a decrease in its catabolism.
GO:0060359	GO	BP	response to ammonium ion	ABAT,ABL1,AOC1,CHRNB2,CRHBP,DIAPH1,DRD2,DRD3,DRD4,GABRB1,GABRB2,GABRB3,GABRG2,HRH1,LRRK2,PARK2,PPP1R9B,PRKCG	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium ion stimulus.
GO:0060371	GO	BP	regulation of atrial cardiac muscle cell membrane depolarization	GJA5,SCN10A,SCN1B,SCN2B,SCN3B,SCN5A	Any process that modulates the establishment or extent of a membrane potential in the depolarizing direction away from the resting potential in an atrial cardiomyocyte.
GO:0060372	GO	BP	regulation of atrial cardiac muscle cell membrane repolarization	CACNA1D,KCNA5,KCNE5,KCNQ1,NPPA,SCN5A	Any process that modulates the establishment or extent of a membrane potential in the polarizing direction towards the resting potential in an atrial cardiomyocyte.
GO:0060373	GO	BP	regulation of ventricular cardiac muscle cell membrane depolarization	CAV3,GPD1L,SCN3B,SCN5A,SMAD7	Any process that modulates the establishment or extent of a membrane potential in the depolarizing direction away from the resting potential in a ventricular cardiomyocyte.
GO:0060379	GO	BP	cardiac muscle cell myoblast differentiation	GREM1,MYOCD,NOTCH1,NRG1,RBPJ,REST,SRF,T,TBX2	The process in which a relatively unspecialized cell acquires specialized features of a cardiac myoblast. A cardiac myoblast is a precursor cell that has been committed to a cardiac muscle cell fate but retains the ability to divide and proliferate throughout life.
GO:0060384	GO	BP	innervation	ISL1,NRP1,NTRK1,POU4F1,SEMA3A,SULF1,SULF2	The process in which a nerve invades a tissue and makes functional synaptic connection within the tissue.
GO:0060389	GO	BP	pathway-restricted SMAD protein phosphorylation	ACVR1,BMP10,BMP2,GDF2,GDF6,GDF7,SMAD7,TGFB1,TGFB2,TGFBR1,TGFBR2,TGFBR3,USP15	The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
GO:0060390	GO	BP	regulation of SMAD protein import into nucleus	BMP4,BMP6,BMPR1A,DAB2,FAM89B,NODAL,NOV,PBLD,POU5F1,RBPMS,SMAD4,TGFB1,TGFB3,TGFBR1,WWTR1	Any process that modulates the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
GO:0060391	GO	BP	positive regulation of SMAD protein import into nucleus	BMP4,BMP6,BMPR1A,DAB2,NODAL,POU5F1,RBPMS,SMAD4,TGFB1,TGFB3,TGFBR1	Any process that increases the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
GO:0060393	GO	BP	regulation of pathway-restricted SMAD protein phosphorylation	ACVR1,ACVR2A,ACVRL1,BMP10,BMP2,BMP4,BMP5,BMP6,BMP7,BMPER,BMPR1A,BMPR2,CSNK2B,DAB2,DKK1,ENG,GDF10,GDF2,GDF6,GDF7,GREM1,HFE,INHBA,LDLRAD4,NODAL,NOG,PBLD,PIN1,PMEPA1,RBPMS,SDCBP,SMAD4,SMAD6,SMAD7,SNX25,STRAP,TGFB1,TGFB3,TGFBR1,TTK	Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
GO:0060394	GO	BP	negative regulation of pathway-restricted SMAD protein phosphorylation	DKK1,ENG,GREM1,LDLRAD4,NOG,PBLD,PMEPA1,SMAD6,SMAD7,SNX25,STRAP	Any process that decreases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
GO:0060395	GO	BP	SMAD protein signal transduction	ATOH8,BMP2,BMP4,BMP6,BMP7,CITED1,FOS,GDF5,HIPK2,JUN,MAGI2,SKI,SLC33A1,SMAD1,SMAD4,SMAD5,SMAD9	The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
GO:0060396	GO	BP	growth hormone receptor signaling pathway	ADAM17,CISH,CSH1,GH1,GH2,GHR,IRS1,IRS2,JAK2,JAK3,LYN,MAPK1,MAPK3,PIK3R1,PRL,PRLR,PTK2,PTPN1,PTPN6,PXN,SOCS1,SOCS2,SOCS3,STAT1,STAT3,STAT5A,STAT5B	The series of molecular signals generated as a consequence of growth hormone receptor binding to its physiological ligand.
GO:0060397	GO	BP	JAK-STAT cascade involved in growth hormone signaling pathway	ADAM17,CISH,CSH1,GH1,GH2,GHR,IRS1,IRS2,JAK2,JAK3,LYN,MAPK1,MAPK3,PRL,PRLR,PTPN1,PTPN6,SOCS1,SOCS2,SOCS3,STAT1,STAT3,STAT5A,STAT5B	The process in which STAT proteins (Signal Transducers and Activators of Transcription) are activated by members of the JAK (janus activated kinase) family of tyrosine kinases, following the binding of physiological ligands to the growth hormone receptor. Once activated, STATs dimerize and translocate to the nucleus and modulate the expression of target genes.
GO:0060398	GO	BP	regulation of growth hormone receptor signaling pathway	GHRL,HNF4A,JAK2,LEPROT,MBD5	Any process that modulates the rate, frequency or extent of the growth hormone receptor signaling pathway. The growth hormone receptor signaling pathway is the series of molecular signals generated as a consequence of growth hormone receptor binding to its physiological ligand.
GO:0060401	GO	BP	cytosolic calcium ion transport	ADRA1A,ATP2A2,ATP2B4,BBC3,CACNA1C,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,DRD2,ERO1A,F2R,FGF2,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,LCK,NOL3,PKD2,PLCG2,PTPRC,RYR1,RYR2,SLC8A1,TRDN,TRPM1,XCL1	The directed movement of calcium ions (Ca2+) into, out of or within the cytosol.
GO:0060402	GO	BP	calcium ion transport into cytosol	ADRA1A,ATP2B4,BBC3,CACNA1C,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,DRD2,ERO1A,F2R,FGF2,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,LCK,NOL3,PKD2,PLCG2,PTPRC,RYR1,RYR2,SLC8A1,TRDN,TRPM1,XCL1	The directed movement of calcium ions (Ca2+) into the cytosol.
GO:0060411	GO	BP	cardiac septum morphogenesis	ACVR1,CITED2,FGF8,FGFR2,GATA4,GATA6,HAND1,HES1,HEY1,HEY2,HEYL,ISL1,JAG1,NKX2-5,NOTCH1,NOTCH2,PARVA,PROX1,SMAD7,SOX11,SOX4,TBX1,TBX2,TBX20,ZFPM1,ZFPM2	The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart.
GO:0060412	GO	BP	ventricular septum morphogenesis	CITED2,FGFR2,HES1,HEY1,HEY2,HEYL,NKX2-5,NOTCH1,PROX1,SMAD7,SOX11,SOX4,ZFPM1,ZFPM2	The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
GO:0060413	GO	BP	atrial septum morphogenesis	ACVR1,GATA4,HEY2,ISL1,NKX2-5,NOTCH2,SOX4,TBX20,ZFPM1	The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
GO:0060415	GO	BP	muscle tissue morphogenesis	ACTC1,ANKRD1,BMP10,BMP2,DLL4,DSP,FGFR2,FKBP1A,HAND1,HEY2,ISL1,MYBPC3,MYH6,MYH7,MYL2,MYL3,MYLK,MYLK2,NKX2-5,NOTCH1,NRG1,PKP2,PROX1,RBPJ,RYR2,S1PR1,SMAD7,TBX1,TBX20,TCAP,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,TTN,ZFPM1,ZFPM2	The process in which the anatomical structures of muscle tissue are generated and organized. Muscle tissue consists of a set of cells that are part of an organ and carry out a contractive function.
GO:0060416	GO	BP	response to growth hormone	ADAM17,AKT1,CISH,CSH1,GH1,GH2,GHR,IGFBP5,IRS1,IRS2,JAK2,JAK3,LYN,MAPK1,MAPK3,PIK3R1,PRL,PRLR,PTK2,PTPN1,PTPN6,PXN,SOCS1,SOCS2,SOCS3,STAT1,STAT3,STAT5A,STAT5B,TRIM16	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
GO:0060419	GO	BP	heart growth	BMP10,C3orf58,MESP1,NOTCH1,PDLIM5,S1PR1,SORBS2,TGFB2,TGFBR3	The increase in size or mass of the heart.
GO:0060420	GO	BP	regulation of heart growth	AKAP6,BASP1,BMP10,ERBB4,FGF2,FGFR2,GSK3A,MEF2C,NOG,NOTCH1,NRG1,PROX1,RBP4,RBPJ,TBX2,TBX20,TBX5,TP73,WT1	Any process that modulates the rate or extent of heart growth. Heart growth is the increase in size or mass of the heart.
GO:0060421	GO	BP	positive regulation of heart growth	AKAP6,BASP1,BMP10,ERBB4,FGF2,FGFR2,MEF2C,NOTCH1,NRG1,PROX1,RBPJ,TBX2,TBX20,WT1	Any process that increases the rate or extent of heart growth. Heart growth is the increase in size or mass of the heart.
GO:0060425	GO	BP	lung morphogenesis	BMP4,CTSH,FGF10,FGFR2,SOX11,TCF21,WNT7B	The process in which the anatomical structures of the lung are generated and organized.
GO:0060428	GO	BP	lung epithelium development	ASCL1,BMP4,ERRFI1,FGF10,FOXJ1,GRHL2,NFIB,STRA6,WNT7B	The biological process whose specific outcome is the progression of the lung epithelium from an initial condition to its mature state. This process begins with the formation of lung epithelium and ends with the mature structure. The lung epithelium is the specialized epithelium that lines the inside of the lung.
GO:0060443	GO	BP	mammary gland morphogenesis	CAV1,CSF1R,ELF3,EPHA2,FGF10,FGFR2,SCRIB	The process in which anatomical structures of the mammary gland are generated and organized. Morphogenesis refers to the creation of shape. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
GO:0060452	GO	BP	positive regulation of cardiac muscle contraction	ADRA1A,KCNQ1,NOS1AP,NPPA,RGS2,RNF207	Any process that increases the frequency, rate or extent of cardiac muscle contraction.
GO:0060467	GO	BP	negative regulation of fertilization	ASTL,SPINK13,ZP2,ZP3,ZP4	Any process that decreases the rate, frequency or extent of fertilization. Fertilization is the union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
GO:0060485	GO	BP	mesenchyme development	ACTA1,ACTA2,ACTC1,ACTG2,ACVR1,AMELX,BASP1,BMP2,BMP4,BMP7,BMPR1A,CITED2,CORO1C,CRELD1,CTNNB1,CUL7,CYP26C1,DAND5,DCHS1,EFNA1,EOMES,ERBB4,FAM83D,FGF8,FGFR2,FOLR1,FOXC1,FOXF1,FOXF2,FOXH1,GATA4,GDNF,GSC,GSK3B,HAND2,HAS2,HES1,HEY1,HEY2,HEYL,HGF,HIF1A,HMGA2,HNRNPAB,HTR2B,ISL1,JAG1,LEF1,LOXL2,LOXL3,LRP6,MEF2C,MEOX1,MESP1,NOG,NOTCH1,NRG1,NRP1,NRTN,OLFM1,OSR1,PAX2,PHACTR4,PHOX2B,PITX2,RBPJ,S100A4,SEMA3A,SFRP2,SHH,SIX1,SIX2,SIX4,SMAD2,SMO,SNAI1,SNAI2,SOX11,SOX8,SOX9,STAT1,TBX1,TBX2,TBX20,TCF21,TGFB1,TGFB2,TGFBR1,TGFBR3,TRIM28,WNT4,WNT8A,WT1	The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells.
GO:0060491	GO	BP	regulation of cell projection assembly	AGRN,APC,ARAP1,ARF6,ARPC2,ATG3,ATG5,ATP8B1,BBS4,BCAS3,BRK1,CAV1,CCDC151,CCL19,CCL21,CCR7,CDC42,CDC42EP1,CDC42EP2,CDC42EP4,CDC42EP5,CLRN1,CYLD,DCDC2,DMTN,DPYSL3,EPHA2,EPS8L1,EPS8L2,EVI5L,EVL,F2RL1,FAM110C,FER,FNBP1L,FSCN1,FUZ,GAP43,GPM6A,HAP1,HRAS,HRG,HTT,IFT140,IFT20,IFT88,KANK1,KCTD17,MIEN1,MYO10,NCKAP1,NEURL1,NLGN1,NRXN1,ODF2,P2RX7,PALM,PFN1,PFN2,PLD1,PLXNB3,PODXL,PPP1R16B,PRKCD,RAB17,RAB5A,RAC1,RAC2,RALA,RAP1GAP,RDX,RHOQ,SAXO1,SLIT2,SRGAP2C,STAP1,TACSTD2,TBC1D30,TBC1D7,TCHP,TENM1,TENM2,TGFB3,TWF2,USP17L2,WASF2,WASH1,WASL,WNT1	Any process that modulates the rate, frequency, or extent of cell projection assembly.
GO:0060537	GO	BP	muscle tissue development	ACTA1,ACTC1,ACVR1,ANKRD1,BMP10,BMP2,BMP4,C3orf58,CAV1,CAV2,CBY1,CFLAR,CHRNA1,CHRND,CSRP3,CXADR,DLL1,DLL4,DSG2,DSP,ENG,FGFR2,FKBP1A,FOXL2,HAND1,HEY2,IGSF8,ISL1,KDM6B,KLHL41,LEMD2,MAML1,MEF2A,MEF2C,MEGF10,MESP1,MYBPC3,MYF5,MYF6,MYH11,MYH14,MYH6,MYH7,MYL2,MYL3,MYL6,MYL6B,MYLK,MYLK2,MYLK3,MYLPF,MYOCD,MYOD1,MYOG,NDUFV2,NEBL,NF1,NKX2-5,NKX2-6,NOTCH1,NRG1,OBSL1,OSR1,PDGFRA,PDGFRB,PDLIM5,PKP2,PROX1,RBP4,RBPJ,RYR1,RYR2,S1PR1,SIK1,SIX1,SIX4,SKI,SKIL,SLC8A1,SMAD7,SORBS2,SRPK3,STRA6,SVIL,TAZ,TBX2,TBX20,TCAP,TCF21,TGFB2,TGFBR3,TNNC1,TNNI3,TNNT2,TPM1,TTN,VEGFA,WNT3A,WT1,ZBTB18,ZFPM1,ZFPM2	The progression of muscle tissue over time, from its initial formation to its mature state. Muscle tissue is a contractile tissue made up of actin and myosin fibers.
GO:0060538	GO	BP	skeletal muscle organ development	ACTA1,BASP1,CAV1,CAV2,CFLAR,CHRNA1,CHRND,CSRP3,DISP1,DLL1,FOXL2,IGSF8,KLHL41,LARGE,LEMD2,MEF2C,MEGF10,MYF5,MYF6,MYH14,MYL6,MYL6B,MYLK2,MYLPF,MYOD1,MYOG,RYR1,SIX1,SIX4,SKI,SKIL,STRA6,SVIL,TAZ,TCF21,WT1,ZBTB18	The progression of a skeletal muscle organ over time from its initial formation to its mature state. A skeletal muscle organ includes the skeletal muscle tissue and its associated connective tissue.
GO:0060539	GO	BP	diaphragm development	BASP1,DISP1,STRA6,TCF21,WT1	The progression of the diaphragm over time from its initial formation to the mature structure. The diaphragm is a skeletal muscle that is responsible for contraction and expansion of the lungs.
GO:0060541	GO	BP	respiratory system development	ASCL1,ATP7A,BAG6,BASP1,BMP4,BMPR2,CCDC39,CCDC40,CEBPA,CHD7,CHI3L1,CTSH,DISP1,DNAAF1,ERRFI1,FGF10,FGF7,FGFR2,FOXF1,FOXJ1,GLI2,GLI3,GRHL2,ITGA3,NFIB,NPHP3,PDGFA,PDPN,PHOX2B,PKDCC,PROX1,RBP4,SFTPD,SHH,SIX4,SKI,SOX11,STRA6,TCF21,TGFB3,VEGFA,WNT7B,WT1,ZIC3	The progression of the respiratory system over time from its formation to its mature structure. The respiratory system carries out respiratory gaseous exchange.
GO:0060544	GO	BP	regulation of necroptotic process	ARHGEF2,BIRC2,BIRC3,CFLAR,RIPK1,RIPK3,SLC25A4,YBX3	Any process that modulates the rate, frequency or extent of a necroptotic process, a necrotic cell death process that results from the activation of endogenous cellular processes, such as signaling involving death domain receptors or Toll-like receptors.
GO:0060556	GO	BP	regulation of vitamin D biosynthetic process	CYP27B1,GFI1,IFNG,IL1B,NFKB1,SNAI1,SNAI2,TNF,VDR	Any process that modulates the rate frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
GO:0060558	GO	BP	regulation of calcidiol 1-monooxygenase activity	CYP27B1,GFI1,IFNG,IL1B,NFKB1,TNF,VDR	Any process that modulates the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O.
GO:0060560	GO	BP	developmental growth involved in morphogenesis	ALCAM,APP,BDNF,BIN3,BMP4,CDK5,COBL,CPNE1,CYFIP1,EIF2AK4,FGF1,FGF10,FGFR2,FLRT1,FLRT3,IMPACT,IQGAP1,MAGI2,MESP1,NLGN3,NOTCH1,NRP1,NRP2,PPP3CB,S1PR1,SALL1,SEMA3A,SEMA3F,SLC9A6,SLIT1,SLIT2,SLIT3,SOX9,USP9X,WNT7B	The increase in size or mass of an anatomical structure that contributes to the structure attaining its shape.
GO:0060562	GO	BP	epithelial tube morphogenesis	ACVR1,ACVRL1,AHI1,BBS4,BBS5,BBS7,BCL10,BMP2,BMP4,CCDC103,CCDC39,CCDC40,CCM2,CELSR1,CITED1,COBL,COL4A1,CSF1R,CSNK2B,CTNNB1,CTSH,DEAF1,DLC1,DLL1,DLL4,DNAAF1,DVL2,ENG,EPHA2,FGF1,FGF10,FGF2,FGFR2,FOLR1,FOXD1,FOXF1,FOXN4,FUZ,GATA3,GATA4,GDF2,GDNF,GLI2,GRHL2,GRHL3,HAND1,HAND2,HES1,HOXA11,HOXD11,IFT122,IHH,KDM2B,KLHL3,LHX1,LMO4,MEF2C,MEGF8,MESP1,MET,MICAL2,MKKS,MTHFD1,MTHFD1L,MTSS1,MYC,NKX2-5,NKX3-1,NOTCH1,NOTCH4,NPHP3,NPNT,NRP1,OSR1,PAK1,PAX2,PAX8,PHACTR4,PKD1,PKD2,PLXNB2,PODXL,PRICKLE1,PRKD2,PRKX,RASIP1,RBPJ,RHOA,RHOB,RYR2,SALL1,SCRIB,SEMA3E,SEMA4C,SETDB2,SFRP2,SHH,SIX1,SKI,SLIT2,SMO,SOX11,SOX17,SOX18,SOX4,SOX8,SOX9,SRF,STARD13,STIL,TBX2,TBX20,TCF21,TGFBR2,TSC2,VANGL2,VEGFA,WNK4,WT1,ZIC3	The process in which the anatomical structures of a tube are generated and organized from an epithelium. Epithelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
GO:0060563	GO	BP	neuroepithelial cell differentiation	BCCIP,BMP2,C10orf11,CITED1,FGF8,HES5,INSM1,JAG2,KIT,LRTOMT,MEF2C,MITF,SOD1,SOX11,SOX4,STRC,USP13,WNT11	The process in which epiblast cells acquire specialized features of neuroepithelial cells.
GO:0060586	GO	BP	multicellular organismal iron ion homeostasis	BMP6,HAMP,SLC11A1,SLC11A2,SLC40A1	Any process involved in the maintenance of the distribution of iron stores within tissues and organs of a multicellular organism.
GO:0060589	GO	MF	nucleoside-triphosphatase regulator activity	ADAP1,ADGRB3,AHSA1,ALDH1A1,ARAP1,ARAP3,ARFGAP1,ARFGAP3,ARHGAP1,ARHGAP15,ARHGAP18,ARHGAP26,ARHGAP27,ARHGAP35,ARHGAP8,ARHGAP9,ARHGEF10L,ARHGEF6,ARL2,ARL2BP,ARRB1,ASAP3,ATP1B1,ATP1B2,ATP1B3,ATPIF1,BAG3,BNIP2,BRSK2,CDC42EP2,CDC42SE1,CPEB2,DEPDC5,DLC1,DNAJB1,DNAJB6,DNAJC1,DNAJC10,DNAJC24,DOCK4,ECT2,ELMOD1,ELMOD2,ERRFI1,EVI5,EVI5L,GDI1,GMIP,GNAQ,GNB5,GPS1,GPS2,GPSM2,HACD3,HTR2B,IPO5,IPO7,IQGAP1,IQGAP2,ITGB1BP1,JUN,KRIT1,LLGL1,LRRK2,MYBPC3,MYO9B,NCKAP1L,NF1,NPRL2,NPRL3,OCRL,PDE6D,PFN1,PFN2,PGAM5,PLCB1,PLN,PREX1,PREX2,RAB3GAP1,RABGAP1,RABGAP1L,RACGAP1,RALBP1,RALGAPA1,RALGAPA2,RALGAPB,RALGDS,RANBP1,RAP1GAP,RAP1GDS1,RAPGEF2,RASA4,RASGRP3,RGS1,RGS10,RGS11,RGS12,RGS14,RGS16,RGS2,RGS20,RGS3,RGS4,RGS5,RGS6,RGS7,RGS8,RHOH,RIMS1,RIN2,RP2,RTKN,RUNDC3A,SGSM2,SGSM3,SH3BGRL3,SH3BP4,SIPA1,SLIT2,SOS1,SRGAP2,SYDE1,SYDE2,TBC1D10B,TBC1D15,TBC1D16,TBC1D2,TBC1D20,TBC1D25,TBC1D30,TBC1D7,TBCD,THY1,TNK2,TOR1AIP1,TOR1AIP2,TSC2,USP6NL,VAV3,WAS,WASL,WNT11	Modulates the rate of NTP hydrolysis by a NTPase.
GO:0060590	GO	MF	ATPase regulator activity	AHSA1,ATP1B1,ATP1B2,ATP1B3,ATPIF1,BAG3,BRSK2,DNAJB1,DNAJB6,DNAJC1,DNAJC10,DNAJC24,MYBPC3,PFN1,PFN2,PLN,TOR1AIP1,TOR1AIP2	Modulates the rate of ATP hydrolysis by an ATPase.
GO:0060612	GO	BP	adipose tissue development	ARID5B,DGAT2,DYRK1B,LRP5,RORC,SH3PXD2B,SOX8,XBP1,ZNF516	The process whose specific outcome is the progression of adipose tissue over time, from its formation to the mature structure. Adipose tissue is specialized tissue that is used to store fat.
GO:0060628	GO	BP	regulation of ER to Golgi vesicle-mediated transport	GAS1,INSIG1,RINT1,RNF139,SCFD1,SORL1,STX18,TBC1D20	Any process that modulates the rate, frequency, or extent of ER to Golgi vesicle-mediated transport, the directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
GO:0060632	GO	BP	regulation of microtubule-based movement	ARMC4,BBS2,BBS4,CCDC39,CCDC40,CCSAP,CFAP20,DNAAF1,DNAH11,HAP1,HDAC6,IGBP1,LAMP1,MKKS,NEFH	Any process that modulates the rate, frequency, or extent of microtubule-based movement, the movement of organelles, other microtubules and other particles along microtubules, mediated by motor proteins.
GO:0060644	GO	BP	mammary gland epithelial cell differentiation	AKT1,AKT2,ERBB4,FOXB1,ID2,IRF6,ZNF703	The process in which a relatively unspecialized epithelial cell becomes a more specialized epithelial cell of the mammary gland.
GO:0060674	GO	BP	placenta blood vessel development	HEY1,HEY2,ITGB8,PKD1,PKD2,RBPJ	The process whose specific outcome is the progression of a blood vessel of the placenta over time, from its formation to the mature structure.
GO:0060675	GO	BP	ureteric bud morphogenesis	BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HOXA11,HOXD11,MYC,NPNT,PAX2,SALL1,SHH,SIX1,TCF21,WT1	The process in which the ureteric bud is generated and organized.
GO:0060688	GO	BP	regulation of morphogenesis of a branching structure	AGT,BMP4,FGFR2,GDNF,HGF,LHX1,LRRK2,NOG,PAX2,PAX8,PDGFA,RTN4,SIX1,SIX2,SIX4,SMO,SOX8,SOX9,SULF1,TACSTD2,TNF,VEGFA	Any process that modulates the rate, frequency, or extent of branching morphogenesis, the process in which the anatomical structures of branches are generated and organized.
GO:0060696	GO	BP	regulation of phospholipid catabolic process	APOC1,APOC2,LDLR,PRKCD,SCARB1	Any process that modulates the rate, frequency, or extent of phospholipid catabolism, the chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester.
GO:0060700	GO	BP	regulation of ribonuclease activity	HSPA1A,NPM1,OAS1,OAS3,TMBIM6	Any process that modulates the rate, frequency, or extent of ribonuclease activity, catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.
GO:0060706	GO	BP	cell differentiation involved in embryonic placenta development	CASP8,E2F7,E2F8,EOMES,PLK4	The process in which a relatively unspecialized cell acquires specialized features of the embryonic placenta.
GO:0060711	GO	BP	labyrinthine layer development	CASP8,FGFR2,HEY1,HEY2,RBPJ,WNT7B	The process in which the labyrinthine layer of the placenta progresses, from its formation to its mature state.
GO:0060732	GO	BP	positive regulation of inositol phosphate biosynthetic process	CD244,GPER1,HRH1,LHCGR,PTH1R,SNCA	Any process that increases the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.
GO:0060759	GO	BP	regulation of response to cytokine stimulus	ADIPOQ,AES,AGPAT1,AGPAT2,APOA1,AXL,BIRC2,BIRC3,CACTIN,CASP8,CCL5,CD24,CD74,CDC37,CHUK,CLIP3,CPNE1,CSF1,CYLD,DNAJA3,EDN1,F2RL1,FADD,GAS6,GFI1,GNB2L1,GSTP1,HIF1A,HIPK1,HSP90AB1,HSPA1A,HSPA1B,IFNA1,IFNA10,IFNA14,IFNA16,IFNA17,IFNA2,IFNA21,IFNA4,IFNA5,IFNA6,IFNA7,IFNA8,IFNAR1,IFNAR2,IFNB1,IFNG,IFNGR1,IFNGR2,IKBKB,IKBKG,IL1RN,IL36RN,IL6ST,IRAK1,IRAK2,IRAK3,JAK1,JAK2,KLF4,MADD,MAP2K5,MAPK7,MAVS,MUL1,NLRC5,NLRP2P,NR1H2,NR1H3,OTULIN,PADI2,PALM3,PARK2,PARP9,PELI3,PIAS1,PPARG,PTPN1,PTPN11,PTPN2,PTPN6,PTPRC,PXDN,PYCARD,PYDC1,PYDC2,RBCK1,RFFL,RIPK1,RNF31,ROBO1,RPS27A,SHARPIN,SIGIRR,SLIT2,SLIT3,SOCS1,SOCS3,SPHK1,STAP1,STAT1,STAT2,SUMO1,SYK,TAF9,TAX1BP1,TICAM2,TNF,TNFAIP3,TNFRSF1A,TRADD,TRAF1,TRAF2,TRAIP,TREM2,TRIM6,TXK,TYK2,UBA52,UBB,UBC,UBE2K,USP18,VRK2,WNT5A,ZNF675	Any process that modulates the rate, frequency, or extent of a response to cytokine stimulus.
GO:0060760	GO	BP	positive regulation of response to cytokine stimulus	AGPAT1,AGPAT2,AXL,CD74,CPNE1,CSF1,EDN1,FADD,GAS6,GFI1,HIF1A,HSPA1A,HSPA1B,MAVS,NLRC5,PARK2,TAF9,TICAM2,TREM2,TRIM6,TXK,UBE2K,WNT5A	Any process that increases the rate, frequency, or extent of a response to cytokine stimulus.
GO:0060761	GO	BP	negative regulation of response to cytokine stimulus	ADIPOQ,AES,APOA1,CACTIN,CCL5,DNAJA3,F2RL1,GAS6,GSTP1,IL1RN,IL36RN,IL6ST,IRAK3,KLF4,MAP2K5,MAPK7,MUL1,NLRC5,NLRP2P,NR1H2,NR1H3,PADI2,PALM3,PELI3,PPARG,PTPN2,PTPRC,PXDN,PYDC1,PYDC2,RFFL,ROBO1,SIGIRR,SLIT2,SLIT3,STAP1,TRAIP,ZNF675	Any process that decreases the rate, frequency, or extent of a response to cytokine stimulus.
GO:0060765	GO	BP	regulation of androgen receptor signaling pathway	ARRB2,BUD31,DAB2,DDX5,EP300,FOXH1,FOXP1,HDAC1,HDAC6,HEYL,NODAL,PARK7,PHB,PIAS2,PRMT2,RNF14,RNF6,SFRP1,SIRT1,SMARCA4,TCF21,TRIM68	Any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway.
GO:0060766	GO	BP	negative regulation of androgen receptor signaling pathway	DAB2,FOXH1,FOXP1,HDAC1,HEYL,NODAL,PHB,PIAS2,SFRP1,SIRT1,SMARCA4,TCF21	Any process that decreases the rate, frequency, or extent of the androgen receptor signaling pathway.
GO:0060788	GO	BP	ectodermal placode formation	GNAS,HDAC1,HDAC2,PROX1,SIX4	The developmental process in which an ectodermal placode forms. An ectodermal placode is a thickening of the ectoderm that is the primordium of many structures derived from the ectoderm.
GO:0060795	GO	BP	cell fate commitment involved in formation of primary germ layer	CDC73,CTR9,EYA2,HOXA11,KLF4,LEO1,NANOG,PAF1,PAX2,POU5F1,RTF1,SIX2,SOX17,SOX2,TRIM15	The commitment of cells to specific cell fates of the endoderm, ectoderm, or mesoderm as a part of gastrulation.
GO:0060828	GO	BP	regulation of canonical Wnt signaling pathway	AES,AMER1,AMER2,APC,APC2,APOE,ARNTL,AXIN1,AXIN2,BAMBI,BICC1,BTRC,CAPRIN2,CAV1,CCAR2,CCNY,CDK14,CHD8,COL1A1,CSNK1A1,CSNK1D,CSNK1G2,CTNNB1,CTNND1,CTNND2,CUL3,CYLD,DAB2,DAB2IP,DACT1,DAPK3,DDIT3,DIXDC1,DKK1,DKK2,DKK3,DRAXIN,DVL1,DVL2,DVL3,EMD,FGFR2,FOLR1,FRAT1,FRAT2,FRZB,FUZ,FZD1,FZD2,FZD5,FZD6,GLI1,GLI3,GPRC5B,GREM1,GSK3A,GSK3B,HDAC1,HECW1,ILK,INVS,JUP,KIAA0922,KLHL12,KREMEN1,KREMEN2,LATS1,LATS2,LEF1,LGR4,LGR5,LGR6,LIMD1,LRP4,LRP5,LRP6,LRRK1,LRRK2,MAD2L2,MCC,MESP1,MLLT3,NFKB1,NKD1,NKD2,NKX2-5,NOG,NPHP3,NRARP,PARK2,PFDN5,PIN1,POU5F1,PPP1CA,PPP2R3A,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTPRO,RBX1,RNF146,RNF220,RPS27A,RSPO1,SCYL2,SDHAF2,SFRP1,SFRP2,SFRP4,SFRP5,SIAH2,SMAD3,SMURF2,SNAI2,SOST,SOX17,SOX2,SOX4,SOX7,SOX9,STK3,STK4,TBX18,TCF7L2,TLE2,TMEM198,TMEM88,TNKS,TNKS2,TRPM4,UBA52,UBB,UBC,UBR5,USP34,WIF1,WLS,WNT1,WNT11,WNT2,WNT2B,WNT3A,WNT4,WNT5A,WNT8A,WNT8B,WNT9A,WWTR1,XIAP,ZBED3,ZNF703,ZNRF3	Any process that modulates the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
GO:0060836	GO	BP	lymphatic endothelial cell differentiation	ACVR2B,ACVRL1,BMPR2,NR2F2,PROX1,SOX18	The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.
GO:0060837	GO	BP	blood vessel endothelial cell differentiation	DLL1,HEY1,HEY2,NOTCH1,NRP1,RBPJ	The process in which a relatively unspecialized cell acquires specialized features of a blood vessel endothelial cell, a thin flattened cell that lines the inside surfaces of blood vessels.
GO:0060839	GO	BP	endothelial cell fate commitment	ACVR1,DLL1,NR2F2,NRP1,PROX1,RBPJ	The commitment of a cell to an endothelial cell fate and its capacity to differentiate into an endothelial cell.
GO:0060840	GO	BP	artery development	ACVR2B,ACVRL1,ANGPTL3,BMP4,BMPR2,DLL4,ENG,FOLR1,FOXF1,GJA5,HES1,HEY1,HEY2,HOXA1,HPGD,JAG1,LRP1,MYLK,NF1,NOTCH1,NRP1,PDGFRB,PROX1,RBPJ,SMAD7,SOX4,STRA6,TBX1,TBX2,TFAP2B,TGFBR1,VEGFA	The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
GO:0060841	GO	BP	venous blood vessel development	ACVR2B,ACVRL1,BMPR2,CCBE1,ENG,FOXF1,NOTCH1,PROX1,TBX20,VEGFA	The progression of the venous blood vessel over time from its initial formation to the mature structure. Venous blood vessels carry blood back to the heart after the capillary bed.
GO:0060850	GO	BP	regulation of transcription involved in cell fate commitment	BMP2,BMP4,CEBPB,CHD5,NR2F2,POU5F1,PPARG,PROX1,RORA,RORC,SOX17	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that contributes to the commitment of a cell to a specific fate.
GO:0060900	GO	BP	embryonic camera-type eye formation	PAX2,PHACTR4,PROX1,SOX11,STRA6,TFAP2A,TWIST1,WNT16,WNT5A	The developmental process pertaining to the initial formation of a camera-type eye from unspecified neurectoderm. This process begins with the differentiation of cells that form the optic field and ends when the optic cup has attained its shape.
GO:0060911	GO	BP	cardiac cell fate commitment	ACVR1,ISL1,MESP1,POU5F1,SOX17,WNT3A,WT1	The commitment of cells to specific cardiac cell fates and their capacity to differentiate into cardiac cells. Cardiac cells are cells that comprise the organ which pumps blood through the circulatory system.
GO:0060914	GO	BP	heart formation	BMP4,FOLR1,ISL1,MEF2C,MESP1,SOX17	The developmental process pertaining to the initial formation of the heart from unspecified parts. This process begins with the specific processes that contribute to the appearance of the heart field and the arrival of cardiac neural crest to the heart region. The process ends when the structural rudiment is recognizable.
GO:0060956	GO	BP	endocardial cell differentiation	ACVR1,NOTCH1,NRG1,SOX17,SOX18	The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of an endocardial cell. An endocardial cell is a specialized endothelial cell that makes up the endocardium portion of the heart. The endocardium is the innermost layer of tissue of the heart, and lines the heart chambers.
GO:0060964	GO	BP	regulation of gene silencing by miRNA	AJUBA,BCDIN3D,DND1,LIMD1,POU5F1,PUM1,PUM2,TGFB1,TRIM71,WTIP,ZC3H12A	Any process that modulates the rate, frequency, or extent of the downregulation of gene expression through the action of microRNAs (miRNAs), endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), miRNAs can downregulate gene expression by either of two posttranscriptional mechanisms: mRNA cleavage or translational repression.
GO:0060965	GO	BP	negative regulation of gene silencing by miRNA	BCDIN3D,DND1,POU5F1,TGFB1,ZC3H12A	Any process that decreases the rate, frequency, or extent of the downregulation of gene expression through the action of microRNAs (miRNAs), endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), miRNAs can downregulate gene expression by either of two posttranscriptional mechanisms: mRNA cleavage or translational repression.
GO:0060966	GO	BP	regulation of gene silencing by RNA	AJUBA,BCDIN3D,DND1,LIMD1,POU5F1,PUM1,PUM2,TERT,TGFB1,TRIM71,WTIP,XPO5,ZC3H12A	Any process that regulates the rate, frequency, or extent of gene silencing by RNA. Gene silencing by RNA is the process in which RNA molecules inactivate expression of target genes.
GO:0060967	GO	BP	negative regulation of gene silencing by RNA	BCDIN3D,DND1,POU5F1,TERT,TGFB1,ZC3H12A	Any process that decreases the rate, frequency, or extent of gene silencing by RNA. Gene silencing by RNA is the process in which RNA molecules inactivate expression of target genes.
GO:0060968	GO	BP	regulation of gene silencing	AICDA,AJUBA,APOBEC1,ASF1A,BCDIN3D,CDK2,DND1,HIST1H3A,HMGA1,LIMD1,MIER1,PHF2,PHF8,POU5F1,PUM1,PUM2,SIN3A,SIRT1,TERT,TET1,TGFB1,TRIM71,WTIP,XPO5,ZC3H12A	Any process that modulates the rate, frequency, or extent of gene silencing, the transcriptional or post-transcriptional process carried out at the cellular level that results in long-term gene inactivation.
GO:0060969	GO	BP	negative regulation of gene silencing	AICDA,APOBEC1,ASF1A,BCDIN3D,DND1,HMGA1,PHF2,PHF8,POU5F1,TERT,TET1,TGFB1,ZC3H12A	Any process that decreases the rate, frequency, or extent of gene silencing, the transcriptional or post-transcriptional process carried out at the cellular level that results in long-term gene inactivation.
GO:0060972	GO	BP	left/right pattern formation	AHI1,CITED2,DNAAF1,MEGF8,PITX2,PKD1L1,SETDB2	The pattern specification process that results in the subdivision of the left/right axis in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
GO:0060973	GO	BP	cell migration involved in heart development	DCHS1,FLRT3,FOLR1,MESP1,NOTCH1,PDGFRB,PITX2,SNAI2,TBX5	The orderly movement of a cell from one site to another that will contribute to the progression of the heart over time, from its initial formation, to the mature organ.
GO:0060976	GO	BP	coronary vasculature development	GATA6,MESP1,NOTCH1,NRP1,PDGFRB,TBX1,TBX5,VEGFA	The process whose specific outcome is the progression of the blood vessels of the heart over time, from its formation to the mature structure.
GO:0060977	GO	BP	coronary vasculature morphogenesis	NOTCH1,NRP1,PDGFRB,TBX1,TBX5,VEGFA	The process in which the anatomical structures of blood vessels of the heart are generated and organized. The blood vessel is the vasculature carrying blood.
GO:0060993	GO	BP	kidney morphogenesis	AHI1,BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HNF1B,HOXA11,HOXD11,KLHL3,LHX1,LRRK2,MYC,NPHP3,NPNT,OSR1,PAX2,PAX8,PRKX,SALL1,SHH,SIX1,SIX2,SMO,SOX4,SOX8,SOX9,TCF21,WNK4,WNT7B,WT1	Morphogenesis of a kidney. A kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0060996	GO	BP	dendritic spine development	ARF4,CTNND2,DLG4,EPHB1,EPHB2,EPHB3,PAK3,PTEN,SHANK1,SHANK3,SLC12A5,SRGAP2,WNT7A	The process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
GO:0060997	GO	BP	dendritic spine morphogenesis	CTNND2,DLG4,EPHB1,EPHB2,EPHB3,PAK3,PTEN,SHANK1,SHANK3,WNT7A	The process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
GO:0060998	GO	BP	regulation of dendritic spine development	APOE,ARF6,BHLHB9,CAMK1,CAMK2B,CAPRIN1,CAPRIN2,CDK5,CDK5R1,CFL1,CPEB3,CUX2,EFNA1,EPHA4,FOXO6,LRP8,LRRK2,MEF2C,NEURL1,NGEF,NLGN1,PDLIM5,PSEN1,PTEN,RELN,SHANK1,SHANK3,SIPA1L1,SRCIN1,SRGAP2C	Any process that modulates the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.
GO:0060999	GO	BP	positive regulation of dendritic spine development	APOE,BHLHB9,CAMK1,CAMK2B,CAPRIN1,CAPRIN2,CPEB3,CUX2,FOXO6,LRP8,NEURL1,NLGN1,PSEN1,RELN,SHANK1,SHANK3	Any process that increases the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.
GO:0061000	GO	BP	negative regulation of dendritic spine development	APOE,EFNA1,NGEF,NLGN1,PTEN,SRGAP2C	Any process that decreases the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.
GO:0061001	GO	BP	regulation of dendritic spine morphogenesis	BHLHB9,CAMK2B,CAPRIN1,CAPRIN2,CDK5,CDK5R1,CFL1,CUX2,EFNA1,EPHA4,LRP8,LRRK2,NGEF,NLGN1,PDLIM5,PTEN,RELN,SHANK3,SIPA1L1,SRCIN1	Any process that modulates the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
GO:0061003	GO	BP	positive regulation of dendritic spine morphogenesis	BHLHB9,CAMK2B,CAPRIN1,CAPRIN2,CUX2,LRP8,RELN	Any process that modulates the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
GO:0061004	GO	BP	pattern specification involved in kidney development	BMP4,FOXD1,OSR1,PAX2,PAX8	Any developmental process that results in the creation of defined areas or spaces within the kidney to which cells respond and eventually are instructed to differentiate.
GO:0061005	GO	BP	cell differentiation involved in kidney development	BASP1,CD24,IQGAP1,JAG1,KLF15,MAGI2,MEF2C,MTSS1,MYO1E,OSR1,PAX2,PDGFB,PODXL,POU3F3,PROM1,PTPRO,SIX2,STAT1,TCF21,WNT4,WT1	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells of the kidney as it progresses from its formation to the mature state.
GO:0061008	GO	BP	hepaticobiliary system development	ARID5B,CCDC39,CCDC40,CEBPA,CEBPB,CEBPG,CITED2,COBL,DNAAF1,E2F7,E2F8,LSR,NF1,NIPBL,NKX2-8,NPHP3,PCSK9,PHF2,PKD2,RPS6KA1,TGFBR3,XBP1,ZIC3	The progression of the hepaticobiliary system over time, from its formation to the mature structure. The hepaticobiliary system is responsible for metabolic and catabolic processing of small molecules absorbed from the blood or gut, hormones and serum proteins, detoxification, storage of glycogen, triglycerides, metals and lipid soluble vitamins and excretion of bile. Included are the synthesis of albumin, blood coagulation factors, complement, and specific binding proteins.
GO:0061013	GO	BP	regulation of mRNA catabolic process	AGO2,BTG2,CNOT1,CNOT7,CNOT8,CPEB3,DHX34,GTPBP1,NANOS1,NANOS2,NANOS3,NBAS,PABPC1,PNPT1,TNRC6B,TNRC6C,TOB1,ZC3H12A,ZC3HAV1,ZFP36,ZFP36L2	Any process that modulates the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.
GO:0061014	GO	BP	positive regulation of mRNA catabolic process	AGO2,BTG2,CNOT1,CNOT7,CNOT8,CPEB3,GTPBP1,NANOS1,NANOS2,NANOS3,PABPC1,PNPT1,TNRC6B,TNRC6C,TOB1,ZC3H12A,ZC3HAV1,ZFP36,ZFP36L2	Any process that increases the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.
GO:0061025	GO	BP	membrane fusion	ADAM2,ANKFY1,ATG7,BAX,BET1L,BNIP1,CAV2,CD9,CHCHD3,CHMP3,CHP1,CLN3,CRISP1,DCSTAMP,DNM1L,EEA1,FAM73A,FAM73B,FIS1,GAS6,GCA,GDAP1,GOSR2,HACE1,HYAL2,IZUMO1,IZUMO1R,LRMP,MFF,MFN1,MFN2,NAPA,NAPG,NKD2,NSF,OPA1,OTOF,PLD6,PVRL2,RAB20,RAB34,RAB39A,RAB7A,RAB8A,RABEP1,RABIF,RIMS1,ROPN1B,RUBCN,SERPINA5,SLC25A46,SNAP23,SNAP29,SNX14,STOML2,STX11,STX17,TECPR1,TGFBRAP1,TMEM8C,TSG101,USP30,UVRAG,VAMP2,VAMP3,VAMP4,VAMP7,VAMP8,VAPA,VPS11,VPS16,VPS33A,VPS33B,VPS39,VPS41,VPS4A,VPS8,VTI1A,VTI1B	The membrane organization process that joins two lipid bilayers to form a single membrane.
GO:0061028	GO	BP	establishment of endothelial barrier	ENG,EZR,F11R,F2RL1,ICAM1,MARVELD2,MLLT4,MSN,MYADM,PDE2A,PDE4D,PPP1R16B,RAP1A,RAP1B,RAP2C,RAPGEF1,RAPGEF2,RAPGEF3,RDX,SOX18,TJP1,TJP2,WNT7B	The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.
GO:0061029	GO	BP	eyelid development in camera-type eye	HDAC1,HDAC2,INHBA,OSR2,SOX11,STRA6,TFAP2A,TWIST1	The progression of the eyelid in a camera-type eye from its formation to the mature state. The eyelid is a membranous cover that helps protect and lubricate the eye.
GO:0061035	GO	BP	regulation of cartilage development	ACVRL1,ADAMTS12,ADAMTS7,BMP1,BMP2,BMP4,BMPR1B,BMPR2,CHADL,EFEMP1,GDF5,GREM1,HOXA11,LOXL2,NKX3-2,PKDCC,PTHLH,SCIN,SCX,SNAI2,SOX5,SOX6,SOX9,TGFBR1,TRPS1,WNT11,WNT9A,ZBTB16	Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
GO:0061036	GO	BP	positive regulation of cartilage development	ACVRL1,BMP1,BMP2,BMP4,BMPR1B,BMPR2,GDF5,HOXA11,LOXL2,PKDCC,SCX,SOX5,SOX6,SOX9,ZBTB16	Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
GO:0061037	GO	BP	negative regulation of cartilage development	ADAMTS12,ADAMTS7,CHADL,EFEMP1,GDF5,GREM1,NKX3-2,PTHLH,SNAI2,SOX9,TGFBR1,WNT11,WNT9A	Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
GO:0061041	GO	BP	regulation of wound healing	ADAMTS18,ADRA2A,ALOX12,ANO6,ANXA1,APCS,APOE,APOH,ARFGEF1,ASIC2,C1QTNF1,CAPN3,CASK,CAV1,CD109,CD34,CLASP1,CLASP2,CLEC4M,DMTN,EDN1,ENPP4,F11,F12,F2,F2R,F2RL1,F3,FAM46A,FAP,FGA,FGB,FGF2,FGG,FOXA2,FOXC2,GP1BA,GSN,HBEGF,HPSE,HRAS,HRG,INSL3,KANK1,KLKB1,KNG1,KRT1,LBH,LYN,MYLK,NOS3,PDGFA,PDGFB,PDGFRA,PHLDB2,PLAT,PLAU,PLAUR,PLEK,PLG,PLPP3,PRKCA,PRKCD,PRKCE,PRKCQ,PRKG1,PROC,REG3A,REG3G,RREB1,SCARA5,SELP,SERPINB2,SERPINE1,SERPINE2,SERPINF2,SOX15,SRSF6,STAB2,STX2,STXBP5,SYK,TC2N,TEC,THBD,THBS1,TLR4,TMPRSS6,TNFAIP3,TNFRSF12A,USF1,VAV2,VEGFB,VIL1,VTN	Any process that modulates the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
GO:0061045	GO	BP	negative regulation of wound healing	ADAMTS18,ALOX12,APCS,APOE,APOH,C1QTNF1,CASK,CD109,CD34,CLASP1,CLASP2,EDN1,F11,F12,F2,FGA,FGB,FGF2,FGG,GP1BA,HRG,KLKB1,KNG1,KRT1,NOS3,PDGFA,PDGFB,PDGFRA,PHLDB2,PLAT,PLAU,PLAUR,PLG,PRKCD,PRKG1,PROC,SERPINB2,SERPINE1,SERPINE2,SERPINF2,THBD,TMPRSS6,VTN	Any process that decreases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
GO:0061053	GO	BP	somite development	COBL,CRB2,DLL1,FOXB1,IHH,LFNG,MEOX1,MTHFD1,PPP2R3A,PTCH1,RIPPLY1,RIPPLY2,SFRP2,SHH,SIX4,SMO,SOX11	The progression of a somite from its initial formation to the mature structure. Somites are mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
GO:0061072	GO	BP	iris morphogenesis	FOXE3,PAX6,PITX2,WNT2,WNT2B,WNT9A	The process in which the iris is generated and organized. The iris is an anatomical structure in the eye whose opening forms the pupil. The iris is responsible for controlling the diameter and size of the pupil and the amount of light reaching the retina.
GO:0061077	GO	BP	chaperone-mediated protein folding	BAG1,CCT2,CHORDC1,CLU,CRTAP,CSNK2A1,DNAJB1,DNAJB8,DNAJC24,DNAJC7,ERO1A,FKBP4,FKBP5,P3H1,PDIA4,PEX19,PPIB,PPID,PTGES3,TOR1A,TRAP1	The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone.
GO:0061081	GO	BP	positive regulation of myeloid leukocyte cytokine production involved in immune response	BCL10,CD74,GPRC5B,NR4A3,SEMA7A,WNT5A	Any process that modulates the rate, frequency, or extent of the production of a cytokine that contributes to the immune response.
GO:0061085	GO	BP	regulation of histone H3-K27 methylation	H2AFY,MTF2,OGT,PHF1,PHF19,SUPT6H	Any process that modulates the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.
GO:0061088	GO	BP	regulation of sequestering of zinc ion	AP3D1,SLC30A2,SLC30A3,SLC30A4,SLC30A8	Any process that modulates the rate, frequency, or extent of sequestering of zinc ion. Sequestering of zinc ion is the process of binding or confining zinc ions such that they are separated from other components of a biological system.
GO:0061097	GO	BP	regulation of protein tyrosine kinase activity	ACE,ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGT,APP,CAV1,CBLC,CCL5,CD24,CSF1R,DOK7,EGF,EPGN,ERBB3,ERCC6,EREG,ERRFI1,FBXW7,FGFR1OP,GAS6,GHRL,GNB2L1,GPRC5A,GPRC5B,HYAL2,IBTK,LRP8,MVP,NCK2,NRG1,PAK2,PDGFB,PTK6,PTPN1,RAP2B,RAP2C,RELN,SHC1,SNX6,SOCS4,SOCS5,SRCIN1,STAP1,TGFA,UNC119,ZFYVE28,ZGPAT	Any process that modulates the rate, frequency, or extent of protein tyrosine kinase activity.
GO:0061098	GO	BP	positive regulation of protein tyrosine kinase activity	ACE,ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGT,CCL5,CD24,CSF1R,DOK7,EGF,EPGN,ERBB3,ERCC6,EREG,FBXW7,GAS6,GHRL,GPRC5B,LRP8,NRG1,PAK2,PDGFB,PTPN1,RELN,SRCIN1,STAP1,TGFA,UNC119	Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
GO:0061099	GO	BP	negative regulation of protein tyrosine kinase activity	CAV1,CBLC,ERRFI1,FGFR1OP,GNB2L1,GPRC5A,HYAL2,IBTK,MVP,PTK6,SNX6,SOCS4,SOCS5,SRCIN1,ZFYVE28,ZGPAT	Any process that decreases the rate, frequency, or extent of protein tyrosine kinase activity.
GO:0061134	GO	MF	peptidase regulator activity	A2M,A2ML1,ADRM1,AGT,AMBP,APAF1,APP,AVP,BAD,BCL2L13,BIRC5,BIRC6,BIRC7,BST2,CARD8,CASP1,CASP8AP2,CAST,CAV1,CD27,CDKN1B,CLPX,COL4A3,CRB2,CST3,CST4,CST5,CST7,CSTA,CSTB,CTSH,DPEP1,EBAG9,FETUB,FURIN,GAS6,GNB2L1,GPC3,ITIH2,ITIH3,ITIH4,KNG1,LCN1,LEF1,LPA,MAL,MT3,NGF,NGFRAP1,NKX3-1,NLRP1,NLRP12,NOD1,NOL3,PCOLCE,PCOLCE2,PCSK1N,PI3,PINK1,PRDX3,PRDX5,PROL1,PROS1,PSMD14,PSME3,PSME4,PSMF1,PTTG1,PYCARD,PZP,RECK,RENBP,RPS27L,RPS6KA1,RPS6KA3,SERPINA1,SERPINA3,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB8,SERPINB9,SERPINC1,SERPIND1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SLPI,SNCA,SPINK1,SPINK2,SPINK5,SPINK9,SPINT2,SPOCK1,SPOCK3,SPP2,TFAP2B,TFPI,TIMP1,TIMP3,TIMP4,TNFAIP8,TNFSF14,UCHL5,USP14,VCP,VIL1,WFDC12,WFDC2,XIAP	Modulates the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
GO:0061135	GO	MF	endopeptidase regulator activity	A2M,ADRM1,AGT,AMBP,APP,AVP,BIRC5,BIRC6,BIRC7,BST2,CAST,CD27,COL4A3,CRB2,CST3,CST4,CST5,CST7,CSTA,CSTB,DPEP1,FETUB,FURIN,GAS6,ITIH2,ITIH3,ITIH4,KNG1,LCN1,LEF1,LPA,MT3,NGF,NOL3,PCSK1N,PI3,PRDX3,PRDX5,PROL1,PROS1,PSMD14,PSME3,PSMF1,PTTG1,PZP,RECK,RENBP,RPS6KA1,RPS6KA3,SERPINA1,SERPINA3,SERPINA5,SERPINA6,SERPINA7,SERPINA9,SERPINB1,SERPINB12,SERPINB13,SERPINB3,SERPINB4,SERPINB6,SERPINB8,SERPINB9,SERPINC1,SERPIND1,SERPINE1,SERPINE2,SERPINF1,SERPINF2,SERPING1,SERPINH1,SLPI,SNCA,SPINK1,SPINK2,SPINK5,SPINK9,SPINT2,SPOCK1,SPOCK3,SPP2,TFAP2B,TFPI,TIMP1,TIMP3,TIMP4,TNFAIP8,TNFSF14,UCHL5,USP14,VIL1,WFDC12,WFDC2,XIAP	Modulates the activity of a peptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides.
GO:0061136	GO	BP	regulation of proteasomal protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ARAF,ATM,ATRAID,BAG5,BAG6,BCAP31,BUB1,BUB1B,BUB3,CAV1,CBFA2T3,CCAR2,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CEBPA,CENPE,CENPF,CLU,COMMD1,CSNK1A1,CSNK1D,CSNK1E,CSNK2A1,CSNK2A2,CUL3,DAB2,DAB2IP,DDRGK1,DLGAP5,DNAJB2,DUSP1,DVL1,DYNC1LI1,DYX1C1,ECSCR,ESPL1,FBXW7,FHIT,GABARAPL2,GEN1,GIPC1,GLMN,GNA12,GNB2L1,GPX1,GSK3B,HERPUD1,HFE,HSP90AB1,HSPBP1,KCNE2,KEAP1,KLHL22,LCMT1,LRRK2,MAD1L1,MAD2L1,MAD2L2,MDM2,N4BP1,NEK6,NELL1,NFE2L2,NKD2,NSMCE2,NUB1,OSBPL7,PANO1,PARK2,PARK7,PCID2,PIAS1,PINK1,PKD1,PLK1,PLK3,PRICKLE1,PRKACA,PRKCG,PSMD10,PSMD14,PSME3,PSMF1,PTEN,RAD23A,RAD23B,RB1,RCHY1,RFWD2,RHBDF1,SDCBP,SGTA,SIRT2,SMAD7,SMC5,SOCS5,STUB1,SUMO1,SUMO2,SVIP,TAF1,TAF9,TERF1,TEX14,TLK2,TMF1,TPR,TRIB1,TRIB2,TTK,UBB,UBE2C,UBE2D1,UBE2E1,UBQLN1,UBQLN2,UBQLN4,UBXN1,UCHL5,UFL1,USP14,USP44,USP5,VCP,WAC,XBP1,XRCC3,ZNF207	Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.
GO:0061138	GO	BP	morphogenesis of a branching epithelium	BMP2,BMP4,CITED1,COL4A1,CTNNB1,CTSH,DLL4,ENG,EPHA2,FGF1,FGF10,FGF2,FGFR2,FOXD1,FOXF1,GDF2,GDNF,GLI2,HOXA11,HOXD11,MET,MYC,NKX3-1,NOTCH4,NPNT,NRP1,PAK1,PAX2,PKD1,RASIP1,SALL1,SEMA3E,SFRP2,SHH,SIX1,SLIT2,SOX8,SOX9,TCF21,TGFBR2,VEGFA,WT1	The process in which the anatomical structures of a branched epithelium are generated and organized.
GO:0061154	GO	BP	endothelial tube morphogenesis	ACVRL1,BMP4,CCM2,CSNK2B,CTNNB1,PRKD2,RBPJ,RHOA,RHOB,STARD13	The process in which the anatomical structures of a tube are generated and organized from an endothelium. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.
GO:0061157	GO	BP	mRNA destabilization	CPEB3,METTL14,METTL3,MEX3D,PUM1,TRIM71,ZC3H12A,ZC3H12D	Any process that decreases the stability of an mRNA molecule, making it more vulnerable to degradative processes. Messenger RNA is the intermediate molecule between DNA and protein. It includes UTR and coding sequences. It does not contain introns.
GO:0061162	GO	BP	establishment of monopolar cell polarity	FOXJ1,FSCN1,GBF1,MSN,SCRIB,SLC9A3R1,SYNE4	The specification and formation of monopolar intracellular organization or cell growth patterns. Monopolar cell organization is directional organization along an axis.
GO:0061178	GO	BP	regulation of insulin secretion involved in cellular response to glucose stimulus	ADCY5,ADRA2A,ANO1,BRSK2,CDK16,CFTR,EFNA5,EPHA5,FOXA2,GPLD1,HLA-DRB1,NR1D1,NR1H4,PIM3,PPP3CB,RFX6,STX4,STXBP4,TMEM27	Any process that modulates the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
GO:0061180	GO	BP	mammary gland epithelium development	AKT1,AKT2,CSF1R,EPHA2,ERBB4,FGFR2,FOXB1,ID2,IRF6,JAK2,SCRIB,ZNF703	The process whose specific outcome is the progression of the mammary gland epithelium over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
GO:0061202	GO	CC	clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane	DNAJC5,GAD1,GAD2,HSPA8,RAB3A,SLC32A1,SYT1,VAMP2	The lipid bilayer surrounding a clathrin-sculpted gamma-aminobutyric acid transport vesicle.
GO:0061213	GO	BP	positive regulation of mesonephros development	AGT,BASP1,GATA3,GDNF,LHX1,NOG,PAX2,PAX8,SIX1,SIX4,SMO,SOX8,SOX9,VEGFA,WT1	Any process that increases the rate, frequency or extent of mesonephros development. Mesonephros development is the process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. The mesonephros is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0061217	GO	BP	regulation of mesonephros development	AGT,BASP1,BMP4,GATA3,GDNF,LHX1,NOG,PAX2,PAX8,SIX1,SIX2,SIX4,SMO,SOX8,SOX9,TACSTD2,VEGFA,WT1	Any process that modulates the rate, frequency or extent of mesonephros development. Mesonephros development is the process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. The mesonephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0061298	GO	BP	retina vasculature development in camera-type eye	ACVR2B,ACVRL1,BMPR2,COL4A1,CYP1B1,FZD4,LRP5,NRP1,PDGFRA,PDGFRB	The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.
GO:0061299	GO	BP	retina vasculature morphogenesis in camera-type eye	COL4A1,CYP1B1,FZD4,LRP5,NRP1	The process in which the vasculature of the retina is generated and organized.
GO:0061303	GO	BP	cornea development in camera-type eye	FOXE3,PAX6,SOX11,WNT2B,WNT6,WNT9A,WNT9B	The progression of the cornea over time, from its formation to the mature structure. The cornea is the transparent structure that covers the anterior of the eye.
GO:0061309	GO	BP	cardiac neural crest cell development involved in outflow tract morphogenesis	FOLR1,HAND2,HES1,JAG1,PITX2	The process aimed at the progression of a cardiac neural crest cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell that contributes to the shaping of the outflow tract.
GO:0061311	GO	BP	cell surface receptor signaling pathway involved in heart development	BMP2,BMP4,CTNNB1,DLL4,GALNT11,HEY1,HEY2,JAG1,NOTCH1,NOTCH2,POU5F1,RBPJ,SNAI1,WNT3A	Any series of molecular signals initiated by the binding of a receptor on the surface of a cell to a physiological ligand, which contributes to the progression of the heart over time.
GO:0061314	GO	BP	Notch signaling involved in heart development	DLL4,GALNT11,HEY1,HEY2,JAG1,NOTCH1,NOTCH2,RBPJ,SNAI1	The series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell and contributing to the progression of the heart over time.
GO:0061326	GO	BP	renal tubule development	AHI1,BMP2,BMP4,CITED1,COL4A1,FGF1,FGF2,FOXD1,GATA3,GDNF,HNF1B,HOXA11,HOXD11,KLHL3,MEF2C,MTSS1,MYC,NPNT,OSR1,PAX2,PAX8,PKD2,POU3F3,SALL1,SHH,SIX1,SOX8,SOX9,STAT1,TCF21,TFAP2B,WNK4,WNT7B,WT1	The progression of the renal tubule over time from its formation to the mature form. A renal tubule is a tube that filters, re-absorbs and secretes substances to rid an organism of waste and to play a role in fluid homeostasis.
GO:0061333	GO	BP	renal tubule morphogenesis	AHI1,BMP2,BMP4,CITED1,COL4A1,FGF1,FGF2,FOXD1,GATA3,GDNF,HOXA11,HOXD11,KLHL3,MEF2C,MTSS1,MYC,NPNT,OSR1,PAX2,PAX8,PKD2,SALL1,SHH,SIX1,SOX8,SOX9,TCF21,WNK4,WT1	The process in which the renal tubule is generated by specification of cell fate, through the maintenance of cell polarity, regulated cell proliferation and morphogenetic cell rearrangements, shape changes and growth. A renal tubule is a tube that filters, re-absorbs and secretes substances to rid an organism of waste and to play a role in fluid homeostasis.
GO:0061337	GO	BP	cardiac conduction	ABCC9,AHCYL1,AKAP9,ANK2,ASPH,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2A3,ATP2B1,ATP2B2,ATP2B3,ATP2B4,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D2,CACNA2D3,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG1,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,CAMK2D,CASQ1,CASQ2,CAV1,CORIN,CTNNA3,CXADR,DMPK,DSC2,DSG2,DSP,FKBP1B,FXYD1,FXYD2,FXYD3,FXYD4,FXYD6,FXYD7,GJA1,GJA5,GJC1,HCN4,ITPR1,ITPR2,ITPR3,JUP,KCNA5,KCND1,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ11,KCNJ12,KCNJ14,KCNJ2,KCNJ4,KCNK1,KCNK15,KCNK3,KCNK6,KCNQ1,MEF2A,NOS1,NPPA,NPPC,NPR1,NPR2,ORAI1,PKP2,PLN,PRKACA,RNF207,RYR1,RYR2,RYR3,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SLC8A2,SLC8A3,SLC9A1,SPTBN4,STIM1,TNNI3,TNNI3K,TRDN,TRPC1,YWHAE	Transfer of an organized electrical impulse across the heart to coordinate the contraction of cardiac muscles. The process begins with generation of an action potential (in the sinoatrial node (SA) in humans) and ends with a change in the rate, frequency, or extent of the contraction of the heart muscles.
GO:0061351	GO	BP	neural precursor cell proliferation	ARTN,ATF5,DOCK7,EML1,EPHB1,FGF13,FGFR2,HOOK3,KIF14,MELK,NUMB,NUMBL,PAFAH1B1,PCM1,PLXNB2,RAB10,RACGAP1,RORA,RYK,SHH,SIX3,SLC39A5,SOX5,TEAD3,TRNP1,WNT2,WNT3A,WNT7A	The multiplication or reproduction of neural precursor cells, resulting in the expansion of a cell population. A neural precursor cell is either a nervous system stem cell or a nervous system progenitor cell.
GO:0061365	GO	BP	positive regulation of triglyceride lipase activity	APOA4,APOA5,APOC2,APOH,GPIHBP1,NR1H2,NR1H3,PNLIP	Any process that increases the activity of triglyceride lipase.
GO:0061371	GO	BP	determination of heart left/right asymmetry	AHI1,BBS4,BBS5,BBS7,CCDC103,CCDC39,CCDC40,DAND5,DLL1,DNAAF1,ENG,FOLR1,FOXN4,GATA4,HAND1,HAND2,IHH,MEF2C,MEGF8,MESP1,MICAL2,MKKS,NKX2-5,NOTCH1,NPHP3,PKD2,SETDB2,SHH,SMO,SOX17,SOX18,SRF,STIL,TBX2,TBX20,VANGL2,ZIC3	Determination of the asymmetric location of the heart with respect to the left and right halves of the organism.
GO:0061383	GO	BP	trabecula morphogenesis	BMP10,DLL4,FBN2,FKBP1A,HEY1,NACA,NOTCH1,NRG1,PLXNB1,RBP4,RBPJ,RHOA,S1PR1,SEMA4D,TEK,TGFBR3	The process of shaping a trabecula in an organ. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.
GO:0061384	GO	BP	heart trabecula morphogenesis	BMP10,DLL4,FKBP1A,HEY1,NACA,NOTCH1,NRG1,RBP4,RBPJ,S1PR1,TEK,TGFBR3	The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.
GO:0061387	GO	BP	regulation of extent of cell growth	ABL1,APOE,BCL11A,BDNF,CDKL5,CLASP2,CTTN,DCC,DNM2,DSCAM,FGF13,GOLGA4,ISLR2,L1CAM,LIMK1,MACF1,MAPT,MEGF8,MT3,NRCAM,NRP1,NTN1,OLFM1,RNF6,RTN4,RTN4R,RUFY3,SEMA3A,SEMA4D,SEMA5A,SEMA7A,SHTN1,TWF2,VEGFA	Any process that modulates the extent of cell growth.
GO:0061418	GO	BP	regulation of transcription from RNA polymerase II promoter in response to hypoxia	ARNT,BACH1,CA9,CITED2,CREBBP,CUL2,EGLN1,EGLN2,EGLN3,EP300,EPAS1,EPO,HIF1A,HIF1AN,HIF3A,NOTCH1,RBPJ,RBX1,RPS27A,SIRT2,STOX1,TCEB1,TCEB2,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,VEGFA,VHL	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
GO:0061436	GO	BP	establishment of skin barrier	ALOX12,ALOX12B,ALOXE3,CLDN1,CLDN4,KDF1,KRT16,SFN,TMEM79,TP63	Establishment of the epithelial barrier, the functional barrier in the skin that limits its permeability.
GO:0061448	GO	BP	connective tissue development	ALX1,AMELX,ARID5B,ATP7A,BMP1,BMP2,BMP4,BMPR1B,BMPR2,CER1,CHI3L1,COL11A2,COL2A1,CREB3L2,DGAT2,DYRK1B,EGR1,EIF2AK3,FGF2,FGF4,FGFR3,FOXD1,GDF2,GDF5,GHRL,GPLD1,HES5,HMGA2,HOXA11,HOXD3,IHH,IL17F,ITGB8,LRP5,MEF2C,MGP,NFIB,NOV,NPPC,OSR1,OSR2,PDGFB,PDGFRB,RORC,SCX,SH3PXD2B,SLC39A13,SNX19,SOX8,SOX9,STC1,SULF1,SULF2,TGFB1,WNT7A,WNT7B,XBP1,ZBTB16,ZNF516	The progression of a connective tissue over time, from its formation to the mature structure.
GO:0061462	GO	BP	protein localization to lysosome	AP3M1,CD81,GCC2,GNPTAB,HGS,HSPA8,LAMTOR4,LAMTOR5,NAGPA,NEDD4,RAB7A,RNF128,SCARB2,SH3BP4,SNX16,SORL1,ZFYVE16	A process in which a protein is transported to, or maintained in, a location within a lysosome.
GO:0061512	GO	BP	protein localization to cilium	ARL6,ATP6V1D,BBS1,BBS4,BBS9,CSNK1D,EHD1,IFT122,IFT140,SNX10,SPATA7,TTC21B	A process in which a protein is transported to, or maintained in, a location within a cilium.
GO:0061515	GO	BP	myeloid cell development	ANXA2,DMTN,FOXP1,G6PD,GATA1,KIT,MED1,ZNF385A	The process whose specific outcome is the progression of a myeloid cell over time, from its formation to the mature structure.
GO:0061548	GO	BP	ganglion development	ASCL1,CTNNB1,FZD3,INSM1,NRP1,NRP2,PHOX2B,SEMA3A,SEMA3F,SIX4	The process whose specific outcome is the progression of a ganglion over time, from its formation to the mature structure.
GO:0061549	GO	BP	sympathetic ganglion development	ASCL1,CTNNB1,FZD3,INSM1,NRP1,NRP2,PHOX2B,SEMA3A,SEMA3F	The process whose specific outcome is the progression of a sympathetic ganglion over time, from its formation to the mature structure.
GO:0061572	GO	BP	actin filament bundle organization	ADD1,ADD2,AIF1,ARRB1,BAIAP2,CORO1B,CUL3,DMTN,DPYSL3,EPS8,EZR,FMN2,FSCN1,FSCN2,HSP90B1,ITGB5,KCTD13,LCP1,LIMA1,MYO1B,NEDD9,PAWR,PDXP,PHACTR1,RHOD,SHROOM1,SHTN1,SORBS1,SPIRE1,SPIRE2,SRC,TNFAIP1,ZYX	A process that results in the assembly, arrangement of constituent parts, or disassembly of an actin filament bundle.
GO:0061617	GO	CC	MICOS complex	APOO,APOOL,CHCHD3,CHCHD6,IMMT	Mitochondrial inner membrane complex involved in maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane. In Saccharomyces cerevisiae the complex has six subunits: MIC10, MIC12, MIC19, MIC26, MIC27, and MIC60.
GO:0061621	GO	BP	canonical glycolysis	ALDOA,ALDOB,ALDOC,ENO1,ENO2,ENO3,GAPDH,GAPDHS,GCK,GPI,HK1,HK2,HK3,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGK1,PKLR,PKM,PPP2R5D,TPI1	The glycolytic process that begins with the conversion of glucose to glucose-6-phosphate by glucokinase activity. Glycolytic processes are the  chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP.
GO:0061630	GO	MF	ubiquitin protein ligase activity	AMFR,ANAPC11,BFAR,BRAP,BTRC,CBL,CBLC,CDC42,FANCL,FBXL22,HECW1,ITCH,LRSAM1,MARCH6,MDM2,MYLIP,NEDD4,PARK2,PPIL2,PRPF19,RBBP6,RBX1,RC3H1,RFFL,RFWD2,RNF111,RNF115,RNF126,RNF128,RNF138,RNF146,RNF152,RNF185,RNF34,RNF4,RNF41,RNF5,SIAH1,SKP1,SMURF1,SMURF2,STUB1,SYVN1,TMEM129,TOPORS,TRIM25,TRIM32,TRIM37,TRIM6,UBE2K,UBE2O,UBE3A,UBOX5,UBR5,UHRF1,UHRF2,VHL,ZNRF1,ZNRF2	Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S --> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate. Note that this may include the extension of ubiquitin chains.
GO:0061631	GO	MF	ubiquitin conjugating enzyme activity	CDC34,UBE2A,UBE2C,UBE2D1,UBE2D2,UBE2D3,UBE2D4,UBE2E1,UBE2E2,UBE2G1,UBE2G2,UBE2J1,UBE2J2,UBE2L3,UBE2O,UBE2QL1,UBE2R2,UBE2S,UBE2T	Isoenergetic transfer of ubiquitin from one protein to another via the reaction X-ubiquitin + Y -> Y-ubiquitin + X, where both the X-ubiquitin and Y-ubiquitin linkages are thioester bonds between the C-terminal glycine of ubiquitin and a sulfhydryl side group of a cysteine residue.
GO:0061635	GO	BP	regulation of protein complex stability	ATG14,HSPA8,SCOC,SNF8,SQSTM1,TAPBP	Any process that affects the structure and integrity of a protein complex by altering the likelihood of its assembly or disassembly.
GO:0061640	GO	BP	cytoskeleton-dependent cytokinesis	ALKBH4,ANK3,ANLN,APC,AURKB,BBS4,CEP55,CKAP2,CNTROB,CUL7,FMN2,KIF20A,KIF23,KIF4A,KIF4B,MITD1,MYH10,NUSAP1,PLK1,RACGAP1,RASA1,RHOA,SNX18,SNX33,SNX9,SPIRE1,SPIRE2,SPTBN1,STAMBP,USP8,ZNF365	A cytokinesis that involves the function of a set of proteins that are part of the microfilament or microtubule cytoskeleton.
GO:0061647	GO	BP	histone H3-K9 modification	BEND3,EHMT2,PRDM5,SETDB2,SIRT6,SUV39H1,SUV39H2	The modification of histone H3 at a lysine in position 9 of the histone.
GO:0061650	GO	MF	ubiquitin-like protein conjugating enzyme activity	CDC34,UBE2A,UBE2C,UBE2D1,UBE2D2,UBE2D3,UBE2D4,UBE2E1,UBE2E2,UBE2G1,UBE2G2,UBE2I,UBE2J1,UBE2J2,UBE2L3,UBE2O,UBE2QL1,UBE2R2,UBE2S,UBE2T	Isoenergetic transfer of a ubiquitin-like protein (ULP) from one protein to another via the reaction X-SCP + Y -> Y-SCP + X, where both the X-SCP and Y-SCP linkages are thioester bonds between the C-terminal amino acid of SCP and a sulfhydryl side group of a cysteine residue.
GO:0061659	GO	MF	ubiquitin-like protein ligase activity	AMFR,ANAPC11,BFAR,BRAP,BTRC,CBL,CBLC,CDC42,FANCL,FBXL22,HECW1,ITCH,LRSAM1,MARCH6,MDM2,MYLIP,NEDD4,PARK2,PIAS1,PIAS2,PIAS4,PPIL2,PRPF19,RBBP6,RBX1,RC3H1,RFFL,RFWD2,RNF111,RNF115,RNF126,RNF128,RNF138,RNF146,RNF152,RNF185,RNF34,RNF4,RNF41,RNF5,SIAH1,SKP1,SMURF1,SMURF2,STUB1,SYVN1,TMEM129,TOPORS,TRIM25,TRIM32,TRIM37,TRIM6,UBE2K,UBE2O,UBE3A,UBOX5,UBR5,UHRF1,UHRF2,VHL,ZNRF1,ZNRF2	Catalysis of the transfer of a ubiquitin-like protein (ULP) to a substrate protein via the reaction X-ULP + S --> X + S-ULP, where X is either an E2 or E3 enzyme, the X-ULP linkage is a thioester bond, and the S-ULP linkage is an isopeptide bond between the C-terminal glycine of ULP and the epsilon-amino group of lysine residues in the substrate.
GO:0061695	GO	CC	transferase complex, transferring phosphorus-containing groups	ACVR1,ACVR1B,ACVR1C,AKAP4,ATG14,BCCIP,BECN1,CAB39,CCND1,CCND2,CCND3,CCNH,CCNT1,CCNY,CDC73,CDK12,CDK13,CDK14,CDK2,CDK4,CDK6,CDK7,CDK9,CDKN1A,CHD6,CHRAC1,CHUK,CPSF3L,CRCP,CTR9,DAB2,DNA2,DNAJA3,EDF1,ENG,ERC1,ERCC2,ERCC3,ERCC5,ERN1,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HELB,HOXC10,HSPD1,IKBKB,IKBKG,INSR,INTS1,INTS10,INTS12,INTS2,INTS3,INTS4,INTS5,INTS6,INTS7,INTS8,INTS9,IRS1,KAT2A,KDM5A,LEO1,MAD2L2,MAP3K13,MAP3K5,MCM3,MMS19,MNAT1,MTOR,MYO6,NEK10,NRBF2,PAF1,PAPD4,PEX2,PFKFB1,PFKL,PFKM,PHKG2,PIK3C3,PIK3CA,PIK3CD,PIK3CG,PIK3R1,PIK3R4,PIK3R5,PIK3R6,POLA1,POLD3,POLE,POLE2,POLE3,POLE4,POLR1C,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POLR2M,POLR3A,POLR3B,POLR3C,POLR3D,POLR3E,POLR3F,POLR3G,POLR3GL,POLR3H,POLR3K,PPARGC1A,PRKAA1,PRKAB2,PRKACA,PRKACB,PRKAG1,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PUF60,PYCARD,PYDC1,RECQL5,REV3L,RPAP2,RPRD1A,RPRD1B,RPRD2,RTF1,SHFM1,SNW1,SORBS1,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TBC1D5,TBP,TERT,TGFBR1,TGFBR2,TP53,TRIM40,TRRAP,URI1,UVRAG,WDR61	A transferase complex capable of catalysis of the transfer of a phosphorus-containing group from one compound (donor) to another (acceptor).
GO:0061700	GO	CC	GATOR2 complex	MIOS,SEC13,SEH1L,WDR24,WDR59	A multiprotein subcomplex of GATOR that regulates mTOR signaling by interacting with the Rag GTPases. In humans this complex consists of Mios, WDR24, WDR59, Seh1L, Sec13.
GO:0061702	GO	CC	inflammasome complex	AIM2,CARD8,CASP1,CASP5,NLRC4,NLRP1,NLRP3,PYCARD	A cytosolic protein complex that is capable of activating caspase-1.
GO:0061733	GO	MF	peptide-lysine-N-acetyltransferase activity	ATAT1,ATF2,BRCA2,CLOCK,CREBBP,CSRP2BP,ELP3,ELP4,EP300,EPC1,HAT1,HCFC1,ING3,KANSL1,KANSL2,KANSL3,KAT2A,KAT2B,KAT5,KAT6A,KAT6B,KAT8,MCRS1,NAA50,NAA60,NCOA3,OGT,PHF20,SAP130,SRCAP,SUPT3H,SUPT7L,TADA1,TADA2A,TADA3,TAF1,TAF10,TAF12,TAF1L,TAF5,TAF5L,TAF6L,TAF9,USP22,WDR5	Catalysis of the reaction: acetyl-CoA + lysine in peptide = CoA + N-acetyl-lysine-peptide.
GO:0061737	GO	BP	leukotriene signaling pathway	CYSLTR1,CYSLTR2,LTB4R,LTB4R2,RGS1	A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-leukotriene interaction and ends with regulation of a downstream cellular process, e.g. transcription.
GO:0065002	GO	BP	intracellular protein transmembrane transport	AKT2,C2CD5,CHCHD4,HSP90AA1,HSPA4,HSPA8,NDUFA13,PAM16,PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,RAB8B,SAMM50,SRP54,TIMM10,TIMM21,TIMM22,TIMM9,TOMM22,ZFAND2B	The directed movement of proteins in a cell, from one side of a membrane to another by means of some agent such as a transporter or pore.
GO:0065004	GO	BP	protein-DNA complex assembly	ANP32B,APITD1,ASF1A,ASF1B,ATRX,BRD2,CABIN1,CASC5,CENPA,CENPC,CENPE,CENPF,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHAF1A,CHAF1B,DAXX,GTF2A2,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HELLS,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H3,HJURP,HMGB2,IPO4,ITGB3BP,KAT6B,MIS12,MIS18A,MIS18BP1,NAA60,NASP,NPM1,OIP5,PADI4,POGZ,RBBP4,RBBP7,RSF1,RUVBL1,SART3,SMARCA5,SOX9,SPTY2D1,STRA13,TAF1,TAF1B,TCF4,UBN1	The aggregation, arrangement and bonding together of proteins and DNA molecules to form a protein-DNA complex.
GO:0065005	GO	BP	protein-lipid complex assembly	ABCA1,ABCA7,ACSL3,APOA1,APOA2,APOA4,APOB,APOC1,APOC3,APOE,APOM,BIN1,DGAT1,MTTP,SNX9,SOAT1,SOAT2	The aggregation, arrangement and bonding together of proteins and lipids to form a protein-lipid complex.
GO:0070001	GO	MF	aspartic-type peptidase activity	ASPRV1,ASTL,BACE1,BACE2,CTSE,HM13,NAPSA,PGC,PIP,REN,SPPL2A,SPPL2B,SPPL3	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile.
GO:0070050	GO	BP	neuron cellular homeostasis	CHMP2B,CHRNA1,FGGY,HAAO,NELL2,PARK2,TYRO3	The cellular homeostatic process that preserves a neuron in a stable, differentiated functional and structural state.
GO:0070059	GO	BP	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	AIFM1,ATF4,ATP2A1,BAG6,BAK1,BAX,BBC3,BCL2,BRSK2,CASP4,CHAC1,DAB2IP,DDIT3,DNAJC10,ERO1A,ITPR1,MAP3K5,PPP1R15A,SELK,TNFRSF10B,TRAF2,TRIB3	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
GO:0070063	GO	MF	RNA polymerase binding	AGO1,AGO2,ANP32B,C14orf166,CCAR2,CDC73,ELP2,ELP3,ELP4,ERBB2,IKBKAP,PAF1,PHRF1,RECQL5,RPRD1B,SMYD2,SPTY2D1,TAF10,UVSSA,WAC,ZNF326	Interacting selectively and non-covalently with an RNA polymerase molecule or complex.
GO:0070064	GO	MF	proline-rich region binding	ABL1,BAIAP2,BAIAP2L1,CCND1,GAREM,GHR,NEDD4	Interacting selectively and non-covalently with a proline-rich region, i.e. a region that contains a high proportion of proline residues, in a protein.
GO:0070069	GO	CC	cytochrome complex	BCS1L,COX10,COX15,COX4I2,MT-CO1,MT-CO2,MT-CO3,MT-CYB,NDUFA4,UQCC3	A protein complex in which at least one of the proteins is a cytochrome, i.e. a heme-containing protein involved in catalysis of redox reactions.
GO:0070071	GO	BP	proton-transporting two-sector ATPase complex assembly	ALDOB,ATPAF2,OXA1L,TMEM70,VMA21	The aggregation, arrangement and bonding together of a proton-transporting two-sector ATPase complex, a large protein complex that catalyzes the synthesis or hydrolysis of ATP by a rotational mechanism, coupled to the transport of protons across a membrane.
GO:0070076	GO	BP	histone lysine demethylation	HIST1H4A,KDM1A,KDM1B,KDM2A,KDM3A,KDM4A,KDM4C,KDM4D,KDM5B,KDM5C,KDM5D,KDM7A,KDM8,PHF8	The modification of a histone by the removal of a methyl group from a lysine residue.
GO:0070083	GO	CC	clathrin-sculpted monoamine transport vesicle membrane	RAB3A,SLC18A1,SLC18A2,SYT1,VAMP2	The lipid bilayer surrounding a clathrin-sculpted monoamine transport vesicle.
GO:0070098	GO	BP	chemokine-mediated signaling pathway	ACKR2,ACKR3,ACKR4,CCL5,CCR1,CCR2,CCR3,CCR4,CCR5,CCR6,CCR7,CCR8,CCR9,CCRL2,CIB1,CMKLR1,CX3CR1,CXCL10,CXCL11,CXCL12,CXCR1,CXCR2,CXCR3,CXCR4,GPR17,GPR75,MPL,PTK2B,THPO,XCR1	A series of molecular signals initiated by the binding of a chemokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0070099	GO	BP	regulation of chemokine-mediated signaling pathway	CCL5,EDN1,HIF1A,PADI2,ROBO1,SLIT2,SLIT3,TREM2	Any process that modulates the rate, frequency or extent of the series of molecular events generated as a consequence of a chemokine binding to a cell surface receptor.
GO:0070100	GO	BP	negative regulation of chemokine-mediated signaling pathway	CCL5,PADI2,ROBO1,SLIT2,SLIT3	Any process that decreases the rate, frequency or extent of the series of molecular events generated as a consequence of a chemokine binding to a cell surface receptor.
GO:0070102	GO	BP	interleukin-6-mediated signaling pathway	CTR9,FER,IL6,IL6R,IL6ST,SMAD4,STAT3	A series of molecular signals initiated by the binding of interleukin-6 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0070120	GO	BP	ciliary neurotrophic factor-mediated signaling pathway	CNTF,CNTFR,IL6R,IL6ST,LIFR	A series of molecular signals initiated by the binding of a ciliary neurotrophic factor (CNTF) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0070124	GO	BP	mitochondrial translational initiation	AURKAIP1,CHCHD1,DAP3,GADD45GIP1,ICT1,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,MTFMT,MTIF2,MTIF3,PTCD3	The process preceding formation of the peptide bond between the first two amino acids of a protein in a mitochondrion. This includes the formation of a complex of the ribosome, mRNA, and an initiation complex that contains the first aminoacyl-tRNA.
GO:0070125	GO	BP	mitochondrial translational elongation	AURKAIP1,CHCHD1,DAP3,GADD45GIP1,GFM1,ICT1,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,PTCD3,TSFM,TUFM	The successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis in a mitochondrion.
GO:0070126	GO	BP	mitochondrial translational termination	AURKAIP1,CHCHD1,DAP3,GADD45GIP1,GFM2,ICT1,MRPL1,MRPL10,MRPL11,MRPL12,MRPL13,MRPL14,MRPL15,MRPL16,MRPL17,MRPL18,MRPL19,MRPL2,MRPL20,MRPL21,MRPL22,MRPL23,MRPL24,MRPL27,MRPL28,MRPL3,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL37,MRPL38,MRPL39,MRPL4,MRPL40,MRPL41,MRPL42,MRPL43,MRPL44,MRPL45,MRPL46,MRPL47,MRPL48,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS10,MRPS11,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18B,MRPS18C,MRPS21,MRPS22,MRPS23,MRPS24,MRPS25,MRPS26,MRPS27,MRPS28,MRPS30,MRPS31,MRPS33,MRPS34,MRPS35,MRPS36,MRPS5,MRPS6,MRPS7,MRPS9,MRRF,MTRF1L,PTCD3	The process resulting in the release of a polypeptide chain from the ribosome in a mitochondrion, usually in response to a termination codon (note that mitochondria use variants of the universal genetic code that differ between different taxa).
GO:0070127	GO	BP	tRNA aminoacylation for mitochondrial protein translation	AARS2,DARS2,EARS2,TARS2,YARS2	The synthesis of aminoacyl tRNA by the formation of an ester bond between the 3'-hydroxyl group of the most 3' adenosine of the tRNA, to be used in ribosome-mediated polypeptide synthesis in a mitochondrion.
GO:0070129	GO	BP	regulation of mitochondrial translation	C1QBP,COA3,MALSU1,MPV17L2,MTG1,MTG2,RMND1,UQCC1,UQCC2	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA in a mitochondrion.
GO:0070131	GO	BP	positive regulation of mitochondrial translation	C1QBP,COA3,MPV17L2,RMND1,UQCC1,UQCC2	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA in a mitochondrion.
GO:0070141	GO	BP	response to UV-A	AKT1,CCND1,CERS1,EGFR,MME,PPID	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-A radiation stimulus. UV-A radiation (UV-A light) spans the wavelengths 315 to 400 nm.
GO:0070160	GO	CC	occluding junction	AMICA1,AMOT,AMOTL1,ANK3,AOC1,APC,BVES,CGN,CLDN1,CLDN10,CLDN11,CLDN12,CLDN14,CLDN15,CLDN16,CLDN17,CLDN18,CLDN19,CLDN2,CLDN20,CLDN22,CLDN23,CLDN3,CLDN4,CLDN5,CLDN6,CLDN7,CLDN8,CLDN9,CLMP,CXADR,DDX58,DLG1,ECT2,EPCAM,F11R,FRMPD2,INADL,MAGI2,MARVELD2,MARVELD3,MICALL2,MPP7,MTDH,OCLN,PARD3,PARD6A,PARD6B,RAB13,RAP2B,RAP2C,RAPGEF2,SHROOM2,SIPA1L3,STRN,TBCD,TGFBR1,TJP1,TJP2,TJP3,UBN1,VAPA,WNK3,WNK4,YBX3	A cell-cell junction that seals cells together in an epithelium in a way that prevents even small molecules from leaking from one side of the sheet to the other.
GO:0070163	GO	BP	regulation of adiponectin secretion	C1QTNF3,HCAR2,IL1B,RAB11FIP1,RAB11FIP3,RAB11FIP5	Any process that modulates the frequency, rate or extent of the regulated release of adiponectin from a cell.
GO:0070167	GO	BP	regulation of biomineral tissue development	ACVR1,ACVR2A,ACVR2B,AHSG,AMELX,AMTN,ANKH,ANO6,ASPN,ATRAID,BCOR,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CCL3,CCR1,CYP27B1,DDR2,ECM1,ENPP1,FBN2,FGF23,GAS6,GPM6B,GREM1,KL,LTF,MEF2C,MMP20,NBR1,NELL1,OSR1,OSR2,P2RX7,PKDCC,PTH,PTK2B,S1PR1,SLC8A1,SOX9,SRGN,STATH,TFAP2A,TMEM119,TWIST1,TXLNG,WNT4,WNT6	Any process that modulates the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
GO:0070168	GO	BP	negative regulation of biomineral tissue development	AHSG,ASPN,BCOR,CCL3,CCR1,ECM1,FGF23,GAS6,GREM1,PTK2B,SOX9,SRGN,STATH	Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
GO:0070169	GO	BP	positive regulation of biomineral tissue development	ACVR1,ACVR2A,ACVR2B,AMELX,AMTN,ANO6,ATRAID,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,FBN2,GPM6B,KL,LTF,MEF2C,NELL1,OSR1,OSR2,P2RX7,PKDCC,PTH,SLC8A1,TFAP2A,TMEM119,WNT4,WNT6	Any process that activates or increases the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
GO:0070170	GO	BP	regulation of tooth mineralization	AMELX,ASPN,BCOR,MMP20,TFAP2A,WNT6	Any process that modulates the frequency, rate or extent of tooth mineralization, the deposition of calcium salts in tooth structures.
GO:0070187	GO	CC	telosome	ACD,CCDC79,POT1,TERF1,TERF2,TERF2IP,TINF2	A nuclear telomere cap complex that is formed by the association of telomeric ssDNA- and dsDNA-binding proteins with telomeric DNA, and is involved in telomere protection and recruitment of telomerase. The complex contains TRF1, TRF2, POT1, RAP1, TIN2 and TPP1 in mammalian cells, and Pot1, Tpz1, Ccq1, Poz1, Rap1, Rif1, Rif2and Rap1 in Schizosaccharomyces. Taz1 and Rap1 (or their mammalian equivalents) form a dsDNA-binding subcomplex, Pot1 and Tpz1 form an ssDNA-binding subcomplex, and the two subcomplexes are bridged by Poz1.
GO:0070189	GO	BP	kynurenine metabolic process	AADAT,CCBL1,CCBL2,IDO2,KMO	The chemical reactions and pathways involving kynurenine, the amino acid 3-(2-aminobenzoyl)-alanine.
GO:0070192	GO	BP	chromosome organization involved in meiotic cell cycle	BAG6,C11orf85,C15orf43,CCDC79,CCNB1IP1,HORMAD1,HORMAD2,MEI4,MEIKIN,MEIOB,P3H4,RNF212,STAG3,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TRIP13	A process of chromosome organization that is involved in a meiotic cell cycle.
GO:0070198	GO	BP	protein localization to chromosome, telomeric region	ACD,ATR,ATRX,BRCA2,NABP2,PINX1,POT1,TERF2,TERF2IP,TERT,TINF2,TNKS,TNKS2,WRAP53	Any process in which a protein is transported to, or maintained at, the telomeric region of a chromosome.
GO:0070199	GO	BP	establishment of protein localization to chromosome	ACD,BRCA2,H2AFY,H2AFY2,HIST1H1B,LRWD1,NABP2,PIH1D1,POT1,RUVBL2,SGF29,TERT,WRAP53	The directed movement of a protein to a specific location on a chromosome.
GO:0070200	GO	BP	establishment of protein localization to telomere	ACD,BRCA2,NABP2,POT1,TERT,WRAP53	The directed movement of a protein to a specific location in the telomeric region of a chromosome.
GO:0070202	GO	BP	regulation of establishment of protein localization to chromosome	CCT2,CCT4,CCT5,CCT6A,CCT7,CCT8,DKC1,SPIDR,TCP1,TERF1,WRAP53	Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location on a chromosome.
GO:0070203	GO	BP	regulation of establishment of protein localization to telomere	CCT2,CCT4,CCT5,CCT6A,CCT7,CCT8,DKC1,TCP1,TERF1,WRAP53	Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location in the telomeric region of a chromosome.
GO:0070206	GO	BP	protein trimerization	ASIC1,BRK1,C1QTNF3,MGST1,MLKL,PKD2L1,PNPT1,SCARA5,SKI,SKIL,TRIM21,TRIM22,TRIM27,TRIM34,TRIM4,TRIM5,TRIM6,WIZ	The formation of a protein trimer, a macromolecular structure consisting of three noncovalently associated identical or nonidentical subunits.
GO:0070207	GO	BP	protein homotrimerization	ASIC1,BRK1,MGST1,MLKL,PKD2L1,PNPT1,SCARA5,SKI,SKIL	The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
GO:0070221	GO	BP	sulfide oxidation, using sulfide:quinone oxidoreductase	ETHE1,SLC25A10,SQRDL,SUOX,TST	A sulfide oxidation process that proceeds via the reaction catalyzed by sulfide:quinone oxidoreductase.
GO:0070227	GO	BP	lymphocyte apoptotic process	AKT1,BAX,CLC,FASLG,GLI3,RIPK1,SIVA1,TNFRSF21	Any apoptotic process in a lymphocyte, a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
GO:0070228	GO	BP	regulation of lymphocyte apoptotic process	ADAM8,AURKB,BBC3,BCL10,BCL6,BIRC7,BMP4,BTK,CCL5,CD3G,FADD,FNIP1,FOXP1,IDO1,IL10,IL2,IRS2,JAK3,LGALS16,LGALS3,LGALS9,NOC2L,PDCD1,PIP,PRELID1,PRKCQ,RIPK3,RORC,TP53,ZC3H8	Any process that modulates the occurrence or rate of lymphocyte death by apoptotic process.
GO:0070229	GO	BP	negative regulation of lymphocyte apoptotic process	AURKB,BCL10,BCL6,BMP4,CCL5,FADD,FOXP1,IL2,IRS2,JAK3,NOC2L,PIP,PRKCQ,RORC	Any process that stops, prevents, or reduces the frequency, rate or extent of lymphocyte death by apoptotic process.
GO:0070230	GO	BP	positive regulation of lymphocyte apoptotic process	ADAM8,BBC3,CCL5,FNIP1,IDO1,IL10,LGALS16,LGALS9,PDCD1,PRELID1,TP53,ZC3H8	Any process that activates or increases the frequency, rate or extent of lymphocyte death by apoptotic process.
GO:0070231	GO	BP	T cell apoptotic process	AKT1,CLC,FASLG,GLI3,RIPK1,SIVA1	Any apoptotic process in a T cell, a type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
GO:0070232	GO	BP	regulation of T cell apoptotic process	ADAM8,BBC3,BMP4,CCL5,FADD,IDO1,JAK3,LGALS16,LGALS3,LGALS9,PDCD1,PIP,PRELID1,PRKCQ,RIPK3,RORC,TP53,ZC3H8	Any process that modulates the occurrence or rate of T cell death by apoptotic process.
GO:0070233	GO	BP	negative regulation of T cell apoptotic process	BMP4,CCL5,FADD,JAK3,PIP,PRKCQ,RORC	Any process that stops, prevents, or reduces the frequency, rate or extent of T cell death by apoptotic process.
GO:0070234	GO	BP	positive regulation of T cell apoptotic process	ADAM8,BBC3,CCL5,IDO1,LGALS16,LGALS9,PDCD1,PRELID1,TP53,ZC3H8	Any process that activates or increases the frequency, rate or extent of T cell death by apoptotic process.
GO:0070243	GO	BP	regulation of thymocyte apoptotic process	ADAM8,BBC3,BMP4,JAK3,RORC,TP53,ZC3H8	Any process that modulates the occurrence or rate of thymocyte death by apoptotic process.
GO:0070252	GO	BP	actin-mediated cell contraction	ACTA1,ACTC1,ACTN2,ACTN3,ANK2,CAMK2D,CAV3,DES,DMD,EMP2,FGF12,GJA1,GJC1,GPD1L,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,MYBPC1,MYBPC2,MYBPC3,MYH2,MYH3,MYH4,MYH6,MYH7,MYH8,MYL1,MYL2,MYL3,MYL4,MYL6,MYL6B,NEB,NEDD4L,PARVA,PKP2,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SHTN1,SNTA1,TCAP,TMOD1,TNNC1,TNNC2,TNNI1,TNNI2,TNNI3,TNNT1,TNNT2,TNNT3,TPM1,TPM2,TPM3,TPM4,TTN,VIL1,VIM	The actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of all or part of the cell body.
GO:0070265	GO	BP	necrotic cell death	ALKBH7,BIRC2,BIRC3,CASP8,CFLAR,DNM1L,FADD,FAS,FASLG,MLKL,PGAM5,PPIF,RIPK1,RIPK3,RPS27A,TLR3,TMEM123,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2,TRPM7,UBA52,UBB,UBC	A type of cell death that is morphologically characterized by an increasingly translucent cytoplasm, swelling of organelles, minor ultrastructural modifications of the nucleus (specifically, dilatation of the nuclear membrane and condensation of chromatin into small, irregular, circumscribed patches) and increased cell volume (oncosis), culminating in the disruption of the plasma membrane and subsequent loss of intracellular contents. Necrotic cells do not fragment into discrete corpses as their apoptotic counterparts do. Moreover, their nuclei remain intact and can aggregate and accumulate in necrotic tissues.
GO:0070266	GO	BP	necroptotic process	BIRC2,BIRC3,CASP8,CFLAR,DNM1L,FADD,FAS,FASLG,MLKL,PGAM5,RIPK1,RIPK3,RPS27A,TLR3,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2,TRPM7,UBA52,UBB,UBC	A programmed necrotic cell death process which begins when a cell receives a signal (e.g. a ligand binding to a death receptor or to a Toll-like receptor), and proceeds through a series of biochemical events (signaling pathways), characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and which typically lead to common morphological features of necrotic cell death. The process ends when the cell has died. The process is divided into a signaling phase, and an execution phase, which is triggered by the former.
GO:0070273	GO	MF	phosphatidylinositol-4-phosphate binding	ARFIP1,ARFIP2,COL4A3BP,DAB2IP,FAM21C,GOLPH3,GOLPH3L,JPH2,LANCL2,OSBP,OSBPL5,OSBPL8,PLEKHA8,PLEKHF1,SESTD1,SNX3	Interacting selectively and non-covalently with phosphatidylinositol-4-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' position.
GO:0070286	GO	BP	axonemal dynein complex assembly	ARMC4,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,DNAAF1,DNAAF2,DNAAF3,DNAAF5,DNAH1,DNAH5,DNAH7,DNAI1,DNAI2,DRC1,DYX1C1,LRRC6,PIH1D3,SPAG1,ZMYND10	The aggregation, arrangement and bonding together of a set of components to form an axonemal dynein complex, a dynein complex found in eukaryotic cilia and flagella, in which the motor domain heads interact with adjacent microtubules to generate a sliding force which is converted to a bending motion.
GO:0070293	GO	BP	renal absorption	AKR1C3,GSN,HAS2,HBB,HNF1A,HYAL2,KCNQ1,KLHL3,SGK1,SLC9A3R1,WNK4	A renal system process in which water, ions, glucose and proteins are taken up from the collecting ducts, glomerulus and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures (e.g. protein absorption is observed in nephrocytes in Drosophila, see PMID:23264686).
GO:0070296	GO	BP	sarcoplasmic reticulum calcium ion transport	ANK2,ATP2A2,CCL3,CCR5,NOL3,RYR1,RYR2,SLN,TRDN	The directed movement of calcium ions (Ca2+) into, out of or within the sarcoplasmic reticulum.
GO:0070300	GO	MF	phosphatidic acid binding	COMMD1,JPH2,MAPKAP1,MARK1,MICALL1,PACSIN2,RAPGEF2,RAPGEF6,SESTD1,UQCC3	Interacting selectively and non-covalently with phosphatidic acid, any of a class of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
GO:0070301	GO	BP	cellular response to hydrogen peroxide	AQP1,CYP1B1,ECT2,FABP1,FXN,HDAC6,IL6,IMPACT,MAP3K5,MAPK7,NET1,NFE2L2,PARK7,PAX2,PDCD10,PLEKHA1,PPIF,RELA,RHOB,RPS3,SETX,SIRT1,STK25,TNFAIP3,ZNF580	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
GO:0070302	GO	BP	regulation of stress-activated protein kinase signaling cascade	AIDA,AMBP,ARHGEF5,ARL6IP5,AXIN1,BIRC7,BMP2,CARD9,CCL19,CCL21,CCR7,CD27,COPS5,CTGF,DAB2IP,DACT1,DAXX,DBNL,DLG1,DNAJA1,DUSP19,DUSP3,DVL2,DVL3,EDA2R,EDN1,EIF2AK2,EPHB1,ERN1,EZR,F2RL1,FGF19,FKTN,FLT4,FOXM1,FOXO1,FZD10,FZD7,GADD45A,GADD45B,GADD45G,GPS2,GSTP1,HACD3,HDAC3,HIPK2,HIPK3,HMGB1,HRAS,IGBP1,IGF1R,IL26,ITCH,LEP,LTBR,LYN,MAP2K1,MAP2K2,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K4,MAP4K5,MAPK1,MAPK3,MAPK8IP1,MAPK8IP2,MAPK8IP3,MARVELD3,MDFIC,MECOM,MEN1,MID1,MINK1,MUL1,MYC,NBR1,NCOR1,NOD2,PAK1,PARK2,PDCD10,PDCD4,PER1,PHLPP1,PINK1,PKN1,PLCB1,PPEF2,PRMT1,PTK2B,PTPN22,PYCARD,RAP2A,RASGRP1,RASSF2,RIPK1,RPS3,SASH1,SDCBP,SEMA4C,SERPINB3,SERPINF2,SLAMF1,STK25,TAOK1,TAOK2,TAOK3,TGFB2,TIRAP,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TPD52L1,TRAF2,TRAF4,TRAF6,ULK4,UNC5CL,VEGFA,WNT16,WNT5A,XDH,ZMYND11,ZNF622,ZNF675	Any process that modulates the frequency, rate or extent of signaling via a stress-activated protein kinase signaling cascade.
GO:0070304	GO	BP	positive regulation of stress-activated protein kinase signaling cascade	ARHGEF5,ARL6IP5,AXIN1,BIRC7,BMP2,CARD9,CCL19,CCL21,CCR7,CD27,CTGF,DAB2IP,DAXX,DBNL,DUSP19,DVL2,DVL3,EDA2R,EDN1,EIF2AK2,ERN1,F2RL1,FGF19,FLT4,FZD10,FZD7,GADD45A,GADD45B,GADD45G,HACD3,HIPK2,HMGB1,HRAS,IL26,LEP,LTBR,LYN,MAP2K7,MAP3K10,MAP3K11,MAP3K2,MAP3K4,MAP3K5,MAP3K6,MAP3K7,MAP3K9,MAP4K1,MAP4K2,MAP4K5,MDFIC,MID1,MINK1,MUL1,NOD2,PAK1,PDCD10,PKN1,PLCB1,PRMT1,PTK2B,PYCARD,RASGRP1,RASSF2,RIPK1,RPS3,SASH1,SDCBP,SEMA4C,SERPINF2,SLAMF1,STK25,TAOK1,TAOK2,TAOK3,TGFB2,TIRAP,TLR6,TLR9,TNF,TNFRSF11A,TNIK,TPD52L1,TRAF2,TRAF4,TRAF6,UNC5CL,VEGFA,WNT16,WNT5A,XDH,ZNF622	Any process that activates or increases the frequency, rate or extent of signaling via the stress-activated protein kinase signaling cascade.
GO:0070306	GO	BP	lens fiber cell differentiation	CRYGD,EPHA2,SIX3,TDRD7,WNT5B,WNT7A,WNT7B	The process in which a relatively unspecialized cell acquires specialized features of a lens fiber cell, any of the elongated, tightly packed cells that make up the bulk of the mature lens in the camera-type eye. The cytoplasm of a lens fiber cell is devoid of most intracellular organelles including the cell nucleus, and contains primarily crystallins, a group of water-soluble proteins expressed in vary large quantities.
GO:0070316	GO	BP	regulation of G0 to G1 transition	DAB2IP,DUX4,FOXO4,RHNO1,SOX15	A cell cycle process that modulates the rate or extent of the transition from the G0 quiescent state to the G1 phase.
GO:0070325	GO	MF	lipoprotein particle receptor binding	AP2M1,APOB,APOE,ARRB2,DKK1,DNAJA1,HSP90B1,LANCL1,LRP1,LRPAP1,PCSK9,RELN,SNX17,SYT1	Interacting selectively and non-covalently with a lipoprotein particle receptor.
GO:0070328	GO	BP	triglyceride homeostasis	ACSM2A,ANGPTL3,ANGPTL4,APOA1,APOA5,APOC2,APOC3,APOC4,C19orf80,C1QTNF3,CETP,DGAT2,FITM2,GCKR,GPIHBP1,HNF4A,LIPC,LPL,MLXIPL,NR1H3,NR1H4,RORA,SCARB1,SIRT1,XBP1	Any process involved in the maintenance of an internal steady state of triglyceride within an organism or cell.
GO:0070344	GO	BP	regulation of fat cell proliferation	E2F1,E2F3,GATA2,PER2,PID1,TFDP1	Any process that modulates the frequency, rate or extent of fat cell proliferation.
GO:0070345	GO	BP	negative regulation of fat cell proliferation	E2F1,E2F3,GATA2,PER2,TFDP1	Any process that stops or decreases the rate or extent of fat cell proliferation.
GO:0070371	GO	BP	ERK1 and ERK2 cascade	AVP,CTSH,EGF,FGF10,HTR2B,IGF1,ITGAV,LGALS9,MAP2K2,MAPK1,MED1,MT3,PTGER4,SOX9	An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
GO:0070372	GO	BP	regulation of ERK1 and ERK2 cascade	ABCA7,ACKR3,ADCYAP1,ADIPOQ,ADRA1A,ALOX15,ANGPT1,APIP,ARHGAP8,ARRB1,ARRB2,ATP6AP1,BMP2,BMPER,BRAF,C3orf33,C5AR1,CCL19,CCL21,CCL3,CCR1,CCR7,CD36,CD44,CD74,CHI3L1,CIB1,CNKSR3,CSF1R,CTGF,CYR61,DAB2IP,DLG1,DSTYK,DUSP26,DUSP3,DUSP6,EGFR,EPHA2,EPHA7,EPHB1,ERBB2,ERBB4,EZR,F2R,F2RL1,FAM83D,FBLN1,FBXW7,FFAR4,FGA,FGB,FGF1,FGF10,FGF18,FGF19,FGF2,FGF21,FGF4,FGFR2,FGFR3,FGFR4,FGG,FLCN,FLT4,FN1,FSHR,GAREM,GAS6,GBP1,GCNT2,GLIPR2,GPER1,GPR183,GPR55,GSTP1,HMGB1,HRAS,HTR2A,HTR2B,HTR2C,ICAM1,IL26,ITGB1BP1,KDR,LGALS9,LMO3,LYN,MAPK3,MIF,MT3,NDRG4,NEK10,NOD2,NODAL,NPNT,NRP1,NTRK1,OPRM1,P2RY1,PDGFA,PDGFB,PDGFRA,PDGFRB,PHB,PHB2,PIN1,PKHD1,PLA2G2A,PLA2G5,PRKCA,PRKCZ,PRKD2,PTK2B,PTPN1,PTPN2,PTPN22,PTPN6,PTPRR,PYCARD,RANBP9,RAP1A,RAPGEF2,RASGRP1,RGS14,ROS1,RPS6KA6,RRAS,S100A7,SCIMP,SEMA7A,SERPINF2,SLAMF1,SLC9A3R1,SPRY1,SPRY2,ST5,STYX,SYK,SYNJ2BP,TEK,THPO,TIRAP,TLR4,TNF,TNFAIP8L3,TNFRSF11A,TNFSF11,TNIP1,TREM2,VEGFA,VEGFB,WNK2	Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
GO:0070373	GO	BP	negative regulation of ERK1 and ERK2 cascade	ADIPOQ,C3orf33,CNKSR3,DAB2IP,DLG1,DUSP26,DUSP3,DUSP6,EZR,FBLN1,FLCN,GBP1,GPER1,GSTP1,ITGB1BP1,LMO3,LYN,PHB,PIN1,PTPN1,PTPN2,PTPRR,RANBP9,RGS14,RPS6KA6,SLC9A3R1,SPRY1,SPRY2,SYNJ2BP,TLR4,TNIP1,WNK2	Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
GO:0070374	GO	BP	positive regulation of ERK1 and ERK2 cascade	ABCA7,ACKR3,ADCYAP1,ADRA1A,ALOX15,ANGPT1,ARHGAP8,ARRB1,ARRB2,ATP6AP1,BMP2,BMPER,BRAF,C5AR1,CCL19,CCL21,CCL3,CCR1,CCR7,CD36,CD44,CD74,CHI3L1,CIB1,CSF1R,CTGF,DSTYK,EGFR,ERBB4,F2R,F2RL1,FBXW7,FFAR4,FGA,FGB,FGF1,FGF10,FGF18,FGF19,FGF2,FGF21,FGF4,FGFR2,FGFR3,FGFR4,FGG,FLT4,FSHR,GAREM,GAS6,GCNT2,GLIPR2,GPER1,GPR183,GPR55,HMGB1,HRAS,HTR2A,HTR2B,HTR2C,ICAM1,IL26,KDR,LGALS9,MAPK3,MIF,MT3,NDRG4,NOD2,NODAL,NPNT,NRP1,NTRK1,OPRM1,P2RY1,PDGFA,PDGFB,PDGFRA,PDGFRB,PHB,PHB2,PLA2G2A,PLA2G5,PRKCA,PRKCZ,PRKD2,PTK2B,PTPN22,PYCARD,RAP1A,RAPGEF2,RASGRP1,S100A7,SCIMP,SEMA7A,SERPINF2,SLAMF1,SPRY2,ST5,TEK,THPO,TIRAP,TNF,TNFAIP8L3,TNFRSF11A,TNFSF11,TREM2,VEGFA,VEGFB	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
GO:0070382	GO	CC	exocytic vesicle	AMPH,ANXA13,BRSK1,CDK16,CLCN3,CLN3,COPS4,COPS5,DLG4,DMXL2,DPYSL3,DTNBP1,GABRA2,GIPC1,GRIN1,HCRT,ICA1,MME,MT3,MTMR2,OTOF,PPT1,PTPRN,PTPRN2,RAB11B,RAB27A,RAB3A,RAB5A,RAB6A,RPH3A,SEMA4C,SEPT5,SLC17A6,SLC17A7,SLC17A8,SLC18A2,SLC30A3,SLC32A1,SLC6A17,SNAPIN,SNCAIP,SV2A,SV2B,SV2C,SVOP,SYN1,SYN2,SYN3,SYNGR3,SYP,SYT1,SYT11,SYT2,SYTL2,TMEM163,TOR1A,TPRG1L,TRAPPC4,UNC13D,VAMP1,VAMP2,VTI1A,VTI1B	A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis.
GO:0070383	GO	BP	DNA cytosine deamination	APOBEC3A,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H	The removal of an amino group from a cytosine residue in DNA, forming a uracil residue.
GO:0070402	GO	MF	NADPH binding	CBR3,CBR4,CRYZ,DECR1,DHFR,GRHPR,HMGCR,KCNAB1,MTRR,TP53I3	Interacting selectively and non-covalently with the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions.
GO:0070403	GO	MF	NAD+ binding	CRYL1,GLUD1,HPGD,SIRT2,SIRT5,SIRT6,UXS1	Interacting selectively and non-covalently with the oxidized form, NAD, of nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions.
GO:0070405	GO	MF	ammonium ion binding	ACHE,APOA2,APOA4,APOA5,APOC1,CETP,CHMP2A,CHMP3,CHRM3,CHRNA1,CHRNA3,CHRNA4,CHRNA7,CHRNB1,CHRNB2,CRP,DRD1,DRD4,DRD5,ESYT2,GPR143,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,JCHAIN,NF1,PCTP,RASGRP1,RPE65,SERPINA5	Interacting selectively and non-covalently with ammonium ions (NH4+).
GO:0070417	GO	BP	cellular response to cold	DNAJC3,EIF2AK3,EIF2AK4,FOXO1,NFKBIA,SAXO1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.
GO:0070419	GO	CC	nonhomologous end joining complex	C9orf142,DCLRE1C,LIG4,NHEJ1,PRKDC,XRCC4,XRCC5,XRCC6,XRCC6BP1	A protein complex that plays a role in DNA double-strand break repair via nonhomologous end joining. Such complexes typically contain a specialized DNA ligase (e.g. Lig4 in eukaryotes) and one or more proteins that bind to DNA ends.
GO:0070423	GO	BP	nucleotide-binding oligomerization domain containing signaling pathway	CARD9,CASP8,CHUK,CYLD,IKBKB,IKBKG,IRAK1,IRAK2,ITCH,MAP2K6,MAP3K7,NOD1,NOD2,OTULIN,RELA,RIPK2,RPS27A,TAB1,TAB2,TAB3,TNFAIP3,TRAF6,UBA52,UBB,UBC,UBE2N,UBE2V1	Any series of molecular signals generated as a consequence of binding to a nucleotide-binding oligomerization domain containing (NOD) protein.
GO:0070424	GO	BP	regulation of nucleotide-binding oligomerization domain containing signaling pathway	BIRC2,BIRC3,ERBB2IP,HSPA1A,HSPA1B,PTPN22,XIAP	Any process that modulates the frequency, rate, or extent of a nucleotide-binding oligomerization domain containing (NOD) pathway.
GO:0070461	GO	CC	SAGA-type complex	ATXN7L3,ENY2,HCFC1,KAT2A,KAT2B,SAP130,SGF29,SUPT20H,SUPT3H,SUPT7L,TADA1,TADA2A,TADA2B,TADA3,TAF10,TAF12,TAF2,TAF4,TAF5,TAF5L,TAF6,TAF6L,TAF7,TAF9,TAF9B,TRRAP,USP22	A histone acetyltransferase complex that acetylates nucleosomal H3 and H2B and is required for the expression of a subset of Pol II-transcribed genes. The budding yeast complex includes the acetyltransferase Gcn5p, several proteins of the Spt and Ada families, and several TBP-associate proteins (TAFs); analogous complexes in other species have analogous compositions, and usually contain homologs of the yeast proteins.
GO:0070469	GO	CC	respiratory chain	BCS1L,COX15,COX4I2,FOXRED1,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NNT,OXA1L,PARK7,SDHA,SDHB,SDHC,SDHD,SNCA,SURF1,UQCC3,UQCRB,UQCRC1,UQCRH	The protein complexes that form the electron transport system (the respiratory chain), associated with a cell membrane, usually the plasma membrane (in prokaryotes) or the inner mitochondrial membrane (on eukaryotes). The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient.
GO:0070482	GO	BP	response to oxygen levels	ACAA2,ADA,ADAM17,ADAM8,AJUBA,ALAS2,ALKBH5,ANG,ANGPTL4,AQP1,ARNT,ARNT2,ATG7,BACH1,BMP2,BMP7,BNIP3,BNIP3L,CA9,CAV1,CBFA2T3,CHRNA4,CHRNA7,CHRNB2,CITED2,CPEB1,CPEB2,CPEB4,CREBBP,CUL2,CYB5R4,DDIT4,DPP4,EGLN1,EGLN2,EGLN3,ENG,EP300,EPAS1,EPO,FABP1,FAM162A,FAS,FMN2,FOXO1,FUNDC1,GATA6,HIF1A,HIF1AN,HIF3A,HIPK2,HMOX2,HP1BP3,HSP90B1,HYOU1,ITPR1,ITPR2,KCND2,KCNMA1,LIMD1,LOXL2,MGARP,MT3,MTOR,NARFL,NDNF,NF1,NKX3-1,NOTCH1,NPEPPS,OPRD1,P4HB,PDK1,PDK3,PICK1,PINK1,PLK3,PML,PRKAA1,PTGIS,RBPJ,RBX1,RGCC,RORA,RPS27A,RYR1,RYR2,SIRT1,SIRT2,SLC8A3,SMAD3,SMAD4,STOX1,SUV39H1,SUV39H2,TBL2,TCEB1,TCEB2,TERT,TGFB2,TGFB3,TH,THBS1,TIGAR,TSC1,TWIST1,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBQLN1,UCP2,USF1,VEGFA,VHL,WTIP	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of oxygen.
GO:0070486	GO	BP	leukocyte aggregation	ADA,ADAM17,AMICA1,ANXA1,ATP7A,BATF,BMP7,BTN3A1,CASP8,CCL19,CCL21,CCR7,CD1C,CD1D,CD2,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD44,CD7,CD74,CD80,CD86,CD8A,CD8B,CEBPB,CHD7,CLEC7A,CTPS1,CXADR,DDOST,DLL4,DOCK8,DPP4,EIF2AK4,ELF4,EOMES,F2RL1,FADD,FKBP1A,FOXP1,FOXP3,GLI3,HLA-E,HMGB1,HSPD1,ICAM1,ICOSLG,IL12B,IL1B,IL2,IL6,INS,IRF4,ITGAL,ITK,JAG2,KIF13B,KIT,LAT,LCK,LCP1,LEF1,LEP,LEPR,LFNG,LIG4,LILRB1,LY9,MICA,MICB,NCK1,NCK2,NHEJ1,PIK3CD,PIK3CG,PPP3CA,PPP3CB,PRLR,PTGER4,PTPN2,PTPN22,PTPRC,RAC2,RAG1,RAG2,RHOH,RIPK3,RORA,RORC,RSAD2,S100A8,S100A9,SEMA4D,SHH,SLA2,SLAMF6,SLC11A1,SOX4,STOML2,THEMIS,TNFRSF4,TNFSF14,TNFSF18,TNFSF4,TREML2,ZAP70,ZFPM1	The adhesion of one leukocyte to one or more other leukocytes via adhesion molecules.
GO:0070491	GO	MF	repressing transcription factor binding	CBX5,DMAP1,EIF4E,GSC,HDAC9,HHEX,MAGEA2,NOC2L,PRDM5,SP1,TCP10L,ZMYND8	Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.
GO:0070492	GO	MF	oligosaccharide binding	LGALS12,LGALS16,LGALS9,LOXL2,SELE,SELP	Interacting selectively and non-covalently with any oligosaccharide, a molecule with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
GO:0070493	GO	BP	thrombin receptor signaling pathway	DGKQ,GP1BA,HPGD,IQGAP2,PLEK	The series of molecular signals generated as a consequence of a thrombin receptor binding to one of its physiological ligands.
GO:0070498	GO	BP	interleukin-1-mediated signaling pathway	EGR1,IKBKB,IL1R1,IRAK1,IRAK2,IRAK3,MAPK3,PLCB1,RPS6KA4,RPS6KA5,TNIP2	A series of molecular signals initiated by the binding of interleukin-1 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
GO:0070507	GO	BP	regulation of microtubule cytoskeleton organization	ABL1,APC,ARHGEF2,ARL2,ATF5,AURKA,AURKB,BECN1,BORA,BRCA1,CAMSAP3,CAV3,CCNB1,CCNF,CCSAP,CDC42,CDK5RAP2,CENPJ,CEP131,CEP250,CEP76,CEP85,CHEK1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CHMP5,CIB1,CLASP1,CLASP2,CLIP1,CLIP3,CTNNB1,CYLD,ECT2,EFNA5,EML2,EPHA3,FES,FGF13,FKBP4,GAS2L1,GAS2L2,GEN1,KATNB1,KIF11,KNSTRN,MAPRE1,MAPT,MDM1,MID1IP1,NEK2,NPM1,PARP3,PDCD6IP,PHLDB1,PHLDB2,PKHD1,PLK1,PLK2,PLK4,PSRC1,RAB6C,RACGAP1,RBM14,RCC2,RNF4,RPS3,SBDS,SENP6,SIRT2,SKA1,SKA2,SKA3,SLAIN2,SNCA,SPAG5,SPICE1,STMN2,TBCD,TERF1,TMEM67,TPR,TPX2,TRAF3IP1,TRIM37,TRIM54,TRPV4,VPS4B,XRCC3	Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
GO:0070509	GO	BP	calcium ion import	ATP2A1,ATP2A2,ATP2B4,BBC3,CACNA1D,CACNA1G,CACNA1H,CACNB2,CASR,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,DRD2,ERO1A,F2R,FGF2,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,LCK,MCU,MCUR1,MICU1,NOL3,PKD2,PLCG2,PTPRC,RYR1,RYR2,SLC8A1,SMDT1,TRDN,TRPC4,TRPV4,XCL1	The directed movement of calcium ions into a cell or organelle.
GO:0070527	GO	BP	platelet aggregation	ACTB,ACTG1,CLIC1,CSRP1,FERMT3,FGA,FGB,FGG,FIBP,FLNA,GAS6,GATA1,GNAS,HBB,HSPB1,ILK,ITGB3,METAP1,MYH9,MYL12A,MYL9,P2RY12,PDGFRA,PIK3CB,PIK3CG,PLEK,RAP2B,STXBP1,STXBP3,TLN1,TYRO3,VCL	The adhesion of one platelet to one or more other platelets via adhesion molecules.
GO:0070528	GO	BP	protein kinase C signaling	ADAM15,AVP,AZU1,DGKQ,FLOT1,HTR2B,MAS1,PDGFB,PLEK,SLC26A6,ZP3,ZP4	A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
GO:0070530	GO	MF	K63-linked polyubiquitin binding	ATRIP,FAAP20,PARP10,PRPF8,RNF168,RNF169,SPRTN,TAB2,UIMC1,ZBTB1,ZRANB1,ZRANB3	Interacting selectively and non-covalently and non-covalently with a polymer of ubiquitin formed by linkages between lysine residues at position 63 of the ubiquitin monomers.
GO:0070531	GO	CC	BRCA1-A complex	BABAM1,BARD1,BRCA1,BRCC3,BRE,FAM175A,UIMC1	A protein complex that contains the BRCA1-BARD1 heterodimer, RAP80/UIMC1, BRCC3/BRCC36, BRE/BRCC45, FAM175A/CCDC98/Abraxas and MERIT40/NBA1, and specifically recognizes and binds K63-linked polyubiquitin chains present on histone H2A and H2AX at DNA damage sites.
GO:0070534	GO	BP	protein K63-linked ubiquitination	ARIH2,BFAR,CDKN2A,ITCH,MAGEL2,NEDD4,PARK2,PRPF19,RNF115,RNF126,RNF152,RNF168,RNF4,RNF5,RNF8,STUB1,TRAF2,TRAF6,TRIM27,TRIM5,TRIM56,UBE2B,UBE2D4,UBE2E2,UBE2E3,UBE2G1,UBE2N,UBE2O,UBE2S,UBE2T,UBE2V1,WWP2,ZFP91	A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation, but is involved in several pathways, notably as a signal to promote error-free DNA postreplication repair.
GO:0070536	GO	BP	protein K63-linked deubiquitination	ATXN3,BABAM1,BRCC3,BRE,CYLD,FAM175B,OTUB2,OTUD1,OTUD5,OTUD7B,PSMD14,SHMT2,TNFAIP3,UIMC1,USP13,USP16,USP17L2,USP20,USP25,USP33,USP8,YOD1,ZRANB1	A protein deubiquitination process in which a K63-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is removed from a protein.
GO:0070542	GO	BP	response to fatty acid	ADCY6,AKR1C2,AKR1C3,CCL19,CCL21,CCR7,CD36,DGAT2,FFAR1,FFAR2,FFAR3,GNAS,GNB1,GNG2,KCNK4,NR1H4,OR51E2,PDK3,PDK4,PID1,PTGER2,PTGFR,TGFBR3,TNFSF4,ZC3H12A	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.
GO:0070544	GO	BP	histone H3-K36 demethylation	KDM2A,KDM4A,KDM7A,KDM8,PHF8	The modification of histone H3 by the removal of a methyl group from lysine at position 36 of the histone.
GO:0070552	GO	CC	BRISC complex	BABAM1,BRCC3,BRE,FAM175B,SHMT2	A protein complex that contains the FAM175B/ABRO1, BRCC3/BRCC36, BRE/BRCC45 and MERIT40/NBA1 proteins, and specifically cleaves K63-linked polyubiquitin chains.
GO:0070555	GO	BP	response to interleukin-1	ADAMTS12,ADAMTS7,AES,ANKRD1,CACTIN,CCL2,CITED1,DAB2IP,EGR1,HDAC4,HYAL1,HYAL2,HYAL3,IGBP1,IKBKB,IL1R1,IRAK1,IRAK2,IRAK3,IRG1,LGALS9,MAPK3,MYD88,MYLK3,PLCB1,PRKCA,PYCARD,RBMX,RELA,RPS6KA4,RPS6KA5,SELE,SNCA,SRC,TAF9,TNFRSF11A,TNIP2,TRAF6,YTHDC2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
GO:0070566	GO	MF	adenylyltransferase activity	ABL1,COASY,FICD,MTPAP,NMNAT1,NMNAT2,NMNAT3,OAS1,OAS2,OAS3,PAPD4,PAPOLA,PAPOLG,PAPSS1,PAPSS2,TRNT1,TUT1	Catalysis of the transfer of an adenylyl group to an acceptor.
GO:0070567	GO	MF	cytidylyltransferase activity	CDS1,CDS2,CMAS,NANS,PCYT1A,PCYT2,TAMM41	Catalysis of the transfer of a cytidylyl group to an acceptor.
GO:0070569	GO	MF	uridylyltransferase activity	TUT1,UAP1,UGP2,ZCCHC11,ZCCHC6	Catalysis of the transfer of an uridylyl group to an acceptor.
GO:0070577	GO	MF	lysine-acetylated histone binding	ATAD2B,BAZ1B,BAZ2A,BRD2,BRD3,BRD4,BRD7,BRD9,BRDT,CARM1,KMT2A,PHIP,PSME4,SMARCA4,TAF1,TAF1L,TRIM24	Interacting selectively and non-covalently with a histone in which a lysine residue has been modified by acetylation.
GO:0070578	GO	CC	RISC-loading complex	AGO1,AGO2,AGO3,AGO4,DICER1,TARBP2	A trimeric ribonucleoprotein complex that and is required for the formation of a mature RNA induced silencing complex (RISC). In humans the complex is composed of the endonuclease Dicer (DICER1) and TRBP (TARBP2) in association with the Argonaute protein Ago2 (EIF2C2/AGO2). Within the complex, Dicer and TRBP are required to process precursor miRNAs (pre-miRNAs) to mature miRNAs and then load them onto Ago2. Ago2 bound to the mature miRNA constitutes the minimal RISC and may subsequently dissociate from Dicer and TRBP.  This complex has endoribonuclease activity.
GO:0070584	GO	BP	mitochondrion morphogenesis	DNM1L,FIS1,MFF,MTM1,MYH14,NUBPL,PID1,PNPT1,SUPV3L1	The process in which the anatomical structures of a mitochondrion are generated and organized.
GO:0070585	GO	BP	protein localization to mitochondrion	AIP,AKT1,CHCHD2,CHCHD4,COX18,COX19,DNAJA1,DNAJC19,FBXO7,FIS1,GDAP1,GFER,GRPEL1,GRPEL2,HK1,HK2,HSP90AA1,HSPA4,HSPA9,IMMP2L,LRRK2,MARCH5,MFF,MFN2,MGARP,MIPEP,MOAP1,MTCH2,MTX1,MTX2,NDUFA13,PAM16,PDE2A,PINK1,PMPCA,PMPCB,SAMM50,SLC25A6,TIMM10,TIMM10B,TIMM13,TIMM17A,TIMM17B,TIMM21,TIMM22,TIMM23,TIMM44,TIMM50,TIMM8A,TIMM8B,TIMM9,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TRNT1,TSPO	A process in which a protein is transported to, or maintained in, a location within the mitochondrion.
GO:0070588	GO	BP	calcium ion transmembrane transport	ANO6,ASPH,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,BBC3,CACFD1,CACNA1C,CACNA1D,CACNA2D4,CACNB4,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,CUL5,DRD2,ERO1A,F2R,FGF2,FKBP1A,FKBP1B,GAS6,GRIN1,HTR2A,HTR2B,HTR2C,IBTK,IL1RAPL1,ITGAV,ITPR1,JPH2,LCK,MCOLN1,MCOLN2,MCOLN3,MCU,MICU1,NOL3,P2RX1,PDE2A,PKD1,PKD2,PLCG2,PSEN1,PTPRC,RASA3,RYR1,RYR2,RYR3,SLC8A1,SLC8A2,SLC8A3,SMDT1,STIM2,TRDN,TRPA1,TRPC1,TRPC3,TRPC4,TRPC4AP,TRPC5,TRPC6,TRPC7,TRPM1,TRPM2,TRPM3,TRPM4,TRPM5,TRPM6,TRPM7,TRPM8,TRPV1,TRPV2,TRPV3,TRPV4,TRPV5,TRPV6,XCL1,ZP3	A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0070603	GO	CC	SWI/SNF superfamily-type complex	ACTL6A,ACTL6B,ACTR5,ACTR8,ANP32E,APPL1,APPL2,ARID1A,ARID1B,ATRX,BAZ1A,BPTF,BRD8,CECR2,CHD3,CHD4,CHD5,CHRAC1,CSNK2A1,DAXX,DPF1,DPF3,EP400,GATAD2A,HDAC1,HDAC2,HMGXB4,ING3,INO80,INO80B,INO80C,INO80E,KAT5,MBD3,MCRS1,MTA2,NACC2,NCR1,NFRKB,PBRM1,PHF10,RB1,RBBP4,RBBP7,RUVBL1,RUVBL2,SALL1,SMARCA1,SMARCA2,SMARCA4,SMARCA5,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,TFPT,TRRAP,UCHL5,YY1	A protein complex that contains an ortholog of the Saccharomyces ATPase Swi2/Snf2 as one of the core components and mediates assembly of nucleosomes, changes to the spacing or structure of nucleosomes, or some combination of those activities in a manner that requires ATP.
GO:0070613	GO	BP	regulation of protein processing	A2M,ADAM8,ASTL,BCL2L12,C19orf80,C1QBP,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CCBE1,CD46,CD55,CD59,CFB,CFH,CFI,CFP,CHAC1,CLEC3B,CR1,F12,GAS1,GSN,HPN,KLKB1,LRRK2,MAGEA3,MASP1,MFI2,MYH9,NKD2,NOL3,PHB,PROS1,RHBDD1,RNF139,SERPINE1,SERPINE2,SERPINF2,SERPING1,SNX12,SUSD4,THBS1,TMEM59,USP17L2,VTN	Any process that modulates the frequency, rate or extent of protein processing, any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein.
GO:0070628	GO	MF	proteasome binding	ADRM1,AMFR,BAG6,DNAJB2,PSMD14,PSMF1,UBD,UCHL5,USP13,USP14	Interacting selectively and non-covalently with a proteasome, a large multisubunit protein complex that catalyzes protein degradation.
GO:0070633	GO	BP	transepithelial transport	AQP1,BEST1,CXADR,GPLD1,RHBG,RHCG,SLC12A2,SLC23A1,SLC23A2,SLC26A6	The directed movement of a substance from one side of an epithelium to the other.
GO:0070646	GO	BP	protein modification by small protein removal	ASXL1,ATXN3,ATXN3L,ATXN7,ATXN7L3,BABAM1,BAP1,BRCC3,BRE,COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,CYLD,EIF3F,ENY2,FAM175B,GPS1,JOSD2,KAT2A,MYSM1,OTUB1,OTUB2,OTUD1,OTUD3,OTUD4,OTUD5,OTUD6A,OTUD7A,OTUD7B,OTULIN,PSMD14,SENP1,SENP2,SENP6,SHMT2,STAMBP,SUPT3H,TAF10,TNFAIP3,TOR1A,TRRAP,UCHL1,UCHL5,UIMC1,USP1,USP10,USP11,USP12,USP13,USP14,USP15,USP16,USP17L2,USP19,USP2,USP20,USP21,USP22,USP25,USP26,USP28,USP3,USP30,USP31,USP32,USP33,USP34,USP35,USP36,USP37,USP38,USP4,USP42,USP44,USP45,USP46,USP47,USP49,USP5,USP51,USP6,USP7,USP8,USP9X,USP9Y,USPL1,VCPIP1,WDR48,YOD1,ZRANB1	A protein modification process in which one or more covalently attached groups of a small protein, such as ubiquitin or a ubiquitin-like protein, are removed from a target protein.
GO:0070652	GO	CC	HAUS complex	HAUS1,HAUS2,HAUS3,HAUS4,HAUS5,HAUS6,HAUS7,HAUS8	A protein complex that localizes to interphase centrosomes and to mitotic spindle tubules and regulates mitotic spindle assembly and centrosome integrity; in human, the complex consists of eight subunits, some of which are homologous to subunits of the Drosophila Augmin complex.
GO:0070661	GO	BP	leukocyte proliferation	ACE,BCL2,BTN3A1,CD40,CD40LG,CD79A,CLU,CR2,CTPS1,DOCK8,ELF4,F2RL1,FLT3,HELLS,HSPD1,IFNB1,IL10,KIT,LILRB1,MEF2C,MS4A1,NPR3,PIK3CG,PPP3CB,PTPRC,SLC11A1,TNFRSF4,TNFSF14,TNFSF18	The expansion of a leukocyte population by cell division.
GO:0070663	GO	BP	regulation of leukocyte proliferation	AGER,AHR,AIF1,ANXA1,ATM,BCL2,BMP4,BTN2A2,CCL19,CCL5,CCR2,CD1D,CD209,CD24,CD274,CD276,CD28,CD300A,CD38,CD3E,CD46,CD55,CD6,CD74,CD81,CDKN2A,CEBPB,CHRNB2,CLC,CLCF1,CSF1,CTLA4,EBI3,FADD,FGF10,FOXP3,GLMN,GPR183,GREM1,GSTP1,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DRB1,HLA-E,HLA-G,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IHH,IKZF3,IL10,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL27,IL4,IL6,IL6ST,IL7,IRF1,IRS2,KIAA0922,LEP,LGALS3,LGALS9,LILRB1,LILRB2,LST1,LYN,MEF2C,MIF,MNDA,MZB1,NCK1,NCK2,NCKAP1L,NFATC2,OCSTAMP,PDCD1LG2,PNP,PRKAR1A,PRNP,PTPN22,PTPRC,PYCARD,RASAL3,RC3H1,RIPK3,SFTPD,SHH,SOX11,TCF3,TIRAP,TMIGD2,TNFAIP3,TNFRSF21,TNFRSF4,TNFSF13B,TNFSF18,TNFSF4,VAV3,VCAM1,XCL1,ZNF335,ZP3,ZP4	Any process that modulates the frequency, rate or extent of leukocyte proliferation.
GO:0070664	GO	BP	negative regulation of leukocyte proliferation	ATM,BMP4,BTN2A2,CD274,CD300A,CDKN2A,CEBPB,CTLA4,FOXP3,GLMN,GREM1,GSTP1,HLA-DRB1,HLA-G,IHH,IL10,KIAA0922,LGALS9,LILRB1,LILRB2,LST1,LYN,MNDA,PDCD1LG2,PRKAR1A,PRNP,RC3H1,SFTPD,SOX11,TNFAIP3,TNFRSF21,XCL1	Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte proliferation.
GO:0070665	GO	BP	positive regulation of leukocyte proliferation	AGER,AIF1,ANXA1,BCL2,CCL19,CCL5,CCR2,CD1D,CD24,CD274,CD276,CD28,CD38,CD3E,CD46,CD55,CD6,CD74,CD81,CHRNB2,CLCF1,CSF1,EBI3,FADD,FGF10,GPR183,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-E,HMGB1,ICOSLG,IGF1,IGF2,IGFBP2,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,IRS2,LEP,LGALS9,LILRB2,LYN,MEF2C,MIF,NCK1,NCK2,NCKAP1L,NFATC2,OCSTAMP,PNP,PTPRC,PYCARD,RASAL3,SHH,TCF3,TIRAP,TMIGD2,TNFRSF4,TNFSF13B,TNFSF4,VAV3,VCAM1,XCL1,ZNF335,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of leukocyte proliferation.
GO:0070670	GO	BP	response to interleukin-4	CITED1,DCSTAMP,IL2RG,IL4R,JAK3,LEF1,SHPK,STAT6,TCF7,XBP1,XCL1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
GO:0070679	GO	MF	inositol 1,4,5 trisphosphate binding	CYTH2,ITPR3,RPH3A,TRPC1,TRPC3,TRPC6	Interacting selectively and non-covalently with inositol 1,4,5 trisphosphate.
GO:0070688	GO	CC	MLL5-L complex	ACTB,HCFC1,KMT2E,OGT,PPP1CA,PPP1CB,PPP1CC,STK38	A protein complex that can methylate lysine-4 of histone H3 and plays an essential role in retinoic-acid-induced granulopoiesis. MLL5 is the catalytic methyltransferase subunit, and the complex also contains serine/threonine kinase 38 (STK38), protein phosphatase 1 catalytic subunits, the host cell factor-1 N-terminal subunit, beta-actin, and O-GlcNAc transferase; the human genes encoding the subunits are MLL5, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT, respectively.
GO:0070695	GO	CC	FHF complex	AKTIP,FAM160A2,HOOK1,HOOK2,HOOK3	A protein complex that is composed of AKTIP/FTS, FAM160A2/p107FHIP, and one or more members of the Hook family of proteins, HOOK1, HOOK2, and HOOK3. The complex is thought to promote vesicle trafficking and/or fusion, and associates with the homotypic vesicular sorting complex (the HOPS complex).
GO:0070696	GO	MF	transmembrane receptor protein serine/threonine kinase binding	BMP2,BMP3,BMP4,BMP5,BMP6,MAGI2,NODAL,SMAD6	Interacting selectively and non-covalently with a receptor that spans a cell membrane and possesses protein serine/threonine kinase activity.
GO:0070700	GO	MF	BMP receptor binding	BMP2,BMP3,BMP4,BMP5,BMP6	Interacting selectively and non-covalently with a BMP receptor.
GO:0070717	GO	MF	poly-purine tract binding	ATXN1,DDX1,DDX3X,EIF4A3,HNRNPDL,KHDRBS1,PABPC1,PABPC3,PABPC4,PATL1,PNPT1,RBPMS,TIA1	Interacting selectively and non-covalently with any stretch of purines (adenine or guanine) in an RNA molecule.
GO:0070723	GO	BP	response to cholesterol	CCL3,CCR5,CYP7A1,GPLD1,LRP6,MLC1,OSBPL7,PTCH1,SMAD2,SMO,TGFB1,TGFBR1,TGFBR2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
GO:0070741	GO	BP	response to interleukin-6	CITED1,CTR9,FER,FOXA2,IL6,IL6R,IL6ST,NFKB1,PHB,PID1,RELA,SBNO2,SELPLG,SMAD4,STAT3,TDGF1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus.
GO:0070761	GO	CC	pre-snoRNP complex	NOP56,NOP58,NUFIP1,PIH1D1,TAF9,ZNHIT6	A ribonucleoprotein complex that contains a precursor small nucleolar RNA (pre-snoRNA) and associated proteins, and forms during small nucleolar ribonucleoprotein complex (snoRNP) assembly. Pre-snoRNP complexes may contain proteins not found in the corresponding mature snoRNP complexes.
GO:0070776	GO	CC	MOZ/MORF histone acetyltransferase complex	BRD1,BRPF1,BRPF3,ING5,KAT6A,KAT6B,MEAF6	A histone acetyltransferase complex that has histone H3 acetyltransferase and coactivator activities. Subunits of the human complex include MYST3/MOZ, MYST4/MORF, ING5, EAF6 and one of BRPF1, BRD1/BRPF2 and BRPF3.
GO:0070813	GO	BP	hydrogen sulfide metabolic process	CBS,CTH,ETHE1,MPST,SQRDL	The chemical reactions and pathways involving hydrogen sulfide, H2S.
GO:0070820	GO	CC	tertiary granule	ADAM8,SLC11A1,STX7,STXBP2,STXBP3,VAMP1	A secretory granule that contains cathepsin and gelatinase and is readily exocytosed upon cell activation; found primarily in mature neutrophil cells.
GO:0070828	GO	BP	heterochromatin organization	BAHD1,CDKN2A,CENPV,HELLS,HMGA1,HMGA2,HP1BP3,MTHFR,SETD7	Any process that results in the specification, formation or maintenance of the physical structure of eukaryotic heterochromatin, a compact and highly condensed form of chromatin.
GO:0070830	GO	BP	bicellular tight junction assembly	APC,ARL2,CLDN1,CLDN12,CLDN14,CLDN15,CLDN17,CLDN18,CLDN20,CLDN22,CLDN23,CLDN3,CLDN9,CRB3,DLG1,ECT2,F11R,FRMPD2,GRHL2,INADL,MARVELD2,MARVELD3,MICALL2,MPP5,MPP7,OCLN,PARD3,PARD6A,PARD6B,PARD6G,PRKCI,RAB13,RAMP2,STRN,TBCD	The aggregation, arrangement and bonding together of a set of components to form a tight junction, an occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet.
GO:0070838	GO	BP	divalent metal ion transport	ADRA1A,ANK2,ANO6,ASPH,ATP2A1,ATP2A2,ATP2A3,ATP2B2,ATP2B4,ATP2C1,BBC3,CACFD1,CACNA1C,CACNA1D,CACNA1G,CACNA1H,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG3,CACNG6,CACNG7,CACNG8,CALCRL,CAMK2A,CASR,CAV1,CCDC109B,CCL19,CCL21,CCL3,CCL5,CCL8,CCR1,CCR5,CCR7,CDH23,CHERP,CHRNA4,CHRNA7,CHRNB2,CRACR2A,CRACR2B,CSN2,CUL5,CYP27B1,DRD2,ERO1A,F2R,FGF2,FKBP1A,FKBP1B,FYN,GAS6,GRIN1,GRIN3A,HTR2A,HTR2B,HTR2C,IBTK,IL1RAPL1,ITGAV,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KCNN4,LCK,MAGT1,MCOLN1,MCOLN2,MCOLN3,MCU,MCUR1,MICU1,MICU2,MMGT1,MT3,NMUR1,NMUR2,NOL3,NPY,P2RX1,PANX1,PDE2A,PKD1,PKD2,PLCG2,PSEN1,PTPRC,RAMP1,RAMP2,RAMP3,RASA3,RYR1,RYR2,RYR3,SLC11A1,SLC11A2,SLC24A1,SLC30A1,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC35G1,SLC39A1,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6,SLC39A8,SLC3A2,SLC40A1,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLN,SMDT1,STIM2,STOML2,TF,TFR2,TMEM165,TPT1,TRDN,TRPA1,TRPC1,TRPC3,TRPC4,TRPC4AP,TRPC5,TRPC6,TRPC7,TRPM1,TRPM2,TRPM3,TRPM4,TRPM5,TRPM6,TRPM7,TRPM8,TRPV1,TRPV2,TRPV3,TRPV4,TRPV5,TRPV6,TUSC3,XCL1,ZP3	The directed movement of divalent metal cations, any metal ion with a +2 electric charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0070849	GO	BP	response to epidermal growth factor	DAB2IP,EEF1A1,EGFR,GAREM,INPP5K,IQGAP1,MAPK1,MAPK3,MED1,PDPK1,PLCG1,SNAI2,SOX9,STAT5B,TDGF1,TPR,VIL1,ZPR1	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
GO:0070851	GO	MF	growth factor receptor binding	ARF4,CBLC,CSF3,EFEMP1,EGF,EPGN,ERAP1,EREG,FER,FGF10,FGF17,FGF18,FGF5,FGF8,FIGF,GREM1,IL10,IL11,IL12A,IL12B,IL1B,IL1RN,IL2,IL3,IL36A,IL36B,IL37,IL4,IL6,ITGA5,ITGB3,JAK2,NPTN,PDGFA,PDGFB,PIBF1,SDCBP,SHC1,SNX1,SNX2,SNX4,TGFA,TIMM50,TNK2,TRIP6,TXLNA,TYMP	Interacting selectively and non-covalently with a growth factor receptor.
GO:0070857	GO	BP	regulation of bile acid biosynthetic process	CYP7A1,FGF19,FGFR4,NR1D1,NR1H4,PROX1,SIRT1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of bile acids.
GO:0070861	GO	BP	regulation of protein exit from endoplasmic reticulum	BCAP31,BRSK2,DERL2,DERL3,EDEM1,EDEM2,ERLEC1,GCC2,OS9,SEC16B,SLC51B,SORL1,SVIP,TMEM30A,TMEM30B,UBAC2,UBE2G2,UBE2J1,YOD1	Any process that modulates the frequency, rate or extent of the directed movement of proteins from the endoplasmic reticulum.
GO:0070863	GO	BP	positive regulation of protein exit from endoplasmic reticulum	BCAP31,EDEM1,EDEM2,SEC16B,SLC51B,SORL1,TMEM30A,TMEM30B	Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the endoplasmic reticulum.
GO:0070873	GO	BP	regulation of glycogen metabolic process	AKT1,AKT2,DYRK2,ENPP1,GCGR,GCK,GRB10,GSK3A,GSK3B,IGF1,IGF2,INPP5K,INS,INSR,IRS1,IRS2,PASK,PHKG2,PPP1R3B,PPP1R3F,PTH,SORBS1,VIMP	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving glycogen.
GO:0070874	GO	BP	negative regulation of glycogen metabolic process	ENPP1,GRB10,GSK3A,GSK3B,INPP5K,INS,PASK,VIMP	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving glycogen.
GO:0070875	GO	BP	positive regulation of glycogen metabolic process	AKT1,AKT2,DYRK2,GCK,IGF1,IGF2,INS,INSR,IRS1,IRS2,PHKG2,PTH,SORBS1	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving glycogen.
GO:0070884	GO	BP	regulation of calcineurin-NFAT signaling cascade	ACTN3,AKAP6,ATP2B4,CHP1,CHP2,CIB1,IGF1,LMCD1,PRNP,SLC9A1,SPPL3	Any process that modulates the frequency, rate or extent of the calcineurin-NFAT signaling cascade.
GO:0070886	GO	BP	positive regulation of calcineurin-NFAT signaling cascade	AKAP6,CHP2,CIB1,IGF1,LMCD1,SLC9A1,SPPL3	Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade.
GO:0070888	GO	MF	E-box binding	AHR,ARNTL,ARNTL2,ASCL1,ASCL2,ATOH8,BHLHE40,BHLHE41,CIART,CLOCK,GATA3,HAND2,LMO2,MYC,MYF5,MYF6,MYOD1,MYOG,NEUROD1,NEUROD2,NEUROG1,NEUROG2,PER1,SCX,SREBF2,TAL1,TCF21,TCF3,TCF4,TFAP4,TWIST1,ZEB1	Interacting selectively and non-covalently with an E-box, a DNA motif with the consensus sequence CANNTG that is found in the promoters of a wide array of genes expressed in neurons, muscle and other tissues.
GO:0070900	GO	BP	mitochondrial tRNA modification	GTPBP3,HSD17B10,MTO1,PUS1,TRIT1,TRMT10C,TRMT61B,TRMU	The covalent alteration of one or more nucleotides within a mitochondrial tRNA molecule to produce a mitochondrial tRNA molecule with a sequence that differs from that coded genetically.
GO:0070911	GO	BP	global genome nucleotide-excision repair	CCNH,CDK7,CETN2,CHD1L,COPS2,COPS3,COPS4,COPS5,COPS6,COPS7A,COPS7B,COPS8,CUL4A,CUL4B,DDB1,DDB2,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,GPS1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,LIG1,LIG3,MNAT1,PARP1,PCNA,POLD1,POLD2,POLD3,POLD4,POLK,RAD23B,RBX1,RFC1,RFC2,RFC3,RFC4,RFC5,RNF111,RPA1,RPA2,RPA3,RPS27A,SUMO1,SUMO2,SUMO3,UBA52,UBB,UBC,UBE2I,UBE2N,UBE2V2,USP45,XPA,XPC,XRCC1	The nucleotide-excision repair process in which DNA lesions are removed from nontranscribed strands and from transcriptionally silent regions over the entire genome.
GO:0070914	GO	BP	UV-damage excision repair	ACTR5,CUL4B,DDB1,DDB2,HIST3H2A,INO80,MC1R,SIRT1,XPC	A DNA repair process that is initiated by an endonuclease that introduces a single-strand incision immediately 5' of a UV-induced damage site. UV-damage excision repair acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
GO:0070918	GO	BP	production of small RNA involved in gene silencing by RNA	ADAR,AGO1,AGO2,AGO3,AGO4,DGCR8,DICER1,DROSHA,HNRNPA2B1,LIN28A,LIN28B,METTL3,PRKRA,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TERT,ZCCHC11	The process in which a double-stranded RNA precursor is processed into short (20-30 nt) fragments. RNA cleavage is catalyzed by a Dicer endonuclease.
GO:0070922	GO	BP	small RNA loading onto RISC	ADAR,AGO1,AGO2,AGO3,AGO4,CLP1,DICER1,TARBP2	The process in which a single-stranded small RNA associates with the RNA-initiated silencing complex (RISC); occurs as part of a process of gene silencing by small RNA.
GO:0070932	GO	BP	histone H3 deacetylation	ELK4,HDAC1,HDAC2,HDAC4,HDAC9,PER1,PER2,SFPQ,SIRT1,SIRT2,SIRT6,SIRT7,SMARCAD1	The modification of histone H3 by the removal of one or more acetyl groups.
GO:0070933	GO	BP	histone H4 deacetylation	HDAC1,HDAC2,HDAC4,HDAC9,RCOR1,REST,SIRT2,SIRT7,SMARCAD1	The modification of histone H4 by the removal of one or more acetyl groups.
GO:0070934	GO	BP	CRD-mediated mRNA stabilization	DHX9,HNRNPU,IGF2BP1,SYNCRIP,YBX1	An mRNA stabilization process in which one or more RNA-binding proteins associate with a sequence in the open reading frame called the coding region instability determinant (CRD).
GO:0070935	GO	BP	3'-UTR-mediated mRNA stabilization	ANGEL2,ELAVL1,HNRNPA0,HNRNPC,MAPK14,MAPKAPK2,MYD88,RBM38,TARDBP,TIRAP,YBX3,ZFP36	An mRNA stabilization process in which one or more RNA-binding proteins associate with the 3'-untranslated region (UTR) of an mRNA.
GO:0070936	GO	BP	protein K48-linked ubiquitination	AMFR,ARIH2,BFAR,CDC34,HACE1,ITCH,KLHL3,MARCH6,NEDD4L,PARK2,RFFL,RNF115,RNF126,RNF146,RNF152,RNF187,RNF216,RNF34,RNF4,RNF5,RNF6,RNF8,SYVN1,TNFAIP3,TOPORS,TTC3,UBE2A,UBE2B,UBE2C,UBE2D1,UBE2D2,UBE2D3,UBE2D4,UBE2E1,UBE2E2,UBE2E3,UBE2G1,UBE2G2,UBE2H,UBE2K,UBE2Q2,UBE2R2,UBE2T,UBE3A,ZNRF1	A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation.
GO:0070937	GO	CC	CRD-mediated mRNA stability complex	CSDE1,DHX9,HNRNPU,IGF2BP1,SYNCRIP,YBX1	A protein complex that binds to, and promotes stabilization of, mRNA molecules containing the coding region instability determinant (CRD). In human, IGF2BP1 and at least four additional proteins: HNRNPU, SYNCRIP, YBX1, and DHX9.
GO:0070938	GO	CC	contractile ring	ALKBH4,ANLN,DAG1,KIF20B,MAEA,MYH9,PDXP,PRC1,UTRN	A cytoskeletal structure composed of filamentous protein that forms beneath the membrane of many cells or organelles, in the plane of cell or organelle division. Ring contraction is associated with centripetal growth of the membrane that divides the cytoplasm of the two daughter cells or organelles.
GO:0070971	GO	CC	endoplasmic reticulum exit site	HLA-A,MIA2,MPPE1,PDCD6,PDCD6IP,SEC31A,TMED5	An endoplasmic reticulum part at which COPII-coated vesicles are produced.
GO:0070972	GO	BP	protein localization to endoplasmic reticulum	ANK2,ANKRD13C,CHMP4A,CHMP4B,DDOST,FAU,GBF1,GPAA1,HSPA5,OS9,PDIA2,PDIA3,PEX16,PPP1R15A,RAB10,RAB3GAP1,RAB3GAP2,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPN1,RPN2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RYR2,SEC11A,SEC11C,SEC16B,SEC61A1,SEC61B,SEC61G,SEC62,SEC63,SPCS1,SPCS2,SPCS3,SRP14,SRP19,SRP54,SRP68,SRP72,SRP9,SRPR,SRPRB,SSR1,SSR2,SSR3,SSR4,TRAM1,UBA52,UBAC2,VAPA,ZFAND2B	A process in which a protein is transported to, or maintained in, a location within the endoplasmic reticulum.
GO:0070977	GO	BP	bone maturation	BMP2,FGFR3,GH1,IGF1,PLXNB1,RHOA,RYR1,SEMA4D	A developmental process, independent of morphogenetic (shape) change, that is required for bone to attain its fully functional state.
GO:0070979	GO	BP	protein K11-linked ubiquitination	ANAPC1,ANAPC10,ANAPC11,ANAPC13,ANAPC2,ANAPC4,ANAPC5,ANAPC7,CDC16,CDC23,CDC26,CDC27,FZR1,PARK2,RNF4,UBE2A,UBE2B,UBE2C,UBE2D3,UBE2D4,UBE2E2,UBE2E3,UBE2H,UBE2L3,UBE2S,UBE2T,UBE2W	A protein ubiquitination process in which ubiquitin monomers are attached to a protein, and then ubiquitin polymers are formed by linkages between lysine residues at position 11 of the ubiquitin monomers. K11-linked polyubiquitination targets the substrate protein for degradation. The anaphase-promoting complex promotes the degradation of mitotic regulators by assembling K11-linked polyubiquitin chains.
GO:0070986	GO	BP	left/right axis specification	AHI1,CITED2,PITX2,PKD1L1,SETDB2	The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes).
GO:0070987	GO	BP	error-free translesion synthesis	NPLOC4,PCNA,POLH,RCHY1,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,SPRTN,UBA52,UBB,UBC,UFD1L,VCP	The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions but does not causes an increase in the endogenous mutation level. For S. cerevisiae, RAD30 encodes DNA polymerase eta, which incorporates two adenines. When incorporated across a thymine-thymine dimer, it does not increase the endogenous mutation level.
GO:0070988	GO	BP	demethylation	AICDA,ALKBH1,ALKBH2,ALKBH3,ALKBH4,ALKBH5,APEX1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,CYP1A2,CYP2C8,CYP2C9,CYP2D6,CYP3A4,CYP3A5,CYP51A1,FTO,HIST1H4A,JMJD6,KDM1A,KDM1B,KDM2A,KDM3A,KDM4A,KDM4C,KDM4D,KDM5B,KDM5C,KDM5D,KDM7A,KDM8,PHF2,PHF8,PPME1,TDG,TET1,TET2,TET3	The process of removing one or more methyl groups from a molecule.
GO:0070989	GO	BP	oxidative demethylation	ALKBH1,ALKBH2,ALKBH3,ALKBH5,CYP1A2,CYP2C8,CYP2C9,CYP2D6,CYP3A4,CYP3A5,FTO,TDG,TET1,TET2,TET3	The process of removing one or more methyl groups from a molecule, involving the oxidation (i.e. electron loss) of one or more atoms in the substrate.
GO:0070997	GO	BP	neuron death	APP,ATN1,BAG5,BCL2,BID,BNIP3,CDK5,ERBB3,GAPDH,KLK6,LIG4,LRRK2,MAGI1,MEOX2,NAE1,NLRP1,NLRP5,NLRP8,SIAH1,TNFRSF21	The process of cell death in a neuron.
GO:0071013	GO	CC	catalytic step 2 spliceosome	ALYREF,AQR,CACTIN,CDC40,CDC5L,CRNKL1,CWC15,CWC22,CWC27,DDX23,DDX41,DDX5,DGCR14,DHX35,DHX38,DHX8,EFTUD2,EIF4A3,FRG1,GPATCH1,HNRNPA1,HNRNPA2B1,HNRNPA3,HNRNPC,HNRNPF,HNRNPH1,HNRNPK,HNRNPM,HNRNPR,HNRNPU,ISY1,LSM2,LSM3,MAGOH,PABPC1,PLRG1,PNN,PPIE,PPIL1,PPIL3,PPWD1,PRPF19,PRPF4B,PRPF6,PRPF8,RALY,RBM22,RBM8A,RBMX,SART1,SF3A1,SF3A2,SF3A3,SF3B1,SF3B2,SF3B3,SKIV2L2,SLU7,SNRNP200,SNRNP40,SNRPA1,SNRPB,SNRPB2,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNW1,SRRM1,SRRM2,SRSF1,SYF2,SYNCRIP,TFIP11,U2AF1,WDR83,XAB2,ZCCHC8	A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs.
GO:0071025	GO	BP	RNA surveillance	DXO,EXOSC10,EXOSC4,EXOSC9,SUPV3L1,XRN1	The set of processes involved in identifying and degrading defective or aberrant RNAs.
GO:0071028	GO	BP	nuclear mRNA surveillance	DXO,EXOSC10,EXOSC4,EXOSC9,XRN1	The set of processes involved in identifying and degrading defective or aberrant mRNAs within the nucleus.
GO:0071044	GO	BP	histone mRNA catabolic process	ATM,DCP2,EXOSC10,EXOSC4,LSM1,MTPAP,PAPD4,PAPD5,UPF1,XRN1	The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA).
GO:0071071	GO	BP	regulation of phospholipid biosynthetic process	ACSL3,FABP3,HTR2A,HTR2B,HTR2C,PDGFA,PDGFB,SLC27A1,XBP1,ZP3	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.
GO:0071073	GO	BP	positive regulation of phospholipid biosynthetic process	ACSL3,FABP3,HTR2A,HTR2B,HTR2C,XBP1,ZP3	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.
GO:0071103	GO	BP	DNA conformation change	ACIN1,AIFM1,ANP32B,APITD1,ASCC3,ASF1A,ASF1B,ASH1L,ATRX,BAHD1,BLM,BRD2,BRIP1,CABIN1,CASC5,CDAN1,CDCA5,CDKN2A,CENPA,CENPC,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHAF1A,CHAF1B,CHD1,CHD1L,CHD2,CHD3,CHD4,CHD5,CHD8,CHMP1A,CTCF,DAXX,DDX1,DDX3X,DFFB,DHX9,DNA2,ERCC2,ERCC3,ERN2,FBXO18,G3BP1,GPER1,H1FNT,H1FOO,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HELB,HELLS,HHEX,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H3,HJURP,HMGA1,HMGA2,HMGB1,HMGB2,HMGB3,IGHMBP2,INO80,IPO4,ITGB3BP,KAT6A,KAT6B,M1AP,MIS18A,MIS18BP1,MRE11A,MTERF1,NAA10,NAA60,NASP,NBN,NCAPD2,NCAPD3,NCAPG,NCAPH,NOC2L,NPM1,NUSAP1,OIP5,PADI4,PAF1,PAPD7,PHF13,PIF1,POT1,PRM1,PRM2,PSME4,PURA,RAD50,RAD51,RAD54B,RBBP4,RBBP7,RECQL,RECQL4,RECQL5,RSF1,RTEL1,RUVBL1,RUVBL2,SART3,SETX,SMARCA5,SMC2,SMC4,SOX9,SPTY2D1,SRPK1,STRA13,SUPV3L1,SYCP3,TOP1,TOP2A,TOP2B,TOP3A,TP53,TSSK6,UBN1,WRN,XRCC5,XRCC6,ZRANB3	A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule.
GO:0071108	GO	BP	protein K48-linked deubiquitination	ATXN3,BAP1,OTUB1,OTUB2,OTUD4,OTUD5,OTUD7B,TNFAIP3,USP17L2,USP20,USP25,USP33,USP34,USP37,USP5,USP8,VCPIP1,YOD1	A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein.
GO:0071141	GO	CC	SMAD protein complex	HMGA2,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD9,SNW1	A protein complex that consists of SMAD proteins; may be homomeric or heteromeric.
GO:0071156	GO	BP	regulation of cell cycle arrest	AKT2,ATM,BIN1,BRCA1,CASP2,CCND1,CCNK,CDK2,CDK4,CDK5,CDK9,CDKN1A,CDKN1B,CDKN2A,CRADD,CRLF3,DAB2IP,FAP,FGF10,FOXE3,FOXM1,FOXO4,GATA6,GML,GPER1,GTSE1,HMGA2,HMGN5,ID2,INSM1,MDM2,MED25,MIF,MLXIPL,MUC1,MYBBP1A,MYOG,NEUROD1,NUPR1L,PHOX2B,PIDD1,PKD2,PML,PPP2R5C,PRKACA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RASSF1,RBM38,RFWD2,RGCC,RPS27A,RRP8,SETMAR,SLC25A33,SOX4,TFAP4,TP53,TP73,TRIAP1,UBA52,UBB,UBC,UHRF2,ZNF268	Any process that modulates the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
GO:0071157	GO	BP	negative regulation of cell cycle arrest	CCND1,CCNK,CDK4,CDK9,FGF10,FOXE3,GPER1,HMGN5,MDM2,MIF,MLXIPL,NUPR1L,PHOX2B,RASSF1,SETMAR,TFAP4,ZNF268	Any process that decreases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
GO:0071158	GO	BP	positive regulation of cell cycle arrest	ATM,BRCA1,CASP2,CDK2,CDKN1A,CDKN1B,CDKN2A,CRADD,CRLF3,DAB2IP,FAP,FOXO4,GATA6,GML,GTSE1,HMGA2,ID2,INSM1,MDM2,MED25,MUC1,MYBBP1A,MYOG,PIDD1,PKD2,PML,PPP2R5C,PRKACA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RGCC,RPS27A,RRP8,SOX4,TP53,TP73,TRIAP1,UBA52,UBB,UBC,UHRF2	Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
GO:0071166	GO	BP	ribonucleoprotein complex localization	AGFG1,ALKBH5,ALYREF,BUD13,CDC40,CHTOP,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FYTTD1,GLE1,HHEX,HNRNPA2B1,LUZP4,MAGOH,NCBP1,NCBP2,NMD3,NOP58,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,POLDIP3,PRPF31,RAE1,RAN,RBM8A,RNPS1,RPS15,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,TGS1,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO1,XPOT,ZC3H11A,ZC3H3	Any process in which a ribonucleoprotein complex is transported to, or maintained in, a specific location within a cell.
GO:0071168	GO	BP	protein localization to chromatin	H2AFY,H2AFY2,HIST1H1B,LRWD1,PIH1D1,PLK1,RAD21,RUVBL2,SGF29,WAPL	Any process in which a protein is transported to, or maintained at, a part of a chromosome that is organized into chromatin.
GO:0071169	GO	BP	establishment of protein localization to chromatin	H2AFY,H2AFY2,HIST1H1B,LRWD1,PIH1D1,RUVBL2,SGF29	The directed movement of a protein to a part of a chromosome that is organized into chromatin.
GO:0071173	GO	BP	spindle assembly checkpoint	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CASC5,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	A cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle.
GO:0071174	GO	BP	mitotic spindle checkpoint	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,KLHL22,MAD1L1,MAD2L1,MAD2L2,PLK1,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	A mitotic cell cycle checkpoint that originates from the spindle and delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and oriented, the completion of anaphase until chromosomes are attached to the spindle, or mitotic exit and cytokinesis when the spindle does not form.
GO:0071203	GO	CC	WASH complex	CAPZA1,CAPZB,CCDC53,DNAJC13,FAM21A,FAM21C,KIAA0196,KIAA1033,SNX27,WASH1	A protein complex that localizes at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization. In human, the WASH complex is composed of F-actin-capping protein subunits alpha and beta, WASH1, FAM21, KIAA1033, KIAA0196 and CCDC53.
GO:0071204	GO	CC	histone pre-mRNA 3'end processing complex	ERI1,LSM11,SLBP,SYNCRIP,YBX1	A ribonucleoprotein that binds to specific sites in, and is required for cleavage of, the 3'-end of histone pre-mRNAs. The complex contains the U7 snRNP and additional proteins, including the stem-loop binding protein (SLBP) and the exonuclease 3'hExo/Eri-1.
GO:0071214	GO	BP	cellular response to abiotic stimulus	ACTR5,ADIRF,ANKRD1,AQP1,ARHGEF2,ASIC1,ATF4,ATM,ATR,AURKB,BAK1,BLM,CAB39,CALM1,CAMKMT,CAPN3,CASP9,CDC25A,CDKN1A,CERS1,CHEK1,CHP1,CLOCK,CNGA1,CNGB1,CNN2,CREBBP,CRIP1,CRY1,CRY2,CRYAB,CUL4B,DDB1,DDB2,DDX3X,ECT2,EEF1D,EIF2AK4,EIF2S1,EP300,EPO,ERCC4,FBXW7,FIGNL1,FNTA,FNTB,GADD45A,GNAT1,GNB1,GNB5,GNGT1,GPLD1,GRB2,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HABP4,HIST3H2A,HUS1,HVCN1,HYAL1,HYAL2,HYAL3,IFI16,IMPACT,INO80,INSRR,INTS7,KCNK18,KCNK4,KDM1A,KDM4D,MAPK14,MC1R,METAP1,METAP2,MFAP4,MME,MYLK,N4BP1,NEDD4,NET1,NEUROD2,NIPBL,NMT1,NMT2,NOC2L,NOX1,NSMF,PCNA,PDE2A,PDE6A,PDE6B,PDE6G,PKD1L3,PKD2,PKD2L1,POLD1,PPEF1,PPID,PRKCA,PRKCQ,PTGER4,PTPRK,RAB11B,RAB11FIP5,RAD1,RAD51,RAD51AP1,RAD9A,RCSD1,RCVRN,REST,RGS9,RGS9BP,RHBDD1,RHNO1,RHO,RHOB,RUVBL2,SAG,SERPINB6,SIRT1,SLC12A6,SLC24A1,SLC9A1,SOX9,SPIDR,STK11,STK39,SWI5,TLK2,TMEM109,TMEM161A,TP53,TRIAP1,TRPM1,TRPV4,TSPYL5,USP28,USP47,WRN,XPC,YAP1,YBX3,YY1,ZBTB1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an abiotic (non-living) stimulus.
GO:0071216	GO	BP	cellular response to biotic stimulus	ADAM9,ANKRD1,APAF1,ATG10,AXL,B2M,CACTIN,CCL2,CCL3,CCL5,CD14,CD36,CD6,CDC73,CTR9,CXCL10,CXCL8,DAB2IP,EIF2AK3,EME1,FBXO18,FZD5,GSK3B,GSTP1,HCK,IL10,IL18,IL1B,IL6,IRAK1,IRG1,LBP,LILRB2,LY96,LYN,MAPK14,MAPK8,MEF2C,MTDH,MUS81,NFKB1,NFKBIL1,NLRP3,NR1D1,NR1H3,PAF1,PDE4B,PRKCE,PTPN22,PYCARD,SBNO2,SCARB1,SERPINE1,SHPK,SIRT2,SLX4,STAP1,SYK,TGFB1,TICAM2,TIRAP,TLR1,TLR2,TLR4,TLR6,TNF,TNFAIP3,TNFRSF1B,TNFSF4,TNIP2,TNIP3,TP53,TRAF6,TXNIP,VIMP,WFS1,XBP1,ZC3H12A	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism.
GO:0071218	GO	BP	cellular response to misfolded protein	ATXN3,DERL1,RNF126,RNF5,STUB1,TOR1A,UBE2W,UFD1L,VCP	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus.
GO:0071219	GO	BP	cellular response to molecule of bacterial origin	ADAM9,ANKRD1,AXL,B2M,CACTIN,CCL2,CCL3,CCL5,CD14,CD36,CD6,CDC73,CTR9,CXCL10,CXCL8,DAB2IP,FZD5,GSTP1,HCK,IL10,IL18,IL1B,IL6,IRAK1,IRG1,LBP,LILRB2,LY96,LYN,MAPK14,MAPK8,MEF2C,MTDH,NFKB1,NFKBIL1,NLRP3,NR1D1,NR1H3,PAF1,PDE4B,PRKCE,PTPN22,PYCARD,SBNO2,SCARB1,SERPINE1,SHPK,SIRT2,STAP1,TGFB1,TICAM2,TIRAP,TLR1,TLR2,TLR4,TLR6,TNF,TNFAIP3,TNFRSF1B,TNFSF4,TNIP2,TNIP3,TRAF6,VIMP,XBP1,ZC3H12A	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
GO:0071221	GO	BP	cellular response to bacterial lipopeptide	CD14,CD36,TIRAP,TLR1,TLR2,TLR6	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bacterial lipopeptide stimulus.
GO:0071222	GO	BP	cellular response to lipopolysaccharide	ADAM9,ANKRD1,AXL,B2M,CACTIN,CCL2,CCL3,CCL5,CD14,CD6,CDC73,CTR9,CXCL10,CXCL8,DAB2IP,GSTP1,HCK,IL10,IL18,IL1B,IL6,IRAK1,IRG1,LBP,LILRB2,LY96,LYN,MAPK14,MAPK8,MEF2C,MTDH,NFKB1,NFKBIL1,NLRP3,NR1D1,NR1H3,PAF1,PDE4B,PRKCE,PTPN22,PYCARD,SBNO2,SCARB1,SERPINE1,SHPK,STAP1,TGFB1,TICAM2,TLR2,TLR4,TNF,TNFAIP3,TNFRSF1B,TNFSF4,TNIP2,TNIP3,TRAF6,VIMP,XBP1,ZC3H12A	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
GO:0071225	GO	BP	cellular response to muramyl dipeptide	ARHGEF2,NOD1,NOD2,PTPN22,RIPK2	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan.
GO:0071229	GO	BP	cellular response to acid chemical	ABCB4,ABL2,ADCY6,ADNP2,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AQP1,BRINP3,CAPN2,CPEB1,CPEB3,CPEB4,DGAT2,EGR1,EPHA3,FFAR2,FFAR3,FOLR1,FOLR2,FZD10,FZD4,FZD7,GLRA1,GNAS,GNB1,GNG2,HTRA2,IPO5,KCNK4,KMT2E,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LTK,LYN,NDUFA13,NEURL1,NR1H4,NSMF,OGT,OR51E2,PAX2,PDGFB,PDK3,PDK4,PID1,PKD2,PTGER2,PTGFR,PTK2B,PTK6,PTK7,RARA,RET,RORB,RPTOR,RRAGA,RRAGB,RRAGC,RRAGD,SETX,SH3BP4,SHMT1,SLC38A9,SNW1,TBX1,TESC,TNFSF4,TWF2,UBR1,UBR2,WNT10B,WNT11,WNT2,WNT3,WNT3A,WNT5A,WNT5B,WNT6,WNT8B,WNT9A,WNT9B,XBP1,ZC3H12A,ZNF35	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by the chemical structure of the anion portion of the dissociated acid (rather than the acid acting as a proton donor). The acid chemical may be in gaseous, liquid or solid form.
GO:0071230	GO	BP	cellular response to amino acid stimulus	CAPN2,CPEB1,CPEB3,CPEB4,FOLR1,FOLR2,GLRA1,IPO5,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,NEURL1,NSMF,RPTOR,RRAGA,RRAGB,RRAGC,RRAGD,SH3BP4,SLC38A9,UBR1,UBR2,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
GO:0071241	GO	BP	cellular response to inorganic substance	ACER1,ADCY1,ADCY10,AKR1C3,ALOX15,ALOX5AP,ANK3,AOC1,AQP1,AQP2,ASPH,ATP13A2,ATRX,B2M,BLM,BMP6,BNIP3,BRAF,CAMK2D,CAPN3,CARF,CDH1,CDK2,CDKN1B,CHP2,CLIC4,CPNE1,CPNE3,CPNE7,CRHBP,DMTN,DPEP1,ECT2,FBP1,FOXO1,GLRA1,GPLD1,GUCY1B3,HFE,HVCN1,IQGAP1,KCNA1,KCNC2,LCE1D,LRRK2,MEF2A,MEF2C,MMP3,MT1F,MT1G,MT1M,MT3,MTR,NEUROD2,PARK2,PPIF,PRNP,RASA4,RASGRP2,RYR3,SCN5A,SLC25A24,SLFN14,SNCA,SPIDR,SYT1,TF,TFAP2A,TFR2,TIGAR,ZNF658	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus.
GO:0071242	GO	BP	cellular response to ammonium ion	ABL1,AOC1,CRHBP,DIAPH1,GABRB1,GABRB2,GABRB3,GABRG2,HRH1,LRRK2,PARK2,PPP1R9B	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium ion stimulus.
GO:0071243	GO	BP	cellular response to arsenic-containing substance	ATF3,ATF4,CPEB2,DDX3X,GSTO1,GSTO2,MKNK2,PPIF	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides.
GO:0071248	GO	BP	cellular response to metal ion	ACER1,ADCY1,AKR1C3,ALOX15,ALOX5AP,ANK3,AOC1,AQP1,AQP2,ASPH,ATP13A2,B2M,BMP6,BNIP3,BRAF,CAMK2D,CAPN3,CARF,CDH1,CDKN1B,CHP2,CLIC4,CPNE1,CPNE3,CPNE7,CRHBP,DMTN,DPEP1,ECT2,FBP1,GLRA1,GPLD1,HFE,HVCN1,IQGAP1,KCNA1,LCE1D,LRRK2,MEF2A,MEF2C,MT1F,MT1G,MT1M,MT3,NEUROD2,PARK2,PPIF,PRNP,RASA4,RASGRP2,RYR3,SCN5A,SLC25A24,SLFN14,SNCA,SYT1,TF,TFAP2A,TFR2,TIGAR,ZNF658	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
GO:0071260	GO	BP	cellular response to mechanical stimulus	ANKRD1,AQP1,CNN2,HABP4,KCNK4,PDE2A,PTGER4,SLC9A1,SOX9	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
GO:0071267	GO	BP	L-methionine salvage	ADI1,APIP,BHMT,BHMT2,ENOPH1,GOT1,MRI1,MTAP	Any process that generates L-methionine from derivatives of it, without de novo synthesis.
GO:0071277	GO	BP	cellular response to calcium ion	ACER1,ADCY1,AKR1C3,ALOX15,ALOX5AP,ASPH,BRAF,CAMK2D,CAPN3,CARF,CHP2,CLIC4,CPNE1,CPNE3,CPNE7,CRHBP,DMTN,DPEP1,ECT2,GPLD1,IQGAP1,LCE1D,MEF2A,MEF2C,NEUROD2,PPIF,RASA4,RASGRP2,RYR3,SCN5A,SLC25A24,SYT1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
GO:0071280	GO	BP	cellular response to copper ion	AOC1,AQP1,AQP2,PRNP,SNCA	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
GO:0071281	GO	BP	cellular response to iron ion	B2M,BMP6,HFE,TF,TFAP2A,TFR2	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus.
GO:0071286	GO	BP	cellular response to magnesium ion	ANK3,FBP1,KCNA1,RYR3,SLFN14	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus.
GO:0071294	GO	BP	cellular response to zinc ion	GLRA1,HVCN1,MT1F,MT1G,MT1M,ZNF658	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
GO:0071295	GO	BP	cellular response to vitamin	CYP24A1,FOLR1,FOLR2,GAS6,PIM1,VDR	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin stimulus.
GO:0071300	GO	BP	cellular response to retinoic acid	ABL2,ADNP2,AQP1,BRINP3,EPHA3,FZD10,FZD4,FZD7,HTRA2,KMT2E,LTK,LYN,NDUFA13,OGT,PAX2,PTK2B,PTK6,PTK7,RARA,RET,RORB,SETX,SNW1,TBX1,TESC,TWF2,WNT10B,WNT11,WNT2,WNT3,WNT3A,WNT5A,WNT5B,WNT6,WNT8B,WNT9A,WNT9B,ZNF35	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
GO:0071312	GO	BP	cellular response to alkaloid	BAD,BLM,CASQ2,CRHBP,GSTM2,HTR1B,NFKB1,PPP1R9B,RAD51,RELA,RYR1,RYR2,RYR3,SLC8A1,SPIDR,TNF,TRPV1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
GO:0071313	GO	BP	cellular response to caffeine	CASQ2,GSTM2,RYR1,RYR2,RYR3,SLC8A1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them.
GO:0071318	GO	BP	cellular response to ATP	CIB2,HSP90B1,P2RX4,P2RY11,P2RY12,PDXP,RYR3,SSH1,TRPV1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.
GO:0071320	GO	BP	cellular response to cAMP	AANAT,AKAP6,AKAP7,AKAP9,AQP1,CFTR,CRHBP,DMTN,EZR,HCN1,HCN2,HCN4,IGFBP5,INPP5K,KCNE1,KCNQ1,PDE4D,RAP1A,RAP1B,RAPGEF1,RAPGEF2,RAPGEF3,SLC26A3,SLC26A6	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
GO:0071321	GO	BP	cellular response to cGMP	HCN2,HCN4,PDE2A,PDE3A,RAPGEF2	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus.
GO:0071322	GO	BP	cellular response to carbohydrate stimulus	CALCRL,CLEC7A,COLEC12,CYP7A1,ERN1,GAS6,GNB2L1,GPER1,KCNB1,MLXIPL,PAX2,PDK3,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SLC26A6,SLC2A5,SOX4,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbohydrate stimulus.
GO:0071331	GO	BP	cellular response to hexose stimulus	CYP7A1,ERN1,GAS6,GNB2L1,GPER1,KCNB1,MLXIPL,PAX2,PDK3,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SLC26A6,SLC2A5,SOX4,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hexose stimulus.
GO:0071333	GO	BP	cellular response to glucose stimulus	CYP7A1,ERN1,GAS6,GNB2L1,GPER1,KCNB1,MLXIPL,PAX2,PDK3,PRKACA,PTPRN,PTPRN2,RAB11B,RAB11FIP2,RAB11FIP5,SOX4,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
GO:0071339	GO	CC	MLL1 complex	CHD8,E2F6,HCFC1,INO80C,KANSL1,KAT8,KMT2A,LAS1L,MAX,MCRS1,MGA,PELP1,PHF20,PRPF31,RBBP5,RNF2,RUVBL1,RUVBL2,SENP3,TAF1,TAF4,TAF6,TAF7,TAF9,TEX10,WDR5	A protein complex that can methylate lysine-4 of histone H3. MLL1/MLL is the catalytic methyltransferase subunit, and the complex also contains the core components ASH2L, HCFC1/HCF1 WDR5 and RBBP5.
GO:0071346	GO	BP	cellular response to interferon-gamma	AIF1,AQP4,B2M,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CCL2,CD44,CD58,CIITA,DAPK1,DAPK3,EPRS,FCGR1A,FCGR1B,GAPDH,GBP1,GBP2,GBP6,HCK,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,ICAM1,IFI30,IFNG,IFNGR1,IFNGR2,IL12RB1,IRF1,IRF2,IRF3,IRF4,IRF5,IRF6,IRF7,IRF8,IRF9,IRG1,JAK1,JAK2,LGALS9,MID1,MT2A,NCAM1,OAS1,OAS2,OAS3,OASL,PIAS1,PML,PRKCD,PTAFR,PTPN1,PTPN11,PTPN2,PTPN6,RPL13A,SLC26A6,SOCS1,SOCS3,SP100,STAT1,SUMO1,SYNCRIP,TDGF1,TRIM21,TRIM22,TRIM25,TRIM26,TRIM31,TRIM34,TRIM38,TRIM5,TRIM62,TRIM68,TRIM8,VCAM1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
GO:0071347	GO	BP	cellular response to interleukin-1	ADAMTS12,ADAMTS7,ANKRD1,CACTIN,CCL2,DAB2IP,EGR1,HYAL1,HYAL2,HYAL3,IKBKB,IL1R1,IRAK1,IRAK2,IRAK3,IRG1,MAPK3,MYLK3,PLCB1,PYCARD,RBMX,RELA,RPS6KA4,RPS6KA5,TNIP2	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
GO:0071353	GO	BP	cellular response to interleukin-4	DCSTAMP,IL2RG,IL4R,JAK3,LEF1,SHPK,STAT6,TCF7,XBP1,XCL1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
GO:0071354	GO	BP	cellular response to interleukin-6	CTR9,FER,IL6,IL6R,IL6ST,NFKB1,PHB,PID1,RELA,SBNO2,SELPLG,SMAD4,STAT3,TDGF1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus.
GO:0071356	GO	BP	cellular response to tumor necrosis factor	ADAM17,ADAMTS12,ADAMTS7,AIM2,ANKRD1,ARHGEF2,BAG4,BIRC2,BIRC3,BRCA1,BTRC,CACTIN,CARD14,CASP8,CCL2,CD27,CD40,CD40LG,CD58,CD70,CDIP1,CHI3L1,CHUK,CIB1,CLIP3,COMMD7,CRHBP,CUL1,CYLD,DAB2IP,DCSTAMP,EDA,EDA2R,EDAR,EDARADD,ERBB2IP,FADD,FBXW11,FOXO3,GBA,GNB2L1,GPER1,IKBKB,IKBKG,INPP5K,IRG1,JAK2,LTA,LTB,LTBR,MADD,MAP3K14,MAP3K7,NFE2L2,NFKB2,NPNT,NSMAF,OCSTAMP,OTULIN,PID1,PLVAP,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTK2B,PYCARD,PYDC1,RBCK1,RELA,RELB,RIPK1,RNF31,RPS27A,SFRP1,SHARPIN,SIRT1,SKP1,SMPD2,SMPD3,SMPD4,STAT1,TAB1,TAB2,TAB3,TAX1BP1,TDGF1,TNF,TNFAIP3,TNFRSF11A,TNFRSF11B,TNFRSF12A,TNFRSF13B,TNFRSF13C,TNFRSF14,TNFRSF17,TNFRSF18,TNFRSF19,TNFRSF1A,TNFRSF1B,TNFRSF21,TNFRSF25,TNFRSF4,TNFRSF6B,TNFSF11,TNFSF12,TNFSF13,TNFSF13B,TNFSF14,TNFSF15,TNFSF18,TNFSF4,TRADD,TRAF1,TRAF2,TRAF3,TXNDC17,UBA3,UBA52,UBB,UBC,UBE2M,YBX3,ZC3H12A,ZFAND6,ZNF268	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
GO:0071359	GO	BP	cellular response to dsRNA	ADAR,AGO1,AGO2,AGO3,AGO4,CAV1,COLEC12,DGCR8,DICER1,DROSHA,FLOT1,HNRNPA2B1,IFIT1,IFNB1,LIN28A,LIN28B,MAVS,MB21D1,METTL3,MUL1,NPM1,PRKRA,RALB,SMAD1,SMAD2,SMAD3,SNIP1,SRRT,TARBP2,TERT,TMEM173,ZCCHC11	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a double-stranded RNA stimulus.
GO:0071360	GO	BP	cellular response to exogenous dsRNA	CAV1,COLEC12,FLOT1,IFIT1,IFNB1,MAVS,MB21D1,MUL1,RALB,TMEM173	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.
GO:0071364	GO	BP	cellular response to epidermal growth factor stimulus	DAB2IP,EEF1A1,EGFR,GAREM,INPP5K,IQGAP1,MED1,PDPK1,PLCG1,SNAI2,SOX9,STAT5B,TDGF1,VIL1,ZPR1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
GO:0071371	GO	BP	cellular response to gonadotropin stimulus	LHCGR,NOTCH1,NSMF,PAX8,WT1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
GO:0071377	GO	BP	cellular response to glucagon stimulus	ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,GCG,GCGR,GNAS,GNB1,GNB2,GNB3,GNB4,GNG10,GNG11,GNG12,GNG13,GNG2,GNG3,GNG4,GNG5,GNG7,GNG8,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
GO:0071379	GO	BP	cellular response to prostaglandin stimulus	ADCY6,AKR1C2,AKR1C3,GNAS,GNB1,GNG2,PTGER2,PTGFR,TNFSF4	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin stimulus.
GO:0071380	GO	BP	cellular response to prostaglandin E stimulus	ADCY6,GNAS,GNB1,GNG2,PTGER2,TNFSF4	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
GO:0071383	GO	BP	cellular response to steroid hormone stimulus	AKR1C3,ANXA1,AQP1,ATP1A1,ATP1A2,ATP1A3,BCAS3,BMP4,BMP7,CCDC62,CRHBP,EGFR,ESR1,GPER1,H2AFZ,IRG1,ISL1,KAT5,KLF9,LEF1,MED1,MGARP,MSN,MYOD1,MYOG,NCOA3,NKX3-1,NR3C1,NRIP1,OCSTAMP,OR51E2,PELP1,PGRMC2,RAMP3,RARA,REST,ROCK2,RUVBL2,SFR1,SFRP1,SRC,TRIM24,UBE2L3,UGT3A2,URI1,WBP2,ZNF703	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
GO:0071384	GO	BP	cellular response to corticosteroid stimulus	AKR1C3,ANXA1,AQP1,GPER1,ISL1,KLF9,REST,UBE2L3	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.
GO:0071385	GO	BP	cellular response to glucocorticoid stimulus	ANXA1,AQP1,ISL1,KLF9,REST,UBE2L3	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
GO:0071391	GO	BP	cellular response to estrogen stimulus	BCAS3,CCDC62,CRHBP,EGFR,ESR1,GPER1,H2AFZ,KAT5,MYOD1,MYOG,NCOA3,NRIP1,OCSTAMP,PELP1,RAMP3,RARA,RUVBL2,SFR1,SFRP1,TRIM24,UGT3A2,WBP2,ZNF703	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
GO:0071392	GO	BP	cellular response to estradiol stimulus	CCDC62,CRHBP,EGFR,ESR1,GPER1,H2AFZ,KAT5,MYOD1,MYOG,NCOA3,NRIP1,RAMP3,RUVBL2,ZNF703	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
GO:0071396	GO	BP	cellular response to lipid	ABCB4,ABL2,ADAM9,ADCY1,ADCY2,ADCY3,ADCY5,ADCY6,ADNP2,AKR1C2,AKR1C3,ANKRD1,ANXA1,AQP1,ATP1A1,ATP1A2,ATP1A3,AXL,B2M,BCAS3,BMP4,BMP7,BRINP3,CACTIN,CCDC62,CCL2,CCL3,CCL5,CD14,CD6,CDC73,CRHBP,CTR9,CXCL10,CXCL8,CYP24A1,CYP7A1,DAB2IP,DGAT2,DYNAP,EGFR,EPHA3,ESR1,FFAR2,FFAR3,FZD10,FZD4,FZD7,GNAI1,GNAS,GNB1,GNG2,GPER1,GPLD1,GSTP1,H2AFZ,HCK,HTRA2,IL10,IL18,IL1B,IL6,IRAK1,IRG1,ISL1,KAT5,KCNK4,KLF9,KMT2E,LBP,LEF1,LILRB2,LRP6,LTK,LY96,LYN,MAPK14,MAPK8,MED1,MEF2C,MGARP,MLC1,MSN,MTDH,MYOD1,MYOG,NCOA3,NDUFA13,NFKB1,NFKBIL1,NKX3-1,NLRP3,NR1D1,NR1H3,NR1H4,NR3C1,NRIP1,OCSTAMP,OGT,OR51E2,OSBPL7,PAF1,PAX2,PDE4B,PDK3,PDK4,PELP1,PGRMC2,PID1,PIM1,PRKCE,PTCH1,PTGER2,PTGFR,PTK2B,PTK6,PTK7,PTPN22,PYCARD,RAMP3,RARA,REST,RET,ROCK2,RORA,RORB,RORC,RUVBL2,SBNO2,SCARB1,SERPINE1,SETX,SFR1,SFRP1,SHPK,SMO,SNW1,SRC,STAP1,TBX1,TESC,TGFB1,TICAM2,TLR2,TLR4,TNF,TNFAIP3,TNFRSF1B,TNFSF4,TNIP2,TNIP3,TRAF6,TRIM24,TWF2,UBE2L3,UGT3A2,URI1,VDR,VIMP,WBP2,WNT10B,WNT11,WNT2,WNT3,WNT3A,WNT5A,WNT5B,WNT6,WNT8B,WNT9A,WNT9B,XBP1,ZC3H12A,ZNF35,ZNF703	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.
GO:0071397	GO	BP	cellular response to cholesterol	CYP7A1,GPLD1,LRP6,MLC1,OSBPL7,PTCH1,SMO	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
GO:0071398	GO	BP	cellular response to fatty acid	ADCY6,AKR1C2,AKR1C3,DGAT2,FFAR2,FFAR3,GNAS,GNB1,GNG2,KCNK4,NR1H4,OR51E2,PDK3,PDK4,PID1,PTGER2,PTGFR,TNFSF4,ZC3H12A	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.
GO:0071404	GO	BP	cellular response to low-density lipoprotein particle stimulus	CD36,CD81,CD9,CDH13,FCER1G,ITGB1,ITGB2,SYK	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
GO:0071407	GO	BP	cellular response to organic cyclic compound	AANAT,ABCB4,ABL1,ADAR,ADCY1,ADCY2,ADCY3,ADCY5,ADCY6,AGO1,AGO2,AGO3,AGO4,AKAP6,AKAP7,AKAP9,AKR1C3,ANXA1,AOC1,APLP1,AQP1,ATP1A1,ATP1A2,ATP1A3,ATP2B4,BAD,BCAS3,BLM,BMP4,BMP7,BRCA1,CASQ2,CAV1,CCDC62,CCL2,CCL3,CCL5,CDH1,CFTR,CIB2,COLEC12,CRHBP,CTNNA1,CTNNB1,CYP1A1,CYP1B1,CYP24A1,CYP7A1,DGCR8,DIAPH1,DICER1,DMTN,DRD1,DRD5,DROSHA,DYNAP,EGFR,EGR1,ESR1,EZR,FLOT1,FOLR1,FOLR2,GABRB1,GABRB2,GABRB3,GABRG2,GNAI1,GNAS,GNB1,GNG2,GPER1,GPLD1,GSTM2,H2AFZ,HCN1,HCN2,HCN4,HNRNPA2B1,HRH1,HSP90B1,IFIT1,IFNB1,IGFBP5,IL18,IL1B,IMPACT,INPP5K,IRG1,ISL1,JUP,KAT5,KCNE1,KCNQ1,KLF9,LEF1,LIN28A,LIN28B,LRP6,LRRK2,MAVS,MB21D1,MED1,MEF2C,METTL3,MGARP,MLC1,MSN,MUL1,MYOD1,MYOG,NCOA3,NFKB1,NKX3-1,NPM1,NR3C1,NR4A3,NRIP1,OCSTAMP,OR51E2,OSBPL7,P2RX4,P2RY11,P2RY12,PARK2,PDE2A,PDE3A,PDE4B,PDE4D,PDGFB,PDXP,PELP1,PGRMC2,PIM1,PPP1R9B,PRKACA,PRKRA,PTCH1,RAD51,RALB,RAMP3,RAP1A,RAP1B,RAPGEF1,RAPGEF2,RAPGEF3,RARA,RELA,REST,ROCK2,RORA,RORC,RUVBL2,RYR1,RYR2,RYR3,SFR1,SFRP1,SHMT1,SIRT2,SLC26A3,SLC26A6,SLC8A1,SLC9A1,SMAD1,SMAD2,SMAD3,SMO,SNCA,SNIP1,SPIDR,SRC,SRRT,SSH1,TARBP2,TERT,TGFB1,TIPARP,TMEM173,TNF,TRIM24,TRPV1,UBE2L3,UGT3A2,URI1,VDR,WBP2,ZC3H12A,ZCCHC11,ZNF703	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
GO:0071420	GO	BP	cellular response to histamine	AOC1,DIAPH1,GABRB1,GABRB2,GABRB3,GABRG2,HRH1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.
GO:0071425	GO	BP	hematopoietic stem cell proliferation	ARIH2,CD34,ETV6,MECOM,RUNX1,SFRP2,WNT10B,WNT2B,WNT5A	The expansion of a hematopoietic stem cell population by cell division. A hematopoietic stem cell is a stem cell from which all cells of the lymphoid and myeloid lineages develop.
GO:0071426	GO	BP	ribonucleoprotein complex export from nucleus	AGFG1,ALKBH5,ALYREF,BUD13,CDC40,CHTOP,CPSF1,CPSF2,CPSF3,DDX19B,DDX25,DDX39A,DDX39B,DHX38,EIF4E,EIF5A,FIP1L1,FYTTD1,GLE1,HHEX,HNRNPA2B1,LUZP4,MAGOH,NCBP1,NCBP2,NMD3,NUP107,NUP133,NUP160,NXF1,NXF2,NXF3,NXF5,PABPN1,POLDIP3,RAE1,RAN,RBM8A,RNPS1,RPS15,SARNP,SLBP,SMG1,SMG5,SMG6,SMG7,SRRM1,SRSF1,SRSF10,SRSF11,SRSF2,SRSF3,SRSF4,SRSF5,SRSF6,SRSF7,SRSF9,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TPR,TSC1,U2AF1,U2AF2,UPF1,UPF2,UPF3B,XPO1,XPOT,ZC3H11A,ZC3H3	The directed movement of a ribonucleoprotein complex from the nucleus to the cytoplasm.
GO:0071428	GO	BP	rRNA-containing ribonucleoprotein complex export from nucleus	NMD3,RAN,RPS15,TSC1,XPO1	The directed movement of a ribonucleoprotein complex that contains ribosomal RNA from the nucleus to the cytoplasm.
GO:0071435	GO	BP	potassium ion export	KCNA5,KCND3,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP2,KCNK18,KCNQ1	The directed movement of potassium ions out of a cell or organelle.
GO:0071436	GO	BP	sodium ion export	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,FXYD2,SLC8A1,SLC9A1	The directed movement of sodium ions out of a cell or organelle.
GO:0071437	GO	CC	invadopodium	DPP4,FAP,FSCN1,ITGA3,ITGB1,NOX1,PAK1,RUFY3,WASH1	A cell projection that emerges from the ECM-facing surface of a cell, is enriched in actin and associated cytoskeletal proteins, and displays localized proteolytic activity toward the substrate.
GO:0071438	GO	CC	invadopodium membrane	DPP4,FAP,ITGA3,ITGB1,NOX1	The portion of the plasma membrane surrounding an invadopodium.
GO:0071439	GO	CC	clathrin complex	BAIAP2L2,CLTA,CLTC,VPS33A,VPS33B,VPS41	A protein complex that consists of three clathrin heavy chains and three clathrin light chains, organized into a symmetrical three-legged structure called a triskelion. In clathrin-coated vesicles clathrin is the main component of the coat and forms a polymeric mechanical scaffold on the vesicle surface.
GO:0071453	GO	BP	cellular response to oxygen levels	ACAA2,ADAM8,AQP1,ARNT,ATG7,BACH1,BMP7,BNIP3,BNIP3L,CA9,CAV1,CITED2,CPEB1,CPEB2,CPEB4,CREBBP,CUL2,EGLN1,EGLN2,EGLN3,EP300,EPAS1,EPO,FABP1,FAM162A,FAS,FMN2,FOXO1,GATA6,HIF1A,HIF1AN,HIF3A,HIPK2,HP1BP3,HYOU1,KCND2,MGARP,MTOR,NDNF,NKX3-1,NOTCH1,NPEPPS,OPRD1,P4HB,PDK1,PDK3,PICK1,PINK1,PLK3,PTGIS,RBPJ,RBX1,RGCC,RORA,RPS27A,SIRT1,SIRT2,SLC8A3,STOX1,SUV39H1,SUV39H2,TBL2,TCEB1,TCEB2,TERT,TIGAR,TSC1,TWIST1,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBQLN1,VEGFA,VHL	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of oxygen.
GO:0071456	GO	BP	cellular response to hypoxia	ACAA2,ADAM8,AQP1,ARNT,BACH1,BMP7,BNIP3,BNIP3L,CA9,CITED2,CPEB1,CPEB2,CREBBP,CUL2,EGLN1,EGLN2,EGLN3,EP300,EPAS1,EPO,FABP1,FAM162A,FMN2,GATA6,HIF1A,HIF1AN,HIF3A,HIPK2,HP1BP3,HYOU1,KCND2,MGARP,MTOR,NDNF,NKX3-1,NOTCH1,NPEPPS,OPRD1,P4HB,PDK1,PDK3,PINK1,PLK3,PTGIS,RBPJ,RBX1,RGCC,RORA,RPS27A,SIRT1,SIRT2,SLC8A3,STOX1,SUV39H1,SUV39H2,TBL2,TCEB1,TCEB2,TERT,TIGAR,TWIST1,UBA52,UBB,UBC,UBE2D1,UBE2D2,UBE2D3,UBQLN1,VEGFA,VHL	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
GO:0071458	GO	CC	integral component of cytoplasmic side of endoplasmic reticulum membrane	HM13,PKD2,SPPL2A,SPPL2B,SPPL2C,SPPL3	The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the cytoplasmic side of the membrane.
GO:0071459	GO	BP	protein localization to chromosome, centromeric region	AURKB,CASC5,CDK1,CENPA,CHAMP1,GSG2,MTBP,RB1,RCC2,SPDL1,ZW10	Any process in which a protein is transported to, or maintained at, the centromeric region of a chromosome.
GO:0071466	GO	BP	cellular response to xenobiotic stimulus	AADAC,ABHD10,ABHD14B,ACSM1,ACSM2B,ACSS1,ACSS2,ACY1,ACY3,ADH1A,ADH1B,ADH1C,ADH4,ADH5,ADH6,ADH7,AHCY,AHR,AKR1A1,AKR1C1,AKR7A2,AKR7A3,AKR7L,ALDH1A1,ALDH1B1,ALDH2,ALDH3A1,AOC1,AOC2,AOC3,APOBEC3A,AS3MT,BPHL,BPNT1,CES1,CES2,CHAC1,CHAC2,CMBL,CNDP2,COMT,CRYZ,CYP11A1,CYP11B1,CYP11B2,CYP17A1,CYP19A1,CYP1A1,CYP1A2,CYP1B1,CYP21A2,CYP24A1,CYP26A1,CYP26B1,CYP26C1,CYP27A1,CYP27B1,CYP2A13,CYP2A6,CYP2B6,CYP2C18,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP2D7,CYP2E1,CYP2F1,CYP2J2,CYP2R1,CYP2S1,CYP2U1,CYP2W1,CYP39A1,CYP3A4,CYP3A43,CYP3A5,CYP3A7,CYP46A1,CYP4A11,CYP4B1,CYP4F11,CYP4F12,CYP4F2,CYP4F22,CYP4F3,CYP4F8,CYP4V2,CYP51A1,CYP7A1,CYP7B1,CYP8B1,DPEP1,EPHX1,EPHX2,ESD,FDX1,FDX1L,FDXR,FMO1,FMO2,FMO3,GCLC,GCLM,GGCT,GGT1,GGT2,GLYAT,GRIN1,GSS,GSTA1,GSTA2,GSTA3,GSTA4,GSTK1,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTO1,GSTO2,GSTP1,GSTT2B,GSTZ1,HNF4A,HPGDS,LPO,MAOA,MAOB,MAT1A,MAT2A,MAT2B,MGST1,MGST2,MGST3,MTR,MTRR,NAT1,NAT2,NNMT,NQO1,NR1I2,OPLAH,PAOX,PAPSS1,PAPSS2,PTGIS,PTGS1,RORA,RORC,S100A12,SLC26A1,SLC26A2,SLC35B2,SLC35B3,SLC35D1,SMOX,SULT1A1,SULT1A2,SULT1A3,SULT1B1,SULT1C2,SULT1C4,SULT1E1,SULT2A1,SULT2B1,SULT4A1,TBXAS1,TPMT,UGDH,UGP2,UGT1A1,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9,UGT2B11,UGT2B15,UGT2B28,UGT2B4	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a xenobiotic compound stimulus. Xenobiotic compounds are compounds foreign to living organisms.
GO:0071467	GO	BP	cellular response to pH	ASIC1,CHP1,GPLD1,HVCN1,HYAL1,IMPACT,INSRR,KCNK18,KCNK4,NOX1,PKD1L3,PKD2L1,RAB11B,RAB11FIP5,SLC9A1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus. pH is a measure of the acidity or basicity of an aqueous solution.
GO:0071468	GO	BP	cellular response to acidic pH	CHP1,IMPACT,NOX1,PKD1L3,PKD2L1,RAB11B,RAB11FIP5,SLC9A1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus with pH < 7. pH is a measure of the acidity or basicity of an aqueous solution.
GO:0071470	GO	BP	cellular response to osmotic stress	AQP1,ARHGEF2,CAB39,CAPN3,DDX3X,EPO,MYLK,PKD2,RCSD1,SERPINB6,SLC12A6,STK39,TRPV4,YBX3	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.
GO:0071474	GO	BP	cellular hyperosmotic response	AQP1,ARHGEF2,EPO,RCSD1,YBX3	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.
GO:0071476	GO	BP	cellular hypotonic response	CAB39,MYLK,SLC12A6,STK39,TRPV4	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hypotonic environment, i.e. an environment with a lower concentration of solutes than the organism or cell.
GO:0071478	GO	BP	cellular response to radiation	ACTR5,ADIRF,AQP1,ATF4,ATM,ATR,AURKB,BAK1,BLM,CALM1,CAMKMT,CASP9,CDC25A,CDKN1A,CERS1,CHEK1,CLOCK,CNGA1,CNGB1,CREBBP,CRIP1,CRY1,CRY2,CRYAB,CUL4B,DDB1,DDB2,ECT2,EEF1D,EIF2AK4,EIF2S1,EP300,ERCC4,FBXW7,FIGNL1,FNTA,FNTB,GADD45A,GNAT1,GNB1,GNB5,GNGT1,GRB2,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HIST3H2A,HUS1,HYAL1,HYAL2,HYAL3,IFI16,IMPACT,INO80,INTS7,KDM1A,KDM4D,MAPK14,MC1R,METAP1,METAP2,MFAP4,MME,N4BP1,NEDD4,NET1,NIPBL,NMT1,NMT2,NOC2L,PCNA,PDE6A,PDE6B,PDE6G,POLD1,PPEF1,PPID,PRKCA,PRKCQ,PTPRK,RAD1,RAD51,RAD51AP1,RAD9A,RCVRN,RGS9,RGS9BP,RHBDD1,RHNO1,RHO,RHOB,RUVBL2,SAG,SIRT1,SLC24A1,SPIDR,STK11,SWI5,TLK2,TMEM109,TMEM161A,TP53,TRIAP1,TRPM1,TSPYL5,USP28,USP47,WRN,XPC,YAP1,YY1,ZBTB1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
GO:0071479	GO	BP	cellular response to ionizing radiation	ATM,ATR,BLM,CDKN1A,CLOCK,CRYAB,ECT2,EEF1D,FIGNL1,GADD45A,GRB2,HUS1,IFI16,INO80,INTS7,KDM1A,KDM4D,MAPK14,NET1,NIPBL,RAD1,RAD51,RAD51AP1,RAD9A,RHNO1,RHOB,SIRT1,SPIDR,SWI5,TLK2,TMEM109,TP53,TSPYL5,WRN,YAP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
GO:0071480	GO	BP	cellular response to gamma radiation	ATM,ATR,CRYAB,KDM1A,TLK2,TMEM109,TSPYL5,WRN,YAP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
GO:0071482	GO	BP	cellular response to light stimulus	ACTR5,AQP1,ATF4,ATR,AURKB,BAK1,CALM1,CAMKMT,CASP9,CDC25A,CDKN1A,CERS1,CHEK1,CNGA1,CNGB1,CREBBP,CRIP1,CRY1,CRY2,CUL4B,DDB1,DDB2,EIF2AK4,EIF2S1,EP300,ERCC4,FBXW7,FNTA,FNTB,GNAT1,GNB1,GNB5,GNGT1,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HIST3H2A,HYAL1,HYAL2,HYAL3,IMPACT,INO80,KDM1A,MC1R,METAP1,METAP2,MFAP4,MME,N4BP1,NEDD4,NMT1,NMT2,NOC2L,PCNA,PDE6A,PDE6B,PDE6G,POLD1,PPEF1,PPID,PRKCA,PRKCQ,PTPRK,RCVRN,RGS9,RGS9BP,RHBDD1,RHNO1,RHO,RUVBL2,SAG,SIRT1,SLC24A1,STK11,TMEM161A,TRIAP1,TRPM1,USP28,USP47,XPC,YY1,ZBTB1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
GO:0071493	GO	BP	cellular response to UV-B	CDKN1A,CRIP1,HYAL1,HYAL2,HYAL3,MFAP4,MME,STK11	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-B radiation stimulus. UV-B radiation (UV-B light) spans the wavelengths 280 to 315 nm.
GO:0071496	GO	BP	cellular response to external stimulus	ALB,ANKRD1,AOC1,AQP1,ASNS,ATF4,ATG14,ATG7,BECN1,BHLHA15,CARTPT,CBS,CDKN1A,CDKN2B,CHMP1A,CNN2,CPEB4,CYP24A1,DAP,DEPDC5,EHMT2,EIF2AK2,EIF2AK3,EIF2AK4,EIF2S1,FADS1,FNIP1,FOLR1,FOLR2,FOXA2,FOXO1,GAS2L1,GAS6,GLRX2,HABP4,HSPA5,HSPA8,IFI16,IMPACT,INHBB,KCNB1,KCNK4,KIAA1324,KIF26A,KLF10,LRRK2,MIOS,MTMR3,MTOR,MYBBP1A,NCOA1,NPRL2,NPRL3,NR1H4,NR4A2,NUAK2,NUDT1,NUPR1L,PCSK9,PDE2A,PDK2,PDK4,PICK1,PIK3C3,PIK3R4,PIM1,PMAIP1,PPP1R9B,PRKAA1,PRKAA2,PTGER4,RALB,RNF152,RPTOR,RRAGA,RRAGB,RRAGC,RRP8,SEH1L,SH3GLB1,SIRT1,SIRT2,SLC9A1,SOX9,SREBF1,SREBF2,TBL2,TP53,TSC1,ULK1,USF1,USF2,USP33,VDR,WDR24,WDR59,WRN,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external stimulus.
GO:0071498	GO	BP	cellular response to fluid shear stress	ASS1,HDAC3,KLF2,KLF4,MAP2K5,MAPK7,MEF2C,MTSS1,NFE2L2,PKD2,SREBF2,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
GO:0071499	GO	BP	cellular response to laminar fluid shear stress	ASS1,KLF2,KLF4,MAP2K5,MAPK7,NFE2L2,SREBF2,XBP1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers.
GO:0071503	GO	BP	response to heparin	AOC1,EGR1,GPIHBP1,SFRP1,SLIT2,SOX9	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus.
GO:0071504	GO	BP	cellular response to heparin	AOC1,EGR1,SFRP1,SLIT2,SOX9	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus.
GO:0071526	GO	BP	semaphorin-plexin signaling pathway	ARHGDIA,FARP2,MET,NRP1,NRP2,PLXNA2,PLXNA3,PLXNA4,PLXNB1,PLXNB2,PLXNB3,PLXND1,RAC1,SEMA3A,SEMA3E,SEMA3F,SEMA4C,SEMA4D	A series of molecular signals generated as a consequence of a semaphorin receptor (composed of a plexin and a neurophilin) binding to a semaphorin ligand.
GO:0071539	GO	BP	protein localization to centrosome	BBS4,C2CD3,CCDC14,CEP131,CEP83,CSNK1D,DCTN2,HOOK3,KIAA0753,PCM1,PIBF1,SNX10,SPAG5,STIL	A process in which a protein is transported to, or maintained at, the centrosome.
GO:0071542	GO	BP	dopaminergic neuron differentiation	CSNK1E,FGF8,FOXA2,LMX1A,LMX1B,LRP6,NR4A2,OTX2,PHOX2A,PHOX2B,PITX3,RYK,VEGFA,WNT1,WNT3A,WNT5A	The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
GO:0071545	GO	BP	inositol phosphate catabolic process	IMPA1,IMPA2,INPP5K,NUDT3,PTEN,SYNJ1	The chemical reactions and pathways resulting in the breakdown of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.
GO:0071546	GO	CC	pi-body	ASZ1,DDX4,PIWIL2,TDRD1,TDRD5,TDRKH	A P granule that contains the PIWIL2-TDRD1 module, a set of proteins that act in the primary piRNA pathway. The pi-body corresponds to the cementing material between mitochondria found in gonocytes.
GO:0071547	GO	CC	piP-body	DDX4,MAEL,PIWIL4,TDRD9,TDRKH	A P granule that contains the PIWIL4-TDRD9 module, a set of proteins that act in the secondary piRNA pathway.
GO:0071550	GO	BP	death-inducing signaling complex assembly	CASP8,FADD,RIPK1,TNF,TNFRSF1A,TRADD,TRAF2	A process of protein complex assembly in which the arrangement and bonding together of the set of components that form the protein complex is mediated by a death domain (DD) interaction, as part of the extrinsic apoptotic signaling pathway.
GO:0071556	GO	CC	integral component of lumenal side of endoplasmic reticulum membrane	BCAP31,CALR,CANX,CD74,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HM13,PKD2,SPPL2A,SPPL2B,SPPL2C,SPPL3,TAPBP	The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane.
GO:0071559	GO	BP	response to transforming growth factor beta	ACVR1,ACVRL1,ADAM9,ANKRD1,ARHGEF18,ARRB2,ATP1B4,BAMBI,BMPR1A,CBL,CCNC,CCNK,CCNT1,CCNT2,CDH5,CDK8,CDK9,CDKN2B,CGN,CITED1,CLDN5,COL1A2,COL3A1,E2F4,E2F5,EID2,ENG,F11R,FERMT2,FKBP1A,FMOD,FNTA,FOS,FOXH1,FURIN,GCNT2,GDF10,GDF15,GDF5,GDF9,HDAC1,HPGD,HYAL2,ID1,ITGB5,JUN,JUNB,KLF10,LEFTY1,LEFTY2,LTBP2,MAPK7,MEF2C,MEN1,MTMR4,MYC,NCOR1,NCOR2,NEDD4L,NEDD8,NLK,PARD3,PARD6A,PARP1,PDCD5,PDGFB,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRKCZ,PTK2,PTPRK,PXN,RBL1,RHOA,RNF111,RPS27A,RUNX3,SERPINE1,SKI,SKIL,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD7,SMURF1,SMURF2,SNW1,SOX5,SOX6,SOX9,SP1,SRC,STRAP,STUB1,TFDP1,TFDP2,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1,TGIF1,TGIF2,TRIM33,UBA52,UBB,UBC,UBE2D1,UBE2D3,UBE2M,UCHL5,USP15,USP9X,USP9Y,WWOX,WWTR1,XCL1,XPO1,ZFHX3,ZFYVE9,ZYX	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
GO:0071560	GO	BP	cellular response to transforming growth factor beta stimulus	ACVR1,ACVRL1,ADAM9,ANKRD1,ARHGEF18,ARRB2,ATP1B4,BAMBI,BMPR1A,CBL,CCNC,CCNK,CCNT1,CCNT2,CDH5,CDK8,CDK9,CDKN2B,CGN,CITED1,CLDN5,COL1A2,COL3A1,E2F4,E2F5,EID2,ENG,F11R,FERMT2,FKBP1A,FMOD,FNTA,FOS,FOXH1,FURIN,GCNT2,GDF10,GDF15,GDF5,GDF9,HDAC1,HPGD,HYAL2,ID1,ITGB5,JUN,JUNB,KLF10,LEFTY1,LEFTY2,LTBP2,MAPK7,MEF2C,MEN1,MTMR4,MYC,NCOR1,NCOR2,NEDD4L,NEDD8,NLK,PARD3,PARD6A,PARP1,PDCD5,PDGFB,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRKCZ,PTK2,PTPRK,PXN,RBL1,RHOA,RNF111,RPS27A,SERPINE1,SKI,SKIL,SMAD1,SMAD2,SMAD3,SMAD4,SMAD5,SMAD7,SMURF1,SMURF2,SNW1,SOX5,SOX6,SOX9,SP1,SRC,STRAP,STUB1,TFDP1,TFDP2,TGFB1,TGFB2,TGFB3,TGFBR1,TGFBR2,TGFBR3,TGFBRAP1,TGIF1,TGIF2,TRIM33,UBA52,UBB,UBC,UBE2D1,UBE2D3,UBE2M,UCHL5,USP15,USP9X,USP9Y,WWOX,WWTR1,XCL1,XPO1,ZFYVE9,ZYX	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
GO:0071564	GO	CC	npBAF complex	ACTL6A,ARID1A,PHF10,SMARCA2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD3,SMARCE1	A SWI/SNF-type complex that is found in neural stem or progenitor cells, and in human contains actin and proteins encoded by the ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, PHF10/BAF45A, ACTL6A/BAF53A genes. The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells.
GO:0071565	GO	CC	nBAF complex	ACTL6B,ARID1A,DPF1,DPF3,SMARCA2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD3,SMARCE1	A SWI/SNF-type complex that is found in post-mitotic neurons, and in human contains actin and proteins encoded by the ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, DPF1/BAF45B, DPF3/BAF45C, ACTL6B/BAF53B genes. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth.
GO:0071569	GO	BP	protein ufmylation	CDK5RAP3,DDRGK1,UBA5,UFC1,UFL1,UFM1	Covalent attachment of the ubiquitin-like protein UFM1 to another protein.
GO:0071577	GO	BP	zinc II ion transmembrane transport	SLC11A2,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC39A1,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6	A process in which a zinc II ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0071593	GO	BP	lymphocyte aggregation	ADA,ADAM17,AMICA1,ANXA1,ATP7A,BATF,BTN3A1,CASP8,CCL19,CCL21,CCR7,CD1C,CD1D,CD2,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD7,CD74,CD80,CD86,CD8A,CD8B,CEBPB,CHD7,CLEC7A,CTPS1,CXADR,DDOST,DLL4,DOCK8,DPP4,EIF2AK4,ELF4,EOMES,F2RL1,FADD,FKBP1A,FOXP1,FOXP3,GLI3,HLA-E,HMGB1,HSPD1,ICAM1,ICOSLG,IL12B,IL2,IL6,INS,IRF4,ITGAL,ITK,JAG2,KIF13B,KIT,LAT,LCK,LCP1,LEF1,LEP,LEPR,LFNG,LIG4,LILRB1,LY9,MICA,MICB,NCK1,NCK2,NHEJ1,PIK3CD,PIK3CG,PPP3CA,PPP3CB,PRLR,PTGER4,PTPN2,PTPN22,PTPRC,RAC2,RAG1,RAG2,RHOH,RIPK3,RORA,RORC,RSAD2,SHH,SLA2,SLAMF6,SLC11A1,SOX4,STOML2,THEMIS,TNFRSF4,TNFSF14,TNFSF18,TNFSF4,TREML2,ZAP70,ZFPM1	The adhesion of one lymphocyte to one or more other lymphocytes via adhesion molecules.
GO:0071599	GO	BP	otic vesicle development	AHI1,CEP290,FGFR2,PROX1,SOX9	The process whose specific outcome is the progression of the otic vesicle over time, from its formation to the mature structure. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.
GO:0071616	GO	BP	acyl-CoA biosynthetic process	ACACA,ACLY,ACOT1,ACOT11,ACOT12,ACOT13,ACOT2,ACOT4,ACOT6,ACOT7,ACOT8,ACOT9,ACSBG1,ACSBG2,ACSF2,ACSF3,ACSL1,ACSL3,ACSL4,ACSL5,ACSL6,ACSS1,AGK,DLD,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FASN,HACD1,HACD2,HSD17B12,MLYCD,OLAH,PDHA1,PDHB,PDHX,PPT1,PPT2,SCD,SLC25A1,TECR,THEM4,THEM5	The chemical reactions and pathways resulting in the formation of acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with an acyl group.
GO:0071617	GO	MF	lysophospholipid acyltransferase activity	ABHD5,AGPAT1,AGPAT2,AGPAT3,AGPAT4,AGPAT5,LPCAT4	Catalysis of the transfer of acyl groups from an acyl-CoA to a lysophospholipid.
GO:0071621	GO	BP	granulocyte chemotaxis	ADGRE2,AMICA1,ANXA1,CCL11,CCL13,CCL24,CCL3,CCL5,CCL7,CKLF,CXADR,CXCL3,CXCL8,CXCR2,EDN2,EDN3,GBF1,ITGB2,LGALS3,NCKAP1L,PDE4B,PIK3CD,PIK3CG,PIP5K1C,PLA2G1B,S100A12,S100A8,S100A9,SAA1,SCG2,SYK,TGFB2,VEGFA,XCL1	The movement of a granulocyte in response to an external stimulus.
GO:0071622	GO	BP	regulation of granulocyte chemotaxis	C1QBP,C5AR2,CAMK1D,CCL19,CCL21,CCL5,CCR7,CD74,CMKLR1,CSF1,CXCL8,DAPK2,JAM3,MPP1,NCKAP1L,RAC1,RAC2,RARRES2,S100A14,S100A7,SLIT2,THBS1,THBS4,TIRAP,XCL1	Any process that modulates the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.
GO:0071624	GO	BP	positive regulation of granulocyte chemotaxis	C1QBP,CAMK1D,CCL19,CCL21,CCR7,CD74,CXCL8,DAPK2,NCKAP1L,RAC1,RAC2,S100A14,S100A7,THBS4,TIRAP,XCL1	Any process that increases the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.
GO:0071625	GO	BP	vocalization behavior	CNTNAP2,MYH14,NLGN3,NLGN4X,NLGN4Y,NRXN1,NRXN2,NRXN3,SHANK1,SHANK2,SHANK3	The behavior in which an organism produces sounds by a mechanism involving its respiratory system.
GO:0071634	GO	BP	regulation of transforming growth factor beta production	ATP6AP2,CD24,CD34,CD46,CDH3,FURIN,GATA6,HIF1A,LGALS9,PTGS2,SERPINF2,SMAD3,SMAD4,TGFB2,THBS1,XCL1	Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta.
GO:0071636	GO	BP	positive regulation of transforming growth factor beta production	ATP6AP2,CD34,CD46,LGALS9,PTGS2,SERPINF2,THBS1,XCL1	Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta.
GO:0071637	GO	BP	regulation of monocyte chemotactic protein-1 production	ADIPOQ,APOD,C1QTNF3,GSTP1,IL1B,LGALS9,TWIST1	Any process that modulates the frequency, rate, or extent of production of monocyte chemotactic protein-1.
GO:0071649	GO	BP	regulation of chemokine (C-C motif) ligand 5 production	ADCYAP1,DDX3X,IL10,MAVS,MUL1,TICAM2	Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.
GO:0071675	GO	BP	regulation of mononuclear cell migration	BMP5,CCL5,CMKLR1,CSF1,LGALS3,RARRES2,SLIT2,THBS1,TNF	Any process that modulates the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
GO:0071679	GO	BP	commissural neuron axon guidance	EPHB2,NFIB,NRP1,RYK,VEGFA	The process in which the migration of an axon growth cone of a commissural neuron is directed to its target in the brain in response to a combination of attractive and repulsive cues.
GO:0071681	GO	BP	cellular response to indole-3-methanol	BRCA1,CDH1,CTNNA1,CTNNB1,JUP	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an indole-3-methanol stimulus.
GO:0071682	GO	CC	endocytic vesicle lumen	APOA1,APOB,APOE,CALR,HBA1,HBB,HP,HPX,HSP90AA1,HSP90B1,HSPH1,HYOU1,LTF,SAA1,SCGB3A2,SPARC	The volume enclosed by the membrane of an endocytic vesicle.
GO:0071694	GO	BP	maintenance of protein location in extracellular region	CER1,FBN1,FBN2,LTBP1,NBL1	Any process in which a protein is maintained in a specific location within the extracellular region and is prevented from moving elsewhere.
GO:0071695	GO	BP	anatomical structure maturation	ACVRL1,BMP2,FGFR3,GH1,IGF1,LYL1,PAX2,PLXNB1,RHOA,RYR1,S1PR1,SEMA4D,SPINK5,TGFB2	A developmental process, independent of morphogenetic (shape) change, that is required for an anatomical structure to attain its fully functional state.
GO:0071709	GO	BP	membrane assembly	ANK3,ANXA2,CAV1,CAV2,CAV3,EMP2,FLOT1,FLOT2,IL1RAPL1,LRP4,NLGN1,NLGN2,NLGN3,NLGN4X,NRXN1,NRXN2,PACSIN2,PTEN,PTPRD,RFTN1,S100A10,SPTBN1,STX2	The aggregation, arrangement and bonding together of a set of components to form a membrane.
GO:0071711	GO	BP	basement membrane organization	COL4A1,CTSS,FLRT2,HPN,NID1,NID2,RAMP2	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.
GO:0071712	GO	BP	ER-associated misfolded protein catabolic process	DERL1,RNF5,TOR1A,UFD1L,VCP	The chemical reactions and pathways resulting in the breakdown of misfolded proteins transported from the endoplasmic reticulum and targeted to cytoplasmic proteasomes for degradation.
GO:0071731	GO	BP	response to nitric oxide	AQP1,CCL19,CCR7,CDK2,DPEP1,EGLN1,FOXO1,GUCY1B3,KCNC2,MMP3,MT3,MTR	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
GO:0071732	GO	BP	cellular response to nitric oxide	AQP1,CDK2,DPEP1,FOXO1,GUCY1B3,KCNC2,MMP3,MT3,MTR	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
GO:0071773	GO	BP	cellular response to BMP stimulus	ACVR1,ACVR2A,ACVR2B,ACVRL1,ADAMTS12,ADAMTS7,BMP10,BMP2,BMP4,BMP6,BMP7,BMPR1A,BMPR1B,BMPR2,CER1,CHRD,CHRDL1,DLX5,ENG,FAM83G,FSTL1,GDF2,GDF6,GDF7,GREM2,HFE,HFE2,MAPK3,MEGF8,NOG,PHOX2B,POU5F1,RGMB,RUNX2,SCX,SKI,SLC33A1,SLC39A5,SMAD1,SMAD4,SMAD5,SMAD6,SMAD7,SMAD9,SMURF1,SMURF2,TGFBR3,TMEM100,UBE2D1,UBE2D3,USP15,USP9X,USP9Y,ZFYVE16	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
GO:0071782	GO	CC	endoplasmic reticulum tubular network	ASPH,KPNB1,OSBPL8,PARP16,RAB10,RAB18,RAB3GAP1,STIM1,TMEM110,ZFYVE27	A subcompartment of the endoplasmic reticulum consisting of tubules having membranes with high curvature in cross-section.
GO:0071786	GO	BP	endoplasmic reticulum tubular network organization	RAB10,RAB18,REEP1,REEP2,RTN3,RTN4	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endoplasmic reticulum (ER) tubular network. The ER tubular network is the ER part that that has membranes with high curvature in cross-section.
GO:0071801	GO	BP	regulation of podosome assembly	CSF2,FSCN1,GSN,HCK,IL5,KIF9,LCP1,TNF	Any process that modulates the frequency, rate or extent of podosome assembly.
GO:0071803	GO	BP	positive regulation of podosome assembly	CSF2,FSCN1,IL5,LCP1,TNF	Any process that activates or increases the rate or extent of podosome assembly.
GO:0071805	GO	BP	potassium ion transmembrane transport	ABCC8,ABCC9,AQP1,ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,ATP1B3,CCT8L2,FXYD2,HCN1,HCN2,HCN3,HCN4,HPN,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNIP2,KCNJ11,KCNJ2,KCNK1,KCNK18,KCNK2,KCNK4,KCNMA1,KCNMB1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNQ1,MTMR6,PKD2L1,REST,SLC12A6,SLC9A7,TMEM175	A process in which a potassium ion is transported from one side of a membrane to the other.
GO:0071806	GO	BP	protein transmembrane transport	AKT2,AZGP1,C2CD5,CHCHD4,HSP90AA1,HSPA4,HSPA8,MCL1,NDUFA13,PAM16,PEX1,PEX10,PEX12,PEX13,PEX14,PEX16,PEX19,PEX2,PEX26,PEX3,PEX5,PEX6,PEX7,RAB8B,SAMM50,SRP54,TIMM10,TIMM21,TIMM22,TIMM9,TOMM22,TOMM70A,ZFAND2B	The directed movement of a protein across a membrane by means of some agent such as a transporter or pore.
GO:0071813	GO	MF	lipoprotein particle binding	ANKRA2,APOL2,APOL5,CD36,CDH13,COLEC12,CRP,GPIHBP1,LIPC,MSR1,PCSK9,SCARB1,SCARF1,STAB1,STAB2,THBS1,VLDLR	Interacting selectively and non-covalently with a lipoprotein particle. A lipoprotein particle, also known as a lipoprotein, is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids.
GO:0071817	GO	CC	MMXD complex	CIAO1,ERCC2,FAM96B,MMS19,SLC25A5	A protein complex that contains the proteins MMS19, MIP18 and XPD, localizes to mitotic spindle during mitosis, and is required for proper chromosome segregation.
GO:0071824	GO	BP	protein-DNA complex subunit organization	ANP32B,ANP32E,APITD1,ARID1A,ARID2,ASF1A,ASF1B,ATRX,BRD2,BRDT,CABIN1,CASC5,CENPA,CENPC,CENPE,CENPF,CENPH,CENPI,CENPK,CENPL,CENPM,CENPN,CENPO,CENPP,CENPQ,CENPT,CENPU,CENPV,CENPW,CHAF1A,CHAF1B,CHD5,CTCF,DAXX,GTF2A2,H1FOO,H2AFB1,H2AFB2,H2AFX,H2AFY,H3F3A,HAT1,HELLS,HIRA,HIST1H2BA,HIST1H2BB,HIST1H2BC,HIST1H2BH,HIST1H2BJ,HIST1H2BL,HIST1H2BM,HIST1H2BN,HIST1H2BO,HIST1H3A,HIST1H4A,HIST2H2BE,HIST2H3A,HIST3H2A,HIST3H3,HJURP,HMGA1,HMGB2,IPO4,ITGB3BP,KAT6B,MIS12,MIS18A,MIS18BP1,NAA60,NASP,NFE2,NPM1,OIP5,PADI4,PAF1,POGZ,PSME4,RBBP4,RBBP7,RNF8,RSF1,RUVBL1,SART3,SET,SETD2,SMARCA4,SMARCA5,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1,SOX9,SPTY2D1,STRA13,SUPT16H,SYCP3,TAF1,TAF1B,TCF4,TNP1,UBN1	Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein-DNA complex.
GO:0071825	GO	BP	protein-lipid complex subunit organization	ABCA1,ABCA5,ABCA7,ABCG1,ACSL3,AGT,AGTR1,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,BIN1,CETP,DGAT1,LCAT,LIPC,LIPG,LPL,MPO,MTTP,PLA2G2A,PLA2G7,PLTP,SCARB1,SNX9,SOAT1,SOAT2	Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein-lipid complex.
GO:0071826	GO	BP	ribonucleoprotein complex subunit organization	ADAR,AGO1,AGO2,AGO3,AGO4,ATXN2,ATXN2L,BICD1,BMS1,C1QBP,CD2BP2,CELF1,CIRBP,CLNS1A,CLP1,CRNKL1,DDX1,DDX20,DDX23,DDX28,DDX39B,DDX3X,DDX6,DENR,DHX30,DICER1,DYNC1H1,EFTUD1,EIF2A,EIF2D,EIF3A,EIF6,ERAL1,FAM103A1,FASTKD2,GCFC2,GEMIN2,GEMIN4,GEMIN5,GEMIN6,GEMIN7,GEMIN8,GFM2,GRB7,KIF5B,KLC1,LIMD1,LSM14A,MCTS1,MPV17L2,MRRF,MTIF2,MTIF3,NCBP1,NCBP2,NOL3,NPM1,NUFIP1,OGFOD1,PATL1,PHAX,PIH1D1,PLD6,PQBP1,PRMT5,PRMT7,PRPF19,PRPF3,PRPF31,PRPF6,PRPF8,PSIP1,RBM5,RC3H1,RPS14,RPS19,SART1,SART3,SBDS,SCAF11,SETX,SF1,SF3A1,SF3A2,SF3A3,SHQ1,SLU7,SMN1,SNRNP200,SNRPB,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG,SNUPN,SRPK2,SRSF1,SRSF10,SRSF12,SRSF5,SRSF6,SRSF9,STRAP,TAF9,TARBP2,TDRD5,TFIP11,TGS1,TICRR,TSR1,TXNL4A,USP39,USP4,VCX,WDR77,YTHDC1,ZNHIT6,ZRSR2	Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a ribonucleoprotein complex.
GO:0071827	GO	BP	plasma lipoprotein particle organization	ABCA1,ABCA5,ABCA7,ABCG1,ACSL3,AGT,AGTR1,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,CETP,DGAT1,LCAT,LIPC,LIPG,LPL,MPO,MTTP,PLA2G2A,PLA2G7,PLTP,SCARB1,SOAT1,SOAT2	A protein-lipid complex subunit organization process that results in the formation, disassembly, or alteration of a plasma lipoprotein particle. A plasma lipoprotein particle is a spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins.
GO:0071850	GO	BP	mitotic cell cycle arrest	CDKN1B,DUSP1,E4F1,FAP,GADD45A,GADD45GIP1,MAGI2,MCPH1,NKX3-1,PNPT1,RGCC	The process in which the mitotic cell cycle is halted during one of the normal phases (G1, S, G2, M).
GO:0071855	GO	MF	neuropeptide receptor binding	APELA,CCKBR,EDN1,GAL,NPPA,POMC,QRFP,SHANK1,SPX	Interacting selectively and non-covalently with a neuropeptide receptor.
GO:0071870	GO	BP	cellular response to catecholamine stimulus	ABL1,ADCY6,APLP1,ATP2B4,DRD1,DRD5,GNAS,GNB1,GNG2,KCNQ1,LRRK2,NR4A3,PARK2,PDE4B,PDE4D,PRKACA,RYR2,SIRT2,SLC9A1,SNCA	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution.
GO:0071872	GO	BP	cellular response to epinephrine stimulus	ATP2B4,KCNQ1,PDE4B,PDE4D,PRKACA,RYR2,SIRT2,SLC9A1,SNCA	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system.
GO:0071875	GO	BP	adrenergic receptor signaling pathway	ADCY9,ADRA2A,ADRA2B,ADRA2C,ADRB1,GNAS,PDE4D,RAPGEF2	A series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
GO:0071877	GO	BP	regulation of adrenergic receptor signaling pathway	ADRA2A,ATP2B4,GSK3A,NOS1,RGS2	Any process that modulates the frequency, rate or extent of an adrenergic receptor signaling pathway activity. An adrenergic receptor signaling pathway is the series of molecular signals generated as a consequence of an adrenergic receptor binding to one of its physiological ligands.
GO:0071880	GO	BP	adenylate cyclase-activating adrenergic receptor signaling pathway	ADCY9,ADRB1,GNAS,PDE4D,RAPGEF2	The series of molecular signals generated as a consequence of an adrenergic receptor binding to its physiological ligand, where the pathway proceeds with activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP (cAMP).
GO:0071887	GO	BP	leukocyte apoptotic process	AKT1,BAX,CLC,CTSL,FASLG,GLI3,HCAR2,IL6,IRF3,RIPK1,SIVA1,TNFRSF21	Any apoptotic process in a leukocyte, an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
GO:0071889	GO	MF	14-3-3 protein binding	DAB2IP,HDAC7,KIF13B,PPP1R12A,RPTOR,SIK1,SRPK2,SYNPO2,ZFP36	Interacting selectively and non-covalently with a 14-3-3 protein. A 14-3-3 protein is any of a large family of approximately 30kDa acidic proteins which exist primarily as homo- and heterodimers within all eukaryotic cells, and have been implicated in the modulation of distinct biological processes by binding to specific phosphorylated sites on diverse target proteins, thereby forcing conformational changes or influencing interactions between their targets and other molecules. Each 14-3-3 protein sequence can be roughly divided into three sections: a divergent amino terminus, the conserved core region and a divergent carboxyl terminus. The conserved middle core region of the 14-3-3s encodes an amphipathic groove that forms the main functional domain, a cradle for interacting with client proteins.
GO:0071897	GO	BP	DNA biosynthetic process	CDKN2D,CHRAC1,CUL4A,CUL4B,DDB1,DTL,FAAP20,ISG15,KIAA0101,MAD2L2,NPLOC4,PCNA,POLA1,POLD1,POLD2,POLD3,POLD4,POLE,POLE3,POLE4,POLG,POLG2,POLH,POLI,POLK,POLM,POLN,POLQ,PRIMPOL,RAD18,RBX1,RCHY1,REV1,REV3L,RFC1,RFC2,RFC3,RFC4,RFC5,RPA1,RPA2,RPA3,RPS27A,SIRT1,SPRTN,TERT,TRIM25,TYMS,UBA52,UBA7,UBB,UBC,UBE2B,UBE2L6,UFD1L,USP1,USP10,USP43,VCP,WRN,WRNIP1,ZBTB1,ZBTB32	The cellular DNA metabolic process resulting in the formation of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one.
GO:0071901	GO	BP	negative regulation of protein serine/threonine kinase activity	ABL1,ADIPOQ,AIDA,APC,APOE,BMP4,BMP7,CAV1,CAV3,CBLC,CD300A,CDK5RAP1,CDK5RAP3,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CEBPA,CIB1,CUL3,DAB2IP,DNAJA1,DUSP1,DUSP10,DUSP16,DUSP19,DUSP2,DUSP22,DUSP3,DUSP6,DUSP7,DUSP8,FBXO31,GBA,GPS1,GPS2,GSTP1,H2AFY,HEXIM1,HEXIM2,HHEX,HIPK3,HYAL2,IL1B,INCA1,INPP5K,IRAK3,LATS1,LATS2,LAX1,LRP5,LRP6,LYN,MBIP,MEN1,MYOCD,NF1,NR2F2,PAQR3,PDCD4,PKIA,PLK1,PPP2CA,PPP2R1A,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCD,PTEN,PTPN1,PTPN22,PTPRJ,PYCARD,RGS14,RGS2,RGS3,RGS4,SERPINB3,SFN,SIRT1,SMPD1,SORL1,SPRED1,SPRED2,STK38,TFAP4,UBE2C,UCHL1,YWHAG,ZNF675	Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.
GO:0071907	GO	BP	determination of digestive tract left/right asymmetry	CCDC103,CCDC39,CCDC40,DNAAF1,MEGF8,NPHP3,ZIC3	Determination of the asymmetric location of various parts of the digestive tract with respect to the left and right halves of the organism. The digestive tract is the anatomical structure through which food passes and is processed.
GO:0071910	GO	BP	determination of liver left/right asymmetry	CCDC39,CCDC40,DNAAF1,NPHP3,PKD2,ZIC3	Determination of the asymmetric location of the liver with respect to the left and right halves of the organism.
GO:0071933	GO	MF	Arp2/3 complex binding	CORO1B,IQGAP2,PICK1,SNX9,WHAMM	Interacting selectively and non-covalently with an Arp2/3 complex, a protein complex that contains two actin-related proteins, Arp2 and Arp3, and five novel proteins (ARPC1-5).
GO:0071941	GO	BP	nitrogen cycle metabolic process	ARG1,ARG2,ASL,ASS1,CPS1,CYP2C9,ISCU,NAGS,OTC,SLC25A15,SLC25A2	A nitrogen compound metabolic process that contributes to the nitrogen cycle. The nitrogen cycle is a series of metabolic pathways by which nitrogen is converted between various forms and redox states; it encompasses pathways in which nitrogen is acted upon directly, such as nitrification, denitrification, nitrogen fixation, and mineralization.
GO:0071949	GO	MF	FAD binding	ACOX1,AGPS,CRY2,CYB5R3,DAO,MICAL1,MICAL2,MICAL3,MTRR,PRODH	Interacting selectively and non-covalently with the oxidized form, FAD, of flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
GO:0071985	GO	BP	multivesicular body sorting pathway	CHMP2B,CHMP3,CHMP5,EXPH5,RAB27A,RAB27B,RUBCN,SNF8,SYTL4,UVRAG,VTA1	A vesicle-mediated transport process in which transmembrane proteins are ubiquitylated to facilitate their entry into luminal vesicles of multivesicular bodies (MVBs); upon subsequent fusion of MVBs with lysosomes or vacuoles, the cargo proteins are degraded.
GO:0071986	GO	CC	Ragulator complex	LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,SLC38A9	A protein complex that contains MAPKSP1 (MP1, Map2k1ip1), ROBLD3 (p14, Mapbpip), C11orf59 (p18), LAMTOR4 and LAMTOR5. The complex is anchored to lipid rafts in late endosome membranes via C11orf59, recruits mTORC1 to lysosomal membranes in amino acid signaling to mTORC1, constitutes a guanine nucleotide exchange factor (GEF) for the Rag GTPases, and is also involved in ERK/MAPK signaling.
GO:0072001	GO	BP	renal system development	ACE,ADIPOQ,AGT,AGTR1,AHI1,ANGPT1,ANGPT2,ARL3,BAG6,BASP1,BMP2,BMP4,BMP7,C1GALT1,CD24,CENPF,CEP290,CER1,CITED1,COL4A1,COL4A3,COL4A4,CTSH,DACT2,DLL1,EGR1,ENPEP,FGF1,FGF2,FGFR2,FOXD1,FOXF1,GATA3,GDNF,GLI2,GPC3,HAS2,HNF1B,HOXA11,HOXD11,HYAL2,IFT140,IQGAP1,ITGA3,ITGA6,ITGA8,ITGB4,JAG1,KLF15,KLHL3,LHX1,LRP4,LRRK2,MAGI2,MEF2C,MPV17,MTSS1,MYC,MYO1E,NF1,NIPBL,NPHP3,NPNT,OSR1,OSR2,PAX2,PAX8,PCSK5,PCSK9,PDGFB,PDGFRA,PDGFRB,PKD1,PKD2,PKHD1,PLCE1,PODXL,POU3F3,PRKX,PROM1,PTPRO,RBP4,REN,RET,ROBO2,SALL1,SHH,SIX1,SIX2,SIX4,SLIT2,SMO,SOX17,SOX4,SOX8,SOX9,STAT1,STRA6,SULF1,SULF2,TBX18,TCF21,TFAP2A,TFAP2B,TGFBR1,TRAF3IP1,VANGL2,VEGFA,WFS1,WNK4,WNT4,WNT7B,WT1,ZBTB16	The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.
GO:0072006	GO	BP	nephron development	AHI1,ANGPT1,ANGPT2,BASP1,BMP2,BMP4,CD24,CITED1,COL4A3,COL4A4,DLL1,EGR1,ENPEP,FGF1,FGF2,FOXD1,GATA3,GDNF,HNF1B,HOXA11,HOXD11,IQGAP1,ITGA3,JAG1,KLF15,KLHL3,LHX1,MAGI2,MEF2C,MPV17,MTSS1,MYC,MYO1E,NPNT,OSR1,PAX2,PAX8,PDGFB,PDGFRA,PDGFRB,PLCE1,PODXL,POU3F3,PROM1,PTPRO,SALL1,SHH,SIX1,SIX2,SMO,SOX8,SOX9,SULF1,SULF2,TCF21,TFAP2B,WNK4,WNT7B,WT1	The process whose specific outcome is the progression of the nephron over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.
GO:0072009	GO	BP	nephron epithelium development	AHI1,BASP1,BMP2,BMP4,CD24,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HNF1B,HOXA11,HOXD11,IQGAP1,JAG1,KLF15,KLHL3,LHX1,MAGI2,MEF2C,MTSS1,MYC,MYO1E,NPNT,OSR1,PAX2,PAX8,PODXL,POU3F3,PROM1,PTPRO,SALL1,SHH,SIX1,SIX2,SMO,SOX8,SOX9,TCF21,TFAP2B,WNK4,WNT7B,WT1	The process whose specific outcome is the progression of the nephron epithelium over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure. The nephron epithelium is a tissue that covers the surface of a nephron.
GO:0072012	GO	BP	glomerulus vasculature development	ANGPT1,ANGPT2,BMP4,EGR1,OSR1,PDGFB,PDGFRA,PDGFRB,TCF21	The biological process whose specific outcome is the progression of a glomerulus vasculature from an initial condition to its mature state. This process begins with the formation of the glomerulus vasculature and ends with the mature structure. The glomerulus vasculature is composed of the tubule structures that carry blood or lymph in the glomerulus.
GO:0072015	GO	BP	glomerular visceral epithelial cell development	IQGAP1,JAG1,MAGI2,MYO1E,PODXL	The process whose specific outcome is the progression of a glomerular visceral epithelial cell over time, from its formation to the mature structure. A glomerular visceral epithelial cell is a specialized epithelial cell that contains \
GO:0072017	GO	BP	distal tubule development	KLHL3,PAX2,PAX8,POU3F3,TFAP2B,WNK4	The process whose specific outcome is the progression of the distal tubule over time, from its formation to the mature structure. In mammals, the distal tubule is a nephron tubule that begins at the macula densa and extends to the connecting tubule.
GO:0072044	GO	BP	collecting duct development	BMP4,DACT2,PAX2,TFAP2B,WNT7B	The process whose specific outcome is the progression of a collecting duct over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. It is the final common path through which urine flows before entering the ureter and then emptying into the bladder.
GO:0072073	GO	BP	kidney epithelium development	AHI1,BASP1,BMP2,BMP4,BMP7,CD24,CER1,CITED1,FGF1,FGF2,FGFR2,FOXD1,GATA3,GDNF,GPC3,HNF1B,HOXA11,HOXD11,IQGAP1,JAG1,KLF15,KLHL3,LHX1,MAGI2,MEF2C,MTSS1,MYC,MYO1E,NPNT,OSR1,PAX2,PAX8,PODXL,POU3F3,PROM1,PTPRO,ROBO2,SALL1,SHH,SIX1,SIX2,SLIT2,SMO,SOX8,SOX9,TCF21,TFAP2B,WNK4,WNT7B,WT1	The process whose specific outcome is the progression of an epithelium in the kidney over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.
GO:0072074	GO	BP	kidney mesenchyme development	BASP1,OSR1,PAX2,SHH,SIX1,SIX2,SIX4,STAT1,TCF21,WNT4,WT1	The biological process whose specific outcome is the progression of a kidney mesenchyme from an initial condition to its mature state. This process begins with the formation of kidney mesenchyme and ends with the mature structure. Kidney mesenchyme is the tissue made up of loosely connected mesenchymal cells in the kidney.
GO:0072075	GO	BP	metanephric mesenchyme development	BASP1,OSR1,PAX2,SHH,SIX1,SIX4,STAT1,TCF21,WNT4,WT1	The biological process whose specific outcome is the progression of a metanephric mesenchyme from an initial condition to its mature state. This process begins with the formation of metanephric mesenchyme and ends with the mature structure. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros.
GO:0072077	GO	BP	renal vesicle morphogenesis	BMP4,LHX1,PAX2,SALL1,SIX2,SMO	The process in which the anatomical structures of the renal vesicle are generated and organized. The renal vesicle is the primordial structure of the nephron epithelium, and is formed by the condensation of mesenchymal cells.
GO:0072078	GO	BP	nephron tubule morphogenesis	AHI1,BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HOXA11,HOXD11,KLHL3,MYC,NPNT,OSR1,PAX2,PAX8,SALL1,SHH,SIX1,SOX8,SOX9,TCF21,WNK4,WT1	The process in which the anatomical structures of a nephron tubule are generated and organized. A nephron tubule is an epithelial tube that is part of the nephron, the functional part of the kidney.
GO:0072079	GO	BP	nephron tubule formation	GATA3,OSR1,PAX2,PAX8,SIX1,SOX8,SOX9	The developmental process pertaining to the initial formation of a nephron tubule from unspecified parts. A nephron tubule is an epithelial tube that is part of the nephron, the functional part of the kidney.
GO:0072080	GO	BP	nephron tubule development	AHI1,BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HNF1B,HOXA11,HOXD11,KLHL3,MEF2C,MTSS1,MYC,NPNT,OSR1,PAX2,PAX8,POU3F3,SALL1,SHH,SIX1,SOX8,SOX9,TCF21,TFAP2B,WNK4,WNT7B,WT1	The progression of a nephron tubule over time, from its initial formation to the mature structure. A nephron tubule is an epithelial tube that is part of the nephron, the functional part of the kidney.
GO:0072087	GO	BP	renal vesicle development	BMP4,LHX1,OSR1,PAX2,SALL1,SIX2,SMO	The process whose specific outcome is the progression of the renal vesicle over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure. The renal vesicle is the primordial structure of the nephron epithelium, and is formed by the condensation of mesenchymal cells.
GO:0072088	GO	BP	nephron epithelium morphogenesis	AHI1,BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HOXA11,HOXD11,KLHL3,LHX1,MYC,NPNT,OSR1,PAX2,PAX8,SALL1,SHH,SIX1,SIX2,SMO,SOX8,SOX9,TCF21,WNK4,WT1	The process in which the anatomical structures of the nephron epithelium are generated and organized. The nephron epithelium is a tissue that covers the surface of a nephron.
GO:0072089	GO	BP	stem cell proliferation	ABCB1,ARIH2,ARTN,BMP2,CD34,DOCK7,EML1,ETV6,FGF13,FGF4,FGF7,FGFR2,GPC3,MECOM,NES,NUMB,NUMBL,OSR1,PAFAH1B1,PLXNB2,RAB10,RACGAP1,RNF43,RUNX1,SFRP2,SHH,SIX2,SOX5,STAT1,TEAD3,TRIM71,WNT10B,WNT2B,WNT5A,ZNRF3	The multiplication or reproduction of stem cells, resulting in the expansion of a stem cell population. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
GO:0072091	GO	BP	regulation of stem cell proliferation	ACE,AGO3,BMP4,CHRD,CTNNB1,CTNNBIP1,DISC1,DRD2,EIF2AK2,EPCAM,FBLN1,FGFR2,FZD3,HMGA2,HMGB2,KDF1,LRP5,LRRK2,LTBP3,MYC,N4BP2L2,NF1,NFIB,PDCD2,PDGFA,PTPRC,SHH,SIX3,SMARCD3,SOX11,SOX9,STAT1,TBX1,TGFBR2,THPO,VEGFA,WNT5A,YAP1,ZNF335	Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
GO:0072102	GO	BP	glomerulus morphogenesis	BMP4,MEF2C,MTSS1,PDGFRA,PDGFRB,TCF21	The process in which the anatomical structures of the glomerulus are generated and organized. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.
GO:0072111	GO	BP	cell proliferation involved in kidney development	BMP2,EGR1,GPC3,OSR1,PDGFRB,SHH,STAT1	The multiplication or reproduction of cells, resulting in the expansion of the population in the kidney.
GO:0072112	GO	BP	glomerular visceral epithelial cell differentiation	BASP1,CD24,IQGAP1,JAG1,KLF15,MAGI2,MYO1E,PODXL,PROM1,PTPRO,WT1	The process in which a relatively unspecialized cell acquires specialized features of a glomerular visceral epithelial cell. A glomerular visceral epithelial cell is a specialized epithelial cell that contains \
GO:0072124	GO	BP	regulation of glomerular mesangial cell proliferation	BMP4,BMP7,EGR1,PDGFB,WT1	Any process that modulates the frequency, rate or extent of glomerular mesangial cell proliferation.
GO:0072132	GO	BP	mesenchyme morphogenesis	ACTA1,ACTA2,ACTC1,ACTG2,BMP2,BMPR1A,DCHS1,FGF8,HEY1,HEYL,ISL1,NOTCH1,OSR1,RBPJ,SMAD2,SNAI2,SOX9,TBX2,TBX20	The process in which the anatomical structures of a mesenchymal tissue are generated and organized. A mesenchymal tissue is made up of loosely packed stellate cells.
GO:0072148	GO	BP	epithelial cell fate commitment	ACVR1,DLL1,JAG2,NR2F2,NRP1,PROX1,RBPJ	The process in which the developmental fate of a cell becomes restricted such that it will develop into an epithelial cell.
GO:0072161	GO	BP	mesenchymal cell differentiation involved in kidney development	OSR1,PAX2,SIX2,STAT1,TCF21,WNT4	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the kidney as it progresses from its formation to the mature state.
GO:0072162	GO	BP	metanephric mesenchymal cell differentiation	OSR1,PAX2,STAT1,TCF21,WNT4	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the metanephros as it progresses from its formation to the mature state.
GO:0072171	GO	BP	mesonephric tubule morphogenesis	BMP2,BMP4,CITED1,FGF1,FGF2,FOXD1,GATA3,GDNF,HOXA11,HOXD11,MYC,NPNT,OSR1,PAX2,SALL1,SHH,SIX1,TCF21,WT1	The process in which the anatomical structures of a mesonephric tubule are generated and organized. A mesonephric tubule is an epithelial tube that is part of the mesonephros.
GO:0072175	GO	BP	epithelial tube formation	BBS4,BCL10,BMP4,CELSR1,COBL,DEAF1,DLC1,DVL2,FOLR1,FUZ,GATA3,GRHL2,GRHL3,IFT122,KDM2B,LMO4,MTHFD1,MTHFD1L,OSR1,PAX2,PAX8,PHACTR4,PLXNB2,PODXL,PRICKLE1,SCRIB,SEMA4C,SIX1,SKI,SOX11,SOX4,SOX8,SOX9,STIL,TSC2,VANGL2	The developmental process pertaining to the initial formation of an epithelial tube.
GO:0072178	GO	BP	nephric duct morphogenesis	AHI1,BMP4,GATA3,LHX1,OSR1,PAX2	The process in which the anatomical structures of the nephric duct are generated and organized. A nephric duct is a tube that drains a primitive kidney.
GO:0072182	GO	BP	regulation of nephron tubule epithelial cell differentiation	CD24,CTNNB1,GATA3,LHX1,LIF,OSR1,PAX2,PAX8,PROM1,STAT1	Any process that modulates the frequency, rate or extent of nephron tubule epithelial cell differentiation.
GO:0072189	GO	BP	ureter development	BMP4,FOXF1,NPHP3,OSR1,PAX2,SOX8	The process whose specific outcome is the progression of the ureter over time, from its formation to the mature structure. The ureter is a muscular tube that transports urine from the kidney to the urinary bladder or from the Malpighian tubule to the hindgut.
GO:0072202	GO	BP	cell differentiation involved in metanephros development	OSR1,PAX2,PDGFB,POU3F3,STAT1,TCF21,WNT4	The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells of the metanephros as it progresses from its formation to the mature state.
GO:0072210	GO	BP	metanephric nephron development	BMP4,OSR1,PAX2,PAX8,PDGFB,PDGFRA,PDGFRB,SALL1,SIX2,SMO,SOX8,SOX9,TCF21,WT1	The process whose specific outcome is the progression of a nephron in the metanephros over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.
GO:0072215	GO	BP	regulation of metanephros development	ADIPOQ,BASP1,BMP4,EGR1,LIF,MYC,PAX2,PAX8,PDGFA,PDGFB,PDGFRB,RET,STAT1,WT1	Any process that modulates the rate, frequency or extent of metanephros development. Metanephros development is the process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0072216	GO	BP	positive regulation of metanephros development	ADIPOQ,BASP1,EGR1,LIF,MYC,PAX2,PAX8,PDGFA,PDGFB,PDGFRB,RET,WT1	Any process that increases the rate, frequency or extent of metanephros development. Metanephros development is the process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. The metanephros is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0072217	GO	BP	negative regulation of metanephros development	ADIPOQ,BMP4,PAX2,PAX8,STAT1,WT1	Any process that decreases the rate, frequency or extent of metanephros development. Metanephros development is the process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. The metanephros is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0072234	GO	BP	metanephric nephron tubule development	OSR1,PAX2,PAX8,POU3F3,SOX8,SOX9,WNT7B	The progression of a metanephric nephron tubule over time, from its initial formation to the mature structure. A metanephric nephron tubule is an epithelial tube that is part of the metanephric nephron, the functional part of the metanephros.
GO:0072239	GO	BP	metanephric glomerulus vasculature development	OSR1,PDGFB,PDGFRA,PDGFRB,TCF21	The biological process whose specific outcome is the progression of a metanephric glomerulus vasculature from an initial condition to its mature state. This process begins with the formation of the metanephric glomerulus vasculature and ends with the mature structure. The metanephric glomerulus vasculature is composed of the tubule structures that carry blood or lymph in the metanephric glomerulus.
GO:0072273	GO	BP	metanephric nephron morphogenesis	BMP4,PAX2,PAX8,SALL1,SIX2,SMO,SOX8,SOX9,WT1	The process in which the anatomical structures of the metanephric nephron are generated and organized. A metanephric nephron is the functional unit of the metanephros.
GO:0072283	GO	BP	metanephric renal vesicle morphogenesis	BMP4,PAX2,SALL1,SIX2,SMO	The process in which the anatomical structures of the metanephric renal vesicle are generated and organized. The renal vesicle is the primordial structure of the metanephric nephron epithelium, and is formed by the condensation of mesenchymal cells.
GO:0072298	GO	BP	regulation of metanephric glomerulus development	ADIPOQ,EGR1,PAX2,RET,WT1	Any process that modulates the rate, frequency or extent of metanephric glomerulus development, the progression of the metanephric glomerulus over time from its initial formation until its mature state. The metanephric glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney, or metanephros.
GO:0072321	GO	BP	chaperone-mediated protein transport	CLIP3,HSPA8,PEX19,TIMM10,TIMM13,TIMM8A,TIMM8B,TIMM9,TOR1A	The directed movement of proteins into, out of or within a cell, or between cells, mediated by chaperone molecules that bind to the transported proteins.
GO:0072329	GO	BP	monocarboxylic acid catabolic process	ABAT,ABCD1,ABCD2,ABCD3,ACAA1,ACAD10,ACAD11,ACADL,ACADM,ACADS,ACADVL,ACOT8,ACOX1,ACOX2,ACOX3,ADIPOQ,AGXT,AGXT2,AKR1A1,ALDH4A1,ALDH5A1,AMACR,BDH2,CEL,CRAT,CROT,CRYL1,CYP26A1,CYP26B1,CYP26C1,CYP4A11,CYP4F12,CYP4F2,DCXR,DECR1,ECHS1,ECI1,ECI2,EHHADH,ETFA,ETFB,ETFDH,FAAH,GCDH,GOT2,HACL1,HADH,HADHA,HADHB,HAO1,HOGA1,HSD17B4,IDUA,LPIN1,MCEE,MMAA,MUT,PCCA,PCCB,PEX13,PEX2,PHYH,PLA2G15,PPARD,PRODH,SCP2,SLC25A17,SLC27A2,SORD,XYLB	The chemical reactions and pathways resulting in the breakdown of monocarboxylic acids, any organic acid containing one carboxyl (-COOH) group.
GO:0072330	GO	BP	monocarboxylic acid biosynthetic process	ABCB11,ABCD3,ACACA,ACADM,ACOT7,ACOT8,ACOX2,ACSF3,AKR1C3,AKR1C4,AKR1D1,ALDH9A1,ALOX12,ALOX12B,ALOX15,ALOX15B,ALOX5,ALOX5AP,ALOXE3,AMACR,BAAT,BBOX1,BCAN,BGN,CBR1,CD74,CH25H,CHST12,CHST14,CSPG4,CSPG5,CYP27A1,CYP39A1,CYP46A1,CYP7A1,CYP7B1,CYP8B1,DCN,DECR2,DEGS1,DHRS9,DSE,DSEL,EDN1,EDN2,ELOVL1,ELOVL2,ELOVL3,ELOVL4,ELOVL5,ELOVL6,ELOVL7,FADS1,FADS3,FAM213B,GGT1,GGT2,GGT5,GGT6,GGT7,GGTLC1,GGTLC2,GGTLC3,HACD1,HACD2,HACD3,HACD4,HOGA1,HPGD,HPGDS,HSD17B4,HSD3B7,LIAS,LIPC,LPL,LTA4H,MCAT,MGST2,MIF,MLYCD,NCAN,NDUFAB1,OXSM,PARK7,PER2,PLA2G1B,PNPLA8,PRG3,PTGDS,PTGES,PTGES3,PTGIS,PTGR1,PTGS1,PTGS2,SCD,SCD5,SCP2,SDS,SHMT1,SLC27A2,SLC27A5,SRR,TBXAS1,TECR,THNSL2,TMLHE,UST,VCAN,XBP1	The chemical reactions and pathways resulting in the formation of monocarboxylic acids, any organic acid containing one carboxyl (-COOH) group.
GO:0072331	GO	BP	signal transduction by p53 class mediator	AEN,ATM,ATRX,BAG6,BATF,BCL3,BOK,BRCA1,CASP2,CDIP1,CDK2,CDKN1A,CDKN1B,CRADD,DDIT4,DDX5,DYRK2,E2F7,EP300,FHIT,FOXM1,GML,GTSE1,HINT1,HIPK2,IFI16,ING4,KAT5,MAGEA2,MDM2,MUC1,MYBBP1A,MYO6,NBN,PAXIP1,PDK2,PHLDA3,PIDD1,PMAIP1,PML,PPP1R13B,PPP2R5C,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PYCARD,RBM38,RFWD2,RPS27A,RPS27L,RPS6KA6,RRP8,SIRT1,SNW1,SOX4,SP100,STK11,TFAP4,TP53,TP53BP2,TP73,TRIAP1,UBA52,UBB,UBC,USP10,USP28,ZNF385B	An intracellular signaling process that is induced by the cell cycle regulator phosphoprotein p53 or an equivalent protein.
GO:0072332	GO	BP	intrinsic apoptotic signaling pathway by p53 class mediator	AEN,BAG6,BCL3,BOK,CDIP1,DDIT4,DDX5,DYRK2,EP300,FHIT,HINT1,HIPK2,IFI16,MYBBP1A,PDK2,PHLDA3,PMAIP1,PML,PPP1R13B,PPP2R5C,PYCARD,RPS27L,RRP8,SIRT1,SNW1,STK11,TP53,TP53BP2,TP73,USP28,ZNF385B	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, and ends when the execution phase of apoptosis is triggered.
GO:0072337	GO	BP	modified amino acid transport	CRYM,CTNS,FOLR1,FOLR2,FOLR3,SERPINA7,SLC16A12,SLC16A2,SLC19A1,SLC19A2,SLC1A4,SLC25A26,SLC25A32,SLC3A1,SLC46A1,SLC6A8,SLC7A9,SLC9A3R1	The directed movement of modified amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0072338	GO	BP	cellular lactam metabolic process	DPEP1,GHR,MME,STAT5A,STAT5B	The chemical reactions and pathways involving lactams, any cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
GO:0072341	GO	MF	modified amino acid binding	ANXA13,ANXA9,AXL,CBS,CD300A,CPNE1,CPNE6,CPS1,DHFR,DPEP1,FCHO2,FOLR1,FOLR2,GAS6,GPR143,GSS,GSTM1,GSTM2,GSTM3,GSTM4,HMGB1,JPH2,LANCL1,MARK1,MTHFR,MTHFS,MUT,NOX4,OSBPL10,OSBPL5,OSBPL8,PTGES,PTGES2,RASGRP1,RPE65,SCARB1,SCIN,SDPR,SYTL2,THBS1,TRIM72,TYMS	Interacting selectively and non-covalently with a modified amino acid.
GO:0072348	GO	BP	sulfur compound transport	CTNS,RACGAP1,SLC13A4,SLC19A2,SLC1A1,SLC1A4,SLC25A26,SLC26A1,SLC26A11,SLC26A2,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC33A1,SLC35B2,SLC35F3,SLC3A1,SLC7A9,SLC9A3R1	The directed movement of compounds that contain sulfur, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0072349	GO	MF	modified amino acid transmembrane transporter activity	CTNS,SLC16A12,SLC16A2,SLC1A4,SLC22A16,SLC22A4,SLC22A5,SLC25A26,SLC3A1,SLC6A8,SLC7A11,SLC7A9	Enables the transfer of modified amino acids from one side of a membrane to the other.
GO:0072350	GO	BP	tricarboxylic acid metabolic process	ACLY,ACO1,ACO2,ASS1,CS,DLD,DLST,FH,GHR,GLUD1,IDH1,IDH2,IDH3A,IDH3B,IDH3G,MDH2,NNT,OGDH,PDHA1,PDHB,SDHA,SDHB,SDHC,SDHD,SIRT4,STAT5A,STAT5B,SUCLA2,SUCLG1,SUCLG2	The chemical reactions and pathways involving dicarboxylic acids, any organic acid containing three carboxyl (COOH) groups or anions (COO-).
GO:0072357	GO	CC	PTW/PP1 phosphatase complex	PPP1CA,PPP1CB,PPP1CC,PPP1R10,PPP1R12A,TOX4,WDR82	A protein serine/threonine phosphatase complex that contains a catalytic subunit (PPP1CA, PPP1CB or PPP1CC) and the regulatory subunits PPP1R10 (PNUTS), TOX4 and WDR82, and plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase.
GO:0072372	GO	CC	primary cilium	ABCA4,ADCY5,ADRBK1,AHI1,ARL13B,ARL3,ARL6,B9D1,B9D2,BBS4,BBS9,C2orf71,C5orf30,CC2D2A,CCSAP,CEP290,CEP41,CEP89,CFAP126,CIB2,CLUAP1,CSNK1A1,CYS1,DCDC2,DHRS3,DRD1,DRD2,DRD5,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,DYNLRB1,DYNLRB2,EFCAB7,FAM161A,FLCN,GNA11,GNAQ,GNAT1,GNAT2,GNB1,GNGT1,GPR161,GRK1,GRK4,GRK7,GRXCR1,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,HSPB11,IFT122,IFT140,IFT172,IFT20,IFT22,IFT27,IFT43,IFT46,IFT52,IFT57,IFT74,IFT80,IFT81,IFT88,INPP5E,IQCB1,IQCE,KIF17,KIF3A,KIF3B,KIF3C,KIFAP3,MAK,MCHR1,MKS1,MYO7A,NAPEPLD,NEK8,NPHP1,NPHP3,OCRL,ODF2,OPN1LW,OPN1MW,OPN1SW,PAFAH1B1,PCDH15,PDE4C,PDE6A,PDE6B,PDE6D,PDE6G,PKD1,PKD1L1,PKD2,PKD2L1,PKHD1,PROM1,RAB10,RAB15,RAB8A,RHO,RILPL1,RILPL2,RP1,RP1L1,RP2,RPGR,RPGRIP1,SAXO1,SHANK2,SMO,SPA17,SPATA7,SPTBN5,SSTR3,STRC,TBC1D30,TBCC,TCTN1,TCTN2,TMEM17,TMEM216,TMEM231,TMEM237,TMEM67,TNPO1,TOPORS,TRAF3IP1,TTBK2,TTC21B,TTC26,TTC30B,TULP1,TULP3,UMOD,UNC119B,WDR19,WDR34,WDR35,WDR60	A cilium found on many different cell types that is typically present in a single copy per cell. A primary cilium may have a variable array of axonemal microtubules and may or may not contain molecular motors.
GO:0072376	GO	BP	protein activation cascade	A2M,APOH,C1QA,C1QB,C1QBP,C1QC,C1R,C1S,C2,C3,C4A,C4B,C5,C6,C7,C8A,C8B,CFB,CFD,CFH,CFHR1,CFHR5,CFP,CLU,F10,F11,F12,F2,F3,F7,F8,F9,FBLN1,FCN1,FCN2,FCN3,FGA,FGB,FGG,GP1BA,GP1BB,GP5,GP9,KLKB1,KNG1,MASP1,MASP2,MBL2,PRCP,RGCC,SERPING1,TFPI,VWF	A response to a stimulus that consists of a sequential series of modifications to a set of proteins where the product of one reaction acts catalytically in the following reaction. The magnitude of the response is typically amplified at each successive step in the cascade. Modifications typically include proteolysis or covalent modification, and may also include binding events.
GO:0072378	GO	BP	blood coagulation, fibrin clot formation	A2M,APOH,C1QBP,F10,F11,F12,F2,F3,F7,F8,F9,FBLN1,FGA,FGB,FGG,GP1BA,GP1BB,GP5,GP9,KLKB1,KNG1,PRCP,SERPING1,TFPI,VWF	A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
GO:0072383	GO	BP	plus-end-directed vesicle transport along microtubule	FYCO1,KIF13A,KIF3A,KIF3B,KIFAP3	The directed movement of a vesicle towards the plus end of a microtubule, mediated by motor proteins. This process begins with the attachment of a vesicle to a microtubule, and ends when the vesicle reaches its final destination.
GO:0072384	GO	BP	organelle transport along microtubule	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,ARHGAP21,BICD1,BICD2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CDC42,CLN3,COPG1,DTNBP1,DYNC1I1,FYCO1,HIF1A,HTT,KIF13A,KIF3A,KIF3B,KIF5B,KIFAP3,LRPPRC,MAP1S,MGARP,NEFL,OPA1,PAFAH1B1,PEX14,RAB1A,RAB6A,RHOT1,RHOT2,SNAPIN,UBB,UXT	The directed movement of an organelle along a microtubule, mediated by motor proteins. This process begins with the attachment of an organelle to a microtubule, and ends when the organelle reaches its final destination.
GO:0072422	GO	BP	signal transduction involved in DNA damage checkpoint	ATM,CASP2,CDC5L,CDK2,CDKN1A,CDKN1B,CHEK2,CRADD,GML,GTSE1,MDM2,MUC1,PIDD1,PML,PPP2R5C,PRKDC,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RPS27A,SOX4,TP53,TRIAP1,UBA52,UBB,UBC	A signal transduction process that contributes to a DNA damage checkpoint.
GO:0072423	GO	BP	response to DNA damage checkpoint signaling	APAF1,EME1,FBXO18,MUS81,SLX4	A process that occurs in response to signals generated as a result of DNA damage checkpoint signaling.
GO:0072431	GO	BP	signal transduction involved in mitotic G1 DNA damage checkpoint	ATM,CASP2,CDK2,CDKN1A,CDKN1B,CRADD,GML,GTSE1,MDM2,MUC1,PIDD1,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RPS27A,SOX4,TP53,TRIAP1,UBA52,UBB,UBC	A signal transduction process that contributes to a mitotic cell cycle G1/S transition DNA damage checkpoint.
GO:0072488	GO	BP	ammonium transmembrane transport	ACACA,ACACB,AQP1,CPT1A,CPT1B,CPT2,PRKAA2,PRKAB2,PRKAG2,SLC12A2,SLC18A3,SLC22A16,SLC22A4,SLC22A5,SLC25A20,SLC6A3	The directed movement of ammonium across a membrane by means of some agent such as a transporter or pore. Ammonium is the cation NH4+.
GO:0072498	GO	BP	embryonic skeletal joint development	COL2A1,CTNNB1,NOG,OSR1,OSR2,WNT9A	The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeletal joints over time, from formation to mature structure.
GO:0072501	GO	BP	cellular divalent inorganic anion homeostasis	ENPP1,GCM2,SLC34A2,SLC34A3,TFAP2B,XPR1	Any process involved in the maintenance of an internal steady state of divalent inorganic anions at the level of a cell.
GO:0072503	GO	BP	cellular divalent inorganic cation homeostasis	ABL1,ABL2,ADCY5,ADRA1A,AGTR1,ANK2,ATP1B1,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP7B,AVPR1B,BAK1,BAX,BBC3,BCAP31,BCL2,BDKRB1,C1QTNF1,C3AR1,CACNA1A,CACNA1C,CALCA,CALCB,CALCR,CALR,CAMK2D,CASQ2,CASR,CAV1,CAV3,CCDC109B,CCKBR,CCL1,CCL11,CCL13,CCL14,CCL15,CCL19,CCL21,CCL23,CCL3,CCL5,CCL7,CCL8,CCR1,CCR2,CCR3,CCR4,CCR5,CCR7,CCR9,CD24,CD36,CD40,CD52,CD55,CDH23,CHERP,CHRNA10,CHRNA7,CHRNA9,CIB2,CLN3,CSRP3,CXCL12,CXCL13,CXCR4,CYSLTR1,DLG4,DMPK,DRD1,DRD2,DRD3,DRD4,DRD5,EDN1,EDN2,EDNRA,ELANE,EPHX2,ERO1A,ESR1,F2,F2R,F2RL1,FGF2,FIS1,FKBP1B,GCM2,GHRL,GLP1R,GNA15,GPER1,GRM1,HERPUD1,HMGB1,HRC,HSP90B1,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KCTD17,KNG1,LCK,LPAR1,LPAR2,LPAR3,MCHR1,MCU,MCUR1,MICU1,MICU2,MT3,NMUR2,NOL3,NPTN,OPRL1,OPRM1,P2RY1,P2RY4,PDE6A,PDE6B,PDGFRA,PKD2,PKHD1,PLCE1,PLCG2,PLN,PML,PRKACA,PROK2,PSEN1,PTPRC,RAP1GDS1,RGN,RMDN3,RYR1,RYR2,S100A8,S100A9,S1PR3,S1PR4,SAA1,SLC11A1,SLC30A1,SLC30A5,SLC30A8,SLC35G1,SLC39A13,SLC39A14,SLC39A6,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SMDT1,SPPL3,STC1,STIM2,STOML2,TAC1,TGM2,TMEM165,TMEM203,TNNI3,TPCN2,TPT1,TRDN,TRPC1,TRPM1,TRPV4,VAPB,WFS1,XCL1,XCR1	Any process involved in the maintenance of an internal steady state of divalent cations at the level of a cell.
GO:0072505	GO	BP	divalent inorganic anion homeostasis	ENPP1,FGF23,FGFR4,GCM2,OTC,SFRP4,SLC34A1,SLC34A2,SLC34A3,TFAP2B,XPR1	Any process involved in the maintenance of an internal steady state of divalent inorganic anions within an organism or cell.
GO:0072507	GO	BP	divalent inorganic cation homeostasis	ABL1,ABL2,ADCY5,ADRA1A,AGTR1,ANK2,ANK3,ATP1B1,ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,ATP6V1B1,ATP7B,AVPR1B,BAK1,BAX,BBC3,BCAP31,BCL2,BDKRB1,C1QTNF1,C3AR1,CACNA1A,CACNA1C,CALCA,CALCB,CALCR,CALR,CAMK2D,CASQ2,CASR,CAV1,CAV3,CCDC109B,CCKBR,CCL1,CCL11,CCL13,CCL14,CCL15,CCL19,CCL21,CCL23,CCL3,CCL5,CCL7,CCL8,CCR1,CCR2,CCR3,CCR4,CCR5,CCR7,CCR9,CD24,CD36,CD40,CD52,CD55,CDH23,CHERP,CHRNA10,CHRNA7,CHRNA9,CIB2,CLN3,CNNM2,CSRP3,CXCL12,CXCL13,CXCR4,CYP27B1,CYSLTR1,DLG4,DMPK,DRD1,DRD2,DRD3,DRD4,DRD5,EDN1,EDN2,EDNRA,ELANE,EPHX2,ERO1A,ESR1,F2,F2R,F2RL1,FAM20A,FGF2,FIS1,FKBP1B,GCM2,GHRL,GLP1R,GNA15,GPER1,GRIN1,GRM1,HERPUD1,HMGB1,HRC,HSP90B1,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,ITPR3,JPH1,JPH2,JPH3,JPH4,KCNA1,KCTD17,KNG1,LCK,LPAR1,LPAR2,LPAR3,MCHR1,MCU,MCUR1,MICU1,MICU2,MT3,NMUR2,NOL3,NPTN,OPRL1,OPRM1,P2RY1,P2RY4,PARK2,PDE6A,PDE6B,PDGFRA,PKD2,PKHD1,PLCE1,PLCG2,PLN,PML,PRKACA,PROK2,PSEN1,PTPRC,RAP1GDS1,RGN,RMDN3,RYR1,RYR2,S100A14,S100A8,S100A9,S1PR3,S1PR4,SAA1,SLC11A1,SLC30A1,SLC30A5,SLC30A8,SLC35G1,SLC39A13,SLC39A14,SLC39A6,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SMDT1,SPPL3,STC1,STIM2,STOML2,TAC1,TFAP2B,TGM2,TMC8,TMEM165,TMEM203,TMTC2,TNNI3,TPCN2,TPT1,TRDN,TRPC1,TRPM1,TRPV4,VAPB,WFS1,XCL1,XCR1	Any process involved in the maintenance of an internal steady state of divalent cations within an organism or cell.
GO:0072509	GO	MF	divalent inorganic cation transmembrane transporter activity	ATP2A1,ATP2A2,ATP2B2,ATP2B4,ATP2C1,CACFD1,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG3,CACNG5,CACNG6,CACNG7,CACNG8,CLDN16,CUL5,FKBP1B,GAS6,GRIN1,GRIN3B,IL1RAPL1,ITGAV,ITPR1,ITPR2,ITPR3,JPH2,MAGT1,MCU,MMGT1,NCS1,OPRM1,ORAI1,P2RX1,PANX1,PDE2A,PKD1,PKD1L1,PKD2,PKD2L1,PSEN1,RASA3,RYR1,RYR2,RYR3,SLC11A2,SLC24A1,SLC24A2,SLC24A5,SLC30A3,SLC30A4,SLC30A5,SLC30A8,SLC39A11,SLC39A13,SLC39A14,SLC39A2,SLC39A4,SLC39A6,SLC3A2,SLC40A1,SLC8A1,SLC8A2,SLC8A3,SLC8B1,STIM2,TPCN1,TPCN2,TRPA1,TRPC1,TRPC3,TRPC4,TRPC5,TRPM1,TRPV1,TRPV4,TRPV5,TRPV6,TUSC3,ZDHHC13,ZDHHC17,ZP3	Enables the transfer of inorganic cations with a valency of two from one side of the membrane to the other. Inorganic cations are atoms or small molecules with a positive charge that do not contain carbon in covalent linkage.
GO:0072522	GO	BP	purine-containing compound biosynthetic process	ACOT7,ADA,ADAL,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADK,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,AMPD1,AMPD2,AMPD3,APRT,AQP1,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,COASY,DCK,DGUOK,GBAS,GMPR,GMPR2,GMPS,GNAS,GUCY1A3,GUCY1B3,HPRT1,HTR2B,HTR2C,MAT2A,MAT2B,MT-ATP6,MT-ATP8,MTHFD1,NPPA,NPPB,NPPC,NPR1,NPR2,OAS1,OAS2,PAICS,PANK2,PAPSS1,PAPSS2,PFAS,PNP,PPAT,PPCDC,PPCS,PRKAG2,PRPS1,RAMP2,SHMT1,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,VPS9D1	The chemical reactions and pathways resulting in the formation of a purine-containing compound, i.e. any compound that contains purine or a formal derivative thereof.
GO:0072523	GO	BP	purine-containing compound catabolic process	ADA,AMPD3,CAT,CECR1,DPYD,ENPP4,GDA,GPX1,HINT1,HPRT1,MLYCD,MPG,MUTYH,NT5C,NT5C1A,NT5C1B,NT5C2,NT5E,NUDT1,NUDT15,NUDT16,NUDT18,NUDT7,OGG1,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A,PNP,SAMHD1,XDH	The chemical reactions and pathways resulting in the breakdown of a purine-containing compound, i.e. any compound that contains purine or a formal derivative thereof.
GO:0072524	GO	BP	pyridine-containing compound metabolic process	ACMSD,ALDOA,ALDOB,ALDOC,AOX1,DERA,DLD,ENO1,ENO2,ENO3,FMO1,FMO2,G6PD,GAPDH,GAPDHS,GCK,GPD1L,GPI,HAAO,HK1,HK2,HK3,IDH1,KCNAB2,KYNU,LDHA,ME1,NADK,NADK2,NADSYN1,NAMPT,NAPRT,NMNAT1,NMNAT2,NMNAT3,NOX1,NUDT12,PDHB,PDHX,PDXK,PDXP,PFKFB1,PFKFB2,PFKFB3,PFKFB4,PFKL,PFKM,PFKP,PGAM1,PGAM2,PGAM4,PGD,PGK1,PGK2,PGLS,PGM1,PGM2,PKLR,PKM,PNP,PNPO,PPP2R5D,PRDX5,PSAT1,PTGIS,PTGS2,QPRT,RPE,RPIA,SHPK,TALDO1,TKT,TP53I3,TPI1,VCP	The chemical reactions and pathways involving a pyridine-containing compound, i.e. any compound that contains pyridine or a formal derivative thereof.
GO:0072525	GO	BP	pyridine-containing compound biosynthetic process	HAAO,KYNU,ME1,NMNAT1,NMNAT2,NMNAT3,PDXK,PNP,PSAT1	The chemical reactions and pathways resulting in the formation of a pyridine-containing compound, i.e. any compound that contains pyridine or a formal derivative thereof.
GO:0072527	GO	BP	pyrimidine-containing compound metabolic process	ACPP,AGXT2,AK3,AK5,ALDH6A1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CAD,CDA,CMPK1,CTPS1,CTPS2,DCK,DCTD,DHFRL1,DHODH,DPYD,DPYS,DUT,ENTPD4,ERH,MBD4,NEIL1,NEIL2,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,NTHL1,OGG1,PRPS1,PUDP,SLC19A2,SLC19A3,SMUG1,TDG,TET2,THTPA,TK1,TK2,TKTL1,TPK1,TYMP,TYMS,UCK1,UCK2,UMPS,UNG,UPB1,UPP1,UPP2	The chemical reactions and pathways involving a pyrimidine-containing compound, i.e. any compound that contains pyrimidine or a formal derivative thereof.
GO:0072528	GO	BP	pyrimidine-containing compound biosynthetic process	AK5,CAD,CDA,CMPK1,CTPS1,DCK,DCTD,DHFRL1,DHODH,DUT,PRPS1,PUDP,TK1,TK2,TYMP,TYMS,UCK1,UCK2,UMPS,UPP1,UPP2	The chemical reactions and pathways resulting in the formation of a pyrimidine-containing compound, i.e. any compound that contains pyrimidine or a formal derivative thereof.
GO:0072529	GO	BP	pyrimidine-containing compound catabolic process	AGXT2,ALDH6A1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,DPYD,DPYS,ENTPD4,MBD4,NEIL1,NEIL2,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,NTHL1,OGG1,SMUG1,TDG,TET2,TYMP,UNG,UPB1,UPP1,UPP2	The chemical reactions and pathways resulting in the breakdown of a pyrimidine-containing compound, i.e. any compound that contains pyrimidine or a formal derivative thereof.
GO:0072530	GO	BP	purine-containing compound transmembrane transport	AQP9,SLC25A17,SLC25A26,SLC25A42,SLC28A2,SLC35B2	The directed movement of a purine-containing compound across a membrane. A purine-containing compound is any compound that contains purine or a formal derivative thereof.
GO:0072531	GO	BP	pyrimidine-containing compound transmembrane transport	AQP9,SLC19A2,SLC25A33,SLC35A3,SLC35B1,SLC35B4	The directed movement of a pyrimidine-containing compound across a membrane. A pyrimidine-containing compound is any compound that contains pyrimidine or a formal derivative thereof.
GO:0072539	GO	BP	T-helper 17 cell differentiation	BATF,IL6,IRF4,LY9,RORA,RORC,SLAMF6	The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 17 (Th17) cell. A Th17 cell is a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.
GO:0072540	GO	BP	T-helper 17 cell lineage commitment	BATF,IL6,IRF4,LY9,SLAMF6	The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.
GO:0072542	GO	MF	protein phosphatase activator activity	B3GAT3,CALM1,IGFBP3,PHACTR4,PPP1R15A,PPP2R4	Increases the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule.
GO:0072546	GO	CC	ER membrane protein complex	EMC1,EMC10,EMC2,EMC3,EMC4,EMC6,EMC7,EMC8,EMC9,MMGT1	A transmembrane protein complex that is involved in protein folding in the endoplasmic reticulum. In S. cerevisiae, it has six members: EMC1, EMC2, AIM27, EMC4, KRE27, and EMC6.
GO:0072562	GO	CC	blood microparticle	A1BG,A2M,ACSM1,ACTA1,ACTB,ACTC1,ACTG1,ACTG2,AFM,AGT,AHSG,ALB,AMBP,ANGPTL4,APCS,APOA1,APOA2,APOA4,APOE,APOL1,BCHE,C1QB,C1QC,C1R,C1S,C3,C4A,C4B,C4BPA,C8A,C8G,C9,CD5L,CFB,CFH,CFHR1,CFHR3,CIB2,CLIC1,CLU,CP,CPN2,CPSF3L,DNPEP,EIF2A,F13A1,F2,FCN2,FCN3,FGA,FGB,FGG,FN1,GC,GRIPAP1,GSN,HBA1,HBB,HBD,HBE1,HBG2,HP,HPR,HPX,HRG,HSPA1A,HSPA1B,HSPA1L,HSPA2,HSPA6,HSPA8,ITGA2B,ITIH1,ITIH2,ITIH4,JCHAIN,KDM4D,KNG1,KRT1,LGALS3BP,MSN,OAZ3,ORM1,ORM2,PFN1,PLG,PON1,POTEE,POTEF,PROS1,PRSS1,PSMC5,PZP,SDCBP,SERPINA3,SERPINC1,SERPINF2,SERPING1,SLC2A1,SLC4A1,STOM,TF,TFRC,TGFB1,TMPRSS13,VTN,YWHAZ,ZBTB38,ZNF177	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
GO:0072578	GO	BP	neurotransmitter-gated ion channel clustering	APOE,DLG4,NLGN1,NRXN1,SHANK3	The receptor clustering process in which neurotransmitter-gated ion channels are localized to distinct domains in the cell membrane.
GO:0072583	GO	BP	clathrin-mediated endocytosis	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,CANX,CDK5,DLL1,FCHO1,FCHO2,FNBP1L,ITSN1,PACSIN1,PICALM,PIP5K1C,SNCA,STON2,SYNJ1	An endocytosis process that begins when material is taken up into clathrin-coated pits, which then pinch off to form clathrin-coated endocytic vesicles.
GO:0072584	GO	BP	caveolin-mediated endocytosis	CAV1,MAPK1,MAPK3,MLC1,PACSIN2	An endocytosis process that begins when material is taken up into plasma membrane caveolae, which then pinch off to form endocytic caveolar carriers.
GO:0072593	GO	BP	reactive oxygen species metabolic process	AKT1,ALOX12,AOX1,APOA4,ARG2,ATP7A,BNIP3,CALM1,CAT,CAV1,CPS1,CYB5R4,CYBA,CYBB,CYGB,CYP1B1,DDAH1,DDAH2,DHFR,DNM2,DRD5,DUOX1,EPHX2,GBF1,GCH1,GCHFR,GLS2,GPX1,GPX3,HBA1,HBB,HSP90AA1,LRRK2,LYPLA1,MAOB,MPO,MPV17L,MT3,NCF1,NCF2,NDUFA13,NDUFS1,NDUFS3,NDUFS4,NNT,NOS1,NOS2,NOS3,NOSIP,NOSTRIN,NOX1,NOX4,NOX5,NOXA1,NQO1,NRROS,PARK7,PAX2,PDGFB,PDK4,PLA2R1,PMAIP1,PRDX1,PRDX2,PRDX3,PRDX5,PREX1,PRG3,PRKG2,PTS,PXDN,PXDNL,SFTPD,SH3PXD2A,SH3PXD2B,SOD1,SOD2,SOD3,SPR,WASL,ZDHHC21	The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
GO:0072595	GO	BP	maintenance of protein localization in organelle	AKT1,ANKRD13C,ARL2,ARL2BP,BBS4,BCL3,GPAA1,HK1,HK2,HSPA5,MORC3,OS9,PDIA2,PDIA3,PINK1,PML,SUN1,SUN2,SUPT7L,SYNE1,TAF3,TAF8,TOPORS	Any process in which a protein is maintained in a specific location a specific location on or in an organelle, and is prevented from moving elsewhere. Encompasses establishment of localization in the membrane or lumen of a membrane-bounded organelle.
GO:0072599	GO	BP	establishment of protein localization to endoplasmic reticulum	CHMP4A,CHMP4B,DDOST,FAU,RAB10,RAB3GAP1,RAB3GAP2,RPL10,RPL10A,RPL11,RPL12,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL23A,RPL24,RPL26,RPL26L1,RPL27,RPL27A,RPL28,RPL29,RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL35A,RPL36,RPL36A,RPL37,RPL37A,RPL38,RPL39,RPL3L,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPLP1,RPLP2,RPN1,RPN2,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27,RPS27A,RPS28,RPS29,RPS3,RPS3A,RPS4X,RPS4Y1,RPS5,RPS6,RPS7,RPS8,RPS9,RPSA,RYR2,SEC11A,SEC11C,SEC61A1,SEC61B,SEC61G,SEC62,SEC63,SPCS1,SPCS2,SPCS3,SRP14,SRP19,SRP54,SRP68,SRP72,SRP9,SRPR,SRPRB,SSR1,SSR2,SSR3,SSR4,TRAM1,UBA52,ZFAND2B	The directed movement of a protein to a specific location in the endoplasmic reticulum.
GO:0072600	GO	BP	establishment of protein localization to Golgi	ATP9B,NRAS,OPTN,RAB33B,RAB6A,SORL1	The directed movement of a protein to a specific location in the Golgi apparatus.
GO:0072643	GO	BP	interferon-gamma secretion	BTN3A1,BTN3A2,F2RL1,LILRB1,TRIM27	The regulated release of interferon-gamma from a cell.
GO:0072655	GO	BP	establishment of protein localization to mitochondrion	AIP,AKT1,CHCHD2,CHCHD4,COX18,COX19,DNAJC19,FBXO7,FIS1,GDAP1,GFER,GRPEL1,GRPEL2,HK1,HK2,HSP90AA1,HSPA4,HSPA9,IMMP2L,MFF,MFN2,MGARP,MIPEP,MOAP1,MTX1,MTX2,NDUFA13,PAM16,PDE2A,PINK1,PMPCA,PMPCB,SAMM50,SLC25A6,TIMM10,TIMM10B,TIMM13,TIMM17A,TIMM17B,TIMM21,TIMM22,TIMM23,TIMM44,TIMM50,TIMM8A,TIMM8B,TIMM9,TOMM20,TOMM22,TOMM34,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TRNT1,TSPO	The directed movement of a protein to the mitochondrion or a part of the mitochondrion.
GO:0072659	GO	BP	protein localization to plasma membrane	ABCA12,ACTN2,ADIPOQ,AMN,ANK1,ANK2,ANK3,ARFRP1,ATP1B1,ATP1B3,BBS1,BBS2,BLZF1,BSG,CALCR,CAV1,CAV3,CDH1,CLASP2,CRB3,DENND4C,DLG1,DPP10,DPP6,EFR3A,EFR3B,EHD2,EHD3,EMP2,EPB41L3,EZR,F11R,FAM126A,FCHO2,FGF13,FLOT1,FLOT2,GAS6,GOLGA4,GOLGA7,GOLPH3,IKBKB,INPP5K,JUP,KCNB1,KCNB2,KCNIP3,KCNIP4,KIF13A,KRT18,MACF1,MAP7,MYADM,MYO5A,NKD2,OPTN,P2RY1,PACS1,PACS2,PACSIN1,PIGW,PIP5K1A,PKP2,PKP3,PLEKHF1,PPIL2,PTCH1,RAB10,RAB11A,RAB13,RAB26,RAB31,RAB34,RAB8A,RAMP1,RAMP2,RAMP3,RAP2A,RAPGEF2,RAPGEF6,RDX,RILPL1,RILPL2,ROCK1,ROCK2,S100A10,SCN3B,SCP2,SLC9A3R1,SMURF1,SPTBN1,SPTBN4,STXBP1,TESC,TMED2,TMEM150A,TMEM88,TNF,TNFRSF1A,TNIK,TSPAN14,TSPAN15,TSPAN33,TSPAN5,TTC7A,TTC7B,VAMP2,WNT4,ZFYVE27	A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
GO:0072661	GO	BP	protein targeting to plasma membrane	ANK1,ANK3,BSG,EHD3,GAS6,INPP5K,KCNB1,KCNB2,MYADM,NKD2,PACS1,PACS2,PIP5K1A,PTCH1,SMURF1,SPTBN1,TESC,TMED2	The process of directing proteins towards the plasma membrane; usually uses signals contained within the protein.
GO:0072665	GO	BP	protein localization to vacuole	AP3M1,CD81,GCC2,GNPTAB,HGS,HSPA8,LAMTOR4,LAMTOR5,NAGPA,NEDD4,RAB7A,RNF128,SCARB2,SH3BP4,SH3GLB1,SMURF1,SNX16,SORL1,ZFYVE16	A process in which a protein is transported to, or maintained at, a location in a vacuole.
GO:0072669	GO	CC	tRNA-splicing ligase complex	C14orf166,C2orf49,DDX1,FAM98B,RTCB,ZBTB8OS	A protein complex that catalyzes the ligation of cleaved pre-tRNAs by directly joining spliced tRNA halves to mature-sized tRNAs by incorporating the precursor-derived splice junction phosphate into the mature tRNA as a canonical 3',5'-phosphodiester.
GO:0072676	GO	BP	lymphocyte migration	ADAM8,CCL2,CCL3,CCR2,CCR7,CKLF,CXCL10,CXCL11,CXCL13,GAS6,GATA3,MYO1G,PIK3CD,PIK3CG,RET,S1PR1,SAA1,TBX21,XCL1,ZAP70	The movement of a lymphocyte within or between different tissues and organs of the body.
GO:0072678	GO	BP	T cell migration	CCL2,CCL3,CCR2,CXCL10,CXCL11,MYO1G,PIK3CD,PIK3CG,S1PR1,ZAP70	The movement of a T cell within or between different tissues and organs of the body.
GO:0072686	GO	CC	mitotic spindle	AGBL5,ASPM,ATAT1,CAPG,CCSAP,CDC42,CDK1,CENPE,CLASP2,DIAPH1,DYNLL1,ECT2,EFHC1,EML1,EML2,FAM83D,GEM,GOLGA2,GPSM2,IKBKG,KIF20B,KIF22,KIF23,KLHL22,KNSTRN,MAD1L1,MAD2L1,MAK,MAP10,MAP4,MAPK1,NUMA1,OR2A4,PKD2,PKHD1,PKP4,RACGAP1,RCC2,RPS3,SIRT2,SPAG5,TPR	A spindle that forms as part of mitosis. Mitotic and meiotic spindles contain distinctive complements of proteins associated with microtubules.
GO:0072698	GO	BP	protein localization to microtubule cytoskeleton	BBS4,C2CD3,CCDC14,CEP131,CEP83,CHAMP1,CRIPT,CSNK1D,DCTN2,DIAPH1,FAM83D,HOOK3,KIAA0753,KIF20B,MAPRE1,MID1,MID2,PCM1,PIBF1,SNX10,SPAG5,STIL	A cellular protein localization process in which a protein is transported to, or maintained at, a location within the microtubule cytoskeleton.
GO:0075713	GO	BP	establishment of integrated proviral latency	BANF1,HMGA1,LIG4,PPIA,PSIP1,XRCC4,XRCC5,XRCC6	A process by which the virus integrates into the host genome and establishes as a stable provirus or prophage.
GO:0075733	GO	BP	intracellular transport of virus	ALYREF,CD209,CLEC4M,DDX39B,DERL1,DYNLT1,IFIT1,KPNA1,KPNB1,NMT2,RAN,RPS27A,TAP1,TAP2,THOC1,THOC2,THOC3,THOC5,THOC6,THOC7,TSG101,UBA52,UBB,UBC,VPS28,VPS37A,VPS37B,VPS37C,VPS37D,XPO1	The directed movement of a virus, or part of a virus, within the host cell.
GO:0080008	GO	CC	Cul4-RING E3 ubiquitin ligase complex	CDKN1B,CRBN,CUL4A,CUL4B,DCAF10,DCAF11,DCAF12,DCAF13,DCAF16,DCAF17,DCAF4,DCAF5,DCAF6,DCAF7,DCAF8,DDB1,DDB2,DTL,ERCC8,FBXW5,RBX1,TRPC4AP	A ubiquitin ligase complex in which a cullin from the Cul4 family and a RING domain protein form the catalytic core; substrate specificity is conferred by an adaptor protein.
GO:0080009	GO	BP	mRNA methylation	CMTR1,CMTR2,KIAA1429,METTL14,METTL3,WTAP	The posttranscriptional addition of methyl groups to specific residues in an mRNA molecule.
GO:0080025	GO	MF	phosphatidylinositol-3,5-bisphosphate binding	CLVS1,CLVS2,COMMD1,FAM21C,GBF1,JPH2,KIF16B,MAPKAP1,PHLDA3,RAG2,SESTD1,SH3PXD2B,SNX14,SNX3,WIPI1,WIPI2	Interacting selectively and non-covalently with phosphatidylinositol-3,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' and 5' positions.
GO:0080111	GO	BP	DNA demethylation	AICDA,ALKBH1,ALKBH2,ALKBH3,APEX1,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,FTO,TDG,TET1,TET2,TET3	The removal of a methyl group from one or more nucleotides within an DNA molecule.
GO:0080154	GO	BP	regulation of fertilization	ASUN,FAM170B,PLCB1,RNASE10,TEKT3	Any process that modulates the rate, frequency or extent of fertilization. Fertilization is the union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
GO:0080182	GO	BP	histone H3-K4 trimethylation	BEND3,CTR9,KMT2A,OGT,TET2,TET3,WDR61,ZNF335	The modification of histone H3 by addition of three methyl groups to lysine at position 4 of the histone.
GO:0085020	GO	BP	protein K6-linked ubiquitination	BARD1,BRCA1,PARK2,RNF4,RNF6,UBE2D4,UBE2S,UBE2T	A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 6 of the ubiquitin monomers, is added to a protein. K6-linked ubiquitination is involved in DNA repair.
GO:0085029	GO	BP	extracellular matrix assembly	ATP7A,FBLN5,GAS6,GPM6B,HAS1,HAS2,HAS3,MFAP4,MYH11,RAMP2,TGFB1,TNXB	The aggregation, arrangement and bonding together of the extracellular matrix.
GO:0086001	GO	BP	cardiac muscle cell action potential	ANK2,ATP1A1,ATP1A2,ATP1B1,CACNA1D,CAV3,DMD,FGF12,GJA1,GJC1,GPD1L,HCN4,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,NEDD4L,PKP2,RYR2,SCN10A,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,SNTA1,YWHAE	An action potential that occurs in a cardiac muscle cell.
GO:0086002	GO	BP	cardiac muscle cell action potential involved in contraction	ANK2,CAV3,FGF12,GJA1,GJC1,GPD1L,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,NEDD4L,PKP2,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SNTA1	An action potential that occurs in a cardiac muscle cell and is involved in its contraction.
GO:0086003	GO	BP	cardiac muscle cell contraction	ANK2,CAMK2D,CAV3,FGF12,GJA1,GJC1,GPD1L,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,NEDD4L,PKP2,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SNTA1	The actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of a cardiac muscle cell.
GO:0086004	GO	BP	regulation of cardiac muscle cell contraction	ANK2,ATP2A2,CAMK2D,CAV1,CTNNA3,DSC2,DSG2,DSP,GJA5,JUP,NOS1AP,PDE4B,PDE4D,PKP2,PLN,RNF207,RYR2,SCN5A,SRI,STC1	Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction.
GO:0086005	GO	BP	ventricular cardiac muscle cell action potential	ANK2,CAV3,GPD1L,KCNE1,KCNE2,KCNE5,KCNH2,KCNQ1,NEDD4L,PKP2,RYR2,SCN3B,SCN5A,SNTA1	An action potential that occurs in a ventricular cardiac muscle cell.
GO:0086006	GO	MF	voltage-gated sodium channel activity involved in cardiac muscle cell action potential	SCN1B,SCN2B,SCN3B,SCN4B,SCN5A	Enables the transmembrane transfer of a sodium ion by a voltage-gated channel through the plasma membrane of a cardiac muscle cell contributing to the depolarization phase of an action potential. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0086008	GO	MF	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1	Enables the transmembrane transfer of a potassium ion by a voltage-gated channel through the plasma membrane of a cardiac muscle cell contributing to the repolarization phase of an action potential. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.
GO:0086009	GO	BP	membrane repolarization	ATP1A1,ATP1A2,ATP1B1,ATP1B2,ATP1B3,KCNA5,KCND3,KCNE1,KCNE2,KCNE5,KCNH2,KCNIP2,KCNJ2,KCNQ1,YWHAE	The process in which ions are transported across a membrane such that the membrane potential changes in the repolarizing direction, toward the steady state potential. For example, the repolarization during an action potential is from a positive membrane potential towards a negative resting potential.
GO:0086010	GO	BP	membrane depolarization during action potential	ANK2,ATP1A2,CACNA1D,KCNH2,KCNJ2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1,YWHAH	The process in which membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
GO:0086011	GO	BP	membrane repolarization during action potential	ATP1A1,ATP1B1,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,YWHAE	The process in which ions are transported across a membrane such that the membrane potential changes in the direction from the positive membrane potential at the peak of the action potential towards the negative resting potential.
GO:0086012	GO	BP	membrane depolarization during cardiac muscle cell action potential	ANK2,ATP1A2,CACNA1D,KCNJ2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC8A1	The process in which cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential.
GO:0086013	GO	BP	membrane repolarization during cardiac muscle cell action potential	ATP1A1,ATP1B1,KCNA5,KCNE1,KCNE5,KCNH2,KCNJ2,KCNQ1,YWHAE	The process in which ions are transported across a membrane such that the cardiac muscle cell plasma membrane potential changes in the direction from the positive membrane potential at the peak of the action potential towards the negative resting potential.
GO:0086014	GO	BP	atrial cardiac muscle cell action potential	ANK2,GJA1,GJC1,KCNA5,KCNE5,KCNQ1,SCN3B	An action potential that occurs in an atrial cardiac muscle cell.
GO:0086015	GO	BP	SA node cell action potential	ANK2,CACNA1D,HCN4,KCNA5,SCN3B,SCN5A	An action potential that occurs in a sinoatrial node cardiac muscle cell.
GO:0086019	GO	BP	cell-cell signaling involved in cardiac conduction	ANK2,CACNA1D,CASQ2,GJA1,GJC1,HCN4,KCNA5,KCNE5,KCNQ1,PKP2,RNF207,RYR2,SCN10A,SCN1B,SCN3B,SCN4B,SCN5A	Any process that mediates the transfer of information from one cell to another and contributes to the heart process that regulates cardiac muscle contraction; beginning with the generation of an action potential in the sinoatrial node and ending with regulation of contraction of the myocardium.
GO:0086036	GO	BP	regulation of cardiac muscle cell membrane potential	ATP2A2,EHD3,FXYD1,PLN,SLC8B1,SLC9A1,TRDN	Any process that modulates the establishment or extent of a membrane potential in a cardiac muscle cell (a cardiomyocyte). A membrane potential is the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
GO:0086064	GO	BP	cell communication by electrical coupling involved in cardiac conduction	ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,CACNA1C,FKBP1B,GJA1,GJA5,PKP2,PRKACA,RYR2,SLC8A1	The process that mediates signaling interactions between one cell and another cell by transfer of current between their adjacent cytoplasms via intercellular protein channels and contributes to the process of cardiac conduction.
GO:0086065	GO	BP	cell communication involved in cardiac conduction	ANK2,ATP1A1,ATP1A2,ATP1A3,ATP1B1,ATP1B2,CACNA1C,CACNA1D,CASQ2,CTNNA3,CXADR,DSC2,DSG2,DSP,FKBP1B,GJA1,GJA5,GJC1,HCN4,JUP,KCNA5,KCNE5,KCNQ1,PKP2,PRKACA,RNF207,RYR2,SCN10A,SCN1B,SCN3B,SCN4B,SCN5A,SLC8A1,TNNI3K	Any process that mediates interactions between a cell and its surroundings that contributes to the process of cardiac conduction. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
GO:0086067	GO	BP	AV node cell to bundle of His cell communication	CXADR,GJA5,SCN10A,SCN4B,SCN5A	The process that mediates interactions between an AV node cell and its surroundings that contributes to the process of the AV node cell communicating with a bundle of His cell in cardiac conduction. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
GO:0086069	GO	BP	bundle of His cell to Purkinje myocyte communication	CTNNA3,DSC2,DSG2,DSP,GJA5,JUP,KCNA5,PKP2,SCN10A,SCN5A,TNNI3K	The process that mediates interactions between a bundle of His cell and its surroundings that contributes to the process of the bundle of His cell communicating with a Purkinje myocyte in cardiac conduction. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
GO:0086073	GO	BP	bundle of His cell-Purkinje myocyte adhesion involved in cell communication	CTNNA3,DSC2,DSG2,DSP,JUP,PKP2	The attachment of a bundle of His cell to a Purkinje myocyte via adhesion molecules that results in the cells being juxtaposed so that they can communicate.
GO:0086083	GO	MF	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	CTNNA3,DSC2,DSG2,DSP,JUP,PKP2	Interacting selectively and non-covalently with any protein or protein complex that results in the connection of a bundle of His cell with a Purkinje myocyte and contributes to the communication between the two cells.
GO:0086091	GO	BP	regulation of heart rate by cardiac conduction	AKAP9,ANK2,CACNA1D,CAMK2D,CAV1,CTNNA3,DSC2,DSG2,DSP,HCN4,JUP,KCNA5,KCNE1,KCNE2,KCNE5,KCNH2,KCNJ2,KCNQ1,PKP2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,YWHAE	A cardiac conduction process that modulates the frequency or rate of heart contraction.
GO:0089711	GO	BP	L-glutamate transmembrane transport	SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A7,SLC25A12,SLC25A13,SLC25A22,SLC7A11	The directed movement of L-glutamate across a membrane.
GO:0090002	GO	BP	establishment of protein localization to plasma membrane	ACTN2,AMN,ANK1,ANK3,ARFRP1,ATP1B1,BBS1,BBS2,BLZF1,BSG,CDH1,CLASP2,EFR3A,EFR3B,EHD3,EZR,F11R,FAM126A,FLOT1,FLOT2,GAS6,GOLGA4,GOLGA7,GOLPH3,IKBKB,INPP5K,JUP,KCNB1,KCNB2,KIF13A,KRT18,MACF1,MYADM,NKD2,OPTN,PACS1,PACS2,PACSIN1,PIP5K1A,PKP2,PKP3,PTCH1,RAB10,RAB13,RAB26,RAB31,RAB34,RDX,RILPL1,RILPL2,ROCK1,ROCK2,S100A10,SLC9A3R1,SMURF1,SPTBN1,SPTBN4,TESC,TMED2,TMEM150A,TNF,TNFRSF1A,TSPAN14,TSPAN15,TSPAN33,TSPAN5,TTC7A,TTC7B,VAMP2,WNT4	The directed movement of a protein to a specific location in the plasma membrane.
GO:0090003	GO	BP	regulation of establishment of protein localization to plasma membrane	ACSL3,AGR2,AKT1,ANXA13,APPL1,AR,ARF6,ARHGEF16,BCL2L1,CIB1,CLIP3,CNST,CSK,DLG1,DPP10,EPHA2,GNB2L1,GOPC,GPER1,IFNG,ITGA3,ITGB1,KIF5B,LDLRAP1,LRRC15,NKD2,NRXN1,PDPK1,PID1,PIK3R1,PKDCC,PLS1,PPFIA1,PPP2R5A,PRKCI,RAMP3,RANGRF,RHOG,RHOQ,SORBS1,STX4,TMBIM1,TMEM59,WNK3	Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location in the plasma membrane.
GO:0090004	GO	BP	positive regulation of establishment of protein localization to plasma membrane	ACSL3,AGR2,AKT1,ANXA13,ARF6,ARHGEF16,CIB1,CLIP3,CNST,DLG1,DPP10,EPHA2,GNB2L1,GPER1,IFNG,ITGA3,ITGB1,KIF5B,NKD2,NRXN1,PDPK1,PIK3R1,PLS1,PRKCI,RAMP3,RANGRF,RHOG,SORBS1,STX4,WNK3	Any process that increases the frequency, rate or extent of the directed movement of a protein to a specific location in the plasma membrane.
GO:0090005	GO	BP	negative regulation of establishment of protein localization to plasma membrane	ANXA13,BCL2L1,CSK,GOPC,LRRC15,PID1,PKDCC,PPFIA1,PPP2R5A,RHOQ,TMBIM1,TMEM59	Any process that decreases the frequency, rate or extent of the directed movement of a protein to a specific location in the plasma membrane.
GO:0090022	GO	BP	regulation of neutrophil chemotaxis	C1QBP,C5AR2,CAMK1D,CCL19,CCL21,CCR7,CD74,CXCL8,DAPK2,JAM3,MPP1,NCKAP1L,RAC1,RAC2,SLIT2,THBS4,TIRAP,XCL1	Any process that modulates the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
GO:0090023	GO	BP	positive regulation of neutrophil chemotaxis	C1QBP,CAMK1D,CCL19,CCL21,CCR7,CD74,CXCL8,DAPK2,NCKAP1L,RAC1,RAC2,THBS4,TIRAP,XCL1	Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
GO:0090025	GO	BP	regulation of monocyte chemotaxis	AIF1,ANO6,CCL5,CCR1,CCR2,CREB3,CXCL10,CXCL12,GREM1,HMGB1,LYN,NBL1,NOV,PLA2G7,S100A14,S100A7,SERPINE1,SLIT2	Any process that modulates the frequency, rate, or extent of monocyte chemotaxis.
GO:0090026	GO	BP	positive regulation of monocyte chemotaxis	AIF1,ANO6,CCL5,CCR1,CCR2,CREB3,CXCL10,CXCL12,HMGB1,PLA2G7,S100A14,S100A7,SERPINE1	Any process that increases the frequency, rate, or extent of monocyte chemotaxis.
GO:0090036	GO	BP	regulation of protein kinase C signaling	ADRA1A,CD40,FLT4,GPD1L,MC1R,MYADM,ULK4,VEGFA,WNT11,WNT5A	Any process that modulates the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
GO:0090037	GO	BP	positive regulation of protein kinase C signaling	ADRA1A,CD40,FLT4,MC1R,VEGFA,WNT11,WNT5A	Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
GO:0090045	GO	BP	positive regulation of deacetylase activity	C6orf89,CREB3,FNTA,MAPK8,PRKD1,PRKD2,VEGFA	Any process that activates or increases the frequency, rate or extent of deacetylase activity, the catalysis of the hydrolysis of an acetyl group or groups from a substrate molecule.
GO:0090049	GO	BP	regulation of cell migration involved in sprouting angiogenesis	CIB1,DLL4,FOXC2,HDAC5,HDAC7,HDAC9,ITGB1BP1,KLF4,MAP2K5,MMRN2,NOTCH1,PDCD10,PTGS2,RHOA,SRPX2,STARD13,VEGFA	Any process that modulates the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
GO:0090050	GO	BP	positive regulation of cell migration involved in sprouting angiogenesis	CIB1,FOXC2,HDAC7,HDAC9,PTGS2,SRPX2,VEGFA	Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
GO:0090051	GO	BP	negative regulation of cell migration involved in sprouting angiogenesis	DLL4,HDAC5,ITGB1BP1,KLF4,MAP2K5,MMRN2,NOTCH1,PDCD10,RHOA,STARD13	Any process that decreases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
GO:0090073	GO	BP	positive regulation of protein homodimerization activity	GNL3L,MEF2C,PARK7,TIRAP,TRAF2,TRAF4,ZNF268	Any process that increases the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
GO:0090075	GO	BP	relaxation of muscle	ATP1A1,ATP1A2,ATP1B1,ATP2A1,ATP2A2,CAMK2D,GSTM2,KCNJ2,P2RX4,PLN,RGS2,SLC8A1,SOD1	A process in which the extent of muscle contraction is reduced. Muscle relaxation can involve a number of processes including the removal of calcium from the cytoplasm to the sarcoplasmic reticulum lumen through the action of Ca2+ ATPases. In some muscles, calcium-independent pathways also play a role in muscle relaxation by decreasing the phosphorylation state of myosin light chain.
GO:0090079	GO	MF	translation regulator activity, nucleic acid binding	ABCF1,BOLL,CELF1,CELF4,CPEB1,CPEB2,CPEB3,DAZ1,DAZL,LARP1,PABPC1,PAIP1,PAIP2B,RPS27L,ZNF540	Any selective and non-covalent interaction with a nucleic acid involved in the initiation, activation, perpetuation, repression or termination of polypeptide synthesis at the ribosome.
GO:0090083	GO	BP	regulation of inclusion body assembly	APOE,BAG5,CLU,DNAJA4,DNAJB1,DNAJB2,DNAJB6,DNAJB8,HSPA1A,HSPA1B,HSPA2,SACS,SNCAIP,SORL1	Any process that modulates the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body.
GO:0090084	GO	BP	negative regulation of inclusion body assembly	DNAJA4,DNAJB1,DNAJB2,DNAJB6,DNAJB8,HSPA1A,HSPA1B,HSPA2,SACS,SORL1	Any process that decreases the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body.
GO:0090085	GO	BP	regulation of protein deubiquitination	DNAJB2,ITCH,PARK7,SART3,TRIM21,UBXN1,VCP	Any process that modulates the frequency, rate or extent of protein deubiquitination. Protein deubiquitination is the removal of one or more ubiquitin groups from a protein.
GO:0090087	GO	BP	regulation of peptide transport	ABCC8,ADCY5,ADRA2A,ADRA2C,AKAP5,ANO1,ARL2,ARL2BP,ARNTL,BAD,BLK,BMP7,BMP8A,BRSK2,C1QTNF3,C8orf4,CA2,CACNA1A,CACNA1C,CACNA1D,CACNA1E,CACNA2D2,CAPN10,CCDC22,CCL19,CCL5,CD27,CD74,CDK16,CFTR,CHD7,CHRM3,CLOCK,CRHBP,CYLD,DOC2B,DRD2,EFNA5,ENSA,EPHA5,FAF1,FAM3D,FFAR1,FFAR2,FFAR3,FGA,FGB,FGG,FOXA2,G3BP2,G6PC2,GCG,GCK,GHRH,GHRHR,GHRL,GIP,GLP1R,GLUD1,GNAS,GPER1,GPLD1,HFE,HLA-DRB1,HNF4A,HTR2C,IFNG,IL10,IL12B,IL1B,IL23A,INHBB,INS,IQGAP1,IRS1,IRS2,ISL1,ITPR1,ITPR2,ITPR3,KCNA5,KCNB1,KCNC2,KCNG2,KCNJ11,KCNS3,LGALS9,MARCKS,MCU,MTNR1B,MYRIP,NEUROD1,NFKBIA,NLGN2,NLRP12,NLRP3,NOS2,NOV,NR1D1,NR1H4,PARK2,PASK,PAX8,PCSK1,PER2,PIM3,PPM1A,PPM1B,PPP3CB,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PSMD10,PSMD9,PYDC2,RAP1A,RAPGEF3,RAPGEF4,RASL10B,RBP4,REST,RFX3,RFX6,RHOA,SEC11A,SEC11C,SFRP1,SIRT4,SLC25A4,SLC25A5,SLC25A6,SLC26A6,SLC2A1,SLC2A2,SLC30A8,SLC8B1,SNAP25,SOX4,SPCS1,SPCS2,SPCS3,SPHK1,STX1A,STX4,STXBP1,STXBP4,SYT5,TCF7L2,TFAP2B,TFR2,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM27,TNF,TNFSF11,TNFSF14,TRIP6,UQCC2,VAMP2,ZC3H12A,ZNF268	Any process that modulates the frequency, rate or extent of the directed movement of peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:0090090	GO	BP	negative regulation of canonical Wnt signaling pathway	AES,AMER1,AMER2,APC,APC2,APOE,AXIN1,AXIN2,BICC1,CAV1,CHD8,CSNK1A1,CTNND1,CUL3,CYLD,DAB2,DAB2IP,DACT1,DDIT3,DKK1,DKK2,DKK3,DRAXIN,DVL1,DVL2,DVL3,FRZB,FUZ,FZD6,GLI1,GLI3,GREM1,GSK3A,GSK3B,HDAC1,HECW1,INVS,KIAA0922,KLHL12,KREMEN2,LATS1,LATS2,LEF1,LIMD1,LRP4,LRP6,MAD2L2,MCC,MESP1,MLLT3,NKD1,NKD2,NKX2-5,NOG,NPHP3,PARK2,PFDN5,PPP2R3A,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTPRO,RBX1,RPS27A,SCYL2,SDHAF2,SFRP1,SFRP2,SFRP4,SFRP5,SIAH2,SNAI2,SOST,SOX17,SOX2,SOX9,STK3,STK4,TBX18,TCF7L2,TLE2,TMEM88,UBA52,UBB,UBC,WIF1,WNT11,WNT3A,WNT4,WNT5A,WNT9A,WWTR1,ZNRF3	Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
GO:0090091	GO	BP	positive regulation of extracellular matrix disassembly	CLASP1,CLASP2,DDR2,FSCN1,MFI2	Any process that increases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.
GO:0090092	GO	BP	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	ACVR1,ACVR1B,ACVR2A,ACVR2B,ACVRL1,ADAM17,ADAMTSL2,ASPN,BAMBI,BCL9L,BMP10,BMP2,BMP4,BMP5,BMP6,BMP7,BMPER,BMPR1A,BMPR2,CAV1,CD109,CDKN1C,CDKN2B,CER1,CHRD,CIDEA,CITED1,CITED2,CRB2,CSNK2B,CYR61,DAB2,DACT2,DAND5,DKK1,EID2,ENG,FAM89B,FBN1,FBN2,FBXL15,FKBP1A,FLCN,FOLR1,FOXD1,FST,FSTL3,GDF10,GDF2,GDF3,GDF5,GDF6,GDF7,GIPC1,GREM1,HES5,HFE,HIPK2,HTRA3,HTRA4,IL17F,ING2,INHBA,ITGA3,LDLRAD4,LEMD3,LTBP1,LTBP4,MAGI2,MEN1,MTMR4,NBL1,NEDD4L,NKX2-1,NODAL,NOG,NOTCH1,NOV,PBLD,PCSK6,PDPK1,PEG10,PIN1,PMEPA1,POU5F1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRDM16,RBPJ,RBPMS,RPS27A,SDCBP,SHH,SIRT1,SKI,SKIL,SKOR1,SKOR2,SMAD2,SMAD3,SMAD4,SMAD6,SMAD7,SMURF1,SMURF2,SNW1,SNX25,SNX6,SOST,SOX11,STK11,STRAP,STUB1,SULF1,TFAP2B,TGFB1,TGFB1I1,TGFB3,TGFBR1,TGFBR2,THBS1,TRIM33,TTK,UBA52,UBB,UBC,UBE2O,UCHL5,USP15,VASN,VWC2,WNT1,WWTR1,XIAP,XPO1,ZFYVE9,ZNF423,ZNF703	Any process that modulates the rate, frequency, or extent of the series of molecular signals generated as a consequence of a transmembrane receptor serine/threonine kinase binding to its physiological ligand.
GO:0090100	GO	BP	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	ACVR1,ACVR1B,ACVR2A,ACVR2B,ACVRL1,ADAM17,BMP10,BMP2,BMP4,BMP5,BMP6,BMP7,BMPR1A,BMPR2,CDKN1C,CDKN2B,CITED1,CITED2,CRB2,CSNK2B,CYR61,DAB2,ENG,FBXL15,FLCN,FOXD1,GDF10,GDF2,GDF5,GDF6,GDF7,GIPC1,HES5,HFE,HIPK2,ING2,INHBA,MEN1,NODAL,NOTCH1,POU5F1,RBPJ,RBPMS,SDCBP,SMAD2,SMAD4,SNW1,SOX11,STK11,SULF1,TGFB1,TGFB1I1,TGFB3,TGFBR1,THBS1,TTK,UBE2O,ZNF423	Any process that increases the rate, frequency, or extent of the series of molecular signals generated as a consequence of a transmembrane receptor serine/threonine kinase binding to its physiological ligand.
GO:0090101	GO	BP	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	ACVR1,ADAM17,ADAMTSL2,ASPN,BAMBI,BCL9L,BMPER,CAV1,CD109,CER1,CHRD,CIDEA,DACT2,DAND5,DKK1,EID2,ENG,FAM89B,FBN1,FBN2,FST,FSTL3,GDF3,GREM1,HIPK2,HTRA3,HTRA4,LDLRAD4,LEMD3,LTBP1,MAGI2,MTMR4,NBL1,NEDD4L,NKX2-1,NOG,NOTCH1,NOV,PBLD,PDPK1,PEG10,PIN1,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRDM16,RPS27A,SIRT1,SKI,SKIL,SKOR1,SKOR2,SMAD2,SMAD3,SMAD6,SMAD7,SMURF1,SMURF2,SNX25,SNX6,SOST,STRAP,STUB1,TGFB1,TGFB1I1,TGFBR1,TGFBR2,TRIM33,UBA52,UBB,UBC,UCHL5,USP15,VASN,VWC2,WNT1,XPO1,ZFYVE9	Any process that decreases the rate, frequency, or extent of the series of molecular signals generated as a consequence of a transmembrane receptor serine/threonine kinase binding to its physiological ligand.
GO:0090103	GO	BP	cochlea morphogenesis	HOXA1,HPN,PAX2,POU3F4,SOX9,TBX1	The process in which the cochlea is generated and organized.
GO:0090114	GO	BP	COPII-coated vesicle budding	ANKRD28,AREG,BET1,CD59,CNIH1,CNIH2,CNIH3,COL7A1,CSNK1D,CTSC,CTSZ,CUL3,F5,F8,FOLR1,GOLGA2,GORASP1,GOSR2,GRIA1,KLHL12,LMAN1,MCFD2,NAPA,NSF,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,STX5,TBC1D20,TFG,TGFA,TMED10,TMED2,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1,VAPA,VAPB	The evagination of an endoplasmic reticulum membrane, resulting in formation of a COPII-coated vesicle.
GO:0090128	GO	BP	regulation of synapse maturation	ADGRL1,ANAPC2,ARHGEF15,CAMK2B,CDC20,DAB2IP,NEURL1,NEUROD2,NRXN1,RELN	Any process that modulates the extent of synapse maturation, the process that organizes a synapse so that it attains its fully functional state.
GO:0090129	GO	BP	positive regulation of synapse maturation	ADGRL1,ANAPC2,CAMK2B,CDC20,DAB2IP,NEURL1,NEUROD2,NRXN1,RELN	Any process that increases the extent of synapse maturation, the process that organizes a synapse so that it attains its fully functional state.
GO:0090130	GO	BP	tissue migration	ACTA1,ACTA2,ACTC1,ACTG2,ANLN,APELA,ARSB,CALCA,CDH13,CORO1B,CXCL13,CYP1B1,DPP4,EFNB2,EGR3,EMP2,EPHB4,FAP,FAT2,FERMT1,FGF2,GIPC1,GPLD1,GREM1,GRHL2,ID1,KDR,KIT,KRT16,KRT2,LOXL2,MYH9,NANOS1,NOS3,NOV,NR4A1,NRP1,PIK3CA,PKN1,PKN2,PKN3,PLEKHG5,PLXND1,PRKX,PRSS3,PTP4A3,RAB13,RHOA,ROBO1,S100A2,S100P,SCG2,SLIT2,SRF,STARD13,TDGF1,TNFSF12,VEGFA,ZEB2	The process in which the population of cells that make up a tissue undergo directed movement.
GO:0090132	GO	BP	epithelium migration	ANLN,APELA,ARSB,CALCA,CDH13,CORO1B,CXCL13,CYP1B1,DPP4,EFNB2,EGR3,EMP2,EPHB4,FAP,FAT2,FERMT1,FGF2,GIPC1,GPLD1,GREM1,GRHL2,ID1,KDR,KIT,KRT16,KRT2,LOXL2,MYH9,NANOS1,NOS3,NOV,NR4A1,NRP1,PIK3CA,PKN1,PKN2,PKN3,PLEKHG5,PLXND1,PRKX,PRSS3,PTP4A3,RAB13,RHOA,ROBO1,S100A2,S100P,SCG2,SLIT2,SRF,STARD13,TDGF1,TNFSF12,VEGFA,ZEB2	The process in which the population of cells that make up an epithelium undergo directed movement.
GO:0090136	GO	BP	epithelial cell-cell adhesion	BVES,CAMSAP3,ITGB5,JUP,KIFC3,KIT,NOV,PLEKHA7,THBS4,VCL	The attachment of an epithelial cell to another epithelial cell via adhesion molecules.
GO:0090140	GO	BP	regulation of mitochondrial fission	BNIP3,DCN,DDHD1,DNM1L,FIS1,INF2,KDR,LRRK2,MARCH5,MFF,MIEF1,MIEF2,MUL1,PARK2,PINK1	Any process that modulates the rate, frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments.
GO:0090141	GO	BP	positive regulation of mitochondrial fission	BNIP3,DCN,DDHD1,DNM1L,FIS1,KDR,MARCH5,MFF,MIEF1,MIEF2,MUL1,PARK2	Any process that increases the rate, frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments.
GO:0090151	GO	BP	establishment of protein localization to mitochondrial membrane	HSP90AA1,HSPA4,NDUFA13,SAMM50,TIMM10,TIMM22,TIMM9,TOMM22	The directed movement of a protein to a specific location in the mitochondrial membrane.
GO:0090161	GO	BP	Golgi ribbon formation	GCC2,GOLGA2,GOLPH3,MYO18A,OPTN,PRMT5,STX16,STX6,TMED5,VAMP4,VTI1A	The formation of a continuous ribbon of interconnected Golgi stacks of flat cisternae.
GO:0090162	GO	BP	establishment of epithelial cell polarity	CLASP1,FBF1,FERMT1,GOLPH3,MSN,MYO18A,PARD3,SIPA1L3,SLC9A3R1,SYNE4	The specification and formation of anisotropic intracellular organization of an epithelial cell.
GO:0090166	GO	BP	Golgi disassembly	CDK1,GBF1,GOLGA2,PLK3,STX5,VRK1	A cellular process that results in the breakdown of a Golgi apparatus that contributes to Golgi inheritance.
GO:0090169	GO	BP	regulation of spindle assembly	CCSAP,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4B,CHMP4C,CHMP5,PLK1,RNF4,SENP6,TPR,VPS4B	Any process that modulates the rate, frequency or extent of spindle assembly. Spindle assembly is the aggregation, arrangement and bonding together of a set of components to form the spindle, the array of microtubules and associated molecules that serves to move duplicated chromosomes apart.
GO:0090174	GO	BP	organelle membrane fusion	ANKFY1,BNIP1,CAV2,CHMP3,CLN3,EEA1,LRMP,NKD2,RAB20,RAB34,RAB39A,RAB7A,RAB8A,RUBCN,SLC25A46,SNAP29,SNX14,STX17,TECPR1,TGFBRAP1,TSG101,UVRAG,VAMP4,VAMP7,VAMP8,VPS11,VPS16,VPS33A,VPS39,VPS41,VPS4A,VPS8,VTI1A	The joining of two lipid bilayers to form a single organelle membrane.
GO:0090175	GO	BP	regulation of establishment of planar polarity	DAB2,DACT1,DVL1,DVL2,DVL3,MAGI2,MLLT3,NKD1,NPHP3,WNT5A	Any process that modulates the rate, frequency or extent of the establishment of planar polarity, the coordinated organization of groups of cells in a tissue, such that they all orient to similar coordinates.
GO:0090181	GO	BP	regulation of cholesterol metabolic process	ABCG1,ACADL,ACADVL,APOE,EPHX2,ERLIN1,ERLIN2,FGF1,LDLRAP1,NR1H4,PRKAA1,SCAP,SEC14L2,SOD1	Any process that modulates the rate, frequency, or extent of cholesterol metabolism, the chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
GO:0090183	GO	BP	regulation of kidney development	ADIPOQ,AGT,BASP1,BMP4,BMP7,CD24,CTNNB1,EGR1,FLCN,FOXD1,GATA3,GDNF,LHX1,LIF,MYC,NOG,OSR1,PAX2,PAX8,PDGFA,PDGFB,PDGFRB,PRKX,PROM1,RET,SHH,SIX1,SIX2,SIX4,SMO,SOX8,SOX9,STAT1,TACSTD2,VEGFA,WT1	Any process that modulates the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0090184	GO	BP	positive regulation of kidney development	ADIPOQ,AGT,BASP1,BMP4,CD24,EGR1,FOXD1,GATA3,GDNF,LHX1,LIF,MYC,NOG,PAX2,PAX8,PDGFA,PDGFB,PDGFRB,PROM1,RET,SHH,SIX1,SIX4,SMO,SOX8,SOX9,VEGFA,WT1	Any process that increases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0090185	GO	BP	negative regulation of kidney development	ADIPOQ,BMP4,BMP7,FLCN,GATA3,OSR1,PAX2,PAX8,SHH,STAT1,TACSTD2,WT1	Any process that decreases the rate, frequency or extent of kidney development. Kidney development is the process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
GO:0090189	GO	BP	regulation of branching involved in ureteric bud morphogenesis	AGT,BMP4,GDNF,LHX1,NOG,PAX2,PAX8,SIX1,SIX2,SIX4,SMO,SOX8,SOX9,TACSTD2,VEGFA	Any process that modulates the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
GO:0090190	GO	BP	positive regulation of branching involved in ureteric bud morphogenesis	AGT,GDNF,LHX1,NOG,PAX2,PAX8,SIX1,SIX4,SMO,SOX8,SOX9,VEGFA	Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
GO:0090192	GO	BP	regulation of glomerulus development	ADIPOQ,BMP4,BMP7,EGR1,NOG,PAX2,PDGFB,RET,WT1	Any process that modulates the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.
GO:0090193	GO	BP	positive regulation of glomerulus development	ADIPOQ,EGR1,NOG,PAX2,PDGFB,RET	Any process that increases the rate, frequency or extent of glomerulus development, the progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney.
GO:0090196	GO	BP	regulation of chemokine secretion	ALOX15B,C5,CHIA,CSF1R,F2RL1,IL33,PYCARD	Any process that modulates the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell.
GO:0090197	GO	BP	positive regulation of chemokine secretion	ALOX15B,C5,CHIA,CSF1R,IL33,PYCARD	Any process that increases the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell.
GO:0090199	GO	BP	regulation of release of cytochrome c from mitochondria	AKT1,AVP,BAD,BAX,BBC3,BCL2L1,BCL2L11,BID,BIK,BMF,BNIP3,CIDEB,DNM1L,FAM162A,FXN,GPER1,GPX1,HGF,HRK,IGF1,MFF,MLLT11,MMP9,MOAP1,NOL3,OPA1,PARK2,PDCD5,PINK1,PLAUR,PMAIP1,PPIF,PRELID1,PSMD10,PYCARD,TNFSF10,TP53,TRIAP1	Any process that modulates the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
GO:0090200	GO	BP	positive regulation of release of cytochrome c from mitochondria	BAD,BAX,BBC3,BCL2L11,BID,BIK,BMF,BNIP3,CIDEB,DNM1L,FAM162A,GPER1,HRK,MFF,MLLT11,MMP9,MOAP1,PDCD5,PINK1,PLAUR,PMAIP1,PPIF,PYCARD,TNFSF10,TP53	Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
GO:0090201	GO	BP	negative regulation of release of cytochrome c from mitochondria	AKT1,AVP,BCL2L1,FXN,GPX1,HGF,IGF1,NOL3,OPA1,PARK2,PPIF,PRELID1,PSMD10,TRIAP1	Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
GO:0090207	GO	BP	regulation of triglyceride metabolic process	AADAC,ABHD5,APOA4,APOA5,APOC2,APOC3,C3,CNEP1R1,CTDNEP1,FBXW7,FITM2,GPLD1,LDLR,NR1H2,NR1H3,PANK2,PLIN5,PNPLA2,SCARB1,SIK1,SREBF1	Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.
GO:0090208	GO	BP	positive regulation of triglyceride metabolic process	AADAC,ABHD5,APOA4,APOA5,APOC2,CNEP1R1,CTDNEP1,GPLD1,LDLR,NR1H2,NR1H3,PLIN5,PNPLA2,SCARB1,SREBF1	Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.
GO:0090209	GO	BP	negative regulation of triglyceride metabolic process	APOC3,FBXW7,GPLD1,PLIN5,SIK1	Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.
GO:0090218	GO	BP	positive regulation of lipid kinase activity	AMBRA1,ATG14,CCL19,CCL21,CCR7,CD81,EEF1A2,EPHA8,ERBB4,FGF2,FGFR3,FGR,FLT1,FLT3,IRS1,KIT,NOD2,PDGFB,PDGFRA,PDGFRB,PIK3R4,PTK2,PTK2B,TEK,TGFB1,TNFAIP8L3	Any process that increases the frequency, rate or extent of lipid kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a simple or complex lipid.
GO:0090224	GO	BP	regulation of spindle organization	AURKA,AURKB,BORA,CCNB1,CCSAP,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4B,CHMP4C,CHMP5,PARP3,PLK1,PSRC1,RNF4,SBDS,SENP6,TPR,TPX2,VPS4B	Any process that modulates the rate, frequency or extent of the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle.
GO:0090231	GO	BP	regulation of spindle checkpoint	ANAPC15,CCNB1,CDK5RAP2,DUSP1,DYNC1LI1,GEN1,GSG2,LCMT1,MAD2L1,NDRG1,PCID2,TPR,USP44,XRCC3	Any process that modulates the rate, frequency, or extent of the spindle checkpoint, a cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and oriented, and chromosomes are attached to the spindle.
GO:0090232	GO	BP	positive regulation of spindle checkpoint	DYNC1LI1,GEN1,MAD2L1,NDRG1,PCID2,TPR,XRCC3	Any process that increases the rate, frequency, or extent of the spindle checkpoint, a cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and oriented, and chromosomes are attached to the spindle.
GO:0090239	GO	BP	regulation of histone H4 acetylation	ARRB1,AUTS2,BRCA1,CTBP1,IWS1,MUC1,PIH1D1,SIRT1,SMARCB1,SPI1	Any process that modulates the rate, frequency, or extent of histone H4 acetylation, the modification of histone H4 by the addition of an acetyl group.
GO:0090240	GO	BP	positive regulation of histone H4 acetylation	ARRB1,AUTS2,BRCA1,MUC1,PIH1D1,SMARCB1	Any process that increases the rate, frequency, or extent of histone H4 acetylation, the modification of histone H4 by the addition of an acetyl group.
GO:0090257	GO	BP	regulation of muscle system process	ACTN3,ADRA1A,ADRBK1,AGT,AKAP6,ANK2,ASPH,ATP1A2,ATP1B1,ATP2A1,ATP2A2,ATP2B4,BMP10,CACNA1C,CALM1,CAMK2B,CAMK2D,CAMK2G,CASQ1,CASQ2,CAV1,CAV3,CHRNA3,CLIC2,CNN1,CTNNA3,CTTN,DAPK3,DMD,DOCK4,DOCK5,DSC2,DSG2,DSP,EDN1,F2R,FBXO32,FKBP1B,GJA5,GLRX3,GPER1,GSK3A,GSTM2,GSTO1,HCN4,HDAC4,HRC,IGF1,IL6ST,JUP,KCNA1,KCNB2,KCNJ2,KCNQ1,LMCD1,MTPN,MYBPC3,MYBPH,MYH7,MYL2,MYL3,MYL5,MYL9,MYLK2,MYOCD,MYOG,NKX2-5,NMU,NMUR2,NOS1,NOS1AP,NOS3,NPPA,NR4A3,P2RX4,PARP1,PDE4B,PDE4D,PDE9A,PIK3CG,PKP2,PLCE1,PLN,PPP1R12B,PRKACA,PRKCA,PROK2,RGS2,RNF207,RYR2,SCN10A,SCN5A,SLC8A1,SLC8A3,SLC9A1,SLN,SMAD7,SOD1,SPHK1,SRF,SRI,STC1,TNNC1,TNNC2,TNNI1,TNNI3K,TNNT1,TNNT3,TPM1,TRIM63,TRPC3,ZC3H12A	Any process that modulates the frequency, rate or extent of a muscle system process, a multicellular organismal process carried out by any of the organs or tissues in a muscle system.
GO:0090263	GO	BP	positive regulation of canonical Wnt signaling pathway	AMER1,APC,ARNTL,AXIN1,AXIN2,BAMBI,CAPRIN2,CAV1,CCAR2,COL1A1,CSNK1A1,CSNK1D,CSNK1G2,CTNNB1,DAPK3,DIXDC1,DKK2,DVL1,DVL2,DVL3,FGFR2,FRAT1,FRAT2,FZD1,FZD2,FZD5,GPRC5B,GSK3B,ILK,JUP,LGR4,LGR5,LGR6,LRP5,LRP6,LRRK1,LRRK2,NFKB1,NRARP,PIN1,PPP1CA,PPP2R3A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RNF146,RNF220,RPS27A,RSPO1,SFRP1,SFRP2,SFRP4,SMAD3,SMURF2,SOX4,TMEM198,TNKS,TNKS2,TRPM4,UBA52,UBB,UBC,UBR5,USP34,WLS,WNT1,WNT2,WNT2B,WNT3A,WNT4,WNT8A,WNT8B,XIAP,ZBED3	Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
GO:0090266	GO	BP	regulation of mitotic cell cycle spindle assembly checkpoint	ANAPC15,CCNB1,DUSP1,DYNC1LI1,GEN1,LCMT1,MAD2L1,PCID2,TPR,USP44,XRCC3	Any process that modulates the rate, frequency, or extent of the mitotic cell cycle spindle assembly checkpoint, a cell cycle checkpoint that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and chromosomes are attached to the spindle.
GO:0090267	GO	BP	positive regulation of mitotic cell cycle spindle assembly checkpoint	DYNC1LI1,GEN1,MAD2L1,PCID2,TPR,XRCC3	Any process that increases the rate, frequency, or extent of the mitotic cell cycle spindle assembly checkpoint, a cell cycle checkpoint that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and chromosomes are attached to the spindle.
GO:0090276	GO	BP	regulation of peptide hormone secretion	ABCC8,ADCY5,ADRA2A,ADRA2C,AKAP5,ANO1,ARL2,ARL2BP,ARNTL,BAD,BLK,BMP8A,BRSK2,CACNA1A,CACNA1C,CACNA1D,CACNA1E,CACNA2D2,CAPN10,CCL5,CDK16,CFTR,CHD7,CHRM3,CLOCK,CRHBP,DOC2B,DRD2,EFNA5,ENSA,EPHA5,FAM3D,FFAR1,FFAR2,FFAR3,FGA,FGB,FGG,FOXA2,G6PC2,GCG,GCK,GHRH,GHRHR,GHRL,GIP,GLP1R,GLUD1,GNAS,GPER1,GPLD1,HFE,HLA-DRB1,HNF4A,HTR2C,IFNG,IL1B,INHBB,INS,IQGAP1,IRS1,IRS2,ISL1,ITPR1,ITPR2,ITPR3,KCNA5,KCNB1,KCNC2,KCNG2,KCNJ11,KCNS3,MARCKS,MCU,MTNR1B,MYRIP,NEUROD1,NLGN2,NOS2,NOV,NR1D1,NR1H4,PARK2,PASK,PAX8,PCSK1,PER2,PIM3,PPP3CB,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PSMD9,RAP1A,RAPGEF3,RAPGEF4,RASL10B,RBP4,REST,RFX3,RFX6,SEC11A,SEC11C,SFRP1,SIRT4,SLC25A4,SLC25A5,SLC25A6,SLC2A1,SLC2A2,SLC30A8,SLC8B1,SNAP25,SOX4,SPCS1,SPCS2,SPCS3,STX1A,STX4,STXBP1,STXBP4,SYT5,TCF7L2,TFAP2B,TFR2,TMEM27,TNF,TNFSF11,UQCC2,VAMP2	Any process that modulates the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
GO:0090277	GO	BP	positive regulation of peptide hormone secretion	ANO1,BAD,BLK,CAPN10,CFTR,DOC2B,DRD2,FGA,FGB,FGG,GCK,GHRH,GHRHR,GHRL,GLUD1,GPER1,GPLD1,HFE,HLA-DRB1,INS,IRS2,ISL1,MCU,MYRIP,NLGN2,PPP3CB,PSMD9,RASL10B,RBP4,RFX6,SLC30A8,SOX4,STX4,TCF7L2,TFR2,TMEM27,TNFSF11	Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
GO:0090278	GO	BP	negative regulation of peptide hormone secretion	ADRA2A,BMP8A,CRHBP,FAM3D,INHBB,IRS1,KCNB1,KCNJ11,NOV,PARK2,PIM3,PSMD9,REST,SFRP1,SIRT4	Any process that decreases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
GO:0090279	GO	BP	regulation of calcium ion import	AKAP6,ANK2,ASPH,ATP1A2,CACNA1C,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CAV3,CCL2,CCL3,CEMIP,CLIC2,CTNNB1,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,DIAPH1,DMD,DRD1,EGF,EPPIN,F2,F2R,F2RL3,FKBP1A,FKBP1B,GPER1,GRM6,GSTM2,GSTO1,HAP1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,LACRT,LGALS3,MRLN,NOS1,NPSR1,PDE4D,PDGFB,PDGFRB,PDPK1,PKD2,PLCG1,PLN,PRKACA,PTK2B,RYR2,SEMG1,SLC30A1,SLC8A1,SLN,SNCA,SRI,STC1,THY1,TRDN,TRIM27,TRPC1,XCL1,ZP3	Any process that modulates the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
GO:0090280	GO	BP	positive regulation of calcium ion import	AKAP6,ASPH,CALM1,CAPN3,CCL2,CCL3,CEMIP,CXCL10,CXCL11,CXCL12,CXCL9,CXCR3,DRD1,F2,F2R,F2RL3,GPER1,GRM6,GSTM2,GSTO1,HAP1,HTT,JPH2,LACRT,LGALS3,NPSR1,PDGFB,PDGFRB,PDPK1,PKD2,PLCG1,SNCA,STC1,THY1,TRDN,TRPC1,XCL1,ZP3	Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
GO:0090281	GO	BP	negative regulation of calcium ion import	CALM1,CASQ2,CLIC2,EPPIN,FKBP1B,GSTM2,GSTO1,MRLN,PKD2,PLN,SEMG1,SLC30A1,SLN,SRI,TRDN,TRIM27	Any process that decreases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
GO:0090286	GO	BP	cytoskeletal anchoring at nuclear membrane	SUN1,SUN2,SYNE1,SYNE2,SYNE3	The process in which cytoskeletal filaments are directly or indirectly linked to the nuclear membrane.
GO:0090287	GO	BP	regulation of cellular response to growth factor stimulus	ACVRL1,ADAM17,ADAMTS12,ADAMTS3,ADAMTSL2,AGT,AGTR2,ARNT,ASPN,BAMBI,BCL9L,BMP4,BMPER,BMPR2,CASK,CAV1,CAV3,CCBE1,CD109,CD63,CDKN1C,CDKN2B,CER1,CHRD,CIDEA,CITED1,CITED2,CRB2,CXCL13,CYR61,DAB2,DAB2IP,DAND5,DCN,DLL1,DMD,DOK5,DSTYK,EID2,ENG,FAM89B,FBN1,FBN2,FBXL15,FGF1,FGF16,FGF18,FGF2,FGF4,FGFBP3,FGFR1,FGFR2,FLCN,FLT1,FOLR1,FOXD1,FSTL3,FUZ,GATA3,GDF3,GDF5,GIPC1,GPC1,GRB10,GREM1,HES5,HHEX,HIF1A,HIPK2,HRG,HTRA3,HTRA4,IL17F,IL1B,ING2,ITGA3,ITGA5,ITGB3,LDLRAD4,LEMD3,LRIT3,LTBP1,LTBP4,MEN1,MMRN2,MT3,MTMR4,MYO1C,NBL1,NEDD4,NEDD4L,NKX2-1,NOG,NOTCH1,NPTN,OTX2,PBLD,PCSK6,PDCD6,PDPK1,PEG10,PIN1,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRDM16,PRKCB,PRKD2,PTPN1,RBPJ,RPS27A,SDCBP,SIRT1,SKI,SKIL,SKOR1,SKOR2,SLIT2,SMAD2,SMAD3,SMAD4,SMAD6,SMAD7,SMURF1,SMURF2,SNW1,SNX25,SNX6,SOST,SOX11,STK11,STRAP,STUB1,SULF1,SULF2,TFAP2B,TGFB1,TGFB1I1,TGFBR1,TGFBR2,THBS1,TRIM33,UBA52,UBB,UBC,UBE2O,UCHL5,USP15,VASN,VEGFA,VEGFB,VTN,VWC2,WNT1,XDH,XIAP,XPO1,ZFYVE9,ZNF423,ZNF703	Any process that modulates the rate, frequency, or extent of a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
GO:0090288	GO	BP	negative regulation of cellular response to growth factor stimulus	ADAM17,ADAMTS12,ADAMTSL2,AGT,AGTR2,ASPN,BAMBI,BCL9L,BMPER,CASK,CAV1,CD109,CER1,CHRD,CIDEA,CXCL13,DAB2IP,DAND5,DCN,EID2,ENG,FAM89B,FBN1,FBN2,FSTL3,FUZ,GATA3,GDF3,GPC1,GREM1,HHEX,HIPK2,HRG,HTRA3,HTRA4,LDLRAD4,LEMD3,LTBP1,MMRN2,MTMR4,NBL1,NEDD4,NEDD4L,NKX2-1,NOG,NOTCH1,PBLD,PDCD6,PDPK1,PEG10,PIN1,PMEPA1,PPM1A,PPP1CA,PPP1CB,PPP1CC,PPP1R15A,PRDM16,PTPN1,RPS27A,SIRT1,SKI,SKIL,SKOR1,SKOR2,SLIT2,SMAD2,SMAD3,SMAD6,SMAD7,SMURF1,SMURF2,SNX25,SNX6,SOST,STRAP,STUB1,SULF1,SULF2,TGFB1,TGFB1I1,TGFBR1,TGFBR2,THBS1,TRIM33,UBA52,UBB,UBC,UCHL5,USP15,VASN,VWC2,WNT1,XDH,XPO1,ZFYVE9	Any process that decreases the rate, frequency, or extent of a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
GO:0090303	GO	BP	positive regulation of wound healing	ADRA2A,ANO6,ANXA1,APOH,ARFGEF1,CAPN3,DMTN,ENPP4,F12,F2,F2R,F3,FOXC2,HBEGF,HPSE,HRAS,INSL3,KANK1,MYLK,PLEK,PLG,PLPP3,PRKCE,REG3A,REG3G,RREB1,SELP,SERPINE1,SERPINF2,SOX15,THBD,THBS1,TLR4,USF1,VEGFB,VTN	Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
GO:0090305	GO	BP	nucleic acid phosphodiester bond hydrolysis	AEN,AGO2,ANG,APLF,APTX,AZGP1,CASP3,CECR2,CHD1L,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,CPSF1,CPSF3,CSTF1,CSTF2,CSTF3,CUL4A,CUL4B,DBR1,DCLRE1A,DCLRE1B,DCLRE1C,DCP2,DDB1,DDB2,DDX1,DFFA,DFFB,DGCR8,DICER1,DIS3,DIS3L2,DNA2,DROSHA,DXO,EDC3,ELAC2,ENDOU,ENDOV,ENPP1,ENPP2,ENPP3,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,ERI1,ERN1,ERN2,EXO1,EXO5,EXOG,EXOSC10,EXOSC4,EXOSC5,FAN1,FBXO18,FEN1,FOXL2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,H1F0,HMGB1,HMGB2,HORMAD1,ISG20,KPNA1,KPNB1,MEI4,MOV10,MRE11A,MUS81,N4BP2,NCBP1,NCBP2,NOCT,NOP14,NTHL1,OGG1,PAN2,PAN3,PARN,PARP1,PCF11,PCNA,PMS2,PNKP,PNPT1,PNRC2,POLD1,POLD2,POLD3,POLD4,POLK,POP1,POP4,POP7,PPP1R8,RAD1,RAD50,RAD9A,RAG1,RBX1,REXO2,RFC1,RFC2,RFC3,RFC4,RFC5,RNASE1,RNASE2,RNASE3,RNASE4,RNASE6,RNASE7,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,RNASET2,RPA1,RPA2,RPA3,RPP30,RPP38,RPP40,RPS27A,SETMAR,SLFN14,SMG6,TOE1,TREX1,TREX2,TUT1,UBA52,UBB,UBC,USB1,UTP20,WRN,XPA,XRN2,ZC3H12A	The nucleic acid metabolic process in which the phosphodiester bonds between nucleotides are cleaved by hydrolysis.
GO:0090307	GO	BP	mitotic spindle assembly	ARHGEF10,AURKB,AURKC,CHEK2,CLASP1,FAM175B,FLNA,GOLGA2,KIF11,KIF23,KIF2A,KIF3B,KIF4A,KIF4B,KIFC1,KPNB1,MAP10,PIBF1,RAB11A,RACGAP1,RHOA,SPICE1,TPX2,ZNF207	The aggregation, arrangement and bonding together of a set of components to form the spindle that contributes to the process of mitosis.
GO:0090311	GO	BP	regulation of protein deacetylation	BRMS1,C6orf89,CAMK2D,CCAR2,CTBP1,DYRK1A,EP300,FNTA,FOXP3,KDM5A,MAPK8,NIPBL,PML,PRKD1,PRKD2,SPRED1,SPRED2,USP17L2,VEGFA	Any process that modulates the rate, frequency, or extent of protein deacetylation, the removal of an acetyl group from a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.
GO:0090312	GO	BP	positive regulation of protein deacetylation	BRMS1,C6orf89,CTBP1,DYRK1A,FNTA,NIPBL,PML,PRKD1,PRKD2,VEGFA	Any process that increases the rate, frequency, or extent of protein deacetylation, the removal of an acetyl group from a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.
GO:0090313	GO	BP	regulation of protein targeting to membrane	AKT2,C2CD5,CEMIP,CHP1,CIB1,DMTN,ERBB2,FIS1,GDI1,INPP5K,ITGB1BP1,KCNB1,KCNE1,MFF,MIEF1,MIEF2,MTCL1,MYO1C,PDZK1,SLC51B,TCAF1,TCAF2,USP17L2	Any process that modulates the frequency, rate or extent of the process of directing proteins towards a membrane, usually using signals contained within the protein.
GO:0090314	GO	BP	positive regulation of protein targeting to membrane	AKT2,C2CD5,CEMIP,CHP1,CIB1,ERBB2,FIS1,ITGB1BP1,KCNB1,MFF,MIEF1,MIEF2,MTCL1,MYO1C,PDZK1,SLC51B,TCAF1,TCAF2	Any process that increases the frequency, rate or extent of the process of directing proteins towards a membrane, usually using signals contained within the protein.
GO:0090315	GO	BP	negative regulation of protein targeting to membrane	DMTN,GDI1,INPP5K,ITGB1BP1,KCNE1,USP17L2	Any process that decreases the frequency, rate or extent of the process of directing proteins towards a membrane, usually using signals contained within the protein.
GO:0090317	GO	BP	negative regulation of intracellular protein transport	ADIPOQ,ANXA13,APC2,APOD,AXIN2,BAG4,BARD1,BMP7,C1QTNF3,CABP1,CCDC22,CHP1,CREB3,CSK,CYLD,DAB2IP,DACT3,DERL2,DERL3,DMTN,DYRK2,EMD,ERLEC1,FAF1,FAM89B,G3BP2,GAS6,GDI1,GOPC,GSK3B,IL10,INPP5K,ITGB1BP1,KCNE1,LRRK2,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOV,OS9,PARK7,PARP10,PBLD,PDE2A,PKD1,PKD2,PKDCC,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,RANGAP1,SFRP5,SIAH3,SLC9A3R1,SNAI2,SOX4,SP100,SUFU,SVIP,TONSL,UBAC2,UBE2G2,UBE2J1,USP17L2,WWTR1,YOD1,ZC3H12A	Any process that decreases the frequency, rate or extent of the directed movement of proteins within cells.
GO:0090322	GO	BP	regulation of superoxide metabolic process	AATF,BMP7,CRP,DHFR,F2RL1,FBLN5,GCH1,GSTP1,PARK7,PRKCD,SOD1,SYK,SZT2,TGFB1,TNF	Any process that modulates the rate, frequency, or extent of superoxide metabolism, the chemical reactions and pathways involving superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species.
GO:0090329	GO	BP	regulation of DNA-dependent DNA replication	ATRX,BLM,BMP4,BMP5,BMP6,CDC7,CDT1,CHEK2,DBF4B,E2F7,E2F8,FBXO18,FBXW7,INO80,LIG3,MRE11A,NBN,PID1,SMC1A,SMC3,STAG2,STOML2,TERF1,TERF2,TICRR,TIPIN,WIZ,WRNIP1,ZNF830,ZRANB3	Any process that modulates the rate, frequency, or extent of DNA-dependent DNA replication, the process in which new strands of DNA are synthesized, using parental DNA as a template for the DNA-dependent DNA polymerases that synthesize the new strands.
GO:0090330	GO	BP	regulation of platelet aggregation	ADAMTS18,ALOX12,C1QTNF1,DMTN,LYN,PRKCA,PRKCD,PRKCQ,PRKG1,SERPINE2,SYK	Any process that modulates the rate, frequency or extent of platelet aggregation. Platelet aggregation is the adhesion of one platelet to one or more other platelets via adhesion molecules.
GO:0090331	GO	BP	negative regulation of platelet aggregation	ADAMTS18,ALOX12,C1QTNF1,PRKCD,PRKG1,SERPINE2	Any process that decreases the rate, frequency or extent of platelet aggregation. Platelet aggregation is the adhesion of one platelet to one or more other platelets via adhesion molecules.
GO:0090335	GO	BP	regulation of brown fat cell differentiation	FNDC5,FTO,INS,LEP,METRNL,PTGS2,SIRT1	Any process that modulates the rate, frequency, or extent of brown fat cell differentiation. Brown fat cell differentiation is the process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.
GO:0090342	GO	BP	regulation of cell aging	ARNTL,CDK6,CDKN2A,FOXM1,HMGA1,HMGA2,ING2,LMNA,MARCH5,MIF,NEK4,NEK6,NUAK1,PNPT1,RSL1D1,SIRT1,TERF2,TERT,TP63,TWIST1,VASH1,WNT1,YPEL3,ZKSCAN3	Any process that modulates the rate, frequency, or extent of cell aging. Cell aging is the progression of the cell from its inception to the end of its lifespan.
GO:0090343	GO	BP	positive regulation of cell aging	CDKN2A,HMGA1,HMGA2,LMNA,SIRT1,YPEL3	Any process that increases the rate, frequency, or extent of cell aging. Cell aging is the progression of the cell from its inception to the end of its lifespan.
GO:0090344	GO	BP	negative regulation of cell aging	CDK6,FOXM1,MARCH5,MIF,SIRT1,TERF2,TERT,TP63,TWIST1,WNT1,ZKSCAN3	Any process that decreases the rate, frequency, or extent of cell aging. Cell aging is the progression of the cell from its inception to the end of its lifespan.
GO:0090382	GO	BP	phagosome maturation	CORO1A,RAB20,RAB31,RAB32,RAB34,RAB38,RAB39A,RAB43,RAB7A	A process that is carried out at the cellular level which results in the arrangement of constituent parts of a phagosome within a cell. Phagosome maturation begins with endocytosis and formation of the early phagosome and ends with the formation of the hybrid organelle, the phagolysosome.
GO:0090398	GO	BP	cellular senescence	ARNTL,CALR,CDKN1A,CDKN2A,HMGA1,HMGA2,HRAS,ID2,KAT6A,MAGEA2,MAP2K1,MAPK14,MAPKAPK5,NSMCE2,OPA1,PLA2R1,PML,PRKCD,SIRT1,SMC5,SMC6,SRF,TBX2,TBX3,TERF2,TP53,ULK3,WNT16	A cell aging process stimulated in response to cellular stress, whereby normal cells lose the ability to divide through irreversible cell cycle arrest.
GO:0090399	GO	BP	replicative senescence	ATM,ATR,CDKN2A,CHEK1,CHEK2,PLA2R1,TERT,TP53,WNT16	A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging.
GO:0090400	GO	BP	stress-induced premature senescence	ARNTL,CDKN1A,MAPK14,MAPKAPK5,PLA2R1,SIRT1,TP53,WNT16	A cellular senescence process associated with the dismantling of a cell as a response to environmental factors such as hydrogen peroxide or X-rays.
GO:0090484	GO	MF	drug transporter activity	ABCG2,EBP,MFSD10,SLC17A3,SLC19A2,SLC19A3,SLC22A18,SLC22A5,SLC38A3,SLC46A1	Enables the directed movement of a drug into, out of or within a cell, or between cells. A drug is any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
GO:0090501	GO	BP	RNA phosphodiester bond hydrolysis	AGO2,ANG,AZGP1,CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,CPSF1,CPSF3,CSTF1,CSTF2,CSTF3,DBR1,DCP2,DGCR8,DICER1,DIS3,DIS3L2,DROSHA,EDC3,ELAC2,ENDOU,ENDOV,ERN1,EXO1,EXOSC10,EXOSC4,EXOSC5,FEN1,ISG20,MOV10,NCBP1,NCBP2,NOCT,NOP14,PAN2,PAN3,PARN,PCF11,PNPT1,POP1,POP4,POP7,PPP1R8,RNASE1,RNASE2,RNASE3,RNASE4,RNASE6,RNASE7,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,RNASET2,RPP30,RPP38,RPP40,SLFN14,SMG6,TOE1,TUT1,USB1,UTP20,XRN2,ZC3H12A	The RNA metabolic process in which the phosphodiester bonds between ribonucleotides are cleaved by hydrolysis.
GO:0090502	GO	BP	RNA phosphodiester bond hydrolysis, endonucleolytic	AGO2,DBR1,DGCR8,DICER1,DROSHA,EDC3,ELAC2,ENDOU,ENDOV,ERN1,EXO1,FEN1,NOP14,POP1,POP4,POP7,RNASE1,RNASE4,RNASE8,RNASEH1,RNASEH2A,RNASEK,RNASEL,RPP30,RPP38,RPP40,SLFN14,SMG6,UTP20,ZC3H12A	The chemical reactions and pathways involving the hydrolysis of internal 3',5'-phosphodiester bonds in one or two strands of ribonucleotides.
GO:0090503	GO	BP	RNA phosphodiester bond hydrolysis, exonucleolytic	CNOT1,CNOT2,CNOT6,CNOT6L,CNOT7,CNOT8,DCP2,DIS3,DIS3L2,EXOSC10,EXOSC4,EXOSC5,ISG20,NOCT,PAN2,PAN3,PARN,PNPT1,TOE1,USB1,XRN2,ZC3H12A	The chemical reactions and pathways involving the hydrolysis of terminal 3',5'-phosphodiester bonds in one or two strands of ribonucleotides.
GO:0090504	GO	BP	epiboly	ACVRL1,COL5A1,CYR61,DDR1,MEGF8,MMP12,PDCD10,PLET1,RHOA,RHOC,TOR1A,WNT7A	The expansion of one cell sheet over other cells or yolk.
GO:0090533	GO	CC	cation-transporting ATPase complex	ATP12A,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A2,FXYD1,FXYD2,PLN,SLC9A1	Protein complex that carries out the reaction: ATP + H2O + cation(out) = ADP + phosphate + cation(in).
GO:0090543	GO	CC	Flemming body	CAPG,CHMP4C,IST1,NUP62,OR2A4,VPS4A,VPS4B	A cell part that is the central region of the midbody characterized by a gap in alpha-tubulin staining. It is a dense structure of antiparallel microtubules from the central spindle in the middle of the intercellular bridge.
GO:0090544	GO	CC	BAF-type complex	ACTL6A,ACTL6B,ARID1A,ARID1B,DPF1,DPF3,NCR1,PBRM1,PHF10,RB1,SMARCA2,SMARCA4,SMARCB1,SMARCC1,SMARCC2,SMARCD1,SMARCD2,SMARCD3,SMARCE1	A SWI/SNF-type complex that contains a subunit from the BAF (Brahma-Associated Factor) family.
GO:0090557	GO	BP	establishment of endothelial intestinal barrier	F11R,MLLT4,RAP2C,RAPGEF2,TJP1,TJP2	The establishment of a barrier between endothelial cell layers of the intestine to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.
GO:0090559	GO	BP	regulation of membrane permeability	ACAA2,AKT1,ALKBH7,ATF2,BAD,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BID,BLOC1S2,BMF,BNIP3,CAMK2A,CASP8,DYNLL1,DYNLL2,E2F1,F11R,GSK3A,GSK3B,GZMB,HEBP2,HSPA1A,MAPK8,MOAP1,MPV17L,MT3,MUL1,NAIF1,NMT1,PMAIP1,PPIF,PPP3CC,PPP3R1,RHOT1,RHOT2,SFN,SIVA1,SLC25A5,SLC35F6,TFDP1,THEM4,TJP2,TMEM102,TP53,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by a membrane.
GO:0090568	GO	CC	nuclear transcriptional repressor complex	APPL1,APPL2,CHD3,CHD4,CHD5,CSNK2A1,GATAD2A,HDAC1,HDAC2,MBD3,MTA2,NACC2,PASD1,RBBP4,RBBP7,SALL1	A protein complex, located in the nucleus, that possesses activity that prevents or downregulates transcription.
GO:0090575	GO	CC	RNA polymerase II transcription factor complex	ARNT,ATF1,ATF4,CCNH,CDK7,CEBPA,CEBPB,CREB1,CTNNB1,DDIT3,E2F1,EDF1,ERCC2,ERCC3,ERCC5,FOXH1,GATA4,GTF2A1,GTF2A2,GTF2F1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HAND1,HIF1A,HIPK2,HMGA1,HNRNPAB,HYAL2,ING2,KAT2A,MMS19,MNAT1,MYF5,MYF6,NEUROD1,NFYA,NFYB,NFYC,NKX2-5,NONO,NR1H3,NR5A1,NR5A2,PPARG,PRMT2,RB1,RXRA,SFPQ,SMAD2,SMAD4,STAT3,SUPT3H,TADA3,TAF1,TAF10,TAF11,TAF12,TAF13,TAF2,TAF3,TAF4,TAF5,TAF5L,TAF6,TAF7,TAF8,TAF9,TAF9B,TBP,TCF12,TCF3,TCF7L2,TP53,TRIM28,TRRAP,VDR,WWOX	A transcription factor complex that acts at promoters of genes transcribed by RNA polymerase II.
GO:0090576	GO	CC	RNA polymerase III transcription factor complex	BRF1,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6	A transcription factor complex that acts at promoters of genes transcribed by RNA polymerase III.
GO:0090596	GO	BP	sensory organ morphogenesis	AGTPBP1,AHI1,ALDH1A3,ATP6V1B1,BBS4,CEP290,CHD7,COL5A1,COL5A2,DLL1,DSCAM,EPHA2,EPHB2,FGFR2,FOXE3,FOXN4,GLI3,GSC,HDAC1,HDAC2,HOXA1,HPN,IFT122,KDM2B,LHX1,LRP5,MEGF11,MYO7A,NF1,NIPBL,NKD1,NOG,OSR1,OSR2,PAX2,PAX6,PAX8,PHACTR4,PITX2,PITX3,POU3F4,PPP2R3A,PROM1,PROX1,PTF1A,PTPRM,RARG,RBP4,RORB,RP1,SALL1,SDK1,SDK2,SHROOM2,SIX1,SIX3,SIX4,SKI,SOD1,SOX11,SOX8,SOX9,STAT3,STRA6,STRC,TBX1,TBX2,TDRD7,TENM3,TFAP2A,TH,THY1,TOPORS,TSPAN12,TULP1,TWIST1,VEGFA,WNT16,WNT2,WNT2B,WNT5A,WNT9A,ZIC1	Morphogenesis of a sensory organ. A sensory organ is defined as a tissue or set of tissues that work together to receive and transmit signals from external or internal stimuli. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
GO:0090611	GO	BP	ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway	CHMP4B,CHMP4C,PDCD6IP,VPS4A,VPS4B	The chemical reactions and pathways resulting in the breakdown of a protein or peptide, via the multivesicular body (MVB) sorting pathway; proteins are sorted into MVBs, and delivered to a lysosome/vacuole for degradation.  This process is independent of ubiquitination.
GO:0090630	GO	BP	activation of GTPase activity	ARHGEF10,ARHGEF16,BCAS3,CCL21,CCR7,CORO1C,CXCL13,DOCK7,ECT2,EPHA1,EPHA2,FOXJ1,GPR65,NTF3,NTRK3,PIP5K1A,RALGAPA1,RALGAPA2,RALGAPB,RASGRF1,RASGRP1,RHOG,SCRIB,SIPA1L1,SYDE1,SYDE2,TAX1BP3,TBC1D7,TIAM1,TSC1	Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP.
GO:0090646	GO	BP	mitochondrial tRNA processing	ELAC2,HSD17B10,KIAA0391,TRMT10C,TRNT1	The process in which a pre-tRNA molecule is converted to a mature tRNA, ready for addition of an aminoacyl group,  in the mitochondrion.
GO:0090662	GO	BP	ATP hydrolysis coupled transmembrane transport	ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP6V1H,FXYD2	The transport of molecules across a membrane and against an electrochemical gradient, using energy from ATP hydrolysis.
GO:0097006	GO	BP	regulation of plasma lipoprotein particle levels	ABCA1,ABCA5,ABCA7,ABCG1,ACSL3,ADIPOQ,AGT,AGTR1,APOA1,APOA2,APOA4,APOB,APOC1,APOC2,APOC3,APOE,APOM,CD36,CETP,DGAT1,DGAT2,EHD1,HMOX1,LCAT,LDLR,LDLRAP1,LIPC,LIPG,LPL,MPO,MSR1,MTTP,PLA2G2A,PLA2G7,PLTP,SCARB1,SOAT1,SOAT2,VLDLR	Any process involved in the maintenance of internal levels of plasma lipoprotein particles within an organism.
GO:0097009	GO	BP	energy homeostasis	AMPD2,LEPR,MRAP2,NR4A3,OMA1,STAT3	Any process involved in the balance between food intake (energy input) and energy expenditure.
GO:0097028	GO	BP	dendritic cell differentiation	BATF,BATF2,BATF3,CAMK4,CCL19,CCR7,CSF2,DCSTAMP,F2RL1,FLT3,IL4,LYN,PRTN3,TGFBR2,TREM2,UBD	The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation.
GO:0097035	GO	BP	regulation of membrane lipid distribution	ABCA7,ABCB4,ANO6,ATP10A,ATP10B,ATP10D,ATP11A,ATP11B,ATP11C,ATP8A1,ATP8B1,ATP9A,ATP9B,P2RX7,PLSCR1,PLSCR2,PLSCR4,PRELID1,PRKCD,TMEM30A,TRIAP1,XKR8	Any process that modulates the proportions or spatial arrangement of lipids in a cellular membrane.
GO:0097038	GO	CC	perinuclear endoplasmic reticulum	ADAM10,BCAP31,CAPN2,DBI,OSBPL3,OSBPL6,OSBPL7,SYT6,TRIM13	The portion of endoplasmic reticulum, the intracellular network of tubules and cisternae, that occurs near the nucleus. The lumen of the perinuclear endoplasmic reticulum is contiguous with the nuclear envelope lumen (also called perinuclear space), the region between the inner and outer nuclear membranes.
GO:0097060	GO	CC	synaptic membrane	ADGRL1,ATAD1,CASK,CHRNA1,CHRND,CNIH2,CNIH3,CNTNAP4,DLG4,DNAJA3,DNM2,ERC1,ERC2,F2R,FLRT3,GPER1,GRIA1,GRIN1,GRM7,IL1RAPL1,KCNA1,KCNC2,KCND2,LRP4,MAGEE1,MTMR2,MUSK,NLGN2,NPTN,NRXN1,P2RY1,PDE2A,PI4K2A,PICALM,PICK1,RIMS1,RIMS4,SCRIB,SHANK1,SHANK2,SHISA9,SNAP25,SNCAIP,SRGAP2,SRPX2,STRN,SYNE1,TENM2,TMEM240,TRPV1,UNC13A,ZC4H2	A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.
GO:0097061	GO	BP	dendritic spine organization	ARF1,CTNND2,DLG4,EPHB1,EPHB2,EPHB3,MTMR2,PAK3,PICK1,PTEN,SHANK1,SHANK3,WNT7A	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a dendritic spine. A dendritic spine is a specialized protrusion from a neuronal dendrite and is involved in synaptic transmission.
GO:0097066	GO	BP	response to thyroid hormone	GAS2L1,GATA1,HPN,KLF9,LMO2,MED1,RDX	A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
GO:0097067	GO	BP	cellular response to thyroid hormone stimulus	GAS2L1,GATA1,KLF9,LMO2,MED1,RDX	A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
GO:0097090	GO	BP	presynaptic membrane organization	CNTN2,IL1RAPL1,LRP4,NLGN1,NLGN2,NLGN3,NLGN4X,NRXN1,PTEN,PTPRD	A process which results in the assembly, arrangement of constituent parts, or disassembly of a presynaptic membrane, including any proteins associated with the membrane, but excluding other cellular components. A presynaptic membrane is a specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction.
GO:0097094	GO	BP	craniofacial suture morphogenesis	FREM1,MEGF8,MSX2,RAB23,TWIST1	The process in which any suture between cranial and/or facial bones is generated and organized.
GO:0097104	GO	BP	postsynaptic membrane assembly	LRP4,NLGN1,NLGN2,NLGN3,NRXN1,NRXN2	The aggregation, arrangement and bonding together of a set of components to form a postsynaptic membrane, a specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft).
GO:0097105	GO	BP	presynaptic membrane assembly	IL1RAPL1,LRP4,NLGN1,NLGN2,NLGN3,NLGN4X,NRXN1,PTEN,PTPRD	The aggregation, arrangement and bonding together of a set of components to form a presynaptic membrane, including any proteins associated with the membrane, but excluding other cellular components. A presynaptic membrane is a  specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction.
GO:0097107	GO	BP	postsynaptic density assembly	NLGN2,NRXN1,NRXN2,PTEN,SHANK3	The aggregation, arrangement and bonding together of a set of components to form a postsynaptic density, a region that lies adjacent to the cytoplasmic face of the postsynaptic membrane at excitatory synapse.
GO:0097110	GO	MF	scaffold protein binding	ATP2B4,CHUK,CIT,CRIPT,DLG4,GRID2,IKBKB,LRP4,MAP3K7,NLGN1,NOS1,P2RY1,SHANK1,SHANK3	Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
GO:0097150	GO	BP	neuronal stem cell population maintenance	CDH2,DLL1,MMP24,PROX1,SOX2,SRRT	Any process in by an organism or tissue maintains a population of neuronal stem cells.
GO:0097164	GO	BP	ammonium ion metabolic process	ABHD3,ACADL,ACADM,ACER1,ACER2,ACER3,ACHE,AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,ALDH9A1,APOA1,APOA2,APOA4,ATP7A,BBOX1,BCHE,CBR4,CDS1,CEPT1,CETP,CHAT,CHKA,CHKB,CHPT1,CLN3,COLQ,CPT1A,CRAT,CROT,DAO,DBI,DMGDH,DRD1,DRD2,DRD3,DRD4,ENPP2,ENPP6,ENPP7,GBA,GCH1,GPAT4,GPLD1,HDC,HTR1A,LCAT,LIPC,LPCAT1,LPCAT2,LPCAT3,LPCAT4,LPIN1,LPIN2,LPIN3,MAOA,MAOB,MBOAT1,MBOAT2,ODC1,PAFAH1B1,PAOX,PARK2,PCYT1A,PCYT1B,PEMT,PHOSPHO1,PLA2G10,PLA2G12A,PLA2G15,PLA2G16,PLA2G1B,PLA2G2A,PLA2G2D,PLA2G2E,PLA2G2F,PLA2G3,PLA2G4A,PLA2G4B,PLA2G4C,PLA2G4D,PLA2G4E,PLA2G4F,PLA2G5,PLA2G6,PLB1,PLBD1,PNPLA8,PON1,PRG3,SAMD8,SAT2,SGMS1,SGMS2,SGPP2,SHMT1,SLC27A1,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SLC5A7,SMOX,SMPD1,SMPD2,SMPD3,SMPD4,SNCA,SNCAIP,SPHK1,SPHK2,SRM,TGFB2,TH,TMLHE	The chemical reactions and pathways involving the ammonium ion.
GO:0097186	GO	BP	amelogenesis	AMELX,FAM20A,ITGA6,ITGB4,KLK4,SLC24A4,STIM1,TBX1	The process whose specific outcome is the formation of tooth enamel, occurring in two stages: secretory stage and maturation stage.
GO:0097191	GO	BP	extrinsic apoptotic signaling pathway	ACVR1B,APPL1,BAD,BAG3,BAX,BCL2,BID,BLOC1S2,CASP3,CASP8,CASP8AP2,CASP9,CD14,CD27,CD70,CFLAR,CIB1,CRADD,DAB2IP,DAPK1,DAXX,DCC,DDX3X,DDX47,DEDD2,DIABLO,ERBB3,FADD,FAS,FASLG,FGFR3,G0S2,GABARAP,GSK3A,GSK3B,HIPK1,IFNG,IL12A,IL6R,INHBA,ITGAV,JAK2,KIAA0141,LY96,MAGED1,MCL1,MLLT11,MOAP1,NGF,PDPK1,RIPK1,RNF41,SIVA1,SMAD3,SORT1,TGFB1,TGFB2,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFRSF1A,TNFSF10,TRADD,TRAF2,UNC5A,UNC5B	A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
GO:0097192	GO	BP	extrinsic apoptotic signaling pathway in absence of ligand	APPL1,CASP3,CASP9,DAPK1,DCC,ERBB3,GSK3A,GSK3B,ITGAV,MAGED1,MCL1,MOAP1,UNC5A,UNC5B	A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
GO:0097193	GO	BP	intrinsic apoptotic signaling pathway	ABL1,AEN,AIFM1,AKT1,APAF1,ARL6IP5,ATF4,ATP2A1,BAD,BAG6,BAK1,BAX,BBC3,BCL2,BCL2L1,BCL2L11,BCL3,BID,BMF,BNIP3,BOK,BRCA1,BRSK2,CASP2,CASP3,CASP4,CASP7,CASP8,CASP9,CD24,CDIP1,CDKN1A,CHAC1,CHEK2,CIDEB,CLU,CRIP1,CUL1,CUL2,CUL3,CUL4A,CUL5,CYCS,CYP1B1,DAB2IP,DDIT3,DDIT4,DDX3X,DDX5,DIABLO,DNAJC10,DYNLL1,DYNLL2,DYRK2,E2F1,EP300,EPHA2,ERO1A,FHIT,FNIP2,GZMB,HIC1,HINT1,HIPK2,HTRA2,IFI16,IKBKE,ITPR1,LGALS12,MAP3K5,MAPK8,MLLT11,MOAP1,MSH6,MYBBP1A,NMT1,PDCD10,PDK1,PDK2,PHLDA3,PMAIP1,PML,PPM1F,PPP1R13B,PPP1R15A,PPP2R5C,PPP3CC,PPP3R1,PRKCD,PRODH,PYCARD,RPS27L,RRP8,SART1,SELK,SFN,SIRT1,SIVA1,SNW1,STK11,STK24,STK25,TFDP1,TNFRSF10B,TOPORS,TP53,TP53BP2,TP73,TRAF2,TRIB3,USP28,XIAP,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF385B,ZNF622	A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP).
GO:0097194	GO	BP	execution phase of apoptosis	ACIN1,ACVR1C,ADD1,AIFM3,APC,BBC3,BCAP31,BIRC2,BLCAP,BMX,BNIP1,CAPN10,CASP2,CASP3,CASP6,CASP7,CASP8,CDH1,CDK5RAP3,CECR2,CIDEB,CIDEC,CLSPN,CTNNB1,DBNL,DEDD2,DFFA,DFFB,DNM1L,DSG1,DSG2,DSG3,DSP,ERN2,FNTA,FOXL2,GAS2,GPER1,GSN,H1F0,HMGB1,HMGB2,HTRA2,KPNA1,KPNB1,LMNA,LMNB1,MADD,MAPT,OCLN,PAK2,PKP1,PLEC,PRKCD,PRKCQ,PTK2,ROCK1,SATB1,SPTAN1,STK24,STK26,TAOK1,TARDBP,TJP1,TJP2,TOP2A,VIM,XKR8	A stage of the apoptotic process that starts with the controlled breakdown of the cell through the action of effector caspases or other effector molecules (e.g. cathepsins, calpains etc.). Key steps of the execution phase are rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
GO:0097201	GO	BP	negative regulation of transcription from RNA polymerase II promoter in response to stress	CITED2,HIF1AN,IMPACT,JUN,NCK1,SIRT2,VHL	Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
GO:0097202	GO	BP	activation of cysteine-type endopeptidase activity	ACER2,AIFM1,ANP32B,APAF1,ASPH,BAD,BAK1,BAX,BBC3,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CIDEB,COL4A3,CTSH,CYCS,CYFIP2,DAP,DIABLO,DLC1,DNAJA3,EIF2AK3,F2R,F3,FADD,FAM162A,FAS,FASLG,GNB2L1,HIP1,HSPD1,HSPE1,IFI16,IFI27,IFT57,JAK2,LCK,LY96,MTCH1,MUL1,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NOD1,PDCD2,PERP,PPARG,PYCARD,RET,RIPK1,ROBO1,RPS27L,S100A8,S100A9,SENP1,SLC11A2,SMAD3,SNCA,TBC1D10A,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase.
GO:0097205	GO	BP	renal filtration	ITGA3,JCHAIN,MYO1E,SULF1,SULF2,XPNPEP3	A renal system process in which fluid circulating through the body is filtered through a barrier system.
GO:0097223	GO	CC	sperm part	ACR,AKAP3,ATP2B4,CASC5,CATSPERD,CXADR,CYLC1,DNAH1,DNAI2,EQTN,FAM170B,IQCF1,LRGUK,PGAM4,PRKACA,RPGR,SAXO1,SEPT12,SERPINA5,SLC26A3,SLC26A6,SLC9A3R1,SPA17,SPACA7,SPATA6,TCTEX1D4,TEKT3,ZP3	Any constituent part of a sperm, a mature male germ cell that develops from a spermatid.
GO:0097237	GO	BP	cellular response to toxic substance	CERS1,CRIP1,MEF2C,OPRD1,PARK2,PINK1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
GO:0097267	GO	BP	omega-hydroxylase P450 pathway	CYP1A1,CYP1A2,CYP1B1,CYP2C19,CYP2C8,CYP2C9,CYP2U1,CYP4A11,CYP4F2	The chemical reactions and pathways by which arachidonic acid is converted to other compounds initially by omega-hydroxylation.
GO:0097285	GO	BP	cell-type specific apoptotic process	AKT1,APP,ATN1,BAX,BCL2,BID,BMPR2,BNIP3,CAPN10,CDK5,CLC,COL4A3,CTSL,DAB2IP,DMPK,ERBB3,FAM162A,FAP,FASLG,GAPDH,GDF6,GLI3,GSN,HCAR2,HIPK1,IL6,IRF3,LIG4,MYC,NAE1,NLRP1,PLK5,RHOB,RIPK1,RYR2,SIAH1,SIVA1,SIX3,TBX1,TNF,TNFRSF21,TP53	Any apoptotic process in a specific cell type.
GO:0097286	GO	BP	iron ion import	HFE,MFI2,PICALM,SLC11A2,TF,TFR2,TFRC	The directed movement of iron ions into a cell or organelle.
GO:0097296	GO	BP	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	CASP8,CD14,CFLAR,FADD,FAS,FASLG,JAK2,LY96,RIPK1,TICAM1,TICAM2,TLR3,TLR4,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2	Any process that initiates the activity of an inactive cysteine-type endopeptidase involved in the apoptotic signaling pathway.
GO:0097300	GO	BP	programmed necrotic cell death	ALKBH7,BIRC2,BIRC3,CASP8,CFLAR,DNM1L,FADD,FAS,FASLG,MLKL,PGAM5,PPIF,RIPK1,RIPK3,RPS27A,TLR3,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2,TRPM7,UBA52,UBB,UBC	A necrotic cell death process that results from the activation of endogenous cellular processes, such as signaling involving death domain receptors or Toll-like receptors.
GO:0097305	GO	BP	response to alcohol	ADCY7,ADH6,ADH7,AQP1,AQP3,BLM,BRCA1,CCDC62,CCL3,CCR5,CDH1,CDKN2D,CHRNB2,CRHBP,CTNNA1,CTNNB1,CYP24A1,CYP27B1,CYP7A1,DRD2,DRD4,DYNAP,EGFR,ESR1,FOXA1,GH1,GHR,GLRA1,GOT2,GPER1,GPLD1,GRIN1,GRIN2A,GRIN2B,GRIN3A,H2AFZ,JUP,KAT5,KLF9,LRP6,MLC1,MSN,MYOD1,MYOG,NCOA3,NKX3-1,NRIP1,OPRM1,OSBPL7,PIM1,PTCH1,RAD51,RAMP3,ROCK2,RORA,RORC,RUVBL2,SDF4,SMAD2,SMO,SOCS2,SOD1,SPIDR,SPP1,STAT3,STAT5B,STRN3,TGFB1,TGFBR1,TGFBR2,TH,VDR,WNT8B,ZNF703	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alcohol stimulus.
GO:0097306	GO	BP	cellular response to alcohol	ADCY7,AQP1,BLM,BRCA1,CCDC62,CDH1,CRHBP,CTNNA1,CTNNB1,CYP24A1,CYP7A1,DYNAP,EGFR,ESR1,GPER1,GPLD1,H2AFZ,JUP,KAT5,KLF9,LRP6,MLC1,MSN,MYOD1,MYOG,NCOA3,NRIP1,OSBPL7,PIM1,PTCH1,RAD51,RAMP3,ROCK2,RORA,RORC,RUVBL2,SMO,SPIDR,VDR,ZNF703	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alcohol stimulus.
GO:0097320	GO	BP	membrane tubulation	BIN2,CHMP4A,EHD2,FNBP1L,MICALL1,PACSIN1,PACSIN2,PACSIN3,SNX33,SNX9,WHAMM	A modification in a plasma membrane resulting in formation of a tubular invagination.
GO:0097342	GO	CC	ripoptosome	CASP10,CASP8,CFLAR,FADD,RIPK1,TICAM1	A protein complex whose core components are the receptor-interacting serine/threonine-protein kinases RIPK1 and RIPK3 (also called RIP1 and RIP3). Formation of the ripoptosome can induce an extrinsic apoptotic signaling pathway or a necroptotic signaling pathway. The composition of this protein complex may depend on several factors including nature of the signal, cell type and more.
GO:0097345	GO	BP	mitochondrial outer membrane permeabilization	BLOC1S2,BNIP3,MOAP1,RHOT1,RHOT2	The process by which the mitochondrial outer membrane becomes permeable to the passing of proteins and other molecules from the intermembrane space to the cytosol as part of the apoptotic signaling pathway.
GO:0097346	GO	CC	INO80-type complex	ACTL6A,ACTR5,ACTR8,ANP32E,BRD8,EP400,ING3,INO80,INO80B,INO80C,INO80E,KAT5,MCRS1,NFRKB,RUVBL1,RUVBL2,TFPT,TRRAP,UCHL5,YY1	A chromatin remodeling protein complex initially purified from S. cerevisiae and containing more than 10 subunits, including the SWR1-related complexes. INO80 (inositol requiring 80)-type complexes have diverse functions, including promoting transcriptional activation and DNA repair.
GO:0097352	GO	BP	autophagosome maturation	CHMP3,CLN3,RUBCN,SNAP29,SNX14,STX17,TECPR1,TSG101,UVRAG,VAMP8,VPS16,VPS33A	The process in which autophagosomes, double-membraned vacuoles containing cytoplasmic material fuse with a vacuole (yeast) or lysosome (e.g. mammals and insects). In the case of yeast, inner membrane-bounded structures (autophagic bodies) appear in the vacuole. Fusion provides an acidic environment and digestive function to the interior of the autophagosome.
GO:0097381	GO	CC	photoreceptor disc membrane	ABCA4,GNAT1,GNB1,GNGT1,GRK1,GRK4,GRK7,GUCA1A,GUCA1B,GUCA1C,GUCY2D,GUCY2F,PDE6A,PDE6B,PDE6G,RHO,SPTBN5	Ovally-shaped membranous stack located inside the photoreceptor outer segment, and containing densely packed molecules of the photoreceptor protein rhodopsin that traverse the lipid bilayer. Disc membranes are apparently derived from the plasma membrane in the region of the cilium that connects the photoreceptor outer segment to the inner segment.
GO:0097413	GO	CC	Lewy body	ATF4,GPX1,HERPUD1,PARK2,PINK1	Cytoplasmic, spherical inclusion commonly found in damaged neurons, and composed of abnormally phosphorylated, neurofilament proteins aggregated with ubiquitin and alpha-synuclein.
GO:0097418	GO	CC	neurofibrillary tangle	CLU,MAPT,NEFH,NEFM,PICALM	Intracellular mass of paired, helically wound protein filaments (also called PHF) lying in the cytoplasm of neuronal cell bodies and neuritic cell processes. Neurofibrillary tangles contain an abnormally phosphorylated form of a microtubule-associated protein, tau. The shape of these inclusions may resemble a flame or a star.
GO:0097422	GO	CC	tubular endosome	ANKRD27,SNX5,SNX6,VPS26A,VPS35	A network of fine tubules in the vicinity of the Golgi complex and around the centriole.
GO:0097431	GO	CC	mitotic spindle pole	ASPM,EML1,FAM83D,GPSM2,KIF20B,MAP10,NUMA1,OR2A4	Either of the ends of a mitotic spindle, a spindle that forms as part of mitosis, where spindle microtubules are organized; usually contains a microtubule organizing center and accessory molecules, spindle microtubules and astral microtubules.
GO:0097435	GO	BP	fibril organization	ADAMTS3,B4GALT7,CD36,COL3A1,COL5A1,CST3,FKBP1A,GSN,HSP90AB1,LTBP2,MFAP4,MUC5AC,RIPK1,RIPK3,SNCA	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of fibrils, insoluble fibrous aggregates consisting of polysaccharides and/or proteins.
GO:0097440	GO	CC	apical dendrite	CLU,CPEB3,MYO1D,NEURL1,NSMF,PTK2B	A dendrite that emerges near the apical pole of a neuron. In bipolar neurons, apical dendrites are located on the opposite side of the soma from the axon.
GO:0097479	GO	BP	synaptic vesicle localization	AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CANX,CDK5,DNAJC5,DNM2,DOC2B,DTNBP1,ITSN1,NLGN1,NRXN1,OTOF,PACSIN1,PCLO,PIP5K1C,PLD2,RAB27A,RAB3A,RAB5A,RIMS1,RIMS2,SEPT5,SNAP25,SNAPIN,SNCA,SNPH,STON2,STX1B,SYNDIG1,SYNJ1,SYT1,TOR1A,UNC13B,VAMP2,WNT3A,WNT7A	Any process in which a synaptic vesicle or vesicles are transported to, and/or maintained in, a specific location.
GO:0097481	GO	CC	neuronal postsynaptic density	DLG4,GPER1,MAPK8IP2,MTMR2,NLGN1,P2RY1,SHANK1,SHANK3,SIGMAR1	A postsynaptic density that is part of a neuron.
GO:0097486	GO	CC	multivesicular body lumen	CTSH,NAPSA,PGA3,PGA4,PGA5,SFTPB,SFTPC	The volume enclosed by the outermost membrane of a multivesicular body.
GO:0097493	GO	MF	structural molecule activity conferring elasticity	AHNAK,COL4A1,EMILIN2,FBN1,FBN2,TTN	The action of a molecule that contributes to the structural integrity of a complex or assembly within or outside a cell, providing elasticity and recoiling.
GO:0097502	GO	BP	mannosylation	ALG1,ALG12,ALG2,ALG3,ALG8,B4GAT1,DPM1,DPM2,DPM3,FKRP,FKTN,GYLTL1B,ISPD,LARGE,PIGB,PIGV,PIGZ,POMGNT2,SDF2,TMEM5	The covalent attachment of a mannose residue to a substrate molecule.
GO:0097503	GO	BP	sialylation	ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL5,ST3GAL6,ST6GAL1,ST6GAL2,ST6GALNAC1,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6	The covalent attachment of sialic acid to a substrate molecule.
GO:0097525	GO	CC	spliceosomal snRNP complex	CD2BP2,DDX23,DDX39B,LSM4,PHF5A,PPIH,PRPF31,PRPF4,PRPF6,PRPF8,SART3,SF3B1,SNRNP200,SNRNP40,SNRNP70,SNRPA,SNRPA1,SNRPB,SNRPB2,SNRPC,SNRPD1,SNRPD2,SNRPD3,SNRPE,SNRPF,SNRPG	A ribonucleoprotein complex involved in formation of the spliceosome and composed of one or more snRNA and multiple protein components.
GO:0097527	GO	BP	necroptotic signaling pathway	FADD,FAS,FASLG,RIPK1,TLR3,TNF	A series of molecular signals which triggers the necroptotic death of a cell. The pathway starts with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered.
GO:0097529	GO	BP	myeloid leukocyte migration	ADGRE2,AMICA1,ANXA1,AZU1,CALCA,CCL11,CCL13,CCL19,CCL2,CCL23,CCL24,CCL3,CCL5,CCL7,CCR7,CHGA,CKLF,CXADR,CXCL3,CXCL8,CXCR2,EDN2,EDN3,EDNRB,FLT1,GBF1,IL6,IL6R,IRAK4,ITGB2,KIT,LGALS3,NCKAP1L,PDE4B,PDGFB,PIK3CD,PIK3CG,PIP5K1C,PLA2G1B,PTPRO,RPS19,S100A12,S100A8,S100A9,SAA1,SCG2,SFTPD,SYK,TGFB2,TNFRSF11A,TNFSF11,UMOD,VEGFA,XCL1	The movement of a myeloid leukocyte within or between different tissues and organs of the body.
GO:0097530	GO	BP	granulocyte migration	ADGRE2,AMICA1,ANXA1,CCL11,CCL13,CCL24,CCL3,CCL5,CCL7,CKLF,CXADR,CXCL3,CXCL8,CXCR2,EDN2,EDN3,GBF1,IRAK4,ITGB2,LGALS3,NCKAP1L,PDE4B,PIK3CD,PIK3CG,PIP5K1C,PLA2G1B,S100A12,S100A8,S100A9,SAA1,SCG2,SYK,TGFB2,UMOD,VEGFA,XCL1	The movement of a granulocyte within or between different tissues and organs of the body.
GO:0097539	GO	CC	ciliary transition fiber	CENPF,CEP164,CEP83,CEP89,FBF1,SCLT1	A nine-bladed, propeller-like protein complex that links the distal end of the basal body and the cilium to the plasma membrane. Functions in protein sorting and gating (i.e. active and passive transport of proteins in and out of the cilium).
GO:0097542	GO	CC	ciliary tip	CLUAP1,CYLD,DYNC2H1,DYNC2LI1,DYNLL1,DYNLL2,DYNLRB1,DYNLRB2,GLI1,GLI2,GLI3,HSPB11,ICK,IFT122,IFT140,IFT172,IFT20,IFT22,IFT27,IFT43,IFT46,IFT52,IFT57,IFT74,IFT80,IFT81,IFT88,KIF3A,KIF3B,KIF3C,KIF7,KIFAP3,SMO,SUFU,TRAF3IP1,TTC21B,TTC26,TTC30B,ULK3,WDR19,WDR34,WDR35,WDR60	Part of the cilium where the axoneme ends. The ciliary tip has been implicated in ciliary assembly and disassembly, as well as signal transduction.
GO:0097546	GO	CC	ciliary base	ARMC4,CEP126,DISC1,GLI1,GLI2,GLI3,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,SUFU,TRAF3IP1,TULP3	Area of the cilium (also called flagellum) where the basal body and the axoneme are anchored to the plasma membrane. The ciliary base encompasses the distal part of the basal body, transition fibers and transition zone and is structurally and functionally very distinct from the rest of the cilium. In this area proteins are sorted and filtered before entering the cilium, and many ciliary proteins localize specifically to this area.
GO:0097553	GO	BP	calcium ion transmembrane import into cytosol	ATP2B4,BBC3,CCL19,CCL21,CCL3,CCR5,CCR7,CHERP,DRD2,ERO1A,F2R,FGF2,HTR2A,HTR2B,HTR2C,IBTK,ITPR1,LCK,NOL3,PKD2,PLCG2,PTPRC,RYR1,RYR2,TRDN,XCL1	A process in which a calcium ion is transported from one side of a membrane to the other into the cytosol by means of some agent such as a transporter or pore.
GO:0097581	GO	BP	lamellipodium organization	ABLIM1,ABLIM3,ARFIP2,ARHGEF4,ARHGEF6,ARHGEF7,CCDC88A,CDH13,CTTN,CYFIP1,GOLPH3,KIT,LRRC16A,PARVB,PTPRO,RAC1,RHOD,S1PR1,SNX1,SNX2,SPATA13,SRGAP2,VCL,WHAMM	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lamellipodium. A lamellipodium is a thin sheetlike process extended by the leading edge of a crawling fibroblast; contains a dense meshwork of actin filaments.
GO:0097602	GO	MF	cullin family protein binding	ANAPC11,CCDC22,PARK2,RBX1,RNF7	Interacting selectively and non-covalently with any member of the cullin family, hydrophobic proteins that act as scaffolds for ubiquitin ligases (E3).
GO:0097651	GO	CC	phosphatidylinositol 3-kinase complex, class I	PIK3CA,PIK3CG,PIK3R1,PIK3R5,PIK3R6	A phosphatidylinositol 3-kinase complex that contains a catalytic and a regulatory subunit of a phosphatidylinositol 3-kinase (PI3K) enzyme, plus one or more adaptor proteins. Class I PI3Ks phosphorylate phosphatidylinositol [PI], phosphatidylinositol-4-phosphate [PI(4)P] and phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2], and are divided into subclasses A and B according to the type of adaptor subunit with which they associate. The class I PI3K subfamily of genes comprises members in vertebrates, worm and fly, but none in yeast.
GO:0098505	GO	MF	G-rich strand telomeric DNA binding	CTC1,HNRNPA1,NABP2,POT1,TERF1,TERF2,TERF2IP	Interacting selectively and non-covalently with G-rich, single-stranded, telomere-associated DNA.
GO:0098531	GO	MF	transcription factor activity, direct ligand regulated sequence-specific DNA binding	AHR,AR,BRD8,ESR1,ESR2,ESRRA,ESRRB,GLMP,GPER1,NKX3-1,NR0B1,NR1D1,NR1D2,NR1H3,NR1H4,NR1I2,NR1I3,NR2E3,NR2F2,NR2F6,NR4A2,NR4A3,NR5A1,NR5A2,NR6A1,PPARA,PPARD,PPARG,PTGER3,RARA,RORA,RORC,RXRA,RXRB,STAT3,THRA,THRB,VDR	A DNA binding transcription factor activity that is directly regulated by binding of a ligand to the protein with this activity.  Examples include the lac and trp repressors in E.coli and many steroid hormone receptors.
GO:0098533	GO	CC	ATPase dependent transmembrane transport complex	ABCA2,ABCA7,ABCB6,ABCB8,ABCD4,ABCF2,ABCG5,ABCG8,ATP12A,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A2,FXYD1,FXYD2,PLN,SLC9A1	A transmembrane protein complex that functions in ATPase dependent active transport across a membrane.
GO:0098534	GO	BP	centriole assembly	C2CD3,CCDC67,CCDC78,CCP110,CDK2,CDK5RAP2,CENPJ,CEP135,CEP152,CEP63,CEP72,CETN2,CNTROB,E2F4,MCIDAS,PLK4,SASS6,WDR62	A cellular process that results in the assembly of one or more centrioles.
GO:0098536	GO	CC	deuterosome	CCDC67,CCDC78,CEP152,PLK4,SASS6	A spherical, electron dense, cytoplasmic structure that is involved in de novo assembly of centrioles.
GO:0098543	GO	BP	detection of other organism	CD1D,HLA-A,HLA-B,HLA-DRB1,NLRC4,NOD1,NOD2,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,SSC5D,TLR1,TLR2,TLR4,TLR6	The series of events in which a stimulus from another organism is received and converted into a molecular signal.
GO:0098554	GO	CC	cytoplasmic side of endoplasmic reticulum membrane	DNAJA1,HM13,PKD2,PTPN1,SPPL2A,SPPL2B,SPPL2C,SPPL3	The side (leaflet) of the plasma membrane that faces the cytoplasm.
GO:0098562	GO	CC	cytoplasmic side of membrane	ACP1,ALOX15,ARRB1,BIRC2,CACNB4,CAV2,CDH1,CDK16,CHMP4A,CHMP4B,CHUK,CYLD,CYTH1,CYTH3,DIABLO,DLG1,DLG4,DNAJA1,DSG1,EEF1A1,EEF1A2,ERRFI1,ESYT2,ESYT3,EXOC1,EZR,FARP1,FER,FERMT2,FES,G6PD,GEM,GNA14,GNA15,GNAI1,GNAS,GNAT2,GNB1,GNB1L,GNG2,GNG5,GNGT2,HCK,HM13,HTRA2,IKBKB,IQGAP1,JUP,KCNAB1,KCNAB2,KCNIP1,KRAS,LDLRAP1,LRRK2,MAP2K2,MIEN1,MYZAP,NPHS2,PGM5,PKD2,PKP4,PTEN,PTP4A1,PTPN1,PTPN22,PTPN3,PTPN4,PTPN7,RAB21,RAB5A,RACGAP1,RASA3,RASAL3,RGS1,RGS19,RGS2,RGS8,RNF31,S100A6,SHROOM4,SNX18,SNX5,SNX9,SPPL2A,SPPL2B,SPPL2C,SPPL3,SPTA1,SPTB,TGM3,TH,TIAM1,TRAF2,TRAF3,TRAF5,TRAF6	The side of a membrane that faces the cytoplasm.
GO:0098573	GO	CC	intrinsic component of mitochondrial membrane	ABCB10,ABCB6,APOO,APOOL,BAK1,BNIP3,CCDC109B,CHCHD3,CHCHD6,COA1,COA3,COX18,CPT1A,DMPK,ETFDH,FIS1,FUNDC1,GDAP1,IMMT,L2HGDH,MCU,MCUR1,MFF,MFN2,MGARP,MICU1,MUL1,OXA1L,PINK1,PPOX,RHOT1,RHOT2,SLC8B1,SMDT1,TIMM17A,TIMM17B,TIMM23,TMEM11,TMEM70,TOMM40,UQCC3	The component of the mitochondrial membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
GO:0098576	GO	CC	lumenal side of membrane	BCAP31,CALR,CANX,CD74,CTSA,HLA-A,HLA-B,HLA-C,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-F,HLA-G,HM13,HSPA8,PKD2,SPPL2A,SPPL2B,SPPL2C,SPPL3,TAPBP	Any side (leaflet) of a membrane that faces the lumen of an organelle.
GO:0098581	GO	BP	detection of external biotic stimulus	C4B,CD1D,HLA-A,HLA-B,HLA-DRB1,LBP,LY96,NLRC4,NOD1,NOD2,PGLYRP1,PGLYRP2,PGLYRP3,PGLYRP4,SCARB1,SSC5D,TLR1,TLR2,TLR4,TLR6	The series of events in which an external biotic stimulus is detected and converted into a molecular signal.  An external biotic stimulus is defined as one caused or produced by a living organism other than the one being stimulated.
GO:0098586	GO	BP	cellular response to virus	CCL19,DDX58,GLI2,IFIH1,IL12A,IRF3,IRF7,LGALS9,MAPK11,MAPK14,ZC3H12A	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
GO:0098631	GO	MF	protein binding involved in cell adhesion	CTNNA3,DSC2,DSG2,DSP,ITGA1,ITGA10,ITGA11,ITGA2,ITGB1,JUP,MADCAM1,PKP2	Any protein binding that is involved in cell adhesion.
GO:0098634	GO	MF	protein binding involved in cell-matrix adhesion	ITGA1,ITGA10,ITGA11,ITGA2,ITGB1,MADCAM1	Any protein binding that is involved in cell-matrix adhesion.
GO:0098639	GO	MF	collagen binding involved in cell-matrix adhesion	ITGA1,ITGA10,ITGA11,ITGA2,ITGB1	Any collagen binding that occurs as part of cell-matrix adhesion.
GO:0098642	GO	CC	network-forming collagen trimer	COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL8A1	A collagen trimer that forms networks.
GO:0098644	GO	CC	complex of collagen trimers	COL11A1,COL11A2,COL1A1,COL1A2,COL2A1,COL3A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL5A1,COL5A2,COL5A3,COL6A1,COL6A3,COL7A1,COL8A1,LUM,TNXB	A complex of collagen trimers such as a fibril or collagen network.
GO:0098651	GO	CC	basement membrane collagen trimer	COL15A1,COL4A1,COL4A2,COL4A3,COL4A4,COL4A6,COL8A1	Any collagen timer that is part of a basement membrane.
GO:0098656	GO	BP	anion transmembrane transport	ACACA,ACACB,ADAMTS8,ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO8,ANO9,APOL1,BEST1,CCT8L2,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN7,CLIC1,CLIC3,CPT1A,CPT1B,CPT2,EMB,FXYD1,FXYD3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,LRRC8A,NMUR2,PQLC2,PRKAA2,PRKAB2,PRKAG2,SLC12A1,SLC12A2,SLC12A3,SLC12A4,SLC12A9,SLC16A1,SLC16A12,SLC16A7,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A6,SLC1A7,SLC20A1,SLC20A2,SLC22A11,SLC22A16,SLC22A4,SLC22A5,SLC22A6,SLC22A8,SLC22A9,SLC25A12,SLC25A13,SLC25A15,SLC25A17,SLC25A20,SLC25A22,SLC25A26,SLC25A3,SLC25A42,SLC26A1,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC34A2,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A9,SLC3A1,SLC4A11,SLC6A14,SLC6A20,SLC6A8,SLC7A11,SLC7A2,SLC7A4,TTYH3	A process in which an anion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0098657	GO	BP	import into cell	ATP1A1,ATP1A2,ATP1B1,ATP2B4,FXYD2,GLUL,HFE,PICALM,SLC1A3,SLC38A1,SLC6A4,SLC9A1,SNAP25,SNCA,TF,TFR2	The directed movement of some substance from outside of a cell into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis.
GO:0098659	GO	BP	inorganic cation import into cell	ATP2B4,HFE,PICALM,SLC9A1,TF,TFR2	The directed movement of inorganic cations from outside of a cell into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis.
GO:0098661	GO	BP	inorganic anion transmembrane transport	ADAMTS8,ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO8,ANO9,APOL1,BEST1,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN7,CLIC1,CLIC3,FXYD1,FXYD3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR2,SLC12A1,SLC12A2,SLC12A3,SLC12A4,SLC12A9,SLC17A2,SLC17A3,SLC17A4,SLC17A7,SLC1A4,SLC20A1,SLC20A2,SLC25A3,SLC26A1,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,SLC34A2,SLC4A11,TTYH3	A process in which an inorganic anion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
GO:0098722	GO	BP	asymmetric stem cell division	DOCK7,FGF13,ING2,RAB10,SOX5,TEAD3	Division of a stem cell during which it retains its identity and buds off a daughter cell with a new identity.
GO:0098727	GO	BP	maintenance of cell number	CDC73,CDH2,CTNNB1,CTR9,DIS3L2,DLL1,DPPA4,EPAS1,EPHA1,FGF2,FOXD3,FZD7,IGF1,KIT,KLF4,LEO1,LIG4,LIN28A,METTL14,METTL3,MMP24,MTF2,NANOG,NANOS2,NOG,NOTCH2,PADI4,PBX1,PIWIL2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU5F1,PRDM14,PROX1,RTF1,SALL1,SALL4,SETD6,SIX2,SKI,SMAD2,SMAD4,SOX2,SOX9,SRRT,STAT3,TDGF1,TET1,ZCCHC11,ZFP36L2,ZIC3,ZNF358,ZSCAN10	Any process by which the numbers of cells of a particular type in a tissue are maintained.
GO:0098732	GO	BP	macromolecule deacylation	BAZ2A,ELK4,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC9,MORF4L1,NACC2,NOTUM,PER1,PER2,PHB,PPT1,PPT2,PRDM5,RCOR1,REST,SALL1,SFPQ,SIN3A,SIRT1,SIRT2,SIRT3,SIRT4,SIRT5,SIRT6,SIRT7,SMARCAD1,SUDS3	The removal of an acyl group, any group or radical of the form RCO- where R is an organic group, from a macromolecule.
GO:0098735	GO	BP	positive regulation of the force of heart contraction	MYL2,NOS1,RYR2,SLC8A1,SLC9A1	Any process that increases the force of heart muscle contraction.
GO:0098739	GO	BP	import across plasma membrane	ATP1A1,ATP1A2,ATP1B1,ATP2B4,FXYD2,SLC9A1	The directed movement of some substance from outside of a cell, across the plasma membrane and into the cytosol.
GO:0098742	GO	BP	cell-cell adhesion via plasma-membrane adhesion molecules	ADGRL1,ALCAM,AMICA1,AMIGO1,AMIGO2,AMIGO3,ATP2C1,CADM1,CADM3,CBLN1,CD164,CD209,CD6,CD84,CDH1,CDH13,CDH17,CDH23,CEACAM1,CELSR2,CLDN1,CLDN10,CLDN11,CLDN12,CLDN14,CLDN15,CLDN16,CLDN17,CLDN18,CLDN19,CLDN2,CLDN20,CLDN22,CLDN23,CLDN4,CLDN5,CLDN6,CLDN7,CLDN8,CLDN9,CXADR,DCHS1,DSCAM,DSCAML1,DSG1,DSG2,FAT2,FAT4,FGFRL1,GRID2,ICAM1,IL1RAPL1,ITGAL,ITGB1,MPZL2,NLGN1,NPTN,NRXN1,PCDHB10,PCDHB11,PCDHB13,PCDHB14,PCDHB16,PCDHB2,PCDHB3,PCDHB4,PCDHB5,PCDHB6,PCDHB9,PCDHGB4,PCDHGC3,PKD1,PTPRD,PTPRM,PTPRT,PVRL1,PVRL2,PVRL3,REG3A,ROBO1,ROBO2,SDK1,SDK2,SELE,TENM2,TENM3,TRO,UMOD,VCAM1	The attachment of one cell to another cell via adhesion molecules that are at least partially embedded in the plasma membrane.
GO:0098751	GO	BP	bone cell development	ANXA2,FOXP1,KIT,MED1,ZNF385A	The process whose specific outcome is the progression of a bone cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
GO:0098754	GO	BP	detoxification	ALB,APOA4,APOE,APOM,ATP7A,CAT,CLIC2,CYGB,EPX,FABP1,FAM213A,GPX1,GPX2,GPX3,GPX4,GPX7,GSR,GSTK1,GSTM1,GSTM2,GSTM3,GSTO1,GSTO2,GSTZ1,HBA1,HBB,IPCEF1,MARC1,MARC2,MGST1,MGST3,MT3,NOS3,PARK7,PRDX2,PRDX3,PRDX4,PRDX5,PRDX6,PTGS1,PTGS2,PXDN,PXDNL,SOD1,SOD2,SOD3,TP53INP1,TPO,TXNDC17,TXNDC2,TXNRD1,TXNRD2,TXNRD3,UBIAD1,VIMP	Any process that reduces or removes the toxicity of a toxic substance. These may include transport of the toxic substance away from sensitive areas and to compartments or complexes whose purpose is sequestration of the toxic substance.
GO:0098773	GO	BP	skin epidermis development	ALX4,APCDD1,ATP7A,DLL1,FGFR2,FOXE1,FUZ,GNAS,HDAC1,HDAC2,INHBA,KDF1,KRT17,KRT71,KRT84,PDGFA,SOX9,SPINK5,TGFB2,TGM3,WNT10A	The process whose specific outcome is the progression of the skin epidermis over time, from its formation to the mature structure.
GO:0098779	GO	BP	mitophagy in response to mitochondrial depolarization	ACIN1,ACTRT1,ADAMTS7,ADRB2,AKR1E2,ALPK1,AMBRA1,ANXA5,ASB2,ATG13,ATG14,ATP1B1,ATPIF1,BECN1,BLOC1S1,BOC,C5,C8orf59,CA7,CALCB,CAPS,CD163L1,CD93,CHAF1B,CHST3,CLVS1,COX8A,CRNKL1,CSPG5,DKKL1,DNAAF2,DPF3,DZANK1,EIF2S1,EVA1B,FABP1,FAM131B,FAM13B,FANCC,FANCF,FCGR3B,FGFBP1,GABRA5,GDF5,GMIP,HAPLN1,HCAR1,HDAC6,HK2,HPR,HSF2BP,IPPK,IST1,ITPKC,KCNK3,KIAA1549L,KRCC1,KRT15,KRT6A,KRT73,LARP1B,LENG9,LMCD1,LSM4,MAP1A,MAP2K1,MAP3K12,MBD5,MDH1,MEX3C,MRPS10,MRPS2,MSTN,MYH11,MYLK,MYOM1,NDUFB9,NEFM,NME2,NR2C2,NTHL1,NUP93,OBSCN,P2RX5,PARK2,PDK1,PEX13,PEX3,PFKP,PGK2,PHYHIP,PI4K2A,PIK3CA,PINK1,PLOD2,PNPO,PPY,PRKD2,PRKG1,REP15,RFWD3,RIMS3,SERPINB10,SFRP4,SLC1A3,SLC1A4,SLC22A3,SLC35B3,SLC35C1,SLC37A4,SLC6A1,SLCO1A2,SMURF1,SNRPB,SNRPD1,SNRPF,SNTG1,SQSTM1,STAT2,STK32A,STOM,SUPT3H,TBC1D5,TEX38,TMEM203,TMEM39A,TMEM39B,TOMM7,TREM1,TXLNA,YIPF1,ZCCHC17,ZNF189,ZNF593	The macromitophagy process that is triggered by a detection of the loss of mitochondrial membrane potential.
GO:0098781	GO	BP	ncRNA transcription	ANG,BRF1,ELL,ELL2,ELL3,GTF3A,GTF3C1,GTF3C2,GTF3C3,GTF3C4,GTF3C5,GTF3C6,ICE1,ICE2,NIFK,POLR1E,RNASEK,RPAP2,SIRT7,SNAPC2,SNAPC3,SNAPC4,SPIN1,TAF1B,ZC3H8	The transcription of non (protein) coding RNA from a DNA template.
GO:0098787	GO	BP	mRNA cleavage involved in mRNA processing	CPSF1,ERN1,NCBP1,NCBP2,TUT1	Cleavage of an immature mRNA transcript to produce one or more more mature mRNA transcripts, prior to translation into polypeptide.
GO:0098791	GO	CC	Golgi subcompartment	AKAP9,AP1B1,AP1G1,AP1M1,AP1M2,AP1S1,AP1S2,AP1S3,AP4B1,AP4E1,AP4M1,AP4S1,APP,ARFGEF1,ARFGEF2,ARFIP1,ARFIP2,ARFRP1,ARL1,ATG9A,ATL1,ATP2C1,ATP7A,ATP7B,ATP9A,ATP9B,ATXN2,AZIN2,B3GALT6,B4GALT1,BACE1,BICD1,BIRC6,CA4,CABP7,CALN1,CBY1,CD74,CDH1,CHAC1,CHID1,CHST2,CHST4,CLASP2,CLIP3,CLN3,CLTA,CLTC,CLTCL1,CLVS1,CLVS2,CNST,COG2,CORO7,DENND5A,DPY30,FAM109A,FAM109B,FURIN,GALNT2,GBF1,GCC2,GCNT1,GGA2,GGA3,GNAS,GOLGA1,GOLGA2,GOLGA4,GOLGA5,GOLGA7,GOLGB1,GOLPH3,GOLPH3L,GPER1,GPR89A,GSAP,HID1,HLA-A,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,IGF2R,INPP5K,KIAA1324,KIF13A,KLHL20,LGR5,LGR6,LLGL1,LPCAT2,MARCH1,MARCH4,MARCH9,MLANA,MMP24,MYO18A,MYO1B,NBEA,NECAB3,NSF,OCRL,OPTN,PIFO,PLEKHA8,PLK3,POSTN,PRKD1,RAB10,RAB11A,RAB13,RAB14,RAB21,RAB27B,RAB29,RAB30,RAB31,RAB34,RAB6A,RAB7B,RAC1,RBFOX1,RGS20,SCAMP1,SCAMP2,SCAMP5,SCOC,SGMS1,SLC11A2,SLC24A5,SLC9A7,SMPD4,SNX9,SORL1,STX10,STX16,STX6,STX8,TAS2R16,TGFBI,TGOLN2,TMBIM4,TMEM115,TMEM165,TMEM59,TMEM79,TRAPPC4,VAMP2,VAMP7,VPS54,VRK1,WIPI1,WLS,ZFYVE1	A compartment that consists of a lumen and an enclosing membrane, and is part of the Golgi Apparatus.
GO:0098792	GO	BP	xenophagy	ACIN1,ACKR3,ACTRT1,ALKBH5,ALPK1,ANXA5,ASB2,ATP1B1,C1orf210,C8orf59,CA7,CALCOCO2,CCDC36,CD163L1,CD93,CHAF1B,CHST3,CLDN7,COX8A,CPA3,CRNKL1,CSPG5,DKKL1,DNAAF2,DPF3,EIF2S1,FABP1,FAM131B,FAM13B,FANCL,FCGR3B,FGF14,FGF7,FGFBP1,FXR2,GABRA5,GMIP,HCAR1,HILPDA,HIST1H3A,HPR,IST1,ITPKC,KCNQ1,KIAA1549L,KRT6A,LENG9,LGALS8,LMCD1,LSM4,MAP1A,MBD5,MDH1,MRPS10,MRPS2,MSTN,MTSS1,MYLK,MYOM1,NTHL1,NUP93,OPTN,PDK4,PEX13,PEX3,PHYHIP,PNPO,PPY,RBM18,REEP2,REP15,RFWD3,SCN1A,SERPINB10,SLC1A3,SLC25A19,SLC35B3,SLC35C1,SLC37A4,SNRPB,SNRPB2,SNRPD1,SNTG1,STAT2,STOM,SUPT3H,TEAD4,TMEM203,TMEM39A,TMEM39B,TNIK,TREM1,UBA52,YIPF1,ZCCHC17,ZNF189,ZNF681	The macroautophagy process in which a region of cytoplasm containing an intracellular pathogen or some part of an intracellular pathogen (e.g. viral capsid) is enclosed in a double membrane bound autophagosome, which then fuses with the lysosome leading to degradation of the contents.
GO:0098793	GO	CC	presynapse	AAK1,ADGRL1,AMPH,BRSK1,BSN,CABP4,CAD,CASK,CDK16,CLCN3,CLN3,CNTNAP4,COPS4,COPS5,DLG4,DMXL2,DTNBP1,ERC1,ERC2,GABRA2,GHRH,GIPC1,GPER1,GRIK3,GRIN1,GRM7,HCRT,ICA1,KCNA1,KCNC2,LRRK2,MME,MT3,MTMR2,NPTN,NRXN1,NUFIP1,OTOF,PCLO,PDE2A,PI4K2A,PICALM,PICK1,PPFIA1,PPFIA2,PPFIA3,PPFIA4,PPT1,PTPRN,PTPRN2,RAB11B,RAB3A,RAB5A,RIMS1,RIMS2,RIMS3,RIMS4,RPH3A,SCRIB,SEMA4C,SEPT5,SLC17A6,SLC17A7,SLC17A8,SLC18A2,SLC30A3,SLC32A1,SLC6A17,SNAP25,SNAPIN,SNCAIP,SV2A,SV2B,SV2C,SVOP,SYN1,SYN2,SYN3,SYNGR3,SYP,SYT1,SYT11,SYT2,TBC1D24,TMEM163,TOR1A,TPRG1L,TRAPPC4,UNC13A,UNC13B,UNC13C,VAMP1,VAMP2,VTI1A,VTI1B	The part of a synapse that is part of the presynaptic cell.
GO:0098794	GO	CC	postsynapse	ACTN2,APP,ARF4,ARFGEF2,ATAD1,BCR,CABP1,CACNA1C,CACNG5,CACNG8,CDK5,CDK5R1,CHRNA1,CHRNA3,CHRND,CNIH2,CNIH3,CPEB4,CRIPT,DGKI,DLG4,DNAJA3,DNM2,DNM3,DTNBP1,F2R,FRMPD4,GIPC1,GPER1,GRIA1,GRID2,GRIN1,GRM7,IL1RAPL1,KCNC2,KCND2,LRP4,MAGEE1,MAGI2,MAPK8IP2,MTMR2,MUSK,NETO1,NEURL1,NLGN1,NLGN2,NR1D1,NSF,NSMF,P2RY1,PDLIM5,PICALM,PRKAR2B,PTK2B,PTPRO,RGS14,SCRIB,SEMA4C,SH2D5,SHANK1,SHANK2,SHANK3,SIGMAR1,SIPA1L1,SPOCK1,SRCIN1,SRGAP2,STRN,STX4,SYNDIG1,SYNE1,SYNPO,TENM2,TRPV1,ZC4H2	The part of a synapse that is part of the post-synaptic cell.
GO:0098798	GO	CC	mitochondrial protein complex	APOO,APOOL,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATPIF1,BAX,BCKDHA,BCKDHB,BCKDK,BCS1L,CCDC109B,CHCHD3,CHCHD6,CLPX,COX4I2,DBT,DLAT,DNA2,FOXRED1,IMMP2L,IMMT,MCU,MICU1,MICU2,MT-ATP6,MT-ATP8,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,PAM16,PARK7,PDK2,PINK1,PNPT1,PPIF,SAMM50,SDHA,SDHB,SDHC,SDHD,SLC25A6,SMDT1,SNCA,SUPV3L1,TIMM10,TIMM10B,TIMM13,TIMM17A,TIMM17B,TIMM21,TIMM23,TIMM8B,TIMM9,TOMM20,TOMM22,TOMM40,TOMM5,TOMM7,TOMM70A,UQCC3,USMG5	A protein complex that is part of a mitochondrion.
GO:0098799	GO	CC	outer mitochondrial membrane protein complex	PINK1,SAMM50,TOMM20,TOMM22,TOMM40,TOMM5,TOMM7,TOMM70A	Any protein complex that is part of the outer mitochondrial membrane.
GO:0098800	GO	CC	inner mitochondrial membrane protein complex	APOO,APOOL,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATPIF1,BCS1L,CCDC109B,CHCHD3,CHCHD6,COX4I2,FOXRED1,IMMP2L,IMMT,MCU,MICU1,MICU2,MT-ATP6,MT-ATP8,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,PAM16,PARK7,PPIF,SDHA,SDHB,SDHC,SDHD,SLC25A6,SMDT1,SNCA,TIMM10,TIMM17A,TIMM17B,TIMM21,TIMM23,UQCC3,USMG5	Any protein complex that is part of the inner mitochondrial membrane.
GO:0098801	GO	BP	regulation of renal system process	ADIPOQ,AGT,AGTR1,CORIN,EMP2,F2R,F2RL1,GAS6,INPP5K,KNG1,NPPB,NPR1,OR51E2,PDGFB,PTPRO,SPX,STC1	Any process that modulates the frequency, rate or extent of a system process, a multicellular organismal process carried out by the renal system.
GO:0098802	GO	CC	plasma membrane receptor complex	ACVR1,ACVR1B,ACVR1C,ALCAM,B2M,BCL10,BIRC2,BMP2,BMPR1A,BMPR1B,CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CARD11,CD247,CD3D,CD3E,CD3G,CD4,CD40,CD6,CD79A,CD8A,CD8B,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB3,CHRNB4,CHUK,CNIH2,CNIH3,CNTFR,CSF2RB,DAB2,DIABLO,DLG4,ENG,GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIN1,GRIN2A,GRIN2B,GRIN3A,GRIN3B,GRM1,HFE,HFE2,HTRA2,IFNL1,IFNLR1,IKBKB,IL10RB,IL12RB1,IL13RA1,IL23R,IL6,IL6R,IL6ST,INSR,IRAK1,IRS1,ITGA1,ITGA10,ITGA11,ITGA2,ITGA3,ITGA4,ITGA8,ITGA9,ITGAD,ITGAL,ITGAV,ITGB1,ITGB2,ITGB3,ITGB5,ITGB7,ITGB8,MYH9,NOS1AP,OLFM2,OSMR,PTK2B,RNF31,SDCBP,SHANK1,SHANK2,SHISA9,SORBS1,STOML2,STXBP5,SYK,TF,TFR2,TFRC,TGFBR1,TGFBR2,TLR1,TLR2,TOLLIP,TRAF2,TRAF3,TRAF5,TRAF6,TRAT1,TRIP6,ZAP70	Any protein complex that is part of the plasma membrane and which functions as a receptor.
GO:0098803	GO	CC	respiratory chain complex	BCS1L,COX4I2,FOXRED1,MT-CO1,MT-CO2,MT-CO3,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,PARK7,SDHA,SDHB,SDHC,SDHD,SNCA,UQCC3	Any protein complex that is part of a respiratory chain
GO:0098813	GO	BP	nuclear chromosome segregation	APITD1,AURKB,AURKC,BAG6,BECN1,BUB3,C11orf85,C15orf43,CASC5,CCDC79,CCNB1,CCNB1IP1,CDC23,CDCA5,CDCA8,CENPE,CENPF,CHAMP1,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CHMP6,CHMP7,CUL3,DDX11,DIS3L2,DLGAP5,DSCC1,ESPL1,FAM175B,FAM83D,FANCM,FBXW7,FMN2,GEM,GSG2,HDAC8,HORMAD1,HORMAD2,INO80,KIF14,KIF18A,KIF22,KIF25,KIF2C,KIFC1,KLHL22,KNSTRN,KPNB1,LATS1,M1AP,MAU2,MCMBP,MEI4,MEIKIN,MEIOB,MRE11A,NAA50,NCAPD2,NCAPD3,NCAPG,NCAPH,NDC80,NIPBL,NUSAP1,P3H4,PAPD7,PDS5B,PHB2,PHF13,PIBF1,PINX1,PLK1,POGZ,PSRC1,RAB11A,RAD51C,RB1,REC8,RNF212,RRS1,SEH1L,SGOL1,SMC1A,SMC2,SMC3,SMC4,SPAG5,SPDL1,SPICE1,STAG2,STAG3,STRA13,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,TEX14,TRIP13,VPS4A,VPS4B,ZNF207,ZW10,ZWINT	The process in which genetic material, in the form of nuclear chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. Nuclear chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
GO:0098815	GO	BP	modulation of excitatory postsynaptic potential	CUX2,DLG4,GRIN1,LRRK2,MTMR2,NLGN1,NLGN2,NLGN3,NLGN4X,NRXN1,PRKCZ,PTEN,PTK2B,RELN,RIMS1,RIMS2,SHANK1,SHANK3,STX1B,WNT7A	Any process that modulates the frequency, rate or extent of excitatory postsynaptic potential (EPSP). EPSP is a process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
GO:0098827	GO	CC	endoplasmic reticulum subcompartment	ASPH,FKBP1A,KPNB1,OSBPL8,PARP16,RAB10,RAB18,RAB3GAP1,RYR1,STIM1,TMEM110,ZFYVE27	A distinct  region of the endoplasmic reticulum
GO:0098857	GO	CC	membrane microdomain	ABCA1,ACE2,ADAM17,ADCY2,AHNAK,AKAP6,ANGPT1,ANXA13,ANXA2,APP,ARID3A,ARID3C,ATP2B4,BMPR1A,BMPR2,BTK,CAPN2,CARD11,CAV1,CAV2,CAV3,CBL,CD14,CD226,CD24,CD36,CD4,CD48,CD55,CD79A,CDH1,CDH13,CLIP3,CLN3,CORO1C,CRB2,CTSD,CXADR,DLC1,DLL1,DMD,EGFR,EHD2,EMP2,ERLIN2,EZR,F2R,FAIM2,FAS,FLOT1,FLOT2,FURIN,FYN,GHSR,GJA1,GPC1,GPM6B,HCK,HDAC6,HYAL2,INSR,IRS1,ITGB1,ITLN1,JAK2,KCNA5,KCND2,KCNE3,KCNMA1,KCNQ1,KDR,KIF18A,LAMP2,LAMTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,LAT,LAT2,LCK,LCP2,LDHB,LRP4,LRP6,LRP8,LRRK2,LYN,MAL,MAL2,MALL,MAPK1,MAPK3,MLC1,MYADM,MYO1C,MYOF,NOS1,NOS1AP,NOS3,NPHS2,NTSR1,PACSIN2,PAG1,PGK1,PI4K2A,PIKFYVE,PLSCR1,PLVAP,PPP2R1B,PPT1,PRKACA,PRKAR1A,PRKAR2A,PRKCDBP,PRNP,PROM2,PSEN1,PTCH1,PTGIS,PTRF,RANGRF,RAP2B,RFTN1,S100A10,SCARB1,SCN5A,SDCBP,SDPR,SELE,SERPINH1,SHH,SLC38A9,SLC6A3,SLC6A4,SLC9A1,SMO,SORBS1,SRC,STOM,STOML2,STX12,SULF1,TDGF1,TEK,TGFBR1,TGFBR2,THY1,TLR1,TLR2,TLR6,TNF,TNFRSF1A,TNFRSF1B,VCL,VDAC2,ZAP70	A membrane region with a lipid composition that is distinct from that of the membrane regions that surround it.
GO:0098858	GO	CC	actin-based cell projection	ABI1,ABI2,ACTA1,ACTA2,ACTC1,ACTG2,ACTN2,ANGPT1,ANTXR1,AOC3,ARF6,ATP6V1B1,CD302,CDC42,CDH23,CEACAM16,CIB1,CIB2,CLIC4,CLRN1,CXADR,DAG1,DFNB31,DMD,DOCK4,ENPP7,EPS8,EZR,FAM65B,FGF13,FSCN1,GAP43,GIF,GPM6A,GRXCR1,GRXCR2,HYAL2,IQGAP2,ITGA3,ITGAV,ITGB1,ITGB3,LCP1,LOXHD1,LRRK2,MSN,MTM1,MYO10,MYO1A,MYO1B,MYO1C,MYO3A,MYO5A,NLGN1,PALM,PCDH15,PDGFA,PDPN,PODXL,PPP1R9B,PROM2,RAPGEF3,RDX,RUFY3,SHTN1,SLC9A3R1,SPATA13,STRC,SYNE2,TBC1D10A,TBC1D10C,TEK,TENM2,TGFB1,TPRN,TRPV4,TSPEAR,TWF1,TWF2,USH1C,USH2A,UTRN,VCAM1,VIL1,WWOX	A cell projection supported by an assembly of actin filaments, and which lacks microtubules.
GO:0098862	GO	CC	cluster of actin-based cell projections	AQP1,ATP6V0A4,B4GALT1,CA4,CD36,CDH23,CDHR2,CEACAM16,CIB2,CLIC1,CUBN,DCDC2,DFNB31,DOCK4,ENPEP,EPS8,ESPN,EZR,FAM65B,GRXCR1,ITLN1,ITPR3,LOXHD1,MME,MYL6,MYO1A,MYO1B,MYO1D,PCDH15,PDZD3,PDZK1,PEX19,PLS1,RALGDS,SHANK2,SI,SLC17A3,SLC22A12,SLC22A5,SLC26A4,SLC26A6,SLC34A1,SLC34A2,SLC3A1,SLC7A9,SLC9A3,SOAT2,STRC,TMPRSS15,TPRN,TSPEAR,TWF2,USH1C,USH2A,VCL,VIL1	A cell part consisting of multiple, closely packed actin-based cell projections. 
GO:0098868	GO	BP	bone growth	CER1,DDR2,EVC,FGFR3,LEP,LEPR,NPPC,STC1	The increase in size or mass of a bone that contributes to the shaping of that bone.
GO:0098869	GO	BP	cellular oxidant detoxification	ALB,APOA4,APOE,APOM,ATP7A,CAT,CLIC2,CYGB,EPX,FABP1,FAM213A,GPX1,GPX2,GPX3,GPX4,GPX7,GSR,GSTK1,GSTO1,GSTO2,GSTZ1,HBA1,HBB,IPCEF1,MGST1,MGST3,MT3,NOS3,PRDX2,PRDX3,PRDX4,PRDX5,PRDX6,PTGS1,PTGS2,PXDN,PXDNL,SOD1,SOD2,SOD3,TP53INP1,TPO,TXNDC17,TXNDC2,TXNRD1,TXNRD2,TXNRD3,UBIAD1,VIMP	Any process carried out at the cellular level that reduces or removes the toxicity superoxide radicals or hydrogen peroxide.
GO:0098900	GO	BP	regulation of action potential	ADRA1A,ANK2,ANK3,ATP2A2,CAMK2D,CAV1,CAV3,CHRNB2,CTNNA3,DSC2,DSG2,DSP,GJA5,JUP,KCNB1,KCNJ2,NOS1AP,PKP2,PTPN3,RANGRF,RNF207,RYR2,SCN5A,SUMO1	Any process that modulates the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels.
GO:0098901	GO	BP	regulation of cardiac muscle cell action potential	ANK2,ANK3,ATP2A2,CAMK2D,CAV1,CAV3,CTNNA3,DSC2,DSG2,DSP,GJA5,JUP,NOS1AP,PKP2,RANGRF,RNF207,RYR2	Any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in a cardiac muscle cell. This typically occurs via modulation of the activity or expression of voltage-gated ion channels.
GO:0098911	GO	BP	regulation of ventricular cardiac muscle cell action potential	CAV1,CTNNA3,DSC2,DSG2,DSP,JUP,NOS1AP,PKP2,RNF207,RYR2	Any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in a ventricular cardiac muscle cell contributing to the regulation of its contraction.  This typically occurs via modulation of the activity or expression of voltage-gated ion channels.
GO:0099504	GO	BP	synaptic vesicle cycle	BLOC1S6,CANX,CDK5,DNAJC5,DOC2B,ITSN1,NLGN1,OTOF,PACSIN1,PCLO,PIP5K1C,PLD2,RAB3A,RAB5A,RIMS1,RIMS2,SEPT5,SLC18A2,SNAP25,SNAPIN,SNCA,SNPH,STON2,STX1B,SYNJ1,SYT1,UNC13B,VAMP2,WNT3A,WNT7A	A biological process in which synaptic vesicles are loaded with neurotransmitters, move to the active zone, exocytose and are then recycled via endocytosis, ultimately leading to reloading with neurotransmitters.
GO:0099515	GO	BP	actin filament-based transport	ACTN4,FNBP1L,MYO5A,SUN2,SYNE2,WASL	The transport of organelles or other particles from one location in the cell to another along actin filaments.
GO:0099516	GO	MF	ion antiporter activity	SLC11A1,SLC22A11,SLC22A4,SLC22A6,SLC22A8,SLC22A9,SLC24A1,SLC24A2,SLC24A5,SLC25A11,SLC25A6,SLC26A1,SLC26A6,SLC26A9,SLC3A2,SLC4A1,SLC7A11,SLC8A1,SLC8A2,SLC8A3,SLC8B1,SLC9A1,SLC9A3,SLC9A7	Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ion A(out) + ion B(in) = ion A(in) + ion B(out) where ion A and ion B are different types of ion.
GO:0099518	GO	BP	vesicle cytoskeletal trafficking	ACTN4,AP3B1,AP3B2,AP3D1,AP3M1,AP3M2,AP3S1,AP3S2,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,CLN3,DTNBP1,DYNC1I1,FNBP1L,FYCO1,HTT,KIF13A,KIF3A,KIF3B,KIF5B,KIFAP3,MYO5A,PAFAH1B1,RAB1A,SNAPIN,WASL	The directed movement of a vesicle along a cytoskeletal fiber such as a microtubule or and actin filament, mediated by motor proteins. 
GO:0099528	GO	MF	G-protein coupled neurotransmitter receptor activity	CHRM2,CHRM3,DRD1,DRD2,DRD3,DRD4,DRD5	Combining with a neurotransmitter and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
GO:0099531	GO	BP	presynaptic process involved in synaptic transmission	BLOC1S6,CDK5,DNAJC5,DOC2B,NLGN1,OTOF,PCLO,PIP5K1C,RAB3A,RIMS1,RIMS2,SEPT5,SNAP25,SNAPIN,SNCA,SNPH,STX1B,SYNJ1,SYT1,UNC13B,VAMP2	The pathway leading to secretion of a neurotransmitter from the presynapse as part of synaptic transmission.
GO:0099565	GO	BP	chemical synaptic transmission, postsynaptic	CHRNA3,CHRNA4,DRD4,GLRA1,GRID2,GRIN1,LRRK2,MAPK8IP2,MEF2C,NLGN3,RAB3GAP1	The part of synaptic transmission occurring in the post-synapse: a signal transduction pathway consisting of neurotransmitter receptor activation and its effects on postsynaptic membrane potential and the ionic composition of the postsynaptic cytosol.
GO:0099568	GO	CC	cytoplasmic region	AKT2,AMBRA1,ANLN,ARF6,ARFGEF2,ARFIP2,ARL6,ARMC4,ASPH,ATG14,ATG16L1,ATG5,ATG7,BSN,C2CD5,CAPN2,CCDC103,CCDC114,CCDC151,CCDC39,CCDC40,CCSAP,CD302,CDH1,CDH2,CDKL5,CEP162,CFAP221,CFAP46,CFAP54,CFAP74,CLASP1,CLASP2,CLDN5,CNKSR1,COBL,CORO1A,CTNNB1,CTTN,CYTIP,DBNL,DCDC2,DLC1,DLG4,DNAAF1,DNAH1,DNAH17,DNAH2,DNAH3,DNAH5,DNAH7,DNAH8,DNAH9,DNAI1,DNAI2,DNALI1,DRC1,DYNC2LI1,EEF1A1,EFHC1,EPB41,EPB41L2,EPS8,ERMN,EXOC1,EXOC2,EXOC3L1,EXOC8,EZR,FAM110C,FGFR2,FLOT1,FLOT2,FMN2,GABARAP,GIPC1,GPSM2,GRIK3,GRM7,GSN,GYPC,GYS2,IFT140,INPP5E,LANCL2,LASP1,LLGL1,LRRK2,MAEA,MAP1LC3B,MAPRE1,MELK,MKLN1,MYADM,MYH10,MYH9,MYO1A,MYO5B,MYO6,MYO9B,MYZAP,NCL,NEDD4,NME8,NSMF,NUMA1,OSBPL8,PAFAH1B1,PCLO,PFN1,PHLDB1,PHLDB2,PIK3C3,PIK3R4,PKD2,PLEKHH2,RAB10,RALB,RAPGEF3,RDX,RHOA,RP1L1,RPGRIP1L,RSPH4A,RSPH9,RYR1,SAXO1,SCIN,SELE,SEPT12,SEPT2,SEPT7,SHROOM2,SHROOM4,SLC2A1,SLC4A1,SNCA,SOD1,SPAG16,SPAG6,SPATA7,SPEF1,SPINK5,SPIRE1,SPIRE2,SPTA1,SPTAN1,SPTBN2,SPTBN4,SPTBN5,STIM1,TCHP,TMEM110,TRPC4,TRPV4,TSC1,TTLL3,TTLL8,UHMK1,VCL,WASH1,WDPCP,WDR34,WDR35	Any (proper) part of the cytoplasm of a single cell of sufficient size to still be considered cytoplasm\
GO:0099738	GO	CC	cell cortex region	BSN,CLASP1,CLASP2,MYO5B,PCLO,PHLDB1,PHLDB2,PKD2,TCHP	The complete extent of cell cortex that underlies some some region of the plasma membrane
GO:1900006	GO	BP	positive regulation of dendrite development	APOE,BHLHB9,BMP5,BMP7,CAMK1,CAMK2B,CAPRIN1,CAPRIN2,CDKL5,COBL,CPEB3,CUL7,CUX1,CUX2,DAB2IP,FBXW8,FOXO6,IL1RAPL1,LRP8,NEURL1,NLGN1,OBSL1,PACSIN1,PSEN1,PTPRD,RELN,SHANK1,SHANK3,VLDLR	Any process that activates or increases the frequency, rate or extent of dendrite development.
GO:1900015	GO	BP	regulation of cytokine production involved in inflammatory response	APOD,CD6,CHID1,CUEDC2,GBP5,LEP,MAPK14,MEFV,NOD2,NOS2,PER1,ZC3H12A	Any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response.
GO:1900016	GO	BP	negative regulation of cytokine production involved in inflammatory response	APOD,CHID1,CUEDC2,MEFV,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response.
GO:1900024	GO	BP	regulation of substrate adhesion-dependent cell spreading	ACTN4,AP1AR,APOA1,ARHGEF7,C1QBP,CALR,CDC42,CIB1,CORO1C,DMTN,FAM21C,FBLN1,FGA,FGB,FGG,FLNA,GBP1,ITGB1BP1,KANK1,LIMS1,LRRC16A,MFI2,MYADM,MYOC,OLFM4,PTK2,RAC1,RAC3,RCC2,RREB1,S100A10,TACSTD2,TRIOBP	Any process that modulates the frequency, rate or extent of substrate adhesion-dependent cell spreading.
GO:1900025	GO	BP	negative regulation of substrate adhesion-dependent cell spreading	ACTN4,AP1AR,CORO1C,DMTN,FBLN1,GBP1,ITGB1BP1,KANK1,MFI2,RCC2,TACSTD2	Any process that stops, prevents or reduces the frequency, rate or extent of substrate adhesion-dependent cell spreading.
GO:1900026	GO	BP	positive regulation of substrate adhesion-dependent cell spreading	APOA1,ARHGEF7,C1QBP,CALR,CDC42,CIB1,DMTN,FGA,FGB,FGG,FLNA,LIMS1,LRRC16A,MYADM,MYOC,OLFM4,RAC1,RAC3,RREB1,S100A10,TRIOBP	Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
GO:1900027	GO	BP	regulation of ruffle assembly	CAV1,EPS8L1,EPS8L2,EVL,HRAS,KANK1,NLGN1,PFN1,PFN2,RDX,STAP1,TACSTD2,USP17L2	Any process that modulates the frequency, rate or extent of ruffle assembly.
GO:1900028	GO	BP	negative regulation of ruffle assembly	EVL,KANK1,PFN2,STAP1,TACSTD2	Any process that stops, prevents or reduces the frequency, rate or extent of ruffle assembly.
GO:1900029	GO	BP	positive regulation of ruffle assembly	EPS8L1,EPS8L2,HRAS,NLGN1,PFN1	Any process that activates or increases the frequency, rate or extent of ruffle assembly.
GO:1900034	GO	BP	regulation of cellular response to heat	AAAS,AKT1S1,ATM,ATR,BAG1,BAG2,BAG3,BAG4,BAG5,C11orf73,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CCAR2,CD34,CHORDC1,CREBBP,CRYAB,DNAJB1,DNAJB6,DNAJC2,DNAJC7,EP300,FKBP4,GSK3B,HSBP1,HSF1,HSP90AA1,HSP90AB1,HSPA1A,HSPA1B,HSPA1L,HSPA8,HSPB8,HSPH1,MAPK1,MAPK3,MAPKAPK2,MLST8,MTOR,NDC1,NUP107,NUP133,NUP153,NUP155,NUP160,NUP188,NUP205,NUP210,NUP214,NUP35,NUP37,NUP43,NUP50,NUP54,NUP58,NUP62,NUP85,NUP88,NUP93,NUP98,NUPL2,POM121,POM121C,PTGES3,RAE1,RANBP2,RPA1,RPA2,RPA3,RPTOR,SEH1L,SIRT1,TPR,YWHAE	Any process that modulates the frequency, rate or extent of cellular response to heat.
GO:1900037	GO	BP	regulation of cellular response to hypoxia	AJUBA,CD34,CHCHD2,HYOU1,RWDD3,TMBIM6,USP19	Any process that modulates the frequency, rate or extent of cellular response to hypoxia.
GO:1900040	GO	BP	regulation of interleukin-2 secretion	CD34,EZR,GBP1,SPTBN1,TRIM27	Any process that modulates the frequency, rate or extent of interleukin-2 secretion.
GO:1900044	GO	BP	regulation of protein K63-linked ubiquitination	BIRC2,OTUB1,PARP10,PTPN22,SASH1,TRIP12,UBR5	Any process that modulates the frequency, rate or extent of protein K63-linked ubiquitination.
GO:1900076	GO	BP	regulation of cellular response to insulin stimulus	AHSG,ENPP1,FFAR3,GPLD1,GRB10,GSK3A,IGF2,IL1B,INPP5K,INS,IRS1,KANK1,MZB1,NGFR,OGT,OSBPL8,PID1,PIK3R1,PIK3R2,PIK3R3,PRKCB,PRKCD,PRKCQ,PRKCZ,PTPN1,PTPN11,PTPN2,PTPRE,RARRES2,RPS6KB1,SIK2,SIRT1,SOCS1,TSC2,VWA2	Any process that modulates the frequency, rate or extent of cellular response to insulin stimulus.
GO:1900077	GO	BP	negative regulation of cellular response to insulin stimulus	AHSG,ENPP1,GRB10,GSK3A,IL1B,INPP5K,IRS1,KANK1,MZB1,PID1,PRKCB,PRKCD,PRKCQ,PRKCZ,PTPN1,PTPN2,PTPRE,RPS6KB1,SOCS1	Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to insulin stimulus.
GO:1900078	GO	BP	positive regulation of cellular response to insulin stimulus	FFAR3,IGF2,INS,IRS1,OSBPL8,PIK3R1,PIK3R2,PIK3R3,PRKCZ,PTPN11,RARRES2,SIRT1	Any process that activates or increases the frequency, rate or extent of cellular response to insulin stimulus.
GO:1900087	GO	BP	positive regulation of G1/S transition of mitotic cell cycle	AIF1,ANKRD17,CDC6,CDK10,DDX3X,LSM10,LSM11,NACC2,PLCB1,PPP1R1C,RDX,UBE2E2	Any cell cycle regulatory process that promotes the commitment of a cell from G1 to S phase of the mitotic cell cycle.
GO:1900101	GO	BP	regulation of endoplasmic reticulum unfolded protein response	AGR2,BAK1,BAX,BBC3,BCL2L11,BFAR,COPS5,CREBRF,DAB2IP,ERN1,GNB2L1,HSPA1A,HSPA5,NCK1,PIK3R1,PPP1R15A,PPP1R15B,PTPN1,TMBIM6,WFS1,XBP1	Any process that modulates the frequency, rate or extent of endoplasmic reticulum unfolded protein response.
GO:1900102	GO	BP	negative regulation of endoplasmic reticulum unfolded protein response	BFAR,CREBRF,GNB2L1,NCK1,PPP1R15A,PPP1R15B,PTPN1,TMBIM6,WFS1,XBP1	Any process that stops, prevents or reduces the frequency, rate or extent of endoplasmic reticulum unfolded protein response.
GO:1900103	GO	BP	positive regulation of endoplasmic reticulum unfolded protein response	AGR2,BAK1,BAX,BBC3,BCL2L11,DAB2IP,ERN1,HSPA1A,PIK3R1,PTPN1,XBP1	Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum unfolded protein response.
GO:1900107	GO	BP	regulation of nodal signaling pathway	DACT2,DAND5,NODAL,SHH,SMAD2	Any process that modulates the frequency, rate or extent of nodal signaling pathway.
GO:1900116	GO	BP	extracellular negative regulation of signal transduction	ADH7,AGTR2,CD46,CER1,DAND5,DKK1,ESR2,FBN1,FBN2,IL18BP,LRPAP1,LTBP1,NBL1	Any negative regulation of signal transduction that takes place in extracellular region.
GO:1900117	GO	BP	regulation of execution phase of apoptosis	BAX,BCL2L1,BOK,CDKN2A,CIDEA,CXCR3,DFFA,DLC1,FAP,FZD3,PAK2,PTGIS,RFFL,RNF34,RPS3,SIRT2,TBX5,TP53,TP53BP2	Any process that modulates the frequency, rate or extent of execution phase of apoptosis.
GO:1900118	GO	BP	negative regulation of execution phase of apoptosis	BCL2L1,CIDEA,CXCR3,DFFA,FZD3,PAK2,RFFL,RNF34	Any process that stops, prevents or reduces the frequency, rate or extent of execution phase of apoptosis.
GO:1900119	GO	BP	positive regulation of execution phase of apoptosis	BAX,BOK,CXCR3,DLC1,FAP,PTGIS,RPS3,SIRT2,TP53,TP53BP2	Any process that activates or increases the frequency, rate or extent of execution phase of apoptosis.
GO:1900120	GO	BP	regulation of receptor binding	ADAM15,ADIPOQ,ANXA2,B2M,GREM2,HFE,IL10,LEF1,MMP9,NKX3-1,NOG,NRP1,PTPRF,RUVBL2	Any process that modulates the frequency, rate or extent of a protein or other molecule binding to a receptor.
GO:1900121	GO	BP	negative regulation of receptor binding	ADAM15,ADIPOQ,ANXA2,B2M,HFE,IL10,LEF1,NKX3-1,NOG,PTPRF,RUVBL2	Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor.
GO:1900125	GO	BP	regulation of hyaluronan biosynthetic process	AP2A1,CLTC,EGF,NFKB1,PDGFB,TGFB1	Any process that modulates the frequency, rate or extent of hyaluronan biosynthetic process.
GO:1900153	GO	BP	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	AGO2,BTG2,CNOT1,CNOT7,CPEB3,NANOS1,NANOS2,NANOS3,PABPC1,TNRC6B,TNRC6C,TOB1,ZFP36,ZFP36L2	Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay.
GO:1900165	GO	BP	negative regulation of interleukin-6 secretion	C1QTNF3,C5AR2,GAS6,PTPN22,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-6 secretion.
GO:1900180	GO	BP	regulation of protein localization to nucleus	AKAP6,AKT1,APC2,APOD,AXIN2,BAMBI,BMP4,BMP6,BMP7,BMPR1A,C1QTNF3,C8orf4,CABP1,CCDC22,CCL19,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CD27,CDH1,CDK1,CDK5RAP3,CDKN2A,CHERP,CHP1,CHP2,CREB3,CSF3,CYLD,DAB2,DAB2IP,DACT1,DACT3,DDX58,DMAP1,DYRK2,ECT2,EGF,EGFR,EIF2AK3,EMD,ERBB4,FAF1,FAM89B,FLCN,FLNA,FZD7,G3BP2,GAS6,GNAQ,GSK3B,HCLS1,HDAC3,HYAL2,IGF1,IL10,IL12B,IL1B,IL23A,IL6,INS,IPO5,JUP,KANK1,KAT7,KPNA1,LACRT,LGALS9,LIF,MAVS,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NODAL,NOV,OGG1,OTUD7B,PARK7,PARP10,PBLD,PDE2A,PIK3R1,PIK3R2,PIN1,PINX1,PKD1,PKD2,POU5F1,PPM1A,PPM1B,PPP3CA,PPP3CB,PPP3R1,PRKCD,PSMD10,PYDC2,RAB23,RBPMS,RHOA,SEMA5A,SFRP5,SHH,SIN3A,SIRT1,SLC9A1,SLC9A3R1,SMAD3,SMAD4,SNAI2,SPHK1,SPPL3,SUFU,TCP1,TERT,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TONSL,TPR,TRIM28,TRIM40,TRIP6,TXN,UBR5,WNT3A,WWTR1,XBP1,ZC3H12A,ZIC1,ZNF268,ZPR1	Any process that modulates the frequency, rate or extent of protein localization to nucleus.
GO:1900181	GO	BP	negative regulation of protein localization to nucleus	APC2,APOD,AXIN2,BMP7,C1QTNF3,CABP1,CCDC22,CHP1,CREB3,CYLD,DAB2IP,DACT3,DYRK2,EMD,FAF1,FAM89B,FLCN,G3BP2,GAS6,GSK3B,IL10,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOV,OTUD7B,PARP10,PBLD,PDE2A,PKD1,PKD2,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,SFRP5,SIN3A,SLC9A3R1,SNAI2,SUFU,TONSL,TRIM40,WWTR1,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus.
GO:1900182	GO	BP	positive regulation of protein localization to nucleus	AKAP6,AKT1,BAMBI,BMP4,BMP6,BMPR1A,C8orf4,CCL19,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CD27,CDH1,CDK1,CDK5RAP3,CDKN2A,CHERP,CHP2,CSF3,DAB2,DACT1,DDX58,DMAP1,ECT2,EGF,EGFR,EIF2AK3,ERBB4,FLNA,HCLS1,HDAC3,HYAL2,IGF1,IL12B,IL1B,IL23A,IL6,INS,IPO5,JUP,KANK1,KAT7,KPNA1,LACRT,LGALS9,LIF,MAVS,NLRP12,NODAL,PARK7,PIK3R1,PIK3R2,PINX1,POU5F1,PPP3CA,PPP3CB,PPP3R1,PRKCD,RBPMS,RHOA,SEMA5A,SLC9A1,SMAD3,SMAD4,SPHK1,SPPL3,TCP1,TERT,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TPR,TRIM28,TRIP6,UBR5,WNT3A,XBP1,ZIC1,ZNF268,ZPR1	Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
GO:1900221	GO	BP	regulation of beta-amyloid clearance	ABCA7,APOE,CLU,LRPAP1,MYOCD,SRF	Any process that modulates the frequency, rate or extent of beta-amyloid clearance.
GO:1900225	GO	BP	regulation of NLRP3 inflammasome complex assembly	CD36,EIF2AK2,GBP5,MEFV,PYDC2,TLR4,TLR6	Any process that modulates the frequency, rate or extent of NLRP3 inflammasome complex assembly.
GO:1900246	GO	BP	positive regulation of RIG-I signaling pathway	ANKRD17,DDX60,DHX58,PUM1,PUM2,TRIM15,USP17L2,ZC3HAV1	Any process that activates or increases the frequency, rate or extent of RIG-I signaling pathway.
GO:1900274	GO	BP	regulation of phospholipase C activity	ABL1,ABL2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY7,ADCY8,ADCY9,ADRA1A,ADRBK1,ANG,ARHGAP6,AVPR1A,AVPR1B,BICD1,C5AR1,CALM1,CAMK4,CREB1,EDNRA,EGFR,ESR1,FGF2,FGFR1,FLT1,GNA15,GNAQ,GPR55,HTR2A,HTR2B,ITK,ITPR1,ITPR2,ITPR3,KIT,LPAR1,LPAR2,NGF,NMUR1,NTRK1,PDE1A,PDE1B,PDE1C,PDGFRA,PDGFRB,PLCB2,PLCG1,PRKACA,PRKACB,PRKACG,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,PRKCA,PRKCD,PRKCE,PRKCG,RASGRP4,S1PR4,SELE,TXK	Any process that modulates the frequency, rate or extent of phospholipase C activity.
GO:1900363	GO	BP	regulation of mRNA polyadenylation	CCNT1,CDK9,CPEB3,CTR9,NELFE,RNF20,RNF40,SUPT5H	Any process that modulates the frequency, rate or extent of mRNA polyadenylation.
GO:1900364	GO	BP	negative regulation of mRNA polyadenylation	CCNT1,CDK9,CTR9,NELFE,RNF20,RNF40,SUPT5H	Any process that stops, prevents or reduces the frequency, rate or extent of mRNA polyadenylation.
GO:1900371	GO	BP	regulation of purine nucleotide biosynthetic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,APOE,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CCR2,CRHR1,DRD1,DRD2,DRD3,DRD4,DRD5,EDNRA,EDNRB,FLCN,GABBR2,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,GUCA1C,GUCA2A,GUCA2B,HTR1B,LHCGR,LTB4R2,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,OPRM1,OXER1,P2RY11,PALM,PDE2A,PDZD3,PID1,PINK1,PPARGC1A,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RCVRN,RLN2,VCP,VIP	Any process that modulates the frequency, rate or extent of purine nucleotide biosynthetic processes.
GO:1900372	GO	BP	negative regulation of purine nucleotide biosynthetic process	ADRA2A,AKAP6,APLP1,CCR2,DRD2,DRD3,DRD4,EDNRB,FLCN,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,HTR1B,LTB4R2,OPRM1,PALM,PDE2A,PDZD3,PID1,PRKCA	Any process that stops, prevents or reduces the frequency, rate or extent of purine nucleotide biosynthetic processes.
GO:1900373	GO	BP	positive regulation of purine nucleotide biosynthetic process	ABCA1,ACR,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,APOE,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CRHR1,DRD1,DRD5,EDNRA,GHRH,GHRHR,GIPR,GLP1R,GNAS,GPER1,GPR161,GPR65,GSK3A,GUCA1C,GUCA2A,GUCA2B,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,P2RY11,PID1,PINK1,PPARGC1A,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RCVRN,RLN2,VCP,VIP	Any process that activates or increases the frequency, rate or extent of purine nucleotide biosynthetic processes.
GO:1900407	GO	BP	regulation of cellular response to oxidative stress	AKT1,ATF4,BAG5,BMP7,DHFR,FBLN5,FBXW7,GCH1,GNB2L1,GPR37,GPR37L1,HDAC6,HGF,HIF1A,HP,HSPB1,HTRA2,INS,LRRK2,MAPK7,MCL1,MET,MMP3,NFE2L2,NOL3,NONO,NR4A3,P4HB,PARK2,PARK7,PINK1,PYCR1,SFPQ,SIRT1,SNCA,SOD1,SOD2,STK26,SZT2,TNF,TRAP1,TXN,UBQLN1,VNN1	Any process that modulates the frequency, rate or extent of cellular response to oxidative stress.
GO:1900408	GO	BP	negative regulation of cellular response to oxidative stress	AKT1,ATF4,BAG5,GNB2L1,GPR37,GPR37L1,HGF,HIF1A,HP,HSPB1,HTRA2,INS,LRRK2,MAPK7,MET,NFE2L2,NOL3,NONO,NR4A3,PARK2,PARK7,PINK1,PYCR1,SIRT1,SOD2,TRAP1,TXN,VNN1	Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidative stress.
GO:1900409	GO	BP	positive regulation of cellular response to oxidative stress	FBXW7,HDAC6,MCL1,MMP3,PARK7,SFPQ,SNCA,SOD1,TNF	Any process that activates or increases the frequency, rate or extent of cellular response to oxidative stress.
GO:1900424	GO	BP	regulation of defense response to bacterium	CYBA,DEFB103A,F2RL1,FOXP1,KLK5,KLK7,PGC,SIRT2	Any process that modulates the frequency, rate or extent of defense response to bacterium.
GO:1900426	GO	BP	positive regulation of defense response to bacterium	CYBA,DEFB103A,F2RL1,KLK5,KLK7,PGC	Any process that activates or increases the frequency, rate or extent of defense response to bacterium.
GO:1900449	GO	BP	regulation of glutamate receptor signaling pathway	CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CNIH2,CNIH3,CRH,CRHBP,DAPK1,DLG4,MAPK8IP2,MEF2C,MINK1,NLGN1,NLGN2,NLGN3,NRXN1,OPRM1,PTK2B,RELN,SHANK1,SHANK3	Any process that modulates the frequency, rate or extent of glutamate receptor signaling pathway.
GO:1900542	GO	BP	regulation of purine nucleotide metabolic process	ABCA1,ACR,ACTN3,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRA2A,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,AKAP6,APLP1,APOE,ARNT,ATP7A,ATPIF1,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CBFA2T3,CCR2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD2,DRD3,DRD4,DRD5,ECD,EDNRA,EDNRB,EGLN1,ENTPD5,FBP1,FLCN,FZD2,GABBR2,GAPDHS,GCK,GHRH,GHRHR,GIPR,GLP1R,GNAI2,GNAI3,GNAS,GNB2L1,GPER1,GPR161,GPR65,GRM2,GRM3,GRM7,GRM8,GSK3A,GUCA1C,GUCA2A,GUCA2B,HDAC4,HIF1A,HTR1B,IGF1,INS,INSR,LHCGR,LTB4R2,MAPK7,MC1R,MC2R,MC3R,MC4R,MC5R,MLXIPL,MRAP,MRAP2,MTNR1A,NCOR1,NF1,NOS3,NPPC,NTRK1,NTRK2,OGT,OPRM1,OXER1,P2RX7,P2RY11,PALM,PARK7,PDE2A,PDZD3,PF4,PGAM1,PID1,PINK1,PKD2,PPARA,PPARGC1A,PPIF,PRKAA1,PRKAA2,PRKAG1,PRKAG2,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RCVRN,RLN2,SLC25A33,SNCA,THBS1,UQCC2,VCP,VEGFA,VIP,WNT5A	Any process that modulates the frequency, rate or extent of purine nucleotide metabolic process.
GO:1900543	GO	BP	negative regulation of purine nucleotide metabolic process	ACTN3,ADRA2A,AKAP6,APLP1,CBFA2T3,CCR2,DRD2,DRD3,DRD4,EDNRB,EGLN1,FBP1,FLCN,GABBR2,GNAI2,GNAI3,GRM2,GRM3,GRM7,GRM8,HDAC4,HTR1B,LTB4R2,MAPK7,MLXIPL,OPRM1,PALM,PDE2A,PDZD3,PID1,PPARA,PPIF,PRKCA,SNCA	Any process that stops, prevents or reduces the frequency, rate or extent of purine nucleotide metabolic process.
GO:1900544	GO	BP	positive regulation of purine nucleotide metabolic process	ABCA1,ACR,ACTN3,ADCY7,ADCYAP1,ADCYAP1R1,ADGRD1,ADM,ADORA2A,ADORA2B,ADRB1,ADRB2,ADRB3,AKAP12,AKAP5,APOE,ARNT,AVPR2,CALCA,CALCR,CALCRL,CAP1,CAP2,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,DRD5,EDNRA,ENTPD5,FZD2,GAPDHS,GHRH,GHRHR,GIPR,GLP1R,GNAS,GNB2L1,GPER1,GPR161,GPR65,GSK3A,GUCA1C,GUCA2A,GUCA2B,HIF1A,IGF1,INS,INSR,LHCGR,MC1R,MC2R,MC3R,MC4R,MC5R,MLXIPL,MRAP,MRAP2,MTNR1A,NF1,NOS3,NTRK1,NTRK2,P2RX7,P2RY11,PARK7,PF4,PID1,PINK1,PPARGC1A,PRKAA1,PRKAA2,PRKCA,PTGIR,PTH,PTHLH,RAF1,RAMP1,RAMP2,RAPGEF3,RCVRN,RLN2,VCP,VIP,WNT5A	Any process that activates or increases the frequency, rate or extent of purine nucleotide metabolic process.
GO:1900740	GO	BP	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	AKT1,BAD,BBC3,BCL2,BCL2L11,BID,BMF,CASP8,DYNLL1,DYNLL2,E2F1,GZMB,MAPK8,NMT1,PMAIP1,PPP3CC,PPP3R1,SFN,TFDP1,TP53,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ	Any process that activates or increases the frequency, rate or extent of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway.
GO:1900744	GO	BP	regulation of p38MAPK cascade	BMP2,DAB2IP,DLG1,EZR,GADD45A,GADD45B,GADD45G,LEP,MAP3K4,PER1,PHLPP1,PRMT1,PTPN22,SASH1,ULK4,VEGFA,XDH	Any process that modulates the frequency, rate or extent of p38MAPK cascade.
GO:1900745	GO	BP	positive regulation of p38MAPK cascade	BMP2,GADD45A,GADD45B,GADD45G,LEP,MAP3K4,PRMT1,SASH1,VEGFA,XDH	Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.
GO:1900746	GO	BP	regulation of vascular endothelial growth factor signaling pathway	ADAMTS3,CCBE1,CD63,DAB2IP,DCN,DLL1,HRG,MYO1C,XDH	Any process that modulates the frequency, rate or extent of vascular endothelial growth factor signaling pathway.
GO:1900750	GO	MF	oligopeptide binding	FOLH1,GSS,GSTM1,GSTM2,GSTM3,GSTM4,LANCL1,PTGES,PTGES2	Interacting selectively and non-covalently with an oligopeptide.
GO:1901016	GO	BP	regulation of potassium ion transmembrane transporter activity	ACTN2,AKAP6,AKAP7,AKAP9,ANK2,ANK3,ATP1B1,ATP1B2,ATP1B3,CAB39,CACNA1D,CASQ2,CAV1,CAV3,FHL1,GAL,GALR2,KCNAB1,KCNE1,KCNE2,KCNE3,KCNG1,KCNQ1,KCNRG,KCNS1,KCNS2,NEDD4,NEDD4L,NOS1AP,NPPA,RNF207,STK39,SUMO1,VAMP2,WWP2,YWHAE	Any process that modulates the frequency, rate or extent of potassium ion transmembrane transporter activity.
GO:1901017	GO	BP	negative regulation of potassium ion transmembrane transporter activity	ACTN2,ANK3,CAB39,CASQ2,CAV3,KCNE1,KCNE2,KCNE3,KCNQ1,KCNRG,NEDD4L,RNF207,STK39,SUMO1	Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transporter activity.
GO:1901018	GO	BP	positive regulation of potassium ion transmembrane transporter activity	ACTN2,AKAP6,AKAP7,AKAP9,ANK2,ATP1B1,ATP1B2,ATP1B3,GAL,GALR2,NOS1AP,NPPA,RNF207	Any process that activates or increases the frequency, rate or extent of potassium ion transmembrane transporter activity.
GO:1901019	GO	BP	regulation of calcium ion transmembrane transporter activity	ADRA2A,AHNAK,AKAP6,ANK2,ASPH,ATP1A2,ATP1B1,CACNB4,CALM1,CAMK2D,CASQ2,CAV3,CLIC2,CRACR2A,CRHR1,DMD,DRD2,DRD4,FKBP1A,FKBP1B,GNB5,GSTM2,GSTO1,HAP1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,NOS1,NOS1AP,NPPA,PDE4B,PDE4D,PKD2,PLN,PRKACA,RYR2,SLC9A1,SLN,SRI,STIM1,STIM2,TLR9,TMEM110,TRDN,UBQLN1	Any process that modulates the frequency, rate or extent of calcium ion transmembrane transporter activity.
GO:1901020	GO	BP	negative regulation of calcium ion transmembrane transporter activity	ADRA2A,ATP1A2,CALM1,CASQ2,CLIC2,CRHR1,DRD2,DRD4,FKBP1B,GNB5,GSTM2,GSTO1,PKD2,PLN,SLN,SRI,TLR9,TRDN,UBQLN1	Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion transmembrane transporter activity.
GO:1901021	GO	BP	positive regulation of calcium ion transmembrane transporter activity	AKAP6,ANK2,ASPH,ATP1B1,CALM1,CRACR2A,GSTM2,GSTO1,HAP1,HTT,JPH2,PKD2,RYR2,SLC9A1,STIM1,STIM2,TMEM110,TRDN	Any process that activates or increases the frequency, rate or extent of calcium ion transmembrane transporter activity.
GO:1901028	GO	BP	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	ACAA2,AKT1,BAD,BAK1,BAX,BBC3,BCL2,BCL2L11,BID,BMF,CASP8,DYNLL1,DYNLL2,E2F1,GSK3A,GSK3B,GZMB,HSPA1A,MAPK8,MPV17L,MUL1,NMT1,PMAIP1,PPP3CC,PPP3R1,SFN,SIVA1,SLC25A5,SLC35F6,TFDP1,TMEM102,TP53,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	Any process that modulates the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway.
GO:1901029	GO	BP	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	ACAA2,HSPA1A,MPV17L,SLC25A5,SLC35F6	Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway.
GO:1901030	GO	BP	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	AKT1,BAD,BAK1,BAX,BBC3,BCL2,BCL2L11,BID,BMF,CASP8,DYNLL1,DYNLL2,E2F1,GSK3A,GSK3B,GZMB,MAPK8,NMT1,PMAIP1,PPP3CC,PPP3R1,SFN,SIVA1,TFDP1,TP53,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway.
GO:1901031	GO	BP	regulation of response to reactive oxygen species	BMP7,DHFR,FBLN5,GCH1,GNB2L1,GPR37,GPR37L1,HDAC6,HGF,HP,LRRK2,MET,NFE2L2,NR4A3,PARK7,PINK1,PYCR1,SNCA,STK26,SZT2,TNF,TRAP1,TXN	Any process that modulates the frequency, rate or extent of response to reactive oxygen species.
GO:1901032	GO	BP	negative regulation of response to reactive oxygen species	GNB2L1,GPR37,GPR37L1,HGF,HP,LRRK2,MET,NFE2L2,NR4A3,PARK7,PINK1,PYCR1,TRAP1,TXN	Any process that stops, prevents or reduces the frequency, rate or extent of response to reactive oxygen species.
GO:1901068	GO	BP	guanosine-containing compound metabolic process	AK3,AK4,CARD11,CASK,DGUOK,DLG1,DLG2,GMPR2,GNAI3,HPRT1,LRRK2,MAGI3,MPP1,MPP2,MPP3,NUDT18,PDE6A,PDE6B,RHOQ,TJP2	The chemical reactions and pathways involving guanosine-containing compounds (guanosines).
GO:1901071	GO	BP	glucosamine-containing compound metabolic process	CHIA,CHIT1,CHST2,CHST4,CHST5,CHST6,CHST7,EXTL2,GNPDA1,LARGE,MGEA5,PGM3	The chemical reactions and pathways involving glucosamine-containing compounds (glucosamines).
GO:1901077	GO	BP	regulation of relaxation of muscle	CAMK2D,HRC,PDE4B,PDE4D,PLN,SLN,SRI	Any process that modulates the frequency, rate or extent of relaxation of muscle.
GO:1901096	GO	BP	regulation of autophagosome maturation	ADRB2,CALCOCO2,PHF23,RUBCN,TBC1D25,UBQLN1,UBQLN4	Any process that modulates the frequency, rate or extent of autophagosome maturation.
GO:1901136	GO	BP	carbohydrate derivative catabolic process	ABHD10,ACAN,ADA,ADAMTS12,ADAMTS9,AGRN,AGXT2,AMDHD2,AMPD3,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,ARSB,BCAN,BGN,CD44,CDA,CECR1,CEMIP,CHIA,CHIT1,CHP1,CSPG4,CSPG5,DCN,DERA,DPYD,DPYS,EDEM1,EDEM2,EDEM3,ENPP4,ENTPD4,FBXO2,FGF2,FMOD,FUCA1,FUCA2,GALC,GALNS,GBA,GBA2,GBA3,GLA,GLB1,GNPDA1,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,HEXA,HEXB,HGSNAT,HINT1,HMMR,HPRT1,HPSE,HPSE2,HSPG2,HYAL1,HYAL2,HYAL3,HYAL4,IDS,IDUA,KERA,LUM,LYVE1,MAN1B1,MBD4,MGEA5,MLYCD,MPG,MUTYH,NAGA,NAGK,NAGLU,NCAN,NEIL1,NEIL2,NEU2,NEU3,NEU4,NGLY1,NPL,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,NTHL1,NUDT1,NUDT15,NUDT16,NUDT18,NUDT7,OGG1,OGN,OMD,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A,PNLIPRP2,PNP,PRELP,RENBP,SAMHD1,SDC1,SDC2,SDC3,SDC4,SGSH,SLC9A1,SMUG1,SPACA3,STAB2,STT3B,TDG,TGFB1,TYMP,UNG,UPB1,UPP1,UPP2,VCAN	The chemical reactions and pathways resulting in the breakdown of carbohydrate derivative.
GO:1901163	GO	BP	regulation of trophoblast cell migration	ACVR1B,ACVR1C,ARHGDIB,C1QBP,NODAL,SMURF2,TIMP1	Any process that modulates the frequency, rate or extent of trophoblast cell migration.
GO:1901184	GO	BP	regulation of ERBB signaling pathway	ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGR2,AGT,AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,APP,ARHGEF7,CBL,CBLC,CDC42,CDH13,CLTA,DAB2IP,EGF,EGFR,EPGN,EPN1,EPS15,EPS15L1,EREG,ERRFI1,FBXW7,FER,GPER1,GPRC5A,GRB2,HAP1,HGS,ITGA1,LGMN,MMP9,MVB12A,MVB12B,NCK2,NUP62,PLAUR,PTPN2,PTPRJ,RAB7A,RBPJ,RHBDF1,RNF115,RNF126,RPS27A,SH3GL2,SH3KBP1,SHC1,SHKBP1,SNX6,SOCS4,SOCS5,SPRY1,SPRY2,STAM,STAM2,TGFA,UBA52,UBB,UBC,ZFYVE28,ZGPAT	Any process that modulates the frequency, rate or extent of ERBB signaling pathway.
GO:1901185	GO	BP	negative regulation of ERBB signaling pathway	AP2A1,AP2A2,AP2B1,AP2M1,AP2S1,ARHGEF7,CBL,CBLC,CDC42,CLTA,DAB2IP,EGF,EGFR,EPN1,EPS15,EPS15L1,ERRFI1,GPRC5A,GRB2,HGS,ITGA1,LGMN,PTPN2,PTPRJ,RAB7A,RNF115,RNF126,RPS27A,SH3GL2,SH3KBP1,SNX6,SOCS4,SOCS5,SPRY1,SPRY2,STAM,STAM2,UBA52,UBB,UBC,ZFYVE28,ZGPAT	Any process that stops, prevents or reduces the frequency, rate or extent of ERBB signaling pathway.
GO:1901186	GO	BP	positive regulation of ERBB signaling pathway	ADAM17,ADRA2A,ADRA2B,ADRA2C,AFAP1L2,AGR2,AGT,EGF,EPGN,EREG,FBXW7,GPER1,HAP1,MMP9,NUP62,PLAUR,RBPJ,SHKBP1,TGFA	Any process that activates or increases the frequency, rate or extent of ERBB signaling pathway.
GO:1901201	GO	BP	regulation of extracellular matrix assembly	AGT,CLASP1,CLASP2,DAG1,NOTCH1,PHLDB1,PHLDB2,RGCC,SMAD3,TGFB1	Any process that modulates the frequency, rate or extent of extracellular matrix assembly.
GO:1901203	GO	BP	positive regulation of extracellular matrix assembly	CLASP1,CLASP2,DAG1,PHLDB1,PHLDB2,RGCC,SMAD3,TGFB1	Any process that activates or increases the frequency, rate or extent of extracellular matrix assembly.
GO:1901213	GO	BP	regulation of transcription from RNA polymerase II promoter involved in heart development	BMP2,BMP4,GREM1,MYOCD,NACA,NOTCH1,POU5F1,RBPJ,SRF,T,TBX2	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that contributes to the development of the heart over time.
GO:1901214	GO	BP	regulation of neuron death	ADAM8,AGAP2,AKT1,AKT1S1,APOE,ATF4,BAX,BBC3,BCL2,BHLHB9,BTBD10,CCL2,CCL3,CCL5,CD34,CDK5,CDK5R1,CHMP4A,CHMP4B,CHP1,CITED1,CLCF1,CLN3,CLU,CNTF,CPEB4,CRLF1,CTNNB1,DAXX,DCC,DDIT3,DDIT4,DHCR24,EGLN2,EGLN3,EPHA7,EPHB1,ERBB3,F2R,FAIM2,FAM134B,FBXW7,FOXB1,FOXO3,GDNF,GNB2L1,GPR75,GRID2,GRM4,HIF1A,HTRA2,IKBKG,ISL1,KCNB1,KDM2B,KIF14,LGMN,LIG4,LRRK2,MAP3K5,MCL1,MEF2C,MSH2,MT3,NAE1,NAIP,NDNF,NF1,NONO,NR4A3,NRBP2,NSMF,NTRK1,NTRK2,PARK2,PARK7,PCSK9,PICALM,PINK1,PM20D1,POU4F1,PPARGC1A,PPT1,PRKCG,PRKCI,PTK2B,RASA1,RILPL1,RRAS2,SARM1,SET,SIGMAR1,SIX1,SIX4,SOD1,SOD2,SORL1,SRPK2,TBK1,TFAP2A,TFAP2B,TGFB2,TGFB3,TOX3,TRAF2,TRIM2,TSC1,TYRO3,UBB,UNC5B,VEGFB,VSTM2L,WFS1,ZNF746,ZPR1	Any process that modulates the frequency, rate or extent of neuron death.
GO:1901215	GO	BP	negative regulation of neuron death	ADAM8,AGAP2,AKT1,APOE,ATF4,BCL2,BHLHB9,BTBD10,CCL2,CD34,CDK5,CHMP4A,CHMP4B,CITED1,CLCF1,CLN3,CNTF,CPEB4,CRLF1,ERBB3,F2R,FAM134B,FOXB1,GDNF,GNB2L1,HIF1A,HTRA2,IKBKG,ISL1,KDM2B,KIF14,LGMN,LIG4,LRRK2,MEF2C,MSH2,MT3,NAIP,NDNF,NONO,NR4A3,NRBP2,NTRK1,NTRK2,PARK2,PARK7,PINK1,PM20D1,POU4F1,PPARGC1A,PPT1,PRKCG,PRKCI,PTK2B,RASA1,SET,SIX1,SIX4,SOD1,SOD2,SORL1,TGFB3,TOX3,TRAF2,TYRO3,UNC5B,VEGFB,VSTM2L,WFS1,ZPR1	Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
GO:1901216	GO	BP	positive regulation of neuron death	APOE,ATF4,BAX,BBC3,CCL3,CDK5,CDK5R1,CLU,CTNNB1,DAXX,DDIT3,DDIT4,EPHA7,FBXW7,FOXO3,MAP3K5,MCL1,NF1,PCSK9,PICALM,SRPK2,TFAP2A,TFAP2B,TGFB2,ZNF746	Any process that activates or increases the frequency, rate or extent of neuron death.
GO:1901222	GO	BP	regulation of NIK/NF-kappaB signaling	ACTN4,ADGRG3,CARD10,CARD14,CHI3L1,COPS8,CPNE1,EIF2AK2,HDAC7,IRAK1,MALT1,MAP3K7,NOD1,NOD2,PTPN22,RELA,RPS3,SASH1,TLR3,TLR6,TNF,TNFRSF10A,TNFRSF10B,TNFSF15,TRAF2,TRAF6,TRIM40,TSPAN6,ZFP91	Any process that modulates the frequency, rate or extent of NIK/NF-kappaB signaling.
GO:1901223	GO	BP	negative regulation of NIK/NF-kappaB signaling	ADGRG3,CPNE1,HDAC7,RELA,TRIM40,TSPAN6	Any process that stops, prevents or reduces the frequency, rate or extent of NIK/NF-kappaB signaling.
GO:1901224	GO	BP	positive regulation of NIK/NF-kappaB signaling	ACTN4,CARD10,CARD14,CHI3L1,COPS8,EIF2AK2,IRAK1,MALT1,MAP3K7,NOD1,NOD2,RPS3,SASH1,TLR3,TLR6,TNF,TNFRSF10A,TNFRSF10B,TNFSF15,TRAF2,TRAF6,ZFP91	Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
GO:1901228	GO	BP	positive regulation of transcription from RNA polymerase II promoter involved in heart development	GREM1,MYOCD,NACA,SRF,T	Any positive regulation of transcription from RNA polymerase II promoter that is involved in heart development.
GO:1901264	GO	BP	carbohydrate derivative transport	ABCG1,CALHM1,GLTP,LBP,NPC2,PLA2G10,SCARB1,SLC17A3,SLC17A5,SLC25A17,SLC25A19,SLC25A24,SLC25A26,SLC25A42,SLC25A6,SLC28A1,SLC28A2,SLC29A1,SLC29A2,SLC35A1,SLC35A2,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2,SLC37A4,SLC50A1,VLDLR	The directed movement of a carbohydrate derivative into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:1901292	GO	BP	nucleoside phosphate catabolic process	AMPD3,CAT,DCTPP1,DNPH1,ENPP1,ENPP3,ENTPD4,GDA,GPX1,HINT1,HPRT1,MBD4,MLYCD,MPG,MUTYH,NEIL1,NEIL2,NT5C,NT5C1A,NT5C1B,NT5C2,NT5E,NT5M,NTHL1,NUDT1,NUDT12,NUDT15,NUDT16,NUDT18,NUDT3,NUDT5,NUDT7,OGG1,PDE1B,PDE2A,PDE3A,PDE4A,PDE4B,PDE4D,PDE5A,PDE9A,PNP,SAMHD1,SMUG1,TDG,UNG,VCP,XDH	The chemical reactions and pathways resulting in the breakdown of a nucleoside phosphate.
GO:1901293	GO	BP	nucleoside phosphate biosynthetic process	ACOT7,ADA,ADCY1,ADCY10,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY9,ADK,ADM,ADORA2A,ADSL,ADSS,ADSSL1,AK1,AK4,AK5,AK7,AK8,AK9,ALDOA,AMPD2,AQP1,ATIC,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CALCRL,CHCHD10,CMPK1,CMPK2,COASY,CTPS1,DCK,DGUOK,GARS,GART,GBAS,GMPS,GNAS,GUCY1A3,GUCY1B3,HPRT1,HTR2B,HTR2C,IMPDH1,IMPDH2,LHPP,MB21D1,ME1,MT-ATP6,MT-ATP8,MTHFD1,NME2,NMNAT1,NMNAT2,NMNAT3,NPPA,NPPB,NPPC,NPR1,NPR2,OAS1,OAS2,PAICS,PANK2,PAPSS1,PAPSS2,PFAS,PNP,PPAT,PPCDC,PPCS,PRKAG2,PRPS1,RAMP2,RRM1,RRM2,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TAAR1,TGFB1,TK1,TYMS,UMPS,VPS9D1	The chemical reactions and pathways resulting in the formation of a nucleoside phosphate.
GO:1901298	GO	BP	regulation of hydrogen peroxide-mediated programmed cell death	HDAC6,HGF,MET,PARK7,PINK1,TRAP1	Any process that modulates the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.
GO:1901299	GO	BP	negative regulation of hydrogen peroxide-mediated programmed cell death	HGF,MET,PARK7,PINK1,TRAP1	Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.
GO:1901317	GO	BP	regulation of sperm motility	EPPIN,IQCF1,PGAM4,RNASE10,SEMG1	Any process that modulates the frequency, rate or extent of sperm motility.
GO:1901338	GO	MF	catecholamine binding	ADRA2A,ADRA2B,ADRA2C,ADRB2,ADRB3,DRD1,DRD4,DRD5,GPR143	Interacting selectively and non-covalently with catecholamine.
GO:1901339	GO	BP	regulation of store-operated calcium channel activity	ASPH,CRACR2A,STIM1,STIM2,TMEM110,UBQLN1	Any process that modulates the frequency, rate or extent of store-operated calcium channel activity.
GO:1901342	GO	BP	regulation of vasculature development	ADM2,AGGF1,ALOX12,AMOT,ANGPT4,ANGPTL3,ANGPTL4,ANXA3,APOH,AQP1,ASB4,BMP4,BMP7,BRCA1,BTG1,CCR2,CCR3,CD34,CHI3L1,CHRNA7,CIB1,COL4A2,COL4A3,CTH,CTNNB1,CTSH,CXCL13,CXCL8,CXCR3,CYP1B1,DAB2IP,DCN,DLL1,DLL4,ECM1,ECSCR,EGLN1,EGR1,EMP2,EPHA1,EPHA2,ERBB2,ETS1,F3,FASLG,FGF1,FGF2,FLT1,FOXC1,FOXC2,FOXO4,GATA2,GATA4,GATA6,GDF2,GHRL,GPER1,GTF2I,HDAC5,HDAC7,HDAC9,HEY1,HEY2,HHEX,HIF1A,HIF1AN,HIPK1,HIPK2,HMOX1,HOXA5,HRG,HSPB1,HTATIP2,HYAL1,IL17F,IL1A,IL1B,IL6,ISL1,ITGA5,ITGB1BP1,JAK1,KDR,KLF4,KLK3,KRIT1,KRT1,LECT1,LEP,MAP2K5,MMRN2,MTDH,MYDGF,MYOCD,NF1,NODAL,NOS3,NOTCH1,NPPB,NPR1,NTRK1,PDCD10,PDCD6,PDCL3,PDE3B,PDGFB,PF4,PIK3R6,PLCG1,PLXND1,PML,PPP1R16B,PRKCA,PRKCB,PRKD1,PRKD2,PTGIS,PTGS2,PTPRM,RAMP2,RAP1A,RAPGEF2,RAPGEF3,RGCC,RHOA,RHOB,RLN2,RNH1,ROCK1,ROCK2,RRAS,RUNX1,SASH1,SEMA3E,SEMA5A,SERPINE1,SERPINF1,SFRP1,SFRP2,SP100,SPARC,SPHK1,SPINK5,SRPX2,STAB1,STARD13,STAT1,SULF1,SYNJ2BP,TEK,THBS1,THBS2,TMEM100,TMIGD2,TNFAIP3,TNFSF12,TSPAN12,TWIST1,VASH1,VASH2,VEGFA,VEGFB,WARS,WNT4,WNT5A,WT1,XDH,ZC3H12A,ZNF304	Any process that modulates the frequency, rate or extent of vasculature development.
GO:1901343	GO	BP	negative regulation of vasculature development	AMOT,ANGPT4,APOH,BMP4,BMP7,CCR2,COL4A2,COL4A3,CXCR3,DAB2IP,DCN,DLL4,ECSCR,FASLG,FOXC1,FOXO4,GDF2,GHRL,GTF2I,HDAC5,HEY2,HHEX,HOXA5,HRG,IL17F,ITGB1BP1,KLF4,KLK3,KRIT1,LECT1,MAP2K5,MMRN2,NOTCH1,NPPB,NPR1,PDCD10,PDE3B,PF4,PML,PTPRM,RGCC,RHOA,ROCK1,ROCK2,SEMA3E,SERPINE1,SERPINF1,SPARC,SPINK5,STAB1,STARD13,STAT1,SULF1,SYNJ2BP,TEK,THBS1,THBS2,VASH1,WNT4,WT1,XDH	Any process that stops, prevents or reduces the frequency, rate or extent of vasculature development.
GO:1901379	GO	BP	regulation of potassium ion transmembrane transport	ACTN2,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ATP1B1,ATP1B2,ATP1B3,CAB39,CACNA1D,CASQ2,CAV1,CAV3,DPP10,DPP6,FHL1,GAL,GALR2,KCNAB1,KCNAB2,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNH2,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNN2,KCNQ1,KCNRG,KCNS1,KCNS2,NEDD4,NEDD4L,NOS1AP,NPPA,RNF207,STK39,SUMO1,VAMP2,WWP2,YWHAE	Any process that modulates the frequency, rate or extent of potassium ion transmembrane transport.
GO:1901380	GO	BP	negative regulation of potassium ion transmembrane transport	ACTN2,ANK3,CAB39,CASQ2,CAV1,CAV3,KCNE1,KCNE2,KCNE3,KCNE5,KCNH2,KCNQ1,KCNRG,NEDD4L,RNF207,STK39,SUMO1	Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transport.
GO:1901381	GO	BP	positive regulation of potassium ion transmembrane transport	ACTN2,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ATP1B1,ATP1B2,ATP1B3,GAL,GALR2,KCNE1,KCNE5,KCNH2,KCNQ1,NOS1AP,NPPA,RNF207	Any process that activates or increases the frequency, rate or extent of potassium ion transmembrane transport.
GO:1901385	GO	BP	regulation of voltage-gated calcium channel activity	AHNAK,CACNB4,CRHR1,DMD,DRD2,DRD4,GNB5,NOS1AP,NPPA,PDE4B,SRI	Any process that modulates the frequency, rate or extent of voltage-gated calcium channel activity.
GO:1901419	GO	BP	regulation of response to alcohol	CYP27B1,KANK2,LANCL2,SIRT1,SNAI2,SNW1	Any process that modulates the frequency, rate or extent of response to alcohol.
GO:1901505	GO	MF	carbohydrate derivative transporter activity	ABCG1,GLTP,PLEKHA8,SLC17A5,SLC25A17,SLC25A24,SLC25A26,SLC25A42,SLC25A6,SLC28A1,SLC28A2,SLC35A1,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2,SLC37A4,SLC50A1,VLDLR	Enables the directed movement of carbohydrate derivative into, out of or within a cell, or between cells.
GO:1901522	GO	BP	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	ATF4,ATF6,BMP2,CARF,CHD6,CREB3,DLX5,EP300,FOXA2,HIF1A,MT3,NCOA1,NOTCH1,RBPJ,RUNX2,SMAD1,SMAD4,SMAD5,SMAD9,USF1,USF2,VEGFA,XBP1	Any positive regulation of transcription from RNA polymerase II promoter that is involved in cellular response to chemical stimulus.
GO:1901532	GO	BP	regulation of hematopoietic progenitor cell differentiation	CIB1,EIF2AK2,FLCN,FNIP1,FOXC1,HES1,HES5,HIST1H4A,HMGB2,L3MBTL1,MEF2C,MIXL1,N4BP2L2,NOTCH1,PDCD2,PF4,PRMT1,RAB7B,SCIN,TESC,THPO,ZBTB1,ZNF16	Any process that modulates the frequency, rate or extent of hematopoietic progenitor cell differentiation.
GO:1901533	GO	BP	negative regulation of hematopoietic progenitor cell differentiation	CIB1,HES1,HES5,HIST1H4A,MIXL1,N4BP2L2,NOTCH1,PF4,PRMT1	Any process that stops, prevents or reduces the frequency, rate or extent of hematopoietic progenitor cell differentiation.
GO:1901534	GO	BP	positive regulation of hematopoietic progenitor cell differentiation	FOXC1,HMGB2,RAB7B,SCIN,TESC,THPO,ZBTB1,ZNF16	Any process that activates or increases the frequency, rate or extent of hematopoietic progenitor cell differentiation.
GO:1901606	GO	BP	alpha-amino acid catabolic process	AADAT,AASS,ACMSD,AFMID,AGXT,AGXT2,ALDH4A1,ALDH6A1,ALDH7A1,AMDHD1,ARG1,ASL,ASPA,ASRGL1,CARNS1,CBS,CCBL1,CCBL2,CRYM,DAO,DDAH1,DDAH2,DDO,DLD,DLST,FAH,FTCD,GAD1,GCDH,GCSH,GLDC,GLS,GLUD1,GLUD2,GLUL,GOT1,GOT2,GSTZ1,HAAO,HAL,HDC,HGD,HIBADH,HMGCL,HNMT,HOGA1,HPD,HYKK,IDO1,IDO2,IL4I1,IVD,KMO,KYNU,MCCC1,MCCC2,MTHFS,MTRR,NOS1,NOS2,NOS3,OGDH,OTC,PAH,PCBD1,PHYKPL,PIPOX,PRODH,QDPR,SDS,SHMT1,SLC25A21,TAT,TDO2,THNSL2,UROC1	The chemical reactions and pathways resulting in the breakdown of an alpha-amino acid.
GO:1901607	GO	BP	alpha-amino acid biosynthetic process	ADI1,AGXT,AGXT2,ALDH18A1,APIP,ASNS,BHMT,BHMT2,CARNS1,CBS,CPS1,CTH,DHFR,ENOPH1,FPGS,GAMT,GATM,GGT1,GLS,GLUD1,GLUD2,GLUL,GOT1,MRI1,MTAP,MTHFD1,MTR,MTRR,OTC,PADI2,PADI4,PHGDH,PLOD1,PSAT1,PSPH,PYCR1,PYCR2,PYCRL,SEPHS2,SRR	The chemical reactions and pathways resulting in the formation of an alpha-amino acid.
GO:1901616	GO	BP	organic hydroxy compound catabolic process	ACADL,ADH4,AKR1B10,AKR1C3,AKR1D1,CEL,CYP24A1,CYP46A1,CYP4A11,CYP4F12,CYP4F2,CYP7A1,ENPP2,FGF23,HAO1,IMPA1,IMPA2,INPP5K,LIPC,LRTOMT,MAOA,MAOB,MIOX,MT3,NUDT3,PDXP,PLA2G15,PNPLA8,PTEN,SCARF1,SMPD3,SMPD4,SNX17,SORD,SRD5A3,SYNJ1,TRERF1	The chemical reactions and pathways resulting in the breakdown of organic hydroxy compound.
GO:1901617	GO	BP	organic hydroxy compound biosynthetic process	ABCB11,ABHD3,ACAA2,ACADM,ACER1,ACER2,ACER3,ACHE,ACLY,ACOT8,ACOX2,AKR1C3,AKR1C4,AKR1D1,ALDH9A1,ALOX12,ALOX15,AMACR,APOA1,APOA2,ARV1,BAAT,BBOX1,CACNA1H,CDS1,CEPT1,CH25H,CHAT,CHKA,CHKB,CHPT1,CITED1,CNBP,CYP11B1,CYP11B2,CYP27A1,CYP27B1,CYP39A1,CYP3A4,CYP46A1,CYP51A1,CYP7A1,CYP7B1,CYP8B1,DAO,DBH,DCT,DDC,DHCR24,DHCR7,DPAGT1,EBP,FDFT1,FDPS,FGF2,G6PD,GATA3,GBA,GCH1,GGPS1,GOT1,GPAT4,HAND2,HMGCR,HMGCS1,HSD17B4,HSD17B7,HSD3B7,IDI1,IDI2,INSM1,IP6K3,LBR,LCAT,LPCAT2,LPIN1,LPIN2,LPIN3,LSS,MSMO1,MVD,MVK,NPC1L1,NSDHL,NUS1,PAH,PARK7,PCK1,PCYT1A,PCYT1B,PDXK,PEMT,PER2,PGP,PHOSPHO1,PLA2G4A,PMVK,PNMT,PRKAG2,PSAT1,SAMD8,SC5D,SCP2,SGMS1,SGMS2,SHMT1,SLC27A1,SLC27A2,SLC27A5,SLC44A1,SLC44A2,SLC44A3,SLC44A4,SLC44A5,SNCA,SPHK1,SPHK2,SQLE,TGFB2,TH,TM7SF2,TMLHE,TRPC1,TYR	The chemical reactions and pathways resulting in the formation of organic hydroxy compound.
GO:1901618	GO	MF	organic hydroxy compound transmembrane transporter activity	ABCB11,ABCG1,AKR1C4,AQP1,AQP2,AQP3,AQP9,SLC16A1,SLC16A7,SLC22A16,SLC22A4,SLC22A5,SLC44A1,SLC44A2,SLC5A3,SLC5A7,SLC6A2,SLC6A3,SLC6A4	Enables the transfer of organic hydroxy compound from one side of the membrane to the other.
GO:1901623	GO	BP	regulation of lymphocyte chemotaxis	ADAM10,ADAM17,CCL2,CCL3,CCL4,CCL5,CCL7,CCR2,CXCL10,CXCL13,KLRK1,PADI2,PTK2B,S100A7,WNT5A,XCL1	Any process that modulates the frequency, rate or extent of lymphocyte chemotaxis.
GO:1901642	GO	BP	nucleoside transmembrane transport	SLC25A17,SLC25A26,SLC25A42,SLC28A2,SLC29A1,SLC29A2,SLC35B2	The directed movement of nucleoside across a membrane.
GO:1901654	GO	BP	response to ketone	ABCB4,ADCY1,ADCY2,ADCY3,ADCY5,ADCY6,AQP1,CAV1,CCL19,CCL21,CCR7,DCPS,GAS6,GHR,GNAI1,GNAS,GNB1,GNG2,IRG1,KLF9,MSN,NDOR1,NKX3-1,NR1H3,PTGER2,ROCK2,SRC,TGFB1,TGFB2,TGFB3,TGFBR3,THBS1,TNFSF4,UGT3A2	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ketone stimulus.
GO:1901655	GO	BP	cellular response to ketone	ADCY1,ADCY2,ADCY3,ADCY5,ADCY6,AQP1,DCPS,GAS6,GNAI1,GNAS,GNB1,GNG2,IRG1,KLF9,MSN,NDOR1,PTGER2,ROCK2,SRC,TNFSF4,UGT3A2	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ketone stimulus.
GO:1901658	GO	BP	glycosyl compound catabolic process	ABHD10,ADA,AGXT2,AMPD3,APOBEC1,APOBEC2,APOBEC3A,APOBEC3C,APOBEC3F,APOBEC3G,APOBEC3H,CDA,CECR1,DERA,DPYD,DPYS,ENPP4,ENTPD4,FUCA1,FUCA2,GBA2,GBA3,HPRT1,MLYCD,NT5C,NT5C1A,NT5C3A,NT5E,NT5M,NUDT18,NUDT7,PNP,TYMP,UPB1,UPP1,UPP2	The chemical reactions and pathways resulting in the breakdown of glycosyl compound.
GO:1901659	GO	BP	glycosyl compound biosynthetic process	ACOT7,ADA,ADSL,ADSS,ADSSL1,AK5,AK9,ALDOA,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CAD,CDA,CHCHD10,CMPK1,COASY,CTPS1,DCK,DCTD,DHFRL1,DHODH,DUT,GBAS,HPRT1,MAT2A,MAT2B,MT-ATP6,MT-ATP8,PANK2,PAPSS1,PAPSS2,PPCDC,PPCS,PRKAG2,PUDP,QTRT1,QTRTD1,SLC25A13,SLC26A1,SLC26A2,SLC35B2,SLC35B3,STOML2,SURF1,TGFB1,TK1,TK2,TYMP,TYMS,TYW5,UCK1,UCK2,UMPS,UPP1,UPP2,VPS9D1	The chemical reactions and pathways resulting in the formation of glycosyl compound.
GO:1901661	GO	BP	quinone metabolic process	ADCK3,ADH4,AKR1B1,AKR1B10,AKR1C1,AKR1C2,AKR1C3,AKR1C4,AKR7A2,CBR1,CBR4,COQ2,COQ3,COQ5,COQ6,COQ7,COQ9,CRYZL1,CYP4F11,CYP4F2,PDSS1,PDSS2,UBIAD1,VKORC1,VKORC1L1	The chemical reactions and pathways involving quinone.
GO:1901673	GO	BP	regulation of mitotic spindle assembly	CCSAP,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4B,CHMP4C,CHMP5,PLK1,TPR,VPS4B	Any process that modulates the frequency, rate or extent of mitotic spindle assembly.
GO:1901677	GO	MF	phosphate transmembrane transporter activity	ABCC11,ANKH,SLC25A17,SLC25A19,SLC25A24,SLC25A33,SLC25A36,SLC25A42,SLC25A6,SLC35A1,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D1,SLC35D2,SLC37A4	Enables the transfer of phosphate from one side of the membrane to the other.
GO:1901678	GO	BP	iron coordination entity transport	ABCB6,ABCB7,ABCG2,FLVCR1,FLVCR2,LCN2,SLC22A17,SLC48A1	The directed movement of an iron coordination entity into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:1901679	GO	BP	nucleotide transmembrane transport	SLC25A17,SLC25A33,SLC25A42,SLC35A3,SLC35B1,SLC35B2,SLC35B4,SLC35D2	The directed movement of nucleotide across a membrane.
GO:1901681	GO	MF	sulfur compound binding	AAMP,ACOT7,ADAMTSL5,ADGRE2,AGRN,ALDH6A1,ANG,AOC1,APOA5,APOB,APOE,AZU1,CBS,CEL,CFH,CHST12,CHST15,CLEC3B,COL13A1,COL25A1,COL5A1,COMP,CTSG,CXCL10,CXCL11,CXCL13,DBI,DPYSL3,ELANE,ENPP1,FGF1,FGF10,FGF12,FGF14,FGFBP1,FGFBP3,FGFR1,FGFR4,FGFRL1,FN1,GAL3ST3,GAL3ST4,GLRA1,GREM2,GSS,GSTM1,GSTM2,GSTM3,GSTM4,GSTP1,HACL1,HBEGF,HLCS,HPSE2,HRG,HS3ST5,KNG1,LANCL1,LIPH,LIPI,LPA,LPL,LTF,MCCC1,MDK,MPO,NDNF,PAFAH1B1,PCCA,PCOLCE,PCOLCE2,PCSK6,PDCD5,PF4,POSTN,PTGES,PTGES2,REG4,RYR2,SCP2,SELL,SELP,SEMA5A,SERPINA5,SERPINE2,SFRP1,SLIT2,SOAT1,SOAT2,TENM1,TGFBR3,THBS1,THBS3,THBS4,TNXB,VEGFA,ZNF146	Interacting selectively and non-covalently with a sulfur compound.
GO:1901682	GO	MF	sulfur compound transmembrane transporter activity	CTNS,SLC13A4,SLC19A2,SLC19A3,SLC1A1,SLC1A4,SLC25A26,SLC26A1,SLC26A2,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC35B2,SLC3A1,SLC7A11,SLC7A9	Enables the transfer of a sulfur compound from one side of the membrane to the other.
GO:1901687	GO	BP	glutathione derivative biosynthetic process	AKR1A1,CHAC1,CHAC2,CNDP2,ESD,GCLC,GCLM,GGCT,GGT1,GGT2,GSS,GSTA1,GSTA2,GSTA3,GSTA4,GSTK1,GSTM1,GSTM2,GSTM3,GSTM4,GSTM5,GSTO1,GSTO2,GSTP1,GSTT2B,GSTZ1,HPGDS,MGST1,MGST2,MGST3,OPLAH	The chemical reactions and pathways resulting in the formation of glutathione derivative.
GO:1901722	GO	BP	regulation of cell proliferation involved in kidney development	BMP4,BMP7,EGR1,FLCN,GATA3,MYC,PDGFB,WT1	Any process that modulates the frequency, rate or extent of cell proliferation involved in kidney development.
GO:1901723	GO	BP	negative regulation of cell proliferation involved in kidney development	BMP4,BMP7,FLCN,GATA3,WT1	Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in kidney development.
GO:1901725	GO	BP	regulation of histone deacetylase activity	C6orf89,CAMK2D,KDM5A,PRKD1,PRKD2,VEGFA	Any process that modulates the frequency, rate or extent of histone deacetylase activity.
GO:1901739	GO	BP	regulation of myoblast fusion	CD53,CFLAR,EHD1,EHD2,FLOT1,MAPK14,MYOD1,MYOG	Any process that modulates the frequency, rate or extent of myoblast fusion.
GO:1901741	GO	BP	positive regulation of myoblast fusion	CD53,EHD1,EHD2,FLOT1,MAPK14,MYOD1	Any process that activates or increases the frequency, rate or extent of myoblast fusion.
GO:1901796	GO	BP	regulation of signal transduction by p53 class mediator	ANKRD1,ATM,ATR,CD44,CD74,CDK5RAP3,CDKN2A,CHD5,DDX5,DYRK1A,EEF1E1,HEXIM1,HIC1,ING2,KDM1A,MDM2,MIF,MSX1,MUC1,PLA2R1,PMAIP1,PSMD10,PTTG1IP,RFFL,RNF34,SETD8,SIRT1,SMYD2,SNAI1,SNAI2,SPRED1,SPRED2,TAF9,TAF9B,TRIAP1,TWIST1,UBB,ZNF385A	Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.
GO:1901797	GO	BP	negative regulation of signal transduction by p53 class mediator	CD44,CD74,DYRK1A,ING2,KDM1A,MDM2,MIF,MUC1,PSMD10,PTTG1IP,RFFL,RNF34,SIRT1,SNAI1,SNAI2,TAF9,TAF9B,TRIAP1,TWIST1,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of signal transduction by p53 class mediator.
GO:1901798	GO	BP	positive regulation of signal transduction by p53 class mediator	ANKRD1,ATM,ATR,CDK5RAP3,CDKN2A,CHD5,DDX5,EEF1E1,HEXIM1,HIC1,MSX1,PLA2R1,PMAIP1,SPRED1,SPRED2,UBB,ZNF385A	Any process that activates or increases the frequency, rate or extent of signal transduction by p53 class mediator.
GO:1901799	GO	BP	negative regulation of proteasomal protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,ATRAID,BAG5,BAG6,BUB1,BUB1B,BUB3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,DAB2IP,FHIT,GABARAPL2,GIPC1,HFE,HSP90AB1,KLHL22,MAD1L1,MAD2L1,MAD2L2,N4BP1,NELL1,PANO1,PARK7,PLK1,PRKCG,PSMF1,SDCBP,SVIP,TAF9,TERF1,TEX14,TLK2,TPR,TTK,UBE2C,UBE2D1,UBE2E1,UBXN1,USP14,USP44,WAC,ZNF207	Any process that stops, prevents or reduces the frequency, rate or extent of proteasomal protein catabolic process.
GO:1901800	GO	BP	positive regulation of proteasomal protein catabolic process	BCAP31,CAV1,CBFA2T3,CEBPA,CLU,CSNK1A1,CSNK1D,CSNK1E,CUL3,DAB2,DAB2IP,DDRGK1,DLGAP5,DNAJB2,DVL1,ECSCR,ESPL1,FBXW7,GNB2L1,GSK3B,HERPUD1,HSPBP1,KCNE2,KEAP1,LRRK2,MDM2,NFE2L2,NKD2,NSMCE2,NUB1,OSBPL7,PARK2,PIAS1,PLK1,PLK3,PRICKLE1,PSMD10,PTEN,RB1,RCHY1,RFWD2,SGTA,SIRT2,SMAD7,SMC5,SOCS5,STUB1,SUMO1,SUMO2,TAF1,TRIB1,TRIB2,UBQLN1,UBQLN2,USP5,VCP,XBP1	Any process that activates or increases the frequency, rate or extent of proteasomal protein catabolic process.
GO:1901836	GO	BP	regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	H2AFY,H2AFY2,MTOR,NCL,NOL11,PIH1D1,SMARCA4,SMARCB1	Any process that modulates the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter.
GO:1901838	GO	BP	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	MTOR,NCL,NOL11,PIH1D1,SMARCA4,SMARCB1	Any process that activates or increases the frequency, rate or extent of transcription of nuclear large rRNA transcript from RNA polymerase I promoter.
GO:1901844	GO	BP	regulation of cell communication by electrical coupling involved in cardiac conduction	CALM1,CAMK2D,CAV1,HRC,PDE4D,SRI,TRDN	Any process that modulates the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction.
GO:1901861	GO	BP	regulation of muscle tissue development	ACTN3,AKAP6,ARNTL,BMP10,BMP2,BMP4,CENPF,DDX17,DDX5,DKK1,DLL1,EFNB2,ERBB4,FGF2,FGF3,FGF8,FGFR2,FLOT1,GPC1,GREM1,GSK3A,HDAC9,MEF2C,MEGF10,MKL2,MSTN,MTPN,MYOCD,MYOG,NACA,NOG,NOTCH1,NR1D2,NRG1,PRICKLE1,RBP4,RBPJ,SHH,SIRT2,SIX4,SOX15,TBX1,TBX2,TBX20,TBX5,TGFB1,TP73,UQCC2,USP19,WNT3A	Any process that modulates the frequency, rate or extent of muscle tissue development.
GO:1901862	GO	BP	negative regulation of muscle tissue development	BMP2,BMP4,DKK1,FGF3,FGF8,GSK3A,MSTN,MYOCD,NOG,PRICKLE1,RBP4,SHH,SIRT2,SIX4,SOX15,TBX5,TGFB1,TP73,USP19	Any process that stops, prevents or reduces the frequency, rate or extent of muscle tissue development.
GO:1901863	GO	BP	positive regulation of muscle tissue development	ACTN3,AKAP6,ARNTL,BMP10,BMP4,DLL1,EFNB2,ERBB4,FGF2,FGFR2,FLOT1,GPC1,GREM1,MEF2C,MKL2,MYOCD,MYOG,NACA,NOTCH1,NRG1,RBPJ,SHH,TBX1,TBX2,TBX20,TGFB1,WNT3A	Any process that activates or increases the frequency, rate or extent of muscle tissue development.
GO:1901879	GO	BP	regulation of protein depolymerization	ACTN2,ADD1,ADD2,APC,ARHGEF2,AURKA,AURKB,CCNB1,CFL2,CIB1,CLASP1,CLASP2,EPS8,F2RL1,FAM21C,FGF13,GAS2L1,GAS2L2,GSN,KATNB1,LIMA1,LRRC16A,MID1IP1,MTPN,NES,PDXP,PLEK,PLEKHH2,SBDS,SCIN,SEMA5A,SH3BGRL3,SLN,STMN2,SYNJ1,TRIM54,TRIOBP,TRPV4,TWF2,VIL1	Any process that modulates the frequency, rate or extent of protein depolymerization.
GO:1901880	GO	BP	negative regulation of protein depolymerization	ADD1,ADD2,APC,ARHGEF2,AURKA,AURKB,CCNB1,CIB1,CLASP1,CLASP2,EPS8,FGF13,GAS2L1,GAS2L2,GSN,KATNB1,LIMA1,MID1IP1,PLEKHH2,SBDS,SCIN,STMN2,TRIM54,TRIOBP,TWF2,VIL1	Any process that stops, prevents or reduces the frequency, rate or extent of protein depolymerization.
GO:1901881	GO	BP	positive regulation of protein depolymerization	ACTN2,CFL2,F2RL1,FAM21C,KATNB1,LRRC16A,NES,PDXP,PLEK,SEMA5A,SLN,STMN2,SYNJ1,TRPV4,VIL1	Any process that activates or increases the frequency, rate or extent of protein depolymerization.
GO:1901888	GO	BP	regulation of cell junction assembly	ACE,ACE2,ACVRL1,AGT,APOD,ARHGAP6,BCAS3,CAV1,CLASP1,CLASP2,COL16A1,CORO1C,DAPK3,DLC1,DMTN,EFNA5,EPHA3,FLOT1,GPM6B,HRG,IKBKB,ITGB1BP1,KDR,LIMS1,MACF1,MYO1C,MYOC,PHLDB2,PKP2,PPM1F,PRKACA,PRKCH,PTEN,PTK2,PTPRJ,RAC1,RAP1A,RAP1B,RAPGEF1,RAPGEF2,RCC2,ROCK1,ROCK2,S100A10,SFRP1,SLC9A1,SNAI1,SNAI2,SRC,TEK,THBS1,TNF,TSC1,VEGFA	Any process that modulates the frequency, rate or extent of cell junction assembly.
GO:1901889	GO	BP	negative regulation of cell junction assembly	ACE,ACVRL1,APOD,ARHGAP6,BCAS3,CLASP2,CORO1C,DLC1,DMTN,IKBKB,ITGB1BP1,PHLDB2,PTEN,RCC2,ROCK1,ROCK2,SRC,THBS1,TNF	Any process that stops, prevents or reduces the frequency, rate or extent of cell junction assembly.
GO:1901890	GO	BP	positive regulation of cell junction assembly	ACE2,AGT,CAV1,COL16A1,FLOT1,HRG,KDR,LIMS1,MYOC,PPM1F,PTPRJ,RAC1,ROCK1,S100A10,SFRP1,TEK,TSC1,VEGFA	Any process that activates or increases the frequency, rate or extent of cell junction assembly.
GO:1901897	GO	BP	regulation of relaxation of cardiac muscle	CAMK2D,HRC,PDE4B,PDE4D,PLN	Any process that modulates the frequency, rate or extent of relaxation of cardiac muscle.
GO:1901976	GO	BP	regulation of cell cycle checkpoint	AKT1,ANAPC15,BRD4,CCAR2,CCNB1,CDK5RAP2,CRY1,DDX39B,DUSP1,DYNC1LI1,FEM1B,GEN1,GSG2,LCMT1,MAD2L1,NDRG1,PCID2,RFWD3,RINT1,RPA2,THOC1,THOC5,TPR,USP44,XRCC3	Any process that modulates the frequency, rate or extent of cell cycle checkpoint.
GO:1901978	GO	BP	positive regulation of cell cycle checkpoint	CCAR2,DYNC1LI1,GEN1,MAD2L1,NDRG1,PCID2,TPR,XRCC3	Any process that activates or increases the frequency, rate or extent of cell cycle checkpoint.
GO:1901981	GO	MF	phosphatidylinositol phosphate binding	ACTN2,ADAP2,AKT1,ALOX15,AMER1,AMER2,ANKFY1,ANXA2,ANXA8,ARAP1,ARAP2,ARAP3,ARFIP1,ARFIP2,ARHGAP9,BBS5,BTK,CLVS1,CLVS2,COL4A3BP,COMMD1,CYTH3,DAB2IP,DAPP1,FAM21C,FCHO2,FERMT2,FRMPD4,GAB2,GBF1,GOLPH3,GOLPH3L,IQGAP1,IQGAP2,JPH2,KCNJ1,KCNJ2,KCNQ1,KIF16B,KRIT1,LANCL2,LDLRAP1,MAPKAP1,MARK1,MYO10,MYO1B,MYO1G,NCF1,NCF4,OGT,OSBP,OSBPL5,OSBPL8,PARD3,PFN1,PFN2,PHLDA3,PLCB1,PLEK,PLEKHA1,PLEKHA8,PLEKHF1,RAB35,RACGAP1,RAG2,RNF34,RPH3A,SCIN,SESTD1,SH3PXD2B,SLC9A1,SNX11,SNX13,SNX14,SNX18,SNX20,SNX21,SNX27,SNX3,SYTL2,TECPR1,TIRAP,TTPA,TULP1,TULP3,TWF1,TWF2,VIL1,WIPI1,WIPI2,ZFYVE1,ZFYVE16,ZFYVE19,ZFYVE26,ZFYVE28	Interacting selectively and non-covalently with phosphatidylinositol phosphate.
GO:1901983	GO	BP	regulation of protein acetylation	ARRB1,AUTS2,BRCA1,BRD7,CAMK1,CHEK1,CTBP1,EID1,FLCN,FOXP3,IL1B,IWS1,KAT5,KLF15,KMT2A,LIF,MAGEA2,MAPK3,MUC1,MYOCD,NOC2L,NOS1,PARK7,PAXIP1,PIH1D1,PPARGC1A,RAPGEF3,RPS6KA4,RPS6KA5,RUVBL2,SET,SIN3A,SIRT1,SMAD4,SMARCB1,SNCA,SOX4,SPI1,TAF7,TERF2IP,WBP2,XBP1	Any process that modulates the frequency, rate or extent of protein acetylation.
GO:1901984	GO	BP	negative regulation of protein acetylation	CTBP1,KLF15,MAGEA2,NOC2L,PARK7,PIH1D1,SET,SIN3A,SIRT1,SNCA,SPI1,TAF7	Any process that stops, prevents or reduces the frequency, rate or extent of protein acetylation.
GO:1901985	GO	BP	positive regulation of protein acetylation	ARRB1,AUTS2,BRCA1,BRD7,CAMK1,FOXP3,IL1B,KAT5,LIF,MAPK3,MUC1,NOS1,PAXIP1,PIH1D1,PPARGC1A,RAPGEF3,RPS6KA4,RPS6KA5,RUVBL2,SMAD4,SMARCB1,SOX4,TERF2IP,WBP2,XBP1	Any process that activates or increases the frequency, rate or extent of protein acetylation.
GO:1901988	GO	BP	negative regulation of cell cycle phase transition	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATF5,ATM,BLM,BRD7,BUB1,BUB1B,BUB3,C10orf99,CASP2,CCNA2,CCND1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC5L,CDC73,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CENPF,CHEK2,CLSPN,CRADD,CSNK2A1,CSNK2A2,DACT1,DGKZ,E2F7,FBXO31,FHL1,FOXN3,GML,GTSE1,H2AFY,HMGA2,JADE1,KANK2,KLHL22,MAD1L1,MAD2L1,MAD2L2,MDM2,MOS,MUC1,MYO16,NACC2,NAE1,NBN,PIDD1,PKD2,PLK1,PLK3,PML,PPP2R5C,PRKDC,PRMT2,PRPF19,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RB1,RBM38,RFWD2,RFWD3,RGCC,RPA2,RPS27A,RPS27L,SLFN11,SMARCA4,SOX4,SUSD2,TAOK3,TERF1,TEX14,TICRR,TP53,TPR,TRIAP1,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP47,ZC3H12D,ZNF207,ZNF655,ZNF830	Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle phase transition.
GO:1901989	GO	BP	positive regulation of cell cycle phase transition	AIF1,ANKRD17,BIRC5,BRD4,CCND1,CDC6,CDC7,CDCA5,CDK10,CDK4,CUL3,DBF4B,DDX3X,DLGAP5,ESPL1,FAM83D,LSM10,LSM11,NACC2,NPM1,NSMCE2,PHB2,PHOX2B,PLCB1,PLK1,PPP1R1C,PTEN,RAB11A,RAD51B,RAD51C,RB1,RCC2,RDX,SMC5,STOX1,STXBP4,TP63,UBE2C,UBE2E2,VPS4B,ZNF16	Any process that activates or increases the frequency, rate or extent of cell cycle phase transition.
GO:1901991	GO	BP	negative regulation of mitotic cell cycle phase transition	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BLM,BRD7,BUB1,BUB1B,BUB3,CASP2,CCNA2,CCND1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC73,CDK2,CDK5RAP3,CDKN1A,CDKN1B,CENPF,CLSPN,CRADD,CSNK2A1,CSNK2A2,DACT1,DGKZ,E2F7,FBXO31,FHL1,FOXN3,GML,GTSE1,HMGA2,JADE1,KANK2,KLHL22,MAD1L1,MAD2L1,MAD2L2,MDM2,MUC1,MYO16,NACC2,NAE1,NBN,PIDD1,PKD2,PLK1,PLK3,PML,PPP2R5C,PRKDC,PRMT2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RB1,RBM38,RFWD2,RFWD3,RGCC,RPA2,RPS27A,RPS27L,SLFN11,SMARCA4,SOX4,TAOK3,TERF1,TEX14,TICRR,TP53,TPR,TRIAP1,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,USP47,ZC3H12D,ZNF207,ZNF655,ZNF830	Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition.
GO:1901992	GO	BP	positive regulation of mitotic cell cycle phase transition	AIF1,ANKRD17,BIRC5,BRD4,CCND1,CDC6,CDC7,CDCA5,CDK10,CDK4,CUL3,DBF4B,DDX3X,DLGAP5,ESPL1,LSM10,LSM11,NACC2,NSMCE2,PHB2,PHOX2B,PLCB1,PLK1,PPP1R1C,PTEN,RAB11A,RAD51B,RAD51C,RB1,RCC2,RDX,SMC5,STOX1,UBE2C,UBE2E2,VPS4B	Any process that activates or increases the frequency, rate or extent of mitotic cell cycle phase transition.
GO:1901998	GO	BP	toxin transport	ABCG1,LRP6,MFSD10,SLC17A3,SLC7A8	The directed movement of a toxin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
GO:1902003	GO	BP	regulation of beta-amyloid formation	ABCA7,APOE,CLU,GSAP,HAP1,LRRTM3,PICALM,SORL1,TMED10	Any process that modulates the frequency, rate or extent of beta-amyloid formation.
GO:1902004	GO	BP	positive regulation of beta-amyloid formation	APOE,CLU,GSAP,LRRTM3,PICALM	Any process that activates or increases the frequency, rate or extent of beta-amyloid formation.
GO:1902017	GO	BP	regulation of cilium assembly	ATG3,ATG5,BBS4,CCDC151,CYLD,DCDC2,EVI5L,FUZ,HAP1,HTT,IFT140,IFT20,IFT88,KCTD17,ODF2,SAXO1,TBC1D30,TBC1D7,TCHP	Any process that modulates the frequency, rate or extent of cilium assembly.
GO:1902033	GO	BP	regulation of hematopoietic stem cell proliferation	ACE,EIF2AK2,N4BP2L2,PDCD2,THPO	Any process that modulates the frequency, rate or extent of hematopoietic stem cell proliferation.
GO:1902041	GO	BP	regulation of extrinsic apoptotic signaling pathway via death domain receptors	ARHGEF2,ATF3,BMP5,BRCA1,CASP8,CFLAR,FADD,FAS,FASLG,FEM1B,FGA,FGB,FGG,GPX1,HMOX1,ICAM1,LGALS3,MADD,NOS3,PARK7,PEA15,PMAIP1,RFFL,RIPK1,RNF34,SCRT2,SERPINE1,SFRP1,SP100,STX4,THBS1,TMBIM1,TMC8,TNFAIP3,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2	Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
GO:1902042	GO	BP	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	ARHGEF2,BMP5,BRCA1,CFLAR,FGA,FGB,FGG,GPX1,HMOX1,ICAM1,NOS3,PARK7,PEA15,RFFL,RNF34,SCRT2,SERPINE1,TMBIM1,TNFAIP3	Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
GO:1902099	GO	BP	regulation of metaphase/anaphase transition of cell cycle	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDC6,CENPE,CENPF,CSNK2A1,CSNK2A2,CUL3,DLGAP5,DUSP1,DYNC1LI1,ESPL1,GEN1,KLHL22,LCMT1,MAD1L1,MAD2L1,MAD2L2,MOS,NEK6,NSMCE2,PCID2,PLK1,PTEN,RB1,SMC5,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of metaphase/anaphase transition of cell cycle.
GO:1902100	GO	BP	negative regulation of metaphase/anaphase transition of cell cycle	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,KLHL22,MAD1L1,MAD2L1,MAD2L2,MOS,PLK1,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,ZNF207	Any process that stops, prevents or reduces the frequency, rate or extent of metaphase/anaphase transition of cell cycle.
GO:1902105	GO	BP	regulation of leukocyte differentiation	ADAM8,ADIPOQ,AGER,ANXA1,APCS,ATP6AP1,AXL,BGLAP,BMP4,BTK,C1QC,CALCA,CAMK4,CARTPT,CASP8,CCL19,CCL3,CCR1,CD2,CD27,CD46,CD80,CD86,CDKN2A,CEBPB,CLPTM1,CSF1,CTLA4,CTNNBIP1,DCSTAMP,FADD,FAM213A,FOXJ1,FOXP1,FOXP3,FSTL3,GAS6,GATA3,GLI2,GLI3,GPR55,HAX1,HCLS1,HLA-B,HLA-G,HMGB1,HOXA7,IFNA2,IFNB1,IFNG,IFNL1,IHH,IKZF3,IL12B,IL12RB1,IL17A,IL23A,IL23R,IL27,IL34,IL4,IL7,INHA,INHBA,IRF1,IRF4,IRF7,JAK3,KIAA0922,KMT2E,LEF1,LGALS9,LIF,LILRB1,LILRB2,LILRB3,LILRB4,LRRC17,LTF,MAFB,MMP14,MTOR,MYB,MYC,NCKAP1L,NKAP,NLRP3,OCSTAMP,OGT,PF4,PNP,PRDM16,PRELID1,PRKCA,PRKCZ,PTPN2,RARA,RC3H1,RIPK1,RUNX1,SART1,SFRP1,SHH,SOCS5,SOD1,SPINK5,SYK,TESC,TESPA1,TGFBR2,TLR3,TLR4,TNF,TNFSF11,TNFSF4,TRAF6,VNN1,XBP1,ZAP70,ZBTB1,ZC3H8,ZFPM1,ZNF675	Any process that modulates the frequency, rate or extent of leukocyte differentiation.
GO:1902106	GO	BP	negative regulation of leukocyte differentiation	ADIPOQ,ANXA1,APCS,BMP4,C1QC,CALCA,CARTPT,CCL3,CDKN2A,CTLA4,FOXJ1,FOXP3,FSTL3,GLI3,GPR55,HLA-G,HMGB1,HOXA7,IFNA2,IFNB1,IFNL1,IHH,IL4,INHA,INHBA,IRF1,JAK3,KIAA0922,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,MYC,PRDM16,PTPN2,RARA,RC3H1,RUNX1,SFRP1,SOCS5,TLR3,TLR4,TNFSF4,ZC3H8,ZFPM1,ZNF675	Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte differentiation.
GO:1902107	GO	BP	positive regulation of leukocyte differentiation	ADAM8,AGER,ANXA1,ATP6AP1,AXL,BTK,CALCA,CASP8,CCL19,CCR1,CD27,CD46,CD80,CD86,CSF1,CTNNBIP1,DCSTAMP,FADD,FOXP3,GAS6,GATA3,GLI2,GLI3,HAX1,HCLS1,HLA-G,HMGB1,IFNG,IHH,IL12B,IL12RB1,IL17A,IL23A,IL23R,IL34,IL4,IL7,KMT2E,LEF1,LGALS9,LIF,LILRB2,MMP14,MYB,NCKAP1L,NKAP,NLRP3,OCSTAMP,OGT,PF4,PNP,PRKCA,PRKCZ,RARA,RIPK1,RUNX1,SART1,SHH,SOCS5,SYK,TESC,TESPA1,TGFBR2,TNF,TNFSF11,TNFSF4,TRAF6,VNN1,XBP1,ZAP70,ZBTB1	Any process that activates or increases the frequency, rate or extent of leukocyte differentiation.
GO:1902108	GO	BP	regulation of mitochondrial membrane permeability involved in apoptotic process	ACAA2,ATF2,BLOC1S2,BNIP3,CAMK2A,MOAP1,NAIF1,RHOT1,RHOT2,THEM4	Any regulation of mitochondrial membrane permeability that is involved in apoptotic process.
GO:1902110	GO	BP	positive regulation of mitochondrial membrane permeability involved in apoptotic process	ATF2,BLOC1S2,BNIP3,MOAP1,RHOT1,RHOT2	Any positive regulation of mitochondrial membrane permeability that is involved in apoptotic process.
GO:1902115	GO	BP	regulation of organelle assembly	AMBRA1,ATG3,ATG5,ATXN2L,BBS4,BMP10,BRCA1,CAV3,CCDC151,CCSAP,CDK5RAP2,CENPJ,CEP295,CEP76,CHMP1A,CHMP1B,CHMP2A,CHMP2B,CHMP4A,CHMP4B,CHMP4C,CHMP5,CNOT1,CNOT2,CNOT6,CNOT6L,CSF2,CYLD,DCDC2,EDN1,EVI5L,EZR,FEZ1,FEZ2,FSCN1,FUZ,GSN,HAP1,HCK,HTT,IFT140,IFT20,IFT88,IL5,KCTD17,KIAA1324,KIF9,LCP1,LRRK2,LRSAM1,MDM1,MSN,MTMR3,MYLK3,NPM1,ODF2,PDCD6IP,PHF23,PIKFYVE,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,PLK1,PLK2,PLK4,PROX1,RAB1B,RAB33B,RAB3GAP1,RAB3GAP2,RAB7A,RALB,RBM14,RDX,RNF4,SAXO1,SCFD1,SDC1,SDC4,SDCBP,SENP6,SH3GLB1,SPICE1,STAM,STX18,TBC1D14,TBC1D30,TBC1D7,TCHP,TNF,TPR,TRIM37,TSG101,UBQLN1,UBQLN2,VPS11,VPS4B	Any process that modulates the frequency, rate or extent of organelle assembly.
GO:1902116	GO	BP	negative regulation of organelle assembly	BRCA1,CAV3,CDK5RAP2,CHMP2A,CHMP4A,CHMP4B,EVI5L,FEZ1,FEZ2,LRRK2,MDM1,PHF23,PINK1,RBM14,SCFD1,TBC1D30,TBC1D7,TCHP,TRIM37	Any process that stops, prevents or reduces the frequency, rate or extent of organelle assembly.
GO:1902117	GO	BP	positive regulation of organelle assembly	BBS4,BMP10,CEP295,CNOT1,CNOT2,CNOT6,CNOT6L,CSF2,EDN1,FSCN1,FUZ,HAP1,HTT,IL5,KCTD17,KIAA1324,LCP1,LRSAM1,MYLK3,PDCD6IP,PIP4K2A,PIP4K2B,PIP4K2C,PLK4,PROX1,RAB3GAP1,RAB3GAP2,RALB,SAXO1,SDC1,SDC4,SDCBP,SH3GLB1,STX18,TNF,VPS4B	Any process that activates or increases the frequency, rate or extent of organelle assembly.
GO:1902166	GO	BP	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	CD44,CD74,ING2,KDM1A,MIF,MUC1,SIRT1,TAF9,TAF9B,TRIAP1,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator.
GO:1902175	GO	BP	regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	AKT1,BAG5,FBXW7,HIF1A,HSPB1,HTRA2,INS,MAPK7,MCL1,NFE2L2,NOL3,NONO,P4HB,PARK2,PARK7,PINK1,SFPQ,SIRT1,SOD1,SOD2,TRAP1,UBQLN1,VNN1	Any process that modulates the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
GO:1902176	GO	BP	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	AKT1,BAG5,HIF1A,HSPB1,HTRA2,INS,MAPK7,NFE2L2,NOL3,NONO,PARK2,PARK7,PINK1,SIRT1,SOD2,TRAP1,VNN1	Any process that stops, prevents or reduces the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
GO:1902186	GO	BP	regulation of viral release from host cell	CAV2,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,DDB1,MID2,PC,PML,TRIM11,TRIM13,TRIM15,TRIM21,TRIM25,TRIM26,TRIM28,TRIM31,TRIM32,TRIM35,TRIM5,TRIM62,TRIM8,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,ZNF502	Any process that modulates the frequency, rate or extent of viral release from host cell.
GO:1902187	GO	BP	negative regulation of viral release from host cell	CHMP3,MID2,PML,TRIM11,TRIM13,TRIM15,TRIM21,TRIM26,TRIM28,TRIM32,TRIM35,TRIM5,TRIM8,VAPB	Any process that stops, prevents or reduces the frequency, rate or extent of viral release from host cell.
GO:1902188	GO	BP	positive regulation of viral release from host cell	CAV2,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,DDB1,PC,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,ZNF502	Any process that activates or increases the frequency, rate or extent of viral release from host cell.
GO:1902224	GO	BP	ketone body metabolic process	AACS,ACAT1,BDH1,BDH2,HMGCL,HMGCLL1,HMGCS2,OXCT1	The chemical reactions and pathways involving ketone body.
GO:1902229	GO	BP	regulation of intrinsic apoptotic signaling pathway in response to DNA damage	ACKR3,BCL2L1,CCAR2,CD44,CD74,CDKN2D,CLU,CXCL12,FBXO18,ING2,KDM1A,MIF,MUC1,NACC2,RPS3,SFRP2,SIRT1,SNAI1,SNAI2,TAF9,TAF9B,TMEM161A,TPT1,TRIAP1,TRIM32,ZNF385A	Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage.
GO:1902230	GO	BP	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	ACKR3,BCL2L1,CCAR2,CD44,CD74,CDKN2D,CLU,CXCL12,ING2,KDM1A,MIF,MUC1,SFRP2,SIRT1,SNAI1,SNAI2,TAF9,TAF9B,TMEM161A,TPT1,TRIAP1,TRIM32,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage.
GO:1902235	GO	BP	regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BBC3,BCL2L11,CREB3,CREB3L1,DDIT3,EIF2AK3,HERPUD1,HSPA1A,LRRK2,MAGEA3,NCK1,OPA1,PARK2,PARK7,PMAIP1,SYVN1,TMBIM6,TXNDC12,VIMP,XBP1	Any process that modulates the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
GO:1902236	GO	BP	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	CREB3,CREB3L1,HERPUD1,HSPA1A,LRRK2,MAGEA3,OPA1,PARK2,PARK7,SYVN1,TMBIM6,TXNDC12,VIMP,XBP1	Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
GO:1902237	GO	BP	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BBC3,BCL2L11,DDIT3,NCK1,PMAIP1	Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
GO:1902253	GO	BP	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	CD44,CD74,ING2,KDM1A,MIF,MSX1,MUC1,PTTG1IP,SIRT1,TAF9,TAF9B,TRIAP1,UBB,ZNF385A	Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway by p53 class mediator.
GO:1902254	GO	BP	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	CD44,CD74,ING2,KDM1A,MIF,MUC1,PTTG1IP,SIRT1,TAF9,TAF9B,TRIAP1,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway by p53 class mediator.
GO:1902259	GO	BP	regulation of delayed rectifier potassium channel activity	AKAP6,AKAP7,ANK3,KCNAB1,KCNE1,KCNE2,KCNE3,KCNG1,KCNQ1,KCNRG,KCNS1,KCNS2,NOS1AP,NPPA,RNF207,SUMO1,VAMP2	Any process that modulates the frequency, rate or extent of delayed rectifier potassium channel activity.
GO:1902260	GO	BP	negative regulation of delayed rectifier potassium channel activity	ANK3,KCNE1,KCNE2,KCNE3,KCNQ1,KCNRG,SUMO1	Any process that stops, prevents or reduces the frequency, rate or extent of delayed rectifier potassium channel activity.
GO:1902261	GO	BP	positive regulation of delayed rectifier potassium channel activity	AKAP6,AKAP7,NOS1AP,NPPA,RNF207	Any process that activates or increases the frequency, rate or extent of delayed rectifier potassium channel activity.
GO:1902275	GO	BP	regulation of chromatin organization	AICDA,APOBEC1,ARRB1,ASF1A,AUTS2,BCOR,BRCA1,BRD7,C6orf89,CAMK2D,CDK9,CHEK1,CHTOP,CTBP1,CTCFL,CTNNB1,CTR9,DNMT1,DNMT3B,EID1,FLCN,FOXP3,H2AFY,HIST1H1B,HMGA1,IL1B,IWS1,JARID2,KDM1A,KDM5A,KMT2A,LIF,MAP1S,MAPK3,MAPK8,MIER1,MTF2,MTHFR,MUC1,MYB,MYOCD,NIPBL,NOC2L,NOS1,NSD1,OGT,OTUB1,PADI2,PAF1,PARP10,PAXIP1,PHF1,PHF19,PHF2,PHF8,PIH1D1,PML,POU5F1,PPARGC1A,PRDM12,PRKD1,PRKD2,RNF20,RNF40,RPS6KA4,RPS6KA5,RUVBL2,SART3,SET,SIN3A,SIRT1,SMAD4,SMARCB1,SNCA,SNW1,SPI1,SPTY2D1,SUPT6H,TAF7,TAL1,TET1,TLK1,TLK2,TPR,TRIP12,TWIST1,UBE2N,UBR5,USP17L2,VEGFA,WBP2,WDR61,XBP1	Any process that modulates the frequency, rate or extent of chromatin organization.
GO:1902305	GO	BP	regulation of sodium ion transmembrane transport	ACTN4,AGT,ANK3,ATP1A2,ATP1B1,ATP1B2,ATP1B3,ATP2B4,BPIFA1,CAMK2D,CAV3,CHP1,COMMD1,DLG1,DMD,DRD4,FGF12,FXYD1,GLRX,GPD1L,NEDD4,NEDD4L,NOS1,PCSK9,PRKCE,PTPN3,RANGRF,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC9A1,SLC9A3R1,SNTA1,TESC,UTRN,WNK2,WNK3,YWHAH	Any process that modulates the frequency, rate or extent of sodium ion transmembrane transport.
GO:1902306	GO	BP	negative regulation of sodium ion transmembrane transport	AGT,ATP1A2,CAMK2D,COMMD1,NEDD4,NEDD4L,PCSK9,PRKCE	Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transport.
GO:1902307	GO	BP	positive regulation of sodium ion transmembrane transport	ACTN4,ANK3,ATP1B1,ATP1B2,ATP1B3,CHP1,DMD,DRD4,FXYD1,GLRX,NOS1,SLC9A1,TESC,WNK2,WNK3	Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transport.
GO:1902358	GO	BP	sulfate transmembrane transport	SLC26A1,SLC26A4,SLC26A6,SLC26A7,SLC26A8	The directed movement of sulfate across a membrane.
GO:1902402	GO	BP	signal transduction involved in mitotic DNA damage checkpoint	ATM,CASP2,CDK2,CDKN1A,CDKN1B,CHEK2,CRADD,GML,GTSE1,MDM2,MUC1,PIDD1,PML,PPP2R5C,PRKDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,RBM38,RFWD2,RPS27A,SOX4,TP53,TRIAP1,UBA52,UBB,UBC	Any intracellular signal transduction that is involved in mitotic DNA damage checkpoint.
GO:1902430	GO	BP	negative regulation of beta-amyloid formation	ABCA7,APOE,CLU,HAP1,SORL1	Any process that stops, prevents or reduces the frequency, rate or extent of beta-amyloid formation.
GO:1902474	GO	BP	positive regulation of protein localization to synapse	DVL1,NLGN2,STX7,WNT5A,WNT7A	Any process that activates or increases the frequency, rate or extent of protein localization to synapse.
GO:1902475	GO	BP	L-alpha-amino acid transmembrane transport	PQLC2,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A6,SLC1A7,SLC25A12,SLC25A13,SLC25A15,SLC25A22,SLC38A3,SLC7A11	The directed movement of L-alpha-amino acid across a membrane.
GO:1902476	GO	BP	chloride transmembrane transport	ANO1,ANO10,ANO2,ANO4,ANO5,ANO6,ANO8,ANO9,APOL1,BEST1,CFTR,CLCA1,CLCA2,CLCA4,CLCN1,CLCN3,CLCN4,CLCN5,CLCN7,CLIC1,CLIC3,FXYD1,FXYD3,GABRB2,GABRB3,GABRG2,GLRA1,GLRA2,GLRA3,GLRB,NMUR2,SLC12A1,SLC12A2,SLC12A3,SLC12A4,SLC12A9,SLC1A4,SLC26A4,SLC26A6,SLC26A7,SLC26A8,SLC26A9,TTYH3	The directed movement of chloride across a membrane.
GO:1902495	GO	CC	transmembrane transporter complex	ABCA2,ABCA7,ABCB6,ABCB8,ABCC8,ABCC9,ABCD4,ABCF2,ABCG5,ABCG8,AKAP6,AKAP9,AMIGO1,ANO6,ASPH,ATP12A,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,BCS1L,BEST1,BEST2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCDC109B,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB3,CHRNB4,CNGA3,CNGB1,CNGB3,CNIH2,CNIH3,CNTNAP1,CNTNAP2,CTTN,DLG2,DLG4,DPP6,FKBP1B,FXYD1,FXYD2,GLRA3,GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIN1,GRIN2A,GRIN2B,GRIN3A,GRIN3B,HCN2,HSPA2,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNH4,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ1,KCNJ11,KCNJ14,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK4,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN4,KCNQ1,KCNS1,KCNS2,LRRC26,LRRC8A,MCU,MICU1,MICU2,MT-CYB,NOS1,NOS1AP,OLFM2,PDE4B,PDE4D,PKD1L1,PKD1L3,PKD2L1,PLN,PPP2R4,PRKACA,PTK2B,RYR2,SCN10A,SCN1B,SCN2A,SCN2B,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHANK1,SHANK2,SHISA9,SLC9A1,SMDT1,SNAP25,STX1A,STXBP5,SUMO1,TRDN,TRPC4,TRPC5,UQCC3,VAMP2	A transmembrane protein complex which enables the transfer of a substance from one side of a membrane to the other.
GO:1902547	GO	BP	regulation of cellular response to vascular endothelial growth factor stimulus	ADAMTS12,ADAMTS3,CCBE1,CD63,DAB2IP,DCN,DLL1,HRG,MYO1C,XDH	Any process that modulates the frequency, rate or extent of cellular response to vascular endothelial growth factor stimulus.
GO:1902548	GO	BP	negative regulation of cellular response to vascular endothelial growth factor stimulus	ADAMTS12,DAB2IP,DCN,HRG,XDH	Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to vascular endothelial growth factor stimulus.
GO:1902554	GO	CC	serine/threonine protein kinase complex	ACVR1,ACVR1B,ACVR1C,AKAP4,CAB39,CCNH,CCNT1,CDK7,CDK9,CHUK,DAB2,DNAJA3,ENG,ERC1,ERCC2,ERCC3,ERCC5,ERN1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HOXC10,HSPD1,IKBKB,IKBKG,KDM5A,MAP3K13,MMS19,MNAT1,PHKG2,PRKACA,PRKACB,PRKAR1B,PUF60,PYCARD,PYDC1,SNW1,TAF7,TBC1D5,TGFBR1,TGFBR2,TRIM40,UVRAG	A protein complex which is capable of protein serine/threonine kinase activity.
GO:1902555	GO	CC	endoribonuclease complex	AGO1,AGO2,AGO3,AGO4,CLP1,DGCR8,DICER1,DROSHA,ERN1,POP1,POP7,RPP30,RPP38,RPP40,TARBP2	A protein complex which is capable of endoribonuclease activity.
GO:1902591	GO	BP	single-organism membrane budding	ANKRD28,ARCN1,AREG,ARF1,ARFGAP1,BET1,CD59,CNIH1,CNIH2,CNIH3,COL7A1,COPA,COPB1,COPB2,COPE,COPG1,COPZ1,CSNK1D,CTSC,CTSZ,CUL3,F5,F8,FOLR1,GBF1,GOLGA2,GOLPH3,GORASP1,GOSR2,GRIA1,KLHL12,LMAN1,MCFD2,MYO18A,NAPA,NSF,PPP6C,PPP6R1,PPP6R3,PREB,RAB1A,RAB1B,RILP,SAR1B,SCFD1,SEC13,SEC16A,SEC16B,SEC22B,SEC23A,SEC23IP,SEC24A,SEC24B,SEC24C,SEC24D,SEC31A,SERPINA1,SNX3,STX5,TBC1D20,TFG,TGFA,TMED10,TMED2,TMED9,TRAPPC1,TRAPPC10,TRAPPC2,TRAPPC2L,TRAPPC3,TRAPPC4,TRAPPC5,TRAPPC6A,TRAPPC6B,TRAPPC9,USO1,VAPA,VAPB	A membrane budding which involves only one organism.
GO:1902600	GO	BP	hydrogen ion transmembrane transport	ATP1A4,ATP4B,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,ATP6V1H,COX10,COX11,COX15,COX4I1,COX4I2,COX5A,COX5B,COX6B1,COX7A1,COX7A2L,COX7B,COX8A,CYB5A,MT-ATP6,MT-ATP8,MT-CO1,MT-CO2,MT-CYB,NDUFA4,NNT,SLC46A1,SLC9A1,STOML2,UQCR10,UQCRC1,UQCRH,VPS9D1	The directed movement of hydrogen ion (proton) across a membrane.
GO:1902603	GO	BP	carnitine transmembrane transport	ACACA,ACACB,CPT1A,CPT1B,CPT2,PRKAA2,PRKAB2,PRKAG2,SLC22A16,SLC22A4,SLC22A5,SLC25A20	The directed movement of carnitine across a membrane.
GO:1902622	GO	BP	regulation of neutrophil migration	ADAM8,C1QBP,C5AR2,CAMK1D,CCL19,CCL21,CCR7,CD74,CXCL8,DAPK2,JAM3,MPP1,NCKAP1L,RAC1,RAC2,SLIT2,THBS4,TIRAP,XCL1	Any process that modulates the frequency, rate or extent of neutrophil migration.
GO:1902624	GO	BP	positive regulation of neutrophil migration	ADAM8,C1QBP,CAMK1D,CCL19,CCL21,CCR7,CD74,CXCL8,DAPK2,NCKAP1L,RAC1,RAC2,THBS4,TIRAP,XCL1	Any process that activates or increases the frequency, rate or extent of neutrophil migration.
GO:1902652	GO	BP	secondary alcohol metabolic process	ABCA1,ABCG1,ACAA2,ACLY,AKR1D1,ANGPTL3,APOA1,APOA4,APOB,APOE,APOL2,ARV1,CEL,CELA3A,CELA3B,CETP,CLN6,CLN8,CNBP,CYP11A1,CYP27B1,CYP3A4,CYP46A1,CYP51A1,CYP7A1,DHCR24,DHCR7,EBP,FDFT1,FDPS,FDX1,G6PD,GGPS1,HMGCR,HMGCS1,HSD17B7,IDI1,IDI2,IL4,LBR,LCAT,LDLRAP1,LSS,MSMO1,MT3,MVD,MVK,NPC1L1,NR0B2,NSDHL,OSBPL1A,OSBPL5,PMVK,PPARD,RXRA,SC5D,SCARF1,SNX17,SOAT1,SOAT2,SQLE,STARD3,TM7SF2,TRERF1	The chemical reactions and pathways involving secondary alcohol.
GO:1902667	GO	BP	regulation of axon guidance	DSCAM,MEGF8,NRP1,PTPRO,SEMA3A,SEMA5A,SLIT2,VEGFA	Any process that modulates the frequency, rate or extent of axon guidance.
GO:1902692	GO	BP	regulation of neuroblast proliferation	CTNNB1,DISC1,DRD2,FZD3,LRRK2,NF1,SIX3,SMARCD3,VEGFA,ZNF335	Any process that modulates the frequency, rate or extent of neuroblast proliferation.
GO:1902710	GO	CC	GABA receptor complex	GABRA1,GABRB1,GABRB2,GABRB3,GABRG2	A protein complex which is capable of GABA receptor activity. Upon binding of gamma-aminobutyric acid (GABA) it transmits the signal from one side of the membrane to the other to initiate a change in cell activity. Major inhibitory receptor in vertebrate brain. Also found in other vertebrate tissues, invertebrates and possibly in plants. Effective benzodiazepine receptor.
GO:1902713	GO	BP	regulation of interferon-gamma secretion	CD2,CD244,IL36RN,LGALS9,NR1H4,PTPN22,RASGRP1,ZC3H12A	Any process that modulates the frequency, rate or extent of interferon-gamma secretion.
GO:1902715	GO	BP	positive regulation of interferon-gamma secretion	CD2,CD244,LGALS9,PTPN22,RASGRP1	Any process that activates or increases the frequency, rate or extent of interferon-gamma secretion.
GO:1902743	GO	BP	regulation of lamellipodium organization	ARHGEF7,ARPC2,ARPIN,BRK1,CLRN1,CORO1B,CORO1C,DMTN,ENPP2,EPHA2,FER,FSCN1,HRG,KANK1,LRRC16A,NCKAP1,PLXNB3,RAC1,RAC2,RREB1,SLIT2,SRC,TWF2,VIL1,WASF2,WNT1	Any process that modulates the frequency, rate or extent of lamellipodium organization.
GO:1902744	GO	BP	negative regulation of lamellipodium organization	ARPIN,HRG,KANK1,PLXNB3,SLIT2	Any process that stops, prevents or reduces the frequency, rate or extent of lamellipodium organization.
GO:1902745	GO	BP	positive regulation of lamellipodium organization	ARHGEF7,ARPC2,BRK1,CLRN1,CORO1B,CORO1C,ENPP2,FSCN1,LRRC16A,NCKAP1,RAC1,RAC2,RREB1,SRC,TWF2,VIL1,WASF2,WNT1	Any process that activates or increases the frequency, rate or extent of lamellipodium organization.
GO:1902749	GO	BP	regulation of cell cycle G2/M phase transition	ATF5,ATM,BLM,BRD4,CCNA2,CCND1,CDC7,CDK4,CDK5RAP3,CDKN2A,CENPF,CLSPN,DBF4B,FHL1,FOXN3,H2AFY,HMGA2,KCNH5,KIF14,NAE1,NBN,NEK10,NPM1,PHOX2B,RAB11A,RAD51B,RAD51C,RCC2,RINT1,STOX1,TAOK3,TICRR,USP47,VPS4B,ZNF830	Any process that modulates the frequency, rate or extent of cell cycle G2/M phase transition.
GO:1902750	GO	BP	negative regulation of cell cycle G2/M phase transition	ATF5,ATM,BLM,CCNA2,CDK5RAP3,CLSPN,FHL1,FOXN3,H2AFY,HMGA2,NAE1,NBN,TAOK3,TICRR,USP47,ZNF830	Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle G2/M phase transition.
GO:1902751	GO	BP	positive regulation of cell cycle G2/M phase transition	BRD4,CCND1,CDC7,CDK4,DBF4B,NPM1,PHOX2B,RAB11A,RAD51B,RAD51C,RCC2,STOX1,VPS4B	Any process that activates or increases the frequency, rate or extent of cell cycle G2/M phase transition.
GO:1902803	GO	BP	regulation of synaptic vesicle transport	CDK5,LRRK2,NLGN1,PARK2,PINK1,RAB3A,RAB3GAP1,RAB5A,RIMS3,RIMS4,SEPT5,SNCA,STX1B,STXBP1,SYN1,SYNJ1,TOR1A,UNC13B	Any process that modulates the frequency, rate or extent of synaptic vesicle transport.
GO:1902806	GO	BP	regulation of cell cycle G1/S phase transition	ADAM17,AIF1,AKT1,ANKRD17,ATM,ATP2B4,BRD7,C10orf99,C8orf4,CASP2,CCND1,CDC6,CDC73,CDK10,CDK2,CDKN1A,CDKN1B,CRADD,DACT1,DDX3X,DGKZ,E2F1,E2F7,EGFR,FAM83D,FBXO31,FBXW7,FGF10,FHL1,GML,GTSE1,ID2,INO80,JADE1,KANK2,KIF14,LSM10,LSM11,MDM2,MUC1,MYO16,NACC2,PHB2,PID1,PIDD1,PIM1,PKD1,PKD2,PLCB1,PLK3,PLK5,PML,PPP1R1C,PPP2R5C,PRKDC,PRMT2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTPN6,RB1,RBM38,RDX,RFWD2,RFWD3,RGCC,RPA2,RPS27A,RPS27L,SLFN11,SMARCA4,SOX4,STXBP4,SUSD2,TCF3,TP53,TP63,TRIAP1,UBA52,UBB,UBC,UBE2E2,ZC3H12D,ZNF655	Any process that modulates the frequency, rate or extent of cell cycle G1/S phase transition.
GO:1902807	GO	BP	negative regulation of cell cycle G1/S phase transition	ATM,BRD7,C10orf99,CASP2,CCND1,CDC73,CDK2,CDKN1A,CDKN1B,CRADD,DACT1,DGKZ,E2F7,FBXO31,FHL1,GML,GTSE1,JADE1,KANK2,MDM2,MUC1,MYO16,NACC2,PIDD1,PKD2,PLK3,PML,PPP2R5C,PRKDC,PRMT2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RB1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SLFN11,SMARCA4,SOX4,SUSD2,TP53,TRIAP1,UBA52,UBB,UBC,ZC3H12D,ZNF655	Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle G1/S phase transition.
GO:1902808	GO	BP	positive regulation of cell cycle G1/S phase transition	AIF1,ANKRD17,CDC6,CDK10,DDX3X,FAM83D,LSM10,LSM11,NACC2,PHB2,PLCB1,PPP1R1C,RDX,STXBP4,TP63,UBE2E2	Any process that activates or increases the frequency, rate or extent of cell cycle G1/S phase transition.
GO:1902850	GO	BP	microtubule cytoskeleton organization involved in mitosis	ARHGEF10,AURKB,AURKC,CENPE,CHAMP1,CHEK2,CLASP1,FAM175B,FLNA,GOLGA2,KIF11,KIF23,KIF2A,KIF3B,KIF4A,KIF4B,KIFC1,KPNB1,MAP10,PIBF1,RAB11A,RACGAP1,RHOA,SEH1L,SPICE1,TPX2,ZNF207	Any microtubule cytoskeleton organization that is involved in mitosis.
GO:1902882	GO	BP	regulation of response to oxidative stress	AKT1,ATF4,BAG5,BMP7,DHFR,FBLN5,FBXW7,GCH1,GNB2L1,GPR37,GPR37L1,HDAC6,HGF,HIF1A,HP,HSPB1,HTRA2,INS,LRRK2,MAPK7,MCL1,MET,MMP3,NFE2L2,NOL3,NONO,NR4A3,P4HB,PARK2,PARK7,PINK1,PYCR1,SFPQ,SIRT1,SNCA,SOD1,SOD2,STK26,STOX1,SZT2,TNF,TRAP1,TXN,UBQLN1,VNN1	Any process that modulates the frequency, rate or extent of response to oxidative stress.
GO:1902893	GO	BP	regulation of pri-miRNA transcription from RNA polymerase II promoter	FOS,GNL3,HIF1A,JUN,LILRB4,NFIB,PPARA,PPARD,SMARCA4,SPI1,SRF,TERT	Any process that modulates the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
GO:1902894	GO	BP	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	LILRB4,NFIB,PPARA,PPARD,SRF	Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
GO:1902895	GO	BP	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	FOS,GNL3,HIF1A,JUN,SMARCA4,SPI1,SRF,TERT	Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
GO:1902902	GO	BP	negative regulation of autophagosome assembly	CHMP4A,CHMP4B,FEZ1,FEZ2,LRRK2,PHF23,PINK1,SCFD1	Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome assembly.
GO:1902911	GO	CC	protein kinase complex	ACVR1,ACVR1B,ACVR1C,AKAP4,BCCIP,CAB39,CCND1,CCND2,CCND3,CCNH,CCNT1,CCNY,CDK12,CDK13,CDK14,CDK2,CDK4,CDK6,CDK7,CDK9,CDKN1A,CHUK,DAB2,DNAJA3,ENG,ERC1,ERCC2,ERCC3,ERCC5,ERN1,GTF2H1,GTF2H2,GTF2H3,GTF2H4,HOXC10,HSPD1,IKBKB,IKBKG,INSR,IRS1,KDM5A,MAP3K13,MAP3K5,MMS19,MNAT1,NEK10,PHKG2,PRKAA1,PRKAB2,PRKACA,PRKACB,PRKAG1,PRKAG2,PRKAR1A,PRKAR1B,PRKAR2A,PUF60,PYCARD,PYDC1,SNW1,SORBS1,TAF7,TBC1D5,TGFBR1,TGFBR2,TRIM40,UVRAG	A protein complex which is capable of protein kinase activity.
GO:1902914	GO	BP	regulation of protein polyubiquitination	BIRC2,HAMP,OTUB1,PARK2,PARP10,PTPN22,SASH1,TRIP12,UBR5,XIAP	Any process that modulates the frequency, rate or extent of protein polyubiquitination.
GO:1902916	GO	BP	positive regulation of protein polyubiquitination	BIRC2,HAMP,PARK2,PTPN22,XIAP	Any process that activates or increases the frequency, rate or extent of protein polyubiquitination.
GO:1902930	GO	BP	regulation of alcohol biosynthetic process	ABCG1,ACSL3,AKR1C3,APOE,BMP2,BMP5,BMP6,CD244,CYP27B1,DKK3,ERLIN1,ERLIN2,FGF1,GFI1,GPER1,HRH1,IFNG,IL1B,LHCGR,NFKB1,PLEK,PRKAA1,PTH1R,PTK2B,REST,SCAP,SEC14L2,SNAI1,SNAI2,SNCA,SOD1,TNF,VDR,WNT4	Any process that modulates the frequency, rate or extent of alcohol biosynthetic process.
GO:1902931	GO	BP	negative regulation of alcohol biosynthetic process	APOE,BMP2,BMP5,CYP27B1,DKK3,ERLIN1,ERLIN2,GFI1,NFKB1,PLEK,REST,SCAP,SNAI1,SNAI2,SOD1,WNT4	Any process that stops, prevents or reduces the frequency, rate or extent of alcohol biosynthetic process.
GO:1902932	GO	BP	positive regulation of alcohol biosynthetic process	ABCG1,ACSL3,BMP6,CD244,FGF1,GPER1,HRH1,IFNG,IL1B,LHCGR,PRKAA1,PTH1R,SNCA,TNF,WNT4	Any process that activates or increases the frequency, rate or extent of alcohol biosynthetic process.
GO:1902936	GO	MF	phosphatidylinositol bisphosphate binding	ACTN2,ADAP2,AKT1,ALOX15,AMER1,AMER2,ANXA2,ANXA8,ARAP3,CLVS1,CLVS2,COMMD1,DAPP1,FAM21C,FCHO2,FRMPD4,GAB2,GBF1,JPH2,KCNJ1,KCNJ2,KCNQ1,KIF16B,KRIT1,LDLRAP1,MAPKAP1,MARK1,MYO1B,MYO1G,NCF1,PARD3,PFN1,PFN2,PHLDA3,PLCB1,PLEK,PLEKHA1,RAB35,RAG2,RPH3A,SCIN,SESTD1,SH3PXD2B,SLC9A1,SNX14,SNX18,SNX20,SNX21,SNX3,SYTL2,TIRAP,TTPA,TULP1,TULP3,TWF1,TWF2,VIL1,WIPI1,WIPI2,ZFYVE1	Interacting selectively and non-covalently with phosphatidylinositol bisphosphate.
GO:1902966	GO	BP	positive regulation of protein localization to early endosome	EZR,MSN,RDX,SORL1,VEGFA	Any process that activates or increases the frequency, rate or extent of protein localization to early endosome.
GO:1902991	GO	BP	regulation of amyloid precursor protein catabolic process	ABCA7,APOE,CLU,FKBP1A,FLOT2,GSAP,HAP1,LRRTM3,PICALM,SORL1,TMED10	Any process that modulates the frequency, rate or extent of amyloid precursor protein catabolic process.
GO:1902992	GO	BP	negative regulation of amyloid precursor protein catabolic process	ABCA7,APOE,CLU,FLOT2,HAP1,PICALM,SORL1	Any process that stops, prevents or reduces the frequency, rate or extent of amyloid precursor protein catabolic process.
GO:1903008	GO	BP	organelle disassembly	ACIN1,ACTRT1,ADAMTS7,ADRB2,AKR1E2,ALPK1,AMBRA1,ANXA5,ASB2,ATG12,ATG13,ATG14,ATG5,ATP1B1,ATPIF1,BECN1,BLOC1S1,BNIP3,BOC,C5,C8orf59,CA7,CALCB,CAPS,CD163L1,CD93,CDK1,CDKN2A,CHAF1B,CHST3,CLVS1,COX8A,CRNKL1,CSPG5,DENR,DKKL1,DNAAF2,DPF3,DZANK1,EIF2D,EIF2S1,EVA1B,FABP1,FAM131B,FAM134B,FAM13B,FANCC,FANCF,FBXO7,FCGR3B,FGFBP1,FIS1,FUNDC1,GABRA5,GBF1,GDF5,GFM2,GMIP,GOLGA2,HAPLN1,HCAR1,HDAC6,HK2,HPR,HSF2BP,IPPK,IST1,ITPKC,KCNK3,KIAA1549L,KIF5B,KIF9,KLC1,KRCC1,KRT15,KRT6A,KRT73,LARP1B,LENG9,LMCD1,LSM4,MAP1A,MAP1LC3A,MAP1LC3B,MAP2K1,MAP3K12,MARK2,MBD5,MCTS1,MDH1,MEX3C,MFN1,MFN2,MRPS10,MRPS2,MRRF,MSTN,MTERF3,MTIF2,MTIF3,MYH11,MYLK,MYOM1,NDUFB9,NEFM,NME2,NR2C2,NTHL1,NUP93,OBSCN,P2RX5,PARK2,PDK1,PEX13,PEX3,PFKP,PGK2,PHYHIP,PI4K2A,PIK3CA,PINK1,PLK3,PLOD2,PNPO,PPY,PRKD2,PRKG1,REP15,RFWD3,RIMS3,RPS27A,SERPINB10,SFRP4,SLC1A3,SLC1A4,SLC22A3,SLC35B3,SLC35C1,SLC37A4,SLC6A1,SLCO1A2,SMURF1,SNRPB,SNRPD1,SNRPF,SNTG1,SPATA18,SQSTM1,STAT2,STK32A,STOM,STX5,SUPT3H,TBC1D5,TEX38,TMEM203,TMEM39A,TMEM39B,TOMM20,TOMM22,TOMM40,TOMM5,TOMM6,TOMM7,TOMM70A,TREM1,TXLNA,UBA52,UBB,UBC,USP30,VDAC1,VRK1,YIPF1,ZCCHC17,ZNF189,ZNF593	The disaggregation of an organelle into its constituent components.
GO:1903010	GO	BP	regulation of bone development	ATP6AP1,GREM1,LILRB1,LTF,TMEM119	Any process that modulates the frequency, rate or extent of bone development.
GO:1903018	GO	BP	regulation of glycoprotein metabolic process	ABCA7,ACER2,ACOT8,APCS,ARFGEF1,BACE2,CCL19,CCL21,CCR7,CHP1,CST3,CTNNB1,FKTN,GATA1,GOLGA2,IGF1,ITM2B,JAK3,KAT2B,MT3,NECAB3,PLCB1,PTX3,PUM3,PXYLP1,RAB1A,RAB1B,RAMP1,SLC51B,SOAT1,TCF7L2,TINF2,TMEM59	Any process that modulates the frequency, rate or extent of glycoprotein metabolic process.
GO:1903019	GO	BP	negative regulation of glycoprotein metabolic process	ABCA7,ACER2,ACOT8,APCS,BACE2,CST3,ITM2B,JAK3,PTX3,TINF2,TMEM59	Any process that stops, prevents or reduces the frequency, rate or extent of glycoprotein metabolic process.
GO:1903020	GO	BP	positive regulation of glycoprotein metabolic process	ARFGEF1,CCL19,CCL21,CCR7,CHP1,CTNNB1,GOLGA2,IGF1,PLCB1,PXYLP1,RAB1A,RAB1B,RAMP1,SLC51B,SOAT1,TCF7L2	Any process that activates or increases the frequency, rate or extent of glycoprotein metabolic process.
GO:1903035	GO	BP	negative regulation of response to wounding	ADAMTS18,ADIPOQ,ALOX12,APCS,APOA1,APOD,APOE,APOH,C1QTNF1,C1QTNF3,CASK,CD109,CD34,CHID1,CLASP1,CLASP2,CUEDC2,EDN1,ELANE,EPHA4,F11,F12,F2,FEM1A,FFAR4,FGA,FGB,FGF2,FGG,GATA3,GBA,GHRL,GHSR,GP1BA,GPER1,GSTP1,HLA-DRB1,HRG,INS,IRG1,ISL1,KLF4,KLK8,KLKB1,KNG1,KRT1,MAPK7,MEFV,METRNL,MMP26,MVK,NLRP12,NLRP3,NOS3,NOV,NR1H3,OTULIN,PDGFA,PDGFB,PDGFRA,PHLDB2,PLAT,PLAU,PLAUR,PLG,PPARA,PRKCD,PRKG1,PROC,PTGER4,PTGIS,PTPN2,PYDC2,RORA,RPS19,SAA1,SERPINB2,SERPINE1,SERPINE2,SERPINF2,SHARPIN,TEK,THBD,TMPRSS6,TNFAIP3,TNFAIP6,TNFRSF1A,TYRO3,VIMP,VTN,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of response to wounding.
GO:1903036	GO	BP	positive regulation of response to wounding	ADAM8,ADRA2A,AGT,AGTR1,ANO6,ANXA1,APOH,ARFGEF1,CAPN3,CCL3,CCR2,CCR7,CD6,CREB3L3,DMTN,ENPP4,F12,F2,F2R,F3,FFAR2,FFAR3,FOXC2,GBP5,GPRC5B,HBEGF,HPSE,HRAS,HYAL2,IL12B,IL15,IL18,IL1B,IL2,IL21,IL23A,IL33,IL6,IL6ST,INSL3,KANK1,KLKB1,LBP,MAPK13,MYLK,NLRP12,NOD2,OSM,OSMR,PDE2A,PLA2G2A,PLA2G7,PLEK,PLG,PLPP3,PRKCE,PTGER3,PTGER4,PTGS2,REG3A,REG3G,RPS19,RREB1,S100A12,S100A8,S100A9,SCARF1,SELP,SERPINE1,SERPINF2,SNX4,SOX15,THBD,THBS1,TLR2,TLR3,TLR4,TLR7,TLR9,TNF,TNFRSF11A,TNFRSF1A,TNFSF11,TNFSF4,TNIP1,USF1,VAMP7,VAMP8,VEGFB,VTN,WNT5A,ZP3	Any process that activates or increases the frequency, rate or extent of response to wounding.
GO:1903037	GO	BP	regulation of leukocyte cell-cell adhesion	ADAM8,AGER,AIF1,AKT1,ANXA1,ASS1,BMP4,BTLA,BTN2A2,CAMK4,CARD11,CAV1,CCL19,CCL2,CCL21,CCL25,CCL28,CCL5,CCR2,CCR7,CD1D,CD2,CD209,CD24,CD247,CD274,CD276,CD28,CD300A,CD3D,CD3E,CD3G,CD4,CD44,CD46,CD47,CD55,CD6,CD80,CD86,CDC42,CDKN2A,CEBPB,CLC,CLPTM1,CSK,CTLA4,CXCL12,DPP4,DUSP3,EBI3,FADD,FLOT2,FOXJ1,FOXP3,FYN,GATA3,GLI2,GLI3,GLMN,GRAP2,GRB2,GSN,HAS2,HAVCR2,HFE,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNA2,IFNB1,IFNG,IFNL1,IGF1,IGF2,IGFBP2,IHH,IL10,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL27,IL4,IL6,IL6ST,IL7,IRF1,IRF4,JAK3,KIAA0922,KLRK1,LAT,LAX1,LCK,LEP,LGALS3,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MLST8,MTOR,MYB,NCK1,NCK2,NCKAP1L,NKAP,NLRP3,NOD2,NR4A3,PAG1,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PPARA,PRELID1,PRKAR1A,PRKCQ,PRKCZ,PRNP,PRR5,PTPN11,PTPN2,PTPN22,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RC3H1,RICTOR,RIPK3,SART1,SFTPD,SHH,SIRPG,SIT1,SOCS5,SOD1,SPINK5,SRC,TESPA1,TGFBR2,THY1,TIGIT,TMIGD2,TNFRSF14,TNFRSF21,TNFSF11,TNFSF18,TNFSF4,TRAF2,TRAF6,VAV1,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZC3H8,ZP3,ZP4	Any process that modulates the frequency, rate or extent of leukocyte cell-cell adhesion.
GO:1903038	GO	BP	negative regulation of leukocyte cell-cell adhesion	ANXA1,ASS1,BMP4,BTN2A2,CCL21,CCL25,CCL28,CD274,CD300A,CDKN2A,CEBPB,CTLA4,CXCL12,DUSP3,FOXJ1,FOXP3,GLI3,GLMN,HAVCR2,HFE,HLA-DRB1,HLA-G,HMGB1,IFNA2,IFNB1,IFNL1,IHH,IL10,IRF1,JAK3,KIAA0922,LAX1,LGALS3,LGALS9,LILRB1,LILRB2,PDCD1LG2,PPARA,PRKAR1A,PRNP,PTPN2,PTPN22,RC3H1,SFTPD,SOCS5,TIGIT,TNFRSF21,TNFSF4,XCL1,ZC3H8	Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte cell-cell adhesion.
GO:1903039	GO	BP	positive regulation of leukocyte cell-cell adhesion	ADAM8,AGER,AIF1,AKT1,ANXA1,BTLA,CARD11,CAV1,CCL19,CCL2,CCL21,CCL5,CCR2,CD1D,CD24,CD247,CD274,CD276,CD28,CD3D,CD3E,CD3G,CD4,CD44,CD46,CD47,CD55,CD6,CD80,CD86,CDC42,CSK,CTLA4,DPP4,EBI3,FADD,FLOT2,FOXP3,FYN,GATA3,GLI2,GLI3,GRAP2,GRB2,HAS2,HHLA2,HLA-A,HLA-DMB,HLA-DPA1,HLA-DPB1,HLA-DQA1,HLA-DQA2,HLA-DQB1,HLA-DQB2,HLA-DRA,HLA-DRB1,HLA-DRB5,HLA-E,HLA-G,HMGB1,HSPD1,HSPH1,ICOS,ICOSLG,IFNG,IGF1,IGF2,IGFBP2,IHH,IL12A,IL12B,IL12RB1,IL18,IL1B,IL2,IL21,IL23A,IL23R,IL4,IL6,IL6ST,IL7,KLRK1,LCK,LEP,LGALS9,LILRB1,LILRB2,LYN,MALT1,MAP3K14,MAP3K7,MAP3K8,MAPKAP1,MLST8,MTOR,MYB,NCK1,NCK2,NCKAP1L,NKAP,NLRP3,NOD2,NR4A3,PAK1,PAK2,PAK3,PDCD1,PDCD1LG2,PDPK1,PIK3CA,PIK3R1,PNP,PRKCQ,PRKCZ,PRR5,PTPN11,PTPN6,PTPRC,PYCARD,RAC1,RARA,RASAL3,RICTOR,SART1,SHH,SIRPG,SOCS5,SRC,TESPA1,TGFBR2,THY1,TMIGD2,TNFRSF14,TNFSF11,TNFSF4,TRAF2,TRAF6,VAV1,VCAM1,VNN1,XBP1,XCL1,YES1,ZAP70,ZBTB1,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of leukocyte cell-cell adhesion.
GO:1903044	GO	BP	protein localization to membrane raft	ATP1B1,CAV1,CD24,FLOT1,FLOT2,RFTN1	A process in which a protein is transported to, or maintained in, a location within a membrane raft.
GO:1903046	GO	BP	meiotic cell cycle process	APITD1,ASZ1,ATM,BAG6,BOLL,BRDT,C11orf85,C15orf43,CCDC79,CCNA1,CCNB1IP1,CDK2,CYP26B1,DMC1,DPEP3,DUSP13,EREG,FANCM,FKBP6,FMN2,GOLGA2,HORMAD1,HORMAD2,HSPA2,ING2,KIAA0430,KLHDC3,M1AP,MEI4,MEIKIN,MEIOB,MLH3,MOS,MRE11A,MSH4,MSH6,P3H4,PIM2,PLD6,PRDM9,RAD1,RAD21,RAD50,RAD51,RAD51B,RAD51D,RAD54B,RAD54L,REC8,RNF212,SGOL1,SMC1A,SMC3,SPDYA,SPIRE1,SPIRE2,STAG3,STRA13,SYCE1,SYCE2,SYCE3,SYCP1,SYCP2,SYCP3,TDRD12,TDRD9,TDRKH,TEX11,TEX14,TEX40,TOP3A,TRIP13,TUBG1,WEE2,XRCC2,ZFP42,ZW10	A process that is part of the meiotic cell cycle.
GO:1903051	GO	BP	negative regulation of proteolysis involved in cellular protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,ATRAID,BAG5,BAG6,BUB1,BUB1B,BUB3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN2A,CENPF,CSNK2A1,CSNK2A2,DAB2IP,FHIT,GABARAPL2,GIPC1,HFE,HSP90AB1,KLHL22,MAD1L1,MAD2L1,MAD2L2,N4BP1,NELL1,PANO1,PARK7,PDCL3,PLK1,PML,PRKCG,PSMF1,SDCBP,SVIP,TAF9,TERF1,TEX14,TLK2,TPR,TRIM39,TTK,UBE2C,UBE2D1,UBE2E1,UBXN1,USP14,USP44,WAC,ZNF207	Any process that stops, prevents or reduces the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.
GO:1903052	GO	BP	positive regulation of proteolysis involved in cellular protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ATPIF1,AXIN1,BCAP31,BTRC,CAV1,CAV3,CBFA2T3,CCDC22,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CEBPA,CLU,CSNK1A1,CSNK1D,CSNK1E,CTSC,CUL1,CUL3,DAB2,DAB2IP,DDRGK1,DLGAP5,DNAJB2,DVL1,ECSCR,ESPL1,FBXO5,FBXW7,FZR1,GBA,GNB2L1,GSK3B,HERPUD1,HSPBP1,KCNE2,KEAP1,LRRK2,MDM2,NFE2L2,NKD2,NSMCE2,NUB1,OSBPL7,PARK2,PIAS1,PLK1,PLK3,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTK2,RB1,RCHY1,RFWD2,RNF139,RPS27A,SGTA,SIRT2,SKP1,SMAD7,SMC5,SMURF1,SOCS5,STUB1,SUMO1,SUMO2,TAF1,TRIB1,TRIB2,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBQLN1,UBQLN2,USP5,VCP,XBP1	Any process that activates or increases the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.
GO:1903053	GO	BP	regulation of extracellular matrix organization	AGT,CHADL,CLASP1,CLASP2,CST3,DAG1,DDR1,DDR2,DPP4,FAP,FGFR4,FSCN1,GPX1,HSPA8,MFI2,NOTCH1,PARK7,PHLDB1,PHLDB2,RGCC,SMAD3,TGFB1	Any process that modulates the frequency, rate or extent of extracellular matrix organization.
GO:1903054	GO	BP	negative regulation of extracellular matrix organization	CHADL,CST3,DPP4,FAP,HSPA8,TGFB1	Any process that stops, prevents or reduces the frequency, rate or extent of extracellular matrix organization.
GO:1903055	GO	BP	positive regulation of extracellular matrix organization	CLASP1,CLASP2,DAG1,DDR2,FSCN1,GPX1,MFI2,PHLDB1,PHLDB2,RGCC,SMAD3,TGFB1	Any process that activates or increases the frequency, rate or extent of extracellular matrix organization.
GO:1903069	GO	BP	regulation of ER-associated ubiquitin-dependent protein catabolic process	BCAP31,CAV1,HERPUD1,NFE2L2,SGTA,SVIP,UBQLN1,UBQLN2,USP14,XBP1	Any process that modulates the frequency, rate or extent of ER-associated ubiquitin-dependent protein catabolic process.
GO:1903071	GO	BP	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BCAP31,CAV1,HERPUD1,NFE2L2,SGTA,UBQLN1,UBQLN2,XBP1	Any process that activates or increases the frequency, rate or extent of ER-associated ubiquitin-dependent protein catabolic process.
GO:1903076	GO	BP	regulation of protein localization to plasma membrane	ACSL3,AGR2,AKT1,ANXA13,AP2M1,APPL1,AR,ARF6,ARHGEF16,BCL2L1,CIB1,CLIP3,CLTC,CNST,CSK,DAB2,DLG1,DPP10,EPHA2,GBP1,GNB2L1,GOPC,GPER1,IFNG,ITGA3,ITGB1,KIF5B,LDLRAP1,LRRC15,LZTFL1,NKD2,NRXN1,NUMB,PDPK1,PID1,PIK3R1,PKDCC,PLS1,PPFIA1,PPP2R5A,PRKCI,RAMP3,RANGRF,RHOG,RHOQ,SORBS1,SPTBN1,STX3,STX4,STX7,STX8,TGFB1,TMBIM1,TMEM59,TREM2,VAMP8,VPS4A,VTI1B,WNK3	Any process that modulates the frequency, rate or extent of protein localization to plasma membrane.
GO:1903077	GO	BP	negative regulation of protein localization to plasma membrane	ANXA13,AP2M1,BCL2L1,CLTC,CSK,DAB2,GBP1,GOPC,LRRC15,LZTFL1,NUMB,PID1,PKDCC,PPFIA1,PPP2R5A,RHOQ,TGFB1,TMBIM1,TMEM59	Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
GO:1903078	GO	BP	positive regulation of protein localization to plasma membrane	ACSL3,AGR2,AKT1,ANXA13,ARF6,ARHGEF16,CIB1,CLIP3,CNST,DLG1,DPP10,EPHA2,GNB2L1,GPER1,IFNG,ITGA3,ITGB1,KIF5B,NKD2,NRXN1,PDPK1,PIK3R1,PLS1,PRKCI,RAMP3,RANGRF,RHOG,SORBS1,SPTBN1,STX3,STX4,TREM2,WNK3	Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane.
GO:1903115	GO	BP	regulation of actin filament-based movement	ANK2,ATP2A2,CAMK2D,CAV1,CTNNA3,DSC2,DSG2,DSP,GJA5,JUP,MYBPC3,MYLK2,NOS1AP,PDE4B,PDE4D,PKP2,PLN,RNF207,RYR2,SCN5A,SRI,STC1,TNNC1	Any process that modulates the frequency, rate or extent of actin filament-based movement.
GO:1903140	GO	BP	regulation of establishment of endothelial barrier	CDH5,CLDN5,IKBKB,IL1B,PROC,ROCK1,ROCK2,S1PR2,S1PR3,TNF,TNFRSF1A	Any process that modulates the frequency, rate or extent of establishment of endothelial barrier.
GO:1903146	GO	BP	regulation of mitophagy	ACTL6A,AMBRA1,ATG7,BECN1,CSNK2A2,CTSK,DNM1L,FBXW7,FZD5,GSK3A,HAX1,HTRA2,KAT2A,MAP1LC3B,MTOR,PARK2,PARK7,PINK1,POLR3A,RPL28,RUVBL1,SLC17A9,SREBF1,SREBF2,U2AF1,U2AF2,USP36,VDAC1,WBP11,WDR75,ZBTB17,ZDHHC8	Any process that modulates the frequency, rate or extent of mitochondrion degradation (mitophagy).
GO:1903169	GO	BP	regulation of calcium ion transmembrane transport	ADRA2A,AHNAK,AKAP6,ANK2,ASPH,ATP1A2,ATP1B1,CACNA1C,CACNB4,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CAV3,CEMIP,CLIC2,CRACR2A,CRHR1,CXCL10,CXCL11,CXCL9,CXCR3,DIAPH1,DMD,DRD1,DRD2,DRD4,F2,F2R,F2RL3,FKBP1A,FKBP1B,GNB5,GPER1,GSTM2,GSTO1,HAP1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,LACRT,LRRK2,NOS1,NOS1AP,NPPA,NPSR1,PDE4B,PDE4D,PDPK1,PKD2,PLCG1,PLN,PRKACA,PTK2B,RYR2,SLC8A1,SLC9A1,SLN,SNCA,SRI,STIM1,STIM2,THY1,TLR9,TMEM110,TRDN,TRPC1,UBQLN1,XCL1	Any process that modulates the frequency, rate or extent of calcium ion transmembrane transport.
GO:1903201	GO	BP	regulation of oxidative stress-induced cell death	AKT1,ATF4,BAG5,FBXW7,GNB2L1,GPR37,GPR37L1,HDAC6,HGF,HIF1A,HSPB1,HTRA2,INS,LRRK2,MAPK7,MCL1,MET,MMP3,NFE2L2,NOL3,NONO,NR4A3,P4HB,PARK2,PARK7,PINK1,PYCR1,SFPQ,SIRT1,SOD1,SOD2,STK26,TRAP1,TXN,UBQLN1,VNN1	Any process that modulates the frequency, rate or extent of oxidative stress-induced cell death.
GO:1903202	GO	BP	negative regulation of oxidative stress-induced cell death	AKT1,ATF4,BAG5,GNB2L1,GPR37,GPR37L1,HGF,HIF1A,HSPB1,HTRA2,INS,LRRK2,MAPK7,MET,NFE2L2,NOL3,NONO,NR4A3,PARK2,PARK7,PINK1,PYCR1,SIRT1,SOD2,TRAP1,TXN,VNN1	Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death.
GO:1903203	GO	BP	regulation of oxidative stress-induced neuron death	ATF4,FBXW7,GNB2L1,HIF1A,MCL1,NONO,NR4A3,PARK2,PARK7,PINK1	Any process that modulates the frequency, rate or extent of oxidative stress-induced neuron death.
GO:1903204	GO	BP	negative regulation of oxidative stress-induced neuron death	ATF4,GNB2L1,HIF1A,NONO,NR4A3,PARK2,PARK7,PINK1	Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron death.
GO:1903205	GO	BP	regulation of hydrogen peroxide-induced cell death	GNB2L1,GPR37,GPR37L1,HDAC6,HGF,LRRK2,MET,NFE2L2,NR4A3,PARK7,PINK1,PYCR1,STK26,TRAP1,TXN	Any process that modulates the frequency, rate or extent of hydrogen peroxide-induced cell death.
GO:1903206	GO	BP	negative regulation of hydrogen peroxide-induced cell death	GNB2L1,GPR37,GPR37L1,HGF,LRRK2,MET,NFE2L2,NR4A3,PARK7,PINK1,PYCR1,TRAP1,TXN	Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced cell death.
GO:1903209	GO	BP	positive regulation of oxidative stress-induced cell death	FBXW7,HDAC6,MCL1,MMP3,SFPQ,SOD1	Any process that activates or increases the frequency, rate or extent of oxidative stress-induced cell death.
GO:1903214	GO	BP	regulation of protein targeting to mitochondrion	ABLIM3,ACSM6,ACTL6A,ARIH2,ATG13,ATPIF1,BAG4,BAP1,CDKL2,CDKN2A,CSNK2A2,CTSK,CYB5R1,DPCR1,DPH6,DTWD2,ELMOD1,EPT1,FAM20B,FBXW7,FZD5,GLS2,GPHA2,GPR26,GSK3A,HAX1,HES1,HHAT,HNMT,HPS4,HSPA1L,HTRA2,HUWE1,IFNL3,IL9R,ITGAX,KAT2A,KCNN3,LEPROT,LRRC46,LRRK2,MICALL2,MIS18A,MRGPRE,MYBPC1,NBPF3,NKAP,NMUR1,NPEPPS,NRG1,OR13C4,OSCP1,PARK2,PARL,PDCD5,PEMT,PINK1,PLAGL2,POLR3A,PRELID3A,PSMB7,PSMD8,RAC2,RHOU,RNASE2,RNF31,RPL28,RUVBL1,SAE1,SH3GLB1,SIAH3,SLC17A9,SNIP1,SREBF1,SREBF2,STARD7,TDRD12,TOMM7,TSGA13,U2AF1,U2AF2,UBE2D3,UBE2J2,UBE2L3,UBL4B,UBL5,UGCG,USP36,VPS11,WBP11,WDR46,WDR75,ZBED3,ZBTB17,ZDHHC8	Any process that modulates the frequency, rate or extent of protein targeting to mitochondrion.
GO:1903299	GO	BP	regulation of hexokinase activity	BAD,FOXA2,GCKR,PARK2,TIGAR	Any process that modulates the frequency, rate or extent of hexokinase activity.
GO:1903305	GO	BP	regulation of regulated secretory pathway	ADRA2A,AP1G1,C12orf4,CACNA1H,CCR2,CD300A,CD84,DOC2A,DOC2B,F2RL1,FAM170B,FES,FGR,GAB2,GLRA1,IQCF1,KCNB1,LAMP1,LGALS9,LRRK2,LYN,NLGN1,PLCB1,RAB15,RAB27A,RAB3A,RAB3D,RAB3GAP1,RAB5A,REST,RIMS3,RIMS4,SCAMP5,SEPT5,SNX4,SPINK13,STX1A,STX1B,STX4,STXBP1,STXBP2,STXBP3,SYK,SYN1,SYT1,TMEM27,TRPV6,UNC13B,UNC13D,VAMP7,VAMP8,ZP3,ZP4	Any process that modulates the frequency, rate or extent of regulated secretory pathway.
GO:1903306	GO	BP	negative regulation of regulated secretory pathway	ADRA2A,CCR2,CD300A,CD84,LGALS9,REST,SPINK13,STXBP3	Any process that stops, prevents or reduces the frequency, rate or extent of regulated secretory pathway.
GO:1903307	GO	BP	positive regulation of regulated secretory pathway	AP1G1,CACNA1H,DOC2B,F2RL1,FAM170B,FGR,GAB2,GLRA1,IQCF1,KCNB1,LAMP1,NLGN1,PLCB1,RAB15,RAB27A,RAB3A,RAB3D,SCAMP5,SNX4,STX1A,STX4,TMEM27,UNC13B,UNC13D,VAMP7,VAMP8,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of regulated secretory pathway.
GO:1903308	GO	BP	regulation of chromatin modification	AICDA,APOBEC1,ARRB1,ASF1A,AUTS2,BCOR,BRCA1,BRD7,C6orf89,CAMK2D,CDK9,CHEK1,CHTOP,CTBP1,CTCFL,CTNNB1,CTR9,DNMT1,DNMT3B,EID1,FLCN,FOXP3,H2AFY,HIST1H1B,HMGA1,IL1B,IWS1,JARID2,KDM1A,KDM5A,KMT2A,LIF,MAPK3,MAPK8,MIER1,MTF2,MTHFR,MUC1,MYB,MYOCD,NIPBL,NOC2L,NOS1,NSD1,OGT,OTUB1,PAF1,PAXIP1,PHF1,PHF19,PHF2,PHF8,PIH1D1,PML,POU5F1,PPARGC1A,PRDM12,PRKD1,PRKD2,RNF20,RNF40,RPS6KA4,RPS6KA5,RUVBL2,SART3,SET,SIN3A,SIRT1,SMAD4,SMARCB1,SNCA,SNW1,SPI1,SUPT6H,TAF7,TET1,TPR,TRIP12,TWIST1,UBE2N,UBR5,USP17L2,VEGFA,WBP2,WDR61,XBP1	Any process that modulates the frequency, rate or extent of chromatin modification.
GO:1903309	GO	BP	negative regulation of chromatin modification	AICDA,APOBEC1,ASF1A,BCOR,BRCA1,CTBP1,DNMT1,DNMT3B,FOXP3,H2AFY,HMGA1,JARID2,KDM5A,MTF2,NOC2L,OTUB1,PHF1,PHF2,PHF8,PIH1D1,SET,SIN3A,SIRT1,SMARCB1,SNCA,SPI1,SUPT6H,TAF7,TET1,TRIP12,TWIST1,UBR5,USP17L2	Any process that stops, prevents or reduces the frequency, rate or extent of chromatin modification.
GO:1903310	GO	BP	positive regulation of chromatin modification	ARRB1,AUTS2,BRCA1,BRD7,C6orf89,CDK9,CHTOP,CTBP1,CTNNB1,CTR9,DNMT1,DNMT3B,FOXP3,HIST1H1B,IL1B,JARID2,KDM1A,KMT2A,LIF,MAPK3,MIER1,MTF2,MUC1,MYB,NIPBL,NOS1,OGT,PAF1,PAXIP1,PHF1,PHF19,PIH1D1,PML,PPARGC1A,PRDM12,PRKD1,PRKD2,RNF20,RNF40,RPS6KA4,RPS6KA5,RUVBL2,SART3,SIN3A,SIRT1,SMAD4,SMARCB1,SNW1,TET1,TPR,UBE2N,VEGFA,WBP2,WDR61,XBP1	Any process that activates or increases the frequency, rate or extent of chromatin modification.
GO:1903311	GO	BP	regulation of mRNA metabolic process	ACIN1,AGO2,AHCYL1,BARD1,BTG2,C1QBP,CCNT1,CDC73,CDK11A,CDK11B,CDK9,CELF3,CELF4,CELF6,CNOT1,CNOT7,CNOT8,CPEB3,CPSF4,CTR9,CWC22,DDX5,DHX34,GTPBP1,HSPA1A,IWS1,JMJD6,LEO1,MAGOH,NANOS1,NANOS2,NANOS3,NBAS,NCBP1,NCBP2,NELFE,NSRP1,PABPC1,PABPN1,PAF1,PAPOLA,PNPT1,PTBP1,PTCD2,RBFOX2,RBM11,RBM15B,RBM25,RBM4,RBM5,RBM8A,RBMX,RBMY1A1,RNF20,RNF40,RNPS1,SAP18,SFSWAP,SNW1,SRPK1,SRPK2,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,SUPT5H,SUPT6H,THRAP3,TIA1,TMBIM6,TNRC6B,TNRC6C,TOB1,TRA2B,U2AF2,WTAP,ZC3H12A,ZC3HAV1,ZFP36,ZFP36L2	Any process that modulates the frequency, rate or extent of mRNA metabolic process.
GO:1903312	GO	BP	negative regulation of mRNA metabolic process	ACIN1,BARD1,C1QBP,CCNT1,CDK9,CTR9,DHX34,NBAS,NELFE,PABPC1,PTBP1,RBMX,RNF20,RNF40,RNPS1,SAP18,SFSWAP,SRSF10,SRSF12,SRSF4,SRSF6,SRSF7,SRSF9,SUPT5H,TMBIM6,TOB1,U2AF2	Any process that stops, prevents or reduces the frequency, rate or extent of mRNA metabolic process.
GO:1903313	GO	BP	positive regulation of mRNA metabolic process	AGO2,BTG2,CDC73,CELF3,CELF4,CNOT1,CNOT7,CNOT8,CPEB3,GTPBP1,HSPA1A,LEO1,NANOS1,NANOS2,NANOS3,NCBP1,NCBP2,PABPC1,PAF1,PNPT1,RBMX,SNW1,THRAP3,TNRC6B,TNRC6C,TOB1,TRA2B,ZC3H12A,ZC3HAV1,ZFP36,ZFP36L2	Any process that activates or increases the frequency, rate or extent of mRNA metabolic process.
GO:1903317	GO	BP	regulation of protein maturation	A2M,ADAM8,ASTL,BCL2L12,C19orf80,C1QBP,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CCBE1,CD46,CD55,CD59,CFB,CFH,CFI,CFP,CHAC1,CLEC3B,CR1,F12,GAS1,GSN,HPN,KLKB1,LRRK2,MAGEA3,MASP1,MFI2,MYH9,NKD2,NOL3,PHB,PROS1,RHBDD1,RNF139,SERPINE1,SERPINE2,SERPINF2,SERPING1,SNX12,SUSD4,TFR2,THBS1,TMEM59,USP17L2,VTN	Any process that modulates the frequency, rate or extent of protein maturation.
GO:1903319	GO	BP	positive regulation of protein maturation	ADAM8,ASTL,C19orf80,CCBE1,CLEC3B,F12,GSN,HPN,KLKB1,MFI2,MYH9,NKD2,PHB,RHBDD1,TFR2	Any process that activates or increases the frequency, rate or extent of protein maturation.
GO:1903321	GO	BP	negative regulation of protein modification by small protein conjugation or removal	ABL1,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ARRB1,ARRB2,ATM,BAG5,BUB1,BUB1B,BUB3,CAPN3,CAV1,CDC16,CDC20,CDC23,CDC26,CDC27,CDKN2A,CENPF,CHP1,CRY1,CTNNB1,DNAJA1,DNAJB2,FBXO5,FZR1,GLMN,GNL3L,GTPBP4,HDAC8,HFE,HSPA1A,HSPA1B,ISG15,KLHL22,LIMK1,MAD1L1,MAD2L1,MAD2L2,MAGEA2,N4BP1,NXN,OGT,OTUB1,PARK7,PARP10,PDCL3,PER2,PIAS3,PINX1,PLK1,PML,PRKCG,PRMT3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSMF1,RPS27A,RPS3,SENP2,SMAD7,SOX4,SPOPL,SVBP,TERF1,TEX14,TNFAIP3,TPR,TRIM21,TRIM39,TRIP12,TTK,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBR5,UBXN1,UFL1,USP4,USP44,VPS28,ZNF207	Any process that stops, prevents or reduces the frequency, rate or extent of protein modification by small protein conjugation or removal.
GO:1903322	GO	BP	positive regulation of protein modification by small protein conjugation or removal	ADRB2,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANGPT1,APITD1,ARRB2,AVPR2,AXIN1,BCL10,BIRC2,BIRC3,BMI1,BRCA1,BTRC,CAV1,CAV3,CCDC22,CCNB1,CDC14B,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDK5RAP3,CDK9,CDKN2A,CLU,COMMD1,CTR9,CUL1,DERL1,DNAJA3,DNAJB2,FANCI,FBXO4,FBXO5,FBXW7,FKBP1A,FZR1,HAMP,HDAC4,HSPBP1,KDM1A,LRRK2,MAGEA2,MAGEC2,MALT1,MTA1,MUL1,NDFIP1,NDFIP2,NDNL2,PARK2,PAXIP1,PHF23,PIAS1,PIAS3,PIAS4,PIN1,PINK1,PLK1,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTK2,PTPN22,PTTG1IP,RASD2,RASSF1,RCHY1,RIPK2,RNF139,RNF20,RNF40,RPS27A,RWDD3,SART3,SENP2,SEPT4,SKP1,SMAD7,SMURF1,SPHK1,SPRTN,STRA13,STUB1,TBC1D7,TOPORS,TRAF6,TRIB3,TSPYL5,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE2L3,UBE2N,UBE2S,UBE3A,UBQLN1,VCP,WFS1,XIAP	Any process that activates or increases the frequency, rate or extent of protein modification by small protein conjugation or removal.
GO:1903358	GO	BP	regulation of Golgi organization	MAP2K1,MAP2K2,MAPK1,MAPK3,RAB33B,STX18,STX5,USP6NL	Any process that modulates the frequency, rate or extent of Golgi organization.
GO:1903363	GO	BP	negative regulation of cellular protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,ANXA2,APC,ATM,ATRAID,BAG5,BAG6,BUB1,BUB1B,BUB3,CCAR2,CDC16,CDC20,CDC23,CDC26,CDC27,CDK5RAP3,CDKN2A,CENPF,CSNK2A1,CSNK2A2,DAB2IP,FHIT,FURIN,GABARAPL2,GIPC1,HFE,HSP90AB1,KLHL22,MAD1L1,MAD2L1,MAD2L2,N4BP1,NELL1,PANO1,PARK7,PDCL3,PLK1,PML,PRKCG,PSMF1,RGP1,RIC1,SDCBP,SVIP,TAF9,TERF1,TEX14,TLK2,TPR,TRIM39,TTK,UBE2C,UBE2D1,UBE2E1,UBXN1,USP14,USP44,WAC,ZNF207	Any process that stops, prevents or reduces the frequency, rate or extent of cellular protein catabolic process.
GO:1903364	GO	BP	positive regulation of cellular protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APOE,ATPIF1,AXIN1,BCAP31,BTRC,CAV1,CAV3,CBFA2T3,CCDC22,CCNB1,CD81,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CEBPA,CLU,CSNK1A1,CSNK1D,CSNK1E,CTSC,CUL1,CUL3,DAB2,DAB2IP,DACT1,DDRGK1,DLGAP5,DNAJB2,DVL1,ECSCR,ESPL1,EZR,FBXO5,FBXW7,FZR1,GBA,GNB2L1,GSK3B,HERPUD1,HSPBP1,KCNE2,KEAP1,LRRK2,MDM2,MSN,NFE2L2,NKD2,NSMCE2,NUB1,OSBPL7,PARK2,PCSK9,PIAS1,PLK1,PLK3,PRICKLE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTK2,PTTG1IP,RB1,RCHY1,RDX,RFWD2,RNF128,RNF139,RPS27A,SGTA,SIRT2,SKP1,SMAD7,SMC5,SMURF1,SOCS5,STUB1,SUMO1,SUMO2,TAF1,TRIB1,TRIB2,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBQLN1,UBQLN2,UQCC2,USP5,VCP,VPS11,XBP1	Any process that activates or increases the frequency, rate or extent of cellular protein catabolic process.
GO:1903376	GO	BP	regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	FBXW7,HIF1A,MCL1,NONO,PARK2,PARK7,PINK1	Any process that modulates the frequency, rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway.
GO:1903377	GO	BP	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	HIF1A,NONO,PARK2,PARK7,PINK1	Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway.
GO:1903391	GO	BP	regulation of adherens junction organization	ACVRL1,APOD,ARHGAP6,BCAS3,CLASP1,CLASP2,COL16A1,CORO1C,DAPK3,DLC1,DMTN,EFNA5,EPHA3,GPM6B,HRG,ITGB1BP1,KDR,LIMS1,MACF1,MYOC,PHLDB2,PPM1F,PTEN,PTK2,PTPN23,PTPRJ,RAC1,RCC2,RDX,ROCK1,ROCK2,S100A10,SFRP1,SLC9A1,SRC,TEK,THBS1,TSC1,VEGFA	Any process that modulates the frequency, rate or extent of adherens junction organization.
GO:1903392	GO	BP	negative regulation of adherens junction organization	ACVRL1,APOD,ARHGAP6,BCAS3,CLASP2,CORO1C,DLC1,DMTN,ITGB1BP1,PHLDB2,PTEN,RCC2,RDX,SRC,THBS1	Any process that stops, prevents or reduces the frequency, rate or extent of adherens junction organization.
GO:1903393	GO	BP	positive regulation of adherens junction organization	COL16A1,HRG,KDR,LIMS1,MYOC,PPM1F,PTPN23,PTPRJ,RAC1,ROCK1,S100A10,SFRP1,TEK,TSC1,VEGFA	Any process that activates or increases the frequency, rate or extent of adherens junction organization.
GO:1903409	GO	BP	reactive oxygen species biosynthetic process	AKT1,ARG2,CYBA,CYP1B1,DDAH2,DUOX1,GBF1,GCH1,GCHFR,MAOB,NOS1,NOS2,NOS3,NQO1,SOD1,SPR	The chemical reactions and pathways resulting in the formation of reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen.
GO:1903421	GO	BP	regulation of synaptic vesicle recycling	CDK5,NLGN1,SNCA,SYNJ1,TOR1A	Any process that modulates the frequency, rate or extent of synaptic vesicle recycling.
GO:1903426	GO	BP	regulation of reactive oxygen species biosynthetic process	AGTR2,AGXT2,AKT1,ASS1,ATP2B4,CAV1,CD34,CLU,CYBA,DDAH1,DDAH2,EDN1,EGFR,ESR1,GLA,HBB,HSP90AA1,HSP90AB1,IFNG,IL1B,INS,INSR,KLF4,MPV17L,NOS1AP,OPRM1,P2RX4,PKD2,PTGIS,PTGS2,RAB27A,SLC18A2,SLC25A33,SNCA,TNF,TRAP1,ZC3H12A,ZNF205	Any process that modulates the frequency, rate or extent of reactive oxygen species biosynthetic process.
GO:1903427	GO	BP	negative regulation of reactive oxygen species biosynthetic process	ATP2B4,CAV1,CD34,GLA,MPV17L,OPRM1,PTGIS,SLC18A2,TRAP1,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species biosynthetic process.
GO:1903428	GO	BP	positive regulation of reactive oxygen species biosynthetic process	AGTR2,AGXT2,AKT1,ASS1,CLU,CYBA,DDAH1,DDAH2,EDN1,EGFR,ESR1,HBB,HSP90AA1,HSP90AB1,IFNG,IL1B,INS,INSR,KLF4,NOS1AP,OPRM1,P2RX4,PKD2,PTGS2,RAB27A,TNF,ZNF205	Any process that activates or increases the frequency, rate or extent of reactive oxygen species biosynthetic process.
GO:1903429	GO	BP	regulation of cell maturation	EDNRB,GAL,LRRK2,NPPC,SIRT2,WEE2	Any process that modulates the frequency, rate or extent of cell maturation.
GO:1903432	GO	BP	regulation of TORC1 signaling	ATM,PIH1D1,RNF152,RRAGA,STK11,TELO2	Any process that modulates the frequency, rate or extent of TORC1 signaling.
GO:1903509	GO	BP	liposaccharide metabolic process	A4GALT,ALDH5A1,ALG1,ARSA,ARSB,ARSD,ARSE,ARSF,ARSG,ARSH,ARSI,ARSJ,ARSK,ASAH1,B3GNT5,B4GALNT1,CERK,CLN3,CLN6,CPTP,CTSA,DPM1,DPM2,DPM3,ENPP7,GALC,GBA,GBA2,GBA3,GBGT1,GLA,GLB1,GLTP,GM2A,GPAA1,GPLD1,HEXA,HEXB,LARGE,MPPE1,NAGA,NANS,NEU1,NEU2,NEU3,NEU4,PGAP1,PGAP2,PGAP3,PIGA,PIGB,PIGC,PIGF,PIGG,PIGH,PIGK,PIGL,PIGM,PIGN,PIGO,PIGP,PIGQ,PIGS,PIGT,PIGU,PIGV,PIGW,PIGX,PIGY,PIGZ,PLAUR,PNLIPRP2,PSAP,PYURF,SMPD1,SMPD2,SMPD3,SMPD4,ST3GAL5,ST3GAL6,ST6GALNAC3,ST6GALNAC4,ST6GALNAC5,ST6GALNAC6,ST8SIA1,ST8SIA2,ST8SIA3,ST8SIA4,ST8SIA5,ST8SIA6,STS,SUMF1,UGCG,UGT8	The chemical reactions and pathways involving liposaccharide.
GO:1903510	GO	BP	mucopolysaccharide metabolic process	ABCC5,ACAN,AGRN,ANGPT1,ARSB,B3GALT6,B3GAT1,B3GAT2,B3GAT3,B3GNT2,B3GNT3,B3GNT4,B3GNT7,B4GALT1,B4GALT2,B4GALT3,B4GALT4,B4GALT5,B4GALT6,B4GALT7,B4GAT1,BCAN,BGN,CD44,CEMIP,CHP1,CHPF,CHPF2,CHST1,CHST11,CHST12,CHST13,CHST14,CHST15,CHST2,CHST3,CHST5,CHST6,CHST7,CHST9,CHSY1,CHSY3,CSGALNACT1,CSGALNACT2,CSPG4,CSPG5,DCN,DSE,DSEL,FGF2,FMOD,GALNS,GLB1,GLCE,GNS,GPC1,GPC2,GPC3,GPC4,GPC5,GPC6,GUSB,GXYLT1,HAS1,HAS2,HAS3,HEXA,HEXB,HMMR,HSPG2,HYAL1,HYAL2,HYAL3,IDS,IDUA,IL1B,KERA,LUM,LYVE1,NCAN,NDNF,OGN,OMD,PRELP,SDC1,SDC2,SDC3,SDC4,SLC35D2,SLC9A1,ST3GAL1,ST3GAL2,ST3GAL3,ST3GAL4,ST3GAL6,STAB2,TGFB1,UST,VCAN	The chemical reactions and pathways involving mucopolysaccharide.
GO:1903513	GO	BP	endoplasmic reticulum to cytosol transport	AUP1,CCL3,CCR5,DERL1,DERL2,FAF2,HERPUD1,HM13,HSP90B1,NOL3,NPLOC4,RHBDD1,RYR1,RYR2,SEC61B,SEL1L,SYVN1,TMEM129,TRDN,UFD1L,VCP,VIMP	The directed movement of substances from endoplasmic reticulum to cytosol.
GO:1903523	GO	BP	negative regulation of blood circulation	ADM,ADRBK1,AGTR2,BMPR2,CRP,DOCK4,DOCK5,F2R,FKBP1B,INS,PDE4D,PIK3CG,PLN,RNF207,SMTNL1,SPTBN4,SPX,SRI,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of blood circulation.
GO:1903524	GO	BP	positive regulation of blood circulation	ADRA1A,AGTR2,ATP2A2,CALCA,CAV1,CPS1,EDN1,EDN2,EDN3,EPHX2,F2R,F2RL1,FGA,FGB,FGG,GPER1,GSK3A,HMOX1,HRC,INS,KCNQ1,NKX2-5,NOS1,NOS1AP,NOS3,NPPA,OR51E2,PDE4D,RGS2,RNF207,RYR2,SCN3B,SCPEP1,SMTNL1,TGFB2,TPM1	Any process that activates or increases the frequency, rate or extent of blood circulation.
GO:1903531	GO	BP	negative regulation of secretion by cell	ADRA2A,ADRA2B,ADRA2C,ANXA1,ANXA4,APOA1,APOA2,BMP8A,BTN2A2,C1QTNF3,C5AR2,CCR2,CD300A,CD34,CD84,CHGA,CIDEA,CRHBP,DPH3,DRD2,DRD3,DRD4,ERP29,EZR,F2R,F2RL1,FAM3D,FBLN1,FFAR4,FGF23,FN1,FOXP3,GAS6,GBP1,GRM7,HTR1B,IFNA2,IL10,IL11,IL1B,IL1RAPL1,IL36RN,INHA,INHBA,INHBB,INS,IRS1,KCNB1,KCNJ11,LGALS9,LGR4,LIF,LILRB1,NLRP12,NLRP3,NOV,NPVF,NR1H3,NR1H4,OPRM1,OSM,PARK2,PIM3,PSMD9,PTGER4,PTPN22,PYDC2,RAB11FIP1,RAB11FIP3,RAB11FIP5,RAB33B,REST,RGCC,RHBDF1,RHBDF2,RSAD2,SERGEF,SFRP1,SIRT4,SLC30A1,SNCA,SPINK13,SRGN,SSC5D,STXBP3,STXBP6,SYT11,TNF,TNFRSF21,TRIM27,VAMP3,VAMP8,VPS4B,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of secretion by cell.
GO:1903532	GO	BP	positive regulation of secretion by cell	ACHE,ADAM8,ADAM9,ADRBK1,AIM2,ALOX15B,ANG,ANKRD1,ANO1,AP1G1,ATP6AP1,BAD,BLK,BMP6,C1QTNF1,C1QTNF3,C5,CACNA1H,CADM1,CAMP,CAPN10,CARD8,CARTPT,CCL19,CCL3,CD2,CD244,CD274,CD34,CD58,CFTR,CHIA,CHMP2A,CHRNB2,CLASP1,CLASP2,CLEC6A,CLEC9A,CRH,CRTAM,CSF1R,DNM1L,DOC2B,DRD2,DTNBP1,EDN1,EDN3,EXOC1,EXPH5,EZR,F2R,F2RL1,FAM170B,FCN1,FFAR2,FGA,FGB,FGG,FGR,GAB2,GAL,GALR1,GATA3,GCK,GDNF,GHRH,GHRHR,GHRL,GLMN,GLRA1,GLUD1,GOLPH3,GOLPH3L,GPER1,GPLD1,HAVCR2,HCAR2,HFE,HGS,HLA-DRB1,HLA-E,HMGB1,HTR2B,HYAL2,IFNG,IGF1,IL10,IL1A,IL26,IL33,IL6,INHA,INHBA,INS,IQCF1,IRS2,ISL1,KCNB1,LAMP1,LGALS9,MAPK11,MAPK14,MCU,MIF,MYO18A,MYRIP,NKX3-1,NLGN1,NLGN2,NLRP1,NLRP10,NLRP12,NLRP2,NLRP3,NOD2,OR51E2,P2RX7,PAEP,PANX1,PDCD6IP,PLA2G1B,PLCB1,PPIA,PPID,PPP3CB,PRKCZ,PSMD9,PTGER4,PTPN22,PYCARD,PYDC1,RAB15,RAB27A,RAB27B,RAB2B,RAB3A,RAB3D,RAB3GAP1,RAB5A,RAB7A,RAB9A,RASGRP1,RASL10B,RBP4,RFX6,RGCC,SAA1,SCAMP5,SDC1,SDC4,SDCBP,SLC30A8,SMPD3,SNF8,SNX4,SOX11,SOX4,SPTBN1,STAM,STX1A,STX1B,STX4,STXBP5,SYTL4,TCF7L2,TFR2,TGFB1,TGFB2,TGFB3,TMEM27,TNF,TNFRSF4,TNFSF11,TNFSF4,TRIM16,TRIM6,TSG101,TWIST1,UNC13B,UNC13D,VAMP7,VAMP8,VPS4A,VPS4B,WLS,WNT5A,XBP1,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of secretion by cell.
GO:1903543	GO	BP	positive regulation of exosomal secretion	CHMP2A,HGS,IFNG,PDCD6IP,RAB7A,SDC1,SDC4,SDCBP,SMPD3,SNF8,STAM,TSG101,VPS4A,VPS4B	Any process that activates or increases the frequency, rate or extent of exosomal secretion.
GO:1903551	GO	BP	regulation of extracellular exosome assembly	PDCD6IP,SDC1,SDC4,SDCBP,STAM,TSG101	Any process that modulates the frequency, rate or extent of extracellular vesicular exosome assembly.
GO:1903555	GO	BP	regulation of tumor necrosis factor superfamily cytokine production	ADAM8,ADIPOQ,ARFGEF2,ARHGEF2,AZU1,BPI,C5AR2,CACTIN,CCL19,CCL3,CCR2,CD14,CD2,CD274,CD34,CD86,CHRNA7,CIDEA,CLU,CYBA,FADD,FOXP1,GAS6,GHRL,GHSR,GSTP1,HAVCR2,HLA-E,HSPB1,IFNG,IL10,IL12B,IL23A,IRAK3,ISL1,JAK2,LBP,LGALS9,LILRB1,LTF,LY96,MAPKAPK2,MAVS,MC1R,NFKBIL1,NLRC3,NOD2,NR1H4,ORM1,PF4,POMC,PTPN22,PYCARD,RARA,RASGRP1,RIPK1,SLAMF1,SPN,THBS1,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR9,TNFAIP3,TNFRSF8,TRIM27,TWIST1,VIMP,ZC3H12A,ZFP36	Any process that modulates the frequency, rate or extent of tumor necrosis factor superfamily cytokine production.
GO:1903556	GO	BP	negative regulation of tumor necrosis factor superfamily cytokine production	ADIPOQ,BPI,C5AR2,CACTIN,CD274,CD34,CHRNA7,CIDEA,GAS6,GHRL,GHSR,GSTP1,HAVCR2,IL10,IRAK3,LBP,LGALS9,LILRB1,LTF,MC1R,NFKBIL1,NLRC3,NR1H4,ORM1,POMC,PTPN22,RARA,SLAMF1,TLR4,TNFAIP3,TRIM27,VIMP,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor superfamily cytokine production.
GO:1903557	GO	BP	positive regulation of tumor necrosis factor superfamily cytokine production	ADAM8,ARFGEF2,ARHGEF2,AZU1,CCL19,CCL3,CCR2,CD14,CD2,CD86,CLU,CYBA,FADD,HAVCR2,HLA-E,HSPB1,IFNG,IL12B,IL23A,ISL1,JAK2,LBP,LGALS9,LY96,MAVS,NOD2,PF4,PYCARD,RASGRP1,RIPK1,SPN,THBS1,TIRAP,TLR1,TLR2,TLR3,TLR4,TLR9,TNFRSF8,TWIST1	Any process that activates or increases the frequency, rate or extent of tumor necrosis factor superfamily cytokine production.
GO:1903573	GO	BP	negative regulation of response to endoplasmic reticulum stress	BFAR,CREB3,CREB3L1,CREBRF,DERL2,DERL3,DNAJC3,ERLEC1,GNB2L1,HERPUD1,HSPA1A,LRRK2,MAGEA3,NCK1,NCK2,OPA1,OS9,PARK2,PARK7,PPP1R15A,PPP1R15B,PTPN1,SVIP,SYVN1,TMBIM6,TXNDC12,UBAC2,UBE2G2,UBE2J1,UBXN1,USP14,USP25,VIMP,WFS1,XBP1,YOD1	Any process that stops, prevents or reduces the frequency, rate or extent of a response to endoplasmic reticulum stress.
GO:1903578	GO	BP	regulation of ATP metabolic process	ACTN3,ARNT,ATP7A,ATPIF1,CBFA2T3,ECD,ENTPD5,FBP1,FLCN,GAPDHS,GCK,HDAC4,HIF1A,IGF1,INS,INSR,MLXIPL,NCOR1,OGT,P2RX7,PARK7,PGAM1,PID1,PINK1,PPARA,PPARGC1A,PPIF,PRKAA1,PRKAA2,PRKAG1,PRKAG2,SLC25A33,SNCA,UQCC2,VCP	Any process that modulates the frequency, rate or extent of ATP metabolic process.
GO:1903579	GO	BP	negative regulation of ATP metabolic process	ACTN3,CBFA2T3,FBP1,FLCN,HDAC4,MLXIPL,PID1,PPARA,PPIF,SNCA	Any process that stops, prevents or reduces the frequency, rate or extent of ATP metabolic process.
GO:1903580	GO	BP	positive regulation of ATP metabolic process	ACTN3,ARNT,ENTPD5,GAPDHS,HIF1A,IGF1,INS,INSR,MLXIPL,P2RX7,PARK7,PID1,PINK1,PPARGC1A,PRKAA1,PRKAA2,VCP	Any process that activates or increases the frequency, rate or extent of ATP metabolic process.
GO:1903650	GO	BP	negative regulation of cytoplasmic transport	ANXA13,APC2,APOD,AXIN2,BAG4,BARD1,BMP7,C1QTNF3,CABP1,CALCA,CALM1,CASQ2,CCDC22,CHP1,CLIC2,CREB3,CSK,CYLD,DAB2IP,DACT3,DERL2,DERL3,DYRK2,EMD,EPO,ERLEC1,FAF1,FAM89B,FKBP1B,G3BP2,GAS6,GOPC,GSK3B,GSTM2,GSTO1,IL10,INSIG1,LRRK2,MDFI,MDFIC,MRLN,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP3,NOS1,NOV,NUP153,OS9,PARK7,PARP10,PBLD,PDE2A,PKD1,PKD2,PKDCC,PLN,PPM1A,PPM1B,PSMD10,PYDC2,RAB23,RANGAP1,SFRP5,SIAH3,SLC9A3R1,SNAI2,SNX12,SNX3,SOX4,SP100,SRI,SUFU,SVIP,TONSL,TPR,TRDN,UBAC2,UBE2G2,UBE2J1,VPS35,WWTR1,YOD1,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic transport.
GO:1903670	GO	BP	regulation of sprouting angiogenesis	CIB1,DLL1,DLL4,FGF2,FOXC2,HDAC5,HDAC7,HDAC9,ITGA5,ITGB1BP1,JAK1,KLF4,MAP2K5,MMRN2,NOTCH1,PDCD10,PPP1R16B,PTGS2,RHOA,SRPX2,STARD13,SYNJ2BP,VEGFA	Any process that modulates the frequency, rate or extent of sprouting angiogenesis.
GO:1903671	GO	BP	negative regulation of sprouting angiogenesis	DLL4,HDAC5,ITGB1BP1,KLF4,MAP2K5,MMRN2,NOTCH1,PDCD10,RHOA,STARD13,SYNJ2BP	Any process that stops, prevents or reduces the frequency, rate or extent of sprouting angiogenesis.
GO:1903672	GO	BP	positive regulation of sprouting angiogenesis	CIB1,DLL1,FGF2,FOXC2,HDAC7,HDAC9,ITGA5,JAK1,PPP1R16B,PTGS2,SRPX2,VEGFA	Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
GO:1903689	GO	BP	regulation of wound healing, spreading of epidermal cells	CLASP1,CLASP2,GSN,PHLDB2,RREB1	Any process that modulates the frequency, rate or extent of wound healing, spreading of epidermal cells.
GO:1903706	GO	BP	regulation of hemopoiesis	ACE,ACVR1B,ACVR2A,ADAM8,ADIPOQ,AGER,ANKRD54,ANXA1,APCS,ARNT,ATP6AP1,AXL,BGLAP,BMP4,BTK,C1QC,CALCA,CAMK4,CARTPT,CASP8,CCL19,CCL3,CCR1,CD2,CD27,CD46,CD80,CD86,CDC73,CDK6,CDKN2A,CEBPB,CIB1,CLPTM1,CSF1,CTLA4,CTNNBIP1,CTR9,DCSTAMP,EIF2AK2,ETS1,FADD,FAM213A,FES,FLCN,FNIP1,FOXC1,FOXJ1,FOXO3,FOXP1,FOXP3,FSTL3,GAS2L1,GAS6,GATA1,GATA3,GLI2,GLI3,GPR55,HAX1,HCLS1,HES1,HES5,HIF1A,HIST1H4A,HLA-B,HLA-G,HMGB1,HMGB2,HOXA5,HOXA7,HOXA9,HOXB8,IFNA2,IFNB1,IFNG,IFNL1,IHH,IKZF3,IL12B,IL12RB1,IL17A,IL23A,IL23R,IL27,IL34,IL4,IL7,INHA,INHBA,IRF1,IRF4,IRF7,JAK3,KIAA0922,KMT2E,L3MBTL1,LDB1,LEF1,LEO1,LGALS9,LIF,LILRB1,LILRB2,LILRB3,LILRB4,LRRC17,LTF,LYN,MAFB,MAPK14,MED1,MEF2C,MEIS1,MEIS2,MIXL1,MMP14,MTOR,MYB,MYC,N4BP2L2,NCKAP1L,NKAP,NLRP3,NOTCH1,OCSTAMP,OGT,PAF1,PDCD2,PF4,PNP,PRDM16,PRELID1,PRKCA,PRKCZ,PRMT1,PTK2B,PTPN2,PURB,RAB7B,RARA,RC3H1,RIPK1,RUNX1,SART1,SCIN,SFRP1,SHH,SOCS5,SOD1,SPI1,SPINK5,SYK,TAL1,TESC,TESPA1,TGFBR2,THPO,TLR3,TLR4,TNF,TNFSF11,TNFSF4,TRAF6,VNN1,WDR61,XBP1,ZAP70,ZBTB1,ZBTB16,ZC3H8,ZFPM1,ZNF16,ZNF675	Any process that modulates the frequency, rate or extent of hemopoiesis.
GO:1903707	GO	BP	negative regulation of hemopoiesis	ADIPOQ,ANXA1,APCS,BMP4,C1QC,CALCA,CARTPT,CCL3,CDC73,CDK6,CDKN2A,CIB1,CTLA4,CTR9,FOXJ1,FOXP3,FSTL3,GAS2L1,GLI3,GPR55,HES1,HES5,HIST1H4A,HLA-G,HMGB1,HOXA5,HOXA7,HOXA9,HOXB8,IFNA2,IFNB1,IFNL1,IHH,IL4,INHA,INHBA,IRF1,JAK3,KIAA0922,LDB1,LEO1,LILRB1,LILRB3,LILRB4,LRRC17,LTF,MAFB,MEIS1,MEIS2,MIXL1,MYC,N4BP2L2,NOTCH1,PAF1,PF4,PRDM16,PRMT1,PTK2B,PTPN2,RARA,RC3H1,RUNX1,SFRP1,SOCS5,TLR3,TLR4,TNFSF4,WDR61,ZBTB16,ZC3H8,ZFPM1,ZNF675	Any process that stops, prevents or reduces the frequency, rate or extent of hemopoiesis.
GO:1903708	GO	BP	positive regulation of hemopoiesis	ACVR1B,ACVR2A,ADAM8,AGER,ANKRD54,ANXA1,ARNT,ATP6AP1,AXL,BTK,CALCA,CASP8,CCL19,CCR1,CD27,CD46,CD80,CD86,CSF1,CTNNBIP1,DCSTAMP,ETS1,FADD,FES,FOXC1,FOXO3,FOXP3,GAS6,GATA1,GATA3,GLI2,GLI3,HAX1,HCLS1,HIF1A,HLA-G,HMGB1,HMGB2,HOXA5,IFNG,IHH,IL12B,IL12RB1,IL17A,IL23A,IL23R,IL34,IL4,IL7,INHBA,KMT2E,LEF1,LGALS9,LIF,LILRB2,MAPK14,MED1,MMP14,MYB,N4BP2L2,NCKAP1L,NKAP,NLRP3,OCSTAMP,OGT,PDCD2,PF4,PNP,PRKCA,PRKCZ,PRMT1,RAB7B,RARA,RIPK1,RUNX1,SART1,SCIN,SHH,SOCS5,SYK,TAL1,TESC,TESPA1,TGFBR2,THPO,TNF,TNFSF11,TNFSF4,TRAF6,VNN1,XBP1,ZAP70,ZBTB1,ZNF16	Any process that activates or increases the frequency, rate or extent of hemopoiesis.
GO:1903725	GO	BP	regulation of phospholipid metabolic process	ACSL3,AMBRA1,APOC1,APOC2,ATG14,CCKBR,CCL19,CCL21,CCR7,CD81,DAB2IP,EPHA8,ERBB4,FABP3,FGF2,FGFR3,FGR,FLT1,FLT3,HTR2A,HTR2B,HTR2C,IRS1,KIT,LDLR,NOD2,PDGFA,PDGFB,PDGFRA,PDGFRB,PIK3IP1,PIK3R1,PIK3R4,PIK3R6,PRKCD,PTK2,PTK2B,RUBCN,SCARB1,SLC27A1,STOML2,TEK,TGFB1,TNFAIP8L3,XBP1,ZP3	Any process that modulates the frequency, rate or extent of phospholipid metabolic process.
GO:1903726	GO	BP	negative regulation of phospholipid metabolic process	APOC1,DAB2IP,PDGFA,PDGFB,PIK3IP1,RUBCN,SLC27A1	Any process that stops, prevents or reduces the frequency, rate or extent of phospholipid metabolic process.
GO:1903727	GO	BP	positive regulation of phospholipid metabolic process	ACSL3,AMBRA1,APOC2,ATG14,CCL19,CCL21,CCR7,CD81,EPHA8,ERBB4,FABP3,FGF2,FGFR3,FGR,FLT1,FLT3,HTR2A,HTR2B,HTR2C,IRS1,KIT,NOD2,PDGFB,PDGFRA,PDGFRB,PIK3R4,PRKCD,PTK2,PTK2B,STOML2,TEK,TGFB1,TNFAIP8L3,XBP1,ZP3	Any process that activates or increases the frequency, rate or extent of phospholipid metabolic process.
GO:1903729	GO	BP	regulation of plasma membrane organization	ACSL3,AGR2,AKT1,ANXA13,AP2M1,APPL1,AR,ARF6,ARHGEF16,BCL2L1,CIB1,CLIP3,CLTC,CNST,CSK,DAB2,DLG1,DNM2,DPP10,EPHA2,GBP1,GNB2L1,GOPC,GPER1,IFNG,ITGA3,ITGB1,KIF5B,LDLRAP1,LRRC15,LZTFL1,NKD2,NOX1,NRXN1,NUMB,PDPK1,PID1,PIK3R1,PKDCC,PLS1,PPFIA1,PPP2R5A,PRKCD,PRKCI,RAMP3,RANGRF,RHOG,RHOQ,SH3GLB1,SORBS1,SPTBN1,STX3,STX4,STX7,STX8,TGFB1,TGFB2,TMBIM1,TMEM59,TREM2,VAMP8,VPS4A,VTI1B,WASL,WNK3	Any process that modulates the frequency, rate or extent of plasma membrane organization.
GO:1903747	GO	BP	regulation of establishment of protein localization to mitochondrion	ABLIM3,ACSM6,ACTL6A,AKT1,ARIH2,ATG13,ATPIF1,BAD,BAG4,BAP1,BBC3,BCL2,BCL2L11,BID,BMF,CASP8,CDKL2,CDKN2A,CSNK2A2,CTSK,CYB5R1,DPCR1,DPH6,DTWD2,DYNLL1,DYNLL2,E2F1,ELMOD1,EPT1,FAM20B,FBXW7,FZD5,GLS2,GPHA2,GPR26,GSK3A,GZMB,HAX1,HES1,HHAT,HNMT,HPS4,HSPA1L,HTRA2,HUWE1,IFNL3,IL9R,ITGAX,KAT2A,KCNN3,LEPROT,LRRC46,LRRK2,MAPK8,MICALL2,MIS18A,MRGPRE,MYBPC1,NBPF3,NKAP,NMT1,NMUR1,NPEPPS,NRG1,OR13C4,OSCP1,PARK2,PARL,PDCD5,PEMT,PINK1,PLAGL2,PMAIP1,POLR3A,PPP3CC,PPP3R1,PRELID3A,PSMB7,PSMD8,RAC2,RHOU,RNASE2,RNF31,RPL28,RUVBL1,SAE1,SFN,SH3GLB1,SIAH3,SLC17A9,SNIP1,SREBF1,SREBF2,STARD7,TDRD12,TFDP1,TOMM7,TP53,TSGA13,U2AF1,U2AF2,UBE2D3,UBE2J2,UBE2L3,UBL4B,UBL5,UGCG,USP36,VPS11,WBP11,WDR46,WDR75,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZBED3,ZBTB17,ZDHHC8	Any process that modulates the frequency, rate or extent of establishment of protein localization to mitochondrion.
GO:1903749	GO	BP	positive regulation of establishment of protein localization to mitochondrion	ABLIM3,ACSM6,ACTL6A,AKT1,ARIH2,ATG13,BAD,BAP1,BBC3,BCL2,BCL2L11,BID,BMF,CASP8,CDKL2,CSNK2A2,CTSK,CYB5R1,DPCR1,DPH6,DTWD2,DYNLL1,DYNLL2,E2F1,ELMOD1,EPT1,FAM20B,FBXW7,FZD5,GLS2,GPHA2,GPR26,GSK3A,GZMB,HES1,HHAT,HNMT,HPS4,HSPA1L,HTRA2,HUWE1,IFNL3,IL9R,ITGAX,KAT2A,KCNN3,LEPROT,LRRC46,MAPK8,MICALL2,MIS18A,MRGPRE,MYBPC1,NBPF3,NKAP,NMT1,NMUR1,NPEPPS,NRG1,OR13C4,OSCP1,PDCD5,PEMT,PINK1,PLAGL2,PMAIP1,POLR3A,PPP3CC,PPP3R1,PRELID3A,PSMB7,PSMD8,RAC2,RHOU,RNASE2,RNF31,RPL28,RUVBL1,SAE1,SFN,SH3GLB1,SLC17A9,SNIP1,SREBF2,STARD7,TDRD12,TFDP1,TOMM7,TP53,TSGA13,U2AF1,U2AF2,UBE2D3,UBE2J2,UBE2L3,UBL4B,UBL5,UGCG,USP36,VPS11,WBP11,WDR46,WDR75,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZBED3,ZBTB17,ZDHHC8	Any process that activates or increases the frequency, rate or extent of establishment of protein localization to mitochondrion.
GO:1903772	GO	BP	regulation of viral budding via host ESCRT complex	MVB12A,SNF8,TSG101,VPS37B,VPS4A	Any process that modulates the frequency, rate or extent of viral budding via host ESCRT complex.
GO:1903779	GO	BP	regulation of cardiac conduction	ABCC9,ACE2,AGT,AHCYL1,ANK2,ASPH,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,ATP2A3,ATP2B1,ATP2B2,ATP2B3,ATP2B4,CALM1,CAMK2D,CASQ1,CASQ2,CAV1,CORIN,DMPK,FKBP1B,FXYD1,FXYD2,FXYD3,FXYD4,FXYD6,FXYD7,GJA5,HRC,ITPR1,ITPR2,ITPR3,KCNJ11,NKX2-5,NOS1,NPPA,NPPC,NPR1,NPR2,ORAI1,PDE4D,PLN,PRKACA,RNF207,RYR1,RYR2,RYR3,SLC8A1,SLC8A2,SLC8A3,SRI,STIM1,TMEM65,TNNI3,TNNI3K,TRDN,TRPC1	Any process that modulates the frequency, rate or extent of cardiac conduction.
GO:1903792	GO	BP	negative regulation of anion transport	ACSL4,AKT1,AKT2,ANO9,APOE,CYP4F2,GPM6B,GRM7,HTR1B,IRS2,LILRB1,NOS1,PLA2R1,SFRP4,SNCA,TCAF2,THBS1	Any process that stops, prevents or reduces the frequency, rate or extent of anion transport.
GO:1903793	GO	BP	positive regulation of anion transport	ABCA7,ABCB4,APOE,CFTR,CHRNB2,CYP4A11,CYP4F2,DRD2,DRD4,GDNF,IL1B,P2RX4,PLA2G10,PLA2R1,PRELID1,PRKCD,RAB3B,RAB3GAP1,SNX4,TCAF1,TNFRSF11A,TNFSF11,TRIAP1,VAMP7,VAMP8	Any process that activates or increases the frequency, rate or extent of anion transport.
GO:1903817	GO	BP	negative regulation of voltage-gated potassium channel activity	ANK3,KCNE1,KCNE2,KCNE3,KCNQ1,KCNRG,RNF207,SUMO1	Any process that stops, prevents or reduces the frequency, rate or extent of voltage-gated potassium channel activity.
GO:1903825	GO	BP	organic acid transmembrane transport	ACACA,ACACB,CPT1A,CPT1B,CPT2,EMB,PQLC2,PRKAA2,PRKAB2,PRKAG2,SLC16A1,SLC16A12,SLC16A7,SLC17A3,SLC17A7,SLC1A1,SLC1A2,SLC1A3,SLC1A4,SLC1A6,SLC1A7,SLC22A12,SLC22A16,SLC22A4,SLC22A5,SLC25A12,SLC25A13,SLC25A15,SLC25A20,SLC25A22,SLC25A26,SLC36A2,SLC36A4,SLC38A1,SLC38A3,SLC38A9,SLC3A1,SLC6A14,SLC6A20,SLC6A8,SLC7A11,SLC7A2,SLC7A4	The directed movement of organic acid across a membrane.
GO:1903828	GO	BP	negative regulation of cellular protein localization	ACTN2,ADIPOQ,ANXA13,AP2M1,APC2,APOD,AXIN2,BAG4,BARD1,BCL2L1,BMP7,C1QTNF3,CABP1,CAV3,CCDC22,CD27,CHP1,CLTC,COMMD1,CREB3,CSK,CYLD,DAB2,DAB2IP,DACT3,DERL2,DERL3,DMTN,DYRK2,EMD,ERLEC1,FAF1,FAM89B,FLCN,G3BP2,GAS6,GBP1,GDI1,GOPC,GPM6B,GSK3B,H2AFY,IL10,INPP5K,ITGB1BP1,KCNE1,LEPROT,LRRC15,LRRK2,LZTFL1,MDFI,MDFIC,MXI1,NEDD4L,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NOV,NUMB,OS9,OTUD7B,PARK7,PARP10,PBLD,PDE2A,PID1,PKD1,PKD2,PKDCC,PPFIA1,PPM1A,PPM1B,PPP2R5A,PSMD10,PYDC2,RAB23,RANGAP1,RHOQ,SFRP5,SIAH3,SIN3A,SLC9A3R1,SNAI2,SNX33,SOX4,SP100,SUFU,SVIP,TAX1BP3,TERF1,TGFB1,TMBIM1,TMEM59,TNFSF14,TONSL,TRIM40,TRIP6,UBAC2,UBE2G2,UBE2J1,USP17L2,WWTR1,YOD1,ZC3H12A,ZNF268	Any process that stops, prevents or reduces the frequency, rate or extent of cellular protein localization. Cellular protein localization is any process in which a protein is transported to, and/or maintained in, a specific location and encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.
GO:1903830	GO	BP	magnesium ion transmembrane transport	CLDN16,MAGT1,MMGT1,TUSC3,ZDHHC13,ZDHHC17	The directed movement of magnesium ion across a membrane.
GO:1903861	GO	BP	positive regulation of dendrite extension	CPNE5,CPNE6,CPNE9,ITSN2,NEDD4L,RASAL1,RIMS1,RIMS2,SMURF1,SYT1,SYT17,SYT2,SYT3,SYT4,UNC13A	Any process that activates or increases the frequency, rate or extent of dendrite extension.
GO:1903894	GO	BP	regulation of IRE1-mediated unfolded protein response	AGR2,BAK1,BAX,BBC3,BCL2L11,BFAR,COPS5,DAB2IP,HSPA1A,HSPA5,PTPN1,TMBIM6	Any process that modulates the frequency, rate or extent of the IRE1-mediated unfolded protein response.
GO:1903896	GO	BP	positive regulation of IRE1-mediated unfolded protein response	AGR2,BAK1,BAX,BBC3,BCL2L11,DAB2IP,HSPA1A,PTPN1	Any process that activates or increases the frequency, rate or extent of the IRE1-mediated unfolded protein response.
GO:1903897	GO	BP	regulation of PERK-mediated unfolded protein response	AGR2,HSPA5,NCK1,PPP1R15A,PPP1R15B,PTPN1	Any process that modulates the frequency, rate or extent of the PERK-mediated unfolded protein response.
GO:1903900	GO	BP	regulation of viral life cycle	ADAR,ADARB1,APCS,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,BST2,BTBD17,CAV2,CCL3,CCL4,CCL5,CCNH,CCNK,CCNT1,CD28,CDK7,CDK9,CHD1,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CTDP1,CXCL8,DDB1,DDX3X,EIF2AK2,EIF2AK4,ELL,EP300,ERCC2,ERCC3,FAM111A,FCN1,FCN3,GSN,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HACD3,HDAC1,HMGA2,HPN,HS3ST5,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNA2,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,JUN,LEF1,LGALS1,LGALS9,LTF,MAVS,MDFIC,MID2,MNAT1,MVB12A,MX1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,NR5A2,OAS1,OAS3,OASL,P4HB,PARK2,PARP10,PC,PKN2,PLSCR1,PML,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,POU2F3,PPIA,PPIB,PPID,PPIE,PPIH,PROX1,PTX3,PVRL2,RAD23A,REST,RNASEL,RSAD2,RSF1,SLPI,SMARCA4,SMARCB1,SNF8,SNW1,SNX3,SP1,SP100,SRPK1,SRPK2,SSRP1,STAU1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TARBP2,TARDBP,TBC1D20,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TMPRSS2,TNF,TNIP1,TOP2A,TRIM11,TRIM13,TRIM14,TRIM15,TRIM21,TRIM25,TRIM26,TRIM27,TRIM28,TRIM31,TRIM32,TRIM35,TRIM38,TRIM5,TRIM6,TRIM62,TRIM8,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,YTHDC2,ZC3H12A,ZC3HAV1,ZNF502,ZNF639	Any process that modulates the frequency, rate or extent of viral life cycle.
GO:1903901	GO	BP	negative regulation of viral life cycle	APCS,APOBEC3A,APOBEC3C,APOBEC3D,APOBEC3F,APOBEC3G,APOBEC3H,BST2,BTBD17,CCL3,CCL4,CCL5,CCNK,CHMP3,EIF2AK2,EIF2AK4,FAM111A,FCN1,FCN3,GSN,HDAC1,HMGA2,IFI16,IFIT1,IFITM1,IFITM2,IFITM3,IFNA2,IFNB1,IFNL3,ILF3,INPP5K,ISG15,ISG20,JUN,LTF,MAVS,MID2,MX1,OAS1,OAS3,OASL,PARK2,PARP10,PLSCR1,PML,POU2F3,PROX1,PTX3,REST,RNASEL,RSAD2,SLPI,SNX3,SP100,SRPK1,SRPK2,TARDBP,TFAP4,TNF,TNIP1,TRIM11,TRIM13,TRIM14,TRIM15,TRIM21,TRIM26,TRIM27,TRIM28,TRIM31,TRIM32,TRIM35,TRIM5,TRIM6,TRIM62,TRIM8,VAPA,VAPB,ZC3H12A,ZC3HAV1,ZNF639	Any process that stops, prevents or reduces the frequency, rate or extent of viral life cycle.
GO:1903902	GO	BP	positive regulation of viral life cycle	ADAR,ADARB1,CAV2,CCL5,CCNH,CCNT1,CD28,CDK7,CDK9,CHD1,CHMP2A,CHMP2B,CHMP3,CHMP4B,CHMP4C,CTDP1,DDB1,DDX3X,ELL,EP300,ERCC2,ERCC3,GTF2F1,GTF2F2,GTF2H1,GTF2H2,GTF2H3,GTF2H4,GTF2H5,HACD3,HPN,IFIT1,JUN,LEF1,LGALS1,LGALS9,MDFIC,MNAT1,NCBP1,NCBP2,NELFA,NELFB,NELFCD,NELFE,NR5A2,P4HB,PC,PKN2,POLR2A,POLR2B,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2H,POLR2I,POLR2J,POLR2K,POLR2L,PPIA,PPIB,PPID,PPIE,PPIH,RAD23A,RSF1,SMARCA4,SMARCB1,SNW1,SP1,SRPK1,SRPK2,SSRP1,STAU1,SUPT16H,SUPT4H1,SUPT5H,TAF11,TARBP2,TBC1D20,TCEA1,TCEB1,TCEB2,TCEB3,TFAP4,TMPRSS2,TOP2A,TRIM11,TRIM38,TSG101,VAPA,VAPB,VPS37B,VPS4A,VPS4B,YTHDC2,ZNF502,ZNF639	Any process that activates or increases the frequency, rate or extent of viral life cycle.
GO:1903955	GO	BP	positive regulation of protein targeting to mitochondrion	ABLIM3,ACSM6,ACTL6A,ARIH2,ATG13,BAP1,CDKL2,CSNK2A2,CTSK,CYB5R1,DPCR1,DPH6,DTWD2,ELMOD1,EPT1,FAM20B,FBXW7,FZD5,GLS2,GPHA2,GPR26,GSK3A,HES1,HHAT,HNMT,HPS4,HSPA1L,HTRA2,HUWE1,IFNL3,IL9R,ITGAX,KAT2A,KCNN3,LEPROT,LRRC46,MICALL2,MIS18A,MRGPRE,MYBPC1,NBPF3,NKAP,NMUR1,NPEPPS,NRG1,OR13C4,OSCP1,PDCD5,PEMT,PINK1,PLAGL2,POLR3A,PRELID3A,PSMB7,PSMD8,RAC2,RHOU,RNASE2,RNF31,RPL28,RUVBL1,SAE1,SH3GLB1,SLC17A9,SNIP1,SREBF2,STARD7,TDRD12,TOMM7,TSGA13,U2AF1,U2AF2,UBE2D3,UBE2J2,UBE2L3,UBL4B,UBL5,UGCG,USP36,VPS11,WBP11,WDR46,WDR75,ZBED3,ZBTB17,ZDHHC8	Any process that activates or increases the frequency, rate or extent of protein targeting to mitochondrion.
GO:1903959	GO	BP	regulation of anion transmembrane transport	AKT1,AKT2,ANO1,ANO6,ANO9,CFTR,CLCN1,CLCN2,CLCN3,CLCN4,CLCN6,CLCNKA,CLCNKB,GPR89A,IRS2,RIPK1,SLC17A3,TCAF1,TCAF2,THBS1,VDAC1,VDAC2,VDAC3	Any process that modulates the frequency, rate or extent of anion transmembrane transport.
GO:1903960	GO	BP	negative regulation of anion transmembrane transport	AKT1,AKT2,ANO9,IRS2,TCAF2,THBS1	Any process that stops, prevents or reduces the frequency, rate or extent of anion transmembrane transport.
GO:1904018	GO	BP	positive regulation of vasculature development	ADM2,AGGF1,ALOX12,ANGPT4,ANGPTL3,ANGPTL4,ANXA3,AQP1,ASB4,BRCA1,BTG1,CCR3,CD34,CHI3L1,CHRNA7,CIB1,CTH,CTSH,CXCL8,CXCR3,CYP1B1,DLL1,ECM1,EGR1,EPHA1,F3,FGF1,FGF2,FLT1,FOXC2,GATA2,GATA4,GATA6,GDF2,GPER1,HDAC7,HDAC9,HIF1A,HIF1AN,HIPK1,HIPK2,HSPB1,HYAL1,IL1A,IL1B,ISL1,ITGA5,JAK1,KDR,MTDH,MYDGF,MYOCD,NODAL,NOS3,NTRK1,PDCD6,PDCL3,PDGFB,PIK3R6,PLCG1,PPP1R16B,PRKCA,PRKCB,PRKD1,PRKD2,PTGIS,PTGS2,RAMP2,RAP1A,RAPGEF2,RAPGEF3,RHOB,RLN2,RRAS,RUNX1,SASH1,SEMA5A,SERPINE1,SFRP2,SPHK1,SRPX2,TEK,THBS1,TMEM100,TMIGD2,TNFSF12,TWIST1,VASH2,VEGFA,VEGFB,WNT5A,ZC3H12A,ZNF304	Any process that activates or increases the frequency, rate or extent of vasculature development.
GO:1904019	GO	BP	epithelial cell apoptotic process	BMPR2,CAPN10,COL4A3,DAB2IP,GSN,HIPK1,RYR2,SIX3	Any apoptotic process in an epithelial cell.
GO:1904029	GO	BP	regulation of cyclin-dependent protein kinase activity	ADAM17,AKT1,APC,ATRAID,BCCIP,BLM,CCND1,CCND2,CCND3,CCNE2,CCNG1,CCNK,CCNT1,CCNT2,CCNY,CDC25A,CDC25C,CDC37,CDC6,CDK5R1,CDK5R2,CDK5RAP1,CDK5RAP3,CDK7,CDKN1A,CDKN1B,CDKN2A,CDKN2B,CDKN2C,CDKN2D,CDKN3,CEBPA,CIB1,CKS1B,CKS2,CUL3,DAB2IP,DIRAS3,DNAJC3,DUS2,DUSP19,EGFR,FBXO31,FGF10,GADD45A,GMFB,GMFG,GTF2H1,GTPBP4,HERC5,HEXIM1,HEXIM2,HHEX,INCA1,LATS1,LATS2,MAPK8IP1,MAPRE3,MBIP,MEN1,MNAT1,MYOCD,NCK1,NELL1,NPM1,NR2F2,PDGFB,PIM1,PKD1,PKD2,PKMYT1,PLK1,PPP1R1B,PROX1,PSMD10,PSRC1,PTEN,RGCC,SERTAD1,SH3BP5,SOCS1,SOCS3,STOX1,TAOK3,TFAP4,TRIB1,UBE2C	Any process that modulates the frequency, rate or extent of cyclin-dependent protein kinase activity.
GO:1904030	GO	BP	negative regulation of cyclin-dependent protein kinase activity	APC,CDK5RAP1,CDKN2A,CEBPA,CIB1,CUL3,DNAJC3,DUS2,DUSP19,FBXO31,GMFB,GMFG,HEXIM1,HEXIM2,HHEX,INCA1,LATS1,LATS2,MAPK8IP1,MBIP,MEN1,MYOCD,NCK1,NPM1,NR2F2,PLK1,PPP1R1B,PTEN,SH3BP5,SOCS1,SOCS3,TAOK3,TFAP4,TRIB1,UBE2C	Any process that stops, prevents or reduces the frequency, rate or extent of cyclin-dependent protein kinase activity.
GO:1904031	GO	BP	positive regulation of cyclin-dependent protein kinase activity	ADAM17,AKT1,ATRAID,CCND1,CCND2,CCND3,CCNY,CDKN1A,DAB2IP,EGFR,FGF10,MAPRE3,NELL1,PDGFB,PIM1,PKD1,PKD2,PROX1,PSMD10,PSRC1,RGCC,STOX1	Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein kinase activity.
GO:1904035	GO	BP	regulation of epithelial cell apoptotic process	AKR1C3,ANGPT1,ANO6,CAST,CD40,CD40LG,ECSCR,FASLG,FGA,FGB,FGG,GAS6,GATA3,GPER1,GSN,ICAM1,IL13,IL4,IL6,KDR,KRIT1,MAPK7,NDNF,NEUROD1,NFE2L2,PIAS4,PRKCI,RAMP2,RGCC,SCG2,SEMA5A,SERPINB13,SERPINE1,SFRP4,TCF7L2,TEK,THBS1,TNFAIP3,TNIP2,WFS1,XBP1	Any process that modulates the frequency, rate or extent of epithelial cell apoptotic process.
GO:1904036	GO	BP	negative regulation of epithelial cell apoptotic process	ANGPT1,CAST,FGA,FGB,FGG,GAS6,GATA3,ICAM1,IL13,IL4,KDR,KRIT1,MAPK7,NDNF,NEUROD1,NFE2L2,RAMP2,SCG2,SEMA5A,SERPINB13,SERPINE1,TCF7L2,TEK,TNFAIP3,TNIP2,WFS1	Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell apoptotic process.
GO:1904037	GO	BP	positive regulation of epithelial cell apoptotic process	AKR1C3,ANO6,CD40,CD40LG,ECSCR,FASLG,GPER1,GSN,IL6,PIAS4,PRKCI,RGCC,SFRP4,THBS1,XBP1	Any process that activates or increases the frequency, rate or extent of epithelial cell apoptotic process.
GO:1904062	GO	BP	regulation of cation transmembrane transport	ACTN2,ACTN4,ADRA2A,AGT,AHNAK,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ASPH,ATP1A2,ATP1B1,ATP1B2,ATP1B3,ATP2B4,BPIFA1,CAB39,CACNA1C,CACNA1D,CACNB4,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CAV1,CAV3,CEMIP,CHP1,CLIC2,COMMD1,CRACR2A,CRHR1,CTSS,CXCL10,CXCL11,CXCL9,CXCR3,DIAPH1,DLG1,DMD,DPP10,DPP6,DRD1,DRD2,DRD4,EPO,F2,F2R,F2RL3,FGF12,FHL1,FKBP1A,FKBP1B,FXYD1,GAL,GALR2,GLRX,GNB5,GPD1L,GPER1,GSTM2,GSTO1,HAMP,HAP1,HOMER1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,KCNAB1,KCNAB2,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNH2,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNN2,KCNQ1,KCNRG,KCNS1,KCNS2,LACRT,LRRK2,MMP9,NEDD4,NEDD4L,NOS1,NOS1AP,NPPA,NPSR1,PCSK9,PDE4B,PDE4D,PDPK1,PKD2,PLCG1,PLN,PPIF,PRKACA,PRKCE,PTK2B,PTPN3,RANGRF,RNF207,RYR2,SCN1B,SCN2B,SCN3B,SCN4B,SCN5A,SLC30A1,SLC8A1,SLC9A1,SLC9A3R1,SLN,SNCA,SNTA1,SRI,STIM1,STIM2,STK39,SUMO1,TESC,THY1,TLR9,TMEM110,TRDN,TRPC1,UBQLN1,UTRN,VAMP2,WNK2,WNK3,WWP2,XCL1,YWHAE,YWHAH	Any process that modulates the frequency, rate or extent of cation transmembrane transport.
GO:1904063	GO	BP	negative regulation of cation transmembrane transport	ACTN2,ADRA2A,AGT,ANK3,ATP1A2,CAB39,CALM1,CAMK2D,CASQ2,CAV1,CAV3,CLIC2,COMMD1,CRHR1,DRD2,DRD4,EPO,FKBP1B,GNB5,GSTM2,GSTO1,HAMP,KCNE1,KCNE2,KCNE3,KCNE5,KCNH2,KCNQ1,KCNRG,MMP9,NEDD4,NEDD4L,PCSK9,PKD2,PLN,PRKCE,RNF207,SLC30A1,SLN,SRI,STK39,SUMO1,TLR9,TRDN,UBQLN1	Any process that stops, prevents or reduces the frequency, rate or extent of cation transmembrane transport.
GO:1904064	GO	BP	positive regulation of cation transmembrane transport	ACTN2,ACTN4,AKAP6,AKAP7,AKAP9,AMIGO1,ANK2,ANK3,ASPH,ATP1B1,ATP1B2,ATP1B3,CALM1,CAPN3,CEMIP,CHP1,CRACR2A,CTSS,CXCL10,CXCL11,CXCL9,CXCR3,DMD,DRD1,DRD4,F2,F2R,F2RL3,FXYD1,GAL,GALR2,GLRX,GPER1,GSTM2,GSTO1,HAP1,HTT,JPH2,KCNE1,KCNE5,KCNH2,KCNQ1,LACRT,NOS1,NOS1AP,NPPA,NPSR1,PDPK1,PKD2,PLCG1,RNF207,RYR2,SLC9A1,SNCA,STIM1,STIM2,TESC,THY1,TMEM110,TRDN,TRPC1,WNK2,WNK3,XCL1	Any process that activates or increases the frequency, rate or extent of cation transmembrane transport.
GO:1904152	GO	BP	regulation of retrograde protein transport, ER to cytosol	BCAP31,BRSK2,DERL2,DERL3,EDEM1,EDEM2,ERLEC1,OS9,SVIP,UBAC2,UBE2G2,UBE2J1,YOD1	Any process that modulates the frequency, rate or extent of retrograde protein transport, ER to cytosol.
GO:1904153	GO	BP	negative regulation of retrograde protein transport, ER to cytosol	DERL2,DERL3,ERLEC1,OS9,SVIP,UBAC2,UBE2G2,UBE2J1,YOD1	Any process that stops, prevents or reduces the frequency, rate or extent of retrograde protein transport, ER to cytosol.
GO:1904181	GO	BP	positive regulation of membrane depolarization	ANK3,DCN,GNB2L1,KDR,MLLT11,MYOC	Any process that activates or increases the frequency, rate or extent of membrane depolarization.
GO:1904224	GO	BP	negative regulation of glucuronosyltransferase activity	UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9	Any process that stops, prevents or reduces the frequency, rate or extent of glucuronosyltransferase activity.
GO:1904251	GO	BP	regulation of bile acid metabolic process	CYP7A1,FGF19,FGFR4,NR1D1,NR1H4,PANK2,PROX1,SIRT1	Any process that modulates the frequency, rate or extent of bile acid metabolic process.
GO:1904261	GO	BP	positive regulation of basement membrane assembly involved in embryonic body morphogenesis	CLASP1,CLASP2,DAG1,PHLDB1,PHLDB2	Any process that activates or increases the frequency, rate or extent of basement membrane assembly involved in embryonic body morphogenesis.
GO:1904264	GO	MF	ubiquitin protein ligase activity involved in ERAD pathway	AMFR,MARCH6,PARK2,RNF185,RNF5,STUB1,SYVN1,TMEM129,TRIM25	Any ubiquitin protein ligase activity that is involved in the ERAD pathway (the targeting of endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome).
GO:1904292	GO	BP	regulation of ERAD pathway	ATXN3,BAG6,BCAP31,BRSK2,CAV1,DERL2,DERL3,EDEM1,EDEM2,ERLEC1,HERPUD1,NFE2L2,OS9,SGTA,SVIP,UBAC2,UBE2G2,UBE2J1,UBQLN1,UBQLN2,UBXN1,USP13,USP14,USP19,USP25,XBP1,YOD1	Any process that modulates the frequency, rate or extent of ERAD pathway.
GO:1904293	GO	BP	negative regulation of ERAD pathway	DERL2,DERL3,ERLEC1,OS9,SVIP,UBAC2,UBE2G2,UBE2J1,UBXN1,USP14,USP25,YOD1	Any process that stops, prevents or reduces the frequency, rate or extent of ERAD pathway.
GO:1904294	GO	BP	positive regulation of ERAD pathway	ATXN3,BAG6,BCAP31,CAV1,EDEM1,EDEM2,HERPUD1,NFE2L2,SGTA,UBQLN1,UBQLN2,USP13,XBP1	Any process that activates or increases the frequency, rate or extent of ERAD pathway.
GO:1904322	GO	BP	cellular response to forskolin	ADCY1,ADCY2,ADCY3,ADCY5,ADCY6,GNAI1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a forskolin stimulus.
GO:1904353	GO	BP	regulation of telomere capping	ATM,AURKB,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NABP2,NBN,NEK2,NEK7,PKIB,PNKP,PRKCQ,RAD50,RTEL1,SMG6,TERF2,TNKS,TNKS2,USP7	Any process that modulates the frequency, rate or extent of telomere capping.
GO:1904354	GO	BP	negative regulation of telomere capping	ATM,NBN,RAD50,SMG6,TERF2	Any process that stops, prevents or reduces the frequency, rate or extent of telomere capping.
GO:1904355	GO	BP	positive regulation of telomere capping	AURKB,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NABP2,NEK2,NEK7,PKIB,PNKP,PRKCQ,RTEL1,TNKS,TNKS2	Any process that activates or increases the frequency, rate or extent of telomere capping.
GO:1904356	GO	BP	regulation of telomere maintenance via telomere lengthening	ACD,ATM,ATR,AURKB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CTC1,GNL3L,HMBOX1,HNRNPA1,HNRNPC,HNRNPU,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MCRS1,NAT10,NEK2,NEK7,OBFC1,PARP1,PINX1,PKIB,PML,PNKP,POT1,PRKCQ,RTEL1,SMG5,SMG6,SRC,TCP1,TEN1,TERF1,TERF2,TINF2,TNKS,TNKS2,WRAP53	Any process that modulates the frequency, rate or extent of telomere maintenance via telomere lengthening.
GO:1904357	GO	BP	negative regulation of telomere maintenance via telomere lengthening	ACD,GNL3L,HNRNPA1,HNRNPC,HNRNPU,MCRS1,NAT10,PARP1,PINX1,PML,SRC,TERF1,TERF2,TINF2,TNKS,TNKS2	Any process that stops, prevents or reduces the frequency, rate or extent of telomere maintenance via telomere lengthening.
GO:1904358	GO	BP	positive regulation of telomere maintenance via telomere lengthening	ACD,ATM,ATR,AURKB,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,HMBOX1,HNRNPA1,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,NEK2,NEK7,OBFC1,PKIB,PNKP,POT1,PRKCQ,RTEL1,TCP1,TNKS,TNKS2,WRAP53	Any process that activates or increases the frequency, rate or extent of telomere maintenance via telomere lengthening.
GO:1904427	GO	BP	positive regulation of calcium ion transmembrane transport	AKAP6,ANK2,ASPH,ATP1B1,CALM1,CAPN3,CEMIP,CRACR2A,CXCL10,CXCL11,CXCL9,CXCR3,DRD1,F2,F2R,F2RL3,GPER1,GSTM2,GSTO1,HAP1,HTT,JPH2,LACRT,NPSR1,PDPK1,PKD2,PLCG1,RYR2,SLC9A1,SNCA,STIM1,STIM2,THY1,TMEM110,TRDN,TRPC1,XCL1	Any process that activates or increases the frequency, rate or extent of calcium ion transmembrane transport.
GO:1904429	GO	BP	regulation of t-circle formation	ERCC1,RTEL1,SLX1A,SLX4,TERF2,XRCC5	Any process that modulates the frequency, rate or extent of t-circle formation.
GO:1904589	GO	BP	regulation of protein import	AKAP6,APC2,APOD,ARHGEF5,AXIN2,BAMBI,BMP4,BMP6,BMP7,BMPR1A,C1QTNF3,C8orf4,CABP1,CCDC22,CCL19,CD27,CDH1,CHERP,CHP1,CHP2,CREB3,CSF3,CYLD,DAB2,DAB2IP,DACT1,DACT3,DDX58,DMAP1,DYRK2,ECT2,EGF,EGFR,EMD,ERBB4,FAF1,FAM89B,FLNA,FZD7,G3BP2,GAS6,GNAQ,GSK3B,HCLS1,HDAC3,HSPA8,HYAL2,IGF1,IL10,IL12B,IL1B,IL23A,IL6,IPO5,JUP,KANK1,KPNA1,LACRT,LGALS9,MAVS,MDFI,MDFIC,MXI1,NF1,NFKBIA,NFKBIE,NFKBIL1,NLRP12,NLRP3,NODAL,NOV,OGG1,PARP10,PBLD,PDCD5,PDE2A,PIK3R1,PIK3R2,PKD1,PKD2,POU5F1,PPM1A,PPM1B,PPP3CA,PPP3CB,PPP3R1,PRKCD,PSMD10,PYDC2,RAB23,RBPMS,RHOA,SEMA5A,SFRP5,SIRT1,SLC9A1,SLC9A3R1,SMAD3,SMAD4,SNAI2,SPHK1,SPPL3,SUFU,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TONSL,TPR,TRIM28,TRIP6,TXN,UBR5,WNT3A,WWTR1,XBP1,ZC3H12A,ZIC1,ZNF268,ZPR1	Any process that modulates the frequency, rate or extent of protein import.
GO:1904591	GO	BP	positive regulation of protein import	AKAP6,ARHGEF5,BAMBI,BMP4,BMP6,BMPR1A,C8orf4,CCL19,CD27,CDH1,CHERP,CHP2,CSF3,DAB2,DACT1,DDX58,DMAP1,ECT2,EGF,EGFR,ERBB4,FLNA,HCLS1,HDAC3,HYAL2,IGF1,IL12B,IL1B,IL23A,IL6,IPO5,JUP,KANK1,KPNA1,LACRT,LGALS9,MAVS,NLRP12,NODAL,PDCD5,PIK3R1,PIK3R2,POU5F1,PPP3CA,PPP3CB,PPP3R1,PRKCD,RBPMS,RHOA,SEMA5A,SLC9A1,SMAD3,SMAD4,SPHK1,SPPL3,TGFB1,TGFB3,TGFBR1,TLR2,TLR3,TLR4,TLR7,TLR9,TMEM173,TNF,TNFSF14,TPR,TRIM28,TRIP6,UBR5,WNT3A,XBP1,ZIC1,ZNF268,ZPR1	Any process that activates or increases the frequency, rate or extent of protein import.
GO:1904659	GO	BP	glucose transmembrane transport	PPBP,SLC2A1,SLC2A2,SLC2A3,SLC2A4,SLC2A5,SLC2A6,SLC5A1	The directed movement of glucose across a membrane.
GO:1904666	GO	BP	regulation of ubiquitin protein ligase activity	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,ATM,BUB1,BUB1B,BUB3,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,DUSP1,DYNC1LI1,GEN1,KLHL22,LCMT1,MAD1L1,MAD2L1,MAD2L2,PCID2,PLK1,PTEN,TERF1,TEX14,TPR,TTK,UBE2C,UBE2D1,UBE2E1,USP44,XRCC3,ZNF207	Any process that modulates the frequency, rate or extent of ubiquitin protein ligase activity.
GO:1904680	GO	MF	peptide transmembrane transporter activity	ABCB9,CDH17,SLC15A1,SLC15A2,TAP2,TAPBP	Catalysis of the transfer of peptide from one side of the membrane to the other.
GO:1904714	GO	BP	regulation of chaperone-mediated autophagy	CTSA,EEF1A1,EEF1A2,GFAP,SNCA,SNRNP70	Any process that modulates the frequency, rate or extent of chaperone-mediated autophagy.
GO:1904814	GO	BP	regulation of protein localization to chromosome, telomeric region	CCT2,CCT4,CCT5,CCT6A,CCT7,CCT8,DKC1,GNL3L,H2AFY,TCP1,TERF1,WRAP53	Any process that modulates the frequency, rate or extent of protein localization to chromosome, telomeric region.
GO:1904816	GO	BP	positive regulation of protein localization to chromosome, telomeric region	CCT2,CCT4,CCT5,CCT6A,CCT7,CCT8,DKC1,GNL3L,TCP1,WRAP53	Any process that activates or increases the frequency, rate or extent of protein localization to chromosome, telomeric region.
GO:1904851	GO	BP	positive regulation of establishment of protein localization to telomere	CCT2,CCT4,CCT5,CCT6A,CCT7,CCT8,DKC1,TCP1,WRAP53	Any process that activates or increases the frequency, rate or extent of establishment of protein localization to telomere.
GO:1904871	GO	BP	positive regulation of protein localization to Cajal body	CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,TCP1	Any process that activates or increases the frequency, rate or extent of protein localization to Cajal body.
GO:1904874	GO	BP	positive regulation of telomerase RNA localization to Cajal body	CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,DKC1,NAF1,NHP2,NOP10,RUVBL1,RUVBL2,SHQ1,TCP1	Any process that activates or increases the frequency, rate or extent of telomerase RNA localization to Cajal body.
GO:1990000	GO	BP	amyloid fibril formation	CD36,FKBP1A,GSN,RIPK1,RIPK3	The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins. An example of this is seen when human RIP1 and RIP3 kinases form a heterodimeric functional amyloid signaling complex (PMID:22817896).
GO:1990023	GO	CC	mitotic spindle midzone	CENPE,EML1,KIF20B,MAP10,OR2A4,RCC2	The area in the center of the anaphase spindle consisting of microtubules, microtubule bundling factors and kinesin motors where the spindle microtubules from opposite poles overlap in an antiparallel manner.
GO:1990090	GO	BP	cellular response to nerve growth factor stimulus	ACAP2,AKT1,CIB1,EHD1,KIDINS220,MAGI2,NTRK1,RAB35,RAP1A,RAPGEF1,RAPGEF2,SORT1,STMN2	A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus.
GO:1990111	GO	CC	spermatoproteasome complex	PSMA8,PSMB10,PSMB8,PSMB9,PSME4	A proteasome specifically found in mammalian testis. Contains the proteasome activator PA200 in the regulatory particle, and beta1i, beta2i, beta5i and/or alpha4s in the core (20S) subunit. Beta1i, beta2i and beta5i are inducible catalytic subunits, closely related to beta1, beta2 and beta5. Alpha4s is a sperm-specific 20S subunit, but unlike other alternative 20S subunits alpha4s lies in the outer alpha-ring and lacks catalytic activity.
GO:1990126	GO	BP	retrograde transport, endosome to plasma membrane	ANKRD27,ANKRD50,FAM21C,MICALL1,RAB11B,SDCCAG3,SNX27,VPS26A,VPS29,VPS35,VPS39,WASH1	The directed movement of membrane-bounded vesicles from endosomes back to the plasma membrane, a trafficking pathway that promotes the recycling of internalized transmembrane proteins.
GO:1990138	GO	BP	neuron projection extension	ALCAM,CDK5,CPNE1,CYFIP1,EIF2AK4,FLRT1,FLRT3,IMPACT,IQGAP1,NLGN3,NRP1,NRP2,PPP3CB,SEMA3A,SEMA3F,SLC9A6,SLIT1,SLIT2,SLIT3,USP9X	Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
GO:1990204	GO	CC	oxidoreductase complex	BCKDHA,BCKDHB,BCKDK,BCS1L,CYBA,CYBB,DBT,DLAT,DLD,FOXRED1,MT-CYB,MT-ND1,MT-ND2,MT-ND3,MT-ND4,MT-ND4L,MT-ND5,NCF1,NCF2,NCF4,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF1,NDUFB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS1,NDUFS2,NDUFS3,NDUFS4,NDUFS5,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NOX1,NOXA1,NOXO1,P4HB,PARK7,PDHA1,PDHB,PDHX,PDK2,SDHA,SDHB,SDHC,SDHD,SNCA,UQCC3	Any protein complex that possesses oxidoreductase activity.
GO:1990239	GO	MF	steroid hormone binding	ATP1A1,ATP1A2,ATP1A3,GPER1,NR3C1	Interacting selectively and non-covalently with a steroid hormone.
GO:1990246	GO	CC	uniplex complex	CCDC109B,MCU,MICU1,MICU2,SMDT1	A calcium channel complex in the mitochondrial inner membrane capable of highly-selective calcium channel activity. Its components include the EF-hand-containing proteins mitochondrial calcium uptake 1 (MICU1) and MICU2, the pore-forming subunit mitochondrial calcium uniporter (MCU) and its paralog MCUb, and the MCU regulator EMRE.
GO:1990247	GO	MF	N6-methyladenosine-containing RNA binding	HNRNPA2B1,HNRNPC,YTHDC1,YTHDC2,YTHDF1,YTHDF2,YTHDF3	Interacting selectively and non-covalently with an RNA molecule modified by N6-methyladenosine (m6A), a modification present at internal sites of mRNAs and some non-coding RNAs.
GO:1990266	GO	BP	neutrophil migration	AMICA1,CCL3,CKLF,CXADR,CXCL3,CXCL8,CXCR2,EDN2,EDN3,GBF1,IRAK4,ITGB2,LGALS3,NCKAP1L,PDE4B,PIK3CD,PIK3CG,PIP5K1C,PLA2G1B,S100A12,S100A8,S100A9,SAA1,SYK,TGFB2,UMOD,XCL1	The movement of an neutrophil within or between different tissues and organs of the body.
GO:1990267	GO	BP	response to transition metal nanoparticle	ACO1,ADAM9,ADIRF,AOC1,AQP1,AQP2,AQP9,ATP13A2,ATP5D,ATP7A,ATP7B,B2M,BCL2,BMP6,CRIP1,D2HGDH,FXN,GLRA1,HAAO,HAMP,HFE,HVCN1,IL1A,LOXL2,LRRK2,MT1F,MT1G,MT1M,PARK2,PARK7,PRNP,SLC30A5,SLC34A1,SLFN14,SNCA,TF,TFAP2A,TFR2,ZACN,ZNF658	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transition metal nanoparticle.
GO:1990351	GO	CC	transporter complex	ABCA2,ABCA7,ABCB6,ABCB8,ABCC8,ABCC9,ABCD4,ABCF2,ABCG5,ABCG8,AKAP6,AKAP9,AMIGO1,ANO6,ASPH,ATP12A,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,ATP2A1,ATP2A2,BCS1L,BEST1,BEST2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNA2D1,CACNA2D4,CACNB2,CACNB3,CACNB4,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,CALM1,CAMK2D,CASQ2,CATSPER1,CATSPER2,CATSPER3,CATSPER4,CATSPERB,CATSPERD,CATSPERG,CCDC109B,CHRNA1,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA7,CHRNA9,CHRNB1,CHRNB2,CHRNB3,CHRNB4,CNGA3,CNGB1,CNGB3,CNIH2,CNIH3,CNTNAP1,CNTNAP2,CTTN,DLG2,DLG4,DPP6,FKBP1B,FXYD1,FXYD2,GLRA3,GRIA1,GRIA2,GRIA3,GRIA4,GRID2,GRIN1,GRIN2A,GRIN2B,GRIN3A,GRIN3B,HCN2,HSPA2,KCNA1,KCNA2,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNG3,KCNG4,KCNH1,KCNH2,KCNH4,KCNIP1,KCNIP2,KCNIP3,KCNIP4,KCNJ1,KCNJ11,KCNJ14,KCNJ16,KCNJ2,KCNJ3,KCNJ4,KCNJ5,KCNJ6,KCNJ8,KCNK1,KCNK4,KCNK6,KCNMA1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN4,KCNQ1,KCNS1,KCNS2,LRRC26,LRRC8A,MCU,MICU1,MICU2,MT-CYB,NOS1,NOS1AP,OLFM2,PDE4B,PDE4D,PKD1L1,PKD1L3,PKD2L1,PLN,PPP2R4,PRKACA,PTK2B,RYR2,SCN10A,SCN1B,SCN2A,SCN2B,SCN3B,SCN4B,SCN5A,SCN8A,SCNN1A,SCNN1B,SCNN1G,SHANK1,SHANK2,SHISA9,SLC9A1,SMDT1,SNAP25,STX1A,STXBP5,SUMO1,TIMM10,TIMM10B,TIMM13,TIMM8B,TIMM9,TRDN,TRPC4,TRPC5,UQCC3,VAMP2	A protein complex facilitating transport of molecules (proteins, small molecules, nucleic acids) into, out of or within a cell, or between cells.
GO:1990391	GO	CC	DNA repair complex	ATM,C9orf142,CETN2,CHRAC1,DCLRE1C,ERCC1,ERCC4,ERCC8,KDM1A,LIG4,MSH2,MSH3,MSH6,NHEJ1,PHF21A,POLD1,POLE,POLE2,POLE3,POLE4,PRKDC,RAD23B,RCOR1,SLX4,SWSAP1,WRN,XPC,XRCC4,XRCC5,XRCC6,XRCC6BP1,ZSWIM7	A protein complex involved in DNA repair processes including direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
GO:1990440	GO	BP	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	ATF3,ATF4,ATF6,ATF6B,CEBPB,CREB3L1,CREB3L3,DDIT3,HSPA5,MBTPS2,TP53,XBP1	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
GO:1990462	GO	CC	omegasome	ATG14,EMC6,TRIM5,ULK1,ZFYVE1	Omega-shaped (as in the Greek capital letter) intracellular membrane-bounded organelle enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. Omegasomes are the first step of the formation of autophagosomes via the pre-autophagosomal structures.
GO:1990542	GO	BP	mitochondrial transmembrane transport	ACACA,ACACB,ATP5A1,ATP5B,ATP5C1,ATP5D,ATP5E,ATP5F1,ATP5G1,ATP5G2,ATP5G3,ATP5H,ATP5I,ATP5J,ATP5J2,ATP5L,ATP5O,ATP5S,CHCHD4,CPT1A,CPT1B,CPT2,HSP90AA1,HSPA4,MCU,MICU1,MT-ATP6,MT-ATP8,NDUFA13,PAM16,PRKAA2,PRKAB2,PRKAG2,SAMM50,SLC25A20,SLC25A33,SMDT1,STOML2,TIMM10,TIMM21,TIMM22,TIMM9,TOMM22	The process in which a solute is transported from one side of a membrane to the other into, out of or within a mitochondrion.
GO:1990592	GO	BP	protein K69-linked ufmylation	DDRGK1,UBA5,UFC1,UFL1,UFM1	A protein ufmylation process in which a polymer of the ubiquitin-like protein UFM1 is formed by linkages between lysine residues at position 69 of the UFM1 monomers, is added to a protein.
GO:1990712	GO	CC	HFE-transferrin receptor complex	B2M,BMPR1A,BMPR1B,HFE,HFE2,TF,TFR2,TFRC	A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
GO:1990748	GO	BP	cellular detoxification	ALB,APOA4,APOE,APOM,ATP7A,CAT,CLIC2,CYGB,EPX,FABP1,FAM213A,GPX1,GPX2,GPX3,GPX4,GPX7,GSR,GSTK1,GSTM1,GSTM2,GSTM3,GSTO1,GSTO2,GSTZ1,HBA1,HBB,IPCEF1,MGST1,MGST3,MT3,NOS3,PRDX2,PRDX3,PRDX4,PRDX5,PRDX6,PTGS1,PTGS2,PXDN,PXDNL,SOD1,SOD2,SOD3,TP53INP1,TPO,TXNDC17,TXNDC2,TXNRD1,TXNRD2,TXNRD3,UBIAD1,VIMP	Any process carried out at the cellular level that reduces or removes the toxicity of a toxic substance. These may include transport of the toxic substance away from sensitive areas and to compartments or complexes whose purpose is sequestration of the toxic substance.
GO:1990752	GO	CC	microtubule end	ACTR1A,ACTR1B,ASPM,CDK5RAP2,CKAP5,CLASP1,CLASP2,CLIP1,DST,FAM175B,KIF18B,KIF2C,KNSTRN,NCKAP5L,SLAIN2,SPAG5,SVIL	Any end of a microtubule. Microtubule ends differ in that the so-called microtubule plus-end is the one that preferentially grows by polymerization, with respect to the minus-end.
GO:1990909	GO	CC	Wnt signalosome	APC,CTNNB1,GSK3B,LRP5,LRP6,LRRK2,WNT3	A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
GO:2000001	GO	BP	regulation of DNA damage checkpoint	BRD4,CCAR2,CRY1,DDX39B,FEM1B,RFWD3,RINT1,RPA2,THOC1,THOC5	Any process that modulates the frequency, rate or extent of a DNA damage checkpoint.
GO:2000008	GO	BP	regulation of protein localization to cell surface	ACTN2,CAV3,COMMD1,CTNNB1,EGF,GBF1,GPD1L,GPM6B,KCNAB2,LEPROT,NEDD4L,RAB11B,RAB11FIP5,RANGRF,SNX33,STX3,STX4,TAX1BP3,TNF,TOR1A	Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
GO:2000009	GO	BP	negative regulation of protein localization to cell surface	ACTN2,CAV3,COMMD1,GPM6B,LEPROT,NEDD4L,SNX33,TAX1BP3	Any process that stops, prevents, or reduces the frequency, rate or extent of protein localization to the cell surface.
GO:2000010	GO	BP	positive regulation of protein localization to cell surface	GPD1L,RANGRF,SNX33,STX3,STX4,TNF	Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
GO:2000018	GO	BP	regulation of male gonad development	CITED2,NR5A1,SOX9,SRY,WNT4,WT1	Any process that modulates the frequency, rate or extent of male gonad development.
GO:2000020	GO	BP	positive regulation of male gonad development	CITED2,NR5A1,SOX9,SRY,WT1	Any process that activates or increases the frequency, rate or extent of male gonad development.
GO:2000021	GO	BP	regulation of ion homeostasis	AGT,AGTR1,AKAP6,ANK2,ANK3,AP3D1,ASPH,ATP1A2,B2M,BBC3,BCL2,CACNA1C,CALCA,CALM1,CAMK2D,CAPN3,CASQ1,CASQ2,CAV1,CAV3,CCL19,CCL21,CCL3,CCR5,CCR7,CEMIP,CHERP,CLIC2,CORIN,CXCL10,CXCL11,CXCL9,CXCR3,DCN,DIAPH1,DMD,DRD1,DRD2,EPO,ERO1A,F2,F2R,F2RL3,FGF2,FHL1,FKBP1A,FKBP1B,GJA5,GNB2L1,GPD1L,GPER1,GSTM2,GSTO1,HAP1,HCN4,HRC,HTR2A,HTR2B,HTR2C,HTT,IBTK,IFI6,ITPR1,JPH1,JPH2,JPH3,JPH4,KDR,KNG1,LACRT,LCK,LRRK2,MLLT11,MYOC,NEDD4L,NOL3,NOS1,NPPB,NPR1,NPSR1,P2RX2,P2RX3,P2RX4,P2RX5,P2RX7,PDE4D,PDPK1,PKD2,PLA2G1B,PLCG1,PLCG2,PML,PRKACA,PTK2B,PTPN3,PTPRC,RANGRF,RYR1,RYR2,SCN10A,SCN1B,SCN2B,SCN3B,SCN5A,SLC30A2,SLC30A3,SLC30A4,SLC30A8,SLC8A1,SMAD7,SNCA,SPX,SRC,SRI,THY1,TRDN,TRPC1,TRPC3,WNK2,WNK3,XCL1	Any process that modulates the frequency, rate or extent of ion homeostasis.
GO:2000027	GO	BP	regulation of organ morphogenesis	AGT,AHI1,AMELX,ASPN,BASP1,BCOR,BMP10,BMP2,BMP4,CD34,CITED2,CTNNB1,DAB2,DACT1,DKK1,DVL1,DVL2,DVL3,FBXW7,FGF7,FGFR2,GATA3,GDNF,GREM1,HAND2,HES1,HGF,HPN,LHX1,LIF,MAGI2,MESP1,MLLT3,MMP20,MYC,NACA,NFIB,NKD1,NOG,NPHP3,PAX2,PAX8,PDGFA,PML,POU5F1,RBPJ,RNF207,SHH,SIX1,SIX2,SIX4,SMO,SOX8,SOX9,SRSF6,STAT1,SULF1,TACSTD2,TBX1,TBX2,TFAP2A,TNF,VEGFA,WNT3A,WNT5A,WNT6,WT1,XBP1	Any process that modulates the frequency, rate or extent of organ morphogenesis.
GO:2000036	GO	BP	regulation of stem cell population maintenance	CNOT1,CNOT2,CNOT3,ELAVL1,HMGA2,NODAL,PAX2,PAX8,ZNF706	Any process that modulates the frequency, rate or extent of stem cell population maintenance.
GO:2000045	GO	BP	regulation of G1/S transition of mitotic cell cycle	ADAM17,AIF1,AKT1,ANKRD17,ATM,BRD7,CASP2,CCND1,CDC6,CDC73,CDK10,CDK2,CDKN1A,CDKN1B,CRADD,DACT1,DDX3X,DGKZ,E2F1,E2F7,EGFR,FBXO31,FGF10,FHL1,GML,GTSE1,ID2,INO80,JADE1,KANK2,KIF14,LSM10,LSM11,MDM2,MUC1,MYO16,NACC2,PID1,PIDD1,PIM1,PKD1,PKD2,PLCB1,PLK3,PLK5,PML,PPP1R1C,PPP2R5C,PRKDC,PRMT2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTPN6,RB1,RBM38,RDX,RFWD2,RFWD3,RGCC,RPA2,RPS27A,RPS27L,SLFN11,SMARCA4,SOX4,TCF3,TP53,TRIAP1,UBA52,UBB,UBC,UBE2E2,ZC3H12D,ZNF655	Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle.
GO:2000047	GO	BP	regulation of cell-cell adhesion mediated by cadherin	DENND6A,EPCAM,FLOT1,FOXA1,FOXA2,MAD2L2,PLG,RGCC,SERPINF2	Any process that modulates the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
GO:2000049	GO	BP	positive regulation of cell-cell adhesion mediated by cadherin	DENND6A,FLOT1,FOXA1,FOXA2,SERPINF2	Any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
GO:2000050	GO	BP	regulation of non-canonical Wnt signaling pathway	CSNK1D,CSNK1E,DAB2,DACT1,MLLT3,NKD1,NPHP3,SFRP1,TIAM1,ZNRF3	Any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway.
GO:2000052	GO	BP	positive regulation of non-canonical Wnt signaling pathway	CSNK1D,CSNK1E,DAB2,MLLT3,NKD1,SFRP1	Any process that activates or increases the frequency, rate or extent of non-canonical Wnt-activated signaling pathway.
GO:2000058	GO	BP	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,AXIN1,BTRC,CAV3,CCDC22,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CDKN2A,CLU,CUL1,FBXO5,FBXW7,FZR1,HFE,PDCL3,PLK1,PML,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTK2,PTK2B,RNF139,RPS27A,SKP1,SMURF1,TRIM39,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1,UBE3A	Any process that modulates the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.
GO:2000059	GO	BP	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	CDKN2A,HFE,PDCL3,PML,TRIM39	Any process that stops, prevents, or reduces the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.
GO:2000060	GO	BP	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,AXIN1,BTRC,CAV3,CCDC22,CCNB1,CDC16,CDC20,CDC23,CDC26,CDC27,CDK1,CLU,CUL1,FBXO5,FBXW7,FZR1,PLK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,PTK2,RNF139,RPS27A,SKP1,SMURF1,UBA52,UBB,UBC,UBE2C,UBE2D1,UBE2E1	Any process that activates or increases the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.
GO:2000064	GO	BP	regulation of cortisol biosynthetic process	BMP2,BMP5,DKK3,REST,WNT4	Any process that modulates the frequency, rate or extent of cortisol biosynthetic process.
GO:2000074	GO	BP	regulation of type B pancreatic cell development	ARNTL,BAD,CLOCK,GSK3A,GSK3B,NKX6-1,RFX3,RHEB	Any process that modulates the frequency, rate or extent of pancreatic B cell development.
GO:2000095	GO	BP	regulation of Wnt signaling pathway, planar cell polarity pathway	DAB2,DACT1,MLLT3,NKD1,NPHP3	Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
GO:2000104	GO	BP	negative regulation of DNA-dependent DNA replication	BLM,CHEK2,FBXO18,FBXW7,LIG3,MRE11A,PID1,SMC1A,SMC3,STAG2,TERF1,TERF2,ZNF830,ZRANB3	Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-dependent DNA replication.
GO:2000105	GO	BP	positive regulation of DNA-dependent DNA replication	ATRX,BMP4,BMP5,BMP6,CDC7,DBF4B,E2F7,E2F8,INO80,STOML2,WIZ	Any process that activates or increases the frequency, rate or extent of DNA-dependent DNA replication.
GO:2000106	GO	BP	regulation of leukocyte apoptotic process	ADAM17,ADAM8,AURKB,AXL,BBC3,BCL10,BCL6,BIRC7,BMP4,BTK,CCL19,CCL21,CCL5,CCR7,CD3G,CDKN2A,CXCL12,FADD,FNIP1,FOXP1,GAS6,HCAR2,HCLS1,IDO1,IL10,IL2,IRF7,IRS2,JAK3,LGALS16,LGALS3,LGALS9,LILRB1,LYN,MEF2C,MERTK,NOC2L,NOD2,PDCD1,PIP,PRELID1,PRKCQ,RAPGEF2,RIPK3,RORC,SIRT1,TP53,VIMP,ZC3H8	Any process that modulates the frequency, rate or extent of leukocyte apoptotic process.
GO:2000107	GO	BP	negative regulation of leukocyte apoptotic process	AURKB,AXL,BCL10,BCL6,BMP4,CCL19,CCL21,CCL5,CCR7,CXCL12,FADD,FOXP1,GAS6,HCLS1,IL2,IRF7,IRS2,JAK3,LILRB1,MERTK,NOC2L,NOD2,PIP,PRKCQ,RORC,VIMP	Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte apoptotic process.
GO:2000108	GO	BP	positive regulation of leukocyte apoptotic process	ADAM8,BBC3,CCL5,CDKN2A,FNIP1,HCAR2,IDO1,IL10,LGALS16,LGALS9,LYN,MEF2C,PDCD1,PRELID1,RAPGEF2,SIRT1,TP53,ZC3H8	Any process that activates or increases the frequency, rate or extent of leukocyte apoptotic process.
GO:2000109	GO	BP	regulation of macrophage apoptotic process	CDKN2A,IRF7,MEF2C,NOD2,SIRT1,VIMP	Any process that modulates the frequency, rate or extent of macrophage apoptotic process.
GO:2000114	GO	BP	regulation of establishment of cell polarity	ARFGEF1,BCAS3,CDH5,FLOT2,GNB2L1,GSN,KANK1,KIF20B,KRIT1,PTK2B,RAP1B,ROCK1,ROCK2,RUFY3,SHTN1	Any process that modulates the frequency, rate or extent of establishment of cell polarity.
GO:2000116	GO	BP	regulation of cysteine-type endopeptidase activity	ACER2,ACVR1C,AIFM1,AIM2,AKT1,ANP32B,APAF1,AQP1,ARL6IP5,ASPH,AVP,BAD,BAK1,BAX,BBC3,BCAP31,BCL2L10,BCL2L11,BCL2L12,BCL2L13,BIRC2,BIRC3,BIRC5,BOK,CARD8,CASP1,CASP2,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CD27,CD44,CDKN1B,CDKN2A,CDKN2D,CFLAR,CIDEB,COL4A3,CSNK2A1,CTSH,CYCS,CYFIP2,DAP,DAPK1,DDX3X,DHCR24,DIABLO,DLC1,DNAJA3,DNAJB6,DPEP1,EIF2AK3,EPHA7,F2R,F3,FABP1,FADD,FAM162A,FAS,FASLG,FIS1,FNIP1,FOXL2,GAS6,GNB2L1,GPER1,GPX1,GSN,HGF,HIP1,HMGB1,HSPD1,HSPE1,HTRA2,IFI16,IFI27,IFI6,IFT57,IGBP1,JAK2,KIAA0141,KLF4,LAMTOR5,LCK,LEF1,LGALS9,LY96,MAGEA3,MAP2K5,MAP3K5,MEFV,MMP9,MT3,MTCH1,MUL1,MYC,NAIP,NDUFA13,NGF,NGFR,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NLRP2,NLRP3,NOD1,NODAL,NOL3,PAK2,PARK7,PAX2,PCID2,PDCD2,PDCD5,PDCD6,PERP,PIH1D1,PLAUR,PMAIP1,PPARG,PPM1F,PRDX3,PRDX5,PSMB9,PYCARD,RAF1,REST,RET,RFFL,RIPK1,RNF34,ROBO1,RPS27L,RPS3,RPS6KA1,RPS6KA3,S100A8,S100A9,SENP1,SERPINB9,SFN,SH3RF1,SIAH2,SIRT1,SLC11A2,SMAD3,SNCA,SOX2,SOX7,SRC,TBC1D10A,TFAP2B,THBS1,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFAIP8,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF14,TNFSF15,TRADD,TRAF2,TRIAP1,USP47,VCP,VEGFA,XDH,XIAP,YWHAE	Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity.
GO:2000117	GO	BP	negative regulation of cysteine-type endopeptidase activity	AKT1,AQP1,AVP,BCL2L12,BIRC5,CASP8,CD27,CD44,CDKN2D,CFLAR,CSNK2A1,DDX3X,DHCR24,DNAJA3,DNAJB6,DPEP1,FABP1,FADD,FAS,FASLG,FNIP1,GAS6,GPX1,HGF,IFI16,IFI6,IGBP1,KLF4,LAMTOR5,LEF1,MAGEA3,MAP2K5,MMP9,MT3,NAIP,NOL3,PAK2,PARK7,PAX2,PCID2,PIH1D1,PLAUR,PRDX3,PRDX5,RAF1,RFFL,RIPK1,RNF34,RPS6KA1,RPS6KA3,SERPINB9,SFN,SH3RF1,SIAH2,SNCA,SRC,TFAP2B,THBS1,TNFAIP8,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF14,TRADD,TRAF2,TRIAP1,USP47,VEGFA,XIAP	Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.
GO:2000121	GO	BP	regulation of removal of superoxide radicals	BMP7,DHFR,FBLN5,GCH1,PARK7,SZT2,TNF	Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
GO:2000134	GO	BP	negative regulation of G1/S transition of mitotic cell cycle	ATM,BRD7,CASP2,CCND1,CDC73,CDK2,CDKN1A,CDKN1B,CRADD,DACT1,DGKZ,E2F7,FBXO31,FHL1,GML,GTSE1,JADE1,KANK2,MDM2,MUC1,MYO16,NACC2,PIDD1,PKD2,PLK3,PML,PPP2R5C,PRKDC,PRMT2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD1,PSMD10,PSMD11,PSMD12,PSMD13,PSMD14,PSMD2,PSMD3,PSMD4,PSMD5,PSMD6,PSMD7,PSMD8,PSMD9,PSME1,PSME2,PSME3,PSME4,PSMF1,PTEN,RB1,RBM38,RFWD2,RFWD3,RPA2,RPS27A,RPS27L,SLFN11,SMARCA4,SOX4,TP53,TRIAP1,UBA52,UBB,UBC,ZC3H12D,ZNF655	Any cell cycle regulatory process that prevents the commitment of a cell from G1 to S phase of the mitotic cell cycle.
GO:2000136	GO	BP	regulation of cell proliferation involved in heart morphogenesis	BMP10,BMP4,CTNNB1,HAND2,HES1,NACA,RBPJ	Any process that modulates the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
GO:2000142	GO	BP	regulation of DNA-templated transcription, initiation	ATF7IP,BCLAF1,CTNNB1,FOSL1,HEY2,HMGB1,HNF1A,HNF1B,JUN,MITF,NKX2-5,PAXIP1,SETX,SRF,TAF1,THRA,TWIST1	Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.
GO:2000144	GO	BP	positive regulation of DNA-templated transcription, initiation	BCLAF1,CTNNB1,FOSL1,HNF1A,HNF1B,JUN,MITF,NKX2-5,PAXIP1,SETX,SRF,TAF1,TWIST1	Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
GO:2000146	GO	BP	negative regulation of cell motility	ACVR1C,ACVRL1,ADAM15,ADARB1,ADIPOQ,AGTR2,AIF1,ALOX15B,ANGPT2,ANGPT4,APOD,APOE,APOH,ARAP3,ARHGDIB,ARPIN,BMP10,BMP5,BST2,C5,C5AR2,CCL2,CCL21,CCL25,CCL28,CD300A,CHRD,CITED2,CLASP1,CLASP2,CLIC4,COL3A1,CORO1B,CORO1C,CSNK2B,CXCL12,CXCL13,CYP1B1,DAB2IP,DACH1,DAG1,DCN,DLC1,DLL4,DPEP1,DPYSL3,DRD2,ENG,EPHA1,EPPIN,EVL,FAM60A,FBLN1,FGF2,FLCN,FUZ,GATA3,GCSAM,GDF2,GREM1,GTPBP4,HAS1,HDAC5,HMGB1,HMOX1,HOXA7,HRG,HYAL2,IFITM1,IGFBP3,IGFBP5,IL4,ITGB1BP1,KANK1,KLF4,KLRK1,KRIT1,KRT16,LDLRAD4,LRP1,MAGI2,MAP2K5,MARVELD3,MCC,MIA3,MMRN2,NBL1,NDRG4,NF1,NF2,NKX2-1,NODAL,NOG,NOTCH1,NOV,NR2F2,PADI2,PBLD,PDCD10,PFN2,PHLDB2,PIN1,PKP2,PLCB1,PLXNB3,PODN,PTEN,PTGER4,PTPN23,PTPRG,PTPRJ,PTPRK,PTPRM,PTPRR,PTPRU,RAP2C,RECK,RGCC,RHOA,RHOB,RNF20,RNF41,SCAI,SEMG1,SERPINE1,SFRP1,SFRP2,SHH,SLIT2,SMAD7,SP100,SPINT2,SRGAP2,STAP1,STARD13,STC1,STK24,STRAP,SULF1,SVBP,SYNJ2BP,TACSTD2,TBX5,TCAF1,TGFB1,THBS1,THY1,TIMP1,TP53INP1,TPM1,TRIB1,VASH1,VCL,WAS,WASL,WNT11	Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
GO:2000169	GO	BP	regulation of peptidyl-cysteine S-nitrosylation	ACE,ATP2B4,DMD,NOS1AP,SNTA1	Any process that modulates the frequency, rate or extent of peptidyl-cysteine S-nitrosylation.
GO:2000171	GO	BP	negative regulation of dendrite development	APOE,BCL11A,DCC,EFNA1,GORASP1,KIAA0319,NGEF,NLGN1,PTEN,RAPGEF2,SRGAP2C,YWHAH	Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
GO:2000177	GO	BP	regulation of neural precursor cell proliferation	CTNNB1,DISC1,DLL4,DRD2,FZD3,GATA2,ID2,INSM1,KDM2B,LHX1,LRRK2,NES,NF1,PROX1,PTPRZ1,SHCBP1,SIRT2,SIX3,SMARCD3,TRIM71,VEGFA,ZNF335	Any process that modulates the frequency, rate or extent of neural precursor cell proliferation.
GO:2000178	GO	BP	negative regulation of neural precursor cell proliferation	GATA2,ID2,KDM2B,NF1,SIRT2	Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
GO:2000179	GO	BP	positive regulation of neural precursor cell proliferation	CTNNB1,DISC1,DLL4,DRD2,FZD3,INSM1,LHX1,NES,PROX1,SMARCD3,VEGFA,ZNF335	Any process that activates or increases the frequency, rate or extent of neural precursor cell proliferation.
GO:2000181	GO	BP	negative regulation of blood vessel morphogenesis	AMOT,ANGPT4,APOH,CCR2,COL4A2,COL4A3,CXCR3,DAB2IP,DCN,DLL4,ECSCR,FASLG,FOXC1,FOXO4,GDF2,GHRL,GTF2I,HDAC5,HHEX,HOXA5,HRG,IL17F,ITGB1BP1,KLF4,KLK3,KRIT1,LECT1,MAP2K5,MMRN2,NOTCH1,NPPB,NPR1,PDCD10,PDE3B,PF4,PML,PTPRM,RGCC,RHOA,ROCK1,ROCK2,SEMA3E,SERPINE1,SERPINF1,SPARC,SPINK5,STAB1,STARD13,STAT1,SULF1,SYNJ2BP,TEK,THBS1,THBS2,VASH1,WNT4,XDH	Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis.
GO:2000188	GO	BP	regulation of cholesterol homeostasis	ACOX1,FGFR4,HNF4A,NPC1,NR1D1,NR1H2,NR1H3,RORA	Any process that modulates the frequency, rate or extent of cholesterol homeostasis.
GO:2000191	GO	BP	regulation of fatty acid transport	ACSL4,AKT1,AKT2,CYP4A11,CYP4F2,IL1B,IRS2,NCOR1,P2RX4,PLA2G10,PLA2R1,SYK,THBS1,TNFRSF11A,TNFSF11	Any process that modulates the frequency, rate or extent of fatty acid transport.
GO:2000192	GO	BP	negative regulation of fatty acid transport	ACSL4,AKT1,AKT2,CYP4F2,IRS2,PLA2R1,THBS1	Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid transport.
GO:2000209	GO	BP	regulation of anoikis	AES,ANKRD13C,BCL2,BCL2L1,BRMS1,CAV1,CEACAM5,ITGA5,ITGB1,MCL1,MYBBP1A,NOTCH1,PDK4,PIK3CA,PTK2,PTRH2,SIK1,SNAI2,SRC,TLE1,ZNF304	Any process that modulates the frequency, rate or extent of anoikis.
GO:2000210	GO	BP	positive regulation of anoikis	AES,BRMS1,MYBBP1A,PTRH2,SIK1	Any process that activates or increases the frequency, rate or extent of anoikis.
GO:2000241	GO	BP	regulation of reproductive process	ACVR1B,ACVR1C,ARHGDIB,ASTL,ASUN,C1QBP,CACNA1H,CIB1,CITED2,DMRT1,DUSP1,FAM170B,FGFR2,GDF9,GLRA1,HORMAD1,IGF1,INHBA,INHBB,IQCF1,MOS,NANOS2,NKX3-1,NODAL,NOX5,NPM2,NPPC,NR5A1,PLCB1,PRDM9,RAD1,RNASE10,SIRT2,SMURF2,SOX9,SPINK13,SRY,SULF1,TEKT3,TIMP1,WEE2,WNT4,WT1,XBP1,ZP2,ZP3,ZP4	Any process that modulates the frequency, rate or extent of reproductive process.
GO:2000242	GO	BP	negative regulation of reproductive process	ACVR1C,ARHGDIB,ASTL,DMRT1,DUSP1,HORMAD1,IGF1,MOS,NANOS2,NKX3-1,NODAL,NPPC,RAD1,SPINK13,SULF1,TIMP1,WEE2,WNT4,WT1,ZP2,ZP3,ZP4	Any process that stops, prevents, or reduces the frequency, rate or extent of reproductive process.
GO:2000243	GO	BP	positive regulation of reproductive process	ACVR1B,C1QBP,CACNA1H,CIB1,CITED2,FAM170B,GLRA1,INHBA,INHBB,IQCF1,NPM2,NR5A1,PLCB1,PRDM9,SIRT2,SMURF2,SOX9,SRY,WT1,XBP1,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of reproductive process.
GO:2000249	GO	BP	regulation of actin cytoskeleton reorganization	ABL1,ABL2,BAIAP2L1,BCAS3,CDK5,CSF1R,CSF3,DAPK3,F11R,FES,HAX1,HCK,HCLS1,HRAS,NTF3,NTRK3,PDGFRA,PHPT1,PTK2B,RAPGEF3,SEMA3E,STAP1,TEK	Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
GO:2000251	GO	BP	positive regulation of actin cytoskeleton reorganization	BAIAP2L1,BCAS3,CDK5,CSF3,FES,HAX1,HCK,HCLS1,HRAS,NTF3,NTRK3,STAP1,TEK	Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization.
GO:2000257	GO	BP	regulation of protein activation cascade	A2M,C1QBP,C2,C3,C4A,C4B,C4BPA,C4BPB,C5,C6,C7,C8A,C8B,C8G,C9,CD46,CD55,CD59,CFB,CFH,CFI,CFP,CR1,FGA,MASP1,PHB,PROS1,SERPING1,SUSD4,VTN	Any process that modulates the frequency, rate or extent of protein activation cascade.
GO:2000258	GO	BP	negative regulation of protein activation cascade	A2M,C4BPA,C4BPB,CD55,CR1,FGA,MASP1,SERPING1,SUSD4	Any process that stops, prevents or reduces the frequency, rate or extent of protein activation cascade.
GO:2000269	GO	BP	regulation of fibroblast apoptotic process	BCL2L11,BTG1,GAS6,IER3IP1,SFRP1,STK17A,STK17B,TP63	Any process that modulates the frequency, rate or extent of fibroblast apoptotic process.
GO:2000271	GO	BP	positive regulation of fibroblast apoptotic process	BCL2L11,BTG1,SFRP1,STK17A,STK17B,TP63	Any process that activates or increases the frequency, rate or extent of fibroblast apoptotic process.
GO:2000272	GO	BP	negative regulation of receptor activity	CALM1,CASQ2,CBLC,CHRFAM7A,CLIC2,CRHBP,ERRFI1,FKBP1B,FOXH1,GPRC5A,GSTM2,GSTO1,HEYL,HFE,PCSK9,PKD2,SNX6,SOCS4,SOCS5,SRI,TRDN,ZFYVE28,ZGPAT	Any process that stops, prevents or reduces the frequency, rate or extent of receptor activity.
GO:2000273	GO	BP	positive regulation of receptor activity	ADAM17,ADRA2A,ADRA2B,ADRA2C,AKAP6,ANXA2,ASPH,BUD31,CALM1,CFTR,EGF,EPGN,EREG,FBXW7,GREM1,GSTM2,GSTO1,HAP1,HFE,HTT,IGF2,JPH2,MED1,MED16,NCOA3,NLGN3,PARK7,PKD2,PPARGC1B,RELN,SHANK3,TGFA,TRDN	Any process that activates or increases the frequency, rate or extent of receptor activity.
GO:2000278	GO	BP	regulation of DNA biosynthetic process	ACD,ACVRL1,ADIPOQ,ANKRD1,AURKB,BMPR2,CCT2,CCT4,CERS1,CTC1,DACH1,DKC1,FGFR4,GDF2,GREM1,GRHL2,HGF,HMBOX1,KLF4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MCRS1,MEN1,MYC,NEK2,NEK7,NVL,OBFC1,PARM1,PDGFB,PDGFRB,PIF1,PINX1,PKIB,PML,PNKP,POT1,PRKCQ,PRKD2,RGCC,SRC,TCP1,TEN1,TERF1,TINF2,TNKS,TP53,WRAP53	Any process that modulates the frequency, rate or extent of DNA biosynthetic process.
GO:2000279	GO	BP	negative regulation of DNA biosynthetic process	ACVRL1,ADIPOQ,ANKRD1,BMPR2,CERS1,CTC1,DACH1,GDF2,MCRS1,MEN1,OBFC1,PIF1,PINX1,PML,POT1,SRC,TEN1,TERF1,TINF2,TP53	Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
GO:2000300	GO	BP	regulation of synaptic vesicle exocytosis	LRRK2,NLGN1,RAB3A,RAB3GAP1,RAB5A,RIMS3,RIMS4,SEPT5,STX1B,STXBP1,SYN1,UNC13B	Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
GO:2000303	GO	BP	regulation of ceramide biosynthetic process	GNB2L1,NSMAF,PRKAA1,PRKCD,SAMD8,SMPD2,SMPD3,TNF,TNFRSF1A	Any process that modulates the frequency, rate or extent of a ceramide biosynthetic process.
GO:2000304	GO	BP	positive regulation of ceramide biosynthetic process	GNB2L1,NSMAF,PRKCD,SMPD2,SMPD3,TNF,TNFRSF1A	Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
GO:2000310	GO	BP	regulation of N-methyl-D-aspartate selective glutamate receptor activity	CRH,CRHBP,DAPK1,DLG4,MAPK8IP2,MEF2C,NLGN1,NRXN1,OPRM1,PTK2B,RELN	Any process that modulates the frequency, rate or extent of N-methyl-D-aspartate selective glutamate receptor activity.
GO:2000311	GO	BP	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	CACNG2,CACNG3,CACNG4,CACNG5,CACNG7,CACNG8,CNIH2,CNIH3,MAPK8IP2,MEF2C,MINK1,NLGN1,NLGN2,NLGN3,NRXN1,RELN,SHANK1,SHANK3	Any process that modulates the frequency, rate or extent of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity.
GO:2000316	GO	BP	regulation of T-helper 17 type immune response	FOXP3,IL12B,IL12RB1,IL23A,IL23R,NLRP10,PRKCQ	Any process that modulates the frequency, rate or extent of T-helper 17 type immune response.
GO:2000318	GO	BP	positive regulation of T-helper 17 type immune response	IL12B,IL12RB1,IL23A,IL23R,NLRP10,PRKCQ	Any process that activates or increases the frequency, rate or extent of T-helper 17 type immune response.
GO:2000319	GO	BP	regulation of T-helper 17 cell differentiation	FOXP3,IL12B,IL12RB1,IL23A,IL23R	Any process that modulates the frequency, rate or extent of T-helper 17 cell differentiation.
GO:2000322	GO	BP	regulation of glucocorticoid receptor signaling pathway	ARNTL,CLOCK,CRY1,CRY2,LMO3,PER1,PHB	Any process that modulates the frequency, rate or extent of glucocorticoid receptor signaling pathway.
GO:2000323	GO	BP	negative regulation of glucocorticoid receptor signaling pathway	ARNTL,CLOCK,CRY1,CRY2,PER1,PHB	Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid receptor signaling pathway.
GO:2000341	GO	BP	regulation of chemokine (C-X-C motif) ligand 2 production	CD74,KLF4,MAP2K5,TIRAP,TNF	Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
GO:2000344	GO	BP	positive regulation of acrosome reaction	CACNA1H,FAM170B,GLRA1,IQCF1,PLCB1,ZP3,ZP4	Any process that activates or increases the frequency, rate or extent of the acrosome reaction.
GO:2000351	GO	BP	regulation of endothelial cell apoptotic process	AKR1C3,ANGPT1,ANO6,CD40,CD40LG,ECSCR,FASLG,FGA,FGB,FGG,GAS6,GATA3,GPER1,ICAM1,IL13,IL4,KDR,KRIT1,MAPK7,NDNF,NFE2L2,PRKCI,RAMP2,RGCC,SCG2,SEMA5A,SERPINE1,TEK,THBS1,TNFAIP3,TNIP2,XBP1	Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
GO:2000352	GO	BP	negative regulation of endothelial cell apoptotic process	ANGPT1,FGA,FGB,FGG,GAS6,GATA3,ICAM1,IL13,IL4,KDR,KRIT1,MAPK7,NDNF,NFE2L2,RAMP2,SCG2,SEMA5A,SERPINE1,TEK,TNFAIP3,TNIP2	Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
GO:2000353	GO	BP	positive regulation of endothelial cell apoptotic process	AKR1C3,ANO6,CD40,CD40LG,ECSCR,FASLG,GPER1,PRKCI,RGCC,THBS1,XBP1	Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
GO:2000369	GO	BP	regulation of clathrin-mediated endocytosis	AAK1,DAB2,NLGN1,PIK3CB,SCYL2,SNAP91,SYNJ1,TNK2,TOR1A,UBQLN2,UNC119,WASL	Any process that modulates the frequency, rate or extent of clathrin-mediated endocytosis.
GO:2000370	GO	BP	positive regulation of clathrin-mediated endocytosis	DAB2,NLGN1,SCYL2,SYNJ1,TOR1A,WASL	Any process that activates or increases the frequency, rate or extent of clathrin-mediated endocytosis.
GO:2000377	GO	BP	regulation of reactive oxygen species metabolic process	AATF,ACE2,AGT,AGTR1,AGTR2,AGXT2,AKR1C3,AKT1,ARF4,ASS1,ATP2B4,BCO2,BMP7,BRCA1,CAV1,CD34,CDKN1A,CLU,COQ7,CRP,CYBA,CYP1B1,DDAH1,DDAH2,DHFR,EDN1,EGFR,ESR1,F2,F2RL1,FBLN5,FOXM1,GADD45A,GCH1,GLA,GRB2,GSTP1,HBB,HDAC6,HP,HSP90AA1,HSP90AB1,IFNG,IL1B,INS,INSR,IRG1,KLF4,MAPK14,MMP3,MPV17,MPV17L,MT3,NOS1AP,NOX5,NOXA1,NOXO1,OPRM1,P2RX4,PARK2,PARK7,PARL,PAX2,PDGFB,PDGFRB,PDK3,PID1,PINK1,PKD2,PLIN5,PRKCD,PTGIS,PTGS2,RAB27A,RAC1,RAC2,RIPK1,RNF41,ROMO1,SIRT2,SIRT5,SLC18A2,SLC25A33,SNCA,SOD1,STK17A,SYK,SZT2,TFAP2A,TGFB1,TGFBR2,THBS1,TNF,TP53,TRAP1,VIMP,XDH,ZC3H12A,ZNF205	Any process that modulates the frequency, rate or extent of reactive oxygen species metabolic process.
GO:2000378	GO	BP	negative regulation of reactive oxygen species metabolic process	AATF,ATP2B4,BRCA1,CAV1,CD34,GLA,HDAC6,HP,MMP3,MPV17L,MT3,OPRM1,PARK2,PAX2,PINK1,PLIN5,PTGIS,SIRT2,SIRT5,SLC18A2,TFAP2A,TRAP1,ZC3H12A	Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process.
GO:2000379	GO	BP	positive regulation of reactive oxygen species metabolic process	ACE2,AGT,AGTR1,AGTR2,AGXT2,AKR1C3,AKT1,ASS1,CDKN1A,CLU,CRP,CYBA,DDAH1,DDAH2,EDN1,EGFR,ESR1,F2,F2RL1,GADD45A,GRB2,GSTP1,HBB,HSP90AA1,HSP90AB1,IFNG,IL1B,INS,INSR,IRG1,KLF4,MAPK14,NOS1AP,NOX5,OPRM1,P2RX4,PARK7,PDGFB,PDGFRB,PID1,PKD2,PRKCD,PTGS2,RAB27A,RIPK1,RNF41,ROMO1,SNCA,SOD1,TGFB1,TGFBR2,THBS1,TNF,TP53,XDH,ZC3H12A,ZNF205	Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
GO:2000380	GO	BP	regulation of mesoderm development	CER1,DKK1,MESP1,MIXL1,NODAL,RPS6KA6,SHH,SMAD2,WNT3A	Any process that modulates the frequency, rate or extent of mesoderm development.
GO:2000392	GO	BP	regulation of lamellipodium morphogenesis	ARHGEF7,ARPIN,CORO1B,CORO1C,ENPP2,KANK1,RREB1,SRC,VIL1	Any process that modulates the frequency, rate or extent of lamellipodium morphogenesis.
GO:2000394	GO	BP	positive regulation of lamellipodium morphogenesis	ARHGEF7,CORO1B,CORO1C,ENPP2,RREB1,SRC,VIL1	Any process that activates or increases the frequency, rate or extent of lamellipodium morphogenesis.
GO:2000401	GO	BP	regulation of lymphocyte migration	ADAM10,ADAM17,ADAM8,AIF1,APOD,CCL2,CCL20,CCL21,CCL3,CCL4,CCL5,CCL7,CCR2,CXCL10,CXCL12,CXCL13,FADD,GCSAM,KLRK1,MSN,PADI2,PTK2B,PYCARD,RIPK3,S100A7,STK10,TMEM102,WASL,WNT5A,XCL1	Any process that modulates the frequency, rate or extent of lymphocyte migration.
GO:2000402	GO	BP	negative regulation of lymphocyte migration	APOD,CCL2,GCSAM,KLRK1,PADI2,WASL	Any process that stops, prevents or reduces the frequency, rate or extent of lymphocyte migration.
GO:2000403	GO	BP	positive regulation of lymphocyte migration	ADAM10,ADAM17,ADAM8,AIF1,CCL20,CCL21,CCL3,CCL4,CCL5,CCL7,CCR2,CXCL10,CXCL12,CXCL13,FADD,PTK2B,PYCARD,S100A7,TMEM102,WNT5A,XCL1	Any process that activates or increases the frequency, rate or extent of lymphocyte migration.
GO:2000404	GO	BP	regulation of T cell migration	ADAM10,ADAM17,ADAM8,AIF1,APOD,CCL20,CCL21,CCL5,CCR2,CXCL10,CXCL12,CXCL13,FADD,PYCARD,RIPK3,S100A7,TMEM102,WNT5A,XCL1	Any process that modulates the frequency, rate or extent of T cell migration.
GO:2000406	GO	BP	positive regulation of T cell migration	ADAM10,ADAM17,ADAM8,AIF1,CCL20,CCL21,CCL5,CCR2,CXCL10,CXCL12,CXCL13,FADD,PYCARD,S100A7,TMEM102,WNT5A,XCL1	Any process that activates or increases the frequency, rate or extent of T cell migration.
GO:2000425	GO	BP	regulation of apoptotic cell clearance	ABCA7,ALOX15,C2,C3,C4A,C4B,CCL2,ITGAV	Any process that modulates the frequency, rate or extent of apoptotic cell clearance.
GO:2000427	GO	BP	positive regulation of apoptotic cell clearance	ABCA7,C2,C3,C4A,C4B,CCL2	Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
GO:2000463	GO	BP	positive regulation of excitatory postsynaptic potential	CUX2,DLG4,GRIN1,NLGN1,NLGN2,NLGN3,NRXN1,PRKCZ,PTEN,PTK2B,RELN,RIMS1,RIMS2,SHANK1,SHANK3,STX1B,WNT7A	Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
GO:2000465	GO	BP	regulation of glycogen (starch) synthase activity	ADIPOQ,GSK3A,GSK3B,IGF2,INPP5K,PPP1R3F	Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
GO:2000479	GO	BP	regulation of cAMP-dependent protein kinase activity	ADIPOQ,ATP2B4,PKIA,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,RAPGEF2,SIRT1	Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
GO:2000480	GO	BP	negative regulation of cAMP-dependent protein kinase activity	PKIA,PRKAR1A,PRKAR1B,PRKAR2A,PRKAR2B,SIRT1	Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
GO:2000482	GO	BP	regulation of interleukin-8 secretion	ANXA1,ANXA4,C5AR2,CAMP,CD2,CD244,CD58,CRP,F2R,F2RL1,FCN1,FFAR2,HYAL2,LGALS9,NLRP10,PTPN22,PYCARD,SSC5D	Any process that modulates the frequency, rate or extent of interleukin-8 secretion.
GO:2000484	GO	BP	positive regulation of interleukin-8 secretion	CAMP,CD2,CD244,CD58,F2R,F2RL1,FCN1,FFAR2,HYAL2,LGALS9,NLRP10,PYCARD	Any process that activates or increases the frequency, rate or extent of interleukin-8 secretion.
GO:2000501	GO	BP	regulation of natural killer cell chemotaxis	CCL2,CCL3,CCL4,CCL5,CCL7,KLRK1,XCL1	Any process that modulates the frequency, rate or extent of natural killer cell chemotaxis.
GO:2000503	GO	BP	positive regulation of natural killer cell chemotaxis	CCL3,CCL4,CCL5,CCL7,XCL1	Any process that activates or increases the frequency, rate or extent of natural killer cell chemotaxis.
GO:2000505	GO	BP	regulation of energy homeostasis	BMP8A,CD36,DLL1,FLCN,FOXO1,LEPR,METRNL,MLXIPL,NR1D2,NR4A3,PASK,PPARGC1A,PRKAA1,PRKAA2	Any process that modulates the frequency, rate or extent of energy homeostasis.
GO:2000510	GO	BP	positive regulation of dendritic cell chemotaxis	C1QBP,CALR,CCL21,CCR7,GAS6,IL12A,LGALS9	Any process that activates or increases the frequency, rate or extent of dendritic cell chemotaxis.
GO:2000514	GO	BP	regulation of CD4-positive, alpha-beta T cell activation	AGER,ANXA1,CCL19,CD55,CD80,CD86,FOXP3,HMGB1,IFNG,IL12B,IL12RB1,IL23A,IL23R,IL27,IRF4,JAK3,LGALS9,MYB,NCKAP1L,NLRP3,PRKCQ,PRKCZ,RARA,RC3H1,SOCS5,TNFSF4,XCL1	Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
GO:2000515	GO	BP	negative regulation of CD4-positive, alpha-beta T cell activation	ANXA1,FOXP3,HMGB1,JAK3,LGALS9,RC3H1,SOCS5,TNFSF4,XCL1	Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
GO:2000516	GO	BP	positive regulation of CD4-positive, alpha-beta T cell activation	ANXA1,CCL19,CD55,CD80,CD86,FOXP3,IFNG,IL12B,IL12RB1,IL23A,IL23R,LGALS9,MYB,NCKAP1L,NLRP3,PRKCQ,PRKCZ,RARA,SOCS5,TNFSF4,XCL1	Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
GO:2000535	GO	BP	regulation of entry of bacterium into host cell	CAV1,EXOC2,EXOC7,FUCA2,ITGAV	Any process that modulates the frequency, rate or extent of entry of bacterium into host cell.
GO:2000542	GO	BP	negative regulation of gastrulation	COL5A1,COL5A2,DKK1,FZD7,MESP1	Any process that stops, prevents or reduces the frequency, rate or extent of gastrulation.
GO:2000543	GO	BP	positive regulation of gastrulation	FOXA2,GNB2L1,LHX1,OSR1,OTX2,SCX,TENM4,WNT3A	Any process that activates or increases the frequency, rate or extent of gastrulation.
GO:2000544	GO	BP	regulation of endothelial cell chemotaxis to fibroblast growth factor	CXCL13,FGF1,FGF16,FGF18,FGF2,FGF4,FGFR1	Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
GO:2000551	GO	BP	regulation of T-helper 2 cell cytokine production	IFNA2,IFNB1,NLRP3,PRKCZ,RSAD2,XCL1	Any process that modulates the frequency, rate or extent of T-helper 2 cell cytokine production.
GO:2000573	GO	BP	positive regulation of DNA biosynthetic process	ACD,AURKB,CCT2,CCT4,DKC1,FGFR4,GREM1,GRHL2,HGF,HMBOX1,KLF4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MYC,NEK2,NEK7,NVL,OBFC1,PARM1,PDGFB,PDGFRB,PKIB,PNKP,POT1,PRKCQ,PRKD2,RGCC,TCP1,TNKS,WRAP53	Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
GO:2000601	GO	BP	positive regulation of Arp2/3 complex-mediated actin nucleation	ABI2,BRK1,CYFIP1,NCKAP1,WASF1	Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation.
GO:2000615	GO	BP	regulation of histone H3-K9 acetylation	BRCA1,CHEK1,KMT2A,PIH1D1,SMAD4,SMARCB1	Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.
GO:2000630	GO	BP	positive regulation of miRNA metabolic process	HRAS,NFKB1,PNPT1,RELA,ZC3H12A	Any process that activates or increases the frequency, rate or extent of miRNA metabolic process.
GO:2000637	GO	BP	positive regulation of gene silencing by miRNA	AJUBA,LIMD1,PUM1,PUM2,WTIP	Any process that activates or increases the frequency, rate or extent of gene silencing by miRNA.
GO:2000641	GO	BP	regulation of early endosome to late endosome transport	DAB2,DNAJC13,EZR,MAP2K1,MAP2K2,MAPK1,MAPK3,MSN,MTMR2,PTPN23,RAB21,RDX,SNX12,SNX3,SRC,VPS11	Any process that modulates the frequency, rate or extent of early endosome to late endosome transport.
GO:2000643	GO	BP	positive regulation of early endosome to late endosome transport	DAB2,EZR,MSN,MTMR2,PTPN23,RAB21,RDX,VPS11	Any process that activates or increases the frequency, rate or extent of early endosome to late endosome transport.
GO:2000644	GO	BP	regulation of receptor catabolic process	ANXA2,APOE,FURIN,HAMP,MTMR2,PCSK9,PTPN1	Any process that modulates the frequency, rate or extent of receptor catabolic process.
GO:2000647	GO	BP	negative regulation of stem cell proliferation	BMP4,CTNNBIP1,FBLN1,KDF1,NF1,NFIB,WNT5A	Any process that stops, prevents or reduces the frequency, rate or extent of stem cell proliferation.
GO:2000648	GO	BP	positive regulation of stem cell proliferation	CHRD,CTNNB1,DISC1,DRD2,EPCAM,FGFR2,FZD3,HMGA2,LRP5,LTBP3,MYC,N4BP2L2,PDCD2,PDGFA,PTPRC,SHH,SMARCD3,SOX11,SOX9,STAT1,TBX1,TGFBR2,THPO,VEGFA,ZNF335	Any process that activates or increases the frequency, rate or extent of stem cell proliferation.
GO:2000649	GO	BP	regulation of sodium ion transmembrane transporter activity	ACTN4,AGT,ANK3,ATP1A2,ATP1B1,CAMK2D,CAV3,CHP1,DMD,DRD4,FGF12,FXYD1,GLRX,GPD1L,NEDD4,NEDD4L,PCSK9,PRKCE,PTPN3,RANGRF,SCN1B,SCN2B,SCN3B,SCN4B,SLC9A1,SLC9A3R1,TESC,UTRN,WNK2,WNK3,YWHAH	Any process that modulates the frequency, rate or extent of sodium ion transmembrane transporter activity.
GO:2000650	GO	BP	negative regulation of sodium ion transmembrane transporter activity	AGT,ATP1A2,CAMK2D,NEDD4,NEDD4L,PCSK9,PRKCE	Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity.
GO:2000651	GO	BP	positive regulation of sodium ion transmembrane transporter activity	ACTN4,ANK3,ATP1B1,CHP1,DMD,DRD4,GLRX,SLC9A1,TESC,WNK2,WNK3	Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transporter activity.
GO:2000665	GO	BP	regulation of interleukin-13 secretion	GATA3,IFNA2,LGALS9,PAEP,PRKCZ,TNFRSF21	Any process that modulates the frequency, rate or extent of interleukin-13 secretion.
GO:2000668	GO	BP	regulation of dendritic cell apoptotic process	AXL,GAS6,LGALS9,LILRB1,LYN,RAPGEF2	Any process that modulates the frequency, rate or extent of dendritic cell apoptotic process.
GO:2000674	GO	BP	regulation of type B pancreatic cell apoptotic process	CAST,IL6,NEUROD1,TCF7L2,WFS1	Any process that modulates the frequency, rate or extent of type B pancreatic cell apoptotic process.
GO:2000677	GO	BP	regulation of transcription regulatory region DNA binding	DDIT3,DOT1L,GATA1,GATA3,HAND1,HAND2,HEY1,HEY2,HMGA2,IGF1,MAD2L2,MSX2,NEUROD1,NSD1,PARK7,PER2,SIN3A,SOX11,TGFB1,TRAF6,TRIM6,TWIST1,ZNF675	Any process that modulates the frequency, rate or extent of transcription regulatory region DNA binding.
GO:2000678	GO	BP	negative regulation of transcription regulatory region DNA binding	DDIT3,GATA1,HAND1,HEY1,HEY2,MAD2L2,MSX2,PER2,SIN3A,SOX11,ZNF675	Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.
GO:2000679	GO	BP	positive regulation of transcription regulatory region DNA binding	GATA3,HAND2,HMGA2,IGF1,NEUROD1,PARK7,TGFB1,TRAF6,TRIM6,TWIST1	Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
GO:2000696	GO	BP	regulation of epithelial cell differentiation involved in kidney development	ADIPOQ,CD24,CTNNB1,GATA3,LHX1,LIF,OSR1,PAX2,PAX8,PRKX,PROM1,STAT1	Any process that modulates the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
GO:2000725	GO	BP	regulation of cardiac muscle cell differentiation	AKAP6,BMP2,BMP4,DKK1,EFNB2,GREM1,GSK3A,MEF2C,MYOCD,PRICKLE1,TGFB1,WNT3A	Any process that modulates the frequency, rate or extent of cardiac muscle cell differentiation.
GO:2000727	GO	BP	positive regulation of cardiac muscle cell differentiation	AKAP6,BMP4,EFNB2,GREM1,MEF2C,MYOCD,TGFB1,WNT3A	Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
GO:2000736	GO	BP	regulation of stem cell differentiation	ALX1,AXIN2,BAMBI,BCL9L,BMP2,BMP5,CLASP1,CLASP2,CNOT1,CNOT2,CNOT3,COL1A1,CRB2,CTNNB1,DAB2,DAB2IP,DAG1,EFNA1,EIF2AK2,ELAVL1,ELL3,EPHA3,EZH2,FAM195B,FOXA1,FOXA2,FOXC1,FUZ,GATA4,GCNT2,GDNF,GLIPR2,GREM1,H1FOO,HES1,HES5,HMGA2,HOXB4,HPN,JAG1,LDLRAD4,LEF1,LTBP3,MAD2L2,MSTN,N4BP2L2,NKX2-1,NKX2-5,NODAL,NOTCH1,OLFM1,OVOL2,PAX2,PAX8,PBLD,PDGFRA,PHLDB1,PHLDB2,PPP2CA,PRICKLE1,REST,RGCC,SDCBP,SDHAF2,SERPINB3,SFRP1,SFRP2,SIX4,SMAD2,SMAD3,SMAD4,SMAD7,SNAI1,SOX5,SOX6,SOX9,SP7,STRAP,TBX5,TCF7L2,TGFB1,TGFB1I1,TGFB2,TGFB3,TGFBR1,TWIST1,VASN,WNT3A,WWTR1,ZFP36L2,ZNF703,ZNF706	Any process that modulates the frequency, rate or extent of stem cell differentiation.
GO:2000737	GO	BP	negative regulation of stem cell differentiation	BMP5,DAB2IP,EFNA1,FOXA1,FOXA2,FUZ,H1FOO,HES1,HES5,HPN,JAG1,LDLRAD4,MAD2L2,MSTN,N4BP2L2,NKX2-1,NOTCH1,OVOL2,PAX2,PAX8,PBLD,PPP2CA,PRICKLE1,REST,SDHAF2,SFRP1,SFRP2,SIX4,SMAD7,STRAP,TBX5,VASN,WNT3A,ZFP36L2,ZNF706	Any process that stops, prevents or reduces the frequency, rate or extent of stem cell differentiation.
GO:2000738	GO	BP	positive regulation of stem cell differentiation	ALX1,AXIN2,BAMBI,BCL9L,BMP2,COL1A1,CRB2,CTNNB1,DAB2,EZH2,FOXC1,GATA4,GCNT2,GLIPR2,HOXB4,LEF1,LTBP3,NKX2-5,NOTCH1,OLFM1,RGCC,SDCBP,SERPINB3,SMAD2,SMAD3,SMAD4,SNAI1,SOX5,SOX6,SOX9,SP7,TBX5,TCF7L2,TGFB1,TGFB1I1,TGFB2,TGFB3,TWIST1,WWTR1,ZNF703	Any process that activates or increases the frequency, rate or extent of stem cell differentiation.
GO:2000739	GO	BP	regulation of mesenchymal stem cell differentiation	LTBP3,PDGFRA,REST,SOX5,SOX6,SOX9	Any process that modulates the frequency, rate or extent of mesenchymal stem cell differentiation.
GO:2000756	GO	BP	regulation of peptidyl-lysine acetylation	ARRB1,AUTS2,BRCA1,BRD7,CHEK1,CTBP1,EID1,FLCN,FOXP3,IL1B,IWS1,KLF15,KMT2A,LIF,MAPK3,MUC1,MYOCD,NOC2L,NOS1,PAXIP1,PIH1D1,PPARGC1A,RPS6KA4,RPS6KA5,RUVBL2,SET,SIN3A,SIRT1,SMAD4,SMARCB1,SNCA,SOX4,SPI1,TAF7,WBP2	Any process that modulates the frequency, rate or extent of peptidyl-lysine acetylation.
GO:2000757	GO	BP	negative regulation of peptidyl-lysine acetylation	CTBP1,KLF15,NOC2L,PIH1D1,SET,SIN3A,SIRT1,SNCA,SPI1,TAF7	Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-lysine acetylation.
GO:2000758	GO	BP	positive regulation of peptidyl-lysine acetylation	ARRB1,AUTS2,BRCA1,BRD7,FOXP3,IL1B,LIF,MAPK3,MUC1,NOS1,PAXIP1,PIH1D1,PPARGC1A,RPS6KA4,RPS6KA5,RUVBL2,SMAD4,SMARCB1,SOX4,WBP2	Any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation.
GO:2000765	GO	BP	regulation of cytoplasmic translation	CPEB1,CPEB2,CPEB3,METTL3,NCK1,UNK,YBX3,YTHDF2,ZNF385A	Any process that modulates the frequency, rate or extent of cytoplasmic translation.
GO:2000772	GO	BP	regulation of cellular senescence	ARNTL,CDK6,CDKN2A,HMGA1,HMGA2,ING2,NEK4,NEK6,NUAK1,PNPT1,RSL1D1,SIRT1,TERF2,TERT,TP63,TWIST1,VASH1,YPEL3,ZKSCAN3	Any process that modulates the frequency, rate or extent of cellular senescence.
GO:2000773	GO	BP	negative regulation of cellular senescence	CDK6,SIRT1,TERF2,TERT,TP63,TWIST1,ZKSCAN3	Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence.
GO:2000774	GO	BP	positive regulation of cellular senescence	CDKN2A,HMGA1,HMGA2,SIRT1,YPEL3	Any process that activates or increases the frequency, rate or extent of cellular senescence.
GO:2000778	GO	BP	positive regulation of interleukin-6 secretion	F2R,F2RL1,HMGB1,HYAL2,LGALS9,NLRP10,PAEP,PYCARD,TWIST1,XBP1	Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
GO:2000779	GO	BP	regulation of double-strand break repair	CHEK1,DEK,FBXO18,FIGNL1,FOXM1,HMGA2,KDM1A,KDM4D,NUDT16,OGG1,OTUB1,PARPBP,PML,POLQ,PPP4C,PPP4R2,RAD51,RAD51AP1,RNF169,RPA2,RTEL1,SETMAR,SIRT6,SLF1,SLF2,SPIDR,TERF2IP,TFIP11,TRIP12,TWIST1,UBR5	Any process that modulates the frequency, rate or extent of double-strand break repair.
GO:2000780	GO	BP	negative regulation of double-strand break repair	FBXO18,HMGA2,OGG1,OTUB1,PARPBP,POLQ,RNF169,TFIP11,TRIP12,TWIST1,UBR5	Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair.
GO:2000781	GO	BP	positive regulation of double-strand break repair	FOXM1,KDM4D,NUDT16,SETMAR,SLF1,SLF2,SPIDR	Any process that activates or increases the frequency, rate or extent of double-strand break repair.
GO:2000785	GO	BP	regulation of autophagosome assembly	AMBRA1,CHMP4A,CHMP4B,FEZ1,FEZ2,IFT20,IFT88,KIAA1324,LRRK2,LRSAM1,MTMR3,PHF23,PIKFYVE,PINK1,PIP4K2A,PIP4K2B,PIP4K2C,RAB1B,RAB33B,RAB3GAP1,RAB3GAP2,RAB7A,RALB,SCFD1,SH3GLB1,TBC1D14,UBQLN1,UBQLN2	Any process that modulates the frequency, rate or extent of autophagosome assembly.
GO:2000786	GO	BP	positive regulation of autophagosome assembly	KIAA1324,LRSAM1,PIP4K2A,PIP4K2B,PIP4K2C,RAB3GAP1,RAB3GAP2,RALB,SH3GLB1	Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
GO:2000810	GO	BP	regulation of bicellular tight junction assembly	IKBKB,MYO1C,PKP2,PRKACA,PRKCH,ROCK1,ROCK2,SNAI1,SNAI2,TNF	Any process that modulates the frequency, rate or extent of tight junction assembly.
GO:2000811	GO	BP	negative regulation of anoikis	BCL2,BCL2L1,CAV1,CEACAM5,ITGA5,ITGB1,MCL1,NOTCH1,PDK4,PIK3CA,PTK2,PTRH2,SNAI2,SRC,TLE1,ZNF304	Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
GO:2000826	GO	BP	regulation of heart morphogenesis	BMP10,BMP2,BMP4,CTNNB1,DKK1,HAND2,HES1,MESP1,NACA,POU5F1,RBPJ,RNF207,SMO,TBX2,WNT3A	Any process that modulates the frequency, rate or extent of heart morphogenesis.
GO:2000831	GO	BP	regulation of steroid hormone secretion	C1QTNF1,CRH,CRHR1,GAL,GALR1,GDF9,GHRL,NKX3-1	Any process that modulates the frequency, rate or extent of steroid hormone secretion.
GO:2000833	GO	BP	positive regulation of steroid hormone secretion	C1QTNF1,CRH,GAL,GALR1,GHRL,NKX3-1	Any process that activates or increases the frequency, rate or extent of steroid hormone secretion.
GO:2000846	GO	BP	regulation of corticosteroid hormone secretion	C1QTNF1,CRH,CRHR1,GAL,GALR1,GHRL	Any process that modulates the frequency, rate or extent of corticosteroid hormone secretion.
GO:2000848	GO	BP	positive regulation of corticosteroid hormone secretion	C1QTNF1,CRH,GAL,GALR1,GHRL	Any process that activates or increases the frequency, rate or extent of corticosteroid hormone secretion.
GO:2000849	GO	BP	regulation of glucocorticoid secretion	CRH,CRHR1,GAL,GALR1,GHRL	Any process that modulates the frequency, rate or extent of glucocorticoid secretion.
GO:2000973	GO	BP	regulation of pro-B cell differentiation	FLCN,FNIP1,HES1,HES5,NOTCH1	Any process that modulates the frequency, rate or extent of pro-B cell differentiation.
GO:2001014	GO	BP	regulation of skeletal muscle cell differentiation	ARNTL,DDX17,DDX5,GPC1,MEF2C,MSTN,MYOCD,NR1D2,SIX4,TBX1,UQCC2	Any process that modulates the frequency, rate or extent of skeletal muscle cell differentiation.
GO:2001020	GO	BP	regulation of response to DNA damage stimulus	ABL1,ACKR3,ANKRD1,APEX1,ARMT1,ATM,ATR,AXIN2,BABAM1,BCL2L1,BCLAF1,BRCA1,BRCC3,BRD4,BRE,CASP9,CCAR2,CD44,CD74,CDK9,CDKN2A,CDKN2D,CHEK1,CLU,CRY1,CXCL12,DDX39B,DDX5,DEK,DYRK1A,EEF1E1,EGFR,ERCC8,EYA1,EYA3,FAM175A,FBXO18,FEM1B,FGF10,FIGNL1,FOXM1,H2AFX,HIC1,HMGA2,HMGB1,IER3,ING2,KDM1A,KDM4D,MCL1,MDM2,MIF,MSX1,MUC1,MYC,NACC2,NEK4,NKX3-1,NPAS2,NSMCE1,NSMCE4A,NUDT16,OGG1,OTUB1,PARPBP,PCNA,PLA2R1,PMAIP1,PML,POLH,POLQ,PPP4C,PPP4R2,PRKCD,PRKCG,PSMD10,PTTG1IP,RAD51,RAD51AP1,RAD52,RFWD3,RINT1,RNF168,RNF169,RNF8,RPA2,RPS3,RTEL1,SETD8,SETMAR,SFRP2,SIRT1,SIRT6,SLF1,SLF2,SMYD2,SNAI1,SNAI2,SPIDR,SPRED1,SPRED2,TAF9,TAF9B,TERF2,TERF2IP,TFIP11,THOC1,THOC5,TIGAR,TMEM161A,TPT1,TRIAP1,TRIM28,TRIM32,TRIP12,TWIST1,UBE2N,UBE2V1,UBE2V2,UBR5,UIMC1,USP1,ZNF385A	Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.
GO:2001021	GO	BP	negative regulation of response to DNA damage stimulus	ACKR3,BCL2L1,BRD4,CCAR2,CD44,CD74,CDKN2D,CLU,CXCL12,DDX39B,DYRK1A,FBXO18,HMGA2,ING2,KDM1A,MDM2,MIF,MUC1,OGG1,OTUB1,PARPBP,POLQ,PSMD10,PTTG1IP,RNF169,RPS3,RTEL1,SFRP2,SIRT1,SNAI1,SNAI2,TAF9,TAF9B,TERF2,TFIP11,THOC1,THOC5,TMEM161A,TPT1,TRIAP1,TRIM32,TRIP12,TWIST1,UBR5,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.
GO:2001022	GO	BP	positive regulation of response to DNA damage stimulus	ANKRD1,APEX1,ATM,ATR,BABAM1,BCLAF1,BRCA1,BRCC3,BRE,CCAR2,CDKN2A,DDX5,EEF1E1,EGFR,ERCC8,EYA1,EYA3,FAM175A,FBXO18,FGF10,FOXM1,H2AFX,HIC1,HMGA2,HMGB1,KDM4D,MSX1,MYC,NACC2,NKX3-1,NPAS2,NSMCE1,NSMCE4A,NUDT16,PCNA,PLA2R1,PMAIP1,PRKCD,PRKCG,RNF168,RNF8,RPS3,SETMAR,SIRT1,SLF1,SLF2,SPIDR,SPRED1,SPRED2,TIGAR,TMEM161A,TRIM28,UBE2N,UIMC1,ZNF385A	Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.
GO:2001026	GO	BP	regulation of endothelial cell chemotaxis	CXCL13,FGF1,FGF16,FGF18,FGF2,FGF4,FGFR1,HRG,HSPB1,KDR,MET,NOTCH1,PRKD1,PRKD2,SEMA5A,THBS1,VEGFA	Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis.
GO:2001028	GO	BP	positive regulation of endothelial cell chemotaxis	FGF16,FGF18,FGF2,FGFR1,HSPB1,KDR,MET,PRKD1,PRKD2,SEMA5A,VEGFA	Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
GO:2001029	GO	BP	regulation of cellular glucuronidation	PRKCE,UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9	Any process that modulates the frequency, rate or extent of cellular glucuronidation.
GO:2001030	GO	BP	negative regulation of cellular glucuronidation	UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A6,UGT1A7,UGT1A8,UGT1A9	Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.
GO:2001044	GO	BP	regulation of integrin-mediated signaling pathway	CD63,DMTN,EMP2,FLNA,ITGB1BP1,PHACTR4,PRKD1,TIMP1	Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway.
GO:2001056	GO	BP	positive regulation of cysteine-type endopeptidase activity	ACER2,ACVR1C,AIFM1,AIM2,ANP32B,APAF1,ARL6IP5,ASPH,BAD,BAK1,BAX,BBC3,BCAP31,BCL2L10,BCL2L11,BCL2L13,BOK,CARD8,CASP1,CASP3,CASP7,CASP8,CASP8AP2,CASP9,CD14,CDKN1B,CDKN2A,CFLAR,CIDEB,COL4A3,CTSH,CYCS,CYFIP2,DAP,DAPK1,DDX3X,DIABLO,DLC1,DNAJA3,EIF2AK3,F2R,F3,FADD,FAM162A,FAS,FASLG,FIS1,FOXL2,GNB2L1,GPER1,GSN,HIP1,HMGB1,HSPD1,HSPE1,HTRA2,IFI16,IFI27,IFT57,JAK2,LCK,LGALS9,LY96,MAP3K5,MEFV,MTCH1,MUL1,MYC,NDUFA13,NGFRAP1,NKX3-1,NLRC4,NLRP1,NLRP12,NLRP2,NLRP3,NOD1,NODAL,PDCD2,PDCD5,PDCD6,PERP,PMAIP1,PPARG,PPM1F,PYCARD,REST,RET,RIPK1,ROBO1,RPS27L,RPS3,S100A8,S100A9,SENP1,SIRT1,SLC11A2,SMAD3,SNCA,SOX7,TBC1D10A,TICAM1,TICAM2,TLR3,TLR4,TNF,TNFRSF10A,TNFRSF10B,TNFSF10,TNFSF15,TRADD,TRAF2,VCP,XDH	Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity.
GO:2001057	GO	BP	reactive nitrogen species metabolic process	AKT1,ARG2,CALM1,CAV1,CPS1,CYGB,CYP1B1,DDAH1,DDAH2,DHFR,DNM2,GCH1,GCHFR,HSP90AA1,LYPLA1,MARC1,MARC2,NOS1,NOS2,NOS3,NOSIP,NOSTRIN,NQO1,PRDX5,PRKG2,PTS,SPR,WASL,ZDHHC21	The chemical reactions and pathways involving a reactive nitrogen species.
GO:2001135	GO	BP	regulation of endocytic recycling	ACTN2,EHD1,EHD2,RAB11B,SORL1	Any process that modulates the frequency, rate or extent of endocytic recycling.
GO:2001140	GO	BP	positive regulation of phospholipid transport	ABCA7,ABCB4,APOE,PRELID1,PRKCD,TRIAP1	Any process that activates or increases the frequency, rate or extent of phospholipid transport.
GO:2001169	GO	BP	regulation of ATP biosynthetic process	FLCN,PID1,PINK1,PPARGC1A,VCP	Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
GO:2001179	GO	BP	regulation of interleukin-10 secretion	CD274,HLA-DRB1,LGALS9,LILRB1,PRKCZ,PYCARD,TNFRSF21	Any process that modulates the frequency, rate or extent of interleukin-10 secretion.
GO:2001182	GO	BP	regulation of interleukin-12 secretion	FOXP1,LGALS9,LILRB1,MAPK11,MAPK14	Any process that modulates the frequency, rate or extent of interleukin-12 secretion.
GO:2001185	GO	BP	regulation of CD8-positive, alpha-beta T cell activation	HFE,HLA-A,HLA-E,IRF1,LILRB1,NCKAP1L,XCL1	Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
GO:2001188	GO	BP	regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	HAVCR2,HLA-DMB,LGALS3,LGALS9,LILRB1	Any process that modulates the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
GO:2001198	GO	BP	regulation of dendritic cell differentiation	AGER,HLA-B,HLA-G,HMGB1,LGALS9,LILRB1,LILRB2	Any process that modulates the frequency, rate or extent of dendritic cell differentiation.
GO:2001212	GO	BP	regulation of vasculogenesis	ASB4,CD34,EMP2,HEY1,HEY2,HIF1AN,KDR,RAP1A,RAPGEF2,TMEM100,XDH	Any process that modulates the frequency, rate or extent of vasculogenesis.
GO:2001214	GO	BP	positive regulation of vasculogenesis	ASB4,CD34,HIF1AN,KDR,RAP1A,RAPGEF2,TMEM100	Any process that activates or increases the frequency, rate or extent of vasculogenesis.
GO:2001222	GO	BP	regulation of neuron migration	COL3A1,DAB2IP,KIF20B,NSMF,PLXNB2,RAPGEF2,SHTN1,SRGAP2,SRGAP2C,ULK4	Any process that modulates the frequency, rate or extent of neuron migration.
GO:2001224	GO	BP	positive regulation of neuron migration	DAB2IP,KIF20B,NSMF,RAPGEF2,SHTN1,SRGAP2C	Any process that activates or increases the frequency, rate or extent of neuron migration.
GO:2001234	GO	BP	negative regulation of apoptotic signaling pathway	ACAA2,ACKR3,ACVR1,AKT1,AR,ARHGEF2,AVP,BAG5,BCL2,BCL2L1,BIRC6,BMP5,BRCA1,CCAR2,CD44,CD74,CDKN2D,CFLAR,CLU,CREB3,CREB3L1,CSF2,CXCL12,DDX3X,EPO,FGA,FGB,FGG,FXN,GATA1,GDNF,GPX1,GSTP1,HERPUD1,HGF,HIF1A,HMOX1,HSPA1A,HSPA1B,HSPB1,HTRA2,HTT,HYOU1,ICAM1,IFI6,IGF1,IL1A,IL1B,ING2,INS,ITGA6,ITGAV,KDM1A,KIAA1324,LGALS3,LRRK2,MAGEA3,MAP2K5,MAPK7,MCL1,MIF,MMP9,MPV17L,MUC1,NDUFA13,NDUFS3,NFE2L2,NOC2L,NOL3,NONO,NOS3,NR4A2,NRG1,OPA1,PARK2,PARK7,PEA15,PELI3,PF4,PHIP,PIH1D1,PINK1,PLAUR,PPIF,PRELID1,PSMD10,PSME3,PTTG1IP,RELA,RFFL,RIPK1,RNF34,SCG2,SCRT2,SERPINE1,SFRP2,SH3RF1,SIAH2,SIRT1,SLC25A5,SLC35F6,SNAI1,SNAI2,SOD2,SRC,SYVN1,TAF9,TAF9B,TCF7L2,TERT,TGFBR1,THBS1,TMBIM1,TMBIM6,TMEM161A,TNF,TNFAIP3,TPT1,TRAP1,TRIAP1,TRIM32,TXNDC12,UNC5B,URI1,VIMP,VNN1,XBP1,YBX3,ZMYND11,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
GO:2001235	GO	BP	positive regulation of apoptotic signaling pathway	AGT,AGTR2,AKT1,ATF3,BAD,BAK1,BAX,BBC3,BCAP31,BCL10,BCL2,BCL2L1,BCL2L11,BCL2L14,BCLAF1,BID,BIK,BMF,BNIP3,CASP8,CAV1,CD14,CFLAR,CIDEB,CLU,CYLD,DAB2IP,DDIT3,DEDD2,DFNA5,DNM1L,DYNLL1,DYNLL2,E2F1,FADD,FAM162A,FAS,FASLG,FBXO18,FBXW7,FIS1,G0S2,GNB2L1,GPER1,GSK3A,GSK3B,GSN,GZMB,HRK,HTRA2,HYAL2,IFNB1,INHBA,JAK2,LCK,LGALS9,LTBR,LY96,MAPK8,MCL1,MFF,MLLT11,MMP9,MOAP1,MSX1,NACC2,NCK1,NKX3-1,NMT1,PAK2,PDCD5,PINK1,PLAUR,PMAIP1,PML,PPIF,PPP2R1B,PPP3CC,PPP3R1,PYCARD,RET,RIPK1,RPS3,S100A8,S100A9,SEPT4,SFN,SFPQ,SFRP1,SIAH1,SIVA1,SLC9A3R1,SOD1,TFDP1,TGFBR1,THBS1,TICAM1,TICAM2,TLR3,TLR4,TNFRSF10A,TNFRSF10B,TNFRSF12A,TNFSF10,TNFSF12,TP53,TPD52L1,TRADD,TRAF2,TRAF7,TRIM39,UBB,WWOX,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,ZNF205	Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
GO:2001236	GO	BP	regulation of extrinsic apoptotic signaling pathway	ACSL5,ACVR1,AGT,AGTR2,AKT1,AR,ARHGEF2,ATF3,BCL10,BCL2,BCL2L1,BCL2L14,BID,BIRC6,BMP5,BRCA1,CASP8,CAV1,CFLAR,CSF2,CYLD,DEDD2,DEPTOR,FADD,FAS,FASLG,FEM1B,FGA,FGB,FGG,G0S2,GATA1,GDNF,GPER1,GPX1,GSTP1,HMOX1,HSPA1A,HSPA1B,HTRA2,HTT,HYAL2,ICAM1,IFI6,IGF1,IL1A,IL1B,INHBA,ITGA6,ITGAV,KIAA1324,LGALS3,LTBR,MADD,MAP2K5,MAPK7,MCL1,NOL3,NOS3,NRG1,PAK2,PARK7,PEA15,PELI3,PF4,PHIP,PMAIP1,PML,PPP2R1B,PSME3,PYCARD,RELA,RET,RFFL,RIPK1,RNF34,SCG2,SCRT2,SERPINE1,SFRP1,SH3RF1,SIAH2,SNAI2,SP100,SRC,STX4,TCF7L2,TERT,TGFBR1,THBS1,TMBIM1,TMC8,TNF,TNFAIP3,TNFRSF10A,TNFRSF10B,TNFRSF12A,TNFSF10,TNFSF12,TRADD,TRAF1,TRAF2,UNC5B,WWOX,ZMYND11	Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway.
GO:2001237	GO	BP	negative regulation of extrinsic apoptotic signaling pathway	ACVR1,AKT1,AR,ARHGEF2,BCL2,BCL2L1,BIRC6,BMP5,BRCA1,CFLAR,CSF2,FGA,FGB,FGG,GATA1,GDNF,GPX1,GSTP1,HMOX1,HSPA1A,HSPA1B,HTT,ICAM1,IFI6,IGF1,IL1A,IL1B,ITGA6,ITGAV,KIAA1324,LGALS3,MAP2K5,MAPK7,MCL1,NOL3,NOS3,NRG1,PARK7,PEA15,PELI3,PF4,PHIP,PSME3,RELA,RFFL,RIPK1,RNF34,SCG2,SCRT2,SERPINE1,SH3RF1,SIAH2,SNAI2,SRC,TCF7L2,TERT,TGFBR1,THBS1,TMBIM1,TNF,TNFAIP3,UNC5B,ZMYND11	Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
GO:2001238	GO	BP	positive regulation of extrinsic apoptotic signaling pathway	AGT,AGTR2,ATF3,BCL10,BCL2L14,BID,CAV1,CYLD,DEDD2,FADD,G0S2,GPER1,HTRA2,HYAL2,INHBA,LTBR,PAK2,PMAIP1,PML,PPP2R1B,PYCARD,RET,RIPK1,SFRP1,THBS1,TNFRSF12A,TNFSF10,TNFSF12,TRAF2,WWOX	Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.
GO:2001239	GO	BP	regulation of extrinsic apoptotic signaling pathway in absence of ligand	AKT1,BCL2,BCL2L1,CSF2,GATA1,GDNF,HSPA1A,HSPA1B,HTRA2,IFI6,IL1A,IL1B,INHBA,KIAA1324,MAP2K5,MAPK7,MCL1,NRG1,PF4,PPP2R1B,RET,SNAI2,TERT,TNF,UNC5B	Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
GO:2001240	GO	BP	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	AKT1,BCL2,BCL2L1,CSF2,GATA1,GDNF,HSPA1A,HSPA1B,IFI6,IL1A,IL1B,KIAA1324,MAP2K5,MAPK7,MCL1,NRG1,PF4,SNAI2,TERT,TNF,UNC5B	Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
GO:2001242	GO	BP	regulation of intrinsic apoptotic signaling pathway	ACKR3,AKT1,ARHGEF2,BAD,BAG5,BAX,BBC3,BCAP31,BCL2,BCL2L1,BCL2L11,BCLAF1,BID,BMF,CAV1,CCAR2,CD44,CD74,CDKN2D,CLU,CREB3,CREB3L1,CXCL12,CYLD,DAPK2,DDIT3,DDX3X,DFNA5,DNM1L,EIF2AK3,EPO,FBXO18,FBXW7,FIS1,GNB2L1,HERPUD1,HIF1A,HSPA1A,HSPB1,HTRA2,HYOU1,ING2,INS,KDM1A,LCK,LRRK2,MAGEA3,MAPK7,MCL1,MIF,MMP9,MSX1,MUC1,NACC2,NCK1,NDUFA13,NDUFS3,NFE2L2,NKX3-1,NOC2L,NOL3,NONO,OPA1,P4HB,PARK2,PARK7,PINK1,PLAUR,PMAIP1,PPIF,PTTG1IP,PYCARD,RPS3,S100A8,S100A9,SEPT4,SFPQ,SFRP2,SIAH1,SIRT1,SLC9A3R1,SNAI1,SNAI2,SOD1,SOD2,SRC,SYVN1,TAF9,TAF9B,TMBIM6,TMEM161A,TP53,TPT1,TRAP1,TRIAP1,TRIM32,TXNDC12,UBB,UBQLN1,URI1,VIMP,VNN1,XBP1,YBX3,ZNF385A	Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway.
GO:2001243	GO	BP	negative regulation of intrinsic apoptotic signaling pathway	ACKR3,AKT1,ARHGEF2,BAG5,BCL2,BCL2L1,CCAR2,CD44,CD74,CDKN2D,CLU,CREB3,CREB3L1,CXCL12,DDX3X,EPO,HERPUD1,HIF1A,HSPA1A,HSPB1,HTRA2,HYOU1,ING2,INS,KDM1A,LRRK2,MAGEA3,MAPK7,MIF,MMP9,MUC1,NDUFA13,NDUFS3,NFE2L2,NOC2L,NOL3,NONO,OPA1,PARK2,PARK7,PINK1,PLAUR,PPIF,PTTG1IP,SFRP2,SIRT1,SNAI1,SNAI2,SOD2,SRC,SYVN1,TAF9,TAF9B,TMBIM6,TMEM161A,TPT1,TRAP1,TRIAP1,TRIM32,TXNDC12,URI1,VIMP,VNN1,XBP1,YBX3,ZNF385A	Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
GO:2001244	GO	BP	positive regulation of intrinsic apoptotic signaling pathway	BAD,BAX,BBC3,BCAP31,BCL2,BCL2L1,BCL2L11,BCLAF1,BID,BMF,CAV1,CLU,DDIT3,DFNA5,DNM1L,FBXO18,FBXW7,FIS1,GNB2L1,LCK,MCL1,MSX1,NACC2,NCK1,NKX3-1,PMAIP1,RPS3,S100A8,S100A9,SEPT4,SFPQ,SIAH1,SLC9A3R1,SOD1,TP53,UBB	Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
GO:2001251	GO	BP	negative regulation of chromosome organization	ACD,AICDA,ANAPC1,ANAPC10,ANAPC11,ANAPC15,ANAPC16,ANAPC2,ANAPC4,ANAPC5,ANAPC7,APC,APOBEC1,ASF1A,ATM,BCOR,BRCA1,BUB1,BUB1B,BUB3,CDC16,CDC20,CDC23,CDC26,CDC27,CENPF,CSNK2A1,CSNK2A2,CTBP1,DNMT1,DNMT3B,ERCC1,ERCC4,ESPL1,FOXP3,GNL3L,H2AFY,HMGA1,HNRNPA1,HNRNPC,HNRNPU,JARID2,KDM5A,KLHL22,MAD1L1,MAD2L1,MAD2L2,MCRS1,MTF2,NAT10,NBN,NOC2L,OTUB1,PARP1,PHF1,PHF2,PHF8,PIH1D1,PINX1,PLK1,PML,RAD50,RTEL1,SET,SETMAR,SIN3A,SIRT1,SMARCB1,SMG6,SNCA,SPI1,SRC,SUPT6H,TAF7,TERF1,TERF2,TERF2IP,TET1,TEX14,TINF2,TNKS,TNKS2,TPR,TRIP12,TTK,TWIST1,UBE2C,UBE2D1,UBE2E1,UBR5,USP17L2,WAPL,XRCC5,ZNF207	Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.
GO:2001252	GO	BP	positive regulation of chromosome organization	ACD,ARRB1,ATM,ATR,ATRX,AURKB,AUTS2,BECN1,BRCA1,BRD7,C6orf89,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CDK9,CHTOP,CTBP1,CTNNB1,CTR9,CUL3,DHX36,DLGAP5,DNMT1,DNMT3B,ERCC1,ESPL1,FOXP3,H2AFY,HIST1H1B,HMBOX1,HNRNPA1,IL1B,JARID2,KDM1A,KMT2A,LIF,LIG4,MAP2K7,MAP3K4,MAPK1,MAPK15,MAPK3,MAPKAPK5,MIER1,MRE11A,MTF2,MUC1,MYB,NABP2,NBN,NEK2,NEK7,NIPBL,NOS1,NSMCE2,OBFC1,OGT,PAF1,PAXIP1,PHF1,PHF19,PIH1D1,PKIB,PLK1,PML,PNKP,POT1,PPARGC1A,PRDM12,PRKCQ,PRKD1,PRKD2,PTEN,RAD50,RB1,RNF20,RNF40,RPS6KA4,RPS6KA5,RTEL1,RUVBL2,SART3,SHCBP1L,SIN3A,SIRT1,SLF1,SLF2,SLX1A,SLX4,SMAD4,SMARCB1,SMC5,SNW1,TAL1,TCP1,TERF2,TET1,TINF2,TNKS,TNKS2,TPR,UBE2N,VEGFA,WBP2,WDR61,WRAP53,XBP1	Any process that activates or increases the frequency, rate or extent of chromosome organization.
GO:2001257	GO	BP	regulation of cation channel activity	ACTN2,AHNAK,AKAP6,AKAP7,ANK2,ANK3,ASPH,CACNB4,CALM1,CAMK2D,CASQ2,CAV1,CLIC2,CRACR2A,CRHR1,CTSS,DMD,DRD2,DRD4,EPO,FKBP1A,FKBP1B,GAL,GALR2,GNB5,GSTM2,GSTO1,HAMP,HAP1,HOMER1,HRC,HTT,JPH1,JPH2,JPH3,JPH4,KCNAB1,KCNE1,KCNE2,KCNE3,KCNE5,KCNG1,KCNIP2,KCNQ1,KCNRG,KCNS1,KCNS2,MMP9,NOS1,NOS1AP,NPPA,PDE4B,PDE4D,PKD2,PRKACA,RNF207,SRI,STIM1,STIM2,SUMO1,TMEM110,TRDN,UBQLN1,VAMP2	Any process that modulates the frequency, rate or extent of cation channel activity.
GO:2001258	GO	BP	negative regulation of cation channel activity	ANK3,CALM1,CASQ2,CLIC2,CRHR1,DRD2,DRD4,EPO,FKBP1B,GNB5,GSTM2,GSTO1,HAMP,KCNE1,KCNE2,KCNE3,KCNQ1,KCNRG,MMP9,PKD2,RNF207,SRI,SUMO1,TRDN,UBQLN1	Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.
GO:2001259	GO	BP	positive regulation of cation channel activity	ACTN2,AKAP6,AKAP7,ANK2,ASPH,CALM1,CRACR2A,CTSS,GAL,GALR2,GSTM2,GSTO1,HAP1,HTT,JPH2,NOS1AP,NPPA,PKD2,RNF207,STIM1,STIM2,TMEM110,TRDN	Any process that activates or increases the frequency, rate or extent of cation channel activity.
GO:2001267	GO	BP	regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	CASP8,CD14,CFLAR,FADD,FAS,FASLG,GSN,HTRA2,JAK2,LGALS9,LY96,MMP9,PARK7,PIH1D1,PLAUR,RIPK1,TICAM1,TICAM2,TLR3,TLR4,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2	Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
GO:2001269	GO	BP	positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	CASP8,CD14,CFLAR,FADD,FAS,FASLG,GSN,HTRA2,JAK2,LGALS9,LY96,RIPK1,TICAM1,TICAM2,TLR3,TLR4,TNFRSF10A,TNFRSF10B,TNFSF10,TRADD,TRAF2	Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
GO:2001273	GO	BP	regulation of glucose import in response to insulin stimulus	FFAR3,IRS1,MZB1,NGFR,OSBPL8,PID1,PIK3R1,PIK3R2,PIK3R3,PTPN11,RARRES2	Any process that modulates the frequency, rate or extent of glucose import in response to insulin stimulus.
GO:2001275	GO	BP	positive regulation of glucose import in response to insulin stimulus	FFAR3,IRS1,OSBPL8,PIK3R1,PIK3R2,PIK3R3,PTPN11,RARRES2	Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus.
GO:2001300	GO	BP	lipoxin metabolic process	ALOX12,ALOX15,ALOX5,ALOX5AP,HPGD,LTC4S,PTGR1	The chemical reactions and pathways involving a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
